DDI-MedLine.d62.s1	DDI-MedLine.d62.s1.e0	DDI-MedLine.d62.s1.e1	null	lib=meth	lemma_1=(	path=<methamphetamine_obl>meth_dep	eib=False	path1=	wib=METH	lpib=meth_NN	relType_1=punct	path2=meth_dep	pos_1=-LRB-
DDI-MedLine.d62.s4	DDI-MedLine.d62.s4.e0	DDI-MedLine.d62.s4.e1	effect	lemma_22=by	relType_16=nmod	path=METH_nsubj<cause_ccomp>increase_obj>abolish_acl:relcl>sch_obl	lemma_20=be	pos_19=WDT	pos_6=NN	pos_8=JJ	relType_24=case	relType_12=compound	lemma_30=antagonist	relType_20=aux:pass	lemma_14=in	pos_13=NN	pos_22=IN	pos_15=DT	pos_18=NN	relType_3=amod	pos_7=HYPH	lemma_10=in	lemma_11=arc	pos_24=IN	relType_25=det	relType_21=acl:relcl	pos_28=NN	relType_26=amod	relType_30=compound	pos_3=JJ	lemma_4=and	pos_2=DT	relType_17=cc	lemma_21=abolish	lib=cause	pos_30=NN	pos_1=VBD	pos_29=NN	relType_23=obl	relType_22=case	pos_9=NN	pos_14=IN	pos_27=NN	relation_0=neutral	pos_16=NN	lemma_5=transient	pos_21=VBN	lemma_24=with	lemma_26=specific	pos_11=NN	path1=METH_nsubj	lemma_12=mrna	pos_17=CC	lemma_23=pretreatment	relType_15=det	lemma_28=d1	lemma_9=increase	lpib=cause_VBD	relType_29=compound	pos_26=JJ	pos_23=NN	lemma_13=level	wib=caused	path2=increase_obj>abolish_acl:relcl>sch_obl	lemma_15=the	lemma_3=rapid	relType_19=nsubj:pass	lemma_19=that	relType_9=obj	relType_6=obl:npmod	pos_10=IN	relType_5=conj	pos_4=CC	relType_14=case	lemma_1=cause	relType_27=compound	relType_8=amod	lemma_2=a	relType_4=cc	relType_13=nmod	lemma_7=-	pos_25=DT	relation_8=beneficial	eib=False	pos_20=VBD	relType_10=case	lemma_8=dependent	relType_28=compound	pos_5=JJ	lemma_25=the	relType_1=ccomp	lemma_6=dose	lemma_18=cortex	lemma_17=and	lemma_27=dopamine	lemma_29=receptor	relType_11=compound	relType_7=punct	relType_2=det	pos_12=NN	relType_18=conj	lemma_16=striatum
DDI-MedLine.d62.s4	DDI-MedLine.d62.s4.e0	DDI-MedLine.d62.s4.e3	null	relType_35=amod	lemma_22=by	relType_16=nmod	pos_35=NN	lemma_20=be	pos_19=WDT	pos_6=NN	pos_8=JJ	relType_31=obl	relType_24=case	pos_31=HYPH	relType_12=compound	lemma_30=antagonist	relType_20=aux:pass	lemma_14=in	pos_13=NN	pos_22=IN	pos_15=DT	pos_18=NN	relType_3=amod	pos_7=HYPH	lemma_10=in	lemma_31=23390	lemma_11=arc	pos_24=IN	relType_25=det	relType_21=acl:relcl	pos_31=CC	pos_28=NN	relType_26=amod	relType_30=compound	pos_3=JJ	lemma_4=and	relType_31=nummod	pos_2=DT	relType_17=cc	lemma_31=but	relType_31=cc	lemma_21=abolish	lib=cause	pos_30=NN	pos_35=JJ	pos_1=VBD	lemma_33=by	pos_32=RB	pos_29=NN	relType_23=obl	relType_22=case	pos_9=NN	pos_14=IN	relType_32=advmod	pos_27=NN	lemma_35=atypical	relation_0=neutral	path=METH_nsubj<cause_ccomp>increase_obj>abolish_acl:relcl>sch_obl>clozapine_conj	pos_16=NN	lemma_5=transient	pos_21=VBN	lemma_24=with	lemma_26=specific	pos_11=NN	path1=METH_nsubj	lemma_12=mrna	pos_31=NN	pos_31=CD	pos_17=CC	lemma_23=pretreatment	relType_15=det	lemma_28=d1	lemma_9=increase	lpib=cause_VBD	relType_29=compound	pos_26=JJ	pos_23=NN	lemma_13=level	wib=caused	lemma_15=the	lemma_3=rapid	pos_33=IN	relType_19=nsubj:pass	lemma_19=that	relType_9=obj	relType_6=obl:npmod	lemma_32=not	pos_10=IN	relType_5=conj	pos_34=DT	pos_4=CC	path2=increase_obj>abolish_acl:relcl>sch_obl>clozapine_conj	relType_14=case	lemma_1=cause	relType_27=compound	relType_8=amod	relType_33=case	lemma_2=a	relType_4=cc	relType_34=det	relType_13=nmod	lemma_7=-	pos_25=DT	relation_8=beneficial	pos_20=VBD	relType_10=case	lemma_8=dependent	relType_31=punct	relType_28=compound	pos_5=JJ	lemma_35=neuroleptic	lemma_25=the	lemma_18=cortex	relType_1=ccomp	lemma_6=dose	lemma_17=and	lemma_31=-	relType_35=compound	lemma_27=dopamine	lemma_29=receptor	lemma_31=sch	eib=True	relType_11=compound	relType_7=punct	relType_2=det	lemma_34=a	pos_12=NN	relType_18=conj	lemma_16=striatum
DDI-MedLine.d62.s4	DDI-MedLine.d62.s4.e1	DDI-MedLine.d62.s4.e3	null	relType_1=cc	relType_1=nummod	pos_1=CC	pos_3=IN	lemma_4=a	path1=	relType_5=compound	pos_1=HYPH	lemma_5=neuroleptic	pos_2=RB	lemma_3=by	pos_1=CD	relType_2=advmod	wib=not	path=<sch_obl>clozapine_conj	pos_4=DT	pos_5=JJ	relType_5=amod	lemma_1=23390	lemma_1=-	lemma_1=but	relType_3=case	lib=not	pos_5=NN	eib=True	path2=clozapine_conj	lpib=not_RB	relType_1=punct	relType_4=det	lemma_5=atypical	lemma_2=not
DDI-MedLine.d59.s4	DDI-MedLine.d59.s4.e0	DDI-MedLine.d59.s4.e1	effect	relType_1=case	relType_2=nummod	wib=microM	pos_6=DT	relation_4=adverse	pos_9=IN	lib=microm	lpib=microm_NN	pos_8=NN	pos_4=RB	eib=False	pos_2=CD	lemma_5=block	lemma_2=10	lemma_6=the	relType_8=obj	lemma_1=at	pos_1=IN	relType_9=case	relType_7=amod	relType_4=advmod	pos_5=VBD	lemma_7=secretory	relation_7=neutral	relType_6=det	relType_3=obl	lemma_3=microm	path2=effect_obj>carbachol_nmod	lemma_9=of	pos_3=NN	lemma_4=preferentially	lemma_8=effect	pos_7=JJ	relType_5=ROOT	path1=D_nsubj	path=D_nsubj<block_ROOT>effect_obj>carbachol_nmod
DDI-MedLine.d59.s5	DDI-MedLine.d59.s5.e0	DDI-MedLine.d59.s5.e1	effect	relType_1=ROOT	pos_2=DT	path=D_nsubj<inhibit_ROOT>increase_ccomp>ca_nsubj>stimulate_amod>carbachol_obl	pos_1=VBD	lemma_2=the	eib=False	relType_2=det	wib=inhibited	relation_0=adverse	lib=inhibit	lemma_1=inhibit	path1=D_nsubj	path2=increase_ccomp>ca_nsubj>stimulate_amod>carbachol_obl	lpib=inhibit_VBD
DDI-MedLine.d47.s0	DDI-MedLine.d47.s0.e0	DDI-MedLine.d47.s0.e1	null	relType_1=nummod	lemma_1=ii	lemma_1=alone	pos_3=IN	pos_1=JJ	relType_2=cc	relType_5=case	lpib=alone_JJ	lemma_2=and	pos_1=CD	lemma_5=with	pos_4=NN	path=buforin_nmod<activity_ROOT>combination_conj>azithromycin_nmod	wib=alone	lib=alone	path2=combination_conj>azithromycin_nmod	pos_5=IN	lemma_4=combination	relType_3=case	path1=buforin_nmod	eib=True	pos_2=CC	relType_4=conj	relType_1=amod	lemma_3=in
DDI-MedLine.d47.s0	DDI-MedLine.d47.s0.e0	DDI-MedLine.d47.s0.e2	null	path=buforin_nmod<activity_ROOT>combination_conj>azithromycin_nmod>minocycline_conj	relType_1=nummod	lemma_1=ii	lemma_1=alone	pos_3=IN	pos_1=JJ	path2=combination_conj>azithromycin_nmod>minocycline_conj	relType_2=cc	relType_5=case	lpib=alone_JJ	pos_6=NN	lemma_2=and	pos_1=CD	lemma_5=with	pos_4=NN	wib=alone	lib=alone	pos_6=CC	lemma_6=and	lemma_6=azithromycin	pos_5=IN	lemma_4=combination	relType_3=case	path1=buforin_nmod	eib=True	pos_2=CC	relType_4=conj	relType_1=amod	relType_6=nmod	lemma_3=in	relType_6=cc
DDI-MedLine.d47.s0	DDI-MedLine.d47.s0.e1	DDI-MedLine.d47.s0.e2	null	wib=minocycline	relType_1=cc	pos_1=CC	eib=False	path2=minocycline_conj	path1=	lib=minocycline	lpib=minocycline_NN	lemma_1=and	path=<azithromycin_nmod>minocycline_conj
DDI-MedLine.d47.s1	DDI-MedLine.d47.s1.e0	DDI-MedLine.d47.s1.e1	null	relType_1=nummod	lemma_1=ii	lemma_1=alone	pos_3=IN	pos_1=JJ	relType_2=cc	relType_5=case	lpib=alone_JJ	lemma_2=and	path=buforin_nmod<activity_nsubj:pass>combination_conj>azithromycin_nmod	pos_1=CD	lemma_5=with	pos_4=NN	relType_1=advmod	wib=alone	lib=alone	path2=combination_conj>azithromycin_nmod	pos_5=IN	lemma_4=combination	relType_3=case	path1=buforin_nmod	eib=True	pos_2=CC	relType_4=conj	lemma_3=in
DDI-MedLine.d47.s1	DDI-MedLine.d47.s1.e0	DDI-MedLine.d47.s1.e2	null	relType_1=nummod	lemma_1=ii	lemma_1=alone	pos_3=IN	pos_1=JJ	path2=combination_conj>azithromycin_nmod>minocycline_conj	relType_2=cc	relType_5=case	lpib=alone_JJ	pos_6=NN	lemma_2=and	pos_1=CD	lemma_5=with	pos_4=NN	relType_1=advmod	wib=alone	lib=alone	pos_6=CC	lemma_6=and	lemma_6=azithromycin	pos_5=IN	lemma_4=combination	relType_3=case	path1=buforin_nmod	eib=True	pos_2=CC	relType_4=conj	relType_6=nmod	lemma_3=in	path=buforin_nmod<activity_nsubj:pass>combination_conj>azithromycin_nmod>minocycline_conj	relType_6=cc
DDI-MedLine.d47.s1	DDI-MedLine.d47.s1.e1	DDI-MedLine.d47.s1.e2	null	wib=minocycline	relType_1=cc	pos_1=CC	eib=False	path2=minocycline_conj	path1=	lib=minocycline	lpib=minocycline_NN	lemma_1=and	path=<azithromycin_nmod>minocycline_conj
DDI-MedLine.d47.s3	DDI-MedLine.d47.s3.e0	DDI-MedLine.d47.s3.e1	null	wib=minocycline	relType_1=cc	pos_1=CC	path=<azithromycin_obl>minocycline_conj	eib=False	path2=minocycline_conj	path1=	lib=minocycline	lpib=minocycline_NN	lemma_1=or
DDI-MedLine.d47.s4	DDI-MedLine.d47.s4.e0	DDI-MedLine.d47.s4.e1	effect	lemma_10=vitro	relType_7=compound	relType_12=obl	pos_14=CC	relType_1=aux	lemma_1=may	relation_4=adverse	lemma_13=with	lemma_4=in	pos_10=FW	lemma_12=combination	lemma_5=inhibit	relType_8=obl	relType_11=case	wib=be	pos_8=NN	relType_14=cc:preconj	relType_2=cop	path1=II_nsubj	relType_9=compound	eib=False	pos_6=NNP	relType_10=advmod	pos_2=VB	pos_12=NN	pos_13=IN	pos_11=IN	lemma_3=active	lemma_11=upon	relType_13=case	lib=be	relType_5=amod	relType_3=ROOT	pos_4=IN	path=II_nsubj<active_ROOT>combination_obl>azithromycin_nmod	relType_4=case	pos_1=MD	lpib=be_VB	path2=combination_obl>azithromycin_nmod	pos_9=FW	lemma_6=Cryptosporidium	relType_6=compound	lemma_14=either	pos_3=JJ	pos_5=VBG	lemma_8=growth	lemma_2=be	pos_7=NN	lemma_9=in	lemma_7=parvum
DDI-MedLine.d47.s4	DDI-MedLine.d47.s4.e0	DDI-MedLine.d47.s4.e2	effect	lemma_10=vitro	relType_7=compound	relType_12=obl	pos_14=CC	lemma_15=azithromycin	relType_1=aux	lemma_1=may	relation_4=adverse	lemma_13=with	lemma_4=in	pos_10=FW	lemma_12=combination	lemma_5=inhibit	relType_8=obl	relType_11=case	wib=be	pos_8=NN	relType_14=cc:preconj	relType_2=cop	path1=II_nsubj	relType_9=compound	pos_6=NNP	relType_10=advmod	pos_2=VB	pos_12=NN	pos_13=IN	pos_11=IN	lemma_3=active	lemma_11=upon	relType_13=case	lib=be	relType_5=amod	relType_3=ROOT	pos_15=NN	pos_4=IN	relType_4=case	relType_15=cc	lemma_15=or	pos_1=MD	lpib=be_VB	relType_15=nmod	pos_9=FW	lemma_6=Cryptosporidium	relType_6=compound	lemma_14=either	pos_3=JJ	pos_5=VBG	eib=True	lemma_8=growth	pos_15=CC	lemma_2=be	path=II_nsubj<active_ROOT>combination_obl>azithromycin_nmod>minocycline_conj	pos_7=NN	lemma_9=in	path2=combination_obl>azithromycin_nmod>minocycline_conj	lemma_7=parvum
DDI-MedLine.d47.s4	DDI-MedLine.d47.s4.e1	DDI-MedLine.d47.s4.e2	null	wib=minocycline	relType_1=cc	pos_1=CC	lemma_1=or	eib=False	path2=minocycline_conj	path1=	lib=minocycline	lpib=minocycline_NN	path=<azithromycin_nmod>minocycline_conj
DDI-MedLine.d74.s2	DDI-MedLine.d74.s2.e0	DDI-MedLine.d74.s2.e1	null	wib=20mM	pos_2=NN	lemma_1=(	path1=arginine_nmod<combination_nmod<response_nmod	lpib=20mm_NN	pos_4=,	eib=False	path=arginine_nmod<combination_nmod<response_nmod<pancreas_dep>glucose_conj	relType_2=dep	lib=20mm	relType_4=punct	lemma_2=20mm	lemma_4=,	lemma_3=)	pos_1=-LRB-	pos_3=-RRB-	path2=glucose_conj	relType_1=punct	relType_3=punct
DDI-MedLine.d74.s2	DDI-MedLine.d74.s2.e0	DDI-MedLine.d74.s2.e2	null	wib=20mM	pos_15=-RRB-	relType_14=punct	relType_10=punct	pos_2=NN	relType_17=cc	pos_12=CD	pos_6=CD	relType_7=cc	lemma_13=ml	relType_11=case	path=arginine_nmod<combination_nmod<response_nmod<pancreas_dep>theophylline_conj	lemma_1=(	relType_13=nmod	path1=arginine_nmod<combination_nmod<response_nmod	lpib=20mm_NN	pos_4=,	pos_9=NNS	pos_16=,	path2=theophylline_conj	lemma_5=(	pos_13=NN	lemma_16=,	relType_9=appos	relType_15=punct	lemma_12=100	lemma_9=mg	lemma_10=.	pos_11=IN	relType_2=dep	lib=20mm	relType_4=punct	lemma_5=glucose	pos_7=CC	relType_5=punct	lemma_2=20mm	relType_6=nummod	lemma_15=)	lemma_4=,	lemma_8=150	relType_5=conj	lemma_17=and	lemma_7=or	lemma_3=)	relType_16=punct	pos_1=-LRB-	lemma_11=per	pos_5=NN	lemma_14=.	eib=True	pos_3=-RRB-	pos_14=.	lemma_6=100	relType_8=conj	pos_10=.	relType_12=nummod	pos_17=CC	pos_8=CD	relType_1=punct	relType_3=punct	pos_5=-LRB-
DDI-MedLine.d74.s2	DDI-MedLine.d74.s2.e1	DDI-MedLine.d74.s2.e2	null	relType_8=nummod	relType_2=nummod	relType_10=punct	relType_7=case	pos_3=CC	relType_9=nmod	relType_3=cc	lemma_1=(	lemma_12=,	lib=mg	eib=False	pos_2=CD	pos_5=NNS	relType_6=punct	lemma_11=)	relType_11=punct	pos_12=,	path2=theophylline_conj	lemma_3=or	relType_12=punct	lemma_13=and	pos_9=NN	lpib=mg_NNS	pos_4=CD	lemma_2=100	lemma_10=.	relType_13=cc	lemma_6=.	lemma_7=per	lemma_5=mg	relType_5=appos	pos_1=-LRB-	pos_13=CC	pos_11=-RRB-	lemma_4=150	pos_6=.	pos_7=IN	wib=mg	path=glucose_conj<pancreas_dep>theophylline_conj	relType_4=conj	lemma_8=100	lemma_9=ml	pos_8=CD	relType_1=punct	pos_10=.	path1=glucose_conj
DDI-MedLine.d74.s4	DDI-MedLine.d74.s4.e0	DDI-MedLine.d74.s4.e1	null	lemma_2=alone	lemma_1=,	relType_7=case	pos_3=CC	path1=	pos_1=,	lemma_4=in	path2=presence_conj>theophylline_nmod	pos_2=JJ	relType_3=cc	lpib=alone_JJ	pos_6=NN	relType_6=conj	eib=False	relType_2=conj	wib=alone	lib=alone	pos_4=IN	relType_5=det	relType_4=case	lemma_6=presence	lemma_7=of	path=<glucose_nsubj>presence_conj>theophylline_nmod	lemma_5=the	pos_7=IN	pos_5=DT	lemma_3=and	relType_1=punct
DDI-MedLine.d74.s5	DDI-MedLine.d74.s5.e0	DDI-MedLine.d74.s5.e1	null	lemma_1=,	pos_1=,	lpib=presence_NN	path1=arginine_nsubj	lemma_5=of	wib=presence	relType_5=case	pos_2=IN	lib=presence	path=arginine_nsubj<cause_ROOT>presence_obl>glucose_nmod	eib=False	relType_3=det	pos_4=NN	relType_4=obl	lemma_4=presence	pos_5=IN	path2=presence_obl>glucose_nmod	relType_2=case	pos_3=DT	lemma_3=the	relType_1=punct	lemma_2=in
DDI-MedLine.d74.s5	DDI-MedLine.d74.s5.e0	DDI-MedLine.d74.s5.e2	null	path2=presence_obl>glucose_nmod>theophylline_conj	lemma_1=,	lemma_6=glucose	pos_1=,	lpib=presence_NN	path1=arginine_nsubj	lemma_5=of	wib=presence	relType_5=case	pos_6=NN	pos_2=IN	lib=presence	relType_3=det	pos_4=NN	relType_4=obl	pos_6=CC	lemma_6=and	lemma_4=presence	pos_5=IN	relType_2=case	eib=True	pos_3=DT	lemma_3=the	relType_1=punct	relType_6=nmod	lemma_2=in	path=arginine_nsubj<cause_ROOT>presence_obl>glucose_nmod>theophylline_conj	relType_6=cc
DDI-MedLine.d74.s5	DDI-MedLine.d74.s5.e1	DDI-MedLine.d74.s5.e2	null	relType_1=cc	path=<glucose_nmod>theophylline_conj	lib=theophylline	pos_1=CC	wib=theophylline	eib=False	path1=	path2=theophylline_conj	lemma_1=and	lpib=theophylline_NN
DDI-MedLine.d74.s6	DDI-MedLine.d74.s6.e0	DDI-MedLine.d74.s6.e1	null	lemma_1=,	pos_1=,	lib=absence	path1=arginine_nsubj	lemma_5=of	relType_5=case	pos_2=IN	eib=False	lemma_4=absence	relType_3=det	pos_4=NN	path2=absence_obl>glucose_nmod	relType_4=obl	path=arginine_nsubj<cause_ROOT>absence_obl>glucose_nmod	lpib=absence_NN	wib=absence	pos_5=IN	relType_2=case	pos_3=DT	lemma_3=the	relType_1=punct	lemma_2=in
DDI-MedLine.d74.s6	DDI-MedLine.d74.s6.e0	DDI-MedLine.d74.s6.e2	null	lemma_1=,	lemma_6=glucose	pos_1=,	lib=absence	path1=arginine_nsubj	lemma_5=of	relType_5=case	pos_6=NN	pos_2=IN	lemma_6=or	lemma_4=absence	relType_3=det	pos_4=NN	path2=absence_obl>glucose_nmod>theophylline_conj	path=arginine_nsubj<cause_ROOT>absence_obl>glucose_nmod>theophylline_conj	relType_4=obl	pos_6=CC	lpib=absence_NN	wib=absence	pos_5=IN	relType_2=case	eib=True	pos_3=DT	lemma_3=the	relType_1=punct	relType_6=nmod	lemma_2=in	relType_6=cc
DDI-MedLine.d74.s6	DDI-MedLine.d74.s6.e1	DDI-MedLine.d74.s6.e2	null	relType_1=cc	path=<glucose_nmod>theophylline_conj	lib=theophylline	pos_1=CC	wib=theophylline	eib=False	path1=	path2=theophylline_conj	lemma_1=or	lpib=theophylline_NN
DDI-MedLine.d74.s11	DDI-MedLine.d74.s11.e0	DDI-MedLine.d74.s11.e1	null	lemma_1=,	lpib=be_VBP	pos_1=,	lemma_4=relatively	relType_2=cc	lemma_6=to	relType_6=case	lemma_5=insensitive	path2=insensitive_conj>glucose_obl	pos_4=RB	eib=False	pos_6=IN	lemma_2=but	wib=are	pos_5=JJ	lib=be	relType_4=advmod	lemma_3=be	path=theophylline_obl<respond_ccomp>insensitive_conj>glucose_obl	relType_5=conj	pos_2=CC	relType_1=punct	relType_3=cop	path1=theophylline_obl	pos_3=VBP
DDI-MedLine.d44.s2	DDI-MedLine.d44.s2.e0	DDI-MedLine.d44.s2.e1	null	pos_58=-RRB-	relType_60=case	pos_61=DT	lemma_13=a	pos_2=NN	relType_61=det	lemma_4=be	lemma_30=/	relType_70=obl	pos_57=NN	pos_55=NN	pos_21=NNS	lemma_33=year	lemma_38=:	relType_55=dep	relType_65=punct	relType_66=amod	relType_76=case	lemma_40=+	lemma_2=chylomicron	relType_17=compound	pos_10=NN	pos_22=IN	lemma_79=per	pos_78=NN	lemma_48=triglyceride	relType_79=case	pos_29=SYM	lemma_3=metabolism	pos_18=NN	pos_80=NN	pos_38=:	relType_24=compound	lemma_20=12	lemma_42=-	lemma_16=like	relType_4=aux:pass	lemma_58=)	lemma_62=randomized	pos_46=NN	lemma_1=upon	lemma_67=-	relType_30=punct	relType_46=nmod	pos_77=CD	lemma_25=disease	relType_54=nummod	relType_13=det	relType_34=punct	pos_66=JJ	relType_5=ROOT	pos_34=,	relType_78=nmod	pos_15=HYPH	lemma_57=dl	pos_45=SYM	relType_49=punct	relType_8=case	relType_1=case	wib=chylomicron	path2=submit_dep>study_obl>administration_nmod>g_nmod>etofibrate_nmod	pos_35=-LRB-	relType_14=obl:npmod	relType_64=dep	pos_75=NN	pos_73=NN	relType_77=nummod	pos_27=JJ	pos_48=NNS	pos_20=CD	relType_6=case	relType_75=nmod	relType_38=punct	relType_16=amod	pos_42=SYM	lemma_61=a	lemma_21=patient	lemma_19=in	lemma_65=,	lemma_63=,	relType_73=obl	pos_6=IN	relType_25=nmod	lemma_70=placebo	lemma_55=mg	relType_43=nummod	pos_1=IN	pos_68=JJ	lemma_78=g	relType_22=case	lemma_41=/	pos_44=NN	pos_12=IN	pos_8=IN	lemma_15=-	pos_64=NN	pos_63=,	lemma_53=-	relType_71=punct	pos_37=NN	relType_59=dep	relType_36=amod	lemma_22=with	relType_41=punct	lemma_11=kinetics	pos_30=HYPH	lemma_73=study	pos_69=,	relType_45=dep	relType_80=compound	relType_7=obl	pos_11=NN	pos_59=VBN	relType_19=case	pos_60=IN	pos_65=,	lemma_34=,	relType_29=dep	lemma_18=model	relType_11=nmod	relType_26=punct	pos_32=CD	pos_7=NN	relType_18=nmod	relType_44=dep	relType_53=dep	lemma_54=42	relType_67=punct	lemma_32=11	pos_23=JJ	lemma_28=59	pos_31=SYM	pos_33=NNS	lemma_74=with	relation_71=neutral	lemma_44=mg	relType_12=case	relType_20=nummod	pos_24=NN	relType_21=nmod	relType_23=amod	relType_27=amod	relType_42=dep	pos_70=NN	lemma_12=of	pos_17=NN	lemma_50=188	relType_62=amod	pos_56=SYM	lemma_29=+	relType_47=punct	pos_52=HYPH	pos_9=DT	relType_37=appos	relType_51=dep	pos_14=NN	pos_62=JJ	pos_72=VBN	lib=chylomicron	pos_79=IN	relType_15=punct	lemma_51=+	pos_47=:	pos_50=CD	relType_68=amod	relType_3=nmod	pos_25=NN	relType_52=punct	lemma_69=,	relType_31=dep	pos_41=HYPH	lemma_17=emulsion	relType_35=punct	pos_71=HYPH	pos_74=IN	pos_4=VBD	lemma_36=total	relType_58=punct	pos_76=IN	pos_53=SYM	lemma_9=the	lemma_76=of	lemma_7=determination	lemma_10=plasma	pos_39=CD	lemma_45=/	lemma_47=;	lemma_39=240	pos_19=IN	lemma_27=aged	relType_33=appos	lemma_68=blind	lemma_6=by	pos_13=DT	relType_50=dep	pos_28=CD	relType_74=case	pos_51=SYM	lemma_35=(	lpib=chylomicron_NN	relType_63=punct	eib=False	lemma_37=cholesterol	path=etofibrate_nmod<effect_nsubj:pass<test_ROOT>submit_dep>study_obl>administration_nmod>g_nmod>etofibrate_nmod	lemma_49=:	lemma_59=submit	lemma_23=coronary	relType_10=compound	lemma_52=/	relType_57=nmod	lemma_14=chylomicron	lemma_24=artery	relType_28=compound	lemma_43=41	pos_16=JJ	lemma_66=double	lemma_75=administration	pos_36=JJ	lemma_80=day	relType_2=compound	lemma_5=test	relType_72=amod	pos_43=CD	pos_54=CD	relType_40=dep	lemma_31=-	relType_69=punct	pos_40=SYM	relType_48=dep	lemma_46=dl	pos_67=HYPH	lemma_72=control	relType_39=dep	path1=etofibrate_nmod<effect_nsubj:pass	relType_56=dep	lemma_56=/	pos_3=NN	pos_49=:	pos_26=,	lemma_60=to	lemma_77=1	lemma_26=,	lemma_71=-	lemma_8=of	pos_5=VBN	relType_32=nummod	relType_9=det	lemma_64=crossover
DDI-MedLine.d44.s6	DDI-MedLine.d44.s6.e0	DDI-MedLine.d44.s6.e1	effect	lemma_2=62	relType_2=nummod	lpib=elicit_VBD	lib=elicit	lemma_5=of	relType_5=case	pos_6=NN	lemma_7=-	pos_1=VBD	eib=False	lemma_6=post	pos_2=CD	pos_4=NN	relType_4=obj	wib=elicited	pos_7=HYPH	lemma_3=%	lemma_4=enhancement	pos_5=IN	path2=enhancement_obj>activity_nmod>heparin_compound	relType_1=ROOT	relType_6=compound	pos_3=NN	relType_7=punct	relType_3=compound	lemma_1=elicit	path=Etofibrate_nsubj<elicit_ROOT>enhancement_obj>activity_nmod>heparin_compound	path1=Etofibrate_nsubj
DDI-MedLine.d86.s0	DDI-MedLine.d86.s0.e0	DDI-MedLine.d86.s0.e1	mechanism	relType_1=cc	path=<diltiazem_nmod>sirolimus_conj	pos_1=CC	lemma_1=and	eib=False	path1=	path2=sirolimus_conj	lpib=sirolimus_NN	wib=sirolimus	lib=sirolimus
DDI-MedLine.d86.s1	DDI-MedLine.d86.s1.e0	DDI-MedLine.d86.s1.e1	null	path2=immunosuppressant_appos	pos_2=DT	lemma_1=,	eib=True	pos_3=NN	wib=macrolide	relType_2=det	path1=	path=<sirolimus_nmod>immunosuppressant_appos	pos_1=,	relType_3=compound	lemma_2=a	relType_1=punct	lemma_3=macrolide	lpib=macrolide_NN	lib=macrolide
DDI-MedLine.d86.s1	DDI-MedLine.d86.s1.e0	DDI-MedLine.d86.s1.e3	null	pos_2=DT	lemma_9=calcium	lemma_1=,	pos_8=DT	pos_3=VBN	pos_1=,	lemma_6=,	relType_7=cc	lemma_9=channel	lemma_2=a	lemma_9=blocker	lemma_3=macrolide	path2=study_conj>diltiazem_nsubj:pass	relType_9=compound	relType_3=appos	relType_3=acl	relType_6=punct	wib=macrolide	path1=sirolimus_nmod	path=sirolimus_nmod<interaction_dep>study_conj>diltiazem_nsubj:pass	lpib=macrolide_NN	pos_9=NN	lemma_5=cyp3a4	pos_7=CC	pos_4=IN	lemma_8=the	relType_4=case	lemma_3=metabolize	relType_5=obl	pos_6=,	pos_5=NN	eib=True	pos_3=NN	lemma_7=and	relType_2=det	lemma_3=immunosuppressant	relType_3=compound	relType_8=det	relType_1=punct	lemma_4=by	lib=macrolide
DDI-MedLine.d86.s1	DDI-MedLine.d86.s1.e1	DDI-MedLine.d86.s1.e3	null	relType_7=compound	pos_1=VBN	pos_5=CC	lpib=metabolize_VBN	pos_6=DT	lemma_7=blocker	lemma_1=metabolize	lemma_3=cyp3a4	lemma_7=channel	path2=study_conj>diltiazem_nsubj:pass	pos_2=IN	relType_5=cc	pos_4=,	lemma_6=the	path=immunosuppressant_appos<sirolimus_nmod<interaction_dep>study_conj>diltiazem_nsubj:pass	relType_4=punct	wib=metabolized	lib=metabolize	lemma_7=calcium	relType_1=acl	lemma_4=,	relType_6=det	relType_2=case	relType_3=obl	eib=True	lemma_5=and	pos_3=NN	lemma_2=by	pos_7=NN	path1=immunosuppressant_appos<sirolimus_nmod
DDI-MedLine.d86.s2	DDI-MedLine.d86.s2.e0	DDI-MedLine.d86.s2.e1	null	pos_6=JJ	lemma_10=calcium	lpib=be_VBP	pos_3=VBN	pos_9=IN	path1=drug_obl	relType_6=amod	relType_9=case	pos_8=CC	pos_10=NN	lemma_1=that	relType_10=compound	path=drug_obl<metabolize_ccomp>enzyme_obl>antagonist_conj	wib=are	lemma_6=same	lib=be	pos_4=IN	relType_5=det	relType_4=case	relType_2=aux:pass	pos_2=VBP	lemma_3=metabolize	lemma_8=and	lemma_5=the	relType_7=obl	path2=enzyme_obl>antagonist_conj	eib=True	relType_3=ccomp	pos_5=DT	lemma_9=for	relType_1=nsubj:pass	lemma_2=be	lemma_7=enzyme	pos_7=NN	relType_8=cc	lemma_4=by	pos_1=WDT
DDI-MedLine.d86.s3	DDI-MedLine.d86.s3.e0	DDI-MedLine.d86.s3.e1	null	pos_2=DT	relType_4=amod	lemma_1=,	pos_4=JJ	relType_7=compound	path=sirolimus_nmod<dose_nmod>dose_conj>diltiazem_nmod	pos_1=,	lpib=single_JJ	pos_9=IN	lemma_2=a	lemma_8=dose	pos_6=HYPH	pos_8=NN	pos_5=CD	eib=False	relType_6=punct	wib=single	path1=sirolimus_nmod	relType_9=case	lemma_6=-	lemma_5=120	lemma_7=mg	relType_3=amod	relType_5=nummod	path2=dose_conj>diltiazem_nmod	lib=single	pos_3=JJ	lemma_4=oral	lemma_9=of	relType_2=det	relType_8=conj	relType_1=punct	pos_7=NN	lemma_3=single
DDI-MedLine.d86.s5	DDI-MedLine.d86.s5.e0	DDI-MedLine.d86.s5.e1	mechanism	lemma_21=736	pos_35=NN	pos_41=NN	lemma_49=/	lemma_25=x	lemma_44=from	pos_6=NN	lemma_16=90	relType_30=cc	lemma_2=under	pos_23=CD	pos_40=CD	lemma_6=time	pos_26=NN	pos_22=IN	relType_43=punct	pos_24=NNS	lemma_46=to	pos_7=HYPH	lemma_39=-	lemma_10=60	lemma_52=with	pos_32=NN	pos_25=SYM	relType_11=iobj	pos_48=NN	lemma_14=%	pos_28=NN	relType_6=compound	lemma_51=,	lemma_13=35	relType_26=dep	path=sirolimus_compound<area_dep<mean_nsubj<increase_appos>increase_parataxis>67_obl>ng_dep>coadministration_nmod>diltiazem_compound	pos_34=CD	pos_42=-RRB-	relType_32=conj	relType_31=amod	relType_40=nummod	relType_36=punct	path2=increase_parataxis>67_obl>ng_dep>coadministration_nmod>diltiazem_compound	pos_31=JJ	pos_13=CD	pos_15=SYM	relType_37=nummod	relType_39=punct	pos_30=CC	pos_27=SYM	relType_34=nummod	relType_28=nmod	pos_8=NN	relType_20=case	lemma_8=curve	lemma_20=from	relType_12=punct	relType_3=det	pos_21=CD	lemma_35=%	pos_39=HYPH	lemma_15=-	lemma_47=96	relType_33=parataxis	pos_19=,	lemma_28=ml	relType_16=nummod	lemma_18=)	lemma_34=43	pos_5=NN	relType_21=obl	pos_11=NN	relType_50=nmod	lemma_4=plasma	relType_52=case	relType_24=nsubj	lemma_19=,	relation_32=beneficial	relType_25=dep	pos_12=-LRB-	lemma_12=(	pos_46=IN	relType_49=dep	pos_44=IN	lemma_9=increase	pos_52=IN	relType_19=punct	pos_20=IN	relType_47=nummod	pos_2=IN	pos_17=NN	pos_18=-RRB-	relType_35=iobj	lemma_38=%	lemma_29=,	pos_50=NN	relType_51=punct	relType_13=nummod	relType_15=dep	lemma_36=(	pos_14=NN	relType_9=appos	pos_1=NN	lib=area	relType_22=advmod	pos_33=VBD	relType_38=dep	relType_46=advmod	relType_42=punct	pos_16=CD	lemma_37=14	pos_38=NN	lemma_42=)	lemma_17=%	lemma_27=/	pos_29=,	relType_17=nmod	relType_2=case	relType_45=obl	pos_9=VBD	relType_44=case	pos_51=,	relType_27=dep	lemma_33=increase	lemma_43=,	relType_23=nummod	lemma_48=ng	pos_45=CD	relType_5=compound	pos_43=,	path1=sirolimus_compound<area_dep<mean_nsubj	lemma_7=-	lemma_45=67	relation_8=beneficial	eib=False	relType_1=dep	pos_37=CD	wib=area	lpib=area_NN	lemma_5=concentration	pos_4=NN	lemma_11=%	lemma_26=h	lemma_31=maximum	lemma_22=to	pos_10=CD	lemma_50=ml	relType_4=compound	relType_18=punct	relType_29=punct	pos_36=-LRB-	relType_14=dep	relType_48=dep	relType_10=nummod	pos_47=CD	lemma_23=1178	relType_8=nmod	pos_3=DT	relType_7=punct	lemma_32=concentration	lemma_41=%	lemma_3=the	lemma_24=ng	relType_41=dep	pos_49=SYM	lemma_1=area	lemma_30=and	lemma_40=81
DDI-MedLine.d86.s5	DDI-MedLine.d86.s5.e0	DDI-MedLine.d86.s5.e2	null	lemma_58=elimination	lemma_21=736	pos_35=NN	pos_41=NN	lemma_49=/	lemma_25=x	lemma_44=from	pos_6=NN	lemma_53=diltiazem	lemma_16=90	relType_30=cc	lemma_2=under	pos_23=CD	pos_40=CD	lemma_6=time	pos_26=NN	pos_22=IN	relType_43=punct	lemma_59=half	pos_24=NNS	lemma_46=to	relType_53=nmod	pos_7=HYPH	lemma_39=-	lemma_10=60	relType_53=compound	path2=increase_parataxis>67_obl>ng_dep>decrease_advcl>elimination_nsubj>life_dep>sirolimus_nmod	lemma_52=with	pos_32=NN	pos_25=SYM	relType_11=iobj	pos_48=NN	lemma_14=%	pos_28=NN	path=sirolimus_compound<area_dep<mean_nsubj<increase_appos>increase_parataxis>67_obl>ng_dep>decrease_advcl>elimination_nsubj>life_dep>sirolimus_nmod	relType_6=compound	lemma_51=,	lemma_13=35	relType_26=dep	pos_34=CD	pos_42=-RRB-	pos_57=JJ	relType_32=conj	relType_31=amod	relType_40=nummod	relType_36=punct	relType_56=det	pos_31=JJ	pos_13=CD	pos_15=SYM	relType_37=nummod	lemma_56=the	relType_39=punct	pos_30=CC	pos_27=SYM	relType_34=nummod	relType_28=nmod	pos_8=NN	relType_20=case	lemma_8=curve	lemma_20=from	relType_12=punct	lemma_55=whereas	relType_3=det	pos_21=CD	lemma_35=%	pos_39=HYPH	lemma_15=-	lemma_47=96	pos_59=NN	pos_53=NN	pos_60=HYPH	pos_61=NN	relType_33=parataxis	pos_19=,	lemma_28=ml	relType_16=nummod	lemma_54=,	relType_61=dep	lemma_18=)	lemma_34=43	pos_5=NN	relType_21=obl	pos_11=NN	relType_50=nmod	lemma_4=plasma	relType_52=case	relType_24=nsubj	lemma_19=,	relation_32=beneficial	relType_25=dep	lemma_57=mean	relType_62=case	lemma_61=life	pos_12=-LRB-	lemma_12=(	pos_46=IN	relType_49=dep	relType_55=mark	pos_58=NN	pos_44=IN	lemma_9=increase	pos_52=IN	relType_19=punct	pos_20=IN	relType_47=nummod	pos_2=IN	pos_17=NN	pos_18=-RRB-	relType_35=iobj	lemma_38=%	lemma_29=,	pos_50=NN	relType_51=punct	relType_13=nummod	relType_15=dep	lemma_36=(	pos_14=NN	relType_54=punct	lemma_53=coadministration	relType_9=appos	pos_1=NN	lib=area	relType_22=advmod	pos_33=VBD	relType_38=dep	relType_46=advmod	relType_42=punct	pos_16=CD	pos_54=,	lemma_37=14	pos_38=NN	lemma_42=)	lemma_62=of	lemma_17=%	lemma_27=/	pos_29=,	relType_17=nmod	relType_57=amod	relType_2=case	relType_45=obl	pos_9=VBD	pos_56=DT	relType_44=case	pos_51=,	relType_27=dep	relType_59=compound	lemma_33=increase	lemma_43=,	relType_58=nsubj	relType_23=nummod	lemma_48=ng	pos_45=CD	lemma_60=-	relType_5=compound	pos_43=,	path1=sirolimus_compound<area_dep<mean_nsubj	lemma_7=-	pos_62=IN	lemma_45=67	relation_8=beneficial	pos_55=IN	relType_1=dep	pos_37=CD	wib=area	lpib=area_NN	lemma_5=concentration	pos_4=NN	lemma_11=%	lemma_26=h	lemma_31=maximum	lemma_22=to	pos_10=CD	lemma_50=ml	relType_4=compound	relType_18=punct	relType_29=punct	pos_36=-LRB-	relType_14=dep	relType_48=dep	relType_10=nummod	pos_47=CD	lemma_23=1178	relType_60=punct	eib=True	pos_3=DT	relType_8=nmod	relType_7=punct	lemma_32=concentration	lemma_41=%	lemma_3=the	lemma_24=ng	relType_41=dep	pos_49=SYM	lemma_1=area	lemma_30=and	lemma_40=81
DDI-MedLine.d86.s5	DDI-MedLine.d86.s5.e1	DDI-MedLine.d86.s5.e2	null	relType_7=compound	lemma_6=elimination	pos_3=IN	pos_7=NN	lemma_10=of	relType_8=punct	path=diltiazem_compound<coadministration_nmod<ng_dep>decrease_advcl>elimination_nsubj>life_dep>sirolimus_nmod	relType_9=dep	relType_2=punct	pos_6=NN	eib=False	lemma_9=life	path2=decrease_advcl>elimination_nsubj>life_dep>sirolimus_nmod	wib=coadministration	pos_8=HYPH	relType_10=case	relType_1=nmod	pos_9=NN	lib=coadministration	lemma_2=,	pos_1=NN	pos_4=DT	pos_5=JJ	relType_5=amod	lemma_1=coadministration	lemma_4=the	relType_3=mark	pos_10=IN	lemma_7=half	lemma_5=mean	lemma_8=-	lpib=coadministration_NN	pos_2=,	relType_4=det	path1=diltiazem_compound<coadministration_nmod	relType_6=nsubj	lemma_3=whereas
DDI-MedLine.d86.s6	DDI-MedLine.d86.s6.e0	DDI-MedLine.d86.s6.e1	null	relType_4=dep	lemma_4=%	relType_10=punct	pos_1=VBN	pos_5=CC	relType_9=advmod	lemma_10=,	relation_0=adverse	pos_6=CD	relType_8=punct	wib=decreased	lemma_8=,	lemma_9=respectively	pos_2=IN	relType_5=cc	path=sirolimus_nmod<distribution_nmod<volume_conj<clearance_nsubj<decrease_ROOT>with_dep>%_dep>give_acl:relcl>sirolimus_nsubj:pass	lemma_1=decrease	lemma_2=with	eib=False	lemma_7=%	lemma_11=when	relType_11=advmod	pos_4=NN	lemma_3=38	pos_11=WRB	relType_2=dep	pos_3=CD	relType_6=nummod	pos_9=RB	path1=sirolimus_nmod<distribution_nmod<volume_conj<clearance_nsubj	relType_3=nummod	path2=with_dep>%_dep>give_acl:relcl>sirolimus_nsubj:pass	relType_1=ROOT	pos_10=,	lemma_5=and	lpib=decrease_VBN	lemma_6=45	pos_8=,	pos_7=NN	lib=decrease	relType_7=conj
DDI-MedLine.d86.s6	DDI-MedLine.d86.s6.e0	DDI-MedLine.d86.s6.e2	null	relType_4=dep	lemma_4=%	relType_10=punct	pos_1=VBN	pos_5=CC	relType_9=advmod	lemma_13=give	lemma_10=,	lemma_14=with	relation_0=adverse	pos_6=CD	relType_8=punct	wib=decreased	lemma_8=,	lemma_9=respectively	pos_13=VBN	relType_12=aux:pass	pos_2=IN	relType_5=cc	lemma_1=decrease	lemma_2=with	relType_12=nsubj:pass	pos_12=VBD	lemma_12=sirolimus	lemma_7=%	lemma_11=when	pos_12=NN	relType_13=acl:relcl	path2=with_dep>%_dep>give_acl:relcl>diltiazem_obl	relType_11=advmod	pos_4=NN	pos_14=IN	lemma_3=38	pos_11=WRB	relType_2=dep	pos_3=CD	lemma_12=be	relType_6=nummod	pos_9=RB	path1=sirolimus_nmod<distribution_nmod<volume_conj<clearance_nsubj	relType_3=nummod	path=sirolimus_nmod<distribution_nmod<volume_conj<clearance_nsubj<decrease_ROOT>with_dep>%_dep>give_acl:relcl>diltiazem_obl	relType_1=ROOT	pos_10=,	eib=True	lemma_5=and	lpib=decrease_VBN	lemma_6=45	pos_8=,	relType_14=case	pos_7=NN	lib=decrease	relType_7=conj
DDI-MedLine.d86.s6	DDI-MedLine.d86.s6.e1	DDI-MedLine.d86.s6.e2	mechanism	relType_2=acl:relcl	path=sirolimus_nsubj:pass<give_acl:relcl>diltiazem_obl	pos_2=VBN	pos_1=VBD	lib=be	pos_3=IN	eib=False	path2=diltiazem_obl	lemma_1=be	relType_1=aux:pass	lemma_2=give	lemma_3=with	lpib=be_VBD	wib=was	path1=sirolimus_nsubj:pass	relType_3=case
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e0	DDI-MedLine.d86.s7.e1	null	lib=desacetyldiltiazem	path2=desacetyldiltiazem_conj	path=<diltiazem_nmod>desacetyldiltiazem_conj	lemma_1=,	eib=False	path1=	pos_1=,	lpib=desacetyldiltiazem_NN	relType_1=punct	wib=desacetyldiltiazem
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e0	DDI-MedLine.d86.s7.e2	null	lib=desacetyldiltiazem	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	wib=desacetyldiltiazem	relType_3=cc	relType_2=punct	path2=desmethyldiltiazem_conj	lemma_2=desacetyldiltiazem	relType_2=conj	lemma_2=,	lpib=desacetyldiltiazem_NN	eib=True	path=<diltiazem_nmod>desmethyldiltiazem_conj	pos_2=,	lemma_3=and	relType_1=punct
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e0	DDI-MedLine.d86.s7.e3	null	lib=desacetyldiltiazem	relType_8=case	lemma_1=,	pos_2=NN	pos_3=CC	lemma_4=be	pos_7=NN	pos_1=,	lemma_6=after	relType_6=case	wib=desacetyldiltiazem	relType_3=cc	relType_2=punct	relType_4=cop	lemma_4=desmethyldiltiazem	pos_6=IN	lemma_2=desacetyldiltiazem	relType_2=conj	path1=diltiazem_nmod<curve_nmod<concentration_nsubj	lemma_2=,	pos_4=NN	pos_8=IN	path2=coadministration_obl>sirolimus_nmod	pos_5=JJ	lpib=desacetyldiltiazem_NN	path=diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>coadministration_obl>sirolimus_nmod	lemma_5=unchanged	lemma_7=coadministration	pos_4=VBD	relType_7=obl	eib=True	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	relType_5=ROOT	lemma_8=of
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e0	DDI-MedLine.d86.s7.e4	null	lib=desacetyldiltiazem	relType_8=case	lemma_1=,	pos_2=NN	pos_3=CC	lemma_4=be	pos_7=NN	pos_16=IN	relType_10=cc	pos_1=,	lemma_9=,	relType_9=nmod	path2=see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	lemma_6=after	path=diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	relType_6=case	wib=desacetyldiltiazem	relType_3=cc	relType_2=punct	lemma_13=of	relType_4=cop	lemma_11=no	lemma_4=desmethyldiltiazem	pos_6=IN	pos_10=CC	relType_12=nsubj:pass	lemma_15=effect	relType_14=det	lemma_2=desacetyldiltiazem	pos_12=NN	pos_13=IN	lemma_14=the	lemma_16=of	relType_2=conj	path1=diltiazem_nmod<curve_nmod<concentration_nsubj	lemma_2=,	pos_4=NN	pos_8=IN	pos_9=NN	relType_13=case	pos_5=JJ	lemma_10=and	lpib=desacetyldiltiazem_NN	pos_11=DT	relType_9=punct	relType_15=nmod	relType_11=det	pos_14=DT	lemma_5=unchanged	lemma_7=coadministration	pos_4=VBD	lemma_12=potentiation	relType_7=obl	pos_15=NNS	relType_16=case	eib=True	relation_17=neutral	pos_2=,	lemma_3=and	relType_4=conj	pos_9=,	relType_1=punct	relType_5=ROOT	lemma_8=of	lemma_9=sirolimus
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e1	DDI-MedLine.d86.s7.e2	null	lib=desmethyldiltiazem	lemma_2=and	path1=desacetyldiltiazem_conj	lemma_1=,	path=desacetyldiltiazem_conj<diltiazem_nmod>desmethyldiltiazem_conj	eib=False	pos_2=CC	wib=desmethyldiltiazem	pos_1=,	path2=desmethyldiltiazem_conj	relType_1=punct	relType_2=cc	lpib=desmethyldiltiazem_NN
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e1	DDI-MedLine.d86.s7.e3	null	lemma_1=,	pos_4=JJ	relType_7=case	wib=desmethyldiltiazem	pos_1=,	lemma_3=desmethyldiltiazem	lemma_5=after	relType_2=cc	relType_5=case	path=desacetyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>coadministration_obl>sirolimus_nmod	pos_6=NN	path1=desacetyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj	lemma_2=and	relType_6=obl	lemma_6=coadministration	pos_3=VBD	lpib=desmethyldiltiazem_NN	path2=coadministration_obl>sirolimus_nmod	relType_3=conj	lemma_3=be	lemma_4=unchanged	pos_5=IN	relType_4=ROOT	lemma_7=of	lib=desmethyldiltiazem	eib=True	pos_7=IN	pos_3=NN	pos_2=CC	relType_1=punct	relType_3=cop
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e1	DDI-MedLine.d86.s7.e4	null	lemma_14=effect	lemma_1=,	pos_4=JJ	lemma_13=the	lemma_15=of	relType_7=case	relType_10=det	path=desacetyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	wib=desmethyldiltiazem	pos_1=,	relType_12=case	pos_13=DT	lemma_3=desmethyldiltiazem	relType_8=punct	lemma_5=after	relType_2=cc	path2=see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	lemma_8=,	relType_5=case	lemma_12=of	pos_6=NN	path1=desacetyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj	lemma_2=and	relType_6=obl	pos_8=NN	lemma_6=coadministration	lemma_11=potentiation	pos_3=VBD	relation_15=neutral	pos_12=IN	lpib=desmethyldiltiazem_NN	lemma_9=and	pos_9=CC	relType_15=case	relType_3=conj	lemma_8=sirolimus	lemma_3=be	lemma_4=unchanged	pos_5=IN	relType_11=nsubj:pass	relType_4=ROOT	pos_15=IN	lemma_7=of	lib=desmethyldiltiazem	pos_11=NN	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	pos_2=CC	relType_13=det	pos_14=NNS	relType_1=punct	relType_14=nmod	relType_3=cop	relType_9=cc	lemma_10=no	pos_8=,	pos_10=DT
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e2	DDI-MedLine.d86.s7.e3	null	pos_3=IN	pos_2=JJ	lemma_5=of	relType_5=case	lemma_4=coadministration	wib=were	path1=desmethyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj	pos_1=VBD	lemma_3=after	eib=False	path=desmethyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>coadministration_obl>sirolimus_nmod	lemma_1=be	pos_4=NN	path2=coadministration_obl>sirolimus_nmod	relType_4=obl	lib=be	relType_2=ROOT	pos_5=IN	relType_3=case	relType_1=cop	lpib=be_VBD	lemma_2=unchanged
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e2	DDI-MedLine.d86.s7.e4	null	pos_3=IN	pos_8=DT	lemma_6=,	relType_7=cc	lemma_8=no	lemma_10=of	path2=see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	pos_2=JJ	lemma_5=of	relType_5=case	lemma_4=coadministration	wib=were	path1=desmethyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj	pos_6=NN	lemma_13=of	pos_1=VBD	lemma_3=after	relType_6=punct	lemma_1=be	relType_9=nsubj:pass	lemma_12=effect	relType_12=nmod	relType_10=case	pos_13=IN	pos_9=NN	pos_4=NN	relType_6=nmod	relType_13=case	relType_4=obl	lib=be	lemma_6=sirolimus	pos_7=CC	pos_12=NNS	relType_2=ROOT	pos_5=IN	pos_10=IN	pos_11=DT	lemma_11=the	lemma_9=potentiation	relType_3=case	pos_6=,	relType_11=det	path=desmethyldiltiazem_conj<diltiazem_nmod<curve_nmod<concentration_nsubj<unchanged_ROOT>see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	relType_1=cop	relation_12=neutral	eib=True	lemma_7=and	relType_8=det	lpib=be_VBD	lemma_2=unchanged
DDI-MedLine.d86.s7	DDI-MedLine.d86.s7.e3	DDI-MedLine.d86.s7.e4	null	pos_7=NNS	relType_8=case	lemma_1=,	lemma_4=potentiation	lemma_3=no	pos_6=DT	pos_1=,	path1=sirolimus_nmod<coadministration_obl	relType_2=cc	path2=see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	lemma_5=of	relType_5=case	relation_6=neutral	lemma_2=and	wib=potentiation	eib=False	lemma_7=effect	lemma_6=the	lib=potentiation	relType_4=nsubj:pass	relType_3=det	pos_4=NN	pos_8=IN	lpib=potentiation_NN	pos_5=IN	relType_7=nmod	relType_6=det	pos_3=DT	pos_2=CC	relType_1=punct	path=sirolimus_nmod<coadministration_obl<unchanged_ROOT>see_conj>potentiation_nsubj:pass>effect_nmod>diltiazem_nmod	lemma_8=of
DDI-MedLine.d86.s8	DDI-MedLine.d86.s8.e0	DDI-MedLine.d86.s8.e1	mechanism	relType_4=amod	pos_3=IN	path=diltiazem_compound<coadministration_nsubj<lead_parataxis>exposure_obl>sirolimus_compound	lemma_2=lead	eib=False	wib=coadministration	pos_4=JJR	lib=coadministration	pos_1=NN	path2=exposure_obl>sirolimus_compound	lemma_4=high	lemma_1=coadministration	relType_1=nsubj	lemma_3=to	relType_3=case	pos_2=VBZ	path1=diltiazem_compound<coadministration_nsubj	lpib=coadministration_NN	relType_2=parataxis
DDI-MedLine.d86.s8	DDI-MedLine.d86.s8.e0	DDI-MedLine.d86.s8.e2	null	relType_8=case	relType_4=amod	lemma_7=presumably	pos_3=IN	path2=inhibition_obl>metabolism_nmod>sirolimus_nmod	pos_16=IN	lemma_2=lead	lemma_6=,	lemma_10=of	relType_5=compound	relType_9=obl	relType_13=punct	lemma_5=exposure	relType_14=compound	lemma_13=-	path=diltiazem_compound<coadministration_nsubj<lead_parataxis>inhibition_obl>metabolism_nmod>sirolimus_nmod	pos_13=HYPH	pos_12=JJ	pos_7=RB	relType_6=punct	wib=coadministration	pos_4=JJR	relType_12=amod	pos_14=NN	relType_10=case	lemma_12=first	lemma_16=of	pos_9=NN	lib=coadministration	pos_1=NN	pos_8=IN	lemma_4=high	lemma_9=inhibition	pos_15=NN	lemma_1=coadministration	lemma_8=by	relType_1=nsubj	lemma_5=sirolimus	lemma_3=to	relType_5=obl	pos_10=IN	pos_11=DT	lemma_11=the	relType_3=case	pos_6=,	relType_11=det	relType_15=nmod	pos_2=VBZ	pos_5=NN	relType_16=case	eib=True	path1=diltiazem_compound<coadministration_nsubj	lpib=coadministration_NN	relType_2=parataxis	relType_7=advmod	lemma_15=metabolism	lemma_14=pass
DDI-MedLine.d86.s8	DDI-MedLine.d86.s8.e1	DDI-MedLine.d86.s8.e2	null	lib=exposure	pos_3=RB	path2=inhibition_obl>metabolism_nmod>sirolimus_nmod	relType_3=advmod	relType_7=det	relType_8=amod	relType_12=case	lemma_8=first	lemma_6=of	lemma_9=-	wib=exposure	relType_6=case	path1=sirolimus_compound<exposure_obl	relType_2=punct	lemma_12=of	pos_8=JJ	pos_9=HYPH	lpib=exposure_NN	eib=False	pos_6=IN	lemma_3=presumably	relType_10=compound	pos_10=NN	lemma_2=,	pos_1=NN	pos_7=DT	pos_12=IN	pos_4=IN	lemma_11=metabolism	lemma_10=pass	relType_4=case	relType_5=obl	relType_9=punct	pos_5=NN	pos_11=NN	lemma_1=exposure	lemma_5=inhibition	pos_2=,	lemma_7=the	path=sirolimus_compound<exposure_obl<lead_parataxis>inhibition_obl>metabolism_nmod>sirolimus_nmod	relType_11=nmod	lemma_4=by	relType_1=obl
DDI-MedLine.d86.s9	DDI-MedLine.d86.s9.e0	DDI-MedLine.d86.s9.e1	advise	path1=sirolimus_compound	eib=False	path=sirolimus_compound<diltiazem_compound>	lemma_1=-	lpib=diltiazem_NN	path2=	pos_1=HYPH	lib=diltiazem	relType_1=punct	wib=diltiazem
DDI-MedLine.d86.s9	DDI-MedLine.d86.s9.e0	DDI-MedLine.d86.s9.e2	null	relType_4=amod	pos_4=JJ	pos_2=NN	relType_5=compound	pos_1=HYPH	lemma_2=diltiazem	relType_2=nmod	lib=diltiazem	lemma_2=interaction	wib=diltiazem	lemma_3=,	relType_2=compound	lemma_4=whole	lemma_1=-	path1=sirolimus_compound<diltiazem_compound<interaction_nmod<extent_nmod<variability_obl	pos_5=NN	pos_3=,	eib=True	lpib=diltiazem_NN	path=sirolimus_compound<diltiazem_compound<interaction_nmod<extent_nmod<variability_obl<monitor_ROOT>concentration_nsubj:pass>sirolimus_compound	path2=concentration_nsubj:pass>sirolimus_compound	relType_1=punct	lemma_5=blood	relType_3=punct
DDI-MedLine.d86.s9	DDI-MedLine.d86.s9.e1	DDI-MedLine.d86.s9.e2	null	path1=diltiazem_compound<interaction_nmod<extent_nmod<variability_obl	lemma_3=whole	relType_2=punct	lpib=interaction_NN	eib=False	path=diltiazem_compound<interaction_nmod<extent_nmod<variability_obl<monitor_ROOT>concentration_nsubj:pass>sirolimus_compound	relType_1=nmod	pos_4=NN	lemma_2=,	pos_1=NN	lib=interaction	lemma_4=blood	relType_3=amod	relType_4=compound	lemma_1=interaction	wib=interaction	pos_3=JJ	pos_2=,	path2=concentration_nsubj:pass>sirolimus_compound
DDI-MedLine.d1.s1	DDI-MedLine.d1.s1.e0	DDI-MedLine.d1.s1.e1	null	relType_4=mark	relType_16=cc	lemma_8=sexual	pos_19=IN	lemma_1=,	pos_15=JJ	relType_5=xcomp	path2=know_xcomp>disease_ccomp>use_conj>medication_nmod	lemma_2=patient	relType_8=amod	pos_1=,	pos_16=CC	path=medication_nmod<arrival_obl<want_ROOT>know_xcomp>disease_ccomp>use_conj>medication_nmod	pos_6=WRB	relType_11=case	pos_17=IN	pos_8=JJ	pos_5=VB	wib=patients	pos_12=JJ	pos_20=HYPH	pos_20=VBG	relType_20=amod	relType_2=nsubj	lpib=patient_NNS	lemma_7=safe	path1=medication_nmod<arrival_obl	lemma_20=support	pos_20=NN	relType_12=amod	lemma_11=in	lemma_14=in	pos_13=NN	lemma_15=general	pos_9=NN	relType_13=ccomp	lemma_9=activity	relType_17=case	pos_11=IN	pos_14=IN	pos_18=NN	lemma_19=of	lemma_5=know	relType_3=ROOT	lemma_4=to	pos_10=VBZ	lib=patient	lemma_13=disease	lemma_17=during	lemma_20=erection	lemma_16=and	lemma_3=want	pos_4=TO	relType_15=acl	pos_2=NNS	relType_10=cop	lemma_20=-	lemma_6=how	relType_7=dep	eib=True	relType_9=nsubj	lemma_12=cardiovascular	relType_19=case	lemma_18=use	pos_7=JJ	relType_20=punct	relType_14=case	relType_20=obl	relType_1=punct	relType_6=advmod	relType_18=conj	lemma_10=be	pos_3=VBP
DDI-MedLine.d1.s5	DDI-MedLine.d1.s5.e0	DDI-MedLine.d1.s5.e1	advise	pos_2=VBN	pos_3=IN	relType_1=aux:pass	pos_6=HYPH	pos_6=VBG	relType_5=acl	relType_6=punct	relType_6=amod	lemma_1=be	path1=Sildenafil_nsubj:pass	lemma_4=patient	pos_4=NNS	lemma_6=-	lemma_2=contraindicate	relType_4=obl	lib=be	relType_2=ROOT	path2=patient_obl>use_acl>nitrate_obj	lemma_5=use	pos_6=RB	relType_3=case	path=Sildenafil_nsubj:pass<contraindicate_ROOT>patient_obl>use_acl>nitrate_obj	wib=is	lemma_6=act	pos_5=VBG	pos_1=VBZ	eib=True	lemma_6=long	lpib=be_VBZ	lemma_3=in	relType_6=advmod
DDI-MedLine.d1.s5	DDI-MedLine.d1.s5.e0	DDI-MedLine.d1.s5.e2	advise	pos_2=VBN	lemma_10=to	pos_3=IN	path=Sildenafil_nsubj:pass<contraindicate_ROOT>need_conj>use_xcomp>nitrate_obj	relType_9=conj	relType_10=mark	lemma_12=short	pos_12=VBG	relType_1=aux:pass	pos_9=VB	lemma_7=who	pos_6=HYPH	pos_12=JJ	pos_6=VBG	lemma_9=need	pos_7=WP	relType_5=acl	relType_6=punct	pos_8=MD	relType_6=amod	lemma_1=be	lemma_6=nitrate	lemma_6=or	relType_12=amod	relType_12=punct	path1=Sildenafil_nsubj:pass	lemma_11=use	lemma_4=patient	lemma_12=-	pos_4=NNS	lemma_6=-	lemma_2=contraindicate	relType_4=obl	lib=be	pos_6=CC	relType_2=ROOT	lemma_5=use	pos_6=RB	relType_3=case	relType_11=xcomp	wib=is	relType_6=obj	lemma_12=act	lemma_6=act	path2=need_conj>use_xcomp>nitrate_obj	pos_5=VBG	pos_1=VBZ	eib=True	lemma_6=long	pos_10=TO	pos_11=VB	relType_12=dep	pos_6=NNS	lemma_8=may	lpib=be_VBZ	relType_7=nsubj	relType_8=aux	pos_12=HYPH	lemma_3=in	relType_6=advmod	relType_6=cc
DDI-MedLine.d1.s5	DDI-MedLine.d1.s5.e1	DDI-MedLine.d1.s5.e2	null	path=nitrate_obj<use_acl<patient_obl<contraindicate_ROOT>need_conj>use_xcomp>nitrate_obj	relType_1=cc	pos_1=CC	path1=nitrate_obj<use_acl<patient_obl	wib=need	pos_6=VB	pos_7=VBG	lemma_3=may	pos_2=WP	lemma_7=-	relType_5=mark	relType_2=nsubj	pos_3=MD	lemma_2=who	lemma_4=need	pos_5=TO	relType_7=amod	pos_7=HYPH	lemma_6=use	lemma_5=to	lemma_7=act	path2=need_conj>use_xcomp>nitrate_obj	relType_6=xcomp	relType_7=dep	eib=True	lemma_7=short	pos_4=VB	relType_7=punct	pos_7=JJ	relType_4=conj	relType_3=aux	lpib=need_VB	lib=need	lemma_1=or
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e0	DDI-MedLine.d1.s6.e1	null	lemma_2=calcium	lemma_1=,	pos_2=NN	eib=True	lpib=calcium_NN	wib=calcium	relType_2=compound	path1=	pos_1=,	path2=antagonist_conj	path=<blocker_obl>antagonist_conj	relType_1=punct	lib=calcium
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e0	DDI-MedLine.d1.s6.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	wib=calcium	path2=diuretic_conj	lemma_3=loop	path1=	pos_1=,	path=<blocker_obl>diuretic_conj	relType_2=punct	relType_3=cc	lemma_2=antagonist	lemma_3=thiazide	relType_2=conj	lemma_2=,	lemma_2=calcium	relType_3=conj	relType_2=compound	pos_2=NNS	eib=True	lpib=calcium_NN	pos_3=NN	pos_2=,	lemma_3=and	relType_3=compound	relType_1=punct	lib=calcium
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e0	DDI-MedLine.d1.s6.e4	null	lemma_1=,	pos_2=NN	path=<blocker_obl>diuretic_conj>inhibitor_conj	pos_3=CC	wib=calcium	lemma_3=loop	path1=	pos_1=,	relType_2=punct	relType_3=cc	lemma_3=diuretic	pos_3=NNS	lemma_2=antagonist	lemma_3=thiazide	relType_2=conj	pos_4=NN	lemma_2=,	path2=diuretic_conj>inhibitor_conj	lemma_4=ace	lemma_2=calcium	relType_3=conj	relType_2=compound	relType_4=compound	pos_2=NNS	eib=True	lpib=calcium_NN	pos_3=NN	pos_2=,	lemma_3=and	relType_3=compound	relType_1=punct	lib=calcium
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e1	DDI-MedLine.d1.s6.e3	null	lpib=thiazide_NN	lemma_2=and	lemma_1=,	pos_2=NN	eib=True	path1=antagonist_conj	lemma_2=loop	relType_2=compound	path2=diuretic_conj	path=antagonist_conj<blocker_obl>diuretic_conj	pos_2=CC	pos_1=,	relType_2=conj	lib=thiazide	relType_1=punct	relType_2=cc	lemma_2=thiazide	wib=thiazide
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e1	DDI-MedLine.d1.s6.e4	null	path=antagonist_conj<blocker_obl>diuretic_conj>inhibitor_conj	lemma_1=,	pos_2=NN	path1=antagonist_conj	pos_1=,	lib=thiazide	relType_2=cc	lemma_2=thiazide	lemma_2=and	lemma_2=loop	relType_2=conj	path2=diuretic_conj>inhibitor_conj	lemma_2=diuretic	relType_2=compound	lemma_3=ace	wib=thiazide	lpib=thiazide_NN	pos_2=NNS	eib=True	pos_3=NN	pos_2=CC	relType_3=compound	relType_1=punct
DDI-MedLine.d1.s6	DDI-MedLine.d1.s6.e3	DDI-MedLine.d1.s6.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	eib=True	relType_2=compound	path1=	lib=ace	wib=ACE	path2=inhibitor_conj	lpib=ace_NN	path=<diuretic_conj>inhibitor_conj	lemma_2=ace	lemma_1=and
DDI-MedLine.d132.s0	DDI-MedLine.d132.s0.e0	DDI-MedLine.d132.s0.e1	null	relType_1=case	lemma_1=in	eib=False	lib=antiretroviral	path=inhibitor_nmod<role_ROOT>therapy_nmod>antiretroviral_amod	wib=antiretroviral	lpib=antiretroviral_JJ	path1=inhibitor_nmod	pos_1=IN	path2=therapy_nmod>antiretroviral_amod
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e0	DDI-MedLine.d132.s1.e1	null	lemma_1=(	path2=nnrti_dep	eib=False	lib=nnrti	path1=	pos_1=-LRB-	relType_1=punct	lpib=nnrti_NN	wib=NNRTI	path=<inhibitor_nmod>nnrti_dep
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e0	DDI-MedLine.d132.s1.e2	null	lemma_2=)	path=<inhibitor_nmod>lead_dep>therapy_obl>antiretroviral_amod	relType_4=amod	path2=lead_dep>therapy_obl>antiretroviral_amod	pos_2=NN	lib=nnrti	path1=	relType_5=nsubj	relType_6=case	relType_2=punct	lemma_1=(	lemma_6=for	pos_5=NNS	pos_6=IN	lemma_3=-	pos_4=VBN	relType_2=dep	lemma_4=base	lemma_5=regimen	pos_1=-LRB-	eib=True	pos_2=-RRB-	pos_3=HYPH	lemma_2=nnrti	relType_1=punct	lpib=nnrti_NN	relType_3=punct	wib=NNRTI
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e0	DDI-MedLine.d132.s1.e3	null	lemma_2=)	path=<inhibitor_nmod>lead_dep>inhibitor_obl	relType_4=amod	pos_2=NN	relType_9=conj	lib=nnrti	pos_7=NN	path1=	relType_5=nsubj	relType_6=case	lemma_10=regard	relType_2=punct	lemma_1=(	lemma_6=for	pos_5=NNS	pos_6=IN	lemma_3=-	lemma_7=antiretroviral	pos_9=NNS	pos_8=CC	relType_10=case	pos_4=VBN	relType_2=dep	relType_7=amod	lemma_4=base	lemma_5=regimen	lemma_11=protease	pos_1=-LRB-	lemma_8=and	relType_7=obl	pos_11=NN	eib=True	pos_2=-RRB-	relType_11=compound	pos_3=HYPH	lemma_2=nnrti	pos_7=JJ	pos_10=VBG	lemma_7=therapy	relType_1=punct	lpib=nnrti_NN	lemma_9=concern	relType_8=cc	relType_3=punct	wib=NNRTI	path2=lead_dep>inhibitor_obl
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e0	DDI-MedLine.d132.s1.e4	null	lemma_2=)	relType_4=amod	pos_2=NN	relType_9=conj	lib=nnrti	pos_7=NN	path1=	relType_5=nsubj	relType_6=case	lemma_10=regard	relType_2=punct	lemma_1=(	lemma_6=for	pos_5=NNS	pos_6=IN	lemma_3=-	lemma_7=antiretroviral	pos_9=NNS	pos_11=-LRB-	relType_11=punct	pos_8=CC	relType_10=case	pos_4=VBN	path=<inhibitor_nmod>lead_dep>inhibitor_obl>pi_dep	relType_2=dep	relType_7=amod	lemma_11=inhibitor	lemma_11=(	lemma_4=base	lemma_5=regimen	relType_11=obl	lemma_11=protease	pos_1=-LRB-	lemma_8=and	relType_7=obl	pos_11=NN	eib=True	pos_2=-RRB-	relType_11=compound	pos_3=HYPH	path2=lead_dep>inhibitor_obl>pi_dep	lemma_2=nnrti	pos_7=JJ	pos_10=VBG	lemma_7=therapy	relType_1=punct	lpib=nnrti_NN	lemma_9=concern	relType_8=cc	relType_3=punct	wib=NNRTI
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e1	DDI-MedLine.d132.s1.e2	null	path2=lead_dep>therapy_obl>antiretroviral_amod	pos_3=VBN	lemma_3=base	lpib=base_VBN	lemma_1=)	pos_2=HYPH	lemma_5=for	relType_5=case	relType_2=punct	path=nnrti_dep<inhibitor_nmod>lead_dep>therapy_obl>antiretroviral_amod	lemma_2=-	eib=False	relType_4=nsubj	pos_4=NNS	relType_3=amod	lib=base	pos_1=-RRB-	pos_5=IN	wib=based	lemma_4=regimen	path1=nnrti_dep	relType_1=punct
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e1	DDI-MedLine.d132.s1.e3	null	pos_6=JJ	pos_3=VBN	lemma_3=base	lpib=base_VBN	relType_7=cc	lemma_1=)	pos_2=HYPH	lemma_5=for	relType_5=case	lemma_6=antiretroviral	relType_2=punct	pos_8=NNS	pos_6=NN	relType_6=obl	lemma_2=-	relType_6=amod	path=nnrti_dep<inhibitor_nmod>lead_dep>inhibitor_obl	relType_9=case	pos_10=NN	relType_4=nsubj	relType_10=compound	pos_4=NNS	pos_9=VBG	relType_3=amod	lib=base	pos_7=CC	pos_1=-RRB-	pos_5=IN	wib=based	lemma_4=regimen	lemma_9=regard	lemma_6=therapy	path1=nnrti_dep	eib=True	lemma_7=and	lemma_8=concern	relType_8=conj	relType_1=punct	lemma_10=protease	path2=lead_dep>inhibitor_obl
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e1	DDI-MedLine.d132.s1.e4	null	relType_10=punct	pos_6=JJ	path=nnrti_dep<inhibitor_nmod>lead_dep>inhibitor_obl>pi_dep	pos_3=VBN	lemma_3=base	lemma_10=inhibitor	lpib=base_VBN	relType_7=cc	lemma_1=)	pos_2=HYPH	lemma_5=for	relType_5=case	lemma_6=antiretroviral	relType_2=punct	pos_8=NNS	pos_6=NN	relType_6=obl	pos_10=-LRB-	lemma_2=-	relType_6=amod	relType_9=case	relType_10=compound	pos_10=NN	relType_4=nsubj	pos_4=NNS	pos_9=VBG	relType_3=amod	lib=base	pos_7=CC	pos_1=-RRB-	lemma_10=(	pos_5=IN	wib=based	lemma_4=regimen	lemma_9=regard	lemma_6=therapy	path1=nnrti_dep	eib=True	path2=lead_dep>inhibitor_obl>pi_dep	lemma_7=and	lemma_8=concern	relType_8=conj	relType_1=punct	relType_10=obl	lemma_10=protease
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e2	DDI-MedLine.d132.s1.e3	null	path=antiretroviral_amod<therapy_obl<lead_dep>inhibitor_obl	relType_5=compound	lpib=therapy_NN	relType_2=cc	lemma_2=and	lemma_3=concern	pos_3=NNS	lemma_1=therapy	path2=inhibitor_obl	pos_1=NN	path1=antiretroviral_amod<therapy_obl	relType_3=conj	lemma_5=protease	relType_4=case	lib=therapy	lemma_4=regard	pos_4=VBG	pos_5=NN	eib=True	pos_2=CC	wib=therapy	relType_1=obl
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e2	DDI-MedLine.d132.s1.e4	null	lemma_5=inhibitor	relType_5=compound	lpib=therapy_NN	relType_2=cc	lemma_2=and	lemma_3=concern	pos_3=NNS	lemma_1=therapy	lemma_5=(	pos_1=NN	path1=antiretroviral_amod<therapy_obl	relType_3=conj	lemma_5=protease	relType_5=punct	relType_4=case	lib=therapy	lemma_4=regard	relType_5=obl	pos_4=VBG	path=antiretroviral_amod<therapy_obl<lead_dep>inhibitor_obl>pi_dep	path2=inhibitor_obl>pi_dep	pos_5=NN	eib=True	pos_2=CC	wib=therapy	relType_1=obl	pos_5=-LRB-
DDI-MedLine.d132.s1	DDI-MedLine.d132.s1.e3	DDI-MedLine.d132.s1.e4	null	lemma_1=(	lpib=pi_NN	lib=pi	eib=False	path=<inhibitor_obl>pi_dep	path1=	wib=PI	pos_1=-LRB-	relType_1=punct	path2=pi_dep
DDI-MedLine.d132.s2	DDI-MedLine.d132.s2.e0	DDI-MedLine.d132.s2.e1	null	pos_7=NNS	relType_8=case	pos_2=VBN	pos_6=JJ	path1=NNRTI_obl<base_amod<regimen_nsubj	path2=advantage_obj>therapy_nmod>base_amod>pi_obl	lpib=base_VBN	pos_1=HYPH	lemma_4=may	lemma_5=have	pos_5=VB	pos_3=NNS	eib=False	relType_6=amod	relType_7=obj	path=NNRTI_obl<base_amod<regimen_nsubj<have_ROOT>advantage_obj>therapy_nmod>base_amod>pi_obl	pos_4=MD	lemma_7=advantage	pos_8=IN	lemma_6=several	lib=base	relType_2=amod	lemma_1=-	relType_4=aux	wib=based	relType_3=nsubj	lemma_3=regimen	lemma_2=base	relType_1=punct	relType_5=ROOT	lemma_8=over
DDI-MedLine.d132.s3	DDI-MedLine.d132.s3.e0	DDI-MedLine.d132.s3.e1	null	lpib=nevirapine_NN	lemma_1=,	eib=False	path1=	pos_1=,	path2=nevirapine_conj	lib=nevirapine	path=<efavirenz_dep>nevirapine_conj	relType_1=punct	wib=nevirapine
DDI-MedLine.d132.s3	DDI-MedLine.d132.s3.e0	DDI-MedLine.d132.s3.e2	null	lpib=nevirapine_NN	lemma_2=or	lemma_1=,	path=<efavirenz_dep>delavirdine_conj	pos_2=NN	eib=True	pos_2=CC	path1=	pos_1=,	lib=nevirapine	relType_1=punct	lemma_2=nevirapine	path2=delavirdine_conj	relType_2=conj	relType_2=cc	wib=nevirapine
DDI-MedLine.d132.s3	DDI-MedLine.d132.s3.e1	DDI-MedLine.d132.s3.e2	null	relType_1=cc	lib=delavirdine	path1=nevirapine_conj	pos_1=CC	lemma_1=or	eib=False	path=nevirapine_conj<efavirenz_dep>delavirdine_conj	wib=delavirdine	path2=delavirdine_conj	lpib=delavirdine_NN
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e0	DDI-MedLine.d132.s4.e1	null	relType_1=cc	lpib=nevirapine_NN	pos_1=CC	lemma_1=and	eib=False	path1=	path2=nevirapine_conj	lib=nevirapine	path=<efavirenz_nsubj:pass>nevirapine_conj	wib=nevirapine
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e0	DDI-MedLine.d132.s4.e2	null	relType_1=cc	relType_8=case	pos_1=CC	pos_2=NN	pos_6=JJ	lemma_2=have	pos_3=VBN	relType_3=aux:pass	relType_5=case	relType_6=amod	lemma_8=with	pos_9=DT	relType_2=aux	relType_2=conj	pos_8=IN	pos_4=VBN	path2=therapy_obl>indinavir_nmod>PI_compound	lemma_4=compare	lemma_6=triple	path1=efavirenz_nsubj:pass	lemma_3=be	pos_5=IN	pos_2=VBP	lemma_5=to	lib=nevirapine	relType_4=ROOT	lpib=nevirapine_NN	relType_7=obl	eib=True	wib=nevirapine	lemma_9=the	lemma_7=therapy	lemma_2=nevirapine	pos_7=NN	path=efavirenz_nsubj:pass<compare_ROOT>therapy_obl>indinavir_nmod>PI_compound	lemma_1=and	relType_9=det
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e0	DDI-MedLine.d132.s4.e3	null	relType_1=cc	relType_8=case	pos_1=CC	pos_2=NN	pos_6=JJ	lemma_2=have	pos_3=VBN	relType_3=aux:pass	relType_5=case	path2=therapy_obl>indinavir_nmod	relType_6=amod	lemma_8=with	pos_9=DT	relType_2=aux	relType_10=compound	lemma_10=PI	relType_2=conj	pos_8=IN	pos_4=VBN	lemma_4=compare	lemma_6=triple	path=efavirenz_nsubj:pass<compare_ROOT>therapy_obl>indinavir_nmod	path1=efavirenz_nsubj:pass	lemma_3=be	pos_5=IN	pos_2=VBP	lemma_5=to	lib=nevirapine	relType_4=ROOT	pos_10=NNP	lpib=nevirapine_NN	relType_7=obl	eib=True	wib=nevirapine	lemma_9=the	lemma_7=therapy	lemma_2=nevirapine	pos_7=NN	lemma_1=and	relType_9=det
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e0	DDI-MedLine.d132.s4.e4	null	relType_1=cc	relType_14=amod	lemma_19=response	pos_2=NN	pos_6=JJ	lemma_13=as	relType_3=aux:pass	lemma_20=be	relType_5=case	relType_10=nmod	relType_20=aux:pass	pos_22=IN	lemma_16=,	pos_10=NN	lemma_10=PI	lemma_12=week	lemma_15=therapy	lemma_4=compare	lemma_3=be	relType_16=punct	lemma_7=therapy	lemma_10=over	relType_8=case	pos_19=NNS	pos_20=VBG	lemma_10=indinavir	relType_22=case	relType_2=conj	relType_12=obl:tmod	pos_8=IN	pos_4=VBN	lemma_6=triple	pos_5=IN	pos_2=VBP	lemma_22=with	lib=nevirapine	pos_11=CD	relType_4=ROOT	relType_15=nmod	pos_21=VBN	relType_7=obl	pos_7=NN	lemma_1=and	path=efavirenz_nsubj:pass<compare_ROOT>observe_advcl>regimen_obl>nevirapine_compound	pos_17=IN	relType_17=mark	lemma_17=with	lemma_8=with	pos_9=DT	relType_2=aux	pos_13=IN	relType_13=case	relType_11=nummod	relType_19=nsubj:pass	path1=efavirenz_nsubj:pass	lemma_5=to	pos_10=IN	pos_10=NNP	lpib=nevirapine_NN	lemma_9=the	path2=observe_advcl>regimen_obl>nevirapine_compound	pos_14=JJ	lemma_2=nevirapine	wib=nevirapine	pos_1=CC	lemma_2=have	pos_3=VBN	relType_18=amod	lemma_18=similar	relType_6=amod	pos_16=,	relType_10=advmod	pos_18=JJ	relType_10=compound	lemma_11=48	lemma_21=observe	relType_21=advcl	pos_15=NN	pos_12=NNS	eib=True	lemma_14=initial	relType_9=det
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e0	DDI-MedLine.d132.s4.e5	null	relType_1=cc	relType_14=amod	lemma_19=response	pos_2=NN	pos_6=JJ	lemma_13=as	relType_3=aux:pass	lemma_20=be	relType_5=case	relType_10=nmod	relType_20=aux:pass	pos_22=IN	lemma_16=,	pos_10=NN	lemma_10=PI	lemma_12=week	lemma_15=therapy	lemma_4=compare	relType_23=compound	lemma_3=be	relType_16=punct	lemma_7=therapy	lemma_10=over	relType_8=case	relType_25=conj	relType_26=acl	pos_19=NNS	pos_20=VBG	path=efavirenz_nsubj:pass<compare_ROOT>observe_advcl>regimen_obl>observe_acl>efavirenz_obl	path2=observe_advcl>regimen_obl>observe_acl>efavirenz_obl	pos_24=CC	lemma_10=indinavir	relType_23=obl	relType_22=case	relType_2=conj	relType_12=obl:tmod	pos_8=IN	pos_4=VBN	lemma_6=triple	lemma_24=and	pos_5=IN	pos_2=VBP	lemma_22=with	lib=nevirapine	pos_11=CD	relType_4=ROOT	relType_15=nmod	pos_21=VBN	relType_7=obl	lemma_27=with	pos_7=NN	lemma_1=and	pos_17=IN	relType_17=mark	pos_23=NN	lemma_17=with	lemma_8=with	pos_9=DT	relType_2=aux	pos_13=IN	relType_13=case	relType_11=nummod	relType_19=nsubj:pass	pos_26=VBN	pos_23=NNS	path1=efavirenz_nsubj:pass	pos_25=NN	lemma_5=to	pos_10=IN	lemma_23=regimen	pos_10=NNP	lpib=nevirapine_NN	lemma_9=the	pos_14=JJ	relType_27=case	lemma_25=superiority	lemma_2=nevirapine	wib=nevirapine	pos_1=CC	lemma_2=have	pos_3=VBN	relType_18=amod	lemma_18=similar	relType_6=amod	pos_16=,	relType_10=advmod	pos_18=JJ	relType_10=compound	lemma_11=48	lemma_23=nevirapine	relType_24=cc	lemma_21=observe	relType_21=advcl	pos_27=IN	pos_15=NN	pos_12=NNS	eib=True	lemma_14=initial	lemma_26=observe	relType_9=det
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e1	DDI-MedLine.d132.s4.e2	null	pos_2=VBN	pos_8=DT	relType_7=case	relType_1=aux	path1=nevirapine_conj<efavirenz_nsubj:pass	path=nevirapine_conj<efavirenz_nsubj:pass<compare_ROOT>therapy_obl>indinavir_nmod>PI_compound	pos_3=VBN	lemma_7=with	pos_6=NN	relType_6=obl	lemma_3=compare	eib=False	lemma_1=have	lib=have	path2=therapy_obl>indinavir_nmod>PI_compound	pos_5=JJ	relType_5=amod	relType_3=ROOT	lemma_4=to	pos_4=IN	lemma_8=the	lemma_5=triple	relType_4=case	relType_2=aux:pass	pos_1=VBP	lpib=have_VBP	lemma_6=therapy	pos_7=IN	wib=have	lemma_2=be	relType_8=det
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e1	DDI-MedLine.d132.s4.e3	null	pos_2=VBN	pos_8=DT	relType_7=case	relType_1=aux	pos_9=NNP	path1=nevirapine_conj<efavirenz_nsubj:pass	pos_3=VBN	lemma_7=with	path2=therapy_obl>indinavir_nmod	pos_6=NN	relType_6=obl	lemma_3=compare	relType_9=compound	lemma_9=PI	lemma_1=have	lib=have	pos_5=JJ	relType_5=amod	relType_3=ROOT	lemma_4=to	pos_4=IN	lemma_8=the	lemma_5=triple	relType_4=case	relType_2=aux:pass	pos_1=VBP	lpib=have_VBP	lemma_6=therapy	eib=True	pos_7=IN	wib=have	lemma_2=be	relType_8=det	path=nevirapine_conj<efavirenz_nsubj:pass<compare_ROOT>therapy_obl>indinavir_nmod
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e1	DDI-MedLine.d132.s4.e4	null	lemma_9=over	pos_2=VBN	lemma_18=response	pos_8=DT	relType_7=case	relType_1=aux	pos_9=NNP	relType_9=advmod	path=nevirapine_conj<efavirenz_nsubj:pass<compare_ROOT>observe_advcl>regimen_obl>nevirapine_compound	path1=nevirapine_conj<efavirenz_nsubj:pass	pos_3=VBN	relType_12=case	pos_16=IN	pos_18=NNS	pos_9=IN	lemma_11=week	pos_20=VBN	pos_17=JJ	relType_9=nmod	lemma_7=with	pos_6=NN	relType_6=obl	lemma_12=as	lemma_19=be	lemma_3=compare	relType_9=compound	relType_13=amod	relType_11=obl:tmod	lemma_9=PI	pos_15=,	pos_11=NNS	lemma_9=indinavir	pos_21=IN	lemma_1=have	pos_14=NN	lemma_16=with	lemma_21=with	relType_20=advcl	pos_9=NN	lib=have	pos_12=IN	relType_15=punct	pos_5=JJ	relType_5=amod	pos_13=JJ	relType_3=ROOT	pos_10=CD	lemma_4=to	pos_4=IN	lemma_8=the	lemma_15=,	lemma_5=triple	relType_4=case	relType_2=aux:pass	relType_16=mark	pos_1=VBP	lpib=have_VBP	lemma_10=48	relType_10=nummod	relType_17=amod	pos_19=VBG	relType_19=aux:pass	relType_21=case	lemma_6=therapy	eib=True	pos_7=IN	lemma_17=similar	wib=have	relType_18=nsubj:pass	path2=observe_advcl>regimen_obl>nevirapine_compound	lemma_2=be	lemma_13=initial	relType_8=det	lemma_14=therapy	lemma_20=observe	relType_14=nmod
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e1	DDI-MedLine.d132.s4.e5	null	relType_22=compound	path1=nevirapine_conj<efavirenz_nsubj:pass	lemma_7=with	pos_6=NN	lemma_22=nevirapine	relType_25=acl	relType_3=ROOT	relType_2=aux:pass	relType_21=case	pos_7=IN	pos_26=IN	relType_14=nmod	relType_22=obl	pos_8=DT	relType_7=case	relType_1=aux	relType_9=advmod	pos_18=NNS	pos_22=NN	lemma_26=with	lemma_11=week	pos_20=VBN	path2=observe_advcl>regimen_obl>observe_acl>efavirenz_obl	lemma_3=compare	lemma_19=be	relType_13=amod	relType_11=obl:tmod	lemma_9=indinavir	pos_9=NN	pos_12=IN	lemma_15=,	lpib=have_VBP	relType_19=aux:pass	pos_25=VBN	relType_17=amod	pos_19=VBG	lemma_6=therapy	wib=have	lemma_2=be	lemma_14=therapy	lemma_23=and	pos_2=VBN	pos_16=IN	relType_12=case	pos_24=NN	pos_23=CC	relType_6=obl	pos_15=,	pos_21=IN	pos_14=NN	lemma_16=with	relType_20=advcl	relType_15=punct	relType_5=amod	pos_13=JJ	lemma_4=to	pos_4=IN	lemma_22=regimen	pos_1=VBP	relType_18=nsubj:pass	lemma_20=observe	lemma_13=initial	relType_8=det	lemma_9=over	lemma_18=response	pos_9=NNP	lemma_25=observe	pos_3=VBN	relType_26=case	pos_9=IN	pos_17=JJ	relType_9=nmod	lemma_12=as	relType_9=compound	lemma_9=PI	pos_11=NNS	lemma_1=have	lemma_21=with	path=nevirapine_conj<efavirenz_nsubj:pass<compare_ROOT>observe_advcl>regimen_obl>observe_acl>efavirenz_obl	lib=have	pos_5=JJ	pos_10=CD	relType_16=mark	relType_23=cc	lemma_8=the	pos_22=NNS	lemma_5=triple	relType_4=case	lemma_24=superiority	relType_24=conj	lemma_10=48	relType_10=nummod	eib=True	lemma_17=similar
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e2	DDI-MedLine.d132.s4.e3	null	eib=False	path=PI_compound<indinavir_nmod>	path2=	path1=PI_compound
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e2	DDI-MedLine.d132.s4.e4	null	lemma_12=observe	lemma_2=48	relType_2=nummod	lemma_13=with	lemma_11=be	pos_6=NN	pos_9=JJ	path=PI_compound<indinavir_nmod<therapy_obl<compare_ROOT>observe_advcl>regimen_obl>nevirapine_compound	lemma_5=initial	pos_3=NNS	path1=PI_compound<indinavir_nmod<therapy_obl	pos_2=CD	relType_12=advcl	wib=indinavir	pos_7=,	lemma_8=with	relType_11=aux:pass	pos_1=IN	relType_9=amod	pos_13=IN	relType_1=nmod	relType_3=obl:tmod	lemma_7=,	pos_1=NN	lib=indinavir	relType_1=advmod	lemma_1=indinavir	pos_8=IN	relType_10=nsubj:pass	relType_13=case	pos_5=JJ	relType_5=amod	pos_4=IN	relType_8=mark	relType_4=case	pos_11=VBG	lpib=indinavir_NN	lemma_10=response	lemma_9=similar	lemma_6=therapy	eib=True	lemma_3=week	relType_7=punct	path2=observe_advcl>regimen_obl>nevirapine_compound	lemma_4=as	pos_12=VBN	relType_6=nmod	pos_10=NNS	lemma_1=over
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e2	DDI-MedLine.d132.s4.e5	null	lemma_12=observe	pos_14=NN	lemma_2=48	relType_2=nummod	lemma_13=with	lemma_11=be	relType_14=compound	pos_17=VBN	relType_18=case	pos_6=NN	pos_9=JJ	relType_14=obl	lemma_5=initial	relType_17=acl	path2=observe_advcl>regimen_obl>observe_acl>efavirenz_obl	pos_3=NNS	path1=PI_compound<indinavir_nmod<therapy_obl	pos_2=CD	relType_12=advcl	wib=indinavir	lemma_14=regimen	lemma_14=nevirapine	pos_7=,	lemma_8=with	relType_11=aux:pass	pos_1=IN	relType_9=amod	pos_13=IN	relType_1=nmod	relType_3=obl:tmod	lemma_7=,	pos_1=NN	lib=indinavir	relType_1=advmod	lemma_1=indinavir	pos_8=IN	relType_10=nsubj:pass	relType_13=case	pos_5=JJ	pos_18=IN	relType_5=amod	pos_4=IN	relType_8=mark	relType_4=case	pos_11=VBG	lpib=indinavir_NN	relType_15=cc	pos_16=NN	lemma_15=and	lemma_10=response	lemma_9=similar	lemma_6=therapy	lemma_18=with	eib=True	lemma_3=week	relType_7=punct	lemma_16=superiority	lemma_4=as	pos_14=NNS	pos_15=CC	lemma_17=observe	path=PI_compound<indinavir_nmod<therapy_obl<compare_ROOT>observe_advcl>regimen_obl>observe_acl>efavirenz_obl	pos_12=VBN	relType_6=nmod	pos_10=NNS	lemma_1=over	relType_16=conj
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e3	DDI-MedLine.d132.s4.e4	null	lemma_12=observe	lemma_2=48	relType_2=nummod	lemma_13=with	lemma_11=be	lpib=week_NNS	pos_6=NN	pos_9=JJ	lemma_5=initial	pos_3=NNS	eib=False	pos_2=CD	relType_12=advcl	pos_7=,	lemma_8=with	relType_11=aux:pass	pos_1=IN	relType_9=amod	wib=weeks	lemma_7=,	relType_3=obl:tmod	pos_13=IN	relType_1=advmod	pos_8=IN	relType_10=nsubj:pass	path=indinavir_nmod<therapy_obl<compare_ROOT>observe_advcl>regimen_obl>nevirapine_compound	pos_5=JJ	relType_13=case	relType_5=amod	pos_4=IN	relType_8=mark	relType_4=case	path1=indinavir_nmod<therapy_obl	pos_11=VBG	lemma_10=response	lemma_9=similar	lemma_6=therapy	lib=week	lemma_3=week	relType_7=punct	path2=observe_advcl>regimen_obl>nevirapine_compound	lemma_4=as	pos_12=VBN	relType_6=nmod	pos_10=NNS	lemma_1=over
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e3	DDI-MedLine.d132.s4.e5	null	lemma_12=observe	lemma_2=48	relType_2=nummod	lemma_13=with	lemma_11=be	relType_14=compound	pos_17=VBN	relType_18=case	lpib=week_NNS	pos_6=NN	pos_9=JJ	relType_17=acl	lemma_5=initial	path2=observe_advcl>regimen_obl>observe_acl>efavirenz_obl	pos_3=NNS	pos_2=CD	relType_12=advcl	lemma_14=regimen	lemma_14=nevirapine	pos_7=,	lemma_8=with	relType_11=aux:pass	pos_1=IN	relType_9=amod	wib=weeks	lemma_7=,	relType_3=obl:tmod	pos_13=IN	pos_14=NN	relType_1=advmod	pos_8=IN	relType_10=nsubj:pass	relType_14=obl	relType_16=conj	relType_13=case	pos_5=JJ	pos_18=IN	relType_5=amod	pos_4=IN	relType_8=mark	relType_4=case	path1=indinavir_nmod<therapy_obl	pos_11=VBG	path=indinavir_nmod<therapy_obl<compare_ROOT>observe_advcl>regimen_obl>observe_acl>efavirenz_obl	relType_15=cc	pos_16=NN	lemma_15=and	lemma_10=response	lemma_9=similar	lemma_6=therapy	lemma_18=with	eib=True	lib=week	lemma_3=week	relType_7=punct	lemma_16=superiority	lemma_4=as	pos_14=NNS	pos_15=CC	lemma_17=observe	pos_12=VBN	relType_6=nmod	pos_10=NNS	lemma_1=over
DDI-MedLine.d132.s4	DDI-MedLine.d132.s4.e4	DDI-MedLine.d132.s4.e5	null	path1=nevirapine_compound	path=nevirapine_compound<regimen_obl>observe_acl>efavirenz_obl	lemma_1=regimen	relType_2=cc	relType_5=case	relType_4=acl	lemma_2=and	eib=False	lemma_5=with	path2=observe_acl>efavirenz_obl	pos_4=VBN	lemma_3=superiority	relType_3=conj	pos_5=IN	lib=regimen	pos_1=NNS	pos_3=NN	pos_2=CC	lemma_4=observe	lpib=regimen_NNS	wib=regimens	relType_1=obl
DDI-MedLine.d132.s5	DDI-MedLine.d132.s5.e0	DDI-MedLine.d132.s5.e1	null	lemma_3=superior	relType_1=aux	lemma_1=may	wib=be	relType_2=cop	eib=False	pos_2=VB	lib=be	path2=nelfinavir_obl>PI_compound	relType_3=ROOT	lemma_4=to	pos_4=IN	relType_5=det	relType_4=case	pos_1=MD	lpib=be_VB	lemma_5=the	pos_3=JJ	pos_5=DT	lemma_2=be	path=nevirapine_obj<suggest_csubj<superior_ROOT>nelfinavir_obl>PI_compound	path1=nevirapine_obj<suggest_csubj
DDI-MedLine.d132.s5	DDI-MedLine.d132.s5.e0	DDI-MedLine.d132.s5.e2	null	lemma_3=superior	relType_1=aux	lemma_1=may	wib=be	relType_2=cop	pos_6=NNP	pos_2=VB	lib=be	relType_3=ROOT	lemma_4=to	path2=nelfinavir_obl	pos_4=IN	relType_5=det	relType_4=case	pos_1=MD	lpib=be_VB	relType_6=compound	lemma_5=the	pos_3=JJ	eib=True	lemma_6=PI	pos_5=DT	lemma_2=be	path=nevirapine_obj<suggest_csubj<superior_ROOT>nelfinavir_obl	path1=nevirapine_obj<suggest_csubj
DDI-MedLine.d132.s5	DDI-MedLine.d132.s5.e1	DDI-MedLine.d132.s5.e2	null	eib=False	path2=	path=PI_compound<nelfinavir_obl>	path1=PI_compound
DDI-MedLine.d132.s6	DDI-MedLine.d132.s6.e0	DDI-MedLine.d132.s6.e1	null	lib=delavirdine	lemma_2=or	path1=nevirapine_compound	path=nevirapine_compound<-_obl>delavirdine_conj	eib=False	pos_2=CC	lemma_1=-	wib=delavirdine	pos_1=HYPH	path2=delavirdine_conj	relType_2=cc	relType_1=obl	lpib=delavirdine_NN
DDI-MedLine.d132.s8	DDI-MedLine.d132.s8.e0	DDI-MedLine.d132.s8.e1	null	lemma_1=over	relType_1=case	path1=efavirenz_nmod	eib=False	wib=indinavir	path2=regimen_nmod>base_amod>indinavir_obl	lpib=indinavir_NN	pos_1=IN	lib=indinavir	path=efavirenz_nmod<superiority_nsubj:pass>regimen_nmod>base_amod>indinavir_obl
DDI-MedLine.d132.s10	DDI-MedLine.d132.s10.e0	DDI-MedLine.d132.s10.e1	null	pos_2=VBN	lpib=have_VBZ	relType_1=aux	eib=False	path1=Efavirenz_nsubj	lemma_1=have	path=Efavirenz_nsubj<demonstrate_ROOT>superiority_obj>nelfinavir_nmod	lib=have	lemma_2=demonstrate	path2=superiority_obj>nelfinavir_nmod	lemma_3=superiority	lemma_4=over	relType_2=ROOT	pos_4=IN	relType_4=case	pos_1=VBZ	pos_3=NN	relType_3=obj	wib=has
DDI-MedLine.d23.s0	DDI-MedLine.d23.s0.e0	DDI-MedLine.d23.s0.e1	null	relType_1=cc	path=<ketamine_nmod>anesthesia_conj>Innovar_compound	pos_2=IN	pos_1=CC	lemma_2=of	relType_2=case	lib=innovar	eib=False	wib=Innovar	lpib=innovar_NNP	path1=	path2=anesthesia_conj>Innovar_compound	lemma_1=and
DDI-MedLine.d23.s0	DDI-MedLine.d23.s0.e0	DDI-MedLine.d23.s0.e2	null	relType_1=cc	pos_1=CC	path2=tolerance_nmod>digitalis_compound	pos_3=NNP	lemma_3=Innovar	pos_2=IN	lib=innovar	lemma_4=on	path=ketamine_nmod<effect_ROOT>tolerance_nmod>digitalis_compound	lemma_3=anesthesia	path1=ketamine_nmod	relType_3=conj	pos_4=IN	lpib=innovar_NNP	relType_4=case	lemma_2=of	relType_2=case	eib=True	pos_3=NN	wib=Innovar	relType_3=compound	lemma_1=and
DDI-MedLine.d23.s0	DDI-MedLine.d23.s0.e1	DDI-MedLine.d23.s0.e2	null	path=Innovar_compound<anesthesia_conj<ketamine_nmod<effect_ROOT>tolerance_nmod>digitalis_compound	pos_2=IN	relType_2=case	eib=False	path2=tolerance_nmod>digitalis_compound	lemma_1=anesthesia	wib=anesthesia	lpib=anesthesia_NN	lib=anesthesia	path1=Innovar_compound<anesthesia_conj<ketamine_nmod	lemma_2=on	relType_1=conj	pos_1=NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e1	null	path2=anesthetize_acl>ketamine_obl	relType_5=case	pos_2=IN	relType_4=acl	lemma_4=anesthetize	pos_3=NNS	eib=False	lpib=tolerance_NN	lemma_5=with	relType_1=nmod	pos_1=NN	path=digitalis_compound<tolerance_nmod<comparison_obl>anesthetize_acl>ketamine_obl	pos_4=VBN	lemma_1=tolerance	relType_3=nmod	lib=tolerance	pos_5=IN	relType_2=case	lemma_3=dog	path1=digitalis_compound<tolerance_nmod	wib=tolerance	lemma_2=in
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e2	null	relType_7=compound	path1=digitalis_compound<tolerance_nmod<comparison_obl	lemma_6=,	relType_5=case	pos_6=NN	pos_2=IN	relType_4=acl	lemma_4=anesthetize	relType_6=obl	pos_3=NNS	path2=vet_nsubj	lpib=tolerance_NN	relType_6=punct	lemma_7=Innovar	lemma_5=with	relType_1=nmod	pos_1=NN	pos_4=VBN	lemma_1=tolerance	pos_7=NNP	relType_3=nmod	lib=tolerance	pos_5=IN	pos_6=,	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>vet_nsubj	relType_2=case	lemma_3=dog	eib=True	wib=tolerance	lemma_6=ketamine	lemma_2=in
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e3	null	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>vet_nsubj>pentobarbital_conj	relType_7=compound	relType_8=cc	path1=digitalis_compound<tolerance_nmod<comparison_obl	lemma_6=,	relType_5=case	pos_6=NN	pos_2=IN	relType_4=acl	lemma_4=anesthetize	relType_6=obl	pos_3=NNS	lpib=tolerance_NN	relType_6=punct	lemma_7=Innovar	lemma_5=with	pos_7=,	pos_8=CC	lemma_8=or	relType_1=nmod	lemma_7=,	pos_1=NN	pos_4=VBN	lemma_1=tolerance	pos_7=NNP	path2=vet_nsubj>pentobarbital_conj	relType_3=nmod	lib=tolerance	pos_5=IN	pos_6=,	relType_2=case	lemma_3=dog	eib=True	relType_7=punct	relType_7=nsubj	lemma_7=vet	wib=tolerance	pos_7=NN	lemma_6=ketamine	lemma_2=in
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e4	null	relType_7=compound	lemma_9=pentobarbital	relType_9=conj	relType_8=cc	relType_10=det	path1=digitalis_compound<tolerance_nmod<comparison_obl	lemma_6=,	relType_12=case	lemma_9=,	relType_5=case	lemma_12=of	pos_6=NN	pos_2=IN	relType_4=acl	lemma_4=anesthetize	relType_6=obl	pos_3=NNS	lpib=tolerance_NN	relType_6=punct	lemma_7=Innovar	lemma_5=with	pos_7=,	lemma_10=the	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>vet_nsubj>dosage_appos>ouabain_nmod	pos_8=CC	lemma_8=or	relType_1=nmod	lemma_7=,	pos_9=NN	pos_1=NN	pos_12=IN	pos_4=VBN	relType_11=appos	lemma_1=tolerance	pos_7=NNP	relType_3=nmod	lib=tolerance	pos_5=IN	lemma_11=dosage	relType_9=punct	pos_6=,	path2=vet_nsubj>dosage_appos>ouabain_nmod	pos_11=NN	relType_2=case	lemma_3=dog	eib=True	relType_7=punct	relType_7=nsubj	lemma_7=vet	wib=tolerance	pos_7=NN	pos_9=,	lemma_6=ketamine	lemma_2=in	pos_10=DT
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e5	null	lemma_6=,	lemma_9=,	relType_19=advmod	relType_22=dep	relType_5=case	pos_13=VBN	pos_6=NN	relType_4=acl	pos_3=NNS	lemma_22=as	lemma_18=be	pos_22=IN	pos_13=NN	relType_1=nmod	lemma_7=,	relation_19=neutral	lib=tolerance	lemma_17=tachycardia	lemma_19=significantly	lemma_21=,	relType_24=det	lemma_3=dog	pos_26=IN	relType_21=punct	lemma_7=vet	lemma_13=need	relType_16=amod	lemma_4=anesthetize	lemma_7=Innovar	pos_9=NN	pos_12=IN	pos_4=VBN	lemma_13=ouabain	lemma_16=ventricular	pos_5=IN	relType_17=obj	pos_11=NN	relType_25=advcl	pos_9=,	pos_7=NN	relType_23=cop	lemma_6=ketamine	lemma_2=in	relType_10=det	path1=digitalis_compound<tolerance_nmod<comparison_obl	relType_12=case	lemma_12=of	pos_2=IN	relType_6=obl	pos_17=NN	lpib=tolerance_NN	pos_14=TO	lemma_5=with	pos_7=,	lemma_10=the	relType_20=ROOT	pos_24=DT	pos_8=CC	lemma_8=or	pos_1=NN	relType_3=nmod	pos_25=NN	relType_14=mark	lemma_26=of	lemma_11=dosage	relType_2=case	relType_18=cop	relType_15=xcomp	lemma_23=be	relType_7=nsubj	wib=tolerance	relType_8=cc	relType_13=acl	pos_10=DT	relType_7=compound	lemma_9=pentobarbital	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>ld50_advcl>ouabain_nmod	relType_9=conj	relType_26=case	relType_13=nmod	pos_21=,	lemma_14=to	relType_6=punct	pos_19=RB	path2=ld50_advcl>ouabain_nmod	pos_15=VB	relType_11=appos	pos_16=JJ	pos_20=JJR	lemma_1=tolerance	pos_7=NNP	lemma_24=the	lemma_25=ld50	lemma_20=high	relType_9=punct	lemma_15=cause	pos_6=,	eib=True	relType_7=punct	pos_23=VBD	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e6	null	lemma_6=,	lemma_9=,	relType_19=advmod	relType_22=dep	relType_5=case	pos_13=VBN	pos_27=,	pos_6=NN	relType_4=acl	pos_3=NNS	lemma_22=as	lemma_18=be	relType_27=nmod	pos_22=IN	pos_13=NN	relType_1=nmod	lemma_7=,	relation_19=neutral	lib=tolerance	lemma_17=tachycardia	lemma_19=significantly	lemma_21=,	relType_24=det	lemma_3=dog	pos_26=IN	relType_21=punct	lemma_7=vet	lemma_13=need	relType_16=amod	lemma_4=anesthetize	lemma_7=Innovar	pos_9=NN	pos_12=IN	pos_4=VBN	lemma_13=ouabain	lemma_16=ventricular	pos_27=NN	pos_5=IN	relType_17=obj	pos_11=NN	lemma_27=ouabain	relType_25=advcl	pos_9=,	pos_7=NN	relType_23=cop	lemma_6=ketamine	lemma_2=in	relType_10=det	path1=digitalis_compound<tolerance_nmod<comparison_obl	relType_12=case	lemma_12=of	pos_2=IN	relType_6=obl	pos_17=NN	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl	lpib=tolerance_NN	pos_14=TO	lemma_5=with	pos_7=,	lemma_10=the	path2=ld50_advcl>ketamine_obl	relType_20=ROOT	pos_24=DT	pos_8=CC	lemma_8=or	pos_1=NN	relType_3=nmod	pos_25=NN	relType_14=mark	lemma_26=of	lemma_11=dosage	relType_28=case	relType_2=case	relType_18=cop	relType_15=xcomp	lemma_23=be	relType_7=nsubj	relType_27=punct	wib=tolerance	relType_8=cc	relType_13=acl	pos_10=DT	relType_7=compound	lemma_9=pentobarbital	relType_9=conj	relType_26=case	relType_13=nmod	pos_21=,	lemma_28=with	lemma_14=to	relType_6=punct	pos_19=RB	pos_15=VB	relType_11=appos	pos_16=JJ	pos_20=JJR	lemma_1=tolerance	pos_7=NNP	lemma_24=the	lemma_25=ld50	lemma_20=high	relType_9=punct	lemma_27=,	lemma_15=cause	pos_6=,	eib=True	relType_7=punct	pos_23=VBD	pos_28=IN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e7	null	relType_29=obl	lemma_6=,	lemma_9=,	relType_19=advmod	relType_22=dep	relType_5=case	pos_13=VBN	pos_27=,	pos_6=NN	relType_4=acl	pos_3=NNS	lemma_22=as	lemma_18=be	relType_27=nmod	pos_22=IN	pos_13=NN	relType_1=nmod	lemma_7=,	relation_19=neutral	lib=tolerance	lemma_17=tachycardia	lemma_19=significantly	lemma_21=,	lemma_29=ketamine	relType_24=det	lemma_3=dog	pos_26=IN	relType_21=punct	lemma_7=vet	lemma_13=need	relType_16=amod	lemma_4=anesthetize	lemma_7=Innovar	pos_29=NN	pos_9=NN	pos_12=IN	pos_4=VBN	lemma_13=ouabain	lemma_16=ventricular	pos_27=NN	pos_5=IN	relType_29=cc	relType_17=obj	pos_11=NN	lemma_27=ouabain	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl>innovar_conj	relType_25=advcl	pos_9=,	pos_7=NN	relType_23=cop	lemma_6=ketamine	lemma_2=in	lemma_29=or	relType_10=det	path1=digitalis_compound<tolerance_nmod<comparison_obl	relType_12=case	lemma_12=of	pos_2=IN	relType_6=obl	pos_17=NN	lpib=tolerance_NN	pos_14=TO	lemma_5=with	pos_7=,	lemma_10=the	relType_20=ROOT	pos_24=DT	pos_8=CC	lemma_8=or	pos_1=NN	pos_29=CC	relType_3=nmod	pos_25=NN	relType_14=mark	lemma_26=of	lemma_11=dosage	relType_28=case	relType_2=case	relType_18=cop	relType_15=xcomp	lemma_23=be	relType_7=nsubj	relType_27=punct	wib=tolerance	relType_8=cc	relType_13=acl	pos_10=DT	relType_7=compound	lemma_9=pentobarbital	relType_9=conj	relType_26=case	relType_13=nmod	pos_21=,	lemma_28=with	lemma_14=to	relType_6=punct	pos_19=RB	path2=ld50_advcl>ketamine_obl>innovar_conj	pos_15=VB	relType_11=appos	pos_16=JJ	pos_20=JJR	lemma_1=tolerance	pos_7=NNP	lemma_24=the	lemma_25=ld50	lemma_20=high	relType_9=punct	lemma_27=,	lemma_15=cause	pos_6=,	eib=True	relType_7=punct	pos_23=VBD	pos_28=IN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e0	DDI-MedLine.d23.s1.e8	null	relType_29=obl	lemma_6=,	lemma_9=,	relType_19=advmod	relType_22=dep	relType_5=case	pos_13=VBN	pos_27=,	pos_6=NN	relType_4=acl	pos_3=NNS	lemma_22=as	lemma_18=be	relType_27=nmod	pos_22=IN	pos_13=NN	relType_1=nmod	lemma_7=,	lemma_30=innovar	relation_19=neutral	relType_30=conj	lib=tolerance	lemma_17=tachycardia	lemma_19=significantly	lemma_21=,	lemma_29=ketamine	relType_24=det	lemma_3=dog	pos_26=IN	relType_21=punct	lemma_7=vet	pos_30=IN	lemma_31=with	lemma_13=need	pos_30=NN	relType_16=amod	lemma_4=anesthetize	lemma_7=Innovar	pos_29=NN	pos_9=NN	pos_12=IN	pos_4=VBN	lemma_13=ouabain	lemma_16=ventricular	pos_27=NN	pos_5=IN	relType_29=cc	relType_17=obj	pos_11=NN	lemma_27=ouabain	relType_25=advcl	pos_9=,	pos_7=NN	relType_23=cop	lemma_6=ketamine	lemma_2=in	lemma_29=or	path2=ld50_advcl>ketamine_obl>pentobarbital_nmod	relType_10=det	path1=digitalis_compound<tolerance_nmod<comparison_obl	relType_12=case	lemma_12=of	pos_31=IN	pos_2=IN	relType_6=obl	pos_17=NN	lpib=tolerance_NN	pos_14=TO	lemma_5=with	pos_7=,	lemma_10=the	relType_20=ROOT	pos_24=DT	pos_8=CC	lemma_8=or	pos_1=NN	pos_29=CC	relType_3=nmod	pos_25=NN	relType_14=mark	lemma_26=of	lemma_11=dosage	lemma_30=than	relType_28=case	relType_2=case	relType_18=cop	relType_15=xcomp	lemma_23=be	relType_7=nsubj	relType_27=punct	wib=tolerance	relType_8=cc	path=digitalis_compound<tolerance_nmod<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl>pentobarbital_nmod	relType_13=acl	relType_30=case	pos_10=DT	relType_7=compound	lemma_9=pentobarbital	relType_9=conj	relType_26=case	relType_31=case	relType_13=nmod	pos_21=,	lemma_28=with	lemma_14=to	relType_6=punct	pos_19=RB	pos_15=VB	relType_11=appos	pos_16=JJ	pos_20=JJR	lemma_1=tolerance	pos_7=NNP	lemma_24=the	lemma_25=ld50	lemma_20=high	relType_9=punct	lemma_27=,	lemma_15=cause	pos_6=,	eib=True	relType_7=punct	pos_23=VBD	pos_28=IN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e2	null	lemma_1=,	lib=innovar	eib=True	path2=vet_nsubj	pos_2=NNP	relType_2=compound	wib=Innovar	lpib=innovar_NNP	pos_1=,	lemma_2=Innovar	relType_1=punct	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>vet_nsubj	path1=ketamine_obl<anesthetize_acl<comparison_obl
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	lib=innovar	pos_2=NNP	relType_2=nsubj	lemma_2=vet	lemma_3=or	path1=ketamine_obl<anesthetize_acl<comparison_obl	lemma_2=,	relType_2=compound	lpib=innovar_NNP	path2=vet_nsubj>pentobarbital_conj	lemma_2=Innovar	eib=True	wib=Innovar	pos_2=,	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>vet_nsubj>pentobarbital_conj	relType_1=punct
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e4	effect	lemma_1=,	pos_2=NN	relType_7=case	pos_3=CC	pos_1=,	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>vet_nsubj>dosage_appos>ouabain_nmod	relType_2=punct	relType_3=cc	pos_6=NN	lib=innovar	pos_2=NNP	relType_2=nsubj	pos_4=,	lemma_2=vet	lemma_3=or	lemma_6=dosage	path1=ketamine_obl<anesthetize_acl<comparison_obl	lemma_2=,	pos_4=NN	relType_4=punct	relType_2=compound	lemma_4=pentobarbital	relType_5=det	lpib=innovar_NNP	lemma_2=Innovar	lemma_4=,	path2=vet_nsubj>dosage_appos>ouabain_nmod	lemma_7=of	lemma_5=the	relType_6=appos	eib=True	pos_7=IN	wib=Innovar	pos_5=DT	pos_2=,	relType_4=conj	relType_1=punct
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e5	null	pos_2=NN	pos_3=CC	pos_6=NN	relation_13=neutral	pos_2=NNP	relType_13=cop	pos_20=NN	lemma_18=be	lemma_10=cause	lemma_16=,	path1=ketamine_obl<anesthetize_acl<comparison_obl	pos_14=RB	relType_4=punct	lemma_2=Innovar	relType_16=punct	relType_21=case	relType_6=appos	pos_7=IN	pos_2=,	pos_11=JJ	relType_15=ROOT	relType_19=det	lemma_1=,	relType_7=case	pos_8=VBN	pos_1=,	relType_2=punct	relType_3=cc	pos_8=NN	pos_9=TO	pos_13=VBD	relType_14=advmod	relType_2=nsubj	lemma_2=vet	relType_11=amod	relType_17=dep	lemma_3=or	lemma_8=need	pos_10=VB	lemma_2=,	lemma_14=significantly	lemma_4=,	relType_9=mark	lemma_5=the	relType_10=xcomp	relType_1=punct	lemma_21=of	lemma_8=ouabain	pos_19=DT	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>ld50_advcl>ouabain_nmod	pos_17=IN	lemma_17=as	pos_4=,	pos_21=IN	lemma_6=dosage	relType_20=advcl	lemma_20=ld50	lemma_4=pentobarbital	relType_5=det	pos_15=JJR	relType_8=acl	relType_18=cop	wib=Innovar	pos_5=DT	lemma_11=ventricular	lemma_15=high	lib=innovar	lemma_12=tachycardia	pos_16=,	lemma_9=to	relType_12=obj	lemma_19=the	pos_4=NN	lemma_13=be	path2=ld50_advcl>ouabain_nmod	relType_2=compound	lpib=innovar_NNP	lemma_7=of	eib=True	relType_8=nmod	relType_4=conj	pos_12=NN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e6	null	pos_2=NN	pos_3=CC	pos_6=NN	relation_13=neutral	pos_2=NNP	relType_13=cop	pos_20=NN	lemma_18=be	lemma_10=cause	lemma_16=,	path1=ketamine_obl<anesthetize_acl<comparison_obl	relType_22=punct	pos_14=RB	relType_4=punct	pos_22=,	lemma_2=Innovar	relType_16=punct	relType_21=case	relType_6=appos	pos_7=IN	pos_2=,	pos_11=JJ	relType_15=ROOT	relType_19=det	relType_22=nmod	lemma_1=,	relType_7=case	pos_8=VBN	pos_22=NN	pos_1=,	relType_2=punct	relType_3=cc	pos_8=NN	pos_9=TO	pos_13=VBD	relType_14=advmod	relType_2=nsubj	lemma_2=vet	relType_11=amod	relType_17=dep	lemma_22=,	lemma_3=or	lemma_8=need	pos_10=VB	lemma_2=,	lemma_14=significantly	lemma_4=,	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl	relType_9=mark	lemma_5=the	relType_10=xcomp	pos_23=IN	relType_1=punct	lemma_21=of	lemma_8=ouabain	lemma_22=ouabain	pos_19=DT	pos_17=IN	lemma_17=as	pos_4=,	path2=ld50_advcl>ketamine_obl	pos_21=IN	lemma_6=dosage	relType_20=advcl	lemma_20=ld50	lemma_4=pentobarbital	relType_5=det	pos_15=JJR	relType_8=acl	relType_23=case	relType_18=cop	wib=Innovar	pos_5=DT	lemma_11=ventricular	lemma_23=with	lemma_15=high	lib=innovar	lemma_12=tachycardia	pos_16=,	lemma_9=to	relType_12=obj	lemma_19=the	pos_4=NN	lemma_13=be	relType_2=compound	lpib=innovar_NNP	lemma_7=of	eib=True	relType_8=nmod	relType_4=conj	pos_12=NN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e7	null	pos_2=NN	pos_3=CC	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl>innovar_conj	lemma_24=ketamine	pos_6=NN	relation_13=neutral	pos_2=NNP	relType_13=cop	pos_20=NN	lemma_18=be	lemma_10=cause	lemma_16=,	path1=ketamine_obl<anesthetize_acl<comparison_obl	relType_22=punct	pos_14=RB	relType_4=punct	pos_22=,	lemma_2=Innovar	relType_16=punct	relType_21=case	relType_6=appos	pos_7=IN	pos_2=,	pos_11=JJ	relType_15=ROOT	relType_19=det	relType_22=nmod	lemma_1=,	relType_7=case	pos_8=VBN	pos_22=NN	pos_1=,	lemma_24=or	relType_2=punct	relType_3=cc	pos_8=NN	pos_9=TO	pos_13=VBD	relType_14=advmod	pos_24=CC	relType_2=nsubj	lemma_2=vet	relType_11=amod	relType_17=dep	lemma_22=,	lemma_3=or	lemma_8=need	pos_10=VB	lemma_2=,	lemma_14=significantly	lemma_4=,	relType_9=mark	lemma_5=the	relType_10=xcomp	pos_23=IN	relType_1=punct	lemma_21=of	lemma_8=ouabain	lemma_22=ouabain	pos_19=DT	relType_24=obl	pos_24=NN	pos_17=IN	lemma_17=as	pos_4=,	pos_21=IN	lemma_6=dosage	relType_20=advcl	lemma_20=ld50	lemma_4=pentobarbital	relType_5=det	pos_15=JJR	relType_8=acl	relType_23=case	relType_18=cop	wib=Innovar	pos_5=DT	lemma_11=ventricular	lemma_23=with	lemma_15=high	lib=innovar	lemma_12=tachycardia	pos_16=,	lemma_9=to	relType_12=obj	relType_24=cc	lemma_19=the	path2=ld50_advcl>ketamine_obl>innovar_conj	pos_4=NN	lemma_13=be	relType_2=compound	lpib=innovar_NNP	lemma_7=of	eib=True	relType_8=nmod	relType_4=conj	pos_12=NN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e1	DDI-MedLine.d23.s1.e8	null	pos_2=NN	pos_3=CC	lemma_25=than	lemma_24=ketamine	pos_6=NN	relation_13=neutral	pos_2=NNP	relType_13=cop	pos_20=NN	lemma_18=be	lemma_10=cause	lemma_16=,	path1=ketamine_obl<anesthetize_acl<comparison_obl	relType_22=punct	pos_14=RB	relType_4=punct	pos_22=,	lemma_2=Innovar	lemma_25=innovar	relType_16=punct	relType_21=case	relType_6=appos	pos_7=IN	pos_26=IN	pos_2=,	pos_11=JJ	relType_15=ROOT	relType_19=det	relType_22=nmod	relType_25=conj	lemma_1=,	relType_7=case	lemma_26=with	pos_8=VBN	pos_22=NN	pos_1=,	lemma_24=or	relType_2=punct	relType_3=cc	relType_25=case	pos_8=NN	pos_9=TO	pos_13=VBD	relType_14=advmod	pos_24=CC	relType_2=nsubj	lemma_2=vet	relType_11=amod	relType_17=dep	lemma_22=,	lemma_3=or	lemma_8=need	pos_10=VB	lemma_2=,	lemma_14=significantly	lemma_4=,	relType_9=mark	lemma_5=the	relType_10=xcomp	pos_25=IN	pos_23=IN	relType_1=punct	lemma_21=of	lemma_8=ouabain	path=ketamine_obl<anesthetize_acl<comparison_obl<high_ROOT>ld50_advcl>ketamine_obl>pentobarbital_nmod	lemma_22=ouabain	path2=ld50_advcl>ketamine_obl>pentobarbital_nmod	pos_19=DT	relType_24=obl	pos_24=NN	pos_17=IN	lemma_17=as	pos_4=,	pos_21=IN	lemma_6=dosage	relType_20=advcl	lemma_20=ld50	lemma_4=pentobarbital	relType_5=det	pos_25=NN	pos_15=JJR	relType_8=acl	relType_23=case	relType_18=cop	wib=Innovar	pos_5=DT	lemma_11=ventricular	relType_26=case	lemma_23=with	lemma_15=high	lib=innovar	lemma_12=tachycardia	pos_16=,	lemma_9=to	relType_12=obj	relType_24=cc	lemma_19=the	pos_4=NN	lemma_13=be	relType_2=compound	lpib=innovar_NNP	lemma_7=of	eib=True	relType_8=nmod	relType_4=conj	pos_12=NN	pos_18=VBD
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e3	null	lpib=pentobarbital_NN	lemma_2=or	lemma_1=,	eib=False	lib=pentobarbital	pos_2=CC	path1=	path2=pentobarbital_conj	pos_1=,	path=<vet_nsubj>pentobarbital_conj	relType_1=punct	wib=pentobarbital	relType_2=cc
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e4	effect	lpib=pentobarbital_NN	lemma_2=or	lemma_1=,	lemma_3=pentobarbital	lemma_5=dosage	path1=	pos_1=,	lemma_6=of	wib=pentobarbital	relType_2=cc	relType_6=case	pos_6=IN	path=<vet_nsubj>dosage_appos>ouabain_nmod	pos_4=DT	path2=dosage_appos>ouabain_nmod	lemma_3=,	relType_3=conj	lemma_4=the	relType_5=appos	pos_5=NN	pos_3=,	eib=True	lib=pentobarbital	pos_3=NN	pos_2=CC	relType_1=punct	relType_4=det	relType_3=punct
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e5	null	lpib=pentobarbital_NN	lemma_2=or	lemma_1=,	lemma_3=pentobarbital	lemma_5=dosage	pos_16=IN	pos_7=NN	pos_17=VBD	relType_10=amod	pos_1=,	relation_10=neutral	lemma_6=of	pos_9=VB	relType_7=acl	pos_8=TO	wib=pentobarbital	relType_2=cc	relType_11=obj	relType_6=case	lemma_11=tachycardia	lemma_16=as	lemma_9=cause	lemma_17=be	lemma_19=ld50	pos_18=DT	pos_20=IN	lemma_18=the	relType_20=case	lemma_13=significantly	pos_15=,	pos_6=IN	pos_12=VBD	relType_14=ROOT	lemma_20=of	pos_13=RB	pos_19=NN	relType_15=punct	path=vet_nsubj<high_ROOT>ld50_advcl>ouabain_nmod	relType_12=cop	path2=ld50_advcl>ouabain_nmod	pos_4=DT	lemma_10=ventricular	lemma_8=to	relType_13=advmod	lemma_3=,	lemma_12=be	relType_3=conj	pos_10=JJ	relType_8=mark	lemma_4=the	lemma_15=,	relType_7=nmod	pos_14=JJR	relType_19=advcl	relType_5=appos	relType_9=xcomp	pos_7=VBN	pos_5=NN	pos_11=NN	pos_3=,	eib=True	path1=vet_nsubj	lib=pentobarbital	pos_3=NN	relType_16=dep	pos_2=CC	lemma_14=high	relType_18=det	relType_1=punct	relType_4=det	relType_3=punct	lemma_7=ouabain	relType_17=cop	lemma_7=need
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e6	null	lemma_2=or	pos_9=VB	lemma_16=as	relType_2=cc	lemma_19=ld50	lemma_11=tachycardia	pos_22=IN	lemma_3=,	relType_8=mark	lemma_21=,	pos_3=,	lib=pentobarbital	relType_21=punct	relType_17=cop	lemma_20=of	lemma_7=need	lpib=pentobarbital_NN	lemma_1=,	pos_17=VBD	lemma_21=ouabain	pos_1=,	relType_6=case	lemma_9=cause	pos_18=DT	relType_20=case	lemma_13=significantly	pos_6=IN	relType_22=case	lemma_8=to	relType_13=advmod	lemma_15=,	relType_7=nmod	lemma_22=with	relType_5=appos	relType_9=xcomp	pos_5=NN	pos_11=NN	relType_18=det	relType_1=punct	pos_7=NN	relType_12=cop	relType_3=punct	lemma_7=ouabain	lemma_18=the	lemma_5=dosage	pos_16=IN	lemma_6=of	relType_21=nmod	pos_8=TO	wib=pentobarbital	relType_11=obj	pos_20=IN	pos_15=,	relType_14=ROOT	path2=ld50_advcl>ketamine_obl	relType_15=punct	lemma_10=ventricular	relType_3=conj	lemma_4=the	relType_19=advcl	path1=vet_nsubj	lemma_3=pentobarbital	path=vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl	relType_10=amod	relation_10=neutral	relType_7=acl	lemma_17=be	pos_21=,	pos_12=VBD	pos_13=RB	pos_19=NN	pos_4=DT	lemma_12=be	pos_10=JJ	pos_14=JJR	pos_7=VBN	eib=True	pos_3=NN	relType_16=dep	pos_2=CC	lemma_14=high	relType_4=det	pos_21=NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e7	null	lemma_2=or	pos_9=VB	lemma_16=as	relType_2=cc	lemma_19=ld50	lemma_11=tachycardia	pos_22=IN	lemma_23=or	lemma_3=,	relType_8=mark	lemma_21=,	pos_3=,	lib=pentobarbital	relType_21=punct	relType_17=cop	lemma_20=of	lemma_7=need	lpib=pentobarbital_NN	lemma_1=,	pos_17=VBD	lemma_21=ouabain	pos_1=,	relType_6=case	lemma_9=cause	pos_18=DT	relType_20=case	lemma_13=significantly	pos_6=IN	path=vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>innovar_conj	relType_23=obl	relType_22=case	lemma_8=to	relType_13=advmod	lemma_15=,	relType_7=nmod	lemma_22=with	relType_5=appos	relType_9=xcomp	pos_5=NN	pos_11=NN	relType_18=det	relType_1=punct	pos_7=NN	relType_12=cop	relType_3=punct	lemma_7=ouabain	lemma_18=the	lemma_5=dosage	pos_16=IN	lemma_6=of	relType_21=nmod	pos_8=TO	wib=pentobarbital	relType_11=obj	pos_20=IN	pos_23=NN	pos_23=CC	pos_15=,	relType_14=ROOT	relType_15=punct	lemma_10=ventricular	relType_3=conj	lemma_4=the	relType_19=advcl	path1=vet_nsubj	lemma_3=pentobarbital	relType_10=amod	relation_10=neutral	relType_7=acl	lemma_17=be	pos_21=,	pos_12=VBD	pos_13=RB	pos_19=NN	path2=ld50_advcl>ketamine_obl>innovar_conj	pos_4=DT	lemma_12=be	lemma_23=ketamine	pos_10=JJ	relType_23=cc	pos_14=JJR	pos_7=VBN	eib=True	pos_3=NN	relType_16=dep	pos_2=CC	lemma_14=high	relType_4=det	pos_21=NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e2	DDI-MedLine.d23.s1.e8	null	lemma_2=or	pos_9=VB	lemma_16=as	relType_2=cc	lemma_19=ld50	lemma_11=tachycardia	relType_24=case	pos_22=IN	lemma_23=or	lemma_3=,	relType_8=mark	pos_24=IN	lemma_21=,	pos_3=,	lib=pentobarbital	relType_21=punct	relType_17=cop	lemma_20=of	lemma_7=need	lpib=pentobarbital_NN	lemma_1=,	pos_17=VBD	lemma_21=ouabain	pos_1=,	relType_6=case	lemma_9=cause	relType_25=case	pos_18=DT	relType_20=case	lemma_13=significantly	pos_6=IN	relType_23=obl	relType_22=case	lemma_8=to	relType_13=advmod	lemma_15=,	relType_7=nmod	lemma_22=with	relType_5=appos	relType_9=xcomp	pos_5=NN	pos_11=NN	pos_25=IN	relType_18=det	relType_1=punct	pos_7=NN	relType_12=cop	relType_3=punct	lemma_7=ouabain	lemma_18=the	path2=ld50_advcl>ketamine_obl>pentobarbital_nmod	lemma_5=dosage	pos_16=IN	pos_24=NN	lemma_6=of	relType_21=nmod	pos_8=TO	wib=pentobarbital	relType_11=obj	lemma_24=than	lemma_25=with	pos_20=IN	pos_23=NN	pos_23=CC	pos_15=,	relType_14=ROOT	relType_15=punct	lemma_10=ventricular	relType_3=conj	lemma_4=the	relType_19=advcl	path1=vet_nsubj	lemma_3=pentobarbital	relType_10=amod	relation_10=neutral	relType_7=acl	lemma_17=be	pos_21=,	lemma_24=innovar	pos_12=VBD	pos_13=RB	pos_19=NN	pos_4=DT	lemma_12=be	lemma_23=ketamine	pos_10=JJ	relType_23=cc	path=vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>pentobarbital_nmod	relType_24=conj	pos_14=JJR	pos_7=VBN	eib=True	pos_3=NN	relType_16=dep	pos_2=CC	lemma_14=high	relType_4=det	pos_21=NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e3	DDI-MedLine.d23.s1.e4	effect	pos_2=DT	lemma_1=,	lemma_2=the	pos_1=,	path1=pentobarbital_conj	eib=False	relType_3=appos	wib=dosage	path2=dosage_appos>ouabain_nmod	pos_4=IN	relType_4=case	lib=dosage	pos_3=NN	relType_2=det	lemma_3=dosage	relType_1=punct	path=pentobarbital_conj<vet_nsubj>dosage_appos>ouabain_nmod	lemma_4=of	lpib=dosage_NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e3	DDI-MedLine.d23.s1.e5	null	pos_2=DT	pos_7=VB	lemma_1=,	pos_6=TO	lemma_2=the	pos_13=,	lemma_13=,	lemma_17=ld50	relType_8=amod	pos_1=,	relType_13=punct	pos_16=DT	lemma_14=as	relType_15=cop	path1=pentobarbital_conj<vet_nsubj	lemma_6=to	relType_16=det	lemma_16=the	relType_18=case	pos_8=JJ	pos_17=NN	relType_3=appos	relType_5=acl	wib=dosage	lemma_12=high	relType_11=advmod	pos_9=NN	pos_18=IN	lemma_18=of	path2=ld50_advcl>ouabain_nmod	relType_7=xcomp	relType_12=ROOT	pos_14=IN	relType_6=mark	pos_4=IN	pos_10=VBD	lemma_5=ouabain	lemma_11=significantly	relType_4=case	lib=dosage	relType_5=nmod	relType_9=obj	relType_14=dep	relType_17=advcl	lemma_5=need	lemma_9=tachycardia	pos_11=RB	lemma_7=cause	relation_7=neutral	pos_5=NN	relType_10=cop	lemma_15=be	pos_15=VBD	eib=True	pos_3=NN	relType_2=det	lemma_8=ventricular	lemma_3=dosage	pos_12=JJR	relType_1=punct	path=pentobarbital_conj<vet_nsubj<high_ROOT>ld50_advcl>ouabain_nmod	lemma_4=of	pos_5=VBN	lemma_10=be	lpib=dosage_NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e3	DDI-MedLine.d23.s1.e6	null	pos_2=DT	pos_7=VB	lemma_1=,	pos_6=TO	lemma_2=the	pos_13=,	lemma_13=,	lemma_17=ld50	relType_8=amod	pos_1=,	relType_13=punct	pos_16=DT	lemma_14=as	relType_15=cop	path1=pentobarbital_conj<vet_nsubj	relType_19=punct	lemma_6=to	relType_16=det	lemma_16=the	relType_18=case	pos_20=IN	pos_8=JJ	pos_17=NN	relType_19=nmod	relType_20=case	lemma_19=ouabain	relType_3=appos	relType_5=acl	wib=dosage	path2=ld50_advcl>ketamine_obl	lemma_12=high	pos_19=NN	relType_11=advmod	pos_9=NN	pos_18=IN	lemma_18=of	relType_7=xcomp	relType_12=ROOT	pos_14=IN	relType_6=mark	pos_4=IN	pos_10=VBD	lemma_5=ouabain	lemma_11=significantly	relType_4=case	lib=dosage	relType_5=nmod	relType_9=obj	relType_14=dep	relType_17=advcl	pos_19=,	lemma_5=need	path=pentobarbital_conj<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl	lemma_9=tachycardia	pos_11=RB	lemma_7=cause	relation_7=neutral	pos_5=NN	relType_10=cop	lemma_15=be	pos_15=VBD	lemma_20=with	eib=True	pos_3=NN	relType_2=det	lemma_8=ventricular	lemma_19=,	lemma_3=dosage	pos_12=JJR	relType_1=punct	lemma_4=of	pos_5=VBN	lemma_10=be	lpib=dosage_NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e3	DDI-MedLine.d23.s1.e7	null	lemma_13=,	pos_16=DT	relType_15=cop	lemma_6=to	relType_21=cc	lemma_16=the	relType_18=case	pos_8=JJ	lemma_18=of	relType_7=xcomp	relType_12=ROOT	lemma_5=ouabain	relType_17=advcl	lemma_5=need	pos_11=RB	lemma_8=ventricular	wib=dosage	pos_2=DT	pos_13=,	lemma_1=,	pos_6=TO	lemma_2=the	lemma_17=ld50	lemma_21=ketamine	pos_1=,	relType_20=case	relType_11=advmod	pos_9=NN	pos_14=IN	relType_6=mark	pos_19=,	lemma_9=tachycardia	pos_5=NN	relType_21=obl	pos_15=VBD	lemma_19=,	lemma_3=dosage	relType_1=punct	lemma_12=high	lemma_10=be	lemma_21=or	path=pentobarbital_conj<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>innovar_conj	path1=pentobarbital_conj<vet_nsubj	relType_19=punct	pos_20=IN	relType_19=nmod	pos_17=NN	relType_3=appos	relType_5=acl	pos_18=IN	pos_4=IN	pos_10=VBD	relType_9=obj	lemma_7=cause	relation_7=neutral	relType_10=cop	lemma_15=be	lemma_4=of	pos_7=VB	relType_8=amod	relType_13=punct	lemma_14=as	relType_16=det	lemma_19=ouabain	pos_19=NN	path2=ld50_advcl>ketamine_obl>innovar_conj	lemma_11=significantly	relType_4=case	lib=dosage	relType_5=nmod	relType_14=dep	pos_21=CC	lemma_20=with	eib=True	pos_3=NN	relType_2=det	pos_12=JJR	pos_5=VBN	pos_21=NN	lpib=dosage_NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e3	DDI-MedLine.d23.s1.e8	null	lemma_13=,	path=pentobarbital_conj<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>pentobarbital_nmod	pos_16=DT	relType_15=cop	lemma_6=to	relType_21=cc	lemma_16=the	relType_18=case	pos_8=JJ	pos_22=IN	lemma_18=of	relType_7=xcomp	relType_12=ROOT	lemma_5=ouabain	relType_17=advcl	lemma_5=need	pos_11=RB	lemma_8=ventricular	wib=dosage	pos_2=DT	pos_13=,	lemma_1=,	pos_6=TO	lemma_2=the	lemma_17=ld50	relType_22=conj	lemma_21=ketamine	pos_22=NN	pos_1=,	relType_20=case	relType_11=advmod	pos_9=NN	relType_22=case	pos_14=IN	relType_6=mark	pos_19=,	lemma_9=tachycardia	lemma_22=than	pos_5=NN	relType_21=obl	pos_15=VBD	lemma_19=,	pos_23=IN	lemma_3=dosage	relType_1=punct	lemma_12=high	lemma_10=be	path2=ld50_advcl>ketamine_obl>pentobarbital_nmod	lemma_21=or	path1=pentobarbital_conj<vet_nsubj	relType_19=punct	pos_20=IN	relType_19=nmod	pos_17=NN	relType_3=appos	relType_5=acl	pos_18=IN	pos_4=IN	pos_10=VBD	relType_9=obj	relType_23=case	lemma_7=cause	relation_7=neutral	relType_10=cop	lemma_15=be	lemma_22=innovar	lemma_4=of	pos_7=VB	relType_8=amod	relType_13=punct	lemma_14=as	lemma_23=with	relType_16=det	lemma_19=ouabain	pos_19=NN	lemma_11=significantly	relType_4=case	lib=dosage	relType_5=nmod	relType_14=dep	pos_21=CC	lemma_20=with	eib=True	pos_3=NN	relType_2=det	pos_12=JJR	pos_5=VBN	pos_21=NN	lpib=dosage_NN
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e4	DDI-MedLine.d23.s1.e5	null	relType_4=amod	relType_3=xcomp	pos_4=JJ	pos_1=VBN	pos_11=VBD	relType_13=advcl	lemma_7=significantly	lemma_11=be	pos_3=VB	lemma_9=,	relType_10=dep	pos_6=VBD	relType_12=det	wib=needed	relType_2=mark	lemma_6=be	lemma_8=high	path=ouabain_nmod<dosage_appos<vet_nsubj<high_ROOT>ld50_advcl>ouabain_nmod	pos_7=RB	eib=False	relation_2=neutral	lemma_2=to	lemma_5=tachycardia	relType_6=cop	pos_13=NN	relType_11=cop	lemma_12=the	path2=ld50_advcl>ouabain_nmod	pos_14=IN	lemma_10=as	lemma_13=ld50	relType_1=acl	relType_8=ROOT	pos_10=IN	relType_9=punct	lemma_4=ventricular	pos_5=NN	lemma_3=cause	lemma_1=need	relType_5=obj	lemma_14=of	path1=ouabain_nmod<dosage_appos<vet_nsubj	pos_12=DT	relType_14=case	relType_7=advmod	lpib=need_VBN	pos_8=JJR	pos_9=,	lib=need	pos_2=TO
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e4	DDI-MedLine.d23.s1.e6	null	relType_4=amod	relType_3=xcomp	pos_4=JJ	pos_1=VBN	pos_16=IN	pos_11=VBD	relType_13=advcl	lemma_7=significantly	lemma_11=be	pos_3=VB	lemma_9=,	relType_10=dep	pos_6=VBD	relType_12=det	wib=needed	relType_2=mark	lemma_6=be	lemma_8=high	lemma_15=ouabain	path=ouabain_nmod<dosage_appos<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl	pos_7=RB	pos_15=,	relation_2=neutral	path2=ld50_advcl>ketamine_obl	lemma_2=to	lemma_5=tachycardia	relType_6=cop	pos_13=NN	lemma_16=with	relType_15=punct	relType_11=cop	lemma_12=the	pos_14=IN	lemma_10=as	pos_15=NN	lemma_13=ld50	lemma_15=,	relType_1=acl	relType_8=ROOT	pos_10=IN	relType_9=punct	relType_15=nmod	lemma_4=ventricular	pos_5=NN	lemma_3=cause	relType_16=case	lemma_1=need	eib=True	relType_5=obj	lemma_14=of	path1=ouabain_nmod<dosage_appos<vet_nsubj	pos_12=DT	relType_14=case	relType_7=advmod	lpib=need_VBN	pos_8=JJR	pos_9=,	lib=need	pos_2=TO
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e4	DDI-MedLine.d23.s1.e7	null	relType_4=amod	relType_3=xcomp	pos_4=JJ	relType_17=cc	pos_1=VBN	pos_16=IN	pos_11=VBD	relType_13=advcl	lemma_7=significantly	lemma_11=be	pos_3=VB	lemma_9=,	relType_10=dep	pos_6=VBD	relType_12=det	wib=needed	relType_2=mark	lemma_6=be	lemma_8=high	lemma_15=ouabain	pos_17=NN	pos_7=RB	pos_15=,	relation_2=neutral	lemma_2=to	lemma_5=tachycardia	path=ouabain_nmod<dosage_appos<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>innovar_conj	relType_6=cop	pos_13=NN	path2=ld50_advcl>ketamine_obl>innovar_conj	relType_15=punct	relType_11=cop	lemma_16=with	lemma_12=the	pos_14=IN	lemma_10=as	pos_15=NN	lemma_13=ld50	lemma_15=,	relType_1=acl	relType_8=ROOT	pos_10=IN	relType_9=punct	lemma_17=or	relType_15=nmod	lemma_4=ventricular	pos_5=NN	lemma_3=cause	relType_16=case	lemma_1=need	eib=True	relType_5=obj	lemma_14=of	lemma_17=ketamine	path1=ouabain_nmod<dosage_appos<vet_nsubj	pos_12=DT	relType_14=case	relType_7=advmod	lpib=need_VBN	pos_8=JJR	pos_9=,	pos_17=CC	relType_17=obl	lib=need	pos_2=TO
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e4	DDI-MedLine.d23.s1.e8	null	lemma_18=than	relType_4=amod	pos_19=IN	relType_3=xcomp	pos_4=JJ	relType_17=cc	pos_1=VBN	pos_16=IN	pos_11=VBD	relType_13=advcl	lemma_7=significantly	lemma_11=be	pos_3=VB	lemma_9=,	relType_10=dep	pos_6=VBD	relType_12=det	wib=needed	relType_2=mark	lemma_6=be	lemma_8=high	lemma_15=ouabain	pos_17=NN	relType_18=case	pos_7=RB	pos_15=,	relation_2=neutral	lemma_2=to	lemma_5=tachycardia	relType_6=cop	pos_13=NN	lemma_16=with	relType_15=punct	relType_11=cop	pos_18=IN	lemma_12=the	pos_14=IN	pos_18=NN	lemma_10=as	lemma_19=with	pos_15=NN	lemma_13=ld50	lemma_15=,	relType_1=acl	relType_8=ROOT	pos_10=IN	relType_9=punct	lemma_17=or	relType_15=nmod	lemma_4=ventricular	pos_5=NN	lemma_3=cause	relType_16=case	lemma_1=need	lemma_18=innovar	eib=True	relType_19=case	relType_5=obj	lemma_14=of	path=ouabain_nmod<dosage_appos<vet_nsubj<high_ROOT>ld50_advcl>ketamine_obl>pentobarbital_nmod	lemma_17=ketamine	path1=ouabain_nmod<dosage_appos<vet_nsubj	pos_12=DT	relType_14=case	relType_7=advmod	lpib=need_VBN	pos_8=JJR	pos_9=,	pos_17=CC	relType_18=conj	relType_17=obl	lib=need	pos_2=TO	path2=ld50_advcl>ketamine_obl>pentobarbital_nmod
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e5	DDI-MedLine.d23.s1.e6	null	pos_2=IN	lemma_1=,	relType_2=case	path1=ouabain_nmod	lemma_2=with	eib=False	lib=ketamine	path2=ketamine_obl	pos_1=,	lpib=ketamine_NN	wib=ketamine	relType_1=punct	path=ouabain_nmod<ld50_advcl>ketamine_obl
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e5	DDI-MedLine.d23.s1.e7	null	lemma_1=,	path=ouabain_nmod<ld50_advcl>ketamine_obl>innovar_conj	pos_3=CC	pos_1=,	relType_3=cc	pos_2=IN	lemma_2=with	lpib=ketamine_NN	wib=ketamine	lemma_3=or	path1=ouabain_nmod	lemma_3=ketamine	path2=ketamine_obl>innovar_conj	relType_2=case	relType_3=obl	eib=True	lib=ketamine	pos_3=NN	relType_1=punct
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e5	DDI-MedLine.d23.s1.e8	null	lemma_1=,	pos_3=CC	pos_1=,	relType_5=case	relType_3=cc	pos_2=IN	lemma_2=with	lemma_5=with	lpib=ketamine_NN	wib=ketamine	path=ouabain_nmod<ld50_advcl>ketamine_obl>pentobarbital_nmod	lemma_3=or	pos_4=NN	path1=ouabain_nmod	path2=ketamine_obl>pentobarbital_nmod	pos_4=IN	lemma_4=innovar	relType_4=case	pos_5=IN	lemma_3=ketamine	relType_2=case	relType_3=obl	eib=True	lib=ketamine	pos_3=NN	lemma_4=than	relType_4=conj	relType_1=punct
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e6	DDI-MedLine.d23.s1.e7	null	path=<ketamine_obl>innovar_conj	relType_1=cc	pos_1=CC	lib=innovar	eib=False	path2=innovar_conj	lpib=innovar_NN	wib=Innovar	path1=	lemma_1=or
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e6	DDI-MedLine.d23.s1.e8	null	relType_1=cc	lemma_2=than	pos_1=CC	pos_2=NN	pos_3=IN	path1=	pos_2=IN	lib=innovar	lpib=innovar_NN	relType_2=conj	lemma_2=innovar	lemma_3=with	relType_3=case	relType_2=case	eib=True	path2=pentobarbital_nmod	wib=Innovar	path=<ketamine_obl>pentobarbital_nmod	lemma_1=or
DDI-MedLine.d23.s1	DDI-MedLine.d23.s1.e7	DDI-MedLine.d23.s1.e8	null	lpib=pentobarbital_NN	pos_2=IN	relType_1=case	lemma_1=than	relType_2=case	lemma_2=with	eib=False	lib=pentobarbital	path2=pentobarbital_nmod	path=innovar_conj<ketamine_obl>pentobarbital_nmod	path1=innovar_conj	pos_1=IN	wib=pentobarbital
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e0	DDI-MedLine.d23.s2.e1	effect	lemma_3=convert	relType_7=case	relType_1=aux:pass	pos_3=VBN	pos_7=VBG	relType_5=compound	pos_9=IN	lemma_8=administration	relType_8=obl	pos_6=NN	pos_8=NN	pos_2=RB	relType_6=obl	path=ouabain_obl<induce_csubj:pass<convert_ROOT>administration_obl>Innovar_nmod	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=be	path2=administration_obl>Innovar_nmod	relType_9=case	lemma_5=sinus	lemma_6=rhythm	lib=be	relType_3=ROOT	lemma_4=to	pos_4=IN	path1=ouabain_obl<induce_csubj:pass	relType_4=case	wib=was	pos_5=NN	lemma_9=of	lemma_2=generally	lemma_7=follow	lpib=be_VBD
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e0	DDI-MedLine.d23.s2.e2	effect	lemma_3=convert	relType_10=punct	relType_7=case	relType_1=aux:pass	pos_3=VBN	lemma_10=,	pos_7=VBG	relType_5=compound	pos_9=IN	lemma_8=administration	relType_8=obl	path=ouabain_obl<induce_csubj:pass<convert_ROOT>administration_obl>Innovar_nmod>ketamine_conj	pos_6=NN	pos_2=RB	relType_6=obl	pos_8=NN	pos_1=VBD	relType_10=nmod	relType_2=advmod	lemma_1=be	relType_9=case	lemma_5=sinus	lemma_6=rhythm	lib=be	relType_3=ROOT	lemma_4=to	pos_4=IN	path1=ouabain_obl<induce_csubj:pass	relType_4=case	wib=was	pos_10=NNP	pos_5=NN	lemma_10=Innovar	pos_10=,	eib=True	lemma_9=of	lemma_2=generally	lemma_7=follow	lpib=be_VBD	path2=administration_obl>Innovar_nmod>ketamine_conj
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e0	DDI-MedLine.d23.s2.e3	effect	lemma_3=convert	relType_10=punct	relType_7=case	lemma_11=,	relType_1=aux:pass	pos_3=VBN	lemma_10=,	pos_7=VBG	relType_12=cc	relType_5=compound	pos_9=IN	lemma_8=administration	pos_12=CC	relType_8=obl	relType_11=conj	path2=administration_obl>Innovar_nmod>droperidol_conj	pos_6=NN	pos_2=RB	relType_6=obl	pos_8=NN	pos_1=VBD	relType_10=nmod	relType_2=advmod	relType_11=punct	lemma_1=be	relType_9=case	lemma_5=sinus	lemma_12=or	lemma_6=rhythm	lib=be	relType_3=ROOT	lemma_4=to	pos_4=IN	path1=ouabain_obl<induce_csubj:pass	relType_4=case	pos_11=,	wib=was	pos_10=NNP	pos_5=NN	lemma_10=Innovar	pos_10=,	pos_11=NN	eib=True	lemma_9=of	path=ouabain_obl<induce_csubj:pass<convert_ROOT>administration_obl>Innovar_nmod>droperidol_conj	lemma_2=generally	lemma_7=follow	lemma_11=ketamine	lpib=be_VBD
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e0	DDI-MedLine.d23.s2.e4	null	lemma_3=convert	relType_10=punct	relType_13=dep	relType_7=case	lemma_11=,	relType_1=aux:pass	pos_3=VBN	lemma_10=,	pos_7=VBG	relType_12=cc	relType_5=compound	pos_9=IN	relType_16=obl	lemma_8=administration	pos_12=CC	relType_8=obl	relType_11=conj	pos_6=NN	pos_8=NN	pos_2=RB	relType_6=obl	pos_17=IN	pos_1=VBD	relType_10=nmod	relType_14=advmod	path=ouabain_obl<induce_csubj:pass<convert_ROOT>but_dep>administration_obl>fentayl_nmod	relType_2=advmod	relType_11=punct	lemma_1=be	relType_9=case	relType_13=conj	pos_13=NN	lemma_5=sinus	lemma_13=but	relType_17=case	lemma_12=or	relType_15=case	lemma_14=not	lemma_6=rhythm	lib=be	pos_14=RB	relType_3=ROOT	lemma_4=to	pos_4=IN	path1=ouabain_obl<induce_csubj:pass	lemma_16=administration	relType_4=case	lemma_13=droperidol	lemma_17=of	pos_16=NN	pos_11=,	wib=was	pos_10=NNP	pos_13=CC	pos_15=IN	pos_5=NN	lemma_10=Innovar	pos_10=,	pos_11=NN	eib=True	lemma_9=of	lemma_2=generally	lemma_11=ketamine	lemma_7=follow	lemma_15=after	path2=but_dep>administration_obl>fentayl_nmod	lpib=be_VBD
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e0	DDI-MedLine.d23.s2.e5	null	relType_13=dep	lemma_10=,	pos_12=CC	pos_6=NN	relType_10=nmod	relType_9=case	pos_13=NN	lemma_5=sinus	pos_18=NN	pos_14=RB	relType_3=ROOT	path1=ouabain_obl<induce_csubj:pass	pos_19=CC	lemma_19=or	pos_10=,	path2=but_dep>administration_obl>pentobarbital_conj	lemma_18=fentayl	lemma_2=generally	relType_7=case	lemma_8=administration	lemma_18=alone	pos_8=NN	relType_20=case	pos_1=VBD	relType_14=advmod	relType_13=conj	relType_15=case	lemma_6=rhythm	lemma_16=administration	lemma_13=droperidol	pos_16=NN	pos_15=IN	pos_5=NN	pos_11=NN	lemma_7=follow	lemma_15=after	lpib=be_VBD	relType_18=nmod	lemma_20=after	relType_10=punct	lemma_11=,	pos_7=VBG	relType_12=cc	relType_16=obl	relType_11=conj	pos_20=IN	pos_17=IN	relType_6=obl	path=ouabain_obl<induce_csubj:pass<convert_ROOT>but_dep>administration_obl>pentobarbital_conj	relType_11=punct	lemma_1=be	relType_17=case	lemma_12=or	lib=be	lemma_4=to	pos_4=IN	lemma_17=of	pos_10=NNP	pos_13=CC	lemma_3=convert	relType_1=aux:pass	pos_3=VBN	relType_18=amod	relType_5=compound	pos_9=IN	relType_8=obl	pos_2=RB	relType_2=advmod	pos_18=JJ	lemma_13=but	lemma_14=not	relType_4=case	relType_19=cc	pos_11=,	wib=was	lemma_10=Innovar	eib=True	lemma_9=of	lemma_11=ketamine
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e1	DDI-MedLine.d23.s2.e2	null	lemma_1=,	eib=False	lib=ketamine	path=<Innovar_nmod>ketamine_conj	path1=	pos_1=,	lpib=ketamine_NN	wib=ketamine	relType_1=punct	path2=ketamine_conj
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e1	DDI-MedLine.d23.s2.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lemma_2=ketamine	relType_3=cc	relType_2=punct	lpib=ketamine_NN	wib=ketamine	path2=droperidol_conj	lemma_3=or	relType_2=conj	lemma_2=,	path=<Innovar_nmod>droperidol_conj	eib=True	lib=ketamine	pos_2=,	relType_1=punct
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e1	DDI-MedLine.d23.s2.e4	null	relType_8=case	lemma_4=droperidol	relType_4=dep	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	path=Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>fentayl_nmod	lemma_2=ketamine	lemma_6=after	relType_6=case	relType_3=cc	relType_2=punct	pos_6=IN	lpib=ketamine_NN	wib=ketamine	lemma_3=or	relType_2=conj	pos_4=NN	lemma_2=,	pos_8=IN	lemma_5=not	lemma_7=administration	path1=Innovar_nmod<administration_obl	pos_5=RB	relType_5=advmod	relType_7=obl	eib=True	pos_4=CC	lib=ketamine	pos_2=,	relType_4=conj	lemma_4=but	path2=but_dep>administration_obl>fentayl_nmod	relType_1=punct	pos_7=NN	lemma_8=of
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e1	DDI-MedLine.d23.s2.e5	null	relType_8=case	lemma_4=droperidol	relType_4=dep	lemma_1=,	pos_2=NN	pos_3=CC	relType_10=cc	pos_1=,	lemma_2=ketamine	lemma_11=after	relType_9=nmod	lemma_6=after	relType_6=case	relType_11=case	relType_3=cc	relType_2=punct	pos_9=JJ	pos_6=IN	pos_10=CC	lpib=ketamine_NN	wib=ketamine	lemma_3=or	relType_9=amod	relType_2=conj	pos_4=NN	lemma_2=,	pos_8=IN	pos_9=NN	pos_11=IN	lemma_5=not	lemma_7=administration	path1=Innovar_nmod<administration_obl	pos_5=RB	lemma_10=or	lemma_9=fentayl	relType_5=advmod	relType_7=obl	path2=but_dep>administration_obl>pentobarbital_conj	eib=True	pos_4=CC	lib=ketamine	pos_2=,	relType_4=conj	lemma_4=but	relType_1=punct	pos_7=NN	lemma_9=alone	lemma_8=of	path=Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>pentobarbital_conj
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e2	DDI-MedLine.d23.s2.e3	null	lemma_2=or	lib=droperidol	lemma_1=,	lpib=droperidol_NN	path=ketamine_conj<Innovar_nmod>droperidol_conj	eib=False	pos_2=CC	pos_1=,	wib=droperidol	path2=droperidol_conj	relType_1=punct	path1=ketamine_conj	relType_2=cc
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e2	DDI-MedLine.d23.s2.e4	null	relType_3=dep	lemma_2=or	lemma_1=,	lpib=droperidol_NN	lemma_6=administration	relType_7=case	pos_3=CC	pos_1=,	lemma_3=droperidol	lemma_5=after	relType_2=cc	relType_5=case	pos_6=NN	path1=ketamine_conj<Innovar_nmod<administration_obl	relType_6=obl	lib=droperidol	pos_4=RB	wib=droperidol	path=ketamine_conj<Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>fentayl_nmod	lemma_4=not	lemma_3=but	relType_3=conj	relType_4=advmod	pos_5=IN	lemma_7=of	eib=True	pos_7=IN	pos_3=NN	pos_2=CC	path2=but_dep>administration_obl>fentayl_nmod	relType_1=punct
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e2	DDI-MedLine.d23.s2.e5	null	relType_3=dep	lemma_2=or	lemma_1=,	lpib=droperidol_NN	lemma_6=administration	relType_7=case	pos_3=CC	relType_8=amod	pos_1=,	lemma_8=alone	lemma_10=after	lemma_3=droperidol	lemma_5=after	relType_2=cc	relType_5=case	pos_6=NN	path1=ketamine_conj<Innovar_nmod<administration_obl	relType_6=obl	pos_8=NN	lib=droperidol	pos_4=RB	pos_8=JJ	lemma_8=fentayl	wib=droperidol	relType_10=case	lemma_4=not	pos_9=CC	lemma_3=but	relType_3=conj	relType_4=advmod	lemma_9=or	pos_5=IN	path=ketamine_conj<Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>pentobarbital_conj	pos_10=IN	lemma_7=of	path2=but_dep>administration_obl>pentobarbital_conj	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	pos_2=CC	relType_1=punct	relType_9=cc
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e3	DDI-MedLine.d23.s2.e4	null	pos_1=CC	pos_3=IN	path=droperidol_conj<Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>fentayl_nmod	lemma_5=of	relType_5=case	pos_2=RB	lemma_3=after	path1=droperidol_conj<Innovar_nmod<administration_obl	eib=False	relType_2=advmod	wib=not	relType_1=dep	pos_4=NN	relType_4=obl	pos_5=IN	lemma_1=but	relType_3=case	lib=not	lemma_4=administration	lpib=not_RB	path2=but_dep>administration_obl>fentayl_nmod	lemma_2=not
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e3	DDI-MedLine.d23.s2.e5	null	relType_8=case	pos_1=CC	pos_3=IN	pos_6=JJ	relType_7=cc	lemma_5=of	relType_5=case	pos_6=NN	pos_2=RB	lemma_3=after	path1=droperidol_conj<Innovar_nmod<administration_obl	relType_2=advmod	relType_6=amod	wib=not	relType_1=dep	pos_4=NN	pos_8=IN	relType_4=obl	pos_7=CC	pos_5=IN	lemma_8=after	lemma_1=but	lemma_7=or	relType_3=case	lib=not	lemma_6=fentayl	path2=but_dep>administration_obl>pentobarbital_conj	eib=True	lemma_4=administration	lpib=not_RB	path=droperidol_conj<Innovar_nmod<administration_obl<convert_ROOT>but_dep>administration_obl>pentobarbital_conj	relType_6=nmod	lemma_6=alone	lemma_2=not
DDI-MedLine.d23.s2	DDI-MedLine.d23.s2.e4	DDI-MedLine.d23.s2.e5	null	lpib=alone_JJ	lib=alone	lemma_2=or	lemma_1=alone	pos_3=IN	lemma_3=after	eib=False	path1=fentayl_nmod	pos_2=CC	path2=pentobarbital_conj	path=fentayl_nmod<administration_obl>pentobarbital_conj	pos_1=JJ	relType_1=amod	relType_2=cc	relType_3=case	wib=alone
DDI-MedLine.d29.s0	DDI-MedLine.d29.s0.e0	DDI-MedLine.d29.s0.e1	null	lib=apparent	pos_2=DT	relType_1=case	lemma_2=the	relType_7=cc	pos_9=IN	lemma_3=apparent	relType_4=nmod	wib=apparent	lemma_5=of	relType_5=case	pos_6=NN	pos_8=NN	eib=False	lemma_8=elimination	path2=volume_nmod>distribution_nmod>cloxacillin_nmod	lemma_4=volume	pos_1=IN	relType_9=case	pos_4=NN	lpib=apparent_JJ	lemma_6=distribution	relType_3=amod	pos_7=CC	pos_5=IN	pos_3=JJ	path1=probenecid_nmod	lemma_9=of	lemma_7=and	relType_2=det	relType_8=conj	path=probenecid_nmod<effect_ROOT>volume_nmod>distribution_nmod>cloxacillin_nmod	relType_6=nmod	lemma_1=on
DDI-MedLine.d29.s2	DDI-MedLine.d29.s2.e0	DDI-MedLine.d29.s2.e1	null	relType_1=cc	pos_1=CC	path2=cephaloridine_conj	eib=False	lib=cephaloridine	path1=	path=<penicillin_nmod>cephaloridine_conj	wib=cephaloridine	lemma_1=and	lpib=cephaloridine_NN
DDI-MedLine.d29.s2	DDI-MedLine.d29.s2.e0	DDI-MedLine.d29.s2.e2	mechanism	relType_1=cc	pos_1=CC	pos_2=VBN	pos_2=NN	pos_3=IN	lemma_2=cephaloridine	lemma_5=of	relType_5=case	lemma_3=after	lib=cephaloridine	path1=penicillin_nmod<concentration_nsubj	lemma_2=reach	relType_4=nsubj	relType_2=conj	pos_4=NN	wib=cephaloridine	lpib=cephaloridine_NN	relType_2=dep	path2=elimination_advcl>administration_nsubj>probenecid_nmod	pos_5=IN	relType_3=mark	eib=True	path=penicillin_nmod<concentration_nsubj<reach_dep>elimination_advcl>administration_nsubj>probenecid_nmod	lemma_4=administration	lemma_1=and
DDI-MedLine.d29.s2	DDI-MedLine.d29.s2.e1	DDI-MedLine.d29.s2.e2	mechanism	wib=reached	pos_1=VBN	lemma_3=administration	relType_2=mark	pos_2=IN	lpib=reach_VBN	eib=False	lemma_1=reach	relType_1=dep	path1=cephaloridine_conj<penicillin_nmod<concentration_nsubj	path2=elimination_advcl>administration_nsubj>probenecid_nmod	pos_4=IN	relType_4=case	lib=reach	relType_3=nsubj	lemma_2=after	pos_3=NN	path=cephaloridine_conj<penicillin_nmod<concentration_nsubj<reach_dep>elimination_advcl>administration_nsubj>probenecid_nmod	lemma_4=of
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e0	DDI-MedLine.d29.s3.e1	null	relType_8=case	pos_2=DT	lpib=have_VBZ	pos_6=DT	lemma_2=a	relType_5=case	eib=False	lemma_6=the	lemma_3=direct	lemma_8=of	relation_2=neutral	lemma_1=have	pos_4=NN	lib=have	relType_4=obj	pos_8=IN	relation_3=neutral	path=probenecid_nsubj<have_ccomp>effect_obj>distribution_nmod>cloxacillin_nmod	relType_3=amod	relType_1=ccomp	lemma_7=distribution	pos_5=IN	relType_7=nmod	relType_6=det	lemma_4=effect	pos_3=JJ	pos_1=VBZ	lemma_5=on	relType_2=det	path2=effect_obj>distribution_nmod>cloxacillin_nmod	pos_7=NN	wib=has	path1=probenecid_nsubj
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e0	DDI-MedLine.d29.s3.e2	null	relType_8=case	pos_2=DT	path2=elimination_nsubj:pass>cloxacillin_nmod	lpib=have_VBZ	pos_6=DT	relType_10=det	relType_12=cc	lemma_2=a	lemma_9=,	relType_9=nmod	pos_12=CC	relType_5=case	lemma_13=distribution	lemma_6=the	lemma_3=direct	lemma_8=of	lemma_9=cloxacillin	relation_2=neutral	lemma_10=the	lemma_1=have	relType_13=conj	pos_13=NN	pos_9=NN	pos_4=NN	path1=probenecid_nsubj<have_ccomp<determine_advcl	lib=have	relType_4=obj	pos_8=IN	lemma_11=elimination	pos_14=IN	path=probenecid_nsubj<have_ccomp<determine_advcl<study_ROOT>elimination_nsubj:pass>cloxacillin_nmod	relation_3=neutral	relType_3=amod	relType_1=ccomp	lemma_7=distribution	pos_5=IN	relType_7=nmod	relType_11=nsubj:pass	relType_9=punct	relType_6=det	lemma_4=effect	pos_3=JJ	pos_1=VBZ	eib=True	lemma_5=on	pos_11=NN	relType_2=det	lemma_12=and	lemma_14=of	relType_14=case	pos_9=,	pos_7=NN	wib=has	pos_10=DT
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e0	DDI-MedLine.d29.s3.e3	null	pos_33=,	relType_29=advmod	relType_28=det	relType_32=nmod	lemma_9=,	pos_12=CC	relType_5=case	lemma_13=distribution	relType_38=conj	path=probenecid_nsubj<have_ccomp<determine_advcl<study_ROOT>presence_obl>probenecid_nmod	lemma_20=,	pos_13=NN	lemma_11=elimination	lemma_22=lack	relType_23=compound	relType_30=amod	pos_16=VBN	lemma_32=function	relType_3=amod	relType_33=punct	lemma_7=distribution	lemma_18=six	pos_32=NN	pos_35=DT	pos_37=CC	relType_19=obl	pos_3=JJ	pos_1=VBZ	lemma_14=of	relType_31=amod	relType_21=nummod	lemma_29=partially	wib=has	relType_8=case	pos_2=DT	pos_31=JJ	relType_35=det	lemma_34=in	relType_18=nummod	pos_19=NNS	lemma_23=kidney	lemma_28=a	lemma_21=five	lemma_15=cloxacillin	lemma_3=direct	lemma_39=of	pos_28=DT	lemma_33=,	relType_13=conj	pos_21=CD	pos_9=NN	path1=probenecid_nsubj<have_ccomp<determine_advcl	pos_8=IN	relation_3=neutral	pos_14=IN	relType_15=aux:pass	pos_5=IN	relType_7=nmod	relType_15=nmod	relType_6=det	lemma_4=effect	pos_11=NN	pos_15=VBD	lemma_27=with	pos_9=,	pos_30=VBN	pos_7=NN	relType_34=case	lpib=have_VBZ	pos_6=DT	relType_10=det	relType_12=cc	pos_24=NN	pos_17=IN	pos_23=NN	lemma_25=and	lemma_37=or	lemma_6=the	relation_2=neutral	lemma_10=the	relType_4=obj	relType_17=case	pos_25=CC	pos_38=NN	relType_11=nsubj:pass	lemma_17=in	lemma_15=be	relType_22=amod	lemma_12=and	relType_20=punct	relType_14=case	relType_27=case	relType_39=case	pos_39=IN	pos_10=DT	path2=presence_obl>probenecid_nmod	lemma_24=function	relType_37=cc	lemma_2=a	relType_9=nmod	relType_16=ROOT	pos_26=CD	pos_22=VBG	relation_31=adverse	lemma_38=absence	relType_26=conj	pos_29=RB	lemma_9=cloxacillin	lemma_36=presence	lemma_1=have	lemma_19=patient	pos_27=IN	pos_4=NN	pos_20=,	lib=have	pos_18=CD	relType_25=cc	pos_15=NN	lemma_16=study	relType_1=ccomp	relType_24=conj	relType_9=punct	pos_36=NN	lemma_26=one	lemma_35=the	eib=True	lemma_5=on	relType_36=obl	relType_2=det	lemma_30=impair	lemma_31=renal	lemma_8=of	pos_34=IN
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e1	DDI-MedLine.d29.s3.e2	null	pos_2=DT	lemma_1=,	lpib=elimination_NN	lemma_2=the	path2=elimination_nsubj:pass>cloxacillin_nmod	path=cloxacillin_nmod<distribution_nmod<effect_obj<have_ccomp<determine_advcl<study_ROOT>elimination_nsubj:pass>cloxacillin_nmod	path1=cloxacillin_nmod<distribution_nmod<effect_obj<have_ccomp<determine_advcl	pos_1=,	relType_3=nsubj:pass	relType_4=cc	lemma_6=of	relType_6=case	eib=False	pos_6=IN	wib=elimination	lemma_3=elimination	lemma_5=distribution	relType_5=conj	lib=elimination	pos_5=NN	pos_4=CC	pos_3=NN	relType_2=det	lemma_4=and	relType_1=punct
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e1	DDI-MedLine.d29.s3.e3	null	relType_14=amod	lemma_27=the	path1=cloxacillin_nmod<distribution_nmod<effect_obj<have_ccomp<determine_advcl	relType_3=nsubj:pass	lemma_22=impair	lemma_12=,	pos_12=,	relType_9=case	lemma_19=with	relType_30=conj	lemma_25=,	lemma_21=partially	lemma_20=a	lemma_18=one	relType_15=compound	lemma_15=kidney	pos_28=NN	lemma_16=function	lemma_10=six	pos_26=IN	lemma_4=and	lemma_26=in	lemma_28=presence	pos_2=DT	lemma_1=,	lemma_2=the	pos_13=CD	relType_17=cc	pos_8=VBN	lemma_7=be	relation_22=adverse	pos_1=,	lemma_7=cloxacillin	relType_6=case	pos_30=NN	lemma_13=five	path=cloxacillin_nmod<distribution_nmod<effect_obj<have_ccomp<determine_advcl<study_ROOT>presence_obl>probenecid_nmod	pos_6=IN	relType_21=advmod	relType_12=punct	pos_14=VBG	relType_7=nmod	lemma_5=distribution	relType_8=ROOT	pos_16=NN	lemma_11=patient	relType_29=cc	lib=elimination	pos_5=NN	relType_19=case	relType_25=punct	pos_17=CC	relType_1=punct	pos_7=NN	lemma_29=or	pos_23=JJ	lpib=elimination_NN	pos_24=NN	lemma_6=of	relType_23=amod	pos_31=IN	relType_13=nummod	pos_29=CC	lemma_14=lack	lemma_3=elimination	pos_7=VBD	relType_5=conj	relType_11=obl	lemma_31=of	relType_22=amod	pos_4=CC	lemma_9=in	relType_20=det	lemma_8=study	path2=presence_obl>probenecid_nmod	pos_19=IN	lemma_24=function	pos_25=,	relType_26=case	pos_9=IN	relType_31=case	relType_4=cc	pos_20=DT	pos_22=VBN	pos_27=DT	relType_27=det	pos_11=NNS	lemma_23=renal	pos_18=CD	wib=elimination	pos_15=NN	pos_10=CD	relType_24=nmod	relType_7=aux:pass	lemma_17=and	lemma_30=absence	relType_10=nummod	pos_21=RB	eib=True	pos_3=NN	relType_2=det	relType_28=obl	relType_18=conj	relType_16=conj
DDI-MedLine.d29.s3	DDI-MedLine.d29.s3.e2	DDI-MedLine.d29.s3.e3	null	lemma_17=renal	relType_11=cc	pos_12=CD	lemma_6=,	pos_10=NN	pos_18=NN	pos_16=VBN	lemma_23=or	lemma_25=of	lemma_11=and	relType_4=nummod	lemma_21=the	path=cloxacillin_nmod<elimination_nsubj:pass<study_ROOT>presence_obl>probenecid_nmod	relType_22=obl	pos_15=RB	lemma_24=absence	lemma_3=in	pos_22=NN	lemma_13=with	path1=cloxacillin_nmod<elimination_nsubj:pass	relType_25=case	relType_16=amod	relType_20=case	pos_1=VBD	relType_10=conj	relation_15=adverse	pos_9=NN	pos_4=CD	lemma_15=partially	relType_2=ROOT	pos_8=VBG	relType_21=det	pos_19=,	relType_17=amod	lemma_12=one	pos_25=IN	lemma_19=,	lpib=be_VBD	relType_18=nmod	lemma_9=kidney	pos_2=VBN	pos_3=IN	lemma_4=six	lemma_18=function	pos_24=NN	relType_19=punct	lemma_2=study	pos_20=IN	pos_23=CC	relType_7=nummod	lemma_1=be	pos_13=IN	relType_13=case	lib=be	pos_11=CC	relType_5=obl	pos_14=DT	lemma_10=function	path2=presence_obl>probenecid_nmod	relType_12=conj	relType_8=amod	relType_1=aux:pass	lemma_5=patient	pos_7=CD	pos_17=JJ	relType_9=compound	eib=False	pos_5=NNS	relType_6=punct	lemma_22=presence	lemma_7=five	relType_14=det	lemma_8=lack	relType_23=cc	lemma_20=in	relType_24=conj	wib=was	relType_3=case	pos_6=,	lemma_14=a	lemma_16=impair	relType_15=advmod	pos_21=DT
DDI-MedLine.d29.s4	DDI-MedLine.d29.s4.e0	DDI-MedLine.d29.s4.e1	null	lemma_1=with	lemma_2=and	relType_1=case	pos_3=IN	eib=False	path1=cloxacillin_nmod<distribution_nmod<volume_nmod	lemma_3=without	relType_3=conj	pos_2=CC	lib=probenecid	path=cloxacillin_nmod<distribution_nmod<volume_nmod<value_obl>probenecid_nmod	pos_1=IN	lpib=probenecid_NN	relType_2=cc	wib=probenecid	path2=probenecid_nmod
DDI-MedLine.d29.s8	DDI-MedLine.d29.s8.e0	DDI-MedLine.d29.s8.e1	mechanism	pos_2=DT	relType_1=case	lpib=elimination_NN	lemma_2=the	path1=	path2=elimination_nmod>cloxacillin_nmod	eib=False	pos_1=IN	wib=elimination	pos_4=IN	lemma_3=elimination	relType_3=nmod	relType_4=case	lib=elimination	lemma_1=of	pos_3=NN	path=<probenecid_nmod>elimination_nmod>cloxacillin_nmod	relType_2=det	lemma_4=of
DDI-MedLine.d118.s0	DDI-MedLine.d118.s0.e0	DDI-MedLine.d118.s0.e1	null	path=<Sirolimus_ROOT>prevent_parataxis>target_nsubj>inhibitor_nmod>rapamycin_compound	path1=	pos_2=JJ	wib=mammalian	eib=False	lib=mammalian	lemma_1=:	lpib=mammalian_JJ	path2=prevent_parataxis>target_nsubj>inhibitor_nmod>rapamycin_compound	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_2=mammalian	relType_3=nsubj	pos_3=NN	relType_1=punct	lemma_3=target	lemma_4=of
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e0	DDI-MedLine.d118.s2.e1	null	pos_3=IN	lemma_3=from	path2=immunosuppressant_obl	pos_2=RB	lemma_2=differently	lib=work	eib=False	relType_2=advmod	lpib=work_VBZ	path=Sirolimus_nsubj<work_ROOT>immunosuppressant_obl	pos_4=DT	lemma_1=work	lemma_4=the	wib=works	relType_3=case	path1=Sirolimus_nsubj	relType_1=ROOT	pos_1=VBZ	relType_4=det
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e0	DDI-MedLine.d118.s2.e2	null	pos_19=IN	relType_14=punct	pos_3=IN	pos_6=JJ	lemma_3=from	lemma_5=currently	lemma_18=profile	pos_13=NNS	pos_9=IN	path=Sirolimus_nsubj<work_ROOT>appear_conj>profile_nsubj>sirolimus_nmod	lemma_13=level	pos_2=RB	lemma_2=differently	relType_13=obl	relType_15=det	relType_16=amod	pos_17=NN	relType_12=compound	lib=work	relType_2=advmod	pos_5=NNS	lemma_12=lipid	relType_6=amod	relType_11=amod	pos_14=,	lemma_15=the	pos_7=,	pos_12=NN	relType_9=case	lpib=work_VBZ	lemma_5=immunosuppressant	lemma_7=,	pos_8=CC	relType_10=case	pos_15=DT	lemma_16=adverse	relType_17=compound	pos_18=NN	pos_4=DT	lemma_19=of	pos_16=JJ	lemma_1=work	lemma_6=available	lemma_4=the	pos_5=RB	lemma_9=except	relType_5=obl	pos_10=IN	pos_11=VBN	lemma_17=reaction	wib=works	relType_3=case	relType_5=advmod	path1=Sirolimus_nsubj	lemma_8=and	relType_1=ROOT	lemma_11=increase	lemma_14=,	pos_1=VBZ	eib=True	relType_19=case	relType_7=punct	relType_18=nsubj	relation_11=beneficial	relType_4=det	lemma_10=for	relType_8=cc	path2=appear_conj>profile_nsubj>sirolimus_nmod
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e0	DDI-MedLine.d118.s2.e3	null	pos_6=JJ	lemma_23=to	lemma_18=profile	pos_13=NNS	relType_4=det	relType_12=compound	lib=work	lemma_12=lipid	pos_22=VB	relType_20=nmod	pos_20=NN	relType_9=case	lemma_5=immunosuppressant	lemma_16=adverse	lemma_7=,	pos_15=DT	relType_17=compound	pos_32=IN	pos_18=NN	lemma_20=do	wib=works	pos_31=VBN	pos_28=NN	pos_1=VBZ	relType_30=nmod	relType_31=amod	pos_20=VBZ	lemma_32=with	relType_32=case	pos_23=TO	relType_22=conj	lemma_3=from	pos_27=JJ	pos_29=IN	relType_25=case	relType_16=amod	relType_20=aux	lemma_22=appear	relType_21=advmod	relType_11=amod	pos_24=VB	relType_5=advmod	path1=Sirolimus_nsubj	lemma_8=and	lemma_11=increase	lemma_14=,	relType_19=case	pos_25=IN	relType_15=det	relType_14=punct	pos_3=IN	relType_29=case	relType_27=amod	relType_23=mark	lemma_28=extent	lemma_13=level	relType_13=obl	pos_17=NN	lemma_31=associate	lemma_15=the	pos_14=,	pos_7=,	pos_8=CC	lemma_20=sirolimus	lemma_27=great	lemma_19=of	path=Sirolimus_nsubj<work_ROOT>appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	path2=appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	lemma_1=work	pos_26=DT	lemma_4=the	lemma_25=to	relType_5=obl	pos_10=IN	relType_18=nsubj	relation_11=beneficial	pos_30=DT	lemma_10=for	relType_8=cc	relType_24=xcomp	lemma_29=with	pos_19=IN	lemma_5=currently	pos_9=IN	pos_2=RB	lemma_2=differently	lemma_26=any	relType_2=advmod	pos_5=NNS	relType_6=amod	lpib=work_VBZ	relType_10=case	pos_4=DT	pos_16=JJ	lemma_6=available	pos_5=RB	lemma_9=except	pos_11=VBN	lemma_17=reaction	relType_3=case	pos_21=RB	relType_1=ROOT	eib=True	relType_26=det	lemma_24=overlap	relType_7=punct	lemma_21=not	pos_12=NN	relType_28=obl	lemma_30=that
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e0	DDI-MedLine.d118.s2.e4	null	pos_6=JJ	lemma_23=to	lemma_18=profile	pos_13=NNS	relType_4=det	relType_12=compound	lib=work	lemma_12=lipid	pos_22=VB	relType_20=nmod	pos_20=NN	relType_9=case	lemma_5=immunosuppressant	lemma_16=adverse	lemma_7=,	pos_15=DT	relType_17=compound	pos_32=IN	pos_18=NN	lemma_20=do	wib=works	pos_31=VBN	pos_28=NN	pos_1=VBZ	relType_30=nmod	relType_31=amod	pos_20=VBZ	lemma_32=with	relType_32=case	pos_23=TO	relType_22=conj	lemma_3=from	pos_27=JJ	pos_29=IN	relType_25=case	relType_16=amod	relType_20=aux	lemma_22=appear	path=Sirolimus_nsubj<work_ROOT>appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	relType_11=amod	relType_21=advmod	path2=appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	pos_24=VB	relType_5=advmod	path1=Sirolimus_nsubj	lemma_8=and	lemma_11=increase	lemma_14=,	lemma_33=or	relType_19=case	pos_25=IN	relType_15=det	relType_14=punct	pos_3=IN	relType_29=case	relType_27=amod	relType_23=mark	lemma_28=extent	lemma_13=level	relType_13=obl	pos_17=NN	lemma_31=associate	lemma_15=the	pos_14=,	pos_7=,	pos_8=CC	lemma_20=sirolimus	lemma_27=great	lemma_19=of	lemma_1=work	pos_26=DT	lemma_4=the	lemma_25=to	pos_33=CC	relType_5=obl	pos_10=IN	relType_33=obl	lemma_33=cyclosporine	relType_18=nsubj	relation_11=beneficial	pos_30=DT	lemma_10=for	relType_8=cc	relType_24=xcomp	lemma_29=with	pos_33=NN	pos_19=IN	lemma_5=currently	pos_9=IN	pos_2=RB	lemma_2=differently	lemma_26=any	relType_2=advmod	pos_5=NNS	relType_6=amod	relType_33=cc	lpib=work_VBZ	relType_10=case	pos_4=DT	pos_16=JJ	lemma_6=available	pos_5=RB	lemma_9=except	pos_11=VBN	lemma_17=reaction	relType_3=case	pos_21=RB	relType_1=ROOT	eib=True	relType_26=det	lemma_24=overlap	relType_7=punct	lemma_21=not	pos_12=NN	relType_28=obl	lemma_30=that
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e1	DDI-MedLine.d118.s2.e2	null	relType_10=punct	lemma_15=of	lemma_10=,	lemma_1=currently	wib=currently	path1=immunosuppressant_obl	relType_9=obl	relType_4=cc	lemma_12=adverse	pos_2=JJ	relType_5=case	lemma_2=available	relType_6=case	pos_8=NN	lib=currently	pos_12=JJ	lemma_6=for	eib=False	pos_6=IN	pos_9=NNS	lemma_7=increase	relType_12=amod	pos_14=NN	pos_13=NN	lpib=currently_RB	relType_1=advmod	relType_15=case	relType_7=amod	path=immunosuppressant_obl<work_ROOT>appear_conj>profile_nsubj>sirolimus_nmod	lemma_3=,	relType_13=compound	lemma_8=lipid	relType_2=amod	relType_8=compound	pos_5=IN	lemma_9=level	pos_11=DT	lemma_14=profile	relation_6=beneficial	lemma_11=the	lemma_13=reaction	relType_11=det	pos_15=IN	pos_7=VBN	pos_3=,	pos_10=,	pos_4=CC	pos_1=RB	lemma_4=and	relType_14=nsubj	relType_3=punct	path2=appear_conj>profile_nsubj>sirolimus_nmod	lemma_5=except
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e1	DDI-MedLine.d118.s2.e3	null	relType_16=nmod	lemma_10=,	lemma_26=that	path1=immunosuppressant_obl	relType_9=obl	pos_2=JJ	lemma_18=appear	relType_5=case	relType_26=nmod	lemma_21=to	pos_13=NN	lemma_16=sirolimus	relType_19=mark	lemma_3=,	pos_16=VBZ	lemma_14=profile	relType_21=case	relType_11=det	pos_3=,	pos_10=,	pos_27=VBN	lemma_17=not	lemma_4=and	lemma_5=except	lemma_15=of	relType_6=case	relType_25=case	pos_8=NN	pos_6=IN	lemma_22=any	relType_12=amod	pos_17=RB	relType_15=case	pos_5=IN	path=immunosuppressant_obl<work_ROOT>appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	pos_16=NN	relType_20=xcomp	lemma_11=the	pos_15=IN	pos_22=DT	lemma_24=extent	pos_25=IN	lemma_19=to	relType_3=punct	pos_23=JJ	relType_10=punct	relType_24=obl	pos_20=VB	wib=currently	pos_24=NN	relType_23=amod	relType_27=amod	lemma_12=adverse	lemma_25=with	lemma_6=for	lemma_7=increase	pos_21=IN	pos_14=NN	lemma_23=great	lpib=currently_RB	lemma_27=associate	path2=appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	relType_7=amod	pos_26=DT	pos_18=VB	relType_2=amod	relType_8=compound	relation_6=beneficial	pos_19=TO	relType_28=case	lemma_20=overlap	pos_4=CC	relType_22=det	pos_1=RB	lemma_16=do	lemma_1=currently	relType_4=cc	lemma_2=available	pos_12=JJ	lib=currently	lemma_28=with	pos_9=NNS	relType_16=aux	relType_1=advmod	relType_13=compound	lemma_8=lipid	lemma_9=level	relType_17=advmod	pos_11=DT	lemma_13=reaction	pos_7=VBN	eib=True	pos_28=IN	relType_14=nsubj	relType_18=conj
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e1	DDI-MedLine.d118.s2.e4	null	relType_29=obl	relType_16=nmod	lemma_10=,	lemma_26=that	path=immunosuppressant_obl<work_ROOT>appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	path1=immunosuppressant_obl	relType_9=obl	pos_2=JJ	lemma_18=appear	relType_5=case	relType_26=nmod	lemma_21=to	pos_13=NN	lemma_16=sirolimus	relType_19=mark	lemma_3=,	pos_16=VBZ	lemma_14=profile	relType_21=case	relType_11=det	pos_3=,	pos_10=,	pos_27=VBN	lemma_17=not	lemma_4=and	lemma_5=except	lemma_15=of	relType_6=case	relType_25=case	pos_8=NN	pos_6=IN	lemma_22=any	lemma_29=cyclosporine	relType_12=amod	pos_29=NN	pos_17=RB	path2=appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	relType_15=case	pos_5=IN	pos_16=NN	relType_29=cc	relType_20=xcomp	lemma_11=the	pos_15=IN	pos_22=DT	lemma_24=extent	pos_25=IN	lemma_19=to	relType_3=punct	lemma_29=or	pos_23=JJ	relType_10=punct	relType_24=obl	pos_20=VB	wib=currently	pos_24=NN	relType_23=amod	relType_27=amod	lemma_12=adverse	lemma_25=with	lemma_6=for	lemma_7=increase	pos_21=IN	pos_14=NN	lemma_23=great	lpib=currently_RB	pos_29=CC	lemma_27=associate	relType_7=amod	pos_26=DT	pos_18=VB	relType_2=amod	relType_8=compound	relation_6=beneficial	pos_19=TO	relType_28=case	lemma_20=overlap	pos_4=CC	relType_22=det	pos_1=RB	lemma_16=do	lemma_1=currently	relType_4=cc	lemma_2=available	pos_12=JJ	lib=currently	lemma_28=with	pos_9=NNS	relType_16=aux	relType_1=advmod	relType_13=compound	lemma_8=lipid	lemma_9=level	relType_17=advmod	pos_11=DT	lemma_13=reaction	pos_7=VBN	eib=True	pos_28=IN	relType_14=nsubj	relType_18=conj
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e2	DDI-MedLine.d118.s2.e3	null	relType_4=mark	relType_5=xcomp	relType_1=aux	relType_7=det	relType_8=amod	lemma_10=with	lemma_13=with	lemma_5=overlap	relType_9=obl	pos_3=VB	lemma_6=to	relType_6=case	lemma_3=appear	pos_8=JJ	pos_2=RB	pos_5=VB	eib=False	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_12=associate	relType_12=amod	relType_10=case	pos_13=IN	pos_9=NN	pos_7=DT	lemma_11=that	relType_13=case	lemma_8=great	relType_3=conj	lemma_4=to	lemma_9=extent	pos_10=IN	pos_11=DT	pos_4=TO	path2=overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	wib=does	lib=do	pos_1=VBZ	lemma_7=any	lpib=do_VBZ	path=sirolimus_nmod<profile_nsubj<appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl	relType_11=nmod	pos_12=VBN	path1=sirolimus_nmod<profile_nsubj	lemma_2=not
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e2	DDI-MedLine.d118.s2.e4	null	relType_4=mark	pos_14=CC	relType_5=xcomp	relType_1=aux	relType_7=det	relType_8=amod	lemma_10=with	lemma_13=with	lemma_5=overlap	relType_9=obl	pos_3=VB	lemma_6=to	relType_6=case	lemma_14=or	lemma_3=appear	pos_8=JJ	pos_2=RB	pos_5=VB	path2=overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_12=associate	relType_12=amod	pos_14=NN	relType_10=case	pos_13=IN	relType_14=obl	pos_9=NN	pos_7=DT	lemma_11=that	relType_13=case	lemma_8=great	relType_3=conj	lemma_4=to	lemma_14=cyclosporine	lemma_9=extent	pos_10=IN	pos_11=DT	relType_14=cc	pos_4=TO	wib=does	lib=do	pos_1=VBZ	eib=True	lemma_7=any	lpib=do_VBZ	relType_11=nmod	pos_12=VBN	path=sirolimus_nmod<profile_nsubj<appear_conj>overlap_xcomp>extent_obl>that_nmod>associate_amod>cyclosporine_obl>tacrolimus_conj	path1=sirolimus_nmod<profile_nsubj	lemma_2=not
DDI-MedLine.d118.s2	DDI-MedLine.d118.s2.e3	DDI-MedLine.d118.s2.e4	null	relType_1=cc	pos_1=CC	lpib=tacrolimus_NN	path2=tacrolimus_conj	eib=False	path=<cyclosporine_obl>tacrolimus_conj	path1=	lib=tacrolimus	wib=tacrolimus	lemma_1=or
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e0	DDI-MedLine.d118.s3.e1	null	lemma_1=,	pos_1=,	wib=combination	pos_2=IN	eib=False	path2=combination_obl>cyclosporine_nmod	path=sirolimus_nsubj<have_ccomp>combination_obl>cyclosporine_nmod	lib=combination	lemma_3=combination	lemma_4=with	pos_4=IN	relType_4=case	path1=sirolimus_nsubj	relType_2=case	relType_3=obl	pos_3=NN	lpib=combination_NN	relType_1=punct	lemma_2=in
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e0	DDI-MedLine.d118.s3.e2	null	path2=combination_obl>cyclosporine_nmod>tacrolimus_conj	lemma_1=,	pos_5=CC	pos_1=,	path=sirolimus_nsubj<have_ccomp>combination_obl>cyclosporine_nmod>tacrolimus_conj	wib=combination	pos_2=IN	relType_5=cc	lib=combination	lemma_3=combination	lemma_4=with	pos_4=IN	relType_4=case	relType_5=nmod	path1=sirolimus_nsubj	pos_5=NN	relType_2=case	relType_3=obl	eib=True	pos_3=NN	lpib=combination_NN	relType_1=punct	lemma_2=in	lemma_5=cyclosporine	lemma_5=or
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e0	DDI-MedLine.d118.s3.e3	null	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	lemma_6=,	relType_12=ccomp	pos_6=NN	relType_5=cc	relType_6=conj	lemma_16=rejection	pos_7=MD	lib=combination	pos_10=NN	lemma_17=episode	pos_8=VB	path1=sirolimus_nsubj	relType_21=case	relType_13=det	lemma_7=might	lemma_1=,	lemma_15=of	lemma_8=have	pos_1=,	relType_20=conj	lemma_6=tacrolimus	relType_19=compound	relType_15=case	pos_16=NN	relType_8=ccomp	pos_15=IN	pos_5=NN	relType_3=obl	lpib=combination_NN	relType_1=punct	relType_10=obj	lemma_2=in	lemma_11=to	lemma_5=or	lemma_14=frequency	lemma_10=potential	relType_7=aux	wib=combination	pos_2=IN	pos_11=TO	relType_14=obj	pos_9=DT	pos_21=IN	pos_14=NN	lemma_4=with	lemma_20=reduction	pos_4=IN	relType_17=nmod	pos_12=VB	relType_2=case	pos_17=NNS	lemma_9=the	lemma_13=the	pos_5=CC	pos_13=DT	relType_16=compound	lemma_21=in	lemma_19=permit	relType_6=punct	path=sirolimus_nsubj<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	pos_19=NN	lemma_3=combination	relation_13=adverse	pos_18=,	lemma_18=,	relType_18=punct	relType_4=case	relType_5=nmod	pos_20=NNS	pos_6=,	lemma_12=reduce	relType_11=mark	eib=True	pos_3=NN	lemma_5=cyclosporine	relType_9=det
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e0	DDI-MedLine.d118.s3.e4	null	lemma_6=,	relType_12=ccomp	pos_6=NN	relType_5=cc	relType_6=conj	lemma_16=rejection	pos_7=MD	lib=combination	pos_10=NN	lemma_17=episode	pos_8=VB	path1=sirolimus_nsubj	relType_21=case	relType_13=det	lemma_7=might	relType_22=nmod	lemma_1=,	lemma_15=of	pos_22=NN	lemma_8=have	pos_1=,	lemma_22=cyclosporine	relType_20=conj	lemma_6=tacrolimus	relType_19=compound	relType_15=case	pos_16=NN	relType_8=ccomp	pos_15=IN	pos_5=NN	relType_3=obl	lpib=combination_NN	relType_1=punct	relType_10=obj	lemma_2=in	lemma_11=to	lemma_5=or	lemma_22=or	lemma_14=frequency	lemma_10=potential	relType_7=aux	wib=combination	pos_2=IN	pos_11=TO	relType_14=obj	relType_22=cc	pos_9=DT	pos_21=IN	pos_14=NN	lemma_4=with	lemma_20=reduction	pos_4=IN	relType_17=nmod	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	pos_12=VB	relType_2=case	pos_17=NNS	lemma_9=the	lemma_13=the	pos_5=CC	pos_13=DT	relType_16=compound	path=sirolimus_nsubj<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	pos_22=CC	lemma_21=in	lemma_19=permit	relType_6=punct	pos_19=NN	lemma_3=combination	relation_13=adverse	pos_18=,	lemma_18=,	relType_18=punct	relType_4=case	relType_5=nmod	pos_20=NNS	pos_6=,	lemma_12=reduce	relType_11=mark	eib=True	pos_3=NN	lemma_5=cyclosporine	relType_9=det
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e1	DDI-MedLine.d118.s3.e2	null	relType_1=cc	pos_1=CC	lpib=tacrolimus_NN	path2=tacrolimus_conj	eib=False	path1=	lib=tacrolimus	wib=tacrolimus	path=<cyclosporine_nmod>tacrolimus_conj	lemma_1=or
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e1	DDI-MedLine.d118.s3.e3	null	relType_1=cc	lemma_13=episode	pos_1=CC	lemma_4=have	relType_14=punct	pos_2=NN	pos_13=NNS	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	lemma_16=reduction	wib=tacrolimus	pos_16=NNS	relType_7=mark	lemma_15=permit	relType_11=case	relType_2=punct	pos_6=NN	relType_13=nmod	pos_17=IN	relation_8=adverse	relType_12=compound	pos_14=,	path1=cyclosporine_nmod<combination_obl	pos_3=MD	lemma_7=to	pos_9=DT	lemma_8=reduce	pos_10=NN	relType_2=conj	lemma_2=,	lemma_3=might	pos_7=TO	pos_8=VB	pos_11=IN	relType_17=case	pos_15=NN	relType_4=ccomp	relType_5=det	relType_8=ccomp	lemma_17=in	lemma_10=frequency	relType_15=compound	relType_6=obj	lemma_14=,	lpib=tacrolimus_NN	lemma_5=the	eib=True	pos_4=VB	lemma_6=potential	lemma_2=tacrolimus	pos_5=DT	lemma_9=the	lemma_11=of	lib=tacrolimus	pos_2=,	relType_3=aux	path=cyclosporine_nmod<combination_obl<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	relType_9=det	pos_12=NN	lemma_12=rejection	relType_10=obj	relType_16=conj	lemma_1=or
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e1	DDI-MedLine.d118.s3.e4	null	relType_1=cc	lemma_13=episode	lemma_18=or	pos_1=CC	lemma_4=have	relType_14=punct	pos_2=NN	pos_13=NNS	lemma_16=reduction	wib=tacrolimus	pos_16=NNS	relType_7=mark	lemma_15=permit	relType_11=case	relType_2=punct	lemma_18=cyclosporine	pos_6=NN	relType_13=nmod	pos_17=IN	relType_18=cc	relation_8=adverse	relType_12=compound	pos_14=,	path1=cyclosporine_nmod<combination_obl	pos_3=MD	lemma_7=to	pos_9=DT	lemma_8=reduce	pos_18=CC	pos_10=NN	relType_2=conj	lemma_2=,	lemma_3=might	pos_7=TO	pos_8=VB	pos_11=IN	relType_17=case	pos_18=NN	relType_18=nmod	pos_15=NN	relType_4=ccomp	relType_5=det	relType_8=ccomp	lemma_17=in	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	lemma_10=frequency	relType_15=compound	relType_6=obj	lemma_14=,	lpib=tacrolimus_NN	lemma_5=the	eib=True	pos_4=VB	lemma_6=potential	lemma_2=tacrolimus	pos_5=DT	lemma_9=the	lemma_11=of	lib=tacrolimus	path=cyclosporine_nmod<combination_obl<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	pos_2=,	relType_3=aux	relType_9=det	pos_12=NN	lemma_12=rejection	relType_10=obj	relType_16=conj	lemma_1=or
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e2	DDI-MedLine.d118.s3.e3	null	pos_7=VB	pos_13=,	lemma_1=,	pos_6=TO	lemma_16=in	pos_8=DT	lemma_13=,	lemma_14=permit	pos_16=IN	pos_2=MD	lemma_9=frequency	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	pos_1=,	lemma_10=of	relType_13=punct	pos_3=VB	lemma_11=rejection	relType_14=compound	lemma_15=reduction	lemma_6=to	path=tacrolimus_conj<cyclosporine_nmod<combination_obl<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod	path1=tacrolimus_conj<cyclosporine_nmod<combination_obl	eib=False	relation_6=adverse	relType_12=nmod	relType_2=aux	relType_10=case	pos_14=NN	pos_9=NN	lib=have	lemma_3=have	pos_4=DT	lemma_7=reduce	lpib=have_VB	relType_6=mark	pos_12=NNS	lemma_4=the	lemma_8=the	relType_9=obj	lemma_5=potential	pos_10=IN	pos_5=NN	relType_16=case	pos_11=NN	pos_15=NNS	relType_3=ccomp	relType_11=compound	relType_5=obj	wib=have	relType_7=ccomp	relType_15=conj	lemma_2=might	relType_8=det	relType_1=punct	relType_4=det	lemma_12=episode
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e2	DDI-MedLine.d118.s3.e4	null	pos_7=VB	pos_13=,	lemma_1=,	pos_6=TO	lemma_16=in	pos_8=DT	lemma_13=,	path=tacrolimus_conj<cyclosporine_nmod<combination_obl<have_ccomp>reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	lemma_14=permit	pos_16=IN	relType_17=cc	pos_2=MD	lemma_9=frequency	pos_1=,	relType_13=punct	lemma_10=of	pos_3=VB	lemma_11=rejection	relType_14=compound	lemma_15=reduction	lemma_6=to	lemma_17=cyclosporine	pos_17=NN	path1=tacrolimus_conj<cyclosporine_nmod<combination_obl	relation_6=adverse	relType_12=nmod	relType_2=aux	relType_10=case	pos_14=NN	pos_9=NN	lib=have	lemma_3=have	pos_4=DT	lemma_7=reduce	lpib=have_VB	relType_6=mark	pos_12=NNS	lemma_4=the	lemma_8=the	relType_9=obj	lemma_5=potential	pos_10=IN	relType_17=nmod	lemma_17=or	path2=reduce_ccomp>frequency_obj>episode_nmod>reduction_conj>cyclosporine_nmod>dosage_conj>tacrolimus_compound	pos_5=NN	relType_16=case	pos_11=NN	pos_15=NNS	relType_3=ccomp	eib=True	relType_11=compound	relType_5=obj	wib=have	relType_7=ccomp	relType_15=conj	pos_17=CC	lemma_2=might	relType_8=det	relType_1=punct	relType_4=det	lemma_12=episode
DDI-MedLine.d118.s3	DDI-MedLine.d118.s3.e3	DDI-MedLine.d118.s3.e4	null	relType_1=cc	path2=dosage_conj>tacrolimus_compound	pos_1=CC	lpib=tacrolimus_NN	eib=False	path=<cyclosporine_nmod>dosage_conj>tacrolimus_compound	path1=	lib=tacrolimus	wib=tacrolimus	lemma_1=or
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e0	DDI-MedLine.d185.s0.e1	null	pos_7=NNS	relType_8=case	path2=pharmacokinetic_nmod>panobinostat_nmod	pos_2=VBN	lpib=mediate_VBN	pos_6=JJ	lemma_3=cyp3a4	relType_4=nmod	pos_1=HYPH	relType_5=case	eib=False	lemma_7=pharmacokinetic	relType_6=amod	lib=mediate	pos_4=NN	pos_8=IN	path1=ketoconazole_obl<mediate_amod<inhibition_nmod	relType_2=amod	lemma_1=-	pos_5=IN	relType_7=nmod	wib=mediated	lemma_5=on	pos_3=NN	lemma_4=inhibition	lemma_2=mediate	relType_3=compound	path=ketoconazole_obl<mediate_amod<inhibition_nmod<effect_ROOT>pharmacokinetic_nmod>panobinostat_nmod	lemma_6=clinical	relType_1=punct	lemma_8=of
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e0	DDI-MedLine.d185.s0.e2	null	pos_7=NNS	relType_8=case	pos_2=VBN	lpib=mediate_VBN	path2=pharmacokinetic_nmod>panobinostat_nmod>lbh589_dep	pos_6=JJ	lemma_3=cyp3a4	relType_4=nmod	pos_1=HYPH	relType_9=nmod	relType_5=case	path=ketoconazole_obl<mediate_amod<inhibition_nmod<effect_ROOT>pharmacokinetic_nmod>panobinostat_nmod>lbh589_dep	lemma_7=pharmacokinetic	relType_6=amod	lib=mediate	lemma_9=(	pos_9=NN	pos_4=NN	pos_8=IN	path1=ketoconazole_obl<mediate_amod<inhibition_nmod	relType_2=amod	lemma_1=-	pos_5=IN	relType_7=nmod	pos_9=-LRB-	relType_9=punct	lemma_9=panobinostat	wib=mediated	eib=True	lemma_5=on	pos_3=NN	lemma_4=inhibition	lemma_2=mediate	relType_3=compound	lemma_6=clinical	relType_1=punct	lemma_8=of
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e0	DDI-MedLine.d185.s0.e3	null	pos_7=NNS	relType_8=case	relType_14=amod	pos_2=VBN	lpib=mediate_VBN	relType_10=punct	pos_6=JJ	lemma_11=,	lemma_10=lbh589	lemma_3=cyp3a4	relType_4=nmod	pos_1=HYPH	relType_9=nmod	relType_10=dep	lemma_15=deacetylase	relType_5=case	relType_12=det	path=ketoconazole_obl<mediate_amod<inhibition_nmod<effect_ROOT>pharmacokinetic_nmod>panobinostat_nmod>inhibitor_appos	lemma_15=histone	lemma_7=pharmacokinetic	relType_6=amod	relType_11=punct	lib=mediate	lemma_9=(	pos_13=RB	lemma_13=orally	pos_10=NN	pos_9=NN	pos_4=NN	pos_8=IN	lemma_12=a	path1=ketoconazole_obl<mediate_amod<inhibition_nmod	lemma_14=active	relType_13=advmod	pos_15=NN	relType_2=amod	lemma_1=-	pos_5=IN	relType_7=nmod	pos_9=-LRB-	pos_11=,	relType_9=punct	lemma_9=panobinostat	wib=mediated	relType_15=compound	path2=pharmacokinetic_nmod>panobinostat_nmod>inhibitor_appos	lemma_10=)	eib=True	lemma_5=on	pos_3=NN	lemma_4=inhibition	pos_10=-RRB-	lemma_2=mediate	pos_14=JJ	relType_3=compound	lemma_6=clinical	pos_12=DT	relType_1=punct	lemma_8=of
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e1	DDI-MedLine.d185.s0.e2	null	lemma_1=(	wib=LBH589	path2=lbh589_dep	eib=False	lib=lbh589	lpib=lbh589_NN	path1=	relType_1=punct	path=<panobinostat_nmod>lbh589_dep	pos_1=-LRB-
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e1	DDI-MedLine.d185.s0.e3	null	path=<panobinostat_nmod>inhibitor_appos	lemma_2=)	lemma_5=orally	relType_7=compound	pos_2=NN	pos_6=JJ	lemma_4=a	lib=lbh589	pos_7=NN	path1=	lemma_6=active	relType_2=punct	path2=inhibitor_appos	lemma_1=(	lemma_7=deacetylase	relType_6=amod	pos_4=DT	relType_2=dep	lemma_3=,	lemma_2=lbh589	lpib=lbh589_NN	pos_5=RB	lemma_7=histone	pos_1=-LRB-	relType_5=advmod	wib=LBH589	pos_3=,	eib=True	pos_2=-RRB-	relType_1=punct	relType_4=det	relType_3=punct
DDI-MedLine.d185.s0	DDI-MedLine.d185.s0.e2	DDI-MedLine.d185.s0.e3	null	path=lbh589_dep<panobinostat_nmod>inhibitor_appos	lib=orally	lemma_1=)	lpib=orally_RB	relType_2=punct	path2=inhibitor_appos	pos_6=NN	pos_4=RB	lemma_6=histone	relType_3=det	lemma_3=a	wib=orally	lemma_2=,	pos_5=JJ	relType_5=amod	pos_1=-RRB-	path1=lbh589_dep	relType_4=advmod	lemma_5=active	lemma_6=deacetylase	relType_6=compound	eib=True	pos_3=DT	pos_2=,	relType_1=punct	lemma_4=orally
DDI-MedLine.d185.s2	DDI-MedLine.d185.s2.e0	DDI-MedLine.d185.s2.e1	null	lemma_1=,	pos_5=CC	relType_7=case	lib=pharmacokinetic	pos_1=,	lemma_2=on	lemma_6=safety	pos_6=NN	pos_2=IN	relType_5=cc	lemma_4=pharmacokinetic	relType_6=conj	wib=pharmacokinetics	eib=False	relType_3=det	pos_4=NNS	relType_4=obl	lpib=pharmacokinetic_NNS	path=ketoconazole_appos<inhibitor_nmod<effect_obj<evaluate_ROOT>pharmacokinetic_obl>panobinostat_nmod	lemma_7=of	relType_2=case	pos_3=DT	lemma_5=and	pos_7=IN	path1=ketoconazole_appos<inhibitor_nmod<effect_obj	lemma_3=the	relType_1=punct	path2=pharmacokinetic_obl>panobinostat_nmod
DDI-MedLine.d185.s5	DDI-MedLine.d185.s5.e0	DDI-MedLine.d185.s5.e1	null	relType_3=dep	path2=ketoconazole_obl	path=panobinostat_compound<dose_nsubj:pass<administer_ROOT>ketoconazole_obl	lemma_4=-	pos_4=HYPH	relType_6=case	eib=False	pos_6=IN	pos_2=VBD	lpib=dose_NN	pos_1=NN	path1=panobinostat_compound<dose_nsubj:pass	wib=dose	relType_4=punct	relType_2=aux:pass	lemma_6=with	lib=dose	lemma_5=administer	lemma_3=co	pos_3=NN	relType_1=nsubj:pass	lemma_2=be	relType_5=ROOT	lemma_1=dose	pos_5=VBN
DDI-MedLine.d185.s7	DDI-MedLine.d185.s7.e0	DDI-MedLine.d185.s7.e1	mechanism	relType_18=dep	relType_4=dep	lemma_22=of	lemma_1=,	relType_10=punct	relType_9=conj	lemma_11=8	lemma_2=there	relType_16=nmod	relType_17=punct	pos_1=,	lemma_14=increase	pos_6=CD	relType_20=cc	relType_19=punct	relType_21=conj	lemma_7=-	path1=ketoconazole_nmod<presence_obl	lemma_21=auc	eib=False	path=ketoconazole_nmod<presence_obl<be_ROOT>increase_nsubj>auc_conj>panobinostat_nmod	lemma_4=1	relType_13=amod	pos_3=VBD	path2=increase_nsubj>auc_conj>panobinostat_nmod	relType_12=punct	pos_8=CC	lemma_5=.	pos_13=NN	lemma_12=-	pos_14=NN	pos_22=IN	relType_22=case	lemma_10=.	pos_4=CD	pos_18=NN	relType_2=expl	relType_15=case	relType_11=nummod	lib=be	relType_3=ROOT	pos_7=HYPH	relType_5=punct	lemma_13=fold	lemma_3=be	relType_6=nummod	pos_16=NN	pos_17=-LRB-	wib=was	pos_11=CD	relation_13=beneficial	pos_2=EX	pos_5=.	lemma_8=and	pos_15=IN	lemma_6=6	lemma_18=max	lemma_15=in	lemma_20=and	relType_7=dep	pos_9=CD	relType_14=nsubj	pos_20=CC	pos_10=.	lemma_9=1	pos_12=HYPH	lemma_17=(	lemma_16=c	relType_1=punct	lpib=be_VBD	lemma_19=)	relType_8=cc	pos_19=-RRB-	pos_21=NN
DDI-MedLine.d185.s12	DDI-MedLine.d185.s12.e0	DDI-MedLine.d185.s12.e1	null	relType_1=case	pos_2=NN	relType_5=csubj:pass	lemma_5=feasible	path2=increase_obl>parameter_nmod>pk_compound>panobinostat_compound	lemma_4=be	relType_7=det	pos_8=VBN	relType_8=amod	path1=panobinostat_nmod<administration_nsubj	lemma_9=increase	relType_9=obl	lemma_8=observe	lemma_6=as	relType_6=case	wib=CYP3A	relType_4=cop	relation_8=beneficial	pos_3=NNS	eib=False	pos_6=IN	lpib=cyp3a_NN	pos_1=IN	relType_10=case	pos_9=NN	lemma_3=inhibitor	pos_7=DT	pos_5=JJ	lemma_10=in	path=panobinostat_nmod<administration_nsubj<feasible_csubj:pass>increase_obl>parameter_nmod>pk_compound>panobinostat_compound	relType_2=compound	lib=cyp3a	relType_3=nmod	pos_10=IN	lemma_1=with	lemma_2=cyp3a	lemma_7=the	pos_4=VBZ
DDI-MedLine.d185.s13	DDI-MedLine.d185.s13.e0	DDI-MedLine.d185.s13.e1	null	path1=panobinostat_nmod<dosing_nsubj:pass	relType_8=amod	relType_1=aux:pass	pos_3=VBN	lemma_10=of	relType_5=compound	path2=necessary_parataxis>monitoring_nsubj>event_nmod>relate_amod>panobinostat_obl	lemma_6=inhibitor	pos_8=JJ	pos_2=RB	relType_6=obl	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=be	pos_7=,	relType_10=case	lemma_7=,	pos_9=NN	lemma_4=with	lib=be	pos_4=IN	path=panobinostat_nmod<dosing_nsubj:pass<study_ccomp>necessary_parataxis>monitoring_nsubj>event_nmod>relate_amod>panobinostat_obl	relType_4=case	pos_10=IN	wib=was	lemma_8=close	lemma_9=monitoring	pos_5=NN	lemma_3=study	relType_3=ccomp	relType_9=nsubj	relType_7=punct	pos_6=NNS	lemma_5=cyp3a	lpib=be_VBD	lemma_2=not
DDI-MedLine.d180.s1	DDI-MedLine.d180.s1.e0	DDI-MedLine.d180.s1.e1	null	lemma_1=(	eib=False	lpib=dznep_NN	path1=	wib=DZNep	path2=dznep_appos	relType_1=punct	pos_1=-LRB-	lib=dznep	path=<a_dep>dznep_appos
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e0	DDI-MedLine.d180.s10.e1	null	pos_1=JJ	relType_4=cc	wib=insensitive	path=DZNep_compound<cell_obl<overexpress_ccomp>cotreatment_conj>dznep_nmod	relType_6=case	eib=False	pos_6=IN	lemma_2=cell	lemma_5=cotreatment	lemma_3=,	lemma_6=with	lemma_1=insensitive	relType_5=conj	lpib=insensitive_JJ	path1=DZNep_compound<cell_obl	relType_2=obl	pos_2=NNS	path2=cotreatment_conj>dznep_nmod	pos_5=NN	lib=insensitive	pos_3=,	pos_4=CC	lemma_4=and	relType_1=amod	relType_3=punct
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e0	DDI-MedLine.d180.s10.e2	null	relType_7=cc	pos_1=JJ	relType_4=cc	wib=insensitive	relType_6=case	path=DZNep_compound<cell_obl<overexpress_ccomp>cotreatment_conj>dznep_nmod>abt_conj	pos_6=IN	lemma_2=cell	lemma_5=cotreatment	lemma_3=,	pos_7=CC	relType_7=nmod	lemma_6=with	lemma_1=insensitive	lemma_7=dznep	relType_5=conj	lpib=insensitive_JJ	path2=cotreatment_conj>dznep_nmod>abt_conj	path1=DZNep_compound<cell_obl	relType_2=obl	pos_2=NNS	pos_5=NN	lib=insensitive	pos_3=,	eib=True	pos_4=CC	lemma_7=and	lemma_4=and	relType_1=amod	pos_7=NN	relType_3=punct
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e0	DDI-MedLine.d180.s10.e3	null	pos_12=CD	pos_1=JJ	relType_8=punct	relType_21=conj	pos_22=IN	pos_10=NN	pos_13=NN	pos_18=NN	lemma_3=,	pos_19=CC	lemma_1=insensitive	lemma_7=dznep	lib=insensitive	pos_3=,	lemma_8=-	lemma_4=and	relType_8=conj	relType_1=amod	relation_23=neutral	lemma_17=inhibited	pos_20=VBN	relType_6=case	pos_8=NN	pos_16=RB	pos_6=IN	pos_8=HYPH	lemma_19=and	relType_22=case	lemma_5=cotreatment	lemma_15=,	relType_7=nmod	relType_2=obl	relType_17=amod	lemma_8=abt	pos_5=NN	pos_8=CD	path=DZNep_compound<cell_obl<overexpress_ccomp>cotreatment_conj>dznep_nmod>apoptosis_conj>cell_nmod>dznep_compound	pos_7=NN	relType_3=punct	lemma_18=growth	pos_8=,	lemma_22=of	lemma_9=a	relType_7=cc	lemma_11=-	lemma_8=,	relType_20=amod	pos_21=NN	pos_15=,	relType_11=punct	lemma_21=apoptosis	pos_9=DT	pos_14=NN	relType_15=punct	relType_16=advmod	lemma_10=bcl	lemma_16=synergistically	relType_5=conj	lpib=insensitive_JJ	pos_4=CC	lemma_12=2	relType_14=conj	relType_8=nummod	relType_4=cc	pos_17=JJ	wib=insensitive	path2=cotreatment_conj>dznep_nmod>apoptosis_conj>cell_nmod>dznep_compound	pos_11=HYPH	lemma_13=family	lemma_14=inhibitor	relType_10=compound	lemma_2=cell	relType_13=compound	pos_7=CC	lemma_6=with	relType_19=cc	lemma_20=induce	path1=DZNep_compound<cell_obl	pos_2=NNS	lemma_8=737	eib=True	lemma_7=and	relType_12=nummod	relType_18=conj	relType_9=det
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e1	DDI-MedLine.d180.s10.e2	effect	relType_1=cc	lpib=abt_NN	pos_1=CC	wib=ABT	eib=False	lib=abt	path2=abt_conj	path1=	lemma_1=and	path=<dznep_nmod>abt_conj
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e1	DDI-MedLine.d180.s10.e3	null	relType_1=cc	relType_14=amod	pos_1=CC	relType_7=compound	relType_12=conj	pos_2=NN	relType_2=nummod	pos_16=IN	path1=	pos_6=CD	lemma_6=2	lemma_9=,	pos_2=HYPH	lemma_2=abt	lemma_7=family	relType_2=punct	pos_8=NN	lemma_2=-	pos_2=CD	lemma_11=inhibited	relType_11=amod	path=<dznep_nmod>apoptosis_conj>cell_nmod>dznep_compound	pos_5=HYPH	relType_10=advmod	pos_12=NN	lemma_13=and	lemma_16=of	relType_3=det	relType_2=conj	lemma_3=a	lemma_2=,	pos_4=NN	relType_13=cc	wib=ABT	pos_15=NN	lemma_12=growth	relType_5=punct	relType_4=compound	lemma_8=inhibitor	relType_6=nummod	path2=apoptosis_conj>cell_nmod>dznep_compound	lemma_4=bcl	lemma_10=synergistically	relType_9=punct	pos_13=CC	pos_14=VBN	lpib=abt_NN	relType_16=case	eib=True	pos_3=DT	relation_16=neutral	lib=abt	lemma_14=induce	relType_15=conj	relType_8=conj	pos_2=,	pos_11=JJ	lemma_15=apoptosis	lemma_2=737	pos_9=,	lemma_5=-	pos_7=NN	pos_10=RB	lemma_1=and
DDI-MedLine.d180.s10	DDI-MedLine.d180.s10.e2	DDI-MedLine.d180.s10.e3	null	lemma_6=family	pos_2=DT	relType_1=nummod	lemma_1=,	lemma_15=of	relType_9=advmod	relType_10=amod	pos_1=,	lemma_4=-	lemma_5=2	relType_12=cc	lemma_1=737	relType_8=punct	lemma_2=a	pos_1=HYPH	pos_12=CC	pos_4=HYPH	lemma_8=,	pos_13=VBN	path1=abt_conj	relType_11=conj	pos_6=NN	pos_5=CD	pos_1=CD	lemma_14=apoptosis	relType_13=amod	wib=Bcl	lemma_3=bcl	pos_14=NN	lemma_11=growth	relType_15=case	lib=bcl	lemma_9=synergistically	relType_4=punct	relType_5=nummod	pos_10=JJ	lemma_1=-	pos_9=RB	path2=apoptosis_conj>cell_nmod>dznep_compound	lpib=bcl_NN	lemma_10=inhibited	relation_14=neutral	pos_15=IN	relType_6=compound	pos_11=NN	eib=True	lemma_7=inhibitor	pos_3=NN	relType_2=det	pos_8=,	lemma_12=and	relType_3=compound	relType_1=punct	pos_7=NN	lemma_13=induce	relType_14=conj	path=abt_conj<dznep_nmod>apoptosis_conj>cell_nmod>dznep_compound	relType_7=conj
DDI-MedLine.d180.s12	DDI-MedLine.d180.s12.e0	DDI-MedLine.d180.s12.e1	null	lemma_13=the	lemma_15=of	relType_7=case	lemma_1=insensitivity	lemma_11=,	pos_2=MD	pos_13=DT	lib=insensitivity	pos_3=VB	lemma_9=-	pos_12=CC	relType_3=aux:pass	path=dznep_compound<insensitivity_nsubj:pass<associate_ROOT>and_dep>combination_dep>induce_acl>abt_nsubj:pass	relType_5=case	pos_6=NN	pos_8=NN	relType_6=obl	pos_9=HYPH	eib=False	relType_15=mark	relType_11=punct	lemma_5=with	lemma_14=combination	relType_2=aux	pos_14=NN	pos_1=NN	lemma_8=bcl	pos_4=VBN	lpib=insensitivity_NN	pos_10=CD	lemma_10=2	lemma_3=be	pos_5=IN	relType_14=dep	path2=and_dep>combination_dep>induce_acl>abt_nsubj:pass	lemma_6=overexpression	pos_11=,	relType_9=punct	relType_4=ROOT	relType_10=nummod	pos_15=IN	lemma_7=of	lemma_4=associate	relType_8=nmod	pos_7=IN	relType_12=dep	lemma_12=and	relType_13=det	wib=insensitivity	relType_1=nsubj:pass	lemma_2=might	path1=dznep_compound<insensitivity_nsubj:pass
DDI-MedLine.d180.s12	DDI-MedLine.d180.s12.e0	DDI-MedLine.d180.s12.e2	null	relType_16=cc	lemma_13=the	lemma_16=abt	lemma_15=of	relType_7=case	lemma_1=insensitivity	lemma_11=,	relType_16=nsubj:pass	pos_2=MD	pos_13=DT	lib=insensitivity	lemma_16=737	pos_3=VB	lemma_9=-	pos_12=CC	relType_3=aux:pass	pos_16=HYPH	relType_5=case	pos_16=CC	pos_6=NN	pos_8=NN	relType_6=obl	pos_9=HYPH	relType_15=mark	relType_11=punct	lemma_5=with	lemma_14=combination	relType_2=aux	pos_14=NN	pos_1=NN	lemma_8=bcl	pos_4=VBN	lpib=insensitivity_NN	path=dznep_compound<insensitivity_nsubj:pass<associate_ROOT>and_dep>combination_dep>induce_acl>abt_nsubj:pass>dznep_conj	pos_16=CD	pos_10=CD	lemma_10=2	lemma_3=be	pos_5=IN	relType_14=dep	relType_16=nummod	lemma_16=-	pos_16=NN	lemma_16=and	path2=and_dep>combination_dep>induce_acl>abt_nsubj:pass>dznep_conj	lemma_6=overexpression	relType_9=punct	pos_11=,	relType_4=ROOT	relType_10=nummod	relType_16=punct	pos_15=IN	lemma_7=of	lemma_4=associate	eib=True	pos_7=IN	relType_8=nmod	relType_12=dep	lemma_12=and	relType_13=det	wib=insensitivity	relType_1=nsubj:pass	lemma_2=might	path1=dznep_compound<insensitivity_nsubj:pass
DDI-MedLine.d180.s12	DDI-MedLine.d180.s12.e1	DDI-MedLine.d180.s12.e2	effect	relType_1=cc	relType_1=nummod	pos_1=CC	eib=True	path2=dznep_conj	pos_1=CD	lpib=dznep_NN	path=<abt_nsubj:pass>dznep_conj	lemma_1=-	path1=	wib=DZNep	lemma_1=737	pos_1=HYPH	relType_1=punct	lemma_1=and	lib=dznep
DDI-MedLine.d181.s4	DDI-MedLine.d181.s4.e0	DDI-MedLine.d181.s4.e1	int	relType_4=amod	pos_4=JJ	path=levothyroxine_nmod<hypothyroidism_nmod<infant_nmod>experience_acl:relcl>interaction_obj>simeticone_nmod	relType_7=case	lemma_1=who	relType_5=compound	lemma_5=drug	lemma_7=with	pos_6=NN	eib=False	pos_2=VBD	lib=experience	relType_3=det	lemma_3=a	wib=experienced	path2=experience_acl:relcl>interaction_obj>simeticone_nmod	path1=levothyroxine_nmod<hypothyroidism_nmod	relType_2=acl:relcl	lemma_4=possible	lemma_6=interaction	relType_1=nsubj	lpib=experience_VBD	lemma_2=experience	relType_6=obj	pos_5=NN	pos_3=DT	pos_7=IN	pos_1=WP
DDI-MedLine.d181.s6	DDI-MedLine.d181.s6.e0	DDI-MedLine.d181.s6.e1	null	relType_4=mark	lib=drop	relType_5=case	lemma_1=drop	pos_2=IN	pos_3=NNS	eib=False	path2=levothyroxine_advcl	lemma_2=before	pos_4=IN	lemma_4=while	pos_5=IN	lemma_3=feed	lpib=drop_NNS	wib=drops	path=infacol_compound<drop_obj<take_dep>levothyroxine_advcl	path1=infacol_compound<drop_obj	pos_1=NNS	relType_2=case	relType_3=obl	lemma_5=on	relType_1=obj
DDI-MedLine.d181.s8	DDI-MedLine.d181.s8.e0	DDI-MedLine.d181.s8.e1	null	lemma_1=with	relType_1=case	lib=simeticone	wib=simeticone	path=thyroxine_nmod<interaction_nsubj:pass>simeticone_nmod	eib=False	path2=simeticone_nmod	lpib=simeticone_NN	pos_1=IN	path1=thyroxine_nmod
DDI-MedLine.d169.s0	DDI-MedLine.d169.s0.e0	DDI-MedLine.d169.s0.e1	null	lemma_7=5	relType_1=aux	path2=absorption_obj>milligram_nmod>iron_nmod	relType_10=cc	relType_10=amod	pos_7=CD	lemma_6=of	pos_9=IN	pos_3=VB	lemma_5=absorption	relType_6=case	lemma_10=heme	pos_8=NNS	pos_2=RB	relType_7=nummod	relType_2=advmod	lemma_1=do	pos_6=IN	pos_10=CC	relType_10=conj	relType_9=case	lemma_10=nonheme	pos_4=DT	relType_3=ROOT	pos_10=JJ	lemma_4=the	path1=calcium_nsubj	lemma_8=milligram	lemma_10=or	wib=does	pos_5=NN	lib=do	pos_1=VBZ	eib=True	relType_8=nmod	lemma_9=of	relation_2=adverse	relType_5=obj	path=calcium_nsubj<inhibit_ROOT>absorption_obj>milligram_nmod>iron_nmod	lemma_3=inhibit	lpib=do_VBZ	relType_4=det	lemma_2=not
DDI-MedLine.d169.s0	DDI-MedLine.d169.s0.e0	DDI-MedLine.d169.s0.e2	null	lemma_7=5	relType_1=aux	path2=absorption_obj>milligram_nmod>iron_nmod	relType_10=cc	relType_10=amod	pos_7=CD	lemma_6=of	pos_9=IN	pos_3=VB	lemma_5=absorption	relType_6=case	lemma_10=heme	pos_8=NNS	pos_2=RB	relType_7=nummod	relType_2=advmod	lemma_1=do	pos_6=IN	pos_10=CC	relType_10=conj	relType_9=case	lemma_10=nonheme	pos_4=DT	relType_3=ROOT	pos_10=JJ	lemma_4=the	path1=calcium_nsubj	lemma_8=milligram	lemma_10=or	wib=does	pos_5=NN	lib=do	pos_1=VBZ	eib=True	relType_8=nmod	lemma_9=of	relation_2=adverse	relType_5=obj	path=calcium_nsubj<inhibit_ROOT>absorption_obj>milligram_nmod>iron_nmod	lemma_3=inhibit	lpib=do_VBZ	relType_4=det	lemma_2=not
DDI-MedLine.d169.s0	DDI-MedLine.d169.s0.e1	DDI-MedLine.d169.s0.e2	null	eib=False	path2=	path=<iron_nmod>	path1=
DDI-MedLine.d169.s1	DDI-MedLine.d169.s1.e0	DDI-MedLine.d169.s1.e1	mechanism	pos_2=DT	relType_4=amod	lemma_2=the	pos_3=RB	relType_3=advmod	relType_7=det	pos_15=JJ	relType_15=amod	relation_10=neutral	lemma_3=only	lemma_4=know	pos_9=WDT	lemma_15=nonheme	relType_6=case	path=calcium_nsubj<component_ROOT>affect_parataxis>absorption_obj>iron_nmod	lemma_14=both	relType_14=cc:preconj	lemma_13=of	pos_8=NN	pos_10=MD	relType_10=aux	pos_6=IN	lemma_1=be	pos_12=NN	relType_12=obj	pos_13=IN	lemma_6=in	pos_7=DT	pos_4=VBN	path2=affect_parataxis>absorption_obj>iron_nmod	lemma_11=affect	relType_13=case	lib=be	path1=calcium_nsubj	lemma_15=heme	relType_15=cc	lemma_15=and	pos_14=DT	wib=is	pos_5=NN	relType_1=cop	lemma_5=component	lemma_9=that	pos_1=VBZ	eib=True	relType_8=nmod	relType_9=nsubj	lemma_10=may	lemma_8=diet	relType_2=det	pos_11=VB	relType_11=parataxis	pos_15=CC	relType_15=conj	lpib=be_VBZ	lemma_7=the	relType_5=ROOT	lemma_12=absorption
DDI-MedLine.d169.s1	DDI-MedLine.d169.s1.e0	DDI-MedLine.d169.s1.e2	mechanism	pos_2=DT	relType_4=amod	lemma_2=the	pos_3=RB	relType_3=advmod	relType_7=det	pos_15=JJ	relType_15=amod	relation_10=neutral	lemma_3=only	lemma_4=know	pos_9=WDT	lemma_15=nonheme	relType_6=case	path=calcium_nsubj<component_ROOT>affect_parataxis>absorption_obj>iron_nmod	lemma_14=both	relType_14=cc:preconj	lemma_13=of	pos_8=NN	pos_10=MD	relType_10=aux	pos_6=IN	lemma_1=be	pos_12=NN	relType_12=obj	pos_13=IN	lemma_6=in	pos_7=DT	pos_4=VBN	path2=affect_parataxis>absorption_obj>iron_nmod	lemma_11=affect	relType_13=case	lib=be	path1=calcium_nsubj	lemma_15=heme	relType_15=cc	lemma_15=and	pos_14=DT	wib=is	pos_5=NN	relType_1=cop	lemma_5=component	lemma_9=that	pos_1=VBZ	eib=True	relType_8=nmod	relType_9=nsubj	lemma_10=may	lemma_8=diet	relType_2=det	pos_11=VB	relType_11=parataxis	pos_15=CC	relType_15=conj	lpib=be_VBZ	lemma_7=the	relType_5=ROOT	lemma_12=absorption
DDI-MedLine.d169.s1	DDI-MedLine.d169.s1.e1	DDI-MedLine.d169.s1.e2	null	eib=False	path2=	path=<iron_nmod>	path1=
DDI-MedLine.d169.s2	DDI-MedLine.d169.s2.e0	DDI-MedLine.d169.s2.e1	mechanism	pos_1=NN	pos_2=IN	wib=effect	relType_2=case	relation_0=neutral	eib=False	path1=calcium_compound	path2=absorption_nmod>iron_compound	lemma_1=effect	lemma_2=on	lib=effect	relType_1=nmod	path=calcium_compound<effect_nmod>absorption_nmod>iron_compound	lpib=effect_NN
DDI-MedLine.d169.s2	DDI-MedLine.d169.s2.e0	DDI-MedLine.d169.s2.e2	null	pos_7=NNS	pos_5=VBZ	relType_8=nsubj	path=calcium_compound<effect_nmod<evidence_nsubj<come_ROOT>study_obl>isolate_ccomp>effect_obj>calcium_nmod	lemma_10=not	lemma_2=on	lemma_5=come	relType_9=aux	relType_6=case	relType_12=det	lemma_9=do	pos_2=IN	relation_13=neutral	pos_4=RB	pos_6=IN	lemma_7=study	pos_8=WDT	relType_10=advmod	pos_13=NN	relType_1=nmod	pos_1=NN	lpib=effect_NN	path1=calcium_compound<effect_nmod<evidence_nsubj	lemma_4=mainly	lemma_12=the	pos_14=IN	wib=effect	relation_0=neutral	relType_4=advmod	relType_3=nmod	lemma_1=effect	path2=study_obl>isolate_ccomp>effect_obj>calcium_nmod	lemma_3=absorption	lemma_6=from	relType_2=case	relType_7=obl	eib=True	pos_11=VB	pos_9=VBD	pos_3=NN	lemma_14=of	lemma_11=isolate	relType_3=compound	pos_12=DT	lemma_3=iron	pos_10=RB	lib=effect	relType_5=ROOT	lemma_8=that	relType_11=ccomp	relType_13=obj	relType_14=case	lemma_13=effect
DDI-MedLine.d169.s2	DDI-MedLine.d169.s2.e1	DDI-MedLine.d169.s2.e2	null	lemma_9=isolate	lemma_3=come	lemma_1=absorption	relType_10=det	relType_12=case	relation_10=neutral	lib=absorption	relType_7=aux	pos_9=VB	relType_11=obj	lemma_12=of	lpib=absorption_NN	pos_2=RB	lemma_5=study	path1=iron_compound<absorption_nmod<effect_nmod<evidence_nsubj	eib=False	relType_2=advmod	pos_5=NNS	pos_8=RB	relType_9=ccomp	pos_3=VBZ	lemma_8=not	lemma_10=the	relType_1=nmod	relType_8=advmod	pos_1=NN	pos_12=IN	wib=absorption	relType_3=ROOT	path=iron_compound<absorption_nmod<effect_nmod<evidence_nsubj<come_ROOT>study_obl>isolate_ccomp>effect_obj>calcium_nmod	pos_4=IN	pos_6=WDT	pos_7=VBD	relType_4=case	lemma_7=do	relType_5=obl	path2=study_obl>isolate_ccomp>effect_obj>calcium_nmod	pos_11=NN	lemma_2=mainly	lemma_11=effect	lemma_6=that	lemma_4=from	relType_6=nsubj	pos_10=DT
DDI-MedLine.d169.s3	DDI-MedLine.d169.s3.e0	DDI-MedLine.d169.s3.e1	null	relType_4=amod	relType_1=case	pos_4=JJ	pos_2=NN	pos_3=IN	lib=absorption	relType_4=cc	lpib=absorption_NN	relType_2=nmod	pos_1=IN	path2=absorption_nmod>iron_nmod	wib=absorption	lemma_2=absorption	path1=calcium_nmod	path=calcium_nmod<effect_obj>absorption_nmod>iron_nmod	relType_3=case	eib=True	pos_4=CC	lemma_4=and	relType_4=conj	lemma_3=of	lemma_4=nonheme	lemma_4=heme	lemma_1=on
DDI-MedLine.d169.s3	DDI-MedLine.d169.s3.e0	DDI-MedLine.d169.s3.e2	null	relType_4=amod	relType_1=case	pos_4=JJ	pos_2=NN	pos_3=IN	lib=absorption	relType_4=cc	lpib=absorption_NN	relType_2=nmod	pos_1=IN	path2=absorption_nmod>iron_nmod	wib=absorption	lemma_2=absorption	path1=calcium_nmod	path=calcium_nmod<effect_obj>absorption_nmod>iron_nmod	relType_3=case	eib=True	pos_4=CC	lemma_4=and	relType_4=conj	lemma_3=of	lemma_4=nonheme	lemma_4=heme	lemma_1=on
DDI-MedLine.d169.s3	DDI-MedLine.d169.s3.e1	DDI-MedLine.d169.s3.e2	null	eib=False	path2=	path=<iron_nmod>	path1=
DDI-MedLine.d169.s5	DDI-MedLine.d169.s5.e0	DDI-MedLine.d169.s5.e1	null	relType_7=case	pos_9=IN	relType_4=cc	pos_2=IN	pos_5=CD	pos_8=NN	pos_12=JJ	lemma_12=nonheme	lemma_7=on	pos_11=NNS	lemma_11=mg	relType_12=amod	relType_9=case	lemma_6=mg	relType_1=nmod	wib=doses	path2=absorption_nmod>iron_nmod	path1=calcium_compound<dose_nmod	pos_3=CD	pos_10=CD	lemma_2=between	lib=dose	relType_3=nummod	lemma_5=1500	relType_5=conj	lemma_8=absorption	relType_10=nummod	lpib=dose_NNS	pos_1=NNS	relType_2=case	eib=True	pos_4=CC	pos_7=IN	lemma_3=200	relType_8=nmod	lemma_4=and	lemma_9=of	pos_6=NNS	relType_11=compound	path=calcium_compound<dose_nmod<effect_obj>absorption_nmod>iron_nmod	relType_6=nmod	lemma_1=dose	lemma_10=5
DDI-MedLine.d169.s5	DDI-MedLine.d169.s5.e0	DDI-MedLine.d169.s5.e2	null	path2=sulfate_obl	relType_14=amod	relType_7=case	lemma_13=as	pos_9=IN	relType_4=cc	pos_2=IN	pos_5=CD	pos_8=NN	pos_12=JJ	lemma_12=nonheme	lemma_12=iron	lemma_7=on	pos_12=-LRB-	relType_12=nmod	pos_11=NNS	lemma_11=mg	relType_12=amod	pos_12=NN	relType_9=case	lemma_6=mg	relType_12=punct	relType_1=nmod	pos_13=IN	wib=doses	path1=calcium_compound<dose_nmod<effect_obj	relType_13=case	pos_3=CD	pos_10=CD	lemma_2=between	lib=dose	relType_3=nummod	lemma_5=1500	relType_5=conj	lemma_8=absorption	relType_10=nummod	lpib=dose_NNS	path=calcium_compound<dose_nmod<effect_obj<evaluate_ROOT>sulfate_obl	pos_1=NNS	eib=True	relType_2=case	pos_4=CC	lemma_3=200	pos_7=IN	lemma_4=and	relType_8=nmod	pos_6=NNS	lemma_9=of	relType_11=compound	pos_14=JJ	lemma_14=ferrous	relType_6=nmod	lemma_1=dose	lemma_12=(	lemma_10=5
DDI-MedLine.d169.s5	DDI-MedLine.d169.s5.e1	DDI-MedLine.d169.s5.e2	null	path2=sulfate_obl	path=iron_nmod<absorption_nmod<effect_obj<evaluate_ROOT>sulfate_obl	lemma_1=(	pos_2=IN	relType_2=case	pos_3=JJ	eib=True	relType_3=amod	path1=iron_nmod<absorption_nmod<effect_obj	lpib=ferrous_JJ	relType_1=punct	lib=ferrous	pos_1=-LRB-	lemma_3=ferrous	lemma_2=as	wib=ferrous
DDI-MedLine.d169.s6	DDI-MedLine.d169.s6.e0	DDI-MedLine.d169.s6.e1	null	relType_7=case	pos_9=IN	relType_4=cc	pos_6=NN	pos_2=IN	pos_5=CD	lemma_5=800	pos_8=NN	relType_12=compound	lemma_7=on	lemma_11=mg	pos_12=NN	relType_9=case	lemma_6=mg	relType_1=nmod	wib=doses	path2=absorption_nmod>iron_nmod	path1=calcium_compound<dose_nmod	pos_3=CD	pos_10=CD	lemma_2=between	lib=dose	relType_3=nummod	relType_5=conj	lemma_8=absorption	relType_10=nummod	lpib=dose_NNS	pos_11=NN	pos_1=NNS	relType_2=case	eib=True	pos_4=CC	pos_7=IN	lemma_3=200	relType_8=nmod	lemma_4=and	lemma_9=of	relType_11=compound	path=calcium_compound<dose_nmod<effect_obj>absorption_nmod>iron_nmod	lemma_12=heme	relType_6=nmod	lemma_1=dose	lemma_10=5
DDI-MedLine.d169.s7	DDI-MedLine.d169.s7.e0	DDI-MedLine.d169.s7.e1	null	pos_2=VBN	pos_3=IN	relType_1=aux:pass	lemma_2=administer	lemma_3=as	pos_1=VBD	lemma_1=be	pos_4=NN	lib=be	relType_2=ROOT	path=calcium_nsubj:pass<administer_ROOT>chloride_obl	relType_4=compound	wib=was	relType_3=case	path2=chloride_obl	lemma_4=calcium	eib=True	path1=calcium_nsubj:pass	lpib=be_VBD
DDI-MedLine.d169.s7	DDI-MedLine.d169.s7.e0	DDI-MedLine.d169.s7.e2	null	pos_2=VBN	pos_3=IN	relType_1=aux:pass	lemma_2=administer	lemma_4=in	relType_7=cc	lemma_6=study	lemma_3=as	relType_6=obl	pos_1=VBD	lemma_1=be	lemma_5=all	pos_4=NN	path2=ingest_conj>mineral_nsubj:pass	relType_4=obl	lib=be	pos_7=CC	relType_2=ROOT	pos_4=IN	relType_5=det	path=calcium_nsubj:pass<administer_ROOT>ingest_conj>mineral_nsubj:pass	relType_4=compound	lemma_4=chloride	relType_4=case	wib=was	relType_3=case	lemma_4=calcium	eib=True	lemma_7=and	pos_5=DT	pos_6=NNS	path1=calcium_nsubj:pass	lpib=be_VBD
DDI-MedLine.d169.s7	DDI-MedLine.d169.s7.e1	DDI-MedLine.d169.s7.e2	null	pos_2=DT	relType_1=case	lemma_1=in	lemma_2=all	relType_4=cc	lpib=study_NNS	pos_3=NNS	eib=False	pos_1=IN	wib=studies	path2=ingest_conj>mineral_nsubj:pass	lib=study	relType_3=obl	lemma_3=study	pos_4=CC	path=chloride_obl<administer_ROOT>ingest_conj>mineral_nsubj:pass	relType_2=det	path1=chloride_obl	lemma_4=and
DDI-MedLine.d169.s9	DDI-MedLine.d169.s9.e0	DDI-MedLine.d169.s9.e1	mechanism	relType_8=nummod	relType_7=case	relType_4=nmod	lemma_10=heme	pos_6=NN	pos_2=IN	path=calcium_compound<dose_nsubj<diminish_ROOT>absorption_obj>iron_nmod	path2=absorption_obj>iron_nmod	relType_9=compound	lemma_5=diminish	lpib=dose_NN	relType_10=compound	lemma_6=absorption	pos_10=NN	pos_9=NN	pos_4=NN	pos_1=NN	lemma_9=mg	wib=dose	lemma_8=5	pos_3=CD	lemma_4=mg	relType_1=nsubj	path1=calcium_compound<dose_nsubj	lib=dose	relType_3=nummod	lemma_7=of	relType_6=obj	lemma_2=of	relType_2=case	eib=True	pos_7=IN	lemma_3=800	pos_8=CD	relType_5=ROOT	lemma_1=dose	pos_5=VBN
DDI-MedLine.d179.s0	DDI-MedLine.d179.s0.e0	DDI-MedLine.d179.s0.e1	int	relType_1=cc	pos_1=CC	lib=docetaxel	lpib=docetaxel_NN	wib=docetaxel	eib=False	path=<sunitinib_nmod>docetaxel_conj	path1=	lemma_1=and	path2=docetaxel_conj
DDI-MedLine.d179.s2	DDI-MedLine.d179.s2.e0	DDI-MedLine.d179.s2.e1	null	relType_1=cc	relType_8=case	pos_2=DT	pos_1=CC	pos_4=JJ	relType_4=amod	pos_3=IN	pos_6=JJ	pos_5=CC	path=sunitinib_nmod<use_nmod<efficacy_obj>that_conj>administration_nmod>sunitinib_nmod	lemma_2=that	relType_5=cc	relType_6=conj	eib=False	relType_2=conj	pos_8=IN	lemma_4=concurrent	lemma_7=administration	relType_7=nmod	relType_3=case	lpib=concurrent_JJ	path2=that_conj>administration_nmod>sunitinib_nmod	wib=concurrent	path1=sunitinib_nmod<use_nmod	lib=concurrent	lemma_3=of	lemma_6=sequential	pos_7=NN	lemma_8=of	lemma_1=and	lemma_5=or
DDI-MedLine.d179.s2	DDI-MedLine.d179.s2.e0	DDI-MedLine.d179.s2.e2	null	relType_1=cc	relType_8=case	pos_2=DT	pos_1=CC	pos_4=JJ	relType_4=amod	pos_3=IN	pos_6=JJ	pos_5=CC	lemma_2=that	relType_9=nmod	path2=that_conj>administration_nmod>sunitinib_nmod>docetaxel_conj	relType_5=cc	relType_6=conj	relType_2=conj	pos_9=NN	pos_8=IN	lemma_9=and	pos_9=CC	lemma_4=concurrent	lemma_7=administration	relType_7=nmod	path=sunitinib_nmod<use_nmod<efficacy_obj>that_conj>administration_nmod>sunitinib_nmod>docetaxel_conj	relType_3=case	lpib=concurrent_JJ	wib=concurrent	eib=True	path1=sunitinib_nmod<use_nmod	lib=concurrent	lemma_3=of	lemma_9=sunitinib	lemma_6=sequential	pos_7=NN	lemma_8=of	relType_9=cc	lemma_1=and	lemma_5=or
DDI-MedLine.d179.s2	DDI-MedLine.d179.s2.e1	DDI-MedLine.d179.s2.e2	null	relType_1=cc	pos_1=CC	lib=docetaxel	lpib=docetaxel_NN	wib=docetaxel	eib=False	path=<sunitinib_nmod>docetaxel_conj	path1=	lemma_1=and	path2=docetaxel_conj
DDI-MedLine.d179.s3	DDI-MedLine.d179.s3.e0	DDI-MedLine.d179.s3.e1	null	relType_1=cc	pos_1=CC	lib=docetaxel	lpib=docetaxel_NN	wib=docetaxel	eib=False	path=<sunitinib_obl>docetaxel_conj	path1=	lemma_1=or	path2=docetaxel_conj
DDI-MedLine.d179.s5	DDI-MedLine.d179.s5.e0	DDI-MedLine.d179.s5.e1	null	relType_4=amod	relType_12=conj	pos_4=JJ	pos_19=IN	pos_2=NN	relType_7=case	relType_11=cc	lemma_2=dose	lemma_16=g1	relType_5=compound	relType_16=compound	wib=exhibited	lemma_5=growth	pos_6=NN	lemma_8=NSCLC	pos_10=NNS	pos_17=NN	pos_1=VBD	path2=arrest_advcl>docetaxel_nsubj	relType_2=obl:npmod	relType_9=compound	eib=False	relType_14=obj	lemma_3=-	lemma_12=arrest	lib=exhibit	pos_14=NN	lemma_9=cell	pos_13=NN	pos_9=NN	relType_19=mark	relType_15=case	pos_18=,	pos_8=NNP	path=Sunitinib_nsubj<exhibit_ROOT>arrest_advcl>docetaxel_nsubj	lemma_11=and	lpib=exhibit_VBD	relType_13=compound	lemma_15=at	lemma_18=,	lemma_19=whereas	relType_8=compound	pos_11=CC	relType_18=punct	pos_16=NN	path1=Sunitinib_nsubj	pos_15=IN	relType_6=obj	relType_1=ROOT	pos_5=NN	pos_7=IN	lemma_7=in	pos_3=HYPH	lemma_4=dependent	lemma_17=phase	lemma_10=line	lemma_1=exhibit	pos_12=VBN	lemma_6=inhibition	relType_10=obl	relType_3=punct	relType_17=obl	lemma_13=cell	lemma_14=cycle
DDI-MedLine.d179.s6	DDI-MedLine.d179.s6.e0	DDI-MedLine.d179.s6.e1	effect	relType_1=cc	pos_1=CC	lib=docetaxel	lpib=docetaxel_NN	wib=docetaxel	eib=False	path=<sunitinib_nmod>docetaxel_conj	path1=	lemma_1=and	path2=docetaxel_conj
DDI-MedLine.d179.s7	DDI-MedLine.d179.s7.e0	DDI-MedLine.d179.s7.e1	effect	path2=sunitinib_obl	pos_2=IN	path1=docetaxel_obl	relType_1=case	relType_2=case	pos_1=VBN	eib=False	lib=follow	lemma_1=follow	lemma_2=by	path=docetaxel_obl<expose_advcl>sunitinib_obl	lpib=follow_VBN	wib=followed
DDI-MedLine.d179.s8	DDI-MedLine.d179.s8.e0	DDI-MedLine.d179.s8.e1	effect	lib=exposure	pos_3=RB	relType_3=advmod	pos_6=DT	lemma_8=exposure	lemma_7=subsequent	pos_9=IN	lemma_5=by	wib=exposure	relType_5=case	relType_8=obl	pos_8=NN	lpib=exposure_NN	eib=False	lemma_6=the	pos_2=VBD	lemma_9=to	relType_9=case	pos_1=NN	pos_4=VBN	path=docetaxel_compound<exposure_obl<activate_acl:relcl<pathway_nsubj:pass<suppress_ccomp>exposure_obl>sunitinib_nmod	lemma_3=efficiently	relType_7=amod	path2=exposure_obl>sunitinib_nmod	relation_3=adverse	relType_4=ccomp	relType_2=aux:pass	pos_5=IN	path1=docetaxel_compound<exposure_obl<activate_acl:relcl<pathway_nsubj:pass	relType_6=det	lemma_4=suppress	lemma_1=exposure	pos_7=JJ	lemma_2=be	relType_1=obl
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e0	DDI-MedLine.d179.s10.e1	null	lemma_21=-	pos_8=JJ	lemma_8=proliferative	pos_6=AFX	pos_20=NN	lemma_20=k	relType_17=compound	pos_18=NN	relType_15=obl	lemma_24=but	relType_3=amod	pos_7=HYPH	lemma_10=in	pos_19=CC	relType_25=det	lemma_18=t790m	relType_26=amod	lemma_12=in	pos_3=JJ	lemma_11=vitro	relType_21=punct	relType_5=ROOT	pos_2=DT	relType_1=case	relType_22=conj	pos_22=NN	relType_27=conj	lpib=single_JJ	relType_4=nmod	relation_8=neutral	pos_24=CC	wib=single	pos_1=IN	relType_11=advmod	lemma_19=and	pos_12=IN	pos_27=NN	path2=superior_parataxis>mutation_nsubj>administration_conj>docetaxel_nmod	lemma_4=agent	path1=Sunitinib_nsubj	lemma_26=sequential	relType_16=case	lemma_15=line	lemma_9=effect	relType_18=nmod	lemma_27=administration	relType_23=nsubj	lemma_28=of	pos_5=VBZ	pos_16=IN	relType_12=case	pos_26=JJ	pos_21=HYPH	pos_17=NNP	pos_14=NN	lemma_16=with	lemma_5=exhibit	pos_23=NNS	relType_9=obj	pos_11=FW	relType_6=obl:npmod	path=Sunitinib_nsubj<exhibit_ROOT>superior_parataxis>mutation_nsubj>administration_conj>docetaxel_nmod	lib=single	relType_28=case	lemma_3=single	lemma_6=anti	relType_8=amod	pos_10=FW	lemma_2=a	relType_14=compound	pos_13=NNP	lemma_7=-	pos_25=DT	eib=False	lemma_17=EGFR	pos_9=NNS	lemma_13=NSCLC	relType_24=cc	relType_10=compound	pos_4=NN	relType_13=compound	lemma_14=cell	lemma_25=the	relType_19=cc	lemma_23=mutation	lemma_1=as	pos_15=NNS	relType_20=compound	relType_7=punct	relType_2=det	pos_28=IN	lemma_22=ras
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e0	DDI-MedLine.d179.s10.e2	null	lemma_21=-	path2=superior_parataxis>mutation_nsubj>follow_acl>sunitinib_obl	pos_8=JJ	lemma_8=proliferative	pos_6=AFX	pos_20=NN	lemma_20=k	relType_17=compound	pos_18=NN	relType_15=obl	lemma_24=but	relType_3=amod	pos_7=HYPH	lemma_10=in	pos_19=CC	relType_25=det	lemma_18=t790m	relType_26=amod	lemma_12=in	pos_3=JJ	lemma_11=vitro	relType_21=punct	relType_5=ROOT	pos_30=IN	pos_2=DT	relType_1=case	lemma_29=docetaxel	relType_22=conj	pos_22=NN	relType_27=conj	lpib=single_JJ	relType_4=nmod	relation_8=neutral	pos_24=CC	wib=single	pos_29=NN	pos_1=IN	relType_11=advmod	lemma_19=and	pos_12=IN	pos_27=NN	lemma_4=agent	relType_29=nmod	lemma_29=follow	path1=Sunitinib_nsubj	lemma_26=sequential	relType_16=case	lemma_15=line	lemma_9=effect	relType_18=nmod	lemma_27=administration	relType_23=nsubj	lemma_28=of	pos_5=VBZ	pos_16=IN	relType_12=case	relType_29=acl	pos_26=JJ	pos_21=HYPH	pos_17=NNP	pos_14=NN	lemma_16=with	lemma_5=exhibit	pos_23=NNS	relType_9=obj	pos_11=FW	relType_6=obl:npmod	lib=single	pos_29=VBN	relType_28=case	relType_30=case	lemma_3=single	lemma_6=anti	path=Sunitinib_nsubj<exhibit_ROOT>superior_parataxis>mutation_nsubj>follow_acl>sunitinib_obl	relType_8=amod	pos_10=FW	lemma_2=a	relType_14=compound	pos_13=NNP	lemma_7=-	pos_25=DT	lemma_17=EGFR	pos_9=NNS	lemma_13=NSCLC	relType_24=cc	relType_10=compound	pos_4=NN	relType_13=compound	lemma_14=cell	lemma_25=the	lemma_30=by	relType_19=cc	lemma_23=mutation	lemma_1=as	pos_15=NNS	eib=True	relType_20=compound	relType_7=punct	relType_2=det	pos_28=IN	lemma_22=ras
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e0	DDI-MedLine.d179.s10.e3	null	lemma_21=-	pos_8=JJ	relType_31=obl	lemma_8=proliferative	pos_31=VBZ	path=Sunitinib_nsubj<exhibit_ROOT>superior_parataxis>sunitinib_obl	pos_6=AFX	pos_20=NN	lemma_20=k	relType_17=compound	relType_32=parataxis	pos_18=NN	relType_15=obl	lemma_24=but	relType_3=amod	pos_7=HYPH	lemma_10=in	pos_19=CC	relType_25=det	lemma_18=t790m	relType_26=amod	lemma_12=in	pos_3=JJ	lemma_11=vitro	relType_21=punct	relType_5=ROOT	pos_30=IN	pos_2=DT	relType_1=case	lemma_29=docetaxel	relType_22=conj	pos_22=NN	relType_27=conj	lpib=single_JJ	relType_31=cop	relType_4=nmod	relation_8=neutral	pos_32=JJ	pos_24=CC	lemma_31=sunitinib	wib=single	pos_29=NN	pos_1=IN	relType_11=advmod	lemma_19=and	pos_12=IN	lemma_33=to	path2=superior_parataxis>sunitinib_obl	pos_27=NN	lemma_4=agent	relType_29=nmod	lemma_29=follow	path1=Sunitinib_nsubj	lemma_26=sequential	relType_16=case	lemma_15=line	pos_31=NN	lemma_9=effect	relType_18=nmod	lemma_32=superior	lemma_27=administration	relType_23=nsubj	lemma_28=of	pos_5=VBZ	pos_16=IN	relType_12=case	relType_29=acl	pos_26=JJ	pos_21=HYPH	pos_17=NNP	pos_14=NN	lemma_16=with	lemma_5=exhibit	pos_33=IN	pos_23=NNS	relType_9=obj	pos_11=FW	relType_6=obl:npmod	lib=single	pos_29=VBN	relType_28=case	relType_30=case	lemma_3=single	lemma_6=anti	relType_8=amod	relType_33=case	pos_10=FW	lemma_2=a	relType_14=compound	pos_13=NNP	lemma_7=-	pos_25=DT	lemma_17=EGFR	pos_9=NNS	lemma_13=NSCLC	relType_24=cc	relType_10=compound	pos_4=NN	relType_13=compound	lemma_14=cell	lemma_25=the	lemma_30=by	lemma_31=be	relType_19=cc	lemma_23=mutation	lemma_1=as	pos_15=NNS	eib=True	relType_20=compound	relType_7=punct	relType_2=det	pos_28=IN	lemma_22=ras
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e0	DDI-MedLine.d179.s10.e4	null	pos_34=NN	lemma_21=-	relType_34=obl	pos_8=JJ	relType_31=obl	lemma_8=proliferative	path2=superior_parataxis>sunitinib_obl>follow_acl>docetaxel_obl	pos_31=VBZ	pos_6=AFX	pos_20=NN	lemma_20=k	relType_17=compound	relType_32=parataxis	pos_18=NN	relType_15=obl	lemma_24=but	relType_3=amod	pos_7=HYPH	lemma_10=in	pos_19=CC	relType_25=det	lemma_18=t790m	relType_26=amod	lemma_12=in	pos_3=JJ	lemma_11=vitro	relType_21=punct	relType_5=ROOT	pos_30=IN	relType_34=acl	pos_2=DT	relType_1=case	lemma_29=docetaxel	relType_22=conj	pos_22=NN	relType_27=conj	lpib=single_JJ	relType_31=cop	relType_4=nmod	relation_8=neutral	pos_34=VBN	pos_32=JJ	pos_24=CC	lemma_31=sunitinib	wib=single	pos_29=NN	pos_1=IN	relType_11=advmod	lemma_19=and	pos_12=IN	lemma_33=to	pos_27=NN	lemma_4=agent	relType_29=nmod	lemma_29=follow	path1=Sunitinib_nsubj	lemma_26=sequential	relType_16=case	lemma_15=line	pos_31=NN	lemma_9=effect	relType_18=nmod	lemma_32=superior	lemma_27=administration	relType_23=nsubj	lemma_28=of	pos_5=VBZ	pos_16=IN	relType_12=case	relType_29=acl	pos_26=JJ	pos_21=HYPH	pos_17=NNP	pos_14=NN	lemma_16=with	lemma_5=exhibit	lemma_35=by	pos_33=IN	pos_23=NNS	lemma_34=sunitinib	relType_9=obj	pos_11=FW	relType_6=obl:npmod	lib=single	pos_29=VBN	relType_28=case	relType_30=case	lemma_3=single	lemma_6=anti	relType_8=amod	relType_33=case	pos_10=FW	lemma_2=a	relType_14=compound	pos_13=NNP	lemma_7=-	pos_25=DT	lemma_17=EGFR	pos_9=NNS	lemma_13=NSCLC	relType_24=cc	relType_10=compound	pos_4=NN	relType_13=compound	lemma_14=cell	lemma_25=the	lemma_30=by	path=Sunitinib_nsubj<exhibit_ROOT>superior_parataxis>sunitinib_obl>follow_acl>docetaxel_obl	lemma_34=follow	lemma_31=be	relType_19=cc	lemma_23=mutation	lemma_1=as	pos_15=NNS	eib=True	relType_20=compound	relType_7=punct	relType_2=det	pos_28=IN	pos_35=IN	relType_35=case	lemma_22=ras
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e1	DDI-MedLine.d179.s10.e2	effect	path2=follow_acl>sunitinib_obl	pos_2=IN	relType_2=case	pos_1=VBN	eib=False	lib=follow	lemma_1=follow	relType_1=acl	lemma_2=by	path1=docetaxel_nmod<administration_conj	lpib=follow_VBN	path=docetaxel_nmod<administration_conj<mutation_nsubj>follow_acl>sunitinib_obl	wib=followed
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e1	DDI-MedLine.d179.s10.e3	null	path2=sunitinib_obl	pos_4=JJ	pos_1=VBN	relType_5=case	lpib=follow_VBN	wib=followed	pos_2=IN	pos_3=VBZ	relType_4=parataxis	lib=follow	lemma_1=follow	relType_1=acl	lemma_3=be	pos_5=IN	lemma_5=to	lemma_3=sunitinib	relType_2=case	relType_3=obl	eib=True	pos_3=NN	lemma_4=superior	path=docetaxel_nmod<administration_conj<mutation_nsubj<superior_parataxis>sunitinib_obl	lemma_2=by	path1=docetaxel_nmod<administration_conj<mutation_nsubj	relType_3=cop
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e1	DDI-MedLine.d179.s10.e4	null	pos_4=JJ	pos_1=VBN	relType_7=case	path2=sunitinib_obl>follow_acl>docetaxel_obl	relType_5=case	lemma_6=follow	lpib=follow_VBN	wib=followed	pos_6=NN	pos_2=IN	relType_6=obl	pos_3=VBZ	pos_6=VBN	lemma_7=by	relType_4=parataxis	path=docetaxel_nmod<administration_conj<mutation_nsubj<superior_parataxis>sunitinib_obl>follow_acl>docetaxel_obl	relType_6=acl	lib=follow	lemma_1=follow	relType_1=acl	lemma_3=be	lemma_6=sunitinib	pos_5=IN	lemma_5=to	lemma_3=sunitinib	relType_2=case	relType_3=obl	eib=True	pos_7=IN	pos_3=NN	lemma_4=superior	lemma_2=by	path1=docetaxel_nmod<administration_conj<mutation_nsubj	relType_3=cop
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e2	DDI-MedLine.d179.s10.e3	null	path2=sunitinib_obl	relType_1=cop	path1=sunitinib_obl<follow_acl<mutation_nsubj	lib=be	pos_1=VBZ	pos_3=IN	eib=False	lemma_2=superior	lemma_1=be	lemma_3=to	lpib=be_VBZ	relType_2=parataxis	path=sunitinib_obl<follow_acl<mutation_nsubj<superior_parataxis>sunitinib_obl	pos_2=JJ	relType_3=case	wib=is
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e2	DDI-MedLine.d179.s10.e4	null	lemma_4=follow	pos_3=IN	path2=sunitinib_obl>follow_acl>docetaxel_obl	lemma_5=by	pos_2=JJ	path=sunitinib_obl<follow_acl<mutation_nsubj<superior_parataxis>sunitinib_obl>follow_acl>docetaxel_obl	relType_5=case	relType_4=acl	path1=sunitinib_obl<follow_acl<mutation_nsubj	lemma_1=be	pos_4=NN	pos_4=VBN	relType_4=obl	lib=be	lemma_3=to	pos_5=IN	relType_3=case	lemma_4=sunitinib	wib=is	relType_1=cop	pos_1=VBZ	eib=True	lemma_2=superior	lpib=be_VBZ	relType_2=parataxis
DDI-MedLine.d179.s10	DDI-MedLine.d179.s10.e3	DDI-MedLine.d179.s10.e4	null	pos_2=IN	relType_2=case	pos_1=VBN	eib=False	lib=follow	lemma_1=follow	relType_1=acl	path1=	path=<sunitinib_obl>follow_acl>docetaxel_obl	lemma_2=by	path2=follow_acl>docetaxel_obl	lpib=follow_VBN	wib=followed
DDI-MedLine.d159.s0	DDI-MedLine.d159.s0.e0	DDI-MedLine.d159.s0.e1	null	relType_1=cc	lpib=alpha_NN	pos_1=CC	pos_2=NN	eib=True	path=carnitine_compound<acid_nmod>	lemma_2=alpha	relType_2=amod	wib=alpha	lemma_2=lipoic	path2=	path1=carnitine_compound	lib=alpha	relType_2=conj	lemma_1=and	pos_2=JJ
DDI-MedLine.d159.s6	DDI-MedLine.d159.s6.e0	DDI-MedLine.d159.s6.e1	effect	pos_2=DT	relType_4=amod	pos_4=JJ	relType_10=punct	pos_15=JJ	lemma_9=toxicity	pos_11=WDT	lemma_10=,	relType_15=amod	relType_5=nsubj	path2=induce_ccomp>toxicity_obj>potentiate_acl:relcl>acid_obl	lemma_6=on	lemma_2=a	relType_15=obl:npmod	lib=elicit	relType_6=case	pos_13=VBN	relType_12=aux:pass	lpib=elicit_VBZ	relation_12=adverse	lemma_7=DEB	lemma_4=protective	pos_6=IN	pos_12=VBD	relType_13=acl:relcl	lemma_14=by	lemma_3=significant	pos_9=NN	lemma_15=alpha	relType_15=punct	pos_8=VBD	lemma_5=effect	pos_14=IN	lemma_15=-	lemma_15=lipoic	pos_15=NN	relType_3=amod	lemma_12=be	pos_7=NNP	lemma_13=potentiate	relType_9=obj	lemma_8=induce	relType_7=nmod	path=carnitine_nsubj<elicit_ROOT>induce_ccomp>toxicity_obj>potentiate_acl:relcl>acid_obl	relType_8=ccomp	relType_11=nsubj:pass	lemma_11=which	relation_7=neutral	relType_1=ROOT	pos_5=NN	pos_3=JJ	pos_1=VBZ	eib=True	pos_10=,	relType_2=det	relation_4=neutral	relType_14=case	lemma_1=elicit	pos_15=HYPH	path1=carnitine_nsubj	relation_12=beneficial	wib=elicits
DDI-MedLine.d164.s0	DDI-MedLine.d164.s0.e0	DDI-MedLine.d164.s0.e1	effect	lemma_1=enhance	relType_1=ROOT	relation_0=beneficial	pos_1=VBZ	eib=False	wib=enhances	path1=Lapatinib_nsubj	path=Lapatinib_nsubj<enhance_ROOT>cytotoxicity_obj>mediate_amod>herceptin_obl	lib=enhance	lpib=enhance_VBZ	path2=cytotoxicity_obj>mediate_amod>herceptin_obl
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e0	DDI-MedLine.d164.s1.e1	effect	pos_2=IN	wib=combined	lib=combine	path=<lapatinib_nsubj>combine_acl>Herceptin_obl	pos_1=VBN	eib=False	lemma_2=with	lpib=combine_VBN	path2=combine_acl>Herceptin_obl	relType_1=acl	lemma_1=combine	path1=	relType_2=case
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e0	DDI-MedLine.d164.s1.e2	null	relType_5=obl:npmod	pos_1=VBN	lemma_3=improve	pos_3=NNP	relation_3=beneficial	relType_11=case	pos_6=HYPH	lemma_11=with	pos_2=IN	pos_8=NN	path1=lapatinib_nsubj	lib=combine	lemma_2=with	relType_6=punct	lemma_8=survival	pos_3=VBD	relType_10=case	pos_9=NN	lemma_6=-	path2=lapatinib_advcl	pos_11=IN	pos_4=DT	wib=combined	relType_7=amod	path=lapatinib_nsubj<improve_ccomp>lapatinib_advcl	lemma_4=the	relType_1=acl	lemma_1=combine	relType_8=compound	lemma_9=rate	relType_9=obj	lemma_10=compare	pos_5=NN	lemma_7=free	relType_2=case	relType_3=ccomp	eib=True	relType_3=obl	lemma_5=progression	lpib=combine_VBN	pos_10=VBN	pos_7=JJ	lemma_3=Herceptin	relType_4=det
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e0	DDI-MedLine.d164.s1.e3	null	lemma_12=alone	relType_5=obl:npmod	pos_1=VBN	lemma_3=improve	lemma_13=for	pos_3=NNP	relation_3=beneficial	relType_14=nmod	relType_11=case	path2=lapatinib_advcl>patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	pos_6=HYPH	lemma_11=with	pos_2=IN	pos_8=NN	path1=lapatinib_nsubj	lib=combine	lemma_2=with	lemma_15=with	relType_12=advmod	relType_6=punct	lemma_8=survival	relType_12=advcl	pos_3=VBD	lemma_14=patient	pos_12=NN	relType_10=case	pos_13=IN	pos_9=NN	lemma_6=-	pos_11=IN	pos_4=DT	relType_13=case	relType_15=case	wib=combined	relType_7=amod	pos_12=RB	lemma_4=the	relType_1=acl	lemma_1=combine	relType_8=compound	lemma_9=rate	relType_9=obj	lemma_10=compare	lemma_12=lapatinib	pos_15=IN	path=lapatinib_nsubj<improve_ccomp>lapatinib_advcl>patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	pos_5=NN	lemma_7=free	relType_2=case	relType_3=ccomp	eib=True	relType_3=obl	lemma_5=progression	lpib=combine_VBN	pos_10=VBN	pos_7=JJ	lemma_3=Herceptin	pos_14=NNS	relType_4=det
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e1	DDI-MedLine.d164.s1.e2	null	path=Herceptin_obl<combine_acl<lapatinib_nsubj<improve_ccomp>lapatinib_advcl	relType_8=case	pos_2=DT	lemma_2=the	lpib=improve_VBD	lemma_6=survival	pos_8=VBN	lemma_4=-	relType_3=obl:npmod	pos_9=IN	lemma_8=compare	pos_4=HYPH	pos_6=NN	relation_0=beneficial	pos_1=VBD	eib=False	lemma_5=free	relType_7=obj	relType_9=case	lib=improve	lemma_7=rate	path2=lapatinib_advcl	pos_5=JJ	relType_4=punct	relType_5=amod	relType_1=ccomp	wib=improved	path1=Herceptin_obl<combine_acl<lapatinib_nsubj	lemma_3=progression	relType_6=compound	lemma_9=with	pos_3=NN	relType_2=det	lemma_1=improve	pos_7=NN
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e1	DDI-MedLine.d164.s1.e3	null	relType_8=case	pos_2=DT	path=Herceptin_obl<combine_acl<lapatinib_nsubj<improve_ccomp>lapatinib_advcl>patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	lemma_2=the	lemma_10=alone	lpib=improve_VBD	lemma_6=survival	pos_8=VBN	lemma_4=-	relType_3=obl:npmod	lemma_13=with	pos_9=IN	lemma_8=compare	pos_4=HYPH	relType_11=case	path2=lapatinib_advcl>patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	pos_6=NN	relation_0=beneficial	pos_1=VBD	lemma_5=free	relType_7=obj	relType_12=nmod	lemma_12=patient	relType_10=advmod	relType_9=case	pos_13=IN	pos_10=NN	lib=improve	lemma_7=rate	pos_11=IN	relType_13=case	pos_5=JJ	lemma_11=for	relType_4=punct	relType_5=amod	lemma_10=lapatinib	pos_12=NNS	relType_1=ccomp	wib=improved	path1=Herceptin_obl<combine_acl<lapatinib_nsubj	lemma_3=progression	relType_6=compound	lemma_9=with	eib=True	pos_3=NN	relType_2=det	relType_10=advcl	lemma_1=improve	pos_10=RB	pos_7=NN
DDI-MedLine.d164.s1	DDI-MedLine.d164.s1.e2	DDI-MedLine.d164.s1.e3	null	lemma_1=alone	lpib=alone_RB	path1=	pos_2=IN	pos_3=NNS	eib=False	relType_1=advmod	wib=alone	lemma_4=with	lib=alone	lemma_2=for	pos_4=IN	relType_3=nmod	relType_4=case	path=<lapatinib_advcl>patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	path2=patient_nmod>cancer_nmod>refractory_amod>herceptin_obl:npmod	relType_2=case	pos_1=RB	lemma_3=patient
DDI-MedLine.d164.s2	DDI-MedLine.d164.s2.e0	DDI-MedLine.d164.s2.e1	null	pos_2=IN	path1=lapatinib_nsubj	lib=interact	lpib=interact_VBZ	pos_1=VBZ	eib=False	lemma_2=with	relType_2=case	relType_1=ccomp	relation_0=adverse	wib=interacts	lemma_1=interact	path=lapatinib_nsubj<interact_ccomp>Herceptin_obl	path2=Herceptin_obl
DDI-MedLine.d164.s2	DDI-MedLine.d164.s2.e0	DDI-MedLine.d164.s2.e2	null	relType_7=compound	lemma_12=particular	lib=interact	lpib=interact_VBZ	pos_3=IN	relType_4=obl:npmod	pos_6=JJ	lemma_10=with	lemma_11=a	pos_3=NNP	relation_0=adverse	lemma_9=,	lemma_4=her2	relType_8=obl	pos_2=IN	pos_8=NN	pos_12=JJ	path1=lapatinib_nsubj	relType_13=obl	lemma_2=with	relType_6=amod	pos_5=HYPH	relType_12=amod	relType_10=case	pos_13=NN	pos_4=NN	path2=focus_obl>adcc_nmod>mediate_amod>Herceptin_obl	pos_14=IN	lemma_13=focus	relType_5=punct	relType_1=ccomp	path=lapatinib_nsubj<interact_ccomp>focus_obl>adcc_nmod>mediate_amod>Herceptin_obl	lemma_1=interact	lemma_7=breast	pos_10=IN	pos_11=DT	relType_9=punct	relType_3=case	relType_11=det	lemma_6=positive	lemma_14=on	relType_2=case	pos_1=VBZ	eib=True	relType_3=obl	lemma_8=cancer	lemma_3=Herceptin	wib=interacts	relType_14=case	pos_9=,	lemma_5=-	pos_7=NN	lemma_3=in
DDI-MedLine.d164.s2	DDI-MedLine.d164.s2.e1	DDI-MedLine.d164.s2.e2	null	relType_8=case	relType_4=amod	relType_1=case	pos_4=JJ	path=Herceptin_obl<interact_ccomp>focus_obl>adcc_nmod>mediate_amod>Herceptin_obl	lemma_1=in	pos_2=NN	lemma_12=on	lemma_9=a	relType_10=amod	relType_12=case	relType_5=compound	lemma_11=focus	lemma_5=breast	lemma_2=her2	pos_6=NN	relType_6=obl	relType_2=obl:npmod	eib=False	lemma_3=-	pos_7=,	lemma_8=with	pos_9=DT	pos_1=IN	lemma_7=,	lib=her2	lpib=her2_NN	path2=focus_obl>adcc_nmod>mediate_amod>Herceptin_obl	pos_8=IN	pos_12=IN	pos_10=JJ	lemma_6=cancer	relType_11=obl	lemma_4=positive	pos_5=NN	lemma_10=particular	path1=Herceptin_obl	pos_11=NN	pos_3=HYPH	relType_7=punct	wib=HER2	relType_3=punct	relType_9=det
DDI-MedLine.d164.s3	DDI-MedLine.d164.s3.e0	DDI-MedLine.d164.s3.e1	effect	relType_8=case	relType_3=dep	lemma_9=her2	relType_10=punct	pos_2=NN	pos_1=VBN	lemma_7=surface	lemma_11=positive	relType_9=obl:npmod	lemma_4=at	relType_14=compound	relType_19=det	path2=lead_acl>enhancement_obl>adcc_nmod>mediate_amod>Herceptin_obl	relType_18=case	lemma_2=her2	pos_6=NN	lemma_6=cell	relType_17=acl	lemma_17=lead	relType_12=compound	eib=False	relType_11=amod	pos_17=VBG	pos_16=,	pos_20=NN	pos_12=NN	pos_21=IN	pos_14=NN	lemma_19=the	pos_13=NN	lemma_16=,	pos_9=NN	pos_18=IN	pos_8=IN	lemma_10=-	lemma_20=enhancement	relType_13=compound	lemma_14=cell	relation_0=neutral	relType_2=compound	pos_4=IN	relType_5=det	pos_10=HYPH	relType_4=case	lemma_21=of	relType_7=nmod	lemma_13=cancer	lpib=induce_VBN	lemma_18=to	path=lapatinib_dep<induce_amod<expression_dep>lead_acl>enhancement_obl>adcc_nmod>mediate_amod>Herceptin_obl	relType_16=punct	wib=induced	relType_15=nmod	relType_21=case	relType_6=compound	lemma_5=the	pos_15=NNS	lemma_15=line	pos_3=NN	lemma_3=expression	pos_5=DT	path1=lapatinib_dep<induce_amod	pos_11=JJ	lemma_1=induce	relType_1=amod	relType_20=obl	pos_7=NN	lib=induce	lemma_8=of	lemma_12=breast	pos_19=DT
DDI-MedLine.d164.s4	DDI-MedLine.d164.s4.e0	DDI-MedLine.d164.s4.e1	effect	path=herceptin_compound<treatment_nsubj>lapatinib_nmod	relType_2=case	eib=False	lemma_1=treatment	path2=lapatinib_nmod	relType_1=nsubj	lemma_2=follow	wib=treatment	lpib=treatment_NN	lib=treatment	pos_1=NN	path1=herceptin_compound	pos_2=VBG
DDI-MedLine.d164.s5	DDI-MedLine.d164.s5.e0	DDI-MedLine.d164.s5.e1	null	pos_6=VB	relType_1=aux	lemma_1=may	lemma_2=have	relType_5=mark	eib=False	pos_2=VB	relType_3=det	pos_5=TO	pos_4=NN	lib=have	relType_4=obj	path=Lapatinib_nsubj<have_ROOT>convert_ccomp>refractory_obj>Herceptin_amod	lpib=have_VB	relType_2=ROOT	relType_6=ccomp	lemma_5=to	pos_1=MD	lemma_4=potential	lemma_6=convert	path1=Lapatinib_nsubj	pos_3=DT	path2=convert_ccomp>refractory_obj>Herceptin_amod	wib=have	lemma_3=the
DDI-MedLine.d164.s5	DDI-MedLine.d164.s5.e0	DDI-MedLine.d164.s5.e2	null	pos_6=VB	relType_1=aux	lemma_1=may	lemma_2=have	pos_9=IN	pos_8=JJ	path2=convert_ccomp>tumor_obl>sensitive_amod>herceptin_obl:npmod	path=Lapatinib_nsubj<have_ROOT>convert_ccomp>tumor_obl>sensitive_amod>herceptin_obl:npmod	relType_5=mark	lemma_7=-	lemma_8=refractory	relType_8=obj	lemma_9=to	pos_2=VB	lemma_7=Herceptin	relType_9=case	relType_3=det	pos_5=TO	pos_4=NN	lib=have	relType_4=obj	relType_7=amod	pos_7=HYPH	lpib=have_VB	relType_2=ROOT	pos_7=NNP	relType_6=ccomp	lemma_5=to	pos_1=MD	lemma_4=potential	lemma_6=convert	eib=True	path1=Lapatinib_nsubj	pos_3=DT	relType_7=punct	wib=have	lemma_3=the
DDI-MedLine.d164.s5	DDI-MedLine.d164.s5.e1	DDI-MedLine.d164.s5.e2	null	lpib=refractory_JJ	relType_2=obj	pos_3=IN	path=Herceptin_amod<refractory_obj<convert_ccomp>tumor_obl>sensitive_amod>herceptin_obl:npmod	eib=False	path2=tumor_obl>sensitive_amod>herceptin_obl:npmod	path1=Herceptin_amod<refractory_obj	wib=refractory	lib=refractory	lemma_1=-	lemma_2=refractory	lemma_3=to	pos_1=HYPH	relType_1=punct	pos_2=JJ	relType_3=case
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e0	DDI-MedLine.d193.s0.e1	null	lemma_1=(	wib=Brilinta	path=<Ticagrelor_ROOT>Brilinta_appos	eib=False	path1=	lpib=brilinta_NNP	path2=Brilinta_appos	relType_1=punct	lib=brilinta	pos_1=-LRB-
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e0	DDI-MedLine.d193.s0.e2	null	lemma_2=)	path1=	lemma_4=-	pos_4=HYPH	relType_6=case	relType_2=punct	lemma_1=(	path2=good_amod>clopidogrel_obl	wib=Brilinta	pos_2=NNP	pos_6=IN	lemma_3=-	lemma_2=Brilinta	relType_4=punct	relType_5=amod	lemma_6=than	pos_3=:	relType_2=appos	pos_5=JJR	pos_1=-LRB-	path=<Ticagrelor_ROOT>good_amod>clopidogrel_obl	eib=True	pos_2=-RRB-	lpib=brilinta_NNP	relType_1=punct	lemma_5=good	lib=brilinta	relType_3=punct
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e0	DDI-MedLine.d193.s0.e3	null	lemma_2=)	lemma_7=(	lemma_7=clopidogrel	pos_7=NN	path1=	lemma_4=-	pos_4=HYPH	relType_6=case	relType_2=punct	path2=good_amod>clopidogrel_obl>Plavix_appos	lemma_1=(	pos_7=-LRB-	wib=Brilinta	pos_2=NNP	pos_6=IN	lemma_3=-	lemma_2=Brilinta	relType_4=punct	relType_5=amod	lemma_6=than	pos_3=:	path=<Ticagrelor_ROOT>good_amod>clopidogrel_obl>Plavix_appos	relType_2=appos	pos_5=JJR	pos_1=-LRB-	relType_7=obl	eib=True	pos_2=-RRB-	relType_7=punct	lpib=brilinta_NNP	relType_1=punct	lemma_5=good	lib=brilinta	relType_3=punct
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e1	DDI-MedLine.d193.s0.e2	null	relType_4=amod	lemma_5=than	lemma_1=)	relType_5=case	relType_2=punct	path2=good_amod>clopidogrel_obl	lemma_2=-	eib=False	lemma_3=-	lemma_4=good	pos_4=JJR	path=Brilinta_appos<Ticagrelor_ROOT>good_amod>clopidogrel_obl	pos_1=-RRB-	pos_2=:	pos_5=IN	wib=better	path1=Brilinta_appos	pos_3=HYPH	relType_1=punct	lpib=good_JJR	relType_3=punct	lib=good
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e1	DDI-MedLine.d193.s0.e3	null	relType_4=amod	path=Brilinta_appos<Ticagrelor_ROOT>good_amod>clopidogrel_obl>Plavix_appos	lemma_5=than	lemma_6=(	lemma_1=)	relType_5=case	relType_2=punct	path2=good_amod>clopidogrel_obl>Plavix_appos	pos_6=NN	relType_6=obl	lemma_6=clopidogrel	pos_6=-LRB-	lemma_2=-	relType_6=punct	lemma_3=-	lemma_4=good	pos_4=JJR	pos_1=-RRB-	pos_2=:	pos_5=IN	wib=better	path1=Brilinta_appos	eib=True	pos_3=HYPH	relType_1=punct	lpib=good_JJR	relType_3=punct	lib=good
DDI-MedLine.d193.s0	DDI-MedLine.d193.s0.e2	DDI-MedLine.d193.s0.e3	null	lemma_1=(	path2=Plavix_appos	eib=False	lib=plavix	path=<clopidogrel_obl>Plavix_appos	path1=	relType_1=punct	lpib=plavix_NNP	pos_1=-LRB-	wib=Plavix
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e0	DDI-MedLine.d193.s1.e1	null	lemma_1=(	path2=AstraZeneca_appos>Brilinta_compound	wib=Brilinta	eib=False	path=<ticagrelor_obj>AstraZeneca_appos>Brilinta_compound	path1=	lpib=brilinta_NNP	relType_1=punct	lib=brilinta	pos_1=-LRB-
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e0	DDI-MedLine.d193.s1.e2	null	lemma_8=antiplatelet	pos_6=DT	relType_8=amod	pos_5=,	path1=	pos_3=NNP	lemma_7=oral	pos_2=HYPH	relType_2=punct	lemma_1=(	pos_8=JJ	wib=Brilinta	pos_2=NNP	lemma_2=-	relType_3=appos	lemma_6=a	pos_4=-RRB-	lemma_2=Brilinta	relType_4=punct	relType_7=amod	path=<ticagrelor_obj>drug_appos	relType_2=compound	lemma_5=,	relType_5=punct	lemma_3=AstraZeneca	lemma_4=)	path2=drug_appos	pos_1=-LRB-	relType_6=det	eib=True	pos_7=JJ	lpib=brilinta_NNP	relType_1=punct	lib=brilinta
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e0	DDI-MedLine.d193.s1.e3	effect	lemma_8=antiplatelet	lemma_14=dose	path1=ticagrelor_obj	pos_6=DT	relType_8=amod	pos_5=,	pos_3=NNP	relType_13=punct	lemma_7=oral	pos_9=IN	relType_8=punct	relType_14=compound	pos_2=HYPH	relType_8=appos	lemma_8=,	lemma_13=-	relType_11=case	relType_2=punct	lemma_11=with	lemma_1=(	pos_8=JJ	pos_8=NN	wib=Brilinta	pos_12=JJ	pos_13=HYPH	pos_2=NNP	lemma_2=-	relType_3=appos	lemma_6=a	pos_4=-RRB-	relType_12=amod	relType_10=obl	relType_9=case	lemma_12=low	pos_10=NN	pos_14=NN	pos_11=IN	lemma_2=Brilinta	relType_4=punct	relType_7=amod	lemma_5=,	relType_2=compound	relType_5=punct	path2=use_obl>aspirin_nmod	lemma_3=AstraZeneca	lemma_4=)	pos_1=-LRB-	relType_6=det	lemma_8=drug	eib=True	pos_7=JJ	lemma_9=for	lpib=brilinta_NNP	relType_1=punct	lib=brilinta	lemma_10=use	pos_8=,	path=ticagrelor_obj<approve_ROOT>use_obl>aspirin_nmod
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e1	DDI-MedLine.d193.s1.e2	null	pos_6=JJ	path1=Brilinta_compound<AstraZeneca_appos	lemma_2=AstraZeneca	wib=AstraZeneca	pos_1=HYPH	lemma_5=a	pos_2=NNP	pos_4=,	relType_6=amod	lib=astrazeneca	lemma_7=antiplatelet	path=Brilinta_compound<AstraZeneca_appos<ticagrelor_obj>drug_appos	lemma_6=oral	relType_7=amod	relType_4=punct	relType_5=det	lemma_1=-	lemma_4=,	relType_2=appos	lemma_3=)	path2=drug_appos	lpib=astrazeneca_NNP	eib=True	pos_3=-RRB-	pos_5=DT	pos_7=JJ	relType_1=punct	relType_3=punct
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e1	DDI-MedLine.d193.s1.e3	effect	relType_8=case	pos_6=JJ	relType_7=appos	lemma_10=with	lemma_8=for	lemma_2=AstraZeneca	relType_9=obl	wib=AstraZeneca	pos_1=HYPH	lemma_5=a	lemma_13=dose	pos_2=NNP	pos_4=,	relType_6=amod	relType_11=amod	pos_7=,	lib=astrazeneca	relType_12=punct	path1=Brilinta_compound<AstraZeneca_appos<ticagrelor_obj	relType_10=case	lemma_7=,	pos_9=NN	lemma_12=-	lemma_7=antiplatelet	pos_8=IN	lemma_11=low	pos_13=NN	lemma_6=oral	relType_7=amod	relType_4=punct	relType_13=compound	lemma_9=use	relType_5=det	lemma_1=-	path2=use_obl>aspirin_nmod	lemma_4=,	pos_10=IN	relType_2=appos	lemma_3=)	lpib=astrazeneca_NNP	eib=True	pos_3=-RRB-	relType_7=punct	pos_5=DT	pos_7=JJ	path=Brilinta_compound<AstraZeneca_appos<ticagrelor_obj<approve_ROOT>use_obl>aspirin_nmod	lemma_7=drug	pos_11=JJ	pos_12=HYPH	relType_1=punct	pos_7=NN	relType_3=punct
DDI-MedLine.d193.s1	DDI-MedLine.d193.s1.e2	DDI-MedLine.d193.s1.e3	null	relType_7=compound	lemma_1=,	lib=use	pos_1=,	pos_6=HYPH	pos_2=IN	lemma_3=use	eib=False	relType_6=punct	lpib=use_NN	path1=drug_appos<ticagrelor_obj	lemma_6=-	lemma_4=with	pos_5=JJ	relType_5=amod	path=drug_appos<ticagrelor_obj<approve_ROOT>use_obl>aspirin_nmod	lemma_2=for	pos_4=IN	path2=use_obl>aspirin_nmod	relType_4=case	lemma_5=low	relType_2=case	relType_3=obl	pos_3=NN	wib=use	lemma_7=dose	relType_1=punct	pos_7=NN
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e0	DDI-MedLine.d193.s2.e1	null	lemma_1=(	path2=Plavix_appos	eib=False	lib=plavix	path=<clopidogrel_obl>Plavix_appos	path1=	relType_1=punct	lpib=plavix_NNP	pos_1=-LRB-	wib=Plavix
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e0	DDI-MedLine.d193.s2.e2	null	lemma_2=)	pos_3=CC	path1=	lpib=plavix_NNP	relType_3=cc	relType_2=punct	lemma_1=(	pos_2=NNP	lib=plavix	path=<clopidogrel_obl>prasugrel_conj	lemma_2=Plavix	relType_2=appos	pos_1=-LRB-	wib=Plavix	eib=True	pos_2=-RRB-	lemma_3=and	relType_1=punct	path2=prasugrel_conj
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e0	DDI-MedLine.d193.s2.e3	null	lemma_2=)	pos_3=CC	path1=	lpib=plavix_NNP	relType_3=cc	relType_2=punct	lemma_1=(	pos_2=NNP	pos_4=-LRB-	lib=plavix	path2=prasugrel_conj>effient_appos	pos_4=NN	lemma_4=(	relType_4=punct	lemma_2=Plavix	relType_2=appos	pos_1=-LRB-	wib=Plavix	eib=True	pos_2=-RRB-	lemma_3=and	relType_4=conj	relType_1=punct	lemma_4=prasugrel	path=<clopidogrel_obl>prasugrel_conj>effient_appos
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e1	DDI-MedLine.d193.s2.e2	null	lib=prasugrel	lemma_2=and	eib=False	path1=Plavix_appos	pos_1=-RRB-	pos_2=CC	lpib=prasugrel_NN	relType_1=punct	lemma_1=)	relType_2=cc	path2=prasugrel_conj	wib=prasugrel	path=Plavix_appos<clopidogrel_obl>prasugrel_conj
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e1	DDI-MedLine.d193.s2.e3	null	lemma_1=)	relType_2=cc	wib=prasugrel	lib=prasugrel	lemma_2=and	lpib=prasugrel_NN	path2=prasugrel_conj>effient_appos	lemma_3=(	pos_3=-LRB-	relType_3=conj	pos_1=-RRB-	path=Plavix_appos<clopidogrel_obl>prasugrel_conj>effient_appos	eib=True	path1=Plavix_appos	pos_3=NN	pos_2=CC	relType_1=punct	relType_3=punct	lemma_3=prasugrel
DDI-MedLine.d193.s2	DDI-MedLine.d193.s2.e2	DDI-MedLine.d193.s2.e3	null	lemma_1=(	eib=False	path1=	lpib=effient_NN	path2=effient_appos	path=<prasugrel_conj>effient_appos	lib=effient	relType_1=punct	wib=Effient	pos_1=-LRB-
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e0	DDI-MedLine.d100.s5.e1	null	lpib=such_JJ	relType_3=fixed	lemma_1=,	relType_2=case	wib=such	pos_3=IN	eib=False	path2=verapamil_nmod	path1=	pos_1=,	lib=such	relType_1=punct	pos_2=JJ	lemma_2=such	path=<blocker_nsubj>verapamil_nmod	lemma_3=as
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e0	DDI-MedLine.d100.s5.e2	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	relType_4=nmod	path=<blocker_nsubj>verapamil_nmod>diltiazem_conj	pos_2=JJ	lemma_3=as	relType_3=fixed	pos_4=,	pos_4=NN	lemma_2=such	lpib=such_JJ	relType_4=punct	lemma_4=,	path2=verapamil_nmod>diltiazem_conj	relType_2=case	wib=such	eib=True	lemma_4=verapamil	lib=such	relType_1=punct
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e0	DDI-MedLine.d100.s5.e3	null	lemma_1=,	pos_3=IN	pos_5=CC	path1=	pos_1=,	relType_4=nmod	pos_2=JJ	lemma_3=as	relType_3=fixed	relType_5=cc	pos_4=,	path2=verapamil_nmod>nifedipine_conj	lemma_5=diltiazem	path=<blocker_nsubj>verapamil_nmod>nifedipine_conj	pos_4=NN	lemma_2=such	lpib=such_JJ	relType_4=punct	lemma_4=,	relType_5=conj	pos_5=NN	relType_2=case	wib=such	eib=True	lemma_5=and	lemma_4=verapamil	lib=such	relType_1=punct
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e1	DDI-MedLine.d100.s5.e2	null	lemma_1=,	eib=False	path1=	path=<verapamil_nmod>diltiazem_conj	lpib=diltiazem_NN	pos_1=,	relType_1=punct	lib=diltiazem	wib=diltiazem	path2=diltiazem_conj
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e1	DDI-MedLine.d100.s5.e3	null	path2=nifedipine_conj	lemma_2=and	lemma_1=,	pos_2=NN	eib=True	pos_2=CC	path1=	pos_1=,	lpib=diltiazem_NN	relType_2=conj	path=<verapamil_nmod>nifedipine_conj	lib=diltiazem	relType_1=punct	wib=diltiazem	relType_2=cc	lemma_2=diltiazem
DDI-MedLine.d100.s5	DDI-MedLine.d100.s5.e2	DDI-MedLine.d100.s5.e3	null	relType_1=cc	path2=nifedipine_conj	pos_1=CC	path1=diltiazem_conj	eib=False	lib=nifedipine	lpib=nifedipine_NN	path=diltiazem_conj<verapamil_nmod>nifedipine_conj	wib=nifedipine	lemma_1=and
DDI-MedLine.d73.s0	DDI-MedLine.d73.s0.e0	DDI-MedLine.d73.s0.e1	null	lemma_1=(	lpib=mptp_NN	path2=mptp_appos	eib=False	lib=mptp	wib=MPTP	path1=	path=<tetrahydropyridine_obj>mptp_appos	relType_1=punct	pos_1=-LRB-
DDI-MedLine.d73.s0	DDI-MedLine.d73.s0.e0	DDI-MedLine.d73.s0.e2	null	lemma_2=)	path2=methamphetamine_conj	pos_2=NN	pos_3=CC	lib=mptp	path1=	lemma_2=mptp	relType_3=cc	relType_2=punct	lemma_1=(	wib=MPTP	path=<tetrahydropyridine_obj>methamphetamine_conj	lpib=mptp_NN	relType_2=appos	pos_1=-LRB-	eib=True	pos_2=-RRB-	lemma_3=and	relType_1=punct
DDI-MedLine.d73.s0	DDI-MedLine.d73.s0.e1	DDI-MedLine.d73.s0.e2	null	lemma_2=and	path2=methamphetamine_conj	eib=False	path=mptp_appos<tetrahydropyridine_obj>methamphetamine_conj	pos_1=-RRB-	pos_2=CC	lpib=methamphetamine_NN	path1=mptp_appos	wib=methamphetamine	lib=methamphetamine	relType_1=punct	lemma_1=)	relType_2=cc
DDI-MedLine.d73.s1	DDI-MedLine.d73.s1.e0	DDI-MedLine.d73.s1.e1	null	pos_12=VBG	lemma_12=follow	pos_8=VBN	relType_10=amod	relType_12=case	relation_10=neutral	path1=mptp_compound<administration_nmod<consequence_nsubj:pass	relType_7=cc	pos_9=IN	relType_4=nmod	lib=administration	lemma_8=compare	lemma_10=similar	pos_2=IN	eib=False	lemma_6=evaluate	pos_11=NNS	lemma_1=administration	lpib=administration_NN	lemma_2=to	lemma_9=to	pos_6=VBN	relType_9=case	relType_1=nmod	relType_3=det	pos_4=NN	pos_1=NN	lemma_5=be	relType_6=ROOT	relType_5=aux:pass	pos_7=CC	pos_10=JJ	path2=effect_obl>administration_nmod>methamphetamine_compound	path=mptp_compound<administration_nmod<consequence_nsubj:pass<evaluate_ROOT>effect_obl>administration_nmod>methamphetamine_compound	relType_11=obl	lemma_4=rat	pos_5=VBD	relType_2=case	pos_3=DT	lemma_11=effect	lemma_7=and	relType_8=conj	lemma_3=the	wib=administration
DDI-MedLine.d73.s2	DDI-MedLine.d73.s2.e0	DDI-MedLine.d73.s2.e1	effect	lemma_8=concentration	lemma_13=could	relType_7=compound	pos_6=JJ	pos_1=VBN	relType_10=det	pos_16=IN	lemma_3=last	relation_14=adverse	lemma_5=of	relType_5=case	pos_8=NNS	pos_2=RB	eib=False	relType_2=advmod	relType_12=nsubj:pass	relType_6=amod	relType_11=amod	lemma_12=effect	relType_13=aux	pos_12=NN	relType_14=aux:pass	path2=prevent_conj>pretreatment_obl>pargyline_compound	lemma_16=by	pos_3=VBG	pos_15=VBN	pos_4=NNS	relType_4=obj	lemma_7=dopamine	lemma_14=be	lemma_9=and	pos_9=CC	relation_0=neutral	relType_3=amod	lemma_4=depletion	relType_1=ccomp	relation_11=neutral	pos_5=IN	pos_14=VB	lpib=induce_VBN	lemma_15=prevent	path=mptp_nsubj<induce_ccomp>prevent_conj>pretreatment_obl>pargyline_compound	lemma_11=neurotoxic	lemma_10=this	wib=induced	lemma_2=long	lemma_6=striatal	relType_16=case	path1=mptp_nsubj	relType_8=nmod	relType_15=conj	pos_11=JJ	lemma_1=induce	pos_7=NN	lib=induce	relType_9=cc	pos_13=MD	pos_10=DT
DDI-MedLine.d73.s3	DDI-MedLine.d73.s3.e0	DDI-MedLine.d73.s3.e1	effect	relType_8=case	relation_1=neutral	pos_2=VBN	lemma_4=damage	path2=tolerance_obj>effect_nmod>amphetamine_nmod	pos_6=DT	pos_7=NN	relType_10=amod	relType_12=case	relation_10=neutral	pos_1=HYPH	lemma_12=of	lemma_7=tolerance	eib=False	lemma_6=a	relType_7=obj	pos_11=NNS	pos_9=DT	relType_4=nsubj	lemma_2=induce	pos_4=NN	pos_12=IN	pos_8=IN	lemma_3=neuronal	lemma_10=disruptive	lemma_8=to	relType_3=amod	pos_10=JJ	relType_2=amod	lemma_1=-	lpib=induce_VBN	wib=induced	pos_5=VBD	relType_6=det	lemma_5=produce	pos_3=JJ	lemma_9=the	lemma_11=effect	relation_4=neutral	path1=mptp_obl<induce_amod<damage_nsubj	relType_11=nmod	relType_1=punct	relType_5=ROOT	lib=induce	path=mptp_obl<induce_amod<damage_nsubj<produce_ROOT>tolerance_obj>effect_nmod>amphetamine_nmod	relType_9=det
DDI-MedLine.d73.s3	DDI-MedLine.d73.s3.e0	DDI-MedLine.d73.s3.e2	effect	relType_8=case	relation_1=neutral	pos_2=VBN	lemma_4=damage	pos_17=DT	pos_6=DT	pos_16=IN	pos_7=NN	relType_10=amod	relType_12=case	relType_18=amod	lemma_13=amphetamine	relation_10=neutral	pos_1=HYPH	pos_19=NNS	lemma_19=effect	lemma_12=of	lemma_7=tolerance	relType_13=nmod	relType_19=nmod	pos_20=IN	relType_20=case	relType_17=det	lemma_6=a	relType_7=obj	lemma_20=of	pos_11=NNS	lemma_15=supersensitivity	pos_9=DT	relType_14=det	pos_18=JJ	lemma_13=and	pos_13=NN	relType_4=nsubj	lemma_2=induce	pos_4=NN	pos_12=IN	pos_8=IN	relation_19=neutral	relType_13=cc	path2=tolerance_obj>effect_nmod>supersensitivity_conj>effect_nmod>apomorphine_nmod	lemma_3=neuronal	lemma_10=disruptive	lemma_8=to	pos_15=NN	relType_3=amod	path=mptp_obl<induce_amod<damage_nsubj<produce_ROOT>tolerance_obj>effect_nmod>supersensitivity_conj>effect_nmod>apomorphine_nmod	pos_10=JJ	relType_2=amod	lemma_1=-	lpib=induce_VBN	lemma_17=the	wib=induced	pos_14=DT	pos_5=VBD	pos_13=CC	relType_6=det	lemma_14=a	relType_16=case	lemma_5=produce	pos_3=JJ	eib=True	lemma_9=the	lemma_11=effect	relType_15=conj	relation_4=neutral	path1=mptp_obl<induce_amod<damage_nsubj	relType_11=nmod	relType_1=punct	relType_5=ROOT	lib=induce	lemma_18=disruptive	relType_9=det	lemma_16=to
DDI-MedLine.d73.s3	DDI-MedLine.d73.s3.e1	DDI-MedLine.d73.s3.e2	null	relType_1=cc	pos_7=NNS	pos_2=DT	pos_1=CC	lemma_6=disruptive	relType_8=case	lpib=supersensitivity_NN	pos_6=JJ	wib=supersensitivity	lemma_2=a	path2=supersensitivity_conj>effect_nmod>apomorphine_nmod	relation_6=neutral	eib=False	lemma_7=effect	relType_6=amod	pos_8=IN	relType_3=conj	lemma_4=to	pos_4=IN	relType_5=det	path=amphetamine_nmod<effect_nmod>supersensitivity_conj>effect_nmod>apomorphine_nmod	relType_4=case	relType_7=nmod	path1=amphetamine_nmod	lemma_3=supersensitivity	lemma_5=the	pos_3=NN	relType_2=det	pos_5=DT	lemma_8=of	lemma_1=and	lib=supersensitivity
DDI-MedLine.d73.s4	DDI-MedLine.d73.s4.e0	DDI-MedLine.d73.s4.e1	null	pos_2=IN	lemma_1=,	path2=MPTP_nmod	relType_2=case	eib=False	path=<methamphetamine_nsubj>MPTP_nmod	lib=mptp	wib=MPTP	path1=	pos_1=,	lpib=mptp_NNP	relType_1=punct	lemma_2=like
DDI-MedLine.d73.s4	DDI-MedLine.d73.s4.e0	DDI-MedLine.d73.s4.e2	effect	lemma_1=,	relType_10=det	lib=mptp	lemma_4=produce	pos_1=,	pos_3=NNP	lemma_3=MPTP	lemma_6=of	relType_6=case	pos_13=VBN	relType_12=aux:pass	lemma_11=action	pos_2=IN	pos_8=NN	path=methamphetamine_nsubj<produce_ROOT>potentiate_conj>pretreatment_obl>pargyline_compound	lemma_9=but	pos_5=NNS	pos_6=IN	wib=MPTP	pos_12=VBD	pos_11=NNS	lemma_14=by	lemma_5=depletion	relType_13=conj	lemma_7=striatal	relation_13=adverse	lemma_2=like	pos_14=IN	pos_9=CC	relType_7=amod	lemma_3=,	lemma_12=be	lemma_13=potentiate	relType_3=nmod	lemma_10=this	relType_11=nsubj:pass	relType_4=ROOT	relation_13=beneficial	path1=methamphetamine_nsubj	pos_4=VBD	path2=potentiate_conj>pretreatment_obl>pargyline_compound	relType_2=case	eib=True	pos_3=,	relType_8=nmod	relType_5=obj	lemma_8=dopamine	pos_7=JJ	lpib=mptp_NNP	relType_9=cc	relType_14=case	relation_4=neutral	relType_1=punct	relType_3=punct	pos_10=DT
DDI-MedLine.d73.s4	DDI-MedLine.d73.s4.e1	DDI-MedLine.d73.s4.e2	null	lemma_6=dopamine	relation_1=neutral	lib=produce	lemma_1=,	pos_8=DT	path=MPTP_nmod<methamphetamine_nsubj<produce_ROOT>potentiate_conj>pretreatment_obl>pargyline_compound	pos_1=,	relType_7=cc	relType_12=case	lemma_7=but	lemma_2=produce	relType_11=conj	lpib=produce_VBD	pos_6=NN	relType_10=aux:pass	lemma_8=this	pos_3=NNS	eib=False	pos_9=NNS	relType_9=nsubj:pass	path1=MPTP_nmod<methamphetamine_nsubj	pos_2=VBD	lemma_11=potentiate	wib=produced	pos_12=IN	pos_5=JJ	relType_5=amod	relation_10=beneficial	pos_7=CC	relation_10=adverse	relType_2=ROOT	pos_4=IN	pos_10=VBD	relType_4=case	pos_11=VBN	lemma_12=by	lemma_9=action	lemma_3=depletion	path2=potentiate_conj>pretreatment_obl>pargyline_compound	lemma_5=striatal	relType_3=obj	relType_8=det	relType_1=punct	relType_6=nmod	lemma_4=of	lemma_10=be
DDI-DrugBank.d449.s0	DDI-DrugBank.d449.s0.e0	DDI-DrugBank.d449.s0.e1	null	lpib=such_JJ	pos_2=IN	relType_1=case	relType_2=fixed	wib=such	eib=False	lemma_1=such	path=<agent_nmod>ketoconazole_nmod	path1=	pos_1=JJ	lib=such	path2=ketoconazole_nmod	lemma_2=as
DDI-DrugBank.d449.s0	DDI-DrugBank.d449.s0.e0	DDI-DrugBank.d449.s0.e2	null	relType_1=case	pos_3=CC	path1=	pos_1=JJ	relType_3=cc	lemma_2=as	pos_2=IN	lemma_3=or	lpib=such_JJ	path=<agent_nmod>ketoconazole_nmod>itraconazole_conj	relType_3=nmod	path2=ketoconazole_nmod>itraconazole_conj	lemma_3=ketoconazole	relType_2=fixed	wib=such	eib=True	lemma_1=such	pos_3=NN	lib=such
DDI-DrugBank.d449.s0	DDI-DrugBank.d449.s0.e1	DDI-DrugBank.d449.s0.e2	null	relType_1=cc	pos_1=CC	wib=itraconazole	eib=False	path2=itraconazole_conj	path=<ketoconazole_nmod>itraconazole_conj	path1=	lpib=itraconazole_NN	lib=itraconazole	lemma_1=or
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e0	DDI-DrugBank.d449.s1.e1	null	lemma_1=,	path=<Nafazodone_ROOT>fluvoxamine_conj	path2=fluvoxamine_conj	eib=False	wib=fluvoxamine	path1=	pos_1=,	lib=fluvoxamine	relType_1=punct	lpib=fluvoxamine_NN
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e0	DDI-DrugBank.d449.s1.e2	null	lemma_1=,	pos_2=NN	eib=True	wib=fluvoxamine	path1=	pos_1=,	pos_2=,	lib=fluvoxamine	lemma_2=fluvoxamine	path2=cimetidine_appos	path=<Nafazodone_ROOT>cimetidine_appos	relType_1=punct	relType_2=conj	lemma_2=,	lpib=fluvoxamine_NN	relType_2=punct
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e0	DDI-DrugBank.d449.s1.e3	advise	relType_4=dep	lemma_1=,	pos_2=NN	path1=	pos_1=,	lpib=fluvoxamine_NN	relType_2=punct	relType_3=appos	lemma_4=consider	lemma_3=(	lib=fluvoxamine	pos_3=-LRB-	relType_2=conj	lemma_2=,	path=<Nafazodone_ROOT>cimetidine_appos>consider_dep>reduction_obj>Xanax_compound	wib=fluvoxamine	path2=cimetidine_appos>consider_dep>reduction_obj>Xanax_compound	eib=True	pos_3=NN	pos_4=VB	pos_2=,	lemma_2=fluvoxamine	lemma_3=cimetidine	relType_1=punct	relType_3=punct
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e1	DDI-DrugBank.d449.s1.e2	null	path=fluvoxamine_conj<Nafazodone_ROOT>cimetidine_appos	lemma_1=,	eib=False	pos_1=,	path2=cimetidine_appos	relType_1=punct	path1=fluvoxamine_conj	lib=cimetidine	wib=cimetidine	lpib=cimetidine_NN
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e1	DDI-DrugBank.d449.s1.e3	advise	path=fluvoxamine_conj<Nafazodone_ROOT>cimetidine_appos>consider_dep>reduction_obj>Xanax_compound	relType_3=dep	lemma_1=,	pos_2=NN	pos_1=,	pos_3=VB	lpib=cimetidine_NN	relType_2=punct	pos_2=-LRB-	path2=cimetidine_appos>consider_dep>reduction_obj>Xanax_compound	lemma_3=consider	relType_2=appos	path1=fluvoxamine_conj	lib=cimetidine	eib=True	relType_1=punct	lemma_2=(	lemma_2=cimetidine	wib=cimetidine
DDI-DrugBank.d449.s1	DDI-DrugBank.d449.s1.e2	DDI-DrugBank.d449.s1.e3	advise	lemma_1=(	relType_2=dep	eib=False	wib=consider	lemma_2=consider	path2=consider_dep>reduction_obj>Xanax_compound	path1=	path=<cimetidine_appos>consider_dep>reduction_obj>Xanax_compound	lib=consider	pos_2=VB	relType_1=punct	lpib=consider_VB	pos_1=-LRB-
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e0	DDI-DrugBank.d449.s2.e1	null	wib=OCs	lemma_1=,	eib=False	lpib=oc_NNS	path1=	pos_1=,	path=<Fluoxetine_ROOT>oc_conj	lib=oc	relType_1=punct	path2=oc_conj
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e0	DDI-DrugBank.d449.s2.e2	null	pos_2=NNS	wib=OCs	lemma_1=,	path=<Fluoxetine_ROOT>sertraline_conj	eib=True	lpib=oc_NNS	lemma_2=oc	path1=	path2=sertraline_conj	pos_1=,	pos_2=,	lib=oc	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e0	DDI-DrugBank.d449.s2.e3	null	wib=OCs	lemma_1=,	path1=	pos_1=,	lib=oc	relType_2=punct	path=<Fluoxetine_ROOT>diltiazem_conj	relType_2=conj	lemma_2=,	path2=diltiazem_conj	lemma_3=,	relType_3=conj	pos_2=NNS	pos_3=,	eib=True	lpib=oc_NNS	pos_3=NN	lemma_2=oc	pos_2=,	relType_1=punct	lemma_3=sertraline	relType_3=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e0	DDI-DrugBank.d449.s2.e4	null	wib=OCs	lemma_4=diltiazem	lemma_1=,	path1=	pos_1=,	lib=oc	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_4=,	path=<Fluoxetine_ROOT>caution_appos>antibiotic_dep	pos_2=NNS	path2=caution_appos>antibiotic_dep	pos_3=,	eib=True	lpib=oc_NNS	pos_3=NN	lemma_2=oc	lemma_5=macrolide	pos_2=,	relType_4=conj	relType_1=punct	lemma_3=sertraline	relType_3=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e1	DDI-DrugBank.d449.s2.e2	null	lpib=sertraline_NN	lemma_1=,	path1=oc_conj	eib=False	path2=sertraline_conj	pos_1=,	path=oc_conj<Fluoxetine_ROOT>sertraline_conj	relType_1=punct	lib=sertraline	wib=sertraline
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e1	DDI-DrugBank.d449.s2.e3	null	lpib=sertraline_NN	lemma_1=,	pos_2=NN	eib=True	path1=oc_conj	pos_1=,	pos_2=,	relType_2=conj	relType_1=punct	lib=sertraline	wib=sertraline	lemma_2=sertraline	lemma_2=,	path2=diltiazem_conj	path=oc_conj<Fluoxetine_ROOT>diltiazem_conj	relType_2=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e1	DDI-DrugBank.d449.s2.e4	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	path=oc_conj<Fluoxetine_ROOT>caution_appos>antibiotic_dep	pos_1=,	lemma_2=sertraline	wib=sertraline	relType_2=punct	lemma_3=diltiazem	relType_2=conj	lemma_2=,	lemma_4=macrolide	lpib=sertraline_NN	lemma_3=,	path1=oc_conj	relType_3=conj	lib=sertraline	path2=caution_appos>antibiotic_dep	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e2	DDI-DrugBank.d449.s2.e3	null	path=sertraline_conj<Fluoxetine_ROOT>diltiazem_conj	lemma_1=,	eib=False	pos_1=,	lpib=diltiazem_NN	path1=sertraline_conj	lib=diltiazem	relType_1=punct	wib=diltiazem	path2=diltiazem_conj
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e2	DDI-DrugBank.d449.s2.e4	null	lemma_1=,	pos_2=NN	pos_1=,	path1=sertraline_conj	lemma_3=macrolide	lemma_2=diltiazem	relType_2=punct	lib=diltiazem	relType_2=conj	wib=diltiazem	lemma_2=,	relType_3=amod	path=sertraline_conj<Fluoxetine_ROOT>caution_appos>antibiotic_dep	path2=caution_appos>antibiotic_dep	pos_3=JJ	eib=True	lpib=diltiazem_NN	pos_2=,	relType_1=punct
DDI-DrugBank.d449.s2	DDI-DrugBank.d449.s2.e3	DDI-DrugBank.d449.s2.e4	null	path=diltiazem_conj<Fluoxetine_ROOT>caution_appos>antibiotic_dep	path2=caution_appos>antibiotic_dep	path1=diltiazem_conj	lpib=macrolide_JJ	lemma_1=,	eib=True	wib=macrolide	relType_2=amod	pos_1=,	lemma_2=macrolide	relType_1=punct	pos_2=JJ	lib=macrolide
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e0	DDI-DrugBank.d8.s0.e1	effect	pos_2=VBN	relType_7=compound	pos_3=IN	pos_6=JJ	lemma_7=cns	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	relType_5=case	relType_6=amod	lemma_1=be	lemma_5=with	pos_4=NN	relType_4=obl	lib=be	path2=depressant_obl	pos_5=IN	lemma_4=combination	relType_3=case	path=ALFENTA_nsubj:pass<administer_advcl>depressant_obl	wib=is	pos_1=VBZ	eib=True	lpib=be_VBZ	path1=ALFENTA_nsubj:pass	pos_7=NN	lemma_3=in	lemma_6=other
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e0	DDI-DrugBank.d8.s0.e2	effect	pos_7=NNS	pos_2=VBN	relType_7=compound	pos_3=IN	pos_6=JJ	lemma_7=cns	relType_7=case	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	relType_5=case	path2=depressant_obl>barbiturate_nmod	path=ALFENTA_nsubj:pass<administer_advcl>depressant_obl>barbiturate_nmod	lemma_7=depressant	lemma_7=such	lemma_8=as	relType_6=amod	lemma_1=be	lemma_5=with	pos_4=NN	pos_8=IN	relType_4=obl	lib=be	pos_5=IN	lemma_4=combination	relType_3=case	wib=is	relType_7=obl	pos_1=VBZ	eib=True	pos_7=JJ	relType_8=fixed	lpib=be_VBZ	path1=ALFENTA_nsubj:pass	pos_7=NN	lemma_3=in	lemma_6=other
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e0	DDI-DrugBank.d8.s0.e3	effect	pos_7=NNS	pos_2=VBN	relType_7=compound	pos_3=IN	pos_6=JJ	lemma_7=cns	relType_7=case	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	lemma_9=,	relType_9=nmod	relType_5=case	lemma_8=as	lemma_7=depressant	lemma_7=such	lemma_9=barbiturate	relType_6=amod	lemma_1=be	pos_9=NNS	lemma_5=with	pos_4=NN	pos_8=IN	relType_4=obl	lib=be	path=ALFENTA_nsubj:pass<administer_advcl>depressant_obl>barbiturate_nmod>tranquilizer_conj	path2=depressant_obl>barbiturate_nmod>tranquilizer_conj	pos_5=IN	lemma_4=combination	relType_9=punct	relType_3=case	wib=is	relType_7=obl	pos_1=VBZ	eib=True	pos_7=JJ	relType_8=fixed	lpib=be_VBZ	path1=ALFENTA_nsubj:pass	pos_9=,	pos_7=NN	lemma_3=in	lemma_6=other
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e0	DDI-DrugBank.d8.s0.e4	effect	pos_7=NNS	pos_2=VBN	relType_7=compound	relType_10=punct	pos_3=IN	pos_6=JJ	lemma_7=cns	relType_7=case	relType_1=aux:pass	lemma_2=administer	lemma_10=,	relType_2=advcl	lemma_9=,	relType_9=nmod	relType_5=case	lemma_10=tranquilizer	lemma_8=as	path2=depressant_obl>barbiturate_nmod>opioid_conj	lemma_7=depressant	lemma_7=such	lemma_9=barbiturate	relType_10=conj	relType_6=amod	path=ALFENTA_nsubj:pass<administer_advcl>depressant_obl>barbiturate_nmod>opioid_conj	lemma_1=be	lemma_5=with	pos_9=NNS	pos_4=NN	pos_8=IN	relType_4=obl	lib=be	pos_5=IN	lemma_4=combination	relType_9=punct	relType_3=case	wib=is	relType_7=obl	pos_10=,	pos_1=VBZ	eib=True	pos_7=JJ	relType_8=fixed	lpib=be_VBZ	path1=ALFENTA_nsubj:pass	pos_9=,	pos_7=NN	lemma_3=in	pos_10=NNS	lemma_6=other
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e0	DDI-DrugBank.d8.s0.e5	effect	pos_7=NNS	relType_14=amod	pos_2=VBN	relType_7=compound	relType_10=punct	pos_3=IN	pos_6=JJ	lemma_7=cns	relType_7=case	lemma_11=,	relType_1=aux:pass	lemma_2=administer	lemma_10=,	relType_12=cc	relType_2=advcl	lemma_9=,	relType_9=nmod	pos_12=CC	path2=depressant_obl>barbiturate_nmod>anesthetic_conj	relType_5=case	lemma_10=tranquilizer	relType_11=conj	lemma_8=as	lemma_7=depressant	lemma_7=such	lemma_9=barbiturate	relType_10=conj	relType_6=amod	lemma_1=be	pos_9=NNS	lemma_5=with	pos_11=NNS	relType_11=punct	pos_13=NN	pos_4=NN	lemma_11=opioid	pos_8=IN	lemma_12=or	relType_4=obl	lib=be	relType_13=compound	pos_5=IN	lemma_4=combination	pos_11=,	relType_9=punct	relType_3=case	wib=is	relType_7=obl	pos_10=,	pos_1=VBZ	eib=True	pos_7=JJ	relType_8=fixed	pos_14=JJ	lpib=be_VBZ	path1=ALFENTA_nsubj:pass	path=ALFENTA_nsubj:pass<administer_advcl>depressant_obl>barbiturate_nmod>anesthetic_conj	pos_7=NN	lemma_3=in	pos_9=,	pos_10=NNS	lemma_6=other	lemma_13=inhalation	lemma_14=general
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e1	DDI-DrugBank.d8.s0.e2	null	lpib=such_JJ	path=<depressant_obl>barbiturate_nmod	relType_1=case	pos_2=IN	relType_2=fixed	wib=such	eib=False	lemma_1=such	path1=	path2=barbiturate_nmod	pos_1=JJ	lib=such	lemma_2=as
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e1	DDI-DrugBank.d8.s0.e3	null	relType_1=case	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	pos_3=NNS	lpib=such_JJ	path=<depressant_obl>barbiturate_nmod>tranquilizer_conj	lemma_3=,	relType_3=nmod	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_3=barbiturate	lemma_1=such	path2=barbiturate_nmod>tranquilizer_conj	lib=such	relType_3=punct
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e1	DDI-DrugBank.d8.s0.e4	null	relType_1=case	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	pos_3=NNS	pos_4=,	lemma_4=tranquilizer	pos_4=NNS	lpib=such_JJ	relType_4=punct	lemma_3=,	path=<depressant_obl>barbiturate_nmod>opioid_conj	relType_3=nmod	lemma_4=,	path2=barbiturate_nmod>opioid_conj	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_3=barbiturate	lemma_1=such	relType_4=conj	lib=such	relType_3=punct
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e1	DDI-DrugBank.d8.s0.e5	null	lemma_5=opioid	relType_1=case	relType_7=compound	relType_8=amod	pos_5=,	path1=	pos_1=JJ	lemma_2=as	lemma_7=inhalation	pos_2=IN	pos_8=JJ	pos_3=NNS	pos_4=,	lemma_4=tranquilizer	pos_5=NNS	lemma_6=or	pos_4=NNS	lpib=such_JJ	relType_4=punct	lemma_3=,	pos_6=CC	lemma_5=,	relType_5=punct	path2=barbiturate_nmod>anesthetic_conj	relType_3=nmod	lemma_4=,	relType_5=conj	path=<depressant_obl>barbiturate_nmod>anesthetic_conj	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_3=barbiturate	lemma_1=such	lemma_8=general	relType_4=conj	lib=such	pos_7=NN	relType_3=punct	relType_6=cc
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e2	DDI-DrugBank.d8.s0.e3	null	path=<barbiturate_nmod>tranquilizer_conj	lpib=tranquilizer_NNS	lemma_1=,	eib=False	wib=tranquilizers	path1=	path2=tranquilizer_conj	pos_1=,	relType_1=punct	lib=tranquilizer
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e2	DDI-DrugBank.d8.s0.e4	null	pos_2=NNS	lpib=tranquilizer_NNS	lemma_1=,	relType_2=punct	eib=True	wib=tranquilizers	path2=opioid_conj	path1=	pos_1=,	pos_2=,	path=<barbiturate_nmod>opioid_conj	relType_1=punct	relType_2=conj	lemma_2=,	lib=tranquilizer	lemma_2=tranquilizer
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e2	DDI-DrugBank.d8.s0.e5	null	lemma_1=,	pos_6=JJ	path1=	pos_1=,	relType_5=compound	relType_4=cc	lemma_3=opioid	relType_2=punct	lpib=tranquilizer_NNS	pos_3=NNS	lemma_6=general	relType_6=amod	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=tranquilizers	lemma_4=or	lib=tranquilizer	lemma_2=tranquilizer	pos_2=NNS	pos_5=NN	lemma_5=inhalation	pos_3=,	eib=True	pos_4=CC	path=<barbiturate_nmod>anesthetic_conj	pos_2=,	path2=anesthetic_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e3	DDI-DrugBank.d8.s0.e4	null	lemma_1=,	eib=False	lib=opioid	path2=opioid_conj	wib=opioids	pos_1=,	lpib=opioid_NNS	path=tranquilizer_conj<barbiturate_nmod>opioid_conj	relType_1=punct	path1=tranquilizer_conj
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e3	DDI-DrugBank.d8.s0.e5	null	lemma_1=,	pos_3=CC	lemma_2=opioid	lib=opioid	pos_1=,	relType_3=cc	relType_2=punct	path1=tranquilizer_conj	lemma_3=or	relType_2=conj	pos_4=NN	lemma_2=,	pos_5=JJ	relType_5=amod	path=tranquilizer_conj<barbiturate_nmod>anesthetic_conj	relType_4=compound	pos_2=NNS	eib=True	wib=opioids	lpib=opioid_NNS	pos_2=,	path2=anesthetic_conj	lemma_4=inhalation	lemma_5=general	relType_1=punct
DDI-DrugBank.d8.s0	DDI-DrugBank.d8.s0.e4	DDI-DrugBank.d8.s0.e5	null	relType_4=amod	lemma_2=or	lemma_1=,	pos_4=JJ	path=opioid_conj<barbiturate_nmod>anesthetic_conj	pos_1=,	lpib=inhalation_NN	relType_2=cc	wib=inhalation	eib=False	lemma_3=inhalation	lib=inhalation	lemma_4=general	pos_3=NN	pos_2=CC	path2=anesthetic_conj	relType_3=compound	relType_1=punct	path1=opioid_conj
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e0	DDI-DrugBank.d8.s3.e1	mechanism	relType_8=case	lemma_10=first	pos_2=VBN	relType_14=punct	pos_3=IN	pos_13=CD	relType_13=dep	path2=inhibit_parataxis>induction_obl>ALFENTA_compound	lpib=be_VBP	relType_1=aux:pass	relType_10=amod	pos_6=CD	lemma_8=for	lemma_13=60	lemma_16=follow	lemma_2=reduce	lemma_15=minute	lemma_3=by	eib=False	pos_12=-LRB-	pos_14=-RRB-	lemma_1=be	lemma_7=%	pos_9=DT	lemma_4=30	lemma_6=50	relType_12=punct	relation_1=adverse	path=anesthetic_nmod<requirement_nsubj:pass<reduce_ccomp>inhibit_parataxis>induction_obl>ALFENTA_compound	lemma_14=)	pos_8=IN	wib=are	pos_4=CD	lemma_12=(	relType_15=obl	lib=be	pos_10=JJ	pos_16=VBG	relType_4=compound	relType_6=nummod	pos_5=IN	lemma_11=sixty	lemma_5=to	pos_1=VBP	pos_11=CD	relType_3=case	relType_2=ccomp	relType_5=advmod	relType_16=case	relType_7=obl	pos_15=NNS	path1=anesthetic_nmod<requirement_nsubj:pass	relType_11=compound	lemma_9=the	pos_7=NN	relType_9=det
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e0	DDI-DrugBank.d8.s3.e2	null	relType_8=case	path2=inhibit_parataxis>use_nsubj>erythromycin_nmod	path=anesthetic_nmod<requirement_nsubj:pass<reduce_ccomp>inhibit_parataxis>use_nsubj>erythromycin_nmod	pos_2=VBN	lemma_10=first	pos_3=IN	pos_13=CD	relType_13=dep	relType_14=punct	lemma_19=concomitant	lpib=be_VBP	relType_1=aux:pass	relType_10=amod	pos_6=CD	lemma_8=for	lemma_13=60	lemma_16=follow	lemma_2=reduce	lemma_15=minute	relType_20=nsubj	pos_18=DT	lemma_3=by	pos_17=NN	lemma_18=the	pos_17=NNP	lemma_17=induction	pos_12=-LRB-	pos_14=-RRB-	lemma_1=be	pos_19=JJ	lemma_7=%	pos_9=DT	lemma_4=30	lemma_6=50	relType_12=punct	relType_17=compound	lemma_14=)	pos_20=NN	lemma_20=use	pos_21=IN	relation_1=adverse	pos_8=IN	wib=are	pos_4=CD	lemma_12=(	lemma_17=ALFENTA	relType_15=obl	lib=be	pos_10=JJ	lemma_21=of	pos_16=VBG	relType_4=compound	relType_6=nummod	pos_5=IN	lemma_11=sixty	lemma_5=to	relType_19=amod	pos_1=VBP	pos_11=CD	relType_3=case	relType_2=ccomp	relType_5=advmod	relType_21=case	relType_16=case	relType_7=obl	pos_15=NNS	eib=True	path1=anesthetic_nmod<requirement_nsubj:pass	relType_11=compound	lemma_9=the	relType_18=det	pos_7=NN	relType_17=obl	relType_9=det
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e0	DDI-DrugBank.d8.s3.e3	null	lemma_19=concomitant	relType_13=dep	relType_20=nsubj	pos_20=NN	lemma_7=%	relType_17=compound	pos_22=IN	wib=are	lemma_17=ALFENTA	relType_15=obl	pos_16=VBG	relType_21=case	relType_8=case	relType_22=nmod	pos_13=CD	pos_22=NN	lemma_16=follow	lemma_13=60	lemma_2=reduce	pos_18=DT	lemma_17=induction	pos_19=JJ	lemma_20=use	lemma_6=50	relType_12=punct	relType_22=case	pos_8=IN	pos_4=CD	relType_6=nummod	pos_5=IN	lemma_22=with	relType_19=amod	pos_11=CD	relType_5=advmod	relType_16=case	relType_7=obl	relType_18=det	pos_12=-LRB-	lemma_21=of	pos_7=NN	path2=inhibit_parataxis>use_nsubj>ALFENTA_nmod	lemma_18=the	lemma_12=(	pos_2=VBN	relType_14=punct	pos_3=IN	lpib=be_VBP	lemma_8=for	pos_17=NN	pos_17=NNP	pos_14=-RRB-	lemma_1=be	pos_9=DT	pos_21=IN	relation_1=adverse	lemma_14=)	lib=be	lemma_5=to	pos_1=VBP	path1=anesthetic_nmod<requirement_nsubj:pass	lemma_9=the	lemma_10=first	relType_1=aux:pass	relType_10=amod	pos_6=CD	lemma_15=minute	lemma_3=by	lemma_4=30	pos_10=JJ	relType_4=compound	lemma_11=sixty	lemma_22=erythromycin	relType_3=case	relType_2=ccomp	path=anesthetic_nmod<requirement_nsubj:pass<reduce_ccomp>inhibit_parataxis>use_nsubj>ALFENTA_nmod	pos_15=NNS	eib=True	relType_11=compound	relType_17=obl	relType_9=det
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e0	DDI-DrugBank.d8.s3.e4	null	pos_23=MD	lemma_19=concomitant	relType_13=dep	relType_25=parataxis	relType_20=nsubj	path2=inhibit_parataxis>clearance_obj>ALFENTA_compound	pos_20=NN	lemma_7=%	relType_17=compound	pos_22=IN	wib=are	lemma_17=ALFENTA	relType_15=obl	pos_16=VBG	lemma_24=significantly	relType_21=case	path=anesthetic_nmod<requirement_nsubj:pass<reduce_ccomp>inhibit_parataxis>clearance_obj>ALFENTA_compound	lemma_25=inhibit	relType_8=case	relType_22=nmod	pos_13=CD	lemma_23=can	pos_22=NN	lemma_16=follow	lemma_13=60	lemma_2=reduce	pos_18=DT	lemma_17=induction	pos_19=JJ	lemma_20=use	lemma_6=50	relType_12=punct	relType_22=case	pos_8=IN	pos_4=CD	relType_24=advmod	relType_6=nummod	pos_5=IN	lemma_22=with	relType_19=amod	pos_11=CD	relType_5=advmod	relType_23=aux	relType_16=case	relType_7=obl	relType_18=det	relation_27=adverse	pos_12=-LRB-	lemma_21=of	pos_7=NN	lemma_18=the	lemma_12=(	pos_2=VBN	relType_14=punct	pos_3=IN	lpib=be_VBP	lemma_8=for	pos_17=NN	pos_17=NNP	pos_14=-RRB-	lemma_1=be	pos_9=DT	pos_21=IN	relation_1=adverse	lemma_14=)	relType_23=nmod	lib=be	lemma_5=to	pos_1=VBP	pos_24=RB	path1=anesthetic_nmod<requirement_nsubj:pass	lemma_9=the	pos_23=NNP	lemma_10=first	relType_1=aux:pass	relType_10=amod	pos_6=CD	lemma_15=minute	lemma_3=by	lemma_23=ALFENTA	lemma_4=30	pos_10=JJ	relType_4=compound	lemma_11=sixty	lemma_22=erythromycin	relType_3=case	relType_2=ccomp	pos_25=VB	pos_15=NNS	eib=True	relType_11=compound	relType_17=obl	relType_9=det
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e1	DDI-DrugBank.d8.s3.e2	null	path2=use_nsubj>erythromycin_nmod	pos_2=DT	lemma_2=the	lpib=induction_NN	lemma_4=use	lemma_5=of	relType_5=case	path1=ALFENTA_compound<induction_obl	path=ALFENTA_compound<induction_obl<inhibit_parataxis>use_nsubj>erythromycin_nmod	eib=False	relType_4=nsubj	pos_4=NN	pos_1=NN	relType_3=amod	pos_5=IN	lemma_3=concomitant	lemma_1=induction	pos_3=JJ	relType_2=det	lib=induction	relType_1=obl	wib=induction
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e1	DDI-DrugBank.d8.s3.e3	null	pos_2=DT	lemma_2=the	lpib=induction_NN	path=ALFENTA_compound<induction_obl<inhibit_parataxis>use_nsubj>ALFENTA_nmod	lemma_4=use	lemma_5=of	relType_5=case	relType_6=case	pos_6=NN	path1=ALFENTA_compound<induction_obl	pos_6=IN	path2=use_nsubj>ALFENTA_nmod	relType_4=nsubj	pos_4=NN	pos_1=NN	relType_3=amod	pos_5=IN	lemma_6=with	lemma_3=concomitant	lemma_1=induction	lemma_6=erythromycin	pos_3=JJ	eib=True	relType_2=det	lib=induction	relType_6=nmod	relType_1=obl	wib=induction
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e1	DDI-DrugBank.d8.s3.e4	null	relType_9=parataxis	pos_2=DT	lemma_7=ALFENTA	lemma_2=the	lpib=induction_NN	relType_7=aux	pos_9=VB	lemma_4=use	lemma_5=of	relType_5=case	relType_6=case	pos_6=NN	path2=clearance_obj>ALFENTA_compound	lemma_9=inhibit	lemma_7=can	path1=ALFENTA_compound<induction_obl	pos_6=IN	pos_8=RB	pos_7=MD	relType_4=nsubj	pos_4=NN	pos_1=NN	relType_8=advmod	lemma_8=significantly	relType_3=amod	relation_10=adverse	pos_7=NNP	pos_5=IN	lemma_6=with	relType_7=nmod	lemma_3=concomitant	lemma_1=induction	lemma_6=erythromycin	pos_3=JJ	eib=True	relType_2=det	lib=induction	path=ALFENTA_compound<induction_obl<inhibit_parataxis>clearance_obj>ALFENTA_compound	relType_6=nmod	relType_1=obl	wib=induction
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e2	DDI-DrugBank.d8.s3.e3	mechanism	lemma_1=with	relType_1=case	path1=erythromycin_nmod	eib=False	path=erythromycin_nmod<use_nsubj>ALFENTA_nmod	lib=alfenta	wib=ALFENTA	path2=ALFENTA_nmod	lpib=alfenta_NNP	pos_1=IN
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e2	DDI-DrugBank.d8.s3.e4	null	relType_1=case	pos_3=RB	lemma_2=ALFENTA	relType_3=advmod	relation_4=adverse	pos_2=MD	lpib=alfenta_NNP	path=erythromycin_nmod<use_nsubj<inhibit_parataxis>clearance_obj>ALFENTA_compound	path2=clearance_obj>ALFENTA_compound	pos_2=NNP	relType_2=nmod	lemma_3=significantly	pos_1=IN	relType_2=aux	path1=erythromycin_nmod<use_nsubj	relType_4=parataxis	lib=alfenta	lemma_4=inhibit	lemma_2=can	lemma_1=with	eib=True	pos_4=VB	wib=ALFENTA
DDI-DrugBank.d8.s3	DDI-DrugBank.d8.s3.e3	DDI-DrugBank.d8.s3.e4	null	lemma_2=significantly	path2=clearance_obj>ALFENTA_compound	pos_2=RB	lemma_1=can	path=ALFENTA_nmod<use_nsubj<inhibit_parataxis>clearance_obj>ALFENTA_compound	eib=False	relType_1=aux	relType_2=advmod	path1=ALFENTA_nmod<use_nsubj	relation_2=adverse	lemma_3=inhibit	lpib=significantly_RB	wib=significantly	lib=significantly	pos_1=MD	pos_3=VB	relType_3=parataxis
DDI-DrugBank.d8.s4	DDI-DrugBank.d8.s4.e0	DDI-DrugBank.d8.s4.e1	mechanism	pos_2=DT	lemma_2=the	lib=reduce	relation_0=adverse	lemma_3=clearance	path2=clearance_obj>ALFENTA_nmod	eib=False	lpib=reduce_VBZ	path=cimetidine_nsubj<reduce_ROOT>clearance_obj>ALFENTA_nmod	pos_4=IN	relType_4=case	relType_1=ROOT	pos_1=VBZ	pos_3=NN	relType_2=det	lemma_1=reduce	wib=reduces	path1=cimetidine_nsubj	relType_3=obj	lemma_4=of
DDI-DrugBank.d8.s5	DDI-DrugBank.d8.s5.e0	DDI-DrugBank.d8.s5.e1	null	pos_6=JJ	pos_2=MD	pos_3=VB	relType_3=aux:pass	relType_5=case	relType_11=case	lemma_13=of	path1=ALFENTA_compound<dose_nsubj:pass	eib=False	relType_10=conj	relType_6=amod	relType_12=nmod	lemma_5=with	pos_9=DT	pos_12=NN	relType_2=aux	pos_8=CC	pos_10=NN	pos_13=IN	wib=doses	pos_4=VBN	pos_11=IN	lemma_12=action	relType_13=case	lemma_10=duration	lemma_7=administration	lemma_3=be	lemma_4=require	pos_5=IN	lib=dose	path2=administration_obl>duration_conj>action_nmod>ALFENTA_nmod	relType_4=ROOT	path=ALFENTA_compound<dose_nsubj:pass<require_ROOT>administration_obl>duration_conj>action_nmod>ALFENTA_nmod	lemma_8=and	lpib=dose_NNS	relType_7=obl	pos_1=NNS	lemma_9=the	lemma_11=of	relType_1=nsubj:pass	lemma_2=will	lemma_6=prolonged	pos_7=NN	lemma_1=dose	relType_8=cc	relType_9=det
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e0	DDI-DrugBank.d416.s0.e1	effect	path2=accuracy_obl>patient_nmod>receive_acl>sulfonamide_obj	relType_1=aux	pos_6=DT	path=pah_nmod<measurement_nsubj:pass<make_ROOT>accuracy_obl>patient_nmod>receive_acl>sulfonamide_obj	lemma_4=make	pos_9=IN	path1=pah_nmod<measurement_nsubj:pass	pos_3=VB	lemma_8=accuracy	relType_3=aux:pass	relType_5=case	relType_8=obl	pos_8=NN	pos_2=RB	relType_10=nmod	eib=False	relType_2=advmod	wib=not	lemma_5=with	relType_9=case	pos_4=VBN	lemma_1=can	relType_7=amod	lemma_7=significant	lemma_11=receive	lemma_3=be	pos_11=VBG	pos_5=IN	relType_11=acl	pos_1=MD	relType_4=ROOT	lib=not	relType_6=det	lemma_6=any	pos_7=JJ	lpib=not_RB	lemma_9=in	pos_10=NNS	lemma_2=not	lemma_10=patient
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e0	DDI-DrugBank.d416.s0.e2	effect	relType_1=aux	pos_6=DT	lemma_4=make	pos_9=IN	path1=pah_nmod<measurement_nsubj:pass	pos_3=VB	lemma_8=accuracy	relType_3=aux:pass	relType_5=case	relType_8=obl	pos_8=NN	pos_2=RB	lemma_12=,	relType_10=nmod	path=pah_nmod<measurement_nsubj:pass<make_ROOT>accuracy_obl>patient_nmod>procaine_conj	relType_2=advmod	pos_12=,	wib=not	lemma_5=with	relType_12=obj	relType_9=case	relType_12=punct	pos_4=VBN	lemma_1=can	relType_7=amod	lemma_7=significant	lemma_11=receive	pos_12=NNS	lemma_3=be	pos_11=VBG	pos_5=IN	relType_11=acl	pos_1=MD	relType_4=ROOT	lib=not	relType_6=det	path2=accuracy_obl>patient_nmod>procaine_conj	lemma_6=any	lemma_12=sulfonamide	eib=True	pos_7=JJ	lpib=not_RB	lemma_9=in	pos_10=NNS	lemma_2=not	lemma_10=patient
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e0	DDI-DrugBank.d416.s0.e3	effect	pos_13=,	pos_14=CC	lemma_13=,	relType_1=aux	pos_6=DT	lemma_4=make	relType_13=punct	pos_9=IN	path1=pah_nmod<measurement_nsubj:pass	pos_3=VB	lemma_8=accuracy	relType_3=aux:pass	lemma_14=or	relType_5=case	relType_8=obl	pos_8=NN	pos_2=RB	lemma_12=,	relType_10=nmod	relType_2=advmod	pos_12=,	wib=not	lemma_5=with	relType_12=obj	relType_9=case	relType_12=punct	pos_13=NN	relType_13=conj	pos_4=VBN	lemma_1=can	relType_7=amod	lemma_7=significant	lemma_11=receive	pos_12=NNS	lemma_3=be	pos_11=VBG	pos_5=IN	path=pah_nmod<measurement_nsubj:pass<make_ROOT>accuracy_obl>patient_nmod>thiazolesulfone_conj	relType_11=acl	pos_1=MD	relType_14=cc	relType_4=ROOT	lib=not	path2=accuracy_obl>patient_nmod>thiazolesulfone_conj	relType_6=det	lemma_6=any	lemma_12=sulfonamide	eib=True	pos_7=JJ	lpib=not_RB	lemma_13=procaine	lemma_9=in	pos_10=NNS	lemma_2=not	lemma_10=patient
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e1	DDI-DrugBank.d416.s0.e2	null	path2=procaine_conj	lemma_1=,	path1=sulfonamide_obj<receive_acl	wib=procaine	eib=False	lib=procaine	lpib=procaine_NN	path=sulfonamide_obj<receive_acl<patient_nmod>procaine_conj	pos_1=,	relType_1=punct
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e1	DDI-DrugBank.d416.s0.e3	null	lemma_1=,	pos_2=NN	path1=sulfonamide_obj<receive_acl	wib=procaine	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	lib=procaine	lemma_3=or	relType_2=conj	lemma_2=,	lpib=procaine_NN	path2=thiazolesulfone_conj	lemma_2=procaine	eib=True	path=sulfonamide_obj<receive_acl<patient_nmod>thiazolesulfone_conj	pos_2=,	relType_1=punct
DDI-DrugBank.d416.s0	DDI-DrugBank.d416.s0.e2	DDI-DrugBank.d416.s0.e3	null	lemma_2=or	lpib=thiazolesulfone_NN	lemma_1=,	eib=False	path2=thiazolesulfone_conj	lib=thiazolesulfone	pos_1=,	pos_2=CC	path1=procaine_conj	wib=thiazolesulfone	path=procaine_conj<patient_nmod>thiazolesulfone_conj	relType_1=punct	relType_2=cc
DDI-DrugBank.d416.s2	DDI-DrugBank.d416.s2.e0	DDI-DrugBank.d416.s2.e1	mechanism	pos_7=NNS	relType_8=case	lemma_8=such	pos_6=JJ	lemma_1=depress	relation_0=adverse	pos_9=IN	path2=secretion_obj>acid_nmod>pah_nmod	pos_2=JJ	pos_8=JJ	eib=False	relType_6=amod	lemma_2=tubular	lpib=depress_VBZ	path1=Probenecid_nsubj	pos_5=JJ	lemma_3=secretion	relType_5=amod	pos_4=IN	relType_2=amod	lemma_6=weak	relType_4=case	relType_7=nmod	lib=depress	lemma_9=as	relType_9=fixed	path=Probenecid_nsubj<depress_ROOT>secretion_obj>acid_nmod>pah_nmod	relType_1=ROOT	pos_1=VBZ	pos_3=NN	lemma_5=certain	relType_3=obj	lemma_7=acid	wib=depresses	lemma_4=of
DDI-DrugBank.d416.s3	DDI-DrugBank.d416.s3.e0	DDI-DrugBank.d416.s3.e1	effect	relType_4=amod	relType_7=compound	pos_4=JJ	pos_3=RB	relType_3=advmod	relType_1=aux	lemma_2=have	lemma_4=low	relType_5=compound	eib=False	pos_2=VB	lemma_7=tm	lib=have	path1=probenecid_obj<receive_acl<patient_nsubj	lemma_3=erroneously	path=probenecid_obj<receive_acl<patient_nsubj<have_ROOT>value_obj>erpf_compound>pah_conj	pos_6=CC	lpib=have_VB	relType_2=ROOT	lemma_6=and	lemma_1=will	path2=value_obj>erpf_compound>pah_conj	pos_1=MD	pos_5=NN	lemma_5=erpf	wib=have	pos_7=NN	relType_6=cc
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e0	DDI-DrugBank.d22.s0.e1	mechanism	path2=amount_obj>digoxin_nmod	relType_1=aux	lemma_1=may	lemma_5=of	relType_5=case	eib=False	relation_1=adverse	lpib=decrease_VB	pos_2=VB	relType_3=det	pos_4=NN	relType_4=obj	path1=acid_nsubj	relType_2=ROOT	wib=decrease	pos_5=IN	pos_1=MD	lemma_4=amount	pos_3=DT	path=acid_nsubj<decrease_ROOT>amount_obj>digoxin_nmod	lemma_2=decrease	lemma_3=the	lib=decrease
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e0	DDI-DrugBank.d22.s0.e2	mechanism	relType_1=aux	lemma_1=may	lemma_6=(	lemma_6=digoxin	lemma_5=of	relType_5=case	pos_6=NN	pos_6=-LRB-	relType_6=punct	relation_1=adverse	lpib=decrease_VB	pos_2=VB	relType_3=det	pos_4=NN	relType_4=obj	path1=acid_nsubj	relType_2=ROOT	wib=decrease	pos_5=IN	pos_1=MD	lemma_4=amount	eib=True	pos_3=DT	lemma_3=the	lemma_2=decrease	relType_6=nmod	path=acid_nsubj<decrease_ROOT>amount_obj>digoxin_nmod>Lanoxin_dep	lib=decrease	path2=amount_obj>digoxin_nmod>Lanoxin_dep
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e0	DDI-DrugBank.d22.s0.e3	null	path=acid_nsubj<decrease_ROOT>amount_obj>digoxin_nmod>Lanoxin_dep>Lanoxicaps_appos	relType_1=aux	lemma_1=may	lemma_6=(	lemma_6=digoxin	lemma_5=of	relType_5=case	pos_6=NN	pos_6=-LRB-	lemma_7=Lanoxin	relType_6=punct	pos_7=,	relation_1=adverse	lpib=decrease_VB	pos_2=VB	relType_3=det	lemma_7=,	pos_4=NN	relType_4=obj	path1=acid_nsubj	relType_2=ROOT	wib=decrease	pos_7=NNP	pos_5=IN	pos_1=MD	lemma_4=amount	path2=amount_obj>digoxin_nmod>Lanoxin_dep>Lanoxicaps_appos	relType_7=dep	eib=True	pos_3=DT	relType_7=punct	lemma_3=the	lemma_2=decrease	relType_6=nmod	lib=decrease
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e1	DDI-DrugBank.d22.s0.e2	null	lemma_1=(	eib=False	path2=Lanoxin_dep	path=<digoxin_nmod>Lanoxin_dep	path1=	wib=Lanoxin	relType_1=punct	lpib=lanoxin_NNP	pos_1=-LRB-	lib=lanoxin
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e1	DDI-DrugBank.d22.s0.e3	null	lemma_1=(	relType_2=dep	eib=True	pos_2=NNP	path1=	path=<digoxin_nmod>Lanoxin_dep>Lanoxicaps_appos	pos_2=,	path2=Lanoxin_dep>Lanoxicaps_appos	wib=Lanoxin	relType_1=punct	lpib=lanoxin_NNP	relType_2=punct	lemma_2=,	pos_1=-LRB-	lemma_2=Lanoxin	lib=lanoxin
DDI-DrugBank.d22.s0	DDI-DrugBank.d22.s0.e2	DDI-DrugBank.d22.s0.e3	null	lemma_1=,	path2=Lanoxicaps_appos	eib=False	lpib=lanoxicaps_NNP	wib=Lanoxicaps	path=<Lanoxin_dep>Lanoxicaps_appos	path1=	pos_1=,	lib=lanoxicaps	relType_1=punct
DDI-DrugBank.d22.s1	DDI-DrugBank.d22.s1.e0	DDI-DrugBank.d22.s1.e1	advise	path2=take_advcl>acid_obj	path1=digoxin_obj	pos_3=JJ	relType_3=amod	eib=True	relType_1=mark	wib=taking	lpib=take_VBG	lemma_2=take	lib=take	lemma_3=aminosalicylic	relType_2=advcl	pos_1=IN	lemma_1=while	path=digoxin_obj<take_ccomp>take_advcl>acid_obj	pos_2=VBG
DDI-DrugBank.d22.s1	DDI-DrugBank.d22.s1.e0	DDI-DrugBank.d22.s1.e2	null	relType_4=amod	relType_2=advcl	lemma_6=of	relType_6=case	pos_5=NNS	pos_6=IN	lemma_3=aminosalicylic	pos_4=JJR	pos_1=IN	lemma_3=acid	lemma_4=high	path1=digoxin_obj	relType_3=amod	lemma_3=,	wib=taking	lemma_2=take	lib=take	path=digoxin_obj<take_ccomp>take_advcl>acid_obj>dose_appos>digoxin_nmod	lemma_1=while	relType_5=appos	path2=take_advcl>acid_obj>dose_appos>digoxin_nmod	lemma_5=dose	pos_3=JJ	pos_3=,	eib=True	relType_1=mark	pos_3=NN	lpib=take_VBG	relType_3=obj	relType_3=punct	pos_2=VBG
DDI-DrugBank.d22.s1	DDI-DrugBank.d22.s1.e1	DDI-DrugBank.d22.s1.e2	null	lemma_1=,	path1=	pos_1=,	lemma_2=high	lemma_3=dose	pos_3=NNS	eib=False	relType_3=appos	path=<acid_obj>dose_appos>digoxin_nmod	wib=higher	lib=high	pos_4=IN	relType_2=amod	relType_4=case	lpib=high_JJR	path2=dose_appos>digoxin_nmod	pos_2=JJR	relType_1=punct	lemma_4=of
DDI-DrugBank.d22.s2	DDI-DrugBank.d22.s2.e0	DDI-DrugBank.d22.s2.e1	mechanism	lpib=also_RB	relType_7=compound	relType_1=aux	lemma_1=may	wib=also	path=acid_nsubj<decrease_ROOT>absorption_obj>b12_nmod	pos_7=NN	lemma_6=of	path2=absorption_obj>b12_nmod	pos_3=VB	lemma_5=absorption	relType_6=case	pos_2=RB	lemma_3=decrease	relType_2=advmod	pos_6=IN	lemma_7=vitamin	pos_4=DT	relType_3=ROOT	path1=acid_nsubj	lib=also	lemma_4=the	pos_1=MD	pos_5=NN	eib=True	relation_2=adverse	relType_5=obj	lemma_2=also	relType_4=det
DDI-DrugBank.d22.s3	DDI-DrugBank.d22.s3.e0	DDI-DrugBank.d22.s3.e1	advise	relType_4=amod	pos_4=JJ	lemma_3=take	wib=supplement	relType_2=mark	pos_2=IN	lemma_1=supplement	pos_3=VBG	lemma_2=while	pos_1=NN	path1=b12_compound<supplement_obj	path2=take_advcl>acid_obj	path=b12_compound<supplement_obj<take_xcomp>take_advcl>acid_obj	lib=supplement	relType_3=advcl	lpib=supplement_NN	lemma_4=aminosalicylic	eib=True	relType_1=obj
DDI-DrugBank.d318.s0	DDI-DrugBank.d318.s0.e0	DDI-DrugBank.d318.s0.e1	effect	lemma_2=antineoplastic	eib=True	wib=Antineoplastic	relType_2=amod	pos_1=:	lpib=antineoplastic_JJ	lib=antineoplastic	path=b_obl<interact_parataxis<administer_dep>agent_parataxis	lemma_1=:	relType_1=punct	path2=agent_parataxis	path1=b_obl<interact_parataxis	pos_2=JJ
DDI-DrugBank.d318.s1	DDI-DrugBank.d318.s1.e0	DDI-DrugBank.d318.s1.e1	null	path2=g._appos>mustard_appos	pos_2=NN	path1=	relType_5=compound	lib=e.	lemma_1=(	lemma_3=g.	relType_3=appos	pos_4=,	path=<agent_nsubj:pass>g._appos>mustard_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_5=NN	lemma_5=nitrogen	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d318.s2	DDI-DrugBank.d318.s2.e0	DDI-DrugBank.d318.s2.e1	null	relType_1=cc	path2=corticotropin_conj	pos_1=CC	eib=False	path1=	wib=Corticotropin	lib=corticotropin	lpib=corticotropin_NN	path=<corticosteroid_nsubj>corticotropin_conj	lemma_1=and
DDI-DrugBank.d318.s2	DDI-DrugBank.d318.s2.e0	DDI-DrugBank.d318.s2.e2	null	relType_1=cc	pos_1=CC	pos_2=NN	eib=True	path1=	wib=Corticotropin	lib=corticotropin	lpib=corticotropin_NN	lemma_2=corticotropin	path=<corticosteroid_nsubj>acth_appos	pos_2=-LRB-	lemma_2=(	relType_2=conj	lemma_1=and	relType_2=punct	path2=acth_appos
DDI-DrugBank.d318.s2	DDI-DrugBank.d318.s2.e1	DDI-DrugBank.d318.s2.e2	null	lemma_1=(	wib=ACTH	lpib=acth_NN	eib=False	path=corticotropin_conj<corticosteroid_nsubj>acth_appos	path1=corticotropin_conj	lib=acth	relType_1=punct	pos_1=-LRB-	path2=acth_appos
DDI-DrugBank.d318.s5	DDI-DrugBank.d318.s5.e0	DDI-DrugBank.d318.s5.e2	null	lpib=amphotericin_NN	pos_2=NN	pos_6=VB	pos_3=VBN	path1=	lib=amphotericin	pos_2=HYPH	lemma_4=hypokalemia	relType_2=punct	lemma_3=induce	lemma_5=may	lemma_2=-	lemma_2=amphotericin	relation_7=adverse	relType_5=aux	relType_4=nsubj	relType_6=parataxis	pos_4=NN	lemma_1=:	wib=amphotericin	pos_5=MD	lemma_2=b	path2=potentiate_parataxis>toxicity_obj>digitalis_compound	relType_3=amod	relType_2=compound	pos_1=:	path=<glycoside_ROOT>potentiate_parataxis>toxicity_obj>digitalis_compound	relType_2=obl	relation_7=beneficial	eib=True	relation_4=neutral	relType_1=punct	lemma_6=potentiate
DDI-DrugBank.d318.s7	DDI-DrugBank.d318.s7.e0	DDI-DrugBank.d318.s7.e1	null	relType_4=amod	relType_7=compound	pos_4=JJ	lemma_7=amphotericin	path1=	relType_5=nsubj:pass	relType_6=case	wib=synergistic	relType_2=mark	pos_2=IN	pos_6=IN	lpib=synergistic_JJ	relType_3=det	lemma_3=a	lemma_2=while	lemma_1=:	lemma_5=relationship	path2=increase_dep>report_advcl>relationship_nsubj:pass>b_nmod	lib=synergistic	pos_1=:	lemma_6=with	pos_5=NN	lemma_4=synergistic	eib=True	pos_3=DT	path=<Flucytosine_ROOT>increase_dep>report_advcl>relationship_nsubj:pass>b_nmod	relType_1=punct	pos_7=NN
DDI-DrugBank.d318.s7	DDI-DrugBank.d318.s7.e0	DDI-DrugBank.d318.s7.e2	null	relType_4=amod	relType_7=compound	pos_4=JJ	pos_7=VBZ	relType_10=punct	lemma_7=amphotericin	lemma_12=use	lemma_16=toxicity	pos_8=VBN	lemma_10=,	path1=	relType_5=nsubj:pass	lemma_14=increase	relType_7=aux	relType_6=case	wib=synergistic	relType_2=mark	path=<Flucytosine_ROOT>increase_dep>toxicity_obj>flucytosine_nmod	pos_17=IN	pos_2=IN	relType_9=advcl	lemma_15=the	pos_6=IN	relType_11=amod	relType_8=aux:pass	lpib=synergistic_JJ	pos_12=NN	relType_13=aux	lemma_13=may	pos_9=VBN	relType_3=det	lemma_3=a	lemma_11=concomitant	lemma_2=while	lemma_1=:	pos_15=DT	lemma_7=have	relType_17=case	lemma_5=relationship	lemma_7=b	lemma_8=be	lib=synergistic	pos_1=:	relType_16=obj	relType_7=nmod	lemma_6=with	pos_14=VB	relType_14=dep	pos_16=NN	lemma_17=of	relation_15=beneficial	relType_12=nsubj	pos_5=NN	lemma_4=synergistic	path2=increase_dep>toxicity_obj>flucytosine_nmod	pos_10=,	eib=True	pos_3=DT	lemma_9=report	pos_11=JJ	relType_1=punct	pos_7=NN	relType_15=det	pos_13=MD
DDI-DrugBank.d318.s7	DDI-DrugBank.d318.s7.e1	DDI-DrugBank.d318.s7.e2	effect	pos_2=VBN	relType_8=dep	lpib=have_VBZ	relType_1=aux	pos_3=VBN	relType_7=aux	relType_11=case	pos_6=NN	path1=b_nmod<relationship_nsubj:pass<report_advcl	path=b_nmod<relationship_nsubj:pass<report_advcl<increase_dep>toxicity_obj>flucytosine_nmod	pos_4=,	eib=False	lemma_10=toxicity	lemma_3=report	pos_9=DT	lemma_1=have	pos_7=MD	lemma_7=may	pos_10=NN	lib=have	pos_8=VB	pos_11=IN	lemma_8=increase	pos_5=JJ	lemma_5=concomitant	relType_4=punct	relType_3=advcl	relType_5=amod	lemma_6=use	relType_2=aux:pass	lemma_4=,	relation_7=beneficial	path2=toxicity_obj>flucytosine_nmod	pos_1=VBZ	lemma_9=the	lemma_11=of	lemma_2=be	wib=has	relType_10=obj	relType_6=nsubj	relType_9=det
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e1	null	lpib=e._NNP	path1=	pos_3=NNP	lib=e.	path2=g._appos>ketoconazole_appos	lemma_1=(	pos_2=NNP	eib=False	lemma_3=g.	relType_3=appos	pos_4=,	relType_4=punct	path=<Imidazoles_nsubj>g._appos>ketoconazole_appos	relType_2=compound	lemma_2=e.	wib=e.	lemma_4=,	pos_1=-LRB-	relType_1=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e2	null	lpib=e._NNP	pos_5=,	lemma_5=ketoconazole	path1=	pos_3=NNP	lib=e.	lemma_1=(	pos_2=NNP	lemma_3=g.	relType_3=appos	pos_4=,	path=<Imidazoles_nsubj>g._appos>miconazole_appos	relType_4=punct	lemma_5=,	path2=g._appos>miconazole_appos	relType_2=compound	relType_5=punct	lemma_2=e.	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_5=NN	eib=True	relType_1=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e3	null	lpib=e._NNP	pos_5=,	lemma_5=ketoconazole	path1=	path2=g._appos>clotrimazole_appos	pos_3=NNP	lemma_6=,	lib=e.	lemma_1=(	pos_6=NN	pos_2=NNP	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	path=<Imidazoles_nsubj>g._appos>clotrimazole_appos	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_6=miconazole	pos_5=NN	relType_6=appos	eib=True	relType_1=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e4	null	lpib=e._NNP	path=<Imidazoles_nsubj>g._appos>fluconazole_appos	relType_7=appos	pos_5=,	lemma_5=ketoconazole	path1=	pos_3=NNP	lemma_6=,	lib=e.	lemma_1=(	pos_6=NN	pos_2=NNP	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	path2=g._appos>fluconazole_appos	pos_7=,	lemma_7=,	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_7=clotrimazole	lemma_2=e.	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_6=miconazole	pos_5=NN	relType_6=appos	eib=True	relType_7=punct	relType_1=punct	pos_7=NN
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e5	null	pos_14=CC	pos_5=,	lemma_5=ketoconazole	lemma_6=,	relType_8=punct	pos_6=NN	pos_2=NNP	relType_12=compound	lemma_7=,	lemma_19=combination	relType_4=punct	lemma_5=,	lemma_7=clotrimazole	wib=e.	pos_1=-LRB-	relType_15=compound	lemma_12=in	lemma_10=)	relType_6=appos	path=Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod	lemma_20=of	lpib=e._NNP	pos_3=NNP	lib=e.	relType_8=appos	pos_16=NNS	pos_8=NN	pos_18=DT	relType_20=case	lemma_3=g.	path2=vitro_advmod>study_conj>combination_nmod>b_nmod	relType_13=advmod	lemma_21=amphotericin	relType_21=compound	lemma_2=e.	lemma_4=,	lemma_8=fluconazole	relType_5=appos	pos_5=NN	lemma_14=and	relType_18=det	relType_1=punct	pos_7=NN	lemma_18=the	pos_8=,	relType_10=punct	relType_7=appos	lemma_8=,	pos_20=IN	lemma_1=(	pos_17=IN	relType_19=nmod	lemma_17=with	pos_4=,	relType_3=appos	relType_11=punct	pos_7=,	lemma_11=:	relType_17=case	path1=Imidazoles_nsubj	lemma_9=etc.	pos_11=:	lemma_6=miconazole	pos_9=FW	pos_12=FW	relType_9=dep	lemma_15=animal	relType_6=punct	pos_19=NN	pos_15=NN	pos_13=FW	relType_2=compound	relType_5=punct	lemma_16=study	relType_14=cc	pos_6=,	eib=True	pos_10=-RRB-	relType_7=punct	lemma_13=vitro	relType_16=conj	pos_21=NN
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e6	null	pos_14=CC	pos_5=,	lemma_5=ketoconazole	lemma_6=,	relType_8=punct	relType_21=cc	pos_6=NN	pos_2=NNP	relType_12=compound	path2=vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	lemma_7=,	lemma_19=combination	relType_4=punct	lemma_5=,	lemma_7=clotrimazole	wib=e.	pos_1=-LRB-	relType_15=compound	lemma_12=in	lemma_21=b	lemma_10=)	relType_6=appos	lemma_20=of	lpib=e._NNP	pos_3=NNP	lib=e.	relType_8=appos	pos_16=NNS	pos_8=NN	pos_18=DT	relType_20=case	lemma_3=g.	relType_13=advmod	lemma_21=amphotericin	relType_21=compound	lemma_2=e.	lemma_4=,	lemma_8=fluconazole	relType_5=appos	pos_5=NN	lemma_14=and	relType_18=det	relType_1=punct	pos_7=NN	lemma_18=the	pos_8=,	relType_10=punct	relType_7=appos	relType_21=nmod	lemma_8=,	pos_20=IN	lemma_1=(	pos_17=IN	relType_19=nmod	lemma_17=with	pos_4=,	relType_3=appos	relType_11=punct	pos_7=,	lemma_11=:	relType_17=case	path1=Imidazoles_nsubj	lemma_9=etc.	pos_11=:	lemma_6=miconazole	pos_9=FW	lemma_21=and	pos_12=FW	relType_9=dep	lemma_15=animal	relType_6=punct	path=Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_19=NN	pos_15=NN	pos_13=FW	relType_2=compound	relType_5=punct	lemma_16=study	relType_14=cc	pos_6=,	pos_21=CC	eib=True	pos_10=-RRB-	relType_7=punct	lemma_13=vitro	relType_16=conj	pos_21=NN
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e7	null	pos_14=CC	pos_5=,	lemma_5=ketoconazole	lemma_6=,	relType_8=punct	lemma_23=that	relType_21=cc	pos_6=NN	pos_2=NNP	relType_12=compound	lemma_7=,	lemma_19=combination	path=Imidazoles_nsubj<suggest_ROOT>induce_ccomp>imidazole_nsubj	relType_4=punct	lemma_5=,	lemma_7=clotrimazole	wib=e.	pos_1=-LRB-	relType_15=compound	lemma_12=in	lemma_21=b	lemma_10=)	relType_6=appos	lemma_20=of	lpib=e._NNP	relType_22=conj	pos_3=NNP	relType_22=ROOT	lib=e.	relType_8=appos	pos_16=NNS	pos_8=NN	pos_18=DT	relType_20=case	lemma_3=g.	relType_13=advmod	lemma_21=amphotericin	relType_21=compound	lemma_2=e.	lemma_4=,	lemma_22=suggest	lemma_8=fluconazole	relType_5=appos	pos_5=NN	lemma_14=and	pos_23=IN	relType_18=det	relType_1=punct	pos_7=NN	lemma_18=the	pos_8=,	relType_10=punct	relType_7=appos	relType_21=nmod	lemma_8=,	relType_23=mark	pos_20=IN	lemma_1=(	pos_17=IN	relType_19=nmod	lemma_17=with	pos_4=,	relType_3=appos	relType_11=punct	pos_7=,	lemma_11=:	path2=induce_ccomp>imidazole_nsubj	relType_17=case	pos_22=VBP	path1=Imidazoles_nsubj	lemma_9=etc.	pos_11=:	lemma_6=miconazole	pos_9=FW	lemma_21=and	pos_12=FW	relType_9=dep	lemma_15=animal	relType_6=punct	lemma_22=imidazole	pos_19=NN	pos_15=NN	pos_13=FW	relType_2=compound	relType_5=punct	lemma_16=study	pos_22=NNS	relType_14=cc	pos_6=,	pos_21=CC	eib=True	pos_10=-RRB-	relType_7=punct	lemma_13=vitro	relType_16=conj	pos_21=NN
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e0	DDI-DrugBank.d318.s8.e8	null	pos_14=CC	pos_5=,	lemma_5=ketoconazole	lemma_6=,	relType_8=punct	lemma_23=that	relType_21=cc	lemma_26=fungal	pos_6=NN	relType_27=obj	pos_2=NNP	relType_12=compound	lemma_7=,	lemma_19=combination	pos_24=NNS	relType_4=punct	path=Imidazoles_nsubj<suggest_ROOT>induce_ccomp>B._obl	lemma_5=,	lemma_28=to	lemma_7=clotrimazole	wib=e.	relType_24=aux	pos_24=MD	pos_1=-LRB-	relType_15=compound	relType_26=amod	lemma_12=in	lemma_21=b	lemma_10=)	relType_6=appos	relType_25=ccomp	lemma_20=of	lpib=e._NNP	relType_22=conj	pos_3=NNP	relType_22=ROOT	lib=e.	relType_8=appos	pos_16=NNS	pos_8=NN	pos_18=DT	relType_20=case	lemma_3=g.	pos_29=NN	pos_27=NN	relType_13=advmod	lemma_21=amphotericin	relType_21=compound	lemma_2=e.	lemma_4=,	lemma_22=suggest	lemma_8=fluconazole	relType_5=appos	pos_5=NN	path2=induce_ccomp>B._obl	lemma_14=and	relType_24=nsubj	pos_23=IN	relType_18=det	relType_1=punct	pos_7=NN	lemma_18=the	pos_8=,	relType_10=punct	relType_7=appos	relation_32=neutral	relType_21=nmod	lemma_8=,	relType_23=mark	relType_29=compound	pos_20=IN	pos_26=JJ	lemma_1=(	pos_17=IN	relType_19=nmod	lemma_17=with	pos_4=,	relType_3=appos	relType_11=punct	pos_7=,	lemma_11=:	relType_17=case	pos_22=VBP	path1=Imidazoles_nsubj	lemma_24=may	lemma_9=etc.	pos_11=:	lemma_6=miconazole	pos_9=FW	relType_28=case	lemma_21=and	lemma_29=amphotericin	lemma_25=induce	pos_12=FW	relType_9=dep	lemma_15=animal	relType_6=punct	lemma_22=imidazole	pos_19=NN	pos_15=NN	pos_13=FW	relType_2=compound	relType_5=punct	lemma_16=study	pos_22=NNS	relType_14=cc	lemma_27=resistance	pos_6=,	pos_25=VB	pos_21=CC	eib=True	pos_10=-RRB-	relType_7=punct	pos_28=IN	lemma_13=vitro	relType_16=conj	pos_21=NN	lemma_24=imidazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e2	null	lemma_1=,	eib=False	lib=miconazole	path=ketoconazole_appos<g._appos>miconazole_appos	path1=ketoconazole_appos	lpib=miconazole_NN	wib=miconazole	pos_1=,	relType_1=punct	path2=miconazole_appos
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e3	null	lemma_1=,	pos_2=NN	eib=True	lib=miconazole	path1=ketoconazole_appos	lpib=miconazole_NN	wib=miconazole	pos_1=,	pos_2=,	path=ketoconazole_appos<g._appos>clotrimazole_appos	relType_1=punct	relType_2=appos	lemma_2=miconazole	lemma_2=,	path2=clotrimazole_appos	relType_2=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e4	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	relType_3=appos	lpib=miconazole_NN	lemma_2=,	lemma_3=,	path1=ketoconazole_appos	relType_2=appos	relType_3=punct	path=ketoconazole_appos<g._appos>fluconazole_appos	pos_3=,	eib=True	path2=fluconazole_appos	lib=miconazole	pos_3=NN	wib=miconazole	lemma_3=clotrimazole	pos_2=,	relType_1=punct	lemma_2=miconazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e5	null	relType_12=conj	lemma_1=,	pos_2=NN	relType_9=advmod	pos_16=IN	relType_4=appos	relType_10=cc	pos_1=,	lemma_13=with	relType_2=punct	pos_17=NN	lemma_8=in	path=ketoconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod	pos_4=,	relType_3=appos	relType_6=punct	pos_10=CC	lpib=miconazole_NN	path2=vitro_advmod>study_conj>combination_nmod>b_nmod	lemma_11=animal	relType_14=det	relType_17=compound	pos_13=IN	lemma_14=the	lemma_16=of	relType_5=dep	pos_4=NN	lemma_2=,	lemma_6=)	lemma_7=:	lemma_9=vitro	lemma_17=amphotericin	relType_13=case	lemma_10=and	relType_4=punct	lemma_3=,	pos_15=NN	pos_12=NNS	pos_8=FW	relType_8=compound	lemma_15=combination	lemma_4=,	relType_2=appos	path1=ketoconazole_appos<g._appos<Imidazoles_nsubj	relType_3=punct	pos_5=FW	pos_7=:	pos_6=-RRB-	pos_14=DT	pos_9=FW	relType_15=nmod	lemma_4=fluconazole	relType_16=case	pos_11=NN	pos_3=,	eib=True	lib=miconazole	pos_3=NN	relType_7=punct	lemma_5=etc.	relType_11=compound	wib=miconazole	lemma_3=clotrimazole	pos_2=,	lemma_12=study	relType_1=punct	lemma_2=miconazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e6	null	relType_12=conj	lemma_1=,	pos_2=NN	relType_17=cc	relType_9=advmod	pos_16=IN	relType_4=appos	relType_10=cc	pos_1=,	lemma_13=with	relType_2=punct	path=ketoconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_17=NN	lemma_8=in	pos_4=,	relType_3=appos	relType_6=punct	pos_10=CC	lpib=miconazole_NN	lemma_11=animal	relType_14=det	relType_17=compound	pos_13=IN	path2=vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	lemma_14=the	relType_5=dep	pos_4=NN	lemma_2=,	lemma_6=)	lemma_7=:	lemma_9=vitro	lemma_16=of	lemma_17=amphotericin	relType_13=case	lemma_10=and	relType_4=punct	lemma_3=,	pos_15=NN	pos_12=NNS	pos_8=FW	relType_8=compound	lemma_15=combination	lemma_17=and	lemma_4=,	relType_2=appos	lemma_17=b	relType_17=nmod	path1=ketoconazole_appos<g._appos<Imidazoles_nsubj	relType_3=punct	pos_5=FW	pos_7=:	pos_6=-RRB-	pos_14=DT	pos_9=FW	relType_15=nmod	lemma_4=fluconazole	relType_16=case	pos_11=NN	pos_3=,	eib=True	lib=miconazole	pos_3=NN	relType_7=punct	lemma_5=etc.	relType_11=compound	wib=miconazole	lemma_3=clotrimazole	pos_2=,	pos_17=CC	lemma_12=study	relType_1=punct	lemma_2=miconazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e7	null	pos_2=NN	relType_17=compound	relType_19=mark	relType_5=dep	lemma_17=amphotericin	lemma_10=and	relType_4=punct	lemma_3=,	lemma_17=b	pos_7=:	pos_5=FW	pos_3=,	lib=miconazole	pos_2=,	lemma_12=study	lemma_1=,	relType_17=cc	relType_9=advmod	pos_18=NNS	pos_1=,	lemma_13=with	relType_2=punct	lemma_8=in	lemma_11=animal	relType_18=ROOT	lemma_14=the	lemma_2=,	lemma_7=:	pos_8=FW	lemma_15=combination	lemma_4=,	lemma_18=imidazole	relType_15=nmod	pos_6=-RRB-	relType_16=case	pos_11=NN	lemma_3=clotrimazole	pos_17=CC	relType_1=punct	relType_3=punct	lemma_2=miconazole	pos_16=IN	relType_4=appos	relType_10=cc	lemma_18=suggest	pos_17=NN	pos_4=,	relType_3=appos	pos_10=CC	lpib=miconazole_NN	pos_13=IN	lemma_6=)	path2=induce_ccomp>imidazole_nsubj	relType_13=case	relType_8=compound	lemma_19=that	relType_17=nmod	pos_14=DT	pos_9=FW	lemma_5=etc.	pos_18=VBP	pos_19=IN	relType_12=conj	path=ketoconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>imidazole_nsubj	relType_6=punct	relType_14=det	lemma_16=of	pos_4=NN	lemma_9=vitro	pos_15=NN	pos_12=NNS	lemma_17=and	relType_2=appos	path1=ketoconazole_appos<g._appos<Imidazoles_nsubj	lemma_4=fluconazole	eib=True	relType_11=compound	pos_3=NN	relType_7=punct	wib=miconazole	relType_18=conj
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e1	DDI-DrugBank.d318.s8.e8	null	lemma_24=to	relation_27=neutral	pos_2=NN	relType_20=nsubj	relType_24=case	relType_17=compound	relType_19=mark	relType_5=dep	lemma_17=amphotericin	lemma_10=and	relType_4=punct	lemma_3=,	lemma_17=b	pos_24=IN	pos_7=:	pos_5=FW	pos_3=,	lib=miconazole	pos_2=,	lemma_12=study	relType_23=obj	lemma_1=,	relType_17=cc	relType_9=advmod	pos_18=NNS	pos_1=,	lemma_13=with	relType_2=punct	lemma_8=in	relType_20=aux	lemma_22=fungal	lemma_11=animal	relType_18=ROOT	lemma_14=the	lemma_2=,	lemma_7=:	lemma_25=amphotericin	pos_8=FW	lemma_15=combination	pos_21=VB	lemma_4=,	lemma_18=imidazole	relType_15=nmod	pos_6=-RRB-	relType_16=case	path2=induce_ccomp>B._obl	pos_11=NN	lemma_3=clotrimazole	pos_17=CC	relType_1=punct	relType_3=punct	lemma_2=miconazole	pos_16=IN	relType_4=appos	relType_10=cc	lemma_18=suggest	pos_23=NN	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=induce	pos_10=CC	lpib=miconazole_NN	lemma_20=imidazole	pos_13=IN	lemma_6=)	relType_25=compound	relType_13=case	relType_8=compound	lemma_19=that	pos_25=NN	relType_21=ccomp	relType_17=nmod	pos_14=DT	pos_9=FW	pos_22=JJ	relType_22=amod	lemma_5=etc.	pos_18=VBP	pos_19=IN	relType_12=conj	lemma_20=may	lemma_23=resistance	pos_20=MD	relType_6=punct	relType_14=det	lemma_16=of	pos_4=NN	lemma_9=vitro	pos_15=NN	pos_12=NNS	pos_20=NNS	lemma_17=and	relType_2=appos	path1=ketoconazole_appos<g._appos<Imidazoles_nsubj	lemma_4=fluconazole	path=ketoconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>B._obl	eib=True	relType_11=compound	pos_3=NN	relType_7=punct	wib=miconazole	relType_18=conj
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e3	null	path=miconazole_appos<g._appos>clotrimazole_appos	lemma_1=,	lib=clotrimazole	path1=miconazole_appos	eib=False	wib=clotrimazole	pos_1=,	relType_1=punct	lpib=clotrimazole_NN	path2=clotrimazole_appos
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e4	null	lemma_1=,	lib=clotrimazole	pos_2=NN	eib=True	path1=miconazole_appos	path2=fluconazole_appos	path=miconazole_appos<g._appos>fluconazole_appos	wib=clotrimazole	pos_1=,	pos_2=,	relType_1=punct	lpib=clotrimazole_NN	relType_2=appos	relType_2=punct	lemma_2=,	lemma_2=clotrimazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e5	null	relType_4=dep	relType_7=compound	lemma_1=,	lemma_13=the	pos_2=NN	lemma_15=of	pos_4=FW	pos_1=,	relType_12=case	lemma_3=fluconazole	pos_13=DT	relType_16=compound	relType_14=nmod	relType_11=conj	relType_2=punct	lib=clotrimazole	relType_3=appos	relType_6=punct	path2=vitro_advmod>study_conj>combination_nmod>b_nmod	wib=clotrimazole	lemma_6=:	pos_11=NNS	lemma_14=combination	lemma_16=amphotericin	pos_7=FW	relType_10=compound	pos_14=NN	pos_10=NN	lemma_4=etc.	relType_8=advmod	lemma_2=,	pos_12=IN	lemma_5=)	lemma_12=with	path1=miconazole_appos<g._appos<Imidazoles_nsubj	lemma_9=and	pos_9=CC	relType_15=case	lemma_3=,	pos_5=-RRB-	pos_8=FW	relType_5=punct	pos_16=NN	relType_2=appos	lemma_8=vitro	path=miconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod	pos_15=IN	lemma_10=animal	pos_3=,	eib=True	lemma_7=in	pos_3=NN	relType_13=det	pos_2=,	relType_9=cc	relType_1=punct	lpib=clotrimazole_NN	lemma_11=study	relType_3=punct	pos_6=:	lemma_2=clotrimazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e6	null	relType_16=cc	relType_4=dep	relType_7=compound	lemma_1=,	lemma_13=the	pos_2=NN	lemma_15=of	relType_16=nmod	pos_4=FW	pos_1=,	relType_12=case	lemma_3=fluconazole	pos_13=DT	relType_16=compound	relType_14=nmod	pos_16=CC	relType_11=conj	relType_2=punct	lib=clotrimazole	relType_3=appos	relType_6=punct	lemma_16=amphotericin	wib=clotrimazole	lemma_6=:	pos_11=NNS	lemma_14=combination	pos_7=FW	relType_10=compound	pos_14=NN	path2=vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_10=NN	lemma_4=etc.	relType_8=advmod	lemma_2=,	pos_12=IN	lemma_5=)	lemma_12=with	path1=miconazole_appos<g._appos<Imidazoles_nsubj	lemma_9=and	pos_9=CC	relType_15=case	lemma_3=,	pos_5=-RRB-	pos_8=FW	relType_5=punct	path=miconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_16=NN	relType_2=appos	lemma_8=vitro	lemma_16=and	lemma_16=b	pos_15=IN	lemma_10=animal	pos_3=,	eib=True	lemma_7=in	pos_3=NN	relType_13=det	pos_2=,	relType_9=cc	relType_1=punct	lpib=clotrimazole_NN	lemma_11=study	relType_3=punct	pos_6=:	lemma_2=clotrimazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e7	null	relType_16=cc	relType_4=dep	relType_7=compound	lemma_1=,	lemma_13=the	pos_2=NN	lemma_15=of	relType_16=nmod	pos_4=FW	pos_1=,	relType_12=case	lemma_3=fluconazole	pos_13=DT	relType_16=compound	pos_17=VBP	relType_14=nmod	pos_16=CC	path=miconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>imidazole_nsubj	relType_11=conj	relType_2=punct	relType_17=conj	relType_17=ROOT	lemma_17=suggest	lib=clotrimazole	relType_3=appos	relType_6=punct	lemma_16=amphotericin	wib=clotrimazole	lemma_6=:	pos_11=NNS	lemma_14=combination	pos_7=FW	relType_10=compound	pos_14=NN	pos_10=NN	lemma_4=etc.	relType_8=advmod	lemma_2=,	path2=induce_ccomp>imidazole_nsubj	lemma_5=)	pos_12=IN	lemma_12=with	path1=miconazole_appos<g._appos<Imidazoles_nsubj	pos_18=IN	lemma_9=and	pos_9=CC	relType_15=case	lemma_3=,	pos_5=-RRB-	lemma_18=that	pos_8=FW	relType_5=punct	pos_16=NN	relType_2=appos	lemma_8=vitro	lemma_16=and	lemma_16=b	pos_15=IN	lemma_10=animal	lemma_17=imidazole	pos_3=,	pos_17=NNS	eib=True	lemma_7=in	relType_18=mark	pos_3=NN	relType_13=det	pos_2=,	relType_9=cc	relType_1=punct	lpib=clotrimazole_NN	lemma_11=study	relType_3=punct	pos_6=:	lemma_2=clotrimazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e2	DDI-DrugBank.d318.s8.e8	null	lemma_24=amphotericin	pos_2=NN	pos_19=MD	relType_16=nmod	lemma_23=to	lemma_17=suggest	pos_7=FW	pos_10=NN	lemma_4=etc.	relType_8=advmod	relType_24=compound	pos_9=CC	lemma_3=,	pos_5=-RRB-	pos_3=,	lemma_7=in	relType_18=mark	relType_13=det	pos_2=,	relType_14=nmod	lemma_22=resistance	relType_16=cc	lemma_1=,	lemma_15=of	pos_22=NN	pos_21=JJ	pos_4=FW	pos_1=,	pos_19=NNS	pos_16=CC	relType_2=punct	path=miconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>B._obl	lemma_14=combination	lemma_2=,	pos_12=IN	lemma_5=)	relType_15=case	lemma_18=that	pos_8=FW	pos_16=NN	lemma_21=fungal	relType_19=nsubj	pos_15=IN	lemma_17=imidazole	path2=induce_ccomp>B._obl	pos_23=IN	relType_1=punct	lpib=clotrimazole_NN	relType_3=punct	pos_6=:	relType_4=dep	relation_25=neutral	pos_20=VB	relType_12=case	pos_24=NN	relType_11=conj	lib=clotrimazole	relType_3=appos	lemma_16=amphotericin	wib=clotrimazole	pos_14=NN	pos_18=IN	path1=miconazole_appos<g._appos<Imidazoles_nsubj	relType_19=aux	lemma_8=vitro	relType_23=case	lemma_16=b	pos_17=NNS	relType_7=compound	lemma_13=the	lemma_3=fluconazole	pos_13=DT	relType_16=compound	pos_17=VBP	lemma_19=may	relType_17=ROOT	relType_17=conj	relType_6=punct	lemma_6=:	pos_11=NNS	relType_21=amod	relType_10=compound	lemma_12=with	lemma_9=and	relType_5=punct	relType_2=appos	lemma_16=and	lemma_20=induce	relType_22=obj	lemma_10=animal	eib=True	pos_3=NN	relType_20=ccomp	lemma_19=imidazole	lemma_11=study	relType_9=cc	lemma_2=clotrimazole
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e3	DDI-DrugBank.d318.s8.e4	null	lpib=fluconazole_NN	lemma_1=,	eib=False	path2=fluconazole_appos	path=clotrimazole_appos<g._appos>fluconazole_appos	wib=fluconazole	pos_1=,	lib=fluconazole	relType_1=punct	path1=clotrimazole_appos
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e3	DDI-DrugBank.d318.s8.e5	null	path=clotrimazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod	lpib=fluconazole_NN	relType_3=dep	lemma_1=,	pos_2=NN	pos_6=FW	wib=fluconazole	pos_1=,	path1=clotrimazole_appos<g._appos<Imidazoles_nsubj	lemma_2=fluconazole	relType_12=det	relType_11=case	relType_2=punct	lemma_11=with	relType_13=nmod	lemma_7=vitro	relType_9=compound	relType_10=conj	lemma_10=study	path2=vitro_advmod>study_conj>combination_nmod>b_nmod	pos_4=-RRB-	pos_7=FW	pos_8=CC	lemma_6=in	pos_13=NN	pos_9=NN	lemma_13=combination	pos_3=FW	lemma_2=,	pos_5=:	pos_11=IN	lemma_12=the	pos_14=IN	lemma_15=amphotericin	relType_4=punct	pos_15=NN	relType_5=punct	lib=fluconazole	lemma_4=)	relType_2=appos	lemma_9=animal	lemma_3=etc.	lemma_8=and	relType_15=compound	relType_6=compound	eib=True	lemma_5=:	lemma_14=of	pos_2=,	pos_12=DT	relType_14=case	relType_7=advmod	relType_1=punct	relType_8=cc	pos_10=NNS
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e3	DDI-DrugBank.d318.s8.e6	null	lpib=fluconazole_NN	relType_3=dep	lemma_1=,	pos_2=NN	pos_6=FW	wib=fluconazole	pos_1=,	path1=clotrimazole_appos<g._appos<Imidazoles_nsubj	lemma_2=fluconazole	relType_12=det	relType_11=case	relType_2=punct	lemma_11=with	relType_13=nmod	lemma_7=vitro	relType_9=compound	relType_10=conj	lemma_10=study	pos_4=-RRB-	pos_7=FW	pos_8=CC	path2=vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	lemma_6=in	pos_9=NN	pos_13=NN	pos_3=FW	lemma_2=,	pos_5=:	pos_11=IN	lemma_12=the	lemma_13=combination	pos_14=IN	lemma_15=amphotericin	relType_4=punct	pos_15=NN	relType_5=punct	lemma_15=b	relType_15=cc	lib=fluconazole	lemma_4=)	relType_2=appos	lemma_9=animal	lemma_3=etc.	relType_15=nmod	lemma_8=and	lemma_15=and	relType_15=compound	relType_6=compound	eib=True	lemma_5=:	lemma_14=of	path=clotrimazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_15=CC	pos_2=,	pos_12=DT	relType_14=case	relType_7=advmod	relType_1=punct	relType_8=cc	pos_10=NNS
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e3	DDI-DrugBank.d318.s8.e7	null	lpib=fluconazole_NN	relType_3=dep	lemma_1=,	pos_2=NN	pos_6=FW	wib=fluconazole	pos_1=,	path1=clotrimazole_appos<g._appos<Imidazoles_nsubj	lemma_2=fluconazole	pos_16=NNS	relType_12=det	relType_16=ROOT	relType_11=case	relType_2=punct	lemma_11=with	path=clotrimazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>imidazole_nsubj	relType_13=nmod	lemma_7=vitro	lemma_16=imidazole	pos_17=IN	relType_17=mark	relType_9=compound	relType_10=conj	lemma_10=study	pos_4=-RRB-	pos_7=FW	pos_8=CC	lemma_6=in	pos_13=NN	pos_9=NN	lemma_13=combination	pos_3=FW	lemma_2=,	path2=induce_ccomp>imidazole_nsubj	pos_5=:	pos_11=IN	lemma_12=the	pos_14=IN	lemma_15=amphotericin	relType_4=punct	pos_15=NN	lemma_17=that	relType_5=punct	lemma_15=b	relType_15=cc	lib=fluconazole	lemma_4=)	relType_2=appos	lemma_9=animal	lemma_3=etc.	relType_15=nmod	lemma_8=and	lemma_15=and	relType_15=compound	relType_6=compound	lemma_16=suggest	eib=True	lemma_5=:	lemma_14=of	pos_15=CC	pos_2=,	pos_12=DT	relType_14=case	relType_7=advmod	relType_1=punct	relType_8=cc	pos_10=NNS	relType_16=conj	pos_16=VBP
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e3	DDI-DrugBank.d318.s8.e8	null	lemma_20=fungal	lpib=fluconazole_NN	pos_2=NN	relType_21=obj	lemma_10=study	pos_4=-RRB-	pos_7=FW	pos_22=IN	pos_13=NN	pos_3=FW	lemma_15=amphotericin	lemma_12=the	pos_20=JJ	relType_23=compound	relType_4=punct	lib=fluconazole	lemma_4=)	lemma_9=animal	lemma_15=and	relType_15=compound	relType_6=compound	lemma_16=suggest	lemma_14=of	pos_15=CC	pos_2=,	pos_12=DT	pos_16=VBP	relType_3=dep	lemma_1=,	pos_18=NNS	relation_23=neutral	pos_1=,	lemma_21=resistance	lemma_2=fluconazole	pos_16=NNS	relType_11=case	relType_2=punct	lemma_11=with	lemma_16=imidazole	relType_19=ccomp	relType_10=conj	lemma_6=in	relType_22=case	pos_9=NN	lemma_13=combination	lemma_2=,	pos_5=:	pos_14=IN	lemma_17=that	lemma_18=imidazole	lemma_19=induce	relType_15=nmod	lemma_8=and	path2=induce_ccomp>B._obl	relType_1=punct	pos_6=FW	relType_12=det	pos_17=IN	relType_17=mark	lemma_7=vitro	relType_20=amod	pos_23=NN	pos_8=CC	pos_11=IN	lemma_15=b	lemma_23=amphotericin	path=clotrimazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>B._obl	lemma_5=:	relType_18=nsubj	pos_19=VB	relType_14=case	relType_7=advmod	relType_8=cc	wib=fluconazole	path1=clotrimazole_appos<g._appos<Imidazoles_nsubj	relType_16=ROOT	relType_13=nmod	relType_9=compound	lemma_18=may	lemma_22=to	relType_18=aux	pos_15=NN	relType_5=punct	relType_15=cc	relType_2=appos	lemma_3=etc.	pos_18=MD	eib=True	pos_10=NNS	relType_16=conj	pos_21=NN
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e4	DDI-DrugBank.d318.s8.e5	null	lib=animal	lemma_1=,	lemma_5=in	relType_9=conj	lemma_10=with	lpib=animal_NN	pos_6=FW	pos_1=,	relType_7=cc	relType_5=compound	lemma_12=combination	relType_14=compound	lemma_13=of	pos_8=NN	path1=fluconazole_appos<g._appos<Imidazoles_nsubj	lemma_4=:	path2=vitro_advmod>study_conj>combination_nmod>b_nmod	pos_9=NNS	relType_12=nmod	lemma_14=amphotericin	pos_12=NN	pos_14=NN	relType_10=case	pos_13=IN	relType_13=case	relType_2=dep	relType_4=punct	pos_4=:	wib=animal	pos_7=CC	lemma_9=study	relType_8=compound	path=fluconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod	lemma_8=animal	pos_10=IN	pos_11=DT	lemma_11=the	lemma_3=)	pos_5=FW	pos_2=FW	relType_11=det	lemma_2=etc.	eib=True	pos_3=-RRB-	lemma_7=and	relType_1=punct	lemma_6=vitro	relType_6=advmod	relType_3=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e4	DDI-DrugBank.d318.s8.e6	null	lib=animal	lemma_1=,	lemma_5=in	relType_9=conj	lemma_10=with	pos_14=CC	lpib=animal_NN	pos_6=FW	pos_1=,	relType_7=cc	relType_5=compound	lemma_12=combination	lemma_14=b	relType_14=compound	relType_14=nmod	lemma_13=of	pos_8=NN	path1=fluconazole_appos<g._appos<Imidazoles_nsubj	lemma_4=:	lemma_14=amphotericin	pos_9=NNS	relType_12=nmod	pos_12=NN	pos_14=NN	relType_10=case	path2=vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	pos_13=IN	relType_13=case	relType_2=dep	relType_4=punct	pos_4=:	wib=animal	pos_7=CC	lemma_9=study	relType_8=compound	lemma_8=animal	pos_10=IN	pos_11=DT	relType_14=cc	lemma_11=the	lemma_3=)	pos_5=FW	pos_2=FW	relType_11=det	path=fluconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>vitro_advmod>study_conj>combination_nmod>b_nmod>imidazole_conj	lemma_2=etc.	eib=True	pos_3=-RRB-	lemma_7=and	lemma_14=and	relType_1=punct	lemma_6=vitro	relType_6=advmod	relType_3=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e4	DDI-DrugBank.d318.s8.e7	null	lib=animal	lemma_1=,	lemma_5=in	relType_9=conj	lemma_10=with	pos_14=CC	lpib=animal_NN	pos_6=FW	pos_16=IN	pos_1=,	relType_7=cc	relType_5=compound	lemma_12=combination	lemma_14=b	relType_14=compound	relType_14=nmod	lemma_13=of	pos_8=NN	lemma_16=that	path1=fluconazole_appos<g._appos<Imidazoles_nsubj	lemma_4=:	lemma_15=suggest	lemma_14=amphotericin	pos_9=NNS	relType_12=nmod	pos_12=NN	pos_14=NN	relType_10=case	pos_13=IN	pos_15=VBP	path2=induce_ccomp>imidazole_nsubj	relType_13=case	relType_2=dep	relType_4=punct	pos_4=:	wib=animal	pos_7=CC	relType_16=mark	lemma_9=study	relType_8=compound	lemma_8=animal	lemma_15=imidazole	pos_10=IN	pos_11=DT	relType_14=cc	lemma_11=the	lemma_3=)	pos_5=FW	pos_2=FW	relType_11=det	lemma_2=etc.	pos_15=NNS	eib=True	pos_3=-RRB-	lemma_7=and	relType_15=conj	path=fluconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>imidazole_nsubj	lemma_14=and	relType_15=ROOT	relType_1=punct	lemma_6=vitro	relType_6=advmod	relType_3=punct
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e4	DDI-DrugBank.d318.s8.e8	null	relType_22=compound	lemma_5=in	pos_17=MD	pos_14=CC	lemma_12=combination	lemma_14=b	lemma_13=of	path1=fluconazole_appos<g._appos<Imidazoles_nsubj	pos_20=NN	lemma_21=to	relType_20=obj	relType_2=dep	relType_4=punct	wib=animal	lemma_19=fungal	pos_5=FW	relType_11=det	relType_21=case	lemma_2=etc.	relType_15=ROOT	relType_17=aux	relType_14=nmod	lib=animal	lemma_1=,	pos_22=NN	pos_1=,	pos_8=NN	lemma_4=:	relType_12=nmod	pos_19=JJ	path=fluconazole_appos<g._appos<Imidazoles_nsubj<suggest_ROOT>induce_ccomp>B._obl	lemma_22=amphotericin	lemma_9=study	relType_19=amod	lemma_11=the	pos_2=FW	lemma_17=imidazole	path2=induce_ccomp>B._obl	pos_3=-RRB-	lemma_14=and	relType_1=punct	lemma_6=vitro	relType_3=punct	lemma_10=with	lpib=animal_NN	pos_6=FW	pos_16=IN	relType_7=cc	lemma_20=resistance	lemma_18=induce	lemma_16=that	relType_17=nsubj	pos_21=IN	pos_14=NN	pos_13=IN	pos_15=VBP	relType_13=case	pos_18=VB	relType_8=compound	lemma_8=animal	lemma_15=imidazole	pos_10=IN	pos_17=NNS	relType_15=conj	lemma_15=suggest	relType_6=advmod	lemma_17=may	relType_9=conj	relType_5=compound	relation_21=neutral	relType_14=compound	lemma_14=amphotericin	pos_9=NNS	relType_10=case	pos_4=:	pos_7=CC	relType_16=mark	relType_14=cc	pos_11=DT	lemma_3=)	pos_15=NNS	eib=True	lemma_7=and	pos_12=NN	relType_18=ccomp
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e5	DDI-DrugBank.d318.s8.e6	null	lib=imidazole	relType_1=cc	pos_1=CC	eib=False	path1=	path2=imidazole_conj	lpib=imidazole_NNS	path=<b_nmod>imidazole_conj	lemma_1=and	wib=imidazoles
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e5	DDI-DrugBank.d318.s8.e7	null	lib=imidazole	relType_1=cc	pos_1=CC	pos_3=IN	lpib=imidazole_NNS	path=b_nmod<combination_nmod<study_conj<vitro_advmod<suggest_ROOT>induce_ccomp>imidazole_nsubj	relType_2=conj	lemma_2=imidazole	path2=induce_ccomp>imidazole_nsubj	wib=imidazoles	lemma_3=that	relType_2=ROOT	pos_2=VBP	lemma_2=suggest	relType_3=mark	path1=b_nmod<combination_nmod<study_conj<vitro_advmod	pos_2=NNS	eib=True	lemma_1=and
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e5	DDI-DrugBank.d318.s8.e8	null	lib=imidazole	relType_1=cc	relType_8=case	pos_1=CC	pos_3=IN	pos_6=JJ	lemma_4=imidazole	lemma_6=fungal	lemma_4=may	relation_6=neutral	pos_5=VB	relType_9=compound	relType_6=amod	relType_7=obj	pos_4=MD	lpib=imidazole_NNS	path=b_nmod<combination_nmod<study_conj<vitro_advmod<suggest_ROOT>induce_ccomp>B._obl	relType_4=nsubj	relType_2=conj	lemma_2=imidazole	pos_4=NNS	pos_8=IN	pos_9=NN	lemma_9=amphotericin	wib=imidazoles	lemma_5=induce	lemma_3=that	lemma_8=to	relType_2=ROOT	relType_4=aux	pos_2=VBP	lemma_2=suggest	relType_3=mark	lemma_7=resistance	path1=b_nmod<combination_nmod<study_conj<vitro_advmod	pos_2=NNS	relType_5=ccomp	path2=induce_ccomp>B._obl	eib=True	pos_7=NN	lemma_1=and
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e6	DDI-DrugBank.d318.s8.e7	null	path2=induce_ccomp>imidazole_nsubj	relType_1=ROOT	path=imidazole_conj<b_nmod<combination_nmod<study_conj<vitro_advmod<suggest_ROOT>induce_ccomp>imidazole_nsubj	lemma_1=suggest	pos_2=IN	eib=False	wib=suggest	lib=suggest	lemma_2=that	lpib=suggest_VBP	pos_1=VBP	path1=imidazole_conj<b_nmod<combination_nmod<study_conj<vitro_advmod	relType_2=mark
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e6	DDI-DrugBank.d318.s8.e8	null	relType_7=case	lemma_3=may	lemma_2=that	relType_2=mark	pos_6=NN	pos_2=IN	pos_8=NN	pos_3=NNS	lemma_7=to	pos_3=MD	pos_5=JJ	lemma_1=suggest	relType_5=amod	wib=suggest	lemma_3=imidazole	relType_4=ccomp	relType_8=compound	lemma_6=resistance	lemma_8=amphotericin	lpib=suggest_VBP	pos_1=VBP	relType_3=nsubj	path1=imidazole_conj<b_nmod<combination_nmod<study_conj<vitro_advmod	lemma_4=induce	relType_6=obj	relType_1=ROOT	path2=induce_ccomp>B._obl	eib=True	pos_7=IN	pos_4=VB	lib=suggest	relation_4=neutral	relType_3=aux	path=imidazole_conj<b_nmod<combination_nmod<study_conj<vitro_advmod<suggest_ROOT>induce_ccomp>B._obl	lemma_5=fungal
DDI-DrugBank.d318.s8	DDI-DrugBank.d318.s8.e7	DDI-DrugBank.d318.s8.e8	effect	relation_1=neutral	relType_1=aux	lemma_1=may	lpib=induce_VB	lemma_3=fungal	relType_5=case	pos_6=NN	path=imidazole_nsubj<induce_ccomp>B._obl	path2=B._obl	pos_2=VB	wib=induce	lemma_2=induce	pos_4=NN	relType_4=obj	lib=induce	relType_3=amod	pos_5=IN	lemma_5=to	pos_1=MD	relType_2=ccomp	relType_6=compound	pos_3=JJ	eib=True	lemma_6=amphotericin	path1=imidazole_nsubj	lemma_4=resistance
DDI-DrugBank.d318.s10	DDI-DrugBank.d318.s10.e0	DDI-DrugBank.d318.s10.e1	null	path=<aminoglycoside_nmod>cyclosporine_conj	lemma_1=,	lpib=cyclosporine_NN	eib=False	path2=cyclosporine_conj	path1=	pos_1=,	lib=cyclosporine	relType_1=punct	wib=cyclosporine
DDI-DrugBank.d318.s10	DDI-DrugBank.d318.s10.e0	DDI-DrugBank.d318.s10.e2	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lemma_2=cyclosporine	relType_3=cc	relType_2=punct	path2=pentamidine_conj	lib=cyclosporine	relType_2=conj	lemma_2=,	lpib=cyclosporine_NN	path=<aminoglycoside_nmod>pentamidine_conj	wib=cyclosporine	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d318.s10	DDI-DrugBank.d318.s10.e1	DDI-DrugBank.d318.s10.e2	null	lemma_2=and	lemma_1=,	path=cyclosporine_conj<aminoglycoside_nmod>pentamidine_conj	lib=pentamidine	eib=False	pos_2=CC	lpib=pentamidine_NN	pos_1=,	path1=cyclosporine_conj	wib=pentamidine	relType_1=punct	relType_2=cc	path2=pentamidine_conj
DDI-DrugBank.d318.s12	DDI-DrugBank.d318.s12.e0	DDI-DrugBank.d318.s12.e2	null	lpib=amphotericin_NN	pos_2=NN	pos_6=VB	relType_7=det	pos_3=VBN	path1=	lib=amphotericin	lemma_8=curariform	lemma_10=of	relation_10=neutral	pos_2=HYPH	lemma_4=hypokalemia	lemma_11=skeletal	relType_2=punct	pos_8=NN	lemma_3=induce	lemma_5=may	lemma_2=-	relType_11=amod	lemma_2=amphotericin	lemma_6=enhance	relType_10=case	relType_5=aux	relType_4=nsubj	relType_6=parataxis	pos_4=NN	pos_7=DT	lemma_1=:	pos_9=NN	wib=amphotericin	pos_5=MD	lemma_2=b	relType_3=amod	relType_2=compound	relType_8=compound	pos_1=:	relType_9=obj	lemma_11=muscle	pos_10=IN	relType_2=obl	relation_7=beneficial	path2=enhance_parataxis>effect_obj>relaxant_nmod	pos_11=NN	eib=True	relType_11=compound	relation_4=neutral	lemma_7=the	path=<relaxant_ROOT>enhance_parataxis>effect_obj>relaxant_nmod	pos_11=JJ	lemma_9=effect	relType_1=punct
DDI-DrugBank.d318.s12	DDI-DrugBank.d318.s12.e0	DDI-DrugBank.d318.s12.e3	null	relType_14=punct	lpib=amphotericin_NN	pos_2=NN	pos_6=VB	relType_7=det	relType_13=dep	pos_3=VBN	path1=	lib=amphotericin	lemma_8=curariform	lemma_10=of	relation_10=neutral	pos_2=HYPH	lemma_4=hypokalemia	lemma_11=skeletal	relType_2=punct	pos_8=NN	lemma_13=g.	lemma_3=induce	lemma_5=may	lemma_2=-	relType_12=compound	pos_14=,	relType_11=amod	pos_11=-LRB-	relType_11=punct	lemma_2=amphotericin	pos_11=NNS	lemma_6=enhance	pos_12=NN	relType_10=case	relType_5=aux	relType_4=nsubj	relType_6=parataxis	pos_4=NN	pos_7=DT	lemma_1=:	pos_9=NN	pos_13=NN	wib=amphotericin	pos_5=MD	lemma_2=b	relType_3=amod	relType_2=compound	relType_8=compound	lemma_11=(	pos_1=:	relType_9=obj	lemma_11=muscle	path2=enhance_parataxis>effect_obj>relaxant_nmod>g._dep>tubocurarine_appos	pos_10=IN	path=<relaxant_ROOT>enhance_parataxis>effect_obj>relaxant_nmod>g._dep>tubocurarine_appos	relType_2=obl	relation_7=beneficial	lemma_14=,	pos_11=NN	eib=True	lemma_12=e.	relType_11=compound	relation_4=neutral	lemma_7=the	pos_11=JJ	lemma_11=relaxant	lemma_9=effect	relType_1=punct	relType_11=nmod
DDI-DrugBank.d318.s12	DDI-DrugBank.d318.s12.e2	DDI-DrugBank.d318.s12.e3	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>tubocurarine_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	path=<relaxant_nmod>g._dep>tubocurarine_appos	pos_3=NN	relType_1=punct
DDI-DrugBank.d318.s14	DDI-DrugBank.d318.s14.e0	DDI-DrugBank.d318.s14.e1	null	relType_6=aux:pass	relType_8=case	pos_5=VBZ	wib=acute	path1=	lemma_2=acute	relType_9=obl	pos_2=JJ	lemma_3=pulmonary	lemma_6=be	lemma_5=have	path2=report_parataxis>patient_obl>receive_acl>transfusion_obj>b_compound	lemma_8=in	lemma_10=receive	relType_12=compound	lemma_11=intravenous	relType_11=amod	pos_9=NNS	relType_4=nsubj:pass	lpib=acute_JJ	pos_6=VBN	relType_5=aux	pos_4=NN	lemma_1=:	pos_8=IN	lib=acute	relType_3=amod	lemma_7=report	path=<transfusion_ROOT>report_parataxis>patient_obl>receive_acl>transfusion_obj>b_compound	relType_2=amod	pos_1=:	relType_10=acl	lemma_4=toxicity	lemma_12=amphotericin	pos_7=VBN	lemma_9=patient	pos_3=JJ	eib=True	pos_10=VBG	pos_11=JJ	relType_1=punct	pos_12=NN	relType_7=parataxis
DDI-DrugBank.d318.s14	DDI-DrugBank.d318.s14.e0	DDI-DrugBank.d318.s14.e2	null	relType_6=aux:pass	relType_8=case	pos_5=VBZ	wib=acute	path1=	relType_12=cc	lemma_2=acute	relType_9=obl	pos_12=CC	pos_2=JJ	lemma_3=pulmonary	lemma_6=be	lemma_5=have	lemma_8=in	lemma_10=receive	relType_12=compound	lemma_11=intravenous	relType_11=amod	lemma_12=b	pos_9=NNS	relType_4=nsubj:pass	lpib=acute_JJ	pos_12=NN	pos_6=VBN	relType_5=aux	pos_13=NN	relType_13=conj	pos_4=NN	lemma_1=:	pos_8=IN	lib=acute	relType_3=amod	lemma_7=report	relType_2=amod	pos_1=:	relType_10=acl	lemma_13=leukocyte	lemma_4=toxicity	path2=report_parataxis>patient_obl>receive_acl>transfusion_obj	lemma_12=amphotericin	pos_7=VBN	lemma_9=patient	pos_3=JJ	eib=True	lemma_12=and	pos_10=VBG	pos_11=JJ	relType_1=punct	path=<transfusion_ROOT>report_parataxis>patient_obl>receive_acl>transfusion_obj	relType_7=parataxis
DDI-DrugBank.d318.s14	DDI-DrugBank.d318.s14.e1	DDI-DrugBank.d318.s14.e2	effect	relType_1=cc	pos_1=CC	lemma_1=and	pos_2=NN	wib=leukocyte	lib=leukocyte	eib=True	path=b_compound<transfusion_obj>	path2=	lpib=leukocyte_NN	relType_2=conj	lemma_2=leukocyte	path1=b_compound
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e1	null	pos_2=VBN	pos_3=IN	pos_6=JJ	relType_9=conj	lemma_9=loss	pos_12=WRB	path2=report_nmod>administer_acl:relcl>apomorphine_nsubj:pass	path1=	wib=Based	lpib=base_VBN	lemma_10=of	relType_4=nmod	lemma_5=of	relType_5=case	eib=False	relType_12=advmod	relType_6=amod	lemma_7=hypotension	pos_8=CC	lemma_3=on	relType_10=case	pos_9=NN	pos_4=NNS	lemma_1=:	lib=base	lemma_4=report	pos_1=:	pos_5=IN	relType_7=nmod	pos_10=IN	lemma_11=consciousness	lemma_12=when	relType_3=case	lemma_8=and	lemma_6=profound	pos_11=NN	relType_2=case	lemma_2=base	relType_11=nmod	relType_1=punct	pos_7=NN	relType_8=cc	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>apomorphine_nsubj:pass
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e2	null	pos_2=VBN	pos_3=IN	pos_6=JJ	relType_9=conj	lemma_9=loss	pos_12=WRB	path1=	wib=Based	lpib=base_VBN	lemma_10=of	relType_4=nmod	lemma_5=of	relType_5=case	pos_13=VBD	lemma_15=with	relType_14=acl:relcl	relType_12=advmod	relType_6=amod	lemma_7=hypotension	lemma_14=administer	pos_8=CC	lemma_3=on	relType_10=case	pos_9=NN	pos_13=NN	pos_4=NNS	lemma_1=:	lemma_13=be	relType_13=aux:pass	relType_15=case	lib=base	path2=report_nmod>administer_acl:relcl>ondansetron_obl	pos_1=:	lemma_4=report	pos_5=IN	relType_7=nmod	pos_10=IN	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>ondansetron_obl	lemma_11=consciousness	lemma_12=when	relType_3=case	lemma_8=and	lemma_6=profound	pos_15=IN	pos_14=VBN	relType_13=nsubj:pass	pos_11=NN	relType_2=case	eib=True	lemma_2=base	relType_11=nmod	relType_1=punct	pos_7=NN	relType_8=cc	lemma_13=apomorphine
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e3	null	pos_2=VBN	pos_3=IN	pos_6=JJ	relType_9=conj	pos_17=DT	lemma_9=loss	pos_12=WRB	relType_18=amod	path1=	wib=Based	lpib=base_VBN	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	lemma_10=of	relType_4=nmod	relType_16=obl	lemma_19=use	lemma_5=of	relType_5=case	pos_20=IN	relType_20=case	pos_13=VBD	relType_17=det	lemma_15=with	relType_14=acl:relcl	relType_12=advmod	relType_6=amod	lemma_7=hypotension	pos_16=,	pos_19=NN	pos_18=JJ	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	lemma_14=administer	pos_8=CC	lemma_3=on	relType_10=case	pos_9=NN	pos_13=NN	pos_4=NNS	lemma_1=:	lemma_13=be	relType_13=aux:pass	lemma_16=,	relType_15=case	relType_19=nsubj:pass	lib=base	lemma_4=report	pos_1=:	pos_5=IN	relType_7=nmod	lemma_18=concomitant	lemma_17=the	pos_10=IN	pos_16=NN	lemma_11=consciousness	lemma_12=when	relType_3=case	relType_16=punct	lemma_8=and	lemma_6=profound	pos_15=IN	pos_14=VBN	relType_13=nsubj:pass	lemma_16=ondansetron	pos_11=NN	relType_2=case	eib=True	lemma_2=base	relType_11=nmod	relType_1=punct	pos_7=NN	relType_8=cc	lemma_13=apomorphine	lemma_20=of
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e4	null	pos_6=JJ	wib=Based	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	pos_1=:	lemma_18=concomitant	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	lemma_19=use	lpib=base_VBN	relType_4=nmod	relType_20=case	pos_13=VBD	pos_9=NN	relType_15=case	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	pos_11=NN	lemma_22=drug	lemma_2=base	pos_23=IN	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	relType_19=nsubj:pass	pos_25=NN	pos_10=IN	relType_23=case	lemma_6=profound	relType_2=case	lemma_21=apomorphine	lemma_25=5ht3	relType_8=cc	relType_9=conj	relType_18=amod	relType_14=acl:relcl	relType_6=amod	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	lemma_13=be	pos_4=NNS	pos_22=NNS	lemma_4=report	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	lemma_24=the	lemma_11=consciousness	relType_3=case	eib=True	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e5	null	pos_6=JJ	relType_29=obl	wib=Based	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	lemma_25=class	pos_27=,	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	pos_1=:	lemma_18=concomitant	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	relType_30=punct	lemma_28=for	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	lemma_19=use	lpib=base_VBN	relType_4=nmod	relType_20=case	pos_13=VBD	relType_25=nmod	pos_29=NN	pos_9=NN	relType_15=case	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	pos_11=NN	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	lemma_22=drug	relType_25=punct	lemma_2=base	pos_23=IN	pos_30=,	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	relType_19=nsubj:pass	pos_25=NN	lemma_26=include	pos_10=IN	relType_23=case	lemma_6=profound	relType_28=case	relType_2=case	pos_26=VBG	lemma_21=apomorphine	lemma_25=5ht3	relType_27=punct	relType_8=cc	relType_9=conj	relType_18=amod	relType_26=case	lemma_25=(	lemma_30=,	relType_14=acl:relcl	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	relType_6=amod	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	pos_25=-LRB-	lemma_29=example	lemma_13=be	pos_4=NNS	pos_22=NNS	lemma_4=report	lemma_24=the	lemma_11=consciousness	lemma_27=,	relType_3=case	eib=True	pos_28=IN	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e6	null	pos_6=JJ	relType_29=obl	wib=Based	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	lemma_25=class	pos_27=,	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	pos_1=:	lemma_18=concomitant	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	relType_30=punct	lemma_28=for	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	lemma_19=use	lpib=base_VBN	lemma_31=ondansetron	relType_4=nmod	relType_20=case	pos_13=VBD	relType_25=nmod	pos_29=NN	pos_9=NN	relType_15=case	pos_31=,	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	pos_11=NN	pos_31=NN	lemma_22=drug	relType_25=punct	lemma_2=base	pos_23=IN	pos_30=,	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	relType_19=nsubj:pass	pos_25=NN	lemma_26=include	lemma_31=,	pos_10=IN	relType_31=dep	relType_23=case	lemma_6=profound	relType_28=case	relType_2=case	pos_26=VBG	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	lemma_21=apomorphine	lemma_25=5ht3	relType_27=punct	relType_8=cc	relType_9=conj	relType_18=amod	relType_26=case	lemma_25=(	lemma_30=,	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	relType_14=acl:relcl	relType_6=amod	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	pos_25=-LRB-	lemma_29=example	lemma_13=be	pos_4=NNS	relType_31=punct	pos_22=NNS	lemma_4=report	lemma_24=the	lemma_11=consciousness	lemma_27=,	relType_3=case	eib=True	pos_28=IN	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e7	null	pos_6=JJ	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_29=obl	wib=Based	relType_32=punct	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	lemma_25=class	pos_27=,	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	pos_1=:	lemma_18=concomitant	pos_32=NN	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	relType_30=punct	lemma_28=for	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	lemma_19=use	lpib=base_VBN	lemma_31=ondansetron	relType_4=nmod	relType_20=case	pos_13=VBD	relType_25=nmod	pos_29=NN	pos_9=NN	relType_15=case	pos_31=,	pos_32=,	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	pos_11=NN	pos_31=NN	lemma_22=drug	relType_25=punct	lemma_2=base	pos_23=IN	pos_30=,	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	relType_19=nsubj:pass	pos_25=NN	lemma_26=include	lemma_31=,	pos_10=IN	relType_31=dep	relType_23=case	lemma_6=profound	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_28=case	relType_2=case	pos_26=VBG	lemma_21=apomorphine	lemma_25=5ht3	relType_27=punct	relType_8=cc	relType_9=conj	relType_18=amod	relType_26=case	lemma_25=(	relType_32=dep	lemma_30=,	relType_14=acl:relcl	relType_6=amod	lemma_32=granisetron	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	pos_25=-LRB-	lemma_29=example	lemma_13=be	pos_4=NNS	relType_31=punct	pos_22=NNS	lemma_4=report	lemma_24=the	lemma_32=,	lemma_11=consciousness	lemma_27=,	relType_3=case	eib=True	pos_28=IN	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e8	null	pos_6=JJ	relType_29=obl	pos_33=,	wib=Based	relType_32=punct	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	lemma_25=class	pos_27=,	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	relType_33=punct	pos_1=:	lemma_18=concomitant	pos_32=NN	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	relType_30=punct	lemma_33=dolasetron	lemma_28=for	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	lemma_19=use	lpib=base_VBN	lemma_31=ondansetron	relType_4=nmod	relType_20=case	pos_13=VBD	relType_25=nmod	lemma_33=,	pos_29=NN	pos_9=NN	relType_15=case	pos_31=,	pos_32=,	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	relType_33=dep	pos_11=NN	pos_31=NN	lemma_22=drug	relType_25=punct	lemma_2=base	pos_23=IN	pos_30=,	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	relType_19=nsubj:pass	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	pos_25=NN	lemma_26=include	lemma_31=,	pos_10=IN	relType_31=dep	relType_23=case	lemma_6=profound	relType_28=case	relType_2=case	pos_26=VBG	lemma_21=apomorphine	lemma_25=5ht3	relType_27=punct	relType_8=cc	pos_33=NN	relType_9=conj	relType_18=amod	relType_26=case	lemma_25=(	relType_32=dep	lemma_30=,	relType_14=acl:relcl	relType_6=amod	lemma_32=granisetron	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	pos_25=-LRB-	lemma_29=example	lemma_13=be	pos_4=NNS	relType_31=punct	pos_22=NNS	lemma_4=report	lemma_24=the	lemma_32=,	lemma_11=consciousness	lemma_27=,	relType_3=case	eib=True	pos_28=IN	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e0	DDI-DrugBank.d357.s0.e9	null	pos_6=JJ	pos_34=NN	relType_29=obl	pos_33=,	wib=Based	relType_32=punct	lemma_10=of	lemma_25=antagonist	lemma_5=of	relType_5=case	lemma_25=class	pos_27=,	relType_35=cc	lemma_35=and	relType_17=det	lemma_7=hypotension	lemma_3=on	pos_13=NN	lemma_16=,	relType_13=aux:pass	relType_34=nmod	relType_33=punct	pos_1=:	lemma_18=concomitant	pos_32=NN	lemma_12=when	relType_16=punct	relType_21=case	pos_14=VBN	relType_13=nsubj:pass	relType_24=det	lemma_16=ondansetron	relType_30=punct	lemma_33=dolasetron	lemma_34=palonosetron	relType_34=punct	lemma_28=for	pos_34=,	lemma_23=of	lemma_20=of	relType_22=nmod	lemma_9=loss	pos_12=WRB	path1=	path=<antagonist_ROOT>report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lpib=base_VBN	lemma_19=use	lemma_31=ondansetron	relType_4=nmod	relType_20=case	pos_13=VBD	relType_25=nmod	lemma_33=,	pos_29=NN	pos_9=NN	relType_15=case	pos_31=,	pos_32=,	lib=base	pos_5=IN	relType_7=nmod	lemma_17=the	pos_16=NN	lemma_8=and	pos_15=IN	relType_33=dep	pos_11=NN	pos_31=NN	lemma_22=drug	relType_25=punct	lemma_34=,	lemma_2=base	pos_23=IN	pos_30=,	relType_11=nmod	relType_1=punct	pos_7=NN	pos_2=VBN	pos_3=IN	pos_17=DT	relType_16=obl	relType_21=nmod	pos_20=IN	lemma_15=with	relType_12=advmod	pos_21=IN	pos_24=DT	pos_8=CC	lemma_1=:	relType_25=compound	relType_19=nsubj:pass	pos_25=NN	lemma_26=include	lemma_31=,	pos_10=IN	relType_31=dep	relType_23=case	lemma_6=profound	relType_28=case	relType_2=case	pos_26=VBG	lemma_21=apomorphine	lemma_25=5ht3	relType_27=punct	relType_8=cc	pos_33=NN	relType_9=conj	relType_18=amod	path2=report_nmod>administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lemma_25=(	relType_26=case	relType_32=dep	lemma_30=,	relType_14=acl:relcl	relType_6=amod	lemma_32=granisetron	pos_16=,	pos_18=JJ	pos_19=NN	lemma_14=administer	relType_10=case	lemma_21=with	pos_25=-LRB-	lemma_29=example	lemma_13=be	pos_4=NNS	relType_31=punct	pos_35=CC	pos_22=NNS	lemma_4=report	lemma_24=the	lemma_32=,	lemma_11=consciousness	lemma_27=,	relType_3=case	eib=True	pos_28=IN	lemma_13=apomorphine	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e2	effect	relType_2=acl:relcl	pos_2=VBN	pos_1=VBD	lib=be	pos_3=IN	eib=False	path1=apomorphine_nsubj:pass	path=apomorphine_nsubj:pass<administer_acl:relcl>ondansetron_obl	relType_1=aux:pass	lemma_1=be	lemma_2=administer	lemma_3=with	lpib=be_VBD	wib=was	path2=ondansetron_obl	relType_3=case
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e3	null	relType_8=case	pos_2=VBN	pos_3=IN	pos_6=JJ	path1=apomorphine_nsubj:pass	pos_7=NN	relType_1=aux:pass	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	lemma_2=administer	pos_1=VBD	pos_4=,	relType_6=amod	lemma_1=be	lemma_8=of	relType_7=nsubj:pass	lemma_4=ondansetron	pos_4=NN	pos_8=IN	relType_2=acl:relcl	relType_4=obl	lib=be	relType_4=punct	path2=contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	relType_5=det	lemma_6=concomitant	lemma_3=with	lemma_4=,	wib=was	relType_3=case	lemma_5=the	eib=True	pos_5=DT	lpib=be_VBD	lemma_7=use
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e4	null	relType_8=case	pos_2=VBN	pos_3=IN	pos_6=JJ	path1=apomorphine_nsubj:pass	pos_7=NN	relType_1=aux:pass	lemma_2=administer	pos_9=IN	relType_9=nmod	relType_12=det	relType_11=case	pos_1=VBD	relType_10=nmod	pos_4=,	relType_6=amod	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	lemma_1=be	lemma_8=of	relType_7=nsubj:pass	relType_9=case	pos_13=NN	pos_9=NN	lemma_4=ondansetron	pos_4=NN	pos_8=IN	lemma_12=the	pos_11=IN	relType_2=acl:relcl	relType_4=obl	lib=be	relType_4=punct	relType_13=compound	relType_5=det	lemma_6=concomitant	lemma_3=with	lemma_4=,	wib=was	relType_3=case	lemma_13=5ht3	lemma_5=the	lemma_9=with	lemma_13=antagonist	eib=True	pos_5=DT	lemma_11=of	lemma_9=apomorphine	pos_12=DT	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	lpib=be_VBD	lemma_7=use	pos_10=NNS	lemma_10=drug
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e5	null	relType_8=case	pos_2=VBN	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	pos_3=IN	pos_6=JJ	pos_16=IN	path1=apomorphine_nsubj:pass	pos_7=NN	relType_1=aux:pass	lemma_2=administer	relType_13=punct	pos_9=IN	lemma_14=include	relType_9=nmod	relType_12=det	relType_11=case	relType_13=nmod	pos_17=NN	pos_1=VBD	relType_10=nmod	pos_4=,	lemma_13=class	pos_15=,	relType_6=amod	lemma_1=be	lemma_8=of	relType_7=nsubj:pass	relType_9=case	pos_13=NN	pos_9=NN	lemma_4=ondansetron	pos_4=NN	pos_8=IN	lemma_12=the	pos_11=IN	relType_15=punct	relType_2=acl:relcl	lemma_13=(	relType_4=obl	pos_18=,	lib=be	relType_4=punct	relType_13=compound	pos_14=VBG	lemma_15=,	lemma_18=,	relType_5=det	relType_18=punct	lemma_6=concomitant	lemma_3=with	lemma_4=,	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	wib=was	pos_13=-LRB-	relType_3=case	lemma_13=5ht3	lemma_17=example	relType_16=case	lemma_5=the	lemma_9=with	lemma_13=antagonist	eib=True	pos_5=DT	lemma_11=of	lemma_9=apomorphine	pos_12=DT	relType_14=case	lpib=be_VBD	lemma_7=use	pos_10=NNS	relType_17=obl	lemma_16=for	lemma_10=drug
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e6	null	pos_6=JJ	path1=apomorphine_nsubj:pass	relType_10=nmod	lemma_13=class	relType_9=case	pos_13=NN	lemma_12=the	relType_2=acl:relcl	relType_4=punct	lemma_3=with	lemma_13=antagonist	lemma_9=apomorphine	pos_12=DT	lemma_7=use	lemma_10=drug	relType_8=case	lemma_2=administer	relType_19=dep	relType_11=case	pos_1=VBD	pos_9=NN	pos_8=IN	lemma_13=(	relType_4=obl	lemma_15=,	pos_14=VBG	pos_19=,	lemma_6=concomitant	lemma_4=,	relType_16=case	lemma_5=the	lemma_19=,	pos_7=NN	lpib=be_VBD	lemma_16=for	pos_2=VBN	pos_3=IN	pos_16=IN	relType_19=punct	relType_12=det	pos_17=NN	pos_4=,	pos_15=,	lemma_1=be	relType_7=nsubj:pass	relType_15=punct	pos_11=IN	lib=be	relType_5=det	lemma_19=ondansetron	lemma_17=example	pos_5=DT	lemma_11=of	relType_14=case	relType_1=aux:pass	relType_13=punct	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	pos_9=IN	lemma_14=include	relType_9=nmod	relType_13=nmod	relType_6=amod	pos_19=NN	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	lemma_4=ondansetron	pos_4=NN	pos_18=,	relType_13=compound	lemma_18=,	relType_18=punct	wib=was	pos_13=-LRB-	relType_3=case	lemma_13=5ht3	lemma_9=with	eib=True	lemma_8=of	pos_10=NNS	relType_17=obl
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e7	null	pos_6=JJ	path1=apomorphine_nsubj:pass	lemma_20=,	relType_10=nmod	lemma_13=class	pos_20=NN	relType_9=case	pos_13=NN	lemma_12=the	relType_2=acl:relcl	relType_4=punct	lemma_3=with	lemma_13=antagonist	lemma_9=apomorphine	pos_12=DT	lemma_7=use	lemma_10=drug	relType_8=case	lemma_2=administer	relType_19=dep	relType_11=case	pos_1=VBD	pos_9=NN	pos_8=IN	lemma_13=(	relType_4=obl	lemma_15=,	pos_14=VBG	pos_19=,	lemma_6=concomitant	lemma_4=,	relType_16=case	lemma_5=the	lemma_19=,	pos_7=NN	lpib=be_VBD	lemma_16=for	pos_2=VBN	pos_3=IN	pos_16=IN	relType_19=punct	relType_12=det	pos_17=NN	pos_4=,	pos_15=,	lemma_1=be	relType_7=nsubj:pass	relType_15=punct	pos_11=IN	lib=be	relType_5=det	lemma_19=ondansetron	lemma_17=example	lemma_20=granisetron	pos_5=DT	lemma_11=of	relType_20=punct	relType_14=case	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_1=aux:pass	relType_13=punct	pos_9=IN	lemma_14=include	relType_9=nmod	relType_13=nmod	relType_20=dep	relType_6=amod	pos_19=NN	lemma_4=ondansetron	pos_4=NN	pos_20=,	pos_18=,	relType_13=compound	lemma_18=,	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_18=punct	wib=was	pos_13=-LRB-	relType_3=case	lemma_13=5ht3	lemma_9=with	eib=True	lemma_8=of	pos_10=NNS	relType_17=obl
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e8	null	pos_6=JJ	path1=apomorphine_nsubj:pass	lemma_20=,	relType_10=nmod	lemma_13=class	pos_20=NN	relType_9=case	pos_13=NN	lemma_12=the	relType_2=acl:relcl	relType_4=punct	lemma_3=with	lemma_21=,	lemma_13=antagonist	lemma_9=apomorphine	relType_21=punct	pos_12=DT	lemma_7=use	lemma_10=drug	relType_8=case	lemma_2=administer	relType_19=dep	relType_11=case	pos_1=VBD	relType_21=dep	pos_9=NN	pos_8=IN	lemma_13=(	relType_4=obl	lemma_15=,	pos_14=VBG	pos_19=,	lemma_6=concomitant	lemma_4=,	relType_16=case	lemma_5=the	lemma_19=,	pos_7=NN	lpib=be_VBD	lemma_16=for	pos_2=VBN	pos_3=IN	pos_16=IN	relType_19=punct	relType_12=det	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	pos_17=NN	pos_4=,	pos_15=,	lemma_1=be	relType_7=nsubj:pass	relType_15=punct	pos_11=IN	lib=be	relType_5=det	lemma_19=ondansetron	lemma_17=example	lemma_20=granisetron	pos_5=DT	lemma_11=of	relType_20=punct	relType_14=case	relType_1=aux:pass	relType_13=punct	pos_9=IN	lemma_14=include	relType_9=nmod	relType_13=nmod	relType_20=dep	pos_21=,	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	relType_6=amod	pos_19=NN	lemma_4=ondansetron	pos_4=NN	pos_20=,	lemma_21=dolasetron	pos_18=,	relType_13=compound	lemma_18=,	relType_18=punct	wib=was	pos_13=-LRB-	relType_3=case	lemma_13=5ht3	lemma_9=with	eib=True	lemma_8=of	pos_10=NNS	relType_17=obl	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e1	DDI-DrugBank.d357.s0.e9	null	pos_6=JJ	path1=apomorphine_nsubj:pass	lemma_22=palonosetron	lemma_20=,	relType_10=nmod	lemma_13=class	pos_20=NN	relType_9=case	pos_13=NN	lemma_12=the	relType_22=punct	relType_2=acl:relcl	relType_4=punct	pos_22=,	lemma_3=with	lemma_21=,	lemma_13=antagonist	lemma_9=apomorphine	relType_21=punct	pos_12=DT	lemma_7=use	lemma_10=drug	relType_8=case	relType_22=nmod	pos_22=NN	lemma_2=administer	relType_19=dep	relType_11=case	pos_1=VBD	lemma_22=,	relType_21=dep	pos_9=NN	pos_8=IN	lemma_13=(	relType_4=obl	lemma_15=,	pos_14=VBG	pos_19=,	lemma_6=concomitant	lemma_4=,	relType_16=case	lemma_5=the	lemma_19=,	pos_7=NN	lpib=be_VBD	lemma_23=and	lemma_16=for	pos_2=VBN	pos_3=IN	pos_16=IN	relType_19=punct	relType_12=det	pos_23=CC	pos_17=NN	pos_4=,	pos_15=,	lemma_1=be	relType_7=nsubj:pass	relType_15=punct	pos_11=IN	lib=be	relType_5=det	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lemma_19=ondansetron	lemma_17=example	lemma_20=granisetron	pos_5=DT	lemma_11=of	relType_20=punct	relType_14=case	relType_1=aux:pass	relType_13=punct	pos_9=IN	path=apomorphine_nsubj:pass<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lemma_14=include	relType_9=nmod	relType_13=nmod	relType_20=dep	pos_21=,	relType_6=amod	pos_19=NN	pos_4=NN	lemma_4=ondansetron	pos_20=,	lemma_21=dolasetron	pos_18=,	relType_13=compound	lemma_18=,	relType_23=cc	relType_18=punct	wib=was	pos_13=-LRB-	relType_3=case	lemma_13=5ht3	lemma_9=with	eib=True	lemma_8=of	pos_10=NNS	relType_17=obl	pos_21=NN
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e3	null	pos_2=DT	lemma_1=,	lemma_2=the	pos_1=,	lemma_4=use	lemma_5=of	relType_5=case	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	lib=concomitant	eib=False	lpib=concomitant_JJ	relType_4=nsubj:pass	path1=ondansetron_obl	pos_4=NN	wib=concomitant	relType_3=amod	path2=contraindicate_parataxis>use_nsubj:pass>apomorphine_nmod	pos_5=IN	lemma_3=concomitant	pos_3=JJ	relType_2=det	relType_1=punct
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e4	null	pos_7=NNS	relType_8=case	pos_2=DT	lemma_1=,	lemma_2=the	pos_1=,	lemma_4=use	lemma_10=antagonist	lemma_5=of	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	relType_5=case	relType_6=case	pos_6=NN	lib=concomitant	pos_6=IN	pos_9=DT	lpib=concomitant_JJ	relType_4=nsubj:pass	relType_10=compound	path1=ondansetron_obl	pos_10=NN	pos_4=NN	pos_8=IN	lemma_10=5ht3	wib=concomitant	relType_3=amod	pos_5=IN	lemma_6=with	relType_7=nmod	lemma_3=concomitant	pos_3=JJ	eib=True	lemma_9=the	relType_2=det	lemma_7=drug	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod	lemma_6=apomorphine	relType_1=punct	relType_6=nmod	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e5	null	pos_7=NNS	relType_8=case	pos_2=DT	pos_14=NN	lemma_1=,	relType_10=punct	lemma_2=the	lemma_13=for	pos_1=,	lemma_11=include	lemma_4=use	lemma_10=antagonist	lemma_5=of	relType_5=case	relType_6=case	relType_11=case	pos_6=NN	lib=concomitant	lemma_12=,	pos_10=-LRB-	relType_10=nmod	lemma_10=class	pos_15=,	pos_6=IN	pos_12=,	pos_9=DT	lpib=concomitant_JJ	relType_4=nsubj:pass	relType_10=compound	relType_12=punct	path1=ondansetron_obl	pos_10=NN	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	pos_4=NN	pos_13=IN	pos_8=IN	lemma_10=5ht3	wib=concomitant	relType_14=obl	relType_15=punct	relType_13=case	lemma_15=,	relType_3=amod	lemma_10=(	pos_11=VBG	pos_5=IN	lemma_6=with	relType_7=nmod	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	lemma_3=concomitant	pos_3=JJ	eib=True	lemma_9=the	relType_2=det	lemma_14=example	lemma_7=drug	lemma_6=apomorphine	relType_1=punct	relType_6=nmod	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e6	null	pos_7=NNS	relType_8=case	pos_2=DT	lemma_1=,	relType_10=punct	lemma_2=the	lemma_16=,	lemma_13=for	pos_1=,	lemma_11=include	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	lemma_4=use	lemma_10=antagonist	lemma_5=of	relType_5=case	relType_6=case	relType_11=case	pos_6=NN	lib=concomitant	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	lemma_12=,	pos_10=-LRB-	relType_10=nmod	lemma_10=class	pos_15=,	pos_6=IN	pos_12=,	pos_16=,	pos_9=DT	lpib=concomitant_JJ	relType_4=nsubj:pass	relType_10=compound	relType_12=punct	path1=ondansetron_obl	pos_10=NN	pos_13=IN	pos_4=NN	pos_14=NN	pos_8=IN	lemma_10=5ht3	wib=concomitant	relType_14=obl	relType_15=punct	relType_13=case	lemma_15=,	relType_3=amod	lemma_10=(	pos_11=VBG	pos_5=IN	lemma_6=with	relType_7=nmod	pos_16=NN	relType_16=punct	lemma_3=concomitant	lemma_16=ondansetron	pos_3=JJ	eib=True	lemma_9=the	relType_16=dep	relType_2=det	lemma_14=example	lemma_7=drug	lemma_6=apomorphine	relType_1=punct	relType_6=nmod	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e7	null	pos_7=NNS	relType_8=case	pos_2=DT	lemma_1=,	relType_10=punct	lemma_2=the	lemma_16=,	lemma_13=for	relType_17=punct	pos_1=,	lemma_11=include	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	lemma_4=use	lemma_10=antagonist	lemma_5=of	relType_5=case	relType_6=case	relType_11=case	pos_6=NN	lib=concomitant	lemma_12=,	pos_17=NN	pos_10=-LRB-	relType_10=nmod	lemma_17=,	lemma_10=class	pos_15=,	pos_6=IN	pos_12=,	pos_16=,	pos_9=DT	lpib=concomitant_JJ	relType_4=nsubj:pass	relType_10=compound	relType_12=punct	path1=ondansetron_obl	pos_10=NN	pos_13=IN	pos_4=NN	pos_14=NN	pos_8=IN	lemma_10=5ht3	wib=concomitant	relType_14=obl	relType_15=punct	relType_13=case	relType_17=dep	pos_17=,	lemma_15=,	relType_3=amod	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	lemma_17=granisetron	lemma_10=(	pos_11=VBG	pos_5=IN	lemma_6=with	relType_7=nmod	pos_16=NN	relType_16=punct	lemma_3=concomitant	lemma_16=ondansetron	pos_3=JJ	eib=True	lemma_9=the	relType_16=dep	relType_2=det	lemma_14=example	lemma_7=drug	lemma_6=apomorphine	relType_1=punct	relType_6=nmod	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e8	null	relType_18=dep	lemma_10=antagonist	lemma_5=of	relType_5=case	pos_6=NN	lemma_12=,	pos_10=-LRB-	relType_10=nmod	pos_12=,	lemma_16=,	pos_10=NN	pos_18=NN	relType_3=amod	pos_11=VBG	relType_16=punct	lemma_16=ondansetron	pos_3=JJ	pos_7=NNS	relType_8=case	pos_2=DT	lemma_1=,	lemma_2=the	lemma_13=for	pos_1=,	lemma_11=include	relType_6=case	relType_11=case	lib=concomitant	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	pos_6=IN	relType_17=dep	relType_12=punct	path1=ondansetron_obl	pos_8=IN	lemma_15=,	lemma_10=(	pos_5=IN	relType_7=nmod	pos_16=NN	lemma_14=example	lemma_6=apomorphine	relType_1=punct	relType_10=punct	relType_17=punct	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	pos_17=NN	pos_15=,	pos_9=DT	relType_4=nsubj:pass	pos_14=NN	pos_13=IN	relType_14=obl	relType_15=punct	relType_13=case	pos_17=,	lemma_3=concomitant	lemma_9=the	lemma_7=drug	lemma_18=dolasetron	relType_6=nmod	lemma_4=use	lemma_17=,	lemma_10=class	pos_16=,	lpib=concomitant_JJ	relType_10=compound	lemma_17=granisetron	pos_4=NN	lemma_10=5ht3	wib=concomitant	pos_18=,	lemma_18=,	relType_18=punct	lemma_6=with	eib=True	relType_16=dep	relType_2=det	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e2	DDI-DrugBank.d357.s0.e9	null	relType_18=dep	lemma_10=antagonist	lemma_5=of	relType_5=case	pos_6=NN	lemma_12=,	pos_10=-LRB-	relType_10=nmod	pos_12=,	lemma_16=,	pos_10=NN	pos_18=NN	relType_3=amod	pos_11=VBG	relType_16=punct	lemma_16=ondansetron	pos_3=JJ	pos_7=NNS	relType_8=case	pos_2=DT	lemma_1=,	lemma_2=the	lemma_13=for	pos_1=,	lemma_11=include	relType_6=case	relType_11=case	lib=concomitant	pos_6=IN	relType_17=dep	relType_12=punct	path1=ondansetron_obl	pos_8=IN	lemma_15=,	lemma_10=(	pos_19=,	pos_5=IN	relType_7=nmod	pos_16=NN	lemma_20=and	lemma_14=example	lemma_19=,	lemma_6=apomorphine	relType_1=punct	relType_10=punct	lemma_19=palonosetron	relType_17=punct	relType_20=cc	relType_19=punct	relType_19=nmod	path=ondansetron_obl<administer_acl:relcl>contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	pos_17=NN	pos_15=,	pos_9=DT	relType_4=nsubj:pass	pos_14=NN	pos_13=IN	relType_14=obl	relType_15=punct	relType_13=case	pos_17=,	path2=contraindicate_parataxis>use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lemma_3=concomitant	lemma_9=the	pos_20=CC	lemma_7=drug	lemma_18=dolasetron	relType_6=nmod	lemma_4=use	lemma_17=,	lemma_10=class	pos_16=,	lpib=concomitant_JJ	pos_19=NN	relType_10=compound	lemma_17=granisetron	pos_4=NN	lemma_10=5ht3	wib=concomitant	pos_18=,	lemma_18=,	relType_18=punct	lemma_6=with	eib=True	relType_16=dep	relType_2=det	lemma_8=of	relType_9=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e4	advise	relType_1=case	pos_3=IN	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod	relType_5=compound	path2=drug_nmod>class_nmod	lemma_5=5ht3	relType_2=nmod	lpib=drug_NNS	lib=drug	pos_1=IN	lemma_5=antagonist	path1=apomorphine_nmod	pos_4=DT	lemma_4=the	lemma_2=drug	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	eib=True	wib=drugs	lemma_3=of	relType_4=det
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e5	advise	relType_8=case	relType_1=case	relType_10=punct	pos_3=IN	lemma_10=,	relType_5=compound	lemma_8=for	relType_9=obl	relType_6=case	lemma_5=5ht3	pos_6=VBG	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	path2=drug_nmod>class_nmod>palonosetron_nmod>ondansetron_dep	relType_2=nmod	lpib=drug_NNS	pos_7=,	lib=drug	lemma_5=(	pos_1=IN	lemma_5=antagonist	lemma_7=,	pos_9=NN	pos_8=IN	path1=apomorphine_nmod	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	lemma_2=drug	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_10=,	lemma_6=include	eib=True	relType_7=punct	lemma_9=example	lemma_5=class	wib=drugs	lemma_3=of	relType_4=det	pos_5=-LRB-
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e6	advise	relType_8=case	relType_1=case	relType_10=punct	pos_3=IN	lemma_11=,	lemma_10=,	relType_5=compound	lemma_8=for	relType_9=obl	relType_6=case	lemma_5=5ht3	pos_6=VBG	path2=drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	relType_2=nmod	lpib=drug_NNS	relType_11=punct	pos_7=,	lib=drug	lemma_5=(	pos_1=IN	lemma_5=antagonist	lemma_7=,	pos_9=NN	pos_8=IN	path1=apomorphine_nmod	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>granisetron_dep	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	relType_11=dep	pos_11=,	lemma_2=drug	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	lemma_6=include	eib=True	lemma_11=ondansetron	relType_7=punct	lemma_9=example	lemma_5=class	wib=drugs	lemma_3=of	relType_4=det	pos_5=-LRB-
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e7	advise	path2=drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_8=case	relType_1=case	relType_10=punct	pos_3=IN	lemma_11=,	lemma_10=,	relType_5=compound	lemma_8=for	relType_9=obl	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>dolasetron_dep	relType_6=case	lemma_5=5ht3	pos_6=VBG	lemma_12=,	relType_2=nmod	lpib=drug_NNS	relType_11=punct	pos_12=,	pos_7=,	lib=drug	lemma_5=(	pos_12=NN	pos_1=IN	lemma_5=antagonist	relType_12=punct	lemma_7=,	pos_9=NN	pos_8=IN	path1=apomorphine_nmod	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	relType_11=dep	lemma_12=granisetron	pos_11=,	lemma_2=drug	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	lemma_6=include	eib=True	lemma_11=ondansetron	relType_12=dep	relType_7=punct	lemma_9=example	lemma_5=class	wib=drugs	lemma_3=of	relType_4=det	pos_5=-LRB-
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e8	advise	relType_8=case	relType_1=case	pos_13=,	relType_10=punct	pos_3=IN	relType_13=dep	lemma_13=,	lemma_11=,	lemma_10=,	relType_13=punct	relType_5=compound	lemma_8=for	relType_9=obl	lemma_13=dolasetron	relType_6=case	lemma_5=5ht3	pos_6=VBG	lemma_12=,	relType_2=nmod	lpib=drug_NNS	relType_11=punct	pos_12=,	pos_7=,	lib=drug	lemma_5=(	pos_12=NN	pos_1=IN	lemma_5=antagonist	relType_12=punct	lemma_7=,	pos_9=NN	pos_13=NN	pos_8=IN	path1=apomorphine_nmod	pos_4=DT	relType_5=punct	lemma_4=the	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod	relType_5=nmod	relType_11=dep	lemma_12=granisetron	pos_11=,	lemma_2=drug	path2=drug_nmod>class_nmod>palonosetron_nmod	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	lemma_6=include	eib=True	lemma_11=ondansetron	relType_12=dep	relType_7=punct	lemma_9=example	lemma_5=class	wib=drugs	lemma_3=of	relType_4=det	pos_5=-LRB-
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e3	DDI-DrugBank.d357.s0.e9	advise	relType_8=case	relType_1=case	pos_13=,	relType_10=punct	pos_3=IN	relType_13=dep	lemma_13=,	lemma_11=,	relType_14=punct	lemma_10=,	relType_13=punct	relType_5=compound	lemma_8=for	relType_9=obl	lemma_13=dolasetron	relType_14=nmod	relType_6=case	lemma_5=5ht3	pos_6=VBG	lemma_12=,	relType_2=nmod	lpib=drug_NNS	pos_14=,	relType_11=punct	pos_12=,	pos_7=,	lib=drug	lemma_5=(	pos_12=NN	pos_1=IN	lemma_5=antagonist	path=apomorphine_nmod<use_nsubj:pass>drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	lemma_7=,	pos_9=NN	relType_12=punct	pos_13=NN	pos_8=IN	pos_14=NN	path1=apomorphine_nmod	pos_4=DT	lemma_14=palonosetron	relType_5=punct	lemma_4=the	relType_5=nmod	relType_11=dep	relType_15=cc	lemma_12=granisetron	pos_11=,	lemma_2=drug	relType_3=case	lemma_15=and	pos_2=NNS	lemma_1=with	pos_5=NN	lemma_14=,	pos_11=NN	pos_10=,	lemma_6=include	eib=True	lemma_11=ondansetron	relType_12=dep	relType_7=punct	lemma_9=example	lemma_5=class	pos_15=CC	wib=drugs	lemma_3=of	relType_4=det	path2=drug_nmod>class_nmod>palonosetron_nmod>alosetron_conj	pos_5=-LRB-
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e4	DDI-DrugBank.d357.s0.e5	null	path1=	lemma_6=,	path2=palonosetron_nmod>ondansetron_dep	lib=include	wib=including	lemma_1=(	eib=False	relType_6=punct	lemma_4=for	lpib=include_VBG	path=<class_nmod>palonosetron_nmod>ondansetron_dep	lemma_3=,	pos_4=IN	relType_4=case	lemma_5=example	relType_5=obl	pos_1=-LRB-	lemma_2=include	pos_6=,	pos_5=NN	relType_2=case	pos_3=,	relType_1=punct	relType_3=punct	pos_2=VBG
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e4	DDI-DrugBank.d357.s0.e6	null	lemma_7=ondansetron	path1=	lemma_6=,	lib=include	wib=including	path2=palonosetron_nmod>granisetron_dep	lemma_1=(	path=<class_nmod>palonosetron_nmod>granisetron_dep	relType_6=punct	lemma_4=for	pos_7=,	lpib=include_VBG	lemma_7=,	lemma_3=,	pos_4=IN	relType_4=case	lemma_5=example	relType_5=obl	pos_1=-LRB-	lemma_2=include	pos_6=,	pos_5=NN	relType_2=case	pos_3=,	eib=True	relType_7=dep	relType_7=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_2=VBG
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e4	DDI-DrugBank.d357.s0.e7	null	lemma_7=ondansetron	relType_8=dep	path1=	lemma_6=,	relType_8=punct	lib=include	wib=including	lemma_8=,	lemma_1=(	pos_8=NN	relType_6=punct	lemma_4=for	pos_7=,	lpib=include_VBG	lemma_7=,	lemma_8=granisetron	path=<class_nmod>palonosetron_nmod>dolasetron_dep	lemma_3=,	pos_4=IN	relType_4=case	lemma_5=example	path2=palonosetron_nmod>dolasetron_dep	relType_5=obl	pos_1=-LRB-	lemma_2=include	pos_6=,	pos_5=NN	relType_2=case	pos_3=,	eib=True	relType_7=dep	relType_7=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	pos_2=VBG
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e4	DDI-DrugBank.d357.s0.e8	null	lemma_7=ondansetron	relType_8=dep	path1=	lemma_6=,	relType_8=punct	lib=include	lemma_9=,	path=<class_nmod>palonosetron_nmod	wib=including	lemma_8=,	relType_9=dep	lemma_1=(	pos_8=NN	relType_6=punct	lemma_4=for	pos_7=,	lemma_9=dolasetron	lpib=include_VBG	lemma_7=,	pos_9=NN	lemma_8=granisetron	path2=palonosetron_nmod	lemma_3=,	pos_4=IN	relType_4=case	lemma_5=example	relType_5=obl	relType_9=punct	pos_1=-LRB-	lemma_2=include	pos_6=,	pos_5=NN	relType_2=case	pos_3=,	eib=True	relType_7=dep	relType_7=punct	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	pos_2=VBG
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e4	DDI-DrugBank.d357.s0.e9	null	relType_10=punct	lemma_7=ondansetron	relType_8=dep	relType_11=cc	lemma_10=,	path1=	lemma_6=,	path=<class_nmod>palonosetron_nmod>alosetron_conj	relType_8=punct	lib=include	path2=palonosetron_nmod>alosetron_conj	lemma_9=,	wib=including	lemma_8=,	relType_9=dep	lemma_1=(	pos_8=NN	relType_10=nmod	relType_6=punct	lemma_4=for	pos_7=,	lemma_9=dolasetron	lemma_10=palonosetron	pos_10=NN	lpib=include_VBG	lemma_7=,	pos_9=NN	lemma_8=granisetron	lemma_3=,	lemma_11=and	pos_4=IN	pos_11=CC	relType_4=case	lemma_5=example	relType_5=obl	relType_9=punct	pos_1=-LRB-	lemma_2=include	pos_6=,	pos_5=NN	relType_2=case	pos_3=,	eib=True	relType_7=dep	pos_10=,	relType_7=punct	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	pos_2=VBG
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e5	DDI-DrugBank.d357.s0.e6	null	path=ondansetron_dep<palonosetron_nmod>granisetron_dep	lemma_1=,	eib=False	lpib=granisetron_NN	path2=granisetron_dep	pos_1=,	path1=ondansetron_dep	wib=granisetron	lib=granisetron	relType_1=punct
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e5	DDI-DrugBank.d357.s0.e7	null	lemma_2=granisetron	relType_2=dep	lemma_1=,	pos_2=NN	eib=True	lpib=granisetron_NN	path=ondansetron_dep<palonosetron_nmod>dolasetron_dep	pos_1=,	path1=ondansetron_dep	wib=granisetron	pos_2=,	lib=granisetron	relType_1=punct	path2=dolasetron_dep	lemma_2=,	relType_2=punct
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e5	DDI-DrugBank.d357.s0.e8	null	relType_3=dep	lemma_1=,	pos_2=NN	pos_1=,	lemma_3=dolasetron	relType_2=punct	path=ondansetron_dep<palonosetron_nmod>	path1=ondansetron_dep	path2=	lemma_2=,	lemma_2=granisetron	relType_2=dep	lemma_3=,	wib=granisetron	pos_3=,	eib=True	lpib=granisetron_NN	pos_3=NN	pos_2=,	lib=granisetron	relType_1=punct	relType_3=punct
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e5	DDI-DrugBank.d357.s0.e9	null	relType_3=dep	lemma_1=,	pos_2=NN	pos_5=CC	pos_1=,	relType_4=nmod	lemma_3=dolasetron	relType_2=punct	relType_5=cc	pos_4=,	path1=ondansetron_dep	pos_4=NN	lemma_2=,	lemma_2=granisetron	relType_2=dep	relType_4=punct	lemma_3=,	lemma_4=palonosetron	wib=granisetron	lemma_4=,	path=ondansetron_dep<palonosetron_nmod>alosetron_conj	pos_3=,	eib=True	lemma_5=and	lpib=granisetron_NN	pos_3=NN	pos_2=,	lib=granisetron	relType_1=punct	relType_3=punct	path2=alosetron_conj
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e6	DDI-DrugBank.d357.s0.e7	null	lemma_1=,	eib=False	lpib=dolasetron_NN	path1=granisetron_dep	pos_1=,	lib=dolasetron	relType_1=punct	path2=dolasetron_dep	path=granisetron_dep<palonosetron_nmod>dolasetron_dep	wib=dolasetron
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e6	DDI-DrugBank.d357.s0.e8	null	relType_2=dep	lemma_1=,	lemma_2=dolasetron	pos_2=NN	eib=True	path=granisetron_dep<palonosetron_nmod>	lpib=dolasetron_NN	path1=granisetron_dep	pos_1=,	lemma_2=,	pos_2=,	path2=	lib=dolasetron	relType_1=punct	wib=dolasetron	relType_2=punct
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e6	DDI-DrugBank.d357.s0.e9	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	relType_2=punct	path=granisetron_dep<palonosetron_nmod>alosetron_conj	path1=granisetron_dep	lemma_2=,	relType_2=dep	lemma_3=,	lemma_3=palonosetron	lpib=dolasetron_NN	relType_3=nmod	lib=dolasetron	lemma_2=dolasetron	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct	wib=dolasetron	path2=alosetron_conj
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e7	DDI-DrugBank.d357.s0.e8	null	lemma_1=,	eib=False	path1=dolasetron_dep	pos_1=,	wib=palonosetron	path2=	lpib=palonosetron_NN	relType_1=punct	path=dolasetron_dep<palonosetron_nmod>	lib=palonosetron
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e7	DDI-DrugBank.d357.s0.e9	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	relType_2=nmod	lemma_2=palonosetron	wib=palonosetron	lemma_2=,	path=dolasetron_dep<palonosetron_nmod>alosetron_conj	path1=dolasetron_dep	lpib=palonosetron_NN	eib=True	pos_2=,	lemma_3=and	relType_1=punct	lib=palonosetron	path2=alosetron_conj
DDI-DrugBank.d357.s0	DDI-DrugBank.d357.s0.e8	DDI-DrugBank.d357.s0.e9	null	lemma_2=and	lpib=alosetron_NN	lib=alosetron	lemma_1=,	eib=False	pos_2=CC	path1=	pos_1=,	path=<palonosetron_nmod>alosetron_conj	relType_1=punct	relType_2=cc	wib=alosetron	path2=alosetron_conj
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e0	DDI-DrugBank.d357.s1.e1	null	relType_1=cc	pos_1=CC	path2=vasodilator_conj	lib=vasodilator	eib=False	path=<medication_ROOT>vasodilator_conj	lpib=vasodilator_NNS	path1=	wib=Vasodilators	lemma_1=and
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e0	DDI-DrugBank.d357.s1.e2	null	relType_1=cc	lemma_4=follow	relType_4=amod	pos_1=CC	relType_12=obl	pos_13=VBG	lemma_14=concomitant	lemma_2=vasodilator	relType_9=advmod	relType_14=amod	pos_15=JJ	lemma_6=event	lemma_7=be	pos_8=VBN	lpib=vasodilator_NNS	path1=	relType_15=amod	wib=Vasodilators	lemma_10=commonly	lemma_15=antihypertensive	relType_11=case	relType_2=punct	lemma_2=:	lemma_13=receive	lemma_12=patient	relType_10=advmod	lemma_11=in	relType_3=det	relType_2=conj	relType_8=parataxis	pos_11=IN	pos_5=JJ	relType_5=amod	pos_12=NNS	lemma_9=more	pos_7=VBD	relType_6=nsubj:pass	pos_2=:	relType_7=aux:pass	lemma_5=adverse	pos_4=VBG	lemma_8=experience	pos_2=NNS	lib=vasodilator	eib=True	pos_3=DT	path=<medication_ROOT>experience_parataxis>patient_obl>receive_acl>medication_obj	pos_6=NNS	lemma_3=the	pos_14=JJ	pos_9=RBR	path2=experience_parataxis>patient_obl>receive_acl>medication_obj	pos_10=RB	relType_13=acl	lemma_1=and
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e0	DDI-DrugBank.d357.s1.e3	null	relType_1=cc	lemma_4=follow	relType_4=amod	pos_1=CC	relType_12=obl	pos_13=VBG	lemma_14=concomitant	lemma_2=vasodilator	relType_9=advmod	relType_14=amod	pos_15=JJ	lemma_6=event	lemma_7=be	pos_8=VBN	lpib=vasodilator_NNS	path1=	relType_15=amod	wib=Vasodilators	lemma_10=commonly	lemma_15=antihypertensive	relType_11=case	relType_2=punct	lemma_2=:	lemma_15=medication	lemma_13=receive	path=<medication_ROOT>experience_parataxis>patient_obl>receive_acl>medication_obj>vasodilator_conj	lemma_12=patient	relType_10=advmod	lemma_11=in	relType_3=det	relType_2=conj	relType_8=parataxis	pos_11=IN	pos_5=JJ	relType_5=amod	pos_12=NNS	lemma_9=more	pos_7=VBD	path2=experience_parataxis>patient_obl>receive_acl>medication_obj>vasodilator_conj	pos_2=:	relType_6=nsubj:pass	relType_7=aux:pass	relType_15=cc	lemma_5=adverse	lemma_15=or	pos_4=VBG	lemma_8=experience	relType_15=obj	pos_2=NNS	lib=vasodilator	pos_15=NNS	eib=True	pos_3=DT	pos_6=NNS	lemma_3=the	pos_14=JJ	pos_9=RBR	pos_15=CC	pos_10=RB	relType_13=acl	lemma_1=and
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e1	DDI-DrugBank.d357.s1.e2	null	relType_6=aux:pass	pos_2=DT	relType_4=amod	pos_4=JJ	relType_14=amod	lemma_2=the	pos_12=VBG	relType_9=advmod	lemma_13=concomitant	lemma_12=receive	relType_5=nsubj:pass	pos_8=RBR	pos_6=VBD	lemma_6=be	path1=vasodilator_conj	wib=following	pos_5=NNS	relType_13=amod	pos_11=NNS	lemma_8=more	lemma_5=event	pos_3=VBG	lemma_7=experience	relType_10=case	relType_8=advmod	lemma_1=:	lemma_9=commonly	pos_13=JJ	relType_3=amod	lemma_10=in	lib=follow	path=vasodilator_conj<medication_ROOT>experience_parataxis>patient_obl>receive_acl>medication_obj	pos_1=:	pos_9=RB	lemma_3=follow	lpib=follow_VBG	pos_10=IN	lemma_11=patient	relType_11=obl	pos_7=VBN	lemma_4=adverse	eib=True	relType_2=det	pos_14=JJ	relType_12=acl	path2=experience_parataxis>patient_obl>receive_acl>medication_obj	relType_1=punct	lemma_14=antihypertensive	relType_7=parataxis
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e1	DDI-DrugBank.d357.s1.e3	null	relType_6=aux:pass	pos_2=DT	relType_4=amod	pos_4=JJ	relType_14=amod	lemma_2=the	pos_12=VBG	relType_9=advmod	pos_14=CC	lemma_13=concomitant	lemma_12=receive	relType_5=nsubj:pass	pos_8=RBR	lemma_14=or	pos_6=VBD	lemma_6=be	path1=vasodilator_conj	wib=following	relType_14=obj	pos_5=NNS	relType_13=amod	pos_11=NNS	lemma_8=more	lemma_5=event	pos_3=VBG	lemma_7=experience	relType_10=case	relType_8=advmod	lemma_1=:	lemma_9=commonly	pos_13=JJ	relType_3=amod	lemma_10=in	lib=follow	pos_1=:	path2=experience_parataxis>patient_obl>receive_acl>medication_obj>vasodilator_conj	pos_9=RB	lemma_3=follow	lpib=follow_VBG	pos_10=IN	lemma_11=patient	relType_11=obl	relType_14=cc	path=vasodilator_conj<medication_ROOT>experience_parataxis>patient_obl>receive_acl>medication_obj>vasodilator_conj	pos_7=VBN	lemma_4=adverse	lemma_14=medication	eib=True	relType_2=det	pos_14=JJ	relType_12=acl	pos_14=NNS	relType_1=punct	lemma_14=antihypertensive	relType_7=parataxis
DDI-DrugBank.d357.s1	DDI-DrugBank.d357.s1.e2	DDI-DrugBank.d357.s1.e3	effect	relType_1=cc	pos_1=CC	path2=vasodilator_conj	lib=vasodilator	path=<medication_obj>vasodilator_conj	eib=False	wib=vasodilators	lpib=vasodilator_NNS	path1=	lemma_1=or
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e1	null	pos_2=IN	path=<antagonist_ROOT>possible_dep>agonist_advcl>apomorphine_nsubj	lpib=apomorphine_NN	lib=apomorphine	eib=False	lemma_2=since	path1=	pos_1=:	wib=apomorphine	relType_1=punct	path2=possible_dep>agonist_advcl>apomorphine_nsubj	lemma_1=:	relType_2=mark
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e2	null	lemma_5=dopamine	lemma_4=a	path1=	relType_5=compound	relType_2=mark	pos_2=IN	lpib=apomorphine_NN	pos_3=VBZ	lemma_1=:	pos_4=DT	lib=apomorphine	lemma_3=apomorphine	lemma_3=be	pos_1=:	wib=apomorphine	relType_3=nsubj	pos_5=NN	path=<antagonist_ROOT>possible_dep>agonist_advcl	lemma_2=since	eib=True	pos_3=NN	path2=possible_dep>agonist_advcl	relType_1=punct	relType_4=det	relType_3=cop
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e3	null	lemma_5=dopamine	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj	pos_7=VBZ	relType_8=dep	lemma_4=a	pos_5=,	lemma_7=be	path1=	relType_5=compound	pos_9=IN	lemma_10=dopamine	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	lpib=apomorphine_NN	relType_7=cop	pos_3=VBZ	relType_10=compound	pos_10=NN	lemma_1=:	pos_4=DT	lib=apomorphine	lemma_5=,	relType_5=punct	lemma_3=apomorphine	lemma_3=be	pos_1=:	lemma_5=agonist	wib=apomorphine	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_9=that	lemma_2=since	eib=True	pos_3=NN	lemma_6=it	relType_1=punct	relType_4=det	relType_3=cop	path2=possible_dep>diminish_ccomp>antagonist_nsubj	relType_6=nsubj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e4	null	lemma_5=dopamine	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lemma_4=a	pos_5=,	lemma_7=be	lemma_10=,	path1=	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	lemma_10=dopamine	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_4=det	relType_5=advcl	lemma_12=as	lpib=apomorphine_NN	relType_12=fixed	relType_7=cop	pos_3=VBZ	relType_10=compound	pos_10=NN	pos_12=IN	lemma_1=:	lemma_11=such	pos_4=DT	lib=apomorphine	lemma_5=,	relType_5=punct	lemma_3=apomorphine	lemma_3=be	pos_1=:	lemma_5=agonist	wib=apomorphine	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_9=that	lemma_2=since	eib=True	pos_10=,	pos_3=NN	relType_13=det	lemma_6=it	pos_11=JJ	relType_1=punct	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_3=cop	pos_10=NNS	relType_6=nsubj	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e5	null	lemma_5=dopamine	relType_14=punct	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lemma_14=neuroleptic	lemma_4=a	pos_5=,	lemma_7=be	lemma_10=,	path1=	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	relType_14=nmod	lemma_10=dopamine	lemma_14=(	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	lemma_12=as	lpib=apomorphine_NN	relType_12=fixed	relType_7=cop	pos_3=VBZ	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	relType_10=compound	pos_10=NN	pos_12=IN	lemma_1=:	lemma_11=such	pos_4=DT	pos_14=-LRB-	lib=apomorphine	lemma_5=,	relType_5=punct	lemma_3=apomorphine	lemma_3=be	pos_1=:	lemma_5=agonist	wib=apomorphine	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lemma_2=since	eib=True	lemma_9=that	pos_10=,	pos_3=NN	relType_13=det	pos_14=NNS	lemma_6=it	pos_11=JJ	relType_1=punct	relType_4=det	relType_3=cop	pos_10=NNS	relType_6=nsubj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e6	null	lemma_5=dopamine	relType_14=punct	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lemma_14=neuroleptic	lemma_4=a	pos_5=,	lemma_7=be	lemma_10=,	path1=	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	relType_14=nmod	lemma_10=dopamine	lemma_14=(	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	lemma_12=as	lpib=apomorphine_NN	relType_12=fixed	pos_15=,	relType_7=cop	relType_15=dep	pos_3=VBZ	relType_10=compound	pos_10=NN	relType_15=punct	pos_12=IN	lemma_1=:	lemma_11=such	pos_4=DT	pos_14=-LRB-	lib=apomorphine	lemma_15=,	lemma_5=,	relType_5=punct	lemma_3=apomorphine	lemma_3=be	pos_1=:	lemma_5=agonist	wib=apomorphine	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_5=NN	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_9=that	lemma_2=since	eib=True	pos_10=,	pos_15=NNS	pos_3=NN	lemma_15=phenothiazine	relType_13=det	pos_14=NNS	lemma_6=it	pos_11=JJ	relType_1=punct	relType_4=det	relType_3=cop	pos_10=NNS	relType_6=nsubj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e7	null	pos_7=VBZ	lemma_14=neuroleptic	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_10=NN	lemma_16=,	pos_14=-LRB-	lemma_5=,	lemma_3=be	pos_1=:	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	lemma_5=dopamine	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	lpib=apomorphine_NN	pos_12=IN	lemma_11=such	lemma_15=,	lemma_3=apomorphine	lemma_5=agonist	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_2=since	lemma_6=it	relType_1=punct	relType_14=punct	relType_10=punct	relType_8=dep	lemma_10=dopamine	relType_2=mark	pos_2=IN	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	relType_3=nsubj	relType_3=cop	relType_6=nsubj	lemma_13=the	pos_13=DT	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	relType_5=compound	pos_9=IN	lemma_14=(	lemma_12=as	pos_16=,	relType_10=compound	pos_4=DT	lib=apomorphine	relType_5=punct	lemma_16=butyrophenone	wib=apomorphine	relType_10=nsubj	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e8	null	pos_7=VBZ	lemma_14=neuroleptic	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_18=CC	pos_10=NN	lemma_16=,	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_14=-LRB-	lemma_5=,	lemma_3=be	pos_1=:	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	lemma_5=dopamine	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	lpib=apomorphine_NN	pos_12=IN	lemma_11=such	lemma_15=,	lemma_3=apomorphine	lemma_5=agonist	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_2=since	lemma_6=it	relType_1=punct	lemma_18=or	relType_14=punct	relType_10=punct	relType_8=dep	relType_17=punct	lemma_10=dopamine	relType_18=cc	relType_2=mark	pos_2=IN	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	relType_3=nsubj	pos_17=NNS	relType_3=cop	relType_6=nsubj	lemma_13=the	pos_13=DT	relType_5=compound	pos_9=IN	lemma_14=(	relType_17=conj	lemma_12=as	pos_16=,	relType_10=compound	lemma_17=thioxanthene	pos_4=DT	lib=apomorphine	relType_5=punct	lemma_16=butyrophenone	wib=apomorphine	relType_10=nsubj	lemma_17=)	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	pos_17=-RRB-	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e0	DDI-DrugBank.d357.s3.e9	null	pos_7=VBZ	lemma_19=metoclopramide	lemma_14=neuroleptic	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_24=case	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_18=CC	pos_10=NN	lemma_16=,	pos_14=-LRB-	lemma_5=,	lemma_22=the	lemma_3=be	pos_1=:	pos_24=IN	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	relType_23=obj	lemma_5=dopamine	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	relType_20=aux	lpib=apomorphine_NN	pos_12=IN	lemma_11=such	lemma_15=,	lemma_3=apomorphine	lemma_5=agonist	pos_19=,	pos_21=VB	lemma_8=possible	relType_9=mark	pos_22=DT	pos_5=NN	lemma_2=since	lemma_19=,	lemma_6=it	relType_1=punct	lemma_18=or	relType_14=punct	relType_10=punct	relType_8=dep	relType_17=punct	path=<antagonist_ROOT>possible_dep>diminish_ccomp>effectiveness_obj>APOKYN_nmod	relType_19=punct	lemma_10=dopamine	lemma_24=of	relType_18=cc	relType_2=mark	pos_23=NN	pos_2=IN	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	relType_21=ccomp	relType_19=conj	relType_3=nsubj	pos_17=NNS	relType_22=det	relType_3=cop	relType_6=nsubj	lemma_23=effectiveness	lemma_13=the	lemma_20=may	pos_13=DT	relType_5=compound	pos_9=IN	lemma_14=(	relType_17=conj	lemma_12=as	pos_20=MD	pos_16=,	pos_19=NN	relType_10=compound	lemma_17=thioxanthene	pos_4=DT	lib=apomorphine	relType_5=punct	lemma_16=butyrophenone	path2=possible_dep>diminish_ccomp>effectiveness_obj>APOKYN_nmod	wib=apomorphine	relType_10=nsubj	lemma_21=diminish	lemma_17=)	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	pos_17=-RRB-	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e2	null	pos_2=DT	lemma_3=dopamine	relType_1=cop	lib=be	pos_1=VBZ	eib=True	pos_3=NN	relType_2=det	path=apomorphine_nsubj<agonist_advcl>	lemma_1=be	lpib=be_VBZ	relType_3=compound	path2=	lemma_2=a	path1=apomorphine_nsubj	wib=is
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e3	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	lemma_6=possible	lemma_2=a	relType_7=mark	lemma_4=it	pos_8=NN	lemma_3=dopamine	relType_6=dep	lemma_1=be	path2=diminish_ccomp>antagonist_nsubj	relType_4=nsubj	lemma_5=be	lemma_7=that	lib=be	relType_3=advcl	lemma_3=,	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	lemma_3=agonist	wib=is	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	relType_3=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e4	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	relType_8=nsubj	lemma_6=possible	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	lemma_1=be	relType_9=case	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	relType_3=punct	pos_8=,
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e5	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	relType_8=nsubj	lemma_6=possible	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lpib=be_VBZ	relType_3=compound	pos_4=PRP	pos_12=-LRB-	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e6	null	pos_2=DT	pos_13=,	pos_6=JJ	pos_5=VBZ	relType_13=dep	lemma_13=,	relType_5=cop	relType_8=nsubj	lemma_6=possible	pos_13=NNS	relType_13=punct	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	pos_12=-LRB-	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e7	null	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	pos_2=DT	pos_13=,	relType_14=punct	pos_6=JJ	pos_5=VBZ	relType_13=dep	lemma_13=,	relType_5=cop	relType_8=nsubj	lemma_6=possible	pos_13=NNS	relType_13=punct	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	pos_14=,	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	lemma_14=,	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	relType_14=conj	lemma_14=butyrophenone	pos_4=PRP	lpib=be_VBZ	relType_3=compound	pos_14=NNS	pos_12=-LRB-	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e8	null	pos_6=JJ	relType_13=dep	lemma_13=,	lemma_6=possible	pos_13=NNS	relType_8=punct	pos_8=NNS	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	relType_6=dep	relType_9=case	lemma_5=be	lemma_3=,	relType_11=det	lemma_3=agonist	pos_3=,	pos_1=VBZ	pos_7=IN	pos_14=NNS	lemma_12=neuroleptic	pos_15=-RRB-	relType_16=cc	pos_2=DT	pos_13=,	relType_5=cop	pos_16=CC	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	relType_12=nmod	relType_12=punct	lemma_10=as	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	lemma_11=the	lemma_9=such	lemma_14=,	relType_1=cop	lemma_8=dopamine	relType_3=compound	pos_12=-LRB-	relType_3=punct	lemma_12=(	pos_8=,	relType_14=punct	pos_5=VBZ	relType_8=nsubj	lemma_8=,	relType_7=mark	lemma_4=it	pos_14=,	lemma_1=be	lemma_8=antagonist	relType_15=punct	lemma_16=or	lib=be	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	lemma_15=thioxanthene	pos_10=IN	wib=is	relType_15=conj	pos_4=PRP	relType_14=conj	relType_13=punct	lemma_2=a	pos_9=JJ	relType_4=nsubj	relType_10=fixed	lemma_7=that	relType_3=advcl	pos_12=NNS	lemma_15=)	pos_11=DT	pos_15=NNS	eib=True	pos_3=NN	relType_2=det	lemma_14=butyrophenone	lpib=be_VBZ
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e1	DDI-DrugBank.d357.s3.e9	null	pos_6=JJ	relType_13=dep	lemma_13=,	lemma_6=possible	pos_13=NNS	relType_21=obj	relType_8=punct	pos_8=NNS	relType_6=dep	relType_9=case	pos_22=IN	lemma_21=effectiveness	lemma_5=be	lemma_3=,	relType_11=det	lemma_3=agonist	pos_3=,	pos_1=VBZ	pos_7=IN	pos_14=NNS	lemma_12=neuroleptic	pos_15=-RRB-	relType_16=cc	pos_2=DT	pos_13=,	relType_5=cop	pos_16=CC	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	path=apomorphine_nsubj<agonist_advcl<possible_dep>diminish_ccomp>effectiveness_obj>APOKYN_nmod	relType_19=ccomp	relType_12=nmod	lemma_17=metoclopramide	relType_12=punct	lemma_20=the	relType_22=case	lemma_10=as	lemma_11=the	lemma_9=such	lemma_14=,	relType_1=cop	lemma_8=dopamine	relType_3=compound	pos_12=-LRB-	relType_3=punct	lemma_12=(	pos_8=,	lemma_22=of	relType_14=punct	pos_5=VBZ	relType_8=nsubj	relType_17=punct	lemma_8=,	relType_7=mark	lemma_4=it	pos_17=NN	pos_14=,	lemma_1=be	lemma_8=antagonist	relType_15=punct	pos_17=,	lemma_16=or	lib=be	path1=apomorphine_nsubj<agonist_advcl	relType_8=compound	lemma_15=thioxanthene	pos_10=IN	wib=is	relType_15=conj	pos_19=VB	pos_4=PRP	relType_14=conj	relType_20=det	relType_13=punct	lemma_2=a	pos_20=DT	path2=diminish_ccomp>effectiveness_obj>APOKYN_nmod	relType_17=conj	pos_9=JJ	lemma_17=,	relType_4=nsubj	relType_10=fixed	lemma_7=that	lemma_18=may	relType_18=aux	relType_3=advcl	pos_12=NNS	lemma_15=)	pos_11=DT	pos_15=NNS	pos_18=MD	eib=True	pos_3=NN	relType_2=det	lemma_14=butyrophenone	lemma_19=diminish	lpib=be_VBZ	pos_21=NN
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e3	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	pos_1=,	pos_6=NN	relType_5=mark	relType_2=nsubj	pos_3=VBZ	lemma_2=it	path2=diminish_ccomp>antagonist_nsubj	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj	lemma_4=possible	lib=be	lemma_5=that	lemma_3=be	pos_5=IN	pos_2=PRP	wib=is	relType_6=compound	eib=True	path1=agonist_advcl	lpib=be_VBZ	relType_1=punct	relType_3=cop
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e4	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_7=case	pos_1=,	lemma_6=,	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_2=nsubj	relType_6=punct	pos_3=VBZ	pos_9=DT	lemma_2=it	pos_8=IN	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	pos_5=IN	pos_2=PRP	pos_6=,	wib=is	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	relType_6=nsubj	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e5	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	pos_1=,	lemma_6=,	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	pos_3=VBZ	pos_9=DT	lemma_2=it	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	pos_2=PRP	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	relType_6=nsubj	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e6	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	lemma_11=,	pos_1=,	lemma_6=,	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_11=phenothiazine	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	pos_2=PRP	pos_11=,	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e7	null	lemma_6=dopamine	relType_4=dep	relType_12=conj	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	lemma_11=,	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	pos_1=,	lemma_6=,	lemma_11=phenothiazine	pos_6=NN	lemma_12=,	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_12=,	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	relType_12=punct	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	pos_12=NNS	lemma_12=butyrophenone	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	pos_2=PRP	pos_11=,	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e8	null	lemma_6=dopamine	relType_4=dep	relType_12=conj	lemma_1=,	pos_4=JJ	relType_10=punct	pos_14=CC	relType_7=case	lemma_11=,	pos_13=NNS	pos_1=,	lemma_6=,	relType_13=punct	lemma_14=or	lemma_11=phenothiazine	pos_6=NN	lemma_12=,	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_12=,	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	relType_12=punct	relType_13=conj	pos_8=IN	lemma_10=neuroleptic	lemma_13=thioxanthene	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	lib=be	lemma_4=possible	lemma_5=that	pos_12=NNS	lemma_12=butyrophenone	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	relType_14=cc	pos_2=PRP	pos_11=,	pos_13=-RRB-	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_13=)	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e2	DDI-DrugBank.d357.s3.e9	null	lemma_6=dopamine	pos_14=CC	pos_13=NNS	lemma_6=,	pos_6=NN	lemma_12=,	pos_10=-LRB-	relType_10=nmod	pos_16=MD	pos_12=,	pos_3=VBZ	lemma_6=antagonist	lemma_3=be	relType_6=compound	lemma_16=may	pos_7=JJ	pos_6=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>effectiveness_obj>APOKYN_nmod	lemma_20=of	lemma_1=,	relType_7=case	pos_1=,	lemma_11=phenothiazine	pos_18=DT	relType_5=mark	lemma_8=as	relType_20=case	relType_2=nsubj	lemma_17=diminish	relType_12=punct	relType_13=conj	pos_8=IN	lemma_10=neuroleptic	lemma_15=,	lemma_10=(	pos_5=IN	lemma_15=metoclopramide	relType_11=dep	path1=agonist_advcl	relType_18=det	relType_1=punct	lemma_18=the	relType_4=dep	relType_10=punct	lemma_11=,	lemma_14=or	pos_20=IN	lemma_7=such	pos_15=,	relType_11=punct	pos_9=DT	lemma_2=it	relType_15=punct	lemma_13=thioxanthene	lemma_4=possible	lib=be	pos_2=PRP	pos_13=-RRB-	wib=is	lemma_9=the	relType_15=conj	relType_19=obj	relType_3=cop	relType_6=nsubj	relType_12=conj	pos_4=JJ	lemma_19=effectiveness	relType_13=punct	path2=diminish_ccomp>effectiveness_obj>APOKYN_nmod	relType_6=punct	relType_17=ccomp	pos_11=NNS	relType_16=aux	pos_19=NN	lemma_5=that	pos_15=NN	pos_12=NNS	lemma_12=butyrophenone	pos_17=VB	relType_14=cc	pos_11=,	pos_6=,	eib=True	lemma_13=)	relType_8=fixed	lpib=be_VBZ	pos_10=NNS	relType_9=det
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e4	null	path2=neuroleptic_nmod	lemma_1=,	pos_3=IN	path1=	pos_1=,	pos_2=JJ	lemma_3=as	relType_3=fixed	eib=False	path=<antagonist_nsubj>neuroleptic_nmod	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_4=the	relType_2=case	wib=such	lib=such	relType_4=det	relType_1=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e5	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	pos_5=NNS	lemma_5=(	lemma_2=such	path2=neuroleptic_nmod>phenothiazine_dep	lpib=such_JJ	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	relType_2=case	wib=such	eib=True	lib=such	relType_4=det	relType_1=punct	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	pos_5=-LRB-
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e6	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	pos_5=NNS	relType_6=punct	lemma_5=(	lemma_2=such	lpib=such_JJ	pos_4=DT	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_4=the	relType_5=punct	relType_5=nmod	path2=neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_6=,	relType_2=case	wib=such	eib=True	pos_6=NNS	lib=such	relType_4=det	relType_1=punct	lemma_6=phenothiazine	pos_5=-LRB-
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e7	null	pos_7=NNS	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	pos_5=NNS	relType_6=punct	pos_7=,	lemma_5=(	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	pos_6=,	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	relType_7=punct	pos_6=NNS	path2=neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lib=such	relType_4=det	relType_1=punct	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e8	effect	pos_7=NNS	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	relType_8=punct	pos_2=JJ	pos_8=NNS	lemma_8=thioxanthene	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	path=<antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_5=NNS	relType_6=punct	pos_7=,	lemma_5=(	pos_8=-RRB-	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_8=)	pos_9=CC	relType_5=punct	path2=neuroleptic_nmod>metoclopramide_conj	lemma_4=the	lemma_9=or	relType_5=nmod	pos_6=,	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	relType_7=punct	pos_6=NNS	relType_8=conj	lib=such	relType_4=det	relType_1=punct	relType_9=cc	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e3	DDI-DrugBank.d357.s3.e9	null	pos_7=NNS	path2=effectiveness_obj>APOKYN_nmod	lemma_1=,	relType_10=punct	pos_3=IN	lemma_13=the	lemma_15=of	lemma_10=,	pos_11=MD	path=antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	pos_1=,	lemma_6=,	pos_13=DT	lemma_14=effectiveness	relType_8=punct	pos_2=JJ	relType_12=ccomp	pos_8=NNS	lemma_8=thioxanthene	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	relType_14=obj	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=aux	pos_7=,	lemma_5=(	pos_8=-RRB-	pos_14=NN	pos_10=NN	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_8=)	pos_9=CC	relType_15=case	relType_5=punct	lemma_4=the	lemma_9=or	relType_5=nmod	lemma_11=may	pos_6=,	pos_12=VB	pos_15=IN	lemma_10=metoclopramide	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	pos_10=,	relType_7=punct	path1=antagonist_nsubj	pos_6=NNS	relType_8=conj	relType_13=det	lib=such	relType_4=det	relType_1=punct	lemma_12=diminish	relType_9=cc	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e4	DDI-DrugBank.d357.s3.e5	null	lemma_1=(	path=<neuroleptic_nmod>phenothiazine_dep	lib=phenothiazine	path2=phenothiazine_dep	eib=False	path1=	wib=phenothiazines	relType_1=punct	pos_1=-LRB-	lpib=phenothiazine_NNS
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e4	DDI-DrugBank.d357.s3.e6	null	lemma_1=(	pos_2=NNS	relType_2=dep	lib=phenothiazine	eib=True	lemma_2=phenothiazine	path1=	wib=phenothiazines	pos_2=,	path2=phenothiazine_dep>butyrophenone_conj	path=<neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	relType_1=punct	relType_2=punct	lemma_2=,	pos_1=-LRB-	lpib=phenothiazine_NNS
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e4	DDI-DrugBank.d357.s3.e7	null	path=<neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_2=phenothiazine	path1=	wib=phenothiazines	relType_2=punct	lemma_1=(	path2=phenothiazine_dep>thioxanthene_conj	lemma_3=butyrophenone	pos_3=NNS	lemma_2=,	lpib=phenothiazine_NNS	relType_2=dep	lemma_3=,	relType_3=conj	pos_1=-LRB-	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e4	DDI-DrugBank.d357.s3.e8	null	pos_5=CC	lemma_2=phenothiazine	path1=	wib=phenothiazines	relType_2=punct	lemma_1=(	relType_5=cc	lemma_3=butyrophenone	pos_3=NNS	pos_4=-RRB-	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	path=<neuroleptic_nmod>metoclopramide_conj	lemma_4=)	path2=metoclopramide_conj	lemma_4=thioxanthene	pos_1=-LRB-	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=or
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e4	DDI-DrugBank.d357.s3.e9	null	path2=effectiveness_obj>APOKYN_nmod	pos_5=CC	lemma_2=phenothiazine	wib=phenothiazines	lemma_6=,	lemma_8=diminish	relType_7=aux	lemma_10=effectiveness	relType_11=case	relType_2=punct	lemma_1=(	pos_6=NN	path=neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	relType_5=cc	lemma_3=butyrophenone	pos_3=NNS	relType_6=conj	relType_6=punct	pos_4=-RRB-	path1=neuroleptic_nmod<antagonist_nsubj	lemma_6=metoclopramide	pos_9=DT	pos_7=MD	lemma_7=may	pos_10=NN	relType_10=obj	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	pos_8=VB	pos_11=IN	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=)	relType_8=ccomp	lemma_4=thioxanthene	pos_1=-LRB-	pos_6=,	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	lemma_9=the	lemma_11=of	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_9=det	lemma_5=or
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e5	DDI-DrugBank.d357.s3.e6	null	path2=butyrophenone_conj	lemma_1=,	lib=butyrophenone	eib=False	lpib=butyrophenone_NNS	wib=butyrophenones	path1=	pos_1=,	path=<phenothiazine_dep>butyrophenone_conj	relType_1=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e5	DDI-DrugBank.d357.s3.e7	null	pos_2=NNS	lemma_1=,	path2=thioxanthene_conj	lib=butyrophenone	eib=True	lpib=butyrophenone_NNS	wib=butyrophenones	path1=	pos_1=,	path=<phenothiazine_dep>thioxanthene_conj	pos_2=,	lemma_2=butyrophenone	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e5	DDI-DrugBank.d357.s3.e8	null	lemma_1=,	pos_1=,	relType_4=cc	relType_2=punct	pos_3=NNS	path=phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	wib=butyrophenones	relType_2=conj	lemma_2=,	relType_3=conj	lemma_4=or	lemma_2=butyrophenone	path2=metoclopramide_conj	lemma_3=)	pos_2=NNS	lib=butyrophenone	eib=True	pos_3=-RRB-	pos_4=CC	lpib=butyrophenone_NNS	path1=phenothiazine_dep	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=thioxanthene
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e5	DDI-DrugBank.d357.s3.e9	effect	path2=effectiveness_obj>APOKYN_nmod	pos_7=VB	lemma_1=,	pos_8=DT	lemma_6=may	pos_5=,	lemma_9=effectiveness	pos_1=,	lemma_10=of	relType_4=cc	relType_2=punct	lemma_5=metoclopramide	pos_3=NNS	wib=butyrophenones	relType_10=case	relType_2=conj	pos_9=NN	lemma_2=,	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_6=aux	lemma_8=the	relType_9=obj	lemma_2=butyrophenone	pos_10=IN	relType_5=conj	pos_6=MD	lemma_3=)	path=phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	pos_2=NNS	pos_5=NN	lemma_7=diminish	lib=butyrophenone	eib=True	pos_3=-RRB-	pos_4=CC	lpib=butyrophenone_NNS	relType_7=ccomp	pos_2=,	relType_8=det	relType_1=punct	relType_3=punct	path1=phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	lemma_3=thioxanthene
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e6	DDI-DrugBank.d357.s3.e7	null	path1=butyrophenone_conj	lib=thioxanthene	lemma_1=,	path2=thioxanthene_conj	eib=False	lpib=thioxanthene_NNS	pos_1=,	relType_1=punct	path=butyrophenone_conj<phenothiazine_dep>thioxanthene_conj	wib=thioxanthenes
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e6	DDI-DrugBank.d357.s3.e8	null	lemma_2=)	lib=thioxanthene	lemma_1=,	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	path=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	lemma_3=or	path1=butyrophenone_conj<phenothiazine_dep	relType_2=conj	lemma_2=thioxanthene	path2=metoclopramide_conj	pos_2=NNS	eib=True	pos_2=-RRB-	lpib=thioxanthene_NNS	relType_1=punct	wib=thioxanthenes
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e6	DDI-DrugBank.d357.s3.e9	effect	lemma_2=)	path2=effectiveness_obj>APOKYN_nmod	lib=thioxanthene	lemma_1=,	pos_6=VB	relType_7=det	pos_3=CC	pos_1=,	pos_9=IN	lemma_8=effectiveness	relType_3=cc	relType_2=punct	pos_8=NN	lemma_6=diminish	lemma_5=may	pos_4=,	relType_8=obj	lemma_3=or	relType_9=case	relType_5=aux	relType_2=conj	pos_4=NN	pos_7=DT	lemma_2=thioxanthene	path=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	lemma_4=metoclopramide	pos_5=MD	relType_4=punct	relType_6=ccomp	lemma_4=,	path1=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	pos_2=NNS	eib=True	pos_2=-RRB-	lemma_9=of	lpib=thioxanthene_NNS	relType_4=conj	lemma_7=the	relType_1=punct	wib=thioxanthenes
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e7	DDI-DrugBank.d357.s3.e8	null	path1=thioxanthene_conj<phenothiazine_dep	lemma_2=or	path=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	lpib=metoclopramide_NN	lib=metoclopramide	eib=False	pos_1=-RRB-	pos_2=CC	wib=metoclopramide	relType_1=punct	lemma_1=)	relType_2=cc	path2=metoclopramide_conj
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e7	DDI-DrugBank.d357.s3.e9	effect	relType_8=case	path2=effectiveness_obj>APOKYN_nmod	lemma_2=or	lib=metoclopramide	path1=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	pos_6=DT	wib=metoclopramide	lemma_4=may	lemma_1=)	relType_2=cc	pos_5=VB	lemma_5=diminish	lemma_6=the	relType_7=obj	pos_4=MD	path=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	lemma_3=metoclopramide	pos_8=IN	lpib=metoclopramide_NN	lemma_3=,	relType_3=conj	pos_1=-RRB-	relType_4=aux	relType_5=ccomp	relType_6=det	pos_3=,	eib=True	pos_3=NN	pos_2=CC	lemma_7=effectiveness	relType_1=punct	pos_7=NN	lemma_8=of	relType_3=punct
DDI-DrugBank.d357.s3	DDI-DrugBank.d357.s3.e8	DDI-DrugBank.d357.s3.e9	effect	path2=effectiveness_obj>APOKYN_nmod	lemma_1=,	pos_2=MD	pos_1=,	lemma_6=of	pos_3=VB	relType_6=case	eib=False	pos_6=IN	lemma_5=effectiveness	lib=diminish	relType_2=aux	lemma_3=diminish	pos_4=DT	lemma_4=the	path1=metoclopramide_conj<neuroleptic_nmod<antagonist_nsubj	pos_5=NN	relType_3=ccomp	path=metoclopramide_conj<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>APOKYN_nmod	lpib=diminish_VB	relType_5=obj	lemma_2=may	relType_1=punct	relType_4=det	wib=diminish
DDI-DrugBank.d357.s4	DDI-DrugBank.d357.s4.e0	DDI-DrugBank.d357.s4.e1	advise	lemma_6=dopamine	lemma_1=,	pos_2=MD	pos_1=,	path2=agonist_obl	pos_3=VB	relType_3=aux:pass	relType_5=case	wib=be	pos_6=NN	lemma_5=with	relType_2=aux	pos_4=VBN	lib=be	lemma_2=should	path1=neuroleptic_obl<treat_acl<patient_nsubj:pass	lemma_3=be	pos_5=IN	lpib=be_VB	relType_4=ROOT	relType_6=compound	eib=True	path=neuroleptic_obl<treat_acl<patient_nsubj:pass<treat_ROOT>agonist_obl	relType_1=punct	lemma_4=treat
DDI-DrugBank.d253.s0	DDI-DrugBank.d253.s0.e0	DDI-DrugBank.d253.s0.e1	null	relType_8=case	pos_6=DT	pos_7=NN	path1=	relType_5=parataxis	lemma_4=may	pos_2=JJ	lemma_5=blunt	pos_5=VB	lemma_3=use	eib=False	path=<agent_ROOT>blunt_parataxis>response_obj>arbutamine_nmod	lemma_6=the	relType_7=obj	pos_4=MD	lemma_1=:	lemma_7=response	pos_8=IN	lemma_8=to	relType_2=amod	pos_1=:	relType_4=aux	lemma_2=concurrent	relType_3=nsubj	lpib=concurrent_JJ	relType_6=det	wib=concurrent	pos_3=NN	lib=concurrent	relType_1=punct	path2=blunt_parataxis>response_obj>arbutamine_nmod
DDI-DrugBank.d253.s1	DDI-DrugBank.d253.s1.e0	DDI-DrugBank.d253.s1.e1	advise	pos_7=NNS	relType_5=obl:npmod	relType_1=aux	relType_10=det	pos_3=VBN	path2=conduct_advcl>test_obj>mediate_amod>arbutamine_obl	pos_6=CD	lemma_4=at	lemma_10=a	lemma_1=should	lemma_3=withdraw	wib=be	relType_9=advcl	eib=False	relType_7=obj	pos_2=VB	lemma_5=least	lemma_9=conduct	pos_8=IN	pos_9=VBG	lib=be	relType_3=ROOT	path1=agent_nsubj:pass	pos_4=IN	relType_8=mark	relType_4=case	relType_2=aux:pass	relType_6=nummod	pos_1=MD	lpib=be_VB	lemma_6=48	lemma_7=hour	path=agent_nsubj:pass<withdraw_ROOT>conduct_advcl>test_obj>mediate_amod>arbutamine_obl	lemma_8=before	pos_5=RBS	lemma_2=be	pos_10=DT
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e1	DDI-DrugBank.d253.s2.e2	null	lemma_1=,	eib=False	path2=lidocaine_conj	path1=	pos_1=,	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	path=<flecainide_nmod>lidocaine_conj	wib=lidocaine
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e1	DDI-DrugBank.d253.s2.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lpib=lidocaine_NN	path=<flecainide_nmod>quinidine_conj	relType_3=cc	relType_2=punct	lemma_3=or	lib=lidocaine	relType_2=conj	lemma_2=,	path2=quinidine_conj	eib=True	pos_2=,	relType_1=punct	lemma_2=lidocaine	wib=lidocaine
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e1	DDI-DrugBank.d253.s2.e4	null	relType_8=case	lemma_1=,	pos_2=NN	pos_6=JJ	pos_3=CC	pos_1=,	path2=have_parataxis>use_nsubj>arbutamine_nmod	lpib=lidocaine_NN	relType_2=punct	relType_3=cc	path1=flecainide_nmod<class_appos	relType_6=amod	pos_4=-RRB-	lemma_8=with	lemma_3=or	lib=lidocaine	relType_2=conj	pos_4=NN	lemma_2=,	pos_5=:	pos_8=IN	path=flecainide_nmod<class_appos<agent_ROOT>have_parataxis>use_nsubj>arbutamine_nmod	relType_4=punct	relType_5=punct	lemma_4=)	lemma_6=concurrent	lemma_4=quinidine	eib=True	lemma_5=:	pos_2=,	relType_4=conj	relType_7=nsubj	relType_1=punct	pos_7=NN	lemma_7=use	lemma_2=lidocaine	wib=lidocaine
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e2	DDI-DrugBank.d253.s2.e3	null	lpib=quinidine_NN	lib=quinidine	path=lidocaine_conj<flecainide_nmod>quinidine_conj	lemma_1=,	lemma_2=or	eib=False	path1=lidocaine_conj	pos_2=CC	path2=quinidine_conj	pos_1=,	relType_1=punct	relType_2=cc	wib=quinidine
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e2	DDI-DrugBank.d253.s2.e4	null	lemma_2=or	lemma_1=,	relType_7=case	pos_1=,	path=lidocaine_conj<flecainide_nmod<class_appos<agent_ROOT>have_parataxis>use_nsubj>arbutamine_nmod	path2=have_parataxis>use_nsubj>arbutamine_nmod	relType_2=cc	lemma_7=with	pos_6=NN	lpib=quinidine_NN	lib=quinidine	lemma_4=:	path1=lidocaine_conj<flecainide_nmod<class_appos	lemma_5=concurrent	pos_5=JJ	relType_4=punct	pos_4=:	relType_5=amod	relType_3=conj	lemma_6=use	lemma_3=quinidine	lemma_3=)	wib=quinidine	eib=True	pos_3=-RRB-	pos_7=IN	pos_3=NN	pos_2=CC	relType_1=punct	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d253.s2	DDI-DrugBank.d253.s2.e3	DDI-DrugBank.d253.s2.e4	null	path1=quinidine_conj<flecainide_nmod<class_appos	path2=have_parataxis>use_nsubj>arbutamine_nmod	lemma_4=use	lemma_1=)	relType_5=case	relType_2=punct	path=quinidine_conj<flecainide_nmod<class_appos<agent_ROOT>have_parataxis>use_nsubj>arbutamine_nmod	lemma_2=:	eib=False	lemma_5=with	relType_4=nsubj	pos_4=NN	relType_3=amod	pos_1=-RRB-	pos_2=:	pos_5=IN	lpib=concurrent_JJ	wib=concurrent	pos_3=JJ	lemma_3=concurrent	lib=concurrent	relType_1=punct
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e0	DDI-DrugBank.d253.s3.e1	null	path=<antidepressant_ROOT>tricyclic_dep	lemma_1=(	lpib=tricyclic_JJ	eib=False	path2=tricyclic_dep	path1=	lib=tricyclic	relType_1=punct	wib=tricyclic	pos_1=-LRB-
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e0	DDI-DrugBank.d253.s3.e2	null	lemma_2=)	path1=	pos_2=JJ	wib=tricyclic	relType_2=punct	path2=atropine_conj	lemma_1=(	lemma_2=tricyclic	relType_2=dep	lemma_3=,	lpib=tricyclic_JJ	lib=tricyclic	pos_1=-LRB-	path=<antidepressant_ROOT>atropine_conj	pos_3=,	eib=True	pos_2=-RRB-	relType_1=punct	relType_3=punct
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e0	DDI-DrugBank.d253.s3.e3	null	lemma_2=)	pos_6=JJ	path2=agent_conj	path=<antidepressant_ROOT>agent_conj	path1=	relType_4=cc	pos_2=JJ	wib=tricyclic	relType_2=punct	lemma_1=(	relType_6=amod	lemma_2=tricyclic	pos_4=NN	lemma_5=other	pos_5=JJ	relType_2=dep	lemma_4=atropine	lemma_6=anticholinergic	relType_5=amod	lemma_3=,	lpib=tricyclic_JJ	lemma_4=or	lib=tricyclic	pos_1=-LRB-	pos_3=,	eib=True	pos_2=-RRB-	pos_4=CC	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e0	DDI-DrugBank.d253.s3.e4	null	lemma_2=)	lemma_6=agent	pos_6=JJ	path1=	lemma_6=,	relType_7=cc	path=<antidepressant_ROOT>glycoside_conj	relType_4=cc	pos_2=JJ	wib=tricyclic	relType_2=punct	lemma_1=(	pos_8=NN	relType_6=conj	relType_6=punct	relType_6=amod	lemma_2=tricyclic	pos_4=NN	lemma_5=other	pos_5=JJ	relType_2=dep	lemma_4=atropine	lemma_6=anticholinergic	relType_5=amod	lemma_3=,	lpib=tricyclic_JJ	pos_7=CC	lemma_4=or	relType_8=compound	lib=tricyclic	lemma_7=or	pos_1=-LRB-	pos_6=,	lemma_8=digitalis	path2=glycoside_conj	pos_3=,	eib=True	pos_2=-RRB-	pos_4=CC	pos_6=NNS	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e0	DDI-DrugBank.d253.s3.e5	null	lemma_2=)	lemma_6=agent	pos_6=JJ	pos_8=:	path2=produce_parataxis>use_nsubj>arbutamine_nmod	path1=	lemma_6=,	relType_7=cc	relType_8=punct	relType_4=cc	path=<antidepressant_ROOT>produce_parataxis>use_nsubj>arbutamine_nmod	wib=tricyclic	pos_2=JJ	pos_8=NNS	relType_2=punct	lemma_11=with	lemma_1=(	pos_8=NN	pos_9=JJ	relType_11=case	relType_6=conj	relType_6=punct	relType_6=amod	lemma_2=tricyclic	lemma_9=concurrent	relType_9=amod	pos_10=NN	pos_4=NN	lemma_5=other	pos_11=IN	pos_5=JJ	relType_2=dep	lemma_4=atropine	lemma_6=anticholinergic	relType_5=amod	lemma_3=,	lpib=tricyclic_JJ	pos_7=CC	lemma_4=or	lemma_8=glycoside	relType_8=compound	lib=tricyclic	relType_10=nsubj	lemma_7=or	pos_1=-LRB-	pos_6=,	lemma_8=digitalis	pos_3=,	eib=True	pos_2=-RRB-	pos_4=CC	pos_6=NNS	relType_8=conj	relType_4=conj	relType_1=punct	lemma_8=:	relType_3=punct	lemma_10=use
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e1	DDI-DrugBank.d253.s3.e2	null	wib=atropine	eib=False	pos_1=-RRB-	lpib=atropine_NN	lemma_1=)	pos_2=,	path=tricyclic_dep<antidepressant_ROOT>atropine_conj	path1=tricyclic_dep	relType_1=punct	lemma_2=,	lib=atropine	relType_2=punct	path2=atropine_conj
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e1	DDI-DrugBank.d253.s3.e3	null	relType_4=amod	pos_4=JJ	lemma_5=anticholinergic	pos_3=CC	path2=agent_conj	lemma_1=)	path1=tricyclic_dep	relType_3=cc	relType_2=punct	lpib=atropine_NN	path=tricyclic_dep<antidepressant_ROOT>agent_conj	lemma_3=or	lemma_2=,	pos_5=JJ	relType_5=amod	relType_3=conj	pos_1=-RRB-	lemma_4=other	lib=atropine	wib=atropine	eib=True	pos_3=NN	lemma_3=atropine	pos_2=,	relType_1=punct
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e1	DDI-DrugBank.d253.s3.e4	null	relType_4=amod	relType_7=compound	pos_4=JJ	lemma_5=anticholinergic	pos_3=CC	pos_5=,	lemma_1=)	path1=tricyclic_dep	relType_3=cc	relType_2=punct	pos_5=NNS	lpib=atropine_NN	lemma_5=agent	lemma_6=or	lemma_3=or	lemma_2=,	pos_5=JJ	relType_5=amod	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	pos_1=-RRB-	lemma_4=other	relType_5=conj	lib=atropine	path2=glycoside_conj	wib=atropine	eib=True	pos_3=NN	lemma_3=atropine	pos_2=,	path=tricyclic_dep<antidepressant_ROOT>glycoside_conj	lemma_7=digitalis	relType_1=punct	pos_7=NN	relType_6=cc
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e1	DDI-DrugBank.d253.s3.e5	null	pos_7=NNS	relType_4=amod	relType_7=compound	pos_4=JJ	lemma_5=anticholinergic	lemma_10=with	pos_3=CC	relType_8=amod	pos_5=,	path2=produce_parataxis>use_nsubj>arbutamine_nmod	lemma_1=)	path1=tricyclic_dep	lemma_8=concurrent	relType_3=cc	relType_2=punct	pos_8=JJ	pos_5=NNS	lpib=atropine_NN	lemma_5=agent	lemma_6=or	lemma_7=glycoside	lemma_3=or	relType_10=case	pos_9=NN	lemma_2=,	lemma_7=:	pos_5=JJ	path=tricyclic_dep<antidepressant_ROOT>produce_parataxis>use_nsubj>arbutamine_nmod	relType_5=amod	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	pos_1=-RRB-	lemma_9=use	lemma_4=other	pos_10=IN	relType_5=conj	pos_7=:	lib=atropine	wib=atropine	eib=True	relType_9=nsubj	pos_3=NN	relType_7=punct	lemma_3=atropine	pos_2=,	lemma_7=digitalis	relType_1=punct	pos_7=NN	relType_7=conj	relType_6=cc
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e2	DDI-DrugBank.d253.s3.e3	null	path=atropine_conj<antidepressant_ROOT>agent_conj	relType_1=cc	lemma_3=anticholinergic	pos_1=CC	pos_3=JJ	relType_3=amod	lib=other	eib=True	lpib=other_JJ	path2=agent_conj	lemma_2=other	relType_2=amod	path1=atropine_conj	wib=other	pos_2=JJ	lemma_1=or
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e2	DDI-DrugBank.d253.s3.e4	null	relType_1=cc	pos_1=CC	lib=other	path1=atropine_conj	relType_5=compound	lemma_3=agent	relType_4=cc	pos_2=JJ	pos_3=NNS	lemma_2=other	wib=other	lemma_3=anticholinergic	lemma_5=digitalis	relType_3=amod	lemma_3=,	relType_3=conj	lpib=other_JJ	lemma_4=or	relType_2=amod	path=atropine_conj<antidepressant_ROOT>glycoside_conj	pos_5=NN	path2=glycoside_conj	pos_3=JJ	pos_3=,	eib=True	pos_4=CC	relType_3=punct	lemma_1=or
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e2	DDI-DrugBank.d253.s3.e5	null	relType_1=cc	relType_8=case	pos_1=CC	pos_6=JJ	lib=other	path2=produce_parataxis>use_nsubj>arbutamine_nmod	path1=atropine_conj	relType_5=compound	lemma_3=agent	relType_4=cc	pos_2=JJ	pos_3=NNS	pos_5=NNS	lemma_2=other	relType_6=amod	lemma_5=glycoside	wib=other	lemma_8=with	path=atropine_conj<antidepressant_ROOT>produce_parataxis>use_nsubj>arbutamine_nmod	pos_5=:	pos_8=IN	lemma_3=anticholinergic	lemma_5=digitalis	relType_3=amod	lemma_3=,	relType_3=conj	lpib=other_JJ	lemma_4=or	relType_5=punct	relType_2=amod	relType_5=conj	lemma_6=concurrent	pos_5=NN	pos_3=JJ	pos_3=,	eib=True	pos_4=CC	lemma_5=:	relType_7=nsubj	pos_7=NN	lemma_7=use	relType_3=punct	lemma_1=or
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e3	DDI-DrugBank.d253.s3.e4	null	lemma_2=or	path2=glycoside_conj	lemma_1=,	eib=True	pos_3=NN	wib=digitalis	pos_2=CC	lpib=digitalis_NN	pos_1=,	relType_3=compound	lemma_3=digitalis	relType_1=punct	path=agent_conj<antidepressant_ROOT>glycoside_conj	lib=digitalis	relType_2=cc	path1=agent_conj
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e3	DDI-DrugBank.d253.s3.e5	null	relType_4=amod	lemma_2=or	lemma_1=,	pos_4=JJ	lemma_3=glycoside	path2=produce_parataxis>use_nsubj>arbutamine_nmod	pos_1=,	relType_5=nsubj	relType_2=cc	relType_6=case	pos_3=NNS	lemma_3=:	pos_6=IN	path=agent_conj<antidepressant_ROOT>produce_parataxis>use_nsubj>arbutamine_nmod	lemma_4=concurrent	relType_3=conj	pos_3=:	lemma_6=with	lemma_5=use	lib=digitalis	relType_3=punct	pos_5=NN	eib=True	pos_3=NN	wib=digitalis	pos_2=CC	lpib=digitalis_NN	relType_3=compound	lemma_3=digitalis	relType_1=punct	path1=agent_conj
DDI-DrugBank.d253.s3	DDI-DrugBank.d253.s3.e4	DDI-DrugBank.d253.s3.e5	null	path2=produce_parataxis>use_nsubj>arbutamine_nmod	pos_2=JJ	path1=glycoside_conj	lemma_3=use	eib=False	path=glycoside_conj<antidepressant_ROOT>produce_parataxis>use_nsubj>arbutamine_nmod	lemma_1=:	lemma_4=with	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_2=concurrent	relType_3=nsubj	lpib=concurrent_JJ	wib=concurrent	pos_3=NN	lib=concurrent	relType_1=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e0	DDI-DrugBank.d105.s0.e1	null	relType_1=case	pos_2=NN	lemma_2=coumarin	path1=	relType_5=compound	path2=derivative_nmod>inhibitor_conj	lib=include	wib=including	lemma_9=platelet	relType_6=conj	pos_3=NNS	relType_9=compound	lemma_3=derivative	pos_4=,	lemma_6=derivative	pos_7=,	lemma_5=indandione	pos_8=CC	lpib=include_VBG	lemma_7=,	pos_9=NN	lemma_9=aggregation	relType_4=punct	relType_2=compound	relType_3=nmod	path=<anticoagulant_nsubj>derivative_nmod>inhibitor_conj	lemma_4=,	lemma_8=and	pos_1=VBG	pos_5=NN	eib=True	relType_7=punct	pos_6=NNS	relType_8=cc	lemma_1=include
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e0	DDI-DrugBank.d105.s0.e2	null	relType_1=case	pos_2=NN	relType_9=conj	lemma_2=coumarin	path1=	relType_5=compound	lib=include	lemma_11=-	wib=including	lemma_9=platelet	pos_11=HYPH	pos_9=JJ	relType_6=conj	path2=derivative_nmod>inhibitor_conj>drug_nmod	pos_3=NNS	relType_9=compound	lemma_3=derivative	pos_4=,	lemma_11=anti	relType_11=amod	lemma_6=derivative	pos_9=NNS	relType_11=punct	pos_7=,	lemma_5=indandione	relType_9=case	pos_8=CC	lpib=include_VBG	lemma_7=,	pos_9=NN	relType_10=fixed	lemma_9=aggregation	lemma_10=as	relType_4=punct	pos_11=AFX	relType_2=compound	relType_3=nmod	lemma_4=,	pos_10=IN	lemma_8=and	lemma_9=such	pos_1=VBG	pos_5=NN	lemma_11=inflammatory	path=<anticoagulant_nsubj>derivative_nmod>inhibitor_conj>drug_nmod	eib=True	lemma_9=inhibitor	relType_11=obl:npmod	relType_7=punct	pos_6=NNS	pos_11=JJ	relType_8=cc	lemma_11=nonsteroidal	lemma_1=include
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e0	DDI-DrugBank.d105.s0.e3	null	relType_1=case	pos_2=NN	relType_9=conj	lemma_2=coumarin	path1=	relType_5=compound	lib=include	lemma_11=-	lemma_11=drug	wib=including	lemma_9=platelet	pos_11=HYPH	pos_9=JJ	relType_6=conj	pos_3=NNS	relType_9=compound	lemma_3=derivative	pos_4=,	lemma_11=anti	relType_11=amod	lemma_6=derivative	pos_9=NNS	relType_11=punct	pos_7=,	pos_11=NNS	lemma_5=indandione	pos_11=-LRB-	relType_9=case	pos_8=CC	lpib=include_VBG	lemma_7=,	pos_9=NN	path=<anticoagulant_nsubj>derivative_nmod>inhibitor_conj>drug_nmod>nsaid_dep	relType_10=fixed	lemma_9=aggregation	lemma_10=as	relType_4=punct	pos_11=AFX	relType_2=compound	path2=derivative_nmod>inhibitor_conj>drug_nmod>nsaid_dep	lemma_11=(	relType_3=nmod	lemma_4=,	pos_10=IN	lemma_8=and	lemma_9=such	pos_1=VBG	pos_5=NN	lemma_11=inflammatory	eib=True	lemma_9=inhibitor	relType_11=obl:npmod	relType_7=punct	pos_6=NNS	pos_11=JJ	relType_11=nmod	relType_8=cc	lemma_11=nonsteroidal	lemma_1=include
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e0	DDI-DrugBank.d105.s0.e4	null	relType_1=case	pos_13=,	pos_2=NN	relType_9=conj	lemma_13=,	pos_14=CC	lemma_2=coumarin	path1=	pos_11=-LRB-	lemma_12=nsaid	relType_5=compound	relType_13=punct	lib=include	lemma_11=-	lemma_11=drug	wib=including	lemma_9=platelet	pos_12=-RRB-	pos_11=HYPH	pos_9=JJ	relType_6=conj	pos_3=NNS	relType_9=compound	lemma_3=derivative	pos_4=,	lemma_11=anti	path2=derivative_nmod>inhibitor_conj>drug_nmod>aspirin_conj	lemma_6=derivative	pos_9=NNS	relType_11=amod	pos_7=,	relType_11=punct	lemma_5=indandione	pos_11=NNS	relType_9=case	pos_8=CC	path=<anticoagulant_nsubj>derivative_nmod>inhibitor_conj>drug_nmod>aspirin_conj	lpib=include_VBG	lemma_7=,	pos_9=NN	relType_12=punct	relType_10=fixed	lemma_9=aggregation	lemma_10=as	relType_4=punct	pos_11=AFX	pos_12=NNS	relType_2=compound	lemma_11=(	relType_3=nmod	lemma_4=,	pos_10=IN	lemma_12=)	relType_14=cc	lemma_8=and	lemma_9=such	pos_1=VBG	pos_5=NN	lemma_11=inflammatory	eib=True	lemma_9=inhibitor	relType_11=obl:npmod	relType_12=dep	relType_7=punct	pos_6=NNS	lemma_14=and	pos_11=JJ	relType_11=nmod	relType_8=cc	lemma_11=nonsteroidal	lemma_1=include
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e0	DDI-DrugBank.d105.s0.e5	effect	pos_2=NN	pos_14=CC	lemma_13=,	lemma_22=administer	relType_22=dep	relType_6=conj	relType_17=det	pos_3=NNS	relType_24=case	lemma_11=anti	relType_20=nmod	pos_20=NN	pos_23=RB	path=anticoagulant_nsubj<increase_ROOT>when_advmod>administer_dep>ardeparin_obl	relType_9=case	lemma_7=,	pos_18=NN	relType_4=punct	pos_11=AFX	pos_24=IN	relation_25=beneficial	lemma_21=when	pos_1=VBG	lemma_9=inhibitor	pos_6=NNS	pos_11=JJ	relType_18=obj	relType_1=case	pos_13=,	relType_21=advmod	relType_11=amod	pos_16=VB	lemma_15=aspirin	relType_12=punct	pos_9=NN	lemma_23=concomitantly	lemma_10=as	path2=when_advmod>administer_dep>ardeparin_obl	lemma_4=,	lemma_17=the	lemma_20=bleeding	lemma_8=and	lemma_9=such	lemma_11=inflammatory	pos_5=NN	lemma_24=with	relType_11=obl:npmod	relType_19=case	relType_12=dep	lemma_14=and	relType_11=nmod	pos_21=WRB	pos_17=DT	lemma_18=risk	lib=include	lemma_11=-	lemma_11=drug	lemma_9=platelet	pos_12=-RRB-	pos_4=,	relType_11=punct	pos_7=,	lemma_5=indandione	pos_8=CC	lemma_19=of	lemma_11=(	relType_3=nmod	pos_10=IN	lemma_16=increase	relType_15=conj	relType_8=cc	lemma_11=nonsteroidal	relType_23=advmod	pos_19=IN	relType_9=conj	lemma_15=may	lemma_2=coumarin	lemma_12=nsaid	relType_13=punct	pos_15=MD	relType_5=compound	wib=including	relType_16=ROOT	pos_11=HYPH	pos_22=VBN	pos_9=JJ	relType_9=compound	lemma_3=derivative	relType_15=aux	pos_11=-LRB-	lemma_6=derivative	pos_9=NNS	pos_11=NNS	lpib=include_VBG	relType_10=fixed	lemma_9=aggregation	pos_15=NN	pos_12=NNS	relType_2=compound	lemma_12=)	relType_14=cc	path1=anticoagulant_nsubj	eib=True	relType_7=punct	lemma_1=include
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e1	DDI-DrugBank.d105.s0.e2	null	relType_1=case	path1=	relType_3=obl:npmod	pos_3=AFX	pos_1=JJ	path2=drug_nmod	lemma_3=inflammatory	lemma_2=as	pos_2=IN	lemma_3=nonsteroidal	lemma_3=-	lemma_3=anti	lpib=such_JJ	relType_3=amod	relType_2=fixed	pos_3=JJ	wib=such	eib=True	path=<inhibitor_conj>drug_nmod	lemma_1=such	pos_3=HYPH	lib=such	relType_3=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e1	DDI-DrugBank.d105.s0.e3	null	relType_1=case	lemma_3=drug	path1=	relType_3=obl:npmod	pos_3=AFX	pos_1=JJ	lemma_3=inflammatory	lemma_2=as	pos_2=IN	pos_3=NNS	lemma_3=nonsteroidal	lemma_3=-	lemma_3=anti	lemma_3=(	pos_3=-LRB-	lpib=such_JJ	relType_3=amod	relType_3=nmod	path=<inhibitor_conj>drug_nmod>nsaid_dep	relType_2=fixed	pos_3=JJ	wib=such	eib=True	lemma_1=such	pos_3=HYPH	path2=drug_nmod>nsaid_dep	lib=such	relType_3=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e1	DDI-DrugBank.d105.s0.e4	null	relType_4=dep	relType_1=case	lemma_3=drug	pos_5=,	path1=	relType_3=obl:npmod	pos_3=AFX	pos_1=JJ	lemma_3=inflammatory	lemma_2=as	pos_2=IN	pos_3=NNS	lemma_3=nonsteroidal	lemma_3=-	pos_4=-RRB-	lemma_3=anti	lemma_3=(	pos_3=-LRB-	pos_4=NNS	lpib=such_JJ	relType_4=punct	relType_3=amod	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	path=<inhibitor_conj>drug_nmod>aspirin_conj	relType_3=nmod	lemma_4=)	path2=drug_nmod>aspirin_conj	relType_2=fixed	lemma_4=nsaid	pos_3=JJ	wib=such	eib=True	lemma_1=such	pos_3=HYPH	lib=such	relType_3=punct	relType_6=cc
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e1	DDI-DrugBank.d105.s0.e5	effect	relType_4=dep	relType_1=case	lemma_3=drug	lemma_10=risk	pos_5=,	pos_16=IN	relType_3=obl:npmod	pos_3=AFX	pos_1=JJ	relType_7=aux	pos_13=WRB	lemma_3=inflammatory	pos_15=RB	relType_11=case	lemma_2=as	pos_2=IN	lemma_12=bleeding	pos_3=NNS	path=inhibitor_conj<derivative_nmod<anticoagulant_nsubj<increase_ROOT>when_advmod>administer_dep>ardeparin_obl	lemma_3=nonsteroidal	lemma_3=-	pos_4=-RRB-	relType_12=nmod	lemma_3=anti	lemma_3=(	pos_9=DT	pos_12=NN	pos_7=MD	pos_3=-LRB-	lemma_7=may	pos_10=NN	lemma_14=administer	relType_10=obj	pos_4=NNS	lemma_16=with	pos_8=VB	pos_11=IN	lpib=such_JJ	lemma_7=aspirin	lemma_8=increase	path2=when_advmod>administer_dep>ardeparin_obl	relType_4=punct	relType_3=amod	pos_6=CC	relType_13=advmod	path1=inhibitor_conj<derivative_nmod<anticoagulant_nsubj	lemma_5=,	relType_5=punct	lemma_6=and	relType_3=nmod	relType_14=dep	relType_8=ROOT	lemma_4=)	lemma_15=concomitantly	pos_14=VBN	relType_2=fixed	relType_16=case	lemma_4=nsaid	pos_3=JJ	wib=such	eib=True	lemma_1=such	pos_3=HYPH	lemma_9=the	relation_14=beneficial	lemma_11=of	lemma_13=when	lib=such	pos_7=NN	relType_9=det	relType_15=advmod	relType_3=punct	relType_7=conj	relType_6=cc
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e2	DDI-DrugBank.d105.s0.e3	null	lemma_1=(	lib=nsaid	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	path2=nsaid_dep	path=<drug_nmod>nsaid_dep	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e2	DDI-DrugBank.d105.s0.e4	null	lemma_2=)	lpib=nsaid_NNS	path1=	relType_4=cc	relType_2=punct	lemma_1=(	lib=nsaid	path2=aspirin_conj	path=<drug_nmod>aspirin_conj	lemma_2=nsaid	relType_2=dep	lemma_3=,	pos_1=-LRB-	pos_2=NNS	pos_3=,	wib=NSAIDs	eib=True	pos_2=-RRB-	pos_4=CC	lemma_4=and	relType_1=punct	relType_3=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e2	DDI-DrugBank.d105.s0.e5	effect	lemma_2=)	lemma_12=administer	lpib=nsaid_NNS	pos_6=VB	relType_7=det	lemma_14=with	lemma_6=increase	pos_9=IN	relType_4=cc	relType_2=punct	lemma_1=(	pos_8=NN	lib=nsaid	relType_10=nmod	lemma_5=may	lemma_10=bleeding	lemma_11=when	relType_8=obj	pos_13=RB	relType_9=case	path=drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj<increase_ROOT>when_advmod>administer_dep>ardeparin_obl	lemma_2=nsaid	relType_5=aux	path1=drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj	pos_10=NN	pos_7=DT	relType_11=advmod	pos_14=IN	relType_6=ROOT	relType_2=dep	pos_11=WRB	path2=when_advmod>administer_dep>ardeparin_obl	pos_5=MD	lemma_3=,	relType_13=advmod	relType_5=conj	pos_1=-LRB-	lemma_5=aspirin	lemma_13=concomitantly	relation_7=beneficial	pos_2=NNS	pos_5=NN	pos_3=,	wib=NSAIDs	eib=True	pos_2=-RRB-	pos_4=CC	lemma_9=of	relType_12=dep	lemma_4=and	lemma_7=the	lemma_8=risk	relType_14=case	pos_12=VBN	relType_1=punct	relType_3=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e3	DDI-DrugBank.d105.s0.e4	null	path=nsaid_dep<drug_nmod>aspirin_conj	path1=nsaid_dep	path2=aspirin_conj	eib=False	pos_3=CC	pos_1=-RRB-	lpib=aspirin_NN	pos_2=,	lemma_3=and	wib=aspirin	relType_1=punct	lemma_1=)	relType_3=cc	lib=aspirin	lemma_2=,	relType_2=punct
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e3	DDI-DrugBank.d105.s0.e5	effect	pos_10=WRB	relType_8=case	relation_5=beneficial	pos_3=CC	pos_6=DT	pos_7=NN	lemma_13=with	lpib=aspirin_NN	lemma_4=may	lemma_1=)	relType_9=nmod	lemma_5=increase	relType_3=cc	relType_2=punct	lemma_9=bleeding	pos_5=VB	path1=nsaid_dep<drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj	lemma_7=risk	lemma_10=when	lemma_6=the	relType_12=advmod	relType_7=obj	pos_4=MD	relType_10=advmod	lemma_11=administer	pos_13=IN	pos_9=NN	pos_4=NN	lemma_2=,	pos_8=IN	relType_13=case	path2=when_advmod>administer_dep>ardeparin_obl	pos_12=RB	lemma_4=aspirin	pos_1=-RRB-	relType_4=aux	relType_11=dep	pos_11=VBN	path=nsaid_dep<drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj<increase_ROOT>when_advmod>administer_dep>ardeparin_obl	relType_6=det	eib=True	lemma_12=concomitantly	pos_2=,	lemma_3=and	wib=aspirin	relType_4=conj	relType_1=punct	relType_5=ROOT	lemma_8=of	lib=aspirin
DDI-DrugBank.d105.s0	DDI-DrugBank.d105.s0.e4	DDI-DrugBank.d105.s0.e5	effect	relType_8=dep	relType_9=advmod	relType_1=aux	lemma_1=may	pos_8=VBN	lemma_10=with	pos_7=WRB	path1=aspirin_conj<drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj	lemma_5=of	relType_5=case	lemma_8=administer	relation_1=beneficial	pos_6=NN	eib=False	lemma_4=risk	pos_2=VB	relType_10=case	relType_3=det	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	path2=when_advmod>administer_dep>ardeparin_obl	relType_2=ROOT	path=aspirin_conj<drug_nmod<inhibitor_conj<derivative_nmod<anticoagulant_nsubj<increase_ROOT>when_advmod>administer_dep>ardeparin_obl	pos_5=IN	wib=increase	pos_9=RB	pos_10=IN	pos_1=MD	lemma_6=bleeding	lpib=increase_VB	pos_3=DT	lemma_3=the	lemma_7=when	relType_7=advmod	relType_6=nmod	lemma_9=concomitantly
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e0	DDI-DrugBank.d509.s0.e1	null	lemma_1=,	pos_2=NN	lemma_4=be	path=aripiprazole_nmod<effect_obj<give_advcl<use_ROOT>take_advcl>ABILIFY_nsubj:pass	pos_1=,	lemma_3=should	pos_6=WRB	path1=aripiprazole_nmod<effect_obj<give_advcl	eib=False	pos_3=MD	lemma_6=when	path2=take_advcl>ABILIFY_nsubj:pass	relType_2=nsubj:pass	lemma_2=caution	relType_4=aux:pass	lemma_5=use	lpib=caution_NN	pos_4=VB	relType_3=aux	lib=caution	relType_1=punct	relType_5=ROOT	wib=caution	relType_6=advmod	pos_5=VBN
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e0	DDI-DrugBank.d509.s0.e2	null	pos_13=VBG	lemma_1=,	pos_7=VBZ	pos_2=NN	lemma_13=centrally	lemma_4=be	pos_8=VBN	lemma_7=be	pos_1=,	relType_8=advcl	pos_9=IN	lemma_9=in	lemma_3=should	pos_6=WRB	relType_11=case	lemma_11=with	pos_12=JJ	lemma_12=other	path1=aripiprazole_nmod<effect_obj<give_advcl	relType_13=amod	path2=take_advcl>drug_obl	pos_3=MD	lemma_6=when	relType_7=nsubj:pass	relType_10=obl	relType_9=case	relType_12=amod	pos_10=NN	pos_13=RB	relType_2=nsubj:pass	pos_11=IN	relType_13=advmod	lemma_2=caution	pos_7=NNP	lemma_13=act	relType_4=aux:pass	relType_7=aux:pass	lemma_8=take	lemma_5=use	lpib=caution_NN	lemma_10=combination	eib=True	lemma_7=ABILIFY	pos_4=VB	relType_3=aux	path=aripiprazole_nmod<effect_obj<give_advcl<use_ROOT>take_advcl>drug_obl	lib=caution	relType_1=punct	relType_5=ROOT	wib=caution	relType_6=advmod	pos_5=VBN
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e0	DDI-DrugBank.d509.s0.e3	null	pos_13=VBG	lemma_1=,	pos_7=VBZ	pos_2=NN	lemma_13=centrally	lemma_4=be	pos_8=VBN	lemma_7=be	path=aripiprazole_nmod<effect_obj<give_advcl<use_ROOT>take_advcl>drug_obl>alcohol_conj	pos_13=NNS	pos_1=,	relType_8=advcl	lemma_13=drug	pos_9=IN	lemma_9=in	lemma_3=should	pos_6=WRB	relType_11=case	lemma_11=with	pos_12=JJ	lemma_12=other	relType_13=obl	path1=aripiprazole_nmod<effect_obj<give_advcl	relType_13=amod	pos_3=MD	lemma_6=when	relType_7=nsubj:pass	relType_10=obl	relType_9=case	relType_12=amod	pos_10=NN	pos_13=RB	relType_2=nsubj:pass	lemma_13=and	pos_11=IN	relType_13=cc	relType_13=advmod	lemma_2=caution	pos_7=NNP	lemma_13=act	relType_4=aux:pass	relType_7=aux:pass	lemma_8=take	lemma_5=use	pos_13=CC	lpib=caution_NN	lemma_10=combination	eib=True	path2=take_advcl>drug_obl>alcohol_conj	lemma_7=ABILIFY	pos_4=VB	relType_3=aux	lib=caution	relType_1=punct	relType_5=ROOT	wib=caution	relType_6=advmod	pos_5=VBN
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e1	DDI-DrugBank.d509.s0.e2	advise	pos_2=VBN	pos_3=IN	pos_6=JJ	relType_1=aux:pass	pos_7=VBG	relType_2=advcl	relType_5=case	pos_7=RB	relType_6=amod	lemma_1=be	lemma_5=with	path2=drug_obl	pos_4=NN	path=ABILIFY_nsubj:pass<take_advcl>drug_obl	relType_4=obl	relType_7=amod	lib=be	lemma_2=take	pos_5=IN	lemma_4=combination	lemma_7=centrally	relType_3=case	wib=is	lemma_7=act	path1=ABILIFY_nsubj:pass	pos_1=VBZ	eib=True	lpib=be_VBZ	relType_7=advmod	lemma_3=in	lemma_6=other
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e1	DDI-DrugBank.d509.s0.e3	advise	pos_7=NNS	pos_2=VBN	path2=drug_obl>alcohol_conj	pos_3=IN	pos_6=JJ	relType_1=aux:pass	pos_7=VBG	relType_7=cc	relType_2=advcl	relType_5=case	pos_7=RB	relType_6=amod	lemma_1=be	lemma_5=with	pos_4=NN	relType_4=obl	relType_7=amod	lib=be	pos_7=CC	path=ABILIFY_nsubj:pass<take_advcl>drug_obl>alcohol_conj	lemma_2=take	pos_5=IN	lemma_4=combination	lemma_7=centrally	relType_3=case	wib=is	lemma_7=act	path1=ABILIFY_nsubj:pass	relType_7=obl	pos_1=VBZ	eib=True	lemma_7=and	lemma_7=drug	lpib=be_VBZ	relType_7=advmod	lemma_3=in	lemma_6=other
DDI-DrugBank.d509.s0	DDI-DrugBank.d509.s0.e2	DDI-DrugBank.d509.s0.e3	null	relType_1=cc	pos_1=CC	path=<drug_obl>alcohol_conj	lib=alcohol	eib=False	path2=alcohol_conj	path1=	wib=alcohol	lpib=alcohol_NN	lemma_1=and
DDI-DrugBank.d509.s2	DDI-DrugBank.d509.s2.e0	DDI-DrugBank.d509.s2.e1	effect	relType_4=mark	relType_8=case	pos_2=DT	lemma_3=potential	lemma_2=the	relation_4=beneficial	lpib=have_VBZ	pos_6=DT	relType_10=amod	lemma_5=enhance	lemma_10=antihypertensive	relation_6=neutral	pos_5=VB	pos_9=JJ	lemma_7=effect	lemma_6=the	lemma_8=of	relType_7=obj	lemma_1=have	relType_9=amod	lib=have	pos_8=IN	lemma_9=certain	path1=aripiprazole_nsubj	lemma_4=to	pos_10=JJ	path2=enhance_ccomp>effect_obj>agent_nmod	pos_4=TO	relType_5=ccomp	relType_1=ROOT	relType_6=det	path=aripiprazole_nsubj<have_ROOT>enhance_ccomp>effect_obj>agent_nmod	pos_1=VBZ	eib=True	pos_3=JJ	relType_2=det	relType_3=obj	pos_7=NN	wib=has
DDI-DrugBank.d509.s3	DDI-DrugBank.d509.s3.e0	DDI-DrugBank.d509.s3.e1	null	eib=False	path=ABILIFY_compound<Aripiprazole_nmod>	path2=	path1=ABILIFY_compound
DDI-DrugBank.d509.s7	DDI-DrugBank.d509.s7.e0	DDI-DrugBank.d509.s7.e1	mechanism	relation_4=beneficial	lemma_4=a	pos_2=MD	pos_3=VB	lemma_1=)	relType_6=case	lib=cause	lemma_5=increase	eib=False	pos_6=IN	relation_2=neutral	lpib=cause_VB	relType_2=aux	lemma_6=in	pos_4=DT	lemma_2=could	wib=cause	pos_1=-RRB-	path1=carbamazepine_appos<cyp3a4_obj<induce_nsubj	path2=increase_obj>clearance_nmod>aripiprazole_compound	pos_5=NN	lemma_3=cause	relType_3=ccomp	relType_5=obj	path=carbamazepine_appos<cyp3a4_obj<induce_nsubj<cause_ccomp>increase_obj>clearance_nmod>aripiprazole_compound	relType_1=punct	relType_4=det
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e0	DDI-DrugBank.d509.s8.e1	null	lemma_2=or	lemma_6=,	lemma_1=)	relType_2=cc	path2=cyp2d6_conj>eg_dep>quinidine_dep	lemma_5=eg	eib=False	pos_4=-LRB-	relType_6=punct	relType_5=dep	lemma_4=(	wib=CYP2D6	relType_4=punct	relType_3=conj	path1=ketoconazole_appos	pos_1=-RRB-	lemma_3=cyp2d6	lpib=cyp2d6_NN	pos_5=FW	pos_6=,	pos_3=NN	pos_2=CC	path=ketoconazole_appos<cyp3a4_nmod>cyp2d6_conj>eg_dep>quinidine_dep	relType_1=punct	lib=cyp2d6
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e0	DDI-DrugBank.d509.s8.e2	null	lemma_2=or	path2=cyp2d6_conj>eg_dep>fluoxetine_dep	lemma_6=,	lemma_1=)	relType_2=cc	lemma_7=quinidine	lemma_5=eg	pos_4=-LRB-	relType_6=punct	pos_7=,	lemma_7=,	relType_5=dep	lemma_4=(	wib=CYP2D6	path=ketoconazole_appos<cyp3a4_nmod>cyp2d6_conj>eg_dep>fluoxetine_dep	relType_4=punct	relType_3=conj	path1=ketoconazole_appos	pos_1=-RRB-	lemma_3=cyp2d6	lpib=cyp2d6_NN	pos_5=FW	pos_6=,	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=CC	relType_1=punct	pos_7=NN	lib=cyp2d6
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e0	DDI-DrugBank.d509.s8.e3	null	lemma_2=or	relType_8=dep	lemma_6=,	relType_8=punct	lemma_1=)	relType_2=cc	lemma_8=,	lemma_7=quinidine	path2=cyp2d6_conj>eg_dep>paroxetine_conj	pos_8=NN	lemma_5=eg	pos_4=-LRB-	relType_6=punct	pos_7=,	lemma_7=,	relType_5=dep	lemma_8=fluoxetine	lemma_4=(	pos_9=CC	wib=CYP2D6	relType_4=punct	relType_3=conj	path1=ketoconazole_appos	pos_1=-RRB-	lemma_9=or	lemma_3=cyp2d6	path=ketoconazole_appos<cyp3a4_nmod>cyp2d6_conj>eg_dep>paroxetine_conj	lpib=cyp2d6_NN	pos_5=FW	pos_6=,	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=CC	relType_1=punct	pos_7=NN	lib=cyp2d6	relType_9=cc	pos_8=,
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e0	DDI-DrugBank.d509.s8.e4	mechanism	lemma_2=or	relType_10=punct	relType_8=dep	lemma_12=inhibit	pos_11=MD	lemma_6=,	relType_8=punct	relation_14=adverse	lemma_1=)	relType_2=cc	lemma_8=,	path1=ketoconazole_appos<cyp3a4_nmod<inhibitor_nsubj	lemma_7=quinidine	pos_8=NN	path2=elimination_obj>aripiprazole_compound	lemma_5=eg	pos_4=-LRB-	relType_6=punct	relType_10=conj	relType_11=aux	pos_7=,	pos_10=NN	lemma_7=,	relType_5=dep	lemma_8=fluoxetine	lemma_4=(	relType_12=ROOT	pos_9=CC	wib=CYP2D6	relType_4=punct	relType_3=conj	lemma_10=paroxetine	pos_1=-RRB-	lemma_9=or	lemma_11=can	lemma_3=cyp2d6	lpib=cyp2d6_NN	pos_5=FW	pos_6=,	pos_12=VB	lemma_10=)	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=CC	pos_10=-RRB-	relType_1=punct	pos_7=NN	lib=cyp2d6	relType_9=cc	path=ketoconazole_appos<cyp3a4_nmod<inhibitor_nsubj<inhibit_ROOT>elimination_obj>aripiprazole_compound	pos_8=,
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e1	DDI-DrugBank.d509.s8.e2	null	wib=fluoxetine	path2=fluoxetine_dep	lemma_1=,	lpib=fluoxetine_NN	path=quinidine_dep<eg_dep>fluoxetine_dep	eib=False	pos_1=,	lib=fluoxetine	relType_1=punct	path1=quinidine_dep
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e1	DDI-DrugBank.d509.s8.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	path=quinidine_dep<eg_dep>paroxetine_conj	relType_3=cc	relType_2=punct	lpib=fluoxetine_NN	lemma_3=or	lemma_2=,	wib=fluoxetine	lemma_2=fluoxetine	relType_2=dep	lib=fluoxetine	path2=paroxetine_conj	eib=True	pos_2=,	relType_1=punct	path1=quinidine_dep
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e1	DDI-DrugBank.d509.s8.e4	mechanism	lemma_1=,	pos_2=NN	pos_6=VB	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	path2=elimination_obj>aripiprazole_compound	lpib=fluoxetine_NN	lemma_5=can	pos_4=-RRB-	relation_7=adverse	lemma_3=or	relType_5=aux	path1=quinidine_dep<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj	pos_4=NN	lemma_2=,	wib=fluoxetine	lemma_2=fluoxetine	relType_2=dep	relType_6=ROOT	pos_5=MD	path=quinidine_dep<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj<inhibit_ROOT>elimination_obj>aripiprazole_compound	relType_4=punct	lib=fluoxetine	lemma_4=)	lemma_6=inhibit	eib=True	lemma_4=paroxetine	pos_2=,	relType_4=conj	relType_1=punct
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e2	DDI-DrugBank.d509.s8.e3	null	path2=paroxetine_conj	lemma_2=or	lemma_1=,	path1=fluoxetine_dep	eib=False	pos_2=CC	pos_1=,	path=fluoxetine_dep<eg_dep>paroxetine_conj	relType_1=punct	lib=paroxetine	lpib=paroxetine_NN	wib=paroxetine	relType_2=cc
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e2	DDI-DrugBank.d509.s8.e4	mechanism	lemma_2=or	lemma_1=,	pos_1=,	lib=paroxetine	relType_2=cc	relation_5=adverse	lemma_5=inhibit	pos_5=VB	path2=elimination_obj>aripiprazole_compound	path=fluoxetine_dep<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj<inhibit_ROOT>elimination_obj>aripiprazole_compound	path1=fluoxetine_dep<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj	pos_4=MD	lpib=paroxetine_NN	wib=paroxetine	relType_3=conj	relType_4=aux	lemma_3=)	eib=True	pos_3=-RRB-	pos_3=NN	lemma_3=paroxetine	pos_2=CC	lemma_4=can	relType_1=punct	relType_5=ROOT	relType_3=punct
DDI-DrugBank.d509.s8	DDI-DrugBank.d509.s8.e3	DDI-DrugBank.d509.s8.e4	mechanism	lemma_2=can	path2=elimination_obj>aripiprazole_compound	path1=paroxetine_conj<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj	relType_3=ROOT	eib=False	relation_2=adverse	pos_1=-RRB-	pos_2=MD	path=paroxetine_conj<eg_dep<cyp2d6_conj<cyp3a4_nmod<inhibitor_nsubj<inhibit_ROOT>elimination_obj>aripiprazole_compound	lemma_3=inhibit	lib=inhibit	relType_2=aux	relType_1=punct	lemma_1=)	lpib=inhibit_VB	pos_3=VB	wib=inhibit
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e0	DDI-DrugBank.d509.s9.e1	null	lpib=coadministration_NNP	lemma_2=Coadministration	path=<Ketoconazole_ROOT>increase_appos>Coadministration_nsubj>ketoconazole_nmod	pos_3=IN	path2=increase_appos>Coadministration_nsubj>ketoconazole_nmod	wib=Coadministration	eib=False	pos_2=NNP	relType_2=nsubj	path1=	pos_1=:	lemma_3=of	relType_1=punct	lib=coadministration	relType_3=case	lemma_1=:
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e0	DDI-DrugBank.d509.s9.e2	null	lpib=coadministration_NNP	path=<Ketoconazole_ROOT>increase_appos>Coadministration_nsubj>dose_nmod>aripiprazole_nmod	relType_20=case	pos_3=IN	relType_18=amod	path1=	lemma_7=/	lemma_13=with	pos_9=IN	relType_4=nmod	pos_16=HYPH	pos_12=-RRB-	pos_20=IN	pos_6=NN	pos_8=NN	pos_5=CD	lemma_11=day	pos_15=CD	pos_17=NN	relType_6=dep	lemma_10=14	wib=Coadministration	path2=increase_appos>Coadministration_nsubj>dose_nmod>aripiprazole_nmod	pos_2=NNP	relType_2=nsubj	pos_4=-LRB-	pos_11=NNS	relType_14=det	pos_18=JJ	pos_19=NN	relType_9=case	lemma_6=mg	relType_12=punct	pos_13=IN	relType_17=compound	pos_4=NN	lib=coadministration	lemma_1=:	lemma_4=(	lemma_18=single	pos_7=SYM	relType_13=case	relType_4=punct	relType_15=nummod	relType_5=nummod	pos_10=CD	pos_1=:	relType_19=nmod	lemma_16=-	lemma_12=)	relType_16=punct	relType_3=case	relType_10=nummod	pos_14=DT	lemma_2=Coadministration	lemma_14=a	lemma_19=dose	relType_7=dep	eib=True	lemma_5=200	relType_8=nmod	lemma_9=for	lemma_17=mg	lemma_3=of	lemma_8=day	relType_1=punct	relType_11=nmod	lemma_15=15	lemma_4=ketoconazole	lemma_20=of
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e0	DDI-DrugBank.d509.s9.e3	null	path2=increase_appos>auc_obj>aripiprazole_nmod	path=<Ketoconazole_ROOT>increase_appos>auc_obj>aripiprazole_nmod	pos_16=HYPH	pos_6=NN	pos_5=CD	lemma_11=day	pos_15=CD	relType_24=case	relType_6=dep	lemma_10=14	pos_2=NNP	relType_9=case	lemma_6=mg	relType_17=compound	lemma_4=(	pos_7=SYM	relType_4=punct	relType_15=nummod	lemma_21=aripiprazole	lemma_22=the	pos_1=:	pos_24=IN	relType_16=punct	lemma_21=increase	lemma_2=Coadministration	lemma_19=dose	lemma_4=ketoconazole	relType_23=obj	lemma_20=of	path1=	lemma_13=with	relType_4=nmod	pos_8=NN	relType_20=case	wib=Coadministration	relType_2=nsubj	relType_12=punct	lib=coadministration	lemma_23=auc	relType_5=nummod	lemma_16=-	pos_22=DT	relType_7=dep	lemma_5=200	relType_11=nmod	lemma_8=day	relType_1=punct	pos_3=IN	relType_21=nmod	lemma_24=of	pos_12=-RRB-	pos_20=IN	pos_23=NN	relType_19=nmod	pos_17=NN	pos_4=-LRB-	pos_13=IN	lemma_1=:	lemma_18=single	relType_13=case	pos_14=DT	relType_22=det	lemma_9=for	lemma_15=15	relType_21=appos	lpib=coadministration_NNP	relType_18=amod	lemma_7=/	pos_9=IN	relation_22=beneficial	pos_11=NNS	relType_14=det	pos_18=JJ	pos_19=NN	pos_4=NN	pos_10=CD	lemma_12=)	relType_3=case	relType_10=nummod	lemma_14=a	eib=True	relType_8=nmod	lemma_17=mg	lemma_3=of	pos_21=VBD	pos_21=NN
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e1	DDI-DrugBank.d509.s9.e2	mechanism	relType_3=dep	relType_4=dep	lemma_9=)	relType_2=nummod	lemma_14=mg	lemma_10=with	pos_15=JJ	relType_15=amod	lemma_11=a	relType_16=nmod	pos_12=CD	relType_13=punct	pos_7=CD	relType_14=compound	lemma_13=-	relType_6=case	pos_8=NNS	pos_13=HYPH	lemma_1=(	pos_17=IN	lemma_6=for	lib=mg	lemma_7=14	eib=False	relType_7=nummod	pos_2=CD	lpib=mg_NN	pos_6=IN	lemma_16=dose	pos_4=SYM	lemma_15=single	pos_14=NN	relType_10=case	relType_17=case	pos_9=-RRB-	lemma_4=/	relType_5=nmod	lemma_17=of	pos_10=IN	lemma_2=200	pos_11=DT	pos_16=NN	relType_9=punct	path1=ketoconazole_nmod	pos_1=-LRB-	relType_11=det	path2=dose_nmod>aripiprazole_nmod	pos_5=NN	lemma_5=day	path=ketoconazole_nmod<Coadministration_nsubj>dose_nmod>aripiprazole_nmod	relType_8=nmod	pos_3=NN	wib=mg	relType_12=nummod	lemma_3=mg	lemma_8=day	relType_1=punct	lemma_12=15
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e1	DDI-DrugBank.d509.s9.e3	null	relType_3=dep	relType_4=dep	lemma_9=)	relType_2=nummod	lemma_14=mg	lemma_10=with	pos_15=JJ	relType_15=amod	lemma_11=a	relType_16=nmod	pos_12=CD	relType_13=punct	pos_7=CD	relType_14=compound	lemma_13=-	relType_6=case	pos_8=NNS	pos_13=HYPH	lemma_20=auc	lemma_1=(	pos_17=IN	lemma_18=aripiprazole	lemma_6=for	relation_18=beneficial	lib=mg	lemma_7=14	relType_7=nummod	lemma_16=dose	pos_2=CD	lpib=mg_NN	pos_6=IN	pos_4=SYM	lemma_18=increase	lemma_15=single	pos_20=NN	pos_21=IN	pos_14=NN	relType_10=case	lemma_19=the	relType_20=obj	relType_17=case	pos_9=-RRB-	pos_18=NN	relType_18=appos	lemma_21=of	lemma_4=/	relType_5=nmod	path1=ketoconazole_nmod<Coadministration_nsubj	pos_19=DT	lemma_17=of	pos_10=IN	lemma_2=200	pos_11=DT	pos_16=NN	relType_9=punct	relType_21=case	pos_1=-LRB-	relType_11=det	pos_5=NN	lemma_5=day	eib=True	relType_8=nmod	path2=auc_obj>aripiprazole_nmod	pos_3=NN	wib=mg	path=ketoconazole_nmod<Coadministration_nsubj<increase_appos>auc_obj>aripiprazole_nmod	lemma_3=mg	relType_12=nummod	lemma_8=day	relType_1=punct	relType_19=det	relType_18=nmod	lemma_12=15	pos_18=VBD
DDI-DrugBank.d509.s9	DDI-DrugBank.d509.s9.e2	DDI-DrugBank.d509.s9.e3	null	pos_2=DT	lemma_2=the	lemma_1=increase	relation_0=beneficial	path=aripiprazole_nmod<dose_nmod<Coadministration_nsubj<increase_appos>auc_obj>aripiprazole_nmod	pos_1=VBD	eib=False	wib=increased	lib=increase	relType_1=appos	pos_4=IN	relType_4=case	path1=aripiprazole_nmod<dose_nmod<Coadministration_nsubj	lpib=increase_VBD	path2=auc_obj>aripiprazole_nmod	pos_3=NN	lemma_3=auc	relType_2=det	relType_3=obj	lemma_4=of
DDI-DrugBank.d509.s11	DDI-DrugBank.d509.s11.e0	DDI-DrugBank.d509.s11.e1	advise	wib=aripiprazole	lib=aripiprazole	lemma_1=with	relType_1=case	lpib=aripiprazole_NN	eib=False	path2=aripiprazole_nmod	path=ketoconazole_nmod<administration_nsubj>aripiprazole_nmod	pos_1=IN	path1=ketoconazole_nmod
DDI-DrugBank.d509.s11	DDI-DrugBank.d509.s11.e0	DDI-DrugBank.d509.s11.e2	null	lemma_2=aripiprazole	relType_1=case	pos_2=NN	relType_2=advcl	lemma_2=occur	lib=aripiprazole	path1=ketoconazole_nmod<administration_nsubj<occur_advcl	relType_2=nmod	pos_1=IN	wib=aripiprazole	lpib=aripiprazole_NN	lemma_3=,	lemma_1=with	pos_2=VBZ	pos_3=,	eib=True	path2=dose_nsubj:pass>aripiprazole_compound	path=ketoconazole_nmod<administration_nsubj<occur_advcl<reduce_ROOT>dose_nsubj:pass>aripiprazole_compound	relType_3=punct
DDI-DrugBank.d509.s11	DDI-DrugBank.d509.s11.e1	DDI-DrugBank.d509.s11.e2	null	wib=occurs	pos_1=VBZ	eib=False	lemma_1=occur	path2=dose_nsubj:pass>aripiprazole_compound	relType_1=advcl	lemma_2=,	pos_2=,	path1=aripiprazole_nmod<administration_nsubj<occur_advcl	lib=occur	lpib=occur_VBZ	path=aripiprazole_nmod<administration_nsubj<occur_advcl<reduce_ROOT>dose_nsubj:pass>aripiprazole_compound	relType_2=punct
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e0	DDI-DrugBank.d509.s15.e1	null	lpib=coadministration_NNP	relType_7=compound	pos_3=IN	lemma_5=10	relType_8=amod	lemma_4=a	pos_7=NN	path1=	lemma_10=of	relType_9=nmod	pos_6=HYPH	pos_8=JJ	pos_5=CD	wib=Coadministration	eib=False	pos_2=NNP	relType_6=punct	lemma_8=single	relType_10=case	path2=Coadministration_dep>dose_nmod>aripiprazole_nmod	pos_9=NN	lib=coadministration	lemma_1=:	lemma_6=-	pos_4=DT	relType_2=dep	lemma_7=mg	relType_5=nummod	pos_1=:	path=<quinidine_nsubj>Coadministration_dep>dose_nmod>aripiprazole_nmod	pos_10=IN	relType_3=case	lemma_2=Coadministration	lemma_3=of	relType_1=punct	relType_4=det	lemma_9=dose
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e0	DDI-DrugBank.d509.s15.e2	null	lpib=coadministration_NNP	relType_7=compound	pos_3=IN	lemma_5=10	relType_8=amod	lemma_4=a	pos_7=NN	path2=Coadministration_dep>dose_nmod>quinidine_nmod	path1=	lemma_10=of	relType_9=nmod	relType_11=case	pos_6=HYPH	lemma_11=with	pos_8=JJ	pos_5=CD	wib=Coadministration	pos_2=NNP	relType_6=punct	lemma_8=single	relType_10=case	pos_9=NN	lib=coadministration	lemma_1=:	lemma_6=-	pos_11=IN	pos_4=DT	relType_2=dep	lemma_7=mg	relType_5=nummod	pos_1=:	pos_10=IN	path=<quinidine_nsubj>Coadministration_dep>dose_nmod>quinidine_nmod	relType_3=case	lemma_2=Coadministration	pos_11=NN	eib=True	lemma_11=aripiprazole	lemma_3=of	relType_11=nmod	relType_1=punct	relType_4=det	lemma_9=dose
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e0	DDI-DrugBank.d509.s15.e3	null	path1=quinidine_nsubj	lemma_5=10	lemma_16=day	relType_16=nmod	lemma_10=of	pos_27=,	pos_6=HYPH	pos_8=JJ	pos_5=CD	relType_4=det	pos_2=NNP	relType_26=nmod	lemma_19=day	pos_26=NN	lemma_17=for	relType_2=dep	lemma_25=of	pos_1=:	lemma_21=,	relType_28=ROOT	lemma_2=Coadministration	lemma_22=a	pos_14=NNS	relType_21=punct	lemma_23=potent	lemma_9=dose	pos_13=CD	pos_15=SYM	lemma_4=a	relType_18=nummod	pos_19=NNS	pos_28=VBD	relType_11=case	pos_30=NN	lemma_11=with	relType_25=case	wib=Coadministration	lemma_8=single	relType_12=nmod	relType_12=punct	pos_9=NN	lib=coadministration	relType_5=nummod	pos_16=NN	pos_22=DT	pos_11=NN	lemma_18=13	lemma_11=aripiprazole	pos_25=IN	relation_29=beneficial	relType_11=nmod	relType_1=punct	pos_7=NN	pos_12=-LRB-	lemma_26=cyp2d6	lemma_12=(	pos_23=JJ	pos_3=IN	relType_30=obj	pos_24=NN	relType_23=amod	lemma_13=166	pos_31=IN	pos_17=IN	relType_19=nmod	pos_20=-RRB-	relType_29=det	relType_13=nummod	relType_15=dep	lemma_28=increase	path=quinidine_nsubj<increase_ROOT>auc_obj>aripiprazole_nmod	lemma_1=:	relType_17=case	lemma_6=-	pos_11=IN	pos_10=IN	lemma_20=)	lemma_31=of	lemma_30=auc	relType_22=det	path2=auc_obj>aripiprazole_nmod	lemma_24=inhibitor	relType_20=punct	relType_27=punct	lpib=coadministration_NNP	relType_7=compound	lemma_14=mg	relType_8=amod	relType_31=case	relType_9=nmod	lemma_29=the	lemma_15=/	pos_21=,	relType_6=punct	relType_10=case	pos_18=CD	pos_4=DT	lemma_7=mg	pos_29=DT	relType_14=dep	lemma_27=,	relType_3=case	relType_24=appos	eib=True	lemma_3=of	pos_12=NN	lemma_12=quinidine
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e0	DDI-DrugBank.d509.s15.e4	null	path1=quinidine_nsubj	pos_34=NN	lemma_5=10	lemma_16=day	relType_16=nmod	relation_38=adverse	lemma_10=of	relType_32=nmod	relType_34=obl	lemma_35=but	pos_27=,	pos_6=HYPH	relType_35=cc	pos_8=JJ	pos_5=CD	relType_4=det	pos_2=NNP	relType_26=nmod	lemma_19=day	pos_26=NN	pos_32=IN	relType_43=punct	lemma_17=for	relType_2=dep	lemma_25=of	pos_1=:	pos_32=NN	lemma_21=,	relType_28=ROOT	relType_41=amod	lemma_2=Coadministration	path2=decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	lemma_22=a	pos_14=NNS	relType_21=punct	lemma_23=potent	relType_32=case	relType_36=conj	lemma_9=dose	pos_13=CD	pos_15=SYM	lemma_4=a	relType_18=nummod	path=quinidine_nsubj<increase_ROOT>decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	pos_19=NNS	pos_28=VBD	relType_11=case	pos_30=NN	lemma_11=with	relType_25=case	lemma_38=auc	wib=Coadministration	pos_41=JJ	lemma_8=single	lemma_39=of	relType_12=nmod	lemma_37=the	relType_12=punct	pos_9=NN	lib=coadministration	pos_33=CD	relType_5=nummod	lemma_42=metabolite	pos_16=NN	pos_22=DT	pos_11=NN	lemma_18=13	pos_42=NN	lemma_11=aripiprazole	pos_25=IN	relation_29=beneficial	relType_11=nmod	relType_1=punct	pos_7=NN	pos_12=-LRB-	lemma_26=cyp2d6	lemma_12=(	pos_23=JJ	pos_3=IN	relType_30=obj	lemma_40=its	pos_24=NN	relType_23=amod	lemma_13=166	lemma_32=aripiprazole	pos_31=IN	pos_17=IN	relType_19=nmod	pos_20=-RRB-	relType_29=det	lemma_34=%	relType_13=nummod	relType_15=dep	lemma_33=112	pos_37=DT	lemma_28=increase	lemma_32=by	lemma_1=:	relType_17=case	lemma_6=-	pos_11=IN	pos_38=NN	pos_10=IN	pos_36=VBD	lemma_20=)	relType_37=det	lemma_31=of	lemma_30=auc	relType_22=det	lemma_36=decrease	lemma_24=inhibitor	relType_20=punct	relType_27=punct	relType_39=case	lemma_43=,	pos_39=IN	lpib=coadministration_NNP	relType_7=compound	lemma_14=mg	relType_8=amod	relType_31=case	relType_9=nmod	pos_43=,	lemma_29=the	lemma_15=/	pos_21=,	relType_33=nummod	pos_40=PRP$	relType_6=punct	relType_42=nmod	relType_10=case	pos_18=CD	pos_4=DT	lemma_7=mg	pos_35=CC	pos_29=DT	relType_14=dep	lemma_27=,	relType_3=case	relType_24=appos	relType_38=obj	eib=True	lemma_3=of	relType_40=nmod:poss	pos_12=NN	lemma_12=quinidine	lemma_41=active
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e1	DDI-DrugBank.d509.s15.e2	mechanism	lemma_1=with	lpib=quinidine_NN	lib=quinidine	relType_1=case	eib=False	path1=aripiprazole_nmod	path2=quinidine_nmod	pos_1=IN	path=aripiprazole_nmod<dose_nmod>quinidine_nmod	wib=quinidine
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e1	DDI-DrugBank.d509.s15.e3	null	relType_4=dep	relType_1=case	relType_8=nummod	pos_2=NN	relType_10=punct	relType_7=case	lemma_11=,	lemma_15=of	lemma_16=cyp2d6	relType_16=nmod	relType_17=punct	relType_19=det	relType_9=nmod	lemma_3=166	relType_12=det	relType_2=punct	lemma_20=auc	pos_6=NN	lpib=quinidine_NN	lib=quinidine	relation_18=beneficial	lemma_14=inhibitor	lemma_17=,	relType_2=nmod	relType_13=amod	relType_11=punct	pos_2=-LRB-	lemma_6=day	pos_9=NNS	lemma_18=increase	relType_18=ROOT	pos_20=NN	pos_1=IN	pos_14=NN	path=aripiprazole_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj<increase_ROOT>auc_obj>aripiprazole_nmod	lemma_19=the	relType_5=dep	relType_20=obj	pos_4=NNS	pos_21=IN	lemma_12=a	relType_6=nmod	pos_17=,	path1=aripiprazole_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj	relType_15=case	pos_13=JJ	pos_3=CD	lemma_4=mg	lemma_21=of	pos_19=DT	relType_14=appos	relType_3=nummod	pos_16=NN	pos_11=,	relType_21=case	wib=quinidine	pos_15=IN	lemma_1=with	lemma_2=quinidine	lemma_13=potent	lemma_9=day	lemma_10=)	eib=True	pos_7=IN	path2=auc_obj>aripiprazole_nmod	pos_10=-RRB-	lemma_5=/	pos_12=DT	pos_8=CD	lemma_2=(	pos_5=SYM	lemma_8=13	lemma_7=for	pos_18=VBD
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e1	DDI-DrugBank.d509.s15.e4	null	pos_2=NN	lemma_27=the	pos_33=,	lemma_22=by	relType_16=nmod	relType_32=nmod	lemma_24=%	pos_6=NN	relation_18=beneficial	pos_20=NN	pos_23=CD	pos_22=IN	relType_5=dep	relType_20=obj	path1=aripiprazole_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj	relType_33=punct	lemma_32=metabolite	pos_32=NN	relType_21=case	pos_28=NN	lemma_10=)	path2=decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	pos_7=IN	relType_31=amod	pos_12=DT	relType_19=det	lemma_2=(	lemma_8=13	lemma_16=cyp2d6	lemma_7=for	relType_22=nmod	relType_1=case	pos_31=JJ	lemma_15=of	relType_7=case	pos_22=NN	pos_29=IN	relType_2=punct	relType_13=amod	pos_2=-LRB-	lemma_33=,	relType_18=ROOT	pos_1=IN	relType_22=case	lemma_12=a	relType_15=case	pos_16=NN	pos_15=IN	lemma_22=aripiprazole	relType_28=obj	pos_26=VBD	pos_8=CD	relation_27=adverse	lemma_21=of	pos_19=DT	relType_4=dep	relType_10=punct	lemma_11=,	relType_24=obl	relType_29=case	relType_17=punct	pos_24=NN	lemma_3=166	relType_12=det	relType_2=nmod	relType_11=punct	lemma_6=day	pos_21=IN	lemma_26=decrease	pos_14=NN	pos_17=,	path=aripiprazole_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj<increase_ROOT>decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	pos_25=CC	pos_13=JJ	relType_30=nmod:poss	lemma_2=quinidine	lemma_13=potent	lemma_5=/	lemma_20=auc	relType_6=nmod	pos_5=SYM	lemma_31=active	relType_23=nummod	relType_8=nummod	lemma_29=of	relType_9=nmod	lemma_28=auc	lemma_23=112	lpib=quinidine_NN	lib=quinidine	pos_27=DT	lemma_14=inhibitor	relType_27=det	lemma_17=,	lemma_25=but	relType_26=conj	pos_9=NNS	lemma_18=increase	lemma_19=the	pos_4=NNS	relType_25=cc	pos_3=CD	lemma_4=mg	relType_14=appos	relType_3=nummod	lemma_30=its	pos_11=,	wib=quinidine	lemma_1=with	lemma_9=day	eib=True	pos_10=-RRB-	pos_30=PRP$	pos_18=VBD
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e2	DDI-DrugBank.d509.s15.e3	null	relType_3=dep	relType_4=dep	path1=quinidine_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj	lemma_9=)	relType_2=nummod	relType_10=punct	lemma_11=a	lemma_10=,	lemma_13=inhibitor	pos_17=VBD	pos_7=CD	lemma_19=auc	lemma_15=cyp2d6	relType_6=case	relType_17=ROOT	pos_8=NNS	pos_20=IN	lemma_1=(	pos_12=JJ	pos_18=DT	relType_20=case	lemma_6=for	pos_3=NNS	lib=mg	lemma_7=13	eib=False	relType_7=nummod	pos_2=CD	pos_6=IN	relation_16=beneficial	relType_13=appos	pos_4=SYM	lemma_20=of	pos_16=,	relType_12=amod	pos_19=NN	path=quinidine_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj<increase_ROOT>auc_obj>aripiprazole_nmod	pos_13=NN	lemma_16=,	lpib=mg_NNS	pos_9=-RRB-	pos_14=IN	pos_15=NN	lemma_12=potent	lemma_4=/	relType_5=nmod	pos_11=DT	relType_9=punct	relType_16=punct	relType_15=nmod	pos_1=-LRB-	relType_11=det	lemma_2=166	pos_5=NN	lemma_5=day	pos_10=,	relType_8=nmod	path2=auc_obj>aripiprazole_nmod	lemma_14=of	wib=mg	relType_18=det	lemma_3=mg	relType_14=case	lemma_8=day	relType_1=punct	relType_19=obj	lemma_18=the	lemma_17=increase
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e2	DDI-DrugBank.d509.s15.e4	null	lemma_9=)	lemma_10=,	lemma_13=inhibitor	relType_32=punct	pos_25=VBD	lemma_15=cyp2d6	pos_8=NNS	pos_3=NNS	lib=mg	lemma_27=auc	relType_27=obj	pos_4=SYM	pos_13=NN	lemma_16=,	relType_30=amod	lemma_24=but	lemma_21=aripiprazole	relType_16=punct	relType_21=case	pos_1=-LRB-	relType_11=det	lemma_5=day	pos_10=,	path2=decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	lemma_14=of	lemma_20=of	lemma_17=increase	relType_3=dep	relType_25=conj	path1=quinidine_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj	relType_2=nummod	pos_17=VBD	relType_6=case	pos_18=DT	relType_20=case	pos_24=CC	relation_16=beneficial	relType_22=nummod	pos_6=IN	relType_13=appos	relType_12=amod	relType_23=obl	pos_14=IN	pos_27=NN	pos_32=,	lemma_30=active	relType_15=nmod	lemma_23=%	pos_5=NN	pos_31=NN	relation_25=adverse	relType_18=det	lemma_8=day	relType_1=punct	lemma_18=the	relType_4=dep	relType_10=punct	lemma_28=of	lemma_22=112	relType_21=nmod	pos_20=IN	lemma_1=(	pos_23=NN	lemma_6=for	relType_7=nummod	pos_30=JJ	pos_21=IN	pos_26=DT	lemma_4=/	lemma_21=by	lemma_2=166	relType_28=case	relType_14=case	relType_19=obj	relType_29=nmod:poss	lemma_11=a	pos_7=CD	lemma_19=auc	relType_17=ROOT	pos_29=PRP$	pos_12=JJ	pos_22=CD	lemma_7=13	pos_2=CD	pos_16=,	relType_31=nmod	pos_19=NN	relType_24=cc	path=quinidine_nmod<dose_nmod<Coadministration_dep<quinidine_nsubj<increase_ROOT>decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	lpib=mg_NNS	pos_9=-RRB-	pos_15=NN	lemma_12=potent	lemma_32=,	relType_5=nmod	pos_11=DT	lemma_29=its	relType_9=punct	eib=True	relType_8=nmod	relType_26=det	pos_28=IN	wib=mg	lemma_31=metabolite	lemma_3=mg	lemma_25=decrease	lemma_26=the	pos_21=NN
DDI-DrugBank.d509.s15	DDI-DrugBank.d509.s15.e3	DDI-DrugBank.d509.s15.e4	null	relType_8=case	relType_9=nmod:poss	wib=%	relType_1=case	relType_2=nummod	pos_6=DT	relation_4=adverse	path1=aripiprazole_nmod<auc_obj	lib=%	relType_10=amod	relType_4=cc	lemma_9=its	lemma_12=,	lemma_10=active	lpib=%_NN	eib=False	pos_2=CD	lemma_6=the	relType_7=obj	pos_12=,	pos_1=IN	relType_12=punct	pos_8=IN	lemma_7=auc	path=aripiprazole_nmod<auc_obj<increase_ROOT>decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	lemma_3=%	pos_10=JJ	lemma_11=metabolite	pos_9=PRP$	relType_5=conj	pos_5=VBD	relType_6=det	lemma_2=112	relType_3=obl	pos_11=NN	path2=decrease_conj>auc_obj>metabolite_nmod>dehydroaripiprazole_appos	pos_4=CC	lemma_5=decrease	pos_3=NN	lemma_4=but	relType_11=nmod	pos_7=NN	lemma_8=of	lemma_1=by
DDI-DrugBank.d509.s16	DDI-DrugBank.d509.s16.e0	DDI-DrugBank.d509.s16.e1	null	relType_14=amod	lemma_14=concomitant	path1=aripiprazole_amod<dose_nsubj:pass	path=aripiprazole_amod<dose_nsubj:pass<reduce_ROOT>occur_advcl>administration_nsubj>quinidine_nmod	pos_16=IN	relType_15=nsubj	pos_2=MD	pos_6=CD	pos_9=IN	lemma_4=reduce	pos_3=VB	pos_13=WRB	relType_3=aux:pass	relType_5=case	relType_8=obl	relType_10=nmod:poss	pos_8=NN	lemma_7=-	lemma_15=administration	path2=occur_advcl>administration_nsubj>quinidine_nmod	eib=False	relType_11=amod	relType_12=nmod	lpib=dose_NN	relType_2=aux	relType_9=case	lemma_6=one	lemma_16=of	pos_1=NN	pos_4=VBN	wib=dose	lemma_8=half	relType_13=advmod	pos_15=NN	pos_7=HYPH	lemma_2=should	lemma_12=dose	relation_3=adverse	lemma_3=be	relType_6=nummod	pos_5=IN	lemma_5=to	lib=dose	lemma_11=normal	relType_4=ROOT	lemma_10=its	relType_16=case	lemma_9=of	relType_7=punct	lemma_13=when	pos_10=PRP$	relType_1=nsubj:pass	pos_11=JJ	pos_14=JJ	pos_12=NN	lemma_1=dose
DDI-DrugBank.d509.s16	DDI-DrugBank.d509.s16.e0	DDI-DrugBank.d509.s16.e2	null	relType_14=amod	lemma_14=concomitant	path1=aripiprazole_amod<dose_nsubj:pass	pos_16=IN	relType_15=nsubj	pos_2=MD	path2=occur_advcl>administration_nsubj>aripiprazole_nmod	pos_6=CD	pos_9=IN	lemma_4=reduce	lemma_17=quinidine	pos_3=VB	pos_13=WRB	relType_3=aux:pass	relType_5=case	path=aripiprazole_amod<dose_nsubj:pass<reduce_ROOT>occur_advcl>administration_nsubj>aripiprazole_nmod	relType_8=obl	relType_10=nmod:poss	pos_8=NN	lemma_7=-	lemma_15=administration	pos_17=NN	pos_17=IN	lemma_17=with	relType_11=amod	relType_12=nmod	lpib=dose_NN	relType_2=aux	relType_9=case	lemma_6=one	lemma_16=of	pos_1=NN	relType_17=case	pos_4=VBN	wib=dose	lemma_8=half	relType_13=advmod	pos_15=NN	pos_7=HYPH	lemma_2=should	lemma_12=dose	relation_3=adverse	lemma_3=be	relType_6=nummod	pos_5=IN	lemma_5=to	lib=dose	relType_17=nmod	lemma_11=normal	relType_4=ROOT	lemma_10=its	relType_16=case	eib=True	lemma_9=of	relType_7=punct	lemma_13=when	pos_10=PRP$	relType_1=nsubj:pass	pos_11=JJ	pos_14=JJ	pos_12=NN	lemma_1=dose
DDI-DrugBank.d509.s16	DDI-DrugBank.d509.s16.e1	DDI-DrugBank.d509.s16.e2	advise	wib=aripiprazole	lib=aripiprazole	lemma_1=with	relType_1=case	lpib=aripiprazole_NN	eib=False	path2=aripiprazole_nmod	path=quinidine_nmod<administration_nsubj>aripiprazole_nmod	path1=quinidine_nmod	pos_1=IN
DDI-DrugBank.d509.s17	DDI-DrugBank.d509.s17.e0	DDI-DrugBank.d509.s17.e1	null	path2=paroxetine_conj	relType_1=cc	pos_1=CC	eib=False	path1=	path=<fluoxetine_nmod>paroxetine_conj	lib=paroxetine	lpib=paroxetine_NN	wib=paroxetine	lemma_1=or
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e0	DDI-DrugBank.d509.s19.e1	null	lpib=coadministration_NNP	lemma_2=Coadministration	relType_2=dep	path=<carbamazepine_nsubj>Coadministration_dep>carbamazepine_nmod	pos_3=IN	wib=Coadministration	eib=False	path2=Coadministration_dep>carbamazepine_nmod	pos_2=NNP	path1=	pos_1=:	lemma_3=of	relType_1=punct	lib=coadministration	relType_3=case	lemma_1=:
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e0	DDI-DrugBank.d509.s19.e2	null	lpib=coadministration_NNP	lemma_4=carbamazepine	relType_14=punct	pos_3=IN	relType_7=appos	path2=aripiprazole_nmod	relType_10=det	path1=	lemma_12=cyp3a4	lemma_10=a	relType_4=nmod	relType_8=punct	lemma_9=,	pos_5=CD	lemma_13=inducer	lemma_15=with	wib=Coadministration	pos_2=NNP	pos_4=-LRB-	relType_12=compound	pos_14=,	relType_11=amod	relType_13=appos	pos_8=-RRB-	lemma_6=mg	path=<carbamazepine_nsubj>aripiprazole_nmod	pos_13=NN	pos_4=NN	lib=coadministration	lemma_1=:	lemma_4=(	lemma_8=)	relType_2=dep	relType_15=case	relType_4=punct	relType_5=nummod	pos_7=NNP	pos_1=:	relType_9=punct	relType_3=case	pos_15=IN	relType_6=compound	lemma_2=Coadministration	lemma_11=potent	lemma_14=,	eib=True	lemma_5=200	lemma_7=BID	pos_6=NNS	pos_11=JJ	lemma_3=of	pos_9=,	relType_1=punct	pos_12=NN	pos_10=DT
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e0	DDI-DrugBank.d509.s19.e3	null	relType_16=nmod	lemma_12=cyp3a4	relType_8=punct	lemma_9=,	lemma_32=value	lemma_16=aripiprazole	pos_5=CD	lemma_13=inducer	pos_2=NNP	relType_12=compound	relType_30=cc	relType_23=det	lemma_25=70	lemma_28=in	pos_26=NN	lemma_6=mg	pos_13=NN	pos_22=IN	lemma_4=(	pos_18=NN	relType_25=nummod	relType_2=dep	relType_4=punct	lemma_23=a	relType_27=obl	lemma_29=cmax	pos_1=:	lemma_19=qd	relType_21=ROOT	relType_16=punct	pos_17=CD	path=carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod	relType_6=compound	lemma_2=Coadministration	lemma_11=potent	relType_32=conj	pos_6=NNS	pos_11=JJ	lemma_17=30	lemma_16=(	pos_32=NNS	lemma_4=carbamazepine	pos_16=-LRB-	relType_4=nmod	pos_30=CC	relType_34=cc:preconj	wib=Coadministration	pos_25=CD	relType_11=amod	relType_13=appos	pos_29=NN	relType_22=case	lib=coadministration	lemma_26=%	relType_15=case	pos_27=NN	lemma_27=decrease	lemma_33=of	relType_5=nummod	relType_29=nmod	pos_16=NN	relation_28=adverse	pos_15=IN	relType_24=amod	lemma_14=,	pos_31=NN	lemma_5=200	lemma_24=approximate	pos_9=,	relType_1=punct	lemma_22=in	relType_14=punct	pos_3=IN	relType_7=appos	relType_10=det	lemma_21=result	pos_24=JJ	relType_31=compound	path2=decrease_obl>cmax_nmod>aripiprazole_nmod	pos_20=-RRB-	lemma_15=with	pos_4=-LRB-	pos_14=,	relType_26=compound	relType_19=appos	lemma_1=:	lemma_8=)	pos_33=IN	lemma_34=both	pos_34=DT	lemma_18=mg	lemma_20=)	relType_28=case	relType_20=punct	pos_10=DT	lpib=coadministration_NNP	relType_33=case	lemma_31=auc	lemma_10=a	path1=carbamazepine_nsubj	relType_17=nummod	pos_19=NN	pos_8=-RRB-	pos_4=NN	pos_7=NNP	pos_23=DT	relType_9=punct	relType_3=case	eib=True	pos_28=IN	lemma_7=BID	relType_18=compound	lemma_3=of	lemma_30=and	pos_12=NN	pos_21=VBD
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e0	DDI-DrugBank.d509.s19.e4	null	relType_16=nmod	lemma_12=cyp3a4	relType_8=punct	pos_39=,	lemma_9=,	pos_35=NN	relType_36=nmod:poss	lemma_32=value	relType_35=cc	relType_38=conj	lemma_16=aripiprazole	pos_5=CD	lemma_35=and	lemma_13=inducer	pos_2=NNP	relType_12=compound	relType_30=cc	relType_23=det	lemma_25=70	lemma_28=in	pos_26=NN	lemma_6=mg	pos_13=NN	pos_22=IN	relType_37=amod	lemma_4=(	pos_18=NN	relType_25=nummod	relType_2=dep	relType_4=punct	lemma_23=a	relType_27=obl	lemma_29=cmax	pos_1=:	pos_40=HYPH	lemma_19=qd	relType_16=punct	pos_17=CD	relType_21=ROOT	relType_6=compound	lemma_2=Coadministration	lemma_11=potent	relType_32=conj	pos_6=NNS	pos_11=JJ	lemma_17=30	lemma_16=(	pos_32=NNS	lemma_4=carbamazepine	pos_16=-LRB-	pos_37=JJ	relType_40=compound	relType_4=nmod	relType_39=punct	pos_30=CC	relType_34=cc:preconj	wib=Coadministration	pos_25=CD	relType_11=amod	relType_13=appos	pos_29=NN	relType_22=case	lib=coadministration	lemma_26=%	relType_15=case	pos_27=NN	lemma_27=decrease	lemma_33=of	relType_5=nummod	relType_29=nmod	pos_16=NN	relation_28=adverse	pos_15=IN	relType_24=amod	lemma_14=,	pos_31=NN	lemma_5=200	lemma_40=-	lemma_24=approximate	pos_40=NN	pos_9=,	relType_1=punct	lemma_22=in	relType_14=punct	pos_3=IN	relType_7=appos	relType_10=det	path2=decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	lemma_21=result	pos_24=JJ	relType_31=compound	pos_20=-RRB-	relType_40=punct	lemma_15=with	pos_4=-LRB-	pos_14=,	lemma_35=aripiprazole	relType_26=compound	lemma_38=metabolite	relType_19=appos	lemma_40=dehydro	lemma_1=:	lemma_8=)	pos_33=IN	pos_38=NN	lemma_34=both	pos_34=DT	lemma_18=mg	lemma_20=)	lemma_36=its	relType_35=nmod	relType_28=case	relType_20=punct	path=carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	lemma_37=active	pos_10=DT	lpib=coadministration_NNP	relType_33=case	lemma_31=auc	lemma_10=a	pos_36=PRP$	lemma_39=,	path1=carbamazepine_nsubj	relType_17=nummod	pos_19=NN	pos_8=-RRB-	pos_4=NN	pos_35=CC	pos_7=NNP	pos_23=DT	relType_9=punct	relType_3=case	eib=True	pos_28=IN	lemma_7=BID	relType_18=compound	lemma_3=of	lemma_30=and	pos_12=NN	pos_21=VBD
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e1	DDI-DrugBank.d509.s19.e2	mechanism	relType_2=nummod	relType_7=det	path1=carbamazepine_nmod<Coadministration_dep	path2=aripiprazole_nmod	relType_8=amod	relType_4=appos	lemma_11=,	relType_12=case	lemma_6=,	lemma_1=(	pos_8=JJ	pos_3=NNS	lib=mg	lemma_9=cyp3a4	eib=False	relType_9=compound	pos_2=CD	relType_6=punct	relType_10=appos	relType_11=punct	lemma_8=potent	pos_10=NN	pos_9=NN	lemma_12=with	pos_7=DT	pos_12=IN	lpib=mg_NNS	lemma_5=)	lemma_10=inducer	pos_5=-RRB-	relType_5=punct	lemma_2=200	pos_11=,	pos_1=-LRB-	pos_6=,	lemma_4=BID	pos_4=NNP	path=carbamazepine_nmod<Coadministration_dep<carbamazepine_nsubj>aripiprazole_nmod	wib=mg	lemma_7=a	relType_3=compound	lemma_3=mg	relType_1=punct
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e1	DDI-DrugBank.d509.s19.e3	null	relType_27=cc	lemma_21=approximate	lemma_6=,	pos_29=NNS	pos_8=JJ	pos_3=NNS	lib=mg	lemma_9=cyp3a4	lemma_26=cmax	pos_31=DT	relType_26=nmod	pos_26=NN	pos_10=NN	pos_13=NN	relType_23=compound	relType_29=conj	pos_5=-RRB-	lemma_30=of	pos_1=-LRB-	lemma_20=a	relType_15=compound	pos_28=NN	relType_31=cc:preconj	lemma_4=BID	pos_14=CD	pos_30=IN	relType_2=nummod	lemma_24=decrease	pos_21=JJ	relation_24=adverse	relType_25=case	lemma_19=in	relType_22=nummod	relType_10=appos	relType_18=ROOT	path=carbamazepine_nmod<Coadministration_dep<carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod	pos_9=NN	pos_12=IN	lemma_5=)	lemma_13=(	pos_16=NN	lemma_23=%	lemma_15=mg	relType_19=case	pos_4=NNP	pos_25=IN	lemma_7=a	relType_3=compound	relType_1=punct	lemma_27=and	lemma_14=30	relType_7=det	lemma_11=,	relType_24=obl	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	lemma_1=(	path2=decrease_obl>cmax_nmod>aripiprazole_nmod	pos_23=NN	path1=carbamazepine_nmod<Coadministration_dep<carbamazepine_nsubj	relType_11=punct	lemma_16=qd	lemma_8=potent	pos_7=DT	lemma_22=70	lemma_18=result	relType_14=nummod	pos_27=CC	relType_20=det	lemma_29=value	relType_16=appos	relType_30=case	pos_19=IN	relType_8=amod	lemma_31=both	relType_13=punct	lemma_13=aripiprazole	pos_20=DT	lemma_28=auc	relType_13=nmod	pos_22=CD	relType_9=compound	pos_2=CD	relType_6=punct	relType_21=amod	lemma_12=with	lpib=mg_NNS	relType_28=compound	lemma_10=inducer	pos_15=NN	relType_5=punct	lemma_2=200	pos_11=,	pos_13=-LRB-	pos_6=,	lemma_17=)	eib=True	wib=mg	pos_17=-RRB-	lemma_3=mg	lemma_25=in	pos_18=VBD
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e1	DDI-DrugBank.d509.s19.e4	null	relType_27=cc	lemma_34=active	lemma_21=approximate	lemma_6=,	relType_32=nmod	pos_35=NN	pos_29=NNS	pos_32=CC	pos_8=JJ	pos_3=NNS	lib=mg	lemma_9=cyp3a4	lemma_26=cmax	pos_31=DT	relType_26=nmod	pos_26=NN	pos_10=NN	pos_13=NN	relType_23=compound	relType_29=conj	pos_5=-RRB-	pos_32=NN	lemma_30=of	pos_1=-LRB-	lemma_20=a	relType_15=compound	pos_28=NN	relType_31=cc:preconj	relType_33=nmod:poss	lemma_37=dehydro	lemma_4=BID	relType_36=punct	pos_14=CD	pos_30=IN	relType_37=punct	relType_2=nummod	lemma_24=decrease	pos_21=JJ	lemma_33=its	path=carbamazepine_nmod<Coadministration_dep<carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	relation_24=adverse	relType_25=case	lemma_19=in	relType_22=nummod	relType_10=appos	relType_18=ROOT	relType_37=compound	relType_35=conj	pos_9=NN	pos_12=IN	lemma_5=)	lemma_32=and	pos_37=NN	lemma_13=(	pos_16=NN	lemma_23=%	lemma_15=mg	lemma_37=-	relType_19=case	pos_4=NNP	pos_25=IN	lemma_7=a	relType_3=compound	pos_33=PRP$	relType_1=punct	lemma_27=and	lemma_14=30	relType_7=det	lemma_11=,	path2=decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	relType_24=obl	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	lemma_32=aripiprazole	lemma_1=(	pos_23=NN	path1=carbamazepine_nmod<Coadministration_dep<carbamazepine_nsubj	relType_11=punct	lemma_16=qd	lemma_8=potent	relType_32=cc	pos_7=DT	lemma_22=70	pos_34=JJ	lemma_18=result	relType_14=nummod	pos_36=,	relType_34=amod	pos_27=CC	relType_20=det	lemma_29=value	relType_16=appos	relType_30=case	pos_19=IN	relType_8=amod	lemma_31=both	relType_13=punct	lemma_13=aripiprazole	pos_20=DT	lemma_28=auc	relType_13=nmod	pos_37=HYPH	pos_22=CD	relType_9=compound	pos_2=CD	relType_6=punct	relType_21=amod	lemma_12=with	lpib=mg_NNS	lemma_35=metabolite	relType_28=compound	lemma_10=inducer	pos_15=NN	relType_5=punct	lemma_2=200	pos_11=,	pos_13=-LRB-	pos_6=,	lemma_17=)	eib=True	wib=mg	pos_17=-RRB-	lemma_3=mg	lemma_36=,	lemma_25=in	pos_18=VBD
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e2	DDI-DrugBank.d509.s19.e3	null	relType_12=obl	relType_2=nummod	pos_8=DT	relType_7=case	lemma_17=value	relType_4=appos	lemma_2=30	relType_16=compound	relType_14=nmod	pos_6=VBD	relType_18=case	relType_17=conj	lemma_1=(	path2=decrease_obl>cmax_nmod>aripiprazole_nmod	pos_9=JJ	relation_11=adverse	lib=mg	eib=False	pos_2=CD	lpib=mg_NN	lemma_16=auc	lemma_4=qd	path1=aripiprazole_nmod<carbamazepine_nsubj	lemma_8=a	relType_9=amod	pos_13=IN	pos_14=NN	lemma_18=of	pos_4=NN	lemma_11=%	pos_18=IN	lemma_5=)	relType_19=cc:preconj	path=aripiprazole_nmod<carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod	relType_13=case	relType_6=ROOT	pos_5=-RRB-	pos_10=CD	lemma_14=cmax	relType_5=punct	relType_15=cc	pos_16=NN	lemma_13=in	relType_10=nummod	pos_1=-LRB-	lemma_6=result	lemma_15=and	lemma_12=decrease	pos_11=NN	lemma_19=both	pos_17=NNS	pos_7=IN	lemma_7=in	pos_3=NN	lemma_9=approximate	lemma_10=70	relType_11=compound	wib=mg	pos_15=CC	relType_3=compound	lemma_3=mg	relType_8=det	relType_1=punct	pos_12=NN	pos_19=DT
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e2	DDI-DrugBank.d509.s19.e4	null	lemma_17=value	pos_24=,	lemma_2=30	pos_6=VBD	lemma_24=,	relType_18=case	lib=mg	lemma_25=dehydro	relType_20=nmod	pos_20=NN	lemma_18=of	relType_6=ROOT	pos_5=-RRB-	lemma_14=cmax	lemma_15=and	pos_1=-LRB-	lemma_6=result	lemma_12=decrease	pos_7=IN	lemma_7=in	pos_15=CC	pos_21=PRP$	relType_14=nmod	relType_2=nummod	pos_8=DT	relType_7=case	lemma_16=auc	path1=aripiprazole_nmod<carbamazepine_nsubj	path=aripiprazole_nmod<carbamazepine_nsubj<result_ROOT>decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	relType_23=conj	lemma_5=)	relType_21=nmod:poss	pos_16=NN	lemma_13=in	lemma_20=and	pos_11=NN	lemma_10=70	lemma_20=aripiprazole	relType_25=punct	relType_3=compound	relType_1=punct	pos_19=DT	path2=decrease_obl>cmax_nmod>aripiprazole_nmod>metabolite_conj>aripiprazole_appos	relType_4=appos	relType_20=cc	relType_24=punct	lemma_1=(	lemma_22=active	pos_23=NN	lemma_23=metabolite	relation_11=adverse	lpib=mg_NN	lemma_25=-	relType_9=amod	pos_13=IN	pos_14=NN	pos_18=IN	relType_25=compound	relType_13=case	pos_25=NN	pos_22=JJ	pos_25=HYPH	lemma_19=both	relType_22=amod	lemma_21=its	pos_17=NNS	lemma_9=approximate	pos_20=CC	relType_8=det	relType_12=obl	relType_16=compound	relType_17=conj	pos_9=JJ	pos_2=CD	lemma_4=qd	lemma_8=a	relType_19=cc:preconj	pos_4=NN	lemma_11=%	pos_10=CD	relType_5=punct	relType_15=cc	relType_10=nummod	eib=True	relType_11=compound	pos_3=NN	wib=mg	lemma_3=mg	pos_12=NN
DDI-DrugBank.d509.s19	DDI-DrugBank.d509.s19.e3	DDI-DrugBank.d509.s19.e4	null	relType_1=cc	pos_1=CC	lib=active	pos_5=,	path1=	pos_6=HYPH	pos_6=NN	lemma_6=dehydro	relType_6=punct	pos_4=NN	path2=metabolite_conj>aripiprazole_appos	path=<aripiprazole_nmod>metabolite_conj>aripiprazole_appos	lemma_6=-	lemma_3=active	relType_3=amod	lemma_5=,	relType_5=punct	pos_2=PRP$	lemma_2=its	lemma_4=metabolite	relType_6=compound	relType_2=nmod:poss	pos_3=JJ	eib=True	relType_4=conj	wib=active	lpib=active_JJ	lemma_1=and
DDI-DrugBank.d509.s20	DDI-DrugBank.d509.s20.e0	DDI-DrugBank.d509.s20.e1	advise	lemma_2=add	path=carbamazepine_nsubj:pass<add_advcl>therapy_obl>aripiprazole_compound	pos_2=VBN	path1=carbamazepine_nsubj:pass	lib=be	pos_1=VBZ	eib=False	pos_3=IN	relType_1=aux:pass	lemma_1=be	lemma_3=to	lpib=be_VBZ	relType_2=advcl	path2=therapy_obl>aripiprazole_compound	relType_3=case	wib=is
DDI-DrugBank.d509.s20	DDI-DrugBank.d509.s20.e0	DDI-DrugBank.d509.s20.e2	null	pos_2=VBN	pos_3=IN	path1=carbamazepine_nsubj:pass<add_advcl	lemma_4=therapy	pos_5=,	relType_1=aux:pass	relType_2=advcl	lemma_1=be	pos_4=NN	lemma_2=add	relType_4=obl	lib=be	lemma_5=,	path=carbamazepine_nsubj:pass<add_advcl<double_ROOT>dose_nsubj:pass>aripiprazole_compound	relType_5=punct	relType_4=compound	lemma_3=to	relType_3=case	wib=is	lemma_4=aripiprazole	pos_1=VBZ	eib=True	path2=dose_nsubj:pass>aripiprazole_compound	lpib=be_VBZ
DDI-DrugBank.d509.s20	DDI-DrugBank.d509.s20.e1	DDI-DrugBank.d509.s20.e2	null	path=aripiprazole_compound<therapy_obl<add_advcl<double_ROOT>dose_nsubj:pass>aripiprazole_compound	eib=False	path1=aripiprazole_compound<therapy_obl<add_advcl	path2=dose_nsubj:pass>aripiprazole_compound	lemma_2=,	pos_2=,	lib=therapy	lpib=therapy_NN	lemma_1=therapy	wib=therapy	pos_1=NN	relType_1=obl	relType_2=punct
DDI-DrugBank.d509.s22	DDI-DrugBank.d509.s22.e0	DDI-DrugBank.d509.s22.e1	advise	pos_2=VBN	pos_3=IN	lemma_3=from	relType_1=aux:pass	lemma_2=withdraw	relType_5=compound	relType_2=advcl	path1=carbamazepine_nsubj:pass<withdraw_advcl	pos_6=NN	relType_6=obl	lemma_5=combination	eib=False	lemma_1=be	pos_7=,	lemma_7=,	pos_4=DT	lib=be	lemma_4=the	path=carbamazepine_nsubj:pass<withdraw_advcl<reduce_ROOT>dose_nsubj:pass>aripiprazole_compound	relType_3=case	wib=is	pos_5=NN	lemma_6=therapy	pos_1=VBZ	path2=dose_nsubj:pass>aripiprazole_compound	relType_7=punct	lpib=be_VBZ	relType_4=det
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e0	DDI-DrugBank.d509.s23.e1	null	path=<famotidine_nmod>valproate_conj	lemma_1=,	eib=False	path2=valproate_conj	path1=	pos_1=,	wib=valproate	relType_1=punct	lpib=valproate_NN	lib=valproate
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e0	DDI-DrugBank.d509.s23.e2	null	lemma_1=,	path=<famotidine_nmod>lithium_conj	pos_2=NN	pos_3=CC	path1=	pos_1=,	wib=valproate	path2=lithium_conj	lib=valproate	relType_3=cc	relType_2=punct	lemma_3=or	relType_2=conj	lemma_2=,	lpib=valproate_NN	eib=True	lemma_2=valproate	pos_2=,	relType_1=punct
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e0	DDI-DrugBank.d509.s23.e3	null	lemma_1=,	pos_2=NN	relType_7=det	pos_3=CC	lemma_4=be	pos_1=,	wib=valproate	lemma_6=on	pos_9=IN	relType_6=case	lib=valproate	pos_8=NNS	relType_3=cc	relType_2=punct	relType_8=obl	pos_6=IN	lemma_5=see	lemma_3=or	relType_9=case	relType_2=conj	pos_4=NN	lemma_2=,	pos_7=DT	path2=pharmacokinetic_obl>aripiprazole_nmod	relType_4=aux:pass	path1=famotidine_nmod<effect_nsubj:pass	lpib=valproate_NN	pos_4=VBD	path=famotidine_nmod<effect_nsubj:pass<see_ROOT>pharmacokinetic_obl>aripiprazole_nmod	eib=True	lemma_9=of	lemma_2=valproate	pos_2=,	relType_4=conj	lemma_7=the	lemma_8=pharmacokinetic	relType_1=punct	relType_5=ROOT	pos_5=VBN	lemma_4=lithium
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e1	DDI-DrugBank.d509.s23.e2	null	wib=lithium	lemma_2=or	lemma_1=,	lpib=lithium_NN	eib=False	pos_2=CC	pos_1=,	path1=valproate_conj	relType_1=punct	relType_2=cc	path=valproate_conj<famotidine_nmod>lithium_conj	path2=lithium_conj	lib=lithium
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e1	DDI-DrugBank.d509.s23.e3	null	pos_7=NNS	relType_8=case	wib=lithium	lemma_2=or	lemma_1=,	pos_6=DT	pos_1=,	lemma_4=see	relType_2=cc	relType_3=aux:pass	relType_5=case	lib=lithium	lpib=lithium_NN	path1=valproate_conj<famotidine_nmod<effect_nsubj:pass	lemma_6=the	path=valproate_conj<famotidine_nmod<effect_nsubj:pass<see_ROOT>pharmacokinetic_obl>aripiprazole_nmod	pos_3=VBD	lemma_7=pharmacokinetic	pos_8=IN	pos_4=VBN	relType_3=conj	lemma_3=be	path2=pharmacokinetic_obl>aripiprazole_nmod	pos_5=IN	relType_4=ROOT	lemma_3=lithium	relType_6=det	relType_7=obl	eib=True	lemma_5=on	pos_3=NN	pos_2=CC	relType_1=punct	lemma_8=of
DDI-DrugBank.d509.s23	DDI-DrugBank.d509.s23.e2	DDI-DrugBank.d509.s23.e3	null	pos_2=VBN	pos_3=IN	path1=lithium_conj<famotidine_nmod<effect_nsubj:pass	relType_1=aux:pass	lemma_6=of	relType_6=case	pos_1=VBD	eib=False	lpib=be_VBD	pos_5=NNS	pos_6=IN	lemma_1=be	lemma_3=on	path=lithium_conj<famotidine_nmod<effect_nsubj:pass<see_ROOT>pharmacokinetic_obl>aripiprazole_nmod	pos_4=DT	lib=be	relType_2=ROOT	lemma_4=the	path2=pharmacokinetic_obl>aripiprazole_nmod	relType_5=obl	lemma_2=see	wib=was	relType_3=case	lemma_5=pharmacokinetic	relType_4=det
DDI-DrugBank.d509.s24	DDI-DrugBank.d509.s24.e0	DDI-DrugBank.d509.s24.e1	null	wib=Affect	relType_1=case	lemma_2=Affect	lib=affect	lemma_3=other	path1=abilify_obl	pos_2=NNP	eib=False	pos_1=IN	pos_4=NNS	lemma_4=drug	relType_4=obl	relType_3=amod	relType_2=compound	lemma_1=to	path2=unlikely_dep>Aripiprazole_nsubj	pos_3=JJ	lpib=affect_NNP	path=abilify_obl<potential_ROOT>unlikely_dep>Aripiprazole_nsubj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e0	DDI-DrugBank.d509.s25.e1	null	pos_2=DT	relType_7=case	lemma_8=cyp2d6	relType_5=case	relType_8=obl	pos_6=NN	lemma_2=no	lpib=have_VBD	pos_8=NN	pos_1=VBD	eib=False	lemma_9=(	lemma_1=have	lemma_3=significant	pos_4=NN	lib=have	relType_4=obj	wib=had	lemma_7=by	relation_3=neutral	relType_3=amod	path1=aripiprazole_nmod<dose_nsubj	pos_5=IN	pos_9=-LRB-	relType_9=punct	relType_1=ROOT	lemma_4=effect	pos_3=JJ	path2=cyp2d6_obl>dextromethorphan_dep	lemma_5=on	pos_7=IN	lemma_6=metabolism	relType_2=det	relType_6=nmod	path=aripiprazole_nmod<dose_nsubj<have_ROOT>cyp2d6_obl>dextromethorphan_dep
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e0	DDI-DrugBank.d509.s25.e2	null	pos_2=DT	relType_12=conj	relType_10=punct	relType_7=case	lemma_11=,	relType_13=punct	relType_10=dep	relType_5=case	relType_8=obl	pos_6=NN	lemma_2=no	lpib=have_VBD	pos_8=NN	lemma_12=cyp2c9	pos_1=VBD	relType_11=punct	lemma_9=(	pos_12=NN	lemma_1=have	lemma_3=significant	path2=cyp2d6_obl>cyp2c9_conj>warfarin_appos	pos_10=NN	pos_4=NN	lib=have	relType_4=obj	wib=had	lemma_7=by	relation_3=neutral	lemma_13=(	relType_3=amod	path=aripiprazole_nmod<dose_nsubj<have_ROOT>cyp2d6_obl>cyp2c9_conj>warfarin_appos	path1=aripiprazole_nmod<dose_nsubj	pos_5=IN	pos_9=-LRB-	pos_11=,	relType_9=punct	pos_13=-LRB-	relType_1=ROOT	lemma_4=effect	pos_3=JJ	lemma_10=)	eib=True	lemma_5=on	pos_7=IN	lemma_6=metabolism	pos_10=-RRB-	relType_2=det	lemma_10=dextromethorphan	relType_6=nmod	lemma_8=cyp2d6
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e0	DDI-DrugBank.d509.s25.e3	null	pos_2=DT	relType_12=conj	relType_14=punct	relType_10=punct	relType_7=case	lemma_11=,	relType_17=punct	relType_13=punct	path=aripiprazole_nmod<dose_nsubj<have_ROOT>cyp2d6_obl>cyp2c19_conj>omeprazole_appos	relType_10=dep	relType_5=case	relType_8=obl	pos_6=NN	lemma_2=no	lpib=have_VBD	pos_8=NN	lemma_12=cyp2c9	pos_1=VBD	lemma_16=cyp2c19	pos_15=,	pos_14=-RRB-	relType_11=punct	lemma_9=(	pos_12=NN	lemma_1=have	lemma_3=significant	pos_14=NN	pos_10=NN	lemma_14=warfarin	lemma_14=)	pos_4=NN	lib=have	relType_4=obj	wib=had	lemma_7=by	relType_15=punct	relation_3=neutral	lemma_13=(	lemma_15=,	relType_3=amod	path2=cyp2d6_obl>cyp2c19_conj>omeprazole_appos	path1=aripiprazole_nmod<dose_nsubj	pos_5=IN	pos_9=-LRB-	relType_14=appos	pos_16=NN	pos_11=,	pos_17=-LRB-	relType_9=punct	pos_13=-LRB-	relType_1=ROOT	lemma_4=effect	pos_3=JJ	lemma_10=)	eib=True	lemma_5=on	pos_7=IN	lemma_6=metabolism	pos_10=-RRB-	relType_2=det	lemma_17=(	lemma_10=dextromethorphan	relType_6=nmod	lemma_8=cyp2d6	relType_16=conj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e0	DDI-DrugBank.d509.s25.e4	null	pos_2=DT	relType_12=conj	relType_14=punct	relType_10=punct	relType_7=case	lemma_11=,	relType_17=punct	relType_13=punct	relType_10=dep	relType_5=case	relType_8=obl	pos_6=NN	lemma_2=no	lpib=have_VBD	pos_8=NN	lemma_12=cyp2c9	pos_1=VBD	lemma_16=cyp2c19	lemma_18=omeprazole	pos_15=,	pos_14=-RRB-	relType_11=punct	lemma_9=(	pos_12=NN	lemma_1=have	lemma_3=significant	pos_14=NN	pos_10=NN	lemma_14=warfarin	lemma_14=)	pos_4=NN	lib=have	relType_4=obj	wib=had	lemma_7=by	relType_15=punct	pos_18=NN	relType_18=appos	relation_3=neutral	lemma_13=(	path=aripiprazole_nmod<dose_nsubj<have_ROOT>cyp2d6_obl>cyp2c19_conj>omeprazole_appos>warfarin_dep	pos_18=,	lemma_15=,	relType_3=amod	lemma_18=,	path1=aripiprazole_nmod<dose_nsubj	relType_18=punct	pos_5=IN	pos_9=-LRB-	relType_14=appos	pos_16=NN	pos_11=,	pos_17=-LRB-	relType_9=punct	pos_13=-LRB-	relType_1=ROOT	lemma_4=effect	pos_3=JJ	lemma_10=)	eib=True	lemma_5=on	pos_7=IN	lemma_6=metabolism	pos_10=-RRB-	relType_2=det	lemma_17=(	lemma_10=dextromethorphan	relType_6=nmod	lemma_8=cyp2d6	relType_16=conj	path2=cyp2d6_obl>cyp2c19_conj>omeprazole_appos>warfarin_dep
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e0	DDI-DrugBank.d509.s25.e5	null	pos_23=-LRB-	relType_10=dep	relType_5=case	relType_21=cc	pos_6=NN	lemma_16=cyp2c19	lemma_20=,	lemma_14=warfarin	pos_10=NN	lemma_7=by	wib=had	pos_18=NN	relType_3=amod	lemma_10=)	pos_3=JJ	pos_7=IN	lemma_23=(	lemma_17=(	pos_2=DT	relType_7=case	relType_22=conj	pos_22=NN	relType_19=dep	pos_8=NN	pos_1=VBD	path=aripiprazole_nmod<dose_nsubj<have_ROOT>cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	relation_3=neutral	lemma_13=(	lemma_15=,	pos_5=IN	pos_16=NN	pos_17=-LRB-	lemma_4=effect	lemma_10=dextromethorphan	lemma_19=warfarin	relType_14=punct	relType_10=punct	lemma_11=,	relType_17=punct	relType_19=punct	lemma_2=no	lemma_12=cyp2c9	lemma_18=omeprazole	pos_15=,	pos_14=-RRB-	relType_11=punct	lemma_3=significant	pos_14=NN	lemma_14=)	relType_15=punct	relType_4=obj	relType_18=appos	path1=aripiprazole_nmod<dose_nsubj	pos_9=-LRB-	lemma_21=and	relType_20=punct	lemma_19=)	relType_6=nmod	relType_23=punct	relType_12=conj	relType_13=punct	relType_8=obl	lpib=have_VBD	lemma_9=(	pos_19=NN	path2=cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	lemma_1=have	pos_4=NN	pos_20=,	lib=have	pos_18=,	lemma_18=,	relType_18=punct	relType_14=appos	pos_11=,	relType_9=punct	pos_13=-LRB-	lemma_22=cyp3a4	pos_21=CC	relType_1=ROOT	eib=True	lemma_5=on	lemma_6=metabolism	pos_10=-RRB-	relType_2=det	pos_12=NN	lemma_8=cyp2d6	pos_19=-RRB-	relType_16=conj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e1	DDI-DrugBank.d509.s25.e2	null	lemma_1=)	lpib=cyp2c9_NN	wib=CYP2C9	relType_2=punct	path=dextromethorphan_dep<cyp2d6_obl>cyp2c9_conj>warfarin_appos	path1=dextromethorphan_dep	eib=False	pos_4=-LRB-	lemma_2=,	lemma_4=(	relType_4=punct	relType_3=conj	pos_1=-RRB-	path2=cyp2c9_conj>warfarin_appos	pos_3=NN	lib=cyp2c9	pos_2=,	lemma_3=cyp2c9	relType_1=punct
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e1	DDI-DrugBank.d509.s25.e3	null	lemma_8=(	path2=cyp2c19_conj>omeprazole_appos	lemma_5=warfarin	lemma_6=,	relType_8=punct	lemma_1=)	lpib=cyp2c9_NN	wib=CYP2C9	relType_2=punct	path1=dextromethorphan_dep	pos_4=-LRB-	relType_6=punct	lemma_2=,	lemma_4=(	lemma_5=)	pos_8=-LRB-	relType_4=punct	pos_5=-RRB-	relType_3=conj	relType_5=punct	pos_1=-RRB-	lemma_7=cyp2c19	relType_5=appos	pos_6=,	pos_5=NN	eib=True	pos_3=NN	lib=cyp2c9	pos_2=,	lemma_3=cyp2c9	relType_1=punct	pos_7=NN	path=dextromethorphan_dep<cyp2d6_obl>cyp2c19_conj>omeprazole_appos	relType_7=conj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e1	DDI-DrugBank.d509.s25.e4	null	lemma_8=(	lemma_5=warfarin	pos_7=NN	lemma_6=,	lemma_9=omeprazole	relType_8=punct	lemma_1=)	lpib=cyp2c9_NN	lemma_9=,	wib=CYP2C9	relType_2=punct	path1=dextromethorphan_dep	pos_4=-LRB-	relType_6=punct	pos_9=NN	relType_9=appos	lemma_2=,	lemma_4=(	lemma_5=)	pos_8=-LRB-	relType_4=punct	pos_5=-RRB-	relType_3=conj	relType_5=punct	pos_1=-RRB-	lemma_7=cyp2c19	relType_9=punct	relType_5=appos	pos_6=,	path2=cyp2c19_conj>omeprazole_appos>warfarin_dep	pos_5=NN	eib=True	pos_3=NN	lib=cyp2c9	pos_2=,	lemma_3=cyp2c9	pos_9=,	path=dextromethorphan_dep<cyp2d6_obl>cyp2c19_conj>omeprazole_appos>warfarin_dep	relType_1=punct	relType_7=conj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e1	DDI-DrugBank.d509.s25.e5	null	relType_14=punct	lemma_8=(	relType_10=punct	lemma_11=,	lemma_5=warfarin	lemma_6=,	relType_12=cc	lemma_9=omeprazole	relType_8=punct	lemma_1=)	lpib=cyp2c9_NN	lemma_9=,	relType_10=dep	wib=CYP2C9	pos_12=CC	lemma_14=(	relType_2=punct	path1=dextromethorphan_dep	path2=cyp3a4_conj>dextromethorphan_dep	pos_4=-LRB-	relType_6=punct	path=dextromethorphan_dep<cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	relType_11=punct	relType_13=conj	pos_10=NN	pos_13=NN	pos_9=NN	relType_9=appos	lemma_2=,	lemma_4=(	lemma_5=)	pos_8=-LRB-	relType_4=punct	pos_14=-LRB-	pos_5=-RRB-	relType_3=conj	relType_5=punct	pos_1=-RRB-	lemma_7=cyp2c19	pos_11=,	relType_9=punct	relType_5=appos	pos_6=,	pos_5=NN	lemma_10=)	eib=True	pos_3=NN	pos_10=-RRB-	lemma_12=and	lib=cyp2c9	pos_2=,	lemma_3=cyp2c9	lemma_10=warfarin	pos_9=,	relType_1=punct	pos_7=NN	lemma_13=cyp3a4	relType_7=conj
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e2	DDI-DrugBank.d509.s25.e3	null	path2=cyp2c19_conj>omeprazole_appos	lib=cyp2c19	lemma_1=)	relType_2=punct	eib=False	pos_4=-LRB-	path=warfarin_appos<cyp2c9_conj<cyp2d6_obl>cyp2c19_conj>omeprazole_appos	lemma_2=,	lemma_4=(	relType_4=punct	relType_3=conj	pos_1=-RRB-	path1=warfarin_appos<cyp2c9_conj	lemma_3=cyp2c19	wib=CYP2C19	pos_3=NN	pos_2=,	lpib=cyp2c19_NN	relType_1=punct
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e2	DDI-DrugBank.d509.s25.e4	null	path=warfarin_appos<cyp2c9_conj<cyp2d6_obl>cyp2c19_conj>omeprazole_appos>warfarin_dep	lib=cyp2c19	pos_5=,	lemma_1=)	relType_2=punct	pos_4=-LRB-	lemma_2=,	lemma_4=(	lemma_5=omeprazole	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	pos_1=-RRB-	path1=warfarin_appos<cyp2c9_conj	lemma_3=cyp2c19	relType_5=appos	path2=cyp2c19_conj>omeprazole_appos>warfarin_dep	pos_5=NN	wib=CYP2C19	eib=True	pos_3=NN	pos_2=,	lpib=cyp2c19_NN	relType_1=punct
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e2	DDI-DrugBank.d509.s25.e5	null	relType_10=punct	relType_9=conj	lib=cyp2c19	pos_5=,	lemma_1=)	relType_2=punct	pos_6=NN	pos_10=-LRB-	relType_6=dep	lemma_9=cyp3a4	path2=cyp3a4_conj>dextromethorphan_dep	pos_4=-LRB-	relType_6=punct	pos_7=,	pos_8=CC	lemma_7=,	pos_9=NN	lemma_6=)	lemma_2=,	lemma_4=(	lemma_5=omeprazole	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	pos_1=-RRB-	path1=warfarin_appos<cyp2c9_conj	lemma_10=(	lemma_3=cyp2c19	path=warfarin_appos<cyp2c9_conj<cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	relType_5=appos	pos_6=-RRB-	lemma_8=and	pos_5=NN	wib=CYP2C19	eib=True	pos_3=NN	relType_7=punct	lemma_6=warfarin	pos_2=,	lpib=cyp2c19_NN	relType_1=punct	relType_8=cc
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e3	DDI-DrugBank.d509.s25.e4	null	lib=warfarin	lemma_1=,	lpib=warfarin_NN	eib=False	path1=	pos_1=,	wib=warfarin	relType_1=punct	path=<omeprazole_appos>warfarin_dep	path2=warfarin_dep
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e3	DDI-DrugBank.d509.s25.e5	null	lemma_2=)	lib=warfarin	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	lemma_6=(	relType_2=punct	pos_6=-LRB-	lpib=warfarin_NN	path2=cyp3a4_conj>dextromethorphan_dep	relType_6=punct	wib=warfarin	lemma_5=cyp3a4	relType_2=dep	lemma_3=,	path=omeprazole_appos<cyp2c19_conj<cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	path1=omeprazole_appos<cyp2c19_conj	relType_5=conj	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_2=-RRB-	pos_4=CC	lemma_4=and	relType_1=punct	relType_3=punct
DDI-DrugBank.d509.s25	DDI-DrugBank.d509.s25.e4	DDI-DrugBank.d509.s25.e5	null	lib=cyp3a4	pos_3=CC	wib=CYP3A4	lemma_1=)	relType_3=cc	relType_2=punct	lemma_4=cyp3a4	path2=cyp3a4_conj>dextromethorphan_dep	eib=False	lemma_5=(	pos_4=NN	lemma_2=,	path=warfarin_dep<omeprazole_appos<cyp2c19_conj<cyp2d6_obl>cyp3a4_conj>dextromethorphan_dep	lpib=cyp3a4_NN	relType_5=punct	pos_1=-RRB-	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	path1=warfarin_dep<omeprazole_appos<cyp2c19_conj	pos_5=-LRB-
DDI-DrugBank.d509.s26	DDI-DrugBank.d509.s26.e0	DDI-DrugBank.d509.s26.e1	null	relType_1=cc	pos_1=CC	wib=dehydroaripiprazole	eib=False	path=<aripiprazole_nsubj>dehydroaripiprazole_conj	path1=	path2=dehydroaripiprazole_conj	lemma_1=and	lib=dehydroaripiprazole	lpib=dehydroaripiprazole_NN
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e0	DDI-DrugBank.d509.s27.e1	null	path2=be_parataxis>coadminister_dep>difference_nsubj:pass>aripiprazole_nmod	relType_7=case	lemma_2=there	path1=	pos_6=NN	lemma_5=significant	lemma_6=difference	eib=False	lpib=be_VBD	lemma_7=between	pos_3=VBD	lemma_1=:	relType_2=expl	pos_4=DT	pos_5=JJ	lemma_4=no	lib=be	relType_5=amod	lemma_3=be	pos_1=:	relType_6=nsubj:pass	relType_3=parataxis	wib=was	pos_2=EX	path=<alcohol_ROOT>be_parataxis>coadminister_dep>difference_nsubj:pass>aripiprazole_nmod	pos_7=IN	relType_1=punct	relType_4=det
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e0	DDI-DrugBank.d509.s27.e2	null	relType_8=dep	relType_7=case	lemma_2=there	pos_8=VBN	path1=	pos_9=IN	pos_6=NN	pos_8=NN	lemma_5=significant	lemma_6=difference	lpib=be_VBD	lemma_7=between	path=<alcohol_ROOT>be_parataxis>coadminister_dep>ethanol_obl	pos_3=VBD	relType_9=case	lemma_8=coadminister	lemma_1=:	path2=be_parataxis>coadminister_dep>ethanol_obl	relType_2=expl	pos_4=DT	pos_5=JJ	lemma_4=no	lib=be	relType_5=amod	lemma_3=be	pos_1=:	relType_6=nsubj:pass	relType_3=parataxis	wib=was	pos_2=EX	lemma_9=with	eib=True	pos_7=IN	relType_8=nmod	lemma_8=aripiprazole	relType_1=punct	relType_4=det
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e0	DDI-DrugBank.d509.s27.e3	null	path2=be_parataxis>coadminister_dep>coadminister_dep>ethanol_obl	relType_8=dep	relType_7=case	lemma_2=there	pos_8=VBN	relType_10=cc	path1=	lemma_13=with	pos_9=IN	relType_11=conj	pos_6=NN	pos_8=NN	lemma_5=significant	lemma_6=difference	lpib=be_VBD	pos_10=CC	lemma_7=between	pos_3=VBD	relType_9=case	pos_13=IN	pos_10=NN	lemma_11=placebo	lemma_8=coadminister	lemma_1=:	relType_2=expl	pos_4=DT	pos_5=JJ	lemma_4=no	lemma_10=and	lib=be	relType_5=amod	lemma_12=coadminister	relType_13=case	lemma_3=be	pos_1=:	relType_6=nsubj:pass	relType_3=parataxis	lemma_10=ethanol	wib=was	pos_2=EX	lemma_9=with	path=<alcohol_ROOT>be_parataxis>coadminister_dep>coadminister_dep>ethanol_obl	pos_11=NN	eib=True	pos_7=IN	relType_8=nmod	relType_12=dep	lemma_8=aripiprazole	pos_12=VBN	relType_1=punct	relType_4=det	relType_10=obl
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e1	DDI-DrugBank.d509.s27.e2	null	pos_2=IN	lemma_1=coadminister	relType_2=case	lemma_2=with	pos_1=VBN	eib=False	relType_1=dep	lib=coadminister	path1=aripiprazole_nmod<difference_nsubj:pass	path=aripiprazole_nmod<difference_nsubj:pass<coadminister_dep>ethanol_obl	lpib=coadminister_VBN	path2=ethanol_obl	wib=coadministered
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e1	DDI-DrugBank.d509.s27.e3	null	pos_1=VBN	pos_3=CC	relType_6=case	relType_3=cc	wib=coadministered	path=aripiprazole_nmod<difference_nsubj:pass<coadminister_dep>coadminister_dep>ethanol_obl	pos_2=IN	lemma_1=coadminister	lemma_2=with	lemma_3=ethanol	pos_6=IN	relType_1=dep	lib=coadminister	lemma_4=placebo	path1=aripiprazole_nmod<difference_nsubj:pass	relType_5=dep	pos_4=NN	lemma_5=coadminister	path2=coadminister_dep>ethanol_obl	lemma_6=with	relType_2=case	relType_3=obl	eib=True	pos_3=NN	lemma_3=and	relType_4=conj	pos_5=VBN	lpib=coadminister_VBN
DDI-DrugBank.d509.s27	DDI-DrugBank.d509.s27.e2	DDI-DrugBank.d509.s27.e3	null	relType_1=cc	relType_3=dep	pos_1=CC	pos_2=NN	pos_3=VBN	path1=ethanol_obl	eib=False	lib=placebo	relType_2=conj	lpib=placebo_NN	lemma_4=with	pos_4=IN	path2=coadminister_dep>ethanol_obl	relType_4=case	lemma_2=placebo	lemma_3=coadminister	wib=placebo	path=ethanol_obl<coadminister_dep>coadminister_dep>ethanol_obl	lemma_1=and
DDI-DrugBank.d509.s28	DDI-DrugBank.d509.s28.e0	DDI-DrugBank.d509.s28.e1	advise	path1=alcohol_obj	relType_1=mark	eib=False	wib=taking	lpib=take_VBG	path=alcohol_obj<avoid_xcomp>take_advcl>abilify_obj	lemma_2=take	lib=take	relType_2=advcl	pos_1=IN	lemma_1=while	path2=take_advcl>abilify_obj	pos_2=VBG
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e0	DDI-DrugBank.d109.s0.e1	null	path1=ketoconazole_compound	eib=False	path=ketoconazole_compound<itraconazole_ROOT>	lpib=itraconazole_NN	lib=itraconazole	path2=	wib=Itraconazole	pos_1=HYPH	relType_1=punct	lemma_1=/
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e0	DDI-DrugBank.d109.s0.e2	null	path1=ketoconazole_compound	path2=Macrolides_appos	pos_2=NN	eib=True	lemma_2=itraconazole	path=ketoconazole_compound<itraconazole_ROOT>Macrolides_appos	relType_2=ROOT	pos_2=,	lpib=itraconazole_NN	lib=itraconazole	wib=Itraconazole	pos_1=HYPH	relType_1=punct	lemma_2=,	lemma_1=/	relType_2=punct
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e0	DDI-DrugBank.d109.s0.e3	null	pos_2=NN	lpib=itraconazole_NN	pos_1=HYPH	path2=include_acl>Erythromycin_obj	relType_2=punct	relType_4=acl	pos_3=NNPS	relType_3=appos	lemma_3=Macrolides	lib=itraconazole	lemma_2=,	lemma_3=,	relType_2=ROOT	lemma_4=include	pos_4=VBG	lemma_1=/	path1=ketoconazole_compound	pos_3=,	eib=True	lemma_2=itraconazole	pos_2=,	wib=Itraconazole	relType_1=punct	relType_3=punct	path=ketoconazole_compound<itraconazole_ROOT>include_acl>Erythromycin_obj
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e1	DDI-DrugBank.d109.s0.e2	null	lib=macrolides	path2=Macrolides_appos	lemma_1=,	eib=False	path1=	pos_1=,	lpib=macrolides_NNPS	relType_1=punct	path=<itraconazole_ROOT>Macrolides_appos	wib=Macrolides
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e1	DDI-DrugBank.d109.s0.e3	null	lib=macrolides	lemma_1=,	lemma_2=Macrolides	path1=	pos_1=,	path2=include_acl>Erythromycin_obj	wib=Macrolides	relType_2=punct	relType_3=acl	pos_2=NNPS	pos_3=VBG	lemma_2=,	lemma_3=include	lpib=macrolides_NNPS	relType_2=appos	eib=True	pos_2=,	relType_1=punct	path=<itraconazole_ROOT>include_acl>Erythromycin_obj
DDI-DrugBank.d109.s0	DDI-DrugBank.d109.s0.e2	DDI-DrugBank.d109.s0.e3	null	path1=Macrolides_appos	lemma_1=,	eib=False	wib=Including	pos_1=,	path=Macrolides_appos<itraconazole_ROOT>include_acl>Erythromycin_obj	lib=include	relType_1=punct	lpib=include_VBG	relType_2=acl	path2=include_acl>Erythromycin_obj	lemma_2=include	pos_2=VBG
DDI-DrugBank.d73.s0	DDI-DrugBank.d73.s0.e0	DDI-DrugBank.d73.s0.e1	effect	relType_8=case	relType_10=punct	lemma_4=a	pos_8=VBN	pos_2=MD	relType_10=amod	pos_9=IN	pos_3=VB	lemma_1=)	pos_7=WRB	lemma_10=block	pos_6=NN	relation_11=adverse	path1=reserpine_dep<drug_nsubj	relation_5=neutral	relType_2=aux	relType_9=case	pos_10=NN	lib=have	lemma_3=have	path2=agent_advcl	lemma_10=-	pos_4=DT	pos_5=JJ	lemma_8=give	relType_5=amod	path=reserpine_dep<drug_nsubj<have_ROOT>agent_advcl	relType_3=ROOT	lpib=have_VB	pos_1=-RRB-	pos_10=HYPH	lemma_5=additive	lemma_6=effect	relType_6=obj	lemma_9=with	eib=True	wib=have	pos_10=VBG	lemma_7=when	lemma_2=may	relType_7=advmod	relType_1=punct	relType_4=det	relType_10=obl	lemma_10=beta
DDI-DrugBank.d73.s2	DDI-DrugBank.d73.s2.e0	DDI-DrugBank.d73.s2.e1	effect	lpib=also_RB	relType_1=aux	lemma_1=may	wib=also	lemma_4=a	pos_8=VBN	relType_8=advcl	pos_9=IN	pos_3=VB	pos_7=WRB	pos_6=NN	pos_2=RB	eib=False	relType_2=advmod	relation_5=neutral	relType_9=case	lemma_3=have	pos_4=DT	pos_5=JJ	lemma_8=give	relType_5=amod	path2=give_advcl>tenormin_obl	relType_3=ROOT	lib=also	lemma_5=additive	path1=blocker_nsubj	path=blocker_nsubj<have_ROOT>give_advcl>tenormin_obl	lemma_6=effect	pos_1=MD	relType_6=obj	lemma_9=with	lemma_7=when	lemma_2=also	relType_7=advmod	relType_4=det
DDI-DrugBank.d73.s3	DDI-DrugBank.d73.s3.e0	DDI-DrugBank.d73.s3.e1	effect	lib=exacerbate	relType_1=aux	lemma_1=may	path2=hypertension_obj>follow_acl:relcl>withdrawal_obj>clonidine_nmod	relType_7=aux	lemma_10=withdrawal	relType_8=acl:relcl	relType_11=case	lemma_7=can	eib=False	lemma_6=which	pos_9=DT	pos_2=VB	pos_7=MD	pos_10=NN	relType_3=det	pos_4=NN	lemma_2=exacerbate	path=blocker_nsubj<exacerbate_ROOT>hypertension_obj>follow_acl:relcl>withdrawal_obj>clonidine_nmod	lemma_4=rebound	pos_8=VB	pos_11=IN	lemma_5=hypertension	relType_2=ROOT	pos_6=WDT	relType_4=compound	path1=blocker_nsubj	pos_1=MD	wib=exacerbate	pos_5=NN	lpib=exacerbate_VB	pos_3=DT	lemma_9=the	relType_5=obj	lemma_11=of	lemma_3=the	relType_9=det	relType_10=obj	relType_6=nsubj	lemma_8=follow
DDI-DrugBank.d73.s4	DDI-DrugBank.d73.s4.e0	DDI-DrugBank.d73.s4.e1	advise	relType_4=amod	pos_4=JJ	relType_7=det	relType_1=aux	lemma_6=before	relType_8=amod	pos_3=VBN	lemma_10=of	relType_9=obl	lemma_1=should	relType_6=case	lemma_3=withdraw	path=blocker_nsubj:pass<withdraw_ROOT>withdrawal_obl>clonidine_nmod	wib=be	lemma_4=several	pos_8=JJ	eib=False	pos_5=NNS	pos_6=IN	pos_2=VB	relType_10=case	pos_9=NN	pos_7=DT	path1=blocker_nsubj:pass	lib=be	relType_3=ROOT	relType_2=aux:pass	relType_5=obl:tmod	pos_10=IN	pos_1=MD	lpib=be_VB	lemma_9=withdrawal	lemma_5=day	path2=withdrawal_obl>clonidine_nmod	lemma_2=be	lemma_7=the	lemma_8=gradual
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e0	DDI-DrugBank.d73.s5.e1	null	path=<clonidine_nsubj:pass>therapy_nmod>blocker_compound	lemma_2=beta	relType_1=case	pos_2=NN	eib=True	lemma_2=-	path2=therapy_nmod>blocker_compound	relType_2=compound	path1=	wib=beta	pos_1=IN	lib=beta	pos_2=HYPH	lpib=beta_NN	relType_2=punct	lemma_1=by
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e0	DDI-DrugBank.d73.s5.e2	null	path2=introduction_appos>blocker_nmod	relType_1=case	relType_7=compound	pos_2=NN	pos_7=NN	path1=	lemma_6=of	pos_2=HYPH	relType_6=case	relType_2=punct	relType_4=det	lemma_2=-	relType_2=nmod	pos_6=IN	pos_1=IN	lemma_1=by	lemma_5=introduction	pos_4=DT	lemma_2=therapy	lemma_3=,	relType_2=compound	lemma_4=the	wib=beta	relType_5=appos	pos_5=NN	pos_3=,	lemma_2=blocker	eib=True	lemma_7=beta	path=<clonidine_nsubj:pass>introduction_appos>blocker_nmod	lib=beta	lpib=beta_NN	relType_3=punct	lemma_2=beta
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e0	DDI-DrugBank.d73.s5.e3	null	pos_7=NNS	relType_1=case	relType_7=compound	path2=stop_advcl>administration_nsubj>clonidine_compound	pos_2=NN	relType_12=obl	lemma_7=blocker	pos_7=NN	relType_7=aux	lemma_6=of	pos_2=HYPH	relType_6=case	path=clonidine_nsubj:pass<delay_ROOT>stop_advcl>administration_nsubj>clonidine_compound	relType_2=punct	relType_9=ROOT	relType_4=det	lemma_9=delay	lemma_2=-	relType_2=nmod	pos_6=IN	lemma_11=several	relType_8=aux:pass	relType_11=amod	pos_1=IN	lemma_1=by	pos_7=MD	pos_9=VBN	relType_10=case	pos_13=IN	lemma_13=after	lemma_5=introduction	pos_8=VB	pos_4=DT	lemma_2=therapy	lemma_3=,	lemma_8=be	pos_12=NNS	relType_2=compound	lemma_4=the	lemma_12=day	lemma_7=should	wib=beta	relType_7=nmod	pos_10=IN	relType_5=appos	pos_5=NN	pos_3=,	lemma_2=blocker	eib=True	lemma_7=beta	relType_13=mark	path1=clonidine_nsubj:pass	pos_11=JJ	lib=beta	lemma_10=for	lpib=beta_NN	relType_3=punct	lemma_2=beta
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e1	DDI-DrugBank.d73.s5.e2	null	path2=introduction_appos>blocker_nmod	relType_4=appos	lpib=therapy_NN	lemma_5=of	relType_5=case	relType_2=punct	pos_6=NN	path1=blocker_compound<therapy_nmod	lemma_6=beta	lemma_1=therapy	relType_3=det	relType_1=nmod	pos_4=NN	lemma_2=,	pos_1=NN	pos_5=IN	lib=therapy	path=blocker_compound<therapy_nmod<clonidine_nsubj:pass>introduction_appos>blocker_nmod	relType_6=compound	eib=True	pos_3=DT	lemma_4=introduction	lemma_3=the	pos_2=,	wib=therapy
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e1	DDI-DrugBank.d73.s5.e3	null	pos_7=VB	path2=stop_advcl>administration_nsubj>clonidine_compound	pos_8=VBN	relType_4=appos	lemma_7=be	relType_10=amod	lpib=therapy_NN	pos_9=IN	lemma_5=of	relType_5=case	relType_2=punct	pos_6=NN	lemma_11=day	relType_12=mark	lemma_8=delay	lemma_6=beta	pos_11=NNS	lemma_1=therapy	lemma_6=should	relType_9=case	relType_3=det	relType_1=nmod	pos_4=NN	lemma_2=,	pos_1=NN	path1=blocker_compound<therapy_nmod<clonidine_nsubj:pass	pos_12=IN	relType_6=aux	pos_10=JJ	lemma_12=after	lemma_6=blocker	pos_5=IN	lib=therapy	path=blocker_compound<therapy_nmod<clonidine_nsubj:pass<delay_ROOT>stop_advcl>administration_nsubj>clonidine_compound	relType_7=aux:pass	relType_8=ROOT	pos_6=MD	relType_11=obl	relType_6=compound	eib=True	pos_3=DT	lemma_4=introduction	lemma_9=for	pos_6=NNS	lemma_3=the	pos_2=,	lemma_10=several	relType_6=nmod	wib=therapy
DDI-DrugBank.d73.s5	DDI-DrugBank.d73.s5.e2	DDI-DrugBank.d73.s5.e3	advise	path2=stop_advcl>administration_nsubj>clonidine_compound	relType_1=aux	pos_3=VBN	lemma_7=after	lemma_1=should	relType_7=mark	wib=be	relType_6=obl	path1=blocker_nmod<introduction_appos<clonidine_nsubj:pass	eib=False	lemma_6=day	lemma_4=for	pos_2=VB	lemma_5=several	pos_5=JJ	lib=be	relType_5=amod	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	pos_1=MD	lpib=be_VB	pos_7=IN	pos_6=NNS	lemma_2=be	path=blocker_nmod<introduction_appos<clonidine_nsubj:pass<delay_ROOT>stop_advcl>administration_nsubj>clonidine_compound	lemma_3=delay
DDI-DrugBank.d73.s6	DDI-DrugBank.d73.s6.e0	DDI-DrugBank.d73.s6.e1	effect	lemma_1=,	path1=indomethacin_appos<drug_nmod<use_nsubj	lemma_5=hypotensive	relType_7=case	pos_2=MD	pos_1=,	pos_3=VB	pos_8=NN	lemma_3=decrease	relation_5=neutral	path=indomethacin_appos<drug_nmod<use_nsubj<decrease_ROOT>effect_obj>blocker_nmod	lpib=decrease_VB	relType_2=aux	lemma_8=beta	path2=effect_obj>blocker_nmod	pos_4=DT	pos_5=JJ	relType_5=amod	relType_3=ROOT	wib=decrease	lemma_4=the	relType_8=compound	lemma_6=effect	lemma_7=of	relType_6=obj	eib=True	pos_7=IN	relation_2=adverse	pos_6=NNS	lemma_2=may	relType_1=punct	relType_4=det	lib=decrease
DDI-DrugBank.d73.s7	DDI-DrugBank.d73.s7.e0	DDI-DrugBank.d73.s7.e1	null	relType_1=cc	pos_1=CC	path1=atenolol_nmod	path2=aspirin_conj	eib=False	path=atenolol_nmod<usage_nmod>aspirin_conj	lpib=aspirin_NN	wib=aspirin	lib=aspirin	lemma_1=and
DDI-DrugBank.d73.s8	DDI-DrugBank.d73.s8.e0	DDI-DrugBank.d73.s8.e1	null	relType_1=cc	path2=blocker_conj	pos_1=CC	pos_2=NN	eib=True	path=<aspirin_nmod>blocker_conj	relType_2=compound	path1=	wib=beta	lib=beta	lpib=beta_NN	lemma_1=and	lemma_2=beta
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e0	DDI-DrugBank.d489.s0.e1	null	relType_1=cc	pos_1=CC	pos_3=RB	relType_3=advmod	lemma_2=have	lemma_3=not	lemma_5=its	pos_5=PRP$	lemma_6=pharmacokinetic	path2=alter_conj>pharmacokinetic_obj>cimetidine_dep	eib=False	relType_2=aux	lib=have	relType_5=nmod:poss	lemma_7=:	pos_4=VBN	relation_3=neutral	path=Kerlone_obl<coadminister_ROOT>alter_conj>pharmacokinetic_obj>cimetidine_dep	pos_2=VBP	pos_7=:	lpib=have_VBP	relType_6=obj	lemma_4=alter	relType_7=punct	wib=have	pos_6=NNS	relType_4=conj	path1=Kerlone_obl	lemma_1=and
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e0	DDI-DrugBank.d489.s0.e2	null	relType_1=cc	pos_1=CC	pos_3=RB	relType_3=advmod	relType_8=dep	lemma_8=cimetidine	lemma_2=have	lemma_3=not	lemma_5=its	pos_5=PRP$	lemma_6=pharmacokinetic	relType_8=punct	lemma_8=,	pos_8=NN	relType_2=aux	lib=have	relType_5=nmod:poss	lemma_7=:	pos_4=VBN	relation_3=neutral	pos_2=VBP	pos_7=:	lpib=have_VBP	relType_6=obj	lemma_4=alter	eib=True	path2=alter_conj>pharmacokinetic_obj>cimetidine_dep>nifedipine_conj	relType_7=punct	wib=have	path=Kerlone_obl<coadminister_ROOT>alter_conj>pharmacokinetic_obj>cimetidine_dep>nifedipine_conj	pos_6=NNS	relType_4=conj	path1=Kerlone_obl	lemma_1=and	pos_8=,
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e0	DDI-DrugBank.d489.s0.e3	null	relType_1=cc	pos_1=CC	pos_3=RB	relType_3=advmod	relType_8=dep	relType_9=conj	lemma_8=cimetidine	lemma_2=have	lemma_3=not	lemma_5=its	pos_5=PRP$	lemma_6=pharmacokinetic	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NN	path=Kerlone_obl<coadminister_ROOT>alter_conj>pharmacokinetic_obj>cimetidine_dep>chlorthalidone_conj	relType_2=aux	pos_9=NN	lib=have	relType_5=nmod:poss	lemma_7=:	pos_4=VBN	path2=alter_conj>pharmacokinetic_obj>cimetidine_dep>chlorthalidone_conj	relation_3=neutral	pos_2=VBP	pos_7=:	lpib=have_VBP	relType_9=punct	relType_6=obj	lemma_4=alter	eib=True	relType_7=punct	wib=have	pos_6=NNS	lemma_9=nifedipine	relType_4=conj	pos_9=,	path1=Kerlone_obl	lemma_1=and	pos_8=,
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e0	DDI-DrugBank.d489.s0.e4	null	relType_1=cc	pos_1=CC	lemma_10=chlorthalidone	relType_10=punct	pos_3=RB	relType_3=advmod	relType_8=dep	relType_9=conj	lemma_8=cimetidine	lemma_2=have	relType_11=cc	lemma_10=,	lemma_3=not	lemma_5=its	pos_5=PRP$	lemma_6=pharmacokinetic	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NN	relType_10=conj	relType_2=aux	pos_10=NN	pos_9=NN	lib=have	relType_5=nmod:poss	lemma_7=:	pos_4=VBN	relation_3=neutral	lemma_11=and	path=Kerlone_obl<coadminister_ROOT>alter_conj>pharmacokinetic_obj>cimetidine_dep>hydrochlorothiazide_conj	pos_11=CC	pos_2=VBP	pos_7=:	lpib=have_VBP	relType_9=punct	relType_6=obj	pos_10=,	lemma_4=alter	eib=True	relType_7=punct	wib=have	path2=alter_conj>pharmacokinetic_obj>cimetidine_dep>hydrochlorothiazide_conj	pos_6=NNS	relType_4=conj	lemma_9=nifedipine	pos_9=,	path1=Kerlone_obl	lemma_1=and	pos_8=,
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e1	DDI-DrugBank.d489.s0.e2	null	path2=nifedipine_conj	lemma_1=,	eib=False	path=<cimetidine_dep>nifedipine_conj	path1=	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	relType_1=punct	wib=nifedipine
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e1	DDI-DrugBank.d489.s0.e3	null	lemma_1=,	pos_2=NN	eib=True	lemma_2=,	path1=	pos_1=,	lib=nifedipine	pos_2=,	lpib=nifedipine_NN	lemma_2=nifedipine	path2=chlorthalidone_conj	relType_1=punct	relType_2=conj	path=<cimetidine_dep>chlorthalidone_conj	wib=nifedipine	relType_2=punct
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e1	DDI-DrugBank.d489.s0.e4	null	path2=hydrochlorothiazide_conj	lemma_1=,	pos_2=NN	lemma_3=chlorthalidone	path1=	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	relType_4=cc	relType_2=punct	path=<cimetidine_dep>hydrochlorothiazide_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_2=nifedipine	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct	wib=nifedipine
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e2	DDI-DrugBank.d489.s0.e3	null	lemma_1=,	eib=False	path1=nifedipine_conj	path=nifedipine_conj<cimetidine_dep>chlorthalidone_conj	pos_1=,	lib=chlorthalidone	path2=chlorthalidone_conj	relType_1=punct	lpib=chlorthalidone_NN	wib=chlorthalidone
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e2	DDI-DrugBank.d489.s0.e4	null	path2=hydrochlorothiazide_conj	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	path=nifedipine_conj<cimetidine_dep>hydrochlorothiazide_conj	wib=chlorthalidone	relType_3=cc	relType_2=punct	relType_2=conj	lpib=chlorthalidone_NN	lemma_2=,	lemma_2=chlorthalidone	eib=True	path1=nifedipine_conj	pos_2=,	lib=chlorthalidone	lemma_3=and	relType_1=punct
DDI-DrugBank.d489.s0	DDI-DrugBank.d489.s0.e3	DDI-DrugBank.d489.s0.e4	null	path2=hydrochlorothiazide_conj	lemma_2=and	path=chlorthalidone_conj<cimetidine_dep>hydrochlorothiazide_conj	path1=chlorthalidone_conj	lemma_1=,	eib=False	pos_2=CC	wib=hydrochlorothiazide	pos_1=,	lib=hydrochlorothiazide	relType_1=punct	relType_2=cc	lpib=hydrochlorothiazide_NN
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e0	DDI-DrugBank.d489.s1.e1	null	lemma_1=with	pos_2=DT	relType_1=case	lemma_3=oral	lib=oral	lemma_2=the	pos_3=JJ	relType_3=amod	eib=False	wib=oral	path=Kerlone_nmod<administration_nsubj:pass>warfarin_nmod>anticoagulant_amod	relType_2=det	path2=warfarin_nmod>anticoagulant_amod	path1=Kerlone_nmod	pos_1=IN	lpib=oral_JJ
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e0	DDI-DrugBank.d489.s1.e2	null	pos_2=DT	relType_1=case	pos_4=JJ	lib=oral	lemma_2=the	relType_4=amod	lemma_4=anticoagulant	pos_1=IN	relType_3=amod	path2=warfarin_nmod	path1=Kerlone_nmod	lpib=oral_JJ	lemma_1=with	path=Kerlone_nmod<administration_nsubj:pass>warfarin_nmod	lemma_3=oral	pos_3=JJ	eib=True	wib=oral	relType_2=det
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e0	DDI-DrugBank.d489.s1.e3	null	pos_2=DT	relType_1=case	pos_4=JJ	lib=oral	path2=potentiate_xcomp>effect_obj>warfarin_nmod	lemma_2=the	relType_4=amod	lemma_4=have	lemma_7=not	lemma_6=show	relType_10=det	path1=Kerlone_nmod<administration_nsubj:pass	relType_4=nmod	pos_9=VB	lemma_4=anticoagulant	pos_8=TO	lemma_13=of	relation_13=neutral	path=Kerlone_nmod<administration_nsubj:pass<show_ROOT>potentiate_xcomp>effect_obj>warfarin_nmod	pos_7=RB	relType_11=amod	lemma_12=effect	lemma_10=the	relType_12=obj	pos_1=IN	pos_6=VBN	pos_13=IN	lemma_5=be	pos_4=NN	relType_13=case	relType_6=ROOT	lemma_8=to	relType_5=aux:pass	relType_3=amod	relation_10=adverse	relation_10=beneficial	relType_8=mark	relType_4=aux	lpib=oral_JJ	lemma_9=potentiate	relType_9=xcomp	lemma_1=with	lemma_3=oral	pos_3=JJ	eib=True	lemma_11=anticoagulant	wib=oral	relType_2=det	pos_11=JJ	relType_7=advmod	pos_12=NN	lemma_4=warfarin	pos_5=VBN	pos_4=VBZ	pos_10=DT
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e1	DDI-DrugBank.d489.s1.e2	null	eib=False	path2=	path=anticoagulant_amod<warfarin_nmod>	path1=anticoagulant_amod
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e1	DDI-DrugBank.d489.s1.e3	null	lib=warfarin	pos_2=VBN	path2=potentiate_xcomp>effect_obj>warfarin_nmod	pos_6=VB	relType_7=det	relType_1=aux	relType_8=amod	relation_9=neutral	pos_3=VBN	lemma_8=anticoagulant	lemma_10=of	path=anticoagulant_amod<warfarin_nmod<administration_nsubj:pass<show_ROOT>potentiate_xcomp>effect_obj>warfarin_nmod	pos_8=JJ	relType_5=mark	pos_4=RB	lpib=warfarin_NN	relation_6=adverse	wib=warfarin	lemma_1=have	relType_10=case	relType_1=nmod	pos_5=TO	pos_9=NN	pos_1=NN	pos_7=DT	lemma_4=not	lemma_3=show	relType_3=ROOT	relType_4=advmod	relType_9=obj	relType_2=aux:pass	lemma_5=to	pos_10=IN	relation_6=beneficial	pos_1=VBZ	eib=True	lemma_1=warfarin	path1=anticoagulant_amod<warfarin_nmod<administration_nsubj:pass	lemma_2=be	lemma_7=the	lemma_9=effect	lemma_6=potentiate	relType_6=xcomp
DDI-DrugBank.d489.s1	DDI-DrugBank.d489.s1.e2	DDI-DrugBank.d489.s1.e3	null	pos_2=VBN	path2=potentiate_xcomp>effect_obj>warfarin_nmod	pos_6=VB	lpib=have_VBZ	relType_1=aux	relType_7=det	relType_8=amod	pos_3=VBN	lemma_8=anticoagulant	lemma_10=of	path=warfarin_nmod<administration_nsubj:pass<show_ROOT>potentiate_xcomp>effect_obj>warfarin_nmod	relation_5=adverse	relation_8=neutral	pos_8=JJ	relType_5=mark	pos_4=RB	eib=False	lemma_1=have	relType_10=case	pos_5=TO	lib=have	pos_7=DT	pos_9=NN	lemma_4=not	lemma_3=show	relType_3=ROOT	relType_4=advmod	relType_9=obj	path1=warfarin_nmod<administration_nsubj:pass	relType_2=aux:pass	lemma_5=to	pos_10=IN	pos_1=VBZ	lemma_2=be	lemma_7=the	lemma_9=effect	relation_5=beneficial	wib=has	lemma_6=potentiate	relType_6=xcomp
DDI-DrugBank.d489.s2	DDI-DrugBank.d489.s2.e0	DDI-DrugBank.d489.s2.e1	effect	path2=agent_advcl>block_amod	relType_8=case	relType_10=punct	lemma_4=a	pos_8=VBN	pos_2=MD	pos_9=IN	pos_3=VB	lemma_1=)	pos_7=WRB	pos_6=NN	path=reserpine_appos<g._dep<drug_nsubj<have_ROOT>agent_advcl>block_amod	relation_5=neutral	relType_2=aux	relType_9=case	pos_10=NN	lib=have	lemma_3=have	path1=reserpine_appos<g._dep<drug_nsubj	lemma_10=-	pos_4=DT	pos_5=JJ	lemma_8=give	relType_5=amod	relType_3=ROOT	lpib=have_VB	pos_1=-RRB-	pos_10=HYPH	lemma_5=additive	lemma_6=effect	relType_6=obj	lemma_9=with	eib=True	wib=have	lemma_7=when	lemma_2=may	relType_7=advmod	relType_1=punct	relType_4=det	relType_10=obl	lemma_10=beta
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e0	DDI-DrugBank.d489.s4.e1	advise	relType_1=cc	path=blocker_obj<receive_acl<patient_obl>clonidine_conj	path2=clonidine_conj	pos_1=CC	wib=clonidine	path1=blocker_obj<receive_acl	lib=clonidine	eib=False	lpib=clonidine_NN	lemma_1=and
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e0	DDI-DrugBank.d489.s4.e2	null	relType_1=cc	pos_1=CC	wib=clonidine	pos_2=NN	path=blocker_obj<receive_acl<patient_obl<discontinue_xcomp<decide_advcl<discontinue_ROOT>blocker_nsubj:pass	relType_5=compound	lpib=clonidine_NN	pos_2=RB	lib=clonidine	relType_2=advmod	pos_5=HYPH	lemma_2=concurrently	relType_2=conj	pos_4=DT	lemma_3=,	relType_5=punct	lemma_4=the	path1=blocker_obj<receive_acl<patient_obl<discontinue_xcomp<decide_advcl	path2=blocker_nsubj:pass	pos_5=NN	pos_3=,	eib=True	lemma_2=clonidine	lemma_5=-	relType_4=det	relType_3=punct	lemma_5=beta	lemma_1=and
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e0	DDI-DrugBank.d489.s4.e3	null	relType_1=cc	relType_6=aux:pass	lemma_9=over	pos_1=CC	path=blocker_obj<receive_acl<patient_obl<discontinue_xcomp<decide_advcl<discontinue_ROOT>withdrawal_obl>clonidine_nmod	wib=clonidine	pos_2=NN	pos_6=VB	lemma_13=the	relType_14=amod	pos_16=IN	lemma_7=discontinue	relType_10=amod	relType_5=nsubj:pass	relType_12=case	pos_13=DT	relType_5=compound	pos_9=IN	lpib=clonidine_NN	lemma_5=should	lemma_6=be	pos_2=RB	lemma_11=day	lib=clonidine	lemma_14=gradual	relType_2=advmod	pos_8=RB	lemma_15=withdrawal	pos_5=HYPH	pos_11=NNS	lemma_12=before	lemma_2=concurrently	relType_9=case	relType_5=aux	lemma_16=of	relType_2=conj	lemma_8=slowly	relType_8=advmod	pos_12=IN	pos_4=DT	pos_5=MD	relType_7=ROOT	lemma_3=,	pos_15=NN	relType_15=obl	pos_10=JJ	relType_5=punct	lemma_4=the	path1=blocker_obj<receive_acl<patient_obl<discontinue_xcomp<decide_advcl	relType_11=obl	lemma_5=blocker	pos_7=VBN	pos_5=NN	relType_16=case	pos_3=,	eib=True	path2=withdrawal_obl>clonidine_nmod	relType_13=det	lemma_2=clonidine	pos_14=JJ	lemma_10=several	lemma_5=-	relType_4=det	relType_3=punct	lemma_5=beta	lemma_1=and
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e1	DDI-DrugBank.d489.s4.e2	null	lemma_4=-	pos_4=HYPH	relType_2=punct	lemma_1=concurrently	path1=clonidine_conj<patient_obl<discontinue_xcomp<decide_advcl	relType_3=det	pos_4=NN	lemma_2=,	relType_1=advmod	relType_4=punct	lemma_4=beta	relType_4=compound	lib=concurrently	path2=blocker_nsubj:pass	wib=concurrently	lpib=concurrently_RB	path=clonidine_conj<patient_obl<discontinue_xcomp<decide_advcl<discontinue_ROOT>blocker_nsubj:pass	eib=True	pos_3=DT	pos_1=RB	lemma_3=the	pos_2=,
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e1	DDI-DrugBank.d489.s4.e3	null	relType_8=case	pos_14=NN	lemma_15=of	lemma_4=should	lemma_4=-	pos_4=HYPH	relType_12=det	lemma_14=withdrawal	relType_11=case	relType_2=punct	pos_5=VB	pos_9=JJ	lemma_1=concurrently	pos_7=RB	lemma_10=day	relType_13=amod	pos_4=MD	path1=clonidine_conj<patient_obl<discontinue_xcomp<decide_advcl	relType_4=nsubj:pass	relType_9=amod	pos_6=VBN	lemma_4=blocker	relType_3=det	lemma_5=be	pos_4=NN	lemma_2=,	relType_1=advmod	pos_8=IN	pos_11=IN	lemma_12=the	relType_14=obl	lemma_7=slowly	relType_6=ROOT	relType_15=case	path=clonidine_conj<patient_obl<discontinue_xcomp<decide_advcl<discontinue_ROOT>withdrawal_obl>clonidine_nmod	relType_4=punct	relType_5=aux:pass	pos_13=JJ	lemma_4=beta	relType_4=compound	relType_4=aux	lemma_9=several	lib=concurrently	wib=concurrently	pos_15=IN	lpib=concurrently_RB	lemma_11=before	eib=True	path2=withdrawal_obl>clonidine_nmod	pos_1=RB	pos_3=DT	lemma_3=the	pos_2=,	pos_12=DT	relType_7=advmod	relType_10=obl	pos_10=NNS	lemma_13=gradual	lemma_6=discontinue	lemma_8=over
DDI-DrugBank.d489.s4	DDI-DrugBank.d489.s4.e2	DDI-DrugBank.d489.s4.e3	advise	pos_7=NNS	relType_8=case	pos_6=JJ	relType_1=aux	pos_3=VBN	relType_10=amod	relType_12=case	path=blocker_nsubj:pass<discontinue_ROOT>withdrawal_obl>clonidine_nmod	lemma_1=should	relType_5=case	lemma_12=of	wib=be	pos_4=RB	eib=False	lemma_5=over	relType_6=amod	pos_9=DT	pos_2=VB	lemma_4=slowly	pos_12=IN	path1=blocker_nsubj:pass	pos_8=IN	lemma_11=withdrawal	lemma_6=several	lemma_10=gradual	lib=be	relType_3=ROOT	pos_10=JJ	relType_4=advmod	relType_2=aux:pass	pos_5=IN	lemma_7=day	pos_1=MD	relType_11=obl	lpib=be_VB	lemma_8=before	lemma_3=discontinue	relType_7=obl	pos_11=NN	path2=withdrawal_obl>clonidine_nmod	lemma_9=the	lemma_2=be	relType_9=det
DDI-DrugBank.d489.s5	DDI-DrugBank.d489.s5.e0	DDI-DrugBank.d489.s5.e1	advise	relType_7=compound	relType_1=aux	lemma_1=may	lemma_7=adrenergic	pos_3=VBN	path2=agent_obl	lemma_4=in	relType_6=case	wib=be	path1=antagonist_nsubj:pass	lemma_7=-	lemma_3=use	lemma_5=combination	pos_6=IN	pos_2=VB	relType_7=amod	lib=be	path=antagonist_nsubj:pass<use_ccomp>agent_obl	pos_7=HYPH	pos_4=IN	relType_4=case	relType_2=aux:pass	lemma_6=with	relType_5=obl	pos_1=MD	lpib=be_VB	relType_7=obl:npmod	pos_5=NN	lemma_7=blocking	relType_3=ccomp	eib=True	relType_7=punct	lemma_7=beta	pos_7=JJ	lemma_2=be	pos_7=NN
DDI-DrugBank.d489.s6	DDI-DrugBank.d489.s6.e0	DDI-DrugBank.d489.s6.e1	effect	pos_2=DT	lib=oral	pos_1=WRB	lemma_2=a	pos_4=NN	relType_1=advmod	path2=add_advcl>antagonist_nsubj:pass	relType_3=amod	lemma_1=when	relType_4=compound	lpib=oral_JJ	lemma_3=oral	pos_3=JJ	lemma_4=calcium	eib=True	wib=oral	path=agent_obj<receive_acl<patient_obl<report_ROOT>add_advcl>antagonist_nsubj:pass	relType_2=det	path1=agent_obj<receive_acl<patient_obl
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e0	DDI-DrugBank.d489.s7.e1	null	pos_2=DT	relType_1=cop	pos_1=VBD	lib=be	lemma_3=dihydropyridine	eib=True	pos_3=NN	path=antagonist_nsubj<derivative_advcl>	path1=antagonist_nsubj	lemma_1=be	relType_2=det	relType_3=compound	path2=	lemma_2=a	lpib=be_VBD	wib=were
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e0	DDI-DrugBank.d489.s7.e2	null	pos_2=DT	lemma_6=,	lemma_2=a	wib=were	path=antagonist_nsubj<derivative_advcl>nifedipine_conj	pos_1=VBD	lemma_3=derivative	relType_6=punct	lemma_4=e.	lemma_1=be	pos_4=NN	lib=be	relType_3=advcl	lemma_3=,	relType_4=compound	relType_5=conj	pos_6=,	pos_5=NN	path2=nifedipine_conj	relType_1=cop	pos_3=,	lemma_3=dihydropyridine	eib=True	pos_3=NN	relType_2=det	path1=antagonist_nsubj	relType_3=compound	lemma_5=g.	lpib=be_VBD	relType_3=punct
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e0	DDI-DrugBank.d489.s7.e3	null	lemma_20=block	relType_26=xcomp	lemma_6=,	pos_12=CC	path2=likely_advcl>occur_xcomp>verapamil_obl	pos_20=NN	relType_20=nmod	pos_13=NN	lemma_7=,	lemma_16=,	lemma_3=,	lemma_13=av	relType_8=mark	pos_25=TO	pos_26=VB	relType_16=punct	lemma_21=,	pos_3=,	lemma_8=while	relType_25=mark	relType_21=punct	pos_2=DT	pos_28=CC	relation_22=adverse	lemma_15=disturbance	lemma_19=heart	pos_1=VBD	lemma_18=complete	relType_22=cop	pos_8=IN	relType_19=compound	lemma_17=include	lemma_14=conduction	pos_5=NN	relType_1=cop	pos_11=NN	lemma_3=dihydropyridine	lemma_11=failure	relType_3=compound	lemma_27=with	path=antagonist_nsubj<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl	pos_7=NN	lpib=be_VBD	lemma_26=occur	relType_3=punct	lemma_23=more	relType_28=cc:preconj	relType_12=cc	pos_24=JJ	lemma_1=be	relType_24=advcl	pos_7=,	relType_9=amod	pos_14=NN	relType_17=case	pos_22=VBD	lemma_10=ventricular	lib=be	lemma_22=be	lemma_25=to	lemma_9=left	relType_5=conj	lemma_12=and	relType_15=conj	lemma_5=g.	relType_27=case	relType_7=conj	relType_23=advmod	relType_10=amod	relType_18=amod	lemma_2=a	relType_14=compound	wib=were	pos_21=,	pos_9=JJ	lemma_3=derivative	relType_6=punct	lemma_4=e.	pos_17=VBG	pos_16=,	lemma_24=likely	relType_11=nsubj	pos_18=JJ	pos_19=NN	pos_27=IN	pos_4=NN	relType_13=compound	relType_3=advcl	pos_10=JJ	lemma_7=nifedipine	relType_4=compound	pos_6=,	lemma_28=either	pos_23=RBR	pos_15=NNS	eib=True	pos_3=NN	relType_7=punct	relType_2=det	path1=antagonist_nsubj
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e0	DDI-DrugBank.d489.s7.e4	null	lemma_20=block	relType_26=xcomp	relType_29=obl	lemma_6=,	pos_12=CC	path2=likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	relType_20=nmod	pos_20=NN	pos_13=NN	lemma_7=,	lemma_16=,	lemma_3=,	lemma_13=av	relType_8=mark	pos_25=TO	pos_26=VB	relType_16=punct	lemma_21=,	pos_3=,	lemma_8=while	relType_25=mark	relType_21=punct	pos_2=DT	pos_28=CC	relation_22=adverse	lemma_15=disturbance	lemma_19=heart	pos_1=VBD	lemma_18=complete	pos_29=NN	relType_22=cop	pos_8=IN	relType_19=compound	lemma_17=include	relType_29=cc	lemma_14=conduction	pos_5=NN	relType_1=cop	pos_11=NN	lemma_3=dihydropyridine	lemma_11=failure	relType_3=compound	lemma_27=with	pos_7=NN	lpib=be_VBD	lemma_26=occur	relType_3=punct	lemma_23=more	lemma_29=or	relType_28=cc:preconj	relType_12=cc	pos_24=JJ	lemma_1=be	relType_24=advcl	pos_7=,	relType_9=amod	pos_14=NN	pos_29=CC	relType_17=case	pos_22=VBD	lemma_10=ventricular	lib=be	lemma_22=be	lemma_25=to	lemma_9=left	relType_5=conj	lemma_12=and	relType_15=conj	lemma_5=g.	relType_27=case	relType_7=conj	relType_23=advmod	relType_10=amod	relType_18=amod	lemma_2=a	relType_14=compound	wib=were	pos_21=,	pos_9=JJ	lemma_29=verapamil	lemma_3=derivative	relType_6=punct	lemma_4=e.	pos_17=VBG	pos_16=,	lemma_24=likely	relType_11=nsubj	pos_18=JJ	pos_19=NN	pos_27=IN	pos_4=NN	path=antagonist_nsubj<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	relType_13=compound	relType_3=advcl	pos_10=JJ	lemma_7=nifedipine	relType_4=compound	pos_6=,	lemma_28=either	pos_23=RBR	pos_15=NNS	eib=True	pos_3=NN	relType_7=punct	relType_2=det	path1=antagonist_nsubj
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e1	DDI-DrugBank.d489.s7.e2	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	lib=e.	lemma_3=g.	eib=False	pos_4=,	path=<derivative_advcl>nifedipine_conj	relType_4=punct	relType_3=conj	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	path2=nifedipine_conj	pos_3=NN	relType_1=punct
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e1	DDI-DrugBank.d489.s7.e3	null	pos_2=NN	pos_5=,	lemma_23=to	pos_13=NNS	lemma_20=be	lemma_5=nifedipine	pos_8=JJ	relType_12=compound	path2=likely_advcl>occur_xcomp>verapamil_obl	relType_17=compound	pos_18=NN	lemma_10=and	relType_4=punct	lemma_5=,	pos_15=VBG	wib=e.	lemma_18=block	pos_7=JJ	lemma_8=ventricular	lemma_26=either	lemma_1=,	pos_23=TO	path1=	pos_1=,	lib=e.	relType_25=case	relType_16=amod	lemma_3=g.	pos_6=IN	relType_21=advmod	lemma_9=failure	relType_26=cc:preconj	lemma_11=av	relType_13=conj	relType_20=cop	pos_9=NN	relType_15=case	relType_6=mark	pos_19=,	lemma_2=e.	lpib=e._NN	lemma_4=,	pos_24=VB	pos_5=NN	lemma_14=,	pos_11=NN	pos_25=IN	lemma_19=,	path=<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl	relType_1=punct	relType_18=nmod	relType_14=punct	relType_10=cc	lemma_22=likely	relType_19=punct	relType_23=mark	lemma_25=with	pos_17=NN	lemma_16=complete	pos_4=,	pos_10=CC	pos_14=,	lemma_13=disturbance	lemma_6=while	relType_7=amod	relType_3=conj	lemma_21=more	relType_5=conj	lemma_15=include	lemma_7=left	pos_22=JJ	lemma_17=heart	relType_24=xcomp	relType_8=amod	pos_26=CC	relType_22=advcl	lemma_24=occur	pos_20=VBD	pos_16=JJ	relType_2=compound	relType_5=punct	pos_21=RBR	lemma_12=conduction	relation_18=adverse	eib=True	relType_9=nsubj	relType_11=compound	pos_3=NN	pos_12=NN
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e1	DDI-DrugBank.d489.s7.e4	null	relType_27=cc	pos_2=NN	pos_5=,	path=<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	lemma_23=to	pos_13=NNS	lemma_20=be	lemma_5=nifedipine	pos_8=JJ	path2=likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	relType_12=compound	relType_17=compound	pos_18=NN	lemma_10=and	relType_4=punct	lemma_5=,	pos_15=VBG	relType_27=obl	wib=e.	lemma_18=block	pos_7=JJ	lemma_8=ventricular	lemma_26=either	lemma_1=,	pos_23=TO	path1=	pos_1=,	lib=e.	relType_25=case	relType_16=amod	lemma_3=g.	pos_6=IN	relType_21=advmod	lemma_9=failure	relType_26=cc:preconj	lemma_11=av	relType_13=conj	relType_20=cop	pos_9=NN	pos_27=NN	relType_15=case	relType_6=mark	pos_19=,	lemma_2=e.	lpib=e._NN	lemma_4=,	pos_24=VB	pos_5=NN	lemma_14=,	lemma_27=verapamil	pos_11=NN	pos_25=IN	lemma_19=,	relType_1=punct	relType_18=nmod	relType_14=punct	relType_10=cc	lemma_22=likely	relType_19=punct	relType_23=mark	lemma_25=with	pos_17=NN	lemma_16=complete	pos_4=,	pos_10=CC	pos_14=,	lemma_13=disturbance	lemma_6=while	relType_7=amod	relType_3=conj	lemma_21=more	relType_5=conj	lemma_15=include	lemma_7=left	pos_22=JJ	pos_27=CC	lemma_17=heart	relType_24=xcomp	relType_8=amod	pos_26=CC	relType_22=advcl	lemma_24=occur	pos_20=VBD	pos_16=JJ	relType_2=compound	relType_5=punct	pos_21=RBR	lemma_12=conduction	lemma_27=or	relation_18=adverse	eib=True	relType_9=nsubj	relType_11=compound	pos_3=NN	pos_12=NN
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e2	DDI-DrugBank.d489.s7.e3	null	relType_4=amod	relType_7=compound	lemma_1=,	pos_4=JJ	relType_10=punct	relType_9=conj	lemma_20=occur	pos_16=VBD	lib=left	lemma_17=more	lemma_10=,	pos_20=VB	pos_1=,	relType_5=nsubj	lemma_11=include	lemma_13=heart	relType_14=nmod	path=nifedipine_conj<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl	relType_2=mark	lemma_3=left	relType_11=case	pos_2=IN	wib=left	pos_8=NN	pos_12=JJ	pos_22=CC	eib=False	pos_15=,	lemma_8=conduction	path2=likely_advcl>occur_xcomp>verapamil_obl	pos_9=NNS	lpib=left_JJ	relType_12=amod	pos_18=JJ	pos_14=NN	lemma_16=be	pos_13=NN	pos_17=RBR	relType_19=mark	relType_15=punct	lemma_2=while	pos_21=IN	lemma_21=with	relation_13=adverse	relType_13=compound	relType_3=amod	pos_6=CC	lemma_15=,	relType_22=cc:preconj	lemma_6=and	relType_8=compound	lemma_9=disturbance	relType_16=cop	pos_11=VBG	lemma_14=block	relType_17=advmod	relType_20=xcomp	lemma_22=either	lemma_18=likely	lemma_12=complete	relType_21=case	lemma_4=ventricular	pos_5=NN	relType_18=advcl	pos_19=TO	pos_3=JJ	lemma_7=av	pos_10=,	path1=nifedipine_conj	lemma_5=failure	relType_1=punct	pos_7=NN	lemma_19=to	relType_6=cc
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e2	DDI-DrugBank.d489.s7.e4	null	lemma_10=,	lemma_23=verapamil	path2=likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	pos_13=NN	relType_19=mark	lemma_2=while	lemma_23=or	relType_3=amod	relType_22=cc:preconj	pos_11=VBG	relType_21=case	relType_18=advcl	pos_3=JJ	pos_10=,	relType_14=nmod	relType_4=amod	lemma_1=,	lib=left	pos_1=,	relType_5=nsubj	lemma_11=include	relType_11=case	pos_8=NN	relType_12=amod	relType_23=obl	lemma_15=,	pos_6=CC	relType_16=cop	relType_20=xcomp	pos_5=NN	path1=nifedipine_conj	lemma_5=failure	relType_1=punct	pos_7=NN	lemma_19=to	relType_10=punct	lemma_17=more	pos_20=VB	relType_2=mark	pos_23=NN	pos_2=IN	pos_23=CC	pos_15=,	lemma_8=conduction	lpib=left_JJ	pos_21=IN	pos_14=NN	lemma_16=be	relType_15=punct	relType_8=compound	lemma_9=disturbance	lemma_14=block	lemma_22=either	lemma_4=ventricular	pos_19=TO	lemma_7=av	lemma_20=occur	relType_6=cc	relType_7=compound	pos_4=JJ	relType_9=conj	pos_16=VBD	lemma_13=heart	lemma_3=left	pos_22=CC	pos_12=JJ	wib=left	pos_9=NNS	pos_18=JJ	lemma_21=with	pos_17=RBR	relation_13=adverse	relType_13=compound	lemma_6=and	relType_23=cc	relType_17=advmod	lemma_18=likely	lemma_12=complete	path=nifedipine_conj<derivative_advcl>likely_advcl>occur_xcomp>verapamil_obl>diltiazem_conj	eib=True
DDI-DrugBank.d489.s7	DDI-DrugBank.d489.s7.e3	DDI-DrugBank.d489.s7.e4	null	relType_1=cc	pos_1=CC	lemma_1=or	eib=False	path1=	lpib=diltiazem_NN	lib=diltiazem	wib=diltiazem	path2=diltiazem_conj	path=<verapamil_obl>diltiazem_conj
DDI-DrugBank.d489.s8	DDI-DrugBank.d489.s8.e0	DDI-DrugBank.d489.s8.e1	effect	relType_1=aux	lemma_1=may	path2=epinephrine_obl	wib=be	relType_2=cop	eib=False	pos_2=VB	lib=be	path1=blocker_nmod<patient_nsubj	lemma_4=to	pos_4=IN	relType_4=case	pos_1=MD	lpib=be_VB	path=blocker_nmod<patient_nsubj<refractory_ccomp>epinephrine_obl	pos_3=JJ	relType_3=ccomp	lemma_3=refractory	lemma_2=be
DDI-DrugBank.d489.s8	DDI-DrugBank.d489.s8.e0	DDI-DrugBank.d489.s8.e2	null	relType_8=case	lemma_5=in	relType_1=aux	lemma_1=may	pos_6=DT	lemma_11=,	lemma_7=treatment	path1=blocker_nmod<patient_nsubj<refractory_ccomp<know_advcl	relType_5=case	wib=be	pos_9=JJ	relType_2=cop	relType_10=nmod	relType_12=compound	path=blocker_nmod<patient_nsubj<refractory_ccomp<know_advcl<interfere_appos>blocker_nsubj	lemma_6=the	lemma_10=shock	relType_11=punct	pos_12=NN	pos_2=VB	relType_9=amod	relType_12=punct	pos_10=NN	lemma_12=-	pos_8=IN	lib=be	path2=blocker_nsubj	lemma_5=epinephrine	lemma_4=to	pos_4=IN	relType_4=case	pos_5=IN	lemma_12=beta	relType_5=obl	pos_1=MD	pos_11=,	lpib=be_VB	relType_6=det	pos_5=NN	relType_7=obl	pos_3=JJ	relType_3=ccomp	eib=True	lemma_3=refractory	lemma_9=anaphylactic	pos_12=HYPH	lemma_2=be	pos_7=NN	lemma_8=of
DDI-DrugBank.d489.s8	DDI-DrugBank.d489.s8.e1	DDI-DrugBank.d489.s8.e2	null	pos_2=DT	relType_1=case	lemma_1=in	lemma_2=the	path=epinephrine_obl<refractory_ccomp<know_advcl<interfere_appos>blocker_nsubj	lemma_3=treatment	relType_8=punct	pos_6=NN	lemma_6=shock	pos_8=NN	lib=treatment	lemma_5=anaphylactic	path1=epinephrine_obl<refractory_ccomp<know_advcl	pos_7=,	pos_8=HYPH	pos_1=IN	lemma_7=,	lemma_8=beta	pos_5=JJ	relType_5=amod	path2=blocker_nsubj	pos_4=IN	relType_8=compound	relType_4=case	lpib=treatment_NN	relType_3=obl	eib=True	pos_3=NN	relType_7=punct	relType_2=det	lemma_8=-	wib=treatment	relType_6=nmod	lemma_4=of
DDI-DrugBank.d497.s0	DDI-DrugBank.d497.s0.e0	DDI-DrugBank.d497.s0.e1	null	lemma_1=(	path2=suspension_appos>brinzolamide_compound	eib=False	wib=brinzolamide	path1=	pos_1=-LRB-	lib=brinzolamide	lpib=brinzolamide_NN	relType_1=punct	path=<AZOPT_nsubj>suspension_appos>brinzolamide_compound
DDI-DrugBank.d497.s0	DDI-DrugBank.d497.s0.e0	DDI-DrugBank.d497.s0.e2	null	lemma_5=1	pos_7=VBZ	pos_2=NN	pos_8=DT	lib=brinzolamide	pos_2=JJ	lemma_2=brinzolamide	lemma_9=anhydrase	lemma_1=(	pos_6=NN	pos_5=CD	lemma_2=ophthalmic	path=AZOPT_nsubj<contain_ROOT>inhibitor_obj	path2=inhibitor_obj	relType_6=dep	pos_9=JJ	relType_9=compound	relType_3=appos	pos_4=-RRB-	lemma_8=a	lpib=brinzolamide_NN	relType_9=amod	lemma_6=%	pos_9=NN	relType_7=ROOT	relType_4=punct	relType_5=nummod	relType_2=compound	wib=brinzolamide	relType_2=amod	lemma_4=)	lemma_7=contain	pos_1=-LRB-	lemma_3=suspension	path1=AZOPT_nsubj	eib=True	pos_3=NN	lemma_9=carbonic	relType_8=det	relType_1=punct
DDI-DrugBank.d497.s0	DDI-DrugBank.d497.s0.e1	DDI-DrugBank.d497.s0.e2	null	path1=brinzolamide_compound<suspension_appos<AZOPT_nsubj	pos_2=NN	relType_7=det	relType_8=amod	pos_1=JJ	pos_6=VBZ	pos_8=JJ	pos_8=NN	path2=inhibitor_obj	lemma_4=1	lpib=ophthalmic_JJ	relType_5=dep	lemma_2=suspension	pos_7=DT	pos_4=CD	path=brinzolamide_compound<suspension_appos<AZOPT_nsubj<contain_ROOT>inhibitor_obj	lemma_1=ophthalmic	relType_6=ROOT	lemma_8=anhydrase	lemma_5=%	relType_8=compound	wib=ophthalmic	relType_2=appos	lemma_3=)	relType_4=nummod	pos_5=NN	eib=True	pos_3=-RRB-	lemma_7=a	relType_1=amod	lemma_8=carbonic	relType_3=punct	lemma_6=contain	lib=ophthalmic
DDI-DrugBank.d497.s2	DDI-DrugBank.d497.s2.e0	DDI-DrugBank.d497.s2.e1	int	lemma_1=,	pos_8=VBN	relType_10=amod	pos_1=,	relType_5=compound	relType_7=aux	pos_9=IN	lemma_11=-	lib=rare	pos_2=JJ	lemma_5=drug	pos_11=HYPH	pos_3=NNS	relType_12=compound	eib=False	path2=therapy_obl>salicylate_compound	wib=rare	relType_11=punct	pos_12=NN	relType_9=case	lemma_7=have	relType_6=nmod	lemma_10=high	lemma_6=interaction	pos_10=JJ	pos_4=IN	lemma_12=dose	relType_2=amod	relType_4=case	relType_8=ROOT	lpib=rare_JJ	relType_3=nsubj	pos_5=NN	lemma_9=with	pos_6=NNS	lemma_2=rare	path1=inhibitor_obl<treat_acl<patient_obl	relType_1=punct	lemma_8=occur	lemma_4=of	path=inhibitor_obl<treat_acl<patient_obl<occur_ROOT>therapy_obl>salicylate_compound	pos_7=VBP	lemma_3=instance
DDI-DrugBank.d497.s3	DDI-DrugBank.d497.s3.e0	DDI-DrugBank.d497.s3.e1	null	lemma_1=(	path2=suspension_appos>brinzolamide_compound	eib=False	wib=brinzolamide	path=azopt_obj<receive_acl<patient_obl>suspension_appos>brinzolamide_compound	lib=brinzolamide	path1=azopt_obj<receive_acl	lpib=brinzolamide_NN	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e0	DDI-DrugBank.d153.s0.e1	null	pos_1=VBG	eib=False	relType_1=acl	path1=	lemma_1=contain	lib=contain	path2=contain_acl>epinephrine_obj	wib=containing	lpib=contain_VBG	path=<solution_nmod>contain_acl>epinephrine_obj
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e0	DDI-DrugBank.d153.s0.e2	null	pos_1=VBG	lemma_2=or	relType_2=obj	pos_2=NN	eib=True	relType_1=acl	pos_2=CC	path1=	lemma_1=contain	lemma_2=epinephrine	path2=contain_acl>epinephrine_obj>norepinephrine_conj	path=<solution_nmod>contain_acl>epinephrine_obj>norepinephrine_conj	lib=contain	relType_2=cc	wib=containing	lpib=contain_VBG
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e0	DDI-DrugBank.d153.s0.e3	null	lemma_2=or	relType_2=obj	pos_2=NN	pos_3=IN	path1=	relType_2=cc	lemma_3=norepinephrine	lemma_6=oxidase	pos_6=NN	lemma_6=monoamine	relType_5=acl	lemma_5=receive	lpib=contain_VBG	lemma_4=patient	pos_4=NNS	relType_4=obl	relType_3=conj	relType_1=acl	lemma_3=to	wib=containing	relType_3=case	pos_1=VBG	relType_6=compound	path2=contain_acl>patient_obl>receive_acl>inhibitor_obj	pos_5=VBG	eib=True	pos_3=NN	pos_2=CC	lemma_1=contain	lemma_2=epinephrine	lib=contain	path=<solution_nmod>contain_acl>patient_obl>receive_acl>inhibitor_obj
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e0	DDI-DrugBank.d153.s0.e4	null	lemma_2=or	relType_2=obj	pos_2=NN	pos_3=IN	path2=contain_acl>patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	path=<solution_nmod>contain_acl>patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	path1=	lemma_6=inhibitor	relType_2=cc	lemma_3=norepinephrine	lemma_6=oxidase	lemma_7=tricyclic	pos_6=NN	lemma_6=monoamine	relType_5=acl	lemma_5=receive	lemma_6=or	lpib=contain_VBG	lemma_4=patient	pos_4=NNS	relType_4=obl	relType_7=amod	pos_6=CC	relType_3=conj	relType_1=acl	lemma_3=to	wib=containing	relType_3=case	pos_1=VBG	relType_6=compound	relType_6=obj	pos_5=VBG	eib=True	pos_3=NN	pos_2=CC	pos_7=JJ	pos_6=NNS	lemma_1=contain	lemma_2=epinephrine	lib=contain	relType_6=cc
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e1	DDI-DrugBank.d153.s0.e2	null	relType_1=cc	lpib=norepinephrine_NN	pos_1=CC	wib=norepinephrine	eib=False	path1=	lib=norepinephrine	path=<epinephrine_obj>norepinephrine_conj	lemma_1=or	path2=norepinephrine_conj
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e1	DDI-DrugBank.d153.s0.e3	effect	relType_1=cc	path2=patient_obl>receive_acl>inhibitor_obj	lpib=norepinephrine_NN	pos_1=CC	lemma_5=oxidase	pos_2=NN	lemma_4=receive	relType_5=compound	path1=epinephrine_obj	pos_2=IN	relType_4=acl	wib=norepinephrine	pos_3=NNS	lemma_1=or	lemma_5=monoamine	lib=norepinephrine	lemma_2=to	relType_2=conj	pos_4=VBG	pos_5=NN	path=epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj	relType_2=case	relType_3=obl	eib=True	lemma_2=norepinephrine	lemma_3=patient
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e1	DDI-DrugBank.d153.s0.e4	effect	relType_1=cc	lpib=norepinephrine_NN	pos_1=CC	lemma_5=oxidase	pos_2=NN	pos_6=JJ	pos_5=CC	lemma_4=receive	relType_5=compound	path1=epinephrine_obj	path=epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	pos_2=IN	relType_4=acl	relType_5=cc	wib=norepinephrine	pos_3=NNS	lemma_1=or	lemma_5=monoamine	pos_5=NNS	relType_6=amod	lib=norepinephrine	lemma_2=to	relType_2=conj	pos_4=VBG	pos_5=NN	relType_2=case	relType_3=obl	eib=True	path2=patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	relType_5=obj	lemma_6=tricyclic	lemma_2=norepinephrine	lemma_5=inhibitor	lemma_3=patient	lemma_5=or
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e2	DDI-DrugBank.d153.s0.e3	effect	path2=patient_obl>receive_acl>inhibitor_obj	relType_1=case	lemma_2=patient	lemma_4=monoamine	wib=patients	path1=norepinephrine_conj<epinephrine_obj	lpib=patient_NNS	path=norepinephrine_conj<epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	lib=patient	relType_4=compound	lemma_1=to	relType_2=obl	pos_2=NNS	lemma_4=oxidase	eib=True
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e2	DDI-DrugBank.d153.s0.e4	effect	relType_1=case	lemma_2=patient	relType_4=cc	lemma_4=monoamine	wib=patients	path1=norepinephrine_conj<epinephrine_obj	lpib=patient_NNS	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	pos_4=NNS	relType_4=obj	pos_5=JJ	relType_5=amod	lemma_4=or	lib=patient	relType_4=compound	path=norepinephrine_conj<epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	lemma_1=to	lemma_5=tricyclic	relType_2=obl	pos_2=NNS	lemma_4=oxidase	eib=True	pos_4=CC	path2=patient_obl>receive_acl>inhibitor_obj>antidepressant_conj	lemma_4=inhibitor
DDI-DrugBank.d153.s0	DDI-DrugBank.d153.s0.e3	DDI-DrugBank.d153.s0.e4	null	path2=antidepressant_conj	path=<inhibitor_obj>antidepressant_conj	relType_1=cc	pos_1=CC	eib=True	lpib=tricyclic_JJ	relType_2=amod	path1=	lib=tricyclic	lemma_2=tricyclic	pos_2=JJ	wib=tricyclic	lemma_1=or
DDI-DrugBank.d153.s3	DDI-DrugBank.d153.s3.e0	DDI-DrugBank.d153.s3.e1	null	relType_1=cc	pos_1=CC	path1=	pos_2=IN	path2=drug_conj	lemma_3=oxytocic	lemma_3=-	wib=ergot	lpib=ergot_NN	relType_3=amod	lib=ergot	lemma_3=type	lemma_2=of	relType_2=case	pos_3=JJ	eib=True	pos_3=NN	pos_3=HYPH	path=<drug_nmod>drug_conj	relType_3=compound	lemma_3=ergot	relType_3=punct	lemma_1=and
DDI-DrugBank.d153.s4	DDI-DrugBank.d153.s4.e0	DDI-DrugBank.d153.s4.e1	null	relType_1=cc	path2=butyrophenone_conj	pos_1=CC	lib=butyrophenone	path=<phenothiazine_nsubj>butyrophenone_conj	eib=False	lpib=butyrophenone_NNS	wib=butyrophenones	path1=	lemma_1=and
DDI-DrugBank.d153.s4	DDI-DrugBank.d153.s4.e0	DDI-DrugBank.d153.s4.e2	effect	relType_1=cc	pos_1=CC	relType_7=compound	pos_6=DT	pos_2=MD	path2=effect_obj>epinephrine_nmod	pos_9=IN	relType_4=cc	pos_3=VB	relation_8=neutral	lemma_7=pressor	pos_8=NN	pos_5=VB	lemma_5=reverse	wib=butyrophenones	lemma_6=the	relType_8=obj	relType_2=aux	relType_9=case	relType_2=conj	lemma_3=reduce	relType_3=ROOT	lemma_4=or	relation_3=adverse	lemma_2=butyrophenone	relType_5=conj	pos_2=NNS	relType_6=det	lib=butyrophenone	eib=True	pos_4=CC	path=phenothiazine_nsubj<reduce_ROOT>effect_obj>epinephrine_nmod	lemma_9=of	lpib=butyrophenone_NNS	lemma_8=effect	lemma_2=may	pos_7=NN	lemma_1=and	path1=phenothiazine_nsubj
DDI-DrugBank.d153.s4	DDI-DrugBank.d153.s4.e1	DDI-DrugBank.d153.s4.e2	effect	relType_8=case	relType_1=aux	lemma_1=may	lib=reduce	pos_3=CC	path2=effect_obj>epinephrine_nmod	lemma_6=pressor	lemma_2=reduce	relType_3=cc	relation_6=neutral	path1=butyrophenone_conj<phenothiazine_nsubj	pos_6=NN	eib=False	lemma_7=effect	relType_7=obj	wib=reduce	relation_1=adverse	pos_2=VB	lemma_3=or	pos_8=IN	lpib=reduce_VB	lemma_4=reverse	relType_2=ROOT	relType_5=det	path=butyrophenone_conj<phenothiazine_nsubj<reduce_ROOT>effect_obj>epinephrine_nmod	pos_1=MD	relType_6=compound	lemma_5=the	pos_4=VB	pos_5=DT	relType_4=conj	pos_7=NN	lemma_8=of
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e0	DDI-DrugBank.d213.s0.e1	null	wib=iodine	relType_1=cc	pos_1=CC	path=<iodine_nsubj>excess_conj>iodine_compound	eib=False	path1=	lib=iodine	lpib=iodine_NN	path2=excess_conj>iodine_compound	lemma_1=or
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e0	DDI-DrugBank.d213.s0.e2	effect	relType_1=cc	pos_1=CC	pos_2=NN	relType_7=case	relation_4=adverse	lemma_3=may	relation_6=neutral	pos_6=NN	pos_3=MD	lib=iodine	relType_2=conj	wib=iodine	path=iodine_nsubj<decrease_ROOT>effect_obj>Carbimazole_nmod	relType_2=compound	lemma_2=iodine	relType_5=det	lemma_6=effect	lpib=iodine_NN	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_5=the	path1=iodine_nsubj	eib=True	pos_7=IN	pos_4=VB	pos_5=DT	lemma_4=decrease	relType_3=aux	lemma_2=excess	path2=effect_obj>Carbimazole_nmod	lemma_1=or
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e0	DDI-DrugBank.d213.s0.e3	null	relType_1=cc	pos_1=CC	path2=increase_conj>deficiency_nsubj>iodine_compound	pos_2=NN	relType_7=case	relType_10=det	relation_4=adverse	lemma_3=may	relType_8=punct	lemma_10=a	lemma_8=,	relation_6=neutral	pos_6=NN	pos_3=MD	lib=iodine	relType_2=conj	wib=iodine	lemma_9=and	pos_9=CC	pos_8=NNP	path=iodine_nsubj<decrease_ROOT>increase_conj>deficiency_nsubj>iodine_compound	relType_2=compound	lemma_2=iodine	relType_5=det	lemma_6=effect	lpib=iodine_NN	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_5=the	path1=iodine_nsubj	eib=True	pos_7=IN	relType_8=nmod	pos_4=VB	pos_5=DT	lemma_8=Carbimazole	pos_8=,	relType_3=aux	lemma_2=excess	relType_9=cc	lemma_4=decrease	lemma_1=or	pos_10=DT
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e0	DDI-DrugBank.d213.s0.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	relType_7=case	relType_10=det	pos_16=IN	relation_4=adverse	lemma_3=may	relType_8=punct	lemma_10=a	lemma_8=,	relation_6=neutral	pos_6=NN	lemma_12=can	lemma_15=effect	pos_3=MD	relType_12=aux	relType_11=nsubj	relType_14=det	relType_13=conj	lib=iodine	lemma_11=deficiency	lemma_14=the	relType_2=conj	lemma_16=of	wib=iodine	pos_13=VB	lemma_9=and	pos_9=CC	pos_8=NNP	pos_15=NN	lemma_11=iodine	relType_2=compound	lemma_2=iodine	relType_5=det	lemma_6=effect	lpib=iodine_NN	relation_15=beneficial	relType_4=ROOT	pos_14=DT	lemma_13=increase	lemma_7=of	relType_6=obj	pos_12=MD	relType_15=obj	relType_16=case	relation_17=neutral	lemma_5=the	pos_11=NN	path1=iodine_nsubj	eib=True	pos_7=IN	relType_8=nmod	pos_4=VB	relType_11=compound	pos_5=DT	lemma_8=Carbimazole	pos_8=,	path2=increase_conj>effect_obj>Carbimazole_nmod	relType_3=aux	path=iodine_nsubj<decrease_ROOT>increase_conj>effect_obj>Carbimazole_nmod	lemma_2=excess	relType_9=cc	lemma_4=decrease	lemma_1=or	pos_10=DT
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e1	DDI-DrugBank.d213.s0.e2	null	lpib=excess_NN	pos_2=MD	lemma_6=of	pos_3=VB	relType_6=case	path1=iodine_compound<excess_conj<iodine_nsubj	lemma_3=decrease	lemma_1=excess	eib=False	pos_6=IN	relType_2=aux	pos_1=NN	lemma_5=effect	pos_4=DT	path=iodine_compound<excess_conj<iodine_nsubj<decrease_ROOT>effect_obj>Carbimazole_nmod	lib=excess	relType_3=ROOT	lemma_4=the	relType_1=conj	pos_5=NN	relation_2=adverse	relType_5=obj	wib=excess	relation_4=neutral	lemma_2=may	relType_4=det	path2=effect_obj>Carbimazole_nmod
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e1	DDI-DrugBank.d213.s0.e3	null	path=iodine_compound<excess_conj<iodine_nsubj<decrease_ROOT>increase_conj>deficiency_nsubj>iodine_compound	path2=increase_conj>deficiency_nsubj>iodine_compound	lpib=excess_NN	lemma_9=a	pos_2=MD	lemma_6=of	pos_3=VB	relType_6=case	path1=iodine_compound<excess_conj<iodine_nsubj	lemma_3=decrease	lemma_1=excess	pos_6=IN	pos_7=,	pos_9=DT	relType_2=aux	pos_8=CC	lemma_7=,	pos_1=NN	lemma_5=effect	pos_4=DT	lib=excess	relType_3=ROOT	lemma_4=the	pos_7=NNP	lemma_7=Carbimazole	relType_7=nmod	relType_1=conj	lemma_8=and	pos_5=NN	eib=True	relation_2=adverse	relType_5=obj	relType_7=punct	wib=excess	relation_4=neutral	lemma_2=may	relType_4=det	relType_8=cc	relType_9=det
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e1	DDI-DrugBank.d213.s0.e4	null	lemma_14=effect	relType_12=conj	lemma_13=the	lpib=excess_NN	lemma_15=of	lemma_9=a	pos_2=MD	pos_11=MD	pos_13=DT	lemma_6=of	pos_3=VB	relType_6=case	path=iodine_compound<excess_conj<iodine_nsubj<decrease_ROOT>increase_conj>effect_obj>Carbimazole_nmod	path1=iodine_compound<excess_conj<iodine_nsubj	lemma_3=decrease	lemma_1=excess	relType_14=obj	pos_6=IN	relType_11=aux	pos_7=,	pos_9=DT	relType_2=aux	pos_8=CC	pos_10=NN	lemma_7=,	relType_10=compound	pos_14=NN	pos_1=NN	relation_15=neutral	lemma_5=effect	pos_4=DT	relType_15=case	lib=excess	lemma_12=increase	relType_3=ROOT	lemma_4=the	pos_7=NNP	lemma_7=Carbimazole	relType_7=nmod	lemma_11=can	lemma_10=deficiency	relType_10=nsubj	relType_1=conj	relation_13=beneficial	lemma_8=and	pos_12=VB	pos_15=IN	pos_5=NN	eib=True	relation_2=adverse	relType_5=obj	relType_7=punct	wib=excess	lemma_10=iodine	path2=increase_conj>effect_obj>Carbimazole_nmod	relType_13=det	lemma_2=may	relation_4=neutral	relType_4=det	relType_8=cc	relType_9=det
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e2	DDI-DrugBank.d213.s0.e3	null	wib=iodine	lemma_2=and	lemma_1=,	path2=increase_conj>deficiency_nsubj>iodine_compound	eib=False	pos_3=DT	path1=Carbimazole_nmod<effect_obj	pos_2=CC	pos_1=,	path=Carbimazole_nmod<effect_obj<decrease_ROOT>increase_conj>deficiency_nsubj>iodine_compound	lemma_3=a	lib=iodine	lpib=iodine_NN	relType_1=punct	relType_2=cc	relType_3=det
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e2	DDI-DrugBank.d213.s0.e4	null	lemma_1=,	pos_6=VB	relType_7=det	pos_1=,	lemma_6=increase	pos_9=IN	relType_2=cc	relation_8=neutral	pos_8=NN	lemma_2=and	relType_6=conj	lemma_5=can	lemma_4=deficiency	relType_8=obj	relType_9=case	lib=iodine	relType_5=aux	relType_3=det	lemma_3=a	pos_4=NN	relType_4=nsubj	pos_7=DT	wib=iodine	pos_5=MD	relType_4=compound	lemma_4=iodine	relation_6=beneficial	lpib=iodine_NN	path=Carbimazole_nmod<effect_obj<decrease_ROOT>increase_conj>effect_obj>Carbimazole_nmod	eib=True	pos_3=DT	lemma_9=of	path1=Carbimazole_nmod<effect_obj	pos_2=CC	lemma_8=effect	path2=increase_conj>effect_obj>Carbimazole_nmod	lemma_7=the	relType_1=punct
DDI-DrugBank.d213.s0	DDI-DrugBank.d213.s0.e3	DDI-DrugBank.d213.s0.e4	effect	lemma_3=increase	pos_2=MD	lib=deficiency	lemma_6=of	pos_3=VB	relType_6=case	eib=False	pos_6=IN	relType_2=aux	pos_1=NN	path=iodine_compound<deficiency_nsubj<increase_conj>effect_obj>Carbimazole_nmod	wib=deficiency	lemma_5=effect	pos_4=DT	lemma_1=deficiency	relType_3=conj	lemma_4=the	relType_1=nsubj	path1=iodine_compound<deficiency_nsubj	lemma_2=can	pos_5=NN	lpib=deficiency_NN	relType_5=obj	relation_4=neutral	relType_4=det	relation_2=beneficial	path2=effect_obj>Carbimazole_nmod
DDI-DrugBank.d213.s1	DDI-DrugBank.d213.s1.e0	DDI-DrugBank.d213.s1.e1	null	relType_1=cc	pos_1=CC	eib=False	path2=digitoxin_conj	path1=	lib=digitoxin	lpib=digitoxin_NN	lemma_1=and	wib=digitoxin	path=<digoxin_nmod>digitoxin_conj
DDI-DrugBank.d213.s1	DDI-DrugBank.d213.s1.e0	DDI-DrugBank.d213.s1.e2	mechanism	relType_1=cc	pos_1=CC	lemma_3=increase	pos_2=NN	lemma_6=take	pos_2=MD	lemma_5=patient	relType_5=nsubj	relation_3=beneficial	lib=digitoxin	pos_3=VB	wib=digitoxin	path=digoxin_nmod<concentration_nsubj<increase_ROOT>take_advcl>agent_obj	path1=digoxin_nmod<concentration_nsubj	pos_5=NNS	lpib=digitoxin_NN	relType_2=aux	relType_6=advcl	relType_2=conj	lemma_7=antithyroid	relType_7=amod	relType_3=ROOT	path2=take_advcl>agent_obj	relType_4=advmod	pos_6=VBP	pos_4=WRB	eib=True	lemma_4=when	pos_7=JJ	lemma_2=may	lemma_2=digitoxin	lemma_1=and
DDI-DrugBank.d213.s1	DDI-DrugBank.d213.s1.e1	DDI-DrugBank.d213.s1.e2	mechanism	relType_3=advmod	pos_6=JJ	relType_1=aux	lemma_1=may	relation_1=beneficial	relType_5=advcl	pos_5=VBP	relType_6=amod	path=digitoxin_conj<digoxin_nmod<concentration_nsubj<increase_ROOT>take_advcl>agent_obj	pos_2=VB	relType_4=nsubj	lemma_4=patient	lib=increase	pos_4=NNS	lemma_2=increase	path2=take_advcl>agent_obj	relType_2=ROOT	wib=increase	lemma_6=antithyroid	pos_1=MD	pos_3=WRB	eib=True	lpib=increase_VB	path1=digitoxin_conj<digoxin_nmod<concentration_nsubj	lemma_5=take	lemma_3=when
DDI-DrugBank.d213.s3	DDI-DrugBank.d213.s3.e0	DDI-DrugBank.d213.s3.e1	effect	path=agent_nsubj<decrease_ROOT>uptake_obj>i131_nmod	relType_1=aux	lemma_1=may	lemma_5=of	relType_5=case	pos_6=NN	lemma_4=uptake	path1=agent_nsubj	path2=uptake_obj>i131_nmod	relation_1=adverse	lpib=decrease_VB	pos_2=VB	pos_4=NN	relType_4=obj	relType_3=amod	relType_2=ROOT	wib=decrease	pos_5=IN	pos_1=MD	relType_6=compound	pos_3=JJ	lemma_3=thyroidal	eib=True	lemma_2=decrease	lemma_6=sodium	lemma_6=iodide	lib=decrease
DDI-DrugBank.d213.s3	DDI-DrugBank.d213.s3.e0	DDI-DrugBank.d213.s3.e2	null	lemma_10=uptake	relType_13=dep	relType_7=det	relType_1=aux	lemma_1=may	lemma_16=day	pos_11=MD	lemma_6=,	pos_9=IN	relType_8=appos	pos_16=NNS	lemma_5=of	relType_5=case	lemma_17=after	path=agent_nsubj<decrease_ROOT>occur_dep>withdrawal_obl>Carbimazole_nmod	pos_20=IN	pos_6=NN	lemma_4=uptake	pos_8=NN	pos_15=CD	relType_16=obl:npmod	relType_10=nmod	relType_14=advmod	pos_18=RB	lemma_14=to	relType_20=case	path1=agent_nsubj	relType_6=punct	relType_11=aux	relation_1=adverse	lpib=decrease_VB	pos_2=VB	relType_9=case	pos_10=NN	pos_19=NN	pos_17=RB	pos_4=NN	pos_7=DT	relType_4=obj	lemma_8=rebound	pos_13=RP	pos_14=IN	lemma_12=occur	relType_15=nummod	relType_3=amod	lemma_15=5	relType_2=ROOT	wib=decrease	pos_5=IN	lemma_19=withdrawal	relType_17=advmod	pos_1=MD	lemma_11=may	lemma_18=sudden	lemma_13=up	pos_6=,	pos_12=VB	path2=occur_dep>withdrawal_obl>Carbimazole_nmod	relType_6=compound	pos_3=JJ	lemma_3=thyroidal	eib=True	relType_18=advmod	relType_12=dep	relType_19=obl	lemma_2=decrease	lemma_7=a	lemma_6=sodium	lemma_6=iodide	relType_6=nmod	lemma_9=in	lib=decrease	lemma_6=i131	lemma_20=of
DDI-DrugBank.d213.s3	DDI-DrugBank.d213.s3.e1	DDI-DrugBank.d213.s3.e2	null	pos_8=RP	pos_2=DT	pos_7=VB	lemma_1=,	relType_8=dep	relType_9=advmod	lemma_15=of	lemma_6=may	pos_1=,	lemma_4=in	pos_9=IN	lemma_2=a	lemma_8=up	lemma_14=withdrawal	lemma_3=rebound	lemma_11=day	path=i131_nmod<uptake_obj<decrease_ROOT>occur_dep>withdrawal_obl>Carbimazole_nmod	eib=False	relType_3=appos	relType_12=advmod	pos_11=NNS	lemma_9=to	lib=rebound	pos_13=RB	lemma_5=uptake	pos_14=NN	relType_14=obl	relType_15=case	relType_13=advmod	pos_12=RB	relType_6=aux	pos_10=CD	pos_4=IN	lemma_7=occur	lemma_12=after	relType_4=case	relType_5=nmod	pos_6=MD	lemma_13=sudden	relType_10=nummod	pos_15=IN	path2=occur_dep>withdrawal_obl>Carbimazole_nmod	pos_5=NN	relType_7=dep	relType_11=obl:npmod	pos_3=NN	relType_2=det	path1=i131_nmod<uptake_obj	relType_1=punct	lpib=rebound_NN	wib=rebound	lemma_10=5
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e1	null	pos_2=NNS	wib=Interactions	path2=interaction_dep>carvedilol_nmod	lpib=interaction_NNS	path=debrisoquin_nmod<metabolizer_nsubj:pass>interaction_dep>carvedilol_nmod	relType_2=dep	pos_3=IN	eib=False	path1=debrisoquin_nmod	pos_1=:	lemma_3=of	relType_1=punct	lemma_2=interaction	relType_3=case	lemma_1=:	lib=interaction
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e2	null	pos_3=IN	relType_7=case	lemma_11=as	relType_4=nmod	lemma_6=inhibitor	pos_8=NN	wib=Interactions	path1=debrisoquin_nmod	lemma_9=(	relType_10=case	lemma_2=interaction	pos_4=NN	lemma_1=:	lib=interaction	pos_11=IN	lemma_4=with	pos_5=JJ	relType_2=dep	lemma_10=such	relType_5=amod	pos_10=JJ	pos_4=IN	relType_11=fixed	pos_1=:	relType_4=case	pos_9=-LRB-	path=debrisoquin_nmod<metabolizer_nsubj:pass>interaction_dep>inhibitor_nmod>quinidine_nmod	lemma_5=strong	relType_9=punct	relType_3=case	lemma_7=of	pos_2=NNS	lpib=interaction_NNS	path2=interaction_dep>inhibitor_nmod>quinidine_nmod	eib=True	pos_7=IN	relType_8=nmod	pos_6=NNS	lemma_3=of	relType_1=punct	relType_6=nmod	lemma_8=cyp2d6	lemma_4=carvedilol
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e3	null	pos_3=IN	relType_7=case	lemma_11=as	relType_4=nmod	lemma_6=inhibitor	path=debrisoquin_nmod<metabolizer_nsubj:pass>interaction_dep>inhibitor_nmod>quinidine_nmod>fluoxetine_conj	pos_8=NN	wib=Interactions	lemma_12=,	path1=debrisoquin_nmod	relType_12=nmod	lemma_9=(	pos_12=,	pos_12=NN	relType_12=punct	relType_10=case	lemma_2=interaction	pos_4=NN	lemma_1=:	lib=interaction	pos_11=IN	lemma_4=with	pos_5=JJ	relType_2=dep	lemma_10=such	relType_5=amod	pos_10=JJ	pos_4=IN	relType_11=fixed	pos_1=:	relType_4=case	pos_9=-LRB-	lemma_5=strong	relType_9=punct	relType_3=case	path2=interaction_dep>inhibitor_nmod>quinidine_nmod>fluoxetine_conj	lemma_7=of	pos_2=NNS	lpib=interaction_NNS	eib=True	pos_7=IN	relType_8=nmod	lemma_12=quinidine	pos_6=NNS	lemma_3=of	relType_1=punct	relType_6=nmod	lemma_8=cyp2d6	lemma_4=carvedilol
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e4	null	pos_13=,	pos_3=IN	relType_7=case	lemma_13=,	relType_13=punct	lemma_11=as	relType_4=nmod	lemma_6=inhibitor	pos_8=NN	wib=Interactions	lemma_12=,	path1=debrisoquin_nmod	relType_12=nmod	lemma_9=(	pos_12=,	pos_12=NN	relType_12=punct	relType_10=case	lemma_2=interaction	pos_13=NN	relType_13=conj	pos_4=NN	lemma_1=:	lib=interaction	pos_11=IN	lemma_4=with	pos_5=JJ	relType_2=dep	lemma_10=such	relType_5=amod	pos_10=JJ	pos_4=IN	lemma_13=fluoxetine	relType_11=fixed	pos_1=:	relType_4=case	pos_9=-LRB-	lemma_5=strong	relType_9=punct	relType_3=case	path2=interaction_dep>inhibitor_nmod>quinidine_nmod>paroxetine_conj	pos_2=NNS	lemma_7=of	lpib=interaction_NNS	eib=True	pos_7=IN	relType_8=nmod	lemma_12=quinidine	pos_6=NNS	lemma_3=of	path=debrisoquin_nmod<metabolizer_nsubj:pass>interaction_dep>inhibitor_nmod>quinidine_nmod>paroxetine_conj	relType_1=punct	relType_6=nmod	lemma_8=cyp2d6	lemma_4=carvedilol
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e5	null	pos_13=,	relType_14=punct	pos_3=IN	relType_7=case	lemma_13=,	relType_13=punct	path2=interaction_dep>inhibitor_nmod>quinidine_nmod>propafenone_conj	lemma_11=as	relType_4=nmod	lemma_6=inhibitor	path=debrisoquin_nmod<metabolizer_nsubj:pass>interaction_dep>inhibitor_nmod>quinidine_nmod>propafenone_conj	pos_8=NN	wib=Interactions	lemma_12=,	path1=debrisoquin_nmod	pos_14=,	relType_12=nmod	lemma_9=(	pos_12=,	pos_12=NN	relType_12=punct	relType_10=case	lemma_2=interaction	pos_13=NN	relType_13=conj	pos_4=NN	pos_14=NN	lemma_1=:	lib=interaction	pos_11=IN	lemma_4=with	pos_5=JJ	relType_2=dep	lemma_10=such	relType_5=amod	pos_10=JJ	pos_4=IN	lemma_13=fluoxetine	relType_11=fixed	pos_1=:	relType_4=case	lemma_14=paroxetine	relType_15=cc	pos_9=-LRB-	lemma_5=strong	relType_9=punct	relType_3=case	lemma_15=and	lemma_7=of	pos_2=NNS	lemma_14=,	lpib=interaction_NNS	eib=True	pos_7=IN	relType_8=nmod	lemma_12=quinidine	pos_6=NNS	pos_15=CC	lemma_3=of	relType_1=punct	relType_6=nmod	lemma_8=cyp2d6	lemma_4=carvedilol	relType_14=conj
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e0	DDI-DrugBank.d269.s1.e6	null	lemma_27=expect	pos_34=NN	lemma_13=,	lemma_23=this	relType_34=compound	lemma_36=+	lemma_32=of	wib=Interactions	lemma_12=,	pos_18=RB	pos_29=VB	pos_12=,	relType_23=det	lemma_2=interaction	pos_13=NN	pos_32=IN	lemma_16=propafenone	lemma_25=would	relType_2=dep	lemma_10=such	pos_24=NNS	relType_31=obj	pos_26=VB	lemma_28=to	pos_1=:	relType_26=aux:pass	relType_16=punct	lemma_15=and	lemma_21=,	lemma_37=)	relType_30=compound	pos_7=IN	pos_27=VBN	pos_6=NNS	pos_15=CC	relType_17=aux	relType_21=punct	relType_32=case	lemma_33=the	relType_37=punct	pos_13=,	relType_28=mark	pos_36=SYM	relType_7=case	pos_28=TO	pos_35=-LRB-	relType_27=conj	lemma_38=enantiomer	relType_36=dep	lemma_11=as	relType_4=nmod	pos_20=VBN	lemma_6=inhibitor	pos_30=NN	pos_8=NN	lemma_19=be	path=debrisoquin_nmod<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	lemma_4=carvedilol	lemma_39=of	relType_12=nmod	lemma_24=drug	pos_37=-RRB-	relType_12=punct	relType_13=conj	lib=interaction	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	lemma_13=fluoxetine	lemma_14=paroxetine	pos_16=NN	lemma_5=strong	relType_19=aux:pass	lemma_14=,	pos_33=DT	lemma_26=be	relType_1=punct	lemma_31=level	relType_14=punct	pos_3=IN	relType_24=nsubj:pass	lemma_30=blood	pos_14=,	relType_22=cc	lemma_20=study	relType_20=ROOT	pos_25=MD	pos_14=NN	lemma_17=have	lemma_1=:	pos_11=IN	lemma_4=with	lemma_18=not	relType_5=amod	pos_4=IN	pos_38=NN	relType_11=fixed	pos_16=-RRB-	pos_9=-LRB-	relType_35=punct	pos_19=VBN	relType_6=nmod	relType_14=conj	relType_39=case	pos_39=IN	relType_38=nmod	relType_13=punct	pos_17=VBP	lemma_34=r	lemma_22=but	relType_29=xcomp	pos_22=CC	pos_21=,	path1=debrisoquin_nmod<metabolizer_nsubj:pass	lemma_35=(	lemma_9=(	relType_10=case	relation_33=beneficial	pos_4=NN	lemma_16=)	pos_5=JJ	pos_10=JJ	relType_4=case	pos_31=NNS	relType_15=cc	pos_23=DT	lemma_29=increase	relType_9=punct	relType_3=case	lemma_7=of	pos_2=NNS	relType_33=det	lpib=interaction_NNS	eib=True	relType_8=nmod	relType_18=advmod	lemma_3=of	relType_25=aux	pos_12=NN	lemma_8=cyp2d6	lemma_12=quinidine	relType_16=conj
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e1	DDI-DrugBank.d269.s1.e2	null	relType_1=case	relType_7=case	lemma_5=cyp2d6	wib=strong	lemma_6=(	pos_2=JJ	pos_6=-LRB-	lemma_7=such	pos_3=NNS	lemma_8=as	eib=False	relType_6=punct	lemma_2=strong	pos_1=IN	lemma_3=inhibitor	pos_8=IN	pos_4=IN	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	lemma_1=with	path2=inhibitor_nmod>quinidine_nmod	pos_5=NN	path1=carvedilol_nmod	lib=strong	pos_7=JJ	relType_8=fixed	path=carvedilol_nmod<interaction_dep>inhibitor_nmod>quinidine_nmod	lpib=strong_JJ	lemma_4=of
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e1	DDI-DrugBank.d269.s1.e3	null	relType_1=case	relType_7=case	lemma_5=cyp2d6	wib=strong	lemma_6=(	lemma_9=,	relType_9=nmod	pos_2=JJ	pos_6=-LRB-	lemma_7=such	pos_3=NNS	lemma_8=as	relType_6=punct	lemma_2=strong	pos_1=IN	pos_9=NN	lemma_3=inhibitor	lemma_9=quinidine	pos_8=IN	pos_4=IN	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	relType_9=punct	lemma_1=with	pos_5=NN	path=carvedilol_nmod<interaction_dep>inhibitor_nmod>quinidine_nmod>fluoxetine_conj	path1=carvedilol_nmod	eib=True	lib=strong	path2=inhibitor_nmod>quinidine_nmod>fluoxetine_conj	pos_7=JJ	relType_8=fixed	pos_9=,	lpib=strong_JJ	lemma_4=of
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e1	DDI-DrugBank.d269.s1.e4	null	relType_1=case	relType_10=punct	relType_7=case	lemma_5=cyp2d6	lemma_10=,	wib=strong	lemma_6=(	lemma_9=,	relType_9=nmod	pos_2=JJ	path=carvedilol_nmod<interaction_dep>inhibitor_nmod>quinidine_nmod>paroxetine_conj	pos_6=-LRB-	lemma_7=such	pos_3=NNS	lemma_8=as	relType_10=conj	relType_6=punct	lemma_2=strong	lemma_10=fluoxetine	pos_1=IN	pos_10=NN	pos_9=NN	lemma_3=inhibitor	lemma_9=quinidine	pos_8=IN	pos_4=IN	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	relType_9=punct	lemma_1=with	path2=inhibitor_nmod>quinidine_nmod>paroxetine_conj	pos_5=NN	pos_10=,	path1=carvedilol_nmod	eib=True	lib=strong	pos_7=JJ	relType_8=fixed	pos_9=,	lpib=strong_JJ	lemma_4=of
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e1	DDI-DrugBank.d269.s1.e5	null	path=carvedilol_nmod<interaction_dep>inhibitor_nmod>quinidine_nmod>propafenone_conj	relType_1=case	relType_10=punct	relType_7=case	lemma_11=,	lemma_5=cyp2d6	lemma_10=,	lemma_11=paroxetine	wib=strong	relType_12=cc	lemma_6=(	lemma_9=,	relType_9=nmod	pos_2=JJ	pos_12=CC	relType_11=conj	pos_6=-LRB-	lemma_7=such	pos_3=NNS	lemma_8=as	relType_10=conj	relType_6=punct	relType_11=punct	lemma_2=strong	lemma_10=fluoxetine	pos_1=IN	pos_10=NN	pos_9=NN	lemma_3=inhibitor	lemma_9=quinidine	path2=inhibitor_nmod>quinidine_nmod>propafenone_conj	pos_8=IN	pos_4=IN	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	pos_11=,	relType_9=punct	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	path1=carvedilol_nmod	eib=True	lib=strong	pos_7=JJ	relType_8=fixed	lemma_12=and	pos_9=,	lpib=strong_JJ	lemma_4=of
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e1	DDI-DrugBank.d269.s1.e6	null	relType_26=xcomp	lemma_10=,	lemma_30=the	lemma_11=paroxetine	lemma_21=drug	relType_32=punct	lemma_9=,	pos_12=CC	pos_2=JJ	pos_35=NN	pos_21=NNS	pos_3=NNS	lemma_10=fluoxetine	pos_10=NN	pos_13=NN	lemma_14=have	pos_36=IN	pos_16=VBN	relType_23=aux:pass	pos_26=VB	pos_25=TO	pos_19=CC	lemma_28=level	lemma_17=study	pos_10=,	relType_25=mark	pos_7=JJ	lemma_15=not	relType_34=punct	pos_15=RB	relType_1=case	relType_7=case	lemma_5=cyp2d6	pos_29=IN	pos_23=VB	lemma_8=as	relType_10=conj	lemma_2=strong	pos_1=IN	relType_13=conj	pos_9=NN	pos_8=IN	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	pos_27=NN	lemma_32=(	lemma_36=of	pos_24=VBN	pos_5=NN	relType_33=dep	pos_11=NN	relType_28=obj	pos_31=NN	lemma_31=r	lemma_13=propafenone	relation_29=beneficial	pos_9=,	lpib=strong_JJ	lemma_33=+	path1=carvedilol_nmod<interaction_dep<metabolizer_nsubj:pass	relType_10=punct	lemma_19=but	lemma_11=,	relType_29=case	pos_14=VBP	wib=strong	relType_12=cc	lemma_6=(	relType_21=nsubj:pass	pos_17=VBN	relType_11=conj	relType_31=compound	lemma_7=such	pos_32=-LRB-	lemma_22=would	relType_11=punct	pos_33=SYM	lemma_16=be	lemma_9=quinidine	pos_28=NNS	lemma_20=this	lemma_27=blood	pos_4=IN	relType_2=amod	relType_3=nmod	lemma_25=to	pos_22=MD	pos_13=-RRB-	relType_35=nmod	lemma_12=and	lemma_23=be	pos_30=DT	lemma_4=of	relType_20=det	lemma_26=increase	relType_27=compound	pos_34=-RRB-	lemma_34=)	relType_13=punct	lemma_29=of	pos_20=DT	relType_9=nmod	relType_16=aux:pass	relType_17=ROOT	pos_6=-LRB-	relType_6=punct	lemma_35=enantiomer	lemma_24=expect	path=carvedilol_nmod<interaction_dep<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	lemma_3=inhibitor	pos_18=,	lemma_18=,	relType_18=punct	relType_4=case	relType_24=conj	relType_5=nmod	relType_14=aux	relType_22=aux	relType_19=cc	pos_11=,	relType_9=punct	lemma_1=with	eib=True	lemma_13=)	lib=strong	relType_8=fixed	relType_15=advmod	relType_36=case	relType_30=det
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e2	DDI-DrugBank.d269.s1.e3	null	wib=fluoxetine	path2=fluoxetine_conj	lemma_1=,	lpib=fluoxetine_NN	eib=False	path1=	pos_1=,	lib=fluoxetine	relType_1=punct	path=<quinidine_nmod>fluoxetine_conj
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e2	DDI-DrugBank.d269.s1.e4	null	wib=fluoxetine	lemma_2=fluoxetine	lemma_1=,	lpib=fluoxetine_NN	pos_2=NN	eib=True	path=<quinidine_nmod>paroxetine_conj	path1=	pos_1=,	pos_2=,	lib=fluoxetine	relType_2=conj	relType_1=punct	path2=paroxetine_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e2	DDI-DrugBank.d269.s1.e5	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_4=cc	relType_2=punct	lpib=fluoxetine_NN	path2=propafenone_conj	path=<quinidine_nmod>propafenone_conj	relType_2=conj	lemma_2=,	wib=fluoxetine	lemma_2=fluoxetine	lemma_3=,	relType_3=conj	lib=fluoxetine	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_3=paroxetine	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e2	DDI-DrugBank.d269.s1.e6	effect	pos_2=NN	lemma_7=not	relType_11=cc	relation_20=beneficial	lemma_10=,	pos_13=NNS	lemma_17=to	relType_9=ROOT	lpib=fluoxetine_NN	pos_7=RB	relType_27=nmod	lemma_6=have	relType_20=obj	relType_23=compound	pos_16=VBN	lemma_3=,	pos_5=-RRB-	lemma_5=propafenone	lemma_22=the	lib=fluoxetine	pos_25=SYM	relType_21=case	relType_13=nsubj:pass	pos_3=,	pos_10=,	lemma_4=and	pos_2=,	pos_12=DT	lemma_1=,	pos_8=VBN	pos_1=,	pos_24=-LRB-	lemma_13=drug	relType_2=punct	lemma_23=r	pos_17=TO	relType_8=aux:pass	relType_2=conj	lemma_2=,	lemma_5=)	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	relType_19=compound	lemma_2=fluoxetine	relType_15=aux:pass	pos_27=NN	lemma_27=enantiomer	lemma_9=study	pos_22=DT	pos_5=NN	relType_25=dep	relType_26=punct	relType_1=punct	lemma_21=of	relType_3=punct	relType_10=punct	lemma_28=of	relType_24=punct	relType_12=det	pos_23=NN	relType_17=mark	relType_18=xcomp	pos_21=IN	path1=quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass	relType_3=conj	relType_6=aux	pos_18=VB	pos_11=CC	relType_5=conj	path=quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	lemma_26=)	lemma_15=be	lemma_16=expect	relType_28=case	pos_4=CC	relType_22=det	lemma_14=would	relType_7=advmod	lemma_20=level	pos_26=-RRB-	relType_4=cc	lemma_19=blood	lemma_18=increase	pos_19=NN	pos_9=VBN	wib=fluoxetine	pos_15=VB	lemma_8=be	relType_5=punct	relType_14=aux	pos_20=NNS	pos_6=VBP	pos_14=MD	eib=True	pos_3=NN	lemma_3=paroxetine	pos_28=IN	lemma_24=(	lemma_25=+	lemma_12=this	lemma_11=but	relType_16=conj
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e3	DDI-DrugBank.d269.s1.e4	null	path2=paroxetine_conj	path=fluoxetine_conj<quinidine_nmod>paroxetine_conj	lemma_1=,	eib=False	path1=fluoxetine_conj	pos_1=,	relType_1=punct	lib=paroxetine	lpib=paroxetine_NN	wib=paroxetine
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e3	DDI-DrugBank.d269.s1.e5	null	lemma_2=paroxetine	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lib=paroxetine	relType_3=cc	relType_2=punct	path2=propafenone_conj	lpib=paroxetine_NN	relType_2=conj	wib=paroxetine	lemma_2=,	path1=fluoxetine_conj	path=fluoxetine_conj<quinidine_nmod>propafenone_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e3	DDI-DrugBank.d269.s1.e6	effect	relType_22=compound	pos_23=-LRB-	pos_2=NN	pos_3=CC	lib=paroxetine	lemma_9=,	lemma_5=have	relation_18=beneficial	relType_26=nmod	pos_4=-RRB-	lemma_18=blood	pos_26=NN	lemma_22=r	pos_18=NN	relType_4=punct	lemma_26=enantiomer	lemma_4=)	relType_11=det	lemma_21=the	lemma_23=(	pos_2=,	lemma_10=but	relType_17=xcomp	path1=fluoxetine_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass	lemma_17=increase	lemma_20=of	lemma_1=,	lemma_19=level	pos_8=VBN	lemma_7=be	pos_22=NN	pos_1=,	pos_19=NNS	relType_2=punct	relType_3=cc	relType_20=case	lemma_4=propafenone	pos_15=VBN	lpib=paroxetine_NN	relType_2=conj	lemma_2=,	lemma_13=would	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	lemma_12=drug	relType_21=det	pos_14=VB	relType_8=ROOT	pos_6=RB	relType_25=punct	lemma_3=and	pos_9=,	relType_1=punct	relType_10=cc	lemma_27=of	pos_20=IN	pos_5=VBP	pos_10=CC	relType_14=aux:pass	path=fluoxetine_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	relType_5=aux	lemma_15=expect	lemma_14=be	pos_16=TO	lemma_25=)	relType_15=conj	relType_27=case	relType_19=obj	lemma_8=study	lemma_16=to	relType_23=punct	pos_24=SYM	lemma_2=paroxetine	pos_25=-RRB-	relType_12=nsubj:pass	lemma_24=+	relType_13=aux	lemma_11=this	pos_27=IN	wib=paroxetine	pos_4=NN	relType_24=dep	lemma_6=not	pos_12=NNS	relType_16=mark	pos_17=VB	relType_7=aux:pass	pos_11=DT	relType_9=punct	pos_7=VBN	eib=True	relType_18=compound	relType_4=conj	pos_21=DT	relType_6=advmod	pos_13=MD
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e4	DDI-DrugBank.d269.s1.e5	null	path=paroxetine_conj<quinidine_nmod>propafenone_conj	lemma_2=and	lemma_1=,	lib=propafenone	eib=False	path2=propafenone_conj	pos_2=CC	lpib=propafenone_NN	pos_1=,	wib=propafenone	relType_1=punct	relType_2=cc	path1=paroxetine_conj
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e4	DDI-DrugBank.d269.s1.e6	effect	relType_6=aux:pass	lemma_12=would	relType_8=punct	relType_2=cc	lemma_2=and	relType_15=mark	lemma_7=study	path1=paroxetine_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass	relType_17=compound	lemma_15=to	relType_13=aux:pass	relType_22=punct	pos_9=CC	lemma_23=+	lemma_22=(	pos_14=VBN	path=paroxetine_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	pos_26=IN	relType_18=obj	lemma_1=,	pos_18=NNS	pos_1=,	lemma_6=be	relation_16=beneficial	relType_25=nmod	pos_16=VB	lemma_20=the	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	relType_23=dep	lemma_24=)	relType_21=compound	relType_4=aux	lemma_10=this	relType_5=advmod	lemma_3=propafenone	pos_3=-RRB-	relType_19=case	relType_1=punct	relType_3=punct	pos_8=,	relType_10=det	pos_15=TO	relType_24=punct	lemma_11=drug	lemma_8=,	lemma_17=blood	relType_16=xcomp	pos_17=NN	pos_4=VBP	lib=propafenone	lemma_9=but	wib=propafenone	pos_6=VBN	pos_13=VB	lemma_19=of	lemma_18=level	relType_3=conj	lpib=propafenone_NN	pos_25=NN	lemma_26=of	lemma_21=r	relType_11=nsubj:pass	lemma_25=enantiomer	lemma_16=increase	pos_12=MD	relType_14=conj	relType_20=det	pos_10=DT	pos_19=IN	lemma_4=have	pos_23=SYM	relType_26=case	pos_20=DT	pos_11=NNS	relType_12=aux	lemma_14=expect	lemma_13=be	lemma_5=not	relType_7=ROOT	pos_5=RB	lemma_3=)	pos_7=VBN	pos_24=-RRB-	pos_22=-LRB-	eib=True	pos_3=NN	pos_2=CC	relType_9=cc	pos_21=NN
DDI-DrugBank.d269.s1	DDI-DrugBank.d269.s1.e5	DDI-DrugBank.d269.s1.e6	effect	pos_20=-LRB-	lemma_19=r	lemma_4=be	lemma_3=not	lemma_6=,	lemma_14=increase	lemma_21=+	lemma_5=study	pos_13=TO	relType_24=case	relType_11=aux:pass	relType_22=punct	lemma_13=to	relType_4=aux:pass	pos_24=IN	relType_15=compound	lemma_22=)	relType_14=xcomp	pos_11=VB	relType_13=mark	relType_5=ROOT	pos_22=-RRB-	path=propafenone_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass<study_ROOT>expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	pos_8=DT	lemma_15=blood	lemma_11=be	pos_16=NNS	pos_18=DT	pos_10=MD	relType_9=nsubj:pass	relType_21=dep	pos_4=VBN	path2=expect_conj>increase_xcomp>level_obj>enantiomer_nmod>carvedilol_nmod	relType_19=compound	pos_1=-RRB-	pos_2=VBP	pos_14=VB	lpib=have_VBP	relation_13=beneficial	wib=have	relType_18=det	pos_21=SYM	pos_12=VBN	relType_1=punct	lemma_18=the	pos_3=RB	relType_7=cc	lemma_7=but	lemma_24=of	pos_17=IN	pos_23=NN	relType_10=aux	lemma_12=expect	lemma_23=enantiomer	relType_2=aux	relType_17=case	relType_23=nmod	relType_16=obj	lemma_17=of	relType_20=punct	relType_8=det	relType_12=conj	relType_3=advmod	lemma_2=have	lemma_9=drug	lemma_1=)	lemma_20=(	lemma_8=this	eib=False	relType_6=punct	pos_9=NNS	pos_19=NN	lib=have	pos_15=NN	pos_7=CC	lemma_16=level	path1=propafenone_conj<quinidine_nmod<inhibitor_nmod<interaction_dep<metabolizer_nsubj:pass	lemma_10=would	pos_6=,	pos_5=VBN
DDI-DrugBank.d269.s3	DDI-DrugBank.d269.s3.e1	DDI-DrugBank.d269.s3.e2	null	wib=monoamine	relType_1=cc	pos_1=CC	pos_2=NN	eib=True	relType_2=compound	lemma_2=oxidase	lib=monoamine	path2=inhibitor_conj	path1=reserpine_conj	path=reserpine_conj<g._dep>inhibitor_conj	lemma_2=monoamine	lpib=monoamine_NN	lemma_1=and
DDI-DrugBank.d269.s4	DDI-DrugBank.d269.s4.e0	DDI-DrugBank.d269.s4.e1	null	path1=	lemma_3=administration	pos_2=JJ	lib=concomitant	wib=Concomitant	eib=False	path=<clonidine_ROOT>potentiate_appos>administration_nsubj>clonidine_nmod	lpib=concomitant_JJ	lemma_1=:	lemma_2=concomitant	path2=potentiate_appos>administration_nsubj>clonidine_nmod	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_3=nsubj	pos_3=NN	relType_1=punct	lemma_4=of
DDI-DrugBank.d269.s4	DDI-DrugBank.d269.s4.e0	DDI-DrugBank.d269.s4.e2	null	path1=	lemma_3=administration	pos_2=JJ	relType_5=case	lib=concomitant	wib=Concomitant	lemma_5=with	lpib=concomitant_JJ	lemma_1=:	path2=potentiate_appos>administration_nsubj>agent_nmod	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	relType_3=nsubj	pos_5=NN	eib=True	lemma_5=clonidine	pos_3=NN	path=<clonidine_ROOT>potentiate_appos>administration_nsubj>agent_nmod	relType_1=punct	lemma_4=of
DDI-DrugBank.d269.s4	DDI-DrugBank.d269.s4.e1	DDI-DrugBank.d269.s4.e2	effect	lemma_1=with	lpib=agent_NNS	relType_1=case	wib=agents	path=clonidine_nmod<administration_nsubj>agent_nmod	lib=agent	eib=False	path2=agent_nmod	path1=clonidine_nmod	pos_1=IN
DDI-DrugBank.d269.s5	DDI-DrugBank.d269.s5.e0	DDI-DrugBank.d269.s5.e1	advise	relType_1=cc	relType_1=case	pos_1=CC	lemma_1=property	path1=	pos_1=HYPH	lib=b	path=<agent_nmod>property_nmod>clonidine_conj	pos_1=IN	lemma_1=block	relType_1=nmod	pos_1=NN	wib=b	lemma_1=and	relation_3=adverse	lemma_1=-	path2=property_nmod>clonidine_conj	pos_1=VBG	lpib=b_NN	lemma_1=with	pos_1=NNS	eib=True	lemma_1=b	relType_1=amod	relType_1=punct	relType_1=obl
DDI-DrugBank.d269.s5	DDI-DrugBank.d269.s5.e0	DDI-DrugBank.d269.s5.e2	null	relType_1=cc	relType_1=case	pos_1=CC	pos_3=TO	pos_2=NN	relType_7=det	lemma_4=be	relType_8=amod	lemma_1=property	lemma_6=,	relType_8=punct	pos_1=HYPH	path2=agent_nsubj:pass	relType_8=obl	pos_8=NN	relType_2=cop	relType_5=advcl	lib=b	lemma_5=terminate	relType_6=punct	relation_15=adverse	pos_8=HYPH	pos_1=IN	lemma_1=block	relType_1=nmod	relType_2=conj	pos_1=NN	pos_7=DT	wib=b	lemma_1=and	path=agent_nmod<treatment_nsubj:pass<terminate_advcl<discontinue_ROOT>agent_nsubj:pass	lemma_8=b	relation_3=adverse	path1=agent_nmod<treatment_nsubj:pass<terminate_advcl	pos_8=VBG	lemma_1=-	lemma_3=to	relType_4=aux:pass	relType_3=mark	pos_6=,	lemma_8=block	pos_1=VBG	lpib=b_NN	lemma_1=with	pos_2=VBZ	pos_1=NNS	eib=True	pos_4=VB	lemma_8=-	lemma_2=clonidine	lemma_2=be	lemma_1=b	relType_1=amod	lemma_7=the	relType_1=punct	pos_5=VBN	relType_1=obl
DDI-DrugBank.d269.s5	DDI-DrugBank.d269.s5.e1	DDI-DrugBank.d269.s5.e2	null	pos_6=DT	pos_5=,	lemma_4=terminate	pos_7=VBG	pos_3=VB	relType_3=aux:pass	path2=agent_nsubj:pass	relType_2=mark	lemma_7=-	relation_8=adverse	lemma_6=the	lemma_1=be	lemma_2=to	pos_4=VBN	relType_7=amod	lib=be	lemma_7=b	pos_7=HYPH	lemma_5=,	relType_5=punct	lemma_3=be	path1=clonidine_conj<property_nmod<agent_nmod<treatment_nsubj:pass<terminate_advcl	lemma_7=block	wib=is	relType_6=det	relType_1=cop	relType_7=obl	path=clonidine_conj<property_nmod<agent_nmod<treatment_nsubj:pass<terminate_advcl<discontinue_ROOT>agent_nsubj:pass	pos_1=VBZ	eib=True	relType_7=punct	lpib=be_VBZ	relType_4=advcl	pos_7=NN	pos_2=TO
DDI-DrugBank.d269.s7	DDI-DrugBank.d269.s7.e0	DDI-DrugBank.d269.s7.e1	null	lemma_6=trough	lib=modest	lemma_3=increase	path1=	lemma_4=in	relType_3=nsubj:pass	pos_2=JJ	lpib=modest_JJ	pos_6=NN	path2=observe_appos>increase_nsubj:pass>concentration_nmod>cyclosporine_compound	pos_3=NNS	eib=False	wib=Modest	lemma_1=:	path=<cyclosporine_ROOT>observe_appos>increase_nsubj:pass>concentration_nmod>cyclosporine_compound	pos_5=JJ	relType_5=amod	lemma_2=modest	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_6=compound	relType_1=punct	relation_2=beneficial	lemma_5=mean
DDI-DrugBank.d269.s7	DDI-DrugBank.d269.s7.e0	DDI-DrugBank.d269.s7.e2	null	pos_7=NNS	lemma_6=trough	lib=modest	lemma_3=increase	relType_7=compound	path1=	relType_12=case	lemma_4=in	relType_3=nsubj:pass	pos_2=JJ	lemma_9=observe	lpib=modest_JJ	pos_6=NN	lemma_12=of	pos_3=NNS	lemma_7=concentration	wib=Modest	relType_8=aux:pass	path2=observe_appos>initiation_obl>treatment_nmod>carvedilol_compound	lemma_7=cyclosporine	relType_10=case	pos_9=VBN	relType_9=appos	pos_12=IN	lemma_1=:	pos_8=VBD	pos_5=JJ	relType_5=amod	lemma_8=be	lemma_2=modest	pos_4=IN	relType_2=amod	path=<cyclosporine_ROOT>observe_appos>initiation_obl>treatment_nmod>carvedilol_compound	pos_1=:	relType_4=case	relType_7=nmod	relType_11=obl	relType_6=compound	lemma_11=initiation	pos_11=NN	eib=True	pos_10=VBG	lemma_10=follow	relType_1=punct	pos_7=NN	relation_2=beneficial	lemma_5=mean
DDI-DrugBank.d269.s7	DDI-DrugBank.d269.s7.e1	DDI-DrugBank.d269.s7.e2	mechanism	lemma_4=follow	lemma_3=observe	lpib=concentration_NNS	pos_3=VBN	path=cyclosporine_compound<concentration_nmod<increase_nsubj:pass<observe_appos>initiation_obl>treatment_nmod>carvedilol_compound	lemma_6=of	lemma_1=concentration	relType_6=case	eib=False	relType_3=appos	lemma_5=initiation	pos_6=IN	path1=cyclosporine_compound<concentration_nmod<increase_nsubj:pass	pos_2=VBD	relType_1=nmod	wib=concentrations	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_4=VBG	pos_5=NN	pos_1=NNS	path2=initiation_obl>treatment_nmod>carvedilol_compound	lib=concentration	lemma_2=be
DDI-DrugBank.d269.s8	DDI-DrugBank.d269.s8.e0	DDI-DrugBank.d269.s8.e1	null	lemma_5=in	relType_1=aux	path=cyclosporine_nmod<dose_nsubj:pass<reduce_ROOT>maintain_advcl>concentration_obj>cyclosporine_compound	relType_8=advcl	lemma_4=reduce	pos_3=VB	relType_3=aux:pass	path2=maintain_advcl>concentration_obj>cyclosporine_compound	relType_7=mark	relType_2=mark	pos_6=NN	lpib=have_VBD	relType_5=mark	pos_1=VBD	eib=False	lemma_7=to	lemma_2=to	lemma_1=have	path1=cyclosporine_nmod<dose_nsubj:pass	lib=have	pos_7=TO	wib=had	pos_4=VBN	pos_8=VB	relation_3=adverse	relType_6=fixed	lemma_3=be	pos_5=IN	lemma_8=maintain	relType_4=ROOT	lemma_6=order	pos_2=TO
DDI-DrugBank.d269.s10	DDI-DrugBank.d269.s10.e0	DDI-DrugBank.d269.s10.e1	advise	relType_7=case	lpib=concentration_NNS	pos_3=VBN	lemma_4=closely	lemma_1=concentration	lemma_5=after	path2=initiation_obl>therapy_nmod>carvedilol_compound	relType_5=case	pos_6=NN	relType_6=obl	pos_4=RB	eib=False	pos_2=VB	path=cyclosporine_compound<concentration_nsubj:pass<monitor_ccomp>initiation_obl>therapy_nmod>carvedilol_compound	lemma_6=initiation	lemma_3=monitor	wib=concentrations	relType_4=advmod	relType_2=aux:pass	pos_5=IN	path1=cyclosporine_compound<concentration_nsubj:pass	lemma_7=of	pos_1=NNS	relType_3=ccomp	pos_7=IN	lib=concentration	relType_1=nsubj:pass	lemma_2=be
DDI-DrugBank.d269.s10	DDI-DrugBank.d269.s10.e0	DDI-DrugBank.d269.s10.e2	null	relType_7=case	relType_10=mark	lpib=concentration_NNS	pos_3=VBN	path2=adjust_conj>dose_nsubj:pass>cyclosporine_nmod	lemma_4=closely	lemma_1=concentration	lemma_5=after	relType_5=case	pos_6=NN	pos_8=NN	relType_6=obl	lemma_13=of	pos_4=RB	relType_12=nsubj:pass	pos_2=VB	pos_13=IN	lemma_8=carvedilol	relType_13=case	lemma_9=and	pos_9=CC	lemma_6=initiation	lemma_3=monitor	wib=concentrations	lemma_12=dose	relType_4=advmod	relType_8=compound	relType_2=aux:pass	pos_5=IN	path=cyclosporine_compound<concentration_nsubj:pass<monitor_ccomp>adjust_conj>dose_nsubj:pass>cyclosporine_nmod	pos_10=IN	pos_11=DT	lemma_11=the	path1=cyclosporine_compound<concentration_nsubj:pass	relType_11=det	lemma_7=of	pos_1=NNS	relType_3=ccomp	eib=True	pos_7=IN	relType_8=nmod	lemma_10=that	lemma_8=therapy	lib=concentration	relType_1=nsubj:pass	lemma_2=be	pos_12=NN	relType_9=cc
DDI-DrugBank.d269.s10	DDI-DrugBank.d269.s10.e1	DDI-DrugBank.d269.s10.e2	advise	path=carvedilol_compound<therapy_nmod<initiation_obl<monitor_ccomp>adjust_conj>dose_nsubj:pass>cyclosporine_nmod	pos_3=IN	relType_5=nsubj:pass	path2=adjust_conj>dose_nsubj:pass>cyclosporine_nmod	lpib=therapy_NN	lemma_6=of	relType_2=cc	relType_6=case	lemma_2=and	eib=False	pos_6=IN	path1=carvedilol_compound<therapy_nmod<initiation_obl	lemma_1=therapy	relType_1=nmod	pos_1=NN	pos_4=DT	lemma_3=that	lemma_4=the	lib=therapy	relType_3=mark	pos_5=NN	lemma_5=dose	pos_2=CC	relType_4=det	wib=therapy
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e0	DDI-DrugBank.d269.s11.e1	null	lib=digoxin	eib=False	path2=increase_parataxis>concentration_nsubj:pass>Digoxin_compound	lpib=digoxin_NNP	path1=	pos_1=:	relType_1=punct	wib=Digoxin	path=<Digoxin_ROOT>increase_parataxis>concentration_nsubj:pass>Digoxin_compound	lemma_1=:
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e0	DDI-DrugBank.d269.s11.e2	null	relation_4=beneficial	relType_9=advmod	lpib=digoxin_NNP	path1=	pos_7=CD	lemma_5=by	relType_3=aux:pass	relType_5=case	lemma_6=about	relType_8=obl	path=<Digoxin_ROOT>increase_parataxis>administer_advcl>digoxin_nsubj:pass	pos_8=NN	pos_9=WRB	pos_2=NNP	relType_7=nummod	lemma_4=increase	relType_2=nsubj:pass	lemma_2=Digoxin	lemma_1=:	pos_4=VBN	relType_4=parataxis	lemma_8=%	lib=digoxin	lemma_2=concentration	relType_2=compound	lemma_3=be	pos_1=:	pos_5=IN	path2=increase_parataxis>administer_advcl>digoxin_nsubj:pass	wib=Digoxin	pos_6=RB	pos_2=NNS	eib=True	lemma_7=15	relType_1=punct	relType_6=advmod	lemma_9=when	pos_3=VBP
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e0	DDI-DrugBank.d269.s11.e3	null	relation_4=beneficial	relType_9=advmod	path=<Digoxin_ROOT>increase_parataxis>administer_advcl>digoxin_nsubj:pass>carvedilol_conj	relType_10=cc	lpib=digoxin_NNP	path1=	pos_7=CD	lemma_5=by	lemma_10=digoxin	relType_3=aux:pass	relType_5=case	lemma_6=about	relType_8=obl	pos_8=NN	pos_9=WRB	pos_2=NNP	relType_7=nummod	pos_10=CC	lemma_4=increase	pos_10=NN	relType_2=nsubj:pass	lemma_2=Digoxin	lemma_1=:	pos_4=VBN	relType_4=parataxis	lemma_8=%	relType_10=nsubj:pass	lemma_10=and	lib=digoxin	lemma_2=concentration	relType_2=compound	lemma_3=be	pos_1=:	pos_5=IN	wib=Digoxin	pos_6=RB	pos_2=NNS	eib=True	lemma_7=15	path2=increase_parataxis>administer_advcl>digoxin_nsubj:pass>carvedilol_conj	relType_1=punct	relType_6=advmod	lemma_9=when	pos_3=VBP
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e1	DDI-DrugBank.d269.s11.e2	null	lemma_3=increase	lpib=concentration_NNS	pos_3=VBN	pos_6=CD	lemma_1=concentration	path1=Digoxin_compound<concentration_nsubj:pass	eib=False	lemma_7=%	lemma_8=when	relType_8=advmod	wib=concentrations	path2=administer_advcl>digoxin_nsubj:pass	pos_4=IN	pos_5=RB	relType_4=case	relType_2=aux:pass	relType_6=nummod	pos_2=VBP	relType_3=parataxis	relType_5=advmod	relType_7=obl	pos_1=NNS	path=Digoxin_compound<concentration_nsubj:pass<increase_parataxis>administer_advcl>digoxin_nsubj:pass	lib=concentration	relType_1=nsubj:pass	lemma_2=be	pos_8=WRB	pos_7=NN	relation_2=beneficial	lemma_4=by	lemma_5=about	lemma_6=15
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e1	DDI-DrugBank.d269.s11.e3	null	lemma_3=increase	lpib=concentration_NNS	pos_3=VBN	pos_6=CD	lemma_1=concentration	lemma_9=digoxin	path1=Digoxin_compound<concentration_nsubj:pass	path=Digoxin_compound<concentration_nsubj:pass<increase_parataxis>administer_advcl>digoxin_nsubj:pass>carvedilol_conj	relType_9=nsubj:pass	lemma_7=%	lemma_8=when	pos_9=NN	relType_8=advmod	lemma_9=and	pos_9=CC	wib=concentrations	pos_4=IN	pos_5=RB	relType_4=case	relType_2=aux:pass	relType_6=nummod	pos_2=VBP	relType_3=parataxis	relType_5=advmod	relType_7=obl	pos_1=NNS	eib=True	path2=administer_advcl>digoxin_nsubj:pass>carvedilol_conj	lib=concentration	relType_1=nsubj:pass	lemma_2=be	pos_8=WRB	pos_7=NN	relation_2=beneficial	relType_9=cc	lemma_4=by	lemma_5=about	lemma_6=15
DDI-DrugBank.d269.s11	DDI-DrugBank.d269.s11.e2	DDI-DrugBank.d269.s11.e3	mechanism	relType_1=cc	pos_1=CC	lemma_1=and	path2=carvedilol_conj	eib=False	lpib=carvedilol_NN	path1=	lib=carvedilol	path=<digoxin_nsubj:pass>carvedilol_conj	wib=carvedilol
DDI-DrugBank.d269.s12	DDI-DrugBank.d269.s12.e0	DDI-DrugBank.d269.s12.e1	effect	relType_1=cc	lpib=coreg_NN	pos_1=CC	lib=coreg	wib=COREG	eib=False	path1=	path=<digoxin_ROOT>conduction_conj>coreg_compound	path2=conduction_conj>coreg_compound	lemma_1=and
DDI-DrugBank.d269.s13	DDI-DrugBank.d269.s13.e0	DDI-DrugBank.d269.s13.e1	advise	relType_3=dep	pos_2=VBN	relType_4=dep	relType_9=conj	pos_5=,	relType_1=aux:pass	lemma_4=initiate	pos_6=VBG	relType_6=conj	eib=False	lemma_2=recommend	lemma_1=be	pos_7=,	pos_8=CC	lemma_8=or	lemma_7=,	path1=digoxin_nmod<monitoring_nsubj:pass	pos_9=VBG	lemma_9=discontinue	lib=be	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_6=adjust	pos_4=VBG	path2=when_dep>initiate_dep>discontinue_conj>COREG_obj	wib=is	pos_3=WRB	pos_1=VBZ	relType_7=punct	lpib=be_VBZ	path=digoxin_nmod<monitoring_nsubj:pass<recommend_ROOT>when_dep>initiate_dep>discontinue_conj>COREG_obj	relType_8=cc	lemma_3=when
DDI-DrugBank.d269.s14	DDI-DrugBank.d269.s14.e0	DDI-DrugBank.d269.s14.e1	mechanism	pos_2=NN	lib=reduce	lemma_3=concentration	relation_0=adverse	wib=reduced	path=Rifampin_nsubj<reduce_parataxis>concentration_obj>carvedilol_nmod	pos_1=VBD	pos_3=NNS	eib=False	path1=Rifampin_nsubj	relType_1=parataxis	relType_2=compound	pos_4=IN	relType_4=case	path2=concentration_obj>carvedilol_nmod	lemma_1=reduce	relType_3=obj	lpib=reduce_VBD	lemma_2=plasma	lemma_4=of
DDI-DrugBank.d269.s16	DDI-DrugBank.d269.s16.e0	DDI-DrugBank.d269.s16.e1	null	pos_2=VBN	lemma_15=observe	lemma_7=(	path2=observe_parataxis>administer_advcl>COREG_nsubj:pass	relType_10=amod	path1=	relType_5=compound	pos_9=IN	relType_3=nsubj:pass	pos_12=-RRB-	pos_13=VBP	pos_6=NN	pos_7=-LRB-	lemma_10=hemodynamic	lemma_2=isolate	lemma_3=case	pos_3=NNS	lib=isolate	eib=False	pos_8=RB	lemma_11=compromise	relType_13=aux	path=<Blockers_ROOT>observe_parataxis>administer_advcl>COREG_nsubj:pass	relType_9=case	relType_12=punct	relType_14=aux:pass	pos_15=VBN	relType_8=advmod	lemma_13=have	lemma_1=:	lemma_14=be	lemma_6=disturbance	relType_16=advmod	relType_11=appos	pos_10=JJ	pos_4=IN	wib=Isolated	relType_2=amod	lemma_5=conduction	pos_1=:	relType_4=case	lemma_8=rarely	lemma_12=)	relType_15=parataxis	pos_5=NN	pos_14=VBN	lemma_16=when	lemma_9=with	pos_11=NN	lpib=isolate_VBN	relType_7=punct	relType_1=punct	relType_6=nmod	lemma_4=of	pos_16=WRB
DDI-DrugBank.d269.s16	DDI-DrugBank.d269.s16.e0	DDI-DrugBank.d269.s16.e2	null	relType_18=dep	pos_2=VBN	lemma_15=observe	lemma_7=(	relType_10=amod	path1=	relType_17=aux:pass	relType_5=compound	pos_9=IN	relType_3=nsubj:pass	relType_17=nsubj:pass	lemma_18=co	pos_20=VBN	lemma_17=be	relType_19=punct	pos_12=-RRB-	pos_13=VBP	pos_6=NN	pos_7=-LRB-	lemma_10=hemodynamic	lemma_2=isolate	lemma_3=case	pos_3=NNS	pos_17=NNP	lib=isolate	pos_8=RB	lemma_11=compromise	relType_13=aux	pos_21=IN	relType_14=aux:pass	relType_9=case	relType_12=punct	pos_15=VBN	relType_20=advcl	lemma_21=with	relType_8=advmod	lemma_13=have	lemma_1=:	lemma_14=be	lemma_6=disturbance	relType_16=advmod	pos_18=NN	relType_11=appos	lemma_19=-	pos_17=VBZ	path2=observe_parataxis>administer_advcl>diltiazem_obl	pos_10=JJ	pos_4=IN	wib=Isolated	relType_2=amod	lemma_5=conduction	pos_1=:	relType_4=case	lemma_8=rarely	lemma_12=)	lemma_17=COREG	relType_15=parataxis	relType_21=case	pos_5=NN	pos_14=VBN	lemma_16=when	lemma_9=with	pos_11=NN	eib=True	lpib=isolate_VBN	relType_7=punct	pos_19=HYPH	path=<Blockers_ROOT>observe_parataxis>administer_advcl>diltiazem_obl	relType_1=punct	relType_6=nmod	lemma_4=of	lemma_20=administer	pos_16=WRB
DDI-DrugBank.d269.s16	DDI-DrugBank.d269.s16.e1	DDI-DrugBank.d269.s16.e2	effect	pos_2=NN	lemma_4=administer	path=COREG_nsubj:pass<administer_advcl>diltiazem_obl	relType_1=aux:pass	relType_5=case	lemma_2=co	eib=False	lemma_3=-	lemma_1=be	lemma_5=with	pos_4=VBN	relType_2=dep	lib=be	path2=diltiazem_obl	pos_5=IN	wib=is	pos_1=VBZ	pos_3=HYPH	lpib=be_VBZ	path1=COREG_nsubj:pass	relType_4=advcl	relType_3=punct
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e0	DDI-DrugBank.d269.s17.e1	null	relType_1=case	lemma_1=,	lemma_1=property	path1=	pos_1=,	lemma_2=if	pos_1=HYPH	relType_2=mark	pos_2=IN	lib=b	pos_1=IN	lemma_1=block	relType_1=nmod	pos_1=NN	wib=b	relation_3=adverse	lemma_1=-	path=<agent_ROOT>,_punct>administer_dep>COREG_nsubj:pass	path2=,_punct>administer_dep>COREG_nsubj:pass	pos_1=VBG	lpib=b_NN	lemma_1=with	pos_1=NNS	eib=True	lemma_1=b	relType_1=amod	relType_1=punct	relType_1=obl
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e0	DDI-DrugBank.d269.s17.e2	null	relType_4=mark	relType_8=case	relType_1=case	lemma_1=,	lemma_9=calcium	lemma_1=property	path2=,_punct>administer_dep>blocker_obl	path1=	pos_1=,	pos_3=NNP	lemma_9=channel	lemma_2=if	relType_3=nsubj:pass	pos_1=HYPH	relType_2=mark	path=<agent_ROOT>,_punct>administer_dep>blocker_obl	pos_2=IN	pos_5=VB	relType_6=dep	lib=b	pos_7=RB	relType_9=compound	pos_3=VBZ	lemma_8=with	pos_1=IN	lemma_1=block	pos_6=VBN	relType_1=nmod	lemma_5=be	pos_9=NN	pos_1=NN	pos_8=IN	wib=b	relType_5=aux:pass	lemma_4=to	relation_3=adverse	lemma_1=-	lemma_3=be	lemma_6=administer	pos_4=TO	pos_1=VBG	lpib=b_NN	lemma_1=with	lemma_7=orally	pos_1=NNS	eib=True	lemma_3=COREG	lemma_1=b	relType_1=amod	relType_7=advmod	relType_1=punct	relType_3=cop	relType_1=obl
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e0	DDI-DrugBank.d269.s17.e3	null	relType_4=mark	relType_8=case	relType_1=case	lemma_1=,	lemma_9=calcium	lemma_1=property	path1=	pos_1=,	pos_3=NNP	lemma_9=channel	relType_9=obl	lemma_2=if	relType_3=nsubj:pass	pos_1=HYPH	lemma_9=blocker	pos_9=IN	relType_10=dep	relType_2=mark	pos_2=IN	pos_5=VB	relType_6=dep	lib=b	pos_7=RB	relType_9=compound	pos_9=NNS	pos_3=VBZ	lemma_10=the	lemma_8=with	pos_1=IN	lemma_1=block	pos_6=VBN	relType_1=nmod	lemma_5=be	pos_9=NN	pos_1=NN	pos_8=IN	wib=b	relType_5=aux:pass	lemma_4=to	relation_3=adverse	path=<agent_ROOT>,_punct>administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep	lemma_1=-	lemma_3=be	lemma_6=administer	pos_4=TO	pos_1=VBG	lpib=b_NN	lemma_1=with	lemma_7=orally	relType_9=acl	pos_1=NNS	eib=True	lemma_3=COREG	lemma_9=of	path2=,_punct>administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep	lemma_1=b	relType_1=amod	relType_7=advmod	relType_1=punct	relType_3=cop	relType_1=obl	pos_10=DT
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e0	DDI-DrugBank.d269.s17.e4	null	relType_4=mark	relType_8=case	relType_1=case	lemma_1=,	lemma_9=calcium	relType_11=cc	lemma_1=property	path1=	pos_1=,	pos_3=NNP	lemma_9=channel	relType_9=obl	lemma_2=if	relType_3=nsubj:pass	pos_1=HYPH	lemma_9=blocker	pos_9=IN	relType_10=dep	relType_2=mark	pos_2=IN	pos_5=VB	relType_6=dep	lib=b	pos_7=RB	relType_9=compound	pos_9=NNS	pos_3=VBZ	lemma_10=the	lemma_8=with	lemma_11=verapamil	pos_1=IN	lemma_1=block	pos_6=VBN	relType_1=nmod	lemma_5=be	pos_9=NN	pos_1=NN	pos_8=IN	wib=b	relType_5=aux:pass	lemma_11=or	lemma_4=to	relation_3=adverse	path2=,_punct>administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound	lemma_1=-	lemma_3=be	lemma_6=administer	pos_11=CC	relType_11=dep	pos_4=TO	pos_1=VBG	lpib=b_NN	lemma_1=with	lemma_7=orally	relType_9=acl	pos_11=NN	pos_1=NNS	eib=True	lemma_3=COREG	lemma_9=of	lemma_1=b	relType_1=amod	relType_7=advmod	relType_1=punct	relType_3=cop	path=<agent_ROOT>,_punct>administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound	relType_1=obl	pos_10=DT
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e1	DDI-DrugBank.d269.s17.e2	null	relType_4=dep	lemma_5=orally	relType_7=compound	lemma_4=administer	lemma_7=channel	pos_3=VB	relType_3=aux:pass	relType_6=case	relType_2=mark	pos_6=IN	lemma_1=be	lemma_2=to	pos_4=VBN	lib=be	lemma_7=calcium	lemma_3=be	pos_5=RB	lemma_6=with	path2=blocker_obl	relType_5=advmod	wib=is	path=COREG_nsubj:pass<administer_dep>blocker_obl	relType_1=cop	pos_1=VBZ	eib=True	lpib=be_VBZ	path1=COREG_nsubj:pass	pos_7=NN	pos_2=TO
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e1	DDI-DrugBank.d269.s17.e3	advise	pos_7=NNS	relType_4=dep	lemma_5=orally	relType_7=compound	pos_8=DT	relType_8=dep	lemma_7=blocker	lemma_4=administer	lemma_7=channel	pos_3=VB	relType_7=acl	relType_3=aux:pass	relType_6=case	relType_2=mark	pos_6=IN	lemma_1=be	lemma_2=to	path=COREG_nsubj:pass<administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep	pos_4=VBN	lib=be	lemma_7=calcium	lemma_8=the	lemma_3=be	pos_5=RB	lemma_6=with	path2=blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep	relType_5=advmod	wib=is	lemma_7=of	relType_1=cop	relType_7=obl	pos_1=VBZ	eib=True	pos_7=IN	lpib=be_VBZ	path1=COREG_nsubj:pass	pos_7=NN	pos_2=TO
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e1	DDI-DrugBank.d269.s17.e4	advise	pos_7=NNS	relType_4=dep	lemma_5=orally	relType_7=compound	lemma_9=verapamil	pos_8=DT	relType_8=dep	lemma_7=blocker	lemma_4=administer	pos_7=NN	lemma_7=channel	pos_3=VB	relType_7=acl	relType_3=aux:pass	relType_6=case	relType_9=dep	relType_2=mark	pos_6=IN	lemma_1=be	path2=blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound	lemma_2=to	pos_9=NN	pos_4=VBN	pos_9=CC	lib=be	lemma_7=calcium	lemma_8=the	lemma_9=or	lemma_3=be	pos_5=RB	lemma_6=with	relType_5=advmod	wib=is	lemma_7=of	relType_1=cop	relType_7=obl	pos_1=VBZ	eib=True	pos_7=IN	lpib=be_VBZ	path1=COREG_nsubj:pass	path=COREG_nsubj:pass<administer_dep>blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound	relType_9=cc	pos_2=TO
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e2	DDI-DrugBank.d269.s17.e3	null	pos_2=DT	lemma_1=of	path2=of_acl>the_dep>recommend_dep>verapamil_dep	relType_2=dep	lemma_2=the	eib=False	wib=verapamil	lib=verapamil	relType_1=acl	path1=	path=<blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep	pos_1=IN	lpib=verapamil_NN
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e2	DDI-DrugBank.d269.s17.e4	null	pos_2=DT	relType_3=dep	lemma_2=the	pos_3=CC	path1=	lpib=verapamil_NN	relType_3=cc	wib=verapamil	lib=verapamil	pos_1=IN	lemma_3=or	lemma_3=verapamil	relType_2=dep	relType_1=acl	lemma_1=of	eib=True	pos_3=NN	path2=of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound	path=<blocker_obl>of_acl>the_dep>recommend_dep>verapamil_dep>type_conj>diltiazem_compound
DDI-DrugBank.d269.s17	DDI-DrugBank.d269.s17.e3	DDI-DrugBank.d269.s17.e4	null	relType_1=cc	pos_1=CC	eib=False	path=<verapamil_dep>type_conj>diltiazem_compound	path1=	lpib=diltiazem_NN	lib=diltiazem	wib=diltiazem	path2=type_conj>diltiazem_compound	lemma_1=or
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e0	DDI-DrugBank.d269.s18.e1	null	relType_1=cc	lemma_2=oral	pos_1=CC	lib=oral	eib=False	pos_2=JJ	path2=hypoglycemic_conj	relType_2=amod	path1=	wib=Oral	lpib=oral_JJ	path=<insulin_ROOT>hypoglycemic_conj	lemma_1=or
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e0	DDI-DrugBank.d269.s18.e2	null	relType_1=cc	pos_1=CC	lib=oral	path1=	pos_2=JJ	path=<insulin_ROOT>enhance_parataxis>agent_nsubj	pos_3=NNS	lemma_3=:	wib=Oral	path2=enhance_parataxis>agent_nsubj	lemma_2=oral	relType_3=conj	pos_3=:	relType_2=amod	lpib=oral_JJ	lemma_3=hypoglycemic	eib=True	relType_3=punct	lemma_1=or
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e0	DDI-DrugBank.d269.s18.e3	null	relType_1=cc	relType_4=amod	pos_1=CC	relType_7=compound	lib=oral	relType_10=punct	pos_6=DT	relation_17=adverse	relation_18=neutral	path1=	lemma_4=-	lemma_5=enhance	lemma_11=reduce	lemma_4=b	relType_4=nmod	relType_5=parataxis	lemma_4=may	relType_8=punct	pos_4=HYPH	pos_2=JJ	relType_9=obl	lemma_4=property	lemma_13=of	pos_5=VB	pos_3=NNS	lemma_4=block	relation_8=adverse	lemma_3=:	lemma_6=the	relType_11=amod	lemma_12=effect	lemma_9=sugar	pos_4=MD	pos_12=NN	path2=enhance_parataxis>effect_obj>insulin_nmod	pos_8=HYPH	wib=Oral	relType_12=obj	relType_4=nsubj	pos_9=NN	pos_4=NN	pos_4=NNS	pos_13=IN	lemma_10=-	lemma_4=with	lemma_2=oral	relType_13=case	relType_4=obl	relType_4=punct	relType_3=conj	pos_3=:	pos_4=IN	lemma_4=agent	relType_2=amod	pos_10=HYPH	relType_4=case	relType_4=aux	pos_11=VBG	lpib=oral_JJ	pos_4=VBG	relType_6=det	lemma_3=hypoglycemic	eib=True	lemma_8=-	path=<insulin_ROOT>enhance_parataxis>effect_obj>insulin_nmod	relation_11=beneficial	pos_7=NN	relType_3=punct	lemma_7=blood	lemma_1=or
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e0	DDI-DrugBank.d269.s18.e4	null	relType_1=cc	pos_14=CC	lemma_5=enhance	relType_9=obl	relType_8=punct	pos_2=JJ	lemma_4=property	lemma_13=of	pos_3=NNS	path2=enhance_parataxis>effect_obj>insulin_nmod>hypoglycemic_conj	wib=Oral	relType_4=punct	pos_3=:	pos_11=VBG	lemma_8=-	relType_14=nmod	relType_4=amod	path1=	lemma_11=reduce	relType_4=nmod	lemma_4=may	pos_5=VB	relType_11=amod	pos_8=HYPH	pos_9=NN	relType_4=obl	lemma_4=agent	lemma_14=insulin	relType_4=aux	path=<insulin_ROOT>enhance_parataxis>effect_obj>insulin_nmod>hypoglycemic_conj	relType_6=det	lemma_14=and	pos_7=NN	lemma_7=blood	relType_3=punct	relType_10=punct	pos_6=DT	relation_17=adverse	lemma_4=-	relType_5=parataxis	relation_8=adverse	lemma_6=the	lemma_12=effect	pos_4=MD	pos_14=NN	pos_13=IN	lemma_4=with	relType_13=case	relType_3=conj	pos_4=IN	relType_2=amod	relation_11=beneficial	lemma_15=oral	pos_1=CC	relType_7=compound	lib=oral	pos_15=JJ	relType_15=amod	relation_18=neutral	lemma_4=b	pos_4=HYPH	lemma_4=block	lemma_3=:	lemma_9=sugar	relType_12=obj	relType_4=nsubj	pos_4=NN	pos_4=NNS	lemma_10=-	lemma_2=oral	pos_10=HYPH	relType_4=case	relType_14=cc	lpib=oral_JJ	pos_4=VBG	lemma_3=hypoglycemic	eib=True	pos_12=NN	lemma_1=or
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e1	DDI-DrugBank.d269.s18.e2	null	wib=Agents	lpib=agent_NNS	path1=hypoglycemic_conj	lib=agent	eib=False	path=hypoglycemic_conj<insulin_ROOT>enhance_parataxis>agent_nsubj	pos_1=:	relType_1=punct	path2=enhance_parataxis>agent_nsubj	lemma_1=:
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e1	DDI-DrugBank.d269.s18.e3	null	lemma_2=agent	lpib=agent_NNS	pos_2=NN	lib=agent	pos_7=NN	pos_2=MD	relType_5=compound	relType_8=punct	relation_14=adverse	pos_3=VB	relation_5=adverse	pos_2=HYPH	relType_11=case	relType_2=punct	pos_6=HYPH	path1=hypoglycemic_conj	pos_2=IN	lemma_2=property	relation_8=beneficial	lemma_2=with	relType_2=nsubj	lemma_2=-	relType_2=nmod	relType_6=punct	lemma_7=sugar	path2=enhance_parataxis>effect_obj>insulin_nmod	relType_2=aux	pos_8=HYPH	relType_9=amod	pos_10=NN	lemma_10=effect	relation_15=neutral	lemma_1=:	pos_9=VBG	lemma_6=-	pos_11=IN	wib=Agents	pos_4=DT	lemma_2=b	lemma_4=the	relType_2=amod	pos_1=:	relType_3=parataxis	lemma_9=reduce	relType_2=obl	path=hypoglycemic_conj<insulin_ROOT>enhance_parataxis>effect_obj>insulin_nmod	pos_2=NNS	pos_5=NN	lemma_3=enhance	relType_2=case	relType_7=obl	eib=True	lemma_2=block	lemma_8=-	lemma_11=of	lemma_2=may	relType_1=punct	relType_4=det	lemma_5=blood	relType_10=obj	pos_2=VBG
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e1	DDI-DrugBank.d269.s18.e4	null	lemma_2=agent	lpib=agent_NNS	pos_2=NN	lib=agent	pos_7=NN	pos_2=MD	relType_12=cc	relType_5=compound	relType_8=punct	relation_14=adverse	pos_3=VB	pos_12=CC	pos_2=HYPH	relation_5=adverse	relType_11=case	relType_2=punct	pos_6=HYPH	path1=hypoglycemic_conj	pos_2=IN	lemma_2=property	relation_8=beneficial	path2=enhance_parataxis>effect_obj>insulin_nmod>hypoglycemic_conj	relType_2=nsubj	lemma_2=with	lemma_2=-	relType_2=nmod	relType_6=punct	lemma_7=sugar	relType_13=amod	relType_12=nmod	pos_12=NN	pos_8=HYPH	relType_2=aux	relType_9=amod	pos_10=NN	lemma_10=effect	relation_15=neutral	lemma_1=:	pos_9=VBG	lemma_6=-	pos_11=IN	wib=Agents	pos_4=DT	lemma_2=b	pos_13=JJ	lemma_12=insulin	lemma_4=the	relType_2=amod	pos_1=:	lemma_13=oral	relType_3=parataxis	path=hypoglycemic_conj<insulin_ROOT>enhance_parataxis>effect_obj>insulin_nmod>hypoglycemic_conj	lemma_9=reduce	relType_2=obl	pos_2=NNS	pos_5=NN	lemma_3=enhance	relType_2=case	relType_7=obl	eib=True	lemma_2=block	lemma_8=-	lemma_12=and	lemma_11=of	lemma_2=may	relType_1=punct	relType_4=det	lemma_5=blood	relType_10=obj	pos_2=VBG
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e2	DDI-DrugBank.d269.s18.e3	effect	relType_1=case	relType_1=aux	lemma_1=may	relType_8=amod	lemma_1=property	lemma_10=of	pos_1=HYPH	path=agent_nsubj<enhance_parataxis>effect_obj>insulin_nmod	pos_6=NN	relation_13=neutral	relType_6=obl	lemma_7=-	relation_12=adverse	lib=b	path1=agent_nsubj	path2=effect_obj>insulin_nmod	pos_5=HYPH	pos_2=VB	pos_1=IN	lemma_1=block	lemma_8=reduce	relType_1=nmod	relType_3=det	pos_4=NN	pos_1=NN	pos_9=NN	relType_10=case	lemma_4=blood	wib=b	pos_7=HYPH	relation_3=adverse	relType_5=punct	pos_8=VBG	lemma_1=-	relType_4=compound	relType_9=obj	pos_10=IN	pos_1=MD	relation_6=beneficial	lemma_2=enhance	pos_1=VBG	lpib=b_NN	lemma_1=with	pos_1=NNS	eib=True	pos_3=DT	relType_7=punct	lemma_3=the	lemma_1=b	relType_1=amod	relType_2=parataxis	relType_1=punct	lemma_5=-	lemma_9=effect	relType_1=obl	lemma_6=sugar
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e2	DDI-DrugBank.d269.s18.e4	effect	relType_1=case	relType_11=cc	relType_1=aux	lemma_1=may	relType_8=amod	lemma_1=property	lemma_10=of	pos_1=HYPH	lemma_12=oral	pos_6=NN	pos_12=JJ	relType_6=obl	lemma_7=-	lemma_11=insulin	relation_12=adverse	relation_13=neutral	lib=b	path1=agent_nsubj	pos_5=HYPH	relType_12=amod	pos_2=VB	pos_1=IN	lemma_1=block	lemma_8=reduce	relType_1=nmod	relType_3=det	pos_4=NN	pos_1=NN	pos_9=NN	relType_10=case	lemma_4=blood	wib=b	lemma_11=and	pos_7=HYPH	relation_3=adverse	relType_5=punct	pos_8=VBG	lemma_1=-	relType_4=compound	relType_9=obj	pos_11=CC	pos_10=IN	pos_1=MD	relation_6=beneficial	lemma_2=enhance	path=agent_nsubj<enhance_parataxis>effect_obj>insulin_nmod>hypoglycemic_conj	pos_1=VBG	lpib=b_NN	lemma_1=with	pos_11=NN	pos_1=NNS	eib=True	pos_3=DT	path2=effect_obj>insulin_nmod>hypoglycemic_conj	relType_7=punct	lemma_3=the	lemma_1=b	relType_1=amod	relType_2=parataxis	relType_1=punct	lemma_5=-	lemma_9=effect	relType_11=nmod	relType_1=obl	lemma_6=sugar
DDI-DrugBank.d269.s18	DDI-DrugBank.d269.s18.e3	DDI-DrugBank.d269.s18.e4	null	relType_1=cc	lemma_2=oral	pos_1=CC	lib=oral	eib=False	wib=oral	path2=hypoglycemic_conj	relType_2=amod	path1=	lpib=oral_JJ	path=<insulin_nmod>hypoglycemic_conj	lemma_1=and	pos_2=JJ
DDI-DrugBank.d269.s19	DDI-DrugBank.d269.s19.e0	DDI-DrugBank.d269.s19.e1	null	relType_1=cc	lemma_2=oral	pos_1=CC	lib=oral	eib=False	wib=oral	path2=hypoglycemic_conj	relType_2=amod	path1=	path=<insulin_obj>hypoglycemic_conj	lpib=oral_JJ	pos_2=JJ	lemma_1=or
DDI-DrugBank.d339.s0	DDI-DrugBank.d339.s0.e0	DDI-DrugBank.d339.s0.e1	null	lib=elevated	wib=Elevated	path=<carbamazepine_ROOT>report_parataxis>level_nsubj:pass>carbamazepine_compound	eib=False	relType_2=amod	path1=	pos_1=:	lemma_2=elevated	relType_1=punct	path2=report_parataxis>level_nsubj:pass>carbamazepine_compound	pos_2=JJ	lemma_1=:	lpib=elevated_JJ
DDI-DrugBank.d339.s0	DDI-DrugBank.d339.s0.e0	DDI-DrugBank.d339.s0.e2	null	pos_10=WRB	lemma_4=have	lemma_3=level	lemma_6=report	relType_7=case	lemma_8=postmarketing	relType_8=amod	path1=	relType_9=obl	relType_3=nsubj:pass	pos_2=JJ	lib=elevated	pos_8=JJ	path=<carbamazepine_ROOT>report_parataxis>administer_advcl>SUPRAX_nsubj:pass	pos_3=NNS	pos_4=VBP	lemma_10=when	relType_10=advmod	path2=report_parataxis>administer_advcl>SUPRAX_nsubj:pass	pos_6=VBN	lemma_5=be	relType_6=parataxis	pos_9=NN	lemma_1=:	lemma_2=elevated	relType_5=aux:pass	wib=Elevated	relType_2=amod	pos_1=:	relType_4=aux	lemma_3=carbamazepine	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	relType_3=compound	relType_1=punct	pos_5=VBN	lemma_9=experience	lpib=elevated_JJ
DDI-DrugBank.d339.s0	DDI-DrugBank.d339.s0.e1	DDI-DrugBank.d339.s0.e2	mechanism	lemma_5=in	pos_6=JJ	lemma_2=have	lib=level	pos_3=VBN	path=carbamazepine_compound<level_nsubj:pass<report_parataxis>administer_advcl>SUPRAX_nsubj:pass	relType_3=aux:pass	relType_5=case	lpib=level_NNS	eib=False	relType_6=amod	lemma_8=when	lemma_1=level	relType_2=aux	lemma_7=experience	relType_8=advmod	relType_4=parataxis	pos_4=VBN	path1=carbamazepine_compound<level_nsubj:pass	lemma_3=be	lemma_4=report	pos_5=IN	pos_2=VBP	lemma_6=postmarketing	path2=administer_advcl>SUPRAX_nsubj:pass	relType_7=obl	pos_1=NNS	relType_1=nsubj:pass	pos_8=WRB	pos_7=NN	wib=levels
DDI-DrugBank.d339.s2	DDI-DrugBank.d339.s2.e0	DDI-DrugBank.d339.s2.e1	null	lib=anticoagulants	wib=Anticoagulants	relType_1=cc	pos_1=CC	eib=False	path1=	path=<Warfarin_ROOT>Anticoagulants_conj	lpib=anticoagulants_NNPS	path2=Anticoagulants_conj	lemma_1=and
DDI-DrugBank.d339.s2	DDI-DrugBank.d339.s2.e0	DDI-DrugBank.d339.s2.e2	effect	relType_1=cc	lemma_11=bleeding	pos_1=CC	lemma_3=increase	relType_9=conj	relType_7=case	pos_3=VBN	relType_10=amod	path1=	relType_5=nsubj:pass	lemma_6=,	pos_13=VBZ	pos_9=IN	relation_3=beneficial	lemma_15=report	path=<Warfarin_ROOT>report_parataxis>administer_advcl>cefixime_nsubj:pass	lemma_7=with	relType_2=punct	lemma_12=,	lemma_2=:	lemma_5=time	relType_6=punct	pos_2=NNPS	pos_12=,	relType_13=aux	relType_14=aux:pass	relType_12=punct	pos_8=CC	lemma_8=or	pos_15=VBN	relType_2=conj	pos_4=NN	pos_16=WRB	lemma_14=be	relType_16=advmod	lib=anticoagulants	relType_3=amod	pos_10=JJ	relType_4=compound	pos_2=:	relType_15=parataxis	pos_6=,	lemma_2=Anticoagulants	wib=Anticoagulants	pos_5=NN	lemma_10=clinical	pos_14=VBN	lemma_16=when	pos_11=NN	eib=True	pos_7=IN	lemma_4=prothrombin	lemma_9=without	path2=report_parataxis>administer_advcl>cefixime_nsubj:pass	relType_11=nmod	lemma_13=have	relType_8=cc	lpib=anticoagulants_NNPS	lemma_1=and
DDI-DrugBank.d339.s2	DDI-DrugBank.d339.s2.e1	DDI-DrugBank.d339.s2.e2	effect	pos_2=VBN	path=Anticoagulants_conj<Warfarin_ROOT>report_parataxis>administer_advcl>cefixime_nsubj:pass	lemma_11=,	pos_5=,	pos_15=WRB	relType_7=cc	lemma_3=prothrombin	relType_6=case	pos_13=VBN	relation_1=beneficial	pos_9=JJ	relType_10=nmod	path1=Anticoagulants_conj	eib=False	lemma_4=time	pos_6=IN	relType_11=punct	lemma_10=bleeding	pos_12=VBZ	relType_12=aux	relType_4=nsubj:pass	relType_9=amod	pos_10=NN	pos_4=NN	lib=increase	lemma_1=:	lemma_2=increase	pos_8=IN	lemma_13=be	relType_13=aux:pass	lemma_15=when	pos_7=CC	lemma_5=,	relType_5=punct	lemma_8=without	relType_2=amod	lemma_9=clinical	pos_1=:	lemma_6=with	pos_11=,	lemma_7=or	pos_14=VBN	lemma_12=have	wib=Increased	pos_3=NN	relType_8=conj	relType_3=compound	path2=report_parataxis>administer_advcl>cefixime_nsubj:pass	relType_1=punct	relType_15=advmod	lemma_14=report	relType_14=parataxis	lpib=increase_VBN
DDI-DrugBank.d339.s3	DDI-DrugBank.d339.s3.e0	DDI-DrugBank.d339.s3.e1	null	pos_1=CC	pos_3=IN	pos_2=RB	eib=False	relType_2=advmod	relType_5=acl	wib=not	relType_1=dep	path2=but_dep>that_obl>use_acl>nitroferricyanide_obj	path1=nitroprusside_obj	pos_4=DT	relType_4=obl	lemma_3=with	lemma_1=but	lemma_5=use	relType_3=case	lib=not	pos_5=VBG	lemma_4=that	lpib=not_RB	lemma_2=not	path=nitroprusside_obj<use_advcl>but_dep>that_obl>use_acl>nitroferricyanide_obj
DDI-DrugBank.d172.s6	DDI-DrugBank.d172.s6.e0	DDI-DrugBank.d172.s6.e1	int	relType_4=amod	pos_2=VBN	pos_4=JJ	pos_3=RB	relType_3=advmod	relType_1=aux	lemma_2=identify	lemma_3=potentially	relType_6=case	lemma_4=significant	eib=False	pos_5=NNS	pos_6=IN	lemma_1=have	lib=have	path1=celecoxib_nmod<study_nsubj	relType_2=ROOT	lemma_6=with	pos_1=VBP	path=celecoxib_nmod<study_nsubj<identify_ROOT>interaction_obj>fluconazole_nmod	lpib=have_VBP	relType_5=obj	wib=have	path2=interaction_obj>fluconazole_nmod	lemma_5=interaction
DDI-DrugBank.d172.s6	DDI-DrugBank.d172.s6.e0	DDI-DrugBank.d172.s6.e2	int	relType_4=amod	pos_2=VBN	pos_4=JJ	pos_3=RB	relType_3=advmod	relType_1=aux	lemma_2=identify	relType_7=cc	lemma_3=potentially	relType_6=case	lemma_4=significant	path2=interaction_obj>fluconazole_nmod>lithium_conj	pos_5=NNS	pos_6=IN	path=celecoxib_nmod<study_nsubj<identify_ROOT>interaction_obj>fluconazole_nmod>lithium_conj	lemma_7=fluconazole	lemma_1=have	lib=have	path1=celecoxib_nmod<study_nsubj	pos_7=CC	relType_2=ROOT	relType_7=nmod	lemma_6=with	pos_1=VBP	lpib=have_VBP	eib=True	relType_5=obj	lemma_7=and	wib=have	lemma_5=interaction	pos_7=NN
DDI-DrugBank.d172.s6	DDI-DrugBank.d172.s6.e1	DDI-DrugBank.d172.s6.e2	null	relType_1=cc	wib=lithium	pos_1=CC	lemma_1=and	lpib=lithium_NN	eib=False	path1=	path=<fluconazole_nmod>lithium_conj	path2=lithium_conj	lib=lithium
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e0	DDI-DrugBank.d172.s7.e1	null	lemma_1=(	lib=nsaid	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	path2=nsaid_dep	path=<drug_nmod>nsaid_dep	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e0	DDI-DrugBank.d172.s7.e2	int	lemma_2=)	pos_7=NNS	lpib=nsaid_NNS	relType_8=amod	relType_6=case	relType_2=punct	lemma_1=(	lib=nsaid	path=drug_nmod<experience_nsubj<suggest_ROOT>potential_obj>interaction_nmod>with_amod>furosemide_dep	path1=drug_nmod<experience_nsubj	lemma_6=for	pos_6=IN	pos_3=VBZ	lemma_8=with	lemma_2=nsaid	pos_8=IN	pos_4=DT	relType_2=dep	relType_3=ROOT	lemma_4=the	relType_7=nmod	lemma_5=potential	pos_1=-LRB-	pos_2=NNS	pos_5=NN	wib=NSAIDs	eib=True	pos_2=-RRB-	relType_5=obj	path2=potential_obj>interaction_nmod>with_amod>furosemide_dep	relType_1=punct	relType_4=det	lemma_3=suggest	lemma_7=interaction
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e0	DDI-DrugBank.d172.s7.e3	int	lemma_2=)	pos_7=NNS	lemma_10=ace	lpib=nsaid_NNS	lemma_9=furosemide	relType_8=amod	relType_6=case	relType_9=dep	relType_2=punct	lemma_1=(	lib=nsaid	path1=drug_nmod<experience_nsubj	lemma_6=for	pos_6=IN	pos_3=VBZ	lemma_8=with	relType_10=compound	lemma_2=nsaid	pos_10=NN	pos_9=NN	pos_8=IN	pos_4=DT	relType_2=dep	pos_9=CC	lemma_9=and	relType_3=ROOT	lemma_4=the	relType_7=nmod	lemma_5=potential	pos_1=-LRB-	pos_2=NNS	pos_5=NN	wib=NSAIDs	eib=True	pos_2=-RRB-	path=drug_nmod<experience_nsubj<suggest_ROOT>potential_obj>interaction_nmod>with_amod>furosemide_dep>inhibitor_conj	relType_5=obj	lemma_7=interaction	relType_1=punct	relType_4=det	lemma_3=suggest	relType_9=cc	path2=potential_obj>interaction_nmod>with_amod>furosemide_dep>inhibitor_conj
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e1	DDI-DrugBank.d172.s7.e2	int	path=nsaid_dep<drug_nmod<experience_nsubj<suggest_ROOT>potential_obj>interaction_nmod>with_amod>furosemide_dep	lemma_1=)	lemma_5=for	relType_5=case	lemma_7=with	eib=False	relType_3=det	pos_4=NN	relType_4=obj	lpib=suggest_VBZ	relType_7=amod	wib=suggests	lemma_6=interaction	relType_2=ROOT	pos_1=-RRB-	pos_5=IN	lemma_2=suggest	lemma_4=potential	path1=nsaid_dep<drug_nmod<experience_nsubj	pos_2=VBZ	pos_3=DT	pos_7=IN	lib=suggest	pos_6=NNS	path2=potential_obj>interaction_nmod>with_amod>furosemide_dep	lemma_3=the	relType_1=punct	relType_6=nmod
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e1	DDI-DrugBank.d172.s7.e3	int	relType_8=dep	lemma_1=)	lemma_5=for	relType_5=case	lemma_7=with	lemma_9=ace	pos_8=NN	relType_9=compound	pos_8=CC	relType_3=det	lemma_8=furosemide	pos_4=NN	pos_9=NN	relType_4=obj	lpib=suggest_VBZ	relType_7=amod	wib=suggests	lemma_6=interaction	relType_2=ROOT	pos_1=-RRB-	pos_5=IN	lemma_2=suggest	lemma_4=potential	lemma_8=and	path1=nsaid_dep<drug_nmod<experience_nsubj	pos_2=VBZ	eib=True	pos_3=DT	pos_7=IN	lib=suggest	path=nsaid_dep<drug_nmod<experience_nsubj<suggest_ROOT>potential_obj>interaction_nmod>with_amod>furosemide_dep>inhibitor_conj	lemma_3=the	pos_6=NNS	relType_1=punct	relType_6=nmod	relType_8=cc	path2=potential_obj>interaction_nmod>with_amod>furosemide_dep>inhibitor_conj
DDI-DrugBank.d172.s7	DDI-DrugBank.d172.s7.e2	DDI-DrugBank.d172.s7.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	eib=True	relType_2=compound	path1=	lib=ace	wib=ACE	path2=inhibitor_conj	path=<furosemide_dep>inhibitor_conj	lpib=ace_NN	lemma_2=ace	lemma_1=and
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e1	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	path2=pharmacokinetic_nmod>glyburide_nmod	lemma_2=the	lemma_3=pharmacokinetic	lib=pharmacokinetic	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod	path1=	relType_4=cc	wib=pharmacokinetics	pos_3=NNS	eib=False	pos_5=HYPH	lemma_6=or	pos_1=IN	pos_8=IN	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	pos_4=CC	relType_2=det	lemma_4=and	lemma_5=/	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e2	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	lemma_2=the	lemma_3=pharmacokinetic	lib=pharmacokinetic	path1=	relType_4=cc	lemma_9=,	relType_9=nmod	wib=pharmacokinetics	pos_3=NNS	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod>ketoconazole_conj	pos_5=HYPH	lemma_6=or	pos_1=IN	lemma_9=glyburide	pos_9=NN	pos_8=IN	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	path2=pharmacokinetic_nmod>glyburide_nmod>ketoconazole_conj	relType_9=punct	eib=True	pos_4=CC	relType_2=det	lemma_4=and	lemma_5=/	pos_9=,	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e3	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	relType_10=punct	lemma_2=the	lemma_3=pharmacokinetic	lib=pharmacokinetic	lemma_10=,	path1=	relType_4=cc	lemma_9=,	relType_9=nmod	lemma_10=ketoconazole	wib=pharmacokinetics	pos_3=NNS	relType_10=conj	pos_5=HYPH	lemma_6=or	pos_1=IN	lemma_9=glyburide	pos_10=NN	pos_9=NN	pos_8=IN	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	path2=pharmacokinetic_nmod>glyburide_nmod>methotrexate_conj	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	relType_9=punct	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod>methotrexate_conj	pos_10=,	eib=True	pos_4=CC	relType_2=det	lemma_4=and	lemma_5=/	pos_9=,	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e4	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	relType_10=punct	lemma_2=the	lemma_11=,	lemma_3=pharmacokinetic	lib=pharmacokinetic	lemma_10=,	lemma_11=methotrexate	path1=	relType_4=cc	lemma_9=,	relType_9=nmod	relType_11=conj	lemma_10=ketoconazole	wib=pharmacokinetics	pos_3=NNS	relType_10=conj	relType_11=punct	pos_5=HYPH	lemma_6=or	pos_1=IN	lemma_9=glyburide	pos_10=NN	pos_9=NN	pos_8=IN	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	pos_11=,	relType_9=punct	path2=pharmacokinetic_nmod>glyburide_nmod>phenytoin_conj	pos_11=NN	pos_10=,	eib=True	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod>phenytoin_conj	pos_4=CC	relType_2=det	lemma_4=and	lemma_5=/	pos_9=,	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e5	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	relType_12=conj	relType_10=punct	lemma_2=the	lemma_11=,	lemma_3=pharmacokinetic	lib=pharmacokinetic	lemma_10=,	lemma_11=methotrexate	path1=	relType_4=cc	lemma_9=,	path2=pharmacokinetic_nmod>glyburide_nmod>tolbutamide_conj	relType_9=nmod	relType_11=conj	lemma_10=ketoconazole	lemma_12=phenytoin	lemma_12=,	wib=pharmacokinetics	pos_3=NNS	relType_10=conj	relType_11=punct	pos_12=,	pos_5=HYPH	lemma_6=or	pos_1=IN	lemma_9=glyburide	pos_10=NN	relType_12=punct	pos_9=NN	pos_8=IN	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	pos_11=,	relType_9=punct	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod>tolbutamide_conj	pos_11=NN	pos_10=,	eib=True	pos_4=CC	relType_2=det	lemma_4=and	lemma_5=/	pos_9=,	pos_12=NN	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e0	DDI-DrugBank.d172.s8.e6	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	relType_12=conj	relType_10=punct	lemma_2=the	pos_13=,	lemma_13=,	lemma_11=,	lemma_3=pharmacokinetic	pos_14=CC	lib=pharmacokinetic	lemma_10=,	lemma_11=methotrexate	path1=	relType_13=punct	relType_4=cc	lemma_9=,	relType_9=nmod	relType_11=conj	lemma_10=ketoconazole	lemma_12=phenytoin	lemma_12=,	wib=pharmacokinetics	pos_3=NNS	relType_10=conj	relType_11=punct	pos_12=,	pos_5=HYPH	lemma_6=or	pos_1=IN	lemma_9=glyburide	pos_10=NN	relType_12=punct	pos_9=NN	pos_13=NN	lemma_13=tolbutamide	pos_8=IN	relType_13=conj	relType_7=conj	lemma_7=pharmacodynamic	pos_6=CC	relType_5=punct	relType_3=nmod	lpib=pharmacokinetic_NNS	relType_14=cc	pos_11=,	relType_9=punct	path=<celecoxib_nsubj:pass>pharmacokinetic_nmod>glyburide_nmod>warfarin_conj	pos_11=NN	pos_10=,	eib=True	pos_4=CC	relType_2=det	lemma_4=and	lemma_14=and	lemma_5=/	path2=pharmacokinetic_nmod>glyburide_nmod>warfarin_conj	pos_9=,	pos_12=NN	lemma_8=of	lemma_1=on	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e1	DDI-DrugBank.d172.s8.e2	null	path2=ketoconazole_conj	lemma_1=,	eib=False	path1=	path=<glyburide_nmod>ketoconazole_conj	pos_1=,	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	relType_1=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e1	DDI-DrugBank.d172.s8.e3	null	lemma_1=,	relType_2=punct	path2=methotrexate_conj	pos_2=NN	eib=True	lemma_2=ketoconazole	path1=	pos_1=,	pos_2=,	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	relType_1=punct	relType_2=conj	lemma_2=,	path=<glyburide_nmod>methotrexate_conj
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e1	DDI-DrugBank.d172.s8.e4	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	lib=ketoconazole	relType_2=punct	lemma_2=ketoconazole	relType_2=conj	lemma_2=,	path2=phenytoin_conj	lemma_3=,	relType_3=conj	wib=ketoconazole	lemma_3=methotrexate	pos_3=,	eib=True	pos_3=NN	pos_2=,	lpib=ketoconazole_NN	relType_1=punct	path=<glyburide_nmod>phenytoin_conj	relType_3=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e1	DDI-DrugBank.d172.s8.e5	null	lemma_1=,	pos_2=NN	lemma_4=phenytoin	path1=	pos_1=,	path2=tolbutamide_conj	lib=ketoconazole	relType_2=punct	pos_4=,	lemma_2=ketoconazole	relType_2=conj	pos_4=NN	lemma_2=,	path=<glyburide_nmod>tolbutamide_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	wib=ketoconazole	lemma_3=methotrexate	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	lpib=ketoconazole_NN	relType_1=punct	relType_3=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e1	DDI-DrugBank.d172.s8.e6	null	lemma_1=,	pos_2=NN	lemma_4=phenytoin	pos_5=,	path1=	pos_1=,	lib=ketoconazole	relType_2=punct	pos_4=,	lemma_2=ketoconazole	relType_2=conj	pos_4=NN	lemma_2=,	path=<glyburide_nmod>warfarin_conj	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=,	wib=ketoconazole	relType_5=conj	lemma_3=methotrexate	path2=warfarin_conj	pos_5=NN	lemma_5=tolbutamide	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	lpib=ketoconazole_NN	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e2	DDI-DrugBank.d172.s8.e3	null	lemma_1=,	path1=ketoconazole_conj	path2=methotrexate_conj	path=ketoconazole_conj<glyburide_nmod>methotrexate_conj	eib=False	lib=methotrexate	wib=methotrexate	pos_1=,	relType_1=punct	lpib=methotrexate_NN
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e2	DDI-DrugBank.d172.s8.e4	null	lemma_1=,	path1=ketoconazole_conj	path=ketoconazole_conj<glyburide_nmod>phenytoin_conj	eib=True	pos_2=NN	lemma_2=methotrexate	lib=methotrexate	lemma_2=,	wib=methotrexate	pos_1=,	pos_2=,	relType_1=punct	lpib=methotrexate_NN	relType_2=conj	path2=phenytoin_conj	relType_2=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e2	DDI-DrugBank.d172.s8.e5	null	lemma_1=,	pos_2=NN	pos_1=,	path2=tolbutamide_conj	lpib=methotrexate_NN	relType_2=punct	path=ketoconazole_conj<glyburide_nmod>tolbutamide_conj	path1=ketoconazole_conj	lemma_3=phenytoin	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_2=methotrexate	pos_3=,	eib=True	pos_3=NN	lib=methotrexate	wib=methotrexate	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e2	DDI-DrugBank.d172.s8.e6	null	lemma_1=,	pos_2=NN	pos_5=CC	pos_1=,	lpib=methotrexate_NN	relType_2=punct	relType_5=cc	path1=ketoconazole_conj	pos_4=,	lemma_4=tolbutamide	lemma_3=phenytoin	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=methotrexate	lemma_4=,	path=ketoconazole_conj<glyburide_nmod>warfarin_conj	path2=warfarin_conj	pos_3=,	eib=True	lemma_5=and	pos_3=NN	lib=methotrexate	wib=methotrexate	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e3	DDI-DrugBank.d172.s8.e4	null	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	pos_1=,	path2=phenytoin_conj	path=methotrexate_conj<glyburide_nmod>phenytoin_conj	relType_1=punct	path1=methotrexate_conj	lpib=phenytoin_NN
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e3	DDI-DrugBank.d172.s8.e5	null	lemma_1=,	lib=phenytoin	path=methotrexate_conj<glyburide_nmod>tolbutamide_conj	pos_2=NN	eib=True	wib=phenytoin	lemma_2=,	pos_1=,	lemma_2=phenytoin	pos_2=,	path2=tolbutamide_conj	relType_1=punct	relType_2=conj	path1=methotrexate_conj	lpib=phenytoin_NN	relType_2=punct
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e3	DDI-DrugBank.d172.s8.e6	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	relType_2=punct	lib=phenytoin	wib=phenytoin	path=methotrexate_conj<glyburide_nmod>warfarin_conj	lemma_2=phenytoin	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path1=methotrexate_conj	path2=warfarin_conj	lemma_3=tolbutamide	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e4	DDI-DrugBank.d172.s8.e5	null	lemma_1=,	lib=tolbutamide	path=phenytoin_conj<glyburide_nmod>tolbutamide_conj	eib=False	pos_1=,	path2=tolbutamide_conj	relType_1=punct	path1=phenytoin_conj	lpib=tolbutamide_NN	wib=tolbutamide
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e4	DDI-DrugBank.d172.s8.e6	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_2=tolbutamide	relType_3=cc	relType_2=punct	wib=tolbutamide	lib=tolbutamide	relType_2=conj	path1=phenytoin_conj	lemma_2=,	path2=warfarin_conj	eib=True	path=phenytoin_conj<glyburide_nmod>warfarin_conj	pos_2=,	lemma_3=and	relType_1=punct	lpib=tolbutamide_NN
DDI-DrugBank.d172.s8	DDI-DrugBank.d172.s8.e5	DDI-DrugBank.d172.s8.e6	null	lib=warfarin	path2=warfarin_conj	lemma_2=and	path=tolbutamide_conj<glyburide_nmod>warfarin_conj	lemma_1=,	lpib=warfarin_NN	eib=False	path1=tolbutamide_conj	pos_2=CC	pos_1=,	wib=warfarin	relType_1=punct	relType_2=cc
DDI-DrugBank.d172.s9	DDI-DrugBank.d172.s9.e0	DDI-DrugBank.d172.s9.e1	null	relType_4=mark	wib=Reports	path1=	path2=suggest_parataxis>diminish_ccomp>nsaid_nsubj	relType_2=nsubj	eib=False	lemma_2=report	lemma_1=:	pos_4=IN	pos_1=:	relType_3=parataxis	pos_2=NNS	lemma_4=that	lib=report	relType_1=punct	path=<inhibitor_ROOT>suggest_parataxis>diminish_ccomp>nsaid_nsubj	lemma_3=suggest	lpib=report_NNS	pos_3=VBP
DDI-DrugBank.d172.s10	DDI-DrugBank.d172.s10.e0	DDI-DrugBank.d172.s10.e1	advise	path1=celebrex_obj	wib=concomitantly	lpib=concomitantly_RB	pos_2=IN	lemma_2=with	lemma_1=concomitantly	lemma_3=-	path=celebrex_obj<take_acl>inhibitor_obl	path2=inhibitor_obl	relType_1=advmod	lemma_3=ace	lib=concomitantly	relType_2=case	eib=True	pos_1=RB	pos_3=NN	pos_3=HYPH	relType_3=compound	relType_3=punct
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e0	DDI-DrugBank.d172.s11.e1	null	lemma_11=,	path1=	lib=clinical	wib=Clinical	lemma_9=marketing	pos_2=JJ	relType_13=parataxis	pos_13=VBN	pos_8=NN	relType_5=cc	pos_3=NNS	relType_9=compound	pos_4=,	eib=False	path2=show_parataxis>reduce_ccomp>nsaid_nsubj	relType_10=conj	relType_11=punct	pos_12=VBP	lemma_14=that	lemma_6=well	lemma_7=as	relType_12=aux	pos_9=NN	lemma_1=:	pos_14=IN	relType_4=punct	relType_6=fixed	relType_2=amod	pos_5=RB	pos_1=:	relType_8=compound	relType_14=mark	lemma_4=,	pos_11=,	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>nsaid_nsubj	pos_6=RB	relType_3=nsubj	lemma_10=observation	relType_7=fixed	lemma_8=post	lpib=clinical_JJ	lemma_2=clinical	lemma_3=study	pos_7=IN	lemma_12=have	relType_1=punct	lemma_13=show	pos_10=NNS	lemma_5=as
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e0	DDI-DrugBank.d172.s11.e2	null	pos_17=DT	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod	lemma_11=,	relType_15=nsubj	relType_18=amod	path1=	lib=clinical	wib=Clinical	pos_15=MD	lemma_15=can	lemma_9=marketing	pos_2=JJ	relType_13=parataxis	lemma_19=effect	pos_13=VBN	pos_20=IN	pos_8=NN	relType_5=cc	relType_20=case	relType_17=det	pos_3=NNS	relType_9=compound	pos_4=,	lemma_15=nsaid	relType_10=conj	relType_15=aux	relType_11=punct	pos_12=VBP	lemma_14=that	pos_16=VB	lemma_6=well	lemma_7=as	relType_12=aux	pos_18=JJ	pos_19=NN	pos_9=NN	lemma_1=:	relation_19=neutral	pos_14=IN	path2=show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod	relType_4=punct	relType_6=fixed	lemma_16=reduce	relType_2=amod	pos_5=RB	pos_1=:	relType_8=compound	relation_16=adverse	relType_14=mark	lemma_4=,	lemma_17=the	pos_11=,	pos_6=RB	relType_3=nsubj	lemma_10=observation	relType_7=fixed	lemma_18=natriuretic	lemma_8=post	lpib=clinical_JJ	pos_15=NNS	lemma_2=clinical	eib=True	lemma_3=study	pos_7=IN	lemma_12=have	relType_16=ccomp	relType_19=obj	relType_1=punct	lemma_13=show	pos_10=NNS	lemma_5=as	lemma_20=of
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e0	DDI-DrugBank.d172.s11.e3	null	lemma_19=effect	pos_2=JJ	relType_21=cc	pos_13=VBN	relType_5=cc	relType_17=det	pos_3=NNS	pos_12=VBP	lemma_14=that	lemma_6=well	relation_19=neutral	lemma_21=furosemide	relType_4=punct	pos_1=:	lemma_10=observation	pos_7=IN	lemma_20=of	relType_15=nsubj	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	path1=	lib=clinical	wib=Clinical	relType_13=parataxis	path2=show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	pos_8=NN	relType_20=case	relType_10=conj	pos_16=VB	pos_9=NN	pos_14=IN	lemma_4=,	lemma_17=the	pos_6=RB	lpib=clinical_JJ	relType_1=punct	lemma_13=show	pos_17=DT	lemma_11=,	relType_21=nmod	pos_20=IN	pos_4=,	relType_11=punct	lemma_1=:	lemma_16=reduce	relType_2=amod	relType_8=compound	relation_16=adverse	relType_14=mark	relType_3=nsubj	relType_7=fixed	lemma_8=post	lemma_2=clinical	relType_16=ccomp	lemma_21=and	relType_19=obj	relType_18=amod	pos_15=MD	lemma_15=can	lemma_9=marketing	relType_9=compound	lemma_15=nsaid	relType_15=aux	lemma_7=as	relType_12=aux	pos_18=JJ	pos_19=NN	relType_6=fixed	pos_5=RB	pos_11=,	lemma_18=natriuretic	pos_21=CC	pos_15=NNS	lemma_3=study	eib=True	lemma_12=have	pos_10=NNS	lemma_5=as	pos_21=NN
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e1	DDI-DrugBank.d172.s11.e2	effect	relType_4=amod	pos_4=JJ	path=nsaid_nsubj<reduce_ccomp>effect_obj>furosemide_nmod	relType_1=aux	lib=reduce	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	eib=False	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	lpib=reduce_VB	pos_1=MD	path2=effect_obj>furosemide_nmod	relType_2=ccomp	pos_5=NN	pos_3=DT	relType_5=obj	lemma_3=the	relation_4=neutral	path1=nsaid_nsubj
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e1	DDI-DrugBank.d172.s11.e3	effect	relType_4=amod	pos_4=JJ	relType_1=aux	lib=reduce	path2=effect_obj>furosemide_nmod>thiazide_conj	relType_7=cc	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	path=nsaid_nsubj<reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	lpib=reduce_VB	pos_7=CC	relType_7=nmod	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	pos_3=DT	relType_5=obj	lemma_7=and	lemma_3=the	relation_4=neutral	pos_7=NN	lemma_7=furosemide	path1=nsaid_nsubj
DDI-DrugBank.d172.s11	DDI-DrugBank.d172.s11.e2	DDI-DrugBank.d172.s11.e3	null	relType_1=cc	wib=thiazides	lpib=thiazide_NNS	pos_1=CC	path2=thiazide_conj	eib=False	path1=	lib=thiazide	path=<furosemide_nmod>thiazide_conj	lemma_1=and
DDI-DrugBank.d172.s13	DDI-DrugBank.d172.s13.e0	DDI-DrugBank.d172.s13.e1	null	path2=use_parataxis>celebrex_nsubj:pass	wib=CELEBREX	lpib=celebrex_NN	eib=False	lib=celebrex	path1=	pos_1=:	relType_1=punct	lemma_1=:	path=<aspirin_ROOT>use_parataxis>celebrex_nsubj:pass
DDI-DrugBank.d172.s13	DDI-DrugBank.d172.s13.e0	DDI-DrugBank.d172.s13.e2	null	path=<aspirin_ROOT>use_parataxis>aspirin_obl	relType_7=compound	pos_2=NN	pos_6=JJ	pos_2=MD	path1=	pos_3=VB	lemma_4=use	relType_3=aux:pass	relType_5=case	lemma_2=celebrex	relType_6=amod	lemma_5=with	relType_2=aux	relType_2=nsubj:pass	lemma_1=:	pos_4=VBN	relType_4=parataxis	lemma_3=be	pos_1=:	pos_5=IN	lemma_2=can	wib=CELEBREX	lpib=celebrex_NN	eib=True	lib=celebrex	path2=use_parataxis>aspirin_obl	lemma_7=dose	relType_1=punct	pos_7=NN	lemma_6=low
DDI-DrugBank.d172.s13	DDI-DrugBank.d172.s13.e1	DDI-DrugBank.d172.s13.e2	advise	path=celebrex_nsubj:pass<use_parataxis>aspirin_obl	relType_1=aux	pos_3=VBN	path2=aspirin_obl	wib=be	pos_6=NN	lemma_3=use	eib=False	path1=celebrex_nsubj:pass	pos_2=VB	lemma_4=with	pos_5=JJ	lemma_1=can	lib=be	relType_5=amod	pos_4=IN	relType_4=case	relType_2=aux:pass	lemma_5=low	lemma_6=dose	relType_3=parataxis	pos_1=MD	lpib=be_VB	relType_6=compound	lemma_2=be
DDI-DrugBank.d172.s14	DDI-DrugBank.d172.s14.e0	DDI-DrugBank.d172.s14.e1	effect	lemma_1=with	wib=CELEBREX	relType_1=case	lpib=celebrex_NN	eib=False	lib=celebrex	path1=	pos_1=IN	path2=celebrex_nmod	path=<aspirin_nmod>celebrex_nmod
DDI-DrugBank.d172.s14	DDI-DrugBank.d172.s14.e0	DDI-DrugBank.d172.s14.e2	null	relType_8=case	path1=aspirin_nmod<administration_nsubj	relType_1=case	relType_14=punct	pos_2=NN	relType_11=cc	pos_16=IN	pos_2=MD	pos_13=NNS	lemma_4=in	lemma_6=increase	pos_3=VB	lemma_13=complication	relType_18=case	lemma_15=compare	lemma_2=celebrex	lemma_5=a	pos_12=JJ	lemma_12=other	pos_17=NN	relType_10=nmod	path=aspirin_nmod<administration_nsubj<result_ROOT>use_advcl>celebrex_nmod	relType_9=compound	relType_2=nmod	pos_14=,	relType_6=amod	lemma_9=gi	relType_12=amod	pos_1=IN	relType_2=aux	lemma_3=result	pos_6=VBN	pos_9=NN	pos_10=NN	lemma_10=ulceration	lemma_7=rate	pos_8=IN	relType_13=conj	pos_15=VBN	pos_18=IN	lemma_18=of	relType_15=case	relType_3=ROOT	lemma_11=or	pos_4=IN	relType_5=det	pos_11=CC	relType_4=case	relType_17=advcl	relation_6=beneficial	lemma_1=with	wib=CELEBREX	lemma_14=,	lpib=celebrex_NN	relType_7=obl	relType_16=case	eib=True	lib=celebrex	pos_5=DT	path2=use_advcl>celebrex_nmod	lemma_2=may	pos_7=NN	lemma_8=of	lemma_17=use	lemma_16=to
DDI-DrugBank.d172.s14	DDI-DrugBank.d172.s14.e1	DDI-DrugBank.d172.s14.e2	null	relType_12=conj	pos_13=,	path1=celebrex_nmod<aspirin_nmod<administration_nsubj	pos_3=IN	relation_4=beneficial	relType_7=case	relType_1=aux	lemma_1=may	lemma_4=a	lemma_13=,	relType_10=cc	relType_16=advcl	relType_13=punct	relType_9=nmod	lemma_5=increase	lemma_14=compare	pos_6=NN	pos_8=NN	relType_6=obl	lemma_12=complication	pos_17=IN	eib=False	pos_10=CC	relType_11=amod	pos_2=VB	pos_9=NN	lemma_15=to	relType_17=case	pos_4=DT	relType_15=case	relType_5=amod	pos_12=NNS	relType_2=ROOT	relType_8=compound	lemma_17=of	wib=result	pos_1=MD	lemma_10=or	pos_16=NN	relType_3=case	lemma_2=result	pos_15=IN	lemma_7=of	lemma_8=gi	pos_14=VBN	path=celebrex_nmod<aspirin_nmod<administration_nsubj<result_ROOT>use_advcl>celebrex_nmod	lemma_6=rate	lemma_16=use	pos_7=IN	lib=result	lemma_9=ulceration	path2=use_advcl>celebrex_nmod	pos_11=JJ	relType_14=case	lemma_11=other	relType_4=det	lemma_3=in	pos_5=VBN	lpib=result_VB
DDI-DrugBank.d172.s15	DDI-DrugBank.d172.s15.e0	DDI-DrugBank.d172.s15.e1	null	path2=aspirin_nmod	lemma_4=substitute	lemma_5=for	relType_5=case	pos_2=RB	eib=False	relType_2=advmod	path=celebrex_nsubj<substitute_ROOT>aspirin_nmod	lemma_1=be	relType_3=det	lemma_3=a	pos_4=NN	lib=be	pos_5=IN	relType_4=ROOT	wib=is	relType_1=cop	pos_1=VBZ	pos_3=DT	path1=celebrex_nsubj	lpib=be_VBZ	lemma_2=not
DDI-DrugBank.d172.s16	DDI-DrugBank.d172.s16.e0	DDI-DrugBank.d172.s16.e1	null	path1=	lemma_3=administration	pos_2=JJ	lib=concomitant	wib=Concomitant	eib=False	lpib=concomitant_JJ	lemma_1=:	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_3=nsubj	path2=result_parataxis>administration_nsubj>fluconazole_nmod	pos_3=NN	relType_1=punct	path=<Fluconazole_ROOT>result_parataxis>administration_nsubj>fluconazole_nmod	lemma_4=of
DDI-DrugBank.d172.s16	DDI-DrugBank.d172.s16.e0	DDI-DrugBank.d172.s16.e2	null	relType_9=parataxis	lemma_12=two	lemma_16=in	relType_7=compound	lemma_5=at	lemma_15=increase	pos_16=IN	lemma_11=a	path1=	pos_12=CD	lemma_3=administration	pos_6=CD	relType_13=punct	relType_14=compound	pos_2=JJ	lemma_5=fluconazole	relType_5=case	lemma_13=-	pos_13=HYPH	lemma_14=fold	lib=concomitant	pos_8=NN	wib=Concomitant	lpib=concomitant_JJ	pos_14=NN	relType_10=case	path=<Fluconazole_ROOT>result_parataxis>increase_obl>concentration_nmod>plasma_compound>celecoxib_compound	lemma_1=:	lemma_2=concomitant	lemma_7=mg	relType_15=obl	pos_15=NN	lemma_10=in	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	relType_6=nummod	lemma_9=result	pos_10=IN	pos_11=DT	relation_15=beneficial	relType_3=nsubj	relType_11=det	pos_5=NN	relType_16=case	eib=True	relType_8=nmod	pos_9=VBD	pos_3=NN	lemma_8=qd	path2=result_parataxis>increase_obl>concentration_nmod>plasma_compound>celecoxib_compound	relType_12=nummod	lemma_6=200	relType_1=punct	pos_7=NN	lemma_4=of
DDI-DrugBank.d172.s16	DDI-DrugBank.d172.s16.e1	DDI-DrugBank.d172.s16.e2	mechanism	relType_1=case	relType_8=nummod	relType_2=nummod	relType_7=det	relType_12=case	relType_5=parataxis	relType_4=nmod	lemma_9=-	relType_6=case	path2=increase_obl>concentration_nmod>plasma_compound>celecoxib_compound	lemma_10=fold	path1=fluconazole_nmod<administration_nsubj	pos_9=HYPH	lib=mg	path=fluconazole_nmod<administration_nsubj<result_parataxis>increase_obl>concentration_nmod>plasma_compound>celecoxib_compound	eib=False	pos_2=CD	lpib=mg_NN	pos_6=IN	lemma_4=qd	lemma_1=at	pos_1=IN	lemma_5=result	lemma_6=in	pos_10=NN	relType_10=compound	pos_4=NN	pos_7=DT	pos_12=IN	relation_10=beneficial	lemma_8=two	lemma_2=200	relType_11=obl	relType_9=punct	pos_5=VBD	lemma_11=increase	lemma_12=in	pos_11=NN	pos_3=NN	wib=mg	lemma_7=a	relType_3=compound	lemma_3=mg	pos_8=CD
DDI-DrugBank.d172.s17	DDI-DrugBank.d172.s17.e0	DDI-DrugBank.d172.s17.e1	mechanism	relType_4=nmod	lemma_5=by	relType_5=case	pos_2=IN	eib=False	lib=metabolism	lpib=metabolism_NN	path1=celecoxib_compound<metabolism_nmod	relType_1=nmod	pos_4=NN	wib=metabolism	pos_1=NN	path=celecoxib_compound<metabolism_nmod<inhibition_ROOT>fluconazole_nmod	lemma_4=2c9	pos_5=IN	lemma_2=via	relType_2=case	pos_3=NN	path2=fluconazole_nmod	lemma_1=metabolism	lemma_3=p450	relType_3=compound
DDI-DrugBank.d172.s18	DDI-DrugBank.d172.s18.e0	DDI-DrugBank.d172.s18.e1	advise	relType_1=aux	path=celebrex_nsubj:pass<introduce_ROOT>patient_obl>receive_acl>fluconazole_obj	pos_3=VBN	lemma_4=at	pos_9=IN	lemma_1=should	lemma_8=dose	relType_8=obl	wib=be	pos_8=NN	eib=False	path1=celebrex_nsubj:pass	relType_6=amod	pos_2=VB	relType_9=case	relType_10=obl	lemma_3=introduce	relType_7=amod	lib=be	pos_6=JJS	relType_3=ROOT	path2=patient_obl>receive_acl>fluconazole_obj	lemma_11=receive	pos_4=IN	relType_5=det	relType_4=case	relType_2=aux:pass	pos_11=VBG	relType_11=acl	pos_1=MD	lemma_7=recommend	lpib=be_VB	pos_7=VBN	lemma_5=the	pos_5=DT	lemma_2=be	lemma_6=low	lemma_9=in	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e0	DDI-DrugBank.d172.s19.e1	null	lemma_4=study	path1=	lemma_5=conduct	lemma_9=,	relType_6=case	lemma_7=healthy	pos_8=NNS	relType_8=obl	relType_10=parataxis	pos_2=IN	eib=False	relType_5=acl	path=<lithium_ROOT>mean_parataxis>increase_ccomp>level_nsubj>plasma_compound>lithium_compound	pos_6=IN	relType_11=amod	relType_12=punct	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_6=in	lemma_1=:	pos_10=VB	lemma_12=-	pos_13=NN	lib=study	relType_4=obl	relType_7=amod	relType_13=compound	lemma_13=state	pos_1=:	relType_9=punct	lemma_8=subject	relType_2=case	pos_3=DT	wib=study	pos_7=JJ	lemma_10=mean	pos_12=HYPH	pos_11=JJ	path2=mean_parataxis>increase_ccomp>level_nsubj>plasma_compound>lithium_compound	pos_9=,	relType_1=punct	lemma_11=steady	pos_5=VBN	lemma_2=in
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e0	DDI-DrugBank.d172.s19.e2	null	path=<lithium_ROOT>mean_parataxis>increase_ccomp>subject_obl>receive_acl>BID_obj>lithium_compound	lemma_4=study	lemma_18=17	pos_16=VBD	relType_15=nsubj	relType_18=nummod	path1=	lemma_17=approximately	lemma_5=conduct	relType_22=acl	lemma_9=,	relType_14=compound	relType_6=case	lemma_7=healthy	pos_8=NNS	relType_8=obl	relType_10=parataxis	pos_2=IN	pos_20=IN	relType_20=case	pos_21=NNS	pos_22=VBG	relation_16=beneficial	relType_5=acl	pos_6=IN	relType_11=amod	pos_19=NN	relType_12=punct	pos_14=NN	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_6=in	lemma_1=:	pos_10=VB	lemma_12=-	pos_13=NN	pos_17=RB	pos_18=CD	lemma_14=plasma	lemma_22=receive	lib=study	relType_4=obl	relType_7=amod	relType_13=compound	lemma_13=state	pos_1=:	lemma_20=in	relType_17=advmod	relType_9=punct	lemma_21=subject	lemma_16=increase	lemma_8=subject	lemma_14=lithium	relType_21=obl	relType_2=case	pos_15=NNS	eib=True	path2=mean_parataxis>increase_ccomp>subject_obl>receive_acl>BID_obj>lithium_compound	pos_3=DT	wib=study	relType_16=ccomp	lemma_19=%	pos_7=JJ	lemma_10=mean	pos_12=HYPH	pos_11=JJ	pos_9=,	relType_1=punct	lemma_11=steady	lemma_15=level	relType_19=obj	pos_5=VBN	lemma_2=in
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e0	DDI-DrugBank.d172.s19.e3	null	lemma_5=conduct	lemma_9=,	pos_8=NNS	pos_21=NNS	pos_25=NNP	pos_23=CD	pos_13=NN	relType_23=compound	lemma_23=450	lemma_14=plasma	relType_24=compound	lib=study	pos_24=NNS	pos_1=:	lemma_14=lithium	wib=study	pos_26=IN	pos_7=JJ	pos_11=JJ	lemma_4=study	lemma_26=with	relType_15=nsubj	relType_18=nummod	path1=	lemma_17=approximately	relType_22=acl	relType_25=obj	relType_6=case	relType_20=case	relation_16=beneficial	pos_6=IN	relType_11=amod	relType_12=punct	lemma_6=in	relType_3=det	lemma_3=a	pos_10=VB	lemma_12=-	pos_17=RB	relType_4=obl	lemma_13=state	relType_21=obl	pos_9=,	relType_1=punct	path2=mean_parataxis>increase_ccomp>subject_obl>receive_acl>BID_obl>CELEBREX_compound	lemma_2=in	lemma_18=17	pos_20=IN	pos_23=NN	pos_2=IN	relType_5=acl	path=<lithium_ROOT>mean_parataxis>increase_ccomp>subject_obl>receive_acl>BID_obl>CELEBREX_compound	pos_14=NN	lemma_1=:	lemma_24=mg	relType_7=amod	lemma_21=subject	lemma_16=increase	lemma_8=subject	relType_2=case	relType_16=ccomp	lemma_23=lithium	lemma_19=%	pos_12=HYPH	lemma_25=BID	relType_19=obj	lemma_15=level	relType_23=nummod	pos_16=VBD	relType_26=case	relType_14=compound	lemma_7=healthy	relType_8=obl	relType_10=parataxis	pos_22=VBG	pos_19=NN	lpib=study_NN	pos_4=NN	pos_18=CD	lemma_22=receive	relType_13=compound	lemma_20=in	relType_17=advmod	relType_9=punct	pos_15=NNS	eib=True	pos_3=DT	lemma_10=mean	lemma_11=steady	pos_5=VBN
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e0	DDI-DrugBank.d172.s19.e4	null	relType_29=obl	lemma_5=conduct	lemma_9=,	path2=mean_parataxis>increase_ccomp>subject_obl>receive_acl>lithium_obj	pos_8=NNS	pos_21=NNS	pos_25=NNP	pos_23=CD	pos_13=NN	pos_32=IN	lemma_29=BID	relType_23=compound	lemma_23=450	lemma_14=plasma	relType_24=compound	lib=study	pos_24=NNS	pos_1=:	pos_31=VBN	pos_28=NN	lemma_14=lithium	lemma_34=receive	lemma_27=200	wib=study	pos_26=IN	pos_7=JJ	pos_11=JJ	lemma_33=subject	pos_30=IN	relType_32=case	relType_34=acl	pos_29=NNP	lemma_4=study	lemma_26=with	relType_15=nsubj	relType_18=nummod	path1=	lemma_17=approximately	relType_22=acl	relType_25=obj	relType_6=case	relType_20=case	pos_34=VBG	relation_16=beneficial	pos_6=IN	relType_11=amod	relType_12=punct	lemma_6=in	relType_3=det	lemma_3=a	path=<lithium_ROOT>mean_parataxis>increase_ccomp>subject_obl>receive_acl>lithium_obj	pos_10=VB	lemma_12=-	pos_17=RB	relType_4=obl	relType_27=nummod	lemma_13=state	relType_21=obl	pos_27=CD	pos_9=,	relType_1=punct	lemma_2=in	pos_33=NNS	lemma_18=17	pos_27=NNP	pos_20=IN	pos_23=NN	pos_2=IN	relType_5=acl	pos_14=NN	lemma_1=:	lemma_24=mg	relType_7=amod	lemma_21=subject	lemma_16=increase	relType_33=obl	lemma_8=subject	relType_2=case	relType_16=ccomp	lemma_23=lithium	lemma_19=%	pos_12=HYPH	lemma_25=BID	relType_19=obj	lemma_30=as	lemma_15=level	relType_30=case	relType_27=compound	relType_23=nummod	pos_16=VBD	lemma_31=compare	relType_26=case	lemma_32=to	relType_31=case	relType_14=compound	lemma_7=healthy	relType_8=obl	relType_10=parataxis	pos_22=VBG	pos_19=NN	lpib=study_NN	pos_4=NN	pos_18=CD	lemma_22=receive	relType_28=compound	relType_13=compound	lemma_20=in	relType_17=advmod	relType_9=punct	lemma_27=CELEBREX	pos_15=NNS	eib=True	pos_3=DT	lemma_10=mean	lemma_28=mg	lemma_11=steady	pos_5=VBN
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e1	DDI-DrugBank.d172.s19.e2	null	path=lithium_compound<plasma_compound<level_nsubj<increase_ccomp>subject_obl>receive_acl>BID_obj>lithium_compound	lemma_1=plasma	lemma_3=increase	relType_7=case	lemma_5=17	pos_8=NNS	relType_8=obl	pos_6=NN	pos_5=CD	pos_4=RB	relType_1=compound	lemma_9=receive	relType_2=nsubj	eib=False	pos_3=VBD	path2=subject_obl>receive_acl>BID_obj>lithium_compound	lemma_6=%	pos_1=NN	path1=lithium_compound<plasma_compound<level_nsubj	pos_9=VBG	wib=plasma	lpib=plasma_NN	relType_5=nummod	relType_4=advmod	lib=plasma	lemma_4=approximately	lemma_2=level	lemma_8=subject	pos_2=NNS	relType_6=obj	relType_9=acl	relType_3=ccomp	pos_7=IN	lemma_7=in	relation_2=beneficial
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e1	DDI-DrugBank.d172.s19.e3	null	lemma_1=plasma	lemma_3=increase	lemma_10=lithium	relType_7=case	lemma_13=with	lemma_5=17	lemma_10=450	pos_8=NNS	relType_8=obl	pos_6=NN	pos_5=CD	pos_4=RB	relType_1=compound	lemma_9=receive	relType_2=nsubj	pos_3=VBD	pos_11=NNS	lemma_11=mg	relType_12=obj	relType_10=compound	pos_13=IN	lemma_6=%	pos_10=NN	pos_1=NN	path1=lithium_compound<plasma_compound<level_nsubj	pos_9=VBG	wib=plasma	relType_13=case	lpib=plasma_NN	path2=subject_obl>receive_acl>BID_obl>CELEBREX_compound	relType_5=nummod	pos_10=CD	relType_4=advmod	lib=plasma	lemma_4=approximately	lemma_12=BID	relType_10=nummod	lemma_2=level	lemma_8=subject	pos_2=NNS	relType_6=obj	relType_9=acl	relType_3=ccomp	eib=True	path=lithium_compound<plasma_compound<level_nsubj<increase_ccomp>subject_obl>receive_acl>BID_obl>CELEBREX_compound	pos_7=IN	lemma_7=in	relType_11=compound	pos_12=NNP	relation_2=beneficial
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e1	DDI-DrugBank.d172.s19.e4	null	pos_8=NNS	relType_18=case	pos_6=NN	pos_5=CD	lemma_14=CELEBREX	lemma_20=subject	pos_10=NN	path1=lithium_compound<plasma_compound<level_nsubj	relType_15=compound	path2=subject_obl>receive_acl>lithium_obj	relType_9=acl	pos_7=IN	lemma_7=in	lemma_21=receive	pos_14=CD	lemma_10=lithium	relType_7=case	lemma_18=compare	lemma_13=with	lemma_10=450	relType_2=nsubj	lemma_11=mg	pos_9=VBG	wib=plasma	relType_5=nummod	lemma_4=approximately	lemma_12=BID	lemma_2=level	lemma_15=mg	pos_12=NNP	relType_19=case	relType_20=obl	lemma_19=to	lemma_3=increase	pos_14=NNP	relType_16=obl	pos_17=IN	lemma_17=as	lemma_9=receive	lemma_16=BID	pos_3=VBD	pos_13=IN	pos_1=NN	relType_17=case	relType_13=case	lemma_14=200	relType_14=nummod	lemma_8=subject	pos_18=VBN	lemma_1=plasma	pos_19=IN	lemma_5=17	relType_14=compound	relType_21=acl	relType_8=obl	pos_4=RB	relType_1=compound	pos_11=NNS	relType_12=obj	relType_10=compound	lemma_6=%	lpib=plasma_NN	pos_15=NN	pos_10=CD	pos_16=NNP	relType_4=advmod	lib=plasma	pos_20=NNS	relType_10=nummod	pos_21=VBG	pos_2=NNS	relType_6=obj	path=lithium_compound<plasma_compound<level_nsubj<increase_ccomp>subject_obl>receive_acl>lithium_obj	relType_3=ccomp	eib=True	relType_11=compound	relation_2=beneficial
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e2	DDI-DrugBank.d172.s19.e3	mechanism	relType_1=nummod	pos_3=NNP	path2=BID_obl>CELEBREX_compound	path1=lithium_compound<BID_obj	lib=mg	pos_1=CD	eib=False	lpib=mg_NNS	lemma_4=with	path=lithium_compound<BID_obj<receive_acl>BID_obl>CELEBREX_compound	relType_2=compound	pos_4=IN	relType_4=case	lemma_2=mg	pos_2=NNS	lemma_3=BID	wib=mg	lemma_1=450	relType_3=obj
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e2	DDI-DrugBank.d172.s19.e4	null	relType_8=case	relType_1=nummod	lemma_10=to	pos_12=VBG	lemma_5=CELEBREX	lemma_12=receive	pos_3=NNP	relType_5=compound	pos_6=NN	pos_5=CD	lemma_8=as	lib=mg	pos_1=CD	pos_11=NNS	lemma_11=subject	relType_9=case	lemma_6=mg	pos_9=VBN	relType_10=case	pos_8=IN	lpib=mg_NNS	lemma_4=with	relType_5=nummod	relType_2=compound	pos_4=IN	pos_7=NNP	relType_4=case	pos_5=NNP	pos_10=IN	relType_11=obl	lemma_2=mg	path2=subject_obl>receive_acl>lithium_obj	path=lithium_compound<BID_obj<receive_acl<subject_obl<increase_ccomp>subject_obl>receive_acl>lithium_obj	pos_2=NNS	relType_6=compound	relType_7=obl	eib=True	lemma_5=200	lemma_3=BID	lemma_7=BID	wib=mg	lemma_1=450	relType_3=obj	relType_12=acl	lemma_9=compare	path1=lithium_compound<BID_obj<receive_acl<subject_obl
DDI-DrugBank.d172.s19	DDI-DrugBank.d172.s19.e3	DDI-DrugBank.d172.s19.e4	null	pos_7=NNS	relType_1=nummod	pos_2=NN	lemma_5=compare	lemma_7=subject	pos_3=NNP	lemma_8=receive	lemma_6=to	lemma_1=200	relType_5=case	relType_6=case	lib=mg	pos_1=CD	eib=False	lpib=mg_NN	pos_6=IN	relType_2=compound	pos_4=IN	pos_8=VBG	relType_4=case	lemma_2=mg	relType_8=acl	path2=subject_obl>receive_acl>lithium_obj	relType_7=obl	relType_3=obl	lemma_3=BID	wib=mg	lemma_4=as	path=CELEBREX_compound<BID_obl<receive_acl<subject_obl<increase_ccomp>subject_obl>receive_acl>lithium_obj	pos_5=VBN	path1=CELEBREX_compound<BID_obl<receive_acl<subject_obl
DDI-DrugBank.d172.s20	DDI-DrugBank.d172.s20.e0	DDI-DrugBank.d172.s20.e1	advise	pos_2=MD	pos_3=VB	lemma_4=closely	relType_3=aux:pass	pos_6=WRB	pos_4=RB	eib=False	lemma_6=when	relType_2=aux	relType_1=nmod	pos_1=NN	lemma_5=monitor	lemma_2=should	lemma_1=treatment	relType_4=advmod	lemma_3=be	lpib=treatment_NN	path1=lithium_compound<treatment_nmod<patient_nsubj:pass	path2=introduce_advcl>CELEBREX_nsubj:pass	wib=treatment	path=lithium_compound<treatment_nmod<patient_nsubj:pass<monitor_ROOT>introduce_advcl>CELEBREX_nsubj:pass	relType_5=ROOT	lib=treatment	pos_5=VBN	relType_6=advmod
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e0	DDI-DrugBank.d172.s21.e1	null	path1=	lemma_6=of	relType_9=nmod	relType_6=case	lpib=interaction_NN	pos_2=IN	lemma_5=study	pos_8=NN	lemma_10=take	eib=False	pos_6=IN	pos_9=NNS	relType_3=det	lemma_3=a	pos_4=NN	lemma_1=:	lib=interaction	path2=have_appos>study_obl>patient_nmod>take_acl>methotrexate_obj	lemma_4=interaction	path=<Methotrexate_ROOT>have_appos>study_obl>patient_nmod>take_acl>methotrexate_obj	relType_7=amod	lemma_8=arthritis	relType_8=compound	relType_4=compound	pos_1=:	relType_10=acl	relType_5=obl	lemma_7=rheumatoid	wib=interaction	pos_5=NN	lemma_9=patient	relType_2=case	pos_3=DT	pos_7=JJ	pos_10=VBG	relType_1=punct	lemma_2=in
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e0	DDI-DrugBank.d172.s21.e2	null	lemma_11=,	lemma_11=methotrexate	path=<Methotrexate_ROOT>have_appos>celebrex_nsubj	path1=	lemma_6=of	relType_9=nmod	relType_11=obj	relType_6=case	lpib=interaction_NN	pos_2=IN	lemma_5=study	pos_8=NN	lemma_10=take	pos_6=IN	relType_11=punct	pos_9=NNS	path2=have_appos>celebrex_nsubj	relType_3=det	lemma_3=a	pos_4=NN	lemma_1=:	lib=interaction	lemma_4=interaction	relType_7=amod	lemma_8=arthritis	relType_8=compound	relType_4=compound	pos_1=:	relType_10=acl	relType_5=obl	lemma_7=rheumatoid	pos_11=,	wib=interaction	pos_5=NN	lemma_9=patient	pos_11=NN	relType_2=case	eib=True	pos_3=DT	pos_7=JJ	pos_10=VBG	relType_1=punct	lemma_2=in
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e0	DDI-DrugBank.d172.s21.e3	null	lemma_11=methotrexate	path2=have_appos>effect_obj>pharmacokinetic_nmod>methotrexate_nmod	relType_18=case	lemma_5=study	lemma_10=take	lemma_16=significant	relType_20=nmod	pos_15=DT	lemma_14=have	pos_1=:	relType_10=acl	lemma_7=rheumatoid	relType_21=case	lemma_9=patient	pos_7=JJ	relType_19=det	path1=	relType_6=case	pos_8=NN	relType_16=amod	pos_6=IN	relType_3=det	lemma_3=a	lemma_12=do	lib=interaction	relType_13=advmod	pos_14=VB	wib=interaction	relType_12=nsubj	pos_5=NN	relType_17=obj	pos_11=NN	lemma_13=not	relType_1=punct	lemma_21=of	relType_15=det	lemma_18=on	lemma_2=in	pos_19=DT	lemma_11=,	lemma_6=of	lemma_15=a	relType_11=obj	pos_2=IN	pos_17=NN	relType_11=punct	pos_21=IN	pos_18=IN	lemma_1=:	relType_7=amod	relType_8=compound	relType_5=obl	relType_2=case	pos_10=VBG	relation_18=neutral	relType_9=nmod	lemma_12=celebrex	lpib=interaction_NN	pos_12=VBD	pos_9=NNS	relType_12=aux	pos_13=RB	lemma_19=the	pos_4=NN	lemma_4=interaction	pos_16=JJ	lemma_8=arthritis	relType_4=compound	pos_20=NNS	relType_14=appos	pos_11=,	eib=True	pos_3=DT	lemma_17=effect	pos_12=NN	path=<Methotrexate_ROOT>have_appos>effect_obj>pharmacokinetic_nmod>methotrexate_nmod	lemma_20=pharmacokinetic
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e1	DDI-DrugBank.d172.s21.e2	null	wib=CELEBREX	lpib=celebrex_NN	path=methotrexate_obj<take_acl<patient_nmod<study_obl<have_appos>celebrex_nsubj	lemma_1=,	eib=False	lib=celebrex	pos_1=,	path1=methotrexate_obj<take_acl<patient_nmod<study_obl	path2=celebrex_nsubj	relType_1=punct
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e1	DDI-DrugBank.d172.s21.e3	null	relType_8=case	lemma_1=,	lemma_4=have	pos_2=NN	pos_3=RB	relType_3=advmod	pos_6=JJ	relType_4=appos	pos_1=,	lemma_2=do	lemma_3=not	relType_11=case	lemma_2=celebrex	lemma_5=a	relType_10=nmod	path2=effect_obj>pharmacokinetic_nmod>methotrexate_nmod	relType_2=nsubj	lemma_7=effect	relType_6=amod	relType_7=obj	pos_9=DT	pos_2=VBD	relType_2=aux	path=methotrexate_obj<take_acl<patient_nmod<study_obl<have_appos>effect_obj>pharmacokinetic_nmod>methotrexate_nmod	pos_8=IN	lemma_8=on	pos_11=IN	relType_5=det	path1=methotrexate_obj<take_acl<patient_nmod<study_obl	relation_7=neutral	wib=CELEBREX	lpib=celebrex_NN	lemma_6=significant	eib=True	pos_4=VB	lemma_9=the	lib=celebrex	pos_5=DT	lemma_11=of	relType_1=punct	pos_7=NN	lemma_10=pharmacokinetic	pos_10=NNS	relType_9=det
DDI-DrugBank.d172.s21	DDI-DrugBank.d172.s21.e2	DDI-DrugBank.d172.s21.e3	null	pos_8=DT	relType_7=case	relType_1=aux	lemma_4=a	lemma_9=pharmacokinetic	wib=did	lemma_10=of	pos_3=VB	relType_9=nmod	pos_6=NN	pos_2=RB	lemma_5=significant	pos_1=VBD	path2=effect_obj>pharmacokinetic_nmod>methotrexate_nmod	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	lemma_7=on	relation_5=neutral	pos_9=NNS	relType_10=case	lemma_3=have	pos_4=DT	pos_5=JJ	relType_5=amod	lemma_8=the	lemma_6=effect	pos_10=IN	lpib=do_VBD	relType_6=obj	lib=do	pos_7=IN	path=celebrex_nsubj<have_appos>effect_obj>pharmacokinetic_nmod>methotrexate_nmod	path1=celebrex_nsubj	relType_8=det	relType_4=det	lemma_2=not
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e0	DDI-DrugBank.d172.s22.e1	null	pos_2=DT	lemma_2=the	path1=	relType_3=nsubj:pass	lemma_3=effect	eib=False	path=<Warfarin_ROOT>study_parataxis>effect_nsubj:pass>celecoxib_nmod	relation_2=neutral	lpib=effect_NN	lemma_1=:	wib=effect	path2=study_parataxis>effect_nsubj:pass>celecoxib_nmod	pos_4=IN	pos_1=:	relType_4=case	pos_3=NN	relType_2=det	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e0	DDI-DrugBank.d172.s22.e2	null	pos_2=DT	lemma_2=the	pos_6=DT	path1=	path2=study_parataxis>effect_nsubj:pass>effect_nmod>warfarin_nmod	path=<Warfarin_ROOT>study_parataxis>effect_nsubj:pass>effect_nmod>warfarin_nmod	relation_10=neutral	relType_3=nsubj:pass	lemma_5=celecoxib	relType_8=punct	relType_5=case	relType_11=case	lemma_3=effect	pos_9=JJ	relType_10=nmod	pos_7=AFX	lemma_6=the	relation_2=neutral	pos_8=HYPH	relType_9=amod	pos_10=NN	lemma_10=effect	lpib=effect_NN	lemma_1=:	lemma_9=coagulant	pos_11=IN	wib=effect	lemma_7=anti	pos_4=IN	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	relType_6=det	pos_5=NN	relType_7=obl:npmod	eib=True	lemma_5=on	pos_3=NN	lemma_8=-	relType_2=det	lemma_11=of	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e0	DDI-DrugBank.d172.s22.e3	null	pos_24=CD	relType_3=nsubj:pass	lemma_5=celecoxib	relType_8=punct	relType_5=case	pos_13=VBN	lemma_20=receive	relType_10=nmod	path2=study_parataxis>group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	relType_27=nmod	lemma_14=in	pos_10=NN	pos_15=DT	lemma_26=5	relType_24=compound	pos_1=:	pos_25=SYM	lemma_8=-	lib=effect	lemma_23=of	pos_2=DT	lemma_2=the	pos_21=JJ	path1=	pos_19=NNS	relType_13=parataxis	relType_11=case	pos_20=VBG	relType_12=nmod	pos_8=HYPH	pos_14=IN	wib=effect	pos_5=IN	pos_16=NN	lemma_24=2	relType_6=det	pos_5=NN	pos_23=IN	relType_25=dep	relType_1=punct	relType_15=det	lemma_28=of	pos_6=DT	relType_26=nummod	lemma_12=warfarin	relType_16=obl	lemma_15=a	lemma_22=dose	path=<Warfarin_ROOT>study_parataxis>group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	lemma_18=healthy	pos_17=IN	relType_19=nmod	pos_27=NNS	lemma_6=the	relation_2=neutral	lemma_25=-	relType_9=amod	lemma_10=effect	lemma_1=:	relType_17=case	lemma_9=coagulant	pos_11=IN	lemma_7=anti	pos_4=IN	lemma_17=of	relType_23=case	lemma_16=group	relType_7=obl:npmod	relType_28=case	relType_20=acl	lemma_11=of	lemma_13=study	relType_14=case	lemma_4=of	relType_18=amod	relation_10=neutral	pos_26=CD	lemma_19=subject	relType_12=aux:pass	lemma_3=effect	pos_9=JJ	pos_7=AFX	lemma_21=daily	pos_12=VBD	relType_21=amod	pos_18=JJ	lpib=effect_NN	lemma_12=be	pos_22=NNS	relType_4=case	relType_5=nmod	lemma_27=mg	relType_22=obj	eib=True	lemma_5=on	pos_3=NN	pos_28=IN	relType_2=det	pos_12=NN
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e1	DDI-DrugBank.d172.s22.e2	null	pos_2=DT	relType_1=case	lemma_2=the	relType_7=case	lemma_4=-	relType_3=obl:npmod	pos_3=AFX	pos_4=HYPH	pos_6=NN	lpib=coagulant_JJ	eib=False	relation_5=neutral	lemma_3=anti	pos_1=IN	pos_5=JJ	relType_4=punct	relType_5=amod	lemma_6=effect	lemma_7=of	path=celecoxib_nmod<effect_nsubj:pass>effect_nmod>warfarin_nmod	lemma_5=coagulant	lib=coagulant	pos_7=IN	wib=coagulant	relType_2=det	path2=effect_nmod>warfarin_nmod	relType_6=nmod	path1=celecoxib_nmod	lemma_1=on
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e1	DDI-DrugBank.d172.s22.e3	null	relType_14=amod	lemma_21=-	pos_6=NN	lemma_13=of	relType_24=case	lpib=coagulant_JJ	relType_4=punct	path2=group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	lemma_10=in	relType_16=acl	pos_16=VBG	pos_24=IN	lemma_16=receive	relType_11=det	pos_7=IN	lemma_18=dose	path1=celecoxib_nmod<effect_nsubj:pass	relType_18=obj	lemma_1=on	relType_9=parataxis	pos_2=DT	relType_1=case	lemma_2=the	pos_18=NNS	relType_7=case	pos_20=CD	pos_8=NN	lemma_15=subject	relType_22=nummod	relType_8=aux:pass	pos_1=IN	relType_21=dep	lemma_9=study	relType_15=nmod	lemma_22=5	relType_17=amod	relType_19=case	pos_21=SYM	lemma_14=healthy	lemma_4=-	pos_3=AFX	lemma_24=of	relation_5=neutral	lemma_3=anti	lemma_12=group	pos_13=IN	relType_23=nmod	pos_8=VBD	relType_13=case	lemma_17=daily	lemma_19=of	lemma_20=2	relType_5=amod	pos_23=NNS	pos_10=IN	lemma_8=warfarin	wib=coagulant	pos_14=JJ	relType_6=nmod	path=celecoxib_nmod<effect_nsubj:pass<study_parataxis>group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	pos_19=IN	relType_12=obl	lemma_11=a	relType_3=obl:npmod	pos_17=JJ	pos_4=HYPH	pos_22=CD	relType_10=case	pos_9=VBN	pos_5=JJ	lemma_8=be	lemma_6=effect	pos_11=DT	lemma_7=of	lemma_5=coagulant	pos_15=NNS	lib=coagulant	eib=True	relType_8=nmod	relType_20=compound	relType_2=det	pos_12=NN	lemma_23=mg
DDI-DrugBank.d172.s22	DDI-DrugBank.d172.s22.e2	DDI-DrugBank.d172.s22.e3	null	pos_2=VBN	pos_3=IN	pos_13=CD	lemma_4=a	relType_16=nmod	relType_1=aux:pass	relType_10=amod	relType_12=case	path1=warfarin_nmod<effect_nmod<effect_nsubj:pass	path=warfarin_nmod<effect_nmod<effect_nsubj:pass<study_parataxis>group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	lemma_6=of	relType_11=obj	pos_16=NNS	relType_6=case	lemma_2=study	lemma_7=healthy	pos_8=NNS	lemma_12=of	pos_17=IN	pos_15=CD	pos_1=VBD	lemma_9=receive	eib=False	lpib=be_VBD	pos_6=IN	lemma_1=be	lemma_13=2	pos_11=NNS	lemma_10=daily	lemma_5=group	lemma_16=mg	pos_12=IN	relType_17=case	pos_9=VBG	pos_4=DT	relType_7=amod	lib=be	path2=group_obl>subject_nmod>receive_acl>dose_obj>mg_nmod>warfarin_nmod	relType_13=compound	pos_14=SYM	pos_10=JJ	lemma_11=dose	lemma_14=-	lemma_15=5	relType_15=nummod	relType_14=dep	relType_5=obl	lemma_17=of	wib=was	relType_3=case	lemma_8=subject	pos_5=NN	relType_9=acl	relType_8=nmod	pos_7=JJ	relType_2=parataxis	relType_4=det	lemma_3=in
DDI-DrugBank.d172.s23	DDI-DrugBank.d172.s23.e0	DDI-DrugBank.d172.s23.e1	null	lemma_3=alter	relType_1=aux	relType_7=case	path2=effect_obj>warfarin_nmod	wib=did	path1=celecoxib_nsubj	pos_3=VB	pos_6=NN	pos_2=RB	pos_1=VBD	eib=False	path=celecoxib_nsubj<alter_ROOT>effect_obj>warfarin_nmod	lemma_1=do	relType_2=advmod	relation_2=neutral	relation_5=neutral	pos_4=DT	pos_5=JJ	relType_5=amod	relType_3=ROOT	lemma_5=anticoagulant	lemma_4=the	lemma_6=effect	lpib=do_VBD	lemma_7=of	relType_6=obj	lib=do	pos_7=IN	relType_4=det	lemma_2=not
DDI-DrugBank.d172.s24	DDI-DrugBank.d172.s24.e0	DDI-DrugBank.d172.s24.e1	advise	lib=warfarin	lemma_1=with	relType_1=case	lpib=warfarin_NN	eib=False	path2=warfarin_nmod	path1=	wib=warfarin	path=<celebrex_dep>warfarin_nmod	pos_1=IN
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e0	DDI-DrugBank.d141.s0.e1	null	lpib=fibric_NNP	lemma_1=,	pos_2=NN	lemma_2=Fibric	wib=Fibric	eib=True	pos_2=NNP	relType_2=compound	lemma_2=acid	path1=	pos_1=,	path2=derivative_conj	relType_1=punct	lib=fibric	path=<drug_ROOT>derivative_conj
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e0	DDI-DrugBank.d141.s0.e2	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	lib=fibric	relType_2=punct	lpib=fibric_NNP	lemma_2=Fibric	pos_2=NNP	relType_2=conj	lemma_2=derivative	lemma_2=,	wib=Fibric	relType_2=compound	pos_2=NNS	lemma_2=acid	eib=True	path2=Niacin_appos	pos_2=,	relType_1=punct	path=<drug_ROOT>Niacin_appos
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e0	DDI-DrugBank.d141.s0.e3	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	pos_3=NNP	lemma_4=Nicotinic	lib=fibric	relType_2=punct	lemma_3=Niacin	lpib=fibric_NNP	lemma_2=Fibric	pos_2=NNP	relType_3=appos	lemma_3=(	pos_3=-LRB-	relType_2=conj	lemma_2=derivative	lemma_2=,	path=<drug_ROOT>Niacin_appos>Acid_dep	wib=Fibric	relType_2=compound	relType_4=compound	path2=Niacin_appos>Acid_dep	pos_2=NNS	lemma_2=acid	eib=True	pos_4=NNP	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e0	DDI-DrugBank.d141.s0.e4	null	relType_4=dep	lemma_4=Acid	lemma_1=,	pos_2=NN	path1=	pos_1=,	pos_3=NNP	path=<drug_ROOT>Niacin_appos>Acid_dep>Erythromycin_appos	lemma_4=Nicotinic	lib=fibric	relType_2=punct	lemma_3=Niacin	lpib=fibric_NNP	path2=Niacin_appos>Acid_dep>Erythromycin_appos	lemma_2=Fibric	pos_2=NNP	relType_3=appos	pos_4=,	lemma_3=(	pos_3=-LRB-	relType_2=conj	lemma_2=derivative	lemma_2=,	relType_4=punct	wib=Fibric	relType_2=compound	relType_4=compound	lemma_4=,	pos_2=NNS	lemma_2=acid	eib=True	pos_4=NNP	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e0	DDI-DrugBank.d141.s0.e5	null	relType_4=dep	lemma_4=Acid	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	pos_3=NNP	lemma_6=Azole	lemma_4=Nicotinic	lib=fibric	relType_2=punct	lemma_3=Niacin	lpib=fibric_NNP	lemma_2=Fibric	pos_2=NNP	relType_3=appos	pos_4=,	pos_6=NNP	lemma_3=(	pos_3=-LRB-	relType_2=conj	lemma_2=derivative	lemma_2=,	lemma_5=Erythromycin	relType_4=punct	wib=Fibric	lemma_5=,	relType_2=compound	relType_5=punct	relType_4=compound	pos_5=NNP	lemma_4=,	path2=Niacin_appos>Acid_dep>Antifungals_appos	relType_5=appos	pos_2=NNS	relType_6=compound	lemma_2=acid	eib=True	path=<drug_ROOT>Niacin_appos>Acid_dep>Antifungals_appos	pos_4=NNP	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e1	DDI-DrugBank.d141.s0.e2	null	wib=Niacin	lemma_1=,	path=derivative_conj<drug_ROOT>Niacin_appos	eib=False	pos_1=,	lib=niacin	path1=derivative_conj	lpib=niacin_NNP	path2=Niacin_appos	relType_1=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e1	DDI-DrugBank.d141.s0.e3	null	lemma_1=,	pos_1=,	pos_3=NNP	lemma_2=Niacin	relType_2=punct	wib=Niacin	pos_2=NNP	pos_2=-LRB-	lib=niacin	path1=derivative_conj	lemma_3=Nicotinic	path2=Niacin_appos>Acid_dep	path=derivative_conj<drug_ROOT>Niacin_appos>Acid_dep	relType_2=appos	eib=True	lpib=niacin_NNP	relType_3=compound	relType_1=punct	lemma_2=(
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e1	DDI-DrugBank.d141.s0.e4	null	relType_3=dep	lemma_1=,	pos_1=,	pos_3=NNP	lemma_2=Niacin	relType_2=punct	wib=Niacin	path2=Niacin_appos>Acid_dep>Erythromycin_appos	pos_2=NNP	pos_2=-LRB-	lib=niacin	path1=derivative_conj	lemma_3=,	lemma_3=Nicotinic	path=derivative_conj<drug_ROOT>Niacin_appos>Acid_dep>Erythromycin_appos	relType_2=appos	pos_3=,	eib=True	lpib=niacin_NNP	relType_3=compound	lemma_3=Acid	relType_1=punct	lemma_2=(	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e1	DDI-DrugBank.d141.s0.e5	null	relType_3=dep	lemma_1=,	relType_4=appos	pos_1=,	pos_3=NNP	lemma_5=Azole	relType_5=compound	lemma_2=Niacin	relType_2=punct	wib=Niacin	pos_2=NNP	pos_4=,	pos_2=-LRB-	lib=niacin	path1=derivative_conj	relType_4=punct	lemma_3=,	lemma_3=Nicotinic	pos_5=NNP	lemma_4=,	relType_2=appos	path2=Niacin_appos>Acid_dep>Antifungals_appos	pos_3=,	eib=True	pos_4=NNP	path=derivative_conj<drug_ROOT>Niacin_appos>Acid_dep>Antifungals_appos	lpib=niacin_NNP	relType_3=compound	lemma_4=Erythromycin	lemma_3=Acid	relType_1=punct	lemma_2=(	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e2	DDI-DrugBank.d141.s0.e3	null	lemma_1=(	lemma_2=Nicotinic	eib=True	pos_2=NNP	relType_2=compound	path=<Niacin_appos>Acid_dep	wib=Nicotinic	path1=	path2=Acid_dep	lib=nicotinic	relType_1=punct	lpib=nicotinic_NNP	pos_1=-LRB-
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e2	DDI-DrugBank.d141.s0.e4	null	lemma_1=(	relType_2=dep	lemma_2=Nicotinic	path=<Niacin_appos>Acid_dep>Erythromycin_appos	path2=Acid_dep>Erythromycin_appos	eib=True	pos_2=NNP	relType_2=compound	lemma_2=Acid	lemma_2=,	wib=Nicotinic	path1=	pos_2=,	lib=nicotinic	relType_1=punct	lpib=nicotinic_NNP	pos_1=-LRB-	relType_2=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e2	DDI-DrugBank.d141.s0.e5	null	path1=	pos_3=NNP	lpib=nicotinic_NNP	relType_2=punct	lemma_1=(	pos_2=NNP	relType_3=appos	path=<Niacin_appos>Acid_dep>Antifungals_appos	lib=nicotinic	lemma_2=,	lemma_3=Erythromycin	relType_2=dep	path2=Acid_dep>Antifungals_appos	lemma_3=,	relType_2=compound	relType_4=compound	pos_1=-LRB-	lemma_2=Nicotinic	pos_3=,	lemma_4=Azole	eib=True	lemma_2=Acid	wib=Nicotinic	pos_4=NNP	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e3	DDI-DrugBank.d141.s0.e4	null	wib=Erythromycin	lpib=erythromycin_NNP	lemma_1=,	path=<Acid_dep>Erythromycin_appos	eib=False	path1=	pos_1=,	path2=Erythromycin_appos	relType_1=punct	lib=erythromycin
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e3	DDI-DrugBank.d141.s0.e5	null	lpib=erythromycin_NNP	lemma_1=,	path2=Antifungals_appos	path=<Acid_dep>Antifungals_appos	path1=	pos_1=,	pos_3=NNP	relType_2=punct	wib=Erythromycin	pos_2=NNP	lib=erythromycin	lemma_2=,	lemma_2=Erythromycin	relType_2=appos	eib=True	lemma_3=Azole	pos_2=,	relType_3=compound	relType_1=punct
DDI-DrugBank.d141.s0	DDI-DrugBank.d141.s0.e4	DDI-DrugBank.d141.s0.e5	null	lemma_2=Azole	lemma_1=,	path1=Erythromycin_appos	lpib=azole_NNP	eib=True	pos_2=NNP	path2=Antifungals_appos	relType_2=compound	pos_1=,	lib=azole	wib=Azole	relType_1=punct	path=Erythromycin_appos<Acid_dep>Antifungals_appos
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e0	DDI-DrugBank.d141.s1.e1	null	lemma_1=(	lemma_2=magnesium	pos_2=NN	eib=True	lemma_2=-	relType_2=compound	path1=	pos_2=HYPH	lemma_2=aluminum	wib=Magnesium	path=<antacid_ROOT>hydroxide_appos	path2=hydroxide_appos	relType_1=punct	lib=magnesium	lpib=magnesium_NN	pos_1=-LRB-	relType_2=punct
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e0	DDI-DrugBank.d141.s1.e2	null	lemma_2=)	pos_2=NN	path1=	pos_2=HYPH	lpib=magnesium_NN	relType_2=punct	lemma_1=(	path2=affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	lemma_2=-	lemma_3=:	wib=Magnesium	path=<antacid_ROOT>affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	lemma_2=aluminum	pos_3=:	relType_2=compound	lemma_2=hydroxide	relType_2=appos	lib=magnesium	pos_1=-LRB-	lemma_2=magnesium	eib=True	pos_2=-RRB-	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e0	DDI-DrugBank.d141.s1.e3	null	lemma_2=)	relType_6=aux:pass	relType_12=obl	pos_2=NN	lemma_7=not	pos_8=VBN	lemma_10=co	path1=	relType_5=nsubj:pass	pos_9=IN	lemma_11=-	pos_2=HYPH	lpib=magnesium_NN	pos_6=VBD	relType_2=punct	lemma_6=be	lemma_1=(	pos_11=HYPH	lemma_12=administration	lemma_13=of	lemma_9=by	lemma_2=-	pos_7=RB	lemma_3=:	pos_5=NNS	relType_11=punct	wib=Magnesium	lemma_5=concentration	relType_9=case	pos_10=NN	lemma_4=Cerivastatin	relType_10=compound	pos_4=NN	relType_8=parataxis	lemma_2=aluminum	pos_13=IN	relType_13=case	path=<antacid_ROOT>affect_parataxis>administration_obl>antacid_nmod	pos_3=:	relType_2=compound	relType_4=compound	lemma_2=hydroxide	relType_2=appos	lib=magnesium	pos_1=-LRB-	lemma_2=magnesium	relation_12=neutral	eib=True	pos_2=-RRB-	lemma_4=plasma	pos_4=NNP	relType_7=advmod	relType_1=punct	pos_12=NN	path2=affect_parataxis>administration_obl>antacid_nmod	relType_3=punct	lemma_8=affect
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e1	DDI-DrugBank.d141.s1.e2	null	lib=cerivastatin	lemma_2=:	path2=affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	eib=False	wib=Cerivastatin	pos_1=-RRB-	lemma_1=)	pos_2=:	relType_1=punct	path1=hydroxide_appos	lpib=cerivastatin_NNP	path=hydroxide_appos<antacid_ROOT>affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	relType_2=punct
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e1	DDI-DrugBank.d141.s1.e3	null	relType_8=case	lemma_9=co	relType_10=punct	pos_3=NNP	relType_12=case	lib=cerivastatin	lemma_1=)	relType_2=punct	lemma_12=of	lemma_3=plasma	lemma_2=:	relType_9=compound	wib=Cerivastatin	relType_4=nsubj:pass	path=hydroxide_appos<antacid_ROOT>affect_parataxis>administration_obl>antacid_nmod	lpib=cerivastatin_NNP	lemma_5=be	pos_4=NNS	lemma_7=affect	pos_8=IN	pos_9=NN	lemma_10=-	lemma_11=administration	pos_12=IN	lemma_6=not	relType_5=aux:pass	lemma_8=by	pos_1=-RRB-	pos_10=HYPH	pos_2=:	lemma_3=Cerivastatin	relType_11=obl	path1=hydroxide_appos	pos_6=RB	pos_5=VBD	relation_7=neutral	pos_7=VBN	pos_11=NN	eib=True	pos_3=NN	relType_3=compound	relType_1=punct	lemma_4=concentration	path2=affect_parataxis>administration_obl>antacid_nmod	relType_6=advmod	relType_7=parataxis
DDI-DrugBank.d141.s1	DDI-DrugBank.d141.s1.e2	DDI-DrugBank.d141.s1.e3	null	lemma_1=plasma	relType_7=compound	lemma_6=by	lemma_10=of	relType_5=parataxis	relType_8=punct	relType_9=obl	relType_3=aux:pass	relType_6=case	path2=administration_obl>antacid_nmod	pos_4=RB	relType_1=compound	eib=False	pos_6=IN	pos_3=VBD	pos_8=HYPH	relType_10=case	relType_2=nsubj:pass	pos_9=NN	pos_1=NN	path=Cerivastatin_compound<concentration_nsubj:pass<affect_parataxis>administration_obl>antacid_nmod	lemma_4=not	wib=plasma	lpib=plasma_NN	lemma_2=concentration	relType_4=advmod	lemma_3=be	lib=plasma	pos_10=IN	pos_2=NNS	lemma_7=co	lemma_9=administration	lemma_8=-	relation_4=neutral	pos_7=NN	lemma_5=affect	path1=Cerivastatin_compound<concentration_nsubj:pass	pos_5=VBN
DDI-DrugBank.d141.s2	DDI-DrugBank.d141.s2.e0	DDI-DrugBank.d141.s2.e1	null	path2=affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	eib=False	wib=Cerivastatin	path1=	path=<CIMETlDINE_ROOT>affect_parataxis>concentration_nsubj:pass>Cerivastatin_compound	pos_1=:	relType_1=punct	lib=cerivastatin	lpib=cerivastatin_NNP	lemma_1=:
DDI-DrugBank.d141.s2	DDI-DrugBank.d141.s2.e0	DDI-DrugBank.d141.s2.e2	null	pos_2=NN	relType_7=case	lemma_4=be	lemma_3=concentration	path1=	relType_3=nsubj:pass	lemma_9=-	lib=cerivastatin	relType_11=case	relation_6=neutral	pos_8=NN	pos_9=HYPH	pos_3=NNS	pos_2=NNP	wib=Cerivastatin	path2=affect_parataxis>administration_obl>cimetidine_nmod	lemma_6=affect	pos_6=VBN	pos_10=NN	lpib=cerivastatin_NNP	relType_6=parataxis	lemma_7=by	path=<CIMETlDINE_ROOT>affect_parataxis>administration_obl>cimetidine_nmod	lemma_1=:	pos_11=IN	lemma_5=not	relType_2=compound	lemma_8=co	pos_5=RB	pos_1=:	relType_4=aux:pass	lemma_2=Cerivastatin	relType_8=compound	relType_9=punct	relType_5=advmod	pos_4=VBD	eib=True	pos_7=IN	lemma_10=administration	lemma_11=of	relType_1=punct	lemma_2=plasma	relType_10=obl
DDI-DrugBank.d141.s2	DDI-DrugBank.d141.s2.e1	DDI-DrugBank.d141.s2.e2	null	lemma_1=plasma	relType_7=compound	lemma_6=by	lemma_10=of	relType_5=parataxis	relType_8=punct	relType_9=obl	relType_3=aux:pass	relType_6=case	path=Cerivastatin_compound<concentration_nsubj:pass<affect_parataxis>administration_obl>cimetidine_nmod	pos_4=RB	relType_1=compound	eib=False	pos_6=IN	pos_3=VBD	path2=administration_obl>cimetidine_nmod	pos_8=HYPH	relType_10=case	relType_2=nsubj:pass	pos_9=NN	pos_1=NN	lemma_4=not	wib=plasma	lpib=plasma_NN	lemma_2=concentration	relType_4=advmod	lemma_3=be	lib=plasma	pos_10=IN	pos_2=NNS	lemma_7=co	lemma_9=administration	lemma_8=-	relation_4=neutral	pos_7=NN	lemma_5=affect	path1=Cerivastatin_compound<concentration_nsubj:pass	pos_5=VBN
DDI-DrugBank.d141.s3	DDI-DrugBank.d141.s3.e0	DDI-DrugBank.d141.s3.e1	null	pos_2=DT	lemma_2=the	relType_8=amod	path1=	path=<cholestyramine_ROOT>evaluate_parataxis>influence_nsubj:pass>cholestyramine_nmod	relType_3=nsubj:pass	lemma_6=bile	pos_6=NN	wib=influence	relType_6=obl	lemma_7=-	relType_9=compound	eib=False	relation_2=neutral	path2=evaluate_parataxis>influence_nsubj:pass>cholestyramine_nmod	lemma_8=acidsequester	pos_9=NN	lemma_1=:	pos_7=HYPH	pos_4=IN	lpib=influence_NN	relType_5=det	pos_8=VBG	pos_1=:	relType_4=case	lemma_3=influence	lemma_5=the	pos_3=NN	relType_7=punct	relType_2=det	pos_5=DT	lemma_9=agent	relType_1=punct	lemma_4=of	lib=influence
DDI-DrugBank.d141.s3	DDI-DrugBank.d141.s3.e0	DDI-DrugBank.d141.s3.e2	null	pos_2=DT	lemma_2=the	relType_8=amod	path1=	relType_3=nsubj:pass	lemma_6=bile	path2=evaluate_parataxis>influence_nsubj:pass>cholestyramine_nmod>pharmacokinetit_nmod>sodium_nmod	relType_14=compound	pos_6=NN	lemma_13=of	wib=influence	relType_6=obl	lemma_7=-	relType_10=nmod	relType_9=compound	path=<cholestyramine_ROOT>evaluate_parataxis>influence_nsubj:pass>cholestyramine_nmod>pharmacokinetit_nmod>sodium_nmod	relation_2=neutral	lemma_12=pharmacokinetit	relType_12=nmod	pos_14=NN	relType_10=case	pos_10=NN	lemma_8=acidsequester	pos_9=NN	pos_13=IN	lemma_1=:	relType_13=case	lemma_10=cholestyramine	lemma_14=cerivastatin	pos_7=HYPH	pos_12=NNS	pos_4=IN	lpib=influence_NN	relType_5=det	pos_8=VBG	pos_1=:	relType_4=case	pos_10=IN	lemma_10=on	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=influence	lemma_5=the	eib=True	pos_3=NN	relType_7=punct	relType_2=det	pos_5=DT	lemma_9=agent	relType_1=punct	lemma_4=of	lib=influence
DDI-DrugBank.d141.s3	DDI-DrugBank.d141.s3.e1	DDI-DrugBank.d141.s3.e2	null	pos_2=DT	relType_1=case	lemma_2=the	lpib=pharmacokinetit_NNS	path1=	relType_5=compound	wib=pharmacokinetits	path2=pharmacokinetit_nmod>sodium_nmod	lemma_5=cerivastatin	pos_3=NNS	pos_1=IN	pos_4=IN	path=<cholestyramine_nmod>pharmacokinetit_nmod>sodium_nmod	relType_3=nmod	relType_4=case	lib=pharmacokinetit	pos_5=NN	eib=True	relType_2=det	lemma_3=pharmacokinetit	lemma_4=of	lemma_1=on
DDI-DrugBank.d141.s4	DDI-DrugBank.d141.s4.e0	DDI-DrugBank.d141.s4.e1	mechanism	lpib=g_NN	relType_1=cc	lib=g	pos_1=CC	relType_2=nummod	eib=False	path1=sodium_compound	path=sodium_compound<cholestyramine_nsubj>	pos_2=CD	lemma_2=12	pos_3=NN	relType_3=conj	path2=	lemma_3=g	lemma_1=and	wib=g
DDI-DrugBank.d141.s4	DDI-DrugBank.d141.s4.e0	DDI-DrugBank.d141.s4.e2	null	relType_1=cc	relType_22=compound	lemma_5=in	pos_14=CC	relType_19=advmod	relType_5=case	relType_4=acl	pos_15=CD	relation_6=adverse	lemma_16=%	lemma_21=to	relType_8=advmod	lemma_17=for	relType_23=compound	relType_15=nummod	pos_19=WRB	relType_21=case	relType_9=fixed	pos_7=IN	pos_6=NNS	lpib=g_NN	relType_2=nummod	relType_7=case	pos_22=NN	pos_20=VBN	lemma_4=result	relType_20=case	path2=decrease_obl>when_advmod>sodium_advcl	lemma_12=for	lemma_8=more	pos_12=IN	pos_5=IN	pos_16=NN	path1=sodium_compound<cholestyramine_nsubj	pos_11=NN	lemma_14=and	relType_11=nmod	lemma_3=g	pos_8=JJR	relType_18=nmod	lemma_1=and	lemma_20=compare	relType_12=case	wib=g	pos_17=IN	pos_23=NN	relType_6=obl	pos_21=IN	relType_17=case	lib=g	relType_3=conj	lemma_13=AUC	lemma_6=decrease	pos_4=VBD	lemma_9=than	lemma_23=cerivastatin	pos_1=CC	lemma_19=when	lemma_22=dosing	pos_18=NNP	lemma_4=cholestyramine	pos_9=IN	pos_13=NNP	relType_13=nmod	pos_2=CD	lemma_15=40	relType_4=nsubj	pos_4=NN	lemma_11=%	lemma_10=22	pos_10=CD	lemma_2=12	relType_14=cc	relType_10=nummod	lemma_7=of	eib=True	lemma_18=Cmax	pos_3=NN	path=sodium_compound<cholestyramine_nsubj<result_acl>decrease_obl>when_advmod>sodium_advcl	relType_16=conj
DDI-DrugBank.d141.s4	DDI-DrugBank.d141.s4.e1	DDI-DrugBank.d141.s4.e2	null	pos_15=NNP	relType_11=cc	pos_12=CD	pos_7=CD	pos_9=IN	lemma_14=for	pos_17=VBN	relType_18=case	pos_2=IN	pos_8=NN	path1=cholestyramine_nsubj	path2=decrease_obl>when_advmod>sodium_advcl	pos_1=VBD	pos_3=NNS	lemma_3=decrease	relType_10=nmod	relType_7=nummod	lemma_13=%	lemma_17=compare	pos_6=IN	lemma_19=dosing	pos_20=NN	path=cholestyramine_nsubj<result_acl>decrease_obl>when_advmod>sodium_advcl	pos_19=NN	relType_9=case	wib=resulted	pos_13=NN	relType_13=conj	pos_18=IN	relType_17=case	lemma_8=%	lemma_12=40	pos_14=IN	relType_16=advmod	relType_19=compound	lemma_11=and	lemma_20=cerivastatin	lemma_6=than	pos_4=IN	relType_6=fixed	relType_1=acl	pos_11=CC	relType_4=case	lemma_18=to	pos_5=JJR	lemma_5=more	lemma_7=22	pos_10=NNP	relType_15=nmod	relType_5=advmod	lemma_16=when	relType_2=case	relType_3=obl	eib=True	relType_8=nmod	relType_20=compound	relation_2=adverse	lemma_9=for	lib=result	relType_12=nummod	relType_14=case	lemma_10=AUC	lpib=result_VBD	lemma_1=result	lemma_4=of	lemma_2=in	pos_16=WRB	lemma_15=Cmax
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e0	DDI-DrugBank.d141.s5.e1	mechanism	relType_1=nummod	wib=hour	pos_2=NN	pos_3=IN	relType_8=dep	lib=hour	lemma_3=before	relType_5=compound	path2=hour_dep>and_dep>0_dep>._punct>sodium_dep	lemma_6=meal	pos_6=NN	path1=cholestyramine_nmod	relType_6=dep	pos_1=CD	lemma_9=.	relType_12=compound	lemma_11=mg	pos_12=NN	pos_4=DT	relType_2=dep	pos_7=CC	pos_10=CD	lemma_4=the	pos_9=.	relType_9=punct	lemma_10=3	relType_3=case	relType_10=nummod	pos_5=NN	lpib=hour_NN	pos_11=NN	lemma_5=evening	relType_7=dep	eib=True	path=cholestyramine_nmod<administration_dep>hour_dep>and_dep>0_dep>._punct>sodium_dep	relType_11=compound	lemma_7=and	lemma_12=cerivastatin	lemma_2=hour	pos_8=CD	relType_4=det	lemma_1=1	lemma_8=0
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e0	DDI-DrugBank.d141.s5.e2	null	relType_1=nummod	wib=hour	pos_2=NN	pos_16=DT	lemma_6=meal	lemma_16=the	pos_6=NN	relType_4=det	lemma_18=evening	relType_24=case	relType_6=dep	relType_12=compound	pos_18=NN	relType_2=dep	pos_12=RB	relType_25=det	pos_24=IN	lemma_10=3	relType_21=case	lemma_22=a	lemma_17=same	pos_14=NNS	relType_14=nmod	lemma_1=1	pos_13=CD	lemma_12=sodium	relation_24=adverse	path1=cholestyramine_nmod	lemma_9=.	lemma_11=mg	relType_23=obl	relType_15=case	relType_17=amod	pos_15=IN	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	relType_7=dep	relType_12=dep	lemma_12=cerivastatin	lemma_15=after	lemma_2=hour	pos_8=CD	lemma_24=in	pos_3=IN	relType_8=dep	pos_23=NN	relType_12=advmod	relType_13=nummod	pos_21=IN	path=cholestyramine_nmod<administration_dep>hour_dep>and_dep>0_dep>._punct>sodium_dep>hour_nmod>result_dep>decrease_obl>auc_nmod>cerivastatin_compound	lemma_4=the	pos_9=.	lemma_20=result	lemma_19=meal	lemma_5=evening	relType_22=det	lemma_13=4	lemma_23=decrease	lib=hour	lemma_3=before	relType_5=compound	pos_17=JJ	path2=hour_dep>and_dep>0_dep>._punct>sodium_dep>hour_nmod>result_dep>decrease_obl>auc_nmod>cerivastatin_compound	relType_16=det	relType_20=dep	lemma_21=in	pos_25=DT	pos_1=CD	pos_20=VBD	pos_19=NN	lemma_12=approximately	pos_4=DT	pos_7=CC	pos_10=CD	lemma_25=the	relType_9=punct	relType_3=case	relType_10=nummod	lpib=hour_NN	eib=True	relType_11=compound	lemma_7=and	relType_18=compound	pos_12=NN	lemma_14=hour	lemma_8=0
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e0	DDI-DrugBank.d141.s5.e3	null	relType_1=nummod	wib=hour	pos_2=NN	pos_16=DT	relType_32=punct	pos_35=NN	lemma_6=meal	pos_41=NN	lemma_16=the	pos_6=NN	relType_45=compound	relType_4=det	lemma_18=evening	relType_24=case	relType_6=dep	relType_12=compound	relType_26=nmod	pos_40=CD	lemma_39=about	pos_26=NN	pos_18=NN	pos_36=IN	relType_2=dep	pos_12=RB	relation_37=adverse	relType_25=det	pos_24=IN	lemma_10=3	lemma_46=cerivastatin	relType_21=case	pos_46=NN	pos_38=IN	lemma_22=a	lemma_17=same	lemma_26=auc	relType_40=nummod	lemma_42=when	pos_14=NNS	lemma_26=cerivastatin	relType_14=nmod	lemma_1=1	pos_13=CD	relType_46=compound	lemma_12=sodium	pos_29=IN	pos_39=RB	relType_29=fixed	relType_43=case	relation_24=adverse	path1=cholestyramine_nmod	lemma_9=.	relType_30=nummod	lemma_40=30	lemma_11=mg	lemma_43=compare	relType_35=conj	relType_23=obl	lemma_36=in	lemma_30=8	relType_15=case	pos_32=,	relType_37=nmod	relType_17=amod	pos_15=IN	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	relType_7=dep	pos_31=NN	relType_12=dep	lemma_12=cerivastatin	lemma_15=after	pos_30=CD	lemma_2=hour	pos_8=CD	pos_42=WRB	lemma_24=in	lemma_33=and	relType_38=case	pos_3=IN	relType_8=dep	pos_44=IN	lemma_37=Cmax	lemma_27=of	lemma_35=decrease	pos_23=NN	lemma_38=of	lemma_28=less	relType_36=case	path=cholestyramine_nmod<administration_dep>hour_dep>and_dep>0_dep>._punct>sodium_dep>decrease_conj>when_advmod>sodium_advcl	relType_12=advmod	relType_13=nummod	relType_26=compound	pos_21=IN	relType_41=nmod	lemma_4=the	pos_9=.	pos_33=CC	lemma_20=result	pos_34=DT	lemma_19=meal	pos_37=NNP	lemma_5=evening	relType_22=det	relType_44=case	lemma_13=4	relType_27=case	lemma_29=than	lemma_23=decrease	lemma_31=%	lemma_45=dosing	pos_45=NN	lib=hour	lemma_3=before	relType_5=compound	pos_17=JJ	relType_16=det	relType_34=det	relType_42=advmod	relType_20=dep	lemma_21=in	pos_25=DT	pos_1=CD	pos_20=VBD	relType_33=cc	relType_31=nmod	pos_19=NN	pos_27=IN	lemma_12=approximately	pos_4=DT	pos_28=JJR	pos_7=CC	pos_10=CD	lemma_25=the	lemma_32=,	lemma_44=to	path2=hour_dep>and_dep>0_dep>._punct>sodium_dep>decrease_conj>when_advmod>sodium_advcl	relType_9=punct	relType_3=case	relType_10=nummod	lpib=hour_NN	relType_28=advmod	eib=True	relType_11=compound	lemma_7=and	lemma_34=a	relType_18=compound	lemma_41=%	pos_43=VBN	relType_39=advmod	pos_12=NN	lemma_14=hour	lemma_8=0
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e1	DDI-DrugBank.d141.s5.e2	null	relType_7=compound	relType_12=obl	relType_2=nummod	pos_6=JJ	lemma_2=4	relType_8=nsubj	lemma_11=a	path1=	wib=approximately	relType_9=dep	pos_8=NN	relation_11=adverse	pos_3=NNS	eib=False	pos_2=CD	relType_6=amod	relType_14=det	pos_12=NN	relType_10=case	pos_13=IN	lemma_14=the	relType_1=advmod	lemma_7=evening	relType_13=case	lib=approximately	lemma_6=same	lemma_10=in	pos_4=IN	relType_5=det	relType_3=nmod	relType_4=case	path=<sodium_dep>hour_nmod>result_dep>decrease_obl>auc_nmod>cerivastatin_compound	lemma_4=after	lemma_1=approximately	lemma_9=result	pos_10=IN	pos_11=DT	lemma_13=in	lemma_3=hour	relType_11=det	path2=hour_nmod>result_dep>decrease_obl>auc_nmod>cerivastatin_compound	pos_14=DT	lemma_12=decrease	lemma_5=the	lpib=approximately_RB	pos_1=RB	pos_9=VBD	pos_5=DT	pos_7=NN	lemma_8=meal
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e1	DDI-DrugBank.d141.s5.e3	null	pos_6=JJ	pos_34=NN	lemma_2=4	relType_31=advmod	pos_35=NN	relType_34=compound	pos_3=NNS	lemma_26=Cmax	relType_26=nmod	relType_20=nmod	pos_20=NN	relType_23=det	path=<sodium_dep>decrease_conj>when_advmod>sodium_advcl	lib=approximately	lemma_10=in	lemma_23=a	lemma_21=,	lemma_34=dosing	relType_11=det	relType_15=compound	lemma_12=decrease	relType_30=nmod	path2=decrease_conj>when_advmod>sodium_advcl	relType_21=punct	lemma_31=when	relType_32=case	relType_2=nummod	lemma_24=decrease	path1=	relation_24=adverse	pos_30=NN	relType_25=case	pos_8=NN	lemma_15=cerivastatin	lemma_17=less	lemma_14=the	lemma_33=to	pos_31=WRB	lemma_7=evening	lemma_28=about	lemma_1=approximately	lemma_30=%	lemma_13=in	lemma_35=cerivastatin	relType_15=nmod	relType_16=case	lemma_5=the	pos_25=IN	pos_7=NN	lemma_29=30	pos_16=IN	relType_8=nsubj	relType_19=nummod	lemma_27=of	pos_24=NN	wib=approximately	relation_11=adverse	relType_22=cc	pos_13=IN	pos_18=IN	lemma_20=%	relType_13=case	lemma_6=same	pos_33=IN	pos_4=IN	relType_5=det	lemma_19=8	relType_3=nmod	pos_10=IN	lemma_32=compare	lemma_15=auc	lemma_3=hour	pos_32=VBN	pos_14=DT	lpib=approximately_RB	pos_1=RB	pos_9=VBD	pos_5=DT	relType_27=case	lemma_18=than	relType_7=compound	relType_12=obl	lemma_11=a	relType_33=case	pos_26=NNP	relType_9=dep	pos_22=CC	pos_21=,	relType_18=fixed	pos_17=JJR	pos_19=CD	pos_2=CD	relType_6=amod	relType_14=det	relType_10=case	lemma_16=of	pos_27=IN	relType_1=advmod	pos_28=RB	relType_29=nummod	pos_15=NN	relType_4=case	relType_24=conj	lemma_4=after	lemma_9=result	pos_23=DT	relType_17=advmod	pos_11=DT	relType_35=compound	pos_29=CD	relType_28=advmod	eib=True	pos_12=NN	lemma_22=and	lemma_25=in	lemma_8=meal
DDI-DrugBank.d141.s5	DDI-DrugBank.d141.s5.e2	DDI-DrugBank.d141.s5.e3	null	pos_19=IN	relType_3=advmod	lemma_9=a	wib=AUC	relType_4=fixed	relType_16=nmod	lemma_17=when	lemma_18=compare	relation_9=adverse	lemma_5=8	path1=cerivastatin_compound<auc_nmod<decrease_obl<result_dep<hour_nmod	relType_11=case	relType_18=case	pos_6=NN	pos_2=IN	pos_5=CD	lemma_13=of	pos_15=CD	relType_14=advmod	pos_21=NN	lemma_12=Cmax	relType_10=conj	lemma_20=dosing	relType_12=nmod	pos_20=NN	pos_7=,	pos_9=DT	lemma_16=%	lemma_11=in	pos_8=CC	lemma_6=%	relType_1=nmod	lemma_7=,	pos_10=NN	pos_1=NN	pos_3=JJR	pos_13=IN	pos_11=IN	lemma_15=30	relType_13=case	lpib=auc_NN	pos_14=RB	relType_15=nummod	relType_5=nummod	lemma_3=less	pos_4=IN	lemma_14=about	relType_21=compound	path=cerivastatin_compound<auc_nmod<decrease_obl<result_dep<hour_nmod<sodium_dep>decrease_conj>when_advmod>sodium_advcl	pos_16=NN	relType_17=advmod	lemma_19=to	lemma_8=and	lemma_1=auc	lemma_21=cerivastatin	pos_17=WRB	pos_18=VBN	lemma_2=of	relType_2=case	eib=True	pos_12=NNP	relType_19=case	relType_20=compound	relType_7=punct	lemma_4=than	path2=decrease_conj>when_advmod>sodium_advcl	relType_9=det	relType_6=nmod	relType_8=cc	lemma_10=decrease	lib=auc
DDI-DrugBank.d141.s6	DDI-DrugBank.d141.s6.e0	DDI-DrugBank.d141.s6.e1	null	lemma_2=at	relType_1=case	pos_1=VBN	relType_4=cc	lemma_1=give	lib=give	pos_2=IN	path2=bedtime_nmod>cholestyramine_conj	eib=False	path1=sodium_nmod	wib=given	lemma_3=bedtime	relType_3=nmod	relType_2=case	pos_4=CC	path=sodium_nmod<schedule_dep>bedtime_nmod>cholestyramine_conj	pos_3=NN	lemma_4=and	lpib=give_VBN
DDI-DrugBank.d141.s6	DDI-DrugBank.d141.s6.e0	DDI-DrugBank.d141.s6.e2	null	relType_22=compound	lemma_11=not	pos_1=VBN	path2=result_acl>decrease_obl>effect_nmod>sodium_nmod	lemma_19=clinical	relType_5=case	lemma_1=give	lemma_8=evening	relType_20=nmod	pos_20=NN	lemma_5=cholestyramine	lemma_22=cerivastatin	pos_11=RB	relType_21=case	relation_20=neutral	lemma_4=and	relType_12=acl	relType_1=case	pos_22=NN	lemma_5=give	lemma_12=result	pos_8=NN	lemma_15=significant	pos_18=DT	pos_10=MD	pos_6=IN	pos_19=JJ	relType_11=advmod	pos_9=NN	wib=given	relType_6=mark	pos_16=NN	lemma_13=in	relType_19=amod	pos_5=NN	relType_18=det	lemma_21=of	lemma_18=the	lemma_2=at	relType_7=det	lemma_6=before	relType_16=obl	lib=give	pos_17=IN	pos_2=IN	relType_10=aux	lemma_16=decrease	pos_21=IN	pos_13=IN	pos_7=DT	relType_17=case	relType_13=case	relType_8=compound	relation_16=adverse	relType_3=nmod	relType_5=conj	lemma_17=in	pos_14=DT	pos_12=VB	relType_2=case	pos_4=CC	lpib=give_VBN	pos_15=JJ	relType_15=amod	relType_4=cc	lemma_9=meal	path1=sodium_nmod	relType_14=det	lemma_20=effect	lemma_3=bedtime	lemma_10=would	lemma_14=a	eib=True	relType_9=nsubj	pos_3=NN	lemma_7=the	path=sodium_nmod<schedule_dep>result_acl>decrease_obl>effect_nmod>sodium_nmod	pos_5=VBN
DDI-DrugBank.d141.s6	DDI-DrugBank.d141.s6.e1	DDI-DrugBank.d141.s6.e2	null	relType_1=case	path=cholestyramine_conj<bedtime_nmod<schedule_dep>result_acl>decrease_obl>effect_nmod>sodium_nmod	relType_12=obl	lemma_7=not	pos_15=JJ	pos_1=VBN	relType_10=det	relType_15=amod	relType_16=nmod	lemma_15=clinical	path2=result_acl>decrease_obl>effect_nmod>sodium_nmod	relType_5=nsubj	pos_9=IN	lemma_10=a	lemma_1=give	lib=give	relType_2=mark	lemma_11=significant	pos_2=IN	lemma_6=would	pos_17=IN	lemma_18=cerivastatin	relation_11=adverse	pos_7=RB	relType_11=amod	relType_14=det	relType_9=case	pos_13=IN	lemma_14=the	relType_3=det	relation_15=neutral	pos_4=NN	relType_17=case	pos_8=VB	lemma_2=before	pos_18=NN	relType_13=case	wib=given	relType_6=aux	lemma_8=result	relType_4=compound	lemma_17=of	pos_16=NN	pos_6=MD	lemma_13=in	relType_8=acl	lemma_16=effect	pos_14=DT	pos_5=NN	lemma_12=decrease	eib=True	pos_3=DT	path1=cholestyramine_conj<bedtime_nmod	lemma_4=evening	relType_18=compound	lemma_3=the	pos_11=JJ	relType_7=advmod	pos_12=NN	lemma_5=meal	lemma_9=in	lpib=give_VBN	pos_10=DT
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e0	DDI-DrugBank.d141.s7.e1	null	lpib=plasma_NN	pos_2=NN	eib=False	relType_2=compound	path1=	pos_1=:	lib=plasma	wib=Plasma	path2=affect_parataxis>level_nsubj:pass>digoxin_compound	relType_1=punct	path=<DIGOXIN_ROOT>affect_parataxis>level_nsubj:pass>digoxin_compound	lemma_2=plasma	lemma_1=:
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e0	DDI-DrugBank.d141.s7.e2	null	lemma_3=digoxin	pos_2=NN	lemma_3=level	path1=	relType_3=nsubj:pass	relType_4=cc	path=<DIGOXIN_ROOT>affect_parataxis>level_nsubj:pass>clearance_conj>digoxin_compound	pos_3=NNS	lemma_1=:	lpib=plasma_NN	relType_2=compound	pos_1=:	lib=plasma	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	wib=Plasma	relType_3=compound	relType_1=punct	lemma_2=plasma	path2=affect_parataxis>level_nsubj:pass>clearance_conj>digoxin_compound
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e0	DDI-DrugBank.d141.s7.e3	null	relType_18=dep	relType_22=compound	pos_2=NN	lemma_11=not	relType_3=nsubj:pass	relType_8=punct	pos_19=.	relation_13=neutral	relType_10=aux:pass	pos_3=NNS	relType_12=parataxis	lemma_21=mg	lemma_13=by	pos_1=:	path2=affect_parataxis>administration_obl>sodium_nmod	lemma_22=cerivastatin	pos_11=RB	lemma_8=-	lemma_4=and	pos_7=JJ	lemma_2=plasma	pos_15=HYPH	pos_22=NN	path1=	lemma_19=.	lemma_6=at	pos_20=CD	relType_6=case	lemma_12=affect	pos_6=IN	pos_8=HYPH	relType_11=advmod	pos_9=NN	lemma_15=-	lemma_5=digoxin	lemma_16=administration	relType_21=compound	pos_16=NN	lemma_5=clearance	pos_5=NN	lemma_18=0	wib=Plasma	relType_3=compound	pos_12=VBN	relType_1=punct	lemma_10=be	relType_20=nummod	relType_16=obl	relType_19=punct	pos_17=IN	pos_14=NN	pos_13=IN	relType_15=punct	lemma_1=:	relType_17=case	relType_13=case	relType_7=amod	lemma_20=2	pos_10=VBD	lemma_17=of	relType_5=conj	pos_4=CC	lemma_3=digoxin	lemma_3=level	relType_5=compound	relType_4=cc	relType_14=compound	relType_9=nmod	lemma_9=state	path=<DIGOXIN_ROOT>affect_parataxis>administration_obl>sodium_nmod	pos_18=CD	lemma_14=co	lpib=plasma_NN	relType_2=compound	lib=plasma	eib=True	pos_3=NN	lemma_7=steady	pos_21=NN
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e1	DDI-DrugBank.d141.s7.e2	null	lemma_2=and	pos_1=NNS	path=digoxin_compound<level_nsubj:pass>clearance_conj>digoxin_compound	lpib=level_NNS	eib=False	lib=level	pos_2=CC	path1=digoxin_compound	relType_1=nsubj:pass	lemma_1=level	path2=clearance_conj>digoxin_compound	relType_2=cc	wib=levels
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e1	DDI-DrugBank.d141.s7.e3	null	lemma_3=digoxin	lemma_15=of	relType_9=advmod	lib=level	relType_17=punct	relType_18=nummod	relType_13=punct	relation_10=neutral	lemma_4=at	lemma_3=clearance	relType_2=cc	lemma_13=-	lemma_12=co	relType_11=case	pos_6=HYPH	relType_10=parataxis	pos_13=HYPH	lemma_2=and	pos_17=.	path=digoxin_compound<level_nsubj:pass<affect_parataxis>administration_obl>sodium_nmod	lemma_10=affect	lpib=level_NNS	relType_12=compound	path1=digoxin_compound<level_nsubj:pass	relType_6=punct	relType_8=aux:pass	pos_20=NN	lemma_1=level	lemma_9=not	pos_12=NN	pos_14=NN	lemma_17=.	relType_14=obl	pos_19=NN	pos_18=CD	pos_8=VBD	lemma_6=-	pos_11=IN	relType_19=compound	pos_5=JJ	lemma_14=administration	relType_15=case	pos_16=CD	relType_5=amod	lemma_8=be	relType_3=conj	lemma_11=by	pos_4=IN	lemma_20=cerivastatin	lemma_5=steady	relType_4=case	relType_7=nmod	pos_9=RB	lemma_19=mg	pos_15=IN	pos_1=NNS	lemma_7=state	eib=True	lemma_16=0	relType_20=compound	pos_3=NN	pos_10=VBN	pos_2=CC	relType_16=dep	relType_1=nsubj:pass	relType_3=compound	lemma_18=2	pos_7=NN	path2=administration_obl>sodium_nmod	wib=levels
DDI-DrugBank.d141.s7	DDI-DrugBank.d141.s7.e2	DDI-DrugBank.d141.s7.e3	null	lemma_2=at	relType_6=aux:pass	relType_12=obl	lemma_7=not	pos_8=VBN	lemma_10=co	lemma_4=-	lemma_5=state	pos_9=IN	path=digoxin_compound<clearance_conj<level_nsubj:pass<affect_parataxis>administration_obl>sodium_nmod	lemma_11=-	pos_4=HYPH	pos_6=VBD	lemma_6=be	pos_11=HYPH	lemma_13=of	pos_2=IN	lemma_12=administration	pos_17=NN	lemma_18=cerivastatin	lemma_9=by	pos_7=RB	relType_11=punct	lemma_3=steady	lemma_14=0	relType_9=case	relType_10=compound	pos_10=NN	pos_13=IN	relType_17=compound	relType_8=parataxis	pos_1=NN	wib=clearance	relType_15=punct	pos_18=NN	relType_13=case	pos_16=CD	lib=clearance	relType_3=amod	relType_4=punct	relType_5=nmod	relType_14=dep	relType_16=nummod	relType_1=conj	pos_15=.	lemma_16=2	relation_7=neutral	pos_5=NN	relType_2=case	pos_3=JJ	eib=True	lemma_15=.	lemma_17=mg	relType_18=compound	lemma_1=clearance	lpib=clearance_NN	relType_7=advmod	pos_12=NN	path2=administration_obl>sodium_nmod	pos_14=CD	path1=digoxin_compound<clearance_conj<level_nsubj:pass	lemma_8=affect
DDI-DrugBank.d141.s8	DDI-DrugBank.d141.s8.e0	DDI-DrugBank.d141.s8.e1	null	lemma_1=plasma	lemma_4=also	relType_7=case	lemma_9=-	relType_3=aux:pass	relType_11=case	pos_8=NN	pos_9=HYPH	pos_4=RB	relType_1=compound	eib=False	relation_5=neutral	pos_3=VBD	lemma_6=affect	pos_6=VBN	pos_10=NN	relType_2=nsubj:pass	path=Cerivastatin_compound<concentration_nsubj:pass<affect_ROOT>administration_obl>digoxin_nmod	pos_1=NN	lemma_7=by	pos_11=IN	lemma_5=not	wib=plasma	lpib=plasma_NN	relType_6=ROOT	lemma_2=concentration	relType_4=advmod	lemma_3=be	pos_5=RB	lemma_8=co	lib=plasma	relType_8=compound	relType_9=punct	relType_5=advmod	pos_2=NNS	pos_7=IN	path2=administration_obl>digoxin_nmod	lemma_10=administration	lemma_11=of	relType_10=obl	path1=Cerivastatin_compound<concentration_nsubj:pass
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e0	DDI-DrugBank.d141.s9.e1	null	relType_4=dep	path1=	lemma_5=of	relType_5=case	lpib=co_NNP	eib=False	pos_2=NNP	lemma_3=-	lemma_2=Co	pos_4=NN	lemma_1=:	path=<WARFARIN_nsubj>administration_dep>warfarin_nmod	relType_2=compound	pos_1=:	pos_5=IN	pos_3=HYPH	path2=administration_dep>warfarin_nmod	lemma_4=administration	relType_1=punct	lib=co	relType_3=punct	wib=Co
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e0	DDI-DrugBank.d141.s9.e2	null	relType_4=dep	path1=	lemma_5=of	relType_5=case	pos_6=NN	lpib=co_NNP	pos_2=NNP	lemma_3=-	lemma_2=Co	pos_4=NN	lemma_1=:	pos_6=CC	relType_2=compound	lemma_6=and	pos_1=:	pos_5=IN	path2=administration_dep>cerivastatin_conj	eib=True	pos_3=HYPH	relType_6=cc	path=<WARFARIN_nsubj>administration_dep>cerivastatin_conj	lemma_6=warfarin	lemma_4=administration	relType_1=punct	relType_6=nmod	lib=co	relType_3=punct	wib=Co
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e0	DDI-DrugBank.d141.s9.e3	null	lemma_16=in	lemma_11=not	lemma_15=change	lemma_5=of	relType_5=case	relType_21=conj	pos_6=NN	pos_8=JJ	relType_24=case	pos_2=NNP	lemma_3=-	pos_20=NN	relType_17=compound	pos_26=NN	pos_18=NN	relType_12=ROOT	relType_15=obl	pos_1=:	pos_19=CC	lemma_7=cerivastatin	pos_11=RB	lemma_19=or	pos_28=NN	lemma_17=prothrombin	pos_7=IN	pos_3=HYPH	lemma_14=any	wib=Co	relType_7=case	path1=WARFARIN_nsubj	lemma_12=result	pos_29=IN	relType_25=case	relType_22=nummod	pos_23=WRB	lemma_2=Co	relType_11=advmod	lemma_8=healthy	pos_6=CC	pos_5=IN	pos_24=VBN	lemma_13=in	pos_27=HYPH	relType_16=case	lemma_9=volunteer	relation_16=neutral	pos_25=IN	relType_1=punct	pos_7=NN	relType_18=nmod	relType_3=punct	path2=when_advmod>administration_advcl>warfarin_nmod	relType_4=dep	pos_16=IN	relType_29=case	pos_17=NN	relType_10=aux	lemma_7=to	lemma_27=-	relType_26=compound	pos_13=IN	lemma_1=:	relType_13=case	pos_10=VBD	lemma_22=vii	lemma_25=to	pos_14=DT	pos_12=VB	lemma_28=administration	lemma_6=warfarin	relType_27=punct	relType_6=nmod	lemma_20=clotting	lib=co	path=WARFARIN_nsubj<result_ROOT>when_advmod>administration_advcl>warfarin_nmod	lemma_23=when	relType_7=conj	relType_6=cc	relType_23=advmod	relType_8=amod	lemma_29=of	lemma_21=factor	relType_9=nmod	pos_22=CD	lpib=co_NNP	pos_9=NNS	relType_14=det	lemma_26=co	lemma_18=time	pos_4=NN	relType_28=advcl	relType_2=compound	lemma_6=and	relType_19=cc	lemma_10=do	lemma_24=compare	pos_15=NNS	eib=True	relType_20=compound	lemma_4=administration	pos_21=NN
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e1	DDI-DrugBank.d141.s9.e2	null	relType_1=cc	path=warfarin_nmod<administration_dep>cerivastatin_conj	lpib=cerivastatin_NN	pos_1=CC	lemma_1=and	eib=False	wib=cerivastatin	lib=cerivastatin	path1=warfarin_nmod	path2=cerivastatin_conj
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e1	DDI-DrugBank.d141.s9.e3	null	relType_1=cc	pos_2=NN	pos_14=CC	lemma_17=vii	relType_24=case	relType_12=compound	pos_13=NN	relType_22=punct	lemma_22=-	relType_3=amod	pos_24=IN	pos_17=CD	relType_15=compound	pos_3=JJ	relType_8=case	lemma_4=volunteer	relType_4=nmod	lemma_2=cerivastatin	relType_11=case	lemma_8=in	relType_20=case	wib=cerivastatin	lemma_11=in	relType_2=conj	pos_8=IN	lemma_15=clotting	lemma_18=when	relType_21=compound	pos_16=NN	path=warfarin_nmod<administration_dep<WARFARIN_nsubj<result_ROOT>when_advmod>administration_advcl>warfarin_nmod	lemma_16=factor	pos_6=RB	lpib=cerivastatin_NN	pos_5=VBD	relType_19=case	lemma_7=result	relType_9=det	lemma_1=and	path2=when_advmod>administration_advcl>warfarin_nmod	lemma_14=or	lemma_24=of	pos_20=IN	pos_23=NN	pos_2=IN	lemma_5=do	lemma_3=healthy	pos_9=DT	lemma_12=prothrombin	relType_5=aux	lemma_10=change	pos_22=HYPH	pos_11=IN	lemma_9=any	path1=warfarin_nmod<administration_dep<WARFARIN_nsubj	relType_2=case	pos_19=VBN	lemma_20=to	relType_10=obl	pos_7=VB	pos_1=CC	relation_10=neutral	lemma_21=co	lemma_13=time	lib=cerivastatin	lemma_19=compare	relType_13=nmod	relType_17=nummod	lemma_2=to	pos_4=NNS	lemma_6=not	relType_7=ROOT	pos_15=NN	lemma_23=administration	pos_18=WRB	relType_14=cc	relType_23=advcl	eib=True	relType_18=advmod	pos_12=NN	relType_6=advmod	pos_10=NNS	relType_16=conj	pos_21=NN
DDI-DrugBank.d141.s9	DDI-DrugBank.d141.s9.e2	DDI-DrugBank.d141.s9.e3	null	lemma_21=-	relType_9=obl	pos_2=JJ	lemma_20=co	relType_18=case	pos_3=NNS	pos_20=NN	wib=healthy	path1=cerivastatin_conj<administration_dep<WARFARIN_nsubj	relType_6=ROOT	lemma_10=in	lemma_15=factor	lemma_6=result	pos_7=IN	lemma_7=in	relType_21=punct	lemma_23=of	relType_1=case	lemma_16=vii	pos_6=VB	relType_7=case	pos_8=DT	pos_22=NN	lemma_18=compare	lemma_17=when	lemma_3=volunteer	relation_8=neutral	lemma_13=or	relType_12=nmod	lemma_11=prothrombin	pos_1=IN	relType_13=cc	lpib=healthy_JJ	lemma_12=time	relType_4=aux	relType_16=nummod	lemma_1=to	lemma_2=healthy	relType_5=advmod	path=cerivastatin_conj<administration_dep<WARFARIN_nsubj<result_ROOT>when_advmod>administration_advcl>warfarin_nmod	pos_11=NN	relType_19=case	pos_23=IN	lemma_19=to	path2=when_advmod>administration_advcl>warfarin_nmod	pos_21=HYPH	pos_14=NN	pos_16=CD	relType_2=amod	relType_3=nmod	pos_10=IN	relType_23=case	pos_13=CC	pos_4=VBD	pos_18=VBN	relType_15=conj	relType_8=det	lib=healthy	lemma_4=do	pos_19=IN	lemma_9=change	relType_14=compound	lemma_22=administration	relType_22=advcl	eib=False	lemma_8=any	pos_9=NNS	relType_10=case	lemma_5=not	pos_15=NN	pos_5=RB	relType_17=advmod	pos_17=WRB	relType_20=compound	relType_11=compound	lemma_14=clotting	pos_12=NN
DDI-DrugBank.d141.s10	DDI-DrugBank.d141.s10.e0	DDI-DrugBank.d141.s10.e1	null	relType_4=amod	pos_4=JJ	lemma_9=3	pos_3=IN	lemma_5=dosing	lemma_11=cerivastatin	pos_7=CD	lemma_6=of	relType_8=punct	pos_2=JJ	relType_9=nummod	wib=were	lemma_3=by	pos_1=VBD	pos_8=.	pos_6=IN	lemma_1=be	lemma_10=mg	lemma_2=unaffected	relType_10=compound	pos_10=NN	lib=be	lemma_4=concurrent	relType_6=mark	relType_2=ROOT	lemma_8=.	relType_5=obl	relType_3=case	path2=dosing_obl>sodium_acl	pos_5=NN	relType_1=cop	pos_11=NN	relType_7=dep	path=warfarin_nmod<isomer_nmod<auc_nsubj<unaffected_ROOT>dosing_obl>sodium_acl	eib=True	pos_9=CD	relType_11=compound	path1=warfarin_nmod<isomer_nmod<auc_nsubj	lpib=be_VBD	lemma_7=0
DDI-DrugBank.d141.s11	DDI-DrugBank.d141.s11.e0	DDI-DrugBank.d141.s11.e1	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	path1=	wib=cerivastatin	lib=cerivastatin	lpib=cerivastatin_NN	path=<warfarin_nmod>cerivastatin_conj	path2=cerivastatin_conj
DDI-DrugBank.d141.s11	DDI-DrugBank.d141.s11.e0	DDI-DrugBank.d141.s11.e2	null	relType_1=cc	path2=pharmacokinetic_obj>sodium_nmod	pos_1=CC	pos_2=NN	pos_3=RB	relType_3=advmod	relType_7=case	lemma_3=not	lemma_2=do	lemma_6=pharmacokinetic	lib=cerivastatin	lemma_2=cerivastatin	pos_8=NN	lemma_8=cerivastatin	wib=cerivastatin	pos_2=VBD	relType_2=aux	relType_2=conj	path=warfarin_nmod<administration_nsubj<alter_ROOT>pharmacokinetic_obj>sodium_nmod	relType_5=det	relType_8=compound	relType_4=ROOT	lpib=cerivastatin_NN	lemma_7=of	relType_6=obj	lemma_5=the	lemma_4=alter	eib=True	pos_7=IN	pos_4=VB	pos_5=DT	pos_6=NNS	relation_4=neutral	path1=warfarin_nmod<administration_nsubj	lemma_1=and
DDI-DrugBank.d141.s11	DDI-DrugBank.d141.s11.e1	DDI-DrugBank.d141.s11.e2	null	path2=pharmacokinetic_obj>sodium_nmod	relType_7=compound	path=cerivastatin_conj<warfarin_nmod<administration_nsubj<alter_ROOT>pharmacokinetic_obj>sodium_nmod	lemma_3=alter	relType_1=aux	pos_7=NN	wib=did	lemma_6=of	pos_3=VB	relType_6=case	pos_2=RB	pos_1=VBD	relType_2=advmod	lemma_1=do	pos_5=NNS	pos_6=IN	relation_2=neutral	path1=cerivastatin_conj<warfarin_nmod<administration_nsubj	pos_4=DT	relType_3=ROOT	lemma_4=the	lemma_7=cerivastatin	lpib=do_VBD	lib=do	eib=True	lemma_5=pharmacokinetic	relType_5=obj	relType_4=det	lemma_2=not
DDI-DrugBank.d141.s12	DDI-DrugBank.d141.s12.e0	DDI-DrugBank.d141.s12.e1	null	lemma_3=hypercholesterolemic	pos_6=JJ	relType_8=dep	pos_5=,	path1=	lib=hypercholesterolemic	pos_2=IN	lemma_7=-	pos_8=NN	path=<ERYTHROMYCIN_ROOT>auc_appos>cerivastatin_compound	eib=False	relType_6=amod	lemma_4=patient	wib=hypercholesterolemic	pos_4=NNS	lemma_1=:	lemma_8=state	relType_4=obl	relType_3=amod	pos_7=HYPH	lemma_5=,	relType_5=punct	path2=auc_appos>cerivastatin_compound	pos_1=:	lpib=hypercholesterolemic_JJ	lemma_6=steady	relType_2=case	pos_3=JJ	relType_7=punct	relType_1=punct	lemma_2=in
DDI-DrugBank.d141.s12	DDI-DrugBank.d141.s12.e0	DDI-DrugBank.d141.s12.e2	null	lemma_11=cmax	pos_6=JJ	pos_5=,	lemma_14=50	relType_19=advmod	lemma_26=administration	relType_26=nmod	pos_26=NN	pos_18=NN	lemma_8=state	lemma_10=and	relType_24=compound	relType_3=amod	pos_7=HYPH	lemma_5=,	pos_1=:	lpib=hypercholesterolemic_JJ	pos_17=CD	pos_3=JJ	lemma_21=10	relType_21=nummod	pos_14=CD	relType_16=cc	path1=	pos_16=CC	lemma_19=respectively	pos_8=NN	relType_20=case	path=<ERYTHROMYCIN_ROOT>auc_appos>day_orphan>administration_nmod>erythromycin_nmod	path2=auc_appos>day_orphan>administration_nmod>erythromycin_nmod	pos_9=NN	pos_21=CD	relType_12=orphan	relType_4=obl	relType_13=advmod	lemma_6=steady	pos_11=NN	relType_25=punct	pos_23=IN	relType_1=punct	lemma_9=cerivastatin	lemma_2=in	lemma_20=after	lemma_3=hypercholesterolemic	relType_8=dep	relType_10=cc	lemma_27=of	pos_24=NN	lib=hypercholesterolemic	relType_11=conj	pos_20=IN	pos_2=IN	lemma_18=%	pos_10=CC	lemma_25=-	lemma_17=24	relType_9=appos	lemma_1=:	lemma_12=increase	relType_22=orphan	lemma_15=%	relType_23=case	relType_14=nummod	lemma_22=day	pos_25=HYPH	relType_2=case	relType_27=case	lemma_23=with	lemma_7=-	relType_9=compound	relType_15=orphan	relType_17=nummod	pos_12=VBD	relType_6=amod	pos_19=RB	pos_13=RB	lemma_24=co	pos_27=IN	lemma_4=patient	wib=hypercholesterolemic	pos_4=NNS	pos_15=NN	relType_5=punct	pos_22=NNS	lemma_13=approximately	lemma_16=and	lemma_9=auc	eib=True	relType_7=punct	relType_18=conj	relation_12=beneficial
DDI-DrugBank.d141.s12	DDI-DrugBank.d141.s12.e1	DDI-DrugBank.d141.s12.e2	mechanism	pos_19=IN	pos_13=CD	wib=AUC	relType_17=punct	relType_12=case	relation_3=beneficial	pos_6=CD	relType_16=compound	relType_2=cc	relType_9=nummod	lemma_9=24	lemma_2=and	lemma_15=with	eib=False	relType_10=conj	path2=day_orphan>administration_nmod>erythromycin_nmod	lemma_14=day	pos_17=HYPH	relType_13=nummod	lemma_7=%	lemma_4=increase	lemma_6=50	pos_8=CC	pos_10=NN	relType_11=advmod	lemma_17=-	relType_4=orphan	pos_1=NN	pos_12=IN	pos_18=NN	relType_7=orphan	lemma_19=of	lemma_16=co	lpib=auc_NN	relType_1=appos	relType_15=case	relType_3=conj	lemma_12=after	lemma_13=10	pos_5=RB	lemma_5=approximately	relType_6=nummod	pos_16=NN	lemma_3=cmax	pos_11=RB	relType_5=advmod	lemma_1=auc	lemma_8=and	lemma_10=%	pos_15=IN	path=cerivastatin_compound<auc_appos>day_orphan>administration_nmod>erythromycin_nmod	pos_4=VBD	pos_9=CD	relType_14=orphan	lemma_18=administration	relType_19=case	pos_3=NN	pos_2=CC	pos_14=NNS	path1=cerivastatin_compound	pos_7=NN	relType_18=nmod	relType_8=cc	lemma_11=respectively	lib=auc
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e0	DDI-DrugBank.d141.s13.e2	null	lemma_5=angiotensin	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_5=enzyme	lemma_2=use	lemma_5=convert	pos_1=VBD	path2=enzyme_obl>inhibitor_dep>betablocker_conj	pos_5=NNS	lemma_1=be	pos_5=HYPH	lemma_5=(	path=sodium_nsubj:pass<use_parataxis>enzyme_obl>inhibitor_dep>betablocker_conj	relType_5=dep	lemma_5=)	lemma_4=with	lib=be	relType_5=amod	pos_5=-RRB-	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	relType_5=obl	wib=was	pos_5=NN	pos_5=VBG	eib=True	lemma_3=concomitantly	path1=sodium_nsubj:pass	relType_2=parataxis	lemma_5=-	lpib=be_VBD	lemma_5=ace	lemma_5=inhibitor	pos_5=-LRB-
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e0	DDI-DrugBank.d141.s13.e3	null	lemma_5=angiotensin	pos_2=VBN	relType_7=compound	pos_3=RB	relType_3=advmod	pos_5=,	pos_7=NN	relType_1=aux:pass	lemma_6=,	lemma_5=enzyme	lemma_7=channel	lemma_2=use	path=sodium_nsubj:pass<use_parataxis>enzyme_obl>inhibitor_dep>blocker_conj	lemma_6=betablocker	lemma_5=convert	lemma_7=-	relType_6=conj	pos_1=VBD	pos_5=NNS	relType_6=punct	lemma_1=be	pos_5=HYPH	pos_5=-LRB-	lemma_5=(	relType_5=dep	lemma_5=)	lemma_4=with	lib=be	relType_5=amod	pos_5=-RRB-	lemma_7=calcium	lemma_5=,	pos_4=IN	relType_5=punct	pos_7=HYPH	relType_4=case	relType_5=obl	wib=was	pos_6=,	pos_5=NN	pos_5=VBG	eib=True	lemma_3=concomitantly	path1=sodium_nsubj:pass	relType_7=punct	pos_6=NNS	relType_2=parataxis	lemma_5=-	lpib=be_VBD	lemma_5=ace	lemma_5=inhibitor	path2=enzyme_obl>inhibitor_dep>blocker_conj
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e0	DDI-DrugBank.d141.s13.e4	null	pos_7=NNS	lemma_5=angiotensin	pos_2=VBN	relType_7=compound	pos_3=RB	relType_3=advmod	lemma_7=blocker	pos_5=,	pos_7=NN	relType_1=aux:pass	lemma_6=,	lemma_5=enzyme	lemma_7=channel	lemma_2=use	path=sodium_nsubj:pass<use_parataxis>enzyme_obl>inhibitor_dep>diuretic_conj	lemma_5=convert	lemma_6=betablocker	relType_6=conj	pos_1=VBD	lemma_7=-	pos_5=NNS	relType_6=punct	lemma_1=be	pos_5=HYPH	pos_7=,	lemma_5=(	lemma_7=,	relType_5=dep	lemma_5=)	lemma_4=with	lib=be	relType_5=amod	pos_5=-RRB-	lemma_7=calcium	lemma_5=,	pos_4=IN	relType_5=punct	pos_7=HYPH	relType_4=case	relType_5=obl	wib=was	pos_6=,	path2=enzyme_obl>inhibitor_dep>diuretic_conj	pos_5=NN	pos_5=VBG	eib=True	lemma_3=concomitantly	path1=sodium_nsubj:pass	relType_7=punct	pos_6=NNS	relType_2=parataxis	lemma_5=-	lpib=be_VBD	lemma_5=ace	lemma_5=inhibitor	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e0	DDI-DrugBank.d141.s13.e5	null	pos_7=NNS	lemma_5=angiotensin	lemma_10=nonsteroidal	pos_2=VBN	relType_7=compound	lemma_10=anti	pos_3=RB	relType_3=advmod	relType_10=punct	lemma_7=blocker	pos_5=,	pos_7=NN	relType_1=aux:pass	path=sodium_nsubj:pass<use_parataxis>enzyme_obl>inhibitor_dep>drug_conj	relType_10=amod	lemma_6=,	lemma_5=enzyme	relType_8=punct	lemma_7=channel	lemma_8=,	lemma_2=use	pos_8=NNS	lemma_6=betablocker	lemma_5=convert	lemma_7=-	relType_6=conj	pos_1=VBD	pos_10=AFX	pos_5=NNS	relType_6=punct	lemma_1=be	pos_5=HYPH	pos_7=,	lemma_5=(	lemma_7=,	relType_5=dep	lemma_5=)	lemma_10=-	lemma_4=with	lemma_9=and	pos_9=CC	lib=be	relType_5=amod	pos_5=-RRB-	lemma_7=calcium	lemma_5=,	pos_4=IN	relType_5=punct	pos_7=HYPH	lemma_8=diuretic	relType_4=case	pos_10=JJ	pos_10=HYPH	relType_5=obl	wib=was	pos_6=,	pos_5=NN	pos_5=VBG	eib=True	lemma_3=concomitantly	path1=sodium_nsubj:pass	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	lemma_10=inflammatory	relType_9=cc	relType_2=parataxis	lemma_5=-	lpib=be_VBD	lemma_5=ace	relType_10=obl:npmod	lemma_5=inhibitor	path2=enzyme_obl>inhibitor_dep>drug_conj	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e0	DDI-DrugBank.d141.s13.e6	null	lemma_10=anti	pos_5=,	lemma_6=,	path=sodium_nsubj:pass<use_parataxis>enzyme_obl>inhibitor_dep>drug_conj>nsaid_dep	lemma_5=enzyme	relType_8=punct	lemma_2=use	pos_8=NNS	lemma_6=betablocker	lemma_5=convert	relType_6=conj	pos_10=-LRB-	lemma_7=,	relType_5=dep	pos_9=CC	pos_5=-RRB-	pos_7=HYPH	lemma_5=,	lemma_8=diuretic	pos_6=NNS	relType_8=conj	relType_9=cc	lemma_5=-	lemma_5=ace	lemma_10=drug	pos_7=NNS	lemma_5=angiotensin	lemma_10=nonsteroidal	pos_1=VBD	relType_10=conj	lemma_5=(	lemma_5=)	lemma_10=(	pos_5=NN	lemma_3=concomitantly	path1=sodium_nsubj:pass	relType_2=parataxis	pos_7=NN	lpib=be_VBD	pos_8=,	pos_2=VBN	relType_10=punct	pos_3=RB	lemma_7=blocker	lemma_7=channel	lemma_8=,	lemma_1=be	pos_7=,	lemma_4=with	lib=be	relType_5=amod	relType_10=obl:npmod	pos_4=IN	relType_5=obl	lemma_10=inflammatory	lemma_5=inhibitor	relType_7=conj	pos_5=-LRB-	relType_7=compound	relType_3=advmod	relType_1=aux:pass	relType_10=amod	pos_10=AFX	lemma_7=-	pos_5=NNS	relType_6=punct	pos_5=HYPH	path2=enzyme_obl>inhibitor_dep>drug_conj>nsaid_dep	lemma_10=-	lemma_9=and	lemma_7=calcium	pos_10=JJ	relType_5=punct	pos_10=HYPH	relType_4=case	wib=was	pos_6=,	pos_5=VBG	eib=True	relType_7=punct	pos_10=NNS
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e2	DDI-DrugBank.d141.s13.e3	null	path2=blocker_conj	lemma_2=calcium	lemma_1=,	pos_2=NN	lemma_2=channel	eib=True	lemma_2=-	lpib=calcium_NN	wib=calcium	path1=betablocker_conj	relType_2=compound	pos_1=,	path=betablocker_conj<inhibitor_dep>blocker_conj	relType_1=punct	pos_2=HYPH	lib=calcium	relType_2=punct
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e2	DDI-DrugBank.d141.s13.e4	null	lemma_1=,	pos_2=NN	path=betablocker_conj<inhibitor_dep>diuretic_conj	wib=calcium	path2=diuretic_conj	pos_1=,	pos_2=HYPH	relType_2=punct	lemma_2=-	path1=betablocker_conj	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_2=channel	relType_2=compound	pos_2=NNS	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_2=,	relType_1=punct	lib=calcium
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e2	DDI-DrugBank.d141.s13.e5	null	relType_5=obl:npmod	lemma_1=,	pos_2=NN	lemma_5=nonsteroidal	wib=calcium	path=betablocker_conj<inhibitor_dep>drug_conj	pos_1=,	relType_4=cc	pos_2=HYPH	relType_2=punct	lemma_3=diuretic	path2=drug_conj	pos_3=NNS	lemma_2=-	pos_5=AFX	path1=betablocker_conj	pos_5=HYPH	relType_2=conj	lemma_2=,	lemma_5=inflammatory	pos_5=JJ	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_5=amod	relType_3=conj	relType_2=compound	relType_5=punct	pos_2=NNS	pos_3=,	lemma_2=blocker	eib=True	pos_4=CC	lpib=calcium_NN	lemma_5=anti	lemma_4=and	pos_2=,	relType_1=punct	lemma_5=-	lib=calcium	relType_3=punct
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e2	DDI-DrugBank.d141.s13.e6	null	relType_5=obl:npmod	lemma_1=,	pos_2=NN	lemma_5=nonsteroidal	wib=calcium	pos_1=,	relType_4=cc	pos_2=HYPH	lemma_5=drug	relType_2=punct	lemma_3=diuretic	pos_3=NNS	lemma_2=-	pos_5=AFX	pos_5=NNS	path1=betablocker_conj	pos_5=HYPH	lemma_5=(	relType_2=conj	lemma_2=,	lemma_5=inflammatory	pos_5=JJ	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_5=amod	relType_3=conj	relType_2=compound	relType_5=punct	relType_5=conj	pos_2=NNS	pos_3=,	lemma_2=blocker	eib=True	path2=drug_conj>nsaid_dep	lpib=calcium_NN	pos_4=CC	lemma_5=anti	lemma_4=and	path=betablocker_conj<inhibitor_dep>drug_conj>nsaid_dep	pos_2=,	relType_1=punct	lemma_5=-	lib=calcium	relType_3=punct	pos_5=-LRB-
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e3	DDI-DrugBank.d141.s13.e4	null	path=blocker_conj<inhibitor_dep>diuretic_conj	lemma_1=,	wib=diuretics	eib=False	path2=diuretic_conj	lib=diuretic	pos_1=,	relType_1=punct	path1=blocker_conj	lpib=diuretic_NNS
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e3	DDI-DrugBank.d141.s13.e5	null	relType_4=amod	lemma_1=,	pos_4=JJ	wib=diuretics	relType_4=obl:npmod	pos_3=CC	pos_1=,	lemma_4=-	path1=blocker_conj	pos_4=HYPH	relType_2=punct	relType_3=cc	path2=drug_conj	lemma_4=anti	pos_4=AFX	lemma_4=inflammatory	relType_2=conj	lemma_2=,	lemma_2=diuretic	relType_4=punct	lib=diuretic	path=blocker_conj<inhibitor_dep>drug_conj	lpib=diuretic_NNS	pos_2=NNS	eib=True	pos_2=,	lemma_3=and	relType_1=punct	lemma_4=nonsteroidal
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e3	DDI-DrugBank.d141.s13.e6	null	relType_4=amod	lemma_1=,	pos_4=JJ	wib=diuretics	relType_4=obl:npmod	pos_3=CC	pos_1=,	lemma_4=-	path1=blocker_conj	pos_4=HYPH	path=blocker_conj<inhibitor_dep>drug_conj>nsaid_dep	relType_2=punct	relType_3=cc	lemma_4=anti	pos_4=-LRB-	pos_4=AFX	lemma_4=inflammatory	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_4=(	lemma_4=drug	lemma_2=diuretic	relType_4=punct	lib=diuretic	lpib=diuretic_NNS	pos_2=NNS	eib=True	path2=drug_conj>nsaid_dep	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	lemma_4=nonsteroidal
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e4	DDI-DrugBank.d141.s13.e5	null	lemma_1=,	path=diuretic_conj<inhibitor_dep>drug_conj	pos_1=,	relType_3=obl:npmod	pos_3=AFX	relType_2=cc	lemma_3=inflammatory	lemma_2=and	path2=drug_conj	lemma_3=nonsteroidal	lemma_3=-	lemma_3=anti	lpib=nonsteroidal_JJ	relType_3=amod	path1=diuretic_conj	lib=nonsteroidal	wib=nonsteroidal	pos_3=JJ	eib=True	pos_3=HYPH	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e4	DDI-DrugBank.d141.s13.e6	null	lemma_1=,	lemma_3=drug	pos_1=,	relType_3=obl:npmod	pos_3=AFX	relType_2=cc	lemma_3=inflammatory	lemma_2=and	pos_3=NNS	lemma_3=nonsteroidal	lemma_3=-	lemma_3=anti	lemma_3=(	pos_3=-LRB-	path=diuretic_conj<inhibitor_dep>drug_conj>nsaid_dep	lpib=nonsteroidal_JJ	relType_3=amod	relType_3=conj	path1=diuretic_conj	lib=nonsteroidal	wib=nonsteroidal	pos_3=JJ	eib=True	path2=drug_conj>nsaid_dep	pos_3=HYPH	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d141.s13	DDI-DrugBank.d141.s13.e5	DDI-DrugBank.d141.s13.e6	null	lemma_1=(	lib=nsaid	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	path2=nsaid_dep	relType_1=punct	pos_1=-LRB-	path=<drug_conj>nsaid_dep
DDI-DrugBank.d287.s0	DDI-DrugBank.d287.s0.e0	DDI-DrugBank.d287.s0.e1	advise	pos_7=NNS	relType_1=aux	lemma_9=beta	pos_3=VBN	path2=patient_obl>take_acl>antagonist_obj	lemma_1=should	path1=Cevimeline_nsubj:pass	lemma_6=to	relType_6=case	wib=be	pos_9=JJ	relType_9=compound	lemma_3=administer	pos_6=IN	lemma_7=patient	pos_2=VB	relType_9=amod	pos_9=NN	lemma_5=caution	lemma_4=with	lib=be	path=Cevimeline_nsubj:pass<administer_ROOT>patient_obl>take_acl>antagonist_obj	relType_3=ROOT	pos_4=IN	pos_8=VBG	relType_4=case	relType_2=aux:pass	relType_5=obl	lemma_8=take	pos_1=MD	relType_8=acl	lpib=be_VB	pos_5=NN	relType_7=obl	eib=True	lemma_9=adrenergic	lemma_2=be
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e0	DDI-DrugBank.d110.s0.e1	null	pos_1=VBG	eib=False	relType_1=acl	path1=	lemma_1=contain	lib=contain	path2=contain_acl>epinephrine_obj	wib=containing	lpib=contain_VBG	path=<solution_nmod>contain_acl>epinephrine_obj
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e0	DDI-DrugBank.d110.s0.e2	null	pos_1=VBG	lemma_2=or	relType_2=obj	pos_2=NN	eib=True	relType_1=acl	pos_2=CC	path1=	lemma_1=contain	lemma_2=epinephrine	path2=contain_acl>epinephrine_obj>norepinephrine_conj	path=<solution_nmod>contain_acl>epinephrine_obj>norepinephrine_conj	lib=contain	relType_2=cc	wib=containing	lpib=contain_VBG
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e0	DDI-DrugBank.d110.s0.e3	null	lemma_2=or	relType_2=obj	pos_2=NN	pos_3=IN	path1=	relType_2=cc	lemma_3=norepinephrine	lemma_6=oxidase	pos_6=NN	lemma_6=monoamine	relType_5=acl	lemma_5=receive	lpib=contain_VBG	lemma_4=patient	pos_4=NNS	relType_4=obl	relType_3=conj	relType_1=acl	lemma_3=to	wib=containing	relType_3=case	pos_1=VBG	relType_6=compound	path2=contain_acl>patient_obl>receive_acl>inhibitor_obj	pos_5=VBG	eib=True	pos_3=NN	pos_2=CC	lemma_1=contain	lemma_2=epinephrine	lib=contain	path=<solution_nmod>contain_acl>patient_obl>receive_acl>inhibitor_obj
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e0	DDI-DrugBank.d110.s0.e4	effect	lemma_2=or	relType_2=obj	pos_2=NN	pos_3=IN	lemma_6=,	path=solution_nmod<administration_nsubj>antidepressant_conj	lemma_6=inhibitor	relType_2=cc	lemma_3=norepinephrine	lemma_6=oxidase	lemma_7=tricyclic	pos_6=NN	lemma_6=monoamine	path1=solution_nmod	relType_5=acl	relType_6=punct	lemma_5=receive	lpib=contain_VBG	lemma_4=patient	pos_4=NNS	relType_4=obl	relType_7=amod	relType_3=conj	relType_1=acl	lemma_3=to	wib=containing	relType_3=case	pos_6=,	path2=antidepressant_conj	pos_1=VBG	relType_6=compound	relType_6=obj	pos_5=VBG	eib=True	pos_3=NN	pos_2=CC	pos_7=JJ	pos_6=NNS	lemma_1=contain	lemma_2=epinephrine	lib=contain
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e0	DDI-DrugBank.d110.s0.e5	effect	pos_7=NNS	lemma_2=or	relType_2=obj	pos_2=NN	pos_3=IN	lemma_6=,	relType_7=cc	lemma_6=inhibitor	relType_2=cc	lemma_3=norepinephrine	lemma_6=oxidase	lemma_7=tricyclic	pos_6=NN	lemma_6=monoamine	path1=solution_nmod	relType_5=acl	relType_6=punct	path=solution_nmod<administration_nsubj>phenothiazine_conj	lemma_5=receive	lpib=contain_VBG	lemma_4=patient	pos_4=NNS	relType_4=obl	relType_7=amod	pos_7=CC	relType_3=conj	relType_1=acl	lemma_3=to	wib=containing	lemma_7=or	relType_3=case	pos_6=,	pos_1=VBG	relType_6=compound	relType_6=obj	pos_5=VBG	eib=True	pos_3=NN	pos_2=CC	pos_7=JJ	pos_6=NNS	lemma_1=contain	lemma_2=epinephrine	lemma_7=antidepressant	lib=contain	path2=phenothiazine_conj	relType_7=conj
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e1	DDI-DrugBank.d110.s0.e2	null	relType_1=cc	lpib=norepinephrine_NN	pos_1=CC	wib=norepinephrine	eib=False	path1=	lib=norepinephrine	path=<epinephrine_obj>norepinephrine_conj	lemma_1=or	path2=norepinephrine_conj
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e1	DDI-DrugBank.d110.s0.e3	effect	relType_1=cc	path2=patient_obl>receive_acl>inhibitor_obj	lpib=norepinephrine_NN	pos_1=CC	lemma_5=oxidase	pos_2=NN	lemma_4=receive	relType_5=compound	path1=epinephrine_obj	pos_2=IN	relType_4=acl	wib=norepinephrine	pos_3=NNS	lemma_1=or	lemma_5=monoamine	lib=norepinephrine	lemma_2=to	relType_2=conj	pos_4=VBG	pos_5=NN	path=epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj	relType_2=case	relType_3=obl	eib=True	lemma_2=norepinephrine	lemma_3=patient
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e1	DDI-DrugBank.d110.s0.e4	effect	relType_1=cc	lpib=norepinephrine_NN	pos_1=CC	lemma_5=oxidase	pos_2=NN	pos_6=JJ	pos_5=,	lemma_4=receive	relType_5=compound	pos_2=IN	relType_4=acl	wib=norepinephrine	pos_3=NNS	lemma_1=or	lemma_5=monoamine	pos_5=NNS	relType_6=amod	lib=norepinephrine	path1=epinephrine_obj<contain_acl<solution_nmod	lemma_2=to	relType_2=conj	lemma_5=,	relType_5=punct	path=epinephrine_obj<contain_acl<solution_nmod<administration_nsubj>antidepressant_conj	pos_4=VBG	path2=antidepressant_conj	pos_5=NN	relType_2=case	relType_3=obl	eib=True	relType_5=obj	lemma_6=tricyclic	lemma_2=norepinephrine	lemma_5=inhibitor	lemma_3=patient
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e1	DDI-DrugBank.d110.s0.e5	effect	relType_1=cc	lpib=norepinephrine_NN	pos_1=CC	lemma_5=oxidase	pos_2=NN	pos_6=JJ	pos_5=,	lemma_4=receive	relType_5=compound	pos_2=IN	relType_4=acl	relType_6=conj	wib=norepinephrine	pos_3=NNS	lemma_1=or	lemma_5=monoamine	path=epinephrine_obj<contain_acl<solution_nmod<administration_nsubj>phenothiazine_conj	pos_5=NNS	relType_6=amod	lib=norepinephrine	lemma_6=or	path1=epinephrine_obj<contain_acl<solution_nmod	lemma_2=to	relType_2=conj	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=antidepressant	pos_4=VBG	pos_5=NN	relType_2=case	relType_3=obl	eib=True	relType_5=obj	lemma_6=tricyclic	pos_6=NNS	lemma_2=norepinephrine	lemma_5=inhibitor	path2=phenothiazine_conj	lemma_3=patient	relType_6=cc
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e2	DDI-DrugBank.d110.s0.e3	effect	path2=patient_obl>receive_acl>inhibitor_obj	relType_1=case	lemma_2=patient	lemma_4=monoamine	wib=patients	path1=norepinephrine_conj<epinephrine_obj	lpib=patient_NNS	path=norepinephrine_conj<epinephrine_obj<contain_acl>patient_obl>receive_acl>inhibitor_obj	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	lib=patient	relType_4=compound	lemma_1=to	relType_2=obl	pos_2=NNS	lemma_4=oxidase	eib=True
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e2	DDI-DrugBank.d110.s0.e4	effect	relType_1=case	lemma_2=patient	path=norepinephrine_conj<epinephrine_obj<contain_acl<solution_nmod<administration_nsubj>antidepressant_conj	lemma_4=monoamine	wib=patients	pos_4=,	lpib=patient_NNS	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	pos_4=NNS	relType_4=obj	pos_5=JJ	path1=norepinephrine_conj<epinephrine_obj<contain_acl<solution_nmod	relType_4=punct	relType_5=amod	lib=patient	relType_4=compound	lemma_4=,	lemma_1=to	lemma_5=tricyclic	relType_2=obl	path2=antidepressant_conj	pos_2=NNS	lemma_4=oxidase	eib=True	lemma_4=inhibitor
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e2	DDI-DrugBank.d110.s0.e5	effect	path=norepinephrine_conj<epinephrine_obj<contain_acl<solution_nmod<administration_nsubj>phenothiazine_conj	relType_1=case	pos_5=CC	lemma_2=patient	lemma_4=monoamine	wib=patients	relType_5=cc	pos_4=,	lpib=patient_NNS	relType_3=acl	pos_5=NNS	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	pos_4=NNS	relType_4=obj	pos_5=JJ	path1=norepinephrine_conj<epinephrine_obj<contain_acl<solution_nmod	relType_4=punct	relType_5=amod	lib=patient	relType_4=compound	lemma_4=,	relType_5=conj	lemma_1=to	lemma_5=tricyclic	relType_2=obl	pos_2=NNS	lemma_4=oxidase	eib=True	lemma_4=inhibitor	lemma_5=antidepressant	path2=phenothiazine_conj	lemma_5=or
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e3	DDI-DrugBank.d110.s0.e4	null	path2=antidepressant_conj	path1=inhibitor_obj<receive_acl<patient_obl<contain_acl<solution_nmod	path=inhibitor_obj<receive_acl<patient_obl<contain_acl<solution_nmod<administration_nsubj>antidepressant_conj	lemma_1=,	eib=True	lpib=tricyclic_JJ	relType_2=amod	pos_1=,	lib=tricyclic	lemma_2=tricyclic	relType_1=punct	pos_2=JJ	wib=tricyclic
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e3	DDI-DrugBank.d110.s0.e5	null	lemma_2=or	lemma_1=,	pos_1=,	relType_2=cc	pos_2=JJ	wib=tricyclic	lemma_2=tricyclic	relType_2=conj	path1=inhibitor_obj<receive_acl<patient_obl<contain_acl<solution_nmod	lpib=tricyclic_JJ	relType_2=amod	lib=tricyclic	lemma_2=antidepressant	pos_2=NNS	eib=True	pos_2=CC	relType_1=punct	path2=phenothiazine_conj	path=inhibitor_obj<receive_acl<patient_obl<contain_acl<solution_nmod<administration_nsubj>phenothiazine_conj
DDI-DrugBank.d110.s0	DDI-DrugBank.d110.s0.e4	DDI-DrugBank.d110.s0.e5	null	path=antidepressant_conj<administration_nsubj>phenothiazine_conj	relType_1=cc	pos_1=CC	lib=phenothiazine	lemma_1=or	eib=False	wib=phenothiazines	path1=antidepressant_conj	path2=phenothiazine_conj	lpib=phenothiazine_NNS
DDI-DrugBank.d110.s3	DDI-DrugBank.d110.s3.e0	DDI-DrugBank.d110.s3.e1	effect	relType_8=case	lemma_13=oxytocic	relType_13=punct	relType_12=cc	lemma_9=obstetric	relation_9=adverse	relType_4=nmod	relType_7=acl	pos_12=CC	lemma_13=-	lemma_5=of	relType_5=case	lemma_6=hypotension	lemma_10=block	pos_13=HYPH	lemma_1=(	pos_2=IN	pos_6=NN	pos_9=JJ	path2=drug_conj	lemma_4=treatment	lemma_7=relate	lemma_13=type	relType_13=amod	relType_11=punct	lemma_11=)	relType_9=amod	pos_13=NN	relType_3=det	pos_4=NN	pos_8=IN	lemma_13=ergot	lemma_8=to	path=drug_nmod<administration_nsubj>drug_conj	relType_13=compound	pos_13=JJ	lemma_2=for	path1=drug_nmod	pos_5=IN	lpib=treatment_NN	pos_1=-LRB-	pos_11=-RRB-	pos_7=VBN	relType_2=case	eib=True	pos_3=DT	lemma_12=and	wib=treatment	lemma_3=the	relType_1=punct	relType_6=nmod	relType_10=obl	lib=treatment	pos_10=NNS
DDI-DrugBank.d110.s5	DDI-DrugBank.d110.s5.e0	DDI-DrugBank.d110.s5.e1	advise	relType_8=case	lemma_5=in	relType_1=aux	pos_6=DT	lemma_9=which	relType_10=det	relType_9=obl	lemma_10=a	lemma_1=should	pos_3=VB	lemma_4=use	relType_3=aux:pass	pos_9=WDT	relType_5=case	path1=chloroprocaine_nsubj:pass	pos_2=RB	lemma_8=in	relType_2=advmod	path2=condition_obl>employ_acl:relcl>drug_nsubj:pass	wib=not	lemma_11=sulfonamide	pos_8=IN	pos_4=VBN	lemma_3=be	pos_5=IN	path=chloroprocaine_nsubj:pass<use_ROOT>condition_obl>employ_acl:relcl>drug_nsubj:pass	pos_1=MD	relType_4=ROOT	lib=not	lemma_7=condition	relType_6=det	lemma_6=any	relType_7=obl	pos_11=NN	eib=True	relType_11=compound	lpib=not_RB	pos_7=NN	lemma_2=not	pos_10=DT
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e0	DDI-DrugBank.d429.s0.e1	null	relType_1=cc	pos_1=CC	eib=False	lpib=kaolin_NN	path1=	path2=kaolin_conj	wib=kaolin	lib=kaolin	path=<antacid_ROOT>kaolin_conj	lemma_1=and
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e0	DDI-DrugBank.d429.s0.e2	null	relType_1=cc	pos_1=CC	lemma_2=:	pos_2=NN	eib=True	lemma_2=kaolin	lpib=kaolin_NN	path1=	path=<antacid_ROOT>reduce_parataxis>antacid_nsubj	wib=kaolin	pos_2=:	path2=reduce_parataxis>antacid_nsubj	lib=kaolin	relType_2=conj	lemma_1=and	relType_2=punct
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e0	DDI-DrugBank.d429.s0.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	lemma_3=antacid	pos_3=CC	path1=	path2=reduce_parataxis>antacid_nsubj>kaolin_conj	relType_2=punct	relType_3=cc	lemma_2=:	pos_3=NNS	path=<antacid_ROOT>reduce_parataxis>antacid_nsubj>kaolin_conj	lemma_2=kaolin	relType_2=conj	lpib=kaolin_NN	pos_2=:	relType_3=nsubj	eib=True	wib=kaolin	lemma_3=and	lib=kaolin	lemma_1=and
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e0	DDI-DrugBank.d429.s0.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	lemma_3=antacid	lemma_5=reduce	pos_3=CC	lemma_4=kaolin	relType_7=case	path1=	relType_5=parataxis	path=<antacid_ROOT>reduce_parataxis>absorption_obj>chloroquine_nmod	relType_2=punct	relType_3=cc	pos_6=NN	pos_5=VB	lemma_2=:	pos_3=NNS	lemma_2=kaolin	pos_4=MD	relation_7=adverse	lemma_6=absorption	relType_2=conj	pos_4=NN	path2=reduce_parataxis>absorption_obj>chloroquine_nmod	lpib=kaolin_NN	relType_4=aux	pos_2=:	relType_3=nsubj	lemma_7=of	relType_6=obj	eib=True	pos_7=IN	wib=kaolin	lemma_3=and	relType_4=conj	lemma_4=can	lib=kaolin	lemma_1=and
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e1	DDI-DrugBank.d429.s0.e2	null	path=kaolin_conj<antacid_ROOT>reduce_parataxis>antacid_nsubj	eib=False	path1=kaolin_conj	pos_1=:	path2=reduce_parataxis>antacid_nsubj	lib=antacid	lemma_1=:	relType_1=punct	wib=Antacids	lpib=antacid_NNS
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e1	DDI-DrugBank.d429.s0.e3	null	pos_2=NNS	lemma_2=and	eib=True	relType_2=nsubj	path1=kaolin_conj	pos_2=CC	pos_1=:	path2=reduce_parataxis>antacid_nsubj>kaolin_conj	lemma_2=antacid	lib=antacid	lemma_1=:	relType_1=punct	relType_2=cc	wib=Antacids	lpib=antacid_NNS	path=kaolin_conj<antacid_ROOT>reduce_parataxis>antacid_nsubj>kaolin_conj
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e1	DDI-DrugBank.d429.s0.e4	null	lemma_4=reduce	lemma_6=of	relation_5=adverse	relType_2=cc	lemma_5=absorption	relType_6=case	lemma_2=and	lemma_3=can	relType_2=nsubj	pos_6=IN	pos_3=MD	lemma_3=kaolin	lib=antacid	lemma_2=antacid	lemma_1=:	relType_4=parataxis	path2=reduce_parataxis>absorption_obj>chloroquine_nmod	relType_3=conj	path1=kaolin_conj	pos_1=:	wib=Antacids	pos_2=NNS	pos_5=NN	eib=True	pos_3=NN	pos_4=VB	pos_2=CC	relType_5=obj	relType_3=aux	relType_1=punct	path=kaolin_conj<antacid_ROOT>reduce_parataxis>absorption_obj>chloroquine_nmod	lpib=antacid_NNS
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e2	DDI-DrugBank.d429.s0.e3	null	relType_1=cc	pos_1=CC	eib=False	lpib=kaolin_NN	path1=	path2=kaolin_conj	wib=kaolin	lib=kaolin	lemma_1=and	path=<antacid_nsubj>kaolin_conj
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e2	DDI-DrugBank.d429.s0.e4	mechanism	relType_1=cc	pos_1=CC	pos_2=NN	pos_2=MD	pos_3=VB	lemma_5=of	relType_5=case	path2=absorption_obj>chloroquine_nmod	lemma_2=kaolin	relType_2=aux	relType_2=conj	pos_4=NN	relType_4=obj	path=antacid_nsubj<reduce_parataxis>absorption_obj>chloroquine_nmod	lemma_3=reduce	lemma_4=absorption	relation_3=adverse	lpib=kaolin_NN	pos_5=IN	relType_3=parataxis	lemma_2=can	eib=True	wib=kaolin	lib=kaolin	path1=antacid_nsubj	lemma_1=and
DDI-DrugBank.d429.s0	DDI-DrugBank.d429.s0.e3	DDI-DrugBank.d429.s0.e4	mechanism	relType_1=aux	lib=reduce	path=kaolin_conj<antacid_nsubj<reduce_parataxis>absorption_obj>chloroquine_nmod	lemma_2=reduce	path2=absorption_obj>chloroquine_nmod	path1=kaolin_conj<antacid_nsubj	eib=False	wib=reduce	relation_1=adverse	pos_2=VB	lemma_1=can	lpib=reduce_VB	pos_4=IN	relType_4=case	pos_1=MD	lemma_3=absorption	pos_3=NN	relType_3=obj	relType_2=parataxis	lemma_4=of
DDI-DrugBank.d429.s2	DDI-DrugBank.d429.s2.e0	DDI-DrugBank.d429.s2.e1	null	eib=False	path2=inhibit_parataxis>cimetidine_nsubj	path=<cimetidine_ROOT>inhibit_parataxis>cimetidine_nsubj	path1=	pos_1=:	relType_1=punct	lib=cimetidine	wib=Cimetidine	lpib=cimetidine_NN	lemma_1=:
DDI-DrugBank.d429.s2	DDI-DrugBank.d429.s2.e0	DDI-DrugBank.d429.s2.e2	null	pos_2=NN	pos_2=MD	path1=	lemma_6=of	pos_3=VB	wib=Cimetidine	lpib=cimetidine_NN	relType_6=case	relType_2=nsubj	pos_6=IN	relType_2=aux	lemma_1=:	pos_4=DT	relation_3=adverse	lemma_4=the	pos_1=:	relType_3=parataxis	lib=cimetidine	lemma_2=can	pos_5=NN	eib=True	path=<cimetidine_ROOT>inhibit_parataxis>metabolism_obj>chloroquine_nmod	relType_5=obj	lemma_3=inhibit	relType_1=punct	relType_4=det	lemma_2=cimetidine	path2=inhibit_parataxis>metabolism_obj>chloroquine_nmod	lemma_5=metabolism
DDI-DrugBank.d429.s2	DDI-DrugBank.d429.s2.e1	DDI-DrugBank.d429.s2.e2	mechanism	relType_1=aux	lpib=inhibit_VB	path2=metabolism_obj>chloroquine_nmod	lemma_5=of	relType_5=case	path=cimetidine_nsubj<inhibit_parataxis>metabolism_obj>chloroquine_nmod	eib=False	lib=inhibit	relation_1=adverse	pos_2=VB	relType_3=det	pos_4=NN	relType_4=obj	lemma_1=can	pos_5=IN	pos_1=MD	wib=inhibit	pos_3=DT	lemma_2=inhibit	lemma_3=the	path1=cimetidine_nsubj	relType_2=parataxis	lemma_4=metabolism
DDI-DrugBank.d429.s4	DDI-DrugBank.d429.s4.e0	DDI-DrugBank.d429.s4.e1	null	pos_7=NNS	lemma_4=study	pos_6=JJ	path1=	relType_8=punct	path2=reduce_appos>chloroquine_nsubj	lemma_8=,	lemma_5=of	relType_5=case	pos_2=IN	eib=False	relType_6=amod	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_1=:	lemma_7=volunteer	lib=study	relType_4=obl	pos_1=:	pos_5=IN	path=<Ampicillin_ROOT>reduce_appos>chloroquine_nsubj	relType_7=nmod	relType_2=case	pos_3=DT	wib=study	relType_1=punct	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d429.s4	DDI-DrugBank.d429.s4.e0	DDI-DrugBank.d429.s4.e2	null	pos_7=NNS	lemma_12=bioavailability	lemma_4=study	path2=reduce_appos>bioavailability_obj>ampicillin_nmod	pos_6=JJ	relType_9=advmod	path1=	relType_8=punct	lemma_8=,	lemma_5=of	relType_5=case	lemma_13=of	pos_2=IN	lemma_10=reduce	relType_6=amod	relType_10=appos	relType_12=obj	pos_13=IN	path=<Ampicillin_ROOT>reduce_appos>bioavailability_obj>ampicillin_nmod	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_1=:	pos_9=NN	lemma_7=volunteer	relType_13=case	lib=study	relType_4=obl	lemma_9=significantly	relation_10=adverse	pos_10=VBD	pos_1=:	pos_5=IN	relType_7=nmod	pos_9=RB	pos_11=DT	lemma_9=chloroquine	lemma_11=the	relType_11=det	relType_2=case	eib=True	pos_3=DT	relType_9=nsubj	wib=study	relType_1=punct	pos_12=NN	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d429.s4	DDI-DrugBank.d429.s4.e1	DDI-DrugBank.d429.s4.e2	mechanism	wib=significantly	lib=significantly	lemma_2=reduce	lemma_5=of	relType_5=case	lemma_4=bioavailability	eib=False	lemma_1=significantly	relation_1=adverse	lpib=significantly_RB	pos_2=VBD	relType_3=det	path1=chloroquine_nsubj	pos_4=NN	relType_4=obj	relType_1=advmod	path2=bioavailability_obj>ampicillin_nmod	pos_5=IN	path=chloroquine_nsubj<reduce_appos>bioavailability_obj>ampicillin_nmod	relType_2=appos	pos_3=DT	pos_1=RB	lemma_3=the
DDI-DrugBank.d429.s6	DDI-DrugBank.d429.s6.e0	DDI-DrugBank.d429.s6.e1	null	path1=	lpib=introduction_NN	pos_2=IN	eib=False	wib=introduction	lemma_1=:	path2=report_parataxis>introduction_obl>chloroquine_nmod	lib=introduction	pos_4=IN	pos_1=:	relType_4=case	relType_2=case	relType_3=obl	lemma_2=after	pos_3=NN	lemma_3=introduction	relType_1=punct	path=<cyclosporin_ROOT>report_parataxis>introduction_obl>chloroquine_nmod	lemma_4=of
DDI-DrugBank.d429.s6	DDI-DrugBank.d429.s6.e0	DDI-DrugBank.d429.s6.e2	null	lemma_7=form	pos_6=JJ	relType_7=appos	relType_10=det	path1=	lpib=introduction_NN	lemma_10=a	relType_8=punct	lemma_9=,	relType_14=compound	lemma_14=serum	pos_2=IN	wib=introduction	relType_12=nsubj:pass	relType_6=amod	relType_11=amod	lemma_5=(	pos_12=NN	pos_8=-RRB-	pos_13=IN	pos_14=NN	lemma_1=:	relType_13=case	lemma_8=)	lemma_6=oral	lemma_12=increase	lib=introduction	pos_4=IN	relType_5=punct	pos_1=:	relType_4=case	relType_5=nmod	path=<cyclosporin_ROOT>report_parataxis>increase_nsubj:pass>level_nmod>cyclosporin_compound	lemma_13=in	lemma_5=chloroquine	lemma_11=sudden	relType_9=punct	pos_5=NN	relType_2=case	relType_3=obl	eib=True	lemma_2=after	pos_10=DT	pos_3=NN	pos_11=JJ	path2=report_parataxis>increase_nsubj:pass>level_nmod>cyclosporin_compound	lemma_3=introduction	pos_9=,	relType_1=punct	pos_7=NN	lemma_4=of	relation_12=beneficial	pos_5=-LRB-
DDI-DrugBank.d429.s6	DDI-DrugBank.d429.s6.e1	DDI-DrugBank.d429.s6.e2	mechanism	lemma_3=form	lib=oral	path1=chloroquine_nmod<introduction_obl	pos_6=DT	pos_5=,	path2=increase_nsubj:pass>level_nmod>cyclosporin_compound	pos_9=IN	pos_2=JJ	lemma_10=serum	relType_8=nsubj:pass	lemma_1=(	pos_8=NN	eib=False	relType_3=appos	lemma_6=a	pos_4=-RRB-	relType_9=case	relType_10=compound	pos_10=NN	lemma_7=sudden	lemma_2=oral	lemma_8=increase	relType_7=amod	relType_4=punct	lemma_5=,	relType_5=punct	path=chloroquine_nmod<introduction_obl<report_parataxis>increase_nsubj:pass>level_nmod>cyclosporin_compound	relType_2=amod	lemma_4=)	lpib=oral_JJ	pos_1=-LRB-	relation_7=beneficial	relType_6=det	wib=oral	pos_3=NN	pos_7=JJ	relType_1=punct	lemma_9=in
DDI-DrugBank.d429.s7	DDI-DrugBank.d429.s7.e0	DDI-DrugBank.d429.s7.e1	null	wib=level	pos_5=,	lib=level	pos_3=VBN	lemma_7=necessary	relType_8=punct	relType_4=cc	lemma_8=,	relType_7=advcl	eib=False	pos_6=IN	path1=cyclosporin_compound<level_nmod<monitoring_nsubj:pass	lemma_3=recommend	lemma_1=level	relType_1=nmod	pos_1=NN	path2=discontinue_conj>chloroquine_nsubj:pass	relType_3=ROOT	relType_6=mark	lemma_5=,	relType_5=punct	relType_2=aux:pass	path=cyclosporin_compound<level_nmod<monitoring_nsubj:pass<recommend_ROOT>discontinue_conj>chloroquine_nsubj:pass	pos_2=VBZ	pos_4=CC	lemma_4=and	pos_7=JJ	lemma_2=be	lemma_6=if	lpib=level_NN	pos_8=,
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e1	int	lpib=interact_VB	lib=interact	pos_3=IN	eib=False	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl	lemma_1=may	wib=interact	relType_1=aux	relType_2=ROOT	relation_1=adverse	pos_2=VB	path2=antidepressant_obl	pos_1=MD	lemma_3=with	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_3=case
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e2	int	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	wib=interact	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>aspirin_conj	pos_4=,	relation_1=adverse	pos_2=VB	pos_4=NNS	path2=antidepressant_obl>aspirin_conj	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_3=case	lpib=interact_VB	eib=True	path1=Chlorotrianisene_nsubj	lemma_2=interact
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e3	int	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>barbiturate_conj	pos_4=,	relation_1=adverse	pos_2=VB	pos_4=NNS	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	relType_3=case	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	eib=True	path2=antidepressant_obl>barbiturate_conj	path1=Chlorotrianisene_nsubj	lemma_2=interact
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e4	int	path2=antidepressant_obl>bromocriptine_conj	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_6=,	relType_6=conj	pos_4=,	relType_6=punct	relation_1=adverse	pos_2=VB	pos_4=NNS	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>bromocriptine_conj	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	eib=True	pos_6=NNS	path1=Chlorotrianisene_nsubj	lemma_2=interact
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e5	int	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_6=,	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>supplement_conj>calcium_compound	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	relation_1=adverse	pos_2=VB	lemma_7=,	pos_4=NNS	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_7=bromocriptine	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	path2=antidepressant_obl>supplement_conj>calcium_compound	eib=True	relType_7=punct	pos_6=NNS	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e6	int	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_6=,	lemma_9=,	pos_8=NNS	path2=antidepressant_obl>corticosteroid_conj	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	relation_1=adverse	pos_2=VB	lemma_8=supplement	lemma_7=,	pos_4=NNS	lemma_8=calcium	relType_4=obl	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>corticosteroid_conj	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_7=bromocriptine	relType_8=compound	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	relType_9=punct	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	eib=True	relType_7=punct	pos_6=NNS	relType_8=conj	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e7	int	lemma_10=corticosteroid	relType_10=punct	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_10=,	lemma_6=,	lemma_9=,	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>corticotropin_conj	pos_8=NNS	pos_8=NN	path2=antidepressant_obl>corticotropin_conj	pos_10=NNS	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	pos_7=,	relation_1=adverse	pos_2=VB	lemma_8=supplement	lemma_7=,	pos_4=NNS	lemma_8=calcium	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_7=bromocriptine	relType_8=compound	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	relType_9=punct	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	pos_10=,	eib=True	relType_7=punct	pos_6=NNS	relType_8=conj	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e8	int	lemma_10=corticosteroid	relType_10=punct	lib=interact	pos_3=IN	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>cyclosporine_conj	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_10=,	lemma_11=,	lemma_6=,	lemma_9=,	lemma_11=corticotropin	pos_8=NNS	relType_11=conj	pos_8=NN	pos_10=NNS	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	relType_11=punct	pos_7=,	relation_1=adverse	pos_2=VB	lemma_8=supplement	lemma_7=,	pos_4=NNS	lemma_8=calcium	relType_4=obl	relType_4=punct	relType_2=ROOT	path2=antidepressant_obl>cyclosporine_conj	lemma_5=,	relType_5=punct	lemma_7=bromocriptine	relType_8=compound	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	pos_11=NN	pos_10=,	eib=True	relType_7=punct	pos_6=NNS	relType_8=conj	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e9	int	lemma_10=corticosteroid	relType_12=conj	relType_10=punct	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_10=,	lemma_11=,	lemma_6=,	lemma_9=,	lemma_11=corticotropin	pos_8=NNS	relType_11=conj	pos_8=NN	pos_10=NNS	lemma_12=,	path2=antidepressant_obl>dantrolene_conj	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	lemma_12=cyclosporine	relType_11=punct	pos_12=,	pos_7=,	relation_1=adverse	pos_12=NN	pos_2=VB	relType_12=punct	lemma_8=supplement	lemma_7=,	pos_4=NNS	lemma_8=calcium	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_7=bromocriptine	relType_8=compound	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	pos_11=NN	pos_10=,	eib=True	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>dantrolene_conj	relType_7=punct	pos_6=NNS	relType_8=conj	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e10	int	lemma_10=corticosteroid	lemma_13=dantrolene	relType_12=conj	pos_13=,	relType_10=punct	lib=interact	pos_3=IN	lemma_13=,	relType_1=aux	lemma_1=may	pos_5=,	wib=interact	lemma_6=barbiturate	lemma_10=,	lemma_11=,	lemma_6=,	relType_13=punct	lemma_9=,	path2=antidepressant_obl>nicotine_conj	lemma_11=corticotropin	pos_8=NNS	relType_11=conj	pos_8=NN	pos_10=NNS	lemma_12=,	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	lemma_12=cyclosporine	relType_11=punct	pos_12=,	pos_7=,	relation_1=adverse	pos_12=NN	pos_2=VB	relType_12=punct	relType_13=conj	lemma_8=supplement	lemma_7=,	pos_13=NN	pos_4=NNS	lemma_8=calcium	relType_4=obl	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>nicotine_conj	lemma_7=bromocriptine	relType_8=compound	lemma_4=antidepressant	lemma_3=with	lemma_4=,	pos_1=MD	relType_5=conj	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	lemma_5=aspirin	pos_5=NN	lpib=interact_VB	pos_11=NN	pos_10=,	eib=True	relType_7=punct	pos_6=NNS	relType_8=conj	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e11	int	lemma_10=corticosteroid	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=conj	pos_12=,	pos_2=VB	pos_13=NN	lemma_7=,	relType_4=punct	lemma_5=,	lemma_3=with	lemma_5=aspirin	pos_10=,	pos_6=NNS	relType_8=conj	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>somatropin_conj	lemma_13=dantrolene	pos_13=,	lib=interact	relType_1=aux	lemma_6=barbiturate	lemma_11=corticotropin	pos_8=NN	lemma_14=nicotine	relType_10=conj	lemma_12=cyclosporine	relType_12=punct	relType_13=conj	relType_4=obl	relType_2=ROOT	lemma_4=antidepressant	lemma_4=,	pos_5=NN	lemma_14=,	pos_11=NN	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_14=punct	relType_10=punct	pos_3=IN	lemma_11=,	lemma_1=may	relType_11=conj	pos_4=,	pos_14=,	relType_11=punct	pos_7=,	relation_1=adverse	pos_14=NN	lemma_8=supplement	relType_8=compound	pos_1=MD	relType_5=conj	lpib=interact_VB	relType_14=conj	relType_7=conj	relType_12=conj	wib=interact	relType_13=punct	relType_6=punct	pos_4=NNS	path2=antidepressant_obl>somatropin_conj	lemma_8=calcium	relType_5=punct	lemma_7=bromocriptine	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	eib=True	relType_7=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e12	int	lemma_10=corticosteroid	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=conj	pos_12=,	pos_2=VB	pos_13=NN	lemma_7=,	relType_4=punct	lemma_5=,	lemma_3=with	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>tamoxifen_conj	lemma_5=aspirin	pos_10=,	pos_6=NNS	relType_8=conj	lemma_13=dantrolene	pos_13=,	lib=interact	relType_1=aux	lemma_6=barbiturate	lemma_11=corticotropin	pos_8=NN	lemma_14=nicotine	relType_10=conj	lemma_12=cyclosporine	relType_12=punct	relType_13=conj	path2=antidepressant_obl>tamoxifen_conj	relType_4=obl	lemma_15=,	relType_2=ROOT	lemma_4=antidepressant	lemma_4=,	pos_5=NN	lemma_14=,	pos_11=NN	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_14=punct	relType_10=punct	pos_3=IN	lemma_11=,	lemma_1=may	relType_11=conj	pos_4=,	pos_15=,	pos_14=,	relType_11=punct	pos_7=,	relation_1=adverse	pos_14=NN	lemma_8=supplement	relType_15=punct	relType_8=compound	pos_1=MD	relType_5=conj	lpib=interact_VB	lemma_15=somatropin	relType_15=conj	relType_14=conj	relType_7=conj	relType_12=conj	wib=interact	relType_13=punct	relType_6=punct	pos_4=NNS	lemma_8=calcium	pos_15=NN	relType_5=punct	lemma_7=bromocriptine	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	eib=True	relType_7=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e0	DDI-DrugBank.d446.s0.e13	int	lemma_10=corticosteroid	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=conj	pos_12=,	pos_2=VB	pos_13=NN	lemma_7=,	lemma_16=,	relType_4=punct	lemma_5=,	lemma_3=with	relType_16=punct	path2=antidepressant_obl>warfarin_conj	lemma_5=aspirin	pos_10=,	pos_6=NNS	relType_8=conj	lemma_13=dantrolene	pos_13=,	lib=interact	relType_17=cc	relType_1=aux	lemma_6=barbiturate	lemma_11=corticotropin	pos_8=NN	lemma_14=nicotine	relType_10=conj	lemma_12=cyclosporine	relType_12=punct	relType_13=conj	relType_4=obl	lemma_15=,	relType_2=ROOT	lemma_4=antidepressant	lemma_4=,	pos_16=NN	pos_5=NN	lemma_14=,	pos_11=NN	pos_17=CC	pos_9=,	pos_7=NN	path1=Chlorotrianisene_nsubj	lemma_2=interact	relType_14=punct	relType_10=punct	pos_3=IN	lemma_11=,	lemma_1=may	relType_11=conj	path=Chlorotrianisene_nsubj<interact_ROOT>antidepressant_obl>warfarin_conj	pos_4=,	pos_15=,	pos_14=,	relType_11=punct	pos_7=,	relation_1=adverse	pos_14=NN	lemma_8=supplement	relType_15=punct	relType_8=compound	pos_1=MD	relType_5=conj	lpib=interact_VB	lemma_15=somatropin	lemma_16=tamoxifen	relType_15=conj	relType_14=conj	relType_7=conj	relType_12=conj	wib=interact	relType_13=punct	relType_6=punct	pos_16=,	pos_4=NNS	lemma_8=calcium	pos_15=NN	relType_5=punct	lemma_7=bromocriptine	lemma_17=and	pos_11=,	relType_9=punct	relType_3=case	pos_6=,	eib=True	relType_7=punct	pos_12=NN	pos_10=NNS	relType_16=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e2	null	path=<antidepressant_obl>aspirin_conj	lemma_1=,	path2=aspirin_conj	eib=False	path1=	lpib=aspirin_NN	pos_1=,	wib=aspirin	relType_1=punct	lib=aspirin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e3	null	lemma_1=,	pos_2=NN	eib=True	path1=	lpib=aspirin_NN	path2=barbiturate_conj	path=<antidepressant_obl>barbiturate_conj	wib=aspirin	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lib=aspirin	lemma_2=,	lemma_2=aspirin	relType_2=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e4	null	lemma_1=,	pos_2=NN	path=<antidepressant_obl>bromocriptine_conj	path1=	lpib=aspirin_NN	pos_1=,	path2=bromocriptine_conj	relType_2=punct	pos_3=NNS	relType_2=conj	lemma_2=,	lemma_2=aspirin	lemma_3=,	relType_3=conj	relType_3=punct	pos_3=,	eib=True	lemma_3=barbiturate	pos_2=,	wib=aspirin	relType_1=punct	lib=aspirin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e5	null	lemma_4=bromocriptine	lemma_1=,	pos_2=NN	path1=	lpib=aspirin_NN	pos_1=,	relType_2=punct	pos_3=NNS	pos_4=,	path2=supplement_conj>calcium_compound	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=aspirin	relType_4=punct	lemma_3=,	relType_3=conj	path=<antidepressant_obl>supplement_conj>calcium_compound	lemma_4=,	relType_3=punct	pos_3=,	eib=True	lemma_3=barbiturate	pos_2=,	relType_4=conj	wib=aspirin	relType_1=punct	lib=aspirin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e6	null	lemma_4=bromocriptine	lemma_1=,	pos_2=NN	lemma_5=supplement	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_2=punct	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=punct	relType_2=conj	path=<antidepressant_obl>corticosteroid_conj	lemma_2=,	pos_4=NN	lemma_2=aspirin	relType_4=punct	lemma_3=,	relType_3=conj	path2=corticosteroid_conj	lemma_4=,	relType_5=conj	relType_3=punct	pos_6=,	pos_5=NN	pos_3=,	eib=True	lemma_3=barbiturate	pos_2=,	relType_4=conj	wib=aspirin	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e7	null	pos_7=NNS	lemma_4=bromocriptine	lemma_1=,	pos_2=NN	lemma_5=supplement	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_2=punct	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=aspirin	lemma_7=corticosteroid	path2=corticotropin_conj	relType_7=conj	path=<antidepressant_obl>corticotropin_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	relType_5=conj	relType_3=punct	pos_6=,	pos_5=NN	pos_3=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_2=,	relType_4=conj	wib=aspirin	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e8	null	pos_7=NNS	lemma_4=bromocriptine	lemma_1=,	pos_2=NN	lemma_5=supplement	path2=cyclosporine_conj	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	pos_8=NN	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=aspirin	lemma_7=corticosteroid	relType_7=conj	lemma_8=corticotropin	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	relType_5=conj	relType_3=punct	pos_6=,	pos_5=NN	path=<antidepressant_obl>cyclosporine_conj	pos_3=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	wib=aspirin	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e9	null	pos_7=NNS	path=<antidepressant_obl>dantrolene_conj	lemma_4=bromocriptine	lemma_1=,	pos_2=NN	relType_9=conj	lemma_5=supplement	lemma_9=cyclosporine	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	pos_8=NN	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_2=aspirin	lemma_7=corticosteroid	relType_7=conj	lemma_8=corticotropin	path2=dantrolene_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	relType_5=conj	relType_9=punct	relType_3=punct	pos_6=,	pos_5=NN	pos_3=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	wib=aspirin	pos_9=,	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e10	null	pos_7=NNS	lemma_4=bromocriptine	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_5=supplement	lemma_9=cyclosporine	lemma_10=,	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	pos_8=NN	pos_3=NNS	pos_4=,	relType_10=conj	pos_5=NNS	relType_6=punct	path=<antidepressant_obl>nicotine_conj	pos_7=,	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_2=aspirin	lemma_7=corticosteroid	relType_7=conj	lemma_8=corticotropin	lemma_10=dantrolene	relType_4=punct	lemma_3=,	path2=nicotine_conj	relType_3=conj	lemma_4=,	relType_5=conj	relType_9=punct	relType_3=punct	pos_6=,	pos_5=NN	pos_3=,	pos_10=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	wib=aspirin	pos_9=,	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e11	null	pos_7=NNS	lemma_4=bromocriptine	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_5=supplement	lemma_9=cyclosporine	lemma_11=,	lemma_10=,	path1=	lpib=aspirin_NN	pos_1=,	relType_5=compound	lemma_6=,	relType_8=punct	lemma_11=nicotine	lemma_9=,	lemma_8=,	relType_11=conj	relType_2=punct	pos_8=NN	pos_3=NNS	path2=somatropin_conj	pos_4=,	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=punct	pos_7=,	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_2=aspirin	lemma_7=corticosteroid	relType_7=conj	lemma_8=corticotropin	lemma_10=dantrolene	relType_4=punct	lemma_3=,	path=<antidepressant_obl>somatropin_conj	relType_3=conj	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	relType_3=punct	pos_6=,	pos_5=NN	pos_11=NN	pos_3=,	pos_10=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	wib=aspirin	pos_9=,	relType_1=punct	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e12	null	pos_7=NNS	lemma_4=bromocriptine	relType_12=conj	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_5=supplement	lemma_9=cyclosporine	lemma_11=,	lemma_10=,	path1=	lpib=aspirin_NN	pos_1=,	path=<antidepressant_obl>tamoxifen_conj	relType_5=compound	lemma_6=,	relType_8=punct	lemma_11=nicotine	lemma_9=,	lemma_8=,	relType_11=conj	relType_2=punct	pos_8=NN	lemma_12=,	pos_3=NNS	pos_4=,	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=punct	pos_12=,	pos_7=,	path2=tamoxifen_conj	relType_12=punct	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_2=aspirin	lemma_7=corticosteroid	relType_7=conj	lemma_8=corticotropin	lemma_10=dantrolene	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	relType_3=punct	lemma_12=somatropin	pos_6=,	pos_5=NN	pos_11=NN	pos_3=,	pos_10=,	eib=True	lemma_3=barbiturate	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	wib=aspirin	pos_9=,	relType_1=punct	pos_12=NN	lib=aspirin	lemma_5=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e1	DDI-DrugBank.d446.s0.e13	null	pos_2=NN	pos_14=CC	lemma_5=supplement	lemma_13=,	lemma_10=,	lpib=aspirin_NN	lemma_6=,	relType_8=punct	lemma_9=,	lemma_13=tamoxifen	lemma_12=,	pos_3=NNS	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	lemma_2=aspirin	lemma_8=corticotropin	lemma_10=dantrolene	relType_4=punct	lemma_3=,	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	wib=aspirin	lib=aspirin	pos_7=NNS	pos_13=,	lemma_1=,	path1=	pos_1=,	relType_2=punct	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	path2=warfarin_conj	pos_5=NN	pos_11=NN	lemma_3=barbiturate	lemma_14=and	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_4=bromocriptine	relType_10=punct	lemma_9=cyclosporine	lemma_11=,	lemma_11=nicotine	lemma_8=,	relType_11=conj	pos_4=,	relType_11=punct	pos_7=,	path=<antidepressant_obl>warfarin_conj	relType_3=conj	relType_5=conj	lemma_12=somatropin	relType_7=conj	lemma_5=calcium	relType_12=conj	relType_9=conj	relType_13=punct	relType_5=compound	pos_5=NNS	relType_6=punct	pos_4=NN	lemma_7=corticosteroid	relType_14=cc	pos_11=,	relType_9=punct	pos_6=,	eib=True	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e3	null	path1=aspirin_conj	lemma_1=,	wib=barbiturates	eib=False	lib=barbiturate	pos_1=,	path2=barbiturate_conj	relType_1=punct	path=aspirin_conj<antidepressant_obl>barbiturate_conj	lpib=barbiturate_NNS
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e4	null	pos_2=NNS	path1=aspirin_conj	path=aspirin_conj<antidepressant_obl>bromocriptine_conj	lemma_1=,	wib=barbiturates	eib=True	lib=barbiturate	lemma_2=,	pos_1=,	lemma_2=barbiturate	pos_2=,	relType_1=punct	relType_2=conj	path2=bromocriptine_conj	relType_2=punct	lpib=barbiturate_NNS
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e5	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	pos_1=,	relType_2=punct	lpib=barbiturate_NNS	path2=supplement_conj>calcium_compound	relType_2=conj	lemma_2=,	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_2=barbiturate	pos_2=NNS	path=aspirin_conj<antidepressant_obl>supplement_conj>calcium_compound	pos_3=,	eib=True	lib=barbiturate	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e6	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	lemma_4=supplement	pos_5=,	path=aspirin_conj<antidepressant_obl>corticosteroid_conj	pos_1=,	relType_2=punct	lpib=barbiturate_NNS	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	path2=corticosteroid_conj	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	lib=barbiturate	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e7	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	lemma_4=supplement	pos_5=,	pos_1=,	lemma_6=,	relType_2=punct	lpib=barbiturate_NNS	relType_6=conj	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	path2=corticotropin_conj	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	pos_6=,	path=aspirin_conj<antidepressant_obl>corticotropin_conj	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	lib=barbiturate	pos_3=NN	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e8	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	lemma_4=supplement	pos_5=,	path2=cyclosporine_conj	pos_1=,	lemma_6=,	relType_2=punct	lpib=barbiturate_NNS	relType_6=conj	relType_6=punct	pos_7=,	path=aspirin_conj<antidepressant_obl>cyclosporine_conj	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	lemma_7=corticotropin	pos_6=,	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	lib=barbiturate	pos_3=NN	relType_7=punct	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e9	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	lemma_4=supplement	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lpib=barbiturate_NNS	pos_8=NN	relType_6=conj	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	path2=dantrolene_conj	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	path=aspirin_conj<antidepressant_obl>dantrolene_conj	lemma_7=corticotropin	pos_6=,	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	lib=barbiturate	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_8=cyclosporine	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e10	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	relType_9=conj	lemma_4=supplement	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	lpib=barbiturate_NNS	pos_8=NN	relType_6=conj	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	pos_9=NN	wib=barbiturates	path2=nicotine_conj	relType_3=conj	lemma_3=,	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	relType_9=punct	lemma_7=corticotropin	path=aspirin_conj<antidepressant_obl>nicotine_conj	pos_6=,	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	lib=barbiturate	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_8=cyclosporine	lemma_9=dantrolene	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e11	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	relType_10=punct	relType_9=conj	lemma_4=supplement	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	lpib=barbiturate_NNS	pos_8=NN	path=aspirin_conj<antidepressant_obl>somatropin_conj	relType_6=conj	path2=somatropin_conj	relType_10=conj	relType_6=punct	pos_7=,	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	pos_9=NN	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	lemma_10=nicotine	relType_9=punct	lemma_7=corticotropin	pos_6=,	pos_2=NNS	pos_3=,	lemma_4=calcium	eib=True	pos_10=,	lib=barbiturate	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_8=cyclosporine	lemma_9=dantrolene	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e12	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	relType_10=punct	relType_9=conj	lemma_4=supplement	lemma_11=,	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	path=aspirin_conj<antidepressant_obl>tamoxifen_conj	relType_11=conj	relType_2=punct	lpib=barbiturate_NNS	pos_8=NN	relType_6=conj	relType_10=conj	relType_6=punct	relType_11=punct	pos_7=,	path2=tamoxifen_conj	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	pos_9=NN	lemma_11=somatropin	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_2=barbiturate	lemma_10=nicotine	pos_11=,	relType_9=punct	lemma_7=corticotropin	pos_6=,	pos_2=NNS	pos_11=NN	pos_3=,	lemma_4=calcium	eib=True	pos_10=,	lib=barbiturate	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_8=cyclosporine	lemma_9=dantrolene	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e2	DDI-DrugBank.d446.s0.e13	null	path1=aspirin_conj	lemma_3=bromocriptine	lemma_1=,	relType_10=punct	relType_12=conj	relType_9=conj	lemma_4=supplement	lemma_11=,	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_11=conj	relType_2=punct	lpib=barbiturate_NNS	pos_8=NN	lemma_12=,	relType_6=conj	relType_10=conj	relType_6=punct	relType_11=punct	pos_12=,	path=aspirin_conj<antidepressant_obl>warfarin_conj	pos_7=,	pos_12=NN	relType_12=punct	lemma_13=and	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=corticosteroid	pos_9=NN	lemma_11=somatropin	relType_13=cc	wib=barbiturates	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_12=tamoxifen	relType_4=compound	lemma_2=barbiturate	lemma_10=nicotine	pos_11=,	relType_9=punct	lemma_7=corticotropin	pos_6=,	pos_13=CC	pos_2=NNS	path2=warfarin_conj	pos_11=NN	pos_3=,	lemma_4=calcium	eib=True	pos_10=,	lib=barbiturate	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_8=cyclosporine	lemma_9=dantrolene	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e4	null	lpib=bromocriptine_NN	path2=bromocriptine_conj	lemma_1=,	path=barbiturate_conj<antidepressant_obl>bromocriptine_conj	eib=False	path1=barbiturate_conj	pos_1=,	wib=bromocriptine	relType_1=punct	lib=bromocriptine
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e5	null	lpib=bromocriptine_NN	lemma_1=,	pos_2=NN	eib=True	lemma_2=bromocriptine	lemma_2=,	path1=barbiturate_conj	path2=supplement_conj>calcium_compound	pos_1=,	pos_2=,	wib=bromocriptine	relType_1=punct	relType_2=conj	lib=bromocriptine	relType_2=punct	path=barbiturate_conj<antidepressant_obl>supplement_conj>calcium_compound
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e6	null	lemma_1=,	pos_2=NN	pos_1=,	wib=bromocriptine	relType_2=punct	pos_3=NNS	pos_4=,	lemma_2=bromocriptine	lemma_3=calcium	relType_2=conj	lemma_2=,	lib=bromocriptine	relType_4=punct	path=barbiturate_conj<antidepressant_obl>corticosteroid_conj	relType_3=conj	lemma_3=supplement	path1=barbiturate_conj	path2=corticosteroid_conj	lemma_4=,	lpib=bromocriptine_NN	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e7	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_5=corticosteroid	wib=bromocriptine	relType_2=punct	path=barbiturate_conj<antidepressant_obl>corticotropin_conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_2=conj	lemma_2=,	lib=bromocriptine	path2=corticotropin_conj	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	path1=barbiturate_conj	lemma_4=,	relType_5=conj	lpib=bromocriptine_NN	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e8	null	lemma_1=,	pos_2=NN	pos_5=,	path2=cyclosporine_conj	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	wib=bromocriptine	relType_2=punct	pos_6=NN	relType_6=conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	relType_2=conj	lemma_2=,	lib=bromocriptine	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	path1=barbiturate_conj	lemma_4=,	relType_5=conj	pos_6=,	lpib=bromocriptine_NN	eib=True	pos_3=NN	pos_2=,	relType_3=compound	path=barbiturate_conj<antidepressant_obl>cyclosporine_conj	relType_1=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e9	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	wib=bromocriptine	relType_2=punct	path=barbiturate_conj<antidepressant_obl>dantrolene_conj	pos_6=NN	relType_6=conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	lib=bromocriptine	path2=dantrolene_conj	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	path1=barbiturate_conj	lemma_4=,	relType_5=conj	pos_6=,	lpib=bromocriptine_NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_3=compound	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e10	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	relType_8=punct	wib=bromocriptine	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	lib=bromocriptine	relType_4=punct	path2=nicotine_conj	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	lemma_8=dantrolene	path1=barbiturate_conj	lemma_4=,	relType_5=conj	pos_6=,	lpib=bromocriptine_NN	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_3=compound	relType_1=punct	pos_7=NN	path=barbiturate_conj<antidepressant_obl>nicotine_conj	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e11	null	path=barbiturate_conj<antidepressant_obl>somatropin_conj	lemma_1=,	pos_2=NN	relType_9=conj	pos_5=,	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	relType_8=punct	wib=bromocriptine	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_3=NNS	path2=somatropin_conj	pos_4=,	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	pos_9=NN	lemma_2=,	lib=bromocriptine	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	lemma_8=dantrolene	path1=barbiturate_conj	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lpib=bromocriptine_NN	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_9=nicotine	pos_2=,	relType_3=compound	pos_9=,	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	pos_5=,	lemma_10=,	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	relType_8=punct	wib=bromocriptine	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_3=NNS	pos_4=,	relType_10=conj	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	lemma_7=cyclosporine	pos_7=,	path2=tamoxifen_conj	pos_10=NN	lemma_7=,	relType_2=conj	pos_9=NN	lemma_2=,	lib=bromocriptine	path=barbiturate_conj<antidepressant_obl>tamoxifen_conj	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	lemma_8=dantrolene	path1=barbiturate_conj	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lpib=bromocriptine_NN	pos_10=,	eib=True	lemma_10=somatropin	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_9=nicotine	pos_2=,	relType_3=compound	pos_9=,	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e3	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_11=,	pos_5=,	lemma_10=,	pos_1=,	lemma_5=corticosteroid	lemma_6=corticotropin	lemma_6=,	relType_12=cc	relType_8=punct	wib=bromocriptine	lemma_9=,	pos_12=CC	lemma_8=,	relType_11=conj	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_3=NNS	pos_4=,	relType_10=conj	pos_5=NNS	lemma_2=bromocriptine	lemma_3=calcium	relType_6=punct	relType_11=punct	lemma_7=cyclosporine	pos_7=,	path=barbiturate_conj<antidepressant_obl>warfarin_conj	pos_10=NN	lemma_7=,	relType_2=conj	pos_9=NN	lemma_2=,	lib=bromocriptine	lemma_11=tamoxifen	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=supplement	lemma_8=dantrolene	path1=barbiturate_conj	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	pos_6=,	lpib=bromocriptine_NN	path2=warfarin_conj	pos_11=NN	pos_10=,	eib=True	lemma_10=somatropin	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_9=nicotine	pos_2=,	relType_3=compound	lemma_12=and	pos_9=,	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e5	null	lemma_1=,	path1=bromocriptine_conj	eib=False	lpib=calcium_NN	wib=calcium	path=bromocriptine_conj<antidepressant_obl>supplement_conj>calcium_compound	path2=supplement_conj>calcium_compound	pos_1=,	relType_1=punct	lib=calcium
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e6	null	path=bromocriptine_conj<antidepressant_obl>corticosteroid_conj	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	relType_2=conj	lemma_2=calcium	lemma_3=,	relType_2=compound	path2=corticosteroid_conj	pos_2=NNS	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e7	null	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	pos_4=,	relType_2=conj	pos_4=NNS	path2=corticotropin_conj	lemma_2=calcium	relType_4=punct	lemma_3=,	relType_2=compound	path=bromocriptine_conj<antidepressant_obl>corticotropin_conj	lemma_4=,	pos_2=NNS	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e8	null	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	wib=calcium	pos_5=,	path2=cyclosporine_conj	pos_1=,	pos_4=,	relType_2=conj	pos_4=NNS	lemma_5=corticotropin	lemma_2=calcium	relType_4=punct	lemma_3=,	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	path=bromocriptine_conj<antidepressant_obl>cyclosporine_conj	pos_2=NNS	pos_5=NN	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e9	null	lemma_6=cyclosporine	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	wib=calcium	pos_5=,	pos_1=,	lemma_6=,	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NNS	lemma_5=corticotropin	lemma_2=calcium	path2=dantrolene_conj	relType_4=punct	lemma_3=,	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	path=bromocriptine_conj<antidepressant_obl>dantrolene_conj	pos_2=NNS	pos_5=NN	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e10	null	lemma_6=cyclosporine	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	wib=calcium	pos_5=,	pos_1=,	lemma_6=,	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=dantrolene	lemma_7=,	relType_2=conj	pos_4=NNS	lemma_5=corticotropin	lemma_2=calcium	relType_4=punct	lemma_3=,	path2=nicotine_conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	pos_2=NNS	pos_5=NN	path=bromocriptine_conj<antidepressant_obl>nicotine_conj	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_7=punct	relType_4=conj	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e11	null	lemma_6=cyclosporine	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	wib=calcium	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=,	pos_6=NN	pos_8=NN	relType_6=conj	path2=somatropin_conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=dantrolene	lemma_7=,	relType_2=conj	pos_4=NNS	lemma_5=corticotropin	path=bromocriptine_conj<antidepressant_obl>somatropin_conj	lemma_2=calcium	relType_4=punct	lemma_3=,	lemma_8=nicotine	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	pos_2=NNS	pos_5=NN	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_7=punct	pos_8=,	relType_8=conj	relType_4=conj	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e12	null	lemma_6=cyclosporine	lemma_4=corticosteroid	lemma_1=,	pos_2=NN	relType_9=conj	wib=calcium	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	path=bromocriptine_conj<antidepressant_obl>tamoxifen_conj	relType_6=punct	pos_7=,	path2=tamoxifen_conj	lemma_7=dantrolene	lemma_7=,	relType_2=conj	pos_9=NN	pos_4=NNS	lemma_5=corticotropin	lemma_2=calcium	relType_4=punct	lemma_3=,	lemma_8=nicotine	lemma_5=,	relType_2=compound	relType_5=punct	lemma_9=somatropin	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	pos_2=NNS	pos_5=NN	lemma_2=supplement	path1=bromocriptine_conj	pos_3=,	eib=True	lpib=calcium_NN	relType_7=punct	pos_8=,	relType_8=conj	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e4	DDI-DrugBank.d446.s0.e13	null	lemma_6=cyclosporine	lemma_4=corticosteroid	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	relType_11=cc	wib=calcium	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	pos_6=NN	pos_8=NN	path=bromocriptine_conj<antidepressant_obl>warfarin_conj	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	pos_7=,	lemma_7=dantrolene	pos_10=NN	lemma_7=,	relType_2=conj	pos_9=NN	pos_4=NNS	lemma_5=corticotropin	lemma_2=calcium	lemma_10=tamoxifen	relType_4=punct	lemma_3=,	lemma_8=nicotine	lemma_11=and	lemma_5=,	relType_2=compound	relType_5=punct	lemma_9=somatropin	pos_11=CC	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	pos_2=NNS	path2=warfarin_conj	lemma_2=supplement	pos_5=NN	path1=bromocriptine_conj	pos_3=,	eib=True	pos_10=,	lpib=calcium_NN	relType_7=punct	pos_8=,	relType_8=conj	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e6	null	lpib=supplement_NNS	relType_2=punct	pos_1=NNS	lib=supplement	eib=False	lemma_1=supplement	pos_2=,	path2=corticosteroid_conj	wib=supplements	path=calcium_compound<supplement_conj<antidepressant_obl>corticosteroid_conj	relType_1=conj	lemma_2=,	path1=calcium_compound<supplement_conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e7	null	relType_2=punct	lemma_3=corticosteroid	pos_3=NNS	lemma_1=supplement	wib=supplements	lemma_2=,	lpib=supplement_NNS	path2=corticotropin_conj	lib=supplement	lemma_3=,	relType_3=conj	path=calcium_compound<supplement_conj<antidepressant_obl>corticotropin_conj	relType_1=conj	path1=calcium_compound<supplement_conj	pos_1=NNS	pos_3=,	eib=True	pos_2=,	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e8	null	path2=cyclosporine_conj	relType_2=punct	lemma_3=corticosteroid	pos_3=NNS	pos_4=,	path=calcium_compound<supplement_conj<antidepressant_obl>cyclosporine_conj	lemma_1=supplement	wib=supplements	pos_4=NN	lemma_2=,	lpib=supplement_NNS	relType_4=punct	lib=supplement	lemma_3=,	relType_3=conj	lemma_4=,	relType_1=conj	path1=calcium_compound<supplement_conj	pos_1=NNS	pos_3=,	eib=True	pos_2=,	lemma_4=corticotropin	relType_4=conj	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e9	null	pos_5=,	relType_2=punct	lemma_3=corticosteroid	pos_3=NNS	pos_4=,	lemma_1=supplement	wib=supplements	pos_4=NN	lemma_2=,	lpib=supplement_NNS	path2=dantrolene_conj	relType_4=punct	lib=supplement	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	path=calcium_compound<supplement_conj<antidepressant_obl>dantrolene_conj	relType_5=conj	relType_1=conj	path1=calcium_compound<supplement_conj	pos_5=NN	pos_1=NNS	pos_3=,	eib=True	pos_2=,	lemma_4=corticotropin	relType_4=conj	relType_3=punct	lemma_5=cyclosporine
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e10	null	pos_5=,	lemma_6=,	relType_2=punct	pos_6=NN	relType_6=conj	lemma_3=corticosteroid	pos_3=NNS	pos_4=,	relType_6=punct	lemma_1=supplement	wib=supplements	lemma_6=dantrolene	pos_4=NN	lemma_2=,	lpib=supplement_NNS	relType_4=punct	lib=supplement	path2=nicotine_conj	path=calcium_compound<supplement_conj<antidepressant_obl>nicotine_conj	relType_3=conj	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	relType_1=conj	pos_6=,	path1=calcium_compound<supplement_conj	pos_5=NN	pos_1=NNS	pos_3=,	eib=True	pos_2=,	lemma_4=corticotropin	relType_4=conj	relType_3=punct	lemma_5=cyclosporine
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e11	null	pos_5=,	lemma_6=,	path=calcium_compound<supplement_conj<antidepressant_obl>somatropin_conj	relType_2=punct	pos_6=NN	relType_6=conj	lemma_3=corticosteroid	pos_3=NNS	path2=somatropin_conj	pos_4=,	relType_6=punct	lemma_7=nicotine	lemma_1=supplement	pos_7=,	wib=supplements	lemma_7=,	lemma_6=dantrolene	pos_4=NN	lemma_2=,	lpib=supplement_NNS	relType_4=punct	lib=supplement	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	relType_1=conj	pos_6=,	path1=calcium_compound<supplement_conj	pos_5=NN	pos_1=NNS	pos_3=,	eib=True	relType_7=punct	pos_2=,	lemma_4=corticotropin	relType_4=conj	pos_7=NN	relType_3=punct	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e12	null	pos_5=,	pos_7=NN	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=corticosteroid	pos_3=NNS	pos_4=,	relType_6=punct	lemma_7=nicotine	lemma_1=supplement	pos_7=,	wib=supplements	path2=tamoxifen_conj	lemma_7=,	lemma_6=dantrolene	pos_4=NN	lemma_2=,	lpib=supplement_NNS	relType_4=punct	lib=supplement	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	relType_1=conj	pos_6=,	path1=calcium_compound<supplement_conj	pos_5=NN	pos_1=NNS	pos_3=,	eib=True	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	lemma_4=corticotropin	relType_4=conj	path=calcium_compound<supplement_conj<antidepressant_obl>tamoxifen_conj	relType_3=punct	lemma_8=somatropin	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e5	DDI-DrugBank.d446.s0.e13	null	path=calcium_compound<supplement_conj<antidepressant_obl>warfarin_conj	relType_9=conj	pos_5=,	relType_10=cc	lemma_9=tamoxifen	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=corticosteroid	pos_3=NNS	pos_4=,	relType_6=punct	lemma_7=nicotine	pos_10=CC	lemma_1=supplement	pos_7=,	wib=supplements	lemma_7=,	lemma_6=dantrolene	pos_4=NN	lemma_2=,	pos_9=NN	lpib=supplement_NNS	lemma_10=and	relType_4=punct	lib=supplement	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	relType_9=punct	relType_1=conj	pos_6=,	path1=calcium_compound<supplement_conj	path2=warfarin_conj	pos_5=NN	pos_1=NNS	pos_3=,	eib=True	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	lemma_4=corticotropin	relType_4=conj	pos_9=,	pos_7=NN	relType_3=punct	lemma_8=somatropin	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e7	null	path2=corticotropin_conj	wib=corticotropin	lemma_1=,	path1=corticosteroid_conj	eib=False	pos_1=,	lib=corticotropin	lpib=corticotropin_NN	relType_1=punct	path=corticosteroid_conj<antidepressant_obl>corticotropin_conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e8	null	path=corticosteroid_conj<antidepressant_obl>cyclosporine_conj	wib=corticotropin	lemma_1=,	pos_2=NN	eib=True	path1=corticosteroid_conj	path2=cyclosporine_conj	pos_1=,	lib=corticotropin	lpib=corticotropin_NN	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e9	null	lemma_1=,	pos_2=NN	pos_1=,	path=corticosteroid_conj<antidepressant_obl>dantrolene_conj	lib=corticotropin	lpib=corticotropin_NN	relType_2=punct	path1=corticosteroid_conj	relType_2=conj	lemma_2=,	path2=dantrolene_conj	lemma_3=,	relType_3=conj	wib=corticotropin	lemma_3=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e10	null	lemma_1=,	pos_2=NN	pos_1=,	lib=corticotropin	lpib=corticotropin_NN	path=corticosteroid_conj<antidepressant_obl>nicotine_conj	relType_2=punct	pos_4=,	path1=corticosteroid_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path2=nicotine_conj	relType_3=conj	lemma_4=,	wib=corticotropin	lemma_3=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	lemma_4=dantrolene	relType_1=punct	relType_3=punct	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e11	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lib=corticotropin	lpib=corticotropin_NN	path=corticosteroid_conj<antidepressant_obl>somatropin_conj	relType_2=punct	path2=somatropin_conj	pos_4=,	path1=corticosteroid_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=nicotine	lemma_4=,	relType_5=conj	pos_5=NN	wib=corticotropin	lemma_3=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	lemma_4=dantrolene	relType_1=punct	relType_3=punct	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lib=corticotropin	lpib=corticotropin_NN	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	path1=corticosteroid_conj	relType_6=punct	path2=tamoxifen_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=nicotine	lemma_6=somatropin	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	wib=corticotropin	lemma_3=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	lemma_4=dantrolene	path=corticosteroid_conj<antidepressant_obl>tamoxifen_conj	relType_1=punct	relType_3=punct	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e6	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lib=corticotropin	lpib=corticotropin_NN	relType_2=punct	path=corticosteroid_conj<antidepressant_obl>warfarin_conj	pos_6=NN	relType_6=conj	pos_4=,	path1=corticosteroid_conj	relType_6=punct	pos_7=,	pos_8=CC	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=nicotine	lemma_6=somatropin	lemma_4=,	relType_5=conj	pos_6=,	lemma_8=and	path2=warfarin_conj	pos_5=NN	wib=corticotropin	lemma_3=cyclosporine	pos_3=,	lemma_7=tamoxifen	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_4=conj	lemma_4=dantrolene	relType_1=punct	pos_7=NN	relType_8=cc	relType_3=punct	relType_7=conj	lemma_2=corticotropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e8	null	lemma_1=,	lpib=cyclosporine_NN	eib=False	path1=corticotropin_conj	path2=cyclosporine_conj	path=corticotropin_conj<antidepressant_obl>cyclosporine_conj	pos_1=,	lib=cyclosporine	relType_1=punct	wib=cyclosporine
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e9	null	path2=dantrolene_conj	lemma_1=,	pos_2=NN	path=corticotropin_conj<antidepressant_obl>dantrolene_conj	lpib=cyclosporine_NN	eib=True	path1=corticotropin_conj	pos_1=,	pos_2=,	lib=cyclosporine	relType_1=punct	wib=cyclosporine	lemma_2=cyclosporine	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e10	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=cyclosporine	path=corticotropin_conj<antidepressant_obl>nicotine_conj	relType_2=punct	lib=cyclosporine	relType_2=conj	lemma_2=,	lemma_3=,	lpib=cyclosporine_NN	path2=nicotine_conj	relType_3=conj	path1=corticotropin_conj	lemma_3=dantrolene	wib=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e11	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=cyclosporine	relType_2=punct	path=corticotropin_conj<antidepressant_obl>somatropin_conj	path2=somatropin_conj	pos_4=,	lib=cyclosporine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	path1=corticotropin_conj	lemma_3=dantrolene	lemma_4=,	wib=cyclosporine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=nicotine	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_5=somatropin	lemma_2=cyclosporine	relType_2=punct	pos_4=,	lib=cyclosporine	path2=tamoxifen_conj	relType_2=conj	pos_4=NN	lemma_2=,	path=corticotropin_conj<antidepressant_obl>tamoxifen_conj	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	path1=corticotropin_conj	lemma_3=dantrolene	relType_5=punct	lemma_4=,	relType_5=conj	wib=cyclosporine	pos_5=NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=nicotine	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e7	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_7=cc	lemma_5=somatropin	path=corticotropin_conj<antidepressant_obl>warfarin_conj	lemma_2=cyclosporine	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	lemma_6=tamoxifen	lib=cyclosporine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	path1=corticotropin_conj	lemma_3=dantrolene	relType_5=punct	pos_7=CC	lemma_4=,	relType_5=conj	wib=cyclosporine	pos_6=,	path2=warfarin_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_7=and	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=nicotine	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e8	DDI-DrugBank.d446.s0.e9	null	path2=dantrolene_conj	lemma_1=,	wib=dantrolene	eib=False	lib=dantrolene	path=cyclosporine_conj<antidepressant_obl>dantrolene_conj	pos_1=,	path1=cyclosporine_conj	relType_1=punct	lpib=dantrolene_NN
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e8	DDI-DrugBank.d446.s0.e10	null	lemma_1=,	pos_2=NN	wib=dantrolene	eib=True	path2=nicotine_conj	lemma_2=dantrolene	lib=dantrolene	pos_1=,	pos_2=,	path1=cyclosporine_conj	relType_1=punct	relType_2=conj	lpib=dantrolene_NN	lemma_2=,	relType_2=punct	path=cyclosporine_conj<antidepressant_obl>nicotine_conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e8	DDI-DrugBank.d446.s0.e11	null	lemma_1=,	pos_2=NN	wib=dantrolene	lib=dantrolene	pos_1=,	relType_2=punct	path2=somatropin_conj	lemma_3=nicotine	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path=cyclosporine_conj<antidepressant_obl>somatropin_conj	lpib=dantrolene_NN	pos_3=,	eib=True	lemma_2=dantrolene	pos_3=NN	pos_2=,	path1=cyclosporine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e8	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	pos_2=NN	wib=dantrolene	lib=dantrolene	pos_1=,	relType_2=punct	lemma_4=somatropin	pos_4=,	path=cyclosporine_conj<antidepressant_obl>tamoxifen_conj	path2=tamoxifen_conj	lemma_3=nicotine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lpib=dantrolene_NN	pos_3=,	eib=True	lemma_2=dantrolene	pos_3=NN	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e8	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	pos_2=NN	wib=dantrolene	pos_5=,	lib=dantrolene	pos_1=,	path=cyclosporine_conj<antidepressant_obl>warfarin_conj	relType_2=punct	lemma_4=somatropin	pos_4=,	lemma_5=tamoxifen	lemma_3=nicotine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=,	relType_5=conj	lpib=dantrolene_NN	path2=warfarin_conj	pos_5=NN	pos_3=,	eib=True	lemma_2=dantrolene	pos_3=NN	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e9	DDI-DrugBank.d446.s0.e10	null	lemma_1=,	lpib=nicotine_NN	path2=nicotine_conj	eib=False	path=dantrolene_conj<antidepressant_obl>nicotine_conj	pos_1=,	wib=nicotine	relType_1=punct	lib=nicotine	path1=dantrolene_conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e9	DDI-DrugBank.d446.s0.e11	null	lemma_1=,	lpib=nicotine_NN	pos_2=NN	path2=somatropin_conj	eib=True	lemma_2=nicotine	relType_2=punct	pos_1=,	pos_2=,	wib=nicotine	relType_1=punct	lib=nicotine	relType_2=conj	lemma_2=,	path=dantrolene_conj<antidepressant_obl>somatropin_conj	path1=dantrolene_conj
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e9	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	lemma_3=somatropin	pos_2=NN	path=dantrolene_conj<antidepressant_obl>tamoxifen_conj	lemma_2=nicotine	pos_1=,	relType_2=punct	wib=nicotine	path2=tamoxifen_conj	lib=nicotine	relType_2=conj	lemma_2=,	path1=dantrolene_conj	lpib=nicotine_NN	lemma_3=,	relType_3=conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e9	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	lemma_3=somatropin	pos_2=NN	lemma_2=nicotine	pos_5=CC	pos_1=,	relType_2=punct	wib=nicotine	relType_5=cc	pos_4=,	lib=nicotine	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tamoxifen	path1=dantrolene_conj	lpib=nicotine_NN	relType_4=punct	lemma_3=,	relType_3=conj	path=dantrolene_conj<antidepressant_obl>warfarin_conj	lemma_4=,	path2=warfarin_conj	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e10	DDI-DrugBank.d446.s0.e11	null	lemma_1=,	path2=somatropin_conj	eib=False	path=nicotine_conj<antidepressant_obl>somatropin_conj	wib=somatropin	pos_1=,	relType_1=punct	path1=nicotine_conj	lpib=somatropin_NN	lib=somatropin
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e10	DDI-DrugBank.d446.s0.e12	null	lemma_1=,	pos_2=NN	eib=True	path=nicotine_conj<antidepressant_obl>tamoxifen_conj	wib=somatropin	pos_1=,	lemma_2=,	pos_2=,	path2=tamoxifen_conj	relType_1=punct	lemma_2=somatropin	relType_2=conj	path1=nicotine_conj	lpib=somatropin_NN	lib=somatropin	relType_2=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e10	DDI-DrugBank.d446.s0.e13	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	wib=somatropin	relType_2=punct	relType_2=conj	path1=nicotine_conj	lemma_2=,	lpib=somatropin_NN	lemma_3=,	path=nicotine_conj<antidepressant_obl>warfarin_conj	relType_3=conj	lemma_2=somatropin	lib=somatropin	path2=warfarin_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=tamoxifen
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e11	DDI-DrugBank.d446.s0.e12	null	path=somatropin_conj<antidepressant_obl>tamoxifen_conj	lemma_1=,	eib=False	path1=somatropin_conj	pos_1=,	lib=tamoxifen	path2=tamoxifen_conj	wib=tamoxifen	relType_1=punct	lpib=tamoxifen_NN
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e11	DDI-DrugBank.d446.s0.e13	null	lemma_2=tamoxifen	lemma_1=,	pos_2=NN	pos_3=CC	path1=somatropin_conj	pos_1=,	lib=tamoxifen	relType_3=cc	relType_2=punct	path=somatropin_conj<antidepressant_obl>warfarin_conj	relType_2=conj	lemma_2=,	lpib=tamoxifen_NN	path2=warfarin_conj	eib=True	pos_2=,	lemma_3=and	wib=tamoxifen	relType_1=punct
DDI-DrugBank.d446.s0	DDI-DrugBank.d446.s0.e12	DDI-DrugBank.d446.s0.e13	null	lib=warfarin	path2=warfarin_conj	lemma_2=and	lemma_1=,	path=tamoxifen_conj<antidepressant_obl>warfarin_conj	lpib=warfarin_NN	eib=False	pos_2=CC	pos_1=,	wib=warfarin	path1=tamoxifen_conj	relType_1=punct	relType_2=cc
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e1	effect	lemma_6=drug	relType_7=case	relType_1=aux	lemma_1=may	relType_8=amod	pos_3=VBN	pos_7=VBG	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>drug_obl>agent_nmod	relType_8=punct	wib=be	pos_8=JJ	relType_6=obl	lemma_8=inflammatory	pos_8=AFX	pos_2=VB	pos_8=HYPH	lemma_3=potentiate	relation_2=beneficial	lemma_8=anti	pos_5=JJ	lib=be	relType_5=amod	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	pos_1=MD	lpib=be_VB	eib=True	relation_2=adverse	lemma_8=-	pos_6=NNS	lemma_5=certain	lemma_2=be	path2=drug_obl>agent_nmod	relType_8=obl:npmod	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_7=include	lemma_4=by	lemma_8=nonsteroidal
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e2	effect	lemma_6=drug	lemma_13=highly	relType_7=case	relType_1=aux	lemma_1=may	relType_8=amod	relType_8=cc	pos_3=VBN	pos_11=WDT	pos_7=VBG	relType_8=punct	pos_8=NNS	relType_12=aux:pass	wib=be	pos_8=JJ	relType_6=obl	pos_9=JJ	lemma_8=inflammatory	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>salicylate_conj	lemma_9=other	relType_10=conj	pos_12=VBP	relType_15=dep	pos_16=,	pos_8=AFX	pos_13=RB	pos_2=VB	pos_8=HYPH	lemma_3=potentiate	pos_8=CC	relType_9=amod	pos_14=NN	pos_15=VBN	lemma_16=,	lemma_11=that	relation_2=beneficial	lemma_8=anti	pos_5=JJ	relType_13=advmod	lib=be	relType_5=amod	relType_3=ROOT	lemma_12=be	pos_4=IN	lemma_15=bind	relType_4=case	relType_2=aux:pass	lemma_8=agent	relType_14=dep	relType_11=dep	pos_1=MD	lpib=be_VB	lemma_14=protein	relType_16=punct	lemma_8=and	eib=True	relType_8=nmod	relation_2=adverse	lemma_8=-	pos_6=NNS	lemma_5=certain	path2=bind_dep>salicylate_conj	lemma_2=be	relType_8=obl:npmod	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_7=include	pos_10=NNS	lemma_4=by	lemma_10=drug	lemma_8=nonsteroidal
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e3	effect	lemma_6=drug	lemma_13=highly	relType_7=case	relType_1=aux	lemma_1=may	relType_8=amod	path2=bind_dep>sulfonamide_conj	pos_3=VBN	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>sulfonamide_conj	relType_8=cc	pos_7=VBG	pos_11=WDT	relType_17=punct	relType_8=punct	pos_8=NNS	relType_12=aux:pass	wib=be	pos_8=JJ	relType_6=obl	pos_9=JJ	lemma_8=inflammatory	relType_17=conj	lemma_9=other	lemma_17=,	relType_10=conj	pos_12=VBP	relType_15=dep	pos_16=,	pos_8=AFX	pos_13=RB	pos_2=VB	pos_8=HYPH	lemma_3=potentiate	pos_8=CC	relType_9=amod	pos_14=NN	pos_15=VBN	lemma_16=,	lemma_11=that	lemma_17=salicylate	relation_2=beneficial	lemma_8=anti	pos_17=,	pos_5=JJ	relType_13=advmod	lib=be	relType_5=amod	relType_3=ROOT	lemma_12=be	pos_4=IN	lemma_15=bind	relType_4=case	relType_2=aux:pass	lemma_8=agent	relType_14=dep	relType_11=dep	pos_1=MD	lpib=be_VB	lemma_14=protein	relType_16=punct	lemma_8=and	pos_17=NNS	eib=True	relType_8=nmod	relation_2=adverse	lemma_8=-	pos_6=NNS	lemma_5=certain	lemma_2=be	relType_8=obl:npmod	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_7=include	pos_10=NNS	lemma_4=by	lemma_10=drug	lemma_8=nonsteroidal
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e4	effect	lemma_13=highly	relType_8=punct	pos_8=NNS	pos_8=JJ	lemma_8=inflammatory	lemma_9=other	pos_12=VBP	pos_2=VB	lemma_16=,	lemma_17=salicylate	lemma_11=that	relType_3=ROOT	relType_2=aux:pass	lpib=be_VB	relType_16=punct	lemma_8=-	pos_6=NNS	lemma_5=certain	lemma_10=drug	path2=bind_dep>chloramphenicol_conj	lemma_6=drug	pos_18=NNS	relType_7=case	relType_1=aux	pos_10=NNS	relType_10=conj	pos_8=HYPH	pos_15=VBN	relType_13=advmod	lemma_15=bind	lemma_8=agent	relType_11=dep	lemma_8=and	lemma_2=be	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_8=nonsteroidal	lemma_1=may	pos_11=WDT	relType_17=punct	pos_7=VBG	relType_6=obl	relType_15=dep	pos_8=AFX	relType_9=amod	lemma_3=potentiate	pos_8=CC	pos_14=NN	pos_17=,	lib=be	relType_5=amod	pos_4=IN	pos_1=MD	pos_17=NNS	relation_2=adverse	relType_8=obl:npmod	relType_8=cc	lemma_7=include	relType_8=amod	pos_3=VBN	relType_12=aux:pass	wib=be	relType_17=conj	pos_9=JJ	lemma_17=,	pos_16=,	pos_13=RB	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>chloramphenicol_conj	lemma_8=anti	pos_5=JJ	pos_18=,	lemma_12=be	lemma_18=sulfonamide	lemma_18=,	relType_18=punct	relType_4=case	relType_14=dep	lemma_14=protein	eib=True	relType_8=nmod	relation_2=beneficial	relType_18=conj	lemma_4=by
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e5	effect	lemma_13=highly	relType_8=punct	pos_8=NNS	pos_8=JJ	lemma_8=inflammatory	lemma_9=other	pos_12=VBP	pos_2=VB	lemma_16=,	lemma_17=salicylate	lemma_11=that	lemma_19=chloramphenicol	relType_3=ROOT	relType_2=aux:pass	lpib=be_VB	relType_16=punct	lemma_8=-	pos_6=NNS	lemma_5=certain	lemma_10=drug	lemma_6=drug	pos_18=NNS	relType_7=case	relType_1=aux	pos_10=NNS	relType_10=conj	pos_8=HYPH	pos_15=VBN	relType_13=advmod	lemma_15=bind	pos_19=,	lemma_8=agent	relType_11=dep	lemma_8=and	lemma_19=,	lemma_2=be	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_8=nonsteroidal	lemma_1=may	pos_11=WDT	relType_17=punct	pos_7=VBG	relType_19=punct	relType_6=obl	relType_15=dep	pos_8=AFX	relType_9=amod	lemma_3=potentiate	pos_8=CC	pos_14=NN	pos_17=,	lib=be	relType_5=amod	pos_4=IN	pos_1=MD	relType_19=conj	pos_17=NNS	relation_2=adverse	relType_8=obl:npmod	relType_8=cc	lemma_7=include	relType_8=amod	pos_3=VBN	path2=bind_dep>probenecid_conj	relType_12=aux:pass	wib=be	relType_17=conj	pos_9=JJ	lemma_17=,	pos_16=,	pos_13=RB	pos_19=NN	lemma_8=anti	pos_5=JJ	pos_18=,	lemma_12=be	lemma_18=sulfonamide	lemma_18=,	relType_18=punct	relType_4=case	relType_14=dep	lemma_14=protein	eib=True	relType_8=nmod	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>probenecid_conj	relation_2=beneficial	relType_18=conj	lemma_4=by
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e6	effect	lemma_13=highly	relType_8=punct	pos_8=NNS	pos_8=JJ	lemma_20=,	lemma_8=inflammatory	lemma_9=other	pos_12=VBP	pos_20=NN	pos_2=VB	lemma_16=,	lemma_17=salicylate	lemma_11=that	lemma_19=chloramphenicol	relType_3=ROOT	relType_2=aux:pass	lpib=be_VB	relType_16=punct	lemma_8=-	pos_6=NNS	lemma_5=certain	lemma_10=drug	lemma_6=drug	pos_18=NNS	relType_7=case	relType_1=aux	pos_10=NNS	relType_10=conj	relType_20=conj	pos_8=HYPH	pos_15=VBN	relType_13=advmod	lemma_15=bind	pos_19=,	lemma_8=agent	relType_11=dep	lemma_8=and	lemma_19=,	lemma_2=be	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_8=nonsteroidal	lemma_1=may	pos_11=WDT	relType_17=punct	pos_7=VBG	relType_19=punct	relType_6=obl	relType_15=dep	pos_8=AFX	relType_9=amod	lemma_3=potentiate	path2=bind_dep>coumarin_conj	pos_8=CC	pos_14=NN	pos_17=,	lib=be	relType_5=amod	pos_4=IN	pos_1=MD	relType_19=conj	lemma_20=probenecid	pos_17=NNS	relation_2=adverse	relType_20=punct	relType_8=obl:npmod	relType_8=cc	lemma_7=include	relType_8=amod	pos_3=VBN	relType_12=aux:pass	wib=be	relType_17=conj	pos_9=JJ	lemma_17=,	pos_16=,	pos_13=RB	pos_19=NN	pos_20=,	lemma_8=anti	pos_5=JJ	pos_18=,	lemma_12=be	lemma_18=sulfonamide	lemma_18=,	relType_18=punct	relType_4=case	relType_14=dep	lemma_14=protein	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>coumarin_conj	eib=True	relType_8=nmod	relation_2=beneficial	relType_18=conj	lemma_4=by
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e7	effect	relType_22=compound	lemma_13=highly	relType_8=punct	pos_8=NNS	pos_21=NNS	relType_21=conj	pos_8=JJ	lemma_20=,	lemma_8=inflammatory	lemma_9=other	pos_12=VBP	pos_20=NN	pos_2=VB	lemma_16=,	lemma_17=salicylate	lemma_11=that	lemma_19=chloramphenicol	relType_3=ROOT	relType_2=aux:pass	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>inhibitor_conj	lpib=be_VB	relType_16=punct	lemma_21=,	lemma_8=-	pos_6=NNS	lemma_5=certain	relType_21=punct	lemma_10=drug	lemma_6=drug	pos_18=NNS	relType_7=case	relType_1=aux	pos_22=NN	pos_10=NNS	relType_10=conj	relType_20=conj	pos_8=HYPH	pos_15=VBN	relType_13=advmod	lemma_15=bind	pos_19=,	lemma_8=agent	path2=bind_dep>inhibitor_conj	relType_11=dep	lemma_8=and	lemma_19=,	lemma_2=be	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_22=monoamine	lemma_8=nonsteroidal	lemma_1=may	pos_11=WDT	relType_17=punct	pos_7=VBG	relType_19=punct	relType_6=obl	relType_15=dep	pos_8=AFX	relType_9=amod	lemma_3=potentiate	pos_8=CC	pos_14=NN	pos_17=,	lib=be	relType_5=amod	pos_4=IN	pos_1=MD	relType_19=conj	lemma_20=probenecid	pos_17=NNS	relation_2=adverse	relType_20=punct	relType_8=obl:npmod	relType_8=cc	lemma_7=include	lemma_21=coumarin	relType_8=amod	pos_3=VBN	relType_12=aux:pass	wib=be	relType_17=conj	pos_9=JJ	pos_21=,	lemma_17=,	pos_16=,	pos_13=RB	pos_19=NN	pos_20=,	lemma_22=oxidase	lemma_8=anti	pos_5=JJ	pos_18=,	lemma_12=be	lemma_18=sulfonamide	lemma_18=,	relType_18=punct	relType_4=case	relType_14=dep	lemma_14=protein	eib=True	relType_8=nmod	relation_2=beneficial	relType_18=conj	lemma_4=by
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e0	DDI-DrugBank.d245.s0.e8	effect	lemma_24=adrenergic	relType_22=compound	lemma_13=highly	relType_8=punct	pos_8=NNS	pos_21=NNS	relType_21=conj	pos_8=JJ	lemma_20=,	path=sulfonylurea_nmod<action_nsubj:pass<potentiate_ROOT>bind_dep>agent_conj	lemma_8=inflammatory	lemma_9=other	pos_12=VBP	pos_20=NN	lemma_24=beta	relType_24=obl:npmod	pos_2=VB	lemma_16=,	lemma_17=salicylate	lemma_11=that	relType_22=punct	lemma_19=chloramphenicol	relType_24=compound	relType_3=ROOT	pos_22=,	relType_2=aux:pass	lpib=be_VB	relType_16=punct	lemma_21=,	lemma_8=-	pos_6=NNS	lemma_5=certain	relType_21=punct	lemma_10=drug	lemma_6=drug	pos_18=NNS	relType_7=case	relType_1=aux	relType_22=conj	pos_22=NN	lemma_22=inhibitor	pos_10=NNS	path2=bind_dep>agent_conj	relType_10=conj	relType_20=conj	lemma_24=blocking	lemma_22=,	pos_8=HYPH	pos_15=VBN	relType_13=advmod	lemma_15=bind	pos_19=,	lemma_8=agent	relType_11=dep	lemma_8=and	relType_24=amod	lemma_19=,	lemma_2=be	path1=sulfonylurea_nmod<action_nsubj:pass	lemma_23=and	lemma_22=monoamine	lemma_8=nonsteroidal	lemma_1=may	pos_11=WDT	relType_17=punct	pos_7=VBG	pos_24=NN	relType_19=punct	pos_24=JJ	pos_23=CC	relType_6=obl	relType_15=dep	pos_8=AFX	relType_9=amod	lemma_3=potentiate	pos_8=CC	pos_14=NN	pos_17=,	lib=be	relType_5=amod	pos_4=IN	pos_1=MD	relType_19=conj	lemma_20=probenecid	pos_17=NNS	relation_2=adverse	relType_20=punct	relType_8=obl:npmod	relType_8=cc	lemma_7=include	lemma_21=coumarin	relType_8=amod	pos_3=VBN	relType_12=aux:pass	wib=be	relType_17=conj	pos_9=JJ	pos_21=,	lemma_17=,	pos_16=,	pos_13=RB	pos_19=NN	pos_20=,	lemma_22=oxidase	lemma_8=anti	pos_5=JJ	pos_18=,	lemma_12=be	lemma_18=sulfonamide	lemma_18=,	relType_23=cc	pos_22=NNS	relType_18=punct	relType_4=case	relType_14=dep	lemma_14=protein	eib=True	relType_8=nmod	relation_2=beneficial	relType_18=conj	lemma_4=by
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e2	null	relType_1=cc	relType_4=dep	pos_1=CC	lemma_3=drug	lib=other	relType_8=dep	pos_8=VBN	lemma_9=,	pos_2=JJ	lemma_7=protein	pos_4=WDT	pos_3=NNS	eib=False	pos_5=VBP	lemma_2=other	path1=agent_nmod<drug_obl	wib=other	lemma_5=be	lemma_8=bind	relType_5=aux:pass	relType_3=conj	lpib=other_JJ	relType_2=amod	pos_6=RB	relType_9=punct	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>salicylate_conj	relType_7=dep	lemma_4=that	path2=bind_dep>salicylate_conj	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	lemma_1=and
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e3	null	relType_1=cc	relType_4=dep	pos_1=CC	relType_10=punct	lemma_3=drug	lib=other	relType_8=dep	pos_8=VBN	path2=bind_dep>sulfonamide_conj	lemma_10=,	lemma_9=,	pos_2=JJ	lemma_7=protein	pos_4=WDT	pos_3=NNS	pos_5=VBP	relType_10=conj	lemma_2=other	path1=agent_nmod<drug_obl	wib=other	lemma_10=salicylate	lemma_5=be	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>sulfonamide_conj	lemma_8=bind	relType_5=aux:pass	relType_3=conj	lpib=other_JJ	relType_2=amod	pos_6=RB	relType_9=punct	relType_7=dep	pos_10=,	eib=True	lemma_4=that	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	pos_10=NNS	lemma_1=and
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e4	null	relType_1=cc	relType_4=dep	pos_1=CC	relType_10=punct	lemma_3=drug	lib=other	relType_8=dep	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>chloramphenicol_conj	pos_8=VBN	lemma_11=,	lemma_10=,	lemma_9=,	pos_2=JJ	relType_11=conj	lemma_7=protein	pos_4=WDT	pos_3=NNS	pos_5=VBP	relType_10=conj	lemma_2=other	relType_11=punct	pos_11=NNS	path1=agent_nmod<drug_obl	wib=other	lemma_11=sulfonamide	lemma_10=salicylate	lemma_5=be	lemma_8=bind	relType_5=aux:pass	relType_3=conj	lpib=other_JJ	relType_2=amod	pos_11=,	pos_6=RB	relType_9=punct	relType_7=dep	pos_10=,	eib=True	lemma_4=that	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	pos_10=NNS	lemma_1=and	path2=bind_dep>chloramphenicol_conj
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e5	null	relType_1=cc	relType_4=dep	pos_1=CC	relType_12=conj	relType_10=punct	lemma_3=drug	lib=other	relType_8=dep	lemma_11=,	pos_8=VBN	lemma_10=,	lemma_9=,	pos_2=JJ	path2=bind_dep>probenecid_conj	relType_11=conj	lemma_7=protein	lemma_12=,	pos_4=WDT	pos_3=NNS	pos_5=VBP	relType_10=conj	lemma_2=other	relType_11=punct	pos_12=,	pos_11=NNS	path1=agent_nmod<drug_obl	wib=other	pos_12=NN	lemma_10=salicylate	relType_12=punct	lemma_5=be	lemma_8=bind	relType_5=aux:pass	relType_3=conj	lpib=other_JJ	relType_2=amod	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>probenecid_conj	pos_11=,	pos_6=RB	relType_9=punct	lemma_12=chloramphenicol	relType_7=dep	pos_10=,	eib=True	lemma_4=that	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	pos_10=NNS	lemma_1=and	lemma_11=sulfonamide
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e6	null	relType_1=cc	relType_4=dep	pos_1=CC	relType_12=conj	relType_10=punct	pos_13=,	lemma_3=drug	lib=other	relType_8=dep	lemma_11=,	pos_8=VBN	lemma_13=,	lemma_10=,	relType_13=punct	lemma_9=,	pos_2=JJ	relType_11=conj	lemma_7=protein	lemma_12=,	pos_4=WDT	pos_3=NNS	pos_5=VBP	relType_10=conj	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>coumarin_conj	lemma_2=other	relType_11=punct	pos_12=,	pos_11=NNS	path1=agent_nmod<drug_obl	wib=other	pos_12=NN	lemma_10=salicylate	relType_12=punct	path2=bind_dep>coumarin_conj	lemma_5=be	pos_13=NN	relType_13=conj	lemma_8=bind	relType_5=aux:pass	relType_3=conj	lpib=other_JJ	relType_2=amod	pos_11=,	pos_6=RB	relType_9=punct	lemma_12=chloramphenicol	relType_7=dep	pos_10=,	eib=True	lemma_13=probenecid	lemma_4=that	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	pos_10=NNS	lemma_1=and	lemma_11=sulfonamide
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e7	null	relType_1=cc	relType_4=dep	pos_1=CC	relType_12=conj	relType_10=punct	pos_13=,	lemma_3=drug	lib=other	relType_8=dep	lemma_11=,	pos_8=VBN	lemma_13=,	lemma_10=,	relType_13=punct	lemma_9=,	pos_2=JJ	relType_11=conj	lemma_7=protein	lemma_12=,	pos_4=WDT	pos_3=NNS	pos_5=VBP	relType_10=conj	pos_14=,	lemma_2=other	relType_11=punct	pos_12=,	pos_11=NNS	path1=agent_nmod<drug_obl	wib=other	pos_12=NN	lemma_15=oxidase	lemma_10=salicylate	relType_12=punct	pos_13=NN	lemma_5=be	relType_13=conj	relType_14=punct	lemma_14=coumarin	lemma_8=bind	relType_5=aux:pass	pos_15=NN	lemma_15=monoamine	relType_3=conj	lpib=other_JJ	relType_2=amod	path2=bind_dep>inhibitor_conj	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>inhibitor_conj	pos_11=,	pos_6=RB	relType_9=punct	relType_15=compound	lemma_14=,	lemma_12=chloramphenicol	relType_7=dep	pos_10=,	eib=True	lemma_13=probenecid	lemma_4=that	relType_14=conj	pos_14=NNS	lemma_6=highly	pos_9=,	pos_7=NN	relType_6=advmod	pos_10=NNS	lemma_1=and	lemma_11=sulfonamide
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e1	DDI-DrugBank.d245.s0.e8	null	relType_1=cc	lemma_3=drug	lemma_13=,	lemma_10=,	lemma_9=,	pos_2=JJ	lemma_12=,	pos_3=NNS	pos_12=,	lemma_10=salicylate	relType_17=compound	pos_13=NN	lemma_5=be	lemma_15=monoamine	lpib=other_JJ	relType_15=compound	lemma_12=chloramphenicol	pos_10=,	pos_14=NNS	relType_16=cc	pos_13=,	pos_8=VBN	pos_16=CC	pos_4=WDT	path2=bind_dep>agent_conj	relType_10=conj	path1=agent_nmod<drug_obl	relType_12=punct	relType_13=conj	lemma_14=coumarin	lemma_15=inhibitor	lemma_8=bind	relType_5=aux:pass	lemma_15=,	pos_6=RB	relType_17=amod	lemma_14=,	relType_7=dep	lemma_13=probenecid	pos_9=,	pos_7=NN	lemma_1=and	lemma_11=sulfonamide	relType_4=dep	relType_14=punct	relType_10=punct	relType_8=dep	lemma_11=,	relType_11=conj	pos_17=NN	pos_5=VBP	pos_15=,	pos_14=,	lemma_2=other	relType_11=punct	lemma_15=oxidase	relType_15=punct	relType_3=conj	relType_2=amod	relType_17=obl:npmod	lemma_4=that	relType_15=conj	lemma_7=protein	relType_14=conj	pos_1=CC	relType_12=conj	lib=other	relType_13=punct	path=agent_nmod<drug_obl<potentiate_ROOT>bind_dep>agent_conj	pos_17=JJ	lemma_17=blocking	pos_11=NNS	wib=other	pos_15=NN	lemma_17=adrenergic	lemma_16=and	pos_11=,	relType_9=punct	pos_15=NNS	lemma_17=beta	eib=True	lemma_6=highly	pos_12=NN	relType_6=advmod	pos_10=NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e3	null	path1=salicylate_conj	lemma_1=,	eib=False	path2=sulfonamide_conj	lib=sulfonamide	pos_1=,	wib=sulfonamides	relType_1=punct	lpib=sulfonamide_NNS	path=salicylate_conj<bind_dep>sulfonamide_conj
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e4	null	pos_2=NNS	lemma_2=sulfonamide	path1=salicylate_conj	lemma_1=,	relType_2=punct	eib=True	path2=chloramphenicol_conj	lib=sulfonamide	pos_1=,	path=salicylate_conj<bind_dep>chloramphenicol_conj	pos_2=,	wib=sulfonamides	relType_1=punct	relType_2=conj	lemma_2=,	lpib=sulfonamide_NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e5	null	lemma_1=,	lib=sulfonamide	path=salicylate_conj<bind_dep>probenecid_conj	pos_1=,	relType_2=punct	lemma_2=sulfonamide	path1=salicylate_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=sulfonamides	pos_2=NNS	path2=probenecid_conj	pos_3=,	eib=True	lemma_3=chloramphenicol	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=sulfonamide_NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e6	null	lemma_1=,	lib=sulfonamide	pos_1=,	relType_2=punct	lemma_2=sulfonamide	path1=salicylate_conj	pos_4=,	lemma_4=probenecid	path2=coumarin_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	wib=sulfonamides	pos_2=NNS	pos_3=,	eib=True	lemma_3=chloramphenicol	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	path=salicylate_conj<bind_dep>coumarin_conj	relType_3=punct	lpib=sulfonamide_NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e7	null	lemma_1=,	path=salicylate_conj<bind_dep>inhibitor_conj	pos_5=,	lib=sulfonamide	pos_1=,	lemma_6=oxidase	relType_2=punct	pos_6=NN	lemma_2=sulfonamide	path1=salicylate_conj	lemma_6=monoamine	pos_4=,	pos_5=NNS	lemma_4=probenecid	relType_2=conj	pos_4=NN	lemma_2=,	lemma_5=coumarin	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	wib=sulfonamides	relType_5=conj	pos_2=NNS	relType_6=compound	pos_3=,	eib=True	lemma_3=chloramphenicol	pos_3=NN	pos_2=,	path2=inhibitor_conj	relType_4=conj	relType_1=punct	relType_3=punct	lpib=sulfonamide_NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e2	DDI-DrugBank.d245.s0.e8	null	lemma_1=,	relType_8=amod	path2=agent_conj	pos_5=,	lib=sulfonamide	pos_1=,	lemma_6=,	relType_7=cc	lemma_6=inhibitor	lemma_6=oxidase	relType_2=punct	pos_6=NN	lemma_2=sulfonamide	path1=salicylate_conj	lemma_6=monoamine	relType_6=conj	pos_8=NN	pos_8=JJ	pos_4=,	pos_5=NNS	relType_6=punct	lemma_4=probenecid	relType_2=conj	pos_4=NN	lemma_2=,	lemma_8=beta	path=salicylate_conj<bind_dep>agent_conj	lemma_5=coumarin	lemma_8=blocking	relType_4=punct	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lemma_4=,	wib=sulfonamides	relType_5=conj	pos_6=,	pos_2=NNS	relType_6=compound	pos_3=,	eib=True	lemma_3=chloramphenicol	pos_3=NN	lemma_7=and	pos_6=NNS	lemma_8=adrenergic	pos_2=,	relType_4=conj	relType_1=punct	relType_8=obl:npmod	relType_3=punct	lpib=sulfonamide_NNS
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e3	DDI-DrugBank.d245.s0.e4	null	wib=chloramphenicol	lemma_1=,	eib=False	lpib=chloramphenicol_NN	path2=chloramphenicol_conj	pos_1=,	path=sulfonamide_conj<bind_dep>chloramphenicol_conj	path1=sulfonamide_conj	relType_1=punct	lib=chloramphenicol
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e3	DDI-DrugBank.d245.s0.e5	null	wib=chloramphenicol	path2=probenecid_conj	lemma_1=,	pos_2=NN	relType_2=punct	eib=True	lpib=chloramphenicol_NN	pos_1=,	lemma_2=chloramphenicol	path=sulfonamide_conj<bind_dep>probenecid_conj	pos_2=,	path1=sulfonamide_conj	relType_1=punct	relType_2=conj	lemma_2=,	lib=chloramphenicol
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e3	DDI-DrugBank.d245.s0.e6	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=chloramphenicol	relType_2=punct	path=sulfonamide_conj<bind_dep>coumarin_conj	path2=coumarin_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_3=probenecid	lib=chloramphenicol	wib=chloramphenicol	pos_3=,	eib=True	lpib=chloramphenicol_NN	pos_3=NN	pos_2=,	path1=sulfonamide_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e3	DDI-DrugBank.d245.s0.e7	null	path=sulfonamide_conj<bind_dep>inhibitor_conj	lemma_1=,	lemma_5=oxidase	pos_2=NN	pos_1=,	lemma_2=chloramphenicol	relType_5=compound	relType_2=punct	pos_4=,	lemma_5=monoamine	relType_2=conj	lemma_2=,	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=coumarin	lemma_4=,	lemma_3=probenecid	lib=chloramphenicol	pos_5=NN	wib=chloramphenicol	pos_3=,	eib=True	lpib=chloramphenicol_NN	pos_3=NN	pos_2=,	path2=inhibitor_conj	path1=sulfonamide_conj	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e3	DDI-DrugBank.d245.s0.e8	null	relType_7=compound	lemma_1=,	lemma_5=oxidase	pos_2=NN	path2=agent_conj	pos_5=,	lemma_7=adrenergic	lemma_5=inhibitor	pos_1=,	lemma_2=chloramphenicol	relType_5=compound	relType_2=punct	pos_4=,	lemma_5=monoamine	pos_5=NNS	relType_2=conj	lemma_2=,	pos_4=NNS	relType_7=amod	path=sulfonamide_conj<bind_dep>agent_conj	lemma_3=,	relType_4=punct	relType_3=conj	lemma_4=coumarin	lemma_5=,	relType_5=punct	pos_6=CC	lemma_6=and	lemma_4=,	lemma_3=probenecid	relType_5=conj	lib=chloramphenicol	relType_7=obl:npmod	pos_5=NN	wib=chloramphenicol	pos_3=,	lemma_7=blocking	eib=True	lpib=chloramphenicol_NN	pos_3=NN	lemma_7=beta	pos_7=JJ	pos_2=,	relType_4=conj	path1=sulfonamide_conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_6=cc
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e4	DDI-DrugBank.d245.s0.e5	null	path2=probenecid_conj	lemma_1=,	eib=False	lib=probenecid	pos_1=,	path=chloramphenicol_conj<bind_dep>probenecid_conj	lpib=probenecid_NN	relType_1=punct	wib=probenecid	path1=chloramphenicol_conj
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e4	DDI-DrugBank.d245.s0.e6	null	lemma_2=probenecid	lemma_1=,	pos_2=NN	path=chloramphenicol_conj<bind_dep>coumarin_conj	eib=True	lib=probenecid	pos_1=,	pos_2=,	relType_2=conj	lpib=probenecid_NN	path2=coumarin_conj	relType_1=punct	wib=probenecid	lemma_2=,	path1=chloramphenicol_conj	relType_2=punct
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e4	DDI-DrugBank.d245.s0.e7	null	lemma_1=,	pos_2=NN	lib=probenecid	pos_1=,	wib=probenecid	lemma_3=coumarin	relType_2=punct	lemma_4=monoamine	path=chloramphenicol_conj<bind_dep>inhibitor_conj	pos_3=NNS	lpib=probenecid_NN	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=probenecid	lemma_3=,	relType_3=conj	relType_4=compound	path1=chloramphenicol_conj	lemma_4=oxidase	pos_3=,	eib=True	pos_2=,	path2=inhibitor_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e4	DDI-DrugBank.d245.s0.e8	null	lemma_1=,	pos_2=NN	path=chloramphenicol_conj<bind_dep>agent_conj	pos_5=CC	pos_6=JJ	path2=agent_conj	lib=probenecid	pos_1=,	wib=probenecid	lemma_3=coumarin	relType_2=punct	lemma_4=monoamine	pos_6=NN	relType_5=cc	pos_3=NNS	pos_4=,	relType_6=amod	lemma_6=beta	lpib=probenecid_NN	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_2=probenecid	lemma_6=adrenergic	relType_4=punct	lemma_3=,	relType_3=conj	relType_4=compound	relType_6=obl:npmod	lemma_4=,	path1=chloramphenicol_conj	lemma_4=oxidase	relType_6=compound	pos_3=,	eib=True	lemma_5=and	lemma_4=inhibitor	pos_2=,	relType_4=conj	relType_1=punct	lemma_6=blocking	relType_3=punct
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e5	DDI-DrugBank.d245.s0.e6	null	lib=coumarin	lemma_1=,	path=probenecid_conj<bind_dep>coumarin_conj	eib=False	path1=probenecid_conj	pos_1=,	lpib=coumarin_NNS	path2=coumarin_conj	relType_1=punct	wib=coumarins
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e5	DDI-DrugBank.d245.s0.e7	null	lib=coumarin	lemma_1=,	lemma_2=coumarin	pos_1=,	relType_2=punct	lemma_3=oxidase	lpib=coumarin_NNS	relType_2=conj	lemma_2=,	path1=probenecid_conj	pos_2=NNS	eib=True	pos_3=NN	pos_2=,	path2=inhibitor_conj	relType_3=compound	relType_1=punct	path=probenecid_conj<bind_dep>inhibitor_conj	lemma_3=monoamine	wib=coumarins
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e5	DDI-DrugBank.d245.s0.e8	null	lib=coumarin	relType_5=obl:npmod	lemma_1=,	lemma_5=beta	path2=agent_conj	lemma_2=coumarin	pos_1=,	relType_5=compound	relType_4=cc	relType_2=punct	lemma_3=oxidase	pos_3=NNS	lpib=coumarin_NNS	lemma_5=blocking	relType_2=conj	lemma_3=inhibitor	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	path=probenecid_conj<bind_dep>agent_conj	relType_3=conj	path1=probenecid_conj	lemma_5=adrenergic	pos_2=NNS	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_3=compound	relType_1=punct	relType_3=punct	lemma_3=monoamine	wib=coumarins
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e6	DDI-DrugBank.d245.s0.e7	null	wib=monoamine	path=coumarin_conj<bind_dep>inhibitor_conj	lemma_1=,	pos_2=NN	eib=True	path1=coumarin_conj	relType_2=compound	lemma_2=oxidase	lib=monoamine	pos_1=,	path2=inhibitor_conj	relType_1=punct	lemma_2=monoamine	lpib=monoamine_NN
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e6	DDI-DrugBank.d245.s0.e8	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	relType_4=obl:npmod	pos_3=CC	path2=agent_conj	path=coumarin_conj<bind_dep>agent_conj	pos_1=,	lemma_2=monoamine	relType_2=punct	lemma_2=inhibitor	wib=monoamine	relType_3=cc	lemma_4=adrenergic	lemma_4=blocking	relType_2=conj	pos_4=NN	lemma_2=,	path1=coumarin_conj	relType_2=compound	lemma_2=oxidase	lib=monoamine	lemma_4=beta	relType_4=compound	pos_2=NNS	eib=True	pos_2=,	lemma_3=and	relType_1=punct	lpib=monoamine_NN
DDI-DrugBank.d245.s0	DDI-DrugBank.d245.s0.e7	DDI-DrugBank.d245.s0.e8	null	lemma_1=,	path2=agent_conj	pos_1=,	relType_3=obl:npmod	relType_2=cc	lemma_2=and	lemma_3=adrenergic	lemma_3=beta	path1=inhibitor_conj	relType_3=amod	wib=beta	path=inhibitor_conj<bind_dep>agent_conj	pos_3=JJ	eib=True	pos_3=NN	pos_2=CC	lemma_3=blocking	relType_3=compound	relType_1=punct	lib=beta	lpib=beta_NN
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e1	null	relType_1=cc	pos_1=CC	lib=other	eib=False	lpib=other_JJ	path2=diuretic_conj	lemma_2=other	relType_2=amod	path1=	wib=other	path=<thiazide_obj>diuretic_conj	pos_2=JJ	lemma_1=and
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e2	null	relType_1=cc	pos_1=CC	lib=other	path1=	pos_2=JJ	lemma_3=diuretic	path=<thiazide_obj>corticosteroid_conj	pos_3=NNS	lemma_2=other	wib=other	lemma_3=,	relType_3=conj	lpib=other_JJ	relType_2=amod	path2=corticosteroid_conj	pos_3=,	eib=True	relType_3=punct	lemma_1=and
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e3	null	relType_1=cc	lemma_4=corticosteroid	pos_1=CC	lib=other	path1=	pos_2=JJ	lemma_3=diuretic	path2=phenothiazine_conj	pos_3=NNS	pos_4=,	lemma_2=other	wib=other	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lpib=other_JJ	relType_2=amod	lemma_4=,	pos_3=,	eib=True	relType_4=conj	relType_3=punct	lemma_1=and	path=<thiazide_obj>phenothiazine_conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e4	null	relType_1=cc	pos_7=NNS	lemma_4=corticosteroid	pos_1=CC	lib=other	path2=estrogen_conj	pos_5=,	path1=	path=<thiazide_obj>estrogen_conj	lemma_7=product	relType_8=punct	pos_2=JJ	lemma_8=,	lemma_3=diuretic	pos_6=NN	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=other	wib=other	lemma_5=phenothiazine	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_2=amod	lemma_4=,	relType_5=conj	relType_6=compound	pos_3=,	eib=True	pos_8=,	relType_4=conj	lemma_6=thyroid	relType_3=punct	lemma_1=and	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e5	null	relType_1=cc	pos_7=NNS	lemma_4=corticosteroid	pos_1=CC	relType_9=conj	lib=other	pos_5=,	relType_10=amod	path1=	lemma_7=product	relType_8=punct	path=<thiazide_obj>contraceptive_conj	lemma_9=,	pos_2=JJ	lemma_8=,	lemma_3=diuretic	pos_6=NN	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=other	pos_9=NNS	wib=other	lemma_9=estrogen	lemma_5=phenothiazine	path2=contraceptive_conj	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_2=amod	pos_10=JJ	lemma_4=,	relType_5=conj	relType_9=punct	relType_6=compound	pos_3=,	eib=True	pos_8=,	relType_4=conj	lemma_10=oral	pos_9=,	lemma_6=thyroid	relType_3=punct	lemma_1=and	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e6	null	relType_1=cc	pos_7=NNS	lemma_4=corticosteroid	pos_1=CC	relType_9=conj	lib=other	lemma_11=,	pos_5=,	relType_10=amod	path1=	lemma_7=product	lemma_11=contraceptive	relType_8=punct	lemma_9=,	pos_2=JJ	lemma_8=,	relType_11=conj	lemma_3=diuretic	pos_6=NN	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_2=other	relType_11=punct	pos_9=NNS	pos_11=NNS	wib=other	lemma_9=estrogen	lemma_5=phenothiazine	path2=phenytoin_conj	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_2=amod	pos_10=JJ	lemma_4=,	relType_5=conj	pos_11=,	path=<thiazide_obj>phenytoin_conj	relType_9=punct	relType_6=compound	pos_3=,	eib=True	pos_8=,	relType_4=conj	lemma_10=oral	pos_9=,	lemma_6=thyroid	relType_3=punct	lemma_1=and	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e7	null	relType_1=cc	pos_7=NNS	lemma_4=corticosteroid	pos_1=CC	relType_12=conj	lemma_13=nicotinic	relType_9=conj	lib=other	lemma_11=,	pos_5=,	relType_10=amod	path1=	lemma_7=product	lemma_11=contraceptive	relType_8=punct	lemma_9=,	pos_2=JJ	lemma_8=,	relType_11=conj	lemma_3=diuretic	pos_6=NN	lemma_12=phenytoin	lemma_12=,	pos_3=NNS	pos_4=,	pos_5=NNS	relType_13=amod	lemma_2=other	relType_11=punct	pos_9=NNS	pos_11=NNS	pos_12=,	wib=other	lemma_9=estrogen	relType_12=punct	lemma_5=phenothiazine	pos_4=NNS	relType_4=punct	lemma_3=,	pos_13=JJ	relType_3=conj	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_2=amod	pos_10=JJ	path2=acid_conj	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	relType_6=compound	path=<thiazide_obj>acid_conj	pos_3=,	eib=True	pos_8=,	relType_4=conj	lemma_10=oral	pos_9=,	pos_12=NN	lemma_6=thyroid	relType_3=punct	lemma_1=and	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e8	null	relType_1=cc	pos_7=NNS	lemma_4=corticosteroid	pos_1=CC	relType_12=conj	lemma_13=nicotinic	pos_13=,	relType_9=conj	lib=other	lemma_11=,	lemma_13=,	pos_5=,	relType_10=amod	path1=	relType_13=punct	lemma_7=product	lemma_11=contraceptive	relType_8=punct	lemma_9=,	pos_2=JJ	lemma_8=,	relType_11=conj	lemma_3=diuretic	pos_6=NN	lemma_12=phenytoin	lemma_12=,	pos_3=NNS	pos_4=,	pos_5=NNS	relType_13=amod	lemma_2=other	relType_11=punct	pos_9=NNS	pos_11=NNS	pos_12=,	wib=other	lemma_9=estrogen	relType_12=punct	lemma_5=phenothiazine	pos_13=NN	relType_13=conj	lemma_13=acid	pos_4=NNS	relType_4=punct	lemma_3=,	pos_13=JJ	relType_3=conj	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_2=amod	pos_10=JJ	path=<thiazide_obj>sympathomimetic_conj	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	relType_6=compound	path2=sympathomimetic_conj	pos_3=,	eib=True	pos_8=,	relType_4=conj	lemma_10=oral	pos_9=,	pos_12=NN	lemma_6=thyroid	relType_3=punct	lemma_1=and	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e0	DDI-DrugBank.d245.s4.e10	null	relType_1=cc	lemma_4=corticosteroid	lemma_13=,	pos_5=,	lemma_11=contraceptive	relType_8=punct	lemma_9=,	pos_2=JJ	pos_6=NN	lemma_12=,	pos_3=NNS	pos_12=,	pos_13=NN	lemma_13=acid	relType_4=punct	lemma_3=,	lpib=other_JJ	lemma_5=,	pos_15=VBG	lemma_14=sympathomimetic	relType_15=acl	relType_15=compound	relType_6=compound	pos_3=,	pos_14=NNS	pos_7=NNS	relType_16=cc	pos_13=,	path1=	pos_16=CC	lemma_12=phenytoin	relType_13=amod	lemma_9=estrogen	relType_12=punct	relType_13=conj	lemma_15=drug	lemma_15=,	lemma_4=,	path2=isoniazid_conj	lemma_14=,	relation_25=adverse	pos_9=,	relType_3=punct	lemma_1=and	pos_8=,	lemma_13=nicotinic	relType_14=punct	lemma_15=block	lemma_11=,	lemma_7=product	lemma_15=calcium	lemma_8=,	relType_11=conj	pos_4=,	pos_15=,	pos_14=,	lemma_2=other	relType_11=punct	relType_15=punct	pos_13=JJ	relType_3=conj	lemma_15=channel	relType_2=amod	relType_5=conj	relType_15=obj	path=<thiazide_obj>isoniazid_conj	relType_15=conj	lemma_10=oral	relType_14=conj	relType_7=conj	pos_1=CC	relType_12=conj	relType_9=conj	lib=other	relType_10=amod	relType_13=punct	lemma_3=diuretic	pos_5=NNS	pos_9=NNS	pos_11=NNS	wib=other	lemma_5=phenothiazine	pos_4=NNS	pos_15=NN	pos_10=JJ	relType_5=punct	lemma_16=and	pos_11=,	relType_9=punct	pos_15=NNS	eib=True	relType_4=conj	pos_12=NN	lemma_6=thyroid
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e2	null	lemma_1=,	eib=False	path1=diuretic_conj	pos_1=,	path=diuretic_conj<thiazide_obj>corticosteroid_conj	wib=corticosteroids	path2=corticosteroid_conj	relType_1=punct	lib=corticosteroid	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e3	null	pos_2=NNS	lemma_1=,	eib=True	path1=diuretic_conj	pos_1=,	lemma_2=corticosteroid	wib=corticosteroids	pos_2=,	relType_1=punct	path=diuretic_conj<thiazide_obj>phenothiazine_conj	relType_2=conj	lemma_2=,	path2=phenothiazine_conj	lib=corticosteroid	relType_2=punct	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e4	null	lemma_1=,	path2=estrogen_conj	pos_1=,	lemma_6=,	path=diuretic_conj<thiazide_obj>estrogen_conj	relType_2=punct	pos_3=NNS	lemma_5=product	pos_5=NNS	relType_6=punct	lemma_2=corticosteroid	lemma_4=thyroid	relType_2=conj	pos_4=NN	lemma_2=,	lemma_3=phenothiazine	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_4=compound	wib=corticosteroids	relType_5=conj	pos_6=,	lib=corticosteroid	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e5	null	pos_7=NNS	lemma_1=,	relType_8=amod	pos_1=,	lemma_6=,	relType_2=punct	pos_8=JJ	pos_3=NNS	lemma_5=product	pos_5=NNS	relType_6=punct	lemma_7=estrogen	lemma_2=corticosteroid	pos_7=,	path2=contraceptive_conj	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=thyroid	lemma_7=,	lemma_8=oral	lemma_3=phenothiazine	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_4=compound	wib=corticosteroids	relType_5=conj	pos_6=,	lib=corticosteroid	pos_2=NNS	pos_3=,	eib=True	relType_7=punct	path=diuretic_conj<thiazide_obj>contraceptive_conj	pos_2=,	relType_1=punct	relType_3=punct	relType_7=conj	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e6	null	pos_7=NNS	lemma_1=,	relType_9=conj	relType_8=amod	pos_1=,	lemma_6=,	path=diuretic_conj<thiazide_obj>phenytoin_conj	lemma_9=,	relType_2=punct	pos_8=JJ	pos_3=NNS	lemma_5=product	pos_5=NNS	relType_6=punct	lemma_7=estrogen	lemma_2=corticosteroid	pos_9=NNS	pos_7=,	lemma_4=thyroid	relType_2=conj	pos_4=NN	lemma_2=,	path2=phenytoin_conj	lemma_7=,	lemma_8=oral	lemma_3=phenothiazine	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_4=compound	wib=corticosteroids	relType_5=conj	relType_9=punct	pos_6=,	lib=corticosteroid	pos_2=NNS	pos_3=,	eib=True	relType_7=punct	pos_2=,	lemma_9=contraceptive	pos_9=,	relType_1=punct	relType_3=punct	relType_7=conj	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e7	null	pos_7=NNS	lemma_1=,	relType_10=punct	path=diuretic_conj<thiazide_obj>acid_conj	relType_9=conj	relType_8=amod	lemma_10=,	pos_1=,	lemma_6=,	lemma_9=,	relType_2=punct	pos_8=JJ	pos_3=NNS	lemma_5=product	relType_10=conj	pos_5=NNS	relType_6=punct	lemma_7=estrogen	relType_11=amod	lemma_2=corticosteroid	pos_9=NNS	pos_7=,	lemma_11=nicotinic	pos_10=NN	lemma_4=thyroid	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=,	lemma_8=oral	lemma_3=phenothiazine	lemma_10=phenytoin	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_4=compound	path2=acid_conj	wib=corticosteroids	relType_5=conj	relType_9=punct	pos_6=,	lib=corticosteroid	pos_2=NNS	pos_3=,	pos_10=,	eib=True	relType_7=punct	pos_2=,	lemma_9=contraceptive	pos_11=JJ	pos_9=,	relType_1=punct	relType_3=punct	relType_7=conj	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e8	null	pos_7=NNS	lemma_11=acid	lemma_1=,	relType_10=punct	relType_9=conj	lemma_11=,	relType_8=amod	lemma_10=,	pos_1=,	lemma_6=,	lemma_9=,	relType_11=conj	relType_2=punct	pos_8=JJ	pos_3=NNS	lemma_5=product	relType_10=conj	pos_5=NNS	relType_6=punct	lemma_7=estrogen	relType_11=amod	lemma_2=corticosteroid	pos_9=NNS	pos_7=,	lemma_11=nicotinic	relType_11=punct	pos_10=NN	lemma_4=thyroid	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=,	lemma_8=oral	lemma_3=phenothiazine	lemma_10=phenytoin	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_4=compound	wib=corticosteroids	relType_5=conj	pos_11=,	relType_9=punct	pos_6=,	lib=corticosteroid	path=diuretic_conj<thiazide_obj>sympathomimetic_conj	pos_2=NNS	path2=sympathomimetic_conj	pos_11=NN	pos_3=,	pos_10=,	eib=True	relType_7=punct	pos_2=,	lemma_9=contraceptive	pos_11=JJ	pos_9=,	relType_1=punct	relType_3=punct	relType_7=conj	lpib=corticosteroid_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e1	DDI-DrugBank.d245.s4.e10	null	pos_13=VBG	pos_14=CC	lemma_13=,	lemma_10=,	pos_13=NNS	lemma_6=,	lemma_9=,	pos_8=JJ	lemma_12=,	pos_3=NNS	lemma_2=corticosteroid	pos_12=,	lemma_11=nicotinic	pos_10=NN	lemma_7=,	pos_13=NN	lemma_3=,	wib=corticosteroids	lib=corticosteroid	pos_3=,	pos_10=,	pos_2=,	pos_11=JJ	lpib=corticosteroid_NNS	pos_7=NNS	pos_13=,	lemma_1=,	relation_22=adverse	pos_1=,	lemma_13=drug	lemma_12=sympathomimetic	relType_2=punct	relType_10=conj	relType_11=amod	path=diuretic_conj<thiazide_obj>isoniazid_conj	relType_12=punct	relType_13=conj	lemma_4=thyroid	relType_2=conj	lemma_2=,	lemma_8=oral	lemma_10=phenytoin	path1=diuretic_conj	path2=isoniazid_conj	pos_11=NN	lemma_14=and	pos_9=,	relType_1=punct	relType_3=punct	relType_10=punct	lemma_11=,	relType_11=conj	lemma_5=product	relType_11=punct	pos_7=,	relType_3=conj	relType_5=conj	lemma_9=contraceptive	relType_13=acl	lemma_11=acid	relType_7=conj	relType_12=conj	relType_9=conj	lemma_13=calcium	relType_8=amod	lemma_13=block	relType_13=punct	lemma_13=channel	pos_5=NNS	relType_6=punct	lemma_7=estrogen	pos_9=NNS	pos_4=NN	lemma_3=phenothiazine	relType_13=compound	pos_12=NNS	relType_4=compound	relType_14=cc	pos_11=,	relType_9=punct	pos_6=,	pos_2=NNS	eib=True	relType_7=punct	relType_13=obj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e3	null	lemma_1=,	lib=phenothiazine	eib=False	path1=corticosteroid_conj	path=corticosteroid_conj<thiazide_obj>phenothiazine_conj	pos_1=,	wib=phenothiazines	relType_1=punct	path2=phenothiazine_conj	lpib=phenothiazine_NNS
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e4	null	lemma_1=,	lemma_2=phenothiazine	path2=estrogen_conj	pos_5=,	pos_1=,	wib=phenothiazines	lemma_4=product	relType_2=punct	path1=corticosteroid_conj	path=corticosteroid_conj<thiazide_obj>estrogen_conj	lemma_3=thyroid	relType_2=conj	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	lemma_5=,	relType_5=punct	pos_2=NNS	lib=phenothiazine	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e5	null	lemma_1=,	lemma_2=phenothiazine	pos_5=,	pos_1=,	wib=phenothiazines	lemma_4=product	lemma_6=,	lemma_7=oral	path=corticosteroid_conj<thiazide_obj>contraceptive_conj	relType_2=punct	relType_6=conj	path1=corticosteroid_conj	relType_6=punct	lemma_3=thyroid	path2=contraceptive_conj	relType_2=conj	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_7=amod	lemma_5=,	relType_5=punct	lemma_6=estrogen	pos_6=,	pos_2=NNS	lib=phenothiazine	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e6	null	lemma_1=,	lemma_2=phenothiazine	pos_5=,	pos_1=,	wib=phenothiazines	lemma_4=product	lemma_6=,	lemma_7=oral	relType_8=punct	lemma_8=,	pos_8=NNS	relType_2=punct	lemma_8=contraceptive	relType_6=conj	path1=corticosteroid_conj	relType_6=punct	lemma_3=thyroid	relType_2=conj	lemma_2=,	path2=phenytoin_conj	pos_4=NNS	lpib=phenothiazine_NNS	relType_7=amod	lemma_5=,	relType_5=punct	lemma_6=estrogen	pos_6=,	pos_2=NNS	lib=phenothiazine	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	path=corticosteroid_conj<thiazide_obj>phenytoin_conj	pos_8=,
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e7	null	lemma_1=,	relType_9=conj	lemma_2=phenothiazine	pos_5=,	relType_10=amod	pos_1=,	wib=phenothiazines	lemma_4=product	lemma_6=,	lemma_7=oral	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NNS	relType_2=punct	lemma_8=contraceptive	relType_6=conj	path1=corticosteroid_conj	relType_6=punct	lemma_3=thyroid	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_7=amod	lemma_5=,	relType_5=punct	pos_10=JJ	path2=acid_conj	lemma_10=nicotinic	lemma_6=estrogen	lemma_9=phenytoin	relType_9=punct	pos_6=,	pos_2=NNS	lib=phenothiazine	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_2=,	relType_3=compound	relType_4=conj	pos_9=,	path=corticosteroid_conj<thiazide_obj>acid_conj	relType_1=punct	pos_8=,
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e8	null	lemma_1=,	relType_10=punct	relType_9=conj	lemma_2=phenothiazine	pos_5=,	lemma_10=,	relType_10=amod	pos_1=,	wib=phenothiazines	lemma_4=product	lemma_6=,	lemma_7=oral	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NNS	relType_2=punct	lemma_8=contraceptive	lemma_10=acid	relType_6=conj	path1=corticosteroid_conj	relType_10=conj	relType_6=punct	lemma_3=thyroid	pos_10=NN	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_7=amod	lemma_5=,	relType_5=punct	pos_10=JJ	lemma_10=nicotinic	lemma_6=estrogen	lemma_9=phenytoin	relType_9=punct	pos_6=,	pos_2=NNS	path2=sympathomimetic_conj	lib=phenothiazine	pos_10=,	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_2=,	path=corticosteroid_conj<thiazide_obj>sympathomimetic_conj	relType_3=compound	relType_4=conj	pos_9=,	relType_1=punct	pos_8=,
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e2	DDI-DrugBank.d245.s4.e10	null	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=conj	relType_12=compound	lemma_3=thyroid	pos_12=,	lemma_13=and	pos_10=NN	lemma_5=,	pos_10=,	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_2=,	relType_12=acl	relation_20=adverse	lemma_1=,	lemma_2=phenothiazine	pos_1=,	wib=phenothiazines	lemma_4=product	lemma_12=block	relType_2=punct	lemma_10=acid	path=corticosteroid_conj<thiazide_obj>isoniazid_conj	relType_10=conj	lemma_12=calcium	relType_12=punct	relType_2=conj	pos_9=NN	lemma_2=,	lpib=phenothiazine_NNS	relType_13=cc	lemma_12=drug	lemma_10=nicotinic	path2=isoniazid_conj	lemma_11=sympathomimetic	relType_3=compound	pos_9=,	relType_1=punct	pos_8=,	relType_10=punct	pos_12=VBG	lemma_11=,	lemma_7=oral	lemma_8=,	relType_11=conj	lemma_8=contraceptive	relType_11=punct	lemma_12=channel	relType_7=amod	pos_13=CC	relType_12=conj	relType_9=conj	relType_10=amod	path1=corticosteroid_conj	relType_6=punct	pos_11=NNS	relType_12=obj	pos_4=NNS	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_11=,	lemma_6=estrogen	lemma_9=phenytoin	relType_9=punct	pos_6=,	pos_2=NNS	lib=phenothiazine	eib=True	pos_3=NN	relType_4=conj	pos_12=NN
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e4	null	lemma_1=,	wib=thyroid	path=phenothiazine_conj<thiazide_obj>estrogen_conj	pos_2=NN	path2=estrogen_conj	pos_1=,	lpib=thyroid_NN	pos_3=NNS	pos_4=,	eib=False	relType_4=punct	relType_3=conj	relType_2=compound	lemma_2=thyroid	lemma_4=,	lemma_3=product	relType_1=punct	lib=thyroid	path1=phenothiazine_conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e5	null	lemma_1=,	wib=thyroid	pos_2=NN	pos_6=JJ	pos_5=,	pos_1=,	lpib=thyroid_NN	path=phenothiazine_conj<thiazide_obj>contraceptive_conj	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=amod	path2=contraceptive_conj	lemma_6=oral	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=thyroid	lemma_4=,	relType_5=conj	eib=True	lemma_3=product	relType_1=punct	lib=thyroid	path1=phenothiazine_conj	lemma_5=estrogen
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e6	null	pos_7=NNS	lemma_1=,	wib=thyroid	pos_2=NN	pos_6=JJ	pos_5=,	lemma_7=contraceptive	pos_1=,	lpib=thyroid_NN	path=phenothiazine_conj<thiazide_obj>phenytoin_conj	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=amod	pos_7=,	lemma_7=,	path2=phenytoin_conj	lemma_6=oral	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=thyroid	lemma_4=,	relType_5=conj	eib=True	lemma_3=product	relType_7=punct	relType_1=punct	lib=thyroid	path1=phenothiazine_conj	relType_7=conj	lemma_5=estrogen
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e7	null	path=phenothiazine_conj<thiazide_obj>acid_conj	pos_7=NNS	lemma_1=,	wib=thyroid	pos_2=NN	pos_6=JJ	pos_5=,	lemma_7=contraceptive	pos_1=,	relType_8=punct	lpib=thyroid_NN	lemma_8=,	pos_8=NN	pos_9=JJ	pos_3=NNS	pos_4=,	pos_5=NNS	relType_6=amod	pos_7=,	relType_9=amod	lemma_7=,	lemma_9=nicotinic	lemma_6=oral	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	path2=acid_conj	lemma_2=thyroid	lemma_4=,	relType_5=conj	eib=True	lemma_3=product	relType_7=punct	pos_8=,	relType_8=conj	lemma_8=phenytoin	relType_1=punct	lib=thyroid	path1=phenothiazine_conj	relType_7=conj	lemma_5=estrogen
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e8	null	pos_7=NNS	lemma_1=,	wib=thyroid	pos_2=NN	pos_6=JJ	relType_9=conj	pos_5=,	lemma_7=contraceptive	pos_1=,	relType_8=punct	lemma_9=,	lpib=thyroid_NN	lemma_8=,	pos_8=NN	pos_9=JJ	pos_3=NNS	pos_4=,	lemma_9=acid	pos_5=NNS	relType_6=amod	pos_7=,	relType_9=amod	lemma_7=,	lemma_9=nicotinic	pos_9=NN	lemma_6=oral	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	path=phenothiazine_conj<thiazide_obj>sympathomimetic_conj	relType_5=punct	lemma_2=thyroid	lemma_4=,	relType_5=conj	relType_9=punct	path2=sympathomimetic_conj	eib=True	lemma_3=product	relType_7=punct	pos_8=,	relType_8=conj	lemma_8=phenytoin	pos_9=,	relType_1=punct	lib=thyroid	path1=phenothiazine_conj	relType_7=conj	lemma_5=estrogen
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e3	DDI-DrugBank.d245.s4.e10	null	pos_7=NNS	lemma_1=,	relType_10=punct	wib=thyroid	pos_2=NN	pos_6=JJ	relType_9=conj	lemma_11=,	pos_5=,	lemma_10=,	lemma_7=contraceptive	pos_1=,	lemma_11=calcium	relType_12=cc	relType_8=punct	lemma_11=drug	lemma_9=,	relType_11=obj	lpib=thyroid_NN	lemma_8=,	pos_12=CC	relType_11=conj	pos_8=NN	pos_9=JJ	lemma_11=block	pos_3=NNS	pos_4=,	lemma_10=sympathomimetic	lemma_9=acid	pos_5=NNS	relType_10=conj	relType_6=amod	lemma_11=channel	relType_11=punct	pos_11=NNS	pos_7=,	relType_9=amod	lemma_7=,	lemma_9=nicotinic	pos_9=NN	lemma_6=oral	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	pos_11=VBG	lemma_2=thyroid	lemma_4=,	relType_11=acl	relType_5=conj	pos_11=,	relType_9=punct	path2=isoniazid_conj	relation_18=adverse	pos_11=NN	pos_10=,	eib=True	relType_11=compound	lemma_3=product	relType_7=punct	pos_8=,	relType_8=conj	lemma_8=phenytoin	lemma_12=and	path=phenothiazine_conj<thiazide_obj>isoniazid_conj	pos_9=,	relType_1=punct	lib=thyroid	pos_10=NNS	path1=phenothiazine_conj	relType_7=conj	lemma_5=estrogen
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e4	DDI-DrugBank.d245.s4.e5	null	lemma_2=oral	lemma_1=,	lib=oral	path1=estrogen_conj	eib=False	wib=oral	relType_2=amod	pos_1=,	path=estrogen_conj<thiazide_obj>contraceptive_conj	relType_1=punct	lpib=oral_JJ	path2=contraceptive_conj	pos_2=JJ
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e4	DDI-DrugBank.d245.s4.e6	null	lemma_1=,	lib=oral	path1=estrogen_conj	pos_1=,	lemma_3=contraceptive	pos_2=JJ	pos_3=NNS	path=estrogen_conj<thiazide_obj>phenytoin_conj	path2=phenytoin_conj	lemma_2=oral	lemma_3=,	relType_3=conj	relType_2=amod	lpib=oral_JJ	pos_3=,	eib=True	wib=oral	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e4	DDI-DrugBank.d245.s4.e7	null	lemma_1=,	lib=oral	path1=estrogen_conj	lemma_4=phenytoin	pos_1=,	lemma_3=contraceptive	pos_2=JJ	pos_3=NNS	lemma_5=nicotinic	pos_4=,	path=estrogen_conj<thiazide_obj>acid_conj	pos_4=NN	lemma_2=oral	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	relType_2=amod	path2=acid_conj	lemma_4=,	lpib=oral_JJ	pos_3=,	eib=True	wib=oral	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e4	DDI-DrugBank.d245.s4.e8	null	lemma_1=,	lib=oral	path1=estrogen_conj	lemma_4=phenytoin	pos_5=,	pos_1=,	lemma_3=contraceptive	pos_2=JJ	pos_3=NNS	lemma_5=nicotinic	pos_4=,	pos_4=NN	lemma_2=oral	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_5=,	relType_5=punct	relType_2=amod	lemma_4=,	relType_5=conj	lpib=oral_JJ	pos_5=NN	path2=sympathomimetic_conj	pos_3=,	eib=True	wib=oral	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=acid	path=estrogen_conj<thiazide_obj>sympathomimetic_conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e4	DDI-DrugBank.d245.s4.e10	null	pos_7=NNS	path=estrogen_conj<thiazide_obj>isoniazid_conj	relType_7=compound	lemma_1=,	lib=oral	path1=estrogen_conj	lemma_4=phenytoin	pos_5=,	pos_1=,	lemma_6=,	pos_7=VBG	lemma_6=sympathomimetic	lemma_7=channel	relType_7=acl	lemma_3=contraceptive	pos_2=JJ	relType_6=conj	pos_3=NNS	lemma_5=nicotinic	pos_4=,	relType_6=punct	relType_7=obj	pos_7=,	pos_8=CC	lemma_7=,	pos_4=NN	relation_13=adverse	lemma_2=oral	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_5=,	relType_5=punct	lemma_7=calcium	relType_2=amod	lemma_4=,	relType_5=conj	lpib=oral_JJ	pos_6=,	lemma_7=block	lemma_8=and	path2=isoniazid_conj	pos_5=NN	pos_3=,	eib=True	wib=oral	relType_7=punct	pos_6=NNS	relType_4=conj	lemma_7=drug	relType_1=punct	pos_7=NN	relType_8=cc	relType_3=punct	lemma_5=acid	relType_7=conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e5	DDI-DrugBank.d245.s4.e6	null	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	path=contraceptive_conj<thiazide_obj>phenytoin_conj	pos_1=,	path2=phenytoin_conj	path1=contraceptive_conj	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e5	DDI-DrugBank.d245.s4.e7	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	lib=phenytoin	wib=phenytoin	lemma_2=phenytoin	lemma_3=nicotinic	relType_2=conj	lemma_2=,	relType_3=amod	path2=acid_conj	pos_3=JJ	eib=True	pos_2=,	path1=contraceptive_conj	relType_1=punct	lpib=phenytoin_NN	path=contraceptive_conj<thiazide_obj>acid_conj
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e5	DDI-DrugBank.d245.s4.e8	null	lemma_1=,	pos_2=NN	path=contraceptive_conj<thiazide_obj>sympathomimetic_conj	pos_1=,	relType_2=punct	lib=phenytoin	wib=phenytoin	lemma_2=phenytoin	lemma_3=nicotinic	lemma_3=acid	relType_2=conj	lemma_2=,	relType_3=amod	lemma_3=,	relType_3=conj	path2=sympathomimetic_conj	pos_3=JJ	pos_3=,	eib=True	pos_3=NN	pos_2=,	path1=contraceptive_conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e5	DDI-DrugBank.d245.s4.e10	null	lemma_1=,	pos_2=NN	lemma_5=channel	pos_5=,	pos_1=,	relType_5=compound	lemma_5=drug	relType_2=punct	lib=phenytoin	pos_4=,	wib=phenytoin	relType_5=acl	pos_5=NNS	lemma_5=block	lemma_2=phenytoin	lemma_3=nicotinic	lemma_3=acid	relType_2=conj	lemma_2=,	pos_4=NNS	path=contraceptive_conj<thiazide_obj>isoniazid_conj	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_6=CC	lemma_6=and	relation_10=adverse	lemma_4=,	lemma_4=sympathomimetic	relType_5=conj	path2=isoniazid_conj	pos_5=NN	pos_3=JJ	pos_3=,	eib=True	pos_5=VBG	pos_3=NN	relType_5=obj	pos_2=,	relType_4=conj	path1=contraceptive_conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN	lemma_5=calcium	relType_6=cc
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e6	DDI-DrugBank.d245.s4.e7	null	lemma_2=nicotinic	lemma_1=,	path=phenytoin_conj<thiazide_obj>acid_conj	eib=True	relType_2=amod	pos_1=,	path2=acid_conj	lib=nicotinic	relType_1=punct	path1=phenytoin_conj	wib=nicotinic	lpib=nicotinic_JJ	pos_2=JJ
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e6	DDI-DrugBank.d245.s4.e8	null	lemma_2=nicotinic	lemma_1=,	pos_2=NN	path=phenytoin_conj<thiazide_obj>sympathomimetic_conj	pos_1=,	pos_2=JJ	lpib=nicotinic_JJ	relType_2=punct	lib=nicotinic	relType_2=conj	path1=phenytoin_conj	lemma_2=,	relType_2=amod	wib=nicotinic	path2=sympathomimetic_conj	lemma_2=acid	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e6	DDI-DrugBank.d245.s4.e10	null	lemma_2=nicotinic	lemma_1=,	pos_2=NN	pos_5=CC	pos_1=,	lemma_4=channel	pos_2=JJ	lpib=nicotinic_JJ	relType_2=punct	relType_4=acl	relType_5=cc	pos_3=NNS	lemma_4=block	pos_4=,	relation_8=adverse	lib=nicotinic	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	pos_4=NNS	relType_4=obj	lemma_4=drug	relType_4=punct	lemma_3=,	lemma_3=sympathomimetic	relType_3=conj	relType_2=amod	relType_4=compound	lemma_4=,	pos_4=VBG	path=phenytoin_conj<thiazide_obj>isoniazid_conj	wib=nicotinic	path2=isoniazid_conj	pos_3=,	lemma_2=acid	eib=True	lemma_4=calcium	lemma_5=and	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e7	DDI-DrugBank.d245.s4.e8	null	path2=sympathomimetic_conj	lemma_1=,	lib=sympathomimetic	path=acid_conj<thiazide_obj>sympathomimetic_conj	lpib=sympathomimetic_NNS	eib=False	path1=acid_conj	pos_1=,	relType_1=punct	wib=sympathomimetics
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e7	DDI-DrugBank.d245.s4.e10	null	path=acid_conj<thiazide_obj>isoniazid_conj	lemma_1=,	lemma_3=drug	pos_1=,	relType_4=cc	relation_5=adverse	relType_2=punct	lemma_3=channel	lib=sympathomimetic	pos_3=NNS	lpib=sympathomimetic_NNS	relType_3=acl	lemma_2=sympathomimetic	lemma_3=calcium	pos_3=VBG	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path1=acid_conj	pos_2=NNS	path2=isoniazid_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_3=block	lemma_4=and	pos_2=,	relType_3=compound	relType_3=obj	relType_1=punct	wib=sympathomimetics	relType_3=punct
DDI-DrugBank.d245.s4	DDI-DrugBank.d245.s4.e8	DDI-DrugBank.d245.s4.e10	null	lemma_1=,	relType_2=obj	pos_2=NN	pos_3=CC	wib=calcium	pos_1=,	relType_2=punct	relType_3=cc	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_2=channel	relation_3=adverse	relType_2=compound	path1=sympathomimetic_conj	relType_2=acl	lemma_2=drug	path=sympathomimetic_conj<thiazide_obj>isoniazid_conj	path2=isoniazid_conj	pos_2=NNS	eib=True	lemma_2=block	lpib=calcium_NN	pos_2=,	lemma_3=and	relType_1=punct	lib=calcium	pos_2=VBG
DDI-DrugBank.d245.s7	DDI-DrugBank.d245.s7.e0	DDI-DrugBank.d245.s7.e1	effect	relType_1=aux	lemma_1=may	pos_3=VBN	relType_6=case	wib=be	eib=False	pos_6=IN	pos_2=VB	path2=therapy_obl>chlorpropamide_nmod	path=barbiturate_nmod<action_nsubj:pass<prolong_ccomp>therapy_obl>chlorpropamide_nmod	lib=be	lemma_5=therapy	pos_4=IN	relType_4=case	relType_2=aux:pass	lemma_6=with	relType_5=obl	pos_1=MD	lpib=be_VB	pos_5=NN	relType_3=ccomp	lemma_2=be	path1=barbiturate_nmod<action_nsubj:pass	lemma_4=by	lemma_3=prolong
DDI-DrugBank.d245.s7	DDI-DrugBank.d245.s7.e0	DDI-DrugBank.d245.s7.e2	null	relType_1=aux	lemma_1=may	pos_3=VBN	relType_6=case	wib=be	path=barbiturate_nmod<action_nsubj:pass<prolong_ccomp<suggest_advcl<employ_ROOT>barbiturate_nsubj:pass	pos_6=IN	pos_7=,	pos_2=VB	lemma_7=,	lib=be	lemma_5=therapy	pos_4=IN	path1=barbiturate_nmod<action_nsubj:pass<prolong_ccomp<suggest_advcl	relType_4=case	relType_2=aux:pass	relType_7=nmod	lemma_6=with	relType_5=obl	path2=barbiturate_nsubj:pass	pos_1=MD	lpib=be_VB	lemma_7=chlorpropamide	pos_5=NN	relType_3=ccomp	eib=True	relType_7=punct	lemma_2=be	pos_7=NN	lemma_4=by	lemma_3=prolong
DDI-DrugBank.d245.s7	DDI-DrugBank.d245.s7.e1	DDI-DrugBank.d245.s7.e2	null	lemma_1=,	wib=barbiturates	eib=False	lib=barbiturate	path1=chlorpropamide_nmod<therapy_obl<prolong_ccomp<suggest_advcl	pos_1=,	path=chlorpropamide_nmod<therapy_obl<prolong_ccomp<suggest_advcl<employ_ROOT>barbiturate_nsubj:pass	path2=barbiturate_nsubj:pass	relType_1=punct	lpib=barbiturate_NNS
DDI-DrugBank.d245.s8	DDI-DrugBank.d245.s8.e0	DDI-DrugBank.d245.s8.e1	null	lpib=like_JJ	pos_8=DT	lib=like	relType_7=case	lemma_10=of	relType_9=obl	relType_3=nsubj:pass	pos_1=HYPH	lemma_4=may	pos_2=JJ	pos_5=VB	eib=False	relation_5=neutral	path=disulfiram_obl:npmod<like_amod<reaction_nsubj:pass<produce_ROOT>ingestion_obl>alcohol_nmod	lemma_3=reaction	pos_4=MD	pos_6=VBN	relType_10=case	lemma_5=be	pos_9=NN	lemma_7=by	lemma_2=like	relType_6=ROOT	relType_5=aux:pass	path1=disulfiram_obl:npmod<like_amod<reaction_nsubj:pass	lemma_8=the	relType_2=amod	lemma_1=-	relType_4=aux	pos_10=IN	lemma_6=produce	pos_7=IN	pos_3=NN	path2=ingestion_obl>alcohol_nmod	relType_8=det	relType_1=punct	wib=like	lemma_9=ingestion
DDI-DrugBank.d245.s9	DDI-DrugBank.d245.s9.e0	DDI-DrugBank.d245.s9.e1	effect	relType_1=cc	lemma_2=oral	lemma_3=hypoglycemic	pos_1=CC	lib=oral	pos_3=JJ	relType_3=amod	eib=True	wib=oral	path2=agent_conj	relType_2=amod	path1=	path=<miconazole_nmod>agent_conj	lpib=oral_JJ	pos_2=JJ	lemma_1=and
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e1	mechanism	lemma_1=,	pos_3=IN	pos_17=DT	lemma_11=,	relType_8=amod	lemma_4=a	pos_15=TO	lemma_8=microsomal	relType_18=amod	pos_1=,	lemma_21=warfarin	lemma_21=-	lemma_6=on	wib=apparently	lemma_18=hepatic	relType_6=case	pos_13=VBN	pos_20=IN	lpib=apparently_RB	pos_8=JJ	pos_2=RB	relType_16=xcomp	relType_20=case	relType_10=nmod	relType_17=det	path1=Tagamet_nsubj:pass	lib=apparently	relType_9=compound	relType_2=advmod	relType_15=mark	pos_6=IN	relType_11=punct	pos_12=VBZ	relType_14=ROOT	pos_16=VB	relation_15=adverse	relType_12=aux	pos_18=JJ	pos_19=NN	pos_9=NN	lemma_13=be	lemma_15=to	relType_13=aux:pass	lemma_5=effect	pos_4=DT	lemma_21=type	relType_7=amod	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod	lemma_3=through	lemma_16=reduce	relType_21=compound	pos_21=HYPH	relType_5=obl	lemma_17=the	pos_11=,	relType_3=case	lemma_10=system	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod	pos_5=NN	lemma_7=certain	pos_14=VBN	eib=True	lemma_12=have	pos_7=JJ	lemma_14=report	lemma_19=metabolism	relation_4=neutral	relType_21=punct	relType_19=obj	relType_1=punct	relType_4=det	lemma_2=apparently	lemma_9=enzyme	pos_10=NNS	pos_21=NN	lemma_20=of
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e2	mechanism	lemma_21=-	lemma_6=on	pos_13=VBN	pos_21=NNS	pos_8=JJ	relType_17=det	relType_10=nmod	relType_15=mark	lemma_15=to	relType_13=aux:pass	lemma_21=type	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_20=of	lemma_1=,	lemma_4=a	lemma_21=warfarin	pos_1=,	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	pos_9=NN	lemma_3=through	relType_21=compound	lemma_17=the	lemma_10=system	pos_5=NN	lemma_7=certain	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>phenytoin_conj	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_21=nmod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	relType_7=amod	lemma_16=reduce	relType_5=obl	relType_19=obj	lemma_14=report	relType_8=amod	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>phenytoin_conj	path1=Tagamet_nsubj:pass	relType_9=compound	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_4=DT	pos_11=,	relType_3=case	eib=True	lemma_12=have	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e3	mechanism	lemma_21=-	lemma_6=on	pos_13=VBN	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_15=mark	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	pos_22=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_20=of	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	lemma_3=through	relType_21=compound	lemma_17=the	lemma_10=system	pos_5=NN	lemma_7=certain	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_21=nmod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>propranolol_conj	lemma_5=effect	relType_7=amod	lemma_16=reduce	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_8=amod	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>propranolol_conj	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_4=DT	pos_11=,	relType_3=case	eib=True	lemma_12=have	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e4	mechanism	lemma_21=-	lemma_6=on	pos_13=VBN	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_15=mark	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	pos_22=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>nifedipine_conj	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_20=of	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_17=the	lemma_10=system	pos_5=NN	lemma_7=certain	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>nifedipine_conj	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_21=nmod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	relType_7=amod	lemma_16=reduce	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_4=DT	pos_11=,	relType_3=case	eib=True	lemma_12=have	pos_23=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e5	mechanism	lemma_21=-	pos_24=,	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_15=mark	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	pos_22=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_20=of	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>chlordiazepoxide_conj	lemma_23=propranolol	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_17=the	lemma_10=system	pos_5=NN	lemma_7=certain	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	relType_7=amod	lemma_16=reduce	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_4=DT	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>chlordiazepoxide_conj	relType_24=conj	pos_11=,	lemma_24=nifedipine	relType_3=case	eib=True	lemma_12=have	pos_23=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e6	mechanism	lemma_21=-	pos_24=,	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_15=mark	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	pos_22=,	lemma_25=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_20=of	relType_25=conj	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	relType_23=conj	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>diazepam_conj	lemma_3=through	relType_21=compound	lemma_17=the	lemma_10=system	pos_5=NN	lemma_7=certain	relType_25=punct	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	relType_7=amod	lemma_16=reduce	pos_25=NN	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	pos_25=,	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_4=DT	lemma_25=chlordiazepoxide	relType_24=conj	pos_11=,	lemma_24=nifedipine	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>diazepam_conj	relType_3=case	eib=True	lemma_12=have	pos_23=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e7	mechanism	lemma_21=-	pos_24=,	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_15=mark	pos_26=NN	lemma_23=,	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>antidepressant_conj	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	pos_22=,	lemma_25=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_27=certain	lemma_28=tricyclic	lemma_20=of	relType_25=conj	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	pos_27=JJ	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_26=diazepam	lemma_17=the	pos_28=JJ	lemma_10=system	pos_5=NN	lemma_7=certain	relType_25=punct	relType_28=amod	relType_26=punct	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	relType_27=amod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	relType_7=amod	lemma_16=reduce	pos_25=NN	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	pos_25=,	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_26=conj	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>antidepressant_conj	lemma_13=be	pos_4=DT	lemma_25=chlordiazepoxide	relType_24=conj	pos_11=,	lemma_24=nifedipine	relType_3=case	eib=True	lemma_12=have	pos_23=,	pos_26=,	lemma_26=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e8	mechanism	lemma_21=-	pos_24=,	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_28=punct	relType_15=mark	pos_26=NN	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	lemma_21=type	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>lidocaine_conj	pos_22=,	lemma_25=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	relType_28=conj	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_27=certain	lemma_28=,	lemma_28=tricyclic	lemma_20=of	relType_25=conj	lemma_1=,	relType_22=conj	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>lidocaine_conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	pos_27=JJ	lemma_28=antidepressant	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_26=diazepam	lemma_17=the	pos_28=JJ	lemma_10=system	pos_5=NN	lemma_7=certain	relType_25=punct	relType_28=amod	relType_26=punct	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	relType_27=amod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_5=effect	pos_28=NNS	relType_7=amod	lemma_16=reduce	pos_25=NN	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	pos_25=,	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_26=conj	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_28=,	pos_4=DT	lemma_25=chlordiazepoxide	relType_24=conj	pos_11=,	lemma_24=nifedipine	relType_3=case	eib=True	lemma_12=have	pos_23=,	pos_26=,	lemma_26=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e9	mechanism	lemma_21=-	pos_24=,	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>theophylline_conj	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_10=nmod	relType_17=det	relType_28=punct	relType_15=mark	pos_26=NN	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	relType_29=conj	lemma_21=type	pos_22=,	lemma_25=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	relType_28=conj	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_27=certain	lemma_28=,	lemma_28=tricyclic	lemma_20=of	relType_25=conj	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	pos_27=JJ	lemma_28=antidepressant	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>theophylline_conj	relType_6=case	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_29=NN	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_26=diazepam	lemma_17=the	pos_28=JJ	lemma_10=system	pos_5=NN	lemma_7=certain	relType_25=punct	relType_28=amod	relType_26=punct	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	relType_27=amod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	lemma_29=,	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_29=lidocaine	lemma_5=effect	pos_28=NNS	relType_7=amod	lemma_16=reduce	pos_25=NN	pos_29=,	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	relType_23=punct	relType_8=amod	pos_25=,	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path1=Tagamet_nsubj:pass	relType_9=compound	relType_26=conj	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_28=,	pos_4=DT	lemma_25=chlordiazepoxide	relType_24=conj	relType_29=punct	pos_11=,	lemma_24=nifedipine	relType_3=case	eib=True	lemma_12=have	pos_23=,	pos_26=,	lemma_26=,	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e0	DDI-DrugBank.d171.s0.e10	mechanism	path2=reduce_xcomp>metabolism_obj>anticoagulant_nmod>metronidazole_conj	lemma_21=-	pos_24=,	lemma_6=on	pos_13=VBN	lemma_24=,	pos_21=NNS	pos_8=JJ	relType_17=det	relType_10=nmod	relType_28=punct	relType_15=mark	relType_30=cc	pos_26=NN	lemma_23=,	lemma_15=to	relType_13=aux:pass	relType_22=punct	relType_29=conj	lemma_21=type	relType_30=conj	pos_22=,	lemma_25=,	lemma_21=,	pos_14=VBN	lemma_21=anticoagulant	relType_28=conj	pos_7=JJ	lemma_19=metabolism	relation_4=neutral	relType_21=punct	lemma_27=certain	lemma_28=,	lemma_28=tricyclic	lemma_20=of	relType_25=conj	lemma_1=,	relType_22=conj	lemma_4=a	pos_22=NN	lemma_21=warfarin	pos_1=,	lemma_23=propranolol	pos_27=JJ	lemma_28=antidepressant	pos_30=CC	relType_6=case	pos_30=NN	relType_20=case	pos_6=IN	pos_16=VB	relation_15=adverse	lemma_22=,	pos_29=NN	pos_9=NN	relType_23=conj	lemma_3=through	relType_21=compound	lemma_26=diazepam	lemma_17=the	pos_28=JJ	lemma_10=system	pos_5=NN	lemma_7=certain	relType_25=punct	relType_28=amod	relType_26=punct	relType_1=punct	lemma_9=enzyme	pos_3=IN	pos_17=DT	lemma_11=,	pos_15=TO	relType_24=punct	pos_24=NN	relType_21=nmod	relType_27=amod	pos_20=IN	relType_16=xcomp	pos_21=HYPH	pos_23=NN	lib=apparently	lemma_29=,	relType_11=punct	pos_12=VBZ	relType_14=ROOT	lemma_29=lidocaine	lemma_5=effect	pos_28=NNS	relType_7=amod	lemma_16=reduce	pos_25=NN	pos_29=,	relType_5=obl	lemma_22=phenytoin	relType_19=obj	lemma_14=report	lemma_30=theophylline	relType_23=punct	relType_8=amod	pos_25=,	lemma_8=microsomal	relType_18=amod	wib=apparently	lemma_18=hepatic	lpib=apparently_RB	pos_21=,	pos_2=RB	path=Tagamet_nsubj:pass<report_ROOT>reduce_xcomp>metabolism_obj>anticoagulant_nmod>metronidazole_conj	path1=Tagamet_nsubj:pass	relType_9=compound	relType_26=conj	relType_2=advmod	relType_12=aux	pos_18=JJ	pos_19=NN	lemma_13=be	pos_28=,	pos_4=DT	lemma_25=chlordiazepoxide	relType_24=conj	relType_29=punct	pos_11=,	lemma_24=nifedipine	relType_3=case	eib=True	lemma_12=have	pos_23=,	pos_26=,	lemma_26=,	lemma_30=and	relType_4=det	lemma_2=apparently	pos_10=NNS	pos_21=NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e2	null	path=<anticoagulant_nmod>phenytoin_conj	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	path1=	pos_1=,	path2=phenytoin_conj	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e3	null	lemma_1=,	lib=phenytoin	pos_2=NN	eib=True	wib=phenytoin	path2=propranolol_conj	lemma_2=,	path1=	pos_1=,	lemma_2=phenytoin	pos_2=,	relType_1=punct	relType_2=conj	path=<anticoagulant_nmod>propranolol_conj	lpib=phenytoin_NN	relType_2=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e4	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	lemma_3=propranolol	lib=phenytoin	wib=phenytoin	lemma_2=phenytoin	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path2=nifedipine_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	path=<anticoagulant_nmod>nifedipine_conj	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e5	null	path2=chlordiazepoxide_conj	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	lemma_3=propranolol	lib=phenytoin	pos_4=,	wib=phenytoin	lemma_2=phenytoin	lemma_4=nifedipine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	path=<anticoagulant_nmod>chlordiazepoxide_conj	lemma_4=,	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e6	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	path2=diazepam_conj	relType_2=punct	lemma_3=propranolol	lib=phenytoin	pos_4=,	wib=phenytoin	path=<anticoagulant_nmod>diazepam_conj	lemma_2=phenytoin	lemma_4=nifedipine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	pos_5=NN	pos_3=,	eib=True	lemma_5=chlordiazepoxide	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e7	null	lemma_1=,	pos_2=NN	relType_8=amod	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_2=punct	pos_6=NN	lemma_3=propranolol	pos_8=JJ	relType_6=conj	lib=phenytoin	pos_4=,	wib=phenytoin	relType_6=punct	lemma_2=phenytoin	lemma_4=nifedipine	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=diazepam	path=<anticoagulant_nmod>antidepressant_conj	lemma_3=,	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	relType_7=amod	lemma_4=,	lemma_8=tricyclic	relType_5=conj	pos_6=,	path2=antidepressant_conj	pos_5=NN	lemma_7=certain	pos_3=,	eib=True	lemma_5=chlordiazepoxide	pos_3=NN	pos_7=JJ	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e8	null	lemma_1=,	pos_2=NN	relType_8=amod	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=,	pos_8=NNS	relType_2=punct	pos_6=NN	lemma_3=propranolol	pos_8=JJ	relType_6=conj	lib=phenytoin	pos_4=,	wib=phenytoin	relType_6=punct	lemma_2=phenytoin	lemma_4=nifedipine	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=diazepam	relType_4=punct	lemma_3=,	relType_7=amod	relType_3=conj	lemma_5=,	path2=lidocaine_conj	relType_5=punct	path=<anticoagulant_nmod>lidocaine_conj	lemma_4=,	lemma_8=tricyclic	relType_5=conj	pos_6=,	pos_5=NN	lemma_7=certain	pos_3=,	eib=True	lemma_5=chlordiazepoxide	pos_3=NN	pos_7=JJ	relType_8=conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lpib=phenytoin_NN	lemma_8=antidepressant	pos_8=,
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e9	null	lemma_1=,	path=<anticoagulant_nmod>theophylline_conj	pos_2=NN	relType_9=conj	relType_8=amod	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NNS	relType_2=punct	pos_6=NN	lemma_3=propranolol	pos_8=JJ	relType_6=conj	lib=phenytoin	pos_4=,	wib=phenytoin	lemma_9=lidocaine	relType_6=punct	lemma_2=phenytoin	path2=theophylline_conj	lemma_4=nifedipine	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_6=diazepam	relType_4=punct	lemma_3=,	relType_7=amod	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	lemma_8=tricyclic	relType_5=conj	relType_9=punct	pos_6=,	pos_5=NN	lemma_7=certain	pos_3=,	eib=True	lemma_5=chlordiazepoxide	pos_3=NN	pos_7=JJ	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN	lemma_8=antidepressant	pos_8=,
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e1	DDI-DrugBank.d171.s0.e10	null	lemma_1=,	pos_2=NN	relType_9=conj	relType_8=amod	pos_5=,	relType_10=cc	path1=	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	path=<anticoagulant_nmod>metronidazole_conj	pos_8=NNS	relType_2=punct	pos_6=NN	lemma_3=propranolol	pos_8=JJ	relType_6=conj	lib=phenytoin	pos_4=,	wib=phenytoin	lemma_9=lidocaine	relType_6=punct	relType_10=conj	pos_10=CC	lemma_2=phenytoin	lemma_4=nifedipine	pos_10=NN	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	lemma_10=and	lemma_6=diazepam	relType_4=punct	lemma_3=,	relType_7=amod	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	lemma_8=tricyclic	relType_5=conj	relType_9=punct	pos_6=,	pos_5=NN	lemma_7=certain	pos_3=,	eib=True	lemma_5=chlordiazepoxide	path2=metronidazole_conj	pos_3=NN	lemma_10=theophylline	pos_7=JJ	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN	lemma_8=antidepressant	pos_8=,
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e3	null	lpib=propranolol_NN	wib=propranolol	lemma_1=,	path=phenytoin_conj<anticoagulant_nmod>propranolol_conj	path2=propranolol_conj	eib=False	pos_1=,	lib=propranolol	relType_1=punct	path1=phenytoin_conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e4	null	lpib=propranolol_NN	path2=nifedipine_conj	wib=propranolol	lemma_1=,	pos_2=NN	eib=True	lemma_2=propranolol	lemma_2=,	pos_1=,	pos_2=,	lib=propranolol	relType_2=conj	relType_1=punct	path1=phenytoin_conj	path=phenytoin_conj<anticoagulant_nmod>nifedipine_conj	relType_2=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e5	null	path2=chlordiazepoxide_conj	path=phenytoin_conj<anticoagulant_nmod>chlordiazepoxide_conj	wib=propranolol	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	lemma_3=nifedipine	relType_2=conj	path1=phenytoin_conj	lemma_2=,	lemma_3=,	relType_3=conj	lpib=propranolol_NN	pos_3=,	eib=True	pos_3=NN	lemma_2=propranolol	pos_2=,	lib=propranolol	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e6	null	wib=propranolol	lemma_1=,	pos_2=NN	pos_1=,	path=phenytoin_conj<anticoagulant_nmod>diazepam_conj	path2=diazepam_conj	relType_2=punct	lemma_3=nifedipine	pos_4=,	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=chlordiazepoxide	lemma_4=,	lpib=propranolol_NN	pos_3=,	eib=True	pos_3=NN	lemma_2=propranolol	pos_2=,	relType_4=conj	lib=propranolol	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e7	null	wib=propranolol	lemma_1=,	pos_2=NN	pos_6=JJ	pos_5=,	pos_1=,	relType_2=punct	lemma_7=tricyclic	lemma_3=nifedipine	pos_4=,	relType_6=amod	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	relType_7=amod	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_4=chlordiazepoxide	relType_5=punct	lemma_4=,	relType_5=conj	path2=antidepressant_conj	lpib=propranolol_NN	path=phenytoin_conj<anticoagulant_nmod>antidepressant_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_2=propranolol	pos_7=JJ	pos_2=,	relType_4=conj	lib=propranolol	lemma_5=diazepam	relType_1=punct	relType_3=punct	lemma_6=certain
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e8	null	path=phenytoin_conj<anticoagulant_nmod>lidocaine_conj	pos_7=NNS	wib=propranolol	lemma_1=,	pos_2=NN	pos_6=JJ	pos_5=,	pos_1=,	relType_2=punct	lemma_7=tricyclic	lemma_3=nifedipine	pos_4=,	relType_6=amod	pos_7=,	lemma_7=,	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	relType_7=conj	relType_7=amod	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	path2=lidocaine_conj	lemma_4=chlordiazepoxide	relType_5=punct	lemma_4=,	relType_5=conj	lpib=propranolol_NN	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_2=propranolol	pos_7=JJ	pos_2=,	relType_4=conj	lib=propranolol	lemma_7=antidepressant	lemma_5=diazepam	relType_1=punct	relType_3=punct	lemma_6=certain
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e9	null	pos_7=NNS	wib=propranolol	lemma_1=,	pos_2=NN	pos_6=JJ	pos_5=,	pos_1=,	relType_8=punct	lemma_8=,	relType_2=punct	path=phenytoin_conj<anticoagulant_nmod>theophylline_conj	lemma_3=nifedipine	lemma_7=tricyclic	pos_8=NN	pos_4=,	relType_6=amod	pos_7=,	path2=theophylline_conj	lemma_8=lidocaine	lemma_7=,	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	relType_7=conj	relType_7=amod	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_4=chlordiazepoxide	relType_5=punct	lemma_4=,	relType_5=conj	lpib=propranolol_NN	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_2=propranolol	pos_7=JJ	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	lib=propranolol	lemma_7=antidepressant	lemma_5=diazepam	relType_1=punct	relType_3=punct	lemma_6=certain
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e2	DDI-DrugBank.d171.s0.e10	null	pos_7=NNS	wib=propranolol	lemma_1=,	pos_2=NN	pos_6=JJ	relType_9=conj	pos_5=,	pos_1=,	relType_8=punct	lemma_8=,	path=phenytoin_conj<anticoagulant_nmod>metronidazole_conj	relType_2=punct	lemma_7=tricyclic	lemma_3=nifedipine	pos_8=NN	pos_4=,	relType_6=amod	pos_7=,	lemma_8=lidocaine	lemma_7=,	relType_2=conj	path1=phenytoin_conj	lemma_2=,	pos_4=NN	pos_9=NN	relType_7=conj	lemma_9=and	pos_9=CC	relType_7=amod	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_4=chlordiazepoxide	relType_5=punct	lemma_4=,	relType_5=conj	lpib=propranolol_NN	pos_5=NN	pos_3=,	eib=True	path2=metronidazole_conj	pos_3=NN	lemma_2=propranolol	pos_7=JJ	relType_7=punct	relType_8=conj	pos_2=,	relType_4=conj	lib=propranolol	lemma_7=antidepressant	lemma_5=diazepam	relType_1=punct	pos_8=,	lemma_9=theophylline	relType_9=cc	relType_3=punct	lemma_6=certain
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e4	null	path1=propranolol_conj	path2=nifedipine_conj	lemma_1=,	eib=False	path=propranolol_conj<anticoagulant_nmod>nifedipine_conj	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	relType_1=punct	wib=nifedipine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e5	null	path1=propranolol_conj	path2=chlordiazepoxide_conj	path=propranolol_conj<anticoagulant_nmod>chlordiazepoxide_conj	lemma_1=,	pos_2=NN	eib=True	lemma_2=,	pos_1=,	lib=nifedipine	pos_2=,	lpib=nifedipine_NN	lemma_2=nifedipine	relType_1=punct	relType_2=conj	wib=nifedipine	relType_2=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e6	null	lemma_1=,	pos_2=NN	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	path2=diazepam_conj	relType_2=punct	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	path1=propranolol_conj	lemma_3=,	relType_3=conj	lemma_2=nifedipine	path=propranolol_conj<anticoagulant_nmod>diazepam_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	wib=nifedipine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e7	null	lemma_1=,	pos_2=NN	pos_6=JJ	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	relType_2=punct	pos_4=,	relType_6=amod	lemma_4=diazepam	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	path1=propranolol_conj	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_2=nifedipine	lemma_4=,	path2=antidepressant_conj	path=propranolol_conj<anticoagulant_nmod>antidepressant_conj	pos_3=,	eib=True	pos_3=NN	lemma_6=tricyclic	lemma_5=certain	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	wib=nifedipine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e8	null	lemma_1=,	pos_2=NN	pos_6=JJ	pos_1=,	lemma_6=,	lib=nifedipine	lpib=nifedipine_NN	relType_2=punct	relType_6=conj	pos_4=,	relType_6=punct	relType_6=amod	lemma_4=diazepam	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	path1=propranolol_conj	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_6=antidepressant	path2=lidocaine_conj	lemma_2=nifedipine	lemma_4=,	path=propranolol_conj<anticoagulant_nmod>lidocaine_conj	pos_6=,	pos_3=,	eib=True	pos_3=NN	lemma_6=tricyclic	pos_6=NNS	lemma_5=certain	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	wib=nifedipine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e9	null	lemma_1=,	pos_2=NN	pos_6=JJ	pos_1=,	lemma_6=,	lib=nifedipine	lemma_7=lidocaine	lpib=nifedipine_NN	path=propranolol_conj<anticoagulant_nmod>theophylline_conj	relType_2=punct	relType_6=conj	pos_4=,	relType_6=punct	relType_6=amod	lemma_4=diazepam	pos_7=,	path2=theophylline_conj	lemma_7=,	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	path1=propranolol_conj	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_6=antidepressant	lemma_2=nifedipine	lemma_4=,	pos_6=,	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_6=tricyclic	pos_6=NNS	lemma_5=certain	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	wib=nifedipine	relType_7=conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e3	DDI-DrugBank.d171.s0.e10	null	lemma_8=theophylline	lemma_1=,	pos_2=NN	pos_6=JJ	pos_1=,	lemma_6=,	lib=nifedipine	lemma_7=lidocaine	lpib=nifedipine_NN	relType_2=punct	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	relType_6=amod	lemma_4=diazepam	pos_7=,	pos_8=CC	lemma_7=,	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	path1=propranolol_conj	pos_5=JJ	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_6=antidepressant	lemma_2=nifedipine	lemma_4=,	path=propranolol_conj<anticoagulant_nmod>metronidazole_conj	pos_6=,	lemma_8=and	pos_3=,	eib=True	path2=metronidazole_conj	pos_3=NN	relType_7=punct	lemma_6=tricyclic	pos_6=NNS	lemma_5=certain	pos_2=,	relType_4=conj	relType_8=conj	relType_1=punct	pos_7=NN	relType_8=cc	relType_3=punct	wib=nifedipine	relType_7=conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e5	null	path2=chlordiazepoxide_conj	wib=chlordiazepoxide	lemma_1=,	lib=chlordiazepoxide	eib=False	path1=nifedipine_conj	pos_1=,	lpib=chlordiazepoxide_NN	path=nifedipine_conj<anticoagulant_nmod>chlordiazepoxide_conj	relType_1=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e6	null	wib=chlordiazepoxide	lemma_1=,	lib=chlordiazepoxide	pos_2=NN	eib=True	path1=nifedipine_conj	path=nifedipine_conj<anticoagulant_nmod>diazepam_conj	lemma_2=chlordiazepoxide	pos_1=,	lpib=chlordiazepoxide_NN	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	path2=diazepam_conj	relType_2=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e7	null	relType_4=amod	lemma_4=certain	lemma_1=,	pos_4=JJ	pos_2=NN	path=nifedipine_conj<anticoagulant_nmod>antidepressant_conj	pos_1=,	relType_2=punct	wib=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	lemma_5=tricyclic	path2=antidepressant_conj	lib=chlordiazepoxide	pos_3=,	eib=True	path1=nifedipine_conj	lemma_2=chlordiazepoxide	pos_3=NN	lpib=chlordiazepoxide_NN	pos_2=,	lemma_3=diazepam	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e8	null	relType_4=amod	path=nifedipine_conj<anticoagulant_nmod>lidocaine_conj	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_4=certain	pos_5=,	pos_1=,	relType_2=punct	wib=chlordiazepoxide	pos_5=NNS	relType_2=conj	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	lemma_5=,	path2=lidocaine_conj	relType_5=punct	relType_5=conj	lemma_5=tricyclic	lib=chlordiazepoxide	pos_3=,	eib=True	path1=nifedipine_conj	lemma_2=chlordiazepoxide	pos_3=NN	lpib=chlordiazepoxide_NN	pos_2=,	lemma_3=diazepam	lemma_5=antidepressant	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e9	null	relType_4=amod	lemma_4=certain	lemma_1=,	pos_4=JJ	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_2=punct	pos_6=NN	wib=chlordiazepoxide	relType_6=conj	pos_5=NNS	relType_6=punct	path2=theophylline_conj	relType_2=conj	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_5=conj	lemma_5=tricyclic	pos_6=,	lib=chlordiazepoxide	path=nifedipine_conj<anticoagulant_nmod>theophylline_conj	eib=True	path1=nifedipine_conj	lemma_2=chlordiazepoxide	pos_3=NN	pos_3=,	lemma_6=lidocaine	lpib=chlordiazepoxide_NN	pos_2=,	lemma_3=diazepam	lemma_5=antidepressant	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e4	DDI-DrugBank.d171.s0.e10	null	relType_4=amod	lemma_4=certain	lemma_1=,	pos_4=JJ	pos_2=NN	path=nifedipine_conj<anticoagulant_nmod>metronidazole_conj	pos_5=,	pos_1=,	lemma_6=,	relType_7=cc	relType_2=punct	pos_6=NN	wib=chlordiazepoxide	relType_6=conj	pos_5=NNS	relType_6=punct	relType_2=conj	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_7=theophylline	relType_5=conj	lemma_5=tricyclic	pos_6=,	lib=chlordiazepoxide	pos_3=,	eib=True	path1=nifedipine_conj	lemma_2=chlordiazepoxide	path2=metronidazole_conj	pos_3=NN	lemma_6=lidocaine	lemma_7=and	lpib=chlordiazepoxide_NN	pos_2=,	lemma_3=diazepam	lemma_5=antidepressant	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e5	DDI-DrugBank.d171.s0.e6	null	lpib=diazepam_NN	lemma_1=,	path1=chlordiazepoxide_conj	lib=diazepam	wib=diazepam	eib=False	pos_1=,	relType_1=punct	path2=diazepam_conj	path=chlordiazepoxide_conj<anticoagulant_nmod>diazepam_conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e5	DDI-DrugBank.d171.s0.e7	null	lpib=diazepam_NN	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_1=,	relType_2=punct	lemma_3=certain	lemma_4=tricyclic	relType_2=conj	lemma_2=,	relType_3=amod	wib=diazepam	lemma_2=diazepam	path2=antidepressant_conj	path1=chlordiazepoxide_conj	pos_3=JJ	eib=True	lib=diazepam	pos_2=,	relType_1=punct	path=chlordiazepoxide_conj<anticoagulant_nmod>antidepressant_conj
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e5	DDI-DrugBank.d171.s0.e8	null	lpib=diazepam_NN	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_1=,	path=chlordiazepoxide_conj<anticoagulant_nmod>lidocaine_conj	relType_2=punct	lemma_3=certain	pos_4=,	lemma_4=tricyclic	relType_2=conj	lemma_2=,	pos_4=NNS	relType_4=punct	relType_3=amod	wib=diazepam	path2=lidocaine_conj	lemma_4=antidepressant	lemma_4=,	lemma_2=diazepam	path1=chlordiazepoxide_conj	pos_3=JJ	eib=True	lib=diazepam	pos_2=,	relType_4=conj	relType_1=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e5	DDI-DrugBank.d171.s0.e9	null	lpib=diazepam_NN	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_5=,	pos_1=,	relType_2=punct	lemma_3=certain	pos_4=,	lemma_4=tricyclic	lemma_5=lidocaine	path2=theophylline_conj	relType_2=conj	lemma_2=,	pos_4=NNS	relType_4=punct	relType_3=amod	wib=diazepam	lemma_5=,	relType_5=punct	lemma_4=antidepressant	path=chlordiazepoxide_conj<anticoagulant_nmod>theophylline_conj	lemma_4=,	relType_5=conj	lemma_2=diazepam	pos_5=NN	path1=chlordiazepoxide_conj	pos_3=JJ	eib=True	lib=diazepam	pos_2=,	relType_4=conj	relType_1=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e5	DDI-DrugBank.d171.s0.e10	null	lpib=diazepam_NN	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_5=,	pos_1=,	relType_2=punct	path=chlordiazepoxide_conj<anticoagulant_nmod>metronidazole_conj	lemma_3=certain	pos_6=NN	relType_6=conj	pos_4=,	lemma_4=tricyclic	lemma_5=lidocaine	relType_2=conj	lemma_2=,	pos_4=NNS	relType_4=punct	relType_3=amod	pos_6=CC	wib=diazepam	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=antidepressant	lemma_4=,	relType_5=conj	lemma_2=diazepam	pos_5=NN	path1=chlordiazepoxide_conj	pos_3=JJ	eib=True	lib=diazepam	lemma_6=theophylline	path2=metronidazole_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_6=cc
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e6	DDI-DrugBank.d171.s0.e7	null	path2=antidepressant_conj	lemma_1=,	pos_3=JJ	relType_3=amod	eib=True	lib=certain	path=diazepam_conj<anticoagulant_nmod>antidepressant_conj	relType_2=amod	lemma_2=certain	path1=diazepam_conj	pos_1=,	relType_1=punct	lpib=certain_JJ	lemma_3=tricyclic	wib=certain	pos_2=JJ
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e6	DDI-DrugBank.d171.s0.e8	null	lemma_1=,	pos_1=,	lemma_3=antidepressant	lemma_3=tricyclic	wib=certain	pos_2=JJ	pos_3=NNS	lib=certain	path=diazepam_conj<anticoagulant_nmod>lidocaine_conj	path1=diazepam_conj	relType_3=amod	lemma_3=,	relType_3=conj	path2=lidocaine_conj	relType_2=amod	lemma_2=certain	lpib=certain_JJ	pos_3=JJ	pos_3=,	eib=True	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e6	DDI-DrugBank.d171.s0.e9	null	lemma_1=,	pos_1=,	lemma_3=antidepressant	lemma_3=tricyclic	wib=certain	pos_2=JJ	path=diazepam_conj<anticoagulant_nmod>theophylline_conj	pos_3=NNS	pos_4=,	lib=certain	path1=diazepam_conj	path2=theophylline_conj	lemma_4=lidocaine	pos_4=NN	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	relType_2=amod	lemma_2=certain	lemma_4=,	lpib=certain_JJ	pos_3=JJ	pos_3=,	eib=True	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e6	DDI-DrugBank.d171.s0.e10	null	lemma_1=,	pos_5=CC	pos_1=,	lemma_3=antidepressant	lemma_3=tricyclic	wib=certain	pos_2=JJ	relType_5=cc	pos_3=NNS	path=diazepam_conj<anticoagulant_nmod>metronidazole_conj	lib=certain	pos_4=,	path1=diazepam_conj	lemma_4=lidocaine	pos_4=NN	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	relType_2=amod	lemma_2=certain	lemma_4=,	relType_5=conj	lpib=certain_JJ	pos_5=NN	pos_3=JJ	pos_3=,	eib=True	lemma_5=and	path2=metronidazole_conj	lemma_5=theophylline	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e7	DDI-DrugBank.d171.s0.e8	null	path=antidepressant_conj<anticoagulant_nmod>lidocaine_conj	lemma_1=,	eib=False	path2=lidocaine_conj	pos_1=,	path1=antidepressant_conj	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	wib=lidocaine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e7	DDI-DrugBank.d171.s0.e9	null	lemma_1=,	pos_2=NN	eib=True	lemma_2=,	pos_1=,	pos_2=,	path1=antidepressant_conj	path2=theophylline_conj	path=antidepressant_conj<anticoagulant_nmod>theophylline_conj	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	relType_2=conj	lemma_2=lidocaine	relType_2=punct	wib=lidocaine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e7	DDI-DrugBank.d171.s0.e10	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_3=theophylline	lpib=lidocaine_NN	relType_2=punct	relType_3=cc	lib=lidocaine	relType_2=conj	lemma_2=,	relType_3=conj	eib=True	path2=metronidazole_conj	pos_3=NN	path=antidepressant_conj<anticoagulant_nmod>metronidazole_conj	pos_2=,	lemma_3=and	path1=antidepressant_conj	relType_1=punct	lemma_2=lidocaine	wib=lidocaine
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e8	DDI-DrugBank.d171.s0.e9	null	lib=theophylline	lemma_1=,	wib=theophylline	eib=False	path1=lidocaine_conj	path=lidocaine_conj<anticoagulant_nmod>theophylline_conj	pos_1=,	path2=theophylline_conj	relType_1=punct	lpib=theophylline_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e8	DDI-DrugBank.d171.s0.e10	null	lemma_2=and	lib=theophylline	lemma_1=,	pos_2=NN	wib=theophylline	eib=True	path2=metronidazole_conj	path1=lidocaine_conj	pos_2=CC	path=lidocaine_conj<anticoagulant_nmod>metronidazole_conj	pos_1=,	relType_2=conj	relType_1=punct	relType_2=cc	lemma_2=theophylline	lpib=theophylline_NN
DDI-DrugBank.d171.s0	DDI-DrugBank.d171.s0.e9	DDI-DrugBank.d171.s0.e10	null	relType_1=cc	wib=metronidazole	pos_1=CC	lib=metronidazole	eib=False	path2=metronidazole_conj	path1=theophylline_conj	lpib=metronidazole_NN	lemma_1=and	path=theophylline_conj<anticoagulant_nmod>metronidazole_conj
DDI-DrugBank.d171.s2	DDI-DrugBank.d171.s2.e0	DDI-DrugBank.d171.s2.e1	advise	pos_4=JJ	path=anticoagulant_amod<dose_nmod<adjustment_nsubj<necessary_conj>administer_advcl>Tagamet_nsubj:pass	pos_2=MD	pos_3=VB	path2=administer_advcl>Tagamet_nsubj:pass	eib=False	lemma_5=when	lpib=dose_NN	relType_2=aux	relType_1=nmod	pos_1=NN	pos_5=WRB	wib=dose	lemma_1=dose	lemma_3=be	lib=dose	lemma_4=necessary	path1=anticoagulant_amod<dose_nmod<adjustment_nsubj	relType_5=advmod	relType_4=conj	lemma_2=may	relType_3=cop
DDI-DrugBank.d171.s3	DDI-DrugBank.d171.s3.e0	DDI-DrugBank.d171.s3.e1	null	path=<phenytoin_nmod>lidocaine_conj	lemma_1=,	eib=False	path2=lidocaine_conj	path1=	pos_1=,	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	wib=lidocaine
DDI-DrugBank.d171.s3	DDI-DrugBank.d171.s3.e0	DDI-DrugBank.d171.s3.e2	null	lemma_2=and	lemma_1=,	pos_2=NN	eib=True	pos_2=CC	path1=	pos_1=,	path2=theophylline_conj	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	relType_2=conj	relType_2=cc	lemma_2=lidocaine	path=<phenytoin_nmod>theophylline_conj	wib=lidocaine
DDI-DrugBank.d171.s3	DDI-DrugBank.d171.s3.e1	DDI-DrugBank.d171.s3.e2	null	relType_1=cc	lib=theophylline	pos_1=CC	wib=theophylline	eib=False	path1=lidocaine_conj	path2=theophylline_conj	path=lidocaine_conj<phenytoin_nmod>theophylline_conj	lemma_1=and	lpib=theophylline_NN
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e0	DDI-DrugBank.d171.s4.e1	mechanism	relType_1=nummod	lemma_13=a	path=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj<demonstrate_ROOT>concomitantly_advmod>mg_obl>b._acl>dosage_obl>theophylline_nmod	pos_2=NN	lemma_5=d.	lemma_19=dosage	relType_12=case	pos_13=DT	pos_7=CD	lemma_4=i.	lemma_9=h.	pos_20=IN	lemma_1=300	pos_17=IN	pos_8=NN	relType_20=case	lib=mg	pos_1=CD	eib=False	relType_7=nummod	lemma_3=q.	lpib=mg_NN	relType_9=compound	relType_10=conj	lemma_16=b.	lemma_17=i.	lemma_6=or	lemma_10=s.	lemma_20=of	pos_19=NN	lemma_14=300	pos_10=NN	relType_11=advmod	pos_9=NN	pos_4=NN	pos_12=IN	lemma_12=with	relType_17=case	pos_18=NN	pos_16=VBN	lemma_11=concomitantly	relType_15=obl	pos_6=CC	relType_16=acl	relType_2=compound	relType_8=compound	relType_4=compound	lemma_7=800	lemma_18=d.	lemma_2=mg	pos_11=RB	lemma_8=mg	relType_14=nummod	pos_5=NN	lemma_15=mg	pos_15=NNS	relType_19=obl	pos_3=NN	relType_5=obj	relType_18=compound	relType_13=det	wib=mg	relType_3=compound	path2=concomitantly_advmod>mg_obl>b._acl>dosage_obl>theophylline_nmod	pos_14=CD	path1=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj	relType_6=cc
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e0	DDI-DrugBank.d171.s4.e2	mechanism	lemma_21=theophylline	relType_1=nummod	relType_22=compound	lemma_13=a	pos_2=NN	lemma_4=i.	lemma_9=h.	pos_22=NNP	lib=mg	lemma_10=s.	pos_10=NN	pos_18=NN	relType_22=punct	pos_16=VBN	relType_15=obl	lemma_22=-	relType_16=acl	pos_11=RB	relType_19=obl	relType_5=obj	relType_13=det	relType_21=punct	pos_14=CD	lemma_20=of	lemma_5=d.	path=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj<demonstrate_ROOT>concomitantly_advmod>mg_obl>b._acl>dosage_obl>theophylline_nmod>Dur_dep	lemma_1=300	pos_8=NN	relType_20=case	relType_10=conj	relType_11=advmod	pos_9=NN	pos_12=IN	pos_6=CC	lemma_2=mg	pos_5=NN	lemma_15=mg	relType_3=compound	lemma_19=dosage	relType_12=case	relType_21=nmod	pos_20=IN	pos_17=IN	relType_7=nummod	lpib=mg_NN	lemma_6=or	relType_17=case	pos_22=HYPH	relType_8=compound	lemma_8=mg	relType_14=nummod	lemma_22=Theo	path1=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj	relType_6=cc	pos_13=DT	pos_7=CD	pos_21=-LRB-	relType_9=compound	pos_1=CD	lemma_16=b.	lemma_3=q.	lemma_17=i.	pos_19=NN	lemma_14=300	lemma_12=with	pos_4=NN	lemma_11=concomitantly	relType_2=compound	relType_4=compound	lemma_21=(	lemma_7=800	lemma_18=d.	path2=concomitantly_advmod>mg_obl>b._acl>dosage_obl>theophylline_nmod>Dur_dep	pos_15=NNS	eib=True	pos_3=NN	relType_18=compound	wib=mg	pos_21=NN
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e0	DDI-DrugBank.d171.s4.e3	null	lemma_21=theophylline	relType_1=nummod	relType_22=compound	lemma_13=a	pos_2=NN	pos_24=NNP	pos_34=NN	lemma_4=i.	relType_22=dep	relType_34=compound	lemma_9=h.	lemma_28=demonstrate	pos_22=NNP	lib=mg	lemma_10=s.	pos_10=NN	relType_32=amod	relType_23=compound	pos_18=NN	relType_22=punct	relType_24=compound	pos_16=VBN	relType_15=obl	lemma_22=-	relType_16=acl	pos_22=,	relType_33=punct	lemma_25=,	pos_11=RB	relType_28=ROOT	path=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj<demonstrate_ROOT>alteration_obj>level_nmod>theophylline_compound	relType_19=obl	relType_5=obj	relType_13=det	relType_21=punct	lemma_23=Key	pos_14=CD	lemma_26=Inc.	lemma_20=of	pos_29=JJR	lemma_5=d.	pos_28=VBD	pos_30=NN	lemma_1=300	pos_8=NN	relType_20=case	pos_32=JJ	relType_10=conj	lemma_31=in	lemma_33=-	lemma_22=,	relType_26=appos	relType_11=advmod	pos_9=NN	pos_12=IN	pos_6=CC	lemma_22=Dur	lemma_2=mg	pos_5=NN	lemma_15=mg	pos_33=HYPH	relType_25=punct	relType_3=compound	lemma_19=dosage	relType_30=obj	relType_12=case	relType_21=nmod	pos_20=IN	pos_31=IN	pos_17=IN	relType_29=amod	relType_7=nummod	lpib=mg_NN	lemma_6=or	relType_17=case	pos_22=HYPH	relType_8=compound	lemma_27=)	lemma_8=mg	relType_14=nummod	lemma_22=Theo	lemma_32=steady	lemma_34=state	relType_27=punct	path1=Tagamet_compound<d._obj<receive_acl<subject_nmod<study_nsubj	relType_6=cc	pos_23=NNP	pos_25=,	pos_13=DT	pos_7=CD	pos_26=NNP	path2=alteration_obj>level_nmod>theophylline_compound	lemma_29=less	relType_31=case	pos_21=-LRB-	relType_9=compound	pos_1=CD	lemma_16=b.	lemma_3=q.	lemma_17=i.	pos_19=NN	lemma_14=300	lemma_12=with	pos_4=NN	lemma_11=concomitantly	relType_2=compound	lemma_24=Pharmaceuticals	relType_4=compound	lemma_21=(	lemma_7=800	lemma_18=d.	lemma_30=alteration	pos_15=NNS	eib=True	pos_3=NN	relType_18=compound	wib=mg	pos_27=-RRB-	pos_21=NN
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e1	DDI-DrugBank.d171.s4.e2	null	lemma_1=(	path2=Dur_dep	lemma_2=Theo	eib=True	path=<theophylline_nmod>Dur_dep	pos_2=NNP	lpib=theo_NNP	relType_2=compound	lemma_2=-	path1=	wib=Theo	lib=theo	relType_1=punct	pos_2=HYPH	pos_1=-LRB-	relType_2=punct
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e1	DDI-DrugBank.d171.s4.e3	null	lemma_2=Dur	pos_5=,	pos_3=NNP	relType_13=punct	pos_9=JJR	lib=theo	path2=alteration_obj>level_nmod>theophylline_compound	relType_14=compound	pos_2=HYPH	lemma_10=alteration	lemma_13=-	path=theophylline_nmod<dosage_obl<b._acl<mg_obl<concomitantly_advmod<demonstrate_ROOT>alteration_obj>level_nmod>theophylline_compound	relType_2=punct	relType_11=case	lemma_1=(	pos_12=JJ	lemma_12=steady	lemma_9=less	pos_13=HYPH	lemma_4=Pharmaceuticals	lemma_14=state	pos_2=NNP	lemma_2=-	pos_6=NNP	lpib=theo_NNP	lemma_6=Inc.	path1=theophylline_nmod<dosage_obl<b._acl<mg_obl<concomitantly_advmod	relType_12=amod	relType_9=amod	lemma_11=in	pos_10=NN	lemma_3=Key	pos_14=NN	lemma_2=,	pos_8=VBD	pos_11=IN	lemma_2=Theo	relType_2=dep	lemma_5=,	relType_2=compound	relType_5=punct	relType_4=compound	wib=Theo	relType_8=ROOT	pos_7=-RRB-	pos_1=-LRB-	relType_6=appos	eib=True	relType_7=punct	lemma_8=demonstrate	pos_4=NNP	pos_2=,	relType_3=compound	relType_1=punct	relType_10=obj	lemma_7=)
DDI-DrugBank.d171.s4	DDI-DrugBank.d171.s4.e2	DDI-DrugBank.d171.s4.e3	null	lemma_2=Key	lemma_1=,	lemma_8=less	relType_8=amod	path=Dur_dep<theophylline_nmod<dosage_obl<b._acl<mg_obl<concomitantly_advmod<demonstrate_ROOT>alteration_obj>level_nmod>theophylline_compound	pos_1=,	pos_3=NNP	lib=key	path2=alteration_obj>level_nmod>theophylline_compound	lpib=key_NNP	lemma_9=alteration	pos_2=NNP	eib=False	pos_4=,	relType_6=punct	relType_11=amod	path1=Dur_dep<theophylline_nmod<dosage_obl<b._acl<mg_obl<concomitantly_advmod	wib=Key	relType_10=case	relType_12=punct	pos_13=NN	pos_9=NN	lemma_6=)	lemma_12=-	relType_7=ROOT	relType_4=punct	lemma_10=in	relType_13=compound	relType_2=compound	pos_7=VBD	relType_9=obj	lemma_13=state	pos_5=NNP	lemma_4=,	pos_10=IN	relType_5=appos	pos_6=-RRB-	lemma_7=demonstrate	pos_12=HYPH	relType_3=compound	pos_11=JJ	lemma_5=Inc.	relType_1=punct	lemma_3=Pharmaceuticals	pos_8=JJR	lemma_11=steady
DDI-DrugBank.d237.s1	DDI-DrugBank.d237.s1.e0	DDI-DrugBank.d237.s1.e1	null	relType_14=amod	pos_2=VBN	pos_13=,	pos_3=IN	pos_8=DT	relType_7=case	lemma_13=,	lemma_15=blood	lemma_11=3a4	relType_1=aux:pass	relType_13=punct	pos_6=CD	relType_2=advcl	lemma_4=conjunction	relType_5=case	path1=cisapride_nsubj:pass	pos_1=VBD	relType_9=compound	eib=False	lemma_1=be	relType_12=nmod	lemma_5=with	lemma_12=inhibitor	relType_10=compound	pos_10=NN	lemma_6=one	pos_9=NN	pos_4=NN	path2=conjunction_obl>level_appos>cisapride_compound	relType_6=nmod	lemma_10=p450	relType_4=obl	path=cisapride_nsubj:pass<take_advcl>conjunction_obl>level_appos>cisapride_compound	lib=be	pos_15=NN	pos_12=NNS	lemma_2=take	lemma_8=the	pos_5=IN	wib=was	relType_3=case	lemma_7=of	relType_15=compound	pos_11=NN	pos_7=IN	relType_11=compound	pos_14=JJ	lemma_14=elevated	relType_8=det	lpib=be_VBD	lemma_3=in	lemma_9=cytochrome
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e0	DDI-DrugBank.d237.s2.e1	null	relType_3=advmod	relType_8=dep	relType_9=conj	path1=	path2=show_dep>inhibit_ccomp>clarithromycin_nsubj	path=<antibiotic_ROOT>show_dep>inhibit_ccomp>clarithromycin_nsubj	relType_4=cc	relType_10=dep	lemma_9=datum	eib=False	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_7=FW	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	relType_7=amod	pos_6=CC	pos_8=FW	relType_2=compound	relType_5=punct	pos_1=:	lemma_3=vitro	lemma_10=show	pos_2=FW	lpib=datum_NNS	relType_11=mark	pos_10=VBP	pos_4=CC	lemma_7=in	wib=data	lemma_4=and	lemma_8=vivo	lemma_5=/	relType_1=punct	lemma_2=in	lib=datum	relType_6=cc
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e0	DDI-DrugBank.d237.s2.e2	null	relType_3=advmod	relType_8=dep	path=<antibiotic_ROOT>show_dep>inhibit_ccomp>clarithromycin_nsubj>erythromycin_conj	relType_9=conj	path1=	relType_4=cc	relType_10=dep	lemma_12=,	lemma_9=datum	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_12=,	pos_7=FW	relType_12=punct	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	relType_7=amod	pos_6=CC	pos_8=FW	relType_2=compound	relType_5=punct	pos_1=:	lemma_3=vitro	lemma_12=clarithromycin	lemma_10=show	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	relType_11=mark	pos_10=VBP	eib=True	pos_4=CC	wib=data	lemma_7=in	lemma_4=and	lemma_8=vivo	lemma_5=/	relType_1=punct	pos_12=NN	path2=show_dep>inhibit_ccomp>clarithromycin_nsubj>erythromycin_conj	lemma_2=in	lib=datum	relType_6=cc
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e0	DDI-DrugBank.d237.s2.e3	null	pos_13=,	path2=show_dep>inhibit_ccomp>clarithromycin_nsubj>troleandomycin_conj	relType_3=advmod	relType_8=dep	relType_9=conj	lemma_13=,	pos_14=CC	path1=	relType_13=punct	relType_4=cc	relType_10=dep	lemma_12=,	lemma_9=datum	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_12=,	pos_7=FW	relType_12=punct	relType_13=conj	pos_13=NN	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	relType_7=amod	pos_6=CC	lemma_13=erythromycin	pos_8=FW	relType_2=compound	relType_5=punct	pos_1=:	lemma_3=vitro	lemma_12=clarithromycin	lemma_10=show	relType_14=cc	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	relType_11=mark	pos_10=VBP	eib=True	pos_4=CC	wib=data	lemma_7=in	lemma_4=and	lemma_14=and	lemma_8=vivo	lemma_5=/	relType_1=punct	pos_12=NN	lemma_2=in	lib=datum	path=<antibiotic_ROOT>show_dep>inhibit_ccomp>clarithromycin_nsubj>troleandomycin_conj	relType_6=cc
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e0	DDI-DrugBank.d237.s2.e4	null	pos_19=IN	pos_13=,	relType_3=advmod	relType_8=dep	relType_9=conj	lemma_13=,	pos_14=CC	pos_17=DT	path2=show_dep>inhibit_ccomp>metabolism_obj>cisapride_nmod	path1=	relType_13=punct	relType_4=cc	relType_10=dep	relType_16=ccomp	lemma_12=,	relType_17=det	lemma_9=datum	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_12=,	lemma_18=metabolism	pos_7=FW	relType_12=punct	relType_13=conj	pos_13=NN	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	pos_18=NN	lemma_19=of	relType_7=amod	pos_15=NN	pos_6=CC	lemma_15=troleandomycin	lemma_13=erythromycin	pos_8=FW	relType_2=compound	relType_5=punct	relType_19=case	pos_1=:	lemma_3=vitro	lemma_12=clarithromycin	lemma_17=the	lemma_10=show	relType_14=cc	path=<antibiotic_ROOT>show_dep>inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	relation_18=adverse	relType_11=mark	pos_10=VBP	eib=True	pos_4=CC	wib=data	lemma_7=in	lemma_15=markedly	lemma_4=and	relType_15=conj	lemma_14=and	pos_16=VBP	lemma_8=vivo	lemma_5=/	lemma_16=inhibit	relType_18=obj	relType_1=punct	pos_12=NN	relType_15=advmod	lemma_2=in	lib=datum	pos_15=RB	relType_6=cc
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e0	DDI-DrugBank.d237.s2.e5	null	pos_14=CC	lemma_13=,	relType_10=dep	lemma_20=,	lemma_12=,	relType_24=case	relType_17=det	pos_12=,	pos_20=NN	relType_20=nmod	pos_7=FW	pos_26=NN	pos_13=NN	pos_3=FW	lemma_11=that	pos_18=NN	lemma_15=troleandomycin	lemma_13=erythromycin	pos_1=:	lemma_10=show	relType_25=det	pos_24=IN	pos_28=NN	lemma_7=in	wib=data	lemma_4=and	relType_18=obj	pos_16=VBP	pos_15=RB	pos_13=,	path1=	pos_23=VB	lemma_9=datum	lemma_22=can	relType_12=punct	relType_13=conj	pos_6=CC	pos_8=FW	lemma_17=the	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	lemma_15=markedly	relType_19=case	lemma_16=inhibit	lemma_14=and	relation_29=beneficial	relType_1=punct	path2=show_dep>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_2=in	lemma_24=in	path=<antibiotic_ROOT>show_dep>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_8=dep	pos_17=DT	lemma_21=which	lemma_6=or	lemma_18=metabolism	lemma_1=:	pos_11=IN	lemma_19=of	relType_7=amod	lemma_12=clarithromycin	pos_22=MD	pos_21=WDT	lemma_28=plasma	relType_16=ccomp	pos_4=CC	relType_15=conj	lemma_25=a	relType_20=punct	lemma_5=/	relType_27=case	lib=datum	lemma_26=increase	relType_6=cc	pos_19=IN	relType_3=advmod	relType_9=conj	relType_13=punct	relType_4=cc	pos_25=DT	pos_9=NNS	pos_5=HYPH	lemma_27=in	pos_27=IN	lemma_20=cisapride	pos_20=,	relType_21=nsubj	relType_28=compound	pos_15=NN	relType_2=compound	relType_5=punct	lemma_3=vitro	relType_22=aux	relType_26=obl	relType_14=cc	relation_18=adverse	relType_11=mark	pos_10=VBP	eib=True	relType_23=acl:relcl	lemma_23=result	lemma_8=vivo	relType_15=advmod	pos_12=NN
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e1	DDI-DrugBank.d237.s2.e2	null	lpib=erythromycin_NN	lemma_1=,	eib=False	path2=erythromycin_conj	path1=	pos_1=,	wib=erythromycin	relType_1=punct	lib=erythromycin	path=<clarithromycin_nsubj>erythromycin_conj
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e1	DDI-DrugBank.d237.s2.e3	null	lpib=erythromycin_NN	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	wib=erythromycin	relType_3=cc	relType_2=punct	relType_2=conj	lib=erythromycin	lemma_2=,	eib=True	pos_2=,	lemma_3=and	path2=troleandomycin_conj	relType_1=punct	path=<clarithromycin_nsubj>troleandomycin_conj	lemma_2=erythromycin
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e1	DDI-DrugBank.d237.s2.e4	mechanism	lpib=erythromycin_NN	relType_8=case	lemma_4=troleandomycin	lemma_1=,	pos_2=NN	pos_3=CC	pos_6=DT	path=clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_1=,	wib=erythromycin	lemma_5=inhibit	relType_3=cc	relType_2=punct	lemma_7=metabolism	pos_4=RB	pos_5=VBP	lemma_6=the	relation_6=adverse	relType_7=obj	relType_2=conj	lib=erythromycin	lemma_2=,	pos_4=NN	lemma_4=markedly	pos_8=IN	relType_4=advmod	relType_5=ccomp	relType_6=det	path2=metabolism_obj>cisapride_nmod	path1=clarithromycin_nsubj	eib=True	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	pos_7=NN	lemma_8=of	lemma_2=erythromycin
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e1	DDI-DrugBank.d237.s2.e5	null	lpib=erythromycin_NN	relType_8=case	lemma_4=troleandomycin	lemma_16=in	lemma_1=,	lemma_17=plasma	pos_2=NN	lemma_15=increase	pos_3=CC	pos_6=DT	pos_16=IN	pos_11=MD	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=,	wib=erythromycin	lemma_9=cisapride	lemma_12=result	lemma_9=,	relType_9=nmod	lemma_5=inhibit	relType_3=cc	relType_2=punct	lemma_7=metabolism	pos_17=NN	pos_4=RB	lemma_10=which	pos_5=VBP	lemma_6=the	relType_11=aux	relType_7=obj	relation_6=adverse	relType_14=det	relType_17=compound	pos_13=IN	relType_2=conj	lib=erythromycin	lemma_2=,	pos_4=NN	path=clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_4=markedly	pos_8=IN	pos_9=NN	relType_13=case	pos_10=WDT	pos_15=NN	relType_15=obl	relType_4=advmod	lemma_11=can	relType_10=nsubj	relType_12=acl:relcl	lemma_13=in	relType_9=punct	pos_14=DT	pos_12=VB	relType_5=ccomp	relType_6=det	lemma_14=a	relType_16=case	path1=clarithromycin_nsubj	eib=True	pos_2=,	lemma_3=and	relType_4=conj	relation_17=beneficial	pos_9=,	relType_1=punct	pos_7=NN	lemma_8=of	lemma_2=erythromycin
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e2	DDI-DrugBank.d237.s2.e3	null	lemma_2=and	lemma_1=,	eib=False	pos_2=CC	wib=troleandomycin	pos_1=,	lpib=troleandomycin_NN	path2=troleandomycin_conj	relType_1=punct	relType_2=cc	path1=erythromycin_conj	lib=troleandomycin	path=erythromycin_conj<clarithromycin_nsubj>troleandomycin_conj
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e2	DDI-DrugBank.d237.s2.e4	mechanism	path=erythromycin_conj<clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	lemma_1=,	pos_3=RB	relType_3=advmod	relType_7=case	relation_4=adverse	pos_1=,	relType_2=cc	pos_6=NN	lemma_2=and	pos_4=VBP	relType_3=conj	relType_4=ccomp	path1=erythromycin_conj<clarithromycin_nsubj	relType_5=det	lemma_4=inhibit	lpib=troleandomycin_NN	lib=troleandomycin	lemma_7=of	relType_6=obj	path2=metabolism_obj>cisapride_nmod	lemma_5=the	eib=True	pos_7=IN	pos_3=NN	lemma_3=troleandomycin	pos_2=CC	pos_5=DT	wib=troleandomycin	lemma_6=metabolism	relType_1=punct	lemma_3=markedly
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e2	DDI-DrugBank.d237.s2.e5	null	lemma_1=,	lemma_13=a	pos_3=RB	relType_3=advmod	relType_7=case	relation_4=adverse	lemma_9=which	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=,	relType_11=acl:relcl	relType_12=case	pos_13=DT	lemma_14=increase	relType_8=punct	relType_16=compound	relType_2=cc	lemma_8=,	pos_9=WDT	pos_6=NN	pos_8=NN	lemma_2=and	lemma_16=plasma	pos_4=VBP	pos_10=MD	relType_10=aux	path=erythromycin_conj<clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_10=can	pos_14=NN	relType_14=obl	pos_12=IN	relType_15=case	relType_3=conj	relType_4=ccomp	path1=erythromycin_conj<clarithromycin_nsubj	relType_5=det	lemma_4=inhibit	lpib=troleandomycin_NN	pos_16=NN	relation_15=beneficial	lemma_11=result	lib=troleandomycin	pos_15=IN	lemma_7=of	relType_6=obj	lemma_8=cisapride	lemma_12=in	lemma_15=in	lemma_5=the	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	lemma_3=troleandomycin	pos_2=CC	pos_5=DT	wib=troleandomycin	lemma_6=metabolism	relType_9=nsubj	pos_11=VB	relType_13=det	relType_1=punct	lemma_3=markedly	pos_8=,
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e3	DDI-DrugBank.d237.s2.e4	mechanism	wib=markedly	lemma_5=of	relType_5=case	lib=markedly	lpib=markedly_RB	eib=False	relation_1=adverse	relType_3=det	pos_4=NN	relType_4=obj	relType_1=advmod	path1=troleandomycin_conj<clarithromycin_nsubj	pos_5=IN	pos_2=VBP	relType_2=ccomp	lemma_1=markedly	path2=metabolism_obj>cisapride_nmod	pos_3=DT	pos_1=RB	lemma_2=inhibit	lemma_3=the	path=troleandomycin_conj<clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	lemma_4=metabolism
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e3	DDI-DrugBank.d237.s2.e5	null	relType_12=obl	lemma_8=can	lemma_7=which	wib=markedly	lemma_11=a	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_6=,	pos_9=VB	relType_14=compound	lemma_5=of	relType_5=case	pos_6=NN	lib=markedly	lpib=markedly_RB	relType_6=punct	pos_8=MD	relation_1=adverse	pos_12=NN	pos_14=NN	relType_10=case	pos_13=IN	relType_3=det	pos_7=WDT	pos_4=NN	relType_9=acl:relcl	relType_4=obj	relType_1=advmod	relType_13=case	lemma_14=plasma	path1=troleandomycin_conj<clarithromycin_nsubj	path=troleandomycin_conj<clarithromycin_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_12=increase	lemma_10=in	pos_5=IN	pos_2=VBP	lemma_9=result	pos_10=IN	pos_11=DT	lemma_13=in	relType_2=ccomp	lemma_1=markedly	pos_6=,	relType_11=det	eib=True	pos_3=DT	pos_1=RB	lemma_6=cisapride	lemma_2=inhibit	lemma_3=the	relType_8=aux	relType_7=nsubj	relType_6=nmod	relation_12=beneficial	lemma_4=metabolism
DDI-DrugBank.d237.s2	DDI-DrugBank.d237.s2.e4	DDI-DrugBank.d237.s2.e5	null	relType_8=case	lemma_1=,	lemma_5=in	lemma_9=plasma	pos_6=DT	pos_1=,	relType_4=acl:relcl	pos_2=WDT	path2=result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_5=case	lemma_4=result	lemma_3=can	lemma_8=in	relType_9=compound	relType_2=nsubj	eib=False	lemma_6=a	pos_3=MD	lemma_7=increase	pos_9=NN	pos_8=IN	pos_5=IN	wib=result	relation_6=beneficial	path1=cisapride_nmod	relType_6=det	lemma_2=which	path=cisapride_nmod<metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_7=obl	pos_4=VB	lib=result	relType_3=aux	relType_1=punct	pos_7=NN	lpib=result_VB
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e0	DDI-DrugBank.d237.s3.e1	null	pos_6=JJ	path1=	lemma_3=administration	relType_3=nsubj:pass	pos_2=JJ	path2=expect_parataxis>administration_nsubj:pass>compound_nmod	relType_6=amod	lemma_1=:	pos_5=JJ	lemma_6=anticholinergic	relType_5=amod	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_2=concurrent	lpib=concurrent_JJ	eib=True	path=<Anticholinergics_ROOT>expect_parataxis>administration_nsubj:pass>compound_nmod	pos_3=NN	lemma_5=certain	lib=concurrent	relType_1=punct	wib=Concurrent	lemma_4=of
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e0	DDI-DrugBank.d237.s3.e2	null	pos_6=JJ	relType_7=case	path1=	lemma_6=,	lemma_3=administration	relType_3=nsubj:pass	path2=expect_parataxis>administration_nsubj:pass>alkaloid_nmod	pos_2=JJ	lemma_9=belladonna	lemma_8=as	lemma_7=such	relType_9=compound	relType_6=punct	relType_6=amod	pos_9=NN	lemma_1=:	pos_8=IN	pos_5=JJ	lemma_6=anticholinergic	relType_5=amod	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_2=concurrent	pos_6=,	lpib=concurrent_JJ	lemma_6=compound	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	lemma_5=certain	relType_8=fixed	lib=concurrent	path=<Anticholinergics_ROOT>expect_parataxis>administration_nsubj:pass>alkaloid_nmod	relType_1=punct	relType_6=nmod	wib=Concurrent	lemma_4=of
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e0	DDI-DrugBank.d237.s3.e3	null	path2=expect_parataxis>administration_nsubj:pass>alkaloid_nmod>dicyclomine_conj	pos_6=JJ	relType_7=case	path1=	lemma_6=,	lemma_3=administration	relType_3=nsubj:pass	relType_9=nmod	pos_2=JJ	lemma_9=belladonna	lemma_8=as	lemma_7=such	relType_9=compound	relType_6=punct	relType_6=amod	pos_9=NNS	pos_9=NN	lemma_1=:	pos_8=IN	pos_5=JJ	lemma_9=and	lemma_6=anticholinergic	pos_9=CC	relType_5=amod	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_9=alkaloid	lemma_2=concurrent	pos_6=,	lpib=concurrent_JJ	path=<Anticholinergics_ROOT>expect_parataxis>administration_nsubj:pass>alkaloid_nmod>dicyclomine_conj	lemma_6=compound	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	lemma_5=certain	relType_8=fixed	lib=concurrent	relType_1=punct	relType_6=nmod	wib=Concurrent	lemma_4=of	relType_9=cc
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e0	DDI-DrugBank.d237.s3.e4	null	pos_6=JJ	lemma_10=,	lemma_6=,	lemma_3=administration	pos_16=DT	relType_3=nsubj:pass	pos_2=JJ	pos_13=VBN	lemma_16=the	lemma_11=would	pos_10=NN	pos_9=CC	pos_1=:	lemma_9=alkaloid	pos_10=,	pos_7=JJ	pos_6=NNS	lemma_5=certain	lib=concurrent	relType_18=obj	pos_18=NNS	relType_7=case	path1=	relation_22=neutral	relType_13=parataxis	lemma_8=as	relType_10=conj	pos_9=NN	pos_8=IN	lemma_6=anticholinergic	path=<Anticholinergics_ROOT>expect_parataxis>compromise_xcomp>effect_obj>cisapride_nmod	relType_17=amod	relType_19=case	relType_1=punct	relType_10=punct	pos_11=MD	lemma_9=belladonna	lemma_7=such	pos_14=TO	relType_11=aux	lemma_1=:	lemma_19=of	relType_5=amod	pos_4=IN	relType_2=amod	relType_14=mark	lpib=concurrent_JJ	pos_12=VB	lemma_6=compound	lemma_18=effect	lemma_15=compromise	relType_15=xcomp	relType_6=nmod	wib=Concurrent	lemma_10=dicyclomine	lemma_4=of	lemma_13=expect	path2=expect_parataxis>compromise_xcomp>effect_obj>cisapride_nmod	pos_19=IN	pos_17=JJ	relType_9=nmod	relType_16=det	relType_12=aux:pass	relType_9=compound	lemma_14=to	lemma_17=beneficial	relType_6=punct	relType_6=amod	pos_9=NNS	pos_5=JJ	lemma_9=and	pos_15=VB	lemma_12=be	relType_4=case	lemma_2=concurrent	pos_6=,	eib=True	pos_3=NN	relType_8=fixed	relType_9=cc
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e1	DDI-DrugBank.d237.s3.e2	null	lemma_1=,	pos_3=IN	pos_1=,	path2=alkaloid_nmod	pos_2=JJ	lemma_3=as	relType_3=fixed	path1=compound_nmod	pos_4=NN	lemma_2=such	lpib=such_JJ	lemma_4=belladonna	relType_4=compound	path=compound_nmod<administration_nsubj:pass>alkaloid_nmod	relType_2=case	wib=such	eib=True	lib=such	relType_1=punct
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e1	DDI-DrugBank.d237.s3.e3	null	lemma_1=,	pos_3=IN	pos_1=,	relType_4=nmod	relType_4=cc	pos_2=JJ	lemma_3=as	relType_3=fixed	path2=alkaloid_nmod>dicyclomine_conj	path1=compound_nmod	pos_4=NN	pos_4=NNS	lemma_2=such	path=compound_nmod<administration_nsubj:pass>alkaloid_nmod>dicyclomine_conj	lpib=such_JJ	lemma_4=belladonna	relType_4=compound	relType_2=case	wib=such	eib=True	pos_4=CC	lemma_4=and	lemma_4=alkaloid	lib=such	relType_1=punct
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e1	DDI-DrugBank.d237.s3.e4	effect	pos_7=VB	lemma_1=,	pos_3=IN	pos_5=,	path1=compound_nmod<administration_nsubj:pass	lemma_7=be	pos_8=VBN	pos_1=,	pos_13=NNS	relType_4=nmod	relType_4=cc	pos_2=JJ	lemma_3=as	lemma_8=expect	pos_12=JJ	relType_3=fixed	lemma_6=would	pos_9=TO	lemma_10=compromise	lemma_9=to	relType_12=amod	relation_15=neutral	pos_4=NN	path=compound_nmod<administration_nsubj:pass<expect_parataxis>compromise_xcomp>effect_obj>cisapride_nmod	lemma_2=such	pos_4=NNS	relType_8=parataxis	pos_10=VB	pos_14=IN	lpib=such_JJ	lemma_5=dicyclomine	lemma_12=beneficial	lemma_4=belladonna	relType_6=aux	lemma_5=,	relType_5=punct	relType_4=compound	relType_7=aux:pass	path2=compromise_xcomp>effect_obj>cisapride_nmod	relType_5=conj	pos_6=MD	pos_11=DT	lemma_11=the	relType_11=det	relType_9=mark	pos_5=NN	relType_2=case	wib=such	eib=True	pos_4=CC	lemma_4=and	relType_10=xcomp	lemma_14=of	relType_13=obj	relType_14=case	lemma_4=alkaloid	lib=such	relType_1=punct	lemma_13=effect
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e2	DDI-DrugBank.d237.s3.e3	null	relType_1=cc	path=<alkaloid_nmod>dicyclomine_conj	pos_1=CC	eib=False	lib=dicyclomine	path1=	path2=dicyclomine_conj	lpib=dicyclomine_NN	wib=dicyclomine	lemma_1=and
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e2	DDI-DrugBank.d237.s3.e4	effect	relType_1=cc	pos_7=VB	pos_1=CC	pos_6=TO	pos_2=NN	path=alkaloid_nmod<administration_nsubj:pass<expect_parataxis>compromise_xcomp>effect_obj>cisapride_nmod	pos_8=DT	lemma_4=be	lib=dicyclomine	relation_10=neutral	relType_5=parataxis	wib=dicyclomine	lemma_6=to	relType_11=case	relType_2=punct	lemma_9=beneficial	pos_9=JJ	pos_10=NNS	pos_3=MD	lpib=dicyclomine_NN	lemma_3=would	relType_9=amod	lemma_10=effect	relType_2=conj	relType_10=obj	lemma_2=,	lemma_2=dicyclomine	relType_7=xcomp	pos_11=IN	relType_6=mark	lemma_8=the	relType_4=aux:pass	path2=compromise_xcomp>effect_obj>cisapride_nmod	lemma_5=expect	lemma_7=compromise	eib=True	pos_4=VB	lemma_11=of	pos_2=,	relType_3=aux	relType_8=det	path1=alkaloid_nmod<administration_nsubj:pass	pos_5=VBN	lemma_1=and
DDI-DrugBank.d237.s3	DDI-DrugBank.d237.s3.e3	DDI-DrugBank.d237.s3.e4	effect	lemma_1=,	pos_6=VB	relType_7=det	relType_8=amod	pos_2=MD	pos_1=,	lemma_10=of	path1=dicyclomine_conj<alkaloid_nmod<administration_nsubj:pass	pos_3=VB	relType_3=aux:pass	relation_8=neutral	lemma_6=compromise	wib=be	pos_8=JJ	lemma_2=would	relType_5=mark	eib=False	pos_9=NNS	relType_2=aux	path=dicyclomine_conj<alkaloid_nmod<administration_nsubj:pass<expect_parataxis>compromise_xcomp>effect_obj>cisapride_nmod	relType_10=case	pos_5=TO	pos_7=DT	relType_4=parataxis	pos_4=VBN	lemma_8=beneficial	lib=be	lemma_3=be	relType_9=obj	lemma_5=to	path2=compromise_xcomp>effect_obj>cisapride_nmod	pos_10=IN	lpib=be_VB	lemma_4=expect	lemma_7=the	lemma_9=effect	relType_1=punct	relType_6=xcomp
DDI-DrugBank.d237.s4	DDI-DrugBank.d237.s4.e0	DDI-DrugBank.d237.s4.e1	null	lemma_5=in	lib=oral	relType_8=amod	path1=	pos_7=VBG	relType_7=acl	pos_2=JJ	relType_5=case	lemma_1=(	pos_8=JJ	relType_6=obl	lemma_4=:	eib=False	lemma_6=patient	wib=Oral	lemma_8=oral	lemma_2=oral	relType_2=dep	relType_4=punct	pos_4=:	lemma_7=receive	pos_5=IN	lpib=oral_JJ	lemma_3=)	pos_1=-LRB-	pos_3=-RRB-	path2=increase_parataxis>patient_obl>receive_acl>anticoagulant_obj	pos_6=NNS	relType_1=punct	path=<anticoagulant_ROOT>increase_parataxis>patient_obl>receive_acl>anticoagulant_obj	relType_3=punct
DDI-DrugBank.d237.s5	DDI-DrugBank.d237.s5.e0	DDI-DrugBank.d237.s5.e1	advise	pos_3=IN	pos_8=DT	relType_7=case	lemma_4=a	lpib=therapy_NN	relType_2=punct	pos_6=NN	relType_6=obl	path1=cisapride_compound<therapy_nmod<start_obl	eib=False	lemma_6=adjustment	lemma_1=therapy	relType_1=nmod	lemma_2=,	pos_1=NN	pos_4=DT	pos_5=JJ	relType_5=amod	lemma_8=the	lemma_5=appropriate	lib=therapy	lemma_3=with	path=cisapride_compound<therapy_nmod<start_obl<check_xcomp>adjustment_obl>dose_nmod>anticoagulant_amod	relType_3=case	lemma_7=of	path2=adjustment_obl>dose_nmod>anticoagulant_amod	pos_7=IN	pos_2=,	relType_8=det	relType_4=det	wib=therapy
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e0	DDI-DrugBank.d237.s6.e1	null	relType_3=dep	path1=	path2=indicate_appos>inhibit_ccomp>nefazodone_nsubj	lemma_5=indicate	eib=False	pos_5=VBP	lemma_4=datum	pos_6=IN	relType_4=nsubj	pos_4=NNS	pos_3=FW	lemma_1=:	relType_6=mark	relType_2=amod	pos_1=:	lemma_3=vitro	relType_5=appos	pos_2=FW	path=<antidepressant_ROOT>indicate_appos>inhibit_ccomp>nefazodone_nsubj	lpib=datum_NNS	wib=data	lemma_6=that	relType_1=punct	lemma_2=in	lib=datum
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e0	DDI-DrugBank.d237.s6.e2	null	relType_3=dep	pos_7=VBZ	pos_8=DT	path1=	lemma_10=of	lemma_5=indicate	lemma_7=nefazodone	pos_5=VBP	lemma_4=datum	pos_6=IN	relation_7=adverse	relType_10=case	relType_4=nsubj	pos_9=NN	pos_4=NNS	pos_3=FW	lemma_1=:	lemma_9=metabolism	relType_6=mark	lemma_8=the	relType_2=amod	pos_1=:	lemma_3=vitro	relType_9=obj	path2=indicate_appos>inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_10=IN	relType_5=appos	pos_2=FW	lpib=datum_NNS	eib=True	wib=data	lemma_7=inhibit	path=<antidepressant_ROOT>indicate_appos>inhibit_ccomp>metabolism_obj>cisapride_nmod	relType_7=ccomp	relType_7=nsubj	relType_8=det	lemma_6=that	relType_1=punct	pos_7=NN	lemma_2=in	lib=datum
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e0	DDI-DrugBank.d237.s6.e3	null	relType_3=dep	pos_7=VBZ	pos_8=DT	relType_17=obl	lemma_11=,	path1=	pos_16=DT	lemma_10=of	lemma_12=which	lemma_5=indicate	relType_16=det	relType_18=case	pos_17=NN	lemma_19=plasma	lemma_16=a	relation_18=beneficial	relType_14=acl:relcl	lemma_7=nefazodone	pos_5=VBP	lemma_4=datum	pos_6=IN	lemma_11=cisapride	relType_11=punct	relType_13=aux	relation_7=adverse	pos_19=NN	relType_10=case	lemma_14=result	relType_4=nsubj	pos_9=NN	pos_18=IN	pos_4=NNS	pos_3=FW	lemma_1=:	relType_19=compound	relType_15=case	lemma_9=metabolism	relType_6=mark	lemma_8=the	relType_2=amod	path=<antidepressant_ROOT>indicate_appos>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=:	lemma_3=vitro	relType_9=obj	pos_14=VB	path2=indicate_appos>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_10=IN	pos_11=,	relType_5=appos	pos_2=FW	pos_15=IN	relType_12=nsubj	lpib=datum_NNS	lemma_15=in	pos_11=NN	lemma_13=can	eib=True	wib=data	lemma_7=inhibit	lemma_18=in	relType_7=ccomp	relType_7=nsubj	relType_8=det	lemma_6=that	relType_1=punct	pos_7=NN	relType_11=nmod	lemma_2=in	lib=datum	pos_12=WDT	pos_13=MD	lemma_17=increase
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e1	DDI-DrugBank.d237.s6.e2	mechanism	pos_2=DT	lemma_2=the	relation_0=adverse	lemma_1=inhibit	path1=nefazodone_nsubj	path=nefazodone_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	eib=False	lib=inhibit	lemma_3=metabolism	pos_4=IN	relType_1=ccomp	relType_4=case	wib=inhibits	lpib=inhibit_VBZ	path2=metabolism_obj>cisapride_nmod	pos_1=VBZ	pos_3=NN	relType_2=det	relType_3=obj	lemma_4=of
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e1	DDI-DrugBank.d237.s6.e3	null	pos_2=DT	lemma_2=the	relType_10=det	pos_5=,	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_12=case	relation_0=adverse	lemma_1=inhibit	relType_7=aux	pos_9=IN	lemma_10=a	lemma_9=in	relType_8=acl:relcl	path1=nefazodone_nsubj	path=nefazodone_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_7=can	lemma_6=which	lib=inhibit	pos_7=MD	relType_9=case	pos_13=NN	pos_12=IN	lemma_3=metabolism	pos_8=VB	lemma_5=cisapride	relType_13=compound	lemma_8=result	lemma_5=,	pos_4=IN	relType_5=punct	pos_6=WDT	relType_1=ccomp	relType_4=case	relType_5=nmod	lemma_13=plasma	relType_11=obl	wib=inhibits	lpib=inhibit_VBZ	pos_5=NN	lemma_11=increase	lemma_12=in	pos_11=NN	pos_1=VBZ	eib=True	pos_3=NN	relType_2=det	relType_3=obj	relation_11=beneficial	lemma_4=of	relType_6=nsubj	pos_10=DT
DDI-DrugBank.d237.s6	DDI-DrugBank.d237.s6.e2	DDI-DrugBank.d237.s6.e3	null	relType_8=case	lemma_1=,	lemma_5=in	lemma_9=plasma	pos_6=DT	pos_1=,	relType_4=acl:relcl	pos_2=WDT	path2=result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_5=case	lemma_4=result	lemma_3=can	lemma_8=in	relType_9=compound	relType_2=nsubj	eib=False	lemma_6=a	pos_3=MD	lemma_7=increase	pos_9=NN	pos_8=IN	pos_5=IN	wib=result	relation_6=beneficial	path1=cisapride_nmod	relType_6=det	lemma_2=which	path=cisapride_nmod<metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_7=obl	pos_4=VB	lib=result	relType_3=aux	relType_1=punct	pos_7=NN	lpib=result_VB
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e0	DDI-DrugBank.d237.s7.e1	null	relType_3=advmod	relType_8=dep	relType_9=conj	path1=	path=<antifungal_ROOT>indicate_dep>inhibit_ccomp>fluconazole_nsubj	relType_4=cc	relType_10=dep	lemma_9=datum	eib=False	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_7=FW	lemma_10=indicate	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	relType_7=amod	pos_6=CC	pos_8=FW	relType_2=compound	relType_5=punct	pos_1=:	path2=indicate_dep>inhibit_ccomp>fluconazole_nsubj	lemma_3=vitro	pos_2=FW	lpib=datum_NNS	relType_11=mark	pos_10=VBP	pos_4=CC	lemma_7=in	wib=data	lemma_4=and	lemma_8=vivo	lemma_5=/	relType_1=punct	lemma_2=in	lib=datum	relType_6=cc
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e0	DDI-DrugBank.d237.s7.e2	null	relType_3=advmod	relType_8=dep	relType_9=conj	path1=	lemma_12=fluconazole	relType_4=cc	relType_10=dep	lemma_12=,	lemma_9=datum	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_12=,	pos_7=FW	relType_12=punct	lemma_10=indicate	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	path=<antifungal_ROOT>indicate_dep>inhibit_ccomp>fluconazole_nsubj>itraconazole_conj	relType_7=amod	pos_6=CC	path2=indicate_dep>inhibit_ccomp>fluconazole_nsubj>itraconazole_conj	relType_2=compound	relType_5=punct	pos_8=FW	pos_1=:	lemma_3=vitro	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	relType_11=mark	pos_10=VBP	eib=True	pos_4=CC	wib=data	lemma_7=in	lemma_4=and	lemma_8=vivo	lemma_5=/	relType_1=punct	pos_12=NN	lemma_2=in	lib=datum	relType_6=cc
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e0	DDI-DrugBank.d237.s7.e3	null	pos_13=,	relType_3=advmod	relType_8=dep	relType_9=conj	lemma_13=,	pos_14=CC	pos_15=JJ	relType_15=amod	path1=	relType_13=punct	lemma_12=fluconazole	relType_4=cc	relType_10=dep	lemma_12=,	lemma_9=datum	path=<antifungal_ROOT>indicate_dep>inhibit_ccomp>fluconazole_nsubj>ketoconazole_conj	pos_9=NNS	pos_5=HYPH	lemma_6=or	pos_12=,	pos_7=FW	relType_12=punct	relType_13=conj	pos_13=NN	lemma_10=indicate	pos_3=FW	lemma_1=:	lemma_11=that	pos_11=IN	relType_7=amod	pos_6=CC	pos_8=FW	relType_2=compound	relType_5=punct	pos_1=:	lemma_3=vitro	relType_14=cc	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	path2=indicate_dep>inhibit_ccomp>fluconazole_nsubj>ketoconazole_conj	relType_11=mark	pos_10=VBP	eib=True	pos_4=CC	wib=data	lemma_7=in	lemma_4=and	lemma_14=and	lemma_8=vivo	lemma_5=/	lemma_15=oral	relType_1=punct	pos_12=NN	lemma_13=itraconazole	lemma_2=in	lib=datum	relType_6=cc
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e0	DDI-DrugBank.d237.s7.e4	null	pos_14=CC	lemma_13=,	relType_10=dep	lemma_12=,	pos_12=,	pos_7=FW	pos_13=NN	pos_3=FW	lemma_11=that	lemma_17=inhibit	pos_1=:	lemma_7=in	wib=data	lemma_4=and	lemma_19=metabolism	lemma_13=itraconazole	lemma_20=of	pos_13=,	path1=	pos_18=DT	relType_20=case	lemma_9=datum	pos_16=RB	relType_12=punct	relType_13=conj	pos_6=CC	pos_8=FW	pos_16=NN	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	path2=indicate_dep>inhibit_ccomp>metabolism_obj>cisapride_nmod	lemma_14=and	relType_18=det	relType_1=punct	relation_19=adverse	lemma_2=in	lemma_18=the	relType_8=dep	lemma_12=fluconazole	pos_20=IN	lemma_6=or	lemma_10=indicate	lemma_1=:	pos_11=IN	relType_16=advmod	relType_7=amod	pos_4=CC	lemma_5=/	lemma_15=oral	relType_19=obj	lib=datum	relType_6=cc	lemma_16=ketoconazole	relType_3=advmod	relType_9=conj	pos_15=JJ	relType_15=amod	relType_13=punct	pos_17=VBP	relType_4=cc	relType_17=ccomp	pos_9=NNS	pos_5=HYPH	pos_19=NN	relType_2=compound	relType_5=punct	lemma_3=vitro	relType_14=cc	path=<antifungal_ROOT>indicate_dep>inhibit_ccomp>metabolism_obj>cisapride_nmod	relType_11=mark	pos_10=VBP	eib=True	lemma_16=markedly	lemma_8=vivo	pos_12=NN	relType_16=conj
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e0	DDI-DrugBank.d237.s7.e5	null	pos_23=MD	pos_14=CC	lemma_13=,	relType_10=dep	lemma_24=result	lemma_12=,	lemma_27=increase	pos_12=,	pos_7=FW	lemma_28=in	pos_13=NN	pos_3=FW	lemma_11=that	lemma_17=inhibit	relType_27=obl	pos_1=:	lemma_21=,	lemma_29=plasma	pos_22=WDT	lemma_7=in	wib=data	lemma_4=and	lemma_19=metabolism	relType_21=punct	lemma_13=itraconazole	lemma_20=of	pos_13=,	lemma_23=can	path1=	relType_24=acl:relcl	relType_25=case	pos_18=DT	relType_20=case	relType_22=nsubj	lemma_9=datum	pos_16=RB	pos_29=NN	relType_12=punct	relType_13=conj	path=<antifungal_ROOT>indicate_dep>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_27=NN	pos_6=CC	pos_8=FW	pos_24=VB	pos_16=NN	pos_2=FW	relType_12=nsubj	lpib=datum_NNS	relType_23=aux	path2=indicate_dep>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_14=and	pos_25=IN	relType_18=det	relType_1=punct	relation_19=adverse	lemma_2=in	lemma_18=the	relType_8=dep	lemma_12=fluconazole	relType_21=nmod	relType_29=compound	lemma_26=a	pos_20=IN	lemma_6=or	lemma_10=indicate	lemma_1=:	pos_11=IN	relType_16=advmod	relType_7=amod	pos_26=DT	lemma_21=cisapride	relType_28=case	pos_4=CC	lemma_5=/	lemma_22=which	lemma_15=oral	relType_19=obj	lib=datum	relType_6=cc	relation_30=beneficial	lemma_16=ketoconazole	relType_3=advmod	relType_9=conj	pos_15=JJ	relType_15=amod	relType_13=punct	pos_17=VBP	relType_4=cc	pos_21=,	relType_17=ccomp	pos_9=NNS	pos_5=HYPH	pos_19=NN	relType_2=compound	relType_5=punct	lemma_3=vitro	relType_14=cc	relType_11=mark	pos_10=VBP	eib=True	relType_26=det	pos_28=IN	lemma_16=markedly	lemma_8=vivo	pos_12=NN	relType_16=conj	lemma_25=in	pos_21=NN
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e1	DDI-DrugBank.d237.s7.e2	null	lemma_1=,	wib=itraconazole	eib=False	path2=itraconazole_conj	path=<fluconazole_nsubj>itraconazole_conj	path1=	pos_1=,	lpib=itraconazole_NN	lib=itraconazole	relType_1=punct
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e1	DDI-DrugBank.d237.s7.e3	null	relType_4=amod	path2=ketoconazole_conj	lemma_1=,	pos_4=JJ	pos_2=NN	pos_3=CC	path1=	pos_1=,	lpib=itraconazole_NN	relType_3=cc	relType_2=punct	lib=itraconazole	relType_2=conj	lemma_2=,	path=<fluconazole_nsubj>ketoconazole_conj	wib=itraconazole	eib=True	lemma_2=itraconazole	lemma_4=oral	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e1	DDI-DrugBank.d237.s7.e4	mechanism	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	relType_7=det	pos_3=CC	lemma_5=ketoconazole	pos_1=,	lpib=itraconazole_NN	pos_9=IN	relType_3=cc	relType_2=punct	pos_8=NN	lemma_5=markedly	relType_8=obj	relation_7=adverse	lib=itraconazole	relType_9=case	relType_2=conj	lemma_2=,	pos_7=DT	path=fluconazole_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_5=RB	relType_6=ccomp	pos_6=VBP	relType_5=conj	lemma_8=metabolism	relType_5=advmod	pos_5=NN	path2=metabolism_obj>cisapride_nmod	lemma_6=inhibit	wib=itraconazole	eib=True	path1=fluconazole_nsubj	lemma_2=itraconazole	lemma_4=oral	lemma_9=of	pos_2=,	lemma_3=and	lemma_7=the	relType_1=punct
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e1	DDI-DrugBank.d237.s7.e5	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	relType_10=punct	relType_7=det	pos_3=CC	pos_11=WDT	lemma_10=,	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=,	lemma_5=ketoconazole	lpib=itraconazole_NN	pos_9=IN	lemma_15=a	relType_16=obl	relation_7=adverse	relType_3=cc	relType_2=punct	pos_17=IN	pos_8=NN	relation_18=beneficial	relType_10=nmod	lemma_12=can	lemma_5=markedly	lemma_13=result	relType_8=obj	relType_11=nsubj	lib=itraconazole	relType_9=case	relType_12=aux	pos_10=NN	relType_13=acl:relcl	relType_2=conj	lemma_14=in	lemma_2=,	pos_7=DT	pos_15=DT	pos_14=IN	relType_17=case	pos_18=NN	pos_13=VB	lemma_18=plasma	path=fluconazole_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_5=RB	relType_6=ccomp	pos_6=VBP	pos_16=NN	relType_5=conj	lemma_8=metabolism	lemma_17=in	lemma_11=which	lemma_16=increase	relType_5=advmod	pos_12=MD	pos_5=NN	pos_10=,	lemma_6=inhibit	wib=itraconazole	eib=True	path1=fluconazole_nsubj	lemma_2=itraconazole	lemma_4=oral	lemma_9=of	relType_18=compound	pos_2=,	lemma_3=and	lemma_7=the	relType_14=case	relType_1=punct	relType_15=det	lemma_10=cisapride
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e2	DDI-DrugBank.d237.s7.e3	null	lemma_2=and	path2=ketoconazole_conj	path=itraconazole_conj<fluconazole_nsubj>ketoconazole_conj	lib=oral	lemma_1=,	pos_3=JJ	lemma_3=oral	eib=False	relType_3=amod	wib=oral	pos_2=CC	path1=itraconazole_conj	pos_1=,	relType_1=punct	lpib=oral_JJ	relType_2=cc
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e2	DDI-DrugBank.d237.s7.e4	mechanism	relType_8=case	lemma_1=,	lib=oral	pos_6=DT	path1=itraconazole_conj<fluconazole_nsubj	pos_1=,	relation_5=adverse	relType_2=cc	path=itraconazole_conj<fluconazole_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	lemma_5=inhibit	lemma_7=metabolism	lemma_2=and	pos_4=RB	pos_5=VBP	lemma_6=the	relType_7=obj	pos_4=NN	lemma_4=markedly	pos_8=IN	relType_3=amod	relType_4=advmod	lpib=oral_JJ	relType_5=ccomp	relType_6=det	path2=metabolism_obj>cisapride_nmod	lemma_3=oral	pos_3=JJ	eib=True	wib=oral	pos_2=CC	relType_4=conj	relType_1=punct	pos_7=NN	lemma_8=of	lemma_4=ketoconazole
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e2	DDI-DrugBank.d237.s7.e5	null	relType_8=case	lemma_16=in	lemma_17=plasma	lemma_1=,	lib=oral	lemma_15=increase	pos_6=DT	pos_16=IN	path1=itraconazole_conj<fluconazole_nsubj	pos_11=MD	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=,	lemma_9=cisapride	lemma_12=result	lemma_9=,	relType_2=cc	relType_9=nmod	relation_5=adverse	lemma_5=inhibit	lemma_7=metabolism	lemma_2=and	pos_17=NN	pos_4=RB	relation_16=beneficial	pos_5=VBP	lemma_6=the	relType_11=aux	relType_7=obj	relType_14=det	relType_17=compound	pos_13=IN	pos_9=NN	pos_4=NN	lemma_4=markedly	pos_8=IN	relType_13=case	path=itraconazole_conj<fluconazole_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_10=WDT	pos_15=NN	relType_3=amod	relType_15=obl	relType_4=advmod	lemma_11=can	relType_10=nsubj	lpib=oral_JJ	relType_12=acl:relcl	relType_9=punct	lemma_13=in	pos_14=DT	pos_12=VB	relType_5=ccomp	relType_6=det	lemma_14=a	relType_16=case	lemma_3=oral	pos_3=JJ	eib=True	wib=oral	pos_2=CC	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lemma_8=of	lemma_4=ketoconazole	lemma_10=which
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e3	DDI-DrugBank.d237.s7.e4	mechanism	wib=markedly	lemma_5=of	relType_5=case	lib=markedly	lpib=markedly_RB	eib=False	path1=ketoconazole_conj<fluconazole_nsubj	relation_1=adverse	relType_3=det	path=ketoconazole_conj<fluconazole_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_4=NN	relType_4=obj	relType_1=advmod	pos_5=IN	pos_2=VBP	relType_2=ccomp	lemma_1=markedly	path2=metabolism_obj>cisapride_nmod	pos_3=DT	pos_1=RB	lemma_2=inhibit	lemma_3=the	lemma_4=metabolism
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e3	DDI-DrugBank.d237.s7.e5	null	relType_12=obl	lemma_8=can	lemma_7=which	wib=markedly	lemma_11=a	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_6=,	pos_9=VB	relType_14=compound	lemma_5=of	relType_5=case	pos_6=NN	lib=markedly	lpib=markedly_RB	path1=ketoconazole_conj<fluconazole_nsubj	relType_6=punct	pos_8=MD	relation_1=adverse	pos_12=NN	pos_14=NN	relType_10=case	pos_13=IN	relType_3=det	pos_7=WDT	pos_4=NN	relType_9=acl:relcl	relType_4=obj	relType_1=advmod	relType_13=case	lemma_14=plasma	lemma_12=increase	lemma_10=in	pos_5=IN	pos_2=VBP	lemma_9=result	pos_10=IN	pos_11=DT	lemma_13=in	relType_2=ccomp	lemma_1=markedly	pos_6=,	relType_11=det	eib=True	path=ketoconazole_conj<fluconazole_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_1=RB	pos_3=DT	lemma_6=cisapride	lemma_2=inhibit	lemma_3=the	relType_8=aux	relType_7=nsubj	relType_6=nmod	relation_12=beneficial	lemma_4=metabolism
DDI-DrugBank.d237.s7	DDI-DrugBank.d237.s7.e4	DDI-DrugBank.d237.s7.e5	null	relType_8=case	lemma_1=,	lemma_5=in	lemma_9=plasma	pos_6=DT	pos_1=,	relType_4=acl:relcl	pos_2=WDT	path2=result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_5=case	lemma_4=result	lemma_3=can	lemma_8=in	relType_9=compound	relType_2=nsubj	eib=False	lemma_6=a	pos_3=MD	lemma_7=increase	pos_9=NN	pos_8=IN	pos_5=IN	wib=result	relation_6=beneficial	path1=cisapride_nmod	relType_6=det	lemma_2=which	path=cisapride_nmod<metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_7=obl	pos_4=VB	lib=result	relType_3=aux	relType_1=punct	pos_7=NN	lpib=result_VB
DDI-DrugBank.d237.s8	DDI-DrugBank.d237.s8.e0	DDI-DrugBank.d237.s8.e1	mechanism	wib=markedly	lemma_5=of	relType_5=case	lib=markedly	lpib=markedly_RB	eib=False	relation_1=adverse	relType_3=det	pos_4=NN	relType_4=obj	relType_1=advmod	pos_5=IN	path1=ketoconazole_nsubj	relType_2=ccomp	lemma_1=markedly	pos_2=VBZ	path2=metabolism_obj>cisapride_nmod	path=ketoconazole_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_3=DT	pos_1=RB	lemma_2=inhibit	lemma_3=the	lemma_4=metabolism
DDI-DrugBank.d237.s8	DDI-DrugBank.d237.s8.e0	DDI-DrugBank.d237.s8.e2	null	relType_8=case	wib=markedly	lemma_9=a	relType_10=amod	lemma_14=increase	lemma_6=,	pos_7=VBG	relType_16=nmod	lemma_5=of	relType_5=case	pos_6=NN	pos_17=IN	lib=markedly	lemma_8=in	lpib=markedly_RB	relType_6=punct	path2=result_dep>increase_obl>auc_nmod>cisapride_nmod	lemma_16=auc	pos_9=DT	relation_1=adverse	relType_12=punct	pos_14=NN	pos_13=NN	relType_3=det	lemma_12=-	pos_4=NN	relType_14=obl	relType_4=obj	relType_1=advmod	pos_8=IN	relType_17=case	relType_15=case	relType_11=nummod	lemma_11=eight	relType_13=compound	pos_10=JJ	lemma_13=fold	pos_5=IN	lemma_17=of	pos_16=NN	path1=ketoconazole_nsubj	pos_11=CD	relType_2=ccomp	lemma_1=markedly	pos_6=,	pos_15=IN	pos_2=VBZ	lemma_15=in	relType_7=dep	eib=True	pos_3=DT	pos_1=RB	lemma_6=cisapride	relation_14=beneficial	lemma_2=inhibit	lemma_10=mean	lemma_3=the	pos_12=HYPH	lemma_7=result	relType_9=det	relType_6=nmod	path=ketoconazole_nsubj<inhibit_ccomp>result_dep>increase_obl>auc_nmod>cisapride_nmod	lemma_4=metabolism
DDI-DrugBank.d237.s8	DDI-DrugBank.d237.s8.e1	DDI-DrugBank.d237.s8.e2	null	lemma_1=,	pos_3=IN	lemma_4=a	pos_1=,	lemma_9=increase	pos_6=CD	relType_12=case	relType_9=obl	wib=resulting	lemma_12=of	pos_8=NN	lemma_7=-	relation_8=beneficial	eib=False	path=cisapride_nmod<metabolism_obj<inhibit_ccomp>result_dep>increase_obl>auc_nmod>cisapride_nmod	path2=result_dep>increase_obl>auc_nmod>cisapride_nmod	relType_10=case	pos_9=NN	lpib=result_VBG	pos_12=IN	pos_4=DT	pos_5=JJ	relType_2=dep	relType_5=amod	lemma_10=in	pos_7=HYPH	lemma_8=fold	relType_8=compound	relType_6=nummod	lemma_11=auc	lemma_6=eight	pos_10=IN	path1=cisapride_nmod<metabolism_obj	relType_3=case	lemma_2=result	pos_11=NN	relType_7=punct	lib=result	relType_11=nmod	relType_1=punct	relType_4=det	lemma_3=in	lemma_5=mean	pos_2=VBG
DDI-DrugBank.d237.s9	DDI-DrugBank.d237.s9.e0	DDI-DrugBank.d237.s9.e1	effect	path=<cisapride_nmod>ketoconazole_conj	relType_1=cc	path2=ketoconazole_conj	pos_1=CC	eib=False	path1=	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	lemma_1=and
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e0	DDI-DrugBank.d237.s10.e1	null	path=<antagonist_ROOT>lead_appos>coadministration_nsubj>cimetidine_compound	eib=False	path1=	pos_1=:	path2=lead_appos>coadministration_nsubj>cimetidine_compound	relType_1=punct	lib=cimetidine	wib=Cimetidine	lpib=cimetidine_NN	lemma_1=:
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e0	DDI-DrugBank.d237.s10.e2	null	path2=lead_appos>concentration_obl>cisapride_nmod	relType_7=compound	pos_2=NN	relType_10=cc	path1=	relType_12=case	lemma_6=increase	relType_9=obl	wib=Cimetidine	lpib=cimetidine_NN	relType_11=conj	lemma_12=of	lemma_5=a	pos_8=NN	relType_2=nsubj	relType_3=appos	lemma_9=concentration	pos_10=CC	relType_6=amod	pos_3=VBZ	pos_6=VBN	lemma_3=lead	pos_9=NN	pos_12=IN	lemma_1=:	lemma_10=and	lemma_7=peak	lemma_4=to	relType_2=compound	pos_4=IN	relType_5=det	relType_8=compound	pos_1=:	relType_4=case	lemma_8=plasma	lemma_11=auc	relation_6=beneficial	lib=cimetidine	path=<antagonist_ROOT>lead_appos>concentration_obl>cisapride_nmod	pos_11=NN	eib=True	pos_5=DT	relType_1=punct	pos_7=NN	lemma_2=coadministration	lemma_2=cimetidine
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e0	DDI-DrugBank.d237.s10.e3	null	relType_7=compound	pos_13=,	pos_2=NN	lemma_13=,	relType_10=cc	relation_18=neutral	path1=	path=<antagonist_ROOT>lead_appos>be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	relType_12=case	lemma_6=increase	relType_9=obl	relType_13=punct	pos_16=DT	lemma_16=no	wib=Cimetidine	relType_16=det	lpib=cimetidine_NN	relType_11=conj	lemma_12=of	pos_14=EX	path2=lead_appos>be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	lemma_5=a	pos_8=NN	relType_13=nmod	pos_17=NN	relType_18=case	relType_2=nsubj	relType_3=appos	lemma_9=concentration	pos_10=CC	relType_6=amod	pos_3=VBZ	relType_17=nsubj	pos_6=VBN	lemma_3=lead	pos_13=NN	pos_9=NN	pos_18=IN	pos_12=IN	lemma_1=:	pos_15=VBZ	lemma_10=and	lemma_13=cisapride	lemma_7=peak	lemma_4=to	relType_2=compound	pos_4=IN	relType_5=det	relType_8=compound	pos_1=:	relType_4=case	lemma_8=plasma	lemma_11=auc	relation_6=beneficial	lib=cimetidine	relType_15=parataxis	pos_11=NN	lemma_15=be	eib=True	lemma_14=there	pos_5=DT	lemma_17=effect	relType_1=punct	pos_7=NN	lemma_2=coadministration	lemma_2=cimetidine	lemma_18=on	relType_14=expl
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e0	DDI-DrugBank.d237.s10.e4	null	pos_2=NN	lemma_13=,	pos_16=DT	lemma_6=increase	relType_9=obl	lemma_19=cisapride	wib=Cimetidine	relType_18=case	pos_14=EX	relType_24=case	lemma_19=absorption	pos_3=VBZ	lemma_3=lead	pos_13=NN	lemma_10=and	lemma_13=cisapride	lemma_7=peak	pos_1=:	lemma_8=plasma	pos_24=IN	lib=cimetidine	lemma_23=coadminister	lemma_2=coadministration	pos_13=,	path1=	path2=lead_appos>be_parataxis>coadminister_advcl>ranitidine_obl	path=<antagonist_ROOT>lead_appos>be_parataxis>coadminister_advcl>ranitidine_obl	pos_8=NN	relType_2=nsubj	lemma_21=it	lemma_9=concentration	pos_23=VBN	pos_9=NN	pos_12=IN	relType_19=compound	lemma_20=when	pos_22=VBZ	lemma_24=with	pos_11=NN	relType_22=aux:pass	relType_1=punct	pos_7=NN	lemma_2=cimetidine	lemma_18=on	relType_10=cc	relType_12=case	relType_21=nsubj:pass	relType_11=conj	lemma_12=of	lemma_5=a	pos_17=NN	relType_19=nmod	relType_3=appos	pos_10=CC	relType_17=nsubj	pos_6=VBN	pos_18=IN	lemma_1=:	lemma_22=be	lemma_4=to	pos_4=IN	relType_5=det	relType_8=compound	relation_6=beneficial	lemma_15=be	pos_5=DT	relType_14=expl	relType_7=compound	pos_21=PRP	relation_18=neutral	relType_13=punct	lemma_16=no	relType_16=det	lpib=cimetidine_NN	relType_13=nmod	relType_20=advmod	relType_6=amod	pos_19=NN	pos_15=VBZ	relType_2=compound	relType_4=case	lemma_11=auc	relType_23=advcl	relType_15=parataxis	pos_20=WRB	eib=True	lemma_14=there	lemma_17=effect
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e1	DDI-DrugBank.d237.s10.e2	mechanism	lemma_8=concentration	lemma_6=peak	relType_7=compound	pos_3=IN	relation_4=beneficial	lemma_4=a	pos_7=NN	lemma_2=lead	lemma_5=increase	relType_8=obl	relType_11=case	pos_6=NN	pos_8=NN	eib=False	relType_10=conj	wib=coadministration	path1=cimetidine_compound<coadministration_nsubj	lemma_7=plasma	path2=concentration_obl>cisapride_nmod	pos_10=NN	lib=coadministration	pos_1=NN	lemma_10=auc	pos_11=IN	pos_4=DT	lemma_9=and	pos_9=CC	relType_5=amod	path=cimetidine_compound<coadministration_nsubj<lead_appos>concentration_obl>cisapride_nmod	lemma_1=coadministration	relType_1=nsubj	lemma_3=to	relType_2=appos	relType_3=case	pos_2=VBZ	relType_6=compound	lpib=coadministration_NN	lemma_11=of	relType_9=cc	relType_4=det	pos_5=VBN
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e1	DDI-DrugBank.d237.s10.e3	null	lemma_8=concentration	lemma_6=peak	relType_7=compound	lemma_12=cisapride	pos_3=IN	relation_4=beneficial	lemma_4=a	pos_7=NN	lemma_2=lead	pos_14=VBZ	lemma_5=increase	relType_8=obl	relType_11=case	pos_6=NN	pos_8=NN	lemma_12=,	pos_17=IN	lemma_13=there	relType_10=conj	wib=coadministration	path1=cimetidine_compound<coadministration_nsubj	relType_12=nmod	pos_12=,	pos_12=NN	lemma_7=plasma	relType_12=punct	pos_10=NN	pos_15=DT	lib=coadministration	pos_1=NN	relType_17=case	lemma_10=auc	pos_11=IN	lemma_14=be	pos_4=DT	lemma_9=and	pos_9=CC	pos_13=EX	relType_5=amod	lemma_1=coadministration	relType_1=nsubj	lemma_3=to	path=cimetidine_compound<coadministration_nsubj<lead_appos>be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	relType_16=nsubj	pos_16=NN	relType_2=appos	lemma_16=effect	lemma_17=on	relType_3=case	relType_13=expl	pos_2=VBZ	relType_6=compound	eib=True	relation_16=neutral	lemma_15=no	path2=be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	lpib=coadministration_NN	lemma_11=of	relType_9=cc	relType_4=det	relType_15=det	pos_5=VBN	relType_14=parataxis
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e1	DDI-DrugBank.d237.s10.e4	null	relType_21=aux:pass	relType_19=advmod	pos_21=VBZ	lemma_22=coadminister	pos_6=NN	lemma_12=,	relType_4=det	pos_12=,	path=cimetidine_compound<coadministration_nsubj<lead_appos>be_parataxis>coadminister_advcl>ranitidine_obl	pos_10=NN	pos_15=DT	pos_18=NN	pos_9=CC	pos_13=EX	lemma_18=cisapride	relType_1=nsubj	pos_19=WRB	lemma_17=on	relType_6=compound	lpib=coadministration_NN	lemma_21=be	lemma_4=a	lemma_2=lead	pos_14=VBZ	lemma_5=increase	relType_11=case	pos_8=NN	relType_10=conj	relType_12=nmod	relType_12=punct	lib=coadministration	lemma_3=to	pos_16=NN	relation_16=neutral	pos_23=IN	pos_7=NN	relType_18=nmod	relType_15=det	lemma_6=peak	lemma_12=cisapride	pos_3=IN	relation_4=beneficial	relType_20=nsubj:pass	pos_17=IN	wib=coadministration	lemma_7=plasma	pos_1=NN	relType_17=case	lemma_20=it	pos_11=IN	lemma_14=be	relType_5=amod	path2=be_parataxis>coadminister_advcl>ranitidine_obl	relType_16=nsubj	lemma_16=effect	relType_23=case	pos_2=VBZ	lemma_11=of	relType_14=parataxis	lemma_8=concentration	relType_7=compound	lemma_19=when	lemma_23=with	relType_8=obl	pos_22=VBN	relType_22=advcl	pos_5=VBN	lemma_13=there	path1=cimetidine_compound<coadministration_nsubj	lemma_10=auc	pos_4=DT	lemma_9=and	lemma_1=coadministration	relType_2=appos	relType_3=case	relType_13=expl	lemma_18=absorption	eib=True	lemma_15=no	relType_18=compound	pos_20=PRP	pos_12=NN	relType_9=cc
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e2	DDI-DrugBank.d237.s10.e3	null	lemma_1=,	lemma_2=there	pos_1=,	relType_5=nsubj	lemma_6=on	relType_6=case	eib=False	pos_6=IN	pos_3=VBZ	path=cisapride_nmod<concentration_obl<lead_appos>be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	lemma_5=effect	relType_2=expl	pos_4=DT	lemma_4=no	lib=be	path1=cisapride_nmod<concentration_obl	lemma_3=be	relType_3=parataxis	pos_2=EX	wib=is	pos_5=NN	path2=be_parataxis>effect_nsubj>absorption_nmod>cisapride_compound	relation_4=neutral	lpib=be_VBZ	relType_1=punct	relType_4=det
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e2	DDI-DrugBank.d237.s10.e4	null	relType_7=compound	lemma_1=,	lemma_2=there	lemma_11=coadminister	pos_7=NN	pos_1=,	relType_5=nsubj	relType_12=case	lemma_6=on	relType_6=case	relType_10=aux:pass	pos_6=IN	relType_9=nsubj:pass	pos_3=VBZ	lemma_8=when	lemma_7=absorption	lemma_12=with	relType_8=advmod	pos_12=IN	path=cisapride_nmod<concentration_obl<lead_appos>be_parataxis>coadminister_advcl>ranitidine_obl	lemma_5=effect	relType_2=expl	pos_4=DT	pos_9=PRP	lemma_4=no	lib=be	path1=cisapride_nmod<concentration_obl	path2=be_parataxis>coadminister_advcl>ranitidine_obl	pos_10=VBZ	lemma_3=be	lemma_7=cisapride	relType_7=nmod	relType_3=parataxis	pos_11=VBN	relType_11=advcl	pos_2=EX	wib=is	pos_5=NN	lemma_9=it	eib=True	relation_4=neutral	lpib=be_VBZ	pos_8=WRB	relType_1=punct	relType_4=det	lemma_10=be
DDI-DrugBank.d237.s10	DDI-DrugBank.d237.s10.e3	DDI-DrugBank.d237.s10.e4	null	path=cisapride_compound<absorption_nmod<effect_nsubj<be_parataxis>coadminister_advcl>ranitidine_obl	lemma_4=be	lemma_1=absorption	pos_3=PRP	path2=coadminister_advcl>ranitidine_obl	lib=absorption	relType_3=nsubj:pass	lemma_3=it	relType_6=case	lpib=absorption_NN	relType_5=advcl	eib=False	relType_2=advmod	pos_6=IN	relType_1=nmod	pos_1=NN	wib=absorption	lemma_5=coadminister	relType_4=aux:pass	lemma_6=with	path1=cisapride_compound<absorption_nmod<effect_nsubj	pos_2=WRB	lemma_2=when	pos_5=VBN	pos_4=VBZ
DDI-DrugBank.d237.s11	DDI-DrugBank.d237.s11.e0	DDI-DrugBank.d237.s11.e1	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	path=<cimetidine_nmod>ranitidine_conj	path1=	wib=ranitidine	path2=ranitidine_conj	lib=ranitidine	lpib=ranitidine_NN
DDI-DrugBank.d237.s11	DDI-DrugBank.d237.s11.e0	DDI-DrugBank.d237.s11.e2	mechanism	relType_1=cc	relType_6=aux:pass	relType_8=case	pos_1=CC	lemma_7=coadminister	pos_2=NN	path=cimetidine_nmod<absorption_nsubj:pass<accelerate_ROOT>coadminister_advcl>cisapride_obl	pos_3=VBN	relType_5=nsubj:pass	relation_3=beneficial	lemma_6=be	path1=cimetidine_nmod<absorption_nsubj:pass	relType_7=advcl	lemma_8=with	relType_2=conj	lemma_3=accelerate	pos_8=IN	path2=coadminister_advcl>cisapride_obl	relType_3=ROOT	relType_4=advmod	lemma_2=ranitidine	relType_2=aux:pass	pos_6=VBP	lib=ranitidine	pos_4=WRB	pos_7=VBN	pos_2=VBZ	eib=True	lemma_4=when	lemma_5=they	lemma_2=be	wib=ranitidine	pos_5=PRP	lemma_1=and	lpib=ranitidine_NN
DDI-DrugBank.d237.s11	DDI-DrugBank.d237.s11.e1	DDI-DrugBank.d237.s11.e2	mechanism	pos_2=VBN	relType_3=advmod	relType_7=case	relType_1=aux:pass	lemma_7=with	relation_1=beneficial	eib=False	pos_5=VBP	lemma_1=be	lemma_2=accelerate	path1=ranitidine_conj<cimetidine_nmod<absorption_nsubj:pass	relType_4=nsubj:pass	pos_6=VBN	relType_6=advcl	lemma_5=be	lib=be	path2=coadminister_advcl>cisapride_obl	relType_5=aux:pass	path=ranitidine_conj<cimetidine_nmod<absorption_nsubj:pass<accelerate_ROOT>coadminister_advcl>cisapride_obl	relType_2=ROOT	lemma_6=coadminister	wib=is	pos_3=WRB	pos_1=VBZ	pos_7=IN	pos_4=PRP	lpib=be_VBZ	lemma_4=they	lemma_3=when
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e0	DDI-DrugBank.d237.s12.e1	null	relType_3=dep	path1=	relType_5=parataxis	lemma_5=indicate	path2=indicate_parataxis>inhibit_ccomp>indinavir_nsubj	eib=False	pos_5=VBP	lemma_4=datum	pos_6=IN	relType_4=nsubj	pos_4=NNS	pos_3=FW	lemma_1=:	relType_6=mark	relType_2=amod	pos_1=:	lemma_3=vitro	path=<inhibitor_ROOT>indicate_parataxis>inhibit_ccomp>indinavir_nsubj	pos_2=FW	lpib=datum_NNS	wib=data	lemma_6=that	relType_1=punct	lemma_2=in	lib=datum
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e0	DDI-DrugBank.d237.s12.e2	null	relType_3=dep	lemma_7=indinavir	path1=	relType_7=cc	relType_5=parataxis	lemma_5=indicate	path=<inhibitor_ROOT>indicate_parataxis>inhibit_ccomp>indinavir_nsubj>ritonavir_conj	pos_5=VBP	lemma_4=datum	pos_6=IN	relType_4=nsubj	pos_4=NNS	pos_3=FW	lemma_1=:	path2=indicate_parataxis>inhibit_ccomp>indinavir_nsubj>ritonavir_conj	pos_7=CC	relType_6=mark	relType_2=amod	pos_1=:	lemma_3=vitro	pos_2=FW	lpib=datum_NNS	eib=True	wib=data	lemma_7=and	relType_7=nsubj	lemma_6=that	relType_1=punct	pos_7=NN	lemma_2=in	lib=datum
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e0	DDI-DrugBank.d237.s12.e3	null	relType_3=dep	lemma_7=indinavir	relType_10=det	path1=	relType_12=case	relType_7=cc	relType_5=parataxis	lemma_5=indicate	relType_11=obj	lemma_8=ritonavir	lemma_12=of	pos_8=NN	lemma_9=inhibit	pos_5=VBP	relType_9=ccomp	lemma_4=datum	path2=indicate_parataxis>inhibit_ccomp>metabolism_obj>cisapride_nmod	pos_6=IN	pos_8=RB	lemma_8=markedly	lemma_10=the	path=<inhibitor_ROOT>indicate_parataxis>inhibit_ccomp>metabolism_obj>cisapride_nmod	relType_4=nsubj	relType_8=advmod	pos_4=NNS	pos_3=FW	lemma_1=:	pos_12=IN	pos_7=CC	relType_6=mark	relation_10=adverse	lemma_11=metabolism	relType_2=amod	pos_1=:	lemma_3=vitro	pos_2=FW	lpib=datum_NNS	pos_11=NN	pos_9=VBP	eib=True	wib=data	lemma_7=and	relType_8=conj	relType_7=nsubj	lemma_6=that	relType_1=punct	pos_7=NN	lemma_2=in	lib=datum	pos_10=DT
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e0	DDI-DrugBank.d237.s12.e4	null	lemma_16=in	relation_20=beneficial	relType_17=det	pos_13=WDT	lemma_4=datum	pos_20=NN	pos_13=NN	relType_8=advmod	pos_3=FW	pos_18=NN	lemma_13=cisapride	pos_1=:	lemma_17=a	wib=data	relType_8=conj	lemma_11=metabolism	lemma_13=which	relType_3=dep	lemma_7=indinavir	path=<inhibitor_ROOT>indicate_parataxis>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	path1=	lemma_8=ritonavir	pos_8=NN	lemma_9=inhibit	lemma_19=in	relType_9=ccomp	pos_6=IN	lemma_8=markedly	lemma_15=result	pos_12=IN	relType_13=nsubj	relType_6=mark	pos_2=FW	lpib=datum_NNS	relType_16=case	pos_11=NN	pos_9=VBP	relType_19=case	relType_1=punct	pos_7=NN	lemma_2=in	pos_17=DT	relType_10=det	pos_16=IN	relType_12=case	relType_7=cc	relType_5=parataxis	lemma_5=indicate	relType_11=obj	lemma_12=of	relType_18=obl	pos_5=VBP	pos_8=RB	lemma_10=the	lemma_1=:	relType_2=amod	relType_7=nsubj	lib=datum	pos_10=DT	pos_19=IN	path2=indicate_parataxis>inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_13=nmod	relType_15=acl:relcl	lemma_18=increase	relType_4=nsubj	pos_4=NNS	lemma_14=can	pos_15=VB	pos_7=CC	relation_10=adverse	lemma_3=vitro	relType_14=aux	pos_14=MD	eib=True	relType_20=compound	lemma_20=plasma	lemma_7=and	lemma_6=that
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e1	DDI-DrugBank.d237.s12.e2	null	relType_1=cc	pos_1=CC	wib=ritonavir	eib=False	path1=	path2=ritonavir_conj	lib=ritonavir	path=<indinavir_nsubj>ritonavir_conj	lemma_1=and	lpib=ritonavir_NN
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e1	DDI-DrugBank.d237.s12.e3	mechanism	relType_1=cc	pos_1=CC	lemma_2=ritonavir	pos_2=NN	lib=ritonavir	lemma_6=of	relType_6=case	lpib=ritonavir_NN	pos_2=RB	relType_4=det	relType_2=advmod	pos_6=IN	path=indinavir_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	relType_2=conj	pos_4=DT	wib=ritonavir	relation_3=adverse	lemma_4=the	path1=indinavir_nsubj	lemma_5=metabolism	pos_5=NN	path2=metabolism_obj>cisapride_nmod	relType_3=ccomp	eib=True	relType_5=obj	lemma_3=inhibit	lemma_2=markedly	lemma_1=and	pos_3=VBP
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e1	DDI-DrugBank.d237.s12.e4	null	relType_1=cc	pos_1=CC	lemma_2=ritonavir	relType_12=obl	pos_2=NN	lemma_8=can	pos_7=NN	lemma_7=which	lemma_11=a	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lib=ritonavir	lemma_6=of	pos_9=VB	relType_14=compound	relType_6=case	lpib=ritonavir_NN	pos_2=RB	relType_4=det	relType_2=advmod	pos_8=MD	pos_6=IN	pos_12=NN	pos_14=NN	relType_10=case	pos_13=IN	relType_2=conj	pos_7=WDT	relType_9=acl:relcl	pos_4=DT	relType_13=case	lemma_14=plasma	wib=ritonavir	lemma_12=increase	lemma_10=in	relation_3=adverse	lemma_4=the	lemma_7=cisapride	relType_7=nmod	lemma_9=result	pos_10=IN	pos_11=DT	lemma_13=in	path1=indinavir_nsubj	relation_13=beneficial	lemma_5=metabolism	relType_11=det	pos_5=NN	relType_3=ccomp	eib=True	relType_5=obj	path=indinavir_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_3=inhibit	relType_8=aux	relType_7=nsubj	lemma_2=markedly	lemma_1=and	pos_3=VBP
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e2	DDI-DrugBank.d237.s12.e3	mechanism	wib=markedly	lemma_5=of	relType_5=case	lib=markedly	lpib=markedly_RB	eib=False	relation_1=adverse	relType_3=det	pos_4=NN	relType_4=obj	relType_1=advmod	pos_5=IN	pos_2=VBP	path=ritonavir_conj<indinavir_nsubj<inhibit_ccomp>metabolism_obj>cisapride_nmod	relType_2=ccomp	lemma_1=markedly	path2=metabolism_obj>cisapride_nmod	pos_3=DT	pos_1=RB	lemma_2=inhibit	lemma_3=the	path1=ritonavir_conj<indinavir_nsubj	lemma_4=metabolism
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e2	DDI-DrugBank.d237.s12.e4	null	relType_10=det	wib=markedly	path2=metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	relType_12=case	relType_7=aux	pos_9=IN	lemma_10=a	lemma_5=of	relType_5=case	relType_8=acl:relcl	pos_6=NN	lib=markedly	lemma_7=can	lpib=markedly_RB	lemma_6=which	relation_1=adverse	pos_7=MD	relType_9=case	pos_13=NN	relType_3=det	pos_4=NN	pos_12=IN	relType_4=obj	relType_1=advmod	pos_8=VB	relType_13=compound	lemma_8=result	pos_6=WDT	pos_5=IN	pos_2=VBP	lemma_13=plasma	relType_11=obl	relType_2=ccomp	lemma_1=markedly	lemma_11=increase	lemma_12=in	pos_11=NN	pos_10=DT	eib=True	pos_3=DT	pos_1=RB	lemma_6=cisapride	lemma_2=inhibit	lemma_3=the	relation_11=beneficial	path1=ritonavir_conj<indinavir_nsubj	relType_6=nmod	path=ritonavir_conj<indinavir_nsubj<inhibit_ccomp>metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	lemma_9=in	relType_6=nsubj	lemma_4=metabolism
DDI-DrugBank.d237.s12	DDI-DrugBank.d237.s12.e3	DDI-DrugBank.d237.s12.e4	null	relType_7=case	pos_2=MD	lemma_4=in	lemma_6=increase	pos_3=VB	path2=result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_6=NN	lemma_5=a	relType_6=obl	pos_8=NN	relType_3=acl:relcl	eib=False	lemma_1=which	relType_2=aux	lemma_3=result	pos_4=IN	relType_1=nsubj	relType_5=det	relType_4=case	relType_8=compound	lemma_8=plasma	wib=result	path1=cisapride_nmod	lemma_2=can	path=cisapride_nmod<metabolism_obj>result_acl:relcl>increase_obl>level_nmod>cisapride_compound	pos_7=IN	lemma_7=in	pos_5=DT	lib=result	relation_5=beneficial	lpib=result_VB	pos_1=WDT
DDI-DrugBank.d237.s13	DDI-DrugBank.d237.s13.e0	DDI-DrugBank.d237.s13.e1	null	pos_2=DT	lemma_2=the	lemma_1=increase	wib=increases	relType_1=csubj:pass	relation_0=beneficial	eib=False	lemma_3=bioavailability	lib=increase	path=cisapride_nmod<Coadministration_nsubj<increase_csubj:pass>bioavailability_obj>cisapride_nmod	pos_4=IN	relType_4=case	pos_1=VBZ	lpib=increase_VBZ	pos_3=NN	relType_2=det	path2=bioavailability_obj>cisapride_nmod	relType_3=obj	lemma_4=of	path1=cisapride_nmod<Coadministration_nsubj
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e0	DDI-DrugBank.d237.s14.e1	advise	lemma_10=to	relType_1=aux	relType_10=mark	lemma_13=qt	path1=Cisapride_nsubj:pass	lemma_1=should	pos_3=VB	lemma_4=use	relType_3=aux:pass	lemma_7=other	relType_6=case	relType_9=dep	pos_8=NNS	relType_8=obl	relType_12=det	lemma_16=certain	relType_16=amod	pos_2=RB	relType_14=obj	eib=False	relType_2=advmod	pos_6=IN	wib=not	lemma_15=:	pos_14=NN	path=Cisapride_nsubj:pass<use_ROOT>know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep	pos_9=VBN	pos_13=NN	relType_15=punct	lemma_14=interval	pos_4=VBN	lemma_12=the	lemma_5=concomitantly	pos_16=JJ	relType_7=amod	lemma_9=know	relType_13=compound	lemma_3=be	pos_5=RB	path2=know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep	lemma_6=with	pos_1=MD	relType_4=ROOT	lib=not	relType_5=advmod	relType_11=xcomp	lemma_8=drug	lemma_11=prolong	pos_10=TO	pos_15=:	pos_11=VB	pos_7=JJ	lpib=not_RB	pos_12=DT	lemma_2=not
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e0	DDI-DrugBank.d237.s14.e2	advise	pos_23=-LRB-	lemma_10=to	relType_3=aux:pass	pos_8=NNS	relType_18=case	relType_24=case	pos_22=NNP	wib=not	pos_13=NN	lemma_12=the	lemma_3=be	path=Cisapride_nsubj:pass<use_ROOT>know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>quinidine_nmod	pos_11=VB	lemma_23=(	pos_7=JJ	pos_12=DT	lemma_2=not	lemma_20=of	relType_22=nmod	pos_21=NNP	relType_1=aux	lemma_25=as	lemma_13=qt	pos_3=VB	lemma_7=other	relType_6=case	relType_16=amod	lemma_18=include	relType_20=case	pos_6=IN	relType_17=dep	lemma_21=Class	pos_4=VBN	relType_21=compound	relType_4=ROOT	relType_5=advmod	lemma_8=drug	pos_25=IN	pos_19=DT	relType_10=mark	relType_17=punct	path1=Cisapride_nsubj:pass	lemma_1=should	relType_12=det	pos_24=JJ	lemma_24=such	pos_20=IN	relType_19=nmod	lemma_22=IA	relType_14=obj	relType_25=fixed	lemma_15=:	pos_14=NN	relType_15=punct	pos_17=,	lemma_5=concomitantly	relType_7=amod	lemma_9=know	lemma_19=that	pos_18=VBG	pos_1=MD	lemma_11=prolong	pos_10=TO	pos_15=:	pos_17=NNS	lpib=not_RB	relType_23=punct	lemma_4=use	relType_9=dep	relType_8=obl	lemma_16=certain	pos_2=RB	lemma_17=,	relType_2=advmod	pos_9=VBN	lemma_14=interval	pos_16=JJ	relType_13=compound	pos_5=RB	lemma_6=with	lib=not	relType_11=xcomp	path2=know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>quinidine_nmod	eib=True	lemma_17=antiarrhythmic
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e0	DDI-DrugBank.d237.s14.e3	advise	pos_23=-LRB-	lemma_10=to	path=Cisapride_nsubj:pass<use_ROOT>know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>quinidine_nmod>procainamide_conj	relType_3=aux:pass	pos_8=NNS	relType_18=case	relType_24=case	pos_22=NNP	relType_26=nmod	wib=not	pos_26=NN	pos_13=NN	relType_26=cc	lemma_12=the	lemma_3=be	lemma_26=quinidine	path2=know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>quinidine_nmod>procainamide_conj	pos_11=VB	lemma_23=(	pos_7=JJ	pos_12=DT	lemma_2=not	lemma_20=of	relType_22=nmod	pos_21=NNP	relType_1=aux	lemma_25=as	lemma_13=qt	pos_3=VB	lemma_7=other	relType_6=case	relType_16=amod	lemma_18=include	relType_20=case	pos_6=IN	relType_17=dep	lemma_21=Class	pos_4=VBN	relType_21=compound	relType_4=ROOT	relType_5=advmod	lemma_8=drug	pos_25=IN	pos_19=DT	relType_10=mark	relType_17=punct	path1=Cisapride_nsubj:pass	lemma_1=should	relType_12=det	pos_24=JJ	lemma_24=such	pos_20=IN	relType_19=nmod	lemma_22=IA	relType_14=obj	relType_25=fixed	lemma_15=:	pos_14=NN	relType_15=punct	pos_17=,	lemma_5=concomitantly	relType_7=amod	lemma_9=know	lemma_19=that	pos_18=VBG	pos_1=MD	lemma_11=prolong	pos_10=TO	pos_15=:	pos_17=NNS	lpib=not_RB	lemma_26=and	relType_23=punct	lemma_4=use	pos_26=CC	relType_9=dep	relType_8=obl	lemma_16=certain	pos_2=RB	lemma_17=,	relType_2=advmod	pos_9=VBN	lemma_14=interval	pos_16=JJ	relType_13=compound	pos_5=RB	lemma_6=with	lib=not	relType_11=xcomp	eib=True	lemma_17=antiarrhythmic
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e0	DDI-DrugBank.d237.s14.e4	advise	pos_23=-LRB-	lemma_10=to	relType_3=aux:pass	pos_8=NNS	relType_18=case	relType_24=case	pos_22=NNP	relType_26=nmod	path2=know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>iii_conj>sotalol_nmod	wib=not	pos_26=NN	pos_13=NN	relType_26=cc	lemma_12=the	relType_30=conj	lemma_3=be	lemma_26=quinidine	pos_11=VB	lemma_23=(	pos_7=JJ	pos_12=DT	lemma_2=not	relType_32=case	lemma_20=of	relType_22=nmod	pos_21=NNP	pos_28=CC	relType_1=aux	lemma_25=as	lemma_13=qt	relType_27=conj	pos_3=VB	lemma_7=other	lemma_29=class	relType_6=case	relType_16=amod	lemma_18=include	relType_20=case	pos_32=JJ	pos_6=IN	lemma_28=and	relType_17=dep	lemma_21=Class	pos_29=NN	pos_4=VBN	pos_27=NN	lemma_33=as	relType_21=compound	relType_4=ROOT	relType_5=advmod	lemma_8=drug	pos_30=CD	pos_25=IN	pos_19=DT	relType_10=mark	relType_17=punct	path1=Cisapride_nsubj:pass	lemma_1=should	relType_29=compound	relType_12=det	pos_24=JJ	lemma_24=such	pos_20=IN	relType_19=nmod	lemma_22=IA	relType_14=obj	relType_25=fixed	pos_31=-LRB-	lemma_15=:	pos_14=NN	lemma_32=such	relType_15=punct	pos_17=,	lemma_5=concomitantly	pos_33=IN	relType_7=amod	lemma_9=know	lemma_19=that	lemma_27=)	pos_18=VBG	pos_1=MD	lemma_30=iii	lemma_11=prolong	pos_10=TO	pos_15=:	pos_17=NNS	lemma_31=(	lpib=not_RB	relType_27=punct	lemma_26=and	relType_23=punct	path=Cisapride_nsubj:pass<use_ROOT>know_dep>prolong_xcomp>interval_obj>antiarrhythmic_dep>that_nmod>iii_conj>sotalol_nmod	lemma_4=use	pos_26=CC	relType_33=fixed	relType_9=dep	relType_8=obl	lemma_16=certain	pos_2=RB	lemma_27=procainamide	lemma_17=,	relType_2=advmod	pos_9=VBN	lemma_14=interval	relType_31=punct	pos_16=JJ	relType_13=compound	pos_5=RB	lemma_6=with	lib=not	relType_11=xcomp	relType_28=cc	eib=True	lemma_17=antiarrhythmic	pos_27=-RRB-
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e1	DDI-DrugBank.d237.s14.e2	null	relType_8=case	lemma_8=such	lemma_1=,	lemma_7=(	path1=	pos_1=,	relType_5=compound	pos_9=IN	lib=include	lemma_5=Class	wib=including	pos_7=-LRB-	pos_8=JJ	eib=False	pos_6=NNP	lpib=include_VBG	path=<antiarrhythmic_dep>that_nmod>quinidine_nmod	lemma_3=that	pos_4=IN	relType_3=nmod	relType_4=case	pos_5=NNP	lemma_9=as	lemma_2=include	relType_9=fixed	relType_2=case	pos_3=DT	relType_7=punct	lemma_6=IA	relType_1=punct	relType_6=nmod	lemma_4=of	path2=that_nmod>quinidine_nmod	pos_2=VBG
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e1	DDI-DrugBank.d237.s14.e3	null	relType_8=case	lemma_8=such	lemma_1=,	lemma_7=(	relType_10=cc	path1=	pos_1=,	relType_5=compound	pos_9=IN	lib=include	lemma_5=Class	wib=including	pos_7=-LRB-	pos_8=JJ	relType_10=nmod	pos_6=NNP	pos_10=CC	path=<antiarrhythmic_dep>that_nmod>quinidine_nmod>procainamide_conj	pos_10=NN	lpib=include_VBG	path2=that_nmod>quinidine_nmod>procainamide_conj	lemma_10=quinidine	lemma_10=and	lemma_3=that	pos_4=IN	relType_3=nmod	relType_4=case	pos_5=NNP	lemma_9=as	lemma_2=include	relType_9=fixed	relType_2=case	eib=True	pos_3=DT	relType_7=punct	lemma_6=IA	relType_1=punct	relType_6=nmod	lemma_4=of	pos_2=VBG
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e1	DDI-DrugBank.d237.s14.e4	null	relType_8=case	lemma_8=such	lemma_1=,	lemma_7=(	relType_10=cc	path1=	pos_1=,	relType_12=cc	relType_5=compound	pos_9=IN	lib=include	pos_12=CC	lemma_5=Class	wib=including	relType_11=conj	pos_17=IN	pos_7=-LRB-	pos_8=JJ	lemma_11=procainamide	lemma_14=iii	relType_10=nmod	pos_15=-LRB-	lemma_17=as	lemma_13=class	pos_6=NNP	pos_10=CC	relType_11=punct	lemma_11=)	pos_10=NN	lpib=include_VBG	path=<antiarrhythmic_dep>that_nmod>iii_conj>sotalol_nmod	lemma_10=quinidine	pos_13=NN	relType_15=punct	lemma_16=such	lemma_10=and	pos_16=JJ	lemma_3=that	relType_13=compound	pos_4=IN	lemma_15=(	relType_3=nmod	relType_4=case	pos_5=NNP	lemma_9=as	lemma_2=include	relType_9=fixed	pos_11=-RRB-	relType_16=case	path2=that_nmod>iii_conj>sotalol_nmod	pos_11=NN	relType_2=case	eib=True	pos_3=DT	relType_17=fixed	relType_7=punct	lemma_12=and	relType_14=conj	lemma_6=IA	relType_1=punct	relType_6=nmod	lemma_4=of	pos_14=CD	pos_2=VBG
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e2	DDI-DrugBank.d237.s14.e3	null	relType_1=cc	path2=procainamide_conj	pos_1=CC	lpib=procainamide_NN	eib=False	path1=	wib=procainamide	path=<quinidine_nmod>procainamide_conj	lemma_1=and	lib=procainamide
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e2	DDI-DrugBank.d237.s14.e4	null	relType_1=cc	lemma_2=)	pos_1=CC	pos_2=NN	relType_7=case	pos_3=CC	lemma_4=class	lemma_6=(	lemma_2=procainamide	relType_3=cc	relType_2=punct	pos_5=CD	pos_6=-LRB-	lemma_7=such	lemma_8=as	relType_6=punct	wib=procainamide	path2=iii_conj>sotalol_nmod	relType_2=conj	pos_4=NN	pos_8=IN	lpib=procainamide_NN	relType_4=compound	relType_5=conj	path=quinidine_nmod<that_nmod>iii_conj>sotalol_nmod	lib=procainamide	eib=True	pos_2=-RRB-	lemma_5=iii	pos_7=JJ	relType_8=fixed	lemma_3=and	path1=quinidine_nmod	lemma_1=and
DDI-DrugBank.d237.s14	DDI-DrugBank.d237.s14.e3	DDI-DrugBank.d237.s14.e4	null	wib=Class	pos_6=JJ	lemma_6=such	lemma_1=)	relType_2=cc	relType_6=case	lpib=class_NN	lemma_2=and	lemma_4=iii	eib=False	path2=iii_conj>sotalol_nmod	lemma_5=(	lemma_7=as	pos_4=CD	relType_5=punct	pos_1=-RRB-	lib=class	path1=procainamide_conj<quinidine_nmod	relType_7=fixed	pos_7=IN	pos_3=NN	pos_2=CC	lemma_3=class	path=procainamide_conj<quinidine_nmod<that_nmod>iii_conj>sotalol_nmod	relType_4=conj	relType_3=compound	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d237.s15	DDI-DrugBank.d237.s15.e0	DDI-DrugBank.d237.s15.e1	null	path=<antidepressant_ROOT>amitriptyline_nmod	lpib=such_JJ	lemma_1=(	relType_3=fixed	relType_2=case	wib=such	pos_3=IN	eib=False	path1=	lib=such	relType_1=punct	pos_2=JJ	lemma_2=such	path2=amitriptyline_nmod	pos_1=-LRB-	lemma_3=as
DDI-DrugBank.d237.s16	DDI-DrugBank.d237.s16.e0	DDI-DrugBank.d237.s16.e1	null	lemma_1=(	lpib=such_JJ	relType_3=fixed	relType_2=case	wib=such	path=<antidepressant_ROOT>maprotiline_nmod	eib=False	pos_3=IN	path2=maprotiline_nmod	path1=	lib=such	relType_1=punct	pos_2=JJ	lemma_2=such	pos_1=-LRB-	lemma_3=as
DDI-DrugBank.d237.s17	DDI-DrugBank.d237.s17.e0	DDI-DrugBank.d237.s17.e1	null	lemma_1=(	lpib=such_JJ	relType_3=fixed	path2=sertindole_nmod	relType_2=case	wib=such	path=<medication_ROOT>sertindole_nmod	eib=False	pos_3=IN	path1=	lib=such	relType_1=punct	pos_2=JJ	lemma_2=such	pos_1=-LRB-	lemma_3=as
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e0	DDI-DrugBank.d237.s18.e1	null	wib=bepridil	lemma_1=,	lib=bepridil	lpib=bepridil_NN	eib=False	path2=bepridil_conj	path1=	pos_1=,	path=<astemizole_ROOT>bepridil_conj	relType_1=punct
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e0	DDI-DrugBank.d237.s18.e2	null	path2=sparfloxacin_conj	wib=bepridil	lemma_1=,	lib=bepridil	pos_2=NN	lpib=bepridil_NN	eib=True	lemma_2=bepridil	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct	path=<astemizole_ROOT>sparfloxacin_conj
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e0	DDI-DrugBank.d237.s18.e3	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_4=cc	relType_2=punct	wib=bepridil	path=<astemizole_ROOT>terodiline_conj	lemma_3=sparfloxacin	relType_2=conj	path2=terodiline_conj	lemma_2=,	lib=bepridil	lemma_2=bepridil	lpib=bepridil_NN	relType_3=conj	lemma_3=,	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e1	DDI-DrugBank.d237.s18.e2	null	path2=sparfloxacin_conj	lemma_1=,	path1=bepridil_conj	eib=False	pos_1=,	lpib=sparfloxacin_NN	wib=sparfloxacin	relType_1=punct	lib=sparfloxacin	path=bepridil_conj<astemizole_ROOT>sparfloxacin_conj
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e1	DDI-DrugBank.d237.s18.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	wib=sparfloxacin	relType_2=conj	path2=terodiline_conj	lemma_2=,	lib=sparfloxacin	lemma_2=sparfloxacin	path=bepridil_conj<astemizole_ROOT>terodiline_conj	path1=bepridil_conj	eib=True	lpib=sparfloxacin_NN	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d237.s18	DDI-DrugBank.d237.s18.e2	DDI-DrugBank.d237.s18.e3	null	lemma_2=and	lib=terodiline	lpib=terodiline_NN	lemma_1=,	path=sparfloxacin_conj<astemizole_ROOT>terodiline_conj	eib=False	pos_2=CC	pos_1=,	path1=sparfloxacin_conj	wib=terodiline	relType_1=punct	relType_2=cc	path2=terodiline_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e1	effect	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	path1=	lemma_2=combination	wib=combination	relType_2=nmod	pos_1=IN	lib=combination	pos_5=JJ	path2=combination_nmod>analgesic_nmod	relType_5=amod	lemma_4=other	lemma_3=with	relType_3=case	lemma_5=narcotic	path=<Codeine_nsubj>combination_nmod>analgesic_nmod	eib=True	lpib=combination_NN
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e2	effect	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	pos_6=JJ	pos_5=,	path1=	lemma_2=combination	wib=combination	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>anesthetic_conj	lemma_6=general	relType_2=nmod	pos_5=NNS	relType_6=amod	pos_1=IN	lib=combination	pos_5=JJ	lemma_5=analgesic	relType_5=amod	lemma_5=,	path2=combination_nmod>analgesic_nmod>anesthetic_conj	relType_5=punct	lemma_4=other	relType_5=nmod	lemma_3=with	relType_3=case	lemma_5=narcotic	eib=True	lpib=combination_NN
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e3	effect	pos_7=NNS	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	pos_6=JJ	pos_5=,	path1=	lemma_2=combination	wib=combination	lemma_6=general	relType_2=nmod	pos_5=NNS	relType_6=amod	pos_7=,	pos_1=IN	lib=combination	lemma_7=,	pos_5=JJ	lemma_5=analgesic	relType_5=amod	lemma_5=,	relType_5=punct	lemma_4=other	relType_5=nmod	lemma_7=anesthetic	lemma_3=with	path2=combination_nmod>analgesic_nmod>phenothiazine_conj	relType_3=case	lemma_5=narcotic	eib=True	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>phenothiazine_conj	relType_7=punct	lpib=combination_NN	relType_7=conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e4	effect	pos_7=NNS	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	pos_6=JJ	pos_5=,	path1=	lemma_2=combination	path2=combination_nmod>analgesic_nmod>tranquilizer_conj	relType_8=punct	wib=combination	lemma_8=,	pos_8=NNS	lemma_8=phenothiazine	lemma_6=general	relType_2=nmod	pos_5=NNS	relType_6=amod	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>tranquilizer_conj	pos_7=,	pos_1=IN	lib=combination	lemma_7=,	pos_5=JJ	lemma_5=analgesic	relType_5=amod	lemma_5=,	relType_5=punct	lemma_4=other	relType_5=nmod	lemma_7=anesthetic	lemma_3=with	relType_3=case	lemma_5=narcotic	eib=True	relType_7=punct	pos_8=,	relType_8=conj	lpib=combination_NN	relType_7=conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e5	effect	pos_7=NNS	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	pos_6=JJ	relType_9=conj	relType_10=punct	pos_5=,	path1=	lemma_2=combination	relType_8=punct	wib=combination	lemma_9=,	path2=combination_nmod>analgesic_nmod>hypnotic_conj	lemma_8=,	pos_8=NNS	lemma_8=phenothiazine	lemma_6=general	relType_2=nmod	pos_5=NNS	relType_6=amod	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>hypnotic_conj	pos_9=NNS	pos_7=,	pos_1=IN	lib=combination	pos_10=NN	lemma_7=,	relType_10=compound	lemma_10=-	pos_5=JJ	lemma_5=analgesic	relType_5=amod	lemma_5=,	relType_5=punct	lemma_9=tranquilizer	pos_10=HYPH	lemma_4=other	relType_5=nmod	lemma_7=anesthetic	lemma_3=with	relType_9=punct	relType_3=case	lemma_5=narcotic	eib=True	relType_7=punct	pos_8=,	relType_8=conj	lpib=combination_NN	pos_9=,	lemma_10=sedative	relType_7=conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e6	effect	pos_7=NNS	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	pos_3=IN	pos_6=JJ	relType_9=conj	relType_10=punct	pos_5=,	relType_11=cc	lemma_10=,	path1=	lemma_2=combination	relType_8=punct	wib=combination	lemma_9=,	lemma_8=,	pos_8=NNS	pos_12=JJ	lemma_8=phenothiazine	lemma_12=other	lemma_6=general	relType_2=nmod	pos_5=NNS	relType_10=conj	relType_6=amod	path2=combination_nmod>analgesic_nmod>depressant_conj	pos_9=NNS	pos_7=,	relType_12=amod	pos_1=IN	lib=combination	pos_10=NN	lemma_7=,	relType_10=compound	pos_13=NN	lemma_10=-	pos_5=JJ	lemma_5=analgesic	relType_5=amod	relType_13=compound	lemma_11=or	lemma_5=,	relType_5=punct	lemma_9=tranquilizer	pos_10=HYPH	lemma_4=other	pos_11=CC	relType_5=nmod	lemma_7=anesthetic	lemma_3=with	lemma_13=cns	relType_9=punct	relType_3=case	lemma_5=narcotic	pos_10=,	eib=True	relType_7=punct	pos_8=,	relType_8=conj	lpib=combination_NN	lemma_10=hypnotic	pos_9=,	lemma_10=sedative	pos_10=NNS	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>depressant_conj	relType_7=conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e0	DDI-DrugBank.d464.s0.e7	effect	pos_2=NN	pos_6=JJ	relType_11=cc	pos_5=,	lemma_10=,	pos_13=NNS	relType_8=punct	lemma_9=,	pos_8=NNS	lemma_12=other	lemma_6=general	lib=combination	pos_10=NN	lemma_7=,	pos_13=NN	lemma_11=or	lemma_5=,	lemma_9=tranquilizer	lemma_4=other	lemma_3=with	pos_10=,	relType_8=conj	pos_7=NNS	relType_4=amod	relType_1=case	path1=	lemma_2=combination	path=<Codeine_nsubj>combination_nmod>analgesic_nmod>depressant_conj>alcohol_nmod	relType_10=conj	lemma_13=depressant	relType_12=amod	pos_1=IN	relType_13=conj	lemma_13=(	pos_14=VBG	lemma_5=narcotic	lpib=combination_NN	lemma_10=hypnotic	pos_9=,	pos_8=,	relType_10=punct	pos_3=IN	wib=combination	lemma_8=,	lemma_8=phenothiazine	relType_2=nmod	pos_7=,	lemma_5=analgesic	relType_5=amod	pos_11=CC	lemma_13=cns	relType_14=case	relType_7=conj	pos_4=JJ	lemma_1=in	relType_9=conj	relType_13=punct	path2=combination_nmod>analgesic_nmod>depressant_conj>alcohol_nmod	lemma_14=include	pos_12=JJ	pos_5=NNS	relType_6=amod	pos_9=NNS	relType_10=compound	lemma_10=-	pos_5=JJ	relType_13=compound	relType_5=punct	pos_10=HYPH	relType_5=nmod	lemma_7=anesthetic	relType_9=punct	pos_13=-LRB-	relType_3=case	eib=True	relType_7=punct	lemma_10=sedative	pos_10=NNS
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e2	null	lib=general	lemma_1=,	lpib=general_JJ	wib=general	eib=False	lemma_2=general	path=<analgesic_nmod>anesthetic_conj	relType_2=amod	path1=	pos_1=,	path2=anesthetic_conj	relType_1=punct	pos_2=JJ
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e3	null	lemma_1=,	path1=	pos_1=,	pos_2=JJ	pos_3=NNS	lpib=general_JJ	path=<analgesic_nmod>phenothiazine_conj	lib=general	wib=general	lemma_3=,	relType_3=conj	relType_2=amod	pos_3=,	eib=True	lemma_2=general	lemma_3=anesthetic	relType_1=punct	relType_3=punct	path2=phenothiazine_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e4	null	lemma_1=,	path1=	path2=tranquilizer_conj	pos_1=,	pos_2=JJ	pos_3=NNS	lpib=general_JJ	pos_4=,	pos_4=NNS	lib=general	relType_4=punct	wib=general	lemma_3=,	relType_3=conj	relType_2=amod	lemma_4=phenothiazine	lemma_4=,	pos_3=,	eib=True	lemma_2=general	path=<analgesic_nmod>tranquilizer_conj	lemma_3=anesthetic	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e5	null	path2=hypnotic_conj	lemma_1=,	pos_5=,	path1=	pos_1=,	path=<analgesic_nmod>hypnotic_conj	pos_2=JJ	pos_6=HYPH	pos_6=NN	pos_3=NNS	lpib=general_JJ	pos_4=,	pos_5=NNS	relType_6=punct	lemma_5=tranquilizer	pos_4=NNS	lemma_6=-	lib=general	relType_4=punct	wib=general	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_2=amod	lemma_4=phenothiazine	lemma_4=,	relType_5=conj	lemma_6=sedative	relType_6=compound	pos_3=,	eib=True	lemma_2=general	lemma_3=anesthetic	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e6	null	lemma_6=hypnotic	lemma_1=,	relType_8=amod	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_7=cc	pos_2=JJ	path2=depressant_conj	pos_6=HYPH	pos_6=NN	pos_8=JJ	relType_6=conj	pos_3=NNS	lpib=general_JJ	pos_4=,	relType_9=compound	pos_5=NNS	relType_6=punct	lemma_5=tranquilizer	pos_9=NN	pos_4=NNS	lemma_6=-	lib=general	relType_4=punct	wib=general	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=CC	relType_2=amod	lemma_4=phenothiazine	lemma_4=,	relType_5=conj	lemma_6=sedative	lemma_7=or	pos_6=,	relType_6=compound	lemma_9=cns	pos_3=,	eib=True	lemma_2=general	lemma_3=anesthetic	pos_6=NNS	relType_4=conj	path=<analgesic_nmod>depressant_conj	relType_1=punct	relType_3=punct	lemma_8=other
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e1	DDI-DrugBank.d464.s0.e7	null	lemma_6=hypnotic	lemma_1=,	relType_9=conj	relType_8=amod	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_7=cc	pos_2=JJ	pos_6=HYPH	pos_6=NN	pos_8=JJ	relType_6=conj	lemma_10=include	pos_3=NNS	lpib=general_JJ	pos_4=,	relType_9=compound	pos_5=NNS	relType_6=punct	pos_9=NNS	lemma_9=(	lemma_5=tranquilizer	relType_10=case	pos_9=NN	pos_4=NNS	lemma_6=-	lib=general	relType_4=punct	wib=general	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=CC	relType_2=amod	lemma_9=depressant	lemma_4=phenothiazine	lemma_4=,	relType_5=conj	lemma_6=sedative	pos_9=-LRB-	lemma_7=or	relType_9=punct	pos_6=,	relType_6=compound	lemma_9=cns	pos_3=,	eib=True	lemma_2=general	lemma_3=anesthetic	pos_6=NNS	pos_10=VBG	path2=depressant_conj>alcohol_nmod	relType_4=conj	relType_1=punct	relType_3=punct	path=<analgesic_nmod>depressant_conj>alcohol_nmod	lemma_8=other
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e2	DDI-DrugBank.d464.s0.e3	null	path=anesthetic_conj<analgesic_nmod>phenothiazine_conj	path1=anesthetic_conj	lemma_1=,	lib=phenothiazine	eib=False	pos_1=,	wib=phenothiazines	relType_1=punct	path2=phenothiazine_conj	lpib=phenothiazine_NNS
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e2	DDI-DrugBank.d464.s0.e4	null	pos_2=NNS	path1=anesthetic_conj	lemma_1=,	relType_2=punct	lib=phenothiazine	path=anesthetic_conj<analgesic_nmod>tranquilizer_conj	eib=True	lemma_2=phenothiazine	path2=tranquilizer_conj	wib=phenothiazines	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	lpib=phenothiazine_NNS
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e2	DDI-DrugBank.d464.s0.e5	null	path2=hypnotic_conj	path1=anesthetic_conj	lemma_1=,	lemma_4=sedative	lemma_2=phenothiazine	pos_1=,	wib=phenothiazines	lemma_4=-	pos_4=HYPH	lemma_3=tranquilizer	relType_2=punct	pos_3=NNS	path=anesthetic_conj<analgesic_nmod>hypnotic_conj	relType_2=conj	pos_4=NN	lemma_2=,	lpib=phenothiazine_NNS	relType_4=punct	lemma_3=,	relType_3=conj	relType_4=compound	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e2	DDI-DrugBank.d464.s0.e6	null	path1=anesthetic_conj	lemma_1=,	lemma_4=sedative	pos_6=JJ	relType_7=compound	pos_5=CC	lemma_7=cns	path=anesthetic_conj<analgesic_nmod>depressant_conj	lemma_2=phenothiazine	pos_1=,	wib=phenothiazines	lemma_4=-	pos_4=HYPH	path2=depressant_conj	lemma_3=tranquilizer	relType_2=punct	relType_5=cc	pos_3=NNS	pos_4=,	relType_6=amod	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=hypnotic	relType_4=compound	lemma_4=,	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	lemma_6=other	lemma_5=or
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e2	DDI-DrugBank.d464.s0.e7	null	pos_7=NNS	relType_8=case	path1=anesthetic_conj	lemma_1=,	lemma_4=sedative	pos_6=JJ	relType_7=compound	pos_5=CC	lemma_7=cns	lemma_2=phenothiazine	lemma_7=(	pos_1=,	wib=phenothiazines	lemma_4=-	pos_4=HYPH	lemma_3=tranquilizer	relType_2=punct	path=anesthetic_conj<analgesic_nmod>depressant_conj>alcohol_nmod	pos_7=-LRB-	relType_5=cc	lemma_7=depressant	pos_3=NNS	pos_4=,	relType_6=amod	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=hypnotic	pos_8=VBG	relType_4=compound	lemma_4=,	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	relType_7=punct	path2=depressant_conj>alcohol_nmod	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	lemma_6=other	lemma_8=include	relType_7=conj	lemma_5=or
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e3	DDI-DrugBank.d464.s0.e4	null	lpib=tranquilizer_NNS	lemma_1=,	path=phenothiazine_conj<analgesic_nmod>tranquilizer_conj	eib=False	wib=tranquilizers	path2=tranquilizer_conj	pos_1=,	relType_1=punct	path1=phenothiazine_conj	lib=tranquilizer
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e3	DDI-DrugBank.d464.s0.e5	null	path2=hypnotic_conj	lemma_1=,	pos_1=,	relType_2=punct	lpib=tranquilizer_NNS	path=phenothiazine_conj<analgesic_nmod>hypnotic_conj	lemma_3=sedative	lemma_3=-	relType_2=conj	lemma_2=,	wib=tranquilizers	lib=tranquilizer	lemma_2=tranquilizer	pos_2=NNS	eib=True	pos_3=NN	pos_3=HYPH	pos_2=,	relType_3=compound	relType_1=punct	relType_3=punct	path1=phenothiazine_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e3	DDI-DrugBank.d464.s0.e6	null	lemma_1=,	pos_1=,	relType_4=cc	path2=depressant_conj	relType_2=punct	pos_6=NN	lpib=tranquilizer_NNS	pos_3=NNS	lemma_3=sedative	lemma_3=-	relType_2=conj	lemma_2=,	lemma_5=other	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	wib=tranquilizers	lemma_4=or	lemma_3=hypnotic	lib=tranquilizer	lemma_2=tranquilizer	pos_2=NNS	relType_6=compound	lemma_6=cns	pos_3=,	eib=True	pos_4=CC	pos_3=NN	pos_3=HYPH	pos_2=,	relType_3=compound	relType_1=punct	relType_3=punct	path=phenothiazine_conj<analgesic_nmod>depressant_conj	path1=phenothiazine_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e3	DDI-DrugBank.d464.s0.e7	null	lemma_1=,	relType_7=case	pos_1=,	pos_7=VBG	relType_4=cc	lemma_6=(	relType_2=punct	pos_6=NN	lpib=tranquilizer_NNS	relType_6=conj	pos_3=NNS	pos_6=-LRB-	relType_6=punct	lemma_3=sedative	lemma_3=-	relType_2=conj	lemma_2=,	lemma_5=other	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	wib=tranquilizers	path=phenothiazine_conj<analgesic_nmod>depressant_conj>alcohol_nmod	lemma_4=or	lemma_3=hypnotic	lemma_6=depressant	lib=tranquilizer	lemma_2=tranquilizer	pos_2=NNS	relType_6=compound	lemma_6=cns	pos_3=,	eib=True	pos_4=CC	pos_3=NN	pos_3=HYPH	pos_6=NNS	path2=depressant_conj>alcohol_nmod	pos_2=,	relType_3=compound	relType_1=punct	lemma_7=include	relType_3=punct	path1=phenothiazine_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e4	DDI-DrugBank.d464.s0.e5	null	path2=hypnotic_conj	lemma_2=sedative	lemma_1=,	lib=sedative	lpib=sedative_NN	wib=sedative	eib=True	pos_2=NN	lemma_2=-	relType_2=compound	pos_1=,	pos_2=HYPH	relType_1=punct	path=tranquilizer_conj<analgesic_nmod>hypnotic_conj	relType_2=punct	path1=tranquilizer_conj
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e4	DDI-DrugBank.d464.s0.e6	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_3=CC	pos_1=,	relType_5=compound	pos_2=HYPH	path2=depressant_conj	relType_2=punct	path1=tranquilizer_conj	path=tranquilizer_conj<analgesic_nmod>depressant_conj	relType_3=cc	lemma_2=hypnotic	lemma_2=-	lemma_3=or	relType_2=conj	lemma_2=,	wib=sedative	lib=sedative	lpib=sedative_NN	relType_2=compound	lemma_4=other	lemma_5=cns	pos_2=NNS	pos_5=NN	lemma_2=sedative	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e4	DDI-DrugBank.d464.s0.e7	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_3=CC	pos_1=,	relType_5=compound	pos_2=HYPH	relType_6=case	relType_2=punct	path1=tranquilizer_conj	relType_3=cc	pos_6=VBG	lemma_2=hypnotic	lemma_2=-	pos_5=NNS	lemma_5=(	lemma_3=or	relType_2=conj	lemma_2=,	wib=sedative	lemma_5=depressant	lib=sedative	lpib=sedative_NN	relType_2=compound	relType_5=punct	lemma_4=other	lemma_5=cns	relType_5=conj	pos_2=NNS	pos_5=NN	lemma_2=sedative	path=tranquilizer_conj<analgesic_nmod>depressant_conj>alcohol_nmod	lemma_6=include	eib=True	path2=depressant_conj>alcohol_nmod	pos_2=,	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e5	DDI-DrugBank.d464.s0.e6	null	lemma_2=or	lemma_1=,	lib=other	pos_1=,	path=hypnotic_conj<analgesic_nmod>depressant_conj	relType_2=cc	path2=depressant_conj	lemma_3=other	path1=hypnotic_conj	wib=other	pos_4=NN	relType_3=amod	lpib=other_JJ	relType_4=compound	lemma_4=cns	pos_3=JJ	eib=True	pos_2=CC	relType_1=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e5	DDI-DrugBank.d464.s0.e7	null	lemma_2=or	lemma_1=,	lib=other	pos_1=,	relType_2=cc	lemma_3=other	relType_5=case	path1=hypnotic_conj	path=hypnotic_conj<analgesic_nmod>depressant_conj>alcohol_nmod	pos_4=-LRB-	wib=other	pos_4=NN	pos_4=NNS	lemma_4=(	relType_4=punct	relType_3=amod	lpib=other_JJ	relType_4=compound	lemma_4=cns	lemma_5=include	pos_3=JJ	pos_5=VBG	eib=True	pos_2=CC	lemma_4=depressant	path2=depressant_conj>alcohol_nmod	relType_4=conj	relType_1=punct
DDI-DrugBank.d464.s0	DDI-DrugBank.d464.s0.e6	DDI-DrugBank.d464.s0.e7	null	lemma_1=(	path=<depressant_conj>alcohol_nmod	relType_2=case	eib=False	path1=	lib=include	path2=alcohol_nmod	lpib=include_VBG	wib=including	relType_1=punct	pos_1=-LRB-	lemma_2=include	pos_2=VBG
DDI-DrugBank.d250.s0	DDI-DrugBank.d250.s0.e0	DDI-DrugBank.d250.s0.e1	null	wib=aminoglycosides	lemma_1=(	eib=False	path1=	pos_1=-LRB-	relType_1=punct	lib=aminoglycoside	path2=aminoglycoside_appos	path=<antibiotic_nsubj:pass>aminoglycoside_appos	lpib=aminoglycoside_NNS
DDI-DrugBank.d250.s0	DDI-DrugBank.d250.s0.e0	DDI-DrugBank.d250.s0.e2	null	wib=aminoglycosides	lemma_1=(	pos_2=NNS	path=<antibiotic_nsubj:pass>aminoglycoside_appos>polymyxin_conj	lemma_2=and	eib=True	pos_2=CC	path1=	path2=aminoglycoside_appos>polymyxin_conj	relType_1=punct	lemma_2=aminoglycoside	relType_2=appos	lib=aminoglycoside	relType_2=cc	pos_1=-LRB-	lpib=aminoglycoside_NNS
DDI-DrugBank.d250.s0	DDI-DrugBank.d250.s0.e1	DDI-DrugBank.d250.s0.e2	null	relType_1=cc	pos_1=CC	eib=False	path2=polymyxin_conj	lpib=polymyxin_NN	path1=	wib=polymyxin	path=<aminoglycoside_appos>polymyxin_conj	lib=polymyxin	lemma_1=and
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e0	DDI-DrugBank.d250.s2.e1	null	lemma_1=(	relType_2=dep	pos_3=,	path2=tubocurarine_appos	lemma_3=,	eib=False	relType_3=punct	lemma_2=eg	path1=	pos_1=-LRB-	pos_2=FW	relType_1=punct	lpib=tubocurarine_NN	wib=tubocurarine	lib=tubocurarine	path=<relaxant_nsubj>tubocurarine_appos
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e0	DDI-DrugBank.d250.s2.e2	null	pos_7=NNS	lemma_4=tubocurarine	pos_6=JJ	pos_5=CC	lemma_11=,	relType_4=appos	path1=	relType_8=punct	lpib=tubocurarine_NN	lemma_8=,	lib=tubocurarine	lemma_1=(	relType_5=cc	relType_10=nmod	lemma_10=ether	path=<relaxant_nsubj>drug_conj>ether_nmod>succinylcholine_conj	pos_4=-RRB-	relType_6=amod	relType_11=punct	relType_9=case	pos_10=NN	pos_4=NN	pos_9=VBG	relType_2=dep	relType_4=punct	lemma_3=,	lemma_4=)	pos_11=,	pos_1=-LRB-	pos_2=FW	wib=tubocurarine	path2=drug_conj>ether_nmod>succinylcholine_conj	pos_3=,	eib=True	lemma_5=and	lemma_2=eg	pos_8=,	lemma_7=drug	lemma_9=include	relType_1=punct	relType_3=punct	lemma_6=other	relType_7=conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e0	DDI-DrugBank.d250.s2.e3	null	pos_7=NNS	relType_12=conj	lemma_4=tubocurarine	pos_6=JJ	pos_5=CC	lemma_11=,	relType_4=appos	path1=	relType_8=punct	lpib=tubocurarine_NN	lemma_8=,	lib=tubocurarine	lemma_1=(	lemma_12=,	relType_5=cc	relType_10=nmod	lemma_10=ether	relType_6=amod	pos_4=-RRB-	relType_11=punct	pos_12=,	relType_9=case	relType_12=punct	pos_10=NN	path=<relaxant_nsubj>drug_conj>ether_nmod>gallamine_conj	pos_4=NN	pos_9=VBG	relType_2=dep	relType_4=punct	lemma_3=,	path2=drug_conj>ether_nmod>gallamine_conj	lemma_4=)	pos_11=,	pos_1=-LRB-	pos_2=FW	wib=tubocurarine	lemma_12=succinylcholine	pos_3=,	eib=True	lemma_5=and	lemma_2=eg	pos_8=,	lemma_7=drug	lemma_9=include	relType_1=punct	pos_12=NN	relType_3=punct	lemma_6=other	relType_7=conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e0	DDI-DrugBank.d250.s2.e4	null	pos_7=NNS	relType_12=conj	pos_13=,	lemma_4=tubocurarine	pos_6=JJ	pos_5=CC	lemma_11=,	lemma_13=,	relType_4=appos	path1=	relType_13=punct	relType_8=punct	lpib=tubocurarine_NN	lemma_8=,	lib=tubocurarine	lemma_1=(	lemma_12=,	relType_5=cc	relType_10=nmod	lemma_10=ether	relType_6=amod	pos_4=-RRB-	relType_11=punct	pos_12=,	lemma_13=gallamine	relType_9=case	relType_12=punct	pos_10=NN	pos_13=NN	relType_13=conj	pos_4=NN	pos_9=VBG	relType_2=dep	relType_4=punct	lemma_3=,	path=<relaxant_nsubj>drug_conj>ether_nmod>decamethonium_conj	lemma_4=)	pos_11=,	pos_1=-LRB-	pos_2=FW	wib=tubocurarine	lemma_12=succinylcholine	pos_3=,	eib=True	lemma_5=and	path2=drug_conj>ether_nmod>decamethonium_conj	lemma_2=eg	pos_8=,	lemma_7=drug	lemma_9=include	relType_1=punct	pos_12=NN	relType_3=punct	lemma_6=other	relType_7=conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e0	DDI-DrugBank.d250.s2.e5	null	pos_7=NNS	relType_12=conj	pos_13=,	lemma_4=tubocurarine	pos_6=JJ	pos_5=CC	lemma_11=,	lemma_13=,	pos_14=CC	relType_4=appos	path1=	relType_13=punct	relType_8=punct	lemma_14=decamethonium	lpib=tubocurarine_NN	lemma_8=,	lib=tubocurarine	lemma_1=(	lemma_12=,	relType_5=cc	lemma_15=sodium	relType_10=nmod	lemma_10=ether	relType_6=amod	pos_4=-RRB-	relType_11=punct	path2=drug_conj>ether_nmod>citrate_conj	pos_12=,	lemma_13=gallamine	relType_9=case	relType_12=punct	pos_10=NN	pos_13=NN	relType_13=conj	pos_4=NN	pos_14=NN	pos_9=VBG	relType_2=dep	relType_4=punct	lemma_3=,	pos_15=NN	lemma_4=)	relType_14=cc	pos_11=,	path=<relaxant_nsubj>drug_conj>ether_nmod>citrate_conj	pos_1=-LRB-	pos_2=FW	wib=tubocurarine	relType_15=compound	lemma_12=succinylcholine	pos_3=,	eib=True	lemma_5=and	lemma_2=eg	pos_8=,	relType_14=conj	lemma_7=drug	lemma_14=and	lemma_9=include	relType_1=punct	pos_12=NN	relType_3=punct	lemma_6=other	relType_7=conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e1	DDI-DrugBank.d250.s2.e2	null	lib=other	pos_5=,	relType_8=punct	lemma_1=)	relType_2=cc	lemma_8=,	lemma_3=other	relType_6=case	lemma_2=and	pos_6=VBG	eib=False	lemma_7=ether	wib=other	path=tubocurarine_appos<relaxant_nsubj>drug_conj>ether_nmod>succinylcholine_conj	pos_4=NNS	lemma_4=drug	relType_3=amod	lpib=other_JJ	lemma_5=,	pos_1=-RRB-	relType_5=punct	relType_7=nmod	path2=drug_conj>ether_nmod>succinylcholine_conj	pos_3=JJ	lemma_6=include	path1=tubocurarine_appos	pos_2=CC	relType_4=conj	relType_1=punct	pos_7=NN	pos_8=,
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e1	DDI-DrugBank.d250.s2.e3	null	lemma_9=succinylcholine	relType_9=conj	lib=other	pos_5=,	relType_8=punct	lemma_1=)	relType_2=cc	lemma_8=,	lemma_3=other	relType_6=case	lemma_9=,	lemma_2=and	pos_6=VBG	lemma_7=ether	wib=other	pos_9=NN	pos_4=NNS	lemma_4=drug	relType_3=amod	lpib=other_JJ	lemma_5=,	pos_1=-RRB-	relType_5=punct	relType_7=nmod	path2=drug_conj>ether_nmod>gallamine_conj	relType_9=punct	path=tubocurarine_appos<relaxant_nsubj>drug_conj>ether_nmod>gallamine_conj	pos_3=JJ	lemma_6=include	eib=True	path1=tubocurarine_appos	pos_2=CC	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	pos_8=,
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e1	DDI-DrugBank.d250.s2.e4	null	lemma_9=succinylcholine	relType_10=punct	path=tubocurarine_appos<relaxant_nsubj>drug_conj>ether_nmod>decamethonium_conj	lib=other	relType_9=conj	pos_5=,	lemma_10=,	relType_8=punct	lemma_1=)	relType_2=cc	lemma_8=,	lemma_3=other	relType_6=case	lemma_9=,	lemma_2=and	pos_6=VBG	relType_10=conj	lemma_7=ether	wib=other	pos_10=NN	pos_9=NN	lemma_10=gallamine	pos_4=NNS	lemma_4=drug	relType_3=amod	lpib=other_JJ	lemma_5=,	pos_1=-RRB-	relType_5=punct	relType_7=nmod	relType_9=punct	pos_3=JJ	lemma_6=include	eib=True	pos_10=,	path1=tubocurarine_appos	path2=drug_conj>ether_nmod>decamethonium_conj	pos_2=CC	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	pos_8=,
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e1	DDI-DrugBank.d250.s2.e5	null	lemma_9=succinylcholine	relType_10=punct	path=tubocurarine_appos<relaxant_nsubj>drug_conj>ether_nmod>citrate_conj	lib=other	relType_9=conj	relType_11=cc	pos_5=,	lemma_10=,	relType_8=punct	lemma_1=)	relType_2=cc	lemma_8=,	lemma_3=other	relType_6=case	lemma_9=,	relType_11=conj	lemma_12=sodium	lemma_2=and	pos_6=VBG	lemma_11=decamethonium	relType_12=compound	relType_10=conj	lemma_7=ether	path2=drug_conj>ether_nmod>citrate_conj	wib=other	pos_12=NN	pos_10=NN	pos_9=NN	lemma_10=gallamine	pos_4=NNS	lemma_4=drug	relType_3=amod	lemma_11=and	lpib=other_JJ	lemma_5=,	pos_1=-RRB-	relType_5=punct	pos_11=CC	relType_7=nmod	relType_9=punct	pos_11=NN	pos_3=JJ	lemma_6=include	eib=True	pos_10=,	path1=tubocurarine_appos	pos_2=CC	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	pos_8=,
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e2	DDI-DrugBank.d250.s2.e3	null	wib=gallamine	lemma_1=,	lib=gallamine	path=succinylcholine_conj<ether_nmod>gallamine_conj	eib=False	pos_1=,	path1=succinylcholine_conj	relType_1=punct	path2=gallamine_conj	lpib=gallamine_NN
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e2	DDI-DrugBank.d250.s2.e4	null	wib=gallamine	lemma_1=,	lib=gallamine	pos_2=NN	eib=True	path=succinylcholine_conj<ether_nmod>decamethonium_conj	path2=decamethonium_conj	lemma_2=,	pos_1=,	path1=succinylcholine_conj	pos_2=,	relType_1=punct	relType_2=conj	lpib=gallamine_NN	lemma_2=gallamine	relType_2=punct
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e2	DDI-DrugBank.d250.s2.e5	null	wib=gallamine	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_2=gallamine	relType_2=punct	relType_3=cc	relType_2=conj	pos_4=NN	lemma_2=,	lpib=gallamine_NN	lemma_3=decamethonium	relType_3=conj	relType_4=compound	path1=succinylcholine_conj	path2=citrate_conj	lib=gallamine	eib=True	pos_3=NN	pos_2=,	lemma_3=and	relType_1=punct	lemma_4=sodium	path=succinylcholine_conj<ether_nmod>citrate_conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e3	DDI-DrugBank.d250.s2.e4	null	lib=decamethonium	lemma_1=,	eib=False	lpib=decamethonium_NN	path2=decamethonium_conj	pos_1=,	path1=gallamine_conj	relType_1=punct	wib=decamethonium	path=gallamine_conj<ether_nmod>decamethonium_conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e3	DDI-DrugBank.d250.s2.e5	null	lemma_1=,	path=gallamine_conj<ether_nmod>citrate_conj	pos_2=NN	pos_1=,	relType_2=cc	lib=decamethonium	lemma_2=and	lemma_3=sodium	lpib=decamethonium_NN	relType_2=conj	eib=True	pos_3=NN	pos_2=CC	relType_3=compound	lemma_2=decamethonium	relType_1=punct	wib=decamethonium	path1=gallamine_conj	path2=citrate_conj
DDI-DrugBank.d250.s2	DDI-DrugBank.d250.s2.e4	DDI-DrugBank.d250.s2.e5	null	relType_1=cc	wib=sodium	pos_1=CC	pos_2=NN	eib=True	lemma_2=sodium	relType_2=compound	path=decamethonium_conj<ether_nmod>citrate_conj	lpib=sodium_NN	path1=decamethonium_conj	lemma_1=and	lib=sodium	path2=citrate_conj
DDI-DrugBank.d250.s3	DDI-DrugBank.d250.s3.e0	DDI-DrugBank.d250.s3.e1	effect	relType_1=aux	lemma_1=may	path2=nephrotoxicity_obj>parenteral_nmod>M_compound	lemma_4=nephrotoxicity	lemma_5=of	relType_5=case	pos_6=HYPH	relation_1=beneficial	lemma_6=Coly	pos_6=NNP	path1=cephalothin_nsubj	wib=enhance	relType_6=punct	lemma_6=Mycin	pos_2=VB	lib=enhance	lpib=enhance_VB	relType_3=det	pos_4=NN	relType_4=obj	lemma_6=-	path=cephalothin_nsubj<enhance_ROOT>nephrotoxicity_obj>parenteral_nmod>M_compound	relType_2=ROOT	pos_5=IN	pos_1=MD	lemma_2=enhance	relType_6=compound	eib=True	pos_3=DT	lemma_3=the
DDI-DrugBank.d317.s5	DDI-DrugBank.d317.s5.e0	DDI-DrugBank.d317.s5.e1	null	relType_1=cc	lpib=fibrinogen_NN	pos_1=CC	eib=False	path=<fibrinogen_nmod>fibrinogen_conj	path1=	lib=fibrinogen	wib=fibrinogen	lemma_1=and	path2=fibrinogen_conj
DDI-DrugBank.d317.s13	DDI-DrugBank.d317.s13.e0	DDI-DrugBank.d317.s13.e1	null	relType_1=cc	pos_1=CC	pos_2=NN	eib=True	path2=steroid_conj	relType_2=compound	path1=	lib=sex	wib=sex	path=<corticosteroid_obl>steroid_conj	lpib=sex_NN	lemma_1=and	lemma_2=sex
DDI-DrugBank.d439.s0	DDI-DrugBank.d439.s0.e0	DDI-DrugBank.d439.s0.e1	effect	relType_7=case	relType_1=aux	lemma_1=may	wib=accentuate	path2=loss_obj>associate_acl>therapy_obl>diuretic_compound	lemma_7=with	lib=accentuate	lemma_2=accentuate	lemma_6=associate	eib=False	path=Corticotropin_nsubj<accentuate_ROOT>loss_obj>associate_acl>therapy_obl>diuretic_compound	pos_2=VB	pos_6=VBN	relType_3=det	pos_4=NN	relType_2=ROOT	relType_6=acl	relType_4=compound	lemma_5=loss	lpib=accentuate_VB	pos_1=MD	lemma_4=electrolyte	pos_5=NN	pos_3=DT	pos_7=IN	relType_5=obj	lemma_3=the	path1=Corticotropin_nsubj
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e0	DDI-DrugBank.d185.s0.e1	null	lib=gel	relType_8=case	lemma_15=800	lemma_4=%	relType_13=dep	pos_5=,	relType_4=appos	relType_16=nmod	relType_17=punct	pos_12=CD	lemma_1=Gel	lemma_13=mg	relType_6=case	relType_2=punct	lemma_9=double	lemma_16=mg	pos_9=JJ	pos_15=CD	eib=False	path1=ACZONE_compound<Gel_nmod<use_nmod<effect_obj	pos_6=IN	pos_11=-LRB-	path2=strength_obl>sulfamethoxazole_dep>trimethoprim_compound	relType_11=punct	lemma_8=with	relType_9=amod	lemma_14=/	lemma_6=in	relType_1=nmod	pos_10=NN	pos_4=NN	lemma_2=,	pos_8=IN	lemma_12=160	pos_13=NN	pos_14=SYM	relType_15=nummod	pos_3=CD	lemma_5=,	lemma_3=5	relType_5=punct	lemma_11=(	relType_14=dep	relType_3=nummod	pos_16=NN	lemma_7=combination	pos_1=NNP	lemma_10=strength	lemma_17=)	relType_7=obl	wib=Gel	pos_2=,	path=ACZONE_compound<Gel_nmod<use_nmod<effect_obj<evaluate_ROOT>strength_obl>sulfamethoxazole_dep>trimethoprim_compound	relType_12=nummod	pos_17=-RRB-	lpib=gel_NNP	pos_7=NN	relType_10=obl
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e0	DDI-DrugBank.d185.s0.e2	null	lib=gel	relType_8=case	lemma_15=800	lemma_4=%	relType_13=dep	pos_5=,	relType_4=appos	relType_16=nmod	relType_17=punct	pos_12=CD	lemma_1=Gel	lemma_13=mg	relType_6=case	relType_2=punct	lemma_9=double	lemma_16=mg	pos_9=JJ	pos_15=CD	path=ACZONE_compound<Gel_nmod<use_nmod<effect_obj<evaluate_ROOT>strength_obl>sulfamethoxazole_dep	path1=ACZONE_compound<Gel_nmod<use_nmod<effect_obj	pos_6=IN	pos_11=-LRB-	relType_11=punct	pos_18=HYPH	lemma_8=with	relType_9=amod	lemma_14=/	lemma_6=in	relType_1=nmod	pos_10=NN	pos_4=NN	lemma_2=,	pos_8=IN	lemma_12=160	pos_13=NN	pos_18=NN	pos_14=SYM	relType_15=nummod	pos_3=CD	path2=strength_obl>sulfamethoxazole_dep	lemma_5=,	lemma_3=5	relType_5=punct	lemma_11=(	relType_18=punct	relType_14=dep	relType_3=nummod	pos_16=NN	lemma_7=combination	pos_1=NNP	lemma_10=strength	lemma_17=)	lemma_18=/	relType_7=obl	eib=True	wib=Gel	relType_18=compound	pos_2=,	relType_12=nummod	pos_17=-RRB-	lemma_18=trimethoprim	lpib=gel_NNP	pos_7=NN	relType_10=obl
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e0	DDI-DrugBank.d185.s0.e3	null	lib=gel	relType_8=case	lemma_15=800	lemma_4=%	relType_13=dep	lemma_19=(	pos_5=,	relType_4=appos	relType_16=nmod	relType_17=punct	pos_12=CD	lemma_1=Gel	relType_19=dep	lemma_13=mg	relType_19=punct	relType_6=case	relType_2=punct	lemma_9=double	lemma_16=mg	pos_9=JJ	pos_15=CD	pos_19=-LRB-	path1=ACZONE_compound<Gel_nmod<use_nmod<effect_obj	pos_6=IN	path2=strength_obl>sulfamethoxazole_dep>smx_appos>tmp_compound	pos_11=-LRB-	relType_11=punct	pos_18=HYPH	lemma_19=sulfamethoxazole	lemma_8=with	pos_19=NN	relType_9=amod	lemma_14=/	lemma_6=in	relType_1=nmod	pos_10=NN	pos_4=NN	lemma_2=,	pos_8=IN	lemma_12=160	pos_13=NN	pos_18=NN	path=ACZONE_compound<Gel_nmod<use_nmod<effect_obj<evaluate_ROOT>strength_obl>sulfamethoxazole_dep>smx_appos>tmp_compound	pos_14=SYM	relType_15=nummod	pos_3=CD	lemma_5=,	lemma_3=5	relType_5=punct	lemma_11=(	relType_18=punct	relType_14=dep	relType_3=nummod	pos_16=NN	lemma_7=combination	pos_1=NNP	lemma_10=strength	lemma_17=)	lemma_18=/	relType_7=obl	eib=True	wib=Gel	relType_18=compound	pos_2=,	relType_12=nummod	pos_17=-RRB-	lemma_18=trimethoprim	lpib=gel_NNP	pos_7=NN	relType_10=obl
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e0	DDI-DrugBank.d185.s0.e4	null	lib=gel	relType_8=case	lemma_15=800	lemma_4=%	relType_13=dep	lemma_19=(	pos_5=,	relType_4=appos	relType_16=nmod	relType_17=punct	pos_12=CD	lemma_20=/	lemma_1=Gel	relType_19=dep	lemma_13=mg	relType_19=punct	relType_6=case	relType_2=punct	lemma_9=double	lemma_16=mg	pos_9=JJ	pos_15=CD	pos_20=HYPH	pos_19=-LRB-	path1=ACZONE_compound<Gel_nmod<use_nmod<effect_obj	pos_6=IN	pos_11=-LRB-	relType_11=punct	pos_18=HYPH	lemma_19=sulfamethoxazole	pos_20=NN	lemma_8=with	pos_19=NN	relType_9=amod	lemma_14=/	lemma_6=in	relType_1=nmod	pos_10=NN	pos_4=NN	lemma_2=,	pos_8=IN	lemma_12=160	pos_13=NN	pos_18=NN	pos_14=SYM	relType_15=nummod	pos_3=CD	lemma_5=,	lemma_3=5	relType_5=punct	lemma_11=(	relType_18=punct	relType_14=dep	relType_3=nummod	pos_16=NN	lemma_7=combination	pos_1=NNP	lemma_10=strength	lemma_17=)	lemma_18=/	path=ACZONE_compound<Gel_nmod<use_nmod<effect_obj<evaluate_ROOT>strength_obl>sulfamethoxazole_dep>smx_appos	relType_7=obl	eib=True	relType_20=compound	lemma_20=tmp	wib=Gel	path2=strength_obl>sulfamethoxazole_dep>smx_appos	relType_18=compound	relType_20=punct	pos_2=,	relType_12=nummod	pos_17=-RRB-	lemma_18=trimethoprim	lpib=gel_NNP	pos_7=NN	relType_10=obl
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e1	DDI-DrugBank.d185.s0.e2	null	lpib=sulfamethoxazole_NN	path1=trimethoprim_compound	eib=False	lib=sulfamethoxazole	wib=sulfamethoxazole	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/	path=trimethoprim_compound<sulfamethoxazole_dep>
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e1	DDI-DrugBank.d185.s0.e3	null	lpib=sulfamethoxazole_NN	relType_2=dep	pos_2=NN	lemma_2=sulfamethoxazole	eib=True	path1=trimethoprim_compound	lib=sulfamethoxazole	path2=smx_appos>tmp_compound	lemma_2=(	pos_2=-LRB-	path=trimethoprim_compound<sulfamethoxazole_dep>smx_appos>tmp_compound	wib=sulfamethoxazole	pos_1=HYPH	relType_1=punct	lemma_1=/	relType_2=punct
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e1	DDI-DrugBank.d185.s0.e4	null	lpib=sulfamethoxazole_NN	pos_2=NN	lemma_2=sulfamethoxazole	lemma_3=tmp	pos_1=HYPH	relType_2=punct	path1=trimethoprim_compound	pos_2=-LRB-	wib=sulfamethoxazole	lemma_3=/	relType_2=dep	lib=sulfamethoxazole	path2=smx_appos	path=trimethoprim_compound<sulfamethoxazole_dep>smx_appos	lemma_1=/	eib=True	pos_3=NN	pos_3=HYPH	relType_3=compound	relType_1=punct	lemma_2=(	relType_3=punct
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e2	DDI-DrugBank.d185.s0.e3	null	lemma_1=(	path=<sulfamethoxazole_dep>smx_appos>tmp_compound	path2=smx_appos>tmp_compound	eib=False	path1=	lpib=tmp_NN	lib=tmp	relType_1=punct	wib=TMP	pos_1=-LRB-
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e2	DDI-DrugBank.d185.s0.e4	null	lemma_1=(	pos_2=NN	lemma_2=/	eib=True	relType_2=compound	path1=	pos_2=HYPH	path2=smx_appos	lpib=tmp_NN	lib=tmp	path=<sulfamethoxazole_dep>smx_appos	wib=TMP	relType_1=punct	lemma_2=tmp	pos_1=-LRB-	relType_2=punct
DDI-DrugBank.d185.s0	DDI-DrugBank.d185.s0.e3	DDI-DrugBank.d185.s0.e4	null	wib=SMX	eib=False	path=tmp_compound<smx_appos>	lib=smx	lpib=smx_NN	path1=tmp_compound	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/
DDI-DrugBank.d185.s1	DDI-DrugBank.d185.s1.e0	DDI-DrugBank.d185.s1.e1	null	relType_1=cc	wib=SMX	pos_1=CC	path=<TMP_nmod>SMX_conj	eib=False	path2=SMX_conj	lib=smx	path1=	lpib=smx_NNP	lemma_1=and
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e0	DDI-DrugBank.d185.s2.e1	null	lemma_1=(	path2=dha_dep	eib=False	lib=dha	path1=	lpib=dha_NN	relType_1=punct	wib=DHA	pos_1=-LRB-	path=<hydroxylamine_nmod>dha_dep
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e0	DDI-DrugBank.d185.s2.e2	null	lemma_2=)	pos_2=NN	pos_8=DT	relType_7=case	lemma_5=than	lemma_10=of	relType_9=obl	lpib=dha_NN	lemma_6=double	relType_3=aux:pass	wib=DHA	relType_5=case	relType_2=punct	lemma_1=(	lib=dha	pos_3=VBD	lemma_9=presence	pos_4=JJR	pos_6=VBN	relType_10=case	pos_9=NN	path2=presence_obl>smx_nmod>tmp_compound	path1=hydroxylamine_nmod<exposure_nsubj:pass	relType_6=ROOT	relType_2=dep	path=hydroxylamine_nmod<exposure_nsubj:pass<double_ROOT>presence_obl>smx_nmod>tmp_compound	lemma_8=the	relType_4=advmod	lemma_3=be	pos_5=IN	pos_10=IN	pos_1=-LRB-	eib=True	lemma_2=dha	pos_2=-RRB-	pos_7=IN	lemma_7=in	relType_8=det	relType_1=punct	lemma_4=more
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e0	DDI-DrugBank.d185.s2.e3	null	lemma_2=)	pos_2=NN	pos_8=DT	relType_7=case	lemma_5=than	path=hydroxylamine_nmod<exposure_nsubj:pass<double_ROOT>presence_obl>smx_nmod	lemma_10=of	relType_9=obl	lpib=dha_NN	lemma_6=double	relType_3=aux:pass	wib=DHA	relType_5=case	relType_2=punct	path2=presence_obl>smx_nmod	lemma_1=(	pos_11=HYPH	relType_11=punct	lib=dha	pos_3=VBD	lemma_9=presence	pos_4=JJR	pos_6=VBN	relType_10=case	pos_9=NN	path1=hydroxylamine_nmod<exposure_nsubj:pass	relType_6=ROOT	relType_2=dep	lemma_11=/	lemma_8=the	relType_4=advmod	lemma_3=be	pos_5=IN	pos_10=IN	pos_1=-LRB-	pos_11=NN	eib=True	lemma_2=dha	pos_2=-RRB-	pos_7=IN	lemma_7=in	relType_11=compound	lemma_11=tmp	relType_8=det	relType_1=punct	lemma_4=more
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e1	DDI-DrugBank.d185.s2.e2	null	relType_3=advmod	relType_7=det	lemma_5=double	path=dha_dep<hydroxylamine_nmod<exposure_nsubj:pass<double_ROOT>presence_obl>smx_nmod>tmp_compound	pos_9=IN	path1=dha_dep<hydroxylamine_nmod<exposure_nsubj:pass	lemma_1=)	relType_6=case	relType_8=obl	pos_8=NN	eib=False	pos_6=IN	pos_2=VBD	relType_9=case	lemma_6=in	path2=presence_obl>smx_nmod>tmp_compound	pos_3=JJR	pos_7=DT	lib=be	relType_5=ROOT	pos_4=IN	pos_1=-RRB-	relType_4=case	relType_2=aux:pass	wib=was	lemma_3=more	lemma_9=of	lemma_4=than	lemma_8=presence	lemma_2=be	lemma_7=the	relType_1=punct	lpib=be_VBD	pos_5=VBN
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e1	DDI-DrugBank.d185.s2.e3	null	relType_10=punct	relType_3=advmod	relType_7=det	lemma_5=double	pos_9=IN	path1=dha_dep<hydroxylamine_nmod<exposure_nsubj:pass	lemma_1=)	relType_6=case	relType_8=obl	path2=presence_obl>smx_nmod	pos_8=NN	pos_6=IN	lemma_10=tmp	pos_2=VBD	relType_9=case	relType_10=compound	lemma_6=in	pos_10=NN	pos_7=DT	pos_3=JJR	lib=be	relType_5=ROOT	pos_4=IN	pos_1=-RRB-	pos_10=HYPH	relType_4=case	relType_2=aux:pass	wib=was	lemma_3=more	lemma_10=/	eib=True	path=dha_dep<hydroxylamine_nmod<exposure_nsubj:pass<double_ROOT>presence_obl>smx_nmod	lemma_9=of	lemma_4=than	lemma_8=presence	lemma_2=be	lemma_7=the	relType_1=punct	lpib=be_VBD	pos_5=VBN
DDI-DrugBank.d185.s2	DDI-DrugBank.d185.s2.e2	DDI-DrugBank.d185.s2.e3	null	path=tmp_compound<smx_nmod>	wib=SMX	eib=False	lib=smx	lpib=smx_NN	path1=tmp_compound	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/
DDI-DrugBank.d185.s3	DDI-DrugBank.d185.s3.e0	DDI-DrugBank.d185.s3.e1	null	wib=SMX	eib=False	lib=smx	lpib=smx_NN	path=tmp_compound<smx_obl>	path1=tmp_compound	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/
DDI-DrugBank.d185.s4	DDI-DrugBank.d185.s4.e0	DDI-DrugBank.d185.s4.e1	null	lib=anticonvulsant	lemma_1=,	lpib=anticonvulsant_NNS	eib=False	wib=anticonvulsants	path1=	path=<rifampin_nmod>anticonvulsant_conj	pos_1=,	relType_1=punct	path2=anticonvulsant_conj
DDI-DrugBank.d185.s5	DDI-DrugBank.d185.s5.e0	DDI-DrugBank.d185.s5.e1	null	pos_2=DT	lemma_1=,	path=<hydroxylamine_nmod>metabolite_appos>dapsone_nmod	path1=	pos_1=,	lemma_2=a	path2=metabolite_appos>dapsone_nmod	eib=False	relType_3=appos	lemma_3=metabolite	wib=metabolite	pos_4=IN	relType_4=case	lpib=metabolite_NN	lib=metabolite	pos_3=NN	relType_2=det	relType_1=punct	lemma_4=of
DDI-DrugBank.d185.s6	DDI-DrugBank.d185.s6.e0	DDI-DrugBank.d185.s6.e1	effect	lemma_3=folic	relType_2=punct	lemma_3=acid	lemma_2=,	pos_1=NN	relType_3=amod	lemma_1=treatment	lpib=treatment_NN	pos_3=JJ	eib=True	path=dapsone_compound<treatment_obl<note_ROOT>antagonist_nsubj:pass	pos_3=NN	wib=treatment	pos_2=,	relType_3=compound	lib=treatment	path2=antagonist_nsubj:pass	relType_1=obl	path1=dapsone_compound<treatment_obl
DDI-DrugBank.d185.s6	DDI-DrugBank.d185.s6.e0	DDI-DrugBank.d185.s6.e2	effect	relType_4=fixed	relType_3=nsubj:pass	lemma_3=folic	lemma_3=such	relType_2=punct	pos_3=NNS	lemma_3=antagonist	path2=antagonist_nsubj:pass>pyrimethamine_nmod	lemma_3=acid	lemma_2=,	pos_1=NN	relType_3=amod	path=dapsone_compound<treatment_obl<note_ROOT>antagonist_nsubj:pass>pyrimethamine_nmod	lemma_1=treatment	pos_4=IN	lpib=treatment_NN	relType_3=case	pos_3=JJ	eib=True	pos_3=NN	wib=treatment	pos_2=,	relType_3=compound	lemma_4=as	lib=treatment	relType_1=obl	path1=dapsone_compound<treatment_obl
DDI-DrugBank.d185.s6	DDI-DrugBank.d185.s6.e1	DDI-DrugBank.d185.s6.e2	null	lpib=such_JJ	pos_2=IN	relType_1=case	relType_2=fixed	wib=such	eib=False	lemma_1=such	path1=	path2=pyrimethamine_nmod	pos_1=JJ	lib=such	path=<antagonist_nsubj:pass>pyrimethamine_nmod	lemma_2=as
DDI-DrugBank.d69.s0	DDI-DrugBank.d69.s0.e0	DDI-DrugBank.d69.s0.e1	effect	path2=patient_nmod>receive_acl:relcl>doxorubicin_obj	pos_2=DT	relType_1=case	lemma_1=in	pos_5=VBZ	wib=patient	lemma_2=a	lemma_5=have	lemma_4=who	eib=False	path1=Cerubidine_nmod	pos_1=IN	relType_5=aux	relType_4=nsubj	lpib=patient_NN	lib=patient	relType_3=nmod	lemma_7=receive	pos_6=RB	pos_7=VBN	pos_3=NN	relType_2=det	lemma_6=previously	path=Cerubidine_nmod<Use_nsubj>patient_nmod>receive_acl:relcl>doxorubicin_obj	pos_4=WP	relType_6=advmod	lemma_3=patient	relType_7=acl:relcl
DDI-DrugBank.d69.s1	DDI-DrugBank.d69.s1.e0	DDI-DrugBank.d69.s1.e1	advise	path2=patient_obl>receive_acl:relcl>dose_obj>doxorubicin_nmod	relType_14=amod	lemma_5=in	relType_9=advmod	relType_1=aux	pos_16=IN	lemma_8=have	relType_10=acl:relcl	lemma_15=dose	lemma_1=should	pos_3=VB	lemma_4=use	relType_3=aux:pass	lemma_7=who	relType_5=case	pos_8=VBP	lemma_12=recommend	pos_2=RB	relType_6=obl	lemma_10=receive	pos_7=WP	path=Cerubidine_nsubj:pass<use_ROOT>patient_obl>receive_acl:relcl>dose_obj>doxorubicin_nmod	eib=False	relType_2=advmod	lemma_6=patient	wib=not	relType_12=amod	pos_13=NN	lemma_16=of	pos_4=VBN	path1=Cerubidine_nsubj:pass	relType_13=compound	lemma_14=cumulative	lemma_3=be	pos_5=IN	pos_9=RB	pos_1=MD	pos_11=DT	lemma_11=the	relType_4=ROOT	lib=not	relType_11=det	relType_15=obj	relType_16=case	pos_15=NNS	lemma_13=maximum	pos_10=VBN	lemma_9=previously	pos_6=NNS	relType_8=aux	lpib=not_RB	relType_7=nsubj	pos_14=JJ	pos_12=VBN	lemma_2=not
DDI-DrugBank.d69.s1	DDI-DrugBank.d69.s1.e0	DDI-DrugBank.d69.s1.e2	null	relType_14=amod	lemma_5=in	relType_17=cc	relType_9=advmod	relType_1=aux	pos_16=IN	lemma_8=have	relType_10=acl:relcl	lemma_15=dose	lemma_1=should	path2=patient_obl>receive_acl:relcl>dose_obj>doxorubicin_nmod>cerubidine_conj	pos_3=VB	relType_3=aux:pass	lemma_4=use	relType_5=case	lemma_7=who	pos_8=VBP	lemma_12=recommend	pos_2=RB	relType_6=obl	lemma_10=receive	pos_17=NN	pos_7=WP	relType_2=advmod	lemma_17=doxorubicin	lemma_6=patient	wib=not	relType_12=amod	pos_13=NN	lemma_16=of	pos_4=VBN	path1=Cerubidine_nsubj:pass	relType_13=compound	lemma_14=cumulative	lemma_3=be	pos_5=IN	pos_9=RB	pos_1=MD	pos_11=DT	relType_17=nmod	lemma_11=the	lemma_17=or	relType_4=ROOT	lib=not	relType_11=det	relType_15=obj	path=Cerubidine_nsubj:pass<use_ROOT>patient_obl>receive_acl:relcl>dose_obj>doxorubicin_nmod>cerubidine_conj	relType_16=case	pos_15=NNS	lemma_13=maximum	eib=True	pos_10=VBN	lemma_9=previously	pos_6=NNS	relType_8=aux	lpib=not_RB	relType_7=nsubj	pos_14=JJ	pos_12=VBN	pos_17=CC	lemma_2=not
DDI-DrugBank.d69.s1	DDI-DrugBank.d69.s1.e1	DDI-DrugBank.d69.s1.e2	null	relType_1=cc	wib=Cerubidine	pos_1=CC	eib=False	lpib=cerubidine_NN	path1=	path2=cerubidine_conj	path=<doxorubicin_nmod>cerubidine_conj	lib=cerubidine	lemma_1=or
DDI-DrugBank.d69.s2	DDI-DrugBank.d69.s2.e0	DDI-DrugBank.d69.s2.e1	effect	pos_2=RB	lpib=use_VBD	lib=use	pos_1=VBD	pos_3=IN	eib=False	relType_1=csubj	path2=Cerubidine_obl	lemma_1=use	relType_2=advmod	path1=Cyclophosphamide_nsubj	lemma_3=with	wib=used	lemma_2=concurrently	relType_3=case	path=Cyclophosphamide_nsubj<use_csubj>Cerubidine_obl
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e1	null	lib=sedative	eib=False	path1=	pos_1=,	lpib=sedative_NNS	wib=Sedatives	relType_1=punct	lemma_1=/	path=<anesthetic_ROOT>opioid_appos>sedative_compound	path2=opioid_appos>sedative_compound
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e2	null	pos_2=NNS	lemma_2=sedative	lib=sedative	lemma_2=/	eib=True	relType_2=compound	path=<anesthetic_ROOT>opioid_appos>hypnotic_compound	path1=	pos_1=,	pos_2=,	lpib=sedative_NNS	path2=opioid_appos>hypnotic_compound	wib=Sedatives	relType_1=punct	lemma_1=/	relType_2=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e3	null	path=<anesthetic_ROOT>opioid_appos	lemma_2=/	path2=opioid_appos	path1=	pos_1=,	relType_2=punct	pos_3=NNS	lemma_3=/	lib=sedative	relType_2=compound	lemma_3=hypnotic	lpib=sedative_NNS	lemma_1=/	pos_2=NNS	lemma_2=sedative	pos_3=,	eib=True	pos_2=,	relType_3=compound	wib=Sedatives	relType_1=punct	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e4	null	relType_8=case	lemma_2=/	lemma_4=opioid	relType_4=appos	path1=	pos_1=,	relType_5=compound	relType_2=punct	path2=opioid_appos>likely_parataxis>administration_nsubj>precedex_nmod	pos_6=HYPH	pos_3=NNS	lemma_4=:	relType_6=punct	lemma_3=/	pos_4=NNS	pos_8=IN	lemma_6=-	lib=sedative	relType_4=punct	pos_4=:	relType_2=compound	lemma_7=administration	lemma_3=hypnotic	lpib=sedative_NNS	pos_5=NNP	lemma_1=/	path=<anesthetic_ROOT>opioid_appos>likely_parataxis>administration_nsubj>precedex_nmod	pos_2=NNS	lemma_2=sedative	pos_3=,	eib=True	pos_2=,	relType_3=compound	relType_7=nsubj	wib=Sedatives	relType_1=punct	pos_7=NN	lemma_5=Co	lemma_8=of	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e5	null	relType_8=case	lemma_9=precedex	path2=opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod	lemma_2=/	lemma_4=opioid	relType_4=appos	path1=	pos_1=,	relType_5=compound	pos_9=IN	relType_9=nmod	relType_2=punct	pos_6=HYPH	pos_3=NNS	lemma_4=:	relType_6=punct	lemma_3=/	relType_9=case	pos_9=NN	pos_4=NNS	pos_8=IN	lemma_6=-	lib=sedative	path=<anesthetic_ROOT>opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod	pos_4=:	relType_4=punct	relType_2=compound	lemma_7=administration	lemma_3=hypnotic	lpib=sedative_NNS	pos_5=NNP	lemma_1=/	pos_2=NNS	lemma_2=sedative	lemma_9=with	pos_3=,	eib=True	pos_2=,	relType_3=compound	relType_7=nsubj	wib=Sedatives	relType_1=punct	pos_7=NN	lemma_5=Co	lemma_8=of	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e6	null	relType_8=case	lemma_9=precedex	path=<anesthetic_ROOT>opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	relType_10=punct	lemma_2=/	lemma_4=opioid	relType_4=appos	lemma_10=,	path1=	pos_1=,	relType_5=compound	pos_9=IN	relType_9=nmod	relType_2=punct	pos_6=HYPH	path2=opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	pos_10=NNS	relType_10=nmod	pos_3=NNS	lemma_4=:	relType_6=punct	lemma_3=/	relType_9=case	pos_9=NN	pos_4=NNS	pos_8=IN	lemma_6=-	lib=sedative	relType_4=punct	pos_4=:	relType_2=compound	lemma_7=administration	lemma_3=hypnotic	lpib=sedative_NNS	pos_5=NNP	lemma_10=anesthetic	lemma_1=/	pos_2=NNS	lemma_2=sedative	lemma_9=with	pos_3=,	pos_10=,	eib=True	pos_2=,	relType_3=compound	relType_7=nsubj	wib=Sedatives	relType_1=punct	pos_7=NN	lemma_5=Co	lemma_8=of	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e7	null	path2=opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	relType_8=case	lemma_9=precedex	relType_10=punct	lemma_2=/	lemma_11=,	lemma_4=opioid	relType_4=appos	lemma_10=,	path1=	pos_1=,	relType_5=compound	pos_9=IN	relType_9=nmod	relType_11=conj	relType_2=punct	pos_6=HYPH	lemma_11=sedative	pos_10=NNS	relType_10=nmod	pos_3=NNS	lemma_4=:	relType_6=punct	relType_11=punct	pos_11=NNS	lemma_3=/	relType_9=case	pos_9=NN	pos_4=NNS	pos_8=IN	lemma_6=-	lib=sedative	relType_4=punct	pos_4=:	relType_2=compound	lemma_7=administration	lemma_3=hypnotic	lpib=sedative_NNS	pos_5=NNP	lemma_10=anesthetic	pos_11=,	lemma_1=/	pos_2=NNS	lemma_2=sedative	lemma_9=with	pos_3=,	pos_10=,	eib=True	path=<anesthetic_ROOT>opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	pos_2=,	relType_3=compound	relType_7=nsubj	wib=Sedatives	relType_1=punct	pos_7=NN	lemma_5=Co	lemma_8=of	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e0	DDI-DrugBank.d197.s1.e8	null	relType_8=case	lemma_9=precedex	relType_12=conj	relType_10=punct	path=<anesthetic_ROOT>opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	lemma_2=/	lemma_11=,	lemma_4=opioid	relType_4=appos	lemma_10=,	path1=	pos_1=,	relType_5=compound	pos_9=IN	relType_9=nmod	relType_11=conj	relType_2=punct	pos_6=HYPH	lemma_11=sedative	pos_10=NNS	lemma_12=,	relType_10=nmod	pos_3=NNS	lemma_4=:	lemma_12=hypnotic	relType_6=punct	relType_11=punct	pos_12=,	pos_11=NNS	lemma_3=/	relType_9=case	relType_12=punct	lemma_13=and	pos_9=NN	pos_4=NNS	pos_8=IN	lemma_6=-	relType_13=cc	lib=sedative	relType_4=punct	pos_4=:	pos_12=NNS	relType_2=compound	lemma_7=administration	lemma_3=hypnotic	lpib=sedative_NNS	pos_5=NNP	lemma_10=anesthetic	pos_11=,	lemma_1=/	pos_13=CC	pos_2=NNS	lemma_2=sedative	lemma_9=with	pos_3=,	pos_10=,	eib=True	path2=opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	pos_2=,	relType_3=compound	relType_7=nsubj	wib=Sedatives	relType_1=punct	pos_7=NN	lemma_5=Co	lemma_8=of	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e2	null	path2=hypnotic_compound	lpib=hypnotic_NNS	eib=False	lib=hypnotic	path=sedative_compound<opioid_appos>hypnotic_compound	pos_1=,	path1=sedative_compound	wib=Hypnotics	relType_1=punct	lemma_1=/
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e3	null	pos_2=NNS	lpib=hypnotic_NNS	lemma_2=hypnotic	lemma_2=/	eib=True	lib=hypnotic	relType_2=compound	pos_1=,	path1=sedative_compound	wib=Hypnotics	pos_2=,	path2=	path=sedative_compound<opioid_appos>	relType_1=punct	lemma_1=/	relType_2=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e4	null	lemma_2=/	lemma_6=administration	relType_7=case	pos_1=,	lemma_3=opioid	relType_2=punct	pos_6=NN	lemma_2=hypnotic	pos_3=NNS	path=sedative_compound<opioid_appos>likely_parataxis>administration_nsubj>precedex_nmod	relType_3=appos	lemma_3=:	pos_5=HYPH	path2=likely_parataxis>administration_nsubj>precedex_nmod	lib=hypnotic	relType_2=compound	pos_3=:	lemma_4=Co	relType_4=compound	relType_5=punct	path1=sedative_compound	wib=Hypnotics	lemma_1=/	lemma_7=of	pos_2=NNS	lpib=hypnotic_NNS	eib=True	pos_7=IN	pos_4=NNP	pos_2=,	relType_1=punct	lemma_5=-	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e5	null	relType_8=case	lemma_2=/	lemma_6=administration	relType_7=case	pos_1=,	lemma_3=opioid	relType_2=punct	pos_6=NN	pos_8=NN	lemma_2=hypnotic	pos_3=NNS	relType_3=appos	lemma_3=:	pos_5=HYPH	lemma_8=with	pos_8=IN	path=sedative_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod	lib=hypnotic	relType_2=compound	pos_3=:	path2=likely_parataxis>administration_nsubj>anesthetic_nmod	lemma_4=Co	relType_4=compound	path1=sedative_compound	wib=Hypnotics	relType_5=punct	lemma_8=precedex	lemma_1=/	lemma_7=of	pos_2=NNS	lpib=hypnotic_NNS	eib=True	pos_7=IN	relType_8=nmod	pos_4=NNP	pos_2=,	relType_1=punct	lemma_5=-	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e6	null	relType_8=case	lemma_2=/	lemma_6=administration	relType_7=case	pos_1=,	lemma_9=,	relType_9=nmod	lemma_3=opioid	relType_2=punct	pos_6=NN	pos_8=NN	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	lemma_2=hypnotic	pos_3=NNS	relType_3=appos	lemma_3=:	pos_9=NNS	pos_5=HYPH	lemma_8=with	lemma_9=anesthetic	pos_8=IN	lib=hypnotic	relType_2=compound	pos_3=:	lemma_4=Co	relType_4=compound	relType_5=punct	path1=sedative_compound	wib=Hypnotics	lemma_8=precedex	relType_9=punct	lemma_1=/	lemma_7=of	pos_2=NNS	lpib=hypnotic_NNS	eib=True	path=sedative_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	pos_7=IN	relType_8=nmod	pos_4=NNP	pos_2=,	pos_9=,	relType_1=punct	lemma_5=-	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e7	null	relType_8=case	relType_10=punct	lemma_2=/	lemma_6=administration	relType_7=case	path=sedative_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	lemma_10=,	pos_1=,	lemma_9=,	relType_9=nmod	lemma_3=opioid	relType_2=punct	pos_6=NN	pos_8=NN	pos_10=NNS	lemma_2=hypnotic	pos_3=NNS	relType_3=appos	relType_10=conj	lemma_3=:	pos_9=NNS	pos_5=HYPH	lemma_8=with	lemma_9=anesthetic	pos_8=IN	lib=hypnotic	relType_2=compound	pos_3=:	lemma_4=Co	relType_4=compound	relType_5=punct	path1=sedative_compound	wib=Hypnotics	lemma_8=precedex	relType_9=punct	lemma_1=/	lemma_7=of	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	pos_2=NNS	lpib=hypnotic_NNS	pos_10=,	eib=True	pos_7=IN	relType_8=nmod	pos_4=NNP	pos_2=,	pos_9=,	relType_1=punct	lemma_5=-	lemma_10=sedative	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e1	DDI-DrugBank.d197.s1.e8	null	relType_8=case	relType_10=punct	lemma_2=/	lemma_6=administration	relType_7=case	lemma_11=,	lemma_10=,	pos_1=,	relType_12=cc	path=sedative_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	lemma_9=,	relType_9=nmod	pos_12=CC	lemma_3=opioid	relType_2=punct	relType_11=conj	pos_6=NN	pos_8=NN	pos_10=NNS	lemma_2=hypnotic	pos_3=NNS	relType_3=appos	relType_10=conj	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	lemma_3=:	relType_11=punct	pos_9=NNS	pos_5=HYPH	pos_11=NNS	lemma_8=with	lemma_9=anesthetic	lemma_11=hypnotic	pos_8=IN	lib=hypnotic	relType_2=compound	pos_3=:	lemma_4=Co	relType_4=compound	relType_5=punct	path1=sedative_compound	wib=Hypnotics	lemma_8=precedex	pos_11=,	relType_9=punct	lemma_1=/	lemma_7=of	pos_2=NNS	lpib=hypnotic_NNS	pos_10=,	eib=True	pos_7=IN	relType_8=nmod	pos_4=NNP	lemma_12=and	pos_2=,	pos_9=,	relType_1=punct	lemma_5=-	lemma_10=sedative	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e3	null	path1=hypnotic_compound	eib=False	lib=opioid	pos_1=,	lpib=opioid_NNS	path2=	path=hypnotic_compound<opioid_appos>	relType_1=punct	lemma_1=/	wib=Opioids
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e4	null	lemma_2=opioid	lib=opioid	pos_1=,	pos_3=NNP	path=hypnotic_compound<opioid_appos>likely_parataxis>administration_nsubj>precedex_nmod	lemma_4=-	relType_5=nsubj	lemma_6=of	pos_4=HYPH	relType_6=case	relType_2=punct	wib=Opioids	lemma_2=:	pos_6=IN	path2=likely_parataxis>administration_nsubj>precedex_nmod	lemma_3=Co	relType_4=punct	pos_2=:	relType_2=appos	lemma_1=/	pos_2=NNS	pos_5=NN	path1=hypnotic_compound	eib=True	lpib=opioid_NNS	relType_3=compound	relType_1=punct	lemma_5=administration
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e5	null	relType_7=case	lemma_2=opioid	lib=opioid	pos_1=,	pos_3=NNP	lemma_4=-	relType_5=nsubj	lemma_6=of	pos_4=HYPH	relType_6=case	lemma_7=with	relType_2=punct	wib=Opioids	lemma_2=:	pos_6=IN	lemma_3=Co	relType_4=punct	path2=likely_parataxis>administration_nsubj>anesthetic_nmod	pos_2=:	relType_7=nmod	relType_2=appos	lemma_1=/	pos_2=NNS	pos_5=NN	path1=hypnotic_compound	path=hypnotic_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod	eib=True	lemma_7=precedex	pos_7=IN	lpib=opioid_NNS	relType_3=compound	relType_1=punct	pos_7=NN	lemma_5=administration
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e6	null	relType_7=case	lemma_2=opioid	lib=opioid	pos_1=,	pos_3=NNP	lemma_4=-	relType_5=nsubj	lemma_6=of	relType_8=punct	pos_4=HYPH	lemma_8=,	relType_6=case	lemma_7=with	pos_8=NNS	relType_2=punct	wib=Opioids	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	lemma_2=:	pos_6=IN	lemma_8=anesthetic	lemma_3=Co	path=hypnotic_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	relType_4=punct	pos_2=:	relType_7=nmod	relType_2=appos	lemma_1=/	pos_2=NNS	pos_5=NN	path1=hypnotic_compound	eib=True	lemma_7=precedex	pos_7=IN	relType_8=nmod	lpib=opioid_NNS	relType_3=compound	relType_1=punct	pos_7=NN	lemma_5=administration	pos_8=,
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e7	null	relType_9=conj	relType_7=case	lemma_2=opioid	lib=opioid	pos_1=,	pos_3=NNP	lemma_4=-	relType_5=nsubj	lemma_6=of	relType_8=punct	lemma_9=,	pos_4=HYPH	lemma_8=,	relType_6=case	lemma_7=with	pos_8=NNS	relType_2=punct	wib=Opioids	lemma_2=:	pos_6=IN	lemma_8=anesthetic	pos_9=NNS	lemma_3=Co	lemma_9=sedative	relType_4=punct	pos_2=:	relType_7=nmod	relType_2=appos	relType_9=punct	lemma_1=/	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	pos_2=NNS	pos_5=NN	path1=hypnotic_compound	eib=True	lemma_7=precedex	path=hypnotic_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	pos_7=IN	relType_8=nmod	lpib=opioid_NNS	relType_3=compound	pos_9=,	relType_1=punct	pos_7=NN	lemma_5=administration	pos_8=,
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e2	DDI-DrugBank.d197.s1.e8	null	relType_10=punct	relType_9=conj	relType_7=case	relType_11=cc	lemma_2=opioid	lib=opioid	lemma_10=,	pos_1=,	pos_3=NNP	lemma_4=-	path=hypnotic_compound<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	relType_5=nsubj	lemma_6=of	relType_8=punct	lemma_9=,	pos_4=HYPH	lemma_8=,	relType_6=case	lemma_7=with	pos_8=NNS	relType_2=punct	wib=Opioids	lemma_2=:	relType_10=conj	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	pos_6=IN	lemma_8=anesthetic	pos_9=NNS	lemma_3=Co	lemma_9=sedative	relType_4=punct	lemma_11=and	pos_11=CC	pos_2=:	relType_7=nmod	relType_2=appos	relType_9=punct	lemma_1=/	pos_2=NNS	pos_5=NN	path1=hypnotic_compound	pos_10=,	eib=True	lemma_7=precedex	pos_7=IN	relType_8=nmod	lpib=opioid_NNS	relType_3=compound	lemma_10=hypnotic	pos_9=,	relType_1=punct	pos_7=NN	pos_10=NNS	lemma_5=administration	pos_8=,
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e3	DDI-DrugBank.d197.s1.e4	null	path1=	lemma_5=of	relType_5=case	lpib=co_NNP	eib=False	pos_2=NNP	lemma_3=-	path2=likely_parataxis>administration_nsubj>precedex_nmod	lemma_2=Co	relType_4=nsubj	pos_4=NN	lemma_1=:	relType_2=compound	pos_1=:	pos_5=IN	pos_3=HYPH	lemma_4=administration	relType_1=punct	lib=co	relType_3=punct	path=<opioid_appos>likely_parataxis>administration_nsubj>precedex_nmod	wib=Co
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e3	DDI-DrugBank.d197.s1.e5	null	path1=	lemma_5=of	relType_5=case	relType_6=case	pos_6=NN	lpib=co_NNP	pos_2=NNP	pos_6=IN	lemma_3=-	path=<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod	lemma_2=Co	relType_4=nsubj	pos_4=NN	lemma_1=:	lemma_6=precedex	relType_2=compound	path2=likely_parataxis>administration_nsubj>anesthetic_nmod	pos_1=:	pos_5=IN	lemma_6=with	eib=True	pos_3=HYPH	lemma_4=administration	relType_1=punct	relType_6=nmod	lib=co	relType_3=punct	wib=Co
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e3	DDI-DrugBank.d197.s1.e6	null	pos_7=NNS	path1=	path=<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	lemma_5=of	relType_5=case	relType_6=case	pos_6=NN	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>sedative_conj	lpib=co_NNP	pos_2=NNP	pos_6=IN	lemma_3=-	pos_7=,	lemma_2=Co	relType_4=nsubj	lemma_7=,	pos_4=NN	lemma_1=:	lemma_6=precedex	relType_2=compound	pos_1=:	pos_5=IN	lemma_6=with	lemma_7=anesthetic	relType_7=nmod	eib=True	pos_3=HYPH	relType_7=punct	lemma_4=administration	relType_1=punct	relType_6=nmod	lib=co	relType_3=punct	wib=Co
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e3	DDI-DrugBank.d197.s1.e7	null	pos_7=NNS	lemma_8=sedative	path1=	relType_8=punct	lemma_8=,	lemma_5=of	relType_5=case	relType_6=case	pos_8=NNS	pos_6=NN	lpib=co_NNP	pos_2=NNP	pos_6=IN	lemma_3=-	pos_7=,	lemma_2=Co	relType_4=nsubj	lemma_7=,	pos_4=NN	lemma_1=:	lemma_6=precedex	relType_2=compound	path=<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	pos_1=:	pos_5=IN	lemma_6=with	lemma_7=anesthetic	relType_7=nmod	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>hypnotic_conj	eib=True	pos_3=HYPH	relType_7=punct	relType_8=conj	lemma_4=administration	relType_1=punct	relType_6=nmod	lib=co	relType_3=punct	pos_8=,	wib=Co
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e3	DDI-DrugBank.d197.s1.e8	null	pos_7=NNS	lemma_8=sedative	relType_9=conj	relType_10=cc	path1=	relType_8=punct	lemma_9=,	lemma_8=,	lemma_5=of	relType_5=case	relType_6=case	pos_8=NNS	pos_6=NN	lpib=co_NNP	pos_2=NNP	path2=likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	path=<opioid_appos>likely_parataxis>administration_nsubj>anesthetic_nmod>opioid_conj	lemma_3=-	pos_6=IN	pos_9=NNS	pos_10=CC	pos_7=,	lemma_2=Co	relType_4=nsubj	lemma_7=,	pos_4=NN	lemma_1=:	lemma_6=precedex	lemma_10=and	lemma_9=hypnotic	relType_2=compound	pos_1=:	pos_5=IN	lemma_6=with	lemma_7=anesthetic	relType_7=nmod	relType_9=punct	eib=True	pos_3=HYPH	relType_7=punct	relType_8=conj	lemma_4=administration	pos_9=,	relType_1=punct	relType_6=nmod	lib=co	relType_3=punct	pos_8=,	wib=Co
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e4	DDI-DrugBank.d197.s1.e5	effect	lemma_1=with	wib=anesthetics	relType_1=case	eib=False	path1=precedex_nmod	lpib=anesthetic_NNS	path2=anesthetic_nmod	pos_1=IN	lib=anesthetic	path=precedex_nmod<administration_nsubj>anesthetic_nmod
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e4	DDI-DrugBank.d197.s1.e6	effect	pos_2=NNS	lemma_1=with	wib=anesthetics	path=precedex_nmod<administration_nsubj>anesthetic_nmod>sedative_conj	relType_1=case	eib=True	lemma_2=anesthetic	path1=precedex_nmod	relType_2=nmod	path2=anesthetic_nmod>sedative_conj	pos_2=,	lpib=anesthetic_NNS	pos_1=IN	lib=anesthetic	lemma_2=,	relType_2=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e4	DDI-DrugBank.d197.s1.e7	effect	relType_1=case	path1=precedex_nmod	relType_2=punct	pos_3=NNS	relType_2=nmod	path=precedex_nmod<administration_nsubj>anesthetic_nmod>hypnotic_conj	lemma_3=sedative	lpib=anesthetic_NNS	pos_1=IN	lemma_2=,	wib=anesthetics	lemma_3=,	relType_3=conj	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	lemma_2=anesthetic	lib=anesthetic	pos_2=,	path2=anesthetic_nmod>hypnotic_conj	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e4	DDI-DrugBank.d197.s1.e8	effect	relType_1=case	pos_5=CC	path1=precedex_nmod	relType_2=punct	relType_5=cc	pos_3=NNS	pos_4=,	relType_2=nmod	lemma_3=sedative	lpib=anesthetic_NNS	pos_1=IN	lemma_2=,	pos_4=NNS	path=precedex_nmod<administration_nsubj>anesthetic_nmod>opioid_conj	path2=anesthetic_nmod>opioid_conj	wib=anesthetics	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=hypnotic	lemma_4=,	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	lemma_2=anesthetic	lemma_5=and	pos_2=,	relType_4=conj	lib=anesthetic	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e5	DDI-DrugBank.d197.s1.e6	null	lemma_1=,	lib=sedative	eib=False	path1=	pos_1=,	lpib=sedative_NNS	wib=sedatives	path2=sedative_conj	relType_1=punct	path=<anesthetic_nmod>sedative_conj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e5	DDI-DrugBank.d197.s1.e7	null	pos_2=NNS	path2=hypnotic_conj	lemma_2=sedative	lemma_1=,	lib=sedative	eib=True	path=<anesthetic_nmod>hypnotic_conj	path1=	pos_1=,	pos_2=,	lpib=sedative_NNS	wib=sedatives	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e5	DDI-DrugBank.d197.s1.e8	null	lemma_1=,	path1=	pos_1=,	relType_4=cc	relType_2=punct	pos_3=NNS	path=<anesthetic_nmod>opioid_conj	relType_2=conj	lemma_2=,	lib=sedative	lemma_3=,	relType_3=conj	path2=opioid_conj	lemma_3=hypnotic	lpib=sedative_NNS	pos_2=NNS	lemma_2=sedative	pos_3=,	eib=True	pos_4=CC	lemma_4=and	pos_2=,	wib=sedatives	relType_1=punct	relType_3=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e6	DDI-DrugBank.d197.s1.e7	null	path2=hypnotic_conj	lpib=hypnotic_NNS	lemma_1=,	wib=hypnotics	lib=hypnotic	eib=False	path=sedative_conj<anesthetic_nmod>hypnotic_conj	pos_1=,	relType_1=punct	path1=sedative_conj
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e6	DDI-DrugBank.d197.s1.e8	null	lemma_1=,	wib=hypnotics	path=sedative_conj<anesthetic_nmod>opioid_conj	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	lemma_2=hypnotic	relType_2=conj	lemma_2=,	path1=sedative_conj	lib=hypnotic	path2=opioid_conj	pos_2=NNS	lpib=hypnotic_NNS	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d197.s1	DDI-DrugBank.d197.s1.e7	DDI-DrugBank.d197.s1.e8	null	lemma_2=and	path1=hypnotic_conj	lemma_1=,	eib=False	lib=opioid	path2=opioid_conj	wib=opioids	pos_2=CC	pos_1=,	lpib=opioid_NNS	path=hypnotic_conj<anesthetic_nmod>opioid_conj	relType_1=punct	relType_2=cc
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e0	DDI-DrugBank.d197.s2.e1	null	lemma_1=,	path2=isoflurane_conj	path=<sevoflurane_nmod>isoflurane_conj	lpib=isoflurane_NN	eib=False	path1=	pos_1=,	lib=isoflurane	relType_1=punct	wib=isoflurane
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e0	DDI-DrugBank.d197.s2.e2	null	lemma_1=,	path2=propofol_conj	pos_2=NN	eib=True	lpib=isoflurane_NN	lemma_2=isoflurane	path1=	pos_1=,	pos_2=,	lib=isoflurane	path=<sevoflurane_nmod>propofol_conj	wib=isoflurane	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e0	DDI-DrugBank.d197.s2.e3	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	wib=isoflurane	relType_2=punct	path=<sevoflurane_nmod>alfentanil_conj	lib=isoflurane	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_2=isoflurane	lemma_3=propofol	pos_3=,	eib=True	lpib=isoflurane_NN	pos_3=NN	pos_2=,	relType_1=punct	path2=alfentanil_conj	relType_3=punct
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e0	DDI-DrugBank.d197.s2.e4	null	lemma_1=,	pos_2=NN	pos_5=CC	path1=	path=<sevoflurane_nmod>midazolam_conj	pos_1=,	wib=isoflurane	relType_2=punct	relType_5=cc	pos_4=,	lemma_4=alfentanil	lib=isoflurane	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=isoflurane	lemma_3=propofol	lemma_4=,	pos_3=,	eib=True	lpib=isoflurane_NN	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	path2=midazolam_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e1	DDI-DrugBank.d197.s2.e2	null	path1=isoflurane_conj	path=isoflurane_conj<sevoflurane_nmod>propofol_conj	lemma_1=,	path2=propofol_conj	eib=False	pos_1=,	wib=propofol	lib=propofol	relType_1=punct	lpib=propofol_NN
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e1	DDI-DrugBank.d197.s2.e3	null	path1=isoflurane_conj	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lemma_2=propofol	path=isoflurane_conj<sevoflurane_nmod>alfentanil_conj	pos_1=,	wib=propofol	pos_2=,	relType_2=conj	lib=propofol	relType_1=punct	path2=alfentanil_conj	lemma_2=,	lpib=propofol_NN
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e1	DDI-DrugBank.d197.s2.e4	null	lemma_3=alfentanil	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	relType_2=punct	path1=isoflurane_conj	lemma_2=propofol	lib=propofol	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=propofol	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	path=isoflurane_conj<sevoflurane_nmod>midazolam_conj	pos_2=,	path2=midazolam_conj	relType_1=punct	relType_3=punct	lpib=propofol_NN
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e2	DDI-DrugBank.d197.s2.e3	null	wib=alfentanil	lemma_1=,	eib=False	path1=propofol_conj	pos_1=,	lib=alfentanil	path=propofol_conj<sevoflurane_nmod>alfentanil_conj	lpib=alfentanil_NN	relType_1=punct	path2=alfentanil_conj
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e2	DDI-DrugBank.d197.s2.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lpib=alfentanil_NN	relType_3=cc	relType_2=punct	path=propofol_conj<sevoflurane_nmod>midazolam_conj	relType_2=conj	lemma_2=,	path1=propofol_conj	wib=alfentanil	eib=True	lemma_2=alfentanil	lib=alfentanil	path2=midazolam_conj	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d197.s2	DDI-DrugBank.d197.s2.e3	DDI-DrugBank.d197.s2.e4	null	lemma_2=and	lemma_1=,	wib=midazolam	eib=False	path1=alfentanil_conj	pos_2=CC	lpib=midazolam_NN	pos_1=,	path2=midazolam_conj	path=alfentanil_conj<sevoflurane_nmod>midazolam_conj	relType_1=punct	relType_2=cc	lib=midazolam
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e0	DDI-DrugBank.d197.s3.e1	null	relType_1=cc	pos_1=CC	path2=isoflurane_conj	lpib=isoflurane_NN	eib=False	path=<dexmedetomidine_nmod>isoflurane_conj	path1=	lib=isoflurane	wib=isoflurane	lemma_1=and
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e0	DDI-DrugBank.d197.s3.e2	null	relType_1=cc	pos_1=CC	path2=propofol_conj	pos_2=NN	eib=True	lpib=isoflurane_NN	lemma_2=isoflurane	path=<dexmedetomidine_nmod>propofol_conj	path1=	pos_2=,	lib=isoflurane	wib=isoflurane	relType_2=conj	lemma_2=,	lemma_1=and	relType_2=punct
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e0	DDI-DrugBank.d197.s3.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	path1=	wib=isoflurane	relType_2=punct	path=<dexmedetomidine_nmod>alfentanil_conj	lib=isoflurane	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_2=isoflurane	lemma_3=propofol	pos_3=,	eib=True	lpib=isoflurane_NN	pos_3=NN	pos_2=,	path2=alfentanil_conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e0	DDI-DrugBank.d197.s3.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_5=CC	path1=	wib=isoflurane	relType_2=punct	relType_5=cc	pos_4=,	lemma_4=alfentanil	lib=isoflurane	relType_2=conj	pos_4=NN	lemma_2=,	path=<dexmedetomidine_nmod>midazolam_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=isoflurane	lemma_3=propofol	lemma_4=,	pos_3=,	eib=True	lpib=isoflurane_NN	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	path2=midazolam_conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e1	DDI-DrugBank.d197.s3.e2	null	path1=isoflurane_conj	lemma_1=,	path2=propofol_conj	eib=False	pos_1=,	wib=propofol	lib=propofol	relType_1=punct	path=isoflurane_conj<dexmedetomidine_nmod>propofol_conj	lpib=propofol_NN
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e1	DDI-DrugBank.d197.s3.e3	null	path1=isoflurane_conj	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lemma_2=propofol	pos_1=,	wib=propofol	pos_2=,	relType_2=conj	lib=propofol	path=isoflurane_conj<dexmedetomidine_nmod>alfentanil_conj	relType_1=punct	path2=alfentanil_conj	lemma_2=,	lpib=propofol_NN
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e1	DDI-DrugBank.d197.s3.e4	null	lemma_3=alfentanil	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	relType_2=punct	path1=isoflurane_conj	lemma_2=propofol	lib=propofol	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=propofol	relType_3=punct	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	path2=midazolam_conj	relType_1=punct	path=isoflurane_conj<dexmedetomidine_nmod>midazolam_conj	lpib=propofol_NN
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e2	DDI-DrugBank.d197.s3.e3	null	wib=alfentanil	path=propofol_conj<dexmedetomidine_nmod>alfentanil_conj	lemma_1=,	eib=False	path1=propofol_conj	pos_1=,	lib=alfentanil	lpib=alfentanil_NN	relType_1=punct	path2=alfentanil_conj
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e2	DDI-DrugBank.d197.s3.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lpib=alfentanil_NN	relType_3=cc	relType_2=punct	relType_2=conj	lemma_2=,	path1=propofol_conj	path=propofol_conj<dexmedetomidine_nmod>midazolam_conj	wib=alfentanil	eib=True	lemma_2=alfentanil	lib=alfentanil	path2=midazolam_conj	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d197.s3	DDI-DrugBank.d197.s3.e3	DDI-DrugBank.d197.s3.e4	null	lemma_2=and	lemma_1=,	wib=midazolam	eib=False	path1=alfentanil_conj	pos_2=CC	lpib=midazolam_NN	pos_1=,	path2=midazolam_conj	relType_1=punct	relType_2=cc	path=alfentanil_conj<dexmedetomidine_nmod>midazolam_conj	lib=midazolam
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e0	DDI-DrugBank.d197.s4.e1	null	lib=reduction	pos_2=DT	lemma_1=,	lemma_5=dosage	pos_1=,	lemma_3=reduction	lemma_4=in	relType_3=nsubj:pass	lemma_2=a	lemma_6=of	relType_6=case	eib=False	path2=reduction_nsubj:pass>dosage_nmod>PRECEDEX_nmod	pos_6=IN	lpib=reduction_NN	wib=reduction	path=precedex_obl<administer_advcl<require_ROOT>reduction_nsubj:pass>dosage_nmod>PRECEDEX_nmod	pos_4=IN	relType_4=case	relType_5=nmod	path1=precedex_obl<administer_advcl	pos_5=NN	pos_3=NN	relType_2=det	relType_1=punct
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e0	DDI-DrugBank.d197.s4.e2	null	lib=reduction	pos_2=DT	lemma_1=,	lemma_5=dosage	pos_8=DT	relType_7=case	pos_1=,	lemma_3=reduction	lemma_4=in	relType_3=nsubj:pass	lemma_2=a	lemma_6=of	relType_6=case	pos_9=JJ	path2=reduction_nsubj:pass>anesthetic_nmod	lemma_7=on	pos_6=IN	relType_9=amod	lpib=reduction_NN	wib=reduction	pos_4=IN	pos_7=NNP	lemma_8=the	path=precedex_obl<administer_advcl<require_ROOT>reduction_nsubj:pass>anesthetic_nmod	relType_4=case	relType_5=nmod	relType_7=nmod	lemma_9=concomitant	path1=precedex_obl<administer_advcl	pos_5=NN	lemma_7=PRECEDEX	eib=True	pos_7=IN	pos_3=NN	relType_2=det	relType_8=det	relType_1=punct
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e0	DDI-DrugBank.d197.s4.e3	null	lib=reduction	pos_2=DT	lemma_1=,	lemma_5=dosage	relType_10=punct	pos_8=DT	relType_7=case	lemma_10=,	pos_1=,	lemma_3=reduction	lemma_4=in	relType_3=nsubj:pass	lemma_2=a	lemma_6=of	relType_6=case	pos_9=JJ	relType_10=nmod	lemma_7=on	pos_6=IN	relType_9=amod	pos_10=NN	lpib=reduction_NN	wib=reduction	path2=reduction_nsubj:pass>anesthetic_nmod>sedative_conj	pos_4=IN	pos_7=NNP	lemma_8=the	relType_4=case	relType_5=nmod	relType_7=nmod	lemma_10=anesthetic	lemma_9=concomitant	path1=precedex_obl<administer_advcl	pos_5=NN	lemma_7=PRECEDEX	pos_10=,	eib=True	pos_7=IN	pos_3=NN	relType_2=det	relType_8=det	relType_1=punct	path=precedex_obl<administer_advcl<require_ROOT>reduction_nsubj:pass>anesthetic_nmod>sedative_conj
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e0	DDI-DrugBank.d197.s4.e4	null	lib=reduction	pos_2=DT	lemma_1=,	lemma_5=dosage	relType_10=punct	pos_8=DT	relType_7=case	lemma_11=,	lemma_10=,	pos_1=,	lemma_3=reduction	lemma_4=in	relType_3=nsubj:pass	lemma_2=a	lemma_6=of	relType_6=case	relType_11=conj	lemma_11=sedative	pos_9=JJ	relType_10=nmod	lemma_7=on	pos_6=IN	relType_11=punct	relType_9=amod	pos_10=NN	lpib=reduction_NN	path=precedex_obl<administer_advcl<require_ROOT>reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod	wib=reduction	pos_4=IN	pos_7=NNP	lemma_8=the	relType_4=case	relType_5=nmod	relType_7=nmod	lemma_10=anesthetic	lemma_9=concomitant	path1=precedex_obl<administer_advcl	pos_11=,	path2=reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod	pos_5=NN	lemma_7=PRECEDEX	pos_10=,	pos_11=NN	eib=True	pos_7=IN	pos_3=NN	relType_2=det	relType_8=det	relType_1=punct
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e0	DDI-DrugBank.d197.s4.e5	null	lib=reduction	pos_2=DT	lemma_1=,	lemma_5=dosage	relType_10=punct	pos_8=DT	relType_7=case	lemma_11=,	lemma_10=,	pos_1=,	relType_12=cc	lemma_3=reduction	lemma_4=in	relType_3=nsubj:pass	lemma_2=a	lemma_6=of	path2=reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod>opioid_conj	pos_12=CC	relType_6=case	relType_11=conj	lemma_11=sedative	pos_12=JJ	pos_9=JJ	relType_10=nmod	lemma_12=hypnotic	lemma_7=on	pos_6=IN	relType_11=punct	relType_12=amod	relType_9=amod	pos_10=NN	lpib=reduction_NN	lemma_12=or	wib=reduction	pos_4=IN	pos_7=NNP	lemma_8=the	relType_4=case	relType_5=nmod	relType_7=nmod	lemma_10=anesthetic	lemma_9=concomitant	path1=precedex_obl<administer_advcl	pos_11=,	path=precedex_obl<administer_advcl<require_ROOT>reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod>opioid_conj	pos_5=NN	lemma_7=PRECEDEX	pos_10=,	pos_11=NN	eib=True	pos_7=IN	pos_3=NN	relType_2=det	relType_8=det	relType_1=punct
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e1	DDI-DrugBank.d197.s4.e2	advise	lib=concomitant	pos_2=DT	relType_1=case	lemma_2=the	pos_3=JJ	relType_3=amod	eib=False	lemma_1=on	path=PRECEDEX_nmod<dosage_nmod<reduction_nsubj:pass>anesthetic_nmod	relType_2=det	path1=PRECEDEX_nmod<dosage_nmod	lpib=concomitant_JJ	path2=anesthetic_nmod	pos_1=IN	lemma_3=concomitant	wib=concomitant
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e1	DDI-DrugBank.d197.s4.e3	advise	pos_2=DT	relType_1=case	lemma_2=the	path1=PRECEDEX_nmod<dosage_nmod	relType_4=nmod	path=PRECEDEX_nmod<dosage_nmod<reduction_nsubj:pass>anesthetic_nmod>sedative_conj	lib=concomitant	pos_4=,	lpib=concomitant_JJ	pos_1=IN	pos_4=NN	wib=concomitant	relType_4=punct	relType_3=amod	path2=anesthetic_nmod>sedative_conj	lemma_4=,	lemma_3=concomitant	pos_3=JJ	eib=True	relType_2=det	lemma_4=anesthetic	lemma_1=on
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e1	DDI-DrugBank.d197.s4.e4	advise	pos_2=DT	relType_1=case	lemma_2=the	pos_5=,	path1=PRECEDEX_nmod<dosage_nmod	relType_4=nmod	lemma_5=sedative	lib=concomitant	pos_4=,	path=PRECEDEX_nmod<dosage_nmod<reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod	lpib=concomitant_JJ	pos_1=IN	pos_4=NN	wib=concomitant	relType_4=punct	relType_3=amod	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lemma_3=concomitant	pos_5=NN	pos_3=JJ	eib=True	relType_2=det	path2=anesthetic_nmod>hypnotic_amod	lemma_4=anesthetic	lemma_1=on
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e1	DDI-DrugBank.d197.s4.e5	advise	lemma_6=hypnotic	pos_2=DT	relType_1=case	lemma_2=the	pos_6=JJ	pos_5=,	path1=PRECEDEX_nmod<dosage_nmod	relType_4=nmod	lemma_5=sedative	lib=concomitant	pos_4=,	path2=anesthetic_nmod>hypnotic_amod>opioid_conj	relType_6=amod	lemma_6=or	lpib=concomitant_JJ	pos_1=IN	path=PRECEDEX_nmod<dosage_nmod<reduction_nsubj:pass>anesthetic_nmod>hypnotic_amod>opioid_conj	pos_4=NN	wib=concomitant	relType_4=punct	relType_3=amod	pos_6=CC	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lemma_3=concomitant	pos_5=NN	pos_3=JJ	eib=True	relType_2=det	lemma_4=anesthetic	lemma_1=on	relType_6=cc
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e2	DDI-DrugBank.d197.s4.e3	null	lemma_1=,	lib=sedative	lpib=sedative_NN	eib=False	path1=	pos_1=,	path2=sedative_conj	relType_1=punct	path=<anesthetic_nmod>sedative_conj	wib=sedative
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e2	DDI-DrugBank.d197.s4.e4	null	lemma_2=sedative	lemma_1=,	lib=sedative	lpib=sedative_NN	path=<anesthetic_nmod>hypnotic_amod	eib=True	path2=hypnotic_amod	pos_2=NN	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct	wib=sedative
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e2	DDI-DrugBank.d197.s4.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	relType_2=punct	relType_3=cc	lemma_3=or	relType_2=conj	path=<anesthetic_nmod>hypnotic_amod>opioid_conj	lemma_2=,	wib=sedative	lib=sedative	lpib=sedative_NN	relType_3=amod	lemma_3=hypnotic	lemma_2=sedative	pos_3=JJ	eib=True	pos_2=,	relType_1=punct	path2=hypnotic_amod>opioid_conj
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e3	DDI-DrugBank.d197.s4.e4	null	lemma_1=,	eib=False	lib=hypnotic	wib=hypnotic	path2=hypnotic_amod	lpib=hypnotic_JJ	path=sedative_conj<anesthetic_nmod>hypnotic_amod	pos_1=,	relType_1=punct	path1=sedative_conj
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e3	DDI-DrugBank.d197.s4.e5	null	lemma_2=or	lemma_1=,	lemma_2=hypnotic	path=sedative_conj<anesthetic_nmod>hypnotic_amod>opioid_conj	eib=True	lib=hypnotic	wib=hypnotic	relType_2=amod	pos_2=CC	lpib=hypnotic_JJ	pos_1=,	relType_1=punct	relType_2=cc	path2=hypnotic_amod>opioid_conj	pos_2=JJ	path1=sedative_conj
DDI-DrugBank.d197.s4	DDI-DrugBank.d197.s4.e4	DDI-DrugBank.d197.s4.e5	null	relType_1=cc	path=<hypnotic_amod>opioid_conj	pos_1=CC	wib=opioid	lpib=opioid_JJ	eib=False	lib=opioid	path2=opioid_conj	path1=	lemma_1=or
DDI-DrugBank.d197.s5	DDI-DrugBank.d197.s5.e0	DDI-DrugBank.d197.s5.e1	null	lemma_4=study	lemma_8=volunteer	path1=	pos_6=CD	relType_4=nmod	lemma_6=10	lemma_9=,	lemma_5=of	relType_5=case	lemma_7=healthy	pos_8=NNS	relType_11=case	pos_2=IN	path2=study_nmod>administration_appos>PRECEDEX_nmod	eib=False	relType_10=appos	lpib=study_NN	pos_10=NN	pos_4=NN	lemma_1=:	pos_11=IN	lib=study	relType_7=amod	pos_3=CD	lemma_3=one	path=<blocker_ROOT>study_nmod>administration_appos>PRECEDEX_nmod	pos_1=:	relType_6=nummod	pos_5=IN	relType_3=nummod	relType_9=punct	relType_2=case	relType_8=nmod	wib=study	pos_7=JJ	lemma_10=administration	lemma_11=of	pos_9=,	relType_1=punct	lemma_2=in
DDI-DrugBank.d197.s5	DDI-DrugBank.d197.s5.e0	DDI-DrugBank.d197.s5.e2	null	lemma_17=plasma	lemma_18=concentration	pos_30=RB	pos_16=DT	lemma_9=,	relType_22=dep	pos_35=NN	lemma_5=of	relType_5=case	pos_8=NNS	relType_38=conj	lemma_32=increase	lemma_28=in	relType_17=compound	pos_26=NN	pos_10=NN	relType_19=mark	relType_37=amod	pos_18=NN	relType_24=compound	lib=study	pos_1=:	pos_40=IN	wib=study	pos_7=JJ	relType_31=amod	pos_14=NNS	relType_21=punct	relType_14=nmod	pos_32=NNS	lemma_13=45	path2=study_nmod>administration_appos>concentration_nmod>result_acl>increase_obl>associate_acl>administration_obl>rocuronium_compound	pos_31=JJ	lemma_4=study	pos_13=CD	pos_37=JJ	path1=	lemma_30=clinically	relType_4=nmod	pos_20=CD	relType_11=case	relType_10=appos	relType_12=nmod	lemma_12=for	pos_12=IN	relType_15=case	lemma_33=in	pos_36=CC	lemma_39=associate	lemma_26=ml	relType_40=case	relType_6=nummod	pos_5=IN	pos_15=IN	pos_12=NNP	relType_25=punct	lemma_10=administration	relation_32=beneficial	pos_9=,	relType_1=punct	relType_18=nmod	lemma_2=in	relType_27=acl	lemma_8=volunteer	relType_12=case	pos_24=NN	lemma_22=one	path=<blocker_ROOT>study_nmod>administration_appos>concentration_nmod>result_acl>increase_obl>associate_acl>administration_obl>rocuronium_compound	pos_2=IN	pos_17=NN	relType_29=det	lemma_12=PRECEDEX	lemma_16=a	lemma_31=meaningful	relType_13=nummod	lemma_35=magnitude	lemma_38=blockade	lemma_1=:	pos_11=IN	lemma_19=of	pos_33=IN	relType_7=amod	lemma_23=)	pos_38=NN	lemma_3=one	pos_27=VBD	lemma_14=minute	pos_39=VBN	pos_34=DT	relType_35=nmod	pos_25=HYPH	relType_2=case	relType_28=case	pos_23=-RRB-	lemma_25=/	relType_30=advmod	lemma_11=of	lemma_36=or	relType_23=punct	pos_19=IN	relType_39=acl	lemma_40=with	relType_33=case	pos_6=CD	lemma_6=10	relType_16=det	relType_34=det	lemma_7=healthy	relType_20=dep	lemma_20=1	pos_21=-LRB-	pos_22=CD	lpib=study_NN	pos_4=NN	lemma_27=result	pos_29=DT	pos_3=CD	lemma_15=at	lemma_21=(	lemma_29=no	relType_3=nummod	relType_9=punct	relType_36=cc	eib=True	relType_8=nmod	pos_28=IN	relType_32=obl	lemma_34=the	lemma_24=ng	relType_26=nsubj	lemma_37=neuromuscular
DDI-DrugBank.d197.s5	DDI-DrugBank.d197.s5.e1	DDI-DrugBank.d197.s5.e2	null	relation_20=beneficial	lemma_15=ml	relType_19=advmod	pos_21=NNS	pos_6=NN	pos_10=-LRB-	pos_3=NNS	lemma_7=concentration	relType_23=det	wib=minutes	lemma_14=/	pos_13=NN	pos_22=IN	path=PRECEDEX_nmod<administration_appos>concentration_nmod>result_acl>increase_obl>associate_acl>administration_obl>rocuronium_compound	pos_20=JJ	path1=PRECEDEX_nmod	relType_16=acl	relType_8=mark	lemma_21=increase	relType_6=compound	relType_26=amod	lpib=minute_NNS	relType_1=case	relType_2=nummod	lemma_24=magnitude	path2=concentration_nmod>result_acl>increase_obl>associate_acl>administration_obl>rocuronium_compound	relType_15=nsubj	relType_27=conj	lemma_4=at	lemma_26=neuromuscular	pos_29=IN	lib=minute	pos_18=DT	relType_28=acl	lemma_18=no	pos_1=IN	relType_12=punct	relType_22=case	pos_8=IN	pos_27=NN	lemma_10=(	relType_7=nmod	relType_11=dep	pos_11=CD	lemma_16=result	relType_21=obl	lemma_27=blockade	lemma_11=one	lemma_9=1	relType_18=det	lemma_19=clinically	pos_7=NN	lemma_22=in	relType_14=punct	relType_10=punct	relType_29=case	lemma_3=minute	pos_24=NN	pos_12=-RRB-	pos_26=JJ	pos_17=IN	lemma_5=a	relType_20=amod	relType_17=case	pos_25=CC	lemma_13=ng	lemma_28=associate	pos_4=IN	relType_5=det	relType_3=nmod	lemma_1=for	lemma_17=in	pos_14=HYPH	pos_9=CD	pos_5=DT	lemma_20=meaningful	lemma_25=or	lemma_29=with	pos_16=VBD	relType_9=dep	lemma_6=plasma	eib=False	pos_28=VBN	pos_2=CD	pos_19=RB	relType_25=cc	lemma_2=45	relType_13=compound	pos_15=NN	relType_4=case	relType_24=nmod	pos_23=DT	lemma_12=)	lemma_23=the	lemma_8=of
DDI-DrugBank.d181.s0	DDI-DrugBank.d181.s0.e0	DDI-DrugBank.d181.s0.e1	null	relType_1=cc	path=<oxytocin_nsubj>oxytocic_conj	pos_1=CC	path2=oxytocic_conj	lib=other	eib=False	lpib=other_JJ	lemma_2=other	relType_2=amod	path1=	wib=other	pos_2=JJ	lemma_1=or
DDI-DrugBank.d181.s0	DDI-DrugBank.d181.s0.e0	DDI-DrugBank.d181.s0.e2	effect	relType_1=cc	relType_4=amod	pos_1=CC	pos_4=JJ	lib=other	relType_5=nsubj	pos_2=JJ	relType_6=case	pos_3=NNS	lemma_3=oxytocic	pos_6=IN	lemma_2=other	lemma_3=(	wib=other	pos_3=-LRB-	lemma_4=concurrent	relType_3=conj	lpib=other_JJ	relType_2=amod	lemma_6=with	path=oxytocin_nsubj<result_ROOT>use_nsubj>dinoprost_nmod	lemma_5=use	path2=use_nsubj>dinoprost_nmod	path1=oxytocin_nsubj	pos_5=NN	eib=True	relType_3=punct	lemma_1=or
DDI-DrugBank.d181.s0	DDI-DrugBank.d181.s0.e1	DDI-DrugBank.d181.s0.e2	effect	path1=oxytocic_conj<oxytocin_nsubj	pos_2=JJ	lemma_1=(	lemma_3=use	eib=False	path=oxytocic_conj<oxytocin_nsubj<result_ROOT>use_nsubj>dinoprost_nmod	lemma_4=with	pos_4=IN	relType_2=amod	relType_4=case	lemma_2=concurrent	path2=use_nsubj>dinoprost_nmod	relType_3=nsubj	pos_1=-LRB-	lpib=concurrent_JJ	wib=concurrent	pos_3=NN	lib=concurrent	relType_1=punct
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e1	null	relType_1=cc	pos_1=CC	lib=other	eib=True	lpib=other_JJ	pos_3=NN	lemma_2=other	relType_2=amod	path1=	wib=other	path=<alcohol_obl>depressant_conj	lemma_3=cns	relType_3=compound	pos_2=JJ	path2=depressant_conj	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e2	null	relType_1=cc	pos_1=CC	lemma_5=potentiate	relType_7=compound	pos_14=CC	lib=other	pos_6=DT	lemma_7=cns	pos_13=NNS	relation_10=neutral	lemma_10=of	lemma_3=cns	relType_5=parataxis	lemma_4=may	pos_2=JJ	lemma_8=depressant	relType_12=det	path=alcohol_obl<interact_ROOT>potentiate_parataxis>effect_obj>medication_nmod>antihistamine_conj	lemma_11=either	lemma_14=or	relType_13=nmod	pos_8=NN	pos_5=VB	pos_3=NNS	lemma_3=depressant	lemma_6=the	lemma_2=other	relation_6=adverse	pos_9=NNS	lemma_3=(	wib=other	path1=alcohol_obl	pos_4=MD	pos_3=-LRB-	relType_10=case	relType_11=cc:preconj	relType_3=conj	lpib=other_JJ	relType_2=amod	relType_8=compound	relType_4=aux	relType_9=obj	pos_11=CC	lemma_13=medication	pos_10=IN	relType_14=cc	relation_6=beneficial	path2=potentiate_parataxis>effect_obj>medication_nmod>antihistamine_conj	relType_6=det	eib=True	pos_3=NN	relType_3=compound	pos_12=DT	lemma_9=effect	pos_7=NN	lemma_12=this	relType_3=punct	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e3	null	relType_1=cc	pos_15=-RRB-	pos_1=CC	lemma_5=potentiate	relType_7=compound	pos_14=CC	lib=other	pos_6=DT	lemma_7=cns	pos_13=NNS	relation_10=neutral	lemma_10=of	lemma_3=cns	relType_5=parataxis	lemma_4=may	pos_2=JJ	lemma_8=depressant	relType_12=det	lemma_11=either	path2=anticholinergic_conj	lemma_14=or	lemma_15=antihistamine	relType_13=nmod	pos_8=NN	pos_5=VB	pos_3=NNS	lemma_3=depressant	path=alcohol_obl<interact_ROOT>anticholinergic_conj	lemma_2=other	lemma_6=the	pos_9=NNS	relation_6=adverse	lemma_3=(	wib=other	path1=alcohol_obl	pos_4=MD	pos_16=,	pos_3=-LRB-	relType_10=case	lemma_16=,	relType_15=punct	relType_11=cc:preconj	relType_3=conj	lpib=other_JJ	relType_2=amod	relType_8=compound	relType_4=aux	relType_9=obj	pos_11=CC	lemma_15=)	lemma_13=medication	pos_10=IN	relType_14=cc	relation_6=beneficial	relType_16=punct	relType_6=det	pos_15=NNS	eib=True	pos_3=NN	relType_15=conj	relType_3=compound	pos_12=DT	lemma_9=effect	pos_7=NN	lemma_12=this	relType_3=punct	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e4	null	relType_1=cc	pos_23=-LRB-	relType_28=dep	pos_14=CC	lemma_7=cns	relType_29=advmod	pos_13=NNS	lemma_10=of	pos_2=JJ	lemma_8=depressant	lemma_11=either	lemma_32=be	relType_34=advmod	relType_32=aux:pass	pos_3=NNS	relation_6=adverse	pos_3=-LRB-	lemma_16=,	lpib=other_JJ	lemma_17=anticholinergic	lemma_27=be	relType_16=punct	pos_33=VBN	lemma_24=anticholinergic	lemma_23=(	pos_12=DT	pos_15=-RRB-	relType_22=nmod	lemma_5=potentiate	relType_17=cc	pos_22=NN	pos_21=JJ	relation_31=beneficial	lemma_4=may	pos_19=NNS	relation_28=neutral	lemma_15=antihistamine	path2=anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	pos_8=NN	pos_5=VB	relType_20=case	lemma_29=when	lemma_3=(	pos_25=NNS	lemma_34=concurrently	relType_33=advcl	lemma_33=use	relType_4=aux	pos_34=RB	relType_24=amod	relType_6=det	pos_32=VBP	pos_26=MD	relType_3=compound	pos_17=CC	lemma_9=effect	pos_7=NN	relType_3=punct	lemma_21=anticholinergic	pos_6=DT	relType_5=parataxis	relType_27=aux:pass	lemma_14=or	relType_12=det	pos_24=JJ	pos_20=IN	lemma_6=the	lemma_2=other	lemma_31=medication	path1=alcohol_obl	pos_4=MD	relType_15=punct	relType_11=cc:preconj	pos_29=WRB	relType_3=conj	relType_2=amod	relType_8=compound	relType_9=obj	pos_11=CC	lemma_18=other	relType_25=nsubj:pass	pos_10=IN	relation_6=beneficial	path=alcohol_obl<interact_ROOT>anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	lemma_17=or	relType_19=conj	relType_31=nsubj:pass	pos_17=NNS	relType_15=conj	pos_30=DT	relType_23=punct	pos_1=CC	relType_7=compound	lib=other	lemma_22=activity	relType_18=amod	relation_10=neutral	lemma_3=cns	lemma_28=potentiate	lemma_25=effect	relType_17=conj	relType_13=nmod	relation_31=adverse	lemma_3=depressant	pos_28=VBN	relType_26=aux	pos_9=NNS	pos_16=,	wib=other	pos_18=JJ	relType_21=amod	pos_27=VB	relType_10=case	lemma_19=medication	lemma_30=this	pos_31=NNS	lemma_15=)	lemma_13=medication	relType_14=cc	lemma_35=with	lemma_26=may	pos_15=NNS	lemma_20=with	eib=True	pos_3=NN	pos_35=IN	relType_35=case	lemma_12=this	relType_30=det	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e5	null	relType_1=cc	pos_23=-LRB-	relType_28=dep	lemma_36=)	pos_39=NN	pos_14=CC	lemma_7=cns	relType_29=advmod	pos_13=NNS	lemma_10=of	pos_2=JJ	lemma_8=depressant	lemma_11=either	lemma_32=be	relType_34=advmod	relType_32=aux:pass	pos_3=NNS	relation_6=adverse	pos_3=-LRB-	lemma_16=,	lpib=other_JJ	lemma_17=anticholinergic	lemma_27=be	relType_16=punct	pos_33=VBN	lemma_24=anticholinergic	lemma_23=(	pos_36=NNS	pos_38=CC	relType_36=punct	pos_12=DT	relType_37=punct	pos_15=-RRB-	relType_22=nmod	lemma_37=,	lemma_5=potentiate	relType_17=cc	pos_22=NN	pos_21=JJ	relation_31=beneficial	relType_39=punct	lemma_4=may	pos_19=NNS	relation_28=neutral	lemma_15=antihistamine	pos_8=NN	pos_5=VB	relType_20=case	lemma_29=when	lemma_3=(	pos_25=NNS	lemma_34=concurrently	relType_33=advcl	lemma_33=use	relType_4=aux	lemma_38=and	pos_34=RB	pos_37=,	relType_24=amod	lemma_39=monoamine	relType_6=det	lemma_39=mao	pos_32=VBP	pos_26=MD	lemma_39=(	relType_3=compound	pos_17=CC	lemma_9=effect	pos_7=NN	relType_3=punct	lemma_21=anticholinergic	lemma_39=oxidase	pos_6=DT	relType_5=parataxis	relType_27=aux:pass	lemma_14=or	relType_12=det	pos_24=JJ	pos_20=IN	relType_39=compound	pos_39=-LRB-	lemma_39=)	lemma_6=the	lemma_2=other	lemma_31=medication	path1=alcohol_obl	pos_4=MD	relType_15=punct	relType_11=cc:preconj	lemma_36=antihistamine	pos_29=WRB	relType_3=conj	relType_2=amod	relType_8=compound	relType_9=obj	pos_11=CC	lemma_18=other	relType_25=nsubj:pass	pos_10=IN	relation_6=beneficial	lemma_17=or	relType_19=conj	relType_31=nsubj:pass	path=alcohol_obl<interact_ROOT>inhibitor_conj	pos_17=NNS	relType_15=conj	path2=inhibitor_conj	pos_30=DT	relType_23=punct	pos_1=CC	relType_7=compound	lib=other	lemma_22=activity	relType_18=amod	relation_10=neutral	lemma_3=cns	lemma_28=potentiate	lemma_25=effect	relType_38=cc	relType_17=conj	relType_13=nmod	pos_36=-RRB-	relation_31=adverse	lemma_3=depressant	pos_28=VBN	relType_26=aux	pos_9=NNS	pos_16=,	wib=other	pos_18=JJ	relType_21=amod	pos_27=VB	relType_10=case	lemma_19=medication	pos_39=-RRB-	lemma_30=this	pos_31=NNS	lemma_15=)	lemma_13=medication	relType_14=cc	lemma_35=with	lemma_26=may	relType_39=dep	pos_15=NNS	lemma_20=with	eib=True	relType_36=obl	pos_3=NN	pos_35=IN	relType_35=case	lemma_12=this	relType_30=det	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e6	null	relType_1=cc	pos_23=-LRB-	relType_28=dep	lemma_36=)	pos_39=NN	pos_14=CC	lemma_7=cns	relType_29=advmod	pos_13=NNS	lemma_10=of	pos_41=NN	pos_2=JJ	lemma_8=depressant	lemma_11=either	lemma_32=be	relType_34=advmod	relType_32=aux:pass	pos_3=NNS	relation_6=adverse	lemma_42=with	pos_3=-LRB-	lemma_16=,	lemma_40=concurrent	lpib=other_JJ	lemma_17=anticholinergic	lemma_27=be	path=alcohol_obl<interact_ROOT>inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	relType_16=punct	pos_33=VBN	lemma_24=anticholinergic	lemma_23=(	pos_36=NNS	pos_38=CC	relType_39=conj	relType_36=punct	pos_12=DT	pos_39=NNS	relType_37=punct	pos_15=-RRB-	pos_40=JJ	relType_22=nmod	lemma_37=,	lemma_5=potentiate	relType_17=cc	pos_22=NN	pos_21=JJ	relation_31=beneficial	relType_39=punct	lemma_4=may	pos_19=NNS	relation_28=neutral	lemma_15=antihistamine	pos_8=NN	pos_5=VB	relType_20=case	lemma_29=when	lemma_3=(	pos_25=NNS	lemma_34=concurrently	relType_33=advcl	lemma_33=use	relType_4=aux	lemma_38=and	pos_34=RB	pos_37=,	relType_24=amod	lemma_39=monoamine	relType_6=det	lemma_39=mao	pos_32=VBP	pos_26=MD	lemma_39=(	relType_3=compound	pos_17=CC	lemma_9=effect	pos_7=NN	relType_3=punct	lemma_21=anticholinergic	lemma_39=oxidase	pos_6=DT	relType_5=parataxis	relType_27=aux:pass	relType_41=nsubj	lemma_14=or	relType_12=det	pos_24=JJ	pos_20=IN	relType_39=compound	pos_39=-LRB-	lemma_39=)	lemma_6=the	lemma_2=other	lemma_31=medication	path1=alcohol_obl	pos_4=MD	relType_15=punct	relType_11=cc:preconj	lemma_36=antihistamine	pos_29=WRB	relType_3=conj	relType_2=amod	relType_8=compound	relType_9=obj	pos_11=CC	lemma_18=other	relType_25=nsubj:pass	pos_10=IN	relation_6=beneficial	lemma_17=or	relType_19=conj	relType_31=nsubj:pass	pos_17=NNS	relType_15=conj	pos_30=DT	relType_23=punct	pos_1=CC	relType_7=compound	lib=other	lemma_22=activity	relType_18=amod	relation_10=neutral	lemma_3=cns	lemma_28=potentiate	lemma_25=effect	relType_38=cc	relType_17=conj	relType_13=nmod	pos_36=-RRB-	relation_31=adverse	lemma_3=depressant	relType_40=amod	pos_28=VBN	relType_26=aux	pos_9=NNS	pos_16=,	wib=other	pos_18=JJ	relType_21=amod	pos_27=VB	relType_10=case	lemma_19=medication	pos_42=IN	path2=inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	pos_39=-RRB-	lemma_30=this	pos_31=NNS	lemma_15=)	lemma_13=medication	relType_14=cc	lemma_35=with	lemma_26=may	relType_39=dep	pos_15=NNS	lemma_20=with	eib=True	relType_36=obl	pos_3=NN	lemma_41=use	pos_35=IN	lemma_39=inhibitor	relType_35=case	lemma_12=this	relType_42=case	relType_30=det	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e0	DDI-DrugBank.d168.s0.e7	null	relType_1=cc	pos_23=-LRB-	relType_28=dep	lemma_36=)	pos_39=NN	pos_14=CC	lemma_7=cns	relType_29=advmod	pos_13=NNS	relType_49=cc	lemma_10=of	pos_41=NN	pos_2=JJ	lemma_8=depressant	lemma_11=either	lemma_32=be	relType_34=advmod	lemma_48=anticholinergic	relType_32=aux:pass	pos_3=NNS	relation_6=adverse	pos_52=NNS	relType_53=case	lemma_42=with	pos_3=-LRB-	lemma_16=,	lemma_40=concurrent	lemma_53=of	lpib=other_JJ	lemma_17=anticholinergic	lemma_27=be	relType_16=punct	pos_33=VBN	lemma_24=anticholinergic	lemma_23=(	pos_36=NNS	pos_38=CC	relType_39=conj	relType_36=punct	pos_12=DT	pos_39=NNS	lemma_52=effect	relType_37=punct	pos_15=-RRB-	pos_40=JJ	relType_22=nmod	lemma_37=,	lemma_5=potentiate	lemma_50=cns	relType_17=cc	pos_22=NN	pos_21=JJ	pos_48=JJ	relation_31=beneficial	lemma_43=antihistamine	pos_53=IN	relType_39=punct	lemma_4=may	pos_19=NNS	relation_28=neutral	lemma_15=antihistamine	pos_8=NN	pos_5=VB	relType_20=case	lemma_29=when	pos_43=NNS	lemma_3=(	pos_25=NNS	lemma_34=concurrently	relType_43=aux	relType_48=amod	relType_52=obj	relType_33=advcl	lemma_51=depressant	lemma_33=use	relType_4=aux	lemma_38=and	pos_34=RB	pos_37=,	relType_24=amod	lemma_39=monoamine	relType_6=det	lemma_39=mao	pos_32=VBP	pos_26=MD	lemma_39=(	relType_3=compound	pos_17=CC	lemma_9=effect	pos_7=NN	relType_46=conj	relType_3=punct	lemma_21=anticholinergic	relType_44=dep	lemma_39=oxidase	relType_45=cc	pos_6=DT	lemma_44=prolong	lemma_46=intensify	relType_5=parataxis	lemma_45=and	relType_43=nmod	relType_27=aux:pass	lemma_49=and	relType_41=nsubj	lemma_14=or	relType_12=det	pos_24=JJ	pos_20=IN	relType_39=compound	pos_39=-LRB-	lemma_39=)	lemma_6=the	lemma_2=other	pos_50=NN	lemma_31=medication	path1=alcohol_obl	pos_4=MD	relType_15=punct	relType_47=det	relType_11=cc:preconj	lemma_36=antihistamine	pos_29=WRB	relType_3=conj	relType_2=amod	relType_8=compound	relType_9=obj	pos_11=CC	lemma_18=other	relType_25=nsubj:pass	pos_10=IN	relation_6=beneficial	lemma_17=or	relType_19=conj	relType_31=nsubj:pass	pos_17=NNS	pos_47=DT	path2=inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	relType_15=conj	pos_30=DT	relType_23=punct	pos_1=CC	relType_7=compound	lemma_47=the	lib=other	lemma_22=activity	relType_18=amod	pos_44=VB	pos_51=NN	relation_10=neutral	lemma_3=cns	lemma_28=potentiate	lemma_25=effect	pos_49=CC	relType_38=cc	relType_17=conj	relType_13=nmod	pos_36=-RRB-	relation_31=adverse	lemma_3=depressant	relType_40=amod	pos_28=VBN	relType_26=aux	pos_9=NNS	pos_16=,	wib=other	pos_18=JJ	relType_21=amod	pos_27=VB	relType_10=case	lemma_19=medication	pos_42=IN	relType_51=compound	path=alcohol_obl<interact_ROOT>inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	pos_39=-RRB-	pos_46=VB	lemma_30=this	pos_31=NNS	lemma_15=)	lemma_13=medication	relType_14=cc	lemma_35=with	lemma_26=may	lemma_43=may	relType_39=dep	pos_15=NNS	lemma_20=with	eib=True	relType_36=obl	relType_50=conj	pos_3=NN	lemma_41=use	pos_43=MD	relation_63=neutral	pos_35=IN	lemma_39=inhibitor	relType_35=case	lemma_12=this	pos_45=CC	relType_42=case	relType_30=det	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e2	null	pos_7=NNS	relType_8=case	lemma_11=medication	wib=potentiate	relType_10=det	pos_2=MD	relType_12=cc	lib=potentiate	relType_5=compound	pos_3=VB	path=depressant_conj<alcohol_obl<interact_ROOT>potentiate_parataxis>effect_obj>medication_nmod>antihistamine_conj	pos_12=CC	path1=depressant_conj<alcohol_obl	relation_6=neutral	lemma_1=(	pos_6=NN	eib=False	lemma_7=effect	lemma_9=either	relType_7=obj	pos_11=NNS	relType_2=aux	lpib=potentiate_VB	lemma_3=potentiate	pos_8=IN	relation_2=beneficial	pos_4=DT	lemma_12=or	pos_9=CC	lemma_4=the	lemma_5=cns	lemma_6=depressant	relType_3=parataxis	lemma_10=this	path2=potentiate_parataxis>effect_obj>medication_nmod>antihistamine_conj	pos_1=-LRB-	pos_5=NN	relType_6=compound	relation_2=adverse	lemma_2=may	relType_9=cc:preconj	relType_11=nmod	relType_1=punct	relType_4=det	lemma_8=of	pos_10=DT
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e3	null	pos_7=NNS	relType_8=case	lemma_11=medication	relType_14=punct	path=depressant_conj<alcohol_obl<interact_ROOT>anticholinergic_conj	wib=potentiate	relType_10=det	pos_2=MD	pos_13=NNS	relType_13=punct	relType_12=cc	lib=potentiate	relType_5=compound	pos_3=VB	pos_12=CC	path1=depressant_conj<alcohol_obl	path2=anticholinergic_conj	relation_6=neutral	lemma_1=(	pos_6=NN	lemma_7=effect	lemma_9=either	pos_14=,	relType_7=obj	pos_11=NNS	relType_2=aux	lpib=potentiate_VB	lemma_3=potentiate	relType_13=conj	pos_8=IN	relation_2=beneficial	pos_4=DT	lemma_12=or	pos_9=CC	lemma_4=the	lemma_5=cns	lemma_6=depressant	relType_3=parataxis	lemma_10=this	pos_13=-RRB-	pos_1=-LRB-	pos_5=NN	relType_6=compound	lemma_14=,	eib=True	lemma_13=)	relation_2=adverse	lemma_2=may	lemma_13=antihistamine	relType_9=cc:preconj	relType_11=nmod	relType_1=punct	relType_4=det	lemma_8=of	pos_10=DT
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e4	null	lemma_17=medication	pos_13=NNS	relType_28=det	lib=potentiate	lemma_20=activity	pos_12=CC	pos_29=NNS	relType_18=case	pos_6=NN	relType_20=nmod	pos_20=NN	lemma_22=anticholinergic	lemma_29=medication	lpib=potentiate_VB	lemma_31=use	pos_9=CC	lemma_6=depressant	relType_3=parataxis	lemma_15=or	relType_24=aux	pos_24=MD	pos_1=-LRB-	pos_31=VBN	relType_6=compound	relType_26=dep	pos_15=CC	path=depressant_conj<alcohol_obl<interact_ROOT>anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	lemma_13=antihistamine	relType_21=punct	pos_7=NNS	relType_8=case	lemma_16=other	wib=potentiate	pos_2=MD	pos_3=VB	path1=depressant_conj<alcohol_obl	lemma_32=concurrently	path2=anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	relType_16=amod	lemma_27=when	pos_28=DT	pos_19=JJ	pos_32=RB	relType_13=conj	relType_23=nsubj:pass	pos_8=IN	lemma_26=potentiate	relType_32=advmod	lemma_25=be	relation_24=neutral	lemma_10=this	relType_19=amod	pos_5=NN	lemma_14=,	relType_29=nsubj:pass	relType_11=nmod	relation_27=adverse	relType_1=punct	relType_25=aux:pass	relType_14=punct	relType_10=det	relType_12=cc	lemma_33=with	lemma_15=anticholinergic	lemma_1=(	lemma_30=be	lemma_9=either	pos_14=,	relType_7=obj	relType_2=aux	lemma_3=potentiate	pos_18=IN	lemma_12=or	pos_33=IN	relType_31=advcl	pos_26=VBN	pos_23=NNS	lemma_4=the	lemma_24=may	pos_13=-RRB-	pos_22=JJ	pos_17=NNS	relType_22=amod	relation_2=adverse	relType_15=conj	relType_9=cc:preconj	pos_10=DT	lemma_11=medication	relType_33=case	relation_27=beneficial	relType_13=punct	relType_5=compound	pos_30=VBP	relType_17=conj	relation_6=neutral	pos_21=-LRB-	lemma_7=effect	pos_11=NNS	relType_27=advmod	relation_2=beneficial	pos_4=DT	pos_16=JJ	lemma_5=cns	lemma_21=(	relType_15=cc	lemma_19=anticholinergic	lemma_23=effect	lemma_28=this	pos_25=VB	lemma_18=with	pos_15=NNS	eib=True	lemma_13=)	relType_30=aux:pass	lemma_2=may	relType_4=det	lemma_8=of	pos_27=WRB
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e5	null	lemma_17=medication	pos_13=NNS	relType_28=det	lemma_37=monoamine	lib=potentiate	lemma_20=activity	relType_34=obl	pos_12=CC	pos_29=NNS	relType_18=case	pos_6=NN	relType_20=nmod	pos_20=NN	lemma_22=anticholinergic	lemma_29=medication	lpib=potentiate_VB	lemma_31=use	pos_9=CC	lemma_6=depressant	relType_3=parataxis	lemma_15=or	relType_24=aux	pos_24=MD	pos_1=-LRB-	pos_31=VBN	relType_6=compound	lemma_37=)	relType_26=dep	pos_37=-LRB-	pos_15=CC	lemma_13=antihistamine	relType_21=punct	path=depressant_conj<alcohol_obl<interact_ROOT>inhibitor_conj	relType_34=punct	relType_37=punct	pos_7=NNS	relType_8=case	lemma_16=other	wib=potentiate	lemma_35=,	pos_2=MD	pos_3=VB	path1=depressant_conj<alcohol_obl	lemma_32=concurrently	relType_16=amod	lemma_27=when	pos_28=DT	pos_19=JJ	pos_32=RB	relType_37=compound	pos_37=-RRB-	relType_13=conj	relType_23=nsubj:pass	pos_8=IN	relType_37=dep	lemma_26=potentiate	relType_32=advmod	pos_37=NN	lemma_25=be	pos_36=CC	relation_24=neutral	lemma_10=this	relType_19=amod	pos_5=NN	lemma_14=,	relType_29=nsubj:pass	relType_11=nmod	relation_27=adverse	relType_1=punct	lemma_37=oxidase	relType_25=aux:pass	relType_14=punct	relType_10=det	pos_34=NNS	relType_12=cc	lemma_33=with	lemma_15=anticholinergic	lemma_1=(	lemma_36=and	lemma_30=be	lemma_9=either	pos_14=,	relType_7=obj	relType_2=aux	lemma_3=potentiate	pos_18=IN	lemma_12=or	pos_33=IN	relType_31=advcl	pos_26=VBN	pos_23=NNS	lemma_4=the	lemma_24=may	lemma_34=antihistamine	lemma_37=(	pos_13=-RRB-	lemma_37=mao	relType_35=punct	pos_22=JJ	pos_17=NNS	relType_22=amod	relation_2=adverse	relType_15=conj	path2=inhibitor_conj	relType_9=cc:preconj	pos_10=DT	lemma_11=medication	pos_34=-RRB-	lemma_34=)	relType_33=case	relation_27=beneficial	relType_13=punct	relType_5=compound	pos_30=VBP	relType_17=conj	relation_6=neutral	pos_21=-LRB-	lemma_7=effect	pos_11=NNS	pos_35=,	relType_27=advmod	relation_2=beneficial	pos_4=DT	pos_16=JJ	lemma_5=cns	lemma_21=(	relType_15=cc	lemma_19=anticholinergic	lemma_23=effect	lemma_28=this	pos_25=VB	lemma_18=with	pos_15=NNS	relType_36=cc	eib=True	lemma_13=)	relType_30=aux:pass	lemma_2=may	relType_4=det	lemma_8=of	pos_27=WRB
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e6	null	lemma_17=medication	pos_39=NN	pos_13=NNS	relType_28=det	lemma_37=monoamine	lib=potentiate	lemma_20=activity	relType_34=obl	pos_12=CC	pos_29=NNS	relType_18=case	pos_6=NN	relType_20=nmod	pos_20=NN	lemma_22=anticholinergic	lemma_29=medication	lpib=potentiate_VB	lemma_31=use	pos_9=CC	lemma_6=depressant	relType_3=parataxis	lemma_15=or	relType_24=aux	pos_24=MD	pos_1=-LRB-	pos_31=VBN	pos_40=IN	relType_6=compound	lemma_37=)	lemma_38=concurrent	relType_26=dep	pos_37=-LRB-	relType_37=conj	pos_15=CC	lemma_13=antihistamine	relType_21=punct	relType_34=punct	relType_37=punct	pos_7=NNS	relType_8=case	lemma_16=other	wib=potentiate	lemma_35=,	pos_2=MD	pos_3=VB	path1=depressant_conj<alcohol_obl	lemma_32=concurrently	relType_16=amod	lemma_27=when	pos_28=DT	pos_19=JJ	pos_32=RB	relType_37=compound	pos_37=-RRB-	relType_13=conj	relType_23=nsubj:pass	pos_8=IN	relType_37=dep	lemma_26=potentiate	relType_32=advmod	pos_38=JJ	pos_37=NN	lemma_25=be	pos_36=CC	relType_40=case	relation_24=neutral	lemma_10=this	relType_19=amod	pos_5=NN	lemma_14=,	relType_29=nsubj:pass	relType_11=nmod	relation_27=adverse	relType_1=punct	lemma_37=oxidase	relType_38=amod	relType_25=aux:pass	lemma_37=inhibitor	relType_14=punct	relType_10=det	pos_34=NNS	relType_12=cc	lemma_33=with	lemma_15=anticholinergic	lemma_1=(	lemma_36=and	lemma_30=be	lemma_9=either	pos_14=,	relType_7=obj	relType_2=aux	lemma_3=potentiate	pos_18=IN	lemma_12=or	pos_33=IN	relType_31=advcl	pos_26=VBN	pos_23=NNS	lemma_4=the	lemma_24=may	lemma_34=antihistamine	lemma_37=(	pos_13=-RRB-	lemma_37=mao	relType_35=punct	pos_22=JJ	pos_17=NNS	relType_22=amod	relation_2=adverse	relType_15=conj	relType_9=cc:preconj	lemma_39=use	pos_10=DT	lemma_11=medication	pos_34=-RRB-	lemma_34=)	lemma_40=with	relType_33=case	relation_27=beneficial	relType_13=punct	relType_5=compound	pos_30=VBP	relType_17=conj	relation_6=neutral	pos_21=-LRB-	lemma_7=effect	pos_11=NNS	pos_35=,	path=depressant_conj<alcohol_obl<interact_ROOT>inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	path2=inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	relType_27=advmod	relation_2=beneficial	pos_4=DT	pos_16=JJ	lemma_5=cns	lemma_21=(	relType_15=cc	relType_39=nsubj	pos_37=NNS	lemma_19=anticholinergic	lemma_23=effect	lemma_28=this	pos_25=VB	lemma_18=with	pos_15=NNS	relType_36=cc	eib=True	lemma_13=)	relType_30=aux:pass	lemma_2=may	relType_4=det	lemma_8=of	pos_27=WRB
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e1	DDI-DrugBank.d168.s0.e7	null	lemma_17=medication	pos_39=NN	path=depressant_conj<alcohol_obl<interact_ROOT>inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	pos_13=NNS	lemma_49=depressant	relType_28=det	lemma_37=monoamine	lib=potentiate	lemma_20=activity	relType_34=obl	pos_12=CC	pos_29=NNS	relType_18=case	pos_42=VB	pos_6=NN	relType_20=nmod	pos_20=NN	lemma_22=anticholinergic	lemma_29=medication	lpib=potentiate_VB	lemma_31=use	pos_9=CC	lemma_41=antihistamine	relType_46=amod	pos_41=MD	lemma_6=depressant	relType_3=parataxis	lemma_15=or	relType_24=aux	lemma_42=prolong	pos_24=MD	pos_1=-LRB-	pos_31=VBN	pos_40=IN	pos_48=NN	relType_6=compound	lemma_37=)	lemma_38=concurrent	relType_26=dep	pos_37=-LRB-	relType_37=conj	pos_15=CC	lemma_13=antihistamine	relType_21=punct	relType_34=punct	relType_37=punct	pos_7=NNS	relType_8=case	lemma_16=other	lemma_45=the	wib=potentiate	lemma_35=,	pos_2=MD	pos_3=VB	path1=depressant_conj<alcohol_obl	lemma_32=concurrently	relType_16=amod	lemma_27=when	pos_28=DT	pos_19=JJ	pos_32=RB	relType_37=compound	pos_37=-RRB-	relType_13=conj	pos_41=NNS	relType_23=nsubj:pass	pos_47=CC	pos_8=IN	relType_37=dep	lemma_26=potentiate	relType_32=advmod	pos_38=JJ	pos_37=NN	lemma_25=be	pos_36=CC	relType_40=case	relation_24=neutral	lemma_10=this	relType_19=amod	pos_5=NN	lemma_14=,	lemma_46=anticholinergic	relType_29=nsubj:pass	relType_11=nmod	relation_27=adverse	relType_1=punct	relType_48=conj	lemma_37=oxidase	relType_38=amod	relType_25=aux:pass	relType_47=cc	lemma_37=inhibitor	relType_44=conj	relType_14=punct	relType_10=det	relType_41=aux	pos_34=NNS	relType_12=cc	lemma_33=with	lemma_15=anticholinergic	relType_42=dep	lemma_1=(	lemma_36=and	lemma_30=be	lemma_9=either	pos_14=,	relType_7=obj	lemma_48=cns	lemma_44=intensify	relType_2=aux	lemma_3=potentiate	pos_18=IN	relType_41=nmod	lemma_12=or	pos_33=IN	lemma_43=and	relType_31=advcl	pos_26=VBN	pos_23=NNS	lemma_4=the	lemma_24=may	lemma_34=antihistamine	lemma_47=and	lemma_37=(	pos_13=-RRB-	lemma_37=mao	relType_35=punct	pos_50=NNS	pos_22=JJ	pos_17=NNS	relType_22=amod	path2=inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	relation_2=adverse	relType_15=conj	relType_9=cc:preconj	relType_50=obj	lemma_39=use	pos_10=DT	lemma_11=medication	pos_34=-RRB-	lemma_34=)	lemma_40=with	relType_33=case	relation_27=beneficial	relType_13=punct	pos_44=VB	relType_49=compound	relType_5=compound	pos_45=DT	pos_30=VBP	relType_17=conj	relation_6=neutral	pos_21=-LRB-	pos_51=IN	lemma_7=effect	lemma_41=may	relType_43=cc	relType_45=det	pos_11=NNS	pos_35=,	pos_43=CC	relType_27=advmod	relation_2=beneficial	pos_4=DT	pos_16=JJ	lemma_50=effect	lemma_5=cns	lemma_21=(	relType_15=cc	relType_39=nsubj	pos_46=JJ	pos_37=NNS	lemma_19=anticholinergic	lemma_23=effect	lemma_51=of	lemma_28=this	pos_25=VB	lemma_18=with	pos_15=NNS	relType_36=cc	eib=True	relType_51=case	lemma_13=)	relType_30=aux:pass	relation_59=neutral	lemma_2=may	relType_4=det	lemma_8=of	pos_49=NN	pos_27=WRB
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e2	DDI-DrugBank.d168.s0.e3	null	lpib=anticholinergic_NNS	wib=anticholinergics	eib=False	lib=anticholinergic	pos_1=-RRB-	lemma_2=,	pos_2=,	relType_1=punct	lemma_1=)	path1=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis	path=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis<interact_ROOT>anticholinergic_conj	path2=anticholinergic_conj	relType_2=punct
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e2	DDI-DrugBank.d168.s0.e4	null	pos_18=VBP	relType_4=amod	lemma_17=medication	pos_4=JJ	relType_18=aux:pass	lemma_7=anticholinergic	wib=anticholinergics	pos_3=CC	lib=anticholinergic	relType_10=amod	lemma_12=may	pos_15=WRB	pos_16=DT	lemma_19=use	relType_17=nsubj:pass	relation_14=adverse	lemma_1=)	relType_16=det	relType_6=case	relType_3=cc	relType_2=punct	path2=anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	pos_8=NN	lemma_14=potentiate	lemma_10=anticholinergic	relType_20=advmod	pos_3=NNS	pos_5=NNS	pos_6=IN	lemma_9=(	pos_11=NNS	relType_12=aux	lemma_18=be	lemma_20=concurrently	lemma_3=or	pos_21=IN	lemma_21=with	lemma_13=be	lemma_2=,	lemma_16=this	relType_13=aux:pass	lemma_3=anticholinergic	pos_13=VB	lemma_15=when	relType_7=amod	relType_3=conj	pos_10=JJ	pos_1=-RRB-	lemma_4=other	relation_11=neutral	lemma_6=with	relType_14=dep	pos_9=-LRB-	relType_5=conj	relType_11=nsubj:pass	relType_19=advcl	relType_9=punct	relType_21=case	pos_12=MD	pos_14=VBN	lpib=anticholinergic_NNS	pos_17=NNS	eib=True	relType_8=nmod	lemma_8=activity	lemma_11=effect	path=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis<interact_ROOT>anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	pos_7=JJ	pos_19=VBN	pos_20=RB	pos_2=,	relation_14=beneficial	relType_1=punct	lemma_5=medication	relType_15=advmod	path1=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e2	DDI-DrugBank.d168.s0.e5	null	lemma_17=medication	relType_18=aux:pass	lemma_7=anticholinergic	pos_3=CC	pos_15=WRB	pos_16=DT	path=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis<interact_ROOT>inhibitor_conj	lemma_10=anticholinergic	pos_3=NNS	lemma_18=be	lemma_23=,	relType_13=aux:pass	relType_22=punct	lemma_22=antihistamine	lemma_25=monoamine	lemma_4=other	relType_21=case	pos_14=VBN	lemma_22=)	lemma_11=effect	pos_7=JJ	pos_2=,	pos_22=-RRB-	relType_22=obl	relType_4=amod	lemma_12=may	lemma_19=use	relType_6=case	relType_3=cc	relType_2=punct	lemma_14=potentiate	pos_8=NN	pos_24=CC	pos_6=IN	lemma_20=concurrently	lemma_3=or	lemma_2=,	lemma_15=when	lemma_24=and	pos_1=-RRB-	relation_11=neutral	lpib=anticholinergic_NNS	lemma_25=mao	relType_25=punct	relType_25=dep	relType_1=punct	lemma_5=medication	path1=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis	wib=anticholinergics	lemma_25=oxidase	pos_21=IN	relType_25=compound	pos_13=VB	relType_7=amod	relType_3=conj	pos_25=NN	pos_9=-LRB-	relType_5=conj	relType_11=nsubj:pass	relType_19=advcl	lemma_25=)	pos_12=MD	pos_17=NNS	lemma_8=activity	pos_20=RB	relation_14=beneficial	pos_19=VBN	path2=inhibitor_conj	relType_23=punct	pos_18=VBP	pos_4=JJ	pos_25=-RRB-	lib=anticholinergic	relType_10=amod	lemma_25=(	relType_17=nsubj:pass	relation_14=adverse	lemma_1=)	relType_16=det	relType_20=advmod	pos_5=NNS	lemma_9=(	pos_11=NNS	relType_12=aux	lemma_21=with	relType_24=cc	pos_25=-LRB-	lemma_13=be	lemma_16=this	lemma_3=anticholinergic	pos_10=JJ	pos_22=NNS	lemma_6=with	relType_14=dep	relType_9=punct	eib=True	relType_8=nmod	pos_23=,	relType_15=advmod
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e2	DDI-DrugBank.d168.s0.e6	null	lemma_17=medication	relType_18=aux:pass	lemma_7=anticholinergic	pos_3=CC	path=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis<interact_ROOT>inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	pos_15=WRB	pos_16=DT	lemma_10=anticholinergic	pos_3=NNS	lemma_18=be	lemma_23=,	relType_13=aux:pass	relType_22=punct	lemma_22=antihistamine	lemma_25=monoamine	lemma_27=use	lemma_4=other	relType_21=case	pos_14=VBN	relType_26=amod	lemma_22=)	lemma_11=effect	pos_7=JJ	pos_2=,	pos_22=-RRB-	relType_22=obl	relType_4=amod	relType_25=conj	lemma_12=may	lemma_19=use	relType_6=case	relType_3=cc	relType_2=punct	lemma_14=potentiate	pos_8=NN	pos_24=CC	pos_6=IN	pos_25=NNS	lemma_20=concurrently	lemma_3=or	lemma_2=,	lemma_15=when	pos_27=NN	lemma_24=and	pos_1=-RRB-	relation_11=neutral	lpib=anticholinergic_NNS	lemma_25=mao	relType_25=punct	relType_25=dep	relType_1=punct	lemma_5=medication	path1=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis	wib=anticholinergics	relType_27=nsubj	pos_26=JJ	lemma_25=oxidase	pos_21=IN	relType_25=compound	pos_13=VB	relType_7=amod	relType_3=conj	pos_25=NN	pos_9=-LRB-	relType_5=conj	relType_11=nsubj:pass	relType_19=advcl	lemma_25=)	pos_12=MD	relType_28=case	pos_17=NNS	lemma_8=activity	pos_20=RB	relation_14=beneficial	pos_19=VBN	relType_23=punct	pos_18=VBP	pos_4=JJ	pos_25=-RRB-	lib=anticholinergic	relType_10=amod	lemma_25=(	relType_17=nsubj:pass	relation_14=adverse	lemma_1=)	relType_16=det	lemma_25=inhibitor	lemma_28=with	relType_20=advmod	pos_5=NNS	lemma_9=(	pos_11=NNS	relType_12=aux	lemma_21=with	relType_24=cc	pos_25=-LRB-	lemma_13=be	path2=inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	lemma_16=this	lemma_3=anticholinergic	pos_10=JJ	pos_22=NNS	lemma_6=with	relType_14=dep	relType_9=punct	eib=True	relType_8=nmod	pos_23=,	lemma_26=concurrent	pos_28=IN	relType_15=advmod
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e2	DDI-DrugBank.d168.s0.e7	null	relType_30=dep	lemma_17=medication	relType_18=aux:pass	lemma_37=depressant	lemma_7=anticholinergic	pos_3=CC	pos_15=WRB	pos_16=DT	pos_29=NNS	relType_35=cc	lemma_35=and	lemma_10=anticholinergic	pos_3=NNS	lemma_18=be	lemma_23=,	relType_13=aux:pass	relType_22=punct	lemma_22=antihistamine	lemma_25=monoamine	lemma_30=prolong	lemma_27=use	lemma_4=other	pos_31=CC	relType_21=case	pos_14=VBN	relType_26=amod	lemma_22=)	lemma_11=effect	relType_32=conj	pos_7=JJ	pos_2=,	pos_22=-RRB-	lemma_32=intensify	relType_22=obl	relType_36=conj	lemma_31=and	lemma_33=the	path=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis<interact_ROOT>inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	relType_4=amod	relType_25=conj	relType_29=aux	lemma_12=may	lemma_19=use	relType_31=cc	relType_6=case	relType_3=cc	relType_2=punct	lemma_14=potentiate	pos_8=NN	pos_24=CC	pos_6=IN	lemma_39=of	pos_25=NNS	relType_37=compound	lemma_20=concurrently	lemma_3=or	lemma_29=may	lemma_2=,	lemma_15=when	pos_27=NN	pos_37=NN	lemma_29=antihistamine	lemma_24=and	pos_1=-RRB-	relType_29=nmod	relation_11=neutral	lpib=anticholinergic_NNS	pos_33=DT	lemma_25=mao	relType_25=punct	relType_25=dep	relType_1=punct	lemma_5=medication	path1=antihistamine_conj<medication_nmod<effect_obj<potentiate_parataxis	wib=anticholinergics	relType_27=nsubj	pos_26=JJ	lemma_25=oxidase	pos_21=IN	relType_25=compound	pos_13=VB	relation_46=neutral	relType_7=amod	relType_3=conj	pos_25=NN	pos_34=JJ	pos_9=-LRB-	pos_38=NNS	relType_5=conj	relType_11=nsubj:pass	relType_19=advcl	lemma_25=)	pos_12=MD	relType_34=amod	relType_28=case	pos_17=NNS	path2=inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	lemma_8=activity	pos_20=RB	pos_32=VB	relation_14=beneficial	pos_19=VBN	relType_39=case	pos_39=IN	relType_23=punct	pos_18=VBP	pos_4=JJ	pos_25=-RRB-	lib=anticholinergic	relType_10=amod	lemma_25=(	relType_17=nsubj:pass	pos_29=MD	relation_14=adverse	lemma_1=)	relType_16=det	lemma_34=anticholinergic	lemma_25=inhibitor	lemma_28=with	relType_20=advmod	pos_5=NNS	lemma_9=(	pos_11=NNS	relType_12=aux	lemma_21=with	relType_24=cc	pos_25=-LRB-	lemma_13=be	lemma_16=this	lemma_3=anticholinergic	pos_35=CC	pos_10=JJ	pos_22=NNS	lemma_6=with	relType_14=dep	relType_9=punct	pos_36=NN	relType_33=det	lemma_36=cns	relType_38=obj	eib=True	relType_8=nmod	pos_23=,	lemma_26=concurrent	pos_28=IN	lemma_38=effect	relType_15=advmod	pos_30=VB
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e3	DDI-DrugBank.d168.s0.e4	null	relType_1=cc	pos_19=IN	pos_1=CC	path=<anticholinergic_conj>potentiate_dep>use_advcl>antihistamine_obl	lemma_7=(	lemma_5=anticholinergic	lib=other	relType_8=amod	path2=potentiate_dep>use_advcl>antihistamine_obl	lemma_8=anticholinergic	path1=	lemma_11=be	pos_13=WRB	pos_2=JJ	relation_8=neutral	relType_16=aux:pass	pos_17=VBN	lemma_12=potentiate	lemma_14=this	pos_6=NN	pos_7=-LRB-	pos_8=JJ	lemma_15=medication	relType_15=nsubj:pass	pos_18=RB	pos_3=NNS	pos_10=MD	relation_11=adverse	eib=False	relType_10=aux	lemma_2=other	pos_9=NNS	relType_9=nsubj:pass	wib=other	relType_14=det	relType_11=aux:pass	lemma_16=be	lemma_6=activity	lemma_4=with	pos_5=JJ	lemma_19=with	relType_13=advmod	relType_5=amod	lemma_3=medication	relType_3=conj	lpib=other_JJ	pos_4=IN	relType_2=amod	relType_17=advcl	relType_4=case	lemma_17=use	pos_14=DT	lemma_10=may	pos_15=NNS	pos_11=VB	relType_12=dep	relType_18=advmod	relType_7=punct	relType_19=case	lemma_13=when	lemma_18=concurrently	relation_11=beneficial	lemma_9=effect	pos_12=VBN	relType_6=nmod	pos_16=VBP	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e3	DDI-DrugBank.d168.s0.e5	null	relType_1=cc	pos_23=-LRB-	lemma_8=anticholinergic	pos_2=JJ	pos_6=NN	pos_7=-LRB-	pos_8=JJ	lemma_15=medication	relType_15=nsubj:pass	pos_18=RB	pos_3=NNS	relType_11=aux:pass	relType_23=compound	lemma_6=activity	lemma_19=with	lemma_3=medication	lpib=other_JJ	relType_17=advcl	lemma_21=,	path=anticholinergic_conj<interact_ROOT>inhibitor_conj	pos_11=VB	lemma_23=oxidase	lemma_23=(	lemma_18=concurrently	relType_21=punct	pos_16=VBP	lemma_11=be	relation_8=neutral	pos_10=MD	relType_9=nsubj:pass	relType_23=dep	relType_13=advmod	lemma_10=may	path1=anticholinergic_conj	relType_19=case	relType_12=dep	lemma_9=effect	pos_12=VBN	relType_20=obl	lemma_17=use	lemma_5=anticholinergic	pos_17=VBN	lemma_12=potentiate	pos_23=NN	pos_20=-RRB-	relation_11=adverse	lemma_20=antihistamine	relType_10=aux	relType_22=cc	lemma_2=other	lemma_16=be	lemma_4=with	relType_5=amod	relType_3=conj	pos_4=IN	lemma_23=)	relType_2=amod	pos_14=DT	lemma_20=)	pos_23=-RRB-	relType_20=punct	relation_11=beneficial	path2=inhibitor_conj	lemma_14=this	relType_6=nmod	relType_23=punct	pos_19=IN	pos_1=CC	lemma_7=(	lib=other	relType_8=amod	lemma_23=monoamine	pos_13=WRB	relType_16=aux:pass	pos_22=CC	pos_21=,	pos_9=NNS	wib=other	relType_14=det	pos_5=JJ	relType_4=case	pos_20=NNS	pos_15=NNS	eib=True	relType_18=advmod	relType_7=punct	lemma_13=when	lemma_23=mao	lemma_22=and	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e3	DDI-DrugBank.d168.s0.e6	null	relType_1=cc	pos_23=-LRB-	lemma_8=anticholinergic	pos_2=JJ	pos_6=NN	pos_7=-LRB-	pos_8=JJ	lemma_15=medication	relType_15=nsubj:pass	pos_18=RB	pos_3=NNS	relType_11=aux:pass	relType_23=compound	lemma_6=activity	lemma_19=with	lemma_3=medication	lpib=other_JJ	relType_17=advcl	lemma_21=,	relType_25=nsubj	pos_11=VB	lemma_23=oxidase	lemma_23=(	pos_26=IN	lemma_18=concurrently	relType_21=punct	pos_16=VBP	lemma_25=use	lemma_26=with	lemma_11=be	relation_8=neutral	pos_10=MD	relType_9=nsubj:pass	relType_23=conj	relType_23=dep	relType_13=advmod	relType_24=amod	lemma_10=may	path1=anticholinergic_conj	relType_19=case	relType_12=dep	lemma_9=effect	pos_12=VBN	relType_20=obl	lemma_17=use	lemma_5=anticholinergic	pos_17=VBN	pos_24=JJ	lemma_12=potentiate	pos_23=NN	pos_20=-RRB-	relation_11=adverse	lemma_20=antihistamine	relType_10=aux	relType_22=cc	lemma_2=other	lemma_16=be	lemma_4=with	relType_5=amod	relType_3=conj	pos_23=NNS	pos_4=IN	lemma_23=)	relType_2=amod	lemma_24=concurrent	pos_25=NN	pos_14=DT	lemma_20=)	pos_23=-RRB-	relType_20=punct	relation_11=beneficial	lemma_14=this	relType_6=nmod	relType_23=punct	pos_19=IN	pos_1=CC	lemma_7=(	lib=other	relType_8=amod	relType_26=case	lemma_23=inhibitor	lemma_23=monoamine	pos_13=WRB	relType_16=aux:pass	pos_22=CC	pos_21=,	path=anticholinergic_conj<interact_ROOT>inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	pos_9=NNS	wib=other	relType_14=det	path2=inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	pos_5=JJ	relType_4=case	pos_20=NNS	pos_15=NNS	eib=True	relType_18=advmod	relType_7=punct	lemma_13=when	lemma_23=mao	lemma_22=and	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e3	DDI-DrugBank.d168.s0.e7	null	relType_1=cc	pos_23=-LRB-	relType_28=dep	pos_34=NN	lemma_8=anticholinergic	lemma_27=may	pos_35=NN	pos_2=JJ	pos_6=NN	pos_7=-LRB-	pos_8=JJ	lemma_15=medication	relType_15=nsubj:pass	pos_18=RB	pos_3=NNS	pos_31=DT	lemma_31=the	relType_27=nmod	relType_11=aux:pass	relType_32=amod	relType_23=compound	lemma_6=activity	lemma_19=with	relType_30=conj	lemma_3=medication	lpib=other_JJ	relType_36=obj	relType_17=advcl	pos_28=VB	lemma_29=and	lemma_21=,	relType_25=nsubj	lemma_35=depressant	pos_11=VB	lemma_23=oxidase	lemma_23=(	pos_26=IN	pos_36=NNS	lemma_18=concurrently	relType_34=conj	relType_21=punct	pos_16=VBP	lemma_25=use	lemma_26=with	lemma_11=be	relation_8=neutral	pos_10=MD	pos_32=JJ	relType_9=nsubj:pass	lemma_27=antihistamine	lemma_37=of	relType_23=conj	relType_23=dep	lemma_36=effect	relType_13=advmod	relType_29=cc	relType_24=amod	lemma_10=may	path1=anticholinergic_conj	relType_19=case	relType_12=dep	lemma_9=effect	pos_12=VBN	relType_20=obl	lemma_17=use	lemma_33=and	lemma_5=anticholinergic	relType_31=det	pos_17=VBN	pos_24=JJ	lemma_12=potentiate	pos_23=NN	pos_20=-RRB-	relation_11=adverse	lemma_20=antihistamine	relType_10=aux	pos_27=NNS	relType_22=cc	lemma_2=other	lemma_16=be	pos_29=CC	lemma_32=anticholinergic	lemma_4=with	relType_5=amod	lemma_34=cns	relType_3=conj	pos_23=NNS	pos_4=IN	lemma_23=)	relType_2=amod	lemma_24=concurrent	pos_25=NN	pos_33=CC	pos_14=DT	lemma_20=)	relType_37=case	pos_23=-RRB-	path2=inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	path=anticholinergic_conj<interact_ROOT>inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	relType_20=punct	relation_11=beneficial	lemma_30=intensify	lemma_14=this	relType_6=nmod	relType_23=punct	pos_19=IN	pos_1=CC	lemma_7=(	lemma_28=prolong	lib=other	relType_8=amod	relType_27=aux	relType_26=case	lemma_23=inhibitor	lemma_23=monoamine	pos_13=WRB	relType_16=aux:pass	pos_22=CC	pos_21=,	pos_27=MD	pos_9=NNS	relType_33=cc	wib=other	relType_14=det	pos_37=IN	pos_5=JJ	relType_4=case	pos_20=NNS	relType_35=compound	pos_15=NNS	eib=True	relType_18=advmod	relation_43=neutral	relType_7=punct	lemma_13=when	lemma_23=mao	pos_30=VB	lemma_22=and	lemma_1=or
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e4	DDI-DrugBank.d168.s0.e5	null	relType_4=dep	pos_3=CC	path=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj<interact_ROOT>inhibitor_conj	path1=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj	lemma_1=)	lemma_4=monoamine	relType_3=cc	wib=monoamine	relType_2=punct	lemma_4=mao	pos_4=-LRB-	pos_4=-RRB-	pos_4=NN	lemma_2=,	lemma_4=(	relType_4=punct	pos_1=-RRB-	lib=monoamine	relType_4=compound	lemma_4=)	lemma_4=oxidase	eib=True	pos_2=,	path2=inhibitor_conj	lemma_3=and	relType_1=punct	lpib=monoamine_NN
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e4	DDI-DrugBank.d168.s0.e6	null	relType_4=dep	relType_7=case	pos_3=CC	path1=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj	lemma_1=)	lemma_7=with	lemma_4=monoamine	relType_3=cc	wib=monoamine	relType_2=punct	pos_6=NN	lemma_4=mao	pos_4=-LRB-	pos_4=-RRB-	lemma_5=concurrent	pos_4=NN	lemma_2=,	path2=inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	lemma_4=(	pos_4=NNS	pos_5=JJ	relType_4=punct	relType_5=amod	pos_1=-RRB-	lib=monoamine	relType_4=compound	lemma_6=use	lemma_4=)	lemma_4=oxidase	eib=True	pos_7=IN	lemma_4=inhibitor	pos_2=,	lemma_3=and	path=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj<interact_ROOT>inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	relType_4=conj	relType_1=punct	lpib=monoamine_NN	relType_6=nsubj
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e4	DDI-DrugBank.d168.s0.e7	null	relType_4=dep	pos_14=CC	relType_7=case	pos_3=CC	relation_23=neutral	relType_10=cc	path1=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj	relType_16=compound	pos_9=VB	lemma_1=)	lemma_7=with	relType_9=dep	pos_8=NNS	lemma_4=monoamine	relType_3=cc	wib=monoamine	relType_2=punct	pos_6=NN	relType_11=conj	relType_12=det	relType_18=case	lemma_4=mao	pos_4=-LRB-	pos_8=MD	pos_10=CC	relType_13=amod	pos_4=-RRB-	lemma_9=prolong	lemma_5=concurrent	lemma_11=intensify	lemma_18=of	pos_4=NN	lemma_2=,	lemma_4=(	path=antihistamine_obl<use_advcl<potentiate_dep<anticholinergic_conj<interact_ROOT>inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	pos_4=NNS	lemma_12=the	pos_18=IN	pos_5=JJ	lemma_10=and	lemma_15=cns	relType_4=punct	relType_5=amod	pos_13=JJ	pos_15=NN	lemma_16=depressant	pos_1=-RRB-	lib=monoamine	relType_4=compound	lemma_6=use	lemma_4=)	relType_14=cc	pos_16=NN	lemma_13=anticholinergic	lemma_8=antihistamine	lemma_4=oxidase	relType_17=obj	pos_17=NNS	eib=True	path2=inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	pos_7=IN	relType_8=nmod	pos_11=VB	lemma_4=inhibitor	relType_15=conj	lemma_14=and	pos_2=,	lemma_3=and	relType_4=conj	lemma_8=may	relType_8=aux	relType_1=punct	pos_12=DT	lemma_17=effect	lpib=monoamine_NN	relType_6=nsubj
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e5	DDI-DrugBank.d168.s0.e6	null	path1=	pos_2=JJ	lemma_1=(	lemma_3=use	eib=False	path2=prolong_dep>use_nsubj>antihistamine_nmod	lemma_4=with	pos_4=IN	relType_2=amod	relType_4=case	path=<inhibitor_conj>prolong_dep>use_nsubj>antihistamine_nmod	lemma_2=concurrent	relType_3=nsubj	pos_1=-LRB-	lpib=concurrent_JJ	wib=concurrent	pos_3=NN	lib=concurrent	relType_1=punct
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e5	DDI-DrugBank.d168.s0.e7	null	lemma_14=effect	relType_12=conj	pos_6=VB	relType_11=cc	lemma_15=of	relType_10=amod	path1=	relType_7=cc	pos_2=JJ	lemma_5=antihistamine	path2=prolong_dep>effect_obj>antihistamine_nmod	lemma_1=(	lemma_10=anticholinergic	lemma_3=use	relType_6=dep	lemma_5=may	relType_14=obj	pos_5=NNS	lemma_13=depressant	path=<inhibitor_conj>prolong_dep>effect_obj>antihistamine_nmod	pos_9=DT	pos_12=NN	relType_5=aux	pos_13=NN	pos_8=VB	lemma_4=with	relType_15=case	pos_5=MD	relType_13=compound	lemma_11=and	pos_7=CC	pos_10=JJ	pos_4=IN	relType_2=amod	pos_11=CC	relType_4=case	lemma_12=cns	relType_5=nmod	lemma_2=concurrent	relation_14=neutral	relType_3=nsubj	pos_1=-LRB-	lpib=concurrent_JJ	pos_15=IN	wib=concurrent	eib=True	pos_3=NN	lemma_7=and	lemma_9=the	relType_8=conj	pos_14=NNS	lib=concurrent	relType_1=punct	relType_9=det	lemma_8=intensify	lemma_6=prolong
DDI-DrugBank.d168.s0	DDI-DrugBank.d168.s0.e6	DDI-DrugBank.d168.s0.e7	null	pos_6=JJ	relType_1=aux	lemma_1=may	pos_3=CC	relation_9=neutral	wib=prolong	relType_7=cc	relType_11=case	relType_3=cc	lemma_4=intensify	pos_8=NN	relType_9=compound	eib=False	path1=antihistamine_nmod<use_nsubj	lemma_2=prolong	relType_6=amod	path2=effect_obj>antihistamine_nmod	pos_2=VB	lemma_10=effect	pos_9=NN	relType_10=obj	pos_11=IN	relType_2=dep	lemma_6=anticholinergic	lib=prolong	pos_7=CC	relType_5=det	path=antihistamine_nmod<use_nsubj<prolong_dep>effect_obj>antihistamine_nmod	lemma_9=depressant	pos_1=MD	lemma_8=cns	lemma_5=the	lpib=prolong_VB	pos_4=VB	pos_5=DT	lemma_7=and	relType_8=conj	lemma_11=of	lemma_3=and	relType_4=conj	pos_10=NNS
DDI-DrugBank.d19.s1	DDI-DrugBank.d19.s1.e0	DDI-DrugBank.d19.s1.e1	advise	relType_7=det	relType_1=aux	pos_3=VBN	path1=DISULFIRAM_nsubj:pass	lemma_1=should	relType_6=case	pos_8=NNS	relType_8=obl	path2=patient_obl>reveive_acl>phenytoin_obj	lemma_3=use	eib=False	pos_6=IN	pos_2=VB	lemma_6=in	path=DISULFIRAM_nsubj:pass<use_ROOT>patient_obl>reveive_acl>phenytoin_obj	pos_7=DT	lemma_5=caution	pos_9=VBG	lemma_4=with	lemma_7=that	lemma_9=reveive	lib=be	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_5=obl	wib=BE	pos_1=MD	lpib=be_VB	pos_5=NN	relType_9=acl	lemma_2=be	lemma_8=patient
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e0	DDI-DrugBank.d19.s2.e1	null	lib=intoxication	pos_3=NNP	relType_5=compound	relType_2=punct	eib=False	relType_3=appos	path2=PRIOR_appos>DISULFIRAM_nmod	lemma_3=PRIOR	wib=INTOXICATION	lemma_2=,	lemma_4=to	relType_4=case	pos_5=NNP	path1=PHENYTOIN_compound	lpib=intoxication_NNP	pos_1=NNP	pos_4=TO	lemma_1=INTOXICATION	pos_2=,	lemma_5=ADMINISTERING	path=PHENYTOIN_compound<INTOXICATION_obl>PRIOR_appos>DISULFIRAM_nmod	relType_1=obl
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e0	DDI-DrugBank.d19.s2.e2	null	lemma_6=DISULFIRAM	pos_6=TO	relType_7=det	lib=intoxication	path=PHENYTOIN_compound<INTOXICATION_obl>patient_nmod>therapy_nmod>phenytoin_compound	pos_3=NNP	relType_5=compound	pos_9=IN	lemma_6=to	relType_6=case	relType_2=punct	pos_8=NN	lemma_9=on	relType_3=appos	pos_6=NNP	path2=patient_nmod>therapy_nmod>phenytoin_compound	wib=INTOXICATION	lemma_3=PRIOR	relType_9=case	lemma_2=,	pos_7=DT	relType_6=nmod	lemma_4=to	relType_4=case	pos_5=NNP	path1=PHENYTOIN_compound	lpib=intoxication_NNP	pos_1=NNP	pos_4=TO	eib=True	relType_8=nmod	lemma_1=INTOXICATION	pos_2=,	lemma_7=a	lemma_8=patient	lemma_5=ADMINISTERING	relType_1=obl
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e0	DDI-DrugBank.d19.s2.e3	null	lemma_6=DISULFIRAM	pos_6=TO	relType_7=det	lemma_11=,	lib=intoxication	pos_3=NNP	relType_5=compound	pos_9=IN	path=PHENYTOIN_compound<INTOXICATION_obl>patient_nmod>obtain_dep>level_nsubj:pass>phenytoin_compound	lemma_6=to	relType_6=case	relType_12=det	relType_2=punct	pos_8=NN	lemma_9=on	relType_10=nmod	relType_3=appos	pos_6=NNP	relType_11=punct	lemma_10=therapy	lemma_3=PRIOR	wib=INTOXICATION	relType_9=case	pos_10=NN	relType_10=compound	pos_13=NN	lemma_2=,	pos_7=DT	lemma_12=a	relType_6=nmod	lemma_10=phenytoin	relType_13=compound	lemma_4=to	relType_4=case	pos_5=NNP	pos_11=,	path1=PHENYTOIN_compound	path2=patient_nmod>obtain_dep>level_nsubj:pass>phenytoin_compound	lpib=intoxication_NNP	pos_1=NNP	pos_4=TO	eib=True	relType_8=nmod	lemma_1=INTOXICATION	pos_2=,	lemma_7=a	pos_12=DT	lemma_8=patient	lemma_5=ADMINISTERING	relType_1=obl	lemma_13=baseline
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e1	DDI-DrugBank.d19.s2.e2	effect	pos_2=DT	relType_1=case	pos_1=TO	path1=DISULFIRAM_nmod<PRIOR_appos	wib=PATIENT	lemma_2=a	eib=False	lemma_4=on	path2=patient_nmod>therapy_nmod>phenytoin_compound	lpib=patient_NN	path=DISULFIRAM_nmod<PRIOR_appos<INTOXICATION_obl>patient_nmod>therapy_nmod>phenytoin_compound	pos_4=IN	lib=patient	relType_3=nmod	relType_4=case	lemma_1=to	pos_3=NN	relType_2=det	lemma_3=patient
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e1	DDI-DrugBank.d19.s2.e3	null	pos_2=DT	relType_1=case	pos_1=TO	relType_7=det	path1=DISULFIRAM_nmod<PRIOR_appos	wib=PATIENT	lemma_6=,	relType_5=compound	lemma_2=a	path=DISULFIRAM_nmod<PRIOR_appos<INTOXICATION_obl>patient_nmod>obtain_dep>level_nsubj:pass>phenytoin_compound	pos_8=NN	relType_6=punct	lemma_4=on	pos_7=DT	lpib=patient_NN	lemma_8=baseline	lemma_5=therapy	pos_4=IN	lib=patient	relType_8=compound	relType_3=nmod	relType_4=case	relType_5=nmod	lemma_1=to	path2=patient_nmod>obtain_dep>level_nsubj:pass>phenytoin_compound	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_2=det	lemma_7=a	lemma_5=phenytoin	lemma_3=patient
DDI-DrugBank.d19.s2	DDI-DrugBank.d19.s2.e2	DDI-DrugBank.d19.s2.e3	null	path=phenytoin_compound<therapy_nmod<patient_nmod>obtain_dep>level_nsubj:pass>phenytoin_compound	lpib=therapy_NN	relType_2=punct	eib=False	lemma_1=therapy	relType_3=det	relType_1=nmod	lemma_3=a	lemma_2=,	pos_4=NN	pos_1=NN	path1=phenytoin_compound<therapy_nmod	lemma_4=baseline	relType_4=compound	lib=therapy	pos_3=DT	pos_2=,	wib=THERAPY	path2=obtain_dep>level_nsubj:pass>phenytoin_compound
DDI-DrugBank.d19.s6	DDI-DrugBank.d19.s6.e0	DDI-DrugBank.d19.s6.e1	advise	relType_1=case	pos_3=CC	path2=begin_obl>disulfiram_obj	lpib=begin_VBG	relType_3=cc	path1=anticoagulant_nmod<dosage_obj	lemma_4=stop	eib=False	pos_1=IN	lemma_3=or	path=anticoagulant_nmod<dosage_obj<adjust_xcomp>begin_obl>disulfiram_obj	pos_4=VBG	lemma_2=begin	relType_2=obl	lemma_1=upon	lib=begin	wib=beginning	relType_4=conj	pos_2=VBG
DDI-DrugBank.d19.s6	DDI-DrugBank.d19.s6.e0	DDI-DrugBank.d19.s6.e2	null	relType_1=case	pos_3=CC	lemma_6=since	lpib=begin_VBG	relType_3=cc	lemma_4=stop	lemma_5=disulfiram	pos_6=IN	pos_1=IN	lemma_3=or	lemma_5=.	relType_6=mark	relType_5=punct	path2=prolong_advcl>disulfiram_nsubj	path=anticoagulant_nmod<dosage_obj<adjust_xcomp<necessary_ROOT>prolong_advcl>disulfiram_nsubj	pos_4=VBG	lemma_2=begin	relType_2=obl	pos_5=.	pos_5=NN	lemma_1=upon	eib=True	lib=begin	relType_5=obj	wib=beginning	relType_4=conj	path1=anticoagulant_nmod<dosage_obj<adjust_xcomp	pos_2=VBG
DDI-DrugBank.d19.s6	DDI-DrugBank.d19.s6.e1	DDI-DrugBank.d19.s6.e2	null	wib=disulfiram	pos_2=IN	path1=disulfiram_obj<begin_obl<adjust_xcomp	lemma_2=since	eib=False	lib=disulfiram	pos_1=.	path2=prolong_advcl>disulfiram_nsubj	lemma_1=.	lpib=disulfiram_NN	relType_1=punct	path=disulfiram_obj<begin_obl<adjust_xcomp<necessary_ROOT>prolong_advcl>disulfiram_nsubj	relType_2=mark
DDI-DrugBank.d19.s7	DDI-DrugBank.d19.s7.e0	DDI-DrugBank.d19.s7.e1	advise	wib=disulfiram	eib=False	lib=disulfiram	lemma_1=when	path2=give_advcl>disulfiram_nsubj:pass	pos_1=WRB	lpib=disulfiram_NN	path=isoniazid_obj<take_acl>give_advcl>disulfiram_nsubj:pass	relType_1=advmod	path1=isoniazid_obj
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e0	DDI-DrugBank.d19.s9.e1	effect	relType_1=cc	pos_1=CC	path=<disulfiram_nmod>nitrite_conj	lpib=nitrite_NN	eib=False	path1=	path2=nitrite_conj	lemma_1=and	lib=nitrite	wib=nitrite
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e0	DDI-DrugBank.d19.s9.e2	null	relType_1=cc	pos_7=NNS	pos_1=CC	relType_14=punct	relType_18=aux:pass	pos_2=NN	lemma_4=diet	path2=suggest_conj>react_ccomp>disulfiram_nsubj	lemma_12=cause	relType_9=aux:pass	relType_16=nsubj:pass	lemma_8=have	lemma_10=report	pos_13=NNS	pos_6=CD	relType_4=nmod	path=disulfiram_nmod<ingestion_nsubj:pass<report_ROOT>suggest_conj>react_ccomp>disulfiram_nsubj	lemma_5=for	lemma_19=suggest	relType_5=case	lib=nitrite	pos_20=IN	lemma_20=that	pos_2=IN	pos_11=TO	relType_20=mark	lemma_7=week	pos_8=VBZ	pos_14=,	lemma_13=tumor	lemma_18=be	lemma_16=it	pos_16=PRP	relType_12=xcomp	pos_9=VBN	relType_3=det	relType_2=conj	pos_4=NN	lemma_17=have	relType_10=ROOT	pos_17=VBZ	relType_6=nummod	pos_5=IN	relType_7=nmod	relType_15=cc	lemma_9=be	relType_19=conj	lemma_6=78	lemma_15=and	pos_12=VB	wib=nitrite	lemma_2=nitrite	lemma_14=,	relType_11=mark	pos_18=VBN	relation_12=neutral	lpib=nitrite_NN	relType_2=case	eib=True	pos_3=DT	path1=disulfiram_nmod<ingestion_nsubj:pass	pos_10=VBN	pos_19=VBN	lemma_3=the	relType_8=aux	pos_15=CC	relType_13=obj	relType_17=aux	lemma_2=in	lemma_1=and	lemma_11=to
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e0	DDI-DrugBank.d19.s9.e3	null	relType_1=cc	relType_18=aux:pass	relType_22=ccomp	pos_2=NN	lemma_12=cause	pos_13=NNS	relType_5=case	pos_22=VB	lemma_18=be	lemma_15=and	relation_12=neutral	lpib=nitrite_NN	pos_15=CC	relType_17=aux	lemma_6=78	lemma_20=that	pos_7=NNS	lemma_13=tumor	relType_16=nsubj:pass	relType_9=aux:pass	lemma_8=have	relType_4=nmod	relType_12=xcomp	relType_3=det	relType_2=conj	pos_17=VBZ	relType_6=nummod	pos_5=IN	relType_7=nmod	pos_21=MD	lemma_2=nitrite	lemma_14=,	pos_10=VBN	pos_23=IN	lemma_2=in	lemma_1=and	lemma_11=to	relType_14=punct	lemma_4=diet	lemma_22=react	lemma_19=suggest	pos_20=IN	pos_2=IN	pos_11=TO	pos_14=,	lemma_16=it	pos_16=PRP	relType_21=aux	lemma_17=have	lemma_21=disulfiram	lemma_21=may	relType_23=case	relType_19=conj	pos_12=VB	pos_18=VBN	relType_2=case	path1=disulfiram_nmod<ingestion_nsubj:pass	pos_19=VBN	pos_1=CC	lemma_10=report	pos_6=CD	lemma_23=with	lemma_5=for	lib=nitrite	path2=suggest_conj>react_ccomp>nitrite_obl	relType_20=mark	lemma_7=week	pos_8=VBZ	pos_9=VBN	pos_4=NN	relType_21=nsubj	relType_10=ROOT	relType_15=cc	lemma_9=be	wib=nitrite	relType_11=mark	eib=True	pos_3=DT	path=disulfiram_nmod<ingestion_nsubj:pass<report_ROOT>suggest_conj>react_ccomp>nitrite_obl	lemma_3=the	relType_8=aux	relType_13=obj	pos_21=NN
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e1	DDI-DrugBank.d19.s9.e2	null	pos_2=DT	relType_1=case	pos_13=,	lemma_1=in	lemma_2=the	pos_7=VBZ	path2=suggest_conj>react_ccomp>disulfiram_nsubj	lemma_10=to	relType_10=mark	pos_8=VBN	lemma_11=cause	lemma_12=tumor	lemma_13=,	relType_13=punct	pos_14=CC	relType_17=aux:pass	relation_10=neutral	relType_7=aux	pos_19=IN	lemma_17=be	lemma_18=suggest	pos_17=VBN	relType_15=nsubj:pass	relType_9=ROOT	pos_5=CD	eib=False	lib=diet	relType_8=aux:pass	lemma_4=for	relType_16=aux	lemma_6=week	relType_12=obj	pos_1=IN	pos_9=VBN	relType_19=mark	lemma_5=78	lemma_7=have	path=nitrite_conj<disulfiram_nmod<ingestion_nsubj:pass<report_ROOT>suggest_conj>react_ccomp>disulfiram_nsubj	relType_5=nummod	lemma_8=be	pos_12=NNS	pos_4=IN	lemma_15=it	pos_16=VBZ	lemma_19=that	relType_3=nmod	wib=diet	lemma_3=diet	relType_4=case	relType_14=cc	pos_15=PRP	lpib=diet_NN	relType_11=xcomp	pos_18=VBN	pos_10=TO	pos_11=VB	lemma_16=have	pos_3=NN	relType_2=det	pos_6=NNS	lemma_9=report	lemma_14=and	relType_6=nmod	path1=nitrite_conj<disulfiram_nmod<ingestion_nsubj:pass	relType_18=conj
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e1	DDI-DrugBank.d19.s9.e3	null	pos_7=VBZ	lemma_10=to	pos_14=CC	lemma_11=cause	lemma_13=,	relType_20=nsubj	relType_15=nsubj:pass	relType_9=ROOT	pos_5=CD	pos_20=NN	lemma_6=week	pos_22=IN	relType_19=mark	pos_16=VBZ	pos_11=VB	pos_6=NNS	path1=nitrite_conj<disulfiram_nmod<ingestion_nsubj:pass	pos_2=DT	relType_1=case	pos_13=,	lemma_2=the	pos_8=VBN	lemma_21=react	relType_20=aux	lib=diet	relType_8=aux:pass	pos_1=IN	relType_22=case	lemma_5=78	relType_5=nummod	pos_21=VB	lemma_22=with	pos_15=PRP	lpib=diet_NN	lemma_16=have	lemma_14=and	relType_10=mark	relType_7=aux	lemma_18=suggest	pos_17=VBN	lemma_7=have	pos_4=IN	lemma_19=that	relType_3=nmod	lemma_3=diet	relType_21=ccomp	lemma_20=disulfiram	pos_18=VBN	path=nitrite_conj<disulfiram_nmod<ingestion_nsubj:pass<report_ROOT>suggest_conj>react_ccomp>nitrite_obl	pos_10=TO	relType_6=nmod	pos_19=IN	lemma_1=in	lemma_12=tumor	lemma_20=may	relType_13=punct	relType_17=aux:pass	relation_10=neutral	lemma_17=be	path2=suggest_conj>react_ccomp>nitrite_obl	pos_20=MD	lemma_4=for	relType_16=aux	relType_12=obj	pos_9=VBN	lemma_8=be	pos_12=NNS	lemma_15=it	relType_4=case	wib=diet	relType_14=cc	relType_11=xcomp	eib=True	pos_3=NN	relType_2=det	lemma_9=report	relType_18=conj
DDI-DrugBank.d19.s9	DDI-DrugBank.d19.s9.e2	DDI-DrugBank.d19.s9.e3	effect	lpib=react_VB	path1=disulfiram_nsubj	pos_3=IN	eib=False	path2=nitrite_obl	lemma_1=may	relType_1=aux	lib=react	lemma_2=react	wib=react	pos_2=VB	lemma_3=with	pos_1=MD	relType_3=case	relType_2=ccomp	path=disulfiram_nsubj<react_ccomp>nitrite_obl
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e0	DDI-DrugBank.d371.s1.e1	mechanism	pos_6=JJ	relType_13=dep	lemma_17=metabolize	relType_10=dep	pos_13=VBP	relType_18=case	lemma_12=,	lemma_19=cytochrome	pos_12=,	pos_20=NN	pos_2=VB	relType_22=punct	pos_10=WDT	pos_22=,	relType_2=aux:pass	lemma_18=by	lemma_15=or	pos_24=IN	lpib=be_VB	path2=inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod	lemma_3=modify	pos_15=CC	lemma_13=inhibit	pos_16=VBP	relType_8=case	relType_1=aux	relation_12=adverse	lemma_22=,	relType_12=punct	pos_8=IN	relType_19=compound	lemma_6=concomitant	lemma_24=as	lemma_14=,	relType_21=obl	relType_24=fixed	lemma_5=the	relType_7=obl	lemma_2=be	path=docetaxel_nmod<metabolism_nsubj:pass<modify_ccomp>inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod	pos_7=NN	lemma_23=such	pos_23=JJ	relType_14=punct	lemma_1=may	pos_17=VBN	pos_14=,	relation_2=neutral	lemma_16=be	pos_18=IN	lib=be	pos_4=IN	relType_5=det	pos_1=MD	relType_23=case	lemma_11=induce	lemma_10=that	pos_5=DT	pos_3=VBN	relation_10=neutral	relType_9=nmod	relType_16=aux:pass	relType_17=conj	wib=be	path1=docetaxel_nmod<metabolism_nsubj:pass	eib=False	lemma_9=compound	relType_6=amod	pos_9=NNS	relType_11=nsubj	pos_19=NN	pos_11=VBP	lemma_7=administration	relType_4=case	relType_15=cc	lemma_21=3a4	relType_3=ccomp	relType_20=compound	lemma_20=p450	lemma_8=of	lemma_4=by	pos_21=NN
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e0	DDI-DrugBank.d371.s1.e2	mechanism	pos_6=JJ	relType_13=dep	lemma_17=metabolize	relType_10=dep	pos_13=VBP	relType_18=case	lemma_12=,	lemma_19=cytochrome	pos_12=,	pos_20=NN	pos_2=VB	relType_22=punct	pos_10=WDT	pos_22=,	relType_2=aux:pass	lemma_18=by	lemma_25=,	lemma_15=or	pos_24=IN	lpib=be_VB	lemma_3=modify	pos_15=CC	lemma_13=inhibit	pos_16=VBP	relType_8=case	path=docetaxel_nmod<metabolism_nsubj:pass<modify_ccomp>inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>terfenadine_conj	relType_1=aux	relation_12=adverse	relType_25=nmod	lemma_22=,	relType_12=punct	pos_8=IN	relType_19=compound	lemma_6=concomitant	lemma_24=as	lemma_14=,	relType_21=obl	relType_24=fixed	lemma_5=the	relType_7=obl	relType_25=punct	lemma_2=be	lemma_23=such	pos_7=NN	pos_23=JJ	relType_14=punct	lemma_1=may	pos_17=VBN	pos_14=,	relation_2=neutral	lemma_16=be	path2=inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>terfenadine_conj	pos_18=IN	lib=be	pos_4=IN	relType_5=det	pos_25=NN	pos_1=MD	relType_23=case	lemma_11=induce	lemma_10=that	pos_5=DT	lemma_25=cyclosporine	pos_25=,	pos_3=VBN	relation_10=neutral	relType_9=nmod	relType_16=aux:pass	relType_17=conj	wib=be	path1=docetaxel_nmod<metabolism_nsubj:pass	lemma_9=compound	relType_6=amod	pos_9=NNS	relType_11=nsubj	pos_19=NN	pos_11=VBP	lemma_7=administration	relType_4=case	relType_15=cc	lemma_21=3a4	relType_3=ccomp	eib=True	relType_20=compound	lemma_20=p450	lemma_8=of	lemma_4=by	pos_21=NN
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e0	DDI-DrugBank.d371.s1.e3	mechanism	pos_6=JJ	relType_13=dep	lemma_17=metabolize	relType_10=dep	pos_13=VBP	relType_18=case	lemma_12=,	lemma_19=cytochrome	pos_12=,	pos_20=NN	pos_2=VB	pos_26=NN	path=docetaxel_nmod<metabolism_nsubj:pass<modify_ccomp>inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>ketoconazole_conj	relType_22=punct	pos_10=WDT	pos_22=,	relType_2=aux:pass	lemma_18=by	lemma_25=,	lemma_15=or	pos_24=IN	lpib=be_VB	lemma_3=modify	pos_15=CC	lemma_13=inhibit	pos_16=VBP	relType_8=case	relType_1=aux	relation_12=adverse	relType_25=nmod	path2=inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>ketoconazole_conj	lemma_22=,	relType_12=punct	pos_8=IN	relType_19=compound	lemma_6=concomitant	lemma_24=as	lemma_14=,	relType_21=obl	relType_24=fixed	lemma_5=the	relType_7=obl	relType_25=punct	lemma_2=be	relType_26=punct	lemma_23=such	pos_7=NN	pos_23=JJ	relType_14=punct	lemma_1=may	pos_17=VBN	pos_14=,	relation_2=neutral	lemma_16=be	pos_18=IN	lib=be	pos_4=IN	relType_5=det	pos_25=NN	pos_1=MD	relType_23=case	lemma_11=induce	lemma_10=that	pos_5=DT	lemma_25=cyclosporine	pos_25=,	pos_3=VBN	relation_10=neutral	relType_9=nmod	relType_16=aux:pass	relType_17=conj	wib=be	path1=docetaxel_nmod<metabolism_nsubj:pass	relType_26=conj	lemma_9=compound	relType_6=amod	pos_9=NNS	relType_11=nsubj	pos_19=NN	pos_11=VBP	lemma_26=terfenadine	lemma_7=administration	relType_4=case	relType_15=cc	lemma_21=3a4	relType_3=ccomp	eib=True	relType_20=compound	pos_26=,	lemma_20=p450	lemma_26=,	lemma_8=of	lemma_4=by	pos_21=NN
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e0	DDI-DrugBank.d371.s1.e4	mechanism	pos_6=JJ	relType_13=dep	lemma_17=metabolize	relType_10=dep	pos_13=VBP	relType_18=case	pos_27=,	lemma_12=,	lemma_19=cytochrome	pos_12=,	pos_20=NN	pos_2=VB	pos_26=NN	relType_22=punct	pos_10=WDT	pos_22=,	relType_2=aux:pass	lemma_18=by	lemma_25=,	lemma_15=or	pos_24=IN	lpib=be_VB	lemma_3=modify	pos_15=CC	lemma_13=inhibit	pos_16=VBP	relType_8=case	relType_1=aux	relType_27=conj	path2=inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>erythromycin_conj	relation_12=adverse	relType_25=nmod	lemma_22=,	relType_12=punct	pos_8=IN	relType_19=compound	pos_27=NN	lemma_6=concomitant	lemma_24=as	lemma_14=,	relType_21=obl	relType_24=fixed	lemma_5=the	relType_7=obl	relType_25=punct	lemma_2=be	relType_26=punct	lemma_23=such	pos_7=NN	pos_23=JJ	relType_14=punct	lemma_1=may	pos_17=VBN	path=docetaxel_nmod<metabolism_nsubj:pass<modify_ccomp>inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>erythromycin_conj	pos_14=,	relation_2=neutral	lemma_16=be	pos_18=IN	lib=be	pos_4=IN	relType_5=det	pos_25=NN	pos_1=MD	relType_23=case	lemma_11=induce	lemma_10=that	pos_5=DT	relType_27=punct	lemma_25=cyclosporine	pos_25=,	pos_3=VBN	relation_10=neutral	relType_9=nmod	relType_16=aux:pass	relType_17=conj	wib=be	path1=docetaxel_nmod<metabolism_nsubj:pass	relType_26=conj	lemma_9=compound	relType_6=amod	pos_9=NNS	relType_11=nsubj	pos_19=NN	pos_11=VBP	lemma_27=ketoconazole	lemma_26=terfenadine	lemma_7=administration	relType_4=case	relType_15=cc	lemma_27=,	lemma_21=3a4	relType_3=ccomp	eib=True	relType_20=compound	pos_26=,	lemma_20=p450	lemma_26=,	lemma_8=of	lemma_4=by	pos_21=NN
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e0	DDI-DrugBank.d371.s1.e5	mechanism	pos_6=JJ	relType_13=dep	lemma_17=metabolize	relType_10=dep	pos_13=VBP	relType_18=case	pos_27=,	lemma_12=,	lemma_19=cytochrome	relType_28=punct	pos_12=,	pos_20=NN	pos_2=VB	pos_26=NN	relType_22=punct	pos_10=WDT	pos_22=,	relType_2=aux:pass	lemma_18=by	lemma_25=,	lemma_15=or	lemma_29=and	pos_24=IN	lpib=be_VB	pos_28=NN	lemma_3=modify	relType_28=conj	pos_15=CC	lemma_28=,	lemma_13=inhibit	pos_16=VBP	relType_8=case	path2=inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>troleandomycin_conj	relType_1=aux	relType_27=conj	relation_12=adverse	relType_25=nmod	path=docetaxel_nmod<metabolism_nsubj:pass<modify_ccomp>inhibit_dep>metabolize_conj>3a4_obl>cyclosporine_nmod>troleandomycin_conj	lemma_22=,	relType_12=punct	pos_8=IN	relType_19=compound	pos_27=NN	lemma_6=concomitant	relType_29=cc	lemma_24=as	lemma_14=,	relType_21=obl	relType_24=fixed	lemma_5=the	relType_7=obl	relType_25=punct	lemma_2=be	relType_26=punct	lemma_23=such	pos_7=NN	pos_23=JJ	relType_14=punct	lemma_1=may	pos_17=VBN	pos_14=,	relation_2=neutral	lemma_16=be	pos_18=IN	pos_29=CC	lib=be	pos_4=IN	relType_5=det	lemma_28=erythromycin	pos_25=NN	pos_1=MD	relType_23=case	lemma_11=induce	lemma_10=that	pos_5=DT	relType_27=punct	lemma_25=cyclosporine	pos_25=,	pos_3=VBN	relation_10=neutral	relType_9=nmod	relType_16=aux:pass	relType_17=conj	wib=be	path1=docetaxel_nmod<metabolism_nsubj:pass	relType_26=conj	lemma_9=compound	relType_6=amod	pos_9=NNS	relType_11=nsubj	pos_19=NN	pos_28=,	pos_11=VBP	lemma_27=ketoconazole	lemma_26=terfenadine	lemma_7=administration	relType_4=case	relType_15=cc	lemma_27=,	lemma_21=3a4	relType_3=ccomp	eib=True	relType_20=compound	pos_26=,	lemma_20=p450	lemma_26=,	lemma_8=of	lemma_4=by	pos_21=NN
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e1	DDI-DrugBank.d371.s1.e2	null	lib=terfenadine	lemma_1=,	path2=terfenadine_conj	path=<cyclosporine_nmod>terfenadine_conj	lpib=terfenadine_NN	eib=False	wib=terfenadine	path1=	pos_1=,	relType_1=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e1	DDI-DrugBank.d371.s1.e3	null	lib=terfenadine	path2=ketoconazole_conj	lemma_1=,	pos_2=NN	lpib=terfenadine_NN	eib=True	lemma_2=terfenadine	wib=terfenadine	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	path=<cyclosporine_nmod>ketoconazole_conj	relType_2=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e1	DDI-DrugBank.d371.s1.e4	null	lemma_1=,	pos_2=NN	path2=erythromycin_conj	path1=	pos_1=,	path=<cyclosporine_nmod>erythromycin_conj	relType_2=punct	lemma_2=terfenadine	relType_2=conj	lemma_2=,	lib=terfenadine	lemma_3=,	relType_3=conj	lemma_3=ketoconazole	pos_3=,	lpib=terfenadine_NN	eib=True	pos_3=NN	wib=terfenadine	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e1	DDI-DrugBank.d371.s1.e5	null	lemma_1=,	pos_2=NN	pos_5=CC	path1=	pos_1=,	lemma_4=erythromycin	relType_2=punct	relType_5=cc	lemma_2=terfenadine	pos_4=,	path=<cyclosporine_nmod>troleandomycin_conj	relType_2=conj	pos_4=NN	lemma_2=,	lib=terfenadine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lemma_3=ketoconazole	pos_3=,	lpib=terfenadine_NN	eib=True	lemma_5=and	pos_3=NN	wib=terfenadine	pos_2=,	relType_4=conj	path2=troleandomycin_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e2	DDI-DrugBank.d371.s1.e3	null	path2=ketoconazole_conj	path=terfenadine_conj<cyclosporine_nmod>ketoconazole_conj	lemma_1=,	eib=False	pos_1=,	lpib=ketoconazole_NN	path1=terfenadine_conj	wib=ketoconazole	lib=ketoconazole	relType_1=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e2	DDI-DrugBank.d371.s1.e4	null	lemma_1=,	pos_2=NN	eib=True	path2=erythromycin_conj	lemma_2=ketoconazole	path=terfenadine_conj<cyclosporine_nmod>erythromycin_conj	pos_1=,	pos_2=,	lpib=ketoconazole_NN	path1=terfenadine_conj	wib=ketoconazole	lib=ketoconazole	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e2	DDI-DrugBank.d371.s1.e5	null	lemma_1=,	path=terfenadine_conj<cyclosporine_nmod>troleandomycin_conj	pos_2=NN	pos_1=,	relType_4=cc	lib=ketoconazole	relType_2=punct	lemma_2=ketoconazole	path1=terfenadine_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=ketoconazole	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	lpib=ketoconazole_NN	path2=troleandomycin_conj	relType_1=punct	lemma_3=erythromycin	relType_3=punct
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e3	DDI-DrugBank.d371.s1.e4	null	lpib=erythromycin_NN	lemma_1=,	path1=ketoconazole_conj	eib=False	path=ketoconazole_conj<cyclosporine_nmod>erythromycin_conj	path2=erythromycin_conj	pos_1=,	wib=erythromycin	relType_1=punct	lib=erythromycin
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e3	DDI-DrugBank.d371.s1.e5	null	lpib=erythromycin_NN	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	wib=erythromycin	relType_3=cc	relType_2=punct	path1=ketoconazole_conj	relType_2=conj	lib=erythromycin	lemma_2=,	path=ketoconazole_conj<cyclosporine_nmod>troleandomycin_conj	eib=True	pos_2=,	lemma_3=and	path2=troleandomycin_conj	relType_1=punct	lemma_2=erythromycin
DDI-DrugBank.d371.s1	DDI-DrugBank.d371.s1.e4	DDI-DrugBank.d371.s1.e5	null	lemma_2=and	lemma_1=,	eib=False	pos_2=CC	wib=troleandomycin	pos_1=,	lpib=troleandomycin_NN	path2=troleandomycin_conj	relType_1=punct	relType_2=cc	path=erythromycin_conj<cyclosporine_nmod>troleandomycin_conj	path1=erythromycin_conj	lib=troleandomycin
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e0	DDI-DrugBank.d367.s1.e1	null	pos_2=DT	path2=effect_obj>binding_nmod>digoxin_nmod	lpib=have_VBZ	path1=mesylate_nsubj	relType_7=case	lemma_6=binding	relType_5=compound	path=mesylate_nsubj<have_ccomp>effect_obj>binding_nmod>digoxin_nmod	pos_6=NN	lemma_2=no	lemma_3=effect	lemma_5=protein	eib=False	relation_2=neutral	lemma_4=on	lemma_1=have	lib=have	pos_4=IN	relType_1=ccomp	relType_4=case	lemma_7=of	pos_5=NN	pos_1=VBZ	pos_7=IN	pos_3=NN	relType_2=det	relType_3=obj	relType_6=nmod	wib=has
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e0	DDI-DrugBank.d367.s1.e2	null	pos_2=DT	lpib=have_VBZ	path1=mesylate_nsubj	relType_7=case	lemma_8=digoxin	lemma_6=binding	relType_5=compound	relType_8=punct	path=mesylate_nsubj<have_ccomp>effect_obj>binding_nmod>digoxin_nmod>warfarin_conj	lemma_8=,	pos_6=NN	lemma_2=no	lemma_3=effect	lemma_5=protein	path2=effect_obj>binding_nmod>digoxin_nmod>warfarin_conj	pos_8=NN	relation_2=neutral	lemma_4=on	lemma_1=have	lib=have	pos_4=IN	relType_1=ccomp	relType_4=case	lemma_7=of	pos_5=NN	pos_1=VBZ	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	relType_2=det	relType_3=obj	relType_6=nmod	wib=has	pos_8=,
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e0	DDI-DrugBank.d367.s1.e3	null	pos_2=DT	relType_9=conj	lpib=have_VBZ	path1=mesylate_nsubj	relType_7=case	lemma_8=digoxin	lemma_6=binding	relType_5=compound	relType_8=punct	lemma_9=,	lemma_8=,	pos_6=NN	path=mesylate_nsubj<have_ccomp>effect_obj>binding_nmod>digoxin_nmod>phenytoin_conj	lemma_2=no	lemma_3=effect	lemma_5=protein	pos_8=NN	relation_2=neutral	lemma_4=on	lemma_1=have	pos_9=NN	lib=have	pos_4=IN	relType_1=ccomp	relType_4=case	relType_9=punct	lemma_7=of	pos_5=NN	pos_1=VBZ	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	relType_2=det	relType_3=obj	pos_9=,	relType_6=nmod	path2=effect_obj>binding_nmod>digoxin_nmod>phenytoin_conj	lemma_9=warfarin	wib=has	pos_8=,
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e0	DDI-DrugBank.d367.s1.e4	null	pos_2=DT	relType_9=conj	lpib=have_VBZ	path1=mesylate_nsubj	relType_7=case	relType_10=cc	lemma_8=digoxin	lemma_6=binding	relType_5=compound	relType_8=punct	lemma_9=,	lemma_8=,	path2=effect_obj>binding_nmod>digoxin_nmod>indomethacin_conj	pos_6=NN	lemma_2=no	lemma_3=effect	lemma_5=protein	pos_8=NN	relType_10=conj	pos_10=CC	relation_2=neutral	lemma_4=on	lemma_1=have	pos_10=NN	path=mesylate_nsubj<have_ccomp>effect_obj>binding_nmod>digoxin_nmod>indomethacin_conj	lib=have	pos_9=NN	lemma_10=phenytoin	pos_4=IN	relType_1=ccomp	relType_4=case	lemma_10=or	relType_9=punct	lemma_7=of	pos_5=NN	pos_1=VBZ	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	relType_2=det	relType_3=obj	pos_9=,	relType_6=nmod	wib=has	lemma_9=warfarin	pos_8=,
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e1	DDI-DrugBank.d367.s1.e2	null	path=<digoxin_nmod>warfarin_conj	lib=warfarin	path2=warfarin_conj	lemma_1=,	lpib=warfarin_NN	eib=False	path1=	pos_1=,	wib=warfarin	relType_1=punct
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e1	DDI-DrugBank.d367.s1.e3	null	lib=warfarin	lemma_2=warfarin	lemma_1=,	lpib=warfarin_NN	pos_2=NN	eib=True	lemma_2=,	path1=	pos_1=,	pos_2=,	wib=warfarin	relType_1=punct	relType_2=conj	path2=phenytoin_conj	relType_2=punct	path=<digoxin_nmod>phenytoin_conj
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e1	DDI-DrugBank.d367.s1.e4	null	lib=warfarin	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	relType_2=punct	relType_3=cc	lpib=warfarin_NN	lemma_3=phenytoin	wib=warfarin	path2=indomethacin_conj	lemma_3=or	relType_2=conj	lemma_2=,	relType_3=conj	path=<digoxin_nmod>indomethacin_conj	lemma_2=warfarin	eib=True	pos_3=NN	pos_2=,	relType_1=punct
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e2	DDI-DrugBank.d367.s1.e3	null	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	pos_1=,	path1=warfarin_conj	path2=phenytoin_conj	relType_1=punct	lpib=phenytoin_NN	path=warfarin_conj<digoxin_nmod>phenytoin_conj
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e2	DDI-DrugBank.d367.s1.e4	null	lemma_2=or	lemma_1=,	lib=phenytoin	pos_2=NN	eib=True	wib=phenytoin	pos_2=CC	pos_1=,	lemma_2=phenytoin	path1=warfarin_conj	path2=indomethacin_conj	relType_1=punct	relType_2=cc	path=warfarin_conj<digoxin_nmod>indomethacin_conj	relType_2=conj	lpib=phenytoin_NN
DDI-DrugBank.d367.s1	DDI-DrugBank.d367.s1.e3	DDI-DrugBank.d367.s1.e4	null	relType_1=cc	lpib=indomethacin_NN	wib=indomethacin	pos_1=CC	lib=indomethacin	eib=False	path2=indomethacin_conj	path=phenytoin_conj<digoxin_nmod>indomethacin_conj	path1=phenytoin_conj	lemma_1=or
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e0	DDI-DrugBank.d367.s3.e1	null	pos_2=VBN	pos_8=DT	lpib=have_VBZ	relType_1=aux	relType_7=case	pos_15=JJ	lemma_9=adverse	pos_3=VBN	pos_13=NNS	relType_12=case	relType_15=amod	pos_6=NN	relType_13=nmod	relType_6=obl	pos_9=JJ	relType_14=acl	lemma_5=any	lemma_3=administer	lemma_8=a	lemma_1=have	relType_9=amod	relType_10=compound	pos_10=NN	path=mesylate_nsubj:pass<administer_ROOT>evidence_obl>interaction_nmod>patient_nmod>receive_acl>diuretic_obj	lib=have	pos_12=IN	path2=evidence_obl>interaction_nmod>patient_nmod>receive_acl>diuretic_obj	lemma_4=without	relType_3=ROOT	pos_14=VBG	pos_4=IN	relType_5=det	relType_4=case	relType_2=aux:pass	lemma_15=thiazide	path1=mesylate_nsubj:pass	lemma_6=evidence	lemma_12=to	lemma_14=receive	lemma_7=of	lemma_11=interaction	pos_11=NN	pos_1=VBZ	eib=True	pos_7=IN	pos_5=DT	lemma_2=be	relType_8=det	relType_11=nmod	wib=has	lemma_10=drug	lemma_13=patient
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e0	DDI-DrugBank.d367.s3.e2	null	pos_2=VBN	pos_8=DT	lpib=have_VBZ	relType_1=aux	relType_7=case	pos_15=JJ	lemma_9=adverse	path=mesylate_nsubj:pass<administer_ROOT>agent_obj	pos_3=VBN	relType_12=case	pos_13=NNS	relType_15=amod	lemma_15=diuretic	relType_16=obl	pos_16=HYPH	lemma_16=beta	pos_6=NN	relType_13=nmod	relType_6=obl	pos_9=JJ	relType_14=acl	relType_16=amod	lemma_5=any	lemma_3=administer	pos_15=,	lemma_8=a	lemma_1=have	relType_9=amod	relType_10=compound	pos_10=NN	lib=have	pos_12=IN	relType_15=punct	lemma_4=without	lemma_15=,	relType_3=ROOT	pos_14=VBG	lemma_16=block	pos_4=IN	relType_5=det	pos_16=VBG	relType_4=case	relType_2=aux:pass	lemma_15=thiazide	path1=mesylate_nsubj:pass	path2=agent_obj	lemma_6=evidence	pos_16=NN	lemma_12=to	lemma_16=-	relType_16=punct	lemma_14=receive	lemma_7=of	relType_15=obj	lemma_11=interaction	pos_11=NN	pos_15=NNS	pos_1=VBZ	eib=True	pos_7=IN	pos_5=DT	lemma_2=be	relType_8=det	relType_11=nmod	relation_19=adverse	wib=has	lemma_10=drug	lemma_13=patient
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e0	DDI-DrugBank.d367.s3.e3	null	pos_13=NNS	lemma_15=diuretic	pos_16=HYPH	pos_6=NN	lemma_3=administer	relType_18=obl:npmod	pos_10=NN	lemma_16=,	pos_18=AFX	lemma_16=agent	relType_3=ROOT	lemma_16=block	pos_16=VBG	relType_2=aux:pass	path1=mesylate_nsubj:pass	lemma_18=nonsteroidal	relType_16=punct	lemma_14=receive	pos_1=VBZ	pos_7=IN	lemma_10=drug	pos_8=DT	relType_7=case	relType_1=aux	relType_17=cc	lemma_9=adverse	pos_16=NNS	lemma_16=beta	relType_16=amod	lemma_5=any	pos_12=IN	lemma_15=,	pos_14=VBG	lemma_16=-	lemma_6=evidence	pos_16=NN	pos_11=NN	lemma_2=be	pos_17=CC	relType_11=nmod	relation_19=adverse	pos_2=VBN	lpib=have_VBZ	relType_12=case	relType_16=obl	relType_6=obl	pos_15=,	relType_9=amod	relType_15=punct	lemma_18=inflammatory	pos_4=IN	relType_5=det	lemma_18=anti	relType_16=obj	lemma_15=thiazide	lemma_12=to	relType_15=obj	path=mesylate_nsubj:pass<administer_ROOT>drug_conj	pos_5=DT	relType_8=det	lemma_13=patient	pos_15=JJ	relType_15=amod	pos_3=VBN	relType_18=amod	relType_13=nmod	relType_14=acl	pos_9=JJ	path2=drug_conj	pos_18=HYPH	lemma_8=a	pos_16=,	pos_18=JJ	lemma_1=have	relType_10=compound	lemma_18=-	lib=have	lemma_4=without	relType_18=punct	relType_4=case	lemma_17=and	lemma_7=of	lemma_11=interaction	pos_15=NNS	eib=True	wib=has
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e1	DDI-DrugBank.d367.s3.e2	null	path1=diuretic_obj<receive_acl<patient_nmod<interaction_nmod<evidence_obl	lemma_1=,	pos_2=NN	pos_1=,	pos_2=HYPH	relType_2=punct	lemma_2=-	path=diuretic_obj<receive_acl<patient_nmod<interaction_nmod<evidence_obl<administer_ROOT>agent_obj	relation_3=adverse	relType_2=amod	wib=beta	path2=agent_obj	relType_2=obl	eib=True	lemma_2=block	relType_1=punct	lib=beta	lpib=beta_NN	lemma_2=beta	pos_2=VBG
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e1	DDI-DrugBank.d367.s3.e3	null	lemma_2=agent	path=diuretic_obj<receive_acl<patient_nmod<interaction_nmod<evidence_obl<administer_ROOT>drug_conj	relType_4=amod	path1=diuretic_obj<receive_acl<patient_nmod<interaction_nmod<evidence_obl	lemma_1=,	pos_2=NN	relType_2=obj	pos_4=JJ	pos_3=CC	relType_4=obl:npmod	pos_1=,	lemma_4=-	pos_2=HYPH	pos_4=HYPH	relType_2=punct	relType_3=cc	path2=drug_conj	lemma_2=-	lemma_4=anti	pos_4=AFX	lemma_4=inflammatory	lemma_2=,	lemma_4=nonsteroidal	relType_4=punct	relation_3=adverse	relType_2=amod	wib=beta	relType_2=obl	pos_2=NNS	eib=True	lemma_2=block	pos_2=,	lemma_3=and	relType_1=punct	lib=beta	lpib=beta_NN	lemma_2=beta	pos_2=VBG
DDI-DrugBank.d367.s3	DDI-DrugBank.d367.s3.e2	DDI-DrugBank.d367.s3.e3	null	lemma_1=,	pos_1=,	relType_3=obl:npmod	pos_3=AFX	relType_2=cc	lemma_3=inflammatory	path1=agent_obj	lemma_2=and	path2=drug_conj	lemma_3=nonsteroidal	lemma_3=-	path=agent_obj<administer_ROOT>drug_conj	lemma_3=anti	lpib=nonsteroidal_JJ	relType_3=amod	lib=nonsteroidal	wib=nonsteroidal	pos_3=JJ	eib=True	pos_3=HYPH	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e0	DDI-DrugBank.d367.s4.e1	mechanism	relType_1=case	lemma_3=1	lemma_11=oral	pos_2=NN	lpib=day_NN	pos_6=CD	lemma_10=of	wib=day	relType_9=nmod	path1=doxazosin_nmod<dose_nmod	lemma_5=a	lemma_7=-	pos_8=NN	eib=False	relType_2=nmod	relType_11=amod	pos_1=IN	relType_10=case	pos_9=NN	path=doxazosin_nmod<dose_nmod<administration_nsubj>day_nmod>regimen_nmod>cimetidine_nmod	path2=day_nmod>regimen_nmod>cimetidine_nmod	pos_3=CD	pos_7=HYPH	pos_4=IN	relType_5=det	relType_8=compound	relType_4=case	relType_6=nummod	lemma_9=regimen	relType_3=nummod	lemma_6=four	pos_10=IN	lemma_2=day	lib=day	pos_5=DT	relType_7=punct	pos_11=JJ	lemma_8=day	lemma_4=of	lemma_1=on
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e0	DDI-DrugBank.d367.s4.e2	null	relType_22=compound	pos_2=NN	lemma_10=of	relType_24=case	relType_26=nmod	pos_26=NN	lemma_12=cimetidine	pos_7=HYPH	lemma_6=four	pos_24=IN	lemma_22=%	lemma_20=a	lemma_2=day	lemma_26=auc	lemma_21=10	pos_14=NNS	pos_11=JJ	relType_21=nummod	pos_15=RB	lemma_1=on	lemma_16=daily	relType_1=case	pos_13=CD	lpib=day_NN	pos_22=NN	path1=doxazosin_nmod<dose_nmod<administration_nsubj	pos_8=NN	relType_25=amod	lemma_19=in	pos_16=RB	relType_11=amod	relType_12=nmod	relType_18=ROOT	pos_1=IN	relType_12=punct	relType_23=obl	pos_9=NN	pos_21=CD	relType_6=nummod	relType_19=case	lib=day	lemma_8=day	pos_12=-LRB-	lemma_24=in	lemma_12=(	lemma_3=1	relType_17=punct	lemma_27=of	wib=day	pos_23=NN	lemma_5=a	lemma_23=increase	relType_2=nmod	relType_13=nummod	relType_16=advmod	relation_23=beneficial	pos_4=IN	relType_5=det	relType_8=compound	lemma_9=regimen	pos_10=IN	lemma_18=result	lemma_25=mean	pos_5=DT	relType_27=case	lemma_4=of	lemma_15=twice	relType_20=det	pos_19=IN	lemma_11=oral	lemma_14=mg	pos_6=CD	pos_20=DT	relType_9=nmod	lemma_7=-	path=doxazosin_nmod<dose_nmod<administration_nsubj<result_ROOT>increase_obl>auc_nmod>doxazosin_nmod	relType_10=case	pos_27=IN	pos_25=JJ	pos_3=CD	relType_4=case	relType_14=appos	relType_3=nummod	lemma_17=)	eib=True	relType_7=punct	pos_17=-RRB-	path2=increase_obl>auc_nmod>doxazosin_nmod	relType_15=advmod	pos_12=NN	lemma_13=400	pos_18=VBD
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e0	DDI-DrugBank.d367.s4.e3	null	relType_22=compound	relType_30=dep	pos_2=NN	relType_32=punct	lemma_10=of	lemma_44=in	lemma_29=p	relType_29=nsubj	relType_24=case	relType_28=punct	path=doxazosin_nmod<dose_nmod<administration_nsubj<result_ROOT>and_dep>increase_dep>life_conj>doxazosin_nmod	pos_32=.	relType_26=nmod	pos_26=NN	lemma_37=a	lemma_12=cimetidine	relType_51=conj	relType_41=advmod	pos_7=HYPH	pos_48=VB	pos_42=JJ	relType_31=parataxis	lemma_6=four	pos_24=IN	lemma_22=%	pos_28=-LRB-	lemma_20=a	lemma_42=significant	pos_46=NN	pos_28=NN	relType_46=nmod	lemma_2=day	lemma_26=auc	lemma_21=10	pos_39=CC	pos_14=NNS	pos_11=JJ	relType_34=punct	relType_21=nummod	pos_15=RB	lemma_1=on	lemma_16=daily	relType_1=case	lemma_28=(	pos_13=CD	lemma_35=,	lpib=day_NN	pos_22=NN	relType_36=dep	pos_40=RB	path1=doxazosin_nmod<dose_nmod<administration_nsubj	relType_28=nmod	pos_8=NN	relType_25=amod	lemma_19=in	pos_16=RB	relType_11=amod	relType_12=nmod	relType_18=ROOT	pos_29=NN	pos_1=IN	relType_12=punct	relType_23=obl	pos_47=CC	pos_9=NN	pos_21=CD	pos_33=CD	lemma_48=mean	pos_38=JJ	pos_45=JJ	pos_36=CC	relation_44=beneficial	relType_43=dep	relType_6=nummod	lemma_52=of	lemma_43=increase	relType_33=dep	relType_19=case	lib=day	relType_52=case	lemma_28=doxazosin	pos_31=CD	lemma_8=day	pos_12=-LRB-	relType_38=amod	lemma_24=in	relType_47=cc	lemma_12=(	path2=and_dep>increase_dep>life_conj>doxazosin_nmod	relType_45=amod	pos_30=SYM	lemma_3=1	pos_44=IN	relType_17=punct	lemma_27=of	wib=day	lemma_31=0	pos_52=IN	lemma_33=006	pos_23=NN	lemma_5=a	lemma_23=increase	lemma_36=and	lemma_30==	relType_2=nmod	relType_13=nummod	pos_37=DT	lemma_41=statistically	relType_16=advmod	relation_23=beneficial	lemma_39=but	lemma_45=mean	pos_4=IN	relType_5=det	relType_8=compound	lemma_9=regimen	lemma_47=and	pos_10=IN	lemma_18=result	lemma_46=cmax	pos_43=NN	lemma_25=mean	relType_35=punct	relType_37=det	pos_5=DT	relType_40=advmod	relType_44=case	lemma_49=half	relType_27=case	lemma_4=of	lemma_15=twice	relType_20=det	pos_19=IN	pos_34=-RRB-	lemma_11=oral	lemma_14=mg	lemma_34=)	pos_51=NN	pos_6=CD	relType_49=compound	pos_20=DT	relType_9=nmod	lemma_7=-	pos_35=,	relType_10=case	pos_27=IN	lemma_32=.	pos_25=JJ	pos_3=CD	relType_42=conj	relType_4=case	relType_14=appos	relType_3=nummod	relType_39=cc	pos_50=HYPH	relType_48=dep	lemma_17=)	lemma_50=-	relType_50=punct	eib=True	lemma_38=slight	relType_7=punct	lemma_40=not	pos_17=-RRB-	lemma_51=life	relType_15=advmod	pos_12=NN	pos_41=RB	lemma_13=400	pos_49=NN	pos_18=VBD
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e1	DDI-DrugBank.d367.s4.e2	null	relType_8=case	relType_14=amod	relType_12=obl	relType_2=nummod	pos_16=IN	lemma_9=a	lemma_4=twice	lemma_1=(	lemma_8=in	pos_4=RB	pos_3=NNS	lib=mg	lemma_2=400	eib=False	relType_3=appos	pos_2=CD	lemma_5=daily	relType_6=punct	pos_9=DT	pos_13=IN	lemma_16=of	lemma_6=)	lemma_11=%	pos_8=IN	lpib=mg_NNS	relType_13=case	path=cimetidine_nmod<regimen_nmod<day_nmod<administration_nsubj<result_ROOT>increase_obl>auc_nmod>doxazosin_nmod	relType_7=ROOT	lemma_12=increase	pos_15=NN	pos_10=CD	relType_4=advmod	pos_5=RB	pos_7=VBD	lemma_14=mean	lemma_13=in	lemma_15=auc	relType_10=nummod	pos_1=-LRB-	relType_5=advmod	pos_6=-RRB-	relType_15=nmod	relType_16=case	pos_11=NN	path1=cimetidine_nmod<regimen_nmod<day_nmod<administration_nsubj	relType_11=compound	wib=mg	pos_14=JJ	lemma_10=10	path2=increase_obl>auc_nmod>doxazosin_nmod	lemma_3=mg	lemma_7=result	relType_1=punct	pos_12=NN	relation_11=beneficial	relType_9=det
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e1	DDI-DrugBank.d367.s4.e3	null	relType_14=amod	pos_24=,	path=cimetidine_nmod<regimen_nmod<day_nmod<administration_nsubj<result_ROOT>and_dep>increase_dep>life_conj>doxazosin_nmod	relType_29=advmod	pos_30=RB	relType_22=dep	lemma_29=not	pos_35=NN	lemma_37=mean	lemma_24=,	pos_3=NNS	lib=mg	lemma_5=daily	lemma_32=increase	relType_40=conj	pos_18=NN	lemma_18=p	lemma_39=-	pos_32=NN	pos_1=-LRB-	relType_31=conj	lemma_17=(	relType_21=punct	relType_8=case	pos_31=JJ	lemma_38=half	relType_2=nummod	pos_28=CC	relType_19=dep	pos_27=JJ	relType_39=punct	lemma_4=twice	pos_20=CD	lemma_31=significant	lemma_8=in	lemma_2=400	lemma_30=statistically	pos_8=IN	relType_37=dep	pos_39=HYPH	lemma_33=in	pos_36=CC	lemma_28=but	lemma_14=mean	lemma_13=in	pos_17=-LRB-	lemma_27=slight	relType_15=nmod	relType_5=advmod	pos_6=-RRB-	relType_16=case	pos_11=NN	lemma_19==	pos_40=NN	relation_32=beneficial	relType_25=dep	lemma_7=result	relType_1=punct	path2=and_dep>increase_dep>life_conj>doxazosin_nmod	lemma_40=life	pos_16=IN	lemma_9=a	relType_17=punct	relType_24=punct	relType_27=amod	lemma_26=a	lemma_1=(	lemma_25=and	pos_17=NN	lemma_36=and	relType_3=appos	pos_9=DT	pos_13=IN	lemma_22=006	lemma_6=)	lemma_34=mean	relType_13=case	pos_25=CC	pos_33=IN	lemma_12=increase	pos_26=DT	lemma_23=)	pos_38=NN	pos_7=VBD	pos_37=VB	pos_34=JJ	lemma_15=auc	relType_17=nmod	relType_35=nmod	relType_34=amod	pos_19=SYM	path1=cimetidine_nmod<regimen_nmod<day_nmod<administration_nsubj	pos_23=-RRB-	relType_18=nsubj	relType_30=advmod	pos_14=JJ	relation_11=beneficial	relType_20=parataxis	relType_23=punct	pos_21=.	relType_12=obl	relType_33=case	relType_32=dep	pos_4=RB	pos_22=CD	lemma_21=.	pos_2=CD	relType_6=punct	lemma_20=0	pos_29=RB	relType_38=compound	pos_41=IN	lemma_35=cmax	lemma_16=of	lemma_11=%	lpib=mg_NNS	relType_41=case	relType_7=ROOT	pos_15=NN	pos_10=CD	lemma_17=doxazosin	relType_4=advmod	pos_5=RB	relType_10=nummod	lemma_41=of	relType_28=cc	relType_36=cc	eib=True	relType_26=det	relType_11=compound	wib=mg	lemma_10=10	lemma_3=mg	pos_12=NN	relType_9=det
DDI-DrugBank.d367.s4	DDI-DrugBank.d367.s4.e2	DDI-DrugBank.d367.s4.e3	null	relType_22=compound	pos_2=NN	lemma_21=mean	relType_8=punct	pos_12=CC	relType_6=dep	relType_4=parataxis	pos_9=CC	pos_14=RB	lemma_25=of	lemma_19=cmax	relation_15=beneficial	pos_1=-LRB-	pos_5=.	pos_11=JJ	lpib=p_NN	lemma_11=slight	lemma_7=)	relType_3=dep	pos_22=NN	lemma_14=statistically	lemma_18=mean	pos_3=SYM	lemma_15=significant	relType_25=case	relType_14=advmod	relType_2=nsubj	lemma_6=006	relType_11=amod	lib=p	lemma_5=.	relType_21=dep	pos_23=HYPH	pos_4=CD	relType_13=advmod	pos_21=VB	lemma_22=half	pos_16=NN	pos_7=-RRB-	lemma_20=and	lemma_13=not	pos_25=IN	relType_1=punct	lemma_24=life	pos_8=,	path2=and_dep>increase_dep>life_conj>doxazosin_nmod	relType_10=det	relType_12=cc	relType_20=cc	pos_24=NN	lemma_8=,	lemma_1=(	pos_17=IN	relType_19=nmod	lemma_4=0	relType_17=case	lemma_23=-	lemma_17=in	lemma_16=increase	lemma_12=but	relType_15=conj	pos_20=CC	pos_10=DT	relType_23=punct	pos_15=JJ	relType_18=amod	pos_6=CD	lemma_10=a	relType_9=dep	lemma_2=p	eib=False	pos_13=RB	pos_18=JJ	pos_19=NN	lemma_9=and	relType_5=punct	relType_24=conj	wib=p	lemma_3==	relType_16=dep	relType_7=punct	path=doxazosin_nmod<auc_nmod<increase_obl<result_ROOT>and_dep>increase_dep>life_conj>doxazosin_nmod	path1=doxazosin_nmod<auc_nmod<increase_obl
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e1	null	lemma_2=anti	relType_2=obl:npmod	eib=True	path1=analgesic_amod	lemma_2=-	pos_2=AFX	wib=inflammatory	lpib=inflammatory_JJ	path2=	pos_1=HYPH	relType_1=punct	pos_2=HYPH	lib=inflammatory	path=analgesic_amod<inflammatory_ROOT>	lemma_1=/	relType_2=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e2	null	relType_4=dep	path=analgesic_amod<inflammatory_ROOT>g._dep>acetaminophen_conj	pos_5=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	lemma_3=e.	lemma_2=anti	relType_2=obl:npmod	lemma_2=-	pos_2=-LRB-	wib=inflammatory	lpib=inflammatory_JJ	pos_4=NN	path2=g._dep>acetaminophen_conj	relType_2=ROOT	lemma_5=,	relType_5=punct	lib=inflammatory	lemma_1=/	lemma_2=inflammatory	lemma_4=g.	eib=True	path1=analgesic_amod	pos_3=NN	relType_3=compound	relType_1=punct	lemma_2=(
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e3	null	relType_4=dep	pos_5=,	lemma_6=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	lemma_3=e.	pos_6=NN	lemma_2=anti	relType_2=obl:npmod	relType_6=conj	lemma_2=-	lemma_6=acetaminophen	relType_6=punct	pos_2=-LRB-	wib=inflammatory	lpib=inflammatory_JJ	pos_4=NN	path2=g._dep>aspirin_conj	relType_2=ROOT	lemma_5=,	relType_5=punct	lib=inflammatory	lemma_1=/	pos_6=,	lemma_2=inflammatory	lemma_4=g.	eib=True	path1=analgesic_amod	pos_3=NN	relType_3=compound	relType_1=punct	lemma_2=(	path=analgesic_amod<inflammatory_ROOT>g._dep>aspirin_conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e4	null	relType_4=dep	pos_5=,	pos_7=NN	lemma_6=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	lemma_3=e.	pos_6=NN	lemma_2=anti	relType_2=obl:npmod	relType_6=conj	path=analgesic_amod<inflammatory_ROOT>g._dep>codeine_conj	lemma_2=-	lemma_6=acetaminophen	relType_6=punct	pos_2=-LRB-	pos_7=,	wib=inflammatory	lpib=inflammatory_JJ	lemma_7=,	pos_4=NN	path2=g._dep>codeine_conj	lemma_7=aspirin	relType_2=ROOT	lemma_5=,	relType_5=punct	lib=inflammatory	lemma_1=/	pos_6=,	lemma_2=inflammatory	lemma_4=g.	eib=True	path1=analgesic_amod	pos_3=NN	relType_7=punct	relType_3=compound	relType_1=punct	lemma_2=(	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e5	null	relType_4=dep	pos_5=,	pos_7=NN	lemma_6=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	lemma_3=e.	pos_6=NN	pos_8=NN	lemma_2=anti	relType_2=obl:npmod	relType_6=conj	path=analgesic_amod<inflammatory_ROOT>g._dep>codeine_conj	lemma_2=-	lemma_6=acetaminophen	relType_6=punct	lemma_8=codeine	pos_2=-LRB-	pos_7=,	wib=inflammatory	lpib=inflammatory_JJ	pos_8=CC	lemma_7=,	pos_4=NN	path2=g._dep>codeine_conj	lemma_7=aspirin	relType_2=ROOT	lemma_5=,	relType_5=punct	lib=inflammatory	lemma_1=/	pos_6=,	lemma_8=and	lemma_2=inflammatory	lemma_4=g.	eib=True	path1=analgesic_amod	pos_3=NN	relType_7=punct	relType_8=conj	relType_3=compound	relType_1=punct	lemma_2=(	relType_8=cc	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e6	null	relType_4=dep	relType_10=punct	path=analgesic_amod<inflammatory_ROOT>g._dep>indomethacin_dep>ibuprofen_compound	relType_9=conj	pos_5=,	pos_7=NN	lemma_10=,	lemma_6=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_9=dep	relType_2=punct	lemma_3=e.	pos_6=NN	pos_8=NN	lemma_2=anti	relType_2=obl:npmod	relType_6=conj	lemma_9=codeine	lemma_2=-	lemma_6=acetaminophen	lemma_8=codeine	relType_6=punct	pos_2=-LRB-	pos_9=NNS	pos_7=,	wib=inflammatory	lpib=inflammatory_JJ	pos_8=CC	lemma_2=(	lemma_7=,	pos_9=NN	pos_4=NN	lemma_7=aspirin	lemma_9=combination	relType_2=ROOT	lemma_5=,	relType_5=punct	lib=inflammatory	lemma_1=/	pos_6=,	lemma_8=and	lemma_2=inflammatory	lemma_4=g.	pos_10=,	eib=True	path1=analgesic_amod	pos_3=NN	relType_7=punct	relType_8=conj	relType_3=compound	relType_1=punct	path2=g._dep>indomethacin_dep>ibuprofen_compound	relType_8=cc	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e0	DDI-DrugBank.d367.s9.e7	null	relType_4=dep	relType_10=punct	relType_9=conj	lemma_11=,	pos_5=,	pos_7=NN	lemma_10=,	lemma_6=,	pos_1=HYPH	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_9=dep	relType_2=punct	lemma_3=e.	pos_6=NN	pos_8=NN	lemma_2=anti	relType_2=obl:npmod	relType_6=conj	lemma_9=codeine	lemma_2=-	path2=g._dep>indomethacin_dep	lemma_6=acetaminophen	relType_6=punct	lemma_8=codeine	relType_11=punct	pos_2=-LRB-	pos_9=NNS	pos_7=,	wib=inflammatory	lpib=inflammatory_JJ	pos_8=CC	lemma_7=,	pos_9=NN	pos_4=NN	lemma_7=aspirin	lemma_9=combination	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_11=ibuprofen	pos_11=,	lib=inflammatory	lemma_1=/	pos_6=,	lemma_8=and	lemma_2=inflammatory	lemma_4=g.	pos_11=NN	pos_10=,	eib=True	path1=analgesic_amod	relType_11=compound	pos_3=NN	relType_7=punct	relType_8=conj	relType_3=compound	relType_1=punct	lemma_2=(	relType_8=cc	path=analgesic_amod<inflammatory_ROOT>g._dep>indomethacin_dep	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e2	null	relType_3=dep	pos_2=NN	path=<inflammatory_ROOT>g._dep>acetaminophen_conj	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	path2=g._dep>acetaminophen_conj	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e3	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_1=(	lemma_3=g.	pos_4=,	path2=g._dep>aspirin_conj	relType_4=punct	lemma_5=,	relType_2=compound	path=<inflammatory_ROOT>g._dep>aspirin_conj	relType_5=punct	lemma_5=acetaminophen	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e4	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lemma_6=,	lib=e.	lemma_1=(	pos_6=NN	relType_6=conj	lemma_3=g.	pos_4=,	relType_6=punct	path2=g._dep>codeine_conj	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_5=acetaminophen	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_6=,	path=<inflammatory_ROOT>g._dep>codeine_conj	pos_5=NN	eib=True	pos_3=NN	lemma_6=aspirin	relType_1=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e5	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lemma_6=,	relType_7=cc	lib=e.	lemma_1=(	pos_6=NN	relType_6=conj	lemma_3=g.	pos_4=,	relType_6=punct	path2=g._dep>codeine_conj	relType_4=punct	lemma_7=codeine	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_5=acetaminophen	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_6=,	path=<inflammatory_ROOT>g._dep>codeine_conj	pos_5=NN	eib=True	pos_3=NN	lemma_7=and	lemma_6=aspirin	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e6	null	relType_3=dep	pos_2=NN	relType_8=dep	pos_5=,	pos_7=NN	path1=	lemma_6=,	relType_7=cc	lib=e.	lemma_9=,	pos_8=NNS	lemma_1=(	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=g.	pos_4=,	lemma_8=codeine	relType_6=punct	lemma_8=combination	relType_4=punct	lemma_7=codeine	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_5=acetaminophen	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	relType_9=punct	pos_1=-LRB-	pos_6=,	pos_5=NN	path=<inflammatory_ROOT>g._dep>indomethacin_dep>ibuprofen_compound	eib=True	pos_3=NN	lemma_7=and	lemma_6=aspirin	relType_8=conj	pos_9=,	relType_1=punct	path2=g._dep>indomethacin_dep>ibuprofen_compound	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e1	DDI-DrugBank.d367.s9.e7	null	relType_3=dep	relType_10=punct	pos_2=NN	relType_8=dep	pos_5=,	lemma_10=,	path1=	lemma_6=,	relType_7=cc	lib=e.	lemma_9=,	pos_8=NNS	lemma_1=(	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=g.	path2=g._dep>indomethacin_dep	pos_4=,	relType_6=punct	lemma_8=codeine	lemma_8=combination	relType_10=compound	pos_10=NN	path=<inflammatory_ROOT>g._dep>indomethacin_dep	relType_4=punct	lemma_7=codeine	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_5=acetaminophen	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	relType_9=punct	pos_1=-LRB-	pos_6=,	lemma_10=ibuprofen	pos_5=NN	pos_10=,	eib=True	pos_3=NN	lemma_7=and	lemma_6=aspirin	relType_8=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e2	DDI-DrugBank.d367.s9.e3	null	lemma_1=,	path=acetaminophen_conj<g._dep>aspirin_conj	path2=aspirin_conj	eib=False	pos_1=,	lpib=aspirin_NN	wib=aspirin	relType_1=punct	lib=aspirin	path1=acetaminophen_conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e2	DDI-DrugBank.d367.s9.e4	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	pos_1=,	lpib=aspirin_NN	path2=codeine_conj	pos_2=,	wib=aspirin	path=acetaminophen_conj<g._dep>codeine_conj	relType_1=punct	relType_2=conj	lib=aspirin	lemma_2=,	lemma_2=aspirin	path1=acetaminophen_conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e2	DDI-DrugBank.d367.s9.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lpib=aspirin_NN	relType_2=punct	path1=acetaminophen_conj	relType_3=cc	relType_2=conj	path2=codeine_conj	path=acetaminophen_conj<g._dep>codeine_conj	lemma_2=,	lemma_2=aspirin	relType_3=conj	eib=True	pos_3=NN	pos_2=,	lemma_3=and	wib=aspirin	relType_1=punct	lib=aspirin	lemma_3=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e2	DDI-DrugBank.d367.s9.e6	null	relType_4=dep	lemma_1=,	pos_2=NN	pos_3=CC	pos_5=,	pos_1=,	lpib=aspirin_NN	path2=indomethacin_dep>ibuprofen_compound	relType_2=punct	path1=acetaminophen_conj	relType_3=cc	path=acetaminophen_conj<g._dep>indomethacin_dep>ibuprofen_compound	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_2=aspirin	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=combination	eib=True	lemma_4=codeine	pos_3=NN	pos_2=,	lemma_3=and	wib=aspirin	relType_4=conj	relType_1=punct	lib=aspirin	lemma_3=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e2	DDI-DrugBank.d367.s9.e7	null	relType_4=dep	lemma_1=,	pos_2=NN	pos_3=CC	pos_5=,	lemma_6=ibuprofen	path2=indomethacin_dep	lpib=aspirin_NN	pos_1=,	lemma_6=,	relType_2=punct	path1=acetaminophen_conj	relType_3=cc	pos_6=NN	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_2=aspirin	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=combination	pos_6=,	relType_6=compound	eib=True	lemma_4=codeine	pos_3=NN	pos_2=,	path=acetaminophen_conj<g._dep>indomethacin_dep	wib=aspirin	lemma_3=and	relType_4=conj	relType_1=punct	lib=aspirin	lemma_3=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e3	DDI-DrugBank.d367.s9.e4	null	path1=aspirin_conj	lemma_1=,	eib=False	pos_1=,	lpib=codeine_NN	lib=codeine	relType_1=punct	path=aspirin_conj<g._dep>codeine_conj	path2=codeine_conj	wib=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e3	DDI-DrugBank.d367.s9.e5	null	path1=aspirin_conj	lemma_2=and	lemma_1=,	pos_2=NN	eib=True	pos_2=CC	pos_1=,	lpib=codeine_NN	lemma_2=codeine	lib=codeine	relType_1=punct	path=aspirin_conj<g._dep>codeine_conj	relType_2=conj	path2=codeine_conj	wib=codeine	relType_2=cc
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e3	DDI-DrugBank.d367.s9.e6	null	path=aspirin_conj<g._dep>indomethacin_dep>ibuprofen_compound	path1=aspirin_conj	relType_3=dep	lemma_1=,	pos_2=NN	pos_1=,	lib=codeine	relType_2=cc	path2=indomethacin_dep>ibuprofen_compound	lemma_2=and	pos_3=NNS	pos_4=,	lpib=codeine_NN	relType_2=conj	lemma_3=combination	relType_4=punct	relType_3=conj	lemma_4=,	wib=codeine	eib=True	pos_3=NN	pos_2=CC	relType_1=punct	lemma_2=codeine	lemma_3=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e3	DDI-DrugBank.d367.s9.e7	null	path1=aspirin_conj	relType_3=dep	lemma_1=,	pos_2=NN	pos_5=,	path2=indomethacin_dep	pos_1=,	relType_5=compound	lib=codeine	relType_2=cc	lemma_2=and	pos_3=NNS	pos_4=,	lpib=codeine_NN	relType_2=conj	lemma_5=ibuprofen	lemma_3=combination	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	wib=codeine	pos_5=NN	eib=True	pos_3=NN	pos_2=CC	path=aspirin_conj<g._dep>indomethacin_dep	relType_1=punct	lemma_2=codeine	lemma_3=codeine
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e4	DDI-DrugBank.d367.s9.e5	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	wib=codeine	lpib=codeine_NN	lib=codeine	path2=codeine_conj	path1=codeine_conj	path=codeine_conj<g._dep>codeine_conj
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e4	DDI-DrugBank.d367.s9.e6	null	relType_1=cc	pos_1=CC	pos_2=NN	lemma_2=combination	lib=codeine	path=codeine_conj<g._dep>indomethacin_dep>ibuprofen_compound	path2=indomethacin_dep>ibuprofen_compound	lpib=codeine_NN	relType_2=conj	relType_2=dep	lemma_3=,	wib=codeine	path1=codeine_conj	pos_2=NNS	pos_3=,	eib=True	lemma_2=codeine	relType_3=punct	lemma_1=and
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e4	DDI-DrugBank.d367.s9.e7	null	relType_1=cc	pos_1=CC	pos_2=NN	path2=indomethacin_dep	lemma_2=combination	lib=codeine	pos_4=,	path=codeine_conj<g._dep>indomethacin_dep	lpib=codeine_NN	relType_2=conj	pos_4=NN	relType_2=dep	relType_4=punct	lemma_3=,	relType_4=compound	lemma_4=ibuprofen	lemma_4=,	wib=codeine	path1=codeine_conj	pos_2=NNS	pos_3=,	eib=True	lemma_2=codeine	relType_3=punct	lemma_1=and
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e5	DDI-DrugBank.d367.s9.e6	null	lpib=combination_NNS	lemma_1=combination	pos_1=NNS	path2=indomethacin_dep>ibuprofen_compound	eib=False	lemma_2=,	relType_1=dep	pos_2=,	wib=combinations	lib=combination	path=codeine_conj<g._dep>indomethacin_dep>ibuprofen_compound	path1=codeine_conj	relType_2=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e5	DDI-DrugBank.d367.s9.e7	null	path2=indomethacin_dep	relType_2=punct	path=codeine_conj<g._dep>indomethacin_dep	lemma_3=ibuprofen	relType_1=dep	wib=combinations	lib=combination	lemma_2=,	lemma_1=combination	lemma_3=,	path1=codeine_conj	lpib=combination_NNS	pos_1=NNS	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_3=punct
DDI-DrugBank.d367.s9	DDI-DrugBank.d367.s9.e6	DDI-DrugBank.d367.s9.e7	null	path=ibuprofen_compound<indomethacin_dep>	lpib=indomethacin_NN	wib=indomethacin	lemma_1=,	lib=indomethacin	path1=ibuprofen_compound	eib=False	pos_1=,	path2=	relType_1=punct
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e0	DDI-DrugBank.d367.s11.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>erythromycin_conj	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct	path=<antibiotic_ROOT>g._dep>erythromycin_conj
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e0	DDI-DrugBank.d367.s11.e2	null	relType_3=dep	pos_2=NN	path2=g._dep>trimethoprim_conj	pos_5=,	path1=	lib=e.	lemma_1=(	lemma_3=g.	pos_4=,	lemma_5=erythromycin	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	path=<antibiotic_ROOT>g._dep>trimethoprim_conj	relType_1=punct
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e0	DDI-DrugBank.d367.s11.e3	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_1=(	pos_6=NN	path2=g._dep>sulfamethoxazole_conj	relType_6=conj	lemma_3=g.	pos_4=,	path=<antibiotic_ROOT>g._dep>sulfamethoxazole_conj	lemma_5=erythromycin	relType_4=punct	pos_6=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_6=and	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	lemma_6=trimethoprim	relType_1=punct	relType_6=cc
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e0	DDI-DrugBank.d367.s11.e4	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	path2=g._dep>amoxicillin_dep	lib=e.	lemma_1=(	pos_6=NN	relType_6=conj	lemma_3=g.	pos_4=,	path=<antibiotic_ROOT>g._dep>amoxicillin_dep	pos_7=,	lemma_7=,	lemma_5=erythromycin	relType_4=punct	pos_6=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_6=and	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	lemma_7=sulfamethoxazole	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	lemma_6=trimethoprim	relType_1=punct	pos_7=NN	relType_7=conj	relType_6=cc
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e1	DDI-DrugBank.d367.s11.e2	null	lemma_1=,	eib=False	path=erythromycin_conj<g._dep>trimethoprim_conj	pos_1=,	path2=trimethoprim_conj	wib=trimethoprim	lib=trimethoprim	relType_1=punct	path1=erythromycin_conj	lpib=trimethoprim_NN
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e1	DDI-DrugBank.d367.s11.e3	null	lemma_2=and	lemma_1=,	pos_2=NN	path2=sulfamethoxazole_conj	eib=True	path=erythromycin_conj<g._dep>sulfamethoxazole_conj	pos_2=CC	lemma_2=trimethoprim	pos_1=,	wib=trimethoprim	lib=trimethoprim	relType_1=punct	relType_2=cc	relType_2=conj	path1=erythromycin_conj	lpib=trimethoprim_NN
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e1	DDI-DrugBank.d367.s11.e4	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=cc	lpib=trimethoprim_NN	lemma_2=and	lemma_2=trimethoprim	lib=trimethoprim	relType_2=conj	path1=erythromycin_conj	lemma_3=,	relType_3=conj	lemma_3=sulfamethoxazole	wib=trimethoprim	path=erythromycin_conj<g._dep>amoxicillin_dep	pos_3=,	eib=True	pos_3=NN	pos_2=CC	path2=amoxicillin_dep	relType_1=punct	relType_3=punct
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e2	DDI-DrugBank.d367.s11.e3	null	lpib=sulfamethoxazole_NN	relType_1=cc	pos_1=CC	path1=trimethoprim_conj	path2=sulfamethoxazole_conj	path=trimethoprim_conj<g._dep>sulfamethoxazole_conj	eib=False	lib=sulfamethoxazole	wib=sulfamethoxazole	lemma_1=and
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e2	DDI-DrugBank.d367.s11.e4	null	lpib=sulfamethoxazole_NN	relType_1=cc	pos_1=CC	path1=trimethoprim_conj	pos_2=NN	lemma_2=sulfamethoxazole	eib=True	lib=sulfamethoxazole	path=trimethoprim_conj<g._dep>amoxicillin_dep	path2=amoxicillin_dep	pos_2=,	wib=sulfamethoxazole	relType_2=conj	lemma_2=,	lemma_1=and	relType_2=punct
DDI-DrugBank.d367.s11	DDI-DrugBank.d367.s11.e3	DDI-DrugBank.d367.s11.e4	null	lemma_1=,	eib=False	pos_1=,	path2=amoxicillin_dep	path=sulfamethoxazole_conj<g._dep>amoxicillin_dep	wib=amoxicillin	relType_1=punct	lpib=amoxicillin_NNP	path1=sulfamethoxazole_conj	lib=amoxicillin
DDI-DrugBank.d367.s13	DDI-DrugBank.d367.s13.e0	DDI-DrugBank.d367.s13.e1	null	relType_3=dep	path=<antihistamine_ROOT>g._dep>chlorpheniramine_dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>chlorpheniramine_dep	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d367.s15	DDI-DrugBank.d367.s15.e0	DDI-DrugBank.d367.s15.e1	null	lemma_1=,	path2=hydrochlorothiazide_appos	eib=False	wib=hydrochlorothiazide	pos_1=,	path=atenolol_appos<g._dep>hydrochlorothiazide_appos	lib=hydrochlorothiazide	relType_1=punct	lpib=hydrochlorothiazide_NN	path1=atenolol_appos
DDI-DrugBank.d367.s15	DDI-DrugBank.d367.s15.e0	DDI-DrugBank.d367.s15.e2	null	lemma_1=,	pos_2=NN	eib=True	path=atenolol_appos<g._dep>propranolol_appos	lemma_2=hydrochlorothiazide	lemma_2=,	wib=hydrochlorothiazide	path2=propranolol_appos	pos_1=,	pos_2=,	lib=hydrochlorothiazide	relType_1=punct	relType_2=appos	lpib=hydrochlorothiazide_NN	path1=atenolol_appos	relType_2=punct
DDI-DrugBank.d367.s15	DDI-DrugBank.d367.s15.e1	DDI-DrugBank.d367.s15.e2	null	lpib=propranolol_NN	wib=propranolol	lemma_1=,	path1=hydrochlorothiazide_appos	eib=False	path=hydrochlorothiazide_appos<g._dep>propranolol_appos	pos_1=,	path2=propranolol_appos	lib=propranolol	relType_1=punct
DDI-DrugBank.d367.s23	DDI-DrugBank.d367.s23.e0	DDI-DrugBank.d367.s23.e1	null	relType_1=cc	pos_1=CC	lpib=tranquilizer_NNS	eib=False	wib=tranquilizers	path1=	path2=tranquilizer_conj	path=<sedative_ROOT>tranquilizer_conj	lemma_1=and	lib=tranquilizer
DDI-DrugBank.d367.s23	DDI-DrugBank.d367.s23.e0	DDI-DrugBank.d367.s23.e2	null	relType_1=cc	relType_4=dep	pos_1=CC	pos_5=,	path1=	relType_2=punct	lemma_3=e.	lpib=tranquilizer_NNS	pos_2=-LRB-	relType_2=conj	pos_4=NN	wib=tranquilizers	lemma_5=,	relType_5=punct	path=<sedative_ROOT>g._dep>diazepam_dep	lib=tranquilizer	lemma_2=tranquilizer	pos_2=NNS	lemma_4=g.	eib=True	pos_3=NN	relType_3=compound	path2=g._dep>diazepam_dep	lemma_2=(	lemma_1=and
DDI-DrugBank.d367.s23	DDI-DrugBank.d367.s23.e1	DDI-DrugBank.d367.s23.e2	null	relType_3=dep	pos_2=NN	lib=e.	path1=tranquilizer_conj	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=tranquilizer_conj<sedative_ROOT>g._dep>diazepam_dep	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	path2=g._dep>diazepam_dep	relType_1=punct
DDI-DrugBank.d223.s2	DDI-DrugBank.d223.s2.e0	DDI-DrugBank.d223.s2.e1	null	lemma_1=(	eib=False	path1=	path=<antidepressant_nmod>tca_dep	lpib=tca_NNS	wib=TCAs	relType_1=punct	path2=tca_dep	pos_1=-LRB-	lib=tca
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e0	DDI-DrugBank.d223.s7.e1	null	relType_10=punct	relType_3=advmod	relType_7=case	relType_5=cop	path1=	lemma_8=p450	lemma_6=substrate	lemma_1=)	relType_2=cc	relType_9=nmod	pos_8=NN	lemma_2=and	pos_4=WDT	relType_6=conj	pos_10=-LRB-	pos_12=JJ	lemma_12=other	eib=False	pos_5=VBP	lpib=many_JJ	relType_11=amod	relType_12=amod	lib=many	relType_4=nsubj	lemma_5=be	pos_9=NN	wib=many	lemma_9=2d6	pos_1=-RRB-	relType_8=compound	lemma_10=(	lemma_3=many	lemma_11=many	path2=antidepressant_dep	pos_3=JJ	pos_7=IN	lemma_4=that	pos_2=CC	pos_6=NNS	pos_11=JJ	path=<cimetidine_ROOT>antidepressant_dep	relType_1=punct	lemma_7=for
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e0	DDI-DrugBank.d223.s7.e2	null	pos_13=,	relType_10=punct	relType_3=advmod	relType_13=dep	relType_7=case	path2=antidepressant_dep>phenothiazine_conj	relType_5=cop	lemma_13=,	pos_13=NNS	path1=	relType_13=punct	lemma_8=p450	lemma_6=substrate	lemma_1=)	relType_2=cc	relType_9=nmod	pos_8=NN	lemma_2=and	pos_4=WDT	relType_6=conj	pos_10=-LRB-	pos_12=JJ	lemma_12=other	pos_5=VBP	lpib=many_JJ	relType_11=amod	relType_12=amod	lib=many	path=<cimetidine_ROOT>antidepressant_dep>phenothiazine_conj	relType_4=nsubj	lemma_5=be	pos_9=NN	wib=many	lemma_9=2d6	pos_1=-RRB-	relType_8=compound	lemma_10=(	lemma_3=many	lemma_11=many	pos_3=JJ	eib=True	pos_7=IN	lemma_4=that	pos_2=CC	pos_6=NNS	pos_11=JJ	lemma_13=antidepressant	relType_1=punct	lemma_7=for
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e0	DDI-DrugBank.d223.s7.e3	null	pos_13=,	relType_14=punct	relType_10=punct	relType_3=advmod	relType_13=dep	relType_7=case	lemma_13=,	relType_5=cop	pos_13=NNS	path1=	relType_13=punct	pos_16=DT	lemma_8=p450	lemma_17=type	lemma_6=substrate	lemma_1=)	relType_2=cc	relType_9=nmod	relType_16=det	lemma_16=the	pos_8=NN	lemma_2=and	pos_4=WDT	relType_6=conj	pos_10=-LRB-	pos_12=JJ	lemma_12=other	pos_17=NN	pos_5=VBP	lpib=many_JJ	pos_14=,	relType_11=amod	relType_17=nummod	relType_12=amod	relType_17=compound	lib=many	relType_4=nsubj	lemma_5=be	pos_9=NN	lemma_17=1c	wib=many	lemma_9=2d6	pos_1=-RRB-	relType_8=compound	lemma_10=(	lemma_3=many	relType_15=cc	lemma_11=many	lemma_14=phenothiazine	lemma_15=and	pos_17=CD	lemma_14=,	path2=antidepressant_dep>propafenone_conj>antiarrhythmic_dep	pos_3=JJ	eib=True	pos_7=IN	lemma_4=that	pos_2=CC	pos_6=NNS	pos_15=CC	pos_14=NNS	pos_11=JJ	lemma_13=antidepressant	path=<cimetidine_ROOT>antidepressant_dep>propafenone_conj>antiarrhythmic_dep	relType_1=punct	relType_14=conj	lemma_7=for
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e0	DDI-DrugBank.d223.s7.e4	null	pos_13=,	relType_14=punct	relType_10=punct	relType_3=advmod	relType_13=dep	relType_7=case	path=<cimetidine_ROOT>antidepressant_dep>propafenone_conj	relType_5=cop	lemma_13=,	pos_13=NNS	path1=	relType_13=punct	pos_16=DT	lemma_8=p450	lemma_17=type	lemma_6=substrate	lemma_1=)	relType_2=cc	relType_9=nmod	relType_16=det	lemma_16=the	pos_8=NN	lemma_2=and	pos_4=WDT	relType_6=conj	pos_10=-LRB-	pos_12=JJ	lemma_12=other	pos_17=NN	pos_5=VBP	lpib=many_JJ	pos_14=,	relType_11=amod	relType_17=nummod	relType_17=dep	relType_12=amod	relType_17=compound	lib=many	relType_4=nsubj	lemma_5=be	pos_9=NN	lemma_17=1c	path2=antidepressant_dep>propafenone_conj	wib=many	lemma_9=2d6	pos_1=-RRB-	relType_8=compound	lemma_10=(	lemma_3=many	relType_15=cc	lemma_11=many	lemma_14=phenothiazine	lemma_15=and	pos_17=CD	lemma_14=,	pos_3=JJ	pos_17=NNS	eib=True	pos_7=IN	lemma_4=that	pos_2=CC	pos_6=NNS	pos_15=CC	pos_14=NNS	pos_11=JJ	lemma_13=antidepressant	lemma_17=antiarrhythmic	relType_1=punct	relType_14=conj	lemma_7=for
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e0	DDI-DrugBank.d223.s7.e5	null	pos_13=,	relType_14=punct	relType_10=punct	relType_3=advmod	relType_13=dep	relType_7=case	lemma_13=,	relType_5=cop	relType_17=cc	pos_13=NNS	path1=	relType_13=punct	pos_16=DT	lemma_8=p450	lemma_17=type	lemma_6=substrate	lemma_1=)	relType_2=cc	relType_9=nmod	relType_16=det	lemma_16=the	relType_17=conj	pos_8=NN	lemma_2=and	pos_4=WDT	relType_6=conj	pos_10=-LRB-	pos_12=JJ	lemma_12=other	pos_17=NN	pos_5=VBP	lpib=many_JJ	pos_14=,	relType_11=amod	relType_17=nummod	relType_17=dep	relType_12=amod	relType_17=compound	lib=many	path=<cimetidine_ROOT>antidepressant_dep>propafenone_conj>flecainide_conj	relType_4=nsubj	lemma_5=be	pos_9=NN	lemma_17=1c	wib=many	lemma_9=2d6	pos_1=-RRB-	relType_8=compound	lemma_10=(	lemma_3=many	relType_15=cc	lemma_17=and	lemma_11=many	lemma_14=phenothiazine	lemma_15=and	pos_17=CD	lemma_14=,	pos_3=JJ	pos_17=NNS	eib=True	pos_7=IN	lemma_17=propafenone	lemma_4=that	pos_2=CC	pos_6=NNS	pos_15=CC	pos_14=NNS	pos_11=JJ	lemma_13=antidepressant	lemma_17=antiarrhythmic	pos_17=CC	relType_1=punct	path2=antidepressant_dep>propafenone_conj>flecainide_conj	relType_14=conj	lemma_7=for
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e1	DDI-DrugBank.d223.s7.e2	null	lemma_1=,	lib=phenothiazine	eib=False	path=<antidepressant_dep>phenothiazine_conj	path1=	wib=phenothiazines	pos_1=,	relType_1=punct	path2=phenothiazine_conj	lpib=phenothiazine_NNS
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e1	DDI-DrugBank.d223.s7.e3	null	lemma_1=,	pos_3=CC	lemma_2=phenothiazine	path1=	wib=phenothiazines	pos_1=,	relType_5=compound	relType_2=punct	relType_3=cc	pos_5=CD	relType_2=conj	lemma_2=,	lpib=phenothiazine_NNS	path=<antidepressant_dep>propafenone_conj>antiarrhythmic_dep	pos_4=DT	relType_5=nummod	lemma_5=1c	lemma_4=the	lemma_5=type	pos_2=NNS	pos_5=NN	lib=phenothiazine	eib=True	pos_2=,	lemma_3=and	relType_1=punct	relType_4=det	path2=propafenone_conj>antiarrhythmic_dep
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e1	DDI-DrugBank.d223.s7.e4	null	lemma_1=,	pos_3=CC	lemma_2=phenothiazine	path1=	wib=phenothiazines	pos_1=,	relType_5=compound	relType_2=punct	relType_3=cc	pos_5=CD	pos_5=NNS	path2=propafenone_conj	relType_2=conj	relType_5=dep	lemma_2=,	lpib=phenothiazine_NNS	pos_4=DT	relType_5=nummod	lemma_5=1c	lemma_4=the	lemma_5=type	pos_2=NNS	pos_5=NN	lib=phenothiazine	lemma_5=antiarrhythmic	eib=True	pos_2=,	lemma_3=and	relType_1=punct	relType_4=det	path=<antidepressant_dep>propafenone_conj
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e1	DDI-DrugBank.d223.s7.e5	null	lemma_1=,	pos_5=CC	pos_3=CC	lemma_2=phenothiazine	path1=	wib=phenothiazines	pos_1=,	relType_5=compound	relType_2=punct	relType_3=cc	pos_5=CD	relType_5=cc	path2=propafenone_conj>flecainide_conj	pos_5=NNS	relType_2=conj	relType_5=dep	lemma_2=,	lpib=phenothiazine_NNS	pos_4=DT	relType_5=nummod	lemma_5=1c	lemma_4=the	lemma_5=propafenone	lemma_5=type	path=<antidepressant_dep>propafenone_conj>flecainide_conj	relType_5=conj	pos_2=NNS	pos_5=NN	lib=phenothiazine	lemma_5=antiarrhythmic	eib=True	lemma_5=and	pos_2=,	lemma_3=and	relType_1=punct	relType_4=det
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e2	DDI-DrugBank.d223.s7.e3	null	lemma_1=,	pos_1=,	relType_2=cc	lemma_2=and	relType_3=det	pos_4=NN	pos_4=CD	lpib=type_NN	relType_4=compound	lemma_4=1c	relType_4=nummod	lib=type	wib=Type	path=phenothiazine_conj<antidepressant_dep>propafenone_conj>antiarrhythmic_dep	eib=True	pos_3=DT	pos_2=CC	lemma_3=the	relType_1=punct	lemma_4=type	path2=propafenone_conj>antiarrhythmic_dep	path1=phenothiazine_conj
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e2	DDI-DrugBank.d223.s7.e4	null	relType_4=dep	lemma_1=,	pos_1=,	relType_2=cc	lemma_2=and	path=phenothiazine_conj<antidepressant_dep>propafenone_conj	path2=propafenone_conj	relType_3=det	pos_4=NN	pos_4=NNS	pos_4=CD	lpib=type_NN	relType_4=compound	lemma_4=antiarrhythmic	lemma_4=1c	relType_4=nummod	lib=type	wib=Type	eib=True	pos_3=DT	pos_2=CC	lemma_3=the	relType_1=punct	lemma_4=type	path1=phenothiazine_conj
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e2	DDI-DrugBank.d223.s7.e5	null	relType_4=dep	lemma_1=,	pos_1=,	relType_4=cc	relType_2=cc	lemma_2=and	path2=propafenone_conj>flecainide_conj	lemma_4=propafenone	relType_3=det	pos_4=NN	pos_4=NNS	pos_4=CD	lpib=type_NN	relType_4=compound	lemma_4=antiarrhythmic	lemma_4=1c	relType_4=nummod	lib=type	wib=Type	eib=True	pos_3=DT	pos_4=CC	path=phenothiazine_conj<antidepressant_dep>propafenone_conj>flecainide_conj	pos_2=CC	lemma_4=and	lemma_3=the	relType_4=conj	relType_1=punct	lemma_4=type	path1=phenothiazine_conj
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e3	DDI-DrugBank.d223.s7.e4	null	eib=False	path2=	path=antiarrhythmic_dep<propafenone_conj>	path1=antiarrhythmic_dep
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e3	DDI-DrugBank.d223.s7.e5	null	relType_1=cc	pos_1=CC	lib=propafenone	eib=True	path2=flecainide_conj	lpib=propafenone_NN	wib=propafenone	lemma_1=propafenone	path=antiarrhythmic_dep<propafenone_conj>flecainide_conj	relType_1=conj	pos_1=NN	lemma_1=and	path1=antiarrhythmic_dep
DDI-DrugBank.d223.s7	DDI-DrugBank.d223.s7.e4	DDI-DrugBank.d223.s7.e5	null	relType_1=cc	lpib=flecainide_NN	pos_1=CC	eib=False	path2=flecainide_conj	lib=flecainide	path1=	wib=flecainide	lemma_1=and	path=<propafenone_conj>flecainide_conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e1	null	lemma_1=(	lib=ssri	eib=False	path1=	path=<inhibitor_nsubj>ssri_dep	wib=SSRIs	path2=ssri_dep	relType_1=punct	pos_1=-LRB-	lpib=ssri_NNS
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e2	null	lemma_2=)	lemma_2=ssri	path1=	lemma_6=,	path2=g._appos>citalopram_conj	relType_2=punct	lemma_1=(	relType_6=punct	lemma_4=e.	wib=SSRIs	pos_4=NN	lpib=ssri_NNS	relType_2=dep	lemma_3=,	relType_4=compound	path=<inhibitor_nsubj>g._appos>citalopram_conj	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_2=NNS	pos_5=NN	lib=ssri	pos_3=,	eib=True	pos_2=-RRB-	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e3	null	lemma_2=)	lemma_2=ssri	path1=	lemma_6=,	relType_2=punct	lemma_1=(	relType_6=punct	lemma_4=e.	pos_7=,	wib=SSRIs	lemma_7=,	pos_4=NN	lpib=ssri_NNS	lemma_7=citalopram	relType_2=dep	lemma_3=,	relType_4=compound	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_2=NNS	pos_5=NN	lib=ssri	pos_3=,	eib=True	pos_2=-RRB-	path2=g._appos>escitalopram_conj	relType_7=punct	lemma_5=g.	relType_1=punct	pos_7=NN	path=<inhibitor_nsubj>g._appos>escitalopram_conj	relType_3=punct	relType_7=conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e4	null	lemma_2=)	lemma_2=ssri	path1=	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lemma_1=(	pos_8=NN	relType_6=punct	lemma_4=e.	pos_7=,	wib=SSRIs	lemma_7=,	pos_4=NN	lpib=ssri_NNS	lemma_7=citalopram	relType_2=dep	lemma_3=,	relType_4=compound	path=<inhibitor_nsubj>g._appos>fluoxetine_conj	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=g._appos>fluoxetine_conj	pos_2=NNS	pos_5=NN	lemma_8=escitalopram	lib=ssri	pos_3=,	eib=True	pos_2=-RRB-	relType_7=punct	pos_8=,	relType_8=conj	lemma_5=g.	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e5	null	lemma_2=)	lemma_2=ssri	relType_9=conj	path1=	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	lemma_1=(	pos_8=NN	relType_6=punct	lemma_4=e.	pos_7=,	wib=SSRIs	lemma_7=,	pos_9=NN	pos_4=NN	lpib=ssri_NNS	lemma_7=citalopram	relType_2=dep	path=<inhibitor_nsubj>g._appos>sertraline_conj	lemma_3=,	relType_4=compound	path2=g._appos>sertraline_conj	lemma_9=fluoxetine	relType_9=punct	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_2=NNS	pos_5=NN	lemma_8=escitalopram	lib=ssri	pos_3=,	eib=True	pos_2=-RRB-	relType_7=punct	pos_8=,	relType_8=conj	lemma_5=g.	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e0	DDI-DrugBank.d223.s8.e6	null	lemma_2=)	lemma_2=ssri	relType_10=punct	path=<inhibitor_nsubj>g._appos>paroxetine_conj	relType_9=conj	relType_11=cc	lemma_10=,	path1=	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	lemma_1=(	pos_8=NN	relType_10=conj	relType_6=punct	lemma_4=e.	pos_7=,	wib=SSRIs	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	lpib=ssri_NNS	lemma_7=citalopram	relType_2=dep	lemma_3=,	lemma_11=and	relType_4=compound	pos_11=CC	lemma_9=fluoxetine	relType_9=punct	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=g._appos>paroxetine_conj	pos_2=NNS	pos_5=NN	lemma_8=escitalopram	lib=ssri	pos_3=,	eib=True	pos_2=-RRB-	lemma_10=sertraline	pos_10=,	relType_7=punct	pos_8=,	relType_8=conj	lemma_5=g.	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e1	DDI-DrugBank.d223.s8.e2	null	path=ssri_dep<inhibitor_nsubj>g._appos>citalopram_conj	pos_5=,	relType_4=appos	lemma_1=)	lib=e.	path2=g._appos>citalopram_conj	relType_2=punct	lemma_3=e.	eib=False	pos_4=NN	lemma_2=,	lemma_5=,	relType_5=punct	pos_1=-RRB-	lpib=e._NN	wib=e.	lemma_4=g.	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct	path1=ssri_dep
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e1	DDI-DrugBank.d223.s8.e3	null	pos_5=,	relType_4=appos	lemma_6=,	lemma_1=)	lib=e.	relType_2=punct	lemma_3=e.	pos_6=NN	relType_6=conj	relType_6=punct	pos_4=NN	lemma_2=,	lemma_6=citalopram	lemma_5=,	relType_5=punct	pos_1=-RRB-	lpib=e._NN	wib=e.	pos_6=,	lemma_4=g.	eib=True	path2=g._appos>escitalopram_conj	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct	path=ssri_dep<inhibitor_nsubj>g._appos>escitalopram_conj	path1=ssri_dep
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e1	DDI-DrugBank.d223.s8.e4	null	pos_5=,	relType_4=appos	lemma_6=,	lemma_1=)	lib=e.	relType_2=punct	lemma_3=e.	pos_6=NN	relType_6=conj	relType_6=punct	pos_7=,	lemma_7=,	pos_4=NN	lemma_2=,	lemma_6=citalopram	lemma_5=,	relType_5=punct	pos_1=-RRB-	lpib=e._NN	wib=e.	path=ssri_dep<inhibitor_nsubj>g._appos>fluoxetine_conj	pos_6=,	lemma_7=escitalopram	path2=g._appos>fluoxetine_conj	lemma_4=g.	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_3=compound	relType_1=punct	pos_7=NN	relType_7=conj	path1=ssri_dep
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e1	DDI-DrugBank.d223.s8.e5	null	pos_5=,	relType_4=appos	lemma_6=,	relType_8=punct	lemma_1=)	lib=e.	lemma_8=,	relType_2=punct	lemma_3=e.	pos_6=NN	pos_8=NN	relType_6=conj	relType_6=punct	path=ssri_dep<inhibitor_nsubj>g._appos>sertraline_conj	pos_7=,	lemma_7=,	lemma_8=fluoxetine	pos_4=NN	lemma_2=,	lemma_6=citalopram	lemma_5=,	relType_5=punct	pos_1=-RRB-	lpib=e._NN	wib=e.	path2=g._appos>sertraline_conj	pos_6=,	lemma_7=escitalopram	lemma_4=g.	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_3=compound	relType_1=punct	pos_7=NN	relType_7=conj	path1=ssri_dep
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e1	DDI-DrugBank.d223.s8.e6	null	lemma_9=sertraline	relType_9=conj	pos_5=,	relType_4=appos	relType_10=cc	lemma_6=,	relType_8=punct	lemma_1=)	lib=e.	lemma_8=,	lemma_9=,	relType_2=punct	lemma_3=e.	pos_6=NN	pos_8=NN	relType_6=conj	relType_6=punct	pos_10=CC	pos_7=,	lemma_7=,	lemma_8=fluoxetine	pos_4=NN	lemma_2=,	pos_9=NN	lemma_6=citalopram	lemma_10=and	lemma_5=,	relType_5=punct	pos_1=-RRB-	path=ssri_dep<inhibitor_nsubj>g._appos>paroxetine_conj	lpib=e._NN	wib=e.	relType_9=punct	pos_6=,	lemma_7=escitalopram	path2=g._appos>paroxetine_conj	lemma_4=g.	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_3=compound	pos_9=,	relType_1=punct	pos_7=NN	relType_7=conj	path1=ssri_dep
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e2	DDI-DrugBank.d223.s8.e3	null	wib=escitalopram	lemma_1=,	lpib=escitalopram_NN	eib=False	path1=citalopram_conj	lib=escitalopram	pos_1=,	path2=escitalopram_conj	path=citalopram_conj<g._appos>escitalopram_conj	relType_1=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e2	DDI-DrugBank.d223.s8.e4	null	path2=fluoxetine_conj	wib=escitalopram	lemma_1=,	pos_2=NN	lpib=escitalopram_NN	eib=True	lib=escitalopram	path1=citalopram_conj	pos_1=,	pos_2=,	relType_2=conj	relType_1=punct	lemma_2=escitalopram	lemma_2=,	path=citalopram_conj<g._appos>fluoxetine_conj	relType_2=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e2	DDI-DrugBank.d223.s8.e5	null	lemma_1=,	pos_2=NN	lib=escitalopram	path2=sertraline_conj	pos_1=,	lemma_2=escitalopram	relType_2=punct	wib=escitalopram	path1=citalopram_conj	relType_2=conj	lemma_2=,	lemma_3=,	lpib=escitalopram_NN	relType_3=conj	lemma_3=fluoxetine	pos_3=,	eib=True	path=citalopram_conj<g._appos>sertraline_conj	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e2	DDI-DrugBank.d223.s8.e6	null	lemma_1=,	pos_2=NN	pos_5=CC	path=citalopram_conj<g._appos>paroxetine_conj	lib=escitalopram	pos_1=,	lemma_2=escitalopram	relType_2=punct	relType_5=cc	wib=escitalopram	pos_4=,	lemma_4=sertraline	path1=citalopram_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=escitalopram_NN	relType_3=conj	lemma_3=fluoxetine	lemma_4=,	path2=paroxetine_conj	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e3	DDI-DrugBank.d223.s8.e4	null	wib=fluoxetine	path2=fluoxetine_conj	lemma_1=,	lpib=fluoxetine_NN	eib=False	pos_1=,	lib=fluoxetine	relType_1=punct	path1=escitalopram_conj	path=escitalopram_conj<g._appos>fluoxetine_conj
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e3	DDI-DrugBank.d223.s8.e5	null	wib=fluoxetine	path=escitalopram_conj<g._appos>sertraline_conj	lemma_2=fluoxetine	lemma_1=,	lpib=fluoxetine_NN	pos_2=NN	eib=True	path2=sertraline_conj	pos_1=,	pos_2=,	lib=fluoxetine	relType_1=punct	relType_2=conj	path1=escitalopram_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e3	DDI-DrugBank.d223.s8.e6	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	relType_2=punct	lpib=fluoxetine_NN	path=escitalopram_conj<g._appos>paroxetine_conj	relType_2=conj	lemma_2=,	wib=fluoxetine	lemma_2=fluoxetine	lemma_3=,	relType_3=conj	lib=fluoxetine	path2=paroxetine_conj	path1=escitalopram_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	lemma_3=sertraline	relType_3=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e4	DDI-DrugBank.d223.s8.e5	null	lpib=sertraline_NN	lemma_1=,	eib=False	path1=fluoxetine_conj	path2=sertraline_conj	pos_1=,	path=fluoxetine_conj<g._appos>sertraline_conj	lib=sertraline	wib=sertraline	relType_1=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e4	DDI-DrugBank.d223.s8.e6	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_2=sertraline	wib=sertraline	relType_2=punct	relType_3=cc	relType_2=conj	lemma_2=,	lpib=sertraline_NN	path1=fluoxetine_conj	lib=sertraline	path2=paroxetine_conj	path=fluoxetine_conj<g._appos>paroxetine_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d223.s8	DDI-DrugBank.d223.s8.e5	DDI-DrugBank.d223.s8.e6	null	path2=paroxetine_conj	lemma_2=and	lemma_1=,	eib=False	pos_2=CC	pos_1=,	path=sertraline_conj<g._appos>paroxetine_conj	path1=sertraline_conj	lib=paroxetine	lpib=paroxetine_NN	wib=paroxetine	relType_1=punct	relType_2=cc
DDI-DrugBank.d223.s9	DDI-DrugBank.d223.s9.e0	DDI-DrugBank.d223.s9.e1	int	eib=False	lpib=tca_NN	path=ssri_compound<tca_compound>	path1=ssri_compound	wib=TCA	lemma_1=-	path2=	pos_1=HYPH	relType_1=punct	lib=tca
DDI-DrugBank.d223.s9	DDI-DrugBank.d223.s9.e0	DDI-DrugBank.d223.s9.e2	null	pos_2=NN	pos_14=CC	lemma_13=inhibition	relType_10=det	lemma_8=depend	relType_12=case	relType_4=acl:relcl	lemma_3=may	lemma_2=tca	relType_7=aux	pos_1=HYPH	pos_9=IN	pos_16=NNS	lemma_12=of	relType_13=nmod	pos_17=IN	lemma_9=on	pos_18=DT	relType_2=nsubj	lemma_15=the	pos_3=MD	lemma_10=the	lemma_16=pharmacokinetic	pos_7=MD	relType_9=case	lemma_2=interaction	pos_13=NN	pos_15=DT	pos_12=IN	relType_17=case	lib=tca	pos_8=VB	pos_5=JJ	lemma_7=will	relType_5=amod	lpib=tca_NN	relType_2=compound	wib=TCA	lemma_1=-	lemma_6=problem	relType_8=ROOT	lemma_17=of	relType_14=cc	relType_11=obl	path=ssri_compound<tca_compound<interaction_nsubj<pose_acl:relcl<extent_nsubj<depend_ROOT>degree_obl>inhibition_nmod>pharmacokinetic_conj>ssri_nmod	lemma_4=pose	pos_2=NNS	relType_6=obj	pos_11=NN	lemma_5=clinical	eib=True	path2=degree_obl>inhibition_nmod>pharmacokinetic_conj>ssri_nmod	pos_4=VB	pos_6=NNS	lemma_14=and	relType_3=aux	relType_18=det	path1=ssri_compound<tca_compound<interaction_nsubj<pose_acl:relcl<extent_nsubj	relType_1=punct	lemma_11=degree	relType_15=det	relType_16=conj	lemma_18=the	pos_10=DT
DDI-DrugBank.d223.s9	DDI-DrugBank.d223.s9.e1	DDI-DrugBank.d223.s9.e2	null	relType_8=case	relType_4=amod	lemma_6=will	pos_4=JJ	pos_7=VB	path1=tca_compound<interaction_nsubj<pose_acl:relcl<extent_nsubj	pos_17=DT	pos_16=IN	pos_2=MD	lemma_12=inhibition	pos_3=VB	relType_11=case	lemma_10=degree	relType_17=det	relType_3=acl:relcl	eib=False	pos_5=NNS	relType_12=nmod	lemma_7=depend	pos_9=DT	relType_14=det	relType_2=aux	lemma_13=and	pos_10=NN	lemma_14=the	lemma_16=of	pos_8=IN	lib=interaction	lemma_8=on	pos_11=IN	relType_13=cc	path=tca_compound<interaction_nsubj<pose_acl:relcl<extent_nsubj<depend_ROOT>degree_obl>inhibition_nmod>pharmacokinetic_conj>ssri_nmod	relType_7=ROOT	relType_6=aux	lemma_3=pose	relType_1=nsubj	lemma_5=problem	wib=interactions	lemma_1=interaction	lemma_4=clinical	lemma_17=the	pos_6=MD	pos_14=DT	pos_13=CC	relType_16=case	lpib=interaction_NNS	pos_1=NNS	pos_15=NNS	path2=degree_obl>inhibition_nmod>pharmacokinetic_conj>ssri_nmod	lemma_9=the	relType_5=obj	lemma_15=pharmacokinetic	relType_15=conj	lemma_11=of	lemma_2=may	pos_12=NN	relType_10=obl	relType_9=det
DDI-DrugBank.d223.s10	DDI-DrugBank.d223.s10.e0	DDI-DrugBank.d223.s10.e1	advise	pos_2=DT	relType_1=case	pos_3=IN	path1=tca_nmod<administration_obl	path=tca_nmod<administration_obl<indicate_ROOT>any_obl>SSRIs_nmod	lib=ssris	eib=False	lpib=ssris_NNPS	wib=SSRIs	pos_1=IN	pos_4=DT	lemma_4=the	path2=any_obl>SSRIs_nmod	relType_3=case	relType_2=obl	lemma_1=with	lemma_2=any	lemma_3=of	relType_4=det
DDI-DrugBank.d223.s12	DDI-DrugBank.d223.s12.e0	DDI-DrugBank.d223.s12.e1	null	path=antidepressant_nmod<use_nsubj<require_ROOT>dose_obj>prescribe_acl>antidepressant_obl	relType_1=case	relType_7=compound	pos_16=IN	lemma_6=cytochrome	relType_17=cc:preconj	relation_4=adverse	lemma_17=either	relType_9=aux	lemma_5=inhibit	path2=dose_obj>prescribe_acl>antidepressant_obl	pos_3=WDT	relType_5=acl:relcl	pos_6=NN	pos_5=VB	pos_8=NN	pos_18=DT	relType_14=advmod	lemma_18=the	relType_2=nmod	lpib=drug_NNS	relType_11=amod	pos_19=JJ	lib=drug	pos_4=MD	relType_8=obj	pos_1=IN	pos_9=MD	relType_12=obj	pos_13=IN	pos_15=VBN	pos_10=VB	lemma_19=tricyclic	lemma_11=low	relType_10=ROOT	lemma_13=than	relType_13=case	lemma_14=usually	lemma_3=that	pos_14=RB	lemma_15=prescribe	pos_12=NNS	lemma_12=dose	relType_4=aux	lemma_9=may	relType_19=amod	lemma_2=drug	relType_3=nsubj	relType_15=acl	lemma_7=p450	pos_2=NNS	path1=antidepressant_nmod<use_nsubj	lemma_1=with	relType_6=compound	relType_16=case	eib=True	lemma_4=can	wib=drugs	pos_17=CC	relType_18=det	pos_7=NN	lemma_8=2d6	lemma_10=require	lemma_16=for	pos_11=JJR
DDI-DrugBank.d223.s14	DDI-DrugBank.d223.s14.e0	DDI-DrugBank.d223.s14.e1	null	lemma_1=plasma	relType_2=obj	relType_3=advmod	lemma_4=a	relType_1=compound	eib=False	pos_1=NN	wib=plasma	pos_4=DT	lpib=plasma_NN	lib=plasma	lemma_3=whenever	path2=go_advcl>tca_nsubj	lemma_2=level	pos_2=NNS	pos_3=WRB	path=tca_compound<level_obj<monitor_xcomp>go_advcl>tca_nsubj	path1=tca_compound<level_obj	relType_4=det
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e0	DDI-DrugBank.d223.s16.e1	null	path=quinidine_appos<e._appos>inhibitor_appos	path1=quinidine_appos	lemma_1=,	pos_2=NN	lemma_2=serotonin	eib=True	lemma_2=selective	lib=selective	relType_2=compound	relType_2=amod	pos_1=,	relType_1=punct	lemma_2=reuptake	pos_2=JJ	wib=selective	lpib=selective_JJ	path2=inhibitor_appos
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e0	DDI-DrugBank.d223.s16.e2	null	lemma_1=,	pos_2=NN	lib=selective	pos_1=,	pos_2=JJ	wib=selective	path=quinidine_appos<e._appos>SSRIs_dep	relType_2=punct	lemma_2=inhibitor	lemma_2=selective	pos_2=-LRB-	path2=SSRIs_dep	lemma_2=serotonin	relType_2=compound	relType_2=amod	lemma_2=[	relType_2=appos	lpib=selective_JJ	pos_2=NNS	path1=quinidine_appos	eib=True	relType_1=punct	lemma_2=reuptake
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e0	DDI-DrugBank.d223.s16.e3	mechanism	relType_3=dep	lemma_1=,	pos_2=NN	pos_6=VB	relType_7=det	lib=selective	pos_1=,	lemma_10=of	lemma_6=increase	pos_2=JJ	wib=selective	relType_2=punct	lemma_2=inhibitor	pos_8=NN	pos_3=NNPS	lemma_3=SSRIs	lemma_5=may	lemma_2=selective	lemma_9=concentration	pos_4=-RRB-	pos_2=-LRB-	relType_10=case	relType_5=aux	path=quinidine_appos<e._appos<cyp2d6_nmod<inhibitor_nsubj<increase_ROOT>concentration_obj>doxepin_nmod	pos_9=NN	pos_7=DT	lemma_3=]	relType_6=ROOT	pos_5=MD	lemma_2=serotonin	relType_4=punct	relation_10=beneficial	relType_2=compound	relType_2=amod	relType_8=compound	lemma_2=[	relType_9=obj	lemma_8=plasma	lemma_4=)	relType_2=appos	pos_10=IN	lpib=selective_JJ	pos_2=NNS	eib=True	pos_3=-RRB-	path1=quinidine_appos<e._appos<cyp2d6_nmod<inhibitor_nsubj	path2=concentration_obj>doxepin_nmod	lemma_7=the	relType_1=punct	lemma_2=reuptake	relType_3=punct
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e1	DDI-DrugBank.d223.s16.e2	null	lib=ssris	eib=False	path=inhibitor_appos<e._appos>SSRIs_dep	lpib=ssris_NNPS	pos_1=-LRB-	wib=SSRIs	path1=inhibitor_appos	lemma_1=[	relType_1=punct	path2=SSRIs_dep
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e1	DDI-DrugBank.d223.s16.e3	mechanism	lemma_8=concentration	relType_7=compound	relation_5=beneficial	pos_6=DT	pos_7=NN	pos_9=IN	lemma_4=may	lemma_5=increase	relType_2=punct	pos_8=NN	pos_5=VB	lib=ssris	lemma_6=the	lpib=ssris_NNPS	pos_2=NNPS	pos_4=MD	relType_8=obj	wib=SSRIs	lemma_7=plasma	relType_9=case	relType_2=dep	lemma_2=]	relType_4=aux	lemma_1=[	path1=inhibitor_appos<e._appos<cyp2d6_nmod<inhibitor_nsubj	lemma_3=)	pos_1=-LRB-	relType_6=det	eib=True	pos_2=-RRB-	pos_3=-RRB-	lemma_9=of	path=inhibitor_appos<e._appos<cyp2d6_nmod<inhibitor_nsubj<increase_ROOT>concentration_obj>doxepin_nmod	path2=concentration_obj>doxepin_nmod	relType_1=punct	relType_5=ROOT	lemma_2=SSRIs	relType_3=punct
DDI-DrugBank.d223.s16	DDI-DrugBank.d223.s16.e2	DDI-DrugBank.d223.s16.e3	mechanism	path=SSRIs_dep<e._appos<cyp2d6_nmod<inhibitor_nsubj<increase_ROOT>concentration_obj>doxepin_nmod	lemma_2=)	relType_8=case	relation_3=beneficial	lemma_3=may	relType_2=punct	pos_6=NN	lemma_6=plasma	eib=False	lemma_7=concentration	relType_7=obj	lemma_1=]	pos_3=MD	lemma_4=increase	lib=increase	pos_8=IN	pos_1=-RRB-	relType_5=det	path1=SSRIs_dep<e._appos<cyp2d6_nmod<inhibitor_nsubj	wib=increase	relType_4=ROOT	relType_6=compound	lemma_5=the	lpib=increase_VB	pos_2=-RRB-	pos_4=VB	pos_5=DT	path2=concentration_obj>doxepin_nmod	relType_3=aux	relType_1=punct	pos_7=NN	lemma_8=of
DDI-DrugBank.d223.s19	DDI-DrugBank.d223.s19.e0	DDI-DrugBank.d223.s19.e1	null	lemma_17=drug	lemma_15=of	pos_5=CC	relType_9=aux:pass	lemma_13=concomitant	lemma_8=have	path1=	lemma_10=report	lemma_14=use	lemma_19=mao	pos_8=VBP	lemma_7=death	pos_2=JJ	relType_12=det	relType_11=case	relType_10=parataxis	relType_18=case	path=<inhibitor_ROOT>report_parataxis>use_obl>inhibitor_nmod	lib=serious	lemma_16=certain	relType_5=cc	relType_16=amod	path2=report_parataxis>use_obl>inhibitor_nmod	relType_13=amod	lpib=serious_JJ	lemma_6=even	relType_4=nsubj:pass	pos_19=NN	pos_14=NN	pos_9=VBN	relType_14=obl	pos_18=IN	pos_4=NNS	lemma_1=:	lemma_12=the	relation_3=neutral	relType_19=compound	relType_15=case	pos_16=JJ	pos_13=JJ	wib=Serious	relType_2=amod	pos_1=:	pos_11=VBG	lemma_9=be	pos_6=RB	relType_17=nmod	pos_15=IN	lemma_18=with	lemma_11=follow	lemma_2=serious	lemma_4=effect	pos_17=NNS	eib=True	lemma_5=and	pos_3=NN	pos_10=VBN	relType_8=aux	relType_3=compound	pos_12=DT	relType_1=punct	pos_7=NN	lemma_3=side	relType_6=advmod	relType_7=conj
DDI-DrugBank.d223.s20	DDI-DrugBank.d223.s20.e0	DDI-DrugBank.d223.s20.e1	advise	pos_7=NNS	relType_8=case	relType_5=obl:npmod	lemma_8=prior	lemma_11=cautious	relType_1=aux	relType_10=det	pos_3=VBN	path=inhibitor_nsubj:pass<discontinue_ROOT>week_obj>initiation_nmod>therapy_nmod>SINEQUAN_nmod	pos_6=CD	lemma_4=at	pos_9=IN	lemma_1=should	path2=week_obj>initiation_nmod>therapy_nmod>SINEQUAN_nmod	path1=inhibitor_nsubj:pass	relType_14=nmod	wib=be	pos_8=JJ	lemma_13=of	lemma_7=week	lemma_15=with	eib=False	relType_11=amod	relType_7=obj	relType_12=nmod	lemma_10=the	lemma_9=to	pos_2=VB	lemma_5=least	relType_9=case	pos_13=IN	pos_14=NN	relType_13=case	relType_15=case	lib=be	relType_3=ROOT	lemma_12=initiation	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_6=nummod	pos_1=MD	lpib=be_VB	pos_15=IN	lemma_3=discontinue	pos_5=RBS	pos_10=DT	lemma_2=be	pos_11=JJ	lemma_14=therapy	pos_12=NN	lemma_6=two
DDI-DrugBank.d223.s22	DDI-DrugBank.d223.s22.e0	DDI-DrugBank.d223.s22.e1	null	eib=False	path=<cimetidine_ROOT>report_appos>cimetidine_nsubj:pass	path1=	path2=report_appos>cimetidine_nsubj:pass	pos_1=:	relType_1=punct	lib=cimetidine	wib=Cimetidine	lpib=cimetidine_NN	lemma_1=:
DDI-DrugBank.d223.s22	DDI-DrugBank.d223.s22.e0	DDI-DrugBank.d223.s22.e2	null	pos_14=NN	pos_2=NN	pos_6=VB	relType_8=amod	lemma_2=have	relType_4=appos	pos_3=VBN	pos_16=IN	path1=	relType_18=amod	relType_14=compound	pos_17=JJ	relType_3=aux:pass	wib=Cimetidine	lpib=cimetidine_NN	path=<cimetidine_ROOT>report_appos>produce_xcomp>concentration_obl>antidepressant_nmod	relation_6=neutral	lemma_14=serum	pos_8=JJ	relType_5=mark	path2=report_appos>produce_xcomp>concentration_obl>antidepressant_nmod	pos_7=RB	lemma_15=concentration	relType_11=amod	lemma_18=tricyclic	pos_9=NNS	pos_18=JJ	relType_2=aux	relType_10=case	relType_12=punct	pos_13=NN	relType_2=nsubj:pass	pos_5=TO	lemma_12=-	lemma_1=:	pos_4=VBN	lemma_7=clinically	lemma_16=of	lemma_8=significant	relType_13=compound	lemma_10=in	relType_15=obl	lemma_3=be	pos_1=:	lemma_4=report	relType_9=obj	lemma_13=state	lemma_5=to	pos_10=IN	lib=cimetidine	lemma_6=produce	relType_17=amod	pos_2=VBZ	lemma_9=fluctuation	relType_16=case	pos_15=NNS	lemma_17=various	eib=True	pos_12=HYPH	pos_11=JJ	relType_7=advmod	relType_1=punct	lemma_11=steady	lemma_2=cimetidine	relType_6=xcomp
DDI-DrugBank.d223.s22	DDI-DrugBank.d223.s22.e1	DDI-DrugBank.d223.s22.e2	mechanism	relType_4=mark	pos_2=VBN	lemma_15=of	lpib=have_VBZ	relType_1=aux	relType_5=xcomp	pos_3=VBN	relType_10=amod	lemma_12=state	pos_9=IN	lemma_17=tricyclic	lemma_11=-	pos_17=JJ	lemma_9=in	pos_8=NNS	pos_11=HYPH	lemma_14=concentration	path1=cimetidine_nsubj:pass	pos_5=VB	relType_16=amod	relType_12=compound	relType_3=appos	relType_11=punct	path=cimetidine_nsubj:pass<report_appos>produce_xcomp>concentration_obl>antidepressant_nmod	lemma_3=report	relType_8=obj	lemma_1=have	relType_9=case	pos_13=NN	relType_14=obl	lib=have	relType_15=case	pos_16=JJ	relType_7=amod	relType_13=compound	lemma_7=significant	lemma_4=to	pos_10=JJ	path2=produce_xcomp>concentration_obl>antidepressant_nmod	relType_2=aux:pass	pos_6=RB	lemma_10=steady	pos_4=TO	relType_17=amod	pos_15=IN	lemma_13=serum	lemma_6=clinically	lemma_5=produce	pos_1=VBZ	eib=True	pos_7=JJ	pos_14=NNS	lemma_2=be	relation_4=neutral	lemma_16=various	pos_12=NN	wib=has	lemma_8=fluctuation	relType_6=advmod
DDI-DrugBank.d223.s23	DDI-DrugBank.d223.s23.e0	DDI-DrugBank.d223.s23.e1	effect	eib=False	path2=initiate_advcl>therapy_nsubj:pass>cimetidine_compound	lemma_1=when	path1=antidepressant_nmod<level_nmod<elevation_obl	path=antidepressant_nmod<level_nmod<elevation_obl<associate_ROOT>initiate_advcl>therapy_nsubj:pass>cimetidine_compound	pos_1=WRB	lib=cimetidine	wib=cimetidine	lpib=cimetidine_NN	relType_1=advmod
DDI-DrugBank.d223.s25	DDI-DrugBank.d223.s25.e0	DDI-DrugBank.d223.s25.e1	null	pos_1=VBG	eib=False	wib=receiving	path=<antidepressant_obl>receive_acl>therapy_obj>cimetidine_compound	path1=	lib=receive	relType_1=acl	relType_2=amod	lpib=receive_VBG	lemma_2=concurrent	path2=receive_acl>therapy_obj>cimetidine_compound	lemma_1=receive	pos_2=JJ
DDI-DrugBank.d223.s25	DDI-DrugBank.d223.s25.e0	DDI-DrugBank.d223.s25.e2	null	lemma_5=discontinuation	wib=receiving	path1=	lib=receive	lpib=receive_VBG	lemma_6=of	pos_2=JJ	relType_6=case	pos_4=,	path=<antidepressant_obl>receive_acl>therapy_obj>discontinuation_appos>cimetidine_nmod	pos_6=IN	lemma_3=therapy	relType_4=punct	path2=receive_acl>therapy_obj>discontinuation_appos>cimetidine_nmod	relType_1=acl	relType_2=amod	lemma_2=concurrent	lemma_4=,	relType_5=appos	lemma_1=receive	pos_1=VBG	pos_5=NN	eib=True	pos_3=NN	relType_3=obj	relType_3=compound	lemma_3=cimetidine
DDI-DrugBank.d223.s25	DDI-DrugBank.d223.s25.e1	DDI-DrugBank.d223.s25.e2	null	path2=discontinuation_appos>cimetidine_nmod	path1=cimetidine_compound	lpib=therapy_NN	relType_2=punct	path=cimetidine_compound<therapy_obj>discontinuation_appos>cimetidine_nmod	eib=False	relType_3=appos	lemma_1=therapy	lemma_2=,	pos_1=NN	pos_4=IN	relType_4=case	relType_1=obj	lib=therapy	lemma_3=discontinuation	pos_3=NN	pos_2=,	lemma_4=of	wib=therapy
DDI-DrugBank.d223.s26	DDI-DrugBank.d223.s26.e0	DDI-DrugBank.d223.s26.e1	null	lemma_5=bear	lemma_4=be	path1=	relType_5=parataxis	lemma_3=should	relType_6=case	path=<alcohol_ROOT>bear_parataxis>increase_ccomp>ingestion_nsubj>alcohol_compound	wib=be	eib=False	pos_6=IN	pos_3=MD	lemma_2=it	lemma_6=in	relType_2=nsubj:pass	lemma_1=:	pos_8=IN	lib=be	relType_8=mark	pos_1=:	relType_4=aux:pass	pos_2=PRP	lpib=be_VB	path2=bear_parataxis>increase_ccomp>ingestion_nsubj>alcohol_compound	lemma_7=mind	relType_7=obl	pos_4=VB	relType_3=aux	relType_1=punct	pos_7=NN	lemma_8=that	pos_5=VBN
DDI-DrugBank.d223.s26	DDI-DrugBank.d223.s26.e0	DDI-DrugBank.d223.s26.e2	null	lemma_5=bear	lemma_18=or	relType_14=amod	lemma_16=any	lemma_4=be	lemma_19=unintentional	path1=	pos_16=DT	relType_5=parataxis	pos_17=JJ	lemma_3=should	relType_6=case	relType_12=det	relType_16=det	lemma_17=intentional	relType_18=cc	wib=be	path=<alcohol_ROOT>bear_parataxis>increase_ccomp>danger_obj>inherent_amod>overdosage_obl>SINEQUAN_compound	pos_10=MD	relType_9=compound	relType_10=aux	pos_6=IN	pos_3=MD	pos_19=JJ	lemma_2=it	pos_18=CC	lemma_6=in	pos_13=NN	relType_2=nsubj:pass	pos_9=NN	lemma_13=danger	lemma_1=:	pos_8=IN	lemma_12=the	relType_15=case	lib=be	relType_8=mark	pos_1=:	relType_4=aux:pass	path2=bear_parataxis>increase_ccomp>danger_obj>inherent_amod>overdosage_obl>SINEQUAN_compound	pos_2=PRP	lemma_9=alcohol	relType_19=conj	lpib=be_VB	relType_17=amod	pos_15=IN	lemma_11=increase	lemma_15=in	lemma_7=mind	relType_7=obl	lemma_10=may	eib=True	relType_9=nsubj	pos_11=VB	pos_4=VB	pos_14=JJ	relType_3=aux	pos_12=DT	relType_11=ccomp	relType_13=obj	relType_1=punct	pos_7=NN	lemma_8=that	relation_11=beneficial	pos_5=VBN	lemma_9=ingestion	lemma_14=inherent
DDI-DrugBank.d223.s26	DDI-DrugBank.d223.s26.e1	DDI-DrugBank.d223.s26.e2	mechanism	lib=ingestion	lemma_3=increase	pos_6=JJ	pos_8=DT	relType_7=case	pos_2=MD	relType_10=cc	path1=alcohol_compound<ingestion_nsubj	pos_3=VB	relType_11=conj	path=alcohol_compound<ingestion_nsubj<increase_ccomp>danger_obj>inherent_amod>overdosage_obl>SINEQUAN_compound	pos_9=JJ	eib=False	lemma_8=any	relType_6=amod	pos_10=CC	relType_2=aux	relType_9=amod	pos_1=NN	path2=danger_obj>inherent_amod>overdosage_obl>SINEQUAN_compound	pos_4=DT	lemma_11=unintentional	lemma_6=inherent	wib=ingestion	lemma_4=the	relType_1=nsubj	lemma_1=ingestion	lemma_10=or	pos_5=NN	lemma_9=intentional	relType_3=ccomp	pos_7=IN	lemma_7=in	relType_5=obj	lemma_5=danger	lemma_2=may	pos_11=JJ	relType_8=det	relType_4=det	lpib=ingestion_NN	relation_2=beneficial
DDI-DrugBank.d223.s28	DDI-DrugBank.d223.s28.e0	DDI-DrugBank.d223.s28.e1	null	relType_9=parataxis	pos_2=DT	path2=report_parataxis>patient_obl>maintain_amod>tolazamide_obl	relType_14=amod	pos_7=VBZ	pos_13=CD	pos_8=VBN	lemma_11=a	lemma_12=type	path1=	relType_7=aux	relType_3=nsubj:pass	lemma_2=a	lib=case	pos_6=NN	relType_16=amod	lemma_6=hypoglycemia	lemma_3=case	pos_17=IN	relType_12=compound	eib=False	relType_8=aux:pass	relType_13=nummod	pos_12=NN	relType_10=case	pos_9=VBN	lemma_15=patient	lemma_1=:	path=<Tolazamide_ROOT>report_parataxis>patient_obl>maintain_amod>tolazamide_obl	lemma_7=have	relType_6=nmod	relType_17=case	lemma_16=maintain	pos_5=JJ	pos_16=VBN	relType_15=obl	relType_5=amod	lemma_10=in	lemma_8=be	pos_15=NN	lemma_14=diabetic	pos_4=IN	pos_1=:	relType_4=case	pos_10=IN	pos_11=DT	lemma_13=ii	lemma_17=on	relType_11=det	lemma_5=severe	pos_3=NN	relType_2=det	lemma_9=report	pos_14=JJ	wib=case	lpib=case_NN	relType_1=punct	lemma_4=of
DDI-DrugBank.d223.s28	DDI-DrugBank.d223.s28.e0	DDI-DrugBank.d223.s28.e2	null	relType_14=amod	relType_28=dep	pos_7=VBZ	lemma_27=the	lemma_12=type	pos_24=CD	relType_3=nsubj:pass	path2=report_parataxis>day_obl>addition_dep>doxepin_nmod	relType_22=dep	lemma_18=tolazamide	pos_6=NN	relType_12=compound	pos_20=NN	relType_24=nummod	pos_18=NN	lemma_28=addition	pos_18=-LRB-	pos_16=VBN	relType_15=obl	lemma_20=gm	lemma_10=in	pos_1=:	lemma_17=on	lemma_13=ii	relType_11=det	pos_28=NN	lemma_18=(	pos_26=IN	relType_21=punct	relType_9=parataxis	pos_2=DT	pos_13=CD	pos_8=VBN	pos_22=NN	path1=	pos_29=IN	lib=case	relType_16=amod	lemma_6=hypoglycemia	lemma_21=/	relType_8=aux:pass	pos_25=NNS	lemma_15=patient	lemma_16=maintain	lemma_14=diabetic	lemma_24=11	relType_1=punct	relType_29=case	relType_19=nummod	relType_7=aux	pos_17=IN	pos_21=HYPH	lemma_3=case	relType_18=obl	relType_13=nummod	lemma_1=:	relType_17=case	lemma_7=have	relType_5=amod	pos_4=IN	lemma_23=)	pos_10=IN	lemma_26=after	lemma_22=day	lemma_5=severe	pos_23=-RRB-	pos_14=JJ	wib=case	relType_6=nmod	lemma_4=of	relType_23=punct	lemma_11=a	relType_26=case	lemma_29=of	lemma_2=a	relType_20=dep	pos_27=DT	relType_27=det	pos_19=CD	lemma_19=1	relType_10=case	pos_9=VBN	pos_5=JJ	pos_15=NN	lemma_8=be	relType_18=punct	relType_4=case	pos_11=DT	path=<Tolazamide_ROOT>report_parataxis>day_obl>addition_dep>doxepin_nmod	lemma_25=day	eib=True	pos_3=NN	relType_2=det	lemma_9=report	lpib=case_NN	pos_12=NN	relType_25=obl
DDI-DrugBank.d223.s28	DDI-DrugBank.d223.s28.e1	DDI-DrugBank.d223.s28.e2	effect	relType_3=dep	path=tolazamide_obl<maintain_amod<patient_obl<report_parataxis>day_obl>addition_dep>doxepin_nmod	relType_2=nummod	relType_10=det	relType_12=case	pos_7=CD	pos_9=IN	lemma_9=after	lemma_7=11	pos_4=HYPH	lemma_2=1	pos_8=NNS	relType_8=obl	lemma_12=of	lemma_1=(	eib=False	relType_7=nummod	pos_2=CD	relType_6=punct	lemma_10=the	relType_9=case	path1=tolazamide_obl<maintain_amod<patient_obl	relType_5=dep	lemma_6=)	lemma_11=addition	pos_12=IN	relType_4=punct	lemma_4=/	relType_11=dep	lpib=gm_NN	pos_1=-LRB-	pos_6=-RRB-	pos_5=NN	lemma_5=day	pos_11=NN	wib=gm	pos_3=NN	lemma_3=gm	lib=gm	lemma_8=day	relType_1=punct	path2=day_obl>addition_dep>doxepin_nmod	pos_10=DT
DDI-DrugBank.d44.s1	DDI-DrugBank.d44.s1.e0	DDI-DrugBank.d44.s1.e1	advise	pos_6=JJ	relType_1=aux	path1=raptiva_nsubj:pass	lemma_1=should	pos_3=VB	lemma_4=use	relType_3=aux:pass	relType_5=case	pos_2=RB	relType_2=advmod	relType_6=amod	wib=not	lemma_5=with	path2=drug_obl	pos_4=VBN	relType_7=amod	lemma_3=be	pos_5=IN	lemma_7=immunosuppressive	pos_1=MD	relType_4=ROOT	lib=not	path=raptiva_nsubj:pass<use_ROOT>drug_obl	eib=True	pos_7=JJ	lpib=not_RB	lemma_6=other	lemma_2=not
DDI-DrugBank.d44.s2	DDI-DrugBank.d44.s2.e0	DDI-DrugBank.d44.s2.e2	null	relType_1=cc	pos_1=CC	lemma_1=,	pos_1=VBN	lemma_1=attenuate	path1=	pos_1=,	pos_1=HYPH	lemma_1=live	wib=live	lpib=live_VB	path=<Acellular_nsubj:pass>vaccine_conj	relType_1=dep	path2=vaccine_conj	lemma_1=-	relType_1=conj	eib=True	relType_1=amod	relType_1=punct	pos_1=VB	lemma_1=and	lib=live
DDI-DrugBank.d44.s2	DDI-DrugBank.d44.s2.e0	DDI-DrugBank.d44.s2.e3	advise	relType_1=cc	lemma_2=not	pos_1=CC	lemma_1=,	pos_1=VBN	lemma_1=attenuate	relType_1=aux	lemma_4=administer	path1=Acellular_nsubj:pass	pos_1=,	lemma_1=vaccine	pos_1=HYPH	lemma_1=should	pos_3=VB	relType_3=aux:pass	lemma_1=live	lemma_5=during	relType_5=case	pos_2=RB	wib=live	relType_2=advmod	lpib=live_VB	path2=treatment_obl>raptiva_compound	relType_1=dep	pos_4=VBN	lemma_1=-	lemma_3=be	pos_5=IN	pos_1=MD	relType_1=conj	relType_4=ROOT	pos_1=NNS	eib=True	path=Acellular_nsubj:pass<administer_ROOT>treatment_obl>raptiva_compound	relType_1=amod	relType_1=punct	pos_1=VB	lemma_1=and	lib=live
DDI-DrugBank.d44.s2	DDI-DrugBank.d44.s2.e2	DDI-DrugBank.d44.s2.e3	advise	relType_1=aux	lemma_4=administer	lemma_1=should	pos_3=VB	relType_3=aux:pass	relType_5=case	lemma_5=during	pos_2=RB	eib=False	path=vaccine_conj<Acellular_nsubj:pass<administer_ROOT>treatment_obl>raptiva_compound	relType_2=advmod	path2=treatment_obl>raptiva_compound	wib=not	pos_4=VBN	lemma_3=be	pos_5=IN	path1=vaccine_conj<Acellular_nsubj:pass	pos_1=MD	relType_4=ROOT	lib=not	lpib=not_RB	lemma_2=not
DDI-DrugBank.d531.s1	DDI-DrugBank.d531.s1.e0	DDI-DrugBank.d531.s1.e1	null	lemma_1=(	path2=efavirenz_appos	eib=False	lpib=efavirenz_NN	path1=	pos_1=-LRB-	lib=efavirenz	relType_1=punct	wib=efavirenz	path=<sustiva_obl>efavirenz_appos
DDI-DrugBank.d531.s2	DDI-DrugBank.d531.s2.e0	DDI-DrugBank.d531.s2.e1	null	lemma_13=observe	pos_2=NN	lemma_7=3a4	relType_10=det	pos_5=,	relType_12=case	relation_0=adverse	lemma_1=inhibit	pos_9=IN	pos_13=VBN	path2=range_obl>concentration_nmod>efavirenz_compound	pos_8=NNS	lemma_12=of	path=efavirenz_nsubj<inhibit_ccomp>range_obl>concentration_nmod>efavirenz_compound	path1=efavirenz_nsubj	eib=False	relType_13=amod	lemma_4=2c19	lemma_10=the	lib=inhibit	relType_8=obj	relType_9=case	pos_4=NN	pos_12=IN	lemma_3=,	pos_6=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_6=and	relType_1=ccomp	lemma_8=isozyme	lemma_11=range	relType_11=obl	wib=inhibits	lpib=inhibit_VBZ	pos_11=NN	pos_3=,	pos_1=VBZ	pos_10=DT	relType_4=conj	lemma_2=2c9	pos_7=NN	lemma_9=in	relType_3=punct	relType_7=conj	relType_6=cc
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e0	DDI-DrugBank.d531.s5.e1	null	wib=rifampin	lemma_1=,	path1=phenobarbital_dep	eib=False	lpib=rifampin_NN	path=phenobarbital_dep<rifabutin_appos>rifampin_dep	pos_1=,	lib=rifampin	relType_1=punct	path2=rifampin_dep
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e0	DDI-DrugBank.d531.s5.e2	null	wib=rifampin	lemma_1=,	path1=phenobarbital_dep	pos_2=NN	relType_2=dep	eib=True	path=phenobarbital_dep<rifabutin_appos>	lpib=rifampin_NN	pos_1=,	lemma_2=rifampin	pos_2=,	lib=rifampin	path2=	relType_1=punct	lemma_2=,	relType_2=punct
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e0	DDI-DrugBank.d531.s5.e3	mechanism	wib=rifampin	lemma_1=,	pos_2=NN	pos_1=,	relType_6=acl:relcl	relType_7=mark	relType_11=case	relType_2=punct	lemma_6=expect	pos_5=VB	relType_3=appos	lpib=rifampin_NN	lemma_7=to	pos_4=MD	relType_8=xcomp	pos_9=DT	pos_6=VBN	pos_10=NN	lemma_5=be	relType_10=obj	lemma_2=,	pos_7=TO	relation_9=beneficial	pos_8=VB	pos_11=IN	lemma_8=increase	relType_2=dep	path=phenobarbital_dep<rifabutin_appos<activity_nsubj:pass<expect_acl:relcl>increase_xcomp>clearance_obj>efavirenz_nmod	relType_5=aux:pass	relType_4=aux	lib=rifampin	lemma_3=)	path1=phenobarbital_dep<rifabutin_appos<activity_nsubj:pass	eib=True	pos_3=-RRB-	pos_3=NN	lemma_9=the	lemma_11=of	lemma_2=rifampin	pos_2=,	path2=increase_xcomp>clearance_obj>efavirenz_nmod	relType_1=punct	relType_9=det	lemma_10=clearance	relType_3=punct	lemma_4=would	lemma_3=rifabutin
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e1	DDI-DrugBank.d531.s5.e2	null	lemma_1=,	eib=False	path=rifampin_dep<rifabutin_appos>	pos_1=,	path2=	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	lib=rifabutin	path1=rifampin_dep
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e1	DDI-DrugBank.d531.s5.e3	mechanism	lemma_2=)	pos_7=VB	lemma_1=,	pos_6=TO	pos_2=NN	pos_8=DT	lemma_4=be	pos_1=,	lemma_10=of	lib=rifabutin	lemma_6=to	relType_5=acl:relcl	relType_2=punct	pos_3=MD	lemma_7=increase	lemma_3=would	relType_10=case	pos_9=NN	lemma_9=clearance	relType_7=xcomp	path1=rifampin_dep<rifabutin_appos<activity_nsubj:pass	relType_6=mark	lemma_8=the	relType_9=obj	relType_4=aux:pass	pos_10=IN	lemma_2=rifabutin	relType_2=appos	relation_7=beneficial	lemma_5=expect	eib=True	path=rifampin_dep<rifabutin_appos<activity_nsubj:pass<expect_acl:relcl>increase_xcomp>clearance_obj>efavirenz_nmod	pos_2=-RRB-	pos_4=VB	relType_3=aux	relType_8=det	lpib=rifabutin_NN	wib=rifabutin	path2=increase_xcomp>clearance_obj>efavirenz_nmod	relType_1=punct	pos_5=VBN
DDI-DrugBank.d531.s5	DDI-DrugBank.d531.s5.e2	DDI-DrugBank.d531.s5.e3	mechanism	relation_5=beneficial	pos_6=VB	relType_7=det	pos_2=MD	relType_4=acl:relcl	lemma_6=increase	pos_9=IN	pos_3=VB	lemma_1=)	relType_3=aux:pass	wib=be	pos_8=NN	lemma_2=would	relType_5=mark	eib=False	relType_8=obj	relType_2=aux	relType_9=case	pos_5=TO	pos_7=DT	pos_4=VBN	lib=be	path1=rifabutin_appos<activity_nsubj:pass	pos_1=-RRB-	lemma_3=be	lemma_5=to	lpib=be_VB	lemma_4=expect	lemma_9=of	lemma_7=the	path2=increase_xcomp>clearance_obj>efavirenz_nmod	relType_1=punct	lemma_8=clearance	path=rifabutin_appos<activity_nsubj:pass<expect_acl:relcl>increase_xcomp>clearance_obj>efavirenz_nmod	relType_6=xcomp
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e0	DDI-DrugBank.d531.s10.e1	null	path2=antifungal_dep>Agents_compound>Benzodiazepines_compound	lpib=benzodiazepines_NNPS	eib=False	lib=benzodiazepines	path1=	path=<antihistamine_ROOT>antifungal_dep>Agents_compound>Benzodiazepines_compound	pos_1=:	relType_1=punct	lemma_1=:	wib=Benzodiazepines
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e0	DDI-DrugBank.d531.s10.e2	null	path1=	pos_3=NNP	relType_5=compound	wib=Benzodiazepines	pos_2=NNP	pos_5=AFX	lib=benzodiazepines	pos_2=NNPS	pos_5=HYPH	path=<antihistamine_ROOT>antifungal_dep>migraine_compound	lemma_1=:	lpib=benzodiazepines_NNPS	pos_4=NNPS	relType_2=compound	relType_5=punct	relType_4=compound	pos_1=:	lemma_3=Motility	lemma_4=Agents	path2=antifungal_dep>migraine_compound	lemma_2=Benzodiazepines	lemma_5=anti	eib=True	lemma_2=GI	relType_3=compound	relType_1=punct	lemma_5=-
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e0	DDI-DrugBank.d531.s10.e3	null	path1=	pos_3=NNP	relType_5=compound	wib=Benzodiazepines	pos_2=NNP	pos_5=AFX	lib=benzodiazepines	pos_2=NNPS	pos_5=HYPH	lemma_1=:	lpib=benzodiazepines_NNPS	pos_4=NNPS	relType_2=compound	relType_5=punct	relType_4=compound	pos_1=:	lemma_3=Motility	lemma_4=Agents	lemma_2=Benzodiazepines	lemma_5=migraine	pos_5=NN	lemma_5=anti	eib=True	path=<antihistamine_ROOT>antifungal_dep	lemma_2=GI	relType_3=compound	relType_1=punct	lemma_5=-	path2=antifungal_dep
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e1	DDI-DrugBank.d531.s10.e2	null	lemma_3=Agents	lib=gi	lemma_4=-	pos_4=HYPH	path=Benzodiazepines_compound<Agents_compound<antifungal_dep>migraine_compound	pos_3=NNPS	path1=Benzodiazepines_compound<Agents_compound	relType_1=compound	pos_2=NNP	lemma_4=anti	lemma_1=GI	pos_4=AFX	lemma_2=Motility	relType_4=punct	lpib=gi_NNP	relType_2=compound	relType_4=compound	pos_1=NNP	path2=migraine_compound	eib=True	wib=GI	relType_3=compound
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e1	DDI-DrugBank.d531.s10.e3	null	lemma_3=Agents	lib=gi	lemma_4=-	pos_4=HYPH	pos_3=NNPS	path1=Benzodiazepines_compound<Agents_compound	relType_1=compound	pos_2=NNP	lemma_4=anti	lemma_1=GI	path2=	pos_4=AFX	pos_4=NN	path=Benzodiazepines_compound<Agents_compound<antifungal_dep>	lemma_2=Motility	relType_4=punct	lpib=gi_NNP	relType_2=compound	relType_4=compound	pos_1=NNP	eib=True	wib=GI	relType_3=compound	lemma_4=migraine
DDI-DrugBank.d531.s10	DDI-DrugBank.d531.s10.e2	DDI-DrugBank.d531.s10.e3	null	eib=False	path=migraine_compound<antifungal_dep>	path2=	path1=migraine_compound
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e0	DDI-DrugBank.d531.s11.e1	null	eib=False	path1=astemizole_amod	path2=	path=astemizole_amod<midazolam_nsubj>
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e0	DDI-DrugBank.d531.s11.e2	null	lemma_1=,	eib=True	wib=midazolam	relType_1=nsubj	lpib=midazolam_NN	pos_1=,	lemma_1=midazolam	path=astemizole_amod<midazolam_nsubj>derivative_appos>cisapride_compound>triazolam_compound	relType_1=punct	path1=astemizole_amod	pos_1=NN	path2=derivative_appos>cisapride_compound>triazolam_compound	lib=midazolam
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e0	DDI-DrugBank.d531.s11.e3	null	path=astemizole_amod<midazolam_nsubj>derivative_appos>cisapride_compound	lemma_1=,	pos_2=NN	eib=True	wib=midazolam	relType_2=compound	relType_1=nsubj	lpib=midazolam_NN	pos_1=,	lemma_2=triazolam	lemma_1=midazolam	relType_1=punct	path2=derivative_appos>cisapride_compound	path1=astemizole_amod	pos_1=NN	lib=midazolam
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e0	DDI-DrugBank.d531.s11.e4	null	lemma_1=,	pos_2=NN	wib=midazolam	pos_1=,	lemma_1=midazolam	lib=midazolam	pos_3=NNS	lemma_3=derivative	relType_3=appos	path2=	pos_1=NN	path=astemizole_amod<midazolam_nsubj<voriconazole_ROOT>	relType_2=compound	relType_1=nsubj	lpib=midazolam_NN	lemma_2=triazolam	lemma_2=cisapride	path1=astemizole_amod<midazolam_nsubj	lemma_2=ergot	eib=True	relType_1=punct
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e1	DDI-DrugBank.d531.s11.e2	null	lib=triazolam	lemma_1=,	path=<midazolam_nsubj>derivative_appos>cisapride_compound>triazolam_compound	eib=False	wib=triazolam	path1=	pos_1=,	relType_1=punct	lpib=triazolam_NN	path2=derivative_appos>cisapride_compound>triazolam_compound
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e1	DDI-DrugBank.d531.s11.e3	null	lib=triazolam	lemma_1=,	pos_2=NN	eib=True	wib=triazolam	relType_2=compound	path=<midazolam_nsubj>derivative_appos>cisapride_compound	lemma_2=triazolam	path1=	pos_1=,	relType_1=punct	path2=derivative_appos>cisapride_compound	lpib=triazolam_NN
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e1	DDI-DrugBank.d531.s11.e4	null	lib=triazolam	lemma_1=,	pos_2=NN	pos_3=NNS	eib=True	path=midazolam_nsubj<voriconazole_ROOT>	wib=triazolam	relType_2=compound	lemma_3=derivative	lemma_2=triazolam	lemma_2=cisapride	pos_1=,	relType_3=appos	path1=midazolam_nsubj	path2=	relType_1=punct	lemma_2=ergot	lpib=triazolam_NN
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e2	DDI-DrugBank.d531.s11.e3	null	path=triazolam_compound<cisapride_compound>	eib=False	path2=	path1=triazolam_compound
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e2	DDI-DrugBank.d531.s11.e4	null	lib=cisapride	pos_2=NNS	path=triazolam_compound<cisapride_compound<derivative_appos<midazolam_nsubj<voriconazole_ROOT>	relType_1=compound	path1=triazolam_compound<cisapride_compound<derivative_appos<midazolam_nsubj	eib=True	lemma_1=ergot	wib=cisapride	path2=	lemma_1=cisapride	relType_2=appos	lemma_2=derivative	pos_1=NN	lpib=cisapride_NN
DDI-DrugBank.d531.s11	DDI-DrugBank.d531.s11.e3	DDI-DrugBank.d531.s11.e4	null	pos_2=NNS	path1=cisapride_compound<derivative_appos<midazolam_nsubj	relType_1=compound	eib=False	lemma_1=ergot	path=cisapride_compound<derivative_appos<midazolam_nsubj<voriconazole_ROOT>	path2=	relType_2=appos	lemma_2=derivative	wib=ergot	pos_1=NN	lpib=ergot_NN	lib=ergot
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e0	DDI-DrugBank.d531.s19.e1	null	path2=dose_nsubj>atazanavir_nmod	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	lemma_4=naive	relType_7=det	relType_8=amod	pos_8=VBN	lemma_5=patient	lemma_6=,	lemma_10=of	path1=SUSTIVA_obl<coadminister_advcl	path=SUSTIVA_obl<coadminister_advcl<mg_ROOT>dose_nsubj>atazanavir_nmod	relType_2=obl:npmod	eib=False	pos_5=NNS	relType_6=punct	lemma_3=-	lemma_8=recommend	pos_1=IN	relType_10=case	pos_9=NN	pos_7=DT	relType_5=obl	pos_10=IN	lpib=treatment_NN	pos_6=,	relType_9=nsubj	pos_3=HYPH	wib=treatment	lemma_2=treatment	lemma_7=the	lib=treatment	relType_3=punct	lemma_9=dose
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e0	DDI-DrugBank.d531.s19.e2	null	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	lemma_4=naive	relType_7=det	relType_8=amod	pos_8=VBN	relType_13=ROOT	lemma_14=with	pos_13=NNS	lemma_5=patient	lemma_6=,	lemma_10=of	lemma_11=be	pos_12=CD	path1=SUSTIVA_obl<coadminister_advcl	lemma_13=mg	relType_2=obl:npmod	pos_5=NNS	relType_6=punct	lemma_3=-	lemma_8=recommend	path=SUSTIVA_obl<coadminister_advcl<mg_ROOT>mg_nmod>ritonavir_compound	lemma_12=300	pos_1=IN	path2=mg_nmod>ritonavir_compound	relType_10=case	pos_9=NN	pos_7=DT	relType_11=cop	pos_14=IN	pos_11=VBZ	relType_5=obl	pos_10=IN	lpib=treatment_NN	pos_6=,	pos_11=NN	eib=True	relType_9=nsubj	pos_3=HYPH	lemma_11=atazanavir	wib=treatment	lemma_2=treatment	lemma_7=the	relType_11=nmod	relType_12=nummod	relType_14=case	lib=treatment	relType_3=punct	lemma_9=dose
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e0	DDI-DrugBank.d531.s19.e3	null	relType_4=amod	relType_1=case	pos_4=JJ	lemma_1=in	pos_2=NN	lemma_4=naive	relType_7=det	relType_17=cc	relType_8=amod	pos_8=VBN	relType_13=ROOT	lemma_14=with	pos_13=NNS	lemma_5=patient	lemma_6=,	lemma_10=of	lemma_11=be	pos_12=CD	lemma_15=ritonavir	lemma_15=100	path1=SUSTIVA_obl<coadminister_advcl	lemma_13=mg	pos_15=CD	relType_2=obl:npmod	pos_5=NNS	relType_6=punct	lemma_3=-	lemma_8=recommend	lemma_12=300	pos_1=IN	relType_10=case	lemma_16=mg	pos_9=NN	pos_7=DT	relType_11=cop	pos_14=IN	pos_15=NN	relType_15=nummod	pos_11=VBZ	lemma_17=and	relType_5=obl	pos_10=IN	lpib=treatment_NN	pos_16=NN	pos_6=,	relType_16=nmod	relType_15=compound	path=SUSTIVA_obl<coadminister_advcl<mg_ROOT>mg_nmod>sustiva_conj	pos_11=NN	eib=True	relType_9=nsubj	pos_3=HYPH	lemma_11=atazanavir	wib=treatment	lemma_2=treatment	path2=mg_nmod>sustiva_conj	lemma_7=the	relType_11=nmod	relType_12=nummod	relType_14=case	pos_17=CC	lib=treatment	relType_3=punct	lemma_9=dose
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e1	DDI-DrugBank.d531.s19.e2	null	relType_2=nummod	pos_3=NNS	eib=False	pos_2=CD	lemma_1=be	path1=atazanavir_nmod<dose_nsubj	path2=mg_nmod>ritonavir_compound	lemma_4=with	lib=be	relType_3=ROOT	pos_4=IN	relType_4=case	path=atazanavir_nmod<dose_nsubj<mg_ROOT>mg_nmod>ritonavir_compound	wib=is	relType_1=cop	pos_1=VBZ	lpib=be_VBZ	lemma_3=mg	lemma_2=300
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e1	DDI-DrugBank.d531.s19.e3	null	relType_2=nummod	relType_7=cc	relType_5=compound	pos_6=NN	pos_5=CD	pos_3=NNS	pos_2=CD	lemma_1=be	lemma_5=ritonavir	path1=atazanavir_nmod<dose_nsubj	lemma_6=mg	lemma_4=with	lib=be	relType_3=ROOT	relType_5=nummod	pos_7=CC	pos_4=IN	relType_4=case	wib=is	pos_5=NN	path=atazanavir_nmod<dose_nsubj<mg_ROOT>mg_nmod>sustiva_conj	relType_1=cop	lemma_5=100	pos_1=VBZ	eib=True	lemma_7=and	lpib=be_VBZ	path2=mg_nmod>sustiva_conj	lemma_3=mg	lemma_2=300	relType_6=nmod
DDI-DrugBank.d531.s19	DDI-DrugBank.d531.s19.e2	DDI-DrugBank.d531.s19.e3	null	relType_1=nummod	path2=sustiva_conj	pos_2=NN	lib=mg	pos_1=CD	eib=False	relType_2=nmod	pos_3=CC	lpib=mg_NN	path=ritonavir_compound<mg_nmod>sustiva_conj	wib=mg	lemma_3=and	lemma_2=mg	path1=ritonavir_compound	lemma_1=100	relType_3=cc
DDI-DrugBank.d531.s20	DDI-DrugBank.d531.s20.e0	DDI-DrugBank.d531.s20.e1	null	relType_1=cc	pos_1=CC	lpib=atazanavir_NN	lemma_1=and	eib=False	lib=atazanavir	path2=atazanavir_conj	path1=	wib=atazanavir	path=<SUSTIVA_nmod>atazanavir_conj
DDI-DrugBank.d531.s29	DDI-DrugBank.d531.s29.e0	DDI-DrugBank.d531.s29.e1	effect	relType_1=cc	pos_1=CC	eib=False	lpib=clarithromycin_NN	path1=	lib=clarithromycin	wib=clarithromycin	path=<SUSTIVA_obj>clarithromycin_conj	path2=clarithromycin_conj	lemma_1=and
DDI-DrugBank.d531.s30	DDI-DrugBank.d531.s30.e0	DDI-DrugBank.d531.s30.e1	null	pos_2=VBN	relType_3=advmod	path=SUSTIVA_nmod<adjustment_nsubj:pass<recommend_ROOT>clarithromycin_advcl	relType_1=aux:pass	lemma_4=give	relType_5=case	path1=SUSTIVA_nmod<adjustment_nsubj:pass	path2=clarithromycin_advcl	eib=False	lemma_2=recommend	lemma_1=be	lemma_5=with	pos_4=VBN	lib=be	relType_2=ROOT	relType_4=case	pos_5=IN	wib=is	pos_3=WRB	pos_1=VBZ	lpib=be_VBZ	lemma_3=when
DDI-DrugBank.d531.s31	DDI-DrugBank.d531.s31.e0	DDI-DrugBank.d531.s31.e1	null	lpib=such_JJ	relType_3=fixed	lemma_1=,	relType_2=case	wib=such	pos_3=IN	eib=False	pos_1=,	lemma_3=as	path=clarithromycin_nmod<Alternatives_nsubj:pass>azithromycin_nmod	lib=such	relType_1=punct	pos_2=JJ	lemma_2=such	path2=azithromycin_nmod	path1=clarithromycin_nmod
DDI-DrugBank.d531.s32	DDI-DrugBank.d531.s32.e0	DDI-DrugBank.d531.s32.e1	null	lpib=such_JJ	relType_3=fixed	lemma_1=,	relType_2=case	wib=such	path2=erythromycin_nmod	eib=False	pos_3=IN	path1=	pos_1=,	lib=such	relType_1=punct	path=<antibiotic_nsubj:pass>erythromycin_nmod	pos_2=JJ	lemma_2=such	lemma_3=as
DDI-DrugBank.d531.s32	DDI-DrugBank.d531.s32.e0	DDI-DrugBank.d531.s32.e2	null	lemma_1=,	pos_3=IN	path2=combination_obl>SUSTIVA_nmod	lemma_7=be	pos_8=VBN	pos_1=,	pos_9=IN	relType_4=nmod	pos_2=JJ	lemma_4=erythromycin	lemma_9=in	relType_11=case	lemma_3=as	lemma_5=have	path1=antibiotic_nsubj:pass	relType_3=fixed	lemma_11=with	pos_4=,	pos_5=VBP	relType_9=case	relType_5=aux	pos_10=NN	pos_4=NN	lemma_2=such	pos_11=IN	lpib=such_JJ	lemma_6=not	relType_4=punct	relType_7=aux:pass	path=antibiotic_nsubj:pass<study_ROOT>combination_obl>SUSTIVA_nmod	lemma_4=,	relType_8=ROOT	pos_6=RB	pos_7=VBN	lemma_10=combination	relType_2=case	wib=such	eib=True	lib=such	relType_1=punct	relType_10=obl	relType_6=advmod	lemma_8=study
DDI-DrugBank.d531.s32	DDI-DrugBank.d531.s32.e1	DDI-DrugBank.d531.s32.e2	null	relType_8=case	lemma_1=,	pos_3=RB	relType_3=advmod	lemma_4=be	path2=combination_obl>SUSTIVA_nmod	lemma_2=have	pos_7=NN	pos_1=,	lemma_3=not	relType_6=case	lemma_5=study	eib=False	pos_6=IN	lemma_8=with	relType_2=aux	lemma_6=in	lib=have	path1=erythromycin_nmod<antibiotic_nsubj:pass	pos_4=VBN	pos_8=IN	relType_4=aux:pass	pos_2=VBP	path=erythromycin_nmod<antibiotic_nsubj:pass<study_ROOT>combination_obl>SUSTIVA_nmod	lemma_7=combination	lpib=have_VBP	relType_7=obl	wib=have	relType_1=punct	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d531.s37	DDI-DrugBank.d531.s37.e0	DDI-DrugBank.d531.s37.e1	null	lemma_1=,	pos_3=VBN	pos_1=,	lemma_4=in	relType_6=case	lib=give	lemma_5=combination	eib=False	relType_2=advmod	pos_6=IN	wib=given	path2=know_acl:relcl>combination_obl>SUSTIVA_nmod	pos_4=IN	relType_4=case	lemma_3=give	lemma_6=with	path1=indinavir_nmod	relType_5=obl	pos_2=WRB	relType_3=case	lemma_2=when	pos_5=NN	path=indinavir_nmod<dose_ROOT>know_acl:relcl>combination_obl>SUSTIVA_nmod	relType_1=punct	lpib=give_VBN
DDI-DrugBank.d531.s38	DDI-DrugBank.d531.s38.e0	DDI-DrugBank.d531.s38.e1	null	lemma_3=1000	pos_7=NNS	relType_9=advmod	path=indinavir_compound<dose_obj<increase_nsubj<compensate_ROOT>metabolism_obl>indinavir_compound	pos_6=CD	relType_12=det	pos_13=VBN	lemma_5=every	relType_11=case	pos_2=IN	pos_8=VBZ	eib=False	relType_13=amod	lemma_6=8	lemma_2=to	lemma_9=not	lpib=dose_NN	pos_4=NN	pos_1=NN	pos_10=VB	lemma_12=the	wib=dose	pos_11=IN	relType_10=ROOT	lemma_11=for	relType_4=obl	path1=indinavir_compound<dose_obj<increase_nsubj	pos_3=CD	lemma_4=mg	relType_5=det	relType_7=obl:tmod	relType_6=nummod	pos_9=RB	lib=dose	relType_3=nummod	lemma_10=compensate	lemma_7=hour	lemma_13=increase	relType_2=case	lemma_8=do	pos_5=DT	path2=metabolism_obl>indinavir_compound	relType_8=aux	pos_12=DT	lemma_1=dose	relType_1=obj	relation_12=beneficial
DDI-DrugBank.d531.s38	DDI-DrugBank.d531.s38.e0	DDI-DrugBank.d531.s38.e2	null	lemma_3=1000	pos_7=NNS	relType_9=advmod	pos_16=IN	pos_6=CD	relType_14=compound	lemma_16=to	relType_12=det	pos_13=VBN	lemma_5=every	relType_11=case	pos_2=IN	pos_8=VBZ	lemma_14=metabolism	relType_13=amod	lemma_6=8	lemma_2=to	lemma_9=not	lpib=dose_NN	pos_14=NN	relType_14=obl	pos_4=NN	pos_1=NN	pos_10=VB	lemma_12=the	wib=dose	pos_11=IN	relType_10=ROOT	lemma_11=for	relType_15=case	relType_4=obl	lemma_14=indinavir	path1=indinavir_compound<dose_obj<increase_nsubj	pos_3=CD	lemma_4=mg	relType_5=det	relType_7=obl:tmod	relType_6=nummod	pos_9=RB	lib=dose	relType_3=nummod	lemma_15=due	lemma_10=compensate	lemma_7=hour	lemma_13=increase	pos_15=IN	path=indinavir_compound<dose_obj<increase_nsubj<compensate_ROOT>SUSTIVA_obl	relType_2=case	eib=True	lemma_8=do	pos_5=DT	relType_8=aux	pos_12=DT	lemma_1=dose	relType_1=obj	relType_16=fixed	relation_12=beneficial	path2=SUSTIVA_obl
DDI-DrugBank.d531.s38	DDI-DrugBank.d531.s38.e1	DDI-DrugBank.d531.s38.e2	mechanism	pos_2=IN	relType_3=fixed	relType_2=case	pos_3=IN	lemma_2=due	eib=False	lib=metabolism	path=indinavir_compound<metabolism_obl<compensate_ROOT>SUSTIVA_obl	lemma_3=to	lemma_1=metabolism	lpib=metabolism_NN	path1=indinavir_compound<metabolism_obl	wib=metabolism	pos_1=NN	relType_1=obl	path2=SUSTIVA_obl
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e0	DDI-DrugBank.d531.s39.e1	mechanism	pos_7=NNS	pos_2=DT	relType_1=case	lemma_3=increase	relType_7=appos	pos_8=DT	lemma_13=give	pos_3=VBN	lemma_14=with	relType_13=advcl	pos_6=CD	relType_4=nmod	lemma_2=a	relType_10=dep	pos_13=VBN	relType_9=nummod	relType_12=aux:pass	eib=False	wib=increased	path2=sustiva_obl	relType_11=punct	lemma_11=)	pos_12=VBD	lemma_5=(	lemma_1=at	path1=indinavir_nsubj:pass	pos_1=IN	pos_4=NN	lib=increase	pos_14=IN	lemma_4=dose	lemma_7=mg	relType_3=amod	lemma_12=be	relType_5=punct	relType_6=nummod	lemma_8=every	lemma_6=1000	pos_11=-RRB-	pos_9=CD	lemma_10=hour	relType_2=det	relType_14=case	relType_8=det	pos_5=-LRB-	path=indinavir_nsubj:pass<give_advcl>sustiva_obl	relation_2=beneficial	pos_10=NNS	lemma_9=8	lpib=increase_VBN
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e0	DDI-DrugBank.d531.s39.e2	null	lemma_13=give	path1=indinavir_nsubj:pass<give_advcl	relType_10=dep	relType_19=advmod	pos_13=VBN	relType_9=nummod	pos_18=RB	lemma_1=at	lib=increase	relType_15=obl	relType_3=amod	lemma_22=the	lemma_21=,	pos_11=-RRB-	relType_21=punct	pos_7=NNS	pos_2=DT	relType_1=case	pos_8=DT	relType_4=nmod	lemma_15=sustiva	wib=increased	lemma_11=)	lemma_5=(	pos_1=IN	pos_14=IN	lemma_4=dose	lemma_15=(	relType_6=nummod	relType_16=nummod	lemma_6=1000	lemma_18=once	pos_22=DT	path2=auc_nsubj:pass>indinavir_compound	relType_17=appos	lemma_9=8	lpib=increase_VBN	lemma_3=increase	relType_7=appos	lemma_14=with	path=indinavir_nsubj:pass<give_advcl<decrease_ROOT>auc_nsubj:pass>indinavir_compound	pos_20=-RRB-	pos_15=-LRB-	lemma_19=daily	relType_11=punct	relType_15=punct	pos_16=CD	lemma_20=)	pos_9=CD	pos_17=NNS	relType_22=det	lemma_10=hour	relType_20=punct	relType_14=case	relType_8=det	lemma_16=600	pos_5=-LRB-	pos_3=VBN	relType_13=advcl	pos_6=CD	lemma_2=a	relType_12=aux:pass	pos_21=,	pos_12=VBD	pos_19=RB	pos_4=NN	lemma_7=mg	pos_15=NN	lemma_12=be	relType_5=punct	lemma_8=every	eib=True	relType_18=advmod	relType_2=det	lemma_17=mg	relation_2=beneficial	pos_10=NNS
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e0	DDI-DrugBank.d531.s39.e3	null	pos_39=NN	pos_34=NN	lemma_13=give	relType_32=punct	relType_34=obl	path1=indinavir_nsubj:pass<give_advcl	relType_10=dep	relType_19=advmod	pos_13=VBN	relType_9=nummod	relType_35=cc	lemma_35=and	pos_18=RB	lemma_39=%	lemma_1=at	lib=increase	relType_23=compound	relType_15=obl	relType_41=advmod	relType_3=amod	lemma_22=the	relType_26=aux:pass	lemma_21=,	relType_29=advcl	pos_11=-RRB-	pos_27=VBN	pos_42=,	relType_39=conj	relType_21=punct	pos_30=IN	pos_32=HYPH	relType_37=punct	pos_7=NNS	pos_2=DT	relType_1=case	relType_25=conj	lemma_25=cmin	pos_8=DT	relType_27=ROOT	relType_4=nmod	relType_43=case	lemma_15=sustiva	lemma_32=-	relType_44=mark	pos_24=CC	wib=increased	lemma_11=)	lemma_5=(	pos_36=CD	pos_1=IN	relType_38=nummod	relType_23=nsubj:pass	lemma_43=compare	pos_33=CD	pos_14=IN	lemma_4=dose	lemma_27=decrease	lemma_23=auc	lemma_24=and	lemma_15=(	path=indinavir_nsubj:pass<give_advcl<decrease_ROOT>give_advcl>indinavir_nsubj:pass	relType_6=nummod	relType_16=nummod	lemma_6=1000	lemma_18=once	relation_28=adverse	relType_45=advmod	pos_22=DT	lemma_37=-	lemma_26=be	relType_17=appos	pos_26=VBD	pos_45=WRB	lemma_38=57	pos_31=CD	lemma_9=8	lpib=increase_VBN	lemma_3=increase	pos_29=JJ	relType_7=appos	pos_44=IN	lemma_14=with	lemma_40=,	relType_36=compound	path2=give_advcl>indinavir_nsubj:pass	relType_31=compound	pos_23=NN	pos_20=-RRB-	pos_15=-LRB-	relType_40=punct	lemma_19=daily	relType_11=punct	lemma_31=33	lemma_34=%	relType_15=punct	relType_42=punct	pos_16=CD	lemma_45=when	pos_25=NN	lemma_41=respectively	lemma_36=39	lemma_20=)	pos_40=,	relType_28=case	pos_9=CD	pos_17=NNS	relType_22=det	lemma_10=hour	relType_20=punct	lemma_23=indinavir	relType_14=case	relType_8=det	relType_30=case	lemma_16=600	pos_5=-LRB-	pos_3=VBN	relType_13=advcl	pos_6=CD	lemma_2=a	relType_12=aux:pass	pos_21=,	relType_33=nummod	pos_37=HYPH	lemma_28=on	lemma_42=,	pos_12=VBD	pos_19=RB	relType_24=cc	pos_4=NN	pos_38=CD	relation_2=beneficial	lemma_7=mg	pos_15=NN	pos_35=CC	lemma_12=be	relType_5=punct	lemma_30=by	lemma_8=every	lemma_44=to	eib=True	relType_18=advmod	lemma_29=average	pos_28=IN	relType_2=det	lemma_17=mg	pos_43=VBN	pos_41=RB	pos_10=NNS	lemma_33=46
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e1	DDI-DrugBank.d531.s39.e2	null	relType_2=nummod	pos_8=DT	path=sustiva_obl<give_advcl<decrease_ROOT>auc_nsubj:pass>indinavir_compound	lemma_1=(	pos_4=RB	pos_3=NNS	lib=mg	lemma_4=once	eib=False	relType_3=appos	pos_2=CD	lemma_5=daily	relType_6=punct	pos_7=,	lemma_7=,	lemma_6=)	lpib=mg_NNS	lemma_8=the	relType_4=advmod	lemma_2=600	pos_5=RB	pos_1=-LRB-	relType_5=advmod	pos_6=-RRB-	path2=auc_nsubj:pass>indinavir_compound	path1=sustiva_obl<give_advcl	relType_7=punct	wib=mg	lemma_3=mg	relType_8=det	relType_1=punct
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e1	DDI-DrugBank.d531.s39.e3	null	relType_22=compound	pos_24=CD	relType_31=advmod	relType_21=cc	pos_13=VBN	lemma_11=cmin	pos_3=NNS	lib=mg	relType_28=punct	lemma_5=daily	pos_20=NN	relType_24=nummod	relType_17=compound	lemma_7=,	lemma_10=and	lemma_15=average	lemma_27=respectively	pos_17=CD	pos_1=-LRB-	lemma_14=on	path1=sustiva_obl<give_advcl	lemma_28=,	lemma_31=when	pos_30=IN	relType_25=conj	relType_2=nummod	pos_8=DT	lemma_17=33	relType_9=nsubj:pass	lemma_9=indinavir	pos_9=NN	pos_23=HYPH	pos_31=WRB	pos_14=IN	relType_5=advmod	pos_6=-RRB-	relType_16=case	pos_11=NN	relType_20=obl	relType_1=punct	relType_26=punct	pos_16=IN	relType_29=case	relType_10=cc	relType_19=nummod	relType_11=conj	path2=give_advcl>indinavir_nsubj:pass	lemma_1=(	relType_3=appos	pos_10=CC	pos_7=,	lemma_16=by	lemma_6=)	lemma_20=%	relType_15=advcl	lemma_23=-	lemma_2=600	pos_25=NN	pos_29=VBN	lemma_21=and	path=sustiva_obl<give_advcl<decrease_ROOT>give_advcl>indinavir_nsubj:pass	relType_8=det	relType_14=case	relType_23=punct	pos_15=JJ	relType_13=ROOT	lemma_30=to	lemma_29=compare	relType_30=mark	relType_12=aux:pass	pos_4=RB	pos_22=CD	pos_19=CD	lemma_4=once	relType_9=compound	pos_2=CD	relType_6=punct	pos_12=VBD	pos_18=HYPH	lemma_19=46	pos_27=RB	lemma_18=-	relType_27=advmod	lpib=mg_NNS	pos_28=,	relation_13=adverse	lemma_13=decrease	lemma_12=be	lemma_8=the	relType_4=advmod	pos_5=RB	relType_18=punct	lemma_25=%	pos_21=CC	lemma_24=57	lemma_9=auc	eib=True	relType_7=punct	pos_26=,	wib=mg	lemma_3=mg	lemma_22=39	lemma_26=,
DDI-DrugBank.d531.s39	DDI-DrugBank.d531.s39.e2	DDI-DrugBank.d531.s39.e3	null	lemma_4=be	lemma_11=46	lemma_12=%	lemma_6=on	relType_19=advmod	relType_2=cc	relType_7=advcl	lemma_20=,	lemma_2=and	path1=indinavir_compound<auc_nsubj:pass	lemma_16=57	lemma_13=and	pos_22=IN	lemma_8=by	relType_4=aux:pass	relType_21=case	lemma_1=auc	lemma_5=decrease	pos_7=JJ	relType_5=ROOT	pos_14=CD	pos_15=HYPH	relType_8=case	relation_4=adverse	lemma_19=respectively	relType_6=case	lemma_3=cmin	pos_6=IN	pos_23=WRB	pos_8=IN	lemma_15=-	relType_13=cc	relType_16=nummod	pos_11=CD	pos_21=VBN	relType_10=punct	wib=AUC	path2=give_advcl>indinavir_nsubj:pass	pos_17=NN	lemma_14=39	relType_15=punct	pos_1=NN	lemma_7=average	lpib=auc_NN	relType_11=nummod	pos_16=CD	relType_3=conj	lemma_17=%	pos_13=CC	path=indinavir_compound<auc_nsubj:pass<decrease_ROOT>give_advcl>indinavir_nsubj:pass	pos_4=VBD	pos_9=CD	relType_20=punct	relType_1=nsubj:pass	lemma_23=when	lib=auc	relType_23=advmod	relType_12=obl	relType_14=compound	relType_17=conj	relType_9=compound	eib=False	pos_19=RB	pos_20=,	lemma_10=-	pos_18=,	lemma_22=to	lemma_18=,	pos_10=HYPH	relType_18=punct	relType_22=mark	lemma_9=33	pos_3=NN	lemma_21=compare	pos_2=CC	pos_12=NN	pos_5=VBN
DDI-DrugBank.d531.s40	DDI-DrugBank.d531.s40.e0	DDI-DrugBank.d531.s40.e1	null	wib=ritonavir	path1=lopinavir_compound	eib=False	lib=ritonavir	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/	path=lopinavir_compound<ritonavir_ROOT>	lpib=ritonavir_NN
DDI-DrugBank.d531.s42	DDI-DrugBank.d531.s42.e0	DDI-DrugBank.d531.s42.e1	null	wib=ritonavir	path1=lopinavir_compound	eib=False	lib=ritonavir	path2=	path=lopinavir_compound<ritonavir_nmod>	pos_1=HYPH	relType_1=punct	lemma_1=/	lpib=ritonavir_NN
DDI-DrugBank.d531.s42	DDI-DrugBank.d531.s42.e0	DDI-DrugBank.d531.s42.e2	advise	lemma_14=ml	pos_2=NN	lemma_8=4	path2=recommend_dep>use_advcl>combination_obl>SUSTIVA_nmod	relType_21=aux:pass	lib=ritonavir	pos_21=VBZ	relType_22=dep	pos_7=-LRB-	pos_5=CD	pos_4=SYM	pos_20=NN	pos_26=NN	lemma_6=mg	lemma_5=133	lemma_19=with	wib=ritonavir	lemma_26=combination	path=lopinavir_compound<ritonavir_nmod<increase_nsubj<take_ROOT>recommend_dep>use_advcl>combination_obl>SUSTIVA_nmod	pos_6=NNS	pos_15=-RRB-	lemma_21=be	pos_13=CD	relType_25=case	pos_16=RB	path1=lopinavir_compound<ritonavir_nmod<increase_nsubj	relType_18=ROOT	pos_23=WRB	relType_12=punct	pos_17=RB	relType_5=nummod	pos_24=VBN	lemma_10=or	pos_11=CD	lemma_11=6	relType_19=case	pos_25=IN	relType_3=compound	lemma_16=twice	lemma_27=with	pos_8=CD	relType_1=punct	relType_20=obl	relType_4=dep	relType_10=cc	lemma_3=533	pos_1=HYPH	lpib=ritonavir_NN	pos_2=IN	relType_2=nmod	pos_10=CC	relType_24=advcl	relType_13=nummod	pos_14=NN	relType_9=appos	relType_15=punct	lemma_13=5	relType_16=advmod	lemma_17=daily	relType_11=nummod	lemma_4=/	lemma_1=/	pos_18=VBN	relType_2=case	lemma_12=.	pos_12=HYPH	relType_27=case	relType_6=nmod	lemma_23=when	relType_14=conj	relType_23=advmod	pos_19=IN	lemma_2=ritonavir	lemma_7=(	relType_8=nummod	pos_22=VBN	pos_9=NNS	lemma_2=to	lemma_20=food	pos_27=IN	pos_3=CD	lemma_18=take	lemma_15=)	relType_26=obl	relType_17=advmod	lemma_22=recommend	lemma_24=use	lemma_9=capsule	eib=True	relType_7=punct	lemma_25=in
DDI-DrugBank.d531.s42	DDI-DrugBank.d531.s42.e1	DDI-DrugBank.d531.s42.e2	advise	path2=recommend_dep>use_advcl>combination_obl>SUSTIVA_nmod	pos_12=CD	lemma_20=be	pos_8=NNS	lemma_4=133	relType_18=case	relType_24=case	lib=mg	relType_20=aux:pass	lemma_3=/	pos_13=NN	pos_9=CC	lemma_9=or	pos_24=IN	lemma_5=mg	relType_4=nummod	path1=ritonavir_nmod<increase_nsubj	relType_19=obl	pos_26=IN	pos_20=VBZ	pos_15=RB	lemma_16=daily	relType_3=dep	relType_1=case	lemma_11=.	pos_22=WRB	lemma_26=with	relType_8=appos	pos_3=SYM	lemma_25=combination	pos_23=VBN	pos_16=RB	lemma_2=533	pos_1=IN	relType_13=conj	relType_21=dep	pos_4=CD	lemma_21=recommend	lemma_1=to	lemma_23=use	pos_21=VBN	path=ritonavir_nmod<increase_nsubj<take_ROOT>recommend_dep>use_advcl>combination_obl>SUSTIVA_nmod	lemma_24=in	relType_14=punct	lemma_13=ml	lemma_6=(	pos_17=VBN	relType_7=nummod	pos_14=-RRB-	relType_11=punct	lemma_14=)	pos_18=IN	relType_22=advmod	relType_16=advmod	lemma_12=5	lemma_17=take	lemma_7=4	pos_25=NN	lemma_15=twice	lemma_8=capsule	relType_26=case	pos_7=CD	lemma_22=when	relType_17=ROOT	lemma_10=6	pos_11=HYPH	pos_6=-LRB-	eib=False	pos_2=CD	pos_5=NNS	relType_6=punct	pos_19=NN	lpib=mg_NNS	lemma_19=food	pos_10=CD	relType_2=compound	relType_5=nmod	relType_23=advcl	relType_10=nummod	lemma_18=with	wib=mg	relType_12=nummod	relType_15=advmod	relType_9=cc	relType_25=obl
DDI-DrugBank.d531.s45	DDI-DrugBank.d531.s45.e0	DDI-DrugBank.d531.s45.e1	null	relType_1=cc	path=<methadone_nmod>withdrawal_nmod>opiate_amod	pos_2=NNS	pos_1=CC	pos_3=IN	eib=False	wib=signs	path1=	lemma_3=of	path2=withdrawal_nmod>opiate_amod	lib=sign	relType_2=conj	lpib=sign_NNS	relType_3=case	lemma_1=and	lemma_2=sign
DDI-DrugBank.d531.s50	DDI-DrugBank.d531.s50.e0	DDI-DrugBank.d531.s50.e1	null	lemma_1=(	path2=efavirenz_appos	eib=False	lpib=efavirenz_NN	path1=	path=<SUSTIVA_obl>efavirenz_appos	pos_1=-LRB-	lib=efavirenz	relType_1=punct	wib=efavirenz
DDI-DrugBank.d531.s52	DDI-DrugBank.d531.s52.e0	DDI-DrugBank.d531.s52.e1	advise	lemma_2=oral	lemma_1=with	relType_1=case	lib=oral	path1=efavirenz_nmod	eib=False	path2=contraceptive_nmod	wib=oral	path=efavirenz_nmod<interaction_nsubj:pass>contraceptive_nmod	relType_2=amod	pos_1=IN	lpib=oral_JJ	pos_2=JJ
DDI-DrugBank.d531.s52	DDI-DrugBank.d531.s52.e0	DDI-DrugBank.d531.s52.e2	null	relType_1=case	lib=oral	lemma_15=should	lemma_9=a	pos_21=JJ	relType_10=amod	relType_12=case	pos_15=MD	path1=efavirenz_nmod<interaction_nsubj:pass<characterize_advcl	relType_8=punct	lemma_3=contraceptive	relType_14=nmod	pos_2=JJ	lemma_8=,	relType_16=aux:pass	pos_17=VBN	lemma_14=contraception	lemma_12=of	relType_17=ROOT	path=efavirenz_nmod<interaction_nsubj:pass<characterize_advcl<use_ROOT>addition_obl>contraceptive_nmod	relType_7=advcl	relType_18=case	pos_20=IN	pos_4=RB	relType_20=case	pos_3=NNS	path2=addition_obl>contraceptive_nmod	lemma_11=method	relType_15=aux	pos_16=VB	pos_3=VBZ	relType_21=amod	pos_9=DT	pos_19=NN	pos_1=IN	pos_14=NN	pos_13=NN	lemma_5=be	lemma_16=be	pos_18=IN	pos_12=IN	lemma_21=oral	lemma_4=not	lemma_2=oral	lemma_10=reliable	relType_5=aux:pass	lemma_13=barrier	relType_13=compound	pos_10=JJ	relType_2=amod	relType_4=advmod	relType_3=nmod	lemma_19=addition	lpib=oral_JJ	pos_6=RB	relType_11=nsubj:pass	pos_7=VBN	lemma_1=with	pos_11=NN	relType_19=obl	lemma_6=fully	eib=True	wib=oral	lemma_18=in	lemma_20=to	relType_3=aux	relType_9=det	lemma_3=have	lemma_7=characterize	relType_6=advmod	pos_5=VBN	lemma_17=use	pos_8=,
DDI-DrugBank.d531.s52	DDI-DrugBank.d531.s52.e1	DDI-DrugBank.d531.s52.e2	null	lemma_16=in	lpib=have_VBZ	relType_1=aux	relType_7=det	relType_8=amod	pos_16=IN	pos_3=VBN	lemma_6=,	lemma_10=of	pos_13=MD	relType_3=aux:pass	lemma_15=use	relType_18=case	pos_8=JJ	pos_2=RB	pos_17=NN	pos_4=RB	relType_5=advcl	path2=addition_obl>contraceptive_nmod	eib=False	relType_2=advmod	relType_6=punct	relType_9=nsubj:pass	relType_12=nmod	pos_19=JJ	relType_13=aux	lemma_1=have	path=contraceptive_nmod<interaction_nsubj:pass<characterize_advcl<use_ROOT>addition_obl>contraceptive_nmod	relType_10=case	relType_14=aux:pass	pos_15=VBN	pos_9=NN	lib=have	pos_7=DT	pos_18=IN	lemma_14=be	lemma_17=addition	lemma_13=should	relType_4=advmod	lemma_3=be	pos_14=VB	lemma_18=to	pos_10=IN	relType_19=amod	lemma_19=oral	path1=contraceptive_nmod<interaction_nsubj:pass<characterize_advcl	lemma_9=method	pos_6=,	relType_16=case	pos_11=NN	lemma_11=barrier	pos_1=VBZ	lemma_4=fully	relType_11=compound	lemma_12=contraception	lemma_7=a	relType_15=ROOT	lemma_5=characterize	pos_12=NN	wib=has	pos_5=VBN	relType_17=obl	lemma_2=not	lemma_8=reliable
DDI-DrugBank.d531.s56	DDI-DrugBank.d531.s56.e0	DDI-DrugBank.d531.s56.e1	null	pos_2=IN	pos_3=NNS	eib=False	path=rifabutin_compound<dose_obj>give_acl:relcl>rifabutin_nsubj:pass	lpib=dose_NN	path1=rifabutin_compound	pos_1=NN	wib=dose	relType_4=advmod	lemma_4=where	relType_3=nmod	lib=dose	pos_4=WRB	relType_2=case	lemma_3=regimen	lemma_1=dose	relType_1=obj	lemma_2=in	path2=give_acl:relcl>rifabutin_nsubj:pass
DDI-DrugBank.d531.s63	DDI-DrugBank.d531.s63.e0	DDI-DrugBank.d531.s63.e1	advise	pos_2=VBN	pos_3=IN	relType_1=aux:pass	relType_2=advcl	relType_5=case	lemma_2=use	path=SUSTIVA_nsubj:pass<use_advcl>combination_obl>ritonavir_nmod	eib=False	lemma_1=be	lemma_5=with	pos_4=NN	path1=SUSTIVA_nsubj:pass	relType_4=obl	lib=be	pos_5=IN	lemma_4=combination	relType_3=case	wib=is	pos_1=VBZ	lpib=be_VBZ	path2=combination_obl>ritonavir_nmod	lemma_3=in
DDI-DrugBank.d531.s67	DDI-DrugBank.d531.s67.e0	DDI-DrugBank.d531.s67.e1	null	relType_1=case	lemma_1=in	pos_2=NN	pos_3=IN	relType_3=case	eib=False	path=inhibitor_obl<use_ROOT>combination_obl>SUSTIVA_nmod	path2=combination_obl>SUSTIVA_nmod	lpib=combination_NN	lemma_2=combination	lemma_3=with	pos_1=IN	lib=combination	wib=combination	path1=inhibitor_obl	relType_2=obl
DDI-DrugBank.d531.s72	DDI-DrugBank.d531.s72.e0	DDI-DrugBank.d531.s72.e1	null	path=<anticoagulant_ROOT>Warfarin_dep	lib=warfarin	lpib=warfarin_NNP	eib=False	wib=Warfarin	path1=	pos_1=:	relType_1=punct	path2=Warfarin_dep	lemma_1=:
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e0	DDI-DrugBank.d531.s74.e1	null	lib=phenytoin	eib=False	lpib=phenytoin_NNP	path1=	pos_1=:	path2=Carbamazepine_dep>Phenytoin_compound	wib=Phenytoin	relType_1=punct	path=<anticonvulsant_ROOT>Carbamazepine_dep>Phenytoin_compound	lemma_1=:
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e0	DDI-DrugBank.d531.s74.e2	null	path=<anticonvulsant_ROOT>Carbamazepine_dep>Phenobarbital_compound	lib=phenytoin	eib=True	pos_2=NNP	lpib=phenytoin_NNP	relType_2=compound	path1=	pos_1=:	path2=Carbamazepine_dep>Phenobarbital_compound	wib=Phenytoin	lemma_2=Phenytoin	relType_1=punct	lemma_1=:
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e0	DDI-DrugBank.d531.s74.e3	null	lemma_2=Phenobarbital	path2=Carbamazepine_dep	lib=phenytoin	eib=True	pos_2=NNP	lpib=phenytoin_NNP	relType_2=compound	path1=	pos_1=:	lemma_2=Phenytoin	wib=Phenytoin	relType_1=punct	path=<anticonvulsant_ROOT>Carbamazepine_dep	lemma_1=:
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e1	DDI-DrugBank.d531.s74.e2	null	eib=False	path2=Phenobarbital_compound	path1=Phenytoin_compound	path=Phenytoin_compound<Carbamazepine_dep>Phenobarbital_compound
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e1	DDI-DrugBank.d531.s74.e3	null	lemma_1=Phenobarbital	relType_1=compound	eib=True	path=Phenytoin_compound<Carbamazepine_dep>	lpib=phenobarbital_NNP	path2=	path1=Phenytoin_compound	pos_1=NNP	lib=phenobarbital	wib=Phenobarbital
DDI-DrugBank.d531.s74	DDI-DrugBank.d531.s74.e2	DDI-DrugBank.d531.s74.e3	null	path=Phenobarbital_compound<Carbamazepine_dep>	eib=False	path2=	path1=Phenobarbital_compound
DDI-DrugBank.d531.s75	DDI-DrugBank.d531.s75.e0	DDI-DrugBank.d531.s75.e1	mechanism	relType_1=cc	pos_1=CC	lemma_1=and	lemma_2=/	eib=False	lpib=efavirenz_NN	pos_3=CC	path=<anticonvulsant_nmod>level_conj>plasma_compound>efavirenz_compound	path1=	lib=efavirenz	lemma_3=or	pos_2=HYPH	relType_3=cc	wib=efavirenz	path2=level_conj>plasma_compound>efavirenz_compound	relType_2=punct
DDI-DrugBank.d531.s77	DDI-DrugBank.d531.s77.e0	DDI-DrugBank.d531.s77.e1	null	path2=Ketoconazole_dep>Itraconazole_compound	eib=False	path=<antifungal_ROOT>Ketoconazole_dep>Itraconazole_compound	path1=	lpib=itraconazole_NNP	pos_1=:	lib=itraconazole	wib=Itraconazole	relType_1=punct	lemma_1=:
DDI-DrugBank.d531.s77	DDI-DrugBank.d531.s77.e0	DDI-DrugBank.d531.s77.e2	null	path2=Ketoconazole_dep	path=<antifungal_ROOT>Ketoconazole_dep	eib=True	pos_2=NNP	relType_2=compound	path1=	lpib=itraconazole_NNP	pos_1=:	lib=itraconazole	wib=Itraconazole	relType_1=punct	lemma_2=Itraconazole	lemma_1=:
DDI-DrugBank.d531.s77	DDI-DrugBank.d531.s77.e1	DDI-DrugBank.d531.s77.e2	null	eib=False	path2=	path1=Itraconazole_compound	path=Itraconazole_compound<Ketoconazole_dep>
DDI-DrugBank.d531.s78	DDI-DrugBank.d531.s78.e0	DDI-DrugBank.d531.s78.e1	null	lib=imidazole	relType_1=cc	pos_2=DT	pos_1=CC	relType_2=dep	eib=False	path2=conduct_conj>imidazole_nsubj:pass	lpib=imidazole_NN	path1=	wib=imidazole	path=<SUSTIVA_nmod>conduct_conj>imidazole_nsubj:pass	lemma_1=and	lemma_2=this
DDI-DrugBank.d531.s78	DDI-DrugBank.d531.s78.e0	DDI-DrugBank.d531.s78.e2	null	lib=imidazole	relType_1=cc	pos_2=DT	pos_1=CC	pos_3=CC	path1=	wib=imidazole	relType_3=nsubj:pass	relType_3=cc	path2=conduct_conj>imidazole_nsubj:pass>antifungal_conj	lpib=imidazole_NN	path=<SUSTIVA_nmod>conduct_conj>imidazole_nsubj:pass>antifungal_conj	relType_2=dep	lemma_3=imidazole	lemma_2=this	eib=True	pos_3=NN	lemma_3=and	relType_3=compound	lemma_3=triazole	lemma_1=and
DDI-DrugBank.d531.s78	DDI-DrugBank.d531.s78.e1	DDI-DrugBank.d531.s78.e2	null	relType_1=cc	lemma_1=triazole	pos_1=CC	relType_1=compound	lib=triazole	eib=True	path1=	path=<imidazole_nsubj:pass>antifungal_conj	wib=triazole	path2=antifungal_conj	lpib=triazole_NN	pos_1=NN	lemma_1=and
DDI-DrugBank.d531.s79	DDI-DrugBank.d531.s79.e0	DDI-DrugBank.d531.s79.e1	mechanism	relType_4=mark	pos_7=NNS	pos_2=DT	lemma_3=potential	relType_8=case	lemma_2=the	lpib=have_VBZ	relation_4=adverse	pos_6=NN	pos_5=VB	lemma_6=plasma	eib=False	lemma_7=concentration	lemma_8=of	relType_7=obj	lemma_1=have	lib=have	pos_8=IN	path1=SUSTIVA_nsubj	lemma_4=to	pos_4=TO	path2=decrease_ccomp>concentration_obj>itraconazole_nmod	relType_5=ccomp	relType_1=ROOT	relType_6=compound	pos_3=JJ	pos_1=VBZ	lemma_5=decrease	relType_2=det	relType_3=obj	wib=has	path=SUSTIVA_nsubj<have_ROOT>decrease_ccomp>concentration_obj>itraconazole_nmod
DDI-DrugBank.d531.s79	DDI-DrugBank.d531.s79.e0	DDI-DrugBank.d531.s79.e2	mechanism	relType_4=mark	path2=decrease_ccomp>concentration_obj>itraconazole_nmod>ketoconazole_conj	pos_2=DT	lemma_3=potential	pos_7=NNS	relType_8=case	lemma_2=the	lpib=have_VBZ	relation_4=adverse	relType_9=nmod	lemma_9=itraconazole	pos_6=NN	pos_5=VB	lemma_6=plasma	lemma_7=concentration	lemma_8=of	relType_7=obj	lemma_1=have	pos_9=NN	lib=have	pos_8=IN	path1=SUSTIVA_nsubj	lemma_9=and	pos_9=CC	lemma_4=to	pos_4=TO	relType_5=ccomp	relType_1=ROOT	relType_6=compound	pos_3=JJ	pos_1=VBZ	eib=True	lemma_5=decrease	relType_2=det	relType_3=obj	wib=has	relType_9=cc	path=SUSTIVA_nsubj<have_ROOT>decrease_ccomp>concentration_obj>itraconazole_nmod>ketoconazole_conj
DDI-DrugBank.d531.s79	DDI-DrugBank.d531.s79.e1	DDI-DrugBank.d531.s79.e2	null	relType_1=cc	path2=ketoconazole_conj	pos_1=CC	path=<itraconazole_nmod>ketoconazole_conj	eib=False	path1=	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	lemma_1=and
DDI-DrugBank.d531.s80	DDI-DrugBank.d531.s80.e0	DDI-DrugBank.d531.s80.e1	null	lpib=saquinavir_NN	path=<inhibitor_ROOT>combination_dep>ritonavir_compound>saquinavir_compound	lib=saquinavir	wib=Saquinavir	eib=False	path1=	pos_1=:	relType_1=punct	path2=combination_dep>ritonavir_compound>saquinavir_compound	lemma_1=:
DDI-DrugBank.d531.s80	DDI-DrugBank.d531.s80.e0	DDI-DrugBank.d531.s80.e2	null	lpib=saquinavir_NN	lib=saquinavir	wib=Saquinavir	pos_2=NN	lemma_2=saquinavir	eib=True	path=<inhibitor_ROOT>combination_dep>ritonavir_compound	lemma_2=/	relType_2=compound	path1=	pos_1=:	path2=combination_dep>ritonavir_compound	relType_1=punct	pos_2=HYPH	lemma_1=:	relType_2=punct
DDI-DrugBank.d531.s80	DDI-DrugBank.d531.s80.e1	DDI-DrugBank.d531.s80.e2	null	path1=saquinavir_compound	wib=ritonavir	eib=False	lib=ritonavir	path2=	pos_1=HYPH	path=saquinavir_compound<ritonavir_compound>	relType_1=punct	lemma_1=/	lpib=ritonavir_NN
DDI-DrugBank.d531.s87	DDI-DrugBank.d531.s87.e0	DDI-DrugBank.d531.s87.e1	null	relType_8=case	pos_3=RB	path1=efavirenz_nmod<level_obj	lpib=have_VBZ	relType_3=advmod	lemma_4=be	lemma_2=have	lemma_3=not	relType_5=parataxis	relType_6=case	lemma_5=study	eib=False	pos_6=IN	lemma_8=with	relType_2=aux	lemma_6=in	lib=have	pos_8=IN	pos_4=VBN	pos_1=:	relType_4=aux:pass	lemma_7=combination	pos_2=VBZ	lemma_1=;	relType_7=obl	path=efavirenz_nmod<level_obj<decrease_ROOT>study_parataxis>combination_obl>SUSTIVA_nmod	path2=study_parataxis>combination_obl>SUSTIVA_nmod	relType_1=punct	pos_7=NN	wib=has	pos_5=VBN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e1	null	lemma_1=(	path2=efavirenz_appos	eib=False	lpib=efavirenz_NN	path1=	pos_1=-LRB-	lib=efavirenz	relType_1=punct	wib=efavirenz	path=<SUSTIVA_nsubj:pass>efavirenz_appos
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e2	null	lemma_2=)	pos_2=NN	pos_6=DT	pos_8=:	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	relType_3=aux:pass	relType_2=punct	lemma_1=(	pos_9=HYPH	relType_6=dep	relType_9=compound	lemma_6=the	pos_3=VBZ	lemma_5=with	lemma_9=/	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	path2=with_dep>the_dep>antacid_dep	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_3=be	pos_5=IN	relType_2=appos	relType_9=punct	pos_1=-LRB-	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep	lemma_9=magnesium	relType_7=dep	eib=True	pos_2=-RRB-	lpib=efavirenz_NN	lemma_7=follow	lib=efavirenz	relType_1=punct	relType_4=advcl	lemma_8=:	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e3	null	lemma_2=)	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>azithromycin_conj	pos_2=NN	pos_6=DT	pos_8=:	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	lemma_9=,	relType_3=aux:pass	relType_9=dep	relType_2=punct	lemma_1=(	pos_9=HYPH	relType_6=dep	relType_9=compound	lemma_6=the	pos_9=NNS	pos_3=VBZ	lemma_5=with	lemma_9=/	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	path2=with_dep>the_dep>antacid_dep>azithromycin_conj	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_3=be	pos_5=IN	relType_2=appos	relType_9=punct	lemma_9=antacid	pos_1=-LRB-	lemma_9=magnesium	relType_7=dep	eib=True	pos_2=-RRB-	lpib=efavirenz_NN	lemma_7=follow	lib=efavirenz	pos_9=,	relType_1=punct	relType_4=advcl	lemma_8=:	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e4	null	lemma_2=)	relType_10=punct	pos_2=NN	pos_6=DT	pos_8=:	lemma_10=,	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	lemma_9=,	relType_3=aux:pass	relType_9=dep	relType_2=punct	lemma_1=(	pos_9=HYPH	relType_6=dep	relType_9=compound	relType_10=conj	lemma_6=the	pos_9=NNS	pos_3=VBZ	lemma_5=with	lemma_9=/	pos_10=NN	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_10=azithromycin	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>cetirizine_conj	lemma_3=be	pos_5=IN	relType_2=appos	relType_9=punct	lemma_9=antacid	pos_1=-LRB-	lemma_9=magnesium	relType_7=dep	pos_10=,	eib=True	path2=with_dep>the_dep>antacid_dep>cetirizine_conj	lpib=efavirenz_NN	pos_2=-RRB-	lemma_7=follow	lib=efavirenz	pos_9=,	relType_1=punct	relType_4=advcl	lemma_8=:	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e5	null	lemma_2=)	relType_10=punct	pos_2=NN	pos_6=DT	pos_8=:	lemma_11=,	lemma_10=,	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	lemma_9=,	relType_3=aux:pass	relType_9=dep	relType_11=conj	relType_2=punct	lemma_1=(	pos_9=HYPH	relType_6=dep	relType_9=compound	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>famotidine_conj	relType_10=conj	lemma_6=the	relType_11=punct	pos_9=NNS	pos_3=VBZ	lemma_5=with	lemma_9=/	pos_10=NN	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_11=cetirizine	lemma_10=azithromycin	lemma_3=be	pos_5=IN	relType_2=appos	pos_11=,	relType_9=punct	lemma_9=antacid	pos_1=-LRB-	lemma_9=magnesium	pos_11=NN	relType_7=dep	pos_10=,	eib=True	pos_2=-RRB-	lpib=efavirenz_NN	lemma_7=follow	lib=efavirenz	pos_9=,	relType_1=punct	relType_4=advcl	lemma_8=:	path2=with_dep>the_dep>antacid_dep>famotidine_conj	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e6	null	lemma_2=)	relType_12=conj	relType_10=punct	pos_2=NN	pos_6=DT	pos_8=:	lemma_11=,	path2=with_dep>the_dep>antacid_dep>fluconazole_conj	lemma_10=,	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	lemma_9=,	relType_3=aux:pass	relType_9=dep	relType_11=conj	relType_2=punct	lemma_1=(	lemma_12=,	pos_9=HYPH	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>fluconazole_conj	relType_6=dep	relType_9=compound	relType_10=conj	lemma_6=the	relType_11=punct	pos_9=NNS	pos_3=VBZ	lemma_5=with	lemma_9=/	pos_12=NN	pos_12=,	relType_12=punct	pos_10=NN	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_11=cetirizine	lemma_10=azithromycin	lemma_3=be	pos_5=IN	relType_2=appos	pos_11=,	relType_9=punct	lemma_9=antacid	pos_1=-LRB-	lemma_9=magnesium	pos_11=NN	relType_7=dep	pos_10=,	eib=True	pos_2=-RRB-	lpib=efavirenz_NN	lemma_7=follow	lib=efavirenz	pos_9=,	relType_1=punct	relType_4=advcl	lemma_8=:	lemma_12=famotidine	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e7	null	lemma_2=)	relType_12=conj	pos_13=,	relType_10=punct	pos_2=NN	lemma_13=,	pos_6=DT	pos_8=:	lemma_11=,	lemma_10=,	relType_13=punct	pos_7=VBG	lemma_4=give	relType_8=punct	lemma_9=aluminum	lemma_9=,	relType_3=aux:pass	relType_9=dep	relType_11=conj	relType_2=punct	lemma_13=fluconazole	lemma_1=(	lemma_12=,	pos_9=HYPH	relType_6=dep	relType_9=compound	relType_10=conj	lemma_6=the	relType_11=punct	pos_9=NNS	pos_3=VBZ	lemma_5=with	lemma_9=/	pos_12=NN	pos_12=,	relType_12=punct	relType_13=conj	pos_10=NN	pos_13=NN	relType_5=dep	pos_9=NN	path1=SUSTIVA_nsubj:pass	pos_4=VBN	lemma_9=hydroxide	lemma_2=efavirenz	lemma_11=cetirizine	lemma_10=azithromycin	lemma_3=be	pos_5=IN	relType_2=appos	pos_11=,	relType_9=punct	lemma_9=antacid	pos_1=-LRB-	lemma_9=magnesium	pos_11=NN	relType_7=dep	pos_10=,	eib=True	pos_2=-RRB-	lpib=efavirenz_NN	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>lamivudine_conj	lemma_7=follow	lib=efavirenz	path2=with_dep>the_dep>antacid_dep>lamivudine_conj	pos_9=,	relType_1=punct	relType_4=advcl	lemma_8=:	lemma_12=famotidine	wib=efavirenz
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e8	null	pos_2=NN	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	relType_3=aux:pass	lemma_13=fluconazole	lemma_12=,	pos_9=HYPH	relType_6=dep	pos_12=,	pos_3=VBZ	pos_10=NN	pos_13=NN	relType_5=dep	lemma_3=be	pos_1=-LRB-	pos_10=,	lib=efavirenz	wib=efavirenz	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>lorazepam_conj	pos_13=,	relType_2=punct	relType_10=conj	relType_12=punct	relType_13=conj	pos_9=NN	pos_4=VBN	pos_5=IN	lemma_14=,	lemma_9=magnesium	pos_11=NN	relType_7=dep	lpib=efavirenz_NN	lemma_7=follow	pos_9=,	relType_1=punct	lemma_8=:	relType_14=punct	relType_10=punct	pos_6=DT	lemma_11=,	pos_7=VBG	lemma_4=give	relType_11=conj	lemma_1=(	lemma_6=the	relType_11=punct	pos_14=,	lemma_5=with	pos_14=NN	lemma_11=cetirizine	lemma_10=azithromycin	path2=with_dep>the_dep>antacid_dep>lorazepam_conj	lemma_9=antacid	pos_2=-RRB-	relType_4=advcl	relType_14=conj	lemma_12=famotidine	lemma_2=)	lemma_14=lamivudine	relType_12=conj	pos_8=:	relType_13=punct	lemma_9=aluminum	relType_9=dep	relType_9=compound	pos_9=NNS	lemma_9=/	path1=SUSTIVA_nsubj:pass	lemma_9=hydroxide	lemma_2=efavirenz	relType_2=appos	pos_11=,	relType_9=punct	eib=True	pos_12=NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e9	null	pos_2=NN	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	relType_3=aux:pass	lemma_13=fluconazole	lemma_12=,	pos_9=HYPH	relType_6=dep	pos_12=,	pos_3=VBZ	pos_10=NN	pos_13=NN	relType_5=dep	lemma_15=lorazepam	lemma_3=be	pos_1=-LRB-	pos_10=,	lib=efavirenz	wib=efavirenz	pos_13=,	relType_2=punct	relType_10=conj	relType_12=punct	relType_13=conj	pos_9=NN	pos_4=VBN	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>nelfinavir_conj	lemma_15=,	pos_5=IN	lemma_14=,	lemma_9=magnesium	pos_11=NN	relType_7=dep	lpib=efavirenz_NN	lemma_7=follow	pos_9=,	relType_1=punct	lemma_8=:	relType_14=punct	relType_10=punct	pos_6=DT	lemma_11=,	pos_7=VBG	lemma_4=give	relType_11=conj	lemma_1=(	pos_15=,	lemma_6=the	relType_11=punct	pos_14=,	lemma_5=with	pos_14=NN	relType_15=punct	lemma_11=cetirizine	lemma_10=azithromycin	lemma_9=antacid	pos_2=-RRB-	relType_15=conj	relType_4=advcl	relType_14=conj	lemma_12=famotidine	lemma_2=)	lemma_14=lamivudine	relType_12=conj	pos_8=:	relType_13=punct	lemma_9=aluminum	relType_9=dep	relType_9=compound	pos_9=NNS	lemma_9=/	path1=SUSTIVA_nsubj:pass	path2=with_dep>the_dep>antacid_dep>nelfinavir_conj	lemma_9=hydroxide	lemma_2=efavirenz	pos_15=NN	relType_2=appos	pos_11=,	relType_9=punct	eib=True	pos_12=NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e10	null	pos_2=NN	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	relType_3=aux:pass	lemma_13=fluconazole	lemma_12=,	pos_9=HYPH	relType_6=dep	pos_12=,	pos_3=VBZ	pos_10=NN	pos_13=NN	relType_5=dep	lemma_16=,	lemma_15=lorazepam	lemma_3=be	relType_16=punct	pos_1=-LRB-	pos_10=,	lib=efavirenz	wib=efavirenz	pos_13=,	relType_2=punct	relType_10=conj	relType_12=punct	relType_13=conj	pos_9=NN	pos_4=VBN	lemma_15=,	pos_5=IN	pos_16=NN	lemma_14=,	lemma_9=magnesium	pos_11=NN	relType_7=dep	lpib=efavirenz_NN	lemma_7=follow	pos_9=,	relType_1=punct	lemma_8=:	relType_14=punct	relType_10=punct	pos_6=DT	lemma_11=,	pos_7=VBG	lemma_4=give	relType_11=conj	lemma_1=(	pos_15=,	lemma_6=the	relType_11=punct	pos_14=,	lemma_5=with	pos_14=NN	relType_15=punct	lemma_11=cetirizine	lemma_10=azithromycin	lemma_9=antacid	pos_2=-RRB-	relType_15=conj	relType_4=advcl	relType_14=conj	lemma_12=famotidine	lemma_16=nelfinavir	lemma_2=)	lemma_14=lamivudine	relType_12=conj	pos_8=:	relType_13=punct	lemma_9=aluminum	relType_9=dep	relType_9=compound	pos_9=NNS	pos_16=,	lemma_9=/	path1=SUSTIVA_nsubj:pass	lemma_9=hydroxide	lemma_2=efavirenz	pos_15=NN	relType_2=appos	pos_11=,	relType_9=punct	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>paroxetine_conj	eib=True	path2=with_dep>the_dep>antacid_dep>paroxetine_conj	pos_12=NN	relType_16=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e0	DDI-DrugBank.d531.s90.e11	null	pos_2=NN	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	relType_3=aux:pass	lemma_13=fluconazole	lemma_12=,	pos_9=HYPH	relType_6=dep	pos_12=,	pos_3=VBZ	pos_18=CC	pos_10=NN	pos_13=NN	relType_5=dep	lemma_16=,	lemma_15=lorazepam	lemma_3=be	relType_16=punct	pos_1=-LRB-	pos_10=,	lib=efavirenz	wib=efavirenz	pos_13=,	path2=with_dep>the_dep>antacid_dep>zidovudine_conj	relType_2=punct	relType_10=conj	relType_12=punct	relType_13=conj	pos_9=NN	pos_4=VBN	lemma_15=,	pos_5=IN	pos_16=NN	lemma_17=paroxetine	lemma_14=,	lemma_9=magnesium	pos_11=NN	relType_7=dep	lpib=efavirenz_NN	lemma_7=follow	pos_9=,	relType_1=punct	lemma_8=:	relType_14=punct	relType_10=punct	pos_6=DT	lemma_11=,	relType_17=punct	pos_7=VBG	lemma_4=give	relType_18=cc	relType_11=conj	lemma_1=(	pos_17=NN	pos_15=,	lemma_6=the	relType_11=punct	pos_14=,	lemma_5=with	pos_14=NN	relType_15=punct	pos_17=,	lemma_11=cetirizine	lemma_10=azithromycin	lemma_9=antacid	pos_2=-RRB-	relType_15=conj	relType_4=advcl	relType_14=conj	lemma_12=famotidine	lemma_16=nelfinavir	lemma_2=)	lemma_14=lamivudine	relType_12=conj	pos_8=:	relType_13=punct	lemma_9=aluminum	relType_9=dep	relType_17=conj	relType_9=compound	lemma_17=,	pos_9=NNS	pos_16=,	lemma_9=/	path1=SUSTIVA_nsubj:pass	lemma_9=hydroxide	lemma_2=efavirenz	pos_15=NN	relType_2=appos	pos_11=,	relType_9=punct	path=SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>zidovudine_conj	lemma_18=and	eib=True	pos_12=NN	relType_16=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e2	null	relType_4=dep	pos_3=VBN	relType_8=punct	lemma_1=)	lemma_6=follow	pos_8=NN	pos_6=VBG	relType_6=dep	lemma_8=aluminum	pos_8=HYPH	relType_5=dep	lemma_7=:	path2=with_dep>the_dep>antacid_dep	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep	lemma_3=give	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	wib=is	pos_2=VBZ	lemma_5=the	eib=True	relType_7=punct	pos_5=DT	lemma_8=/	lpib=be_VBZ	lemma_2=be	relType_1=punct	lemma_8=hydroxide
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e3	null	relType_4=dep	relType_8=dep	pos_3=VBN	relType_8=punct	lemma_1=)	lemma_8=,	lemma_6=follow	pos_8=NNS	pos_8=NN	pos_6=VBG	relType_6=dep	lemma_8=aluminum	pos_8=HYPH	lemma_8=antacid	relType_5=dep	lemma_7=:	path2=with_dep>the_dep>antacid_dep>azithromycin_conj	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	lemma_3=give	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	wib=is	pos_2=VBZ	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>azithromycin_conj	lemma_5=the	eib=True	relType_7=punct	pos_5=DT	lemma_8=/	lpib=be_VBZ	lemma_2=be	relType_1=punct	lemma_8=hydroxide	pos_8=,
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e4	null	relType_4=dep	relType_8=dep	relType_9=conj	pos_3=VBN	relType_8=punct	lemma_1=)	lemma_9=,	lemma_8=,	lemma_6=follow	pos_8=NNS	pos_8=NN	pos_6=VBG	relType_6=dep	lemma_8=aluminum	pos_8=HYPH	lemma_8=antacid	relType_5=dep	pos_9=NN	lemma_7=:	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	lemma_3=give	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	relType_9=punct	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>cetirizine_conj	wib=is	pos_2=VBZ	lemma_5=the	eib=True	path2=with_dep>the_dep>antacid_dep>cetirizine_conj	relType_7=punct	pos_5=DT	lemma_9=azithromycin	lemma_8=/	lpib=be_VBZ	lemma_2=be	pos_9=,	relType_1=punct	lemma_8=hydroxide	pos_8=,
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e5	null	relType_4=dep	relType_10=punct	relType_8=dep	relType_9=conj	pos_3=VBN	lemma_10=,	relType_8=punct	lemma_1=)	lemma_9=,	lemma_8=,	lemma_6=follow	pos_8=NNS	pos_8=NN	pos_6=VBG	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>famotidine_conj	relType_6=dep	relType_10=conj	lemma_8=aluminum	pos_8=HYPH	lemma_8=antacid	pos_10=NN	relType_5=dep	pos_9=NN	lemma_7=:	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	lemma_3=give	lemma_10=cetirizine	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	relType_9=punct	wib=is	pos_2=VBZ	lemma_5=the	pos_10=,	eib=True	relType_7=punct	pos_5=DT	lemma_9=azithromycin	lemma_8=/	lpib=be_VBZ	lemma_2=be	pos_9=,	relType_1=punct	path2=with_dep>the_dep>antacid_dep>famotidine_conj	lemma_8=hydroxide	pos_8=,
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e6	null	relType_4=dep	relType_10=punct	relType_8=dep	relType_9=conj	lemma_11=,	path2=with_dep>the_dep>antacid_dep>fluconazole_conj	pos_3=VBN	lemma_10=,	relType_8=punct	lemma_1=)	lemma_9=,	lemma_8=,	lemma_6=follow	pos_8=NNS	relType_11=conj	pos_8=NN	pos_6=VBG	relType_6=dep	relType_10=conj	relType_11=punct	lemma_8=aluminum	pos_8=HYPH	lemma_8=antacid	pos_10=NN	relType_5=dep	pos_9=NN	lemma_7=:	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>fluconazole_conj	pos_1=-RRB-	pos_4=IN	relType_8=compound	relType_2=aux:pass	lemma_3=give	lemma_10=cetirizine	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	relType_9=punct	wib=is	pos_2=VBZ	lemma_5=the	pos_10=,	pos_11=NN	eib=True	relType_7=punct	pos_5=DT	lemma_9=azithromycin	lemma_8=/	lpib=be_VBZ	lemma_2=be	pos_9=,	relType_1=punct	lemma_11=famotidine	lemma_8=hydroxide	pos_8=,
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e7	null	relType_4=dep	relType_12=conj	relType_10=punct	relType_8=dep	relType_9=conj	lemma_11=,	pos_3=VBN	lemma_10=,	relType_8=punct	lemma_12=fluconazole	lemma_1=)	lemma_9=,	lemma_8=,	lemma_6=follow	pos_8=NNS	relType_11=conj	pos_8=NN	pos_6=VBG	lemma_12=,	relType_6=dep	relType_10=conj	relType_11=punct	lemma_8=aluminum	pos_12=,	pos_8=HYPH	relType_12=punct	lemma_8=antacid	pos_10=NN	relType_5=dep	pos_9=NN	lemma_7=:	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	lemma_3=give	lemma_10=cetirizine	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	relType_9=punct	wib=is	pos_2=VBZ	lemma_5=the	pos_10=,	pos_11=NN	eib=True	relType_7=punct	pos_5=DT	pos_8=,	lemma_9=azithromycin	lemma_8=/	lpib=be_VBZ	path2=with_dep>the_dep>antacid_dep>lamivudine_conj	lemma_2=be	pos_9=,	relType_1=punct	pos_12=NN	lemma_11=famotidine	lemma_8=hydroxide	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>lamivudine_conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e8	null	relType_4=dep	relType_12=conj	pos_13=,	relType_10=punct	relType_8=dep	relType_9=conj	lemma_11=,	lemma_13=,	pos_3=VBN	lemma_10=,	relType_13=punct	relType_8=punct	lemma_12=fluconazole	lemma_1=)	lemma_9=,	lemma_8=,	lemma_6=follow	pos_8=NNS	relType_11=conj	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>lorazepam_conj	pos_6=VBG	pos_8=NN	lemma_12=,	relType_6=dep	relType_10=conj	relType_11=punct	lemma_8=aluminum	pos_12=,	pos_8=HYPH	relType_12=punct	relType_13=conj	lemma_8=antacid	pos_10=NN	relType_5=dep	pos_9=NN	lemma_7=:	pos_13=NN	lemma_4=with	lib=be	relType_3=advcl	lemma_8=magnesium	pos_4=IN	pos_1=-RRB-	relType_8=compound	relType_2=aux:pass	lemma_3=give	path2=with_dep>the_dep>antacid_dep>lorazepam_conj	lemma_10=cetirizine	lemma_13=lamivudine	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	pos_7=:	relType_9=punct	wib=is	pos_2=VBZ	lemma_5=the	pos_10=,	pos_11=NN	eib=True	relType_7=punct	pos_5=DT	lemma_9=azithromycin	lemma_8=/	lpib=be_VBZ	lemma_2=be	pos_9=,	relType_1=punct	pos_12=NN	lemma_11=famotidine	lemma_8=hydroxide	pos_8=,
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e9	null	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=dep	lemma_8=aluminum	pos_12=,	pos_10=NN	pos_13=NN	relType_5=dep	lemma_8=magnesium	relType_2=aux:pass	lemma_10=cetirizine	pos_7=:	pos_10=,	pos_13=,	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>nelfinavir_conj	lemma_6=follow	pos_8=NN	relType_10=conj	pos_8=HYPH	relType_12=punct	relType_13=conj	lemma_8=antacid	pos_9=NN	lemma_7=:	pos_1=-RRB-	lemma_14=,	lemma_5=the	pos_11=NN	lemma_9=azithromycin	lemma_2=be	pos_9=,	relType_1=punct	lemma_11=famotidine	pos_8=,	relType_4=dep	relType_14=punct	relType_10=punct	relType_8=dep	lemma_11=,	lemma_12=fluconazole	lemma_8=,	relType_11=conj	pos_14=,	relType_11=punct	pos_14=NN	lemma_4=with	lemma_14=lorazepam	lib=be	pos_4=IN	relType_8=compound	lemma_13=lamivudine	wib=is	pos_2=VBZ	pos_5=DT	lemma_8=/	relType_14=conj	lemma_8=hydroxide	relType_12=conj	relType_9=conj	pos_3=VBN	relType_13=punct	lemma_1=)	pos_6=VBG	path2=with_dep>the_dep>antacid_dep>nelfinavir_conj	relType_3=advcl	lemma_3=give	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	relType_9=punct	eib=True	relType_7=punct	lpib=be_VBZ	pos_12=NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e10	null	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=dep	lemma_8=aluminum	pos_12=,	pos_10=NN	pos_13=NN	relType_5=dep	lemma_8=magnesium	relType_2=aux:pass	lemma_10=cetirizine	pos_7=:	pos_10=,	pos_13=,	lemma_6=follow	pos_8=NN	lemma_15=nelfinavir	relType_10=conj	pos_8=HYPH	relType_12=punct	relType_13=conj	lemma_8=antacid	pos_9=NN	lemma_7=:	lemma_15=,	pos_1=-RRB-	lemma_14=,	lemma_5=the	pos_11=NN	lemma_9=azithromycin	lemma_2=be	pos_9=,	relType_1=punct	lemma_11=famotidine	pos_8=,	relType_4=dep	relType_14=punct	relType_10=punct	relType_8=dep	lemma_11=,	lemma_12=fluconazole	lemma_8=,	relType_11=conj	pos_15=,	pos_14=,	relType_11=punct	pos_14=NN	relType_15=punct	lemma_4=with	lemma_14=lorazepam	lib=be	pos_4=IN	relType_8=compound	lemma_13=lamivudine	wib=is	pos_2=VBZ	pos_5=DT	relType_15=conj	lemma_8=/	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>paroxetine_conj	relType_14=conj	lemma_8=hydroxide	relType_12=conj	relType_9=conj	pos_3=VBN	relType_13=punct	lemma_1=)	pos_6=VBG	pos_15=NN	relType_3=advcl	lemma_3=give	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	relType_9=punct	eib=True	relType_7=punct	lpib=be_VBZ	path2=with_dep>the_dep>antacid_dep>paroxetine_conj	pos_12=NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e1	DDI-DrugBank.d531.s90.e11	null	lemma_13=,	lemma_10=,	relType_8=punct	lemma_9=,	pos_8=NNS	lemma_12=,	relType_6=dep	lemma_8=aluminum	pos_12=,	pos_10=NN	pos_13=NN	relType_5=dep	lemma_16=,	lemma_8=magnesium	relType_2=aux:pass	lemma_10=cetirizine	pos_7=:	relType_16=punct	pos_10=,	pos_13=,	relType_17=cc	path2=with_dep>the_dep>antacid_dep>zidovudine_conj	lemma_6=follow	pos_8=NN	path=efavirenz_appos<SUSTIVA_nsubj:pass<give_advcl>with_dep>the_dep>antacid_dep>zidovudine_conj	lemma_15=nelfinavir	relType_10=conj	pos_8=HYPH	relType_12=punct	relType_13=conj	lemma_8=antacid	pos_9=NN	lemma_7=:	lemma_15=,	pos_1=-RRB-	pos_16=NN	lemma_14=,	lemma_5=the	pos_11=NN	lemma_9=azithromycin	lemma_2=be	pos_17=CC	pos_9=,	relType_1=punct	lemma_11=famotidine	pos_8=,	relType_4=dep	relType_14=punct	relType_10=punct	relType_8=dep	lemma_11=,	lemma_12=fluconazole	lemma_8=,	relType_11=conj	pos_15=,	pos_14=,	relType_11=punct	lemma_16=paroxetine	pos_14=NN	relType_15=punct	lemma_4=with	lemma_14=lorazepam	lib=be	pos_4=IN	relType_8=compound	lemma_13=lamivudine	wib=is	pos_2=VBZ	pos_5=DT	relType_15=conj	lemma_8=/	relType_14=conj	lemma_8=hydroxide	relType_12=conj	relType_9=conj	pos_3=VBN	relType_13=punct	lemma_1=)	pos_6=VBG	pos_16=,	pos_15=NN	relType_3=advcl	lemma_3=give	lemma_17=and	pos_11=,	path1=efavirenz_appos<SUSTIVA_nsubj:pass	relType_9=punct	eib=True	relType_7=punct	lpib=be_VBZ	pos_12=NN	relType_16=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e3	null	path2=azithromycin_conj	lemma_1=,	eib=False	path1=	pos_1=,	lib=azithromycin	relType_1=punct	path=<antacid_dep>azithromycin_conj	wib=azithromycin	lpib=azithromycin_NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e4	null	path2=cetirizine_conj	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	path1=	pos_1=,	lemma_2=azithromycin	pos_2=,	path=<antacid_dep>cetirizine_conj	lib=azithromycin	relType_1=punct	relType_2=conj	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e5	null	path=<antacid_dep>famotidine_conj	lemma_1=,	pos_2=NN	path1=	pos_1=,	lib=azithromycin	relType_2=punct	relType_2=conj	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN	path2=famotidine_conj	lemma_3=,	relType_3=conj	lemma_2=azithromycin	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e6	null	lemma_1=,	pos_2=NN	path=<antacid_dep>fluconazole_conj	path1=	pos_1=,	lib=azithromycin	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN	lemma_4=famotidine	path2=fluconazole_conj	lemma_3=,	relType_4=punct	relType_3=conj	lemma_2=azithromycin	lemma_4=,	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e7	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lib=azithromycin	lemma_5=fluconazole	path=<antacid_dep>lamivudine_conj	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN	lemma_4=famotidine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_2=azithromycin	lemma_4=,	relType_5=conj	path2=lamivudine_conj	pos_5=NN	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e8	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_6=,	lib=azithromycin	lemma_6=lamivudine	lemma_5=fluconazole	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN	lemma_4=famotidine	path2=lorazepam_conj	path=<antacid_dep>lorazepam_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_2=azithromycin	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e9	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_6=,	lib=azithromycin	lemma_6=lamivudine	lemma_5=fluconazole	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=azithromycin	path=<antacid_dep>nelfinavir_conj	lpib=azithromycin_NN	lemma_4=famotidine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_2=azithromycin	path2=nelfinavir_conj	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	lemma_7=lorazepam	relType_7=punct	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e10	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_8=punct	lib=azithromycin	lemma_6=lamivudine	lemma_8=,	lemma_5=fluconazole	relType_2=punct	pos_6=NN	pos_8=NN	lemma_8=nelfinavir	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=azithromycin	lpib=azithromycin_NN	lemma_4=famotidine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_2=azithromycin	lemma_4=,	relType_5=conj	path2=paroxetine_conj	pos_6=,	pos_5=NN	lemma_3=cetirizine	pos_3=,	eib=True	pos_3=NN	lemma_7=lorazepam	relType_7=punct	path=<antacid_dep>paroxetine_conj	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e2	DDI-DrugBank.d531.s90.e11	null	lemma_1=,	pos_2=NN	relType_9=conj	path2=zidovudine_conj	pos_5=,	path=<antacid_dep>zidovudine_conj	relType_10=cc	path1=	pos_1=,	lemma_6=,	relType_8=punct	lib=azithromycin	lemma_6=lamivudine	lemma_9=,	lemma_8=,	lemma_5=fluconazole	relType_2=punct	pos_6=NN	pos_8=NN	lemma_8=nelfinavir	relType_6=conj	pos_4=,	relType_6=punct	pos_10=CC	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	wib=azithromycin	lpib=azithromycin_NN	lemma_4=famotidine	lemma_10=and	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_2=azithromycin	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	pos_5=NN	lemma_3=cetirizine	lemma_9=paroxetine	pos_3=,	eib=True	pos_3=NN	lemma_7=lorazepam	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e4	null	path2=cetirizine_conj	lemma_1=,	eib=False	path=azithromycin_conj<antacid_dep>cetirizine_conj	lib=cetirizine	pos_1=,	path1=azithromycin_conj	relType_1=punct	lpib=cetirizine_NN	wib=cetirizine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e5	null	path=azithromycin_conj<antacid_dep>famotidine_conj	lemma_1=,	pos_2=NN	path2=famotidine_conj	eib=True	lemma_2=cetirizine	lib=cetirizine	pos_1=,	pos_2=,	path1=azithromycin_conj	relType_1=punct	lpib=cetirizine_NN	relType_2=conj	wib=cetirizine	lemma_2=,	relType_2=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e6	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	pos_1=,	path1=azithromycin_conj	lpib=cetirizine_NN	relType_2=punct	relType_2=conj	lemma_2=,	path2=fluconazole_conj	lemma_3=,	relType_3=conj	lib=cetirizine	path=azithromycin_conj<antacid_dep>fluconazole_conj	relType_3=punct	pos_3=,	eib=True	lemma_2=cetirizine	pos_3=NN	pos_2=,	relType_1=punct	wib=cetirizine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e7	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	pos_1=,	path1=azithromycin_conj	lpib=cetirizine_NN	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lib=cetirizine	lemma_4=,	relType_3=punct	path2=lamivudine_conj	lemma_4=fluconazole	pos_3=,	eib=True	lemma_2=cetirizine	path=azithromycin_conj<antacid_dep>lamivudine_conj	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	wib=cetirizine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e8	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	path1=azithromycin_conj	lpib=cetirizine_NN	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	path2=lorazepam_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=cetirizine	lemma_4=,	relType_5=conj	relType_3=punct	pos_5=NN	lemma_4=fluconazole	pos_3=,	eib=True	lemma_2=cetirizine	pos_3=NN	lemma_5=lamivudine	pos_2=,	relType_4=conj	path=azithromycin_conj<antacid_dep>lorazepam_conj	relType_1=punct	wib=cetirizine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e9	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	path1=azithromycin_conj	lpib=cetirizine_NN	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=lorazepam	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=cetirizine	path2=nelfinavir_conj	lemma_4=,	relType_5=conj	relType_3=punct	pos_6=,	path=azithromycin_conj<antacid_dep>nelfinavir_conj	pos_5=NN	lemma_4=fluconazole	pos_3=,	eib=True	lemma_2=cetirizine	pos_3=NN	lemma_5=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	wib=cetirizine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e10	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	path1=azithromycin_conj	lpib=cetirizine_NN	path=azithromycin_conj<antacid_dep>paroxetine_conj	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	lemma_6=lorazepam	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=cetirizine	lemma_4=,	relType_5=conj	path2=paroxetine_conj	relType_3=punct	pos_6=,	pos_5=NN	lemma_4=fluconazole	pos_3=,	eib=True	lemma_2=cetirizine	pos_3=NN	relType_7=punct	lemma_5=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	wib=cetirizine	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e3	DDI-DrugBank.d531.s90.e11	null	lemma_3=famotidine	lemma_1=,	pos_2=NN	path2=zidovudine_conj	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	path1=azithromycin_conj	lpib=cetirizine_NN	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_8=paroxetine	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	lemma_6=lorazepam	lemma_9=and	pos_9=CC	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=cetirizine	lemma_4=,	relType_5=conj	relType_3=punct	pos_6=,	pos_5=NN	path=azithromycin_conj<antacid_dep>zidovudine_conj	lemma_4=fluconazole	pos_3=,	eib=True	lemma_2=cetirizine	pos_3=NN	relType_7=punct	lemma_5=lamivudine	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	relType_9=cc	relType_1=punct	pos_7=NN	wib=cetirizine	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e5	null	lemma_1=,	path2=famotidine_conj	eib=False	lpib=famotidine_NN	pos_1=,	lib=famotidine	path=cetirizine_conj<antacid_dep>famotidine_conj	relType_1=punct	wib=famotidine	path1=cetirizine_conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e6	null	lemma_1=,	relType_2=punct	path2=fluconazole_conj	path=cetirizine_conj<antacid_dep>fluconazole_conj	eib=True	pos_2=NN	lemma_2=,	lpib=famotidine_NN	pos_1=,	lib=famotidine	pos_2=,	relType_1=punct	relType_2=conj	wib=famotidine	lemma_2=famotidine	path1=cetirizine_conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e7	null	lemma_1=,	pos_2=NN	lpib=famotidine_NN	pos_1=,	lemma_3=fluconazole	relType_2=punct	relType_2=conj	lemma_2=,	path=cetirizine_conj<antacid_dep>lamivudine_conj	lemma_3=,	relType_3=conj	lib=famotidine	wib=famotidine	path1=cetirizine_conj	path2=lamivudine_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_2=famotidine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e8	null	lemma_1=,	pos_2=NN	lpib=famotidine_NN	path=cetirizine_conj<antacid_dep>lorazepam_conj	pos_1=,	lemma_3=fluconazole	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	path2=lorazepam_conj	relType_4=punct	lemma_3=,	relType_3=conj	lib=famotidine	lemma_4=,	wib=famotidine	path1=cetirizine_conj	pos_3=,	eib=True	pos_3=NN	lemma_4=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_2=famotidine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e9	null	lemma_1=,	pos_2=NN	pos_5=,	lpib=famotidine_NN	pos_1=,	lemma_3=fluconazole	relType_2=punct	lemma_5=lorazepam	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	path=cetirizine_conj<antacid_dep>nelfinavir_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=famotidine	path2=nelfinavir_conj	lemma_4=,	relType_5=conj	wib=famotidine	path1=cetirizine_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_4=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_2=famotidine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e10	null	lemma_1=,	pos_2=NN	pos_5=,	lpib=famotidine_NN	pos_1=,	lemma_3=fluconazole	lemma_6=,	path=cetirizine_conj<antacid_dep>paroxetine_conj	relType_2=punct	lemma_5=lorazepam	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	lemma_6=nelfinavir	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=famotidine	lemma_4=,	relType_5=conj	path2=paroxetine_conj	wib=famotidine	path1=cetirizine_conj	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_4=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_2=famotidine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e4	DDI-DrugBank.d531.s90.e11	null	lemma_1=,	pos_2=NN	path2=zidovudine_conj	pos_5=,	lpib=famotidine_NN	pos_1=,	lemma_3=fluconazole	lemma_6=,	relType_2=punct	lemma_5=lorazepam	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	lemma_7=paroxetine	pos_7=,	lemma_6=nelfinavir	pos_8=CC	lemma_7=,	relType_2=conj	path=cetirizine_conj<antacid_dep>zidovudine_conj	lemma_2=,	pos_4=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=famotidine	lemma_4=,	relType_5=conj	wib=famotidine	path1=cetirizine_conj	pos_6=,	lemma_8=and	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_4=lamivudine	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_8=cc	relType_3=punct	lemma_2=famotidine	relType_7=conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e6	null	lpib=fluconazole_NN	lemma_1=,	path2=fluconazole_conj	path1=famotidine_conj	eib=False	wib=fluconazole	pos_1=,	lib=fluconazole	relType_1=punct	path=famotidine_conj<antacid_dep>fluconazole_conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e7	null	path2=lamivudine_conj	path=famotidine_conj<antacid_dep>lamivudine_conj	lpib=fluconazole_NN	lemma_1=,	pos_2=NN	eib=True	path1=famotidine_conj	wib=fluconazole	pos_1=,	pos_2=,	lib=fluconazole	relType_1=punct	lemma_2=fluconazole	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e8	null	lpib=fluconazole_NN	lemma_1=,	pos_2=NN	wib=fluconazole	pos_1=,	lemma_2=fluconazole	relType_2=punct	relType_2=conj	lemma_2=,	path2=lorazepam_conj	lemma_3=,	relType_3=conj	lib=fluconazole	relType_3=punct	pos_3=,	eib=True	path1=famotidine_conj	pos_3=NN	pos_2=,	relType_1=punct	path=famotidine_conj<antacid_dep>lorazepam_conj	lemma_3=lamivudine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e9	null	lpib=fluconazole_NN	lemma_1=,	pos_2=NN	wib=fluconazole	pos_1=,	lemma_2=fluconazole	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	path2=nelfinavir_conj	lib=fluconazole	lemma_4=,	pos_3=,	eib=True	path1=famotidine_conj	pos_3=NN	lemma_4=lorazepam	pos_2=,	relType_4=conj	relType_1=punct	path=famotidine_conj<antacid_dep>nelfinavir_conj	relType_3=punct	lemma_3=lamivudine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e10	null	lpib=fluconazole_NN	lemma_1=,	pos_2=NN	pos_5=,	wib=fluconazole	pos_1=,	lemma_2=fluconazole	relType_2=punct	lemma_5=nelfinavir	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lib=fluconazole	lemma_4=,	relType_5=conj	path2=paroxetine_conj	pos_5=NN	pos_3=,	eib=True	path1=famotidine_conj	pos_3=NN	lemma_4=lorazepam	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	path=famotidine_conj<antacid_dep>paroxetine_conj	lemma_3=lamivudine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e5	DDI-DrugBank.d531.s90.e11	null	lpib=fluconazole_NN	lemma_1=,	pos_2=NN	path2=zidovudine_conj	pos_5=,	wib=fluconazole	pos_1=,	lemma_6=,	relType_7=cc	lemma_2=fluconazole	relType_2=punct	pos_6=NN	relType_6=conj	lemma_5=nelfinavir	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	lib=fluconazole	lemma_4=,	relType_5=conj	lemma_6=paroxetine	pos_6=,	pos_5=NN	pos_3=,	eib=True	path1=famotidine_conj	pos_3=NN	lemma_7=and	lemma_4=lorazepam	pos_2=,	relType_4=conj	path=famotidine_conj<antacid_dep>zidovudine_conj	relType_1=punct	relType_3=punct	lemma_3=lamivudine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e6	DDI-DrugBank.d531.s90.e7	null	path2=lamivudine_conj	lemma_1=,	eib=False	path1=fluconazole_conj	pos_1=,	path=fluconazole_conj<antacid_dep>lamivudine_conj	wib=lamivudine	lpib=lamivudine_NN	lib=lamivudine	relType_1=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e6	DDI-DrugBank.d531.s90.e8	null	path2=lorazepam_conj	lemma_1=,	pos_2=NN	path=fluconazole_conj<antacid_dep>lorazepam_conj	eib=True	path1=fluconazole_conj	pos_1=,	pos_2=,	lemma_2=lamivudine	relType_2=conj	wib=lamivudine	lpib=lamivudine_NN	lib=lamivudine	relType_1=punct	lemma_2=,	relType_2=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e6	DDI-DrugBank.d531.s90.e9	null	lemma_1=,	pos_2=NN	pos_1=,	lib=lamivudine	relType_2=punct	lemma_3=lorazepam	path1=fluconazole_conj	wib=lamivudine	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path2=nelfinavir_conj	lemma_2=lamivudine	lpib=lamivudine_NN	pos_3=,	eib=True	pos_3=NN	path=fluconazole_conj<antacid_dep>nelfinavir_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e6	DDI-DrugBank.d531.s90.e10	null	lemma_1=,	pos_2=NN	lemma_4=nelfinavir	pos_1=,	lib=lamivudine	relType_2=punct	lemma_3=lorazepam	pos_4=,	path1=fluconazole_conj	wib=lamivudine	path=fluconazole_conj<antacid_dep>paroxetine_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=lamivudine	lemma_4=,	lpib=lamivudine_NN	path2=paroxetine_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e6	DDI-DrugBank.d531.s90.e11	null	lemma_1=,	pos_2=NN	path2=zidovudine_conj	pos_5=,	lemma_4=nelfinavir	pos_1=,	lib=lamivudine	path=fluconazole_conj<antacid_dep>zidovudine_conj	relType_2=punct	lemma_3=lorazepam	pos_4=,	path1=fluconazole_conj	wib=lamivudine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_2=lamivudine	lemma_4=,	relType_5=conj	lpib=lamivudine_NN	lemma_5=paroxetine	pos_5=NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e7	DDI-DrugBank.d531.s90.e8	null	wib=lorazepam	path2=lorazepam_conj	lemma_1=,	eib=False	path=lamivudine_conj<antacid_dep>lorazepam_conj	pos_1=,	lib=lorazepam	lpib=lorazepam_NN	relType_1=punct	path1=lamivudine_conj
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e7	DDI-DrugBank.d531.s90.e9	null	wib=lorazepam	lemma_1=,	pos_2=NN	eib=True	path=lamivudine_conj<antacid_dep>nelfinavir_conj	pos_1=,	lemma_2=lorazepam	path2=nelfinavir_conj	pos_2=,	lib=lorazepam	relType_2=conj	lpib=lorazepam_NN	relType_1=punct	path1=lamivudine_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e7	DDI-DrugBank.d531.s90.e10	null	wib=lorazepam	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	pos_1=,	lpib=lorazepam_NN	relType_2=punct	lemma_2=lorazepam	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lib=lorazepam	path2=paroxetine_conj	path1=lamivudine_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	path=lamivudine_conj<antacid_dep>paroxetine_conj	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e7	DDI-DrugBank.d531.s90.e11	null	wib=lorazepam	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	pos_5=CC	path2=zidovudine_conj	pos_1=,	lpib=lorazepam_NN	relType_2=punct	relType_5=cc	pos_4=,	lemma_2=lorazepam	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lib=lorazepam	lemma_4=,	path1=lamivudine_conj	pos_3=,	eib=True	lemma_4=paroxetine	path=lamivudine_conj<antacid_dep>zidovudine_conj	pos_3=NN	lemma_5=and	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e8	DDI-DrugBank.d531.s90.e9	null	lemma_1=,	lpib=nelfinavir_NN	eib=False	path1=lorazepam_conj	pos_1=,	wib=nelfinavir	path2=nelfinavir_conj	path=lorazepam_conj<antacid_dep>nelfinavir_conj	relType_1=punct	lib=nelfinavir
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e8	DDI-DrugBank.d531.s90.e10	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lpib=nelfinavir_NN	path1=lorazepam_conj	pos_1=,	wib=nelfinavir	pos_2=,	relType_2=conj	relType_1=punct	lemma_2=nelfinavir	path2=paroxetine_conj	lemma_2=,	path=lorazepam_conj<antacid_dep>paroxetine_conj	lib=nelfinavir
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e8	DDI-DrugBank.d531.s90.e11	null	lemma_1=,	pos_2=NN	path2=zidovudine_conj	pos_1=,	wib=nelfinavir	relType_4=cc	lemma_2=nelfinavir	relType_2=punct	relType_2=conj	lemma_2=,	lib=nelfinavir	lemma_3=,	relType_3=conj	path=lorazepam_conj<antacid_dep>zidovudine_conj	pos_3=,	eib=True	lpib=nelfinavir_NN	path1=lorazepam_conj	pos_3=NN	lemma_3=paroxetine	pos_4=CC	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e9	DDI-DrugBank.d531.s90.e10	null	path2=paroxetine_conj	lemma_1=,	eib=False	path1=nelfinavir_conj	pos_1=,	path=nelfinavir_conj<antacid_dep>paroxetine_conj	relType_1=punct	lib=paroxetine	lpib=paroxetine_NN	wib=paroxetine
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e9	DDI-DrugBank.d531.s90.e11	null	lemma_2=paroxetine	lemma_1=,	pos_2=NN	pos_3=CC	path2=zidovudine_conj	pos_1=,	lib=paroxetine	relType_3=cc	relType_2=punct	path1=nelfinavir_conj	lpib=paroxetine_NN	relType_2=conj	wib=paroxetine	lemma_2=,	path=nelfinavir_conj<antacid_dep>zidovudine_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d531.s90	DDI-DrugBank.d531.s90.e10	DDI-DrugBank.d531.s90.e11	null	lib=zidovudine	lemma_2=and	lemma_1=,	eib=False	path2=zidovudine_conj	path=paroxetine_conj<antacid_dep>zidovudine_conj	pos_2=CC	lpib=zidovudine_NN	pos_1=,	relType_1=punct	relType_2=cc	wib=zidovudine	path1=paroxetine_conj
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e0	DDI-DrugBank.d531.s91.e1	null	relType_1=cc	path2=nrti_conj	pos_1=CC	lib=nrti	eib=False	path1=	wib=NRTIs	path=<sustiva_obl>nrti_conj	lpib=nrti_NNS	lemma_1=and
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e0	DDI-DrugBank.d531.s91.e2	null	relType_1=cc	lemma_2=nrti	pos_1=CC	pos_3=IN	lib=nrti	path1=	wib=NRTIs	pos_2=JJ	lemma_2=other	lpib=nrti_NNS	relType_2=conj	relType_2=amod	lemma_3=than	relType_3=case	pos_2=NNS	eib=True	path2=other_amod>lamivudine_obl	path=<sustiva_obl>other_amod>lamivudine_obl	lemma_1=and
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e0	DDI-DrugBank.d531.s91.e3	null	relType_1=cc	lemma_2=nrti	pos_1=CC	pos_3=IN	lib=nrti	path1=	wib=NRTIs	relType_4=cc	pos_2=JJ	path=<sustiva_obl>other_amod>lamivudine_obl>zidovudine_conj	lemma_2=other	path2=other_amod>lamivudine_obl>zidovudine_conj	lpib=nrti_NNS	relType_2=conj	pos_4=NN	relType_4=obl	relType_2=amod	lemma_3=than	relType_3=case	pos_2=NNS	eib=True	pos_4=CC	lemma_4=lamivudine	lemma_4=and	lemma_1=and
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e1	DDI-DrugBank.d531.s91.e2	null	lemma_1=other	pos_2=IN	lemma_2=than	relType_2=case	lib=other	eib=False	lpib=other_JJ	path2=other_amod>lamivudine_obl	wib=other	path1=nrti_conj	pos_1=JJ	path=nrti_conj<sustiva_obl>other_amod>lamivudine_obl	relType_1=amod
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e1	DDI-DrugBank.d531.s91.e3	null	lemma_2=than	lib=other	pos_3=CC	path=nrti_conj<sustiva_obl>other_amod>lamivudine_obl>zidovudine_conj	pos_1=JJ	relType_3=cc	pos_2=IN	path2=other_amod>lamivudine_obl>zidovudine_conj	wib=other	path1=nrti_conj	lemma_1=other	lpib=other_JJ	relType_2=case	relType_3=obl	eib=True	pos_3=NN	lemma_3=and	relType_1=amod	lemma_3=lamivudine
DDI-DrugBank.d531.s91	DDI-DrugBank.d531.s91.e2	DDI-DrugBank.d531.s91.e3	null	lib=zidovudine	relType_1=cc	pos_1=CC	eib=False	path2=zidovudine_conj	lpib=zidovudine_NN	path1=	path=<lamivudine_obl>zidovudine_conj	lemma_1=and	wib=zidovudine
DDI-DrugBank.d531.s92	DDI-DrugBank.d531.s92.e0	DDI-DrugBank.d531.s92.e1	null	path=nrti_nsubj:pass<metabolize_advcl>route_obl>efavirenz_nmod	pos_2=VBN	lemma_5=different	pos_3=IN	relType_7=case	lemma_4=a	lpib=be_VBP	relType_1=aux:pass	relType_2=advcl	pos_6=NN	relType_6=obl	eib=False	lemma_1=be	lemma_3=via	wib=are	pos_4=DT	pos_5=JJ	lib=be	relType_5=amod	lemma_6=route	path2=route_obl>efavirenz_nmod	path1=nrti_nsubj:pass	pos_1=VBP	relType_3=case	lemma_7=than	lemma_2=metabolize	pos_7=IN	relType_4=det
DDI-DrugBank.d107.s0	DDI-DrugBank.d107.s0.e0	DDI-DrugBank.d107.s0.e1	effect	relType_1=cc	lemma_4=in	relType_10=acl:relcl	relType_18=case	pos_6=NN	lemma_5=whom	relType_20=nmod	pos_20=NN	pos_15=DT	lemma_18=of	lemma_6=diuretic	lemma_14=experience	relType_21=case	relType_6=compound	lib=especially	lemma_24=therapy	lemma_7=therapy	lemma_23=of	relType_22=obl	relType_9=advmod	pos_22=NN	lemma_12=may	relType_25=case	relType_16=amod	relType_8=aux:pass	relType_19=compound	lemma_16=excessive	lemma_3=that	relType_13=advmod	pos_14=VB	pos_5=WP	lemma_10=institute	relType_17=obj	pos_10=VBN	pos_25=IN	pos_23=IN	pos_7=NN	relType_15=det	lemma_1=and	path=diuretic_nmod<patient_dep>that_conj>institute_acl:relcl>experience_dep>initiation_obl>enalapril_nmod	lemma_11=,	wib=especially	pos_24=NN	lemma_15=a	lemma_25=with	pos_17=NN	path1=diuretic_nmod	lemma_9=recently	relType_11=punct	relType_7=nsubj:pass	lemma_2=especially	pos_21=IN	pos_18=IN	pos_8=VBD	relType_3=conj	pos_4=IN	pos_9=RB	relType_5=obl	relType_23=case	pos_12=MD	lemma_22=initiation	lpib=especially_RB	pos_1=CC	lemma_13=occasionally	path2=that_conj>institute_acl:relcl>experience_dep>initiation_obl>enalapril_nmod	pos_2=RB	lemma_19=blood	eib=False	relType_2=advmod	relType_12=aux	pos_13=RB	pos_19=NN	lemma_21=after	lemma_20=pressure	pos_16=JJ	lemma_8=be	relType_4=case	relType_24=nmod	relType_14=dep	lemma_17=reduction	pos_11=,	pos_3=DT
DDI-DrugBank.d107.s0	DDI-DrugBank.d107.s0.e0	DDI-DrugBank.d107.s0.e2	effect	relType_1=cc	lemma_4=in	relType_10=acl:relcl	relType_18=case	pos_6=NN	lemma_5=whom	relType_26=nmod	relType_20=nmod	pos_20=NN	pos_26=NN	pos_15=DT	lemma_18=of	relType_26=cc	lemma_6=diuretic	lemma_14=experience	relType_21=case	relType_6=compound	lib=especially	lemma_24=therapy	lemma_7=therapy	lemma_23=of	relType_22=obl	relType_9=advmod	pos_22=NN	lemma_12=may	relType_25=case	relType_16=amod	relType_8=aux:pass	lemma_26=or	relType_19=compound	lemma_16=excessive	lemma_3=that	relType_13=advmod	lemma_26=enalapril	pos_14=VB	pos_5=WP	path=diuretic_nmod<patient_dep>that_conj>institute_acl:relcl>experience_dep>initiation_obl>enalapril_nmod>enalaprilat_conj	lemma_10=institute	relType_17=obj	pos_10=VBN	pos_25=IN	pos_23=IN	pos_7=NN	relType_15=det	lemma_1=and	lemma_11=,	wib=especially	pos_24=NN	lemma_15=a	lemma_25=with	pos_17=NN	path1=diuretic_nmod	lemma_9=recently	relType_11=punct	relType_7=nsubj:pass	lemma_2=especially	pos_21=IN	pos_18=IN	pos_8=VBD	relType_3=conj	pos_4=IN	pos_9=RB	relType_5=obl	relType_23=case	pos_12=MD	lemma_22=initiation	lpib=especially_RB	pos_1=CC	lemma_13=occasionally	pos_26=CC	pos_2=RB	lemma_19=blood	relType_2=advmod	relType_12=aux	pos_13=RB	pos_19=NN	lemma_21=after	lemma_20=pressure	pos_16=JJ	lemma_8=be	relType_4=case	relType_24=nmod	relType_14=dep	lemma_17=reduction	pos_11=,	eib=True	pos_3=DT	path2=that_conj>institute_acl:relcl>experience_dep>initiation_obl>enalapril_nmod>enalaprilat_conj
DDI-DrugBank.d107.s0	DDI-DrugBank.d107.s0.e1	DDI-DrugBank.d107.s0.e2	null	relType_1=cc	pos_1=CC	path2=enalaprilat_conj	eib=False	lpib=enalaprilat_NN	path1=	path=<enalapril_nmod>enalaprilat_conj	wib=enalaprilat	lib=enalaprilat	lemma_1=or
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e0	DDI-DrugBank.d107.s1.e1	null	relType_1=cc	pos_1=CC	path2=enalaprilat_conj	eib=False	lpib=enalaprilat_NN	path1=	path=<enalapril_nmod>enalaprilat_conj	wib=enalaprilat	lib=enalaprilat	lemma_1=or
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e0	DDI-DrugBank.d107.s1.e2	effect	relType_1=cc	pos_1=CC	pos_2=NN	pos_8=DT	lemma_7=discontinue	pos_2=MD	pos_7=VBG	wib=enalaprilat	lemma_6=either	lemma_5=by	pos_3=VB	relType_3=aux:pass	relType_5=case	path2=discontinue_obl>diuretic_obj	lemma_1=or	lemma_2=enalaprilat	relType_2=aux	relType_2=conj	pos_4=VBN	lemma_4=minimize	pos_6=CC	lpib=enalaprilat_NN	lemma_8=the	lemma_3=be	pos_5=IN	relType_4=ROOT	relType_6=cc:preconj	lemma_2=can	relType_7=obl	eib=True	relType_8=det	path=enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>diuretic_obj	path1=enalapril_nmod<effect_nmod<possibility_nsubj:pass	lib=enalaprilat
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e0	DDI-DrugBank.d107.s1.e3	null	relType_1=cc	pos_19=IN	pos_1=CC	pos_2=NN	pos_8=DT	relType_16=advcl	lemma_7=discontinue	pos_2=MD	pos_7=VBG	wib=enalaprilat	lemma_6=either	lemma_5=by	pos_3=VB	relType_3=aux:pass	relType_5=case	pos_17=IN	relType_12=compound	lemma_10=increase	relType_10=conj	lemma_2=enalaprilat	relType_2=aux	path=enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod	pos_13=NN	relType_2=conj	pos_9=NN	lemma_15=to	relType_17=case	pos_4=VBN	pos_18=NN	relType_15=case	pos_9=CC	lemma_4=minimize	lemma_13=intake	pos_6=CC	lemma_19=with	lpib=enalaprilat_NN	lemma_8=the	lemma_9=or	lemma_3=be	relType_9=obj	pos_5=IN	lemma_17=of	pos_16=NN	pos_11=DT	lemma_11=the	path2=discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod	relType_4=ROOT	relType_11=det	relType_6=cc:preconj	lemma_9=diuretic	lemma_2=can	lemma_12=salt	lemma_14=prior	pos_15=IN	relType_7=obl	eib=True	relType_19=case	pos_10=VBG	lemma_18=treatment	pos_14=JJ	relType_9=cc	relType_13=obj	relType_8=det	relType_14=case	lemma_16=initiation	pos_12=NN	relType_18=nmod	relation_11=beneficial	lib=enalaprilat	path1=enalapril_nmod<effect_nmod<possibility_nsubj:pass	lemma_1=or
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e0	DDI-DrugBank.d107.s1.e4	null	relType_1=cc	pos_2=NN	lemma_6=either	lemma_5=by	relType_3=aux:pass	relType_5=case	relType_12=compound	relType_20=nmod	pos_20=NN	pos_13=NN	lemma_15=to	pos_18=NN	lemma_19=with	pos_9=CC	lemma_4=minimize	lemma_9=or	lemma_3=be	relType_11=det	path2=discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	lemma_18=treatment	path1=enalapril_nmod<effect_nmod<possibility_nsubj:pass	pos_8=DT	relType_16=advcl	path=enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	pos_2=MD	lemma_7=discontinue	pos_3=VB	lemma_10=increase	relType_10=conj	relType_2=conj	pos_9=NN	pos_4=VBN	relType_15=case	lemma_13=intake	pos_6=CC	pos_5=IN	pos_16=NN	lemma_11=the	relType_4=ROOT	pos_15=IN	relType_7=obl	relType_19=case	relType_18=nmod	pos_7=VBG	relType_20=cc	wib=enalaprilat	pos_17=IN	lemma_2=enalaprilat	relType_2=aux	relType_17=case	lpib=enalaprilat_NN	relType_9=obj	lemma_17=of	lemma_20=enalapril	relType_6=cc:preconj	lemma_12=salt	lemma_14=prior	lemma_20=or	pos_10=VBG	pos_20=CC	relation_11=beneficial	pos_14=JJ	relType_14=case	relType_8=det	lemma_16=initiation	lib=enalaprilat	pos_19=IN	pos_1=CC	lemma_8=the	pos_11=DT	lemma_9=diuretic	lemma_2=can	eib=True	relType_13=obj	pos_12=NN	relType_9=cc	lemma_1=or
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e1	DDI-DrugBank.d107.s1.e2	effect	pos_5=CC	relType_1=aux	relType_7=det	pos_3=VBN	path2=discontinue_obl>diuretic_obj	path=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>diuretic_obj	wib=be	pos_6=VBG	relType_6=obl	path1=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass	eib=False	lemma_3=minimize	pos_2=VB	pos_7=DT	lemma_1=can	lib=be	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	pos_1=MD	lpib=be_VB	lemma_2=be	lemma_7=the	relType_5=cc:preconj	lemma_4=by	lemma_6=discontinue	lemma_5=either
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e1	DDI-DrugBank.d107.s1.e3	null	relType_9=conj	pos_5=CC	relType_1=aux	relType_7=det	relType_10=det	pos_16=IN	pos_3=VBN	lemma_9=increase	relType_18=case	wib=be	pos_8=NN	pos_6=VBG	relType_6=obl	pos_17=NN	lemma_11=salt	path1=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass	lemma_3=minimize	lemma_14=to	lemma_17=treatment	lemma_10=the	relType_8=obj	lemma_15=initiation	pos_2=VB	relType_12=obj	pos_8=CC	lemma_8=or	lemma_16=of	pos_18=IN	pos_7=DT	relation_9=beneficial	pos_9=VBG	path=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod	pos_14=IN	relType_15=advcl	relType_13=case	lemma_1=can	lib=be	pos_13=JJ	relType_3=ROOT	pos_15=NN	pos_4=IN	lemma_8=diuretic	relType_4=case	relType_2=aux:pass	lemma_13=prior	lemma_12=intake	pos_1=MD	relType_17=nmod	lpib=be_VB	path2=discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod	lemma_18=with	relType_16=case	pos_11=NN	pos_10=DT	eib=True	relType_11=compound	lemma_2=be	lemma_7=the	relType_14=case	pos_12=NN	relType_5=cc:preconj	relType_8=cc	lemma_4=by	lemma_6=discontinue	lemma_5=either
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e1	DDI-DrugBank.d107.s1.e4	null	path=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	relType_9=conj	pos_5=CC	relType_1=aux	relType_7=det	relType_10=det	pos_16=IN	pos_3=VBN	lemma_9=increase	relType_18=case	wib=be	pos_8=NN	pos_6=VBG	relType_6=obl	pos_17=NN	relType_19=nmod	lemma_11=salt	path1=enalaprilat_conj<enalapril_nmod<effect_nmod<possibility_nsubj:pass	lemma_3=minimize	lemma_14=to	lemma_17=treatment	lemma_10=the	relType_8=obj	lemma_15=initiation	pos_2=VB	relType_12=obj	pos_8=CC	lemma_8=or	lemma_16=of	pos_19=NN	pos_18=IN	pos_7=DT	relation_9=beneficial	pos_9=VBG	pos_14=IN	relType_15=advcl	relType_13=case	lemma_1=can	lib=be	pos_13=JJ	relType_3=ROOT	pos_15=NN	pos_4=IN	lemma_8=diuretic	relType_4=case	relType_2=aux:pass	lemma_13=prior	pos_19=CC	lemma_12=intake	lemma_19=enalapril	pos_1=MD	relType_19=cc	relType_17=nmod	lpib=be_VB	lemma_19=or	lemma_18=with	relType_16=case	pos_11=NN	pos_10=DT	eib=True	relType_11=compound	path2=discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	lemma_2=be	lemma_7=the	relType_14=case	pos_12=NN	relType_5=cc:preconj	relType_8=cc	lemma_4=by	lemma_6=discontinue	lemma_5=either
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e2	DDI-DrugBank.d107.s1.e3	null	relType_1=cc	pos_1=CC	pos_6=JJ	relType_7=case	relType_8=advcl	pos_9=IN	relType_6=case	relType_11=case	path1=diuretic_obj	lemma_11=with	relation_1=beneficial	pos_8=NN	lemma_6=prior	relType_10=nmod	eib=False	lemma_5=intake	lemma_7=to	path=diuretic_obj<discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod	lemma_10=treatment	relType_9=case	wib=increasing	relType_3=det	relType_2=conj	pos_4=NN	lib=increase	lemma_8=initiation	lemma_2=increase	pos_10=NN	pos_11=IN	relType_4=compound	lemma_4=salt	pos_5=NN	path2=increase_conj>initiation_advcl>enalapril_nmod	pos_3=DT	pos_7=IN	lemma_9=of	relType_5=obj	lpib=increase_VBG	lemma_3=the	lemma_1=or	pos_2=VBG
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e2	DDI-DrugBank.d107.s1.e4	null	relType_1=cc	pos_1=CC	pos_6=JJ	relType_7=case	relType_12=cc	relType_8=advcl	pos_9=IN	lemma_12=enalapril	pos_12=CC	relType_6=case	relType_11=case	path1=diuretic_obj	lemma_11=with	relation_1=beneficial	pos_8=NN	lemma_6=prior	relType_10=nmod	lemma_5=intake	path2=increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	lemma_7=to	lemma_10=treatment	relType_12=nmod	relType_9=case	wib=increasing	relType_3=det	relType_2=conj	pos_4=NN	lib=increase	lemma_8=initiation	lemma_2=increase	pos_10=NN	pos_11=IN	lemma_12=or	relType_4=compound	lemma_4=salt	path=diuretic_obj<discontinue_obl>increase_conj>initiation_advcl>enalapril_nmod>enalaprilat_conj	pos_5=NN	eib=True	pos_3=DT	pos_7=IN	lemma_9=of	relType_5=obj	lpib=increase_VBG	lemma_3=the	pos_12=NN	lemma_1=or	pos_2=VBG
DDI-DrugBank.d107.s1	DDI-DrugBank.d107.s1.e3	DDI-DrugBank.d107.s1.e4	null	relType_1=cc	pos_1=CC	path2=enalaprilat_conj	eib=False	lpib=enalaprilat_NN	path1=	path=<enalapril_nmod>enalaprilat_conj	wib=enalaprilat	lib=enalaprilat	lemma_1=or
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e0	DDI-DrugBank.d107.s3.e1	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	wib=enalapril	path1=	path=<enalapril_nmod>iv_conj>enalapril_compound	lib=enalapril	path2=iv_conj>enalapril_compound	lpib=enalapril_NN
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e0	DDI-DrugBank.d107.s3.e2	effect	relType_1=cc	pos_1=CC	pos_2=NN	pos_6=JJ	relation_4=beneficial	path2=agent_obl	lemma_5=by	relType_3=aux:pass	relType_5=case	lemma_6=antihypertensive	relType_6=amod	pos_3=VBZ	lemma_2=enalapril	relType_2=conj	lpib=enalapril_NN	pos_4=VBN	relType_4=parataxis	path1=enalapril_nmod<effect_nsubj:pass	relType_2=compound	path=enalapril_nmod<effect_nsubj:pass<augment_parataxis>agent_obl	lemma_3=be	pos_5=IN	lemma_2=iv	lib=enalapril	eib=True	wib=enalapril	lemma_4=augment	lemma_1=and
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e0	DDI-DrugBank.d107.s3.e3	effect	relType_1=cc	pos_1=CC	lemma_6=agent	relType_10=punct	pos_2=NN	pos_6=JJ	relType_6=nsubj	pos_13=,	lemma_13=,	relation_4=beneficial	relation_9=neutral	relType_13=punct	lemma_5=by	relType_3=aux:pass	relType_5=case	lemma_6=antihypertensive	pos_8=NN	relType_6=obl	pos_10=-LRB-	relType_6=amod	pos_3=VBZ	lemma_11=e.	lemma_2=enalapril	relType_2=conj	lemma_4=augment	lpib=enalapril_NN	pos_4=VBN	relType_4=parataxis	pos_9=NN	path1=enalapril_nmod<effect_nsubj:pass	lemma_9=release	relType_2=compound	pos_6=WDT	lemma_3=be	relType_8=compound	relType_9=obj	pos_5=IN	lemma_10=(	lemma_2=iv	lib=enalapril	lemma_7=cause	lemma_12=g.	pos_11=NN	eib=True	relType_12=appos	relType_11=compound	wib=enalapril	relType_7=ccomp	pos_6=NNS	path=enalapril_nmod<effect_nsubj:pass<augment_parataxis>cause_ccomp>release_obj>g._appos>diuretic_dep	lemma_8=renin	lemma_6=that	pos_12=NN	pos_7=VBP	path2=cause_ccomp>release_obj>g._appos>diuretic_dep	lemma_1=and
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e1	DDI-DrugBank.d107.s3.e2	effect	lib=iv	pos_3=VBN	path2=agent_obl	lemma_5=antihypertensive	pos_1=NN	pos_5=JJ	relType_5=amod	pos_4=IN	lpib=iv_NN	relType_4=case	relType_2=aux:pass	relType_3=parataxis	relType_1=conj	path=enalapril_compound<iv_conj<enalapril_nmod<effect_nsubj:pass<augment_parataxis>agent_obl	path1=enalapril_compound<iv_conj<enalapril_nmod<effect_nsubj:pass	lemma_3=augment	pos_2=VBZ	wib=IV	lemma_1=iv	eib=True	lemma_2=be	relation_2=beneficial	lemma_4=by
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e1	DDI-DrugBank.d107.s3.e3	effect	relType_7=compound	lib=iv	pos_3=VBN	relType_5=nsubj	lemma_5=antihypertensive	pos_8=NN	lemma_12=,	lemma_6=cause	pos_5=NNS	lemma_10=e.	pos_12=,	lemma_9=(	lemma_5=agent	relType_8=obj	relType_10=compound	relType_12=punct	pos_10=NN	pos_1=NN	relation_2=beneficial	pos_5=JJ	relType_11=appos	relType_5=amod	lemma_5=that	pos_4=IN	pos_5=WDT	lpib=iv_NN	lemma_11=g.	relType_4=case	relType_2=aux:pass	relType_6=ccomp	pos_6=VBP	relType_3=parataxis	relType_5=obl	lemma_7=renin	pos_9=-LRB-	relType_9=punct	relType_1=conj	path1=enalapril_compound<iv_conj<enalapril_nmod<effect_nsubj:pass	lemma_3=augment	relation_7=neutral	pos_2=VBZ	wib=IV	pos_11=NN	lemma_1=iv	eib=True	path=enalapril_compound<iv_conj<enalapril_nmod<effect_nsubj:pass<augment_parataxis>cause_ccomp>release_obj>g._appos>diuretic_dep	lemma_8=release	lemma_2=be	pos_7=NN	path2=cause_ccomp>release_obj>g._appos>diuretic_dep	lemma_4=by
DDI-DrugBank.d107.s3	DDI-DrugBank.d107.s3.e2	DDI-DrugBank.d107.s3.e3	null	relation_1=neutral	relType_7=appos	relType_8=punct	lemma_8=,	lemma_6=e.	lpib=cause_VBP	lib=cause	pos_6=NN	lemma_3=renin	eib=False	lemma_5=(	lemma_1=that	pos_4=NN	relType_4=obj	lemma_2=cause	relType_5=punct	wib=cause	relType_1=nsubj	pos_2=VBP	lemma_7=g.	path=agent_obl<augment_parataxis>cause_ccomp>release_obj>g._appos>diuretic_dep	relType_2=ccomp	relType_6=compound	pos_3=NN	pos_8=,	path1=agent_obl	relType_3=compound	pos_7=NN	path2=cause_ccomp>release_obj>g._appos>diuretic_dep	lemma_4=release	pos_1=WDT	pos_5=-LRB-
DDI-DrugBank.d107.s4	DDI-DrugBank.d107.s4.e0	DDI-DrugBank.d107.s4.e1	null	path2=result_dep>patient_obl>treat_acl:relcl>drug_obl	lemma_14=nonsteroidal	relType_14=amod	relType_14=punct	lemma_8=function	relType_14=obl:npmod	path1=	lemma_13=with	lemma_11=be	lemma_9=who	relType_5=case	lemma_6=compromise	pos_2=IN	pos_8=NN	wib=patients	lpib=patient_NNS	relType_10=aux	relType_6=amod	lemma_5=with	lemma_7=renal	relType_11=aux:pass	pos_6=VBN	pos_13=IN	relType_3=det	lemma_4=patient	pos_14=AFX	pos_4=NNS	lemma_1=:	lemma_14=anti	lemma_3=some	relType_13=case	lemma_12=treat	relType_4=obl	relType_7=amod	lemma_14=-	lib=patient	path=<agent_ROOT>result_dep>patient_obl>treat_acl:relcl>drug_obl	pos_1=:	relType_9=obj	pos_5=IN	pos_11=VBG	relType_12=acl:relcl	lemma_14=inflammatory	pos_14=HYPH	relType_2=case	pos_10=VBP	eib=True	pos_3=DT	relType_8=nmod	pos_7=JJ	pos_14=JJ	pos_12=VBN	relType_1=punct	lemma_2=in	lemma_10=be	pos_9=WP
DDI-DrugBank.d107.s4	DDI-DrugBank.d107.s4.e0	DDI-DrugBank.d107.s4.e2	null	lemma_14=nonsteroidal	relType_14=amod	relType_14=punct	pos_19=IN	lemma_8=function	path2=result_dep>administration_nsubj>enalapril_nmod	relType_17=punct	relType_14=obl:npmod	path1=	lemma_13=with	lemma_11=be	lemma_9=who	relType_16=compound	relType_5=case	lemma_6=compromise	pos_2=IN	pos_8=NN	wib=patients	lpib=patient_NNS	relType_10=aux	lemma_15=the	pos_14=,	relType_6=amod	pos_17=HYPH	lemma_5=with	lemma_7=renal	relType_11=aux:pass	pos_6=VBN	pos_13=IN	relType_3=det	lemma_4=patient	pos_14=AFX	pos_4=NNS	lemma_1=:	lemma_14=anti	relType_14=obl	lemma_3=some	pos_15=DT	relType_13=case	lemma_16=co	lemma_12=treat	relType_4=obl	relType_7=amod	lemma_14=drug	pos_18=NN	lemma_19=of	lemma_14=-	lemma_17=-	lib=patient	pos_1=:	relType_9=obj	pos_5=IN	pos_11=VBG	pos_16=NN	relType_12=acl:relcl	lemma_14=inflammatory	path=<agent_ROOT>result_dep>administration_nsubj>enalapril_nmod	pos_14=HYPH	lemma_14=,	relType_2=case	pos_10=VBP	eib=True	pos_3=DT	relType_8=nmod	lemma_18=administration	relType_19=case	pos_7=JJ	relType_18=nsubj	pos_14=JJ	pos_14=NNS	pos_12=VBN	relType_1=punct	relType_15=det	lemma_2=in	lemma_10=be	pos_9=WP
DDI-DrugBank.d107.s4	DDI-DrugBank.d107.s4.e1	DDI-DrugBank.d107.s4.e2	effect	path=drug_obl<treat_acl:relcl<patient_obl<result_dep>administration_nsubj>enalapril_nmod	pos_2=DT	lemma_1=,	path2=administration_nsubj>enalapril_nmod	lemma_2=the	pos_1=,	lemma_4=-	relType_5=nsubj	lemma_6=of	pos_4=HYPH	relType_6=case	eib=False	pos_6=IN	lpib=co_NN	relType_4=punct	lemma_3=co	pos_5=NN	pos_3=NN	relType_2=det	wib=co	relType_3=compound	relType_1=punct	lib=co	lemma_5=administration	path1=drug_obl<treat_acl:relcl<patient_obl
DDI-DrugBank.d107.s6	DDI-DrugBank.d107.s6.e0	DDI-DrugBank.d107.s6.e1	null	relType_1=cc	wib=sulindac	pos_1=CC	eib=False	lib=sulindac	path1=	path=<indomethacin_nsubj:pass>sulindac_conj	lpib=sulindac_NN	path2=sulindac_conj	lemma_1=or
DDI-DrugBank.d107.s6	DDI-DrugBank.d107.s6.e0	DDI-DrugBank.d107.s6.e2	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_3=VBN	pos_7=VBG	relType_7=acl	relType_6=obl	lemma_3=administer	lemma_6=patient	lemma_5=hypertensive	path2=patient_obl>receive_acl>vasotec_obj	pos_2=VBD	relType_2=conj	lpib=sulindac_NN	lemma_2=sulindac	wib=sulindac	pos_5=JJ	relType_5=amod	relType_3=ROOT	lemma_4=to	pos_4=IN	path1=indomethacin_nsubj:pass	lib=sulindac	relType_4=case	relType_2=aux:pass	lemma_7=receive	eib=True	path=indomethacin_nsubj:pass<administer_ROOT>patient_obl>receive_acl>vasotec_obj	pos_6=NNS	lemma_2=be	lemma_1=or
DDI-DrugBank.d107.s6	DDI-DrugBank.d107.s6.e1	DDI-DrugBank.d107.s6.e2	null	relType_4=amod	pos_2=VBN	pos_4=JJ	pos_3=IN	relType_1=aux:pass	lemma_2=administer	lemma_5=patient	lemma_6=receive	lemma_4=hypertensive	pos_6=VBG	pos_1=VBD	eib=False	pos_5=NNS	lemma_1=be	path2=patient_obl>receive_acl>vasotec_obj	lib=be	relType_2=ROOT	relType_6=acl	lemma_3=to	relType_5=obl	wib=was	relType_3=case	path=sulindac_conj<indomethacin_nsubj:pass<administer_ROOT>patient_obl>receive_acl>vasotec_obj	lpib=be_VBD	path1=sulindac_conj<indomethacin_nsubj:pass
DDI-DrugBank.d107.s8	DDI-DrugBank.d107.s8.e0	DDI-DrugBank.d107.s8.e1	effect	path=nsaid_nsubj<diminish_ccomp>effect_obj>inhibitor_nmod	lemma_2=diminish	relType_4=amod	pos_4=JJ	relType_7=compound	relType_1=aux	lemma_1=may	lemma_6=of	relType_6=case	lemma_4=antihypertensive	pos_6=IN	lib=diminish	pos_2=VB	relType_3=det	lemma_7=ace	lemma_5=effect	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	path2=effect_obj>inhibitor_nmod	pos_3=DT	relType_5=obj	lpib=diminish_VB	lemma_3=the	relation_4=neutral	pos_7=NN	wib=diminish	path1=nsaid_nsubj
DDI-DrugBank.d107.s9	DDI-DrugBank.d107.s9.e0	DDI-DrugBank.d107.s9.e1	advise	pos_2=IN	path=nsaid_obj<take_acl>inhibitor_obl	lib=concomitantly	relType_2=case	lemma_2=with	eib=True	pos_1=RB	pos_3=NN	lemma_1=concomitantly	wib=concomitantly	lemma_3=ace	lpib=concomitantly_RB	path1=nsaid_obj	relType_3=compound	path2=inhibitor_obl	relType_1=advmod
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e1	null	relType_1=cc	path2=IV_conj>enalapril_compound	pos_1=CC	lpib=enalapril_NNP	path=<Enalapril_nsubj:pass>IV_conj>enalapril_compound	eib=False	wib=enalapril	path1=	lib=enalapril	lemma_1=and
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e2	null	relType_1=cc	pos_1=CC	relType_8=dep	relType_7=case	path1=Enalapril_nsubj:pass	lemma_4=be	relType_8=amod	path2=agent_obl	relType_5=parataxis	relType_8=punct	path=Enalapril_nsubj:pass<use_parataxis>agent_obl	lemma_7=with	pos_8=NN	pos_8=JJ	relation_11=adverse	pos_2=NNP	pos_8=HYPH	lemma_2=enalapril	relType_2=conj	lemma_8=beta	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	relType_2=compound	pos_8=VBG	relType_8=compound	relType_4=aux:pass	lemma_5=use	pos_6=RB	lib=enalapril	lemma_8=block	lpib=enalapril_NNP	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_8=adrenergic	relType_3=aux	lemma_3=have	relType_6=advmod	pos_5=VBN	lemma_1=and	pos_3=VBP
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e3	null	relType_1=cc	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>methyldopa_conj	pos_1=CC	relType_8=dep	relType_7=case	path1=Enalapril_nsubj:pass	lemma_4=be	relType_8=amod	relType_5=parataxis	relType_8=punct	lemma_8=,	lemma_7=with	pos_8=NNS	relType_8=obl	pos_8=NN	pos_8=JJ	relation_11=adverse	pos_2=NNP	pos_8=HYPH	lemma_2=enalapril	relType_2=conj	lemma_8=beta	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	relType_2=compound	pos_8=VBG	path2=agent_obl>methyldopa_conj	relType_8=compound	relType_4=aux:pass	lemma_8=agent	lemma_5=use	pos_6=RB	lib=enalapril	lemma_8=block	lpib=enalapril_NNP	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_8=adrenergic	relType_3=aux	lemma_3=have	relType_6=advmod	pos_5=VBN	lemma_1=and	pos_8=,	pos_3=VBP
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e4	null	relType_1=cc	lemma_9=methyldopa	pos_1=CC	relType_8=dep	relType_7=case	path1=Enalapril_nsubj:pass	lemma_4=be	relType_8=amod	relType_9=conj	relType_5=parataxis	path2=agent_obl>nitrate_conj	relType_8=punct	lemma_9=,	lemma_8=,	lemma_7=with	pos_8=NNS	relType_8=obl	pos_8=NN	pos_8=JJ	relation_11=adverse	pos_2=NNP	pos_8=HYPH	lemma_2=enalapril	relType_2=conj	lemma_8=beta	pos_9=NN	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	relType_2=compound	pos_8=VBG	relType_8=compound	relType_4=aux:pass	lemma_8=agent	lemma_5=use	pos_6=RB	lib=enalapril	relType_9=punct	lemma_8=block	lpib=enalapril_NNP	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>nitrate_conj	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_8=adrenergic	relType_3=aux	pos_9=,	lemma_3=have	relType_6=advmod	pos_5=VBN	lemma_1=and	pos_8=,	pos_3=VBP
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e5	null	relType_1=cc	lemma_9=methyldopa	pos_1=CC	relType_10=punct	relType_8=dep	relType_7=case	path1=Enalapril_nsubj:pass	lemma_4=be	relType_8=amod	relType_9=conj	lemma_10=,	lemma_11=calcium	lemma_10=nitrate	relType_5=parataxis	relType_8=punct	lemma_11=-	lemma_9=,	lemma_8=,	lemma_7=with	pos_8=NNS	relType_8=obl	pos_11=HYPH	pos_8=NN	pos_8=JJ	pos_10=NNS	lemma_11=block	relation_11=adverse	pos_2=NNP	relType_10=conj	relType_11=punct	relType_11=amod	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>agent_conj	pos_8=HYPH	lemma_2=enalapril	relType_2=conj	lemma_8=beta	pos_9=NN	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	relType_2=compound	path2=agent_obl>agent_conj	relType_8=compound	pos_8=VBG	relType_4=aux:pass	lemma_8=agent	pos_11=VBG	relType_11=obl	lemma_5=use	pos_6=RB	lib=enalapril	relType_9=punct	lemma_8=block	lpib=enalapril_NNP	pos_10=,	pos_11=NN	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_8=adrenergic	relType_3=aux	relation_20=adverse	pos_9=,	lemma_3=have	relType_6=advmod	pos_5=VBN	lemma_1=and	pos_8=,	pos_3=VBP
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e6	null	relType_1=cc	lemma_9=methyldopa	pos_1=CC	relType_10=punct	path2=agent_obl>hydralazine_conj	relType_8=dep	relType_7=case	path1=Enalapril_nsubj:pass	lemma_4=be	relType_8=amod	relType_9=conj	lemma_10=,	lemma_11=calcium	lemma_11=,	lemma_10=nitrate	relType_5=parataxis	relType_8=punct	lemma_11=-	lemma_9=,	lemma_8=,	lemma_7=with	pos_8=NNS	relType_8=obl	pos_11=HYPH	lemma_11=agent	pos_8=NN	pos_8=JJ	pos_10=NNS	lemma_11=block	relType_11=conj	relation_11=adverse	pos_2=NNP	relType_10=conj	relType_11=punct	relType_11=amod	pos_11=NNS	pos_8=HYPH	lemma_2=enalapril	relType_2=conj	lemma_8=beta	pos_9=NN	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	relType_2=compound	pos_8=VBG	relType_8=compound	relType_4=aux:pass	lemma_8=agent	pos_11=VBG	relType_11=obl	lemma_5=use	pos_6=RB	lib=enalapril	relType_9=punct	pos_11=,	lemma_8=block	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>hydralazine_conj	lpib=enalapril_NNP	pos_10=,	pos_11=NN	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_8=adrenergic	relType_3=aux	relation_20=adverse	pos_9=,	lemma_3=have	relType_6=advmod	pos_5=VBN	lemma_1=and	pos_8=,	pos_3=VBP
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e7	null	relType_1=cc	lemma_9=methyldopa	lemma_4=be	lemma_10=,	lemma_11=calcium	relType_8=punct	lemma_9=,	lemma_7=with	pos_8=NNS	pos_8=JJ	lemma_12=,	pos_2=NNP	pos_12=,	relType_4=aux:pass	pos_11=VBG	pos_10=,	pos_7=IN	lemma_8=-	relType_3=aux	relation_20=adverse	pos_3=VBP	relType_7=case	path1=Enalapril_nsubj:pass	lemma_12=hydralazine	pos_8=NN	lemma_11=block	relType_10=conj	relType_11=amod	pos_8=HYPH	relType_12=punct	lemma_2=enalapril	relType_2=conj	pos_9=NN	pos_4=VBN	lemma_6=concomitantly	lemma_2=IV	pos_8=VBG	lemma_8=agent	lemma_5=use	pos_6=RB	lib=enalapril	lemma_8=block	pos_11=NN	pos_9=,	lemma_3=have	lemma_1=and	pos_8=,	relType_10=punct	relType_8=dep	lemma_11=,	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>prazosin_conj	relType_5=parataxis	lemma_11=-	lemma_8=,	relType_11=conj	relation_11=adverse	relType_11=punct	relType_8=compound	relType_11=obl	lpib=enalapril_NNP	wib=enalapril	lemma_8=adrenergic	pos_1=CC	relType_12=conj	relType_9=conj	relType_8=amod	lemma_10=nitrate	relType_8=obl	pos_11=HYPH	lemma_11=agent	pos_5=VBN	pos_11=NNS	lemma_8=beta	path2=agent_obl>prazosin_conj	relType_2=compound	pos_11=,	relType_9=punct	eib=True	pos_12=NN	relType_6=advmod	pos_10=NNS
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e0	DDI-DrugBank.d107.s10.e8	null	relType_1=cc	lemma_9=methyldopa	lemma_4=be	lemma_10=,	lemma_11=calcium	relType_8=punct	lemma_9=,	lemma_7=with	pos_8=NNS	pos_8=JJ	lemma_12=,	pos_2=NNP	pos_12=,	lemma_13=and	pos_13=NN	relType_4=aux:pass	pos_11=VBG	path=Enalapril_nsubj:pass<use_parataxis>agent_obl>digoxin_conj	pos_10=,	pos_7=IN	lemma_8=-	relType_3=aux	relation_20=adverse	pos_3=VBP	relType_7=case	path1=Enalapril_nsubj:pass	lemma_12=hydralazine	pos_8=NN	lemma_11=block	relType_10=conj	relType_11=amod	pos_8=HYPH	relType_12=punct	relType_13=conj	lemma_2=enalapril	relType_2=conj	pos_9=NN	pos_4=VBN	relType_13=cc	lemma_6=concomitantly	lemma_2=IV	pos_8=VBG	lemma_8=agent	lemma_5=use	pos_6=RB	lib=enalapril	lemma_8=block	pos_11=NN	pos_9=,	lemma_3=have	lemma_1=and	pos_8=,	relType_10=punct	relType_8=dep	lemma_11=,	relType_5=parataxis	lemma_11=-	lemma_8=,	relType_11=conj	relation_11=adverse	relType_11=punct	path2=agent_obl>digoxin_conj	relType_8=compound	relType_11=obl	pos_13=CC	lpib=enalapril_NNP	wib=enalapril	lemma_8=adrenergic	pos_1=CC	relType_12=conj	relType_9=conj	relType_8=amod	lemma_10=nitrate	relType_8=obl	pos_11=HYPH	lemma_11=agent	pos_5=VBN	lemma_13=prazosin	pos_11=NNS	lemma_8=beta	relType_2=compound	pos_11=,	relType_9=punct	eib=True	pos_12=NN	relType_6=advmod	pos_10=NNS
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e2	null	relType_7=compound	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	lemma_7=adrenergic	path2=agent_obl	pos_7=VBG	relation_9=adverse	lemma_4=use	relType_3=aux:pass	relType_6=case	lemma_7=-	lpib=iv_NNP	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl	pos_6=IN	relType_2=aux	relType_4=parataxis	pos_4=VBN	lemma_5=concomitantly	relType_7=amod	pos_7=HYPH	lemma_3=be	pos_5=RB	pos_2=VBP	lemma_6=with	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	lemma_1=IV	wib=IV	relType_7=dep	eib=True	relType_7=punct	lemma_7=beta	pos_7=JJ	pos_7=NN
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e3	null	pos_7=NNS	relType_7=compound	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	lemma_7=adrenergic	pos_7=VBG	relation_9=adverse	lemma_4=use	relType_3=aux:pass	relType_6=case	lemma_7=-	lpib=iv_NNP	pos_6=IN	pos_7=,	relType_2=aux	lemma_7=,	relType_4=parataxis	pos_4=VBN	lemma_5=concomitantly	relType_7=amod	pos_7=HYPH	path2=agent_obl>methyldopa_conj	lemma_3=be	pos_5=RB	lemma_7=agent	pos_2=VBP	lemma_6=with	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	lemma_1=IV	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>methyldopa_conj	wib=IV	relType_7=dep	relType_7=obl	eib=True	relType_7=punct	lemma_7=beta	pos_7=JJ	pos_7=NN
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e4	null	pos_7=NNS	relType_7=compound	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	lemma_7=adrenergic	pos_7=VBG	relation_9=adverse	path2=agent_obl>nitrate_conj	relType_8=punct	lemma_4=use	relType_3=aux:pass	lemma_8=,	relType_6=case	pos_8=NN	lemma_7=-	lpib=iv_NNP	pos_6=IN	pos_7=,	relType_2=aux	lemma_7=,	relType_4=parataxis	pos_4=VBN	lemma_5=concomitantly	relType_7=amod	pos_7=HYPH	lemma_3=be	pos_5=RB	lemma_7=agent	lemma_8=methyldopa	pos_2=VBP	lemma_6=with	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	lemma_1=IV	wib=IV	relType_7=dep	relType_7=obl	eib=True	relType_7=punct	lemma_7=beta	pos_7=JJ	relType_8=conj	pos_7=NN	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>nitrate_conj	pos_8=,
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e5	null	pos_7=NNS	relType_7=compound	relType_10=punct	relType_9=conj	lemma_10=calcium	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	lemma_7=adrenergic	pos_7=VBG	relType_10=amod	relation_9=adverse	relType_8=punct	lemma_4=use	lemma_9=,	relType_3=aux:pass	lemma_8=,	relType_6=case	lemma_10=block	pos_8=NN	lemma_7=-	lpib=iv_NNP	pos_6=IN	pos_9=NNS	pos_7=,	relType_2=aux	pos_10=NN	lemma_7=,	pos_4=VBN	relType_4=parataxis	lemma_10=-	lemma_5=concomitantly	relType_7=amod	pos_7=HYPH	path2=agent_obl>agent_conj	pos_10=HYPH	lemma_3=be	pos_5=RB	lemma_7=agent	lemma_8=methyldopa	pos_2=VBP	lemma_6=with	relType_9=punct	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	relation_18=adverse	lemma_1=IV	wib=IV	relType_7=dep	relType_7=obl	eib=True	relType_7=punct	lemma_9=nitrate	lemma_7=beta	pos_7=JJ	relType_8=conj	pos_10=VBG	pos_9=,	pos_7=NN	relType_10=obl	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>agent_conj	pos_8=,
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e6	null	pos_7=NNS	relType_7=compound	relType_10=punct	path2=agent_obl>hydralazine_conj	relType_9=conj	lemma_10=calcium	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	lemma_7=adrenergic	pos_7=VBG	relType_10=amod	lemma_10=,	relation_9=adverse	relType_8=punct	lemma_4=use	lemma_9=,	relType_3=aux:pass	lemma_8=,	relType_6=case	lemma_10=block	pos_8=NN	lemma_7=-	lpib=iv_NNP	relType_10=conj	pos_6=IN	pos_9=NNS	pos_7=,	relType_2=aux	pos_10=NN	lemma_7=,	relType_4=parataxis	pos_4=VBN	lemma_10=-	lemma_10=agent	lemma_5=concomitantly	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>hydralazine_conj	relType_7=amod	pos_7=HYPH	pos_10=HYPH	lemma_3=be	pos_5=RB	lemma_7=agent	lemma_8=methyldopa	pos_2=VBP	lemma_6=with	relType_9=punct	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	relation_18=adverse	lemma_1=IV	wib=IV	relType_7=dep	relType_7=obl	eib=True	pos_10=,	relType_7=punct	lemma_9=nitrate	lemma_7=beta	pos_7=JJ	relType_8=conj	pos_10=VBG	pos_9=,	pos_7=NN	relType_10=obl	pos_10=NNS	pos_8=,
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e7	null	pos_7=NNS	relType_7=compound	relType_10=punct	relType_9=conj	lemma_10=calcium	lemma_11=,	lemma_2=have	lib=iv	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>prazosin_conj	lemma_7=adrenergic	pos_7=VBG	relType_10=amod	lemma_10=,	relType_8=punct	relation_9=adverse	lemma_4=use	lemma_9=,	relType_3=aux:pass	lemma_8=,	relType_6=case	lemma_10=block	relType_11=conj	pos_8=NN	lemma_7=-	lpib=iv_NNP	relType_10=conj	pos_6=IN	relType_11=punct	pos_9=NNS	pos_7=,	relType_2=aux	pos_10=NN	lemma_7=,	pos_4=VBN	relType_4=parataxis	path2=agent_obl>prazosin_conj	lemma_10=-	lemma_10=agent	lemma_5=concomitantly	lemma_11=hydralazine	relType_7=amod	pos_7=HYPH	pos_10=HYPH	lemma_3=be	pos_5=RB	lemma_7=agent	lemma_8=methyldopa	pos_2=VBP	lemma_6=with	pos_11=,	relType_9=punct	relType_1=conj	pos_1=NNP	lemma_7=block	relType_5=advmod	relation_18=adverse	lemma_1=IV	wib=IV	relType_7=dep	relType_7=obl	eib=True	pos_10=,	pos_11=NN	relType_7=punct	lemma_9=nitrate	lemma_7=beta	pos_7=JJ	relType_8=conj	pos_10=VBG	pos_9=,	pos_7=NN	relType_10=obl	pos_10=NNS	pos_8=,
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e1	DDI-DrugBank.d107.s10.e8	null	lemma_10=,	relType_8=punct	lemma_9=,	pos_12=CC	relType_3=aux:pass	lpib=iv_NNP	pos_10=NN	lemma_7=,	relType_4=parataxis	lemma_11=hydralazine	lemma_12=prazosin	pos_7=HYPH	lemma_3=be	path=enalapril_compound<IV_conj<Enalapril_nsubj:pass<use_parataxis>agent_obl>digoxin_conj	wib=IV	pos_10=,	pos_7=JJ	relType_8=conj	pos_7=NNS	relation_9=adverse	relType_6=case	pos_8=NN	relType_10=conj	pos_6=IN	pos_4=VBN	pos_2=VBP	relType_1=conj	pos_1=NNP	relType_5=advmod	lemma_1=IV	relType_7=obl	relType_7=dep	pos_11=NN	lemma_7=beta	pos_9=,	pos_7=NN	pos_8=,	relType_10=punct	lemma_10=calcium	lemma_11=,	lib=iv	pos_7=VBG	relType_12=cc	lemma_8=,	relType_11=conj	relType_11=punct	pos_7=,	relType_2=aux	lemma_5=concomitantly	relType_7=amod	path2=agent_obl>digoxin_conj	lemma_7=block	lemma_9=nitrate	lemma_12=and	pos_10=VBG	relType_10=obl	relType_7=compound	relType_12=conj	relType_9=conj	lemma_2=have	lemma_7=adrenergic	pos_3=VBN	path1=enalapril_compound<IV_conj<Enalapril_nsubj:pass	relType_10=amod	lemma_4=use	lemma_10=block	lemma_7=-	pos_9=NNS	lemma_10=-	lemma_10=agent	pos_10=HYPH	pos_5=RB	lemma_7=agent	lemma_8=methyldopa	lemma_6=with	pos_11=,	relType_9=punct	relation_18=adverse	eib=True	relType_7=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e3	null	lemma_1=,	lib=methyldopa	eib=False	path1=	pos_1=,	lpib=methyldopa_NN	path=<agent_obl>methyldopa_conj	relType_1=punct	wib=methyldopa	path2=methyldopa_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e4	null	path=<agent_obl>nitrate_conj	lemma_1=,	pos_2=NN	lib=methyldopa	eib=True	lemma_2=methyldopa	path1=	path2=nitrate_conj	pos_1=,	pos_2=,	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e5	null	relType_4=amod	lemma_1=,	pos_2=NN	path2=agent_conj	path1=	pos_1=,	lemma_4=-	pos_4=HYPH	relType_2=punct	pos_3=NNS	lemma_4=block	relation_7=adverse	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=obl	relType_4=punct	lemma_3=,	path=<agent_obl>agent_conj	lemma_2=methyldopa	relType_3=conj	pos_4=VBG	pos_3=,	lemma_4=calcium	lib=methyldopa	eib=True	pos_2=,	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_3=punct	lemma_3=nitrate
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e6	null	relType_4=amod	lemma_1=,	pos_2=NN	path1=	pos_1=,	lemma_4=-	pos_4=HYPH	relType_2=punct	pos_3=NNS	lemma_4=block	pos_4=,	relation_7=adverse	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	relType_4=obl	relType_4=punct	lemma_3=,	lemma_2=methyldopa	relType_3=conj	lemma_4=agent	lemma_4=,	path=<agent_obl>hydralazine_conj	pos_4=VBG	pos_3=,	lemma_4=calcium	lib=methyldopa	eib=True	pos_2=,	relType_4=conj	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_3=punct	lemma_3=nitrate	path2=hydralazine_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e7	null	relType_4=amod	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_4=-	pos_4=HYPH	relType_2=punct	path2=prazosin_conj	pos_3=NNS	lemma_4=block	pos_4=,	relation_7=adverse	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	relType_4=obl	relType_4=punct	lemma_3=,	lemma_2=methyldopa	relType_3=conj	lemma_5=,	lemma_4=agent	relType_5=punct	lemma_4=,	relType_5=conj	pos_4=VBG	lemma_5=hydralazine	path=<agent_obl>prazosin_conj	pos_5=NN	pos_3=,	lemma_4=calcium	lib=methyldopa	eib=True	pos_2=,	relType_4=conj	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_3=punct	lemma_3=nitrate
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e2	DDI-DrugBank.d107.s10.e8	null	relType_4=amod	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_4=-	pos_4=HYPH	relType_2=punct	pos_6=NN	relType_6=conj	pos_3=NNS	lemma_4=block	pos_4=,	lemma_6=prazosin	path2=digoxin_conj	relation_7=adverse	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	relType_4=obl	relType_4=punct	lemma_3=,	pos_6=CC	lemma_2=methyldopa	relType_3=conj	lemma_5=,	lemma_4=agent	relType_5=punct	lemma_6=and	lemma_4=,	relType_5=conj	pos_4=VBG	lemma_5=hydralazine	path=<agent_obl>digoxin_conj	pos_5=NN	pos_3=,	lemma_4=calcium	lib=methyldopa	eib=True	pos_2=,	relType_4=conj	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_3=punct	lemma_3=nitrate	relType_6=cc
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e3	DDI-DrugBank.d107.s10.e4	null	path=methyldopa_conj<agent_obl>nitrate_conj	lemma_1=,	eib=False	lpib=nitrate_NNS	path1=methyldopa_conj	path2=nitrate_conj	pos_1=,	wib=nitrates	lib=nitrate	relType_1=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e3	DDI-DrugBank.d107.s10.e5	null	lemma_1=,	lpib=nitrate_NNS	path2=agent_conj	pos_1=,	relation_5=adverse	relType_2=punct	lemma_3=calcium	lemma_3=-	lib=nitrate	pos_3=VBG	relType_2=conj	lemma_2=,	relType_3=amod	path1=methyldopa_conj	wib=nitrates	lemma_2=nitrate	pos_2=NNS	relType_3=obl	eib=True	pos_3=NN	pos_3=HYPH	path=methyldopa_conj<agent_obl>agent_conj	lemma_3=block	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e3	DDI-DrugBank.d107.s10.e6	null	lemma_1=,	lpib=nitrate_NNS	pos_1=,	lemma_3=agent	relation_5=adverse	relType_2=punct	pos_3=NNS	lemma_3=calcium	lemma_3=-	lib=nitrate	pos_3=VBG	relType_2=conj	lemma_2=,	relType_3=amod	lemma_3=,	relType_3=conj	path1=methyldopa_conj	wib=nitrates	path=methyldopa_conj<agent_obl>hydralazine_conj	lemma_2=nitrate	pos_2=NNS	relType_3=obl	pos_3=,	eib=True	pos_3=NN	pos_3=HYPH	lemma_3=block	pos_2=,	relType_1=punct	relType_3=punct	path2=hydralazine_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e3	DDI-DrugBank.d107.s10.e7	null	lemma_1=,	lpib=nitrate_NNS	pos_1=,	lemma_3=agent	relation_5=adverse	relType_2=punct	path2=prazosin_conj	pos_3=NNS	pos_4=,	lemma_3=calcium	lemma_3=-	lib=nitrate	pos_3=VBG	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	path1=methyldopa_conj	wib=nitrates	lemma_4=,	lemma_4=hydralazine	lemma_2=nitrate	pos_2=NNS	relType_3=obl	pos_3=,	eib=True	pos_3=NN	pos_3=HYPH	lemma_3=block	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	path=methyldopa_conj<agent_obl>prazosin_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e3	DDI-DrugBank.d107.s10.e8	null	lemma_1=,	pos_5=CC	lpib=nitrate_NNS	pos_1=,	lemma_3=agent	relation_5=adverse	lemma_5=prazosin	relType_2=punct	relType_5=cc	pos_3=NNS	pos_4=,	lemma_3=calcium	lemma_3=-	path2=digoxin_conj	lib=nitrate	pos_3=VBG	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	path1=methyldopa_conj	path=methyldopa_conj<agent_obl>digoxin_conj	wib=nitrates	lemma_4=,	relType_5=conj	lemma_4=hydralazine	lemma_2=nitrate	pos_2=NNS	pos_5=NN	relType_3=obl	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_3=HYPH	lemma_3=block	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e4	DDI-DrugBank.d107.s10.e5	null	lemma_1=,	pos_2=NN	path=nitrate_conj<agent_obl>agent_conj	wib=calcium	path2=agent_conj	pos_1=,	pos_2=HYPH	relType_2=punct	lemma_2=-	path1=nitrate_conj	lemma_2=calcium	relation_3=adverse	relType_2=amod	relType_2=obl	eib=True	lemma_2=block	lpib=calcium_NN	relType_1=punct	lib=calcium	pos_2=VBG
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e4	DDI-DrugBank.d107.s10.e6	null	lemma_2=agent	lemma_1=,	pos_2=NN	wib=calcium	path2=hydralazine_conj	pos_1=,	pos_2=HYPH	relType_2=punct	lemma_2=-	path=nitrate_conj<agent_obl>hydralazine_conj	path1=nitrate_conj	relType_2=conj	lemma_2=,	lemma_2=calcium	relation_3=adverse	relType_2=amod	relType_2=obl	pos_2=NNS	eib=True	lemma_2=block	lpib=calcium_NN	pos_2=,	relType_1=punct	lib=calcium	pos_2=VBG
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e4	DDI-DrugBank.d107.s10.e7	null	lemma_2=agent	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	lemma_3=hydralazine	pos_2=HYPH	relType_2=punct	path2=prazosin_conj	lemma_2=-	path=nitrate_conj<agent_obl>prazosin_conj	path1=nitrate_conj	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_3=,	relType_3=conj	relation_3=adverse	relType_2=amod	relType_2=obl	pos_2=NNS	pos_3=,	eib=True	lemma_2=block	lpib=calcium_NN	pos_3=NN	pos_2=,	relType_1=punct	lib=calcium	relType_3=punct	pos_2=VBG
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e4	DDI-DrugBank.d107.s10.e8	null	lemma_2=agent	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	lemma_3=hydralazine	relType_4=cc	pos_2=HYPH	relType_2=punct	lemma_2=-	path=nitrate_conj<agent_obl>digoxin_conj	path2=digoxin_conj	path1=nitrate_conj	relType_2=conj	lemma_2=,	pos_4=NN	lemma_2=calcium	lemma_3=,	relType_3=conj	relation_3=adverse	relType_2=amod	relType_2=obl	lemma_4=prazosin	pos_2=NNS	pos_3=,	eib=True	lemma_2=block	lpib=calcium_NN	pos_3=NN	pos_4=CC	lemma_4=and	pos_2=,	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct	pos_2=VBG
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e5	DDI-DrugBank.d107.s10.e6	null	lemma_1=,	eib=False	pos_1=,	wib=hydralazine	lpib=hydralazine_NN	path=agent_conj<agent_obl>hydralazine_conj	relType_1=punct	lib=hydralazine	path1=agent_conj	path2=hydralazine_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e5	DDI-DrugBank.d107.s10.e7	null	path2=prazosin_conj	lemma_1=,	pos_2=NN	lemma_2=hydralazine	eib=True	path=agent_conj<agent_obl>prazosin_conj	pos_1=,	pos_2=,	wib=hydralazine	lpib=hydralazine_NN	relType_1=punct	lib=hydralazine	relType_2=conj	path1=agent_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e5	DDI-DrugBank.d107.s10.e8	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	path=agent_conj<agent_obl>digoxin_conj	path2=digoxin_conj	lemma_3=prazosin	relType_2=conj	lemma_2=,	relType_3=conj	wib=hydralazine	lemma_2=hydralazine	eib=True	pos_3=NN	pos_2=,	lemma_3=and	lpib=hydralazine_NN	relType_1=punct	lib=hydralazine	path1=agent_conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e6	DDI-DrugBank.d107.s10.e7	null	path2=prazosin_conj	path1=hydralazine_conj	lemma_1=,	lpib=prazosin_NN	eib=False	wib=prazosin	lib=prazosin	pos_1=,	path=hydralazine_conj<agent_obl>prazosin_conj	relType_1=punct
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e6	DDI-DrugBank.d107.s10.e8	null	lemma_2=and	path1=hydralazine_conj	lemma_1=,	pos_2=NN	eib=True	lpib=prazosin_NN	wib=prazosin	lemma_2=prazosin	pos_2=CC	lib=prazosin	path=hydralazine_conj<agent_obl>digoxin_conj	pos_1=,	path2=digoxin_conj	relType_1=punct	relType_2=cc	relType_2=conj
DDI-DrugBank.d107.s10	DDI-DrugBank.d107.s10.e7	DDI-DrugBank.d107.s10.e8	null	relType_1=cc	lib=digoxin	pos_1=CC	lemma_1=and	eib=False	wib=digoxin	path2=digoxin_conj	lpib=digoxin_NN	path=prazosin_conj<agent_obl>digoxin_conj	path1=prazosin_conj
DDI-DrugBank.d107.s11	DDI-DrugBank.d107.s11.e0	DDI-DrugBank.d107.s11.e1	null	path=Enalapril_compound<IV_nsubj:pass<use_ROOT>digitalis_obl	lemma_2=have	lib=iv	pos_3=VBN	lemma_4=use	relType_3=aux:pass	relType_6=case	lpib=iv_NNP	eib=False	pos_6=IN	relType_2=aux	pos_4=VBN	lemma_5=concomitantly	path2=digitalis_obl	lemma_3=be	pos_5=RB	lemma_6=with	pos_1=NNP	relType_4=ROOT	relType_5=advmod	pos_2=VBZ	lemma_1=IV	wib=IV	path1=Enalapril_compound<IV_nsubj:pass	relType_1=nsubj:pass
DDI-DrugBank.d107.s12	DDI-DrugBank.d107.s12.e0	DDI-DrugBank.d107.s12.e1	null	relType_1=cc	path2=IV_conj>enalapril_compound	pos_1=CC	lpib=enalapril_NNP	eib=False	wib=enalapril	path1=	path=<Enalapril_nsubj>IV_conj>enalapril_compound	lib=enalapril	lemma_1=and
DDI-DrugBank.d107.s12	DDI-DrugBank.d107.s12.e0	DDI-DrugBank.d107.s12.e2	effect	relType_1=cc	pos_1=CC	relType_7=case	relType_5=nsubj	relType_8=punct	pos_3=VB	relation_6=neutral	pos_8=NN	lemma_6=cause	relType_6=dep	pos_2=NNP	lemma_4=potassium	pos_8=HYPH	pos_6=VBN	path=Enalapril_nsubj<attenuate_parataxis>cause_dep>diuretic_obl	lemma_2=enalapril	relType_2=conj	pos_4=NN	lemma_7=by	path1=Enalapril_nsubj	path2=cause_dep>diuretic_obl	lemma_2=IV	lemma_3=attenuate	lemma_8=type	relType_2=compound	lemma_8=thiazide	relType_4=compound	lemma_5=loss	relType_8=compound	relType_3=parataxis	lib=enalapril	pos_5=NN	lpib=enalapril_NNP	eib=True	pos_7=IN	lemma_8=-	wib=enalapril	lemma_1=and
DDI-DrugBank.d107.s12	DDI-DrugBank.d107.s12.e1	DDI-DrugBank.d107.s12.e2	effect	relType_7=compound	lemma_7=thiazide	lib=iv	lemma_6=by	relType_6=case	lemma_7=-	lpib=iv_NNP	pos_6=IN	pos_2=VB	relType_4=nsubj	relType_5=dep	pos_4=NN	lemma_4=loss	path2=cause_dep>diuretic_obl	pos_7=HYPH	path=enalapril_compound<IV_conj<Enalapril_nsubj<attenuate_parataxis>cause_dep>diuretic_obl	lemma_5=cause	relType_1=conj	pos_1=NNP	lemma_1=IV	lemma_3=potassium	wib=IV	eib=True	pos_3=NN	relType_7=punct	path1=enalapril_compound<IV_conj<Enalapril_nsubj	relation_4=neutral	relType_3=compound	lemma_2=attenuate	relType_2=parataxis	pos_7=NN	lemma_7=type	pos_5=VBN
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e0	DDI-DrugBank.d107.s13.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>spironolactone_conj	path1=	lib=e.	lemma_1=(	path=<diuretic_nsubj>g._dep>spironolactone_conj	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e0	DDI-DrugBank.d107.s13.e2	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_5=spironolactone	lemma_1=(	lemma_3=g.	pos_4=,	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	path2=g._dep>triamterene_conj	path=<diuretic_nsubj>g._dep>triamterene_conj	relType_1=punct
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e0	DDI-DrugBank.d107.s13.e3	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	path=<diuretic_nsubj>g._dep>amiloride_conj	lemma_6=,	relType_7=cc	lib=e.	lemma_5=spironolactone	lemma_1=(	pos_6=NN	relType_6=conj	lemma_6=triamterene	lemma_3=g.	pos_4=,	relType_6=punct	relType_4=punct	path2=g._dep>amiloride_conj	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	lemma_7=or	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e0	DDI-DrugBank.d107.s13.e4	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lemma_6=,	relType_7=cc	relType_8=punct	lib=e.	lemma_9=,	path=<diuretic_nsubj>supplement_conj>potassium_compound	lemma_5=spironolactone	lemma_1=(	pos_6=NN	pos_8=NN	relType_6=conj	lemma_6=triamterene	lemma_3=g.	pos_4=,	relType_6=punct	pos_8=-RRB-	path2=supplement_conj>potassium_compound	lemma_8=)	relType_4=punct	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	lemma_7=or	relType_9=punct	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	lemma_8=amiloride	relType_8=conj	pos_9=,	relType_1=punct
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e0	DDI-DrugBank.d107.s13.e5	null	relType_3=dep	pos_2=NN	lemma_11=,	pos_5=,	path1=	lemma_6=,	relType_7=cc	lemma_10=supplement	relType_12=cc	relType_8=punct	lib=e.	lemma_9=,	pos_12=CC	lemma_5=spironolactone	lemma_1=(	pos_6=NN	pos_8=NN	relType_6=conj	path=<diuretic_nsubj>substitute_conj>contain_amod>potassium_obl	lemma_6=triamterene	lemma_3=g.	pos_4=,	relType_10=conj	relType_6=punct	relType_11=punct	pos_8=-RRB-	relType_10=compound	pos_10=NN	lemma_12=or	lemma_8=)	relType_4=punct	pos_7=CC	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_11=,	lemma_7=or	relType_9=punct	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	path2=substitute_conj>contain_amod>potassium_obl	pos_3=NN	lemma_8=amiloride	lemma_10=potassium	relType_8=conj	pos_9=,	relType_1=punct	pos_10=NNS
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e1	DDI-DrugBank.d107.s13.e2	null	lpib=triamterene_NN	lemma_1=,	path=spironolactone_conj<g._dep>triamterene_conj	wib=triamterene	eib=False	path2=triamterene_conj	path1=spironolactone_conj	pos_1=,	relType_1=punct	lib=triamterene
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e1	DDI-DrugBank.d107.s13.e3	null	path=spironolactone_conj<g._dep>amiloride_conj	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_2=triamterene	relType_2=punct	relType_3=cc	lpib=triamterene_NN	path2=amiloride_conj	path1=spironolactone_conj	lemma_3=or	relType_2=conj	lemma_2=,	wib=triamterene	eib=True	pos_2=,	relType_1=punct	lib=triamterene
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e1	DDI-DrugBank.d107.s13.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_5=,	pos_1=,	path1=spironolactone_conj<g._dep	lemma_2=triamterene	relType_2=punct	relType_3=cc	lpib=triamterene_NN	pos_4=-RRB-	lemma_3=or	relType_2=conj	pos_4=NN	lemma_2=,	path2=supplement_conj>potassium_compound	relType_4=punct	wib=triamterene	lemma_5=,	relType_5=punct	lemma_4=)	path=spironolactone_conj<g._dep<diuretic_nsubj>supplement_conj>potassium_compound	lemma_4=amiloride	eib=True	pos_2=,	relType_4=conj	relType_1=punct	lib=triamterene
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e1	DDI-DrugBank.d107.s13.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_5=,	path=spironolactone_conj<g._dep<diuretic_nsubj>substitute_conj>contain_amod>potassium_obl	pos_1=,	path1=spironolactone_conj<g._dep	lemma_2=triamterene	relType_2=punct	relType_3=cc	lpib=triamterene_NN	pos_6=NN	relType_6=conj	lemma_6=supplement	lemma_6=potassium	pos_4=-RRB-	pos_7=,	lemma_3=or	pos_8=CC	lemma_8=or	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	wib=triamterene	lemma_5=,	relType_5=punct	lemma_4=)	lemma_4=amiloride	relType_6=compound	eib=True	path2=substitute_conj>contain_amod>potassium_obl	relType_7=punct	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	relType_8=cc	lib=triamterene
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e2	DDI-DrugBank.d107.s13.e3	null	path=triamterene_conj<g._dep>amiloride_conj	path2=amiloride_conj	lemma_2=or	lemma_1=,	eib=False	pos_2=CC	path1=triamterene_conj	pos_1=,	relType_1=punct	lpib=amiloride_NN	relType_2=cc	wib=amiloride	lib=amiloride
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e2	DDI-DrugBank.d107.s13.e4	null	lemma_2=or	lemma_1=,	path=triamterene_conj<g._dep<diuretic_nsubj>supplement_conj>potassium_compound	pos_1=,	relType_2=cc	pos_4=,	lpib=amiloride_NN	path2=supplement_conj>potassium_compound	relType_4=punct	relType_3=conj	lemma_3=amiloride	lemma_4=,	lemma_3=)	lib=amiloride	eib=True	pos_3=-RRB-	pos_3=NN	pos_2=CC	path1=triamterene_conj<g._dep	relType_1=punct	relType_3=punct	wib=amiloride
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e2	DDI-DrugBank.d107.s13.e5	null	lemma_2=or	lemma_1=,	lemma_5=supplement	pos_1=,	lemma_6=,	relType_7=cc	relType_5=compound	relType_2=cc	pos_4=,	pos_5=NNS	relType_6=punct	lpib=amiloride_NN	path=triamterene_conj<g._dep<diuretic_nsubj>substitute_conj>contain_amod>potassium_obl	relType_4=punct	pos_7=CC	relType_3=conj	lemma_3=amiloride	lemma_4=,	relType_5=conj	lemma_7=or	lemma_3=)	pos_6=,	lib=amiloride	lemma_5=potassium	pos_5=NN	eib=True	pos_3=-RRB-	path2=substitute_conj>contain_amod>potassium_obl	pos_3=NN	pos_2=CC	path1=triamterene_conj<g._dep	relType_1=punct	relType_3=punct	wib=amiloride
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e3	DDI-DrugBank.d107.s13.e4	null	path2=supplement_conj>potassium_compound	lib=potassium	path=amiloride_conj<g._dep<diuretic_nsubj>supplement_conj>potassium_compound	eib=False	pos_1=-RRB-	path1=amiloride_conj<g._dep	pos_2=,	wib=potassium	relType_1=punct	lemma_1=)	lpib=potassium_NN	lemma_2=,	relType_2=punct
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e3	DDI-DrugBank.d107.s13.e5	null	pos_5=CC	lemma_1=)	relType_2=punct	path=amiloride_conj<g._dep<diuretic_nsubj>substitute_conj>contain_amod>potassium_obl	relType_5=cc	pos_3=NNS	lib=potassium	pos_4=,	path1=amiloride_conj<g._dep	wib=potassium	lpib=potassium_NN	lemma_2=,	relType_4=punct	relType_3=conj	pos_1=-RRB-	lemma_3=supplement	lemma_4=,	lemma_3=potassium	eib=True	path2=substitute_conj>contain_amod>potassium_obl	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct	lemma_5=or
DDI-DrugBank.d107.s13	DDI-DrugBank.d107.s13.e4	DDI-DrugBank.d107.s13.e5	null	path1=potassium_compound<supplement_conj	pos_1=NNS	lib=supplement	eib=False	path2=substitute_conj>contain_amod>potassium_obl	pos_3=CC	lemma_1=supplement	pos_2=,	wib=supplements	lemma_3=or	path=potassium_compound<supplement_conj<diuretic_nsubj>substitute_conj>contain_amod>potassium_obl	relType_2=punct	relType_1=conj	lemma_2=,	relType_3=cc	lpib=supplement_NNS
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e0	DDI-DrugBank.d107.s16.e1	null	lpib=lithium_NN	eib=False	path1=	pos_1=:	path=<lithium_ROOT>report_parataxis>toxicity_nsubj:pass>lithium_compound	relType_1=punct	wib=Lithium	path2=report_parataxis>toxicity_nsubj:pass>lithium_compound	lemma_1=:	lib=lithium
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e0	DDI-DrugBank.d107.s16.e2	null	pos_7=NNS	pos_2=NN	lemma_4=be	path1=	relType_5=parataxis	lemma_8=receive	relType_6=case	lib=lithium	lpib=lithium_NN	path=<lithium_ROOT>report_parataxis>patient_obl>receive_acl>lithium_obj	pos_6=IN	pos_3=VBZ	lemma_7=patient	lemma_6=in	relType_2=nsubj:pass	lemma_1=:	pos_4=VBN	lemma_5=report	path2=report_parataxis>patient_obl>receive_acl>lithium_obj	lemma_2=lithium	relType_2=compound	pos_8=VBG	pos_1=:	relType_4=aux:pass	relType_8=acl	wib=Lithium	relType_7=obl	eib=True	relType_3=aux	relType_1=punct	lemma_3=have	pos_5=VBN	lemma_2=toxicity
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e0	DDI-DrugBank.d107.s16.e3	null	pos_7=NNS	pos_2=NN	relType_13=dep	relType_9=advmod	lemma_4=be	lemma_10=with	lemma_15=of	relType_16=nmod	relType_17=punct	path1=	relType_5=parataxis	lemma_12=which	lemma_11=drug	lemma_8=receive	path=<lithium_ROOT>report_parataxis>patient_obl>receive_acl>drug_obl>elimination_dep>inhibitor_nmod	relType_6=case	relType_12=det	lib=lithium	pos_13=VBP	relType_18=case	lemma_19=ace	lemma_13=cause	lemma_18=include	lpib=lithium_NN	lemma_14=elimination	lemma_17=,	pos_6=IN	pos_3=VBZ	pos_11=NNS	lemma_7=patient	pos_19=NN	pos_14=NN	relType_10=case	lemma_6=in	relType_2=nsubj:pass	pos_9=NN	lemma_1=:	pos_4=VBN	lemma_5=report	relType_19=compound	pos_17=,	relType_15=case	lemma_2=lithium	relType_2=compound	pos_8=VBG	pos_1=:	relType_4=aux:pass	relType_9=obj	pos_9=RB	relType_14=dep	lemma_16=sodium	pos_10=IN	relType_11=obl	pos_16=NN	path2=report_parataxis>patient_obl>receive_acl>drug_obl>elimination_dep>inhibitor_nmod	wib=Lithium	relType_8=acl	lemma_9=lithium	pos_18=VBG	relation_14=neutral	pos_15=IN	relType_7=obl	eib=True	relType_3=aux	relType_1=punct	lemma_3=have	lemma_9=concomitantly	pos_5=VBN	lemma_2=toxicity	pos_12=WDT
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e1	DDI-DrugBank.d107.s16.e2	null	lemma_5=in	lemma_2=have	pos_3=VBN	pos_7=VBG	lib=toxicity	relType_7=acl	relType_3=aux:pass	relType_5=case	relType_6=obl	eib=False	lemma_6=patient	relType_2=aux	pos_1=NN	path2=patient_obl>receive_acl>lithium_obj	relType_4=parataxis	pos_4=VBN	path=lithium_compound<toxicity_nsubj:pass<report_parataxis>patient_obl>receive_acl>lithium_obj	lemma_3=be	lemma_4=report	lemma_7=receive	wib=toxicity	pos_5=IN	pos_2=VBZ	lpib=toxicity_NN	pos_6=NNS	relType_1=nsubj:pass	lemma_1=toxicity	path1=lithium_compound<toxicity_nsubj:pass
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e1	DDI-DrugBank.d107.s16.e3	null	lemma_5=in	path2=patient_obl>receive_acl>drug_obl>elimination_dep>inhibitor_nmod	relType_13=dep	lemma_12=cause	lemma_2=have	pos_11=WDT	pos_3=VBN	pos_7=VBG	lib=toxicity	pos_9=IN	relType_7=acl	relType_3=aux:pass	relType_5=case	lemma_13=elimination	pos_8=NN	relType_6=obl	lemma_8=concomitantly	pos_10=NNS	lemma_15=sodium	lemma_18=ace	lemma_6=patient	pos_8=RB	pos_12=VBP	pos_17=VBG	pos_16=,	relType_8=obj	relType_2=aux	relType_9=case	pos_13=NN	lemma_16=,	relType_8=advmod	pos_1=NN	relType_17=case	relType_4=parataxis	pos_4=VBN	pos_14=IN	pos_18=NN	pos_15=NN	lemma_8=lithium	path=lithium_compound<toxicity_nsubj:pass<report_parataxis>patient_obl>receive_acl>drug_obl>elimination_dep>inhibitor_nmod	lemma_3=be	lemma_4=report	wib=toxicity	pos_5=IN	lemma_7=receive	lemma_17=include	relType_16=punct	lemma_11=which	relType_11=det	relType_15=nmod	pos_2=VBZ	lemma_9=with	relation_12=neutral	lpib=toxicity_NN	eib=True	relType_12=dep	lemma_14=of	relType_18=compound	pos_6=NNS	relType_1=nsubj:pass	relType_14=case	lemma_1=toxicity	relType_10=obl	path1=lithium_compound<toxicity_nsubj:pass	lemma_10=drug
DDI-DrugBank.d107.s16	DDI-DrugBank.d107.s16.e2	DDI-DrugBank.d107.s16.e3	effect	lemma_6=elimination	lemma_3=drug	relType_7=case	lemma_4=which	path1=lithium_obj	wib=concomitantly	lpib=concomitantly_RB	lemma_9=,	pos_6=NN	pos_2=IN	pos_8=NN	pos_4=WDT	lemma_10=include	pos_3=NNS	lemma_2=with	relType_6=dep	pos_5=VBP	lemma_1=concomitantly	path=lithium_obj<receive_acl>drug_obl>elimination_dep>inhibitor_nmod	relType_10=case	relType_5=dep	relType_1=advmod	lemma_5=cause	relType_9=punct	lemma_11=ace	lemma_7=of	lib=concomitantly	lemma_8=sodium	pos_11=NN	relType_2=case	relType_3=obl	eib=True	pos_7=IN	pos_1=RB	relType_8=nmod	relType_11=compound	pos_10=VBG	relation_4=neutral	pos_9=,	relType_4=det	path2=drug_obl>elimination_dep>inhibitor_nmod
DDI-DrugBank.d107.s17	DDI-DrugBank.d107.s17.e0	DDI-DrugBank.d107.s17.e1	null	lib=level	pos_3=VBN	path2=administer_advcl>enalapril_nsubj:pass	relType_5=mark	pos_4=RB	lpib=level_NNS	eib=False	lemma_1=level	pos_2=VB	path1=lithium_compound<level_nsubj:pass	path=lithium_compound<level_nsubj:pass<monitor_ccomp>administer_advcl>enalapril_nsubj:pass	lemma_3=monitor	relType_4=advmod	relType_2=aux:pass	lemma_4=frequently	pos_5=IN	pos_1=NNS	relType_3=ccomp	relType_1=nsubj:pass	lemma_2=be	wib=levels	lemma_5=if
DDI-DrugBank.d107.s17	DDI-DrugBank.d107.s17.e0	DDI-DrugBank.d107.s17.e2	null	relType_6=aux:pass	lib=level	pos_3=VBN	pos_9=IN	pos_6=VBZ	lemma_7=administer	lemma_6=be	pos_6=NN	relType_7=advcl	lemma_8=concomitantly	relType_5=mark	pos_4=RB	lpib=level_NNS	path=lithium_compound<level_nsubj:pass<monitor_ccomp>administer_advcl>lithium_obl	pos_8=RB	lemma_1=level	pos_2=VB	relType_9=case	path1=lithium_compound<level_nsubj:pass	lemma_6=enalapril	relType_8=advmod	lemma_3=monitor	relType_4=advmod	relType_2=aux:pass	lemma_4=frequently	pos_5=IN	relType_6=nsubj:pass	pos_7=VBN	path2=administer_advcl>lithium_obl	lemma_9=with	pos_1=NNS	relType_3=ccomp	eib=True	relType_1=nsubj:pass	lemma_2=be	wib=levels	lemma_5=if
DDI-DrugBank.d107.s17	DDI-DrugBank.d107.s17.e1	DDI-DrugBank.d107.s17.e2	advise	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	path1=enalapril_nsubj:pass	eib=False	lemma_1=be	path2=lithium_obl	lemma_4=with	lib=be	pos_4=IN	relType_4=case	path=enalapril_nsubj:pass<administer_advcl>lithium_obl	wib=is	pos_1=VBZ	lemma_3=concomitantly	lpib=be_VBZ
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e0	DDI-DrugBank.d395.s0.e1	null	wib=Bismuth	lpib=bismuth_NNP	lemma_2=Bismuth	eib=True	pos_2=NNP	relType_2=compound	path1=	lib=bismuth	pos_1=:	path2=subsalicylate_dep	relType_1=punct	lemma_1=:	path=<Bismuth_ROOT>subsalicylate_dep
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e0	DDI-DrugBank.d395.s0.e2	null	lpib=bismuth_NNP	lemma_2=Bismuth	pos_2=NN	pos_3=VBN	path1=	lemma_4=concomitantly	relType_5=case	relType_2=punct	pos_4=RB	pos_2=NNP	lemma_5=with	path=<Bismuth_ROOT>subsalicylate_dep>enoxacin_nmod	lemma_2=,	lemma_1=:	wib=Bismuth	relType_2=dep	lemma_2=subsalicylate	relType_2=compound	relType_4=advmod	lib=bismuth	pos_1=:	lemma_3=give	pos_5=IN	relType_3=case	eib=True	pos_2=,	path2=subsalicylate_dep>enoxacin_nmod	relType_1=punct
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e0	DDI-DrugBank.d395.s0.e3	null	lpib=bismuth_NNP	lemma_2=Bismuth	pos_2=NN	lemma_6=enoxacin	pos_3=VBN	path1=	lemma_4=concomitantly	pos_7=CD	relType_5=case	pos_8=NNS	relType_2=punct	pos_6=NN	pos_4=RB	path2=subsalicylate_dep>enoxacin_nmod>administration_nmod>enoxacin_compound	pos_2=NNP	relType_7=nummod	lemma_5=with	path=<Bismuth_ROOT>subsalicylate_dep>enoxacin_nmod>administration_nmod>enoxacin_compound	lemma_6=or	relType_9=case	lemma_2=,	lemma_1=:	pos_9=VBG	wib=Bismuth	relType_2=dep	lemma_2=subsalicylate	pos_6=CC	relType_2=compound	relType_4=advmod	lib=bismuth	pos_1=:	lemma_3=give	pos_5=IN	relType_3=case	lemma_9=follow	eib=True	lemma_8=minute	relType_8=conj	pos_2=,	relType_1=punct	relType_6=nmod	lemma_7=60	relType_6=cc
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e0	DDI-DrugBank.d395.s0.e4	null	lpib=bismuth_NNP	lemma_2=Bismuth	pos_2=NN	lemma_6=enoxacin	lemma_11=,	pos_3=VBN	path1=	lemma_4=concomitantly	pos_7=CD	lemma_10=enoxacin	relType_5=case	pos_8=NNS	relType_2=punct	pos_6=NN	pos_4=RB	relType_10=nmod	pos_2=NNP	relType_7=nummod	pos_12=VBD	relType_11=punct	relation_15=adverse	lemma_5=with	lemma_6=or	relType_12=amod	relType_9=case	relType_10=compound	pos_10=NN	lemma_2=,	lemma_1=:	pos_9=VBG	wib=Bismuth	relType_2=dep	lemma_2=subsalicylate	pos_6=CC	relType_2=compound	relType_4=advmod	lib=bismuth	pos_1=:	lemma_3=give	pos_5=IN	pos_11=,	relType_3=case	lemma_12=decrease	lemma_9=follow	eib=True	path=<Bismuth_ROOT>subsalicylate_dep>bioavailability_appos>enoxacin_compound	relType_6=cc	lemma_8=minute	relType_8=conj	lemma_10=administration	pos_2=,	relType_1=punct	relType_6=nmod	lemma_7=60	path2=subsalicylate_dep>bioavailability_appos>enoxacin_compound
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e1	DDI-DrugBank.d395.s0.e2	mechanism	pos_2=VBN	lemma_1=,	pos_3=RB	relType_3=advmod	path1=	pos_1=,	lib=give	eib=False	lemma_2=give	lemma_4=with	wib=given	pos_4=IN	path=<subsalicylate_dep>enoxacin_nmod	relType_4=case	relType_2=case	lemma_3=concomitantly	path2=enoxacin_nmod	relType_1=punct	lpib=give_VBN
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e1	DDI-DrugBank.d395.s0.e3	null	pos_7=NNS	relType_8=case	pos_2=VBN	lemma_1=,	pos_3=RB	relType_3=advmod	pos_5=CC	lemma_7=minute	lemma_6=60	path1=	pos_1=,	pos_6=CD	lemma_5=enoxacin	path=<subsalicylate_dep>enoxacin_nmod>administration_nmod>enoxacin_compound	lib=give	lemma_8=follow	relType_5=cc	lemma_2=give	lemma_4=with	wib=given	path2=enoxacin_nmod>administration_nmod>enoxacin_compound	pos_4=IN	pos_8=VBG	relType_4=case	relType_6=nummod	relType_5=nmod	pos_5=NN	relType_2=case	eib=True	lemma_3=concomitantly	relType_1=punct	lpib=give_VBN	relType_7=conj	lemma_5=or
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e1	DDI-DrugBank.d395.s0.e4	null	pos_7=NNS	relType_8=case	pos_2=VBN	lemma_1=,	relType_10=punct	pos_3=RB	relType_3=advmod	pos_5=CC	lemma_7=minute	pos_11=VBD	lemma_10=,	lemma_6=60	path1=	pos_1=,	pos_6=CD	lemma_5=enoxacin	relType_9=nmod	lib=give	lemma_8=follow	relType_5=cc	relation_12=adverse	relType_9=compound	path2=bioavailability_appos>enoxacin_compound	relType_11=amod	lemma_2=give	pos_9=NN	lemma_4=with	lemma_9=enoxacin	wib=given	pos_4=IN	pos_8=VBG	relType_4=case	relType_6=nummod	relType_5=nmod	path=<subsalicylate_dep>bioavailability_appos>enoxacin_compound	pos_5=NN	relType_2=case	pos_10=,	eib=True	lemma_3=concomitantly	lemma_9=administration	relType_1=punct	lemma_11=decrease	lpib=give_VBN	relType_7=conj	lemma_5=or
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e2	DDI-DrugBank.d395.s0.e3	null	relType_1=cc	lemma_4=follow	lpib=minute_NNS	pos_1=CC	relType_2=nummod	lemma_3=minute	path1=	lib=minute	path2=administration_nmod>enoxacin_compound	pos_3=NNS	eib=False	pos_2=CD	wib=minutes	lemma_2=60	path=<enoxacin_nmod>administration_nmod>enoxacin_compound	relType_3=conj	relType_4=case	pos_4=VBG	lemma_1=or
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e2	DDI-DrugBank.d395.s0.e4	null	relType_1=cc	lemma_4=follow	lpib=minute_NNS	pos_1=CC	relType_2=nummod	path1=enoxacin_nmod	lemma_3=minute	lemma_6=,	lemma_5=enoxacin	relType_5=compound	lib=minute	pos_3=NNS	path2=bioavailability_appos>enoxacin_compound	pos_2=CD	relType_6=punct	wib=minutes	lemma_2=60	relation_7=adverse	path=enoxacin_nmod<subsalicylate_dep>bioavailability_appos>enoxacin_compound	relType_7=amod	relType_3=conj	pos_7=VBD	relType_4=case	relType_5=nmod	lemma_7=decrease	pos_4=VBG	pos_6=,	pos_5=NN	eib=True	lemma_5=administration	lemma_1=or
DDI-DrugBank.d395.s0	DDI-DrugBank.d395.s0.e3	DDI-DrugBank.d395.s0.e4	null	lemma_3=decrease	relType_3=amod	eib=False	path2=bioavailability_appos>enoxacin_compound	path=enoxacin_compound<administration_nmod<enoxacin_nmod<subsalicylate_dep>bioavailability_appos>enoxacin_compound	relation_2=adverse	lemma_2=,	pos_3=VBD	pos_2=,	lemma_1=administration	lpib=administration_NN	lib=administration	relType_1=nmod	relType_2=punct	pos_1=NN	wib=administration	path1=enoxacin_compound<administration_nmod<enoxacin_nmod
DDI-DrugBank.d395.s1	DDI-DrugBank.d395.s1.e0	DDI-DrugBank.d395.s1.e1	advise	relType_1=cc	lpib=bismuth_NN	pos_1=CC	pos_2=NN	eib=True	relType_2=compound	wib=bismuth	path2=subsalicylate_conj	path1=	lib=bismuth	path=<enoxacin_nmod>subsalicylate_conj	lemma_1=and	lemma_2=bismuth
DDI-DrugBank.d395.s2	DDI-DrugBank.d395.s2.e0	DDI-DrugBank.d395.s2.e1	null	lpib=enoxacin_NNP	path=<caffeine_ROOT>inhibitor_appos>Enoxacin_nsubj	eib=False	path2=inhibitor_appos>Enoxacin_nsubj	path1=	pos_1=:	relType_1=punct	lib=enoxacin	lemma_1=:	wib=Enoxacin
DDI-DrugBank.d395.s2	DDI-DrugBank.d395.s2.e0	DDI-DrugBank.d395.s2.e2	null	relType_4=amod	pos_4=JJ	relType_10=punct	lemma_16=metabolism	relType_7=det	path1=	lemma_12=isozyme	lemma_6=of	relType_16=obl	path2=inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	lib=enoxacin	relType_6=case	lemma_14=for	pos_17=IN	pos_8=NN	relType_2=cop	relType_9=compound	pos_2=NNP	relType_2=nsubj	relType_13=amod	pos_6=IN	lemma_15=the	relType_12=nmod	relType_3=det	lemma_3=a	pos_9=NN	pos_7=DT	lemma_1=:	pos_15=DT	lemma_10=-	pos_14=IN	relType_17=case	lpib=enoxacin_NNP	lemma_4=potent	relType_11=nummod	lemma_13=responsible	pos_13=JJ	pos_12=NNS	pos_10=HYPH	relType_8=compound	pos_1=:	lemma_17=of	pos_16=NN	pos_11=CD	relType_5=appos	lemma_11=450	wib=Enoxacin	lemma_2=Enoxacin	pos_2=VBZ	pos_5=NN	lemma_9=p	eib=True	pos_3=DT	path=<caffeine_ROOT>inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	lemma_8=cytochrome	lemma_2=be	lemma_7=the	relType_14=case	relType_1=punct	relType_15=det	lemma_5=inhibitor
DDI-DrugBank.d395.s2	DDI-DrugBank.d395.s2.e1	DDI-DrugBank.d395.s2.e2	mechanism	pos_2=DT	relType_7=compound	pos_6=DT	pos_16=IN	relType_4=appos	lemma_13=for	lemma_2=a	lemma_9=-	lemma_10=450	lemma_5=of	relType_5=case	pos_8=NN	pos_12=JJ	pos_9=HYPH	path=Enoxacin_nsubj<inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	eib=False	lemma_6=the	lemma_1=be	pos_11=NNS	relType_14=det	relType_12=amod	path1=Enoxacin_nsubj	lemma_7=cytochrome	lemma_12=responsible	pos_13=IN	pos_4=NN	lemma_14=the	lemma_16=of	relType_13=case	relType_15=obl	lib=be	relType_3=amod	pos_15=NN	pos_10=CD	relType_8=compound	path2=isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	pos_5=IN	relType_9=punct	relType_10=nummod	lemma_11=isozyme	pos_14=DT	wib=is	relType_6=det	lemma_8=p	relType_16=case	relType_1=cop	pos_3=JJ	pos_1=VBZ	lemma_3=potent	relType_2=det	lemma_4=inhibitor	lpib=be_VBZ	relType_11=nmod	pos_7=NN	lemma_15=metabolism
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e0	DDI-DrugBank.d395.s3.e1	mechanism	path1=enoxacin_nsubj	pos_2=DT	pos_8=DT	lemma_5=relate	relType_7=case	relType_13=dep	path=enoxacin_nsubj<cause_ROOT>increase_obj>elimination_nmod>life_dep>caffeine_nmod	lemma_4=-	lemma_6=increase	lemma_2=a	pos_4=HYPH	lemma_3=dose	lib=cause	pos_6=NN	pos_5=VBN	pos_9=JJ	wib=caused	pos_1=VBD	relType_10=nmod	eib=False	lemma_9=mean	relType_9=amod	lemma_10=elimination	pos_10=NN	relType_12=punct	lemma_12=-	pos_13=NN	lemma_11=half	pos_14=IN	lemma_13=life	relType_4=punct	relType_5=amod	relation_0=neutral	lemma_8=the	relType_6=obj	relType_1=ROOT	pos_11=NN	relType_3=obl	pos_7=IN	lemma_7=in	pos_3=NN	relType_11=compound	relType_2=det	lemma_14=of	path2=increase_obj>elimination_nmod>life_dep>caffeine_nmod	pos_12=HYPH	relType_14=case	relType_8=det	relation_5=beneficial	lpib=cause_VBD	lemma_1=cause
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e0	DDI-DrugBank.d395.s3.e2	null	path1=enoxacin_nsubj	pos_2=DT	lemma_15=caffeine	pos_8=DT	lemma_5=relate	relType_7=case	relType_13=dep	relation_17=adverse	lemma_4=-	lemma_6=increase	lemma_2=a	pos_4=HYPH	lemma_3=dose	lib=cause	pos_20=IN	pos_6=NN	pos_18=DT	pos_5=VBN	pos_9=JJ	wib=caused	pos_1=VBD	relType_10=nmod	relType_20=case	pos_15=,	pos_16=RB	lemma_17=decrease	pos_17=VBG	relType_17=dep	lemma_9=mean	relType_9=amod	lemma_10=elimination	pos_10=NN	relType_12=punct	lemma_12=-	pos_13=NN	path2=decrease_dep>clearance_obj>caffeine_nmod	relType_15=punct	pos_19=NN	lemma_11=half	pos_14=IN	relType_16=advmod	lemma_13=life	relType_4=punct	relType_5=amod	pos_15=NN	lemma_15=,	relation_0=neutral	lemma_8=the	relType_15=nmod	lemma_16=thereby	relType_6=obj	relType_1=ROOT	path=enoxacin_nsubj<cause_ROOT>decrease_dep>clearance_obj>caffeine_nmod	pos_11=NN	relType_3=obl	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	relType_11=compound	relType_2=det	lemma_14=of	lemma_19=clearance	pos_12=HYPH	relType_18=det	relType_14=case	relType_8=det	relType_19=obj	relation_5=beneficial	lpib=cause_VBD	lemma_1=cause	lemma_18=the	lemma_20=of
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e0	DDI-DrugBank.d395.s3.e3	null	path1=enoxacin_nsubj	pos_39=NN	relType_13=dep	lemma_5=relate	relType_41=conj	lemma_23=to	relType_36=nmod	lemma_6=increase	pos_24=CD	pos_41=NN	pos_6=NN	pos_31=HYPH	relType_10=nmod	relType_24=nummod	path=enoxacin_nsubj<cause_ROOT>decrease_dep>lead_conj>increase_obl>life_conj>caffeine_nmod	pos_10=NN	pos_13=NN	relType_26=cc	relType_4=punct	lemma_28=to	lemma_27=lead	pos_32=NN	pos_40=HYPH	relType_21=case	pos_35=DT	lemma_16=thereby	pos_37=CC	pos_7=IN	lemma_7=in	lemma_19=clearance	lemma_14=of	lemma_20=of	pos_2=DT	relType_35=det	pos_8=DT	relType_7=case	lemma_34=in	relType_27=conj	lib=cause	pos_18=DT	relType_20=case	pos_1=VBD	lemma_29=a	pos_16=RB	relType_30=nummod	lemma_17=decrease	relType_17=dep	lemma_9=mean	lemma_10=elimination	relType_12=punct	lemma_12=-	relType_32=compound	pos_14=IN	relType_38=det	lemma_15=,	lemma_36=AUC	relation_0=neutral	lemma_37=and	lemma_22=up	relType_15=nmod	pos_11=NN	relType_3=obl	lemma_39=half	pos_22=RB	lemma_40=-	pos_30=CD	pos_23=IN	relType_18=det	relType_34=case	lemma_38=the	pos_27=VBG	lemma_18=the	lemma_15=caffeine	relation_17=adverse	lemma_4=-	lpib=cause_VBD	relType_21=nmod	lemma_3=dose	pos_20=IN	relType_29=det	wib=caused	relType_39=compound	relType_40=punct	pos_15=,	pos_21=IN	relType_9=amod	lemma_41=life	relType_15=punct	relType_22=advmod	lemma_11=half	relType_16=advmod	relType_5=amod	path2=decrease_dep>lead_conj>increase_obl>life_conj>caffeine_nmod	pos_25=NN	relType_33=obl	lemma_21=by	pos_38=DT	relType_28=case	pos_12=HYPH	relType_14=case	relType_8=det	relType_19=obj	lemma_26=and	pos_33=NN	lemma_1=cause	lemma_33=increase	relType_23=advmod	lemma_42=of	relType_37=cc	lemma_2=a	pos_26=CC	pos_4=HYPH	pos_9=JJ	lemma_32=fold	pos_36=NNP	pos_17=VBG	pos_42=IN	pos_19=NN	relType_31=punct	lemma_13=life	pos_15=NN	pos_29=DT	lemma_8=the	lemma_25=%	lemma_30=five	lemma_31=-	lemma_21=caffeine	relation_34=beneficial	relType_6=obj	relType_1=ROOT	lemma_24=80	lemma_35=the	eib=True	relType_11=compound	pos_3=NN	pos_28=IN	relType_2=det	relation_5=beneficial	pos_5=VBN	relType_42=case	pos_34=IN	relType_25=obl	pos_21=NN
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e1	DDI-DrugBank.d395.s3.e2	null	relType_3=dep	lemma_1=,	pos_1=,	wib=thereby	lemma_6=of	relType_6=case	pos_2=RB	lemma_3=decrease	eib=False	relType_2=advmod	pos_6=IN	lpib=thereby_RB	lemma_2=thereby	pos_3=VBG	path2=decrease_dep>clearance_obj>caffeine_nmod	lib=thereby	pos_4=DT	path1=caffeine_nmod<life_dep<elimination_nmod<increase_obj	lemma_4=the	lemma_5=clearance	pos_5=NN	relation_2=adverse	path=caffeine_nmod<life_dep<elimination_nmod<increase_obj<cause_ROOT>decrease_dep>clearance_obj>caffeine_nmod	relType_5=obj	relType_1=punct	relType_4=det
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e1	DDI-DrugBank.d395.s3.e3	null	pos_13=VBG	path=caffeine_nmod<life_dep<elimination_nmod<increase_obj<cause_ROOT>decrease_dep>lead_conj>increase_obl>life_conj>caffeine_nmod	pos_12=CC	pos_22=NNP	pos_26=HYPH	pos_15=DT	lemma_7=by	relType_8=advmod	pos_18=NN	lemma_26=-	lemma_21=the	relType_24=det	relType_19=obl	pos_7=IN	lemma_13=lead	relType_5=obj	relType_3=dep	relType_22=nmod	lemma_1=,	relType_7=case	relType_9=advmod	pos_1=,	relType_27=conj	wib=thereby	lemma_8=up	relType_6=case	relType_20=case	lemma_3=decrease	pos_6=IN	relType_13=conj	pos_14=IN	pos_27=NN	relType_21=det	relType_7=nmod	relType_16=nummod	lemma_5=clearance	pos_5=NN	lemma_18=fold	lemma_10=80	pos_11=NN	lemma_16=five	lemma_22=AUC	relType_26=punct	relType_1=punct	pos_7=NN	lemma_23=and	relType_15=det	lemma_28=of	relType_17=punct	relType_12=cc	lemma_6=of	lemma_15=a	pos_20=IN	pos_23=CC	pos_17=HYPH	lemma_25=half	pos_8=RB	lpib=thereby_RB	pos_24=DT	lemma_2=thereby	pos_3=VBG	relType_25=compound	pos_16=CD	lemma_19=increase	path2=decrease_dep>lead_conj>increase_obl>life_conj>caffeine_nmod	lemma_4=the	pos_25=NN	relType_11=obl	lemma_7=caffeine	relType_28=case	relation_2=adverse	lemma_12=and	relType_14=case	pos_9=IN	relation_19=beneficial	pos_2=RB	lemma_14=to	relType_2=advmod	lemma_9=to	pos_19=NN	lemma_17=-	lemma_11=%	lib=thereby	pos_4=DT	path1=caffeine_nmod<life_dep<elimination_nmod<increase_obj	pos_10=CD	relType_23=cc	lemma_24=the	lemma_20=in	lemma_27=life	relType_10=nummod	eib=True	pos_28=IN	relType_18=compound	relType_4=det	pos_21=DT
DDI-DrugBank.d395.s3	DDI-DrugBank.d395.s3.e2	DDI-DrugBank.d395.s3.e3	null	relType_8=case	lemma_22=of	relType_1=case	pos_3=IN	relType_3=advmod	relType_17=cc	relation_12=beneficial	lemma_9=a	relType_16=nmod	pos_7=VBG	wib=up	lemma_11=-	lemma_19=half	lemma_7=lead	pos_11=HYPH	relType_21=conj	pos_18=DT	path2=lead_conj>increase_obl>life_conj>caffeine_nmod	pos_2=RB	relType_13=obl	lemma_18=the	pos_20=HYPH	pos_21=NN	relType_12=compound	eib=False	relType_2=advmod	lemma_15=the	relType_11=punct	pos_9=DT	pos_12=NN	pos_19=NN	pos_1=IN	lemma_14=in	pos_13=NN	pos_22=IN	pos_15=DT	relType_22=case	pos_8=IN	pos_4=CD	pos_14=IN	lpib=up_RB	relType_19=compound	relType_7=conj	lemma_21=life	lemma_2=up	lemma_8=to	path1=caffeine_nmod<clearance_obj	pos_6=CC	lemma_5=%	pos_10=CD	lemma_6=and	pos_16=NNP	lemma_3=to	lemma_17=and	relType_5=obl	relType_10=nummod	lemma_4=80	relType_4=nummod	lemma_13=increase	pos_5=NN	lemma_20=-	lemma_12=fold	path=caffeine_nmod<clearance_obj<decrease_dep>lead_conj>increase_obl>life_conj>caffeine_nmod	lemma_10=five	lemma_16=AUC	relType_20=punct	relType_18=det	relType_14=case	pos_17=CC	relType_9=det	lib=up	relType_15=det	lemma_1=by	relType_6=cc
DDI-DrugBank.d395.s4	DDI-DrugBank.d395.s4.e0	DDI-DrugBank.d395.s4.e1	null	relType_5=obl:npmod	pos_3=RB	relType_3=advmod	lib=level	pos_6=JJR	pos_7=WRB	lemma_3=also	relType_2=cop	lemma_6=high	lpib=level_NNS	eib=False	path2=administer_advcl>caffeine_nsubj:pass	lemma_1=level	pos_2=VBD	pos_4=CD	relType_6=ROOT	lemma_5=%	relType_1=nsubj	path=enoxacin_compound<level_nsubj<high_ROOT>administer_advcl>caffeine_nsubj:pass	relType_4=nummod	pos_5=NN	path1=enoxacin_compound<level_nsubj	pos_1=NNS	lemma_7=when	lemma_2=be	relType_7=advmod	lemma_4=20	wib=levels
DDI-DrugBank.d395.s4	DDI-DrugBank.d395.s4.e0	DDI-DrugBank.d395.s4.e2	null	relType_5=obl:npmod	pos_3=RB	relType_3=advmod	relType_8=cc	lib=level	pos_6=JJR	path=enoxacin_compound<level_nsubj<high_ROOT>administer_advcl>caffeine_nsubj:pass>enoxacin_conj	pos_7=WRB	relType_8=nsubj:pass	lemma_3=also	pos_8=NN	relType_2=cop	lemma_8=caffeine	lemma_6=high	lpib=level_NNS	path2=administer_advcl>caffeine_nsubj:pass>enoxacin_conj	lemma_1=level	pos_2=VBD	pos_8=CC	pos_4=CD	relType_6=ROOT	lemma_5=%	relType_1=nsubj	relType_4=nummod	lemma_8=and	pos_5=NN	path1=enoxacin_compound<level_nsubj	pos_1=NNS	eib=True	lemma_7=when	lemma_2=be	relType_7=advmod	lemma_4=20	wib=levels
DDI-DrugBank.d395.s4	DDI-DrugBank.d395.s4.e1	DDI-DrugBank.d395.s4.e2	mechanism	lpib=enoxacin_NN	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	wib=enoxacin	path=<caffeine_nsubj:pass>enoxacin_conj	path1=	lib=enoxacin	path2=enoxacin_conj
DDI-DrugBank.d395.s5	DDI-DrugBank.d395.s5.e0	DDI-DrugBank.d395.s5.e1	null	lemma_9=consume	pos_2=VBN	relType_7=case	path2=patient_obl>consume_acl>caffeine_obj	pos_1=HYPH	path=caffeine_obl<relate_amod<effect_nsubj<occur_ROOT>patient_obl>consume_acl>caffeine_obj	pos_8=NNS	relType_8=obl	lemma_5=have	lib=relate	eib=False	pos_5=VBP	path1=caffeine_obl<relate_amod<effect_nsubj	pos_6=VBN	relType_5=aux	relType_4=nsubj	pos_4=NNS	lemma_3=adverse	pos_9=VBG	relation_3=neutral	relType_6=ROOT	relType_3=amod	wib=related	lemma_6=occur	relType_2=amod	lemma_1=-	relType_9=acl	lemma_4=effect	pos_3=JJ	pos_7=IN	lemma_7=in	lpib=relate_VBN	lemma_8=patient	relType_1=punct	lemma_2=relate
DDI-DrugBank.d395.s5	DDI-DrugBank.d395.s5.e0	DDI-DrugBank.d395.s5.e2	null	lemma_9=consume	pos_2=VBN	lemma_10=caffeine	relType_7=case	relType_10=mark	lemma_13=with	pos_1=HYPH	path=caffeine_obl<relate_amod<effect_nsubj<occur_ROOT>therapy_advcl>enoxacin_nmod	pos_8=NNS	relType_8=obl	lemma_5=have	relType_11=case	lib=relate	pos_5=VBP	relType_12=advcl	path1=caffeine_obl<relate_amod<effect_nsubj	pos_6=VBN	relType_5=aux	relType_4=nsubj	pos_10=NN	pos_13=IN	pos_4=NNS	lemma_3=adverse	pos_9=VBG	lemma_10=while	pos_11=IN	relation_3=neutral	relType_13=case	relType_6=ROOT	lemma_11=on	relType_3=amod	wib=related	lemma_12=therapy	lemma_6=occur	relType_2=amod	lemma_1=-	pos_10=IN	path2=therapy_advcl>enoxacin_nmod	relType_9=acl	lemma_4=effect	pos_3=JJ	eib=True	pos_7=IN	lemma_7=in	lpib=relate_VBN	lemma_8=patient	relType_1=punct	pos_12=NN	relType_10=obj	lemma_2=relate
DDI-DrugBank.d395.s5	DDI-DrugBank.d395.s5.e1	DDI-DrugBank.d395.s5.e2	effect	lpib=therapy_NN	lemma_2=on	pos_2=IN	eib=False	path=caffeine_obj<consume_acl<patient_obl<occur_ROOT>therapy_advcl>enoxacin_nmod	pos_1=IN	lemma_4=with	lemma_3=therapy	relType_3=advcl	pos_4=IN	relType_4=case	lib=therapy	path1=caffeine_obj<consume_acl<patient_obl	lemma_1=while	path2=therapy_advcl>enoxacin_nmod	relType_2=case	relType_1=mark	pos_3=NN	wib=therapy
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e0	DDI-DrugBank.d395.s6.e1	null	path1=	path=<cyclosporine_ROOT>report_appos>level_nsubj:pass>cyclosporine_nmod	lemma_3=serum	pos_2=JJ	lemma_5=of	relType_5=case	lib=elevated	eib=False	lemma_4=level	relType_4=nsubj:pass	pos_4=NNS	lemma_1=:	path2=report_appos>level_nsubj:pass>cyclosporine_nmod	lemma_2=elevated	wib=Elevated	relType_2=amod	pos_1=:	pos_5=IN	pos_3=NN	relType_3=compound	relType_1=punct	lpib=elevated_JJ
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e0	DDI-DrugBank.d395.s6.e2	null	lemma_6=cyclosporine	lemma_10=concomitant	pos_8=VBN	lemma_7=be	relType_10=amod	path1=	lemma_3=serum	relType_12=case	pos_9=IN	relType_8=appos	pos_2=JJ	lemma_5=of	path=<cyclosporine_ROOT>report_appos>use_obl>cyclosporine_nmod	relType_5=case	lemma_12=of	pos_6=NN	lib=elevated	lemma_4=level	relType_4=nsubj:pass	relType_9=case	lemma_6=have	lemma_11=use	pos_4=NNS	lemma_1=:	pos_12=IN	lemma_2=elevated	wib=Elevated	relType_6=aux	pos_10=JJ	relType_2=amod	pos_1=:	pos_5=IN	relType_7=aux:pass	pos_6=VBP	lemma_8=report	relType_11=obl	pos_7=VBN	lemma_9=with	pos_11=NN	eib=True	pos_3=NN	relType_3=compound	path2=report_appos>use_obl>cyclosporine_nmod	relType_1=punct	relType_6=nmod	lpib=elevated_JJ
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e0	DDI-DrugBank.d395.s6.e3	null	lemma_6=cyclosporine	relType_14=amod	pos_17=DT	lemma_10=concomitant	pos_8=VBN	lemma_7=be	pos_16=IN	relType_10=amod	path1=	lemma_3=serum	relType_12=case	lemma_13=with	pos_9=IN	relType_18=amod	relType_8=appos	pos_2=JJ	lemma_5=of	relType_5=case	lemma_12=of	pos_6=NN	lib=elevated	relType_13=nmod	relType_17=det	lemma_4=level	path2=report_appos>use_obl>member_nmod>class_nmod	path=<cyclosporine_ROOT>report_appos>use_obl>member_nmod>class_nmod	relType_4=nsubj:pass	pos_18=JJ	relType_9=case	lemma_6=have	lemma_11=use	pos_13=NN	pos_13=IN	lemma_16=of	pos_4=NNS	lemma_1=:	pos_12=IN	lemma_14=other	lemma_2=elevated	relType_13=case	wib=Elevated	relType_6=aux	pos_10=JJ	relType_2=amod	pos_1=:	lemma_15=member	pos_5=IN	relType_7=aux:pass	pos_6=VBP	lemma_8=report	lemma_17=the	relType_11=obl	lemma_18=quinolone	relType_15=nmod	pos_7=VBN	lemma_13=cyclosporine	relType_16=case	lemma_9=with	pos_11=NN	pos_15=NNS	eib=True	pos_3=NN	pos_14=JJ	relType_3=compound	relType_1=punct	relType_6=nmod	lpib=elevated_JJ
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e1	DDI-DrugBank.d395.s6.e2	null	pos_2=VBN	relType_7=case	relType_1=aux	pos_3=VBN	pos_6=NN	relType_6=obl	eib=False	relType_3=appos	path1=cyclosporine_nmod<level_nsubj:pass	lemma_3=report	lemma_1=have	lib=have	lemma_4=with	pos_5=JJ	lemma_5=concomitant	relType_5=amod	pos_4=IN	lemma_6=use	path=cyclosporine_nmod<level_nsubj:pass<report_appos>use_obl>cyclosporine_nmod	relType_4=case	relType_2=aux:pass	pos_1=VBP	lpib=have_VBP	lemma_7=of	pos_7=IN	path2=use_obl>cyclosporine_nmod	wib=have	lemma_2=be
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e1	DDI-DrugBank.d395.s6.e3	null	relType_8=case	pos_2=VBN	relType_7=case	relType_1=aux	pos_3=VBN	lemma_10=member	relType_12=det	relType_11=case	pos_6=NN	pos_8=NN	relType_6=obl	pos_9=JJ	relType_10=nmod	lemma_9=other	relType_3=appos	relType_13=amod	path1=cyclosporine_nmod<level_nsubj:pass	lemma_3=report	lemma_1=have	lemma_8=with	relType_9=amod	lib=have	pos_8=IN	lemma_12=the	pos_11=IN	lemma_4=with	pos_5=JJ	lemma_5=concomitant	relType_5=amod	pos_13=JJ	pos_4=IN	lemma_6=use	relType_4=case	relType_2=aux:pass	path2=use_obl>member_nmod>class_nmod	pos_1=VBP	lpib=have_VBP	lemma_7=of	eib=True	pos_7=IN	relType_8=nmod	lemma_13=quinolone	wib=have	lemma_11=of	lemma_8=cyclosporine	lemma_2=be	pos_12=DT	path=cyclosporine_nmod<level_nsubj:pass<report_appos>use_obl>member_nmod>class_nmod	pos_10=NNS
DDI-DrugBank.d395.s6	DDI-DrugBank.d395.s6.e2	DDI-DrugBank.d395.s6.e3	mechanism	relType_1=case	pos_6=JJ	lib=other	path1=cyclosporine_nmod	path=cyclosporine_nmod<use_obl>member_nmod>class_nmod	pos_2=JJ	pos_3=NNS	lemma_2=other	relType_6=amod	path2=member_nmod>class_nmod	wib=other	pos_1=IN	lpib=other_JJ	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	lemma_1=with	lemma_5=the	lemma_3=member	eib=True	lemma_6=quinolone	pos_5=DT	lemma_4=of
DDI-DrugBank.d395.s7	DDI-DrugBank.d395.s7.e0	DDI-DrugBank.d395.s7.e1	null	path2=raise_parataxis>Enoxacin_nsubj	lpib=enoxacin_NNP	eib=False	path1=	path=<Digoxin_ROOT>raise_parataxis>Enoxacin_nsubj	pos_1=:	relType_1=punct	lib=enoxacin	lemma_1=:	wib=Enoxacin
DDI-DrugBank.d395.s7	DDI-DrugBank.d395.s7.e0	DDI-DrugBank.d395.s7.e2	null	pos_2=MD	path1=	pos_3=VB	lib=enoxacin	path=<Digoxin_ROOT>raise_parataxis>level_obj>digoxin_compound	path2=raise_parataxis>level_obj>digoxin_compound	pos_2=NNP	relType_2=nsubj	relType_2=aux	pos_4=NN	lemma_1=:	lemma_3=raise	lpib=enoxacin_NNP	relType_4=compound	pos_1=:	relType_3=parataxis	lemma_4=serum	wib=Enoxacin	lemma_2=Enoxacin	eib=True	lemma_2=may	relType_1=punct
DDI-DrugBank.d395.s7	DDI-DrugBank.d395.s7.e1	DDI-DrugBank.d395.s7.e2	mechanism	lib=raise	path=Enoxacin_nsubj<raise_parataxis>level_obj>digoxin_compound	lemma_2=raise	eib=False	lemma_1=may	relType_1=aux	wib=raise	pos_3=NN	lemma_3=serum	relType_3=compound	lpib=raise_VB	pos_2=VB	relType_2=parataxis	path1=Enoxacin_nsubj	pos_1=MD	path2=level_obj>digoxin_compound
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e0	DDI-DrugBank.d395.s8.e1	null	relType_1=obl	pos_3=WRB	relType_3=advmod	lpib=toxicity_NN	eib=False	path1=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj	wib=toxicity	lib=toxicity	path=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj<occur_conj>advise_ccomp>give_advcl>enoxacin_nsubj:pass	pos_2=VBP	lemma_1=toxicity	lemma_2=occur	relType_2=conj	pos_1=NN	path2=advise_ccomp>give_advcl>enoxacin_nsubj:pass	lemma_3=when
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e0	DDI-DrugBank.d395.s8.e2	null	path=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj<occur_conj>advise_ccomp>give_advcl>enoxacin_nsubj:pass>digoxin_conj	relType_3=advmod	path1=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj	lib=toxicity	relType_4=cc	lemma_2=occur	relType_4=nsubj:pass	relType_2=conj	pos_4=NN	pos_1=NN	path2=advise_ccomp>give_advcl>enoxacin_nsubj:pass>digoxin_conj	wib=toxicity	pos_2=VBP	pos_3=WRB	lpib=toxicity_NN	eib=True	pos_4=CC	lemma_4=and	lemma_4=enoxacin	lemma_1=toxicity	relType_1=obl	lemma_3=when
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e0	DDI-DrugBank.d395.s8.e3	null	pos_12=TO	lemma_9=physician	relType_3=advmod	path1=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj	lib=toxicity	relType_8=punct	relType_4=cc	relType_14=compound	lemma_8=,	lemma_2=occur	lemma_14=serum	relType_10=aux:pass	relType_12=mark	lemma_6=give	pos_7=RB	pos_5=VBP	pos_9=NNS	relType_9=nsubj:pass	relType_4=nsubj:pass	pos_14=NN	pos_6=VBN	relType_6=advcl	lemma_5=be	relType_2=conj	pos_4=NN	pos_1=NN	path2=advise_ccomp>obtain_xcomp>level_obj>digoxin_compound	pos_13=VB	lemma_10=be	path=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj<occur_conj>advise_ccomp>obtain_xcomp>level_obj>digoxin_compound	lemma_5=digoxin	relType_5=aux:pass	lemma_11=advise	wib=toxicity	pos_2=VBP	pos_11=VBN	relType_5=conj	lemma_12=to	lemma_7=concomitantly	pos_5=NN	pos_3=WRB	lemma_13=obtain	lpib=toxicity_NN	eib=True	pos_4=CC	pos_10=VBP	lemma_4=and	lemma_4=enoxacin	relType_11=ccomp	relType_7=advmod	lemma_1=toxicity	relType_13=xcomp	relType_1=obl	pos_8=,	lemma_3=when
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e0	DDI-DrugBank.d395.s8.e4	null	relType_16=cc	pos_12=TO	lemma_9=physician	relType_3=advmod	path1=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj	lib=toxicity	relType_8=punct	relType_4=cc	relType_14=compound	pos_16=CC	path2=advise_ccomp>obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	lemma_8=,	lemma_2=occur	relType_17=conj	lemma_14=serum	relType_10=aux:pass	relType_12=mark	lemma_6=give	pos_7=RB	pos_5=VBP	pos_9=NNS	relType_9=nsubj:pass	relType_4=nsubj:pass	pos_14=NN	pos_6=VBN	relType_6=advcl	lemma_5=be	relType_2=conj	pos_4=NN	pos_1=NN	pos_13=VB	lemma_10=be	lemma_5=digoxin	relType_5=aux:pass	pos_15=NN	lemma_15=level	lemma_15=digoxin	lemma_11=advise	pos_17=VB	wib=toxicity	pos_2=VBP	pos_11=VBN	relType_5=conj	lemma_12=to	lemma_16=and	lemma_17=adjust	lemma_7=concomitantly	relType_15=compound	pos_5=NN	pos_3=WRB	lemma_13=obtain	relType_15=obj	pos_15=NNS	lpib=toxicity_NN	eib=True	pos_4=CC	pos_10=VBP	lemma_4=and	lemma_4=enoxacin	relType_11=ccomp	relType_7=advmod	lemma_1=toxicity	relType_13=xcomp	path=digoxin_compound<toxicity_obl<suggestive_amod<symptom_nsubj<occur_conj>advise_ccomp>obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	relType_1=obl	pos_8=,	lemma_3=when
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e1	DDI-DrugBank.d395.s8.e2	effect	relType_1=cc	lib=digoxin	path=<enoxacin_nsubj:pass>digoxin_conj	pos_1=CC	lemma_1=and	eib=False	path1=	path2=digoxin_conj	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e1	DDI-DrugBank.d395.s8.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_5=,	lemma_7=be	pos_3=VBN	pos_8=VBN	lemma_10=obtain	lemma_4=concomitantly	pos_9=TO	pos_4=RB	path1=enoxacin_nsubj:pass<give_advcl	lemma_9=to	lemma_11=serum	relType_2=conj	pos_10=VB	lib=digoxin	path2=obtain_xcomp>level_obj>digoxin_compound	relType_3=advcl	lemma_6=physician	lemma_5=,	relType_5=punct	lemma_2=digoxin	relType_4=advmod	relType_2=aux:pass	path=enoxacin_nsubj:pass<give_advcl<advise_ccomp>obtain_xcomp>level_obj>digoxin_compound	pos_2=VBP	lemma_3=give	relType_6=nsubj:pass	relType_7=aux:pass	lemma_8=advise	relType_8=ccomp	lpib=digoxin_NN	wib=digoxin	relType_9=mark	pos_11=NN	eib=True	relType_11=compound	relType_10=xcomp	pos_6=NNS	lemma_2=be	pos_7=VBP	lemma_1=and
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e1	DDI-DrugBank.d395.s8.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_5=,	lemma_7=be	pos_3=VBN	pos_8=VBN	lemma_10=obtain	lemma_4=concomitantly	pos_9=TO	pos_4=RB	relType_12=compound	path1=enoxacin_nsubj:pass<give_advcl	lemma_12=level	lemma_9=to	relType_12=obj	lemma_13=and	lemma_11=serum	relType_2=conj	pos_10=VB	path=enoxacin_nsubj:pass<give_advcl<advise_ccomp>obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	relType_13=cc	lib=digoxin	relType_3=advcl	lemma_6=physician	pos_12=NNS	lemma_5=,	relType_5=punct	lemma_2=digoxin	relType_4=advmod	relType_2=aux:pass	lemma_3=give	pos_2=VBP	relType_6=nsubj:pass	relType_7=aux:pass	lemma_8=advise	pos_14=VB	relType_8=ccomp	path2=obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	lpib=digoxin_NN	pos_13=CC	wib=digoxin	relType_9=mark	pos_11=NN	eib=True	lemma_12=digoxin	relType_11=compound	relType_10=xcomp	pos_6=NNS	lemma_2=be	lemma_14=adjust	pos_12=NN	pos_7=VBP	relType_14=conj	lemma_1=and
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e2	DDI-DrugBank.d395.s8.e3	null	relType_6=aux:pass	pos_2=VBN	pos_3=RB	relType_3=advmod	lemma_5=physician	lpib=be_VBP	relType_1=aux:pass	relType_5=nsubj:pass	relType_2=advcl	pos_9=VB	pos_8=TO	lemma_6=be	lemma_7=advise	lemma_10=serum	pos_4=,	eib=False	pos_5=NNS	lemma_9=obtain	lemma_1=be	lemma_2=give	relType_10=compound	pos_10=NN	path1=digoxin_conj<enoxacin_nsubj:pass<give_advcl	wib=are	path2=obtain_xcomp>level_obj>digoxin_compound	lemma_8=to	lib=be	relType_4=punct	relType_8=mark	pos_6=VBP	lemma_4=,	pos_1=VBP	relType_9=xcomp	pos_7=VBN	lemma_3=concomitantly	relType_7=ccomp	path=digoxin_conj<enoxacin_nsubj:pass<give_advcl<advise_ccomp>obtain_xcomp>level_obj>digoxin_compound
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e2	DDI-DrugBank.d395.s8.e4	null	relType_6=aux:pass	pos_2=VBN	pos_3=RB	relType_3=advmod	lemma_5=physician	lpib=be_VBP	relType_1=aux:pass	relType_5=nsubj:pass	relType_12=cc	relType_2=advcl	pos_9=VB	pos_8=TO	relType_11=obj	pos_12=CC	lemma_6=be	lemma_7=advise	lemma_10=serum	pos_4=,	pos_5=NNS	lemma_9=obtain	lemma_1=be	pos_11=NNS	lemma_2=give	relType_10=compound	relType_13=conj	pos_10=NN	path=digoxin_conj<enoxacin_nsubj:pass<give_advcl<advise_ccomp>obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	path1=digoxin_conj<enoxacin_nsubj:pass<give_advcl	wib=are	pos_13=VB	lemma_8=to	lib=be	relType_4=punct	relType_8=mark	lemma_11=level	pos_6=VBP	lemma_4=,	path2=obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	pos_1=VBP	relType_9=xcomp	pos_7=VBN	pos_11=NN	eib=True	lemma_3=concomitantly	relType_11=compound	relType_7=ccomp	lemma_12=and	lemma_13=adjust	lemma_11=digoxin
DDI-DrugBank.d395.s8	DDI-DrugBank.d395.s8.e3	DDI-DrugBank.d395.s8.e4	null	lemma_2=and	pos_1=NNS	lpib=level_NNS	eib=False	path=digoxin_compound<level_obj<obtain_xcomp>adjust_conj>dose_obj>digoxin_compound	path1=digoxin_compound<level_obj	lib=level	pos_2=CC	relType_3=conj	lemma_3=adjust	lemma_1=level	pos_3=VB	path2=adjust_conj>dose_obj>digoxin_compound	relType_2=cc	relType_1=obj	wib=levels
DDI-DrugBank.d395.s9	DDI-DrugBank.d395.s9.e0	DDI-DrugBank.d395.s9.e1	null	pos_7=NNS	wib=Seizures	lemma_4=be	path1=	relType_5=parataxis	relType_6=case	eib=False	lpib=seizure_NNS	pos_6=IN	lemma_7=patient	lemma_6=in	relType_2=nsubj:pass	lemma_2=seizure	lemma_1=:	pos_4=VBN	lemma_5=report	path2=report_parataxis>patient_obl>take_acl>enoxacin_obj	path=<agent_ROOT>report_parataxis>patient_obl>take_acl>enoxacin_obj	pos_8=VBG	pos_1=:	relType_4=aux:pass	lemma_8=take	relType_8=acl	pos_2=NNS	relType_7=obl	relType_3=aux	relType_1=punct	lemma_3=have	lib=seizure	pos_5=VBN	pos_3=VBP
DDI-DrugBank.d395.s9	DDI-DrugBank.d395.s9.e0	DDI-DrugBank.d395.s9.e3	null	pos_7=NNS	lemma_9=concomitantly	wib=Seizures	lemma_12=anti	path=<agent_ROOT>report_parataxis>patient_obl>take_acl>fenbufen_obl	relType_9=advmod	lemma_4=be	lemma_10=with	lemma_12=inflammatory	path1=	relType_5=parataxis	relType_12=obl:npmod	relType_6=case	pos_12=JJ	relType_12=compound	lpib=seizure_NNS	pos_6=IN	lemma_7=patient	relType_12=amod	relType_12=punct	relType_10=case	lemma_6=in	pos_12=NN	relType_2=nsubj:pass	pos_9=NN	lemma_12=-	lemma_2=seizure	lemma_1=:	pos_4=VBN	lemma_5=report	lemma_9=enoxacin	lemma_12=drug	pos_8=VBG	pos_1=:	relType_4=aux:pass	relType_9=obj	pos_9=RB	lemma_8=take	pos_10=IN	pos_11=DT	relType_8=acl	lemma_11=the	relType_11=det	pos_2=NNS	path2=report_parataxis>patient_obl>take_acl>fenbufen_obl	lemma_12=nonsteroidal	relType_7=obl	eib=True	pos_12=HYPH	relType_3=aux	relType_1=punct	lemma_3=have	lib=seizure	pos_5=VBN	pos_12=AFX	pos_3=VBP
DDI-DrugBank.d395.s9	DDI-DrugBank.d395.s9.e1	DDI-DrugBank.d395.s9.e3	effect	relType_4=amod	pos_4=JJ	relType_4=obl:npmod	wib=concomitantly	lemma_4=-	lpib=concomitantly_RB	pos_4=HYPH	path2=fenbufen_obl	pos_2=IN	lemma_2=with	lemma_4=anti	lemma_1=concomitantly	pos_4=AFX	relType_3=det	lemma_4=inflammatory	pos_4=NN	relType_1=advmod	lemma_4=drug	path1=enoxacin_obj	relType_4=punct	relType_4=compound	lib=concomitantly	relType_2=case	eib=True	pos_3=DT	pos_1=RB	lemma_3=the	lemma_4=nonsteroidal	path=enoxacin_obj<take_acl>fenbufen_obl
DDI-DrugBank.d395.s12	DDI-DrugBank.d395.s12.e0	DDI-DrugBank.d395.s12.e1	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	wib=antacids	path1=	lib=antacid	path2=antacid_conj	path=<Sucralfate_ROOT>antacid_conj	lpib=antacid_NNS
DDI-DrugBank.d395.s12	DDI-DrugBank.d395.s12.e0	DDI-DrugBank.d395.s12.e2	null	path=<Sucralfate_ROOT>form_parataxis>Quinolones_nsubj	relType_1=cc	pos_2=NNS	pos_1=CC	lemma_1=and	lemma_2=:	eib=True	wib=antacids	path1=	pos_2=:	lib=antacid	path2=form_parataxis>Quinolones_nsubj	lemma_2=antacid	relType_2=conj	lpib=antacid_NNS	relType_2=punct
DDI-DrugBank.d395.s12	DDI-DrugBank.d395.s12.e1	DDI-DrugBank.d395.s12.e2	null	lpib=quinolones_NNPS	wib=Quinolones	eib=False	pos_1=:	path1=antacid_conj	path2=form_parataxis>Quinolones_nsubj	relType_1=punct	path=antacid_conj<Sucralfate_ROOT>form_parataxis>Quinolones_nsubj	lemma_1=:	lib=quinolones
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e0	DDI-DrugBank.d395.s13.e1	null	lemma_1=with	relType_1=case	eib=False	wib=antacids	path1=	path2=antacid_nmod	path=<quinolone_nmod>antacid_nmod	pos_1=IN	lib=antacid	lpib=antacid_NNS
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e0	DDI-DrugBank.d395.s13.e2	null	path2=antacid_nmod>contain_acl>calcium_obj	lemma_1=with	pos_2=NNS	relType_1=case	eib=True	lemma_2=contain	relType_2=nmod	wib=antacids	path1=	path=<quinolone_nmod>antacid_nmod>contain_acl>calcium_obj	pos_1=IN	lib=antacid	relType_2=acl	lemma_2=antacid	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e0	DDI-DrugBank.d395.s13.e3	null	relType_1=case	lemma_2=contain	path1=	path2=antacid_nmod>contain_acl>calcium_obj>magnesium_conj	relType_2=nmod	lemma_3=calcium	path=<quinolone_nmod>antacid_nmod>contain_acl>calcium_obj>magnesium_conj	pos_1=IN	lib=antacid	lemma_2=antacid	lemma_3=,	relType_2=acl	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	pos_3=NN	wib=antacids	relType_3=obj	relType_3=punct	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e0	DDI-DrugBank.d395.s13.e4	null	relType_1=case	lemma_2=contain	pos_5=CC	path1=	relType_5=cc	pos_4=,	relType_2=nmod	path2=antacid_nmod>contain_acl>calcium_obj>aluminum_conj	lemma_3=calcium	pos_1=IN	lib=antacid	lemma_2=antacid	lemma_4=magnesium	pos_4=NN	relType_4=punct	lemma_3=,	lemma_5=or	lemma_4=,	relType_2=acl	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	pos_3=NN	wib=antacids	relType_3=obj	relType_4=conj	path=<quinolone_nmod>antacid_nmod>contain_acl>calcium_obj>aluminum_conj	relType_3=punct	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e1	DDI-DrugBank.d395.s13.e2	null	pos_1=VBG	eib=False	relType_1=acl	path1=	path2=contain_acl>calcium_obj	lemma_1=contain	lib=contain	wib=containing	lpib=contain_VBG	path=<antacid_nmod>contain_acl>calcium_obj
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e1	DDI-DrugBank.d395.s13.e3	null	pos_1=VBG	lemma_2=calcium	relType_2=obj	pos_2=NN	eib=True	path=<antacid_nmod>contain_acl>calcium_obj>magnesium_conj	relType_1=acl	path1=	path2=contain_acl>calcium_obj>magnesium_conj	lemma_1=contain	pos_2=,	lib=contain	wib=containing	lpib=contain_VBG	lemma_2=,	relType_2=punct
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e1	DDI-DrugBank.d395.s13.e4	null	relType_2=obj	pos_2=NN	path1=	relType_4=cc	relType_2=punct	lpib=contain_VBG	lemma_2=,	lemma_2=calcium	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	relType_1=acl	wib=containing	pos_1=VBG	path=<antacid_nmod>contain_acl>calcium_obj>aluminum_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_1=contain	pos_2=,	path2=contain_acl>calcium_obj>aluminum_conj	lib=contain	relType_3=punct
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e2	DDI-DrugBank.d395.s13.e3	null	lemma_1=,	eib=False	path2=magnesium_conj	path1=	pos_1=,	path=<calcium_obj>magnesium_conj	lib=magnesium	lpib=magnesium_NN	relType_1=punct	wib=magnesium
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e2	DDI-DrugBank.d395.s13.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lpib=magnesium_NN	relType_3=cc	relType_2=punct	lemma_3=or	relType_2=conj	lemma_2=,	path2=aluminum_conj	path=<calcium_obj>aluminum_conj	lib=magnesium	lemma_2=magnesium	eib=True	pos_2=,	relType_1=punct	wib=magnesium
DDI-DrugBank.d395.s13	DDI-DrugBank.d395.s13.e3	DDI-DrugBank.d395.s13.e4	null	path1=magnesium_conj	path2=aluminum_conj	lemma_2=or	lemma_1=,	wib=aluminum	lib=aluminum	eib=False	pos_2=CC	pos_1=,	lpib=aluminum_NN	relType_1=punct	relType_2=cc	path=magnesium_conj<calcium_obj>aluminum_conj
DDI-DrugBank.d395.s16	DDI-DrugBank.d395.s16.e0	DDI-DrugBank.d395.s16.e1	null	pos_1=VBG	path=<multivitamin_obl>contain_acl>zinc_obj	eib=False	relType_1=acl	path1=	lemma_1=contain	lib=contain	wib=containing	lpib=contain_VBG	path2=contain_acl>zinc_obj
DDI-DrugBank.d395.s16	DDI-DrugBank.d395.s16.e0	DDI-DrugBank.d395.s16.e2	null	lemma_6=drug	relType_12=obl	relType_2=obj	pos_2=NN	pos_3=RB	relType_3=advmod	relType_9=conj	relation_4=adverse	pos_2=MD	lemma_2=zinc	relType_14=compound	relType_5=case	lemma_11=insufficient	pos_6=NN	path2=result_conj>plasma_obl>quinolone_conj	lemma_3=substantially	relType_11=amod	lemma_5=with	path=multivitamin_obl<interfere_ROOT>result_conj>plasma_obl>quinolone_conj	lemma_7=absorption	relType_2=aux	pos_8=CC	relType_10=case	pos_12=NN	lpib=contain_VBG	lemma_12=plasma	lemma_13=and	pos_14=NN	relType_13=cc	lemma_10=in	relType_1=acl	pos_5=IN	lemma_9=result	pos_10=IN	wib=containing	relType_4=ROOT	lemma_8=and	pos_13=CC	path1=multivitamin_obl	pos_1=VBG	relType_6=compound	lemma_14=tissue	relType_7=obl	pos_9=VBP	eib=True	lemma_4=interfere	pos_4=VB	lemma_1=contain	lemma_2=may	pos_11=JJ	lib=contain	pos_7=NN	relType_8=cc
DDI-DrugBank.d395.s16	DDI-DrugBank.d395.s16.e1	DDI-DrugBank.d395.s16.e2	mechanism	lemma_2=substantially	relType_1=aux	lemma_1=may	relType_10=amod	relType_12=cc	relType_7=cc	wib=substantially	relType_5=compound	pos_9=IN	pos_3=VB	pos_8=VBP	pos_12=CC	lemma_5=drug	lemma_3=interfere	pos_6=NN	path2=result_conj>plasma_obl>quinolone_conj	pos_2=RB	relType_6=obl	eib=False	relType_2=advmod	lemma_10=insufficient	relType_9=case	lemma_6=absorption	pos_13=NN	lemma_4=with	path=zinc_obj<contain_acl<multivitamin_obl<interfere_ROOT>result_conj>plasma_obl>quinolone_conj	lemma_13=tissue	relType_13=compound	relType_3=ROOT	pos_7=CC	lemma_8=result	pos_4=IN	pos_10=JJ	path1=zinc_obj<contain_acl<multivitamin_obl	relType_4=case	lpib=substantially_RB	pos_1=MD	relType_11=obl	pos_5=NN	pos_11=NN	lib=substantially	relation_2=adverse	lemma_7=and	lemma_12=and	relType_8=conj	lemma_9=in	lemma_11=plasma
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e0	DDI-DrugBank.d395.s17.e1	null	pos_1=VBG	path=<antacid_nsubj>contain_acl>hydroxide_obj	pos_2=NN	eib=True	relType_2=compound	relType_1=acl	path1=	path2=contain_acl>hydroxide_obj	lemma_1=contain	lib=contain	wib=containing	lpib=contain_VBG	lemma_2=aluminum
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e0	DDI-DrugBank.d395.s17.e2	null	relType_2=obj	pos_2=NN	path=<antacid_nsubj>contain_acl>hydroxide_obj>hydroxide_conj	path1=	relType_2=cc	lemma_2=and	lpib=contain_VBG	lemma_2=aluminum	lemma_3=magnesium	relType_2=compound	relType_1=acl	lemma_2=hydroxide	wib=containing	pos_1=VBG	eib=True	pos_3=NN	path2=contain_acl>hydroxide_obj>hydroxide_conj	pos_2=CC	lemma_1=contain	relType_3=compound	lib=contain
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e0	DDI-DrugBank.d395.s17.e3	null	relType_2=obj	pos_2=NN	relType_7=case	pos_3=VB	relType_2=cc	path2=absorption_obj>enoxacin_nmod	pos_6=NN	lemma_2=and	path=antacid_nsubj<reduce_ROOT>absorption_obj>enoxacin_nmod	lemma_5=oral	relation_6=adverse	lemma_6=absorption	lpib=contain_VBG	lemma_2=aluminum	lemma_3=hydroxide	pos_4=DT	lemma_3=reduce	pos_5=JJ	relType_5=amod	lemma_3=magnesium	relType_3=conj	relType_3=ROOT	relType_2=compound	lemma_4=the	relType_1=acl	lemma_2=hydroxide	wib=containing	lemma_7=of	pos_1=VBG	relType_6=obj	eib=True	pos_7=IN	pos_3=NN	pos_2=CC	lemma_1=contain	relType_3=compound	lib=contain	relType_4=det	path1=antacid_nsubj
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e1	DDI-DrugBank.d395.s17.e2	null	relType_1=cc	lemma_2=magnesium	pos_1=CC	pos_2=NN	eib=True	relType_2=compound	path2=hydroxide_conj	path1=	path=<hydroxide_obj>hydroxide_conj	lib=magnesium	lpib=magnesium_NN	wib=magnesium	lemma_1=and
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e1	DDI-DrugBank.d395.s17.e3	mechanism	relType_1=cc	relType_4=amod	pos_1=CC	pos_4=JJ	pos_2=NN	lemma_6=of	lpib=magnesium_NN	lemma_2=reduce	lemma_5=absorption	relType_6=case	path2=absorption_obj>enoxacin_nmod	pos_6=IN	pos_2=VB	relType_3=det	relType_2=conj	relType_2=ROOT	relType_2=compound	relation_3=adverse	lemma_2=hydroxide	lib=magnesium	path1=hydroxide_obj<contain_acl<antacid_nsubj	pos_5=NN	lemma_2=magnesium	eib=True	pos_3=DT	lemma_4=oral	relType_5=obj	lemma_3=the	path=hydroxide_obj<contain_acl<antacid_nsubj<reduce_ROOT>absorption_obj>enoxacin_nmod	wib=magnesium	lemma_1=and
DDI-DrugBank.d395.s17	DDI-DrugBank.d395.s17.e2	DDI-DrugBank.d395.s17.e3	mechanism	pos_2=DT	lemma_2=the	lib=reduce	relation_0=adverse	path1=hydroxide_conj<hydroxide_obj<contain_acl<antacid_nsubj	path=hydroxide_conj<hydroxide_obj<contain_acl<antacid_nsubj<reduce_ROOT>absorption_obj>enoxacin_nmod	lemma_5=of	relType_5=case	path2=absorption_obj>enoxacin_nmod	eib=False	wib=reduce	pos_4=NN	relType_4=obj	lemma_4=absorption	lpib=reduce_VB	relType_3=amod	pos_5=IN	relType_1=ROOT	lemma_3=oral	pos_3=JJ	relType_2=det	lemma_1=reduce	pos_1=VB
DDI-DrugBank.d395.s18	DDI-DrugBank.d395.s18.e0	DDI-DrugBank.d395.s18.e1	mechanism	relType_8=case	pos_2=VBN	pos_3=IN	path=enoxacin_nmod<bioavailability_nsubj:pass<reduce_ROOT>coadministration_obl>ranitidine_nmod	relType_1=aux:pass	lemma_2=reduce	relType_6=case	lemma_3=by	eib=False	pos_6=IN	lemma_1=be	relation_1=adverse	pos_8=IN	pos_4=CD	path2=coadministration_obl>ranitidine_nmod	lib=be	lemma_5=%	relType_2=ROOT	lemma_6=with	relType_5=obl	lemma_4=60	relType_3=case	relType_4=nummod	wib=is	lemma_7=coadministration	pos_5=NN	relType_7=obl	pos_1=VBZ	lpib=be_VBZ	path1=enoxacin_nmod<bioavailability_nsubj:pass	pos_7=NN	lemma_8=of
DDI-DrugBank.d395.s20	DDI-DrugBank.d395.s20.e0	DDI-DrugBank.d395.s20.e1	null	lpib=enoxacin_NNP	eib=False	path2=inhibitor_appos>Enoxacin_nsubj	path=<Theophylline_ROOT>inhibitor_appos>Enoxacin_nsubj	path1=	pos_1=:	relType_1=punct	lib=enoxacin	lemma_1=:	wib=Enoxacin
DDI-DrugBank.d395.s20	DDI-DrugBank.d395.s20.e0	DDI-DrugBank.d395.s20.e2	null	relType_4=amod	pos_4=JJ	relType_10=punct	lemma_16=metabolism	relType_7=det	path1=	lemma_12=isozyme	lemma_6=of	relType_16=obl	path2=inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	lib=enoxacin	relType_6=case	lemma_14=for	pos_17=IN	pos_8=NN	relType_2=cop	relType_9=compound	pos_2=NNP	relType_2=nsubj	relType_13=amod	pos_6=IN	lemma_15=the	relType_12=nmod	relType_3=det	lemma_3=a	pos_9=NN	pos_7=DT	lemma_1=:	pos_15=DT	lemma_10=-	pos_14=IN	relType_17=case	lpib=enoxacin_NNP	lemma_4=potent	relType_11=nummod	lemma_13=responsible	pos_13=JJ	pos_12=NNS	pos_10=HYPH	path=<Theophylline_ROOT>inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	relType_8=compound	pos_1=:	lemma_17=of	pos_16=NN	pos_11=CD	relType_5=appos	lemma_11=450	wib=Enoxacin	lemma_2=Enoxacin	pos_2=VBZ	pos_5=NN	lemma_9=p	eib=True	pos_3=DT	lemma_8=cytochrome	lemma_2=be	lemma_7=the	relType_14=case	relType_1=punct	relType_15=det	lemma_5=inhibitor
DDI-DrugBank.d395.s20	DDI-DrugBank.d395.s20.e1	DDI-DrugBank.d395.s20.e2	mechanism	pos_2=DT	relType_7=compound	pos_6=DT	pos_16=IN	relType_4=appos	lemma_13=for	lemma_2=a	lemma_9=-	lemma_10=450	lemma_5=of	relType_5=case	pos_8=NN	pos_12=JJ	pos_9=HYPH	path=Enoxacin_nsubj<inhibitor_appos>isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	eib=False	lemma_6=the	lemma_1=be	pos_11=NNS	relType_14=det	relType_12=amod	path1=Enoxacin_nsubj	lemma_7=cytochrome	lemma_12=responsible	pos_13=IN	pos_4=NN	lemma_14=the	lemma_16=of	relType_13=case	relType_15=obl	lib=be	relType_3=amod	pos_15=NN	pos_10=CD	relType_8=compound	path2=isozyme_nmod>responsible_amod>metabolism_obl>methylxanthine_nmod	pos_5=IN	relType_9=punct	relType_10=nummod	lemma_11=isozyme	pos_14=DT	wib=is	relType_6=det	lemma_8=p	relType_16=case	relType_1=cop	pos_3=JJ	pos_1=VBZ	lemma_3=potent	relType_2=det	lemma_4=inhibitor	lpib=be_VBZ	relType_11=nmod	pos_7=NN	lemma_15=metabolism
DDI-DrugBank.d395.s21	DDI-DrugBank.d395.s21.e0	DDI-DrugBank.d395.s21.e1	mechanism	path2=metabolism_obl>theophylline_nmod	lpib=interfere_VBZ	relation_0=adverse	lemma_5=of	relType_5=case	pos_2=IN	lemma_2=with	eib=False	path1=Enoxacin_nsubj	wib=interferes	relType_3=det	pos_4=NN	relType_4=obl	path=Enoxacin_nsubj<interfere_ROOT>metabolism_obl>theophylline_nmod	lib=interfere	pos_5=IN	relType_1=ROOT	lemma_1=interfere	relType_2=case	pos_1=VBZ	pos_3=DT	lemma_3=the	lemma_4=metabolism
DDI-DrugBank.d395.s21	DDI-DrugBank.d395.s21.e0	DDI-DrugBank.d395.s21.e2	null	lemma_14=dose	path2=metabolism_obl>result_acl>in_dep>a_dep>%_dep>decrease_orphan>clearance_nmod>theophylline_compound	relType_17=orphan	pos_8=DT	relType_8=dep	lpib=interfere_VBZ	relation_17=adverse	pos_12=CD	relation_0=adverse	relType_10=dep	lemma_5=of	relType_5=case	relType_11=case	relType_9=nummod	relType_18=case	pos_6=NN	pos_2=IN	pos_6=VBG	relType_16=amod	pos_17=NN	path=Enoxacin_nsubj<interfere_ROOT>metabolism_obl>result_acl>in_dep>a_dep>%_dep>decrease_orphan>clearance_nmod>theophylline_compound	lemma_2=with	lemma_13=%	lemma_17=decrease	lemma_8=a	pos_14=NN	path1=Enoxacin_nsubj	wib=interferes	relType_3=det	lemma_9=42	pos_4=NN	pos_10=NN	pos_13=NN	relType_14=obl	pos_11=IN	lemma_15=-	relType_15=punct	pos_18=IN	relType_4=obl	pos_16=VBN	relType_13=compound	relType_6=acl	lemma_16=relate	lib=interfere	pos_5=IN	lemma_11=to	lemma_6=result	lemma_10=%	relType_1=ROOT	lemma_1=interfere	relType_2=case	pos_1=VBZ	eib=True	pos_3=DT	lemma_6=theophylline	pos_7=IN	lemma_7=in	relType_7=dep	pos_9=CD	lemma_12=74	lemma_3=the	lemma_18=in	relType_12=nummod	relType_6=nmod	pos_15=HYPH	lemma_4=metabolism
DDI-DrugBank.d395.s21	DDI-DrugBank.d395.s21.e1	DDI-DrugBank.d395.s21.e2	null	relType_3=dep	relType_10=punct	path1=theophylline_nmod	lemma_11=relate	pos_7=CD	relType_9=obl	lemma_4=42	lemma_6=to	relType_6=case	path=theophylline_nmod<metabolism_obl>result_acl>in_dep>a_dep>%_dep>decrease_orphan>clearance_nmod>theophylline_compound	wib=resulting	pos_2=IN	pos_8=NN	path2=result_acl>in_dep>a_dep>%_dep>decrease_orphan>clearance_nmod>theophylline_compound	relation_11=adverse	eib=False	relType_7=nummod	pos_6=IN	relType_11=amod	pos_13=IN	lemma_3=a	relType_5=dep	lpib=result_VBG	pos_9=NN	pos_4=CD	lemma_8=%	lemma_10=-	relType_13=case	relType_12=orphan	relType_2=dep	lemma_5=%	pos_10=HYPH	relType_1=acl	relType_8=compound	pos_11=VBN	lemma_7=74	lemma_13=in	relType_4=nummod	pos_1=VBG	pos_5=NN	lemma_12=decrease	pos_3=DT	lib=result	lemma_1=result	pos_12=NN	lemma_2=in	lemma_9=dose
DDI-DrugBank.d395.s22	DDI-DrugBank.d395.s22.e0	DDI-DrugBank.d395.s22.e1	null	pos_2=VBN	relType_7=case	relType_9=advmod	path2=coadminister_advcl>theophylline_nsubj:pass	pos_1=HYPH	pos_8=NNS	relType_8=obl	lemma_5=have	lib=relate	pos_9=WRB	eib=False	pos_5=VBP	path1=Theophylline_obl<relate_amod<effect_nsubj	pos_6=VBN	relType_5=aux	relType_4=nsubj	pos_4=NNS	lemma_3=adverse	relation_3=neutral	relType_6=ROOT	relType_3=amod	wib=related	lemma_6=occur	relType_2=amod	lemma_1=-	lemma_4=effect	pos_3=JJ	pos_7=IN	lemma_7=in	path=Theophylline_obl<relate_amod<effect_nsubj<occur_ROOT>coadminister_advcl>theophylline_nsubj:pass	lpib=relate_VBN	lemma_8=patient	relType_1=punct	lemma_9=when	lemma_2=relate
DDI-DrugBank.d395.s22	DDI-DrugBank.d395.s22.e0	DDI-DrugBank.d395.s22.e2	null	path=Theophylline_obl<relate_amod<effect_nsubj<occur_ROOT>coadminister_advcl>theophylline_nsubj:pass>enoxacin_conj	pos_2=VBN	relType_7=case	relType_9=advmod	relType_10=cc	pos_1=HYPH	pos_8=NNS	relType_8=obl	lemma_5=have	lib=relate	pos_9=WRB	pos_5=VBP	path1=Theophylline_obl<relate_amod<effect_nsubj	pos_10=CC	pos_6=VBN	relType_5=aux	relType_4=nsubj	pos_10=NN	pos_4=NNS	lemma_3=adverse	path2=coadminister_advcl>theophylline_nsubj:pass>enoxacin_conj	relType_10=nsubj:pass	relation_3=neutral	relType_6=ROOT	lemma_10=and	relType_3=amod	wib=related	lemma_6=occur	relType_2=amod	lemma_1=-	lemma_4=effect	pos_3=JJ	eib=True	pos_7=IN	lemma_7=in	lemma_10=theophylline	lpib=relate_VBN	lemma_8=patient	relType_1=punct	lemma_9=when	lemma_2=relate
DDI-DrugBank.d395.s22	DDI-DrugBank.d395.s22.e1	DDI-DrugBank.d395.s22.e2	effect	lpib=enoxacin_NN	path=<theophylline_nsubj:pass>enoxacin_conj	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	wib=enoxacin	path1=	lib=enoxacin	path2=enoxacin_conj
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e0	DDI-DrugBank.d395.s23.e1	null	wib=Quinolones	path=<Warfarin_ROOT>decrease_parataxis>Quinolones_nsubj	eib=False	path1=	pos_1=:	path2=decrease_parataxis>Quinolones_nsubj	relType_1=punct	lib=quinolones	lemma_1=:	lpib=quinolones_NNP
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e0	DDI-DrugBank.d395.s23.e2	null	path1=	lib=quinolones	relType_2=punct	pos_2=NNP	relType_2=nsubj	path2=decrease_parataxis>Quinolones_nsubj>enoxacin_nmod	pos_3=VBG	lemma_2=,	lemma_1=:	wib=Quinolones	lemma_3=include	pos_1=:	relType_3=case	lemma_2=Quinolones	eib=True	pos_2=,	path=<Warfarin_ROOT>decrease_parataxis>Quinolones_nsubj>enoxacin_nmod	relType_1=punct	lpib=quinolones_NNP
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e0	DDI-DrugBank.d395.s23.e3	null	relType_8=case	pos_6=DT	path1=	relType_5=parataxis	relType_4=nmod	lemma_9=r	lemma_9=-	lib=quinolones	relType_2=punct	pos_5=VB	pos_9=HYPH	relType_9=compound	pos_2=NNP	relType_2=nsubj	pos_4=,	lemma_7=clearance	lemma_6=the	relation_6=adverse	relType_7=obj	pos_3=VBG	pos_9=NN	pos_4=NN	lemma_2=,	lemma_1=:	pos_8=IN	wib=Quinolones	relType_4=punct	lemma_3=include	pos_1=:	lemma_4=,	path=<Warfarin_ROOT>decrease_parataxis>clearance_obj>warfarin_nmod	relType_9=punct	relType_3=case	relType_6=det	lemma_2=Quinolones	eib=True	lemma_5=decrease	path2=decrease_parataxis>clearance_obj>warfarin_nmod	pos_2=,	lemma_4=enoxacin	relType_1=punct	pos_7=NN	lemma_8=of	lpib=quinolones_NNP
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e0	DDI-DrugBank.d395.s23.e4	null	relType_8=case	pos_15=JJ	pos_6=DT	relType_10=det	relType_15=amod	lemma_15=racemic	lemma_11=less	path1=	relType_5=parataxis	relType_4=nmod	lemma_9=r	lemma_9=-	relType_9=nmod	lemma_9=,	lib=quinolones	relType_2=punct	pos_12=JJ	pos_5=VB	pos_9=HYPH	relType_9=compound	pos_2=NNP	relType_2=nsubj	pos_4=,	lemma_7=clearance	lemma_6=the	relation_6=adverse	relType_7=obj	relType_13=appos	lemma_10=the	relType_12=amod	pos_11=RBR	pos_3=VBG	relType_11=advmod	pos_9=NN	pos_4=NN	lemma_2=,	lemma_1=:	pos_8=IN	pos_13=NN	pos_14=IN	wib=Quinolones	relType_4=punct	lemma_3=include	pos_1=:	lemma_4=,	relType_9=punct	relType_3=case	relType_6=det	lemma_2=Quinolones	path=<Warfarin_ROOT>decrease_parataxis>clearance_obj>isomer_appos>warfarin_nmod	lemma_12=active	eib=True	lemma_5=decrease	lemma_14=of	path2=decrease_parataxis>clearance_obj>isomer_appos>warfarin_nmod	pos_2=,	lemma_4=enoxacin	relType_14=case	pos_9=,	relType_1=punct	pos_7=NN	lemma_8=of	lemma_9=warfarin	lemma_13=isomer	lpib=quinolones_NNP	pos_10=DT
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e1	DDI-DrugBank.d395.s23.e2	null	lemma_1=,	relType_2=case	eib=False	path1=	pos_1=,	path2=enoxacin_nmod	lemma_2=include	lib=include	relType_1=punct	lpib=include_VBG	wib=including	path=<Quinolones_nsubj>enoxacin_nmod	pos_2=VBG
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e1	DDI-DrugBank.d395.s23.e3	mechanism	lemma_8=r	lemma_1=,	relType_7=case	relation_4=adverse	path1=Quinolones_nsubj	pos_1=,	relType_8=punct	lib=include	wib=including	pos_6=NN	pos_8=NN	path2=clearance_obj>warfarin_nmod	path=Quinolones_nsubj<decrease_parataxis>clearance_obj>warfarin_nmod	pos_8=HYPH	lpib=include_VBG	relType_4=parataxis	lemma_3=,	relType_5=det	relType_8=compound	relType_3=nmod	lemma_2=include	lemma_7=of	relType_6=obj	lemma_5=the	relType_2=case	pos_3=,	eib=True	pos_7=IN	pos_3=NN	pos_4=VB	pos_5=DT	lemma_8=-	lemma_3=enoxacin	relType_1=punct	lemma_6=clearance	relType_3=punct	lemma_4=decrease	pos_2=VBG
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e1	DDI-DrugBank.d395.s23.e4	null	relType_14=amod	lemma_8=r	lemma_1=,	lemma_14=racemic	relType_7=case	relation_4=adverse	path1=Quinolones_nsubj	pos_1=,	relType_8=punct	lib=include	wib=including	lemma_8=,	path2=clearance_obj>isomer_appos>warfarin_nmod	pos_6=NN	pos_8=NN	lemma_13=of	relType_11=amod	lemma_11=active	pos_9=DT	relType_10=advmod	pos_8=HYPH	pos_12=NN	pos_13=IN	lpib=include_VBG	relType_4=parataxis	relType_13=case	lemma_12=isomer	lemma_3=,	relType_5=det	relType_8=compound	relType_3=nmod	lemma_8=warfarin	relType_12=appos	lemma_2=include	lemma_7=of	relType_6=obj	lemma_10=less	lemma_5=the	relType_2=case	pos_3=,	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	pos_4=VB	pos_5=DT	lemma_8=-	pos_8=,	lemma_3=enoxacin	lemma_9=the	pos_10=RBR	pos_11=JJ	pos_14=JJ	relType_1=punct	relType_9=det	lemma_6=clearance	relType_3=punct	lemma_4=decrease	path=Quinolones_nsubj<decrease_parataxis>clearance_obj>isomer_appos>warfarin_nmod	pos_2=VBG
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e2	DDI-DrugBank.d395.s23.e3	mechanism	lemma_1=,	pos_1=,	lemma_5=of	relType_5=case	pos_6=HYPH	path1=enoxacin_nmod<Quinolones_nsubj	pos_6=NN	path2=clearance_obj>warfarin_nmod	relType_6=punct	relation_1=adverse	lpib=decrease_VB	pos_2=VB	lemma_4=clearance	path=enoxacin_nmod<Quinolones_nsubj<decrease_parataxis>clearance_obj>warfarin_nmod	relType_3=det	pos_4=NN	relType_4=obj	lemma_6=-	wib=decrease	pos_5=IN	relType_6=compound	eib=True	pos_3=DT	lemma_6=r	lemma_3=the	lemma_2=decrease	relType_2=parataxis	relType_1=punct	lib=decrease
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e2	DDI-DrugBank.d395.s23.e4	null	lemma_1=,	lemma_8=less	relType_7=det	pos_1=,	lemma_6=,	pos_8=RBR	path=enoxacin_nmod<Quinolones_nsubj<decrease_parataxis>clearance_obj>isomer_appos>warfarin_nmod	lemma_5=of	relType_5=case	relType_11=case	path2=clearance_obj>isomer_appos>warfarin_nmod	pos_6=HYPH	path1=enoxacin_nmod<Quinolones_nsubj	pos_6=NN	pos_9=JJ	pos_12=JJ	relType_6=punct	relType_10=appos	relation_1=adverse	relType_12=amod	lpib=decrease_VB	pos_2=VB	lemma_4=clearance	relType_9=amod	relType_3=det	pos_10=NN	pos_4=NN	pos_7=DT	relType_4=obj	relType_8=advmod	lemma_6=-	pos_11=IN	lemma_9=active	wib=decrease	pos_5=IN	lemma_10=isomer	pos_6=,	relType_6=compound	eib=True	pos_3=DT	lemma_6=r	lemma_11=of	lemma_3=the	lemma_2=decrease	lemma_6=warfarin	lemma_7=the	relType_2=parataxis	relType_1=punct	relType_6=nmod	lemma_12=racemic	lib=decrease
DDI-DrugBank.d395.s23	DDI-DrugBank.d395.s23.e3	DDI-DrugBank.d395.s23.e4	null	pos_2=DT	relType_4=amod	lemma_1=,	pos_4=JJ	lemma_2=the	relType_3=advmod	pos_1=,	pos_3=RBR	lemma_6=of	relType_6=case	path1=warfarin_nmod	eib=False	pos_6=IN	lib=less	lpib=less_RBR	lemma_7=racemic	path2=isomer_appos>warfarin_nmod	relType_7=amod	path=warfarin_nmod<clearance_obj>isomer_appos>warfarin_nmod	wib=less	lemma_3=less	relType_5=appos	pos_5=NN	lemma_4=active	lemma_5=isomer	relType_2=det	pos_7=JJ	relType_1=punct
DDI-DrugBank.d395.s24	DDI-DrugBank.d395.s24.e0	DDI-DrugBank.d395.s24.e1	null	pos_18=VBP	relType_10=punct	pos_22=WRB	relType_7=det	relType_1=aux	lemma_8=active	relType_8=amod	relType_16=compound	lemma_6=of	pos_20=VBN	pos_3=VB	relType_19=advmod	lemma_20=be	relType_21=acl	relType_6=case	lemma_22=when	pos_8=JJ	pos_2=RB	lemma_12=,	pos_17=NN	relation_13=neutral	lemma_19=not	relType_9=compound	eib=False	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_3=affect	lemma_17=time	pos_12=,	pos_19=RB	relType_20=aux:pass	relation_2=neutral	relType_12=punct	path1=Enoxacin_nsubj	lemma_13=and	pos_9=NN	lemma_21=observe	pos_7=DT	relType_22=advmod	lemma_10=-	lemma_11=isomer	relType_13=cc	pos_4=DT	relType_15=case	relType_18=aux	relType_3=ROOT	path=Enoxacin_nsubj<affect_ROOT>change_conj>observe_acl>coadminister_advcl>enoxacin_nsubj:pass	lemma_4=the	pos_10=HYPH	pos_16=NN	relType_17=nmod	lemma_5=clearance	pos_13=CC	pos_15=IN	wib=does	lemma_16=clotting	pos_5=NN	lib=do	lemma_15=in	pos_21=VBN	pos_11=NN	pos_1=VBZ	path2=change_conj>observe_acl>coadminister_advcl>enoxacin_nsubj:pass	relType_5=obj	lemma_14=change	pos_14=NNS	lpib=do_VBZ	lemma_7=the	relType_11=nmod	lemma_18=have	relType_4=det	relType_14=conj	lemma_2=not	lemma_9=s
DDI-DrugBank.d395.s24	DDI-DrugBank.d395.s24.e0	DDI-DrugBank.d395.s24.e2	null	relType_19=advmod	lemma_20=be	pos_8=JJ	lemma_12=,	relation_13=neutral	lemma_1=do	pos_12=,	relType_20=aux:pass	lemma_13=and	relType_3=ROOT	pos_1=VBZ	relType_5=obj	lemma_14=change	pos_14=NNS	lemma_2=not	lemma_9=s	pos_22=WRB	path=Enoxacin_nsubj<affect_ROOT>change_conj>observe_acl>coadminister_advcl>enoxacin_nsubj:pass>warfarin_conj	relType_1=aux	pos_20=VBN	pos_3=VB	relType_6=case	lemma_19=not	lemma_17=time	pos_6=IN	lemma_3=affect	relType_12=punct	relType_23=nsubj:pass	pos_9=NN	relType_13=cc	relType_15=case	pos_16=NN	lemma_5=clearance	pos_15=IN	pos_21=VBN	pos_5=NN	pos_11=NN	lpib=do_VBZ	relType_11=nmod	lemma_23=and	path2=change_conj>observe_acl>coadminister_advcl>enoxacin_nsubj:pass>warfarin_conj	relType_10=punct	relType_7=det	lemma_8=active	lemma_6=of	pos_23=NN	pos_23=CC	pos_17=NN	relation_2=neutral	pos_7=DT	relType_22=advmod	lemma_11=isomer	lemma_4=the	relType_17=nmod	pos_13=CC	wib=does	lemma_16=clotting	lemma_18=have	relType_14=conj	pos_18=VBP	relType_8=amod	relType_16=compound	relType_21=acl	lemma_22=when	pos_2=RB	relType_9=compound	relType_2=advmod	pos_19=RB	path1=Enoxacin_nsubj	lemma_21=observe	lemma_23=enoxacin	lemma_10=-	pos_4=DT	relType_18=aux	relType_23=cc	pos_10=HYPH	lib=do	lemma_15=in	eib=True	lemma_7=the	relType_4=det
DDI-DrugBank.d395.s24	DDI-DrugBank.d395.s24.e1	DDI-DrugBank.d395.s24.e2	null	relType_1=cc	lib=warfarin	path2=warfarin_conj	pos_1=CC	lpib=warfarin_NN	eib=False	path1=	wib=warfarin	path=<enoxacin_nsubj:pass>warfarin_conj	lemma_1=and
DDI-DrugBank.d395.s25	DDI-DrugBank.d395.s25.e0	DDI-DrugBank.d395.s25.e1	advise	relType_1=cc	pos_1=CC	path1=	relType_4=cc	path2=enoxacin_conj	pos_3=NNS	lemma_3=derivative	eib=False	wib=derivatives	path=<warfarin_nsubj:pass>enoxacin_conj	relType_3=conj	pos_2=PRP$	lemma_2=its	lpib=derivative_NNS	relType_2=nmod:poss	pos_4=CC	lemma_4=and	lib=derivative	lemma_1=or
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e0	DDI-DrugBank.d241.s0.e1	effect	pos_2=VBN	lib=be	path=FLOLAN_nsubj:pass<administer_advcl>diuretic_obl	pos_1=VBZ	eib=False	pos_3=IN	relType_1=aux:pass	lemma_1=be	path1=FLOLAN_nsubj:pass	lemma_2=administer	lpib=be_VBZ	relType_2=advcl	lemma_3=with	path2=diuretic_obl	relType_3=case	wib=is
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e0	DDI-DrugBank.d241.s0.e2	effect	pos_2=VBN	pos_3=IN	path2=agent_conj	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	lemma_5=antihypertensive	lemma_4=diuretic	path=FLOLAN_nsubj:pass<administer_advcl>agent_conj	pos_4=,	lemma_1=be	pos_4=NNS	pos_5=JJ	relType_4=obl	lib=be	relType_4=punct	relType_5=amod	lemma_3=with	lemma_4=,	relType_3=case	wib=is	pos_1=VBZ	eib=True	path1=FLOLAN_nsubj:pass	lpib=be_VBZ
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e0	DDI-DrugBank.d241.s0.e3	effect	pos_2=VBN	path2=vasodilator_conj	pos_3=IN	pos_5=,	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	lemma_5=antihypertensive	lemma_7=other	lemma_4=diuretic	pos_4=,	pos_5=NNS	lemma_1=be	lemma_5=agent	lemma_6=or	pos_4=NNS	path=FLOLAN_nsubj:pass<administer_advcl>vasodilator_conj	pos_5=JJ	relType_4=obl	relType_7=amod	lib=be	relType_4=punct	relType_5=amod	pos_6=CC	lemma_5=,	relType_5=punct	lemma_3=with	lemma_4=,	relType_5=conj	relType_3=case	wib=is	pos_1=VBZ	eib=True	pos_7=JJ	path1=FLOLAN_nsubj:pass	lpib=be_VBZ	relType_6=cc
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e1	DDI-DrugBank.d241.s0.e2	null	lemma_1=,	eib=True	path2=agent_conj	lib=antihypertensive	lemma_2=antihypertensive	path=diuretic_obl<administer_advcl>agent_conj	pos_1=,	lpib=antihypertensive_JJ	wib=antihypertensive	relType_2=amod	relType_1=punct	pos_2=JJ	path1=diuretic_obl
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e1	DDI-DrugBank.d241.s0.e3	null	path=diuretic_obl<administer_advcl>vasodilator_conj	lemma_2=agent	relType_4=amod	path2=vasodilator_conj	lemma_1=,	pos_4=JJ	pos_3=CC	lib=antihypertensive	pos_1=,	pos_2=JJ	relType_2=punct	relType_3=cc	lemma_2=antihypertensive	wib=antihypertensive	lemma_3=or	relType_2=conj	lemma_2=,	relType_2=amod	lemma_4=other	pos_2=NNS	eib=True	lpib=antihypertensive_JJ	pos_2=,	relType_1=punct	path1=diuretic_obl
DDI-DrugBank.d241.s0	DDI-DrugBank.d241.s0.e2	DDI-DrugBank.d241.s0.e3	null	lemma_2=or	path2=vasodilator_conj	lemma_1=,	pos_3=JJ	relType_3=amod	lib=other	eib=False	lpib=other_JJ	pos_2=CC	pos_1=,	path=agent_conj<administer_advcl>vasodilator_conj	wib=other	relType_1=punct	relType_2=cc	path1=agent_conj	lemma_3=other
DDI-DrugBank.d241.s1	DDI-DrugBank.d241.s1.e0	DDI-DrugBank.d241.s1.e1	null	relType_1=cc	pos_1=CC	lpib=anticoagulant_NNS	eib=False	wib=anticoagulants	path=<agent_nsubj:pass>anticoagulant_conj	path2=anticoagulant_conj	path1=	lib=anticoagulant	lemma_1=or
DDI-DrugBank.d241.s1	DDI-DrugBank.d241.s1.e0	DDI-DrugBank.d241.s1.e2	effect	relType_1=cc	pos_1=CC	pos_7=VBZ	pos_8=DT	relType_10=mark	pos_5=,	lemma_7=be	pos_3=VBN	lemma_4=concomitantly	path=agent_nsubj:pass<use_advcl<be_ROOT>potential_nsubj>increase_acl>FLOLAN_nsubj	pos_4=RB	lemma_3=use	lpib=anticoagulant_NNS	wib=anticoagulants	path1=agent_nsubj:pass<use_advcl	pos_6=EX	relType_2=conj	pos_9=NN	lemma_9=potential	relType_7=ROOT	relType_3=advcl	lemma_5=,	relType_5=punct	lemma_8=the	relType_4=advmod	lib=anticoagulant	relType_2=aux:pass	pos_2=VBP	relType_6=expl	pos_10=IN	pos_2=NNS	eib=True	relType_9=nsubj	path2=potential_nsubj>increase_acl>FLOLAN_nsubj	lemma_2=be	relType_8=det	lemma_10=for	lemma_6=there	lemma_2=anticoagulant	lemma_1=or
DDI-DrugBank.d241.s1	DDI-DrugBank.d241.s1.e1	DDI-DrugBank.d241.s1.e2	effect	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_7=det	relType_8=nsubj	lpib=be_VBP	relType_1=aux:pass	lemma_5=there	relType_2=advcl	pos_6=VBZ	lemma_8=potential	pos_9=IN	lemma_2=use	path1=anticoagulant_conj<agent_nsubj:pass<use_advcl	lemma_6=be	pos_8=NN	pos_4=,	eib=False	lemma_1=be	pos_5=EX	pos_7=DT	wib=are	relType_6=ROOT	relType_4=punct	lib=be	path=anticoagulant_conj<agent_nsubj:pass<use_advcl<be_ROOT>potential_nsubj>increase_acl>FLOLAN_nsubj	lemma_4=,	pos_1=VBP	relType_5=expl	relType_9=mark	lemma_3=concomitantly	path2=potential_nsubj>increase_acl>FLOLAN_nsubj	lemma_9=for	lemma_7=the
DDI-DrugBank.d241.s2	DDI-DrugBank.d241.s2.e0	DDI-DrugBank.d241.s2.e1	null	relType_1=case	lemma_1=in	lemma_4=be	path2=anticoagulant_obl	lib=clinical	wib=clinical	lemma_6=on	path1=FLOLAN_nmod<infusion_obj<receive_acl<patient_nsubj:pass	pos_2=JJ	relType_6=case	pos_3=NNS	eib=False	pos_6=IN	pos_1=IN	lemma_5=maintain	relType_2=amod	relType_4=aux:pass	lemma_3=trial	lpib=clinical_JJ	path=FLOLAN_nmod<infusion_obj<receive_acl<patient_nsubj:pass<maintain_ROOT>anticoagulant_obl	pos_4=VBD	relType_3=obl	lemma_2=clinical	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e1	null	pos_2=VBN	pos_1=VBD	lib=be	pos_3=IN	relType_3=case	eib=False	relType_2=ROOT	relType_1=aux:pass	lemma_1=be	path1=FLOLAN_nsubj:pass	lemma_3=with	lpib=be_VBD	wib=was	path=FLOLAN_nsubj:pass<use_ROOT>digoxin_obl	lemma_2=use	path2=digoxin_obl
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e2	null	pos_2=VBN	pos_3=IN	relType_1=aux:pass	lemma_2=use	pos_1=VBD	pos_4=,	lemma_1=be	pos_4=NN	relType_4=obl	lib=be	relType_4=punct	relType_2=ROOT	path2=digoxin_obl>diuretic_conj	path=FLOLAN_nsubj:pass<use_ROOT>digoxin_obl>diuretic_conj	lemma_3=with	lemma_4=digoxin	lemma_4=,	wib=was	relType_3=case	eib=True	path1=FLOLAN_nsubj:pass	lpib=be_VBD
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e3	null	pos_2=VBN	pos_3=IN	pos_5=,	relType_1=aux:pass	lemma_2=use	pos_1=VBD	pos_4=,	pos_5=NNS	lemma_1=be	pos_4=NN	relType_4=obl	lib=be	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	lemma_4=digoxin	lemma_3=with	lemma_4=,	relType_5=conj	wib=was	relType_3=case	path2=digoxin_obl>anticoagulant_conj	eib=True	path1=FLOLAN_nsubj:pass	lemma_5=diuretic	lpib=be_VBD	path=FLOLAN_nsubj:pass<use_ROOT>digoxin_obl>anticoagulant_conj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e4	null	pos_2=VBN	pos_3=IN	pos_5=,	relType_1=aux:pass	lemma_6=,	lemma_7=oral	lemma_6=anticoagulant	lemma_2=use	relType_6=conj	pos_1=VBD	pos_4=,	pos_5=NNS	relType_6=punct	lemma_1=be	pos_4=NN	relType_4=obl	relType_7=amod	lib=be	relType_4=punct	relType_2=ROOT	lemma_5=,	relType_5=punct	path2=digoxin_obl>vasodilator_conj	path=FLOLAN_nsubj:pass<use_ROOT>digoxin_obl>vasodilator_conj	lemma_3=with	lemma_4=digoxin	lemma_4=,	relType_5=conj	wib=was	relType_3=case	pos_6=,	eib=True	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	lemma_5=diuretic	lpib=be_VBD
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e5	null	pos_2=VBN	pos_3=IN	pos_5=,	relType_1=aux:pass	relType_10=amod	lemma_6=,	lemma_7=oral	lemma_6=anticoagulant	relType_8=punct	lemma_8=,	lemma_10=supplemental	lemma_2=use	pos_8=NNS	relType_6=conj	pos_1=VBD	pos_4=,	pos_5=NNS	relType_6=punct	lemma_1=be	pos_4=NN	lemma_9=and	relType_4=obl	relType_7=amod	lib=be	relType_4=punct	pos_9=CC	relType_2=ROOT	lemma_5=,	relType_5=punct	pos_10=JJ	lemma_4=digoxin	lemma_3=with	lemma_4=,	relType_5=conj	path=FLOLAN_nsubj:pass<use_ROOT>digoxin_obl>oxygen_conj	wib=was	relType_3=case	pos_6=,	lemma_8=vasodilator	eib=True	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	lemma_5=diuretic	lpib=be_VBD	relType_9=cc	pos_8=,	path2=digoxin_obl>oxygen_conj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e6	null	relType_14=amod	lemma_16=in	lemma_13=a	pos_5=,	lemma_6=,	lemma_6=anticoagulant	relType_8=punct	lemma_2=use	pos_8=NNS	relType_18=case	relType_6=conj	pos_20=NN	lemma_11=oxygen	pos_9=CC	relType_15=obl	relType_4=punct	lemma_5=,	lemma_3=with	lemma_21=failure	lemma_8=vasodilator	lemma_12=in	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	relType_13=det	lemma_11=.	relType_22=acl	lemma_10=supplemental	pos_1=VBD	pos_19=JJ	pos_12=IN	relType_4=obl	relType_2=ROOT	lemma_4=,	relType_19=amod	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	relType_16=case	pos_11=NN	lemma_5=diuretic	lpib=be_VBD	pos_8=,	pos_2=VBN	pos_3=IN	pos_16=IN	relType_12=case	lemma_7=oral	relType_21=nmod	lemma_8=,	relType_11=conj	pos_4=,	relType_11=punct	lemma_1=be	pos_18=IN	pos_11=.	relType_7=amod	lib=be	path=FLOLAN_nsubj:pass<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	lemma_4=digoxin	relType_5=conj	lemma_14=pharmacokinetic	relType_17=nmod	pos_17=NNS	lemma_19=congestive	pos_14=JJ	relType_1=aux:pass	relType_10=amod	pos_13=DT	pos_22=VBG	pos_5=NNS	relType_6=punct	lemma_15=substudy	pos_4=NN	lemma_22=receive	lemma_9=and	pos_15=NN	lemma_17=patient	pos_10=JJ	relType_5=punct	lemma_20=heart	wib=was	relType_3=case	pos_6=,	lemma_18=with	eib=True	relType_20=compound	relType_9=cc	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e7	null	relType_14=amod	lemma_16=in	lemma_13=a	pos_5=,	lemma_6=,	lemma_6=anticoagulant	relType_8=punct	lemma_2=use	pos_8=NNS	relType_18=case	relType_6=conj	pos_20=NN	lemma_11=oxygen	pos_9=CC	relType_15=obl	relType_4=punct	lemma_23=or	lemma_5=,	lemma_3=with	lemma_21=failure	lemma_8=vasodilator	lemma_12=in	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	relType_13=det	relType_23=obj	lemma_11=.	relType_22=acl	lemma_10=supplemental	pos_1=VBD	pos_19=JJ	pos_12=IN	path=FLOLAN_nsubj:pass<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_4=obl	relType_2=ROOT	lemma_4=,	relType_19=amod	relType_16=case	pos_11=NN	lemma_5=diuretic	lpib=be_VBD	pos_8=,	pos_2=VBN	pos_3=IN	lemma_23=furosemide	pos_16=IN	relType_12=case	lemma_7=oral	relType_21=nmod	lemma_8=,	relType_11=conj	pos_23=NN	pos_23=CC	pos_4=,	relType_11=punct	lemma_1=be	pos_18=IN	pos_11=.	relType_7=amod	lib=be	lemma_4=digoxin	relType_5=conj	lemma_14=pharmacokinetic	relType_17=nmod	pos_17=NNS	lemma_19=congestive	pos_14=JJ	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_1=aux:pass	relType_10=amod	pos_13=DT	pos_22=VBG	pos_5=NNS	relType_6=punct	lemma_15=substudy	pos_4=NN	lemma_22=receive	lemma_9=and	pos_15=NN	lemma_17=patient	pos_10=JJ	relType_5=punct	relType_23=cc	lemma_20=heart	wib=was	relType_3=case	pos_6=,	lemma_18=with	eib=True	relType_20=compound	relType_9=cc	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e8	null	relType_14=amod	lemma_16=in	lemma_13=a	pos_5=,	lemma_6=,	lemma_6=anticoagulant	relType_8=punct	lemma_2=use	pos_8=NNS	relType_18=case	relType_6=conj	lemma_24=digoxin	pos_25=WP	pos_20=NN	pos_26=NN	lemma_11=oxygen	pos_9=CC	relType_15=obl	relType_4=punct	lemma_23=or	lemma_5=,	lemma_3=with	lemma_21=failure	pos_24=IN	lemma_8=vasodilator	lemma_12=in	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	relType_13=det	relType_23=obj	path=FLOLAN_nsubj:pass<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	lemma_11=.	relType_22=acl	lemma_10=supplemental	pos_1=VBD	pos_19=JJ	pos_12=IN	relType_4=obl	relType_2=ROOT	lemma_4=,	relType_24=mark	relType_19=amod	relType_16=case	pos_11=NN	lemma_5=diuretic	relType_25=dep	lemma_27=with	lpib=be_VBD	lemma_24=in	pos_8=,	pos_2=VBN	pos_3=IN	lemma_23=furosemide	pos_16=IN	relType_12=case	lemma_7=oral	pos_24=NN	relType_21=nmod	lemma_8=,	relType_11=conj	pos_23=NN	pos_23=CC	pos_4=,	relType_11=punct	lemma_1=be	pos_18=IN	pos_11=.	relType_7=amod	lib=be	lemma_25=whom	lemma_4=digoxin	relType_5=conj	lemma_14=pharmacokinetic	relType_17=nmod	lemma_26=therapy	pos_17=NNS	lemma_19=congestive	pos_14=JJ	relType_27=case	relType_1=aux:pass	relType_10=amod	pos_13=DT	pos_22=VBG	pos_5=NNS	relType_6=punct	lemma_15=substudy	pos_27=IN	pos_4=NN	lemma_22=receive	relType_26=nsubj:pass	lemma_9=and	pos_15=NN	lemma_17=patient	pos_10=JJ	relType_5=punct	relType_23=cc	relType_24=conj	lemma_20=heart	wib=was	relType_3=case	pos_6=,	lemma_18=with	eib=True	relType_20=compound	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_9=cc	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e9	null	relType_14=amod	lemma_16=in	lemma_13=a	pos_5=,	lemma_6=,	lemma_6=anticoagulant	path=FLOLAN_nsubj:pass<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_8=punct	lemma_2=use	pos_8=NNS	relType_18=case	relType_6=conj	lemma_24=digoxin	pos_25=WP	pos_20=NN	pos_26=NN	relType_32=amod	lemma_11=oxygen	pos_9=CC	relType_15=obl	relType_4=punct	lemma_23=or	lemma_31=apparent	lemma_34=value	lemma_5=,	lemma_3=with	lemma_32=oral	lemma_21=failure	pos_24=IN	relType_29=advcl	lemma_8=vasodilator	lemma_12=in	relType_30=punct	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	relType_13=det	relType_31=amod	relType_23=obj	pos_31=JJ	lemma_11=.	relType_22=acl	pos_28=VBD	lemma_10=supplemental	relType_28=nmod	pos_1=VBD	pos_32=JJ	pos_19=JJ	pos_12=IN	relType_4=obl	relType_2=ROOT	pos_28=NNP	lemma_4=,	relType_24=mark	relType_19=amod	relType_16=case	pos_11=NN	lemma_29=initiate	lemma_5=diuretic	relType_25=dep	lemma_27=with	pos_30=,	lpib=be_VBD	lemma_24=in	pos_8=,	pos_2=VBN	pos_3=IN	lemma_23=furosemide	pos_16=IN	pos_34=NNS	lemma_28=FLOLAN	relType_12=case	lemma_7=oral	pos_24=NN	relType_21=nmod	lemma_8=,	relType_11=conj	pos_23=NN	pos_23=CC	relType_28=aux:pass	pos_4=,	relType_11=punct	lemma_1=be	pos_18=IN	pos_11=.	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_7=amod	lib=be	lemma_25=whom	lemma_4=digoxin	relType_5=conj	lemma_14=pharmacokinetic	relType_17=nmod	pos_29=VBN	lemma_33=clearance	lemma_26=therapy	pos_17=NNS	lemma_19=congestive	pos_14=JJ	relType_27=case	pos_33=NN	relType_1=aux:pass	relType_10=amod	pos_13=DT	lemma_30=,	pos_22=VBG	pos_5=NNS	relType_6=punct	lemma_15=substudy	relType_33=compound	pos_27=IN	pos_4=NN	lemma_22=receive	relType_26=nsubj:pass	lemma_9=and	pos_15=NN	lemma_17=patient	pos_10=JJ	relType_5=punct	relType_23=cc	relType_24=conj	lemma_20=heart	wib=was	relType_3=case	pos_6=,	lemma_18=with	eib=True	relType_20=compound	lemma_35=for	lemma_28=be	pos_35=IN	relType_35=case	relType_9=cc	pos_21=NN	relType_34=obj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e0	DDI-DrugBank.d241.s3.e10	null	relType_14=amod	lemma_16=in	lemma_13=a	pos_5=,	lemma_38==	lemma_6=,	relType_36=nmod	lemma_6=anticoagulant	relType_8=punct	lemma_2=use	pos_8=NNS	relType_18=case	relType_6=conj	lemma_24=digoxin	pos_25=WP	pos_20=NN	pos_26=NN	relType_32=amod	lemma_11=oxygen	pos_9=CC	relType_15=obl	relType_4=punct	lemma_23=or	lemma_31=apparent	lemma_34=value	lemma_5=,	lemma_39=23	lemma_37=n	lemma_3=with	lemma_32=oral	lemma_21=failure	pos_24=IN	relType_29=advcl	lemma_8=vasodilator	lemma_12=in	relType_30=punct	pos_7=JJ	path1=FLOLAN_nsubj:pass	pos_6=NNS	relType_8=conj	relType_13=det	relType_31=amod	relType_36=punct	relType_23=obj	pos_31=JJ	lemma_11=.	relType_22=acl	pos_28=VBD	lemma_10=supplemental	relType_28=nmod	pos_1=VBD	pos_32=JJ	pos_19=JJ	pos_38=SYM	pos_12=IN	pos_37=NN	relType_4=obl	relType_2=ROOT	pos_28=NNP	lemma_4=,	relType_24=mark	pos_41=CC	relType_19=amod	relType_16=case	pos_11=NN	lemma_41=and	lemma_29=initiate	lemma_36=furosemide	lemma_5=diuretic	relType_25=dep	lemma_27=with	pos_30=,	lpib=be_VBD	lemma_24=in	pos_8=,	pos_2=VBN	pos_3=IN	lemma_23=furosemide	pos_16=IN	pos_34=NNS	lemma_28=FLOLAN	relType_12=case	lemma_7=oral	pos_24=NN	relType_21=nmod	pos_40=-RRB-	lemma_8=,	relType_11=conj	pos_23=NN	pos_23=CC	relType_28=aux:pass	relType_37=nsubj	relType_40=punct	pos_4=,	relType_11=punct	lemma_1=be	lemma_36=(	relType_41=cc	pos_18=IN	pos_11=.	relType_38=dep	relType_7=amod	lib=be	lemma_25=whom	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_40=)	lemma_4=digoxin	relType_5=conj	lemma_14=pharmacokinetic	relType_17=nmod	pos_29=VBN	lemma_33=clearance	lemma_26=therapy	pos_17=NNS	lemma_19=congestive	pos_14=JJ	relType_27=case	pos_39=CD	pos_33=NN	relType_1=aux:pass	relType_10=amod	pos_13=DT	path=FLOLAN_nsubj:pass<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_30=,	pos_22=VBG	pos_5=NNS	relType_6=punct	lemma_15=substudy	relType_33=compound	pos_27=IN	pos_4=NN	lemma_22=receive	relType_26=nsubj:pass	lemma_9=and	pos_15=NN	lemma_17=patient	pos_10=JJ	relType_5=punct	relType_23=cc	relType_24=conj	pos_36=-LRB-	lemma_20=heart	wib=was	pos_36=NN	relType_3=case	pos_6=,	relType_39=dep	lemma_18=with	eib=True	relType_20=compound	lemma_35=for	lemma_28=be	pos_35=IN	relType_35=case	relType_9=cc	pos_21=NN	relType_34=obj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e2	null	lemma_1=,	wib=diuretics	eib=False	path2=diuretic_conj	lib=diuretic	path1=	pos_1=,	relType_1=punct	path=<digoxin_obl>diuretic_conj	lpib=diuretic_NNS
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e3	null	pos_2=NNS	lemma_1=,	lemma_2=diuretic	relType_2=punct	wib=diuretics	eib=True	lib=diuretic	path2=anticoagulant_conj	path1=	path=<digoxin_obl>anticoagulant_conj	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	lpib=diuretic_NNS
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e4	null	relType_4=amod	path2=vasodilator_conj	lemma_1=,	pos_4=JJ	wib=diuretics	path1=	pos_1=,	lemma_3=anticoagulant	relType_2=punct	pos_3=NNS	relType_2=conj	lemma_2=,	lemma_2=diuretic	lemma_3=,	relType_3=conj	lib=diuretic	lpib=diuretic_NNS	path=<digoxin_obl>vasodilator_conj	pos_2=NNS	pos_3=,	eib=True	lemma_4=oral	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e5	null	relType_4=amod	lemma_1=,	pos_4=JJ	wib=diuretics	pos_5=,	path1=	pos_1=,	lemma_3=anticoagulant	lemma_5=vasodilator	relType_2=punct	path=<digoxin_obl>oxygen_conj	pos_3=NNS	pos_5=NNS	relType_2=conj	lemma_2=,	lemma_2=diuretic	relType_7=amod	lemma_3=,	pos_6=CC	path2=oxygen_conj	relType_3=conj	lemma_5=,	relType_5=punct	lib=diuretic	lemma_6=and	relType_5=conj	lpib=diuretic_NNS	pos_2=NNS	pos_3=,	eib=True	lemma_4=oral	pos_7=JJ	pos_2=,	lemma_7=supplemental	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e6	null	relType_4=amod	relType_12=obl	lemma_1=,	pos_4=JJ	lemma_8=oxygen	wib=diuretics	relType_10=det	pos_5=,	pos_1=,	pos_9=IN	lemma_3=anticoagulant	relType_8=punct	lemma_10=a	relType_14=nmod	path=digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	lemma_5=vasodilator	relType_2=punct	pos_8=NN	relType_16=amod	pos_17=NN	pos_3=NNS	lemma_15=with	pos_8=.	lemma_16=congestive	pos_5=NNS	relType_11=amod	lemma_14=patient	relType_9=case	lemma_12=substudy	pos_13=IN	lemma_11=pharmacokinetic	relType_2=conj	relType_17=compound	lemma_2=,	pos_18=NN	lemma_18=failure	relType_13=case	relType_15=case	pos_16=JJ	lemma_2=diuretic	relType_7=amod	lemma_3=,	pos_6=CC	path1=digoxin_obl	relType_3=conj	lemma_5=,	relType_5=punct	lib=diuretic	lemma_6=and	lemma_8=.	relType_5=conj	lemma_13=in	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	pos_19=VBG	lpib=diuretic_NNS	pos_15=IN	pos_2=NNS	lemma_19=receive	relType_19=acl	pos_3=,	pos_10=DT	eib=True	lemma_4=oral	pos_7=JJ	relType_8=conj	pos_2=,	lemma_7=supplemental	pos_11=JJ	pos_14=NNS	lemma_17=heart	relType_1=punct	pos_12=NN	relType_18=nmod	lemma_9=in	relType_3=punct	relType_6=cc
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e7	null	pos_5=,	lemma_3=anticoagulant	relType_8=punct	pos_3=NNS	lemma_20=furosemide	pos_20=NN	lemma_14=patient	relType_9=case	lemma_12=substudy	relType_17=compound	lemma_11=pharmacokinetic	relType_20=obj	pos_18=NN	lemma_3=,	path1=digoxin_obl	lemma_5=,	pos_3=,	pos_7=JJ	relType_8=conj	pos_2=,	pos_11=JJ	pos_14=NNS	relType_14=nmod	relType_4=amod	lemma_1=,	pos_1=,	relType_2=punct	pos_8=NN	relType_16=amod	pos_8=.	relType_11=amod	relType_2=conj	lemma_2=,	lemma_18=failure	relType_15=case	lemma_2=diuretic	pos_6=CC	lemma_8=.	lemma_13=in	pos_19=VBG	lpib=diuretic_NNS	pos_15=IN	lemma_4=oral	relType_1=punct	relType_18=nmod	relType_3=punct	lemma_8=oxygen	relType_10=det	relType_20=cc	lemma_5=vasodilator	pos_17=NN	lemma_15=with	lemma_16=congestive	pos_13=IN	relType_13=case	relType_7=amod	relType_3=conj	lib=diuretic	relType_5=conj	lemma_19=receive	lemma_20=or	pos_20=CC	lemma_17=heart	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	path=digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	lemma_9=in	pos_10=DT	relType_6=cc	relType_12=obl	pos_4=JJ	wib=diuretics	pos_9=IN	lemma_10=a	pos_5=NNS	pos_16=JJ	relType_5=punct	lemma_6=and	pos_2=NNS	relType_19=acl	eib=True	lemma_7=supplemental	pos_12=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e8	null	pos_5=,	lemma_3=anticoagulant	relType_8=punct	relType_22=dep	relType_21=conj	relType_21=mark	relType_24=case	pos_3=NNS	lemma_20=furosemide	pos_20=NN	lemma_14=patient	relType_9=case	lemma_12=substudy	relType_17=compound	lemma_11=pharmacokinetic	relType_20=obj	pos_18=NN	lemma_3=,	path1=digoxin_obl	lemma_5=,	pos_24=IN	path=digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	pos_3=,	pos_7=JJ	relType_8=conj	pos_2=,	pos_11=JJ	pos_14=NNS	relType_14=nmod	relType_4=amod	lemma_1=,	pos_1=,	relType_2=punct	pos_8=NN	relType_16=amod	pos_8=.	relType_11=amod	relType_23=nsubj:pass	relType_2=conj	lemma_2=,	lemma_18=failure	relType_15=case	lemma_2=diuretic	pos_6=CC	lemma_8=.	lemma_21=digoxin	lemma_13=in	pos_19=VBG	lpib=diuretic_NNS	pos_15=IN	lemma_24=with	lemma_4=oral	relType_1=punct	relType_18=nmod	relType_3=punct	lemma_8=oxygen	relType_10=det	relType_20=cc	lemma_5=vasodilator	pos_23=NN	pos_17=NN	lemma_15=with	lemma_16=congestive	pos_21=IN	pos_13=IN	relType_13=case	relType_7=amod	pos_22=WP	relType_3=conj	lib=diuretic	relType_5=conj	lemma_19=receive	lemma_20=or	pos_20=CC	lemma_17=heart	lemma_9=in	pos_10=DT	relType_6=cc	relType_12=obl	pos_4=JJ	wib=diuretics	pos_9=IN	lemma_10=a	lemma_21=in	pos_5=NNS	lemma_22=whom	pos_16=JJ	relType_5=punct	lemma_6=and	pos_2=NNS	lemma_23=therapy	relType_19=acl	eib=True	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	lemma_7=supplemental	pos_12=NN	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e9	null	pos_5=,	lemma_32=for	lemma_3=anticoagulant	relType_8=punct	pos_25=VBD	relType_22=dep	pos_27=,	relType_21=conj	relType_21=mark	pos_25=NNP	relType_24=case	pos_3=NNS	lemma_20=furosemide	pos_20=NN	lemma_14=patient	relType_9=case	lemma_12=substudy	relType_17=compound	lemma_11=pharmacokinetic	pos_32=IN	relType_20=obj	pos_18=NN	lemma_3=,	path1=digoxin_obl	lemma_5=,	relType_31=obj	pos_24=IN	relType_30=compound	pos_3=,	pos_7=JJ	relType_8=conj	pos_2=,	pos_11=JJ	pos_14=NNS	lemma_30=clearance	relType_14=nmod	relType_32=case	relType_4=amod	lemma_1=,	pos_1=,	relType_2=punct	pos_30=NN	pos_8=NN	relType_16=amod	lemma_28=apparent	pos_8=.	relType_25=nmod	relType_11=amod	relType_23=nsubj:pass	relType_2=conj	lemma_2=,	lemma_18=failure	relType_15=case	lemma_25=be	lemma_2=diuretic	pos_6=CC	lemma_8=.	lemma_21=digoxin	lemma_13=in	pos_28=JJ	pos_19=VBG	lpib=diuretic_NNS	pos_15=IN	lemma_24=with	lemma_26=initiate	lemma_4=oral	relType_28=amod	relType_1=punct	relType_18=nmod	relType_3=punct	relType_25=aux:pass	lemma_31=value	pos_29=JJ	lemma_8=oxygen	relType_10=det	relType_20=cc	lemma_5=vasodilator	pos_23=NN	pos_17=NN	relType_29=amod	lemma_15=with	lemma_16=congestive	pos_21=IN	pos_13=IN	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_13=case	relType_7=amod	pos_22=WP	pos_26=VBN	relType_3=conj	lib=diuretic	relType_5=conj	relType_26=advcl	lemma_19=receive	lemma_20=or	pos_20=CC	lemma_17=heart	relType_27=punct	lemma_9=in	pos_10=DT	relType_6=cc	relType_12=obl	pos_4=JJ	wib=diuretics	pos_9=IN	lemma_10=a	lemma_25=FLOLAN	lemma_21=in	path=digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	pos_5=NNS	lemma_22=whom	pos_16=JJ	relType_5=punct	lemma_6=and	pos_31=NNS	lemma_27=,	pos_2=NNS	lemma_23=therapy	relType_19=acl	eib=True	lemma_7=supplemental	pos_12=NN	lemma_29=oral	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e1	DDI-DrugBank.d241.s3.e10	null	pos_34=NN	pos_5=,	lemma_33=furosemide	lemma_32=for	lemma_3=anticoagulant	relType_8=punct	pos_25=VBD	relType_22=dep	pos_27=,	relType_21=conj	relType_21=mark	pos_25=NNP	relType_24=case	pos_3=NNS	lemma_20=furosemide	pos_20=NN	lemma_14=patient	relType_9=case	lemma_12=substudy	relType_17=compound	lemma_11=pharmacokinetic	pos_32=IN	relType_20=obj	pos_18=NN	lemma_3=,	path1=digoxin_obl	lemma_5=,	relType_31=obj	relType_33=punct	lemma_33=(	pos_33=-LRB-	pos_24=IN	lemma_37=)	relType_30=compound	pos_3=,	pos_38=CC	pos_7=JJ	relType_8=conj	pos_2=,	pos_11=JJ	pos_14=NNS	lemma_30=clearance	relType_14=nmod	relType_33=nmod	relType_32=case	relType_37=punct	relType_4=amod	lemma_1=,	pos_1=,	relType_36=dep	relType_2=punct	pos_30=NN	pos_8=NN	relType_16=amod	lemma_28=apparent	pos_8=.	relType_25=nmod	relType_11=amod	relType_34=nsubj	pos_36=CD	pos_37=-RRB-	relType_23=nsubj:pass	relType_2=conj	lemma_2=,	lemma_18=failure	relType_15=case	lemma_25=be	lemma_2=diuretic	pos_6=CC	lemma_8=.	lemma_21=digoxin	lemma_38=and	lemma_13=in	pos_28=JJ	pos_19=VBG	lpib=diuretic_NNS	pos_15=IN	lemma_24=with	lemma_26=initiate	lemma_4=oral	relType_28=amod	relType_1=punct	relType_18=nmod	relType_3=punct	relType_25=aux:pass	lemma_31=value	pos_29=JJ	lemma_8=oxygen	relType_10=det	relType_35=dep	relType_20=cc	lemma_5=vasodilator	pos_23=NN	pos_17=NN	relType_29=amod	lemma_15=with	lemma_16=congestive	pos_21=IN	pos_13=IN	path=digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_13=case	relType_7=amod	pos_22=WP	pos_26=VBN	relType_3=conj	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lib=diuretic	relType_5=conj	lemma_34=n	relType_26=advcl	lemma_19=receive	pos_35=SYM	lemma_20=or	pos_20=CC	lemma_17=heart	relType_27=punct	lemma_9=in	pos_33=NN	pos_10=DT	relType_6=cc	relType_12=obl	pos_4=JJ	wib=diuretics	lemma_36=23	pos_9=IN	lemma_10=a	lemma_25=FLOLAN	relType_38=cc	lemma_21=in	pos_5=NNS	lemma_22=whom	pos_16=JJ	relType_5=punct	lemma_6=and	pos_31=NNS	lemma_27=,	lemma_35==	pos_2=NNS	lemma_23=therapy	relType_19=acl	eib=True	lemma_7=supplemental	pos_12=NN	lemma_29=oral	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e3	null	path=diuretic_conj<digoxin_obl>anticoagulant_conj	lemma_1=,	lpib=anticoagulant_NNS	eib=False	path1=diuretic_conj	wib=anticoagulants	path2=anticoagulant_conj	pos_1=,	lib=anticoagulant	relType_1=punct
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e4	null	path2=vasodilator_conj	lemma_1=,	pos_1=,	relType_2=punct	lpib=anticoagulant_NNS	wib=anticoagulants	relType_2=conj	lemma_2=,	relType_3=amod	path1=diuretic_conj	lib=anticoagulant	pos_2=NNS	lemma_3=oral	pos_3=JJ	eib=True	pos_2=,	relType_1=punct	lemma_2=anticoagulant	path=diuretic_conj<digoxin_obl>vasodilator_conj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e5	null	lemma_1=,	pos_6=JJ	pos_5=CC	pos_1=,	lemma_6=supplemental	relType_2=punct	relType_5=cc	lpib=anticoagulant_NNS	wib=anticoagulants	pos_4=,	relType_6=amod	path=diuretic_conj<digoxin_obl>oxygen_conj	relType_2=conj	lemma_2=,	pos_4=NNS	relType_4=punct	relType_3=amod	path2=oxygen_conj	path1=diuretic_conj	lemma_4=vasodilator	lib=anticoagulant	lemma_4=,	pos_2=NNS	lemma_3=oral	pos_3=JJ	eib=True	lemma_5=and	pos_2=,	relType_4=conj	relType_1=punct	lemma_2=anticoagulant
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e6	null	relType_8=case	path1=diuretic_conj<digoxin_obl	lemma_1=,	path=diuretic_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	pos_6=JJ	lemma_7=oxygen	pos_5=CC	pos_15=JJ	relType_15=amod	lemma_9=a	lemma_14=with	relType_10=amod	pos_1=,	relType_12=case	pos_13=NNS	relType_16=compound	lemma_6=supplemental	relType_2=punct	relType_18=acl	relType_13=nmod	pos_17=NN	relType_5=cc	lemma_8=in	lpib=anticoagulant_NNS	wib=anticoagulants	pos_4=,	relType_6=amod	lemma_17=failure	pos_9=DT	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_7=.	pos_8=IN	pos_12=IN	pos_14=IN	relType_4=punct	relType_3=amod	pos_10=JJ	lemma_4=vasodilator	lib=anticoagulant	lemma_11=substudy	lemma_4=,	pos_16=NN	relType_11=obl	pos_18=VBG	relType_17=nmod	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	pos_2=NNS	lemma_18=receive	pos_7=.	lemma_3=oral	pos_11=NN	pos_3=JJ	lemma_12=in	eib=True	lemma_15=congestive	lemma_5=and	lemma_16=heart	relType_7=punct	pos_2=,	relType_4=conj	relType_14=case	relType_1=punct	pos_7=NN	relType_9=det	lemma_10=pharmacokinetic	lemma_2=anticoagulant	relType_7=conj	lemma_13=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e7	null	relType_8=case	path1=diuretic_conj<digoxin_obl	path=diuretic_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	lemma_1=,	pos_6=JJ	lemma_7=oxygen	pos_5=CC	pos_15=JJ	pos_7=NN	lemma_9=a	lemma_14=with	relType_10=amod	pos_1=,	relType_12=case	pos_13=NNS	relType_15=amod	relType_16=compound	lemma_6=supplemental	relType_2=punct	relType_18=acl	relType_13=nmod	pos_17=NN	relType_5=cc	lemma_8=in	lpib=anticoagulant_NNS	wib=anticoagulants	pos_4=,	relType_6=amod	lemma_17=failure	pos_9=DT	pos_19=NN	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_7=.	pos_8=IN	pos_12=IN	pos_14=IN	relType_4=punct	relType_3=amod	pos_10=JJ	lemma_4=vasodilator	lib=anticoagulant	lemma_19=furosemide	pos_19=CC	lemma_11=substudy	lemma_4=,	pos_16=NN	relType_11=obl	pos_18=VBG	relType_17=nmod	relType_19=cc	lemma_19=or	pos_2=NNS	lemma_18=receive	pos_7=.	lemma_3=oral	pos_11=NN	pos_3=JJ	lemma_12=in	eib=True	lemma_15=congestive	lemma_5=and	lemma_16=heart	relType_7=punct	pos_2=,	relType_4=conj	relType_14=case	relType_19=obj	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_1=punct	relType_9=det	lemma_10=pharmacokinetic	lemma_2=anticoagulant	relType_7=conj	lemma_13=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e8	null	pos_6=JJ	lemma_7=oxygen	pos_13=NNS	relType_5=cc	lpib=anticoagulant_NNS	lemma_17=failure	pos_20=NN	lemma_7=.	relType_4=punct	relType_3=amod	pos_19=CC	lemma_11=substudy	lemma_19=or	lemma_12=in	pos_3=JJ	lemma_5=and	pos_2=,	lemma_22=therapy	relType_22=nsubj:pass	relType_8=case	lemma_1=,	pos_22=NN	pos_21=WP	pos_1=,	relType_2=punct	lemma_8=in	path=diuretic_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_20=conj	relType_21=dep	relType_2=conj	lemma_2=,	pos_8=IN	pos_12=IN	pos_14=IN	lemma_4=vasodilator	lib=anticoagulant	lemma_19=furosemide	lemma_4=,	pos_16=NN	lemma_16=heart	pos_11=NN	lemma_15=congestive	pos_23=IN	relType_1=punct	pos_7=NN	lemma_10=pharmacokinetic	path1=diuretic_conj<digoxin_obl	lemma_21=whom	lemma_9=a	lemma_14=with	relType_12=case	lemma_6=supplemental	pos_20=IN	pos_17=NN	pos_4=,	pos_9=DT	pos_18=VBG	relType_11=obl	relType_17=nmod	relType_23=case	pos_7=.	lemma_3=oral	relType_14=case	relType_19=obj	lemma_2=anticoagulant	relType_7=conj	lemma_13=patient	pos_15=JJ	pos_5=CC	relType_15=amod	relType_10=amod	relType_16=compound	lemma_23=with	relType_18=acl	relType_13=nmod	relType_20=mark	wib=anticoagulants	relType_6=amod	pos_19=NN	pos_4=NNS	pos_10=JJ	lemma_20=in	relType_19=cc	pos_2=NNS	lemma_18=receive	eib=True	relType_7=punct	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_4=conj	lemma_20=digoxin	relType_9=det
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e9	null	path=diuretic_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	pos_24=NNP	pos_6=JJ	lemma_7=oxygen	pos_13=NNS	relType_5=cc	lpib=anticoagulant_NNS	lemma_17=failure	pos_20=NN	lemma_7=.	relType_4=punct	relType_3=amod	lemma_29=clearance	pos_19=CC	lemma_11=substudy	lemma_19=or	lemma_12=in	pos_3=JJ	lemma_5=and	pos_2=,	lemma_24=be	lemma_22=therapy	relType_22=nsubj:pass	relType_24=aux:pass	relType_8=case	lemma_1=,	pos_30=NNS	pos_22=NN	pos_21=WP	pos_1=,	pos_27=JJ	relType_2=punct	lemma_8=in	relType_20=conj	pos_29=NN	relType_21=dep	relType_2=conj	lemma_2=,	pos_8=IN	pos_12=IN	pos_14=IN	lemma_31=for	lemma_4=vasodilator	lib=anticoagulant	lemma_19=furosemide	lemma_24=FLOLAN	lemma_4=,	pos_16=NN	pos_25=VBN	pos_28=JJ	lemma_25=initiate	lemma_16=heart	pos_11=NN	lemma_15=congestive	relType_25=advcl	pos_23=IN	relType_28=amod	relType_26=punct	relType_1=punct	pos_7=NN	lemma_10=pharmacokinetic	path1=diuretic_conj<digoxin_obl	lemma_21=whom	lemma_9=a	lemma_14=with	relType_30=obj	relType_12=case	relType_27=amod	relType_29=compound	lemma_6=supplemental	pos_24=VBD	pos_20=IN	pos_31=IN	pos_17=NN	pos_4=,	pos_9=DT	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	pos_18=VBG	relType_11=obl	relType_17=nmod	relType_23=case	pos_7=.	lemma_3=oral	relType_14=case	relType_19=obj	lemma_2=anticoagulant	relType_7=conj	lemma_13=patient	lemma_28=oral	pos_15=JJ	pos_5=CC	relType_15=amod	relType_10=amod	relType_16=compound	lemma_23=with	relType_31=case	relType_18=acl	relType_13=nmod	relType_20=mark	wib=anticoagulants	relType_6=amod	lemma_27=apparent	pos_19=NN	pos_4=NNS	pos_10=JJ	lemma_20=in	relType_24=nmod	relType_19=cc	lemma_30=value	pos_2=NNS	lemma_18=receive	eib=True	relType_7=punct	pos_26=,	relType_4=conj	lemma_20=digoxin	lemma_26=,	relType_9=det
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e2	DDI-DrugBank.d241.s3.e10	null	pos_24=NNP	lemma_36=)	pos_6=JJ	lemma_7=oxygen	pos_13=NNS	relType_32=punct	relType_32=nmod	relType_5=cc	lpib=anticoagulant_NNS	lemma_17=failure	pos_20=NN	lemma_7=.	relType_4=punct	relType_3=amod	lemma_29=clearance	pos_19=CC	pos_32=NN	lemma_11=substudy	lemma_19=or	pos_35=CD	lemma_12=in	pos_37=CC	pos_3=JJ	lemma_5=and	pos_2=,	relType_36=punct	lemma_24=be	lemma_22=therapy	relType_22=nsubj:pass	relType_24=aux:pass	relType_8=case	lemma_1=,	pos_30=NNS	pos_22=NN	pos_21=WP	pos_1=,	lemma_35=23	pos_27=JJ	relType_2=punct	lemma_8=in	relType_33=nsubj	relType_20=conj	pos_29=NN	relType_21=dep	relType_2=conj	lemma_2=,	pos_8=IN	pos_12=IN	pos_14=IN	lemma_31=for	lemma_32=(	lemma_4=vasodilator	lemma_37=and	lib=anticoagulant	lemma_19=furosemide	lemma_24=FLOLAN	lemma_4=,	pos_16=NN	pos_25=VBN	pos_28=JJ	lemma_25=initiate	lemma_16=heart	lemma_34==	pos_11=NN	lemma_15=congestive	relType_25=advcl	pos_23=IN	relType_28=amod	relType_26=punct	relType_1=punct	pos_7=NN	lemma_10=pharmacokinetic	path1=diuretic_conj<digoxin_obl	pos_34=SYM	lemma_21=whom	lemma_9=a	lemma_14=with	relType_30=obj	relType_12=case	relType_35=dep	relType_27=amod	relType_29=compound	lemma_6=supplemental	pos_24=VBD	pos_20=IN	pos_31=IN	pos_17=NN	pos_4=,	pos_32=-LRB-	pos_9=DT	relType_34=dep	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	pos_18=VBG	relType_11=obl	relType_17=nmod	relType_23=case	pos_7=.	lemma_3=oral	lemma_32=furosemide	relType_14=case	relType_19=obj	path=diuretic_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_2=anticoagulant	pos_33=NN	relType_7=conj	lemma_13=patient	lemma_28=oral	lemma_33=n	pos_15=JJ	pos_5=CC	relType_37=cc	relType_15=amod	relType_10=amod	relType_16=compound	lemma_23=with	relType_31=case	relType_18=acl	relType_13=nmod	pos_36=-RRB-	relType_20=mark	wib=anticoagulants	relType_6=amod	lemma_27=apparent	pos_19=NN	pos_4=NNS	pos_10=JJ	lemma_20=in	relType_24=nmod	relType_19=cc	lemma_30=value	pos_2=NNS	lemma_18=receive	eib=True	relType_7=punct	pos_26=,	relType_4=conj	lemma_20=digoxin	lemma_26=,	relType_9=det
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e4	null	lemma_2=oral	path2=vasodilator_conj	lib=oral	lemma_1=,	eib=False	wib=oral	relType_2=amod	pos_1=,	path=anticoagulant_conj<digoxin_obl>vasodilator_conj	relType_1=punct	lpib=oral_JJ	pos_2=JJ	path1=anticoagulant_conj
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e5	null	lemma_1=,	lib=oral	path=anticoagulant_conj<digoxin_obl>oxygen_conj	pos_1=,	relType_4=cc	pos_2=JJ	pos_3=NNS	lemma_3=vasodilator	lemma_2=oral	pos_5=JJ	relType_5=amod	lemma_3=,	path2=oxygen_conj	relType_3=conj	relType_2=amod	lpib=oral_JJ	lemma_5=supplemental	path1=anticoagulant_conj	pos_3=,	eib=True	pos_4=CC	wib=oral	lemma_4=and	relType_1=punct	relType_3=punct
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e6	null	relType_14=amod	lemma_1=,	lib=oral	pos_8=DT	relType_7=case	path1=anticoagulant_conj<digoxin_obl	lemma_14=congestive	lemma_9=pharmacokinetic	relType_16=nmod	pos_1=,	lemma_13=with	relType_4=cc	pos_2=JJ	lemma_16=failure	relType_11=case	lemma_10=substudy	pos_6=NN	pos_9=JJ	relType_17=acl	relType_6=conj	pos_3=NNS	relType_6=punct	lemma_3=vasodilator	relType_12=nmod	lemma_8=a	lemma_12=patient	pos_17=VBG	relType_9=amod	lemma_11=in	pos_10=NN	pos_13=IN	pos_11=IN	lemma_2=oral	relType_13=case	pos_5=JJ	path=anticoagulant_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	lemma_3=,	relType_5=amod	relType_3=conj	pos_12=NNS	pos_15=NN	relType_2=amod	lemma_6=.	lemma_17=receive	pos_16=NN	lpib=oral_JJ	lemma_5=supplemental	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	relType_15=compound	pos_6=.	pos_3=,	eib=True	pos_4=CC	pos_7=IN	wib=oral	lemma_7=in	lemma_4=and	pos_14=JJ	relType_8=det	relType_1=punct	lemma_6=oxygen	relType_10=obl	relType_3=punct	lemma_15=heart
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e7	null	lemma_18=or	relType_14=amod	lemma_1=,	lib=oral	pos_8=DT	relType_7=case	path1=anticoagulant_conj<digoxin_obl	lemma_14=congestive	lemma_9=pharmacokinetic	relType_16=nmod	pos_1=,	lemma_13=with	relType_4=cc	pos_2=JJ	lemma_16=failure	relType_18=cc	relType_11=case	lemma_10=substudy	pos_6=NN	pos_9=JJ	relType_17=acl	relType_6=conj	pos_3=NNS	lemma_18=furosemide	relType_6=punct	lemma_3=vasodilator	relType_12=nmod	lemma_8=a	lemma_12=patient	pos_17=VBG	relType_10=obl	relType_9=amod	lemma_11=in	pos_10=NN	pos_13=IN	pos_18=CC	pos_11=IN	pos_18=NN	lemma_2=oral	relType_13=case	pos_5=JJ	relType_5=amod	lemma_3=,	pos_15=NN	relType_3=conj	pos_12=NNS	relType_2=amod	lemma_6=.	lemma_17=receive	pos_16=NN	lpib=oral_JJ	lemma_5=supplemental	path=anticoagulant_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_15=compound	pos_6=.	pos_3=,	eib=True	pos_4=CC	pos_7=IN	wib=oral	lemma_7=in	lemma_4=and	pos_14=JJ	relType_8=det	relType_18=obj	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_1=punct	lemma_6=oxygen	relType_3=punct	lemma_15=heart
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e8	null	relType_14=amod	lemma_14=congestive	relType_16=nmod	pos_2=JJ	lemma_10=substudy	pos_6=NN	relType_6=conj	pos_3=NNS	lemma_18=furosemide	pos_18=CC	pos_22=IN	pos_10=NN	relType_19=mark	pos_18=NN	lemma_3=,	lemma_17=receive	lemma_21=therapy	relType_15=compound	pos_6=.	pos_3=,	pos_7=IN	lemma_7=in	lemma_4=and	relType_18=obj	lemma_1=,	pos_8=DT	relType_7=case	path1=anticoagulant_conj<digoxin_obl	pos_1=,	lemma_13=with	relType_11=case	relType_17=acl	lemma_19=in	relType_12=nmod	lemma_12=patient	lemma_11=in	relType_22=case	lemma_22=with	pos_16=NN	lemma_5=supplemental	relType_1=punct	relType_3=punct	lemma_15=heart	lemma_18=or	lemma_9=pharmacokinetic	relType_21=nsubj:pass	relType_18=cc	pos_20=WP	relType_9=amod	pos_13=IN	pos_11=IN	relType_13=case	relType_5=amod	relType_3=conj	relType_2=amod	relType_19=conj	path=anticoagulant_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	pos_4=CC	pos_14=JJ	relType_8=det	lemma_6=oxygen	relType_10=obl	pos_19=IN	lib=oral	relType_4=cc	lemma_16=failure	relType_20=dep	pos_9=JJ	relType_6=punct	lemma_3=vasodilator	lemma_8=a	pos_17=VBG	pos_19=NN	lemma_2=oral	pos_5=JJ	pos_15=NN	pos_12=NNS	lemma_6=.	lpib=oral_JJ	lemma_19=digoxin	eib=True	lemma_20=whom	wib=oral	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e9	null	relType_14=amod	lemma_14=congestive	relType_16=nmod	pos_2=JJ	pos_29=NNS	lemma_10=substudy	pos_6=NN	lemma_26=apparent	relType_6=conj	pos_3=NNS	lemma_18=furosemide	pos_18=CC	pos_22=IN	pos_10=NN	relType_19=mark	lemma_30=for	relType_29=obj	pos_18=NN	relType_23=aux:pass	lemma_3=,	lemma_25=,	lemma_17=receive	lemma_21=therapy	relType_15=compound	pos_28=NN	pos_6=.	relType_26=amod	pos_3=,	pos_7=IN	lemma_7=in	lemma_4=and	relType_18=obj	pos_30=IN	lemma_1=,	pos_8=DT	relType_7=case	path1=anticoagulant_conj<digoxin_obl	lemma_27=oral	pos_1=,	lemma_13=with	pos_27=JJ	path=anticoagulant_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_11=case	relType_17=acl	lemma_19=in	relType_12=nmod	lemma_12=patient	lemma_11=in	relType_22=case	lemma_22=with	pos_16=NN	pos_24=VBN	lemma_5=supplemental	relType_25=punct	relType_1=punct	relType_3=punct	lemma_15=heart	lemma_18=or	lemma_9=pharmacokinetic	relType_27=amod	relType_21=nsubj:pass	relType_18=cc	pos_26=JJ	pos_20=WP	relType_24=advcl	relType_9=amod	pos_13=IN	relType_23=nmod	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	pos_11=IN	relType_13=case	relType_5=amod	lemma_24=initiate	relType_3=conj	relType_2=amod	relType_19=conj	pos_4=CC	lemma_23=be	pos_14=JJ	relType_8=det	lemma_6=oxygen	relType_10=obl	lemma_23=FLOLAN	lemma_29=value	relType_30=case	pos_23=NNP	pos_19=IN	lib=oral	pos_25=,	lemma_28=clearance	relType_4=cc	lemma_16=failure	relType_20=dep	pos_9=JJ	relType_6=punct	lemma_3=vasodilator	lemma_8=a	pos_17=VBG	pos_19=NN	lemma_2=oral	relType_28=compound	pos_5=JJ	pos_15=NN	pos_12=NNS	lemma_6=.	lpib=oral_JJ	lemma_19=digoxin	eib=True	lemma_20=whom	wib=oral	pos_23=VBD	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e3	DDI-DrugBank.d241.s3.e10	null	relType_14=amod	lemma_14=congestive	relType_16=nmod	pos_2=JJ	pos_29=NNS	lemma_10=substudy	pos_6=NN	lemma_26=apparent	relType_6=conj	pos_3=NNS	lemma_18=furosemide	lemma_33==	pos_18=CC	pos_22=IN	pos_10=NN	relType_19=mark	lemma_30=for	relType_29=obj	pos_18=NN	relType_23=aux:pass	lemma_3=,	pos_35=-RRB-	lemma_25=,	lemma_17=receive	pos_32=NN	lemma_21=therapy	relType_15=compound	pos_28=NN	pos_6=.	relType_26=amod	pos_34=CD	pos_3=,	pos_7=IN	lemma_7=in	lemma_4=and	relType_18=obj	pos_30=IN	lemma_1=,	pos_8=DT	relType_7=case	path1=anticoagulant_conj<digoxin_obl	lemma_27=oral	pos_1=,	lemma_13=with	pos_27=JJ	relType_11=case	relType_17=acl	lemma_19=in	lemma_31=furosemide	relType_12=nmod	lemma_12=patient	lemma_11=in	relType_22=case	pos_36=CC	lemma_22=with	pos_16=NN	pos_24=VBN	lemma_5=supplemental	relType_33=dep	pos_31=NN	relType_25=punct	relType_1=punct	lemma_32=n	path=anticoagulant_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_3=punct	lemma_15=heart	lemma_18=or	lemma_9=pharmacokinetic	relType_27=amod	relType_21=nsubj:pass	relType_18=cc	pos_26=JJ	lemma_36=and	pos_20=WP	pos_33=SYM	relType_24=advcl	pos_31=-LRB-	relType_9=amod	pos_13=IN	relType_23=nmod	pos_11=IN	relType_32=nsubj	relType_13=case	relType_5=amod	lemma_24=initiate	relType_34=dep	relType_3=conj	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_2=amod	relType_19=conj	relType_35=punct	pos_4=CC	lemma_31=(	lemma_23=be	pos_14=JJ	relType_8=det	lemma_6=oxygen	relType_10=obl	lemma_23=FLOLAN	lemma_29=value	relType_30=case	pos_23=NNP	pos_19=IN	lib=oral	pos_25=,	lemma_28=clearance	relType_4=cc	lemma_16=failure	relType_20=dep	pos_9=JJ	relType_6=punct	lemma_3=vasodilator	lemma_8=a	pos_17=VBG	relType_31=nmod	pos_19=NN	relType_31=punct	lemma_2=oral	relType_28=compound	pos_5=JJ	pos_15=NN	pos_12=NNS	lemma_6=.	lpib=oral_JJ	lemma_19=digoxin	relType_36=cc	eib=True	lemma_20=whom	wib=oral	pos_23=VBD	lemma_34=23	lemma_35=)	pos_21=NN
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e5	null	path=vasodilator_conj<digoxin_obl>oxygen_conj	lemma_2=and	lpib=supplemental_JJ	path1=vasodilator_conj	lib=supplemental	lemma_1=,	pos_3=JJ	relType_3=amod	eib=False	path2=oxygen_conj	wib=supplemental	pos_2=CC	pos_1=,	lemma_3=supplemental	relType_1=punct	relType_2=cc
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e6	null	lemma_1=,	lib=supplemental	lemma_5=in	lemma_15=receive	pos_6=DT	pos_4=.	pos_1=,	pos_9=IN	lemma_12=congestive	lemma_8=substudy	lemma_13=heart	relType_2=cc	relType_5=case	path1=vasodilator_conj<digoxin_obl	relType_8=obl	lemma_11=with	relType_11=case	pos_8=NN	lemma_2=and	pos_12=JJ	relType_10=nmod	lemma_6=a	lemma_7=pharmacokinetic	relType_12=amod	relType_9=case	path=vasodilator_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	lemma_4=.	pos_13=NN	pos_14=NN	pos_4=NN	pos_11=IN	relType_7=amod	relType_4=punct	relType_3=amod	relType_13=compound	pos_15=VBG	pos_5=IN	lemma_3=supplemental	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	relType_15=acl	relType_6=det	lpib=supplemental_JJ	pos_3=JJ	eib=True	wib=supplemental	pos_2=CC	pos_7=JJ	lemma_14=failure	relType_4=conj	lemma_4=oxygen	relType_1=punct	relType_14=nmod	lemma_9=in	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e7	null	relType_16=cc	lemma_1=,	lib=supplemental	lemma_5=in	lemma_15=receive	pos_6=DT	pos_4=.	pos_1=,	pos_9=IN	lemma_12=congestive	lemma_8=substudy	lemma_13=heart	relType_14=nmod	relType_2=cc	lemma_16=furosemide	pos_16=CC	relType_5=case	path1=vasodilator_conj<digoxin_obl	relType_8=obl	lemma_11=with	relType_11=case	pos_8=NN	lemma_2=and	pos_12=JJ	relType_10=nmod	lemma_6=a	lemma_7=pharmacokinetic	relType_12=amod	relType_9=case	lemma_4=.	pos_13=NN	pos_14=NN	pos_4=NN	pos_11=IN	lemma_16=or	relType_7=amod	relType_4=punct	relType_3=amod	relType_13=compound	pos_15=VBG	relType_16=obj	pos_5=IN	lemma_3=supplemental	pos_16=NN	relType_15=acl	relType_6=det	lpib=supplemental_JJ	pos_3=JJ	eib=True	wib=supplemental	path=vasodilator_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	pos_2=CC	pos_7=JJ	lemma_14=failure	relType_4=conj	lemma_4=oxygen	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_1=punct	lemma_9=in	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e8	null	relType_16=cc	relType_18=dep	lemma_17=digoxin	lemma_1=,	lib=supplemental	lemma_5=in	lemma_15=receive	pos_6=DT	pos_4=.	pos_1=,	pos_18=WP	pos_9=IN	lemma_12=congestive	lemma_8=substudy	lemma_13=heart	path=vasodilator_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_2=cc	lemma_16=furosemide	pos_16=CC	relType_5=case	lemma_18=whom	path1=vasodilator_conj<digoxin_obl	relType_8=obl	lemma_11=with	relType_11=case	pos_8=NN	lemma_2=and	pos_12=JJ	pos_17=NN	relType_10=nmod	relType_17=conj	pos_17=IN	relType_17=mark	relType_20=case	lemma_6=a	lemma_7=pharmacokinetic	pos_20=IN	relType_12=amod	pos_19=NN	relType_9=case	lemma_4=.	pos_13=NN	pos_14=NN	pos_4=NN	pos_11=IN	lemma_16=or	relType_7=amod	relType_4=punct	relType_3=amod	relType_13=compound	relType_19=nsubj:pass	pos_15=VBG	relType_16=obj	pos_5=IN	lemma_3=supplemental	pos_16=NN	lemma_17=in	relType_15=acl	relType_6=det	lemma_19=therapy	lpib=supplemental_JJ	pos_3=JJ	lemma_20=with	eib=True	wib=supplemental	pos_2=CC	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	pos_7=JJ	lemma_14=failure	relType_4=conj	lemma_4=oxygen	relType_1=punct	relType_14=nmod	lemma_9=in	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e9	null	relType_18=dep	lemma_5=in	pos_4=.	relType_21=aux:pass	pos_18=WP	lemma_8=substudy	relType_2=cc	relType_5=case	lemma_2=and	relType_10=nmod	relType_27=obj	lemma_6=a	relType_9=case	pos_26=NN	pos_13=NN	lemma_23=,	lemma_27=value	relType_4=punct	relType_3=amod	pos_15=VBG	lemma_22=initiate	relType_15=acl	pos_3=JJ	pos_7=JJ	lemma_14=failure	lemma_28=for	relType_14=nmod	path=vasodilator_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_16=cc	pos_21=NNP	lemma_1=,	lemma_21=be	pos_1=,	lemma_12=congestive	pos_16=CC	relType_11=case	lemma_11=with	pos_8=NN	relType_20=case	relType_25=amod	lemma_7=pharmacokinetic	relType_12=amod	pos_5=IN	pos_16=NN	relType_24=amod	relType_6=det	lemma_19=therapy	relType_1=punct	pos_6=DT	relType_21=nmod	pos_24=JJ	path1=vasodilator_conj<digoxin_obl	pos_20=IN	pos_17=IN	relType_17=mark	pos_17=NN	lemma_21=FLOLAN	pos_27=NNS	lemma_24=apparent	relType_26=compound	pos_14=NN	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	pos_11=IN	lemma_16=or	relType_7=amod	relType_19=nsubj:pass	relType_16=obj	lemma_3=supplemental	lemma_17=in	relType_28=case	wib=supplemental	lemma_25=oral	lemma_9=in	relType_23=punct	lemma_17=digoxin	lemma_15=receive	lib=supplemental	pos_9=IN	lemma_13=heart	lemma_16=furosemide	lemma_18=whom	relType_8=obl	relType_17=conj	pos_22=VBN	pos_12=JJ	relType_22=advcl	pos_19=NN	lemma_4=.	lemma_26=clearance	pos_4=NN	pos_25=JJ	relType_13=compound	lpib=supplemental_JJ	lemma_20=with	eib=True	pos_23=,	pos_28=IN	pos_2=CC	relType_4=conj	lemma_4=oxygen	pos_21=VBD	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e4	DDI-DrugBank.d241.s3.e10	null	relType_18=dep	lemma_5=in	pos_4=.	relType_30=nsubj	relType_21=aux:pass	pos_18=WP	lemma_8=substudy	lemma_32=23	relType_2=cc	relType_5=case	lemma_2=and	relType_10=nmod	relType_27=obj	lemma_6=a	relType_9=case	pos_26=NN	pos_13=NN	lemma_23=,	lemma_31==	lemma_27=value	relType_4=punct	relType_3=amod	pos_15=VBG	relType_33=punct	lemma_22=initiate	relType_15=acl	pos_3=JJ	pos_7=JJ	lemma_14=failure	lemma_28=for	relType_14=nmod	relType_16=cc	pos_21=NNP	lemma_1=,	lemma_21=be	pos_1=,	lemma_12=congestive	pos_16=CC	relType_11=case	pos_30=NN	lemma_11=with	pos_8=NN	relType_20=case	lemma_34=and	relType_25=amod	lemma_7=pharmacokinetic	relType_12=amod	pos_29=NN	relType_29=nmod	pos_5=IN	pos_16=NN	relType_24=amod	lemma_30=n	relType_6=det	lemma_19=therapy	pos_32=CD	relType_1=punct	pos_31=SYM	pos_6=DT	relType_21=nmod	pos_24=JJ	path1=vasodilator_conj<digoxin_obl	pos_20=IN	pos_17=IN	relType_17=mark	pos_17=NN	lemma_21=FLOLAN	pos_27=NNS	lemma_24=apparent	relType_26=compound	pos_14=NN	pos_11=IN	lemma_16=or	relType_7=amod	relType_19=nsubj:pass	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_16=obj	lemma_3=supplemental	lemma_17=in	relType_31=dep	pos_29=-LRB-	relType_28=case	wib=supplemental	lemma_25=oral	lemma_29=furosemide	pos_34=CC	lemma_9=in	relType_23=punct	lemma_17=digoxin	lemma_15=receive	lib=supplemental	pos_33=-RRB-	pos_9=IN	relType_32=dep	lemma_13=heart	lemma_16=furosemide	lemma_18=whom	path=vasodilator_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_8=obl	relType_17=conj	pos_22=VBN	pos_12=JJ	relType_22=advcl	lemma_33=)	pos_19=NN	lemma_4=.	lemma_26=clearance	pos_4=NN	pos_25=JJ	lemma_29=(	relType_13=compound	relType_29=punct	relType_34=cc	lpib=supplemental_JJ	lemma_20=with	eib=True	pos_23=,	pos_28=IN	pos_2=CC	relType_4=conj	lemma_4=oxygen	pos_21=VBD	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e5	DDI-DrugBank.d241.s3.e6	null	pos_7=NNS	relType_8=case	relType_4=amod	pos_4=JJ	pos_12=VBG	lib=pharmacokinetic	pos_1=.	lemma_12=receive	relType_6=case	pos_2=IN	pos_9=JJ	lemma_4=pharmacokinetic	eib=False	lemma_5=substudy	pos_6=IN	lemma_8=with	lemma_7=patient	relType_9=amod	relType_10=compound	lemma_6=in	path1=oxygen_conj<digoxin_obl	lemma_3=a	relType_3=det	path=oxygen_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	pos_8=IN	pos_10=NN	lemma_10=heart	lemma_1=.	relType_7=nmod	lemma_9=congestive	relType_5=obl	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj	pos_5=NN	pos_11=NN	relType_2=case	pos_3=DT	wib=pharmacokinetic	lemma_11=failure	relType_12=acl	relType_11=nmod	relType_1=punct	lpib=pharmacokinetic_JJ	lemma_2=in
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e5	DDI-DrugBank.d241.s3.e7	null	pos_7=NNS	relType_8=case	relType_4=amod	pos_4=JJ	pos_12=VBG	lib=pharmacokinetic	pos_1=.	lemma_12=receive	relType_6=case	pos_2=IN	pos_9=JJ	lemma_4=pharmacokinetic	lemma_5=substudy	lemma_13=or	pos_6=IN	lemma_8=with	lemma_7=patient	relType_9=amod	relType_10=compound	lemma_6=in	path1=oxygen_conj<digoxin_obl	lemma_3=a	relType_3=det	pos_10=NN	pos_8=IN	lemma_10=heart	pos_13=NN	relType_13=cc	lemma_1=.	relType_7=nmod	lemma_9=congestive	relType_5=obl	path=oxygen_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	pos_13=CC	pos_5=NN	pos_11=NN	relType_2=case	eib=True	pos_3=DT	wib=pharmacokinetic	lemma_11=failure	relType_12=acl	relType_13=obj	relType_11=nmod	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>furosemide_obj>digoxin_conj	relType_1=punct	lpib=pharmacokinetic_JJ	lemma_2=in	lemma_13=furosemide
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e5	DDI-DrugBank.d241.s3.e8	null	pos_7=NNS	relType_8=case	relType_4=amod	pos_14=NN	pos_4=JJ	pos_12=VBG	relType_16=nsubj:pass	lib=pharmacokinetic	pos_1=.	lemma_12=receive	pos_15=WP	relType_6=case	lemma_14=in	pos_2=IN	pos_9=JJ	pos_17=IN	lemma_4=pharmacokinetic	lemma_17=with	lemma_5=substudy	lemma_13=or	pos_6=IN	relType_15=dep	lemma_8=with	lemma_7=patient	relType_9=amod	relType_10=compound	lemma_6=in	path1=oxygen_conj<digoxin_obl	lemma_3=a	relType_3=det	pos_10=NN	pos_8=IN	lemma_10=heart	pos_13=NN	relType_13=cc	pos_14=IN	relType_17=case	lemma_14=digoxin	lemma_15=whom	lemma_1=.	relType_7=nmod	lemma_9=congestive	relType_5=obl	relType_14=mark	pos_16=NN	pos_13=CC	pos_5=NN	pos_11=NN	relType_2=case	eib=True	pos_3=DT	path=oxygen_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	wib=pharmacokinetic	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	lemma_11=failure	relType_14=conj	relType_12=acl	relType_13=obj	relType_11=nmod	lemma_16=therapy	relType_1=punct	lpib=pharmacokinetic_JJ	lemma_2=in	lemma_13=furosemide
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e5	DDI-DrugBank.d241.s3.e9	null	relType_18=aux:pass	lib=pharmacokinetic	lemma_20=,	lemma_18=be	lemma_14=in	pos_10=NN	pos_13=NN	lemma_22=oral	relType_23=compound	pos_24=NNS	lemma_14=digoxin	relType_24=obj	relType_12=acl	lemma_13=furosemide	pos_7=NNS	relType_8=case	relType_4=amod	relType_16=nsubj:pass	pos_21=JJ	lemma_19=initiate	relType_6=case	relType_25=case	lemma_5=substudy	lemma_13=or	pos_6=IN	lemma_6=in	path1=oxygen_conj<digoxin_obl	lemma_3=a	relType_3=det	lemma_10=heart	pos_8=IN	pos_14=IN	relType_13=cc	lemma_1=.	relType_7=nmod	pos_16=NN	pos_5=NN	pos_11=NN	path=oxygen_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	lemma_11=failure	pos_25=IN	relType_11=nmod	relType_1=punct	relType_18=nmod	wib=pharmacokinetic	lemma_2=in	lemma_18=FLOLAN	pos_12=VBG	pos_1=.	lemma_25=for	pos_17=IN	pos_2=IN	pos_23=NN	lemma_4=pharmacokinetic	lemma_17=with	relType_15=dep	lemma_8=with	pos_14=NN	relType_9=amod	relType_17=case	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>value_obj>furosemide_nmod	lemma_9=congestive	relType_14=mark	relType_5=obl	relType_19=advcl	lemma_24=value	pos_13=CC	pos_22=JJ	relType_2=case	relType_22=amod	pos_19=VBN	relType_20=punct	lemma_16=therapy	relType_14=conj	pos_4=JJ	pos_18=NNP	lemma_12=receive	pos_15=WP	pos_9=JJ	relType_21=amod	lemma_7=patient	relType_10=compound	pos_20=,	lemma_15=whom	lemma_23=clearance	lemma_21=apparent	eib=True	pos_3=DT	relType_13=obj	lpib=pharmacokinetic_JJ	pos_18=VBD
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e5	DDI-DrugBank.d241.s3.e10	null	relType_28=dep	relType_18=aux:pass	lemma_27=n	lib=pharmacokinetic	lemma_20=,	lemma_26=furosemide	pos_30=-RRB-	relType_26=nmod	lemma_18=be	pos_26=NN	lemma_14=in	pos_10=NN	pos_13=NN	lemma_22=oral	relType_23=compound	pos_24=NNS	lemma_14=digoxin	relType_24=obj	pos_31=CC	relType_30=punct	path=oxygen_conj<digoxin_obl<use_ROOT>substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_12=acl	pos_28=SYM	lemma_13=furosemide	lemma_31=and	pos_7=NNS	relType_8=case	relType_4=amod	lemma_26=(	relType_16=nsubj:pass	pos_21=JJ	relType_31=cc	lemma_19=initiate	relType_6=case	relType_25=case	lemma_5=substudy	lemma_13=or	pos_6=IN	lemma_6=in	path1=oxygen_conj<digoxin_obl	lemma_3=a	relType_3=det	lemma_10=heart	pos_8=IN	pos_14=IN	relType_13=cc	pos_27=NN	lemma_1=.	relType_7=nmod	pos_16=NN	pos_5=NN	pos_11=NN	lemma_11=failure	pos_25=IN	relType_29=dep	relType_11=nmod	relType_26=punct	relType_1=punct	relType_18=nmod	wib=pharmacokinetic	lemma_2=in	lemma_18=FLOLAN	lemma_30=)	pos_12=VBG	pos_1=.	lemma_25=for	relType_27=nsubj	pos_17=IN	pos_2=IN	pos_23=NN	lemma_4=pharmacokinetic	lemma_17=with	relType_15=dep	lemma_8=with	pos_14=NN	relType_9=amod	relType_17=case	path2=substudy_obl>patient_nmod>failure_nmod>receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_9=congestive	relType_14=mark	relType_5=obl	relType_19=advcl	lemma_24=value	pos_13=CC	pos_26=-LRB-	pos_22=JJ	relType_2=case	relType_22=amod	pos_19=VBN	relType_20=punct	lemma_16=therapy	relType_14=conj	pos_4=JJ	pos_18=NNP	lemma_12=receive	pos_15=WP	pos_9=JJ	relType_21=amod	lemma_7=patient	relType_10=compound	lemma_28==	pos_20=,	lemma_29=23	lemma_15=whom	lemma_23=clearance	lemma_21=apparent	pos_29=CD	eib=True	pos_3=DT	relType_13=obj	lpib=pharmacokinetic_JJ	pos_18=VBD
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e6	DDI-DrugBank.d241.s3.e7	null	relType_1=cc	lib=digoxin	path=<furosemide_obj>digoxin_conj	pos_1=CC	lemma_1=or	eib=False	path1=	path2=digoxin_conj	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e6	DDI-DrugBank.d241.s3.e8	mechanism	relType_1=cc	relType_3=dep	pos_1=CC	pos_2=NN	lemma_4=therapy	path=furosemide_obj<receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_5=case	relType_2=mark	pos_2=IN	path2=initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	lemma_5=with	relType_4=nsubj:pass	path1=furosemide_obj	relType_2=conj	pos_4=NN	lib=digoxin	lemma_2=digoxin	pos_5=IN	lpib=digoxin_NN	wib=digoxin	pos_3=WP	eib=True	lemma_3=whom	lemma_2=in	lemma_1=or
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e6	DDI-DrugBank.d241.s3.e9	null	relType_1=cc	relType_6=aux:pass	relType_3=dep	pos_1=CC	pos_2=NN	lemma_4=therapy	lemma_13=for	relType_10=amod	relType_8=punct	lemma_8=,	relType_5=case	pos_6=VBD	lemma_9=apparent	relType_2=mark	lemma_6=be	relType_7=advcl	pos_2=IN	pos_9=JJ	pos_6=NNP	lemma_5=with	relType_4=nsubj:pass	relType_12=obj	relType_9=amod	path2=initiate_advcl>value_obj>furosemide_nmod	pos_13=IN	path1=furosemide_obj	relType_2=conj	pos_4=NN	path=furosemide_obj<receive_acl>initiate_advcl>value_obj>furosemide_nmod	relType_13=case	lib=digoxin	pos_12=NNS	pos_10=JJ	lemma_2=digoxin	pos_5=IN	lemma_11=clearance	lemma_12=value	lpib=digoxin_NN	wib=digoxin	pos_7=VBN	lemma_7=initiate	pos_11=NN	pos_3=WP	eib=True	relType_11=compound	pos_8=,	lemma_10=oral	lemma_6=FLOLAN	relType_6=nmod	lemma_3=whom	lemma_2=in	lemma_1=or
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e6	DDI-DrugBank.d241.s3.e10	null	relType_1=cc	path=furosemide_obj<receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_3=dep	pos_1=CC	relType_6=aux:pass	relType_14=punct	pos_2=NN	lemma_4=therapy	lemma_17=23	relType_15=nsubj	lemma_13=for	relType_10=amod	relType_8=punct	relType_14=nmod	path2=initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_8=,	lemma_14=(	relType_5=case	pos_6=VBD	lemma_9=apparent	relType_2=mark	lemma_6=be	relType_7=advcl	pos_2=IN	pos_9=JJ	pos_18=-RRB-	pos_6=NNP	lemma_5=with	relType_17=dep	relType_4=nsubj:pass	relType_12=obj	relType_9=amod	pos_13=IN	pos_14=NN	path1=furosemide_obj	relType_2=conj	pos_4=NN	lemma_19=and	relType_13=case	lib=digoxin	pos_14=-LRB-	pos_15=NN	pos_12=NNS	pos_10=JJ	lemma_2=digoxin	relType_18=punct	pos_5=IN	pos_19=CC	lemma_11=clearance	lemma_12=value	lemma_15=n	relType_19=cc	lemma_14=furosemide	pos_17=CD	lpib=digoxin_NN	lemma_18=)	wib=digoxin	pos_7=VBN	lemma_7=initiate	pos_11=NN	pos_3=WP	lemma_16==	eib=True	relType_11=compound	relType_16=dep	pos_16=SYM	pos_8=,	lemma_10=oral	lemma_6=FLOLAN	relType_6=nmod	lemma_3=whom	lemma_2=in	lemma_1=or
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e7	DDI-DrugBank.d241.s3.e8	mechanism	lemma_1=in	lpib=therapy_NN	relType_3=nsubj:pass	pos_2=WP	eib=False	path2=initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	pos_1=IN	lemma_4=with	lemma_3=therapy	relType_2=dep	pos_4=IN	path=digoxin_conj<furosemide_obj<receive_acl>initiate_advcl>therapy_nsubj:pass>FLOLAN_nmod	relType_4=case	lib=therapy	path1=digoxin_conj<furosemide_obj	lemma_2=whom	relType_1=mark	pos_3=NN	wib=therapy
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e7	DDI-DrugBank.d241.s3.e9	null	lemma_1=in	relType_8=amod	relType_12=case	lpib=therapy_NN	relType_3=nsubj:pass	pos_2=WP	lemma_6=initiate	relType_11=obj	pos_8=JJ	pos_9=JJ	path=digoxin_conj<furosemide_obj<receive_acl>initiate_advcl>value_obj>furosemide_nmod	lemma_9=oral	pos_11=NNS	pos_7=,	lemma_12=for	pos_1=IN	path2=initiate_advcl>value_obj>furosemide_nmod	pos_6=VBN	lemma_5=be	relType_6=advcl	lemma_7=,	relType_9=amod	pos_10=NN	relType_10=compound	pos_12=IN	lemma_4=with	lemma_3=therapy	relType_2=dep	lemma_8=apparent	relType_5=aux:pass	pos_4=IN	relType_4=case	relType_5=nmod	lib=therapy	pos_5=NNP	path1=digoxin_conj<furosemide_obj	lemma_2=whom	pos_5=VBD	lemma_5=FLOLAN	lemma_11=value	eib=True	relType_1=mark	pos_3=NN	relType_7=punct	lemma_10=clearance	wib=therapy
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e7	DDI-DrugBank.d241.s3.e10	null	pos_14=NN	lemma_1=in	pos_15=SYM	relType_8=amod	relType_17=punct	relType_12=case	relType_13=punct	lpib=therapy_NN	relType_3=nsubj:pass	pos_2=WP	path2=initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_6=initiate	relType_11=obj	relType_18=cc	relType_13=nmod	pos_8=JJ	pos_9=JJ	lemma_15==	lemma_9=oral	relType_15=dep	pos_11=NNS	pos_7=,	lemma_12=for	lemma_14=n	pos_1=IN	pos_6=VBN	relType_6=advcl	lemma_5=be	lemma_7=,	relType_9=amod	pos_10=NN	relType_10=compound	pos_12=IN	pos_13=NN	lemma_4=with	lemma_3=therapy	pos_16=CD	relType_2=dep	lemma_8=apparent	lemma_13=(	relType_5=aux:pass	pos_4=IN	relType_4=case	relType_5=nmod	lib=therapy	pos_5=NNP	path1=digoxin_conj<furosemide_obj	lemma_16=23	pos_13=-LRB-	lemma_2=whom	pos_18=CC	pos_5=VBD	lemma_5=FLOLAN	lemma_11=value	lemma_17=)	lemma_18=and	eib=True	relType_1=mark	pos_3=NN	relType_7=punct	relType_16=dep	relType_14=nsubj	pos_17=-RRB-	lemma_10=clearance	wib=therapy	path=digoxin_conj<furosemide_obj<receive_acl>initiate_advcl>decrease_conj>digoxin_nsubj:pass	lemma_13=furosemide
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e8	DDI-DrugBank.d241.s3.e9	null	path1=FLOLAN_nmod<therapy_nsubj:pass	pos_7=NNS	relType_4=amod	pos_2=VBN	pos_4=JJ	relType_8=case	relType_1=aux:pass	lemma_8=for	relType_2=advcl	path2=value_obj>furosemide_nmod	pos_6=NN	lemma_7=value	pos_1=VBD	lemma_5=oral	eib=False	path=FLOLAN_nmod<therapy_nsubj:pass<initiate_advcl>value_obj>furosemide_nmod	lemma_1=be	relType_7=obj	pos_8=IN	pos_5=JJ	lib=be	lemma_3=,	relType_5=amod	wib=was	lemma_2=initiate	relType_6=compound	pos_3=,	lpib=be_VBD	lemma_6=clearance	relType_3=punct	lemma_4=apparent
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e8	DDI-DrugBank.d241.s3.e10	null	path1=FLOLAN_nmod<therapy_nsubj:pass	pos_7=NNS	relType_4=amod	pos_2=VBN	pos_4=JJ	relType_8=case	pos_14=CC	lemma_9=furosemide	relType_1=aux:pass	pos_12=CD	relType_13=punct	lemma_8=for	relType_2=advcl	relType_9=nmod	pos_6=NN	lemma_12=23	lemma_7=value	pos_1=VBD	lemma_5=oral	lemma_1=be	relType_7=obj	lemma_9=(	pos_10=NN	pos_9=NN	pos_8=IN	pos_5=JJ	lib=be	lemma_3=,	relType_5=amod	lemma_10=n	path2=decrease_conj>digoxin_nsubj:pass	relType_11=dep	pos_9=-LRB-	relType_14=cc	relType_10=nsubj	pos_11=SYM	wib=was	relType_9=punct	pos_13=-RRB-	lemma_2=initiate	relType_6=compound	pos_3=,	lemma_11==	eib=True	relType_12=dep	lemma_13=)	lemma_14=and	path=FLOLAN_nmod<therapy_nsubj:pass<initiate_advcl>decrease_conj>digoxin_nsubj:pass	lpib=be_VBD	lemma_6=clearance	relType_3=punct	lemma_4=apparent
DDI-DrugBank.d241.s3	DDI-DrugBank.d241.s3.e9	DDI-DrugBank.d241.s3.e10	null	lpib=n_NN	relType_3=dep	relType_4=dep	pos_2=NN	wib=n	lemma_1=(	pos_3=SYM	relType_2=nsubj	eib=False	lemma_4=23	path1=furosemide_nmod<value_obj	lib=n	lemma_5=)	pos_4=CD	pos_6=CC	pos_5=-RRB-	path2=decrease_conj>digoxin_nsubj:pass	relType_5=punct	lemma_6=and	lemma_2=n	pos_1=-LRB-	lemma_3==	path=furosemide_nmod<value_obj<initiate_advcl>decrease_conj>digoxin_nsubj:pass	relType_1=punct	relType_6=cc
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e0	DDI-DrugBank.d241.s5.e1	null	relType_1=aux	lemma_1=may	pos_3=NNS	eib=False	lpib=show_VB	path=digoxin_nmod<patient_nsubj<show_ROOT>elevation_obj>concentration_nmod>digoxin_compound	lemma_3=elevation	pos_2=VB	path2=elevation_obj>concentration_nmod>digoxin_compound	lib=show	wib=show	relType_2=ROOT	pos_4=IN	relType_4=case	pos_1=MD	lemma_2=show	relType_3=obj	path1=digoxin_nmod<patient_nsubj	lemma_4=of
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e0	DDI-DrugBank.d241.s5.e2	mechanism	relType_8=case	lemma_10=with	relType_1=aux	lemma_1=may	pos_7=NN	relType_5=compound	path=digoxin_nmod<patient_nsubj<show_ROOT>initiation_obl>FLOLAN_nmod	relType_9=nmod	lemma_6=after	relType_6=case	pos_3=NNS	lpib=show_VB	pos_5=NNS	pos_6=IN	lemma_8=of	lemma_3=elevation	pos_2=VB	lemma_5=concentration	relType_10=case	pos_9=NN	lemma_7=initiation	pos_8=IN	lib=show	wib=show	lemma_5=digoxin	path2=initiation_obl>FLOLAN_nmod	relType_2=ROOT	pos_4=IN	relType_4=case	relType_5=nmod	pos_10=IN	pos_1=MD	lemma_2=show	lemma_9=therapy	pos_5=NN	relType_7=obl	eib=True	relType_3=obj	path1=digoxin_nmod<patient_nsubj	lemma_4=of
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e0	DDI-DrugBank.d241.s5.e3	null	relType_8=case	pos_18=NNS	lemma_10=with	relType_1=aux	lemma_1=may	pos_7=NN	lemma_11=,	relType_5=compound	pos_11=NNP	lemma_11=FLOLAN	lemma_12=which	pos_13=MD	relType_9=nmod	lemma_6=after	relType_6=case	pos_15=RB	pos_20=IN	pos_17=IN	relType_20=case	lemma_16=significant	pos_3=NNS	relType_18=obl	lpib=show_VB	pos_5=NNS	pos_6=IN	lemma_8=of	relType_11=punct	lemma_18=patient	lemma_3=elevation	pos_19=JJ	relType_13=aux	pos_2=VB	lemma_5=concentration	relType_10=case	lemma_13=may	relType_14=cop	pos_9=NN	lemma_15=clinically	lemma_7=initiation	pos_8=IN	lemma_14=be	relType_17=case	lib=show	pos_16=JJ	wib=show	lemma_5=digoxin	relType_2=ROOT	pos_4=IN	relType_4=case	relType_5=nmod	pos_14=VB	pos_10=IN	pos_1=MD	pos_11=,	path2=initiation_obl>significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound	lemma_2=show	lemma_17=in	lemma_19=prone	relType_19=amod	lemma_9=therapy	relType_12=nsubj	pos_5=NN	relType_7=obl	eib=True	relType_3=obj	lemma_20=to	relType_11=nmod	relType_16=acl:relcl	relType_15=advmod	path1=digoxin_nmod<patient_nsubj	lemma_4=of	pos_12=WDT	path=digoxin_nmod<patient_nsubj<show_ROOT>initiation_obl>significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e1	DDI-DrugBank.d241.s5.e2	null	lemma_3=initiation	path=digoxin_compound<concentration_nmod<elevation_obj<show_ROOT>initiation_obl>FLOLAN_nmod	lpib=concentration_NNS	lemma_1=concentration	relType_6=case	pos_2=IN	eib=False	pos_6=IN	path1=digoxin_compound<concentration_nmod<elevation_obj	relType_1=nmod	path2=initiation_obl>FLOLAN_nmod	wib=concentrations	lemma_5=therapy	pos_4=IN	relType_4=case	relType_5=nmod	lemma_6=with	pos_5=NN	pos_1=NNS	relType_2=case	relType_3=obl	lemma_2=after	pos_3=NN	lib=concentration	lemma_4=of
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e1	DDI-DrugBank.d241.s5.e3	null	lemma_3=initiation	pos_15=JJ	pos_16=IN	relType_8=nsubj	relType_15=amod	lpib=concentration_NNS	path=digoxin_compound<concentration_nmod<elevation_obj<show_ROOT>initiation_obl>significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound	lemma_1=concentration	relType_9=aux	relType_6=case	lemma_8=which	pos_2=IN	pos_12=JJ	pos_6=IN	path1=digoxin_compound<concentration_nmod<elevation_obj	pos_7=,	pos_9=MD	pos_8=WDT	lemma_14=patient	pos_13=IN	relType_1=nmod	lemma_7=,	pos_10=VB	relType_11=advmod	relType_14=obl	relType_13=case	lemma_5=therapy	wib=concentrations	pos_4=IN	pos_7=NNP	relType_4=case	relType_5=nmod	lemma_6=with	relType_7=nmod	lemma_9=may	relType_12=acl:relcl	lemma_13=in	path2=initiation_obl>significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound	pos_11=RB	pos_5=NN	relType_10=cop	relType_16=case	pos_1=NNS	relType_2=case	eib=True	lemma_2=after	relType_3=obl	pos_3=NN	relType_7=punct	lemma_11=clinically	lemma_12=significant	lemma_15=prone	pos_14=NNS	lib=concentration	lemma_7=FLOLAN	lemma_4=of	lemma_10=be	lemma_16=to
DDI-DrugBank.d241.s5	DDI-DrugBank.d241.s5.e2	DDI-DrugBank.d241.s5.e3	null	lemma_1=,	lemma_10=to	pos_6=JJ	relType_7=case	lemma_4=be	pos_1=,	relType_6=acl:relcl	lemma_3=may	pos_2=WDT	lemma_9=prone	pos_8=NNS	relType_8=obl	wib=be	path1=FLOLAN_nmod	relType_4=cop	pos_9=JJ	relType_2=nsubj	eib=False	pos_3=MD	relType_9=amod	relType_10=case	path2=significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound	lib=be	pos_5=RB	pos_10=IN	path=FLOLAN_nmod<initiation_obl>significant_acl:relcl>patient_obl>prone_amod>toxicity_obl>digoxin_compound	lpib=be_VB	relType_5=advmod	lemma_2=which	lemma_6=significant	pos_7=IN	lemma_7=in	pos_4=VB	relType_3=aux	lemma_5=clinically	lemma_8=patient	relType_1=punct
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e0	DDI-DrugBank.d525.s0.e1	null	relType_4=mark	relType_8=case	pos_2=VBN	lpib=have_VBZ	relType_1=aux	relType_5=xcomp	pos_6=DT	pos_7=NN	pos_3=VBN	path=Eprosartan_nsubj:pass<show_ROOT>have_xcomp>effect_obj>pharmacokinetic_nmod>digoxin_nmod	path1=Eprosartan_nsubj:pass	lemma_5=have	relType_11=case	relation_6=neutral	pos_5=VB	relType_10=nmod	eib=False	lemma_7=effect	relType_7=obj	pos_9=DT	lemma_1=have	lib=have	pos_8=IN	lemma_8=on	pos_11=IN	lemma_3=show	relType_3=ROOT	lemma_4=to	relType_2=aux:pass	lemma_10=pharmacokinetic	pos_4=TO	path2=have_xcomp>effect_obj>pharmacokinetic_nmod>digoxin_nmod	relType_6=det	pos_1=VBZ	lemma_9=the	lemma_11=of	lemma_2=be	lemma_6=no	wib=has	pos_10=NNS	relType_9=det
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e0	DDI-DrugBank.d525.s0.e2	null	relType_4=mark	relType_8=case	pos_2=VBN	lemma_13=the	lemma_15=of	lpib=have_VBZ	relType_1=aux	relType_5=xcomp	pos_6=DT	pos_7=NN	pos_3=VBN	relType_12=cc	pos_13=DT	pos_12=CC	path1=Eprosartan_nsubj:pass	relType_11=case	lemma_5=have	relation_6=neutral	pos_5=VB	lemma_14=pharmacodynamic	relType_10=nmod	lemma_7=effect	path=Eprosartan_nsubj:pass<show_ROOT>have_xcomp>effect_obj>pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod	relType_7=obj	relType_12=nmod	pos_9=DT	pos_12=NN	lemma_1=have	lib=have	pos_8=IN	lemma_8=on	pos_11=IN	lemma_3=show	relType_15=case	relType_3=ROOT	lemma_4=to	relType_2=aux:pass	lemma_10=pharmacokinetic	pos_4=TO	pos_15=IN	path2=have_xcomp>effect_obj>pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod	relType_6=det	pos_1=VBZ	eib=True	lemma_12=digoxin	lemma_9=the	lemma_12=and	lemma_11=of	relType_13=det	pos_14=NNS	lemma_2=be	relType_14=conj	lemma_6=no	wib=has	pos_10=NNS	relType_9=det
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e0	DDI-DrugBank.d525.s0.e3	null	relType_4=mark	relType_8=case	relType_16=cc	pos_2=VBN	lemma_13=the	lemma_15=of	lpib=have_VBZ	relType_1=aux	relType_5=xcomp	pos_6=DT	pos_7=NN	path=Eprosartan_nsubj:pass<show_ROOT>have_xcomp>effect_obj>pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod>glyburide_conj	pos_3=VBN	relType_16=nmod	relType_12=cc	pos_13=DT	pos_12=CC	pos_16=CC	path1=Eprosartan_nsubj:pass	relType_11=case	lemma_5=have	relation_6=neutral	pos_5=VB	path2=have_xcomp>effect_obj>pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod>glyburide_conj	lemma_14=pharmacodynamic	relType_10=nmod	lemma_7=effect	relType_7=obj	relType_12=nmod	pos_9=DT	pos_12=NN	lemma_1=have	lib=have	pos_8=IN	lemma_8=on	pos_11=IN	lemma_3=show	relType_15=case	relType_3=ROOT	lemma_4=to	relType_2=aux:pass	lemma_10=pharmacokinetic	pos_16=NN	lemma_16=warfarin	lemma_16=and	pos_4=TO	pos_15=IN	relType_6=det	pos_1=VBZ	eib=True	lemma_12=digoxin	lemma_9=the	lemma_12=and	lemma_11=of	relType_13=det	pos_14=NNS	lemma_2=be	relType_14=conj	lemma_6=no	wib=has	pos_10=NNS	relType_9=det
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e1	DDI-DrugBank.d525.s0.e2	null	relType_1=cc	pos_2=DT	pos_1=CC	lemma_2=the	path2=pharmacodynamic_conj>warfarin_nmod	pos_3=NNS	eib=False	lib=pharmacodynamic	path1=digoxin_nmod	lpib=pharmacodynamic_NNS	wib=pharmacodynamics	relType_3=conj	pos_4=IN	relType_4=case	lemma_3=pharmacodynamic	relType_2=det	path=digoxin_nmod<pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod	lemma_4=of	lemma_1=and
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e1	DDI-DrugBank.d525.s0.e3	null	relType_1=cc	path2=pharmacodynamic_conj>warfarin_nmod>glyburide_conj	pos_2=DT	pos_1=CC	lemma_2=the	pos_5=CC	path=digoxin_nmod<pharmacokinetic_nmod>pharmacodynamic_conj>warfarin_nmod>glyburide_conj	lemma_5=warfarin	relType_5=cc	pos_3=NNS	lib=pharmacodynamic	path1=digoxin_nmod	lpib=pharmacodynamic_NNS	wib=pharmacodynamics	relType_3=conj	pos_4=IN	relType_4=case	relType_5=nmod	pos_5=NN	eib=True	lemma_3=pharmacodynamic	lemma_5=and	relType_2=det	lemma_4=of	lemma_1=and
DDI-DrugBank.d525.s0	DDI-DrugBank.d525.s0.e2	DDI-DrugBank.d525.s0.e3	null	relType_1=cc	pos_1=CC	wib=glyburide	eib=False	path1=	lpib=glyburide_NN	path2=glyburide_conj	path=<warfarin_nmod>glyburide_conj	lib=glyburide	lemma_1=and
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e0	DDI-DrugBank.d525.s2.e1	null	path1=eprosartan_nsubj:pass<metabolize_advcl	relType_21=obj	lemma_9=,	lemma_17=expect	pos_6=NN	relType_12=compound	pos_20=PRP$	pos_13=NN	relType_22=punct	pos_22=,	lemma_8=system	lemma_3=metabolize	relType_6=compound	pos_1=VBZ	relType_18=mark	lemma_20=its	lemma_15=not	lemma_2=not	pos_15=RB	relType_19=xcomp	lemma_21=metabolism	relType_11=case	pos_8=NN	pos_16=VB	lemma_22=,	lemma_12=cyp450	lemma_18=to	lemma_5=the	pos_9=,	pos_7=NN	lemma_23=and	pos_17=VBN	pos_23=CC	lemma_1=be	lemma_13=enzyme	lemma_16=be	pos_11=IN	lib=be	pos_4=IN	relType_5=det	wib=is	lemma_14=would	pos_5=DT	pos_19=VB	lemma_11=of	relType_20=nmod:poss	path2=ketoconazole_conj	relType_7=compound	lemma_6=cytochrome	relType_1=aux:pass	pos_3=VBN	lemma_10=inhibitor	relation_18=neutral	relType_16=aux:pass	relType_17=ROOT	relType_8=obl	relType_13=nmod	pos_2=RB	eib=False	relType_2=advmod	relType_10=nsubj:pass	path=eprosartan_nsubj:pass<metabolize_advcl<expect_ROOT>ketoconazole_conj	relType_3=advcl	relType_23=cc	relType_4=case	relType_14=aux	relType_9=punct	lemma_7=p450	pos_14=MD	lpib=be_VBZ	relType_15=advmod	pos_12=NN	pos_18=TO	lemma_19=affect	pos_10=NNS	lemma_4=by	pos_21=NN
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e0	DDI-DrugBank.d525.s2.e2	null	path1=eprosartan_nsubj:pass<metabolize_advcl	relType_21=obj	lemma_9=,	lemma_17=expect	pos_6=NN	relType_12=compound	pos_20=PRP$	pos_13=NN	relType_22=punct	pos_22=,	lemma_8=system	lemma_3=metabolize	relType_6=compound	pos_1=VBZ	relType_18=mark	lemma_20=its	lemma_15=not	lemma_2=not	pos_15=RB	relType_19=xcomp	lemma_21=metabolism	relType_11=case	lemma_24=ketoconazole	pos_8=NN	pos_24=CC	pos_16=VB	lemma_22=,	lemma_24=and	lemma_12=cyp450	lemma_18=to	path2=ketoconazole_conj>fluconazole_conj	lemma_5=the	pos_9=,	pos_7=NN	lemma_23=and	pos_24=NN	pos_17=VBN	pos_23=CC	lemma_1=be	lemma_13=enzyme	lemma_16=be	pos_11=IN	lib=be	pos_4=IN	relType_5=det	wib=is	lemma_14=would	pos_5=DT	pos_19=VB	lemma_11=of	relType_20=nmod:poss	relType_7=compound	lemma_6=cytochrome	relType_1=aux:pass	pos_3=VBN	lemma_10=inhibitor	relation_18=neutral	relType_16=aux:pass	relType_17=ROOT	relType_8=obl	relType_13=nmod	pos_2=RB	relType_2=advmod	relType_24=cc	relType_10=nsubj:pass	relType_3=advcl	relType_23=cc	relType_4=case	relType_24=conj	relType_14=aux	relType_9=punct	lemma_7=p450	pos_14=MD	path=eprosartan_nsubj:pass<metabolize_advcl<expect_ROOT>ketoconazole_conj>fluconazole_conj	eib=True	lpib=be_VBZ	relType_15=advmod	pos_12=NN	pos_18=TO	lemma_19=affect	pos_10=NNS	lemma_4=by	pos_21=NN
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e0	DDI-DrugBank.d525.s2.e3	null	path1=eprosartan_nsubj:pass<metabolize_advcl	relType_38=mark	relType_32=punct	relType_21=obj	relType_33=advmod	lemma_9=,	pos_41=NN	lemma_17=expect	pos_6=NN	relType_12=compound	relType_30=cc	pos_20=PRP$	pos_13=NN	relType_22=punct	relType_41=obj	pos_22=,	lemma_8=system	lemma_25=,	lemma_3=metabolize	relType_6=compound	relType_26=amod	pos_1=VBZ	relType_18=mark	relType_37=conj	lemma_20=its	relType_31=conj	lemma_37=show	lemma_15=not	relType_34=punct	pos_34=,	lemma_26=potent	lemma_2=not	pos_15=RB	pos_40=DT	relType_25=conj	lemma_31=2c9	relType_19=xcomp	lemma_21=metabolism	lemma_25=fluconazole	pos_30=CC	pos_38=TO	relType_11=case	lemma_24=ketoconazole	pos_8=NN	pos_37=VBN	pos_24=CC	pos_16=VB	lemma_22=,	pos_29=NN	pos_32=,	relType_27=appos	lemma_24=and	lemma_12=cyp450	lemma_42=on	relType_39=xcomp	relType_29=nmod	lemma_18=to	pos_35=VBP	pos_39=VB	lemma_5=the	pos_31=NN	lemma_39=have	relType_25=punct	lemma_34=,	pos_9=,	lemma_40=no	pos_7=NN	lemma_23=and	lemma_29=cyp3a	lemma_28=of	pos_24=NN	lemma_35=have	pos_17=VBN	pos_26=JJ	pos_23=CC	pos_27=NNS	lemma_1=be	lemma_13=enzyme	lemma_16=be	pos_11=IN	lib=be	pos_4=IN	relType_5=det	pos_25=NN	wib=is	relType_28=case	lemma_14=would	pos_5=DT	pos_19=VB	lemma_11=of	relType_36=aux:pass	lemma_38=to	relType_20=nmod:poss	relation_42=neutral	relType_7=compound	pos_36=VBN	pos_25=,	lemma_6=cytochrome	relType_1=aux:pass	pos_3=VBN	lemma_10=inhibitor	relation_18=neutral	lemma_41=effect	lemma_36=be	relType_16=aux:pass	relType_17=ROOT	relType_8=obl	relType_13=nmod	pos_2=RB	path2=show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	relType_2=advmod	pos_42=IN	relType_24=cc	relType_10=nsubj:pass	lemma_33=respectively	pos_33=RB	relType_3=advcl	relType_42=case	relType_23=cc	relType_4=case	relType_24=conj	relType_14=aux	lemma_32=,	path=eprosartan_nsubj:pass<metabolize_advcl<expect_ROOT>show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	relType_9=punct	lemma_7=p450	pos_14=MD	eib=True	lemma_27=inhibitor	pos_28=IN	lpib=be_VBZ	relType_35=aux	relType_40=det	relType_15=advmod	pos_12=NN	pos_18=TO	lemma_19=affect	pos_10=NNS	lemma_4=by	lemma_30=and	pos_21=NN
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e1	DDI-DrugBank.d525.s2.e2	null	relType_1=cc	lpib=fluconazole_NN	pos_1=CC	path2=fluconazole_conj	eib=False	path1=	wib=fluconazole	lib=fluconazole	path=<ketoconazole_conj>fluconazole_conj	lemma_1=and
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e1	DDI-DrugBank.d525.s2.e3	null	relType_1=cc	lemma_6=cyp3a	lpib=fluconazole_NN	pos_1=CC	pos_19=IN	pos_2=NN	pos_17=DT	lemma_11=,	relType_4=appos	lemma_8=2c9	pos_15=TO	wib=fluconazole	relation_18=neutral	relType_7=cc	lemma_17=no	lemma_9=,	lemma_2=fluconazole	lemma_5=of	relType_5=case	pos_13=VBN	relType_2=punct	pos_6=NN	pos_8=NN	relType_16=xcomp	relType_17=det	path1=ketoconazole_conj	path2=show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	relType_15=mark	relType_11=punct	pos_12=VBP	pos_16=VB	relType_12=aux	relType_10=advmod	relType_2=conj	lemma_13=be	lemma_2=,	pos_4=NNS	relType_13=aux:pass	lemma_15=to	pos_18=NN	relType_3=amod	pos_7=CC	pos_5=IN	lib=fluconazole	pos_11=,	relType_9=punct	path=ketoconazole_conj<expect_ROOT>show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	pos_14=VBN	pos_3=JJ	lemma_3=potent	eib=True	lemma_12=have	lemma_16=have	lemma_18=effect	lemma_7=and	lemma_4=inhibitor	relType_19=case	relType_8=conj	pos_2=,	lemma_14=show	pos_10=RB	pos_9=,	lemma_10=respectively	relType_6=nmod	relType_18=obj	relType_14=conj	lemma_1=and	lemma_19=on
DDI-DrugBank.d525.s2	DDI-DrugBank.d525.s2.e2	DDI-DrugBank.d525.s2.e3	null	lemma_1=,	relType_10=punct	relType_9=advmod	lemma_10=,	pos_1=,	pos_16=DT	relType_8=punct	lemma_16=no	path=fluconazole_conj<ketoconazole_conj<expect_ROOT>show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	pos_2=JJ	lemma_8=,	lemma_9=respectively	pos_13=VBN	relType_16=det	relType_18=case	relType_12=aux:pass	lemma_15=have	lemma_7=2c9	pos_17=NN	pos_3=NNS	path2=show_conj>have_xcomp>effect_obj>pharmacokinetic_nmod>eprosartan_amod	eib=False	relType_3=appos	pos_14=TO	relType_11=aux	lemma_14=to	relType_13=conj	lemma_3=inhibitor	pos_18=IN	lemma_11=have	pos_11=VBP	pos_15=VB	pos_6=CC	lemma_12=be	pos_4=IN	lib=potent	relType_2=amod	lemma_6=and	relType_4=case	relType_5=nmod	pos_9=RB	relType_14=mark	pos_5=NN	relType_17=obj	pos_10=,	lpib=potent_JJ	relation_16=neutral	path1=fluconazole_conj<ketoconazole_conj	wib=potent	pos_8=,	lemma_2=potent	relType_15=xcomp	lemma_5=cyp3a	pos_12=VBN	relType_1=punct	pos_7=NN	lemma_13=show	lemma_4=of	lemma_17=effect	lemma_18=on	relType_7=conj	relType_6=cc
DDI-DrugBank.d525.s3	DDI-DrugBank.d525.s3.e0	DDI-DrugBank.d525.s3.e1	null	lpib=also_RB	lemma_3=no	wib=also	lemma_2=have	path1=Ranitidine_nsubj	relType_5=case	eib=False	relType_3=det	pos_4=NN	relType_4=obj	relType_1=advmod	relation_3=neutral	relType_2=ROOT	lib=also	pos_5=IN	path2=effect_obj>pharmacokinetic_nmod>eprosartan_amod	pos_2=VBZ	lemma_4=effect	lemma_1=also	lemma_5=on	pos_3=DT	pos_1=RB	path=Ranitidine_nsubj<have_ROOT>effect_obj>pharmacokinetic_nmod>eprosartan_amod
DDI-DrugBank.d525.s4	DDI-DrugBank.d525.s4.e0	DDI-DrugBank.d525.s4.e1	null	relType_14=punct	pos_3=IN	relType_3=advmod	relType_7=case	relType_17=aux:pass	lemma_19=use	lemma_7=i.	lemma_15=dose	wib=up	lemma_23=thiazide	lemma_17=be	pos_17=VBN	lemma_6=b.	relType_8=obl	lemma_20=concomitantly	lemma_1=(	pos_8=NN	pos_2=RB	relType_15=nsubj:pass	pos_18=RB	lemma_13=d.	lemma_12=q.	relType_19=ROOT	relType_12=compound	relType_20=advmod	relType_2=advmod	pos_5=NNS	pos_14=-RRB-	lemma_11=mg	relType_16=aux	pos_12=NN	pos_21=IN	relType_13=conj	pos_6=VBN	pos_13=NN	lemma_14=)	relType_5=dep	lemma_21=with	pos_23=NN	relType_23=compound	pos_4=CD	lpib=up_RB	lemma_4=400	lemma_2=up	pos_9=CC	pos_10=CD	relType_6=acl	path=Eprosartan_compound<dose_nsubj:pass<use_ROOT>diuretic_obl	lemma_9=or	lemma_3=to	path1=Eprosartan_compound<dose_nsubj:pass	lemma_5=mg	lemma_10=800	pos_1=-LRB-	relType_4=nummod	relType_10=nummod	relType_21=case	pos_22=DT	lemma_18=safely	pos_11=NN	pos_15=NNS	eib=True	pos_7=IN	lemma_8=d.	relType_11=compound	lemma_16=have	relType_18=advmod	pos_20=RB	pos_19=VBN	lemma_22=a	relType_22=det	relType_9=cc	relType_1=punct	lib=up	path2=diuretic_obl	pos_16=VBP
DDI-DrugBank.d525.s4	DDI-DrugBank.d525.s4.e0	DDI-DrugBank.d525.s4.e2	null	pos_23=-LRB-	lemma_6=b.	relType_15=nsubj:pass	pos_18=RB	lemma_13=d.	relType_12=compound	pos_13=NN	relType_5=dep	relType_23=compound	lpib=up_RB	pos_9=CC	lemma_9=or	lemma_5=mg	relType_21=case	pos_1=-LRB-	relType_4=nummod	pos_7=IN	lemma_22=a	lemma_23=(	pos_16=VBP	relType_7=case	lemma_19=use	lemma_15=dose	pos_8=NN	relType_19=ROOT	lemma_12=q.	lemma_11=mg	relType_13=conj	relType_23=obl	pos_4=CD	relType_6=acl	lemma_3=to	pos_22=DT	lemma_18=safely	pos_11=NN	lemma_8=d.	lemma_16=have	relType_1=punct	path2=diuretic_obl>hydrochlorothiazide_appos	relType_14=punct	pos_3=IN	wib=up	lemma_23=thiazide	pos_17=VBN	lemma_1=(	pos_23=NN	pos_14=-RRB-	pos_21=IN	pos_6=VBN	lemma_14=)	lemma_4=400	path1=Eprosartan_compound<dose_nsubj:pass	lemma_10=800	relType_22=det	lemma_23=diuretic	pos_20=RB	pos_19=VBN	lib=up	relType_23=punct	relType_3=advmod	relType_17=aux:pass	lemma_7=i.	lemma_17=be	lemma_20=concomitantly	relType_8=obl	pos_2=RB	relType_20=advmod	relType_2=advmod	pos_5=NNS	relType_16=aux	lemma_21=with	lemma_2=up	pos_10=CD	relType_10=nummod	path=Eprosartan_compound<dose_nsubj:pass<use_ROOT>diuretic_obl>hydrochlorothiazide_appos	pos_15=NNS	eib=True	relType_18=advmod	relType_11=compound	pos_12=NN	relType_9=cc
DDI-DrugBank.d525.s4	DDI-DrugBank.d525.s4.e1	DDI-DrugBank.d525.s4.e2	null	lemma_1=(	path2=hydrochlorothiazide_appos	eib=False	path1=	wib=hydrochlorothiazide	path=<diuretic_obl>hydrochlorothiazide_appos	lib=hydrochlorothiazide	relType_1=punct	lpib=hydrochlorothiazide_NN	pos_1=-LRB-
DDI-DrugBank.d525.s5	DDI-DrugBank.d525.s5.e0	DDI-DrugBank.d525.s5.e1	null	lemma_3=up	pos_3=RB	relType_3=advmod	lemma_8=i.	relType_17=punct	pos_16=JJ	relType_13=advcl	lemma_11=be	pos_13=VBN	path2=use_advcl>blocker_obl	lemma_16=sustained	pos_2=IN	pos_5=CD	path1=Eprosartan_compound<dose_nsubj	relType_16=amod	relType_14=advmod	lemma_15=with	pos_17=HYPH	relType_10=aux	relType_12=advmod	relType_9=nsubj:pass	lemma_14=concomitantly	lemma_19=calcium	lemma_19=channel	relType_11=aux:pass	pos_19=NN	lemma_6=mg	pos_9=VBN	lemma_17=-	wib=doses	pos_8=IN	pos_18=NN	relType_19=compound	relType_15=case	lemma_12=safely	relType_7=ROOT	lemma_13=use	pos_14=RB	relType_5=nummod	pos_12=RB	lemma_4=to	pos_4=IN	relType_8=mark	relType_1=nsubj	relType_4=advmod	lemma_9=d.	pos_11=VBN	lib=dose	lemma_18=release	pos_15=IN	pos_7=VBN	lemma_7=b.	lpib=dose_NNS	lemma_2=of	pos_1=NNS	relType_2=case	eib=True	pos_10=VBP	lemma_5=300	relType_18=compound	pos_6=NNS	lemma_10=have	relType_6=nmod	lemma_1=dose	path=Eprosartan_compound<dose_nsubj<b._ROOT>use_advcl>blocker_obl
DDI-DrugBank.d525.s5	DDI-DrugBank.d525.s5.e0	DDI-DrugBank.d525.s5.e2	null	relType_22=compound	lemma_21=-	pos_13=VBN	pos_5=CD	path1=Eprosartan_compound<dose_nsubj	pos_19=-LRB-	lemma_14=concomitantly	relType_11=aux:pass	lemma_6=mg	pos_18=NN	lemma_13=use	pos_14=RB	pos_12=RB	relType_8=mark	relType_1=nsubj	lemma_7=b.	relType_19=obl	pos_6=NNS	relType_21=punct	lemma_10=have	lemma_20=sustain	lemma_1=dose	pos_22=NN	lemma_11=be	pos_20=VBN	pos_19=NNS	relType_16=amod	relType_14=advmod	relType_9=nsubj:pass	pos_8=IN	relType_19=compound	relType_15=case	relType_5=nummod	lib=dose	pos_15=IN	lemma_2=of	pos_1=NNS	lemma_19=calcium	pos_3=RB	lemma_8=i.	lemma_19=blocker	lemma_19=(	relType_17=punct	relType_19=punct	lemma_22=release	pos_2=IN	relType_20=amod	pos_21=HYPH	lemma_15=with	pos_17=HYPH	relType_10=aux	relType_12=advmod	lemma_19=channel	wib=doses	lemma_16=sustained	lemma_12=safely	lemma_4=to	pos_4=IN	lemma_9=d.	lemma_18=release	lpib=dose_NNS	relType_2=case	lemma_5=300	relType_6=nmod	lemma_3=up	relType_3=advmod	relType_13=advcl	pos_19=NN	lemma_17=-	pos_9=VBN	pos_16=JJ	relType_7=ROOT	path2=use_advcl>blocker_obl>nifedipine_appos	relType_4=advmod	path=Eprosartan_compound<dose_nsubj<b._ROOT>use_advcl>blocker_obl>nifedipine_appos	pos_11=VBN	pos_7=VBN	pos_10=VBP	eib=True	relType_18=compound
DDI-DrugBank.d525.s5	DDI-DrugBank.d525.s5.e1	DDI-DrugBank.d525.s5.e2	null	pos_2=VBN	path=<blocker_obl>nifedipine_appos	path1=	lemma_2=sustain	lemma_1=(	eib=False	lemma_3=-	pos_4=NN	path2=nifedipine_appos	relType_2=amod	relType_4=compound	pos_1=-LRB-	lib=sustain	pos_3=HYPH	relType_1=punct	relType_3=punct	lemma_4=release	lpib=sustain_VBN	wib=sustained
DDI-DrugBank.d278.s0	DDI-DrugBank.d278.s0.e0	DDI-DrugBank.d278.s0.e1	null	relType_18=parataxis	wib=dosed	relType_7=compound	relType_8=dep	pos_16=VBD	lemma_13=for	relType_10=amod	lemma_15=dose	relType_19=det	relType_9=nmod	pos_6=NFP	path2=alter_parataxis>pharmacokinetic_obj>eptifibatide_nmod	lemma_2=as	pos_2=IN	path1=Enoxaparin_nsubj	lemma_11=injection	pos_1=VBD	eib=False	lemma_4=1	relType_6=punct	lemma_20=pharmacokinetic	relType_16=aux	path=Enoxaparin_nsubj<dose_ROOT>alter_parataxis>pharmacokinetic_obj>eptifibatide_nmod	pos_12=NN	lemma_18=alter	lemma_12=q12h	pos_13=IN	lemma_5=.	relType_3=det	lemma_3=a	pos_9=NN	pos_17=RB	lemma_19=the	relType_20=obj	pos_4=CD	lemma_14=four	pos_21=IN	relType_13=case	lemma_7=mg	relType_4=obl	pos_10=JJ	relType_5=punct	pos_18=VB	lemma_6=0	lemma_21=of	pos_20=NNS	pos_8=SYM	lib=dose	relType_17=advmod	lpib=dose_VBD	relType_15=nmod	relType_21=case	pos_5=.	relType_12=nsubj	relType_14=nummod	relType_1=ROOT	relation_17=neutral	pos_11=NN	relType_2=case	pos_15=NNS	pos_3=DT	relType_11=compound	lemma_10=subcutaneous	lemma_17=not	lemma_8=/	pos_7=NN	lemma_1=dose	pos_14=CD	lemma_16=do	lemma_9=kg	pos_19=DT
DDI-DrugBank.d152.s0	DDI-DrugBank.d152.s0.e0	DDI-DrugBank.d152.s0.e1	null	lemma_3=oral	pos_3=JJ	relType_3=amod	lemma_2=contain	eib=False	path=estrogen_obl<contain_amod<contraceptive_obl>	relType_2=amod	lemma_1=-	path2=	lib=contain	pos_1=HYPH	path1=estrogen_obl<contain_amod	wib=containing	lpib=contain_VBG	relType_1=punct	pos_2=VBG
DDI-DrugBank.d359.s1	DDI-DrugBank.d359.s1.e0	DDI-DrugBank.d359.s1.e1	advise	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_1=aux:pass	path2=phenurone_obl	lemma_2=administer	relType_2=advcl	eib=False	path=PEGANONE_nsubj:pass<administer_advcl>phenurone_obl	lemma_1=be	lemma_4=with	lib=be	pos_4=IN	relType_4=case	path1=PEGANONE_nsubj:pass	wib=is	lemma_3=concurrently	pos_1=VBZ	lpib=be_VBZ
DDI-DrugBank.d359.s1	DDI-DrugBank.d359.s1.e0	DDI-DrugBank.d359.s1.e2	advise	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	path2=phenurone_obl>phenacemide_appos	lemma_1=be	lemma_5=(	lemma_4=with	path=PEGANONE_nsubj:pass<administer_advcl>phenurone_obl>phenacemide_appos	lib=be	pos_4=IN	relType_5=punct	relType_4=case	relType_5=obl	path1=PEGANONE_nsubj:pass	wib=is	pos_5=NN	lemma_3=concurrently	pos_1=VBZ	eib=True	lemma_5=phenurone	lpib=be_VBZ	pos_5=-LRB-
DDI-DrugBank.d359.s1	DDI-DrugBank.d359.s1.e1	DDI-DrugBank.d359.s1.e2	null	lemma_1=(	wib=phenacemide	lpib=phenacemide_NN	eib=False	path1=	pos_1=-LRB-	relType_1=punct	lib=phenacemide	path=<phenurone_obl>phenacemide_appos	path2=phenacemide_appos
DDI-DrugBank.d359.s2	DDI-DrugBank.d359.s2.e0	DDI-DrugBank.d359.s2.e1	int	path=<antiepileptic_nmod>phenytoin_conj	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	path1=	pos_1=,	path2=phenytoin_conj	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d359.s2	DDI-DrugBank.d359.s2.e0	DDI-DrugBank.d359.s2.e2	int	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	relType_5=compound	relType_3=cc	relType_2=punct	lib=phenytoin	wib=phenytoin	path2=anticoagulant_conj	lemma_2=phenytoin	relType_2=conj	lemma_2=,	pos_4=DT	lemma_5=coumarin	lemma_4=the	path=<antiepileptic_nmod>anticoagulant_conj	pos_5=NN	eib=True	pos_2=,	lemma_3=and	relType_1=punct	relType_4=det	lpib=phenytoin_NN
DDI-DrugBank.d359.s2	DDI-DrugBank.d359.s2.e1	DDI-DrugBank.d359.s2.e2	null	lib=coumarin	lemma_1=,	pos_1=,	wib=coumarin	relType_2=cc	lemma_2=and	path2=anticoagulant_conj	relType_3=det	path1=phenytoin_conj	pos_4=NN	lemma_4=coumarin	lpib=coumarin_NN	relType_4=compound	path=phenytoin_conj<antiepileptic_nmod>anticoagulant_conj	eib=True	pos_3=DT	pos_2=CC	lemma_3=the	relType_1=punct
DDI-DrugBank.d359.s3	DDI-DrugBank.d359.s3.e0	DDI-DrugBank.d359.s3.e1	mechanism	path1=phenytoin_nsubj	lpib=act_VBZ	lemma_5=of	relType_5=case	lemma_2=as	pos_2=IN	eib=False	relType_3=det	lemma_3=a	pos_4=NN	lemma_4=stimulator	lib=act	relType_4=obl	pos_5=IN	relType_1=ROOT	relType_2=case	pos_1=VBZ	wib=acts	pos_3=DT	path=phenytoin_nsubj<act_ROOT>stimulator_obl>metabolism_nmod>coumarin_compound	lemma_1=act	path2=stimulator_obl>metabolism_nmod>coumarin_compound
DDI-DrugBank.d359.s3	DDI-DrugBank.d359.s3.e0	DDI-DrugBank.d359.s3.e2	mechanism	path1=phenytoin_nsubj	lemma_12=cause	relType_9=aux:pass	pos_16=IN	pos_17=DT	lemma_8=have	lpib=act_VBZ	lemma_10=report	relType_7=cc	relType_14=compound	lemma_5=of	relType_5=case	pos_13=VBN	lemma_2=as	pos_15=NNS	pos_6=NN	pos_2=IN	pos_11=TO	lemma_14=serum	relType_17=det	pos_8=VBZ	relType_10=conj	relType_13=amod	relation_12=neutral	pos_14=NN	relType_12=xcomp	pos_9=VBN	relType_3=det	lemma_3=a	pos_4=NN	lemma_4=stimulator	lemma_16=of	relation_13=adverse	pos_18=NN	lib=act	lemma_13=decrease	relType_4=obl	pos_7=CC	pos_5=IN	lemma_18=coumarin	lemma_17=the	lemma_9=be	path2=report_conj>cause_xcomp>level_obj>anticoagulant_nmod	pos_12=VB	relType_15=obj	relType_1=ROOT	relType_6=compound	relType_11=mark	lemma_6=coumarin	relType_16=case	relType_2=case	pos_1=VBZ	eib=True	wib=acts	path=phenytoin_nsubj<act_ROOT>report_conj>cause_xcomp>level_obj>anticoagulant_nmod	pos_3=DT	lemma_6=metabolism	lemma_7=and	pos_10=VBN	lemma_1=act	relType_18=compound	relType_8=aux	relType_6=nmod	lemma_15=level	lemma_11=to
DDI-DrugBank.d359.s3	DDI-DrugBank.d359.s3.e1	DDI-DrugBank.d359.s3.e2	null	pos_7=VB	pos_6=TO	lemma_4=be	relType_8=amod	pos_8=VBN	relType_2=cc	lemma_6=to	relType_12=det	relType_11=case	relation_6=neutral	lemma_2=and	pos_10=NNS	relType_9=compound	lib=metabolism	path1=coumarin_compound<metabolism_nmod<stimulator_obl	pos_3=VBZ	relation_7=adverse	lpib=metabolism_NN	pos_13=NN	relType_1=nmod	pos_9=NN	wib=metabolism	pos_1=NN	lemma_5=report	pos_4=VBN	path=coumarin_compound<metabolism_nmod<stimulator_obl<act_ROOT>report_conj>cause_xcomp>level_obj>anticoagulant_nmod	relType_7=xcomp	relType_10=obj	pos_11=IN	lemma_12=the	lemma_10=level	relType_13=compound	relType_6=mark	lemma_8=decrease	relType_4=aux:pass	relType_5=conj	path2=report_conj>cause_xcomp>level_obj>anticoagulant_nmod	lemma_7=cause	lemma_9=serum	eib=True	pos_2=CC	lemma_11=of	lemma_1=metabolism	relType_3=aux	pos_12=DT	lemma_13=coumarin	lemma_3=have	pos_5=VBN
DDI-DrugBank.d359.s4	DDI-DrugBank.d359.s4.e0	DDI-DrugBank.d359.s4.e1	mechanism	relType_4=mark	path=anticoagulant_nsubj:pass<report_ROOT>increase_xcomp>prolong_conj>life_obj>phenytoin_nmod	pos_2=VBN	relType_7=compound	relType_14=punct	relation_4=beneficial	relType_5=xcomp	relType_1=aux	pos_6=DT	lemma_12=serum	pos_16=IN	pos_3=VBN	lemma_5=increase	pos_8=NNS	pos_5=VB	relType_12=compound	eib=False	lemma_7=serum	relType_10=conj	lemma_6=the	lemma_3=report	relType_8=obj	lemma_1=have	pos_12=NN	pos_13=NN	lemma_16=of	lib=have	pos_10=VB	path2=increase_xcomp>prolong_conj>life_obj>phenytoin_nmod	lemma_9=and	pos_9=CC	lemma_8=level	relType_13=compound	pos_15=NN	relType_3=ROOT	lemma_15=life	lemma_4=to	lemma_14=-	lemma_10=prolong	relType_2=aux:pass	pos_11=DT	pos_1=VBP	lpib=have_VBP	lemma_11=the	pos_4=TO	relType_11=det	lemma_13=half	relType_15=obj	relType_6=det	pos_14=HYPH	relType_16=case	wib=have	lemma_2=be	pos_7=NN	relType_9=cc	path1=anticoagulant_nsubj:pass
DDI-DrugBank.d359.s5	DDI-DrugBank.d359.s5.e0	DDI-DrugBank.d359.s5.e1	null	lib=coumarin	relType_1=cc	pos_2=DT	pos_1=CC	path=<ethotoin_nmod>anticoagulant_conj	lemma_2=the	eib=True	pos_3=NN	lpib=coumarin_NN	path2=anticoagulant_conj	path1=	wib=coumarin	relType_2=det	relType_3=compound	lemma_3=coumarin	lemma_1=and
DDI-DrugBank.d359.s6	DDI-DrugBank.d359.s6.e0	DDI-DrugBank.d359.s6.e1	advise	relType_1=case	lemma_2=patient	path1=	wib=patients	path=<peganone_dep>patient_nmod>receive_acl>anticoagulant_obj	path2=patient_nmod>receive_acl>anticoagulant_obj	lpib=patient_NNS	relType_2=nmod	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NN	lemma_4=coumarin	lib=patient	relType_4=compound	lemma_1=to	pos_2=NNS	eib=True
DDI-DrugBank.d219.s0	DDI-DrugBank.d219.s0.e0	DDI-DrugBank.d219.s0.e1	null	lemma_1=report	lemma_3=that	pos_1=NNS	pos_3=IN	wib=Reports	eib=False	path=inhibitor_compound<report_nsubj<suggest_ROOT>diminish_ccomp>nsaid_nsubj	relType_2=ROOT	relType_1=nsubj	path1=inhibitor_compound<report_nsubj	pos_2=VBP	lemma_2=suggest	relType_3=mark	lib=report	path2=diminish_ccomp>nsaid_nsubj	lpib=report_NNS
DDI-DrugBank.d219.s0	DDI-DrugBank.d219.s0.e0	DDI-DrugBank.d219.s0.e2	null	relType_10=punct	pos_3=IN	wib=Reports	path=inhibitor_compound<report_nsubj<suggest_ROOT>diminish_ccomp>effect_obj>inhibitor_nmod	pos_6=DT	pos_9=IN	lemma_4=may	relation_8=neutral	pos_8=NN	pos_5=VB	lemma_5=diminish	lemma_6=the	pos_4=MD	relType_8=obj	relType_9=case	relType_10=compound	pos_10=NN	relType_4=nsubj	pos_4=NNS	path2=diminish_ccomp>effect_obj>inhibitor_nmod	lemma_10=-	lemma_1=report	lemma_3=that	relType_7=amod	relType_2=ROOT	pos_10=HYPH	relType_1=nsubj	relType_4=aux	path1=inhibitor_compound<report_nsubj	pos_2=VBP	lemma_2=suggest	relType_3=mark	lemma_7=antihypertensive	relType_5=ccomp	relType_6=det	lemma_4=nsaid	pos_1=NNS	eib=True	lemma_9=of	lemma_8=effect	pos_7=JJ	lib=report	lemma_10=ace	lpib=report_NNS
DDI-DrugBank.d219.s0	DDI-DrugBank.d219.s0.e1	DDI-DrugBank.d219.s0.e2	effect	path=nsaid_nsubj<diminish_ccomp>effect_obj>inhibitor_nmod	lemma_2=diminish	relType_4=amod	pos_4=JJ	relType_7=compound	relType_1=aux	lemma_1=may	lemma_6=of	relType_6=case	lemma_4=antihypertensive	lemma_7=-	pos_6=IN	lib=diminish	pos_2=VB	relType_3=det	lemma_7=ace	lemma_5=effect	pos_7=HYPH	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	path2=effect_obj>inhibitor_nmod	pos_3=DT	relType_5=obj	lpib=diminish_VB	relType_7=punct	lemma_3=the	relation_4=neutral	pos_7=NN	wib=diminish	path1=nsaid_nsubj
DDI-DrugBank.d219.s1	DDI-DrugBank.d219.s1.e0	DDI-DrugBank.d219.s1.e1	advise	wib=concomitantly	lpib=concomitantly_RB	pos_2=IN	lemma_2=with	lemma_1=concomitantly	lemma_3=-	path2=inhibitor_obl	relType_1=advmod	path=nsaid_obj<take_acl>inhibitor_obl	lemma_3=ace	path1=nsaid_obj	lib=concomitantly	relType_2=case	eib=True	pos_1=RB	pos_3=NN	pos_3=HYPH	relType_3=compound	relType_3=punct
DDI-DrugBank.d219.s2	DDI-DrugBank.d219.s2.e0	DDI-DrugBank.d219.s2.e1	null	pos_2=DT	lemma_2=the	path=<antacid_ROOT>have_appos>administration_nsubj>antacid_nmod	path1=	lemma_5=of	relType_5=case	lib=concomitant	eib=False	lpib=concomitant_JJ	relType_4=nsubj	pos_4=NN	lemma_1=:	wib=concomitant	relType_3=amod	pos_1=:	pos_5=IN	lemma_3=concomitant	path2=have_appos>administration_nsubj>antacid_nmod	pos_3=JJ	relType_2=det	lemma_4=administration	relType_1=punct
DDI-DrugBank.d219.s2	DDI-DrugBank.d219.s2.e0	DDI-DrugBank.d219.s2.e2	null	pos_2=DT	lemma_2=the	lemma_15=of	relType_7=det	relType_8=amod	relation_9=neutral	path1=	lemma_7=no	pos_6=VBZ	relType_14=nmod	lemma_5=of	relType_5=case	lemma_13=of	lib=concomitant	lemma_6=antacid	pos_8=JJ	relType_12=nmod	lpib=concomitant_JJ	pos_12=NN	pos_14=NN	lemma_6=have	relType_10=case	relType_4=nsubj	pos_9=NN	pos_4=NN	pos_7=DT	lemma_1=:	pos_13=IN	path=<antacid_ROOT>have_appos>effect_obj>extent_nmod>absorption_nmod>Lodine_nmod	wib=concomitant	relType_13=case	relType_15=case	lemma_8=apparent	relType_3=amod	pos_1=:	relType_9=obj	pos_5=IN	pos_10=IN	lemma_10=on	pos_11=DT	path2=have_appos>effect_obj>extent_nmod>absorption_nmod>Lodine_nmod	lemma_11=the	lemma_3=concomitant	relType_11=det	pos_15=IN	lemma_12=extent	pos_3=JJ	relType_6=appos	eib=True	relType_2=det	pos_6=NNS	lemma_4=administration	lemma_14=absorption	lemma_9=effect	relType_1=punct	relType_6=nmod
DDI-DrugBank.d219.s2	DDI-DrugBank.d219.s2.e1	DDI-DrugBank.d219.s2.e2	null	relType_8=case	pos_2=DT	path1=antacid_nmod<administration_nsubj	lemma_9=absorption	lpib=have_VBZ	pos_6=DT	path2=effect_obj>extent_nmod>absorption_nmod>Lodine_nmod	lemma_10=of	lemma_3=apparent	relType_9=nmod	relType_5=case	lemma_2=no	eib=False	lemma_6=the	path=antacid_nmod<administration_nsubj<have_appos>effect_obj>extent_nmod>absorption_nmod>Lodine_nmod	lemma_8=of	lemma_1=have	relType_10=case	pos_9=NN	pos_4=NN	lib=have	relType_4=obj	pos_8=IN	relation_3=neutral	relType_1=appos	relType_3=amod	pos_5=IN	relType_7=nmod	pos_10=IN	relType_6=det	lemma_4=effect	pos_3=JJ	pos_1=VBZ	lemma_5=on	relType_2=det	pos_7=NN	wib=has	lemma_7=extent
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e0	DDI-DrugBank.d219.s4.e1	null	path2=reduce_dep>administer_advcl>Lodine_nsubj:pass	lib=lodine	lemma_2=when	wib=Lodine	eib=False	relType_2=advmod	path=<aspirin_ROOT>reduce_dep>administer_advcl>Lodine_nsubj:pass	path1=	pos_1=:	lpib=lodine_NNP	relType_1=punct	pos_2=WRB	lemma_1=:
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e0	DDI-DrugBank.d219.s4.e2	null	path2=reduce_dep>administer_advcl>aspirin_obl	wib=Lodine	lemma_3=Lodine	lemma_4=administer	path1=	pos_3=NNP	relType_3=nsubj:pass	lpib=lodine_NNP	relType_3=aux:pass	relType_5=case	relType_2=advmod	pos_3=VBZ	lemma_5=with	path=<aspirin_ROOT>reduce_dep>administer_advcl>aspirin_obl	lemma_1=:	pos_4=VBN	lemma_3=be	pos_1=:	pos_5=IN	pos_2=WRB	lib=lodine	lemma_2=when	eib=True	relType_1=punct	relType_4=advcl
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e0	DDI-DrugBank.d219.s4.e3	null	wib=Lodine	pos_16=IN	lemma_3=Lodine	lemma_4=administer	path1=	pos_3=NNP	lemma_6=,	lemma_11=reduce	lemma_13=although	relType_3=nsubj:pass	lpib=lodine_NNP	pos_17=JJ	relType_3=aux:pass	relType_5=case	pos_6=NN	pos_8=NN	relType_6=obl	relType_10=aux:pass	lemma_12=,	relType_15=nsubj:pass	relation_12=adverse	relType_2=advmod	relType_6=punct	lemma_8=protein	relType_9=nsubj:pass	pos_3=VBZ	lemma_5=with	pos_12=,	relType_14=det	lemma_17=free	relType_12=punct	pos_13=IN	lemma_14=the	lemma_16=of	pos_9=NN	relType_7=nmod:poss	lemma_1=:	pos_4=VBN	pos_15=NN	pos_7=PRP$	pos_10=VBZ	relType_8=compound	lemma_3=be	pos_1=:	pos_5=IN	relType_11=dep	pos_11=VBN	pos_2=WRB	lemma_7=its	pos_6=,	pos_14=DT	relType_17=amod	lib=lodine	lemma_2=when	relType_16=case	eib=True	lemma_9=binding	path2=reduce_dep>alter_advcl>clearance_nsubj:pass>etodolac_nmod	lemma_6=aspirin	relType_13=mark	relType_1=punct	relType_4=advcl	path=<aspirin_ROOT>reduce_dep>alter_advcl>clearance_nsubj:pass>etodolac_nmod	lemma_15=clearance	lemma_10=be
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e1	DDI-DrugBank.d219.s4.e2	mechanism	pos_2=VBN	lib=be	pos_1=VBZ	pos_3=IN	eib=False	path=Lodine_nsubj:pass<administer_advcl>aspirin_obl	relType_1=aux:pass	lemma_1=be	path2=aspirin_obl	lemma_2=administer	lpib=be_VBZ	relType_2=advcl	lemma_3=with	path1=Lodine_nsubj:pass	relType_3=case	wib=is
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e1	DDI-DrugBank.d219.s4.e3	null	pos_2=VBN	lemma_13=clearance	relType_10=punct	pos_3=IN	pos_15=JJ	relType_15=amod	relType_1=aux:pass	lemma_2=administer	lemma_5=its	lemma_10=,	relType_2=advcl	pos_5=PRP$	lemma_15=free	relation_9=adverse	relType_12=det	relType_9=dep	pos_6=NN	path1=Lodine_nsubj:pass<administer_advcl	pos_4=,	pos_8=VBZ	lemma_11=although	lemma_1=be	lemma_7=binding	relType_8=aux:pass	relType_7=nsubj:pass	pos_9=VBN	pos_13=NN	pos_4=NN	relType_5=nmod:poss	lemma_12=the	pos_11=IN	pos_14=IN	relType_4=obl	lib=be	relType_4=punct	lemma_6=protein	lemma_4=aspirin	lemma_8=be	path2=alter_advcl>clearance_nsubj:pass>etodolac_nmod	lemma_3=with	lemma_4=,	lemma_9=reduce	relType_3=case	wib=is	relType_6=compound	relType_13=nsubj:pass	relType_11=mark	pos_10=,	pos_1=VBZ	eib=True	lemma_14=of	lpib=be_VBZ	pos_12=DT	relType_14=case	pos_7=NN	path=Lodine_nsubj:pass<administer_advcl<reduce_dep>alter_advcl>clearance_nsubj:pass>etodolac_nmod
DDI-DrugBank.d219.s4	DDI-DrugBank.d219.s4.e2	DDI-DrugBank.d219.s4.e3	null	lemma_1=,	pos_5=VBZ	lib=protein	pos_1=,	relation_5=adverse	lpib=protein_NN	relType_11=case	lemma_8=although	pos_12=JJ	lemma_12=free	relType_6=dep	eib=False	pos_7=,	pos_9=DT	relType_4=nsubj:pass	relType_12=amod	pos_6=VBN	pos_10=NN	lemma_5=be	lemma_7=,	pos_4=NN	pos_8=IN	relType_10=nsubj:pass	pos_11=IN	relType_5=aux:pass	lemma_3=protein	relType_8=mark	path2=alter_advcl>clearance_nsubj:pass>etodolac_nmod	pos_2=PRP$	lemma_2=its	lemma_4=binding	wib=protein	relType_2=nmod:poss	lemma_6=reduce	pos_3=NN	path1=aspirin_obl<administer_advcl	relType_7=punct	lemma_9=the	lemma_11=of	path=aspirin_obl<administer_advcl<reduce_dep>alter_advcl>clearance_nsubj:pass>etodolac_nmod	relType_3=compound	lemma_10=clearance	relType_1=punct	relType_9=det
DDI-DrugBank.d219.s6	DDI-DrugBank.d219.s6.e0	DDI-DrugBank.d219.s6.e1	null	lemma_1=,	path=nsaid_obl<recommend_ROOT>administration_nsubj:pass>Lodine_nmod	pos_1=,	lemma_3=administration	relType_3=nsubj:pass	pos_2=JJ	path2=administration_nsubj:pass>Lodine_nmod	lib=concomitant	eib=False	lpib=concomitant_JJ	wib=concomitant	lemma_2=concomitant	pos_4=IN	relType_2=amod	relType_4=case	pos_3=NN	path1=nsaid_obl	relType_1=punct	lemma_4=of
DDI-DrugBank.d219.s6	DDI-DrugBank.d219.s6.e0	DDI-DrugBank.d219.s6.e2	null	lemma_1=,	pos_5=CC	pos_1=,	lemma_3=administration	relType_3=nsubj:pass	pos_2=JJ	lib=concomitant	relType_5=cc	lemma_5=Lodine	path=nsaid_obl<recommend_ROOT>administration_nsubj:pass>Lodine_nmod>aspirin_conj	lpib=concomitant_JJ	path2=administration_nsubj:pass>Lodine_nmod>aspirin_conj	wib=concomitant	lemma_2=concomitant	pos_4=IN	relType_2=amod	relType_4=case	relType_5=nmod	pos_5=NNP	eib=True	lemma_5=and	pos_3=NN	path1=nsaid_obl	relType_1=punct	lemma_4=of
DDI-DrugBank.d219.s6	DDI-DrugBank.d219.s6.e1	DDI-DrugBank.d219.s6.e2	advise	relType_1=cc	pos_1=CC	path2=aspirin_conj	eib=False	path1=	lpib=aspirin_NN	wib=aspirin	lib=aspirin	path=<Lodine_nmod>aspirin_conj	lemma_1=and
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e0	DDI-DrugBank.d219.s7.e1	null	pos_2=IN	lemma_1=,	relType_2=case	pos_3=JJ	lib=other	eib=False	lpib=other_JJ	relType_3=amod	path1=Lodine_conj	pos_1=,	wib=other	path2=nsaid_nmod	path=Lodine_conj<cyclosporine_nsubj>nsaid_nmod	relType_1=punct	lemma_3=other	lemma_2=like
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e0	DDI-DrugBank.d219.s7.e2	mechanism	lemma_12=cause	relType_16=nmod	lemma_10=,	pos_13=NNS	relType_5=case	lemma_23=serum	lemma_24=level	pos_8=JJ	relation_13=neutral	path1=Lodine_conj<cyclosporine_nsubj	lemma_21=to	lemma_14=in	pos_15=DT	lemma_2=like	relType_23=compound	relType_12=ROOT	lemma_16=elimination	pos_24=NNS	relType_4=punct	relType_3=amod	lemma_25=of	lpib=other_JJ	lemma_11=may	relType_21=case	lemma_4=nsaid	pos_3=JJ	pos_10=,	relation_12=neutral	pos_7=IN	pos_6=NNS	lemma_1=,	relType_7=case	pos_1=,	relType_4=nmod	path=Lodine_conj<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod	pos_19=NNS	relType_25=case	pos_18=DT	pos_20=VBG	pos_14=IN	lemma_8=renal	lemma_13=change	pos_5=IN	lemma_4=,	pos_16=NN	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod	pos_25=IN	relType_18=det	relType_1=punct	relType_15=det	lemma_20=lead	relType_10=punct	relType_24=obl	pos_11=MD	lemma_3=other	pos_17=IN	pos_2=IN	relType_19=nmod	pos_23=NN	pos_4=,	lemma_7=on	relType_11=aux	lemma_15=the	pos_21=IN	relType_17=case	lemma_22=elevated	lemma_17=of	lemma_5=through	pos_12=VB	pos_22=JJ	relType_2=case	relType_22=amod	relType_20=acl	relType_14=case	relType_6=nmod	lib=other	relType_8=amod	lemma_19=drug	lemma_18=this	relType_9=nmod	relation_6=neutral	lemma_9=prostaglandin	pos_9=NNS	wib=other	pos_4=NNS	lemma_6=effect	eib=True	relType_13=obj
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e0	DDI-DrugBank.d219.s7.e3	mechanism	lemma_12=cause	relType_16=nmod	lemma_10=,	pos_13=NNS	relType_5=case	lemma_23=serum	lemma_24=level	pos_8=JJ	relation_13=neutral	path1=Lodine_conj<cyclosporine_nsubj	relType_26=nmod	lemma_21=to	pos_26=NN	lemma_14=in	pos_15=DT	lemma_2=like	relType_23=compound	relType_12=ROOT	lemma_16=elimination	pos_24=NNS	relType_4=punct	relType_3=amod	lemma_25=of	lpib=other_JJ	lemma_11=may	relType_21=case	lemma_4=nsaid	pos_3=JJ	pos_10=,	relation_12=neutral	pos_7=IN	pos_6=NNS	lemma_26=cyclosporine	lemma_1=,	relType_7=case	pos_1=,	relType_4=nmod	pos_19=NNS	relType_25=case	pos_18=DT	pos_20=VBG	pos_14=IN	lemma_8=renal	lemma_13=change	pos_5=IN	lemma_4=,	pos_16=NN	pos_25=IN	relType_18=det	relType_26=punct	relType_1=punct	relType_15=det	lemma_20=lead	relType_10=punct	relType_24=obl	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>digoxin_conj	pos_11=MD	lemma_3=other	pos_17=IN	pos_2=IN	relType_19=nmod	pos_23=NN	pos_4=,	lemma_7=on	relType_11=aux	lemma_15=the	pos_21=IN	relType_17=case	lemma_22=elevated	lemma_17=of	lemma_5=through	pos_12=VB	pos_22=JJ	relType_2=case	relType_22=amod	relType_20=acl	relType_14=case	relType_6=nmod	lib=other	relType_8=amod	lemma_19=drug	lemma_18=this	relType_9=nmod	relation_6=neutral	lemma_9=prostaglandin	pos_9=NNS	wib=other	pos_4=NNS	lemma_6=effect	path=Lodine_conj<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>digoxin_conj	eib=True	pos_26=,	relType_13=obj	lemma_26=,
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e0	DDI-DrugBank.d219.s7.e4	mechanism	lemma_12=cause	relType_16=nmod	lemma_10=,	pos_13=NNS	relType_5=case	lemma_23=serum	pos_27=,	lemma_24=level	pos_8=JJ	relation_13=neutral	path1=Lodine_conj<cyclosporine_nsubj	relType_26=nmod	lemma_27=digoxin	lemma_21=to	pos_26=NN	lemma_14=in	pos_15=DT	lemma_2=like	relType_23=compound	relType_12=ROOT	lemma_16=elimination	pos_24=NNS	relType_4=punct	relType_3=amod	lemma_25=of	lpib=other_JJ	lemma_11=may	relType_21=case	lemma_4=nsaid	pos_3=JJ	pos_10=,	relation_12=neutral	pos_7=IN	pos_6=NNS	lemma_26=cyclosporine	lemma_1=,	relType_7=case	pos_1=,	relType_27=conj	relType_4=nmod	pos_19=NNS	relType_25=case	pos_18=DT	pos_20=VBG	pos_14=IN	pos_27=NN	lemma_8=renal	lemma_13=change	pos_5=IN	lemma_4=,	pos_16=NN	pos_25=IN	relType_18=det	relType_26=punct	relType_1=punct	relType_15=det	lemma_20=lead	relType_10=punct	relType_24=obl	pos_11=MD	lemma_3=other	pos_17=IN	pos_2=IN	relType_19=nmod	pos_23=NN	pos_4=,	lemma_7=on	relType_11=aux	lemma_15=the	pos_21=IN	relType_17=case	lemma_22=elevated	lemma_17=of	lemma_5=through	pos_12=VB	pos_22=JJ	relType_2=case	relType_22=amod	relType_20=acl	relType_14=case	relType_27=punct	relType_6=nmod	lib=other	relType_8=amod	lemma_19=drug	lemma_18=this	relType_9=nmod	relation_6=neutral	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>methotrexate_conj	lemma_9=prostaglandin	pos_9=NNS	wib=other	pos_4=NNS	lemma_6=effect	lemma_27=,	path=Lodine_conj<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>methotrexate_conj	eib=True	pos_26=,	relType_13=obj	lemma_26=,
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e1	DDI-DrugBank.d219.s7.e2	mechanism	lemma_22=of	lemma_1=,	lemma_20=serum	relation_9=neutral	relType_16=nmod	lemma_19=elevated	relType_22=case	pos_1=,	pos_9=VB	pos_21=NNS	pos_16=NNS	relation_8=neutral	relType_12=det	lemma_13=elimination	relType_11=case	lemma_9=cause	path1=nsaid_nmod<cyclosporine_nsubj	relType_13=nmod	pos_2=IN	lemma_3=effect	relType_9=ROOT	relType_17=acl	relType_18=case	pos_3=NNS	lemma_17=lead	eib=False	pos_8=MD	lemma_5=renal	relation_2=neutral	lemma_4=on	pos_17=VBG	pos_7=,	pos_19=JJ	pos_20=NN	lemma_11=in	pos_22=IN	lemma_10=change	lemma_7=,	pos_13=NN	relType_10=obj	pos_15=DT	lemma_16=drug	lemma_12=the	pos_11=IN	lpib=effect_NNS	path=nsaid_nmod<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod	relType_6=nmod	pos_5=JJ	pos_14=IN	lemma_2=through	lemma_21=level	relType_5=amod	lemma_6=prostaglandin	pos_4=IN	pos_18=IN	relType_3=nmod	relType_4=case	lemma_18=to	relType_19=amod	relType_21=obl	lemma_15=this	wib=effects	relType_2=case	relType_20=compound	relType_7=punct	lemma_14=of	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod	pos_6=NNS	lemma_8=may	relType_8=aux	pos_12=DT	relType_14=case	lib=effect	relType_1=punct	relType_15=det	pos_10=NNS
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e1	DDI-DrugBank.d219.s7.e3	mechanism	lemma_20=serum	relation_9=neutral	relType_16=nmod	pos_9=VB	lemma_13=elimination	pos_21=NNS	path1=nsaid_nmod<cyclosporine_nsubj	relType_18=case	relType_9=ROOT	pos_3=NNS	lemma_17=lead	pos_8=MD	pos_20=NN	pos_22=IN	pos_13=NN	lemma_7=,	pos_15=DT	lemma_23=,	lemma_12=the	lemma_23=cyclosporine	lemma_14=of	pos_6=NNS	pos_12=DT	lib=effect	lemma_1=,	pos_1=,	pos_16=NNS	relation_8=neutral	relType_11=case	lemma_9=cause	pos_10=NNS	relType_17=acl	lemma_5=renal	lemma_4=on	pos_19=JJ	lemma_11=in	relType_22=case	pos_14=IN	lemma_6=prostaglandin	lemma_18=to	relType_19=amod	path=nsaid_nmod<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>digoxin_conj	relType_21=obl	lemma_15=this	relType_1=punct	lemma_16=drug	relType_15=det	relType_10=obj	lemma_22=of	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>digoxin_conj	relType_12=det	pos_23=NN	pos_2=IN	relation_2=neutral	pos_7=,	lemma_10=change	pos_18=IN	relType_23=nmod	pos_11=IN	lemma_2=through	relType_5=amod	pos_4=IN	relType_3=nmod	relType_2=case	lemma_8=may	relType_14=case	relType_6=nmod	relType_23=punct	lemma_19=elevated	relType_13=nmod	lemma_3=effect	pos_17=VBG	lpib=effect_NNS	pos_5=JJ	relType_4=case	wib=effects	eib=True	relType_20=compound	pos_23=,	relType_7=punct	relType_8=aux	lemma_21=level
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e1	DDI-DrugBank.d219.s7.e4	mechanism	lemma_20=serum	relation_9=neutral	relType_16=nmod	pos_24=,	pos_9=VB	lemma_13=elimination	lemma_24=,	pos_21=NNS	path1=nsaid_nmod<cyclosporine_nsubj	relType_18=case	relType_9=ROOT	pos_3=NNS	lemma_17=lead	lemma_24=digoxin	pos_8=MD	pos_20=NN	pos_22=IN	pos_13=NN	lemma_7=,	pos_15=DT	lemma_23=,	lemma_12=the	lemma_23=cyclosporine	lemma_14=of	pos_6=NNS	pos_12=DT	lib=effect	lemma_1=,	pos_1=,	pos_16=NNS	relation_8=neutral	relType_11=case	lemma_9=cause	pos_10=NNS	relType_17=acl	lemma_5=renal	lemma_4=on	pos_19=JJ	lemma_11=in	relType_22=case	pos_14=IN	lemma_6=prostaglandin	lemma_18=to	relType_19=amod	relType_21=obl	lemma_15=this	relType_1=punct	lemma_16=drug	relType_15=det	relType_10=obj	lemma_22=of	relType_24=punct	pos_24=NN	path=nsaid_nmod<cyclosporine_nsubj<cause_ROOT>change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>methotrexate_conj	relType_12=det	pos_23=NN	pos_2=IN	relation_2=neutral	pos_7=,	lemma_10=change	pos_18=IN	relType_23=nmod	pos_11=IN	lemma_2=through	relType_5=amod	pos_4=IN	relType_3=nmod	relType_2=case	lemma_8=may	relType_14=case	relType_6=nmod	relType_23=punct	lemma_19=elevated	relType_13=nmod	lemma_3=effect	path2=change_obj>elimination_nmod>lead_acl>level_obl>cyclosporine_nmod>methotrexate_conj	pos_17=VBG	lpib=effect_NNS	pos_5=JJ	relType_4=case	relType_24=conj	wib=effects	eib=True	relType_20=compound	pos_23=,	relType_7=punct	relType_8=aux	lemma_21=level
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e2	DDI-DrugBank.d219.s7.e3	null	lib=digoxin	lemma_1=,	eib=False	path1=	pos_1=,	path2=digoxin_conj	path=<cyclosporine_nmod>digoxin_conj	relType_1=punct	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e2	DDI-DrugBank.d219.s7.e4	null	path=<cyclosporine_nmod>methotrexate_conj	lib=digoxin	lemma_1=,	relType_2=punct	path2=methotrexate_conj	pos_2=NN	eib=True	lemma_2=digoxin	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d219.s7	DDI-DrugBank.d219.s7.e3	DDI-DrugBank.d219.s7.e4	null	lemma_1=,	path2=methotrexate_conj	eib=False	lib=methotrexate	wib=methotrexate	pos_1=,	relType_1=punct	lpib=methotrexate_NN	path=digoxin_conj<cyclosporine_nmod>methotrexate_conj	path1=digoxin_conj
DDI-DrugBank.d219.s9	DDI-DrugBank.d219.s9.e0	DDI-DrugBank.d219.s9.e1	null	relType_4=amod	lemma_2=or	lemma_1=,	pos_4=JJ	lib=other	path=<Lodine_acl:relcl>nsaid_conj	path1=	pos_1=,	relType_2=cc	eib=False	wib=other	relType_3=det	lpib=other_JJ	lemma_4=other	lemma_3=any	pos_3=DT	pos_2=CC	path2=nsaid_conj	relType_1=punct
DDI-DrugBank.d219.s10	DDI-DrugBank.d219.s10.e0	DDI-DrugBank.d219.s10.e1	null	pos_6=JJ	path2=have_parataxis>administer_advcl>furosemide_obl	lemma_10=with	pos_7=NN	path1=	lemma_6=pharmacokinetic	lpib=etodolac_NNP	relType_9=advcl	pos_2=NNP	eib=False	relType_2=nsubj	lemma_2=Etodolac	path=<diuretic_ROOT>have_parataxis>administer_advcl>furosemide_obl	relType_6=amod	relType_7=obj	pos_3=VBZ	lemma_5=apparent	lemma_8=when	relType_10=case	pos_9=VBN	relType_8=advmod	lemma_3=have	wib=Etodolac	lemma_1=:	pos_4=DT	pos_5=JJ	lemma_4=no	relType_5=amod	pos_1=:	lemma_9=administer	relType_3=parataxis	pos_10=IN	lib=etodolac	pos_8=WRB	relType_1=punct	relType_4=det	lemma_7=interaction
DDI-DrugBank.d219.s10	DDI-DrugBank.d219.s10.e0	DDI-DrugBank.d219.s10.e2	null	pos_6=JJ	lemma_10=with	relType_11=cc	pos_7=NN	path1=	path=<diuretic_ROOT>have_parataxis>administer_advcl>furosemide_obl>hydrochlorothiazide_conj	lemma_6=pharmacokinetic	path2=have_parataxis>administer_advcl>furosemide_obl>hydrochlorothiazide_conj	lpib=etodolac_NNP	relType_9=advcl	pos_2=NNP	relType_2=nsubj	lemma_2=Etodolac	lemma_11=furosemide	relType_6=amod	relType_7=obj	pos_3=VBZ	lemma_5=apparent	lemma_8=when	relType_10=case	pos_9=VBN	relType_8=advmod	lemma_3=have	wib=Etodolac	lemma_1=:	pos_4=DT	pos_5=JJ	lemma_4=no	relType_5=amod	lemma_11=or	pos_11=CC	pos_1=:	lemma_9=administer	relType_3=parataxis	pos_10=IN	relType_11=obl	lib=etodolac	pos_11=NN	eib=True	pos_8=WRB	relType_1=punct	relType_4=det	lemma_7=interaction
DDI-DrugBank.d219.s10	DDI-DrugBank.d219.s10.e1	DDI-DrugBank.d219.s10.e2	null	relType_1=cc	path2=hydrochlorothiazide_conj	pos_1=CC	eib=False	path=<furosemide_obl>hydrochlorothiazide_conj	path1=	wib=hydrochlorothiazide	lib=hydrochlorothiazide	lpib=hydrochlorothiazide_NN	lemma_1=or
DDI-DrugBank.d219.s11	DDI-DrugBank.d219.s11.e0	DDI-DrugBank.d219.s11.e1	effect	relType_4=amod	pos_4=JJ	relType_1=aux	lib=reduce	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	eib=False	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	lpib=reduce_VB	pos_1=MD	path2=effect_obj>furosemide_nmod	relType_2=ccomp	pos_5=NN	pos_3=DT	relType_5=obj	lemma_3=the	path=Lodine_nsubj<reduce_ccomp>effect_obj>furosemide_nmod	relation_4=neutral	path1=Lodine_nsubj
DDI-DrugBank.d219.s11	DDI-DrugBank.d219.s11.e0	DDI-DrugBank.d219.s11.e2	effect	relType_4=amod	pos_4=JJ	relType_1=aux	lib=reduce	path2=effect_obj>furosemide_nmod>thiazide_conj	relType_7=cc	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	path=Lodine_nsubj<reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	lpib=reduce_VB	pos_7=CC	relType_7=nmod	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	pos_3=DT	relType_5=obj	lemma_7=and	lemma_3=the	relation_4=neutral	path1=Lodine_nsubj	pos_7=NN	lemma_7=furosemide
DDI-DrugBank.d219.s11	DDI-DrugBank.d219.s11.e1	DDI-DrugBank.d219.s11.e2	null	relType_1=cc	wib=thiazides	lpib=thiazide_NNS	pos_1=CC	path2=thiazide_conj	eib=False	path1=	lib=thiazide	path=<furosemide_nmod>thiazide_conj	lemma_1=and
DDI-DrugBank.d219.s14	DDI-DrugBank.d219.s14.e0	DDI-DrugBank.d219.s14.e1	null	lib=etodolac	eib=False	path=<glyburide_ROOT>have_parataxis>Etodolac_nsubj	wib=Etodolac	path1=	path2=have_parataxis>Etodolac_nsubj	pos_1=:	lemma_1=:	relType_1=punct	lpib=etodolac_NNP
DDI-DrugBank.d219.s14	DDI-DrugBank.d219.s14.e0	DDI-DrugBank.d219.s14.e2	null	relType_4=amod	pos_4=JJ	lemma_3=no	lemma_2=have	pos_8=VBN	path1=	relType_8=advcl	pos_9=IN	pos_7=WRB	lemma_8=administer	lpib=etodolac_NNP	pos_6=NN	pos_2=NNP	relType_2=nsubj	lemma_2=Etodolac	relType_9=case	relType_3=det	wib=Etodolac	lemma_1=:	pos_5=JJ	relType_5=amod	lemma_6=interaction	path2=have_parataxis>administer_advcl>glyburide_obl	pos_1=:	relType_6=obj	pos_2=VBZ	lib=etodolac	lemma_9=with	eib=True	path=<glyburide_ROOT>have_parataxis>administer_advcl>glyburide_obl	pos_3=DT	lemma_5=pharmacokinetic	lemma_7=when	relType_2=parataxis	relType_1=punct	relType_7=advmod	lemma_4=apparent
DDI-DrugBank.d219.s14	DDI-DrugBank.d219.s14.e1	DDI-DrugBank.d219.s14.e2	null	relType_8=case	pos_2=DT	relType_4=amod	pos_4=JJ	lpib=have_VBZ	lemma_3=apparent	lemma_7=administer	path1=Etodolac_nsubj	pos_6=WRB	relType_7=advcl	lemma_2=no	lemma_4=pharmacokinetic	eib=False	path=Etodolac_nsubj<have_parataxis>administer_advcl>glyburide_obl	lemma_6=when	lemma_8=with	lemma_1=have	lib=have	relType_1=parataxis	pos_8=IN	relType_3=amod	pos_7=VBN	pos_5=NN	path2=administer_advcl>glyburide_obl	pos_3=JJ	pos_1=VBZ	relType_5=obj	relType_2=det	lemma_5=interaction	wib=has	relType_6=advmod
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e0	DDI-DrugBank.d219.s15.e1	null	lib=nsaid	path=<lithium_ROOT>produce_appos>nsaid_nsubj	path2=produce_appos>nsaid_nsubj	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	pos_1=:	relType_1=punct	lemma_1=:
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e0	DDI-DrugBank.d219.s15.e2	null	relType_7=compound	lpib=nsaid_NNS	lemma_2=have	lemma_4=a	pos_3=VBN	pos_7=NN	path1=	lemma_6=of	relType_6=case	path=<lithium_ROOT>produce_appos>elevation_obj>level_nmod>lithium_compound	lib=nsaid	relType_2=nsubj	relType_3=appos	lemma_5=elevation	pos_6=IN	relType_2=aux	lemma_2=nsaid	lemma_7=plasma	lemma_3=produce	lemma_1=:	relation_3=neutral	pos_4=DT	pos_1=:	pos_2=VBP	path2=produce_appos>elevation_obj>level_nmod>lithium_compound	pos_2=NNS	pos_5=NN	wib=NSAIDs	eib=True	relType_5=obj	relType_1=punct	relType_4=det
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e0	DDI-DrugBank.d219.s15.e3	null	relType_7=compound	lpib=nsaid_NNS	relType_10=det	lemma_2=have	lemma_4=a	pos_3=VBN	pos_7=NN	path1=	relType_12=case	lemma_10=a	lemma_6=of	relType_6=case	pos_8=NNS	relType_11=conj	pos_8=NN	lib=nsaid	lemma_11=reduction	relType_2=nsubj	relType_3=appos	lemma_5=elevation	relType_13=amod	pos_6=IN	relType_2=aux	lemma_2=nsaid	lemma_7=plasma	lemma_3=produce	pos_12=IN	lemma_1=:	relation_3=neutral	path2=produce_appos>elevation_obj>reduction_conj>clearance_nmod>lithium_compound	pos_4=DT	lemma_9=and	pos_9=CC	lemma_8=level	pos_13=JJ	lemma_8=lithium	relType_8=compound	pos_1=:	pos_2=VBP	pos_2=NNS	pos_5=NN	lemma_12=in	pos_11=NN	wib=NSAIDs	eib=True	relType_8=nmod	lemma_13=renal	relType_5=obj	relType_9=cc	relType_1=punct	relType_4=det	path=<lithium_ROOT>produce_appos>elevation_obj>reduction_conj>clearance_nmod>lithium_compound	pos_10=DT
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e1	DDI-DrugBank.d219.s15.e2	mechanism	relation_1=neutral	pos_2=VBN	relType_1=aux	path=nsaid_nsubj<produce_appos>elevation_obj>level_nmod>lithium_compound	lemma_2=produce	lemma_5=of	relType_5=case	pos_6=NN	lemma_6=plasma	eib=False	lemma_1=have	relType_3=det	lemma_3=a	lib=have	pos_4=NN	relType_4=obj	pos_5=IN	relType_2=appos	path2=elevation_obj>level_nmod>lithium_compound	pos_1=VBP	lpib=have_VBP	relType_6=compound	pos_3=DT	wib=have	lemma_4=elevation	path1=nsaid_nsubj
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e1	DDI-DrugBank.d219.s15.e3	null	pos_7=NNS	relation_1=neutral	pos_2=VBN	relType_7=compound	relType_1=aux	pos_7=NN	lemma_9=a	lemma_2=produce	lemma_7=lithium	lemma_5=of	relType_5=case	relType_11=case	pos_6=NN	pos_12=JJ	lemma_6=plasma	relType_10=conj	pos_9=DT	relType_12=amod	lemma_1=have	lemma_11=in	pos_8=CC	pos_10=NN	relType_3=det	lemma_3=a	lib=have	pos_4=NN	relType_4=obj	lemma_7=level	pos_11=IN	lemma_10=reduction	pos_5=IN	path2=elevation_obj>reduction_conj>clearance_nmod>lithium_compound	relType_7=nmod	relType_2=appos	pos_1=VBP	lpib=have_VBP	lemma_8=and	relType_6=compound	path=nsaid_nsubj<produce_appos>elevation_obj>reduction_conj>clearance_nmod>lithium_compound	eib=True	pos_3=DT	wib=have	lemma_12=renal	lemma_4=elevation	relType_8=cc	path1=nsaid_nsubj	relType_9=det
DDI-DrugBank.d219.s15	DDI-DrugBank.d219.s15.e2	DDI-DrugBank.d219.s15.e3	null	path2=reduction_conj>clearance_nmod>lithium_compound	lemma_5=in	pos_6=JJ	lib=level	relType_2=cc	relType_5=case	lemma_2=and	lpib=level_NNS	eib=False	relType_6=amod	lemma_1=level	relType_1=nmod	lemma_3=a	pos_4=NN	relType_3=det	pos_5=IN	path=lithium_compound<level_nmod<elevation_obj>reduction_conj>clearance_nmod>lithium_compound	path1=lithium_compound<level_nmod	pos_1=NNS	pos_3=DT	pos_2=CC	lemma_4=reduction	relType_4=conj	lemma_6=renal	wib=levels
DDI-DrugBank.d219.s18	DDI-DrugBank.d219.s18.e0	DDI-DrugBank.d219.s18.e1	effect	relType_1=cc	wib=lithium	pos_1=CC	lemma_1=and	lpib=lithium_NN	eib=False	path1=	path=<nsaid_nsubj:pass>lithium_conj	path2=lithium_conj	lib=lithium
DDI-DrugBank.d219.s18	DDI-DrugBank.d219.s18.e0	DDI-DrugBank.d219.s18.e2	null	relType_1=cc	wib=lithium	pos_1=CC	relType_12=obl	pos_2=NN	pos_5=,	lemma_10=carefully	pos_3=VBN	path1=nsaid_nsubj:pass<administer_advcl	relType_7=aux	lemma_4=concurrently	lib=lithium	lemma_9=observe	relType_11=case	lemma_13=of	relType_9=ROOT	pos_4=RB	lpib=lithium_NN	lemma_6=subject	lemma_3=administer	relType_8=aux:pass	relType_10=advmod	pos_7=MD	pos_13=IN	pos_9=VBN	relType_2=conj	lemma_12=sign	pos_8=VB	pos_11=IN	relType_13=case	lemma_11=for	relType_3=advcl	lemma_8=be	pos_12=NNS	lemma_2=lithium	lemma_5=,	relType_5=punct	relType_4=advmod	relType_2=aux:pass	relType_6=nsubj:pass	pos_2=VBP	lemma_7=should	path2=sign_obl>toxicity_nmod>lithium_compound	eib=True	pos_6=NNS	path=nsaid_nsubj:pass<administer_advcl<observe_ROOT>sign_obl>toxicity_nmod>lithium_compound	lemma_2=be	pos_10=RB	lemma_1=and
DDI-DrugBank.d219.s18	DDI-DrugBank.d219.s18.e1	DDI-DrugBank.d219.s18.e2	null	pos_7=VB	pos_2=VBN	pos_3=RB	relType_3=advmod	path1=lithium_conj<nsaid_nsubj:pass<administer_advcl	relType_9=advmod	pos_8=VBN	lpib=be_VBP	relType_1=aux:pass	lemma_2=administer	relType_5=nsubj:pass	lemma_7=be	relType_12=case	relType_2=advcl	lemma_8=observe	lemma_12=of	pos_4=,	eib=False	pos_5=NNS	lemma_1=be	pos_11=NNS	path=lithium_conj<nsaid_nsubj:pass<administer_advcl<observe_ROOT>sign_obl>toxicity_nmod>lithium_compound	lemma_6=should	relType_10=case	lemma_5=subject	pos_12=IN	wib=are	relType_4=punct	lib=be	lemma_11=sign	relType_6=aux	relType_7=aux:pass	pos_9=RB	relType_8=ROOT	lemma_4=,	pos_10=IN	pos_6=MD	relType_11=obl	pos_1=VBP	path2=sign_obl>toxicity_nmod>lithium_compound	lemma_9=carefully	lemma_3=concurrently	lemma_10=for
DDI-DrugBank.d219.s19	DDI-DrugBank.d219.s19.e0	DDI-DrugBank.d219.s19.e1	null	lpib=phenylbutazone_NN	path=<phenylbutazone_ROOT>cause_appos>phenylbutazone_nsubj	eib=False	path1=	path2=cause_appos>phenylbutazone_nsubj	pos_1=:	lib=phenylbutazone	relType_1=punct	lemma_1=:	wib=Phenylbutazone
DDI-DrugBank.d219.s19	DDI-DrugBank.d219.s19.e0	DDI-DrugBank.d219.s19.e2	null	lemma_9=)	lemma_3=increase	pos_2=NN	path1=	lemma_13=fraction	relation_3=beneficial	pos_7=CD	lemma_5=by	path2=cause_appos>fraction_obl>etodolac_nmod	lemma_2=phenylbutazone	relType_5=case	lemma_6=about	relType_8=obl	pos_8=NN	pos_12=JJ	lemma_12=free	lemma_7=80	relType_13=obl	relType_2=nsubj	relType_7=nummod	pos_4=-LRB-	path=<phenylbutazone_ROOT>cause_appos>fraction_obl>etodolac_nmod	relation_2=neutral	relType_12=amod	relType_10=case	pos_13=NN	lemma_1=:	lemma_4=(	lemma_2=cause	wib=Phenylbutazone	lpib=phenylbutazone_NN	lemma_8=%	pos_9=-RRB-	pos_14=IN	relType_4=punct	lemma_10=in	pos_1=:	pos_5=IN	pos_10=IN	relType_2=appos	pos_11=DT	pos_6=RB	relType_9=punct	lemma_11=the	relType_11=det	pos_2=VBZ	eib=True	pos_3=NN	lemma_14=of	relType_3=obj	relType_14=case	lib=phenylbutazone	relType_1=punct	relType_6=advmod
DDI-DrugBank.d219.s19	DDI-DrugBank.d219.s19.e1	DDI-DrugBank.d219.s19.e2	mechanism	relType_12=obl	relType_2=obj	pos_2=NN	relType_10=det	path=phenylbutazone_nsubj<cause_appos>fraction_obl>etodolac_nmod	pos_6=CD	pos_9=IN	relType_8=punct	lib=cause	relation_1=beneficial	lemma_13=of	wib=causes	eib=False	relType_11=amod	lemma_3=(	lemma_7=%	lemma_10=the	pos_12=NN	path2=fraction_obl>etodolac_nmod	pos_3=-LRB-	pos_8=-RRB-	relType_9=case	pos_13=IN	lemma_2=increase	lemma_6=80	relType_13=case	lemma_8=)	relType_1=appos	lemma_12=fraction	relation_0=neutral	pos_4=IN	pos_5=RB	path1=phenylbutazone_nsubj	relType_4=case	relType_6=nummod	lpib=cause_VBZ	relType_5=advmod	relType_7=obl	pos_1=VBZ	pos_11=JJ	lemma_11=free	pos_7=NN	lemma_9=in	relType_3=punct	lemma_4=by	lemma_1=cause	lemma_5=about	pos_10=DT
DDI-DrugBank.d219.s20	DDI-DrugBank.d219.s20.e0	DDI-DrugBank.d219.s20.e1	advise	path2=coadministration_obl>phenylbutazone_nmod	pos_3=VBN	lemma_6=of	relType_6=case	eib=False	pos_6=IN	relation_2=neutral	lemma_3=change	lemma_5=coadministration	pos_1=NN	wib=clearance	lib=clearance	relType_3=advcl	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_5=obl	path=etodolac_compound<clearance_nsubj:pass<change_advcl>coadministration_obl>phenylbutazone_nmod	pos_2=VBZ	pos_5=NN	path1=etodolac_compound<clearance_nsubj:pass	lemma_1=clearance	lpib=clearance_NN	relType_1=nsubj:pass	lemma_2=be	lemma_4=by
DDI-DrugBank.d219.s21	DDI-DrugBank.d219.s21.e0	DDI-DrugBank.d219.s21.e1	null	lib=etodolac	eib=False	path=<Phenytoin_ROOT>have_parataxis>Etodolac_nsubj	wib=Etodolac	path1=	path2=have_parataxis>Etodolac_nsubj	pos_1=:	lemma_1=:	relType_1=punct	lpib=etodolac_NNP
DDI-DrugBank.d219.s21	DDI-DrugBank.d219.s21.e0	DDI-DrugBank.d219.s21.e2	null	relType_4=amod	pos_4=JJ	lemma_3=no	lemma_2=have	pos_8=VBN	path1=	pos_9=IN	pos_7=WRB	lemma_8=administer	lpib=etodolac_NNP	relType_8=acl:relcl	pos_6=NN	pos_2=NNP	relType_2=nsubj	lemma_2=Etodolac	relType_9=case	relType_3=det	wib=Etodolac	lemma_1=:	pos_5=JJ	path2=have_parataxis>interaction_obj>administer_acl:relcl>phenytoin_obl	path=<Phenytoin_ROOT>have_parataxis>interaction_obj>administer_acl:relcl>phenytoin_obl	relType_5=amod	lemma_6=interaction	pos_1=:	relType_6=obj	pos_2=VBZ	lib=etodolac	lemma_9=with	eib=True	pos_3=DT	lemma_5=pharmacokinetic	lemma_7=when	relType_2=parataxis	relType_1=punct	relType_7=advmod	lemma_4=apparent
DDI-DrugBank.d219.s21	DDI-DrugBank.d219.s21.e1	DDI-DrugBank.d219.s21.e2	null	relType_8=case	pos_2=DT	relType_4=amod	pos_4=JJ	lpib=have_VBZ	path2=interaction_obj>administer_acl:relcl>phenytoin_obl	lemma_3=apparent	lemma_7=administer	path1=Etodolac_nsubj	pos_6=WRB	lemma_2=no	lemma_4=pharmacokinetic	eib=False	lemma_6=when	lemma_8=with	lemma_1=have	lib=have	relType_1=parataxis	pos_8=IN	relType_3=amod	pos_7=VBN	pos_5=NN	pos_3=JJ	pos_1=VBZ	path=Etodolac_nsubj<have_parataxis>interaction_obj>administer_acl:relcl>phenytoin_obl	relType_5=obj	relType_2=det	lemma_5=interaction	wib=has	relType_6=advmod	relType_7=acl:relcl
DDI-DrugBank.d219.s22	DDI-DrugBank.d219.s22.e0	DDI-DrugBank.d219.s22.e1	null	pos_2=DT	lemma_2=the	path2=synergistic_parataxis>effect_nsubj>warfarin_nmod	path1=	lemma_3=effect	pos_3=NNS	eib=False	relation_2=neutral	path=<Warfarin_ROOT>synergistic_parataxis>effect_nsubj>warfarin_nmod	lemma_1=:	lpib=effect_NNS	pos_4=IN	pos_1=:	relType_4=case	relType_3=nsubj	wib=effects	relType_2=det	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d219.s22	DDI-DrugBank.d219.s22.e0	DDI-DrugBank.d219.s22.e2	null	pos_2=DT	lemma_2=the	pos_5=CC	lemma_5=warfarin	path1=	lemma_3=effect	relType_5=cc	pos_3=NNS	relation_2=neutral	lemma_1=:	lpib=effect_NNS	path=<Warfarin_ROOT>synergistic_parataxis>effect_nsubj>warfarin_nmod>nsaid_conj	pos_4=IN	pos_1=:	relType_4=case	relType_5=nmod	relType_3=nsubj	pos_5=NN	path2=synergistic_parataxis>effect_nsubj>warfarin_nmod>nsaid_conj	wib=effects	eib=True	lemma_5=and	relType_2=det	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d219.s22	DDI-DrugBank.d219.s22.e1	DDI-DrugBank.d219.s22.e2	effect	relType_1=cc	lib=nsaid	pos_1=CC	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	path2=nsaid_conj	path=<warfarin_nmod>nsaid_conj	lemma_1=and
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e0	DDI-DrugBank.d219.s23.e1	mechanism	relType_1=cc	lib=lodine	wib=Lodine	lpib=lodine_NN	pos_1=CC	eib=False	path1=	path2=lodine_conj	lemma_1=and	path=<warfarin_nmod>lodine_conj
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e0	DDI-DrugBank.d219.s23.e2	mechanism	relType_1=cc	lib=lodine	wib=Lodine	lpib=lodine_NN	pos_1=CC	lemma_1=and	pos_2=NN	eib=True	lemma_2=(	pos_2=-LRB-	path=warfarin_nmod<administration_nsubj>capsule_appos>etodolac_compound	path2=capsule_appos>etodolac_compound	relType_2=conj	lemma_2=lodine	path1=warfarin_nmod	relType_2=punct
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e0	DDI-DrugBank.d219.s23.e3	null	relType_1=cc	relType_8=case	wib=Lodine	pos_1=CC	pos_7=VBZ	pos_2=NN	path2=binding_obl>warfarin_nmod	relType_12=case	relType_4=cc	relType_2=punct	lemma_12=of	lpib=lodine_NN	lemma_8=in	pos_3=NNS	relType_3=appos	pos_5=NNS	relType_6=punct	lemma_10=protein	pos_2=-LRB-	relType_9=amod	relType_10=compound	pos_9=VBN	pos_10=NN	relType_2=conj	lemma_6=)	lemma_11=binding	pos_8=IN	pos_12=IN	relation_10=adverse	lemma_3=etodolac	relType_5=conj	relType_11=obl	lemma_9=reduce	lemma_2=lodine	pos_6=-RRB-	lemma_5=tablet	lib=lodine	pos_11=NN	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	relType_7=ccomp	relType_3=compound	lemma_3=capsule	path1=warfarin_nmod<administration_nsubj	path=warfarin_nmod<administration_nsubj<result_ccomp>binding_obl>warfarin_nmod	lemma_7=result	lemma_2=(	lemma_1=and
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e0	DDI-DrugBank.d219.s23.e4	null	relType_1=cc	pos_7=VBZ	pos_2=NN	pos_14=CC	lemma_13=,	lemma_17=no	lemma_23=free	relType_17=det	pos_3=NNS	lemma_10=protein	pos_22=IN	pos_10=NN	pos_13=NN	pos_18=NN	path2=be_conj>change_nsubj>clearance_nmod>warfarin_nmod	relation_20=neutral	lemma_4=and	lemma_3=capsule	lemma_2=(	relType_8=case	wib=Lodine	pos_13=,	lemma_18=change	relType_2=punct	lemma_15=there	lemma_8=in	lemma_19=in	pos_2=-LRB-	lemma_20=the	relType_22=case	relType_2=conj	lemma_11=binding	pos_8=IN	pos_12=IN	lemma_9=reduce	lemma_2=lodine	pos_6=-RRB-	lib=lodine	pos_11=NN	relType_19=case	relType_3=compound	lemma_7=result	lemma_1=and	lemma_22=of	pos_23=JJ	pos_17=DT	pos_15=EX	relType_12=case	relType_21=nmod	relType_23=amod	lemma_12=of	lpib=lodine_NN	relType_3=appos	relType_9=amod	lemma_16=be	lemma_6=)	relType_5=conj	relType_11=obl	lemma_21=clearance	pos_4=CC	relType_7=ccomp	relType_18=nsubj	relType_20=det	relType_15=expl	pos_19=IN	pos_1=CC	path1=warfarin_nmod<administration_nsubj<result_ccomp	pos_16=VBD	relType_13=punct	relType_4=cc	pos_20=DT	relType_13=nmod	lemma_13=warfarin	pos_5=NNS	relType_6=punct	relType_10=compound	pos_9=VBN	lemma_14=but	relation_10=adverse	lemma_3=etodolac	relType_14=cc	lemma_5=tablet	eib=True	pos_3=NN	path=warfarin_nmod<administration_nsubj<result_ccomp<demonstrate_ROOT>be_conj>change_nsubj>clearance_nmod>warfarin_nmod	relType_16=conj	pos_21=NN
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e1	DDI-DrugBank.d219.s23.e2	null	lemma_1=(	lib=etodolac	path1=lodine_conj<warfarin_nmod	wib=etodolac	lpib=etodolac_NN	eib=False	path=lodine_conj<warfarin_nmod<administration_nsubj>capsule_appos>etodolac_compound	relType_1=punct	path2=capsule_appos>etodolac_compound	pos_1=-LRB-
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e1	DDI-DrugBank.d219.s23.e3	null	path=lodine_conj<warfarin_nmod<administration_nsubj<result_ccomp>binding_obl>warfarin_nmod	pos_2=NN	relType_7=case	pos_3=CC	relType_8=amod	pos_8=VBN	path2=binding_obl>warfarin_nmod	pos_6=VBZ	lemma_9=protein	relType_11=case	relType_3=cc	lemma_1=(	relType_9=compound	relation_8=adverse	lemma_8=reduce	path1=lodine_conj<warfarin_nmod<administration_nsubj	pos_10=NN	pos_9=NN	pos_4=NNS	lemma_5=)	pos_11=IN	wib=etodolac	pos_5=-RRB-	lemma_4=tablet	relType_2=compound	relType_5=punct	relType_6=ccomp	relType_2=appos	lemma_2=etodolac	pos_1=-LRB-	lemma_6=result	lemma_2=capsule	pos_2=NNS	lib=etodolac	lpib=etodolac_NN	eib=True	pos_7=IN	lemma_7=in	lemma_11=of	lemma_3=and	relType_4=conj	lemma_10=binding	relType_1=punct	relType_10=obl
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e1	DDI-DrugBank.d219.s23.e4	null	pos_2=NN	pos_3=CC	pos_16=DT	pos_6=VBZ	relType_18=case	pos_14=EX	lemma_12=,	pos_12=,	pos_20=NN	relType_20=nmod	lemma_17=change	pos_10=NN	lemma_20=clearance	path2=be_conj>change_nsubj>clearance_nmod>warfarin_nmod	wib=etodolac	pos_5=-RRB-	lemma_4=tablet	relType_21=case	pos_1=-LRB-	lemma_6=result	lemma_2=capsule	pos_7=IN	lemma_7=in	lemma_18=in	relType_19=det	path=lodine_conj<warfarin_nmod<administration_nsubj<result_ccomp<demonstrate_ROOT>be_conj>change_nsubj>clearance_nmod>warfarin_nmod	relType_7=case	pos_8=VBN	relType_11=case	relType_3=cc	relType_12=nmod	lemma_8=reduce	relType_12=punct	pos_9=NN	lemma_5=)	relType_13=cc	relType_6=ccomp	pos_15=VBD	lemma_3=and	relType_1=punct	lemma_21=of	pos_19=DT	path1=lodine_conj<warfarin_nmod<administration_nsubj<result_ccomp	lemma_12=warfarin	lemma_9=protein	lemma_1=(	pos_17=NN	relation_8=adverse	relType_17=nsubj	pos_21=IN	pos_18=IN	pos_11=IN	pos_13=CC	pos_22=JJ	lemma_15=be	relType_22=amod	relType_15=conj	lemma_11=of	lemma_22=free	relType_10=obl	relType_14=expl	relType_8=amod	relation_18=neutral	lemma_16=no	relType_16=det	relType_9=compound	lemma_19=the	pos_4=NNS	lemma_13=but	relType_2=compound	relType_5=punct	relType_2=appos	lemma_2=etodolac	pos_2=NNS	lib=etodolac	lpib=etodolac_NN	eib=True	lemma_14=there	relType_4=conj	lemma_10=binding	pos_12=NN
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e2	DDI-DrugBank.d219.s23.e3	null	pos_5=VBZ	path2=binding_obl>warfarin_nmod	lemma_10=of	lemma_1=capsule	relType_9=obl	relType_2=cc	relType_6=case	pos_8=NN	path=etodolac_compound<capsule_appos<administration_nsubj<result_ccomp>binding_obl>warfarin_nmod	lemma_2=and	lemma_3=tablet	pos_3=NNS	eib=False	pos_6=IN	lemma_8=protein	pos_4=-RRB-	relation_6=adverse	wib=capsules	lemma_5=result	relType_10=case	lpib=capsule_NNS	lemma_6=in	pos_9=NN	lemma_7=reduce	relType_1=appos	relType_7=amod	relType_4=punct	lib=capsule	relType_3=conj	relType_8=compound	lemma_4=)	pos_10=IN	path1=etodolac_compound<capsule_appos<administration_nsubj	relType_5=ccomp	pos_7=VBN	pos_1=NNS	lemma_9=binding	pos_2=CC
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e2	DDI-DrugBank.d219.s23.e4	null	pos_5=VBZ	lemma_11=,	lemma_11=warfarin	pos_21=JJ	relType_12=cc	lemma_10=of	lemma_1=capsule	relType_9=obl	pos_12=CC	relType_2=cc	relType_6=case	pos_20=IN	pos_17=IN	pos_8=NN	lemma_2=and	pos_18=DT	lemma_3=tablet	lemma_13=there	pos_3=NNS	relType_19=nmod	relType_20=case	path1=etodolac_compound<capsule_appos<administration_nsubj<result_ccomp	pos_6=IN	lemma_8=protein	pos_4=-RRB-	relType_11=punct	relation_6=adverse	relType_21=amod	wib=capsules	lemma_5=result	relType_10=case	lpib=capsule_NNS	lemma_6=in	pos_9=NN	pos_15=DT	pos_19=NN	relType_17=case	lemma_14=be	path2=be_conj>change_nsubj>clearance_nmod>warfarin_nmod	lemma_7=reduce	relType_1=appos	relType_7=amod	relType_4=punct	pos_13=EX	lemma_16=change	lib=capsule	relType_3=conj	path=etodolac_compound<capsule_appos<administration_nsubj<result_ccomp<demonstrate_ROOT>be_conj>change_nsubj>clearance_nmod>warfarin_nmod	relType_8=compound	relType_16=nsubj	lemma_4=)	pos_10=IN	pos_11=,	pos_16=NN	lemma_17=in	relType_13=expl	relType_5=ccomp	pos_7=VBN	lemma_12=but	pos_11=NN	pos_1=NNS	eib=True	lemma_19=clearance	lemma_15=no	relation_16=neutral	lemma_9=binding	pos_2=CC	pos_14=VBD	relType_18=det	relType_11=nmod	relType_15=det	relType_14=conj	lemma_21=free	lemma_18=the	lemma_20=of
DDI-DrugBank.d219.s23	DDI-DrugBank.d219.s23.e3	DDI-DrugBank.d219.s23.e4	null	lemma_1=,	lemma_6=change	relType_7=case	lemma_4=be	pos_8=DT	pos_1=,	lemma_10=of	relType_2=cc	pos_3=EX	relType_9=nmod	pos_6=NN	eib=False	lemma_3=there	relation_5=neutral	relType_11=amod	lemma_2=but	relType_10=case	pos_9=NN	lemma_9=clearance	path2=be_conj>change_nsubj>clearance_nmod>warfarin_nmod	lib=be	lemma_8=the	relType_5=det	path=warfarin_nmod<binding_obl<result_ccomp<demonstrate_ROOT>be_conj>change_nsubj>clearance_nmod>warfarin_nmod	pos_10=IN	lemma_5=no	wib=was	relType_3=expl	path1=warfarin_nmod<binding_obl<result_ccomp	pos_4=VBD	pos_7=IN	lemma_7=in	pos_2=CC	pos_5=DT	relType_4=conj	pos_11=JJ	lemma_11=free	relType_8=det	relType_1=punct	lpib=be_VBD	relType_6=nsubj
DDI-DrugBank.d219.s24	DDI-DrugBank.d219.s24.e0	DDI-DrugBank.d219.s24.e1	null	lemma_2=alone	pos_2=RB	path=warfarin_nmod<effect_nmod<difference_nsubj<administer_ccomp>administer_conj>warfarin_nsubj	pos_1=VBN	eib=False	path2=administer_conj>warfarin_nsubj	relType_2=advmod	path1=warfarin_nmod<effect_nmod<difference_nsubj	pos_3=CC	relType_1=ccomp	lemma_3=and	lemma_1=administer	lpib=administer_VBN	lib=administer	wib=administered	relType_3=cc
DDI-DrugBank.d219.s24	DDI-DrugBank.d219.s24.e0	DDI-DrugBank.d219.s24.e2	null	lemma_2=alone	pos_1=VBN	pos_3=CC	lemma_4=administer	path=warfarin_nmod<effect_nmod<difference_nsubj<administer_ccomp>administer_conj>lodine_obl	lemma_1=administer	relType_5=case	relType_3=cc	pos_2=RB	relType_2=advmod	path1=warfarin_nmod<effect_nmod<difference_nsubj	lemma_5=with	relType_4=nsubj	pos_4=NN	pos_4=VBN	relType_1=ccomp	pos_5=IN	lib=administer	wib=administered	eib=True	lemma_3=and	relType_4=conj	lpib=administer_VBN	lemma_4=warfarin	path2=administer_conj>lodine_obl
DDI-DrugBank.d219.s24	DDI-DrugBank.d219.s24.e1	DDI-DrugBank.d219.s24.e2	null	pos_2=IN	path2=lodine_obl	relType_2=case	lemma_2=with	pos_1=VBN	eib=False	path1=warfarin_nsubj	path=warfarin_nsubj<administer_conj>lodine_obl	lemma_1=administer	lpib=administer_VBN	relType_1=conj	lib=administer	wib=administered
DDI-DrugBank.d219.s25	DDI-DrugBank.d219.s25.e0	DDI-DrugBank.d219.s25.e1	null	relType_1=cc	lib=lodine	wib=Lodine	lpib=lodine_NN	pos_1=CC	eib=False	path1=	path2=lodine_conj	lemma_1=and	path=<warfarin_nmod>lodine_conj
DDI-DrugBank.d219.s26	DDI-DrugBank.d219.s26.e0	DDI-DrugBank.d219.s26.e1	effect	pos_2=VBN	lemma_4=receive	pos_1=HYPH	wib=treated	relType_4=acl	pos_3=NNS	eib=False	path1=etodolac_obl<treat_amod	lemma_2=treat	pos_5=JJ	lpib=treat_VBN	lemma_5=concomitant	relType_5=amod	lib=treat	relType_2=amod	lemma_1=-	pos_4=VBG	relType_3=obl	path=etodolac_obl<treat_amod<patient_obl>receive_acl>therapy_obj>warfarin_compound	path2=receive_acl>therapy_obj>warfarin_compound	relType_1=punct	lemma_3=patient
DDI-DrugBank.d219.s27	DDI-DrugBank.d219.s27.e0	DDI-DrugBank.d219.s27.e1	null	lpib=give_VB	relType_8=case	relType_4=amod	pos_4=JJ	pos_6=JJ	relType_1=aux	relType_13=punct	pos_16=DT	lemma_4=false	lemma_8=for	lemma_19=phenolic	relType_16=det	lemma_12=urobilin	lib=give	lemma_7=reaction	lemma_16=the	relType_18=case	pos_9=JJ	pos_17=NN	relType_10=nmod	eib=False	relType_6=amod	relType_7=obj	pos_11=-LRB-	pos_5=HYPH	relType_11=punct	path2=presence_nmod>metabolite_nmod>etodolac_nmod	lemma_2=give	pos_2=VB	relType_9=amod	pos_12=NN	pos_10=NN	relType_3=det	lemma_3=a	relType_15=fixed	lemma_15=to	pos_8=IN	pos_18=IN	pos_14=IN	lemma_18=of	pos_21=IN	relType_2=acl:relcl	lemma_20=metabolite	lemma_1=can	pos_19=JJ	relType_5=punct	lemma_21=of	relType_20=nmod	lemma_11=(	pos_20=NNS	pos_1=MD	relType_19=amod	relType_17=nmod	pos_13=-RRB-	relType_21=case	pos_15=IN	lemma_6=positive	path1=lodine_obj<take_nsubj<give_acl:relcl<patient_nmod<urine_dep	lemma_9=urinary	lemma_10=bilirubin	lemma_17=presence	wib=give	pos_3=DT	relType_12=dep	lemma_13=)	relType_14=case	lemma_14=due	lemma_5=-	pos_7=NN	path=lodine_obj<take_nsubj<give_acl:relcl<patient_nmod<urine_dep<interaction_ROOT>presence_nmod>metabolite_nmod>etodolac_nmod
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e0	DDI-DrugBank.d104.s0.e1	effect	lemma_3=slightly	pos_3=RB	relType_3=advmod	relType_1=aux	lemma_1=may	lemma_6=of	relType_6=case	relation_1=beneficial	pos_6=IN	path=fenfluramine_nsubj<increase_ROOT>effect_obj>drug_nmod	pos_2=VB	lib=increase	lemma_2=increase	lemma_5=effect	pos_4=DT	relType_7=amod	relType_2=ROOT	lemma_4=the	wib=increase	pos_1=MD	lemma_7=antihypertensive	pos_5=NN	eib=True	lpib=increase_VB	relType_5=obj	pos_7=JJ	path2=effect_obj>drug_nmod	relation_4=neutral	path1=fenfluramine_nsubj	relType_4=det
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e0	DDI-DrugBank.d104.s0.e2	effect	pos_7=NNS	lemma_3=slightly	relType_10=punct	pos_3=RB	relType_3=advmod	relType_9=conj	relType_1=aux	lemma_1=may	lemma_10=,	path=fenfluramine_nsubj<increase_ROOT>effect_obj>drug_nmod>guanethidine_conj	lemma_6=of	relType_6=case	relation_1=beneficial	pos_8=NN	pos_6=IN	pos_7=,	pos_2=VB	lemma_7=,	pos_9=NN	lib=increase	path2=effect_obj>drug_nmod>guanethidine_conj	lemma_2=increase	lemma_5=effect	pos_4=DT	relType_7=amod	relType_2=ROOT	lemma_4=the	relType_8=compound	relType_7=nmod	wib=increase	pos_1=MD	lemma_7=antihypertensive	pos_5=NN	pos_10=,	eib=True	lpib=increase_VB	lemma_9=g.	relType_5=obj	relType_7=punct	pos_7=JJ	lemma_8=e.	lemma_7=drug	path1=fenfluramine_nsubj	relation_4=neutral	relType_4=det
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e0	DDI-DrugBank.d104.s0.e3	effect	pos_7=NNS	lemma_3=slightly	relType_10=punct	pos_3=RB	relType_3=advmod	relType_9=conj	relType_1=aux	lemma_1=may	lemma_11=,	lemma_10=,	lemma_6=of	relType_6=case	relType_11=conj	relation_1=beneficial	pos_8=NN	pos_6=IN	relType_11=punct	pos_7=,	pos_2=VB	lemma_7=,	pos_9=NN	lib=increase	lemma_2=increase	lemma_5=effect	pos_4=DT	relType_7=amod	path=fenfluramine_nsubj<increase_ROOT>effect_obj>drug_nmod>methyldopa_conj	relType_2=ROOT	lemma_4=the	relType_8=compound	relType_7=nmod	wib=increase	pos_1=MD	pos_11=,	lemma_7=antihypertensive	pos_5=NN	pos_11=NN	pos_10=,	eib=True	lpib=increase_VB	lemma_9=g.	relType_5=obj	relType_7=punct	pos_7=JJ	lemma_8=e.	lemma_7=drug	path1=fenfluramine_nsubj	relation_4=neutral	relType_4=det	lemma_11=guanethidine	path2=effect_obj>drug_nmod>methyldopa_conj
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e0	DDI-DrugBank.d104.s0.e4	effect	pos_7=NNS	lemma_3=slightly	relType_12=conj	relType_10=punct	pos_3=RB	relType_3=advmod	relType_9=conj	relType_1=aux	lemma_1=may	lemma_11=,	lemma_10=,	lemma_6=of	lemma_12=methyldopa	relType_6=case	relType_11=conj	relation_1=beneficial	pos_8=NN	lemma_12=,	pos_6=IN	relType_11=punct	pos_12=,	pos_7=,	pos_12=NN	pos_2=VB	relType_12=punct	lemma_7=,	path=fenfluramine_nsubj<increase_ROOT>effect_obj>drug_nmod>reserpine_appos	lib=increase	pos_9=NN	lemma_2=increase	lemma_5=effect	pos_4=DT	relType_7=amod	relType_2=ROOT	lemma_4=the	relType_8=compound	path2=effect_obj>drug_nmod>reserpine_appos	relType_7=nmod	wib=increase	pos_1=MD	pos_11=,	lemma_7=antihypertensive	pos_5=NN	pos_11=NN	pos_10=,	eib=True	lpib=increase_VB	lemma_9=g.	relType_5=obj	relType_7=punct	pos_7=JJ	lemma_8=e.	lemma_7=drug	path1=fenfluramine_nsubj	relation_4=neutral	relType_4=det	lemma_11=guanethidine
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e1	DDI-DrugBank.d104.s0.e2	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	lib=e.	lemma_3=g.	eib=False	pos_4=,	path2=guanethidine_conj	relType_4=punct	relType_3=conj	relType_2=compound	path=<drug_nmod>guanethidine_conj	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_3=NN	relType_1=punct
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e1	DDI-DrugBank.d104.s0.e3	null	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lib=e.	path2=methyldopa_conj	lemma_3=g.	pos_4=,	path=<drug_nmod>methyldopa_conj	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_5=NN	lemma_5=guanethidine	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e1	DDI-DrugBank.d104.s0.e4	null	lemma_6=methyldopa	lemma_1=,	pos_2=NN	pos_5=,	path1=	pos_1=,	lemma_6=,	lib=e.	pos_6=NN	relType_6=conj	lemma_3=g.	pos_4=,	relType_6=punct	relType_4=punct	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	path2=reserpine_appos	lemma_5=guanethidine	eib=True	pos_3=NN	path=<drug_nmod>reserpine_appos	relType_1=punct
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e2	DDI-DrugBank.d104.s0.e3	null	path1=guanethidine_conj	lemma_1=,	lib=methyldopa	eib=False	pos_1=,	path=guanethidine_conj<drug_nmod>methyldopa_conj	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	path2=methyldopa_conj
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e2	DDI-DrugBank.d104.s0.e4	null	path1=guanethidine_conj	path2=reserpine_appos	lemma_1=,	pos_2=NN	lib=methyldopa	eib=True	lemma_2=methyldopa	pos_1=,	pos_2=,	lpib=methyldopa_NN	relType_1=punct	wib=methyldopa	relType_2=conj	lemma_2=,	relType_2=punct	path=guanethidine_conj<drug_nmod>reserpine_appos
DDI-DrugBank.d104.s0	DDI-DrugBank.d104.s0.e3	DDI-DrugBank.d104.s0.e4	null	path2=reserpine_appos	lemma_1=,	eib=False	path1=methyldopa_conj	lib=reserpine	pos_1=,	wib=reserpine	relType_1=punct	path=methyldopa_conj<drug_nmod>reserpine_appos	lpib=reserpine_NN
DDI-DrugBank.d104.s1	DDI-DrugBank.d104.s1.e0	DDI-DrugBank.d104.s1.e1	advise	pos_7=NNS	relType_1=aux	pos_3=VBN	lemma_1=should	relType_6=case	wib=be	lemma_3=use	eib=False	path1=drug_nsubj:pass	pos_6=IN	lemma_7=patient	pos_2=VB	lemma_6=in	lemma_5=caution	lemma_4=with	lib=be	relType_3=ROOT	pos_4=IN	pos_8=VBG	relType_4=case	relType_2=aux:pass	path2=patient_obl>take_acl>fenfluramine_obj	relType_5=obl	lemma_8=take	pos_1=MD	relType_8=acl	lpib=be_VB	pos_5=NN	relType_7=obl	lemma_2=be	path=drug_nsubj:pass<use_ROOT>patient_obl>take_acl>fenfluramine_obj
DDI-DrugBank.d546.s0	DDI-DrugBank.d546.s0.e0	DDI-DrugBank.d546.s0.e1	null	relType_3=nsubj:pass	pos_2=JJ	lib=concomitant	path2=avoid_parataxis>use_nsubj:pass>fenoldopam_nmod	wib=Concomitant	path1=blocker_nmod	lemma_3=use	eib=False	lpib=concomitant_JJ	lemma_1=:	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	pos_3=NN	relType_1=punct	lemma_4=of	path=blocker_nmod<interaction_ROOT>avoid_parataxis>use_nsubj:pass>fenoldopam_nmod
DDI-DrugBank.d546.s0	DDI-DrugBank.d546.s0.e0	DDI-DrugBank.d546.s0.e2	null	relType_3=nsubj:pass	pos_2=JJ	relType_5=case	pos_6=HYPH	pos_6=NN	lib=concomitant	path=blocker_nmod<interaction_ROOT>avoid_parataxis>use_nsubj:pass>blocker_nmod	wib=Concomitant	path1=blocker_nmod	lemma_3=use	relType_6=punct	path2=avoid_parataxis>use_nsubj:pass>blocker_nmod	lemma_5=with	lemma_6=beta	lpib=concomitant_JJ	lemma_1=:	lemma_6=-	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_5=fenoldopam	relType_5=nmod	pos_5=IN	pos_5=NN	relType_6=compound	eib=True	pos_3=NN	relType_1=punct	lemma_4=of
DDI-DrugBank.d546.s0	DDI-DrugBank.d546.s0.e1	DDI-DrugBank.d546.s0.e2	advise	lemma_1=with	path2=blocker_nmod	relType_1=case	pos_2=NN	eib=True	lemma_2=-	path1=fenoldopam_nmod	relType_2=compound	wib=beta	pos_2=HYPH	pos_1=IN	lib=beta	path=fenoldopam_nmod<use_nsubj:pass>blocker_nmod	lpib=beta_NN	relType_2=punct	lemma_2=beta
DDI-DrugBank.d546.s2	DDI-DrugBank.d546.s2.e0	DDI-DrugBank.d546.s2.e1	null	pos_2=VBN	lemma_6=drug	lpib=have_VBZ	relType_1=aux	relType_7=case	pos_3=VBN	relType_5=case	relType_6=obl	pos_4=RB	lemma_7=such	lemma_8=as	eib=False	lemma_4=safely	lemma_3=administer	lemma_5=with	lemma_1=have	lib=have	pos_8=IN	path=fenoldopam_nsubj:pass<administer_parataxis>drug_obl>digitalis_nmod	relType_4=advmod	path2=drug_obl>digitalis_nmod	relType_2=aux:pass	pos_5=IN	relType_3=parataxis	path1=fenoldopam_nsubj:pass	pos_1=VBZ	pos_7=JJ	pos_6=NNS	relType_8=fixed	lemma_2=be	wib=has
DDI-DrugBank.d546.s2	DDI-DrugBank.d546.s2.e0	DDI-DrugBank.d546.s2.e2	null	pos_2=VBN	lemma_6=drug	lpib=have_VBZ	relType_1=aux	relType_7=case	pos_3=VBN	relType_10=amod	relType_9=nmod	relType_5=case	relType_6=obl	pos_4=RB	lemma_7=such	lemma_8=as	lemma_4=safely	lemma_3=administer	lemma_5=with	lemma_1=have	pos_9=NN	lib=have	pos_8=IN	path2=drug_obl>digitalis_nmod>nitroglycerin_conj	lemma_9=and	pos_9=CC	pos_10=JJ	lemma_9=digitalis	relType_4=advmod	relType_2=aux:pass	pos_5=IN	relType_3=parataxis	path1=fenoldopam_nsubj:pass	lemma_10=sublingual	pos_1=VBZ	eib=True	pos_7=JJ	pos_6=NNS	relType_8=fixed	lemma_2=be	path=fenoldopam_nsubj:pass<administer_parataxis>drug_obl>digitalis_nmod>nitroglycerin_conj	wib=has	relType_9=cc
DDI-DrugBank.d546.s2	DDI-DrugBank.d546.s2.e1	DDI-DrugBank.d546.s2.e2	null	relType_1=cc	pos_1=CC	lpib=sublingual_JJ	lemma_2=sublingual	eib=False	relType_2=amod	path1=	path2=nitroglycerin_conj	lib=sublingual	path=<digitalis_nmod>nitroglycerin_conj	pos_2=JJ	lemma_1=and	wib=sublingual
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e0	DDI-DrugBank.d546.s3.e1	null	relType_1=case	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	lemma_3=-	lemma_3=alpha	path=<agent_nmod>blocker_nmod	lpib=such_JJ	path2=blocker_nmod	relType_2=fixed	wib=such	eib=True	lemma_1=such	pos_3=NN	pos_3=HYPH	relType_3=compound	lib=such	relType_3=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e0	DDI-DrugBank.d546.s3.e2	null	relType_1=case	path1=	lemma_4=channel	lemma_4=-	pos_1=JJ	pos_4=HYPH	lemma_2=as	lemma_3=blocker	pos_2=IN	pos_3=NNS	path=<agent_nmod>blocker_nmod>blocker_conj	lemma_3=-	lemma_3=alpha	pos_4=NN	lpib=such_JJ	relType_4=punct	lemma_3=,	path2=blocker_nmod>blocker_conj	relType_4=compound	relType_3=nmod	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_4=calcium	lemma_1=such	pos_3=NN	pos_3=HYPH	relType_3=compound	lib=such	relType_3=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e0	DDI-DrugBank.d546.s3.e3	null	relType_1=case	path1=	lemma_4=channel	lemma_4=-	relType_5=compound	pos_1=JJ	pos_4=HYPH	lemma_2=as	lemma_3=blocker	pos_2=IN	pos_3=NNS	path=<agent_nmod>blocker_nmod>inhibitor_conj	pos_4=,	lemma_3=-	lemma_3=alpha	lemma_4=blocker	pos_4=NN	pos_4=NNS	lpib=such_JJ	relType_4=punct	lemma_3=,	relType_4=compound	relType_3=nmod	path2=blocker_nmod>inhibitor_conj	lemma_4=,	pos_5=NN	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_4=calcium	lemma_1=such	pos_3=NN	pos_3=HYPH	relType_4=conj	relType_3=compound	lib=such	lemma_5=ace	relType_3=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e0	DDI-DrugBank.d546.s3.e4	null	relType_1=case	pos_5=,	lemma_5=inhibitor	path1=	lemma_4=channel	lemma_4=-	relType_5=compound	pos_1=JJ	pos_4=HYPH	lemma_2=as	lemma_3=blocker	pos_2=IN	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_3=-	lemma_3=alpha	lemma_4=blocker	pos_4=NN	pos_4=NNS	lpib=such_JJ	relType_4=punct	lemma_3=,	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	relType_4=compound	relType_3=nmod	lemma_4=,	relType_5=conj	path=<agent_nmod>blocker_nmod>diuretic_conj	pos_5=NN	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_4=calcium	lemma_1=such	pos_3=NN	pos_3=HYPH	relType_4=conj	relType_3=compound	lib=such	lemma_5=ace	path2=blocker_nmod>diuretic_conj	relType_3=punct	relType_6=cc
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e0	DDI-DrugBank.d546.s3.e5	null	pos_7=NNS	relType_1=case	lemma_7=(	path2=blocker_nmod>like_dep>thiazide_amod	pos_5=,	lemma_5=inhibitor	path1=	lemma_4=channel	lemma_4=-	relType_5=compound	pos_1=JJ	pos_4=HYPH	lemma_2=as	lemma_3=blocker	pos_2=IN	pos_7=-LRB-	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_3=-	lemma_3=alpha	pos_8=CC	lemma_4=blocker	pos_4=NN	pos_4=NNS	lpib=such_JJ	relType_4=punct	path=<agent_nmod>blocker_nmod>like_dep>thiazide_amod	lemma_3=,	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	relType_4=compound	relType_3=nmod	lemma_4=,	relType_5=conj	pos_5=NN	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_4=calcium	lemma_1=such	pos_3=NN	pos_3=HYPH	lemma_7=diuretic	relType_7=punct	relType_8=cc:preconj	relType_4=conj	relType_3=compound	lib=such	lemma_5=ace	relType_3=punct	lemma_8=both	relType_7=conj	relType_6=cc
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e1	DDI-DrugBank.d546.s3.e2	null	path2=blocker_conj	lemma_2=calcium	path=<blocker_nmod>blocker_conj	lemma_1=,	pos_2=NN	lemma_2=channel	eib=True	lemma_2=-	lpib=calcium_NN	wib=calcium	relType_2=compound	path1=	pos_1=,	relType_1=punct	pos_2=HYPH	lib=calcium	relType_2=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e1	DDI-DrugBank.d546.s3.e3	null	lemma_1=,	pos_2=NN	wib=calcium	path1=	pos_1=,	pos_2=HYPH	relType_2=punct	lemma_2=-	path=<blocker_nmod>inhibitor_conj	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_2=channel	relType_2=compound	lemma_3=ace	pos_2=NNS	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_3=NN	pos_2=,	path2=inhibitor_conj	relType_3=compound	relType_1=punct	lib=calcium
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e1	DDI-DrugBank.d546.s3.e4	null	lemma_1=,	pos_2=NN	wib=calcium	path2=diuretic_conj	path1=	pos_1=,	relType_4=cc	pos_2=HYPH	relType_2=punct	pos_3=NNS	lemma_2=-	relType_2=conj	lemma_3=inhibitor	lemma_2=,	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_3=conj	relType_2=compound	path=<blocker_nmod>diuretic_conj	lemma_3=ace	pos_2=NNS	pos_3=,	lemma_2=blocker	eib=True	pos_4=CC	lpib=calcium_NN	pos_3=NN	lemma_4=and	pos_2=,	relType_3=compound	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e1	DDI-DrugBank.d546.s3.e5	null	lemma_1=,	pos_2=NN	wib=calcium	path1=	pos_1=,	relType_4=cc	pos_2=HYPH	relType_2=punct	pos_3=NNS	lemma_2=-	pos_5=NNS	lemma_5=(	relType_2=conj	lemma_3=inhibitor	lemma_2=,	lemma_2=calcium	lemma_2=channel	lemma_3=,	pos_6=CC	relType_3=conj	relType_2=compound	relType_5=punct	lemma_3=ace	relType_5=conj	relType_6=cc:preconj	pos_2=NNS	pos_3=,	lemma_2=blocker	eib=True	pos_4=CC	lpib=calcium_NN	pos_3=NN	lemma_4=and	pos_2=,	relType_3=compound	lemma_5=diuretic	relType_1=punct	pos_5=-LRB-	lib=calcium	relType_3=punct	path2=like_dep>thiazide_amod	lemma_6=both	path=<blocker_nmod>like_dep>thiazide_amod
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e2	DDI-DrugBank.d546.s3.e3	null	path=blocker_conj<blocker_nmod>inhibitor_conj	lemma_1=,	pos_2=NN	eib=True	relType_2=compound	pos_1=,	lib=ace	wib=ACE	path2=inhibitor_conj	lpib=ace_NN	path1=blocker_conj	relType_1=punct	lemma_2=ace
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e2	DDI-DrugBank.d546.s3.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	path2=diuretic_conj	path=blocker_conj<blocker_nmod>diuretic_conj	pos_1=,	wib=ACE	path1=blocker_conj	relType_2=punct	lemma_2=inhibitor	relType_3=cc	relType_2=conj	lemma_2=ace	lemma_2=,	relType_2=compound	lib=ace	pos_2=NNS	eib=True	pos_2=,	lemma_3=and	lpib=ace_NN	relType_1=punct
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e2	DDI-DrugBank.d546.s3.e5	null	lemma_1=,	pos_2=NN	pos_5=CC	pos_3=CC	pos_1=,	wib=ACE	path1=blocker_conj	relType_2=punct	lemma_2=inhibitor	path=blocker_conj<blocker_nmod>like_dep>thiazide_amod	relType_3=cc	lemma_4=diuretic	pos_4=-LRB-	relType_2=conj	lemma_2=ace	lemma_2=,	pos_4=NNS	lemma_4=(	lemma_5=both	relType_4=punct	relType_2=compound	lib=ace	pos_2=NNS	eib=True	pos_2=,	lemma_3=and	relType_4=conj	lpib=ace_NN	relType_1=punct	relType_5=cc:preconj	path2=like_dep>thiazide_amod
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e3	DDI-DrugBank.d546.s3.e4	null	lemma_2=and	lemma_1=,	wib=diuretics	eib=False	path2=diuretic_conj	lib=diuretic	pos_2=CC	pos_1=,	path1=inhibitor_conj	path=inhibitor_conj<blocker_nmod>diuretic_conj	relType_1=punct	relType_2=cc	lpib=diuretic_NNS
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e3	DDI-DrugBank.d546.s3.e5	null	lemma_1=,	wib=diuretics	pos_1=,	relType_2=cc	lemma_3=diuretic	lemma_2=and	pos_3=NNS	lemma_3=(	path1=inhibitor_conj	pos_3=-LRB-	path=inhibitor_conj<blocker_nmod>like_dep>thiazide_amod	relType_3=conj	lib=diuretic	lpib=diuretic_NNS	eib=True	pos_4=CC	pos_2=CC	lemma_4=both	relType_1=punct	relType_4=cc:preconj	relType_3=punct	path2=like_dep>thiazide_amod
DDI-DrugBank.d546.s3	DDI-DrugBank.d546.s3.e4	DDI-DrugBank.d546.s3.e5	null	lemma_1=(	lemma_2=both	eib=False	path1=diuretic_conj	pos_2=CC	relType_2=cc:preconj	lib=thiazide	path=diuretic_conj<blocker_nmod>like_dep>thiazide_amod	relType_1=punct	lpib=thiazide_JJ	path2=like_dep>thiazide_amod	pos_1=-LRB-	wib=thiazide
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e1	null	lib=coumarin	lemma_1=,	pos_2=NN	eib=True	wib=Coumarin	lemma_2=-	path=<hypoglycemic_parataxis>anticoagulant_conj	relType_2=compound	lpib=coumarin_NN	path2=anticoagulant_conj	path1=	pos_1=,	lemma_2=coumarin	lemma_2=type	relType_1=punct	pos_2=HYPH	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e2	null	lib=coumarin	lemma_1=,	pos_2=NN	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_2=HYPH	path=<hypoglycemic_parataxis>Phenytoin_conj	relType_2=punct	path2=Phenytoin_conj	lemma_2=-	relType_2=conj	lemma_2=,	wib=Coumarin	relType_2=compound	lpib=coumarin_NN	pos_2=NNS	eib=True	pos_2=,	relType_1=punct	lemma_2=anticoagulant
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e3	null	lib=coumarin	lemma_1=,	pos_2=NN	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	pos_2=HYPH	relType_2=punct	lemma_2=-	path2=Cyclosporine_conj	relType_2=conj	lemma_2=,	lemma_3=,	wib=Coumarin	relType_3=conj	relType_2=compound	lpib=coumarin_NN	path=<hypoglycemic_parataxis>Cyclosporine_conj	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e4	null	lib=coumarin	lemma_1=,	pos_2=NN	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	pos_2=HYPH	relType_2=punct	path2=Rifampin_conj	lemma_2=-	pos_4=,	lemma_4=Cyclosporine	relType_2=conj	lemma_2=,	path=<hypoglycemic_parataxis>Rifampin_conj	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	relType_2=compound	lpib=coumarin_NN	lemma_4=,	pos_2=NNS	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e5	null	lib=coumarin	lemma_1=,	pos_2=NN	pos_5=,	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	path=<hypoglycemic_parataxis>Theophylline_conj	pos_2=HYPH	relType_2=punct	lemma_2=-	pos_4=,	lemma_4=Cyclosporine	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_5=NNP	lemma_4=,	relType_5=conj	pos_2=NNS	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_3=Phenytoin	path2=Theophylline_conj	relType_3=punct	lemma_2=anticoagulant
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e6	null	lib=coumarin	lemma_1=,	pos_2=NN	pos_5=,	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	lemma_6=,	pos_2=HYPH	relType_2=punct	relType_6=conj	lemma_2=-	pos_4=,	pos_6=NNP	relType_6=punct	lemma_4=Cyclosporine	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	pos_2=NNS	pos_3=,	path=<hypoglycemic_parataxis>Terfenadine_conj	eib=True	lemma_6=Theophylline	path2=Terfenadine_conj	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e7	null	lib=coumarin	lemma_1=,	pos_2=NN	pos_5=,	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	lemma_6=,	pos_2=HYPH	relType_2=punct	relType_6=conj	lemma_7=Terfenadine	lemma_2=-	pos_4=,	pos_6=NNP	relType_6=punct	lemma_4=Cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	pos_2=NNS	path2=Cisapride_conj	pos_3=,	eib=True	lemma_6=Theophylline	relType_7=punct	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_3=Phenytoin	path=<hypoglycemic_parataxis>Cisapride_conj	relType_3=punct	lemma_2=anticoagulant	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e8	null	lib=coumarin	lemma_1=,	pos_2=NN	lemma_8=Cisapride	pos_5=,	lemma_2=type	path2=Astemizole_conj	path1=	pos_1=,	lemma_2=coumarin	pos_3=NNP	lemma_6=,	relType_8=punct	pos_2=HYPH	lemma_8=,	relType_2=punct	relType_6=conj	lemma_7=Terfenadine	lemma_2=-	pos_4=,	pos_6=NNP	relType_6=punct	lemma_4=Cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	pos_8=NNP	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	pos_2=NNS	pos_3=,	eib=True	lemma_6=Theophylline	relType_7=punct	pos_4=NNP	relType_8=conj	path=<hypoglycemic_parataxis>Astemizole_conj	pos_2=,	relType_4=conj	pos_8=,	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e9	null	lib=coumarin	lemma_1=,	pos_2=NN	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	pos_5=,	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_9=,	pos_2=HYPH	lemma_8=,	relType_2=punct	relType_6=conj	lemma_7=Terfenadine	lemma_2=-	pos_4=,	pos_6=NNP	relType_6=punct	lemma_4=Cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	pos_8=NNP	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	pos_2=NNS	path2=Rifabutin_conj	pos_3=,	eib=True	lemma_6=Theophylline	relType_7=punct	path=<hypoglycemic_parataxis>Rifabutin_conj	pos_4=NNP	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e10	null	lib=coumarin	lemma_1=,	relType_10=punct	pos_2=NN	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	pos_5=,	lemma_2=type	lemma_2=coumarin	path1=	pos_1=,	pos_3=NNP	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_10=,	lemma_9=,	pos_2=HYPH	lemma_8=,	lemma_10=Rifabutin	relType_2=punct	relType_6=conj	lemma_7=Terfenadine	lemma_2=-	pos_4=,	pos_6=NNP	path=<hypoglycemic_parataxis>Tacrolimus_conj	relType_6=punct	relType_10=conj	lemma_4=Cyclosporine	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	pos_8=NNP	relType_4=punct	lemma_3=,	wib=Coumarin	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lpib=coumarin_NN	lemma_5=Rifampin	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	relType_9=punct	pos_10=NNP	pos_6=,	pos_2=NNS	pos_3=,	pos_10=,	eib=True	lemma_6=Theophylline	path2=Tacrolimus_conj	relType_7=punct	pos_4=NNP	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	lemma_3=Phenytoin	relType_3=punct	lemma_2=anticoagulant	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e11	null	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_9=,	relType_6=conj	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_5=Rifampin	pos_3=,	pos_10=,	lemma_6=Theophylline	relType_8=conj	pos_2=,	lib=coumarin	lemma_1=,	lemma_12=short	path1=	pos_1=,	pos_3=NNP	lemma_10=Rifabutin	relType_2=punct	lemma_7=Terfenadine	lemma_2=-	relType_10=conj	relType_12=amod	relType_12=punct	relType_2=conj	lemma_12=-	lemma_2=,	wib=Coumarin	lpib=coumarin_NN	pos_5=NNP	lemma_4=,	relType_12=dep	pos_4=NNP	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	relType_10=punct	pos_12=VBG	lemma_11=,	lemma_2=type	lemma_3=Phenytoin	pos_2=HYPH	lemma_8=,	relType_11=conj	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	pos_8=NNP	relType_3=conj	relType_5=conj	pos_10=NNP	lemma_12=act	pos_12=HYPH	lemma_2=anticoagulant	relType_7=conj	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	lemma_2=coumarin	path=<hypoglycemic_parataxis>benzodiazepine_conj	pos_11=NNP	pos_12=JJ	relType_6=punct	lemma_4=Cyclosporine	path2=benzodiazepine_conj	relType_2=compound	relType_5=punct	pos_7=NNP	pos_11=,	relType_9=punct	pos_6=,	pos_2=NNS	eib=True	relType_7=punct	relType_4=conj	lemma_11=Tacrolimus
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e12	null	path2=hypoglycemic_appos	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_9=,	lemma_12=,	relType_6=conj	pos_12=,	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_5=Rifampin	pos_3=,	pos_10=,	lemma_6=Theophylline	relType_8=conj	pos_2=,	lib=coumarin	lemma_1=,	lemma_12=short	path1=	pos_1=,	pos_3=NNP	lemma_10=Rifabutin	relType_2=punct	lemma_7=Terfenadine	lemma_2=-	relType_10=conj	relType_13=amod	relType_12=amod	relType_12=punct	relType_2=conj	lemma_12=-	lemma_2=,	wib=Coumarin	lpib=coumarin_NN	lemma_13=oral	pos_5=NNP	lemma_4=,	lemma_12=benzodiazepine	relType_12=dep	pos_4=NNP	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	relType_10=punct	pos_12=VBG	lemma_11=,	lemma_2=type	pos_2=HYPH	lemma_8=,	relType_11=conj	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	lemma_11=Tacrolimus	pos_8=NNP	pos_13=JJ	relType_3=conj	relType_5=conj	pos_10=NNP	lemma_12=act	pos_12=HYPH	path=<hypoglycemic_parataxis>hypoglycemic_appos	lemma_2=anticoagulant	relType_7=conj	relType_12=conj	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	lemma_2=coumarin	pos_11=NNP	pos_12=JJ	relType_6=punct	lemma_4=Cyclosporine	pos_12=NNS	relType_2=compound	relType_5=punct	pos_7=NNP	pos_11=,	relType_9=punct	pos_6=,	pos_2=NNS	eib=True	relType_7=punct	relType_4=conj	lemma_3=Phenytoin
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e13	null	pos_2=NN	pos_5=,	lemma_10=,	pos_14=:	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_9=,	lemma_12=,	relType_6=conj	lemma_16=significant	relType_24=case	pos_12=,	lemma_7=,	path=<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_4=punct	lemma_3=,	lemma_5=,	lemma_22=the	lemma_5=Rifampin	pos_24=IN	relType_21=case	lemma_14=:	pos_3=,	pos_10=,	lemma_6=Theophylline	relType_8=conj	pos_2=,	pos_14=NNS	pos_15=RB	lib=coumarin	lemma_1=,	lemma_12=short	path1=	pos_1=,	pos_3=NNP	pos_20=VBN	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_10=Rifabutin	relType_2=punct	relType_16=amod	lemma_7=Terfenadine	lemma_19=be	lemma_2=-	relType_10=conj	relType_13=amod	relType_12=amod	relType_12=punct	relType_23=obl	relType_2=conj	lemma_12=-	lemma_2=,	wib=Coumarin	lpib=coumarin_NN	lemma_13=oral	pos_5=NNP	lemma_4=,	lemma_23=use	relType_19=aux:pass	pos_22=DT	lemma_12=benzodiazepine	relType_12=dep	lemma_14=hypoglycemic	pos_4=NNP	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	relType_14=punct	relType_10=punct	pos_12=VBG	lemma_11=,	lemma_2=type	lemma_3=Phenytoin	pos_2=HYPH	lemma_8=,	lemma_24=of	relType_11=conj	pos_23=NN	pos_17=NN	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	pos_21=IN	lemma_15=clinically	pos_8=NNP	pos_13=JJ	relType_3=conj	relType_5=conj	pos_10=NNP	lemma_21=by	lemma_12=act	relType_22=det	pos_19=VB	lemma_20=precipitate	pos_12=HYPH	relType_20=parataxis	lemma_2=anticoagulant	relType_7=conj	relType_12=conj	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	lemma_2=coumarin	pos_11=NNP	relType_17=nsubj:pass	pos_12=JJ	relType_6=punct	lemma_4=Cyclosporine	pos_16=JJ	lemma_18=may	relType_18=aux	pos_12=NNS	relType_2=compound	relType_5=punct	pos_7=NNP	lemma_17=hypoglycemia	relType_14=appos	pos_11=,	relType_9=punct	pos_6=,	pos_2=NNS	pos_18=MD	eib=True	relType_7=punct	relType_4=conj	relType_15=advmod	lemma_11=Tacrolimus
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e0	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	pos_2=NN	pos_5=,	lemma_10=,	pos_14=:	lemma_6=,	lemma_9=Astemizole	relType_8=punct	lemma_9=,	pos_25=NNP	lemma_12=,	relType_6=conj	path=<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lemma_16=significant	relType_24=case	pos_12=,	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_22=the	lemma_5=Rifampin	pos_24=IN	relType_21=case	relType_26=amod	lemma_14=:	pos_3=,	pos_10=,	lemma_6=Theophylline	lemma_26=oral	relType_8=conj	pos_2=,	pos_14=NNS	pos_15=RB	lib=coumarin	lemma_1=,	lemma_12=short	path1=	pos_1=,	pos_3=NNP	pos_20=VBN	pos_27=JJ	lemma_10=Rifabutin	relType_2=punct	relType_25=case	relType_16=amod	lemma_7=Terfenadine	lemma_19=be	lemma_27=hypoglycemic	lemma_2=-	relType_10=conj	relType_13=amod	relType_25=nmod	relType_12=amod	relType_12=punct	relType_23=obl	relType_2=conj	lemma_12=-	lemma_2=,	wib=Coumarin	lpib=coumarin_NN	lemma_13=oral	pos_5=NNP	lemma_4=,	lemma_25=DIFLUCAN	lemma_23=use	relType_19=aux:pass	pos_22=DT	lemma_12=benzodiazepine	relType_12=dep	lemma_14=hypoglycemic	pos_4=NNP	pos_25=IN	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	relType_14=punct	relType_10=punct	pos_12=VBG	lemma_11=,	lemma_2=type	lemma_3=Phenytoin	relType_27=amod	pos_2=HYPH	lemma_8=,	lemma_24=of	lemma_25=with	relType_11=conj	pos_26=JJ	pos_23=NN	pos_17=NN	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	pos_21=IN	lemma_15=clinically	pos_8=NNP	pos_13=JJ	relType_3=conj	relType_5=conj	pos_10=NNP	lemma_21=by	lemma_12=act	relType_22=det	pos_19=VB	lemma_20=precipitate	pos_12=HYPH	relType_20=parataxis	lemma_2=anticoagulant	relType_7=conj	relType_12=conj	lemma_8=Cisapride	pos_9=NNP	relType_9=conj	lemma_2=coumarin	pos_11=NNP	relType_17=nsubj:pass	pos_12=JJ	relType_6=punct	lemma_4=Cyclosporine	pos_16=JJ	lemma_18=may	relType_18=aux	pos_12=NNS	relType_2=compound	relType_5=punct	pos_7=NNP	lemma_17=hypoglycemia	relType_14=appos	pos_11=,	relType_9=punct	pos_6=,	pos_2=NNS	pos_18=MD	eib=True	relType_7=punct	relType_4=conj	relType_15=advmod	lemma_11=Tacrolimus
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e2	null	path=anticoagulant_conj<hypoglycemic_parataxis>Phenytoin_conj	lemma_1=,	lib=phenytoin	eib=False	lpib=phenytoin_NNP	pos_1=,	wib=Phenytoin	relType_1=punct	path1=anticoagulant_conj	path2=Phenytoin_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e3	null	lemma_1=,	lib=phenytoin	eib=True	path2=Cyclosporine_conj	path=anticoagulant_conj<hypoglycemic_parataxis>Cyclosporine_conj	lpib=phenytoin_NNP	pos_2=NNP	pos_1=,	pos_2=,	lemma_2=Phenytoin	wib=Phenytoin	relType_1=punct	relType_2=conj	lemma_2=,	path1=anticoagulant_conj	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e4	null	lemma_1=,	pos_1=,	pos_3=NNP	wib=Phenytoin	relType_2=punct	path2=Rifampin_conj	lib=phenytoin	pos_2=NNP	lemma_2=Phenytoin	relType_2=conj	path=anticoagulant_conj<hypoglycemic_parataxis>Rifampin_conj	lemma_2=,	lemma_3=,	relType_3=conj	lpib=phenytoin_NNP	path1=anticoagulant_conj	pos_3=,	eib=True	lemma_3=Cyclosporine	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e5	null	lemma_1=,	pos_1=,	pos_3=NNP	wib=Phenytoin	relType_2=punct	lib=phenytoin	pos_2=NNP	pos_4=,	lemma_2=Phenytoin	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lpib=phenytoin_NNP	lemma_4=,	path=anticoagulant_conj<hypoglycemic_parataxis>Theophylline_conj	path1=anticoagulant_conj	lemma_4=Rifampin	pos_3=,	eib=True	lemma_3=Cyclosporine	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	path2=Theophylline_conj	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e6	null	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	wib=Phenytoin	relType_2=punct	lib=phenytoin	pos_2=NNP	pos_4=,	lemma_2=Phenytoin	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_5=NNP	lemma_4=,	relType_5=conj	path1=anticoagulant_conj	lemma_4=Rifampin	pos_3=,	eib=True	lemma_3=Cyclosporine	path2=Terfenadine_conj	pos_4=NNP	lemma_5=Theophylline	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	path=anticoagulant_conj<hypoglycemic_parataxis>Terfenadine_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e7	null	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	wib=Phenytoin	relType_2=punct	path=anticoagulant_conj<hypoglycemic_parataxis>Cisapride_conj	relType_6=conj	lib=phenytoin	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lemma_6=Terfenadine	lemma_2=Phenytoin	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_5=NNP	lemma_4=,	relType_5=conj	path1=anticoagulant_conj	pos_6=,	lemma_4=Rifampin	path2=Cisapride_conj	pos_3=,	eib=True	lemma_3=Cyclosporine	pos_4=NNP	lemma_5=Theophylline	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e8	null	lemma_1=,	pos_5=,	path2=Astemizole_conj	pos_1=,	pos_3=NNP	lemma_6=,	wib=Phenytoin	relType_2=punct	relType_6=conj	lib=phenytoin	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	pos_7=,	lemma_6=Terfenadine	lemma_2=Phenytoin	lemma_7=,	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_7=NNP	pos_5=NNP	path=anticoagulant_conj<hypoglycemic_parataxis>Astemizole_conj	lemma_4=,	relType_5=conj	path1=anticoagulant_conj	pos_6=,	lemma_4=Rifampin	pos_3=,	eib=True	lemma_3=Cyclosporine	relType_7=punct	pos_4=NNP	lemma_5=Theophylline	lemma_7=Cisapride	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e9	null	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_8=,	relType_2=punct	relType_6=conj	lib=phenytoin	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	pos_7=,	lemma_6=Terfenadine	lemma_2=Phenytoin	lemma_8=Astemizole	lemma_7=,	relType_2=conj	lemma_2=,	pos_8=NNP	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	path1=anticoagulant_conj	pos_6=,	lemma_4=Rifampin	path2=Rifabutin_conj	pos_3=,	eib=True	path=anticoagulant_conj<hypoglycemic_parataxis>Rifabutin_conj	lemma_3=Cyclosporine	relType_7=punct	pos_4=NNP	lemma_5=Theophylline	lemma_7=Cisapride	pos_2=,	relType_4=conj	relType_8=conj	pos_8=,	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e10	null	lemma_9=Rifabutin	lemma_1=,	pos_9=NNP	relType_9=conj	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	relType_6=conj	lib=phenytoin	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	pos_7=,	lemma_6=Terfenadine	lemma_2=Phenytoin	lemma_8=Astemizole	lemma_7=,	relType_2=conj	lemma_2=,	path=anticoagulant_conj<hypoglycemic_parataxis>Tacrolimus_conj	pos_8=NNP	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_7=NNP	pos_5=NNP	lemma_4=,	relType_5=conj	relType_9=punct	path1=anticoagulant_conj	pos_6=,	lemma_4=Rifampin	pos_3=,	eib=True	lemma_3=Cyclosporine	path2=Tacrolimus_conj	relType_7=punct	pos_4=NNP	lemma_5=Theophylline	lemma_7=Cisapride	pos_2=,	relType_4=conj	relType_8=conj	pos_8=,	pos_9=,	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e11	null	lemma_11=short	lemma_9=Rifabutin	lemma_1=,	relType_10=punct	pos_9=NNP	relType_9=conj	pos_5=,	lemma_10=,	pos_1=,	pos_3=NNP	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_11=-	path=anticoagulant_conj<hypoglycemic_parataxis>benzodiazepine_conj	lemma_9=,	lemma_8=,	relType_2=punct	pos_11=HYPH	relType_6=conj	lib=phenytoin	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	relType_10=conj	relType_11=punct	relType_11=amod	pos_7=,	lemma_6=Terfenadine	lemma_2=Phenytoin	lemma_8=Astemizole	lemma_7=,	relType_2=conj	lemma_2=,	pos_8=NNP	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	lemma_5=,	lpib=phenytoin_NNP	relType_5=punct	pos_7=NNP	lemma_10=Tacrolimus	pos_11=VBG	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=conj	relType_9=punct	pos_10=NNP	path1=anticoagulant_conj	pos_6=,	lemma_4=Rifampin	pos_3=,	pos_10=,	eib=True	lemma_3=Cyclosporine	lemma_11=act	relType_7=punct	pos_4=NNP	lemma_5=Theophylline	lemma_7=Cisapride	pos_2=,	relType_4=conj	relType_8=conj	pos_8=,	pos_9=,	relType_1=punct	pos_11=JJ	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e12	null	lemma_9=Rifabutin	path2=hypoglycemic_appos	pos_5=,	lemma_10=,	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_9=,	relType_6=conj	pos_2=NNP	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	lpib=phenytoin_NNP	pos_11=VBG	lemma_4=Rifampin	pos_3=,	pos_10=,	lemma_7=Cisapride	relType_8=conj	pos_2=,	pos_11=JJ	lemma_1=,	pos_1=,	pos_3=NNP	relType_2=punct	lib=phenytoin	relType_10=conj	relType_11=amod	lemma_6=Terfenadine	relType_12=amod	relType_2=conj	lemma_2=,	lemma_10=Tacrolimus	pos_5=NNP	lemma_4=,	relType_11=dep	pos_4=NNP	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_11=short	relType_10=punct	lemma_11=,	lemma_11=-	lemma_8=,	relType_11=conj	lemma_12=oral	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	lemma_2=Phenytoin	lemma_8=Astemizole	pos_8=NNP	relType_3=conj	relType_5=conj	pos_10=NNP	relType_7=conj	pos_9=NNP	relType_9=conj	pos_11=HYPH	pos_12=JJ	relType_6=punct	path=anticoagulant_conj<hypoglycemic_parataxis>hypoglycemic_appos	pos_11=NNS	relType_5=punct	pos_7=NNP	pos_11=,	relType_9=punct	path1=anticoagulant_conj	pos_6=,	lemma_11=benzodiazepine	eib=True	lemma_3=Cyclosporine	lemma_11=act	relType_7=punct	lemma_5=Theophylline	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e13	null	lemma_9=Rifabutin	relType_18=aux:pass	pos_17=MD	pos_5=,	lemma_10=,	pos_13=NNS	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_19=precipitate	lemma_9=,	relType_6=conj	pos_2=NNP	lemma_18=be	lemma_22=use	lemma_7=,	lemma_13=hypoglycemic	pos_14=RB	relType_4=punct	lemma_3=,	lemma_5=,	lpib=phenytoin_NNP	pos_11=VBG	lemma_21=the	lemma_4=Rifampin	lemma_13=:	pos_3=,	pos_10=,	lemma_7=Cisapride	relType_8=conj	pos_2=,	pos_11=JJ	relType_17=aux	lemma_23=of	lemma_16=hypoglycemia	lemma_14=clinically	relType_22=obl	lemma_1=,	lemma_20=by	relType_16=nsubj:pass	pos_22=NN	pos_1=,	pos_3=NNP	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	lemma_15=significant	relType_20=case	lib=phenytoin	relType_14=advmod	relType_10=conj	path=anticoagulant_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_11=amod	relType_13=appos	lemma_6=Terfenadine	relType_12=amod	relType_2=conj	lemma_2=,	lemma_10=Tacrolimus	relType_21=det	pos_5=NNP	lemma_4=,	relType_11=dep	pos_16=NN	pos_13=:	pos_4=NNP	pos_23=IN	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_11=short	relType_10=punct	lemma_11=,	lemma_11=-	lemma_8=,	relType_11=conj	lemma_12=oral	pos_20=IN	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	lemma_2=Phenytoin	lemma_8=Astemizole	relType_19=parataxis	pos_8=NNP	relType_3=conj	pos_18=VB	relType_5=conj	relType_23=case	pos_10=NNP	pos_19=VBN	relType_7=conj	lemma_17=may	pos_9=NNP	relType_9=conj	pos_15=JJ	relType_15=amod	relType_13=punct	pos_11=HYPH	pos_12=JJ	relType_6=punct	pos_11=NNS	relType_5=punct	pos_7=NNP	pos_11=,	relType_9=punct	path1=anticoagulant_conj	pos_6=,	lemma_11=benzodiazepine	eib=True	lemma_3=Cyclosporine	lemma_11=act	relType_7=punct	lemma_5=Theophylline	relType_4=conj	pos_21=DT
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e1	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	lemma_9=Rifabutin	pos_24=NNP	relType_18=aux:pass	pos_17=MD	pos_5=,	lemma_10=,	pos_13=NNS	lemma_6=,	wib=Phenytoin	relType_8=punct	lemma_19=precipitate	lemma_9=,	relType_6=conj	relType_24=case	pos_2=NNP	lemma_18=be	lemma_22=use	lemma_7=,	lemma_13=hypoglycemic	pos_14=RB	relType_4=punct	lemma_3=,	lemma_5=,	lpib=phenytoin_NNP	pos_11=VBG	pos_24=IN	lemma_21=the	lemma_4=Rifampin	lemma_13=:	lemma_24=DIFLUCAN	relType_26=amod	pos_3=,	pos_10=,	lemma_7=Cisapride	relType_8=conj	pos_2=,	pos_11=JJ	relType_17=aux	lemma_23=of	lemma_16=hypoglycemia	lemma_14=clinically	relType_22=obl	lemma_1=,	lemma_20=by	relType_16=nsubj:pass	pos_22=NN	pos_1=,	pos_3=NNP	relType_2=punct	lemma_15=significant	relType_20=case	lib=phenytoin	relType_14=advmod	relType_25=amod	relType_10=conj	relType_11=amod	relType_13=appos	lemma_6=Terfenadine	relType_12=amod	relType_2=conj	lemma_2=,	lemma_10=Tacrolimus	relType_21=det	pos_5=NNP	lemma_4=,	relType_11=dep	pos_16=NN	lemma_24=with	pos_13=:	pos_4=NNP	pos_23=IN	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_11=short	relType_10=punct	lemma_11=,	lemma_11=-	lemma_8=,	relType_11=conj	lemma_12=oral	pos_20=IN	pos_26=JJ	pos_4=,	pos_6=NNP	relType_11=punct	pos_7=,	lemma_2=Phenytoin	lemma_8=Astemizole	relType_19=parataxis	pos_8=NNP	relType_3=conj	pos_18=VB	relType_5=conj	relType_23=case	pos_10=NNP	pos_19=VBN	lemma_25=oral	relType_7=conj	lemma_17=may	pos_9=NNP	relType_9=conj	pos_15=JJ	relType_15=amod	path=anticoagulant_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	relType_13=punct	pos_11=HYPH	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_25=JJ	relType_5=punct	pos_7=NNP	relType_24=nmod	pos_11=,	relType_9=punct	path1=anticoagulant_conj	pos_6=,	lemma_26=hypoglycemic	lemma_11=benzodiazepine	eib=True	lemma_3=Cyclosporine	lemma_11=act	relType_7=punct	lemma_5=Theophylline	relType_4=conj	pos_21=DT
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e3	null	lemma_1=,	path1=Phenytoin_conj	eib=False	wib=Cyclosporine	path2=Cyclosporine_conj	path=Phenytoin_conj<hypoglycemic_parataxis>Cyclosporine_conj	lpib=cyclosporine_NNP	pos_1=,	lib=cyclosporine	relType_1=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e4	null	path=Phenytoin_conj<hypoglycemic_parataxis>Rifampin_conj	path2=Rifampin_conj	lemma_1=,	eib=True	path1=Phenytoin_conj	wib=Cyclosporine	pos_2=NNP	lpib=cyclosporine_NNP	pos_1=,	pos_2=,	lib=cyclosporine	relType_2=conj	relType_1=punct	lemma_2=Cyclosporine	lemma_2=,	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e5	null	lemma_1=,	wib=Cyclosporine	pos_1=,	pos_3=NNP	path=Phenytoin_conj<hypoglycemic_parataxis>Theophylline_conj	lemma_2=Cyclosporine	relType_2=punct	pos_2=NNP	lpib=cyclosporine_NNP	lib=cyclosporine	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	pos_3=,	eib=True	path1=Phenytoin_conj	lemma_3=Rifampin	pos_2=,	relType_1=punct	path2=Theophylline_conj	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e6	null	lemma_1=,	wib=Cyclosporine	path=Phenytoin_conj<hypoglycemic_parataxis>Terfenadine_conj	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_2=Cyclosporine	relType_2=punct	pos_2=NNP	pos_4=,	lpib=cyclosporine_NNP	lib=cyclosporine	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	pos_3=,	eib=True	path1=Phenytoin_conj	path2=Terfenadine_conj	lemma_3=Rifampin	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e7	null	lemma_1=,	wib=Cyclosporine	pos_5=,	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_2=Cyclosporine	relType_2=punct	pos_2=NNP	pos_4=,	lpib=cyclosporine_NNP	lib=cyclosporine	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	path2=Cisapride_conj	pos_3=,	eib=True	path1=Phenytoin_conj	lemma_3=Rifampin	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	path=Phenytoin_conj<hypoglycemic_parataxis>Cisapride_conj	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e8	null	lemma_1=,	wib=Cyclosporine	pos_5=,	path2=Astemizole_conj	pos_1=,	pos_3=NNP	lemma_4=Theophylline	lemma_6=,	lemma_2=Cyclosporine	relType_2=punct	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lpib=cyclosporine_NNP	path=Phenytoin_conj<hypoglycemic_parataxis>Astemizole_conj	lib=cyclosporine	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	lemma_6=Cisapride	pos_6=,	pos_3=,	eib=True	path1=Phenytoin_conj	lemma_3=Rifampin	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e9	null	lemma_1=,	wib=Cyclosporine	pos_5=,	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_6=,	path=Phenytoin_conj<hypoglycemic_parataxis>Rifabutin_conj	lemma_2=Cyclosporine	relType_2=punct	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lpib=cyclosporine_NNP	pos_7=,	lib=cyclosporine	lemma_7=,	relType_2=conj	lemma_2=,	lemma_7=Astemizole	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	lemma_6=Cisapride	pos_6=,	path2=Rifabutin_conj	pos_3=,	eib=True	path1=Phenytoin_conj	relType_7=punct	lemma_3=Rifampin	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e10	null	lemma_1=,	wib=Cyclosporine	pos_5=,	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_6=,	relType_8=punct	lemma_2=Cyclosporine	lemma_8=,	relType_2=punct	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lpib=cyclosporine_NNP	path=Phenytoin_conj<hypoglycemic_parataxis>Tacrolimus_conj	pos_7=,	lib=cyclosporine	lemma_7=,	relType_2=conj	lemma_2=,	lemma_7=Astemizole	pos_8=NNP	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	lemma_8=Rifabutin	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	lemma_6=Cisapride	pos_6=,	pos_3=,	eib=True	path1=Phenytoin_conj	path2=Tacrolimus_conj	relType_7=punct	lemma_3=Rifampin	pos_4=NNP	relType_8=conj	pos_2=,	relType_4=conj	pos_8=,	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e11	null	lemma_1=,	relType_10=punct	pos_9=NNP	relType_9=conj	wib=Cyclosporine	pos_5=,	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_6=,	relType_10=amod	relType_8=punct	lemma_9=,	relType_10=dep	lemma_2=Cyclosporine	lemma_8=,	relType_2=punct	path=Phenytoin_conj<hypoglycemic_parataxis>benzodiazepine_conj	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lpib=cyclosporine_NNP	pos_7=,	lib=cyclosporine	lemma_10=short	lemma_7=,	relType_2=conj	lemma_2=,	lemma_10=-	lemma_7=Astemizole	pos_8=NNP	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	pos_10=JJ	pos_10=HYPH	lemma_8=Rifabutin	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	lemma_6=Cisapride	relType_9=punct	pos_6=,	lemma_10=act	pos_3=,	eib=True	path1=Phenytoin_conj	lemma_9=Tacrolimus	relType_7=punct	lemma_3=Rifampin	pos_4=NNP	relType_8=conj	pos_2=,	relType_4=conj	pos_8=,	pos_10=VBG	pos_9=,	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e12	null	path2=hypoglycemic_appos	lemma_1=,	relType_10=punct	lemma_11=oral	pos_9=NNP	relType_9=conj	wib=Cyclosporine	pos_5=,	lemma_10=,	lemma_4=Theophylline	pos_1=,	pos_3=NNP	lemma_6=,	relType_10=amod	relType_8=punct	lemma_9=,	relType_10=dep	lemma_2=Cyclosporine	lemma_8=,	relType_2=punct	pos_10=NNS	path=Phenytoin_conj<hypoglycemic_parataxis>hypoglycemic_appos	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	relType_10=conj	relType_11=amod	lpib=cyclosporine_NNP	pos_7=,	lib=cyclosporine	lemma_10=short	lemma_7=,	relType_2=conj	lemma_2=,	lemma_10=-	lemma_7=Astemizole	pos_8=NNP	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	pos_10=JJ	pos_10=HYPH	lemma_8=Rifabutin	lemma_10=benzodiazepine	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	relType_5=conj	lemma_6=Cisapride	relType_9=punct	pos_6=,	lemma_10=act	pos_3=,	pos_10=,	eib=True	path1=Phenytoin_conj	lemma_9=Tacrolimus	relType_7=punct	lemma_3=Rifampin	pos_4=NNP	relType_8=conj	pos_2=,	relType_4=conj	pos_8=,	pos_10=VBG	pos_9=,	relType_1=punct	pos_11=JJ	relType_3=punct	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e13	null	relType_18=parataxis	relType_14=amod	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	relType_10=dep	lemma_13=clinically	relType_15=nsubj:pass	lemma_15=hypoglycemia	relType_6=conj	pos_16=MD	pos_2=NNP	path=Phenytoin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_22=IN	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	relType_12=appos	lemma_9=Tacrolimus	lemma_16=may	relType_8=conj	pos_2=,	pos_11=JJ	lemma_1=,	wib=Cyclosporine	pos_1=,	pos_3=NNP	pos_12=:	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	relType_10=conj	relType_11=amod	lemma_10=short	relType_12=punct	lemma_20=the	relType_22=case	relType_2=conj	lemma_2=,	relType_13=advmod	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	lemma_6=Cisapride	relType_21=obl	lemma_10=act	relType_19=case	pos_4=NNP	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_22=of	relType_10=punct	lemma_8=,	lemma_19=by	pos_4=,	pos_6=NNP	pos_7=,	lib=cyclosporine	lemma_14=significant	lemma_7=Astemizole	pos_8=NNP	relType_3=conj	lemma_8=Rifabutin	relType_5=conj	lemma_21=use	pos_18=VBN	lemma_3=Rifampin	pos_10=VBG	pos_14=JJ	lemma_12=:	relType_20=det	relType_7=conj	pos_19=IN	lemma_11=oral	pos_9=NNP	relType_9=conj	lemma_4=Theophylline	relType_10=amod	relType_17=aux:pass	pos_20=DT	lemma_17=be	lemma_2=Cyclosporine	relType_6=punct	lpib=cyclosporine_NNP	relType_16=aux	pos_13=RB	lemma_10=-	pos_15=NN	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_7=NNP	pos_10=HYPH	lemma_18=precipitate	pos_17=VB	lemma_10=benzodiazepine	relType_9=punct	pos_6=,	eib=True	path1=Phenytoin_conj	relType_7=punct	lemma_12=hypoglycemic	relType_4=conj	pos_10=NNS	pos_21=NN
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e2	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	relType_18=parataxis	relType_14=amod	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	relType_10=dep	lemma_13=clinically	relType_15=nsubj:pass	lemma_15=hypoglycemia	relType_6=conj	pos_16=MD	pos_2=NNP	pos_22=IN	lemma_7=,	lemma_23=DIFLUCAN	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	relType_12=appos	lemma_9=Tacrolimus	lemma_16=may	relType_8=conj	pos_2=,	pos_11=JJ	lemma_1=,	wib=Cyclosporine	pos_1=,	pos_3=NNP	pos_12=:	relType_2=punct	relType_25=amod	relType_10=conj	relType_11=amod	lemma_10=short	relType_12=punct	lemma_20=the	relType_22=case	relType_2=conj	lemma_2=,	relType_13=advmod	pos_5=NNP	lemma_4=,	lemma_5=Terfenadine	lemma_6=Cisapride	relType_24=amod	relType_21=obl	lemma_10=act	relType_19=case	pos_4=NNP	pos_23=IN	pos_9=,	relType_1=punct	relType_3=punct	pos_8=,	lemma_22=of	relType_10=punct	path=Phenytoin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lemma_8=,	pos_24=JJ	lemma_19=by	pos_4=,	pos_6=NNP	pos_7=,	lib=cyclosporine	lemma_14=significant	relType_23=nmod	lemma_7=Astemizole	lemma_24=oral	pos_8=NNP	relType_3=conj	lemma_8=Rifabutin	relType_5=conj	relType_23=case	lemma_21=use	pos_18=VBN	lemma_3=Rifampin	pos_10=VBG	pos_14=JJ	lemma_12=:	relType_20=det	relType_7=conj	pos_23=NNP	pos_19=IN	lemma_11=oral	pos_9=NNP	relType_9=conj	lemma_4=Theophylline	relType_10=amod	relType_17=aux:pass	lemma_23=with	pos_20=DT	lemma_17=be	lemma_2=Cyclosporine	relType_6=punct	lpib=cyclosporine_NNP	relType_16=aux	pos_13=RB	lemma_25=hypoglycemic	lemma_10=-	pos_25=JJ	pos_15=NN	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_7=NNP	pos_10=HYPH	lemma_18=precipitate	pos_17=VB	lemma_10=benzodiazepine	relType_9=punct	pos_6=,	eib=True	path1=Phenytoin_conj	relType_7=punct	lemma_12=hypoglycemic	relType_4=conj	pos_10=NNS	pos_21=NN
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e4	null	path=Cyclosporine_conj<hypoglycemic_parataxis>Rifampin_conj	path2=Rifampin_conj	lpib=rifampin_NNP	path1=Cyclosporine_conj	lemma_1=,	eib=False	wib=Rifampin	pos_1=,	lib=rifampin	relType_1=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e5	null	lpib=rifampin_NNP	path1=Cyclosporine_conj	lemma_1=,	eib=True	pos_2=NNP	path=Cyclosporine_conj<hypoglycemic_parataxis>Theophylline_conj	wib=Rifampin	pos_1=,	pos_2=,	lib=rifampin	lemma_2=Rifampin	relType_1=punct	path2=Theophylline_conj	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e6	null	lpib=rifampin_NNP	path=Cyclosporine_conj<hypoglycemic_parataxis>Terfenadine_conj	lemma_1=,	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	wib=Rifampin	lib=rifampin	lemma_2=Rifampin	path1=Cyclosporine_conj	pos_3=,	eib=True	path2=Terfenadine_conj	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=Theophylline
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e7	null	lemma_4=Terfenadine	lpib=rifampin_NNP	lemma_1=,	pos_1=,	pos_3=NNP	path=Cyclosporine_conj<hypoglycemic_parataxis>Cisapride_conj	relType_2=punct	pos_2=NNP	pos_4=,	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	path1=Cyclosporine_conj	path2=Cisapride_conj	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_3=Theophylline
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e8	null	lemma_4=Terfenadine	lpib=rifampin_NNP	lemma_1=,	pos_5=,	path2=Astemizole_conj	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	pos_4=,	lemma_5=Cisapride	relType_2=conj	lemma_2=,	path=Cyclosporine_conj<hypoglycemic_parataxis>Astemizole_conj	lemma_3=,	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	pos_5=NNP	relType_5=conj	path1=Cyclosporine_conj	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_3=Theophylline
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e9	null	lemma_4=Terfenadine	lpib=rifampin_NNP	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	relType_2=punct	path=Cyclosporine_conj<hypoglycemic_parataxis>Rifabutin_conj	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lemma_5=Cisapride	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	pos_5=NNP	relType_5=conj	pos_6=,	lemma_6=Astemizole	path2=Rifabutin_conj	path1=Cyclosporine_conj	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_3=Theophylline
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e10	null	lemma_4=Terfenadine	lpib=rifampin_NNP	lemma_1=,	lemma_7=Rifabutin	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	relType_2=punct	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lemma_5=Cisapride	pos_7=,	lemma_7=,	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	pos_5=NNP	relType_5=conj	pos_6=,	lemma_6=Astemizole	path1=Cyclosporine_conj	path=Cyclosporine_conj<hypoglycemic_parataxis>Tacrolimus_conj	pos_3=,	eib=True	path2=Tacrolimus_conj	relType_7=punct	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_3=Theophylline	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e11	null	lemma_4=Terfenadine	lpib=rifampin_NNP	lemma_1=,	lemma_7=Rifabutin	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	relType_8=punct	lemma_9=-	lemma_8=,	relType_9=dep	relType_2=punct	lemma_8=Tacrolimus	pos_9=JJ	pos_9=HYPH	relType_6=conj	lemma_9=act	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lemma_5=Cisapride	pos_7=,	relType_9=amod	lemma_7=,	relType_2=conj	lemma_2=,	pos_9=VBG	relType_7=conj	pos_8=NNP	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	pos_5=NNP	relType_5=conj	relType_9=punct	pos_6=,	lemma_6=Astemizole	path1=Cyclosporine_conj	pos_3=,	eib=True	relType_7=punct	pos_4=NNP	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	lemma_9=short	relType_1=punct	relType_3=punct	lemma_3=Theophylline	path=Cyclosporine_conj<hypoglycemic_parataxis>benzodiazepine_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e12	null	lemma_4=Terfenadine	lpib=rifampin_NNP	path2=hypoglycemic_appos	lemma_1=,	lemma_7=Rifabutin	relType_9=conj	pos_5=,	relType_10=amod	pos_1=,	pos_3=NNP	lemma_6=,	relType_8=punct	lemma_9=-	lemma_9=,	lemma_8=,	relType_9=dep	relType_2=punct	lemma_8=Tacrolimus	pos_9=JJ	pos_9=HYPH	relType_6=conj	lemma_9=act	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	path=Cyclosporine_conj<hypoglycemic_parataxis>hypoglycemic_appos	lemma_5=Cisapride	pos_9=NNS	pos_7=,	lemma_9=benzodiazepine	relType_9=amod	lemma_7=,	relType_2=conj	lemma_2=,	pos_9=VBG	pos_8=NNP	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=NNP	pos_10=JJ	wib=Rifampin	lib=rifampin	lemma_4=,	lemma_2=Rifampin	pos_5=NNP	relType_5=conj	relType_9=punct	pos_6=,	lemma_6=Astemizole	path1=Cyclosporine_conj	pos_3=,	eib=True	relType_7=punct	pos_4=NNP	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	lemma_9=short	lemma_10=oral	pos_9=,	relType_1=punct	relType_3=punct	lemma_3=Theophylline	relType_7=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e13	null	lemma_7=Rifabutin	pos_5=,	lemma_6=,	relType_8=punct	lemma_9=,	relType_18=case	pos_9=HYPH	relType_6=conj	relType_14=nsubj:pass	pos_2=NNP	pos_20=NN	lemma_7=,	lemma_14=hypoglycemia	relType_4=punct	lemma_3=,	pos_12=RB	lemma_5=,	lemma_18=by	lemma_2=Rifampin	relType_21=case	lemma_6=Astemizole	pos_3=,	relType_8=conj	pos_2=,	lemma_11=hypoglycemic	relType_19=det	lemma_1=,	pos_1=,	pos_3=NNP	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	lemma_8=Tacrolimus	relType_13=amod	pos_16=VB	lemma_5=Cisapride	lemma_20=use	relType_2=conj	lemma_2=,	pos_9=VBG	relType_17=parataxis	lib=rifampin	lemma_4=,	pos_5=NNP	lemma_17=precipitate	pos_4=NNP	pos_9=,	relType_1=punct	relType_20=obl	lemma_13=significant	lemma_21=of	relType_3=punct	lemma_3=Theophylline	pos_8=,	path=Cyclosporine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_19=DT	lpib=rifampin_NNP	lemma_9=-	lemma_8=,	pos_17=VBN	lemma_9=act	pos_4=,	pos_6=NNP	relType_12=advmod	relType_11=punct	pos_7=,	lemma_9=benzodiazepine	pos_21=IN	lemma_11=:	relType_9=amod	pos_14=NN	lemma_16=be	pos_18=IN	pos_8=NNP	pos_13=JJ	relType_3=conj	wib=Rifampin	relType_5=conj	pos_11=:	path1=Cyclosporine_conj	lemma_10=oral	relType_7=conj	lemma_4=Terfenadine	relType_9=conj	lemma_15=may	relType_10=amod	pos_15=MD	relType_16=aux:pass	relType_9=dep	pos_9=JJ	relType_6=punct	relType_15=aux	pos_9=NNS	pos_11=NNS	lemma_19=the	lemma_12=clinically	relType_11=appos	pos_10=JJ	relType_5=punct	pos_7=NNP	relType_9=punct	pos_6=,	eib=True	relType_7=punct	lemma_9=short	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e3	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	lemma_7=Rifabutin	pos_5=,	lemma_6=,	relType_8=punct	lemma_9=,	relType_18=case	pos_9=HYPH	relType_6=conj	relType_14=nsubj:pass	pos_22=NNP	pos_2=NNP	pos_20=NN	pos_22=IN	lemma_7=,	lemma_14=hypoglycemia	relType_4=punct	lemma_3=,	pos_12=RB	lemma_5=,	lemma_18=by	lemma_2=Rifampin	relType_21=case	lemma_6=Astemizole	pos_3=,	relType_8=conj	pos_2=,	lemma_11=hypoglycemic	relType_19=det	relType_22=nmod	lemma_1=,	pos_1=,	pos_3=NNP	relType_2=punct	lemma_8=Tacrolimus	relType_13=amod	pos_16=VB	lemma_5=Cisapride	lemma_20=use	relType_22=case	relType_2=conj	lemma_2=,	pos_9=VBG	relType_17=parataxis	lib=rifampin	lemma_4=,	pos_5=NNP	lemma_17=precipitate	lemma_22=with	relType_24=amod	pos_4=NNP	pos_9=,	relType_1=punct	relType_20=obl	lemma_13=significant	lemma_21=of	relType_3=punct	lemma_3=Theophylline	pos_8=,	pos_19=DT	pos_23=JJ	lpib=rifampin_NNP	relType_23=amod	lemma_9=-	lemma_8=,	path=Cyclosporine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	pos_17=VBN	pos_24=JJ	lemma_9=act	pos_4=,	pos_6=NNP	relType_12=advmod	relType_11=punct	pos_7=,	lemma_9=benzodiazepine	pos_21=IN	lemma_11=:	relType_9=amod	pos_14=NN	lemma_16=be	pos_18=IN	pos_8=NNP	pos_13=JJ	relType_3=conj	wib=Rifampin	relType_5=conj	pos_11=:	path1=Cyclosporine_conj	lemma_23=oral	lemma_10=oral	relType_7=conj	lemma_4=Terfenadine	relType_9=conj	lemma_15=may	relType_10=amod	pos_15=MD	relType_16=aux:pass	relType_9=dep	pos_9=JJ	relType_6=punct	relType_15=aux	pos_9=NNS	pos_11=NNS	lemma_19=the	lemma_12=clinically	lemma_22=DIFLUCAN	lemma_24=hypoglycemic	relType_11=appos	pos_10=JJ	relType_5=punct	pos_7=NNP	relType_9=punct	pos_6=,	eib=True	relType_7=punct	lemma_9=short	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e5	null	wib=Theophylline	lib=theophylline	lemma_1=,	eib=False	path=Rifampin_conj<hypoglycemic_parataxis>Theophylline_conj	path1=Rifampin_conj	pos_1=,	relType_1=punct	path2=Theophylline_conj	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e6	null	wib=Theophylline	path=Rifampin_conj<hypoglycemic_parataxis>Terfenadine_conj	lib=theophylline	lemma_1=,	relType_2=punct	eib=True	pos_2=NNP	path2=Terfenadine_conj	path1=Rifampin_conj	pos_1=,	pos_2=,	lemma_2=Theophylline	relType_1=punct	relType_2=conj	lemma_2=,	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e7	null	wib=Theophylline	lemma_1=,	lemma_3=Terfenadine	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	lemma_2=Theophylline	path=Rifampin_conj<hypoglycemic_parataxis>Cisapride_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path1=Rifampin_conj	lib=theophylline	path2=Cisapride_conj	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e8	null	wib=Theophylline	lemma_1=,	lemma_3=Terfenadine	path2=Astemizole_conj	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	pos_4=,	lemma_2=Theophylline	relType_2=conj	lemma_2=,	path=Rifampin_conj<hypoglycemic_parataxis>Astemizole_conj	lemma_3=,	relType_4=punct	relType_3=conj	path1=Rifampin_conj	lemma_4=,	lib=theophylline	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=Cisapride	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e9	null	wib=Theophylline	path=Rifampin_conj<hypoglycemic_parataxis>Rifabutin_conj	lemma_1=,	lemma_3=Terfenadine	pos_5=,	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	pos_4=,	lemma_5=Astemizole	lemma_2=Theophylline	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path1=Rifampin_conj	pos_5=NNP	lemma_4=,	relType_5=conj	path2=Rifabutin_conj	lib=theophylline	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=Cisapride	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e10	null	wib=Theophylline	lemma_1=,	lemma_3=Terfenadine	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	relType_2=punct	relType_6=conj	pos_2=NNP	pos_4=,	lemma_5=Astemizole	pos_6=NNP	relType_6=punct	lemma_2=Theophylline	path=Rifampin_conj<hypoglycemic_parataxis>Tacrolimus_conj	relType_2=conj	lemma_2=,	lemma_6=Rifabutin	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path1=Rifampin_conj	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	lib=theophylline	pos_3=,	eib=True	path2=Tacrolimus_conj	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=Cisapride	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e11	null	wib=Theophylline	lemma_1=,	relType_8=dep	lemma_3=Terfenadine	relType_8=amod	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	lemma_8=act	relType_8=punct	relType_2=punct	pos_8=JJ	relType_6=conj	path=Rifampin_conj<hypoglycemic_parataxis>benzodiazepine_conj	pos_2=NNP	pos_4=,	lemma_5=Astemizole	pos_6=NNP	relType_6=punct	lemma_7=Tacrolimus	pos_7=,	pos_8=HYPH	lemma_2=Theophylline	lemma_7=,	relType_2=conj	lemma_2=,	lemma_6=Rifabutin	relType_7=conj	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	lemma_5=,	relType_5=punct	path1=Rifampin_conj	pos_7=NNP	pos_8=VBG	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	lib=theophylline	pos_3=,	eib=True	lemma_8=short	lemma_8=-	relType_7=punct	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=Cisapride	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e12	null	wib=Theophylline	path2=hypoglycemic_appos	lemma_1=,	relType_8=dep	lemma_3=Terfenadine	relType_8=amod	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	lemma_8=act	relType_8=punct	lemma_8=,	pos_8=NNS	relType_2=punct	pos_8=JJ	pos_9=JJ	relType_6=conj	pos_2=NNP	pos_4=,	lemma_5=Astemizole	pos_6=NNP	relType_6=punct	lemma_7=Tacrolimus	lemma_9=oral	pos_7=,	pos_8=HYPH	lemma_2=Theophylline	relType_9=amod	lemma_7=,	relType_2=conj	lemma_2=,	lemma_6=Rifabutin	relType_7=conj	path=Rifampin_conj<hypoglycemic_parataxis>hypoglycemic_appos	lemma_3=,	relType_4=punct	relType_3=conj	lemma_5=,	relType_5=punct	path1=Rifampin_conj	pos_7=NNP	pos_8=VBG	lemma_8=benzodiazepine	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	lib=theophylline	pos_3=,	eib=True	lemma_8=short	lemma_8=-	relType_7=punct	pos_4=NNP	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=Cisapride	relType_3=punct	lpib=theophylline_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e13	null	pos_5=,	lemma_6=,	relType_8=punct	pos_8=NNS	pos_8=JJ	lemma_13=hypoglycemia	relType_6=conj	pos_2=NNP	path=Rifampin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_13=NN	lemma_7=,	pos_16=VBN	relType_4=punct	lemma_3=,	lemma_5=,	pos_11=RB	relType_13=nsubj:pass	pos_3=,	relType_19=obl	lemma_8=-	relType_8=conj	pos_2=,	lemma_20=of	lemma_1=,	pos_1=,	pos_3=NNP	lemma_19=use	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	pos_18=DT	relType_20=case	lemma_9=oral	relType_10=appos	relType_12=amod	pos_8=HYPH	lemma_2=Theophylline	relType_11=advmod	relType_2=conj	lemma_2=,	lemma_10=hypoglycemic	relType_15=aux:pass	path1=Rifampin_conj	pos_8=VBG	lemma_8=benzodiazepine	pos_5=NNP	lemma_4=,	lib=theophylline	lemma_8=short	pos_4=NNP	lemma_10=:	relType_18=det	relType_1=punct	lemma_4=Cisapride	relType_3=punct	pos_8=,	lemma_18=the	lemma_16=precipitate	relType_10=punct	relType_8=dep	lemma_3=Terfenadine	lemma_8=act	lemma_8=,	pos_20=IN	pos_17=IN	pos_4=,	lemma_5=Astemizole	pos_6=NNP	lemma_7=Tacrolimus	pos_7=,	lemma_17=by	relType_9=amod	relType_17=case	relType_3=conj	relType_5=conj	lemma_15=be	lemma_12=significant	relType_7=conj	lpib=theophylline_NNP	wib=Theophylline	relType_16=parataxis	relType_8=amod	pos_12=JJ	pos_9=JJ	relType_6=punct	pos_19=NN	lemma_14=may	lemma_6=Rifabutin	pos_15=VB	pos_10=:	relType_5=punct	pos_7=NNP	relType_14=aux	pos_6=,	pos_14=MD	eib=True	lemma_11=clinically	relType_7=punct	relType_4=conj	pos_10=NNS
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e4	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	pos_5=,	lemma_6=,	relType_8=punct	pos_8=NNS	pos_8=JJ	lemma_13=hypoglycemia	relType_6=conj	pos_2=NNP	pos_13=NN	lemma_7=,	lemma_22=oral	pos_16=VBN	relType_4=punct	lemma_3=,	lemma_5=,	pos_11=RB	relType_21=case	relType_13=nsubj:pass	pos_3=,	relType_19=obl	lemma_8=-	relType_8=conj	pos_2=,	lemma_23=hypoglycemic	lemma_20=of	pos_21=NNP	lemma_1=,	pos_1=,	pos_3=NNP	lemma_19=use	relType_2=punct	pos_18=DT	relType_20=case	lemma_9=oral	relType_10=appos	relType_12=amod	pos_8=HYPH	lemma_2=Theophylline	relType_11=advmod	relType_2=conj	lemma_2=,	lemma_10=hypoglycemic	relType_15=aux:pass	path1=Rifampin_conj	pos_8=VBG	lemma_8=benzodiazepine	pos_5=NNP	lemma_4=,	lib=theophylline	lemma_8=short	pos_4=NNP	lemma_10=:	relType_18=det	relType_1=punct	lemma_4=Cisapride	relType_3=punct	pos_8=,	lemma_18=the	pos_23=JJ	lemma_16=precipitate	relType_10=punct	relType_8=dep	lemma_3=Terfenadine	lemma_8=act	relType_21=nmod	relType_23=amod	lemma_8=,	pos_20=IN	pos_17=IN	pos_4=,	lemma_5=Astemizole	pos_6=NNP	lemma_7=Tacrolimus	pos_7=,	lemma_17=by	pos_21=IN	relType_9=amod	relType_17=case	relType_3=conj	relType_5=conj	path=Rifampin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	pos_22=JJ	lemma_15=be	relType_22=amod	lemma_12=significant	relType_7=conj	lpib=theophylline_NNP	wib=Theophylline	relType_16=parataxis	lemma_21=DIFLUCAN	relType_8=amod	pos_12=JJ	pos_9=JJ	relType_6=punct	pos_19=NN	lemma_21=with	lemma_14=may	lemma_6=Rifabutin	pos_15=VB	pos_10=:	relType_5=punct	pos_7=NNP	relType_14=aux	pos_6=,	pos_14=MD	eib=True	lemma_11=clinically	relType_7=punct	relType_4=conj	pos_10=NNS
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e6	null	lib=terfenadine	lemma_1=,	path=Theophylline_conj<hypoglycemic_parataxis>Terfenadine_conj	eib=False	path2=Terfenadine_conj	pos_1=,	lpib=terfenadine_NNP	relType_1=punct	wib=Terfenadine	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e7	null	lib=terfenadine	path2=Cisapride_conj	lemma_1=,	relType_2=punct	eib=True	pos_2=NNP	pos_1=,	pos_2=,	lemma_2=Terfenadine	path=Theophylline_conj<hypoglycemic_parataxis>Cisapride_conj	lpib=terfenadine_NNP	relType_1=punct	relType_2=conj	wib=Terfenadine	lemma_2=,	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e8	null	lemma_1=,	path=Theophylline_conj<hypoglycemic_parataxis>Astemizole_conj	path2=Astemizole_conj	pos_1=,	pos_3=NNP	lemma_3=Cisapride	relType_2=punct	pos_2=NNP	lpib=terfenadine_NNP	relType_2=conj	lemma_2=,	lib=terfenadine	lemma_3=,	relType_3=conj	wib=Terfenadine	pos_3=,	eib=True	pos_2=,	lemma_2=Terfenadine	relType_1=punct	relType_3=punct	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e9	null	lemma_1=,	pos_1=,	pos_3=NNP	lemma_3=Cisapride	relType_2=punct	pos_2=NNP	pos_4=,	lpib=terfenadine_NNP	relType_2=conj	lemma_2=,	lemma_4=Astemizole	lib=terfenadine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	wib=Terfenadine	path2=Rifabutin_conj	pos_3=,	eib=True	path=Theophylline_conj<hypoglycemic_parataxis>Rifabutin_conj	pos_4=NNP	pos_2=,	lemma_2=Terfenadine	relType_4=conj	relType_1=punct	relType_3=punct	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e10	null	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	lemma_3=Cisapride	relType_2=punct	pos_2=NNP	pos_4=,	lpib=terfenadine_NNP	relType_2=conj	lemma_2=,	lemma_4=Astemizole	lib=terfenadine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	pos_5=NNP	lemma_4=,	relType_5=conj	lemma_5=Rifabutin	wib=Terfenadine	pos_3=,	eib=True	path=Theophylline_conj<hypoglycemic_parataxis>Tacrolimus_conj	path2=Tacrolimus_conj	pos_4=NNP	pos_2=,	lemma_2=Terfenadine	relType_4=conj	relType_1=punct	relType_3=punct	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e11	null	lemma_1=,	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	pos_7=VBG	lemma_3=Cisapride	relType_2=punct	path=Theophylline_conj<hypoglycemic_parataxis>benzodiazepine_conj	lemma_7=-	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	lpib=terfenadine_NNP	relType_2=conj	lemma_2=,	lemma_6=Tacrolimus	lemma_4=Astemizole	lib=terfenadine	relType_7=amod	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	lemma_5=,	relType_5=punct	pos_7=HYPH	pos_5=NNP	lemma_4=,	relType_5=conj	lemma_5=Rifabutin	wib=Terfenadine	pos_6=,	lemma_7=act	pos_3=,	relType_7=dep	eib=True	lemma_7=short	relType_7=punct	pos_4=NNP	pos_7=JJ	pos_2=,	lemma_2=Terfenadine	relType_4=conj	relType_1=punct	relType_3=punct	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e12	null	pos_7=NNS	path2=hypoglycemic_appos	lemma_1=,	relType_8=amod	pos_5=,	pos_1=,	pos_3=NNP	lemma_6=,	pos_7=VBG	lemma_3=Cisapride	lemma_7=benzodiazepine	relType_2=punct	pos_8=JJ	lemma_7=-	relType_6=conj	pos_2=NNP	pos_4=,	pos_6=NNP	relType_6=punct	pos_7=,	lpib=terfenadine_NNP	lemma_7=,	relType_2=conj	lemma_2=,	lemma_6=Tacrolimus	path=Theophylline_conj<hypoglycemic_parataxis>hypoglycemic_appos	lemma_8=oral	lemma_4=Astemizole	lib=terfenadine	relType_7=conj	relType_7=amod	relType_4=punct	lemma_3=,	pos_7=HYPH	relType_3=conj	lemma_5=,	relType_5=punct	pos_5=NNP	lemma_4=,	relType_5=conj	lemma_5=Rifabutin	wib=Terfenadine	pos_6=,	lemma_7=act	pos_3=,	relType_7=dep	eib=True	lemma_7=short	relType_7=punct	pos_4=NNP	pos_7=JJ	pos_2=,	lemma_2=Terfenadine	relType_4=conj	relType_1=punct	relType_3=punct	path1=Theophylline_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e13	null	pos_5=,	lemma_6=,	pos_8=JJ	relType_6=conj	relType_17=det	pos_2=NNP	lpib=terfenadine_NNP	path=Theophylline_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_7=,	lemma_10=clinically	pos_18=NN	relType_4=punct	lemma_3=,	pos_7=HYPH	lemma_5=,	pos_9=:	pos_3=,	lemma_7=short	pos_7=JJ	pos_2=,	pos_11=JJ	pos_7=NNS	lemma_1=,	pos_1=,	pos_3=NNP	lemma_12=hypoglycemia	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	relType_11=amod	pos_15=VBN	relType_2=conj	lemma_2=,	lemma_6=Tacrolimus	lemma_8=oral	lemma_4=Astemizole	lib=terfenadine	lemma_9=:	pos_14=VB	pos_5=NNP	lemma_4=,	lemma_17=the	relType_16=case	relType_7=dep	relType_19=case	lemma_18=use	pos_4=NNP	lemma_2=Terfenadine	pos_10=RB	relType_1=punct	relType_3=punct	pos_17=DT	pos_16=IN	pos_7=VBG	lemma_9=hypoglycemic	lemma_3=Cisapride	relType_18=obl	pos_4=,	pos_6=NNP	pos_7=,	relType_14=aux:pass	lemma_16=by	relType_9=appos	lemma_14=be	lemma_19=of	relType_7=amod	relType_3=conj	relType_5=conj	lemma_5=Rifabutin	relType_7=conj	path1=Theophylline_conj	pos_19=IN	lemma_15=precipitate	relType_8=amod	lemma_7=benzodiazepine	lemma_11=significant	lemma_7=-	relType_6=punct	relType_12=nsubj:pass	pos_9=NNS	relType_13=aux	relType_10=advmod	lemma_13=may	relType_5=punct	relType_15=parataxis	relType_9=punct	wib=Terfenadine	pos_6=,	lemma_7=act	eib=True	relType_7=punct	relType_4=conj	pos_12=NN	pos_13=MD
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e5	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	pos_5=,	lemma_6=,	pos_8=JJ	relType_6=conj	relType_17=det	pos_2=NNP	relType_20=nmod	lpib=terfenadine_NNP	lemma_7=,	lemma_10=clinically	pos_18=NN	relType_4=punct	lemma_3=,	pos_7=HYPH	lemma_5=,	pos_9=:	pos_3=,	lemma_7=short	pos_7=JJ	pos_2=,	pos_11=JJ	pos_7=NNS	lemma_1=,	pos_21=JJ	pos_1=,	pos_3=NNP	lemma_12=hypoglycemia	lemma_22=hypoglycemic	relType_2=punct	relType_20=case	relType_11=amod	pos_15=VBN	lemma_21=oral	relType_2=conj	lemma_2=,	lemma_6=Tacrolimus	lemma_8=oral	lemma_4=Astemizole	lib=terfenadine	lemma_9=:	pos_14=VB	pos_5=NNP	lemma_4=,	lemma_17=the	relType_16=case	relType_7=dep	relType_19=case	lemma_18=use	pos_4=NNP	lemma_2=Terfenadine	pos_10=RB	relType_1=punct	relType_3=punct	pos_17=DT	pos_16=IN	pos_7=VBG	lemma_9=hypoglycemic	lemma_3=Cisapride	pos_20=IN	relType_18=obl	pos_4=,	pos_6=NNP	pos_7=,	relType_14=aux:pass	lemma_16=by	relType_9=appos	lemma_14=be	lemma_19=of	relType_7=amod	relType_3=conj	relType_5=conj	lemma_5=Rifabutin	pos_22=JJ	relType_22=amod	relType_7=conj	path1=Theophylline_conj	pos_19=IN	lemma_20=DIFLUCAN	lemma_15=precipitate	relType_8=amod	lemma_7=benzodiazepine	lemma_11=significant	lemma_7=-	path=Theophylline_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	relType_6=punct	relType_12=nsubj:pass	pos_9=NNS	relType_21=amod	relType_13=aux	relType_10=advmod	lemma_13=may	relType_5=punct	relType_15=parataxis	relType_9=punct	wib=Terfenadine	pos_6=,	lemma_7=act	lemma_20=with	eib=True	relType_7=punct	pos_20=NNP	relType_4=conj	pos_12=NN	pos_13=MD
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e7	null	lib=cisapride	wib=Cisapride	path2=Cisapride_conj	lemma_1=,	eib=False	lpib=cisapride_NNP	path1=Terfenadine_conj	path=Terfenadine_conj<hypoglycemic_parataxis>Cisapride_conj	pos_1=,	relType_1=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e8	null	lib=cisapride	wib=Cisapride	lemma_1=,	eib=True	path1=Terfenadine_conj	lpib=cisapride_NNP	path=Terfenadine_conj<hypoglycemic_parataxis>Astemizole_conj	pos_2=NNP	path2=Astemizole_conj	pos_1=,	pos_2=,	lemma_2=Cisapride	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e9	null	lemma_1=,	path1=Terfenadine_conj	lpib=cisapride_NNP	pos_1=,	pos_3=NNP	lemma_2=Cisapride	relType_2=punct	lib=cisapride	pos_2=NNP	relType_2=conj	lemma_2=,	lemma_3=,	lemma_3=Astemizole	relType_3=conj	path=Terfenadine_conj<hypoglycemic_parataxis>Rifabutin_conj	wib=Cisapride	path2=Rifabutin_conj	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e10	null	lemma_1=,	path1=Terfenadine_conj	lpib=cisapride_NNP	pos_1=,	pos_3=NNP	path=Terfenadine_conj<hypoglycemic_parataxis>Tacrolimus_conj	lemma_2=Cisapride	relType_2=punct	lib=cisapride	pos_2=NNP	pos_4=,	relType_2=conj	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=Astemizole	relType_3=conj	lemma_4=Rifabutin	lemma_4=,	wib=Cisapride	pos_3=,	eib=True	path2=Tacrolimus_conj	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e11	null	lemma_1=,	pos_6=JJ	path1=Terfenadine_conj	lpib=cisapride_NNP	pos_5=,	lemma_6=short	pos_1=,	pos_3=NNP	lemma_2=Cisapride	relType_2=punct	pos_6=HYPH	lib=cisapride	pos_6=VBG	relType_6=dep	pos_2=NNP	pos_4=,	relType_6=punct	lemma_5=Tacrolimus	relType_6=amod	relType_2=conj	lemma_2=,	lemma_6=-	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	lemma_3=Astemizole	relType_3=conj	lemma_4=Rifabutin	lemma_5=,	relType_5=punct	path=Terfenadine_conj<hypoglycemic_parataxis>benzodiazepine_conj	pos_5=NNP	lemma_4=,	relType_5=conj	wib=Cisapride	lemma_6=act	pos_3=,	eib=True	pos_4=NNP	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e12	null	path2=hypoglycemic_appos	lemma_1=,	pos_6=JJ	path1=Terfenadine_conj	lpib=cisapride_NNP	pos_5=,	lemma_6=short	pos_1=,	pos_3=NNP	lemma_6=,	lemma_7=oral	lemma_2=Cisapride	relType_2=punct	pos_6=HYPH	lib=cisapride	pos_6=VBG	relType_6=conj	relType_6=dep	pos_2=NNP	pos_4=,	relType_6=punct	lemma_5=Tacrolimus	relType_6=amod	relType_2=conj	lemma_2=,	lemma_6=-	relType_7=amod	relType_4=punct	lemma_3=,	lemma_3=Astemizole	relType_3=conj	lemma_4=Rifabutin	lemma_5=,	relType_5=punct	lemma_6=benzodiazepine	pos_5=NNP	lemma_4=,	relType_5=conj	pos_6=,	path=Terfenadine_conj<hypoglycemic_parataxis>hypoglycemic_appos	wib=Cisapride	lemma_6=act	pos_3=,	eib=True	pos_4=NNP	pos_6=NNS	pos_7=JJ	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e13	null	pos_6=JJ	pos_5=,	lemma_6=,	pos_16=DT	relType_8=punct	lemma_2=Cisapride	pos_8=NNS	pos_6=HYPH	lemma_16=the	relType_18=case	relType_6=conj	relType_6=dep	pos_2=NNP	lemma_10=significant	lemma_18=of	relType_13=aux:pass	relType_4=punct	lemma_3=,	lemma_5=,	wib=Cisapride	pos_14=VBN	pos_3=,	pos_7=JJ	pos_6=NNS	pos_2=,	lemma_11=hypoglycemia	lemma_1=,	relType_9=advmod	path1=Terfenadine_conj	lemma_6=short	pos_1=,	pos_3=NNP	lemma_12=may	relType_8=appos	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	lemma_5=Tacrolimus	relType_2=conj	lemma_2=,	relType_15=case	lemma_4=Rifabutin	pos_5=NNP	lemma_4=,	pos_15=IN	pos_11=NN	pos_4=NNP	relType_1=punct	lemma_8=:	relType_3=punct	lemma_17=use	lpib=cisapride_NNP	lemma_7=oral	lemma_14=precipitate	lemma_9=clinically	pos_17=NN	pos_4=,	pos_18=IN	lemma_6=-	pos_13=VB	relType_7=amod	lemma_15=by	relType_3=conj	path=Terfenadine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_6=benzodiazepine	pos_9=RB	relType_5=conj	relType_11=nsubj:pass	pos_12=MD	relType_14=parataxis	pos_8=:	lemma_8=hypoglycemic	relType_10=amod	relType_16=det	lib=cisapride	pos_6=VBG	relType_6=punct	relType_6=amod	relType_12=aux	lemma_13=be	lemma_3=Astemizole	pos_10=JJ	relType_5=punct	pos_6=,	lemma_6=act	eib=True	relType_4=conj	relType_17=obl
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e6	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	pos_6=JJ	lemma_19=DIFLUCAN	pos_5=,	lemma_6=,	pos_16=DT	relType_8=punct	lemma_2=Cisapride	pos_8=NNS	pos_6=HYPH	lemma_16=the	relType_18=case	lemma_20=oral	relType_6=conj	relType_6=dep	pos_2=NNP	lemma_10=significant	lemma_18=of	relType_13=aux:pass	pos_20=JJ	lemma_19=with	relType_4=punct	lemma_3=,	lemma_5=,	wib=Cisapride	pos_14=VBN	pos_3=,	pos_7=JJ	pos_6=NNS	pos_2=,	lemma_11=hypoglycemia	lemma_1=,	relType_9=advmod	path1=Terfenadine_conj	lemma_6=short	pos_21=JJ	pos_1=,	pos_3=NNP	lemma_12=may	relType_8=appos	relType_2=punct	lemma_5=Tacrolimus	lemma_21=hypoglycemic	relType_2=conj	lemma_2=,	relType_15=case	lemma_4=Rifabutin	pos_5=NNP	lemma_4=,	pos_15=IN	pos_11=NN	relType_19=case	path=Terfenadine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	pos_4=NNP	relType_1=punct	lemma_8=:	relType_3=punct	lemma_17=use	lpib=cisapride_NNP	lemma_7=oral	lemma_14=precipitate	lemma_9=clinically	relType_19=nmod	pos_17=NN	relType_20=amod	pos_4=,	pos_18=IN	lemma_6=-	pos_13=VB	relType_7=amod	lemma_15=by	relType_3=conj	lemma_6=benzodiazepine	pos_9=RB	relType_5=conj	relType_11=nsubj:pass	pos_12=MD	relType_14=parataxis	pos_19=IN	pos_8=:	lemma_8=hypoglycemic	relType_10=amod	relType_16=det	lib=cisapride	pos_6=VBG	relType_6=punct	relType_6=amod	relType_21=amod	relType_12=aux	lemma_13=be	lemma_3=Astemizole	pos_10=JJ	relType_5=punct	pos_6=,	lemma_6=act	eib=True	relType_4=conj	pos_19=NNP	relType_17=obl
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e8	null	wib=Astemizole	path1=Cisapride_conj	lib=astemizole	lemma_1=,	eib=False	path2=Astemizole_conj	pos_1=,	lpib=astemizole_NNP	relType_1=punct	path=Cisapride_conj<hypoglycemic_parataxis>Astemizole_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e9	null	wib=Astemizole	lib=astemizole	path1=Cisapride_conj	path2=Rifabutin_conj	lemma_1=,	eib=True	path=Cisapride_conj<hypoglycemic_parataxis>Rifabutin_conj	pos_2=NNP	pos_1=,	pos_2=,	lemma_2=Astemizole	lpib=astemizole_NNP	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e10	null	lib=astemizole	path1=Cisapride_conj	lemma_1=,	pos_1=,	pos_3=NNP	lemma_2=Astemizole	relType_2=punct	wib=Astemizole	pos_2=NNP	relType_2=conj	lemma_2=,	path=Cisapride_conj<hypoglycemic_parataxis>Tacrolimus_conj	lemma_3=,	relType_3=conj	lemma_3=Rifabutin	lpib=astemizole_NNP	pos_3=,	eib=True	path2=Tacrolimus_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e11	null	lib=astemizole	path1=Cisapride_conj	lemma_1=,	pos_1=,	pos_3=NNP	lemma_2=Astemizole	relType_2=punct	wib=Astemizole	pos_2=NNP	pos_4=,	pos_5=HYPH	lemma_5=act	relType_2=conj	relType_5=dep	lemma_2=,	path=Cisapride_conj<hypoglycemic_parataxis>benzodiazepine_conj	pos_5=JJ	relType_4=punct	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	relType_5=amod	relType_5=punct	lemma_5=short	lemma_3=Rifabutin	lemma_4=,	lpib=astemizole_NNP	pos_3=,	pos_5=VBG	eib=True	pos_4=NNP	lemma_4=Tacrolimus	pos_2=,	relType_4=conj	relType_1=punct	lemma_5=-	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e12	null	lib=astemizole	path1=Cisapride_conj	path2=hypoglycemic_appos	lemma_1=,	pos_6=JJ	pos_5=,	pos_1=,	pos_3=NNP	lemma_2=Astemizole	path=Cisapride_conj<hypoglycemic_parataxis>hypoglycemic_appos	relType_2=punct	wib=Astemizole	pos_2=NNP	pos_4=,	pos_5=NNS	relType_6=amod	pos_5=HYPH	lemma_5=act	relType_2=conj	relType_5=dep	lemma_2=,	pos_5=JJ	lemma_6=oral	relType_4=punct	lemma_3=,	relType_5=amod	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=short	lemma_3=Rifabutin	lemma_4=,	lpib=astemizole_NNP	relType_5=conj	pos_3=,	pos_5=VBG	eib=True	pos_4=NNP	lemma_4=Tacrolimus	pos_2=,	relType_4=conj	relType_1=punct	lemma_5=-	lemma_5=benzodiazepine	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e13	null	pos_6=JJ	pos_5=,	pos_13=VBN	pos_2=NNP	lemma_5=act	pos_10=NN	relType_5=dep	relType_8=advmod	pos_15=DT	relType_4=punct	lemma_3=,	lemma_5=,	lemma_5=short	lemma_11=may	pos_7=:	pos_3=,	pos_2=,	lemma_5=-	lemma_5=benzodiazepine	pos_7=NNS	lemma_1=,	pos_1=,	pos_3=NNP	relType_13=parataxis	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	wib=Astemizole	relType_2=conj	lemma_2=,	lemma_7=:	pos_14=IN	lemma_8=clinically	lemma_3=Rifabutin	lemma_4=,	pos_16=NN	lemma_16=use	pos_4=NNP	relType_1=punct	relType_15=det	relType_3=punct	path1=Cisapride_conj	relType_7=appos	pos_11=MD	relType_16=obl	lemma_2=Astemizole	pos_17=IN	pos_4=,	lemma_15=the	pos_8=RB	relType_11=aux	relType_9=amod	relType_17=case	lemma_6=oral	relType_5=amod	relType_3=conj	lemma_10=hypoglycemia	lemma_17=of	lpib=astemizole_NNP	relType_5=conj	pos_12=VB	lemma_4=Tacrolimus	relType_14=case	lemma_13=precipitate	path=Cisapride_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lib=astemizole	relType_12=aux:pass	pos_9=JJ	pos_5=NNS	relType_6=amod	pos_5=HYPH	lemma_14=by	lemma_7=hypoglycemic	relType_10=nsubj:pass	pos_5=JJ	lemma_12=be	relType_5=punct	lemma_9=significant	pos_5=VBG	eib=True	relType_7=punct	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e7	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	pos_6=JJ	pos_5=,	pos_13=VBN	relType_18=case	pos_2=NNP	lemma_5=act	pos_10=NN	relType_5=dep	relType_8=advmod	pos_15=DT	pos_20=JJ	relType_4=punct	lemma_3=,	lemma_5=,	lemma_5=short	lemma_11=may	pos_7=:	pos_3=,	pos_2=,	lemma_5=-	lemma_5=benzodiazepine	pos_7=NNS	lemma_1=,	pos_1=,	pos_3=NNP	relType_13=parataxis	relType_2=punct	wib=Astemizole	pos_19=JJ	relType_2=conj	lemma_2=,	lemma_7=:	pos_14=IN	lemma_8=clinically	lemma_3=Rifabutin	lemma_4=,	pos_16=NN	relType_19=amod	lemma_19=oral	lemma_16=use	pos_4=NNP	lemma_20=hypoglycemic	relType_1=punct	relType_18=nmod	relType_15=det	relType_3=punct	path1=Cisapride_conj	relType_7=appos	pos_11=MD	relType_16=obl	lemma_2=Astemizole	pos_17=IN	lemma_18=DIFLUCAN	relType_20=amod	pos_4=,	lemma_15=the	pos_8=RB	relType_11=aux	relType_9=amod	pos_18=IN	relType_17=case	lemma_6=oral	relType_5=amod	relType_3=conj	lemma_10=hypoglycemia	lemma_17=of	lpib=astemizole_NNP	relType_5=conj	pos_12=VB	lemma_4=Tacrolimus	relType_14=case	lemma_13=precipitate	path=Cisapride_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lib=astemizole	pos_18=NNP	relType_12=aux:pass	pos_9=JJ	pos_5=NNS	relType_6=amod	pos_5=HYPH	lemma_14=by	lemma_7=hypoglycemic	relType_10=nsubj:pass	pos_5=JJ	lemma_12=be	relType_5=punct	lemma_9=significant	lemma_18=with	pos_5=VBG	eib=True	relType_7=punct	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e9	null	path2=Rifabutin_conj	lemma_1=,	wib=Rifabutin	path1=Astemizole_conj	lpib=rifabutin_NNP	eib=False	pos_1=,	path=Astemizole_conj<hypoglycemic_parataxis>Rifabutin_conj	relType_1=punct	lib=rifabutin
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e10	null	lemma_2=Rifabutin	lemma_1=,	wib=Rifabutin	path1=Astemizole_conj	lpib=rifabutin_NNP	eib=True	pos_2=NNP	path2=Tacrolimus_conj	pos_1=,	path=Astemizole_conj<hypoglycemic_parataxis>Tacrolimus_conj	pos_2=,	relType_1=punct	relType_2=conj	lib=rifabutin	lemma_2=,	relType_2=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e11	null	relType_4=dep	lemma_2=Rifabutin	lemma_1=,	pos_4=JJ	relType_4=amod	pos_1=,	pos_3=NNP	lemma_4=-	pos_4=HYPH	lemma_4=act	lib=rifabutin	relType_2=punct	lemma_4=short	lemma_3=Tacrolimus	pos_2=NNP	path=Astemizole_conj<hypoglycemic_parataxis>benzodiazepine_conj	relType_2=conj	lemma_2=,	wib=Rifabutin	lemma_3=,	path2=benzodiazepine_conj	relType_3=conj	relType_4=punct	pos_4=VBG	pos_3=,	path1=Astemizole_conj	lpib=rifabutin_NNP	eib=True	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e12	null	relType_4=dep	path2=hypoglycemic_appos	lemma_1=,	lemma_2=Rifabutin	pos_4=JJ	relType_4=amod	pos_1=,	pos_3=NNP	lemma_4=-	pos_4=HYPH	lemma_4=act	lib=rifabutin	relType_2=punct	lemma_4=short	lemma_3=Tacrolimus	lemma_5=oral	pos_2=NNP	pos_4=,	relType_2=conj	lemma_2=,	pos_4=NNS	pos_5=JJ	wib=Rifabutin	lemma_3=,	relType_4=punct	relType_3=conj	relType_5=amod	lemma_4=,	pos_4=VBG	lemma_4=benzodiazepine	pos_3=,	path1=Astemizole_conj	lpib=rifabutin_NNP	eib=True	path=Astemizole_conj<hypoglycemic_parataxis>hypoglycemic_appos	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e13	null	relType_4=dep	lemma_2=Rifabutin	lemma_1=,	pos_4=JJ	relType_4=amod	relType_8=amod	pos_16=IN	pos_1=,	pos_3=NNP	lemma_4=-	lemma_11=be	pos_4=HYPH	lemma_4=act	lib=rifabutin	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_15=use	relType_2=punct	pos_8=JJ	lemma_4=short	lemma_3=Tacrolimus	lemma_5=oral	pos_2=NNP	pos_4=,	pos_7=RB	relType_6=punct	pos_10=MD	relType_10=aux	relType_12=parataxis	lemma_6=:	relType_9=nsubj:pass	relType_14=det	relType_11=aux:pass	pos_13=IN	lemma_14=the	lemma_16=of	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lemma_7=clinically	lemma_13=by	relType_13=case	pos_5=JJ	lemma_8=significant	wib=Rifabutin	lemma_3=,	relType_4=punct	relType_3=conj	relType_5=amod	lemma_12=precipitate	pos_15=NN	relType_15=obl	lemma_4=,	pos_4=VBG	pos_14=DT	lemma_4=benzodiazepine	relType_16=case	lemma_10=may	pos_3=,	path1=Astemizole_conj	lpib=rifabutin_NNP	eib=True	relType_6=appos	lemma_9=hypoglycemia	pos_11=VB	pos_6=NNS	path=Astemizole_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_2=,	relType_4=conj	relType_7=advmod	relType_1=punct	lemma_6=hypoglycemic	pos_12=VBN	relType_3=punct	pos_6=:
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e8	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	lib=rifabutin	lemma_15=use	pos_8=JJ	lemma_4=short	pos_2=NNP	pos_7=RB	relType_12=parataxis	relType_11=aux:pass	lemma_7=clinically	lemma_13=by	relType_15=obl	relType_4=punct	lemma_3=,	pos_3=,	relType_6=appos	pos_11=VB	pos_6=NNS	pos_2=,	relType_4=amod	lemma_1=,	lemma_17=DIFLUCAN	pos_1=,	pos_3=NNP	lemma_11=be	lemma_4=act	relType_2=punct	pos_10=MD	lemma_5=oral	relType_9=nsubj:pass	pos_19=JJ	lemma_14=the	relType_2=conj	pos_9=NN	lemma_2=,	lemma_8=significant	wib=Rifabutin	lemma_12=precipitate	lemma_4=,	path=Astemizole_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	relType_19=amod	lemma_4=benzodiazepine	relType_16=case	lemma_10=may	pos_12=VBN	relType_1=punct	lemma_6=hypoglycemic	relType_3=punct	pos_6=:	relType_4=dep	pos_16=IN	lemma_4=-	lemma_18=oral	pos_17=IN	lemma_17=with	pos_17=NNP	pos_4=,	relType_10=aux	pos_13=IN	relType_17=case	relType_13=case	relType_5=amod	relType_3=conj	relType_17=nmod	pos_14=DT	lemma_19=hypoglycemic	path1=Astemizole_conj	lpib=rifabutin_NNP	relType_7=advmod	lemma_2=Rifabutin	pos_4=JJ	relType_8=amod	relType_18=amod	pos_4=HYPH	lemma_3=Tacrolimus	relType_6=punct	lemma_6=:	relType_14=det	pos_18=JJ	lemma_16=of	pos_4=NNS	pos_5=JJ	pos_15=NN	pos_4=VBG	lemma_9=hypoglycemia	eib=True	relType_4=conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e9	DDI-DrugBank.d776.s2.e10	null	lemma_1=,	eib=False	path2=Tacrolimus_conj	path1=Rifabutin_conj	pos_1=,	path=Rifabutin_conj<hypoglycemic_parataxis>Tacrolimus_conj	lib=tacrolimus	relType_1=punct	wib=Tacrolimus	lpib=tacrolimus_NNP
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e9	DDI-DrugBank.d776.s2.e11	null	relType_3=dep	lemma_1=,	pos_1=,	relType_2=punct	path=Rifabutin_conj<hypoglycemic_parataxis>benzodiazepine_conj	pos_2=NNP	lemma_2=Tacrolimus	lemma_3=-	lemma_3=short	pos_3=VBG	wib=Tacrolimus	relType_2=conj	lemma_2=,	relType_3=amod	path2=benzodiazepine_conj	lemma_3=act	path1=Rifabutin_conj	lpib=tacrolimus_NNP	pos_3=JJ	eib=True	pos_3=HYPH	lib=tacrolimus	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e9	DDI-DrugBank.d776.s2.e12	null	relType_3=dep	path2=hypoglycemic_appos	lemma_1=,	pos_4=JJ	relType_4=amod	pos_1=,	relType_2=punct	pos_3=NNS	pos_2=NNP	lemma_2=Tacrolimus	lemma_3=-	lemma_3=short	pos_3=VBG	wib=Tacrolimus	relType_2=conj	lemma_2=,	relType_3=amod	lemma_3=,	relType_3=conj	lemma_3=act	path1=Rifabutin_conj	lpib=tacrolimus_NNP	pos_3=JJ	pos_3=,	eib=True	lemma_4=oral	pos_3=HYPH	path=Rifabutin_conj<hypoglycemic_parataxis>hypoglycemic_appos	lib=tacrolimus	pos_2=,	relType_1=punct	lemma_3=benzodiazepine	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e9	DDI-DrugBank.d776.s2.e13	null	relType_3=dep	relType_4=amod	lemma_1=,	pos_4=JJ	lemma_13=the	lemma_15=of	lemma_14=use	pos_1=,	relType_12=case	pos_13=DT	relType_9=aux	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_2=punct	relType_8=nsubj:pass	pos_8=NN	relType_10=aux:pass	path=Rifabutin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_3=NNS	pos_2=NNP	lemma_2=Tacrolimus	pos_5=NNS	lemma_3=-	pos_9=MD	lemma_3=short	pos_14=NN	pos_3=VBG	wib=Tacrolimus	relType_2=conj	pos_10=VB	lemma_2=,	pos_5=:	pos_12=IN	relType_14=obl	relType_15=case	relType_7=amod	relType_3=amod	lemma_3=,	relType_3=conj	lemma_7=significant	lemma_3=act	relType_5=punct	path1=Rifabutin_conj	lemma_9=may	pos_11=VBN	pos_6=RB	lemma_5=hypoglycemic	lpib=tacrolimus_NNP	relType_5=appos	pos_15=IN	lemma_12=by	lemma_11=precipitate	lemma_6=clinically	pos_3=JJ	pos_3=,	eib=True	lemma_4=oral	lemma_5=:	pos_3=HYPH	lemma_8=hypoglycemia	pos_7=JJ	relType_11=parataxis	relType_13=det	lib=tacrolimus	pos_2=,	relType_1=punct	lemma_3=benzodiazepine	relType_6=advmod	relType_3=punct	lemma_10=be
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e9	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	relType_16=nmod	lemma_14=use	relType_10=aux:pass	pos_3=NNS	pos_2=NNP	lemma_3=-	lemma_3=short	relType_3=amod	lemma_3=,	lemma_7=significant	path1=Rifabutin_conj	lemma_9=may	lemma_11=precipitate	pos_3=JJ	pos_3=,	lemma_8=hypoglycemia	pos_3=HYPH	pos_7=JJ	relType_13=det	pos_2=,	relType_3=dep	relType_4=amod	lemma_1=,	lemma_15=of	pos_1=,	lemma_16=DIFLUCAN	relType_9=aux	relType_2=punct	pos_8=NN	lemma_18=hypoglycemic	pos_9=MD	wib=Tacrolimus	relType_2=conj	pos_10=VB	lemma_2=,	pos_5=:	pos_12=IN	relType_15=case	lemma_3=act	pos_6=RB	relType_5=appos	lpib=tacrolimus_NNP	relType_17=amod	pos_15=IN	relType_16=case	lemma_4=oral	relType_1=punct	relType_3=punct	lemma_10=be	pos_16=IN	relType_12=case	relType_8=nsubj:pass	lemma_2=Tacrolimus	lemma_17=oral	pos_14=NN	lemma_16=with	pos_3=VBG	relType_14=obl	relType_7=amod	relType_3=conj	lemma_12=by	lemma_6=clinically	lemma_5=:	lemma_3=benzodiazepine	relType_11=parataxis	pos_4=JJ	lemma_13=the	relType_18=amod	pos_13=DT	pos_17=JJ	pos_5=NNS	pos_18=JJ	relType_5=punct	pos_16=NNP	pos_11=VBN	lemma_5=hypoglycemic	eib=True	path=Rifabutin_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lib=tacrolimus	relType_6=advmod
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e10	DDI-DrugBank.d776.s2.e11	null	lemma_1=,	pos_1=,	path=Tacrolimus_conj<hypoglycemic_parataxis>benzodiazepine_conj	pos_2=HYPH	pos_2=JJ	relType_2=punct	lemma_2=-	lib=short	relType_2=dep	path2=benzodiazepine_conj	relType_2=amod	wib=Short	lemma_2=act	path1=Tacrolimus_conj	lpib=short_JJ	eib=True	relType_1=punct	lemma_2=short	pos_2=VBG
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e10	DDI-DrugBank.d776.s2.e12	null	path2=hypoglycemic_appos	lemma_1=,	path=Tacrolimus_conj<hypoglycemic_parataxis>hypoglycemic_appos	pos_1=,	pos_2=HYPH	pos_2=JJ	relType_2=punct	lemma_2=-	lib=short	relType_2=conj	lemma_2=,	relType_2=dep	relType_3=amod	relType_2=amod	wib=Short	pos_2=NNS	lemma_2=act	path1=Tacrolimus_conj	lpib=short_JJ	pos_3=JJ	lemma_3=oral	eib=True	pos_2=,	relType_1=punct	lemma_2=benzodiazepine	lemma_2=short	pos_2=VBG
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e10	DDI-DrugBank.d776.s2.e13	null	lemma_1=,	pos_6=JJ	relType_9=aux:pass	relType_4=appos	pos_1=,	pos_9=VB	pos_2=HYPH	pos_2=JJ	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_12=det	relType_11=case	relType_2=punct	relType_10=parataxis	relType_13=obl	lemma_4=:	lemma_2=-	lib=short	path=Tacrolimus_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_7=hypoglycemia	pos_8=MD	relType_6=amod	relType_7=nsubj:pass	lemma_4=hypoglycemic	pos_13=NN	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_12=the	pos_11=IN	pos_14=IN	relType_2=dep	lemma_13=use	relType_4=punct	relType_3=amod	pos_4=:	lemma_11=by	relType_2=amod	pos_5=RB	lemma_9=be	relType_5=advmod	wib=Short	pos_2=NNS	lemma_2=act	lemma_10=precipitate	path1=Tacrolimus_conj	lpib=short_JJ	pos_3=JJ	lemma_3=oral	eib=True	lemma_6=significant	pos_10=VBN	lemma_14=of	pos_2=,	lemma_8=may	relType_8=aux	lemma_5=clinically	pos_12=DT	relType_1=punct	pos_7=NN	lemma_2=benzodiazepine	relType_14=case	lemma_2=short	pos_2=VBG
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e10	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	lemma_17=hypoglycemic	lemma_1=,	pos_6=JJ	pos_15=NNP	relType_9=aux:pass	relType_4=appos	pos_1=,	pos_9=VB	pos_17=JJ	pos_2=HYPH	pos_2=JJ	relType_12=det	relType_11=case	relType_2=punct	relType_10=parataxis	lemma_15=DIFLUCAN	relType_16=amod	relType_13=obl	lemma_4=:	lemma_2=-	lib=short	path=Tacrolimus_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lemma_7=hypoglycemia	pos_8=MD	relType_6=amod	lemma_15=with	relType_7=nsubj:pass	lemma_4=hypoglycemic	pos_13=NN	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_12=the	pos_11=IN	pos_14=IN	relType_2=dep	relType_15=case	lemma_13=use	relType_4=punct	relType_3=amod	pos_4=:	lemma_11=by	pos_16=JJ	lemma_16=oral	relType_2=amod	pos_5=RB	lemma_9=be	relType_15=nmod	relType_5=advmod	wib=Short	pos_15=IN	pos_2=NNS	relType_17=amod	lemma_2=act	lemma_10=precipitate	path1=Tacrolimus_conj	lpib=short_JJ	pos_3=JJ	lemma_3=oral	eib=True	lemma_6=significant	pos_10=VBN	lemma_14=of	pos_2=,	lemma_8=may	relType_8=aux	lemma_5=clinically	pos_12=DT	relType_1=punct	pos_7=NN	lemma_2=benzodiazepine	relType_14=case	lemma_2=short	pos_2=VBG
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e11	DDI-DrugBank.d776.s2.e12	null	lemma_2=oral	path2=hypoglycemic_appos	lemma_1=,	lib=oral	eib=False	path=benzodiazepine_conj<hypoglycemic_parataxis>hypoglycemic_appos	relType_2=amod	pos_1=,	wib=Oral	lpib=oral_JJ	relType_1=punct	pos_2=JJ	path1=benzodiazepine_conj
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e11	DDI-DrugBank.d776.s2.e13	null	relType_9=parataxis	relType_12=obl	lemma_1=,	lib=oral	lemma_12=use	pos_1=,	lemma_10=by	relType_7=aux	pos_2=JJ	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	pos_6=NN	lemma_13=of	lemma_6=hypoglycemia	pos_4=RB	lemma_5=significant	pos_3=NNS	relType_3=appos	lemma_3=:	relType_8=aux:pass	path=benzodiazepine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_4=clinically	pos_7=MD	wib=Oral	lemma_7=may	pos_9=VBN	lemma_9=precipitate	path1=benzodiazepine_conj	relType_10=case	pos_13=IN	pos_8=VB	lemma_2=oral	relType_13=case	pos_5=JJ	relType_5=amod	lemma_8=be	pos_3=:	relType_2=amod	relType_4=advmod	relType_6=nsubj:pass	pos_10=IN	pos_11=DT	lpib=oral_JJ	lemma_11=the	relType_11=det	lemma_3=hypoglycemic	eib=True	relType_1=punct	pos_12=NN	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e11	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	relType_9=parataxis	relType_12=obl	lemma_1=,	lib=oral	lemma_12=use	pos_14=NNP	pos_15=JJ	lemma_16=hypoglycemic	relType_15=amod	lemma_14=with	pos_1=,	lemma_10=by	relType_7=aux	relType_14=nmod	pos_2=JJ	pos_6=NN	lemma_13=of	lemma_6=hypoglycemia	relType_16=amod	pos_4=RB	lemma_5=significant	pos_3=NNS	relType_3=appos	lemma_3=:	relType_8=aux:pass	lemma_4=clinically	pos_7=MD	wib=Oral	lemma_7=may	pos_9=VBN	lemma_9=precipitate	path1=benzodiazepine_conj	relType_10=case	pos_13=IN	pos_8=VB	pos_14=IN	lemma_2=oral	relType_13=case	pos_5=JJ	pos_16=JJ	relType_5=amod	lemma_14=DIFLUCAN	lemma_8=be	pos_3=:	relType_2=amod	relType_4=advmod	relType_6=nsubj:pass	pos_10=IN	pos_11=DT	lpib=oral_JJ	lemma_11=the	relType_11=det	lemma_3=hypoglycemic	path=benzodiazepine_conj<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	eib=True	relType_14=case	lemma_15=oral	relType_1=punct	pos_12=NN	relType_3=punct
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e12	DDI-DrugBank.d776.s2.e13	null	relType_6=aux:pass	relType_8=case	pos_6=VB	path=hypoglycemic_appos<hypoglycemic_parataxis>precipitate_parataxis>use_obl>DIFLUCAN_nmod	lemma_4=hypoglycemia	path2=precipitate_parataxis>use_obl>DIFLUCAN_nmod	relType_11=case	lemma_6=be	pos_2=RB	lemma_5=may	relType_7=parataxis	eib=False	relType_2=advmod	pos_9=DT	relType_4=nsubj:pass	lemma_3=significant	relType_5=aux	pos_10=NN	pos_4=NN	lemma_1=:	pos_8=IN	pos_11=IN	path1=hypoglycemic_appos	pos_5=MD	relType_3=amod	lemma_8=by	wib=Clinically	pos_1=:	pos_7=VBN	pos_3=JJ	lemma_2=clinically	lib=clinically	lemma_9=the	lemma_11=of	relType_1=punct	relType_10=obl	lpib=clinically_RB	lemma_10=use	relType_9=det	lemma_7=precipitate
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e12	DDI-DrugBank.d776.s2.e14	null	path2=precipitate_parataxis>use_obl>agent_nmod	relType_6=aux:pass	relType_8=case	relType_14=amod	pos_6=VB	relType_12=case	lemma_4=hypoglycemia	relType_11=case	path=hypoglycemic_appos<hypoglycemic_parataxis>precipitate_parataxis>use_obl>agent_nmod	lemma_6=be	pos_2=RB	lemma_5=may	relType_7=parataxis	relType_2=advmod	relType_13=amod	relType_12=nmod	pos_9=DT	relType_4=nsubj:pass	lemma_3=significant	relType_5=aux	pos_10=NN	lemma_12=with	pos_4=NN	pos_12=IN	lemma_1=:	pos_8=IN	pos_11=IN	lemma_12=DIFLUCAN	path1=hypoglycemic_appos	pos_5=MD	pos_13=JJ	relType_3=amod	lemma_8=by	wib=Clinically	pos_1=:	lemma_13=oral	pos_7=VBN	pos_3=JJ	eib=True	pos_12=NNP	lemma_2=clinically	lib=clinically	lemma_9=the	lemma_14=hypoglycemic	lemma_11=of	pos_14=JJ	relType_1=punct	relType_10=obl	lpib=clinically_RB	lemma_10=use	relType_9=det	lemma_7=precipitate
DDI-DrugBank.d776.s2	DDI-DrugBank.d776.s2.e13	DDI-DrugBank.d776.s2.e14	effect	lemma_2=oral	path1=DIFLUCAN_nmod	lemma_1=with	relType_1=case	lemma_3=hypoglycemic	lib=oral	pos_3=JJ	relType_3=amod	eib=True	wib=oral	path2=agent_nmod	relType_2=amod	path=DIFLUCAN_nmod<use_obl>agent_nmod	pos_1=IN	lpib=oral_JJ	pos_2=JJ
DDI-DrugBank.d776.s3	DDI-DrugBank.d776.s3.e0	DDI-DrugBank.d776.s3.e1	effect	relType_1=cc	path=<DIFLUCAN_nmod>glyburide_conj	pos_1=CC	wib=glyburide	eib=False	path1=	lpib=glyburide_NN	path2=glyburide_conj	lib=glyburide	lemma_1=and
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e0	DDI-DrugBank.d776.s4.e1	mechanism	pos_2=DT	lemma_2=the	lib=reduce	relation_0=adverse	eib=False	lpib=reduce_VBZ	lemma_3=metabolism	pos_4=IN	relType_4=case	path=DIFLUCAN_nsubj<reduce_ROOT>metabolism_obj>tolbutamide_nmod	path1=DIFLUCAN_nsubj	relType_1=ROOT	pos_1=VBZ	pos_3=NN	relType_2=det	lemma_1=reduce	wib=reduces	relType_3=obj	lemma_4=of	path2=metabolism_obj>tolbutamide_nmod
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e0	DDI-DrugBank.d776.s4.e2	mechanism	pos_2=DT	lemma_2=the	path2=metabolism_obj>tolbutamide_nmod>glyburide_conj	lib=reduce	pos_5=,	relation_0=adverse	lpib=reduce_VBZ	lemma_3=metabolism	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	relType_5=nmod	path1=DIFLUCAN_nsubj	relType_1=ROOT	pos_5=NN	lemma_5=tolbutamide	path=DIFLUCAN_nsubj<reduce_ROOT>metabolism_obj>tolbutamide_nmod>glyburide_conj	pos_1=VBZ	eib=True	pos_3=NN	relType_2=det	lemma_1=reduce	wib=reduces	relType_3=obj	lemma_4=of
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e0	DDI-DrugBank.d776.s4.e3	mechanism	pos_2=DT	lemma_2=the	lib=reduce	pos_5=,	lemma_6=,	relType_7=cc	relation_0=adverse	pos_6=NN	relType_6=conj	lpib=reduce_VBZ	relType_6=punct	path2=metabolism_obj>tolbutamide_nmod>glipizide_conj	lemma_6=glyburide	lemma_3=metabolism	pos_7=CC	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	relType_5=nmod	pos_6=,	path1=DIFLUCAN_nsubj	relType_1=ROOT	pos_5=NN	lemma_5=tolbutamide	pos_1=VBZ	eib=True	pos_3=NN	lemma_7=and	relType_2=det	lemma_1=reduce	wib=reduces	path=DIFLUCAN_nsubj<reduce_ROOT>metabolism_obj>tolbutamide_nmod>glipizide_conj	relType_3=obj	lemma_4=of
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e1	DDI-DrugBank.d776.s4.e2	null	lemma_1=,	wib=glyburide	eib=False	path1=	lpib=glyburide_NN	path=<tolbutamide_nmod>glyburide_conj	pos_1=,	path2=glyburide_conj	relType_1=punct	lib=glyburide
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e1	DDI-DrugBank.d776.s4.e3	null	lemma_1=,	pos_2=NN	path2=glipizide_conj	pos_3=CC	path1=	pos_1=,	lib=glyburide	lemma_2=glyburide	relType_3=cc	relType_2=punct	path=<tolbutamide_nmod>glipizide_conj	wib=glyburide	relType_2=conj	lemma_2=,	lpib=glyburide_NN	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d776.s4	DDI-DrugBank.d776.s4.e2	DDI-DrugBank.d776.s4.e3	null	wib=glipizide	lemma_2=and	lemma_1=,	eib=False	path2=glipizide_conj	path=glyburide_conj<tolbutamide_nmod>glipizide_conj	pos_2=CC	pos_1=,	lib=glipizide	lpib=glipizide_NN	relType_1=punct	relType_2=cc	path1=glyburide_conj
DDI-DrugBank.d776.s5	DDI-DrugBank.d776.s5.e0	DDI-DrugBank.d776.s5.e1	advise	relType_4=mark	pos_2=VBN	lemma_8=sulfonylurea	pos_3=RB	relType_3=advmod	relType_8=amod	relType_1=aux:pass	lemma_8=hypoglycemic	lemma_7=other	lemma_2=use	pos_8=NN	pos_8=JJ	lemma_1=be	path2=monitor_advcl>this_dep>agent_conj	lemma_6=or	relType_5=dep	lemma_8=oral	lemma_4=with	relType_7=amod	lib=be	pos_6=CC	relType_2=ROOT	pos_4=IN	relType_8=compound	lemma_5=this	path=DIFLUCAN_nsubj:pass<use_ROOT>monitor_advcl>this_dep>agent_conj	wib=is	pos_1=VBZ	eib=True	lemma_3=concomitantly	pos_5=DT	pos_7=JJ	path1=DIFLUCAN_nsubj:pass	lpib=be_VBZ	relType_6=cc
DDI-DrugBank.d776.s5	DDI-DrugBank.d776.s5.e0	DDI-DrugBank.d776.s5.e2	null	relType_8=punct	lemma_2=use	pos_8=NNS	pos_8=JJ	relType_17=det	pos_10=NN	relType_5=dep	relType_13=aux:pass	pos_18=NN	pos_14=RB	lemma_12=should	lemma_10=glucose	pos_1=VBZ	pos_7=JJ	path1=DIFLUCAN_nsubj:pass	relType_8=conj	lemma_15=monitor	lemma_18=dose	relType_4=mark	relType_16=cc	lemma_8=sulfonylurea	pos_16=CC	lemma_7=other	pos_8=NN	lemma_11=concentration	relType_14=advmod	pos_15=VBN	lemma_20=the	pos_9=NN	lemma_8=oral	pos_6=CC	relType_2=ROOT	lemma_8=agent	lemma_17=the	lemma_3=concomitantly	relType_19=case	pos_8=,	pos_2=VBN	pos_3=RB	pos_17=DT	lemma_8=,	path=DIFLUCAN_nsubj:pass<use_ROOT>monitor_advcl>adjust_conj>dose_nsubj:pass>sulfonylurea_nmod	lemma_14=carefully	lemma_1=be	lemma_6=or	lemma_4=with	relType_15=advcl	pos_13=VB	lemma_19=of	relType_7=amod	lib=be	pos_4=IN	relType_8=compound	relType_11=nsubj:pass	wib=is	pos_12=MD	pos_5=DT	relType_18=nsubj:pass	relType_20=det	relType_6=cc	pos_19=IN	relType_3=advmod	relType_8=amod	relType_1=aux:pass	lemma_8=hypoglycemic	pos_20=DT	relType_9=compound	pos_11=NNS	relType_12=aux	relType_10=compound	lemma_13=be	lemma_5=this	lemma_16=and	path2=monitor_advcl>adjust_conj>dose_nsubj:pass>sulfonylurea_nmod	eib=True	lemma_9=blood	lpib=be_VBZ
DDI-DrugBank.d776.s5	DDI-DrugBank.d776.s5.e1	DDI-DrugBank.d776.s5.e2	null	relType_6=aux:pass	lemma_1=,	lemma_13=the	pos_2=NN	pos_6=VB	relType_10=det	pos_8=VBN	pos_1=,	relType_12=case	relType_8=advcl	pos_13=DT	lpib=blood_NN	lemma_5=should	lemma_6=be	lemma_12=of	pos_7=RB	eib=False	lemma_10=the	relType_4=nsubj:pass	path2=adjust_conj>dose_nsubj:pass>sulfonylurea_nmod	relType_5=aux	pos_4=NNS	pos_12=IN	lemma_9=and	pos_9=CC	pos_5=MD	lemma_2=blood	relType_2=compound	lib=blood	lemma_11=dose	lemma_3=glucose	relType_11=nsubj:pass	lemma_7=carefully	lemma_8=monitor	pos_11=NN	path1=agent_conj<this_dep	pos_3=NN	relType_13=det	relType_3=compound	relType_7=advmod	relType_1=punct	lemma_4=concentration	relType_9=cc	path=agent_conj<this_dep<monitor_advcl>adjust_conj>dose_nsubj:pass>sulfonylurea_nmod	wib=blood	pos_10=DT
DDI-DrugBank.d776.s6	DDI-DrugBank.d776.s6.e0	DDI-DrugBank.d776.s6.e1	null	relType_7=case	lemma_10=concomitant	relType_10=amod	path1=	lemma_6=increase	relType_3=nsubj:pass	lemma_4=may	lpib=prothrombin_NNP	pos_8=NNS	relType_8=obl	lemma_3=time	pos_5=VB	lemma_9=receive	pos_2=NNP	eib=False	path=<anticoagulant_ROOT>increase_parataxis>patient_obl>receive_acl>anticoagulant_obj>DIFLUCAN_compound	pos_4=MD	pos_6=VBN	lemma_5=be	relType_6=parataxis	lemma_1=:	path2=increase_parataxis>patient_obl>receive_acl>anticoagulant_obj>DIFLUCAN_compound	pos_9=VBG	relType_5=aux:pass	pos_10=JJ	relType_2=compound	pos_1=:	relType_4=aux	relType_9=acl	pos_7=IN	lemma_7=in	pos_3=NN	lemma_2=Prothrombin	lib=prothrombin	lemma_8=patient	relType_1=punct	relation_5=beneficial	wib=Prothrombin
DDI-DrugBank.d776.s6	DDI-DrugBank.d776.s6.e0	DDI-DrugBank.d776.s6.e2	null	relType_12=conj	relation_5=beneficial	relType_7=case	relType_11=cc	lemma_10=concomitant	lemma_12=type	relType_10=amod	path1=	lemma_6=increase	pos_11=NNP	relType_3=nsubj:pass	lemma_4=may	lemma_12=coumarin	lpib=prothrombin_NNP	pos_8=NNS	relType_8=obl	lemma_3=time	pos_5=VB	lemma_9=receive	pos_2=NNP	relType_12=compound	pos_4=MD	relType_12=punct	pos_6=VBN	lemma_5=be	relType_6=parataxis	lemma_12=-	lemma_1=:	pos_9=VBG	relType_5=aux:pass	lemma_11=and	pos_10=JJ	relType_2=compound	pos_11=CC	pos_1=:	relType_4=aux	relType_9=acl	lemma_11=DIFLUCAN	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	relType_11=compound	path2=increase_parataxis>patient_obl>receive_acl>anticoagulant_obj	lemma_2=Prothrombin	pos_12=HYPH	lib=prothrombin	lemma_8=patient	relType_1=punct	pos_12=NN	path=<anticoagulant_ROOT>increase_parataxis>patient_obl>receive_acl>anticoagulant_obj	wib=Prothrombin
DDI-DrugBank.d776.s6	DDI-DrugBank.d776.s6.e1	DDI-DrugBank.d776.s6.e2	effect	lib=coumarin	relType_1=cc	path1=DIFLUCAN_compound	pos_1=CC	pos_2=NN	eib=True	lemma_2=-	relType_2=compound	lpib=coumarin_NN	lemma_2=coumarin	lemma_2=type	wib=coumarin	path2=	path=DIFLUCAN_compound<anticoagulant_obj>	pos_2=HYPH	relType_2=conj	lemma_1=and	relType_2=punct
DDI-DrugBank.d776.s7	DDI-DrugBank.d776.s7.e0	DDI-DrugBank.d776.s7.e1	null	path=antifungal_obl<report_ROOT>patient_obl>receive_acl>fluconazole_obj	relType_18=aux:pass	pos_14=CC	lemma_13=,	lemma_6=,	relType_3=nsubj:pass	relType_8=punct	relType_24=case	pos_3=NNS	lemma_18=be	pos_26=NN	pos_22=IN	pos_10=NN	relType_5=dep	lemma_4=(	relType_4=punct	pos_29=VBG	lemma_15=melena	pos_24=IN	relType_16=punct	relType_17=aux	pos_13=,	lemma_1=,	pos_1=,	lemma_25=prothrombin	lemma_5=bruise	relType_19=ROOT	relType_20=case	relType_10=conj	lemma_2=bleed	lemma_19=report	relType_22=case	path2=patient_obl>receive_acl>fluconazole_obj	lemma_3=event	lemma_22=with	relType_21=obl	lemma_14=and	relType_1=punct	pos_7=NN	lemma_24=in	pos_8=,	pos_2=VBG	lemma_11=,	relType_29=acl	path1=antifungal_obl	lemma_8=,	pos_20=IN	lemma_23=increase	pos_4=-LRB-	relType_11=punct	lemma_10=bleeding	lemma_26=time	relType_9=amod	wib=bleeding	lemma_17=have	lemma_28=patient	relType_23=nmod	relType_25=compound	pos_28=NNS	pos_23=NNS	relType_2=amod	pos_25=NN	lemma_29=receive	pos_16=-RRB-	pos_18=VBN	relType_15=conj	pos_19=VBN	relType_27=case	lemma_9=gastrointestinal	relType_7=conj	relType_12=conj	lemma_21=association	relType_13=punct	lib=bleed	pos_17=VBP	relation_22=beneficial	lemma_7=epistaxis	pos_9=JJ	eib=False	relType_6=punct	lpib=bleed_VBG	lemma_27=in	lemma_12=hematuria	pos_27=IN	lemma_16=)	pos_15=NN	lemma_20=in	relType_26=obl	relType_14=cc	pos_11=,	pos_6=,	pos_5=VBG	relType_28=obl	pos_12=NN	pos_21=NN
DDI-DrugBank.d776.s7	DDI-DrugBank.d776.s7.e0	DDI-DrugBank.d776.s7.e2	null	relType_18=aux:pass	pos_14=CC	lemma_13=,	pos_30=RB	lemma_6=,	relType_3=nsubj:pass	relType_8=punct	path=antifungal_obl<report_ROOT>patient_obl>receive_acl>warfarin_obl	relType_24=case	pos_3=NNS	lemma_18=be	pos_26=NN	pos_22=IN	pos_10=NN	relType_5=dep	lemma_4=(	relType_4=punct	pos_29=VBG	lemma_15=melena	pos_24=IN	relType_16=punct	relType_17=aux	lemma_31=with	path2=patient_obl>receive_acl>warfarin_obl	pos_13=,	lemma_1=,	pos_1=,	lemma_25=prothrombin	pos_30=NN	lemma_5=bruise	relType_19=ROOT	relType_20=case	relType_10=conj	lemma_2=bleed	lemma_19=report	relType_22=case	lemma_3=event	lemma_30=fluconazole	lemma_22=with	relType_21=obl	lemma_14=and	relType_1=punct	pos_7=NN	lemma_24=in	pos_8=,	pos_2=VBG	lemma_11=,	relType_30=obj	relType_29=acl	path1=antifungal_obl	lemma_8=,	pos_20=IN	pos_31=IN	lemma_23=increase	pos_4=-LRB-	relType_11=punct	lemma_10=bleeding	lemma_26=time	relType_9=amod	wib=bleeding	lemma_17=have	lemma_28=patient	relType_23=nmod	relType_25=compound	pos_28=NNS	pos_23=NNS	relType_2=amod	pos_25=NN	lemma_29=receive	pos_16=-RRB-	pos_18=VBN	relType_15=conj	pos_19=VBN	relType_30=advmod	relType_27=case	lemma_9=gastrointestinal	relType_7=conj	relType_12=conj	lemma_21=association	relType_13=punct	lib=bleed	pos_17=VBP	relType_31=case	relation_22=beneficial	lemma_7=epistaxis	pos_9=JJ	relType_6=punct	lpib=bleed_VBG	lemma_27=in	lemma_12=hematuria	pos_27=IN	lemma_16=)	pos_15=NN	lemma_20=in	relType_26=obl	relType_14=cc	pos_11=,	lemma_30=concurrently	pos_6=,	pos_5=VBG	eib=True	relType_28=obl	pos_12=NN	pos_21=NN
DDI-DrugBank.d776.s7	DDI-DrugBank.d776.s7.e1	DDI-DrugBank.d776.s7.e2	effect	pos_2=IN	lpib=concurrently_RB	relType_2=case	lemma_1=concurrently	path=fluconazole_obj<receive_acl>warfarin_obl	eib=False	pos_1=RB	lemma_2=with	path2=warfarin_obl	path1=fluconazole_obj	lib=concurrently	relType_1=advmod	wib=concurrently
DDI-DrugBank.d776.s8	DDI-DrugBank.d776.s8.e0	DDI-DrugBank.d776.s8.e1	advise	lib=coumarin	relType_1=cc	path1=DIFLUCAN_compound	pos_1=CC	pos_2=NN	eib=True	lemma_2=-	relType_2=compound	lpib=coumarin_NN	lemma_2=coumarin	lemma_2=type	wib=coumarin	path2=	path=DIFLUCAN_compound<anticoagulant_obj>	pos_2=HYPH	relType_2=conj	lemma_1=and	relType_2=punct
DDI-DrugBank.d776.s10	DDI-DrugBank.d776.s10.e0	DDI-DrugBank.d776.s10.e1	null	lpib=diflucan_NNP	eib=False	path1=	path2=increase_parataxis>DIFLUCAN_nsubj	pos_1=:	lib=diflucan	relType_1=punct	lemma_1=:	wib=DIFLUCAN	path=<Phenytoin_ROOT>increase_parataxis>DIFLUCAN_nsubj
DDI-DrugBank.d776.s10	DDI-DrugBank.d776.s10.e0	DDI-DrugBank.d776.s10.e2	null	path1=	lemma_6=of	relType_6=case	lpib=diflucan_NNP	pos_2=NNP	relType_2=nsubj	pos_5=NNS	pos_6=IN	lemma_2=DIFLUCAN	lemma_5=concentration	relType_3=det	pos_4=NN	lemma_1=:	lemma_2=increase	wib=DIFLUCAN	path=<Phenytoin_ROOT>increase_parataxis>concentration_obj>phenytoin_nmod	path2=increase_parataxis>concentration_obj>phenytoin_nmod	relType_4=compound	pos_1=:	pos_2=VBZ	eib=True	pos_3=DT	lemma_4=plasma	relType_5=obj	lemma_3=the	lib=diflucan	relType_2=parataxis	relType_1=punct	relation_2=beneficial
DDI-DrugBank.d776.s10	DDI-DrugBank.d776.s10.e1	DDI-DrugBank.d776.s10.e2	mechanism	pos_2=DT	lemma_2=the	lemma_1=increase	wib=increases	lemma_5=of	relType_5=case	lemma_3=plasma	relation_0=beneficial	eib=False	lib=increase	pos_4=NNS	relType_4=obj	relType_1=parataxis	pos_5=IN	path=DIFLUCAN_nsubj<increase_parataxis>concentration_obj>phenytoin_nmod	path1=DIFLUCAN_nsubj	pos_1=VBZ	lpib=increase_VBZ	pos_3=NN	relType_2=det	relType_3=compound	lemma_4=concentration	path2=concentration_obj>phenytoin_nmod
DDI-DrugBank.d776.s11	DDI-DrugBank.d776.s11.e0	DDI-DrugBank.d776.s11.e1	null	lpib=concentration_NNS	lemma_4=receive	lemma_1=concentration	path2=patient_nmod>receive_acl>DIFLUCAN_obj	pos_2=IN	relType_4=acl	pos_3=NNS	eib=False	relType_1=nmod	wib=concentrations	relType_3=nmod	path1=phenytoin_compound<concentration_nmod	pos_4=VBG	path=phenytoin_compound<concentration_nmod<monitoring_nsubj:pass>patient_nmod>receive_acl>DIFLUCAN_obj	pos_1=NNS	relType_2=case	lib=concentration	lemma_2=in	lemma_3=patient
DDI-DrugBank.d776.s11	DDI-DrugBank.d776.s11.e0	DDI-DrugBank.d776.s11.e2	null	pos_5=CC	lpib=concentration_NNS	lemma_4=receive	lemma_1=concentration	path2=patient_nmod>receive_acl>DIFLUCAN_obj>phenytoin_conj	pos_2=IN	relType_4=acl	relType_5=cc	pos_3=NNS	relType_1=nmod	wib=concentrations	relType_3=nmod	pos_5=NNP	path=phenytoin_compound<concentration_nmod<monitoring_nsubj:pass>patient_nmod>receive_acl>DIFLUCAN_obj>phenytoin_conj	path1=phenytoin_compound<concentration_nmod	pos_4=VBG	lemma_5=DIFLUCAN	pos_1=NNS	relType_2=case	eib=True	lemma_5=and	relType_5=obj	lib=concentration	lemma_2=in	lemma_3=patient
DDI-DrugBank.d776.s11	DDI-DrugBank.d776.s11.e1	DDI-DrugBank.d776.s11.e2	advise	relType_1=cc	pos_1=CC	lib=phenytoin	wib=phenytoin	eib=False	path=<DIFLUCAN_obj>phenytoin_conj	path1=	path2=phenytoin_conj	lpib=phenytoin_NN	lemma_1=and
DDI-DrugBank.d776.s13	DDI-DrugBank.d776.s13.e0	DDI-DrugBank.d776.s13.e1	null	lpib=diflucan_NNP	eib=False	path=<cyclosporine_ROOT>increase_parataxis>DIFLUCAN_nsubj	path1=	path2=increase_parataxis>DIFLUCAN_nsubj	pos_1=:	lib=diflucan	relType_1=punct	lemma_1=:	wib=DIFLUCAN
DDI-DrugBank.d776.s13	DDI-DrugBank.d776.s13.e0	DDI-DrugBank.d776.s13.e2	null	pos_3=RB	relType_3=advmod	relation_4=beneficial	pos_2=MD	path1=	lpib=diflucan_NNP	pos_2=NNP	relType_2=nsubj	lemma_3=significantly	lemma_4=increase	lemma_2=DIFLUCAN	relType_2=aux	lemma_1=:	relType_4=parataxis	wib=DIFLUCAN	path2=increase_parataxis>level_obj>cyclosporine_compound	pos_1=:	path=<cyclosporine_ROOT>increase_parataxis>level_obj>cyclosporine_compound	eib=True	pos_4=VB	lemma_2=may	lib=diflucan	relType_1=punct
DDI-DrugBank.d776.s13	DDI-DrugBank.d776.s13.e1	DDI-DrugBank.d776.s13.e2	mechanism	lemma_2=significantly	path=DIFLUCAN_nsubj<increase_parataxis>level_obj>cyclosporine_compound	pos_2=RB	lemma_3=increase	path2=level_obj>cyclosporine_compound	eib=False	lemma_1=may	relType_1=aux	relType_2=advmod	lpib=significantly_RB	wib=significantly	lib=significantly	pos_1=MD	pos_3=VB	relType_3=parataxis	relation_2=beneficial	path1=DIFLUCAN_nsubj
DDI-DrugBank.d776.s14	DDI-DrugBank.d776.s14.e0	DDI-DrugBank.d776.s14.e1	null	lemma_4=creatinine	pos_5=VBZ	relType_7=case	lpib=concentration_NNS	lemma_3=serum	path1=cyclosporine_compound<concentration_nmod<monitoring_nsubj:pass	lemma_1=concentration	relType_2=cc	pos_8=NNS	relType_8=obl	lemma_2=and	lemma_9=receive	eib=False	path2=patient_obl>receive_acl>DIFLUCAN_obj	pos_6=VBN	relType_1=nmod	lemma_5=be	pos_4=NN	pos_9=VBG	relType_6=ROOT	relType_5=aux:pass	wib=concentrations	lemma_6=recommend	path=cyclosporine_compound<concentration_nmod<monitoring_nsubj:pass<recommend_ROOT>patient_obl>receive_acl>DIFLUCAN_obj	relType_9=acl	pos_1=NNS	pos_7=IN	lemma_7=in	pos_3=NN	pos_2=CC	relType_4=conj	lib=concentration	relType_3=compound	lemma_8=patient
DDI-DrugBank.d776.s14	DDI-DrugBank.d776.s14.e0	DDI-DrugBank.d776.s14.e2	null	lemma_4=creatinine	pos_5=VBZ	relType_7=case	lemma_10=DIFLUCAN	lpib=concentration_NNS	relType_10=cc	lemma_3=serum	path1=cyclosporine_compound<concentration_nmod<monitoring_nsubj:pass	lemma_1=concentration	relType_2=cc	pos_8=NNS	relType_8=obl	lemma_2=and	lemma_9=receive	pos_10=CC	pos_6=VBN	relType_1=nmod	lemma_5=be	pos_4=NN	pos_9=VBG	relType_6=ROOT	lemma_10=and	relType_5=aux:pass	wib=concentrations	lemma_6=recommend	pos_10=NNP	relType_9=acl	pos_1=NNS	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	pos_2=CC	path2=patient_obl>receive_acl>DIFLUCAN_obj>cyclosporine_conj	lib=concentration	relType_3=compound	relType_4=conj	lemma_8=patient	relType_10=obj	path=cyclosporine_compound<concentration_nmod<monitoring_nsubj:pass<recommend_ROOT>patient_obl>receive_acl>DIFLUCAN_obj>cyclosporine_conj
DDI-DrugBank.d776.s14	DDI-DrugBank.d776.s14.e1	DDI-DrugBank.d776.s14.e2	advise	relType_1=cc	pos_1=CC	lpib=cyclosporine_NN	eib=False	path2=cyclosporine_conj	path1=	lib=cyclosporine	wib=cyclosporine	path=<DIFLUCAN_obj>cyclosporine_conj	lemma_1=and
DDI-DrugBank.d776.s16	DDI-DrugBank.d776.s16.e0	DDI-DrugBank.d776.s16.e1	null	lpib=rifampin_NNP	eib=False	wib=Rifampin	path1=	pos_1=:	lib=rifampin	relType_1=punct	path=<Rifampin_ROOT>enhance_appos>Rifampin_nsubj	lemma_1=:	path2=enhance_appos>Rifampin_nsubj
DDI-DrugBank.d776.s16	DDI-DrugBank.d776.s16.e0	DDI-DrugBank.d776.s16.e2	null	lpib=rifampin_NNP	path2=enhance_appos>metabolism_obj>DIFLUCAN_nmod	path1=	lemma_7=administer	lemma_5=of	relType_5=case	lemma_6=concurrently	pos_2=NNP	relType_2=nsubj	relType_3=det	pos_4=NN	lemma_1=:	relType_4=obj	relation_2=beneficial	relType_7=amod	wib=Rifampin	pos_1=:	pos_5=IN	lib=rifampin	lemma_2=Rifampin	relType_2=appos	lemma_2=enhance	pos_6=RB	pos_7=VBN	pos_2=VBZ	path=<Rifampin_ROOT>enhance_appos>metabolism_obj>DIFLUCAN_nmod	eib=True	pos_3=DT	lemma_3=the	relType_1=punct	relType_6=advmod	lemma_4=metabolism
DDI-DrugBank.d776.s16	DDI-DrugBank.d776.s16.e1	DDI-DrugBank.d776.s16.e2	mechanism	pos_2=DT	lemma_2=the	lpib=enhance_VBZ	relation_0=beneficial	eib=False	wib=enhances	path=Rifampin_nsubj<enhance_appos>metabolism_obj>DIFLUCAN_nmod	relType_6=amod	lib=enhance	pos_6=VBN	path1=Rifampin_nsubj	lemma_3=metabolism	path2=metabolism_obj>DIFLUCAN_nmod	relType_1=appos	lemma_5=concurrently	pos_4=IN	pos_5=RB	relType_4=case	lemma_6=administer	relType_5=advmod	lemma_1=enhance	pos_1=VBZ	pos_3=NN	relType_2=det	relType_3=obj	lemma_4=of
DDI-DrugBank.d776.s17	DDI-DrugBank.d776.s17.e0	DDI-DrugBank.d776.s17.e1	advise	lemma_4=administer	pos_1=WRB	path=DIFLUCAN_nmod<dose_obl<give_ROOT>administer_advcl>rifampin_obl	relType_3=aux:pass	relType_5=case	path2=administer_advcl>rifampin_obl	eib=False	pos_3=VBZ	lemma_5=with	lemma_2=it	relType_2=nsubj:pass	relType_1=advmod	pos_4=VBN	lib=be	lemma_1=when	lemma_3=be	pos_5=IN	pos_2=PRP	wib=is	lpib=be_VBZ	relType_4=advcl	path1=DIFLUCAN_nmod<dose_obl
DDI-DrugBank.d776.s18	DDI-DrugBank.d776.s18.e0	DDI-DrugBank.d776.s18.e1	null	lpib=diflucan_NNP	eib=False	path1=	path2=increase_parataxis>DIFLUCAN_nsubj	pos_1=:	lib=diflucan	relType_1=punct	lemma_1=:	wib=DIFLUCAN	path=<Theophylline_ROOT>increase_parataxis>DIFLUCAN_nsubj
DDI-DrugBank.d776.s18	DDI-DrugBank.d776.s18.e0	DDI-DrugBank.d776.s18.e2	null	path1=	lemma_6=of	relType_6=case	path2=increase_parataxis>concentration_obj>theophylline_nmod	lpib=diflucan_NNP	pos_2=NNP	relType_2=nsubj	path=<Theophylline_ROOT>increase_parataxis>concentration_obj>theophylline_nmod	pos_5=NNS	pos_6=IN	lemma_2=DIFLUCAN	lemma_5=concentration	relType_3=det	pos_4=NN	lemma_1=:	lemma_2=increase	wib=DIFLUCAN	relType_4=compound	pos_1=:	lemma_4=serum	pos_2=VBZ	eib=True	pos_3=DT	relType_5=obj	lemma_3=the	lib=diflucan	relType_2=parataxis	relType_1=punct	relation_2=beneficial
DDI-DrugBank.d776.s18	DDI-DrugBank.d776.s18.e1	DDI-DrugBank.d776.s18.e2	mechanism	pos_2=DT	path=DIFLUCAN_nsubj<increase_parataxis>concentration_obj>theophylline_nmod	lemma_2=the	lemma_1=increase	lemma_3=serum	wib=increases	lemma_5=of	relType_5=case	relation_0=beneficial	eib=False	lib=increase	pos_4=NNS	relType_4=obj	relType_1=parataxis	pos_5=IN	path1=DIFLUCAN_nsubj	pos_1=VBZ	lpib=increase_VBZ	pos_3=NN	relType_2=det	path2=concentration_obj>theophylline_nmod	relType_3=compound	lemma_4=concentration
DDI-DrugBank.d776.s19	DDI-DrugBank.d776.s19.e0	DDI-DrugBank.d776.s19.e1	null	lpib=concentration_NNS	lemma_4=receive	lemma_1=concentration	pos_2=IN	relType_4=acl	path2=patient_nmod>receive_acl>diflucan_obj	pos_3=NNS	eib=False	relType_1=nmod	path1=theophylline_compound<concentration_nmod	wib=concentrations	path=theophylline_compound<concentration_nmod<monitoring_nsubj:pass>patient_nmod>receive_acl>diflucan_obj	relType_3=nmod	pos_4=VBG	pos_1=NNS	relType_2=case	lib=concentration	lemma_2=in	lemma_3=patient
DDI-DrugBank.d776.s19	DDI-DrugBank.d776.s19.e0	DDI-DrugBank.d776.s19.e2	null	pos_5=CC	path=theophylline_compound<concentration_nmod<monitoring_nsubj:pass>patient_nmod>theophylline_conj	lpib=concentration_NNS	lemma_4=receive	lemma_1=concentration	pos_2=IN	relType_4=acl	relType_5=cc	pos_3=NNS	relType_1=nmod	path2=patient_nmod>theophylline_conj	path1=theophylline_compound<concentration_nmod	wib=concentrations	relType_3=nmod	pos_4=VBG	pos_5=NN	pos_1=NNS	relType_2=case	eib=True	lemma_5=and	relType_5=obj	lib=concentration	lemma_5=diflucan	lemma_2=in	lemma_3=patient
DDI-DrugBank.d776.s19	DDI-DrugBank.d776.s19.e1	DDI-DrugBank.d776.s19.e2	advise	relType_1=cc	path1=diflucan_obj<receive_acl	lib=theophylline	path=diflucan_obj<receive_acl<patient_nmod>theophylline_conj	pos_1=CC	wib=theophylline	eib=False	path2=theophylline_conj	lemma_1=and	lpib=theophylline_NN
DDI-DrugBank.d776.s20	DDI-DrugBank.d776.s20.e0	DDI-DrugBank.d776.s20.e1	null	path=<Terfenadine_ROOT>perform_parataxis>occurrence_obl>patient_nmod>receive_acl>antifungal_obj	relType_12=obl	pos_3=IN	pos_18=NNS	relType_8=amod	relType_16=nmod	relType_10=amod	path1=	lpib=occurrence_NN	lemma_6=of	relType_9=nmod	lemma_15=qtc	relType_6=case	relType_11=case	lemma_12=prolongation	lemma_13=of	pos_2=IN	relType_3=fixed	pos_8=JJ	pos_17=IN	lemma_2=because	lemma_8=cardiac	pos_6=IN	lemma_18=patient	pos_9=NNS	pos_20=NN	relType_14=det	pos_12=NN	lemma_16=interval	pos_13=IN	lib=occurrence	lemma_14=the	lemma_1=:	lemma_5=occurrence	pos_11=IN	relType_17=case	pos_4=DT	relType_13=case	relType_7=amod	pos_15=NN	pos_10=JJ	lemma_10=secondary	lemma_4=the	pos_1=:	relType_5=obl	pos_16=NN	path2=perform_parataxis>occurrence_obl>patient_nmod>receive_acl>antifungal_obj	lemma_17=in	lemma_20=azole	lemma_9=dysrhythmia	pos_14=DT	pos_19=VBG	relType_15=compound	pos_5=NN	lemma_19=receive	relType_19=acl	relType_2=case	eib=True	relType_20=compound	pos_7=JJ	wib=occurrence	lemma_3=of	lemma_7=serious	relType_1=punct	relType_4=det	relType_18=nmod	lemma_11=to
DDI-DrugBank.d776.s20	DDI-DrugBank.d776.s20.e0	DDI-DrugBank.d776.s20.e2	null	relType_16=nmod	lemma_12=prolongation	lemma_13=of	pos_8=JJ	relType_4=det	lemma_2=because	lemma_8=cardiac	lemma_18=patient	pos_20=NN	lemma_16=interval	pos_22=IN	relType_20=obj	lemma_5=occurrence	pos_1=:	lemma_20=azole	relType_15=compound	pos_7=JJ	path=<Terfenadine_ROOT>perform_parataxis>occurrence_obl>patient_nmod>receive_acl>conjunction_obl>terfenadine_nmod	lemma_7=serious	pos_18=NNS	path1=	lemma_15=qtc	relType_6=case	relType_11=case	relType_20=case	pos_6=IN	lemma_20=antifungal	lib=occurrence	lemma_14=the	relType_22=case	lemma_10=secondary	lemma_22=with	pos_16=NN	lemma_9=dysrhythmia	pos_19=VBG	pos_5=NN	relType_21=obl	wib=occurrence	relType_1=punct	relType_18=nmod	lemma_11=to	pos_3=IN	lemma_6=of	pos_20=IN	pos_17=IN	pos_2=IN	relType_3=fixed	pos_13=IN	lemma_1=:	relType_17=case	pos_11=IN	relType_13=case	relType_7=amod	lemma_4=the	relType_5=obl	lemma_17=in	pos_14=DT	lemma_21=conjunction	lemma_19=receive	relType_2=case	relType_12=obl	relType_8=amod	relType_10=amod	lpib=occurrence_NN	path2=perform_parataxis>occurrence_obl>patient_nmod>receive_acl>conjunction_obl>terfenadine_nmod	relType_9=nmod	pos_9=NNS	relType_14=det	pos_4=DT	pos_15=NN	pos_10=JJ	lemma_20=in	pos_20=NNS	relType_19=acl	eib=True	relType_20=compound	lemma_3=of	pos_12=NN	pos_21=NN
DDI-DrugBank.d776.s20	DDI-DrugBank.d776.s20.e1	DDI-DrugBank.d776.s20.e2	effect	relType_1=case	lemma_1=in	path1=antifungal_obj	pos_2=NN	wib=conjunction	eib=False	pos_3=IN	lpib=conjunction_NN	path=antifungal_obj<receive_acl>conjunction_obl>terfenadine_nmod	lemma_2=conjunction	path2=conjunction_obl>terfenadine_nmod	pos_1=IN	lemma_3=with	lib=conjunction	relType_3=case	relType_2=obl
DDI-DrugBank.d776.s22	DDI-DrugBank.d776.s22.e0	DDI-DrugBank.d776.s22.e1	null	wib=demonstrated	lemma_1=demonstrate	lpib=demonstrate_VBD	relType_1=ROOT	pos_1=VBD	path=fluconazole_nmod<dose_nmod<study_nsubj<demonstrate_ROOT>take_ccomp>DIFLUCAN_nsubj	pos_2=IN	eib=False	path1=fluconazole_nmod<dose_nmod<study_nsubj	lemma_2=that	lib=demonstrate	path2=take_ccomp>DIFLUCAN_nsubj	relType_2=mark
DDI-DrugBank.d776.s22	DDI-DrugBank.d776.s22.e0	DDI-DrugBank.d776.s22.e2	null	path=fluconazole_nmod<dose_nmod<study_nsubj<demonstrate_ROOT>take_ccomp>increase_dep>level_obj>terfenadine_nmod	wib=demonstrated	relType_12=conj	lemma_3=take	relType_11=cc	pos_3=VBN	path2=take_ccomp>increase_dep>level_obj>terfenadine_nmod	pos_3=NNP	lemma_14=increase	lemma_4=in	pos_7=CD	lemma_6=of	pos_9=IN	lemma_2=that	pos_14=VBZ	pos_16=NNS	relType_6=case	pos_8=NNS	relType_2=mark	pos_17=IN	pos_2=IN	lemma_7=400	pos_1=VBD	relType_10=nmod	lemma_13=significantly	relType_7=nummod	lemma_10=day	pos_5=NNS	pos_6=IN	pos_13=RB	relType_9=case	pos_10=NN	relType_17=case	lemma_15=plasma	relType_13=advmod	pos_15=NN	lemma_11=or	pos_4=IN	pos_11=CC	relType_4=case	lemma_16=level	relType_16=obj	relType_14=dep	relType_5=obl	lemma_17=of	lemma_9=per	lib=demonstrate	lemma_8=mg	relType_3=nsubj	relType_15=compound	lemma_1=demonstrate	relType_1=ROOT	lpib=demonstrate_VBD	lemma_5=dose	lemma_3=DIFLUCAN	relType_3=ccomp	eib=True	relType_8=nmod	relation_14=beneficial	path1=fluconazole_nmod<dose_nmod<study_nsubj	pos_12=JJR	lemma_12=great
DDI-DrugBank.d776.s22	DDI-DrugBank.d776.s22.e1	DDI-DrugBank.d776.s22.e2	mechanism	lemma_15=of	pos_1=VBN	relType_7=case	lemma_14=level	lemma_3=dose	lpib=take_VBN	pos_2=IN	pos_5=CD	pos_8=NN	pos_3=NNS	relType_14=obj	eib=False	relType_10=conj	pos_12=VBZ	lemma_6=mg	lemma_5=400	relType_11=advmod	pos_13=NN	lemma_1=take	relType_15=case	pos_9=CC	lemma_12=increase	relType_13=compound	relType_5=nummod	pos_4=IN	lemma_11=significantly	path2=increase_dep>level_obj>terfenadine_nmod	lemma_9=or	relType_1=ccomp	lib=take	relType_4=case	lemma_7=per	pos_10=JJR	lemma_13=plasma	pos_11=RB	path1=DIFLUCAN_nsubj	wib=taken	pos_15=IN	lemma_10=great	relType_2=case	relType_3=obl	relType_8=nmod	pos_7=IN	path=DIFLUCAN_nsubj<take_ccomp>increase_dep>level_obj>terfenadine_nmod	relType_12=dep	pos_6=NNS	pos_14=NNS	relation_11=beneficial	lemma_8=day	relType_6=nmod	lemma_4=of	relType_9=cc	lemma_2=in
DDI-DrugBank.d776.s23	DDI-DrugBank.d776.s23.e0	DDI-DrugBank.d776.s23.e1	advise	relType_8=case	relType_1=case	pos_3=IN	lemma_2=dose	path1=fluconazole_nmod	lemma_7=great	eib=False	relType_2=nmod	pos_5=NNS	lemma_6=or	lemma_8=with	path2=dose_nmod>terfenadine_nmod	lemma_1=at	pos_1=IN	wib=doses	pos_8=IN	pos_4=CD	lemma_4=400	pos_6=CC	relType_5=nmod	lib=dose	path=fluconazole_nmod<use_nsubj:pass>dose_nmod>terfenadine_nmod	relType_3=case	lemma_5=mg	relType_4=nummod	pos_2=NNS	lpib=dose_NNS	pos_7=JJR	lemma_3=of	relType_7=conj	relType_6=cc
DDI-DrugBank.d776.s24	DDI-DrugBank.d776.s24.e0	DDI-DrugBank.d776.s24.e1	advise	relType_1=case	lemma_2=dose	path1=fluconazole_nmod	lemma_7=/	pos_9=IN	path=fluconazole_nmod<coadministration_nsubj:pass>dose_nmod>terfenadine_nmod	pos_6=NN	pos_8=NN	pos_5=CD	relType_6=obl	eib=False	relType_2=nmod	lemma_3=low	path2=dose_nmod>terfenadine_nmod	lemma_1=at	pos_1=IN	lemma_6=mg	lemma_5=400	relType_9=case	wib=doses	pos_3=JJR	pos_7=SYM	relType_3=amod	relType_5=nummod	pos_4=IN	relType_4=case	lib=dose	pos_2=NNS	lpib=dose_NNS	lemma_9=with	relType_7=dep	relType_8=nmod	lemma_4=than	lemma_8=day
DDI-DrugBank.d776.s25	DDI-DrugBank.d776.s25.e0	DDI-DrugBank.d776.s25.e1	null	path2=report_parataxis>event_nmod>pointes_nmod>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	lemma_17=whom	lemma_13=pointes	lemma_2=there	lemma_4=be	path1=	relType_5=parataxis	lemma_6=of	lemma_9=,	pos_12=FW	lemma_16=to	relType_6=case	pos_8=NNS	lemma_8=event	relType_13=nmod	relType_4=cop	lemma_7=cardiac	lemma_10=include	relType_12=compound	eib=False	pos_5=NNS	pos_6=IN	lemma_11=torsade	pos_17=WP	path=<Cisapride_ROOT>report_parataxis>event_nmod>pointes_nmod>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	relType_10=case	lemma_14=in	lib=have	lemma_15=patient	lemma_1=:	pos_4=VBN	lemma_5=report	pos_14=IN	relType_2=expl	relType_7=amod	pos_13=FW	pos_1=:	pos_11=FW	relType_9=punct	lpib=have_VBP	relType_15=nmod	pos_2=EX	pos_16=TO	relType_16=case	lemma_12=de	pos_15=NNS	relType_8=nmod	relType_11=compound	wib=have	pos_7=JJ	pos_10=VBG	relType_3=aux	relType_14=case	pos_9=,	relType_1=punct	lemma_3=have	relType_17=obl	pos_3=VBP
DDI-DrugBank.d776.s25	DDI-DrugBank.d776.s25.e0	DDI-DrugBank.d776.s25.e2	null	lemma_17=whom	lemma_13=pointes	lemma_2=there	lemma_4=be	path1=	relType_5=parataxis	lemma_6=of	lemma_9=,	pos_12=FW	lemma_16=to	relType_6=case	relType_18=cc	pos_8=NNS	lemma_8=event	relType_13=nmod	relType_4=cop	lemma_18=fluconazole	lemma_7=cardiac	lemma_10=include	relType_12=compound	pos_5=NNS	pos_6=IN	lemma_11=torsade	pos_17=WP	pos_18=CC	relType_10=case	lemma_14=in	lib=have	lemma_15=patient	lemma_1=:	pos_4=VBN	lemma_5=report	pos_14=IN	pos_18=NN	relType_2=expl	relType_7=amod	pos_13=FW	pos_1=:	pos_11=FW	path2=report_parataxis>event_nmod>pointes_nmod>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>cisapride_conj	relType_9=punct	lpib=have_VBP	relType_15=nmod	pos_2=EX	pos_16=TO	relType_16=case	lemma_12=de	path=<Cisapride_ROOT>report_parataxis>event_nmod>pointes_nmod>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>cisapride_conj	pos_15=NNS	eib=True	relType_8=nmod	relType_11=compound	lemma_18=and	wib=have	pos_7=JJ	pos_10=VBG	relType_18=nsubj:pass	relType_3=aux	relType_14=case	pos_9=,	relType_1=punct	lemma_3=have	relType_17=obl	pos_3=VBP
DDI-DrugBank.d776.s25	DDI-DrugBank.d776.s25.e1	DDI-DrugBank.d776.s25.e2	effect	lib=cisapride	path=<fluconazole_nsubj:pass>cisapride_conj	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	path1=	path2=cisapride_conj	wib=cisapride	lpib=cisapride_NN
DDI-DrugBank.d776.s26	DDI-DrugBank.d776.s26.e0	DDI-DrugBank.d776.s26.e1	mechanism	relType_1=nummod	pos_2=NN	pos_3=RB	relType_3=advmod	pos_5=CC	path1=	lemma_4=daily	lemma_1=200	relType_5=cc	pos_4=RB	lib=mg	pos_1=CD	eib=False	lpib=mg_NN	lemma_3=once	relType_2=dep	relType_4=advmod	lemma_2=mg	lemma_5=and	wib=mg	path2=mg_dep>mg_conj>cisapride_advmod	path=<fluconazole_nsubj>mg_dep>mg_conj>cisapride_advmod
DDI-DrugBank.d776.s26	DDI-DrugBank.d776.s26.e0	DDI-DrugBank.d776.s26.e2	null	pos_7=NNS	relType_14=amod	relType_1=nummod	lemma_9=time	relType_8=nummod	pos_2=NN	pos_3=RB	relType_3=advmod	pos_5=CC	relType_10=det	lemma_13=a	lemma_15=increase	pos_16=IN	pos_6=CD	pos_13=DT	lemma_10=a	lemma_4=daily	lemma_1=200	path2=increase_obj>level_nmod>cisapride_compound	relType_12=ccomp	relType_9=obl:tmod	relType_5=cc	pos_4=RB	lemma_11=day	lib=mg	pos_1=CD	lpib=mg_NN	lemma_3=once	pos_12=VBD	pos_9=NNS	lemma_14=significant	lemma_16=in	lemma_12=yield	relType_2=dep	lemma_7=mg	pos_15=NN	lemma_8=four	relType_4=advmod	relType_6=nummod	relation_15=beneficial	lemma_2=mg	pos_6=RB	lemma_6=20	relType_15=obj	relType_16=case	path=fluconazole_nsubj<yield_ccomp>increase_obj>level_nmod>cisapride_compound	pos_11=NN	eib=True	relType_11=obl:npmod	path1=fluconazole_nsubj	lemma_5=and	lemma_6=cisapride	relType_13=det	wib=mg	pos_14=JJ	pos_8=CD	relType_6=advmod	relType_7=conj	pos_10=DT
DDI-DrugBank.d776.s26	DDI-DrugBank.d776.s26.e1	DDI-DrugBank.d776.s26.e2	null	relType_4=obl:tmod	relType_1=nummod	pos_8=DT	path2=increase_obj>level_nmod>cisapride_compound	relType_11=case	pos_6=NN	lemma_3=four	lemma_5=a	pos_9=JJ	lib=mg	pos_1=CD	eib=False	lemma_10=increase	lemma_4=time	lemma_7=yield	lemma_6=day	lemma_8=a	relType_9=amod	lemma_11=in	pos_10=NN	relType_2=conj	relType_10=obj	pos_4=NNS	relation_9=beneficial	lpib=mg_NNS	pos_11=IN	pos_3=CD	relType_5=det	pos_7=VBD	relType_6=obl:npmod	path1=cisapride_advmod<mg_conj<mg_dep<fluconazole_nsubj	relType_3=nummod	lemma_9=significant	lemma_2=mg	pos_2=NNS	pos_5=DT	relType_7=ccomp	wib=mg	relType_8=det	path=cisapride_advmod<mg_conj<mg_dep<fluconazole_nsubj<yield_ccomp>increase_obj>level_nmod>cisapride_compound	lemma_1=20
DDI-DrugBank.d776.s27	DDI-DrugBank.d776.s27.e0	DDI-DrugBank.d776.s27.e1	advise	lib=cisapride	lemma_1=with	path2=cisapride_nmod	relType_1=case	eib=False	path=<fluconazole_nmod>cisapride_nmod	path1=	wib=cisapride	pos_1=IN	lpib=cisapride_NN
DDI-DrugBank.d776.s28	DDI-DrugBank.d776.s28.e0	DDI-DrugBank.d776.s28.e1	null	pos_2=DT	lib=use	lemma_2=the	path1=	lemma_3=use	eib=False	lpib=use_NN	lemma_1=:	pos_4=IN	pos_1=:	relType_4=case	relType_3=nsubj	path2=metabolize_appos>use_nsubj>fluconazole_nmod	pos_3=NN	wib=use	relType_2=det	relType_1=punct	path=<astemizole_ROOT>metabolize_appos>use_nsubj>fluconazole_nmod	lemma_4=of
DDI-DrugBank.d776.s28	DDI-DrugBank.d776.s28.e0	DDI-DrugBank.d776.s28.e2	null	pos_2=DT	lemma_5=in	lib=use	lemma_2=the	lemma_7=concurrently	path1=	lemma_5=fluconazole	relType_5=case	lemma_3=use	pos_7=RB	lemma_6=patient	lpib=use_NN	lemma_1=:	pos_4=IN	pos_8=VBG	pos_1=:	relType_4=case	relType_5=nmod	path2=metabolize_appos>use_nsubj>patient_nmod>take_acl>astemizole_obj	pos_5=IN	lemma_8=take	relType_8=acl	path=<astemizole_ROOT>metabolize_appos>use_nsubj>patient_nmod>take_acl>astemizole_obj	relType_3=nsubj	pos_5=NN	eib=True	pos_3=NN	wib=use	relType_2=det	pos_6=NNS	relType_7=advmod	relType_1=punct	relType_6=nmod	lemma_4=of
DDI-DrugBank.d776.s28	DDI-DrugBank.d776.s28.e1	DDI-DrugBank.d776.s28.e2	mechanism	relType_1=case	lemma_1=in	pos_3=RB	relType_3=advmod	lemma_2=patient	path1=fluconazole_nmod	relType_4=acl	wib=patients	lpib=patient_NNS	eib=False	relType_2=nmod	pos_1=IN	path2=patient_nmod>take_acl>astemizole_obj	lib=patient	pos_4=VBG	lemma_4=take	pos_2=NNS	lemma_3=concurrently	path=fluconazole_nmod<use_nsubj>patient_nmod>take_acl>astemizole_obj
DDI-DrugBank.d776.s31	DDI-DrugBank.d776.s31.e0	DDI-DrugBank.d776.s31.e1	null	relType_8=case	lemma_10=to	lemma_2=there	lemma_4=be	pos_7=NN	path1=	relType_5=parataxis	lemma_6=of	relType_9=nmod	relType_6=case	relType_4=cop	lemma_8=in	eib=False	pos_5=NNS	pos_6=IN	lemma_7=uveitis	lemma_11=whom	pos_9=NNS	relType_10=case	lib=have	lemma_3=have	lemma_1=:	pos_4=VBN	lemma_5=report	pos_8=IN	relType_2=expl	pos_1=:	relType_7=nmod	relType_11=obl	lpib=have_VBP	pos_2=EX	lemma_9=patient	pos_10=TO	pos_11=WP	wib=have	relType_3=aux	path2=report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	relType_1=punct	path=<Rifabutin_ROOT>report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	pos_3=VBP
DDI-DrugBank.d776.s31	DDI-DrugBank.d776.s31.e0	DDI-DrugBank.d776.s31.e2	null	relType_8=case	path2=report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>rifabutin_conj	lemma_10=to	lemma_2=there	lemma_4=be	pos_7=NN	path1=	relType_12=cc	relType_5=parataxis	lemma_6=of	lemma_12=fluconazole	pos_12=CC	relType_9=nmod	relType_6=case	relType_4=cop	lemma_8=in	pos_5=NNS	pos_6=IN	lemma_7=uveitis	lemma_11=whom	pos_9=NNS	relType_12=nsubj:pass	pos_12=NN	relType_10=case	lib=have	lemma_1=:	pos_4=VBN	lemma_5=report	pos_8=IN	relType_2=expl	path=<Rifabutin_ROOT>report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>rifabutin_conj	pos_1=:	relType_7=nmod	relType_11=obl	lpib=have_VBP	pos_2=EX	lemma_9=patient	pos_10=TO	eib=True	pos_11=WP	wib=have	lemma_12=and	relType_3=aux	relType_1=punct	lemma_3=have	pos_3=VBP
DDI-DrugBank.d776.s31	DDI-DrugBank.d776.s31.e1	DDI-DrugBank.d776.s31.e2	effect	relType_1=cc	pos_1=CC	eib=False	path=<fluconazole_nsubj:pass>rifabutin_conj	path1=	path2=rifabutin_conj	lpib=rifabutin_NN	wib=rifabutin	lib=rifabutin	lemma_1=and
DDI-DrugBank.d776.s32	DDI-DrugBank.d776.s32.e0	DDI-DrugBank.d776.s32.e1	advise	relType_1=cc	lpib=fluconazole_NN	pos_1=CC	path=<rifabutin_obj>fluconazole_conj	path2=fluconazole_conj	eib=False	path1=	wib=fluconazole	lib=fluconazole	lemma_1=and
DDI-DrugBank.d776.s33	DDI-DrugBank.d776.s33.e0	DDI-DrugBank.d776.s33.e1	null	relType_8=case	lemma_10=to	lemma_2=there	lemma_4=be	pos_7=NN	path1=	relType_5=parataxis	lemma_6=of	relType_9=nmod	relType_6=case	relType_4=cop	lemma_8=in	eib=False	path=<Tacrolimus_ROOT>report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	pos_5=NNS	pos_6=IN	lemma_11=whom	pos_9=NNS	lemma_7=nephrotoxicity	relType_10=case	lib=have	lemma_1=:	pos_4=VBN	lemma_5=report	pos_8=IN	relType_2=expl	pos_1=:	relType_7=nmod	relType_11=obl	lpib=have_VBP	pos_2=EX	lemma_9=patient	pos_10=TO	pos_11=WP	wib=have	relType_3=aux	path2=report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass	relType_1=punct	lemma_3=have	pos_3=VBP
DDI-DrugBank.d776.s33	DDI-DrugBank.d776.s33.e0	DDI-DrugBank.d776.s33.e2	null	relType_8=case	lemma_10=to	lemma_2=there	lemma_4=be	pos_7=NN	path1=	relType_12=cc	relType_5=parataxis	lemma_6=of	lemma_12=fluconazole	pos_12=CC	relType_9=nmod	relType_6=case	relType_4=cop	lemma_8=in	path=<Tacrolimus_ROOT>report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>tacrolimus_conj	pos_5=NNS	pos_6=IN	lemma_11=whom	relType_12=nsubj:pass	pos_9=NNS	pos_12=NN	lemma_7=nephrotoxicity	relType_10=case	lib=have	lemma_1=:	pos_4=VBN	lemma_5=report	pos_8=IN	relType_2=expl	pos_1=:	relType_7=nmod	relType_11=obl	lpib=have_VBP	pos_2=EX	lemma_9=patient	pos_10=TO	eib=True	pos_11=WP	wib=have	lemma_12=and	relType_3=aux	path2=report_parataxis>patient_nmod>coadminister_acl:relcl>fluconazole_nsubj:pass>tacrolimus_conj	relType_1=punct	lemma_3=have	pos_3=VBP
DDI-DrugBank.d776.s33	DDI-DrugBank.d776.s33.e1	DDI-DrugBank.d776.s33.e2	effect	relType_1=cc	pos_1=CC	lemma_1=and	lpib=tacrolimus_NN	path2=tacrolimus_conj	eib=False	path1=	lib=tacrolimus	wib=tacrolimus	path=<fluconazole_nsubj:pass>tacrolimus_conj
DDI-DrugBank.d776.s34	DDI-DrugBank.d776.s34.e0	DDI-DrugBank.d776.s34.e1	advise	relType_1=cc	lpib=fluconazole_NN	pos_1=CC	path2=fluconazole_conj	eib=False	path1=	wib=fluconazole	lib=fluconazole	path=<tacrolimus_obj>fluconazole_conj	lemma_1=and
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e0	DDI-DrugBank.d776.s35.e1	null	path1=	lemma_5=of	relType_5=case	path2=result_parataxis>administration_obl>midazolam_nmod	eib=False	lemma_2=follow	pos_4=NN	lemma_1=:	relType_4=obl	path=<benzodiazepine_ROOT>result_parataxis>administration_obl>midazolam_nmod	relType_3=amod	lib=follow	wib=Following	pos_1=:	pos_5=IN	lpib=follow_VBG	lemma_3=oral	relType_2=case	pos_3=JJ	lemma_4=administration	relType_1=punct	pos_2=VBG
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e0	DDI-DrugBank.d776.s35.e2	null	path2=result_parataxis>fluconazole_nsubj	path1=	lemma_6=,	lemma_6=midazolam	lemma_5=of	relType_5=case	pos_6=NN	relType_6=punct	lemma_2=follow	pos_4=NN	lemma_1=:	relType_6=nmod	relType_4=obl	relType_3=amod	lib=follow	wib=Following	pos_1=:	pos_5=IN	lpib=follow_VBG	pos_6=,	lemma_3=oral	relType_2=case	pos_3=JJ	eib=True	lemma_4=administration	relType_1=punct	path=<benzodiazepine_ROOT>result_parataxis>fluconazole_nsubj	pos_2=VBG
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e0	DDI-DrugBank.d776.s35.e3	null	relType_8=case	path2=result_parataxis>increase_obl>concentration_nmod>midazolam_compound	pos_7=NN	path1=	lemma_6=,	lemma_6=midazolam	lemma_5=of	relType_5=case	relType_11=case	pos_6=NN	pos_9=JJ	lemma_8=in	lemma_10=increase	relType_6=punct	lemma_2=follow	lemma_7=fluconazole	relType_9=amod	lemma_11=in	pos_4=NN	lemma_1=:	pos_8=IN	pos_11=IN	relType_4=obl	relType_3=amod	lib=follow	wib=Following	path=<benzodiazepine_ROOT>result_parataxis>increase_obl>concentration_nmod>midazolam_compound	pos_1=:	pos_7=VBD	pos_5=IN	lemma_9=substantial	lpib=follow_VBG	pos_6=,	lemma_3=oral	relType_2=case	pos_3=JJ	eib=True	lemma_4=administration	relation_11=beneficial	relType_7=nsubj	lemma_7=result	relType_1=punct	relType_6=nmod	relType_10=obl	pos_10=NNS	relType_7=parataxis	pos_2=VBG
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e1	DDI-DrugBank.d776.s35.e2	mechanism	lpib=fluconazole_NN	lemma_1=,	eib=False	path1=midazolam_nmod<administration_obl	path2=fluconazole_nsubj	wib=fluconazole	pos_1=,	lib=fluconazole	relType_1=punct	path=midazolam_nmod<administration_obl<result_parataxis>fluconazole_nsubj
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e1	DDI-DrugBank.d776.s35.e3	null	lpib=fluconazole_NN	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	pos_3=IN	wib=fluconazole	pos_1=,	lemma_2=fluconazole	relType_6=case	lemma_5=increase	relType_2=nsubj	path1=midazolam_nmod<administration_obl	pos_5=NNS	pos_6=IN	pos_2=VBD	lemma_6=in	path2=increase_obl>concentration_nmod>midazolam_compound	lib=fluconazole	relType_5=obl	relType_3=case	lemma_2=result	path=midazolam_nmod<administration_obl<result_parataxis>increase_obl>concentration_nmod>midazolam_compound	eib=True	relType_2=parataxis	relType_1=punct	relation_5=beneficial	lemma_3=in	lemma_4=substantial
DDI-DrugBank.d776.s35	DDI-DrugBank.d776.s35.e2	DDI-DrugBank.d776.s35.e3	null	lemma_5=in	path=fluconazole_nsubj<result_parataxis>increase_obl>concentration_nmod>midazolam_compound	relation_3=beneficial	relType_5=case	pos_2=IN	pos_1=VBD	eib=False	lemma_4=increase	wib=resulted	lemma_3=substantial	pos_4=NNS	relType_1=parataxis	path2=increase_obl>concentration_nmod>midazolam_compound	relType_4=obl	relType_3=amod	pos_5=IN	relType_2=case	pos_3=JJ	path1=fluconazole_nsubj	lib=result	lpib=result_VBD	lemma_1=result	lemma_2=in
DDI-DrugBank.d776.s36	DDI-DrugBank.d776.s36.e0	DDI-DrugBank.d776.s36.e1	effect	pos_2=TO	relType_5=xcomp	path=midazolam_nmod<effect_nsubj<appear_ROOT>pronounced_xcomp>administration_obl>fluconazole_nmod	lemma_7=oral	pos_9=IN	lemma_8=administration	pos_3=VB	relType_6=case	lemma_6=follow	relType_8=obl	relType_2=mark	pos_8=NN	pos_6=VBG	lib=appear	eib=False	lemma_2=to	relType_9=case	pos_5=JJ	relType_7=amod	relType_4=advmod	lemma_3=be	path2=pronounced_xcomp>administration_obl>fluconazole_nmod	lemma_5=pronounced	lpib=appear_VBZ	pos_4=RBR	relType_1=ROOT	pos_1=VBZ	path1=midazolam_nmod<effect_nsubj	lemma_9=of	pos_7=JJ	relType_3=cop	lemma_1=appear	wib=appears	lemma_4=more
DDI-DrugBank.d776.s36	DDI-DrugBank.d776.s36.e0	DDI-DrugBank.d776.s36.e2	null	pos_2=TO	relType_5=xcomp	relType_10=mark	lemma_7=oral	pos_9=IN	lemma_8=administration	pos_3=VB	relType_6=case	lemma_6=follow	relType_8=obl	relType_2=mark	lemma_10=fluconazole	lemma_11=with	pos_8=NN	pos_6=VBG	lib=appear	relType_10=nmod	lemma_2=to	relType_9=case	pos_10=NN	pos_11=IN	pos_5=JJ	relType_7=amod	path2=pronounced_xcomp>administer_advcl>fluconazole_nsubj	relType_4=advmod	lemma_3=be	lemma_5=pronounced	lpib=appear_VBZ	pos_10=IN	pos_4=RBR	path=midazolam_nmod<effect_nsubj<appear_ROOT>pronounced_xcomp>administer_advcl>fluconazole_nsubj	relType_1=ROOT	relType_11=mark	pos_1=VBZ	eib=True	path1=midazolam_nmod<effect_nsubj	lemma_9=of	pos_7=JJ	lemma_10=than	relType_3=cop	lemma_1=appear	wib=appears	lemma_4=more
DDI-DrugBank.d776.s36	DDI-DrugBank.d776.s36.e1	DDI-DrugBank.d776.s36.e2	null	pos_2=IN	lpib=fluconazole_NN	path2=administer_advcl>fluconazole_nsubj	lemma_1=than	lemma_2=with	relType_1=mark	eib=False	path1=fluconazole_nmod<administration_obl	wib=fluconazole	lib=fluconazole	pos_1=IN	path=fluconazole_nmod<administration_obl<pronounced_xcomp>administer_advcl>fluconazole_nsubj	relType_2=mark
DDI-DrugBank.d776.s37	DDI-DrugBank.d776.s37.e0	DDI-DrugBank.d776.s37.e1	advise	relType_7=compound	path1=benzodiazepine_nsubj:pass	lemma_1=,	relType_10=punct	pos_6=DT	lpib=be_VBP	lemma_10=,	lemma_14=with	pos_1=,	relType_13=advcl	relType_4=acl:relcl	lemma_8=p450	relType_9=obl	lemma_5=by	lemma_11=be	pos_2=WDT	relType_3=aux:pass	relType_5=case	pos_13=VBN	pos_8=NN	eib=False	relType_12=advmod	lemma_6=the	relType_11=aux:pass	lemma_7=cytochrome	relType_2=nsubj:pass	pos_9=NN	pos_4=VBN	wib=are	lemma_9=system	pos_11=VBP	pos_14=IN	lib=be	pos_12=RB	relType_8=compound	lemma_3=be	lemma_4=metabolize	pos_5=IN	lemma_13=administer	path2=fluconazole_obl	relType_6=det	lemma_2=which	pos_10=,	lemma_12=concomitantly	relType_14=case	relType_1=punct	pos_7=NN	path=benzodiazepine_nsubj:pass<administer_advcl>fluconazole_obl	pos_3=VBP
DDI-DrugBank.d776.s37	DDI-DrugBank.d776.s37.e0	DDI-DrugBank.d776.s37.e2	null	relType_18=aux:pass	pos_17=MD	lemma_10=,	lemma_8=p450	relType_9=obl	lemma_5=by	relType_3=aux:pass	relType_5=case	pos_13=VBN	lemma_18=be	relType_11=aux:pass	relation_21=adverse	wib=are	relType_15=obl	pos_12=RB	lemma_22=the	lemma_3=be	pos_10=,	relType_17=aux	pos_3=VBP	lemma_1=,	relType_16=nsubj:pass	pos_1=,	lemma_11=be	pos_8=NN	relType_19=ROOT	relType_20=case	relType_2=nsubj:pass	pos_9=NN	pos_4=VBN	pos_14=IN	lemma_15=,	lemma_4=metabolize	pos_5=IN	pos_16=NN	lemma_13=administer	pos_22=DT	relType_6=det	lemma_2=which	relType_21=obl	lemma_16=consideration	lemma_21=decrease	lemma_19=give	relType_1=punct	pos_7=NN	lemma_15=fluconazole	relType_10=punct	pos_6=DT	lpib=be_VBP	lemma_14=with	pos_20=IN	lemma_17=should	relType_12=advmod	pos_15=,	lemma_6=the	lemma_7=cytochrome	relType_15=punct	lemma_9=system	path1=benzodiazepine_nsubj:pass<administer_advcl	lib=be	pos_18=VB	relType_8=compound	lemma_12=concomitantly	relType_22=det	pos_19=VBN	lemma_20=to	relType_14=case	relType_7=compound	relType_13=advcl	path2=dosage_obj>benzodiazepine_compound	relType_4=acl:relcl	pos_2=WDT	path=benzodiazepine_nsubj:pass<administer_advcl<give_ROOT>dosage_obj>benzodiazepine_compound	pos_11=VBP	pos_15=NN	pos_21=VBG	eib=True
DDI-DrugBank.d776.s37	DDI-DrugBank.d776.s37.e1	DDI-DrugBank.d776.s37.e2	null	lemma_1=,	pos_2=NN	lemma_2=consideration	pos_8=DT	lemma_4=be	pos_1=,	pos_7=VBG	path2=dosage_obj>benzodiazepine_compound	lemma_5=give	lemma_3=should	lemma_6=to	relType_6=case	wib=consideration	eib=False	pos_6=IN	relation_6=adverse	pos_3=MD	relType_2=nsubj:pass	path=fluconazole_obl<administer_advcl<give_ROOT>dosage_obj>benzodiazepine_compound	lemma_8=the	relType_4=aux:pass	lemma_7=decrease	path1=fluconazole_obl<administer_advcl	lib=consideration	relType_7=obl	lpib=consideration_NN	pos_4=VB	relType_3=aux	relType_8=det	relType_1=punct	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e0	DDI-DrugBank.d776.s38.e1	mechanism	pos_2=VBN	pos_3=IN	lemma_4=ethinyl	wib=tablets	path2=estradiol_obl	lemma_2=coadminister	path=fluconazole_compound<tablet_nsubj<coadminister_ROOT>estradiol_obl	pos_4=NN	relType_2=ROOT	lpib=tablet_NNS	lemma_1=tablet	relType_1=nsubj	relType_4=compound	lemma_3=with	relType_3=case	path1=fluconazole_compound<tablet_nsubj	lib=tablet	pos_1=NNS	eib=True
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e0	DDI-DrugBank.d776.s38.e2	mechanism	path2=estradiol_obl>contraceptive_conj>contain_amod>levonorgestrel_obl	pos_2=VBN	pos_3=IN	pos_5=CC	lemma_4=-	lemma_4=ethinyl	pos_4=HYPH	relType_5=cc	path=fluconazole_compound<tablet_nsubj<coadminister_ROOT>estradiol_obl>contraceptive_conj>contain_amod>levonorgestrel_obl	wib=tablets	lemma_2=coadminister	pos_4=NN	relType_4=obl	relType_4=punct	relType_2=ROOT	lpib=tablet_NNS	lemma_1=tablet	relType_1=nsubj	relType_4=compound	lemma_3=with	lemma_4=estradiol	relType_3=case	path1=fluconazole_compound<tablet_nsubj	lib=tablet	pos_1=NNS	eib=True	lemma_5=and
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e0	DDI-DrugBank.d776.s38.e3	null	pos_2=VBN	pos_3=IN	pos_5=CC	relType_8=amod	lemma_4=-	pos_7=VBG	lemma_4=ethinyl	pos_4=HYPH	pos_6=HYPH	pos_6=NN	pos_8=JJ	relType_6=obl	relType_5=cc	wib=tablets	relType_6=punct	lemma_2=coadminister	path=fluconazole_compound<tablet_nsubj<coadminister_ROOT>estradiol_obl>contraceptive_conj	pos_4=NN	lemma_6=-	lemma_8=oral	relType_4=obl	relType_7=amod	relType_4=punct	relType_2=ROOT	lpib=tablet_NNS	lemma_1=tablet	relType_1=nsubj	relType_4=compound	lemma_3=with	lemma_4=estradiol	relType_3=case	lemma_6=levonorgestrel	lemma_7=contain	path1=fluconazole_compound<tablet_nsubj	lib=tablet	pos_1=NNS	eib=True	lemma_5=and	path2=estradiol_obl>contraceptive_conj
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e0	DDI-DrugBank.d776.s38.e4	null	pos_2=VBN	pos_3=IN	relType_9=conj	pos_5=CC	relType_10=det	relType_8=amod	lemma_4=-	pos_7=VBG	lemma_10=a	lemma_4=ethinyl	pos_4=HYPH	relType_9=dep	pos_6=HYPH	pos_6=NN	pos_8=JJ	relType_6=obl	path2=produce_dep>increase_obj>estradiol_nmod	relType_5=cc	wib=tablets	relType_12=compound	relation_16=beneficial	relType_6=punct	relType_11=amod	pos_9=NNS	lemma_2=coadminister	lemma_11=overall	pos_13=NN	lemma_14=in	pos_4=NN	lemma_6=-	lemma_8=oral	pos_14=IN	relType_4=obl	relType_7=amod	relType_4=punct	lemma_12=mean	pos_15=NN	relType_2=ROOT	lpib=tablet_NNS	lemma_1=tablet	relType_1=nsubj	relType_4=compound	lemma_15=ethinyl	lemma_3=with	lemma_4=estradiol	relType_3=case	lemma_6=levonorgestrel	lemma_7=contain	lemma_13=increase	relType_15=compound	path1=fluconazole_compound<tablet_nsubj	lemma_9=produce	lib=tablet	pos_1=NNS	eib=True	relation_12=neutral	lemma_5=and	pos_9=VBD	lemma_9=contraceptive	path=fluconazole_compound<tablet_nsubj<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod	pos_11=JJ	relType_13=obj	relType_14=case	pos_12=NN	pos_10=DT
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e0	DDI-DrugBank.d776.s38.e5	null	pos_2=VBN	pos_3=IN	relType_9=conj	pos_5=CC	relType_10=det	relType_8=amod	path=fluconazole_compound<tablet_nsubj<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	lemma_4=-	pos_7=VBG	lemma_10=a	lemma_4=ethinyl	pos_4=HYPH	relType_9=dep	pos_6=HYPH	pos_6=NN	pos_8=JJ	relType_6=obl	relType_5=cc	path2=produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	wib=tablets	relType_12=compound	relation_16=beneficial	relType_6=punct	relType_11=amod	pos_9=NNS	lemma_2=coadminister	lemma_11=overall	pos_13=NN	lemma_14=in	pos_4=NN	lemma_6=-	lemma_8=oral	pos_14=IN	relType_4=obl	relType_7=amod	relType_4=punct	lemma_12=mean	pos_15=NN	relType_2=ROOT	lemma_15=estradiol	lpib=tablet_NNS	lemma_1=tablet	relType_1=nsubj	relType_4=compound	lemma_15=ethinyl	relType_15=cc	lemma_3=with	lemma_4=estradiol	relType_3=case	lemma_6=levonorgestrel	lemma_7=contain	lemma_13=increase	relType_15=compound	path1=fluconazole_compound<tablet_nsubj	relType_15=nmod	lemma_15=and	lemma_9=produce	lib=tablet	pos_1=NNS	eib=True	relation_12=neutral	lemma_5=and	pos_9=VBD	pos_15=CC	lemma_9=contraceptive	pos_11=JJ	relType_13=obj	relType_14=case	pos_12=NN	pos_10=DT
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e1	DDI-DrugBank.d776.s38.e2	null	lemma_2=and	path2=contraceptive_conj>contain_amod>levonorgestrel_obl	eib=False	pos_2=CC	lpib=levonorgestrel_NN	path1=	lemma_1=-	path=<estradiol_obl>contraceptive_conj>contain_amod>levonorgestrel_obl	lib=levonorgestrel	pos_1=HYPH	relType_1=punct	relType_2=cc	wib=levonorgestrel
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e1	DDI-DrugBank.d776.s38.e3	null	relType_4=amod	lemma_4=contain	path1=	pos_1=HYPH	relType_2=cc	wib=levonorgestrel	lemma_2=and	lemma_5=oral	lemma_3=-	path2=contraceptive_conj	pos_5=JJ	relType_5=amod	path=<estradiol_obl>contraceptive_conj	lemma_1=-	lib=levonorgestrel	pos_4=VBG	lemma_3=levonorgestrel	relType_3=obl	eib=True	pos_3=NN	pos_3=HYPH	pos_2=CC	lpib=levonorgestrel_NN	relType_1=punct	relType_3=punct
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e1	DDI-DrugBank.d776.s38.e4	null	relType_4=amod	lemma_12=ethinyl	relType_7=det	lemma_4=contain	relType_8=amod	pos_1=HYPH	relType_2=cc	pos_6=VBD	relType_11=case	wib=levonorgestrel	pos_8=JJ	lemma_2=and	path2=produce_dep>increase_obj>estradiol_nmod	relType_6=conj	relType_6=dep	lemma_5=oral	relType_9=compound	relType_12=compound	lemma_10=increase	lemma_3=-	pos_12=NN	lemma_9=mean	lemma_11=in	pos_10=NN	pos_9=NN	relType_10=obj	pos_7=DT	pos_11=IN	pos_5=JJ	path=estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod	relType_5=amod	lemma_1=-	path1=estradiol_obl	lib=levonorgestrel	pos_4=VBG	lemma_6=produce	lemma_3=levonorgestrel	relation_7=neutral	relType_3=obl	eib=True	pos_3=NN	pos_3=HYPH	pos_2=CC	lpib=levonorgestrel_NN	pos_6=NNS	lemma_7=a	relation_11=beneficial	relType_1=punct	lemma_8=overall	relType_3=punct	lemma_6=contraceptive
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e1	DDI-DrugBank.d776.s38.e5	null	relType_4=amod	lemma_12=ethinyl	relType_7=det	lemma_4=contain	relType_8=amod	relType_12=cc	path=estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	pos_1=HYPH	pos_12=CC	relType_2=cc	lemma_12=estradiol	pos_6=VBD	relType_11=case	wib=levonorgestrel	pos_8=JJ	lemma_2=and	path2=produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	relType_6=conj	relType_6=dep	lemma_5=oral	relType_9=compound	relType_12=compound	lemma_10=increase	lemma_3=-	relType_12=nmod	pos_12=NN	lemma_9=mean	lemma_11=in	pos_10=NN	pos_9=NN	relType_10=obj	pos_7=DT	pos_11=IN	pos_5=JJ	relType_5=amod	lemma_1=-	path1=estradiol_obl	lib=levonorgestrel	pos_4=VBG	lemma_6=produce	lemma_3=levonorgestrel	relation_7=neutral	relType_3=obl	eib=True	pos_3=NN	pos_3=HYPH	pos_2=CC	lpib=levonorgestrel_NN	pos_6=NNS	lemma_12=and	lemma_7=a	relation_11=beneficial	relType_1=punct	lemma_8=overall	relType_3=punct	lemma_6=contraceptive
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e2	DDI-DrugBank.d776.s38.e3	null	lemma_3=oral	path=levonorgestrel_obl<contain_amod<contraceptive_conj>	pos_3=JJ	relType_3=amod	lemma_2=contain	eib=False	path1=levonorgestrel_obl<contain_amod	relType_2=amod	lemma_1=-	path2=	lib=contain	pos_1=HYPH	relType_1=punct	wib=containing	lpib=contain_VBG	pos_2=VBG
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e2	DDI-DrugBank.d776.s38.e4	null	relType_4=dep	relType_7=compound	pos_6=JJ	lemma_2=contain	lemma_4=produce	pos_9=IN	pos_1=HYPH	path1=levonorgestrel_obl<contain_amod<contraceptive_conj<estradiol_obl	lemma_6=overall	lemma_5=a	pos_8=NN	path2=produce_dep>increase_obj>estradiol_nmod	relation_8=beneficial	relType_6=amod	relType_8=obj	relType_9=case	relType_10=compound	pos_10=NN	lpib=contain_VBG	pos_4=NNS	lemma_8=increase	lemma_4=contraceptive	relType_3=amod	relType_2=amod	lemma_1=-	relType_5=det	wib=containing	lemma_10=ethinyl	pos_4=VBD	lemma_3=oral	pos_3=JJ	eib=True	path=levonorgestrel_obl<contain_amod<contraceptive_conj<estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod	pos_5=DT	relType_4=conj	lemma_7=mean	relation_4=neutral	lib=contain	relType_1=punct	pos_7=NN	lemma_9=in	pos_2=VBG
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e2	DDI-DrugBank.d776.s38.e5	null	relType_4=dep	relType_7=compound	pos_6=JJ	lemma_2=contain	lemma_4=produce	relType_10=cc	pos_9=IN	pos_1=HYPH	path1=levonorgestrel_obl<contain_amod<contraceptive_conj<estradiol_obl	lemma_6=overall	lemma_5=a	pos_8=NN	path2=produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	relType_10=nmod	relation_8=beneficial	pos_10=CC	relType_6=amod	relType_8=obj	relType_9=case	relType_10=compound	pos_10=NN	lpib=contain_VBG	pos_4=NNS	path=levonorgestrel_obl<contain_amod<contraceptive_conj<estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	lemma_8=increase	lemma_10=and	lemma_4=contraceptive	relType_3=amod	relType_2=amod	lemma_1=-	relType_5=det	lemma_10=estradiol	wib=containing	lemma_10=ethinyl	pos_4=VBD	lemma_3=oral	pos_3=JJ	eib=True	pos_5=DT	relType_4=conj	lemma_7=mean	relation_4=neutral	lib=contain	relType_1=punct	pos_7=NN	lemma_9=in	pos_2=VBG
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e3	DDI-DrugBank.d776.s38.e4	null	pos_2=DT	relType_7=compound	lib=produce	relation_4=beneficial	lemma_2=a	lemma_3=overall	relType_6=case	lemma_1=produce	lemma_5=increase	lpib=produce_VBD	path2=produce_dep>increase_obj>estradiol_nmod	pos_1=VBD	pos_6=IN	relType_1=dep	lemma_6=in	pos_4=NN	path1=contraceptive_conj<estradiol_obl	wib=produced	relation_0=neutral	relType_3=amod	path=contraceptive_conj<estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod	relType_4=compound	pos_5=NN	pos_3=JJ	eib=True	relType_5=obj	relType_2=det	pos_7=NN	lemma_7=ethinyl	lemma_4=mean
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e3	DDI-DrugBank.d776.s38.e5	null	pos_2=DT	relType_7=compound	lib=produce	relation_4=beneficial	relType_7=cc	lemma_2=a	lemma_3=overall	relType_6=case	lemma_1=produce	lemma_5=increase	lpib=produce_VBD	path2=produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	pos_1=VBD	pos_6=IN	relType_1=dep	lemma_6=in	pos_4=NN	path1=contraceptive_conj<estradiol_obl	wib=produced	lemma_7=estradiol	relation_0=neutral	relType_3=amod	pos_7=CC	relType_4=compound	relType_7=nmod	pos_5=NN	pos_3=JJ	eib=True	relType_5=obj	relType_2=det	lemma_7=and	pos_7=NN	lemma_7=ethinyl	path=contraceptive_conj<estradiol_obl<coadminister_ROOT>produce_dep>increase_obj>estradiol_nmod>level_conj>levonorgestrel_compound	lemma_4=mean
DDI-DrugBank.d776.s38	DDI-DrugBank.d776.s38.e4	DDI-DrugBank.d776.s38.e5	null	relType_1=cc	pos_1=CC	eib=False	path2=level_conj>levonorgestrel_compound	lpib=levonorgestrel_NN	path1=	lib=levonorgestrel	lemma_1=and	path=<estradiol_nmod>level_conj>levonorgestrel_compound	wib=levonorgestrel
DDI-DrugBank.d776.s39	DDI-DrugBank.d776.s39.e0	DDI-DrugBank.d776.s39.e1	null	relType_1=cc	pos_1=CC	eib=False	path2=level_conj>levonorgestrel_compound	lpib=levonorgestrel_NN	path1=	lib=levonorgestrel	lemma_1=and	path=<estradiol_nmod>level_conj>levonorgestrel_compound	wib=levonorgestrel
DDI-DrugBank.d776.s40	DDI-DrugBank.d776.s40.e0	DDI-DrugBank.d776.s40.e1	null	relType_1=cc	pos_1=CC	path2=value_conj>levonorgestrel_compound	path=<estradiol_nmod>value_conj>levonorgestrel_compound	eib=False	lpib=levonorgestrel_NN	path1=	lib=levonorgestrel	lemma_1=and	wib=levonorgestrel
DDI-DrugBank.d776.s40	DDI-DrugBank.d776.s40.e0	DDI-DrugBank.d776.s40.e2	null	relType_1=cc	pos_1=CC	pos_2=NN	lemma_3=value	path1=	lemma_2=auc	wib=levonorgestrel	path=<estradiol_nmod>treatment_nmod>fluconazole_compound	pos_3=NNS	lemma_2=levonorgestrel	lemma_4=with	relType_3=conj	relType_2=compound	pos_4=IN	relType_4=case	lib=levonorgestrel	path2=treatment_nmod>fluconazole_compound	eib=True	lpib=levonorgestrel_NN	lemma_1=and
DDI-DrugBank.d776.s40	DDI-DrugBank.d776.s40.e1	DDI-DrugBank.d776.s40.e2	null	pos_2=NNS	pos_1=NN	lpib=auc_NN	path2=treatment_nmod>fluconazole_compound	relType_1=compound	pos_3=IN	relType_3=case	eib=False	wib=AUC	relType_2=conj	path1=levonorgestrel_compound<value_conj	lemma_2=value	lemma_3=with	lemma_1=auc	path=levonorgestrel_compound<value_conj<estradiol_nmod>treatment_nmod>fluconazole_compound	lib=auc
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e0	DDI-DrugBank.d776.s41.e1	mechanism	relType_1=aux	lpib=inhibit_VB	lemma_5=of	relType_5=case	pos_6=NN	lib=inhibit	path=fluconazole_nsubj<inhibit_ccomp>metabolism_obj>estradiol_nmod	pos_2=VB	relation_1=adverse	relType_3=det	pos_4=NN	relType_4=obj	lemma_1=can	path2=metabolism_obj>estradiol_nmod	pos_5=IN	pos_1=MD	relType_2=ccomp	wib=inhibit	relType_6=compound	lemma_6=ethinyl	eib=True	pos_3=DT	path1=fluconazole_nsubj	lemma_2=inhibit	lemma_3=the	lemma_4=metabolism
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e0	DDI-DrugBank.d776.s41.e2	mechanism	lemma_6=estradiol	relType_1=aux	path=fluconazole_nsubj<inhibit_ccomp>metabolism_obj>estradiol_nmod>levonorgestrel_conj	lpib=inhibit_VB	lemma_5=of	path2=metabolism_obj>estradiol_nmod>levonorgestrel_conj	relType_5=case	pos_6=NN	lib=inhibit	relation_1=adverse	pos_2=VB	relType_3=det	pos_4=NN	relType_4=obj	lemma_1=can	pos_6=CC	lemma_6=and	pos_5=IN	pos_1=MD	relType_2=ccomp	wib=inhibit	relType_6=compound	lemma_6=ethinyl	eib=True	pos_3=DT	path1=fluconazole_nsubj	relType_6=cc	lemma_2=inhibit	lemma_3=the	relType_6=nmod	lemma_4=metabolism
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e0	DDI-DrugBank.d776.s41.e3	null	lemma_6=estradiol	relType_1=aux	relType_10=det	pos_7=NN	lemma_12=that	pos_9=VBZ	lpib=inhibit_VB	lemma_8=there	lemma_5=of	relType_5=case	lemma_7=levonorgestrel	pos_6=NN	relType_9=ROOT	relType_12=mark	pos_8=EX	pos_7=,	lib=inhibit	relType_11=nsubj	pos_2=VB	relation_1=adverse	relType_3=det	lemma_7=,	pos_4=NN	pos_12=IN	relType_4=obj	path2=evidence_nsubj>inducer_ccomp>fluconazole_nsubj	lemma_1=can	pos_6=CC	lemma_6=and	path1=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl	pos_5=IN	path=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>fluconazole_nsubj	lemma_9=be	pos_1=MD	relType_8=expl	relType_2=ccomp	wib=inhibit	relType_6=compound	lemma_6=ethinyl	pos_11=NN	lemma_11=evidence	pos_10=DT	eib=True	pos_3=DT	relType_6=cc	relType_7=punct	lemma_2=inhibit	lemma_3=the	relType_6=nmod	lemma_10=no	relType_7=conj	lemma_4=metabolism
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e0	DDI-DrugBank.d776.s41.e4	null	pos_15=JJ	lemma_6=estradiol	relType_1=aux	relType_10=det	pos_7=NN	lemma_12=that	path=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod	pos_9=VBZ	pos_13=VBZ	relType_15=amod	lpib=inhibit_VB	lemma_8=there	lemma_5=of	relType_5=case	lemma_7=levonorgestrel	lemma_13=fluconazole	pos_6=NN	relType_9=ROOT	pos_17=IN	relType_12=mark	pos_8=EX	relType_13=cop	pos_7=,	lib=inhibit	relType_11=nsubj	pos_2=VB	relType_14=det	relation_1=adverse	pos_13=NN	relType_3=det	lemma_7=,	pos_4=NN	pos_12=IN	relType_4=obj	lemma_13=be	relType_17=case	pos_18=NN	lemma_18=ethinyl	lemma_1=can	pos_6=CC	relType_13=nsubj	lemma_6=and	path1=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl	pos_5=IN	lemma_17=of	lemma_9=be	pos_1=MD	pos_16=NN	lemma_15=net	relType_8=expl	relType_2=ccomp	wib=inhibit	pos_14=DT	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod	relType_6=compound	lemma_6=ethinyl	lemma_14=a	pos_11=NN	lemma_11=evidence	pos_10=DT	eib=True	pos_3=DT	lemma_16=inducer	relType_6=cc	relType_7=punct	relType_16=ccomp	lemma_2=inhibit	relType_18=compound	lemma_3=the	relType_6=nmod	lemma_10=no	relType_7=conj	lemma_4=metabolism
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e0	DDI-DrugBank.d776.s41.e5	null	lemma_8=there	lemma_5=of	relType_5=case	lemma_7=levonorgestrel	lemma_13=fluconazole	pos_6=NN	relType_9=ROOT	relType_12=mark	relType_13=cop	lib=inhibit	pos_2=VB	pos_18=CC	pos_13=NN	lemma_7=,	pos_18=NN	wib=inhibit	relType_6=compound	lemma_6=ethinyl	lemma_11=evidence	lemma_16=inducer	relType_1=aux	pos_13=VBZ	lpib=inhibit_VB	pos_8=EX	relType_3=det	pos_12=IN	lemma_18=ethinyl	lemma_1=can	pos_6=CC	relType_13=nsubj	lemma_18=estradiol	pos_5=IN	pos_16=NN	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	pos_11=NN	lemma_2=inhibit	pos_7=NN	relType_18=nmod	lemma_18=or	relType_10=det	pos_9=VBZ	relType_18=cc	path=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	pos_17=IN	pos_7=,	relation_1=adverse	relType_4=obj	relType_17=case	path1=fluconazole_nsubj<inhibit_ccomp<evidence_nsubj<be_advcl	lemma_17=of	pos_1=MD	pos_14=DT	relType_16=ccomp	relType_6=nmod	relType_7=conj	pos_10=DT	relType_6=cc	lemma_4=metabolism	pos_15=JJ	lemma_6=estradiol	relType_15=amod	lemma_12=that	relType_14=det	relType_11=nsubj	pos_4=NN	lemma_13=be	lemma_6=and	lemma_9=be	lemma_15=net	relType_8=expl	relType_2=ccomp	lemma_14=a	eib=True	pos_3=DT	relType_7=punct	relType_18=compound	lemma_3=the	lemma_10=no
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e1	DDI-DrugBank.d776.s41.e2	null	relType_1=cc	path2=levonorgestrel_conj	pos_1=CC	eib=False	lpib=levonorgestrel_NN	path1=	lib=levonorgestrel	path=<estradiol_nmod>levonorgestrel_conj	lemma_1=and	wib=levonorgestrel
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e1	DDI-DrugBank.d776.s41.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	relType_6=nsubj	lemma_4=be	path=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>fluconazole_nsubj	pos_3=EX	relType_7=mark	relType_2=punct	wib=levonorgestrel	pos_6=NN	path1=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl	lemma_3=there	lemma_2=levonorgestrel	relType_2=conj	lemma_2=,	lemma_7=that	path2=evidence_nsubj>inducer_ccomp>fluconazole_nsubj	relType_5=det	lib=levonorgestrel	lemma_6=evidence	lemma_5=no	relType_3=expl	pos_4=VBZ	relType_4=ROOT	eib=True	pos_7=IN	pos_5=DT	lpib=levonorgestrel_NN	pos_2=,	lemma_1=and
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e1	DDI-DrugBank.d776.s41.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	relType_6=nsubj	lemma_4=be	relType_8=nsubj	lemma_9=a	lemma_13=ethinyl	relType_10=amod	relType_12=case	pos_3=EX	relType_7=mark	relType_8=cop	relType_2=punct	wib=levonorgestrel	pos_6=NN	pos_8=NN	lemma_12=of	path1=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl	pos_8=VBZ	lemma_3=there	lemma_2=levonorgestrel	pos_9=DT	pos_13=NN	relType_2=conj	lemma_2=,	pos_12=IN	lemma_7=that	relType_13=compound	lemma_8=be	pos_10=JJ	relType_5=det	lib=levonorgestrel	lemma_6=evidence	path=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod	lemma_5=no	lemma_8=fluconazole	relType_3=expl	pos_4=VBZ	relType_4=ROOT	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod	pos_11=NN	eib=True	pos_7=IN	pos_5=DT	lpib=levonorgestrel_NN	pos_2=,	relType_11=ccomp	lemma_11=inducer	lemma_1=and	lemma_10=net	relType_9=det
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e1	DDI-DrugBank.d776.s41.e5	null	relType_1=cc	pos_1=CC	pos_2=NN	relType_6=nsubj	lemma_4=be	relType_8=nsubj	lemma_9=a	lemma_13=ethinyl	relType_10=amod	relType_12=case	pos_3=EX	relType_7=mark	relType_8=cop	relType_2=punct	wib=levonorgestrel	pos_6=NN	pos_8=NN	lemma_12=of	path1=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl	relType_13=nmod	pos_8=VBZ	lemma_3=there	lemma_2=levonorgestrel	lemma_13=or	pos_9=DT	pos_13=NN	relType_2=conj	lemma_2=,	pos_12=IN	lemma_7=that	relType_13=cc	relType_13=compound	lemma_8=be	lemma_13=estradiol	pos_10=JJ	relType_5=det	lib=levonorgestrel	lemma_6=evidence	lemma_5=no	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	lemma_8=fluconazole	relType_3=expl	pos_4=VBZ	relType_4=ROOT	pos_13=CC	pos_11=NN	eib=True	pos_7=IN	pos_5=DT	lpib=levonorgestrel_NN	pos_2=,	path=estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	relType_11=ccomp	lemma_11=inducer	lemma_1=and	lemma_10=net	relType_9=det
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e2	DDI-DrugBank.d776.s41.e3	null	lemma_1=,	lemma_2=there	pos_1=,	relType_5=nsubj	lemma_5=evidence	eib=False	pos_6=IN	pos_3=VBZ	path=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>fluconazole_nsubj	relType_2=expl	path2=evidence_nsubj>inducer_ccomp>fluconazole_nsubj	pos_4=DT	lemma_4=no	lib=be	relType_3=ROOT	relType_6=mark	lemma_3=be	pos_2=EX	wib=is	pos_5=NN	lpib=be_VBZ	lemma_6=that	relType_1=punct	relType_4=det	path1=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e2	DDI-DrugBank.d776.s41.e4	null	lemma_1=,	pos_7=VBZ	pos_8=DT	lemma_12=ethinyl	lemma_2=there	pos_7=NN	lemma_7=be	relType_10=ccomp	pos_1=,	relType_5=nsubj	lemma_5=evidence	relType_11=case	pos_9=JJ	lemma_9=net	relType_12=compound	pos_6=IN	lemma_7=fluconazole	relType_7=cop	pos_3=VBZ	lemma_8=a	pos_12=NN	relType_9=amod	pos_10=NN	pos_11=IN	relType_2=expl	pos_4=DT	lemma_10=inducer	lemma_4=no	lib=be	relType_3=ROOT	relType_6=mark	lemma_3=be	pos_2=EX	wib=is	path=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod	pos_5=NN	eib=True	lemma_11=of	lpib=be_VBZ	relType_7=nsubj	relType_8=det	lemma_6=that	relType_1=punct	relType_4=det	path1=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e2	DDI-DrugBank.d776.s41.e5	null	lemma_1=,	path=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl<be_ROOT>evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	pos_7=VBZ	pos_8=DT	lemma_12=ethinyl	lemma_2=there	pos_7=NN	lemma_7=be	relType_10=ccomp	pos_1=,	relType_5=nsubj	relType_12=cc	lemma_5=evidence	pos_12=CC	lemma_12=estradiol	relType_11=case	pos_9=JJ	lemma_9=net	relType_12=compound	pos_6=IN	lemma_7=fluconazole	relType_7=cop	relType_12=nmod	pos_3=VBZ	lemma_8=a	pos_12=NN	relType_9=amod	pos_10=NN	pos_11=IN	relType_2=expl	pos_4=DT	lemma_10=inducer	lemma_4=no	lemma_12=or	lib=be	relType_3=ROOT	relType_6=mark	lemma_3=be	path2=evidence_nsubj>inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	pos_2=EX	wib=is	pos_5=NN	eib=True	lemma_11=of	lpib=be_VBZ	relType_7=nsubj	relType_8=det	lemma_6=that	relType_1=punct	relType_4=det	path1=levonorgestrel_conj<estradiol_nmod<metabolism_obj<inhibit_ccomp<evidence_nsubj<be_advcl
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e3	DDI-DrugBank.d776.s41.e4	null	pos_2=DT	lemma_4=inducer	lemma_2=a	lemma_5=of	relType_5=case	pos_6=NN	lemma_1=be	pos_4=NN	lib=be	relType_3=amod	relType_4=ccomp	pos_5=IN	wib=is	relType_6=compound	lemma_6=ethinyl	relType_1=cop	path=fluconazole_nsubj<inducer_ccomp>estradiol_nmod	pos_3=JJ	pos_1=VBZ	eib=True	path1=fluconazole_nsubj	lemma_3=net	relType_2=det	path2=estradiol_nmod	lpib=be_VBZ
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e3	DDI-DrugBank.d776.s41.e5	null	pos_2=DT	lemma_6=estradiol	lemma_4=inducer	lemma_2=a	lemma_5=of	relType_5=case	pos_6=NN	lemma_1=be	lemma_6=or	pos_4=NN	lib=be	relType_3=amod	pos_6=CC	relType_4=ccomp	pos_5=IN	wib=is	relType_6=compound	lemma_6=ethinyl	relType_1=cop	pos_3=JJ	pos_1=VBZ	eib=True	path1=fluconazole_nsubj	lemma_3=net	relType_2=det	path2=estradiol_nmod>metabolism_conj>levonorgestrel_compound	lpib=be_VBZ	relType_6=nmod	path=fluconazole_nsubj<inducer_ccomp>estradiol_nmod>metabolism_conj>levonorgestrel_compound	relType_6=cc
DDI-DrugBank.d776.s41	DDI-DrugBank.d776.s41.e4	DDI-DrugBank.d776.s41.e5	null	relType_1=cc	path2=metabolism_conj>levonorgestrel_compound	pos_1=CC	path=<estradiol_nmod>metabolism_conj>levonorgestrel_compound	eib=False	lpib=levonorgestrel_NN	path1=	lib=levonorgestrel	lemma_1=or	wib=levonorgestrel
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e0	DDI-DrugBank.d78.s0.e1	null	lemma_1=,	path=<antacid_ROOT>Sucralfate_conj	path2=Sucralfate_conj	eib=False	path1=	wib=Sucralfate	lpib=sucralfate_NNP	lib=sucralfate	pos_1=,	relType_1=punct
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e0	DDI-DrugBank.d78.s0.e2	null	lemma_1=,	pos_5=,	path1=	pos_1=,	pos_3=NNP	relType_2=punct	lemma_2=Sucralfate	path2=form_parataxis>Quinolones_nsubj>Multivitamins_compound	lemma_4=cation	pos_2=NNP	lpib=sucralfate_NNP	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_5=,	relType_5=punct	lib=sucralfate	lemma_3=Metal	path=<antacid_ROOT>form_parataxis>Quinolones_nsubj>Multivitamins_compound	eib=True	wib=Sucralfate	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e0	DDI-DrugBank.d78.s0.e3	null	lemma_1=,	pos_5=,	path1=	pos_1=,	pos_3=NNP	relType_2=punct	lemma_2=Sucralfate	lemma_4=cation	pos_2=NNP	pos_6=NNPS	path=<antacid_ROOT>form_parataxis>Quinolones_nsubj	lpib=sucralfate_NNP	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_6=Multivitamins	lemma_5=,	relType_5=punct	lib=sucralfate	path2=form_parataxis>Quinolones_nsubj	lemma_3=Metal	relType_6=compound	eib=True	wib=Sucralfate	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e1	DDI-DrugBank.d78.s0.e2	null	lemma_1=,	pos_1=,	lpib=metal_NNP	path=Sucralfate_conj<antacid_ROOT>form_parataxis>Quinolones_nsubj>Multivitamins_compound	path1=Sucralfate_conj	path2=form_parataxis>Quinolones_nsubj>Multivitamins_compound	pos_3=NNS	pos_2=NNP	eib=False	pos_4=,	lib=metal	relType_4=punct	relType_3=conj	wib=Metal	relType_2=compound	lemma_2=Metal	lemma_4=,	lemma_3=cation	relType_1=punct
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e1	DDI-DrugBank.d78.s0.e3	null	lemma_1=,	pos_1=,	lpib=metal_NNP	relType_5=compound	path1=Sucralfate_conj	pos_3=NNS	pos_2=NNP	pos_4=,	path=Sucralfate_conj<antacid_ROOT>form_parataxis>Quinolones_nsubj	pos_5=NNPS	lib=metal	relType_4=punct	relType_3=conj	wib=Metal	relType_2=compound	lemma_2=Metal	lemma_4=,	path2=form_parataxis>Quinolones_nsubj	lemma_3=cation	eib=True	lemma_5=Multivitamins	relType_1=punct
DDI-DrugBank.d78.s0	DDI-DrugBank.d78.s0.e2	DDI-DrugBank.d78.s0.e3	null	eib=False	path2=	path1=Multivitamins_compound	path=Multivitamins_compound<Quinolones_nsubj>
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e1	null	lemma_1=with	relType_1=case	eib=False	wib=antacids	path1=	path2=antacid_nmod	path=<quinolone_nmod>antacid_nmod	pos_1=IN	lib=antacid	lpib=antacid_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e2	mechanism	pos_2=NNS	lemma_1=with	relType_1=case	eib=True	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj	relType_2=nmod	lemma_2=contain	wib=antacids	path1=	pos_1=IN	lib=antacid	relType_2=acl	lemma_2=antacid	lpib=antacid_NNS	path2=antacid_nmod>contain_acl>aluminum_obj	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e3	mechanism	relType_1=case	lemma_2=contain	lemma_3=aluminum	path1=	path2=antacid_nmod>contain_acl>aluminum_obj>magnesium_conj	relType_2=nmod	pos_1=IN	lib=antacid	lemma_2=antacid	lemma_3=,	relType_2=acl	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	pos_3=NN	wib=antacids	relType_3=obj	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>magnesium_conj	relType_3=punct	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e4	mechanism	relType_1=case	lemma_2=contain	pos_5=CC	lemma_3=aluminum	path1=	relType_5=cc	pos_4=,	relType_2=nmod	pos_1=IN	lib=antacid	lemma_2=antacid	lemma_4=magnesium	pos_4=NN	relType_4=punct	lemma_3=,	lemma_5=or	lemma_4=,	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>calcium_conj	relType_2=acl	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	pos_3=NN	wib=antacids	relType_3=obj	relType_4=conj	path2=antacid_nmod>contain_acl>aluminum_obj>calcium_conj	relType_3=punct	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e5	mechanism	relType_1=case	lemma_2=contain	pos_5=CC	relType_7=case	lemma_3=aluminum	path1=	lemma_6=,	lemma_7=with	pos_6=NN	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>sucralfate_conj	relType_5=cc	relType_6=conj	pos_4=,	relType_2=nmod	relType_6=punct	pos_1=IN	lib=antacid	path2=antacid_nmod>contain_acl>aluminum_obj>sucralfate_conj	lemma_2=antacid	lemma_4=magnesium	pos_4=NN	relType_4=punct	lemma_3=,	lemma_5=or	lemma_4=,	relType_2=acl	pos_6=,	pos_2=NNS	lemma_1=with	pos_3=,	eib=True	pos_7=IN	pos_3=NN	wib=antacids	lemma_6=calcium	relType_3=obj	relType_4=conj	relType_3=punct	lpib=antacid_NNS	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e6	mechanism	relType_1=case	lemma_2=contain	pos_5=CC	relType_7=case	lemma_13=as	lemma_3=aluminum	path1=	lemma_6=,	relType_12=case	pos_9=IN	relType_8=punct	lemma_8=,	lemma_7=with	lemma_11=cation	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod	pos_6=NN	pos_8=NN	pos_12=JJ	relType_5=cc	relType_6=conj	pos_4=,	relType_2=nmod	relType_6=punct	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod	pos_11=NNS	lemma_10=metal	pos_1=IN	lib=antacid	relType_9=case	lemma_2=antacid	lemma_4=magnesium	pos_4=NN	pos_10=NN	relType_10=compound	pos_13=IN	lemma_8=sucralfate	relType_4=punct	lemma_3=,	lemma_5=or	lemma_4=,	relType_2=acl	pos_6=,	lemma_12=such	pos_2=NNS	lemma_1=with	relType_13=fixed	lemma_9=with	pos_3=,	eib=True	pos_7=IN	pos_3=NN	wib=antacids	relType_8=conj	lemma_6=calcium	relType_3=obj	relType_4=conj	relType_11=nmod	relType_3=punct	lpib=antacid_NNS	pos_8=,	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e7	mechanism	relType_1=case	relType_14=punct	lemma_2=contain	pos_5=CC	relType_7=case	lemma_13=as	pos_16=IN	lemma_3=aluminum	lemma_16=with	path1=	lemma_6=,	relType_12=case	pos_9=IN	relType_8=punct	lemma_8=,	lemma_7=with	lemma_11=cation	pos_6=NN	pos_8=NN	pos_12=JJ	relType_5=cc	relType_6=conj	pos_4=,	relType_2=nmod	relType_6=punct	pos_14=,	pos_11=NNS	lemma_10=metal	pos_1=IN	lib=antacid	relType_9=case	lemma_2=antacid	lemma_4=magnesium	pos_4=NN	pos_10=NN	relType_10=compound	pos_13=IN	pos_14=NN	lemma_14=iron	lemma_8=sucralfate	relType_4=punct	lemma_3=,	lemma_5=or	lemma_4=,	lemma_15=or	relType_2=acl	relType_15=cc	pos_6=,	lemma_12=such	pos_2=NNS	lemma_1=with	relType_13=fixed	lemma_14=,	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	lemma_9=with	pos_3=,	relType_16=case	eib=True	pos_7=IN	pos_3=NN	wib=antacids	relType_8=conj	lemma_6=calcium	relType_3=obj	relType_4=conj	pos_15=CC	relType_11=nmod	relType_14=nmod	relType_3=punct	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	lpib=antacid_NNS	pos_8=,	pos_2=VBG
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e8	mechanism	lemma_13=as	lemma_6=,	relType_8=punct	lemma_7=with	pos_6=NN	relType_5=cc	relType_6=conj	relType_9=case	lib=antacid	pos_10=NN	lemma_4=magnesium	relType_4=punct	lemma_3=,	lemma_15=or	pos_3=,	pos_7=IN	relType_8=conj	pos_15=CC	relType_14=nmod	relType_1=case	lemma_2=contain	relType_7=case	path1=	lemma_11=cation	pos_8=NN	lemma_17=multivitamin	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	relType_17=acl	pos_1=IN	lemma_8=sucralfate	lemma_4=,	relType_2=acl	lemma_12=such	relType_13=fixed	lemma_14=,	relType_16=case	lemma_6=calcium	relType_3=obj	relType_11=nmod	relType_3=punct	lpib=antacid_NNS	pos_8=,	lemma_5=or	pos_2=VBG	relType_14=punct	pos_16=IN	relType_12=case	lemma_8=,	pos_4=,	relType_2=nmod	pos_14=,	lemma_10=metal	pos_14=NN	lemma_16=with	pos_13=IN	lemma_2=antacid	lemma_14=iron	lemma_17=contain	pos_17=NNS	wib=antacids	pos_5=CC	lemma_3=aluminum	pos_9=IN	relType_17=conj	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_17=VBG	relType_10=compound	pos_4=NN	relType_15=cc	pos_6=,	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	pos_2=NNS	lemma_1=with	lemma_9=with	eib=True	pos_3=NN	relType_4=conj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e9	mechanism	lemma_13=as	lemma_6=,	relType_8=punct	lemma_7=with	pos_6=NN	relType_5=cc	relType_6=conj	relType_9=case	lib=antacid	pos_10=NN	pos_18=CC	lemma_4=magnesium	pos_18=NN	relType_4=punct	lemma_3=,	lemma_15=or	pos_3=,	pos_7=IN	relType_8=conj	pos_15=CC	relType_18=obj	relType_14=nmod	relType_1=case	lemma_2=contain	relType_7=case	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	path1=	lemma_11=cation	pos_8=NN	lemma_17=multivitamin	relType_17=acl	pos_1=IN	lemma_8=sucralfate	lemma_4=,	relType_2=acl	lemma_12=such	relType_13=fixed	lemma_14=,	relType_16=case	lemma_18=iron	lemma_6=calcium	relType_3=obj	relType_11=nmod	relType_3=punct	lpib=antacid_NNS	pos_8=,	lemma_5=or	pos_2=VBG	lemma_18=or	relType_14=punct	pos_16=IN	relType_12=case	lemma_8=,	relType_18=cc	pos_4=,	relType_2=nmod	pos_14=,	lemma_10=metal	pos_14=NN	lemma_16=with	pos_13=IN	lemma_2=antacid	lemma_14=iron	lemma_17=contain	pos_17=NNS	wib=antacids	pos_5=CC	lemma_3=aluminum	pos_9=IN	relType_17=conj	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_17=VBG	relType_10=compound	pos_4=NN	relType_15=cc	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	pos_6=,	pos_2=NNS	lemma_1=with	lemma_9=with	eib=True	pos_3=NN	relType_4=conj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e10	mechanism	lemma_13=as	lemma_6=,	relType_8=punct	lemma_7=with	pos_6=NN	lemma_29=as	relType_5=cc	relType_6=conj	relType_9=case	lib=antacid	pos_10=NN	pos_18=CC	lemma_4=magnesium	pos_18=NN	relType_4=punct	lemma_3=,	lemma_15=or	relType_24=obj	relType_21=case	relType_26=amod	pos_3=,	pos_7=IN	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_26=trivalent	relType_8=conj	pos_15=CC	relType_18=obj	relType_14=nmod	relType_1=case	lemma_2=contain	relType_7=case	relType_22=conj	path1=	relType_27=conj	lemma_24=divalent	pos_29=IN	relType_29=fixed	lemma_11=cation	pos_8=NN	lemma_17=multivitamin	relType_17=acl	relType_23=acl	pos_1=IN	lemma_8=sucralfate	lemma_19=zinc	pos_19=,	lemma_4=,	relType_2=acl	pos_28=JJ	lemma_12=such	relType_13=fixed	lemma_14=,	lemma_27=cation	relType_16=case	lemma_18=iron	lemma_6=calcium	relType_3=obj	lemma_19=,	relType_11=nmod	relType_3=punct	lpib=antacid_NNS	pos_8=,	lemma_5=or	pos_2=VBG	lemma_18=or	relType_14=punct	pos_16=IN	relType_12=case	relType_20=cc	pos_24=NN	relType_19=punct	lemma_8=,	relType_18=cc	lemma_23=contain	pos_26=JJ	lemma_25=and	lemma_28=such	pos_4=,	relType_2=nmod	pos_27=NNS	pos_14=,	lemma_10=metal	pos_21=IN	pos_14=NN	lemma_16=with	pos_13=IN	lemma_2=antacid	lemma_14=iron	pos_25=CC	lemma_17=contain	pos_23=VBG	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_19=conj	relType_28=case	pos_17=NNS	wib=antacids	lemma_20=or	pos_20=CC	pos_5=CC	lemma_3=aluminum	pos_9=IN	relType_17=conj	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_17=VBG	pos_19=NN	relType_10=compound	lemma_21=with	pos_4=NN	relType_25=cc	lemma_22=formulation	pos_22=NNS	relType_15=cc	pos_6=,	pos_2=NNS	lemma_1=with	lemma_9=with	eib=True	pos_3=NN	relType_4=conj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e11	mechanism	lemma_13=as	lemma_6=,	relType_8=punct	lemma_7=with	pos_6=NN	lemma_29=as	relType_5=cc	relType_6=conj	path2=antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_9=case	lib=antacid	pos_10=NN	pos_18=CC	lemma_4=magnesium	pos_18=NN	relType_4=punct	lemma_3=,	lemma_15=or	relType_24=obj	relType_21=case	relType_26=amod	relType_30=punct	pos_3=,	pos_7=IN	relType_30=nmod	lemma_26=trivalent	relType_8=conj	pos_15=CC	relType_18=obj	relType_14=nmod	relType_1=case	lemma_2=contain	relType_7=case	relType_22=conj	path1=	relType_27=conj	lemma_24=divalent	pos_29=IN	relType_29=fixed	lemma_11=cation	pos_8=NN	lemma_17=multivitamin	relType_17=acl	relType_23=acl	pos_1=IN	lemma_8=sucralfate	lemma_19=zinc	pos_19=,	lemma_4=,	relType_2=acl	pos_28=JJ	lemma_12=such	relType_13=fixed	lemma_14=,	lemma_27=cation	relType_16=case	lemma_18=iron	lemma_6=calcium	relType_3=obj	lemma_19=,	relType_11=nmod	relType_3=punct	lpib=antacid_NNS	pos_8=,	lemma_5=or	pos_2=VBG	lemma_18=or	relType_14=punct	pos_16=IN	relType_12=case	relType_20=cc	path=<quinolone_nmod>antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_24=NN	relType_19=punct	lemma_8=,	relType_18=cc	lemma_23=contain	pos_26=JJ	lemma_25=and	lemma_28=such	pos_4=,	relType_2=nmod	pos_27=NNS	pos_14=,	pos_30=NNP	lemma_10=metal	pos_21=IN	pos_14=NN	lemma_16=with	pos_13=IN	lemma_2=antacid	lemma_14=iron	pos_25=CC	lemma_17=contain	pos_23=VBG	relType_19=conj	relType_28=case	pos_17=NNS	wib=antacids	lemma_20=or	lemma_30=VIDEX	pos_20=CC	pos_5=CC	pos_30=-LRB-	lemma_3=aluminum	pos_9=IN	relType_17=conj	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_17=VBG	pos_19=NN	relType_10=compound	lemma_21=with	pos_4=NN	relType_25=cc	lemma_22=formulation	pos_22=NNS	relType_15=cc	pos_6=,	pos_2=NNS	lemma_1=with	lemma_9=with	eib=True	pos_3=NN	relType_4=conj	lemma_30=(
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e0	DDI-DrugBank.d78.s1.e12	null	pos_39=NN	lemma_13=as	lemma_6=,	relType_8=punct	lemma_7=with	lemma_40=for	pos_6=NN	lemma_29=as	relType_5=cc	relType_6=conj	path2=absorption_obl>quinolone_nmod	lemma_41=oral	path=quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	relType_9=case	lib=antacid	pos_10=NN	pos_18=CC	lemma_4=magnesium	lemma_31=)	relType_43=punct	lemma_31=didanosine	pos_18=NN	lemma_35=tablet	relType_4=punct	lemma_3=,	pos_31=-RRB-	relType_33=punct	lemma_42=solution	lemma_32=chewable	pos_49=NN	lemma_34=buffer	lemma_15=or	relType_24=obj	relType_21=case	pos_40=IN	relType_41=amod	lemma_45=substantially	relType_26=amod	relType_30=punct	pos_3=,	pos_7=IN	relType_30=nmod	lemma_26=trivalent	relType_8=conj	pos_15=CC	relType_39=conj	relType_18=obj	relType_14=nmod	pos_50=IN	relType_1=case	lemma_2=contain	relType_7=case	relType_22=conj	relType_27=conj	lemma_24=divalent	lemma_38=pediatric	pos_29=IN	relType_47=case	relType_29=fixed	lemma_11=cation	pos_34=VBN	pos_8=NN	lemma_17=multivitamin	relType_17=acl	pos_32=JJ	relType_23=acl	pos_41=JJ	pos_47=IN	lemma_37=the	pos_1=IN	lemma_33=/	lemma_8=sucralfate	pos_38=JJ	pos_45=RB	lemma_48=the	pos_36=CC	relType_40=case	relType_49=obl	lemma_19=zinc	pos_19=,	lemma_4=,	relType_2=acl	pos_28=JJ	relType_45=advmod	lemma_12=such	relType_13=fixed	lemma_14=,	lemma_27=cation	relType_16=case	pos_33=HYPH	lemma_18=iron	pos_31=NN	relType_46=ROOT	pos_42=NN	relType_48=det	relType_50=case	lemma_6=calcium	relType_3=obj	lemma_19=,	relType_11=nmod	relType_3=punct	relType_38=amod	lpib=antacid_NNS	pos_8=,	lemma_5=or	pos_2=VBG	lemma_18=or	lemma_46=interfere	relType_14=punct	pos_48=DT	pos_16=IN	relType_12=case	relType_35=dep	relType_20=cc	pos_24=NN	relType_19=punct	lemma_8=,	relType_18=cc	lemma_23=contain	pos_26=JJ	lemma_25=and	lemma_28=such	pos_4=,	relType_2=nmod	pos_27=NNS	pos_14=,	pos_30=NNP	pos_37=DT	lemma_10=metal	pos_21=IN	pos_14=NN	lemma_16=with	path1=quinolone_nmod<administration_nsubj	lemma_2=antacid	pos_13=IN	lemma_14=iron	pos_25=CC	lemma_17=contain	pos_23=VBG	pos_44=MD	relType_31=dep	relType_19=conj	relType_37=det	relType_34=amod	relType_28=case	pos_17=NNS	wib=antacids	lemma_20=or	lemma_30=VIDEX	pos_20=CC	lemma_43=,	lemma_44=may	lemma_36=or	pos_35=NNS	pos_5=CC	pos_30=-LRB-	lemma_3=aluminum	lemma_39=powder	lemma_49=absorption	lemma_50=of	pos_9=IN	relType_32=dep	pos_43=,	relType_17=conj	pos_12=JJ	relType_6=punct	pos_11=NNS	pos_17=VBG	relType_42=nmod	pos_19=NN	relType_10=compound	lemma_21=with	pos_4=NN	relType_25=cc	relType_31=punct	lemma_22=formulation	pos_22=NNS	pos_46=VB	lemma_47=with	relType_15=cc	pos_6=,	pos_2=NNS	lemma_1=with	lemma_9=with	relType_36=cc	eib=True	pos_3=NN	relType_4=conj	relation_56=adverse	relType_44=aux	lemma_30=(
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e2	null	pos_1=VBG	eib=False	path2=contain_acl>aluminum_obj	relType_1=acl	path1=	lemma_1=contain	lib=contain	wib=containing	lpib=contain_VBG	path=<antacid_nmod>contain_acl>aluminum_obj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e3	null	pos_1=VBG	relType_2=obj	pos_2=NN	eib=True	relType_1=acl	path1=	path=<antacid_nmod>contain_acl>aluminum_obj>magnesium_conj	lemma_1=contain	pos_2=,	lib=contain	wib=containing	lpib=contain_VBG	lemma_2=,	lemma_2=aluminum	path2=contain_acl>aluminum_obj>magnesium_conj	relType_2=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e4	null	relType_2=obj	pos_2=NN	path1=	relType_4=cc	relType_2=punct	path2=contain_acl>aluminum_obj>calcium_conj	lpib=contain_VBG	lemma_2=,	path=<antacid_nmod>contain_acl>aluminum_obj>calcium_conj	lemma_2=aluminum	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	relType_1=acl	wib=containing	pos_1=VBG	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_1=contain	pos_2=,	lib=contain	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e5	null	relType_2=obj	pos_2=NN	path=<antacid_nmod>contain_acl>aluminum_obj>sucralfate_conj	pos_5=,	path1=	relType_4=cc	relType_6=case	relType_2=punct	pos_6=IN	lpib=contain_VBG	lemma_2=,	lemma_2=aluminum	path2=contain_acl>aluminum_obj>sucralfate_conj	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_1=acl	lemma_6=with	relType_5=conj	wib=containing	pos_1=VBG	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_1=contain	pos_2=,	lib=contain	relType_3=punct	lemma_5=calcium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e6	null	relType_8=case	relType_2=obj	pos_2=NN	pos_5=,	path1=	lemma_9=metal	relType_4=cc	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod	relType_6=case	relType_11=case	relType_2=punct	pos_10=NNS	relType_10=nmod	lemma_12=as	relType_9=compound	relType_12=fixed	lemma_10=cation	pos_6=IN	pos_7=,	lemma_8=with	lemma_7=,	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	relType_7=conj	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_1=acl	lemma_7=sucralfate	lemma_6=with	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod	relType_5=conj	wib=containing	pos_1=VBG	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	relType_7=punct	lemma_1=contain	pos_2=,	pos_11=JJ	lib=contain	pos_7=NN	relType_3=punct	lemma_5=calcium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e7	null	relType_8=case	pos_13=,	relType_2=obj	pos_2=NN	pos_14=CC	lemma_13=,	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	pos_5=,	path1=	lemma_9=metal	relType_13=punct	relType_4=cc	lemma_14=or	relType_6=case	relType_11=case	relType_2=punct	relType_13=nmod	pos_10=NNS	relType_10=nmod	lemma_12=as	relType_9=compound	lemma_13=iron	lemma_15=with	relType_12=fixed	lemma_10=cation	pos_6=IN	pos_7=,	lemma_8=with	pos_13=NN	lemma_7=,	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	relType_7=conj	relType_15=case	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_1=acl	lemma_7=sucralfate	lemma_6=with	relType_14=cc	relType_5=conj	wib=containing	pos_15=IN	pos_1=VBG	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	relType_7=punct	lemma_1=contain	pos_2=,	pos_11=JJ	lib=contain	pos_7=NN	relType_3=punct	lemma_5=calcium	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e8	null	relType_8=case	pos_13=,	lemma_16=multivitamin	relType_2=obj	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	path1=	lemma_9=metal	relType_13=punct	relType_4=cc	pos_16=NNS	lemma_14=or	relType_6=case	relType_11=case	relType_2=punct	relType_13=nmod	pos_10=NNS	relType_10=nmod	lemma_12=as	relType_9=compound	lemma_13=iron	lemma_15=with	relType_12=fixed	lemma_10=cation	pos_6=IN	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	pos_7=,	lemma_8=with	pos_13=NN	lemma_7=,	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	relType_7=conj	relType_15=case	lemma_16=contain	lemma_3=,	lemma_3=magnesium	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_1=acl	pos_16=VBG	relType_16=acl	lemma_7=sucralfate	lemma_6=with	relType_14=cc	relType_5=conj	wib=containing	pos_15=IN	pos_1=VBG	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	relType_7=punct	lemma_1=contain	pos_2=,	pos_11=JJ	lib=contain	pos_7=NN	relType_3=punct	relType_16=conj	lemma_5=calcium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e9	null	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	relType_10=nmod	relType_12=fixed	pos_13=NN	lemma_7=,	lemma_3=,	lemma_3=magnesium	relType_16=acl	lemma_5=,	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	pos_16=VBG	pos_1=VBG	pos_3=,	pos_2=,	pos_11=JJ	relType_8=case	pos_13=,	relType_17=cc	path1=	pos_16=NNS	relType_6=case	relType_11=case	relType_2=punct	pos_6=IN	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	lemma_16=contain	relType_15=case	relType_1=acl	pos_15=IN	pos_5=NN	relType_17=obj	lemma_1=contain	pos_17=CC	lib=contain	pos_7=NN	relType_3=punct	lemma_14=or	pos_17=NN	lemma_15=with	lemma_10=cation	pos_7=,	lemma_8=with	relType_3=conj	lemma_4=or	relType_5=conj	wib=containing	lemma_17=or	pos_4=CC	relType_7=conj	lemma_5=calcium	lemma_16=multivitamin	relType_2=obj	relType_13=punct	lemma_9=metal	relType_4=cc	relType_13=nmod	lemma_12=as	relType_9=compound	lemma_13=iron	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	lemma_17=iron	relType_5=punct	lemma_7=sucralfate	lemma_6=with	relType_14=cc	eib=True	pos_3=NN	relType_7=punct	pos_10=NNS	relType_16=conj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e10	null	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	pos_21=NNS	relType_21=conj	relType_10=nmod	relType_12=fixed	pos_13=NN	lemma_7=,	pos_18=NN	lemma_21=formulation	lemma_3=,	lemma_3=magnesium	relType_16=acl	lemma_5=,	pos_16=VBG	pos_19=CC	lemma_19=or	pos_1=VBG	pos_3=,	pos_2=,	pos_11=JJ	relType_23=obj	relType_8=case	pos_13=,	relType_17=cc	path1=	relType_22=acl	pos_27=JJ	pos_16=NNS	relType_6=case	relType_11=case	relType_2=punct	relType_20=case	relType_25=amod	pos_24=CC	pos_6=IN	pos_26=NNS	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	lemma_16=contain	relType_15=case	lemma_24=and	relType_1=acl	lemma_26=cation	pos_15=IN	pos_5=NN	relType_17=obj	lemma_1=contain	pos_17=CC	lib=contain	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	pos_7=NN	relType_3=punct	lemma_22=contain	lemma_14=or	pos_20=IN	pos_23=NN	pos_17=NN	lemma_15=with	lemma_10=cation	pos_7=,	lemma_8=with	lemma_18=zinc	relType_3=conj	lemma_4=or	relType_5=conj	wib=containing	lemma_17=or	pos_4=CC	relType_27=case	relType_7=conj	lemma_5=calcium	lemma_16=multivitamin	relType_2=obj	relType_13=punct	lemma_9=metal	relType_4=cc	lemma_27=such	lemma_28=as	pos_22=VBG	relType_13=nmod	lemma_12=as	relType_9=compound	lemma_13=iron	relType_26=conj	relType_24=cc	lemma_17=iron	lemma_25=trivalent	pos_25=JJ	pos_18=,	lemma_18=,	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_5=punct	relType_18=punct	lemma_7=sucralfate	lemma_6=with	relType_14=cc	relType_19=cc	relType_18=conj	lemma_20=with	eib=True	pos_3=NN	relType_7=punct	pos_28=IN	relType_28=fixed	pos_10=NNS	relType_16=conj	lemma_23=divalent
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e11	null	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	pos_21=NNS	relType_21=conj	path=<antacid_nmod>contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_10=nmod	relType_12=fixed	pos_13=NN	lemma_7=,	pos_18=NN	lemma_21=formulation	lemma_3=,	lemma_3=magnesium	relType_16=acl	lemma_5=,	path2=contain_acl>aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_16=VBG	pos_19=CC	lemma_19=or	pos_1=VBG	pos_3=,	pos_2=,	pos_11=JJ	relType_23=obj	relType_8=case	pos_29=NNP	pos_13=,	relType_17=cc	path1=	relType_22=acl	pos_27=JJ	pos_16=NNS	relType_6=case	relType_11=case	relType_2=punct	relType_20=case	relType_25=amod	pos_24=CC	pos_6=IN	pos_26=NNS	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	lemma_16=contain	relType_15=case	lemma_24=and	relType_1=acl	relType_29=nmod	lemma_26=cation	pos_15=IN	pos_5=NN	relType_17=obj	lemma_1=contain	pos_17=CC	lib=contain	pos_7=NN	relType_3=punct	lemma_22=contain	lemma_14=or	pos_20=IN	pos_23=NN	pos_17=NN	lemma_15=with	lemma_10=cation	pos_7=,	lemma_8=with	lemma_18=zinc	relType_3=conj	lemma_4=or	relType_5=conj	wib=containing	lemma_17=or	pos_29=-LRB-	pos_4=CC	relType_27=case	relType_7=conj	lemma_5=calcium	lemma_16=multivitamin	relType_2=obj	relType_13=punct	lemma_9=metal	relType_4=cc	lemma_27=such	lemma_28=as	pos_22=VBG	relType_13=nmod	lemma_12=as	relType_9=compound	lemma_13=iron	relType_26=conj	lemma_29=VIDEX	relType_24=cc	lemma_17=iron	lemma_25=trivalent	pos_25=JJ	lemma_29=(	pos_18=,	lemma_18=,	relType_5=punct	relType_18=punct	lemma_7=sucralfate	relType_29=punct	lemma_6=with	relType_14=cc	relType_19=cc	relType_18=conj	lemma_20=with	eib=True	pos_3=NN	relType_7=punct	pos_28=IN	relType_28=fixed	pos_10=NNS	relType_16=conj	lemma_23=divalent
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e1	DDI-DrugBank.d78.s1.e12	null	relType_30=dep	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	relType_32=punct	relType_45=ROOT	lemma_30=didanosine	pos_41=NN	pos_21=NNS	relType_21=conj	relType_35=cc	relType_38=conj	relType_10=nmod	pos_30=-RRB-	relType_12=fixed	path2=absorption_obl>quinolone_nmod	pos_13=NN	lemma_7=,	relType_37=amod	pos_18=NN	lemma_21=formulation	lemma_3=,	lemma_3=magnesium	relType_16=acl	lemma_5=,	path=antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	pos_16=VBG	relType_33=amod	pos_19=CC	pos_48=NN	pos_33=VBN	lemma_19=or	pos_1=VBG	relType_30=punct	pos_3=,	pos_42=,	pos_2=,	pos_11=JJ	relType_48=obl	pos_32=HYPH	relType_23=obj	pos_40=JJ	relType_8=case	pos_29=NNP	pos_13=,	pos_31=JJ	relType_17=cc	pos_45=VB	pos_37=JJ	relType_22=acl	pos_27=JJ	pos_16=NNS	relType_6=case	relType_11=case	relType_2=punct	pos_30=NN	relType_20=case	relType_25=amod	pos_24=CC	pos_6=IN	pos_26=NNS	relType_43=aux	lpib=contain_VBG	pos_9=NN	lemma_2=,	lemma_2=aluminum	pos_8=IN	pos_12=IN	lemma_11=such	lemma_16=contain	relType_15=case	lemma_24=and	relType_1=acl	relType_29=nmod	lemma_41=solution	lemma_26=cation	lemma_45=interfere	pos_15=IN	pos_5=NN	relType_17=obj	relType_44=advmod	relType_46=case	lemma_37=pediatric	lemma_1=contain	pos_17=CC	lib=contain	pos_7=NN	relType_3=punct	pos_46=IN	lemma_22=contain	lemma_34=tablet	lemma_30=)	lemma_48=absorption	pos_34=NNS	lemma_36=the	pos_44=RB	lemma_14=or	lemma_40=oral	pos_20=IN	pos_23=NN	pos_17=NN	lemma_15=with	lemma_10=cation	pos_36=DT	pos_7=,	lemma_8=with	lemma_18=zinc	lemma_49=of	relType_47=det	relType_36=det	lemma_39=for	relType_41=nmod	relType_42=punct	relType_34=dep	relType_3=conj	lemma_4=or	pos_38=NN	relation_54=adverse	relType_5=conj	relType_31=dep	wib=containing	lemma_17=or	pos_29=-LRB-	lemma_31=chewable	pos_47=DT	pos_4=CC	relType_27=case	relType_39=case	lemma_32=/	relType_7=conj	lemma_5=calcium	path1=antacid_nmod<quinolone_nmod<administration_nsubj	lemma_33=buffer	pos_39=IN	lemma_16=multivitamin	relType_2=obj	lemma_47=the	relType_13=punct	lemma_9=metal	relType_4=cc	lemma_27=such	lemma_46=with	lemma_38=powder	lemma_28=as	pos_22=VBG	relType_13=nmod	lemma_12=as	lemma_42=,	relType_9=compound	lemma_13=iron	relType_26=conj	lemma_35=or	relType_40=amod	lemma_29=VIDEX	relType_24=cc	lemma_17=iron	lemma_44=substantially	lemma_25=trivalent	pos_25=JJ	relType_49=case	lemma_29=(	pos_18=,	pos_35=CC	lemma_18=,	relType_5=punct	relType_18=punct	lemma_7=sucralfate	relType_29=punct	lemma_6=with	relType_14=cc	relType_19=cc	lemma_43=may	relType_18=conj	lemma_20=with	eib=True	pos_49=IN	pos_3=NN	relType_7=punct	pos_28=IN	relType_28=fixed	pos_43=MD	pos_10=NNS	relType_16=conj	lemma_23=divalent
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e3	null	lemma_1=,	path=<aluminum_obj>magnesium_conj	eib=False	path2=magnesium_conj	path1=	pos_1=,	relType_1=punct	lib=magnesium	lpib=magnesium_NN	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	path=<aluminum_obj>calcium_conj	lpib=magnesium_NN	relType_3=cc	relType_2=punct	lemma_3=or	relType_2=conj	lemma_2=,	path2=calcium_conj	lib=magnesium	lemma_2=magnesium	eib=True	pos_2=,	relType_1=punct	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	path=<aluminum_obj>sucralfate_conj	path1=	pos_1=,	lpib=magnesium_NN	relType_5=case	relType_3=cc	relType_2=punct	pos_4=,	lemma_5=with	lemma_3=or	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	path2=sucralfate_conj	pos_5=IN	lemma_4=,	lib=magnesium	lemma_2=magnesium	lemma_4=calcium	eib=True	pos_2=,	relType_4=conj	relType_1=punct	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e6	null	lemma_1=,	pos_2=NN	lemma_6=sucralfate	pos_3=CC	path=<aluminum_obj>cation_nmod>iron_nmod	relType_7=case	path1=	pos_1=,	lemma_6=,	lemma_11=as	lpib=magnesium_NN	relType_9=nmod	relType_5=case	lemma_7=with	relType_3=cc	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_9=NNS	lemma_5=with	lemma_3=or	relType_10=case	relType_2=conj	pos_4=NN	lemma_2=,	lemma_9=cation	pos_11=IN	lemma_8=metal	lemma_10=such	relType_4=punct	pos_10=JJ	relType_8=compound	relType_11=fixed	pos_5=IN	lemma_4=,	lib=magnesium	path2=cation_nmod>iron_nmod	pos_6=,	lemma_2=magnesium	lemma_4=calcium	eib=True	pos_7=IN	pos_2=,	relType_4=conj	relType_1=punct	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e7	null	lemma_1=,	pos_2=NN	lemma_6=sucralfate	pos_3=CC	relType_7=case	lemma_14=with	path1=	pos_1=,	lemma_6=,	lemma_11=as	lpib=magnesium_NN	relType_9=nmod	relType_5=case	lemma_7=with	relType_3=cc	relType_2=punct	pos_6=NN	pos_8=NN	lemma_12=,	relType_6=conj	pos_4=,	lemma_12=iron	relType_6=punct	lemma_13=or	pos_9=NNS	lemma_5=with	relType_12=nmod	pos_12=,	lemma_3=or	relType_10=case	relType_12=punct	relType_2=conj	pos_4=NN	lemma_2=,	lemma_9=cation	pos_11=IN	relType_13=cc	pos_14=IN	lemma_8=metal	lemma_10=such	relType_4=punct	pos_10=JJ	relType_8=compound	relType_11=fixed	pos_5=IN	lemma_4=,	path=<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	lib=magnesium	path2=cation_nmod>iron_nmod>multivitamin_conj	pos_6=,	pos_13=CC	lemma_2=magnesium	lemma_4=calcium	eib=True	pos_7=IN	pos_2=,	relType_4=conj	relType_14=case	relType_1=punct	pos_12=NN	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e8	null	lemma_1=,	pos_2=NN	lemma_6=sucralfate	pos_3=CC	relType_7=case	lemma_14=with	lemma_15=contain	path1=	pos_1=,	lemma_6=,	lemma_11=as	lpib=magnesium_NN	relType_9=nmod	relType_5=case	lemma_7=with	relType_3=cc	relType_2=punct	pos_6=NN	pos_8=NN	lemma_12=,	relType_6=conj	pos_4=,	lemma_12=iron	relType_6=punct	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	lemma_13=or	pos_9=NNS	lemma_5=with	relType_12=nmod	pos_12=,	lemma_3=or	relType_10=case	relType_12=punct	relType_2=conj	pos_4=NN	lemma_2=,	path=<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	lemma_9=cation	pos_11=IN	relType_13=cc	pos_14=IN	lemma_8=metal	lemma_10=such	relType_4=punct	pos_10=JJ	pos_15=VBG	relType_8=compound	relType_11=fixed	pos_5=IN	lemma_4=,	lib=magnesium	pos_6=,	pos_13=CC	relType_15=acl	lemma_2=magnesium	lemma_4=calcium	pos_15=NNS	eib=True	pos_7=IN	relType_15=conj	pos_2=,	relType_4=conj	relType_14=case	relType_1=punct	pos_12=NN	lemma_15=multivitamin	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e9	null	relType_16=cc	lemma_1=,	pos_2=NN	lemma_6=sucralfate	pos_3=CC	relType_7=case	lemma_14=with	lemma_15=contain	path1=	pos_1=,	lemma_6=,	lemma_11=as	lpib=magnesium_NN	relType_9=nmod	pos_16=CC	relType_5=case	lemma_7=with	relType_3=cc	relType_2=punct	pos_6=NN	pos_8=NN	lemma_12=,	relType_6=conj	pos_4=,	lemma_12=iron	relType_6=punct	lemma_13=or	pos_9=NNS	lemma_5=with	relType_12=nmod	pos_12=,	path=<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	lemma_3=or	relType_10=case	relType_12=punct	relType_2=conj	pos_4=NN	lemma_2=,	lemma_9=cation	pos_11=IN	relType_13=cc	pos_14=IN	lemma_8=metal	lemma_16=or	lemma_10=such	relType_4=punct	pos_10=JJ	pos_15=VBG	relType_8=compound	relType_11=fixed	relType_16=obj	pos_5=IN	lemma_4=,	pos_16=NN	lib=magnesium	lemma_16=iron	pos_6=,	pos_13=CC	relType_15=acl	lemma_2=magnesium	lemma_4=calcium	pos_15=NNS	eib=True	pos_7=IN	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	relType_15=conj	pos_2=,	relType_4=conj	relType_14=case	relType_1=punct	pos_12=NN	lemma_15=multivitamin	wib=magnesium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e10	null	pos_2=NN	pos_3=CC	lemma_6=,	path=<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_5=case	lemma_7=with	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	lemma_27=as	pos_18=CC	lemma_19=with	lemma_10=such	relType_4=punct	pos_15=VBG	lemma_16=iron	relType_15=acl	pos_7=IN	pos_2=,	wib=magnesium	relType_16=cc	relType_25=conj	lemma_1=,	lemma_6=sucralfate	relType_7=case	pos_22=NN	path1=	pos_1=,	lemma_11=as	lpib=magnesium_NN	pos_16=CC	relType_3=cc	relType_2=punct	pos_8=NN	lemma_13=or	relType_20=conj	relType_12=nmod	pos_25=NNS	lemma_3=or	relType_12=punct	relType_2=conj	lemma_2=,	pos_14=IN	relType_13=cc	relType_27=fixed	lemma_22=divalent	pos_5=IN	lemma_4=,	pos_16=NN	lib=magnesium	relType_24=amod	lemma_2=magnesium	relType_19=case	relType_1=punct	lemma_23=and	lemma_26=such	lemma_18=or	lemma_14=with	relType_17=punct	lemma_21=contain	relType_18=cc	pos_24=JJ	pos_26=JJ	pos_23=CC	pos_17=NN	pos_4=,	lemma_12=iron	lemma_5=with	lemma_9=cation	pos_11=IN	pos_17=,	lemma_16=or	relType_8=compound	relType_11=fixed	relType_16=obj	pos_13=CC	lemma_4=calcium	relType_15=conj	relType_14=case	lemma_20=formulation	pos_19=IN	lemma_15=contain	relType_26=case	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_9=nmod	relType_21=acl	relType_17=conj	lemma_17=,	lemma_25=cation	relType_6=punct	pos_9=NNS	relType_10=case	pos_27=IN	pos_4=NN	lemma_8=metal	lemma_17=zinc	pos_10=JJ	relType_23=cc	pos_20=NNS	lemma_24=trivalent	relType_22=obj	pos_6=,	pos_21=VBG	pos_15=NNS	eib=True	relType_4=conj	lemma_15=multivitamin	pos_12=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e11	null	pos_2=NN	pos_3=CC	lemma_6=,	relType_5=case	lemma_7=with	pos_6=NN	lemma_12=,	relType_6=conj	relType_28=punct	pos_12=,	lemma_27=as	pos_18=CC	lemma_19=with	lemma_10=such	relType_4=punct	pos_15=VBG	lemma_16=iron	pos_28=-LRB-	relType_15=acl	pos_7=IN	pos_2=,	wib=magnesium	relType_16=cc	relType_25=conj	lemma_1=,	lemma_28=(	lemma_6=sucralfate	relType_7=case	pos_22=NN	path1=	pos_1=,	lemma_11=as	lpib=magnesium_NN	pos_16=CC	relType_3=cc	relType_2=punct	relType_28=nmod	pos_8=NN	lemma_13=or	relType_20=conj	relType_12=nmod	pos_25=NNS	lemma_3=or	relType_12=punct	relType_2=conj	path=<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	lemma_2=,	pos_14=IN	relType_13=cc	relType_27=fixed	lemma_22=divalent	pos_5=IN	pos_28=NNP	lemma_4=,	pos_16=NN	lib=magnesium	relType_24=amod	lemma_2=magnesium	relType_19=case	relType_1=punct	lemma_23=and	lemma_26=such	lemma_18=or	lemma_14=with	relType_17=punct	lemma_21=contain	relType_18=cc	pos_24=JJ	pos_26=JJ	pos_23=CC	pos_17=NN	pos_4=,	lemma_12=iron	lemma_5=with	lemma_9=cation	pos_11=IN	pos_17=,	lemma_16=or	relType_8=compound	relType_11=fixed	relType_16=obj	pos_13=CC	lemma_4=calcium	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_15=conj	relType_14=case	lemma_20=formulation	pos_19=IN	lemma_15=contain	relType_26=case	lemma_28=VIDEX	relType_9=nmod	relType_21=acl	relType_17=conj	lemma_17=,	lemma_25=cation	relType_6=punct	pos_9=NNS	relType_10=case	pos_27=IN	pos_4=NN	lemma_8=metal	lemma_17=zinc	pos_10=JJ	relType_23=cc	pos_20=NNS	lemma_24=trivalent	relType_22=obj	pos_6=,	pos_21=VBG	pos_15=NNS	eib=True	relType_4=conj	lemma_15=multivitamin	pos_12=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e2	DDI-DrugBank.d78.s1.e12	null	relType_30=dep	pos_2=NN	pos_3=CC	relation_52=adverse	lemma_6=,	relType_5=case	lemma_7=with	lemma_32=buffer	lemma_33=tablet	pos_6=NN	lemma_42=may	lemma_12=,	pos_47=NN	relType_6=conj	pos_31=HYPH	lemma_31=/	lemma_36=pediatric	relType_28=punct	pos_42=MD	path2=absorption_obl>quinolone_nmod	pos_12=,	lemma_27=as	lemma_43=substantially	pos_18=CC	relType_32=amod	lemma_19=with	lemma_10=such	relType_4=punct	lemma_46=the	pos_15=VBG	relType_44=ROOT	lemma_16=iron	pos_28=-LRB-	pos_35=DT	relType_15=acl	pos_38=IN	pos_7=IN	relType_37=conj	pos_2=,	pos_39=JJ	wib=magnesium	relType_16=cc	relType_25=conj	relType_35=det	lemma_1=,	lemma_28=(	lemma_6=sucralfate	relType_7=case	pos_22=NN	pos_1=,	lemma_11=as	lpib=magnesium_NN	pos_16=CC	relType_45=case	relType_3=cc	relType_2=punct	relType_28=nmod	pos_8=NN	relType_48=case	lemma_29=)	lemma_13=or	relType_20=conj	relType_12=nmod	pos_25=NNS	pos_29=NN	lemma_3=or	relType_12=punct	relType_2=conj	lemma_2=,	pos_14=IN	relType_13=cc	relType_27=fixed	pos_37=NN	pos_43=RB	lemma_22=divalent	relType_36=amod	pos_5=IN	pos_28=NNP	lemma_41=,	lemma_4=,	pos_16=NN	relType_41=punct	lib=magnesium	relType_43=advmod	lemma_40=solution	pos_46=DT	relType_24=amod	lemma_2=magnesium	relType_33=dep	lemma_39=oral	relType_19=case	pos_40=NN	relType_29=dep	relType_1=punct	lemma_23=and	lemma_26=such	lemma_18=or	relType_38=case	lemma_14=with	relType_17=punct	lemma_21=contain	relType_18=cc	pos_24=JJ	pos_26=JJ	pos_23=CC	pos_17=NN	pos_4=,	pos_30=JJ	lemma_12=iron	lemma_5=with	lemma_9=cation	pos_11=IN	pos_17=,	lemma_16=or	lemma_44=interfere	pos_45=IN	relType_8=compound	relType_11=fixed	relType_16=obj	pos_32=VBN	pos_13=CC	lemma_4=calcium	pos_41=,	relType_15=conj	lemma_37=powder	relType_42=aux	relType_14=case	pos_34=CC	lemma_30=chewable	pos_48=IN	lemma_20=formulation	pos_19=IN	pos_29=-RRB-	path1=aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	lemma_15=contain	pos_44=VB	relType_26=case	lemma_28=VIDEX	path=aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	relType_9=nmod	relType_21=acl	relType_47=obl	relType_17=conj	lemma_29=didanosine	relType_46=det	lemma_17=,	lemma_25=cation	relType_6=punct	pos_9=NNS	relType_10=case	pos_27=IN	lemma_38=for	pos_4=NN	relType_31=punct	lemma_8=metal	lemma_17=zinc	pos_36=JJ	pos_10=JJ	relType_23=cc	relType_29=punct	pos_20=NNS	lemma_48=of	lemma_34=or	lemma_24=trivalent	lemma_47=absorption	relType_40=nmod	relType_22=obj	pos_6=,	pos_21=VBG	relType_34=cc	lemma_35=the	pos_15=NNS	eib=True	lemma_45=with	relType_4=conj	lemma_15=multivitamin	pos_12=NN	pos_33=NNS	relType_39=amod
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e4	null	path1=magnesium_conj	path=magnesium_conj<aluminum_obj>calcium_conj	lemma_2=or	lemma_1=,	path2=calcium_conj	eib=False	lpib=calcium_NN	wib=calcium	pos_2=CC	pos_1=,	relType_1=punct	relType_2=cc	lib=calcium
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e5	null	lemma_2=or	lemma_1=,	wib=calcium	path=magnesium_conj<aluminum_obj>sucralfate_conj	pos_1=,	relType_2=cc	lemma_3=calcium	lemma_4=with	path1=magnesium_conj	lemma_3=,	relType_3=conj	path2=sucralfate_conj	pos_4=IN	relType_4=case	pos_3=,	eib=True	lpib=calcium_NN	pos_3=NN	pos_2=CC	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e6	null	lemma_2=or	lemma_1=,	lemma_7=metal	relType_7=compound	wib=calcium	pos_5=,	pos_1=,	relType_2=cc	relType_6=case	pos_8=NNS	pos_9=JJ	lemma_3=calcium	pos_6=IN	relType_9=case	relType_10=fixed	lemma_4=with	path1=magnesium_conj	lemma_10=as	lemma_3=,	relType_3=conj	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	lemma_6=with	pos_10=IN	relType_5=conj	path2=cation_nmod>iron_nmod	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod	lemma_9=such	pos_5=NN	pos_3=,	eib=True	relType_8=nmod	lpib=calcium_NN	pos_3=NN	pos_2=CC	lemma_5=sucralfate	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	lemma_8=cation
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e7	null	lemma_2=or	lemma_1=,	lemma_7=metal	relType_7=compound	lemma_11=iron	lemma_11=,	wib=calcium	pos_5=,	pos_1=,	relType_12=cc	lemma_13=with	pos_12=CC	relType_2=cc	relType_6=case	pos_8=NNS	pos_9=JJ	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	lemma_3=calcium	pos_6=IN	relType_11=punct	relType_9=case	pos_13=IN	relType_10=fixed	lemma_4=with	path1=magnesium_conj	lemma_12=or	lemma_10=as	relType_13=case	lemma_3=,	relType_3=conj	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	lemma_6=with	pos_10=IN	relType_5=conj	pos_11=,	path2=cation_nmod>iron_nmod>multivitamin_conj	lemma_9=such	pos_5=NN	pos_11=NN	pos_3=,	eib=True	relType_8=nmod	lpib=calcium_NN	pos_3=NN	pos_2=CC	lemma_5=sucralfate	relType_11=nmod	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	lemma_8=cation
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e8	null	lemma_2=or	lemma_1=,	lemma_7=metal	relType_7=compound	lemma_11=iron	lemma_11=,	wib=calcium	pos_5=,	pos_1=,	relType_12=cc	lemma_13=with	pos_12=CC	relType_2=cc	relType_6=case	pos_8=NNS	relType_14=acl	pos_9=JJ	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	lemma_3=calcium	pos_6=IN	relType_11=punct	relType_9=case	pos_13=IN	relType_10=fixed	lemma_4=with	path1=magnesium_conj	lemma_12=or	lemma_10=as	relType_13=case	lemma_14=multivitamin	lemma_3=,	relType_3=conj	lemma_5=,	pos_4=IN	relType_5=punct	pos_14=VBG	relType_4=case	lemma_6=with	pos_10=IN	relType_5=conj	pos_11=,	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	lemma_9=such	pos_5=NN	pos_11=NN	pos_3=,	eib=True	relType_8=nmod	lpib=calcium_NN	pos_3=NN	pos_2=CC	relType_14=conj	lemma_14=contain	lemma_5=sucralfate	pos_14=NNS	relType_11=nmod	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	lemma_8=cation
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e9	null	lemma_2=or	lemma_1=,	lemma_7=metal	relType_7=compound	lemma_11=iron	lemma_11=,	wib=calcium	pos_5=,	pos_1=,	relType_12=cc	lemma_13=with	pos_12=CC	relType_2=cc	relType_6=case	pos_8=NNS	relType_14=acl	pos_9=JJ	lemma_3=calcium	pos_6=IN	relType_11=punct	relType_9=case	pos_13=IN	relType_10=fixed	lemma_4=with	path1=magnesium_conj	lemma_12=or	lemma_10=as	relType_13=case	lemma_14=multivitamin	pos_15=NN	lemma_3=,	relType_3=conj	lemma_5=,	pos_4=IN	relType_5=punct	pos_14=VBG	relType_4=case	lemma_6=with	relType_15=cc	pos_10=IN	relType_5=conj	pos_11=,	lemma_15=or	lemma_9=such	relType_15=obj	pos_5=NN	pos_11=NN	pos_3=,	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	eib=True	relType_8=nmod	lpib=calcium_NN	pos_3=NN	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	pos_2=CC	relType_14=conj	lemma_14=contain	pos_15=CC	lemma_5=sucralfate	pos_14=NNS	relType_11=nmod	lemma_15=iron	relType_1=punct	pos_7=NN	lib=calcium	relType_3=punct	lemma_8=cation
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e10	null	lemma_2=or	pos_5=,	relType_21=obj	lemma_24=cation	pos_12=CC	relType_2=cc	lemma_19=formulation	pos_8=NNS	relType_18=case	lemma_21=divalent	relType_9=case	lemma_16=,	path1=magnesium_conj	pos_24=NNS	lemma_3=,	lemma_5=,	lemma_22=and	lemma_15=or	relType_16=punct	lemma_23=trivalent	pos_3=,	pos_26=IN	lemma_14=contain	pos_15=CC	pos_14=NNS	lemma_15=iron	lemma_1=,	relType_17=cc	wib=calcium	pos_1=,	lemma_13=with	pos_19=NNS	relType_6=case	relType_25=case	lemma_16=zinc	pos_20=VBG	pos_6=IN	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_10=as	pos_14=VBG	pos_16=NN	lemma_9=such	pos_5=NN	pos_11=NN	pos_17=CC	relType_11=nmod	relType_1=punct	pos_7=NN	lemma_7=metal	relType_3=punct	pos_23=JJ	lemma_11=iron	lemma_11=,	relType_12=cc	relType_23=amod	lemma_3=calcium	relType_11=punct	relType_22=cc	pos_13=IN	pos_18=IN	lemma_20=contain	lemma_4=with	lemma_12=or	relType_13=case	lemma_14=multivitamin	relType_3=conj	pos_4=IN	pos_10=IN	relType_5=conj	lemma_17=or	relType_19=conj	relType_15=obj	relType_26=fixed	lpib=calcium_NN	relType_20=acl	lemma_5=sucralfate	relType_14=conj	relType_7=compound	lemma_26=as	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	pos_22=CC	relType_14=acl	pos_9=JJ	pos_16=,	relType_10=fixed	pos_25=JJ	pos_15=NN	relType_5=punct	relType_4=case	relType_24=conj	lemma_6=with	relType_15=cc	pos_11=,	lemma_18=with	eib=True	relType_8=nmod	pos_3=NN	lemma_25=such	pos_2=CC	lib=calcium	relType_16=conj	lemma_8=cation	pos_21=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e11	null	lemma_2=or	path=magnesium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_5=,	relType_21=obj	lemma_24=cation	pos_12=CC	relType_2=cc	lemma_19=formulation	pos_8=NNS	relType_18=case	lemma_21=divalent	relType_27=nmod	relType_9=case	lemma_16=,	path1=magnesium_conj	pos_24=NNS	lemma_3=,	lemma_5=,	lemma_22=and	lemma_15=or	relType_16=punct	lemma_23=trivalent	pos_3=,	pos_26=IN	lemma_14=contain	pos_15=CC	pos_14=NNS	lemma_15=iron	lemma_1=,	relType_17=cc	wib=calcium	pos_1=,	lemma_13=with	pos_19=NNS	relType_6=case	relType_25=case	lemma_16=zinc	pos_20=VBG	pos_6=IN	lemma_10=as	pos_14=VBG	pos_16=NN	lemma_9=such	pos_5=NN	pos_11=NN	pos_27=-LRB-	pos_17=CC	relType_11=nmod	relType_1=punct	pos_7=NN	lemma_7=metal	relType_3=punct	pos_23=JJ	lemma_11=iron	lemma_11=,	pos_27=NNP	relType_12=cc	relType_23=amod	lemma_3=calcium	relType_11=punct	relType_22=cc	pos_13=IN	pos_18=IN	lemma_20=contain	lemma_4=with	lemma_12=or	relType_13=case	lemma_14=multivitamin	relType_3=conj	pos_4=IN	pos_10=IN	relType_5=conj	lemma_17=or	relType_19=conj	relType_15=obj	relType_26=fixed	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	lpib=calcium_NN	relType_20=acl	lemma_5=sucralfate	relType_27=punct	relType_14=conj	relType_7=compound	lemma_26=as	pos_22=CC	relType_14=acl	pos_9=JJ	pos_16=,	relType_10=fixed	pos_25=JJ	pos_15=NN	lemma_27=VIDEX	relType_5=punct	relType_4=case	relType_24=conj	lemma_6=with	relType_15=cc	lemma_27=(	pos_11=,	lemma_18=with	eib=True	relType_8=nmod	pos_3=NN	lemma_25=such	pos_2=CC	lib=calcium	relType_16=conj	lemma_8=cation	pos_21=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e3	DDI-DrugBank.d78.s1.e12	null	relType_28=dep	lemma_2=or	lemma_46=absorption	pos_39=NN	relType_35=amod	pos_5=,	lemma_30=/	relType_21=obj	lemma_42=substantially	lemma_24=cation	pos_12=CC	relType_2=cc	lemma_19=formulation	pos_8=NNS	relType_18=case	relType_28=punct	lemma_21=divalent	lemma_44=with	path2=absorption_obl>quinolone_nmod	relType_27=nmod	relType_9=case	lemma_16=,	lemma_28=didanosine	pos_24=NNS	lemma_3=,	lemma_5=,	lemma_22=and	pos_41=MD	lemma_15=or	relType_16=punct	lemma_23=trivalent	pos_31=VBN	pos_46=NN	pos_28=NN	relType_30=punct	pos_3=,	pos_26=IN	lemma_14=contain	relType_31=amod	pos_15=CC	pos_14=NNS	lemma_15=iron	path=magnesium_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	path1=magnesium_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	pos_32=NNS	relType_36=conj	lemma_1=,	lemma_45=the	relType_17=cc	relType_39=nmod	wib=calcium	pos_1=,	lemma_13=with	pos_19=NNS	relType_47=case	relType_6=case	relType_25=case	lemma_16=zinc	pos_20=VBG	pos_35=JJ	lemma_43=interfere	pos_47=IN	pos_6=IN	pos_43=VB	lemma_38=oral	pos_38=JJ	lemma_10=as	pos_14=VBG	pos_28=-RRB-	lemma_31=buffer	pos_16=NN	pos_30=HYPH	lemma_9=such	pos_5=NN	pos_11=NN	lemma_33=or	pos_27=-LRB-	relType_29=dep	pos_17=CC	relType_11=nmod	relType_1=punct	pos_7=NN	lemma_7=metal	relType_3=punct	relType_38=amod	relType_46=obl	pos_23=JJ	pos_29=JJ	lemma_47=of	lemma_11=iron	lemma_11=,	pos_27=NNP	relType_41=aux	pos_44=IN	relType_12=cc	lemma_40=,	relType_23=amod	relation_50=adverse	lemma_35=pediatric	lemma_28=)	lemma_37=for	relType_40=punct	lemma_3=calcium	relType_11=punct	relType_22=cc	pos_13=IN	pos_18=IN	lemma_20=contain	lemma_4=with	lemma_12=or	relType_13=case	lemma_14=multivitamin	relType_3=conj	pos_4=IN	pos_33=CC	lemma_36=powder	pos_10=IN	relType_5=conj	pos_34=DT	lemma_17=or	relType_19=conj	relType_37=case	relType_15=obj	pos_40=,	relType_26=fixed	lpib=calcium_NN	relType_20=acl	relType_44=case	lemma_5=sucralfate	relType_27=punct	relType_14=conj	relType_7=compound	lemma_26=as	lemma_29=chewable	relType_32=dep	pos_45=DT	relType_43=ROOT	relType_34=det	pos_22=CC	relType_42=advmod	relType_14=acl	pos_9=JJ	lemma_41=may	relType_45=det	relType_33=cc	pos_16=,	pos_37=IN	relType_10=fixed	pos_25=JJ	pos_15=NN	lemma_27=VIDEX	relType_5=punct	relType_4=case	relType_24=conj	lemma_39=solution	lemma_6=with	relType_15=cc	lemma_27=(	lemma_32=tablet	pos_42=RB	pos_11=,	pos_36=NN	lemma_18=with	eib=True	relType_8=nmod	pos_3=NN	lemma_25=such	pos_2=CC	lemma_34=the	lib=calcium	relType_16=conj	lemma_8=cation	pos_21=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e5	null	lpib=sucralfate_NN	pos_2=IN	lemma_1=,	relType_2=case	lemma_2=with	path=calcium_conj<aluminum_obj>sucralfate_conj	eib=False	path2=sucralfate_conj	path1=calcium_conj	pos_1=,	lib=sucralfate	relType_1=punct	wib=sucralfate
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e6	null	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod	lemma_1=,	relType_7=case	pos_1=,	relType_5=compound	lemma_6=cation	pos_2=IN	lemma_8=as	lemma_7=such	lemma_2=with	lemma_5=metal	pos_8=IN	lemma_3=sucralfate	lemma_4=with	lemma_3=,	relType_3=conj	pos_4=IN	path1=calcium_conj	relType_4=case	lib=sucralfate	path2=cation_nmod>iron_nmod	wib=sucralfate	lpib=sucralfate_NN	pos_5=NN	relType_2=case	pos_3=,	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=fixed	relType_1=punct	relType_6=nmod	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e7	null	lemma_1=,	relType_7=case	relType_10=cc	pos_1=,	relType_5=compound	lemma_6=cation	lemma_9=,	relType_9=nmod	lemma_9=iron	relType_11=case	lemma_11=with	pos_2=IN	lemma_8=as	lemma_7=such	lemma_2=with	lemma_5=metal	pos_10=CC	pos_9=NN	pos_8=IN	lemma_3=sucralfate	pos_11=IN	lemma_4=with	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	lemma_3=,	relType_3=conj	pos_4=IN	path1=calcium_conj	relType_4=case	lib=sucralfate	lemma_10=or	path2=cation_nmod>iron_nmod>multivitamin_conj	relType_9=punct	wib=sucralfate	lpib=sucralfate_NN	pos_5=NN	relType_2=case	pos_3=,	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=fixed	pos_9=,	relType_1=punct	relType_6=nmod	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e8	null	relType_12=conj	lemma_1=,	pos_12=VBG	relType_7=case	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	relType_10=cc	pos_1=,	relType_5=compound	lemma_6=cation	lemma_9=,	relType_9=nmod	lemma_9=iron	relType_11=case	lemma_11=with	pos_2=IN	lemma_8=as	lemma_7=such	lemma_2=with	lemma_5=metal	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	pos_10=CC	lemma_12=contain	pos_9=NN	pos_8=IN	lemma_3=sucralfate	pos_11=IN	lemma_4=with	lemma_3=,	relType_3=conj	pos_12=NNS	pos_4=IN	path1=calcium_conj	relType_4=case	lemma_12=multivitamin	lib=sucralfate	lemma_10=or	relType_9=punct	wib=sucralfate	lpib=sucralfate_NN	pos_5=NN	relType_2=case	pos_3=,	eib=True	pos_3=NN	pos_7=JJ	pos_6=NNS	relType_8=fixed	relType_12=acl	pos_9=,	relType_1=punct	relType_6=nmod	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e9	null	relType_12=conj	lemma_1=,	pos_12=VBG	relType_7=case	relType_10=cc	pos_1=,	relType_5=compound	lemma_6=cation	lemma_9=,	relType_9=nmod	lemma_9=iron	relType_11=case	lemma_11=with	pos_2=IN	lemma_8=as	lemma_7=such	lemma_2=with	lemma_13=iron	lemma_5=metal	lemma_13=or	pos_10=CC	lemma_12=contain	pos_13=NN	pos_9=NN	pos_8=IN	lemma_3=sucralfate	pos_11=IN	lemma_4=with	relType_13=cc	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	lemma_3=,	relType_3=conj	pos_12=NNS	pos_4=IN	path1=calcium_conj	relType_4=case	lemma_12=multivitamin	lib=sucralfate	lemma_10=or	relType_9=punct	wib=sucralfate	pos_13=CC	lpib=sucralfate_NN	pos_5=NN	relType_2=case	pos_3=,	eib=True	pos_3=NN	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	pos_7=JJ	pos_6=NNS	relType_8=fixed	relType_12=acl	relType_13=obj	pos_9=,	relType_1=punct	relType_6=nmod	relType_3=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e10	null	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_9=,	lemma_21=trivalent	lemma_2=with	lemma_14=zinc	pos_13=NN	lemma_3=sucralfate	lemma_17=formulation	lemma_3=,	lemma_22=cation	lemma_15=or	pos_24=IN	wib=sucralfate	lpib=sucralfate_NN	pos_3=,	pos_7=JJ	pos_6=NNS	pos_15=CC	relType_12=acl	lemma_1=,	relType_7=case	relType_22=conj	pos_21=JJ	pos_1=,	relType_11=case	lemma_11=with	lemma_8=as	lemma_5=metal	lemma_13=or	pos_9=NN	pos_8=IN	relType_13=cc	lib=sucralfate	lemma_10=or	lemma_24=as	pos_5=NN	lemma_14=,	relType_16=case	lemma_20=and	relType_24=fixed	pos_9=,	relType_1=punct	lemma_23=such	relType_3=punct	pos_23=JJ	relType_14=punct	pos_12=VBG	pos_16=IN	relType_10=cc	relType_20=cc	lemma_6=cation	pos_2=IN	lemma_7=such	pos_10=CC	pos_14=,	pos_14=NN	lemma_16=with	pos_11=IN	lemma_4=with	relType_3=conj	pos_4=IN	pos_18=VBG	relType_23=case	pos_13=CC	relType_2=case	pos_17=NNS	pos_20=CC	relType_19=obj	relType_6=nmod	relType_14=conj	relType_12=conj	relType_5=compound	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_9=nmod	lemma_9=iron	relType_18=acl	relType_17=conj	lemma_13=iron	lemma_19=divalent	lemma_12=contain	relType_21=amod	pos_19=NN	pos_12=NNS	pos_22=NNS	path1=calcium_conj	relType_4=case	lemma_12=multivitamin	relType_15=cc	relType_9=punct	eib=True	lemma_18=contain	pos_3=NN	relType_8=fixed	relType_13=obj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e11	null	lemma_9=,	lemma_21=trivalent	pos_25=NNP	lemma_2=with	lemma_14=zinc	pos_13=NN	lemma_3=sucralfate	lemma_17=formulation	lemma_3=,	lemma_22=cation	lemma_15=or	pos_24=IN	wib=sucralfate	lpib=sucralfate_NN	pos_3=,	pos_7=JJ	pos_6=NNS	pos_15=CC	relType_12=acl	lemma_25=VIDEX	lemma_1=,	relType_7=case	relType_22=conj	pos_21=JJ	pos_1=,	relType_11=case	lemma_11=with	lemma_8=as	lemma_5=metal	lemma_13=or	relType_25=nmod	pos_9=NN	pos_8=IN	relType_13=cc	lib=sucralfate	lemma_10=or	lemma_24=as	pos_5=NN	lemma_14=,	relType_16=case	lemma_20=and	relType_24=fixed	relType_25=punct	pos_9=,	relType_1=punct	lemma_23=such	relType_3=punct	path=calcium_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_23=JJ	relType_14=punct	pos_12=VBG	pos_16=IN	relType_10=cc	relType_20=cc	lemma_6=cation	pos_2=IN	lemma_7=such	pos_10=CC	pos_14=,	pos_14=NN	lemma_16=with	pos_11=IN	lemma_4=with	relType_3=conj	pos_4=IN	pos_18=VBG	relType_23=case	pos_13=CC	relType_2=case	pos_17=NNS	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_20=CC	relType_19=obj	relType_6=nmod	relType_14=conj	relType_12=conj	lemma_25=(	relType_5=compound	relType_9=nmod	lemma_9=iron	relType_18=acl	relType_17=conj	lemma_13=iron	lemma_19=divalent	lemma_12=contain	relType_21=amod	pos_19=NN	pos_25=-LRB-	pos_12=NNS	pos_22=NNS	path1=calcium_conj	relType_4=case	lemma_12=multivitamin	relType_15=cc	relType_9=punct	eib=True	lemma_18=contain	pos_3=NN	relType_8=fixed	relType_13=obj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e4	DDI-DrugBank.d78.s1.e12	null	relType_30=dep	pos_34=NN	lemma_9=,	lemma_21=trivalent	pos_25=NNP	lemma_2=with	relType_28=punct	path2=absorption_obl>quinolone_nmod	lemma_14=zinc	lemma_32=the	lemma_42=with	pos_32=DT	pos_26=NN	pos_13=NN	lemma_3=sucralfate	pos_38=,	lemma_28=/	lemma_17=formulation	lemma_3=,	relType_33=amod	lemma_22=cation	lemma_15=or	pos_24=IN	pos_31=CC	wib=sucralfate	lpib=sucralfate_NN	lemma_26=didanosine	lemma_43=the	relType_26=dep	pos_3=,	lemma_33=pediatric	pos_7=JJ	pos_6=NNS	pos_15=CC	lemma_30=tablet	relType_12=acl	relType_34=conj	relation_47=adverse	lemma_25=VIDEX	lemma_1=,	pos_30=NNS	relType_7=case	relType_22=conj	pos_21=JJ	pos_1=,	relType_31=cc	pos_27=JJ	lemma_36=oral	lemma_39=may	lemma_45=of	pos_40=RB	relType_45=case	relType_11=case	lemma_11=with	lemma_31=or	relType_38=punct	pos_41=VB	lemma_8=as	lemma_5=metal	lemma_13=or	relType_25=nmod	lemma_40=substantially	pos_9=NN	lemma_38=,	pos_44=NN	pos_8=IN	relType_13=cc	pos_37=NN	relType_37=nmod	relType_39=aux	pos_28=HYPH	relType_36=amod	relType_43=det	lib=sucralfate	relType_32=det	lemma_10=or	lemma_24=as	pos_5=NN	lemma_14=,	relType_16=case	lemma_20=and	relType_24=fixed	pos_39=MD	relType_25=punct	pos_9=,	relType_1=punct	lemma_23=such	relType_26=punct	relType_3=punct	pos_23=JJ	relType_14=punct	pos_12=VBG	pos_16=IN	relType_10=cc	relType_20=cc	lemma_6=cation	pos_2=IN	lemma_7=such	relType_29=amod	pos_10=CC	pos_14=,	pos_14=NN	lemma_16=with	pos_11=IN	lemma_4=with	pos_45=IN	relType_3=conj	pos_4=IN	pos_18=VBG	relType_23=case	pos_29=VBN	pos_13=CC	lemma_37=solution	lemma_26=)	relType_2=case	pos_17=NNS	relType_40=advmod	pos_20=CC	lemma_34=powder	relType_27=dep	relType_19=obj	relType_6=nmod	relType_14=conj	pos_43=DT	lemma_29=buffer	relType_12=conj	pos_26=-RRB-	lemma_25=(	relType_5=compound	relType_9=nmod	lemma_9=iron	relType_44=obl	relType_18=acl	relType_17=conj	relType_41=ROOT	path=calcium_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	lemma_13=iron	lemma_19=divalent	lemma_12=contain	relType_21=amod	pos_42=IN	pos_19=NN	pos_25=-LRB-	pos_12=NNS	pos_36=JJ	pos_22=NNS	relType_4=case	lemma_12=multivitamin	relType_15=cc	pos_33=JJ	path1=calcium_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	lemma_27=chewable	relType_9=punct	lemma_44=absorption	eib=True	lemma_18=contain	pos_3=NN	relType_8=fixed	lemma_35=for	pos_35=IN	lemma_41=interfere	relType_13=obj	relType_35=case	relType_42=case
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e6	null	lemma_1=,	lpib=metal_NN	pos_1=,	relType_4=nmod	lemma_6=as	relType_5=case	pos_2=IN	path1=sucralfate_conj	lemma_4=cation	lemma_2=with	eib=False	pos_6=IN	pos_4=NNS	lib=metal	pos_5=JJ	lemma_5=such	relType_6=fixed	path2=cation_nmod>iron_nmod	wib=metal	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod	relType_2=case	pos_3=NN	relType_3=compound	relType_1=punct	lemma_3=metal
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e7	null	lemma_1=,	lpib=metal_NN	pos_7=NN	pos_1=,	pos_9=IN	relType_4=nmod	lemma_6=as	relType_5=case	pos_2=IN	path1=sucralfate_conj	lemma_4=cation	lemma_2=with	pos_6=IN	lemma_7=iron	pos_7=,	relType_9=case	pos_8=CC	lemma_8=or	lemma_7=,	pos_4=NNS	lib=metal	pos_5=JJ	lemma_5=such	relType_6=fixed	relType_7=nmod	path2=cation_nmod>iron_nmod>multivitamin_conj	wib=metal	lemma_9=with	relType_2=case	eib=True	pos_3=NN	relType_7=punct	relType_3=compound	relType_1=punct	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj	relType_8=cc	lemma_3=metal
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e8	null	lemma_1=,	lpib=metal_NN	pos_1=,	pos_9=IN	relType_4=nmod	lemma_6=as	relType_5=case	pos_2=IN	pos_10=NNS	path1=sucralfate_conj	lemma_4=cation	lemma_2=with	relType_10=conj	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	pos_6=IN	lemma_7=iron	lemma_10=contain	pos_7=,	relType_9=case	pos_8=CC	lemma_8=or	lemma_7=,	pos_4=NNS	lib=metal	pos_5=JJ	lemma_5=such	relType_6=fixed	relType_7=nmod	relType_10=acl	lemma_10=multivitamin	wib=metal	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj	relType_2=case	lemma_9=with	eib=True	pos_3=NN	relType_7=punct	pos_10=VBG	relType_3=compound	relType_1=punct	pos_7=NN	relType_8=cc	lemma_3=metal
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e9	null	lemma_1=,	lpib=metal_NN	lemma_11=iron	relType_11=cc	pos_1=,	pos_9=IN	relType_4=nmod	relType_11=obj	lemma_6=as	relType_5=case	pos_2=IN	pos_10=NNS	path1=sucralfate_conj	lemma_4=cation	lemma_2=with	relType_10=conj	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	pos_6=IN	lemma_10=contain	lemma_7=iron	pos_7=,	relType_9=case	pos_8=CC	lemma_8=or	lemma_7=,	pos_4=NNS	lib=metal	pos_5=JJ	lemma_5=such	lemma_11=or	relType_6=fixed	pos_11=CC	relType_7=nmod	relType_10=acl	lemma_10=multivitamin	wib=metal	lemma_9=with	relType_2=case	pos_11=NN	eib=True	pos_3=NN	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	relType_7=punct	pos_10=VBG	relType_3=compound	relType_1=punct	pos_7=NN	relType_8=cc	lemma_3=metal
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e10	null	relType_11=cc	relType_5=case	lemma_12=,	lemma_19=trivalent	lemma_2=with	lemma_22=as	lemma_10=contain	pos_12=,	relType_9=case	pos_18=CC	pos_22=IN	lemma_7=,	lib=metal	relType_16=acl	lemma_11=or	pos_16=VBG	relType_10=acl	relType_21=case	lemma_10=multivitamin	lemma_1=,	pos_21=JJ	pos_1=,	relType_4=nmod	lemma_6=as	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_17=divalent	path1=sucralfate_conj	relType_10=conj	lemma_13=or	pos_6=IN	relType_20=conj	pos_19=JJ	relType_12=punct	pos_14=IN	relType_13=cc	lemma_16=contain	lemma_5=such	relType_7=nmod	relType_19=amod	relType_17=obj	pos_11=NN	relType_3=compound	relType_1=punct	pos_7=NN	lemma_11=iron	lemma_15=formulation	lemma_14=with	lemma_12=zinc	lemma_20=cation	relType_11=obj	relType_22=fixed	relType_18=cc	pos_2=IN	pos_17=NN	pos_7=,	pos_8=CC	lemma_8=or	pos_11=CC	pos_13=CC	wib=metal	relType_2=case	relType_15=conj	pos_10=VBG	relType_14=case	relType_8=cc	lemma_3=metal	relType_12=conj	lpib=metal_NN	pos_9=IN	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_4=cation	lemma_21=such	lemma_7=iron	pos_4=NNS	pos_5=JJ	relType_6=fixed	pos_20=NNS	lemma_9=with	pos_15=NNS	lemma_18=and	eib=True	pos_3=NN	relType_7=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e11	null	pos_23=-LRB-	relType_11=cc	relType_5=case	lemma_23=VIDEX	lemma_12=,	lemma_19=trivalent	lemma_2=with	lemma_22=as	lemma_10=contain	pos_12=,	relType_9=case	pos_18=CC	pos_22=IN	lemma_7=,	lib=metal	relType_16=acl	lemma_11=or	pos_16=VBG	relType_10=acl	relType_21=case	lemma_10=multivitamin	lemma_23=(	path=sucralfate_conj<aluminum_obj>cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	lemma_1=,	pos_21=JJ	pos_1=,	relType_4=nmod	lemma_6=as	lemma_17=divalent	path1=sucralfate_conj	relType_10=conj	lemma_13=or	pos_6=IN	relType_20=conj	pos_19=JJ	relType_12=punct	pos_14=IN	relType_13=cc	lemma_16=contain	lemma_5=such	relType_7=nmod	relType_19=amod	relType_17=obj	pos_11=NN	relType_3=compound	relType_1=punct	pos_7=NN	lemma_11=iron	lemma_15=formulation	lemma_14=with	lemma_12=zinc	lemma_20=cation	relType_11=obj	relType_22=fixed	relType_18=cc	pos_2=IN	pos_17=NN	pos_7=,	pos_8=CC	lemma_8=or	relType_23=nmod	pos_11=CC	pos_13=CC	wib=metal	relType_2=case	path2=cation_nmod>iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_15=conj	pos_10=VBG	relType_14=case	relType_8=cc	lemma_3=metal	pos_23=NNP	relType_23=punct	relType_12=conj	lpib=metal_NN	pos_9=IN	lemma_4=cation	lemma_21=such	lemma_7=iron	pos_4=NNS	pos_5=JJ	relType_6=fixed	pos_20=NNS	lemma_9=with	pos_15=NNS	lemma_18=and	eib=True	pos_3=NN	relType_7=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e5	DDI-DrugBank.d78.s1.e12	null	pos_23=-LRB-	relType_28=dep	relType_11=cc	lemma_30=the	pos_35=NN	lemma_25=chewable	relType_5=case	lemma_23=VIDEX	lemma_12=,	lemma_19=trivalent	lemma_28=tablet	lemma_2=with	lemma_22=as	path2=absorption_obl>quinolone_nmod	lemma_10=contain	pos_12=,	lemma_26=/	relType_9=case	pos_18=CC	pos_22=IN	lemma_7=,	pos_26=HYPH	lib=metal	lemma_43=of	relType_16=acl	lemma_11=or	pos_16=VBG	relType_10=acl	lemma_24=didanosine	pos_32=NN	relType_21=case	path1=sucralfate_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	lemma_10=multivitamin	pos_40=IN	lemma_37=may	pos_27=VBN	lemma_23=(	relType_32=conj	relType_31=amod	pos_37=MD	relType_36=punct	pos_31=JJ	lemma_1=,	pos_41=DT	pos_21=JJ	pos_1=,	relType_4=nmod	relType_43=case	lemma_6=as	lemma_17=divalent	relType_10=conj	lemma_13=or	pos_6=IN	relType_20=conj	lemma_41=the	pos_19=JJ	relType_12=punct	pos_14=IN	relType_13=cc	lemma_24=)	lemma_16=contain	lemma_5=such	lemma_33=for	relType_40=case	relType_7=nmod	relType_29=cc	relType_19=amod	relType_17=obj	pos_39=VB	pos_11=NN	pos_42=NN	relType_3=compound	relType_25=dep	lemma_35=solution	relType_26=punct	relType_1=punct	pos_7=NN	lemma_29=or	lemma_11=iron	lemma_15=formulation	lemma_14=with	relType_24=punct	pos_24=NN	relType_27=amod	lemma_12=zinc	lemma_20=cation	relType_11=obj	relType_22=fixed	relType_18=cc	pos_2=IN	pos_17=NN	lemma_27=buffer	relType_38=advmod	pos_7=,	pos_8=CC	lemma_8=or	pos_29=CC	relType_23=nmod	relation_44=adverse	pos_28=NNS	pos_33=IN	pos_11=CC	pos_34=JJ	lemma_42=absorption	relType_39=ROOT	lemma_32=powder	pos_13=CC	wib=metal	relType_35=nmod	relType_34=amod	pos_36=,	relType_2=case	lemma_39=interfere	relType_15=conj	pos_10=VBG	relType_14=case	pos_30=DT	relType_8=cc	lemma_3=metal	pos_23=NNP	relType_23=punct	relType_12=conj	lpib=metal_NN	pos_38=RB	pos_43=IN	lemma_40=with	relType_33=case	lemma_34=oral	relType_37=aux	pos_9=IN	lemma_4=cation	lemma_21=such	lemma_7=iron	relType_41=det	relType_24=dep	path=sucralfate_conj<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	pos_4=NNS	pos_25=JJ	relType_42=obl	pos_5=JJ	relType_6=fixed	pos_20=NNS	lemma_38=substantially	pos_24=-RRB-	lemma_9=with	pos_15=NNS	lemma_18=and	eib=True	pos_3=NN	relType_7=punct	lemma_31=pediatric	lemma_36=,	pos_12=NN	pos_10=NNS	relType_30=det
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e7	null	lemma_2=or	lemma_1=,	pos_3=IN	relType_3=case	eib=False	path2=multivitamin_conj	pos_2=CC	path1=	pos_1=,	lemma_3=with	path=<iron_nmod>multivitamin_conj	relType_1=punct	lib=multivitamin	relType_2=cc	wib=multivitamins	lpib=multivitamin_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e8	null	lemma_2=or	lemma_1=,	pos_3=IN	lemma_4=contain	path1=	pos_1=,	relType_2=cc	relType_4=acl	path=<iron_nmod>multivitamin_conj>contain_acl>iron_obj	lib=multivitamin	path2=multivitamin_conj>contain_acl>iron_obj	pos_4=NNS	wib=multivitamins	lemma_3=with	pos_4=VBG	relType_3=case	lemma_4=multivitamin	eib=True	pos_2=CC	relType_4=conj	relType_1=punct	lpib=multivitamin_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e9	null	lemma_2=or	lemma_1=,	pos_3=IN	pos_5=CC	lemma_4=contain	path2=multivitamin_conj>contain_acl>iron_obj>zinc_conj	path1=	pos_1=,	relType_2=cc	path=<iron_nmod>multivitamin_conj>contain_acl>iron_obj>zinc_conj	relType_4=acl	relType_5=cc	lib=multivitamin	pos_4=NNS	wib=multivitamins	lemma_5=iron	lemma_5=or	lemma_3=with	pos_4=VBG	relType_3=case	lemma_4=multivitamin	pos_5=NN	eib=True	relType_5=obj	pos_2=CC	relType_4=conj	relType_1=punct	lpib=multivitamin_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e10	null	relType_8=case	lemma_2=or	lemma_1=,	pos_3=IN	relType_9=conj	pos_5=CC	lemma_4=contain	pos_15=JJ	pos_16=IN	path1=	pos_1=,	lemma_6=,	relType_7=cc	lemma_6=zinc	relType_12=cc	pos_12=CC	relType_2=cc	relType_11=obj	lemma_16=as	lemma_9=formulation	pos_6=NN	relType_4=acl	relType_5=cc	relType_6=conj	relType_6=punct	lemma_10=contain	relType_13=amod	pos_9=NNS	lemma_14=cation	lemma_8=with	lib=multivitamin	pos_4=NNS	wib=multivitamins	pos_8=IN	lemma_11=divalent	lemma_15=such	relType_15=case	lemma_5=iron	pos_13=JJ	pos_7=CC	relType_10=acl	lemma_5=or	lemma_3=with	pos_4=VBG	lemma_7=or	relType_3=case	pos_6=,	lemma_4=multivitamin	pos_5=NN	path=<iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	pos_11=NN	eib=True	relType_5=obj	pos_2=CC	lemma_12=and	pos_10=VBG	lemma_13=trivalent	relType_4=conj	pos_14=NNS	relType_1=punct	relType_14=conj	relType_16=fixed	path2=multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lpib=multivitamin_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e11	null	relType_8=case	lemma_2=or	lemma_1=,	pos_3=IN	relType_9=conj	pos_5=CC	lemma_4=contain	pos_15=JJ	pos_16=IN	relType_17=punct	path1=	pos_1=,	lemma_6=,	relType_7=cc	lemma_6=zinc	relType_12=cc	pos_12=CC	relType_2=cc	relType_11=obj	lemma_16=as	lemma_9=formulation	pos_6=NN	relType_4=acl	relType_5=cc	relType_6=conj	pos_17=NNP	relType_6=punct	lemma_10=contain	relType_13=amod	pos_9=NNS	lemma_14=cation	lemma_8=with	lib=multivitamin	pos_4=NNS	wib=multivitamins	pos_8=IN	lemma_11=divalent	lemma_15=such	relType_15=case	lemma_5=iron	pos_13=JJ	pos_7=CC	relType_10=acl	lemma_5=or	lemma_3=with	pos_17=-LRB-	pos_4=VBG	lemma_7=or	relType_17=nmod	relType_3=case	pos_6=,	lemma_4=multivitamin	pos_5=NN	pos_11=NN	eib=True	path=<iron_nmod>multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_5=obj	pos_2=CC	lemma_12=and	pos_10=VBG	lemma_13=trivalent	relType_4=conj	path2=multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_14=NNS	lemma_17=VIDEX	lemma_17=(	relType_1=punct	relType_14=conj	relType_16=fixed	lpib=multivitamin_NNS
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e6	DDI-DrugBank.d78.s1.e12	null	relType_18=dep	lemma_2=or	lemma_4=contain	lemma_27=for	lemma_6=,	lemma_6=zinc	pos_12=CC	relType_2=cc	lemma_16=as	relType_22=dep	lemma_19=chewable	pos_6=NN	relType_4=acl	relType_5=cc	relType_6=conj	pos_20=HYPH	path2=absorption_obl>quinolone_nmod	lemma_10=contain	pos_26=NN	lib=multivitamin	lemma_11=divalent	pos_18=NN	lemma_36=absorption	lemma_23=or	relType_33=ROOT	path=iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	relType_10=acl	lemma_3=with	relation_37=adverse	pos_35=DT	lemma_4=multivitamin	relType_24=det	relType_30=punct	relType_5=obj	pos_14=NNS	lemma_17=(	relType_8=case	relType_35=det	lemma_1=,	pos_1=,	relType_19=dep	lemma_9=formulation	lemma_18=didanosine	relType_25=amod	relType_13=amod	pos_32=RB	pos_19=JJ	pos_29=NN	lemma_34=with	lemma_37=of	pos_8=IN	relType_32=advmod	relType_15=case	lemma_32=substantially	relType_29=nmod	pos_17=-LRB-	lemma_18=)	pos_28=JJ	pos_21=VBN	pos_5=NN	pos_11=NN	lemma_22=tablet	lemma_26=powder	lemma_17=VIDEX	relType_28=amod	pos_30=,	relType_1=punct	relType_34=case	lemma_5=or	lpib=multivitamin_NNS	pos_3=IN	pos_16=IN	lemma_20=/	relType_17=punct	relType_12=cc	relType_7=cc	relType_11=obj	pos_23=CC	pos_17=NNP	pos_18=-RRB-	lemma_8=with	pos_24=DT	wib=multivitamins	lemma_5=iron	pos_13=JJ	lemma_33=interfere	relType_17=nmod	relType_37=case	lemma_25=pediatric	lemma_13=trivalent	lemma_12=and	pos_10=VBG	relType_20=punct	path1=iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	pos_33=VB	relType_27=case	relType_14=conj	lemma_28=oral	relType_9=conj	pos_5=CC	pos_15=JJ	lemma_30=,	relType_26=conj	relType_6=punct	pos_9=NNS	lemma_14=cation	relType_21=amod	lemma_29=solution	pos_37=IN	pos_27=IN	lemma_31=may	pos_4=NNS	lemma_15=such	pos_25=JJ	pos_7=CC	relType_23=cc	pos_22=NNS	relType_18=punct	lemma_24=the	pos_4=VBG	lemma_7=or	pos_36=NN	relType_3=case	pos_6=,	lemma_35=the	eib=True	relType_36=obl	pos_2=CC	relType_4=conj	pos_31=MD	relType_31=aux	lemma_21=buffer	relType_16=fixed	pos_34=IN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e7	DDI-DrugBank.d78.s1.e8	null	pos_1=VBG	path2=contain_acl>iron_obj	eib=False	relType_1=acl	path1=	lemma_1=contain	lib=contain	wib=containing	lpib=contain_VBG	path=<multivitamin_conj>contain_acl>iron_obj
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e7	DDI-DrugBank.d78.s1.e9	null	pos_1=VBG	lemma_2=or	relType_2=obj	pos_2=NN	eib=True	relType_1=acl	pos_2=CC	path1=	lemma_1=contain	path2=contain_acl>iron_obj>zinc_conj	lib=contain	relType_2=cc	path=<multivitamin_conj>contain_acl>iron_obj>zinc_conj	wib=containing	lpib=contain_VBG	lemma_2=iron
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e7	DDI-DrugBank.d78.s1.e10	null	lemma_2=or	relType_2=obj	pos_2=NN	lemma_13=as	relType_10=amod	path1=	pos_7=VBG	relType_12=case	relType_4=cc	relType_7=acl	lemma_6=formulation	relType_2=cc	relType_5=case	lemma_11=cation	relType_11=conj	pos_8=NN	pos_12=JJ	relType_6=conj	lemma_3=zinc	lemma_5=with	pos_11=NNS	relType_8=obj	pos_13=IN	path=<multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	path2=contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lpib=contain_VBG	lemma_2=iron	lemma_9=and	pos_9=CC	lemma_3=,	relType_3=conj	lemma_4=or	pos_10=JJ	relType_1=acl	pos_5=IN	wib=containing	lemma_7=contain	lemma_12=such	pos_1=VBG	relType_13=fixed	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_8=divalent	pos_2=CC	pos_6=NNS	lemma_1=contain	relType_9=cc	lib=contain	relType_3=punct	lemma_10=trivalent
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e7	DDI-DrugBank.d78.s1.e11	null	lemma_2=or	pos_14=NNP	relType_2=obj	pos_2=NN	relType_14=punct	lemma_13=as	relType_10=amod	path1=	pos_7=VBG	relType_12=case	relType_4=cc	relType_7=acl	lemma_6=formulation	relType_2=cc	lemma_14=VIDEX	lemma_14=(	relType_5=case	lemma_11=cation	relType_11=conj	pos_8=NN	pos_12=JJ	relType_6=conj	lemma_3=zinc	lemma_5=with	pos_11=NNS	relType_8=obj	pos_13=IN	lpib=contain_VBG	lemma_2=iron	lemma_9=and	pos_9=CC	pos_14=-LRB-	lemma_3=,	path2=contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_3=conj	lemma_4=or	pos_10=JJ	relType_1=acl	pos_5=IN	wib=containing	lemma_7=contain	lemma_12=such	pos_1=VBG	relType_13=fixed	path=<multivitamin_conj>contain_acl>iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_8=divalent	pos_2=CC	pos_6=NNS	lemma_1=contain	relType_9=cc	lib=contain	relType_14=nmod	relType_3=punct	lemma_10=trivalent
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e7	DDI-DrugBank.d78.s1.e12	null	path=multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	lemma_2=or	pos_2=NN	lemma_15=didanosine	lemma_13=as	relType_29=advmod	lemma_14=VIDEX	relType_2=cc	relType_5=case	pos_27=,	relType_6=conj	relType_24=case	relType_26=nmod	path2=absorption_obl>quinolone_nmod	lemma_32=the	pos_32=DT	pos_26=NN	pos_9=CC	pos_14=-LRB-	lemma_3=,	relation_33=adverse	pos_24=IN	lemma_21=the	pos_1=VBG	lemma_30=interfere	pos_3=,	lemma_34=of	pos_6=NNS	relType_14=nmod	lemma_31=with	pos_15=-RRB-	lemma_28=may	relType_19=dep	pos_19=NNS	lemma_6=formulation	lemma_11=cation	pos_8=NN	relType_25=amod	lpib=contain_VBG	relType_23=conj	relType_1=acl	relType_21=det	pos_5=IN	relType_32=det	lemma_12=such	relType_13=fixed	lemma_33=absorption	lemma_1=contain	lib=contain	relType_34=case	relType_3=punct	relType_14=punct	pos_14=NNP	path1=multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	lemma_16=chewable	relType_17=punct	relType_12=case	pos_7=VBG	relType_20=cc	relType_11=conj	pos_31=IN	pos_23=NN	lemma_3=zinc	pos_17=HYPH	relType_15=dep	lemma_5=with	relType_8=obj	pos_13=IN	relType_15=punct	lemma_2=iron	relType_3=conj	lemma_4=or	wib=containing	relType_33=obl	pos_22=JJ	pos_18=VBN	relType_22=amod	pos_4=CC	lemma_8=divalent	lemma_20=or	lemma_19=tablet	pos_20=CC	lemma_25=oral	relType_27=punct	lemma_18=buffer	pos_33=NN	lemma_10=trivalent	relType_30=ROOT	relType_2=obj	relType_10=amod	relType_18=amod	lemma_22=pediatric	relType_31=case	relType_4=cc	relType_7=acl	lemma_14=(	pos_12=JJ	pos_29=RB	pos_11=NNS	pos_28=MD	pos_25=JJ	lemma_9=and	pos_16=JJ	lemma_29=substantially	pos_15=NN	lemma_26=solution	pos_10=JJ	lemma_24=for	lemma_23=powder	lemma_15=)	lemma_27=,	lemma_7=contain	eib=True	pos_3=NN	relType_16=dep	pos_2=CC	relType_28=aux	pos_30=VB	pos_21=DT	relType_9=cc	pos_34=IN	lemma_17=/
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e8	DDI-DrugBank.d78.s1.e9	null	relType_1=cc	path2=zinc_conj	pos_1=CC	wib=zinc	lemma_1=or	eib=False	path1=	path=<iron_obj>zinc_conj	lib=zinc	lpib=zinc_NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e8	DDI-DrugBank.d78.s1.e10	null	relType_1=cc	pos_1=CC	wib=zinc	pos_2=NN	pos_3=CC	path1=	lemma_2=zinc	lib=zinc	relType_11=case	relType_2=punct	relType_3=cc	pos_6=VBG	pos_9=JJ	lemma_12=as	relType_10=conj	pos_5=NNS	lemma_9=trivalent	lemma_10=cation	relType_7=obj	relType_12=fixed	path=<iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	lemma_3=or	pos_8=CC	relType_9=amod	relType_2=conj	lemma_2=,	pos_12=IN	lpib=zinc_NN	lemma_4=with	lemma_11=such	pos_4=IN	relType_6=acl	relType_4=case	relType_5=conj	lemma_7=divalent	lemma_8=and	path2=formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	eib=True	pos_2=,	pos_11=JJ	lemma_5=formulation	pos_7=NN	relType_8=cc	pos_10=NNS	lemma_6=contain	lemma_1=or
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e8	DDI-DrugBank.d78.s1.e11	null	relType_1=cc	pos_1=CC	wib=zinc	pos_2=NN	pos_3=CC	path1=	lemma_2=zinc	relType_13=punct	lemma_13=VIDEX	lib=zinc	relType_11=case	relType_2=punct	relType_3=cc	pos_13=NNP	relType_13=nmod	pos_6=VBG	pos_9=JJ	lemma_12=as	relType_10=conj	pos_5=NNS	lemma_9=trivalent	lemma_10=cation	relType_7=obj	relType_12=fixed	lemma_3=or	pos_8=CC	relType_9=amod	relType_2=conj	lemma_2=,	pos_12=IN	lpib=zinc_NN	lemma_4=with	lemma_11=such	lemma_13=(	path2=formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_4=IN	relType_6=acl	relType_4=case	path=<iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	relType_5=conj	lemma_7=divalent	pos_13=-LRB-	lemma_8=and	eib=True	pos_2=,	pos_11=JJ	lemma_5=formulation	pos_7=NN	relType_8=cc	pos_10=NNS	lemma_6=contain	lemma_1=or
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e8	DDI-DrugBank.d78.s1.e12	null	relType_1=cc	relType_18=dep	lemma_25=solution	pos_2=NN	lemma_30=with	pos_3=CC	lemma_27=may	path=iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	lemma_13=VIDEX	pos_16=HYPH	pos_31=DT	pos_29=VB	relType_12=fixed	path2=absorption_obl>quinolone_nmod	lemma_31=the	path1=iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	pos_19=CC	pos_32=NN	relType_16=punct	lemma_19=or	pos_2=,	pos_11=JJ	lemma_5=formulation	pos_30=IN	relType_29=ROOT	wib=zinc	pos_18=NNS	relType_22=conj	pos_22=NN	pos_21=JJ	relType_11=case	relType_2=punct	relType_3=cc	relType_10=conj	relType_25=nmod	lemma_28=substantially	lemma_3=or	lemma_20=the	relType_2=conj	lemma_2=,	pos_12=IN	lemma_11=such	lemma_13=(	lemma_33=of	lemma_16=/	relType_6=acl	lemma_23=for	lemma_8=and	relType_17=amod	relType_24=amod	pos_23=IN	relType_26=punct	pos_7=NN	relType_14=punct	relType_31=det	lib=zinc	pos_17=VBN	pos_24=JJ	lemma_9=trivalent	lemma_10=cation	pos_14=-RRB-	relType_7=obj	relType_15=dep	relType_9=amod	pos_8=CC	pos_14=NN	lemma_14=)	lemma_4=with	lemma_24=oral	pos_33=IN	pos_4=IN	pos_25=NN	relType_5=conj	lemma_7=divalent	relType_23=case	lemma_29=interfere	relType_8=cc	relType_20=det	lemma_18=tablet	relType_30=case	pos_1=CC	pos_15=JJ	relType_27=aux	relType_33=case	lemma_2=zinc	relType_13=punct	pos_20=DT	lemma_32=absorption	pos_13=NNP	relation_31=adverse	relType_13=nmod	pos_6=VBG	pos_9=JJ	lemma_12=as	pos_5=NNS	pos_27=MD	relType_21=amod	pos_28=RB	lpib=zinc_NN	lemma_21=pediatric	relType_4=case	relType_14=dep	relType_19=cc	pos_13=-LRB-	lemma_15=chewable	eib=True	lemma_17=buffer	relType_28=advmod	relType_32=obl	lemma_14=didanosine	lemma_22=powder	pos_26=,	lemma_26=,	pos_10=NNS	lemma_6=contain	lemma_1=or
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e9	DDI-DrugBank.d78.s1.e10	null	lemma_2=or	lemma_1=,	lemma_6=divalent	pos_3=IN	relType_9=conj	relType_8=amod	lpib=formulation_NNS	path=zinc_conj<iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	pos_1=,	relType_7=cc	lemma_11=as	lemma_4=formulation	relType_2=cc	pos_6=NN	pos_8=JJ	eib=False	relType_5=acl	pos_9=NNS	relType_10=case	pos_4=NNS	lib=formulation	lemma_9=cation	pos_11=IN	lemma_8=trivalent	lemma_10=such	pos_7=CC	pos_10=JJ	path1=zinc_conj	relType_11=fixed	wib=formulations	lemma_3=with	relType_3=case	path2=formulation_conj>contain_acl>divalent_obj>VIDEX_nmod	relType_6=obj	pos_5=VBG	lemma_7=and	pos_2=CC	relType_4=conj	lemma_5=contain	relType_1=punct
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e9	DDI-DrugBank.d78.s1.e11	null	lemma_2=or	lemma_1=,	lemma_6=divalent	pos_3=IN	relType_9=conj	relType_8=amod	lpib=formulation_NNS	pos_1=,	relType_7=cc	lemma_11=as	lemma_4=formulation	relType_2=cc	pos_6=NN	pos_8=JJ	relType_5=acl	path=zinc_conj<iron_obj>formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	pos_9=NNS	relType_12=nmod	relType_12=punct	relType_10=case	pos_4=NNS	lib=formulation	lemma_9=cation	pos_11=IN	lemma_8=trivalent	path2=formulation_conj>contain_acl>divalent_obj>VIDEX_nmod>didanosine_dep	lemma_10=such	pos_7=CC	pos_10=JJ	path1=zinc_conj	relType_11=fixed	wib=formulations	lemma_3=with	relType_3=case	relType_6=obj	pos_5=VBG	lemma_12=VIDEX	eib=True	pos_12=NNP	lemma_7=and	pos_2=CC	relType_4=conj	lemma_5=contain	relType_1=punct	pos_12=-LRB-	lemma_12=(
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e9	DDI-DrugBank.d78.s1.e12	null	lemma_2=or	relType_13=dep	lemma_30=the	relType_2=cc	relType_21=conj	lemma_32=of	pos_6=NN	pos_8=JJ	relType_31=obl	path2=absorption_obl>quinolone_nmod	pos_18=CC	pos_22=IN	pos_13=NN	pos_32=IN	pos_20=JJ	lemma_8=trivalent	lemma_10=such	pos_16=VBN	pos_28=VB	lemma_25=,	lemma_3=with	relType_28=ROOT	lemma_28=interfere	lemma_27=substantially	lemma_20=pediatric	relType_19=det	pos_15=HYPH	relType_32=case	lemma_1=,	relation_29=adverse	pos_1=,	lemma_11=as	pos_29=IN	relType_16=amod	relType_12=nmod	relType_17=dep	lemma_24=solution	relType_12=punct	relType_22=case	lemma_22=for	lemma_16=buffer	pos_26=MD	lemma_13=didanosine	pos_31=NN	pos_12=NNP	lemma_17=tablet	relType_25=punct	relType_1=punct	pos_12=-LRB-	lemma_12=(	pos_19=DT	lemma_18=or	pos_23=JJ	lemma_6=divalent	pos_3=IN	relType_29=case	lpib=formulation_NNS	relType_7=cc	pos_24=NN	relType_23=amod	relType_18=cc	relType_20=amod	lemma_31=absorption	relType_5=acl	relType_15=punct	lemma_9=cation	pos_11=IN	relType_11=fixed	pos_13=-RRB-	lemma_23=oral	lemma_12=VIDEX	pos_17=NNS	pos_14=JJ	path=zinc_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	pos_30=DT	lemma_29=with	lemma_14=chewable	relType_9=conj	relType_8=amod	pos_25=,	relType_13=punct	lemma_4=formulation	lemma_15=/	path1=zinc_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	relType_26=aux	pos_27=RB	pos_9=NNS	relType_10=case	lemma_19=the	pos_4=NNS	relType_27=advmod	lib=formulation	pos_7=CC	pos_10=JJ	wib=formulations	relType_24=nmod	relType_14=dep	lemma_26=may	relType_3=case	relType_6=obj	pos_5=VBG	eib=True	lemma_13=)	lemma_7=and	pos_2=CC	lemma_21=powder	relType_4=conj	lemma_5=contain	relType_30=det	pos_21=NN
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e10	DDI-DrugBank.d78.s1.e11	null	lemma_1=(	lib=didanosine	wib=didanosine	eib=False	path=<VIDEX_nmod>didanosine_dep	path1=	path2=didanosine_dep	lpib=didanosine_NN	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e10	DDI-DrugBank.d78.s1.e12	null	lemma_2=)	relType_3=dep	relType_14=punct	pos_2=NN	pos_8=DT	lemma_15=may	relation_17=adverse	relType_7=cc	pos_15=MD	pos_4=HYPH	lemma_13=solution	relType_17=ROOT	relType_11=case	relType_2=punct	lemma_12=oral	lemma_1=(	pos_12=JJ	pos_9=JJ	lemma_10=powder	relType_13=nmod	lib=didanosine	relType_6=dep	relType_18=case	relType_10=conj	relType_15=aux	path2=absorption_obl>quinolone_nmod	pos_14=,	pos_16=RB	lemma_9=pediatric	pos_20=NN	relType_12=amod	pos_21=IN	relType_9=amod	lemma_19=the	pos_10=NN	pos_13=NN	pos_18=IN	lemma_6=tablet	pos_11=IN	relType_16=advmod	lemma_17=interfere	lemma_11=for	path=VIDEX_nmod<divalent_obj<contain_acl<formulation_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	relType_2=dep	relType_4=punct	relType_5=amod	pos_7=CC	lemma_16=substantially	lemma_8=the	lemma_21=of	lemma_4=/	path1=VIDEX_nmod<divalent_obj<contain_acl<formulation_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	pos_17=VB	lemma_3=chewable	lemma_2=didanosine	lemma_7=or	relType_21=case	pos_1=-LRB-	lemma_14=,	lemma_18=with	lemma_5=buffer	pos_3=JJ	wib=didanosine	eib=True	pos_2=-RRB-	lemma_20=absorption	pos_6=NNS	relType_8=det	lpib=didanosine_NN	relType_1=punct	relType_19=det	relType_20=obl	pos_5=VBN	pos_19=DT
DDI-DrugBank.d78.s1	DDI-DrugBank.d78.s1.e11	DDI-DrugBank.d78.s1.e12	null	relType_4=amod	pos_13=,	lemma_11=oral	relType_9=conj	relType_7=det	lemma_13=,	relType_8=amod	lemma_8=pediatric	relType_13=punct	path1=didanosine_dep<VIDEX_nmod<divalent_obj<contain_acl<formulation_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj	lib=chewable	lemma_1=)	wib=chewable	pos_2=JJ	lemma_15=substantially	relType_16=ROOT	pos_20=IN	pos_17=IN	pos_8=JJ	lemma_16=interfere	lemma_4=buffer	pos_18=DT	lemma_17=with	lemma_18=the	lemma_19=absorption	relType_20=case	eib=False	pos_5=NNS	path2=absorption_obl>quinolone_nmod	relType_11=amod	pos_16=VB	relType_12=nmod	lemma_20=of	lemma_6=or	lemma_9=powder	relation_15=adverse	lemma_3=/	pos_19=NN	relType_10=case	relType_5=dep	pos_9=NN	pos_7=DT	lemma_14=may	pos_4=VBN	lemma_12=solution	relType_17=case	relType_2=dep	pos_6=CC	lemma_2=chewable	pos_1=-RRB-	relType_14=aux	pos_10=IN	lpib=chewable_JJ	lemma_5=tablet	path=didanosine_dep<VIDEX_nmod<divalent_obj<contain_acl<formulation_conj<iron_obj<contain_acl<multivitamin_conj<iron_nmod<cation_nmod<aluminum_obj<contain_acl<antacid_nmod<quinolone_nmod<administration_nsubj<interfere_ROOT>absorption_obl>quinolone_nmod	pos_14=MD	relType_19=obl	pos_3=HYPH	lemma_7=the	pos_11=JJ	relType_18=det	relType_1=punct	pos_12=NN	lemma_10=for	relType_15=advmod	relType_3=punct	pos_15=RB	relType_6=cc
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e0	DDI-DrugBank.d78.s3.e1	null	eib=False	path2=Theobromine_compound	path1=caffeine_compound	path=caffeine_compound<Grepafloxacin_nsubj>Theobromine_compound
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e0	DDI-DrugBank.d78.s3.e2	null	path=caffeine_compound<Grepafloxacin_nsubj>	relType_1=compound	eib=True	path1=caffeine_compound	lib=theobromine	lemma_1=Theobromine	path2=	lpib=theobromine_NNP	wib=Theobromine	pos_1=NNP
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e0	DDI-DrugBank.d78.s3.e3	null	lemma_1=,	pos_1=,	wib=Theobromine	lemma_3=other	path=caffeine_compound<Grepafloxacin_nsubj>quinolone_nmod	pos_2=IN	relType_1=compound	lib=theobromine	lemma_1=Theobromine	lemma_2=like	relType_3=amod	path1=caffeine_compound	relType_1=nsubj	pos_1=NNP	relType_2=case	pos_3=JJ	eib=True	lpib=theobromine_NNP	relType_1=punct	lemma_1=Grepafloxacin	path2=quinolone_nmod
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e0	DDI-DrugBank.d78.s3.e4	null	path2=metabolism_obj>caffeine_nmod	lemma_1=,	pos_6=VB	relType_7=det	pos_1=,	pos_9=IN	relType_4=nmod	wib=Theobromine	lemma_3=other	pos_2=IN	pos_8=NN	relType_1=compound	lemma_5=may	pos_4=,	relation_8=adverse	lib=theobromine	lemma_1=Theobromine	relType_8=obj	relType_9=case	relType_5=aux	pos_4=NNS	pos_7=DT	lemma_2=like	relType_6=ROOT	pos_5=MD	relType_4=punct	relType_3=amod	relType_1=nsubj	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	pos_1=NNP	path1=caffeine_compound<Grepafloxacin_nsubj	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lemma_7=the	lpib=theobromine_NNP	relType_1=punct	lemma_1=Grepafloxacin	path=caffeine_compound<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e0	DDI-DrugBank.d78.s3.e5	null	lemma_1=,	pos_6=VB	relType_7=det	lemma_10=caffeine	relType_10=cc	pos_1=,	pos_9=IN	relType_4=nmod	wib=Theobromine	lemma_3=other	pos_2=IN	pos_8=NN	relType_10=nmod	relType_1=compound	lemma_5=may	pos_4=,	relation_8=adverse	lib=theobromine	pos_10=CC	path=caffeine_compound<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod>theobromine_conj	lemma_1=Theobromine	relType_8=obj	relType_9=case	relType_5=aux	pos_10=NN	pos_4=NNS	pos_7=DT	lemma_2=like	relType_6=ROOT	lemma_10=and	pos_5=MD	relType_4=punct	relType_3=amod	relType_1=nsubj	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	pos_1=NNP	path1=caffeine_compound<Grepafloxacin_nsubj	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lemma_7=the	lpib=theobromine_NNP	relType_1=punct	lemma_1=Grepafloxacin	path2=metabolism_obj>caffeine_nmod>theobromine_conj
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e1	DDI-DrugBank.d78.s3.e2	null	eib=False	path1=Theobromine_compound	path2=	path=Theobromine_compound<Grepafloxacin_nsubj>
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e1	DDI-DrugBank.d78.s3.e3	null	lemma_1=,	pos_1=,	lemma_3=other	pos_2=IN	path1=Theobromine_compound	lemma_2=like	lpib=grepafloxacin_NNP	path=Theobromine_compound<Grepafloxacin_nsubj>quinolone_nmod	relType_3=amod	relType_1=nsubj	wib=Grepafloxacin	pos_1=NNP	relType_2=case	pos_3=JJ	eib=True	lib=grepafloxacin	relType_1=punct	lemma_1=Grepafloxacin	path2=quinolone_nmod
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e1	DDI-DrugBank.d78.s3.e4	null	path2=metabolism_obj>caffeine_nmod	lemma_1=,	pos_6=VB	relType_7=det	pos_1=,	pos_9=IN	relType_4=nmod	lemma_3=other	path1=Theobromine_compound<Grepafloxacin_nsubj	pos_2=IN	pos_8=NN	lemma_5=may	pos_4=,	relType_8=obj	relation_7=adverse	relType_9=case	relType_5=aux	pos_4=NNS	pos_7=DT	lemma_2=like	lpib=grepafloxacin_NNP	relType_6=ROOT	pos_5=MD	relType_4=punct	path=Theobromine_compound<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod	relType_3=amod	relType_1=nsubj	wib=Grepafloxacin	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	pos_1=NNP	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lib=grepafloxacin	lemma_7=the	relType_1=punct	lemma_1=Grepafloxacin
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e1	DDI-DrugBank.d78.s3.e5	null	lemma_1=,	pos_6=VB	relType_7=det	lemma_10=caffeine	relType_10=cc	pos_1=,	pos_9=IN	relType_4=nmod	path=Theobromine_compound<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod>theobromine_conj	lemma_3=other	path1=Theobromine_compound<Grepafloxacin_nsubj	pos_2=IN	pos_8=NN	relType_10=nmod	lemma_5=may	pos_4=,	pos_10=CC	relType_8=obj	relation_7=adverse	relType_9=case	relType_5=aux	pos_10=NN	pos_4=NNS	pos_7=DT	lemma_2=like	lpib=grepafloxacin_NNP	relType_6=ROOT	lemma_10=and	pos_5=MD	relType_4=punct	relType_3=amod	relType_1=nsubj	wib=Grepafloxacin	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	pos_1=NNP	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lib=grepafloxacin	lemma_7=the	relType_1=punct	lemma_1=Grepafloxacin	path2=metabolism_obj>caffeine_nmod>theobromine_conj
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e2	DDI-DrugBank.d78.s3.e3	null	pos_2=IN	lemma_1=,	relType_2=case	pos_3=JJ	lib=other	eib=False	lpib=other_JJ	relType_3=amod	path=<Grepafloxacin_nsubj>quinolone_nmod	path1=	pos_1=,	wib=other	relType_1=punct	path2=quinolone_nmod	lemma_3=other	lemma_2=like
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e2	DDI-DrugBank.d78.s3.e4	mechanism	path2=metabolism_obj>caffeine_nmod	lemma_1=,	pos_6=VB	lib=other	relType_7=det	pos_1=,	pos_9=IN	relType_4=nmod	lemma_3=other	pos_2=IN	pos_8=NN	lemma_5=may	pos_4=,	relation_6=adverse	wib=other	relType_8=obj	relType_9=case	relType_5=aux	pos_4=NNS	pos_7=DT	lemma_2=like	relType_6=ROOT	pos_5=MD	relType_4=punct	relType_3=amod	lpib=other_JJ	path=Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lemma_7=the	relType_1=punct	path1=Grepafloxacin_nsubj
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e2	DDI-DrugBank.d78.s3.e5	mechanism	lemma_1=,	pos_6=VB	lib=other	relType_7=det	lemma_10=caffeine	relType_10=cc	pos_1=,	pos_9=IN	relType_4=nmod	lemma_3=other	pos_2=IN	pos_8=NN	relType_10=nmod	lemma_5=may	pos_4=,	pos_10=CC	relation_6=adverse	wib=other	relType_8=obj	relType_9=case	path=Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod>theobromine_conj	relType_5=aux	pos_10=NN	pos_4=NNS	pos_7=DT	lemma_2=like	relType_6=ROOT	lemma_10=and	pos_5=MD	relType_4=punct	relType_3=amod	lpib=other_JJ	lemma_4=,	lemma_8=metabolism	lemma_4=quinolone	relType_2=case	pos_3=JJ	eib=True	lemma_6=inhibit	lemma_9=of	lemma_7=the	relType_1=punct	path2=metabolism_obj>caffeine_nmod>theobromine_conj	path1=Grepafloxacin_nsubj
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e3	DDI-DrugBank.d78.s3.e4	mechanism	path2=metabolism_obj>caffeine_nmod	path=quinolone_nmod<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod	lemma_1=,	path1=quinolone_nmod<Grepafloxacin_nsubj	pos_2=MD	pos_1=,	lemma_6=of	pos_3=VB	lpib=inhibit_VB	relType_6=case	eib=False	pos_6=IN	lib=inhibit	relType_2=aux	pos_4=DT	relType_3=ROOT	lemma_4=the	wib=inhibit	pos_5=NN	relation_2=adverse	relType_5=obj	lemma_3=inhibit	lemma_2=may	relType_1=punct	relType_4=det	lemma_5=metabolism
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e3	DDI-DrugBank.d78.s3.e5	mechanism	lemma_1=,	pos_7=NN	path1=quinolone_nmod<Grepafloxacin_nsubj	pos_2=MD	pos_1=,	relType_7=cc	lemma_6=of	pos_3=VB	lpib=inhibit_VB	relType_6=case	path=quinolone_nmod<Grepafloxacin_nsubj<inhibit_ROOT>metabolism_obj>caffeine_nmod>theobromine_conj	pos_6=IN	lib=inhibit	relType_2=aux	pos_4=DT	relType_3=ROOT	pos_7=CC	lemma_4=the	relType_7=nmod	wib=inhibit	lemma_7=caffeine	pos_5=NN	eib=True	relation_2=adverse	relType_5=obj	lemma_7=and	lemma_3=inhibit	lemma_2=may	relType_1=punct	relType_4=det	path2=metabolism_obj>caffeine_nmod>theobromine_conj	lemma_5=metabolism
DDI-DrugBank.d78.s3	DDI-DrugBank.d78.s3.e4	DDI-DrugBank.d78.s3.e5	null	wib=theobromine	relType_1=cc	path2=theobromine_conj	path=<caffeine_nmod>theobromine_conj	pos_1=CC	eib=False	lib=theobromine	path1=	lpib=theobromine_NN	lemma_1=and
DDI-DrugBank.d78.s5	DDI-DrugBank.d78.s5.e0	DDI-DrugBank.d78.s5.e1	null	wib=theobromine	relType_1=cc	path2=theobromine_conj	path=<caffeine_nmod>theobromine_conj	pos_1=CC	eib=False	lib=theobromine	path1=	lpib=theobromine_NN	lemma_1=and
DDI-DrugBank.d78.s6	DDI-DrugBank.d78.s6.e0	DDI-DrugBank.d78.s6.e1	null	eib=False	path1=	wib=Grepafloxacin	lib=grepafloxacin	pos_1=:	lemma_1=:	relType_1=punct	path=<Theophylline_ROOT>inhibitor_appos>Grepafloxacin_nsubj	path2=inhibitor_appos>Grepafloxacin_nsubj	lpib=grepafloxacin_NNP
DDI-DrugBank.d78.s6	DDI-DrugBank.d78.s6.e0	DDI-DrugBank.d78.s6.e2	null	relType_4=amod	pos_4=JJ	path2=inhibitor_appos>metabolism_nmod>theophylline_nmod	lemma_2=Grepafloxacin	relType_7=det	path1=	pos_9=IN	lemma_6=of	relType_6=case	pos_8=NN	relType_2=cop	pos_2=NNP	relType_2=nsubj	pos_6=IN	path=<Theophylline_ROOT>inhibitor_appos>metabolism_nmod>theophylline_nmod	relType_9=case	relType_3=det	lemma_3=a	pos_7=DT	lemma_1=:	lpib=grepafloxacin_NNP	lemma_4=competitive	pos_1=:	wib=Grepafloxacin	lemma_8=metabolism	relType_5=appos	pos_2=VBZ	pos_5=NN	eib=True	pos_3=DT	relType_8=nmod	lemma_9=of	lib=grepafloxacin	lemma_2=be	lemma_7=the	relType_1=punct	lemma_5=inhibitor
DDI-DrugBank.d78.s6	DDI-DrugBank.d78.s6.e1	DDI-DrugBank.d78.s6.e2	mechanism	relType_8=case	pos_2=DT	pos_6=DT	relType_4=appos	lemma_2=a	lemma_5=of	relType_5=case	lemma_7=metabolism	eib=False	lemma_6=the	lemma_1=be	lemma_3=competitive	pos_4=NN	pos_8=IN	path2=metabolism_nmod>theophylline_nmod	lib=be	relType_3=amod	pos_5=IN	relType_7=nmod	wib=is	relType_6=det	path=Grepafloxacin_nsubj<inhibitor_appos>metabolism_nmod>theophylline_nmod	relType_1=cop	pos_3=JJ	pos_1=VBZ	relType_2=det	lemma_4=inhibitor	lpib=be_VBZ	pos_7=NN	lemma_8=of	path1=Grepafloxacin_nsubj
DDI-DrugBank.d78.s7	DDI-DrugBank.d78.s7.e0	DDI-DrugBank.d78.s7.e1	null	pos_3=WRB	path=theophylline_compound<concentration_nsubj<increase_ROOT>initiate_advcl>grepafloxacin_nsubj:pass	path1=theophylline_compound<concentration_nsubj	pos_1=NNS	wib=concentrations	eib=False	relType_2=ROOT	path2=initiate_advcl>grepafloxacin_nsubj:pass	relType_3=advmod	lpib=concentration_NNS	relType_1=nsubj	lib=concentration	pos_2=VBP	lemma_1=concentration	lemma_2=increase	relation_1=beneficial	lemma_3=when
DDI-DrugBank.d78.s7	DDI-DrugBank.d78.s7.e0	DDI-DrugBank.d78.s7.e2	null	relType_3=advmod	path=theophylline_compound<concentration_nsubj<increase_ROOT>initiate_advcl>patient_obl>maintain_acl>theophylline_obl	lemma_4=be	relType_7=det	lpib=concentration_NNS	lemma_1=concentration	relType_6=case	lemma_4=grepafloxacin	relType_8=obl	relation_1=beneficial	pos_8=JJ	relType_5=advcl	path1=theophylline_compound<concentration_nsubj	pos_6=IN	relType_4=nsubj:pass	relType_10=case	lemma_6=in	pos_9=VBN	pos_4=NN	pos_7=DT	lemma_5=initiate	lemma_2=increase	wib=concentrations	relType_2=ROOT	relType_1=nsubj	relType_4=aux:pass	pos_2=VBP	pos_10=IN	lemma_10=on	relType_9=acl	pos_3=WRB	pos_1=NNS	eib=True	path2=initiate_advcl>patient_obl>maintain_acl>theophylline_obl	lib=concentration	lemma_7=a	lemma_8=patient	lemma_9=maintain	pos_5=VBN	pos_4=VBZ	lemma_3=when
DDI-DrugBank.d78.s7	DDI-DrugBank.d78.s7.e1	DDI-DrugBank.d78.s7.e2	mechanism	pos_2=VBN	pos_3=IN	relType_7=case	lemma_4=a	relType_1=aux:pass	path=grepafloxacin_nsubj:pass<initiate_advcl>patient_obl>maintain_acl>theophylline_obl	lemma_5=patient	relType_2=advcl	lemma_6=maintain	eib=False	lemma_7=on	lemma_1=be	pos_6=VBN	path1=grepafloxacin_nsubj:pass	pos_4=DT	pos_5=JJ	lib=be	relType_6=acl	relType_5=obl	relType_3=case	path2=patient_obl>maintain_acl>theophylline_obl	wib=is	lemma_2=initiate	pos_1=VBZ	pos_7=IN	lpib=be_VBZ	relType_4=det	lemma_3=in
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e0	DDI-DrugBank.d78.s8.e1	null	pos_2=DT	relType_1=case	lemma_1=in	wib=patient	lemma_2=a	relType_5=case	path1=grepafloxacin_nmod<course_obj	relType_4=acl	eib=False	pos_1=IN	path=grepafloxacin_nmod<course_obj<initiate_advcl>patient_obl>maintain_acl>theophylline_obl	pos_4=VBN	lib=patient	lemma_4=maintain	pos_5=IN	path2=patient_obl>maintain_acl>theophylline_obl	lpib=patient_JJ	pos_3=JJ	relType_3=obl	lemma_5=on	relType_2=det	lemma_3=patient
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e0	DDI-DrugBank.d78.s8.e2	null	pos_2=DT	relType_1=case	lemma_1=in	relType_7=det	wib=patient	lemma_6=,	lemma_2=a	relType_5=case	path1=grepafloxacin_nmod<course_obj<initiate_advcl	pos_6=NN	relType_4=acl	relType_6=obl	path2=dose_nsubj:pass>theophylline_compound	relType_6=punct	pos_1=IN	pos_7=DT	pos_4=VBN	path=grepafloxacin_nmod<course_obj<initiate_advcl<halve_ROOT>dose_nsubj:pass>theophylline_compound	lib=patient	lemma_4=maintain	pos_5=IN	pos_6=,	lpib=patient_JJ	pos_3=JJ	relType_3=obl	eib=True	lemma_5=on	lemma_6=theophylline	relType_2=det	lemma_7=the	lemma_3=patient
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e0	DDI-DrugBank.d78.s8.e3	null	lemma_8=theophylline	pos_2=DT	relType_1=case	pos_19=IN	lemma_1=in	relType_7=det	pos_16=IN	wib=patient	lemma_12=halve	lemma_13=for	path2=period_obl>use_nmod>grepafloxacin_nmod	lemma_6=,	lemma_11=be	lemma_2=a	pos_17=JJ	relType_5=case	path1=grepafloxacin_nmod<course_obj<initiate_advcl	pos_6=NN	relType_4=acl	relType_6=obl	pos_8=NN	pos_10=MD	relType_10=aux	relType_6=punct	path=grepafloxacin_nmod<course_obj<initiate_advcl<halve_ROOT>period_obl>use_nmod>grepafloxacin_nmod	lemma_17=concurrent	relType_9=nsubj:pass	relType_14=det	relType_11=aux:pass	pos_1=IN	pos_13=IN	lemma_14=the	lemma_16=of	pos_9=NN	pos_7=DT	pos_4=VBN	pos_18=NN	relType_12=ROOT	relType_13=case	lemma_19=of	relType_15=obl	pos_15=NN	lemma_8=maintenance	lib=patient	lemma_4=maintain	relType_8=compound	pos_5=IN	pos_6=,	pos_14=DT	lpib=patient_JJ	relType_17=amod	relType_16=case	pos_3=JJ	relType_3=obl	eib=True	lemma_5=on	lemma_6=theophylline	pos_11=VB	lemma_18=use	relType_2=det	relType_19=case	lemma_10=should	lemma_7=the	lemma_15=period	pos_12=VBN	relType_18=nmod	lemma_3=patient	lemma_9=dose
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e0	DDI-DrugBank.d78.s8.e4	null	wib=patient	lemma_12=halve	lemma_6=,	relType_5=case	lemma_23=serum	path1=grepafloxacin_nmod<course_obj<initiate_advcl	pos_6=NN	relType_4=acl	lemma_17=concurrent	relType_20=nmod	pos_20=NN	relType_11=aux:pass	pos_22=IN	relType_23=compound	pos_18=NN	relType_12=ROOT	relType_15=obl	lpib=patient_JJ	pos_3=JJ	pos_11=VB	lemma_9=dose	lemma_8=theophylline	pos_2=DT	relType_1=case	lemma_13=for	lemma_11=be	path2=initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	pos_8=NN	pos_10=MD	relType_9=nsubj:pass	pos_1=IN	lemma_14=the	relType_22=case	pos_9=NN	pos_4=VBN	lemma_21=monitoring	pos_5=IN	relType_17=amod	lemma_20=and	relType_16=case	relType_3=obl	lemma_6=theophylline	relType_19=case	lemma_18=use	lemma_10=should	pos_12=VBN	relType_18=nmod	lemma_3=patient	lemma_22=of	relType_7=det	pos_16=IN	relType_20=cc	path=grepafloxacin_nmod<course_obj<initiate_advcl<halve_ROOT>initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	relType_21=nsubj:pass	pos_23=NN	relType_6=obl	relType_10=aux	pos_13=IN	pos_7=DT	relType_13=case	lemma_19=of	lemma_8=maintenance	lib=patient	relType_8=compound	pos_14=DT	pos_20=CC	pos_19=IN	lemma_1=in	lemma_2=a	pos_17=JJ	relType_6=punct	relType_14=det	lemma_16=of	lemma_20=grepafloxacin	pos_15=NN	lemma_4=maintain	pos_6=,	eib=True	lemma_5=on	relType_2=det	lemma_7=the	lemma_15=period	pos_21=NN
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e1	DDI-DrugBank.d78.s8.e2	null	pos_2=DT	lib=theophylline	lemma_1=,	path=theophylline_obl<maintain_acl<patient_obl<initiate_advcl<halve_ROOT>dose_nsubj:pass>theophylline_compound	wib=theophylline	path2=dose_nsubj:pass>theophylline_compound	eib=False	lemma_2=the	relType_2=det	pos_1=,	relType_1=punct	path1=theophylline_obl<maintain_acl<patient_obl<initiate_advcl	lpib=theophylline_NN
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e1	DDI-DrugBank.d78.s8.e3	null	relType_6=aux:pass	relType_8=case	pos_2=DT	lemma_1=,	lemma_2=the	pos_6=VB	pos_1=,	path2=period_obl>use_nmod>grepafloxacin_nmod	lemma_8=for	lemma_10=period	lemma_3=theophylline	lemma_5=should	relType_11=case	path=theophylline_obl<maintain_acl<patient_obl<initiate_advcl<halve_ROOT>period_obl>use_nmod>grepafloxacin_nmod	lemma_6=be	relType_13=nmod	pos_12=JJ	pos_9=DT	relType_4=nsubj:pass	relType_12=amod	path1=theophylline_obl<maintain_acl<patient_obl<initiate_advcl	relType_5=aux	lemma_7=halve	pos_4=NN	pos_10=NN	pos_8=IN	pos_13=NN	pos_11=IN	lpib=theophylline_NN	pos_14=IN	lemma_4=dose	lemma_3=maintenance	pos_5=MD	relType_7=ROOT	lemma_13=use	lemma_12=concurrent	pos_7=VBN	lib=theophylline	wib=theophylline	eib=True	pos_3=NN	lemma_9=the	relType_2=det	lemma_14=of	lemma_11=of	relType_3=compound	relType_14=case	relType_1=punct	relType_10=obl	relType_9=det
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e1	DDI-DrugBank.d78.s8.e4	null	relType_6=aux:pass	relType_8=case	pos_2=DT	lemma_1=,	lemma_2=the	pos_6=VB	relType_16=nsubj:pass	pos_1=,	lemma_8=for	lemma_10=period	lemma_3=theophylline	path2=initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	lemma_5=should	relType_11=case	lemma_6=be	relType_13=nmod	pos_12=JJ	pos_17=IN	path=theophylline_obl<maintain_acl<patient_obl<initiate_advcl<halve_ROOT>initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	pos_9=DT	relType_4=nsubj:pass	relType_12=amod	path1=theophylline_obl<maintain_acl<patient_obl<initiate_advcl	relType_5=aux	lemma_7=halve	pos_4=NN	pos_10=NN	pos_8=IN	pos_13=NN	pos_11=IN	lpib=theophylline_NN	pos_14=IN	lemma_4=dose	lemma_16=monitoring	relType_17=case	pos_18=NN	lemma_3=maintenance	pos_5=MD	relType_7=ROOT	lemma_13=use	pos_15=NN	relType_15=cc	lemma_17=of	pos_16=NN	relType_15=nmod	lemma_15=and	lemma_12=concurrent	lemma_15=grepafloxacin	pos_7=VBN	lib=theophylline	wib=theophylline	eib=True	pos_3=NN	lemma_9=the	relType_2=det	lemma_14=of	lemma_11=of	pos_15=CC	relType_18=compound	relType_3=compound	relType_14=case	relType_1=punct	relType_10=obl	lemma_18=serum	relType_9=det
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e2	DDI-DrugBank.d78.s8.e3	advise	lemma_1=maintenance	pos_2=NN	lib=maintenance	lemma_4=be	relType_7=det	lemma_2=dose	relType_10=amod	relType_12=case	path2=period_obl>use_nmod>grepafloxacin_nmod	pos_9=IN	lemma_3=should	relType_6=case	relType_8=obl	lemma_12=of	pos_8=NN	lemma_6=for	relType_1=compound	path=theophylline_compound<dose_nsubj:pass<halve_ROOT>period_obl>use_nmod>grepafloxacin_nmod	eib=False	lemma_8=period	pos_6=IN	lpib=maintenance_NN	pos_3=MD	relType_9=case	lemma_11=use	relType_2=nsubj:pass	pos_1=NN	pos_7=DT	lemma_10=concurrent	pos_12=IN	lemma_5=halve	pos_10=JJ	relType_4=aux:pass	pos_11=NN	lemma_9=of	pos_4=VB	wib=maintenance	relType_3=aux	lemma_7=the	relType_11=nmod	relType_5=ROOT	path1=theophylline_compound<dose_nsubj:pass	pos_5=VBN
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e2	DDI-DrugBank.d78.s8.e4	null	lemma_1=maintenance	pos_2=NN	lemma_15=of	lib=maintenance	lemma_4=be	relType_7=det	lemma_2=dose	relType_10=amod	relType_12=case	lemma_16=serum	pos_9=IN	relType_16=compound	path2=initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	lemma_3=should	relType_6=case	relType_8=obl	lemma_12=of	relType_13=nmod	pos_8=NN	lemma_6=for	relType_1=compound	relType_14=nsubj:pass	lemma_8=period	pos_6=IN	lpib=maintenance_NN	pos_3=MD	relType_9=case	lemma_13=and	lemma_11=use	pos_13=NN	relType_2=nsubj:pass	pos_14=NN	pos_1=NN	pos_7=DT	lemma_10=concurrent	pos_12=IN	relType_13=cc	lemma_5=halve	relType_15=case	pos_10=JJ	relType_4=aux:pass	pos_16=NN	pos_13=CC	pos_15=IN	pos_11=NN	lemma_14=monitoring	eib=True	lemma_9=of	pos_4=VB	wib=maintenance	relType_3=aux	lemma_7=the	relType_11=nmod	relType_5=ROOT	path1=theophylline_compound<dose_nsubj:pass	pos_5=VBN	path=theophylline_compound<dose_nsubj:pass<halve_ROOT>initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	lemma_13=grepafloxacin
DDI-DrugBank.d78.s8	DDI-DrugBank.d78.s8.e3	DDI-DrugBank.d78.s8.e4	null	relType_1=cc	lpib=monitoring_NN	pos_1=CC	lemma_2=monitoring	pos_2=NN	pos_3=IN	path=grepafloxacin_nmod<use_nmod<period_obl<halve_ROOT>initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	path2=initiate_parataxis>monitoring_nsubj:pass>concentration_nmod>theophylline_compound	wib=monitoring	eib=False	relType_2=nsubj:pass	pos_4=NN	relType_4=compound	lemma_4=serum	relType_3=case	lib=monitoring	lemma_3=of	path1=grepafloxacin_nmod<use_nmod<period_obl	lemma_1=and
DDI-DrugBank.d78.s9	DDI-DrugBank.d78.s9.e0	DDI-DrugBank.d78.s9.e1	null	path2=observe_appos>subject_obl>receive_acl>warfarin_obj	lemma_3=subject	path1=	lemma_4=receive	pos_2=IN	relType_4=acl	pos_3=NNS	eib=False	path=<Warfarin_ROOT>observe_appos>subject_obl>receive_acl>warfarin_obj	lib=subject	lemma_1=:	lpib=subject_NNS	pos_1=:	pos_4=VBG	relType_2=case	relType_3=obl	wib=subjects	relType_1=punct	lemma_2=in
DDI-DrugBank.d78.s9	DDI-DrugBank.d78.s9.e0	DDI-DrugBank.d78.s9.e2	null	lemma_13=observe	pos_6=DT	lemma_5=warfarin	pos_5=,	lemma_3=subject	lemma_6=no	path1=	lemma_4=receive	pos_9=IN	relation_8=neutral	pos_14=WRB	pos_13=VBN	relType_8=nsubj:pass	relType_12=aux:pass	pos_2=IN	relType_4=acl	pos_8=NN	relType_14=advmod	pos_3=NNS	pos_12=VBD	path2=observe_appos>coadminister_advcl>grepafloxacin_nsubj:pass	relType_13=appos	relType_9=case	relType_10=compound	pos_10=NN	lib=subject	lemma_1=:	lpib=subject_NNS	lemma_8=change	relType_7=amod	lemma_12=be	lemma_7=significant	lemma_5=,	relType_5=punct	pos_1=:	lemma_11=time	pos_4=VBG	relType_6=det	pos_5=NN	lemma_10=clotting	pos_11=NN	relType_2=case	relType_3=obl	eib=True	relType_5=obj	pos_7=JJ	wib=subjects	relType_11=nmod	path=<Warfarin_ROOT>observe_appos>coadminister_advcl>grepafloxacin_nsubj:pass	relType_1=punct	lemma_9=in	lemma_14=when	lemma_2=in
DDI-DrugBank.d78.s9	DDI-DrugBank.d78.s9.e1	DDI-DrugBank.d78.s9.e2	null	pos_10=WRB	pos_2=DT	lemma_1=,	lemma_5=in	wib=significant	pos_1=,	path2=coadminister_advcl>grepafloxacin_nsubj:pass	relType_5=case	lemma_9=observe	pos_6=NN	lemma_2=no	eib=False	lemma_10=when	relType_8=aux:pass	path=warfarin_obj<receive_acl<subject_obl<observe_appos>coadminister_advcl>grepafloxacin_nsubj:pass	lpib=significant_JJ	relType_4=nsubj:pass	relType_10=advmod	lemma_3=significant	pos_9=VBN	pos_4=NN	path1=warfarin_obj<receive_acl<subject_obl	relType_9=appos	pos_8=VBD	relation_3=neutral	relType_3=amod	lemma_8=be	pos_5=IN	relType_7=nmod	lemma_4=change	relType_6=compound	pos_3=JJ	lemma_7=time	relType_2=det	lib=significant	lemma_6=clotting	relType_1=punct	pos_7=NN
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e0	DDI-DrugBank.d78.s10.e1	effect	relType_4=mark	pos_7=NNS	relType_8=case	pos_2=VBN	relation_4=beneficial	relType_5=xcomp	relType_1=aux	pos_6=DT	pos_3=VBN	lemma_5=enhance	path1=quinolone_nsubj:pass	relation_6=neutral	pos_5=VB	path2=enhance_xcomp>effect_obj>warfarin_nmod	eib=False	lemma_7=effect	lemma_6=the	relType_7=obj	lemma_3=report	lemma_1=have	path=quinolone_nsubj:pass<report_advcl>enhance_xcomp>effect_obj>warfarin_nmod	lib=have	pos_8=IN	relType_3=advcl	lemma_4=to	relType_2=aux:pass	pos_1=VBP	lpib=have_VBP	pos_4=TO	relType_6=det	wib=have	lemma_2=be	lemma_8=of
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e0	DDI-DrugBank.d78.s10.e2	null	lemma_24=if	lemma_26=quinolone	relType_5=xcomp	relType_21=aux:pass	lemma_5=enhance	path=quinolone_nsubj:pass<report_advcl<monitor_ROOT>administer_advcl>antimicrobial_nsubj:pass	lemma_12=,	relType_14=nsubj:pass	pos_12=,	lemma_3=report	pos_23=RB	pos_13=NN	pos_18=NN	pos_9=CC	lemma_9=or	relType_2=aux:pass	lemma_15=or	relType_25=det	pos_24=IN	pos_4=TO	path2=administer_advcl>antimicrobial_nsubj:pass	relType_26=amod	lemma_23=closely	pos_15=CC	relType_4=mark	pos_7=NNS	relType_8=case	lemma_21=be	lemma_16=other	relType_1=aux	path1=quinolone_nsubj:pass<report_advcl	relType_22=ROOT	relType_16=amod	pos_5=VB	relType_20=aux	relType_12=punct	pos_9=NN	pos_8=IN	lemma_14=time	pos_21=VB	relType_24=mark	lpib=have_VBP	lemma_19=test	relType_17=amod	relType_6=det	lemma_22=monitor	wib=have	lemma_2=be	pos_2=VBN	relation_4=beneficial	pos_6=DT	relType_11=conj	pos_26=JJ	relType_10=nmod:poss	lemma_6=the	relType_7=obj	pos_14=NN	lemma_13=prothrombin	lemma_4=to	pos_1=VBP	relType_19=conj	lemma_25=a	lemma_9=warfarin	relType_23=advmod	lemma_11=derivative	pos_3=VBN	pos_17=JJ	relType_9=nmod	pos_22=VBN	relation_6=neutral	lemma_17=suitable	pos_25=DT	lemma_7=effect	pos_20=MD	pos_11=NNS	lemma_1=have	pos_19=NN	lemma_20=should	lib=have	pos_16=JJ	relType_13=compound	relType_3=advcl	relType_15=cc	lemma_10=its	eib=True	relType_18=compound	pos_10=PRP$	lemma_18=anticoagulation	lemma_8=of	relType_9=cc
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e0	DDI-DrugBank.d78.s10.e3	null	path=quinolone_nsubj:pass<report_advcl<monitor_ROOT>administer_advcl>warfarin_obl	lemma_24=if	lemma_26=quinolone	relType_5=xcomp	relType_21=aux:pass	lemma_5=enhance	lemma_12=,	relType_14=nsubj:pass	pos_12=,	lemma_3=report	pos_23=RB	pos_13=NN	pos_18=NN	pos_9=CC	lemma_9=or	relType_26=aux:pass	relType_2=aux:pass	lemma_15=or	relType_25=det	pos_24=IN	pos_4=TO	relType_26=amod	pos_27=VBN	lemma_23=closely	pos_15=CC	lemma_26=antimicrobial	relType_27=advcl	relType_4=mark	pos_7=NNS	relType_8=case	lemma_21=be	lemma_16=other	relType_1=aux	path1=quinolone_nsubj:pass<report_advcl	relType_22=ROOT	relType_16=amod	pos_5=VB	relType_20=aux	relType_12=punct	pos_9=NN	pos_8=IN	lemma_14=time	pos_21=VB	relType_24=mark	lpib=have_VBP	lemma_19=test	relType_17=amod	relType_6=det	lemma_22=monitor	lemma_26=be	wib=have	lemma_2=be	pos_2=VBN	relation_4=beneficial	pos_6=DT	relType_11=conj	pos_26=JJ	relType_10=nmod:poss	lemma_6=the	relType_7=obj	lemma_27=administer	pos_14=NN	path2=administer_advcl>warfarin_obl	lemma_13=prothrombin	lemma_4=to	pos_1=VBP	relType_19=conj	relType_28=case	lemma_25=a	lemma_9=warfarin	relType_23=advmod	lemma_11=derivative	pos_3=VBN	pos_17=JJ	relType_9=nmod	pos_22=VBN	relation_6=neutral	lemma_17=suitable	pos_25=DT	lemma_28=with	lemma_7=effect	pos_20=MD	pos_11=NNS	lemma_1=have	pos_19=NN	lemma_20=should	pos_26=VBZ	lib=have	relType_26=nsubj:pass	pos_16=JJ	relType_13=compound	relType_3=advcl	relType_15=cc	lemma_10=its	eib=True	pos_28=IN	relType_18=compound	pos_10=PRP$	lemma_18=anticoagulation	lemma_8=of	relType_9=cc
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e1	DDI-DrugBank.d78.s10.e2	null	relType_1=cc	lemma_16=if	pos_1=CC	pos_17=DT	relType_8=amod	pos_16=IN	relType_18=amod	relType_7=cc	relType_5=compound	pos_15=RB	lemma_14=monitor	relType_11=conj	pos_6=NN	pos_8=JJ	pos_9=JJ	lemma_5=prothrombin	pos_3=NNS	relType_17=det	lemma_3=derivative	pos_4=,	relType_14=ROOT	relType_12=aux	lemma_6=time	pos_18=JJ	relType_9=amod	relType_10=compound	pos_10=NN	path=warfarin_nmod<effect_obj<enhance_xcomp<report_advcl<monitor_ROOT>administer_advcl>antimicrobial_nsubj:pass	lemma_10=anticoagulation	lemma_13=be	wib=derivatives	relType_13=aux:pass	pos_13=VB	relType_4=punct	pos_7=CC	relType_3=conj	relType_16=mark	pos_2=PRP$	lemma_2=its	relType_6=nsubj:pass	lemma_12=should	lemma_4=,	lemma_18=quinolone	lemma_7=or	lemma_9=suitable	path1=warfarin_nmod<effect_obj<enhance_xcomp<report_advcl	lpib=derivative_NNS	path2=administer_advcl>antimicrobial_nsubj:pass	pos_5=NN	relType_2=nmod:poss	lemma_8=other	pos_12=MD	pos_11=NN	pos_14=VBN	lemma_15=closely	eib=True	lemma_17=a	lib=derivative	relType_15=advmod	lemma_11=test	lemma_1=or
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e1	DDI-DrugBank.d78.s10.e3	null	relType_1=cc	lemma_16=if	pos_1=CC	relType_18=aux:pass	pos_17=DT	relType_8=amod	pos_16=IN	relType_18=amod	relType_7=cc	relType_5=compound	pos_15=RB	path=warfarin_nmod<effect_obj<enhance_xcomp<report_advcl<monitor_ROOT>administer_advcl>warfarin_obl	lemma_14=monitor	relType_11=conj	pos_20=IN	pos_6=NN	pos_8=JJ	pos_9=JJ	relType_20=case	lemma_5=prothrombin	pos_3=NNS	relType_17=det	lemma_3=derivative	pos_4=,	lemma_18=antimicrobial	relType_14=ROOT	lemma_18=be	relType_12=aux	lemma_6=time	pos_18=JJ	relType_9=amod	relType_10=compound	pos_10=NN	lemma_10=anticoagulation	lemma_13=be	wib=derivatives	path2=administer_advcl>warfarin_obl	relType_13=aux:pass	pos_13=VB	relType_4=punct	pos_7=CC	relType_3=conj	relType_16=mark	pos_2=PRP$	lemma_2=its	relType_6=nsubj:pass	lemma_12=should	lemma_4=,	lemma_18=quinolone	relType_19=advcl	lemma_7=or	lemma_9=suitable	path1=warfarin_nmod<effect_obj<enhance_xcomp<report_advcl	lpib=derivative_NNS	pos_12=MD	pos_5=NN	relType_2=nmod:poss	lemma_8=other	pos_14=VBN	pos_11=NN	lemma_15=closely	lemma_17=a	eib=True	lemma_20=with	lemma_19=administer	relType_18=nsubj:pass	pos_19=VBN	pos_18=VBZ	lib=derivative	relType_15=advmod	lemma_11=test	lemma_1=or
DDI-DrugBank.d78.s10	DDI-DrugBank.d78.s10.e2	DDI-DrugBank.d78.s10.e3	advise	pos_2=VBN	lib=be	path1=antimicrobial_nsubj:pass	pos_1=VBZ	eib=False	pos_3=IN	path=antimicrobial_nsubj:pass<administer_advcl>warfarin_obl	relType_1=aux:pass	lemma_1=be	lemma_2=administer	lpib=be_VBZ	path2=warfarin_obl	relType_2=advcl	lemma_3=with	relType_3=case	wib=is
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e0	DDI-DrugBank.d78.s11.e1	null	lib=theophylline	relType_1=case	wib=theophylline	eib=False	path=grepafloxacin_nmod<effect_obj>theophylline_nmod	path2=theophylline_nmod	pos_1=IN	path1=grepafloxacin_nmod	lemma_1=on	lpib=theophylline_NN
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e0	DDI-DrugBank.d78.s11.e2	null	path1=grepafloxacin_nmod<effect_obj<evaluate_acl<study_nsubj	path=grepafloxacin_nmod<effect_obj<evaluate_acl<study_nsubj<indicate_parataxis>inhibit_ccomp>grepafloxacin_nsubj	relType_1=case	pos_2=NN	pos_3=IN	relType_2=nmod	pos_1=IN	lpib=theophylline_NN	lemma_3=that	lemma_2=indicate	relType_3=mark	lemma_2=theophylline	pos_2=VBZ	lib=theophylline	path2=inhibit_ccomp>grepafloxacin_nsubj	wib=theophylline	eib=True	relType_2=parataxis	lemma_1=on
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e0	DDI-DrugBank.d78.s11.e3	null	path1=grepafloxacin_nmod<effect_obj<evaluate_acl<study_nsubj	relType_1=case	pos_2=NN	pos_3=IN	relation_5=adverse	lemma_4=grepafloxacin	relType_2=nmod	pos_1=IN	relType_4=nsubj	pos_4=NN	lpib=theophylline_NN	path=grepafloxacin_nmod<effect_obj<evaluate_acl<study_nsubj<indicate_parataxis>inhibit_ccomp>metabolism_obj>theophylline_compound	lemma_3=that	lemma_2=indicate	relType_4=ccomp	lemma_4=inhibit	relType_3=mark	lemma_2=theophylline	pos_2=VBZ	lib=theophylline	wib=theophylline	eib=True	path2=inhibit_ccomp>metabolism_obj>theophylline_compound	relType_2=parataxis	pos_4=VBZ	lemma_1=on
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e1	DDI-DrugBank.d78.s11.e2	null	pos_2=IN	lib=indicate	wib=indicates	path1=theophylline_nmod<effect_obj<evaluate_acl<study_nsubj	path2=inhibit_ccomp>grepafloxacin_nsubj	path=theophylline_nmod<effect_obj<evaluate_acl<study_nsubj<indicate_parataxis>inhibit_ccomp>grepafloxacin_nsubj	pos_1=VBZ	eib=False	lemma_1=indicate	lpib=indicate_VBZ	lemma_2=that	relType_1=parataxis	relType_2=mark
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e1	DDI-DrugBank.d78.s11.e3	null	lib=indicate	lemma_2=that	relType_2=mark	pos_2=IN	pos_3=VBZ	lemma_1=indicate	lpib=indicate_VBZ	relType_1=parataxis	relation_3=adverse	path=theophylline_nmod<effect_obj<evaluate_acl<study_nsubj<indicate_parataxis>inhibit_ccomp>metabolism_obj>theophylline_compound	relType_3=nsubj	lemma_3=grepafloxacin	wib=indicates	path1=theophylline_nmod<effect_obj<evaluate_acl<study_nsubj	pos_1=VBZ	eib=True	relType_3=ccomp	pos_3=NN	path2=inhibit_ccomp>metabolism_obj>theophylline_compound	lemma_3=inhibit
DDI-DrugBank.d78.s11	DDI-DrugBank.d78.s11.e2	DDI-DrugBank.d78.s11.e3	mechanism	pos_1=VBZ	eib=False	path=grepafloxacin_nsubj<inhibit_ccomp>metabolism_obj>theophylline_compound	relType_1=ccomp	relation_0=adverse	lib=inhibit	path2=metabolism_obj>theophylline_compound	lemma_1=inhibit	wib=inhibits	lpib=inhibit_VBZ	path1=grepafloxacin_nsubj
DDI-DrugBank.d78.s13	DDI-DrugBank.d78.s13.e0	DDI-DrugBank.d78.s13.e1	null	relType_1=case	lib=cyp3a4	lemma_1=in	pos_2=NN	pos_5=CC	wib=CYP3A4	pos_3=VBN	relType_4=nmod	relType_5=cc	eib=False	pos_1=IN	pos_4=NN	relType_2=dep	relType_3=amod	lpib=cyp3a4_NN	path1=grepafloxacin_nmod	path=grepafloxacin_nmod<effect_obj>metabolism_nmod>metabolism_conj>theophylline_compound	lemma_5=and	lemma_2=cyp3a4	path2=metabolism_nmod>metabolism_conj>theophylline_compound	lemma_3=mediate	lemma_4=metabolism
DDI-DrugBank.d78.s14	DDI-DrugBank.d78.s14.e0	DDI-DrugBank.d78.s14.e1	mechanism	relType_4=mark	pos_2=VBN	relType_5=xcomp	relType_1=aux	pos_6=DT	relation_4=adverse	pos_3=VBN	relType_8=punct	path1=quinolone_nsubj:pass	relType_11=case	pos_5=VB	eib=False	lemma_6=the	lemma_3=report	lemma_1=have	pos_8=HYPH	relType_9=amod	pos_9=VBN	lemma_9=mediate	pos_10=NN	lib=have	pos_11=IN	relType_3=ROOT	lemma_4=to	relType_2=aux:pass	lemma_10=metabolism	pos_1=VBP	lpib=have_VBP	pos_4=TO	relType_6=det	relType_7=obl	path2=decrease_xcomp>metabolism_obj>cyclosporine_nmod	lemma_5=decrease	lemma_7=cyp3a4	lemma_8=-	wib=have	path=quinolone_nsubj:pass<report_ROOT>decrease_xcomp>metabolism_obj>cyclosporine_nmod	lemma_11=of	lemma_2=be	pos_7=NN	relType_10=obj
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e0	DDI-DrugBank.d78.s16.e1	null	wib=astemizole	lib=astemizole	lemma_1=,	eib=False	lpib=astemizole_NN	path1=	pos_1=,	path=<terfenadine_obj>astemizole_conj	relType_1=punct	path2=astemizole_conj
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e0	DDI-DrugBank.d78.s16.e2	null	wib=astemizole	lib=astemizole	path=<terfenadine_obj>cisapride_conj	lemma_1=,	pos_2=NN	eib=True	lpib=astemizole_NN	lemma_2=,	path1=	path2=cisapride_conj	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=astemizole	relType_2=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e0	DDI-DrugBank.d78.s16.e3	null	lib=astemizole	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	lemma_3=cisapride	path=<terfenadine_obj>midazolam_conj	relType_2=conj	lemma_2=,	lemma_2=astemizole	lemma_3=,	relType_3=conj	lpib=astemizole_NN	wib=astemizole	pos_3=,	eib=True	pos_3=NN	pos_2=,	path2=midazolam_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e0	DDI-DrugBank.d78.s16.e4	null	lib=astemizole	lemma_1=,	pos_2=NN	pos_5=CC	path1=	pos_1=,	relType_2=punct	lemma_3=cisapride	relType_5=cc	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=astemizole	lemma_4=midazolam	relType_4=punct	lemma_3=,	relType_3=conj	lpib=astemizole_NN	lemma_4=,	wib=astemizole	path2=triazolam_conj	pos_3=,	eib=True	path=<terfenadine_obj>triazolam_conj	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e1	DDI-DrugBank.d78.s16.e2	null	lib=cisapride	lemma_1=,	eib=False	pos_1=,	path2=cisapride_conj	wib=cisapride	relType_1=punct	path=astemizole_conj<terfenadine_obj>cisapride_conj	path1=astemizole_conj	lpib=cisapride_NN
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e1	DDI-DrugBank.d78.s16.e3	null	lib=cisapride	lemma_1=,	pos_2=NN	eib=True	lemma_2=cisapride	pos_1=,	wib=cisapride	pos_2=,	path2=midazolam_conj	relType_2=conj	relType_1=punct	path1=astemizole_conj	path=astemizole_conj<terfenadine_obj>midazolam_conj	lemma_2=,	lpib=cisapride_NN	relType_2=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e1	DDI-DrugBank.d78.s16.e4	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	lemma_3=midazolam	path1=astemizole_conj	relType_2=punct	lib=cisapride	wib=cisapride	relType_2=conj	lemma_2=,	path=astemizole_conj<terfenadine_obj>triazolam_conj	lemma_3=,	relType_3=conj	lemma_2=cisapride	lpib=cisapride_NN	path2=triazolam_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e2	DDI-DrugBank.d78.s16.e3	null	path=cisapride_conj<terfenadine_obj>midazolam_conj	lemma_1=,	wib=midazolam	eib=False	lpib=midazolam_NN	pos_1=,	path2=midazolam_conj	relType_1=punct	path1=cisapride_conj	lib=midazolam
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e2	DDI-DrugBank.d78.s16.e4	null	lemma_1=,	pos_2=NN	wib=midazolam	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	lib=midazolam	relType_2=conj	lemma_2=,	path1=cisapride_conj	lpib=midazolam_NN	path2=triazolam_conj	eib=True	path=cisapride_conj<terfenadine_obj>triazolam_conj	lemma_2=midazolam	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d78.s16	DDI-DrugBank.d78.s16.e3	DDI-DrugBank.d78.s16.e4	null	lemma_2=and	lib=triazolam	path2=triazolam_conj	path1=midazolam_conj	path=midazolam_conj<terfenadine_obj>triazolam_conj	lemma_1=,	eib=False	wib=triazolam	pos_2=CC	pos_1=,	relType_1=punct	relType_2=cc	lpib=triazolam_NN
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e0	DDI-DrugBank.d78.s19.e1	null	lemma_1=(	lib=nsaid	lpib=nsaid_NNS	wib=NSAIDs	eib=False	path1=	path2=nsaid_dep	path=<drug_ROOT>nsaid_dep	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e0	DDI-DrugBank.d78.s19.e2	null	lemma_2=)	lpib=nsaid_NNS	lemma_6=administration	path=<drug_ROOT>increase_dep>administration_nsubj>drug_nmod	relType_7=case	pos_8=DT	path1=	lemma_9=inflammatory	relType_2=punct	lemma_1=(	pos_6=NN	pos_9=JJ	lib=nsaid	relType_9=compound	pos_9=AFX	lemma_3=:	lemma_8=a	relType_9=amod	lemma_2=nsaid	lemma_9=nonsteroidal	pos_4=DT	pos_5=JJ	relType_2=dep	lemma_5=concomitant	relType_5=amod	pos_3=:	lemma_4=the	path2=increase_dep>administration_nsubj>drug_nmod	pos_1=-LRB-	lemma_7=of	pos_2=NNS	wib=NSAIDs	eib=True	pos_2=-RRB-	pos_7=IN	relType_8=det	relType_1=punct	relType_4=det	lemma_9=anti	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e0	DDI-DrugBank.d78.s19.e3	null	lemma_2=)	lpib=nsaid_NNS	lemma_6=administration	relType_7=case	pos_8=DT	relType_10=det	lemma_9=drug	path1=	pos_9=IN	lemma_10=a	relType_9=nmod	lemma_9=inflammatory	relType_2=punct	lemma_1=(	pos_6=NN	pos_9=JJ	lib=nsaid	relType_9=compound	pos_9=AFX	lemma_3=:	path=<drug_ROOT>increase_dep>administration_nsubj>drug_nmod>quinolone_nmod	lemma_8=a	relType_9=amod	lemma_2=nsaid	relType_9=case	pos_9=NN	lemma_9=nonsteroidal	pos_4=DT	pos_5=JJ	relType_2=dep	lemma_5=concomitant	relType_5=amod	pos_3=:	lemma_4=the	path2=increase_dep>administration_nsubj>drug_nmod>quinolone_nmod	pos_1=-LRB-	lemma_7=of	pos_2=NNS	lemma_9=with	wib=NSAIDs	eib=True	pos_2=-RRB-	pos_7=IN	relType_8=det	relType_1=punct	relType_4=det	lemma_9=anti	relType_3=punct	relType_6=nsubj	pos_10=DT
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e1	DDI-DrugBank.d78.s19.e2	null	relType_4=amod	pos_4=JJ	relType_7=det	relType_8=amod	lemma_8=nonsteroidal	relType_5=nsubj	lemma_6=of	lemma_1=)	relType_6=case	relType_2=punct	lib=concomitant	pos_8=JJ	lemma_2=:	lemma_8=inflammatory	pos_6=IN	pos_8=AFX	lpib=concomitant_JJ	relType_3=det	pos_7=DT	wib=concomitant	lemma_8=anti	path=nsaid_dep<drug_ROOT>increase_dep>administration_nsubj>drug_nmod	path1=nsaid_dep	pos_1=-RRB-	relType_8=compound	pos_2=:	path2=increase_dep>administration_nsubj>drug_nmod	pos_5=NN	eib=True	pos_3=DT	lemma_3=the	lemma_7=a	relType_1=punct	lemma_5=administration	lemma_4=concomitant
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e1	DDI-DrugBank.d78.s19.e3	null	relType_8=case	relType_4=amod	pos_4=JJ	relType_7=det	relType_8=amod	lemma_9=a	lemma_8=nonsteroidal	relType_5=nsubj	lemma_6=of	lemma_1=)	relType_6=case	relType_2=punct	lib=concomitant	pos_8=JJ	lemma_2=:	lemma_8=inflammatory	pos_8=NN	pos_6=IN	pos_8=AFX	lpib=concomitant_JJ	lemma_8=with	pos_9=DT	relType_3=det	pos_7=DT	pos_8=IN	wib=concomitant	lemma_8=anti	path1=nsaid_dep	pos_1=-RRB-	relType_8=compound	pos_2=:	path2=increase_dep>administration_nsubj>drug_nmod>quinolone_nmod	path=nsaid_dep<drug_ROOT>increase_dep>administration_nsubj>drug_nmod>quinolone_nmod	pos_5=NN	lemma_8=drug	eib=True	pos_3=DT	relType_8=nmod	lemma_3=the	lemma_7=a	relType_1=punct	relType_9=det	lemma_5=administration	lemma_4=concomitant
DDI-DrugBank.d78.s19	DDI-DrugBank.d78.s19.e2	DDI-DrugBank.d78.s19.e3	effect	lemma_1=with	pos_2=DT	relType_1=case	path=<drug_nmod>quinolone_nmod	lib=quinolone	eib=False	wib=quinolone	relType_2=det	path1=	pos_1=IN	lemma_2=a	lpib=quinolone_NN	path2=quinolone_nmod
DDI-DrugBank.d78.s20	DDI-DrugBank.d78.s20.e0	DDI-DrugBank.d78.s20.e1	null	pos_19=IN	pos_3=IN	relType_7=case	lemma_11=,	path=<agent_ROOT>report_dep>patient_obl>treat_acl>quinolone_obl	path1=	lemma_6=,	pos_7=VBG	relType_16=obl	pos_16=NNS	pos_17=VBN	pos_13=VBN	pos_8=NN	relType_17=acl	pos_18=RB	eib=False	relType_10=conj	relType_6=punct	lemma_16=patient	relType_11=punct	pos_12=VBP	lpib=disturbance_NNS	lemma_18=concomitantly	relType_12=aux	path2=report_dep>patient_obl>treat_acl>quinolone_obl	pos_10=NN	relType_2=nsubj:pass	pos_4=NN	lib=disturbance	lemma_1=:	lemma_13=be	relType_13=aux:pass	lemma_4=blood	lemma_9=and	pos_9=CC	relType_15=case	lemma_5=glucose	lemma_19=with	lemma_8=hyperglycemia	relType_4=compound	pos_1=:	relType_5=nmod	lemma_10=hypoglycemia	relType_14=dep	lemma_17=treat	pos_11=,	wib=Disturbances	relType_3=case	pos_6=,	pos_15=IN	pos_2=NNS	pos_5=NN	pos_14=VBN	lemma_15=in	relType_8=nmod	lemma_12=have	relType_18=advmod	relType_19=case	lemma_14=report	lemma_3=of	relType_1=punct	lemma_7=include	relType_9=cc	lemma_2=disturbance
DDI-DrugBank.d78.s20	DDI-DrugBank.d78.s20.e0	DDI-DrugBank.d78.s20.e2	null	pos_19=IN	path=<agent_ROOT>report_dep>patient_obl>treat_acl>quinolone_obl>agent_conj	pos_3=IN	relType_7=case	lemma_11=,	path1=	lemma_6=,	pos_7=VBG	relType_20=cc	relType_16=obl	pos_16=NNS	pos_17=VBN	pos_13=VBN	pos_8=NN	relType_17=acl	pos_18=RB	lemma_22=antidiabetic	lemma_16=patient	relType_10=conj	relType_6=punct	lemma_18=concomitantly	relType_11=punct	pos_12=VBP	lpib=disturbance_NNS	lemma_21=a	relType_12=aux	pos_10=NN	relType_2=nsubj:pass	pos_4=NN	lib=disturbance	lemma_1=:	lemma_13=be	relType_13=aux:pass	lemma_4=blood	lemma_9=and	pos_9=CC	relType_15=case	lemma_5=glucose	lemma_19=with	lemma_8=hyperglycemia	path2=report_dep>patient_obl>treat_acl>quinolone_obl>agent_conj	relType_4=compound	pos_1=:	relType_21=det	relType_5=nmod	lemma_10=hypoglycemia	relType_14=dep	lemma_17=treat	pos_20=NNS	pos_11=,	wib=Disturbances	relType_3=case	pos_6=,	pos_15=IN	pos_2=NNS	pos_5=NN	pos_14=VBN	lemma_15=in	lemma_20=and	pos_22=JJ	relType_22=amod	eib=True	relType_8=nmod	lemma_12=have	relType_18=advmod	relType_19=case	lemma_14=report	pos_20=CC	lemma_3=of	relType_20=obl	relType_1=punct	pos_21=DT	lemma_7=include	relType_9=cc	lemma_2=disturbance	lemma_20=quinolone
DDI-DrugBank.d78.s20	DDI-DrugBank.d78.s20.e1	DDI-DrugBank.d78.s20.e2	effect	relType_1=cc	path=<quinolone_obl>agent_conj	pos_2=DT	pos_1=CC	lemma_1=and	lemma_3=antidiabetic	pos_3=JJ	relType_3=amod	eib=True	wib=antidiabetic	path2=agent_conj	lib=antidiabetic	relType_2=det	path1=	lemma_2=a	lpib=antidiabetic_JJ
DDI-DrugBank.d186.s0	DDI-DrugBank.d186.s0.e0	DDI-DrugBank.d186.s0.e1	effect	relType_1=cc	pos_1=CC	eib=False	path2=HALDOL_conj	path=<lithium_obl>HALDOL_conj	path1=	wib=HALDOL	lpib=haldol_NNP	lemma_1=plus	lib=haldol
DDI-DrugBank.d186.s1	DDI-DrugBank.d186.s1.e0	DDI-DrugBank.d186.s1.e1	null	relType_1=cc	pos_1=CC	lemma_1=and	eib=False	path1=	wib=HALDOL	lpib=haldol_NN	lib=haldol	path=<lithium_nmod>haldol_conj	path2=haldol_conj
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e0	DDI-DrugBank.d186.s3.e1	null	lemma_1=,	path=agent_obl<note_ROOT>capable_ccomp>HALDOL_nsubj	lemma_4=be	pos_1=,	path2=capable_ccomp>HALDOL_nsubj	lemma_3=should	wib=be	eib=False	pos_6=IN	pos_3=MD	lemma_2=it	relType_2=nsubj:pass	lib=be	lemma_5=note	relType_6=mark	relType_4=aux:pass	pos_2=PRP	lpib=be_VB	pos_4=VB	path1=agent_obl	relType_3=aux	lemma_6=that	relType_1=punct	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e0	DDI-DrugBank.d186.s3.e2	effect	lemma_1=,	lemma_4=be	pos_1=,	lemma_10=of	path=agent_obl<note_ROOT>capable_ccomp>depressant_obl	relType_7=aux	lemma_3=should	path2=capable_ccomp>depressant_obl	relType_8=cop	wib=be	pos_9=JJ	relation_11=adverse	lemma_9=capable	relType_12=compound	relType_9=ccomp	pos_6=IN	relType_11=amod	pos_3=MD	pos_12=NN	lemma_2=it	pos_7=MD	lemma_7=may	relType_10=case	relType_2=nsubj:pass	lemma_11=potentiate	pos_8=VB	lib=be	lemma_5=note	lemma_8=be	relType_6=mark	pos_7=NNP	relType_4=aux:pass	pos_11=VBG	lemma_12=cns	pos_10=IN	pos_2=PRP	lpib=be_VB	lemma_7=HALDOL	eib=True	pos_4=VB	path1=agent_obl	relation_11=beneficial	relType_3=aux	relType_7=nsubj	lemma_6=that	relType_1=punct	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e0	DDI-DrugBank.d186.s3.e3	effect	relType_12=obl	lemma_1=,	lemma_4=be	lemma_13=as	lemma_12=depressant	pos_1=,	relType_12=case	lemma_10=of	relType_7=aux	lemma_3=should	relType_8=cop	wib=be	pos_12=JJ	pos_9=JJ	relation_11=adverse	lemma_9=capable	relType_12=compound	relType_9=ccomp	pos_6=IN	relType_11=amod	pos_3=MD	pos_12=NN	lemma_2=it	pos_7=MD	lemma_7=may	relType_10=case	relType_2=nsubj:pass	lemma_11=potentiate	pos_13=IN	path2=capable_ccomp>depressant_obl>anesthetic_nmod	pos_8=VB	lib=be	lemma_5=note	lemma_8=be	relType_6=mark	pos_12=NNS	pos_7=NNP	relType_4=aux:pass	pos_11=VBG	lemma_12=cns	pos_10=IN	pos_2=PRP	lpib=be_VB	lemma_7=HALDOL	lemma_12=such	relType_13=fixed	path=agent_obl<note_ROOT>capable_ccomp>depressant_obl>anesthetic_nmod	eib=True	pos_4=VB	path1=agent_obl	relation_11=beneficial	relType_3=aux	relType_7=nsubj	lemma_6=that	relType_1=punct	relType_5=ROOT	pos_5=VBN
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e0	DDI-DrugBank.d186.s3.e4	effect	relType_12=obl	lemma_1=,	relType_14=punct	lemma_4=be	lemma_13=as	lemma_12=depressant	pos_1=,	relType_12=case	lemma_10=of	relType_7=aux	relType_14=nmod	lemma_3=should	relType_8=cop	wib=be	pos_12=JJ	pos_9=JJ	path2=capable_ccomp>depressant_obl>anesthetic_nmod>opiate_conj	relation_11=adverse	lemma_9=capable	relType_12=compound	relType_9=ccomp	pos_6=IN	relType_11=amod	pos_14=,	pos_3=MD	pos_12=NN	lemma_2=it	pos_7=MD	lemma_7=may	relType_10=case	relType_2=nsubj:pass	lemma_11=potentiate	pos_13=IN	lemma_14=anesthetic	pos_8=VB	lib=be	lemma_5=note	lemma_8=be	relType_6=mark	pos_12=NNS	pos_7=NNP	relType_4=aux:pass	pos_11=VBG	lemma_12=cns	pos_10=IN	pos_2=PRP	lpib=be_VB	lemma_7=HALDOL	lemma_12=such	relType_13=fixed	lemma_14=,	eib=True	pos_4=VB	path1=agent_obl	pos_14=NNS	relType_3=aux	relType_7=nsubj	relation_11=beneficial	lemma_6=that	relType_1=punct	relType_5=ROOT	path=agent_obl<note_ROOT>capable_ccomp>depressant_obl>anesthetic_nmod>opiate_conj	pos_5=VBN
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e0	DDI-DrugBank.d186.s3.e5	effect	relType_16=cc	relType_12=obl	lemma_1=,	relType_14=punct	lemma_4=be	lemma_13=as	lemma_12=depressant	pos_1=,	relType_12=case	lemma_10=of	relType_7=aux	relType_14=nmod	pos_16=CC	lemma_3=should	relType_8=cop	wib=be	pos_12=JJ	pos_9=JJ	relation_11=adverse	lemma_9=capable	relType_12=compound	relType_9=ccomp	pos_15=,	pos_6=IN	relType_11=amod	pos_14=,	pos_3=MD	pos_12=NN	lemma_2=it	pos_7=MD	lemma_7=may	relType_10=case	relType_2=nsubj:pass	lemma_11=potentiate	pos_13=IN	relType_15=punct	lemma_14=anesthetic	pos_8=VB	lib=be	lemma_5=note	lemma_8=be	relType_6=mark	pos_12=NNS	lemma_15=,	pos_7=NNP	relType_4=aux:pass	pos_11=VBG	lemma_12=cns	pos_10=IN	lemma_16=and	pos_2=PRP	lpib=be_VB	lemma_7=HALDOL	lemma_12=such	relType_13=fixed	lemma_14=,	pos_15=NNS	eib=True	path2=capable_ccomp>depressant_obl>anesthetic_nmod>alcohol_conj	pos_4=VB	lemma_15=opiate	path1=agent_obl	path=agent_obl<note_ROOT>capable_ccomp>depressant_obl>anesthetic_nmod>alcohol_conj	pos_14=NNS	relType_3=aux	relType_7=nsubj	relType_15=conj	lemma_6=that	relType_1=punct	relType_5=ROOT	relation_11=beneficial	pos_5=VBN
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e1	DDI-DrugBank.d186.s3.e2	effect	lemma_5=potentiate	relation_4=beneficial	relType_1=aux	lemma_1=may	relation_4=adverse	wib=be	pos_6=NN	relType_2=cop	path1=HALDOL_nsubj	pos_2=VB	lib=be	relType_5=amod	path2=depressant_obl	pos_4=IN	path=HALDOL_nsubj<capable_ccomp>depressant_obl	relType_4=case	pos_1=MD	lpib=be_VB	relType_6=compound	lemma_6=cns	pos_3=JJ	relType_3=ccomp	eib=True	pos_5=VBG	lemma_2=be	lemma_3=capable	lemma_4=of
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e1	DDI-DrugBank.d186.s3.e3	effect	lemma_5=potentiate	pos_6=JJ	relation_4=beneficial	relType_1=aux	lemma_1=may	path=HALDOL_nsubj<capable_ccomp>depressant_obl>anesthetic_nmod	lemma_6=such	relation_4=adverse	path2=depressant_obl>anesthetic_nmod	relType_6=case	wib=be	pos_6=NN	relType_6=obl	relType_2=cop	path1=HALDOL_nsubj	lemma_7=as	pos_2=VB	lib=be	relType_5=amod	pos_4=IN	relType_4=case	lemma_6=depressant	pos_1=MD	lpib=be_VB	relType_7=fixed	relType_6=compound	lemma_6=cns	pos_3=JJ	relType_3=ccomp	eib=True	pos_5=VBG	pos_7=IN	pos_6=NNS	lemma_2=be	lemma_3=capable	lemma_4=of
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e1	DDI-DrugBank.d186.s3.e4	effect	lemma_5=potentiate	pos_6=JJ	relation_4=beneficial	relType_1=aux	lemma_1=may	lemma_6=such	relation_4=adverse	relType_8=punct	lemma_8=,	relType_6=case	pos_8=NNS	wib=be	pos_6=NN	relType_6=obl	relType_2=cop	path2=depressant_obl>anesthetic_nmod>opiate_conj	path1=HALDOL_nsubj	lemma_8=anesthetic	lemma_7=as	pos_2=VB	lib=be	relType_5=amod	pos_4=IN	relType_4=case	lemma_6=depressant	pos_1=MD	lpib=be_VB	relType_7=fixed	relType_6=compound	lemma_6=cns	pos_3=JJ	relType_3=ccomp	eib=True	pos_5=VBG	pos_7=IN	relType_8=nmod	pos_6=NNS	lemma_2=be	lemma_3=capable	lemma_4=of	path=HALDOL_nsubj<capable_ccomp>depressant_obl>anesthetic_nmod>opiate_conj	pos_8=,
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e1	DDI-DrugBank.d186.s3.e5	effect	lemma_5=potentiate	path=HALDOL_nsubj<capable_ccomp>depressant_obl>anesthetic_nmod>alcohol_conj	pos_6=JJ	relType_9=conj	relation_4=beneficial	relType_1=aux	lemma_1=may	lemma_6=such	relation_4=adverse	relType_10=cc	relType_8=punct	lemma_9=,	lemma_8=,	relType_6=case	pos_8=NNS	wib=be	pos_6=NN	relType_6=obl	relType_2=cop	pos_10=CC	path1=HALDOL_nsubj	lemma_8=anesthetic	pos_9=NNS	lemma_7=as	pos_2=VB	lemma_10=and	lib=be	relType_5=amod	pos_4=IN	relType_4=case	lemma_6=depressant	path2=depressant_obl>anesthetic_nmod>alcohol_conj	pos_1=MD	relType_9=punct	lpib=be_VB	lemma_9=opiate	relType_7=fixed	relType_6=compound	lemma_6=cns	pos_3=JJ	relType_3=ccomp	eib=True	pos_5=VBG	pos_7=IN	relType_8=nmod	pos_6=NNS	lemma_2=be	lemma_3=capable	pos_9=,	lemma_4=of	pos_8=,
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e2	DDI-DrugBank.d186.s3.e3	null	lpib=such_JJ	pos_2=IN	relType_1=case	relType_2=fixed	path=<depressant_obl>anesthetic_nmod	wib=such	eib=False	lemma_1=such	path1=	pos_1=JJ	path2=anesthetic_nmod	lib=such	lemma_2=as
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e2	DDI-DrugBank.d186.s3.e4	null	relType_1=case	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	pos_3=NNS	lpib=such_JJ	lemma_3=,	relType_3=nmod	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_1=such	lemma_3=anesthetic	path2=anesthetic_nmod>opiate_conj	lib=such	relType_3=punct	path=<depressant_obl>anesthetic_nmod>opiate_conj
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e2	DDI-DrugBank.d186.s3.e5	null	relType_1=case	pos_5=CC	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	relType_5=cc	path=<depressant_obl>anesthetic_nmod>alcohol_conj	pos_3=NNS	pos_4=,	path2=anesthetic_nmod>alcohol_conj	pos_4=NNS	lpib=such_JJ	relType_4=punct	lemma_3=,	relType_3=nmod	lemma_4=,	lemma_4=opiate	relType_2=fixed	pos_3=,	wib=such	eib=True	lemma_5=and	lemma_1=such	lemma_3=anesthetic	relType_4=conj	lib=such	relType_3=punct
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e3	DDI-DrugBank.d186.s3.e4	null	lemma_1=,	eib=False	lpib=opiate_NNS	path1=	pos_1=,	wib=opiates	relType_1=punct	lib=opiate	path2=opiate_conj	path=<anesthetic_nmod>opiate_conj
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e3	DDI-DrugBank.d186.s3.e5	null	lemma_1=,	pos_3=CC	path1=	pos_1=,	lib=opiate	relType_3=cc	relType_2=punct	path=<anesthetic_nmod>alcohol_conj	lemma_2=opiate	lpib=opiate_NNS	relType_2=conj	lemma_2=,	pos_2=NNS	eib=True	path2=alcohol_conj	pos_2=,	lemma_3=and	wib=opiates	relType_1=punct
DDI-DrugBank.d186.s3	DDI-DrugBank.d186.s3.e4	DDI-DrugBank.d186.s3.e5	null	path=opiate_conj<anesthetic_nmod>alcohol_conj	lemma_2=and	lemma_1=,	lib=alcohol	eib=False	path2=alcohol_conj	pos_2=CC	pos_1=,	wib=alcohol	relType_1=punct	relType_2=cc	lpib=alcohol_NN	path1=opiate_conj
DDI-DrugBank.d186.s4	DDI-DrugBank.d186.s4.e0	DDI-DrugBank.d186.s4.e1	mechanism	relType_1=cc	wib=rifampin	pos_1=CC	eib=False	path=<haloperidol_nsubj:pass>rifampin_conj	lpib=rifampin_NN	path1=	lib=rifampin	lemma_1=and	path2=rifampin_conj
DDI-DrugBank.d186.s4	DDI-DrugBank.d186.s4.e0	DDI-DrugBank.d186.s4.e2	null	relType_1=cc	wib=rifampin	pos_1=CC	pos_2=NN	path1=	relType_2=punct	lemma_3=plasma	lpib=rifampin_NN	relType_2=conj	lemma_2=,	path=<haloperidol_nsubj:pass>decrease_conj>level_nsubj:pass>haloperidol_compound	lib=rifampin	eib=True	pos_3=NN	lemma_2=rifampin	path2=decrease_conj>level_nsubj:pass>haloperidol_compound	pos_2=,	relType_3=compound	lemma_1=and
DDI-DrugBank.d186.s4	DDI-DrugBank.d186.s4.e1	DDI-DrugBank.d186.s4.e2	null	wib=plasma	lpib=plasma_NN	lemma_1=,	pos_2=NN	path=rifampin_conj<haloperidol_nsubj:pass>decrease_conj>level_nsubj:pass>haloperidol_compound	eib=False	relType_2=compound	pos_1=,	lib=plasma	path2=decrease_conj>level_nsubj:pass>haloperidol_compound	relType_1=punct	lemma_2=plasma	path1=rifampin_conj
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e0	DDI-DrugBank.d186.s5.e1	null	path=<haloperidol_obl>rifampin_conj	relType_1=cc	wib=rifampin	pos_1=CC	eib=False	lpib=rifampin_NN	path1=	lib=rifampin	lemma_1=and	path2=rifampin_conj
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e0	DDI-DrugBank.d186.s5.e2	null	relType_1=cc	path1=haloperidol_obl<treat_acl<patient_obl	wib=rifampin	pos_1=CC	pos_2=NN	path2=discontinuation_nsubj>rifampin_nmod	relType_2=punct	path=haloperidol_obl<treat_acl<patient_obl<produce_ROOT>discontinuation_nsubj>rifampin_nmod	lpib=rifampin_NN	relType_2=conj	lemma_2=,	pos_4=IN	relType_4=case	lib=rifampin	relType_3=nsubj	eib=True	lemma_3=discontinuation	pos_3=NN	lemma_2=rifampin	pos_2=,	lemma_4=of	lemma_1=and
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e0	DDI-DrugBank.d186.s5.e3	null	relType_1=cc	path1=haloperidol_obl<treat_acl<patient_obl	wib=rifampin	pos_1=CC	pos_2=NN	relType_8=dep	pos_6=DT	lemma_11=-	relType_2=punct	pos_11=HYPH	relation_6=neutral	relType_12=compound	lemma_9=.	lemma_6=a	lpib=rifampin_NN	relType_11=punct	pos_12=NN	lemma_14=in	pos_13=NN	relType_2=conj	lemma_2=,	pos_14=IN	relType_7=amod	pos_10=CD	pos_4=IN	lemma_5=rifampin	lemma_8=3	relType_4=case	relType_5=nmod	pos_9=.	lib=rifampin	relType_9=punct	lemma_10=3	relType_3=nsubj	relType_10=nummod	pos_5=VBD	lemma_13=increase	relType_6=det	pos_5=NN	lemma_5=produce	lemma_12=fold	eib=True	lemma_3=discontinuation	pos_3=NN	relation_14=beneficial	pos_7=JJ	lemma_2=rifampin	pos_2=,	lemma_7=mean	path=haloperidol_obl<treat_acl<patient_obl<produce_ROOT>increase_obj>concentration_nmod>haloperidol_compound	relType_13=obj	pos_8=CD	relType_14=case	relType_5=ROOT	lemma_4=of	path2=increase_obj>concentration_nmod>haloperidol_compound	lemma_1=and
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e1	DDI-DrugBank.d186.s5.e2	null	lemma_1=,	pos_2=NN	pos_3=IN	relType_2=nsubj	eib=False	path1=rifampin_conj<haloperidol_obl<treat_acl<patient_obl	lemma_2=discontinuation	lib=discontinuation	relType_3=case	pos_1=,	wib=discontinuation	lpib=discontinuation_NN	lemma_3=of	relType_1=punct	path2=discontinuation_nsubj>rifampin_nmod	path=rifampin_conj<haloperidol_obl<treat_acl<patient_obl<produce_ROOT>discontinuation_nsubj>rifampin_nmod
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e1	DDI-DrugBank.d186.s5.e3	null	path=rifampin_conj<haloperidol_obl<treat_acl<patient_obl<produce_ROOT>increase_obj>concentration_nmod>haloperidol_compound	lemma_1=,	lemma_9=3	pos_2=NN	pos_3=IN	pos_6=JJ	relType_10=punct	lemma_2=discontinuation	lemma_4=produce	pos_1=,	wib=discontinuation	pos_7=CD	lpib=discontinuation_NN	relType_4=nmod	relType_8=punct	relType_9=nummod	lemma_5=a	relType_2=nsubj	pos_8=.	path1=rifampin_conj<haloperidol_obl<treat_acl<patient_obl	relType_6=amod	lemma_4=rifampin	pos_12=NN	relType_12=obj	pos_13=IN	pos_4=NN	lemma_10=-	relType_13=case	lemma_12=increase	lemma_6=mean	lemma_7=3	lemma_8=.	pos_10=HYPH	relType_5=det	lemma_13=in	relType_3=case	relType_4=ROOT	pos_4=VBD	pos_11=NN	relType_7=dep	pos_9=CD	eib=True	relType_11=compound	lib=discontinuation	pos_5=DT	relation_4=neutral	lemma_3=of	relType_1=punct	lemma_11=fold	path2=increase_obj>concentration_nmod>haloperidol_compound	relation_12=beneficial
DDI-DrugBank.d186.s5	DDI-DrugBank.d186.s5.e2	DDI-DrugBank.d186.s5.e3	mechanism	pos_2=DT	relType_4=dep	lib=produce	lemma_9=increase	pos_6=CD	lemma_2=a	lemma_1=produce	lemma_3=mean	lpib=produce_VBD	lemma_4=3	lemma_7=-	pos_8=NN	pos_1=VBD	relation_8=beneficial	eib=False	relType_10=case	lemma_5=.	pos_9=NN	wib=produced	pos_4=CD	relation_0=neutral	relType_3=amod	pos_7=HYPH	path1=rifampin_nmod<discontinuation_nsubj	lemma_10=in	relType_5=punct	lemma_8=fold	relType_8=compound	relType_9=obj	relType_6=nummod	pos_10=IN	path=rifampin_nmod<discontinuation_nsubj<produce_ROOT>increase_obj>concentration_nmod>haloperidol_compound	pos_5=.	relType_1=ROOT	pos_3=JJ	lemma_6=3	relType_7=punct	relType_2=det	path2=increase_obj>concentration_nmod>haloperidol_compound
DDI-DrugBank.d186.s6	DDI-DrugBank.d186.s6.e0	DDI-DrugBank.d186.s6.e1	advise	pos_2=VBN	lemma_5=in	pos_3=CC	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	relType_5=case	lemma_4=discontinue	relType_3=cc	path=rifampin_nsubj:pass<administer_advcl>patient_obl>treat_amod>haloperidol_obl	eib=False	lemma_1=be	lemma_3=or	pos_4=VBN	lib=be	path2=patient_obl>treat_amod>haloperidol_obl	pos_5=IN	path1=rifampin_nsubj:pass	wib=is	pos_1=VBZ	relType_4=conj	lpib=be_VBZ
DDI-DrugBank.d514.s0	DDI-DrugBank.d514.s0.e0	DDI-DrugBank.d514.s0.e1	null	lpib=be_VBP	pos_2=JJ	path1=opioid_nsubj	lemma_1=be	lemma_2=strong	path2=	wib=are	lib=be	relType_3=amod	relType_2=amod	path=opioid_nsubj<depressant_ROOT>	pos_1=VBP	relType_1=cop	pos_3=JJ	eib=True	pos_3=NN	lemma_3=nervous	relType_3=compound	lemma_3=system	lemma_3=central
DDI-DrugBank.d514.s1	DDI-DrugBank.d514.s1.e0	DDI-DrugBank.d514.s1.e1	effect	path=depressant_nmod<combination_obl<kill_ROOT>heroin_nsubj	lemma_1=,	path1=depressant_nmod<combination_obl	eib=False	pos_1=,	lib=heroin	relType_1=punct	wib=heroin	lpib=heroin_NN	path2=heroin_nsubj
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e1	effect	pos_2=VBN	relType_7=case	relType_8=amod	pos_1=HYPH	pos_6=NN	pos_8=JJ	lib=relate	pos_9=JJ	pos_3=NNS	pos_4=VBP	relType_9=compound	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	lemma_4=reveal	lemma_9=central	relType_9=amod	pos_9=NN	lemma_5=frequent	lemma_6=involvement	lemma_9=system	pos_5=JJ	relType_5=amod	wib=related	relType_2=amod	lemma_1=-	relType_3=nmod	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_8=other	path2=involvement_obj>depressant_nmod	eib=True	pos_7=IN	lemma_2=relate	lemma_9=nervous	lpib=relate_VBN	relType_1=punct	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod	lemma_3=death
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e2	effect	pos_2=VBN	relType_7=case	relType_8=amod	pos_1=HYPH	lemma_9=,	relType_9=nmod	pos_6=NN	pos_8=JJ	lib=relate	pos_9=JJ	lemma_10=include	pos_3=NNS	pos_4=VBP	relType_9=compound	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod>alcohol_nmod	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	pos_9=NNS	lemma_4=reveal	lemma_9=central	path2=involvement_obj>depressant_nmod>alcohol_nmod	relType_9=amod	relType_10=case	pos_9=NN	lemma_5=frequent	lemma_6=involvement	lemma_9=system	pos_5=JJ	relType_5=amod	wib=related	relType_2=amod	lemma_1=-	relType_3=nmod	lemma_9=depressant	relType_9=punct	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_8=other	eib=True	pos_7=IN	lemma_2=relate	lemma_9=nervous	pos_10=VBG	lpib=relate_VBN	pos_9=,	relType_1=punct	lemma_3=death
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e3	effect	pos_2=VBN	relType_7=case	lemma_11=,	relType_8=amod	pos_1=HYPH	lemma_9=,	relType_9=nmod	path2=involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos	pos_6=NN	pos_8=JJ	lib=relate	pos_9=JJ	lemma_10=include	pos_3=NNS	pos_4=VBP	relType_9=compound	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	relType_11=punct	pos_9=NNS	lemma_4=reveal	lemma_9=central	relType_9=amod	relType_10=case	pos_9=NN	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos	lemma_5=frequent	lemma_6=involvement	lemma_9=system	pos_5=JJ	relType_5=amod	lemma_11=alcohol	wib=related	relType_2=amod	lemma_1=-	relType_3=nmod	lemma_9=depressant	pos_11=,	relType_9=punct	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_8=other	pos_11=NN	eib=True	pos_7=IN	lemma_2=relate	lemma_9=nervous	pos_10=VBG	lpib=relate_VBN	pos_9=,	relType_1=punct	relType_11=nmod	lemma_3=death
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e4	effect	pos_2=VBN	relType_7=case	lemma_11=,	relType_8=amod	lemma_13=as	relType_12=case	pos_1=HYPH	lemma_9=,	relType_9=nmod	pos_6=NN	pos_8=JJ	lib=relate	pos_9=JJ	pos_12=JJ	lemma_10=include	pos_3=NNS	pos_4=VBP	relType_9=compound	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod	pos_9=NNS	relType_11=punct	lemma_4=reveal	lemma_9=central	relType_9=amod	relType_10=case	pos_13=IN	pos_9=NN	lemma_5=frequent	lemma_6=involvement	lemma_9=system	pos_5=JJ	relType_5=amod	lemma_11=alcohol	wib=related	pos_12=NNS	relType_2=amod	lemma_1=-	relType_3=nmod	lemma_9=depressant	pos_11=,	relType_9=punct	relType_4=ROOT	lemma_12=such	lemma_7=of	relType_6=obj	relType_13=fixed	lemma_8=other	lemma_12=benzodiazepine	pos_11=NN	eib=True	pos_7=IN	lemma_2=relate	relType_12=appos	path2=involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod	lemma_9=nervous	pos_10=VBG	lpib=relate_VBN	pos_9=,	relType_1=punct	relType_11=nmod	lemma_3=death
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e5	effect	pos_2=VBN	relType_14=punct	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>Valium_dep	relType_7=case	lemma_11=,	relType_8=amod	lemma_13=as	relType_12=case	pos_1=HYPH	lemma_9=,	relType_9=nmod	relType_14=nmod	lemma_14=(	pos_6=NN	pos_8=JJ	lib=relate	pos_9=JJ	pos_12=JJ	lemma_10=include	pos_3=NNS	pos_4=VBP	relType_9=compound	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	relType_11=punct	pos_9=NNS	lemma_4=reveal	lemma_9=central	relType_9=amod	relType_10=case	pos_13=IN	pos_14=NN	pos_9=NN	lemma_5=frequent	lemma_6=involvement	lemma_9=system	pos_5=JJ	relType_5=amod	lemma_11=alcohol	wib=related	pos_12=NNS	lemma_14=diazepam	pos_14=-LRB-	relType_2=amod	lemma_1=-	relType_3=nmod	lemma_9=depressant	pos_11=,	relType_9=punct	relType_4=ROOT	lemma_12=such	lemma_7=of	relType_6=obj	relType_13=fixed	lemma_8=other	lemma_12=benzodiazepine	pos_11=NN	eib=True	pos_7=IN	lemma_2=relate	relType_12=appos	path2=involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>Valium_dep	lemma_9=nervous	pos_10=VBG	lpib=relate_VBN	pos_9=,	relType_1=punct	relType_11=nmod	lemma_3=death
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e0	DDI-DrugBank.d514.s2.e6	effect	lemma_13=as	lemma_9=,	pos_6=NN	pos_8=JJ	lemma_10=include	pos_3=NNS	path1=heroin_obl<relate_amod<death_nmod<study_nsubj	lemma_9=central	lemma_16=,	lemma_23=,	lemma_11=alcohol	pos_14=-LRB-	lemma_9=depressant	relType_16=punct	lemma_20=a	relType_12=appos	pos_7=IN	lemma_9=nervous	relType_14=nmod	relType_22=obl	lemma_2=relate	lemma_3=death	pos_15=-RRB-	pos_15=NNP	relType_17=cc	relType_7=case	pos_22=NN	lemma_4=reveal	pos_9=NN	lemma_5=frequent	relType_4=ROOT	lemma_12=such	relType_13=fixed	lemma_12=benzodiazepine	pos_11=NN	relType_19=case	pos_17=CC	relType_11=nmod	pos_9=,	relType_1=punct	lemma_19=to	pos_2=VBN	relType_14=punct	lemma_11=,	relType_12=case	pos_1=HYPH	pos_4=VBP	relType_11=punct	relType_15=dep	relType_9=amod	pos_13=IN	pos_14=NN	relType_15=punct	lemma_9=system	lemma_6=involvement	relType_5=amod	lemma_14=diazepam	wib=related	relType_2=amod	lemma_1=-	relType_3=nmod	lemma_21=rise	pos_10=VBG	relType_20=det	lemma_8=other	relType_23=punct	pos_19=IN	relType_8=amod	pos_20=DT	relType_9=nmod	lemma_14=(	pos_12=JJ	lib=relate	path=heroin_obl<relate_amod<death_nmod<study_nsubj<reveal_ROOT>involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>methadone_conj	pos_9=JJ	relType_9=compound	path2=involvement_obj>depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>methadone_conj	pos_9=NNS	pos_16=,	relType_21=amod	relType_10=case	pos_5=JJ	pos_18=,	pos_12=NNS	lemma_18=,	relType_18=punct	lemma_15=)	lemma_17=and	pos_11=,	relType_9=punct	pos_21=VBG	lemma_22=degree	lemma_7=of	relType_6=obj	eib=True	pos_23=,	lpib=relate_VBN	lemma_15=Valium
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e1	DDI-DrugBank.d514.s2.e2	null	lemma_1=,	relType_2=case	eib=False	path1=	pos_1=,	path=<depressant_nmod>alcohol_nmod	lib=include	path2=alcohol_nmod	lpib=include_VBG	wib=including	relType_1=punct	lemma_2=include	pos_2=VBG
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e1	DDI-DrugBank.d514.s2.e3	null	lemma_1=,	path1=	path=<depressant_nmod>alcohol_nmod>benzodiazepine_appos	pos_1=,	path2=alcohol_nmod>benzodiazepine_appos	lib=include	wib=including	lemma_3=alcohol	lpib=include_VBG	lemma_3=,	relType_3=nmod	lemma_2=include	relType_2=case	pos_3=,	eib=True	pos_3=NN	relType_1=punct	relType_3=punct	pos_2=VBG
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e1	DDI-DrugBank.d514.s2.e4	null	lemma_1=,	pos_4=JJ	relType_4=appos	path1=	pos_1=,	lib=include	wib=including	lemma_3=alcohol	path=<depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod	lpib=include_VBG	pos_4=NNS	relType_5=fixed	lemma_3=,	relType_3=nmod	relType_4=case	pos_5=IN	lemma_4=such	lemma_2=include	lemma_4=benzodiazepine	relType_2=case	pos_3=,	eib=True	pos_3=NN	path2=alcohol_nmod>benzodiazepine_appos>diazepam_nmod	relType_1=punct	relType_3=punct	lemma_5=as	pos_2=VBG
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e1	DDI-DrugBank.d514.s2.e5	null	lemma_1=,	pos_4=JJ	relType_4=appos	path1=	pos_1=,	lib=include	lemma_6=(	wib=including	pos_6=NN	lemma_3=alcohol	pos_6=-LRB-	relType_6=punct	lpib=include_VBG	pos_4=NNS	relType_5=fixed	lemma_6=diazepam	lemma_3=,	relType_3=nmod	path2=alcohol_nmod>benzodiazepine_appos>diazepam_nmod>Valium_dep	relType_4=case	pos_5=IN	lemma_4=such	lemma_2=include	lemma_4=benzodiazepine	path=<depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>Valium_dep	relType_2=case	pos_3=,	eib=True	pos_3=NN	relType_1=punct	relType_6=nmod	relType_3=punct	lemma_5=as	pos_2=VBG
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e1	DDI-DrugBank.d514.s2.e6	null	pos_13=VBG	lemma_1=,	pos_4=JJ	relType_10=punct	relType_4=appos	lemma_7=Valium	lemma_10=,	path1=	pos_1=,	relType_8=punct	lib=include	lemma_6=(	wib=including	lemma_8=,	relType_12=det	relType_11=case	pos_6=NN	lemma_3=alcohol	pos_6=-LRB-	relType_6=punct	relType_13=amod	pos_15=,	lemma_14=degree	pos_14=NN	lpib=include_VBG	relType_14=obl	relType_15=punct	pos_4=NNS	lemma_12=a	pos_11=IN	lemma_9=and	pos_9=CC	relType_5=fixed	lemma_6=diazepam	lemma_3=,	lemma_15=,	path=<depressant_nmod>alcohol_nmod>benzodiazepine_appos>diazepam_nmod>methadone_conj	pos_7=NNP	relType_3=nmod	relType_4=case	pos_5=IN	lemma_4=such	lemma_11=to	path2=alcohol_nmod>benzodiazepine_appos>diazepam_nmod>methadone_conj	pos_7=-RRB-	lemma_2=include	lemma_4=benzodiazepine	relType_2=case	pos_3=,	eib=True	relType_7=dep	pos_10=,	pos_3=NN	relType_7=punct	lemma_13=rise	relType_9=cc	pos_12=DT	relType_1=punct	relType_6=nmod	relType_3=punct	lemma_5=as	lemma_7=)	pos_8=,	pos_2=VBG
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e2	DDI-DrugBank.d514.s2.e3	null	path=<alcohol_nmod>benzodiazepine_appos	lemma_1=,	path2=benzodiazepine_appos	eib=False	path1=	wib=benzodiazepines	pos_1=,	relType_1=punct	lpib=benzodiazepine_NNS	lib=benzodiazepine
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e2	DDI-DrugBank.d514.s2.e4	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	pos_2=JJ	lib=benzodiazepine	lemma_3=as	path2=benzodiazepine_appos>diazepam_nmod	relType_3=fixed	path=<alcohol_nmod>benzodiazepine_appos>diazepam_nmod	lpib=benzodiazepine_NNS	lemma_2=such	wib=benzodiazepines	relType_2=appos	pos_2=NNS	relType_2=case	eib=True	relType_1=punct	lemma_2=benzodiazepine
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e2	DDI-DrugBank.d514.s2.e5	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	path=<alcohol_nmod>benzodiazepine_appos>diazepam_nmod>Valium_dep	relType_4=nmod	pos_2=JJ	lib=benzodiazepine	lemma_3=as	relType_3=fixed	pos_4=-LRB-	lemma_4=diazepam	path2=benzodiazepine_appos>diazepam_nmod>Valium_dep	lpib=benzodiazepine_NNS	pos_4=NN	lemma_2=such	lemma_4=(	relType_4=punct	wib=benzodiazepines	relType_2=appos	pos_2=NNS	relType_2=case	eib=True	relType_1=punct	lemma_2=benzodiazepine
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e2	DDI-DrugBank.d514.s2.e6	null	relType_12=obl	lemma_1=,	pos_13=,	pos_3=IN	lemma_13=,	relType_10=det	path1=	pos_1=,	lemma_6=,	relType_7=cc	pos_9=IN	relType_4=nmod	relType_8=punct	lemma_10=a	relType_13=punct	pos_2=JJ	lemma_8=,	lib=benzodiazepine	lemma_3=as	relType_3=fixed	lemma_5=Valium	pos_4=-LRB-	relType_6=punct	relType_11=amod	lemma_4=diazepam	lemma_9=to	relType_9=case	relType_5=dep	lpib=benzodiazepine_NNS	pos_4=NN	lemma_2=such	path2=benzodiazepine_appos>diazepam_nmod>methadone_conj	lemma_4=(	lemma_5=)	lemma_11=rise	relType_4=punct	pos_5=-RRB-	pos_7=CC	relType_5=punct	wib=benzodiazepines	pos_11=VBG	pos_5=NNP	relType_2=appos	pos_6=,	pos_2=NNS	relType_2=case	eib=True	path=<alcohol_nmod>benzodiazepine_appos>diazepam_nmod>methadone_conj	lemma_7=and	lemma_12=degree	relType_1=punct	pos_12=NN	lemma_2=benzodiazepine	pos_8=,	pos_10=DT
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e3	DDI-DrugBank.d514.s2.e4	null	lpib=such_JJ	pos_2=IN	relType_1=case	relType_2=fixed	wib=such	eib=False	lemma_1=such	path1=	pos_1=JJ	lib=such	path2=diazepam_nmod	lemma_2=as	path=<benzodiazepine_appos>diazepam_nmod
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e3	DDI-DrugBank.d514.s2.e5	null	relType_1=case	path1=	pos_1=JJ	lemma_2=as	pos_2=IN	path2=diazepam_nmod>Valium_dep	lemma_3=(	pos_3=-LRB-	path=<benzodiazepine_appos>diazepam_nmod>Valium_dep	lpib=such_JJ	relType_3=nmod	relType_2=fixed	wib=such	eib=True	lemma_1=such	pos_3=NN	lemma_3=diazepam	lib=such	relType_3=punct
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e3	DDI-DrugBank.d514.s2.e6	null	relType_8=case	relType_4=dep	relType_1=case	pos_5=,	lemma_9=a	relType_10=amod	path1=	pos_1=JJ	path=<benzodiazepine_appos>diazepam_nmod>methadone_conj	lemma_2=as	pos_2=IN	lemma_12=,	pos_4=-RRB-	pos_12=,	lemma_3=(	pos_7=,	pos_9=DT	relType_12=punct	pos_3=-LRB-	lemma_7=,	pos_8=IN	lpib=such_JJ	lemma_8=to	relType_4=punct	pos_6=CC	lemma_5=,	relType_5=punct	path2=diazepam_nmod>methadone_conj	lemma_6=and	relType_3=nmod	lemma_4=)	relType_11=obl	lemma_10=rise	lemma_4=Valium	relType_2=fixed	pos_11=NN	wib=such	eib=True	lemma_1=such	pos_3=NN	relType_7=punct	pos_4=NNP	pos_10=VBG	lemma_3=diazepam	lib=such	lemma_11=degree	relType_3=punct	relType_9=det	relType_6=cc
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e4	DDI-DrugBank.d514.s2.e5	null	lemma_1=(	wib=Valium	path2=Valium_dep	eib=False	path1=	path=<diazepam_nmod>Valium_dep	relType_1=punct	lpib=valium_NNP	pos_1=-LRB-	lib=valium
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e4	DDI-DrugBank.d514.s2.e6	null	lemma_2=)	lemma_2=Valium	relType_10=punct	relType_7=det	relType_8=amod	pos_5=,	lemma_10=,	path1=	path2=methadone_conj	lemma_9=degree	relType_9=obl	relType_4=cc	lpib=valium_NNP	lemma_6=to	relType_6=case	relType_2=punct	lemma_1=(	wib=Valium	lemma_8=rise	pos_2=NNP	pos_6=IN	pos_9=NN	pos_7=DT	relType_2=dep	lemma_3=,	lemma_5=,	relType_5=punct	pos_8=VBG	path=<diazepam_nmod>methadone_conj	pos_1=-LRB-	lib=valium	pos_3=,	pos_10=,	eib=True	pos_2=-RRB-	pos_4=CC	lemma_4=and	lemma_7=a	relType_1=punct	relType_3=punct
DDI-DrugBank.d514.s2	DDI-DrugBank.d514.s2.e5	DDI-DrugBank.d514.s2.e6	null	pos_3=CC	pos_6=DT	path2=methadone_conj	pos_7=VBG	lemma_8=degree	lemma_1=)	lemma_9=,	relType_5=case	relType_8=obl	relType_3=cc	relType_2=punct	pos_8=NN	pos_4=,	eib=False	lemma_6=a	lemma_2=,	relType_7=amod	relType_4=punct	lib=rise	pos_1=-RRB-	pos_5=IN	lemma_5=to	lemma_4=,	wib=rising	relType_9=punct	lpib=rise_VBG	lemma_7=rise	relType_6=det	path1=Valium_dep	pos_2=,	lemma_3=and	path=Valium_dep<diazepam_nmod>methadone_conj	pos_9=,	relType_1=punct
DDI-DrugBank.d514.s3	DDI-DrugBank.d514.s3.e0	DDI-DrugBank.d514.s3.e1	null	path1=benzodiazepine_nsubj:pass	relType_7=case	lpib=be_VBP	relType_1=aux:pass	pos_3=VBN	lemma_4=in	pos_6=NN	pos_2=RB	relType_6=obl	lemma_3=use	eib=False	relType_2=advmod	lemma_1=be	wib=are	lemma_6=treatment	lemma_2=often	lib=be	relType_3=ROOT	path=benzodiazepine_nsubj:pass<use_ROOT>treatment_obl>addiction_nmod>heroin_compound	pos_4=IN	relType_5=det	relType_4=case	pos_1=VBP	lemma_7=of	lemma_5=the	pos_7=IN	pos_5=DT	path2=treatment_obl>addiction_nmod>heroin_compound
DDI-DrugBank.d514.s4	DDI-DrugBank.d514.s4.e0	DDI-DrugBank.d514.s4.e1	effect	relType_8=case	pos_3=TO	relType_5=xcomp	lemma_4=be	lemma_10=with	path2=fatal_xcomp>use_advcl>combination_obl>heroin_nmod	path1=Cocaine_nsubj	lemma_7=use	relType_9=obl	path=Cocaine_nsubj<prove_ROOT>fatal_xcomp>use_advcl>combination_obl>heroin_nmod	pos_6=WRB	relType_7=advcl	relType_4=cop	lemma_8=in	wib=sometimes	lemma_1=sometimes	eib=False	lemma_6=when	relType_10=case	pos_9=NN	relType_1=advmod	pos_8=IN	lib=sometimes	pos_5=JJ	lemma_9=combination	relType_2=ROOT	lemma_3=to	lemma_5=fatal	relType_3=mark	pos_10=IN	lpib=sometimes_RB	pos_7=VBN	pos_2=VBZ	pos_1=RB	pos_4=VB	lemma_2=prove	relType_6=advmod
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e0	DDI-DrugBank.d17.s6.e1	null	lemma_1=,	lib=other	path1=	pos_1=,	pos_2=JJ	pos_4=RB	eib=False	lemma_2=other	wib=other	lemma_3=,	lpib=other_JJ	relType_4=advmod	lemma_4=especially	relType_2=appos	pos_3=,	path2=other_appos>use_conj>agent_nsubj>diazoxide_amod	path=<medication_nsubj>other_appos>use_conj>agent_nsubj>diazoxide_amod	relType_1=punct	relType_3=punct
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e0	DDI-DrugBank.d17.s6.e2	null	lemma_1=,	lib=other	pos_5=,	path2=other_appos>use_conj>agent_nsubj>diazoxide_amod>preanesthetic_conj	path1=	pos_1=,	pos_2=JJ	pos_4=RB	lemma_2=other	path=<medication_nsubj>other_appos>use_conj>agent_nsubj>diazoxide_amod>preanesthetic_conj	wib=other	lemma_6=or	relType_5=amod	lemma_3=,	pos_6=CC	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_4=advmod	pos_5=RB	lemma_4=especially	relType_2=appos	pos_3=,	lemma_5=diazoxide	eib=True	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e0	DDI-DrugBank.d17.s6.e3	null	lemma_1=,	relType_9=conj	lib=other	pos_14=CC	pos_15=JJ	pos_5=,	relType_15=amod	path1=	pos_1=,	relType_12=case	pos_2=JJ	lemma_14=or	lemma_15=muscle	relType_11=conj	pos_9=JJ	pos_10=NNS	pos_4=RB	relType_13=obl	lemma_2=other	lemma_7=preanesthetic	lemma_6=or	wib=other	pos_8=CC	lemma_9=anesthetic	lemma_11=use	pos_13=NN	relType_15=punct	pos_12=IN	lemma_13=surgery	lemma_15=-	lemma_10=agent	path2=other_appos>use_conj>surgery_obl>relaxant_conj	relType_5=amod	lemma_3=,	pos_6=CC	pos_15=NN	lpib=other_JJ	lemma_5=,	relType_5=punct	relType_4=advmod	pos_5=RB	lemma_4=especially	pos_11=VBN	relType_14=cc	relType_2=appos	relType_10=nsubj	lemma_15=skeletal	lemma_8=and	relType_15=compound	lemma_12=in	pos_3=,	path=<medication_nsubj>other_appos>use_conj>surgery_obl>relaxant_conj	eib=True	lemma_5=diazoxide	pos_7=JJ	relType_1=punct	relType_8=cc	relType_3=punct	pos_15=HYPH	relType_7=conj	relType_6=cc
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e1	DDI-DrugBank.d17.s6.e2	null	lemma_2=or	path=<diazoxide_amod>preanesthetic_conj	path2=preanesthetic_conj	lemma_1=,	eib=False	lib=preanesthetic	pos_2=CC	path1=	pos_1=,	relType_1=punct	relType_2=cc	lpib=preanesthetic_JJ	wib=preanesthetic
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e1	DDI-DrugBank.d17.s6.e3	null	relType_8=case	lemma_2=or	lemma_1=,	path1=diazoxide_amod<agent_nsubj	lemma_6=agent	lemma_3=preanesthetic	relType_10=cc	pos_1=,	relType_9=obl	relType_4=cc	lemma_11=-	relType_2=cc	lpib=preanesthetic_JJ	lemma_11=skeletal	pos_11=HYPH	lemma_8=in	lib=preanesthetic	pos_10=CC	relType_11=amod	relType_11=punct	lemma_9=surgery	pos_9=NN	pos_8=IN	lemma_5=anesthetic	wib=preanesthetic	pos_5=JJ	relType_3=conj	lemma_11=muscle	relType_5=conj	lemma_10=or	path2=surgery_obl>relaxant_conj	pos_7=VBN	pos_11=NN	pos_3=JJ	eib=True	pos_4=CC	relType_11=compound	pos_2=CC	lemma_4=and	pos_6=NNS	pos_11=JJ	relType_1=punct	lemma_7=use	relType_6=nsubj	relType_7=conj	path=diazoxide_amod<agent_nsubj<use_conj>surgery_obl>relaxant_conj
DDI-DrugBank.d17.s6	DDI-DrugBank.d17.s6.e2	DDI-DrugBank.d17.s6.e3	null	relType_1=cc	pos_1=CC	lemma_5=in	relType_8=amod	path=preanesthetic_conj<diazoxide_amod<agent_nsubj<use_conj>surgery_obl>relaxant_conj	relType_7=cc	lemma_3=agent	relType_8=punct	lemma_4=use	pos_2=JJ	relType_5=case	pos_6=NN	pos_8=JJ	relType_6=obl	pos_8=NN	pos_3=NNS	lemma_8=muscle	pos_8=HYPH	lemma_6=surgery	relType_2=conj	pos_4=VBN	pos_7=CC	lpib=anesthetic_JJ	relType_8=compound	pos_5=IN	path2=surgery_obl>relaxant_conj	wib=anesthetic	relType_3=nsubj	path1=preanesthetic_conj<diazoxide_amod<agent_nsubj	lemma_7=or	eib=True	lemma_2=anesthetic	lemma_8=-	relType_4=conj	lib=anesthetic	lemma_1=and	lemma_8=skeletal
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e0	DDI-DrugBank.d17.s9.e1	null	relType_1=cc	wib=Corticosteroids	path2=Corticosteroids_conj	pos_1=CC	eib=False	path=<b_ROOT>Corticosteroids_conj	path1=	lib=corticosteroids	lpib=corticosteroids_NNPS	lemma_1=or
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e0	DDI-DrugBank.d17.s9.e2	null	relType_1=cc	wib=Corticosteroids	pos_1=CC	lemma_2=Corticosteroids	lemma_2=or	eib=True	path=<b_ROOT>Corticotropin_conj	pos_2=CC	pos_2=NNPS	path1=	path2=Corticotropin_conj	lib=corticosteroids	lpib=corticosteroids_NNPS	relType_2=cc	relType_2=conj	lemma_1=or
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e0	DDI-DrugBank.d17.s9.e3	null	relType_1=cc	pos_1=CC	lemma_2=or	path2=Corticotropin_conj>ACTH_appos	path1=	pos_3=NNP	relType_2=cc	wib=Corticosteroids	path=<b_ROOT>Corticotropin_conj>ACTH_appos	pos_2=NNPS	lemma_3=(	pos_3=-LRB-	relType_2=conj	relType_3=conj	lemma_2=Corticosteroids	eib=True	pos_2=CC	lib=corticosteroids	lpib=corticosteroids_NNPS	lemma_3=Corticotropin	relType_3=punct	lemma_1=or
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e1	DDI-DrugBank.d17.s9.e2	null	relType_1=cc	pos_1=CC	eib=False	path1=Corticosteroids_conj	wib=Corticotropin	lpib=corticotropin_NNP	lib=corticotropin	path2=Corticotropin_conj	path=Corticosteroids_conj<b_ROOT>Corticotropin_conj	lemma_1=or
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e1	DDI-DrugBank.d17.s9.e3	null	relType_1=cc	pos_1=CC	eib=True	pos_2=NNP	path1=Corticosteroids_conj	path2=Corticotropin_conj>ACTH_appos	lemma_2=Corticotropin	wib=Corticotropin	lpib=corticotropin_NNP	lib=corticotropin	pos_2=-LRB-	lemma_2=(	relType_2=conj	path=Corticosteroids_conj<b_ROOT>Corticotropin_conj>ACTH_appos	relType_2=punct	lemma_1=or
DDI-DrugBank.d17.s9	DDI-DrugBank.d17.s9.e2	DDI-DrugBank.d17.s9.e3	null	lemma_1=(	wib=ACTH	path=<Corticotropin_conj>ACTH_appos	eib=False	path1=	lib=acth	lpib=acth_NNP	relType_1=punct	path2=ACTH_appos	pos_1=-LRB-
DDI-DrugBank.d17.s12	DDI-DrugBank.d17.s12.e0	DDI-DrugBank.d17.s12.e1	effect	relType_1=aux	lemma_1=may	lemma_5=of	relType_5=case	relation_1=beneficial	eib=False	lemma_4=possibility	wib=enhance	pos_2=VB	lib=enhance	lpib=enhance_VB	path2=possibility_obj>toxicity_nmod>digitalis_compound	relType_3=det	pos_4=NN	relType_4=obj	relType_2=ROOT	pos_5=IN	pos_1=MD	lemma_2=enhance	pos_3=DT	lemma_3=the	path1=diuretic_nmod<use_nsubj	path=diuretic_nmod<use_nsubj<enhance_ROOT>possibility_obj>toxicity_nmod>digitalis_compound
DDI-DrugBank.d17.s21	DDI-DrugBank.d17.s21.e0	DDI-DrugBank.d17.s21.e1	null	relType_6=nsubj	lemma_5=as	relType_1=aux:pass	pos_3=VBN	relType_8=advcl	relType_7=aux	pos_2=RB	relType_5=mark	path1=diuretic_nmod<use_nsubj:pass	pos_4=,	eib=False	relType_2=advmod	lemma_1=be	lemma_3=recommend	pos_7=MD	lemma_7=may	pos_8=VB	relType_4=punct	lib=be	relType_3=ROOT	pos_5=IN	lemma_4=,	lemma_8=provoke	pos_6=PRP	wib=is	lemma_6=they	pos_1=VBZ	path=diuretic_nmod<use_nsubj:pass<recommend_ROOT>provoke_advcl>toxicity_obj>lithium_compound	lpib=be_VBZ	lemma_2=not	path2=provoke_advcl>toxicity_obj>lithium_compound
DDI-DrugBank.d17.s25	DDI-DrugBank.d17.s25.e0	DDI-DrugBank.d17.s25.e3	effect	lemma_12=thiazide	relType_12=conj	relType_1=aux	lib=reduce	pos_5=,	relation_9=neutral	relType_12=cc	pos_12=CC	lemma_2=reduce	relType_11=case	pos_6=NN	lemma_4=diuretic	pos_9=JJ	lemma_12=,	relType_6=conj	pos_12=JJ	relType_12=amod	relType_12=compound	path1=agent_nsubj	relType_10=conj	lemma_12=sparing	relType_12=nmod	lemma_6=natriuretic	wib=reduce	pos_7=,	pos_12=,	pos_2=VB	relType_9=amod	pos_8=CC	relType_12=punct	relType_3=det	lemma_7=,	pos_4=NN	lemma_10=effect	relType_4=obj	pos_11=IN	lemma_1=can	relation_1=adverse	lpib=reduce_VB	relType_2=ROOT	lemma_5=,	relType_5=punct	pos_1=MD	lemma_12=potassium	path2=diuretic_obj>diuretic_conj	lemma_9=antihypertensive	lemma_12=loop	lemma_8=and	path=agent_nsubj<reduce_ROOT>diuretic_obj>diuretic_conj	eib=True	pos_3=DT	relType_7=punct	lemma_12=and	lemma_11=of	lemma_3=the	pos_12=NN	relType_8=cc	pos_10=NNS
DDI-DrugBank.d17.s26	DDI-DrugBank.d17.s26.e0	DDI-DrugBank.d17.s26.e1	advise	relType_1=cc	pos_1=CC	path2=agent_conj	path1=	pos_2=HYPH	pos_2=AFX	pos_2=JJ	path=<hydroflumethiazide_nsubj:pass>agent_conj	relType_2=punct	lemma_2=anti	relType_2=obl:npmod	lemma_2=-	lpib=nonsteroidal_JJ	relType_2=amod	lib=nonsteroidal	wib=nonsteroidal	lemma_2=inflammatory	eib=True	lemma_2=nonsteroidal	lemma_1=and
DDI-DrugBank.d17.s26	DDI-DrugBank.d17.s26.e0	DDI-DrugBank.d17.s26.e2	null	relType_1=cc	path1=hydroflumethiazide_nsubj:pass<use_advcl	pos_5=,	pos_9=VB	lemma_14=if	pos_2=AFX	pos_2=JJ	relType_18=case	relType_12=mark	pos_8=MD	lemma_16=desire	pos_15=DT	lemma_18=of	pos_16=VBN	lemma_5=,	relType_2=aux:pass	pos_11=RB	wib=nonsteroidal	lemma_2=nonsteroidal	relType_19=det	lemma_8=should	relType_9=aux:pass	lemma_4=concomitantly	relType_2=punct	relType_16=amod	lemma_2=-	relType_11=advmod	relType_2=conj	lpib=nonsteroidal_JJ	lemma_11=closely	pos_14=IN	lib=nonsteroidal	pos_2=VBP	path2=determine_xcomp>obtain_advcl>effect_nsubj:pass>diuretic_nmod	relType_6=det	relation_17=neutral	pos_10=VBN	lemma_2=be	pos_7=NN	relType_15=det	lemma_1=and	pos_19=DT	lemma_2=agent	pos_6=DT	pos_2=HYPH	pos_17=NN	lemma_2=anti	lemma_3=use	lemma_15=the	lemma_6=the	relType_7=nsubj:pass	pos_18=IN	pos_13=VB	relType_2=amod	relType_14=mark	lemma_12=to	lemma_2=inflammatory	lemma_10=observe	pos_12=TO	pos_1=CC	pos_3=VBN	relType_17=nsubj:pass	relation_21=neutral	pos_4=RB	relType_2=obl:npmod	lemma_7=patient	lemma_19=the	relType_10=ROOT	path=hydroflumethiazide_nsubj:pass<use_advcl<observe_ROOT>determine_xcomp>obtain_advcl>effect_nsubj:pass>diuretic_nmod	relType_3=advcl	relType_5=punct	relType_4=advmod	lemma_9=be	pos_2=NNS	eib=True	relType_8=aux	lemma_13=determine	lemma_17=effect	relType_13=xcomp
DDI-DrugBank.d17.s26	DDI-DrugBank.d17.s26.e1	DDI-DrugBank.d17.s26.e2	null	lemma_12=determine	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_16=nsubj:pass	relType_15=amod	lpib=be_VBP	relType_1=aux:pass	relType_2=advcl	relType_7=aux	lemma_2=use	path=agent_conj<hydroflumethiazide_nsubj:pass<use_advcl<observe_ROOT>determine_xcomp>obtain_advcl>effect_nsubj:pass>diuretic_nmod	lemma_9=observe	pos_6=NN	relType_9=ROOT	pos_11=TO	lemma_13=if	pos_17=IN	pos_18=DT	pos_4=,	eib=False	lemma_6=patient	lemma_1=be	relType_8=aux:pass	lemma_15=desire	relType_14=det	relType_10=advmod	pos_7=MD	relType_12=xcomp	pos_9=VBN	pos_13=IN	lemma_14=the	pos_15=VBN	relation_15=neutral	relType_17=case	wib=are	pos_8=VB	relType_4=punct	lib=be	lemma_8=be	relType_5=det	path1=agent_conj<hydroflumethiazide_nsubj:pass<use_advcl	relType_6=nsubj:pass	lemma_7=should	relation_11=neutral	path2=determine_xcomp>obtain_advcl>effect_nsubj:pass>diuretic_nmod	lemma_4=,	pos_16=NN	lemma_16=effect	lemma_17=of	pos_1=VBP	lemma_10=closely	pos_14=DT	pos_12=VB	relType_11=mark	lemma_5=the	lemma_3=concomitantly	pos_5=DT	relType_13=mark	relType_18=det	pos_10=RB	lemma_18=the	lemma_11=to
DDI-DrugBank.d17.s28	DDI-DrugBank.d17.s28.e0	DDI-DrugBank.d17.s28.e1	effect	relType_1=aux	lemma_1=may	relType_5=case	path2=norepinephrine_obl	eib=False	relation_1=adverse	lpib=decrease_VB	pos_2=VB	pos_4=NN	relType_4=obj	relType_3=amod	relType_2=ROOT	wib=decrease	pos_5=IN	lemma_5=to	pos_1=MD	lemma_3=arterial	pos_3=JJ	lemma_2=decrease	path=Thiazides_nsubj<decrease_ROOT>norepinephrine_obl	path1=Thiazides_nsubj	lemma_4=responsiveness	lib=decrease
DDI-DrugBank.d17.s31	DDI-DrugBank.d17.s31.e0	DDI-DrugBank.d17.s31.e1	effect	path1=drug_nsubj	path=drug_nsubj<increase_ROOT>responsiveness_obj>tubocurarine_nmod	relType_1=aux	lemma_1=may	path2=responsiveness_obj>tubocurarine_nmod	relType_5=case	relation_1=beneficial	eib=False	pos_2=VB	relType_3=det	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	relType_2=ROOT	pos_5=IN	wib=increase	lemma_5=to	pos_1=MD	lpib=increase_VB	pos_3=DT	lemma_3=the	lemma_4=responsiveness
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e0	DDI-DrugBank.d308.s0.e1	effect	lemma_6=drug	pos_7=VBZ	relType_1=aux	pos_8=VBN	lemma_7=be	pos_3=VBN	lemma_12=NERVOUS	relType_8=advcl	path2=use_advcl>NARCOTICS_obl>DEPRESSANTS_compound	pos_9=IN	relType_11=case	lemma_11=with	pos_6=NN	lemma_1=must	relType_12=compound	pos_2=VB	relType_9=case	lemma_8=use	pos_11=IN	lib=be	relType_3=ROOT	relType_4=advmod	lemma_3=consider	relType_5=det	relType_2=aux:pass	relType_6=nsubj:pass	relType_7=aux:pass	lemma_12=CENTRAL	lemma_10=CONJUNCTION	wib=BE	pos_1=MD	lpib=be_VB	pos_10=NNP	pos_4=WRB	lemma_5=the	eib=True	path=HYDROXYZINE_nmod<action_nsubj:pass<consider_ROOT>use_advcl>NARCOTICS_obl>DEPRESSANTS_compound	pos_12=NNP	pos_5=DT	lemma_4=when	lemma_12=SYSTEM	lemma_2=be	relType_10=obl	lemma_9=in	path1=HYDROXYZINE_nmod<action_nsubj:pass
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e0	DDI-DrugBank.d308.s0.e2	effect	lemma_6=drug	pos_7=VBZ	relType_1=aux	pos_8=VBN	path=HYDROXYZINE_nmod<action_nsubj:pass<consider_ROOT>use_advcl>NARCOTICS_obl	pos_3=VBN	lemma_7=be	lemma_12=NERVOUS	relType_8=advcl	pos_9=IN	lemma_13=AS	relType_11=case	pos_13=NNP	path2=use_advcl>NARCOTICS_obl	pos_6=NN	lemma_11=with	lemma_1=must	relType_12=compound	pos_2=VB	relType_9=case	lemma_8=use	pos_11=IN	lemma_12=SUCH	lib=be	relType_13=compound	relType_3=ROOT	relType_4=advmod	lemma_3=consider	relType_5=det	relType_2=aux:pass	relType_6=nsubj:pass	relType_7=aux:pass	lemma_12=CENTRAL	lemma_10=CONJUNCTION	wib=BE	pos_1=MD	lpib=be_VB	pos_10=NNP	pos_4=WRB	lemma_5=the	eib=True	pos_12=NNP	lemma_12=DEPRESSANTS	pos_5=DT	lemma_4=when	lemma_12=SYSTEM	pos_12=NNPS	lemma_2=be	relType_10=obl	lemma_9=in	path1=HYDROXYZINE_nmod<action_nsubj:pass
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e0	DDI-DrugBank.d308.s0.e3	effect	lemma_6=drug	pos_14=NNP	pos_7=VBZ	relType_14=punct	pos_15=NNP	relType_1=aux	pos_8=VBN	lemma_7=be	pos_3=VBN	lemma_12=NERVOUS	relType_8=advcl	pos_9=IN	lemma_13=AS	relType_11=case	pos_13=NNP	lemma_11=with	pos_6=NN	path2=use_advcl>NARCOTICS_obl>ANALGESICS_conj	lemma_1=must	relType_12=compound	lemma_14=NARCOTICS	pos_14=,	pos_2=VB	relType_9=case	lemma_8=use	relType_14=obl	relType_15=punct	path=HYDROXYZINE_nmod<action_nsubj:pass<consider_ROOT>use_advcl>NARCOTICS_obl>ANALGESICS_conj	lemma_15=-	pos_11=IN	lemma_12=SUCH	lemma_15=NARCOTIC	lib=be	relType_13=compound	relType_3=ROOT	relType_4=advmod	lemma_3=consider	relType_5=det	relType_2=aux:pass	relType_6=nsubj:pass	relType_7=aux:pass	lemma_12=CENTRAL	lemma_10=CONJUNCTION	wib=BE	pos_1=MD	lpib=be_VB	pos_10=NNP	pos_4=WRB	lemma_15=NON	lemma_14=,	relType_15=compound	lemma_5=the	eib=True	pos_12=NNP	lemma_12=DEPRESSANTS	pos_5=DT	lemma_4=when	lemma_12=SYSTEM	pos_12=NNPS	lemma_2=be	relType_10=obl	lemma_9=in	pos_15=HYPH	path1=HYDROXYZINE_nmod<action_nsubj:pass
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e0	DDI-DrugBank.d308.s0.e4	effect	lemma_6=drug	pos_14=NNP	pos_7=VBZ	relType_14=punct	pos_15=NNP	relType_1=aux	pos_8=VBN	lemma_7=be	pos_3=VBN	lemma_12=NERVOUS	relType_8=advcl	pos_9=IN	lemma_13=AS	relType_11=case	path2=use_advcl>NARCOTICS_obl>BARBITURATES_conj	lemma_11=with	pos_6=NN	pos_13=NNP	lemma_1=must	relType_12=compound	lemma_14=NARCOTICS	pos_14=,	pos_2=VB	relType_9=case	lemma_8=use	relType_14=obl	relType_15=punct	lemma_15=-	pos_11=IN	lemma_12=SUCH	lemma_15=ANALGESICS	lemma_15=NARCOTIC	lib=be	relType_13=compound	relType_3=ROOT	relType_4=advmod	lemma_3=consider	relType_5=det	relType_2=aux:pass	relType_6=nsubj:pass	relType_7=aux:pass	lemma_12=CENTRAL	pos_15=NNPS	lemma_10=CONJUNCTION	wib=BE	pos_1=MD	relType_15=cc	lpib=be_VB	pos_10=NNP	lemma_15=and	pos_4=WRB	lemma_15=NON	lemma_14=,	relType_15=compound	lemma_5=the	eib=True	pos_12=NNP	lemma_12=DEPRESSANTS	pos_5=DT	lemma_4=when	lemma_12=SYSTEM	pos_12=NNPS	relType_15=conj	lemma_2=be	pos_15=CC	relType_10=obl	lemma_9=in	path=HYDROXYZINE_nmod<action_nsubj:pass<consider_ROOT>use_advcl>NARCOTICS_obl>BARBITURATES_conj	pos_15=HYPH	path1=HYDROXYZINE_nmod<action_nsubj:pass
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e1	DDI-DrugBank.d308.s0.e2	null	relType_1=compound	path1=DEPRESSANTS_compound	pos_2=NNP	eib=False	relType_2=compound	lemma_1=SUCH	lemma_2=AS	wib=SUCH	path2=	lib=such	path=DEPRESSANTS_compound<NARCOTICS_obl>	pos_1=NNP	lpib=such_NNP
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e1	DDI-DrugBank.d308.s0.e3	null	lemma_3=NARCOTICS	pos_3=NNP	lemma_4=-	wib=SUCH	path2=ANALGESICS_conj	pos_4=HYPH	lpib=such_NNP	relType_1=compound	path1=DEPRESSANTS_compound	pos_2=NNP	lemma_4=NARCOTIC	relType_4=punct	lemma_3=,	relType_2=compound	lemma_1=SUCH	relType_4=compound	lemma_2=AS	lemma_4=NON	pos_1=NNP	path=DEPRESSANTS_compound<NARCOTICS_obl>ANALGESICS_conj	relType_3=obl	eib=True	pos_3=,	pos_4=NNP	lib=such	relType_3=punct
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e1	DDI-DrugBank.d308.s0.e4	null	lemma_3=NARCOTICS	pos_3=NNP	lemma_4=-	wib=SUCH	relType_4=cc	pos_4=HYPH	lpib=such_NNP	relType_1=compound	path1=DEPRESSANTS_compound	pos_2=NNP	lemma_4=ANALGESICS	lemma_4=NARCOTIC	relType_4=punct	lemma_3=,	pos_4=NNPS	relType_2=compound	lemma_1=SUCH	relType_4=compound	lemma_2=AS	lemma_4=NON	path=DEPRESSANTS_compound<NARCOTICS_obl>BARBITURATES_conj	pos_1=NNP	relType_3=obl	pos_3=,	eib=True	pos_4=CC	path2=BARBITURATES_conj	lemma_4=and	pos_4=NNP	relType_4=conj	lib=such	relType_3=punct
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e2	DDI-DrugBank.d308.s0.e3	null	lemma_1=,	lib=non	eib=True	pos_2=NNP	lemma_2=-	lemma_2=NON	relType_2=compound	wib=NON	path1=	pos_1=,	lemma_2=NARCOTIC	path2=ANALGESICS_conj	relType_1=punct	pos_2=HYPH	lpib=non_NNP	relType_2=punct	path=<NARCOTICS_obl>ANALGESICS_conj
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e2	DDI-DrugBank.d308.s0.e4	null	lemma_1=,	lemma_2=ANALGESICS	path1=	pos_1=,	pos_2=HYPH	relType_2=cc	relType_2=punct	lemma_2=and	pos_2=NNP	lemma_2=-	lemma_2=NON	wib=NON	path=<NARCOTICS_obl>BARBITURATES_conj	pos_2=NNPS	relType_2=conj	lpib=non_NNP	relType_2=compound	lemma_2=NARCOTIC	lib=non	eib=True	path2=BARBITURATES_conj	pos_2=CC	relType_1=punct
DDI-DrugBank.d308.s0	DDI-DrugBank.d308.s0.e3	DDI-DrugBank.d308.s0.e4	null	relType_1=cc	pos_1=CC	lpib=barbiturates_NNPS	eib=False	path2=BARBITURATES_conj	path1=ANALGESICS_conj	path=ANALGESICS_conj<NARCOTICS_obl>BARBITURATES_conj	wib=BARBITURATES	lemma_1=and	lib=barbiturates
DDI-DrugBank.d308.s1	DDI-DrugBank.d308.s1.e0	DDI-DrugBank.d308.s1.e1	advise	pos_2=VBN	pos_3=RB	relType_3=advmod	lpib=be_VBP	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	eib=False	lemma_1=be	path2=hydroxyzine_obl	wib=are	lemma_4=with	lib=be	pos_4=IN	relType_4=case	path=depressant_nsubj:pass<administer_advcl>hydroxyzine_obl	path1=depressant_nsubj:pass	pos_1=VBP	lemma_3=concomitantly
DDI-DrugBank.d308.s3	DDI-DrugBank.d308.s3.e0	DDI-DrugBank.d308.s3.e1	null	lemma_3=caution	path=drug_nmod<use_obl<advise_ROOT>caution_conj>increase_ccomp>effect_nsubj:pass>alcohol_nmod	relType_4=mark	lemma_1=,	path1=drug_nmod<use_obl	relType_7=case	pos_1=,	wib=cautioned	relType_2=cc	pos_6=NN	lemma_2=and	eib=False	relation_5=neutral	path2=caution_conj>increase_ccomp>effect_nsubj:pass>alcohol_nmod	pos_3=VBD	relType_3=conj	pos_4=IN	relType_5=det	relType_6=nsubj:pass	lemma_6=effect	lemma_7=of	lemma_5=the	lpib=caution_VBD	pos_7=IN	lemma_4=that	pos_2=CC	pos_5=DT	lib=caution	relType_1=punct
DDI-DrugBank.d515.s0	DDI-DrugBank.d515.s0.e0	DDI-DrugBank.d515.s0.e1	null	path=ifosfamide_obj<involve_acl>use_advcl>ifosfamide_nsubj:pass	pos_2=IN	wib=even	eib=False	pos_1=RB	lib=even	lpib=even_RB	relType_1=advmod	lemma_2=though	lemma_1=even	path2=use_advcl>ifosfamide_nsubj:pass	path1=ifosfamide_obj	relType_2=mark
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e0	DDI-DrugBank.d549.s0.e1	null	relType_1=cc	path2=nifedipine_conj	pos_1=CC	lemma_1=and	lemma_2=either	eib=False	pos_2=CC	path1=	lib=nifedipine	lpib=nifedipine_NN	relType_2=cc:preconj	wib=nifedipine	path=<iloprost_nmod>nifedipine_conj
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e0	DDI-DrugBank.d549.s0.e2	null	relType_1=cc	pos_1=CC	path2=nifedipine_conj>diltiazem_conj	path1=	lib=nifedipine	lpib=nifedipine_NN	relType_2=cc:preconj	lemma_3=nifedipine	lemma_3=,	relType_3=conj	path=<iloprost_nmod>nifedipine_conj>diltiazem_conj	lemma_2=either	pos_3=,	eib=True	pos_3=NN	pos_2=CC	relType_3=punct	wib=nifedipine	lemma_1=and
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e0	DDI-DrugBank.d549.s0.e3	null	relType_1=cc	pos_1=CC	lemma_4=diltiazem	pos_5=CC	path1=	lib=nifedipine	lpib=nifedipine_NN	relType_2=cc:preconj	path=<iloprost_nmod>nifedipine_conj>captopril_conj	lemma_3=nifedipine	relType_5=cc	pos_4=,	pos_4=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lemma_2=either	pos_3=,	eib=True	pos_3=NN	pos_2=CC	path2=nifedipine_conj>captopril_conj	relType_4=conj	relType_3=punct	wib=nifedipine	lemma_1=and	lemma_5=or
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e1	DDI-DrugBank.d549.s0.e2	null	lemma_1=,	eib=False	path1=	pos_1=,	lpib=diltiazem_NN	relType_1=punct	lib=diltiazem	wib=diltiazem	path2=diltiazem_conj	path=<nifedipine_conj>diltiazem_conj
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e1	DDI-DrugBank.d549.s0.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lemma_2=diltiazem	relType_3=cc	relType_2=punct	lemma_3=or	lib=diltiazem	relType_2=conj	wib=diltiazem	lemma_2=,	eib=True	path2=captopril_conj	lpib=diltiazem_NN	pos_2=,	path=<nifedipine_conj>captopril_conj	relType_1=punct
DDI-DrugBank.d549.s0	DDI-DrugBank.d549.s0.e2	DDI-DrugBank.d549.s0.e3	null	lemma_2=or	path1=diltiazem_conj	wib=captopril	lemma_1=,	eib=False	path2=captopril_conj	pos_2=CC	pos_1=,	path=diltiazem_conj<nifedipine_conj>captopril_conj	lpib=captopril_NN	relType_1=punct	relType_2=cc	lib=captopril
DDI-DrugBank.d549.s1	DDI-DrugBank.d549.s1.e0	DDI-DrugBank.d549.s1.e1	effect	relType_4=mark	pos_2=DT	lemma_3=potential	lemma_2=the	relation_4=beneficial	lpib=have_VBZ	pos_6=DT	path2=increase_ccomp>effect_obj>vasodilator_nmod	pos_9=IN	lemma_5=increase	pos_8=NN	pos_5=VB	eib=False	path1=iloprost_nsubj	lemma_6=the	lemma_7=hypotensive	relType_8=obj	lemma_1=have	relType_9=case	lib=have	relType_7=amod	path=iloprost_nsubj<have_ROOT>increase_ccomp>effect_obj>vasodilator_nmod	lemma_4=to	pos_4=TO	relation_7=neutral	relType_5=ccomp	relType_1=ROOT	relType_6=det	pos_3=JJ	pos_1=VBZ	lemma_9=of	relType_2=det	pos_7=JJ	lemma_8=effect	relType_3=obj	wib=has
DDI-DrugBank.d549.s1	DDI-DrugBank.d549.s1.e0	DDI-DrugBank.d549.s1.e2	effect	relType_4=mark	pos_2=DT	lemma_3=potential	lemma_2=the	relation_4=beneficial	lpib=have_VBZ	pos_6=DT	relType_10=cc	pos_9=IN	path2=increase_ccomp>effect_obj>vasodilator_nmod>agent_conj	lemma_5=increase	pos_8=NN	path=iloprost_nsubj<have_ROOT>increase_ccomp>effect_obj>vasodilator_nmod>agent_conj	pos_5=VB	relType_10=nmod	path1=iloprost_nsubj	lemma_6=the	lemma_7=hypotensive	pos_10=CC	relType_11=amod	lemma_10=vasodilator	relType_8=obj	lemma_1=have	relType_9=case	lib=have	lemma_10=and	lemma_11=antihypertensive	relType_7=amod	lemma_4=to	pos_4=TO	relation_7=neutral	relType_5=ccomp	relType_1=ROOT	relType_6=det	pos_3=JJ	pos_1=VBZ	eib=True	lemma_9=of	relType_2=det	pos_7=JJ	lemma_8=effect	relType_3=obj	pos_11=JJ	wib=has	pos_10=NNS
DDI-DrugBank.d549.s1	DDI-DrugBank.d549.s1.e1	DDI-DrugBank.d549.s1.e2	null	relType_1=cc	pos_1=CC	eib=True	path2=agent_conj	lib=antihypertensive	lemma_2=antihypertensive	path1=	relType_2=amod	lpib=antihypertensive_JJ	wib=antihypertensive	path=<vasodilator_nmod>agent_conj	pos_2=JJ	lemma_1=and
DDI-DrugBank.d549.s2	DDI-DrugBank.d549.s2.e0	DDI-DrugBank.d549.s2.e1	effect	lemma_16=in	relType_14=punct	pos_19=IN	pos_2=NN	relType_7=det	relType_1=advcl	pos_16=IN	relType_8=nsubj	relType_10=amod	relType_12=case	relation_0=adverse	lemma_5=there	lemma_1=inhibit	pos_6=VBZ	lemma_8=potential	pos_9=IN	lemma_11=risk	lemma_6=be	lemma_12=of	relType_13=nmod	pos_8=NN	relType_18=acl	lemma_13=bleeding	pos_4=,	eib=False	lemma_10=increase	pos_14=,	lib=inhibit	relType_9=case	pos_13=NN	pos_5=EX	relation_9=beneficial	pos_7=DT	lemma_2=platelet	pos_12=IN	relType_6=ROOT	relType_4=punct	lemma_17=patient	relType_2=compound	lemma_15=particularly	lemma_4=,	relType_17=nmod	wib=inhibits	path=iloprost_nsubj<inhibit_advcl<be_ROOT>potential_nsubj>risk_nmod>patient_nmod>maintain_acl>anticoagulant_obl	lpib=inhibit_VBZ	relType_5=expl	path2=potential_nsubj>risk_nmod>patient_nmod>maintain_acl>anticoagulant_obl	lemma_14=,	relType_16=case	pos_18=VBN	pos_11=NN	pos_1=VBZ	pos_17=NNS	relType_19=case	lemma_3=function	pos_3=NN	pos_10=VBN	lemma_9=for	relType_3=obj	lemma_7=a	relType_11=nmod	lemma_18=maintain	relType_15=advmod	path1=iloprost_nsubj<inhibit_advcl	pos_15=RB	lemma_19=on
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e1	null	pos_2=VBN	pos_3=RB	relType_3=advmod	path2=anticoagulant_obl	relType_1=aux:pass	lemma_2=use	path1=iloprost_nsubj:pass	pos_1=VBD	eib=False	lemma_1=be	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl	lemma_4=with	lib=be	relType_2=ROOT	pos_4=IN	relType_4=case	wib=was	lemma_3=concurrently	lpib=be_VBD
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e2	null	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_2=use	path1=iloprost_nsubj:pass	pos_1=VBD	pos_5=NNS	lemma_1=be	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>diuretic_conj	lemma_4=with	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	path2=anticoagulant_obl>diuretic_conj	relType_5=obl	wib=was	lemma_3=concurrently	eib=True	lpib=be_VBD
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e3	null	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_6=,	lemma_2=use	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>glycoside_conj	pos_5=NNS	relType_6=punct	lemma_1=be	path2=anticoagulant_obl>glycoside_conj	lemma_4=with	lemma_6=diuretic	relType_7=amod	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_5=obl	wib=was	pos_6=,	lemma_3=concurrently	eib=True	pos_7=JJ	pos_6=NNS	lpib=be_VBD
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e4	null	pos_7=NNS	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_6=,	lemma_2=use	pos_8=NN	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	pos_5=NNS	relType_6=punct	lemma_1=be	lemma_7=glycoside	pos_7=,	lemma_7=,	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>blocker_conj	lemma_4=with	lemma_8=calcium	lemma_6=diuretic	relType_7=amod	lib=be	path2=anticoagulant_obl>blocker_conj	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_8=compound	relType_5=obl	wib=was	pos_6=,	lemma_3=concurrently	lemma_8=channel	eib=True	relType_7=punct	pos_7=JJ	pos_6=NNS	lpib=be_VBD	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e5	null	pos_7=NNS	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_6=,	relType_8=punct	lemma_8=,	path2=anticoagulant_obl>analgesic_conj	lemma_2=use	pos_8=NNS	pos_8=NN	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	pos_5=NNS	relType_6=punct	lemma_1=be	lemma_7=glycoside	pos_7=,	lemma_7=,	lemma_4=with	lemma_8=calcium	lemma_6=diuretic	relType_7=amod	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_8=compound	relType_5=obl	wib=was	pos_6=,	lemma_8=blocker	lemma_3=concurrently	lemma_8=channel	eib=True	relType_7=punct	pos_7=JJ	pos_6=NNS	relType_8=conj	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>analgesic_conj	pos_8=,	lpib=be_VBD	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e6	null	pos_7=NNS	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_9=conj	pos_5=,	relType_1=aux:pass	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	lemma_2=use	pos_8=NNS	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>antipyretic_conj	pos_8=NN	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	pos_5=NNS	relType_6=punct	lemma_1=be	pos_9=NNS	lemma_7=glycoside	pos_7=,	lemma_7=,	lemma_4=with	lemma_8=calcium	lemma_6=diuretic	relType_7=amod	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_8=compound	relType_5=obl	path2=anticoagulant_obl>antipyretic_conj	wib=was	relType_9=punct	pos_6=,	lemma_8=blocker	lemma_9=analgesic	lemma_3=concurrently	lemma_8=channel	eib=True	relType_7=punct	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_8=,	pos_9=,	lpib=be_VBD	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e7	null	pos_7=NNS	pos_2=VBN	relType_10=punct	pos_3=RB	relType_3=advmod	relType_9=conj	pos_5=,	relType_1=aux:pass	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	lemma_2=use	pos_8=NNS	pos_8=NN	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	path2=anticoagulant_obl>antiinflammatory_conj	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=amod	lemma_1=be	pos_9=NNS	lemma_7=glycoside	pos_7=,	lemma_10=antipyretic	lemma_7=,	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>antiinflammatory_conj	lemma_4=with	lemma_8=calcium	lemma_6=diuretic	relType_7=amod	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_8=compound	relType_5=obl	wib=was	relType_9=punct	pos_6=,	lemma_8=blocker	lemma_9=analgesic	lemma_3=concurrently	lemma_8=channel	pos_10=,	eib=True	relType_7=punct	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_8=,	pos_11=JJ	pos_9=,	lpib=be_VBD	pos_10=NNS	lemma_11=nonsteroidal	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e0	DDI-DrugBank.d549.s3.e8	null	pos_7=NNS	path=iloprost_nsubj:pass<use_ROOT>anticoagulant_obl>corticosteroid_conj	pos_2=VBN	relType_10=punct	pos_3=RB	relType_3=advmod	relType_9=conj	lemma_11=,	pos_5=,	relType_1=aux:pass	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	lemma_11=antiinflammatory	lemma_2=use	pos_8=NNS	path2=anticoagulant_obl>corticosteroid_conj	relType_11=conj	pos_8=NN	relType_6=conj	path1=iloprost_nsubj:pass	pos_1=VBD	lemma_7=cardiac	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=amod	lemma_1=be	pos_9=NNS	pos_11=NNS	lemma_7=glycoside	pos_7=,	relType_11=punct	lemma_10=antipyretic	lemma_7=,	lemma_4=with	lemma_8=calcium	lemma_6=diuretic	relType_7=amod	lib=be	relType_2=ROOT	pos_4=IN	lemma_5=anticoagulant	lemma_5=,	relType_5=punct	relType_4=case	relType_8=compound	relType_5=obl	pos_11=,	wib=was	relType_9=punct	pos_6=,	lemma_8=blocker	lemma_9=analgesic	lemma_3=concurrently	lemma_8=channel	pos_10=,	eib=True	relType_7=punct	pos_7=JJ	pos_6=NNS	relType_8=conj	pos_8=,	pos_11=JJ	pos_9=,	lpib=be_VBD	pos_10=NNS	lemma_11=nonsteroidal	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e2	null	lemma_1=,	wib=diuretics	eib=False	path2=diuretic_conj	lib=diuretic	path1=	pos_1=,	relType_1=punct	path=<anticoagulant_obl>diuretic_conj	lpib=diuretic_NNS
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e3	null	lemma_1=,	wib=diuretics	path1=	pos_1=,	lemma_3=cardiac	relType_2=punct	path=<anticoagulant_obl>glycoside_conj	relType_2=conj	lemma_2=,	lemma_2=diuretic	relType_3=amod	lib=diuretic	lpib=diuretic_NNS	pos_2=NNS	path2=glycoside_conj	pos_3=JJ	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e4	null	path2=blocker_conj	lemma_1=,	wib=diuretics	lemma_3=glycoside	path1=	pos_1=,	lemma_4=channel	lemma_3=cardiac	relType_2=punct	pos_3=NNS	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=diuretic	relType_3=amod	lemma_3=,	relType_3=conj	lib=diuretic	relType_4=compound	lpib=diuretic_NNS	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	lemma_4=calcium	pos_2=,	relType_1=punct	path=<anticoagulant_obl>blocker_conj	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e5	null	lemma_1=,	wib=diuretics	lemma_3=glycoside	path1=	pos_1=,	lemma_4=channel	lemma_3=cardiac	relType_2=punct	pos_3=NNS	pos_4=,	lemma_4=blocker	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_2=diuretic	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	lib=diuretic	relType_4=compound	lemma_4=,	path2=analgesic_conj	lpib=diuretic_NNS	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	lemma_4=calcium	path=<anticoagulant_obl>analgesic_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e6	null	lemma_1=,	wib=diuretics	lemma_3=glycoside	pos_5=,	path1=	pos_1=,	lemma_4=channel	lemma_3=cardiac	relType_2=punct	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_4=blocker	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_5=analgesic	lemma_2=diuretic	path=<anticoagulant_obl>antipyretic_conj	relType_3=amod	lemma_3=,	relType_3=conj	relType_4=punct	lemma_5=,	relType_5=punct	lib=diuretic	relType_4=compound	lemma_4=,	path2=antipyretic_conj	relType_5=conj	lpib=diuretic_NNS	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	lemma_4=calcium	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e7	null	lemma_1=,	wib=diuretics	lemma_3=glycoside	pos_5=,	path1=	pos_1=,	lemma_4=channel	lemma_6=,	lemma_3=cardiac	relType_2=punct	path2=antiinflammatory_conj	relType_6=conj	pos_3=NNS	lemma_7=nonsteroidal	pos_4=,	pos_5=NNS	relType_6=punct	lemma_4=blocker	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_5=analgesic	lemma_2=diuretic	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_7=amod	lib=diuretic	relType_4=compound	lemma_4=,	relType_5=conj	lemma_6=antipyretic	pos_6=,	path=<anticoagulant_obl>antiinflammatory_conj	lpib=diuretic_NNS	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	lemma_4=calcium	pos_7=JJ	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e1	DDI-DrugBank.d549.s3.e8	null	pos_7=NNS	lemma_1=,	wib=diuretics	lemma_3=glycoside	pos_5=,	path1=	pos_1=,	lemma_4=channel	lemma_6=,	lemma_3=cardiac	relType_2=punct	relType_6=conj	pos_3=NNS	lemma_7=nonsteroidal	pos_4=,	pos_5=NNS	relType_6=punct	pos_7=,	path=<anticoagulant_obl>corticosteroid_conj	lemma_4=blocker	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_5=analgesic	lemma_2=diuretic	relType_4=punct	relType_3=amod	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_7=amod	lib=diuretic	relType_4=compound	path2=corticosteroid_conj	lemma_4=,	relType_5=conj	lemma_6=antipyretic	pos_6=,	lpib=diuretic_NNS	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	lemma_4=calcium	relType_7=punct	pos_7=JJ	pos_6=NNS	lemma_7=antiinflammatory	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_7=conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e3	null	path2=glycoside_conj	lemma_1=,	lemma_2=cardiac	wib=cardiac	eib=True	path=diuretic_conj<anticoagulant_obl>glycoside_conj	path1=diuretic_conj	relType_2=amod	lib=cardiac	pos_1=,	relType_1=punct	pos_2=JJ	lpib=cardiac_JJ
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e4	null	path2=blocker_conj	lemma_1=,	lib=cardiac	pos_1=,	pos_2=JJ	relType_2=punct	lpib=cardiac_JJ	path=diuretic_conj<anticoagulant_obl>blocker_conj	lemma_3=channel	lemma_3=calcium	relType_2=conj	lemma_2=,	lemma_2=cardiac	path1=diuretic_conj	relType_2=amod	lemma_2=glycoside	pos_2=NNS	wib=cardiac	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e5	null	lemma_1=,	lib=cardiac	pos_1=,	pos_2=JJ	relType_2=punct	lpib=cardiac_JJ	lemma_3=blocker	lemma_3=channel	pos_3=NNS	lemma_3=calcium	relType_2=conj	lemma_2=,	lemma_2=cardiac	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_2=amod	path=diuretic_conj<anticoagulant_obl>analgesic_conj	path2=analgesic_conj	lemma_2=glycoside	pos_2=NNS	pos_3=,	wib=cardiac	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e6	null	lemma_1=,	lib=cardiac	pos_1=,	pos_2=JJ	relType_2=punct	lpib=cardiac_JJ	lemma_3=blocker	lemma_3=channel	pos_3=NNS	path=diuretic_conj<anticoagulant_obl>antipyretic_conj	pos_4=,	lemma_3=calcium	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_2=cardiac	lemma_3=,	relType_4=punct	relType_3=conj	path1=diuretic_conj	relType_2=amod	lemma_4=analgesic	lemma_4=,	path2=antipyretic_conj	lemma_2=glycoside	pos_2=NNS	pos_3=,	wib=cardiac	eib=True	pos_3=NN	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e7	null	lemma_1=,	pos_6=JJ	pos_5=,	lib=cardiac	pos_1=,	pos_2=JJ	relType_2=punct	lpib=cardiac_JJ	path=diuretic_conj<anticoagulant_obl>antiinflammatory_conj	lemma_3=blocker	lemma_3=channel	path2=antiinflammatory_conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_3=calcium	relType_6=amod	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_2=cardiac	lemma_3=,	relType_4=punct	relType_3=conj	path1=diuretic_conj	lemma_5=antipyretic	lemma_5=,	relType_2=amod	relType_5=punct	lemma_4=analgesic	lemma_4=,	relType_5=conj	lemma_2=glycoside	pos_2=NNS	pos_3=,	wib=cardiac	eib=True	lemma_6=nonsteroidal	pos_3=NN	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e2	DDI-DrugBank.d549.s3.e8	null	lemma_1=,	pos_6=JJ	lemma_6=antiinflammatory	pos_5=,	lib=cardiac	pos_1=,	lemma_6=,	pos_2=JJ	relType_2=punct	lpib=cardiac_JJ	lemma_3=blocker	lemma_3=channel	relType_6=conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_3=calcium	relType_6=amod	relType_6=punct	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_2=cardiac	lemma_3=,	relType_4=punct	relType_3=conj	path1=diuretic_conj	lemma_5=antipyretic	lemma_5=,	relType_2=amod	relType_5=punct	lemma_4=analgesic	path2=corticosteroid_conj	lemma_4=,	relType_5=conj	lemma_2=glycoside	pos_6=,	pos_2=NNS	path=diuretic_conj<anticoagulant_obl>corticosteroid_conj	pos_3=,	wib=cardiac	eib=True	lemma_6=nonsteroidal	pos_3=NN	pos_6=NNS	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e3	DDI-DrugBank.d549.s3.e4	null	path1=glycoside_conj	path2=blocker_conj	lemma_2=calcium	lemma_1=,	pos_2=NN	lemma_2=channel	eib=True	path=glycoside_conj<anticoagulant_obl>blocker_conj	lpib=calcium_NN	wib=calcium	relType_2=compound	pos_1=,	relType_1=punct	lib=calcium
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e3	DDI-DrugBank.d549.s3.e5	null	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	path=glycoside_conj<anticoagulant_obl>analgesic_conj	relType_2=punct	path1=glycoside_conj	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_2=channel	relType_2=compound	path2=analgesic_conj	pos_2=NNS	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_2=,	relType_1=punct	lib=calcium
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e3	DDI-DrugBank.d549.s3.e6	null	lemma_1=,	pos_2=NN	wib=calcium	pos_1=,	relType_2=punct	path1=glycoside_conj	pos_3=NNS	relType_2=conj	lemma_2=,	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_3=conj	relType_2=compound	path2=antipyretic_conj	pos_2=NNS	lemma_3=analgesic	pos_3=,	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_2=,	relType_1=punct	lib=calcium	relType_3=punct	path=glycoside_conj<anticoagulant_obl>antipyretic_conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e3	DDI-DrugBank.d549.s3.e7	null	lemma_1=,	pos_2=NN	lemma_5=nonsteroidal	wib=calcium	pos_1=,	path=glycoside_conj<anticoagulant_obl>antiinflammatory_conj	relType_2=punct	path1=glycoside_conj	path2=antiinflammatory_conj	pos_3=NNS	pos_4=,	lemma_4=antipyretic	relType_2=conj	lemma_2=,	pos_4=NNS	pos_5=JJ	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_4=punct	relType_3=conj	relType_5=amod	relType_2=compound	lemma_4=,	pos_2=NNS	lemma_3=analgesic	pos_3=,	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_2=,	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e3	DDI-DrugBank.d549.s3.e8	null	lemma_1=,	pos_2=NN	lemma_5=nonsteroidal	wib=calcium	pos_5=,	pos_1=,	relType_2=punct	path1=glycoside_conj	pos_3=NNS	pos_4=,	pos_5=NNS	lemma_4=antipyretic	path=glycoside_conj<anticoagulant_obl>corticosteroid_conj	relType_2=conj	lemma_2=,	pos_4=NNS	pos_5=JJ	lemma_2=calcium	lemma_2=channel	lemma_3=,	relType_4=punct	relType_3=conj	relType_5=amod	relType_2=compound	lemma_5=,	relType_5=punct	path2=corticosteroid_conj	lemma_4=,	lemma_5=antiinflammatory	relType_5=conj	pos_2=NNS	lemma_3=analgesic	pos_3=,	lemma_2=blocker	eib=True	lpib=calcium_NN	pos_2=,	relType_4=conj	relType_1=punct	lib=calcium	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e4	DDI-DrugBank.d549.s3.e5	null	lpib=analgesic_NNS	lemma_1=,	eib=False	path=blocker_conj<anticoagulant_obl>analgesic_conj	pos_1=,	lib=analgesic	wib=analgesics	path1=blocker_conj	relType_1=punct	path2=analgesic_conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e4	DDI-DrugBank.d549.s3.e6	null	lpib=analgesic_NNS	pos_2=NNS	lemma_1=,	relType_2=punct	eib=True	pos_1=,	pos_2=,	relType_2=conj	lib=analgesic	wib=analgesics	path1=blocker_conj	path2=antipyretic_conj	relType_1=punct	lemma_2=,	path=blocker_conj<anticoagulant_obl>antipyretic_conj	lemma_2=analgesic
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e4	DDI-DrugBank.d549.s3.e7	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_1=,	wib=analgesics	path1=blocker_conj	path=blocker_conj<anticoagulant_obl>antiinflammatory_conj	relType_2=punct	path2=antiinflammatory_conj	pos_3=NNS	lib=analgesic	relType_2=conj	lemma_2=,	lemma_2=analgesic	lpib=analgesic_NNS	lemma_3=,	relType_3=conj	lemma_3=antipyretic	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_1=punct	lemma_4=nonsteroidal	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e4	DDI-DrugBank.d549.s3.e8	null	relType_4=amod	lemma_1=,	pos_4=JJ	lemma_4=antiinflammatory	pos_1=,	wib=analgesics	path1=blocker_conj	relType_2=punct	pos_3=NNS	pos_4=,	path=blocker_conj<anticoagulant_obl>corticosteroid_conj	lib=analgesic	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_2=analgesic	lpib=analgesic_NNS	relType_4=punct	lemma_3=,	relType_3=conj	path2=corticosteroid_conj	lemma_4=,	lemma_3=antipyretic	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=nonsteroidal	relType_3=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e5	DDI-DrugBank.d549.s3.e6	null	lib=antipyretic	lpib=antipyretic_NNS	lemma_1=,	wib=antipyretics	eib=False	pos_1=,	path2=antipyretic_conj	relType_1=punct	path=analgesic_conj<anticoagulant_obl>antipyretic_conj	path1=analgesic_conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e5	DDI-DrugBank.d549.s3.e7	null	lemma_1=,	wib=antipyretics	pos_1=,	relType_2=punct	path2=antiinflammatory_conj	lemma_3=nonsteroidal	relType_2=conj	lemma_2=,	lib=antipyretic	lpib=antipyretic_NNS	relType_3=amod	lemma_2=antipyretic	pos_2=NNS	pos_3=JJ	eib=True	pos_2=,	path=analgesic_conj<anticoagulant_obl>antiinflammatory_conj	relType_1=punct	path1=analgesic_conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e5	DDI-DrugBank.d549.s3.e8	null	lemma_1=,	wib=antipyretics	pos_1=,	relType_2=punct	pos_3=NNS	path=analgesic_conj<anticoagulant_obl>corticosteroid_conj	lemma_3=nonsteroidal	relType_2=conj	lemma_2=,	lib=antipyretic	lpib=antipyretic_NNS	relType_3=amod	lemma_3=,	relType_3=conj	path2=corticosteroid_conj	lemma_2=antipyretic	pos_2=NNS	pos_3=JJ	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=antiinflammatory	path1=analgesic_conj
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e6	DDI-DrugBank.d549.s3.e7	null	path2=antiinflammatory_conj	lemma_1=,	path1=antipyretic_conj	eib=True	path=antipyretic_conj<anticoagulant_obl>antiinflammatory_conj	relType_2=amod	pos_1=,	lib=nonsteroidal	lemma_2=nonsteroidal	relType_1=punct	pos_2=JJ	wib=nonsteroidal	lpib=nonsteroidal_JJ
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e6	DDI-DrugBank.d549.s3.e8	null	lemma_1=,	pos_1=,	pos_2=JJ	relType_2=punct	path=antipyretic_conj<anticoagulant_obl>corticosteroid_conj	relType_2=conj	lemma_2=,	lpib=nonsteroidal_JJ	lemma_2=antiinflammatory	relType_2=amod	lib=nonsteroidal	path2=corticosteroid_conj	wib=nonsteroidal	pos_2=NNS	path1=antipyretic_conj	eib=True	pos_2=,	lemma_2=nonsteroidal	relType_1=punct
DDI-DrugBank.d549.s3	DDI-DrugBank.d549.s3.e7	DDI-DrugBank.d549.s3.e8	null	path=antiinflammatory_conj<anticoagulant_obl>corticosteroid_conj	lemma_1=,	eib=False	pos_1=,	wib=corticosteroids	path1=antiinflammatory_conj	path2=corticosteroid_conj	relType_1=punct	lib=corticosteroid	lpib=corticosteroid_NNS
DDI-DrugBank.d549.s4	DDI-DrugBank.d549.s4.e0	DDI-DrugBank.d549.s4.e1	null	pos_2=DT	relType_7=case	lemma_6=pharmacokinetic	lemma_2=no	lpib=have_VBD	lemma_3=effect	pos_1=VBD	eib=False	relation_2=neutral	lemma_4=on	lemma_1=have	lib=have	wib=had	pos_4=IN	relType_5=det	relType_4=case	path1=iloprost_nmod<infusion_nsubj	path2=effect_obj>pharmacokinetic_nmod>digoxin_nmod	path=iloprost_nmod<infusion_nsubj<have_ROOT>effect_obj>pharmacokinetic_nmod>digoxin_nmod	lemma_7=of	relType_1=ROOT	lemma_5=the	pos_7=IN	pos_3=NN	relType_2=det	pos_5=DT	pos_6=NNS	relType_3=obj	relType_6=nmod
DDI-DrugBank.d549.s5	DDI-DrugBank.d549.s5.e0	DDI-DrugBank.d549.s5.e1	null	pos_7=NNS	lemma_3=alter	relType_1=aux	wib=did	pos_9=IN	relType_8=punct	path2=pharmacokinetic_obj>iloprost_nmod	pos_3=VB	lemma_6=(	pos_2=RB	pos_6=-LRB-	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_6=punct	lemma_7=pharmacokinetic	relType_7=obj	relation_2=neutral	pos_8=-RRB-	relType_9=case	relType_5=dep	pos_4=DT	lemma_8=)	relType_3=ROOT	path1=acid_nsubj	lemma_4=the	lpib=do_VBD	lemma_5=clearance	pos_5=NN	lib=do	lemma_9=of	relType_4=det	path=acid_nsubj<alter_ROOT>pharmacokinetic_obj>iloprost_nmod	lemma_2=not
DDI-DrugBank.d97.s3	DDI-DrugBank.d97.s3.e0	DDI-DrugBank.d97.s3.e1	null	relType_4=amod	lemma_1=,	lemma_4=lower	pos_3=IN	relType_7=case	pos_1=,	relType_5=compound	path=indinavir_nmod<clearance_obj>result_acl>concentration_obl>indinavir_nmod	wib=resulting	relType_6=obl	eib=False	lpib=result_VBG	pos_4=VBN	path1=indinavir_nmod	lemma_5=plasma	relType_2=acl	relType_3=case	lemma_2=result	path2=result_acl>concentration_obl>indinavir_nmod	lemma_7=of	pos_5=NN	pos_7=IN	lib=result	pos_6=NNS	lemma_6=concentration	relType_1=punct	lemma_3=in	pos_2=VBG
DDI-DrugBank.d97.s4	DDI-DrugBank.d97.s4.e0	DDI-DrugBank.d97.s4.e1	null	relType_1=cc	pos_1=CC	lemma_6=cyp3a4	lemma_3=drug	lib=other	relType_6=nsubj	relation_4=adverse	relType_5=nsubj	path2=decrease_acl:relcl>clearance_obj>indinavir_nmod	relType_7=aux	pos_2=JJ	lemma_5=inhibit	relType_8=acl:relcl	relType_11=case	pos_6=NN	pos_4=WDT	pos_3=NNS	eib=False	path1=CRIXIVAN_nmod	pos_5=VBP	lemma_2=other	wib=other	pos_9=DT	relation_7=adverse	pos_7=MD	lemma_7=may	pos_10=NN	relType_4=obj	pos_8=VB	pos_11=IN	relType_3=conj	lpib=other_JJ	path=CRIXIVAN_nmod<Coadministration_ROOT>decrease_acl:relcl>clearance_obj>indinavir_nmod	lemma_8=decrease	relType_2=amod	lemma_4=that	lemma_9=the	lemma_11=of	lemma_10=clearance	relType_10=obj	lemma_1=and	relType_9=det
DDI-DrugBank.d97.s4	DDI-DrugBank.d97.s4.e0	DDI-DrugBank.d97.s4.e2	null	relType_1=cc	path=CRIXIVAN_nmod<Coadministration_ROOT>decrease_acl:relcl>result_conj>concentration_obl>indinavir_nmod	path2=decrease_acl:relcl>result_conj>concentration_obl>indinavir_nmod	pos_1=CC	lemma_6=cyp3a4	lemma_17=plasma	lemma_3=drug	lib=other	relType_6=nsubj	pos_18=NNS	lemma_18=concentration	relation_4=adverse	relType_5=nsubj	relType_12=cc	relType_7=aux	pos_13=MD	pos_12=CC	pos_19=IN	pos_2=JJ	lemma_5=inhibit	relType_8=acl:relcl	relType_11=case	pos_6=NN	relType_16=amod	pos_17=NN	pos_4=WDT	pos_3=NNS	relType_18=obl	relation_16=beneficial	path1=CRIXIVAN_nmod	pos_5=VBP	lemma_2=other	relType_12=nmod	wib=other	pos_9=DT	relType_13=aux	pos_7=MD	lemma_7=may	pos_10=NN	lemma_13=may	lemma_14=result	relType_17=compound	relation_7=adverse	relType_4=obj	pos_8=VB	pos_11=IN	lemma_19=of	relType_15=case	pos_16=VBN	relType_3=conj	lpib=other_JJ	lemma_8=decrease	relType_2=amod	pos_14=VB	lemma_16=increase	pos_15=IN	lemma_12=indinavir	lemma_15=in	eib=True	relType_19=case	lemma_4=that	lemma_9=the	lemma_12=and	lemma_11=of	relType_14=conj	lemma_10=clearance	pos_12=NN	relType_10=obj	lemma_1=and	relType_9=det
DDI-DrugBank.d97.s4	DDI-DrugBank.d97.s4.e1	DDI-DrugBank.d97.s4.e2	null	path2=result_conj>concentration_obl>indinavir_nmod	relType_1=cc	pos_7=NNS	pos_1=CC	relType_8=case	relation_4=beneficial	pos_2=MD	lemma_4=in	pos_3=VB	lemma_5=increase	path=indinavir_nmod<clearance_obj<decrease_acl:relcl>result_conj>concentration_obl>indinavir_nmod	pos_6=NN	lemma_6=plasma	eib=False	lemma_7=concentration	relType_2=aux	lemma_3=result	pos_8=IN	relType_5=amod	relType_3=conj	pos_4=IN	relType_4=case	path1=indinavir_nmod<clearance_obj	wib=result	relType_6=compound	relType_7=obl	lib=result	lemma_2=may	lemma_8=of	pos_5=VBN	lpib=result_VB	lemma_1=and
DDI-DrugBank.d97.s8	DDI-DrugBank.d97.s8.e0	DDI-DrugBank.d97.s8.e1	null	wib=amiodarone	path=<Antiarrhythmics_ROOT>amiodarone_dep	eib=False	path2=amiodarone_dep	path1=	pos_1=:	lib=amiodarone	lpib=amiodarone_NN	relType_1=punct	lemma_1=:
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e0	DDI-DrugBank.d97.s10.e1	null	lemma_1=,	eib=False	lib=ergonovine	path1=	pos_1=,	relType_1=punct	wib=ergonovine	path2=ergonovine_conj	path=<dihydroergotamine_dep>ergonovine_conj	lpib=ergonovine_NN
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e0	DDI-DrugBank.d97.s10.e2	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lemma_2=ergonovine	lib=ergonovine	path1=	pos_1=,	pos_2=,	path=<dihydroergotamine_dep>ergotamine_conj	relType_2=conj	relType_1=punct	wib=ergonovine	lemma_2=,	path2=ergotamine_conj	lpib=ergonovine_NN
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e0	DDI-DrugBank.d97.s10.e3	null	lemma_1=,	pos_2=NN	lemma_2=ergonovine	lemma_3=ergotamine	lib=ergonovine	path1=	pos_1=,	relType_2=punct	relType_2=conj	path=<dihydroergotamine_dep>methylergonovine_conj	lemma_2=,	lemma_3=,	relType_3=conj	path2=methylergonovine_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	wib=ergonovine	relType_3=punct	lpib=ergonovine_NN
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e1	DDI-DrugBank.d97.s10.e2	null	path1=ergonovine_conj	lemma_1=,	lpib=ergotamine_NN	path=ergonovine_conj<dihydroergotamine_dep>ergotamine_conj	eib=False	pos_1=,	wib=ergotamine	relType_1=punct	lib=ergotamine	path2=ergotamine_conj
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e1	DDI-DrugBank.d97.s10.e3	null	path1=ergonovine_conj	path=ergonovine_conj<dihydroergotamine_dep>methylergonovine_conj	lpib=ergotamine_NN	lemma_1=,	pos_2=NN	eib=True	pos_1=,	pos_2=,	wib=ergotamine	relType_1=punct	lemma_2=ergotamine	path2=methylergonovine_conj	relType_2=conj	lib=ergotamine	lemma_2=,	relType_2=punct
DDI-DrugBank.d97.s10	DDI-DrugBank.d97.s10.e2	DDI-DrugBank.d97.s10.e3	null	lemma_1=,	eib=False	path1=ergotamine_conj	path=ergotamine_conj<dihydroergotamine_dep>methylergonovine_conj	pos_1=,	wib=methylergonovine	lpib=methylergonovine_NN	lib=methylergonovine	relType_1=punct	path2=methylergonovine_conj
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e0	DDI-DrugBank.d97.s12.e1	null	lpib=hypnotic_NNS	path=sedative_compound<hypnotic_ROOT>	wib=hypnotics	lib=hypnotic	eib=False	path1=sedative_compound	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e0	DDI-DrugBank.d97.s12.e2	null	pos_2=NNS	lemma_2=:	lpib=hypnotic_NNS	lemma_2=hypnotic	eib=True	wib=hypnotics	lib=hypnotic	path=sedative_compound<hypnotic_ROOT>midazolam_dep	relType_2=ROOT	path1=sedative_compound	pos_2=:	pos_1=HYPH	path2=midazolam_dep	relType_1=punct	lemma_1=/	relType_2=punct
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e0	DDI-DrugBank.d97.s12.e3	null	relType_3=dep	path=sedative_compound<hypnotic_ROOT>midazolam_dep>triazolam_appos	wib=hypnotics	pos_1=HYPH	lemma_3=midazolam	relType_2=punct	lemma_2=:	lemma_2=hypnotic	lemma_3=,	lib=hypnotic	relType_2=ROOT	path1=sedative_compound	pos_2=:	lemma_1=/	pos_2=NNS	lpib=hypnotic_NNS	path2=midazolam_dep>triazolam_appos	pos_3=,	eib=True	pos_3=NN	relType_1=punct	relType_3=punct
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e1	DDI-DrugBank.d97.s12.e2	null	wib=midazolam	eib=False	lpib=midazolam_NN	path1=	pos_1=:	lemma_1=:	path2=midazolam_dep	relType_1=punct	path=<hypnotic_ROOT>midazolam_dep	lib=midazolam
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e1	DDI-DrugBank.d97.s12.e3	null	relType_2=dep	path2=midazolam_dep>triazolam_appos	pos_2=NN	eib=True	wib=midazolam	lpib=midazolam_NN	path1=	path=<hypnotic_ROOT>midazolam_dep>triazolam_appos	pos_1=:	lemma_2=midazolam	pos_2=,	relType_1=punct	relType_2=punct	lemma_2=,	lemma_1=:	lib=midazolam
DDI-DrugBank.d97.s12	DDI-DrugBank.d97.s12.e2	DDI-DrugBank.d97.s12.e3	null	lib=triazolam	path=<midazolam_dep>triazolam_appos	lemma_1=,	eib=False	wib=triazolam	path2=triazolam_appos	path1=	pos_1=,	relType_1=punct	lpib=triazolam_NN
DDI-DrugBank.d97.s16	DDI-DrugBank.d97.s16.e0	DDI-DrugBank.d97.s16.e1	null	lib=pimozide	path=<neuroleptic_ROOT>pimozide_dep	eib=False	path2=pimozide_dep	path1=	pos_1=:	wib=pimozide	relType_1=punct	lemma_1=:	lpib=pimozide_NN
DDI-DrugBank.d97.s19	DDI-DrugBank.d97.s19.e0	DDI-DrugBank.d97.s19.e1	null	relType_1=cc	pos_1=CC	lemma_4=class	lemma_5=of	relType_5=case	lpib=class_NN	pos_6=NN	pos_2=IN	path1=CRIXIVAN_nmod	lemma_2=to	relType_3=det	pos_4=NN	lemma_6=protease	path2=class_conj>inhibitor_nmod	pos_5=IN	lib=class	path=CRIXIVAN_nmod<loss_obl>class_conj>inhibitor_nmod	wib=class	relType_6=compound	relType_2=case	eib=True	pos_3=DT	lemma_3=the	relType_4=conj	lemma_1=or
DDI-DrugBank.d97.s20	DDI-DrugBank.d97.s20.e0	DDI-DrugBank.d97.s20.e1	null	wib=rifampin	eib=False	lpib=rifampin_NN	path1=	pos_1=:	lib=rifampin	path=<Antimycobacterial_ROOT>rifampin_dep	relType_1=punct	path2=rifampin_dep	lemma_1=:
DDI-DrugBank.d97.s21	DDI-DrugBank.d97.s21.e0	DDI-DrugBank.d97.s21.e1	null	relType_1=cc	pos_1=CC	lemma_4=class	lemma_5=of	relType_5=case	lpib=class_NN	pos_6=NN	pos_2=IN	path1=CRIXIVAN_nmod	lemma_2=to	relType_3=det	pos_4=NN	lemma_6=protease	path2=class_conj>inhibitor_nmod	pos_5=IN	lib=class	path=CRIXIVAN_nmod<loss_obl>class_conj>inhibitor_nmod	wib=class	relType_6=compound	relType_2=case	eib=True	pos_3=DT	lemma_3=the	relType_4=conj	lemma_1=or
DDI-DrugBank.d97.s21	DDI-DrugBank.d97.s21.e0	DDI-DrugBank.d97.s21.e2	null	relType_1=cc	pos_1=CC	relType_8=amod	pos_8=VBN	lemma_4=class	lemma_6=inhibitor	lemma_7=other	path=CRIXIVAN_nmod<loss_obl>class_conj>inhibitor_nmod>agent_conj	lemma_5=of	relType_5=case	lpib=class_NN	pos_6=NN	pos_2=IN	pos_9=JJ	path1=CRIXIVAN_nmod	path2=class_conj>inhibitor_nmod>agent_conj	lemma_6=or	lemma_2=to	relType_9=amod	relType_3=det	lemma_8=coadminister	pos_4=NN	lemma_9=antiretroviral	relType_7=amod	pos_6=CC	lemma_6=protease	pos_5=IN	lib=class	wib=class	relType_6=compound	relType_2=case	eib=True	pos_3=DT	pos_7=JJ	pos_6=NNS	lemma_3=the	relType_4=conj	relType_6=nmod	lemma_1=or	relType_6=cc
DDI-DrugBank.d97.s21	DDI-DrugBank.d97.s21.e1	DDI-DrugBank.d97.s21.e2	null	relType_1=cc	relType_4=amod	pos_1=CC	pos_4=JJ	lib=other	path2=agent_conj	pos_3=VBN	path1=	pos_2=JJ	lemma_2=other	wib=other	relType_3=amod	lpib=other_JJ	relType_2=amod	lemma_3=coadminister	lemma_4=antiretroviral	eib=True	path=<inhibitor_nmod>agent_conj	lemma_1=or
DDI-DrugBank.d97.s22	DDI-DrugBank.d97.s22.e0	DDI-DrugBank.d97.s22.e1	null	eib=False	lpib=lovastatin_NN	path1=	pos_1=:	relType_1=punct	path=<inhibitor_ROOT>lovastatin_dep	lib=lovastatin	path2=lovastatin_dep	wib=lovastatin	lemma_1=:
DDI-DrugBank.d97.s22	DDI-DrugBank.d97.s22.e0	DDI-DrugBank.d97.s22.e2	null	relType_2=dep	pos_2=NN	path=<inhibitor_ROOT>lovastatin_dep>simvastatin_appos	eib=True	lpib=lovastatin_NN	lemma_2=,	path1=	path2=lovastatin_dep>simvastatin_appos	pos_1=:	pos_2=,	relType_1=punct	lemma_2=lovastatin	lib=lovastatin	wib=lovastatin	lemma_1=:	relType_2=punct
DDI-DrugBank.d97.s22	DDI-DrugBank.d97.s22.e1	DDI-DrugBank.d97.s22.e2	null	wib=simvastatin	lemma_1=,	eib=False	lpib=simvastatin_NN	path1=	pos_1=,	relType_1=punct	path2=simvastatin_appos	lib=simvastatin	path=<lovastatin_dep>simvastatin_appos
DDI-DrugBank.d97.s24	DDI-DrugBank.d97.s24.e0	DDI-DrugBank.d97.s24.e1	null	lpib=atazanavir_NN	eib=False	path2=atazanavir_dep	lib=atazanavir	path1=	pos_1=:	relType_1=punct	path=<inhibitor_ROOT>atazanavir_dep	wib=atazanavir	lemma_1=:
DDI-DrugBank.d97.s25	DDI-DrugBank.d97.s25.e0	DDI-DrugBank.d97.s25.e1	null	relType_1=cc	pos_1=CC	lpib=atazanavir_NN	eib=False	lib=atazanavir	path2=atazanavir_conj	path1=	path=<crixivan_nsubj:pass>atazanavir_conj	wib=atazanavir	lemma_1=and
DDI-DrugBank.d97.s26	DDI-DrugBank.d97.s26.e0	DDI-DrugBank.d97.s26.e1	advise	relType_1=cc	pos_1=CC	lpib=atazanavir_NN	eib=False	lib=atazanavir	path2=atazanavir_conj	path1=	wib=atazanavir	lemma_1=and	path=<CRIXIVAN_obl>atazanavir_conj
DDI-DrugBank.d97.s35	DDI-DrugBank.d97.s35.e0	DDI-DrugBank.d97.s35.e1	advise	pos_10=WRB	lemma_6=hour	relType_1=case	relType_2=nummod	lemma_9=consider	relType_7=aux	lemma_5=8	relType_9=ROOT	pos_5=CD	pos_3=NNS	lib=mg	lemma_11=take	eib=False	pos_2=CD	lemma_10=when	relType_8=aux:pass	relType_10=advmod	pos_1=IN	pos_7=MD	pos_9=VBN	path2=when_advmod>take_dep>mg_obj>delavirdine_compound	lpib=mg_NNS	pos_8=VB	pos_4=DT	path=CRIXIVAN_nmod<reduction_nsubj:pass<consider_ROOT>when_advmod>take_dep>mg_obj>delavirdine_compound	relType_5=nummod	lemma_8=be	lemma_2=600	relType_3=nmod	relType_6=nsubj:pass	lemma_7=should	pos_11=VBG	relType_11=dep	lemma_1=to	pos_6=NNS	wib=mg	lemma_3=mg	path1=CRIXIVAN_nmod<reduction_nsubj:pass	lemma_4=every	relType_4=det
DDI-DrugBank.d97.s37	DDI-DrugBank.d97.s37.e0	DDI-DrugBank.d97.s37.e1	advise	relType_1=cc	path=<Indinavir_compound>didanosine_conj	path2=didanosine_conj	pos_1=CC	lib=didanosine	wib=didanosine	eib=False	path1=	lpib=didanosine_NN	lemma_1=and
DDI-DrugBank.d97.s40	DDI-DrugBank.d97.s40.e0	DDI-DrugBank.d97.s40.e1	null	lemma_1=,	path=indinavir_nmod<dose_ROOT>know_acl:relcl>combination_obl>efavirenz_nmod	pos_3=VBN	pos_1=,	lemma_4=in	relType_6=case	lib=give	lemma_5=combination	path2=know_acl:relcl>combination_obl>efavirenz_nmod	eib=False	relType_2=advmod	pos_6=IN	wib=given	pos_4=IN	relType_4=case	lemma_3=give	lemma_6=with	path1=indinavir_nmod	relType_5=obl	pos_2=WRB	relType_3=case	lemma_2=when	pos_5=NN	relType_1=punct	lpib=give_VBN
DDI-DrugBank.d97.s41	DDI-DrugBank.d97.s41.e0	DDI-DrugBank.d97.s41.e1	null	lemma_3=1000	pos_7=NNS	relType_9=advmod	path=indinavir_compound<dose_obj<increase_nsubj<compensate_ROOT>metabolism_obl>indinavir_compound	pos_6=CD	relType_12=det	pos_13=VBN	lemma_5=every	relType_11=case	pos_2=IN	pos_8=VBZ	eib=False	relType_13=amod	lemma_6=8	lemma_2=to	lemma_9=not	lpib=dose_NN	pos_4=NN	pos_1=NN	pos_10=VB	lemma_12=the	wib=dose	pos_11=IN	relType_10=ROOT	lemma_11=for	relType_4=obl	path1=indinavir_compound<dose_obj<increase_nsubj	pos_3=CD	lemma_4=mg	relType_5=det	relType_7=obl:tmod	relType_6=nummod	pos_9=RB	lib=dose	relType_3=nummod	lemma_10=compensate	lemma_7=hour	lemma_13=increase	relType_2=case	lemma_8=do	pos_5=DT	path2=metabolism_obl>indinavir_compound	relType_8=aux	pos_12=DT	lemma_1=dose	relType_1=obj	relation_12=beneficial
DDI-DrugBank.d97.s41	DDI-DrugBank.d97.s41.e0	DDI-DrugBank.d97.s41.e2	null	lemma_3=1000	pos_7=NNS	relType_9=advmod	pos_16=IN	pos_6=CD	relType_14=compound	relType_12=det	pos_13=VBN	lemma_5=every	relType_11=case	pos_2=IN	pos_8=VBZ	lemma_14=metabolism	relType_13=amod	lemma_6=8	lemma_2=to	lemma_9=not	lpib=dose_NN	pos_14=NN	relType_14=obl	pos_4=NN	pos_1=NN	pos_10=VB	lemma_12=the	wib=dose	pos_11=IN	relType_10=ROOT	lemma_11=for	relType_15=case	relType_4=obl	lemma_14=indinavir	path1=indinavir_compound<dose_obj<increase_nsubj	pos_3=CD	lemma_4=mg	relType_5=det	relType_7=obl:tmod	relType_6=nummod	pos_9=RB	path=indinavir_compound<dose_obj<increase_nsubj<compensate_ROOT>efavirenz_obl	lib=dose	path2=efavirenz_obl	relType_3=nummod	lemma_15=due	lemma_10=compensate	lemma_7=hour	lemma_13=increase	pos_15=IN	relType_2=case	lemma_8=do	eib=True	pos_5=DT	relType_8=aux	pos_12=DT	lemma_1=dose	relType_1=obj	relType_16=fixed	relation_12=beneficial	lemma_16=to
DDI-DrugBank.d97.s41	DDI-DrugBank.d97.s41.e1	DDI-DrugBank.d97.s41.e2	mechanism	pos_2=IN	relType_3=fixed	relType_2=case	pos_3=IN	lemma_2=due	eib=False	path=indinavir_compound<metabolism_obl<compensate_ROOT>efavirenz_obl	lib=metabolism	lemma_3=to	lemma_1=metabolism	lpib=metabolism_NN	path1=indinavir_compound<metabolism_obl	path2=efavirenz_obl	wib=metabolism	pos_1=NN	relType_1=obl
DDI-DrugBank.d97.s47	DDI-DrugBank.d97.s47.e0	DDI-DrugBank.d97.s47.e1	mechanism	relType_8=case	lemma_5=in	path=Indinavir_compound<concentration_nsubj:pass<decrease_ROOT>presence_obl>nevirapine_nmod	pos_6=DT	lpib=concentration_NNS	pos_2=MD	pos_3=VB	lemma_1=concentration	relType_3=aux:pass	relType_5=case	lemma_7=presence	eib=False	lemma_6=the	relType_2=aux	pos_8=IN	pos_4=VBN	path2=presence_obl>nevirapine_nmod	path1=Indinavir_compound<concentration_nsubj:pass	wib=concentrations	relation_3=adverse	lemma_3=be	pos_5=IN	relType_4=ROOT	relType_6=det	relType_7=obl	pos_1=NNS	lib=concentration	relType_1=nsubj:pass	lemma_2=may	pos_7=NN	lemma_8=of	lemma_4=decrease
DDI-DrugBank.d97.s50	DDI-DrugBank.d97.s50.e0	DDI-DrugBank.d97.s50.e1	null	lpib=concentration_NN	path1=indinavir_compound<concentration_compound	path2=ritonavir_compound	wib=concentration	relType_1=compound	eib=False	path=indinavir_compound<concentration_compound<concentration_ROOT>ritonavir_compound	lib=concentration	lemma_1=concentration	pos_1=NN
DDI-DrugBank.d97.s52	DDI-DrugBank.d97.s52.e0	DDI-DrugBank.d97.s52.e1	effect	relType_1=case	lemma_1=in	pos_2=NN	path=indinavir_obj<receive_acl>combination_obl>ritonavir_nmod	pos_3=IN	eib=False	wib=combination	lpib=combination_NN	lemma_2=combination	path2=combination_obl>ritonavir_nmod	lemma_3=with	pos_1=IN	lib=combination	path1=indinavir_obj	relType_3=case	relType_2=obl
DDI-DrugBank.d97.s52	DDI-DrugBank.d97.s52.e0	DDI-DrugBank.d97.s52.e2	null	path=indinavir_obj<receive_acl<patient_obl<high_ccomp>that_obl>receive_acl>q8h_obj>crixivan_compound	relType_1=case	lemma_1=in	pos_2=NN	pos_3=IN	lemma_6=receive	lemma_2=combination	relType_4=nmod	wib=combination	pos_6=VBG	path1=indinavir_obj<receive_acl<patient_obl	lemma_4=ritonavir	pos_1=IN	lib=combination	pos_4=NN	lemma_5=that	pos_4=IN	relType_6=acl	relType_4=case	lemma_3=with	relType_5=obl	relType_3=case	relType_2=obl	eib=True	pos_5=DT	lpib=combination_NN	lemma_4=than	path2=that_obl>receive_acl>q8h_obj>crixivan_compound
DDI-DrugBank.d97.s52	DDI-DrugBank.d97.s52.e1	DDI-DrugBank.d97.s52.e2	null	pos_2=DT	relType_1=case	lemma_1=than	eib=False	relType_3=acl	path=ritonavir_nmod<combination_obl<receive_acl<patient_obl<high_ccomp>that_obl>receive_acl>q8h_obj>crixivan_compound	wib=receiving	lib=receive	lpib=receive_VBG	pos_1=IN	lemma_2=that	pos_3=VBG	path2=that_obl>receive_acl>q8h_obj>crixivan_compound	lemma_3=receive	relType_2=obl	path1=ritonavir_nmod<combination_obl<receive_acl<patient_obl
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e0	DDI-DrugBank.d97.s57.e1	null	wib=bepridil	lib=bepridil	lpib=bepridil_NN	eib=False	path=<Antiarrhythmics_ROOT>bepridil_dep	path1=	pos_1=:	relType_1=punct	lemma_1=:	path2=bepridil_dep
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e0	DDI-DrugBank.d97.s57.e2	null	wib=bepridil	relType_2=dep	lib=bepridil	pos_2=NN	lpib=bepridil_NN	eib=True	lemma_2=bepridil	path1=	pos_1=:	pos_2=,	path2=bepridil_dep>lidocaine_conj	path=<Antiarrhythmics_ROOT>bepridil_dep>lidocaine_conj	relType_1=punct	lemma_2=,	lemma_1=:	relType_2=punct
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e0	DDI-DrugBank.d97.s57.e3	null	relType_4=dep	pos_4=JJ	pos_2=NN	path1=	lemma_3=lidocaine	relType_2=punct	wib=bepridil	lemma_3=(	pos_3=-LRB-	lemma_2=,	lemma_1=:	lemma_5=)	relType_2=dep	lib=bepridil	lemma_2=bepridil	lpib=bepridil_NN	relType_3=conj	lemma_4=systemic	pos_5=-RRB-	relType_5=punct	pos_6=CC	lemma_6=and	pos_1=:	eib=True	pos_3=NN	path2=bepridil_dep>quinidine_conj	path=<Antiarrhythmics_ROOT>bepridil_dep>quinidine_conj	pos_2=,	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e1	DDI-DrugBank.d97.s57.e2	null	lemma_1=,	eib=False	path2=lidocaine_conj	path1=	pos_1=,	path=<bepridil_dep>lidocaine_conj	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	wib=lidocaine
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e1	DDI-DrugBank.d97.s57.e3	null	relType_3=dep	lemma_1=,	lemma_3=systemic	pos_2=NN	pos_5=CC	path1=	pos_1=,	path=<bepridil_dep>quinidine_conj	lpib=lidocaine_NN	relType_2=punct	relType_5=cc	pos_4=-RRB-	pos_2=-LRB-	lib=lidocaine	relType_2=conj	relType_4=punct	path2=quinidine_conj	lemma_4=)	pos_3=JJ	eib=True	lemma_5=and	relType_1=punct	lemma_2=(	lemma_2=lidocaine	wib=lidocaine
DDI-DrugBank.d97.s57	DDI-DrugBank.d97.s57.e2	DDI-DrugBank.d97.s57.e3	null	path1=lidocaine_conj	relType_4=cc	pos_2=JJ	wib=systemic	lpib=systemic_JJ	lemma_1=(	eib=False	path=lidocaine_conj<bepridil_dep>quinidine_conj	relType_2=dep	path2=quinidine_conj	lemma_3=)	lib=systemic	pos_1=-LRB-	pos_4=CC	pos_3=-RRB-	lemma_4=and	lemma_2=systemic	relType_1=punct	relType_3=punct
DDI-DrugBank.d97.s59	DDI-DrugBank.d97.s59.e0	DDI-DrugBank.d97.s59.e1	advise	pos_2=VBN	pos_3=IN	eib=False	path=antiarrhythmic_obl<recommend_parataxis>coadminister_advcl>CRIXIVAN_obl	lemma_1=when	pos_1=WRB	lib=coadminister	relType_2=advcl	lemma_3=with	lemma_2=coadminister	path2=coadminister_advcl>CRIXIVAN_obl	relType_3=case	relType_1=advmod	lpib=coadminister_VBN	path1=antiarrhythmic_obl	wib=coadministered
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e0	DDI-DrugBank.d97.s60.e1	null	path=<anticonvulsant_ROOT>carbamazepine_dep	path2=carbamazepine_dep	lpib=carbamazepine_NN	eib=False	path1=	wib=carbamazepine	pos_1=:	relType_1=punct	lemma_1=:	lib=carbamazepine
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e0	DDI-DrugBank.d97.s60.e2	null	relType_2=dep	pos_2=NN	eib=True	lpib=carbamazepine_NN	path2=carbamazepine_dep>phenobarbital_conj	path=<anticonvulsant_ROOT>carbamazepine_dep>phenobarbital_conj	wib=carbamazepine	path1=	pos_1=:	pos_2=,	relType_1=punct	lemma_2=carbamazepine	lemma_2=,	lemma_1=:	relType_2=punct	lib=carbamazepine
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e0	DDI-DrugBank.d97.s60.e3	null	pos_2=NN	lpib=carbamazepine_NN	path1=	relType_2=punct	wib=carbamazepine	lemma_2=carbamazepine	lemma_2=,	lemma_1=:	lib=carbamazepine	relType_2=dep	lemma_3=,	relType_3=conj	path=<anticonvulsant_ROOT>carbamazepine_dep>phenytoin_conj	pos_1=:	path2=carbamazepine_dep>phenytoin_conj	lemma_3=phenobarbital	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e1	DDI-DrugBank.d97.s60.e2	null	lemma_1=,	eib=False	lpib=phenobarbital_NN	path2=phenobarbital_conj	wib=phenobarbital	path1=	pos_1=,	relType_1=punct	lib=phenobarbital	path=<carbamazepine_dep>phenobarbital_conj
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e1	DDI-DrugBank.d97.s60.e3	null	path=<carbamazepine_dep>phenytoin_conj	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lpib=phenobarbital_NN	lemma_2=,	wib=phenobarbital	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	path2=phenytoin_conj	lib=phenobarbital	lemma_2=phenobarbital
DDI-DrugBank.d97.s60	DDI-DrugBank.d97.s60.e2	DDI-DrugBank.d97.s60.e3	null	path1=phenobarbital_conj	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	pos_1=,	path2=phenytoin_conj	path=phenobarbital_conj<carbamazepine_dep>phenytoin_conj	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d97.s63	DDI-DrugBank.d97.s63.e0	DDI-DrugBank.d97.s63.e1	effect	pos_4=JJ	lemma_4=effective	relType_1=aux	lemma_1=may	lemma_5=due	pos_3=VB	lemma_6=to	relType_5=case	pos_2=RB	eib=False	relType_2=advmod	pos_6=IN	relation_6=adverse	wib=not	path=CRIXIVAN_nsubj<effective_ROOT>concentration_obl>indinavir_compound	relType_7=amod	relType_6=fixed	lemma_3=be	pos_5=IN	lemma_7=decrease	pos_1=MD	relType_4=ROOT	lib=not	path2=concentration_obl>indinavir_compound	pos_7=VBN	path1=CRIXIVAN_nsubj	lpib=not_RB	relType_3=cop	lemma_2=not
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e0	DDI-DrugBank.d97.s64.e1	null	lemma_1=,	path=<Blockers_ROOT>Dihydropyridine_appos	eib=False	path2=Dihydropyridine_appos	path1=	lpib=dihydropyridine_NNP	pos_1=,	wib=Dihydropyridine	lib=dihydropyridine	relType_1=punct
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e0	DDI-DrugBank.d97.s64.e2	null	relType_4=dep	lemma_1=,	pos_5=,	path1=	pos_1=,	relType_2=punct	lemma_3=e.	lemma_2=:	lemma_2=Dihydropyridine	pos_2=NNP	pos_4=NN	lemma_5=,	relType_5=punct	path2=g._dep>felodipine_conj	pos_2=:	wib=Dihydropyridine	relType_2=appos	path=<Blockers_ROOT>g._dep>felodipine_conj	lemma_4=g.	eib=True	pos_3=NN	lpib=dihydropyridine_NNP	relType_3=compound	relType_1=punct	lib=dihydropyridine
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e0	DDI-DrugBank.d97.s64.e3	null	relType_4=dep	lemma_1=,	pos_5=,	path1=	pos_1=,	lemma_6=,	relType_2=punct	lemma_3=e.	pos_6=NN	lemma_2=:	lemma_2=Dihydropyridine	relType_6=conj	pos_2=NNP	lemma_6=felodipine	relType_6=punct	path=<Blockers_ROOT>g._dep>nifedipine_conj	pos_4=NN	lemma_5=,	relType_5=punct	pos_2=:	wib=Dihydropyridine	relType_2=appos	pos_6=,	path2=g._dep>nifedipine_conj	lemma_4=g.	eib=True	pos_3=NN	lpib=dihydropyridine_NNP	relType_3=compound	relType_1=punct	lib=dihydropyridine
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e0	DDI-DrugBank.d97.s64.e4	null	relType_4=dep	lemma_1=,	pos_5=,	pos_7=NN	path1=	path2=g._dep>nicardipine_appos	pos_1=,	lemma_6=,	relType_2=punct	lemma_3=e.	pos_6=NN	lemma_2=:	lemma_2=Dihydropyridine	relType_6=conj	pos_2=NNP	lemma_6=felodipine	relType_6=punct	pos_7=,	lemma_7=,	pos_4=NN	lemma_5=,	relType_5=punct	lemma_7=nifedipine	pos_2=:	wib=Dihydropyridine	relType_2=appos	path=<Blockers_ROOT>g._dep>nicardipine_appos	pos_6=,	lemma_4=g.	eib=True	pos_3=NN	relType_7=punct	lpib=dihydropyridine_NNP	relType_3=compound	relType_1=punct	lib=dihydropyridine	relType_7=conj
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e1	DDI-DrugBank.d97.s64.e2	null	path=Dihydropyridine_appos<Blockers_ROOT>g._dep>felodipine_conj	relType_3=dep	pos_2=NN	lib=e.	lemma_3=g.	eib=False	pos_4=,	lemma_1=:	path1=Dihydropyridine_appos	relType_4=punct	relType_2=compound	path2=g._dep>felodipine_conj	pos_1=:	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_3=NN	relType_1=punct
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e1	DDI-DrugBank.d97.s64.e3	null	relType_3=dep	lemma_5=felodipine	pos_2=NN	pos_5=,	lib=e.	lemma_3=g.	pos_4=,	lemma_1=:	path1=Dihydropyridine_appos	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	pos_1=:	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	path=Dihydropyridine_appos<Blockers_ROOT>g._dep>nifedipine_conj	pos_5=NN	path2=g._dep>nifedipine_conj	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e1	DDI-DrugBank.d97.s64.e4	null	relType_3=dep	lemma_5=felodipine	pos_2=NN	path=Dihydropyridine_appos<Blockers_ROOT>g._dep>nicardipine_appos	pos_5=,	path2=g._dep>nicardipine_appos	lemma_6=,	lib=e.	pos_6=NN	relType_6=conj	lemma_3=g.	pos_4=,	relType_6=punct	lemma_1=:	path1=Dihydropyridine_appos	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	pos_1=:	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_6=nifedipine	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e2	DDI-DrugBank.d97.s64.e3	null	path2=nifedipine_conj	lemma_1=,	eib=False	path1=felodipine_conj	pos_1=,	lib=nifedipine	lpib=nifedipine_NN	relType_1=punct	wib=nifedipine	path=felodipine_conj<g._dep>nifedipine_conj
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e2	DDI-DrugBank.d97.s64.e4	null	path=felodipine_conj<g._dep>nicardipine_appos	lemma_1=,	pos_2=NN	eib=True	path1=felodipine_conj	lemma_2=,	pos_1=,	lib=nifedipine	pos_2=,	lpib=nifedipine_NN	lemma_2=nifedipine	path2=nicardipine_appos	relType_1=punct	relType_2=conj	wib=nifedipine	relType_2=punct
DDI-DrugBank.d97.s64	DDI-DrugBank.d97.s64.e3	DDI-DrugBank.d97.s64.e4	null	lemma_1=,	eib=False	path1=nifedipine_conj	path=nifedipine_conj<g._dep>nicardipine_appos	pos_1=,	path2=nicardipine_appos	lpib=nicardipine_NN	relType_1=punct	wib=nicardipine	lib=nicardipine
DDI-DrugBank.d97.s68	DDI-DrugBank.d97.s68.e0	DDI-DrugBank.d97.s68.e1	null	lpib=concentration_NN	wib=concentration	relType_1=compound	eib=False	path=clarithromycin_compound<concentration_compound<concentration_ROOT>indinavir_compound	lib=concentration	path1=clarithromycin_compound<concentration_compound	path2=indinavir_compound	pos_1=NN	lemma_1=concentration
DDI-DrugBank.d97.s70	DDI-DrugBank.d97.s70.e0	DDI-DrugBank.d97.s70.e1	null	eib=False	wib=atorvastatin	path=<inhibitor_ROOT>atorvastatin_dep	path2=atorvastatin_dep	lpib=atorvastatin_NN	path1=	pos_1=:	lemma_1=:	relType_1=punct	lib=atorvastatin
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e0	DDI-DrugBank.d97.s72.e1	null	relType_1=case	relType_7=compound	lpib=careful_JJ	pos_6=VB	pos_5=CC	lib=careful	lemma_3=monitoring	pos_2=JJ	path1=atorvastatin_nmod	lemma_7=-	relType_5=cc	relType_6=conj	pos_4=,	lemma_2=careful	lemma_7=coa	pos_1=IN	lemma_7=reductase	path=atorvastatin_nmod<dose_obj>consider_conj>inhibitor_obj	wib=careful	relType_4=punct	pos_7=HYPH	relType_2=amod	relType_3=nmod	lemma_7=hmg	path2=consider_conj>inhibitor_obj	lemma_4=,	lemma_1=with	eib=True	pos_3=NN	relType_7=punct	pos_7=NN	lemma_6=consider	lemma_5=or
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e0	DDI-DrugBank.d97.s72.e2	null	pos_7=NNS	relType_1=case	relType_7=compound	relType_14=punct	lpib=careful_JJ	pos_6=VB	pos_5=CC	relType_9=advmod	pos_15=JJ	pos_16=IN	relType_12=case	relType_11=acl:relcl	lib=careful	lemma_3=monitoring	pos_8=VBP	lemma_16=as	pos_2=JJ	path1=atorvastatin_nmod	lemma_7=-	relType_5=cc	relType_6=conj	relType_13=obl	pos_4=,	pos_14=,	relType_7=obj	relType_8=aux:pass	lemma_2=careful	relType_7=nsubj:pass	lemma_9=not	lemma_7=coa	pos_1=IN	lemma_7=reductase	relType_10=advmod	path=atorvastatin_nmod<dose_obj>consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod	pos_7=WDT	pos_13=NN	pos_12=IN	lemma_15=such	wib=careful	lemma_7=that	lemma_10=primarily	relType_15=case	relType_4=punct	pos_7=HYPH	lemma_8=be	lemma_11=metabolize	relType_2=amod	relType_3=nmod	lemma_7=hmg	pos_9=RB	lemma_4=,	pos_11=VBN	lemma_12=by	lemma_1=with	lemma_14=,	eib=True	lemma_7=inhibitor	pos_3=NN	relType_7=punct	pos_10=RB	lemma_13=cyp3a4	pos_7=NN	relType_16=fixed	path2=consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod	lemma_6=consider	lemma_5=or
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e0	DDI-DrugBank.d97.s72.e3	null	pos_7=NNS	relType_1=case	relType_7=compound	relType_14=punct	lpib=careful_JJ	pos_6=VB	pos_5=CC	relType_9=advmod	pos_15=JJ	pos_16=IN	lemma_17=pravastatin	relType_17=punct	relType_12=case	relType_11=acl:relcl	lib=careful	lemma_3=monitoring	pos_8=VBP	lemma_16=as	pos_2=JJ	path1=atorvastatin_nmod	path=atorvastatin_nmod<dose_obj>consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>fluvastatin_conj	lemma_7=-	relType_5=cc	relType_6=conj	relType_13=obl	pos_17=NN	pos_4=,	lemma_17=,	pos_14=,	relType_7=obj	relType_8=aux:pass	lemma_2=careful	relType_7=nsubj:pass	lemma_9=not	lemma_7=coa	pos_1=IN	lemma_7=reductase	relType_10=advmod	pos_13=NN	pos_7=WDT	pos_12=IN	lemma_15=such	wib=careful	lemma_7=that	lemma_10=primarily	pos_17=,	relType_15=case	relType_4=punct	pos_7=HYPH	lemma_8=be	lemma_11=metabolize	relType_2=amod	relType_3=nmod	lemma_7=hmg	pos_9=RB	lemma_4=,	pos_11=VBN	relType_17=nmod	lemma_12=by	lemma_1=with	lemma_14=,	eib=True	lemma_7=inhibitor	pos_3=NN	relType_7=punct	pos_10=RB	lemma_13=cyp3a4	pos_7=NN	path2=consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>fluvastatin_conj	relType_16=fixed	lemma_6=consider	lemma_5=or
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e0	DDI-DrugBank.d97.s72.e4	null	lib=careful	lemma_16=as	pos_2=JJ	path1=atorvastatin_nmod	relType_5=cc	relType_6=conj	lemma_2=careful	lemma_9=not	lemma_7=reductase	pos_13=NN	path=atorvastatin_nmod<dose_obj>consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj	pos_18=NN	relType_4=punct	pos_7=HYPH	lemma_11=metabolize	pos_19=CC	lemma_19=or	pos_7=NNS	relType_1=case	pos_6=VB	relType_9=advmod	relType_8=aux:pass	pos_1=IN	pos_12=IN	relType_15=case	lemma_4=,	lemma_14=,	lemma_7=inhibitor	pos_10=RB	lemma_13=cyp3a4	pos_7=NN	lemma_5=or	relType_14=punct	pos_16=IN	lemma_17=pravastatin	relType_17=punct	relType_12=case	relType_11=acl:relcl	lemma_3=monitoring	pos_8=VBP	relType_13=obl	pos_17=NN	lemma_18=fluvastatin	pos_4=,	pos_14=,	relType_7=obj	relType_7=nsubj:pass	wib=careful	pos_17=,	relType_2=amod	relType_3=nmod	pos_9=RB	relType_17=nmod	lemma_12=by	relType_7=compound	lpib=careful_JJ	pos_15=JJ	pos_5=CC	lemma_7=-	lemma_17=,	relType_10=advmod	lemma_7=coa	pos_7=WDT	lemma_15=such	lemma_7=that	lemma_10=primarily	pos_18=,	lemma_8=be	lemma_18=,	relType_18=punct	lemma_7=hmg	pos_11=VBN	relType_19=cc	path2=consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj	lemma_1=with	eib=True	pos_3=NN	relType_7=punct	relType_18=conj	relType_16=fixed	lemma_6=consider
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e0	DDI-DrugBank.d97.s72.e5	advise	lib=careful	lemma_16=as	pos_2=JJ	path1=atorvastatin_nmod	relType_5=cc	relType_6=conj	pos_20=NN	lemma_2=careful	lemma_9=not	lemma_7=reductase	pos_13=NN	pos_22=IN	pos_18=NN	relType_4=punct	pos_7=HYPH	lemma_11=metabolize	pos_19=CC	lemma_19=or	pos_7=NNS	relType_1=case	pos_6=VB	relType_9=advmod	relType_20=case	relType_20=conj	relType_8=aux:pass	pos_1=IN	relType_22=case	pos_12=IN	relType_15=case	lemma_4=,	lemma_22=with	lemma_20=rosuvastatin	lemma_14=,	lemma_7=inhibitor	pos_10=RB	lemma_13=cyp3a4	pos_7=NN	lemma_5=or	relType_14=punct	pos_16=IN	lemma_17=pravastatin	relType_17=punct	relType_12=case	relType_11=acl:relcl	lemma_3=monitoring	relType_21=nmod	pos_8=VBP	pos_20=IN	relType_13=obl	pos_17=NN	pos_21=NN	lemma_18=fluvastatin	pos_4=,	pos_14=,	relType_7=obj	relType_7=nsubj:pass	lemma_21=combination	wib=careful	pos_17=,	relType_2=amod	relType_3=nmod	pos_9=RB	relType_17=nmod	lemma_12=by	relType_7=compound	lpib=careful_JJ	pos_15=JJ	pos_5=CC	lemma_7=-	lemma_17=,	relType_10=advmod	lemma_7=coa	pos_7=WDT	path=atorvastatin_nmod<dose_obj>consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	lemma_15=such	lemma_7=that	lemma_10=primarily	pos_18=,	path2=consider_conj>inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	lemma_8=be	lemma_18=,	relType_18=punct	lemma_20=in	lemma_7=hmg	pos_11=VBN	relType_19=cc	lemma_1=with	eib=True	pos_3=NN	relType_7=punct	relType_18=conj	relType_16=fixed	lemma_6=consider
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e1	DDI-DrugBank.d97.s72.e2	null	pos_3=RB	relType_3=advmod	lpib=be_VBP	path1=	lemma_3=not	lemma_5=metabolize	lemma_6=by	relType_8=punct	lemma_8=,	path=<inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod	relType_6=case	relType_5=acl:relcl	pos_9=JJ	pos_4=RB	eib=False	pos_6=IN	lemma_4=primarily	relType_9=case	lemma_1=that	wib=are	relType_10=fixed	lemma_10=as	lib=be	relType_4=advmod	relType_2=aux:pass	pos_2=VBP	pos_10=IN	path2=metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod	lemma_9=such	relType_7=obl	lemma_7=cyp3a4	pos_8=,	relType_1=nsubj:pass	lemma_2=be	pos_7=NN	pos_5=VBN	pos_1=WDT
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e1	DDI-DrugBank.d97.s72.e3	null	pos_3=RB	relType_3=advmod	lemma_11=,	lpib=be_VBP	path1=	lemma_3=not	lemma_5=metabolize	lemma_6=by	relType_8=punct	lemma_8=,	relType_6=case	relType_5=acl:relcl	pos_9=JJ	pos_4=RB	path2=metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>fluvastatin_conj	lemma_11=pravastatin	pos_6=IN	relType_11=punct	lemma_4=primarily	relType_9=case	lemma_1=that	wib=are	relType_10=fixed	lemma_10=as	lib=be	relType_4=advmod	relType_2=aux:pass	pos_2=VBP	pos_10=IN	pos_11=,	path=<inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>fluvastatin_conj	lemma_9=such	relType_7=obl	pos_11=NN	eib=True	lemma_7=cyp3a4	pos_8=,	relType_1=nsubj:pass	lemma_2=be	relType_11=nmod	pos_7=NN	pos_5=VBN	pos_1=WDT
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e1	DDI-DrugBank.d97.s72.e4	null	relType_12=conj	pos_3=RB	relType_3=advmod	lemma_11=,	lpib=be_VBP	path1=	lemma_3=not	lemma_5=metabolize	lemma_6=by	relType_8=punct	lemma_8=,	relType_6=case	relType_5=acl:relcl	lemma_12=fluvastatin	pos_9=JJ	lemma_12=,	pos_4=RB	path2=metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj	lemma_11=pravastatin	lemma_13=or	pos_6=IN	relType_11=punct	pos_12=,	pos_12=NN	lemma_4=primarily	relType_9=case	relType_12=punct	lemma_1=that	wib=are	relType_10=fixed	relType_13=cc	lemma_10=as	lib=be	relType_4=advmod	relType_2=aux:pass	pos_2=VBP	pos_10=IN	pos_11=,	pos_13=CC	lemma_9=such	relType_7=obl	pos_11=NN	eib=True	lemma_7=cyp3a4	path=<inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj	pos_8=,	relType_1=nsubj:pass	lemma_2=be	relType_11=nmod	pos_7=NN	pos_5=VBN	pos_1=WDT
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e1	DDI-DrugBank.d97.s72.e5	advise	relType_12=conj	pos_3=RB	relType_3=advmod	lemma_11=,	pos_16=IN	path=<inhibitor_obj>metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	lpib=be_VBP	path1=	lemma_3=not	lemma_5=metabolize	lemma_6=by	relType_8=punct	lemma_8=,	relType_6=case	relType_5=acl:relcl	lemma_12=fluvastatin	pos_9=JJ	lemma_12=,	pos_4=RB	lemma_11=pravastatin	lemma_13=or	pos_6=IN	relType_11=punct	pos_12=,	pos_12=NN	lemma_4=primarily	relType_9=case	relType_12=punct	lemma_1=that	pos_14=NN	lemma_14=in	lemma_16=with	wib=are	relType_10=fixed	relType_13=cc	pos_14=IN	lemma_10=as	lib=be	pos_15=NN	relType_4=advmod	lemma_15=combination	relType_2=aux:pass	pos_2=VBP	pos_10=IN	pos_11=,	relType_15=nmod	pos_13=CC	lemma_9=such	relType_16=case	lemma_14=rosuvastatin	relType_7=obl	pos_11=NN	eib=True	lemma_7=cyp3a4	pos_8=,	relType_14=conj	relType_1=nsubj:pass	lemma_2=be	relType_11=nmod	relType_14=case	pos_7=NN	pos_5=VBN	pos_1=WDT	path2=metabolize_acl:relcl>cyp3a4_obl>pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e2	DDI-DrugBank.d97.s72.e3	null	lemma_1=,	wib=fluvastatin	eib=False	path=<pravastatin_nmod>fluvastatin_conj	path1=	lib=fluvastatin	pos_1=,	lpib=fluvastatin_NN	path2=fluvastatin_conj	relType_1=punct
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e2	DDI-DrugBank.d97.s72.e4	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	lpib=fluvastatin_NN	relType_3=cc	relType_2=punct	wib=fluvastatin	lib=fluvastatin	lemma_3=or	relType_2=conj	lemma_2=,	lemma_2=fluvastatin	path=<pravastatin_nmod>rosuvastatin_conj	eib=True	path2=rosuvastatin_conj	pos_2=,	relType_1=punct
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e2	DDI-DrugBank.d97.s72.e5	null	lemma_1=,	lemma_4=rosuvastatin	pos_2=NN	path=<pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	pos_3=CC	path1=	pos_1=,	lemma_4=in	lpib=fluvastatin_NN	relType_6=case	relType_2=punct	relType_3=cc	lemma_5=combination	wib=fluvastatin	pos_6=IN	lib=fluvastatin	lemma_3=or	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=fluvastatin	pos_4=IN	relType_4=case	relType_5=nmod	lemma_6=with	pos_5=NN	eib=True	pos_2=,	relType_4=conj	relType_1=punct	path2=rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e3	DDI-DrugBank.d97.s72.e4	null	lemma_2=or	path1=fluvastatin_conj	lemma_1=,	wib=rosuvastatin	eib=False	lib=rosuvastatin	path2=rosuvastatin_conj	pos_2=CC	pos_1=,	path=fluvastatin_conj<pravastatin_nmod>rosuvastatin_conj	lpib=rosuvastatin_NN	relType_1=punct	relType_2=cc
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e3	DDI-DrugBank.d97.s72.e5	null	lemma_3=rosuvastatin	lemma_2=or	lemma_1=,	pos_3=IN	pos_1=,	lpib=rosuvastatin_NN	relType_4=nmod	relType_2=cc	relType_5=case	wib=rosuvastatin	lemma_5=with	pos_4=NN	path1=fluvastatin_conj	relType_3=conj	pos_5=IN	lemma_4=combination	relType_3=case	path=fluvastatin_conj<pravastatin_nmod>rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	eib=True	lib=rosuvastatin	pos_3=NN	pos_2=CC	relType_1=punct	lemma_3=in	path2=rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod
DDI-DrugBank.d97.s72	DDI-DrugBank.d97.s72.e4	DDI-DrugBank.d97.s72.e5	null	path=<rosuvastatin_conj>combination_nmod>CRIXIVAN_nmod	relType_1=case	lemma_1=in	pos_2=NN	pos_3=IN	eib=False	path2=combination_nmod>CRIXIVAN_nmod	relType_2=nmod	path1=	lpib=combination_NN	lemma_2=combination	lemma_3=with	pos_1=IN	lib=combination	wib=combination	relType_3=case
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e0	DDI-DrugBank.d97.s73.e1	null	lpib=cyclosporine_NN	eib=False	path1=	path2=cyclosporine_dep	pos_1=:	lib=cyclosporine	path=<immunosuppressant_ROOT>cyclosporine_dep	relType_1=punct	wib=cyclosporine	lemma_1=:
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e0	DDI-DrugBank.d97.s73.e2	null	relType_2=dep	pos_2=NN	lpib=cyclosporine_NN	eib=True	path2=cyclosporine_dep>tacrolimus_conj	path1=	pos_1=:	pos_2=,	lib=cyclosporine	path=<immunosuppressant_ROOT>cyclosporine_dep>tacrolimus_conj	relType_1=punct	wib=cyclosporine	lemma_2=cyclosporine	lemma_2=,	lemma_1=:	relType_2=punct
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e0	DDI-DrugBank.d97.s73.e3	null	pos_2=NN	path1=	lemma_2=cyclosporine	relType_2=punct	lemma_3=tacrolimus	lib=cyclosporine	path=<immunosuppressant_ROOT>cyclosporine_dep>sirolimus_conj	lemma_2=,	lemma_1=:	relType_2=dep	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	pos_1=:	wib=cyclosporine	path2=cyclosporine_dep>sirolimus_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e1	DDI-DrugBank.d97.s73.e2	null	lemma_1=,	lpib=tacrolimus_NN	path2=tacrolimus_conj	eib=False	path1=	pos_1=,	lib=tacrolimus	wib=tacrolimus	path=<cyclosporine_dep>tacrolimus_conj	relType_1=punct
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e1	DDI-DrugBank.d97.s73.e3	null	lemma_1=,	lpib=tacrolimus_NN	pos_2=NN	eib=True	lemma_2=tacrolimus	path1=	path2=sirolimus_conj	lib=tacrolimus	path=<cyclosporine_dep>sirolimus_conj	pos_1=,	wib=tacrolimus	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d97.s73	DDI-DrugBank.d97.s73.e2	DDI-DrugBank.d97.s73.e3	null	path=tacrolimus_conj<cyclosporine_dep>sirolimus_conj	lemma_1=,	eib=False	pos_1=,	path2=sirolimus_conj	path1=tacrolimus_conj	relType_1=punct	lpib=sirolimus_NN	wib=sirolimus	lib=sirolimus
DDI-DrugBank.d97.s78	DDI-DrugBank.d97.s78.e0	DDI-DrugBank.d97.s78.e1	advise	lemma_6=hour	relType_1=case	pos_7=VBZ	relType_2=nummod	relType_9=advmod	pos_8=VBN	lemma_7=be	relType_10=amod	lemma_5=8	pos_5=CD	pos_9=WRB	path=CRIXIVAN_nmod<reduction_nsubj:pass<recommend_ROOT>when_advmod>itraconazole_dep	lib=mg	pos_3=NNS	eib=False	pos_2=CD	lemma_8=recommend	lemma_10=administer	pos_1=IN	lpib=mg_NNS	pos_4=DT	relType_5=nummod	lemma_2=600	relType_3=nmod	relType_6=nsubj:pass	relType_7=aux:pass	relType_8=ROOT	lemma_1=to	path2=when_advmod>itraconazole_dep	pos_6=NNS	wib=mg	pos_10=VBG	lemma_3=mg	path1=CRIXIVAN_nmod<reduction_nsubj:pass	lemma_4=every	relType_4=det	lemma_9=when
DDI-DrugBank.d97.s83	DDI-DrugBank.d97.s83.e0	DDI-DrugBank.d97.s83.e1	null	lpib=concentration_NN	path1=indinavir_compound<concentration_compound	path=indinavir_compound<concentration_compound<concentration_ROOT>rifabutin_compound	wib=concentration	relType_1=compound	eib=False	lib=concentration	lemma_1=concentration	path2=rifabutin_compound	pos_1=NN
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e0	DDI-DrugBank.d97.s84.e1	null	relType_4=amod	relType_1=case	pos_4=JJ	relType_9=conj	relType_2=det:predet	relType_7=det	path1=rifabutin_nmod	lemma_9=increase	lemma_10=of	path2=dose_nmod>increase_conj>CRIXIVAN_nmod	path=rifabutin_nmod<reduction_nsubj:pass>dose_nmod>increase_conj>CRIXIVAN_nmod	lemma_8=dose	pos_8=NN	relation_8=beneficial	eib=False	lib=standard	lemma_2=half	pos_1=IN	relType_10=case	relType_3=det	pos_9=NN	pos_7=DT	pos_6=CC	lemma_4=standard	lpib=standard_JJ	lemma_6=and	relType_8=compound	relType_5=nmod	pos_10=IN	lemma_1=to	wib=standard	pos_5=NN	lemma_5=dose	pos_3=DT	lemma_3=the	lemma_7=a	pos_2=PDT	relType_6=cc
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e0	DDI-DrugBank.d97.s84.e2	null	pos_12=CD	lemma_10=of	lemma_13=mg	path=rifabutin_nmod<reduction_nsubj:pass<recommend_ROOT>coadminister_advcl>rifabutin_nsubj:pass	pos_15=CD	pos_13=NN	pos_18=NN	lemma_22=8	pos_14=-LRB-	relType_15=nummod	lemma_4=standard	lemma_11=CRIXIVAN	lemma_24=be	relType_24=aux:pass	relType_4=amod	relType_1=case	lemma_12=1000	pos_19=NNS	relType_11=case	pos_8=NN	relType_22=nummod	lemma_26=when	pos_1=IN	relType_23=nsubj:pass	relType_3=det	pos_9=NN	pos_6=CC	lpib=standard_JJ	relType_21=det	relType_25=ROOT	relType_16=nummod	lemma_1=to	pos_25=VBN	pos_5=NN	lemma_5=dose	relType_26=advmod	path1=rifabutin_nmod<reduction_nsubj:pass	lemma_15=three	lemma_7=a	relType_11=nmod	lemma_25=recommend	lemma_11=to	relType_14=punct	relType_7=det	relType_17=punct	lemma_9=increase	lemma_8=dose	pos_20=-RRB-	pos_17=HYPH	relType_19=appos	pos_7=DT	pos_11=IN	pos_16=CD	pos_23=NNS	relType_8=compound	pos_10=IN	lemma_18=mg	lemma_20=)	wib=standard	lemma_16=333	relType_20=punct	pos_2=PDT	relType_6=cc	pos_4=JJ	relType_9=conj	relType_2=det:predet	pos_11=NNP	lemma_14=(	relType_13=nmod	lemma_21=every	pos_22=CD	relation_8=beneficial	lib=standard	lemma_2=half	pos_26=WRB	relType_10=case	lemma_17=-	pos_24=VBP	lemma_6=and	relType_5=nmod	path2=coadminister_advcl>rifabutin_nsubj:pass	eib=True	pos_3=DT	relType_18=compound	lemma_3=the	lemma_23=hour	relType_12=nummod	lemma_19=capsule	pos_21=DT
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e0	DDI-DrugBank.d97.s84.e3	null	relType_27=cc	pos_12=CD	lemma_10=of	lemma_13=mg	pos_15=CD	pos_13=NN	pos_18=NN	lemma_22=8	pos_14=-LRB-	relType_15=nummod	lemma_4=standard	lemma_11=CRIXIVAN	lemma_24=be	relType_24=aux:pass	relType_4=amod	relType_1=case	lemma_12=1000	pos_19=NNS	path=rifabutin_nmod<reduction_nsubj:pass<recommend_ROOT>coadminister_advcl>rifabutin_nsubj:pass>crixivan_conj	relType_11=case	pos_8=NN	relType_22=nummod	lemma_26=when	pos_1=IN	relType_23=nsubj:pass	relType_3=det	pos_9=NN	pos_27=NN	pos_6=CC	lpib=standard_JJ	relType_21=det	relType_25=ROOT	relType_16=nummod	lemma_1=to	pos_25=VBN	pos_5=NN	lemma_5=dose	relType_26=advmod	path1=rifabutin_nmod<reduction_nsubj:pass	lemma_15=three	lemma_7=a	relType_11=nmod	lemma_25=recommend	lemma_11=to	lemma_27=and	relType_14=punct	relType_7=det	relType_17=punct	lemma_9=increase	lemma_8=dose	pos_20=-RRB-	pos_17=HYPH	relType_19=appos	pos_7=DT	pos_11=IN	pos_16=CD	relType_27=nsubj:pass	pos_23=NNS	relType_8=compound	pos_10=IN	lemma_18=mg	lemma_20=)	wib=standard	lemma_16=333	pos_27=CC	relType_20=punct	pos_2=PDT	relType_6=cc	pos_4=JJ	relType_9=conj	relType_2=det:predet	pos_11=NNP	lemma_14=(	relType_13=nmod	lemma_21=every	pos_22=CD	relation_8=beneficial	lemma_27=rifabutin	lib=standard	lemma_2=half	pos_26=WRB	relType_10=case	lemma_17=-	pos_24=VBP	lemma_6=and	relType_5=nmod	eib=True	pos_3=DT	relType_18=compound	path2=coadminister_advcl>rifabutin_nsubj:pass>crixivan_conj	lemma_3=the	lemma_23=hour	relType_12=nummod	lemma_19=capsule	pos_21=DT
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e1	DDI-DrugBank.d97.s84.e2	null	relType_1=case	relType_10=punct	relType_2=nummod	pos_13=NNS	pos_12=CD	pos_14=VBP	pos_6=CD	lemma_5=three	path1=CRIXIVAN_nmod<increase_conj<dose_nmod<reduction_nsubj:pass	pos_8=NN	pos_5=CD	lemma_7=-	lemma_15=recommend	lib=mg	eib=False	pos_4=-LRB-	pos_2=CD	lpib=mg_NN	pos_9=NNS	path=CRIXIVAN_nmod<increase_conj<dose_nmod<reduction_nsubj:pass<recommend_ROOT>coadminister_advcl>rifabutin_nsubj:pass	relType_14=aux:pass	pos_1=IN	pos_15=VBN	relType_9=appos	lemma_4=(	lemma_14=be	relType_16=advmod	relType_4=punct	lemma_6=333	relType_5=nummod	pos_7=HYPH	relType_8=compound	lemma_13=hour	relType_3=nmod	relType_6=nummod	lemma_11=every	pos_11=DT	lemma_1=to	lemma_8=mg	lemma_9=capsule	relType_11=det	path2=coadminister_advcl>rifabutin_nsubj:pass	relType_13=nsubj:pass	lemma_16=when	lemma_10=)	lemma_12=8	pos_3=NN	relType_7=punct	pos_10=-RRB-	wib=mg	relType_12=nummod	lemma_3=mg	relType_15=ROOT	pos_16=WRB	lemma_2=1000
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e1	DDI-DrugBank.d97.s84.e3	null	path=CRIXIVAN_nmod<increase_conj<dose_nmod<reduction_nsubj:pass<recommend_ROOT>coadminister_advcl>rifabutin_nsubj:pass>crixivan_conj	relType_1=case	relType_10=punct	relType_2=nummod	relType_17=cc	pos_13=NNS	pos_12=CD	pos_14=VBP	pos_6=CD	relType_17=nsubj:pass	lemma_5=three	path1=CRIXIVAN_nmod<increase_conj<dose_nmod<reduction_nsubj:pass	pos_8=NN	pos_5=CD	lemma_7=-	lemma_15=recommend	pos_17=NN	lib=mg	pos_4=-LRB-	pos_2=CD	lpib=mg_NN	pos_9=NNS	relType_14=aux:pass	pos_1=IN	pos_15=VBN	relType_9=appos	lemma_4=(	lemma_14=be	relType_16=advmod	relType_4=punct	lemma_6=333	relType_5=nummod	pos_7=HYPH	relType_8=compound	lemma_13=hour	relType_3=nmod	relType_6=nummod	lemma_11=every	lemma_17=and	pos_11=DT	lemma_1=to	lemma_8=mg	lemma_9=capsule	relType_11=det	relType_13=nsubj:pass	lemma_16=when	lemma_10=)	lemma_12=8	eib=True	pos_3=NN	relType_7=punct	pos_10=-RRB-	path2=coadminister_advcl>rifabutin_nsubj:pass>crixivan_conj	wib=mg	relType_12=nummod	lemma_3=mg	relType_15=ROOT	pos_17=CC	lemma_17=rifabutin	pos_16=WRB	lemma_2=1000
DDI-DrugBank.d97.s84	DDI-DrugBank.d97.s84.e2	DDI-DrugBank.d97.s84.e3	advise	relType_1=cc	pos_1=CC	path2=crixivan_conj	eib=False	path=<rifabutin_nsubj:pass>crixivan_conj	path1=	lpib=crixivan_NN	lib=crixivan	lemma_1=and	wib=CRIXIVAN
DDI-DrugBank.d97.s87	DDI-DrugBank.d97.s87.e0	DDI-DrugBank.d97.s87.e1	advise	lemma_16=in	lemma_19=concomitant	relType_8=nummod	pos_3=RB	relType_3=advmod	relType_7=case	pos_16=IN	lemma_11=a	pos_2=MD	lemma_3=not	pos_12=CD	relType_13=punct	lemma_6=maximum	relType_14=compound	relType_9=nmod	lemma_13=-	pos_13=HYPH	relType_18=acl	pos_6=NN	lemma_5=a	eib=False	path2=period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound	pos_9=NNS	pos_19=JJ	lpib=dose_NN	path1=Sildenafil_compound<dose_nsubj	relType_2=aux	relType_10=case	pos_14=NN	pos_1=NN	lemma_9=mg	wib=dose	lemma_8=25	relType_15=obl	pos_15=NN	lemma_10=in	lemma_2=should	lemma_17=patient	relType_1=nsubj	relType_5=det	pos_18=VBG	lib=dose	pos_10=IN	pos_11=DT	relType_17=nmod	relType_19=amod	relType_4=ROOT	relType_11=det	lemma_12=48	lemma_7=of	relType_6=obj	lemma_4=exceed	relType_16=case	lemma_18=receive	pos_17=NNS	pos_7=IN	pos_4=VB	pos_5=DT	lemma_14=hour	relType_12=nummod	lemma_15=period	pos_8=CD	lemma_1=dose	path=Sildenafil_compound<dose_nsubj<exceed_ROOT>period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound
DDI-DrugBank.d97.s90	DDI-DrugBank.d97.s90.e0	DDI-DrugBank.d97.s90.e1	advise	lemma_16=in	lemma_19=concomitant	relType_8=nummod	pos_3=RB	relType_3=advmod	relType_7=case	lemma_8=10	pos_16=IN	lemma_11=a	pos_2=MD	lemma_3=not	pos_12=CD	relType_13=punct	lemma_6=maximum	relType_14=compound	relType_9=nmod	lemma_13=-	pos_13=HYPH	relType_18=acl	pos_6=NN	lemma_5=a	eib=False	path2=period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound	path=Tadalafil_compound<dose_nsubj<exceed_ROOT>period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound	pos_9=NNS	pos_19=JJ	lpib=dose_NN	relType_2=aux	relType_10=case	pos_14=NN	pos_1=NN	lemma_9=mg	wib=dose	relType_15=obl	pos_15=NN	lemma_10=in	lemma_2=should	lemma_17=patient	relType_1=nsubj	relType_5=det	pos_18=VBG	lib=dose	pos_10=IN	pos_11=DT	relType_17=nmod	relType_19=amod	relType_4=ROOT	relType_11=det	lemma_12=72	lemma_7=of	relType_6=obj	lemma_4=exceed	relType_16=case	lemma_18=receive	pos_17=NNS	pos_7=IN	pos_4=VB	path1=Tadalafil_compound<dose_nsubj	pos_5=DT	lemma_14=hour	relType_12=nummod	lemma_15=period	pos_8=CD	lemma_1=dose
DDI-DrugBank.d97.s93	DDI-DrugBank.d97.s93.e0	DDI-DrugBank.d97.s93.e1	advise	relType_8=nummod	pos_3=RB	relType_3=advmod	relType_7=case	path=Vardenafil_compound<dose_nsubj<exceed_ROOT>period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound	lemma_13=a	relType_17=obl	pos_21=JJ	pos_2=MD	lemma_3=not	relType_12=case	pos_13=DT	relType_16=compound	lemma_6=maximum	pos_19=NNS	lemma_20=receive	relType_18=case	pos_6=NN	lemma_5=a	pos_17=NN	relType_19=nmod	pos_20=VBG	eib=False	path2=period_obl>patient_nmod>receive_acl>therapy_obj>indinavir_compound	lemma_9=.	pos_11=NNS	lemma_11=mg	relType_21=amod	lpib=dose_NN	relType_2=aux	lemma_19=patient	lemma_21=concomitant	relType_15=punct	pos_1=NN	pos_12=IN	lemma_15=-	wib=dose	pos_18=IN	lemma_2=should	pos_10=CD	lemma_14=24	relType_1=nsubj	relType_5=det	pos_9=.	lib=dose	pos_16=NN	relType_9=punct	relType_4=ROOT	relType_10=nummod	relType_14=nummod	lemma_7=of	relType_6=obj	lemma_16=hour	lemma_4=exceed	lemma_12=in	path1=Vardenafil_compound<dose_nsubj	lemma_8=2	pos_7=IN	lemma_17=period	pos_4=VB	pos_5=DT	lemma_18=in	relType_13=det	relType_20=acl	relType_11=nmod	pos_8=CD	lemma_1=dose	pos_14=CD	pos_15=HYPH	lemma_10=5
DDI-DrugBank.d433.s2	DDI-DrugBank.d433.s2.e0	DDI-DrugBank.d433.s2.e1	null	pos_6=JJ	relType_2=advcl	relType_5=case	lemma_2=use	lemma_10=hepatic	lemma_24=already	lemma_12=,	pos_12=,	relType_9=case	pos_22=IN	lemma_16=agent	lemma_18=add	lemma_15=new	lemma_4=combination	pos_1=VBZ	lemma_14=when	pos_7=NNS	relType_16=nsubj:pass	pos_8=VBN	pos_16=NNS	pos_14=WRB	relType_25=case	relType_14=advmod	lemma_13=or	relType_12=punct	lemma_20=the	relType_22=case	relType_13=cc	lemma_25=on	relType_4=obl	relType_24=advmod	pos_5=IN	relType_7=nmod	path1=Rebif_nsubj:pass	relType_21=obl	pos_11=NN	relType_19=case	pos_25=IN	lemma_19=to	lemma_22=of	pos_2=VBN	pos_3=IN	lemma_21=regimen	lemma_7=product	path2=combination_obl>product_nmod>add_conj>Rebif_obl	lemma_11=injury	lemma_1=be	lemma_5=with	relType_23=nmod	lib=be	pos_23=NNS	relType_11=obl	pos_13=CC	wib=is	pos_24=RB	pos_18=VBN	relType_20=det	path=Rebif_nsubj:pass<use_advcl>combination_obl>product_nmod>add_conj>Rebif_obl	pos_19=IN	pos_15=JJ	relType_8=amod	relType_15=amod	relType_1=aux:pass	relType_10=amod	relType_17=aux:pass	pos_9=IN	pos_17=VBP	pos_20=DT	lemma_17=be	eib=False	relType_6=amod	pos_4=NN	lemma_23=patient	lemma_8=associate	pos_10=JJ	relType_3=case	lemma_9=with	lpib=be_VBZ	lemma_3=in	relType_18=conj	lemma_6=other	pos_21=NN
DDI-DrugBank.d227.s0	DDI-DrugBank.d227.s0.e0	DDI-DrugBank.d227.s0.e1	effect	path2=effect_obj>relaxant_nmod	pos_2=DT	lemma_4=relaxant	lemma_2=the	relType_7=det	relation_0=adverse	lib=potentiate	lemma_6=of	relType_6=case	path=isoflurane_nsubj<potentiate_ROOT>effect_obj>relaxant_nmod	pos_8=NN	relation_0=beneficial	lemma_8=muscle	lemma_3=muscle	pos_6=IN	pos_4=NN	pos_7=DT	lemma_1=potentiate	lemma_5=effect	path1=isoflurane_nsubj	relType_8=compound	relType_4=compound	lpib=potentiate_VBZ	wib=potentiates	lemma_7=all	relType_1=ROOT	pos_5=NN	pos_1=VBZ	eib=True	pos_3=NN	relType_5=obj	relType_2=det	relation_4=neutral	relType_3=compound
DDI-DrugBank.d227.s0	DDI-DrugBank.d227.s0.e0	DDI-DrugBank.d227.s0.e2	effect	pos_2=DT	lemma_4=relaxant	lemma_2=the	relType_7=det	relType_9=advmod	relation_0=adverse	lib=potentiate	lemma_6=of	relType_8=punct	lemma_8=,	relType_6=case	pos_8=NNS	pos_8=NN	relation_0=beneficial	lemma_8=muscle	lemma_3=muscle	pos_9=RBS	pos_6=IN	relType_11=amod	relType_10=advmod	pos_4=NN	pos_7=DT	lemma_1=potentiate	lemma_5=effect	path1=isoflurane_nsubj	lemma_10=notably	relType_8=compound	path2=reduce_parataxis>relaxant_nsubj:pass	path=isoflurane_nsubj<potentiate_ROOT>reduce_parataxis>relaxant_nsubj:pass	relType_4=compound	lemma_11=muscle	lpib=potentiate_VBZ	wib=potentiates	lemma_7=all	relType_1=ROOT	pos_5=NN	lemma_8=relaxant	pos_11=NN	lemma_11=nondepolarizing	pos_1=VBZ	eib=True	relType_8=nmod	relType_11=compound	pos_3=NN	relType_5=obj	relType_2=det	relation_4=neutral	relType_3=compound	pos_11=JJ	pos_10=RB	lemma_9=most	pos_8=,
DDI-DrugBank.d227.s0	DDI-DrugBank.d227.s0.e1	DDI-DrugBank.d227.s0.e2	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_3=RB	path=relaxant_nmod<effect_obj<potentiate_ROOT>reduce_parataxis>relaxant_nsubj:pass	relType_3=advmod	pos_1=,	lib=most	lemma_3=notably	relType_2=advmod	wib=most	pos_4=NN	lemma_2=most	path2=reduce_parataxis>relaxant_nsubj:pass	relType_4=compound	lpib=most_RBS	pos_2=RBS	eib=True	lemma_4=nondepolarizing	path1=relaxant_nmod<effect_obj	relType_1=punct	lemma_4=muscle
DDI-DrugBank.d465.s0	DDI-DrugBank.d465.s0.e0	DDI-DrugBank.d465.s0.e1	effect	path2=that_obl>vasodilator_nmod	relType_1=aux	lemma_1=may	lemma_6=of	lemma_7=other	relType_6=case	wib=be	relType_2=cop	eib=False	lemma_3=additive	pos_6=IN	pos_2=VB	path=dinitrate_nmod<effect_nsubj<additive_ROOT>that_obl>vasodilator_nmod	lemma_4=with	relType_7=amod	lib=be	lemma_5=that	relType_3=ROOT	pos_4=IN	relType_4=case	relType_5=obl	pos_1=MD	lpib=be_VB	path1=dinitrate_nmod<effect_nsubj	pos_3=JJ	pos_5=DT	pos_7=JJ	lemma_2=be
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e0	DDI-DrugBank.d163.s0.e1	null	path=<a_ROOT>advise_parataxis>relationship_obl>accutane_nmod	pos_3=IN	path1=	lemma_6=of	relType_6=case	pos_2=IN	relType_3=fixed	lpib=relationship_NN	lemma_2=because	eib=False	pos_6=IN	path2=advise_parataxis>relationship_obl>accutane_nmod	lemma_1=:	pos_4=DT	lemma_5=relationship	lemma_4=the	pos_1=:	relType_5=obl	pos_5=NN	lib=relationship	relType_2=case	wib=relationship	lemma_3=of	relType_1=punct	relType_4=det
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e0	DDI-DrugBank.d163.s0.e2	null	path2=advise_parataxis>relationship_obl>a_nmod	pos_3=IN	relType_7=case	pos_7=NN	path1=	lemma_6=of	path=<a_ROOT>advise_parataxis>relationship_obl>a_nmod	relType_6=case	pos_2=IN	relType_3=fixed	pos_8=NN	lpib=relationship_NN	lemma_2=because	pos_6=IN	lemma_7=to	lemma_1=:	lemma_8=vitamin	pos_4=DT	lemma_5=relationship	lemma_4=the	relType_8=compound	pos_1=:	relType_7=nmod	relType_5=obl	lemma_7=accutane	pos_5=NN	lib=relationship	relType_2=case	eib=True	pos_7=IN	wib=relationship	lemma_3=of	relType_1=punct	relType_4=det
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e0	DDI-DrugBank.d163.s0.e3	null	path=<a_ROOT>advise_parataxis>supplement_obl	relType_14=amod	pos_3=IN	relType_7=case	pos_7=NN	path1=	lemma_11=be	lemma_6=of	relType_8=punct	lemma_8=,	relType_6=case	pos_2=IN	relType_3=fixed	pos_8=NN	lpib=relationship_NN	lemma_2=because	pos_10=MD	relType_10=aux	relType_12=parataxis	pos_6=IN	lemma_7=to	lemma_8=a	pos_9=NNS	relType_9=nsubj:pass	lemma_12=advise	relType_11=aux:pass	pos_13=IN	lemma_13=against	lemma_14=take	lemma_1=:	lemma_8=vitamin	pos_4=DT	lemma_5=relationship	relType_13=case	pos_15=NN	pos_14=VBG	lemma_4=the	relType_8=compound	pos_1=:	relType_7=nmod	relType_5=obl	lemma_15=vitamin	lemma_7=accutane	relType_15=compound	pos_5=NN	lib=relationship	lemma_9=patient	relType_2=case	eib=True	pos_7=IN	path2=advise_parataxis>supplement_obl	relType_8=nmod	pos_11=VB	wib=relationship	lemma_10=should	lemma_3=of	pos_12=VBN	relType_1=punct	relType_4=det	pos_8=,
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e0	DDI-DrugBank.d163.s0.e4	null	lemma_15=supplement	relType_14=amod	pos_3=IN	relType_7=case	pos_7=NN	lemma_15=contain	path1=	lemma_11=be	relType_16=compound	lemma_6=of	relType_8=punct	lemma_8=,	relType_6=case	pos_2=IN	relType_3=fixed	pos_8=NN	lpib=relationship_NN	lemma_2=because	pos_10=MD	relType_10=aux	relType_12=parataxis	pos_6=IN	lemma_7=to	lemma_8=a	pos_9=NNS	relType_9=nsubj:pass	lemma_12=advise	path2=advise_parataxis>supplement_obl>contain_acl>a_obj	relType_11=aux:pass	pos_13=IN	lemma_13=against	lemma_14=take	lemma_1=:	lemma_8=vitamin	pos_4=DT	lemma_5=relationship	relType_13=case	relType_15=obl	pos_15=NN	pos_14=VBG	pos_15=VBG	lemma_4=the	relType_8=compound	pos_1=:	relType_7=nmod	relType_5=obl	pos_16=NN	lemma_15=vitamin	relType_15=acl	lemma_7=accutane	relType_15=compound	pos_5=NN	lib=relationship	lemma_9=patient	relType_2=case	path=<a_ROOT>advise_parataxis>supplement_obl>contain_acl>a_obj	eib=True	pos_7=IN	relType_8=nmod	pos_11=VB	pos_15=NNS	wib=relationship	lemma_10=should	lemma_3=of	pos_12=VBN	relType_1=punct	relType_4=det	lemma_16=vitamin	pos_8=,
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e1	DDI-DrugBank.d163.s0.e2	effect	relType_1=case	pos_2=NN	eib=True	lemma_1=to	path=accutane_nmod<relationship_obl>a_nmod	relType_2=compound	path2=a_nmod	path1=accutane_nmod	wib=vitamin	pos_1=IN	lib=vitamin	lemma_2=vitamin	lpib=vitamin_NN
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e1	DDI-DrugBank.d163.s0.e3	null	relType_1=case	pos_2=NN	relType_7=case	lemma_7=against	lemma_4=should	relType_8=amod	lemma_9=vitamin	relType_3=nsubj:pass	lemma_2=a	relType_2=punct	pos_5=VB	pos_3=NNS	relType_9=compound	relType_2=nmod	pos_4=MD	wib=vitamin	pos_1=IN	pos_6=VBN	lemma_5=be	relType_6=parataxis	pos_9=NN	lemma_2=,	relType_5=aux:pass	relType_2=compound	pos_8=VBG	relType_4=aux	path=accutane_nmod<relationship_obl<advise_parataxis>supplement_obl	lemma_2=vitamin	lemma_1=to	lib=vitamin	lemma_8=take	path1=accutane_nmod<relationship_obl	lemma_6=advise	eib=True	pos_7=IN	pos_2=,	path2=supplement_obl	lemma_3=patient	lpib=vitamin_NN
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e1	DDI-DrugBank.d163.s0.e4	null	relType_1=case	pos_2=NN	relType_7=case	lemma_7=against	lemma_4=should	relType_8=amod	lemma_9=vitamin	relType_9=obl	relType_3=nsubj:pass	lemma_2=a	relType_10=compound	relType_2=punct	pos_5=VB	lemma_9=supplement	pos_3=NNS	relType_9=compound	relType_2=nmod	pos_9=NNS	pos_4=MD	wib=vitamin	pos_1=IN	pos_6=VBN	lemma_5=be	relType_6=parataxis	pos_9=NN	lemma_2=,	lemma_9=contain	pos_9=VBG	pos_10=NN	lemma_10=vitamin	relType_5=aux:pass	relType_2=compound	pos_8=VBG	relType_4=aux	lemma_8=take	lemma_2=vitamin	lemma_1=to	lib=vitamin	path1=accutane_nmod<relationship_obl	path2=supplement_obl>contain_acl>a_obj	relType_9=acl	lemma_6=advise	path=accutane_nmod<relationship_obl<advise_parataxis>supplement_obl>contain_acl>a_obj	eib=True	pos_7=IN	pos_2=,	lemma_3=patient	lpib=vitamin_NN
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e2	DDI-DrugBank.d163.s0.e3	null	lemma_1=,	lemma_4=be	lemma_2=patient	pos_1=,	pos_7=VBG	relType_5=parataxis	path=a_nmod<relationship_obl<advise_parataxis>supplement_obl	lemma_3=should	relType_6=case	pos_8=NN	wib=patients	lpib=patient_NNS	pos_6=IN	pos_3=MD	relType_2=nsubj:pass	lemma_7=take	lemma_8=vitamin	relType_7=amod	lib=patient	relType_8=compound	relType_4=aux:pass	lemma_6=against	pos_2=NNS	lemma_5=advise	eib=True	path1=a_nmod<relationship_obl	pos_4=VB	relType_3=aux	relType_1=punct	path2=supplement_obl	pos_5=VBN
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e2	DDI-DrugBank.d163.s0.e4	null	lemma_1=,	lemma_4=be	lemma_2=patient	path=a_nmod<relationship_obl<advise_parataxis>supplement_obl>contain_acl>a_obj	pos_1=,	pos_7=VBG	lemma_9=vitamin	relType_5=parataxis	lemma_3=should	relType_6=case	pos_8=NNS	relType_8=obl	pos_8=NN	wib=patients	relType_9=compound	lpib=patient_NNS	pos_6=IN	pos_3=MD	lemma_8=supplement	relType_2=nsubj:pass	pos_9=NN	lemma_7=take	lemma_8=vitamin	relType_7=amod	lemma_8=contain	pos_8=VBG	lib=patient	relType_8=compound	relType_4=aux:pass	lemma_6=against	relType_8=acl	path2=supplement_obl>contain_acl>a_obj	pos_2=NNS	lemma_5=advise	eib=True	path1=a_nmod<relationship_obl	pos_4=VB	relType_3=aux	relType_1=punct	pos_5=VBN
DDI-DrugBank.d163.s0	DDI-DrugBank.d163.s0.e3	DDI-DrugBank.d163.s0.e4	null	pos_1=VBG	path=<supplement_obl>contain_acl>a_obj	pos_2=NN	eib=True	relType_2=compound	relType_1=acl	path1=	lemma_1=contain	lib=contain	path2=contain_acl>a_obj	lemma_2=vitamin	wib=containing	lpib=contain_VBG
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e0	DDI-DrugBank.d163.s2.e1	null	path1=	lemma_3=treatment	relType_3=nsubj:pass	path=<tetracycline_ROOT>avoid_parataxis>treatment_nsubj:pass>accutane_nmod	pos_2=JJ	lib=concomitant	wib=Concomitant	eib=False	lpib=concomitant_JJ	lemma_1=:	lemma_4=with	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	pos_3=NN	relType_1=punct	path2=avoid_parataxis>treatment_nsubj:pass>accutane_nmod
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e0	DDI-DrugBank.d163.s2.e2	null	pos_5=CC	path1=	lemma_3=treatment	relType_3=nsubj:pass	pos_2=JJ	path=<tetracycline_ROOT>avoid_parataxis>treatment_nsubj:pass>accutane_nmod>tetracycline_conj	path2=avoid_parataxis>treatment_nsubj:pass>accutane_nmod>tetracycline_conj	lib=concomitant	relType_5=cc	wib=Concomitant	lpib=concomitant_JJ	lemma_5=accutane	lemma_1=:	lemma_4=with	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	pos_5=NN	eib=True	lemma_5=and	pos_3=NN	relType_1=punct
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e0	DDI-DrugBank.d163.s2.e3	null	pos_7=VB	pos_5=CC	pos_8=VBN	lemma_7=be	path1=	lemma_3=treatment	pos_9=IN	relType_3=nsubj:pass	pos_2=JJ	lib=concomitant	relType_5=cc	relType_6=conj	wib=Concomitant	lpib=concomitant_JJ	lemma_6=should	relType_8=parataxis	lemma_5=accutane	lemma_1=:	lemma_4=with	lemma_2=concomitant	relType_6=aux	path2=avoid_parataxis>associate_advcl>use_nsubj:pass>accutane_compound	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	relType_7=aux:pass	lemma_6=tetracycline	pos_6=MD	lemma_8=avoid	relType_9=mark	pos_5=NN	eib=True	lemma_5=and	pos_3=NN	lemma_9=because	pos_6=NNS	path=<tetracycline_ROOT>avoid_parataxis>associate_advcl>use_nsubj:pass>accutane_compound	relType_1=punct
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e0	DDI-DrugBank.d163.s2.e4	null	relType_28=appos	relType_3=nsubj:pass	pos_2=JJ	pos_13=VBN	pos_27=,	relType_5=cc	relType_6=conj	lemma_28=some	relType_25=appos	pos_20=NN	pos_10=NN	relType_32=amod	pos_15=DT	relType_22=punct	pos_11=VBZ	pos_1=:	lemma_22=(	lemma_20=pseudotumor	lemma_5=and	relType_30=nmod	relType_31=amod	pos_6=NNS	lemma_34=of	lemma_10=use	pos_31=JJ	pos_18=NNS	path=<tetracycline_ROOT>avoid_parataxis>associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	pos_8=VBN	lemma_7=be	path1=	pos_29=IN	lib=concomitant	pos_32=JJ	pos_28=DT	lemma_5=accutane	lemma_11=have	pos_14=IN	lemma_33=use	pos_16=NN	relType_24=amod	relType_9=mark	pos_5=NN	relType_33=dep	lemma_23=benign	relType_19=case	pos_12=VBN	relType_1=punct	relType_26=punct	relType_18=nmod	relType_15=det	relType_34=case	lemma_13=associate	pos_23=JJ	lemma_18=case	pos_30=WDT	relType_29=case	lemma_14=with	lemma_30=which	relType_16=obl	lemma_15=a	relType_21=nmod	relType_23=amod	lemma_24=intracranial	pos_24=JJ	pos_17=IN	wib=Concomitant	relType_11=aux	lemma_6=should	path2=avoid_parataxis>associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	relType_8=parataxis	lemma_1=:	relType_17=case	lemma_4=with	lemma_19=of	lemma_31=involved	relType_6=aux	lemma_16=number	pos_4=IN	relType_2=amod	pos_25=NN	lemma_17=of	pos_6=MD	lemma_8=avoid	lemma_26=)	lemma_9=because	relType_14=case	relType_27=punct	lemma_32=concomitant	pos_33=NN	pos_7=VB	pos_19=IN	lemma_21=cerebri	pos_5=CC	pos_26=-RRB-	relType_13=advcl	lemma_3=treatment	pos_9=IN	lemma_29=of	lemma_10=accutane	relType_12=aux:pass	lpib=concomitant_JJ	relType_10=compound	relType_10=nsubj:pass	lemma_2=concomitant	lemma_12=be	relType_4=case	relType_5=nmod	relType_7=aux:pass	lemma_6=tetracycline	lemma_25=hypertension	lemma_27=,	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_34=IN	pos_21=NN
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e1	DDI-DrugBank.d163.s2.e2	advise	wib=tetracyclines	path2=tetracycline_conj	relType_1=cc	path=<accutane_nmod>tetracycline_conj	pos_1=CC	lpib=tetracycline_NNS	eib=False	path1=	lib=tetracycline	lemma_1=and
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e1	DDI-DrugBank.d163.s2.e3	null	wib=tetracyclines	relType_1=cc	pos_1=CC	lpib=tetracycline_NNS	pos_2=MD	pos_3=VB	relType_3=aux:pass	lib=tetracycline	lemma_2=tetracycline	relType_5=mark	path1=accutane_nmod<treatment_nsubj:pass	relType_2=aux	relType_2=conj	pos_4=VBN	relType_4=parataxis	lemma_4=avoid	lemma_2=should	lemma_3=be	pos_5=IN	lemma_5=because	path2=associate_advcl>use_nsubj:pass>accutane_compound	pos_2=NNS	eib=True	path=accutane_nmod<treatment_nsubj:pass<avoid_parataxis>associate_advcl>use_nsubj:pass>accutane_compound	lemma_1=and
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e1	DDI-DrugBank.d163.s2.e4	null	wib=tetracyclines	relType_1=cc	pos_7=VBZ	lemma_17=cerebri	relType_3=aux:pass	lemma_28=concomitant	pos_6=NN	lemma_13=of	relType_26=nmod	lemma_23=,	lemma_20=intracranial	relType_4=parataxis	pos_20=JJ	relType_22=punct	pos_18=-LRB-	lemma_25=of	lemma_2=should	lemma_3=be	relType_6=nsubj:pass	lemma_6=accutane	pos_26=WDT	lemma_30=of	relType_11=det	relType_6=compound	lemma_22=)	lemma_18=(	pos_14=NNS	relType_14=nmod	pos_22=-RRB-	pos_30=IN	lemma_15=of	pos_8=VBN	pos_2=MD	pos_27=JJ	pos_3=VB	lemma_2=tetracycline	relType_25=case	relType_5=mark	relType_9=advcl	relType_8=aux:pass	pos_19=JJ	lemma_16=pseudotumor	pos_29=NN	relType_2=conj	lemma_29=use	pos_4=VBN	lemma_4=avoid	relType_15=case	lemma_6=use	pos_5=IN	pos_16=NN	relType_19=amod	pos_28=JJ	pos_15=IN	lemma_27=involved	pos_25=IN	relType_29=dep	relType_28=amod	lemma_1=and	lemma_10=with	relType_7=aux	lemma_19=benign	relType_27=amod	lib=tetracycline	pos_17=NN	relType_20=amod	path1=accutane_nmod<treatment_nsubj:pass	pos_24=DT	relType_2=aux	pos_13=IN	lemma_7=have	relType_13=case	lemma_5=because	pos_10=IN	relType_17=nmod	lemma_26=which	lemma_14=case	relType_21=appos	relType_30=case	path2=associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	relType_23=punct	pos_1=CC	relType_12=obl	lemma_24=some	lpib=tetracycline_NNS	lemma_11=a	relType_16=compound	lemma_9=associate	lemma_21=hypertension	relType_10=case	pos_9=VBN	lemma_8=be	relType_18=punct	pos_11=DT	relType_24=appos	pos_2=NNS	eib=True	pos_23=,	path=accutane_nmod<treatment_nsubj:pass<avoid_parataxis>associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	lemma_12=number	pos_12=NN	pos_21=NN
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e2	DDI-DrugBank.d163.s2.e3	null	relType_4=mark	relType_1=aux	pos_3=VBN	path=tetracycline_conj<accutane_nmod<treatment_nsubj:pass<avoid_parataxis>associate_advcl>use_nsubj:pass>accutane_compound	lemma_1=should	wib=be	eib=False	lemma_3=avoid	pos_2=VB	lib=be	pos_4=IN	lemma_4=because	relType_2=aux:pass	relType_3=parataxis	path2=associate_advcl>use_nsubj:pass>accutane_compound	pos_1=MD	lpib=be_VB	lemma_2=be	path1=tetracycline_conj<accutane_nmod<treatment_nsubj:pass
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e2	DDI-DrugBank.d163.s2.e4	null	relType_28=dep	relType_16=nmod	pos_13=NNS	relType_5=nsubj:pass	pos_6=VBZ	lemma_23=some	pos_21=-RRB-	relType_24=case	pos_20=NN	pos_2=VB	relType_9=case	lemma_6=have	relType_22=punct	relType_20=appos	lemma_16=cerebri	pos_22=,	lemma_4=because	relType_2=aux:pass	relType_3=parataxis	pos_24=IN	lpib=be_VB	relType_15=compound	pos_28=NN	relType_26=amod	lemma_14=of	lemma_17=(	relType_21=punct	relType_4=mark	relType_1=aux	pos_8=VBN	lemma_7=be	lemma_19=intracranial	relType_8=advcl	pos_27=JJ	pos_29=IN	path=tetracycline_conj<accutane_nmod<treatment_nsubj:pass<avoid_parataxis>associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	lemma_27=concomitant	pos_25=WDT	relType_25=nmod	pos_19=JJ	lemma_22=,	lemma_25=which	lemma_5=accutane	pos_12=IN	pos_14=IN	lemma_26=involved	lemma_13=case	pos_16=NN	pos_17=-LRB-	lemma_5=use	relType_19=amod	pos_5=NN	pos_11=NN	lemma_2=be	lemma_21=)	relType_10=det	relType_29=case	relType_17=punct	relType_12=case	lemma_20=hypertension	relType_27=amod	lemma_1=should	lemma_24=of	lemma_12=of	pos_26=JJ	lemma_3=avoid	lib=be	relType_6=aux	pos_4=IN	pos_1=MD	relType_11=obl	relType_14=case	relType_23=appos	pos_10=DT	path2=associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	lemma_15=pseudotumor	pos_3=VBN	relType_18=amod	relType_5=compound	pos_9=IN	lemma_10=a	lemma_29=of	lemma_18=benign	wib=be	relType_13=nmod	lemma_11=number	pos_18=JJ	lemma_8=associate	pos_15=NN	relType_7=aux:pass	pos_23=DT	pos_7=VBN	lemma_9=with	eib=True	path1=tetracycline_conj<accutane_nmod<treatment_nsubj:pass	lemma_28=use
DDI-DrugBank.d163.s2	DDI-DrugBank.d163.s2.e3	DDI-DrugBank.d163.s2.e4	effect	relType_14=amod	path2=number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	lemma_10=of	relType_3=aux:pass	path=accutane_compound<use_nsubj:pass<associate_advcl>number_obl>some_appos>which_nmod>use_dep>tetracycline_nmod	relType_5=case	lemma_6=a	lpib=use_NN	lemma_25=of	lemma_3=be	lemma_15=intracranial	lemma_20=of	relType_8=case	relType_25=case	relType_20=case	lemma_1=use	relType_12=nmod	lemma_19=some	pos_8=IN	pos_4=VBN	lemma_13=(	pos_5=IN	pos_16=NN	relType_6=det	relType_7=obl	pos_11=NN	pos_25=IN	lemma_7=number	pos_7=NN	pos_19=DT	pos_23=JJ	lib=use	pos_6=DT	relType_17=punct	pos_24=NN	relType_21=nmod	relType_23=amod	pos_20=IN	lemma_21=which	lemma_23=concomitant	lemma_5=with	relType_19=appos	relType_2=aux	pos_1=NN	lemma_22=involved	pos_10=IN	lemma_16=hypertension	pos_2=VBZ	lemma_4=associate	pos_21=WDT	pos_22=JJ	relType_22=amod	lemma_11=pseudotumor	pos_14=JJ	relType_1=nsubj:pass	relType_4=advcl	relType_16=appos	pos_15=JJ	lemma_2=have	relType_15=amod	pos_3=VBN	relType_13=punct	relType_9=nmod	eib=False	pos_9=NNS	relType_10=case	relType_24=dep	pos_18=,	lemma_9=case	lemma_18=,	lemma_14=benign	relType_18=punct	pos_13=-LRB-	lemma_24=use	path1=accutane_compound<use_nsubj:pass	lemma_17=)	lemma_12=cerebri	relType_11=compound	wib=use	pos_17=-RRB-	pos_12=NN	lemma_8=of
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e0	DDI-DrugBank.d163.s4.e1	null	path=Progesterone_compound<Preparations_ROOT>method_parataxis>preparation_nsubj>progesterone_compound	pos_3=NNP	lemma_4=-	pos_4=HYPH	relType_2=punct	lemma_2=:	path1=Progesterone_compound	eib=False	lemma_3=Micro	relType_4=punct	relType_5=amod	lpib=preparations_NNPS	pos_2=:	lemma_1=Preparations	lib=preparations	path2=method_parataxis>preparation_nsubj>progesterone_compound	wib=Preparations	relType_1=ROOT	lemma_5=dose	relType_3=obl	pos_1=NNPS	pos_5=VBN
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e0	DDI-DrugBank.d163.s4.e2	null	lemma_7=(	lemma_11=not	relType_8=dep	lemma_13=a	pos_3=NNP	lemma_4=-	pos_13=DT	lemma_8=minipill	pos_4=HYPH	pos_9=WDT	pos_8=NNS	relType_2=punct	pos_6=NN	pos_7=-LRB-	lemma_2=:	path1=Progesterone_compound	relType_10=aux	path2=method_parataxis>preparation_nsubj>minipill_dep>contain_acl:relcl>estrogen_obj	lemma_6=preparation	lemma_12=contain	relType_11=advmod	lemma_3=Micro	path=Progesterone_compound<Preparations_ROOT>method_parataxis>preparation_nsubj>minipill_dep>contain_acl:relcl>estrogen_obj	relType_4=punct	relType_5=amod	lemma_6=progesterone	lpib=preparations_NNPS	pos_2=:	lemma_1=Preparations	lib=preparations	relType_12=acl:relcl	wib=Preparations	pos_11=RB	pos_12=VB	lemma_10=do	relType_1=ROOT	lemma_5=dose	relType_6=compound	relType_3=obl	lemma_9=that	eib=True	relType_9=nsubj	pos_10=VBP	relType_7=punct	pos_6=NNS	relType_13=det	pos_1=NNPS	pos_5=VBN	relType_6=nsubj
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e0	DDI-DrugBank.d163.s4.e3	null	lemma_13=a	lemma_11=not	pos_8=NNS	pos_6=NN	pos_7=-LRB-	relType_17=det	pos_22=IN	relType_4=punct	lemma_6=progesterone	lemma_1=Preparations	lib=preparations	wib=Preparations	pos_11=RB	relType_6=compound	lemma_17=a	pos_6=NNS	relType_13=det	lemma_20=of	path2=method_parataxis>therapy_obl>accutane_compound	pos_3=NNP	lemma_8=minipill	relType_2=punct	lemma_2=:	relType_20=case	pos_16=VB	relType_11=advmod	relType_22=case	relType_16=cop	lemma_5=dose	relType_3=obl	pos_1=NNPS	relType_14=punct	relType_8=dep	pos_17=DT	lemma_4=-	relType_21=nmod	pos_9=WDT	pos_20=IN	path1=Progesterone_compound	relType_14=obj	relType_10=aux	pos_14=-RRB-	relType_19=parataxis	pos_14=NN	lemma_16=be	lemma_14=)	relType_5=amod	lpib=preparations_NNPS	pos_12=VB	relType_6=nsubj	lemma_14=estrogen	lemma_22=during	lemma_7=(	lemma_18=inadequate	lemma_15=may	relType_18=amod	pos_13=DT	pos_15=MD	pos_4=HYPH	lemma_21=contraception	relType_15=aux	lemma_6=preparation	lemma_12=contain	pos_18=JJ	pos_19=NN	lemma_3=Micro	path=Progesterone_compound<Preparations_ROOT>method_parataxis>therapy_obl>accutane_compound	pos_2=:	relType_12=acl:relcl	lemma_19=method	lemma_10=do	relType_1=ROOT	lemma_9=that	pos_10=VBP	eib=True	relType_9=nsubj	relType_7=punct	pos_5=VBN	pos_21=NN
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e1	DDI-DrugBank.d163.s4.e2	null	relType_3=dep	path=progesterone_compound<preparation_nsubj>minipill_dep>contain_acl:relcl>estrogen_obj	pos_7=VB	pos_8=DT	path2=minipill_dep>contain_acl:relcl>estrogen_obj	relType_2=punct	path1=progesterone_compound	pos_4=WDT	lemma_5=do	pos_3=NNS	eib=False	pos_5=VBP	pos_2=-LRB-	lemma_8=a	lpib=preparation_NNS	relType_5=aux	relType_4=nsubj	lemma_6=not	lib=preparation	wib=preparations	relType_1=nsubj	lemma_1=preparation	pos_6=RB	lemma_7=contain	pos_1=NNS	lemma_4=that	lemma_3=minipill	relType_8=det	lemma_2=(	relType_6=advmod	relType_7=acl:relcl
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e1	DDI-DrugBank.d163.s4.e3	effect	relType_3=dep	pos_7=VB	lemma_9=)	pos_8=DT	lemma_15=of	relType_16=nmod	path=progesterone_compound<preparation_nsubj<method_parataxis>therapy_obl>accutane_compound	lemma_11=be	relType_12=det	relType_2=punct	pos_17=IN	path1=progesterone_compound<preparation_nsubj	pos_4=WDT	lemma_5=do	pos_3=NNS	pos_10=MD	pos_5=VBP	relType_10=aux	relType_13=amod	pos_2=-LRB-	lemma_8=a	lpib=preparation_NNS	lemma_9=estrogen	pos_14=NN	relType_5=aux	relType_4=nsubj	pos_9=NN	relType_11=cop	relType_17=case	lemma_12=a	pos_9=-RRB-	relType_15=case	lemma_6=not	pos_13=JJ	lib=preparation	wib=preparations	relType_1=nsubj	relType_9=obj	lemma_1=preparation	lemma_17=during	pos_16=NN	pos_6=RB	relType_9=punct	lemma_7=contain	lemma_16=contraception	pos_15=IN	path2=therapy_obl>accutane_compound	lemma_10=may	pos_1=NNS	eib=True	pos_11=VB	lemma_4=that	lemma_3=minipill	lemma_13=inadequate	lemma_14=method	pos_12=DT	relType_8=det	lemma_2=(	relType_6=advmod	relType_14=parataxis	relType_7=acl:relcl
DDI-DrugBank.d163.s4	DDI-DrugBank.d163.s4.e2	DDI-DrugBank.d163.s4.e3	null	path=estrogen_obj<contain_acl:relcl<minipill_dep<preparation_nsubj<method_parataxis>therapy_obl>accutane_compound	lemma_8=contraception	relType_7=case	lemma_4=a	pos_2=MD	pos_9=IN	pos_3=VB	lemma_1=)	lemma_9=during	wib=be	pos_6=NN	pos_8=NN	eib=False	lemma_5=inadequate	relType_2=aux	relType_9=case	relType_6=parataxis	pos_4=DT	pos_5=JJ	path1=estrogen_obj<contain_acl:relcl<minipill_dep<preparation_nsubj	lib=be	relType_5=amod	pos_1=-RRB-	lemma_3=be	lpib=be_VB	path2=therapy_obl>accutane_compound	lemma_7=of	relType_8=nmod	pos_7=IN	lemma_2=may	relType_1=punct	relType_4=det	relType_3=cop	lemma_6=method
DDI-DrugBank.d163.s5	DDI-DrugBank.d163.s5.e0	DDI-DrugBank.d163.s5.e1	null	path1=contraceptive_nsubj<effective_advcl	lpib=be_VBP	lemma_7=be	pos_14=VBP	lemma_5=there	pos_9=IN	lemma_11=from	lemma_15=use	pos_8=NNS	relType_11=case	relType_16=amod	pos_2=RB	relType_10=nmod	pos_4=,	relType_2=advmod	relType_15=acl:relcl	lemma_1=be	relType_7=cop	relType_12=nmod	relType_9=case	lemma_6=have	pos_10=NN	pos_5=EX	pos_15=VBN	lemma_2=highly	wib=are	pos_11=IN	lemma_14=have	pos_16=JJ	pos_16=VBN	lib=be	relType_3=advcl	relType_4=punct	relType_6=aux	pos_12=NNS	relType_13=nsubj	lemma_10=pregnancy	lemma_16=oral	relType_14=aux	lemma_16=combine	pos_6=VBP	lemma_4=,	lemma_8=report	relType_8=ROOT	lemma_12=woman	lemma_3=effective	pos_1=VBP	lemma_13=who	relType_5=expl	pos_7=VBN	relType_1=cop	pos_3=JJ	eib=True	lemma_9=of	pos_13=WP	path=contraceptive_nsubj<effective_advcl<report_ROOT>pregnancy_nmod>woman_nmod>use_acl:relcl>contraceptive_obj	path2=pregnancy_nmod>woman_nmod>use_acl:relcl>contraceptive_obj
DDI-DrugBank.d163.s7	DDI-DrugBank.d163.s7.e0	DDI-DrugBank.d163.s7.e1	null	relType_7=case	relType_1=advcl	path1=contraceptive_nsubj	lemma_4=effectiveness	wib=differ	lemma_7=with	pos_2=IN	lpib=differ_VBP	eib=False	lemma_5=when	pos_6=VBN	relType_6=advcl	lemma_1=differ	pos_4=NN	pos_5=WRB	path=contraceptive_nsubj<differ_advcl>use_advcl>accutane_obl	lib=differ	relType_4=obl	pos_3=PRP$	lemma_6=use	lemma_3=they	pos_1=VBP	relType_5=advmod	relType_2=case	pos_7=IN	relType_3=nmod:poss	path2=use_advcl>accutane_obl	lemma_2=in
DDI-DrugBank.d163.s10	DDI-DrugBank.d163.s10.e0	DDI-DrugBank.d163.s10.e1	null	path2=show_appos>accutane_nsubj:pass	eib=False	path1=	pos_1=:	lpib=accutane_NN	lib=accutane	relType_1=punct	path=<Phenytoin_ROOT>show_appos>accutane_nsubj:pass	lemma_1=:	wib=Accutane
DDI-DrugBank.d163.s10	DDI-DrugBank.d163.s10.e0	DDI-DrugBank.d163.s10.e2	null	lemma_2=accutane	pos_7=VB	pos_6=TO	pos_2=NN	pos_3=RB	relType_3=advmod	lemma_4=be	pos_8=DT	lemma_2=have	lemma_9=pharmacokinetic	path1=	lemma_3=not	lemma_10=of	lib=accutane	lemma_6=to	path2=show_appos>alter_xcomp>pharmacokinetic_obj>phenytoin_nmod	lemma_5=show	pos_9=NNS	relType_2=aux	relType_10=case	relType_2=nsubj:pass	lemma_1=:	path=<Phenytoin_ROOT>show_appos>alter_xcomp>pharmacokinetic_obj>phenytoin_nmod	pos_4=VBN	lemma_7=alter	relType_7=xcomp	relType_6=mark	lemma_8=the	pos_1=:	relType_4=aux:pass	relType_9=obj	pos_10=IN	relType_5=appos	wib=Accutane	relation_7=neutral	pos_2=VBZ	eib=True	lpib=accutane_NN	relType_8=det	relType_1=punct	pos_5=VBN
DDI-DrugBank.d163.s10	DDI-DrugBank.d163.s10.e1	DDI-DrugBank.d163.s10.e2	null	pos_6=VB	lpib=have_VBZ	relType_1=aux	relType_7=det	relType_4=appos	pos_3=VBN	pos_9=IN	relType_3=aux:pass	pos_8=NNS	lemma_6=alter	pos_2=RB	relType_5=mark	eib=False	relType_2=advmod	relation_5=neutral	path2=alter_xcomp>pharmacokinetic_obj>phenytoin_nmod	relType_8=obj	lemma_1=have	relType_9=case	pos_5=TO	lib=have	pos_7=DT	pos_4=VBN	path1=accutane_nsubj:pass	lemma_4=show	lemma_3=be	lemma_5=to	relType_6=xcomp	pos_1=VBZ	lemma_9=of	lemma_8=pharmacokinetic	lemma_7=the	wib=has	lemma_2=not	path=accutane_nsubj:pass<show_appos>alter_xcomp>pharmacokinetic_obj>phenytoin_nmod
DDI-DrugBank.d163.s13	DDI-DrugBank.d163.s13.e0	DDI-DrugBank.d163.s13.e1	null	relType_1=cc	path=<phenytoin_nmod>accutane_conj	pos_1=CC	eib=False	path2=accutane_conj	path1=	lpib=accutane_NN	lib=accutane	lemma_1=and	wib=Accutane
DDI-DrugBank.d163.s16	DDI-DrugBank.d163.s16.e0	DDI-DrugBank.d163.s16.e1	null	eib=True	wib=Systemic	relType_2=amod	path1=	path2=know_parataxis>corticosteroid_nsubj:pass	path=<Corticosteroids_ROOT>know_parataxis>corticosteroid_nsubj:pass	pos_1=:	lemma_2=systemic	relType_1=punct	pos_2=JJ	lib=systemic	lemma_1=:	lpib=systemic_JJ
DDI-DrugBank.d163.s17	DDI-DrugBank.d163.s17.e0	DDI-DrugBank.d163.s17.e1	null	relType_1=cc	pos_1=CC	eib=False	path=<corticosteroid_nmod>accutane_conj	path2=accutane_conj	path1=	lpib=accutane_NN	lib=accutane	lemma_1=and	wib=Accutane
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e0	DDI-DrugBank.d81.s0.e1	null	lpib=dynacirc_NNP	path=<nitroglycerin_ROOT>coadminister_parataxis>DynaCirc_nsubj:pass	eib=False	path2=coadminister_parataxis>DynaCirc_nsubj:pass	path1=	pos_1=:	lib=dynacirc	relType_1=punct	lemma_1=:	wib=DynaCirc
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e0	DDI-DrugBank.d81.s0.e2	null	lpib=dynacirc_NNP	lemma_2=(	eib=True	pos_2=NNP	path1=	pos_1=:	pos_2=-LRB-	lemma_2=DynaCirc	lib=dynacirc	path=<nitroglycerin_ROOT>coadminister_parataxis>DynaCirc_nsubj:pass>isradipine_appos	relType_1=punct	relType_2=nsubj:pass	path2=coadminister_parataxis>DynaCirc_nsubj:pass>isradipine_appos	relType_2=punct	lemma_1=:	wib=DynaCirc
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e0	DDI-DrugBank.d81.s0.e3	null	relType_8=case	lemma_7=coadminister	lemma_4=have	path2=coadminister_parataxis>nitroglycerin_obl	path1=	lemma_2=DynaCirc	relType_2=punct	pos_5=VBN	lemma_3=isradipine	pos_2=NNP	relType_3=appos	pos_2=-LRB-	lemma_8=with	lib=dynacirc	lemma_5=be	relType_2=nsubj:pass	lemma_1=:	pos_8=IN	relType_5=aux:pass	pos_1=:	relType_4=aux	pos_6=RB	lemma_3=)	pos_7=VBN	lpib=dynacirc_NNP	lemma_6=safely	eib=True	pos_3=-RRB-	pos_3=NN	path=<nitroglycerin_ROOT>coadminister_parataxis>nitroglycerin_obl	relType_1=punct	lemma_2=(	relType_6=advmod	relType_3=punct	relType_7=parataxis	pos_4=VBZ	wib=DynaCirc
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e1	DDI-DrugBank.d81.s0.e2	null	path2=isradipine_appos	lemma_1=(	wib=isradipine	eib=False	lpib=isradipine_NN	path1=	path=<DynaCirc_nsubj:pass>isradipine_appos	lib=isradipine	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e1	DDI-DrugBank.d81.s0.e3	null	lemma_2=)	wib=isradipine	pos_2=NN	lemma_2=isradipine	relType_7=case	lemma_4=be	lpib=isradipine_NN	lib=isradipine	lemma_7=with	relType_2=punct	lemma_1=(	pos_3=VBZ	pos_6=VBN	relType_6=parataxis	pos_4=VBN	path1=DynaCirc_nsubj:pass	path=DynaCirc_nsubj:pass<coadminister_parataxis>nitroglycerin_obl	lemma_6=coadminister	pos_5=RB	relType_4=aux:pass	relType_2=appos	pos_1=-LRB-	relType_5=advmod	eib=True	pos_2=-RRB-	pos_7=IN	lemma_5=safely	relType_3=aux	relType_1=punct	lemma_3=have	path2=nitroglycerin_obl
DDI-DrugBank.d81.s0	DDI-DrugBank.d81.s0.e2	DDI-DrugBank.d81.s0.e3	null	path=isradipine_appos<DynaCirc_nsubj:pass<coadminister_parataxis>nitroglycerin_obl	lpib=have_VBZ	lemma_2=have	pos_3=VBN	path1=isradipine_appos<DynaCirc_nsubj:pass	relType_5=parataxis	lemma_1=)	relType_3=aux:pass	relType_6=case	pos_4=RB	eib=False	lemma_4=safely	pos_6=IN	relType_2=aux	lib=have	lemma_5=coadminister	pos_1=-RRB-	relType_4=advmod	lemma_3=be	lemma_6=with	pos_2=VBZ	relType_1=punct	wib=has	pos_5=VBN	path2=nitroglycerin_obl
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e0	DDI-DrugBank.d81.s1.e1	null	pos_7=NNS	pos_2=DT	pos_6=JJ	relType_10=mark	lemma_8=have	path1=	path=<Hydrochlorothiazide_ROOT>show_appos>result_ccomp>administration_nsubj>DynaCirc_nmod	lemma_4=in	lemma_2=a	path2=show_appos>result_ccomp>administration_nsubj>DynaCirc_nmod	lemma_13=of	lemma_12=administration	pos_8=VBZ	eib=False	relType_6=amod	relType_11=amod	pos_13=IN	lpib=study_NN	pos_9=VBN	relType_9=appos	lemma_11=concomitant	lemma_1=:	lemma_7=volunteer	pos_5=JJ	relType_13=case	lib=study	relType_5=amod	pos_4=IN	pos_1=:	relType_4=case	relType_7=nmod	lemma_5=normal	pos_10=IN	relType_3=nsubj	relType_12=nsubj	lemma_3=study	lemma_10=that	wib=study	pos_3=NN	relType_2=det	relType_8=aux	pos_11=JJ	relType_1=punct	pos_12=NN	lemma_6=healthy	lemma_9=show
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e0	DDI-DrugBank.d81.s1.e2	null	pos_7=NNS	pos_2=DT	relType_14=punct	pos_14=NNP	pos_6=JJ	relType_10=mark	lemma_8=have	path1=	lemma_4=in	lemma_2=a	lemma_14=DynaCirc	relType_14=nmod	lemma_14=(	lemma_13=of	lemma_12=administration	pos_8=VBZ	relType_6=amod	relType_11=amod	lemma_9=show	pos_13=IN	lpib=study_NN	pos_9=VBN	relType_9=appos	lemma_11=concomitant	lemma_1=:	lemma_7=volunteer	pos_5=JJ	relType_13=case	lib=study	relType_5=amod	pos_14=-LRB-	pos_4=IN	pos_1=:	relType_4=case	path=<Hydrochlorothiazide_ROOT>show_appos>result_ccomp>administration_nsubj>DynaCirc_nmod>isradipine_dep	lemma_5=normal	relType_7=nmod	pos_10=IN	relType_3=nsubj	relType_12=nsubj	lemma_3=study	eib=True	lemma_10=that	wib=study	pos_3=NN	relType_2=det	relType_8=aux	pos_11=JJ	relType_1=punct	pos_12=NN	lemma_6=healthy	path2=show_appos>result_ccomp>administration_nsubj>DynaCirc_nmod>isradipine_dep
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e0	DDI-DrugBank.d81.s1.e3	null	pos_7=NNS	pos_15=-RRB-	pos_2=DT	relType_14=punct	pos_14=NNP	path2=show_appos>result_ccomp>administration_nsubj>hydrochlorothiazide_conj	pos_6=JJ	relType_16=cc	relType_10=mark	lemma_8=have	path1=	lemma_15=isradipine	lemma_4=in	lemma_2=a	path=<Hydrochlorothiazide_ROOT>show_appos>result_ccomp>administration_nsubj>hydrochlorothiazide_conj	lemma_14=DynaCirc	relType_14=nmod	pos_16=CC	lemma_14=(	lemma_13=of	lemma_12=administration	pos_8=VBZ	relType_6=amod	relType_11=amod	relType_15=dep	pos_13=IN	lpib=study_NN	pos_9=VBN	relType_9=appos	lemma_11=concomitant	lemma_1=:	relType_15=punct	lemma_7=volunteer	pos_5=JJ	relType_13=case	lib=study	relType_5=amod	pos_14=-LRB-	pos_15=NN	pos_4=IN	pos_1=:	relType_4=case	relType_7=nmod	lemma_5=normal	lemma_15=)	pos_10=IN	lemma_16=and	relType_3=nsubj	relType_12=nsubj	lemma_3=study	eib=True	lemma_10=that	wib=study	pos_3=NN	relType_2=det	relType_8=aux	pos_11=JJ	relType_1=punct	pos_12=NN	lemma_6=healthy	lemma_9=show
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e1	DDI-DrugBank.d81.s1.e2	null	lemma_1=(	wib=isradipine	path2=isradipine_dep	eib=False	lpib=isradipine_NN	path1=	lib=isradipine	relType_1=punct	path=<DynaCirc_nmod>isradipine_dep	pos_1=-LRB-
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e1	DDI-DrugBank.d81.s1.e3	null	lemma_2=)	path2=hydrochlorothiazide_conj	wib=isradipine	pos_2=NN	lemma_2=isradipine	pos_3=CC	lpib=isradipine_NN	lib=isradipine	path1=DynaCirc_nmod	path=DynaCirc_nmod<administration_nsubj>hydrochlorothiazide_conj	relType_3=cc	relType_2=punct	lemma_1=(	relType_2=dep	pos_1=-LRB-	eib=True	pos_2=-RRB-	lemma_3=and	relType_1=punct
DDI-DrugBank.d81.s1	DDI-DrugBank.d81.s1.e2	DDI-DrugBank.d81.s1.e3	null	path2=hydrochlorothiazide_conj	lemma_2=and	eib=False	path1=isradipine_dep<DynaCirc_nmod	pos_1=-RRB-	pos_2=CC	wib=hydrochlorothiazide	lemma_1=)	lib=hydrochlorothiazide	path=isradipine_dep<DynaCirc_nmod<administration_nsubj>hydrochlorothiazide_conj	relType_1=punct	lpib=hydrochlorothiazide_NN	relType_2=cc
DDI-DrugBank.d81.s2	DDI-DrugBank.d81.s2.e0	DDI-DrugBank.d81.s2.e1	null	path2=therapy_nmod>hydrochlorothiazide_compound	relType_1=case	eib=False	lib=exist	relType_2=amod	path1=	lpib=exist_VBG	wib=existing	path=<isradipine_nmod>therapy_nmod>hydrochlorothiazide_compound	pos_1=IN	lemma_1=to	lemma_2=exist	pos_2=VBG
DDI-DrugBank.d81.s2	DDI-DrugBank.d81.s2.e0	DDI-DrugBank.d81.s2.e2	null	lemma_4=do	relType_1=case	pos_6=VB	relType_7=case	path2=have_conj>isradipine_nsubj	pos_8=DT	relType_10=amod	path1=isradipine_nmod<addition_nsubj	pos_9=JJ	lemma_12=,	lemma_8=any	path=isradipine_nmod<addition_nsubj<result_ROOT>have_conj>isradipine_nsubj	pos_12=,	pos_11=NNS	pos_1=IN	relType_9=amod	relType_12=punct	lemma_13=and	lemma_5=not	relType_13=cc	lemma_3=therapy	relType_6=ROOT	pos_10=JJ	lib=exist	relType_2=amod	pos_5=RB	relType_3=nmod	relType_4=aux	relation_11=neutral	lpib=exist_VBG	lemma_10=adverse	relType_11=obl	lemma_1=to	lemma_9=unexpected	lemma_6=result	relType_5=advmod	pos_13=CC	pos_4=VBD	lemma_3=hydrochlorothiazide	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	lemma_11=effect	relType_3=compound	wib=existing	relType_8=det	lemma_2=exist	pos_2=VBG
DDI-DrugBank.d81.s2	DDI-DrugBank.d81.s2.e1	DDI-DrugBank.d81.s2.e2	null	lemma_5=in	relType_10=punct	pos_3=RB	relType_3=advmod	relType_11=cc	path2=have_conj>isradipine_nsubj	pos_6=DT	relType_8=amod	lemma_10=,	lemma_3=not	lemma_2=do	lpib=therapy_NN	relType_9=obl	lemma_8=adverse	relation_8=neutral	relType_5=case	lemma_4=result	pos_8=JJ	eib=False	lemma_7=unexpected	pos_9=NNS	lemma_1=therapy	pos_2=VBD	relType_2=aux	relType_1=nmod	pos_1=NN	path=hydrochlorothiazide_compound<therapy_nmod<isradipine_nmod<addition_nsubj<result_ROOT>have_conj>isradipine_nsubj	relType_7=amod	lemma_11=and	pos_11=CC	pos_5=IN	lib=therapy	relType_4=ROOT	relType_6=det	lemma_6=any	pos_10=,	path1=hydrochlorothiazide_compound<therapy_nmod<isradipine_nmod<addition_nsubj	pos_4=VB	pos_7=JJ	lemma_9=effect	wib=therapy
DDI-DrugBank.d81.s3	DDI-DrugBank.d81.s3.e0	DDI-DrugBank.d81.s3.e1	null	relType_4=amod	pos_4=JJ	relType_10=punct	relType_7=case	relType_8=amod	lemma_10=,	path1=	lpib=single_JJ	relType_12=case	relType_5=compound	relType_9=nmod	lemma_6=study	lemma_12=of	pos_6=NN	pos_2=IN	relType_6=obl	pos_8=JJ	eib=False	pos_9=NNS	wib=single	relType_11=nsubj	relType_3=det	lemma_3=a	path=<Propranolol_ROOT>have_parataxis>coadministration_nsubj>propranolol_nmod	lemma_1=:	pos_12=IN	lemma_8=normal	pos_1=:	lemma_11=coadministration	lib=single	path2=have_parataxis>coadministration_nsubj>propranolol_nmod	pos_5=NN	lemma_5=dose	pos_11=NN	relType_2=case	lemma_9=volunteer	pos_10=,	pos_3=DT	pos_7=IN	lemma_7=in	lemma_4=single	relType_1=punct	lemma_2=in
DDI-DrugBank.d81.s3	DDI-DrugBank.d81.s3.e0	DDI-DrugBank.d81.s3.e2	null	lemma_10=,	lemma_13=propranolol	relType_22=dep	pos_6=NN	pos_8=JJ	lemma_20=but	pos_13=NN	pos_1=:	lemma_11=coadministration	lemma_17=on	lemma_15=small	relType_24=det	pos_10=,	pos_7=IN	lemma_7=in	pos_26=IN	lemma_4=single	relType_4=amod	relType_7=case	pos_22=NN	lemma_21=no	path1=	lpib=single_JJ	relation_22=neutral	relType_13=parataxis	pos_18=DT	pos_13=VBD	relType_25=nmod	wib=single	relType_3=det	lemma_3=a	pos_12=IN	lemma_8=normal	relType_21=det	lemma_19=rate	pos_16=NN	path2=have_parataxis>but_dep>effect_dep>extent_nmod>bioavailability_nmod>isradipine_compound	pos_5=NN	lemma_5=dose	pos_11=NN	lemma_9=volunteer	relation_16=neutral	pos_23=IN	relType_18=det	relType_1=punct	lemma_13=have	lemma_2=in	lemma_18=the	relType_10=punct	relType_12=case	lemma_23=on	lemma_25=extent	lemma_12=of	pos_17=IN	pos_2=IN	relType_6=obl	relType_19=nmod	pos_24=DT	lemma_1=:	relType_17=case	relType_16=obj	pos_25=NN	lemma_26=of	lemma_16=effect	lib=single	relType_23=case	pos_14=DT	relType_2=case	pos_20=CC	lemma_22=effect	pos_4=JJ	pos_15=JJ	relType_8=amod	relType_15=amod	relType_26=case	relType_5=compound	relType_9=nmod	lemma_6=study	relType_13=nmod	relType_20=dep	pos_9=NNS	relType_14=det	relType_11=nsubj	pos_19=NN	lemma_24=the	lemma_14=a	eib=True	pos_3=DT	path=<Propranolol_ROOT>have_parataxis>but_dep>effect_dep>extent_nmod>bioavailability_nmod>isradipine_compound	pos_21=DT
DDI-DrugBank.d81.s3	DDI-DrugBank.d81.s3.e1	DDI-DrugBank.d81.s3.e2	null	pos_2=DT	relType_8=dep	pos_6=DT	relation_9=neutral	lemma_2=a	relType_10=dep	relType_5=case	relType_12=det	relType_11=case	relType_13=nmod	lpib=have_VBD	pos_1=VBD	eib=False	lemma_6=the	pos_9=DT	lemma_1=have	pos_8=CC	pos_10=NN	lemma_10=effect	pos_13=NN	pos_4=NN	lib=have	relType_4=obj	wib=had	relType_1=parataxis	lemma_7=rate	pos_11=IN	lemma_12=the	pos_14=IN	relation_3=neutral	lemma_11=on	relType_3=amod	path2=but_dep>effect_dep>extent_nmod>bioavailability_nmod>isradipine_compound	pos_5=IN	relType_7=nmod	path=propranolol_nmod<coadministration_nsubj<have_parataxis>but_dep>effect_dep>extent_nmod>bioavailability_nmod>isradipine_compound	lemma_9=no	lemma_3=small	relType_6=det	lemma_4=effect	pos_3=JJ	lemma_8=but	lemma_5=on	lemma_13=extent	relType_2=det	lemma_14=of	pos_12=DT	relType_14=case	pos_7=NN	path1=propranolol_nmod<coadministration_nsubj	relType_9=det
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e0	DDI-DrugBank.d81.s6.e1	null	pos_14=CC	pos_2=JJ	pos_8=NNS	pos_6=HYPH	relType_14=cc:preconj	relType_21=conj	relType_9=ROOT	pos_3=NNS	relType_26=parataxis	wib=healthy	lemma_8=condition	relType_15=nmod:poss	pos_26=NN	relType_22=punct	relType_25=nummod	pos_22=,	lemma_5=steady	lemma_7=state	lemma_27=between	pos_11=JJ	lemma_24=be	relType_1=case	pos_21=NNP	relType_24=cop	lemma_21=Cmax	lemma_3=volunteer	pos_25=CD	relType_11=amod	lemma_22=,	pos_1=IN	lemma_17=bioavailability	pos_16=POS	lpib=healthy_JJ	lemma_15=drug	lemma_26=%	relation_11=neutral	lemma_19=AUC	lemma_1=to	lemma_2=healthy	lemma_25=20	lemma_20=and	relType_16=case	lemma_14=either	lemma_11=relevant	pos_7=NN	relType_23=nsubj	lemma_4=under	path=propranolol_nsubj<have_ROOT>%_parataxis>isradipine_nmod	relType_10=det	relType_20=cc	lemma_13=on	pos_24=VBD	path1=propranolol_nsubj	pos_17=NN	lemma_12=effect	pos_13=IN	lemma_6=-	relType_13=case	relType_5=amod	pos_23=NNS	pos_4=IN	relType_2=amod	relType_3=nmod	relType_17=nmod	relType_19=conj	pos_9=VBD	pos_20=CC	path2=%_parataxis>isradipine_nmod	relType_27=case	lib=healthy	lemma_9=have	pos_10=DT	relType_7=compound	lemma_23=difference	eib=False	relType_6=punct	relType_12=obj	pos_27=IN	pos_5=JJ	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	relType_8=nmod	pos_19=NNP	pos_12=NN	lemma_10=no	lemma_16=s
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e0	DDI-DrugBank.d81.s6.e2	null	pos_14=CC	relType_29=advmod	pos_2=JJ	pos_8=NNS	pos_6=HYPH	relType_14=cc:preconj	relType_21=conj	relType_9=ROOT	pos_3=NNS	relType_26=parataxis	relType_30=cc	wib=healthy	lemma_8=condition	relType_15=nmod:poss	pos_26=NN	relType_22=punct	relType_25=nummod	pos_22=,	lemma_5=steady	pos_32=NN	pos_28=NN	lemma_7=state	relType_32=conj	lemma_27=between	pos_11=JJ	lemma_24=be	relType_1=case	pos_21=NNP	relType_24=cop	lemma_21=Cmax	pos_30=CC	lemma_3=volunteer	relType_28=nmod	pos_25=CD	lemma_31=in	relType_11=amod	lemma_22=,	pos_1=IN	lemma_17=bioavailability	pos_16=POS	lpib=healthy_JJ	lemma_15=drug	lemma_26=%	lemma_29=singly	relation_11=neutral	lemma_19=AUC	lemma_1=to	lemma_2=healthy	lemma_25=20	lemma_20=and	relType_16=case	lemma_14=either	path=propranolol_nsubj<have_ROOT>%_parataxis>isradipine_nmod>propranolol_nmod	lemma_11=relevant	pos_7=NN	relType_23=nsubj	lemma_4=under	relType_10=det	relType_20=cc	lemma_13=on	lemma_33=with	pos_24=VBD	path1=propranolol_nsubj	pos_31=IN	pos_17=NN	lemma_12=effect	pos_13=IN	lemma_28=give	lemma_6=-	relType_13=case	pos_33=IN	relType_5=amod	pos_23=NNS	pos_4=IN	relType_2=amod	relType_3=nmod	relType_17=nmod	relType_19=conj	lemma_28=isradipine	relType_28=case	pos_9=VBD	pos_20=CC	relType_27=case	lib=healthy	lemma_9=have	pos_10=DT	relType_7=compound	relType_33=case	relType_31=case	path2=%_parataxis>isradipine_nmod>propranolol_nmod	lemma_23=difference	pos_28=VBN	relType_6=punct	pos_29=RB	relType_12=obj	pos_27=IN	pos_5=JJ	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	lemma_32=combination	eib=True	relType_8=nmod	pos_19=NNP	lemma_30=and	pos_12=NN	lemma_10=no	lemma_16=s
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e0	DDI-DrugBank.d81.s6.e3	null	pos_14=CC	pos_34=NN	relType_29=advmod	pos_2=JJ	pos_8=NNS	pos_6=HYPH	relType_14=cc:preconj	relType_21=conj	relType_9=ROOT	lemma_35=and	relType_35=cc	pos_3=NNS	relType_26=parataxis	relType_30=cc	wib=healthy	lemma_8=condition	relType_15=nmod:poss	pos_26=NN	relType_22=punct	relType_34=nmod	pos_36=IN	relType_25=nummod	pos_22=,	lemma_5=steady	pos_32=NN	pos_28=NN	path2=%_parataxis>propranolol_conj	lemma_7=state	relType_32=conj	lemma_27=between	pos_11=JJ	lemma_24=be	relType_34=punct	pos_34=,	path=propranolol_nsubj<have_ROOT>%_parataxis>propranolol_conj	relType_1=case	pos_21=NNP	relType_24=cop	lemma_21=Cmax	pos_30=CC	lemma_3=volunteer	relType_28=nmod	pos_25=CD	lemma_31=in	relType_11=amod	lemma_22=,	pos_1=IN	lemma_17=bioavailability	pos_16=POS	lpib=healthy_JJ	lemma_15=drug	lemma_26=%	lemma_29=singly	relation_11=neutral	lemma_19=AUC	lemma_1=to	lemma_2=healthy	lemma_25=20	lemma_20=and	relType_16=case	lemma_14=either	lemma_34=,	lemma_11=relevant	pos_7=NN	relType_23=nsubj	lemma_4=under	relType_10=det	relType_20=cc	lemma_13=on	lemma_36=between	lemma_33=with	pos_24=VBD	path1=propranolol_nsubj	pos_31=IN	pos_17=NN	lemma_12=effect	pos_13=IN	lemma_28=give	lemma_6=-	relType_13=case	pos_33=IN	relType_5=amod	pos_23=NNS	pos_4=IN	relType_2=amod	relType_3=nmod	relType_17=nmod	relType_19=conj	lemma_28=isradipine	relType_28=case	pos_9=VBD	pos_20=CC	relType_27=case	lib=healthy	lemma_9=have	pos_10=DT	relType_7=compound	relType_33=case	lemma_34=propranolol	relType_31=case	lemma_23=difference	pos_28=VBN	relType_6=punct	pos_29=RB	relType_12=obj	pos_27=IN	pos_5=JJ	pos_18=,	pos_15=NN	pos_35=CC	lemma_18=,	relType_18=punct	relType_4=case	lemma_32=combination	eib=True	relType_8=nmod	pos_19=NNP	lemma_30=and	pos_12=NN	relType_36=case	lemma_10=no	lemma_16=s
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e0	DDI-DrugBank.d81.s6.e4	null	pos_14=CC	pos_34=NN	relType_41=conj	relType_29=advmod	pos_41=NN	pos_2=JJ	pos_8=NNS	pos_6=HYPH	relType_14=cc:preconj	relType_21=conj	relType_9=ROOT	lemma_35=and	relType_35=cc	lemma_39=and	pos_3=NNS	relType_26=parataxis	relType_30=cc	lemma_42=with	wib=healthy	lemma_8=condition	relType_15=nmod:poss	pos_26=NN	relType_22=punct	relType_34=nmod	pos_36=IN	relType_25=nummod	pos_22=,	lemma_5=steady	lemma_37=give	pos_32=NN	pos_40=IN	pos_28=NN	lemma_7=state	relType_37=conj	lemma_37=propranolol	relType_32=conj	pos_39=CC	lemma_27=between	pos_11=JJ	lemma_24=be	relType_34=punct	pos_34=,	relType_1=case	pos_21=NNP	relType_24=cop	lemma_21=Cmax	path2=%_parataxis>propranolol_conj>isradipine_nmod	pos_30=CC	lemma_3=volunteer	relType_28=nmod	pos_37=VBN	pos_25=CD	lemma_31=in	relType_11=amod	lemma_22=,	pos_1=IN	lemma_17=bioavailability	pos_16=POS	lpib=healthy_JJ	lemma_15=drug	lemma_26=%	pos_37=NN	relType_40=case	lemma_29=singly	relation_11=neutral	lemma_19=AUC	lemma_1=to	lemma_2=healthy	lemma_25=20	lemma_20=and	relType_16=case	lemma_14=either	lemma_34=,	lemma_11=relevant	pos_7=NN	relType_23=nsubj	lemma_4=under	relType_10=det	relType_20=cc	lemma_13=on	lemma_36=between	lemma_33=with	pos_24=VBD	path1=propranolol_nsubj	pos_31=IN	pos_17=NN	lemma_38=singly	relType_38=advmod	lemma_12=effect	pos_13=IN	lemma_28=give	lemma_6=-	relType_13=case	pos_33=IN	relType_5=amod	lemma_41=combination	pos_23=NNS	pos_4=IN	relType_2=amod	relType_3=nmod	path=propranolol_nsubj<have_ROOT>%_parataxis>propranolol_conj>isradipine_nmod	relType_17=nmod	relType_19=conj	relType_37=case	lemma_28=isradipine	relType_28=case	pos_9=VBD	lemma_40=in	pos_20=CC	relType_27=case	lib=healthy	lemma_9=have	pos_10=DT	relType_7=compound	pos_38=RB	relType_33=case	lemma_34=propranolol	relType_31=case	lemma_23=difference	pos_28=VBN	relType_6=punct	pos_29=RB	pos_42=IN	relType_12=obj	pos_27=IN	pos_5=JJ	pos_18=,	pos_15=NN	pos_35=CC	relType_42=case	lemma_18=,	relType_18=punct	relType_4=case	relType_39=cc	lemma_32=combination	eib=True	relType_8=nmod	pos_19=NNP	lemma_30=and	pos_12=NN	relType_36=case	lemma_10=no	lemma_16=s
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e1	DDI-DrugBank.d81.s6.e2	null	relType_1=case	pos_1=VBN	pos_3=CC	path1=	lemma_4=in	relType_6=case	lemma_1=give	lib=give	relType_3=cc	pos_2=RB	path=<isradipine_nmod>propranolol_nmod	lemma_5=combination	eib=False	relType_2=advmod	pos_6=IN	path2=propranolol_nmod	lemma_2=singly	wib=given	pos_4=IN	relType_4=case	lemma_6=with	relType_5=conj	pos_5=NN	lemma_3=and	lpib=give_VBN
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e1	DDI-DrugBank.d81.s6.e3	null	relType_1=case	pos_1=VBN	pos_3=CC	path1=isradipine_nmod	lemma_4=in	pos_9=IN	relType_6=case	lemma_1=give	lib=give	relType_3=cc	pos_2=RB	lemma_5=combination	relType_2=advmod	pos_6=IN	pos_7=,	relType_9=case	pos_8=CC	lemma_7=,	lemma_2=singly	lemma_7=propranolol	wib=given	path2=propranolol_conj	pos_4=IN	relType_4=case	relType_7=nmod	path=isradipine_nmod<%_parataxis>propranolol_conj	lemma_6=with	relType_5=conj	lemma_8=and	pos_5=NN	eib=True	relType_7=punct	lemma_3=and	pos_7=NN	relType_8=cc	lpib=give_VBN	lemma_9=between
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e1	DDI-DrugBank.d81.s6.e4	null	relType_1=case	pos_1=VBN	pos_3=CC	path=isradipine_nmod<%_parataxis>propranolol_conj>isradipine_nmod	path1=isradipine_nmod	relType_12=cc	lemma_4=in	lemma_10=give	pos_9=IN	pos_12=CC	relType_6=case	lemma_1=give	lib=give	relType_3=cc	pos_2=RB	lemma_5=combination	lemma_15=with	relType_2=advmod	relType_10=conj	pos_6=IN	pos_7=,	lemma_14=combination	relType_9=case	pos_8=CC	pos_10=NN	lemma_7=,	relType_10=case	relType_11=advmod	lemma_2=singly	path2=propranolol_conj>isradipine_nmod	pos_13=IN	pos_14=NN	lemma_7=propranolol	relType_13=case	wib=given	relType_15=case	pos_4=IN	lemma_11=singly	relType_4=case	relType_7=nmod	lemma_6=with	relType_5=conj	lemma_13=in	pos_11=RB	lemma_8=and	pos_15=IN	pos_5=NN	eib=True	relType_7=punct	lemma_10=propranolol	pos_10=VBN	lemma_12=and	relType_14=conj	lemma_3=and	pos_7=NN	relType_8=cc	lpib=give_VBN	lemma_9=between
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e2	DDI-DrugBank.d81.s6.e3	null	lpib=propranolol_NN	lemma_2=and	lemma_3=between	wib=propranolol	lemma_1=,	pos_3=IN	path2=propranolol_conj	eib=False	path1=propranolol_nmod<isradipine_nmod	pos_2=CC	pos_1=,	lib=propranolol	relType_1=punct	relType_2=cc	relType_3=case	path=propranolol_nmod<isradipine_nmod<%_parataxis>propranolol_conj
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e2	DDI-DrugBank.d81.s6.e4	null	lemma_4=propranolol	wib=propranolol	lemma_1=,	pos_3=IN	relType_7=case	pos_1=,	lemma_4=give	pos_9=IN	relType_2=cc	path=propranolol_nmod<isradipine_nmod<%_parataxis>propranolol_conj>isradipine_nmod	pos_8=NN	lemma_2=and	lemma_3=between	lemma_8=combination	relType_9=case	pos_4=NN	path2=propranolol_conj>isradipine_nmod	pos_4=VBN	pos_6=CC	path1=propranolol_nmod<isradipine_nmod	lemma_6=and	pos_5=RB	relType_4=case	relType_3=case	relType_5=advmod	lpib=propranolol_NN	lemma_9=with	eib=True	pos_7=IN	lemma_7=in	lemma_5=singly	pos_2=CC	relType_8=conj	relType_4=conj	lib=propranolol	relType_1=punct	relType_6=cc
DDI-DrugBank.d81.s6	DDI-DrugBank.d81.s6.e3	DDI-DrugBank.d81.s6.e4	null	relType_1=case	pos_1=VBN	pos_3=CC	path2=isradipine_nmod	path1=	lemma_4=in	relType_6=case	lemma_1=give	lib=give	relType_3=cc	pos_2=RB	lemma_5=combination	eib=False	relType_2=advmod	pos_6=IN	lemma_2=singly	wib=given	pos_4=IN	relType_4=case	lemma_6=with	relType_5=conj	pos_5=NN	path=<propranolol_conj>isradipine_nmod	lemma_3=and	lpib=give_VBN
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e0	DDI-DrugBank.d81.s7.e1	null	pos_7=NNS	lemma_5=in	lemma_4=study	pos_6=JJ	lemma_9=a	path1=	relType_8=punct	lemma_11=-	lemma_13=course	lemma_8=,	relType_5=case	pos_11=HYPH	pos_2=IN	relType_12=compound	eib=False	relType_6=amod	relType_11=punct	pos_9=DT	pos_12=NN	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_12=week	lemma_1=:	pos_13=NN	pos_14=IN	lemma_7=volunteer	path=<cimetidine_ROOT>show_parataxis>study_obl>b._acl>course_nsubj>cimetidine_nmod	lib=study	relType_4=obl	lemma_10=one	relType_13=nsubj	pos_10=CD	path2=show_parataxis>study_obl>b._acl>course_nsubj>cimetidine_nmod	pos_1=:	pos_5=IN	relType_7=nmod	relType_10=nummod	relType_2=case	pos_3=DT	wib=study	lemma_14=of	relType_14=case	relType_1=punct	relType_9=det	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e0	DDI-DrugBank.d81.s7.e2	null	lemma_5=in	pos_6=JJ	pos_24=CD	relType_8=punct	relType_5=case	relType_12=compound	relType_24=nummod	pos_26=NN	pos_13=NN	lemma_12=week	lib=study	pos_1=:	relType_21=case	lemma_22=a	wib=study	lemma_14=of	pos_7=NNS	lemma_4=study	path1=	pos_20=VBN	lemma_13=course	lemma_26=dose	relType_3=det	lemma_3=a	pos_14=IN	relType_15=case	relType_4=obl	relType_13=nsubj	pos_5=IN	relType_7=nmod	relType_16=nummod	relType_15=nmod	pos_15=IN	pos_22=DT	lemma_19=i.	lemma_15=cimetidine	relType_19=case	relType_20=obl	path2=show_parataxis>study_obl>b._acl>dose_obl>isradipine_nmod	relType_1=punct	lemma_18=b.	lemma_2=in	pos_8=,	pos_23=JJ	lemma_9=a	lemma_27=of	relType_23=amod	lemma_11=-	lemma_8=,	pos_2=IN	relType_11=punct	pos_9=DT	pos_21=IN	lemma_1=:	relType_25=compound	pos_16=CD	pos_25=NN	relType_17=nmod	lemma_24=5	lemma_23=single	pos_18=VBN	relType_2=case	pos_17=NNS	relType_22=det	lemma_20=d.	relType_14=case	relType_27=case	lemma_6=healthy	pos_19=IN	pos_11=HYPH	relType_18=acl	relType_6=amod	lemma_25=mg	lemma_21=with	lpib=study_NN	pos_27=IN	pos_4=NN	lemma_10=one	pos_15=NN	lemma_15=at	pos_10=CD	lemma_16=400	relType_26=obl	relType_10=nummod	path=<cimetidine_ROOT>show_parataxis>study_obl>b._acl>dose_obl>isradipine_nmod	eib=True	pos_3=DT	lemma_17=mg	pos_12=NN	lemma_7=volunteer	relType_9=det
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e0	DDI-DrugBank.d81.s7.e3	null	lemma_5=in	lemma_32=show	pos_6=JJ	lemma_33=a	pos_34=NN	pos_24=CD	relType_8=punct	relType_5=case	relType_12=compound	relType_24=nummod	pos_26=NN	pos_13=NN	lemma_12=week	relType_32=parataxis	relType_30=amod	lemma_34=increase	lib=study	pos_1=:	relType_21=case	pos_28=NN	path=<cimetidine_ROOT>show_parataxis>increase_obj>concentration_nmod>isradipine_compound	lemma_22=a	wib=study	lemma_14=of	relation_35=beneficial	pos_7=NNS	lemma_4=study	path1=	pos_20=VBN	lemma_13=course	relType_28=nmod	lemma_26=dose	relType_3=det	lemma_3=a	pos_14=IN	path2=show_parataxis>increase_obj>concentration_nmod>isradipine_compound	relType_15=case	relType_4=obl	relType_13=nsubj	pos_5=IN	relType_7=nmod	relType_16=nummod	relType_15=nmod	pos_15=IN	pos_22=DT	lemma_19=i.	pos_33=DT	lemma_15=cimetidine	pos_31=NN	relType_19=case	relType_20=obl	relType_1=punct	lemma_18=b.	lemma_2=in	pos_8=,	pos_23=JJ	lemma_9=a	lemma_27=of	relType_23=amod	lemma_11=-	lemma_8=,	pos_2=IN	relType_29=det	pos_30=JJ	relType_11=punct	pos_9=DT	pos_21=IN	lemma_1=:	lemma_31=day	relType_25=compound	pos_32=VBD	lemma_35=in	pos_16=CD	pos_25=NN	relType_17=nmod	lemma_24=5	lemma_23=single	pos_18=VBN	lemma_28=isradipine	relType_2=case	pos_17=NNS	relType_28=case	relType_22=det	lemma_20=d.	relType_14=case	relType_27=case	lemma_6=healthy	pos_19=IN	lemma_29=the	pos_11=HYPH	relType_18=acl	lemma_28=on	relType_6=amod	relType_31=nmod	lemma_25=mg	lemma_21=with	lpib=study_NN	pos_27=IN	pos_4=NN	lemma_10=one	pos_15=NN	lemma_15=at	pos_10=CD	lemma_16=400	pos_29=DT	lemma_30=sixth	relType_26=obl	relType_10=nummod	relType_33=det	eib=True	pos_3=DT	pos_28=IN	lemma_17=mg	pos_35=IN	relType_35=case	pos_12=NN	lemma_7=volunteer	relType_9=det	relType_34=obj
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e1	DDI-DrugBank.d81.s7.e2	mechanism	relType_1=case	relType_12=obl	relType_2=nummod	pos_8=DT	relType_7=case	lemma_4=b.	path2=dose_obl>isradipine_nmod	relType_5=case	lemma_7=with	lemma_13=of	relType_4=acl	relType_6=obl	pos_9=JJ	pos_3=NNS	lib=mg	lemma_2=400	eib=False	pos_2=CD	lemma_9=single	lemma_8=a	lemma_11=mg	lemma_1=at	pos_1=IN	pos_6=VBN	relType_9=amod	pos_13=IN	pos_4=VBN	lpib=mg_NNS	relType_13=case	pos_10=CD	lemma_12=dose	relType_3=nmod	lemma_6=d.	pos_5=IN	lemma_5=i.	path1=cimetidine_nmod<course_nsubj	relType_10=nummod	path=cimetidine_nmod<course_nsubj<b._acl>dose_obl>isradipine_nmod	pos_11=NN	pos_7=IN	relType_11=compound	wib=mg	lemma_3=mg	relType_8=det	pos_12=NN	lemma_10=5
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e1	DDI-DrugBank.d81.s7.e3	null	relType_18=parataxis	relType_1=case	relType_12=obl	lemma_18=show	relType_2=nummod	pos_8=DT	relType_7=case	lemma_20=increase	relation_20=beneficial	lemma_4=b.	relType_14=nmod	relType_19=det	relType_5=case	lemma_7=with	lemma_14=isradipine	lemma_13=of	relType_4=acl	relType_6=obl	pos_9=JJ	relType_16=amod	pos_17=NN	pos_3=NNS	lib=mg	lemma_2=400	lemma_19=a	lemma_21=in	pos_2=CD	lemma_15=the	lemma_9=single	lemma_16=sixth	lemma_8=a	lemma_11=mg	pos_20=NN	path2=increase_obj>concentration_nmod>isradipine_compound	lemma_1=at	pos_1=IN	pos_6=VBN	relType_9=amod	pos_13=IN	pos_14=NN	pos_15=DT	relType_20=obj	pos_21=IN	pos_4=VBN	lpib=mg_NNS	pos_14=IN	relType_13=case	pos_16=JJ	pos_10=CD	lemma_12=dose	pos_18=VBD	relType_3=nmod	lemma_6=d.	pos_5=IN	pos_19=DT	lemma_5=i.	relType_17=nmod	relType_10=nummod	relType_21=case	lemma_14=on	path=cimetidine_nmod<course_nsubj<b._acl<study_obl<show_parataxis>increase_obj>concentration_nmod>isradipine_compound	path1=cimetidine_nmod<course_nsubj<b._acl<study_obl	pos_11=NN	eib=True	pos_7=IN	relType_11=compound	wib=mg	lemma_3=mg	relType_8=det	relType_14=case	pos_12=NN	relType_15=det	lemma_17=day	lemma_10=5
DDI-DrugBank.d81.s7	DDI-DrugBank.d81.s7.e2	DDI-DrugBank.d81.s7.e3	null	relType_8=case	pos_2=DT	relType_1=case	lemma_2=the	pos_6=DT	relType_5=parataxis	relType_4=nmod	lemma_4=day	lemma_5=show	lemma_8=in	lemma_3=sixth	eib=False	lemma_6=a	path1=isradipine_nmod<dose_obl<b._acl<study_obl	lib=sixth	relType_7=obj	lemma_7=increase	path2=increase_obj>concentration_nmod>isradipine_compound	pos_1=IN	pos_4=NN	wib=sixth	pos_8=IN	relType_3=amod	lpib=sixth_JJ	relation_6=beneficial	pos_5=VBD	path=isradipine_nmod<dose_obl<b._acl<study_obl<show_parataxis>increase_obj>concentration_nmod>isradipine_compound	relType_6=det	pos_3=JJ	relType_2=det	pos_7=NN	lemma_1=on
DDI-DrugBank.d81.s8	DDI-DrugBank.d81.s8.e0	DDI-DrugBank.d81.s8.e1	advise	relType_4=dep	wib=therapy	pos_6=JJ	path2=in_dep>a_dep>advise_dep>patient_nsubj:pass>receive_acl>monitoring_obj>cimetidine_compound	pos_3=VBN	lemma_4=in	lpib=therapy_NN	lemma_8=receive	lemma_5=a	pos_7=RB	eib=False	lemma_6=patient	path=isradipine_compound<therapy_nsubj:pass<initiate_ROOT>in_dep>a_dep>advise_dep>patient_nsubj:pass>receive_acl>monitoring_obj>cimetidine_compound	lemma_1=therapy	relType_5=dep	pos_1=NN	relType_3=ROOT	pos_4=IN	pos_8=VBG	relType_2=aux:pass	path1=isradipine_compound<therapy_nsubj:pass	lib=therapy	relType_6=nsubj:pass	relType_8=acl	pos_2=VBZ	lemma_7=currently	pos_5=DT	relType_1=nsubj:pass	lemma_2=be	relType_7=advmod	lemma_3=initiate
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e0	DDI-DrugBank.d81.s9.e1	null	pos_7=NNS	lemma_5=in	lemma_4=study	pos_6=JJ	lemma_9=a	path1=	relType_8=punct	lemma_11=-	lemma_13=course	lemma_8=,	relType_5=case	pos_11=HYPH	pos_2=IN	relType_12=compound	eib=False	path=<Rifampicin_ROOT>study_obl>follow_dep>course_nsubj>rifampicin_nmod	relType_6=amod	relType_11=punct	pos_9=DT	pos_12=NN	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	pos_13=NN	lemma_1=:	pos_14=IN	lemma_7=volunteer	lib=study	relType_4=obl	relType_13=nsubj	pos_10=CD	pos_1=:	lemma_12=day	pos_5=IN	relType_7=nmod	relType_10=nummod	relType_2=case	pos_3=DT	wib=study	lemma_10=six	lemma_14=of	relType_14=case	relType_1=punct	relType_9=det	path2=study_obl>follow_dep>course_nsubj>rifampicin_nmod	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e0	DDI-DrugBank.d81.s9.e2	null	relType_18=dep	lemma_5=in	pos_6=JJ	pos_24=CD	relType_8=punct	relType_5=case	relType_12=compound	path=<Rifampicin_ROOT>study_obl>follow_dep>dose_obl>isradipine_nmod	relType_24=nummod	lemma_19=day	pos_26=NN	pos_13=NN	lib=study	pos_1=:	relType_21=case	lemma_18=/	lemma_22=a	wib=study	lemma_10=six	lemma_14=of	pos_7=NNS	lemma_4=study	path1=	pos_20=VBN	lemma_13=course	lemma_26=dose	lemma_20=follow	relType_3=det	lemma_3=a	pos_14=IN	relType_15=case	relType_4=obl	relType_13=nsubj	lemma_12=day	pos_5=IN	relType_7=nmod	relType_16=nummod	pos_18=SYM	relType_15=nmod	pos_15=IN	pos_22=DT	relType_1=punct	lemma_2=in	pos_8=,	pos_23=JJ	path2=study_obl>follow_dep>dose_obl>isradipine_nmod	lemma_9=a	lemma_27=of	relType_23=amod	lemma_11=-	lemma_8=,	pos_2=IN	pos_17=NN	relType_19=nmod	relType_11=punct	pos_9=DT	pos_21=IN	lemma_1=:	relType_25=compound	pos_16=CD	pos_25=NN	relType_17=nmod	lemma_21=by	lemma_24=5	lemma_23=single	relType_2=case	relType_22=det	relType_14=case	relType_27=case	lemma_15=rifampicin	lemma_6=healthy	lemma_16=600	pos_11=HYPH	relType_20=dep	relType_6=amod	lemma_25=mg	pos_19=NN	lpib=study_NN	pos_27=IN	pos_4=NN	pos_15=NN	lemma_15=at	pos_10=CD	relType_26=obl	relType_10=nummod	eib=True	pos_3=DT	lemma_17=mg	pos_12=NN	lemma_7=volunteer	relType_9=det
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e0	DDI-DrugBank.d81.s9.e3	null	relType_18=dep	lemma_5=in	pos_6=JJ	pos_24=CD	relType_8=punct	relType_5=case	relType_31=obl	lemma_28=result	relType_12=compound	relType_24=nummod	lemma_19=day	pos_26=NN	pos_13=NN	pos_32=IN	lemma_30=a	lib=study	pos_1=:	relType_21=case	pos_28=NN	lemma_18=/	lemma_22=a	wib=study	lemma_10=six	lemma_14=of	relType_32=case	pos_7=NNS	lemma_31=reduction	lemma_4=study	lemma_29=in	path1=	pos_20=VBN	lemma_13=course	pos_28=VBD	pos_29=IN	relType_28=nmod	relType_28=acl	lemma_26=dose	lemma_20=follow	relType_3=det	lemma_3=a	pos_14=IN	relType_15=case	path=<Rifampicin_ROOT>study_obl>result_acl>reduction_obl>level_nmod>isradipine_compound	relType_4=obl	relType_13=nsubj	lemma_12=day	pos_5=IN	relType_7=nmod	relType_16=nummod	pos_18=SYM	relType_15=nmod	pos_15=IN	pos_22=DT	pos_31=NN	relType_1=punct	lemma_2=in	pos_8=,	pos_23=JJ	relType_29=case	lemma_9=a	lemma_27=of	relType_23=amod	lemma_11=-	lemma_32=in	lemma_8=,	pos_2=IN	pos_17=NN	relType_19=nmod	relType_11=punct	pos_9=DT	pos_21=IN	lemma_1=:	relType_25=compound	pos_16=CD	pos_25=NN	relType_17=nmod	lemma_21=by	lemma_24=5	lemma_23=single	lemma_28=isradipine	relType_2=case	relType_22=det	relType_14=case	relType_27=case	lemma_15=rifampicin	pos_30=DT	lemma_6=healthy	lemma_16=600	pos_11=HYPH	relType_20=dep	relType_6=amod	lemma_25=mg	pos_19=NN	lpib=study_NN	pos_27=IN	path2=study_obl>result_acl>reduction_obl>level_nmod>isradipine_compound	pos_4=NN	pos_15=NN	lemma_15=at	pos_10=CD	relType_26=obl	relType_10=nummod	eib=True	pos_3=DT	lemma_17=mg	pos_12=NN	relType_30=det	lemma_7=volunteer	relType_9=det
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e1	DDI-DrugBank.d81.s9.e2	mechanism	relType_4=dep	relType_1=case	relType_12=obl	relType_2=nummod	pos_8=DT	relType_7=case	path2=dose_obl>isradipine_nmod	lemma_6=follow	lemma_13=of	pos_9=JJ	relType_6=dep	lib=mg	eib=False	pos_2=CD	lpib=mg_NN	lemma_9=single	pos_4=SYM	lemma_8=a	lemma_11=mg	lemma_1=at	pos_1=IN	pos_6=VBN	relType_9=amod	pos_13=IN	lemma_7=by	relType_13=case	pos_10=CD	lemma_12=dose	lemma_2=600	relType_3=nmod	lemma_4=/	relType_5=nmod	path1=rifampicin_nmod<course_nsubj	relType_10=nummod	pos_5=NN	lemma_5=day	pos_11=NN	path=rifampicin_nmod<course_nsubj<follow_dep>dose_obl>isradipine_nmod	pos_7=IN	relType_11=compound	pos_3=NN	wib=mg	lemma_3=mg	relType_8=det	pos_12=NN	lemma_10=5
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e1	DDI-DrugBank.d81.s9.e3	null	relType_4=dep	relType_1=case	relType_12=obl	relType_2=nummod	pos_8=DT	relType_7=case	pos_16=DT	relType_14=nmod	relType_16=det	lemma_6=follow	lemma_14=isradipine	relType_18=case	path=rifampicin_nmod<course_nsubj<follow_dep<study_obl>result_acl>reduction_obl>level_nmod>isradipine_compound	lemma_13=of	pos_9=JJ	relType_14=acl	lemma_16=a	pos_17=NN	relType_6=dep	lib=mg	pos_2=CD	lpib=mg_NN	lemma_9=single	pos_4=SYM	lemma_8=a	lemma_11=mg	lemma_1=at	pos_1=IN	pos_6=VBN	relType_9=amod	pos_13=IN	pos_14=NN	lemma_7=by	lemma_14=result	pos_18=IN	relType_13=case	relType_15=case	pos_10=CD	lemma_12=dose	lemma_2=600	relType_3=nmod	lemma_4=/	relType_5=nmod	lemma_17=reduction	relType_10=nummod	pos_15=IN	pos_5=NN	lemma_5=day	lemma_15=in	pos_11=NN	eib=True	pos_7=IN	relType_11=compound	pos_3=NN	path1=rifampicin_nmod<course_nsubj<follow_dep	pos_14=VBD	lemma_18=in	wib=mg	lemma_3=mg	path2=result_acl>reduction_obl>level_nmod>isradipine_compound	relType_8=det	pos_12=NN	relType_17=obl	lemma_10=5
DDI-DrugBank.d81.s9	DDI-DrugBank.d81.s9.e2	DDI-DrugBank.d81.s9.e3	null	lemma_5=in	relType_5=case	pos_2=IN	pos_1=VBD	eib=False	wib=resulted	relType_3=det	lemma_3=a	pos_4=NN	relType_4=obl	relType_1=acl	pos_5=IN	path=isradipine_nmod<dose_obl<follow_dep<study_obl>result_acl>reduction_obl>level_nmod>isradipine_compound	path1=isradipine_nmod<dose_obl<follow_dep	relType_2=case	pos_3=DT	lemma_4=reduction	lib=result	path2=result_acl>reduction_obl>level_nmod>isradipine_compound	lpib=result_VBD	lemma_1=result	lemma_2=in
DDI-DrugBank.d81.s10	DDI-DrugBank.d81.s10.e0	DDI-DrugBank.d81.s10.e1	mechanism	pos_3=VBN	lpib=therapy_NN	path=rifampicin_compound<therapy_nsubj:pass<require_advcl<likely_ROOT>concentration_nsubj>isradipine_compound	lemma_3=require	pos_4=,	eib=False	lemma_1=therapy	pos_1=NN	relType_4=punct	path2=concentration_nsubj>isradipine_compound	relType_3=advcl	relType_2=aux:pass	lib=therapy	lemma_4=,	pos_2=VBZ	path1=rifampicin_compound<therapy_nsubj:pass<require_advcl	relType_1=nsubj:pass	lemma_2=be	wib=therapy
DDI-DrugBank.d81.s10	DDI-DrugBank.d81.s10.e0	DDI-DrugBank.d81.s10.e2	null	lpib=therapy_NN	lemma_13=markedly	pos_8=NNS	pos_24=JJR	lemma_1=therapy	pos_16=VBN	relType_4=punct	relType_2=aux:pass	lib=therapy	lemma_15=or	lemma_21=increase	pos_14=VBN	relType_14=xcomp	relType_19=obl	pos_26=IN	relation_21=beneficial	pos_7=JJ	relType_8=conj	pos_15=CC	path2=reduce_xcomp>consequence_obl>metabolism_nmod>clearance_conj>isradipine_nmod	lemma_16=abolish	wib=therapy	lemma_20=of	lemma_10=likely	lemma_18=a	relType_22=nmod	relType_25=conj	pos_22=NN	relType_5=nsubj	relType_9=cop	relation_8=neutral	pos_18=DT	relType_20=case	lemma_22=metabolism	lemma_7=therapeutic	relType_13=advmod	pos_6=CC	lemma_4=,	lemma_5=isradipine	relType_24=amod	pos_21=VBN	pos_5=NN	pos_9=VBP	lemma_8=effect	lemma_2=be	relType_18=det	lemma_23=and	lemma_11=to	lemma_14=reduce	pos_20=IN	pos_17=IN	pos_11=TO	lemma_17=as	pos_23=CC	pos_4=,	pos_1=NN	relType_17=case	relType_7=amod	pos_25=NN	lemma_26=of	pos_12=VB	pos_2=VBZ	path1=rifampicin_compound<therapy_nsubj:pass<require_advcl	relType_1=nsubj:pass	relType_6=cc	lemma_25=clearance	pos_3=VBN	relType_26=case	relType_5=compound	relation_14=adverse	relType_12=aux:pass	lemma_3=require	lemma_24=high	pos_5=NNS	relType_21=amod	pos_13=RB	pos_19=NN	lemma_5=concentration	path=rifampicin_compound<therapy_nsubj:pass<require_advcl<likely_ROOT>reduce_xcomp>consequence_obl>metabolism_nmod>clearance_conj>isradipine_nmod	relType_10=ROOT	relType_3=advcl	lemma_12=be	pos_10=JJ	lemma_6=and	relType_23=cc	relType_15=cc	lemma_9=be	relType_11=mark	eib=True	lemma_19=consequence	relType_16=conj
DDI-DrugBank.d81.s10	DDI-DrugBank.d81.s10.e1	DDI-DrugBank.d81.s10.e2	null	lemma_22=of	relType_12=conj	pos_6=JJ	relType_9=advmod	relType_11=cc	relType_5=cop	lemma_13=as	pos_16=IN	lpib=concentration_NNS	relation_9=adverse	lemma_1=concentration	relType_2=cc	lemma_6=likely	relType_7=mark	pos_17=VBN	lemma_15=consequence	relType_21=conj	path=isradipine_compound<concentration_nsubj<likely_ROOT>reduce_xcomp>consequence_obl>metabolism_nmod>clearance_conj>isradipine_nmod	lemma_2=and	lemma_10=reduce	relType_20=amod	lemma_12=abolish	eib=False	pos_5=VBP	relation_16=beneficial	relType_8=aux:pass	lemma_7=to	relType_14=det	lemma_18=metabolism	lemma_3=therapeutic	pos_13=IN	lemma_16=of	lemma_5=be	lemma_19=and	pos_22=IN	pos_4=NNS	pos_7=TO	relType_22=case	pos_8=VB	lemma_9=markedly	pos_18=NN	relType_13=case	relType_6=ROOT	relation_3=neutral	pos_20=JJR	relType_15=obl	pos_15=NN	relType_3=amod	wib=concentrations	lemma_8=be	lemma_11=or	relType_1=nsubj	pos_11=CC	pos_9=RB	pos_19=CC	relType_19=cc	lemma_20=high	pos_14=DT	relType_17=amod	lemma_14=a	path1=isradipine_compound<concentration_nsubj	relType_16=case	lemma_4=effect	pos_1=NNS	pos_3=JJ	lemma_21=clearance	pos_10=VBN	pos_2=CC	relType_10=xcomp	relType_4=conj	lib=concentration	path2=reduce_xcomp>consequence_obl>metabolism_nmod>clearance_conj>isradipine_nmod	pos_12=VBN	relType_18=nmod	pos_21=NN	lemma_17=increase
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e0	DDI-DrugBank.d81.s11.e1	null	pos_7=NNS	lemma_5=in	lemma_4=study	pos_6=JJ	pos_16=IN	path1=	relType_8=punct	lemma_8=,	relType_5=case	path2=see_appos>interaction_nsubj:pass>isradipine_nmod	relType_15=nsubj:pass	pos_2=IN	pos_12=JJ	lemma_14=pharmacodynamic	eib=False	lemma_13=or	relType_6=amod	relType_11=amod	pos_9=DT	relType_10=advmod	relType_12=amod	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_10=clinically	lemma_1=:	lemma_11=relevant	relType_13=cc	lemma_7=volunteer	lib=study	relType_4=obl	pos_15=NN	pos_1=:	lemma_15=interaction	pos_5=IN	relType_7=nmod	lemma_9=no	path=<Warfarin_ROOT>see_appos>interaction_nsubj:pass>isradipine_nmod	pos_13=CC	lemma_12=pharmacokinetic	lemma_16=between	relType_16=case	relType_2=case	pos_3=DT	wib=study	pos_14=JJ	pos_11=JJ	pos_10=RB	relType_1=punct	relType_9=det	relType_14=conj	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e0	DDI-DrugBank.d81.s11.e2	null	pos_7=NNS	lemma_5=in	lemma_4=study	pos_6=JJ	relType_17=cc	pos_16=IN	path2=see_appos>interaction_nsubj:pass>isradipine_nmod>warfarin_conj	relType_18=amod	path1=	relType_8=punct	lemma_8=,	relType_5=case	relType_15=nsubj:pass	pos_2=IN	pos_12=JJ	lemma_14=pharmacodynamic	pos_17=NN	lemma_13=or	relType_6=amod	relType_11=amod	pos_9=DT	relType_10=advmod	relType_12=amod	pos_18=JJ	lpib=study_NN	relType_3=det	lemma_3=a	pos_4=NN	lemma_10=clinically	lemma_1=:	lemma_11=relevant	relType_13=cc	lemma_7=volunteer	lib=study	relType_4=obl	pos_15=NN	pos_1=:	lemma_15=interaction	pos_5=IN	relType_7=nmod	lemma_9=no	lemma_17=isradipine	lemma_17=and	relType_17=nmod	pos_13=CC	lemma_12=pharmacokinetic	lemma_16=between	relType_16=case	path=<Warfarin_ROOT>see_appos>interaction_nsubj:pass>isradipine_nmod>warfarin_conj	relType_2=case	eib=True	pos_3=DT	wib=study	pos_14=JJ	pos_11=JJ	pos_17=CC	pos_10=RB	relType_1=punct	relType_9=det	lemma_18=racemic	relType_14=conj	lemma_2=in	lemma_6=healthy	pos_8=,
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e0	DDI-DrugBank.d81.s11.e3	null	lemma_5=in	pos_6=JJ	relType_8=punct	lemma_22=two	relType_5=case	relType_15=nsubj:pass	lemma_10=clinically	lib=study	relType_20=appos	path=<Warfarin_ROOT>see_appos>administer_advcl>dose_nsubj:pass>warfarin_nmod	pos_1=:	lemma_15=interaction	lemma_21=when	lemma_20=see	lemma_12=pharmacokinetic	wib=study	pos_26=IN	pos_11=JJ	pos_19=VBD	pos_7=NNS	lemma_4=study	relType_17=cc	path1=	pos_20=VBN	lemma_19=be	lemma_13=or	relType_22=nummod	path2=see_appos>administer_advcl>dose_nsubj:pass>warfarin_nmod	relType_11=amod	relType_21=advmod	pos_25=NNS	relType_12=amod	relType_3=det	lemma_3=a	relType_13=cc	relType_4=obl	pos_5=IN	relType_7=nmod	lemma_9=no	relType_19=aux:pass	relType_24=amod	relType_16=case	pos_17=CC	pos_10=RB	pos_21=WRB	relType_1=punct	lemma_11=relevant	lemma_18=racemic	lemma_19=warfarin	lemma_2=in	pos_8=,	pos_23=JJ	pos_16=IN	relType_23=amod	lemma_8=,	pos_24=JJ	lemma_25=dose	pos_2=IN	pos_17=NN	pos_9=DT	lemma_1=:	lemma_24=oral	relType_25=nsubj:pass	lemma_26=of	relType_17=nmod	relType_19=conj	pos_13=CC	lemma_23=single	relType_2=case	pos_14=JJ	relType_14=conj	lemma_6=healthy	relType_18=amod	relType_26=case	pos_12=JJ	lemma_14=pharmacodynamic	pos_22=CD	relType_6=amod	relType_10=advmod	pos_18=JJ	pos_19=NN	lpib=study_NN	pos_4=NN	pos_15=NN	lemma_17=isradipine	lemma_17=and	lemma_16=between	eib=True	pos_3=DT	lemma_7=volunteer	relType_9=det
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e0	DDI-DrugBank.d81.s11.e4	null	relType_28=dep	lemma_36=)	lemma_5=in	pos_6=JJ	pos_34=NN	lemma_31=mg	relType_44=nmod	relType_8=punct	lemma_22=two	pos_35=NN	relType_34=compound	relType_5=case	relType_15=nsubj:pass	lemma_39=during	pos_40=CD	relType_27=nmod	lemma_10=clinically	lemma_37=be	lib=study	relType_20=appos	pos_1=:	lemma_15=interaction	lemma_21=when	lemma_20=see	lemma_12=pharmacokinetic	wib=study	pos_26=IN	relType_40=nummod	lemma_48=b.	pos_11=JJ	relType_36=punct	path2=see_appos>administer_advcl>b._advcl>isradipine_obl	lemma_50=d.	relType_33=nmod	pos_19=VBD	pos_7=NNS	pos_29=.	lemma_4=study	relType_17=cc	path1=	pos_20=VBN	relType_47=nsubj	lemma_19=be	lemma_13=or	relType_22=nummod	relType_21=advmod	relType_11=amod	relType_30=nummod	pos_25=NNS	relType_12=amod	lemma_40=11	pos_41=NNS	relType_3=det	lemma_3=a	pos_44=NN	relType_13=cc	pos_27=NN	relType_4=obl	lemma_27=warfarin	pos_5=IN	relType_7=nmod	lemma_9=no	relType_19=aux:pass	lemma_33=kg	lemma_47=mg	relType_24=amod	lemma_43=multipledose	relType_16=case	pos_31=NN	relType_50=amod	path=<Warfarin_ROOT>see_appos>administer_advcl>b._advcl>isradipine_obl	pos_27=-LRB-	relType_43=compound	pos_30=CD	pos_17=CC	pos_21=WRB	pos_10=RB	relType_1=punct	lemma_11=relevant	lemma_18=racemic	lemma_19=warfarin	relType_35=appos	lemma_2=in	pos_8=,	lemma_46=5	pos_23=JJ	pos_46=CD	pos_16=IN	lemma_30=7	relType_23=amod	lemma_8=,	pos_24=JJ	relType_31=compound	lemma_25=dose	pos_2=IN	pos_17=NN	pos_9=DT	relType_45=mark	lemma_1=:	relType_41=obl	lemma_24=oral	pos_45=IN	relType_25=nsubj:pass	lemma_26=of	lemma_35=weight	relType_17=nmod	relType_19=conj	pos_43=NN	pos_13=CC	lemma_23=single	relType_2=case	lemma_28=0	pos_37=VBD	pos_14=JJ	lemma_49=i.	relType_27=punct	pos_47=NNS	relType_14=conj	relType_39=case	lemma_32=/	lemma_6=healthy	lemma_29=.	pos_33=NN	pos_39=IN	lemma_42=of	relType_18=amod	relType_48=advcl	relType_26=case	relType_32=dep	pos_28=CD	relType_46=nummod	pos_12=JJ	pos_36=-RRB-	lemma_14=pharmacodynamic	pos_22=CD	relType_6=amod	lemma_34=body	relType_10=advmod	pos_18=JJ	pos_19=NN	pos_42=IN	lpib=study_NN	relType_37=aux:pass	pos_48=VBN	pos_4=NN	lemma_44=treatment	relType_49=case	pos_32=SYM	pos_15=NN	lemma_38=administer	relType_29=punct	lemma_17=isradipine	lemma_17=and	lemma_27=(	pos_50=VBN	lemma_16=between	relType_38=advcl	pos_38=VBN	eib=True	pos_3=DT	lemma_45=with	pos_49=IN	lemma_41=day	relType_42=case	lemma_7=volunteer	relType_9=det
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e1	DDI-DrugBank.d81.s11.e2	null	relType_1=cc	path2=warfarin_conj	path=<isradipine_nmod>warfarin_conj	pos_1=CC	lpib=racemic_JJ	eib=False	lib=racemic	relType_2=amod	path1=	lemma_2=racemic	wib=racemic	pos_2=JJ	lemma_1=and
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e1	DDI-DrugBank.d81.s11.e3	null	relType_1=cc	pos_1=CC	relType_8=amod	relType_4=appos	lemma_9=dose	lemma_4=see	pos_6=CD	lemma_10=of	wib=racemic	relType_3=aux:pass	pos_2=JJ	path2=administer_advcl>dose_nsubj:pass>warfarin_nmod	pos_8=JJ	lib=racemic	pos_3=VBD	pos_9=NNS	lemma_5=when	relType_9=nsubj:pass	lemma_2=racemic	relType_10=case	pos_5=WRB	pos_4=VBN	lemma_8=oral	lpib=racemic_JJ	relType_7=amod	relType_3=conj	lemma_3=warfarin	relType_2=amod	lemma_3=be	relType_6=nummod	pos_10=IN	relType_5=advmod	path=isradipine_nmod<interaction_nsubj:pass<see_appos>administer_advcl>dose_nsubj:pass>warfarin_nmod	eib=True	path1=isradipine_nmod<interaction_nsubj:pass	pos_3=NN	pos_7=JJ	lemma_1=and	lemma_7=single	lemma_6=two
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e1	DDI-DrugBank.d81.s11.e4	null	relType_1=cc	lemma_22=administer	pos_12=CD	lemma_4=see	lemma_10=of	relType_21=aux:pass	pos_24=CD	lemma_31=mg	relType_3=aux:pass	pos_2=JJ	lemma_33=i.	pos_8=JJ	lib=racemic	lemma_34=d.	lemma_5=when	relType_24=nummod	lemma_32=b.	lemma_30=5	pos_18=NN	lpib=racemic_JJ	lemma_14=7	lemma_3=be	lemma_28=treatment	relType_15=compound	pos_28=NN	pos_26=IN	pos_7=JJ	relType_29=mark	pos_14=CD	lemma_9=dose	lemma_21=be	lemma_11=warfarin	pos_29=IN	pos_34=VBN	relType_28=nmod	relType_30=nummod	relType_9=nsubj:pass	lemma_2=racemic	pos_25=NNS	lemma_27=multipledose	pos_4=VBN	lemma_8=oral	pos_27=NN	lemma_16=/	relType_6=nummod	lemma_24=11	relType_5=advmod	lemma_15=mg	pos_11=NN	path1=isradipine_nmod<interaction_nsubj:pass	relType_12=dep	pos_30=CD	pos_23=IN	relType_11=nmod	lemma_1=and	relType_4=appos	wib=racemic	relType_32=advcl	pos_20=-RRB-	pos_17=NN	relType_11=punct	pos_3=VBD	relType_31=nsubj	relType_19=appos	pos_5=WRB	pos_33=IN	relType_7=amod	relType_3=conj	relType_2=amod	lemma_11=(	lemma_26=of	pos_10=IN	lemma_19=weight	relType_17=nmod	relType_23=case	pos_32=VBN	lemma_20=)	relType_14=nummod	relType_34=amod	path=isradipine_nmod<interaction_nsubj:pass<see_appos>administer_advcl>b._advcl>isradipine_obl	relType_20=punct	lemma_29=with	lemma_7=single	path2=administer_advcl>b._advcl>isradipine_obl	lemma_13=.	relType_27=compound	pos_1=CC	lemma_23=during	relType_8=amod	relType_33=case	relType_13=punct	relType_26=case	pos_6=CD	lemma_12=0	pos_22=VBN	relType_22=advcl	pos_11=-LRB-	pos_9=NNS	pos_19=NN	relType_10=case	pos_15=NN	lemma_3=warfarin	lemma_17=kg	pos_31=NNS	lemma_25=day	eib=True	lemma_18=body	pos_3=NN	relType_16=dep	pos_16=SYM	relType_18=compound	pos_13=.	pos_21=VBD	relType_25=obl	lemma_6=two
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e2	DDI-DrugBank.d81.s11.e3	null	pos_7=NNS	relType_8=case	pos_2=VBN	relType_3=advmod	path1=warfarin_conj<isradipine_nmod<interaction_nsubj:pass	pos_6=JJ	relType_1=aux:pass	lemma_5=single	path2=administer_advcl>dose_nsubj:pass>warfarin_nmod	pos_1=VBD	eib=False	relType_6=amod	lemma_1=be	lemma_4=two	relType_7=nsubj:pass	path=warfarin_conj<isradipine_nmod<interaction_nsubj:pass<see_appos>administer_advcl>dose_nsubj:pass>warfarin_nmod	pos_8=IN	pos_4=CD	pos_5=JJ	lemma_6=oral	lib=be	relType_5=amod	lemma_2=see	relType_2=appos	wib=was	relType_4=nummod	pos_3=WRB	lemma_7=dose	lpib=be_VBD	lemma_8=of	lemma_3=when
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e2	DDI-DrugBank.d81.s11.e4	null	pos_6=JJ	path1=warfarin_conj<isradipine_nmod<interaction_nsubj:pass	lemma_31=i.	pos_12=CD	lemma_12=7	lemma_28=5	lemma_13=mg	relType_10=dep	relType_29=nsubj	pos_29=NNS	lemma_25=multipledose	relType_24=case	relType_26=nmod	pos_26=NN	lemma_14=/	pos_13=NN	relType_32=amod	lemma_30=b.	pos_14=SYM	lemma_29=mg	relType_30=advcl	lemma_2=see	pos_24=IN	relType_21=case	relType_4=nummod	lemma_20=administer	pos_19=VBD	pos_7=NNS	relType_8=case	lemma_11=.	pos_20=VBN	lemma_26=treatment	relType_28=nummod	pos_1=VBD	lemma_19=be	relType_22=nummod	lemma_4=two	relType_23=obl	pos_9=NN	lemma_10=0	pos_8=IN	pos_4=CD	pos_16=NN	relType_19=aux:pass	relType_15=nmod	lemma_18=)	pos_3=WRB	lemma_32=d.	relType_17=appos	lemma_7=dose	lemma_27=with	pos_30=VBN	lemma_22=11	lpib=be_VBD	pos_2=VBN	lemma_5=single	lemma_24=of	pos_31=IN	pos_17=NN	pos_18=-RRB-	relType_11=punct	lemma_1=be	relType_7=nsubj:pass	pos_21=IN	relType_20=advcl	pos_11=.	relType_25=compound	lemma_17=weight	lemma_21=during	lemma_6=oral	lib=be	relType_5=amod	pos_23=NNS	pos_25=NN	pos_9=-LRB-	pos_32=VBN	lemma_16=body	path=warfarin_conj<isradipine_nmod<interaction_nsubj:pass<see_appos>administer_advcl>b._advcl>isradipine_obl	lemma_9=warfarin	path2=administer_advcl>b._advcl>isradipine_obl	lemma_3=when	relType_27=mark	relType_3=advmod	lemma_23=day	relType_1=aux:pass	lemma_15=kg	relType_16=compound	relType_31=case	relType_9=nmod	pos_28=CD	pos_22=CD	relType_6=amod	lemma_9=(	pos_27=IN	pos_5=JJ	relType_13=compound	pos_15=NN	pos_10=CD	relType_18=punct	relType_14=dep	relType_2=appos	wib=was	relType_9=punct	eib=True	relType_12=nummod	lemma_8=of
DDI-DrugBank.d81.s11	DDI-DrugBank.d81.s11.e3	DDI-DrugBank.d81.s11.e4	null	lemma_9=weight	pos_21=NNS	relType_6=dep	lib=mg	relType_12=advcl	relType_11=aux:pass	relType_17=compound	lemma_21=mg	relType_19=mark	pos_18=NN	relType_2=dep	lemma_19=with	relType_15=obl	lemma_17=multipledose	lemma_5=mg	pos_1=-LRB-	relType_4=nummod	lemma_10=)	lemma_20=5	lemma_18=treatment	lemma_24=d.	lemma_15=day	pos_14=CD	lemma_11=be	pos_20=CD	pos_8=NN	lemma_4=7	lemma_22=b.	pos_9=NN	pos_4=CD	relType_7=nmod	pos_24=VBN	lemma_6=/	relType_24=amod	pos_5=NN	relType_16=case	lemma_7=kg	pos_23=IN	pos_12=VBN	relType_1=punct	pos_7=NN	relType_18=nmod	relType_3=punct	relType_10=punct	pos_16=IN	lemma_13=during	relType_20=nummod	lemma_2=0	lemma_1=(	pos_17=NN	lpib=mg_NN	lemma_23=i.	pos_13=IN	relType_9=appos	relType_13=case	pos_6=SYM	relType_8=compound	lemma_14=11	relType_23=case	pos_3=.	relType_14=nummod	path1=warfarin_nmod<dose_nsubj:pass	lemma_8=body	pos_19=IN	lemma_12=administer	pos_11=VBD	relType_5=compound	pos_22=VBN	relType_22=advcl	eib=False	pos_2=CD	lemma_3=.	lemma_16=of	relType_21=nsubj	pos_15=NNS	path=warfarin_nmod<dose_nsubj:pass<administer_advcl>b._advcl>isradipine_obl	pos_10=-RRB-	wib=mg	path2=b._advcl>isradipine_obl
DDI-DrugBank.d81.s12	DDI-DrugBank.d81.s12.e0	DDI-DrugBank.d81.s12.e1	null	relType_1=cc	path2=binding_conj>isradipine_compound	wib=isradipine	pos_1=CC	eib=False	lemma_1=nor	lpib=isradipine_NN	path1=	lib=isradipine	path=<warfarin_nsubj:pass>binding_conj>isradipine_compound
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e0	DDI-DrugBank.d81.s13.e1	null	pos_2=DT	lemma_2=the	path1=	lemma_5=of	path=<Digoxin_ROOT>affect_parataxis>administration_nsubj>DynaCirc_nmod	relType_5=case	lib=concomitant	eib=False	lpib=concomitant_JJ	relType_4=nsubj	pos_4=NN	lemma_1=:	wib=concomitant	relType_3=amod	pos_1=:	pos_5=IN	path2=affect_parataxis>administration_nsubj>DynaCirc_nmod	lemma_3=concomitant	pos_3=JJ	relType_2=det	lemma_4=administration	relType_1=punct
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e0	DDI-DrugBank.d81.s13.e2	null	pos_2=DT	lemma_2=the	path2=affect_parataxis>administration_nsubj>isradipine_dep	path1=	lemma_6=(	lemma_6=DynaCirc	lemma_5=of	relType_5=case	lib=concomitant	pos_6=-LRB-	pos_6=NNP	relType_6=punct	lpib=concomitant_JJ	relType_4=nsubj	pos_4=NN	lemma_1=:	wib=concomitant	relType_3=amod	pos_1=:	path=<Digoxin_ROOT>affect_parataxis>administration_nsubj>isradipine_dep	pos_5=IN	lemma_3=concomitant	pos_3=JJ	eib=True	relType_2=det	lemma_4=administration	relType_1=punct	relType_6=nmod
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e0	DDI-DrugBank.d81.s13.e3	null	pos_2=DT	lemma_2=the	path=<Digoxin_ROOT>affect_parataxis>administration_nsubj>digoxin_conj	pos_7=NN	path1=	lemma_6=(	lemma_6=DynaCirc	lemma_5=of	relType_5=case	lemma_7=isradipine	lib=concomitant	pos_6=-LRB-	pos_6=NNP	relType_6=punct	lpib=concomitant_JJ	pos_8=CC	relType_4=nsubj	pos_4=NN	lemma_1=:	wib=concomitant	relType_3=amod	pos_1=:	pos_5=IN	pos_7=-RRB-	lemma_3=concomitant	lemma_8=and	path2=affect_parataxis>administration_nsubj>digoxin_conj	pos_3=JJ	eib=True	relType_7=dep	relType_7=punct	relType_2=det	lemma_4=administration	relType_1=punct	relType_6=nmod	relType_8=cc	lemma_7=)
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e0	DDI-DrugBank.d81.s13.e4	null	relType_18=parataxis	relType_14=amod	lemma_9=digoxin	lemma_5=of	relType_5=case	relType_21=conj	lemma_20=,	relType_9=case	pos_13=NN	relType_24=compound	relType_3=amod	pos_1=:	relation_20=neutral	lemma_18=affect	pos_3=JJ	lemma_17=not	pos_26=IN	pos_11=JJ	lemma_15=study	lemma_7=)	pos_2=DT	lemma_2=the	pos_21=JJ	path1=	relType_25=obj	lemma_7=isradipine	lib=concomitant	lemma_13=dose	relType_11=amod	lemma_11=single	pos_19=JJ	relType_12=punct	pos_9=NN	lemma_12=-	pos_17=RB	relType_23=conj	pos_5=IN	path=<Digoxin_ROOT>affect_parataxis>clearance_obj>digoxin_nmod	pos_7=-RRB-	relType_19=amod	relType_15=nmod	lemma_8=and	relType_7=dep	relType_1=punct	pos_7=NN	path2=affect_parataxis>clearance_obj>digoxin_nmod	pos_23=JJ	relType_10=det	lemma_23=total	pos_24=NN	lemma_6=(	lemma_6=DynaCirc	pos_6=NNP	relType_22=cc	pos_8=CC	lemma_1=:	pos_18=VB	pos_25=NN	lemma_26=of	lemma_14=pharmacokinetic	lemma_3=concomitant	relType_20=punct	pos_12=HYPH	pos_14=JJ	relType_6=nmod	lemma_9=in	relType_8=cc	lemma_16=do	pos_10=DT	lemma_24=body	relType_9=conj	pos_16=VBD	lemma_25=clearance	relType_26=case	pos_9=IN	lemma_10=a	lemma_19=renal	pos_22=CC	pos_6=-LRB-	relType_6=punct	relType_16=aux	lpib=concomitant_JJ	relType_4=nsubj	pos_4=NN	pos_20=,	wib=concomitant	relType_13=compound	pos_15=NN	relType_17=advmod	lemma_21=nonrenal	eib=True	relType_7=punct	relType_2=det	lemma_4=administration	lemma_22=and
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e1	DDI-DrugBank.d81.s13.e2	null	lemma_1=(	wib=isradipine	path=DynaCirc_nmod<administration_nsubj>isradipine_dep	path2=isradipine_dep	eib=False	lpib=isradipine_NN	lib=isradipine	relType_1=punct	path1=DynaCirc_nmod	pos_1=-LRB-
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e1	DDI-DrugBank.d81.s13.e3	null	lemma_2=)	wib=isradipine	pos_2=NN	lemma_2=isradipine	pos_3=CC	lpib=isradipine_NN	path=DynaCirc_nmod<administration_nsubj>digoxin_conj	lib=isradipine	path1=DynaCirc_nmod	relType_3=cc	relType_2=punct	lemma_1=(	path2=digoxin_conj	relType_2=dep	pos_1=-LRB-	eib=True	pos_2=-RRB-	lemma_3=and	relType_1=punct
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e1	DDI-DrugBank.d81.s13.e4	null	relType_14=amod	pos_2=NN	pos_6=JJ	path=DynaCirc_nmod<administration_nsubj<affect_parataxis>clearance_obj>digoxin_nmod	pos_3=CC	lemma_12=not	lemma_4=in	relType_10=nmod	path1=DynaCirc_nmod<administration_nsubj	lemma_10=study	pos_20=NN	pos_10=NN	relType_20=obj	lemma_20=clearance	relType_2=dep	pos_7=HYPH	pos_12=RB	lemma_16=nonrenal	relType_21=case	pos_1=-LRB-	lemma_6=single	relType_17=cc	relType_13=parataxis	relType_3=cc	relType_2=punct	pos_8=NN	relType_19=compound	lemma_15=,	lemma_14=renal	relation_14=neutral	lemma_3=and	pos_17=CC	relType_1=punct	lemma_21=of	lemma_2=isradipine	lemma_9=pharmacokinetic	path2=clearance_obj>digoxin_nmod	lib=isradipine	lemma_8=dose	lemma_1=(	lemma_5=a	relType_12=advmod	pos_15=,	relType_11=aux	lemma_13=affect	pos_21=IN	relType_9=amod	relType_15=punct	pos_13=VB	pos_4=IN	relType_5=det	relType_8=compound	lemma_4=digoxin	pos_2=-RRB-	pos_5=DT	pos_14=JJ	lemma_2=)	wib=isradipine	pos_11=VBD	lpib=isradipine_NN	lemma_7=-	pos_9=JJ	relType_6=amod	pos_18=JJ	pos_19=NN	pos_4=NN	pos_16=JJ	lemma_18=total	relType_4=case	lemma_17=and	lemma_19=body	eib=True	relType_7=punct	relType_4=conj	relType_18=conj	relType_16=conj	lemma_11=do
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e2	DDI-DrugBank.d81.s13.e3	null	lemma_2=and	lib=digoxin	path1=isradipine_dep	eib=False	path=isradipine_dep<administration_nsubj>digoxin_conj	pos_1=-RRB-	pos_2=CC	path2=digoxin_conj	relType_1=punct	lemma_1=)	relType_2=cc	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e2	DDI-DrugBank.d81.s13.e4	null	relType_16=cc	relType_7=compound	lemma_3=digoxin	relType_14=punct	pos_3=IN	lemma_11=not	pos_15=JJ	relType_8=amod	lemma_4=a	pos_7=NN	path2=clearance_obj>digoxin_nmod	lemma_5=single	lemma_1=)	relType_2=cc	relType_9=nmod	pos_16=CC	pos_17=JJ	lemma_12=affect	pos_6=HYPH	relType_17=conj	pos_20=IN	pos_8=JJ	lemma_2=and	relType_20=case	relType_10=aux	relType_6=punct	relType_12=parataxis	relType_13=amod	pos_14=,	path=isradipine_dep<administration_nsubj<affect_parataxis>clearance_obj>digoxin_nmod	lemma_17=total	pos_19=NN	relType_11=advmod	pos_9=NN	lemma_6=-	pos_18=NN	pos_4=DT	pos_5=JJ	lib=digoxin	lemma_15=nonrenal	relType_5=amod	pos_13=JJ	relType_3=conj	pos_1=-RRB-	lemma_9=study	pos_10=VBD	path1=isradipine_dep<administration_nsubj	lemma_16=and	pos_11=RB	relType_3=case	lpib=digoxin_NN	pos_12=VB	wib=digoxin	lemma_10=do	lemma_14=,	relation_12=neutral	eib=True	lemma_13=renal	lemma_18=body	pos_3=NN	lemma_19=clearance	pos_2=CC	relType_15=conj	relType_18=compound	lemma_8=pharmacokinetic	lemma_7=dose	relType_19=obj	relType_1=punct	relType_4=det	lemma_3=in	lemma_20=of
DDI-DrugBank.d81.s13	DDI-DrugBank.d81.s13.e3	DDI-DrugBank.d81.s13.e4	null	pos_2=DT	relType_1=case	lemma_13=nonrenal	lemma_1=in	pos_6=JJ	pos_14=CC	relType_9=advmod	pos_15=JJ	relation_9=neutral	path2=clearance_obj>digoxin_nmod	lemma_4=-	lpib=single_JJ	relType_5=compound	relType_16=compound	lemma_6=pharmacokinetic	lemma_2=a	pos_4=HYPH	path1=digoxin_conj<administration_nsubj	relType_10=parataxis	relType_18=case	lemma_12=,	pos_17=NN	lemma_10=affect	eib=False	relType_6=amod	relType_11=amod	pos_12=,	wib=single	lemma_7=study	pos_1=IN	lemma_9=not	relType_12=punct	relType_13=conj	lemma_18=of	pos_10=VB	pos_18=IN	pos_8=VBD	relType_4=punct	relType_3=amod	pos_13=JJ	relType_7=nmod	pos_9=RB	lemma_15=total	relType_14=cc	pos_16=NN	lib=single	pos_5=NN	lemma_5=dose	relType_17=obj	path=digoxin_conj<administration_nsubj<affect_parataxis>clearance_obj>digoxin_nmod	pos_3=JJ	lemma_8=do	lemma_16=body	lemma_11=renal	lemma_17=clearance	relType_2=det	relType_15=conj	lemma_14=and	relType_8=aux	pos_11=JJ	pos_7=NN	lemma_3=single
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e0	DDI-DrugBank.d81.s14.e1	null	relType_6=aux:pass	relType_8=case	lemma_3=severe	pos_5=VBZ	lpib=anesthesia_NN	lib=anesthesia	path=fentanyl_compound<anesthesia_ROOT>report_parataxis>anesthesia_obl>fentanyl_compound	path2=report_parataxis>anesthesia_obl>fentanyl_compound	relType_2=punct	lemma_5=have	lemma_6=be	lemma_2=:	eib=False	relType_4=nsubj:pass	pos_6=VBN	relType_5=aux	pos_4=NN	pos_1=NN	pos_8=IN	lemma_8=during	lemma_4=hypotension	relType_3=amod	lemma_7=report	pos_2=:	pos_7=VBN	relType_1=ROOT	pos_3=JJ	path1=fentanyl_compound	lemma_1=anesthesia	relType_7=parataxis	wib=Anesthesia
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e0	DDI-DrugBank.d81.s14.e2	null	relType_6=aux:pass	relType_8=case	lemma_3=severe	relType_12=obl	lemma_12=use	pos_5=VBZ	lemma_10=with	lpib=anesthesia_NN	lib=anesthesia	relType_9=obl	relType_2=punct	lemma_5=have	lemma_6=be	lemma_13=of	lemma_2=:	path2=report_parataxis>use_obl>blocker_nmod	relType_9=compound	path=fentanyl_compound<anesthesia_ROOT>report_parataxis>use_obl>blocker_nmod	relType_11=amod	relType_14=det	relType_4=nsubj:pass	lemma_9=fentanyl	pos_6=VBN	relType_5=aux	relType_10=case	pos_9=NN	pos_4=NN	pos_1=NN	pos_8=IN	lemma_8=during	lemma_11=concomitant	pos_13=IN	relType_13=case	lemma_4=hypotension	relType_3=amod	pos_15=NN	lemma_7=report	pos_2=:	pos_10=IN	pos_14=DT	relType_15=compound	pos_7=VBN	relType_1=ROOT	lemma_14=a	pos_3=JJ	lemma_9=anesthesia	path1=fentanyl_compound	eib=True	lemma_1=anesthesia	pos_11=JJ	lemma_15=beta	pos_12=NN	relType_7=parataxis	wib=Anesthesia
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e0	DDI-DrugBank.d81.s14.e3	null	relType_6=aux:pass	relType_8=case	lemma_3=severe	relType_12=obl	lemma_12=use	pos_5=VBZ	lemma_10=with	lpib=anesthesia_NN	lib=anesthesia	pos_16=DT	relType_9=obl	lemma_15=blocker	relType_16=det	lemma_17=calcium	relType_2=punct	lemma_5=have	lemma_6=be	lemma_13=of	pos_17=NN	lemma_2=:	lemma_16=a	relType_9=compound	relType_11=amod	relType_14=det	relType_4=nsubj:pass	lemma_9=fentanyl	relType_17=compound	pos_6=VBN	relType_5=aux	relType_10=case	pos_9=NN	pos_4=NN	pos_1=NN	pos_8=IN	lemma_8=during	lemma_11=concomitant	pos_13=IN	relType_13=case	path=fentanyl_compound<anesthesia_ROOT>report_parataxis>use_obl>blocker_nmod>blocker_conj	lemma_4=hypotension	relType_3=amod	pos_15=NN	lemma_7=report	lemma_17=channel	pos_2=:	relType_15=cc	pos_10=IN	relType_15=nmod	pos_14=DT	lemma_15=and	relType_15=compound	pos_7=VBN	relType_1=ROOT	lemma_14=a	pos_3=JJ	lemma_9=anesthesia	path1=fentanyl_compound	eib=True	lemma_1=anesthesia	pos_15=CC	pos_11=JJ	lemma_15=beta	pos_12=NN	path2=report_parataxis>use_obl>blocker_nmod>blocker_conj	relType_7=parataxis	wib=Anesthesia
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e1	DDI-DrugBank.d81.s14.e2	effect	relType_7=compound	pos_6=DT	lpib=anesthesia_NN	lib=anesthesia	lemma_4=use	lemma_5=of	relType_5=case	pos_2=IN	path1=fentanyl_compound<anesthesia_obl	lemma_2=with	lemma_6=a	path=fentanyl_compound<anesthesia_obl<report_parataxis>use_obl>blocker_nmod	pos_4=NN	pos_1=NN	relType_4=obl	relType_3=amod	wib=anesthesia	pos_5=IN	lemma_3=concomitant	path2=use_obl>blocker_nmod	relType_6=det	relType_2=case	pos_3=JJ	eib=True	lemma_1=anesthesia	lemma_7=beta	pos_7=NN	relType_1=obl
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e1	DDI-DrugBank.d81.s14.e3	effect	relType_7=compound	lemma_9=calcium	path2=use_obl>blocker_nmod>blocker_conj	pos_8=DT	pos_6=DT	lemma_7=blocker	lpib=anesthesia_NN	lib=anesthesia	relType_7=cc	lemma_9=channel	lemma_4=use	lemma_5=of	relType_5=case	pos_2=IN	path=fentanyl_compound<anesthesia_obl<report_parataxis>use_obl>blocker_nmod>blocker_conj	path1=fentanyl_compound<anesthesia_obl	lemma_2=with	relType_9=compound	lemma_6=a	lemma_8=a	pos_9=NN	pos_4=NN	pos_1=NN	relType_4=obl	relType_3=amod	pos_7=CC	wib=anesthesia	pos_5=IN	relType_7=nmod	lemma_3=concomitant	relType_6=det	relType_2=case	pos_3=JJ	eib=True	lemma_1=anesthesia	lemma_7=and	lemma_7=beta	relType_8=det	pos_7=NN	relType_1=obl
DDI-DrugBank.d81.s14	DDI-DrugBank.d81.s14.e2	DDI-DrugBank.d81.s14.e3	null	relType_1=cc	path2=blocker_conj	pos_2=DT	pos_1=CC	path=<blocker_nmod>blocker_conj	lemma_3=channel	eib=True	lpib=calcium_NN	wib=calcium	pos_3=NN	relType_2=det	lemma_3=calcium	path1=	relType_3=compound	lemma_2=a	lib=calcium	lemma_1=and
DDI-DrugBank.d81.s15	DDI-DrugBank.d81.s15.e0	DDI-DrugBank.d81.s15.e1	null	path2=isradipine_appos	lemma_1=(	wib=isradipine	eib=False	lpib=isradipine_NN	path1=	path=<DynaCirc_nmod>isradipine_appos	lib=isradipine	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d95.s0	DDI-DrugBank.d95.s0.e0	DDI-DrugBank.d95.s0.e1	null	lpib=l_NN	wib=L	pos_2=NN	eib=True	lemma_2=-	lib=l	relType_2=compound	lemma_2=l	path=cyclosporine_compound<arginine_nsubj>	lemma_1=-	path1=cyclosporine_compound	path2=	pos_1=HYPH	relType_1=punct	pos_2=HYPH	relType_2=punct
DDI-DrugBank.d95.s0	DDI-DrugBank.d95.s0.e0	DDI-DrugBank.d95.s0.e2	null	path1=cyclosporine_compound<arginine_nsubj	pos_2=NN	relType_7=case	pos_2=MD	pos_1=HYPH	pos_3=VB	pos_2=HYPH	relation_5=adverse	relation_8=neutral	relType_2=punct	pos_6=NN	wib=L	lemma_2=-	relType_2=nsubj	relType_2=aux	path=cyclosporine_compound<arginine_nsubj<counteract_ROOT>effect_obj>cyclosporin_nmod	lpib=l_NN	pos_4=DT	pos_5=JJ	lemma_3=counteract	relType_5=amod	relType_3=ROOT	lib=l	relType_2=compound	lemma_2=l	lemma_1=-	lemma_4=the	lemma_6=effect	path2=effect_obj>cyclosporin_nmod	lemma_7=of	relType_6=obj	lemma_5=antinaturetic	eib=True	pos_7=IN	lemma_2=may	relType_1=punct	relType_4=det	lemma_2=arginine
DDI-DrugBank.d95.s0	DDI-DrugBank.d95.s0.e1	DDI-DrugBank.d95.s0.e2	effect	relType_4=amod	lib=counteract	pos_4=JJ	lpib=counteract_VB	relType_1=aux	lemma_1=may	lemma_2=counteract	lemma_6=of	path1=arginine_nsubj	relType_6=case	lemma_4=antinaturetic	wib=counteract	eib=False	pos_6=IN	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	relType_2=ROOT	path=arginine_nsubj<counteract_ROOT>effect_obj>cyclosporin_nmod	pos_1=MD	path2=effect_obj>cyclosporin_nmod	pos_5=NN	pos_3=DT	relType_5=obj	lemma_3=the	relation_4=neutral
DDI-DrugBank.d95.s1	DDI-DrugBank.d95.s1.e0	DDI-DrugBank.d95.s1.e1	null	path1=Ibuprofen_compound	wib=L	lemma_2=L	eib=True	pos_2=NNP	lemma_2=-	lib=l	relType_2=compound	lemma_1=-	pos_2=HYPH	path2=	pos_1=HYPH	relType_1=punct	path=Ibuprofen_compound<arginine_nsubj>	lpib=l_NNP	relType_2=punct
DDI-DrugBank.d95.s1	DDI-DrugBank.d95.s1.e0	DDI-DrugBank.d95.s1.e2	null	relation_5=beneficial	lemma_3=increase	pos_2=NN	pos_2=MD	lemma_6=of	pos_1=HYPH	pos_3=VB	pos_2=HYPH	lemma_5=absorption	relType_6=case	lpib=l_NNP	relType_2=punct	wib=L	lemma_2=L	pos_2=NNP	lemma_2=-	relType_2=nsubj	pos_6=IN	path=Ibuprofen_compound<arginine_nsubj<increase_ROOT>absorption_obj>ibuprofen_nmod	relType_2=aux	pos_4=DT	relType_3=ROOT	lib=l	relType_2=compound	lemma_4=the	lemma_1=-	pos_5=NN	path2=absorption_obj>ibuprofen_nmod	eib=True	relType_5=obj	path1=Ibuprofen_compound<arginine_nsubj	lemma_2=may	relType_1=punct	relType_4=det	lemma_2=arginine
DDI-DrugBank.d95.s1	DDI-DrugBank.d95.s1.e1	DDI-DrugBank.d95.s1.e2	mechanism	relType_1=aux	lemma_1=may	path1=arginine_nsubj	lemma_5=of	relType_5=case	relation_1=beneficial	path=arginine_nsubj<increase_ROOT>absorption_obj>ibuprofen_nmod	eib=False	pos_2=VB	relType_3=det	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	lemma_4=absorption	relType_2=ROOT	pos_5=IN	wib=increase	pos_1=MD	path2=absorption_obj>ibuprofen_nmod	lpib=increase_VB	pos_3=DT	lemma_3=the
DDI-DrugBank.d95.s2	DDI-DrugBank.d95.s2.e0	DDI-DrugBank.d95.s2.e1	null	lpib=l_NN	path=nitrate_compound<arginine_compound>	wib=L	pos_2=NN	eib=True	lemma_2=-	lib=l	relType_2=compound	lemma_2=l	lemma_1=-	path2=	pos_1=HYPH	relType_1=punct	pos_2=HYPH	path1=nitrate_compound	relType_2=punct
DDI-DrugBank.d95.s2	DDI-DrugBank.d95.s2.e0	DDI-DrugBank.d95.s2.e2	null	pos_7=NNS	relType_8=case	lemma_5=potentiate	pos_2=NN	pos_3=RB	relType_3=advmod	pos_6=DT	path1=nitrate_compound<arginine_compound<supplement_nsubj	lemma_3=theoretically	relation_9=neutral	pos_1=HYPH	lemma_4=may	pos_2=HYPH	relType_2=punct	pos_5=VB	pos_9=JJ	wib=L	lemma_2=-	relType_2=nsubj	lemma_7=effect	lemma_6=the	relType_7=obj	pos_4=MD	relation_7=adverse	relType_9=amod	pos_8=IN	lpib=l_NN	path2=effect_obj>nitrate_nmod	lib=l	relType_2=compound	lemma_2=l	lemma_1=-	relType_4=aux	path=nitrate_compound<arginine_compound<supplement_nsubj<potentiate_ROOT>effect_obj>nitrate_nmod	lemma_9=organic	relation_7=beneficial	pos_2=NNS	relType_6=det	lemma_2=supplement	eib=True	relType_1=punct	relType_5=ROOT	lemma_2=arginine	lemma_8=of
DDI-DrugBank.d95.s2	DDI-DrugBank.d95.s2.e1	DDI-DrugBank.d95.s2.e2	effect	relType_7=case	relType_8=amod	relation_3=beneficial	lemma_3=may	pos_8=JJ	pos_2=RB	lemma_2=theoretically	eib=False	relType_2=advmod	relation_5=neutral	lemma_4=potentiate	lemma_1=supplement	pos_3=MD	wib=supplements	lpib=supplement_NNS	path2=effect_obj>nitrate_nmod	lib=supplement	relation_3=adverse	relType_1=nsubj	relType_5=det	lemma_6=effect	relType_4=ROOT	lemma_7=of	relType_6=obj	lemma_5=the	pos_1=NNS	path=arginine_compound<supplement_nsubj<potentiate_ROOT>effect_obj>nitrate_nmod	pos_7=IN	pos_4=VB	path1=arginine_compound<supplement_nsubj	pos_5=DT	pos_6=NNS	lemma_8=organic	relType_3=aux
DDI-DrugBank.d95.s3	DDI-DrugBank.d95.s3.e0	DDI-DrugBank.d95.s3.e1	null	path2=take_dep>supplement_nsubj>arginine_compound	path1=	lemma_4=-	pos_1=HYPH	path=<citrate_ROOT>take_dep>supplement_nsubj>arginine_compound	pos_4=HYPH	pos_2=RB	lemma_2=theoretically	relType_2=advmod	pos_4=NN	lemma_4=l	relType_4=punct	lemma_3=,	lemma_1=-	relType_4=compound	lib=theoretically	pos_3=,	wib=Theoretically	eib=True	relType_1=punct	relType_3=punct	lpib=theoretically_RB
DDI-DrugBank.d95.s3	DDI-DrugBank.d95.s3.e0	DDI-DrugBank.d95.s3.e2	null	path=<citrate_ROOT>take_dep>citrate_obl	relType_7=case	lemma_4=supplement	path1=	lemma_4=-	pos_1=HYPH	pos_4=HYPH	lemma_7=with	path2=take_dep>citrate_obl	pos_8=NN	pos_2=RB	pos_5=VBN	lemma_2=theoretically	relType_2=advmod	relType_4=nsubj	relType_5=dep	pos_4=NN	pos_4=NNS	lemma_4=l	lemma_4=arginine	lemma_6=concomitantly	relType_4=punct	lemma_3=,	relType_8=compound	lemma_1=-	relType_4=compound	pos_6=RB	lib=theoretically	pos_3=,	wib=Theoretically	eib=True	pos_7=IN	relType_1=punct	lemma_8=sildenafil	relType_6=advmod	relType_3=punct	lpib=theoretically_RB	lemma_5=take
DDI-DrugBank.d95.s3	DDI-DrugBank.d95.s3.e1	DDI-DrugBank.d95.s3.e2	effect	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_5=compound	lemma_1=supplement	wib=supplements	lpib=supplement_NNS	lemma_4=with	relType_2=dep	lib=supplement	path2=citrate_obl	pos_4=IN	lemma_2=take	relType_1=nsubj	relType_4=case	path=arginine_compound<supplement_nsubj<take_dep>citrate_obl	pos_5=NN	pos_1=NNS	eib=True	lemma_3=concomitantly	path1=arginine_compound<supplement_nsubj	lemma_5=sildenafil
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e0	DDI-DrugBank.d530.s0.e1	null	relType_2=case	eib=True	path2=sulfate_nmod	lemma_3=phenelzine	pos_3=NN	lemma_1=-	path1=	pos_1=,	relType_3=compound	lib=include	path=<inhibitor_compound>sulfate_nmod	lpib=include_VBG	wib=including	relType_1=punct	lemma_2=include	pos_2=VBG
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e0	DDI-DrugBank.d530.s0.e2	null	lemma_3=sulfate	path1=	pos_1=,	lemma_4=tranylcypromine	lib=include	wib=including	lemma_3=phenelzine	lpib=include_VBG	pos_4=NN	lemma_3=,	lemma_1=-	relType_3=nmod	relType_4=compound	lemma_2=include	path2=sulfate_nmod>sulfate_conj	relType_2=case	pos_3=,	eib=True	path=<inhibitor_compound>sulfate_nmod>sulfate_conj	pos_3=NN	relType_3=compound	relType_1=punct	relType_3=punct	pos_2=VBG
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e0	DDI-DrugBank.d530.s0.e3	null	path=<inhibitor_compound>sulfate_nmod>pargyline_conj	lemma_3=sulfate	path1=	pos_1=,	lemma_4=tranylcypromine	relType_4=cc	lib=include	wib=including	path2=sulfate_nmod>pargyline_conj	lemma_3=phenelzine	lpib=include_VBG	pos_4=NN	lemma_3=,	lemma_1=-	relType_3=nmod	relType_4=compound	lemma_2=include	relType_2=case	pos_3=,	eib=True	pos_4=CC	lemma_4=sulfate	pos_3=NN	lemma_4=and	relType_4=conj	relType_3=compound	relType_1=punct	relType_3=punct	pos_2=VBG
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e1	DDI-DrugBank.d530.s0.e2	null	path2=sulfate_conj	path=<sulfate_nmod>sulfate_conj	lpib=tranylcypromine_NN	lib=tranylcypromine	lemma_1=,	pos_2=NN	eib=True	relType_2=compound	path1=	pos_1=,	relType_1=punct	lemma_2=tranylcypromine	wib=tranylcypromine
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e1	DDI-DrugBank.d530.s0.e3	null	lemma_2=sulfate	lemma_2=and	lpib=tranylcypromine_NN	lib=tranylcypromine	path2=pargyline_conj	lemma_1=,	eib=True	pos_2=NN	lemma_2=tranylcypromine	relType_2=compound	pos_2=CC	path1=	pos_1=,	relType_1=punct	relType_2=cc	relType_2=conj	path=<sulfate_nmod>pargyline_conj	wib=tranylcypromine
DDI-DrugBank.d530.s0	DDI-DrugBank.d530.s0.e2	DDI-DrugBank.d530.s0.e3	null	relType_1=cc	lib=pargyline	path=sulfate_conj<sulfate_nmod>pargyline_conj	path2=pargyline_conj	pos_1=CC	wib=pargyline	eib=False	lpib=pargyline_NN	path1=sulfate_conj	lemma_1=and
DDI-DrugBank.d530.s1	DDI-DrugBank.d530.s1.e0	DDI-DrugBank.d530.s1.e1	effect	relType_1=cc	pos_1=CC	pos_2=NN	lib=selective	path1=	pos_2=HYPH	pos_2=JJ	pos_2=AFX	wib=selective	relType_2=punct	relType_2=obl:npmod	lemma_2=-	lemma_2=selective	path=<phenylalanine_nsubj>inhibitor_conj	lemma_2=non	lemma_2=mao	relType_2=compound	relType_2=amod	lpib=selective_JJ	eib=True	path2=inhibitor_conj	lemma_1=and
DDI-DrugBank.d530.s2	DDI-DrugBank.d530.s2.e0	DDI-DrugBank.d530.s2.e1	null	lpib=l_NN	wib=L	pos_2=NN	eib=True	path=selegiline_compound<phenylalanine_nsubj>	lemma_2=-	lib=l	relType_2=compound	lemma_2=l	lemma_1=-	path2=	pos_1=HYPH	relType_1=punct	pos_2=HYPH	path1=selegiline_compound	relType_2=punct
DDI-DrugBank.d530.s2	DDI-DrugBank.d530.s2.e0	DDI-DrugBank.d530.s2.e3	null	relType_4=amod	pos_4=JJ	pos_2=NN	path2=selegiline_conj	path=selegiline_compound<phenylalanine_nsubj>selegiline_conj	pos_1=HYPH	lemma_2=phenylalanine	pos_2=HYPH	relType_2=cc	path1=selegiline_compound	relType_2=punct	lemma_2=and	lemma_4=selective	wib=L	lemma_2=-	relType_2=nsubj	lemma_4=mao	relType_3=det	pos_4=NN	lpib=l_NN	lib=l	relType_2=compound	lemma_2=l	lemma_1=-	relType_4=compound	eib=True	pos_3=DT	pos_2=CC	lemma_4=inhibitor	lemma_3=the	relType_1=punct
DDI-DrugBank.d530.s2	DDI-DrugBank.d530.s2.e1	DDI-DrugBank.d530.s2.e3	effect	relType_1=cc	pos_2=DT	pos_1=CC	lemma_2=the	path2=selegiline_conj	lib=selective	path1=	wib=selective	lemma_3=inhibitor	relType_3=amod	lpib=selective_JJ	pos_3=JJ	lemma_3=mao	eib=True	pos_3=NN	relType_2=det	path=<phenylalanine_nsubj>selegiline_conj	relType_3=compound	lemma_3=selective	lemma_1=and
DDI-DrugBank.d530.s3	DDI-DrugBank.d530.s3.e1	DDI-DrugBank.d530.s3.e2	null	pos_7=NNS	relType_8=case	relType_4=amod	pos_4=JJ	wib=potentiate	relType_1=aux	lemma_1=may	lib=potentiate	relType_5=compound	lemma_7=reaction	relation_1=beneficial	pos_6=NN	lemma_4=tardive	relType_9=compound	relType_7=obj	relation_1=adverse	pos_2=VB	lpib=potentiate_VB	relType_3=det	pos_9=NN	path1=phenylalanine_nsubj	pos_8=IN	lemma_6=side	relType_2=ROOT	path=phenylalanine_nsubj<potentiate_ROOT>reaction_obj>drug_nmod	pos_1=MD	path2=reaction_obj>drug_nmod	lemma_9=neuroleptic	pos_5=NN	relType_6=compound	eib=True	pos_3=DT	lemma_5=dyskinesia	lemma_3=the	lemma_2=potentiate	lemma_8=of
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e0	DDI-DrugBank.d41.s0.e1	null	relType_1=cc	pos_1=CC	eib=False	path1=	lib=charcoal	wib=Charcoal	lpib=charcoal_NNP	path2=Administration_conj>Charcoal_compound	path=<cholestyramine_nsubj>Administration_conj>Charcoal_compound	lemma_1=and
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e0	DDI-DrugBank.d41.s0.e2	null	relType_1=cc	pos_1=CC	pos_3=IN	relType_3=case	eib=True	pos_2=NNP	lemma_2=Administration	relType_2=compound	path1=	lemma_2=Charcoal	lib=charcoal	path2=cholestyramine_nmod	lemma_3=of	wib=Charcoal	lpib=charcoal_NNP	relType_2=conj	path=<cholestyramine_nsubj>cholestyramine_nmod	lemma_1=and
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e0	DDI-DrugBank.d41.s0.e3	null	relType_1=cc	pos_1=CC	pos_3=IN	path1=	lemma_2=Charcoal	lemma_4=cholestyramine	relType_4=nmod	relType_4=cc	path=<cholestyramine_nsubj>cholestyramine_nmod>charcoal_conj	pos_2=NNP	lemma_2=Administration	path2=cholestyramine_nmod>charcoal_conj	relType_2=conj	pos_4=NN	relType_5=amod	lemma_4=or	relType_2=compound	lib=charcoal	wib=Charcoal	lpib=charcoal_NNP	relType_3=case	eib=True	pos_4=CC	lemma_5=activate	lemma_3=of	pos_5=VBN	lemma_1=and
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e0	DDI-DrugBank.d41.s0.e4	null	relType_1=cc	lemma_5=in	pos_13=NNS	lemma_30=the	pos_12=CC	relType_10=dep	relType_5=case	pos_7=-LRB-	path1=cholestyramine_nsubj	pos_2=NNP	lemma_21=a	lemma_10=13	pos_14=-LRB-	lemma_24=significant	lemma_32=metabolite	pos_32=NN	pos_17=CD	pos_11=-RRB-	pos_28=NN	pos_26=IN	relType_31=amod	pos_6=NNS	pos_9=SYM	lemma_26=in	pos_19=VBD	lemma_22=rapid	pos_31=JJ	relType_15=nsubj	lemma_5=charcoal	lemma_9==	relType_4=nmod	lemma_19=result	relType_28=nmod	pos_8=NN	relType_19=ROOT	relType_20=case	lemma_11=)	relType_17=dep	relType_13=conj	relType_2=conj	pos_27=NN	lemma_33=of	relType_21=det	pos_5=IN	lib=charcoal	wib=Charcoal	lemma_15=n	lpib=charcoal_NNP	relation_28=adverse	lemma_18=)	pos_5=NN	lemma_16==	lemma_5=activate	lemma_13=volunteer	lemma_23=and	lemma_1=and	relType_14=punct	pos_3=IN	relType_8=nsubj	relType_12=cc	pos_24=JJ	pos_20=IN	lemma_27=plasma	pos_23=CC	lemma_28=m1	lemma_17=96	pos_18=-RRB-	path2=metabolite_dep>leflunomide_nmod	relType_11=punct	lemma_8=n	pos_33=IN	relType_5=amod	lemma_4=or	pos_25=NN	relType_5=conj	pos_29=-LRB-	pos_22=JJ	relType_22=amod	pos_4=CC	lemma_12=and	pos_30=DT	relType_6=nmod	relType_27=compound	pos_1=CC	lemma_31=active	lemma_7=(	relType_33=case	relType_26=case	lemma_2=Charcoal	lemma_4=cholestyramine	relType_32=dep	relType_4=cc	lemma_14=(	relType_9=dep	lemma_2=Administration	lemma_6=patient	pos_4=NN	lemma_29=(	pos_15=NN	pos_10=CD	relType_2=compound	relType_23=cc	relType_18=punct	lemma_20=in	path=cholestyramine_nsubj<result_ROOT>metabolite_dep>leflunomide_nmod	relType_24=conj	relType_29=punct	relType_3=case	eib=True	relType_16=dep	relType_7=punct	pos_16=SYM	lemma_3=of	lemma_25=decrease	pos_21=DT	pos_5=VBN	relType_30=det	relType_25=obl
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e1	DDI-DrugBank.d41.s0.e2	null	pos_2=IN	path=Charcoal_compound<Administration_conj<cholestyramine_nsubj>cholestyramine_nmod	lemma_2=of	relType_2=case	eib=False	relType_1=conj	path2=cholestyramine_nmod	lib=administration	lemma_1=Administration	lpib=administration_NNP	pos_1=NNP	wib=Administration	path1=Charcoal_compound<Administration_conj
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e1	DDI-DrugBank.d41.s0.e3	null	relType_4=amod	pos_3=CC	lib=administration	lpib=administration_NNP	relType_3=cc	pos_2=IN	lemma_3=or	path2=cholestyramine_nmod>charcoal_conj	lemma_1=Administration	path1=Charcoal_compound<Administration_conj	pos_4=VBN	relType_3=nmod	relType_1=conj	pos_1=NNP	wib=Administration	lemma_2=of	relType_2=case	eib=True	lemma_4=activate	pos_3=NN	lemma_3=cholestyramine	path=Charcoal_compound<Administration_conj<cholestyramine_nsubj>cholestyramine_nmod>charcoal_conj
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e1	DDI-DrugBank.d41.s0.e4	null	relType_11=cc	pos_3=CC	lemma_4=in	lemma_8==	lemma_9=13	lemma_32=of	relType_28=punct	lemma_14=n	relType_27=nmod	pos_26=NN	pos_32=IN	relType_30=amod	lemma_11=and	lemma_4=charcoal	pos_8=SYM	pos_28=-LRB-	lemma_20=a	lemma_10=)	lemma_4=activate	lemma_3=cholestyramine	lemma_27=m1	relType_32=case	relType_4=amod	lemma_28=(	pos_15=SYM	relation_26=adverse	lemma_24=decrease	pos_21=JJ	lemma_7=n	relType_3=cc	relType_25=case	lemma_15==	lemma_19=in	relType_18=ROOT	lemma_3=or	lemma_1=Administration	relType_23=conj	pos_4=VBN	pos_27=NN	lemma_13=(	lemma_30=active	relType_1=conj	pos_1=NNP	wib=Administration	lemma_2=of	pos_31=NN	relType_19=case	pos_25=IN	lemma_12=volunteer	pos_7=NN	lemma_21=rapid	pos_23=JJ	relType_10=punct	relType_8=dep	lemma_26=plasma	relType_24=obl	relType_17=punct	pos_24=NN	lemma_6=(	lemma_23=significant	pos_2=IN	relType_29=det	pos_30=JJ	path2=metabolite_dep>leflunomide_nmod	relType_22=cc	relType_15=dep	relType_26=compound	pos_14=NN	path1=Charcoal_compound<Administration_conj<cholestyramine_nsubj	pos_16=CD	pos_4=IN	pos_11=CC	relType_3=nmod	lemma_18=result	relType_31=dep	relType_2=case	pos_9=CD	relType_7=nsubj	relType_20=det	pos_19=IN	relType_12=conj	lemma_5=patient	relType_13=punct	lib=administration	pos_20=DT	lpib=administration_NNP	relType_9=dep	lemma_29=the	pos_22=CC	pos_6=-LRB-	pos_5=NNS	relType_6=punct	relType_21=amod	pos_4=NN	pos_29=DT	pos_12=NNS	relType_4=case	relType_5=nmod	pos_13=-LRB-	lemma_16=96	lemma_17=)	eib=True	pos_3=NN	pos_10=-RRB-	relType_16=dep	relType_14=nsubj	relType_4=conj	path=Charcoal_compound<Administration_conj<cholestyramine_nsubj<result_ROOT>metabolite_dep>leflunomide_nmod	pos_17=-RRB-	lemma_31=metabolite	lemma_22=and	lemma_25=in	pos_18=VBD
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e2	DDI-DrugBank.d41.s0.e3	null	path=<cholestyramine_nmod>charcoal_conj	relType_1=cc	lemma_2=activate	pos_1=CC	pos_2=VBN	wib=activated	eib=True	lib=activate	relType_2=amod	path1=	path2=charcoal_conj	lpib=activate_VBN	lemma_1=or
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e2	DDI-DrugBank.d41.s0.e4	mechanism	relType_1=cc	pos_2=NN	relType_13=dep	lemma_27=the	lemma_29=metabolite	relType_8=punct	relType_21=conj	pos_3=NNS	relType_6=dep	lemma_6==	lemma_21=significant	lemma_4=(	relType_24=compound	pos_9=CC	relType_4=punct	lemma_30=of	wib=activated	relType_9=cc	lemma_19=rapid	lemma_23=in	pos_14=CD	pos_30=IN	relType_22=obl	pos_15=-RRB-	lemma_5=n	lemma_10=volunteer	lemma_18=a	lemma_26=(	pos_22=NN	pos_21=JJ	path1=cholestyramine_nmod<cholestyramine_nsubj	relType_5=nsubj	pos_18=DT	relType_10=conj	relType_25=nmod	relation_23=adverse	pos_19=JJ	pos_29=NN	relType_2=conj	lib=activate	relType_19=amod	pos_28=JJ	lpib=activate_VBN	relType_12=nsubj	lemma_16=result	pos_5=NN	lemma_20=and	lemma_22=decrease	relType_7=dep	pos_13=SYM	pos_23=IN	relType_18=det	relType_28=amod	relType_29=dep	relType_26=punct	lemma_28=active	path=cholestyramine_nmod<cholestyramine_nsubj<result_ROOT>metabolite_dep>leflunomide_nmod	lemma_2=in	lemma_3=patient	pos_2=VBN	lemma_13==	relType_20=cc	pos_24=NN	pos_17=IN	pos_2=IN	path2=metabolite_dep>leflunomide_nmod	pos_4=-LRB-	relType_11=punct	lemma_12=n	relType_15=punct	relType_17=case	lemma_8=)	lemma_24=plasma	pos_6=SYM	relType_2=amod	lemma_11=(	relType_3=nmod	pos_25=NN	lemma_17=in	relType_23=case	pos_26=-LRB-	relType_2=case	pos_20=CC	relType_30=case	pos_1=CC	pos_16=VBD	pos_7=CD	relType_16=ROOT	pos_27=DT	relType_27=det	lemma_7=13	pos_11=-LRB-	pos_8=-RRB-	lemma_25=m1	lemma_9=and	relType_14=dep	lemma_15=)	lemma_2=charcoal	lemma_2=activate	lemma_14=96	eib=True	pos_12=NN	pos_10=NNS	lemma_1=or
DDI-DrugBank.d41.s0	DDI-DrugBank.d41.s0.e3	DDI-DrugBank.d41.s0.e4	mechanism	lemma_16=in	lemma_4=n	relType_28=dep	relType_13=dep	lemma_2=patient	pos_10=-LRB-	pos_12=SYM	relType_6=dep	relType_17=det	lpib=patient_NNS	pos_3=-LRB-	pos_22=IN	relType_5=dep	pos_20=JJ	relType_23=compound	pos_19=CC	pos_28=NN	lemma_12==	lemma_17=a	relType_15=ROOT	relation_20=adverse	lemma_7=)	relType_1=case	pos_13=CD	pos_27=JJ	pos_29=IN	wib=patients	relType_20=conj	lemma_3=(	pos_1=IN	lemma_15=result	lemma_19=and	relType_22=case	lemma_10=(	lemma_11=n	pos_7=-RRB-	lemma_8=and	relType_21=obl	relType_16=case	pos_11=NN	lemma_9=volunteer	pos_15=VBD	relType_12=dep	lemma_21=decrease	relType_25=punct	relType_3=punct	lemma_24=m1	lemma_22=in	relType_14=punct	relType_10=punct	pos_17=DT	pos_16=IN	relType_29=case	pos_24=NN	relType_27=amod	pos_23=NN	path2=metabolite_dep>leflunomide_nmod	relType_2=nmod	pos_14=-RRB-	pos_8=CC	lemma_14=)	lemma_28=metabolite	pos_26=DT	lib=patient	lemma_20=significant	lemma_23=plasma	relType_8=cc	pos_5=SYM	path=charcoal_conj<cholestyramine_nmod<cholestyramine_nsubj<result_ROOT>metabolite_dep>leflunomide_nmod	lemma_1=in	lemma_13=96	relType_9=conj	lemma_6=13	path1=charcoal_conj<cholestyramine_nmod<cholestyramine_nsubj	relType_18=amod	pos_6=CD	lemma_25=(	lemma_29=of	eib=False	pos_9=NNS	relType_11=nsubj	pos_18=JJ	pos_25=-LRB-	relType_4=nsubj	pos_4=NN	lemma_5==	relType_24=nmod	relType_19=cc	pos_2=NNS	lemma_27=active	relType_26=det	relType_7=punct	lemma_26=the	lemma_18=rapid	pos_21=NN
DDI-DrugBank.d41.s3	DDI-DrugBank.d41.s3.e0	DDI-DrugBank.d41.s3.e1	effect	path=<ARAVA_nmod>methotrexate_nmod	lemma_1=with	relType_1=case	eib=False	lib=methotrexate	path1=	wib=methotrexate	pos_1=IN	path2=methotrexate_nmod	lpib=methotrexate_NN
DDI-DrugBank.d41.s9	DDI-DrugBank.d41.s9.e0	DDI-DrugBank.d41.s9.e1	null	pos_13=VBG	lemma_10=to	lemma_11=cause	lemma_6=,	lemma_5=study	pos_15=CD	pos_3=FW	lemma_7=m1	pos_18=NN	lib=study	relType_3=amod	pos_1=:	pos_17=CD	relType_15=compound	lemma_13=range	pos_11=VB	lemma_23=of	relType_22=obl	pos_22=NN	pos_21=JJ	pos_4=FW	path1=	lemma_19=in	relType_8=aux:pass	lemma_20=the	pos_14=IN	path2=show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>diclofenac_nmod	lemma_16=-	lemma_22=fraction	relType_19=case	pos_23=IN	relType_1=punct	pos_7=NN	lemma_2=in	lemma_9=show	relType_4=dep	relType_10=mark	pos_2=IN	relType_18=obl	lemma_18=%	relType_7=nsubj:pass	relType_9=appos	lemma_1=:	pos_8=VBD	lemma_12=increase	lemma_17=50	relType_5=obl	path=<nsaid_ROOT>show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>diclofenac_nmod	relType_23=case	lemma_4=vitro	lemma_14=from	relType_2=case	pos_10=TO	relation_11=beneficial	relType_14=case	lemma_21=free	relType_20=det	relType_13=acl	pos_19=IN	relation_10=neutral	pos_20=DT	lpib=study_NNS	eib=False	relType_17=nummod	pos_5=NNS	relType_6=punct	relType_21=amod	relType_12=obj	wib=studies	pos_9=VBN	lemma_8=be	pos_12=NNS	lemma_15=13	pos_6=,	relType_11=xcomp	relType_16=dep	pos_16=SYM	lemma_3=in
DDI-DrugBank.d41.s9	DDI-DrugBank.d41.s9.e0	DDI-DrugBank.d41.s9.e2	null	pos_13=VBG	lemma_10=to	lemma_11=cause	lemma_6=,	lemma_5=study	pos_15=CD	pos_3=FW	lemma_7=m1	pos_18=NN	lib=study	relType_3=amod	pos_1=:	pos_17=CD	relType_15=compound	lemma_13=range	pos_11=VB	lemma_23=of	relType_22=obl	pos_22=NN	pos_21=JJ	pos_4=FW	path1=	lemma_19=in	pos_24=CC	relType_8=aux:pass	lemma_20=the	pos_14=IN	lemma_24=and	lemma_16=-	lemma_22=fraction	relType_19=case	pos_23=IN	relType_1=punct	pos_7=NN	lemma_2=in	lemma_9=show	relType_4=dep	path=<nsaid_ROOT>show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>diclofenac_nmod>ibuprofen_conj	relType_10=mark	pos_24=NN	pos_2=IN	relType_18=obl	lemma_18=%	relType_7=nsubj:pass	relType_9=appos	lemma_1=:	pos_8=VBD	lemma_12=increase	lemma_17=50	relType_5=obl	path2=show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>diclofenac_nmod>ibuprofen_conj	relType_23=case	lemma_24=diclofenac	lemma_4=vitro	lemma_14=from	relType_2=case	pos_10=TO	relation_11=beneficial	relType_14=case	lemma_21=free	relType_20=det	relType_13=acl	pos_19=IN	relation_10=neutral	pos_20=DT	lpib=study_NNS	relType_17=nummod	pos_5=NNS	relType_6=punct	relType_21=amod	relType_12=obj	relType_24=cc	wib=studies	pos_9=VBN	lemma_8=be	pos_12=NNS	lemma_15=13	relType_24=nmod	pos_6=,	relType_11=xcomp	eib=True	relType_16=dep	pos_16=SYM	lemma_3=in
DDI-DrugBank.d41.s9	DDI-DrugBank.d41.s9.e1	DDI-DrugBank.d41.s9.e2	null	relType_1=cc	lib=ibuprofen	pos_1=CC	lpib=ibuprofen_NN	eib=False	path=<diclofenac_nmod>ibuprofen_conj	path1=	wib=ibuprofen	path2=ibuprofen_conj	lemma_1=and
DDI-DrugBank.d41.s12	DDI-DrugBank.d41.s12.e0	DDI-DrugBank.d41.s12.e1	null	pos_13=VBG	lemma_10=to	lemma_11=cause	lemma_6=,	lemma_5=study	pos_15=CD	pos_3=FW	lemma_7=m1	pos_18=NN	lib=study	relType_3=amod	pos_1=:	pos_17=CD	relType_15=compound	lemma_13=range	pos_11=VB	lemma_23=of	relType_22=obl	pos_22=NN	pos_21=JJ	pos_4=FW	path1=	lemma_19=in	relType_8=aux:pass	lemma_20=the	pos_14=IN	path=<Tolbutamide_ROOT>show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>tolbutamide_nmod	lemma_16=-	lemma_22=fraction	relType_19=case	pos_23=IN	relType_1=punct	pos_7=NN	lemma_2=in	lemma_9=show	relType_4=dep	relType_10=mark	pos_2=IN	relType_18=obl	lemma_18=%	relType_7=nsubj:pass	relType_9=appos	lemma_1=:	pos_8=VBD	lemma_12=increase	lemma_17=50	relType_5=obl	relType_23=case	lemma_4=vitro	lemma_14=from	relType_2=case	pos_10=TO	relation_11=beneficial	relType_14=case	lemma_21=free	relType_20=det	relType_13=acl	pos_19=IN	relation_10=neutral	pos_20=DT	lpib=study_NNS	eib=False	relType_17=nummod	pos_5=NNS	relType_6=punct	relType_21=amod	relType_12=obj	wib=studies	pos_9=VBN	lemma_8=be	pos_12=NNS	lemma_15=13	pos_6=,	relType_11=xcomp	path2=show_appos>cause_xcomp>increase_obj>range_acl>%_obl>fraction_obl>tolbutamide_nmod	relType_16=dep	pos_16=SYM	lemma_3=in
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e0	DDI-DrugBank.d41.s14.e1	null	pos_6=DT	path1=	pos_9=IN	lemma_8=dose	lemma_5=of	relType_5=case	pos_8=NN	eib=False	lemma_6=a	lemma_2=follow	relType_9=case	path=<Rifampin_ROOT>increase_parataxis>administration_obl>dose_nmod>ARAVA_nmod	path2=increase_parataxis>administration_obl>dose_nmod>ARAVA_nmod	pos_4=NN	lemma_1=:	relType_4=obl	relType_7=amod	relType_3=amod	lib=follow	wib=Following	pos_1=:	pos_5=IN	lpib=follow_VBG	lemma_3=concomitant	relType_6=det	relType_2=case	pos_3=JJ	relType_8=nmod	lemma_9=of	pos_7=JJ	lemma_4=administration	relType_1=punct	lemma_7=single	pos_2=VBG
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e0	DDI-DrugBank.d41.s14.e2	null	lemma_14=dose	lemma_10=to	pos_12=VBG	lemma_15=of	pos_6=DT	lemma_12=receive	path1=	lemma_10=ARAVA	pos_9=IN	lemma_8=dose	lemma_5=of	relType_5=case	pos_8=NN	relType_10=nmod	relType_14=obj	lemma_6=a	lemma_13=multiple	lemma_2=follow	relType_13=amod	pos_11=NNS	lemma_11=subject	relType_9=case	relType_10=case	pos_4=NN	lemma_1=:	path=<Rifampin_ROOT>increase_parataxis>administration_obl>subject_nmod>receive_acl>dose_obj>rifampin_nmod	relType_15=case	relType_4=obl	relType_7=amod	pos_13=JJ	relType_3=amod	lib=follow	wib=Following	pos_1=:	pos_5=IN	lpib=follow_VBG	pos_10=IN	lemma_3=concomitant	pos_10=NNP	pos_15=IN	relType_6=det	relType_2=case	pos_3=JJ	eib=True	relType_8=nmod	lemma_9=of	pos_7=JJ	lemma_4=administration	relType_12=acl	pos_14=NNS	relType_11=nmod	relType_1=punct	path2=increase_parataxis>administration_obl>subject_nmod>receive_acl>dose_obj>rifampin_nmod	lemma_7=single	pos_2=VBG
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e0	DDI-DrugBank.d41.s14.e3	null	lemma_10=to	relType_21=parataxis	relType_16=nmod	lemma_10=ARAVA	pos_24=CD	lemma_20=be	lemma_5=of	relType_5=case	relType_10=nmod	lemma_6=a	lemma_2=follow	relType_20=aux:pass	relType_24=nummod	lemma_11=subject	relType_9=case	relType_17=compound	lemma_16=,	pos_18=NN	relType_22=punct	relType_3=amod	pos_30=WRB	pos_1=:	lpib=follow_VBG	relType_16=punct	lemma_21=increase	lemma_22=(	pos_3=JJ	pos_7=JJ	lemma_29=see	pos_14=NNS	relType_12=acl	lemma_15=of	lemma_19=level	lemma_30=when	path1=	pos_19=NNS	pos_8=NN	lemma_28=that	relType_13=amod	lemma_17=m1	pos_28=DT	relType_23=dep	lemma_23=~	relType_15=case	relType_4=obl	pos_5=IN	pos_16=NN	pos_15=IN	pos_21=VBN	relType_6=det	path2=increase_parataxis>that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	relType_25=dep	relType_11=nmod	relType_26=punct	relType_1=punct	pos_2=VBG	lemma_14=dose	lemma_27=over	pos_12=VBG	pos_6=DT	relType_29=acl	lemma_8=dose	pos_17=NN	relType_14=obj	lemma_13=multiple	lemma_1=:	relType_7=amod	pos_13=JJ	lemma_18=peak	relType_19=nsubj:pass	lib=follow	wib=Following	pos_25=NN	pos_10=IN	lemma_3=concomitant	pos_10=NNP	pos_29=VBN	lemma_26=)	relType_2=case	relType_30=advmod	relType_27=case	lemma_7=single	pos_26=-RRB-	lemma_12=receive	pos_23=SYM	path=<Rifampin_ROOT>increase_parataxis>that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	pos_9=IN	relation_22=beneficial	lemma_24=40	pos_20=VBD	pos_11=NNS	pos_16=,	relType_10=case	pos_27=IN	pos_4=NN	lemma_16=rifampin	lemma_25=%	pos_22=-LRB-	eib=True	relType_8=nmod	lemma_9=of	relType_18=compound	lemma_4=administration	relType_28=obl
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e1	DDI-DrugBank.d41.s14.e2	mechanism	relType_4=amod	relType_1=case	pos_4=JJ	lemma_6=of	relType_6=case	path=ARAVA_nmod<dose_nmod<administration_obl>subject_nmod>receive_acl>dose_obj>rifampin_nmod	path1=ARAVA_nmod<dose_nmod	eib=False	path2=subject_nmod>receive_acl>dose_obj>rifampin_nmod	relType_2=nmod	relType_3=acl	pos_5=NNS	pos_6=IN	lemma_4=multiple	lemma_3=receive	pos_1=IN	pos_3=VBG	lib=subject	lpib=subject_NNS	lemma_2=subject	lemma_1=to	pos_2=NNS	lemma_5=dose	relType_5=obj	wib=subjects
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e1	DDI-DrugBank.d41.s14.e3	null	relType_4=amod	relType_1=case	pos_4=JJ	pos_11=VBD	relType_17=punct	relType_13=punct	lemma_14=~	lemma_11=be	lemma_6=of	pos_20=VBN	relType_6=case	relType_18=case	lemma_9=peak	pos_8=NN	lemma_18=over	pos_15=CD	lemma_7=rifampin	relType_9=compound	relType_3=acl	relType_2=nmod	pos_5=NNS	pos_6=IN	lemma_8=m1	relType_12=parataxis	lemma_15=40	lemma_4=multiple	pos_7=,	relType_21=advmod	lemma_16=%	lemma_3=receive	path=ARAVA_nmod<dose_nmod<administration_obl<increase_parataxis>that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	pos_1=IN	pos_3=VBG	lemma_7=,	pos_9=NN	relType_11=aux:pass	lib=subject	lpib=subject_NNS	relType_10=nsubj:pass	path2=that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	pos_18=IN	lemma_2=subject	lemma_13=(	lemma_10=level	lemma_12=increase	pos_14=SYM	relType_15=nummod	relType_8=compound	lemma_19=that	relType_7=nmod	relType_14=dep	pos_16=NN	lemma_1=to	pos_13=-LRB-	lemma_20=see	lemma_21=when	lemma_17=)	pos_2=NNS	lemma_5=dose	relType_19=obl	eib=True	relType_16=dep	relType_5=obj	relType_7=punct	relType_20=acl	wib=subjects	pos_17=-RRB-	pos_21=WRB	pos_12=VBN	pos_7=NN	pos_10=NNS	path1=ARAVA_nmod<dose_nmod<administration_obl	relation_12=beneficial	pos_19=DT
DDI-DrugBank.d41.s14	DDI-DrugBank.d41.s14.e2	DDI-DrugBank.d41.s14.e3	null	relation_5=beneficial	lemma_1=,	lemma_7=(	pos_2=NN	relType_8=dep	lemma_9=40	lemma_12=over	pos_15=WRB	pos_1=,	relType_12=case	pos_13=DT	lemma_6=increase	relType_10=dep	relType_9=nummod	pos_7=-LRB-	relType_13=obl	relType_14=acl	path1=rifampin_nmod<dose_obj<receive_acl<subject_nmod<administration_obl	eib=False	lemma_4=level	wib=M1	relType_11=punct	lemma_11=)	lemma_3=peak	relType_4=nsubj:pass	pos_6=VBN	pos_10=NN	lemma_5=be	lib=m1	relType_6=parataxis	pos_4=NNS	pos_12=IN	path2=that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	lemma_15=when	lemma_8=~	relType_5=aux:pass	lemma_14=see	relType_2=compound	lemma_13=that	pos_8=SYM	path=rifampin_nmod<dose_obj<receive_acl<subject_nmod<administration_obl<increase_parataxis>that_obl>see_acl>give_advcl>ARAVA_nsubj:pass	pos_5=VBD	lemma_10=%	pos_11=-RRB-	pos_14=VBN	pos_9=CD	pos_3=NN	relType_7=punct	relType_3=compound	lpib=m1_NN	relType_1=punct	relType_15=advmod	lemma_2=m1
DDI-DrugBank.d41.s15	DDI-DrugBank.d41.s15.e0	DDI-DrugBank.d41.s15.e1	null	relType_4=mark	pos_2=TO	lemma_7=multiple	path=ARAVA_compound<level_nsubj<continue_acl<potential_obl<use_ROOT>receive_advcl>ARAVA_obj	relation_4=beneficial	relType_5=xcomp	lib=level	pos_11=MD	relType_13=ROOT	relType_15=nsubj	lemma_17=to	pos_3=VB	lemma_9=,	lemma_14=if	pos_20=DT	relType_6=case	pos_13=VBN	lemma_5=increase	relType_2=mark	relType_8=obl	relType_12=aux:pass	pos_8=NN	pos_5=VB	relType_17=mark	path1=ARAVA_compound<level_nsubj<continue_acl<potential_obl	lemma_20=both	lpib=level_NNS	eib=False	relType_3=acl	pos_6=IN	relType_11=aux	pos_17=TO	relType_20=cc:preconj	lemma_18=be	relType_16=aux	lemma_1=level	lemma_2=to	lemma_16=be	lemma_11=should	pos_10=NN	lemma_15=patient	relType_10=nsubj:pass	pos_14=IN	path2=receive_advcl>ARAVA_obj	relType_7=amod	lemma_13=use	relType_18=aux	lemma_12=be	lemma_4=to	pos_18=VB	relType_1=nsubj	lemma_6=with	lemma_8=dosing	relType_14=mark	relType_19=advcl	relType_9=punct	pos_4=TO	pos_12=VB	pos_19=VBG	lemma_19=receive	pos_1=NNS	pos_15=NNS	pos_7=JJ	pos_9=,	lemma_10=caution	wib=levels	pos_16=VBP	lemma_3=continue
DDI-DrugBank.d41.s15	DDI-DrugBank.d41.s15.e0	DDI-DrugBank.d41.s15.e2	null	relType_4=mark	pos_2=TO	lemma_7=multiple	pos_21=NNP	relation_4=beneficial	relType_5=xcomp	lib=level	pos_11=MD	relType_13=ROOT	relType_15=nsubj	lemma_17=to	relType_21=obj	pos_3=VB	lemma_9=,	lemma_14=if	pos_20=DT	relType_6=case	pos_13=VBN	lemma_5=increase	relType_2=mark	relType_8=obl	relType_12=aux:pass	pos_8=NN	pos_5=VB	relType_17=mark	relType_21=cc	path1=ARAVA_compound<level_nsubj<continue_acl<potential_obl	lemma_20=both	lpib=level_NNS	relType_3=acl	pos_6=IN	relType_11=aux	pos_17=TO	relType_20=cc:preconj	lemma_18=be	relType_16=aux	lemma_1=level	lemma_2=to	lemma_16=be	lemma_11=should	pos_10=NN	lemma_15=patient	relType_10=nsubj:pass	pos_14=IN	relType_7=amod	lemma_13=use	relType_18=aux	lemma_12=be	lemma_4=to	pos_18=VB	relType_1=nsubj	path=ARAVA_compound<level_nsubj<continue_acl<potential_obl<use_ROOT>receive_advcl>ARAVA_obj>rifampin_conj	lemma_21=ARAVA	lemma_6=with	lemma_8=dosing	relType_14=mark	relType_19=advcl	relType_9=punct	pos_4=TO	pos_12=VB	pos_19=VBG	pos_21=CC	lemma_19=receive	path2=receive_advcl>ARAVA_obj>rifampin_conj	pos_1=NNS	eib=True	pos_15=NNS	lemma_21=and	pos_7=JJ	pos_9=,	lemma_10=caution	wib=levels	pos_16=VBP	lemma_3=continue
DDI-DrugBank.d41.s15	DDI-DrugBank.d41.s15.e1	DDI-DrugBank.d41.s15.e2	advise	relType_1=cc	lpib=rifampin_NNP	wib=rifampin	pos_1=CC	eib=False	path1=	lib=rifampin	path=<ARAVA_obj>rifampin_conj	lemma_1=and	path2=rifampin_conj
DDI-DrugBank.d41.s16	DDI-DrugBank.d41.s16.e0	DDI-DrugBank.d41.s16.e1	null	relType_3=dep	pos_2=VBN	lemma_7=ratio	relType_9=advmod	path1=	relType_8=punct	relation_1=beneficial	pos_9=WRB	eib=False	pos_4=-LRB-	relType_6=amod	pos_8=-RRB-	pos_6=VBN	lib=increase	lemma_1=:	lemma_2=increase	lemma_4=(	pos_5=JJ	lemma_8=)	relType_4=punct	relType_5=amod	relType_2=amod	pos_1=:	lemma_9=when	lemma_5=international	lemma_3=inr	path2=ratio_parataxis>administer_acl:relcl>ARAVA_nsubj:pass	wib=Increased	pos_3=NN	relType_1=punct	pos_7=NN	path=<Warfarin_ROOT>ratio_parataxis>administer_acl:relcl>ARAVA_nsubj:pass	relType_7=parataxis	lemma_6=normalize	lpib=increase_VBN
DDI-DrugBank.d41.s16	DDI-DrugBank.d41.s16.e0	DDI-DrugBank.d41.s16.e2	null	relType_3=dep	path2=ratio_parataxis>administer_acl:relcl>ARAVA_nsubj:pass>warfarin_conj	pos_2=VBN	lemma_7=ratio	relType_9=advmod	relType_10=cc	path1=	lemma_10=ARAVA	relType_8=punct	relation_1=beneficial	pos_9=WRB	pos_4=-LRB-	pos_10=CC	relType_6=amod	pos_8=-RRB-	pos_6=VBN	lib=increase	lemma_1=:	lemma_2=increase	lemma_4=(	relType_10=nsubj:pass	pos_5=JJ	lemma_8=)	lemma_10=and	relType_4=punct	relType_5=amod	path=<Warfarin_ROOT>ratio_parataxis>administer_acl:relcl>ARAVA_nsubj:pass>warfarin_conj	relType_2=amod	pos_1=:	lemma_9=when	lemma_5=international	pos_10=NNP	lemma_3=inr	eib=True	wib=Increased	pos_3=NN	relType_1=punct	pos_7=NN	relType_7=parataxis	lemma_6=normalize	lpib=increase_VBN
DDI-DrugBank.d41.s16	DDI-DrugBank.d41.s16.e1	DDI-DrugBank.d41.s16.e2	effect	relType_1=cc	lib=warfarin	path2=warfarin_conj	pos_1=CC	lpib=warfarin_NN	eib=False	path=<ARAVA_nsubj:pass>warfarin_conj	path1=	wib=warfarin	lemma_1=and
DDI-DrugBank.d252.s0	DDI-DrugBank.d252.s0.e0	DDI-DrugBank.d252.s0.e1	null	lemma_2=alone	relType_4=amod	relType_8=case	pos_4=JJ	lib=use	pos_13=VBG	pos_15=JJ	pos_5=CC	relType_1=advcl	pos_6=DT	lemma_6=no	pos_7=NN	lemma_11=,	relType_15=amod	lemma_15=concomitant	lemma_4=little	relType_16=obl	lemma_9=pupil	relation_6=neutral	pos_17=IN	pos_2=RB	relType_5=cc	relType_6=conj	pos_1=VBD	relType_10=nmod	relType_9=compound	lemma_17=with	eib=False	relType_2=advmod	lemma_1=use	lemma_7=effect	relType_11=punct	lemma_13=result	pos_3=VBZ	lemma_12=mydriasis	pos_12=NN	path=BETAGAN_nsubj<use_advcl<occur_ROOT>effect_nsubj>mydriasis_appos>result_acl>therapy_obl>betagan_nmod	pos_10=NN	pos_9=NN	pos_8=IN	relType_17=case	lemma_8=on	pos_14=IN	pos_16=NN	pos_11=,	lemma_14=from	lpib=use_VBD	relType_12=appos	path1=BETAGAN_nsubj<use_advcl	relType_3=aux	relType_7=nsubj	relType_14=case	wib=used	lemma_10=size	lemma_3=have	lemma_16=therapy	relType_13=acl	path2=effect_nsubj>mydriasis_appos>result_acl>therapy_obl>betagan_nmod	lemma_5=or
DDI-DrugBank.d252.s0	DDI-DrugBank.d252.s0.e0	DDI-DrugBank.d252.s0.e2	null	lemma_2=alone	relType_4=amod	relType_8=case	pos_4=JJ	lib=use	pos_13=VBG	pos_15=JJ	pos_5=CC	relType_1=advcl	pos_6=DT	lemma_6=no	pos_7=NN	lemma_11=,	relType_15=amod	lemma_15=concomitant	lemma_4=little	relType_16=obl	lemma_9=pupil	relType_18=cc	relation_6=neutral	pos_17=IN	pos_2=RB	relType_5=cc	relType_6=conj	pos_1=VBD	relType_10=nmod	relType_9=compound	lemma_17=with	relType_2=advmod	lemma_1=use	lemma_7=effect	relType_11=punct	lemma_13=result	pos_3=VBZ	lemma_12=mydriasis	pos_12=NN	lemma_18=betagan	pos_18=CC	pos_10=NN	pos_9=NN	pos_8=IN	relType_17=case	lemma_8=on	pos_14=IN	pos_18=NN	relType_18=nmod	path=BETAGAN_nsubj<use_advcl<occur_ROOT>effect_nsubj>mydriasis_appos>result_acl>therapy_obl>betagan_nmod>epinephrine_conj	path2=effect_nsubj>mydriasis_appos>result_acl>therapy_obl>betagan_nmod>epinephrine_conj	pos_16=NN	pos_11=,	lemma_14=from	lpib=use_VBD	lemma_18=and	eib=True	relType_12=appos	path1=BETAGAN_nsubj<use_advcl	relType_3=aux	relType_7=nsubj	relType_14=case	wib=used	lemma_10=size	lemma_3=have	lemma_16=therapy	relType_13=acl	lemma_5=or
DDI-DrugBank.d252.s0	DDI-DrugBank.d252.s0.e1	DDI-DrugBank.d252.s0.e2	effect	lpib=epinephrine_NN	path=<betagan_nmod>epinephrine_conj	relType_1=cc	pos_1=CC	eib=False	path1=	wib=epinephrine	path2=epinephrine_conj	lib=epinephrine	lemma_1=and
DDI-DrugBank.d252.s1	DDI-DrugBank.d252.s1.e0	DDI-DrugBank.d252.s1.e1	advise	pos_2=VBN	pos_3=IN	relType_8=amod	relType_1=aux:pass	lemma_2=administer	lemma_9=drug	lemma_11=as	relType_2=advcl	pos_6=NN	relType_6=obl	lemma_7=-	path=blocker_nsubj:pass<administer_advcl>patient_obl>reserpine_nmod	eib=False	relType_5=acl	lemma_1=be	pos_9=NNS	lemma_5=receive	relType_10=case	lemma_4=patient	pos_4=NNS	path1=blocker_nsubj:pass	pos_11=IN	relType_4=obl	lemma_10=such	lib=be	pos_7=HYPH	pos_10=JJ	pos_8=VBG	relType_11=fixed	lemma_3=to	relType_9=obj	lemma_6=catecholamine	relType_3=case	path2=patient_obl>reserpine_nmod	wib=is	lemma_8=deplete	pos_5=VBG	pos_1=VBZ	relType_7=punct	lpib=be_VBZ
DDI-DrugBank.d252.s2	DDI-DrugBank.d252.s2.e0	DDI-DrugBank.d252.s2.e1	advise	path2=antagonist_obl	relType_4=amod	relType_1=case	pos_4=JJ	lib=oral	lemma_1=along	pos_6=JJ	pos_5=CC	pos_3=CC	relType_7=compound	relType_3=cc:preconj	path1=agent_obj	pos_2=IN	relType_5=cc	relType_6=conj	path=agent_obj<receive_acl>antagonist_obl	lemma_2=with	pos_1=IN	lemma_7=calcium	lemma_3=either	lpib=oral_JJ	lemma_6=intravenous	relType_2=case	eib=True	lemma_4=oral	wib=oral	pos_7=NN	lemma_5=or
DDI-DrugBank.d252.s4	DDI-DrugBank.d252.s4.e0	DDI-DrugBank.d252.s4.e1	effect	lemma_1=with	relType_1=case	eib=False	path2=digitalis_nmod	wib=digitalis	path1=	lpib=digitalis_NN	pos_1=IN	lib=digitalis	path=<agent_nmod>digitalis_nmod
DDI-DrugBank.d252.s4	DDI-DrugBank.d252.s4.e0	DDI-DrugBank.d252.s4.e2	effect	relType_1=case	pos_2=NN	path1=	relType_2=cc	path=<agent_nmod>digitalis_nmod>antagonist_conj	lemma_2=and	relType_2=nmod	lemma_3=calcium	pos_1=IN	lib=digitalis	lemma_1=with	path2=digitalis_nmod>antagonist_conj	eib=True	pos_3=NN	wib=digitalis	pos_2=CC	lpib=digitalis_NN	relType_3=compound	lemma_2=digitalis
DDI-DrugBank.d252.s4	DDI-DrugBank.d252.s4.e1	DDI-DrugBank.d252.s4.e2	null	path=<digitalis_nmod>antagonist_conj	relType_1=cc	pos_1=CC	lemma_2=calcium	pos_2=NN	eib=True	lpib=calcium_NN	wib=calcium	relType_2=compound	path1=	path2=antagonist_conj	lib=calcium	lemma_1=and
DDI-DrugBank.d252.s5	DDI-DrugBank.d252.s5.e0	DDI-DrugBank.d252.s5.e1	mechanism	relType_1=cc	pos_1=CC	pos_2=NN	path2=agent_conj	path1=	pos_2=HYPH	pos_2=JJ	relType_2=punct	relType_2=obl:npmod	lemma_2=-	path=<compound_nsubj>agent_conj	relType_2=compound	relType_2=amod	wib=beta	lemma_2=adrenergic	eib=True	lemma_2=blocking	lib=beta	lpib=beta_NN	lemma_1=and	lemma_2=beta
DDI-DrugBank.d320.s0	DDI-DrugBank.d320.s0.e0	DDI-DrugBank.d320.s0.e1	advise	pos_7=NNS	path=Chirocaine_nsubj:pass<use_csubj>patient_obl>receive_acl>anesthetic_obj	relType_1=aux	pos_3=VBN	relType_10=amod	path1=Chirocaine_nsubj:pass	lemma_1=should	lemma_8=receive	relType_3=csubj	relType_6=case	path2=patient_obl>receive_acl>anesthetic_obj	wib=be	pos_9=JJ	lemma_3=use	lemma_9=other	eib=False	lemma_10=local	pos_6=IN	lemma_7=patient	pos_2=VB	relType_9=amod	lemma_6=in	lemma_5=caution	lemma_4=with	lib=be	pos_10=JJ	pos_4=IN	pos_8=VBG	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_1=MD	relType_8=acl	lpib=be_VB	pos_5=NN	relType_7=obl	lemma_2=be
DDI-DrugBank.d320.s1	DDI-DrugBank.d320.s1.e0	DDI-DrugBank.d320.s1.e1	null	relType_1=case	path1=levobupivacaine_nmod<metabolism_obj	path2=levobupivacaine_obl	eib=True	lpib=desbutyl_NN	pos_2=NN	relType_2=compound	lib=desbutyl	pos_1=IN	wib=desbutyl	lemma_1=to	lemma_2=desbutyl	path=levobupivacaine_nmod<metabolism_obj<mediate_ccomp>levobupivacaine_obl
DDI-DrugBank.d320.s1	DDI-DrugBank.d320.s1.e0	DDI-DrugBank.d320.s1.e2	null	relType_1=case	pos_2=NN	lpib=desbutyl_NN	lemma_3=hydroxy	lemma_2=levobupivacaine	lib=desbutyl	lemma_2=desbutyl	wib=desbutyl	relType_2=cc	lemma_2=and	lemma_3=-	pos_1=IN	path1=levobupivacaine_nmod<metabolism_obj	pos_3=CD	relType_2=compound	relType_3=nummod	lemma_1=to	relType_2=obl	eib=True	path2=levobupivacaine_obl>levobupivacaine_conj	lemma_3=3	pos_3=HYPH	pos_2=CC	pos_3=NN	path=levobupivacaine_nmod<metabolism_obj<mediate_ccomp>levobupivacaine_obl>levobupivacaine_conj	relType_3=compound	relType_3=punct
DDI-DrugBank.d320.s1	DDI-DrugBank.d320.s1.e1	DDI-DrugBank.d320.s1.e2	null	relType_1=cc	pos_1=CC	relType_2=nummod	pos_2=NN	path2=levobupivacaine_conj	path=<levobupivacaine_obl>levobupivacaine_conj	path1=	pos_2=HYPH	lib=hydroxy	relType_2=punct	wib=hydroxy	lemma_2=-	pos_2=CD	lpib=hydroxy_NN	lemma_2=3	lemma_2=hydroxy	relType_2=compound	eib=True	lemma_1=and
DDI-DrugBank.d320.s2	DDI-DrugBank.d320.s2.e0	DDI-DrugBank.d320.s2.e1	null	relType_9=advmod	lpib=be_VBP	pos_3=VBN	lemma_9=potentially	relation_9=adverse	lemma_7=family	relType_11=case	lemma_11=with	pos_6=NN	relType_3=acl:relcl	eib=False	pos_8=MD	lemma_1=that	path=chirocaine_obl<administer_acl<agent_nsubj<interact_ROOT>Chirocaine_obl	pos_10=VB	wib=are	pos_11=IN	relType_10=ROOT	lib=be	pos_4=IN	relType_5=det	relType_4=case	relType_2=aux:pass	lemma_5=this	pos_2=VBP	lemma_3=metabolize	pos_9=RB	relType_6=compound	lemma_10=interact	relType_7=obl	pos_5=DT	lemma_8=may	relType_1=nsubj:pass	lemma_2=be	path1=chirocaine_obl<administer_acl<agent_nsubj	relType_8=aux	pos_7=NN	lemma_6=isoenzyme	lemma_4=by	path2=Chirocaine_obl	pos_1=WDT
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e0	DDI-DrugBank.d320.s3.e1	mechanism	relType_7=compound	relType_1=aux	path1=levobupivacaine_nmod<metabolism_nsubj:pass	lemma_1=may	pos_3=VBN	lemma_11=as	pos_8=NNS	relType_8=obl	wib=be	path=levobupivacaine_nmod<metabolism_nsubj:pass<affect_ccomp>inducer_obl>phenytoin_nmod	eib=False	path2=inducer_obl>phenytoin_nmod	lemma_3=affect	relType_6=amod	relation_2=neutral	lemma_9=(	pos_2=VB	pos_6=VBN	relType_10=case	pos_11=IN	lemma_10=such	lib=be	pos_10=JJ	pos_4=IN	relType_5=det	relType_11=fixed	relType_4=case	relType_2=aux:pass	pos_9=-LRB-	pos_1=MD	relType_9=punct	lpib=be_VB	lemma_5=the	lemma_6=know	relType_3=ccomp	lemma_7=cyp3a4	pos_5=DT	lemma_8=inducer	lemma_2=be	pos_7=NN	lemma_4=by
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e0	DDI-DrugBank.d320.s3.e2	mechanism	relType_7=compound	relType_1=aux	path1=levobupivacaine_nmod<metabolism_nsubj:pass	lemma_1=may	pos_3=VBN	lemma_11=as	path2=inducer_obl>phenytoin_nmod>phenobarbital_conj	pos_8=NNS	relType_8=obl	wib=be	lemma_12=phenytoin	lemma_12=,	lemma_3=affect	relType_6=amod	relType_12=nmod	lemma_9=(	pos_12=,	relation_2=neutral	path=levobupivacaine_nmod<metabolism_nsubj:pass<affect_ccomp>inducer_obl>phenytoin_nmod>phenobarbital_conj	pos_2=VB	pos_12=NN	pos_6=VBN	relType_10=case	relType_12=punct	pos_11=IN	lemma_10=such	lib=be	pos_10=JJ	pos_4=IN	relType_5=det	relType_11=fixed	relType_4=case	relType_2=aux:pass	pos_9=-LRB-	pos_1=MD	relType_9=punct	lpib=be_VB	lemma_5=the	lemma_6=know	relType_3=ccomp	eib=True	lemma_7=cyp3a4	pos_5=DT	lemma_8=inducer	lemma_2=be	pos_7=NN	lemma_4=by
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e0	DDI-DrugBank.d320.s3.e3	mechanism	relType_7=compound	pos_13=,	lemma_13=,	relType_1=aux	path1=levobupivacaine_nmod<metabolism_nsubj:pass	lemma_1=may	pos_3=VBN	relType_13=punct	lemma_11=as	path2=inducer_obl>phenytoin_nmod>rifampin_conj	pos_8=NNS	relType_8=obl	wib=be	lemma_12=phenytoin	lemma_12=,	lemma_3=affect	relType_6=amod	relType_12=nmod	lemma_9=(	pos_12=,	relation_2=neutral	pos_12=NN	pos_2=VB	relType_12=punct	pos_6=VBN	relType_10=case	pos_13=NN	lemma_13=phenobarbital	relType_13=conj	path=levobupivacaine_nmod<metabolism_nsubj:pass<affect_ccomp>inducer_obl>phenytoin_nmod>rifampin_conj	pos_11=IN	lemma_10=such	lib=be	pos_10=JJ	pos_4=IN	relType_5=det	relType_11=fixed	relType_4=case	relType_2=aux:pass	pos_9=-LRB-	pos_1=MD	relType_9=punct	lpib=be_VB	lemma_5=the	lemma_6=know	relType_3=ccomp	eib=True	lemma_7=cyp3a4	pos_5=DT	lemma_8=inducer	lemma_2=be	pos_7=NN	lemma_4=by
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e0	DDI-DrugBank.d320.s3.e4	mechanism	lemma_13=,	path1=levobupivacaine_nmod<metabolism_nsubj:pass	relType_20=nsubj	pos_8=NNS	lemma_12=,	pos_12=,	pos_2=VB	pos_13=NN	lemma_13=phenobarbital	lemma_16=cyp3a4	lemma_23=,	pos_18=-LRB-	lemma_10=such	relType_2=aux:pass	lemma_17=inhibitor	lpib=be_VB	lemma_18=(	lemma_19=azole	lemma_7=cyp3a4	pos_13=,	relType_1=aux	pos_22=NN	lemma_11=as	lemma_12=phenytoin	lemma_3=affect	relType_12=nmod	relType_12=punct	relType_13=conj	relType_21=dep	relType_19=compound	lemma_21=e.	lemma_15=,	pos_16=NN	lemma_5=the	lemma_6=know	relType_17=appos	lemma_2=be	pos_7=NN	relType_14=punct	lemma_1=may	path=levobupivacaine_nmod<metabolism_nsubj:pass<affect_ccomp>inducer_obl>inhibitor_appos>e._dep>g._obj>ketoconazole_appos	pos_15=,	pos_14=-RRB-	relation_2=neutral	lemma_22=g.	pos_14=NN	pos_6=VBN	lemma_14=)	relType_15=punct	pos_11=IN	lib=be	pos_4=IN	lemma_14=rifampin	relType_5=det	relType_11=fixed	pos_9=-LRB-	pos_1=MD	pos_17=NNS	pos_5=DT	relType_14=conj	relType_23=punct	relType_7=compound	pos_3=VBN	relType_13=punct	relType_16=compound	relType_8=obl	wib=be	relType_6=amod	lemma_9=(	pos_19=NN	relType_10=case	pos_21=VBP	pos_10=JJ	relType_18=punct	relType_4=case	pos_20=NNS	path2=inducer_obl>inhibitor_appos>e._dep>g._obj>ketoconazole_appos	lemma_20=antimycotic	relType_9=punct	relType_22=obj	relType_3=ccomp	eib=True	pos_23=,	lemma_8=inducer	pos_12=NN	lemma_4=by
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e1	DDI-DrugBank.d320.s3.e2	null	lemma_1=,	eib=False	lpib=phenobarbital_NN	path=<phenytoin_nmod>phenobarbital_conj	path2=phenobarbital_conj	wib=phenobarbital	path1=	pos_1=,	relType_1=punct	lib=phenobarbital
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e1	DDI-DrugBank.d320.s3.e3	null	path=<phenytoin_nmod>rifampin_conj	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lpib=phenobarbital_NN	wib=phenobarbital	path1=	pos_1=,	pos_2=,	relType_2=conj	relType_1=punct	lemma_2=phenobarbital	lemma_2=,	lib=phenobarbital	path2=rifampin_conj
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e1	DDI-DrugBank.d320.s3.e4	null	lemma_1=,	lemma_7=(	pos_2=NN	pos_1=,	relType_5=compound	lemma_6=inhibitor	relType_10=dep	relType_11=obj	relType_2=punct	pos_7=-LRB-	pos_8=NN	lemma_9=antimycotic	lemma_12=,	pos_4=,	lemma_10=e.	pos_9=NNS	pos_12=,	relType_12=punct	relType_2=conj	lemma_2=,	lemma_5=cyp3a4	relType_4=punct	path2=inhibitor_appos>e._dep>g._obj>ketoconazole_appos	relType_3=conj	lemma_3=rifampin	path=phenytoin_nmod<inducer_obl>inhibitor_appos>e._dep>g._obj>ketoconazole_appos	wib=phenobarbital	relType_8=compound	lemma_11=g.	lemma_4=,	lemma_3=)	lemma_8=azole	lemma_2=phenobarbital	pos_5=NN	pos_11=NN	relType_6=appos	pos_10=VBP	eib=True	pos_3=-RRB-	relType_9=nsubj	lpib=phenobarbital_NN	pos_3=NN	relType_7=punct	pos_6=NNS	path1=phenytoin_nmod	pos_2=,	relType_1=punct	relType_3=punct	lib=phenobarbital
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e2	DDI-DrugBank.d320.s3.e3	null	path1=phenobarbital_conj	wib=rifampin	lemma_1=,	eib=False	lpib=rifampin_NN	pos_1=,	lib=rifampin	relType_1=punct	path2=rifampin_conj	path=phenobarbital_conj<phenytoin_nmod>rifampin_conj
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e2	DDI-DrugBank.d320.s3.e4	null	lemma_2=)	wib=rifampin	lemma_1=,	relType_7=compound	pos_2=NN	lemma_11=,	relType_8=nsubj	lemma_5=inhibitor	pos_1=,	lemma_6=(	lemma_10=g.	relType_9=dep	lemma_7=azole	relType_2=punct	pos_8=NNS	lemma_4=cyp3a4	pos_6=-LRB-	path1=phenobarbital_conj<phenytoin_nmod	pos_5=NNS	relType_6=punct	lpib=rifampin_NN	relType_11=punct	pos_10=NN	relType_2=conj	pos_4=NN	relType_10=obj	lemma_3=,	path2=inhibitor_appos>e._dep>g._obj>ketoconazole_appos	lemma_8=antimycotic	relType_4=compound	lib=rifampin	lemma_9=e.	pos_11=,	relType_5=appos	pos_3=,	pos_9=VBP	eib=True	pos_2=-RRB-	lemma_2=rifampin	relType_1=punct	pos_7=NN	relType_3=punct	path=phenobarbital_conj<phenytoin_nmod<inducer_obl>inhibitor_appos>e._dep>g._obj>ketoconazole_appos
DDI-DrugBank.d320.s3	DDI-DrugBank.d320.s3.e3	DDI-DrugBank.d320.s3.e4	null	pos_7=NNS	lib=cyp3a4	relType_10=punct	relType_8=dep	wib=CYP3A4	relType_4=appos	lemma_10=,	lemma_3=cyp3a4	pos_8=VBP	lemma_1=)	path1=rifampin_conj<phenytoin_nmod	relType_2=punct	pos_6=NN	eib=False	lemma_5=(	pos_9=NN	lemma_7=antimycotic	pos_4=NNS	lemma_2=,	path2=inhibitor_appos>e._dep>g._obj>ketoconazole_appos	lpib=cyp3a4_NN	relType_5=punct	pos_1=-RRB-	relType_9=obj	relType_6=compound	pos_10=,	lemma_6=azole	pos_3=NN	lemma_9=g.	lemma_4=inhibitor	lemma_8=e.	pos_2=,	relType_3=compound	relType_7=nsubj	relType_1=punct	path=rifampin_conj<phenytoin_nmod<inducer_obl>inhibitor_appos>e._dep>g._obj>ketoconazole_appos	pos_5=-LRB-
DDI-DrugBank.d320.s5	DDI-DrugBank.d320.s5.e0	DDI-DrugBank.d320.s5.e1	null	relType_1=ROOT	path=antibiotic_nsubj<e._ROOT>g._obj>erythromycin_appos	relType_2=obj	pos_2=NN	pos_3=,	path1=antibiotic_nsubj	eib=False	lemma_3=,	path2=g._obj>erythromycin_appos	lpib=e._VBP	lemma_2=g.	wib=e.	lib=e.	pos_1=VBP	relType_3=punct	lemma_1=e.
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e0	DDI-DrugBank.d320.s6.e1	null	relType_1=ROOT	relType_2=obj	pos_2=NN	pos_3=,	lemma_3=,	eib=False	path=antagonist_nsubj<e._ROOT>g._obj>verapamil_appos	path1=antagonist_nsubj	lpib=e._VBP	lemma_2=g.	wib=e.	path2=g._obj>verapamil_appos	lib=e.	pos_1=VBP	relType_3=punct	lemma_1=e.
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e0	DDI-DrugBank.d320.s6.e2	null	pos_7=NNS	lemma_8=(	relType_2=obj	pos_2=NN	pos_5=,	relType_4=appos	relType_8=punct	lib=e.	pos_6=NN	pos_4=-RRB-	lpib=e._VBP	pos_4=NN	lemma_1=e.	pos_8=-LRB-	lemma_7=inducer	path2=inducer_conj>omeprazole_dep	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_2=g.	wib=e.	lemma_4=)	pos_1=VBP	relType_1=ROOT	relType_6=compound	path=antagonist_nsubj<e._ROOT>inducer_conj>omeprazole_dep	pos_3=,	eib=True	lemma_6=cyp1a2	lemma_4=verapamil	path1=antagonist_nsubj	relType_3=punct	relType_7=conj
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e0	DDI-DrugBank.d320.s6.e3	null	pos_7=NNS	lemma_9=)	lemma_8=(	relType_2=obj	pos_2=NN	pos_5=,	relType_4=appos	relType_10=cc	relType_13=punct	lemma_9=omeprazole	relType_8=punct	lib=e.	relType_9=dep	pos_6=NN	lemma_11=cyp1a2	path=antagonist_nsubj<e._ROOT>furafylline_conj	pos_10=CC	pos_4=-RRB-	lpib=e._VBP	lemma_12=inhibitor	pos_9=NN	pos_4=NN	lemma_1=e.	pos_8=-LRB-	pos_9=-RRB-	lemma_7=inducer	lemma_10=and	lemma_13=(	relType_4=punct	lemma_3=,	pos_12=NNS	lemma_5=,	relType_5=punct	lemma_2=g.	wib=e.	lemma_4=)	pos_1=VBP	path2=furafylline_conj	relType_9=punct	pos_13=-LRB-	relType_1=ROOT	relType_6=compound	pos_11=NN	pos_3=,	eib=True	relType_11=compound	lemma_6=cyp1a2	lemma_4=verapamil	relType_12=dep	path1=antagonist_nsubj	relType_3=punct	relType_7=conj
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e0	DDI-DrugBank.d320.s6.e4	null	pos_7=NNS	lemma_9=)	lemma_8=(	relType_2=obj	pos_2=NN	pos_14=CC	pos_5=,	relType_4=appos	relType_10=cc	relType_13=punct	lemma_9=omeprazole	relType_8=punct	lib=e.	relType_9=dep	pos_6=NN	lemma_11=cyp1a2	pos_10=CC	pos_4=-RRB-	lpib=e._VBP	lemma_12=inhibitor	pos_14=NN	path2=furafylline_conj>clarithromycin_conj	pos_4=NN	lemma_1=e.	pos_9=NN	pos_8=-LRB-	pos_9=-RRB-	lemma_14=furafylline	lemma_7=inducer	lemma_10=and	lemma_13=(	relType_4=punct	lemma_3=,	pos_12=NNS	lemma_5=,	relType_5=punct	lemma_2=g.	wib=e.	lemma_4=)	relType_14=cc	pos_1=VBP	relType_9=punct	pos_13=-LRB-	relType_1=ROOT	relType_6=compound	pos_11=NN	path=antagonist_nsubj<e._ROOT>furafylline_conj>clarithromycin_conj	pos_3=,	eib=True	relType_11=compound	lemma_6=cyp1a2	lemma_4=verapamil	relType_12=dep	path1=antagonist_nsubj	relType_14=conj	lemma_14=and	relType_3=punct	relType_7=conj
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e1	DDI-DrugBank.d320.s6.e2	null	lemma_4=inducer	lemma_1=)	relType_2=punct	eib=False	lemma_5=(	lib=cyp1a2	pos_4=NNS	lemma_2=,	path2=inducer_conj>omeprazole_dep	path=verapamil_appos<g._obj<e._ROOT>inducer_conj>omeprazole_dep	relType_5=punct	pos_1=-RRB-	lemma_3=cyp1a2	lpib=cyp1a2_NN	path1=verapamil_appos<g._obj	wib=CYP1A2	pos_3=NN	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e1	DDI-DrugBank.d320.s6.e3	null	relType_10=punct	lemma_4=inducer	relType_7=cc	lemma_1=)	relType_9=dep	relType_2=punct	pos_6=NN	pos_8=NN	lemma_8=cyp1a2	pos_10=-LRB-	relType_6=dep	relType_6=punct	pos_9=NNS	lemma_5=(	lemma_6=omeprazole	lib=cyp1a2	lemma_6=)	pos_4=NNS	lemma_2=,	pos_7=CC	relType_5=punct	pos_1=-RRB-	lemma_3=cyp1a2	relType_8=compound	lemma_10=(	lpib=cyp1a2_NN	path2=furafylline_conj	path1=verapamil_appos<g._obj	pos_6=-RRB-	wib=CYP1A2	eib=True	lemma_9=inhibitor	pos_3=NN	lemma_7=and	pos_2=,	relType_3=compound	path=verapamil_appos<g._obj<e._ROOT>furafylline_conj	relType_4=conj	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e1	DDI-DrugBank.d320.s6.e4	null	relType_10=punct	relType_11=cc	lemma_4=inducer	relType_7=cc	lemma_11=furafylline	lemma_1=)	relType_9=dep	relType_11=conj	relType_2=punct	path=verapamil_appos<g._obj<e._ROOT>furafylline_conj>clarithromycin_conj	pos_6=NN	pos_8=NN	lemma_8=cyp1a2	pos_10=-LRB-	relType_6=dep	relType_6=punct	pos_9=NNS	lemma_5=(	lemma_6=omeprazole	lib=cyp1a2	path2=furafylline_conj>clarithromycin_conj	lemma_6=)	pos_4=NNS	lemma_2=,	lemma_11=and	pos_7=CC	relType_5=punct	pos_1=-RRB-	lemma_3=cyp1a2	relType_8=compound	lemma_10=(	pos_11=CC	lpib=cyp1a2_NN	path1=verapamil_appos<g._obj	pos_6=-RRB-	wib=CYP1A2	pos_11=NN	eib=True	lemma_9=inhibitor	pos_3=NN	lemma_7=and	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e2	DDI-DrugBank.d320.s6.e3	null	relType_4=dep	lemma_1=)	relType_2=cc	path1=omeprazole_dep<inducer_conj	path=omeprazole_dep<inducer_conj<e._ROOT>furafylline_conj	lemma_2=and	eib=False	lemma_5=(	lib=cyp1a2	pos_4=NNS	relType_5=punct	pos_1=-RRB-	lemma_3=cyp1a2	lpib=cyp1a2_NN	path2=furafylline_conj	wib=CYP1A2	pos_3=NN	pos_2=CC	lemma_4=inhibitor	relType_3=compound	relType_1=punct	pos_5=-LRB-
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e2	DDI-DrugBank.d320.s6.e4	null	path=omeprazole_dep<inducer_conj<e._ROOT>furafylline_conj>clarithromycin_conj	relType_4=dep	lemma_6=furafylline	lemma_1=)	relType_2=cc	path1=omeprazole_dep<inducer_conj	pos_6=NN	lemma_2=and	relType_6=conj	lemma_5=(	lib=cyp1a2	path2=furafylline_conj>clarithromycin_conj	pos_4=NNS	pos_6=CC	relType_5=punct	pos_1=-RRB-	lemma_3=cyp1a2	lemma_6=and	lpib=cyp1a2_NN	wib=CYP1A2	eib=True	pos_3=NN	pos_2=CC	lemma_4=inhibitor	relType_3=compound	relType_1=punct	relType_6=cc	pos_5=-LRB-
DDI-DrugBank.d320.s6	DDI-DrugBank.d320.s6.e3	DDI-DrugBank.d320.s6.e4	null	relType_1=cc	pos_1=CC	eib=False	lpib=clarithromycin_NN	path1=	lib=clarithromycin	wib=clarithromycin	path=<furafylline_conj>clarithromycin_conj	path2=clarithromycin_conj	lemma_1=and
DDI-DrugBank.d320.s7	DDI-DrugBank.d320.s7.e0	DDI-DrugBank.d320.s7.e1	null	path1=levobupivacaine_nsubj:pass	relType_9=conj	relType_10=mark	relType_1=aux:pass	pos_3=VBN	relType_7=cc	relType_5=compound	lemma_6=inhibitor	pos_8=NN	pos_2=RB	relType_6=obl	lemma_8=cyp1a2	path2=rise_advcl>level_nsubj>levobupivacaine_compound	eib=False	relType_2=advmod	lemma_3=administer	relType_11=amod	lemma_1=be	pos_9=NNS	lemma_2=concurrently	lemma_4=with	lemma_5=cyp3a4	lemma_10=as	lib=be	relType_3=advcl	pos_7=CC	pos_4=IN	relType_8=compound	relType_4=case	pos_10=IN	lemma_11=systemic	wib=is	pos_5=NN	pos_1=VBZ	lemma_9=inhibitor	lemma_7=and	pos_6=NNS	lpib=be_VBZ	pos_11=JJ	path=levobupivacaine_nsubj:pass<administer_advcl>rise_advcl>level_nsubj>levobupivacaine_compound
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e0	DDI-DrugBank.d454.s0.e1	effect	lemma_5=depressive	relType_1=aux	lemma_1=may	relType_7=case	relation_1=beneficial	relType_6=dep	eib=False	relation_5=neutral	wib=enhance	path1=lofexidine_nsubj	pos_2=VB	lib=enhance	lpib=enhance_VB	relType_4=iobj	relType_3=det	pos_4=NN	pos_5=JJ	relType_5=amod	relType_2=ROOT	lemma_4=cns	lemma_6=effect	pos_1=MD	lemma_2=enhance	lemma_7=of	path=lofexidine_nsubj<enhance_ROOT>cns_iobj>effect_dep>alcohol_nmod	pos_3=DT	pos_7=IN	pos_6=NNS	lemma_3=the	path2=cns_iobj>effect_dep>alcohol_nmod
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e0	DDI-DrugBank.d454.s0.e2	effect	lemma_5=depressive	relType_1=aux	lemma_1=may	relType_7=case	relType_8=punct	lemma_8=,	relation_1=beneficial	pos_8=NN	lemma_8=alcohol	relType_6=dep	relation_5=neutral	wib=enhance	path1=lofexidine_nsubj	pos_2=VB	lib=enhance	lpib=enhance_VB	relType_4=iobj	relType_3=det	pos_4=NN	pos_5=JJ	relType_5=amod	relType_2=ROOT	lemma_4=cns	lemma_6=effect	pos_1=MD	lemma_2=enhance	lemma_7=of	path=lofexidine_nsubj<enhance_ROOT>cns_iobj>effect_dep>alcohol_nmod>barbiturate_conj	path2=cns_iobj>effect_dep>alcohol_nmod>barbiturate_conj	eib=True	pos_3=DT	pos_7=IN	relType_8=nmod	pos_6=NNS	lemma_3=the	pos_8=,
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e0	DDI-DrugBank.d454.s0.e3	effect	path2=cns_iobj>effect_dep>alcohol_nmod>sedative_conj	relType_9=conj	lemma_5=depressive	relType_1=aux	lemma_1=may	relType_7=case	relType_10=amod	relType_8=punct	lemma_8=,	relation_1=beneficial	pos_8=NN	lemma_8=alcohol	relType_6=dep	lemma_9=barbiturate	relation_5=neutral	wib=enhance	pos_9=NNS	path1=lofexidine_nsubj	pos_2=VB	lib=enhance	lpib=enhance_VB	relType_4=iobj	relType_3=det	pos_4=NN	pos_5=JJ	lemma_9=and	pos_9=CC	relType_5=amod	relType_2=ROOT	pos_10=JJ	lemma_4=cns	lemma_6=effect	pos_1=MD	lemma_2=enhance	lemma_7=of	eib=True	pos_3=DT	pos_7=IN	relType_8=nmod	path=lofexidine_nsubj<enhance_ROOT>cns_iobj>effect_dep>alcohol_nmod>sedative_conj	lemma_10=other	pos_6=NNS	lemma_3=the	relType_9=cc	pos_8=,
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e1	DDI-DrugBank.d454.s0.e2	null	lemma_1=,	wib=barbiturates	eib=False	lib=barbiturate	path1=	path2=barbiturate_conj	pos_1=,	relType_1=punct	path=<alcohol_nmod>barbiturate_conj	lpib=barbiturate_NNS
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e1	DDI-DrugBank.d454.s0.e3	null	lemma_1=,	path1=	pos_1=,	relType_2=cc	lemma_3=other	lpib=barbiturate_NNS	lemma_2=and	path=<alcohol_nmod>sedative_conj	path2=sedative_conj	relType_2=conj	wib=barbiturates	relType_3=amod	lemma_2=barbiturate	pos_2=NNS	pos_3=JJ	eib=True	lib=barbiturate	pos_2=CC	relType_1=punct
DDI-DrugBank.d454.s0	DDI-DrugBank.d454.s0.e2	DDI-DrugBank.d454.s0.e3	null	relType_1=cc	pos_1=CC	path=barbiturate_conj<alcohol_nmod>sedative_conj	lib=other	eib=False	lpib=other_JJ	lemma_2=other	relType_2=amod	path1=barbiturate_conj	wib=other	path2=sedative_conj	pos_2=JJ	lemma_1=and
DDI-DrugBank.d454.s4	DDI-DrugBank.d454.s4.e0	DDI-DrugBank.d454.s4.e1	effect	relType_1=aux	lemma_1=may	lib=reduce	lemma_2=reduce	lemma_5=of	relType_5=case	path2=efficacy_obj>lofexidine_nmod	lemma_4=efficacy	eib=False	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	pos_4=NN	relType_4=obj	lpib=reduce_VB	relType_2=ROOT	pos_5=IN	pos_1=MD	path1=antidepressant_nmod<use_nsubj	path=antidepressant_nmod<use_nsubj<reduce_ROOT>efficacy_obj>lofexidine_nmod	pos_3=DT	lemma_3=the
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e0	DDI-DrugBank.d30.s0.e1	null	lib=digoxin	lemma_1=,	eib=False	path1=	path=<hydrochlorothiazide_nmod>digoxin_conj	path2=digoxin_conj	pos_1=,	relType_1=punct	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e0	DDI-DrugBank.d30.s0.e2	null	path2=warfarin_conj	lib=digoxin	path=<hydrochlorothiazide_nmod>warfarin_conj	lemma_1=,	pos_2=NN	relType_2=punct	eib=True	lemma_2=digoxin	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e0	DDI-DrugBank.d30.s0.e3	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	path=<hydrochlorothiazide_nmod>cimetidine_conj	relType_2=punct	relType_2=conj	lemma_2=,	lib=digoxin	lemma_3=,	relType_3=conj	lemma_3=warfarin	lemma_2=digoxin	relType_3=punct	lpib=digoxin_NN	wib=digoxin	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	path2=cimetidine_conj
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e0	DDI-DrugBank.d30.s0.e4	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_4=cc	relType_2=punct	path2=phenobarbital_conj	path=<hydrochlorothiazide_nmod>phenobarbital_conj	relType_2=conj	pos_4=NN	lemma_2=,	lib=digoxin	lemma_3=,	relType_3=conj	lemma_3=warfarin	lemma_2=digoxin	lpib=digoxin_NN	wib=digoxin	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=cimetidine	lemma_4=and	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e1	DDI-DrugBank.d30.s0.e2	null	lib=warfarin	path2=warfarin_conj	lemma_1=,	lpib=warfarin_NN	eib=False	path=digoxin_conj<hydrochlorothiazide_nmod>warfarin_conj	pos_1=,	wib=warfarin	relType_1=punct	path1=digoxin_conj
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e1	DDI-DrugBank.d30.s0.e3	null	lib=warfarin	lemma_2=warfarin	lemma_1=,	lpib=warfarin_NN	pos_2=NN	eib=True	pos_1=,	pos_2=,	wib=warfarin	relType_1=punct	path=digoxin_conj<hydrochlorothiazide_nmod>cimetidine_conj	relType_2=conj	path2=cimetidine_conj	lemma_2=,	relType_2=punct	path1=digoxin_conj
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e1	DDI-DrugBank.d30.s0.e4	null	lib=warfarin	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	lpib=warfarin_NN	path2=phenobarbital_conj	wib=warfarin	relType_2=conj	lemma_2=,	relType_3=conj	path=digoxin_conj<hydrochlorothiazide_nmod>phenobarbital_conj	lemma_2=warfarin	eib=True	pos_3=NN	pos_2=,	lemma_3=and	lemma_3=cimetidine	relType_1=punct	path1=digoxin_conj
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e2	DDI-DrugBank.d30.s0.e3	null	lemma_1=,	path2=cimetidine_conj	eib=False	pos_1=,	path1=warfarin_conj	relType_1=punct	lib=cimetidine	wib=cimetidine	lpib=cimetidine_NN	path=warfarin_conj<hydrochlorothiazide_nmod>cimetidine_conj
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e2	DDI-DrugBank.d30.s0.e4	null	lemma_2=and	path=warfarin_conj<hydrochlorothiazide_nmod>phenobarbital_conj	lemma_1=,	pos_2=NN	eib=True	path2=phenobarbital_conj	pos_2=CC	pos_1=,	path1=warfarin_conj	relType_2=conj	relType_1=punct	relType_2=cc	lib=cimetidine	lemma_2=cimetidine	wib=cimetidine	lpib=cimetidine_NN
DDI-DrugBank.d30.s0	DDI-DrugBank.d30.s0.e3	DDI-DrugBank.d30.s0.e4	null	relType_1=cc	pos_1=CC	eib=False	path=cimetidine_conj<hydrochlorothiazide_nmod>phenobarbital_conj	lpib=phenobarbital_NN	path2=phenobarbital_conj	wib=phenobarbital	path1=cimetidine_conj	lemma_1=and	lib=phenobarbital
DDI-DrugBank.d30.s1	DDI-DrugBank.d30.s1.e0	DDI-DrugBank.d30.s1.e1	mechanism	lpib=inducer_NN	wib=inducer	pos_2=DT	lemma_1=,	path=Rifampin_nsubj<decrease_ROOT>concentration_obj>losartan_nmod	pos_1=,	relType_5=compound	lemma_10=concentration	lemma_2=a	lemma_5=drug	relType_11=case	pos_6=NN	eib=False	relType_3=appos	lib=inducer	pos_7=,	pos_9=DT	relation_7=adverse	lemma_7=,	path1=Rifampin_nsubj	relType_10=obj	pos_8=VBD	pos_11=IN	lemma_8=decrease	pos_4=IN	relType_4=case	relType_8=ROOT	path2=concentration_obj>losartan_nmod	pos_5=NN	pos_3=NN	lemma_6=metabolism	relType_2=det	relType_7=punct	lemma_3=inducer	lemma_9=the	lemma_11=of	relType_1=punct	relType_6=nmod	lemma_4=of	pos_10=NNS	relType_9=det
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e0	DDI-DrugBank.d30.s3.e1	null	lemma_5=conversion	path=Ketoconazole_nsubj<affect_ROOT>conversion_obj>losartan_nmod	relType_1=aux	wib=did	lemma_6=of	pos_3=VB	relType_6=case	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_3=affect	relation_2=neutral	path1=Ketoconazole_nsubj	pos_4=DT	relType_3=ROOT	lemma_4=the	path2=conversion_obj>losartan_nmod	lpib=do_VBD	pos_5=NN	lib=do	relType_5=obj	relType_4=det	lemma_2=not
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e0	DDI-DrugBank.d30.s3.e2	null	lemma_5=conversion	pos_8=DT	relType_7=case	relType_1=aux	pos_7=NN	wib=did	lemma_6=of	pos_3=VB	lemma_11=after	relType_6=case	relType_11=case	pos_12=JJ	pos_2=RB	pos_9=JJ	relType_13=obl	pos_1=VBD	relType_10=nmod	lemma_12=intravenous	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_3=affect	relation_2=neutral	lemma_7=to	relType_12=amod	relType_9=amod	pos_10=NN	pos_13=NN	path1=Ketoconazole_nsubj	pos_11=IN	pos_14=IN	pos_4=DT	lemma_7=losartan	lemma_9=active	relType_3=ROOT	lemma_4=the	lemma_8=the	relType_7=nmod	lemma_10=metabolite	lpib=do_VBD	path=Ketoconazole_nsubj<affect_ROOT>administration_obl>losartan_nmod	path2=administration_obl>losartan_nmod	pos_5=NN	lib=do	eib=True	pos_7=IN	relType_5=obj	lemma_14=of	lemma_13=administration	relType_14=case	relType_8=det	relType_4=det	lemma_2=not
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e0	DDI-DrugBank.d30.s3.e3	null	relType_16=cc	lemma_5=conversion	pos_8=DT	relType_7=case	relType_1=aux	pos_7=NN	wib=did	lemma_6=of	pos_3=VB	lemma_11=after	pos_16=CC	relType_6=case	relType_11=case	pos_12=JJ	pos_2=RB	pos_9=JJ	relType_13=obl	pos_1=VBD	relType_10=nmod	lemma_12=intravenous	relType_2=advmod	lemma_1=do	pos_6=IN	lemma_3=affect	pos_15=,	lemma_7=to	lemma_15=losartan	relation_2=neutral	relType_12=amod	relType_9=amod	pos_10=NN	pos_13=NN	path2=have_conj>erythromycin_nsubj	relType_15=punct	path1=Ketoconazole_nsubj	pos_11=IN	pos_14=IN	pos_4=DT	lemma_7=losartan	lemma_9=active	pos_15=NN	lemma_15=,	relType_3=ROOT	lemma_4=the	lemma_8=the	relType_7=nmod	lemma_10=metabolite	lemma_16=and	lpib=do_VBD	relType_15=nmod	pos_5=NN	lib=do	eib=True	pos_7=IN	path=Ketoconazole_nsubj<affect_ROOT>have_conj>erythromycin_nsubj	relType_5=obj	lemma_14=of	lemma_13=administration	relType_14=case	relType_8=det	relType_4=det	lemma_2=not
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e1	DDI-DrugBank.d30.s3.e2	null	relType_8=case	pos_2=DT	relType_1=case	lib=active	lemma_2=the	pos_6=JJ	relType_4=nmod	lemma_5=after	relType_5=case	path=losartan_nmod<conversion_obj<affect_ROOT>administration_obl>losartan_nmod	eib=False	relType_6=amod	pos_1=IN	pos_4=NN	pos_8=IN	lemma_3=active	relType_3=amod	path1=losartan_nmod<conversion_obj	lemma_7=administration	pos_5=IN	lemma_4=metabolite	lemma_1=to	path2=administration_obl>losartan_nmod	lemma_6=intravenous	relType_7=obl	pos_3=JJ	relType_2=det	wib=active	lpib=active_JJ	pos_7=NN	lemma_8=of
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e1	DDI-DrugBank.d30.s3.e3	null	relType_8=case	pos_2=DT	relType_1=case	lib=active	lemma_2=the	pos_6=JJ	relType_10=cc	relType_4=nmod	lemma_5=after	relType_9=nmod	lemma_9=,	relType_5=case	pos_10=CC	relType_6=amod	pos_1=IN	path2=have_conj>erythromycin_nsubj	pos_4=NN	pos_9=NN	pos_8=IN	lemma_3=active	lemma_10=and	lemma_9=losartan	relType_3=amod	path1=losartan_nmod<conversion_obj	lemma_7=administration	pos_5=IN	lemma_4=metabolite	lemma_1=to	relType_9=punct	lemma_6=intravenous	relType_7=obl	pos_3=JJ	eib=True	relType_2=det	wib=active	lpib=active_JJ	pos_9=,	pos_7=NN	lemma_8=of	path=losartan_nmod<conversion_obj<affect_ROOT>have_conj>erythromycin_nsubj
DDI-DrugBank.d30.s3	DDI-DrugBank.d30.s3.e2	DDI-DrugBank.d30.s3.e3	null	lpib=erythromycin_NN	path=losartan_nmod<administration_obl<affect_ROOT>have_conj>erythromycin_nsubj	lemma_2=and	lemma_1=,	eib=False	path2=have_conj>erythromycin_nsubj	pos_2=CC	pos_1=,	wib=erythromycin	relType_1=punct	relType_2=cc	lib=erythromycin	path1=losartan_nmod<administration_obl
DDI-DrugBank.d30.s4	DDI-DrugBank.d30.s4.e0	DDI-DrugBank.d30.s4.e1	mechanism	pos_2=DT	lemma_1=,	relation_12=beneficial	wib=inhibitor	pos_1=,	relType_12=cc	relType_5=compound	lemma_2=a	lpib=inhibitor_NN	relType_11=obj	pos_12=CC	pos_6=NN	lemma_11=concentration	pos_9=JJ	pos_13=VBD	eib=False	relType_3=appos	pos_7=,	relation_7=adverse	relType_9=amod	relType_10=compound	pos_10=NN	lemma_7=,	relType_13=conj	lemma_3=inhibitor	pos_8=VBD	path=Fluconazole_nsubj<decrease_ROOT>increase_conj>concentration_obj>losartan_compound	lemma_9=active	lemma_8=decrease	pos_4=IN	relType_4=case	relType_8=ROOT	lemma_10=metabolite	path2=increase_conj>concentration_obj>losartan_compound	lemma_13=increase	pos_5=NN	pos_11=NN	pos_3=NN	relType_7=punct	relType_2=det	lemma_12=and	path1=Fluconazole_nsubj	lib=inhibitor	lemma_6=2c9	relType_1=punct	relType_6=nmod	lemma_4=of	lemma_5=p450
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e0	DDI-DrugBank.d30.s8.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>spironolactone_conj	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<diuretic_nmod>g._dep>spironolactone_conj	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e0	DDI-DrugBank.d30.s8.e2	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_5=spironolactone	lemma_1=(	lemma_3=g.	pos_4=,	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_5=NN	eib=True	pos_3=NN	path=<diuretic_nmod>g._dep>triamterene_conj	path2=g._dep>triamterene_conj	relType_1=punct
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e0	DDI-DrugBank.d30.s8.e3	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lemma_6=,	lib=e.	lemma_5=spironolactone	lemma_1=(	pos_6=NN	relType_6=conj	lemma_6=triamterene	lemma_3=g.	pos_4=,	relType_6=punct	relType_4=punct	path2=g._dep>amiloride_conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	path=<diuretic_nmod>g._dep>amiloride_conj	pos_3=NN	relType_1=punct
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e0	DDI-DrugBank.d30.s8.e4	null	relType_3=dep	pos_2=NN	pos_5=,	path1=	lemma_6=,	relType_8=punct	lib=e.	path=<diuretic_nmod>supplement_conj>potassium_compound	lemma_8=,	lemma_5=spironolactone	lemma_1=(	pos_6=NN	relType_6=conj	lemma_6=triamterene	lemma_7=amiloride	lemma_3=g.	pos_4=,	relType_6=punct	path2=supplement_conj>potassium_compound	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	relType_5=conj	pos_7=-RRB-	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_1=punct	pos_7=NN	lemma_7=)	relType_7=conj
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e1	DDI-DrugBank.d30.s8.e2	null	lpib=triamterene_NN	lemma_1=,	path=spironolactone_conj<g._dep>triamterene_conj	wib=triamterene	eib=False	path2=triamterene_conj	path1=spironolactone_conj	pos_1=,	relType_1=punct	lib=triamterene
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e1	DDI-DrugBank.d30.s8.e3	null	lpib=triamterene_NN	path2=amiloride_conj	path=spironolactone_conj<g._dep>amiloride_conj	lemma_1=,	relType_2=punct	pos_2=NN	wib=triamterene	eib=True	path1=spironolactone_conj	pos_1=,	pos_2=,	lemma_2=triamterene	relType_1=punct	relType_2=conj	lemma_2=,	lib=triamterene
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e1	DDI-DrugBank.d30.s8.e4	null	lemma_1=,	pos_2=NN	pos_1=,	path1=spironolactone_conj<g._dep	lemma_2=triamterene	relType_2=punct	lpib=triamterene_NN	pos_4=,	relType_2=conj	lemma_2=,	path2=supplement_conj>potassium_compound	path=spironolactone_conj<g._dep<diuretic_nmod>supplement_conj>potassium_compound	relType_4=punct	wib=triamterene	relType_3=conj	lemma_3=amiloride	lemma_4=,	lemma_3=)	eib=True	pos_3=-RRB-	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=triamterene
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e2	DDI-DrugBank.d30.s8.e3	null	path=triamterene_conj<g._dep>amiloride_conj	path2=amiloride_conj	lemma_1=,	eib=False	path1=triamterene_conj	pos_1=,	relType_1=punct	lpib=amiloride_NN	wib=amiloride	lib=amiloride
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e2	DDI-DrugBank.d30.s8.e4	null	lemma_2=)	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	lemma_2=amiloride	lpib=amiloride_NN	relType_2=conj	path=triamterene_conj<g._dep<diuretic_nmod>supplement_conj>potassium_compound	path2=supplement_conj>potassium_compound	lemma_3=,	lib=amiloride	pos_3=,	eib=True	pos_2=-RRB-	path1=triamterene_conj<g._dep	relType_1=punct	relType_3=punct	wib=amiloride
DDI-DrugBank.d30.s8	DDI-DrugBank.d30.s8.e3	DDI-DrugBank.d30.s8.e4	null	path2=supplement_conj>potassium_compound	lib=potassium	eib=False	path=amiloride_conj<g._dep<diuretic_nmod>supplement_conj>potassium_compound	pos_1=-RRB-	path1=amiloride_conj<g._dep	pos_2=,	wib=potassium	relType_1=punct	lemma_1=)	lpib=potassium_NN	lemma_2=,	relType_2=punct
DDI-DrugBank.d30.s9	DDI-DrugBank.d30.s9.e0	DDI-DrugBank.d30.s9.e1	null	pos_2=DT	lemma_1=,	lemma_2=the	lib=antihypertensive	pos_1=,	lemma_3=antihypertensive	lemma_5=of	relType_5=case	eib=False	path=agent_obl<blunt_ROOT>effect_nsubj:pass>losartan_nmod	wib=antihypertensive	relType_4=nsubj:pass	pos_4=NN	relation_3=neutral	relType_3=amod	path2=effect_nsubj:pass>losartan_nmod	pos_5=IN	lemma_4=effect	pos_3=JJ	relType_2=det	path1=agent_obl	lpib=antihypertensive_JJ	relType_1=punct
DDI-DrugBank.d30.s9	DDI-DrugBank.d30.s9.e0	DDI-DrugBank.d30.s9.e3	null	pos_2=DT	pos_7=VB	lemma_1=,	lemma_2=the	relType_10=det	lemma_6=may	pos_8=VBN	lemma_7=be	lib=antihypertensive	path=agent_obl<blunt_ROOT>indomethacin_obl	pos_1=,	lemma_3=antihypertensive	pos_9=IN	lemma_11=-	lemma_11=drug	lemma_5=of	relType_5=case	pos_11=HYPH	pos_6=NN	lemma_9=by	lemma_11=anti	relType_11=punct	relType_11=amod	wib=antihypertensive	lemma_6=losartan	relType_4=nsubj:pass	lemma_10=the	relType_9=case	pos_4=NN	relation_3=neutral	relType_3=amod	pos_11=AFX	relType_6=aux	lemma_11=non	pos_5=IN	relType_7=aux:pass	relType_8=ROOT	lemma_11=steroidal	pos_6=MD	lemma_11=inflammatory	lemma_4=effect	pos_3=JJ	lemma_8=blunt	eib=True	path2=indomethacin_obl	relType_11=obl:npmod	pos_11=NN	relType_11=compound	relType_2=det	path1=agent_obl	lpib=antihypertensive_JJ	pos_11=JJ	relType_1=punct	relType_6=nmod	pos_10=DT
DDI-DrugBank.d30.s9	DDI-DrugBank.d30.s9.e1	DDI-DrugBank.d30.s9.e3	effect	lemma_6=drug	pos_6=JJ	path=losartan_nmod<effect_nsubj:pass<blunt_ROOT>indomethacin_obl	relType_1=aux	lemma_1=may	lemma_3=blunt	pos_3=VBN	lemma_6=inflammatory	pos_6=HYPH	lemma_6=non	wib=be	pos_6=NN	relType_6=punct	relType_6=amod	pos_6=AFX	pos_2=VB	lemma_6=-	path1=losartan_nmod<effect_nsubj:pass	lib=be	relType_3=ROOT	pos_4=IN	relType_5=det	relType_4=case	relType_2=aux:pass	relType_6=obl:npmod	pos_1=MD	lemma_6=steroidal	lpib=be_VB	relType_6=compound	lemma_5=the	eib=True	path2=indomethacin_obl	pos_5=DT	lemma_2=be	lemma_4=by	lemma_6=anti
DDI-DrugBank.d746.s0	DDI-DrugBank.d746.s0.e0	DDI-DrugBank.d746.s0.e1	null	lemma_7=digitalized	relType_12=obl	relType_1=aux	pos_3=VBN	lemma_12=combination	lemma_1=should	lemma_9=,	relType_3=csubj	relType_6=case	pos_8=NNS	relType_8=obl	wib=be	lemma_13=of	lemma_3=use	eib=False	path1=ARAMINE_nsubj:pass	pos_6=IN	pos_2=VB	lemma_10=since	lemma_6=in	relType_10=case	pos_13=IN	lemma_5=caution	lemma_4=with	relType_13=case	relType_7=amod	lib=be	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_10=IN	pos_1=MD	pos_11=DT	relType_9=punct	lpib=be_VB	lemma_11=the	relType_11=det	pos_5=NN	path2=combination_obl>digitalis_nmod	pos_7=JJ	lemma_2=be	lemma_8=patient	pos_9=,	pos_12=NN	path=ARAMINE_nsubj:pass<use_csubj>combination_obl>digitalis_nmod
DDI-DrugBank.d746.s0	DDI-DrugBank.d746.s0.e0	DDI-DrugBank.d746.s0.e2	null	lemma_7=digitalized	relType_12=obl	pos_14=CC	pos_15=JJ	relType_1=aux	relType_15=amod	pos_3=VBN	lemma_12=combination	lemma_1=should	lemma_9=,	relType_14=nmod	relType_3=csubj	relType_6=case	pos_8=NNS	path=ARAMINE_nsubj:pass<use_csubj>combination_obl>digitalis_nmod>amine_conj	relType_8=obl	wib=be	lemma_13=of	lemma_3=use	path1=ARAMINE_nsubj:pass	pos_6=IN	pos_2=VB	pos_14=NN	lemma_10=since	lemma_6=in	relType_10=case	pos_13=IN	lemma_5=caution	lemma_4=with	relType_13=case	relType_7=amod	lib=be	pos_4=IN	lemma_14=digitalis	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_10=IN	pos_1=MD	pos_11=DT	relType_14=cc	relType_9=punct	lpib=be_VB	lemma_11=the	relType_11=det	pos_5=NN	eib=True	pos_7=JJ	lemma_14=and	lemma_2=be	lemma_8=patient	pos_9=,	pos_12=NN	lemma_15=sympathomimetic	path2=combination_obl>digitalis_nmod>amine_conj
DDI-DrugBank.d746.s0	DDI-DrugBank.d746.s0.e1	DDI-DrugBank.d746.s0.e2	effect	relType_1=cc	path=<digitalis_nmod>amine_conj	pos_1=CC	lib=sympathomimetic	lemma_1=and	eib=True	lemma_2=sympathomimetic	path2=amine_conj	relType_2=amod	path1=	lpib=sympathomimetic_JJ	pos_2=JJ	wib=sympathomimetic
DDI-DrugBank.d746.s1	DDI-DrugBank.d746.s1.e0	DDI-DrugBank.d746.s1.e1	null	path2=antidepressant_conj	relType_1=cc	pos_1=CC	eib=True	lpib=tricyclic_JJ	path=<inhibitor_nsubj>antidepressant_conj	relType_2=amod	path1=	lib=tricyclic	lemma_2=tricyclic	pos_2=JJ	wib=tricyclic	lemma_1=or
DDI-DrugBank.d746.s1	DDI-DrugBank.d746.s1.e0	DDI-DrugBank.d746.s1.e2	effect	relType_1=cc	pos_1=CC	relation_4=beneficial	path=inhibitor_nsubj<potentiate_ROOT>action_obj>amine_nmod	relation_4=adverse	lemma_5=action	pos_2=MD	lemma_6=of	pos_3=VB	pos_2=JJ	wib=tricyclic	relType_6=case	pos_6=IN	lemma_2=tricyclic	relType_2=aux	lemma_3=potentiate	relType_2=conj	pos_4=DT	relType_7=amod	lpib=tricyclic_JJ	relType_3=ROOT	lemma_4=the	relType_2=amod	lemma_7=sympathomimetic	lib=tricyclic	lemma_2=antidepressant	path1=inhibitor_nsubj	pos_2=NNS	pos_5=NN	eib=True	relType_5=obj	pos_7=JJ	lemma_2=may	path2=action_obj>amine_nmod	relType_4=det	lemma_1=or
DDI-DrugBank.d746.s1	DDI-DrugBank.d746.s1.e1	DDI-DrugBank.d746.s1.e2	effect	path=antidepressant_conj<inhibitor_nsubj<potentiate_ROOT>action_obj>amine_nmod	pos_6=JJ	wib=potentiate	relType_1=aux	lemma_1=may	lib=potentiate	lemma_6=sympathomimetic	path1=antidepressant_conj<inhibitor_nsubj	lemma_5=of	relType_5=case	relation_1=beneficial	lemma_4=action	relType_6=amod	relation_1=adverse	pos_2=VB	lpib=potentiate_VB	relType_3=det	pos_4=NN	relType_4=obj	relType_2=ROOT	pos_5=IN	pos_1=MD	eib=True	pos_3=DT	lemma_3=the	path2=action_obj>amine_nmod	lemma_2=potentiate
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e0	DDI-DrugBank.d630.s1.e1	advise	relType_1=cc	path=aspirin_obj<receive_acl<patient_obl>methazolamide_conj	pos_1=CC	eib=False	wib=methazolamide	path1=aspirin_obj<receive_acl	path2=methazolamide_conj	lemma_1=and	lpib=methazolamide_NN	lib=methazolamide
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e0	DDI-DrugBank.d630.s1.e2	null	relType_1=cc	pos_2=NN	lemma_10=,	lemma_6=,	relType_8=punct	pos_12=CC	pos_13=NN	relType_23=compound	relType_22=punct	lemma_14=have	pos_16=VBN	lemma_22=-	lemma_3=,	lemma_18=concomitant	lemma_5=anorexia	pos_3=,	pos_10=,	relType_19=obl	lemma_2=methazolamide	lpib=methazolamide_NN	lemma_20=of	pos_21=JJ	lemma_19=use	lemma_7=tachypnea	relType_20=case	path2=report_dep>use_obl>aspirin_nmod	wib=methazolamide	relType_13=conj	pos_15=VBN	relType_2=conj	pos_9=NN	lib=methazolamide	relType_15=aux:pass	pos_5=NN	pos_11=NN	path1=aspirin_obj<receive_acl<patient_obl	lemma_16=report	pos_7=NN	relType_3=punct	lemma_1=and	pos_8=,	relType_10=punct	pos_14=VBP	relType_12=cc	lemma_8=,	relType_11=conj	pos_20=IN	pos_17=IN	pos_23=NN	lemma_17=with	relType_17=case	pos_22=HYPH	path=aspirin_obj<receive_acl<patient_obl<advise_ROOT>report_dep>use_obl>aspirin_nmod	pos_4=IN	relType_5=obl	lemma_2=concomitantly	lemma_15=be	lemma_12=and	lemma_4=as	relType_7=conj	pos_1=CC	relType_9=conj	relType_18=amod	lemma_13=death	pos_2=RB	relType_2=advmod	relType_6=punct	relType_21=amod	pos_18=JJ	pos_19=NN	relType_4=case	relType_14=aux	lemma_9=lethargy	lemma_21=high	pos_6=,	eib=True	relType_16=dep	lemma_11=coma	lemma_23=dose
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e0	DDI-DrugBank.d630.s1.e3	null	relType_1=cc	pos_2=NN	lemma_10=,	lemma_6=,	relType_8=punct	pos_12=CC	pos_13=NN	relType_23=compound	relType_22=punct	lemma_14=have	pos_16=VBN	lemma_22=-	lemma_3=,	lemma_18=concomitant	lemma_5=anorexia	pos_3=,	pos_10=,	path2=report_dep>use_obl>aspirin_nmod>inhibitor_conj	relType_19=obl	lemma_2=methazolamide	lpib=methazolamide_NN	lemma_20=of	pos_21=JJ	lemma_19=use	lemma_7=tachypnea	relType_20=case	relType_25=amod	pos_24=CC	wib=methazolamide	relType_13=conj	pos_15=VBN	relType_2=conj	pos_9=NN	lib=methazolamide	relType_15=aux:pass	lemma_24=and	pos_5=NN	pos_11=NN	path1=aspirin_obj<receive_acl<patient_obl	lemma_16=report	pos_7=NN	relType_3=punct	lemma_1=and	pos_8=,	relType_10=punct	pos_14=VBP	relType_12=cc	pos_24=NN	lemma_8=,	relType_11=conj	pos_20=IN	pos_17=IN	pos_23=NN	lemma_24=aspirin	lemma_17=with	path=aspirin_obj<receive_acl<patient_obl<advise_ROOT>report_dep>use_obl>aspirin_nmod>inhibitor_conj	relType_17=case	pos_22=HYPH	relType_25=compound	pos_4=IN	pos_25=NN	relType_5=obl	lemma_2=concomitantly	lemma_15=be	lemma_12=and	lemma_4=as	relType_7=conj	pos_1=CC	relType_9=conj	relType_18=amod	lemma_13=death	pos_2=RB	relType_2=advmod	relType_6=punct	relType_21=amod	pos_18=JJ	pos_19=NN	relType_24=cc	lemma_25=anhydrase	pos_25=JJ	relType_4=case	relType_24=nmod	relType_14=aux	lemma_25=carbonic	lemma_9=lethargy	lemma_21=high	pos_6=,	eib=True	relType_16=dep	lemma_11=coma	lemma_23=dose
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e1	DDI-DrugBank.d630.s1.e2	null	pos_19=IN	path1=methazolamide_conj<patient_obl	relType_12=conj	relType_22=compound	pos_3=IN	relType_11=cc	lemma_21=-	pos_16=IN	pos_5=,	lemma_10=coma	pos_22=NN	wib=concomitantly	lpib=concomitantly_RB	lemma_15=report	lemma_22=dose	lemma_9=,	pos_17=JJ	pos_13=VBP	relType_2=punct	lemma_3=as	pos_6=NN	pos_8=NN	relType_20=amod	pos_21=HYPH	relType_6=conj	relType_18=obl	eib=False	relType_10=conj	lemma_1=concomitantly	path2=report_dep>use_obl>aspirin_nmod	relType_15=dep	pos_7=,	relType_13=aux	relType_14=aux:pass	lemma_4=anorexia	pos_10=NN	lemma_7=,	pos_15=VBN	pos_4=NN	lemma_2=,	relType_1=advmod	lemma_13=have	lemma_14=be	lemma_16=with	pos_18=NN	lemma_19=of	pos_20=JJ	relType_4=obl	lemma_17=concomitant	lemma_11=and	lemma_5=,	relType_5=punct	pos_11=CC	path=methazolamide_conj<patient_obl<advise_ROOT>report_dep>use_obl>aspirin_nmod	lemma_20=high	relType_9=punct	relType_3=case	lemma_12=death	relType_17=amod	lemma_6=tachypnea	pos_14=VBN	lib=concomitantly	relType_16=case	relType_19=case	pos_1=RB	relType_7=punct	lemma_18=use	relType_8=conj	pos_2=,	relType_21=punct	pos_9=,	pos_12=NN	lemma_8=lethargy
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e1	DDI-DrugBank.d630.s1.e3	null	relType_22=compound	relType_11=cc	lemma_21=-	pos_5=,	wib=concomitantly	lpib=concomitantly_RB	lemma_15=report	lemma_9=,	pos_13=VBP	pos_6=NN	relType_6=conj	pos_10=NN	lemma_7=,	pos_20=JJ	pos_18=NN	path=methazolamide_conj<patient_obl<advise_ROOT>report_dep>use_obl>aspirin_nmod>inhibitor_conj	relType_24=compound	lemma_11=and	lemma_5=,	lemma_6=tachypnea	pos_14=VBN	path2=report_dep>use_obl>aspirin_nmod>inhibitor_conj	relType_8=conj	pos_2=,	relType_21=punct	lemma_8=lethargy	path1=methazolamide_conj<patient_obl	pos_22=NN	relType_2=punct	lemma_3=as	pos_8=NN	relType_10=conj	lemma_4=anorexia	pos_15=VBN	lemma_2=,	relType_4=obl	lemma_12=death	relType_17=amod	relType_24=amod	relType_16=case	relType_19=case	lemma_18=use	pos_9=,	lemma_13=have	lemma_23=and	pos_3=IN	pos_16=IN	pos_24=NN	lemma_22=dose	pos_24=JJ	pos_23=NN	pos_21=HYPH	relType_20=amod	pos_23=CC	lemma_24=anhydrase	relType_18=obl	lemma_1=concomitantly	relType_15=dep	lemma_23=aspirin	pos_7=,	relType_14=aux:pass	lemma_16=with	relType_23=nmod	lemma_14=be	lemma_19=of	lemma_17=concomitant	pos_11=CC	lib=concomitantly	pos_1=RB	pos_19=IN	relType_12=conj	lemma_10=coma	pos_17=JJ	relType_13=aux	pos_4=NN	relType_1=advmod	relType_5=punct	relType_23=cc	lemma_20=high	relType_9=punct	relType_3=case	lemma_24=carbonic	eib=True	relType_7=punct	pos_12=NN
DDI-DrugBank.d630.s1	DDI-DrugBank.d630.s1.e2	DDI-DrugBank.d630.s1.e3	effect	relType_1=cc	pos_1=CC	wib=carbonic	pos_2=NN	eib=True	lemma_2=carbonic	relType_2=compound	lib=carbonic	relType_2=amod	path1=	lpib=carbonic_JJ	path2=inhibitor_conj	pos_2=JJ	path=<aspirin_nmod>inhibitor_conj	lemma_1=and	lemma_2=anhydrase
DDI-DrugBank.d756.s0	DDI-DrugBank.d756.s0.e0	DDI-DrugBank.d756.s0.e1	effect	relType_1=aux	pos_3=VBN	path1=opioid_nmod<dosage_nsubj:pass	lemma_1=should	wib=be	pos_6=NN	relType_6=obl	eib=False	pos_7=,	pos_2=VB	lemma_6=half	lemma_7=,	lemma_8=because	pos_8=IN	lemma_3=reduce	lib=be	relType_3=ROOT	pos_4=IN	relType_8=mark	path=opioid_nmod<dosage_nsubj:pass<reduce_ROOT>amplify_advcl>levomepromazine_nsubj	relType_4=case	relType_2=aux:pass	pos_5=RB	lemma_5=approximately	pos_1=MD	lpib=be_VB	relType_5=advmod	relation_2=adverse	relType_7=punct	lemma_2=be	path2=amplify_advcl>levomepromazine_nsubj	lemma_4=by
DDI-DrugBank.d756.s0	DDI-DrugBank.d756.s0.e0	DDI-DrugBank.d756.s0.e2	null	relType_1=aux	relType_10=det	pos_3=VBN	pos_9=VBZ	path1=opioid_nmod<dosage_nsubj:pass	lemma_1=should	relType_14=compound	pos_16=NNS	pos_15=HYPH	wib=be	pos_6=NN	relType_6=obl	pos_17=IN	relType_9=advcl	lemma_11=therapeutic	relType_11=amod	pos_7=,	lemma_10=the	path=opioid_nmod<dosage_nsubj:pass<reduce_ROOT>amplify_advcl>action_obj>effect_conj>opioid_nmod	pos_2=VB	lemma_6=half	lemma_9=amplify	relType_12=obj	lemma_7=,	lemma_8=because	pos_9=NN	lemma_13=and	pos_8=IN	lemma_12=action	pos_14=NN	relType_13=cc	lemma_15=-	relType_15=punct	lemma_3=reduce	relType_17=case	lib=be	relType_3=ROOT	pos_12=NNS	pos_4=IN	relType_8=mark	lemma_14=side	pos_5=RB	relType_4=case	relType_2=aux:pass	lemma_5=approximately	lemma_17=of	pos_1=MD	lemma_16=effect	lpib=be_VB	relType_5=advmod	pos_13=CC	eib=True	relType_9=nsubj	relation_2=adverse	relation_16=neutral	relType_7=punct	lemma_9=levomepromazine	lemma_2=be	pos_11=JJ	path2=amplify_advcl>action_obj>effect_conj>opioid_nmod	lemma_4=by	relType_16=conj	pos_10=DT
DDI-DrugBank.d756.s0	DDI-DrugBank.d756.s0.e1	DDI-DrugBank.d756.s0.e2	effect	pos_2=DT	lemma_2=the	pos_5=CC	relType_1=advcl	lpib=amplify_VBZ	pos_9=IN	pos_8=NNS	pos_6=NN	lemma_7=-	relType_5=cc	eib=False	wib=amplifies	lemma_4=action	lemma_3=therapeutic	relType_9=case	pos_4=NNS	relType_4=obj	lemma_1=amplify	lemma_6=side	path=levomepromazine_nsubj<amplify_advcl>action_obj>effect_conj>opioid_nmod	relType_3=amod	pos_7=HYPH	path1=levomepromazine_nsubj	path2=action_obj>effect_conj>opioid_nmod	relation_7=neutral	relType_6=compound	pos_3=JJ	pos_1=VBZ	lemma_5=and	lemma_9=of	relType_7=punct	relType_2=det	lemma_8=effect	relType_8=conj	lib=amplify
DDI-DrugBank.d756.s1	DDI-DrugBank.d756.s1.e0	DDI-DrugBank.d756.s1.e1	null	lemma_1=(	path=<tramadol_nmod>Ultram_appos	lpib=ultram_NNP	path2=Ultram_appos	eib=False	lib=ultram	path1=	relType_1=punct	wib=Ultram	pos_1=-LRB-
DDI-DrugBank.d756.s2	DDI-DrugBank.d756.s2.e0	DDI-DrugBank.d756.s2.e1	effect	pos_2=VBN	lib=be	pos_1=VBZ	pos_3=IN	eib=False	path=levomepromazine_nsubj:pass<give_advcl>benzodiazepine_obl	relType_1=aux:pass	lemma_1=be	lpib=be_VBZ	path1=levomepromazine_nsubj:pass	lemma_2=give	relType_2=advcl	lemma_3=with	relType_3=case	wib=is	path2=benzodiazepine_obl
DDI-DrugBank.d756.s2	DDI-DrugBank.d756.s2.e0	DDI-DrugBank.d756.s2.e2	effect	pos_2=VBN	pos_3=IN	path2=benzodiazepine_obl>barbiturate_conj	relType_1=aux:pass	path1=levomepromazine_nsubj:pass	relType_2=advcl	relType_4=cc	path=levomepromazine_nsubj:pass<give_advcl>benzodiazepine_obl>barbiturate_conj	lemma_1=be	lemma_2=give	pos_4=NNS	relType_4=obl	lib=be	lemma_4=or	lemma_3=with	relType_3=case	lemma_4=benzodiazepine	wib=is	pos_1=VBZ	eib=True	pos_4=CC	lpib=be_VBZ
DDI-DrugBank.d756.s2	DDI-DrugBank.d756.s2.e1	DDI-DrugBank.d756.s2.e2	null	relType_1=cc	path=<benzodiazepine_obl>barbiturate_conj	pos_1=CC	wib=barbiturates	eib=False	lib=barbiturate	path1=	path2=barbiturate_conj	lemma_1=or	lpib=barbiturate_NNS
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e0	DDI-DrugBank.d756.s4.e1	advise	lemma_3=anticholinergic	lemma_1=with	relType_1=case	pos_3=JJ	relType_3=amod	lib=other	eib=True	lpib=other_JJ	lemma_2=other	path=<levomepromazine_obl>drug_nmod	path1=	relType_2=amod	wib=other	pos_1=IN	path2=drug_nmod	pos_2=JJ
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e0	DDI-DrugBank.d756.s4.e2	advise	relType_4=amod	relType_1=case	pos_4=JJ	lemma_3=drug	lib=other	path1=	pos_2=JJ	pos_3=NNS	lemma_2=other	lemma_4=tricyclic	path=<levomepromazine_obl>drug_nmod>antidepressant_appos	wib=other	lemma_3=(	pos_1=IN	pos_3=-LRB-	lemma_3=anticholinergic	relType_3=amod	lpib=other_JJ	relType_2=amod	relType_3=nmod	path2=drug_nmod>antidepressant_appos	lemma_1=with	pos_3=JJ	eib=True	relType_3=punct
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e0	DDI-DrugBank.d756.s4.e3	advise	relType_4=amod	relType_1=case	pos_4=JJ	lemma_3=drug	lib=other	relType_4=appos	path1=	relType_4=cc	pos_2=JJ	pos_3=NNS	lemma_2=other	lemma_4=tricyclic	pos_5=HYPH	lemma_3=(	wib=other	pos_1=IN	pos_3=-LRB-	pos_4=NNS	path2=drug_nmod>antidepressant_appos>agent_conj	lemma_3=anticholinergic	pos_5=JJ	lemma_5=antiparkinsonian	relType_5=amod	relType_3=amod	lpib=other_JJ	relType_5=punct	relType_2=amod	relType_3=nmod	lemma_4=antidepressant	lemma_1=with	pos_3=JJ	eib=True	pos_4=CC	lemma_4=and	lemma_5=-	path=<levomepromazine_obl>drug_nmod>antidepressant_appos>agent_conj	relType_3=punct
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e1	DDI-DrugBank.d756.s4.e2	null	lemma_1=(	eib=True	lpib=tricyclic_JJ	relType_2=amod	path1=	lib=tricyclic	path=<drug_nmod>antidepressant_appos	lemma_2=tricyclic	relType_1=punct	path2=antidepressant_appos	pos_2=JJ	wib=tricyclic	pos_1=-LRB-
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e1	DDI-DrugBank.d756.s4.e3	null	path=<drug_nmod>antidepressant_appos>agent_conj	path1=	relType_2=cc	pos_2=JJ	wib=tricyclic	lemma_1=(	lemma_2=and	lemma_3=antiparkinsonian	lemma_3=-	path2=antidepressant_appos>agent_conj	lemma_2=tricyclic	relType_3=amod	lpib=tricyclic_JJ	relType_2=amod	lib=tricyclic	lemma_2=antidepressant	relType_2=appos	pos_1=-LRB-	pos_2=NNS	pos_3=JJ	eib=True	pos_3=HYPH	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d756.s4	DDI-DrugBank.d756.s4.e2	DDI-DrugBank.d756.s4.e3	null	relType_1=cc	pos_1=CC	eib=True	lemma_2=-	lib=antiparkinsonian	path2=agent_conj	relType_2=amod	path1=	wib=antiparkinsonian	lpib=antiparkinsonian_JJ	lemma_2=antiparkinsonian	path=<antidepressant_appos>agent_conj	pos_2=HYPH	pos_2=JJ	lemma_1=and	relType_2=punct
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e0	DDI-DrugBank.d756.s7.e1	null	lpib=stimulante_NNS	relType_1=cc	pos_1=CC	lemma_2=/	pos_3=CC	pos_6=DT	path1=	lemma_4=stimulante	path2=type_nmod>amphetamine_compound>ephedrine_compound	pos_2=HYPH	lib=stimulante	lemma_5=of	path=<caffeine_nsubj>type_nmod>amphetamine_compound>ephedrine_compound	relType_5=case	relType_3=cc	relType_2=punct	eib=False	lemma_6=the	lemma_3=or	pos_4=NNS	wib=stimulantes	pos_5=IN	relType_6=det	relType_4=conj	lemma_1=and
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e0	DDI-DrugBank.d756.s7.e2	null	lpib=stimulante_NNS	relType_1=cc	pos_1=CC	relType_7=compound	lemma_2=/	pos_3=CC	pos_6=DT	path1=	lemma_7=/	lemma_4=stimulante	pos_2=HYPH	lib=stimulante	lemma_5=of	relType_5=case	lemma_7=ephedrine	relType_2=punct	relType_3=cc	lemma_6=the	lemma_3=or	pos_4=NNS	path=<caffeine_nsubj>type_nmod>amphetamine_compound	path2=type_nmod>amphetamine_compound	pos_7=HYPH	wib=stimulantes	pos_5=IN	relType_6=det	eib=True	relType_7=punct	relType_4=conj	pos_7=NN	lemma_1=and
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e0	DDI-DrugBank.d756.s7.e3	effect	lpib=stimulante_NNS	relType_1=cc	pos_1=CC	relType_7=compound	lemma_13=action	lemma_2=/	pos_3=CC	pos_6=DT	pos_13=NNS	lemma_7=/	lemma_4=stimulante	relType_9=aux	pos_2=HYPH	lib=stimulante	lemma_5=of	relType_5=case	lemma_7=ephedrine	lemma_10=counteract	relType_3=cc	relType_2=punct	pos_8=NN	pos_12=JJ	relation_11=adverse	lemma_6=the	path2=action_obj>levomepromazine_nmod	lemma_12=specific	pos_9=MD	relType_12=amod	lemma_3=or	pos_10=VB	pos_4=NNS	pos_14=IN	relType_10=ROOT	path=caffeine_nsubj<counteract_ROOT>action_obj>levomepromazine_nmod	pos_7=HYPH	lemma_8=type	relType_8=compound	wib=stimulantes	pos_5=IN	lemma_9=may	pos_11=DT	lemma_11=the	relType_11=det	relType_6=det	path1=caffeine_nsubj	eib=True	lemma_8=amphetamine	relType_8=nmod	relType_7=punct	lemma_14=of	relType_4=conj	relType_13=obj	relType_14=case	pos_7=NN	lemma_1=and
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e1	DDI-DrugBank.d756.s7.e2	null	lpib=amphetamine_NN	eib=False	path=ephedrine_compound<amphetamine_compound>	path2=	lib=amphetamine	pos_1=HYPH	relType_1=punct	lemma_1=/	path1=ephedrine_compound	wib=amphetamine
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e1	DDI-DrugBank.d756.s7.e3	effect	pos_7=NNS	relType_8=case	pos_2=NN	pos_6=JJ	relation_4=adverse	lemma_2=type	lemma_3=may	lemma_4=counteract	lib=amphetamine	pos_1=HYPH	lemma_7=action	relType_2=nmod	lemma_6=specific	relType_6=amod	path2=action_obj>levomepromazine_nmod	path=ephedrine_compound<amphetamine_compound<type_nmod<caffeine_nsubj<counteract_ROOT>action_obj>levomepromazine_nmod	pos_3=MD	relType_7=obj	lemma_2=amphetamine	pos_8=IN	lpib=amphetamine_NN	relType_2=compound	relType_5=det	relType_4=ROOT	lemma_1=/	lemma_5=the	eib=True	pos_4=VB	pos_5=DT	path1=ephedrine_compound<amphetamine_compound<type_nmod<caffeine_nsubj	relType_3=aux	relType_1=punct	lemma_8=of	wib=amphetamine
DDI-DrugBank.d756.s7	DDI-DrugBank.d756.s7.e2	DDI-DrugBank.d756.s7.e3	effect	relType_7=case	pos_2=MD	path1=amphetamine_compound<type_nmod<caffeine_nsubj	pos_3=VB	eib=False	lemma_5=specific	lemma_1=type	path2=action_obj>levomepromazine_nmod	relType_2=aux	relType_1=nmod	pos_1=NN	lpib=type_NN	wib=type	pos_4=DT	pos_5=JJ	lemma_3=counteract	relType_5=amod	relType_3=ROOT	path=amphetamine_compound<type_nmod<caffeine_nsubj<counteract_ROOT>action_obj>levomepromazine_nmod	lemma_4=the	lemma_6=action	lemma_7=of	relType_6=obj	lib=type	pos_7=IN	relation_2=adverse	pos_6=NNS	lemma_2=may	relType_4=det
DDI-DrugBank.d736.s1	DDI-DrugBank.d736.s1.e0	DDI-DrugBank.d736.s1.e1	null	relType_1=cc	wib=ACTH	pos_1=CC	lpib=acth_NN	eib=False	path1=	lib=acth	path=<steroid_nmod>acth_conj	path2=acth_conj	lemma_1=or
DDI-DrugBank.d736.s3	DDI-DrugBank.d736.s3.e0	DDI-DrugBank.d736.s3.e1	effect	relType_1=aux	lemma_1=may	path2=responsiveness_obj>norepinephrine_nmod	path1=thiazide_nsubj	relType_5=case	eib=False	relation_1=adverse	lpib=decrease_VB	pos_2=VB	pos_4=NN	relType_4=obj	relType_3=amod	relType_2=ROOT	wib=decrease	pos_5=IN	lemma_5=to	pos_1=MD	lemma_3=arterial	path=thiazide_nsubj<decrease_ROOT>responsiveness_obj>norepinephrine_nmod	pos_3=JJ	lemma_2=decrease	lemma_4=responsiveness	lib=decrease
DDI-DrugBank.d736.s5	DDI-DrugBank.d736.s5.e0	DDI-DrugBank.d736.s5.e1	effect	path1=drug_nsubj	path=drug_nsubj<increase_ROOT>responsiveness_obj>tubocurarine_nmod	relType_1=aux	lemma_1=may	path2=responsiveness_obj>tubocurarine_nmod	lemma_5=of	relType_5=case	relation_1=beneficial	eib=False	pos_2=VB	relType_3=det	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	relType_2=ROOT	pos_5=IN	wib=increase	pos_1=MD	lpib=increase_VB	pos_3=DT	lemma_3=the	lemma_4=responsiveness
DDI-DrugBank.d736.s6	DDI-DrugBank.d736.s6.e0	DDI-DrugBank.d736.s6.e1	mechanism	lib=renal	lemma_1=renal	pos_2=NN	pos_1=JJ	lemma_4=reduce	lemma_5=by	relType_3=aux:pass	lemma_2=clearance	relType_5=case	eib=False	lpib=renal_JJ	path2=thiazide_obl	pos_3=VBZ	relType_2=nsubj:pass	pos_4=VBN	relation_3=adverse	lemma_3=be	pos_5=IN	relType_4=ROOT	path1=lithium_compound<clearance_nsubj:pass	path=lithium_compound<clearance_nsubj:pass<reduce_ROOT>thiazide_obl	relType_1=amod	wib=renal
DDI-DrugBank.d736.s6	DDI-DrugBank.d736.s6.e0	DDI-DrugBank.d736.s6.e2	null	lib=renal	path2=increase_dep>risk_obj>toxicity_nmod>lithium_compound	lemma_1=renal	pos_2=NN	pos_8=DT	lemma_6=,	pos_7=VBG	lemma_10=of	pos_1=JJ	lemma_4=reduce	lemma_5=by	relType_3=aux:pass	lemma_2=clearance	relType_5=case	relType_6=obl	lpib=renal_JJ	relType_6=punct	pos_3=VBZ	lemma_7=increase	relType_10=case	relType_2=nsubj:pass	pos_9=NN	pos_4=VBN	lemma_9=risk	path=lithium_compound<clearance_nsubj:pass<reduce_ROOT>increase_dep>risk_obj>toxicity_nmod>lithium_compound	relation_3=adverse	lemma_8=the	lemma_3=be	relType_9=obj	pos_5=IN	pos_10=IN	relType_4=ROOT	lemma_6=thiazide	pos_6=,	relation_7=beneficial	path1=lithium_compound<clearance_nsubj:pass	relType_7=dep	eib=True	pos_6=NNS	relType_1=amod	relType_8=det	wib=renal
DDI-DrugBank.d736.s6	DDI-DrugBank.d736.s6.e1	DDI-DrugBank.d736.s6.e2	null	path2=increase_dep>risk_obj>toxicity_nmod>lithium_compound	lemma_1=,	pos_1=,	lemma_5=of	relType_5=case	path1=thiazide_obl	relation_1=beneficial	path=thiazide_obl<reduce_ROOT>increase_dep>risk_obj>toxicity_nmod>lithium_compound	eib=False	lemma_4=risk	wib=increasing	relType_3=det	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	relType_2=dep	pos_5=IN	pos_3=DT	lpib=increase_VBG	lemma_3=the	relType_1=punct	pos_2=VBG
DDI-DrugBank.d736.s7	DDI-DrugBank.d736.s7.e0	DDI-DrugBank.d736.s7.e1	effect	relType_8=case	pos_3=TO	lemma_5=potentiate	relation_4=beneficial	relType_1=aux	lemma_1=may	pos_6=DT	relation_4=adverse	relType_10=amod	lpib=add_VB	relType_4=cc	path=thiazide_nsubj<add_ROOT>action_obl>drug_nmod	lemma_10=antihypertensive	path1=thiazide_nsubj	pos_5=VB	pos_9=JJ	lemma_7=action	lemma_9=other	lemma_6=the	pos_2=VB	relType_9=amod	pos_8=IN	lib=add	lemma_2=add	relType_2=ROOT	lemma_4=or	pos_10=JJ	lemma_3=to	pos_1=MD	relType_5=conj	relType_3=case	path2=action_obl>drug_nmod	relType_6=det	relType_7=obl	eib=True	pos_4=CC	wib=add	pos_7=NN	lemma_8=of
DDI-DrugBank.d736.s8	DDI-DrugBank.d736.s8.e0	DDI-DrugBank.d736.s8.e1	null	path=<drug_obl>	eib=False	path2=	path1=
DDI-DrugBank.d706.s0	DDI-DrugBank.d706.s0.e0	DDI-DrugBank.d706.s0.e1	effect	relType_8=case	relType_10=punct	lemma_4=a	pos_8=VBN	pos_2=MD	relType_10=amod	pos_9=IN	pos_3=VB	lemma_1=)	pos_7=WRB	lemma_10=block	pos_6=NN	relation_11=adverse	relation_5=neutral	relType_2=aux	path=reserpine_appos<g._dep<drug_nsubj<have_ROOT>agent_advcl	relType_9=case	pos_10=NN	lib=have	lemma_3=have	path1=reserpine_appos<g._dep<drug_nsubj	path2=agent_advcl	lemma_10=-	pos_4=DT	pos_5=JJ	lemma_8=give	relType_5=amod	relType_3=ROOT	lpib=have_VB	pos_1=-RRB-	pos_10=HYPH	lemma_5=additive	lemma_6=effect	relType_6=obj	lemma_9=with	eib=True	wib=have	pos_10=VBG	lemma_7=when	lemma_2=may	relType_7=advmod	relType_1=punct	relType_4=det	relType_10=obl	lemma_10=beta
DDI-DrugBank.d715.s0	DDI-DrugBank.d715.s0.e0	DDI-DrugBank.d715.s0.e1	advise	pos_2=NNS	wib=patients	relType_1=case	lpib=patient_NNS	eib=False	lemma_2=patient	relType_3=acl	lib=patient	pos_3=VBG	path=DEMSER_obl<observe_ROOT>patient_obl>receive_acl>phenothiazine_obj	lemma_3=receive	pos_1=IN	lemma_1=to	path1=DEMSER_obl	relType_2=obl	path2=patient_obl>receive_acl>phenothiazine_obj
DDI-DrugBank.d715.s0	DDI-DrugBank.d715.s0.e0	DDI-DrugBank.d715.s0.e2	advise	relType_1=case	lemma_2=patient	relType_4=cc	wib=patients	lpib=patient_NNS	relType_3=acl	lemma_3=receive	pos_1=IN	pos_3=VBG	pos_4=NNS	relType_4=obj	lemma_4=or	lib=patient	lemma_4=phenothiazine	lemma_1=to	path2=patient_obl>haloperidol_conj	path1=DEMSER_obl	relType_2=obl	path=DEMSER_obl<observe_ROOT>patient_obl>haloperidol_conj	pos_2=NNS	eib=True	pos_4=CC
DDI-DrugBank.d715.s0	DDI-DrugBank.d715.s0.e1	DDI-DrugBank.d715.s0.e2	null	relType_1=cc	pos_1=CC	lpib=haloperidol_NN	lib=haloperidol	eib=False	path1=phenothiazine_obj<receive_acl	path=phenothiazine_obj<receive_acl<patient_obl>haloperidol_conj	wib=haloperidol	path2=haloperidol_conj	lemma_1=or
DDI-DrugBank.d715.s1	DDI-DrugBank.d715.s1.e0	DDI-DrugBank.d715.s1.e1	effect	lemma_1=with	relType_1=case	path=DEMSER_nmod<use_nsubj>alcohol_nmod	lib=alcohol	eib=False	path1=DEMSER_nmod	wib=alcohol	pos_1=IN	path2=alcohol_nmod	lpib=alcohol_NN
DDI-DrugBank.d715.s1	DDI-DrugBank.d715.s1.e0	DDI-DrugBank.d715.s1.e2	effect	relType_1=case	lemma_2=or	pos_2=NN	path2=alcohol_nmod>depressant_conj	relType_2=cc	lpib=alcohol_NN	lemma_3=other	lemma_2=alcohol	relType_2=nmod	wib=alcohol	pos_1=IN	pos_4=NN	path=DEMSER_nmod<use_nsubj>alcohol_nmod>depressant_conj	relType_3=amod	lib=alcohol	path1=DEMSER_nmod	relType_4=compound	lemma_4=cns	lemma_1=with	pos_3=JJ	eib=True	pos_2=CC
DDI-DrugBank.d715.s1	DDI-DrugBank.d715.s1.e1	DDI-DrugBank.d715.s1.e2	null	relType_1=cc	pos_1=CC	lib=other	eib=True	lpib=other_JJ	pos_3=NN	lemma_2=other	relType_2=amod	path1=	wib=other	lemma_3=cns	relType_3=compound	pos_2=JJ	path2=depressant_conj	path=<alcohol_nmod>depressant_conj	lemma_1=or
DDI-DrugBank.d640.s0	DDI-DrugBank.d640.s0.e0	DDI-DrugBank.d640.s0.e1	null	path1=	lemma_3=reduction	lemma_4=in	relType_5=compound	relType_7=aux	pos_9=IN	relType_8=appos	pos_2=JJ	pos_14=WRB	relType_11=case	pos_6=NN	relType_13=nmod	pos_10=NNS	relType_14=advmod	pos_3=NNS	relType_12=compound	pos_12=NN	relType_10=obl	pos_7=MD	lemma_7=may	relType_9=case	pos_13=NN	lemma_1=:	path2=occur_appos>start_advcl>inhibitor_nsubj:pass	pos_8=VB	relType_6=nmod	pos_11=IN	lpib=excessive_JJ	lemma_11=on	pos_15=NN	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	lemma_15=ace	lemma_12=diuretic	relType_3=nsubj	lemma_13=therapy	relType_15=compound	pos_5=NN	lemma_6=pressure	lib=excessive	eib=True	wib=Excessive	lemma_2=excessive	relType_1=punct	lemma_5=blood	lemma_8=occur	lemma_9=in	path=<diuretic_ROOT>occur_appos>start_advcl>inhibitor_nsubj:pass	lemma_14=when	lemma_10=patient
DDI-DrugBank.d640.s1	DDI-DrugBank.d640.s1.e0	DDI-DrugBank.d640.s1.e1	null	relType_8=case	pos_13=VBG	relType_17=obl	relType_11=cc	relType_1=aux	pos_16=IN	pos_3=VBN	lemma_8=for	relType_14=compound	path=UNIVASC_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>initiation_obl>UNIVASC_nmod	relType_18=case	lemma_19=treatment	wib=be	pos_6=NN	pos_9=JJ	pos_17=NN	relType_19=nmod	pos_20=IN	relType_20=case	lemma_15=intake	lemma_3=minimize	eib=False	lemma_10=day	relType_12=advmod	relType_13=amod	pos_2=VB	relType_9=amod	pos_14=NN	pos_19=NN	lemma_18=of	pos_18=IN	pos_8=IN	lemma_1=can	lemma_5=discontinue	lemma_6=diuretic	lib=be	relType_5=amod	relType_3=ROOT	lemma_11=or	pos_12=RB	pos_4=IN	pos_15=NN	lemma_14=salt	pos_11=CC	relType_4=case	relType_2=aux:pass	lemma_12=cautiously	lemma_9=several	pos_1=MD	lemma_17=initiation	lpib=be_VB	lemma_13=increase	relType_6=compound	relType_16=case	relType_7=obl	pos_5=VBG	lemma_20=with	lemma_16=before	path2=initiation_obl>UNIVASC_nmod	relType_15=conj	lemma_2=be	lemma_7=therapy	pos_7=NN	relType_10=obl	pos_10=NNS	lemma_4=by	relation_12=beneficial	path1=UNIVASC_nmod<effect_nmod<possibility_nsubj:pass
DDI-DrugBank.d640.s1	DDI-DrugBank.d640.s1.e0	DDI-DrugBank.d640.s1.e2	null	pos_13=VBG	relType_11=cc	path=UNIVASC_nmod<effect_nmod<possibility_nsubj:pass<minimize_ROOT>reduce_parataxis>dose_nsubj:pass>moexpril_nmod	lemma_23=this	relType_28=det	lemma_4=by	pos_27=,	relType_18=case	lemma_19=treatment	pos_6=NN	pos_2=VB	pos_22=IN	lemma_18=of	lemma_6=diuretic	relType_3=ROOT	lemma_11=or	pos_12=RB	pos_29=VBG	lemma_12=cautiously	relType_2=aux:pass	lemma_9=several	lemma_17=initiation	lemma_29=start	lpib=be_VB	relType_6=compound	relType_21=punct	lemma_24=be	lemma_7=therapy	relType_8=case	pos_21=NNP	relType_24=cop	relType_1=aux	pos_30=NN	relType_20=case	lemma_15=intake	lemma_28=the	relType_13=amod	path2=reduce_parataxis>dose_nsubj:pass>moexpril_nmod	pos_28=DT	pos_8=IN	relType_30=nsubj:pass	lemma_1=can	lemma_5=discontinue	relType_25=advmod	lemma_14=salt	relType_16=case	relType_7=obl	lemma_16=before	lemma_2=be	pos_7=NN	path1=UNIVASC_nmod<effect_nmod<possibility_nsubj:pass	relType_23=nsubj	pos_16=IN	lemma_8=for	relType_21=nmod	pos_20=IN	pos_26=JJ	pos_31=IN	relType_19=nmod	pos_17=NN	relType_29=amod	pos_24=VBZ	lemma_3=minimize	lemma_10=day	relType_12=advmod	relType_9=amod	pos_14=NN	pos_18=IN	lemma_26=possible	lib=be	relType_5=amod	pos_4=IN	pos_11=CC	pos_1=MD	lemma_13=increase	relType_26=advcl	lemma_31=of	relType_15=conj	relType_27=punct	relType_10=obl	pos_21=.	pos_3=VBN	lemma_25=not	relType_31=case	relType_14=compound	wib=be	pos_9=JJ	lemma_21=.	pos_19=NN	pos_25=RB	pos_15=NN	lemma_30=dose	lemma_22=if	relType_4=case	pos_23=DT	lemma_27=,	relType_22=mark	lemma_21=UNIVASC	pos_5=VBG	lemma_20=with	eib=True	pos_10=NNS	relType_17=obl	relation_12=beneficial
DDI-DrugBank.d640.s1	DDI-DrugBank.d640.s1.e1	DDI-DrugBank.d640.s1.e2	null	lemma_10=dose	pos_6=JJ	pos_8=DT	lemma_4=be	pos_1=.	lemma_6=possible	lemma_2=if	relType_11=case	relType_2=mark	pos_2=IN	relType_4=cop	eib=False	path2=reduce_parataxis>dose_nsubj:pass>moexpril_nmod	path1=UNIVASC_nmod<initiation_obl	pos_7=,	relType_9=amod	relType_6=advcl	pos_10=NN	lemma_7=,	relType_10=nsubj:pass	pos_9=VBG	pos_11=IN	lemma_5=not	lib=be	lemma_8=the	pos_5=RB	lemma_1=.	lemma_9=start	relType_3=nsubj	relType_5=advmod	wib=is	pos_3=DT	relType_7=punct	lemma_11=of	lpib=be_VBZ	lemma_3=this	relType_8=det	path=UNIVASC_nmod<initiation_obl<minimize_ROOT>reduce_parataxis>dose_nsubj:pass>moexpril_nmod	relType_1=punct	pos_4=VBZ
DDI-DrugBank.d640.s2	DDI-DrugBank.d640.s2.e0	DDI-DrugBank.d640.s2.e1	null	path2=diuretic_conj	relType_2=cc	wib=Supplements	lemma_2=and	lemma_3=-	lemma_1=supplement	pos_3=VBG	lpib=supplement_NNS	lib=supplement	relType_3=amod	path=potassium_compound<supplement_ROOT>diuretic_conj	relType_1=ROOT	lemma_3=potassium	pos_1=NNS	relType_3=obl	eib=True	lemma_3=spare	path1=potassium_compound	pos_3=NN	pos_3=HYPH	pos_2=CC	relType_3=punct
DDI-DrugBank.d640.s2	DDI-DrugBank.d640.s2.e0	DDI-DrugBank.d640.s2.e2	null	path2=increase_parataxis>UNIVASC_nsubj	path=potassium_compound<supplement_ROOT>increase_parataxis>UNIVASC_nsubj	relType_2=cc	wib=Supplements	lemma_3=diuretic	lemma_2=and	pos_3=NNS	lemma_3=:	lemma_3=-	lemma_1=supplement	pos_3=VBG	lpib=supplement_NNS	lib=supplement	relType_3=amod	relType_3=conj	pos_3=:	relType_1=ROOT	lemma_3=potassium	pos_1=NNS	relType_3=obl	eib=True	lemma_3=spare	path1=potassium_compound	pos_3=NN	pos_3=HYPH	pos_2=CC	relType_3=punct
DDI-DrugBank.d640.s2	DDI-DrugBank.d640.s2.e1	DDI-DrugBank.d640.s2.e2	null	path2=increase_parataxis>UNIVASC_nsubj	eib=False	path1=diuretic_conj	pos_1=:	lpib=univasc_NNP	wib=UNIVASC	path=diuretic_conj<supplement_ROOT>increase_parataxis>UNIVASC_nsubj	lib=univasc	relType_1=punct	lemma_1=:
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e0	DDI-DrugBank.d640.s3.e1	null	lemma_1=(	wib=spironolactone	eib=False	path1=	lpib=spironolactone_NN	path2=spironolactone_dep	relType_1=punct	lib=spironolactone	pos_1=-LRB-	path=<diuretic_nmod>spironolactone_dep
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e0	DDI-DrugBank.d640.s3.e2	null	lemma_1=(	relType_2=dep	wib=spironolactone	pos_2=NN	eib=True	lemma_2=spironolactone	path1=	pos_2=,	lpib=spironolactone_NN	path2=spironolactone_dep>triamterene_conj	relType_1=punct	path=<diuretic_nmod>spironolactone_dep>triamterene_conj	lib=spironolactone	lemma_2=,	pos_1=-LRB-	relType_2=punct
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e0	DDI-DrugBank.d640.s3.e3	null	pos_2=NN	path1=	lpib=spironolactone_NN	relType_2=punct	lemma_1=(	path=<diuretic_nmod>spironolactone_dep>amiloride_conj	lib=spironolactone	lemma_2=,	relType_2=dep	lemma_3=,	relType_3=conj	lemma_2=spironolactone	pos_1=-LRB-	lemma_3=triamterene	wib=spironolactone	pos_3=,	eib=True	path2=spironolactone_dep>amiloride_conj	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e0	DDI-DrugBank.d640.s3.e4	null	pos_2=NN	pos_5=CC	path1=	lpib=spironolactone_NN	path=<diuretic_nmod>supplement_conj>potassium_compound	relType_2=punct	lemma_1=(	relType_5=cc	pos_4=-RRB-	lib=spironolactone	pos_4=NN	lemma_2=,	path2=supplement_conj>potassium_compound	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=spironolactone	lemma_4=)	lemma_4=amiloride	pos_1=-LRB-	lemma_3=triamterene	wib=spironolactone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=or
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e0	DDI-DrugBank.d640.s3.e5	effect	relType_8=case	pos_2=NN	pos_5=CC	path1=	lpib=spironolactone_NN	lemma_9=ace	path=<diuretic_nmod>supplement_conj>inhibitor_nmod	relType_2=punct	lemma_1=(	pos_6=NN	relType_5=cc	relType_6=conj	relType_9=compound	pos_7=RB	lemma_6=supplement	lemma_6=potassium	path2=supplement_conj>inhibitor_nmod	pos_4=-RRB-	lemma_8=with	lib=spironolactone	pos_9=NN	pos_4=NN	lemma_2=,	pos_8=IN	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	lemma_2=spironolactone	lemma_4=)	lemma_4=amiloride	pos_1=-LRB-	lemma_7=concomitantly	lemma_3=triamterene	relType_6=compound	wib=spironolactone	pos_3=,	eib=True	pos_3=NN	pos_6=NNS	pos_2=,	relType_4=conj	relType_7=advmod	relType_1=punct	relType_3=punct	lemma_5=or
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e1	DDI-DrugBank.d640.s3.e2	null	lpib=triamterene_NN	path=<spironolactone_dep>triamterene_conj	lemma_1=,	wib=triamterene	eib=False	path2=triamterene_conj	path1=	pos_1=,	relType_1=punct	lib=triamterene
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e1	DDI-DrugBank.d640.s3.e3	null	lpib=triamterene_NN	path2=amiloride_conj	lemma_1=,	relType_2=punct	pos_2=NN	wib=triamterene	eib=True	path=<spironolactone_dep>amiloride_conj	path1=	pos_1=,	pos_2=,	lemma_2=triamterene	relType_1=punct	relType_2=conj	lemma_2=,	lib=triamterene
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e1	DDI-DrugBank.d640.s3.e4	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=triamterene	relType_4=cc	path=spironolactone_dep<diuretic_nmod>supplement_conj>potassium_compound	relType_2=punct	lpib=triamterene_NN	relType_2=conj	lemma_2=,	path2=supplement_conj>potassium_compound	wib=triamterene	relType_3=conj	lemma_4=or	lemma_3=amiloride	lemma_3=)	path1=spironolactone_dep	eib=True	pos_3=-RRB-	pos_4=CC	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=triamterene
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e1	DDI-DrugBank.d640.s3.e5	effect	lemma_1=,	pos_2=NN	lemma_5=supplement	relType_7=case	pos_1=,	relType_5=compound	lemma_2=triamterene	relType_4=cc	lemma_7=with	relType_2=punct	lpib=triamterene_NN	pos_8=NN	pos_5=NNS	path2=supplement_conj>inhibitor_nmod	relType_2=conj	lemma_2=,	lemma_6=concomitantly	wib=triamterene	relType_3=conj	lemma_4=or	relType_8=compound	lemma_3=amiloride	relType_5=conj	pos_6=RB	lemma_3=)	lemma_5=potassium	pos_5=NN	path1=spironolactone_dep	path=spironolactone_dep<diuretic_nmod>supplement_conj>inhibitor_nmod	eib=True	pos_3=-RRB-	pos_4=CC	pos_3=NN	pos_7=IN	pos_2=,	relType_1=punct	relType_6=advmod	relType_3=punct	lemma_8=ace	lib=triamterene
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e2	DDI-DrugBank.d640.s3.e3	null	path2=amiloride_conj	lemma_1=,	eib=False	path=triamterene_conj<spironolactone_dep>amiloride_conj	path1=triamterene_conj	pos_1=,	relType_1=punct	lpib=amiloride_NN	wib=amiloride	lib=amiloride
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e2	DDI-DrugBank.d640.s3.e4	null	lemma_2=)	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	lemma_2=amiloride	lemma_3=or	path=triamterene_conj<spironolactone_dep<diuretic_nmod>supplement_conj>potassium_compound	lpib=amiloride_NN	relType_2=conj	path2=supplement_conj>potassium_compound	lib=amiloride	path1=triamterene_conj<spironolactone_dep	eib=True	pos_2=-RRB-	relType_1=punct	wib=amiloride
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e2	DDI-DrugBank.d640.s3.e5	effect	lemma_2=)	relType_7=compound	lemma_1=,	pos_2=NN	pos_3=CC	lemma_4=supplement	pos_1=,	relType_6=case	relType_2=punct	path=triamterene_conj<spironolactone_dep<diuretic_nmod>supplement_conj>inhibitor_nmod	relType_3=cc	lemma_4=potassium	path2=supplement_conj>inhibitor_nmod	pos_6=IN	lemma_2=amiloride	lemma_3=or	lpib=amiloride_NN	relType_2=conj	pos_4=NN	pos_4=NNS	lemma_7=ace	lemma_5=concomitantly	relType_4=compound	pos_5=RB	lemma_6=with	relType_5=advmod	lib=amiloride	path1=triamterene_conj<spironolactone_dep	eib=True	pos_2=-RRB-	relType_4=conj	relType_1=punct	pos_7=NN	wib=amiloride
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e3	DDI-DrugBank.d640.s3.e4	null	path2=supplement_conj>potassium_compound	lemma_2=or	lib=potassium	eib=False	path=amiloride_conj<spironolactone_dep<diuretic_nmod>supplement_conj>potassium_compound	pos_1=-RRB-	pos_2=CC	wib=potassium	relType_1=punct	lemma_1=)	relType_2=cc	lpib=potassium_NN	path1=amiloride_conj<spironolactone_dep
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e3	DDI-DrugBank.d640.s3.e5	effect	lemma_2=or	lemma_4=concomitantly	lemma_1=)	relType_2=cc	relType_5=case	pos_6=NN	pos_4=RB	pos_3=NNS	lib=potassium	path2=supplement_conj>inhibitor_nmod	lemma_5=with	wib=potassium	lpib=potassium_NN	lemma_6=ace	relType_3=conj	pos_1=-RRB-	lemma_3=supplement	relType_4=advmod	pos_5=IN	path=amiloride_conj<spironolactone_dep<diuretic_nmod>supplement_conj>inhibitor_nmod	relType_6=compound	lemma_3=potassium	eib=True	pos_3=NN	pos_2=CC	relType_3=compound	relType_1=punct	path1=amiloride_conj<spironolactone_dep
DDI-DrugBank.d640.s3	DDI-DrugBank.d640.s3.e4	DDI-DrugBank.d640.s3.e5	effect	pos_3=IN	path2=inhibitor_nmod	pos_2=RB	relType_2=advmod	lemma_1=supplement	path=potassium_compound<supplement_conj>inhibitor_nmod	wib=supplements	pos_4=NN	lpib=supplement_NNS	lemma_4=ace	lib=supplement	relType_4=compound	lemma_3=with	relType_1=conj	relType_3=case	lemma_2=concomitantly	pos_1=NNS	eib=True	path1=potassium_compound
DDI-DrugBank.d640.s5	DDI-DrugBank.d640.s5.e0	DDI-DrugBank.d640.s5.e1	null	wib=Interaction	path1=	pos_3=NNS	pos_2=NNP	eib=False	path2=fail_parataxis>study_nsubj>warfarin_nmod	lemma_1=:	lib=interaction	lemma_4=with	lemma_2=Interaction	relType_2=compound	pos_4=IN	pos_1=:	relType_4=case	relType_3=nsubj	lemma_3=study	lpib=interaction_NNP	relType_1=punct	path=<anticoagulant_ROOT>fail_parataxis>study_nsubj>warfarin_nmod
DDI-DrugBank.d640.s5	DDI-DrugBank.d640.s5.e0	DDI-DrugBank.d640.s5.e2	null	wib=Interaction	pos_7=VB	pos_6=TO	lemma_13=the	pos_8=DT	relType_9=advmod	pos_17=DT	pos_16=IN	lemma_5=warfarin	lemma_12=on	relType_10=amod	path1=	lemma_10=important	relType_12=case	pos_13=DT	relType_5=parataxis	lemma_9=clinically	relType_14=compound	relType_11=obj	lemma_6=to	lemma_7=identify	lemma_14=serum	lemma_5=fail	pos_3=NNS	relType_17=det	pos_2=NNP	lemma_15=concentration	lemma_8=any	pos_14=NN	lemma_16=of	pos_12=IN	lemma_1=:	lib=interaction	relType_7=xcomp	lemma_4=with	lemma_2=Interaction	relType_6=mark	pos_10=JJ	relType_2=compound	pos_4=IN	path2=fail_parataxis>identify_xcomp>effect_obj>concentration_nmod>anticoagulant_nmod	pos_1=:	relType_4=case	relType_5=nmod	pos_9=RB	relation_11=neutral	lemma_17=the	relType_3=nsubj	relType_15=nmod	pos_5=VBD	pos_5=NN	relType_16=case	path=<anticoagulant_ROOT>fail_parataxis>identify_xcomp>effect_obj>concentration_nmod>anticoagulant_nmod	pos_11=NN	lemma_3=study	eib=True	pos_15=NNS	lemma_11=effect	lpib=interaction_NNP	relType_13=det	relType_8=det	relType_1=punct
DDI-DrugBank.d640.s5	DDI-DrugBank.d640.s5.e1	DDI-DrugBank.d640.s5.e2	null	relType_8=case	lemma_3=identify	relType_3=xcomp	pos_6=JJ	lemma_13=the	pos_7=NN	lemma_1=fail	relType_12=case	pos_13=DT	path1=warfarin_nmod<study_nsubj	pos_3=VB	lemma_4=any	path2=identify_xcomp>effect_obj>concentration_nmod>anticoagulant_nmod	relType_2=mark	lemma_10=serum	lemma_12=of	lemma_11=concentration	relation_6=neutral	pos_1=VBD	eib=False	lemma_7=effect	relType_6=amod	relType_7=obj	pos_11=NNS	pos_9=DT	lemma_2=to	relType_10=compound	lib=fail	pos_10=NN	lemma_6=important	pos_12=IN	relType_1=parataxis	pos_8=IN	lemma_8=on	pos_4=DT	pos_5=RB	path=warfarin_nmod<study_nsubj<fail_parataxis>identify_xcomp>effect_obj>concentration_nmod>anticoagulant_nmod	lpib=fail_VBD	relType_5=advmod	wib=failed	lemma_9=the	relType_13=det	lemma_5=clinically	relType_11=nmod	relType_4=det	pos_2=TO	relType_9=det
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e0	DDI-DrugBank.d640.s6.e1	null	pos_2=VBN	eib=False	wib=Increased	pos_3=NN	path=<lithium_ROOT>report_parataxis>level_nsubj:pass>lithium_compound	relType_2=amod	path1=	pos_1=:	lemma_3=serum	relType_3=compound	path2=report_parataxis>level_nsubj:pass>lithium_compound	relType_1=punct	lib=increase	lemma_1=:	lemma_2=increase	relation_1=beneficial	lpib=increase_VBN
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e0	DDI-DrugBank.d640.s6.e2	null	pos_2=VBN	pos_5=CC	relType_7=case	path2=report_parataxis>level_nsubj:pass>symptom_conj>toxicity_nmod>lithium_compound	path1=	lemma_3=serum	relation_1=beneficial	relType_5=cc	relType_6=conj	lemma_4=level	relType_4=nsubj:pass	pos_4=NN	lib=increase	lemma_1=:	lemma_2=increase	pos_4=NNS	relType_2=amod	relType_4=compound	pos_1=:	path=<lithium_ROOT>report_parataxis>level_nsubj:pass>symptom_conj>toxicity_nmod>lithium_compound	lemma_7=of	eib=True	pos_7=IN	wib=Increased	pos_3=NN	lemma_5=and	pos_6=NNS	relType_3=compound	relType_1=punct	lemma_6=symptom	lemma_4=lithium	lpib=increase_VBN
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e0	DDI-DrugBank.d640.s6.e3	null	pos_2=VBN	lemma_11=report	pos_5=CC	relType_7=case	pos_13=NNS	path1=	lemma_3=serum	relType_12=case	relType_9=aux	relation_1=beneficial	pos_8=NN	relType_13=obl	relType_5=cc	relType_6=conj	relType_10=aux:pass	relType_14=acl	lemma_4=level	lemma_13=patient	path2=report_parataxis>patient_obl>receive_acl>inhibitor_obj	relType_4=nsubj:pass	pos_4=NN	lib=increase	lemma_1=:	lemma_2=increase	pos_4=NNS	pos_12=IN	pos_15=NN	pos_14=VBG	lemma_8=lithium	relType_2=amod	relType_4=compound	pos_1=:	relType_8=compound	lemma_15=ace	lemma_8=toxicity	pos_11=VBN	lemma_14=receive	lemma_7=of	relType_15=compound	lemma_12=in	pos_9=VBP	eib=True	pos_7=IN	wib=Increased	pos_3=NN	lemma_5=and	relType_8=nmod	pos_10=VBN	pos_6=NNS	relType_11=parataxis	relType_3=compound	path=<lithium_ROOT>report_parataxis>patient_obl>receive_acl>inhibitor_obj	relType_1=punct	lemma_6=symptom	lemma_9=have	lemma_4=lithium	lemma_10=be	lpib=increase_VBN
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e0	DDI-DrugBank.d640.s6.e4	null	pos_2=VBN	lemma_11=report	pos_5=CC	relType_7=case	pos_13=NNS	path1=	lemma_3=serum	relType_12=case	relType_16=obl	relType_9=aux	pos_15=NNS	relation_1=beneficial	pos_17=IN	pos_8=NN	relType_13=obl	relType_5=cc	relType_6=conj	relType_10=aux:pass	relType_14=acl	lemma_17=with	lemma_4=level	lemma_13=patient	relType_4=nsubj:pass	pos_4=NN	lib=increase	lemma_1=:	lemma_2=increase	pos_4=NNS	pos_12=IN	lemma_15=inhibitor	relType_17=case	relType_15=case	pos_15=NN	pos_14=VBG	lemma_8=lithium	relType_2=amod	relType_4=compound	pos_1=:	relType_8=compound	lemma_15=ace	path2=report_parataxis>patient_obl>receive_acl>therapy_obl>lithium_nmod	lemma_8=toxicity	pos_11=VBN	pos_16=NN	lemma_15=during	lemma_14=receive	pos_15=IN	lemma_7=of	relType_15=compound	relType_15=obj	lemma_12=in	pos_9=VBP	path=<lithium_ROOT>report_parataxis>patient_obl>receive_acl>therapy_obl>lithium_nmod	eib=True	pos_7=IN	wib=Increased	pos_3=NN	lemma_5=and	relType_8=nmod	pos_10=VBN	pos_6=NNS	relType_11=parataxis	relType_3=compound	lemma_16=therapy	relType_1=punct	lemma_6=symptom	lemma_9=have	lemma_4=lithium	lemma_10=be	lpib=increase_VBN
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e1	DDI-DrugBank.d640.s6.e2	null	lib=level	path2=symptom_conj>toxicity_nmod>lithium_compound	relType_2=cc	lemma_2=and	pos_3=NNS	lpib=level_NNS	eib=False	lemma_1=level	lemma_3=symptom	relType_3=conj	pos_4=IN	relType_4=case	path1=lithium_compound	pos_1=NNS	pos_2=CC	relType_1=nsubj:pass	lemma_4=of	wib=levels	path=lithium_compound<level_nsubj:pass>symptom_conj>toxicity_nmod>lithium_compound
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e1	DDI-DrugBank.d640.s6.e3	null	path2=patient_obl>receive_acl>inhibitor_obj	lemma_5=toxicity	pos_8=VBN	lib=level	lemma_7=be	relType_5=compound	pos_9=IN	path=lithium_compound<level_nsubj:pass<report_parataxis>patient_obl>receive_acl>inhibitor_obj	relType_2=cc	lemma_9=in	lemma_5=lithium	lemma_2=and	pos_10=NNS	pos_3=NNS	lpib=level_NNS	relType_12=compound	lemma_1=level	relType_9=case	lemma_6=have	lemma_12=ace	path1=lithium_compound<level_nsubj:pass	relType_8=parataxis	lemma_3=symptom	relType_3=conj	relType_6=aux	pos_4=IN	lemma_11=receive	relType_4=case	pos_11=VBG	relType_5=nmod	relType_7=aux:pass	pos_6=VBP	lemma_8=report	relType_11=acl	pos_7=VBN	pos_5=NN	pos_1=NNS	eib=True	pos_2=CC	relType_1=nsubj:pass	pos_12=NN	relType_10=obl	lemma_4=of	wib=levels	lemma_10=patient
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e1	DDI-DrugBank.d640.s6.e4	null	lemma_5=toxicity	pos_8=VBN	lib=level	path2=patient_obl>receive_acl>therapy_obl>lithium_nmod	lemma_7=be	relType_12=case	lemma_14=with	relType_5=compound	pos_9=IN	relType_2=cc	lemma_9=in	lemma_5=lithium	lemma_2=and	pos_10=NNS	relType_13=obl	pos_3=NNS	lpib=level_NNS	relType_12=compound	lemma_1=level	lemma_12=inhibitor	relType_9=case	lemma_6=have	path=lithium_compound<level_nsubj:pass<report_parataxis>patient_obl>receive_acl>therapy_obl>lithium_nmod	path1=lithium_compound<level_nsubj:pass	lemma_12=ace	relType_8=parataxis	relType_12=obj	pos_12=IN	pos_13=NN	pos_14=IN	lemma_3=symptom	relType_3=conj	relType_6=aux	pos_4=IN	lemma_11=receive	pos_12=NNS	relType_4=case	pos_11=VBG	relType_5=nmod	relType_7=aux:pass	pos_6=VBP	lemma_8=report	relType_11=acl	lemma_13=therapy	pos_7=VBN	pos_5=NN	lemma_12=during	pos_1=NNS	eib=True	pos_2=CC	relType_1=nsubj:pass	relType_14=case	pos_12=NN	relType_10=obl	lemma_4=of	wib=levels	lemma_10=patient
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e2	DDI-DrugBank.d640.s6.e3	null	path2=patient_obl>receive_acl>inhibitor_obj	lemma_5=in	lemma_2=have	pos_3=VBN	pos_7=VBG	lib=toxicity	relType_7=acl	relType_3=aux:pass	relType_5=case	pos_8=NN	relType_6=obl	lemma_6=patient	relType_2=aux	relType_1=nmod	pos_1=NN	relType_4=parataxis	pos_4=VBN	relType_8=compound	lemma_3=be	path=lithium_compound<toxicity_nmod<symptom_conj<level_nsubj:pass<report_parataxis>patient_obl>receive_acl>inhibitor_obj	lemma_4=report	wib=toxicity	path1=lithium_compound<toxicity_nmod<symptom_conj<level_nsubj:pass	pos_2=VBP	pos_5=IN	lemma_7=receive	lpib=toxicity_NN	eib=True	pos_6=NNS	lemma_1=toxicity	lemma_8=ace
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e2	DDI-DrugBank.d640.s6.e4	null	relType_8=case	lemma_5=in	lemma_10=with	lemma_2=have	path2=patient_obl>receive_acl>therapy_obl>lithium_nmod	pos_3=VBN	pos_7=VBG	lib=toxicity	relType_9=obl	relType_7=acl	relType_3=aux:pass	relType_5=case	pos_8=NNS	pos_8=NN	relType_6=obl	lemma_6=patient	relType_8=obj	relType_2=aux	relType_10=case	relType_1=nmod	pos_9=NN	lemma_8=during	pos_1=NN	pos_8=IN	relType_4=parataxis	pos_4=VBN	relType_8=compound	lemma_3=be	lemma_4=report	lemma_7=receive	wib=toxicity	path1=lithium_compound<toxicity_nmod<symptom_conj<level_nsubj:pass	pos_2=VBP	pos_5=IN	lemma_8=inhibitor	path=lithium_compound<toxicity_nmod<symptom_conj<level_nsubj:pass<report_parataxis>patient_obl>receive_acl>therapy_obl>lithium_nmod	pos_10=IN	lemma_9=therapy	lpib=toxicity_NN	eib=True	pos_6=NNS	lemma_1=toxicity	lemma_8=ace
DDI-DrugBank.d640.s6	DDI-DrugBank.d640.s6.e3	DDI-DrugBank.d640.s6.e4	effect	relType_1=case	pos_2=NN	lemma_2=therapy	pos_3=IN	eib=False	path=inhibitor_obj<receive_acl>therapy_obl>lithium_nmod	lib=therapy	lpib=therapy_NN	lemma_3=with	pos_1=IN	lemma_1=during	wib=therapy	relType_3=case	relType_2=obl	path2=therapy_obl>lithium_nmod	path1=inhibitor_obj
DDI-DrugBank.d640.s8	DDI-DrugBank.d640.s8.e0	DDI-DrugBank.d640.s8.e1	effect	relType_7=case	relType_1=aux:pass	pos_3=VBN	path=diuretic_nsubj:pass<use_advcl<increase_ROOT>risk_nsubj:pass>toxicity_nmod>lithium_compound	pos_6=NN	pos_2=RB	lemma_3=use	path2=risk_nsubj:pass>toxicity_nmod>lithium_compound	pos_4=,	eib=False	relType_2=advmod	lemma_1=be	path1=diuretic_nsubj:pass<use_advcl	lemma_6=risk	relType_4=punct	lib=be	relType_3=advcl	relType_5=det	relType_6=nsubj:pass	lemma_4=,	wib=is	lemma_7=of	lemma_5=the	pos_1=VBZ	pos_7=IN	pos_5=DT	lpib=be_VBZ	lemma_2=also
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e0	DDI-DrugBank.d640.s9.e1	null	pos_2=VBN	pos_3=RB	relType_3=advmod	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	pos_1=VBD	eib=False	lemma_1=be	path1=UNIVASC_nsubj:pass	lemma_4=with	lib=be	path=UNIVASC_nsubj:pass<administer_advcl>hydrochlorothiazide_obl	pos_4=IN	relType_4=case	path2=hydrochlorothiazide_obl	wib=was	lemma_3=concomitantly	lpib=be_VBD
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e0	DDI-DrugBank.d640.s9.e2	null	pos_2=VBN	path2=hydrochlorothiazide_obl>digoxin_conj	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_2=administer	relType_2=advcl	pos_1=VBD	lemma_1=be	lemma_5=hydrochlorothiazide	path1=UNIVASC_nsubj:pass	lemma_4=with	lib=be	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	path=UNIVASC_nsubj:pass<administer_advcl>hydrochlorothiazide_obl>digoxin_conj	relType_5=obl	wib=was	pos_5=NN	eib=True	lemma_3=concomitantly	lpib=be_VBD
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e0	DDI-DrugBank.d640.s9.e3	null	pos_2=VBN	pos_3=RB	relType_3=advmod	pos_5=,	relType_1=aux:pass	lemma_2=administer	lemma_6=,	relType_7=cc	relType_2=advcl	lemma_6=digoxin	pos_6=NN	relType_6=conj	pos_1=VBD	relType_6=punct	lemma_1=be	lemma_5=hydrochlorothiazide	path1=UNIVASC_nsubj:pass	path=UNIVASC_nsubj:pass<administer_advcl>hydrochlorothiazide_obl>cimetidine_conj	lemma_4=with	lib=be	pos_7=CC	lemma_5=,	pos_4=IN	relType_5=punct	relType_4=case	path2=hydrochlorothiazide_obl>cimetidine_conj	relType_5=obl	wib=was	lemma_7=or	pos_6=,	pos_5=NN	eib=True	lemma_3=concomitantly	lpib=be_VBD
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e1	DDI-DrugBank.d640.s9.e2	null	lib=digoxin	lemma_1=,	eib=False	path=<hydrochlorothiazide_obl>digoxin_conj	path1=	pos_1=,	path2=digoxin_conj	relType_1=punct	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e1	DDI-DrugBank.d640.s9.e3	null	lemma_1=,	pos_2=NN	pos_3=CC	path1=	pos_1=,	relType_2=punct	relType_3=cc	lemma_3=or	relType_2=conj	lemma_2=,	lib=digoxin	lemma_2=digoxin	path=<hydrochlorothiazide_obl>cimetidine_conj	lpib=digoxin_NN	wib=digoxin	eib=True	pos_2=,	relType_1=punct	path2=cimetidine_conj
DDI-DrugBank.d640.s9	DDI-DrugBank.d640.s9.e2	DDI-DrugBank.d640.s9.e3	null	lemma_2=or	lemma_1=,	path2=cimetidine_conj	path=digoxin_conj<hydrochlorothiazide_obl>cimetidine_conj	eib=False	pos_2=CC	pos_1=,	relType_1=punct	lib=cimetidine	relType_2=cc	wib=cimetidine	lpib=cimetidine_NN	path1=digoxin_conj
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e0	DDI-DrugBank.d640.s10.e1	null	relType_8=case	pos_2=VBN	lemma_9=calcium	lemma_9=block	lpib=have_VBZ	relType_1=aux	pos_3=VBN	path2=agent_obl	lemma_4=in	lemma_9=channel	relType_9=obl	lemma_9=-	relType_6=obl	pos_9=HYPH	relation_12=adverse	lemma_3=use	relType_9=compound	pos_7=RB	path=UNIVASC_nsubj:pass<use_ROOT>agent_obl	lemma_8=with	lemma_1=have	lemma_6=trial	relType_9=amod	path1=UNIVASC_nsubj:pass	pos_9=NN	lib=have	pos_8=IN	pos_9=VBG	pos_5=JJ	relType_5=amod	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_9=punct	lemma_7=concomitantly	lemma_5=clinical	pos_1=VBZ	eib=True	pos_6=NNS	lemma_2=be	relType_7=advmod	wib=has
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e0	DDI-DrugBank.d640.s10.e2	null	relType_8=case	pos_2=VBN	lemma_9=calcium	lemma_9=block	lpib=have_VBZ	relType_1=aux	pos_3=VBN	lemma_4=in	lemma_9=channel	relType_9=obl	path2=agent_obl>diuretic_conj	lemma_9=-	lemma_9=,	relType_6=obl	pos_9=HYPH	relation_12=adverse	lemma_3=use	relType_9=compound	pos_7=RB	pos_9=NNS	lemma_8=with	lemma_1=have	path=UNIVASC_nsubj:pass<use_ROOT>agent_obl>diuretic_conj	lemma_6=trial	relType_9=amod	path1=UNIVASC_nsubj:pass	pos_9=NN	lib=have	pos_8=IN	pos_9=VBG	pos_5=JJ	relType_5=amod	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_9=punct	lemma_7=concomitantly	lemma_5=clinical	pos_1=VBZ	eib=True	lemma_9=agent	pos_6=NNS	lemma_2=be	relType_7=advmod	pos_9=,	wib=has
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e0	DDI-DrugBank.d640.s10.e3	null	relType_8=case	lemma_10=diuretic	pos_2=VBN	lemma_9=calcium	relType_10=punct	lemma_9=block	lpib=have_VBZ	relType_1=aux	pos_3=VBN	lemma_10=,	lemma_4=in	lemma_9=channel	relType_9=obl	pos_11=NNP	lemma_9=-	lemma_9=,	relType_6=obl	pos_9=HYPH	relation_12=adverse	lemma_3=use	relType_9=compound	pos_7=RB	relType_10=conj	pos_9=NNS	lemma_8=with	lemma_1=have	lemma_6=trial	relType_9=amod	path1=UNIVASC_nsubj:pass	pos_9=NN	lib=have	pos_8=IN	pos_9=VBG	pos_5=JJ	path=UNIVASC_nsubj:pass<use_ROOT>agent_obl>blocker_conj	relType_5=amod	relType_3=ROOT	pos_4=IN	lemma_11=H2	relType_4=case	relType_2=aux:pass	relType_9=punct	lemma_7=concomitantly	path2=agent_obl>blocker_conj	lemma_5=clinical	pos_1=VBZ	eib=True	pos_10=,	relType_11=compound	lemma_9=agent	pos_6=NNS	lemma_2=be	relType_7=advmod	pos_9=,	wib=has	pos_10=NNS
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e0	DDI-DrugBank.d640.s10.e4	null	relType_8=case	lemma_10=diuretic	pos_2=VBN	lemma_9=calcium	relType_10=punct	lemma_9=block	lpib=have_VBZ	relType_1=aux	lemma_11=,	pos_3=VBN	lemma_10=,	lemma_4=in	lemma_9=channel	relType_9=obl	pos_11=NNP	lemma_9=-	lemma_9=,	relType_11=conj	relType_6=obl	pos_9=HYPH	relation_12=adverse	lemma_3=use	relType_9=compound	pos_7=RB	relType_10=conj	relType_11=punct	pos_9=NNS	pos_11=NNS	lemma_8=with	lemma_1=have	lemma_6=trial	relType_9=amod	path1=UNIVASC_nsubj:pass	pos_9=NN	lib=have	pos_8=IN	pos_9=VBG	pos_5=JJ	relType_5=amod	path=UNIVASC_nsubj:pass<use_ROOT>agent_obl>digoxin_conj	relType_3=ROOT	pos_4=IN	lemma_11=blocker	path2=agent_obl>digoxin_conj	lemma_11=H2	relType_4=case	relType_2=aux:pass	pos_11=,	relType_9=punct	lemma_7=concomitantly	lemma_5=clinical	pos_1=VBZ	eib=True	pos_10=,	relType_11=compound	lemma_9=agent	pos_6=NNS	lemma_2=be	relType_7=advmod	pos_9=,	wib=has	pos_10=NNS
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e0	DDI-DrugBank.d640.s10.e5	null	relType_8=case	lemma_10=diuretic	pos_2=VBN	lemma_9=calcium	relType_10=punct	lemma_9=block	relType_12=conj	lpib=have_VBZ	relType_1=aux	lemma_11=,	relType_14=amod	pos_3=VBN	lemma_10=,	lemma_4=in	lemma_9=channel	relType_9=obl	pos_11=NNP	lemma_9=-	lemma_9=,	relType_11=conj	relType_6=obl	pos_9=HYPH	lemma_12=,	lemma_3=use	relation_12=adverse	relType_9=compound	pos_7=RB	relType_10=conj	relType_13=amod	relType_11=punct	pos_9=NNS	pos_11=NNS	pos_12=,	lemma_8=with	lemma_1=have	lemma_6=trial	relType_9=amod	relType_12=punct	path1=UNIVASC_nsubj:pass	pos_9=NN	lib=have	pos_8=IN	pos_9=VBG	pos_5=JJ	relType_5=amod	pos_13=JJ	relType_3=ROOT	pos_4=IN	path2=agent_obl>agent_conj	lemma_11=blocker	lemma_11=H2	relType_4=case	path=UNIVASC_nsubj:pass<use_ROOT>agent_obl>agent_conj	relType_2=aux:pass	lemma_13=oral	pos_11=,	relType_9=punct	lemma_7=concomitantly	lemma_5=clinical	pos_1=VBZ	eib=True	pos_10=,	relType_11=compound	lemma_12=digoxin	lemma_14=hypoglycemic	lemma_9=agent	pos_6=NNS	pos_14=JJ	lemma_2=be	relType_7=advmod	pos_9=,	pos_12=NN	wib=has	pos_10=NNS
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e1	DDI-DrugBank.d640.s10.e2	null	lemma_1=,	wib=diuretics	eib=False	path2=diuretic_conj	lib=diuretic	path=<agent_obl>diuretic_conj	path1=	pos_1=,	relType_1=punct	lpib=diuretic_NNS
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e1	DDI-DrugBank.d640.s10.e3	null	path2=blocker_conj	lemma_1=,	wib=diuretics	path1=	pos_1=,	pos_3=NNP	relType_2=punct	relType_2=conj	lemma_2=,	path=<agent_obl>blocker_conj	lemma_2=diuretic	lib=diuretic	lpib=diuretic_NNS	pos_2=NNS	eib=True	pos_2=,	relType_3=compound	relType_1=punct	lemma_3=H2
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e1	DDI-DrugBank.d640.s10.e4	null	lemma_1=,	wib=diuretics	path1=	pos_1=,	pos_3=NNP	relType_2=punct	lemma_3=blocker	pos_3=NNS	path2=digoxin_conj	relType_2=conj	lemma_2=,	lemma_2=diuretic	lemma_3=,	relType_3=conj	lib=diuretic	path=<agent_obl>digoxin_conj	lpib=diuretic_NNS	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_3=compound	relType_1=punct	lemma_3=H2	relType_3=punct
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e1	DDI-DrugBank.d640.s10.e5	null	lemma_1=,	pos_6=JJ	wib=diuretics	path2=agent_conj	path1=	pos_1=,	pos_3=NNP	relType_2=punct	lemma_3=blocker	pos_3=NNS	lemma_5=oral	pos_4=,	relType_6=amod	relType_2=conj	pos_4=NN	lemma_2=,	pos_5=JJ	lemma_2=diuretic	relType_4=punct	lemma_3=,	relType_5=amod	path=<agent_obl>agent_conj	relType_3=conj	lib=diuretic	lemma_4=digoxin	lemma_4=,	lpib=diuretic_NNS	pos_2=NNS	pos_3=,	eib=True	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	lemma_6=hypoglycemic	lemma_3=H2	relType_3=punct
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e2	DDI-DrugBank.d640.s10.e3	null	path2=blocker_conj	path=diuretic_conj<agent_obl>blocker_conj	lemma_1=,	lpib=h2_NNP	eib=True	pos_2=NNP	path1=diuretic_conj	relType_2=compound	pos_1=,	lemma_2=H2	lib=h2	relType_1=punct	wib=H2
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e2	DDI-DrugBank.d640.s10.e4	null	lemma_1=,	pos_1=,	relType_2=punct	path=diuretic_conj<agent_obl>digoxin_conj	lpib=h2_NNP	pos_2=NNP	lemma_2=H2	path2=digoxin_conj	lib=h2	relType_2=conj	lemma_2=,	path1=diuretic_conj	relType_2=compound	wib=H2	pos_2=NNS	lemma_2=blocker	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e2	DDI-DrugBank.d640.s10.e5	null	relType_4=amod	lemma_1=,	lemma_3=digoxin	pos_4=JJ	path=diuretic_conj<agent_obl>agent_conj	path2=agent_conj	pos_1=,	relType_2=punct	lpib=h2_NNP	pos_2=NNP	lemma_2=H2	lib=h2	relType_2=conj	lemma_2=,	pos_5=JJ	relType_5=amod	lemma_3=,	relType_3=conj	path1=diuretic_conj	relType_2=compound	lemma_5=hypoglycemic	wib=H2	pos_2=NNS	pos_3=,	lemma_2=blocker	eib=True	lemma_4=oral	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e3	DDI-DrugBank.d640.s10.e4	null	lib=digoxin	lemma_1=,	eib=False	path=blocker_conj<agent_obl>digoxin_conj	pos_1=,	path2=digoxin_conj	relType_1=punct	path1=blocker_conj	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e3	DDI-DrugBank.d640.s10.e5	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	path2=agent_conj	pos_1=,	path=blocker_conj<agent_obl>agent_conj	path1=blocker_conj	relType_2=punct	lemma_4=hypoglycemic	relType_2=conj	lemma_2=,	lib=digoxin	relType_3=amod	lemma_2=digoxin	lpib=digoxin_NN	wib=digoxin	lemma_3=oral	pos_3=JJ	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d640.s10	DDI-DrugBank.d640.s10.e4	DDI-DrugBank.d640.s10.e5	null	path=digoxin_conj<agent_obl>agent_conj	lemma_2=oral	lemma_3=hypoglycemic	lemma_1=,	lib=oral	pos_3=JJ	relType_3=amod	eib=True	wib=oral	path2=agent_conj	relType_2=amod	pos_1=,	relType_1=punct	lpib=oral_JJ	pos_2=JJ	path1=digoxin_conj
DDI-DrugBank.d580.s1	DDI-DrugBank.d580.s1.e0	DDI-DrugBank.d580.s1.e1	mechanism	pos_2=DT	relType_7=compound	lemma_1=,	lemma_6=cytochrome	relType_4=appos	relType_11=ROOT	pos_13=NNS	pos_1=,	path2=level_obj>furoate_nmod	lemma_2=a	lemma_9=,	lemma_5=of	relType_5=case	pos_6=NN	pos_8=NN	lemma_13=level	pos_10=MD	relType_12=compound	relType_10=aux	pos_12=NN	lemma_12=plasma	pos_4=NN	path=ketoconazole_nsubj<increase_ROOT>level_obj>furoate_nmod	pos_14=IN	pos_15=NN	relType_3=amod	relation_10=beneficial	lib=potent	lemma_15=mometasone	pos_5=IN	path1=ketoconazole_nsubj	relType_9=punct	lemma_7=p450	relType_15=compound	relType_6=compound	lemma_11=increase	lemma_10=may	pos_3=JJ	lemma_3=potent	lpib=potent_JJ	eib=True	relType_8=nmod	pos_11=VB	wib=potent	relType_2=det	lemma_4=inhibitor	lemma_8=3a4	lemma_14=of	relType_13=obj	relType_14=case	pos_9=,	relType_1=punct	pos_7=NN
DDI-DrugBank.d739.s0	DDI-DrugBank.d739.s0.e0	DDI-DrugBank.d739.s0.e1	null	lemma_10=to	lemma_5=10	pos_8=JJ	pos_5=CD	pos_18=RB	relType_24=case	lemma_1=at	lpib=dose_NN	lemma_6=mg	pos_13=NN	lemma_11=pharmacokinetic	relType_20=obj	relation_19=neutral	lemma_14=-	lemma_22=the	lemma_18=clinically	relType_25=det	pos_24=IN	relType_21=case	pos_28=NN	lemma_17=cause	relType_26=amod	pos_7=IN	lemma_28=dose	pos_6=NNS	pos_11=JJ	lemma_9=dose	pos_2=DT	relType_1=case	path1=	pos_27=JJ	pos_29=IN	path2=dose_nmod>dose_dep>cause_dep>change_obj>kinetics_nmod>dose_nmod>theophylline_nmod	relType_28=nmod	pos_16=RB	relType_11=amod	pos_19=JJ	relType_17=dep	relType_12=amod	pos_1=IN	relType_5=nummod	lemma_19=significant	lemma_13=state	lib=dose	path=<montelukast_ROOT>dose_nmod>dose_dep>cause_dep>change_obj>kinetics_nmod>dose_nmod>theophylline_nmod	relType_19=amod	pos_22=DT	pos_15=VBD	relation_16=neutral	lemma_7=once	relType_14=punct	relType_29=case	wib=Dose	relType_8=nsubj	relType_27=amod	relType_7=mark	lemma_24=of	lemma_3=dose	pos_26=JJ	pos_23=NN	relType_13=obl	pos_21=IN	lemma_20=change	relType_23=nmod	relType_16=advmod	lemma_27=intravenous	pos_4=IN	relType_3=nmod	pos_10=IN	pos_14=HYPH	relType_22=det	lemma_25=a	relType_6=nmod	lemma_4=of	lemma_15=do	lemma_29=of	lemma_2=a	relType_9=dep	lemma_12=steady	pos_12=JJ	lemma_21=in	pos_25=DT	eib=False	relType_15=aux	relType_10=case	pos_9=VBN	relType_4=case	pos_17=VB	pos_20=NNS	lemma_8=daily	relType_18=advmod	pos_3=NN	relType_2=det	lemma_26=single	lemma_16=not	lemma_23=kinetics
DDI-DrugBank.d739.s1	DDI-DrugBank.d739.s1.e0	DDI-DrugBank.d739.s1.e1	null	relType_11=cc	pos_16=DT	pos_6=NN	relation_13=neutral	lemma_20=mg	pos_20=NN	relType_5=dep	lemma_11=or	lemma_18=30	path=warfarin_nmod<profile_iobj<change_ROOT>influence_conj>effect_obj>dose_nmod>warfarin_nmod	pos_1=-LRB-	relType_6=compound	lemma_10=)	pos_19=HYPH	relType_13=det	lemma_17=single	lemma_23=of	pos_2=DT	relType_3=dep	relType_22=nmod	lemma_15=of	pos_22=NN	relType_18=nummod	pos_21=JJ	lemma_6=p450	lemma_21=oral	pos_9=NN	lemma_9=2c9	relType_15=case	lemma_19=-	relation_11=neutral	relType_7=nmod	lemma_8=and	pos_15=IN	relType_17=amod	lemma_12=influence	pos_23=IN	relType_1=punct	pos_7=NN	lemma_14=effect	relType_10=punct	lemma_22=dose	path2=influence_conj>effect_obj>dose_nmod>warfarin_nmod	relType_19=punct	lemma_1=(	lemma_16=a	relType_14=obj	pos_14=NN	pos_8=CC	pos_4=IN	pos_11=CC	relType_23=case	pos_12=VB	relType_8=cc	lemma_4=of	relType_12=conj	lemma_5=cytochrome	lemma_13=the	relType_9=conj	lemma_7=2a6	pos_13=DT	lemma_2=a	pos_17=JJ	relType_16=det	eib=False	path1=warfarin_nmod<profile_iobj	pos_5=NNS	relType_21=amod	lib=substrate	lpib=substrate_NN	pos_18=CD	relType_4=case	lemma_3=substrate	wib=substrate	relType_20=compound	pos_3=NN	pos_10=-RRB-	relType_2=det
DDI-DrugBank.d739.s3	DDI-DrugBank.d739.s3.e0	DDI-DrugBank.d739.s3.e1	null	pos_2=DT	relType_3=dep	lemma_5=cytochrome	path2=fexofenadine_conj	lemma_7=3a4	relType_5=compound	relType_8=punct	lemma_2=a	lemma_6=p450	lemma_1=(	pos_6=NN	eib=False	lib=substrate	pos_8=-RRB-	lpib=substrate_NN	lemma_8=)	pos_9=CC	pos_4=IN	lemma_9=or	relType_4=case	relType_7=nmod	lemma_3=substrate	path1=terfenadine_nmod	pos_1=-LRB-	path=terfenadine_nmod<profile_obj>fexofenadine_conj	pos_5=NN	relType_6=compound	wib=substrate	pos_3=NN	relType_2=det	relType_1=punct	pos_7=NN	lemma_4=of	relType_9=cc
DDI-DrugBank.d739.s3	DDI-DrugBank.d739.s3.e0	DDI-DrugBank.d739.s3.e2	null	lemma_10=,	relType_21=obj	relType_8=punct	pos_6=NN	pos_20=NN	pos_10=NN	pos_13=NN	relType_23=compound	pos_9=CC	lemma_9=or	path1=terfenadine_nmod<profile_obj	lemma_15=and	pos_1=-LRB-	relType_6=compound	pos_10=,	lemma_17=not	pos_26=IN	pos_15=CC	relType_9=cc	relType_19=det	pos_2=DT	relType_3=dep	lemma_26=with	lemma_13=metabolite	lemma_21=interval	relType_11=nmod:poss	lemma_6=p450	relType_10=conj	relType_25=nmod	path=terfenadine_nmod<profile_obj<change_ROOT>prolong_conj>terfenadine_obl	relType_12=amod	relType_22=case	pos_17=RB	lemma_20=qtc	relType_7=nmod	path2=prolong_conj>terfenadine_obl	pos_5=NN	lemma_14=,	pos_12=VBN	relType_1=punct	pos_7=NN	pos_11=PRP$	pos_19=DT	relType_14=punct	relType_10=punct	lemma_7=3a4	pos_24=HYPH	lemma_11=its	relType_24=punct	lemma_1=(	pos_23=NN	pos_14=,	lemma_10=fexofenadine	lemma_8=)	lemma_22=follow	pos_4=IN	pos_18=VB	pos_25=NN	lemma_23=co	lemma_24=-	lemma_18=prolong	lemma_4=of	lemma_16=do	lemma_5=cytochrome	pos_16=VBD	relType_26=case	relType_5=compound	lemma_2=a	pos_22=VBG	relType_16=aux	lib=substrate	pos_8=-RRB-	lemma_19=the	lpib=substrate_NN	lemma_25=administration	relType_4=case	relType_15=cc	relType_17=advmod	lemma_3=substrate	wib=substrate	eib=True	relType_20=compound	pos_3=NN	relType_2=det	relType_13=obj	relType_18=conj	lemma_12=carboxylate	pos_21=NN
DDI-DrugBank.d739.s3	DDI-DrugBank.d739.s3.e1	DDI-DrugBank.d739.s3.e2	null	pos_13=VBG	lemma_1=,	relType_9=conj	relType_10=det	pos_5=,	relType_16=nmod	pos_3=VBN	pos_1=,	relType_7=aux	lemma_11=qtc	pos_9=VB	relType_14=compound	pos_15=HYPH	pos_17=IN	lemma_17=with	eib=False	pos_8=RB	lemma_8=not	lemma_9=prolong	lemma_10=the	relType_12=obj	pos_14=NN	wib=carboxylated	lpib=carboxylate_VBN	pos_4=NN	relType_8=advmod	relType_4=obj	lemma_15=-	relType_15=punct	relType_17=case	lemma_14=co	relType_13=case	relType_3=amod	path=fexofenadine_conj<profile_obj<change_ROOT>prolong_conj>terfenadine_obl	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	lemma_16=administration	pos_7=VBD	lib=carboxylate	pos_2=PRP$	lemma_2=its	lemma_3=carboxylate	lemma_4=metabolite	lemma_7=do	pos_16=NN	path2=prolong_conj>terfenadine_obl	lemma_13=follow	relType_2=nmod:poss	pos_11=NN	pos_10=DT	relType_11=compound	path1=fexofenadine_conj<profile_obj	relType_1=punct	pos_12=NN	lemma_12=interval	relType_6=cc
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e0	DDI-DrugBank.d739.s4.e1	null	pos_6=JJ	relType_22=dep	relType_24=case	lemma_20=concentration	lemma_1=at	relType_20=obj	lemma_14=do	relType_25=det	pos_24=IN	lemma_5=mg	relType_21=case	relType_4=nummod	relType_26=amod	lemma_26=oral	lemma_15=not	pos_15=RB	relType_8=case	relType_1=case	lemma_2=dose	pos_12=:	pos_18=DT	lemma_19=plasma	pos_16=RB	relType_17=dep	pos_1=IN	relType_12=punct	pos_8=IN	pos_4=CD	relType_19=compound	lemma_8=to	lib=dose	pos_11=NN	relation_16=neutral	lemma_7=dose	relType_18=det	lemma_21=of	lemma_18=the	pos_3=IN	lemma_9=pharmacokinetic	lemma_13=-	lemma_24=of	pos_13=HYPH	pos_26=JJ	pos_23=NN	lemma_23=component	relType_2=nmod	lemma_4=100	pos_21=IN	relType_9=amod	relType_23=nmod	relType_16=advmod	relType_11=obl	path2=alter_dep>concentration_obj>component_nmod>contraceptive_nmod	lemma_22=either	lpib=dose_NNS	path=montelukast_nsubj<dose_ROOT>alter_dep>concentration_obj>component_nmod>contraceptive_nmod	lemma_6=daily	pos_14=VBD	lemma_25=a	lemma_12=:	relType_10=amod	relType_13=punct	lemma_16=significantly	lemma_11=state	pos_22=CC	pos_9=JJ	pos_25=DT	eib=False	pos_5=NNS	relType_6=amod	pos_19=NN	relType_7=ROOT	lemma_17=alter	pos_10=JJ	pos_17=VB	relType_5=nmod	relType_14=aux	pos_20=NNS	lemma_10=steady	relType_3=case	pos_2=NNS	pos_7=VBN	wib=Doses	lemma_3=of	relType_15=advmod	path1=montelukast_nsubj
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e0	DDI-DrugBank.d739.s4.e2	null	pos_6=JJ	relType_22=dep	relType_24=case	lemma_20=concentration	relType_27=nmod	lemma_1=at	relType_20=obj	lemma_14=do	relType_25=det	pos_24=IN	lemma_5=mg	relType_21=case	relType_4=nummod	relType_26=amod	lemma_26=oral	lemma_15=not	pos_15=RB	relType_8=case	relType_1=case	lemma_2=dose	path=montelukast_nsubj<dose_ROOT>alter_dep>concentration_obj>component_nmod>contraceptive_nmod>contain_acl>mcg_obj>norethindrone_compound	pos_12=:	pos_18=DT	lemma_19=plasma	pos_16=RB	relType_17=dep	pos_1=IN	relType_12=punct	pos_8=IN	pos_4=CD	relType_19=compound	pos_27=NN	lemma_8=to	lib=dose	pos_11=NN	relation_16=neutral	lemma_7=dose	relType_18=det	lemma_21=of	pos_27=VBG	lemma_18=the	pos_3=IN	relType_27=acl	lemma_9=pharmacokinetic	lemma_13=-	lemma_24=of	pos_13=HYPH	pos_26=JJ	pos_23=NN	lemma_23=component	relType_2=nmod	lemma_4=100	lemma_27=contain	pos_21=IN	relType_9=amod	relType_23=nmod	relType_16=advmod	path2=alter_dep>concentration_obj>component_nmod>contraceptive_nmod>contain_acl>mcg_obj>norethindrone_compound	relType_11=obl	lemma_22=either	lpib=dose_NNS	lemma_6=daily	pos_14=VBD	lemma_25=a	lemma_12=:	relType_10=amod	relType_13=punct	lemma_27=contraceptive	lemma_16=significantly	lemma_11=state	pos_22=CC	pos_9=JJ	pos_25=DT	pos_5=NNS	relType_6=amod	pos_19=NN	relType_7=ROOT	lemma_17=alter	pos_10=JJ	pos_17=VB	relType_5=nmod	relType_14=aux	pos_20=NNS	lemma_10=steady	relType_3=case	pos_2=NNS	pos_7=VBN	eib=True	wib=Doses	lemma_3=of	relType_15=advmod	path1=montelukast_nsubj
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e0	DDI-DrugBank.d739.s4.e3	null	relType_30=dep	pos_6=JJ	lemma_30=/	relType_22=dep	relType_24=case	lemma_31=ethinyl	lemma_20=concentration	relType_27=nmod	lemma_1=at	relType_20=obj	lemma_14=do	lemma_29=mg	relType_25=det	pos_24=IN	lemma_5=mg	relType_21=case	relType_4=nummod	pos_28=NN	relType_26=amod	lemma_26=oral	lemma_15=not	pos_15=RB	relType_8=case	relType_1=case	lemma_28=norethindrone	lemma_2=dose	relType_28=nummod	pos_12=:	pos_18=DT	lemma_19=plasma	pos_16=RB	relType_17=dep	pos_29=NN	pos_1=IN	relType_12=punct	pos_8=IN	pos_4=CD	relType_19=compound	pos_27=NN	lemma_8=to	lib=dose	pos_11=NN	pos_31=NN	relation_16=neutral	lemma_7=dose	relType_18=det	lemma_21=of	pos_27=VBG	lemma_18=the	pos_30=SYM	pos_3=IN	relType_27=acl	lemma_9=pharmacokinetic	lemma_13=-	lemma_24=of	relType_29=compound	pos_13=HYPH	pos_26=JJ	pos_23=NN	lemma_23=component	relType_31=compound	relType_2=nmod	lemma_4=100	lemma_27=contain	pos_21=IN	relType_9=amod	relType_23=nmod	relType_16=advmod	relType_11=obl	lemma_22=either	lpib=dose_NNS	lemma_6=daily	path2=alter_dep>concentration_obj>component_nmod>contraceptive_nmod>contain_acl>mcg_obj>estradiol_compound	pos_14=VBD	lemma_25=a	lemma_12=:	relType_10=amod	relType_13=punct	lemma_27=contraceptive	lemma_16=significantly	pos_28=CD	lemma_11=state	pos_22=CC	pos_9=JJ	pos_25=DT	pos_5=NNS	relType_6=amod	pos_19=NN	relType_28=compound	relType_7=ROOT	lemma_17=alter	pos_10=JJ	path=montelukast_nsubj<dose_ROOT>alter_dep>concentration_obj>component_nmod>contraceptive_nmod>contain_acl>mcg_obj>estradiol_compound	pos_17=VB	relType_5=nmod	relType_14=aux	pos_20=NNS	lemma_10=steady	relType_3=case	pos_2=NNS	pos_7=VBN	eib=True	lemma_28=1	wib=Doses	lemma_3=of	relType_15=advmod	path1=montelukast_nsubj
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e1	DDI-DrugBank.d739.s4.e2	null	pos_1=VBG	eib=False	path=<contraceptive_nmod>contain_acl>mcg_obj>norethindrone_compound	relType_1=acl	path1=	lemma_1=contain	lib=contain	path2=contain_acl>mcg_obj>norethindrone_compound	wib=containing	lpib=contain_VBG
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e1	DDI-DrugBank.d739.s4.e3	null	relType_4=dep	pos_2=NN	relType_2=nummod	lemma_2=norethindrone	lemma_5=ethinyl	path1=	relType_5=compound	path2=contain_acl>mcg_obj>estradiol_compound	lemma_2=1	pos_2=CD	pos_4=SYM	lpib=contain_VBG	relType_2=compound	relType_1=acl	lemma_4=/	wib=containing	pos_1=VBG	pos_5=NN	path=<contraceptive_nmod>contain_acl>mcg_obj>estradiol_compound	eib=True	pos_3=NN	lemma_1=contain	relType_3=compound	lemma_3=mg	lib=contain
DDI-DrugBank.d739.s4	DDI-DrugBank.d739.s4.e2	DDI-DrugBank.d739.s4.e3	null	path1=norethindrone_compound	relType_3=dep	relType_1=nummod	pos_2=NN	lemma_4=ethinyl	pos_3=SYM	lib=mg	pos_1=CD	eib=False	lpib=mg_NN	path2=estradiol_compound	lemma_3=/	pos_4=NN	path=norethindrone_compound<mcg_obj>estradiol_compound	relType_2=compound	relType_4=compound	lemma_2=mg	wib=mg	lemma_1=1
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e0	DDI-DrugBank.d739.s5.e1	null	relType_1=cc	pos_1=CC	lib=prednisolone	eib=False	path=<prednisone_nmod>prednisolone_conj	wib=prednisolone	path1=	lpib=prednisolone_NN	path2=prednisolone_conj	lemma_1=or
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e0	DDI-DrugBank.d739.s5.e2	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_6=JJ	lib=prednisolone	pos_5=CC	lemma_3=administration	path=prednisone_nmod<profile_nmod<change_obj>administration_nmod>prednisone_nmod	lemma_2=prednisolone	path1=prednisone_nmod<profile_nmod	path2=administration_nmod>prednisone_nmod	lemma_2=follow	relType_6=amod	relType_2=conj	lemma_5=either	lemma_6=oral	pos_4=IN	wib=prednisolone	relType_3=nmod	relType_4=case	relType_2=case	eib=True	pos_3=NN	lpib=prednisolone_NN	relType_5=cc:preconj	lemma_4=of	lemma_1=or	pos_2=VBG
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e0	DDI-DrugBank.d739.s5.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_6=JJ	lib=prednisolone	pos_5=CC	path2=administration_nmod>prednisone_nmod>prednisolone_conj	relType_8=amod	lemma_3=administration	relType_7=cc	pos_8=JJ	lemma_2=prednisolone	path1=prednisone_nmod<profile_nmod	lemma_2=follow	relType_6=amod	relType_2=conj	lemma_8=intravenous	lemma_5=either	lemma_6=oral	pos_7=CC	pos_4=IN	wib=prednisolone	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_7=or	lemma_7=prednisone	relType_2=case	eib=True	pos_3=NN	path=prednisone_nmod<profile_nmod<change_obj>administration_nmod>prednisone_nmod>prednisolone_conj	lpib=prednisolone_NN	pos_7=NN	relType_5=cc:preconj	lemma_4=of	lemma_1=or	pos_2=VBG
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e1	DDI-DrugBank.d739.s5.e2	null	relType_1=case	pos_2=NN	pos_3=IN	path=prednisolone_conj<prednisone_nmod<profile_nmod<change_obj>administration_nmod>prednisone_nmod	lemma_4=either	wib=following	lemma_5=oral	eib=False	relType_2=nmod	path2=administration_nmod>prednisone_nmod	pos_5=JJ	relType_5=amod	lib=follow	lemma_1=follow	lpib=follow_VBG	relType_3=case	pos_1=VBG	lemma_2=administration	pos_4=CC	lemma_3=of	relType_4=cc:preconj	path1=prednisolone_conj<prednisone_nmod<profile_nmod
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e1	DDI-DrugBank.d739.s5.e3	null	relType_1=case	pos_2=NN	pos_3=IN	path2=administration_nmod>prednisone_nmod>prednisolone_conj	lemma_4=either	lemma_7=intravenous	pos_6=NN	wib=following	lemma_5=oral	relType_2=nmod	lemma_6=or	path=prednisolone_conj<prednisone_nmod<profile_nmod<change_obj>administration_nmod>prednisone_nmod>prednisolone_conj	relType_6=nmod	pos_5=JJ	relType_7=amod	relType_5=amod	pos_6=CC	lib=follow	lemma_1=follow	lpib=follow_VBG	relType_3=case	lemma_6=prednisone	pos_1=VBG	lemma_2=administration	eib=True	pos_4=CC	pos_7=JJ	lemma_3=of	relType_4=cc:preconj	path1=prednisolone_conj<prednisone_nmod<profile_nmod	relType_6=cc
DDI-DrugBank.d739.s5	DDI-DrugBank.d739.s5.e2	DDI-DrugBank.d739.s5.e3	null	relType_1=cc	pos_1=CC	wib=intravenous	lpib=intravenous_JJ	eib=False	path=<prednisone_nmod>prednisolone_conj	lemma_2=intravenous	path1=	relType_2=amod	path2=prednisolone_conj	pos_2=JJ	lib=intravenous	lemma_1=or
DDI-DrugBank.d739.s6	DDI-DrugBank.d739.s6.e0	DDI-DrugBank.d739.s6.e1	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_8=DT	pos_1=,	lemma_6=,	wib=induces	lemma_10=of	pos_2=WDT	path1=Phenobarbital_nsubj	lemma_3=induce	relType_3=acl:relcl	relType_2=nsubj	eib=False	relType_6=punct	relation_6=adverse	relation_2=neutral	pos_3=VBZ	relType_10=case	pos_9=NN	relType_7=ROOT	lemma_8=the	pos_7=VBD	relType_9=obj	path2=auc_obj>montelukast_nmod	lemma_7=decrease	pos_10=IN	lemma_4=hepatic	pos_6=,	lpib=induce_VBZ	lemma_2=which	pos_5=NN	lemma_9=auc	relType_5=obj	relType_8=det	path=Phenobarbital_nsubj<decrease_ROOT>auc_obj>montelukast_nmod	relType_1=punct	lib=induce	lemma_5=metabolism
DDI-DrugBank.d739.s6	DDI-DrugBank.d739.s6.e0	DDI-DrugBank.d739.s6.e2	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_8=DT	pos_1=,	lemma_6=,	wib=induces	lemma_10=of	pos_12=CD	relType_13=obl:npmod	lemma_15=a	pos_2=WDT	path1=Phenobarbital_nsubj	relType_16=amod	lemma_3=induce	lemma_11=approximately	relType_3=acl:relcl	relType_2=nsubj	lemma_13=%	relType_6=punct	relType_17=nummod	pos_18=HYPH	relation_2=neutral	relType_20=nmod	pos_3=VBZ	pos_20=NN	relation_6=adverse	pos_21=IN	lemma_14=follow	pos_19=NN	relType_10=case	pos_13=NN	relType_11=advmod	pos_9=NN	pos_15=DT	lemma_18=-	lemma_12=40	relType_19=compound	pos_16=JJ	relType_7=ROOT	pos_14=VBG	lemma_21=of	lemma_8=the	pos_7=VBD	relType_9=obj	relType_18=punct	lemma_7=decrease	pos_10=IN	lemma_19=mg	lemma_4=hepatic	pos_11=RB	pos_17=CD	path2=%_obl:npmod>dose_nmod>montelukast_nmod	pos_6=,	relType_21=case	lpib=induce_VBZ	lemma_2=which	pos_5=NN	lemma_9=auc	pos_11=NN	eib=True	path=Phenobarbital_nsubj<decrease_ROOT>%_obl:npmod>dose_nmod>montelukast_nmod	relType_5=obj	lemma_17=10	lemma_20=dose	relType_12=nummod	lemma_11=montelukast	relType_8=det	relType_11=nmod	relType_1=punct	relType_14=case	lib=induce	relType_15=det	lemma_5=metabolism	lemma_16=single
DDI-DrugBank.d739.s6	DDI-DrugBank.d739.s6.e1	DDI-DrugBank.d739.s6.e2	null	lemma_4=follow	lemma_10=dose	relType_2=nummod	pos_6=JJ	relType_3=obl:npmod	pos_7=CD	relType_8=punct	wib=approximately	relType_11=case	lemma_5=a	relType_10=nmod	relType_9=compound	eib=False	relType_7=nummod	pos_2=CD	relType_6=amod	pos_8=HYPH	pos_10=NN	pos_9=NN	relType_1=advmod	lemma_9=mg	pos_11=IN	lib=approximately	lemma_7=10	lemma_3=%	relType_5=det	relType_4=case	path=montelukast_nmod<auc_obj<decrease_ROOT>%_obl:npmod>dose_nmod>montelukast_nmod	lemma_1=approximately	pos_4=VBG	path2=%_obl:npmod>dose_nmod>montelukast_nmod	path1=montelukast_nmod<auc_obj	lpib=approximately_RB	pos_1=RB	pos_3=NN	lemma_8=-	pos_5=DT	lemma_11=of	lemma_2=40	lemma_6=single
DDI-DrugBank.d739.s8	DDI-DrugBank.d739.s8.e0	DDI-DrugBank.d739.s8.e1	null	relType_1=cc	wib=rifampin	pos_1=CC	lemma_1=or	eib=False	path=<phenobarbital_nmod>rifampin_conj	lpib=rifampin_NN	path1=	lib=rifampin	path2=rifampin_conj
DDI-DrugBank.d739.s8	DDI-DrugBank.d739.s8.e0	DDI-DrugBank.d739.s8.e2	advise	relType_1=cc	relType_4=dep	wib=rifampin	pos_1=CC	pos_2=NN	relType_7=case	relType_3=aux:pass	lemma_7=with	relType_2=punct	path1=phenobarbital_nmod<inducer_nsubj:pass	lpib=rifampin_NN	pos_5=HYPH	pos_6=VBN	relType_6=advcl	relType_2=conj	pos_4=NN	lemma_2=,	path2=montelukast_obl	lemma_4=co	relType_5=punct	lemma_3=be	lemma_6=administer	lib=rifampin	path=phenobarbital_nmod<inducer_nsubj:pass<administer_advcl>montelukast_obl	eib=True	pos_7=IN	lemma_2=rifampin	pos_2=,	lemma_5=-	lemma_1=or	pos_3=VBP
DDI-DrugBank.d739.s8	DDI-DrugBank.d739.s8.e1	DDI-DrugBank.d739.s8.e2	advise	relType_3=dep	lemma_1=,	lpib=be_VBP	pos_1=,	lemma_4=-	pos_4=HYPH	relType_6=case	relType_5=advcl	eib=False	pos_6=IN	wib=are	path=rifampin_conj<phenobarbital_nmod<inducer_nsubj:pass<administer_advcl>montelukast_obl	path2=montelukast_obl	lib=be	relType_4=punct	relType_2=aux:pass	pos_2=VBP	lemma_6=with	lemma_5=administer	lemma_3=co	path1=rifampin_conj<phenobarbital_nmod<inducer_nsubj:pass	pos_3=NN	lemma_2=be	relType_1=punct	pos_5=VBN
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e1	null	relType_14=punct	pos_8=DT	relType_7=case	relType_1=aux	pos_12=VBG	lemma_12=follow	lemma_9=pharmacokinetic	pos_13=NNS	pos_14=:	wib=did	lemma_10=of	lemma_13=drug	pos_3=VB	relType_9=nmod	path2=theophylline_parataxis	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	lemma_7=on	relation_5=neutral	pos_9=NNS	lemma_4=clinically	relType_12=amod	relType_10=case	pos_5=JJ	relType_5=amod	relType_3=ROOT	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_10=IN	lpib=do_VBD	pos_11=DT	lemma_11=the	relType_11=det	relType_6=obj	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis	lib=do	lemma_14=:	pos_7=IN	pos_6=NNS	relType_8=det	lemma_3=have	lemma_2=not	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e2	null	relType_14=punct	pos_8=DT	relType_7=case	relType_1=aux	pos_12=VBG	lemma_12=follow	lemma_9=pharmacokinetic	pos_13=NNS	pos_14=:	wib=did	lemma_10=of	lemma_13=drug	pos_3=VB	path2=theophylline_parataxis>prednisone_conj	relType_9=nmod	lemma_15=theophylline	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	pos_1=VBD	relType_2=advmod	lemma_1=do	lemma_7=on	pos_15=,	relation_5=neutral	pos_9=NNS	lemma_4=clinically	relType_12=amod	relType_10=case	relType_15=punct	lemma_3=have	pos_5=JJ	relType_5=amod	pos_15=NN	relType_3=ROOT	lemma_15=,	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_10=IN	lpib=do_VBD	pos_11=DT	lemma_11=the	relType_15=parataxis	relType_11=det	relType_6=obj	lib=do	lemma_14=:	eib=True	pos_7=IN	pos_6=NNS	relType_8=det	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>prednisone_conj	lemma_2=not	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e3	null	relType_14=punct	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>prednisolone_conj	pos_8=DT	relType_7=case	relType_1=aux	pos_12=VBG	lemma_12=follow	lemma_9=pharmacokinetic	pos_13=NNS	pos_14=:	wib=did	lemma_10=of	lemma_13=drug	pos_3=VB	relType_9=nmod	lemma_15=theophylline	relType_13=nmod	lemma_16=prednisone	pos_2=RB	lemma_5=important	pos_4=RB	pos_1=VBD	relType_2=advmod	lemma_1=do	lemma_7=on	pos_15=,	relation_5=neutral	pos_9=NNS	pos_16=,	lemma_4=clinically	relType_12=amod	relType_10=case	lemma_16=,	relType_15=punct	pos_5=JJ	relType_5=amod	pos_15=NN	relType_3=ROOT	lemma_15=,	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_10=IN	lpib=do_VBD	pos_11=DT	lemma_11=the	relType_15=parataxis	pos_16=NN	relType_11=det	relType_16=punct	relType_6=obj	lib=do	lemma_14=:	eib=True	pos_7=IN	pos_6=NNS	path2=theophylline_parataxis>prednisolone_conj	relType_8=det	lemma_3=have	relType_16=conj	lemma_2=not	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e4	null	lemma_17=prednisolone	relType_14=punct	pos_8=DT	relType_7=case	relType_1=aux	pos_12=VBG	lemma_12=follow	lemma_9=pharmacokinetic	relType_17=punct	pos_13=NNS	pos_14=:	wib=did	lemma_10=of	lemma_13=drug	lemma_18=oral	relType_18=amod	pos_3=VB	relType_9=nmod	lemma_15=theophylline	relType_17=conj	relType_13=nmod	lemma_16=prednisone	pos_2=RB	lemma_5=important	pos_4=RB	pos_1=VBD	pos_17=NN	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>contraceptive_conj	lemma_17=,	relType_2=advmod	lemma_1=do	lemma_7=on	pos_15=,	relation_5=neutral	pos_9=NNS	pos_16=,	lemma_4=clinically	relType_12=amod	pos_18=JJ	relType_10=case	path2=theophylline_parataxis>contraceptive_conj	lemma_16=,	relType_15=punct	pos_17=,	pos_5=JJ	relType_5=amod	pos_15=NN	relType_3=ROOT	lemma_15=,	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_10=IN	lpib=do_VBD	pos_11=DT	lemma_11=the	relType_15=parataxis	pos_16=NN	relType_11=det	relType_16=punct	relType_6=obj	lib=do	lemma_14=:	eib=True	pos_7=IN	pos_6=NNS	relType_8=det	lemma_3=have	relType_16=conj	lemma_2=not	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e5	null	pos_13=NNS	pos_14=:	lemma_10=of	pos_19=-LRB-	lemma_1=do	lemma_16=,	relType_3=ROOT	path2=theophylline_parataxis>contraceptive_conj>mg_appos>norethindrone_compound	relType_16=punct	relType_11=det	lemma_14=:	pos_7=IN	pos_6=NNS	lemma_2=not	pos_8=DT	relType_7=case	relType_1=aux	lemma_13=drug	pos_3=VB	pos_19=NNS	pos_1=VBD	relType_12=amod	lemma_15=,	pos_16=NN	lemma_11=the	lemma_3=have	lemma_17=prednisolone	relType_14=punct	pos_12=VBG	lemma_19=(	lemma_9=pharmacokinetic	relType_17=punct	wib=did	lemma_18=oral	relType_19=punct	lemma_16=prednisone	pos_17=NN	relation_5=neutral	lemma_7=on	pos_15=,	lemma_4=clinically	relType_15=punct	pos_17=,	lemma_19=contraceptive	relType_5=amod	pos_10=IN	relType_19=conj	relType_8=det	lemma_12=follow	relType_18=amod	relType_9=nmod	lemma_15=theophylline	relType_17=conj	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	lemma_17=,	relType_2=advmod	pos_9=NNS	pos_16=,	pos_18=JJ	relType_10=case	pos_5=JJ	pos_15=NN	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_11=DT	lpib=do_VBD	relType_15=parataxis	relType_6=obj	lib=do	eib=True	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>contraceptive_conj>mg_appos>norethindrone_compound	relType_16=conj	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e7	null	pos_13=NNS	pos_14=:	lemma_10=of	relType_22=dep	pos_19=-LRB-	lemma_1=do	pos_20=NN	pos_23=CD	lemma_21=mg	lemma_16=,	lemma_23=ethinyl	relType_23=compound	lemma_20=norethindrone	relType_3=ROOT	lemma_22=/	relType_16=punct	relType_11=det	lemma_14=:	pos_7=IN	pos_6=NNS	lemma_2=not	pos_8=DT	relType_7=case	relType_1=aux	lemma_13=drug	pos_3=VB	pos_19=NNS	pos_20=CD	pos_1=VBD	relType_12=amod	lemma_23=35	lemma_15=,	pos_16=NN	lemma_23=estradiol	lemma_11=the	relType_25=punct	relType_26=punct	lemma_3=have	lemma_17=prednisolone	relType_14=punct	pos_12=VBG	lemma_19=(	lemma_9=pharmacokinetic	relType_17=punct	wib=did	lemma_18=oral	relType_20=nummod	pos_24=NN	relType_19=punct	pos_23=NN	lemma_16=prednisone	pos_17=NN	pos_21=NN	relation_5=neutral	lemma_7=on	pos_15=,	lemma_4=clinically	relType_15=punct	relType_23=nmod	pos_17=,	lemma_19=contraceptive	relType_5=amod	pos_10=IN	relType_19=conj	lemma_25=)	relType_8=det	pos_22=SYM	relType_21=appos	relType_23=nummod	pos_25=-RRB-	lemma_12=follow	relType_18=amod	lemma_24=mcg	relType_9=nmod	lemma_15=theophylline	relType_17=conj	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	lemma_20=1	lemma_17=,	relType_2=advmod	pos_9=NNS	pos_16=,	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>terfenadine_conj	pos_18=JJ	relType_10=case	relType_24=dep	pos_5=JJ	pos_15=NN	lemma_8=the	relType_4=advmod	path2=theophylline_parataxis>terfenadine_conj	lemma_6=effect	pos_11=DT	lpib=do_VBD	relType_15=parataxis	relType_6=obj	lib=do	eib=True	relType_20=compound	pos_26=,	lemma_26=,	relType_16=conj	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e8	null	pos_13=NNS	pos_14=:	lemma_10=of	relType_22=dep	pos_27=,	pos_19=-LRB-	lemma_1=do	pos_20=NN	pos_23=CD	lemma_21=mg	lemma_16=,	lemma_23=ethinyl	relType_23=compound	lemma_20=norethindrone	relType_3=ROOT	lemma_22=/	relType_16=punct	relType_11=det	lemma_14=:	pos_7=IN	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>digoxin_conj	pos_6=NNS	lemma_2=not	pos_8=DT	relType_7=case	relType_1=aux	relType_27=conj	lemma_13=drug	pos_3=VB	pos_19=NNS	pos_20=CD	pos_1=VBD	relType_12=amod	pos_27=NN	lemma_23=35	lemma_15=,	pos_16=NN	lemma_23=estradiol	lemma_11=the	relType_25=punct	relType_26=punct	lemma_3=have	lemma_17=prednisolone	relType_14=punct	pos_12=VBG	lemma_19=(	lemma_9=pharmacokinetic	relType_17=punct	wib=did	lemma_18=oral	relType_20=nummod	pos_24=NN	relType_19=punct	pos_23=NN	lemma_16=prednisone	pos_17=NN	pos_21=NN	relation_5=neutral	lemma_7=on	pos_15=,	lemma_4=clinically	relType_15=punct	relType_23=nmod	pos_17=,	lemma_19=contraceptive	relType_5=amod	pos_10=IN	path2=theophylline_parataxis>digoxin_conj	relType_19=conj	lemma_25=)	relType_8=det	relType_27=punct	pos_22=SYM	relType_21=appos	relType_23=nummod	pos_25=-RRB-	lemma_12=follow	relType_18=amod	lemma_27=terfenadine	lemma_24=mcg	relType_9=nmod	lemma_15=theophylline	relType_17=conj	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	lemma_20=1	lemma_17=,	relType_2=advmod	pos_9=NNS	pos_16=,	pos_18=JJ	relType_10=case	relType_24=dep	pos_5=JJ	pos_15=NN	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_11=DT	lpib=do_VBD	relType_15=parataxis	lemma_27=,	relType_6=obj	lib=do	eib=True	relType_20=compound	pos_26=,	lemma_26=,	relType_16=conj	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e0	DDI-DrugBank.d739.s10.e9	null	pos_13=NNS	pos_14=:	lemma_10=of	relType_22=dep	pos_27=,	pos_19=-LRB-	relType_28=punct	lemma_1=do	path2=theophylline_parataxis>warfarin_conj	pos_20=NN	pos_23=CD	lemma_21=mg	lemma_16=,	lemma_23=ethinyl	relType_23=compound	lemma_20=norethindrone	relType_3=ROOT	lemma_22=/	lemma_29=and	relType_16=punct	relType_11=det	pos_28=NN	lemma_14=:	pos_7=IN	relType_28=conj	pos_6=NNS	lemma_28=,	lemma_2=not	pos_8=DT	relType_7=case	relType_1=aux	relType_27=conj	lemma_13=drug	pos_3=VB	pos_19=NNS	pos_20=CD	pos_1=VBD	relType_12=amod	pos_27=NN	lemma_23=35	lemma_15=,	lemma_28=digoxin	pos_16=NN	lemma_23=estradiol	relType_29=cc	lemma_11=the	relType_25=punct	relType_26=punct	lemma_3=have	lemma_17=prednisolone	relType_14=punct	path=montelukast_nmod<dose_nsubj<have_ROOT>theophylline_parataxis>warfarin_conj	pos_12=VBG	lemma_19=(	lemma_9=pharmacokinetic	relType_17=punct	wib=did	lemma_18=oral	relType_20=nummod	pos_24=NN	relType_19=punct	pos_23=NN	lemma_16=prednisone	pos_17=NN	pos_21=NN	relation_5=neutral	lemma_7=on	pos_15=,	lemma_4=clinically	relType_15=punct	pos_29=CC	relType_23=nmod	pos_17=,	lemma_19=contraceptive	relType_5=amod	pos_10=IN	relType_19=conj	lemma_25=)	relType_8=det	relType_27=punct	pos_22=SYM	relType_21=appos	relType_23=nummod	pos_25=-RRB-	lemma_12=follow	relType_18=amod	lemma_27=terfenadine	lemma_24=mcg	relType_9=nmod	lemma_15=theophylline	relType_17=conj	relType_13=nmod	pos_2=RB	lemma_5=important	pos_4=RB	lemma_20=1	lemma_17=,	relType_2=advmod	pos_9=NNS	pos_16=,	pos_18=JJ	relType_10=case	relType_24=dep	pos_28=,	pos_5=JJ	pos_15=NN	lemma_8=the	relType_4=advmod	lemma_6=effect	pos_11=DT	lpib=do_VBD	relType_15=parataxis	lemma_27=,	relType_6=obj	lib=do	eib=True	relType_20=compound	pos_26=,	lemma_26=,	relType_16=conj	path1=montelukast_nmod<dose_nsubj
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e2	null	path2=prednisone_conj	lemma_1=,	eib=False	path=<theophylline_parataxis>prednisone_conj	path1=	pos_1=,	wib=prednisone	relType_1=punct	lpib=prednisone_NN	lib=prednisone
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e3	null	path=<theophylline_parataxis>prednisolone_conj	lemma_1=,	pos_2=NN	relType_2=punct	eib=True	path1=	pos_1=,	pos_2=,	wib=prednisone	path2=prednisolone_conj	lemma_2=prednisone	relType_1=punct	lpib=prednisone_NN	relType_2=conj	lemma_2=,	lib=prednisone
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e4	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	path=<theophylline_parataxis>contraceptive_conj	path1=	pos_1=,	relType_2=punct	lpib=prednisone_NN	path2=contraceptive_conj	relType_2=conj	lemma_2=,	lemma_2=prednisone	lemma_3=,	relType_3=conj	lemma_3=prednisolone	wib=prednisone	pos_3=,	eib=True	lemma_4=oral	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=prednisone
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e5	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_5=contraceptive	path1=	pos_1=,	relType_2=punct	lpib=prednisone_NN	path=<theophylline_parataxis>contraceptive_conj>mg_appos>norethindrone_compound	pos_5=NNS	lemma_5=(	relType_2=conj	lemma_2=,	lemma_2=prednisone	lemma_3=,	relType_3=conj	lemma_3=prednisolone	relType_5=punct	wib=prednisone	relType_5=conj	path2=contraceptive_conj>mg_appos>norethindrone_compound	pos_3=,	eib=True	lemma_4=oral	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=prednisone	pos_5=-LRB-
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e7	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_5=contraceptive	relType_7=appos	relType_8=dep	lemma_6=1	path1=	pos_1=,	pos_6=CD	relType_9=nmod	relType_10=dep	relType_2=punct	lpib=prednisone_NN	pos_6=NN	relType_9=nummod	lemma_12=,	path2=terfenadine_conj	relType_9=compound	pos_5=NNS	relType_11=punct	lemma_11=)	pos_12=,	lemma_6=norethindrone	lemma_9=estradiol	lemma_5=(	relType_12=punct	pos_10=NN	relType_2=conj	pos_9=NN	lemma_2=,	lemma_2=prednisone	lemma_7=mg	lemma_3=,	relType_3=conj	lemma_3=prednisolone	path=<theophylline_parataxis>terfenadine_conj	relType_5=punct	lemma_10=mcg	relType_6=nummod	lemma_9=ethinyl	wib=prednisone	pos_8=SYM	relType_5=conj	pos_11=-RRB-	relType_6=compound	pos_3=,	pos_9=CD	eib=True	lemma_4=oral	pos_3=NN	lemma_9=35	lemma_8=/	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct	lib=prednisone	pos_5=-LRB-
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e8	null	relType_4=amod	pos_13=,	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_5=contraceptive	relType_7=appos	relType_8=dep	lemma_13=,	lemma_6=1	path1=	pos_1=,	pos_6=CD	relType_13=punct	relType_9=nmod	relType_10=dep	relType_2=punct	lpib=prednisone_NN	pos_6=NN	relType_9=nummod	lemma_12=,	relType_9=compound	pos_5=NNS	relType_11=punct	lemma_11=)	pos_12=,	lemma_6=norethindrone	path2=digoxin_conj	lemma_9=estradiol	lemma_5=(	relType_12=punct	relType_13=conj	pos_10=NN	pos_13=NN	relType_2=conj	pos_9=NN	lemma_2=,	lemma_2=prednisone	lemma_7=mg	lemma_3=,	relType_3=conj	lemma_3=prednisolone	relType_5=punct	lemma_10=mcg	relType_6=nummod	lemma_9=ethinyl	wib=prednisone	pos_8=SYM	relType_5=conj	pos_11=-RRB-	relType_6=compound	pos_3=,	pos_9=CD	eib=True	lemma_4=oral	lemma_13=terfenadine	pos_3=NN	lemma_9=35	lemma_8=/	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct	path=<theophylline_parataxis>digoxin_conj	lib=prednisone	pos_5=-LRB-
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e1	DDI-DrugBank.d739.s10.e9	null	relType_4=amod	pos_13=,	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_5=contraceptive	relType_7=appos	relType_8=dep	lemma_13=,	relType_14=punct	lemma_6=1	path1=	pos_1=,	pos_6=CD	relType_13=punct	relType_9=nmod	relType_10=dep	relType_2=punct	lpib=prednisone_NN	pos_6=NN	relType_9=nummod	lemma_12=,	relType_9=compound	pos_5=NNS	pos_14=,	relType_11=punct	lemma_11=)	pos_12=,	lemma_6=norethindrone	lemma_9=estradiol	lemma_5=(	relType_12=punct	relType_13=conj	pos_10=NN	pos_13=NN	relType_2=conj	pos_9=NN	lemma_2=,	pos_14=NN	lemma_2=prednisone	lemma_7=mg	lemma_3=,	relType_3=conj	lemma_3=prednisolone	relType_5=punct	lemma_14=digoxin	lemma_10=mcg	relType_6=nummod	lemma_9=ethinyl	wib=prednisone	pos_8=SYM	relType_15=cc	relType_5=conj	lemma_15=and	pos_11=-RRB-	path2=warfarin_conj	path=<theophylline_parataxis>warfarin_conj	relType_6=compound	lemma_14=,	pos_3=,	pos_9=CD	eib=True	lemma_4=oral	lemma_13=terfenadine	pos_3=NN	relType_14=conj	lemma_9=35	lemma_8=/	pos_2=,	pos_15=CC	relType_1=punct	pos_7=NN	relType_3=punct	lib=prednisone	pos_5=-LRB-
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e3	null	lemma_1=,	lib=prednisolone	eib=False	path=prednisone_conj<theophylline_parataxis>prednisolone_conj	wib=prednisolone	pos_1=,	lpib=prednisolone_NN	path1=prednisone_conj	path2=prednisolone_conj	relType_1=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e4	null	lemma_1=,	pos_2=NN	lib=prednisolone	pos_1=,	path=prednisone_conj<theophylline_parataxis>contraceptive_conj	path1=prednisone_conj	relType_2=punct	lemma_2=prednisolone	path2=contraceptive_conj	relType_2=conj	lemma_2=,	relType_3=amod	wib=prednisolone	lemma_3=oral	pos_3=JJ	eib=True	pos_2=,	lpib=prednisolone_NN	relType_1=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e5	null	lemma_1=,	pos_2=NN	lib=prednisolone	pos_1=,	path1=prednisone_conj	relType_2=punct	lemma_2=prednisolone	pos_4=-LRB-	relType_2=conj	lemma_2=,	pos_4=NNS	lemma_4=(	path=prednisone_conj<theophylline_parataxis>contraceptive_conj>mg_appos>norethindrone_compound	relType_3=amod	lemma_4=contraceptive	relType_4=punct	wib=prednisolone	lemma_3=oral	path2=contraceptive_conj>mg_appos>norethindrone_compound	pos_3=JJ	eib=True	pos_2=,	relType_4=conj	lpib=prednisolone_NN	relType_1=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e7	null	lemma_5=1	lemma_1=,	relType_8=nummod	pos_2=NN	relType_10=punct	lib=prednisolone	lemma_11=,	pos_1=,	lemma_7=/	relType_5=compound	path1=prednisone_conj	relType_9=dep	relType_2=punct	pos_6=NN	pos_8=NN	pos_5=CD	path2=terfenadine_conj	lemma_2=prednisolone	pos_4=-LRB-	relType_11=punct	lemma_6=mg	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lemma_4=(	pos_7=SYM	lemma_4=contraceptive	relType_3=amod	relType_4=punct	relType_5=nummod	lemma_8=35	relType_8=compound	wib=prednisolone	lemma_9=mcg	pos_11=,	path=prednisone_conj<theophylline_parataxis>terfenadine_conj	pos_5=NN	lemma_3=oral	lemma_10=)	pos_3=JJ	relType_6=appos	eib=True	relType_7=dep	lemma_8=ethinyl	relType_8=nmod	lemma_8=estradiol	pos_10=-RRB-	lemma_5=norethindrone	pos_2=,	relType_4=conj	lpib=prednisolone_NN	pos_8=CD	relType_1=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e8	null	lemma_5=1	relType_12=conj	lemma_1=,	relType_8=nummod	pos_2=NN	relType_10=punct	lib=prednisolone	lemma_11=,	pos_1=,	lemma_7=/	relType_5=compound	path1=prednisone_conj	relType_9=dep	relType_2=punct	pos_6=NN	pos_8=NN	pos_5=CD	lemma_12=,	path=prednisone_conj<theophylline_parataxis>digoxin_conj	lemma_2=prednisolone	pos_4=-LRB-	relType_11=punct	pos_12=,	path2=digoxin_conj	relType_12=punct	lemma_6=mg	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lemma_4=(	pos_7=SYM	lemma_4=contraceptive	relType_3=amod	relType_4=punct	relType_5=nummod	lemma_8=35	relType_8=compound	wib=prednisolone	lemma_9=mcg	pos_11=,	pos_5=NN	lemma_12=terfenadine	lemma_3=oral	lemma_10=)	pos_3=JJ	relType_6=appos	eib=True	relType_7=dep	lemma_8=ethinyl	relType_8=nmod	lemma_8=estradiol	pos_10=-RRB-	lemma_5=norethindrone	pos_2=,	relType_4=conj	lpib=prednisolone_NN	pos_8=CD	relType_1=punct	pos_12=NN
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e2	DDI-DrugBank.d739.s10.e9	null	lemma_5=1	relType_12=conj	lemma_1=,	relType_8=nummod	pos_2=NN	relType_10=punct	lib=prednisolone	lemma_11=,	pos_13=,	lemma_13=,	pos_14=CC	pos_1=,	lemma_7=/	relType_13=punct	relType_5=compound	path1=prednisone_conj	relType_9=dep	relType_2=punct	pos_6=NN	pos_8=NN	pos_5=CD	lemma_12=,	lemma_2=prednisolone	pos_4=-LRB-	relType_11=punct	pos_12=,	relType_12=punct	lemma_6=mg	pos_13=NN	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	pos_4=NNS	lemma_4=(	pos_7=SYM	path=prednisone_conj<theophylline_parataxis>warfarin_conj	lemma_4=contraceptive	relType_3=amod	relType_4=punct	relType_5=nummod	lemma_8=35	relType_8=compound	wib=prednisolone	lemma_9=mcg	relType_14=cc	pos_11=,	path2=warfarin_conj	pos_5=NN	lemma_12=terfenadine	lemma_3=oral	lemma_10=)	pos_3=JJ	relType_6=appos	eib=True	relType_7=dep	lemma_8=ethinyl	relType_8=nmod	lemma_8=estradiol	pos_10=-RRB-	lemma_14=and	lemma_5=norethindrone	pos_2=,	relType_4=conj	lpib=prednisolone_NN	lemma_13=digoxin	pos_8=CD	relType_1=punct	pos_12=NN
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e3	DDI-DrugBank.d739.s10.e4	null	lemma_2=oral	path1=prednisolone_conj	path=prednisolone_conj<theophylline_parataxis>contraceptive_conj	lemma_1=,	lib=oral	eib=False	wib=oral	relType_2=amod	pos_1=,	relType_1=punct	lpib=oral_JJ	path2=contraceptive_conj	pos_2=JJ
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e3	DDI-DrugBank.d739.s10.e5	null	path1=prednisolone_conj	lemma_1=,	lib=oral	pos_1=,	lemma_3=contraceptive	pos_2=JJ	path=prednisolone_conj<theophylline_parataxis>contraceptive_conj>mg_appos>norethindrone_compound	pos_3=NNS	lemma_3=(	pos_3=-LRB-	lemma_2=oral	relType_3=conj	relType_2=amod	lpib=oral_JJ	path2=contraceptive_conj>mg_appos>norethindrone_compound	eib=True	wib=oral	relType_1=punct	relType_3=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e3	DDI-DrugBank.d739.s10.e7	null	path1=prednisolone_conj	relType_7=compound	lemma_1=,	lib=oral	lemma_9=)	relType_8=dep	relType_10=punct	lemma_7=35	lemma_10=,	pos_1=,	pos_7=CD	lemma_8=mcg	lemma_3=contraceptive	pos_2=JJ	pos_8=NN	path2=terfenadine_conj	pos_3=NNS	relType_6=dep	relType_7=nummod	lemma_4=1	lemma_3=(	pos_3=-LRB-	pos_4=NN	pos_4=CD	pos_9=-RRB-	lemma_2=oral	lemma_7=estradiol	pos_6=SYM	relType_3=conj	relType_2=amod	relType_4=compound	relType_7=nmod	lpib=oral_JJ	relType_9=punct	lemma_5=mg	relType_5=appos	lemma_6=/	relType_4=nummod	pos_5=NN	path=prednisolone_conj<theophylline_parataxis>terfenadine_conj	pos_10=,	lemma_4=norethindrone	eib=True	wib=oral	relType_1=punct	pos_7=NN	lemma_7=ethinyl	relType_3=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e3	DDI-DrugBank.d739.s10.e8	null	path1=prednisolone_conj	relType_7=compound	lemma_1=,	lib=oral	lemma_9=)	relType_8=dep	relType_10=punct	lemma_11=terfenadine	lemma_11=,	lemma_7=35	lemma_10=,	pos_1=,	pos_7=CD	lemma_8=mcg	lemma_3=contraceptive	pos_2=JJ	relType_11=conj	pos_8=NN	pos_3=NNS	relType_6=dep	relType_7=nummod	lemma_4=1	relType_11=punct	path=prednisolone_conj<theophylline_parataxis>digoxin_conj	path2=digoxin_conj	lemma_3=(	pos_3=-LRB-	pos_4=NN	pos_4=CD	pos_9=-RRB-	lemma_2=oral	lemma_7=estradiol	pos_6=SYM	relType_3=conj	relType_2=amod	relType_4=compound	relType_7=nmod	lpib=oral_JJ	pos_11=,	relType_9=punct	lemma_5=mg	relType_5=appos	lemma_6=/	relType_4=nummod	pos_5=NN	pos_11=NN	pos_10=,	lemma_4=norethindrone	eib=True	wib=oral	relType_1=punct	pos_7=NN	lemma_7=ethinyl	relType_3=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e3	DDI-DrugBank.d739.s10.e9	null	path1=prednisolone_conj	relType_7=compound	lemma_1=,	lib=oral	lemma_9=)	relType_8=dep	relType_10=punct	lemma_11=terfenadine	lemma_11=,	relType_12=conj	lemma_7=35	lemma_10=,	pos_1=,	pos_7=CD	lemma_8=mcg	lemma_3=contraceptive	pos_2=JJ	relType_11=conj	pos_8=NN	lemma_12=,	pos_3=NNS	relType_6=dep	relType_7=nummod	lemma_4=1	relType_11=punct	pos_12=,	lemma_3=(	pos_12=NN	relType_12=punct	pos_3=-LRB-	lemma_13=and	pos_4=NN	pos_4=CD	pos_9=-RRB-	lemma_2=oral	relType_13=cc	lemma_7=estradiol	pos_6=SYM	relType_3=conj	relType_2=amod	relType_4=compound	relType_7=nmod	lpib=oral_JJ	pos_11=,	relType_9=punct	lemma_5=mg	relType_5=appos	lemma_6=/	relType_4=nummod	pos_13=CC	path2=warfarin_conj	pos_5=NN	pos_11=NN	path=prednisolone_conj<theophylline_parataxis>warfarin_conj	lemma_4=norethindrone	eib=True	pos_10=,	lemma_12=digoxin	wib=oral	relType_1=punct	pos_7=NN	lemma_7=ethinyl	relType_3=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e4	DDI-DrugBank.d739.s10.e5	null	lemma_1=(	lib=norethindrone	lpib=norethindrone_NN	eib=False	path1=	wib=norethindrone	path2=mg_appos>norethindrone_compound	relType_1=punct	pos_1=-LRB-	path=<contraceptive_conj>mg_appos>norethindrone_compound
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e4	DDI-DrugBank.d739.s10.e7	null	relType_4=dep	pos_2=NN	relType_2=nummod	lemma_2=norethindrone	lemma_5=ethinyl	lemma_6=mcg	relType_5=compound	relType_8=punct	lemma_8=,	lemma_2=1	lemma_1=(	pos_6=NN	pos_5=CD	path2=terfenadine_conj	relType_6=dep	relType_3=appos	pos_2=CD	pos_4=SYM	lib=norethindrone	lemma_5=estradiol	relType_5=nummod	relType_2=compound	lemma_4=/	lemma_5=35	relType_5=nmod	wib=norethindrone	pos_7=-RRB-	pos_1=-LRB-	pos_5=NN	lpib=norethindrone_NN	eib=True	pos_3=NN	relType_7=punct	lemma_3=mg	path1=contraceptive_conj	path=contraceptive_conj<theophylline_parataxis>terfenadine_conj	relType_1=punct	lemma_7=)	pos_8=,
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e4	DDI-DrugBank.d739.s10.e8	null	relType_4=dep	pos_2=NN	relType_2=nummod	lemma_2=norethindrone	lemma_5=ethinyl	relType_9=conj	lemma_6=mcg	relType_5=compound	relType_8=punct	lemma_9=,	lemma_8=,	lemma_2=1	lemma_1=(	pos_6=NN	pos_5=CD	relType_6=dep	relType_3=appos	pos_2=CD	pos_4=SYM	path2=digoxin_conj	pos_9=NN	lib=norethindrone	lemma_5=estradiol	relType_5=nummod	relType_2=compound	lemma_4=/	lemma_5=35	relType_5=nmod	wib=norethindrone	pos_7=-RRB-	relType_9=punct	path=contraceptive_conj<theophylline_parataxis>digoxin_conj	pos_1=-LRB-	pos_5=NN	lemma_9=terfenadine	lpib=norethindrone_NN	eib=True	pos_3=NN	relType_7=punct	lemma_3=mg	pos_9=,	path1=contraceptive_conj	relType_1=punct	lemma_7=)	pos_8=,
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e4	DDI-DrugBank.d739.s10.e9	null	relType_4=dep	relType_10=punct	pos_2=NN	relType_2=nummod	lemma_2=norethindrone	lemma_5=ethinyl	relType_9=conj	relType_11=cc	lemma_6=mcg	lemma_10=,	relType_5=compound	relType_8=punct	lemma_9=,	lemma_10=digoxin	lemma_8=,	lemma_2=1	lemma_1=(	pos_6=NN	pos_5=CD	relType_6=dep	relType_3=appos	relType_10=conj	pos_2=CD	pos_4=SYM	pos_10=NN	pos_9=NN	lib=norethindrone	lemma_11=and	lemma_5=estradiol	relType_5=nummod	relType_2=compound	lemma_4=/	lemma_5=35	pos_11=CC	path=contraceptive_conj<theophylline_parataxis>warfarin_conj	relType_5=nmod	wib=norethindrone	pos_7=-RRB-	relType_9=punct	pos_1=-LRB-	path2=warfarin_conj	pos_5=NN	lemma_9=terfenadine	lpib=norethindrone_NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_3=mg	pos_9=,	path1=contraceptive_conj	relType_1=punct	lemma_7=)	pos_8=,
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e5	DDI-DrugBank.d739.s10.e7	null	relType_3=dep	relType_1=nummod	pos_2=NN	lemma_5=mcg	relType_4=nmod	lemma_4=ethinyl	pos_3=SYM	path2=terfenadine_conj	lib=mg	pos_1=CD	relType_6=punct	lpib=mg_NN	pos_7=,	lemma_3=/	lemma_4=35	relType_5=dep	pos_4=NN	lemma_6=)	lemma_7=,	pos_4=CD	relType_4=compound	relType_2=appos	lemma_2=mg	path1=norethindrone_compound<mg_appos<contraceptive_conj	lemma_4=estradiol	relType_4=nummod	pos_6=-RRB-	pos_5=NN	path=norethindrone_compound<mg_appos<contraceptive_conj<theophylline_parataxis>terfenadine_conj	eib=True	relType_7=punct	wib=mg	lemma_1=1
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e5	DDI-DrugBank.d739.s10.e8	null	relType_3=dep	relType_1=nummod	pos_2=NN	lemma_5=mcg	relType_4=nmod	relType_8=punct	lemma_4=ethinyl	lemma_8=,	pos_3=SYM	pos_8=NN	lib=mg	pos_1=CD	relType_6=punct	lpib=mg_NN	path2=digoxin_conj	pos_7=,	lemma_3=/	lemma_4=35	relType_5=dep	pos_4=NN	lemma_6=)	lemma_7=,	pos_4=CD	lemma_8=terfenadine	relType_4=compound	relType_2=appos	lemma_2=mg	path1=norethindrone_compound<mg_appos<contraceptive_conj	lemma_4=estradiol	relType_4=nummod	path=norethindrone_compound<mg_appos<contraceptive_conj<theophylline_parataxis>digoxin_conj	pos_6=-RRB-	pos_5=NN	eib=True	relType_7=punct	relType_8=conj	wib=mg	lemma_1=1	pos_8=,
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e5	DDI-DrugBank.d739.s10.e9	null	relType_3=dep	relType_1=nummod	pos_2=NN	lemma_5=mcg	relType_9=conj	relType_10=cc	relType_4=nmod	relType_8=punct	lemma_4=ethinyl	lemma_9=digoxin	lemma_9=,	lemma_8=,	pos_3=SYM	pos_8=NN	lib=mg	pos_1=CD	relType_6=punct	lpib=mg_NN	pos_10=CC	pos_7=,	lemma_3=/	lemma_4=35	relType_5=dep	pos_4=NN	lemma_6=)	lemma_7=,	pos_9=NN	pos_4=CD	lemma_10=and	lemma_8=terfenadine	relType_4=compound	relType_2=appos	lemma_2=mg	path1=norethindrone_compound<mg_appos<contraceptive_conj	lemma_4=estradiol	relType_9=punct	relType_4=nummod	pos_6=-RRB-	path2=warfarin_conj	pos_5=NN	eib=True	relType_7=punct	relType_8=conj	wib=mg	pos_9=,	path=norethindrone_compound<mg_appos<contraceptive_conj<theophylline_parataxis>warfarin_conj	lemma_1=1	pos_8=,
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e7	DDI-DrugBank.d739.s10.e8	null	path=terfenadine_conj<theophylline_parataxis>digoxin_conj	lib=digoxin	lemma_1=,	eib=False	pos_1=,	path2=digoxin_conj	path1=terfenadine_conj	relType_1=punct	lpib=digoxin_NN	wib=digoxin
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e7	DDI-DrugBank.d739.s10.e9	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	path1=terfenadine_conj	relType_2=conj	lemma_2=,	lib=digoxin	lemma_2=digoxin	lpib=digoxin_NN	wib=digoxin	path=terfenadine_conj<theophylline_parataxis>warfarin_conj	path2=warfarin_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d739.s10	DDI-DrugBank.d739.s10.e8	DDI-DrugBank.d739.s10.e9	null	lib=warfarin	path2=warfarin_conj	lemma_2=and	path=digoxin_conj<theophylline_parataxis>warfarin_conj	lemma_1=,	lpib=warfarin_NN	eib=False	pos_2=CC	pos_1=,	wib=warfarin	relType_1=punct	relType_2=cc	path1=digoxin_conj
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e0	DDI-DrugBank.d739.s12.e1	null	path2=hypnotic_conj	lemma_2=sedative	lemma_1=,	lib=sedative	lpib=sedative_JJ	eib=True	path=<hormone_obj>hypnotic_conj	relType_2=amod	path1=	pos_1=,	relType_1=punct	pos_2=JJ	wib=sedative
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e0	DDI-DrugBank.d739.s12.e2	null	lemma_1=,	path2=agent_conj	path=<hormone_obj>agent_conj	path1=	pos_1=,	relType_3=obl:npmod	pos_3=AFX	lemma_3=inflammatory	pos_2=JJ	relType_2=punct	lemma_2=hypnotic	lemma_3=-	lemma_3=anti	relType_2=conj	lemma_2=,	wib=sedative	lib=sedative	lpib=sedative_JJ	relType_3=amod	relType_2=amod	lemma_3=non	lemma_3=steroidal	pos_2=NNS	lemma_2=sedative	pos_3=JJ	eib=True	pos_3=HYPH	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e0	DDI-DrugBank.d739.s12.e3	null	lemma_1=,	path1=	pos_1=,	relType_3=obl:npmod	pos_3=AFX	lemma_3=agent	lemma_3=inflammatory	pos_2=JJ	relType_2=punct	lemma_2=hypnotic	pos_3=NNS	lemma_3=-	lemma_3=anti	relType_2=conj	lemma_2=,	wib=sedative	lib=sedative	lpib=sedative_JJ	path2=benzodiazepine_conj	relType_3=amod	relType_3=conj	lemma_3=,	relType_2=amod	lemma_3=non	lemma_3=steroidal	pos_2=NNS	lemma_2=sedative	pos_3=JJ	pos_3=,	eib=True	pos_3=HYPH	pos_2=,	relType_1=punct	relType_3=punct	path=<hormone_obj>benzodiazepine_conj
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e0	DDI-DrugBank.d739.s12.e4	null	lemma_1=,	pos_5=CC	path1=	pos_1=,	relType_3=obl:npmod	pos_3=AFX	lemma_3=agent	lemma_3=inflammatory	pos_2=JJ	relType_2=punct	relType_5=cc	lemma_2=hypnotic	pos_3=NNS	pos_4=,	lemma_3=-	lemma_3=anti	relType_2=conj	lemma_2=,	pos_4=NNS	wib=sedative	path2=decongestant_conj	path=<hormone_obj>decongestant_conj	lib=sedative	relType_4=punct	lpib=sedative_JJ	relType_3=amod	relType_3=conj	lemma_3=,	relType_2=amod	lemma_3=non	lemma_4=,	lemma_3=steroidal	lemma_4=benzodiazepine	pos_2=NNS	lemma_2=sedative	pos_3=JJ	pos_3=,	eib=True	lemma_5=and	pos_3=HYPH	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e1	DDI-DrugBank.d739.s12.e2	null	lemma_1=,	path2=agent_conj	pos_1=,	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	path1=hypnotic_conj	relType_2=obl:npmod	lemma_2=anti	wib=steroidal	lemma_2=-	lib=steroidal	lemma_2=non	lpib=steroidal_JJ	relType_2=amod	lemma_2=steroidal	path=hypnotic_conj<hormone_obj>agent_conj	lemma_2=inflammatory	eib=True	relType_1=punct
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e1	DDI-DrugBank.d739.s12.e3	null	lemma_2=agent	lemma_1=,	pos_1=,	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	path1=hypnotic_conj	relType_2=obl:npmod	lemma_2=anti	wib=steroidal	lemma_2=-	lib=steroidal	lemma_2=non	lpib=steroidal_JJ	relType_2=conj	lemma_2=,	path2=benzodiazepine_conj	path=hypnotic_conj<hormone_obj>benzodiazepine_conj	relType_2=amod	lemma_2=steroidal	pos_2=NNS	lemma_2=inflammatory	eib=True	pos_2=,	relType_1=punct
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e1	DDI-DrugBank.d739.s12.e4	null	lemma_2=agent	lemma_1=,	pos_1=,	relType_4=cc	pos_2=HYPH	pos_2=JJ	pos_2=AFX	relType_2=punct	path1=hypnotic_conj	relType_2=obl:npmod	lemma_2=anti	wib=steroidal	lemma_2=-	pos_3=NNS	lib=steroidal	lemma_2=non	lpib=steroidal_JJ	relType_2=conj	lemma_2=,	path2=decongestant_conj	lemma_3=,	relType_3=conj	relType_2=amod	lemma_2=steroidal	pos_2=NNS	lemma_2=inflammatory	path=hypnotic_conj<hormone_obj>decongestant_conj	pos_3=,	eib=True	pos_4=CC	lemma_4=and	pos_2=,	relType_1=punct	lemma_3=benzodiazepine	relType_3=punct
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e2	DDI-DrugBank.d739.s12.e3	null	path1=agent_conj	lemma_1=,	path=agent_conj<hormone_obj>benzodiazepine_conj	path2=benzodiazepine_conj	eib=False	pos_1=,	wib=benzodiazepines	relType_1=punct	lpib=benzodiazepine_NNS	lib=benzodiazepine
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e2	DDI-DrugBank.d739.s12.e4	null	lemma_1=,	pos_3=CC	pos_1=,	relType_2=punct	relType_3=cc	lib=benzodiazepine	relType_2=conj	lpib=benzodiazepine_NNS	lemma_2=,	path2=decongestant_conj	wib=benzodiazepines	pos_2=NNS	eib=True	path=agent_conj<hormone_obj>decongestant_conj	pos_2=,	lemma_3=and	relType_1=punct	lemma_2=benzodiazepine	path1=agent_conj
DDI-DrugBank.d739.s12	DDI-DrugBank.d739.s12.e3	DDI-DrugBank.d739.s12.e4	null	path2=decongestant_conj	lemma_2=and	lemma_1=,	lpib=decongestant_NNS	eib=False	path=benzodiazepine_conj<hormone_obj>decongestant_conj	pos_2=CC	pos_1=,	relType_1=punct	relType_2=cc	path1=benzodiazepine_conj	wib=decongestants	lib=decongestant
DDI-DrugBank.d739.s13	DDI-DrugBank.d739.s13.e0	DDI-DrugBank.d739.s13.e1	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_8=DT	pos_1=,	lemma_6=,	wib=induces	lemma_10=of	pos_2=WDT	path1=Phenobarbital_nsubj	lemma_3=induce	relType_3=acl:relcl	relType_2=nsubj	eib=False	relType_6=punct	relation_6=adverse	relation_2=neutral	pos_3=VBZ	relType_10=case	pos_9=NN	relType_7=ROOT	lemma_8=the	pos_7=VBD	relType_9=obj	path2=auc_obj>montelukast_nmod	lemma_7=decrease	pos_10=IN	lemma_4=hepatic	pos_6=,	lpib=induce_VBZ	lemma_2=which	pos_5=NN	lemma_9=auc	relType_5=obj	relType_8=det	path=Phenobarbital_nsubj<decrease_ROOT>auc_obj>montelukast_nmod	relType_1=punct	lib=induce	lemma_5=metabolism
DDI-DrugBank.d739.s13	DDI-DrugBank.d739.s13.e0	DDI-DrugBank.d739.s13.e2	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_8=DT	pos_1=,	lemma_6=,	wib=induces	lemma_10=of	pos_12=CD	relType_13=obl:npmod	lemma_15=a	pos_2=WDT	path1=Phenobarbital_nsubj	relType_16=amod	lemma_3=induce	lemma_11=approximately	relType_3=acl:relcl	relType_2=nsubj	lemma_13=%	relType_6=punct	relType_17=nummod	pos_18=HYPH	relation_2=neutral	relType_20=nmod	pos_3=VBZ	pos_20=NN	relation_6=adverse	pos_21=IN	lemma_14=follow	pos_19=NN	relType_10=case	pos_13=NN	relType_11=advmod	pos_9=NN	pos_15=DT	lemma_18=-	lemma_12=40	relType_19=compound	pos_16=JJ	relType_7=ROOT	pos_14=VBG	lemma_21=of	lemma_8=the	pos_7=VBD	relType_9=obj	relType_18=punct	lemma_7=decrease	pos_10=IN	lemma_19=mg	lemma_4=hepatic	pos_11=RB	pos_17=CD	path2=%_obl:npmod>dose_nmod>montelukast_nmod	pos_6=,	relType_21=case	lpib=induce_VBZ	lemma_2=which	pos_5=NN	lemma_9=auc	pos_11=NN	eib=True	path=Phenobarbital_nsubj<decrease_ROOT>%_obl:npmod>dose_nmod>montelukast_nmod	relType_5=obj	lemma_17=10	lemma_20=dose	relType_12=nummod	lemma_11=montelukast	relType_8=det	relType_11=nmod	relType_1=punct	relType_14=case	lib=induce	relType_15=det	lemma_5=metabolism	lemma_16=single
DDI-DrugBank.d739.s13	DDI-DrugBank.d739.s13.e1	DDI-DrugBank.d739.s13.e2	null	lemma_4=follow	lemma_10=dose	relType_2=nummod	pos_6=JJ	relType_3=obl:npmod	pos_7=CD	relType_8=punct	wib=approximately	relType_11=case	lemma_5=a	relType_10=nmod	relType_9=compound	eib=False	relType_7=nummod	pos_2=CD	relType_6=amod	pos_8=HYPH	pos_10=NN	pos_9=NN	relType_1=advmod	lemma_9=mg	pos_11=IN	lib=approximately	lemma_7=10	lemma_3=%	relType_5=det	relType_4=case	path=montelukast_nmod<auc_obj<decrease_ROOT>%_obl:npmod>dose_nmod>montelukast_nmod	lemma_1=approximately	pos_4=VBG	path2=%_obl:npmod>dose_nmod>montelukast_nmod	path1=montelukast_nmod<auc_obj	lpib=approximately_RB	pos_1=RB	pos_3=NN	lemma_8=-	pos_5=DT	lemma_11=of	lemma_2=40	lemma_6=single
DDI-DrugBank.d739.s15	DDI-DrugBank.d739.s15.e0	DDI-DrugBank.d739.s15.e1	null	relType_1=cc	wib=rifampin	pos_1=CC	lemma_1=or	eib=False	path=<phenobarbital_nmod>rifampin_conj	lpib=rifampin_NN	path1=	lib=rifampin	path2=rifampin_conj
DDI-DrugBank.d739.s15	DDI-DrugBank.d739.s15.e0	DDI-DrugBank.d739.s15.e2	advise	relType_1=cc	relType_4=dep	wib=rifampin	pos_1=CC	pos_2=NN	relType_7=case	relType_3=aux:pass	lemma_7=with	relType_2=punct	path1=phenobarbital_nmod<inducer_nsubj:pass	lpib=rifampin_NN	pos_5=HYPH	pos_6=VBN	relType_6=advcl	relType_2=conj	pos_4=NN	lemma_2=,	path2=montelukast_obl	lemma_4=co	relType_5=punct	lemma_3=be	lemma_6=administer	lib=rifampin	path=phenobarbital_nmod<inducer_nsubj:pass<administer_advcl>montelukast_obl	eib=True	pos_7=IN	lemma_2=rifampin	pos_2=,	lemma_5=-	lemma_1=or	pos_3=VBP
DDI-DrugBank.d739.s15	DDI-DrugBank.d739.s15.e1	DDI-DrugBank.d739.s15.e2	advise	relType_3=dep	lemma_1=,	lpib=be_VBP	pos_1=,	lemma_4=-	pos_4=HYPH	relType_6=case	relType_5=advcl	eib=False	pos_6=IN	wib=are	path=rifampin_conj<phenobarbital_nmod<inducer_nsubj:pass<administer_advcl>montelukast_obl	path2=montelukast_obl	lib=be	relType_4=punct	relType_2=aux:pass	pos_2=VBP	lemma_6=with	lemma_5=administer	lemma_3=co	path1=rifampin_conj<phenobarbital_nmod<inducer_nsubj:pass	pos_3=NN	lemma_2=be	relType_1=punct	pos_5=VBN
DDI-DrugBank.d346.s0	DDI-DrugBank.d346.s0.e0	DDI-DrugBank.d346.s0.e1	null	relType_1=cc	pos_1=CC	path2=other_amod>opiate_obl	lemma_3=other	path1=revia_nmod	eib=False	lpib=drug_NNS	lib=drug	relType_2=conj	path=revia_nmod<interaction_obj>other_amod>opiate_obl	relType_3=amod	pos_4=IN	relType_4=case	lemma_2=drug	pos_2=NNS	pos_3=JJ	lemma_4=than	wib=drugs	lemma_1=and
DDI-DrugBank.d346.s2	DDI-DrugBank.d346.s2.e0	DDI-DrugBank.d346.s2.e1	effect	relType_1=cc	wib=disulfiram	pos_1=CC	path2=disulfiram_conj	eib=False	lib=disulfiram	path1=	path=<revia_nmod>disulfiram_conj	lpib=disulfiram_NN	lemma_1=and
DDI-DrugBank.d346.s3	DDI-DrugBank.d346.s3.e0	DDI-DrugBank.d346.s3.e1	effect	relType_1=cc	pos_1=CC	lpib=thioridazine_NN	lib=thioridazine	eib=False	wib=thioridazine	path=<revia_nmod>thioridazine_conj	path1=	lemma_1=and	path2=thioridazine_conj
DDI-DrugBank.d346.s4	DDI-DrugBank.d346.s4.e0	DDI-DrugBank.d346.s4.e1	effect	relType_1=aux	lemma_1=may	lemma_3=benefit	pos_3=VB	pos_2=RB	path2=from_advcl>opioid_dep	eib=False	relType_2=advmod	wib=not	path1=revia_obj<take_acl<patient_nsubj	relType_3=ROOT	pos_4=IN	pos_1=MD	lib=not	lpib=not_RB	path=revia_obj<take_acl<patient_nsubj<benefit_ROOT>from_advcl>opioid_dep	lemma_4=from	relType_4=advcl	lemma_2=not
DDI-DrugBank.d346.s4	DDI-DrugBank.d346.s4.e0	DDI-DrugBank.d346.s4.e2	effect	lemma_5=opioid	lemma_8=such	relType_8=case	relType_14=punct	pos_15=JJ	relType_11=cc	relType_1=aux	lemma_1=may	relType_15=amod	relType_17=punct	path2=from_advcl>opioid_dep>contain_acl>medicine_obj>analgesic_conj	pos_13=NNS	lemma_3=benefit	pos_9=IN	pos_3=VB	lemma_10=cough	pos_16=NNS	relType_18=cc	path=revia_obj<take_acl<patient_nsubj<benefit_ROOT>from_advcl>opioid_dep>contain_acl>medicine_obj>analgesic_conj	pos_8=JJ	pos_2=RB	pos_12=JJ	lemma_16=preparation	relType_10=nmod	lemma_17=,	relType_2=advmod	relType_5=acl	pos_14=,	wib=not	pos_7=,	pos_19=JJ	relType_12=amod	relType_13=conj	pos_18=CC	path1=revia_obj<take_acl<patient_nsubj	lemma_7=,	relType_5=dep	pos_10=NN	pos_17=,	pos_5=JJ	lemma_15=antidiarrheal	lemma_11=and	relType_3=ROOT	pos_4=IN	pos_11=CC	pos_1=MD	relType_19=amod	lemma_9=as	lib=not	relType_9=fixed	lemma_13=preparation	relType_6=obj	lemma_14=,	lemma_18=and	pos_5=VBG	eib=True	relType_7=punct	pos_6=NNS	lpib=not_RB	lemma_19=opioid	lemma_5=contain	relType_4=advcl	lemma_4=from	lemma_6=medicine	lemma_12=cold	relType_16=conj	lemma_2=not
DDI-DrugBank.d346.s4	DDI-DrugBank.d346.s4.e1	DDI-DrugBank.d346.s4.e2	null	relType_12=conj	pos_4=JJ	relType_2=obj	relType_10=punct	relType_9=conj	pos_13=,	lemma_13=,	relType_8=amod	lemma_2=medicine	pos_14=CC	lemma_10=,	pos_15=JJ	path1=	relType_13=punct	relType_7=cc	relType_15=amod	lemma_15=opioid	pos_6=NN	pos_8=JJ	path=<opioid_dep>contain_acl>medicine_obj>analgesic_conj	relType_11=amod	pos_9=NNS	lemma_12=preparation	path2=contain_acl>medicine_obj>analgesic_conj	lpib=contain_VBG	lemma_6=cough	lemma_9=preparation	relType_5=fixed	lemma_3=,	pos_7=CC	pos_12=NNS	relType_1=acl	relType_4=case	pos_5=IN	lemma_4=such	lemma_8=cold	relType_14=cc	wib=containing	pos_1=VBG	pos_2=NNS	lemma_11=antidiarrheal	pos_3=,	pos_10=,	eib=True	lemma_7=and	lemma_14=and	lemma_1=contain	pos_11=JJ	lib=contain	relType_6=nmod	relType_3=punct	lemma_5=as
DDI-DrugBank.d346.s5	DDI-DrugBank.d346.s5.e0	DDI-DrugBank.d346.s5.e1	effect	pos_2=DT	lemma_1=,	lemma_2=the	path2=great_ccomp>amount_nsubj>opioid_nmod	pos_1=,	lib=amount	lemma_3=amount	eib=False	path=revia_obj<receive_acl<patient_obl<administer_acl:relcl>great_ccomp>amount_nsubj>opioid_nmod	pos_4=IN	relType_4=case	relType_3=nsubj	lpib=amount_NN	pos_3=NN	path1=revia_obj<receive_acl<patient_obl	relType_2=det	wib=amount	relType_1=punct	lemma_4=of
DDI-DrugBank.d14.s0	DDI-DrugBank.d14.s0.e0	DDI-DrugBank.d14.s0.e1	effect	path2=that_obl>vasodilator_nmod	relType_1=aux	lemma_1=may	lemma_6=of	lemma_7=other	relType_6=case	wib=be	relType_2=cop	eib=False	lemma_3=additive	pos_6=IN	pos_2=VB	lemma_4=with	relType_7=amod	lib=be	lemma_5=that	relType_3=ROOT	path1=nitroglycerin_nmod<effect_nsubj	pos_4=IN	relType_4=case	relType_5=obl	pos_1=MD	path=nitroglycerin_nmod<effect_nsubj<additive_ROOT>that_obl>vasodilator_nmod	lpib=be_VB	pos_3=JJ	pos_5=DT	pos_7=JJ	lemma_2=be
DDI-DrugBank.d14.s2	DDI-DrugBank.d14.s2.e0	DDI-DrugBank.d14.s2.e1	effect	relType_1=cc	wib=organic	pos_1=CC	lemma_2=organic	eib=False	lpib=organic_JJ	lib=organic	relType_2=amod	path1=	path2=nitrate_conj	path=<blocker_nsubj:pass>nitrate_conj	pos_2=JJ	lemma_1=and
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e1	null	relType_1=cc	lib=theophylline	pos_1=CC	wib=theophylline	eib=False	path1=	path2=theophylline_conj	path=<nizatidine_obl>theophylline_conj	lemma_1=and	lpib=theophylline_NN
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e2	null	path2=chlordiazepoxide_conj	relType_1=cc	lib=theophylline	pos_1=CC	pos_2=NN	wib=theophylline	eib=True	path1=	pos_2=,	relType_2=conj	path=<nizatidine_obl>chlordiazepoxide_conj	lemma_2=theophylline	lemma_2=,	lemma_1=and	relType_2=punct	lpib=theophylline_NN
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	path1=	relType_2=punct	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	lpib=theophylline_NN	path2=lorazepam_conj	lemma_3=,	relType_3=conj	lemma_2=theophylline	lib=theophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	pos_2=,	path=<nizatidine_obl>lorazepam_conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e4	null	relType_1=cc	pos_1=CC	pos_2=NN	path1=	relType_2=punct	pos_4=,	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	lpib=theophylline_NN	relType_4=punct	lemma_3=,	relType_3=conj	path2=lidocaine_conj	lemma_4=,	lemma_2=theophylline	lib=theophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	lemma_4=lorazepam	pos_2=,	relType_4=conj	path=<nizatidine_obl>lidocaine_conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e5	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_5=,	path1=	relType_2=punct	pos_4=,	lemma_5=lidocaine	path=<nizatidine_obl>phenytoin_conj	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	path2=phenytoin_conj	pos_4=NN	lpib=theophylline_NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lemma_2=theophylline	pos_5=NN	lib=theophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	lemma_4=lorazepam	pos_2=,	relType_4=conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e0	DDI-DrugBank.d475.s0.e6	null	relType_1=cc	pos_1=CC	pos_2=NN	pos_5=,	path1=	lemma_6=,	relType_7=cc	path=<nizatidine_obl>warfarin_conj	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	lemma_5=lidocaine	lemma_3=chlordiazepoxide	relType_2=conj	lemma_2=,	pos_4=NN	lpib=theophylline_NN	relType_4=punct	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=phenytoin	lemma_4=,	relType_5=conj	lemma_2=theophylline	pos_6=,	path2=warfarin_conj	pos_5=NN	lib=theophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	lemma_7=and	lemma_4=lorazepam	pos_2=,	relType_4=conj	relType_3=punct	lemma_1=and
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e1	DDI-DrugBank.d475.s0.e2	null	path2=chlordiazepoxide_conj	wib=chlordiazepoxide	lemma_1=,	lib=chlordiazepoxide	eib=False	pos_1=,	lpib=chlordiazepoxide_NN	path1=theophylline_conj	relType_1=punct	path=theophylline_conj<nizatidine_obl>chlordiazepoxide_conj
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e1	DDI-DrugBank.d475.s0.e3	null	wib=chlordiazepoxide	path2=lorazepam_conj	lemma_1=,	lib=chlordiazepoxide	pos_2=NN	eib=True	lemma_2=chlordiazepoxide	pos_1=,	lpib=chlordiazepoxide_NN	path1=theophylline_conj	path=theophylline_conj<nizatidine_obl>lorazepam_conj	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e1	DDI-DrugBank.d475.s0.e4	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	wib=chlordiazepoxide	lemma_3=lorazepam	path=theophylline_conj<nizatidine_obl>lidocaine_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path2=lidocaine_conj	lib=chlordiazepoxide	pos_3=,	eib=True	lemma_2=chlordiazepoxide	pos_3=NN	lpib=chlordiazepoxide_NN	path1=theophylline_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e1	DDI-DrugBank.d475.s0.e5	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	wib=chlordiazepoxide	lemma_3=lorazepam	pos_4=,	lemma_4=lidocaine	relType_2=conj	pos_4=NN	lemma_2=,	path=theophylline_conj<nizatidine_obl>phenytoin_conj	path2=phenytoin_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lib=chlordiazepoxide	pos_3=,	eib=True	lemma_2=chlordiazepoxide	pos_3=NN	lpib=chlordiazepoxide_NN	path1=theophylline_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e1	DDI-DrugBank.d475.s0.e6	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	relType_2=punct	wib=chlordiazepoxide	lemma_3=lorazepam	pos_4=,	lemma_4=lidocaine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=,	relType_5=conj	path2=warfarin_conj	pos_5=NN	path=theophylline_conj<nizatidine_obl>warfarin_conj	lib=chlordiazepoxide	pos_3=,	eib=True	lemma_2=chlordiazepoxide	pos_3=NN	lpib=chlordiazepoxide_NN	path1=theophylline_conj	pos_2=,	relType_4=conj	lemma_5=phenytoin	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e2	DDI-DrugBank.d475.s0.e3	null	wib=lorazepam	path2=lorazepam_conj	lemma_1=,	path1=chlordiazepoxide_conj	eib=False	pos_1=,	lib=lorazepam	lpib=lorazepam_NN	path=chlordiazepoxide_conj<nizatidine_obl>lorazepam_conj	relType_1=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e2	DDI-DrugBank.d475.s0.e4	null	wib=lorazepam	lemma_1=,	path1=chlordiazepoxide_conj	pos_2=NN	eib=True	path2=lidocaine_conj	lemma_2=,	pos_1=,	lemma_2=lorazepam	pos_2=,	lib=lorazepam	lpib=lorazepam_NN	relType_1=punct	relType_2=conj	path=chlordiazepoxide_conj<nizatidine_obl>lidocaine_conj	relType_2=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e2	DDI-DrugBank.d475.s0.e5	null	wib=lorazepam	path=chlordiazepoxide_conj<nizatidine_obl>phenytoin_conj	lemma_1=,	pos_2=NN	pos_1=,	lemma_3=lidocaine	lpib=lorazepam_NN	relType_2=punct	lemma_2=lorazepam	relType_2=conj	lemma_2=,	path2=phenytoin_conj	lemma_3=,	relType_3=conj	lib=lorazepam	path1=chlordiazepoxide_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e2	DDI-DrugBank.d475.s0.e6	null	wib=lorazepam	lemma_1=,	pos_2=NN	pos_5=CC	lemma_4=phenytoin	pos_1=,	lemma_3=lidocaine	lpib=lorazepam_NN	relType_2=punct	relType_5=cc	pos_4=,	lemma_2=lorazepam	relType_2=conj	pos_4=NN	lemma_2=,	path=chlordiazepoxide_conj<nizatidine_obl>warfarin_conj	relType_4=punct	lemma_3=,	relType_3=conj	lib=lorazepam	lemma_4=,	path2=warfarin_conj	path1=chlordiazepoxide_conj	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e3	DDI-DrugBank.d475.s0.e4	null	lemma_1=,	path1=lorazepam_conj	eib=False	path2=lidocaine_conj	path=lorazepam_conj<nizatidine_obl>lidocaine_conj	pos_1=,	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	wib=lidocaine
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e3	DDI-DrugBank.d475.s0.e5	null	lemma_1=,	pos_2=NN	lemma_2=lidocaine	eib=True	path1=lorazepam_conj	lemma_2=,	pos_1=,	path=lorazepam_conj<nizatidine_obl>phenytoin_conj	pos_2=,	relType_1=punct	lib=lidocaine	lpib=lidocaine_NN	relType_2=conj	path2=phenytoin_conj	relType_2=punct	wib=lidocaine
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e3	DDI-DrugBank.d475.s0.e6	null	lemma_1=,	pos_2=NN	path=lorazepam_conj<nizatidine_obl>warfarin_conj	pos_1=,	relType_4=cc	lpib=lidocaine_NN	relType_2=punct	lemma_3=phenytoin	lib=lidocaine	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path2=warfarin_conj	pos_3=,	eib=True	path1=lorazepam_conj	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct	lemma_2=lidocaine	wib=lidocaine
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e4	DDI-DrugBank.d475.s0.e5	null	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	path1=lidocaine_conj	pos_1=,	path2=phenytoin_conj	relType_1=punct	lpib=phenytoin_NN	path=lidocaine_conj<nizatidine_obl>phenytoin_conj
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e4	DDI-DrugBank.d475.s0.e6	null	lemma_1=,	path=lidocaine_conj<nizatidine_obl>warfarin_conj	pos_2=NN	pos_3=CC	path1=lidocaine_conj	pos_1=,	relType_3=cc	relType_2=punct	lib=phenytoin	wib=phenytoin	lemma_2=phenytoin	relType_2=conj	lemma_2=,	path2=warfarin_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d475.s0	DDI-DrugBank.d475.s0.e5	DDI-DrugBank.d475.s0.e6	null	lib=warfarin	path2=warfarin_conj	lemma_2=and	lemma_1=,	lpib=warfarin_NN	eib=False	pos_2=CC	pos_1=,	wib=warfarin	path=phenytoin_conj<nizatidine_obl>warfarin_conj	relType_1=punct	relType_2=cc	path1=phenytoin_conj
DDI-DrugBank.d475.s3	DDI-DrugBank.d475.s3.e0	DDI-DrugBank.d475.s3.e1	null	lemma_3=increase	path2=increase_nsubj:pass>level_nmod>salicylate_compound	lemma_1=daily	lemma_4=in	relType_5=compound	relType_3=nsubj:pass	path1=aspirin_nmod<dose_nmod<patient_obl	relType_2=punct	pos_3=NNS	eib=False	path=aspirin_nmod<dose_nmod<patient_obl<see_ROOT>increase_nsubj:pass>level_nmod>salicylate_compound	lemma_2=,	relType_1=advmod	pos_4=IN	lib=daily	relType_4=case	lemma_5=serum	wib=daily	lpib=daily_RB	pos_5=NN	pos_1=RB	pos_2=,	relation_2=beneficial
DDI-DrugBank.d475.s3	DDI-DrugBank.d475.s3.e0	DDI-DrugBank.d475.s3.e2	mechanism	lemma_6=level	lemma_3=increase	relType_9=advmod	pos_8=VBN	lemma_7=be	lemma_1=daily	lemma_4=in	relType_5=compound	relType_3=nsubj:pass	path1=aspirin_nmod<dose_nmod<patient_obl	relType_2=punct	path=aspirin_nmod<dose_nmod<patient_obl<see_ROOT>administer_advcl>nizatidine_nsubj:pass	pos_6=NN	pos_9=WRB	pos_3=NNS	lemma_2=,	relType_1=advmod	pos_4=IN	pos_7=VBD	lib=daily	relType_4=case	relType_7=aux:pass	lemma_5=serum	relType_8=ROOT	lemma_6=salicylate	wib=daily	path2=administer_advcl>nizatidine_nsubj:pass	lpib=daily_RB	pos_5=NN	relType_6=compound	lemma_8=see	eib=True	pos_1=RB	pos_6=NNS	pos_2=,	relType_6=nmod	relation_2=beneficial	lemma_9=when
DDI-DrugBank.d475.s3	DDI-DrugBank.d475.s3.e1	DDI-DrugBank.d475.s3.e2	null	path1=salicylate_compound<level_nmod<increase_nsubj:pass	lib=level	pos_3=VBN	lpib=level_NNS	eib=False	lemma_1=level	pos_2=VBD	path=salicylate_compound<level_nmod<increase_nsubj:pass<see_ROOT>administer_advcl>nizatidine_nsubj:pass	relType_1=nmod	lemma_3=see	relType_3=ROOT	relType_4=advmod	relType_2=aux:pass	path2=administer_advcl>nizatidine_nsubj:pass	pos_4=WRB	pos_1=NNS	lemma_4=when	lemma_2=be	wib=levels
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e0	DDI-DrugBank.d761.s0.e1	null	relType_8=case	relType_4=amod	pos_13=,	pos_4=JJ	wib=multiple	lemma_13=,	lemma_9=30	lemma_15=of	pos_7=NN	relType_10=amod	path1=	path2=result_parataxis>study_obl>coadministration_appos>XENICAL_nmod	relType_13=punct	relType_9=nummod	pos_6=NN	pos_2=IN	lemma_8=in	lemma_10=normal	eib=False	relType_12=nmod	lemma_4=multiple	pos_5=HYPH	lemma_7=study	pos_14=NN	lemma_12=subject	relType_3=det	lemma_3=a	path=<alcohol_ROOT>result_parataxis>study_obl>coadministration_appos>XENICAL_nmod	lemma_1=:	pos_8=IN	relType_15=case	pos_12=NNS	pos_10=JJ	relType_5=punct	lemma_11=weight	pos_1=:	lemma_6=dose	lpib=multiple_JJ	relType_14=appos	pos_15=IN	relType_6=compound	relType_7=obl	relType_2=case	pos_9=CD	pos_11=NN	pos_3=DT	relType_11=compound	lemma_14=coadministration	relType_1=punct	lib=multiple	lemma_5=-	lemma_2=in
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e0	DDI-DrugBank.d761.s0.e2	null	relType_8=case	relType_4=amod	pos_13=,	pos_4=JJ	relType_16=cc	pos_19=IN	wib=multiple	lemma_13=,	lemma_9=30	lemma_15=of	pos_7=NN	relType_16=nmod	pos_18=NNS	relType_10=amod	path1=	relType_13=punct	pos_16=CC	relType_9=nummod	pos_6=NN	pos_2=IN	lemma_8=in	lemma_10=normal	relType_17=nummod	relType_12=nmod	lemma_4=multiple	pos_5=HYPH	lemma_7=study	pos_14=NN	lemma_12=subject	lemma_17=40	relType_3=det	lemma_3=a	lemma_18=gram	lemma_1=:	pos_8=IN	lemma_16=XENICAL	lemma_19=of	relType_15=case	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_16=NNP	lemma_11=weight	pos_1=:	lemma_6=dose	lpib=multiple_JJ	path2=result_parataxis>study_obl>coadministration_appos>gram_conj>alcohol_nmod	relType_14=appos	lemma_16=and	pos_17=CD	pos_15=IN	relType_6=compound	relType_7=obl	relType_2=case	pos_9=CD	eib=True	pos_3=DT	pos_11=NN	relType_11=compound	relType_19=case	path=<alcohol_ROOT>result_parataxis>study_obl>coadministration_appos>gram_conj>alcohol_nmod	lemma_14=coadministration	relType_1=punct	lib=multiple	lemma_5=-	relType_18=conj	lemma_2=in
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e0	DDI-DrugBank.d761.s0.e3	null	lemma_20=alcohol	pos_20=-LRB-	wib=multiple	lemma_13=,	pos_34=NN	relType_16=nmod	relType_30=aux	relType_34=obl	relType_22=dep	relType_31=advmod	relType_9=nummod	pos_6=NN	lemma_31=not	relType_20=nmod	pos_20=NN	lemma_7=study	lemma_23=,	lemma_18=gram	relType_32=parataxis	lemma_16=XENICAL	relType_25=nummod	pos_1=:	pos_17=CD	pos_28=NN	relType_6=compound	pos_30=VBD	path=<alcohol_ROOT>result_parataxis>alteration_obl>pharmacokinetic_nmod>alcohol_compound	lemma_5=-	relType_8=case	relType_4=amod	pos_13=,	relType_16=cc	lemma_15=of	pos_18=NNS	lemma_9=30	pos_22=NN	path1=	pos_16=CC	lemma_30=do	relType_28=nmod	lemma_8=in	lemma_29=)	pos_25=CD	relType_12=nmod	pos_26=NNS	relType_26=appos	relType_3=det	lemma_3=a	lemma_28=wine	pos_8=IN	lemma_21=e.	relType_15=case	relType_24=advmod	lemma_33=in	relType_21=compound	pos_15=IN	relType_7=obl	pos_11=NN	relType_19=case	lemma_14=coadministration	relType_1=punct	pos_7=NN	lemma_2=in	lemma_24=approximately	lemma_26=glass	lemma_27=of	pos_2=IN	lemma_32=result	lemma_22=g.	pos_14=NN	lemma_17=40	lemma_1=:	lemma_19=of	pos_33=IN	pos_24=RB	relType_2=case	pos_9=CD	pos_32=VB	relType_20=punct	relType_27=case	lib=multiple	lemma_34=alteration	relType_23=punct	pos_19=IN	pos_29=-RRB-	pos_4=JJ	pos_31=RB	lemma_25=3	relType_33=case	relType_10=amod	relType_13=punct	lemma_20=(	path2=result_parataxis>alteration_obl>pharmacokinetic_nmod>alcohol_compound	lemma_10=normal	relType_17=nummod	lemma_35=of	lemma_4=multiple	pos_5=HYPH	lemma_12=subject	pos_27=IN	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_16=NNP	lemma_11=weight	lemma_6=dose	relType_29=punct	lpib=multiple_JJ	relType_14=appos	lemma_16=and	eib=True	pos_3=DT	relType_11=compound	pos_23=,	pos_35=IN	relType_35=case	relType_18=conj	pos_21=NN
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e0	DDI-DrugBank.d761.s0.e4	null	lemma_20=alcohol	pos_20=-LRB-	wib=multiple	lemma_13=,	pos_34=NN	relType_16=nmod	relType_30=aux	relType_36=nmod	relType_34=obl	relType_22=dep	relType_31=advmod	relType_9=nummod	pos_6=NN	lemma_31=not	relType_20=nmod	pos_20=NN	lemma_7=study	lemma_23=,	lemma_18=gram	relType_32=parataxis	lemma_16=XENICAL	relType_25=nummod	pos_1=:	pos_17=CD	pos_28=NN	relType_6=compound	pos_30=VBD	pos_36=NNS	lemma_5=-	path2=result_parataxis>pharmacodynamic_obj>orlistat_compound	relType_37=punct	relType_8=case	relType_4=amod	pos_13=,	relType_16=cc	lemma_37=,	lemma_15=of	pos_18=NNS	lemma_9=30	pos_22=NN	path1=	pos_16=CC	lemma_30=do	relType_28=nmod	lemma_8=in	lemma_29=)	pos_25=CD	relType_12=nmod	pos_26=NNS	relType_26=appos	relType_3=det	lemma_3=a	lemma_28=wine	pos_8=IN	lemma_21=e.	relType_15=case	relType_24=advmod	lemma_33=in	relType_21=compound	pos_37=,	pos_15=IN	relType_7=obl	pos_11=NN	relType_19=case	lemma_14=coadministration	relType_1=punct	pos_7=NN	lemma_2=in	lemma_24=approximately	lemma_26=glass	lemma_27=of	relType_36=compound	pos_2=IN	lemma_32=result	lemma_22=g.	pos_14=NN	lemma_17=40	lemma_1=:	lemma_19=of	pos_33=IN	path=<alcohol_ROOT>result_parataxis>pharmacodynamic_obj>orlistat_compound	pos_24=RB	relType_2=case	pos_9=CD	pos_32=VB	relType_20=punct	relType_27=case	lib=multiple	lemma_34=alteration	relType_23=punct	pos_19=IN	pos_29=-RRB-	pos_4=JJ	lemma_36=alcohol	pos_31=RB	lemma_25=3	relType_33=case	relType_10=amod	relType_13=punct	lemma_20=(	lemma_10=normal	relType_17=nummod	lemma_35=of	lemma_4=multiple	pos_5=HYPH	lemma_12=subject	pos_27=IN	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_16=NNP	lemma_11=weight	lemma_36=pharmacokinetic	lemma_6=dose	relType_29=punct	lpib=multiple_JJ	relType_14=appos	lemma_16=and	pos_36=NN	eib=True	pos_3=DT	relType_11=compound	pos_23=,	pos_35=IN	relType_35=case	relType_18=conj	pos_21=NN
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e0	DDI-DrugBank.d761.s0.e5	null	lemma_20=alcohol	pos_20=-LRB-	wib=multiple	lemma_13=,	pos_34=NN	relType_16=nmod	relType_30=aux	relType_36=nmod	relType_34=obl	relType_22=dep	relType_31=advmod	pos_41=NN	relType_9=nummod	pos_6=NN	pos_47=NN	lemma_31=not	relType_20=nmod	pos_20=NN	lemma_7=study	lemma_23=,	relType_43=punct	lemma_18=gram	relType_32=parataxis	lemma_16=XENICAL	relType_25=nummod	relType_46=amod	pos_1=:	lemma_41=fat	lemma_42=excretion	pos_17=CD	pos_28=NN	relType_6=compound	pos_30=VBD	path2=result_parataxis>pharmacodynamic_obj>exposure_conj>orlistat_nmod	pos_36=NNS	lemma_5=-	relType_37=punct	pos_40=JJ	relType_8=case	relType_4=amod	pos_13=,	relType_16=cc	lemma_37=,	pos_45=CC	lemma_15=of	pos_18=NNS	lemma_9=30	lemma_44=,	pos_22=NN	path1=	relType_39=punct	pos_16=CC	lemma_45=or	lemma_30=do	relType_28=nmod	relType_48=case	lemma_8=in	lemma_29=)	pos_25=CD	lemma_46=systemic	relType_12=nmod	pos_26=NNS	relType_26=appos	relType_3=det	lemma_3=a	lemma_28=wine	pos_8=IN	lemma_21=e.	relType_15=case	relType_24=advmod	lemma_33=in	relType_21=compound	lemma_38=orlistat	lemma_43=)	pos_37=,	pos_15=IN	relType_44=punct	pos_43=-RRB-	relType_7=obl	pos_11=NN	relType_19=case	pos_42=NN	lemma_39=(	lemma_14=coadministration	relType_1=punct	pos_7=NN	relType_47=conj	lemma_2=in	lemma_24=approximately	lemma_26=glass	relType_45=cc	lemma_27=of	relType_36=compound	pos_44=,	relType_42=dep	lemma_47=exposure	pos_2=IN	pos_39=-LRB-	lemma_32=result	lemma_22=g.	pos_14=NN	lemma_17=40	lemma_1=:	path=<alcohol_ROOT>result_parataxis>pharmacodynamic_obj>exposure_conj>orlistat_nmod	lemma_19=of	pos_33=IN	pos_38=NN	pos_38=NNS	pos_24=RB	relType_2=case	pos_9=CD	relType_41=compound	pos_32=VB	relType_20=punct	relType_27=case	lib=multiple	pos_48=IN	lemma_34=alteration	relType_23=punct	pos_19=IN	pos_29=-RRB-	pos_4=JJ	lemma_36=alcohol	pos_31=RB	lemma_25=3	relType_33=case	relType_10=amod	relType_13=punct	lemma_40=fecal	lemma_20=(	lemma_10=normal	relType_40=amod	relType_17=nummod	lemma_35=of	relType_38=compound	lemma_4=multiple	pos_5=HYPH	lemma_12=subject	pos_27=IN	pos_12=NNS	pos_10=JJ	relType_5=punct	pos_16=NNP	lemma_11=weight	lemma_36=pharmacokinetic	lemma_6=dose	relType_29=punct	lpib=multiple_JJ	pos_46=JJ	relType_14=appos	lemma_16=and	pos_36=NN	lemma_38=pharmacodynamic	lemma_48=to	relType_38=obj	eib=True	pos_3=DT	relType_11=compound	pos_23=,	pos_35=IN	relType_35=case	relType_18=conj	pos_21=NN
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e1	DDI-DrugBank.d761.s0.e2	null	relType_1=cc	lib=gram	pos_1=CC	relType_2=nummod	pos_3=NNS	eib=False	pos_2=CD	path2=gram_conj>alcohol_nmod	path=XENICAL_nmod<coadministration_appos>gram_conj>alcohol_nmod	lemma_3=gram	wib=grams	relType_3=conj	pos_4=IN	relType_4=case	path1=XENICAL_nmod	lemma_2=40	lemma_4=of	lemma_1=and	lpib=gram_NNS
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e1	DDI-DrugBank.d761.s0.e3	null	relType_1=cc	lib=gram	lemma_15=do	pos_1=CC	relType_14=punct	relType_2=nummod	relType_9=advmod	pos_7=NN	relType_12=case	path1=XENICAL_nmod<coadministration_appos<study_obl	relType_8=punct	lemma_8=,	lemma_6=e.	lemma_12=of	lemma_13=wine	pos_6=NN	relType_13=nmod	relType_18=case	pos_20=IN	relType_20=case	pos_3=NNS	pos_2=CD	lemma_3=gram	pos_14=-RRB-	relType_15=aux	pos_16=RB	lemma_5=alcohol	pos_11=NNS	lemma_19=alteration	wib=grams	lemma_5=(	pos_19=NN	lemma_20=of	pos_13=NN	lemma_14=)	pos_18=IN	pos_12=IN	lemma_11=glass	relType_16=advmod	relType_11=appos	relType_3=conj	pos_10=CD	pos_4=IN	relType_5=punct	path2=alteration_obl>pharmacokinetic_nmod>alcohol_compound	relType_4=case	pos_17=VB	relType_5=nmod	pos_9=RB	lemma_7=g.	relType_17=parataxis	lemma_10=3	path=XENICAL_nmod<coadministration_appos<study_obl<result_parataxis>alteration_obl>pharmacokinetic_nmod>alcohol_compound	relType_10=nummod	pos_5=NN	relType_6=compound	relType_7=dep	pos_15=VBD	eib=True	relType_19=obl	lemma_9=approximately	lemma_18=in	pos_8=,	lemma_17=result	lemma_16=not	lemma_2=40	lemma_4=of	lemma_1=and	lpib=gram_NNS	pos_5=-LRB-
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e1	DDI-DrugBank.d761.s0.e4	null	relType_1=cc	lib=gram	path2=pharmacodynamic_obj>orlistat_compound	relType_8=punct	pos_21=NNS	relType_18=case	pos_6=NN	pos_3=NNS	lemma_5=alcohol	pos_13=NN	relType_22=punct	pos_22=,	lemma_10=3	relType_6=compound	relType_19=obl	lemma_18=in	lemma_20=of	relType_2=nummod	relType_9=advmod	lemma_13=wine	relType_20=case	pos_16=RB	lemma_5=(	lemma_22=,	pos_12=IN	path=XENICAL_nmod<coadministration_appos<study_obl<result_parataxis>pharmacodynamic_obj>orlistat_compound	relType_17=parataxis	relType_21=compound	pos_5=NN	relType_7=dep	pos_15=VBD	lemma_9=approximately	pos_7=NN	lemma_2=40	lemma_1=and	pos_8=,	relType_14=punct	relType_12=case	relType_21=nmod	lemma_8=,	lemma_12=of	pos_20=IN	lemma_21=alcohol	lemma_3=gram	pos_14=-RRB-	lemma_14=)	pos_18=IN	lemma_11=glass	relType_16=advmod	relType_3=conj	pos_4=IN	pos_9=RB	lemma_7=g.	lemma_17=result	lemma_4=of	lemma_15=do	lpib=gram_NNS	pos_5=-LRB-	pos_1=CC	path1=XENICAL_nmod<coadministration_appos<study_obl	lemma_6=e.	relType_13=nmod	pos_2=CD	relType_15=aux	pos_11=NNS	lemma_19=alteration	wib=grams	pos_19=NN	relType_11=appos	lemma_21=pharmacokinetic	pos_10=CD	relType_5=punct	relType_4=case	pos_17=VB	relType_5=nmod	relType_10=nummod	eib=True	lemma_16=not	pos_21=NN
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e1	DDI-DrugBank.d761.s0.e5	null	relType_1=cc	lib=gram	relType_8=punct	pos_21=NNS	relType_18=case	pos_6=NN	pos_3=NNS	relType_28=punct	relType_30=cc	lemma_5=alcohol	pos_26=NN	pos_13=NN	lemma_31=systemic	relType_23=compound	relType_22=punct	pos_22=,	pos_32=NN	lemma_10=3	relType_6=compound	relType_19=obl	lemma_18=in	relType_31=amod	relType_32=conj	relType_23=obj	lemma_20=of	pos_31=JJ	relType_2=nummod	relType_9=advmod	pos_24=-LRB-	pos_30=CC	path=XENICAL_nmod<coadministration_appos<study_obl<result_parataxis>pharmacodynamic_obj>exposure_conj>orlistat_nmod	lemma_13=wine	lemma_32=exposure	relType_20=case	relType_25=amod	lemma_30=or	pos_16=RB	lemma_5=(	lemma_22=,	lemma_27=excretion	pos_12=IN	lemma_33=to	pos_27=NN	pos_28=-RRB-	relType_21=compound	relType_17=parataxis	pos_5=NN	relType_7=dep	pos_15=VBD	lemma_9=approximately	lemma_23=pharmacodynamic	pos_7=NN	lemma_2=40	lemma_1=and	pos_8=,	relType_14=punct	relType_12=case	relType_24=punct	relType_21=nmod	lemma_8=,	lemma_28=)	lemma_12=of	pos_20=IN	pos_23=NN	lemma_21=alcohol	lemma_29=,	lemma_3=gram	pos_14=-RRB-	lemma_26=fat	relType_26=compound	lemma_14=)	pos_18=IN	lemma_11=glass	relType_16=advmod	pos_33=IN	relType_3=conj	pos_23=NNS	pos_4=IN	pos_9=RB	lemma_7=g.	pos_29=,	lemma_17=result	relType_27=dep	lemma_4=of	lemma_15=do	lpib=gram_NNS	pos_5=-LRB-	pos_1=CC	relType_33=case	path1=XENICAL_nmod<coadministration_appos<study_obl	lemma_6=e.	relType_13=nmod	path2=pharmacodynamic_obj>exposure_conj>orlistat_nmod	pos_2=CD	relType_15=aux	pos_11=NNS	lemma_19=alteration	wib=grams	pos_19=NN	pos_25=JJ	relType_11=appos	lemma_21=pharmacokinetic	pos_10=CD	relType_5=punct	relType_4=case	pos_17=VB	relType_5=nmod	relType_29=punct	relType_10=nummod	lemma_25=fecal	eib=True	lemma_23=orlistat	lemma_24=(	lemma_16=not	pos_21=NN
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e2	DDI-DrugBank.d761.s0.e3	null	pos_7=NNS	relType_8=case	relType_3=dep	relType_10=punct	pos_2=NN	relType_7=appos	pos_16=IN	pos_11=VBD	lemma_12=not	pos_6=CD	lib=e.	lemma_7=glass	relType_9=nmod	relType_13=parataxis	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_12=advmod	relType_11=aux	lemma_13=result	lemma_9=wine	lemma_14=in	lemma_15=alteration	pos_9=NN	lemma_16=of	pos_8=IN	pos_14=IN	pos_13=VB	relType_15=obl	relType_4=punct	pos_15=NN	pos_12=RB	relType_2=compound	path2=alteration_obl>pharmacokinetic_nmod>alcohol_compound	pos_5=RB	lemma_5=approximately	relType_6=nummod	lemma_2=e.	lpib=e._NN	path1=alcohol_nmod<gram_conj<coadministration_appos<study_obl	wib=e.	lemma_4=,	pos_1=-LRB-	relType_5=advmod	relType_16=case	lemma_10=)	lemma_6=3	path=alcohol_nmod<gram_conj<coadministration_appos<study_obl<result_parataxis>alteration_obl>pharmacokinetic_nmod>alcohol_compound	pos_3=NN	pos_10=-RRB-	relType_14=case	relType_1=punct	lemma_8=of	lemma_11=do
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e2	DDI-DrugBank.d761.s0.e4	null	pos_7=NNS	relType_8=case	relType_3=dep	relType_10=punct	pos_2=NN	relType_7=appos	path2=pharmacodynamic_obj>orlistat_compound	pos_11=VBD	pos_16=IN	lemma_17=pharmacokinetic	lemma_12=not	pos_6=CD	lib=e.	lemma_7=glass	relType_9=nmod	relType_13=parataxis	lemma_1=(	pos_17=NN	lemma_3=g.	pos_4=,	relType_12=advmod	relType_11=aux	lemma_13=result	relType_17=compound	lemma_9=wine	lemma_14=in	lemma_15=alteration	pos_9=NN	lemma_16=of	pos_8=IN	pos_14=IN	pos_13=VB	path=alcohol_nmod<gram_conj<coadministration_appos<study_obl<result_parataxis>pharmacodynamic_obj>orlistat_compound	pos_18=,	relType_15=obl	relType_4=punct	pos_15=NN	pos_12=RB	lemma_18=,	relType_2=compound	pos_5=RB	lemma_5=approximately	relType_6=nummod	lemma_2=e.	lpib=e._NN	path1=alcohol_nmod<gram_conj<coadministration_appos<study_obl	wib=e.	lemma_4=,	relType_18=punct	relType_17=nmod	pos_1=-LRB-	relType_5=advmod	relType_16=case	lemma_10=)	lemma_17=alcohol	lemma_6=3	eib=True	pos_17=NNS	pos_3=NN	pos_10=-RRB-	relType_14=case	relType_1=punct	lemma_8=of	lemma_11=do
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e2	DDI-DrugBank.d761.s0.e5	null	relType_22=compound	pos_20=-LRB-	pos_2=NN	lemma_12=not	path=alcohol_nmod<gram_conj<coadministration_appos<study_obl<result_parataxis>pharmacodynamic_obj>exposure_conj>orlistat_nmod	relType_17=compound	lemma_9=wine	lemma_14=in	relType_26=cc	relType_15=obl	relType_4=punct	pos_12=RB	path1=alcohol_nmod<gram_conj<coadministration_appos<study_obl	lemma_25=,	wib=e.	pos_1=-LRB-	pos_28=NN	lemma_19=pharmacodynamic	lemma_10=)	relType_28=conj	lemma_27=systemic	pos_7=NNS	relType_8=case	relType_3=dep	lemma_19=orlistat	pos_22=NN	pos_21=JJ	pos_27=JJ	pos_19=NNS	lib=e.	lemma_7=glass	relType_13=parataxis	pos_29=IN	lemma_3=g.	lemma_13=result	pos_9=NN	lemma_26=or	pos_8=IN	pos_14=IN	relType_19=compound	lemma_23=excretion	relType_23=dep	lemma_24=)	lemma_5=approximately	relType_6=nummod	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_5=advmod	relType_16=case	lemma_17=alcohol	relType_25=punct	relType_1=punct	relType_10=punct	relType_7=appos	lemma_29=to	pos_16=IN	relType_29=case	relType_24=punct	relType_27=amod	lemma_1=(	pos_23=NN	pos_17=NN	pos_4=,	relType_12=advmod	relType_11=aux	pos_13=VB	lemma_22=fat	relType_17=nmod	pos_17=NNS	relType_20=punct	relType_14=case	relType_19=obj	pos_25=,	pos_11=VBD	lemma_17=pharmacokinetic	pos_6=CD	pos_26=CC	relType_9=nmod	lemma_20=(	lemma_28=exposure	lemma_21=fecal	path2=pharmacodynamic_obj>exposure_conj>orlistat_nmod	relType_21=amod	pos_19=NN	lemma_15=alteration	lemma_16=of	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	pos_5=RB	relType_18=punct	pos_24=-RRB-	lemma_6=3	eib=True	pos_3=NN	pos_10=-RRB-	lemma_8=of	lemma_11=do
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e3	DDI-DrugBank.d761.s0.e4	null	wib=pharmacokinetics	pos_1=NNS	eib=False	path1=alcohol_compound<pharmacokinetic_nmod<alteration_obl	path2=pharmacodynamic_obj>orlistat_compound	lib=pharmacokinetic	lpib=pharmacokinetic_NNS	path=alcohol_compound<pharmacokinetic_nmod<alteration_obl<result_parataxis>pharmacodynamic_obj>orlistat_compound	pos_2=,	relType_1=nmod	lemma_1=pharmacokinetic	lemma_2=,	relType_2=punct
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e3	DDI-DrugBank.d761.s0.e5	null	relType_12=conj	lib=pharmacokinetic	relType_10=cc	relType_8=punct	lemma_9=,	lemma_5=fecal	relType_2=punct	pos_6=NN	lemma_12=exposure	wib=pharmacokinetics	pos_3=NNS	path2=pharmacodynamic_obj>exposure_conj>orlistat_nmod	pos_4=-LRB-	pos_10=CC	lemma_7=excretion	relType_11=amod	pos_12=NN	pos_8=-RRB-	pos_13=IN	relType_1=nmod	lemma_2=,	lemma_4=(	lemma_13=to	lemma_6=fat	pos_5=JJ	lemma_8=)	relType_13=case	relType_4=punct	relType_5=amod	lpib=pharmacokinetic_NNS	lemma_10=or	relType_9=punct	lemma_1=pharmacokinetic	lemma_11=systemic	lemma_3=orlistat	relType_6=compound	pos_1=NNS	relType_7=dep	eib=True	path1=alcohol_compound<pharmacokinetic_nmod<alteration_obl	pos_3=NN	lemma_3=pharmacodynamic	pos_2=,	relType_3=compound	relType_3=obj	pos_11=JJ	pos_9=,	pos_7=NN	path=alcohol_compound<pharmacokinetic_nmod<alteration_obl<result_parataxis>pharmacodynamic_obj>exposure_conj>orlistat_nmod
DDI-DrugBank.d761.s0	DDI-DrugBank.d761.s0.e4	DDI-DrugBank.d761.s0.e5	null	lemma_10=exposure	relType_8=cc	lemma_3=fecal	lemma_5=excretion	lemma_9=systemic	relType_11=case	relType_2=punct	pos_9=JJ	eib=False	relType_10=conj	relType_6=punct	lib=pharmacodynamic	pos_2=-LRB-	pos_7=,	relType_9=amod	pos_8=CC	lemma_8=or	lemma_7=,	relType_5=dep	pos_4=NN	path=orlistat_compound<pharmacodynamic_obj>exposure_conj>orlistat_nmod	lemma_6=)	pos_10=NN	pos_11=IN	lpib=pharmacodynamic_NNS	wib=pharmacodynamics	relType_3=amod	relType_4=compound	relType_1=obj	lemma_11=to	pos_6=-RRB-	pos_5=NN	pos_1=NNS	pos_3=JJ	relType_7=punct	lemma_1=pharmacodynamic	lemma_2=(	lemma_4=fat	path2=exposure_conj>orlistat_nmod	path1=orlistat_compound
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e0	DDI-DrugBank.d761.s1.e1	null	path1=	wib=Preliminary	pos_2=JJ	lemma_5=a	pos_3=NNS	path=<cyclosporine_ROOT>indicate_parataxis>datum_nsubj>study_nmod>xenical_compound	eib=False	lpib=preliminary_JJ	lemma_2=preliminary	lemma_1=:	pos_4=IN	relType_2=amod	relType_5=det	pos_1=:	relType_4=case	relType_3=nsubj	lemma_3=datum	path2=indicate_parataxis>datum_nsubj>study_nmod>xenical_compound	lib=preliminary	pos_5=DT	relType_1=punct	lemma_4=from
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e0	DDI-DrugBank.d761.s1.e2	null	path2=indicate_parataxis>datum_nsubj>study_nmod>xenical_compound>cyclosporine_conj	path1=	wib=Preliminary	pos_2=JJ	pos_6=NN	lemma_5=a	pos_3=NNS	lpib=preliminary_JJ	lemma_2=preliminary	lemma_1=:	path=<cyclosporine_ROOT>indicate_parataxis>datum_nsubj>study_nmod>xenical_compound>cyclosporine_conj	pos_6=CC	pos_4=IN	lemma_6=and	relType_2=amod	relType_5=det	pos_1=:	relType_4=case	relType_3=nsubj	lemma_6=xenical	relType_6=compound	lemma_3=datum	eib=True	lib=preliminary	pos_5=DT	relType_1=punct	lemma_4=from	relType_6=cc
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e0	DDI-DrugBank.d761.s1.e3	null	relType_7=compound	pos_7=NN	lemma_11=a	path1=	wib=Preliminary	path=<cyclosporine_ROOT>indicate_parataxis>reduction_obj>level_nmod>cyclosporine_compound	relType_9=nmod	pos_2=JJ	relType_10=parataxis	pos_6=NN	lemma_5=a	pos_8=NN	pos_3=NNS	lemma_7=cyclosporine	lpib=preliminary_JJ	lemma_2=preliminary	pos_12=NN	relType_12=obj	pos_13=IN	pos_9=NN	lemma_10=indicate	lemma_1=:	relType_13=case	pos_6=CC	pos_4=IN	lemma_6=and	relType_2=amod	relType_5=det	pos_1=:	relType_4=case	relType_8=compound	lemma_9=study	lemma_8=interaction	pos_11=DT	lemma_13=in	relType_3=nsubj	relType_11=det	lemma_6=xenical	relType_6=compound	lemma_12=reduction	path2=indicate_parataxis>reduction_obj>level_nmod>cyclosporine_compound	lemma_3=datum	eib=True	pos_10=VBP	lib=preliminary	pos_5=DT	lemma_7=drug	relType_1=punct	lemma_4=from	relType_7=conj	relType_6=cc
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e0	DDI-DrugBank.d761.s1.e4	null	path=<cyclosporine_ROOT>indicate_parataxis>coadminister_advcl>XENICAL_nsubj:pass	relType_7=compound	pos_7=NN	lemma_11=a	path1=	wib=Preliminary	relType_14=compound	relType_9=nmod	pos_2=JJ	relType_10=parataxis	pos_6=NN	lemma_5=a	pos_8=NN	pos_3=NNS	lemma_7=cyclosporine	lpib=preliminary_JJ	lemma_2=preliminary	pos_12=NN	relType_12=obj	pos_14=NN	pos_13=IN	pos_9=NN	lemma_10=indicate	lemma_1=:	relType_16=advmod	relType_13=case	lemma_14=plasma	pos_6=CC	pos_4=IN	lemma_6=and	relType_2=amod	relType_5=det	pos_1=:	relType_4=case	relType_8=compound	lemma_9=study	lemma_14=cyclosporine	lemma_8=interaction	pos_11=DT	lemma_13=in	relType_3=nsubj	relType_11=det	lemma_6=xenical	relType_15=nmod	relType_6=compound	lemma_12=reduction	lemma_16=when	pos_15=NNS	lemma_3=datum	eib=True	pos_10=VBP	lib=preliminary	pos_5=DT	lemma_7=drug	relType_1=punct	lemma_4=from	lemma_15=level	path2=indicate_parataxis>coadminister_advcl>XENICAL_nsubj:pass	pos_16=WRB	relType_7=conj	relType_6=cc
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e0	DDI-DrugBank.d761.s1.e5	null	pos_19=IN	relType_7=compound	path2=indicate_parataxis>coadminister_advcl>cyclosporine_obl	pos_7=NN	lemma_11=a	pos_17=VBD	path1=	relType_17=aux:pass	wib=Preliminary	relType_17=nsubj:pass	relType_14=compound	relType_9=nmod	pos_2=JJ	lemma_17=be	lemma_18=coadminister	relType_10=parataxis	pos_6=NN	lemma_5=a	pos_8=NN	pos_3=NNS	pos_17=NNP	lemma_7=cyclosporine	lpib=preliminary_JJ	lemma_2=preliminary	pos_12=NN	relType_12=obj	pos_14=NN	pos_13=IN	pos_9=NN	lemma_10=indicate	lemma_1=:	relType_16=advmod	relType_13=case	lemma_14=plasma	lemma_17=XENICAL	lemma_19=with	pos_6=CC	pos_4=IN	lemma_6=and	relType_2=amod	relType_5=det	pos_1=:	relType_4=case	relType_8=compound	lemma_9=study	lemma_14=cyclosporine	lemma_8=interaction	pos_11=DT	lemma_13=in	path=<cyclosporine_ROOT>indicate_parataxis>coadminister_advcl>cyclosporine_obl	relType_3=nsubj	relType_11=det	lemma_6=xenical	relType_15=nmod	relType_6=compound	lemma_12=reduction	lemma_16=when	pos_18=VBN	relType_18=advcl	pos_15=NNS	lemma_3=datum	eib=True	pos_10=VBP	relType_19=case	lib=preliminary	pos_5=DT	lemma_7=drug	relType_1=punct	lemma_4=from	lemma_15=level	pos_16=WRB	relType_7=conj	relType_6=cc
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e1	DDI-DrugBank.d761.s1.e2	null	relType_1=cc	pos_1=CC	lpib=cyclosporine_NN	eib=False	path2=cyclosporine_conj	path1=	lib=cyclosporine	wib=cyclosporine	path=<xenical_compound>cyclosporine_conj	lemma_1=and
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e1	DDI-DrugBank.d761.s1.e3	null	relType_1=cc	relType_8=case	pos_1=CC	lemma_4=study	pos_2=NN	pos_6=DT	relType_5=parataxis	relType_4=nmod	lemma_5=indicate	lemma_2=cyclosporine	path2=reduction_obj>level_nmod>cyclosporine_compound	lemma_8=in	pos_5=VBP	lemma_6=a	path=xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>reduction_obj>level_nmod>cyclosporine_compound	relType_7=obj	lemma_3=interaction	lib=cyclosporine	lemma_7=reduction	relType_2=conj	pos_4=NN	pos_8=IN	lpib=cyclosporine_NN	relType_2=compound	wib=cyclosporine	lemma_2=drug	relType_6=det	path1=xenical_compound<study_nmod<datum_nsubj	eib=True	pos_3=NN	relType_3=compound	pos_7=NN	lemma_1=and
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e1	DDI-DrugBank.d761.s1.e4	null	relType_1=cc	relType_8=case	pos_1=CC	lemma_4=study	pos_2=NN	lemma_9=plasma	lemma_9=cyclosporine	pos_6=DT	relType_5=parataxis	relType_4=nmod	lemma_5=indicate	lemma_2=cyclosporine	path=xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>coadminister_advcl>XENICAL_nsubj:pass	lemma_8=in	relType_10=nmod	relType_9=compound	pos_5=VBP	lemma_6=a	path2=coadminister_advcl>XENICAL_nsubj:pass	lemma_3=interaction	relType_7=obj	lemma_11=when	lib=cyclosporine	lemma_7=reduction	relType_2=conj	pos_4=NN	pos_9=NN	pos_8=IN	relType_11=advmod	pos_11=WRB	lemma_10=level	lpib=cyclosporine_NN	relType_2=compound	wib=cyclosporine	lemma_2=drug	relType_6=det	path1=xenical_compound<study_nmod<datum_nsubj	eib=True	pos_3=NN	relType_3=compound	pos_7=NN	pos_10=NNS	lemma_1=and
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e1	DDI-DrugBank.d761.s1.e5	null	relType_1=cc	relType_8=case	pos_1=CC	lemma_4=study	pos_2=NN	lemma_9=plasma	lemma_9=cyclosporine	pos_6=DT	lemma_12=XENICAL	lemma_14=with	relType_13=advcl	relType_5=parataxis	relType_4=nmod	lemma_5=indicate	lemma_2=cyclosporine	pos_13=VBN	relType_12=aux:pass	lemma_13=coadminister	lemma_8=in	relType_10=nmod	relType_9=compound	path2=coadminister_advcl>cyclosporine_obl	pos_5=VBP	lemma_6=a	relType_12=nsubj:pass	pos_12=VBD	relType_7=obj	lemma_3=interaction	lemma_11=when	lib=cyclosporine	lemma_7=reduction	relType_2=conj	pos_4=NN	pos_9=NN	pos_8=IN	relType_11=advmod	pos_14=IN	pos_11=WRB	lemma_10=level	lpib=cyclosporine_NN	lemma_12=be	relType_2=compound	wib=cyclosporine	lemma_2=drug	relType_6=det	path1=xenical_compound<study_nmod<datum_nsubj	eib=True	pos_12=NNP	pos_3=NN	relType_3=compound	relType_14=case	pos_7=NN	pos_10=NNS	lemma_1=and	path=xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>coadminister_advcl>cyclosporine_obl
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e2	DDI-DrugBank.d761.s1.e3	null	pos_2=NN	relType_7=case	path2=reduction_obj>level_nmod>cyclosporine_compound	pos_6=NN	lemma_5=a	lpib=drug_NN	path1=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj	relType_1=compound	pos_4=VBP	eib=False	lib=drug	lemma_2=interaction	pos_1=NN	relType_4=parataxis	lemma_4=indicate	relType_2=compound	relType_5=det	wib=drug	relType_3=nmod	lemma_6=reduction	lemma_1=drug	relType_6=obj	lemma_3=study	pos_7=IN	lemma_7=in	pos_3=NN	pos_5=DT	path=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>reduction_obj>level_nmod>cyclosporine_compound
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e2	DDI-DrugBank.d761.s1.e4	null	pos_10=WRB	pos_2=NN	relType_7=case	path=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>coadminister_advcl>XENICAL_nsubj:pass	relType_9=nmod	pos_6=NN	lemma_5=a	pos_8=NN	lpib=drug_NN	path1=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj	relType_1=compound	pos_4=VBP	lemma_10=when	path2=coadminister_advcl>XENICAL_nsubj:pass	pos_9=NNS	lib=drug	relType_10=advmod	lemma_2=interaction	pos_1=NN	relType_4=parataxis	lemma_4=indicate	relType_2=compound	relType_5=det	wib=drug	relType_3=nmod	relType_8=compound	lemma_6=reduction	lemma_8=plasma	lemma_9=level	lemma_1=drug	relType_6=obj	lemma_3=study	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	pos_5=DT	lemma_8=cyclosporine
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e2	DDI-DrugBank.d761.s1.e5	null	pos_10=WRB	path=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj<indicate_parataxis>coadminister_advcl>cyclosporine_obl	pos_2=NN	relType_7=case	pos_11=VBD	lemma_13=with	lemma_11=be	pos_11=NNP	relType_9=nmod	pos_6=NN	lemma_5=a	pos_8=NN	lpib=drug_NN	path1=cyclosporine_conj<xenical_compound<study_nmod<datum_nsubj	relType_1=compound	pos_4=VBP	path2=coadminister_advcl>cyclosporine_obl	lemma_10=when	relType_12=advcl	pos_9=NNS	lib=drug	relType_10=advmod	relType_11=aux:pass	pos_13=IN	lemma_2=interaction	pos_1=NN	relType_4=parataxis	lemma_4=indicate	lemma_12=coadminister	relType_13=case	relType_2=compound	relType_5=det	wib=drug	relType_3=nmod	relType_8=compound	lemma_11=XENICAL	lemma_6=reduction	lemma_8=plasma	lemma_9=level	lemma_1=drug	relType_11=nsubj:pass	relType_6=obj	lemma_3=study	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	pos_5=DT	lemma_8=cyclosporine	pos_12=VBN
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e3	DDI-DrugBank.d761.s1.e4	null	wib=plasma	pos_2=NNS	lpib=plasma_NN	lemma_1=plasma	pos_3=WRB	path=cyclosporine_compound<level_nmod<reduction_obj<indicate_parataxis>coadminister_advcl>XENICAL_nsubj:pass	relType_1=compound	relType_3=advmod	eib=False	relType_2=nmod	path2=coadminister_advcl>XENICAL_nsubj:pass	lib=plasma	path1=cyclosporine_compound<level_nmod<reduction_obj	pos_1=NN	lemma_2=level	lemma_3=when
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e3	DDI-DrugBank.d761.s1.e5	null	lemma_4=XENICAL	lemma_1=plasma	relType_3=advmod	lemma_4=be	relType_6=case	relType_5=advcl	relType_1=compound	path2=coadminister_advcl>cyclosporine_obl	relType_2=nmod	path=cyclosporine_compound<level_nmod<reduction_obj<indicate_parataxis>coadminister_advcl>cyclosporine_obl	pos_6=IN	relType_4=nsubj:pass	pos_1=NN	wib=plasma	lpib=plasma_NN	lemma_5=coadminister	relType_4=aux:pass	lib=plasma	lemma_6=with	lemma_2=level	pos_2=NNS	pos_3=WRB	pos_4=VBD	eib=True	pos_4=NNP	path1=cyclosporine_compound<level_nmod<reduction_obj	pos_5=VBN	lemma_3=when
DDI-DrugBank.d761.s1	DDI-DrugBank.d761.s1.e4	DDI-DrugBank.d761.s1.e5	mechanism	path1=XENICAL_nsubj:pass	pos_2=VBN	pos_1=VBD	lib=be	pos_3=IN	eib=False	relType_1=aux:pass	lemma_1=be	relType_2=advcl	path2=cyclosporine_obl	lemma_2=coadminister	lemma_3=with	lpib=be_VBD	wib=was	path=XENICAL_nsubj:pass<coadminister_advcl>cyclosporine_obl	relType_3=case
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e0	DDI-DrugBank.d761.s2.e1	null	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_7=subject	path1=	lemma_6=weight	lpib=normal_JJ	path2=alter_appos>subject_obl>receive_acl>mg_obj>xenical_compound	lemma_8=receive	pos_6=NN	pos_2=IN	eib=False	pos_5=HYPH	lemma_1=:	lib=normal	pos_3=CD	relType_5=punct	pos_8=VBG	pos_1=:	relType_3=nummod	relType_8=acl	lemma_3=12	wib=normal	relType_6=compound	relType_7=obl	relType_2=case	path=<Digoxin_ROOT>alter_appos>subject_obl>receive_acl>mg_obj>xenical_compound	relType_1=punct	lemma_5=-	lemma_2=in
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e0	DDI-DrugBank.d761.s2.e2	null	path2=alter_appos>XENICAL_nsubj	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_13=a	lemma_7=subject	relType_14=obl:npmod	path1=	pos_13=DT	lemma_6=weight	lpib=normal_JJ	lemma_8=receive	relType_9=nummod	pos_6=NN	pos_2=IN	relType_9=compound	lemma_11=three	lemma_14=day	pos_5=HYPH	lemma_10=mg	pos_14=NN	lemma_16=6	pos_9=NN	relType_10=obj	relType_12=obl:tmod	lemma_1=:	lib=normal	pos_16=CD	relType_15=case	relType_11=nummod	pos_18=,	lemma_12=time	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	pos_8=VBG	relType_18=punct	pos_1=:	relType_16=nummod	relType_3=nummod	lemma_9=120	relType_8=acl	lemma_3=12	wib=normal	pos_11=CD	relType_17=nmod	pos_15=IN	relType_6=compound	lemma_15=for	path=<Digoxin_ROOT>alter_appos>XENICAL_nsubj	relType_7=obl	relType_2=case	lemma_9=xenical	eib=True	pos_9=CD	pos_17=NNS	relType_13=det	relType_1=punct	lemma_5=-	pos_10=NNS	lemma_2=in	lemma_17=day
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e0	DDI-DrugBank.d761.s2.e3	null	lemma_13=a	lemma_7=subject	lemma_27=dose	lpib=normal_JJ	lemma_8=receive	relType_9=nummod	pos_6=NN	relType_24=case	relType_27=nmod	path2=alter_appos>pharmacokinetic_obj>dose_nmod>digoxin_nmod	lemma_19=XENICAL	lemma_22=the	pos_1=:	relType_25=det	pos_24=IN	relType_6=compound	lemma_15=for	relType_26=amod	relType_13=det	lemma_5=-	pos_19=VBD	lemma_17=day	relType_23=obj	pos_7=NNS	relType_4=amod	relType_14=obl:npmod	path1=	relation_22=neutral	lemma_6=weight	lemma_14=day	pos_9=NN	relType_12=obl:tmod	pos_27=NN	relType_15=case	lemma_12=time	pos_8=VBG	pos_21=VB	relType_16=nummod	lemma_9=120	pos_11=CD	relType_19=nsubj	pos_15=IN	pos_22=DT	relType_7=obl	relType_1=punct	relType_10=obj	lemma_2=in	lemma_4=normal	lemma_28=of	path=<Digoxin_ROOT>alter_appos>pharmacokinetic_obj>dose_nmod>digoxin_nmod	lemma_24=of	pos_26=JJ	pos_2=IN	lemma_10=mg	pos_14=NN	lemma_16=6	lemma_1=:	lib=normal	pos_16=CD	relType_11=nummod	pos_23=NNS	relType_19=aux	relType_8=acl	relType_17=nmod	relType_28=case	relType_2=case	pos_9=CD	pos_17=NNS	relType_22=det	pos_20=RB	lemma_25=a	relType_21=appos	lemma_19=do	pos_4=JJ	lemma_21=alter	pos_13=DT	pos_25=DT	relType_20=advmod	relType_9=compound	lemma_11=three	pos_5=HYPH	lemma_23=pharmacokinetic	pos_18=,	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	relType_18=punct	relType_3=nummod	lemma_3=12	wib=normal	lemma_9=xenical	eib=True	pos_28=IN	lemma_26=single	pos_19=NNP	pos_10=NNS	lemma_20=not
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e1	DDI-DrugBank.d761.s2.e2	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	lemma_10=,	lemma_1=120	relType_9=nmod	pos_6=NN	lemma_5=a	path2=XENICAL_nsubj	lib=mg	pos_1=CD	eib=False	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	pos_4=NNS	lpib=mg_NNS	lemma_8=6	pos_3=CD	relType_5=det	relType_6=obl:npmod	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_appos>XENICAL_nsubj	path1=xenical_compound<mg_obj<receive_acl<subject_obl	relType_3=nummod	lemma_2=mg	pos_2=NNS	lemma_9=day	pos_10=,	pos_7=IN	pos_5=DT	wib=mg	pos_8=CD	lemma_7=for
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e1	DDI-DrugBank.d761.s2.e3	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	pos_17=DT	pos_16=IN	pos_11=VBD	lemma_10=,	lemma_12=not	relType_18=amod	pos_11=NNP	lemma_1=120	relType_9=nmod	path2=pharmacokinetic_obj>dose_nmod>digoxin_nmod	pos_20=IN	pos_6=NN	lemma_5=a	relType_19=nmod	relType_20=case	relation_13=neutral	relType_17=det	lib=mg	pos_1=CD	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_appos>pharmacokinetic_obj>dose_nmod>digoxin_nmod	relType_12=advmod	lemma_4=time	relType_11=aux	relType_13=appos	lemma_6=day	lemma_3=three	pos_9=NNS	relType_14=det	relType_11=nsubj	pos_18=JJ	pos_19=NN	lemma_20=of	lemma_14=the	lemma_16=of	pos_4=NNS	lpib=mg_NNS	lemma_18=single	pos_13=VB	lemma_8=6	pos_3=CD	pos_12=RB	relType_5=det	lemma_11=XENICAL	relType_6=obl:npmod	relType_3=nummod	path1=xenical_compound<mg_obj<receive_acl<subject_obl	lemma_2=mg	lemma_13=alter	pos_14=DT	relType_15=obj	pos_2=NNS	relType_16=case	lemma_17=a	lemma_9=day	pos_10=,	pos_15=NNS	eib=True	pos_7=IN	lemma_19=dose	lemma_15=pharmacokinetic	pos_5=DT	wib=mg	pos_8=CD	lemma_7=for	lemma_11=do
DDI-DrugBank.d761.s2	DDI-DrugBank.d761.s2.e2	DDI-DrugBank.d761.s2.e3	null	lemma_3=alter	relType_1=aux	relType_7=det	relType_8=amod	wib=did	lemma_10=of	lemma_6=of	pos_3=VB	relType_9=nmod	relType_6=case	path2=pharmacokinetic_obj>dose_nmod>digoxin_nmod	pos_8=JJ	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	pos_5=NNS	pos_6=IN	lemma_8=single	relation_2=neutral	relType_10=case	pos_9=NN	pos_7=DT	path1=XENICAL_nsubj	pos_4=DT	lemma_4=the	pos_10=IN	lpib=do_VBD	lib=do	lemma_5=pharmacokinetic	relType_5=obj	lemma_7=a	relType_4=det	lemma_2=not	path=XENICAL_nsubj<alter_appos>pharmacokinetic_obj>dose_nmod>digoxin_nmod	lemma_9=dose
DDI-DrugBank.d761.s3	DDI-DrugBank.d761.s3.e0	DDI-DrugBank.d761.s3.e1	null	relType_1=cc	pos_1=CC	relType_14=punct	lpib=analogue_NNS	lemma_4=a	pos_7=NN	lemma_9=a	path1=	relType_14=compound	pos_6=NN	lemma_3=:	path2=show_parataxis>reduction_obj>absorption_nmod>carotene_compound	pos_9=DT	lemma_7=study	pos_12=NN	relType_12=obj	pos_13=IN	pos_14=NN	relType_2=conj	relType_8=parataxis	lemma_11=%	pos_8=VBD	pos_4=DT	pos_5=JJ	relType_13=case	lemma_10=30	relType_5=amod	lemma_6=interaction	pos_3=:	pos_10=CD	lemma_14=-	lemma_13=in	relType_10=nummod	pos_2=NNS	relType_6=compound	lemma_12=reduction	pos_14=HYPH	pos_11=NN	eib=True	lemma_5=pharmacokinetic	path=<supplement_ROOT>show_parataxis>reduction_obj>absorption_nmod>carotene_compound	wib=Analogues	relType_11=compound	lib=analogue	lemma_8=show	relType_7=nsubj	lemma_2=analogue	lemma_14=beta	relType_4=det	relType_3=punct	lemma_1=and	relType_9=det
DDI-DrugBank.d761.s3	DDI-DrugBank.d761.s3.e0	DDI-DrugBank.d761.s3.e2	null	relType_1=cc	pos_19=IN	pos_1=CC	relType_14=punct	lemma_14=carotene	lpib=analogue_NNS	lemma_14=supplement	lemma_4=a	pos_7=NN	lemma_9=a	path1=	relType_14=compound	pos_6=NN	lemma_3=:	pos_9=DT	lemma_7=study	pos_12=NN	relType_12=obj	path2=show_parataxis>administer_advcl>xenical_obl	pos_13=IN	pos_14=NN	relType_2=conj	relType_8=parataxis	lemma_11=%	pos_16=WRB	pos_8=VBD	pos_17=RB	relType_16=advmod	pos_4=DT	pos_5=JJ	relType_13=case	lemma_19=with	lemma_10=30	relType_5=amod	pos_15=NN	lemma_6=interaction	pos_3=:	pos_10=CD	lemma_14=-	path=<supplement_ROOT>show_parataxis>administer_advcl>xenical_obl	relType_17=advmod	lemma_13=in	relType_10=nummod	relType_15=nmod	pos_2=NNS	relType_6=compound	lemma_12=reduction	pos_14=HYPH	lemma_16=when	pos_11=NN	pos_18=VBN	lemma_17=concomitantly	eib=True	lemma_18=administer	lemma_5=pharmacokinetic	relType_11=compound	wib=Analogues	relType_18=advcl	relType_19=case	lib=analogue	lemma_8=show	relType_7=nsubj	lemma_15=absorption	lemma_2=analogue	lemma_14=beta	relType_4=det	relType_3=punct	lemma_1=and	relType_9=det
DDI-DrugBank.d761.s3	DDI-DrugBank.d761.s3.e1	DDI-DrugBank.d761.s3.e2	mechanism	pos_2=NN	relType_3=advmod	wib=supplement	lemma_4=concomitantly	path=carotene_compound<absorption_nmod<reduction_obj<show_parataxis>administer_advcl>xenical_obl	relType_6=case	pos_4=RB	relType_5=advcl	relType_1=compound	eib=False	relType_2=nmod	pos_6=IN	lemma_1=supplement	path1=carotene_compound<absorption_nmod<reduction_obj	pos_1=NN	lib=supplement	lemma_2=absorption	relType_4=advmod	lpib=supplement_NN	lemma_6=with	lemma_5=administer	pos_3=WRB	path2=administer_advcl>xenical_obl	pos_5=VBN	lemma_3=when
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e0	DDI-DrugBank.d761.s5.e1	null	path2=absorption_nmod>d_nmod	pos_2=DT	relType_1=case	lemma_2=the	lib=absorption	path=orlistat_nmod<effect_nsubj:pass>absorption_nmod>d_nmod	pos_6=NN	lpib=absorption_NN	pos_1=IN	wib=absorption	pos_5=JJ	relType_5=amod	pos_4=IN	relType_3=nmod	relType_4=case	path1=orlistat_nmod	lemma_5=supplemental	relType_6=compound	lemma_3=absorption	eib=True	pos_3=NN	relType_2=det	lemma_4=of	lemma_6=vitamin	lemma_1=on
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e0	DDI-DrugBank.d761.s5.e2	null	pos_2=DT	relType_1=case	relType_7=compound	lemma_2=the	pos_7=NN	lemma_6=,	lib=absorption	pos_6=NN	lpib=absorption_NN	relType_6=punct	lemma_7=vitamin	path2=absorption_nmod>d_nmod>a_conj	pos_1=IN	wib=absorption	pos_5=JJ	path=orlistat_nmod<effect_nsubj:pass>absorption_nmod>d_nmod>a_conj	relType_5=amod	pos_4=IN	relType_3=nmod	relType_4=case	lemma_6=d	path1=orlistat_nmod	lemma_5=supplemental	pos_6=,	relType_6=compound	lemma_3=absorption	eib=True	pos_3=NN	relType_2=det	relType_6=nmod	lemma_4=of	lemma_6=vitamin	lemma_1=on
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e0	DDI-DrugBank.d761.s5.e3	null	pos_2=DT	relType_1=case	relType_7=compound	relType_10=punct	lemma_2=the	relType_9=advmod	relType_8=cc	pos_7=NN	lemma_6=,	lib=absorption	pos_6=NN	lpib=absorption_NN	path=orlistat_nmod<effect_nsubj:pass>absorption_nmod>d_nmod>k_conj	relType_12=compound	relType_6=punct	path2=absorption_nmod>d_nmod>k_conj	lemma_7=vitamin	relType_11=amod	pos_7=,	pos_12=NN	pos_1=IN	pos_8=CC	lemma_7=,	wib=absorption	lemma_10=-	pos_5=JJ	relType_7=conj	relType_5=amod	lemma_9=nutritionally	pos_4=IN	pos_10=HYPH	relType_3=nmod	relType_4=case	lemma_6=d	path1=orlistat_nmod	pos_9=RB	pos_11=VBN	lemma_5=supplemental	pos_6=,	lemma_8=and	relType_6=compound	lemma_11=derive	lemma_3=absorption	eib=True	pos_3=NN	relType_7=punct	relType_2=det	lemma_12=vitamin	lemma_7=a	relType_6=nmod	lemma_4=of	lemma_6=vitamin	lemma_1=on
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e1	DDI-DrugBank.d761.s5.e2	null	lemma_1=,	pos_2=NN	eib=True	relType_2=compound	path1=	pos_1=,	path=<d_nmod>a_conj	wib=vitamin	relType_1=punct	lib=vitamin	lemma_2=vitamin	path2=a_conj	lpib=vitamin_NN
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e1	DDI-DrugBank.d761.s5.e3	null	lemma_6=derive	relType_7=compound	lemma_1=,	pos_2=NN	path2=k_conj	pos_3=CC	pos_7=NN	lemma_4=nutritionally	path1=	pos_1=,	lemma_2=a	relType_2=punct	relType_3=cc	pos_4=RB	relType_6=amod	lemma_7=vitamin	pos_5=HYPH	wib=vitamin	pos_6=VBN	relType_2=conj	lemma_2=,	relType_2=compound	relType_5=punct	relType_4=advmod	lemma_2=vitamin	lib=vitamin	path=<d_nmod>k_conj	eib=True	pos_2=,	lemma_3=and	relType_1=punct	lemma_5=-	lpib=vitamin_NN
DDI-DrugBank.d761.s5	DDI-DrugBank.d761.s5.e2	DDI-DrugBank.d761.s5.e3	null	path1=a_conj	lemma_1=,	pos_3=RB	path2=k_conj	lemma_3=nutritionally	relType_3=advmod	pos_1=,	lemma_4=-	wib=nutritionally	pos_4=HYPH	relType_2=cc	path=a_conj<d_nmod>k_conj	pos_6=NN	lemma_2=and	lib=nutritionally	relType_4=punct	relType_5=amod	lpib=nutritionally_RB	lemma_5=derive	relType_6=compound	eib=True	pos_2=CC	relType_1=punct	pos_5=VBN	lemma_6=vitamin
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e0	DDI-DrugBank.d761.s6.e1	null	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_7=subject	path1=	lemma_6=weight	lpib=normal_JJ	lemma_8=receive	pos_6=NN	pos_2=IN	eib=False	pos_5=HYPH	lemma_1=:	lib=normal	pos_3=CD	path=<glyburide_ROOT>alter_appos>subject_obl>receive_acl>mg_obj>orlistat_compound	relType_5=punct	pos_8=VBG	pos_1=:	relType_3=nummod	path2=alter_appos>subject_obl>receive_acl>mg_obj>orlistat_compound	relType_8=acl	lemma_3=12	wib=normal	relType_6=compound	relType_7=obl	relType_2=case	relType_1=punct	lemma_5=-	lemma_2=in
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e0	DDI-DrugBank.d761.s6.e2	null	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_13=a	lemma_7=subject	relType_14=obl:npmod	path1=	pos_13=DT	lemma_6=weight	lpib=normal_JJ	lemma_8=receive	relType_9=nummod	pos_6=NN	pos_2=IN	relType_9=compound	lemma_11=three	lemma_14=day	pos_5=HYPH	lemma_9=80	lemma_10=mg	pos_14=NN	pos_9=NN	relType_10=obj	relType_12=obl:tmod	lemma_1=:	lib=normal	pos_16=CD	relType_15=case	relType_11=nummod	pos_18=,	lemma_12=time	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	pos_8=VBG	path=<glyburide_ROOT>alter_appos>orlistat_nsubj	relType_18=punct	pos_1=:	relType_16=nummod	relType_3=nummod	relType_8=acl	lemma_3=12	wib=normal	path2=alter_appos>orlistat_nsubj	pos_11=CD	lemma_16=5	pos_15=IN	relType_17=nmod	relType_6=compound	lemma_15=for	relType_7=obl	relType_2=case	lemma_9=orlistat	eib=True	pos_9=CD	pos_17=NNS	relType_13=det	relType_1=punct	lemma_5=-	pos_10=NNS	lemma_2=in	lemma_17=day
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e0	DDI-DrugBank.d761.s6.e3	null	relType_28=dep	lemma_13=a	lemma_7=subject	lpib=normal_JJ	lemma_8=receive	relType_9=nummod	path=<glyburide_ROOT>alter_appos>pharmacokinetic_obj>glyburide_nmod	pos_6=NN	lemma_32=of	lemma_9=80	pos_32=IN	lemma_31=)	relType_30=amod	lemma_22=the	pos_31=-RRB-	pos_1=:	pos_28=NN	relType_6=compound	lemma_15=for	relType_13=det	lemma_5=-	pos_19=VBD	lemma_17=day	relType_23=obj	relType_32=case	pos_7=NNS	lemma_26=(	relType_4=amod	lemma_19=orlistat	relType_25=conj	relType_14=obl:npmod	path1=	relation_22=neutral	lemma_24=or	lemma_6=weight	pos_24=CC	lemma_14=day	pos_25=NNS	pos_9=NN	relType_12=obl:tmod	pos_27=NN	relType_15=case	lemma_12=time	pos_8=VBG	pos_21=VB	relType_16=nummod	pos_11=CD	lemma_16=5	relType_19=nsubj	pos_15=IN	pos_22=DT	relType_7=obl	lemma_30=lower	relType_26=punct	relType_1=punct	relType_10=obj	lemma_2=in	lemma_4=normal	pos_2=IN	lemma_29=-	lemma_10=mg	lemma_25=pharmacodynamic	pos_14=NN	pos_30=VBG	lemma_1=:	lib=normal	pos_16=CD	relType_11=nummod	lemma_27=blood	pos_23=NNS	relType_19=aux	path2=alter_appos>pharmacokinetic_obj>glyburide_nmod	relType_8=acl	relType_17=nmod	pos_29=HYPH	lemma_28=glucose	pos_26=-LRB-	relType_2=case	pos_9=CD	pos_17=NNS	relType_22=det	pos_20=RB	relType_27=dep	relType_21=appos	lemma_19=do	pos_4=JJ	lemma_21=alter	pos_13=DT	relType_20=advmod	relType_9=compound	lemma_11=three	pos_5=HYPH	pos_19=NN	relType_24=cc	lemma_23=pharmacokinetic	relType_31=punct	pos_18=,	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	relType_18=punct	relType_29=punct	relType_3=nummod	lemma_3=12	wib=normal	lemma_9=orlistat	eib=True	pos_10=NNS	lemma_20=not
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e1	DDI-DrugBank.d761.s6.e2	null	relType_4=obl:tmod	relType_1=nummod	path2=orlistat_nsubj	relType_2=obj	lemma_1=80	relType_8=nummod	relType_7=case	relType_10=punct	lemma_10=,	relType_9=nmod	pos_6=NN	lemma_5=a	lib=mg	pos_1=CD	eib=False	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	pos_4=NNS	lpib=mg_NNS	lemma_8=5	pos_3=CD	relType_5=det	relType_6=obl:npmod	relType_3=nummod	lemma_2=mg	pos_2=NNS	path1=orlistat_compound<mg_obj<receive_acl<subject_obl	lemma_9=day	pos_10=,	pos_7=IN	pos_5=DT	wib=mg	pos_8=CD	path=orlistat_compound<mg_obj<receive_acl<subject_obl<alter_appos>orlistat_nsubj	lemma_7=for
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e1	DDI-DrugBank.d761.s6.e3	null	relType_1=nummod	lemma_21=-	lemma_10=,	lemma_12=not	pos_6=NN	relation_13=neutral	relType_24=case	lib=mg	pos_20=NN	pos_18=-LRB-	pos_12=RB	pos_24=IN	pos_10=,	lemma_18=(	pos_7=IN	relType_21=punct	lemma_17=pharmacodynamic	lemma_7=for	relType_16=cc	relType_7=case	path2=pharmacokinetic_obj>glyburide_nmod	path=orlistat_compound<mg_obj<receive_acl<subject_obl<alter_appos>pharmacokinetic_obj>glyburide_nmod	relType_19=dep	pos_16=CC	lemma_4=time	relType_13=appos	lemma_11=orlistat	lemma_14=the	lemma_2=mg	pos_11=NN	lemma_20=glucose	lemma_15=pharmacokinetic	pos_8=CD	relType_10=punct	lemma_24=of	lemma_5=a	pos_21=HYPH	relType_12=advmod	relType_11=aux	lemma_6=day	lemma_3=three	pos_13=VB	lemma_16=or	lemma_23=)	relType_5=det	relType_6=obl:npmod	pos_14=DT	relType_15=obj	relType_22=amod	pos_17=NNS	pos_23=-RRB-	pos_5=DT	relType_4=obl:tmod	relType_23=punct	relType_2=obj	lemma_1=80	relType_8=nummod	pos_11=VBD	relType_9=nmod	relType_17=conj	pos_22=VBG	relType_20=dep	lemma_19=blood	pos_1=CD	pos_9=NNS	relType_14=det	relType_11=nsubj	pos_19=NN	pos_4=NNS	lpib=mg_NNS	lemma_8=5	pos_3=CD	relType_18=punct	relType_3=nummod	lemma_22=lower	lemma_13=alter	pos_2=NNS	path1=orlistat_compound<mg_obj<receive_acl<subject_obl	lemma_9=day	pos_15=NNS	eib=True	wib=mg	lemma_11=do
DDI-DrugBank.d761.s6	DDI-DrugBank.d761.s6.e2	DDI-DrugBank.d761.s6.e3	null	pos_7=NNS	lemma_8=(	pos_12=VBG	lemma_3=alter	relType_1=aux	path2=pharmacokinetic_obj>glyburide_nmod	relType_13=punct	wib=did	relType_8=punct	pos_3=VB	lemma_11=-	relType_10=dep	relType_9=dep	pos_11=HYPH	path=orlistat_nsubj<alter_appos>pharmacokinetic_obj>glyburide_nmod	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	pos_5=NNS	relType_11=punct	relation_2=neutral	lemma_6=or	relType_12=amod	pos_10=NN	pos_9=NN	pos_8=-LRB-	pos_14=IN	pos_4=DT	lemma_7=pharmacodynamic	pos_6=CC	lemma_4=the	lpib=do_VBD	lemma_10=glucose	pos_13=-RRB-	lib=do	lemma_5=pharmacokinetic	relType_6=cc	relType_5=obj	lemma_13=)	lemma_12=lower	lemma_14=of	lemma_9=blood	relType_14=case	relType_4=det	lemma_2=not	relType_7=conj	path1=orlistat_nsubj
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e0	DDI-DrugBank.d761.s7.e1	null	relType_8=case	pos_2=VBN	lemma_2=extend	relType_10=amod	path1=	pos_13=NNS	path2=alter_dep>subject_obl>receive_acl>mg_obj>xenical_compound	lemma_11=-	path=<Nifedipine_ROOT>alter_dep>subject_obl>receive_acl>mg_obj>xenical_compound	lemma_9=17	relType_9=nummod	pos_11=HYPH	lemma_1=(	relType_14=acl	relType_13=obl	lemma_8=in	lemma_10=normal	relType_12=compound	eib=False	pos_5=NNS	relType_6=punct	lemma_3=-	relType_11=punct	pos_4=NN	lemma_6=)	lemma_7=:	pos_8=IN	lemma_12=weight	lib=extend	pos_14=VBG	pos_10=JJ	relType_2=amod	wib=extended	relType_4=compound	lemma_13=subject	pos_7=:	lpib=extend_VBN	pos_1=-LRB-	relType_5=appos	lemma_5=tablet	pos_6=-RRB-	lemma_14=receive	pos_9=CD	pos_3=HYPH	relType_7=punct	relType_1=punct	pos_12=NN	relType_3=punct	lemma_4=release
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e0	DDI-DrugBank.d761.s7.e2	null	lemma_2=extend	pos_24=,	pos_13=NNS	lemma_24=,	relType_9=nummod	pos_15=CD	relType_12=compound	lemma_3=-	pos_20=NN	lemma_15=120	lemma_12=weight	lib=extend	relType_15=nummod	pos_7=:	lpib=extend_VBN	pos_1=-LRB-	lemma_14=receive	pos_17=CD	relType_15=compound	relType_21=case	pos_3=HYPH	relType_19=det	relType_8=case	pos_18=NNS	path1=	relType_18=obl:tmod	pos_16=NNS	lemma_17=three	lemma_8=in	path2=alter_dep>XENICAL_nsubj	relType_22=nummod	lemma_16=mg	lemma_7=:	pos_8=IN	pos_14=VBG	lemma_20=day	wib=extended	lemma_15=xenical	relType_5=appos	pos_6=-RRB-	relType_20=obl:npmod	relType_1=punct	lemma_22=6	relType_3=punct	lemma_4=release	pos_19=DT	pos_2=VBN	relType_24=punct	lemma_11=-	lemma_9=17	lemma_1=(	relType_13=obl	relType_11=punct	pos_21=IN	lemma_6=)	relType_23=nmod	pos_23=NNS	relType_2=amod	relType_16=obj	pos_9=CD	lemma_23=day	relType_10=amod	lemma_21=for	pos_11=HYPH	relType_14=acl	lemma_10=normal	path=<Nifedipine_ROOT>alter_dep>XENICAL_nsubj	pos_22=CD	lemma_19=a	relType_17=nummod	pos_5=NNS	relType_6=punct	lemma_18=time	pos_4=NN	pos_15=NN	pos_10=JJ	lemma_13=subject	relType_4=compound	lemma_5=tablet	eib=True	relType_7=punct	pos_12=NN
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e0	DDI-DrugBank.d761.s7.e3	null	lemma_2=extend	pos_24=,	pos_13=NNS	relType_28=det	pos_25=VBD	lemma_24=,	relType_9=nummod	pos_25=NNP	pos_15=CD	relType_12=compound	lemma_3=-	pos_20=NN	lemma_15=120	lemma_12=weight	relType_29=obj	lib=extend	relType_15=nummod	pos_7=:	lemma_30=of	lpib=extend_VBN	pos_1=-LRB-	lemma_14=receive	pos_17=CD	relType_15=compound	relType_21=case	relType_25=nsubj	pos_3=HYPH	relType_19=det	path2=alter_dep>bioavailability_obj>nifedipine_nmod	pos_30=IN	relType_8=case	pos_18=NNS	lemma_27=alter	pos_26=RB	path1=	relType_18=obl:tmod	pos_16=NNS	relation_28=neutral	lemma_17=three	lemma_8=in	lemma_28=the	relType_22=nummod	pos_28=DT	pos_29=NN	lemma_16=mg	lemma_7=:	pos_8=IN	pos_14=VBG	lemma_20=day	wib=extended	lemma_15=xenical	relType_5=appos	pos_6=-RRB-	relType_26=advmod	relType_20=obl:npmod	relType_1=punct	lemma_22=6	relType_3=punct	lemma_4=release	pos_19=DT	pos_2=VBN	lemma_25=XENICAL	relType_24=punct	lemma_11=-	lemma_9=17	lemma_1=(	relType_13=obl	lemma_26=not	relType_11=punct	pos_21=IN	lemma_6=)	relType_23=nmod	pos_23=NNS	relType_2=amod	relType_16=obj	pos_9=CD	relType_27=dep	relType_30=case	lemma_23=day	relType_10=amod	lemma_21=for	pos_11=HYPH	relType_14=acl	lemma_10=normal	pos_22=CD	lemma_19=a	relType_17=nummod	pos_5=NNS	relType_6=punct	pos_27=VB	lemma_18=time	pos_4=NN	pos_15=NN	pos_10=JJ	lemma_29=bioavailability	lemma_13=subject	relType_4=compound	lemma_25=do	path=<Nifedipine_ROOT>alter_dep>bioavailability_obj>nifedipine_nmod	lemma_5=tablet	eib=True	relType_7=punct	relType_25=aux	pos_12=NN
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e1	DDI-DrugBank.d761.s7.e2	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	lemma_10=,	lemma_1=120	relType_9=nmod	pos_6=NN	lemma_5=a	path2=XENICAL_nsubj	lib=mg	pos_1=CD	eib=False	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	pos_4=NNS	lpib=mg_NNS	lemma_8=6	pos_3=CD	relType_5=det	relType_6=obl:npmod	relType_3=nummod	path1=xenical_compound<mg_obj<receive_acl<subject_obl	lemma_2=mg	pos_2=NNS	lemma_9=day	pos_10=,	pos_7=IN	pos_5=DT	wib=mg	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_dep>XENICAL_nsubj	pos_8=CD	lemma_7=for
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e1	DDI-DrugBank.d761.s7.e3	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	relType_13=dep	pos_16=IN	pos_11=VBD	lemma_10=,	lemma_12=not	pos_11=NNP	lemma_1=120	relType_9=nmod	pos_6=NN	lemma_5=a	relation_13=neutral	lib=mg	pos_1=CD	lemma_15=bioavailability	relType_12=advmod	lemma_4=time	relType_11=aux	lemma_6=day	lemma_3=three	pos_9=NNS	relType_14=det	relType_11=nsubj	lemma_14=the	lemma_16=of	pos_4=NNS	lpib=mg_NNS	path2=bioavailability_obj>nifedipine_nmod	lemma_8=6	pos_13=VB	pos_15=NN	pos_3=CD	pos_12=RB	relType_5=det	lemma_11=XENICAL	relType_6=obl:npmod	relType_3=nummod	path1=xenical_compound<mg_obj<receive_acl<subject_obl	lemma_2=mg	lemma_13=alter	pos_14=DT	relType_15=obj	pos_2=NNS	relType_16=case	lemma_9=day	pos_10=,	eib=True	pos_7=IN	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_dep>bioavailability_obj>nifedipine_nmod	pos_5=DT	wib=mg	pos_8=CD	lemma_7=for	lemma_11=do
DDI-DrugBank.d761.s7	DDI-DrugBank.d761.s7.e2	DDI-DrugBank.d761.s7.e3	null	relType_3=dep	lemma_3=alter	relType_1=aux	wib=did	lemma_5=bioavailability	lemma_6=of	pos_3=VB	relType_6=case	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	pos_6=IN	relation_2=neutral	path1=XENICAL_nsubj	path2=bioavailability_obj>nifedipine_nmod	pos_4=DT	lemma_4=the	lpib=do_VBD	pos_5=NN	lib=do	relType_5=obj	path=XENICAL_nsubj<alter_dep>bioavailability_obj>nifedipine_nmod	relType_4=det	lemma_2=not
DDI-DrugBank.d761.s8	DDI-DrugBank.d761.s8.e0	DDI-DrugBank.d761.s8.e1	null	lemma_4=normal	relType_4=amod	pos_4=JJ	relType_10=det	path1=	relType_12=case	path=<contraceptive_ROOT>result_parataxis>treatment_nsubj>XENICAL_nmod	lemma_6=weight	lpib=normal_JJ	lemma_9=,	pos_8=NNS	relType_8=obl	lemma_12=of	pos_6=NN	pos_2=IN	lemma_7=female	eib=False	pos_5=HYPH	lemma_10=the	relType_11=nsubj	pos_12=IN	lemma_1=:	path2=result_parataxis>treatment_nsubj>XENICAL_nmod	lib=normal	relType_7=amod	lemma_11=treatment	pos_3=CD	relType_5=punct	pos_1=:	relType_3=nummod	wib=normal	relType_9=punct	lemma_8=subject	relType_6=compound	pos_11=NN	relType_2=case	lemma_3=20	pos_7=JJ	pos_9=,	relType_1=punct	lemma_5=-	lemma_2=in	pos_10=DT
DDI-DrugBank.d761.s8	DDI-DrugBank.d761.s8.e0	DDI-DrugBank.d761.s8.e2	null	lemma_27=the	lpib=normal_JJ	lemma_9=,	lemma_19=for	pos_8=NNS	pos_21=NNS	lemma_32=of	pos_6=NN	pos_15=CD	relType_17=det	relType_18=obl:npmod	pos_32=IN	pos_18=NN	relType_30=amod	lemma_11=treatment	relType_15=nummod	relType_33=amod	pos_1=:	lemma_31=action	pos_28=NN	relType_6=compound	lemma_17=a	relType_24=det	pos_26=IN	relType_16=obl:tmod	pos_7=JJ	lemma_22=result	pos_14=NNS	lemma_13=XENICAL	lemma_5=-	lemma_23=in	lemma_26=in	relType_32=case	relType_4=amod	pos_13=CD	path1=	lemma_6=weight	pos_16=NNS	relType_22=parataxis	pos_20=CD	lemma_7=female	lemma_20=23	pos_25=NNS	lemma_30=suppress	pos_12=IN	pos_11=NN	pos_31=NN	relType_19=case	lemma_15=three	pos_23=IN	pos_9=,	relType_1=punct	lemma_2=in	lemma_4=normal	relation_25=neutral	lemma_16=time	relType_10=det	pos_17=DT	path=<contraceptive_ROOT>result_parataxis>change_obl>action_nmod>contraceptive_nmod	relType_12=case	relType_20=nummod	relType_21=nmod	lemma_24=no	lemma_18=day	lemma_12=of	pos_2=IN	lemma_29=-	relType_13=nummod	lemma_10=the	pos_24=DT	pos_30=VBG	lemma_1=:	lemma_28=ovulation	lib=normal	pos_22=VBD	relType_7=amod	relType_23=case	pos_29=HYPH	lemma_8=subject	relType_2=case	relation_30=adverse	lemma_13=120	path2=result_parataxis>change_obl>action_nmod>contraceptive_nmod	pos_10=DT	pos_19=IN	pos_4=JJ	lemma_14=mg	relType_26=case	relType_8=obl	pos_13=NNP	relType_13=nmod	pos_27=DT	relType_27=det	lemma_25=change	pos_5=HYPH	relType_31=nmod	relType_11=nsubj	lemma_33=oral	pos_3=CD	relType_5=punct	relType_29=punct	lemma_21=day	pos_33=JJ	relType_3=nummod	wib=normal	relType_9=punct	eib=True	lemma_3=20	relType_14=nsubj	relType_28=obl	relType_25=obl
DDI-DrugBank.d761.s8	DDI-DrugBank.d761.s8.e1	DDI-DrugBank.d761.s8.e2	null	relType_4=obl:tmod	relType_1=nummod	relType_8=nummod	relType_7=case	pos_21=JJ	relType_17=punct	pos_13=NNS	relType_18=amod	lemma_10=result	relation_17=adverse	lemma_1=120	relType_16=obl	relType_9=nmod	relType_12=det	relType_11=case	relType_10=parataxis	lemma_12=no	pos_6=NN	lemma_5=a	relType_13=obl	relType_19=nmod	pos_20=IN	relType_20=case	lib=mg	pos_1=CD	eib=False	relType_2=nsubj	lemma_15=the	lemma_4=time	pos_17=HYPH	lemma_6=day	lemma_3=three	pos_9=NNS	relType_21=amod	pos_19=NN	lemma_11=in	lemma_14=in	lemma_17=-	lemma_21=oral	pos_15=DT	lemma_16=ovulation	pos_4=NNS	lpib=mg_NNS	pos_11=IN	pos_14=IN	lemma_18=suppress	pos_3=CD	lemma_13=change	path1=XENICAL_nmod<treatment_nsubj	relType_5=det	pos_10=VBD	relType_6=obl:npmod	pos_18=VBG	relType_3=nummod	pos_16=NN	lemma_19=action	lemma_2=mg	pos_2=NNS	lemma_8=23	lemma_9=day	path2=change_obl>action_nmod>contraceptive_nmod	relation_12=neutral	pos_7=IN	pos_5=DT	wib=mg	path=XENICAL_nmod<treatment_nsubj<result_parataxis>change_obl>action_nmod>contraceptive_nmod	pos_12=DT	pos_8=CD	relType_14=case	relType_15=det	lemma_7=for	lemma_20=of
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e0	DDI-DrugBank.d761.s9.e1	null	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_7=subject	path1=	lemma_6=weight	lpib=normal_JJ	path2=alter_appos>subject_obl>receive_acl>mg_obj>xenical_compound	lemma_8=receive	pos_6=NN	pos_2=IN	eib=False	pos_5=HYPH	lemma_1=:	lib=normal	pos_3=CD	relType_5=punct	pos_8=VBG	pos_1=:	relType_3=nummod	relType_8=acl	lemma_3=12	wib=normal	relType_6=compound	relType_7=obl	relType_2=case	path=<Phenytoin_ROOT>alter_appos>subject_obl>receive_acl>mg_obj>xenical_compound	relType_1=punct	lemma_5=-	lemma_2=in
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e0	DDI-DrugBank.d761.s9.e2	null	path2=alter_appos>XENICAL_nsubj	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_13=a	lemma_7=subject	relType_14=obl:npmod	path1=	pos_13=DT	lemma_6=weight	lpib=normal_JJ	lemma_17=day	lemma_8=receive	relType_9=nummod	pos_6=NN	pos_2=IN	relType_9=compound	lemma_11=three	lemma_14=day	pos_5=HYPH	lemma_10=mg	pos_14=NN	pos_9=NN	relType_10=obj	relType_12=obl:tmod	lemma_1=:	lib=normal	pos_16=CD	relType_15=case	relType_11=nummod	pos_18=,	lemma_12=time	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	pos_8=VBG	relType_18=punct	pos_1=:	relType_16=nummod	relType_3=nummod	lemma_9=120	relType_8=acl	lemma_3=12	wib=normal	pos_11=CD	relType_17=nmod	pos_15=IN	lemma_16=7	relType_6=compound	lemma_15=for	relType_7=obl	relType_2=case	lemma_9=xenical	eib=True	pos_9=CD	pos_17=NNS	relType_13=det	relType_1=punct	lemma_5=-	pos_10=NNS	lemma_2=in	path=<Phenytoin_ROOT>alter_appos>XENICAL_nsubj
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e0	DDI-DrugBank.d761.s9.e3	null	lemma_13=a	lemma_7=subject	lpib=normal_JJ	lemma_8=receive	relType_9=nummod	pos_6=NN	relType_24=case	relType_28=punct	path=<Phenytoin_ROOT>alter_appos>pharmacokinetic_obj>dose_nmod>phenytoin_nmod	lemma_19=XENICAL	lemma_22=the	pos_1=:	path2=alter_appos>pharmacokinetic_obj>dose_nmod>phenytoin_nmod	lemma_29=mg	relType_25=det	pos_24=IN	relType_6=compound	lemma_15=for	relType_26=amod	relType_30=nmod	relType_13=det	lemma_5=-	pos_19=VBD	lemma_17=day	relType_23=obj	pos_7=NNS	relType_4=amod	relType_14=obl:npmod	path1=	relation_22=neutral	lemma_6=weight	lemma_27=300	pos_30=NN	lemma_14=day	pos_29=NN	pos_9=NN	relType_12=obl:tmod	relType_15=case	lemma_12=time	relType_27=nummod	pos_8=VBG	pos_28=HYPH	pos_21=VB	relType_16=nummod	lemma_9=120	pos_11=CD	relType_19=nsubj	pos_15=IN	pos_22=DT	relType_7=obl	pos_27=CD	relType_1=punct	relType_10=obj	lemma_2=in	lemma_4=normal	relType_29=compound	lemma_24=of	pos_26=JJ	pos_31=IN	pos_2=IN	lemma_10=mg	pos_14=NN	lemma_1=:	lib=normal	pos_16=CD	relType_11=nummod	pos_23=NNS	relType_19=aux	relType_8=acl	relType_17=nmod	lemma_31=of	relType_2=case	pos_9=CD	pos_17=NNS	relType_22=det	pos_20=RB	lemma_25=a	relType_21=appos	lemma_19=do	pos_4=JJ	lemma_21=alter	pos_13=DT	relType_31=case	pos_25=DT	relType_20=advmod	relType_9=compound	lemma_11=three	pos_5=HYPH	lemma_23=pharmacokinetic	pos_18=,	pos_3=CD	pos_12=NNS	lemma_18=,	relType_5=punct	lemma_30=dose	relType_18=punct	lemma_28=-	relType_3=nummod	lemma_3=12	wib=normal	lemma_16=7	lemma_9=xenical	eib=True	lemma_26=single	pos_19=NNP	pos_10=NNS	lemma_20=not
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e1	DDI-DrugBank.d761.s9.e2	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	lemma_10=,	lemma_1=120	relType_9=nmod	pos_6=NN	lemma_5=a	path2=XENICAL_nsubj	lib=mg	pos_1=CD	eib=False	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	pos_4=NNS	lpib=mg_NNS	pos_3=CD	relType_5=det	relType_6=obl:npmod	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_appos>XENICAL_nsubj	path1=xenical_compound<mg_obj<receive_acl<subject_obl	relType_3=nummod	lemma_2=mg	pos_2=NNS	lemma_9=day	pos_10=,	pos_7=IN	pos_5=DT	wib=mg	lemma_8=7	pos_8=CD	lemma_7=for
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e1	DDI-DrugBank.d761.s9.e3	null	relType_1=nummod	lemma_10=,	lemma_12=not	pos_6=NN	relation_13=neutral	pos_20=HYPH	relType_17=det	lib=mg	lemma_21=mg	pos_12=RB	lemma_11=XENICAL	lemma_19=300	path2=pharmacokinetic_obj>dose_nmod>phenytoin_nmod	lemma_20=-	lemma_17=a	pos_10=,	pos_7=IN	lemma_23=of	lemma_7=for	relType_22=nmod	relType_7=case	pos_22=NN	lemma_1=120	lemma_4=time	relType_13=appos	lemma_14=the	relType_21=compound	lemma_2=mg	relType_16=case	lemma_15=pharmacokinetic	pos_23=IN	pos_8=CD	relType_10=punct	pos_17=DT	pos_16=IN	relType_19=nummod	path=xenical_compound<mg_obj<receive_acl<subject_obl<alter_appos>pharmacokinetic_obj>dose_nmod>phenytoin_nmod	lemma_22=dose	lemma_5=a	relType_12=advmod	relType_11=aux	lemma_6=day	lemma_3=three	lemma_18=single	pos_13=VB	relType_5=det	relType_6=obl:npmod	path1=xenical_compound<mg_obj<receive_acl<subject_obl	relType_23=case	pos_14=DT	relType_15=obj	pos_5=DT	relType_20=punct	relType_4=obl:tmod	relType_2=obj	relType_8=nummod	pos_11=VBD	relType_18=amod	pos_11=NNP	relType_9=nmod	pos_19=CD	pos_1=CD	pos_9=NNS	relType_14=det	relType_11=nsubj	pos_18=JJ	lemma_16=of	pos_4=NNS	lpib=mg_NNS	pos_3=CD	relType_3=nummod	lemma_13=alter	pos_2=NNS	lemma_9=day	pos_15=NNS	eib=True	wib=mg	lemma_8=7	pos_21=NN	lemma_11=do
DDI-DrugBank.d761.s9	DDI-DrugBank.d761.s9.e2	DDI-DrugBank.d761.s9.e3	null	path=XENICAL_nsubj<alter_appos>pharmacokinetic_obj>dose_nmod>phenytoin_nmod	relType_10=punct	lemma_3=alter	relType_1=aux	relType_7=det	relType_8=amod	wib=did	lemma_9=300	lemma_6=of	pos_3=VB	relType_6=case	relType_9=nummod	lemma_13=of	pos_8=JJ	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	pos_5=NNS	pos_6=IN	lemma_8=single	lemma_11=mg	relType_12=nmod	relation_2=neutral	pos_12=NN	pos_13=IN	pos_7=DT	lemma_10=-	path1=XENICAL_nsubj	pos_4=DT	relType_13=case	lemma_12=dose	lemma_4=the	pos_10=HYPH	path2=pharmacokinetic_obj>dose_nmod>phenytoin_nmod	lpib=do_VBD	lib=do	pos_11=NN	pos_9=CD	lemma_5=pharmacokinetic	relType_11=compound	relType_5=obj	lemma_7=a	relType_4=det	lemma_2=not
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e0	DDI-DrugBank.d761.s10.e1	null	relType_14=punct	path1=	pos_9=IN	lemma_16=hypercholesterolemic	pos_15=RB	relType_8=obl	relType_18=acl	lemma_4=2	pos_2=IN	pos_6=NN	pos_8=NN	relType_13=nmod	relType_16=amod	lemma_13=weight	eib=False	pos_14=,	relType_11=amod	lpib=way_NN	path2=affect_appos>patient_nsubj>receive_acl>mg_obj>xenical_compound	pos_5=HYPH	relType_17=nsubj	relType_9=case	relType_12=punct	pos_13=NN	relType_3=det	lemma_3=a	lemma_12=-	lemma_1=:	path=<pravastatin_ROOT>affect_appos>patient_nsubj>receive_acl>mg_obj>xenical_compound	pos_4=CD	pos_16=JJ	relType_7=amod	lemma_10=24	pos_10=CD	lemma_17=patient	relType_5=punct	pos_1=:	lemma_15=mildly	lemma_6=way	pos_18=VBG	lemma_11=normal	relType_10=nummod	relType_4=nummod	lemma_7=crossover	relType_6=compound	lemma_14=,	lemma_18=receive	relType_2=case	pos_17=NNS	pos_3=DT	lemma_9=of	wib=way	pos_7=JJ	pos_12=HYPH	pos_11=JJ	lib=way	relType_1=punct	lemma_5=-	relType_15=advmod	lemma_2=in	lemma_8=study
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e0	DDI-DrugBank.d761.s10.e2	null	lemma_24=day	pos_6=NN	lemma_13=weight	relType_28=punct	lpib=way_NN	lemma_20=mg	relType_23=det	relType_24=obl:npmod	relType_9=case	pos_13=NN	relType_20=obj	lemma_19=120	lemma_23=a	relType_27=obl	pos_1=:	lemma_6=way	relType_4=nummod	relType_6=compound	pos_7=JJ	pos_11=JJ	relType_21=nummod	lemma_5=-	lemma_28=,	pos_15=RB	path1=	lemma_16=hypercholesterolemic	lemma_22=time	relType_25=case	pos_8=NN	relType_16=amod	relType_11=amod	relType_12=punct	relType_3=det	lemma_3=a	lemma_12=-	lemma_19=xenical	pos_21=CD	pos_4=CD	relType_19=compound	relType_22=obl:tmod	lemma_27=day	path=<pravastatin_ROOT>affect_appos>XENICAL_nsubj	lemma_14=,	wib=way	pos_25=IN	relType_1=punct	lemma_2=in	relType_14=punct	relType_26=nummod	relType_19=nummod	lemma_25=for	pos_24=NN	lemma_4=2	pos_2=IN	pos_27=NNS	pos_14=,	relType_17=nsubj	lemma_1=:	relType_7=amod	lemma_26=6	pos_18=VBG	lemma_7=crossover	relType_2=case	pos_17=NNS	pos_12=HYPH	path2=affect_appos>XENICAL_nsubj	lib=way	lemma_8=study	pos_9=IN	lemma_21=three	relType_8=obl	relType_18=acl	pos_26=CD	relType_13=nmod	pos_19=CD	pos_5=HYPH	pos_19=NN	pos_28=,	pos_16=JJ	lemma_10=24	pos_10=CD	lemma_17=patient	relType_5=punct	pos_22=NNS	lemma_15=mildly	pos_20=NNS	pos_23=DT	lemma_11=normal	relType_10=nummod	lemma_18=receive	eib=True	pos_3=DT	lemma_9=of	relType_15=advmod
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e0	DDI-DrugBank.d761.s10.e3	null	lemma_30=not	lemma_24=day	lemma_29=do	pos_30=RB	relType_29=nsubj	pos_6=NN	lemma_13=weight	relType_28=punct	lpib=way_NN	lemma_20=mg	relType_23=det	relType_24=obl:npmod	lemma_32=the	pos_32=DT	relType_9=case	pos_13=NN	pos_31=VB	relType_20=obj	lemma_19=120	path=<pravastatin_ROOT>affect_appos>pharmacokinetic_obj>pravastatin_nmod	lemma_23=a	relType_27=obl	pos_1=:	lemma_6=way	relType_4=nummod	relType_6=compound	lemma_31=affect	pos_7=JJ	lemma_34=of	pos_11=JJ	relType_21=nummod	lemma_5=-	lemma_28=,	pos_15=RB	pos_29=NNP	relType_29=aux	pos_29=VBD	path1=	lemma_16=hypercholesterolemic	lemma_22=time	relType_25=case	pos_8=NN	relType_16=amod	relType_31=appos	relType_11=amod	relType_12=punct	relType_3=det	lemma_3=a	lemma_12=-	lemma_19=xenical	pos_21=CD	pos_4=CD	relType_19=compound	relType_22=obl:tmod	lemma_27=day	relType_32=det	lemma_14=,	wib=way	pos_25=IN	relType_1=punct	relType_34=case	lemma_2=in	relType_14=punct	relType_26=nummod	relType_19=nummod	lemma_25=for	relation_32=neutral	pos_24=NN	lemma_4=2	pos_2=IN	pos_27=NNS	pos_14=,	relType_17=nsubj	lemma_1=:	lemma_33=pharmacokinetic	relType_7=amod	lemma_26=6	pos_18=VBG	path2=affect_appos>pharmacokinetic_obj>pravastatin_nmod	lemma_7=crossover	relType_2=case	pos_17=NNS	relType_30=advmod	pos_12=HYPH	lib=way	lemma_8=study	pos_9=IN	lemma_21=three	relType_8=obl	relType_18=acl	pos_26=CD	relType_13=nmod	pos_19=CD	pos_5=HYPH	pos_19=NN	pos_28=,	pos_16=JJ	lemma_10=24	pos_10=CD	lemma_17=patient	relType_5=punct	pos_22=NNS	lemma_29=XENICAL	relType_33=obj	lemma_15=mildly	pos_20=NNS	pos_23=DT	lemma_11=normal	relType_10=nummod	lemma_18=receive	eib=True	pos_3=DT	lemma_9=of	relType_15=advmod	pos_33=NNS	pos_34=IN
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e1	DDI-DrugBank.d761.s10.e2	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	lemma_10=,	relType_9=obl	lemma_1=120	pos_6=NN	lemma_5=a	path2=XENICAL_nsubj	lib=mg	pos_1=CD	eib=False	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	path1=xenical_compound<mg_obj<receive_acl<patient_nsubj	pos_4=NNS	lpib=mg_NNS	lemma_8=6	pos_3=CD	relType_5=det	relType_6=obl:npmod	relType_3=nummod	lemma_2=mg	pos_2=NNS	lemma_9=day	pos_10=,	pos_7=IN	path=xenical_compound<mg_obj<receive_acl<patient_nsubj<affect_appos>XENICAL_nsubj	pos_5=DT	wib=mg	pos_8=CD	lemma_7=for
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e1	DDI-DrugBank.d761.s10.e3	null	relType_4=obl:tmod	relType_1=nummod	relType_2=obj	relType_8=nummod	relType_10=punct	relType_7=case	pos_16=IN	pos_11=VBD	lemma_10=,	lemma_12=not	relType_9=obl	lemma_1=120	pos_11=NNP	pos_6=NN	lemma_5=a	relation_13=neutral	lib=mg	pos_1=CD	relType_12=advmod	lemma_4=time	relType_11=aux	relType_13=appos	lemma_6=day	lemma_3=three	pos_9=NNS	path1=xenical_compound<mg_obj<receive_acl<patient_nsubj	relType_11=nsubj	lemma_13=affect	relType_14=det	lemma_14=the	lemma_16=of	pos_4=NNS	lpib=mg_NNS	pos_13=VB	lemma_8=6	pos_3=CD	pos_12=RB	relType_5=det	lemma_11=XENICAL	relType_6=obl:npmod	relType_3=nummod	lemma_2=mg	pos_14=DT	relType_15=obj	pos_2=NNS	relType_16=case	lemma_9=day	pos_10=,	pos_15=NNS	eib=True	pos_7=IN	lemma_15=pharmacokinetic	path=xenical_compound<mg_obj<receive_acl<patient_nsubj<affect_appos>pharmacokinetic_obj>pravastatin_nmod	pos_5=DT	wib=mg	path2=pharmacokinetic_obj>pravastatin_nmod	pos_8=CD	lemma_7=for	lemma_11=do
DDI-DrugBank.d761.s10	DDI-DrugBank.d761.s10.e2	DDI-DrugBank.d761.s10.e3	null	relType_1=aux	wib=did	lemma_6=of	pos_3=VB	relType_6=case	path=XENICAL_nsubj<affect_appos>pharmacokinetic_obj>pravastatin_nmod	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	lemma_3=affect	pos_5=NNS	pos_6=IN	relation_2=neutral	path1=XENICAL_nsubj	pos_4=DT	lemma_4=the	lpib=do_VBD	lib=do	lemma_5=pharmacokinetic	relType_5=obj	path2=pharmacokinetic_obj>pravastatin_nmod	relType_4=det	lemma_2=not
DDI-DrugBank.d761.s11	DDI-DrugBank.d761.s11.e0	DDI-DrugBank.d761.s11.e1	null	pos_7=NNS	lemma_4=normal	relType_4=amod	pos_4=JJ	lemma_7=subject	path1=	lemma_10=of	lemma_6=weight	lpib=normal_JJ	relType_8=punct	lemma_8=,	pos_6=NN	pos_2=IN	eib=False	pos_5=HYPH	relType_10=case	pos_9=NN	lemma_1=:	lib=normal	pos_3=CD	relType_5=punct	path=<Warfarin_ROOT>result_appos>administration_nsubj>XENICAL_nmod	pos_1=:	relType_3=nummod	pos_10=IN	lemma_3=12	wib=normal	relType_6=compound	relType_7=obl	relType_2=case	relType_9=nsubj	lemma_9=administration	path2=result_appos>administration_nsubj>XENICAL_nmod	relType_1=punct	lemma_5=-	lemma_2=in	pos_8=,
DDI-DrugBank.d761.s11	DDI-DrugBank.d761.s11.e0	DDI-DrugBank.d761.s11.e2	null	lemma_7=subject	lemma_16=day	lemma_10=of	relType_8=punct	lpib=normal_JJ	pos_6=NN	lemma_27=either	pos_22=VB	lemma_19=day	pos_15=DT	lemma_17=for	lemma_20=do	pos_1=:	lemma_11=XENICAL	lemma_13=three	relType_14=obl:tmod	relType_6=compound	relType_24=det	relType_22=appos	pos_26=IN	lemma_22=result	pos_14=NNS	lemma_5=-	lemma_12=mg	lemma_23=in	lemma_26=in	pos_7=NNS	relType_4=amod	pos_13=CD	relType_18=nummod	path1=	lemma_6=weight	pos_19=NNS	relType_16=obl:npmod	relType_20=aux	relType_21=advmod	pos_9=NN	lemma_14=time	pos_16=NN	pos_11=CD	relType_12=nsubj	relType_7=obl	lemma_9=administration	lemma_11=120	pos_23=IN	relType_11=nmod	relType_1=punct	relType_15=det	lemma_2=in	pos_8=,	lemma_4=normal	relation_25=neutral	lemma_18=16	lemma_15=a	lemma_8=,	pos_17=IN	pos_2=IN	relType_19=nmod	relType_13=nummod	pos_24=DT	lemma_1=:	relType_17=case	lib=normal	relType_11=nummod	path=<Warfarin_ROOT>result_appos>change_obl>pharmacokinetic_nmod>warfarin_compound	pos_25=NN	pos_10=IN	relType_23=case	relType_2=case	pos_27=CC	lemma_24=any	pos_4=JJ	relType_26=case	pos_11=NNP	path2=result_appos>change_obl>pharmacokinetic_nmod>warfarin_compound	pos_20=VBD	lemma_25=change	pos_5=HYPH	relType_10=case	pos_18=CD	pos_3=CD	pos_12=NNS	relType_27=cc:preconj	relType_5=punct	relType_3=nummod	lemma_3=12	wib=normal	pos_21=RB	eib=True	relType_9=nsubj	lemma_21=not	relType_25=obl
DDI-DrugBank.d761.s11	DDI-DrugBank.d761.s11.e1	DDI-DrugBank.d761.s11.e2	null	relType_4=obl:tmod	lemma_16=in	relType_1=nummod	lemma_8=16	relType_8=nummod	lemma_11=not	relType_7=case	lemma_15=change	pos_16=IN	relType_17=cc:preconj	lemma_1=120	lemma_17=either	lemma_12=result	relType_9=nmod	pos_6=NN	lemma_5=a	lib=mg	pos_1=CD	eib=False	relType_2=nsubj	relType_10=aux	lemma_4=time	lemma_6=day	lemma_3=three	pos_9=NNS	relType_14=det	pos_13=IN	relType_11=advmod	pos_4=NNS	lpib=mg_NNS	path1=XENICAL_nmod<administration_nsubj	relType_13=case	relType_15=obl	pos_15=NN	pos_3=CD	pos_10=VBD	relType_5=det	path2=change_obl>pharmacokinetic_nmod>warfarin_compound	relType_6=obl:npmod	relType_3=nummod	lemma_13=in	lemma_2=mg	pos_11=RB	relation_14=neutral	pos_14=DT	pos_12=VB	pos_2=NNS	lemma_10=do	relType_16=case	path=XENICAL_nmod<administration_nsubj<result_appos>change_obl>pharmacokinetic_nmod>warfarin_compound	lemma_9=day	relType_12=appos	pos_7=IN	pos_5=DT	wib=mg	pos_17=CC	lemma_14=any	pos_8=CD	lemma_7=for
DDI-DrugBank.d761.s12	DDI-DrugBank.d761.s12.e0	DDI-DrugBank.d761.s12.e1	null	lemma_3=vitamin	path=xenical_compound<administration_obl<unaltered_advcl<tend_ROOT>decline_xcomp>subject_obl>take_acl>xenical_obj	lemma_8=decline	relType_5=nsubj	pos_9=IN	lib=administration	lemma_9=in	relType_7=mark	pos_6=VBD	lemma_4=k	relType_2=punct	path1=xenical_compound<administration_obl<unaltered_advcl	lemma_11=take	eib=False	pos_5=NNS	lemma_7=to	lemma_10=subject	lemma_1=administration	lpib=administration_NN	relType_8=xcomp	relType_9=case	pos_4=NN	lemma_2=,	pos_1=NN	pos_7=TO	pos_8=VB	relType_6=ROOT	lemma_6=tend	relType_4=compound	pos_11=VBG	relType_11=acl	lemma_5=level	pos_3=NN	pos_2=,	relType_3=compound	relType_10=obl	path2=decline_xcomp>subject_obl>take_acl>xenical_obj	pos_10=NNS	relType_1=obl	wib=administration
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e0	DDI-DrugBank.d761.s13.e1	mechanism	lemma_1=absorption	pos_2=MD	lib=absorption	pos_3=VB	relType_3=aux:pass	relType_5=case	lpib=absorption_NN	eib=False	path1=k_compound<absorption_nsubj:pass	lemma_5=with	relType_2=aux	pos_1=NN	pos_4=VBN	wib=absorption	relation_3=adverse	lemma_3=be	path=k_compound<absorption_nsubj:pass<decrease_advcl>xenical_obl	pos_5=IN	relType_1=nsubj:pass	lemma_2=may	relType_4=advcl	path2=xenical_obl	lemma_4=decrease
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e0	DDI-DrugBank.d761.s13.e2	null	pos_7=NNS	relType_8=case	lemma_1=absorption	path2=patient_nsubj:pass>dose_nmod>warfarin_nmod	pos_2=MD	relType_10=amod	lemma_6=,	relType_12=case	lib=absorption	pos_3=VB	path1=k_compound<absorption_nsubj:pass<decrease_advcl	relType_3=aux:pass	relType_5=case	path=k_compound<absorption_nsubj:pass<decrease_advcl<monitor_ROOT>patient_nsubj:pass>dose_nmod>warfarin_nmod	lemma_12=of	pos_6=NN	lpib=absorption_NN	relType_6=obl	pos_9=JJ	relType_6=punct	lemma_5=with	pos_11=NNS	relType_7=nsubj:pass	lemma_7=patient	relType_2=aux	relType_9=amod	pos_1=NN	pos_8=IN	pos_4=VBN	wib=absorption	lemma_8=on	pos_12=IN	pos_10=JJ	lemma_11=dose	relation_3=adverse	lemma_3=be	pos_5=IN	pos_6=,	lemma_6=xenical	lemma_9=chronic	eib=True	lemma_10=stable	relType_1=nsubj:pass	lemma_2=may	relType_11=nmod	relType_4=advcl	lemma_4=decrease
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e0	DDI-DrugBank.d761.s13.e3	null	pos_7=NNS	relType_8=case	lemma_1=absorption	pos_2=MD	relType_10=amod	relType_12=case	lemma_6=,	pos_14=VBP	lib=absorption	pos_3=VB	path1=k_compound<absorption_nsubj:pass<decrease_advcl	relType_3=aux:pass	relType_5=case	lemma_12=of	pos_6=NN	lpib=absorption_NN	relType_6=obl	pos_9=JJ	lemma_13=warfarin	relType_13=nmod	relType_6=punct	relType_15=acl:relcl	lemma_5=with	pos_11=NNS	relType_7=nsubj:pass	lemma_7=patient	relType_14=aux:pass	relType_2=aux	relType_9=amod	pos_13=NN	pos_15=VBN	pos_1=NN	pos_8=IN	pos_4=VBN	wib=absorption	lemma_8=on	pos_12=IN	lemma_14=be	lemma_15=prescribe	pos_10=JJ	lemma_11=dose	relation_3=adverse	lemma_3=be	pos_5=IN	pos_6=,	lemma_6=xenical	lemma_9=chronic	lemma_13=who	path2=patient_nsubj:pass>prescribe_acl:relcl>XENICAL_obj	eib=True	lemma_10=stable	pos_13=WP	relType_1=nsubj:pass	lemma_2=may	relType_11=nmod	relType_13=obj	relType_4=advcl	lemma_4=decrease	path=k_compound<absorption_nsubj:pass<decrease_advcl<monitor_ROOT>patient_nsubj:pass>prescribe_acl:relcl>XENICAL_obj
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e1	DDI-DrugBank.d761.s13.e2	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_3=IN	relType_7=case	lemma_2=patient	path2=patient_nsubj:pass>dose_nmod>warfarin_nmod	pos_1=,	wib=patients	lpib=patient_NNS	eib=False	lemma_3=on	relType_2=nsubj:pass	lemma_4=chronic	lemma_5=stable	path=xenical_obl<decrease_advcl<monitor_ROOT>patient_nsubj:pass>dose_nmod>warfarin_nmod	path1=xenical_obl<decrease_advcl	pos_5=JJ	relType_5=amod	lib=patient	lemma_6=dose	relType_3=case	lemma_7=of	pos_2=NNS	pos_7=IN	pos_6=NNS	relType_1=punct	relType_6=nmod
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e1	DDI-DrugBank.d761.s13.e3	null	relType_4=amod	lemma_1=,	pos_4=JJ	pos_3=IN	relType_7=case	lemma_2=patient	relType_9=aux:pass	pos_1=,	relType_10=acl:relcl	pos_8=NN	wib=patients	lpib=patient_NNS	relType_8=obj	pos_8=WP	lemma_3=on	relType_2=nsubj:pass	lemma_4=chronic	lemma_5=stable	pos_5=JJ	path1=xenical_obl<decrease_advcl	relType_5=amod	lib=patient	lemma_6=dose	path=xenical_obl<decrease_advcl<monitor_ROOT>patient_nsubj:pass>prescribe_acl:relcl>XENICAL_obj	lemma_9=be	lemma_8=warfarin	lemma_8=who	relType_3=case	lemma_10=prescribe	lemma_7=of	pos_2=NNS	path2=patient_nsubj:pass>prescribe_acl:relcl>XENICAL_obj	pos_9=VBP	eib=True	pos_7=IN	relType_8=nmod	pos_10=VBN	pos_6=NNS	relType_1=punct	relType_6=nmod
DDI-DrugBank.d761.s13	DDI-DrugBank.d761.s13.e2	DDI-DrugBank.d761.s13.e3	advise	lib=be	path=warfarin_nmod<dose_nmod<patient_nsubj:pass>prescribe_acl:relcl>XENICAL_obj	lemma_3=prescribe	eib=False	relType_3=acl:relcl	lpib=be_VBP	path2=prescribe_acl:relcl>XENICAL_obj	lemma_1=who	pos_3=VBN	relType_2=aux:pass	pos_2=VBP	lemma_2=be	relType_1=obj	pos_1=WP	wib=are	path1=warfarin_nmod<dose_nmod
DDI-DrugBank.d744.s0	DDI-DrugBank.d744.s0.e0	DDI-DrugBank.d744.s0.e1	null	relType_1=cc	relType_4=amod	pos_1=CC	pos_4=JJ	lib=oral	lemma_2=/	pos_3=CC	path1=	pos_2=HYPH	relType_3=cc	relType_2=punct	eib=False	path2=agent_conj>hypoglycemic_amod	lemma_3=or	lpib=oral_JJ	lemma_4=oral	wib=oral	path=<insulin_obl>agent_conj>hypoglycemic_amod	lemma_1=and
DDI-DrugBank.d744.s0	DDI-DrugBank.d744.s0.e0	DDI-DrugBank.d744.s0.e2	advise	relType_1=cc	relType_4=amod	pos_1=CC	pos_4=JJ	lib=oral	pos_7=VB	lemma_2=/	lemma_7=require	pos_3=CC	lemma_6=may	lemma_18=therapy	pos_13=NNS	lemma_10=of	relType_16=obl	pos_19=IN	pos_2=HYPH	path=insulin_obl<treat_csubj<require_ROOT>initiation_obl>therapy_nmod>SOMAVERT_nmod	lemma_8=dose	relType_3=cc	relType_2=punct	relType_13=nmod	pos_8=NN	pos_12=JJ	pos_17=IN	path1=insulin_obl<treat_csubj	pos_5=NNS	lemma_15=the	pos_9=NNS	lemma_5=agent	lemma_13=agent	relType_12=amod	lemma_11=this	lemma_3=or	relType_10=case	pos_15=DT	relType_17=case	pos_14=IN	pos_18=NN	pos_5=JJ	lemma_19=with	relType_7=ROOT	relType_5=amod	relType_6=aux	lemma_9=reduction	relType_8=compound	relType_9=obj	lemma_17=of	pos_10=IN	relType_5=conj	lpib=oral_JJ	pos_6=MD	pos_11=DT	lemma_14=after	lemma_5=hypoglycemic	relType_11=det	pos_16=NN	lemma_12=therapeutic	eib=True	lemma_4=oral	relType_19=case	wib=oral	path2=initiation_obl>therapy_nmod>SOMAVERT_nmod	relType_14=case	lemma_16=initiation	relType_18=nmod	relType_15=det	lemma_1=and
DDI-DrugBank.d744.s0	DDI-DrugBank.d744.s0.e1	DDI-DrugBank.d744.s0.e2	advise	path=hypoglycemic_amod<agent_conj<insulin_obl<treat_csubj<require_ROOT>initiation_obl>therapy_nmod>SOMAVERT_nmod	lpib=agent_NNS	relType_12=obl	relType_7=det	lib=agent	lemma_5=reduction	relType_8=amod	pos_2=MD	lemma_6=of	lemma_10=after	pos_3=VB	relType_14=nmod	relType_9=nmod	relType_6=case	lemma_13=of	pos_8=JJ	path1=hypoglycemic_amod<agent_conj<insulin_obl<treat_csubj	lemma_3=require	lemma_15=with	eib=False	pos_5=NNS	pos_6=IN	pos_9=NNS	lemma_7=this	relType_2=aux	relType_10=case	pos_13=IN	pos_14=NN	pos_4=NN	pos_7=DT	lemma_4=dose	relType_13=case	relType_15=case	wib=agents	relType_3=ROOT	lemma_12=initiation	relType_4=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_1=conj	relType_11=det	pos_15=IN	lemma_1=agent	pos_1=NNS	relType_5=obj	path2=initiation_obl>therapy_nmod>SOMAVERT_nmod	lemma_9=agent	lemma_2=may	lemma_14=therapy	pos_12=NN	lemma_8=therapeutic
DDI-DrugBank.d744.s1	DDI-DrugBank.d744.s1.e0	DDI-DrugBank.d744.s1.e1	mechanism	lpib=often_RB	lemma_2=need	path1=opioid_nmod<patient_nsubj	eib=False	pos_2=VBD	pos_4=NN	relType_1=advmod	pos_3=JJR	path=opioid_nmod<patient_nsubj<need_ROOT>concentration_obj>pegvisomant_compound	relType_3=amod	relType_2=ROOT	relType_4=compound	lemma_3=high	lemma_4=serum	path2=concentration_obj>pegvisomant_compound	wib=often	pos_1=RB	lemma_1=often	lib=often
DDI-DrugBank.d744.s1	DDI-DrugBank.d744.s1.e0	DDI-DrugBank.d744.s1.e2	null	pos_7=VB	pos_11=PRP	pos_6=TO	lemma_8=appropriate	relType_10=punct	relType_8=amod	relType_15=nsubj	lemma_14=with	lpib=often_RB	lemma_2=need	relType_5=compound	path1=opioid_nmod<patient_nsubj	lemma_11=I	lemma_6=to	pos_13=VBN	pos_8=JJ	lemma_13=compare	pos_5=NNS	relType_12=parataxis	pos_16=RB	path2=suppression_parataxis>receive_advcl>opioid_obj	pos_17=VBG	pos_2=VBD	relType_11=nsubj	lemma_5=concentration	pos_9=NN	pos_4=NN	lemma_15=patient	relType_1=advmod	pos_3=JJR	relType_7=xcomp	lemma_10=-	pos_14=IN	relType_13=case	relType_16=advmod	relType_3=amod	lemma_9=igf	path=opioid_nmod<patient_nsubj<need_ROOT>suppression_parataxis>receive_advcl>opioid_obj	relType_2=ROOT	relType_6=mark	pos_10=:	lemma_12=suppression	relType_4=compound	relType_9=obj	relType_17=advcl	relType_14=mark	lemma_17=receive	lemma_3=high	lemma_4=serum	lemma_5=pegvisomant	pos_5=NN	wib=often	pos_15=NNS	eib=True	pos_1=RB	relType_5=obj	lemma_1=often	lemma_16=not	lemma_7=achieve	lib=often	pos_12=NN
DDI-DrugBank.d744.s1	DDI-DrugBank.d744.s1.e1	DDI-DrugBank.d744.s1.e2	null	pos_13=VBG	relType_4=amod	relType_3=xcomp	pos_4=JJ	lemma_10=with	relType_10=mark	path1=pegvisomant_compound<concentration_obj	lpib=concentration_NNS	lemma_12=not	relType_13=advcl	lemma_9=compare	pos_3=VB	lemma_1=concentration	lemma_3=achieve	relType_2=mark	pos_8=NN	lemma_13=receive	eib=False	relType_12=advmod	relType_6=punct	lemma_5=igf	path2=suppression_parataxis>receive_advcl>opioid_obj	pos_11=NNS	lemma_2=to	relType_11=nsubj	relType_9=case	lemma_4=appropriate	pos_9=VBN	relType_8=parataxis	lemma_6=-	wib=concentrations	pos_12=RB	path=pegvisomant_compound<concentration_obj<need_ROOT>suppression_parataxis>receive_advcl>opioid_obj	pos_7=PRP	pos_10=IN	lemma_11=patient	lemma_8=suppression	pos_5=NN	pos_1=NNS	relType_5=obj	lib=concentration	relType_7=nsubj	lemma_7=I	relType_1=obj	pos_6=:	pos_2=TO
DDI-DrugBank.d671.s0	DDI-DrugBank.d671.s0.e0	DDI-DrugBank.d671.s0.e1	null	lemma_1=(	eib=False	lpib=pemoline_NN	path1=	pos_1=-LRB-	wib=pemoline	lib=pemoline	relType_1=punct	path=<CYLERT_nmod>pemoline_dep	path2=pemoline_dep
DDI-DrugBank.d671.s2	DDI-DrugBank.d671.s2.e0	DDI-DrugBank.d671.s2.e1	effect	pos_2=IN	lib=concomitantly	relType_2=case	lemma_2=with	eib=True	pos_1=RB	pos_3=NN	lemma_1=concomitantly	path=CYLERT_obj<receive_acl>medication_obl	wib=concomitantly	lpib=concomitantly_RB	path1=CYLERT_obj	path2=medication_obl	relType_3=compound	lemma_3=antiepileptic	relType_1=advmod
DDI-DrugBank.d635.s0	DDI-DrugBank.d635.s0.e0	DDI-DrugBank.d635.s0.e1	advise	relType_7=compound	relType_1=aux	lemma_1=should	pos_3=VB	lemma_4=use	relType_3=aux:pass	path2=AUTOHALER_obl	relType_6=case	pos_2=RB	lemma_7=MAXAIR	relType_2=advmod	pos_6=IN	wib=not	pos_4=VBN	path=bronchodilator_nsubj:pass<use_ROOT>AUTOHALER_obl	lemma_5=concomitantly	pos_7=NNP	lemma_3=be	pos_5=RB	lemma_6=with	pos_1=MD	relType_4=ROOT	lib=not	relType_5=advmod	eib=True	path1=bronchodilator_nsubj:pass	lpib=not_RB	lemma_2=not
DDI-DrugBank.d622.s0	DDI-DrugBank.d622.s0.e0	DDI-DrugBank.d622.s0.e1	effect	relType_1=cc	pos_1=CC	lib=pralidoxime	wib=pralidoxime	path2=pralidoxime_conj	eib=False	lpib=pralidoxime_NN	path=<atropine_nsubj:pass>pralidoxime_conj	path1=	lemma_1=and
DDI-DrugBank.d622.s0	DDI-DrugBank.d622.s0.e0	DDI-DrugBank.d622.s0.e2	null	relType_1=cc	wib=pralidoxime	pos_2=NN	pos_5=,	pos_26=JJR	relType_31=advmod	relType_21=cc	relType_18=case	lemma_12=,	pos_10=-LRB-	pos_29=VB	pos_12=,	pos_20=NN	relType_20=nmod	pos_13=NN	lemma_16=,	lemma_18=of	lemma_5=,	lemma_25=occur	relType_2=aux:pass	pos_11=VBG	lemma_22=nose	relType_30=advcl	relType_24=aux	relType_16=punct	pos_24=MD	lemma_20=mouth	lemma_7=sign	relType_19=det	lemma_31=when	pos_7=NNS	relType_8=case	lemma_9=atropinization	relType_22=conj	pos_22=NN	lemma_15=tachycardia	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	pos_8=IN	pos_31=WRB	lemma_4=together	lemma_17=dryness	lemma_10=(	relType_25=ROOT	pos_2=VBP	relType_11=dep	relType_6=det	lemma_2=pralidoxime	lemma_14=,	relType_26=advmod	lpib=pralidoxime_NN	lemma_11=flush	lemma_2=be	pos_30=VBN	lemma_1=and	pos_19=DT	relType_14=punct	relType_10=punct	pos_6=DT	path1=atropine_nsubj:pass<use_advcl	pos_17=NN	lemma_3=use	lemma_29=be	lemma_6=the	pos_14=,	lemma_26=early	pos_18=IN	lib=pralidoxime	lemma_23=)	lemma_13=mydriasis	lemma_24=may	lemma_21=and	pos_23=-RRB-	path=atropine_nsubj:pass<use_advcl<occur_ROOT>early_advmod>expect_advcl>use_advcl>atropine_nsubj:pass	relType_15=conj	relType_7=nsubj	relType_27=mark	relType_23=punct	pos_1=CC	pos_3=VBN	relType_9=nmod	lemma_27=than	relType_17=conj	relType_29=aux:pass	path2=early_advmod>expect_advcl>use_advcl>atropine_nsubj:pass	pos_4=RB	pos_16=,	pos_28=MD	lemma_19=the	pos_27=IN	pos_15=NN	relType_3=advcl	relType_5=punct	lemma_28=might	relType_4=advmod	pos_25=VB	pos_21=CC	eib=True	lemma_30=expect	relType_28=aux	lemma_8=of
DDI-DrugBank.d622.s0	DDI-DrugBank.d622.s0.e1	DDI-DrugBank.d622.s0.e2	null	pos_25=JJR	pos_23=MD	lemma_13=,	relType_2=advcl	relType_10=dep	lemma_6=sign	lemma_2=use	relType_21=conj	lemma_10=flush	lemma_12=mydriasis	wib=are	relType_22=punct	relType_4=punct	pos_30=WRB	lemma_26=than	pos_28=VB	lemma_27=might	relType_29=advcl	lemma_22=)	relType_26=mark	pos_7=IN	pos_26=IN	pos_6=NNS	pos_22=-RRB-	pos_13=,	relType_7=case	lemma_30=when	path=pralidoxime_conj<atropine_nsubj:pass<use_advcl<occur_ROOT>early_advmod>expect_advcl>use_advcl>atropine_nsubj:pass	lemma_3=together	lemma_19=mouth	path1=pralidoxime_conj<atropine_nsubj:pass<use_advcl	pos_8=NN	pos_18=DT	lemma_15=,	lemma_16=dryness	relType_25=advmod	lemma_4=,	pos_16=NN	pos_24=VB	lemma_14=tachycardia	lemma_20=and	relType_23=aux	relType_24=ROOT	lemma_5=the	relType_18=det	lemma_18=the	pos_2=VBN	pos_3=RB	lemma_11=,	lpib=be_VBP	relType_20=cc	pos_17=IN	relType_19=nmod	relType_28=aux:pass	pos_4=,	pos_15=,	relType_11=punct	lemma_1=be	pos_14=NN	relType_15=punct	lemma_25=early	lemma_8=atropinization	relType_17=case	lib=be	lemma_23=may	relType_5=det	pos_9=-LRB-	lemma_17=of	pos_1=VBP	pos_29=VBN	pos_5=DT	relType_30=advmod	pos_10=VBG	pos_20=CC	lemma_29=expect	relType_14=conj	relType_6=nsubj	relType_12=conj	relType_3=advmod	relType_1=aux:pass	relType_27=aux	relType_13=punct	lemma_21=nose	path2=early_advmod>expect_advcl>use_advcl>atropine_nsubj:pass	lemma_24=occur	eib=False	pos_27=MD	lemma_9=(	pos_19=NN	pos_11=,	relType_9=punct	lemma_7=of	relType_8=nmod	lemma_28=be	pos_12=NN	relType_16=conj	pos_21=NN
DDI-DrugBank.d622.s1	DDI-DrugBank.d622.s1.e0	DDI-DrugBank.d622.s1.e1	null	pos_2=VBN	lemma_6=administration	lpib=have_VBZ	relType_1=aux	relType_7=case	lemma_3=large	path1=atropine_nmod<dose_nsubj	relType_4=cc	pos_6=NN	relType_2=cop	eib=False	lemma_1=have	lib=have	relType_3=advcl	path=atropine_nmod<dose_nsubj<large_advcl>delay_conj>administration_nsubj:pass>pralidoxime_nmod	relType_5=det	relType_6=nsubj:pass	lemma_7=of	lemma_5=the	path2=delay_conj>administration_nsubj:pass>pralidoxime_nmod	pos_1=VBZ	pos_3=JJ	pos_4=CC	pos_7=IN	lemma_4=and	pos_5=DT	lemma_2=be	wib=has
DDI-DrugBank.d622.s2	DDI-DrugBank.d622.s2.e0	DDI-DrugBank.d622.s2.e1	null	pos_2=IN	path1=pralidoxime_nmod<use_obl<bear_advcl	wib=barbiturates	lemma_2=since	eib=False	lib=barbiturate	path2=use_parataxis>potentiate_advcl>barbiturate_nsubj:pass	pos_1=:	path=pralidoxime_nmod<use_obl<bear_advcl<keep_ROOT>use_parataxis>potentiate_advcl>barbiturate_nsubj:pass	relType_1=punct	lemma_1=:	relType_2=mark	lpib=barbiturate_NNS
DDI-DrugBank.d622.s2	DDI-DrugBank.d622.s2.e0	DDI-DrugBank.d622.s2.e2	null	path=pralidoxime_nmod<use_obl<bear_advcl<keep_ROOT>use_parataxis>potentiate_advcl>anticholinesterase_obl	relation_4=beneficial	pos_6=DT	relation_4=adverse	relType_3=nsubj:pass	lemma_5=by	relType_3=aux:pass	relType_5=case	relType_2=mark	lpib=barbiturate_NNS	pos_2=IN	pos_3=NNS	lemma_4=potentiate	lemma_6=the	lemma_1=:	pos_4=VBN	path1=pralidoxime_nmod<use_obl<bear_advcl	wib=barbiturates	lemma_3=be	pos_1=:	pos_5=IN	relType_6=det	lemma_2=since	eib=True	lemma_3=barbiturate	lib=barbiturate	path2=use_parataxis>potentiate_advcl>anticholinesterase_obl	relType_1=punct	relType_4=advcl	pos_3=VBP
DDI-DrugBank.d622.s2	DDI-DrugBank.d622.s2.e1	DDI-DrugBank.d622.s2.e2	effect	pos_2=VBN	pos_3=IN	lpib=be_VBP	relType_1=aux:pass	relType_2=advcl	path2=anticholinesterase_obl	relation_1=beneficial	path=barbiturate_nsubj:pass<potentiate_advcl>anticholinesterase_obl	lemma_3=by	eib=False	lemma_1=be	relation_1=adverse	wib=are	pos_4=DT	lib=be	lemma_4=the	path1=barbiturate_nsubj:pass	pos_1=VBP	lemma_2=potentiate	relType_3=case	relType_4=det
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e0	DDI-DrugBank.d622.s3.e1	null	lib=theophylline	lemma_1=,	wib=theophylline	eib=False	path=<morphine_compound>theophylline_conj	path1=	pos_1=,	path2=theophylline_conj	relType_1=punct	lpib=theophylline_NN
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e0	DDI-DrugBank.d622.s3.e2	null	path=<morphine_compound>aminophylline_conj	lib=theophylline	path2=aminophylline_conj	lemma_1=,	pos_2=NN	wib=theophylline	eib=True	path1=	pos_1=,	pos_2=,	relType_2=conj	relType_1=punct	lemma_2=theophylline	lemma_2=,	relType_2=punct	lpib=theophylline_NN
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e0	DDI-DrugBank.d622.s3.e3	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	path2=succinylcholine_conj	path=<morphine_compound>succinylcholine_conj	relType_2=conj	lemma_2=,	lpib=theophylline_NN	lemma_3=,	relType_3=conj	lemma_2=theophylline	lib=theophylline	lemma_3=aminophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e0	DDI-DrugBank.d622.s3.e4	null	path=<morphine_compound>reserpine_conj	lemma_1=,	pos_2=NN	path2=reserpine_conj	path1=	pos_1=,	lemma_4=succinylcholine	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	lpib=theophylline_NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lemma_2=theophylline	lib=theophylline	lemma_3=aminophylline	pos_3=,	wib=theophylline	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e0	DDI-DrugBank.d622.s3.e5	null	relType_7=compound	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_4=succinylcholine	relType_2=punct	lemma_7=-	pos_4=,	path2=	relType_2=conj	pos_4=NN	lemma_2=,	lpib=theophylline_NN	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	pos_7=HYPH	lemma_4=,	relType_5=conj	path=morphine_compound<tranquilizer_nsubj:pass>	lemma_2=theophylline	path1=morphine_compound	lemma_5=reserpine	pos_5=NN	lib=theophylline	lemma_3=aminophylline	pos_3=,	wib=theophylline	eib=True	lemma_7=phenothiazine	pos_3=NN	relType_7=punct	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	lemma_7=type	relType_3=punct	relType_7=conj	relType_6=cc
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e1	DDI-DrugBank.d622.s3.e2	null	path2=aminophylline_conj	lemma_1=,	eib=False	path=theophylline_conj<morphine_compound>aminophylline_conj	lib=aminophylline	pos_1=,	path1=theophylline_conj	wib=aminophylline	lpib=aminophylline_NN	relType_1=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e1	DDI-DrugBank.d622.s3.e3	null	path2=succinylcholine_conj	lemma_1=,	pos_2=NN	eib=True	lemma_2=aminophylline	lib=aminophylline	pos_1=,	path1=theophylline_conj	wib=aminophylline	lpib=aminophylline_NN	pos_2=,	path=theophylline_conj<morphine_compound>succinylcholine_conj	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e1	DDI-DrugBank.d622.s3.e4	null	lemma_1=,	pos_2=NN	path2=reserpine_conj	pos_1=,	wib=aminophylline	relType_2=punct	path=theophylline_conj<morphine_compound>reserpine_conj	lib=aminophylline	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_3=succinylcholine	pos_3=,	eib=True	lemma_2=aminophylline	pos_3=NN	path1=theophylline_conj	pos_2=,	lpib=aminophylline_NN	relType_1=punct	relType_3=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e1	DDI-DrugBank.d622.s3.e5	null	lemma_1=,	pos_2=NN	pos_5=CC	pos_1=,	wib=aminophylline	path=theophylline_conj<morphine_compound<tranquilizer_nsubj:pass>	relType_2=punct	pos_6=HYPH	pos_6=NN	lemma_6=type	relType_5=cc	relType_6=conj	pos_4=,	lemma_4=reserpine	relType_6=punct	lib=aminophylline	path2=	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=-	relType_4=punct	lemma_3=,	relType_3=conj	lemma_3=succinylcholine	lemma_4=,	relType_6=compound	pos_3=,	eib=True	lemma_2=aminophylline	lemma_5=and	pos_3=NN	pos_2=,	lpib=aminophylline_NN	relType_4=conj	relType_1=punct	path1=theophylline_conj<morphine_compound	relType_3=punct	lemma_6=phenothiazine
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e2	DDI-DrugBank.d622.s3.e3	null	path2=succinylcholine_conj	lemma_1=,	eib=False	wib=succinylcholine	pos_1=,	lib=succinylcholine	lpib=succinylcholine_NN	path=aminophylline_conj<morphine_compound>succinylcholine_conj	relType_1=punct	path1=aminophylline_conj
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e2	DDI-DrugBank.d622.s3.e4	null	lemma_1=,	pos_2=NN	eib=True	path2=reserpine_conj	wib=succinylcholine	pos_1=,	lib=succinylcholine	pos_2=,	lpib=succinylcholine_NN	path=aminophylline_conj<morphine_compound>reserpine_conj	relType_1=punct	path1=aminophylline_conj	relType_2=conj	lemma_2=,	relType_2=punct	lemma_2=succinylcholine
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e2	DDI-DrugBank.d622.s3.e5	null	lemma_1=,	pos_2=NN	path1=aminophylline_conj<morphine_compound	pos_1=,	relType_5=compound	relType_4=cc	relType_2=punct	lemma_2=succinylcholine	lib=succinylcholine	pos_5=HYPH	path2=	lemma_5=phenothiazine	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	relType_5=punct	lemma_5=type	lpib=succinylcholine_NN	relType_5=conj	path=aminophylline_conj<morphine_compound<tranquilizer_nsubj:pass>	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	wib=succinylcholine	lemma_4=and	pos_2=,	relType_1=punct	lemma_3=reserpine	lemma_5=-	relType_3=punct
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e3	DDI-DrugBank.d622.s3.e4	null	lemma_1=,	path=succinylcholine_conj<morphine_compound>reserpine_conj	path2=reserpine_conj	eib=False	lib=reserpine	pos_1=,	path1=succinylcholine_conj	wib=reserpine	relType_1=punct	lpib=reserpine_NN
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e3	DDI-DrugBank.d622.s3.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lemma_2=reserpine	lemma_4=-	pos_4=HYPH	relType_3=cc	relType_2=punct	path1=succinylcholine_conj<morphine_compound	path2=	relType_2=conj	pos_4=NN	lemma_2=,	path=succinylcholine_conj<morphine_compound<tranquilizer_nsubj:pass>	relType_4=punct	relType_4=compound	lemma_4=phenothiazine	wib=reserpine	eib=True	lib=reserpine	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	lemma_4=type	lpib=reserpine_NN
DDI-DrugBank.d622.s3	DDI-DrugBank.d622.s3.e4	DDI-DrugBank.d622.s3.e5	null	lemma_1=,	pos_1=,	wib=phenothiazine	relType_2=cc	path=reserpine_conj<morphine_compound<tranquilizer_nsubj:pass>	path1=reserpine_conj<morphine_compound	lemma_2=and	lpib=phenothiazine_NN	lemma_3=-	path2=	lemma_3=phenothiazine	relType_3=conj	lemma_3=type	lib=phenothiazine	eib=True	pos_3=NN	pos_3=HYPH	pos_2=CC	relType_3=compound	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e0	DDI-DrugBank.d737.s0.e1	null	path=carbidopa_compound<levodopa_ROOT>	lpib=levodopa_NN	eib=False	lib=levodopa	path2=	pos_1=HYPH	relType_1=punct	wib=Levodopa	lemma_1=/	path1=carbidopa_compound
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e0	DDI-DrugBank.d737.s0.e2	null	path2=influence_parataxis>levodopa_nsubj>carbidopa_compound	lemma_2=:	pos_2=NN	lpib=levodopa_NN	eib=True	lib=levodopa	relType_2=ROOT	lemma_2=levodopa	pos_2=:	path=carbidopa_compound<levodopa_ROOT>influence_parataxis>levodopa_nsubj>carbidopa_compound	pos_1=HYPH	relType_1=punct	wib=Levodopa	lemma_1=/	relType_2=punct	path1=carbidopa_compound
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e0	DDI-DrugBank.d737.s0.e3	null	pos_2=NN	pos_1=HYPH	lemma_3=carbidopa	path=carbidopa_compound<levodopa_ROOT>influence_parataxis>levodopa_nsubj	relType_2=punct	lemma_2=:	lemma_3=/	relType_2=ROOT	pos_2=:	lemma_1=/	path1=carbidopa_compound	path2=influence_parataxis>levodopa_nsubj	lpib=levodopa_NN	eib=True	lib=levodopa	pos_3=NN	pos_3=HYPH	lemma_2=levodopa	relType_3=compound	relType_1=punct	relType_3=punct	wib=Levodopa
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e0	DDI-DrugBank.d737.s0.e4	null	lemma_4=do	lemma_6=influence	pos_2=NN	pos_6=VB	relType_7=det	pos_9=IN	pos_1=HYPH	lemma_4=levodopa	relation_8=neutral	lemma_3=carbidopa	pos_8=NNS	relType_2=punct	lemma_2=:	path2=influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	relType_8=obj	lemma_3=/	path=carbidopa_compound<levodopa_ROOT>influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	relType_9=case	relType_4=nsubj	relType_6=parataxis	pos_4=NN	pos_7=DT	lemma_5=not	relType_2=ROOT	pos_5=RB	relType_4=aux	pos_2=:	lemma_1=/	relType_5=advmod	path1=carbidopa_compound	lpib=levodopa_NN	eib=True	lib=levodopa	pos_3=NN	pos_3=HYPH	lemma_9=of	lemma_2=levodopa	lemma_8=pharmacokinetic	relType_3=compound	lemma_7=the	relType_1=punct	relType_3=punct	pos_4=VBZ	wib=Levodopa
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e1	DDI-DrugBank.d737.s0.e2	null	path2=influence_parataxis>levodopa_nsubj>carbidopa_compound	eib=False	path1=	lpib=carbidopa_NN	wib=Carbidopa	pos_1=:	lemma_1=:	relType_1=punct	lib=carbidopa	path=<levodopa_ROOT>influence_parataxis>levodopa_nsubj>carbidopa_compound
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e1	DDI-DrugBank.d737.s0.e3	null	path2=influence_parataxis>levodopa_nsubj	lemma_2=carbidopa	pos_2=NN	lemma_2=/	eib=True	relType_2=compound	path1=	lpib=carbidopa_NN	wib=Carbidopa	pos_1=:	pos_2=HYPH	lemma_1=:	relType_1=punct	path=<levodopa_ROOT>influence_parataxis>levodopa_nsubj	lib=carbidopa	relType_2=punct
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e1	DDI-DrugBank.d737.s0.e4	null	pos_7=NNS	relType_8=case	pos_2=NN	lemma_2=/	pos_6=DT	path1=	relType_5=parataxis	pos_2=HYPH	relType_2=punct	relation_6=neutral	pos_5=VB	pos_4=RB	lemma_6=the	lemma_7=pharmacokinetic	relType_7=obj	path2=influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	pos_3=VBZ	lemma_5=influence	lemma_1=:	lib=carbidopa	lemma_4=not	pos_8=IN	lemma_3=do	relType_2=compound	relType_4=advmod	pos_1=:	wib=Carbidopa	path=<levodopa_ROOT>influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	lemma_3=levodopa	relType_3=nsubj	relType_6=det	lemma_2=carbidopa	eib=True	pos_3=NN	lpib=carbidopa_NN	relType_3=aux	relType_1=punct	lemma_8=of
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e2	DDI-DrugBank.d737.s0.e3	null	lpib=levodopa_NN	eib=False	lib=levodopa	path2=	pos_1=HYPH	relType_1=punct	path=carbidopa_compound<levodopa_nsubj>	wib=Levodopa	lemma_1=/	path1=carbidopa_compound
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e2	DDI-DrugBank.d737.s0.e4	null	pos_2=NN	pos_3=RB	relType_3=advmod	relType_7=case	lemma_3=not	lemma_2=do	lemma_6=pharmacokinetic	pos_1=HYPH	relType_2=nsubj	relType_2=aux	lemma_4=influence	relType_4=parataxis	path2=pharmacokinetic_obj>pramipexole_nmod	relType_5=det	path1=carbidopa_compound<levodopa_nsubj	lemma_1=/	lemma_7=of	relType_6=obj	pos_2=VBZ	lemma_5=the	lpib=levodopa_NN	eib=True	lib=levodopa	pos_4=VB	pos_7=IN	pos_5=DT	pos_6=NNS	lemma_2=levodopa	relation_4=neutral	relType_1=punct	path=carbidopa_compound<levodopa_nsubj<influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	wib=Levodopa
DDI-DrugBank.d737.s0	DDI-DrugBank.d737.s0.e3	DDI-DrugBank.d737.s0.e4	null	relType_1=aux	lemma_6=of	pos_3=VB	relType_6=case	pos_2=RB	eib=False	relType_2=advmod	lemma_1=do	pos_5=NNS	pos_6=IN	relation_2=neutral	path=levodopa_nsubj<influence_parataxis>pharmacokinetic_obj>pramipexole_nmod	path2=pharmacokinetic_obj>pramipexole_nmod	pos_4=DT	lemma_4=the	relType_3=parataxis	lemma_3=influence	wib=does	lib=do	pos_1=VBZ	lemma_5=pharmacokinetic	relType_5=obj	lpib=do_VBZ	path1=levodopa_nsubj	relType_4=det	lemma_2=not
DDI-DrugBank.d737.s2	DDI-DrugBank.d737.s2.e0	DDI-DrugBank.d737.s2.e1	null	lemma_9=)	relType_10=punct	relType_8=dep	lemma_4=volunteer	lemma_8=11	lemma_10=,	path1=	pos_6=NN	pos_2=IN	lemma_6=n	lemma_3=healthy	eib=False	wib=healthy	lemma_5=(	pos_4=NNS	lemma_1=:	pos_9=-RRB-	lpib=healthy_JJ	pos_7=SYM	relType_4=obl	relType_3=amod	relType_5=punct	pos_1=:	relType_9=punct	path=<selegiline_ROOT>influence_appos>selegiline_nsubj	lemma_7==	relType_2=case	pos_3=JJ	relType_7=dep	pos_10=,	lib=healthy	path2=influence_appos>selegiline_nsubj	relType_1=punct	pos_8=CD	lemma_2=in	relType_6=nsubj	pos_5=-LRB-
DDI-DrugBank.d737.s2	DDI-DrugBank.d737.s2.e0	DDI-DrugBank.d737.s2.e2	null	lemma_9=)	relType_10=punct	relType_8=dep	lemma_4=volunteer	pos_11=VBD	lemma_8=11	lemma_10=,	lemma_11=do	path1=	lemma_12=not	pos_16=IN	path2=influence_appos>pharmacokinetic_obj>pramipexole_nmod	pos_6=NN	pos_2=IN	relation_13=neutral	lemma_6=n	lemma_3=healthy	lemma_13=influence	relType_12=advmod	relType_11=aux	relType_13=appos	wib=healthy	lemma_5=(	relType_11=nsubj	relType_14=det	lemma_14=the	lemma_16=of	pos_4=NNS	lemma_1=:	lemma_11=selegiline	pos_9=-RRB-	lpib=healthy_JJ	pos_7=SYM	pos_13=VB	relType_4=obl	relType_3=amod	pos_12=RB	relType_5=punct	pos_1=:	relType_9=punct	pos_14=DT	relType_15=obj	lemma_7==	relType_16=case	pos_11=NN	relType_2=case	pos_3=JJ	eib=True	relType_7=dep	pos_10=,	pos_15=NNS	lemma_15=pharmacokinetic	lib=healthy	relType_1=punct	pos_8=CD	lemma_2=in	relType_6=nsubj	path=<selegiline_ROOT>influence_appos>pharmacokinetic_obj>pramipexole_nmod	pos_5=-LRB-
DDI-DrugBank.d737.s2	DDI-DrugBank.d737.s2.e1	DDI-DrugBank.d737.s2.e2	null	relType_1=aux	wib=did	lemma_6=of	pos_3=VB	relType_6=case	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relType_3=appos	pos_5=NNS	pos_6=IN	relation_2=neutral	path2=pharmacokinetic_obj>pramipexole_nmod	pos_4=DT	path=selegiline_nsubj<influence_appos>pharmacokinetic_obj>pramipexole_nmod	lemma_4=the	lpib=do_VBD	lemma_3=influence	lib=do	lemma_5=pharmacokinetic	relType_5=obj	relType_4=det	path1=selegiline_nsubj	lemma_2=not
DDI-DrugBank.d737.s3	DDI-DrugBank.d737.s3.e0	DDI-DrugBank.d737.s3.e1	null	pos_5=VBZ	lemma_3=pharmacokinetic	path1=	relType_5=parataxis	pos_2=NNP	eib=False	lib=population	pos_6=IN	lemma_2=Population	wib=Population	relType_4=nsubj	path=<Amantadine_ROOT>suggest_parataxis>unlikely_ccomp>amantadine_nsubj	pos_4=NN	lemma_1=:	relType_3=amod	relType_6=mark	relType_2=compound	pos_1=:	path2=suggest_parataxis>unlikely_ccomp>amantadine_nsubj	pos_3=JJ	lemma_4=analysis	lpib=population_NNP	lemma_5=suggest	relType_1=punct	lemma_6=that
DDI-DrugBank.d737.s3	DDI-DrugBank.d737.s3.e0	DDI-DrugBank.d737.s3.e2	null	lemma_13=clearance	pos_7=VBZ	pos_5=VBZ	lemma_3=pharmacokinetic	pos_7=NN	lemma_7=be	path1=	relation_10=neutral	relType_5=parataxis	lemma_10=alter	lemma_12=oral	lemma_8=unlikely	pos_8=JJ	pos_9=TO	pos_12=JJ	path=<Amantadine_ROOT>suggest_parataxis>unlikely_ccomp>alter_xcomp>clearance_obj>pramipexole_nmod	pos_2=NNP	lib=population	pos_6=IN	relType_7=cop	lemma_2=Population	lemma_7=amantadine	lemma_9=to	relType_12=amod	wib=Population	pos_13=NN	relType_4=nsubj	pos_4=NN	pos_10=VB	lemma_1=:	pos_14=IN	relType_3=amod	relType_6=mark	relType_2=compound	pos_1=:	pos_11=DT	relType_8=ccomp	lemma_11=the	relType_11=det	path2=suggest_parataxis>unlikely_ccomp>alter_xcomp>clearance_obj>pramipexole_nmod	relType_9=mark	pos_3=JJ	eib=True	lemma_4=analysis	lemma_14=of	relType_10=xcomp	lpib=population_NNP	relType_7=nsubj	lemma_5=suggest	relType_1=punct	lemma_6=that	relType_13=obj	relType_14=case
DDI-DrugBank.d737.s3	DDI-DrugBank.d737.s3.e1	DDI-DrugBank.d737.s3.e2	null	relType_8=case	pos_3=TO	pos_6=JJ	pos_2=JJ	eib=False	lemma_7=clearance	relType_6=amod	lemma_1=be	relType_7=obj	path2=alter_xcomp>clearance_obj>pramipexole_nmod	pos_8=IN	relation_3=neutral	relType_4=xcomp	lemma_6=oral	lib=be	relType_5=det	lemma_3=to	relType_3=mark	relType_2=ccomp	path=amantadine_nsubj<unlikely_ccomp>alter_xcomp>clearance_obj>pramipexole_nmod	wib=is	lemma_2=unlikely	relType_1=cop	lemma_5=the	pos_1=VBZ	lemma_4=alter	pos_4=VB	path1=amantadine_nsubj	pos_5=DT	lpib=be_VBZ	pos_7=NN	lemma_8=of
DDI-DrugBank.d737.s4	DDI-DrugBank.d737.s4.e0	DDI-DrugBank.d737.s4.e1	null	path=<cimetidine_ROOT>cause_appos>cimetidine_nsubj	eib=False	path1=	pos_1=:	relType_1=punct	path2=cause_appos>cimetidine_nsubj	lib=cimetidine	wib=Cimetidine	lpib=cimetidine_NN	lemma_1=:
DDI-DrugBank.d737.s4	DDI-DrugBank.d737.s4.e0	DDI-DrugBank.d737.s4.e2	null	relType_22=compound	pos_2=NN	lemma_10=of	wib=Cimetidine	pos_8=JJ	relType_24=case	lemma_4=known	lemma_13=via	lemma_7=renal	relation_19=neutral	lemma_15=cationic	pos_1=:	lemma_21=50	pos_24=IN	lib=cimetidine	lemma_22=%	lemma_20=a	pos_7=JJ	pos_2=,	pos_11=JJ	relType_21=nummod	lemma_12=basis	pos_19=VBD	lemma_8=tubular	relType_23=obj	relType_4=amod	pos_22=NN	path1=	relType_6=case	relType_2=punct	relType_2=nsubj	path=<cimetidine_ROOT>cause_appos>increase_obj>auc_nmod>pramipexole_compound	pos_6=IN	relType_11=amod	relType_12=nmod	lemma_14=the	relType_3=det	lemma_3=a	pos_9=NN	lemma_2=,	pos_21=CD	pos_16=NN	relType_5=appos	lemma_16=transport	pos_5=NN	relType_1=punct	lemma_2=cimetidine	lemma_24=in	lemma_17=system	lemma_6=of	pos_23=NN	pos_17=NN	lemma_23=increase	relType_19=appos	pos_13=IN	lemma_1=:	relType_13=case	lemma_19=cause	relType_7=amod	relation_23=beneficial	pos_10=IN	relType_17=nmod	pos_14=DT	lemma_11=organic	lemma_5=inhibitor	relType_20=det	pos_4=JJ	pos_15=JJ	relType_8=amod	relType_15=amod	relType_16=compound	pos_20=DT	relType_9=nmod	lpib=cimetidine_NN	path2=cause_appos>increase_obj>auc_nmod>pramipexole_compound	relType_14=det	relType_10=case	lemma_9=secretion	pos_18=,	pos_12=NNS	lemma_18=,	relType_18=punct	eib=True	pos_3=DT
DDI-DrugBank.d737.s4	DDI-DrugBank.d737.s4.e1	DDI-DrugBank.d737.s4.e2	mechanism	relType_14=amod	pos_6=JJ	relType_16=nmod	lemma_5=of	relType_5=case	lemma_7=tubular	lpib=known_JJ	relType_9=case	wib=known	relType_3=amod	lemma_21=%	relType_15=compound	pos_3=JJ	relation_21=beneficial	pos_7=JJ	relType_13=det	lemma_18=cause	lemma_6=renal	relType_19=det	lemma_23=in	pos_2=DT	lemma_22=increase	lemma_1=,	pos_22=NN	pos_1=,	pos_20=CD	pos_8=NN	path=cimetidine_nsubj<cause_appos>increase_obj>auc_nmod>pramipexole_compound	pos_12=IN	lemma_8=secretion	lemma_16=system	relType_21=compound	lemma_11=basis	pos_5=IN	pos_16=NN	relation_17=neutral	lemma_4=inhibitor	pos_23=IN	relType_11=nmod	relType_1=punct	pos_19=DT	relType_4=appos	relType_17=punct	relType_12=case	lemma_12=via	relType_20=nummod	path2=increase_obj>auc_nmod>pramipexole_compound	lemma_20=50	relType_18=appos	pos_17=,	relType_7=amod	relType_23=case	path1=cimetidine_nsubj	pos_14=JJ	lemma_3=known	lemma_13=the	relType_10=amod	pos_13=DT	pos_9=IN	lemma_2=a	lemma_15=transport	lemma_14=cationic	lemma_17=,	eib=False	lemma_19=a	relType_6=amod	pos_11=NNS	pos_4=NN	pos_15=NN	pos_10=JJ	relType_22=obj	lib=known	relType_8=nmod	lemma_9=of	relType_2=det	lemma_10=organic	pos_21=NN	pos_18=VBD
DDI-DrugBank.d737.s5	DDI-DrugBank.d737.s5.e0	DDI-DrugBank.d737.s5.e1	null	path=<Probenecid_nsubj>Probenecid_dep	lpib=probenecid_NNP	eib=False	path2=Probenecid_dep	path1=	lib=probenecid	pos_1=:	relType_1=punct	lemma_1=:	wib=Probenecid
DDI-DrugBank.d737.s5	DDI-DrugBank.d737.s5.e0	DDI-DrugBank.d737.s5.e2	null	relType_4=amod	pos_4=JJ	path=Probenecid_nsubj<influence_ROOT>pharmacokinetic_obj>pramipexole_compound	pos_15=JJ	relType_8=amod	relType_15=amod	relType_16=nmod	relType_17=punct	lib=probenecid	lemma_10=of	lemma_6=of	relation_21=neutral	relType_19=advmod	relType_9=nmod	relType_6=case	relType_2=punct	pos_8=JJ	relType_20=advmod	lemma_4=known	lemma_16=transporter	pos_2=NNP	lemma_17=,	lemma_19=not	pos_6=IN	relType_11=amod	pos_19=RB	relType_12=nmod	lemma_13=via	lemma_12=acid	lemma_7=renal	relType_14=det	relType_10=case	pos_13=IN	relType_3=det	lemma_3=a	path1=Probenecid_nsubj	lemma_2=,	lemma_1=:	pos_9=NN	wib=Probenecid	lemma_9=secretion	lemma_14=the	relType_13=case	pos_17=,	relType_2=dep	lemma_18=do	relType_7=amod	relType_18=aux	pos_12=NNS	lemma_21=influence	pos_1=:	pos_21=VB	pos_10=IN	pos_16=NN	lemma_20=noticeably	relType_21=ROOT	relType_5=appos	pos_14=DT	path2=pharmacokinetic_obj>pramipexole_compound	pos_5=NN	lemma_2=Probenecid	lemma_15=aruonic	lpib=probenecid_NNP	eib=True	pos_3=DT	pos_20=RB	lemma_11=organic	pos_7=JJ	pos_2=,	pos_11=JJ	relType_1=punct	lemma_5=inhibitor	lemma_8=tubular	pos_18=VBD
DDI-DrugBank.d737.s5	DDI-DrugBank.d737.s5.e1	DDI-DrugBank.d737.s5.e2	null	pos_2=DT	relType_14=amod	lemma_1=,	lemma_13=the	pos_6=JJ	lemma_15=transporter	lemma_19=noticeably	relType_4=appos	pos_17=VBD	relType_10=amod	pos_1=,	lemma_12=via	relType_12=case	pos_13=DT	pos_9=IN	pos_20=VB	lemma_2=a	relType_19=advmod	lemma_5=of	relType_5=case	lemma_7=tubular	pos_8=NN	pos_18=RB	eib=False	relType_6=amod	pos_19=RB	pos_11=NNS	pos_16=,	relType_20=ROOT	lpib=known_JJ	relType_9=case	lemma_16=,	pos_4=NN	pos_12=IN	lemma_20=influence	relation_19=neutral	lemma_8=secretion	lemma_18=not	wib=known	relType_7=amod	pos_15=NN	relType_3=amod	pos_10=JJ	pos_5=IN	relType_16=punct	relType_15=nmod	path2=pharmacokinetic_obj>pramipexole_compound	lib=known	pos_3=JJ	relType_8=nmod	relType_18=advmod	lemma_9=of	lemma_17=do	path=Probenecid_dep<Probenecid_nsubj<influence_ROOT>pharmacokinetic_obj>pramipexole_compound	relType_2=det	lemma_4=inhibitor	pos_7=JJ	lemma_10=organic	relType_13=det	pos_14=JJ	lemma_14=aruonic	relType_11=nmod	path1=Probenecid_dep<Probenecid_nsubj	relType_1=punct	lemma_6=renal	relType_17=aux	lemma_11=acid	lemma_3=known
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e1	null	path1=cimetidine_appos	lemma_1=,	eib=False	pos_1=,	wib=ranitidine	path=cimetidine_appos<g._dep>ranitidine_appos	relType_1=punct	lib=ranitidine	lpib=ranitidine_NN	path2=ranitidine_appos
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e2	null	path1=cimetidine_appos	lemma_1=,	pos_2=NN	eib=True	path2=diltiazem_appos	pos_1=,	lemma_2=ranitidine	pos_2=,	wib=ranitidine	path=cimetidine_appos<g._dep>diltiazem_appos	relType_1=punct	relType_2=appos	relType_2=punct	lemma_2=,	lib=ranitidine	lpib=ranitidine_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e3	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	path1=cimetidine_appos	lemma_3=diltiazem	relType_3=appos	lemma_2=,	lemma_3=,	path2=triamterene_appos	lemma_2=ranitidine	relType_2=appos	lib=ranitidine	pos_3=,	path=cimetidine_appos<g._dep>triamterene_appos	eib=True	pos_3=NN	pos_2=,	wib=ranitidine	relType_1=punct	relType_3=punct	lpib=ranitidine_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e4	null	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	path2=verapamil_appos	relType_2=punct	path1=cimetidine_appos	pos_4=,	lemma_3=diltiazem	relType_3=appos	lemma_4=triamterene	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_2=ranitidine	lemma_4=,	relType_2=appos	path=cimetidine_appos<g._dep>verapamil_appos	lib=ranitidine	pos_3=,	eib=True	pos_3=NN	pos_2=,	wib=ranitidine	relType_1=punct	relType_3=punct	lpib=ranitidine_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e5	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	relType_2=punct	path1=cimetidine_appos	pos_4=,	lemma_3=diltiazem	relType_3=appos	lemma_4=triamterene	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=verapamil	lemma_5=,	relType_5=punct	lemma_2=ranitidine	path2=quinidine_appos	lemma_4=,	relType_2=appos	relType_5=appos	lib=ranitidine	pos_5=NN	pos_3=,	eib=True	path=cimetidine_appos<g._dep>quinidine_appos	pos_3=NN	pos_2=,	wib=ranitidine	relType_1=punct	relType_3=punct	lpib=ranitidine_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e6	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	relType_7=cc	relType_2=punct	pos_6=NN	path1=cimetidine_appos	pos_4=,	lemma_3=diltiazem	relType_3=appos	lemma_4=triamterene	relType_6=punct	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path2=quinine_conj	lemma_5=verapamil	lemma_5=,	path=cimetidine_appos<g._dep>quinine_conj	relType_5=punct	pos_7=CC	lemma_2=ranitidine	lemma_4=,	relType_2=appos	relType_5=appos	lib=ranitidine	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	pos_3=NN	lemma_7=and	lemma_6=quinidine	pos_2=,	wib=ranitidine	relType_1=punct	relType_3=punct	lpib=ranitidine_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e7	mechanism	lemma_1=,	lemma_11=oral	pos_2=NN	relType_10=det	pos_5=,	relType_4=appos	pos_9=VBZ	pos_1=,	lemma_6=,	relType_7=cc	relType_8=punct	relation_14=adverse	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	relType_2=punct	pos_6=NN	pos_8=NN	lemma_12=clearance	lemma_13=of	pos_4=,	lemma_3=diltiazem	relType_3=appos	lemma_4=triamterene	relType_6=punct	relType_9=ccomp	relType_11=amod	lemma_10=the	relType_12=obj	pos_8=-RRB-	pos_13=IN	pos_4=NN	lemma_2=,	path2=clearance_obj>pramipexole_nmod	relType_13=case	lemma_8=quinine	lemma_8=)	relType_4=punct	lemma_3=,	lemma_5=verapamil	pos_7=CC	lemma_5=,	relType_5=punct	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_2=ranitidine	lemma_4=,	relType_2=appos	relType_5=appos	lib=ranitidine	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	pos_3=NN	lemma_7=and	lemma_6=quinidine	relType_8=conj	pos_2=,	pos_11=JJ	wib=ranitidine	relType_1=punct	pos_12=NN	relType_3=punct	lpib=ranitidine_NN	pos_10=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e8	null	pos_2=NN	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_8=punct	relType_20=nsubj	pos_6=NN	lemma_13=of	lemma_4=triamterene	relType_23=det	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	relType_4=punct	lemma_3=,	lemma_5=,	lemma_26=system	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_8=conj	pos_2=,	pos_11=JJ	wib=ranitidine	lemma_28=e.	relType_14=nmod	pos_15=RB	lemma_20=that	lemma_1=,	pos_1=,	lemma_25=transport	relType_2=punct	pos_8=NN	relType_9=ccomp	relType_11=amod	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	relType_16=nummod	lemma_4=,	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	pos_27=-LRB-	lemma_6=quinidine	relType_29=dep	pos_30=,	relType_1=punct	relType_3=punct	lemma_24=anionic	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	lemma_16=20	pos_24=JJ	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	lemma_29=g.	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NN	lemma_17=%	relType_14=case	relType_27=punct	lpib=ranitidine_NN	pos_10=DT	pos_19=IN	lemma_11=oral	relation_14=adverse	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	pos_20=DT	lemma_30=,	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	path2=secrete_advcl>g._dep>cephalosporin_conj	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	pos_4=NN	relType_21=advcl	relType_28=compound	pos_18=,	lemma_5=verapamil	pos_7=CC	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	relType_26=obl	lemma_27=(	pos_23=DT	relType_2=appos	lib=ranitidine	pos_6=,	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e9	null	pos_2=NN	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_8=punct	relType_20=nsubj	pos_6=NN	lemma_13=of	lemma_4=triamterene	relType_23=det	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	relType_4=punct	lemma_3=,	lemma_5=,	lemma_26=system	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_31=conj	relType_8=conj	pos_2=,	pos_11=JJ	wib=ranitidine	lemma_28=e.	relType_14=nmod	pos_15=RB	lemma_20=that	lemma_1=,	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	pos_1=,	lemma_25=transport	relType_2=punct	pos_8=NN	relType_9=ccomp	relType_11=amod	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	pos_31=,	relType_16=nummod	lemma_4=,	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	pos_27=-LRB-	lemma_6=quinidine	relType_29=dep	pos_30=,	relType_1=punct	relType_3=punct	lemma_24=anionic	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	lemma_16=20	pos_24=JJ	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_31=cephalosporin	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	lemma_29=g.	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NN	lemma_17=%	lemma_31=,	relType_14=case	relType_27=punct	lpib=ranitidine_NN	pos_10=DT	pos_19=IN	lemma_11=oral	relation_14=adverse	pos_20=DT	lemma_30=,	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	path2=secrete_advcl>g._dep>penicillin_conj	pos_4=NN	relType_21=advcl	relType_31=punct	relType_28=compound	pos_18=,	lemma_5=verapamil	pos_7=CC	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	pos_31=NNS	relType_26=obl	lemma_27=(	pos_23=DT	relType_2=appos	lib=ranitidine	pos_6=,	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e10	null	pos_2=NN	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_32=punct	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	relType_8=punct	relType_20=nsubj	pos_6=NN	lemma_13=of	lemma_4=triamterene	relType_23=det	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	relType_4=punct	lemma_3=,	lemma_5=,	lemma_26=system	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_31=conj	relType_32=conj	relType_8=conj	pos_2=,	pos_11=JJ	wib=ranitidine	lemma_28=e.	relType_14=nmod	pos_32=NNS	pos_15=RB	lemma_20=that	lemma_1=,	pos_1=,	lemma_25=transport	relType_2=punct	pos_8=NN	relType_9=ccomp	relType_11=amod	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	pos_31=,	pos_32=,	relType_16=nummod	lemma_4=,	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	pos_27=-LRB-	lemma_6=quinidine	relType_29=dep	pos_30=,	relType_1=punct	relType_3=punct	lemma_24=anionic	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	path2=secrete_advcl>g._dep>indomethacin_conj	lemma_16=20	pos_24=JJ	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_31=cephalosporin	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	lemma_29=g.	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NN	lemma_17=%	lemma_31=,	relType_14=case	relType_27=punct	lpib=ranitidine_NN	pos_10=DT	pos_19=IN	lemma_11=oral	relation_14=adverse	pos_20=DT	lemma_30=,	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	pos_4=NN	relType_21=advcl	relType_31=punct	relType_28=compound	pos_18=,	lemma_5=verapamil	pos_7=CC	lemma_32=penicillin	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	lemma_32=,	pos_31=NNS	relType_26=obl	lemma_27=(	pos_23=DT	relType_2=appos	lib=ranitidine	pos_6=,	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e11	null	relType_33=conj	pos_2=NN	pos_33=,	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_32=punct	relType_8=punct	relType_20=nsubj	pos_6=NN	lemma_13=of	lemma_4=triamterene	relType_23=det	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	relType_4=punct	lemma_3=,	lemma_5=,	relType_33=punct	lemma_26=system	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_31=conj	relType_32=conj	relType_8=conj	pos_2=,	pos_11=JJ	wib=ranitidine	lemma_28=e.	relType_14=nmod	pos_32=NNS	pos_15=RB	lemma_20=that	lemma_1=,	pos_1=,	lemma_25=transport	relType_2=punct	pos_8=NN	relType_9=ccomp	relType_11=amod	lemma_33=,	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	pos_31=,	pos_32=,	relType_16=nummod	lemma_4=,	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	pos_27=-LRB-	lemma_6=quinidine	relType_29=dep	pos_30=,	lemma_33=indomethacin	relType_1=punct	relType_3=punct	lemma_24=anionic	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	lemma_16=20	pos_24=JJ	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_31=cephalosporin	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	lemma_29=g.	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NN	lemma_17=%	lemma_31=,	relType_14=case	relType_27=punct	pos_33=NN	lpib=ranitidine_NN	pos_10=DT	pos_19=IN	lemma_11=oral	relation_14=adverse	pos_20=DT	lemma_30=,	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	pos_4=NN	relType_21=advcl	relType_31=punct	relType_28=compound	pos_18=,	lemma_5=verapamil	pos_7=CC	lemma_32=penicillin	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	lemma_32=,	pos_31=NNS	relType_26=obl	lemma_27=(	pos_23=DT	relType_2=appos	lib=ranitidine	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	pos_6=,	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e12	null	relType_33=conj	pos_2=NN	pos_34=NN	pos_33=,	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_32=punct	relType_8=punct	lemma_34=hydrochlorothiazide	relType_20=nsubj	relType_35=cc	pos_6=NN	lemma_13=of	lemma_35=and	lemma_4=triamterene	relType_23=det	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	relType_4=punct	lemma_3=,	lemma_5=,	relType_33=punct	lemma_26=system	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_31=conj	relType_32=conj	relType_8=conj	pos_2=,	pos_11=JJ	relType_34=conj	wib=ranitidine	relType_34=punct	lemma_28=e.	relType_14=nmod	pos_34=,	pos_32=NNS	pos_15=RB	lemma_20=that	lemma_1=,	pos_1=,	lemma_25=transport	relType_2=punct	pos_8=NN	relType_9=ccomp	relType_11=amod	lemma_33=,	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	pos_31=,	pos_32=,	relType_16=nummod	lemma_4=,	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	pos_27=-LRB-	lemma_6=quinidine	lemma_34=,	relType_29=dep	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	pos_30=,	lemma_33=indomethacin	relType_1=punct	relType_3=punct	lemma_24=anionic	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	lemma_16=20	pos_24=JJ	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_31=cephalosporin	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	lemma_29=g.	lemma_9=decrease	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NN	path2=secrete_advcl>g._dep>chlorpropamide_conj	lemma_17=%	lemma_31=,	relType_14=case	relType_27=punct	pos_33=NN	lpib=ranitidine_NN	pos_10=DT	pos_19=IN	lemma_11=oral	relation_14=adverse	pos_20=DT	lemma_30=,	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	pos_4=NN	relType_21=advcl	relType_31=punct	relType_28=compound	pos_18=,	pos_35=CC	lemma_5=verapamil	pos_7=CC	lemma_32=penicillin	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	lemma_32=,	pos_31=NNS	relType_26=obl	lemma_27=(	pos_23=DT	relType_2=appos	lib=ranitidine	pos_6=,	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e0	DDI-DrugBank.d737.s6.e13	null	lemma_36=)	relType_33=conj	pos_2=NN	pos_34=NN	pos_33=,	pos_5=,	lemma_22=by	lemma_15=about	lemma_6=,	relType_32=punct	relType_8=punct	lemma_34=hydrochlorothiazide	relType_20=nsubj	relType_35=cc	pos_6=NN	lemma_13=of	lemma_35=and	lemma_43=on	lemma_4=triamterene	relType_23=det	relType_44=det	relType_37=cop	pos_26=NN	pos_22=IN	relType_19=mark	lemma_8=quinine	lemma_37=be	relType_4=punct	lemma_3=,	path=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_46=clearance	lemma_5=,	relType_33=punct	lemma_26=system	relType_41=amod	pos_46=NN	pos_28=NN	relType_30=punct	pos_3=,	relType_6=appos	relType_46=nmod	relType_31=conj	relType_32=conj	relType_8=conj	pos_2=,	pos_11=JJ	relType_34=conj	wib=ranitidine	relType_34=punct	lemma_28=e.	relType_14=nmod	pos_34=,	relType_36=punct	lemma_41=little	pos_32=NNS	pos_15=RB	lemma_20=that	relType_36=conj	pos_39=TO	lemma_1=,	pos_1=,	lemma_25=transport	relType_43=case	relType_47=case	relType_2=punct	pos_8=NN	lemma_39=to	relType_9=ccomp	pos_41=JJ	pos_47=IN	relType_11=amod	lemma_33=,	pos_29=NN	relType_22=case	lemma_2=,	pos_14=IN	pos_38=JJ	pos_45=JJ	pos_31=,	pos_32=,	relType_16=nummod	lemma_4=,	pos_40=VB	relType_5=appos	relType_24=amod	pos_21=VBN	lemma_19=while	pos_5=NN	lemma_42=effect	pos_27=-LRB-	pos_42=NN	lemma_6=quinidine	lemma_34=,	relType_29=dep	pos_30=,	lemma_33=indomethacin	relType_1=punct	relType_3=punct	lemma_24=anionic	lemma_38=likely	relType_45=amod	lemma_47=of	relType_10=det	relType_4=appos	pos_9=VBZ	relType_7=cc	pos_44=DT	lemma_16=20	pos_24=JJ	path1=cimetidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	pos_17=NN	pos_4=,	relType_3=appos	lemma_21=secrete	lemma_31=cephalosporin	lemma_44=the	lemma_10=the	pos_14=NN	pos_13=IN	relType_25=compound	relType_13=case	lemma_8=)	pos_16=CD	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_29=g.	lemma_9=decrease	pos_25=NN	lemma_17=%	lemma_31=,	lemma_36=chlorpropamide	relType_42=obj	relType_14=case	relType_27=punct	relation_53=neutral	pos_33=NN	lpib=ranitidine_NN	pos_10=DT	lemma_45=oral	pos_19=IN	lemma_11=oral	relType_39=mark	pos_43=IN	relType_40=xcomp	relation_14=adverse	pos_20=DT	lemma_30=,	pos_36=-RRB-	lemma_12=clearance	lemma_3=diltiazem	relType_6=punct	lemma_14=pramipexole	lemma_14=by	relType_12=obj	pos_8=-RRB-	pos_4=NN	relType_21=advcl	relType_31=punct	relType_28=compound	pos_18=,	pos_35=CC	lemma_5=verapamil	pos_7=CC	lemma_32=penicillin	lemma_18=,	relType_5=punct	relType_18=punct	lemma_2=ranitidine	lemma_32=,	pos_31=NNS	relType_26=obl	lemma_27=(	pos_23=DT	relType_38=parataxis	relType_2=appos	pos_36=NN	lib=ranitidine	pos_6=,	lemma_40=have	pos_37=VBP	eib=True	pos_3=NN	lemma_7=and	lemma_23=the	relType_15=advmod	pos_12=NN	relType_17=obl
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e2	null	path=ranitidine_appos<g._dep>diltiazem_appos	lemma_1=,	eib=False	path2=diltiazem_appos	pos_1=,	lpib=diltiazem_NN	relType_1=punct	path1=ranitidine_appos	wib=diltiazem	lib=diltiazem
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e3	null	path=ranitidine_appos<g._dep>triamterene_appos	lemma_1=,	pos_2=NN	relType_2=punct	eib=True	path2=triamterene_appos	pos_1=,	lpib=diltiazem_NN	pos_2=,	relType_1=punct	path1=ranitidine_appos	relType_2=appos	wib=diltiazem	lemma_2=,	lib=diltiazem	lemma_2=diltiazem
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e4	null	lemma_1=,	pos_2=NN	pos_1=,	path=ranitidine_appos<g._dep>verapamil_appos	path2=verapamil_appos	lemma_2=diltiazem	relType_2=punct	relType_3=appos	path1=ranitidine_appos	lib=diltiazem	wib=diltiazem	lemma_2=,	lemma_3=,	relType_2=appos	lemma_3=triamterene	pos_3=,	eib=True	pos_3=NN	lpib=diltiazem_NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e5	null	lemma_1=,	pos_2=NN	relType_4=appos	path=ranitidine_appos<g._dep>quinidine_appos	pos_1=,	lemma_2=diltiazem	relType_2=punct	pos_4=,	relType_3=appos	path1=ranitidine_appos	lib=diltiazem	wib=diltiazem	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path2=quinidine_appos	lemma_4=,	relType_2=appos	lemma_3=triamterene	pos_3=,	eib=True	pos_3=NN	lemma_4=verapamil	lpib=diltiazem_NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e6	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	path=ranitidine_appos<g._dep>quinine_conj	lemma_2=diltiazem	relType_2=punct	lemma_5=quinidine	pos_4=,	relType_3=appos	path1=ranitidine_appos	lib=diltiazem	wib=diltiazem	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path2=quinine_conj	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=,	relType_2=appos	relType_5=appos	lemma_3=triamterene	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_4=verapamil	lpib=diltiazem_NN	pos_2=,	relType_1=punct	relType_3=punct	relType_6=cc
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e7	mechanism	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	relType_10=amod	pos_1=,	relType_12=case	relType_11=obj	lemma_2=diltiazem	relType_2=punct	lemma_12=of	relation_12=adverse	lemma_5=quinidine	pos_8=VBZ	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_9=DT	lib=diltiazem	wib=diltiazem	pos_4=NN	lemma_2=,	pos_12=IN	path2=clearance_obj>pramipexole_nmod	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	relType_4=punct	lemma_3=,	pos_6=CC	lemma_5=,	relType_5=punct	lemma_6=and	lemma_8=decrease	pos_10=JJ	lemma_7=quinine	lemma_11=clearance	lemma_4=,	relType_2=appos	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	lemma_3=triamterene	pos_5=NN	pos_11=NN	pos_3=,	eib=True	pos_3=NN	lemma_4=verapamil	relType_7=punct	lemma_9=the	lpib=diltiazem_NN	pos_2=,	lemma_10=oral	relType_1=punct	pos_7=NN	relType_9=det	relType_3=punct	lemma_7=)	relType_7=conj	relType_6=cc
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e8	null	relType_28=dep	pos_2=NN	pos_5=,	lemma_25=system	pos_15=CD	lemma_5=quinidine	lemma_16=%	pos_13=NN	lemma_13=by	lemma_24=transport	relType_24=compound	pos_14=RB	relType_4=punct	lemma_3=,	relType_15=nummod	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	relType_21=case	pos_28=NN	pos_3=,	relType_18=mark	pos_2=,	lemma_7=)	lemma_26=(	lemma_1=,	pos_1=,	pos_20=VBN	lemma_13=pramipexole	relType_2=punct	relation_12=adverse	relType_14=advmod	lemma_23=anionic	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_6=CC	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_23=JJ	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	relType_23=amod	relType_11=obj	lemma_12=of	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	pos_18=IN	relType_13=case	pos_17=,	lemma_19=that	pos_25=NN	lemma_11=clearance	pos_29=,	lemma_21=by	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_10=oral	lemma_18=while	relType_7=conj	relType_6=cc	relType_27=compound	relType_10=amod	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	path2=secrete_advcl>g._dep>cephalosporin_conj	pos_4=NN	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	relType_29=punct	lemma_28=g.	relType_2=appos	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e9	null	relType_28=dep	pos_2=NN	pos_5=,	lemma_25=system	pos_15=CD	lemma_5=quinidine	lemma_16=%	pos_13=NN	lemma_13=by	lemma_24=transport	relType_24=compound	pos_14=RB	relType_4=punct	lemma_3=,	relType_15=nummod	relType_30=conj	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	relType_21=case	pos_28=NN	relType_30=punct	pos_3=,	relType_18=mark	pos_2=,	lemma_7=)	lemma_26=(	lemma_1=,	pos_30=NNS	pos_1=,	pos_20=VBN	lemma_13=pramipexole	relType_2=punct	relation_12=adverse	relType_14=advmod	lemma_23=anionic	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_6=CC	lemma_30=cephalosporin	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_23=JJ	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	relType_23=amod	relType_11=obj	lemma_12=of	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	pos_18=IN	relType_13=case	pos_17=,	lemma_19=that	pos_25=NN	lemma_11=clearance	pos_29=,	lemma_21=by	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_10=oral	lemma_18=while	relType_7=conj	relType_6=cc	relType_27=compound	relType_10=amod	lemma_30=,	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	path2=secrete_advcl>g._dep>penicillin_conj	pos_4=NN	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	relType_29=punct	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	lemma_28=g.	relType_2=appos	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e10	null	relType_28=dep	pos_2=NN	pos_5=,	lemma_25=system	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	pos_15=CD	lemma_5=quinidine	lemma_16=%	pos_13=NN	lemma_13=by	lemma_24=transport	relType_24=compound	pos_14=RB	relType_4=punct	lemma_3=,	relType_15=nummod	relType_30=conj	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	relType_21=case	pos_28=NN	relType_30=punct	pos_3=,	relType_18=mark	relType_31=conj	pos_2=,	lemma_7=)	lemma_26=(	lemma_1=,	pos_30=NNS	pos_1=,	pos_20=VBN	lemma_13=pramipexole	relType_2=punct	relation_12=adverse	relType_14=advmod	lemma_23=anionic	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_31=,	pos_6=CC	lemma_30=cephalosporin	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_23=JJ	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	path2=secrete_advcl>g._dep>indomethacin_conj	relType_23=amod	relType_11=obj	lemma_12=of	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	pos_18=IN	relType_13=case	pos_17=,	lemma_19=that	pos_25=NN	lemma_11=clearance	pos_29=,	lemma_31=,	lemma_21=by	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_10=oral	lemma_18=while	relType_7=conj	relType_6=cc	relType_27=compound	relType_10=amod	lemma_30=,	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	pos_4=NN	relType_31=punct	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	relType_29=punct	pos_31=NNS	lemma_28=g.	relType_2=appos	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	lemma_31=penicillin	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e11	null	relType_28=dep	pos_2=NN	pos_5=,	lemma_25=system	relType_32=punct	pos_15=CD	lemma_5=quinidine	lemma_16=%	pos_13=NN	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	lemma_13=by	lemma_24=transport	relType_24=compound	pos_14=RB	relType_4=punct	lemma_3=,	relType_15=nummod	relType_30=conj	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	pos_32=NN	lemma_32=indomethacin	relType_21=case	pos_28=NN	relType_30=punct	pos_3=,	relType_18=mark	relType_31=conj	relType_32=conj	pos_2=,	lemma_7=)	lemma_26=(	lemma_1=,	pos_30=NNS	pos_1=,	pos_20=VBN	lemma_13=pramipexole	relType_2=punct	relation_12=adverse	relType_14=advmod	lemma_23=anionic	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_31=,	pos_32=,	pos_6=CC	lemma_30=cephalosporin	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_23=JJ	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	relType_23=amod	relType_11=obj	lemma_12=of	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	pos_18=IN	relType_13=case	pos_17=,	lemma_19=that	pos_25=NN	lemma_11=clearance	pos_29=,	lemma_31=,	lemma_21=by	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_10=oral	lemma_18=while	relType_7=conj	relType_6=cc	relType_27=compound	relType_10=amod	lemma_30=,	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	pos_4=NN	relType_31=punct	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	lemma_32=,	relType_29=punct	pos_31=NNS	lemma_28=g.	relType_2=appos	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	lemma_31=penicillin	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e12	null	relType_28=dep	relType_33=conj	pos_2=NN	pos_33=,	pos_5=,	lemma_25=system	relType_32=punct	pos_15=CD	lemma_5=quinidine	lemma_16=%	pos_13=NN	lemma_13=by	lemma_24=transport	relType_24=compound	pos_14=RB	relType_4=punct	lemma_3=,	relType_15=nummod	relType_30=conj	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	relType_33=punct	pos_32=NN	lemma_32=indomethacin	relType_21=case	pos_28=NN	relType_30=punct	pos_3=,	relType_18=mark	relType_31=conj	relType_32=conj	pos_2=,	lemma_7=)	lemma_26=(	lemma_1=,	pos_30=NNS	pos_1=,	pos_20=VBN	lemma_13=pramipexole	relType_2=punct	lemma_34=and	relType_14=advmod	relation_12=adverse	lemma_23=anionic	lemma_33=,	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_31=,	pos_32=,	pos_6=CC	lemma_30=cephalosporin	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_11=NN	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_23=JJ	relType_4=appos	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	relType_23=amod	relType_11=obj	lemma_12=of	pos_4=,	relType_3=appos	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	lemma_33=hydrochlorothiazide	pos_18=IN	relType_13=case	pos_17=,	lemma_19=that	pos_25=NN	path2=secrete_advcl>g._dep>chlorpropamide_conj	lemma_11=clearance	pos_29=,	lemma_31=,	lemma_21=by	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_10=oral	pos_34=CC	lemma_18=while	pos_33=NN	relType_7=conj	relType_6=cc	relType_27=compound	relType_10=amod	lemma_30=,	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	pos_4=NN	relType_31=punct	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	lemma_32=,	relType_29=punct	pos_31=NNS	lemma_28=g.	relType_2=appos	relType_34=cc	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	lemma_31=penicillin	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e1	DDI-DrugBank.d737.s6.e13	null	relType_28=dep	relType_33=conj	pos_2=NN	relType_38=mark	pos_33=,	pos_5=,	lemma_25=system	relType_32=punct	pos_35=NN	pos_41=NN	pos_15=CD	lemma_5=quinidine	lemma_40=little	lemma_16=%	relType_45=nmod	pos_13=NN	lemma_13=by	lemma_24=transport	relType_41=obj	relType_24=compound	pos_14=RB	relType_15=nummod	lemma_3=,	relType_4=punct	relType_30=conj	lemma_5=,	lemma_8=decrease	lemma_14=about	lemma_22=the	relType_33=punct	pos_35=-RRB-	pos_32=NN	lemma_32=indomethacin	relType_21=case	pos_28=NN	lemma_43=the	relType_30=punct	pos_3=,	relType_18=mark	relType_31=conj	relType_32=conj	pos_2=,	lemma_7=)	lemma_26=(	pos_40=JJ	lemma_1=,	pos_30=NNS	pos_37=JJ	pos_1=,	pos_20=VBN	lemma_13=pramipexole	pos_38=TO	relType_2=punct	lemma_34=and	relType_14=advmod	relation_12=adverse	lemma_23=anionic	lemma_33=,	relType_35=conj	wib=diltiazem	lemma_2=,	pos_12=IN	pos_27=NN	pos_31=,	pos_32=,	pos_6=CC	lemma_42=on	relType_39=xcomp	lemma_30=cephalosporin	relType_43=det	lemma_7=quinine	lemma_15=20	lemma_4=,	pos_16=NN	pos_7=-RRB-	relType_8=ccomp	relType_44=amod	relType_5=appos	relType_19=nsubj	pos_22=DT	pos_5=NN	pos_39=VB	pos_11=NN	relType_46=case	lemma_39=have	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_19=DT	pos_46=IN	pos_23=JJ	relType_4=appos	relType_17=punct	relType_12=case	pos_24=NN	relType_16=obl	relType_23=amod	lemma_44=oral	relType_11=obj	lemma_12=of	pos_44=JJ	pos_4=,	path=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_3=appos	lemma_29=,	pos_9=DT	pos_21=IN	pos_13=IN	lib=diltiazem	relType_20=advcl	lemma_33=hydrochlorothiazide	pos_18=IN	relType_13=case	pos_17=,	relation_51=neutral	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_36=VBP	lemma_19=that	pos_25=NN	lemma_11=clearance	pos_29=,	lemma_31=,	lemma_21=by	relType_35=punct	lemma_3=triamterene	pos_26=-LRB-	relType_22=det	lemma_9=the	lemma_4=verapamil	lemma_38=to	lemma_10=oral	lemma_46=of	pos_34=CC	lemma_18=while	path1=ranitidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	pos_43=DT	pos_33=NN	relType_7=conj	relType_6=cc	relType_27=compound	pos_45=NN	relType_10=amod	lemma_41=effect	lemma_36=be	lemma_30=,	lemma_27=e.	lemma_2=diltiazem	relType_13=nmod	pos_8=VBZ	lemma_17=,	relType_36=cop	relType_40=amod	relType_37=parataxis	pos_42=IN	lemma_37=likely	pos_4=NN	relType_31=punct	lemma_35=chlorpropamide	pos_10=JJ	relType_5=punct	lemma_6=and	lemma_20=secrete	lemma_32=,	relType_29=punct	pos_31=NNS	lemma_28=g.	lemma_45=clearance	relType_2=appos	relType_34=cc	eib=True	pos_3=NN	relType_7=punct	lpib=diltiazem_NN	lemma_31=penicillin	lemma_35=)	relType_42=case	relType_25=obl	relType_9=det
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e3	null	lpib=triamterene_NN	path=diltiazem_appos<g._dep>triamterene_appos	lemma_1=,	path1=diltiazem_appos	wib=triamterene	eib=False	path2=triamterene_appos	pos_1=,	relType_1=punct	lib=triamterene
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e4	null	lpib=triamterene_NN	lemma_1=,	relType_2=punct	pos_2=NN	path1=diltiazem_appos	eib=True	wib=triamterene	pos_1=,	pos_2=,	path=diltiazem_appos<g._dep>verapamil_appos	lemma_2=triamterene	relType_1=punct	relType_2=appos	path2=verapamil_appos	lemma_2=,	lib=triamterene
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e5	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=triamterene	relType_2=punct	lpib=triamterene_NN	path1=diltiazem_appos	relType_3=appos	lemma_3=verapamil	path=diltiazem_appos<g._dep>quinidine_appos	lemma_2=,	wib=triamterene	lemma_3=,	path2=quinidine_appos	relType_2=appos	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=triamterene
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e6	null	lemma_1=,	pos_2=NN	pos_5=CC	relType_4=appos	pos_1=,	lemma_2=triamterene	relType_2=punct	lpib=triamterene_NN	relType_5=cc	path1=diltiazem_appos	pos_4=,	relType_3=appos	lemma_3=verapamil	lemma_2=,	pos_4=NN	relType_4=punct	wib=triamterene	path2=quinine_conj	lemma_3=,	lemma_4=,	relType_2=appos	lemma_4=quinidine	pos_3=,	eib=True	path=diltiazem_appos<g._dep>quinine_conj	lemma_5=and	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lib=triamterene
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e7	mechanism	lemma_1=,	pos_7=VBZ	pos_2=NN	pos_8=DT	pos_5=CC	relType_4=appos	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	pos_1=,	lemma_6=quinine	lemma_2=triamterene	relType_11=case	relType_2=punct	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lpib=triamterene_NN	pos_6=NN	pos_9=JJ	relType_5=cc	relType_6=conj	pos_4=,	relType_3=appos	relType_6=punct	lemma_9=oral	relType_9=amod	pos_10=NN	lemma_3=verapamil	lemma_2=,	pos_4=NN	path2=clearance_obj>pramipexole_nmod	lemma_6=)	relType_10=obj	pos_11=IN	relType_4=punct	wib=triamterene	lemma_3=,	relation_10=adverse	lemma_8=the	lemma_7=decrease	lemma_4=,	relType_2=appos	pos_6=-RRB-	lemma_4=quinidine	pos_3=,	eib=True	lemma_5=and	pos_3=NN	relType_7=ccomp	lemma_11=of	pos_2=,	relType_8=det	lemma_10=clearance	relType_1=punct	relType_3=punct	lib=triamterene
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e8	null	pos_7=VBZ	pos_2=NN	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	pos_10=NN	lemma_14=20	lemma_16=,	lemma_19=secrete	relType_23=compound	lemma_13=about	relType_15=obl	relType_4=punct	lemma_3=,	lemma_12=pramipexole	relType_16=punct	lemma_21=the	pos_3=,	lemma_5=and	pos_2=,	lemma_28=,	pos_14=CD	lemma_1=,	lemma_20=by	pos_8=DT	lemma_23=transport	pos_1=,	lemma_6=quinine	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_9=oral	relType_12=nmod	lemma_3=verapamil	lemma_2=,	pos_12=IN	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	lemma_22=anionic	pos_27=NN	relType_13=advmod	lemma_18=that	relType_21=det	lemma_4=,	pos_6=-RRB-	lemma_4=quinidine	lemma_24=system	relType_25=punct	lemma_10=clearance	relType_1=punct	relType_10=obj	relType_3=punct	lib=triamterene	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	pos_20=IN	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	relType_3=appos	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	lemma_15=%	lemma_7=decrease	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	pos_5=CC	lemma_25=(	lemma_2=triamterene	pos_9=JJ	relType_6=punct	path2=secrete_advcl>g._dep>cephalosporin_conj	pos_16=,	pos_13=RB	pos_25=-LRB-	pos_4=NN	pos_28=,	pos_15=NN	wib=triamterene	relation_10=adverse	lemma_8=the	relType_2=appos	eib=True	pos_3=NN	pos_12=NN	pos_21=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e9	null	pos_7=VBZ	pos_2=NN	pos_29=NNS	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	lemma_16=,	lemma_14=20	pos_10=NN	lemma_19=secrete	relType_23=compound	lemma_13=about	relType_29=conj	relType_15=obl	relType_4=punct	lemma_3=,	lemma_12=pramipexole	relType_16=punct	lemma_21=the	pos_3=,	lemma_5=and	pos_2=,	lemma_28=,	pos_14=CD	lemma_1=,	lemma_20=by	pos_8=DT	lemma_23=transport	pos_1=,	lemma_6=quinine	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_9=oral	relType_12=nmod	lemma_3=verapamil	lemma_2=,	pos_12=IN	lemma_22=anionic	pos_27=NN	relType_13=advmod	lemma_18=that	relType_21=det	lemma_4=,	pos_6=-RRB-	lemma_4=quinidine	lemma_24=system	relType_25=punct	lemma_10=clearance	relType_1=punct	relType_10=obj	relType_3=punct	lib=triamterene	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	pos_20=IN	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	relType_3=appos	lemma_29=,	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	lemma_15=%	lemma_29=cephalosporin	lemma_7=decrease	pos_29=,	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	pos_5=CC	lemma_25=(	lemma_2=triamterene	pos_9=JJ	relType_6=punct	pos_16=,	pos_13=RB	pos_25=-LRB-	path2=secrete_advcl>g._dep>penicillin_conj	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	pos_4=NN	pos_28=,	pos_15=NN	wib=triamterene	relation_10=adverse	lemma_8=the	relType_29=punct	relType_2=appos	eib=True	pos_3=NN	pos_12=NN	pos_21=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e10	null	pos_7=VBZ	pos_2=NN	pos_29=NNS	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	pos_10=NN	lemma_14=20	lemma_16=,	lemma_19=secrete	relType_23=compound	lemma_13=about	relType_29=conj	relType_15=obl	relType_4=punct	lemma_3=,	relType_30=conj	lemma_12=pramipexole	relType_16=punct	lemma_21=the	lemma_30=penicillin	relType_30=punct	pos_3=,	lemma_5=and	pos_2=,	lemma_28=,	pos_14=CD	lemma_1=,	lemma_20=by	pos_8=DT	pos_30=NNS	lemma_23=transport	pos_1=,	lemma_6=quinine	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_9=oral	relType_12=nmod	lemma_3=verapamil	lemma_2=,	pos_12=IN	lemma_22=anionic	pos_27=NN	relType_13=advmod	lemma_18=that	relType_21=det	lemma_4=,	pos_6=-RRB-	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	lemma_4=quinidine	lemma_24=system	relType_25=punct	pos_30=,	lemma_10=clearance	relType_1=punct	relType_10=obj	relType_3=punct	lib=triamterene	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	path2=secrete_advcl>g._dep>indomethacin_conj	pos_20=IN	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	relType_3=appos	lemma_29=,	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	lemma_15=%	lemma_29=cephalosporin	lemma_7=decrease	pos_29=,	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	pos_5=CC	lemma_25=(	lemma_2=triamterene	lemma_30=,	pos_9=JJ	relType_6=punct	pos_16=,	pos_13=RB	pos_25=-LRB-	pos_4=NN	pos_28=,	pos_15=NN	wib=triamterene	relation_10=adverse	lemma_8=the	relType_29=punct	relType_2=appos	eib=True	pos_3=NN	pos_12=NN	pos_21=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e11	null	pos_7=VBZ	pos_2=NN	pos_29=NNS	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	pos_10=NN	lemma_14=20	lemma_16=,	lemma_19=secrete	relType_23=compound	lemma_13=about	relType_29=conj	relType_15=obl	relType_4=punct	lemma_3=,	relType_30=conj	lemma_12=pramipexole	relType_16=punct	lemma_21=the	lemma_30=penicillin	relType_30=punct	pos_3=,	lemma_5=and	relType_31=conj	pos_2=,	lemma_28=,	pos_14=CD	lemma_1=,	lemma_20=by	pos_8=DT	pos_30=NNS	lemma_23=transport	pos_1=,	lemma_6=quinine	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_9=oral	relType_12=nmod	lemma_3=verapamil	lemma_2=,	pos_12=IN	lemma_22=anionic	pos_27=NN	pos_31=,	relType_13=advmod	lemma_18=that	relType_21=det	lemma_4=,	pos_6=-RRB-	lemma_4=quinidine	lemma_24=system	pos_31=NN	relType_25=punct	pos_30=,	lemma_10=clearance	relType_1=punct	relType_10=obj	relType_3=punct	lib=triamterene	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	pos_20=IN	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	relType_3=appos	lemma_29=,	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	lemma_15=%	lemma_29=cephalosporin	lemma_7=decrease	pos_29=,	lemma_31=,	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	pos_5=CC	lemma_25=(	lemma_2=triamterene	lemma_30=,	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	pos_9=JJ	relType_6=punct	pos_16=,	pos_13=RB	pos_25=-LRB-	pos_4=NN	pos_28=,	relType_31=punct	pos_15=NN	wib=triamterene	relation_10=adverse	lemma_8=the	relType_29=punct	relType_2=appos	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	lemma_31=indomethacin	eib=True	pos_3=NN	pos_12=NN	pos_21=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e12	null	pos_7=VBZ	pos_2=NN	relType_32=punct	pos_29=NNS	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	pos_10=NN	lemma_14=20	lemma_16=,	lemma_19=secrete	relType_23=compound	lemma_13=about	relType_29=conj	relType_15=obl	relType_4=punct	lemma_3=,	relType_30=conj	pos_32=NN	lemma_12=pramipexole	relType_16=punct	lemma_21=the	lemma_30=penicillin	relType_30=punct	pos_3=,	lemma_5=and	relType_31=conj	relType_32=conj	pos_2=,	lemma_28=,	pos_14=CD	lemma_1=,	lemma_20=by	pos_8=DT	pos_30=NNS	lemma_23=transport	pos_1=,	lemma_6=quinine	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_9=oral	relType_12=nmod	lemma_3=verapamil	lemma_2=,	pos_12=IN	lemma_22=anionic	pos_27=NN	pos_31=,	relType_13=advmod	pos_32=,	lemma_18=that	relType_21=det	lemma_4=,	pos_6=-RRB-	lemma_4=quinidine	lemma_24=system	pos_31=NN	relType_25=punct	pos_30=,	lemma_10=clearance	relType_1=punct	relType_10=obj	relType_3=punct	lib=triamterene	lemma_33=and	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	pos_20=IN	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	relType_3=appos	lemma_29=,	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	lemma_15=%	lemma_29=cephalosporin	lemma_7=decrease	path2=secrete_advcl>g._dep>chlorpropamide_conj	pos_29=,	lemma_31=,	pos_33=CC	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	pos_5=CC	lemma_25=(	lemma_2=triamterene	lemma_30=,	pos_9=JJ	relType_6=punct	lemma_32=hydrochlorothiazide	relType_33=cc	pos_16=,	pos_13=RB	pos_25=-LRB-	pos_4=NN	pos_28=,	relType_31=punct	pos_15=NN	wib=triamterene	relation_10=adverse	lemma_8=the	lemma_32=,	relType_29=punct	relType_2=appos	lemma_31=indomethacin	eib=True	pos_3=NN	pos_12=NN	pos_21=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e2	DDI-DrugBank.d737.s6.e13	null	pos_7=VBZ	pos_2=NN	pos_34=NN	lemma_41=on	relType_42=det	relType_32=punct	relType_44=nmod	pos_29=NNS	pos_6=NN	lemma_26=e.	relType_5=cc	relType_6=conj	relType_28=punct	pos_26=NN	pos_10=NN	lemma_14=20	lemma_16=,	lemma_19=secrete	pos_42=DT	relType_23=compound	lemma_13=about	relType_29=conj	relType_15=obl	relType_4=punct	lemma_3=,	relType_30=conj	relType_40=obj	pos_32=NN	lemma_12=pramipexole	lemma_37=to	relType_35=cop	relType_16=punct	path=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_21=the	lemma_30=penicillin	path1=diltiazem_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	pos_3=,	relType_30=punct	lemma_5=and	relType_31=conj	relType_32=conj	pos_2=,	relType_34=conj	relType_34=punct	pos_39=JJ	lemma_28=,	lemma_39=little	pos_14=CD	lemma_36=likely	lemma_1=,	relType_36=parataxis	lemma_20=by	pos_8=DT	pos_30=NNS	lemma_23=transport	pos_1=,	lemma_6=quinine	lemma_45=of	relType_45=case	relType_11=case	relType_2=punct	lpib=triamterene_NN	pos_18=DT	relType_20=case	lemma_43=oral	lemma_9=oral	relType_12=nmod	lemma_34=chlorpropamide	pos_37=TO	lemma_3=verapamil	lemma_2=,	pos_12=IN	pos_44=NN	lemma_22=anionic	pos_27=NN	pos_31=,	relType_13=advmod	pos_32=,	lemma_18=that	lemma_42=the	relType_21=det	lemma_4=,	pos_35=VBP	pos_6=-RRB-	pos_43=JJ	lemma_4=quinidine	lemma_24=system	pos_31=NN	relType_25=punct	pos_40=NN	pos_30=,	lemma_10=clearance	relType_1=punct	lemma_44=clearance	relType_10=obj	relType_3=punct	lib=triamterene	lemma_40=effect	lemma_33=and	relType_24=obl	relType_4=appos	relType_12=case	pos_24=NN	lemma_38=have	pos_20=IN	pos_17=IN	relType_17=mark	pos_23=NN	pos_4=,	relType_3=appos	relType_38=xcomp	lemma_29=,	relType_26=compound	lemma_27=g.	relType_9=amod	lemma_17=while	lemma_6=)	pos_11=IN	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_45=IN	lemma_15=%	lemma_29=cephalosporin	lemma_7=decrease	pos_29=,	lemma_31=,	pos_33=CC	relType_19=advcl	relType_14=nummod	lemma_12=by	pos_22=JJ	relType_22=amod	relType_7=ccomp	lemma_11=of	relType_18=nsubj	pos_19=VBN	relType_8=det	relType_27=dep	relType_43=amod	pos_34=-RRB-	pos_5=CC	lemma_34=)	lemma_25=(	lemma_2=triamterene	lemma_30=,	pos_38=VB	pos_9=JJ	relation_49=neutral	relType_6=punct	pos_41=IN	lemma_32=hydrochlorothiazide	relType_33=cc	pos_16=,	pos_13=RB	pos_25=-LRB-	pos_4=NN	pos_28=,	relType_31=punct	relType_41=case	pos_15=NN	wib=triamterene	relation_10=adverse	pos_36=JJ	lemma_8=the	lemma_32=,	relType_29=punct	relType_37=mark	relType_2=appos	lemma_31=indomethacin	lemma_35=be	eib=True	pos_3=NN	pos_12=NN	pos_21=DT	relType_39=amod
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e4	null	lemma_1=,	eib=False	wib=verapamil	lib=verapamil	path1=triamterene_appos	pos_1=,	path=triamterene_appos<g._dep>verapamil_appos	lpib=verapamil_NN	relType_1=punct	path2=verapamil_appos
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e5	null	lemma_1=,	pos_2=NN	eib=True	wib=verapamil	lib=verapamil	path1=triamterene_appos	pos_1=,	pos_2=,	path2=quinidine_appos	path=triamterene_appos<g._dep>quinidine_appos	relType_1=punct	lpib=verapamil_NN	relType_2=appos	relType_2=punct	lemma_2=,	lemma_2=verapamil
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e6	null	lemma_1=,	pos_2=NN	path1=triamterene_appos	pos_1=,	relType_4=cc	lpib=verapamil_NN	relType_2=punct	relType_3=appos	wib=verapamil	lib=verapamil	lemma_2=,	lemma_2=verapamil	lemma_3=,	path2=quinine_conj	lemma_3=quinidine	relType_2=appos	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	path=triamterene_appos<g._dep>quinine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e7	mechanism	lemma_1=,	pos_2=NN	relType_7=det	relType_8=amod	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_1=,	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	lemma_10=of	pos_6=VBZ	relType_4=cc	lpib=verapamil_NN	relType_2=punct	pos_8=JJ	relation_8=adverse	relType_3=appos	wib=verapamil	lib=verapamil	relType_10=case	pos_9=NN	lemma_2=,	pos_7=DT	path2=clearance_obj>pramipexole_nmod	lemma_2=verapamil	lemma_5=)	lemma_8=oral	lemma_9=clearance	lemma_5=quinine	lemma_3=,	pos_5=-RRB-	relType_5=punct	lemma_3=quinidine	relType_6=ccomp	relType_9=obj	lemma_6=decrease	pos_10=IN	relType_2=appos	relType_5=conj	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	lemma_7=the	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e8	null	relType_22=compound	pos_2=NN	lemma_22=transport	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	pos_27=,	pos_8=JJ	lemma_11=pramipexole	lib=verapamil	pos_26=NN	lemma_12=about	lemma_2=verapamil	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_14=%	relType_18=advcl	relType_26=dep	pos_3=,	lemma_4=and	pos_2=,	lemma_1=,	pos_13=CD	pos_22=NN	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	relType_11=case	relType_2=punct	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	lemma_5=quinine	lemma_15=,	lemma_17=that	relType_6=ccomp	lemma_25=e.	pos_5=NN	pos_11=NN	relType_19=case	relType_11=nmod	relType_1=punct	relType_3=punct	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	relType_7=det	pos_17=DT	pos_16=IN	lemma_26=g.	relType_24=punct	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_14=obl	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	relType_9=obj	pos_25=NN	lemma_6=decrease	pos_10=IN	relType_5=conj	pos_18=VBN	pos_4=CC	relType_27=punct	relType_20=det	pos_19=IN	relType_8=amod	relType_4=cc	pos_20=DT	path2=secrete_advcl>g._dep>cephalosporin_conj	relType_21=amod	relType_10=case	lemma_16=while	relType_16=mark	relType_5=punct	lemma_3=quinidine	relType_2=appos	lemma_27=,	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e9	null	relType_22=compound	pos_2=NN	lemma_22=transport	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	pos_27=,	pos_8=JJ	lemma_11=pramipexole	relType_28=punct	lib=verapamil	pos_26=NN	lemma_12=about	lemma_2=verapamil	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_14=%	relType_18=advcl	relType_26=dep	pos_3=,	relType_28=conj	lemma_4=and	pos_2=,	lemma_28=,	lemma_1=,	pos_13=CD	pos_22=NN	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	relType_11=case	relType_2=punct	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	lemma_5=quinine	lemma_15=,	lemma_17=that	relType_6=ccomp	lemma_25=e.	pos_5=NN	pos_11=NN	relType_19=case	relType_11=nmod	relType_1=punct	relType_3=punct	relType_7=det	pos_17=DT	pos_16=IN	lemma_26=g.	relType_24=punct	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_14=obl	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	pos_28=NNS	relType_9=obj	pos_25=NN	lemma_6=decrease	pos_10=IN	relType_5=conj	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	pos_18=VBN	pos_4=CC	relType_27=punct	relType_20=det	pos_19=IN	lemma_28=cephalosporin	relType_8=amod	relType_4=cc	pos_20=DT	relType_21=amod	relType_10=case	path2=secrete_advcl>g._dep>penicillin_conj	pos_28=,	lemma_16=while	relType_16=mark	relType_5=punct	lemma_3=quinidine	relType_2=appos	lemma_27=,	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e10	null	relType_22=compound	pos_2=NN	lemma_22=transport	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	pos_29=NNS	pos_27=,	pos_8=JJ	lemma_11=pramipexole	relType_28=punct	lib=verapamil	pos_26=NN	lemma_12=about	lemma_2=verapamil	relType_29=conj	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_29=penicillin	lemma_14=%	relType_18=advcl	relType_26=dep	pos_3=,	relType_28=conj	lemma_4=and	pos_2=,	lemma_28=,	lemma_1=,	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	pos_13=CD	pos_22=NN	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	relType_11=case	relType_2=punct	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	lemma_5=quinine	lemma_15=,	lemma_17=that	relType_6=ccomp	lemma_25=e.	pos_5=NN	pos_11=NN	relType_19=case	relType_11=nmod	relType_1=punct	relType_3=punct	relType_7=det	pos_17=DT	pos_16=IN	lemma_26=g.	relType_24=punct	path2=secrete_advcl>g._dep>indomethacin_conj	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	lemma_29=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_14=obl	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	pos_28=NNS	relType_9=obj	pos_25=NN	lemma_6=decrease	pos_29=,	pos_10=IN	relType_5=conj	pos_18=VBN	pos_4=CC	relType_27=punct	relType_20=det	pos_19=IN	lemma_28=cephalosporin	relType_8=amod	relType_4=cc	pos_20=DT	relType_21=amod	relType_10=case	pos_28=,	lemma_16=while	relType_16=mark	relType_5=punct	lemma_3=quinidine	relType_29=punct	relType_2=appos	lemma_27=,	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e11	null	relType_22=compound	pos_2=NN	lemma_22=transport	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	pos_29=NNS	pos_27=,	pos_8=JJ	lemma_11=pramipexole	relType_28=punct	lib=verapamil	pos_26=NN	lemma_12=about	lemma_30=indomethacin	lemma_2=verapamil	relType_29=conj	relType_30=conj	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_29=penicillin	lemma_14=%	relType_18=advcl	relType_26=dep	pos_3=,	relType_30=punct	relType_28=conj	lemma_4=and	pos_2=,	lemma_28=,	lemma_1=,	pos_13=CD	pos_22=NN	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	relType_11=case	relType_2=punct	pos_30=NN	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	lemma_5=quinine	lemma_15=,	lemma_17=that	relType_6=ccomp	lemma_25=e.	pos_5=NN	pos_11=NN	relType_19=case	pos_30=,	relType_11=nmod	relType_1=punct	relType_3=punct	relType_7=det	pos_17=DT	pos_16=IN	lemma_26=g.	relType_24=punct	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	lemma_29=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_14=obl	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	pos_28=NNS	relType_9=obj	pos_25=NN	lemma_6=decrease	pos_29=,	pos_10=IN	relType_5=conj	pos_18=VBN	pos_4=CC	relType_27=punct	relType_20=det	pos_19=IN	lemma_28=cephalosporin	relType_8=amod	relType_4=cc	pos_20=DT	lemma_30=,	relType_21=amod	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	relType_10=case	pos_28=,	lemma_16=while	relType_16=mark	relType_5=punct	lemma_3=quinidine	relType_29=punct	relType_2=appos	lemma_27=,	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e12	null	relType_22=compound	pos_2=NN	lemma_22=transport	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	lemma_31=hydrochlorothiazide	pos_29=NNS	pos_27=,	pos_32=CC	pos_8=JJ	lemma_11=pramipexole	relType_28=punct	lib=verapamil	pos_26=NN	lemma_12=about	lemma_30=indomethacin	lemma_2=verapamil	relType_29=conj	relType_30=conj	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_29=penicillin	lemma_14=%	relType_18=advcl	relType_26=dep	pos_3=,	relType_30=punct	relType_28=conj	lemma_4=and	relType_31=conj	pos_2=,	lemma_28=,	lemma_1=,	pos_13=CD	pos_22=NN	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	relType_11=case	relType_2=punct	pos_30=NN	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	lemma_32=and	lemma_5=quinine	pos_31=,	lemma_15=,	lemma_17=that	relType_6=ccomp	lemma_25=e.	pos_5=NN	pos_11=NN	pos_31=NN	relType_19=case	pos_30=,	relType_11=nmod	relType_1=punct	relType_3=punct	relType_7=det	pos_17=DT	pos_16=IN	lemma_26=g.	relType_24=punct	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	lemma_29=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_32=cc	relType_14=obl	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	pos_28=NNS	relType_9=obj	pos_25=NN	path2=secrete_advcl>g._dep>chlorpropamide_conj	lemma_6=decrease	pos_10=IN	relType_5=conj	pos_29=,	lemma_31=,	pos_18=VBN	pos_4=CC	relType_27=punct	relType_20=det	pos_19=IN	lemma_28=cephalosporin	relType_8=amod	relType_4=cc	pos_20=DT	lemma_30=,	relType_21=amod	relType_10=case	pos_28=,	relType_31=punct	lemma_16=while	relType_16=mark	relType_5=punct	lemma_3=quinidine	relType_29=punct	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	relType_2=appos	lemma_27=,	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e3	DDI-DrugBank.d737.s6.e13	null	lemma_34=be	relType_22=compound	relType_33=conj	pos_2=NN	lemma_22=transport	pos_39=NN	lemma_10=of	pos_6=VBZ	lpib=verapamil_NN	lemma_31=hydrochlorothiazide	pos_29=NNS	pos_27=,	pos_32=CC	pos_8=JJ	lemma_11=pramipexole	relType_28=punct	lib=verapamil	pos_26=NN	lemma_12=about	lemma_30=indomethacin	lemma_2=verapamil	relType_37=xcomp	relType_29=conj	relType_30=conj	lemma_3=,	pos_5=-RRB-	lemma_11=by	pos_12=RB	lemma_29=penicillin	relType_33=punct	pos_42=JJ	lemma_14=%	pos_40=IN	relType_42=amod	relType_18=advcl	relType_26=dep	pos_3=,	relType_30=punct	lemma_38=little	relType_28=conj	lemma_4=and	relType_31=conj	pos_2=,	lemma_44=of	lemma_28=,	pos_41=DT	lemma_1=,	pos_13=CD	pos_22=NN	pos_21=JJ	lemma_23=system	pos_1=,	pos_24=-LRB-	lemma_33=chlorpropamide	relType_11=case	relType_2=punct	pos_30=NN	pos_35=JJ	lemma_41=the	lemma_20=the	relType_23=obl	pos_9=NN	lemma_21=anionic	lemma_2=,	lemma_9=clearance	lemma_5=)	lemma_8=oral	pos_38=JJ	lemma_32=and	lemma_5=quinine	pos_31=,	lemma_15=,	lemma_17=that	relType_40=case	relType_6=ccomp	relType_35=parataxis	lemma_25=e.	pos_5=NN	pos_11=NN	pos_31=NN	relType_19=case	pos_30=,	relType_11=nmod	relType_1=punct	relType_3=punct	relType_38=amod	lemma_39=effect	relType_7=det	pos_17=DT	pos_16=IN	pos_44=IN	lemma_26=g.	relType_24=punct	relType_43=nmod	lemma_18=secrete	pos_23=NN	lemma_19=by	relation_47=neutral	relType_39=obj	relation_8=adverse	relType_3=appos	relType_12=advmod	wib=verapamil	pos_15=,	lemma_29=,	relType_13=nummod	relType_17=nsubj	pos_14=NN	relType_32=cc	relType_14=obl	pos_36=TO	relType_15=punct	pos_7=DT	pos_11=IN	relType_25=compound	pos_28=NNS	lemma_42=oral	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	path=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_9=obj	pos_25=NN	pos_37=VB	lemma_6=decrease	pos_29=,	pos_10=IN	relType_5=conj	lemma_31=,	pos_43=NN	pos_18=VBN	pos_4=CC	relType_44=case	relType_27=punct	relType_20=det	pos_33=NN	lemma_43=clearance	pos_19=IN	lemma_28=cephalosporin	relType_8=amod	pos_33=-RRB-	lemma_35=likely	relType_4=cc	pos_20=DT	lemma_30=,	lemma_40=on	lemma_33=)	relType_21=amod	relType_41=det	relType_10=case	pos_28=,	relType_31=punct	lemma_37=have	lemma_16=while	relType_36=mark	relType_16=mark	relType_5=punct	relType_34=cop	lemma_3=quinidine	lemma_36=to	relType_29=punct	relType_2=appos	lemma_27=,	eib=True	pos_3=NN	lemma_13=20	lemma_24=(	lemma_7=the	path1=triamterene_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	pos_34=VBP
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e5	null	path=verapamil_appos<g._dep>quinidine_appos	lpib=quinidine_NN	lib=quinidine	lemma_1=,	path1=verapamil_appos	eib=False	pos_1=,	path2=quinidine_appos	relType_1=punct	wib=quinidine
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e6	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	path=verapamil_appos<g._dep>quinine_conj	relType_3=cc	relType_2=punct	lpib=quinidine_NN	lib=quinidine	path1=verapamil_appos	lemma_2=,	path2=quinine_conj	relType_2=appos	wib=quinidine	lemma_2=quinidine	eib=True	pos_2=,	lemma_3=and	relType_1=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e7	mechanism	lemma_1=,	pos_2=NN	pos_5=VBZ	pos_3=CC	pos_6=DT	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_1=,	lemma_7=oral	pos_9=IN	relType_2=punct	relType_3=cc	pos_8=NN	lpib=quinidine_NN	lib=quinidine	lemma_6=the	relation_6=adverse	pos_4=-RRB-	relType_8=obj	relType_9=case	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	pos_4=NN	lemma_2=,	path2=clearance_obj>pramipexole_nmod	relType_7=amod	relType_4=punct	lemma_4=)	relType_2=appos	lemma_4=quinine	wib=quinidine	relType_5=ccomp	relType_6=det	lemma_2=quinidine	eib=True	lemma_5=decrease	lemma_9=of	pos_7=JJ	pos_2=,	lemma_3=and	relType_4=conj	lemma_8=clearance	relType_1=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e8	null	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_12=CD	pos_16=DT	relType_18=case	relType_10=nmod	relType_15=mark	relation_6=adverse	pos_4=-RRB-	relType_9=case	pos_10=NN	pos_13=NN	pos_20=JJ	relType_24=compound	relType_4=punct	relType_17=advcl	lemma_18=by	lemma_4=)	lemma_10=pramipexole	pos_11=RB	relType_5=ccomp	lemma_5=decrease	lemma_23=(	pos_7=JJ	lemma_17=secrete	pos_2=,	relType_19=det	relType_22=obl	lemma_1=,	pos_22=NN	pos_1=,	lemma_10=by	relType_3=cc	relType_2=punct	pos_8=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	pos_15=IN	relType_6=det	lemma_14=,	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	relType_26=punct	relType_1=punct	pos_19=DT	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_7=oral	pos_24=NN	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	lemma_6=the	pos_14=,	relType_8=obj	pos_18=IN	relType_7=amod	pos_25=NN	relType_16=nsubj	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_23=punct	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	pos_9=IN	lpib=quinidine_NN	lib=quinidine	lemma_13=%	path2=secrete_advcl>g._dep>cephalosporin_conj	relType_10=case	lemma_19=the	pos_4=NN	lemma_24=e.	relType_2=appos	wib=quinidine	eib=True	lemma_9=of	pos_26=,	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e9	null	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_12=CD	pos_16=DT	pos_27=,	relType_18=case	relType_10=nmod	relType_15=mark	relation_6=adverse	pos_4=-RRB-	relType_9=case	pos_10=NN	pos_13=NN	pos_20=JJ	relType_24=compound	relType_4=punct	relType_17=advcl	lemma_18=by	lemma_4=)	lemma_27=cephalosporin	lemma_10=pramipexole	pos_11=RB	relType_5=ccomp	lemma_5=decrease	lemma_23=(	pos_7=JJ	lemma_17=secrete	pos_2=,	relType_19=det	relType_22=obl	lemma_1=,	pos_22=NN	pos_1=,	relType_27=conj	lemma_10=by	relType_2=punct	relType_3=cc	pos_8=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	pos_15=IN	relType_6=det	lemma_14=,	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	relType_26=punct	relType_1=punct	pos_19=DT	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_7=oral	pos_24=NN	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	pos_27=NNS	lemma_6=the	pos_14=,	relType_8=obj	pos_18=IN	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	relType_7=amod	pos_25=NN	relType_16=nsubj	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_27=punct	relType_23=punct	pos_9=IN	lpib=quinidine_NN	lib=quinidine	lemma_13=%	relType_10=case	path2=secrete_advcl>g._dep>penicillin_conj	lemma_19=the	pos_4=NN	lemma_24=e.	relType_2=appos	lemma_27=,	wib=quinidine	eib=True	lemma_9=of	pos_26=,	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e10	null	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_12=CD	pos_16=DT	pos_27=,	relType_18=case	relType_10=nmod	relType_28=punct	relType_15=mark	relation_6=adverse	pos_4=-RRB-	relType_9=case	pos_10=NN	pos_13=NN	pos_20=JJ	relType_24=compound	relType_4=punct	relType_17=advcl	lemma_18=by	lemma_4=)	lemma_27=cephalosporin	lemma_10=pramipexole	pos_11=RB	relType_5=ccomp	lemma_5=decrease	lemma_23=(	relType_28=conj	pos_7=JJ	lemma_17=secrete	pos_2=,	relType_19=det	lemma_28=,	relType_22=obl	lemma_1=,	pos_22=NN	pos_1=,	relType_27=conj	lemma_10=by	relType_2=punct	relType_3=cc	pos_8=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	pos_15=IN	relType_6=det	lemma_14=,	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	relType_26=punct	relType_1=punct	pos_19=DT	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_7=oral	pos_24=NN	path2=secrete_advcl>g._dep>indomethacin_conj	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	pos_27=NNS	lemma_6=the	pos_14=,	relType_8=obj	pos_18=IN	pos_28=NNS	relType_7=amod	pos_25=NN	relType_16=nsubj	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_27=punct	relType_23=punct	lemma_28=penicillin	pos_9=IN	lpib=quinidine_NN	lib=quinidine	lemma_13=%	relType_10=case	lemma_19=the	pos_4=NN	pos_28=,	lemma_24=e.	relType_2=appos	lemma_27=,	wib=quinidine	eib=True	lemma_9=of	pos_26=,	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e11	null	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_12=CD	pos_16=DT	lemma_29=indomethacin	pos_27=,	relType_18=case	relType_10=nmod	relType_28=punct	relType_15=mark	relation_6=adverse	pos_4=-RRB-	relType_9=case	pos_10=NN	pos_13=NN	pos_20=JJ	relType_29=conj	relType_24=compound	relType_4=punct	relType_17=advcl	lemma_18=by	lemma_4=)	lemma_27=cephalosporin	lemma_10=pramipexole	pos_11=RB	relType_5=ccomp	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	lemma_5=decrease	lemma_23=(	relType_28=conj	pos_7=JJ	lemma_17=secrete	pos_2=,	relType_19=det	lemma_28=,	relType_22=obl	lemma_1=,	pos_22=NN	pos_1=,	relType_27=conj	lemma_10=by	relType_3=cc	relType_2=punct	pos_8=NN	pos_29=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	pos_15=IN	relType_6=det	lemma_14=,	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	relType_26=punct	relType_1=punct	pos_19=DT	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_7=oral	pos_24=NN	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	pos_27=NNS	lemma_29=,	lemma_6=the	pos_14=,	relType_8=obj	pos_18=IN	pos_28=NNS	relType_7=amod	pos_25=NN	relType_16=nsubj	pos_29=,	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_27=punct	relType_23=punct	lemma_28=penicillin	pos_9=IN	lpib=quinidine_NN	lib=quinidine	lemma_13=%	relType_10=case	lemma_19=the	pos_4=NN	pos_28=,	lemma_24=e.	relType_29=punct	relType_2=appos	lemma_27=,	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	wib=quinidine	eib=True	lemma_9=of	pos_26=,	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e12	null	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_12=CD	pos_16=DT	lemma_29=indomethacin	pos_27=,	relType_18=case	relType_10=nmod	relType_28=punct	relType_15=mark	relation_6=adverse	pos_4=-RRB-	relType_9=case	pos_10=NN	pos_13=NN	pos_20=JJ	relType_29=conj	relType_24=compound	relType_30=conj	relType_4=punct	relType_17=advcl	lemma_18=by	lemma_4=)	lemma_27=cephalosporin	lemma_10=pramipexole	pos_11=RB	pos_31=CC	relType_5=ccomp	relType_30=punct	lemma_5=decrease	lemma_23=(	relType_28=conj	pos_7=JJ	lemma_17=secrete	pos_2=,	lemma_30=hydrochlorothiazide	relType_19=det	lemma_28=,	relType_22=obl	lemma_31=and	lemma_1=,	pos_22=NN	pos_1=,	relType_27=conj	lemma_10=by	relType_31=cc	relType_3=cc	relType_2=punct	pos_30=NN	pos_8=NN	pos_29=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	pos_15=IN	relType_6=det	lemma_14=,	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	pos_30=,	relType_26=punct	relType_1=punct	pos_19=DT	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_7=oral	pos_24=NN	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	pos_27=NNS	lemma_29=,	lemma_6=the	pos_14=,	relType_8=obj	pos_18=IN	pos_28=NNS	relType_7=amod	pos_25=NN	relType_16=nsubj	path2=secrete_advcl>g._dep>chlorpropamide_conj	pos_29=,	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_27=punct	relType_23=punct	lemma_28=penicillin	pos_9=IN	lemma_30=,	lpib=quinidine_NN	lib=quinidine	lemma_13=%	relType_10=case	lemma_19=the	pos_4=NN	pos_28=,	lemma_24=e.	relType_29=punct	relType_2=appos	lemma_27=,	wib=quinidine	eib=True	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	lemma_9=of	pos_26=,	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e4	DDI-DrugBank.d737.s6.e13	null	pos_33=VBP	pos_23=-LRB-	lemma_12=20	pos_2=NN	pos_3=CC	pos_12=CD	pos_16=DT	relType_32=punct	lemma_29=indomethacin	lemma_40=the	pos_27=,	relType_18=case	path1=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	relType_10=nmod	relType_28=punct	relType_15=mark	lemma_37=little	relation_6=adverse	pos_4=-RRB-	pos_35=TO	lemma_41=oral	relType_9=case	pos_10=NN	pos_13=NN	relType_37=amod	relation_45=neutral	pos_20=JJ	relType_29=conj	relType_24=compound	lemma_43=of	relType_30=conj	relType_4=punct	lemma_35=to	relType_17=advcl	lemma_18=by	pos_32=NN	lemma_4=)	lemma_27=cephalosporin	lemma_10=pramipexole	pos_11=RB	lemma_32=)	pos_31=CC	pos_36=VB	relType_41=amod	relType_5=ccomp	relType_30=punct	lemma_5=decrease	lemma_23=(	relType_28=conj	relType_32=conj	pos_7=JJ	lemma_17=secrete	pos_2=,	lemma_30=hydrochlorothiazide	relType_19=det	lemma_28=,	lemma_39=on	lemma_42=clearance	relType_22=obl	lemma_31=and	pos_40=DT	lemma_1=,	relType_33=cop	pos_22=NN	pos_37=JJ	pos_1=,	relType_27=conj	lemma_10=by	relType_31=cc	relType_43=case	relType_3=cc	relType_2=punct	pos_30=NN	pos_8=NN	pos_41=JJ	relType_35=mark	pos_29=NN	lemma_15=while	relType_11=advmod	lemma_2=,	relType_21=compound	lemma_4=quinine	pos_15=IN	relType_6=det	lemma_14=,	pos_42=NN	lemma_20=anionic	lemma_11=about	lemma_3=and	relType_25=dep	pos_30=,	relType_26=punct	relType_1=punct	pos_32=-RRB-	pos_19=DT	path=verapamil_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_14=punct	pos_5=VBZ	lemma_25=g.	pos_6=DT	lemma_33=be	lemma_7=oral	pos_24=NN	pos_17=VBN	lemma_16=that	relType_13=obl	relType_20=amod	lemma_22=system	pos_27=NNS	lemma_29=,	lemma_6=the	pos_14=,	relType_8=obj	lemma_34=likely	pos_18=IN	pos_28=NNS	relType_7=amod	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_38=NN	pos_25=NN	relType_16=nsubj	pos_29=,	pos_34=JJ	pos_10=IN	lemma_2=quinidine	lemma_21=transport	relType_27=punct	relType_39=case	pos_39=IN	relType_23=punct	lemma_36=have	relType_36=xcomp	pos_43=IN	lemma_28=penicillin	pos_9=IN	lemma_30=,	lpib=quinidine_NN	lib=quinidine	lemma_13=%	relType_34=parataxis	relType_42=nmod	relType_10=case	lemma_19=the	pos_4=NN	pos_28=,	lemma_24=e.	relType_29=punct	relType_2=appos	lemma_27=,	wib=quinidine	lemma_32=chlorpropamide	relType_38=obj	eib=True	lemma_9=of	pos_26=,	lemma_38=effect	relType_4=conj	relType_12=nummod	lemma_8=clearance	lemma_26=,	relType_40=det	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e6	null	lemma_2=and	path1=quinidine_appos	lemma_1=,	path2=quinine_conj	lpib=quinine_NN	eib=False	pos_2=CC	lib=quinine	pos_1=,	path=quinidine_appos<g._dep>quinine_conj	relType_1=punct	relType_2=cc	wib=quinine
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e7	mechanism	relType_8=case	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_1=,	pos_6=JJ	relation_4=adverse	pos_1=,	relType_2=cc	lemma_2=and	lemma_7=clearance	relType_6=amod	relType_7=obj	pos_8=IN	path2=clearance_obj>pramipexole_nmod	wib=quinine	lemma_3=quinine	lemma_6=oral	lpib=quinine_NN	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	lemma_3=)	lemma_5=the	eib=True	pos_3=-RRB-	pos_3=NN	pos_2=CC	pos_5=DT	relType_1=punct	pos_7=NN	lemma_8=of	relType_3=punct	pos_4=VBZ	lemma_4=decrease
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e8	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	lemma_2=and	lemma_9=by	pos_20=NN	relType_9=case	lemma_14=while	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	pos_16=VBN	lpib=quinine_NN	lemma_25=,	lemma_22=(	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	pos_1=,	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	lemma_15=that	pos_9=NN	pos_8=IN	pos_14=IN	relType_19=amod	pos_11=CD	lemma_20=transport	relType_21=obl	lemma_5=the	pos_3=-RRB-	relType_25=punct	relType_18=det	pos_10=RB	relType_1=punct	pos_7=NN	relType_3=punct	lemma_18=the	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_24=NN	lemma_24=g.	pos_17=IN	pos_23=NN	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	relType_7=obj	lemma_17=by	relType_17=case	lemma_3=quinine	lemma_6=oral	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	lemma_9=pramipexole	pos_5=DT	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	path2=secrete_advcl>g._dep>cephalosporin_conj	relType_6=amod	lemma_23=e.	relType_10=advmod	relType_24=dep	lemma_16=secrete	lemma_19=anionic	lemma_3=)	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_2=CC	pos_12=NN	lemma_8=of	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e9	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	lemma_2=and	lemma_9=by	pos_20=NN	relType_9=case	lemma_14=while	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	pos_16=VBN	lpib=quinine_NN	lemma_25=,	lemma_22=(	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	pos_1=,	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	pos_26=NNS	lemma_15=that	pos_9=NN	pos_8=IN	pos_14=IN	relType_19=amod	lemma_26=cephalosporin	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	pos_11=CD	lemma_20=transport	relType_21=obl	lemma_5=the	pos_3=-RRB-	relType_25=punct	relType_18=det	pos_10=RB	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_18=the	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_24=NN	lemma_24=g.	pos_17=IN	pos_23=NN	relType_7=obj	lemma_17=by	relType_17=case	lemma_3=quinine	lemma_6=oral	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	lemma_9=pramipexole	pos_5=DT	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	relType_26=conj	relType_6=amod	lemma_23=e.	relType_10=advmod	path2=secrete_advcl>g._dep>penicillin_conj	relType_24=dep	lemma_16=secrete	lemma_19=anionic	lemma_3=)	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_2=CC	pos_26=,	lemma_26=,	pos_12=NN	lemma_8=of	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e10	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	pos_27=,	lemma_2=and	lemma_9=by	pos_20=NN	relType_9=case	lemma_14=while	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	pos_16=VBN	lpib=quinine_NN	lemma_25=,	lemma_22=(	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	pos_1=,	relType_27=conj	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	pos_26=NNS	lemma_15=that	pos_9=NN	pos_8=IN	pos_14=IN	relType_19=amod	lemma_26=cephalosporin	pos_11=CD	lemma_20=transport	relType_21=obl	lemma_5=the	pos_3=-RRB-	relType_25=punct	relType_18=det	lemma_27=penicillin	pos_10=RB	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_18=the	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_24=NN	path2=secrete_advcl>g._dep>indomethacin_conj	lemma_24=g.	pos_17=IN	pos_23=NN	pos_27=NNS	relType_7=obj	lemma_17=by	relType_17=case	lemma_3=quinine	lemma_6=oral	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	lemma_9=pramipexole	pos_5=DT	relType_27=punct	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	relType_26=conj	relType_6=amod	lemma_23=e.	relType_10=advmod	relType_24=dep	lemma_16=secrete	lemma_19=anionic	lemma_27=,	lemma_3=)	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_2=CC	pos_26=,	lemma_26=,	pos_12=NN	lemma_8=of	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e11	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	pos_27=,	lemma_2=and	lemma_9=by	relType_28=punct	pos_20=NN	relType_9=case	lemma_14=while	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	pos_16=VBN	lpib=quinine_NN	lemma_25=,	lemma_22=(	pos_28=NN	relType_28=conj	lemma_28=,	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	pos_1=,	relType_27=conj	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	pos_26=NNS	lemma_15=that	pos_9=NN	pos_8=IN	pos_14=IN	relType_19=amod	lemma_26=cephalosporin	pos_11=CD	lemma_20=transport	relType_21=obl	lemma_5=the	pos_3=-RRB-	relType_25=punct	relType_18=det	lemma_27=penicillin	pos_10=RB	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_18=the	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_24=NN	lemma_24=g.	pos_17=IN	pos_23=NN	pos_27=NNS	relType_7=obj	lemma_17=by	relType_17=case	lemma_3=quinine	lemma_6=oral	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	lemma_9=pramipexole	lemma_28=indomethacin	pos_5=DT	relType_27=punct	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	relType_26=conj	relType_6=amod	lemma_23=e.	relType_10=advmod	relType_24=dep	pos_28=,	lemma_16=secrete	lemma_19=anionic	lemma_27=,	lemma_3=)	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_2=CC	pos_26=,	lemma_26=,	pos_12=NN	lemma_8=of	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e12	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	pos_27=,	lemma_2=and	lemma_9=by	relType_28=punct	relType_30=cc	pos_20=NN	relType_9=case	lemma_14=while	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	relType_29=conj	pos_16=VBN	lpib=quinine_NN	lemma_25=,	lemma_22=(	pos_28=NN	relType_28=conj	lemma_28=,	lemma_29=hydrochlorothiazide	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	pos_1=,	relType_27=conj	pos_30=CC	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	pos_26=NNS	pos_29=NN	lemma_15=that	pos_9=NN	pos_8=IN	pos_14=IN	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	relType_19=amod	lemma_26=cephalosporin	pos_11=CD	lemma_20=transport	relType_21=obl	lemma_5=the	pos_3=-RRB-	relType_25=punct	relType_18=det	lemma_27=penicillin	pos_10=RB	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_18=the	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_24=NN	lemma_24=g.	pos_17=IN	pos_23=NN	pos_27=NNS	lemma_29=,	relType_7=obj	lemma_17=by	relType_17=case	lemma_3=quinine	lemma_6=oral	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	path2=secrete_advcl>g._dep>chlorpropamide_conj	pos_29=,	lemma_9=pramipexole	lemma_28=indomethacin	pos_5=DT	relType_27=punct	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	relType_26=conj	relType_6=amod	lemma_23=e.	relType_10=advmod	relType_24=dep	pos_28=,	lemma_16=secrete	relType_29=punct	lemma_19=anionic	lemma_27=,	lemma_3=)	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	pos_2=CC	pos_26=,	lemma_26=,	lemma_30=and	pos_12=NN	lemma_8=of	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e5	DDI-DrugBank.d737.s6.e13	null	pos_6=JJ	lemma_13=,	lemma_12=%	relType_2=cc	pos_41=NN	pos_27=,	lemma_32=be	lemma_37=effect	lemma_2=and	lemma_9=by	relType_28=punct	relType_30=cc	pos_34=TO	pos_20=NN	relType_9=case	lemma_14=while	lemma_31=)	pos_15=DT	wib=quinine	relType_22=punct	relType_23=compound	relType_29=conj	lemma_31=chlorpropamide	relType_32=cop	pos_16=VBN	lpib=quinine_NN	pos_31=-RRB-	lemma_25=,	path1=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	lemma_22=(	pos_38=IN	pos_28=NN	relType_28=conj	path=quinidine_appos<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_31=conj	lemma_28=,	lemma_29=hydrochlorothiazide	pos_40=JJ	relType_8=case	pos_13=,	lemma_1=,	relType_16=advcl	relation_4=adverse	relType_15=nsubj	relType_34=mark	pos_1=,	relType_27=conj	pos_30=CC	pos_18=DT	lemma_7=clearance	pos_19=JJ	lemma_10=about	pos_26=NNS	pos_29=NN	lemma_15=that	pos_9=NN	pos_8=IN	lemma_39=the	pos_14=IN	lemma_38=on	pos_37=NN	relType_35=xcomp	relType_33=parataxis	relType_37=obj	relType_36=amod	relType_39=det	relType_19=amod	lemma_26=cephalosporin	pos_11=CD	lemma_20=transport	lemma_34=to	relType_21=obl	lemma_36=little	lemma_5=the	pos_32=VBP	pos_31=NN	pos_3=-RRB-	relType_25=punct	relType_18=det	lemma_27=penicillin	pos_10=RB	relType_26=punct	relType_1=punct	pos_7=NN	pos_35=VB	relType_3=punct	lemma_18=the	relType_38=case	pos_24=NN	lemma_24=g.	lemma_35=have	lemma_40=oral	pos_17=IN	pos_23=NN	pos_27=NNS	lemma_29=,	relType_7=obj	lemma_17=by	lemma_41=clearance	relType_17=case	relType_41=nmod	lemma_3=quinine	lemma_6=oral	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_11=nummod	relType_3=conj	relType_4=ccomp	relType_5=det	lib=quinine	lemma_11=20	relType_14=mark	pos_29=,	lemma_9=pramipexole	lemma_28=indomethacin	pos_5=DT	relType_27=punct	lemma_42=of	relType_12=obl	pos_25=,	relType_13=punct	pos_9=IN	relType_9=nmod	lemma_21=system	relType_40=amod	relType_26=conj	lemma_33=likely	relType_6=amod	lemma_23=e.	relType_10=advmod	pos_42=IN	pos_39=DT	relType_24=dep	pos_28=,	lemma_16=secrete	relType_31=punct	pos_36=JJ	relType_29=punct	lemma_19=anionic	pos_33=JJ	lemma_27=,	lemma_3=)	pos_22=-LRB-	eib=True	relType_20=compound	pos_3=NN	relation_43=neutral	pos_2=CC	pos_26=,	lemma_26=,	lemma_30=and	pos_12=NN	lemma_8=of	relType_42=case	pos_4=VBZ	lemma_4=decrease	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e7	mechanism	relType_4=amod	pos_4=JJ	lemma_6=of	lemma_1=)	relType_6=case	eib=False	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	relation_1=adverse	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>clearance_obj>pramipexole_nmod	relType_3=det	wib=decreases	path2=clearance_obj>pramipexole_nmod	pos_1=-RRB-	lemma_5=clearance	relType_2=ccomp	pos_2=VBZ	pos_5=NN	lemma_4=oral	pos_3=DT	relType_5=obj	lemma_3=the	lemma_2=decrease	relType_1=punct	lib=decrease	lpib=decrease_VBZ
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e8	null	pos_20=-LRB-	pos_16=DT	relType_22=dep	lemma_16=the	relType_9=nummod	lemma_17=anionic	relType_12=mark	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_4=amod	relType_7=case	pos_22=NN	relType_14=advcl	relType_6=case	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	relType_3=det	pos_12=IN	lemma_21=e.	relType_15=case	relType_13=nsubj	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_1=punct	pos_7=NN	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	lemma_6=of	pos_8=RB	relType_11=punct	lemma_22=g.	relation_1=adverse	lemma_8=about	wib=decreases	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	lemma_15=by	lemma_7=pramipexole	pos_2=VBZ	pos_9=CD	relType_20=punct	relType_10=obl	lpib=decrease_VBZ	relType_23=punct	pos_4=JJ	pos_13=DT	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	path2=secrete_advcl>g._dep>cephalosporin_conj	pos_19=NN	lemma_13=that	pos_11=,	relType_2=ccomp	eib=True	pos_3=DT	pos_23=,	relType_18=compound	lemma_3=the	lemma_2=decrease	lemma_19=system	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e9	null	pos_20=-LRB-	pos_24=,	pos_16=DT	relType_22=dep	lemma_24=,	lemma_16=the	relType_9=nummod	lemma_17=anionic	relType_12=mark	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	pos_24=NNS	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_4=amod	relType_7=case	pos_22=NN	relType_14=advcl	relType_6=case	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	relType_3=det	pos_12=IN	lemma_21=e.	relType_15=case	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	relType_13=nsubj	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_1=punct	pos_7=NN	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	relType_24=punct	lemma_6=of	pos_8=RB	relType_11=punct	lemma_22=g.	relation_1=adverse	lemma_8=about	wib=decreases	lemma_15=by	lemma_7=pramipexole	pos_2=VBZ	pos_9=CD	relType_20=punct	relType_10=obl	lpib=decrease_VBZ	relType_23=punct	pos_4=JJ	pos_13=DT	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	lemma_24=cephalosporin	pos_19=NN	path2=secrete_advcl>g._dep>penicillin_conj	relType_24=conj	lemma_13=that	pos_11=,	relType_2=ccomp	eib=True	pos_3=DT	pos_23=,	relType_18=compound	lemma_3=the	lemma_2=decrease	lemma_19=system	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e10	null	pos_20=-LRB-	pos_24=,	pos_16=DT	relType_22=dep	lemma_24=,	lemma_16=the	relType_9=nummod	lemma_17=anionic	relType_12=mark	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	pos_24=NNS	lemma_25=,	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_4=amod	relType_25=conj	relType_7=case	pos_22=NN	relType_14=advcl	relType_6=case	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NNS	relType_3=det	pos_12=IN	lemma_21=e.	relType_15=case	relType_13=nsubj	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_25=punct	relType_1=punct	pos_7=NN	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	relType_24=punct	lemma_6=of	path2=secrete_advcl>g._dep>indomethacin_conj	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	pos_8=RB	relType_11=punct	lemma_22=g.	relation_1=adverse	lemma_8=about	wib=decreases	lemma_15=by	lemma_7=pramipexole	pos_2=VBZ	pos_9=CD	relType_20=punct	relType_10=obl	lpib=decrease_VBZ	relType_23=punct	pos_4=JJ	pos_25=,	pos_13=DT	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	lemma_24=cephalosporin	pos_19=NN	lemma_25=penicillin	relType_24=conj	lemma_13=that	pos_11=,	relType_2=ccomp	eib=True	pos_3=DT	pos_23=,	relType_18=compound	lemma_3=the	lemma_2=decrease	lemma_19=system	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e11	null	pos_20=-LRB-	pos_24=,	pos_16=DT	relType_22=dep	lemma_24=,	lemma_16=the	relType_9=nummod	lemma_17=anionic	relType_12=mark	pos_26=NN	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	pos_24=NNS	lemma_25=,	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_4=amod	relType_25=conj	relType_7=case	pos_22=NN	relType_14=advcl	relType_6=case	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	pos_25=NNS	relType_3=det	pos_12=IN	lemma_21=e.	relType_15=case	relType_13=nsubj	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_25=punct	relType_26=punct	relType_1=punct	pos_7=NN	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	relType_24=punct	lemma_6=of	pos_8=RB	relType_11=punct	lemma_22=g.	relation_1=adverse	lemma_8=about	wib=decreases	lemma_15=by	lemma_7=pramipexole	pos_2=VBZ	pos_9=CD	relType_20=punct	relType_10=obl	lemma_26=indomethacin	lpib=decrease_VBZ	relType_23=punct	pos_4=JJ	pos_25=,	pos_13=DT	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	lemma_24=cephalosporin	relType_26=conj	pos_19=NN	lemma_25=penicillin	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	relType_24=conj	lemma_13=that	pos_11=,	relType_2=ccomp	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	eib=True	pos_3=DT	pos_23=,	relType_18=compound	pos_26=,	lemma_3=the	lemma_2=decrease	lemma_19=system	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e12	null	pos_20=-LRB-	pos_24=,	pos_16=DT	relType_22=dep	lemma_24=,	lemma_16=the	relType_9=nummod	pos_27=,	lemma_17=anionic	relType_12=mark	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	pos_26=NN	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	pos_24=NNS	lemma_25=,	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_4=amod	relType_25=conj	pos_28=CC	relType_7=case	pos_22=NN	relType_27=conj	lemma_27=hydrochlorothiazide	relType_14=advcl	relType_6=case	pos_6=IN	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj	lemma_28=and	pos_25=NNS	relType_3=det	pos_12=IN	lemma_21=e.	relType_15=case	pos_27=NN	relType_13=nsubj	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_25=punct	relType_26=punct	relType_1=punct	pos_7=NN	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	relType_24=punct	lemma_6=of	pos_8=RB	relType_11=punct	lemma_22=g.	relation_1=adverse	lemma_8=about	wib=decreases	lemma_15=by	lemma_7=pramipexole	path2=secrete_advcl>g._dep>chlorpropamide_conj	pos_2=VBZ	pos_9=CD	relType_20=punct	relType_27=punct	relType_10=obl	lemma_26=indomethacin	lpib=decrease_VBZ	relType_23=punct	pos_4=JJ	pos_25=,	pos_13=DT	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	lemma_24=cephalosporin	relType_26=conj	pos_19=NN	lemma_25=penicillin	relType_24=conj	lemma_13=that	pos_11=,	lemma_27=,	relType_2=ccomp	relType_28=cc	eib=True	pos_3=DT	pos_23=,	relType_18=compound	pos_26=,	lemma_3=the	lemma_2=decrease	lemma_19=system	lemma_26=,	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e6	DDI-DrugBank.d737.s6.e13	null	pos_20=-LRB-	pos_39=NN	pos_24=,	pos_16=DT	relType_22=dep	pos_35=NN	lemma_24=,	lemma_16=the	relType_9=nummod	pos_27=,	lemma_40=of	lemma_17=anionic	relType_12=mark	pos_26=NN	pos_10=NN	lemma_23=,	lemma_7=by	relType_8=advmod	pos_18=NN	relType_29=conj	pos_36=IN	pos_24=NNS	lemma_25=,	relType_31=parataxis	pos_32=TO	pos_40=IN	path=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_14=VBN	relType_19=obl	pos_7=IN	relType_5=obj	relType_33=xcomp	relType_4=amod	relType_25=conj	pos_31=JJ	pos_28=CC	relType_7=case	relType_39=nmod	pos_22=NN	relType_27=conj	lemma_27=hydrochlorothiazide	relType_14=advcl	relType_6=case	lemma_29=)	lemma_39=clearance	pos_6=IN	lemma_28=and	lemma_34=little	lemma_37=the	pos_25=NNS	pos_29=NN	relType_3=det	pos_12=IN	lemma_38=oral	pos_38=JJ	lemma_21=e.	relType_15=case	pos_27=NN	relType_13=nsubj	relType_40=case	pos_1=-RRB-	relType_21=compound	relType_7=nmod	lemma_9=20	lemma_14=secrete	lemma_5=clearance	relType_17=amod	pos_15=IN	lemma_10=%	pos_5=NN	lemma_4=oral	relType_25=punct	lemma_31=likely	relType_26=punct	relType_1=punct	pos_7=NN	relType_38=amod	lemma_33=have	lib=decrease	lemma_11=,	lemma_12=while	lemma_18=transport	relType_24=punct	lemma_6=of	lemma_30=be	lemma_29=chlorpropamide	pos_8=RB	relType_11=punct	lemma_36=on	lemma_22=g.	pos_37=DT	relation_1=adverse	lemma_8=about	wib=decreases	path1=quinine_conj<g._dep<secrete_acl:relcl<coadministration_nsubj<decrease_ccomp<suggest_csubj	lemma_35=effect	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_15=by	lemma_7=pramipexole	pos_34=JJ	relType_37=det	pos_2=VBZ	relType_34=amod	pos_9=CD	pos_33=VB	relType_20=punct	relType_27=punct	relType_10=obl	lemma_26=indomethacin	lpib=decrease_VBZ	relType_23=punct	pos_29=-RRB-	pos_4=JJ	pos_25=,	pos_13=DT	lemma_32=to	lemma_1=)	pos_17=JJ	lemma_20=(	relType_16=det	pos_30=VBP	lemma_24=cephalosporin	relation_40=neutral	relType_26=conj	relType_35=obj	pos_19=NN	relType_32=mark	lemma_25=penicillin	relType_24=conj	lemma_13=that	relType_29=punct	pos_11=,	lemma_27=,	relType_2=ccomp	relType_28=cc	eib=True	pos_3=DT	pos_23=,	relType_30=cop	relType_18=compound	pos_26=,	lemma_3=the	lemma_2=decrease	lemma_19=system	lemma_26=,	relType_36=case	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e8	null	relType_1=case	relType_14=punct	lemma_4=%	lemma_12=transport	relType_10=det	pos_5=,	pos_8=VBN	relType_17=punct	lib=about	relType_8=advcl	pos_9=IN	lemma_8=secrete	lemma_16=g.	lemma_14=(	lemma_15=e.	lpib=about_RB	lemma_13=system	pos_2=RB	relType_13=obl	lemma_9=by	relType_12=compound	eib=False	relType_2=advmod	path=pramipexole_nmod<clearance_obj<decrease_ccomp>secrete_advcl>g._dep>cephalosporin_conj	path2=secrete_advcl>g._dep>cephalosporin_conj	pos_6=IN	relType_11=amod	lemma_17=,	lemma_10=the	pos_1=IN	relType_9=case	lemma_6=while	pos_13=NN	pos_4=NN	pos_7=DT	lemma_7=that	pos_17=,	relType_4=obl	wib=about	pos_14=-LRB-	pos_3=CD	relType_6=mark	lemma_5=,	relType_5=punct	pos_15=NN	relType_3=nummod	pos_16=NN	relType_15=compound	lemma_11=anionic	relType_16=dep	lemma_2=about	lemma_3=20	path1=pramipexole_nmod<clearance_obj	relType_7=nsubj	pos_11=JJ	pos_12=NN	lemma_1=by	pos_10=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e9	null	relType_1=case	relType_14=punct	lemma_4=%	lemma_12=transport	pos_18=NNS	relType_10=det	pos_5=,	pos_8=VBN	relType_17=punct	lib=about	relType_8=advcl	pos_9=IN	lemma_8=secrete	lemma_16=g.	lemma_14=(	lemma_15=e.	lpib=about_RB	lemma_13=system	pos_2=RB	relType_13=obl	lemma_9=by	relType_12=compound	lemma_17=,	relType_2=advmod	pos_6=IN	relType_11=amod	lemma_10=the	pos_1=IN	relType_9=case	path2=secrete_advcl>g._dep>penicillin_conj	lemma_6=while	pos_13=NN	pos_4=NN	pos_7=DT	path=pramipexole_nmod<clearance_obj<decrease_ccomp>secrete_advcl>g._dep>penicillin_conj	lemma_7=that	pos_17=,	relType_4=obl	pos_18=,	wib=about	pos_14=-LRB-	pos_3=CD	relType_6=mark	lemma_5=,	relType_5=punct	pos_15=NN	lemma_18=,	relType_18=punct	relType_3=nummod	pos_16=NN	relType_15=compound	eib=True	lemma_11=anionic	relType_16=dep	lemma_2=about	lemma_3=20	lemma_18=cephalosporin	path1=pramipexole_nmod<clearance_obj	relType_7=nsubj	pos_11=JJ	pos_12=NN	relType_18=conj	lemma_1=by	pos_10=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e10	null	relType_1=case	relType_14=punct	lemma_4=%	lemma_12=transport	pos_18=NNS	relType_10=det	pos_5=,	pos_8=VBN	relType_17=punct	lib=about	relType_8=advcl	path=pramipexole_nmod<clearance_obj<decrease_ccomp>secrete_advcl>g._dep>indomethacin_conj	lemma_8=secrete	path2=secrete_advcl>g._dep>indomethacin_conj	pos_9=IN	lemma_16=g.	pos_19=NNS	relType_19=punct	lemma_14=(	lemma_15=e.	lpib=about_RB	lemma_13=system	pos_2=RB	relType_13=obl	lemma_9=by	relType_12=compound	lemma_17=,	relType_2=advmod	pos_6=IN	relType_11=amod	lemma_10=the	pos_1=IN	relType_9=case	lemma_6=while	pos_13=NN	pos_4=NN	pos_7=DT	lemma_7=that	pos_17=,	relType_4=obl	pos_18=,	wib=about	pos_14=-LRB-	pos_3=CD	relType_6=mark	lemma_5=,	relType_5=punct	pos_15=NN	lemma_18=,	relType_18=punct	pos_19=,	relType_3=nummod	pos_16=NN	relType_19=conj	relType_15=compound	eib=True	lemma_11=anionic	relType_16=dep	lemma_2=about	lemma_3=20	lemma_18=cephalosporin	lemma_19=,	path1=pramipexole_nmod<clearance_obj	relType_7=nsubj	pos_11=JJ	lemma_19=penicillin	pos_12=NN	relType_18=conj	lemma_1=by	pos_10=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e11	null	relType_1=case	relType_14=punct	lemma_4=%	lemma_12=transport	pos_18=NNS	relType_10=det	pos_5=,	pos_8=VBN	relType_17=punct	lib=about	relType_8=advcl	pos_9=IN	lemma_8=secrete	lemma_16=g.	pos_19=NNS	relType_19=punct	lemma_14=(	lemma_15=e.	lpib=about_RB	lemma_13=system	lemma_20=,	pos_2=RB	relType_13=obl	lemma_20=indomethacin	lemma_9=by	relType_12=compound	lemma_17=,	relType_2=advmod	relType_20=conj	pos_6=IN	relType_11=amod	pos_20=NN	lemma_10=the	pos_1=IN	relType_9=case	lemma_6=while	pos_13=NN	pos_4=NN	path=pramipexole_nmod<clearance_obj<decrease_ccomp>secrete_advcl>g._dep>hydrochlorothiazide_conj	pos_7=DT	pos_20=,	lemma_7=that	pos_17=,	relType_4=obl	pos_18=,	wib=about	pos_14=-LRB-	pos_3=CD	relType_6=mark	lemma_5=,	relType_5=punct	pos_15=NN	lemma_18=,	relType_18=punct	pos_19=,	relType_3=nummod	pos_16=NN	relType_19=conj	path2=secrete_advcl>g._dep>hydrochlorothiazide_conj	relType_15=compound	eib=True	lemma_11=anionic	relType_16=dep	lemma_2=about	lemma_3=20	lemma_18=cephalosporin	lemma_19=,	path1=pramipexole_nmod<clearance_obj	relType_7=nsubj	pos_11=JJ	lemma_19=penicillin	relType_20=punct	pos_12=NN	relType_18=conj	lemma_1=by	pos_10=DT
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e12	null	pos_5=,	lemma_16=g.	relType_21=conj	lemma_13=system	lemma_20=,	lemma_9=by	relType_12=compound	pos_20=NN	relType_9=case	pos_13=NN	pos_14=-LRB-	path=pramipexole_nmod<clearance_obj<decrease_ccomp>secrete_advcl>g._dep>chlorpropamide_conj	lemma_5=,	lemma_21=,	relType_15=compound	lemma_11=anionic	path1=pramipexole_nmod<clearance_obj	pos_11=JJ	relType_21=punct	lemma_12=transport	relType_1=case	pos_18=NNS	pos_8=VBN	relType_8=advcl	pos_19=NNS	lemma_15=e.	relType_20=conj	pos_6=IN	relType_11=amod	pos_1=IN	lemma_1=by	relType_4=obl	relType_6=mark	pos_19=,	pos_16=NN	lemma_19=,	lemma_19=penicillin	relType_14=punct	lemma_4=%	relType_10=det	relType_17=punct	relType_19=punct	lpib=about_RB	relType_13=obl	lemma_20=indomethacin	relType_22=cc	lemma_10=the	lemma_6=while	pos_7=DT	pos_17=,	path2=secrete_advcl>g._dep>chlorpropamide_conj	relType_19=conj	lemma_2=about	relType_20=punct	relType_7=nsubj	pos_10=DT	lib=about	pos_9=IN	lemma_8=secrete	lemma_14=(	pos_22=CC	pos_21=,	pos_2=RB	lemma_17=,	relType_2=advmod	pos_4=NN	pos_20=,	lemma_7=that	pos_18=,	wib=about	pos_15=NN	pos_3=CD	lemma_18=,	relType_5=punct	relType_18=punct	relType_3=nummod	lemma_21=hydrochlorothiazide	eib=True	relType_16=dep	lemma_3=20	lemma_18=cephalosporin	pos_12=NN	lemma_22=and	relType_18=conj	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e7	DDI-DrugBank.d737.s6.e13	null	path=pramipexole_nmod<clearance_obj<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_5=,	relType_25=parataxis	lemma_29=effect	lemma_16=g.	relType_21=conj	lemma_13=system	pos_26=TO	lemma_20=,	lemma_9=by	pos_31=DT	relType_12=compound	lemma_31=the	pos_20=NN	lemma_25=likely	relType_9=case	lemma_27=have	pos_13=NN	relType_32=amod	relType_29=obj	pos_14=-LRB-	lemma_5=,	lemma_26=to	lemma_32=oral	lemma_21=,	relType_15=compound	lemma_30=on	relType_26=mark	lemma_11=anionic	lemma_34=of	pos_11=JJ	relType_21=punct	lemma_24=be	lemma_12=transport	relType_33=nmod	pos_30=IN	relType_1=case	relType_24=cop	pos_18=NNS	pos_8=VBN	relType_8=advcl	pos_19=NNS	lemma_15=e.	pos_32=JJ	relType_20=conj	pos_6=IN	relType_11=amod	pos_29=NN	pos_1=IN	lemma_1=by	lemma_23=chlorpropamide	relType_23=conj	relType_4=obl	relType_6=mark	relType_27=xcomp	pos_19=,	pos_16=NN	pos_28=JJ	lemma_19=,	lemma_19=penicillin	relType_28=amod	relType_34=case	relType_14=punct	lemma_4=%	relType_10=det	relType_31=det	relType_17=punct	path1=pramipexole_nmod<clearance_obj<decrease_ccomp<suggest_csubj	relType_19=punct	lpib=about_RB	pos_23=NN	relType_13=obl	lemma_20=indomethacin	relType_22=cc	lemma_10=the	lemma_6=while	lemma_28=little	pos_7=DT	pos_17=,	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_23=)	relType_19=conj	lemma_33=clearance	pos_23=-RRB-	lemma_2=about	relType_20=punct	relType_7=nsubj	relation_33=neutral	pos_33=NN	relType_30=case	pos_10=DT	relType_23=punct	lib=about	pos_9=IN	lemma_8=secrete	lemma_14=(	pos_22=CC	pos_21=,	pos_2=RB	lemma_17=,	relType_2=advmod	pos_27=VB	pos_4=NN	pos_20=,	pos_25=JJ	lemma_7=that	pos_24=VBP	pos_18=,	wib=about	pos_15=NN	pos_3=CD	lemma_18=,	relType_5=punct	relType_18=punct	relType_3=nummod	lemma_21=hydrochlorothiazide	eib=True	relType_16=dep	lemma_3=20	lemma_18=cephalosporin	pos_12=NN	lemma_22=and	relType_18=conj	pos_34=IN	pos_21=NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e8	DDI-DrugBank.d737.s6.e9	null	wib=penicillins	lemma_1=,	path=cephalosporin_conj<g._dep>penicillin_conj	eib=False	lib=penicillin	path1=cephalosporin_conj	pos_1=,	lpib=penicillin_NNS	path2=penicillin_conj	relType_1=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e8	DDI-DrugBank.d737.s6.e10	null	pos_2=NNS	wib=penicillins	lemma_1=,	eib=True	lib=penicillin	path1=cephalosporin_conj	pos_1=,	lpib=penicillin_NNS	pos_2=,	relType_2=conj	path2=indomethacin_conj	relType_1=punct	lemma_2=penicillin	path=cephalosporin_conj<g._dep>indomethacin_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e8	DDI-DrugBank.d737.s6.e11	null	wib=penicillins	path2=hydrochlorothiazide_conj	lemma_1=,	path1=cephalosporin_conj	pos_1=,	relType_2=punct	lib=penicillin	lpib=penicillin_NNS	relType_2=conj	lemma_2=,	lemma_3=,	path=cephalosporin_conj<g._dep>hydrochlorothiazide_conj	relType_3=conj	lemma_3=indomethacin	pos_2=NNS	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	lemma_2=penicillin	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e8	DDI-DrugBank.d737.s6.e12	null	wib=penicillins	lemma_1=,	pos_5=CC	path1=cephalosporin_conj	pos_1=,	relType_2=punct	relType_5=cc	pos_4=,	lemma_4=hydrochlorothiazide	lib=penicillin	lpib=penicillin_NNS	path2=chlorpropamide_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lemma_3=indomethacin	pos_2=NNS	pos_3=,	eib=True	lemma_5=and	pos_3=NN	path=cephalosporin_conj<g._dep>chlorpropamide_conj	pos_2=,	relType_4=conj	relType_1=punct	lemma_2=penicillin	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e8	DDI-DrugBank.d737.s6.e13	mechanism	wib=penicillins	lemma_8=likely	lemma_1=,	lemma_6=chlorpropamide	pos_15=JJ	pos_5=CC	relType_15=amod	lemma_7=be	relType_16=nmod	pos_1=,	lemma_13=on	relType_2=punct	pos_6=NN	pos_8=JJ	pos_9=TO	relType_5=cc	relType_6=conj	pos_17=IN	pos_4=,	lemma_4=hydrochlorothiazide	lib=penicillin	relType_6=punct	relType_11=amod	path=cephalosporin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_7=cop	lemma_12=effect	lpib=penicillin_NNS	relType_14=det	lemma_9=to	pos_12=NN	relType_12=obj	pos_13=IN	lemma_14=the	lemma_16=clearance	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=)	relType_8=parataxis	pos_10=VB	relType_17=case	relation_15=neutral	relType_13=case	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_3=,	relType_4=punct	relType_3=conj	lemma_4=,	pos_16=NN	lemma_17=of	lemma_11=little	pos_14=DT	pos_6=-RRB-	lemma_3=indomethacin	pos_2=NNS	relType_9=mark	pos_3=,	eib=True	lemma_5=and	pos_3=NN	path1=cephalosporin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj	relType_10=xcomp	pos_2=,	relType_4=conj	pos_11=JJ	lemma_10=have	lemma_15=oral	relType_1=punct	lemma_2=penicillin	relType_3=punct	pos_7=VBP
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e9	DDI-DrugBank.d737.s6.e10	null	lpib=indomethacin_NN	wib=indomethacin	lemma_1=,	lib=indomethacin	path=penicillin_conj<g._dep>indomethacin_conj	eib=False	path1=penicillin_conj	pos_1=,	path2=indomethacin_conj	relType_1=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e9	DDI-DrugBank.d737.s6.e11	null	path2=hydrochlorothiazide_conj	lpib=indomethacin_NN	wib=indomethacin	lemma_1=,	lib=indomethacin	pos_2=NN	eib=True	lemma_2=indomethacin	path1=penicillin_conj	pos_1=,	pos_2=,	relType_1=punct	path=penicillin_conj<g._dep>hydrochlorothiazide_conj	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e9	DDI-DrugBank.d737.s6.e12	null	lemma_1=,	pos_2=NN	path1=penicillin_conj	pos_1=,	relType_4=cc	relType_2=punct	wib=indomethacin	path2=chlorpropamide_conj	relType_2=conj	lemma_2=,	lpib=indomethacin_NN	lib=indomethacin	lemma_3=,	relType_3=conj	path=penicillin_conj<g._dep>chlorpropamide_conj	lemma_3=hydrochlorothiazide	pos_3=,	eib=True	pos_4=CC	lemma_2=indomethacin	pos_3=NN	lemma_4=and	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e9	DDI-DrugBank.d737.s6.e13	mechanism	relType_14=amod	lemma_1=,	lemma_13=the	pos_2=NN	lemma_15=clearance	lemma_12=on	pos_16=IN	relType_10=amod	pos_1=,	relType_12=case	pos_13=DT	relType_4=cc	pos_9=VB	pos_8=TO	relType_11=obj	relType_2=punct	lemma_6=be	relation_13=neutral	wib=indomethacin	path=penicillin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_6=cop	lemma_16=of	relType_2=conj	lemma_2=,	pos_12=IN	lemma_5=)	lemma_9=have	lpib=indomethacin_NN	lib=indomethacin	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_3=,	pos_5=-RRB-	relType_3=conj	lemma_7=likely	relType_5=punct	lemma_8=to	relType_8=mark	pos_10=JJ	pos_15=NN	pos_6=VBP	relType_5=conj	relType_3=punct	relType_9=xcomp	relType_15=nmod	pos_5=NN	relType_16=case	pos_11=NN	lemma_3=hydrochlorothiazide	pos_3=,	eib=True	pos_4=CC	lemma_2=indomethacin	pos_3=NN	lemma_4=and	pos_7=JJ	lemma_11=effect	relType_13=det	pos_2=,	pos_14=JJ	lemma_5=chlorpropamide	relType_1=punct	lemma_14=oral	path1=penicillin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj	relType_7=parataxis	lemma_10=little
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e10	DDI-DrugBank.d737.s6.e11	null	path2=hydrochlorothiazide_conj	lemma_1=,	eib=False	wib=hydrochlorothiazide	pos_1=,	path=indomethacin_conj<g._dep>hydrochlorothiazide_conj	lib=hydrochlorothiazide	relType_1=punct	lpib=hydrochlorothiazide_NN	path1=indomethacin_conj
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e10	DDI-DrugBank.d737.s6.e12	null	lemma_1=,	pos_2=NN	pos_3=CC	wib=hydrochlorothiazide	pos_1=,	relType_3=cc	relType_2=punct	lib=hydrochlorothiazide	path2=chlorpropamide_conj	relType_2=conj	lemma_2=,	eib=True	lemma_2=hydrochlorothiazide	pos_2=,	lemma_3=and	relType_1=punct	path=indomethacin_conj<g._dep>chlorpropamide_conj	lpib=hydrochlorothiazide_NN	path1=indomethacin_conj
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e10	DDI-DrugBank.d737.s6.e13	mechanism	pos_14=NN	lemma_1=,	pos_2=NN	pos_6=JJ	lemma_15=of	pos_3=CC	relType_5=cop	lemma_4=chlorpropamide	lemma_8=have	wib=hydrochlorothiazide	pos_1=,	lemma_6=likely	relType_7=mark	relType_12=det	relType_11=case	relType_3=cc	relType_2=punct	pos_9=JJ	pos_5=VBP	relType_13=amod	pos_4=-RRB-	lemma_7=to	relType_8=xcomp	relType_9=amod	lib=hydrochlorothiazide	path1=indomethacin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj	lemma_5=be	relType_2=conj	pos_4=NN	lemma_2=,	relType_6=parataxis	pos_7=TO	pos_8=VB	pos_10=NN	lemma_10=effect	path=indomethacin_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	pos_11=IN	lemma_12=the	relType_15=case	lemma_11=on	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_4=punct	pos_13=JJ	relation_11=neutral	lemma_13=oral	lemma_4=)	pos_15=IN	eib=True	lemma_2=hydrochlorothiazide	lemma_9=little	lemma_14=clearance	pos_2=,	lemma_3=and	relType_4=conj	pos_12=DT	relType_1=punct	relType_14=nmod	lpib=hydrochlorothiazide_NN	relType_10=obj
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e11	DDI-DrugBank.d737.s6.e12	null	lemma_2=and	lemma_1=,	eib=False	pos_2=CC	pos_1=,	wib=chlorpropamide	path=hydrochlorothiazide_conj<g._dep>chlorpropamide_conj	path1=hydrochlorothiazide_conj	relType_1=punct	path2=chlorpropamide_conj	relType_2=cc	lib=chlorpropamide	lpib=chlorpropamide_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e11	DDI-DrugBank.d737.s6.e13	mechanism	pos_7=VB	lemma_8=little	lemma_1=,	lemma_3=chlorpropamide	pos_6=TO	lemma_13=clearance	lemma_4=be	path=hydrochlorothiazide_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_8=amod	relation_9=neutral	pos_1=,	relType_5=parataxis	relType_2=cc	lemma_6=to	lemma_12=oral	lib=chlorpropamide	relType_13=nmod	pos_8=JJ	lemma_2=and	relType_4=cop	pos_12=JJ	pos_4=VBP	wib=chlorpropamide	relType_12=amod	relType_10=case	pos_13=NN	pos_9=NN	lemma_7=have	relType_7=xcomp	pos_14=IN	pos_5=JJ	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	relType_3=conj	relType_6=mark	relType_9=obj	lemma_5=likely	pos_10=IN	lemma_10=on	pos_11=DT	lemma_11=the	lemma_3=)	relType_11=det	eib=True	pos_3=-RRB-	pos_3=NN	pos_2=CC	lemma_14=of	relType_14=case	lemma_9=effect	path1=hydrochlorothiazide_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj	relType_1=punct	relType_3=punct	lpib=chlorpropamide_NN
DDI-DrugBank.d737.s6	DDI-DrugBank.d737.s6.e12	DDI-DrugBank.d737.s6.e13	mechanism	relType_4=mark	relType_8=case	pos_6=JJ	relType_5=xcomp	lpib=be_VBP	relType_10=amod	relType_12=case	lemma_1=)	lemma_12=of	lemma_5=have	relation_6=neutral	pos_5=VB	relType_2=cop	eib=False	lemma_7=effect	relType_6=amod	relType_7=obj	pos_9=DT	pos_12=IN	pos_8=IN	wib=are	lemma_8=on	lib=be	path2=have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_4=to	pos_10=JJ	pos_1=-RRB-	path1=chlorpropamide_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj	pos_2=VBP	lemma_11=clearance	relType_3=parataxis	pos_4=TO	path=chlorpropamide_conj<g._dep<secrete_advcl<decrease_ccomp<suggest_csubj<likely_parataxis>have_xcomp>effect_obj>clearance_nmod>pramipexole_nmod	lemma_6=little	lemma_3=likely	pos_11=NN	pos_3=JJ	lemma_9=the	lemma_10=oral	lemma_2=be	relType_11=nmod	relType_1=punct	pos_7=NN	relType_9=det
DDI-DrugBank.d737.s7	DDI-DrugBank.d737.s7.e0	DDI-DrugBank.d737.s7.e1	null	pos_2=IN	lemma_1=elimination	lpib=elimination_NN	lemma_2=because	eib=False	relType_2=mark	path=pramipexole_compound<elimination_obj<affect_xcomp>metabolize_advcl>pramipexole_nsubj:pass	path1=pramipexole_compound<elimination_obj	relType_1=obj	pos_1=NN	wib=elimination	lib=elimination	path2=metabolize_advcl>pramipexole_nsubj:pass
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e1	null	lib=pramipexole	pos_2=IN	wib=pramipexole	lemma_2=since	eib=False	lpib=pramipexole_NN	path2=possible_dep>agonist_advcl>pramipexole_nsubj	path1=	pos_1=:	relType_1=punct	lemma_1=:	relType_2=mark	path=<antagonist_ROOT>possible_dep>agonist_advcl>pramipexole_nsubj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e2	null	lemma_5=dopamine	wib=pramipexole	lpib=pramipexole_NN	lemma_4=a	path1=	relType_5=compound	relType_2=mark	pos_2=IN	pos_3=VBZ	lemma_1=:	lib=pramipexole	pos_4=DT	lemma_3=be	pos_1=:	relType_3=nsubj	pos_5=NN	path=<antagonist_ROOT>possible_dep>agonist_advcl	lemma_2=since	eib=True	pos_3=NN	path2=possible_dep>agonist_advcl	lemma_3=pramipexole	relType_1=punct	relType_4=det	relType_3=cop
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e3	null	lemma_5=dopamine	wib=pramipexole	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj	pos_7=VBZ	relType_8=dep	lpib=pramipexole_NN	lemma_4=a	pos_5=,	lemma_7=be	path1=	relType_5=compound	pos_9=IN	lemma_10=dopamine	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	relType_7=cop	pos_3=VBZ	relType_10=compound	pos_10=NN	lemma_1=:	lib=pramipexole	pos_4=DT	lemma_5=,	relType_5=punct	lemma_3=be	pos_1=:	lemma_5=agonist	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_9=that	lemma_2=since	eib=True	pos_3=NN	lemma_3=pramipexole	lemma_6=it	relType_1=punct	relType_4=det	relType_3=cop	path2=possible_dep>diminish_ccomp>antagonist_nsubj	relType_6=nsubj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e4	null	lemma_5=dopamine	wib=pramipexole	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lpib=pramipexole_NN	lemma_4=a	pos_5=,	lemma_7=be	path1=	lemma_10=,	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	lemma_10=dopamine	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_4=det	relType_5=advcl	lemma_12=as	relType_12=fixed	relType_7=cop	pos_3=VBZ	relType_10=compound	pos_10=NN	pos_12=IN	lemma_1=:	lemma_11=such	lib=pramipexole	pos_4=DT	lemma_5=,	relType_5=punct	lemma_3=be	pos_1=:	lemma_5=agonist	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_9=that	lemma_2=since	eib=True	pos_10=,	pos_3=NN	lemma_3=pramipexole	relType_13=det	lemma_6=it	pos_11=JJ	relType_1=punct	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_3=cop	pos_10=NNS	relType_6=nsubj	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e5	null	lemma_5=dopamine	wib=pramipexole	relType_14=punct	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lemma_14=neuroleptic	lpib=pramipexole_NN	lemma_4=a	pos_5=,	lemma_7=be	path1=	lemma_10=,	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	relType_14=nmod	lemma_10=dopamine	lemma_14=(	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	lemma_12=as	relType_12=fixed	relType_7=cop	pos_3=VBZ	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	relType_10=compound	pos_10=NN	pos_12=IN	lemma_1=:	lemma_11=such	lib=pramipexole	pos_4=DT	pos_14=-LRB-	lemma_5=,	relType_5=punct	lemma_3=be	pos_1=:	lemma_5=agonist	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	pos_5=NN	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lemma_2=since	eib=True	lemma_9=that	pos_10=,	pos_3=NN	lemma_3=pramipexole	relType_13=det	pos_14=NNS	lemma_6=it	pos_11=JJ	relType_1=punct	relType_4=det	relType_3=cop	pos_10=NNS	relType_6=nsubj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e6	null	lemma_5=dopamine	wib=pramipexole	relType_14=punct	pos_7=VBZ	relType_10=punct	relType_8=dep	lemma_13=the	lemma_14=neuroleptic	lpib=pramipexole_NN	lemma_4=a	pos_5=,	lemma_7=be	path1=	lemma_10=,	pos_13=DT	relType_5=compound	pos_9=IN	lemma_10=antagonist	relType_14=nmod	lemma_10=dopamine	lemma_14=(	relType_11=case	relType_2=mark	pos_2=IN	pos_8=JJ	relType_5=advcl	lemma_12=as	relType_12=fixed	pos_15=,	relType_7=cop	relType_15=dep	pos_3=VBZ	relType_10=compound	pos_10=NN	relType_15=punct	pos_12=IN	lemma_1=:	lemma_11=such	lib=pramipexole	pos_4=DT	pos_14=-LRB-	lemma_15=,	lemma_5=,	relType_5=punct	lemma_3=be	pos_1=:	lemma_5=agonist	relType_10=nsubj	pos_6=PRP	relType_3=nsubj	lemma_8=possible	relType_9=mark	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_5=NN	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_9=that	lemma_2=since	eib=True	pos_10=,	pos_15=NNS	pos_3=NN	lemma_3=pramipexole	lemma_15=phenothiazine	relType_13=det	pos_14=NNS	lemma_6=it	pos_11=JJ	relType_1=punct	relType_4=det	relType_3=cop	pos_10=NNS	relType_6=nsubj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e7	null	wib=pramipexole	pos_7=VBZ	lemma_14=neuroleptic	lpib=pramipexole_NN	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_10=NN	lemma_16=,	pos_14=-LRB-	lemma_5=,	lemma_3=be	pos_1=:	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	lemma_5=dopamine	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	pos_12=IN	lemma_11=such	lemma_15=,	lemma_5=agonist	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_2=since	lemma_6=it	relType_1=punct	relType_14=punct	relType_10=punct	relType_8=dep	lemma_10=dopamine	relType_2=mark	pos_2=IN	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	lib=pramipexole	relType_3=nsubj	relType_3=cop	relType_6=nsubj	lemma_13=the	pos_13=DT	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	relType_5=compound	pos_9=IN	lemma_14=(	lemma_12=as	pos_16=,	relType_10=compound	pos_4=DT	relType_5=punct	lemma_16=butyrophenone	relType_10=nsubj	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	lemma_3=pramipexole	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e8	null	wib=pramipexole	pos_7=VBZ	lemma_14=neuroleptic	lpib=pramipexole_NN	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_18=CC	pos_10=NN	lemma_16=,	path2=possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_14=-LRB-	lemma_5=,	lemma_3=be	pos_1=:	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	lemma_5=dopamine	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	pos_12=IN	lemma_11=such	lemma_15=,	lemma_5=agonist	lemma_8=possible	relType_9=mark	pos_5=NN	lemma_2=since	lemma_6=it	relType_1=punct	lemma_18=or	relType_14=punct	relType_10=punct	relType_8=dep	relType_17=punct	lemma_10=dopamine	relType_18=cc	relType_2=mark	pos_2=IN	path=<antagonist_ROOT>possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	lib=pramipexole	relType_3=nsubj	pos_17=NNS	relType_3=cop	relType_6=nsubj	lemma_13=the	pos_13=DT	relType_5=compound	pos_9=IN	lemma_14=(	relType_17=conj	lemma_12=as	pos_16=,	relType_10=compound	lemma_17=thioxanthene	pos_4=DT	relType_5=punct	lemma_16=butyrophenone	relType_10=nsubj	lemma_17=)	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	lemma_3=pramipexole	pos_17=-RRB-	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e0	DDI-DrugBank.d737.s10.e9	null	wib=pramipexole	pos_7=VBZ	lemma_19=metoclopramide	lemma_14=neuroleptic	lpib=pramipexole_NN	pos_5=,	lemma_10=,	lemma_10=antagonist	pos_8=JJ	relType_24=case	relType_5=advcl	relType_12=fixed	pos_3=VBZ	pos_18=CC	pos_10=NN	lemma_16=,	pos_14=-LRB-	lemma_5=,	lemma_22=the	lemma_3=be	pos_1=:	pos_24=IN	pos_6=PRP	relType_16=punct	pos_10=,	relType_13=det	pos_14=NNS	pos_11=JJ	relType_14=nmod	relType_23=obj	lemma_5=dopamine	lemma_4=a	lemma_7=be	path1=	pos_16=NNS	relType_11=case	relType_20=aux	pos_12=IN	lemma_11=such	lemma_15=,	lemma_5=agonist	pos_19=,	pos_21=VB	lemma_8=possible	relType_9=mark	pos_22=DT	pos_5=NN	lemma_2=since	lemma_19=,	lemma_6=it	relType_1=punct	lemma_18=or	relType_14=punct	path=<antagonist_ROOT>possible_dep>diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	relType_10=punct	relType_8=dep	relType_17=punct	relType_19=punct	lemma_10=dopamine	lemma_24=of	relType_18=cc	relType_2=mark	pos_23=NN	pos_2=IN	pos_15=,	relType_7=cop	relType_15=dep	relType_15=punct	lemma_1=:	lib=pramipexole	path2=possible_dep>diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	relType_21=ccomp	relType_19=conj	relType_3=nsubj	pos_17=NNS	relType_22=det	relType_3=cop	relType_6=nsubj	lemma_23=effectiveness	lemma_13=the	lemma_20=may	pos_13=DT	relType_5=compound	pos_9=IN	lemma_14=(	relType_17=conj	lemma_12=as	pos_20=MD	pos_16=,	pos_19=NN	relType_10=compound	lemma_17=thioxanthene	pos_4=DT	relType_5=punct	lemma_16=butyrophenone	relType_10=nsubj	lemma_21=diminish	lemma_17=)	lemma_9=that	pos_15=NNS	eib=True	lemma_15=phenothiazine	pos_3=NN	lemma_3=pramipexole	pos_17=-RRB-	relType_4=det	pos_10=NNS	relType_16=conj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e2	null	pos_2=DT	lemma_3=dopamine	path=pramipexole_nsubj<agonist_advcl>	relType_1=cop	lib=be	pos_1=VBZ	eib=True	pos_3=NN	relType_2=det	lemma_1=be	lpib=be_VBZ	relType_3=compound	path2=	lemma_2=a	path1=pramipexole_nsubj	wib=is
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e3	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	lemma_6=possible	lemma_2=a	relType_7=mark	lemma_4=it	pos_8=NN	lemma_3=dopamine	relType_6=dep	lemma_1=be	path2=diminish_ccomp>antagonist_nsubj	relType_4=nsubj	lemma_5=be	lemma_7=that	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj	lib=be	relType_3=advcl	lemma_3=,	relType_8=compound	lemma_3=agonist	wib=is	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	path1=pramipexole_nsubj<agonist_advcl	relType_3=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e4	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	relType_8=nsubj	lemma_6=possible	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	lemma_1=be	relType_9=case	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_7=that	lemma_10=as	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	lib=be	relType_3=advcl	lemma_3=,	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	path1=pramipexole_nsubj<agonist_advcl	relType_3=punct	pos_8=,
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e5	null	pos_2=DT	pos_6=JJ	pos_5=VBZ	relType_5=cop	relType_8=nsubj	lemma_6=possible	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lpib=be_VBZ	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	relType_3=compound	pos_4=PRP	pos_12=-LRB-	path1=pramipexole_nsubj<agonist_advcl	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e6	null	pos_2=DT	pos_13=,	pos_6=JJ	pos_5=VBZ	relType_13=dep	lemma_13=,	relType_5=cop	relType_8=nsubj	lemma_6=possible	pos_13=NNS	relType_13=punct	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	relType_8=punct	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	relType_1=cop	pos_3=,	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	eib=True	pos_1=VBZ	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	pos_4=PRP	lpib=be_VBZ	relType_3=compound	pos_12=-LRB-	path1=pramipexole_nsubj<agonist_advcl	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e7	null	pos_2=DT	pos_13=,	relType_14=punct	pos_6=JJ	pos_5=VBZ	relType_13=dep	lemma_13=,	relType_5=cop	relType_8=nsubj	lemma_6=possible	pos_13=NNS	relType_13=punct	relType_8=punct	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_2=a	lemma_8=,	relType_7=mark	lemma_4=it	pos_8=NNS	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	pos_9=JJ	relType_6=dep	pos_14=,	lemma_1=be	relType_12=nmod	relType_9=case	relType_12=punct	relType_4=nsubj	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_5=be	lemma_8=antagonist	relType_10=fixed	lemma_12=(	lemma_7=that	lemma_10=as	lib=be	relType_3=advcl	lemma_3=,	pos_12=NNS	relType_8=compound	pos_10=IN	pos_11=DT	lemma_11=the	relType_11=det	lemma_3=agonist	wib=is	lemma_9=such	lemma_14=,	relType_1=cop	pos_3=,	pos_1=VBZ	eib=True	pos_7=IN	pos_3=NN	lemma_8=dopamine	relType_2=det	relType_14=conj	lemma_14=butyrophenone	pos_4=PRP	lpib=be_VBZ	relType_3=compound	pos_14=NNS	pos_12=-LRB-	path1=pramipexole_nsubj<agonist_advcl	relType_3=punct	lemma_12=neuroleptic	pos_8=,
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e8	null	pos_6=JJ	relType_13=dep	lemma_13=,	lemma_6=possible	pos_13=NNS	relType_8=punct	pos_8=NNS	relType_6=dep	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	relType_9=case	lemma_5=be	lemma_3=,	relType_11=det	lemma_3=agonist	pos_3=,	pos_1=VBZ	pos_7=IN	pos_14=NNS	lemma_12=neuroleptic	pos_15=-RRB-	relType_16=cc	pos_2=DT	pos_13=,	relType_5=cop	pos_16=CC	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	relType_12=nmod	relType_12=punct	lemma_10=as	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	lemma_11=the	lemma_9=such	lemma_14=,	relType_1=cop	lemma_8=dopamine	relType_3=compound	pos_12=-LRB-	relType_3=punct	lemma_12=(	pos_8=,	relType_14=punct	pos_5=VBZ	relType_8=nsubj	lemma_8=,	relType_7=mark	lemma_4=it	pos_14=,	lemma_1=be	lemma_8=antagonist	relType_15=punct	lemma_16=or	lib=be	relType_8=compound	lemma_15=thioxanthene	pos_10=IN	wib=is	relType_15=conj	pos_4=PRP	path1=pramipexole_nsubj<agonist_advcl	relType_14=conj	relType_13=punct	lemma_2=a	pos_9=JJ	relType_4=nsubj	relType_10=fixed	lemma_7=that	relType_3=advcl	pos_12=NNS	lemma_15=)	pos_11=DT	pos_15=NNS	eib=True	pos_3=NN	relType_2=det	lemma_14=butyrophenone	lpib=be_VBZ
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e1	DDI-DrugBank.d737.s10.e9	null	pos_6=JJ	relType_13=dep	lemma_13=,	lemma_6=possible	pos_13=NNS	relType_21=obj	relType_8=punct	pos_8=NNS	relType_6=dep	relType_9=case	pos_22=IN	lemma_21=effectiveness	lemma_5=be	lemma_3=,	path2=diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	relType_11=det	lemma_3=agonist	pos_3=,	pos_1=VBZ	pos_7=IN	pos_14=NNS	lemma_12=neuroleptic	pos_15=-RRB-	relType_16=cc	pos_2=DT	pos_13=,	relType_5=cop	pos_16=CC	lemma_13=phenothiazine	pos_8=NN	lemma_3=dopamine	relType_19=ccomp	relType_12=nmod	lemma_17=metoclopramide	relType_12=punct	lemma_20=the	relType_22=case	lemma_10=as	lemma_11=the	lemma_9=such	lemma_14=,	relType_1=cop	lemma_8=dopamine	relType_3=compound	pos_12=-LRB-	relType_3=punct	lemma_12=(	pos_8=,	lemma_22=of	relType_14=punct	pos_5=VBZ	relType_8=nsubj	relType_17=punct	lemma_8=,	relType_7=mark	lemma_4=it	pos_17=NN	pos_14=,	lemma_1=be	lemma_8=antagonist	relType_15=punct	pos_17=,	lemma_16=or	lib=be	relType_8=compound	lemma_15=thioxanthene	pos_10=IN	wib=is	relType_15=conj	pos_19=VB	pos_4=PRP	path1=pramipexole_nsubj<agonist_advcl	relType_14=conj	relType_20=det	relType_13=punct	lemma_2=a	pos_20=DT	relType_17=conj	pos_9=JJ	lemma_17=,	relType_4=nsubj	relType_10=fixed	lemma_7=that	lemma_18=may	relType_18=aux	relType_3=advcl	pos_12=NNS	lemma_15=)	pos_11=DT	pos_15=NNS	pos_18=MD	eib=True	path=pramipexole_nsubj<agonist_advcl<possible_dep>diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	pos_3=NN	relType_2=det	lemma_14=butyrophenone	lemma_19=diminish	lpib=be_VBZ	pos_21=NN
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e3	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	pos_1=,	pos_6=NN	relType_5=mark	relType_2=nsubj	pos_3=VBZ	lemma_2=it	path2=diminish_ccomp>antagonist_nsubj	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj	lemma_4=possible	lib=be	lemma_5=that	lemma_3=be	pos_5=IN	pos_2=PRP	wib=is	relType_6=compound	eib=True	path1=agonist_advcl	lpib=be_VBZ	relType_1=punct	relType_3=cop
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e4	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_7=case	pos_1=,	lemma_6=,	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_2=nsubj	relType_6=punct	pos_3=VBZ	pos_9=DT	lemma_2=it	pos_8=IN	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	pos_5=IN	pos_2=PRP	pos_6=,	wib=is	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	relType_6=nsubj	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e5	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	pos_1=,	lemma_6=,	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	pos_3=VBZ	pos_9=DT	lemma_2=it	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	pos_2=PRP	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	relType_6=nsubj	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e6	null	lemma_6=dopamine	relType_4=dep	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	lemma_11=,	pos_1=,	lemma_6=,	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_11=phenothiazine	pos_6=NN	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	pos_2=PRP	pos_11=,	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e7	null	lemma_6=dopamine	relType_4=dep	relType_12=conj	lemma_1=,	pos_4=JJ	relType_10=punct	relType_7=case	lemma_11=,	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	pos_1=,	lemma_6=,	lemma_11=phenothiazine	pos_6=NN	lemma_12=,	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_12=,	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	relType_12=punct	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	pos_8=IN	lemma_10=neuroleptic	lemma_4=possible	lib=be	lemma_5=that	pos_12=NNS	lemma_12=butyrophenone	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	pos_2=PRP	pos_11=,	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e8	null	lemma_6=dopamine	relType_4=dep	relType_12=conj	lemma_1=,	pos_4=JJ	relType_10=punct	pos_14=CC	relType_7=case	lemma_11=,	pos_13=NNS	pos_1=,	lemma_6=,	relType_13=punct	lemma_14=or	lemma_11=phenothiazine	pos_6=NN	lemma_12=,	relType_5=mark	lemma_8=as	lemma_7=such	relType_10=nmod	pos_10=-LRB-	relType_2=nsubj	relType_6=punct	relType_11=punct	pos_12=,	pos_3=VBZ	pos_11=NNS	pos_9=DT	lemma_2=it	relType_12=punct	relType_13=conj	pos_8=IN	lemma_10=neuroleptic	lemma_13=thioxanthene	path=agonist_advcl<possible_dep>diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	lib=be	lemma_4=possible	lemma_5=that	pos_12=NNS	lemma_12=butyrophenone	lemma_6=antagonist	lemma_3=be	lemma_10=(	pos_5=IN	relType_11=dep	path2=diminish_ccomp>antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	relType_14=cc	pos_2=PRP	pos_11=,	pos_13=-RRB-	pos_6=,	wib=is	relType_6=compound	eib=True	lemma_13=)	lemma_9=the	path1=agonist_advcl	pos_7=JJ	pos_6=NNS	relType_8=fixed	lpib=be_VBZ	relType_1=punct	relType_3=cop	pos_10=NNS	relType_6=nsubj	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e2	DDI-DrugBank.d737.s10.e9	null	lemma_6=dopamine	pos_14=CC	pos_13=NNS	path=agonist_advcl<possible_dep>diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	lemma_6=,	pos_6=NN	lemma_12=,	pos_10=-LRB-	relType_10=nmod	pos_16=MD	pos_12=,	pos_3=VBZ	path2=diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	lemma_3=be	lemma_6=antagonist	relType_6=compound	lemma_16=may	pos_7=JJ	pos_6=NNS	lemma_20=of	lemma_1=,	relType_7=case	pos_1=,	lemma_11=phenothiazine	pos_18=DT	relType_5=mark	lemma_8=as	relType_20=case	relType_2=nsubj	lemma_17=diminish	relType_12=punct	relType_13=conj	pos_8=IN	lemma_10=neuroleptic	lemma_15=,	lemma_10=(	pos_5=IN	lemma_15=metoclopramide	relType_11=dep	path1=agonist_advcl	relType_18=det	relType_1=punct	lemma_18=the	relType_4=dep	relType_10=punct	lemma_11=,	lemma_14=or	pos_20=IN	lemma_7=such	pos_15=,	relType_11=punct	pos_9=DT	lemma_2=it	relType_15=punct	lemma_13=thioxanthene	lemma_4=possible	lib=be	pos_2=PRP	pos_13=-RRB-	wib=is	lemma_9=the	relType_15=conj	relType_19=obj	relType_3=cop	relType_6=nsubj	relType_12=conj	pos_4=JJ	lemma_19=effectiveness	relType_13=punct	relType_6=punct	relType_17=ccomp	pos_11=NNS	relType_16=aux	pos_19=NN	lemma_5=that	pos_15=NN	pos_12=NNS	lemma_12=butyrophenone	pos_17=VB	relType_14=cc	pos_11=,	pos_6=,	eib=True	lemma_13=)	relType_8=fixed	lpib=be_VBZ	pos_10=NNS	relType_9=det
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e4	null	path2=neuroleptic_nmod	lemma_1=,	pos_3=IN	path1=	pos_1=,	pos_2=JJ	lemma_3=as	relType_3=fixed	eib=False	path=<antagonist_nsubj>neuroleptic_nmod	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_4=the	relType_2=case	wib=such	lib=such	relType_4=det	relType_1=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e5	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	pos_5=NNS	lemma_5=(	lemma_2=such	path2=neuroleptic_nmod>phenothiazine_dep	lpib=such_JJ	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	relType_2=case	wib=such	eib=True	lib=such	relType_4=det	relType_1=punct	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep	pos_5=-LRB-
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e6	null	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	pos_5=NNS	relType_6=punct	lemma_5=(	lemma_2=such	lpib=such_JJ	pos_4=DT	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	lemma_4=the	relType_5=punct	relType_5=nmod	path2=neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	pos_6=,	relType_2=case	wib=such	eib=True	pos_6=NNS	lib=such	relType_4=det	relType_1=punct	lemma_6=phenothiazine	pos_5=-LRB-
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e7	null	pos_7=NNS	path=<antagonist_nsubj>neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	pos_2=JJ	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	pos_5=NNS	relType_6=punct	pos_7=,	lemma_5=(	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	relType_5=punct	lemma_4=the	relType_5=nmod	pos_6=,	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	relType_7=punct	pos_6=NNS	path2=neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lib=such	relType_4=det	relType_1=punct	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e8	null	pos_7=NNS	lemma_1=,	pos_3=IN	path1=	pos_1=,	lemma_6=,	relType_8=punct	pos_2=JJ	pos_8=NNS	lemma_8=thioxanthene	lemma_3=as	lemma_5=neuroleptic	relType_3=fixed	relType_6=dep	path=<antagonist_nsubj>neuroleptic_nmod>metoclopramide_conj	pos_5=NNS	relType_6=punct	pos_7=,	lemma_5=(	pos_8=-RRB-	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_8=)	pos_9=CC	relType_5=punct	path2=neuroleptic_nmod>metoclopramide_conj	lemma_4=the	lemma_9=or	relType_5=nmod	pos_6=,	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	relType_7=punct	pos_6=NNS	relType_8=conj	lib=such	relType_4=det	relType_1=punct	relType_9=cc	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e3	DDI-DrugBank.d737.s10.e9	effect	pos_7=NNS	lemma_1=,	relType_10=punct	pos_3=IN	lemma_13=the	lemma_15=of	lemma_10=,	pos_11=MD	pos_1=,	lemma_6=,	pos_13=DT	lemma_14=effectiveness	path2=effectiveness_obj>MIRAPEX_nmod	relType_8=punct	pos_2=JJ	path=antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	pos_8=NNS	lemma_8=thioxanthene	lemma_3=as	lemma_5=neuroleptic	relType_12=ccomp	relType_3=fixed	relType_6=dep	relType_14=obj	relType_10=conj	pos_5=NNS	relType_6=punct	relType_11=aux	pos_7=,	lemma_5=(	pos_8=-RRB-	pos_14=NN	pos_10=NN	lemma_7=,	lemma_2=such	lpib=such_JJ	pos_4=DT	lemma_8=)	pos_9=CC	relType_15=case	relType_5=punct	lemma_4=the	lemma_9=or	relType_5=nmod	lemma_11=may	pos_6=,	pos_12=VB	pos_15=IN	lemma_10=metoclopramide	relType_2=case	wib=such	eib=True	lemma_7=butyrophenone	pos_10=,	relType_7=punct	path1=antagonist_nsubj	pos_6=NNS	relType_8=conj	relType_13=det	lib=such	relType_4=det	relType_1=punct	lemma_12=diminish	relType_9=cc	lemma_6=phenothiazine	relType_7=conj	pos_5=-LRB-
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e4	DDI-DrugBank.d737.s10.e5	null	lemma_1=(	path=<neuroleptic_nmod>phenothiazine_dep	lib=phenothiazine	path2=phenothiazine_dep	eib=False	path1=	wib=phenothiazines	relType_1=punct	pos_1=-LRB-	lpib=phenothiazine_NNS
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e4	DDI-DrugBank.d737.s10.e6	null	lemma_1=(	pos_2=NNS	relType_2=dep	lib=phenothiazine	eib=True	lemma_2=phenothiazine	path1=	wib=phenothiazines	pos_2=,	path2=phenothiazine_dep>butyrophenone_conj	path=<neuroleptic_nmod>phenothiazine_dep>butyrophenone_conj	relType_1=punct	relType_2=punct	lemma_2=,	pos_1=-LRB-	lpib=phenothiazine_NNS
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e4	DDI-DrugBank.d737.s10.e7	null	path=<neuroleptic_nmod>phenothiazine_dep>thioxanthene_conj	lemma_2=phenothiazine	path1=	wib=phenothiazines	relType_2=punct	lemma_1=(	path2=phenothiazine_dep>thioxanthene_conj	lemma_3=butyrophenone	pos_3=NNS	lemma_2=,	lpib=phenothiazine_NNS	relType_2=dep	lemma_3=,	relType_3=conj	pos_1=-LRB-	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e4	DDI-DrugBank.d737.s10.e8	null	pos_5=CC	lemma_2=phenothiazine	path1=	wib=phenothiazines	relType_2=punct	lemma_1=(	relType_5=cc	lemma_3=butyrophenone	pos_3=NNS	pos_4=-RRB-	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	path=<neuroleptic_nmod>metoclopramide_conj	lemma_4=)	path2=metoclopramide_conj	lemma_4=thioxanthene	pos_1=-LRB-	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=or
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e4	DDI-DrugBank.d737.s10.e9	effect	path=neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	pos_5=CC	lemma_2=phenothiazine	wib=phenothiazines	lemma_6=,	lemma_8=diminish	relType_7=aux	path2=effectiveness_obj>MIRAPEX_nmod	lemma_10=effectiveness	relType_11=case	relType_2=punct	lemma_1=(	pos_6=NN	relType_5=cc	relType_6=conj	lemma_3=butyrophenone	pos_3=NNS	relType_6=punct	pos_4=-RRB-	path1=neuroleptic_nmod<antagonist_nsubj	lemma_6=metoclopramide	pos_9=DT	pos_7=MD	lemma_7=may	pos_10=NN	relType_10=obj	lemma_2=,	pos_4=NNS	lpib=phenothiazine_NNS	pos_8=VB	pos_11=IN	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=)	relType_8=ccomp	lemma_4=thioxanthene	pos_1=-LRB-	pos_6=,	pos_2=NNS	lib=phenothiazine	pos_3=,	eib=True	lemma_9=the	lemma_11=of	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	relType_9=det	lemma_5=or
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e5	DDI-DrugBank.d737.s10.e6	null	path2=butyrophenone_conj	lemma_1=,	lib=butyrophenone	eib=False	lpib=butyrophenone_NNS	wib=butyrophenones	path1=	pos_1=,	path=<phenothiazine_dep>butyrophenone_conj	relType_1=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e5	DDI-DrugBank.d737.s10.e7	null	pos_2=NNS	lemma_1=,	path2=thioxanthene_conj	lib=butyrophenone	eib=True	lpib=butyrophenone_NNS	wib=butyrophenones	path1=	pos_1=,	path=<phenothiazine_dep>thioxanthene_conj	pos_2=,	lemma_2=butyrophenone	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e5	DDI-DrugBank.d737.s10.e8	null	lemma_1=,	pos_1=,	relType_4=cc	relType_2=punct	pos_3=NNS	path=phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	wib=butyrophenones	relType_2=conj	lemma_2=,	relType_3=conj	lemma_4=or	lemma_2=butyrophenone	path2=metoclopramide_conj	lemma_3=)	pos_2=NNS	lib=butyrophenone	eib=True	pos_3=-RRB-	pos_4=CC	lpib=butyrophenone_NNS	path1=phenothiazine_dep	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=thioxanthene
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e5	DDI-DrugBank.d737.s10.e9	effect	path=phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	pos_7=VB	lemma_1=,	pos_8=DT	lemma_6=may	pos_5=,	lemma_9=effectiveness	pos_1=,	lemma_10=of	path2=effectiveness_obj>MIRAPEX_nmod	relType_4=cc	relType_2=punct	lemma_5=metoclopramide	pos_3=NNS	wib=butyrophenones	relType_10=case	relType_2=conj	pos_9=NN	lemma_2=,	relType_3=conj	lemma_4=or	lemma_5=,	relType_5=punct	relType_6=aux	lemma_8=the	relType_9=obj	lemma_2=butyrophenone	pos_10=IN	relType_5=conj	pos_6=MD	lemma_3=)	pos_2=NNS	pos_5=NN	lemma_7=diminish	lib=butyrophenone	eib=True	pos_3=-RRB-	pos_4=CC	lpib=butyrophenone_NNS	relType_7=ccomp	pos_2=,	relType_8=det	relType_1=punct	relType_3=punct	path1=phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	lemma_3=thioxanthene
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e6	DDI-DrugBank.d737.s10.e7	null	path1=butyrophenone_conj	lib=thioxanthene	lemma_1=,	path2=thioxanthene_conj	eib=False	lpib=thioxanthene_NNS	pos_1=,	relType_1=punct	path=butyrophenone_conj<phenothiazine_dep>thioxanthene_conj	wib=thioxanthenes
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e6	DDI-DrugBank.d737.s10.e8	null	lemma_2=)	lib=thioxanthene	lemma_1=,	pos_3=CC	pos_1=,	relType_3=cc	relType_2=punct	path=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	lemma_3=or	path1=butyrophenone_conj<phenothiazine_dep	relType_2=conj	lemma_2=thioxanthene	path2=metoclopramide_conj	pos_2=NNS	eib=True	pos_2=-RRB-	lpib=thioxanthene_NNS	relType_1=punct	wib=thioxanthenes
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e6	DDI-DrugBank.d737.s10.e9	effect	lemma_2=)	lib=thioxanthene	lemma_1=,	path=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	pos_6=VB	relType_7=det	pos_3=CC	pos_1=,	pos_9=IN	path2=effectiveness_obj>MIRAPEX_nmod	lemma_8=effectiveness	relType_3=cc	relType_2=punct	pos_8=NN	lemma_6=diminish	lemma_5=may	pos_4=,	relType_8=obj	lemma_3=or	relType_9=case	relType_5=aux	relType_2=conj	pos_4=NN	pos_7=DT	lemma_2=thioxanthene	lemma_4=metoclopramide	pos_5=MD	relType_4=punct	relType_6=ccomp	lemma_4=,	path1=butyrophenone_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	pos_2=NNS	eib=True	pos_2=-RRB-	lemma_9=of	lpib=thioxanthene_NNS	relType_4=conj	lemma_7=the	relType_1=punct	wib=thioxanthenes
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e7	DDI-DrugBank.d737.s10.e8	null	path1=thioxanthene_conj<phenothiazine_dep	lemma_2=or	path=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod>metoclopramide_conj	lpib=metoclopramide_NN	lib=metoclopramide	eib=False	pos_1=-RRB-	pos_2=CC	wib=metoclopramide	relType_1=punct	lemma_1=)	relType_2=cc	path2=metoclopramide_conj
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e7	DDI-DrugBank.d737.s10.e9	effect	relType_8=case	lemma_2=or	lib=metoclopramide	path1=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj	pos_6=DT	wib=metoclopramide	path2=effectiveness_obj>MIRAPEX_nmod	lemma_4=may	lemma_1=)	relType_2=cc	pos_5=VB	lemma_5=diminish	lemma_6=the	relType_7=obj	pos_4=MD	lemma_3=metoclopramide	pos_8=IN	lpib=metoclopramide_NN	lemma_3=,	relType_3=conj	pos_1=-RRB-	relType_4=aux	path=thioxanthene_conj<phenothiazine_dep<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	relType_5=ccomp	relType_6=det	pos_3=,	eib=True	pos_3=NN	pos_2=CC	lemma_7=effectiveness	relType_1=punct	pos_7=NN	lemma_8=of	relType_3=punct
DDI-DrugBank.d737.s10	DDI-DrugBank.d737.s10.e8	DDI-DrugBank.d737.s10.e9	effect	lemma_1=,	pos_2=MD	pos_1=,	path2=effectiveness_obj>MIRAPEX_nmod	lemma_6=of	pos_3=VB	relType_6=case	eib=False	pos_6=IN	lemma_5=effectiveness	lib=diminish	relType_2=aux	lemma_3=diminish	pos_4=DT	lemma_4=the	path=metoclopramide_conj<neuroleptic_nmod<antagonist_nsubj<diminish_ccomp>effectiveness_obj>MIRAPEX_nmod	path1=metoclopramide_conj<neuroleptic_nmod<antagonist_nsubj	pos_5=NN	relType_3=ccomp	relType_5=obj	lpib=diminish_VB	lemma_2=may	relType_1=punct	relType_4=det	wib=diminish
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e0	DDI-DrugBank.d632.s0.e1	advise	pos_7=NNS	relType_14=punct	pos_3=RB	relType_3=advmod	lemma_5=consider	path=SYMLIN_compound<therapy_nsubj:pass<consider_ROOT>patient_obl>alter_acl:relcl>motility_obj>g._dep>agent_dep	lemma_4=be	pos_2=MD	lemma_9=drug	lemma_3=not	relType_11=acl:relcl	relType_17=punct	relType_18=amod	lpib=therapy_NN	relation_10=neutral	lemma_16=g.	lemma_14=(	relType_6=case	lemma_15=e.	pos_12=JJ	pos_5=VBN	lemma_12=gastrointestinal	lemma_6=for	lemma_17=,	pos_6=IN	pos_9=NNS	path2=patient_obl>alter_acl:relcl>motility_obj>g._dep>agent_dep	lemma_1=therapy	lemma_7=patient	relType_2=aux	relType_12=amod	pos_13=NN	pos_18=JJ	pos_1=NN	pos_11=VBP	pos_17=,	pos_10=WDT	pos_14=-LRB-	pos_15=NN	lemma_2=should	pos_8=VBG	relType_9=obj	relType_4=aux:pass	lib=therapy	lemma_8=take	relType_10=nsubj	pos_16=NN	relType_8=acl	lemma_11=alter	lemma_13=motility	relType_15=compound	relType_7=obl	eib=True	lemma_18=anticholinergic	lemma_10=that	pos_4=VB	relType_16=dep	relType_1=nsubj:pass	relType_13=obj	relType_5=ROOT	path1=SYMLIN_compound<therapy_nsubj:pass	wib=therapy
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e0	DDI-DrugBank.d632.s0.e2	advise	pos_7=NNS	relType_18=dep	pos_19=IN	relType_14=punct	pos_3=RB	relType_3=advmod	lemma_5=consider	lemma_4=be	pos_18=NNS	pos_2=MD	lemma_9=drug	lemma_3=not	relType_11=acl:relcl	path2=patient_obl>alter_acl:relcl>motility_obj>g._dep>agent_dep>atropine_nmod	relType_17=punct	lpib=therapy_NN	relType_18=amod	relation_10=neutral	lemma_16=g.	relType_19=fixed	lemma_14=(	relType_6=case	lemma_15=e.	relType_18=case	pos_12=JJ	pos_5=VBN	lemma_12=gastrointestinal	lemma_6=for	lemma_19=as	lemma_17=,	pos_6=IN	lemma_18=such	pos_9=NNS	lemma_1=therapy	lemma_7=patient	relType_2=aux	relType_12=amod	pos_13=NN	pos_18=JJ	pos_1=NN	pos_11=VBP	pos_17=,	pos_10=WDT	pos_14=-LRB-	pos_15=NN	lemma_2=should	pos_8=VBG	relType_9=obj	relType_4=aux:pass	lib=therapy	lemma_8=take	relType_10=nsubj	pos_16=NN	relType_8=acl	lemma_11=alter	lemma_13=motility	relType_15=compound	relType_7=obl	path=SYMLIN_compound<therapy_nsubj:pass<consider_ROOT>patient_obl>alter_acl:relcl>motility_obj>g._dep>agent_dep>atropine_nmod	eib=True	lemma_18=anticholinergic	lemma_10=that	pos_4=VB	relType_16=dep	lemma_18=agent	relType_1=nsubj:pass	relType_13=obj	relType_5=ROOT	path1=SYMLIN_compound<therapy_nsubj:pass	wib=therapy
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e0	DDI-DrugBank.d632.s0.e3	advise	relType_18=dep	pos_34=NN	lemma_4=be	pos_33=,	lemma_3=not	lpib=therapy_NN	lemma_20=atropine	lemma_23=that	lemma_16=g.	relType_34=compound	relType_21=cc	pos_29=NNS	relType_18=case	lemma_19=as	lemma_29=nutrient	lemma_18=such	relType_20=nmod	pos_20=NN	lemma_1=therapy	pos_13=NN	pos_10=WDT	pos_14=-LRB-	lemma_2=should	relType_33=punct	relType_4=aux:pass	lib=therapy	pos_32=NN	relType_25=det	lemma_13=motility	relType_15=compound	relType_26=amod	relType_30=punct	pos_4=VB	relType_5=ROOT	path1=SYMLIN_compound<therapy_nsubj:pass	wib=therapy	pos_7=NNS	pos_18=NNS	lemma_5=consider	relType_22=conj	pos_2=MD	path=SYMLIN_compound<therapy_nsubj:pass<consider_ROOT>patient_obl>alter_acl:relcl>motility_obj>slow_dep>absorption_iobj>g._dep>inhibitor_appos	relType_6=case	lemma_15=e.	pos_6=IN	lemma_33=,	relType_12=amod	pos_27=NN	pos_8=VBG	relType_29=nmod	lemma_8=take	pos_16=NN	relType_7=obl	pos_31=NN	lemma_26=intestinal	lemma_18=agent	relType_23=nsubj	relType_14=punct	lemma_28=of	pos_3=RB	relType_17=punct	relType_11=acl:relcl	relType_31=compound	pos_26=JJ	pos_20=-RRB-	lemma_12=gastrointestinal	lemma_6=for	relType_2=aux	pos_1=NN	pos_17=,	lemma_22=agent	relType_9=obj	lemma_34=alpha	relType_27=iobj	relType_8=acl	lemma_20=)	lemma_27=absorption	relType_28=case	lemma_21=and	lemma_18=anticholinergic	lemma_10=that	relType_20=punct	pos_23=WDT	relType_1=nsubj:pass	pos_19=IN	relType_3=advmod	lemma_24=slow	pos_30=-LRB-	lemma_9=drug	relType_18=amod	relation_10=neutral	relType_32=dep	path2=patient_obl>alter_acl:relcl>motility_obj>slow_dep>absorption_iobj>g._dep>inhibitor_appos	relType_19=fixed	lemma_14=(	lemma_31=e.	pos_12=JJ	pos_25=DT	lemma_17=,	pos_9=NNS	lemma_7=patient	pos_18=JJ	relType_24=dep	lemma_32=g.	pos_11=VBP	pos_24=VBP	pos_15=NN	lemma_25=the	pos_22=NNS	relType_10=nsubj	lemma_11=alter	pos_21=CC	eib=True	relType_16=dep	pos_28=IN	lemma_34=glucosidase	relType_13=obj	pos_5=VBN	lemma_30=(
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e1	DDI-DrugBank.d632.s0.e2	null	lpib=such_JJ	pos_2=IN	relType_1=case	relType_2=fixed	wib=such	eib=False	lemma_1=such	path=<agent_dep>atropine_nmod	path1=	pos_1=JJ	lib=such	path2=atropine_nmod	lemma_2=as
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e1	DDI-DrugBank.d632.s0.e3	null	relType_1=case	pos_8=DT	relType_13=punct	lemma_17=alpha	pos_1=JJ	relType_4=cc	relType_14=compound	path=agent_dep<g._dep<motility_obj>slow_dep>absorption_iobj>g._dep>inhibitor_appos	lemma_2=as	relType_11=case	pos_2=IN	pos_9=JJ	pos_17=NN	path1=agent_dep<g._dep	pos_5=NNS	lemma_7=slow	lemma_14=e.	relType_12=nmod	relType_15=dep	lemma_5=agent	pos_16=,	relType_9=amod	pos_14=NN	pos_10=NN	lemma_16=,	relType_17=compound	lemma_17=glucosidase	relType_10=iobj	pos_11=IN	lpib=such_JJ	lemma_13=(	pos_15=NN	path2=slow_dep>absorption_iobj>g._dep>inhibitor_appos	pos_12=NNS	lemma_8=the	pos_6=WDT	lemma_12=nutrient	relType_3=nmod	lemma_9=intestinal	lemma_15=g.	relType_5=conj	lemma_3=)	pos_13=-LRB-	relType_16=punct	lemma_10=absorption	relType_2=fixed	relType_7=dep	wib=such	eib=True	pos_3=-RRB-	pos_4=CC	lemma_1=such	pos_3=NN	lemma_4=and	lemma_3=atropine	lemma_11=of	relType_8=det	lemma_6=that	lib=such	pos_7=VBP	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d632.s0	DDI-DrugBank.d632.s0.e2	DDI-DrugBank.d632.s0.e3	null	lemma_10=nutrient	lpib=agent_NNS	relType_14=punct	relType_8=iobj	relType_13=dep	lib=agent	pos_6=DT	path=atropine_nmod<agent_dep<g._dep<motility_obj>slow_dep>absorption_iobj>g._dep>inhibitor_appos	lemma_3=agent	lemma_7=intestinal	pos_9=IN	lemma_1=)	relType_2=cc	pos_8=NN	path1=atropine_nmod<agent_dep<g._dep	lemma_2=and	pos_4=WDT	relType_10=nmod	pos_3=NNS	lemma_13=g.	relType_12=compound	pos_5=VBP	lemma_6=the	pos_11=-LRB-	relType_11=punct	pos_14=,	relType_9=case	pos_13=NN	relType_4=nsubj	relType_5=dep	lemma_15=alpha	relType_7=amod	wib=agents	pos_15=NN	lemma_15=glucosidase	path2=slow_dep>absorption_iobj>g._dep>inhibitor_appos	relType_3=conj	pos_1=-RRB-	lemma_11=(	lemma_8=absorption	relType_15=compound	relType_6=det	lemma_14=,	eib=True	lemma_12=e.	lemma_9=of	lemma_4=that	pos_2=CC	lemma_5=slow	pos_7=JJ	relType_1=punct	pos_12=NN	pos_10=NNS
DDI-DrugBank.d632.s3	DDI-DrugBank.d632.s3.e0	DDI-DrugBank.d632.s3.e1	advise	relType_6=aux:pass	path1=analgesic_nmod<effectiveness_nmod<determinant_advcl	relType_8=case	lemma_12=prior	pos_6=VB	pos_14=CC	lib=agent	lemma_11=hour	relType_16=advcl	relType_9=obl:npmod	relType_12=case	lpib=agent_NN	lemma_7=administer	lemma_1=)	relType_11=obj	lemma_8=at	lemma_14=or	pos_16=NNS	lemma_5=should	lemma_17=after	relType_2=punct	lemma_6=be	lemma_15=2	pos_12=JJ	pos_17=IN	pos_15=CD	eib=False	pos_9=RBS	relType_4=nsubj:pass	pos_13=IN	relType_5=aux	relType_3=det	pos_4=NN	lemma_2=,	pos_8=IN	relType_17=case	lemma_13=to	relType_13=case	pos_5=MD	relType_7=ROOT	pos_10=CD	pos_1=-RRB-	lemma_4=agent	lemma_10=1	relType_14=cc	relType_10=nummod	lemma_16=hour	pos_7=VBN	wib=agent	pos_11=NN	pos_3=DT	relType_15=conj	path=analgesic_nmod<effectiveness_nmod<determinant_advcl<administer_ROOT>hour_advcl>injection_nmod>SYMLIN_compound	lemma_3=the	pos_2=,	relType_1=punct	lemma_9=least	path2=hour_advcl>injection_nmod>SYMLIN_compound
DDI-DrugBank.d632.s4	DDI-DrugBank.d632.s4.e0	DDI-DrugBank.d632.s4.e1	null	relType_1=cc	path=<sulfonylurea_nmod>biguanide_conj	pos_1=CC	eib=False	lib=biguanide	path2=biguanide_conj	path1=	lpib=biguanide_NNS	wib=biguanides	lemma_1=or
DDI-DrugBank.d632.s4	DDI-DrugBank.d632.s4.e0	DDI-DrugBank.d632.s4.e2	null	relType_1=cc	pos_1=CC	relType_7=compound	pos_3=RB	relType_3=advmod	pos_6=JJ	lib=biguanide	lemma_3=not	lemma_2=do	pos_9=IN	wib=biguanides	pos_8=NN	relType_6=amod	path1=sulfonylurea_nmod<use_nsubj	pos_2=VBD	relType_8=obj	relType_2=aux	relType_9=case	relType_2=conj	relType_5=det	lemma_7=event	path2=profile_obj>SYMLIN_nmod	relType_4=ROOT	pos_2=NNS	lemma_5=the	lemma_4=alter	eib=True	lemma_2=biguanide	pos_4=VB	lemma_6=adverse	path=sulfonylurea_nmod<use_nsubj<alter_ROOT>profile_obj>SYMLIN_nmod	pos_5=DT	lemma_8=profile	lemma_9=of	relation_4=neutral	lpib=biguanide_NNS	pos_7=NN	lemma_1=or
DDI-DrugBank.d632.s4	DDI-DrugBank.d632.s4.e1	DDI-DrugBank.d632.s4.e2	null	relType_8=case	lemma_3=alter	relType_1=aux	lemma_6=event	pos_7=NN	lemma_7=profile	wib=did	pos_3=VB	pos_6=NN	pos_2=RB	pos_1=VBD	eib=False	relType_2=advmod	lemma_1=do	relation_2=neutral	relType_7=obj	pos_8=IN	pos_4=DT	pos_5=JJ	relType_5=amod	path=biguanide_conj<sulfonylurea_nmod<use_nsubj<alter_ROOT>profile_obj>SYMLIN_nmod	relType_3=ROOT	lemma_4=the	lemma_5=adverse	lpib=do_VBD	path2=profile_obj>SYMLIN_nmod	relType_6=compound	lib=do	path1=biguanide_conj<sulfonylurea_nmod<use_nsubj	relType_4=det	lemma_8=of	lemma_2=not
DDI-DrugBank.d632.s5	DDI-DrugBank.d632.s5.e0	DDI-DrugBank.d632.s5.e1	null	path=SYMLIN_nmod<effect_obj>kinetics_nmod>agent_nmod	pos_2=DT	relType_1=case	lemma_2=the	pos_6=JJ	path2=kinetics_nmod>agent_nmod	path1=SYMLIN_nmod	lpib=kinetics_NN	lemma_5=oral	relType_6=amod	lib=kinetics	pos_1=IN	pos_5=JJ	relType_5=amod	pos_4=IN	relType_3=nmod	relType_4=case	lemma_6=antidiabetic	lemma_3=kinetics	wib=kinetics	eib=True	pos_3=NN	relType_2=det	lemma_4=of	lemma_1=on
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e0	DDI-DrugBank.d632.s6.e1	null	relType_1=cc	pos_1=CC	eib=False	path1=	path=<symlin_nsubj:pass>insulin_conj	path2=insulin_conj	lib=insulin	lpib=insulin_NN	wib=Insulin	lemma_1=and
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e0	DDI-DrugBank.d632.s6.e2	null	relType_1=cc	pos_2=DT	pos_1=CC	relType_4=dep	pos_2=NN	lemma_2=the	lemma_3=pharmacokinetic	lemma_4=parameter	path1=	lemma_5=of	relType_5=case	lemma_2=insulin	relType_2=conj	lpib=insulin_NN	wib=Insulin	pos_4=NNS	path2=parameter_dep>SYMLIN_nmod	relType_3=amod	pos_5=IN	pos_3=JJ	eib=True	relType_2=det	lib=insulin	lemma_1=and	path=<symlin_nsubj:pass>parameter_dep>SYMLIN_nmod
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e0	DDI-DrugBank.d632.s6.e3	null	relType_1=cc	relType_6=aux:pass	pos_2=NN	lemma_11=regular	lemma_3=pharmacokinetic	lemma_5=of	relType_5=case	pos_6=VBD	lemma_2=insulin	lemma_12=,	pos_12=,	lemma_8=when	lemma_13=NPH	lpib=insulin_NN	relType_3=amod	lemma_18=30	lemma_15=and	relType_21=case	pos_3=JJ	pos_15=CC	pos_11=JJ	pos_2=DT	lemma_2=the	lemma_4=parameter	lemma_19=premixed	relation_8=neutral	lemma_6=be	relType_20=conj	pos_19=JJ	relType_17=dep	relType_12=punct	relType_13=conj	relType_2=conj	lemma_23=human	pos_5=IN	relType_16=nummod	lemma_9=mix	relType_19=amod	lemma_14=,	lib=insulin	lemma_21=of	lemma_22=recombinant	lemma_1=and	relType_4=dep	relType_14=punct	pos_23=JJ	path1=symlin_nsubj:pass	relType_8=dep	lemma_10=with	relType_23=amod	path=symlin_nsubj:pass<alter_ROOT>when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	pos_6=NNP	pos_14=,	pos_17=SYM	pos_21=IN	wib=Insulin	lemma_7=alter	pos_16=CD	pos_10=IN	relType_11=obl	pos_22=JJ	relType_22=amod	pos_8=WRB	relType_6=nmod	lemma_20=formulation	pos_1=CC	relType_9=dep	pos_13=NNP	lemma_16=70	relType_10=case	pos_9=VBN	pos_4=NNS	pos_18=CD	relType_7=ROOT	pos_20=NNS	relType_15=cc	path2=when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	lemma_6=SYMLIN	pos_7=VBN	eib=True	relType_2=det	relType_18=compound	lemma_17=/
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e1	DDI-DrugBank.d632.s6.e2	null	relType_3=dep	pos_1=DT	lib=pharmacokinetic	lemma_1=the	lemma_2=pharmacokinetic	pos_2=JJ	path1=insulin_conj	pos_3=NNS	eib=False	relType_1=det	path=insulin_conj<symlin_nsubj:pass>parameter_dep>SYMLIN_nmod	path2=parameter_dep>SYMLIN_nmod	pos_4=IN	relType_2=amod	relType_4=case	wib=pharmacokinetic	lemma_3=parameter	lemma_4=of	lpib=pharmacokinetic_JJ
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e1	DDI-DrugBank.d632.s6.e3	null	pos_14=CC	lemma_13=,	lib=pharmacokinetic	lemma_1=the	pos_2=JJ	lemma_19=formulation	lemma_6=alter	pos_15=CD	pos_3=NNS	relType_9=case	relType_17=compound	lemma_5=be	relType_6=ROOT	lemma_10=regular	relType_15=nummod	lemma_5=SYMLIN	pos_17=CD	lemma_17=30	lemma_20=of	relType_3=dep	pos_13=,	pos_8=VBN	pos_21=JJ	pos_19=NNS	lemma_8=mix	relType_20=case	relType_5=aux:pass	lemma_16=/	pos_5=NNP	pos_5=VBD	relType_7=dep	pos_12=NNP	lemma_12=NPH	lemma_14=and	relType_1=det	wib=pharmacokinetic	pos_1=DT	relType_8=dep	lemma_11=,	lemma_2=pharmacokinetic	pos_7=WRB	lemma_18=premixed	pos_20=IN	relType_11=punct	pos_6=VBN	pos_4=IN	relType_2=amod	lemma_15=70	relType_19=conj	pos_22=JJ	relType_22=amod	lemma_3=parameter	relType_10=obl	path=insulin_conj<symlin_nsubj:pass<alter_ROOT>when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	lemma_4=of	relType_12=conj	relType_18=amod	relType_13=punct	pos_9=IN	relation_6=neutral	lemma_22=human	relType_21=amod	pos_18=JJ	lemma_21=recombinant	pos_10=JJ	relType_4=case	relType_5=nmod	relType_14=cc	pos_11=,	path2=when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	lemma_9=with	eib=True	path1=insulin_conj<symlin_nsubj:pass	relType_16=dep	pos_16=SYM	lemma_7=when	lpib=pharmacokinetic_JJ
DDI-DrugBank.d632.s6	DDI-DrugBank.d632.s6.e2	DDI-DrugBank.d632.s6.e3	mechanism	lemma_13=30	relType_3=dep	pos_2=VBN	relType_4=dep	relType_14=amod	pos_6=JJ	pos_13=CD	relation_1=neutral	pos_16=IN	path=SYMLIN_nmod<parameter_dep<symlin_nsubj:pass<alter_ROOT>when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	lemma_15=formulation	relType_1=aux:pass	relType_10=cc	path1=SYMLIN_nmod<parameter_dep<symlin_nsubj:pass	relType_18=amod	lemma_9=,	pos_17=JJ	lemma_14=premixed	relType_5=case	wib=were	relType_6=obl	pos_12=SYM	pos_1=VBD	lemma_2=alter	lemma_12=/	pos_10=CC	lemma_18=human	lemma_1=be	lemma_5=with	pos_7=,	lemma_17=recombinant	pos_18=JJ	lemma_16=of	lemma_7=,	pos_4=VBN	lemma_6=regular	lemma_10=and	relType_11=nummod	pos_8=NNP	lib=be	relType_13=compound	relType_2=ROOT	lemma_11=70	pos_5=IN	relType_9=punct	pos_11=CD	relType_17=amod	lemma_4=mix	path2=when_dep>mix_dep>regular_obl>formulation_conj>insulin_nmod	pos_3=WRB	relType_16=case	pos_15=NNS	eib=True	relType_12=dep	relType_7=punct	lemma_8=NPH	relType_8=conj	relType_15=conj	pos_14=JJ	pos_9=,	lpib=be_VBD	lemma_3=when
DDI-DrugBank.d632.s7	DDI-DrugBank.d632.s7.e0	DDI-DrugBank.d632.s7.e1	null	relType_1=cc	wib=insulin	pos_1=CC	eib=False	path=<SYMLIN_nsubj:pass>insulin_conj	path1=	path2=insulin_conj	lib=insulin	lpib=insulin_NN	lemma_1=and
DDI-DrugBank.d734.s0	DDI-DrugBank.d734.s0.e0	DDI-DrugBank.d734.s0.e1	effect	relType_4=amod	pos_4=JJ	relType_1=aux	lemma_1=may	wib=accentuate	path=diuretic_nsubj<accentuate_ROOT>hypotension_obj>occur_acl:relcl>phenothiazine_obl	lemma_4=orthostatic	relType_7=aux	pos_9=IN	relType_8=acl:relcl	lib=accentuate	lemma_2=accentuate	eib=False	pos_2=VB	pos_7=MD	lemma_7=may	relType_9=case	relType_3=det	pos_8=VB	path2=hypotension_obj>occur_acl:relcl>phenothiazine_obl	relType_2=ROOT	pos_6=WDT	lemma_5=hypotension	lpib=accentuate_VB	pos_1=MD	pos_5=NN	lemma_9=with	pos_3=DT	relType_5=obj	lemma_3=the	lemma_6=that	lemma_8=occur	relType_6=nsubj	path1=diuretic_nsubj
DDI-DrugBank.d734.s1	DDI-DrugBank.d734.s1.e0	DDI-DrugBank.d734.s1.e1	effect	relType_1=cc	pos_1=CC	pos_2=VBN	lemma_3=compound	path1=guanethidine_nmod<effect_nsubj:pass	lemma_4=may	relation_5=adverse	pos_7=WRB	lib=relate	pos_5=VB	pos_3=NNS	eib=False	pos_4=MD	pos_6=VBN	lemma_5=be	relType_6=ROOT	relType_5=aux:pass	path=guanethidine_nmod<effect_nsubj:pass<counteract_ROOT>use_advcl>phenothiazine_nsubj:pass	wib=related	relType_3=conj	relType_2=amod	relType_4=aux	lemma_6=counteract	lemma_7=when	lpib=relate_VBN	relType_7=advmod	path2=use_advcl>phenothiazine_nsubj:pass	lemma_1=and	lemma_2=relate
DDI-DrugBank.d734.s2	DDI-DrugBank.d734.s2.e0	DDI-DrugBank.d734.s2.e1	mechanism	lemma_1=with	relType_1=case	lib=phenothiazine	path=propranolol_nmod<administration_nsubj>phenothiazine_nmod	eib=False	wib=phenothiazines	pos_1=IN	path2=phenothiazine_nmod	path1=propranolol_nmod	lpib=phenothiazine_NNS
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e0	DDI-DrugBank.d590.s0.e1	mechanism	lemma_1=with	relType_1=case	path=TRITEC_nmod<Coadministration_nsubj>clarithromycin_nmod	eib=False	path2=clarithromycin_nmod	lpib=clarithromycin_NN	lib=clarithromycin	wib=clarithromycin	pos_1=IN	path1=TRITEC_nmod
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e0	DDI-DrugBank.d590.s0.e2	null	relType_4=amod	relType_1=case	pos_2=NN	pos_3=IN	relation_4=beneficial	lib=clarithromycin	relType_5=compound	relType_2=nmod	wib=clarithromycin	lemma_4=increase	pos_2=VBD	pos_1=IN	pos_4=VBN	path2=concentration_obl>ranitidine_compound	path1=TRITEC_nmod<Coadministration_nsubj	relType_2=ROOT	lemma_5=plasma	lemma_2=clarithromycin	relType_3=case	lemma_2=result	path=TRITEC_nmod<Coadministration_nsubj<result_ROOT>concentration_obl>ranitidine_compound	lemma_1=with	pos_5=NN	eib=True	lpib=clarithromycin_NN	lemma_3=in
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e0	DDI-DrugBank.d590.s0.e3	null	pos_2=NN	pos_24=CD	lemma_8=57	pos_6=NN	pos_7=-LRB-	relType_24=nummod	pos_13=NN	relType_24=compound	path1=TRITEC_nmod<Coadministration_nsubj	lemma_21=,	lemma_14=bismuth	relType_15=compound	relType_6=compound	lemma_16=concentration	lemma_10=)	pos_6=NNS	lemma_17=(	relType_21=punct	relType_4=amod	relType_1=case	relType_18=nummod	lib=clarithromycin	pos_16=NNS	lemma_24=14	wib=clarithromycin	relType_12=amod	pos_1=IN	pos_9=NN	relType_23=conj	pos_4=VBN	relType_2=ROOT	lemma_5=plasma	lemma_2=clarithromycin	pos_17=-LRB-	relation_13=beneficial	pos_5=NN	lpib=clarithromycin_NN	relation_24=beneficial	lemma_6=concentration	pos_8=CD	relType_10=punct	pos_3=IN	pos_24=HYPH	relation_4=beneficial	lemma_11=,	relType_17=punct	relType_24=punct	path=TRITEC_nmod<Coadministration_nsubj<result_ROOT>increase_conj>concentration_obj>clarithromycin_compound	pos_24=NN	pos_20=-RRB-	relType_6=obl	lemma_23=increase	relType_2=nmod	relType_22=cc	relType_11=punct	lemma_4=increase	relType_19=appos	pos_14=NN	relType_9=appos	lemma_12=increase	lemma_20=)	lemma_24=-	lemma_19=%	relType_20=punct	path2=increase_conj>concentration_obj>clarithromycin_compound	lemma_18=48	lemma_7=(	relType_8=nummod	lemma_15=trough	relType_5=compound	lemma_9=%	relType_14=compound	pos_22=CC	pos_21=,	pos_12=VBD	pos_2=VBD	pos_19=NN	pos_18=CD	lemma_24=hydroxy	relType_13=compound	pos_15=NN	lemma_13=plasma	pos_11=,	lemma_6=ranitidine	relType_3=case	lemma_2=result	lemma_1=with	eib=True	pos_10=-RRB-	relType_7=punct	pos_23=VBD	lemma_3=in	lemma_22=and	relType_16=conj
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e1	DDI-DrugBank.d590.s0.e2	null	lemma_3=increase	pos_3=VBN	pos_2=IN	pos_1=VBD	eib=False	wib=resulted	pos_4=NN	path1=clarithromycin_nmod<Coadministration_nsubj	path2=concentration_obl>ranitidine_compound	relType_3=amod	relType_4=compound	path=clarithromycin_nmod<Coadministration_nsubj<result_ROOT>concentration_obl>ranitidine_compound	relType_1=ROOT	relType_2=case	lemma_4=plasma	lib=result	lpib=result_VBD	lemma_1=result	relation_2=beneficial	lemma_2=in
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e1	DDI-DrugBank.d590.s0.e3	null	lemma_9=)	lemma_10=,	relType_21=cc	lemma_20=,	relType_12=compound	pos_23=CD	wib=resulted	pos_13=NN	relType_23=compound	pos_18=NN	relType_3=amod	relType_16=punct	pos_17=CD	pos_10=,	lemma_17=48	lib=result	lemma_1=result	lemma_16=(	lemma_22=increase	relType_22=conj	pos_16=-LRB-	lemma_5=ranitidine	relType_8=appos	pos_8=NN	pos_1=VBD	relType_11=amod	path=clarithromycin_nmod<Coadministration_nsubj<result_ROOT>increase_conj>concentration_obj>clarithromycin_compound	lemma_12=plasma	pos_23=HYPH	lemma_8=%	pos_5=NN	lemma_11=increase	lemma_4=plasma	lemma_2=in	lemma_3=increase	relType_10=punct	lemma_6=(	relType_19=punct	lemma_23=14	lemma_14=trough	pos_23=NN	pos_2=IN	relType_7=nummod	lemma_18=%	pos_14=NN	relType_18=appos	path1=clarithromycin_nmod<Coadministration_nsubj	pos_22=VBD	lemma_23=-	relType_5=obl	lemma_7=57	relType_2=case	lemma_21=and	relType_15=conj	relType_20=punct	relation_11=beneficial	lemma_19=)	path2=increase_conj>concentration_obj>clarithromycin_compound	lpib=result_VBD	relType_23=punct	relType_23=nummod	pos_11=VBD	pos_3=VBN	lemma_13=bismuth	relType_5=compound	pos_7=CD	relType_14=compound	relation_22=beneficial	pos_6=-LRB-	lemma_15=concentration	relType_17=nummod	pos_5=NNS	relType_6=punct	lemma_5=concentration	pos_4=NN	pos_20=,	pos_9=-RRB-	relType_13=compound	relType_4=compound	lemma_23=hydroxy	relType_9=punct	pos_21=CC	relType_1=ROOT	pos_15=NNS	eib=True	pos_12=NN	relation_2=beneficial	pos_19=-RRB-
DDI-DrugBank.d590.s0	DDI-DrugBank.d590.s0.e2	DDI-DrugBank.d590.s0.e3	null	pos_15=-RRB-	pos_19=NN	lemma_4=%	pos_13=CD	relType_17=cc	lemma_3=57	relType_4=appos	lpib=concentration_NNS	relType_19=nummod	lemma_6=,	lemma_19=hydroxy	lemma_1=concentration	relType_19=punct	lemma_10=trough	relType_2=punct	relType_11=conj	pos_8=NN	lemma_11=concentration	relType_9=compound	pos_19=CD	relType_6=punct	pos_12=-LRB-	lemma_19=14	pos_2=-LRB-	path=ranitidine_compound<concentration_obl<result_ROOT>increase_conj>concentration_obj>clarithromycin_compound	pos_11=NNS	lemma_7=increase	relType_13=nummod	pos_16=,	relType_10=compound	relType_12=punct	pos_10=NN	pos_14=NN	pos_9=NN	pos_4=NN	relType_15=punct	lemma_16=,	lemma_5=)	relType_19=compound	lemma_19=-	relType_7=amod	wib=concentrations	pos_3=CD	pos_5=-RRB-	relType_5=punct	lemma_18=increase	relType_8=compound	pos_7=VBD	lemma_8=plasma	relType_14=appos	relType_3=nummod	lemma_9=bismuth	lemma_15=)	lemma_17=and	relation_6=beneficial	relType_16=punct	pos_6=,	lemma_14=%	pos_1=NNS	path1=ranitidine_compound<concentration_obl	eib=True	pos_19=HYPH	lib=concentration	pos_17=CC	relation_17=beneficial	path2=increase_conj>concentration_obj>clarithromycin_compound	lemma_13=48	lemma_2=(	relType_18=conj	relType_1=obl	lemma_12=(	pos_18=VBD
DDI-DrugBank.d590.s1	DDI-DrugBank.d590.s1.e0	DDI-DrugBank.d590.s1.e1	null	relType_4=amod	pos_4=JJ	relType_7=det	lemma_8=rate	relation_4=adverse	pos_9=IN	relType_6=case	wib=results	pos_2=IN	lemma_4=slight	pos_8=NN	eib=False	path1=aspirin_compound	pos_6=IN	lpib=result_NNS	relType_9=case	path2=decrease_nmod>rate_nmod>absorption_nmod>salicylate_compound	relType_1=nmod	lemma_3=a	relType_3=det	lemma_6=in	pos_7=DT	path=aspirin_compound<result_nmod>decrease_nmod>rate_nmod>absorption_nmod>salicylate_compound	relType_5=nmod	pos_5=NN	pos_1=NNS	relType_2=case	lemma_5=decrease	pos_3=DT	relType_8=nmod	lemma_9=of	lib=result	lemma_7=the	lemma_1=result	lemma_2=in
DDI-DrugBank.d590.s2	DDI-DrugBank.d590.s2.e0	DDI-DrugBank.d590.s2.e1	mechanism	relType_8=nummod	path1=antacid_nmod<dose_nmod<Coadministration_nsubj	relType_2=nummod	pos_5=VBZ	relType_7=det	lemma_2=170	pos_13=NNS	lemma_9=%	relation_9=adverse	lemma_13=concentration	relType_6=case	relType_11=case	lemma_1=(	relType_13=nmod	relType_9=compound	relType_12=compound	eib=False	relType_3=appos	pos_2=CD	pos_6=IN	pos_4=-RRB-	pos_12=NN	lemma_5=result	lemma_11=in	lemma_6=in	pos_10=NN	pos_9=NN	lemma_12=plasma	pos_7=DT	path2=decrease_obl>concentration_nmod>ranitidine_nmod	pos_11=IN	path=antacid_nmod<dose_nmod<Coadministration_nsubj<result_ROOT>decrease_obl>concentration_nmod>ranitidine_nmod	pos_14=IN	lemma_3=meq	relType_4=punct	wib=mEq	lemma_4=)	lpib=meq_NN	pos_1=-LRB-	lib=meq	pos_3=NN	lemma_14=of	lemma_7=a	relType_14=case	pos_8=CD	relType_1=punct	relType_5=ROOT	relType_10=obl	lemma_10=decrease	lemma_8=28
DDI-DrugBank.d590.s2	DDI-DrugBank.d590.s2.e0	DDI-DrugBank.d590.s2.e2	mechanism	path1=antacid_nmod<dose_nmod<Coadministration_nsubj	lemma_2=170	pos_13=NNS	pos_16=MD	relType_12=compound	pos_4=-RRB-	lemma_5=result	pos_22=IN	pos_10=NN	pos_18=NN	lemma_3=meq	lemma_21=bismuth	relType_4=punct	lemma_4=)	lemma_15=and	pos_1=-LRB-	lib=meq	lemma_16=may	lemma_14=of	pos_15=CC	relType_5=ROOT	lemma_20=of	lemma_19=concentration	relType_2=nummod	relation_9=adverse	pos_19=NNS	relType_6=case	relType_11=case	lemma_22=from	relType_20=case	pos_6=IN	lemma_17=decrease	lemma_11=in	lemma_6=in	lemma_12=plasma	pos_9=NN	relType_22=case	pos_14=IN	lemma_18=plasma	relType_15=nmod	lemma_7=a	pos_8=CD	relType_1=punct	pos_5=VBZ	relType_7=det	relation_17=adverse	relType_21=nmod	pos_20=IN	lemma_1=(	relType_3=appos	pos_7=DT	pos_11=IN	wib=mEq	relType_14=case	relType_19=obj	relType_10=obl	path=antacid_nmod<dose_nmod<Coadministration_nsubj<result_ROOT>decrease_conj>TRITEC_obl	relType_8=nummod	lemma_9=%	lemma_13=concentration	relType_17=conj	relType_13=nmod	relType_9=compound	pos_2=CD	relType_16=aux	lemma_15=ranitidine	pos_15=NN	pos_17=VB	relType_15=cc	lpib=meq_NN	path2=decrease_conj>TRITEC_obl	eib=True	pos_3=NN	relType_18=compound	pos_12=NN	lemma_10=decrease	lemma_8=28	pos_21=NN
DDI-DrugBank.d590.s2	DDI-DrugBank.d590.s2.e1	DDI-DrugBank.d590.s2.e2	null	relType_1=cc	relType_8=case	pos_1=CC	pos_2=MD	lemma_6=of	pos_3=VB	relType_6=case	lemma_3=decrease	eib=False	pos_5=NNS	pos_6=IN	lpib=decrease_VB	relType_2=aux	lib=decrease	lemma_5=concentration	lemma_7=bismuth	pos_4=NN	pos_8=IN	relType_3=conj	lemma_8=from	wib=decrease	relType_4=compound	path1=ranitidine_nmod<concentration_nmod<decrease_obl	relType_7=nmod	path2=decrease_conj>TRITEC_obl	relation_2=adverse	lemma_4=plasma	relType_5=obj	lemma_2=may	path=ranitidine_nmod<concentration_nmod<decrease_obl<result_ROOT>decrease_conj>TRITEC_obl	pos_7=NN	lemma_1=and
DDI-DrugBank.d590.s4	DDI-DrugBank.d590.s4.e0	DDI-DrugBank.d590.s4.e1	null	lemma_1=,	pos_3=IN	lemma_2=refer	pos_1=,	wib=refer	eib=False	pos_2=VB	pos_4=DT	path2=insert_obl>package_compound>zantac_compound	lib=refer	path=ranitidine_obl<associate_amod<interaction_nmod<information_obl<refer_ROOT>insert_obl>package_compound>zantac_compound	relType_2=ROOT	lemma_4=the	lemma_3=to	relType_3=case	path1=ranitidine_obl<associate_amod<interaction_nmod<information_obl	lpib=refer_VB	relType_1=punct	relType_4=det
DDI-DrugBank.d654.s0	DDI-DrugBank.d654.s0.e0	DDI-DrugBank.d654.s0.e1	null	relType_1=nummod	pos_2=NN	pos_3=RB	relType_3=advmod	relation_4=beneficial	path1=	lemma_4=daily	lemma_1=200	lemma_5=increase	pos_4=RB	lemma_3=twice	lib=mg	pos_1=CD	eib=False	lpib=mg_NN	relType_5=amod	relType_2=compound	relType_4=advmod	path=<ketoconazole_nmod>auc_dep>retapamulin_compound	lemma_2=mg	path2=auc_dep>retapamulin_compound	wib=mg	pos_5=VBN
DDI-DrugBank.d654.s0	DDI-DrugBank.d654.s0.e0	DDI-DrugBank.d654.s0.e2	mechanism	relType_1=nummod	pos_2=NN	pos_6=JJ	pos_14=CC	pos_12=CD	pos_6=NN	lemma_3=twice	lib=mg	pos_22=IN	pos_20=JJ	pos_18=NN	lemma_12=24	pos_17=CD	relType_6=compound	relType_12=appos	path=<ketoconazole_nmod>auc_dep>cmax_conj>application_nmod>ointment_nmod>retapamulin_compound	lemma_8=auc	path1=	lemma_5=increase	lemma_6=retapamulin	pos_8=NN	lemma_6=geometric	path2=auc_dep>cmax_conj>application_nmod>ointment_nmod>retapamulin_compound	relType_22=case	lemma_10=0	relType_11=dep	lemma_2=mg	relType_16=case	relType_19=case	lemma_14=and	pos_7=NN	relType_18=nmod	lemma_22=of	lemma_21=application	pos_3=RB	relType_8=dep	relation_4=beneficial	lemma_15=cmax	pos_16=IN	lemma_17=81	relType_21=nmod	lemma_11=-	lemma_4=daily	relType_20=amod	lemma_18=%	lpib=mg_NN	lemma_19=after	lemma_16=by	relType_5=amod	pos_9=-LRB-	pos_11=SYM	pos_13=-RRB-	relType_15=conj	pos_19=IN	relType_7=compound	relType_3=advmod	relType_13=punct	lemma_1=200	pos_4=RB	pos_1=CD	relType_17=nummod	relType_6=amod	lemma_9=(	lemma_20=topical	pos_15=NN	pos_10=CD	relType_2=compound	relType_4=advmod	relType_14=cc	relType_9=punct	relType_10=nummod	eib=True	lemma_13=)	wib=mg	lemma_7=mean	pos_5=VBN	pos_21=NN
DDI-DrugBank.d654.s0	DDI-DrugBank.d654.s0.e1	DDI-DrugBank.d654.s0.e2	null	relType_3=dep	pos_2=NN	relType_7=appos	pos_15=JJ	relType_15=amod	relType_16=nmod	pos_12=CD	pos_7=CD	pos_1=JJ	relType_8=punct	lemma_7=24	lemma_1=geometric	relType_11=case	lemma_5=0	relType_13=nmod	pos_17=IN	pos_5=CD	relType_6=dep	eib=False	pos_4=-LRB-	relType_10=conj	lemma_13=%	lemma_15=topical	lib=geometric	pos_8=-RRB-	pos_10=NN	pos_13=NN	lemma_4=(	relType_17=case	lemma_6=-	pos_11=IN	pos_14=IN	path=retapamulin_compound<auc_dep>cmax_conj>application_nmod>ointment_nmod>retapamulin_compound	lemma_8=)	pos_9=CC	lemma_9=and	relType_4=punct	lemma_16=application	relType_5=nummod	pos_6=SYM	lemma_11=by	relType_2=compound	lemma_12=81	lemma_17=of	pos_16=NN	lemma_14=after	wib=geometric	lemma_10=cmax	path1=retapamulin_compound	path2=cmax_conj>application_nmod>ointment_nmod>retapamulin_compound	pos_3=NN	lemma_3=auc	relType_12=nummod	relType_1=amod	relType_14=case	lpib=geometric_JJ	relType_9=cc	lemma_2=mean
DDI-DrugBank.d654.s1	DDI-DrugBank.d654.s1.e0	DDI-DrugBank.d654.s1.e1	null	relType_1=case	relType_7=compound	path=retapamulin_nmod<exposure_obl<unnecessary_ROOT>adjustment_nsubj>retapamulin_nmod	relType_8=nsubj	lemma_5=patient	lemma_6=,	lemma_4=in	lemma_8=adjustment	pos_9=IN	pos_2=JJ	pos_8=NNS	wib=following	eib=False	pos_5=NNS	relType_6=punct	relType_9=case	lemma_2=topical	pos_4=IN	lib=follow	lemma_1=follow	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	path1=retapamulin_nmod<exposure_obl	lemma_7=dosage	lpib=follow_VBG	path2=adjustment_nsubj>retapamulin_nmod	pos_6=,	pos_1=VBG	pos_3=NN	lemma_9=for	pos_7=NN	lemma_3=application
DDI-DrugBank.d654.s1	DDI-DrugBank.d654.s1.e0	DDI-DrugBank.d654.s1.e2	null	relType_1=case	relType_7=compound	relType_14=punct	lemma_13=co	relType_13=dep	pos_18=NNS	pos_16=IN	relType_8=nsubj	pos_12=WRB	relType_11=ROOT	lemma_21=as	lemma_5=patient	lemma_6=,	lemma_4=in	lemma_8=adjustment	pos_9=IN	relType_19=punct	pos_2=JJ	pos_8=NNS	pos_17=NN	relType_20=case	relType_10=nmod	relType_18=obl	wib=following	lemma_20=such	relType_12=advmod	pos_5=NNS	relType_6=punct	pos_21=IN	relType_9=case	lemma_16=with	pos_10=NN	pos_13=NN	pos_15=VBN	relType_17=compound	path2=administer_advcl>inhibitor_obl>ketoconazole_nmod	lemma_11=unnecessary	pos_20=JJ	relType_21=fixed	relType_15=advcl	path=retapamulin_nmod<exposure_obl<unnecessary_ROOT>administer_advcl>inhibitor_obl>ketoconazole_nmod	lemma_15=administer	lemma_2=topical	lemma_18=inhibitor	pos_4=IN	lib=follow	lemma_1=follow	relType_2=amod	relType_3=nmod	relType_4=case	relType_5=nmod	path1=retapamulin_nmod<exposure_obl	lemma_7=dosage	lpib=follow_VBG	pos_19=,	lemma_12=when	pos_6=,	pos_1=VBG	relType_10=cop	pos_14=HYPH	relType_16=case	pos_10=VBP	eib=True	pos_3=NN	lemma_9=for	lemma_10=retapamulin	lemma_17=cyp3a4	pos_11=JJ	lemma_19=,	pos_7=NN	lemma_3=application	lemma_14=-	lemma_10=be
DDI-DrugBank.d654.s1	DDI-DrugBank.d654.s1.e1	DDI-DrugBank.d654.s1.e2	null	relType_4=dep	relType_10=punct	relType_3=advmod	relType_7=case	lpib=be_VBP	lemma_10=,	relType_9=obl	pos_2=JJ	lemma_7=with	relType_11=case	pos_8=NN	lemma_12=as	path1=retapamulin_nmod<adjustment_nsubj	eib=False	relType_12=fixed	lemma_1=be	pos_9=NNS	pos_5=HYPH	lemma_8=cyp3a4	pos_6=VBN	relType_6=advcl	pos_4=NN	path2=administer_advcl>inhibitor_obl>ketoconazole_nmod	pos_12=IN	wib=are	lemma_11=such	lib=be	path=retapamulin_nmod<adjustment_nsubj<unnecessary_ROOT>administer_advcl>inhibitor_obl>ketoconazole_nmod	lemma_4=co	relType_2=ROOT	relType_5=punct	relType_8=compound	lemma_6=administer	pos_1=VBP	pos_3=WRB	relType_1=cop	pos_10=,	pos_7=IN	lemma_9=inhibitor	pos_11=JJ	lemma_2=unnecessary	lemma_5=-	lemma_3=when
DDI-DrugBank.d654.s2	DDI-DrugBank.d654.s2.e0	DDI-DrugBank.d654.s2.e1	null	lpib=retapamulin_NN	lib=retapamulin	lemma_1=,	wib=retapamulin	eib=False	path2=retapamulin_appos	pos_1=,	path1=ALTABAX_nmod	relType_1=punct	path=ALTABAX_nmod<application_obl>retapamulin_appos
DDI-DrugBank.d124.s1	DDI-DrugBank.d124.s1.e0	DDI-DrugBank.d124.s1.e1	null	relType_1=cc	pos_1=CC	eib=False	path2=FORTOVASE_conj	path=<INVIRASE_obl>FORTOVASE_conj	path1=	wib=FORTOVASE	lib=fortovase	lpib=fortovase_NNP	lemma_1=and
DDI-DrugBank.d124.s2	DDI-DrugBank.d124.s2.e0	DDI-DrugBank.d124.s2.e1	null	pos_4=JJ	relType_1=aux	lemma_1=may	pos_3=VB	lemma_5=for	lemma_4=predictive	relType_5=case	pos_2=RB	eib=False	relType_2=advmod	wib=not	path2=INVIRASE_obl	path=fortovase_nmod<study_nmod<observation_nsubj<predictive_ROOT>INVIRASE_obl	lemma_3=be	pos_5=IN	pos_1=MD	relType_4=ROOT	lib=not	path1=fortovase_nmod<study_nmod<observation_nsubj	lpib=not_RB	relType_3=cop	lemma_2=not
DDI-DrugBank.d124.s3	DDI-DrugBank.d124.s3.e0	DDI-DrugBank.d124.s3.e1	null	relType_8=case	pos_7=VB	pos_2=VBN	lemma_7=refer	relType_1=aux:pass	relType_10=amod	relType_12=case	relType_2=advcl	path=ritonavir_nsubj:pass<coadminister_advcl<refer_ROOT>information_obl>ritonavir_nmod	lemma_5=should	eib=False	lemma_4=prescriber	lemma_1=be	lemma_12=for	pos_9=DT	lemma_2=coadminister	relType_5=aux	relType_4=nsubj	pos_4=NNS	pos_8=IN	pos_12=IN	pos_5=MD	lib=be	lemma_3=,	relType_7=ROOT	lemma_8=to	path1=ritonavir_nsubj:pass<coadminister_advcl	relType_11=obl	pos_6=RB	wib=is	lemma_10=prescribe	pos_11=NN	pos_3=,	pos_1=VBZ	lemma_9=the	pos_10=VBG	lemma_11=information	lpib=be_VBZ	lemma_6=also	relType_6=advmod	relType_3=punct	path2=information_obl>ritonavir_nmod	relType_9=det
DDI-DrugBank.d124.s9	DDI-DrugBank.d124.s9.e0	DDI-DrugBank.d124.s9.e1	null	relType_1=cc	pos_1=CC	wib=ritonavir	eib=False	path=<invirase_nmod>ritonavir_conj	path1=	path2=ritonavir_conj	lib=ritonavir	lemma_1=and	lpib=ritonavir_NN
DDI-DrugBank.d124.s12	DDI-DrugBank.d124.s12.e0	DDI-DrugBank.d124.s12.e1	null	eib=False	lib=ritonavir	path1=invirase_compound	path2=	pos_1=HYPH	relType_1=punct	path=invirase_compound<ritonavir_obl>	lemma_1=/	wib=Ritonavir	lpib=ritonavir_NN
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e0	DDI-DrugBank.d124.s14.e1	null	lpib=amiodarone_NNP	eib=False	path1=	pos_1=:	path=<Antiarrhythmics_ROOT>Amiodarone_dep	wib=Amiodarone	lib=amiodarone	relType_1=punct	path2=Amiodarone_dep	lemma_1=:
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e0	DDI-DrugBank.d124.s14.e2	null	lpib=amiodarone_NNP	relType_2=dep	eib=True	pos_2=NNP	path1=	pos_1=:	lemma_2=Amiodarone	wib=Amiodarone	pos_2=,	lib=amiodarone	path=<Antiarrhythmics_ROOT>Amiodarone_dep>bepridil_conj	relType_1=punct	lemma_2=,	lemma_1=:	relType_2=punct	path2=Amiodarone_dep>bepridil_conj
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e0	DDI-DrugBank.d124.s14.e3	null	path1=	lemma_3=bepridil	lib=amiodarone	path2=Amiodarone_dep>flecainide_conj	relType_2=punct	lpib=amiodarone_NNP	pos_2=NNP	lemma_2=Amiodarone	wib=Amiodarone	lemma_2=,	lemma_1=:	path=<Antiarrhythmics_ROOT>Amiodarone_dep>flecainide_conj	relType_2=dep	lemma_3=,	relType_3=conj	pos_1=:	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e0	DDI-DrugBank.d124.s14.e4	null	path=<Antiarrhythmics_ROOT>Amiodarone_dep>propafenone_conj	path1=	lemma_3=bepridil	lib=amiodarone	relType_2=punct	lpib=amiodarone_NNP	pos_2=NNP	pos_4=,	lemma_2=Amiodarone	wib=Amiodarone	pos_4=NN	lemma_2=,	lemma_1=:	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	pos_1=:	path2=Amiodarone_dep>propafenone_conj	lemma_4=,	pos_3=,	eib=True	pos_3=NN	pos_2=,	lemma_4=flecainide	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e0	DDI-DrugBank.d124.s14.e5	null	pos_5=,	path1=	lemma_3=bepridil	lib=amiodarone	relType_2=punct	lpib=amiodarone_NNP	pos_2=NNP	pos_4=,	lemma_2=Amiodarone	wib=Amiodarone	pos_4=NN	lemma_2=,	lemma_1=:	relType_2=dep	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_5=propafenone	relType_5=punct	pos_1=:	path2=Amiodarone_dep>quinidine_appos	lemma_4=,	relType_5=conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	path=<Antiarrhythmics_ROOT>Amiodarone_dep>quinidine_appos	pos_2=,	lemma_4=flecainide	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e1	DDI-DrugBank.d124.s14.e2	null	wib=bepridil	lemma_1=,	lib=bepridil	lpib=bepridil_NN	eib=False	path2=bepridil_conj	path1=	pos_1=,	path=<Amiodarone_dep>bepridil_conj	relType_1=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e1	DDI-DrugBank.d124.s14.e3	null	wib=bepridil	lemma_1=,	lib=bepridil	pos_2=NN	lpib=bepridil_NN	eib=True	path=<Amiodarone_dep>flecainide_conj	path2=flecainide_conj	lemma_2=bepridil	path1=	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e1	DDI-DrugBank.d124.s14.e4	null	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	wib=bepridil	path2=propafenone_conj	path=<Amiodarone_dep>propafenone_conj	relType_2=conj	lemma_2=,	lib=bepridil	lemma_2=bepridil	lpib=bepridil_NN	relType_3=conj	lemma_3=,	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=flecainide
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e1	DDI-DrugBank.d124.s14.e5	null	path=<Amiodarone_dep>quinidine_appos	lemma_1=,	pos_2=NN	path1=	pos_1=,	relType_2=punct	wib=bepridil	pos_4=,	lemma_4=propafenone	relType_2=conj	pos_4=NN	lemma_2=,	lib=bepridil	lemma_2=bepridil	lpib=bepridil_NN	relType_3=conj	lemma_3=,	relType_4=punct	path2=quinidine_appos	lemma_4=,	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_3=flecainide
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e2	DDI-DrugBank.d124.s14.e3	null	lpib=flecainide_NN	lemma_1=,	path1=bepridil_conj	eib=False	path2=flecainide_conj	lib=flecainide	pos_1=,	wib=flecainide	relType_1=punct	path=bepridil_conj<Amiodarone_dep>flecainide_conj
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e2	DDI-DrugBank.d124.s14.e4	null	path=bepridil_conj<Amiodarone_dep>propafenone_conj	lpib=flecainide_NN	lemma_1=,	path1=bepridil_conj	pos_2=NN	eib=True	lemma_2=flecainide	path2=propafenone_conj	lib=flecainide	pos_1=,	pos_2=,	wib=flecainide	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e2	DDI-DrugBank.d124.s14.e5	null	lemma_1=,	pos_2=NN	lib=flecainide	pos_1=,	relType_2=punct	lpib=flecainide_NN	relType_2=conj	lemma_2=,	path=bepridil_conj<Amiodarone_dep>quinidine_appos	lemma_3=,	relType_3=conj	path2=quinidine_appos	lemma_3=propafenone	path1=bepridil_conj	pos_3=,	eib=True	lemma_2=flecainide	pos_3=NN	pos_2=,	wib=flecainide	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e3	DDI-DrugBank.d124.s14.e4	null	lemma_1=,	lib=propafenone	path=flecainide_conj<Amiodarone_dep>propafenone_conj	eib=False	path1=flecainide_conj	path2=propafenone_conj	lpib=propafenone_NN	pos_1=,	wib=propafenone	relType_1=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e3	DDI-DrugBank.d124.s14.e5	null	lemma_1=,	pos_2=NN	lib=propafenone	eib=True	path1=flecainide_conj	lemma_2=,	lpib=propafenone_NN	pos_1=,	pos_2=,	path2=quinidine_appos	wib=propafenone	path=flecainide_conj<Amiodarone_dep>quinidine_appos	relType_1=punct	relType_2=conj	lemma_2=propafenone	relType_2=punct
DDI-DrugBank.d124.s14	DDI-DrugBank.d124.s14.e4	DDI-DrugBank.d124.s14.e5	null	path1=propafenone_conj	lpib=quinidine_NN	lib=quinidine	path=propafenone_conj<Amiodarone_dep>quinidine_appos	lemma_1=,	eib=False	pos_1=,	path2=quinidine_appos	relType_1=punct	wib=quinidine
DDI-DrugBank.d124.s15	DDI-DrugBank.d124.s15.e0	DDI-DrugBank.d124.s15.e1	null	wib=astemizole	lib=astemizole	path2=astemizole_dep	eib=False	lpib=astemizole_NN	path1=	pos_1=:	relType_1=punct	lemma_1=:	path=<antihistamine_ROOT>astemizole_dep
DDI-DrugBank.d124.s15	DDI-DrugBank.d124.s15.e0	DDI-DrugBank.d124.s15.e2	null	lib=astemizole	relType_2=obj	pos_2=NN	pos_2=NFP	path1=	lemma_2=*	lemma_2=astemizole	lemma_1=:	path2=astemizole_dep>terfenadine_appos	relType_2=dep	lemma_3=,	lpib=astemizole_NN	path=<antihistamine_ROOT>astemizole_dep>terfenadine_appos	pos_1=:	wib=astemizole	pos_3=,	eib=True	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s15	DDI-DrugBank.d124.s15.e1	DDI-DrugBank.d124.s15.e2	null	lpib=*_NFP	eib=False	wib=*	path2=terfenadine_appos	path=<astemizole_dep>terfenadine_appos	path1=	relType_1=obj	pos_1=NFP	pos_2=,	lib=*	lemma_2=,	lemma_1=*	relType_2=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e0	DDI-DrugBank.d124.s16.e1	null	path2=dihydroergotamine_dep	lpib=dihydroergotamine_NN	wib=Dihydroergotamine	eib=False	path1=	pos_1=:	relType_1=punct	lib=dihydroergotamine	lemma_1=:	path=<derivative_ROOT>dihydroergotamine_dep
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e0	DDI-DrugBank.d124.s16.e2	null	lpib=dihydroergotamine_NN	path=<derivative_ROOT>dihydroergotamine_dep>ergonovine_conj	relType_2=dep	wib=Dihydroergotamine	pos_2=NN	eib=True	path1=	pos_1=:	lemma_2=dihydroergotamine	pos_2=,	relType_1=punct	lib=dihydroergotamine	path2=dihydroergotamine_dep>ergonovine_conj	lemma_2=,	lemma_1=:	relType_2=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e0	DDI-DrugBank.d124.s16.e3	null	lpib=dihydroergotamine_NN	pos_2=NN	path=<derivative_ROOT>dihydroergotamine_dep>ergotamine_conj	path1=	relType_2=punct	path2=dihydroergotamine_dep>ergotamine_conj	lemma_2=,	lemma_1=:	lemma_3=ergonovine	relType_2=dep	wib=Dihydroergotamine	lemma_3=,	relType_3=conj	pos_1=:	lemma_2=dihydroergotamine	lib=dihydroergotamine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e0	DDI-DrugBank.d124.s16.e4	null	lpib=dihydroergotamine_NN	pos_2=NN	path1=	path2=dihydroergotamine_dep>methylergonovine_amod	relType_2=punct	lemma_4=ergotamine	pos_4=,	pos_4=NN	lemma_2=,	lemma_1=:	path=<derivative_ROOT>dihydroergotamine_dep>methylergonovine_amod	lemma_3=ergonovine	relType_2=dep	wib=Dihydroergotamine	lemma_3=,	relType_4=punct	relType_3=conj	pos_1=:	lemma_2=dihydroergotamine	lemma_4=,	lib=dihydroergotamine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e0	DDI-DrugBank.d124.s16.e5	null	lpib=dihydroergotamine_NN	relType_12=obl	pos_2=NN	relType_11=cc	relType_10=amod	path1=	relType_13=punct	relType_18=amod	pos_9=IN	lemma_8=potential	lemma_13=-	relType_6=case	relType_8=obl	relType_2=punct	pos_13=HYPH	pos_17=IN	pos_8=NN	pos_5=VBN	lemma_17=as	lemma_4=ergotamine	pos_4=,	pos_6=IN	lemma_7=to	pos_18=JJ	lemma_12=life	relType_9=case	lemma_5=methylergonovine	relType_5=dep	pos_4=NN	lemma_2=,	lemma_1=:	lemma_16=such	lemma_6=due	lemma_3=ergonovine	pos_5=JJ	relType_2=dep	pos_16=JJ	wib=Dihydroergotamine	lemma_3=,	relType_4=punct	relType_3=conj	relType_5=amod	pos_10=JJ	lemma_11=and	pos_14=VBG	pos_11=CC	pos_1=:	lemma_2=dihydroergotamine	lemma_10=serious	lemma_4=,	lemma_5=contraindicate	lib=dihydroergotamine	path2=dihydroergotamine_dep>methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	relType_15=nmod	relType_7=fixed	relType_16=case	lemma_18=acute	path=<derivative_ROOT>dihydroergotamine_dep>methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	pos_3=,	pos_15=NNS	eib=True	pos_7=IN	lemma_15=reaction	pos_3=NN	relType_17=fixed	lemma_14=threaten	lemma_9=for	relType_14=conj	pos_2=,	relType_4=conj	relType_1=punct	pos_12=NN	relType_3=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e1	DDI-DrugBank.d124.s16.e2	null	lemma_1=,	eib=False	lib=ergonovine	path1=	pos_1=,	relType_1=punct	wib=ergonovine	path2=ergonovine_conj	path=<dihydroergotamine_dep>ergonovine_conj	lpib=ergonovine_NN
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e1	DDI-DrugBank.d124.s16.e3	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lemma_2=ergonovine	lib=ergonovine	path1=	pos_1=,	pos_2=,	path=<dihydroergotamine_dep>ergotamine_conj	relType_2=conj	relType_1=punct	wib=ergonovine	lemma_2=,	path2=ergotamine_conj	lpib=ergonovine_NN
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e1	DDI-DrugBank.d124.s16.e4	null	lemma_1=,	pos_2=NN	lemma_2=ergonovine	path=<dihydroergotamine_dep>methylergonovine_amod	lemma_3=ergotamine	lib=ergonovine	path1=	pos_1=,	relType_2=punct	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	pos_3=,	eib=True	pos_3=NN	path2=methylergonovine_amod	pos_2=,	relType_1=punct	wib=ergonovine	relType_3=punct	lpib=ergonovine_NN
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e1	DDI-DrugBank.d124.s16.e5	null	relType_8=case	relType_4=amod	relType_4=dep	lemma_1=,	pos_4=JJ	pos_2=NN	lemma_11=life	lemma_2=ergonovine	pos_13=VBG	lemma_7=potential	lemma_3=ergotamine	pos_15=JJ	relType_10=cc	lib=ergonovine	path1=	pos_1=,	lemma_5=due	lemma_8=for	pos_16=IN	relType_14=nmod	lemma_16=as	pos_17=JJ	lemma_6=to	relType_5=case	relType_2=punct	pos_9=JJ	pos_6=IN	pos_10=CC	relType_9=amod	relType_12=punct	relType_13=conj	relType_2=conj	lemma_12=-	lemma_2=,	pos_8=IN	pos_4=VBN	lemma_15=such	lemma_13=threaten	path2=methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	lemma_10=and	relType_15=case	lemma_3=,	relType_3=conj	relType_6=fixed	pos_5=IN	lemma_17=acute	relType_11=obl	relType_17=amod	path=<dihydroergotamine_dep>methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	lemma_4=methylergonovine	relType_7=obl	pos_3=,	pos_11=NN	eib=True	pos_3=NN	lemma_9=serious	lemma_14=reaction	pos_2=,	pos_12=HYPH	pos_14=NNS	lemma_4=contraindicate	relType_1=punct	pos_7=NN	wib=ergonovine	relType_3=punct	relType_16=fixed	lpib=ergonovine_NN
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e2	DDI-DrugBank.d124.s16.e3	null	path1=ergonovine_conj	lemma_1=,	lpib=ergotamine_NN	path=ergonovine_conj<dihydroergotamine_dep>ergotamine_conj	eib=False	pos_1=,	wib=ergotamine	relType_1=punct	lib=ergotamine	path2=ergotamine_conj
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e2	DDI-DrugBank.d124.s16.e4	null	path1=ergonovine_conj	lemma_1=,	lpib=ergotamine_NN	pos_2=NN	eib=True	path=ergonovine_conj<dihydroergotamine_dep>methylergonovine_amod	path2=methylergonovine_amod	pos_1=,	pos_2=,	wib=ergotamine	relType_1=punct	lemma_2=ergotamine	relType_2=conj	lib=ergotamine	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e2	DDI-DrugBank.d124.s16.e5	null	relType_3=dep	lemma_10=life	lemma_1=,	relType_12=conj	pos_2=NN	pos_12=VBG	relType_7=case	lemma_12=threaten	relType_8=amod	pos_3=VBN	pos_13=NNS	pos_1=,	wib=ergotamine	lemma_11=-	lemma_15=as	relType_2=punct	pos_11=HYPH	pos_6=NN	pos_8=JJ	lemma_4=due	relType_6=obl	relType_13=nmod	relType_16=amod	lemma_8=serious	relType_11=punct	pos_10=NN	relType_15=fixed	relType_2=conj	lemma_2=,	path2=methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	lemma_9=and	pos_9=CC	lpib=ergotamine_NN	relType_5=fixed	relType_3=amod	lemma_14=such	pos_16=JJ	pos_4=IN	relType_4=case	pos_5=IN	lemma_5=to	lemma_3=contraindicate	lemma_13=reaction	pos_15=IN	path1=ergonovine_conj	pos_3=JJ	lemma_3=methylergonovine	eib=True	pos_7=IN	lemma_6=potential	pos_2=,	relType_9=cc	pos_14=JJ	relType_14=case	relType_1=punct	lemma_2=ergotamine	relType_10=obl	lemma_16=acute	lib=ergotamine	lemma_7=for	path=ergonovine_conj<dihydroergotamine_dep>methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e3	DDI-DrugBank.d124.s16.e4	null	path=ergotamine_conj<dihydroergotamine_dep>methylergonovine_amod	lemma_1=,	eib=False	path1=ergotamine_conj	path2=methylergonovine_amod	pos_1=,	wib=methylergonovine	lib=methylergonovine	lpib=methylergonovine_JJ	relType_1=punct
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e3	DDI-DrugBank.d124.s16.e5	null	pos_2=VBN	lemma_1=,	relType_10=punct	pos_3=IN	pos_15=JJ	relType_15=amod	relType_4=fixed	pos_1=,	lemma_14=as	relType_9=obl	lib=methylergonovine	lpib=methylergonovine_JJ	pos_2=JJ	relType_6=case	relType_11=conj	lemma_3=due	lemma_6=for	path=ergotamine_conj<dihydroergotamine_dep>methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	lemma_9=life	lemma_2=methylergonovine	pos_6=IN	relType_12=nmod	lemma_11=threaten	pos_8=CC	pos_9=NN	lemma_10=-	pos_14=IN	lemma_2=contraindicate	lemma_13=such	path2=methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	relType_2=dep	relType_13=case	relType_7=amod	pos_13=JJ	relType_14=fixed	pos_12=NNS	lemma_4=to	pos_4=IN	pos_10=HYPH	relType_2=amod	pos_11=VBG	lemma_5=potential	relType_5=obl	relType_3=case	lemma_8=and	lemma_12=reaction	pos_5=NN	eib=True	path1=ergotamine_conj	pos_7=JJ	lemma_15=acute	wib=methylergonovine	lemma_7=serious	relType_1=punct	relType_8=cc
DDI-DrugBank.d124.s16	DDI-DrugBank.d124.s16.e4	DDI-DrugBank.d124.s16.e5	null	relType_14=amod	pos_3=IN	pos_6=JJ	pos_1=VBN	lemma_13=as	path1=	relType_12=case	relType_7=cc	path=<methylergonovine_amod>contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound	lemma_11=reaction	lemma_9=-	lemma_5=for	relType_5=case	relType_8=obl	lemma_1=contraindicate	pos_2=IN	relType_3=fixed	pos_8=NN	pos_9=HYPH	pos_12=JJ	lemma_2=due	eib=False	relType_10=conj	relType_6=amod	lpib=contraindicate_VBN	relType_1=dep	pos_11=NNS	wib=CONTRAINDICATED	lemma_10=threaten	pos_13=IN	pos_4=NN	lemma_8=life	relType_4=obl	pos_7=CC	lemma_3=to	pos_5=IN	lemma_6=serious	lemma_4=potential	relType_9=punct	lib=contraindicate	lemma_12=such	relType_13=fixed	relType_2=case	lemma_7=and	pos_10=VBG	lemma_14=acute	pos_14=JJ	relType_11=nmod	path2=contraindicate_dep>potential_obl>reaction_nmod>toxicity_nmod>ergot_compound
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e0	DDI-DrugBank.d124.s17.e1	null	path2=reduce_dep>contraindicated_advmod>rifampin_amod	wib=rifampin	eib=False	path1=	pos_1=:	lib=rifampin	relType_1=punct	lpib=rifampin_JJ	lemma_1=:	path=<Agents_ROOT>reduce_dep>contraindicated_advmod>rifampin_amod
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e0	DDI-DrugBank.d124.s17.e2	null	wib=rifampin	pos_3=IN	relType_7=det	path1=	pos_9=IN	lemma_6=of	pos_2=JJ	relType_6=case	lemma_3=since	pos_8=NN	relType_2=advmod	pos_6=IN	lemma_2=contraindicated	lemma_7=this	relType_9=case	lpib=rifampin_JJ	lemma_5=coadministration	pos_7=DT	lemma_1=:	pos_4=DT	lemma_4=the	relType_2=amod	pos_1=:	lemma_8=product	lib=rifampin	relType_5=obl	path2=reduce_dep>contraindicated_advmod>coadministration_obl>saquinavir_nmod	relType_3=case	pos_5=NN	lemma_9=with	eib=True	relType_8=nmod	lemma_2=rifampin	relType_1=punct	relType_4=det	path=<Agents_ROOT>reduce_dep>contraindicated_advmod>coadministration_obl>saquinavir_nmod
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e0	DDI-DrugBank.d124.s17.e3	null	wib=rifampin	pos_3=IN	relType_7=det	path=<Agents_ROOT>reduce_dep>contraindicated_advmod>coadministration_obl>regimen_nmod>antiretroviral_amod	lemma_11=a	path1=	pos_9=IN	lemma_6=of	lemma_10=saquinavir	pos_2=JJ	relType_6=case	path2=reduce_dep>contraindicated_advmod>coadministration_obl>regimen_nmod>antiretroviral_amod	lemma_3=since	pos_8=NN	relType_10=nmod	relType_2=advmod	pos_6=IN	lemma_2=contraindicated	lemma_7=this	relType_9=case	relType_10=case	lpib=rifampin_JJ	pos_10=NN	lemma_5=coadministration	pos_7=DT	lemma_1=:	pos_4=DT	lemma_10=in	lemma_4=the	relType_2=amod	pos_1=:	lemma_8=product	lib=rifampin	relType_5=obl	pos_10=IN	pos_11=DT	relType_3=case	relType_11=det	pos_5=NN	lemma_9=with	eib=True	relType_8=nmod	lemma_2=rifampin	relType_1=punct	relType_4=det
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e0	DDI-DrugBank.d124.s17.e4	null	wib=rifampin	lemma_12=regimen	pos_3=IN	lemma_13=reduce	relType_7=det	relType_13=dep	lemma_11=a	path1=	pos_13=VBZ	pos_9=IN	lemma_6=of	lemma_10=saquinavir	pos_16=NNS	pos_2=JJ	relType_6=case	path2=reduce_dep>concentration_obj>saquinavir_nmod	lemma_3=since	pos_8=NN	pos_12=JJ	pos_17=IN	relType_10=nmod	relType_2=advmod	pos_6=IN	relation_15=adverse	relType_12=nmod	lemma_2=contraindicated	lemma_7=this	relType_12=amod	pos_12=NN	relType_9=case	relType_10=case	lpib=rifampin_JJ	pos_10=NN	lemma_5=coadministration	lemma_14=the	pos_7=DT	lemma_1=:	lemma_15=plasma	relType_17=case	path=<Agents_ROOT>reduce_dep>concentration_obj>saquinavir_nmod	pos_4=DT	pos_15=NN	lemma_10=in	lemma_4=the	relType_2=amod	pos_1=:	relType_16=obj	lemma_8=product	lib=rifampin	relType_5=obl	pos_10=IN	pos_11=DT	lemma_12=antiretroviral	lemma_17=of	relType_3=case	relType_11=det	pos_14=DT	relType_15=compound	pos_5=NN	lemma_16=concentration	lemma_9=with	eib=True	relType_8=nmod	lemma_2=rifampin	relType_1=punct	relType_4=det	relType_14=det
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e1	DDI-DrugBank.d124.s17.e2	null	relType_8=case	lpib=contraindicated_JJ	pos_6=DT	lemma_7=product	pos_1=JJ	lemma_5=of	relType_5=case	lemma_4=coadministration	pos_2=IN	path=rifampin_amod<contraindicated_advmod>coadministration_obl>saquinavir_nmod	lib=contraindicated	eib=False	lemma_8=with	wib=CONTRAINDICATED	relType_3=det	pos_4=NN	relType_1=advmod	pos_8=IN	relType_4=obl	pos_5=IN	relType_7=nmod	path2=coadministration_obl>saquinavir_nmod	relType_6=det	lemma_1=contraindicated	relType_2=case	lemma_2=since	pos_3=DT	lemma_3=the	lemma_6=this	path1=rifampin_amod	pos_7=NN
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e1	DDI-DrugBank.d124.s17.e3	null	relType_8=case	lpib=contraindicated_JJ	pos_6=DT	relType_10=det	path=rifampin_amod<contraindicated_advmod>coadministration_obl>regimen_nmod>antiretroviral_amod	lemma_7=product	pos_1=JJ	pos_9=IN	lemma_10=a	relType_9=nmod	lemma_5=of	relType_5=case	lemma_4=coadministration	pos_2=IN	lib=contraindicated	lemma_8=with	wib=CONTRAINDICATED	relType_9=case	relType_3=det	pos_9=NN	pos_4=NN	relType_1=advmod	pos_8=IN	path2=coadministration_obl>regimen_nmod>antiretroviral_amod	relType_4=obl	pos_5=IN	relType_7=nmod	relType_6=det	lemma_9=saquinavir	lemma_1=contraindicated	relType_2=case	lemma_2=since	eib=True	pos_3=DT	lemma_3=the	lemma_6=this	path1=rifampin_amod	pos_7=NN	lemma_9=in	pos_10=DT
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e1	DDI-DrugBank.d124.s17.e4	null	relType_8=case	lpib=contraindicated_JJ	lemma_13=the	pos_6=DT	relType_10=det	pos_16=IN	pos_13=DT	lemma_7=product	pos_9=IN	pos_1=JJ	lemma_10=a	relType_14=compound	relType_9=nmod	lemma_5=of	relType_5=case	lemma_4=coadministration	pos_2=IN	path2=concentration_obj>saquinavir_nmod	lib=contraindicated	lemma_15=concentration	path1=rifampin_amod<contraindicated_advmod	relType_11=amod	pos_12=VBZ	lemma_8=with	lemma_11=antiretroviral	wib=CONTRAINDICATED	relType_9=case	pos_14=NN	relType_3=det	pos_9=NN	pos_4=NN	lemma_16=of	relType_1=advmod	pos_8=IN	relation_13=adverse	lemma_14=plasma	relType_4=obl	pos_5=IN	relType_7=nmod	lemma_12=reduce	path=rifampin_amod<contraindicated_advmod<reduce_dep>concentration_obj>saquinavir_nmod	relType_15=obj	relType_6=det	lemma_9=saquinavir	relType_16=case	lemma_1=contraindicated	relType_2=case	lemma_2=since	eib=True	pos_3=DT	pos_11=NN	relType_12=dep	pos_15=NNS	relType_13=det	lemma_3=the	lemma_11=regimen	pos_11=JJ	lemma_6=this	relType_11=nmod	pos_7=NN	lemma_9=in	pos_10=DT
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e2	DDI-DrugBank.d124.s17.e3	null	path=saquinavir_nmod<coadministration_obl>regimen_nmod>antiretroviral_amod	pos_2=DT	relType_1=case	lemma_1=in	eib=False	relType_2=det	path1=saquinavir_nmod	lib=antiretroviral	wib=antiretroviral	lpib=antiretroviral_JJ	pos_1=IN	lemma_2=a	path2=regimen_nmod>antiretroviral_amod
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e2	DDI-DrugBank.d124.s17.e4	null	pos_7=NNS	relType_8=case	pos_2=DT	relType_1=case	path1=saquinavir_nmod<coadministration_obl<contraindicated_advmod	lemma_1=in	relType_4=dep	relation_4=adverse	lemma_4=reduce	lemma_2=a	pos_6=NN	lemma_6=plasma	lemma_3=antiretroviral	path2=concentration_obj>saquinavir_nmod	lemma_7=concentration	lib=antiretroviral	relType_7=obj	wib=antiretroviral	pos_1=IN	pos_8=IN	relType_3=amod	relType_5=det	relType_3=nmod	relType_6=compound	lemma_5=the	pos_3=JJ	lemma_3=regimen	eib=True	path=saquinavir_nmod<coadministration_obl<contraindicated_advmod<reduce_dep>concentration_obj>saquinavir_nmod	pos_3=NN	relType_2=det	pos_5=DT	lpib=antiretroviral_JJ	lemma_8=of	pos_4=VBZ
DDI-DrugBank.d124.s17	DDI-DrugBank.d124.s17.e3	DDI-DrugBank.d124.s17.e4	null	wib=regimen	lemma_1=regimen	lemma_6=of	lpib=regimen_NN	lemma_2=reduce	path=antiretroviral_amod<regimen_nmod<coadministration_obl<contraindicated_advmod<reduce_dep>concentration_obj>saquinavir_nmod	relType_6=case	path2=concentration_obj>saquinavir_nmod	eib=False	pos_5=NNS	pos_6=IN	relation_1=adverse	lemma_5=concentration	relType_1=nmod	relType_3=det	pos_4=NN	pos_1=NN	relType_2=dep	relType_4=compound	pos_2=VBZ	lib=regimen	pos_3=DT	lemma_4=plasma	relType_5=obj	lemma_3=the	path1=antiretroviral_amod<regimen_nmod<coadministration_obl<contraindicated_advmod
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e0	DDI-DrugBank.d124.s18.e1	null	lemma_1=(	path=<saquinavir_obj>fortovase_appos	eib=False	path1=	lpib=fortovase_NN	wib=FORTOVASE	path2=fortovase_appos	relType_1=punct	lib=fortovase	pos_1=-LRB-
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e0	DDI-DrugBank.d124.s18.e2	null	lemma_2=)	path=saquinavir_obj<take_dep>inhibitor_obl	path1=saquinavir_obj	pos_2=NN	pos_3=IN	lemma_2=fortovase	relType_2=punct	lemma_3=as	lemma_1=(	pos_6=NN	path2=inhibitor_obl	lemma_5=sole	pos_4=DT	pos_5=JJ	relType_5=amod	lemma_6=protease	lemma_4=the	relType_2=appos	relType_3=case	pos_1=-LRB-	relType_6=compound	eib=True	pos_2=-RRB-	lpib=fortovase_NN	wib=FORTOVASE	relType_1=punct	relType_4=det	lib=fortovase
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e0	DDI-DrugBank.d124.s18.e3	null	lemma_2=)	path1=saquinavir_obj	pos_2=NN	pos_3=IN	pos_8=DT	lemma_11=decrease	lemma_10=of	relType_9=obl	lemma_6=inhibitor	lemma_2=fortovase	relType_6=case	relType_2=punct	lemma_3=as	lemma_1=(	pos_6=NN	relType_6=obl	relType_4=det	pos_6=IN	relType_11=amod	lemma_7=to	relType_10=case	pos_9=NN	relation_13=adverse	lemma_5=sole	lemma_6=due	pos_4=DT	pos_5=JJ	lemma_9=risk	relType_5=amod	lemma_6=protease	lemma_4=the	lemma_8=the	pos_11=VBN	pos_10=IN	relType_2=appos	relType_3=case	pos_1=-LRB-	relType_7=fixed	relType_6=compound	eib=True	pos_2=-RRB-	pos_7=IN	lpib=fortovase_NN	wib=FORTOVASE	relType_8=det	path=saquinavir_obj<take_dep>risk_obl>concentration_nmod>saquinavir_compound	relType_1=punct	path2=risk_obl>concentration_nmod>saquinavir_compound	lib=fortovase
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e1	DDI-DrugBank.d124.s18.e2	null	relType_4=amod	pos_4=JJ	relType_5=compound	lemma_4=sole	lemma_1=)	lemma_2=as	pos_2=IN	path1=fortovase_appos<saquinavir_obj	path=fortovase_appos<saquinavir_obj<take_dep>inhibitor_obl	lib=sole	relType_3=det	path2=inhibitor_obl	lemma_5=protease	wib=sole	pos_1=-RRB-	pos_5=NN	relType_2=case	eib=True	pos_3=DT	lpib=sole_JJ	lemma_3=the	relType_1=punct
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e1	DDI-DrugBank.d124.s18.e3	null	relType_4=amod	pos_4=JJ	relType_7=det	lemma_5=due	relType_10=amod	relType_5=compound	pos_9=IN	lemma_4=sole	lemma_1=)	lemma_6=to	relType_5=case	relType_8=obl	lemma_2=as	pos_2=IN	pos_8=NN	path1=fortovase_appos<saquinavir_obj	relation_11=adverse	lib=sole	pos_6=IN	relType_9=case	relType_3=det	pos_7=DT	lemma_5=protease	wib=sole	pos_1=-RRB-	relType_6=fixed	pos_5=IN	relType_5=obl	pos_5=NN	relType_2=case	eib=True	pos_3=DT	path=fortovase_appos<saquinavir_obj<take_dep>risk_obl>concentration_nmod>saquinavir_compound	lemma_9=of	pos_10=VBN	lpib=sole_JJ	lemma_3=the	lemma_7=the	lemma_8=risk	relType_1=punct	path2=risk_obl>concentration_nmod>saquinavir_compound	lemma_5=inhibitor	lemma_10=decrease
DDI-DrugBank.d124.s18	DDI-DrugBank.d124.s18.e2	DDI-DrugBank.d124.s18.e3	null	relType_1=case	lpib=risk_NN	relation_5=adverse	lemma_5=of	relType_5=case	lemma_1=due	pos_2=IN	eib=False	lemma_4=risk	lib=risk	relType_6=amod	lemma_2=to	pos_1=IN	pos_6=VBN	relType_3=det	pos_4=NN	relType_4=obl	path=inhibitor_obl<take_dep>risk_obl>concentration_nmod>saquinavir_compound	pos_5=IN	lemma_6=decrease	path1=inhibitor_obl	wib=risk	relType_2=fixed	pos_3=DT	lemma_3=the	path2=risk_obl>concentration_nmod>saquinavir_compound
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e0	DDI-DrugBank.d124.s19.e1	null	wib=ritonavir	path=invirase_compound<ritonavir_compound>	eib=False	lib=ritonavir	path1=invirase_compound	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/	lpib=ritonavir_NN
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e0	DDI-DrugBank.d124.s19.e2	null	lemma_2=ritonavir	lemma_2=or	wib=ritonavir	pos_2=NN	eib=True	path2=ritonavir_conj>fortovase_compound	path=invirase_compound<ritonavir_compound>ritonavir_conj>fortovase_compound	relType_2=compound	pos_2=CC	lib=ritonavir	path1=invirase_compound	pos_1=HYPH	relType_1=punct	relType_2=cc	lemma_1=/	lpib=ritonavir_NN
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e0	DDI-DrugBank.d124.s19.e3	null	lemma_2=ritonavir	lemma_2=or	pos_2=NN	path2=ritonavir_conj	lib=ritonavir	pos_1=HYPH	relType_2=cc	lemma_3=fortovase	lpib=ritonavir_NN	lemma_3=/	path=invirase_compound<ritonavir_compound>ritonavir_conj	wib=ritonavir	relType_2=compound	lemma_1=/	eib=True	pos_3=NN	pos_3=HYPH	pos_2=CC	relType_3=compound	path1=invirase_compound	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e1	DDI-DrugBank.d124.s19.e2	null	relType_1=cc	pos_1=CC	lemma_1=or	path2=ritonavir_conj>fortovase_compound	eib=False	path1=	lpib=fortovase_NN	wib=FORTOVASE	lib=fortovase	path=<ritonavir_compound>ritonavir_conj>fortovase_compound
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e1	DDI-DrugBank.d124.s19.e3	null	relType_1=cc	pos_1=CC	pos_2=NN	lemma_2=/	eib=True	relType_2=compound	path=<ritonavir_compound>ritonavir_conj	path1=	lpib=fortovase_NN	path2=ritonavir_conj	wib=FORTOVASE	pos_2=HYPH	lib=fortovase	lemma_2=fortovase	relType_2=punct	lemma_1=or
DDI-DrugBank.d124.s19	DDI-DrugBank.d124.s19.e2	DDI-DrugBank.d124.s19.e3	null	path=fortovase_compound<ritonavir_conj>	wib=ritonavir	eib=False	path1=fortovase_compound	lib=ritonavir	path2=	pos_1=HYPH	relType_1=punct	lemma_1=/	lpib=ritonavir_NN
DDI-DrugBank.d124.s22	DDI-DrugBank.d124.s22.e0	DDI-DrugBank.d124.s22.e1	null	eib=False	lpib=lovastatin_NN	path1=	pos_1=:	relType_1=punct	path=<inhibitor_ROOT>lovastatin_dep	lib=lovastatin	path2=lovastatin_dep	wib=lovastatin	lemma_1=:
DDI-DrugBank.d124.s22	DDI-DrugBank.d124.s22.e0	DDI-DrugBank.d124.s22.e2	null	path=<inhibitor_ROOT>lovastatin_dep>potential_appos>warning_compound>simvastatin_compound	relType_2=dep	pos_2=NN	eib=True	lpib=lovastatin_NN	lemma_2=,	path1=	pos_1=:	pos_2=,	path2=lovastatin_dep>potential_appos>warning_compound>simvastatin_compound	relType_1=punct	lemma_2=lovastatin	lib=lovastatin	wib=lovastatin	lemma_1=:	relType_2=punct
DDI-DrugBank.d124.s22	DDI-DrugBank.d124.s22.e1	DDI-DrugBank.d124.s22.e2	null	wib=simvastatin	path=<lovastatin_dep>potential_appos>warning_compound>simvastatin_compound	lemma_1=,	eib=False	lpib=simvastatin_NN	path1=	pos_1=,	relType_1=punct	lib=simvastatin	path2=potential_appos>warning_compound>simvastatin_compound
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e0	DDI-DrugBank.d124.s23.e1	null	path=<sedative_ROOT>hypnotic_appos	lpib=hypnotic_NNS	eib=False	lib=hypnotic	path1=	pos_1=,	wib=Hypnotics	path2=hypnotic_appos	relType_1=punct	lemma_1=/
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e0	DDI-DrugBank.d124.s23.e2	null	pos_2=NNS	lemma_2=:	lpib=hypnotic_NNS	path2=triazolam_dep	lemma_2=hypnotic	path=<sedative_ROOT>triazolam_dep	eib=True	lib=hypnotic	path1=	pos_1=,	wib=Hypnotics	pos_2=:	relType_1=punct	relType_2=appos	lemma_1=/	relType_2=punct
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e0	DDI-DrugBank.d124.s23.e3	null	relType_3=dep	path1=	path2=triazolam_dep>midazolam_appos	pos_1=,	relType_2=punct	lemma_2=:	lemma_2=hypnotic	lemma_3=triazolam	lemma_3=,	lib=hypnotic	wib=Hypnotics	pos_2=:	relType_2=appos	lemma_1=/	pos_2=NNS	lpib=hypnotic_NNS	pos_3=,	eib=True	path=<sedative_ROOT>triazolam_dep>midazolam_appos	pos_3=NN	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e1	DDI-DrugBank.d124.s23.e2	null	lib=triazolam	path2=triazolam_dep	path1=hypnotic_appos	eib=False	wib=triazolam	pos_1=:	path=hypnotic_appos<sedative_ROOT>triazolam_dep	lemma_1=:	relType_1=punct	lpib=triazolam_NN
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e1	DDI-DrugBank.d124.s23.e3	null	relType_2=dep	lib=triazolam	pos_2=NN	eib=True	path1=hypnotic_appos	wib=triazolam	lemma_2=triazolam	pos_1=:	path2=triazolam_dep>midazolam_appos	pos_2=,	path=hypnotic_appos<sedative_ROOT>triazolam_dep>midazolam_appos	lemma_1=:	relType_1=punct	lemma_2=,	lpib=triazolam_NN	relType_2=punct
DDI-DrugBank.d124.s23	DDI-DrugBank.d124.s23.e2	DDI-DrugBank.d124.s23.e3	null	lemma_1=,	wib=midazolam	eib=False	path=<triazolam_dep>midazolam_appos	lpib=midazolam_NN	path1=	pos_1=,	relType_1=punct	path2=midazolam_appos	lib=midazolam
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e1	null	path2=dapsone_conj	lemma_1=,	eib=False	wib=dapsone	pos_1=,	lib=dapsone	relType_1=punct	path1=blocker_conj	path=blocker_conj<eg_dep>dapsone_conj	lpib=dapsone_NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e2	null	lemma_1=,	path=blocker_conj<eg_dep>disopyramide_conj	pos_2=NN	eib=True	wib=dapsone	path2=disopyramide_conj	pos_1=,	pos_2=,	lib=dapsone	relType_1=punct	path1=blocker_conj	relType_2=conj	lemma_2=,	lpib=dapsone_NN	relType_2=punct	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e3	null	lemma_1=,	pos_2=NN	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	wib=dapsone	relType_2=conj	lemma_2=,	lemma_3=,	path2=quinine_conj	lemma_3=disopyramide	relType_3=conj	path=blocker_conj<eg_dep>quinine_conj	lpib=dapsone_NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e4	null	lemma_1=,	pos_2=NN	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	pos_4=,	wib=dapsone	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_4=,	lemma_4=quinine	path=blocker_conj<eg_dep>amiodarone_conj	lpib=dapsone_NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	path2=amiodarone_conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e5	null	lemma_1=,	pos_2=NN	lemma_5=amiodarone	pos_5=,	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	pos_4=,	wib=dapsone	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	path2=quinidine_conj	lemma_4=,	relType_5=conj	lemma_4=quinine	lpib=dapsone_NN	pos_5=NN	pos_3=,	eib=True	pos_3=NN	path=blocker_conj<eg_dep>quinidine_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e6	null	lemma_1=,	pos_2=NN	lemma_5=amiodarone	pos_5=,	pos_1=,	lemma_6=,	lib=dapsone	path1=blocker_conj	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	wib=dapsone	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	path=blocker_conj<eg_dep>warfarin_conj	lemma_4=,	relType_5=conj	lemma_4=quinine	lpib=dapsone_NN	pos_6=,	path2=warfarin_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_6=quinidine	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	pos_2=NN	lemma_5=amiodarone	pos_5=,	pos_1=,	lemma_6=,	lib=dapsone	path1=blocker_conj	relType_2=punct	pos_6=NN	lemma_7=warfarin	relType_6=conj	path2=tacrolimus_conj	pos_4=,	relType_6=punct	wib=dapsone	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	path=blocker_conj<eg_dep>tacrolimus_conj	lemma_4=quinine	relType_5=conj	lpib=dapsone_NN	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_6=quinidine	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	pos_2=NN	lemma_5=amiodarone	pos_5=,	path2=cyclosporine_conj	pos_1=,	lemma_6=,	lib=dapsone	relType_8=punct	path1=blocker_conj	lemma_8=,	relType_2=punct	pos_6=NN	lemma_7=warfarin	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	wib=dapsone	path=blocker_conj<eg_dep>cyclosporine_conj	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	lemma_8=tacrolimus	lemma_4=,	relType_5=conj	lemma_4=quinine	lpib=dapsone_NN	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	lemma_6=quinidine	relType_8=conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	relType_9=conj	lemma_9=cyclosporine	lemma_5=amiodarone	pos_5=,	pos_1=,	lemma_6=,	lib=dapsone	relType_8=punct	path1=blocker_conj	lemma_9=,	lemma_8=,	path=blocker_conj<eg_dep>derivative_conj	relType_2=punct	pos_6=NN	lemma_7=warfarin	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	wib=dapsone	pos_7=,	path2=derivative_conj	relType_10=compound	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	lemma_8=tacrolimus	lemma_4=,	relType_5=conj	lemma_4=quinine	relType_9=punct	lpib=dapsone_NN	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	lemma_6=quinidine	relType_8=conj	pos_2=,	relType_4=conj	lemma_10=ergot	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	relType_9=conj	lemma_9=cyclosporine	relType_10=punct	lemma_5=amiodarone	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lib=dapsone	relType_8=punct	path1=blocker_conj	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	lemma_7=warfarin	pos_8=NN	pos_10=NNS	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	wib=dapsone	pos_7=,	relType_10=compound	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	relType_4=punct	lemma_3=,	lemma_3=disopyramide	relType_3=conj	lemma_5=,	relType_5=punct	lemma_8=tacrolimus	lemma_4=,	relType_5=conj	lemma_4=quinine	relType_9=punct	lpib=dapsone_NN	pos_6=,	pos_5=NN	path=blocker_conj<eg_dep>pimozide_conj	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	lemma_6=quinidine	relType_8=conj	pos_2=,	relType_4=conj	lemma_10=ergot	lemma_10=derivative	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	relType_9=conj	lemma_9=cyclosporine	relType_10=punct	lemma_11=,	lemma_5=amiodarone	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lib=dapsone	relType_8=punct	path1=blocker_conj	lemma_9=,	lemma_8=,	relType_11=conj	relType_2=punct	pos_6=NN	lemma_7=warfarin	pos_8=NN	pos_10=NNS	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	wib=dapsone	relType_11=punct	pos_7=,	relType_10=compound	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	path=blocker_conj<eg_dep>carbamazepine_conj	lemma_3=,	lemma_3=disopyramide	relType_3=conj	relType_4=punct	lemma_5=,	relType_5=punct	lemma_8=tacrolimus	lemma_4=,	relType_5=conj	lemma_4=quinine	pos_11=,	relType_9=punct	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	pos_5=NN	pos_11=NN	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	lemma_6=quinidine	relType_8=conj	pos_2=,	relType_4=conj	lemma_10=ergot	lemma_10=derivative	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj	lemma_2=dapsone
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e12	null	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	path2=fentanyl_conj	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	pos_10=NN	lemma_7=,	relType_4=punct	lemma_3=,	path=blocker_conj<eg_dep>fentanyl_conj	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	lemma_10=ergot	pos_2=,	lemma_1=,	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	lemma_7=warfarin	pos_8=NN	relType_10=conj	relType_12=punct	relType_2=conj	pos_9=NN	lemma_2=,	lemma_3=disopyramide	lemma_8=tacrolimus	lemma_4=,	lemma_4=quinine	pos_5=NN	pos_11=NN	lemma_6=quinidine	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_2=dapsone	relType_10=punct	lemma_12=carbamazepine	lemma_9=cyclosporine	lemma_11=,	lemma_8=,	relType_11=conj	pos_4=,	wib=dapsone	relType_11=punct	pos_7=,	relType_3=conj	relType_5=conj	lemma_10=derivative	relType_7=conj	relType_12=conj	relType_9=conj	lemma_5=amiodarone	relType_6=punct	relType_10=compound	pos_4=NN	relType_5=punct	pos_11=,	relType_9=punct	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	pos_10=NNS
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e13	null	pos_2=NN	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	path2=alfentanyl_conj	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	lemma_10=ergot	pos_2=,	pos_13=,	lemma_1=,	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	lemma_7=warfarin	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_13=fentanyl	lemma_3=disopyramide	lemma_8=tacrolimus	lemma_4=,	lemma_4=quinine	pos_5=NN	pos_11=NN	lemma_6=quinidine	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_2=dapsone	relType_10=punct	lemma_12=carbamazepine	lemma_9=cyclosporine	lemma_11=,	lemma_8=,	relType_11=conj	pos_4=,	wib=dapsone	relType_11=punct	pos_7=,	relType_3=conj	relType_5=conj	lemma_10=derivative	relType_7=conj	path=blocker_conj<eg_dep>alfentanyl_conj	relType_12=conj	relType_9=conj	lemma_5=amiodarone	relType_13=punct	relType_6=punct	relType_10=compound	pos_4=NN	relType_5=punct	pos_11=,	relType_9=punct	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	pos_10=NNS
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e14	null	pos_2=NN	lemma_14=alfentanyl	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	lemma_10=ergot	pos_2=,	path2=alprazolam_conj	pos_13=,	lemma_1=,	pos_1=,	lib=dapsone	path1=blocker_conj	relType_2=punct	lemma_7=warfarin	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_13=fentanyl	lemma_3=disopyramide	lemma_8=tacrolimus	lemma_4=,	lemma_4=quinine	pos_5=NN	lemma_14=,	pos_11=NN	lemma_6=quinidine	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_2=dapsone	relType_14=punct	relType_10=punct	lemma_12=carbamazepine	lemma_9=cyclosporine	lemma_11=,	lemma_8=,	relType_11=conj	pos_4=,	wib=dapsone	relType_11=punct	pos_14=,	pos_7=,	pos_14=NN	relType_3=conj	relType_5=conj	lemma_10=derivative	relType_14=conj	relType_7=conj	relType_12=conj	relType_9=conj	lemma_5=amiodarone	relType_13=punct	relType_6=punct	relType_10=compound	pos_4=NN	relType_5=punct	path=blocker_conj<eg_dep>alprazolam_conj	pos_11=,	relType_9=punct	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	pos_10=NNS
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e15	null	pos_2=NN	lemma_14=alfentanyl	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	lemma_10=ergot	pos_2=,	relType_16=cc	pos_13=,	lemma_1=,	pos_1=,	lib=dapsone	path1=blocker_conj	pos_16=CC	relType_2=punct	lemma_7=warfarin	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_13=fentanyl	lemma_15=,	lemma_3=disopyramide	lemma_8=tacrolimus	lemma_4=,	lemma_4=quinine	pos_5=NN	lemma_14=,	pos_11=NN	lemma_6=quinidine	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_2=dapsone	relType_14=punct	relType_10=punct	lemma_12=carbamazepine	lemma_9=cyclosporine	lemma_11=,	path=blocker_conj<eg_dep>triazolam_conj	lemma_8=,	relType_11=conj	lemma_15=alprazolam	pos_4=,	pos_15=,	wib=dapsone	relType_11=punct	pos_14=,	pos_7=,	pos_14=NN	relType_15=punct	relType_3=conj	relType_5=conj	relType_15=conj	lemma_10=derivative	relType_14=conj	relType_7=conj	relType_12=conj	relType_9=conj	lemma_5=amiodarone	relType_13=punct	relType_6=punct	relType_10=compound	pos_4=NN	pos_15=NN	relType_5=punct	lemma_16=and	pos_11=,	relType_9=punct	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	path2=triazolam_conj	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	pos_10=NNS
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e0	DDI-DrugBank.d124.s26.e16	mechanism	pos_2=NN	lemma_14=alfentanyl	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_17=triazolam	lemma_12=,	relType_6=conj	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	relType_4=punct	lemma_3=,	lemma_5=,	pos_3=,	pos_10=,	lemma_22=concentration	relType_8=conj	lemma_10=ergot	pos_2=,	relation_35=beneficial	relType_16=cc	pos_13=,	lemma_1=,	lemma_24=coadminister	pos_1=,	lib=dapsone	path2=coadminister_advcl>saquinavir_obl	pos_20=VBN	pos_16=CC	relType_2=punct	relType_25=case	lemma_7=warfarin	pos_8=NN	relType_10=conj	pos_23=WRB	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_13=fentanyl	lemma_15=,	lemma_3=disopyramide	lemma_8=tacrolimus	relType_21=compound	lemma_4=,	pos_24=VBN	lemma_4=quinine	pos_5=NN	lemma_14=,	pos_11=NN	lemma_6=quinidine	pos_25=IN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_2=dapsone	relType_14=punct	relType_10=punct	lemma_12=carbamazepine	lemma_9=cyclosporine	lemma_11=,	relType_17=punct	lemma_8=,	lemma_25=with	relType_11=conj	path1=blocker_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	pos_17=NN	lemma_15=alprazolam	pos_4=,	pos_15=,	wib=dapsone	relType_11=punct	pos_14=,	relType_24=advcl	relType_20=ROOT	pos_7=,	pos_14=NN	relType_15=punct	relType_3=conj	relType_19=aux	lemma_21=plasma	relType_5=conj	relType_15=conj	pos_19=VB	lemma_10=derivative	lemma_23=when	relType_14=conj	relType_7=conj	relType_23=advmod	relType_12=conj	relType_9=conj	lemma_5=amiodarone	relType_13=punct	relType_17=conj	relType_6=punct	relType_10=compound	pos_4=NN	path=blocker_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	lemma_18=may	relType_18=aux	pos_15=NN	relType_5=punct	pos_22=NNS	lemma_20=elevate	lemma_16=and	pos_11=,	relType_9=punct	relType_22=obj	lpib=dapsone_NN	pos_6=,	lemma_11=pimozide	lemma_17=)	pos_18=MD	eib=True	pos_3=NN	relType_7=punct	lemma_19=have	relType_4=conj	pos_17=-RRB-	pos_12=NN	pos_10=NNS	pos_21=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e2	null	lemma_1=,	eib=False	path=dapsone_conj<eg_dep>disopyramide_conj	path2=disopyramide_conj	pos_1=,	path1=dapsone_conj	relType_1=punct	wib=disopyramide	lpib=disopyramide_NN	lib=disopyramide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e3	null	lemma_1=,	pos_2=NN	eib=True	path2=quinine_conj	lemma_2=,	path=dapsone_conj<eg_dep>quinine_conj	pos_1=,	pos_2=,	relType_2=conj	path1=dapsone_conj	relType_1=punct	wib=disopyramide	lpib=disopyramide_NN	lib=disopyramide	lemma_2=disopyramide	relType_2=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e4	null	lemma_1=,	pos_2=NN	pos_1=,	path1=dapsone_conj	relType_2=punct	path=dapsone_conj<eg_dep>amiodarone_conj	relType_2=conj	lemma_2=disopyramide	lemma_2=,	lemma_3=quinine	lemma_3=,	relType_3=conj	lpib=disopyramide_NN	relType_3=punct	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	wib=disopyramide	lib=disopyramide	path2=amiodarone_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e5	null	lemma_1=,	pos_2=NN	pos_1=,	path1=dapsone_conj	relType_2=punct	path=dapsone_conj<eg_dep>quinidine_conj	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	path2=quinidine_conj	lemma_4=,	lpib=disopyramide_NN	relType_3=punct	lemma_4=amiodarone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	wib=disopyramide	lib=disopyramide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e6	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	path1=dapsone_conj	relType_2=punct	lemma_5=quinidine	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path=dapsone_conj<eg_dep>warfarin_conj	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	lemma_4=amiodarone	path2=warfarin_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	wib=disopyramide	lib=disopyramide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	path1=dapsone_conj	relType_2=punct	pos_6=NN	relType_6=conj	lemma_5=quinidine	path2=tacrolimus_conj	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path=dapsone_conj<eg_dep>tacrolimus_conj	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	pos_6=,	lemma_4=amiodarone	pos_5=NN	pos_3=,	eib=True	pos_3=NN	lemma_6=warfarin	pos_2=,	relType_4=conj	relType_1=punct	wib=disopyramide	lib=disopyramide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	pos_2=NN	lemma_7=tacrolimus	pos_5=,	path2=cyclosporine_conj	pos_1=,	lemma_6=,	path1=dapsone_conj	relType_2=punct	pos_6=NN	relType_6=conj	lemma_5=quinidine	pos_4=,	relType_6=punct	pos_7=,	path=dapsone_conj<eg_dep>cyclosporine_conj	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	pos_6=,	lemma_4=amiodarone	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	lemma_6=warfarin	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	wib=disopyramide	lib=disopyramide	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	lemma_7=tacrolimus	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	path1=dapsone_conj	lemma_8=,	lemma_9=ergot	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_5=quinidine	relType_9=compound	pos_4=,	relType_6=punct	pos_7=,	path2=derivative_conj	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	pos_9=NN	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	pos_6=,	lemma_4=amiodarone	path=dapsone_conj<eg_dep>derivative_conj	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_6=warfarin	pos_2=,	relType_4=conj	lemma_8=cyclosporine	relType_1=punct	pos_7=NN	wib=disopyramide	lib=disopyramide	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	lemma_7=tacrolimus	relType_9=conj	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	path1=dapsone_conj	lemma_9=,	lemma_8=,	lemma_9=ergot	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_5=quinidine	relType_9=compound	pos_4=,	lemma_9=derivative	relType_6=punct	pos_9=NNS	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	pos_9=NN	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path=dapsone_conj<eg_dep>pimozide_conj	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	relType_9=punct	pos_6=,	lemma_4=amiodarone	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_6=warfarin	pos_2=,	relType_4=conj	lemma_8=cyclosporine	pos_9=,	relType_1=punct	pos_7=NN	wib=disopyramide	lib=disopyramide	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	lemma_7=tacrolimus	relType_9=conj	relType_10=punct	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	path1=dapsone_conj	lemma_9=,	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_5=quinidine	relType_9=compound	pos_4=,	lemma_9=derivative	relType_10=conj	relType_6=punct	pos_9=NNS	pos_7=,	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	pos_9=NN	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	path=dapsone_conj<eg_dep>carbamazepine_conj	lemma_4=,	relType_5=conj	lpib=disopyramide_NN	relType_3=punct	relType_9=punct	pos_6=,	lemma_4=amiodarone	pos_5=NN	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_6=warfarin	pos_2=,	relType_4=conj	lemma_8=cyclosporine	pos_9=,	relType_1=punct	pos_7=NN	wib=disopyramide	lib=disopyramide	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	relType_10=punct	pos_2=NN	lemma_7=tacrolimus	relType_9=conj	lemma_11=carbamazepine	lemma_11=,	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	path1=dapsone_conj	lemma_9=,	path2=fentanyl_conj	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_11=conj	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_5=quinidine	relType_9=compound	pos_4=,	lemma_9=derivative	relType_10=conj	relType_6=punct	relType_11=punct	pos_9=NNS	pos_7=,	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_2=disopyramide	pos_9=NN	path=dapsone_conj<eg_dep>fentanyl_conj	lemma_3=quinine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	pos_11=,	lpib=disopyramide_NN	relType_3=punct	relType_9=punct	pos_6=,	lemma_4=amiodarone	pos_5=NN	pos_11=NN	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	lemma_6=warfarin	pos_2=,	relType_4=conj	lemma_8=cyclosporine	pos_9=,	relType_1=punct	pos_7=NN	wib=disopyramide	lib=disopyramide	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e13	null	pos_2=NN	lemma_11=carbamazepine	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	lemma_5=quinidine	lemma_9=derivative	path2=alfentanyl_conj	pos_12=,	pos_10=NN	lemma_7=,	lemma_2=disopyramide	relType_4=punct	lemma_3=,	lemma_5=,	path=dapsone_conj<eg_dep>alfentanyl_conj	lemma_4=amiodarone	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	lemma_8=cyclosporine	lib=disopyramide	lemma_1=,	pos_1=,	path1=dapsone_conj	relType_2=punct	pos_8=NN	relType_10=conj	relType_12=punct	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	pos_5=NN	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_7=tacrolimus	lemma_11=,	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_11=conj	pos_4=,	relType_11=punct	pos_7=,	lemma_3=quinine	relType_3=conj	relType_5=conj	lpib=disopyramide_NN	lemma_6=warfarin	wib=disopyramide	relType_7=conj	relType_12=conj	relType_9=conj	relType_9=compound	relType_6=punct	pos_9=NNS	pos_4=NN	relType_5=punct	pos_11=,	relType_9=punct	pos_6=,	lemma_12=fentanyl	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e14	null	pos_2=NN	lemma_11=carbamazepine	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	lemma_5=quinidine	lemma_9=derivative	pos_12=,	path=dapsone_conj<eg_dep>alprazolam_conj	pos_10=NN	lemma_7=,	pos_13=NN	lemma_2=disopyramide	relType_4=punct	lemma_3=,	lemma_5=,	lemma_4=amiodarone	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	lemma_8=cyclosporine	path2=alprazolam_conj	lib=disopyramide	pos_13=,	lemma_1=,	pos_1=,	path1=dapsone_conj	relType_2=punct	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	pos_5=NN	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_7=tacrolimus	lemma_11=,	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_11=conj	pos_4=,	relType_11=punct	pos_7=,	lemma_3=quinine	relType_3=conj	relType_5=conj	lpib=disopyramide_NN	lemma_6=warfarin	wib=disopyramide	relType_7=conj	relType_12=conj	lemma_13=alfentanyl	relType_9=conj	relType_13=punct	relType_9=compound	relType_6=punct	pos_9=NNS	pos_4=NN	relType_5=punct	pos_11=,	relType_9=punct	pos_6=,	lemma_12=fentanyl	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e15	null	pos_2=NN	lemma_11=carbamazepine	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	lemma_12=,	relType_6=conj	lemma_5=quinidine	lemma_9=derivative	pos_12=,	pos_10=NN	lemma_7=,	pos_13=NN	lemma_2=disopyramide	relType_4=punct	lemma_3=,	lemma_5=,	lemma_15=and	lemma_4=amiodarone	pos_3=,	pos_10=,	relType_8=conj	pos_15=CC	pos_2=,	lemma_8=cyclosporine	lib=disopyramide	pos_13=,	lemma_1=,	lemma_14=alprazolam	pos_1=,	path1=dapsone_conj	relType_2=punct	pos_8=NN	relType_10=conj	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	pos_5=NN	lemma_14=,	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	path=dapsone_conj<eg_dep>triazolam_conj	pos_8=,	relType_14=punct	relType_10=punct	lemma_7=tacrolimus	lemma_11=,	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_11=conj	pos_4=,	pos_14=,	relType_11=punct	pos_7=,	pos_14=NN	lemma_3=quinine	relType_3=conj	relType_5=conj	lpib=disopyramide_NN	lemma_6=warfarin	wib=disopyramide	relType_14=conj	relType_7=conj	relType_12=conj	lemma_13=alfentanyl	relType_9=conj	relType_13=punct	relType_9=compound	relType_6=punct	pos_9=NNS	pos_4=NN	relType_5=punct	relType_15=cc	pos_11=,	relType_9=punct	pos_6=,	lemma_12=fentanyl	path2=triazolam_conj	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e1	DDI-DrugBank.d124.s26.e16	mechanism	pos_17=MD	pos_2=NN	lemma_11=carbamazepine	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_21=obj	relType_8=punct	lemma_9=,	pos_21=NNS	pos_6=NN	lemma_12=,	relType_6=conj	relType_24=case	lemma_5=quinidine	lemma_9=derivative	pos_12=,	pos_20=NN	pos_10=NN	lemma_7=,	pos_13=NN	lemma_2=disopyramide	relType_4=punct	lemma_3=,	lemma_5=,	lemma_19=elevate	pos_24=IN	relType_16=punct	lemma_15=and	lemma_23=coadminister	lemma_4=amiodarone	pos_3=,	pos_10=,	relType_8=conj	pos_15=CC	pos_2=,	lemma_8=cyclosporine	relType_17=aux	lib=disopyramide	pos_13=,	lemma_1=,	pos_22=WRB	lemma_14=alprazolam	pos_1=,	path2=coadminister_advcl>saquinavir_obl	relType_2=punct	pos_8=NN	relType_19=ROOT	relType_10=conj	pos_23=VBN	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	pos_16=NN	lemma_24=with	pos_5=NN	lemma_14=,	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_14=punct	relType_10=punct	lemma_7=tacrolimus	path=dapsone_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	lemma_11=,	lemma_8=,	lemma_9=ergot	lemma_10=pimozide	relType_11=conj	pos_4=,	pos_14=,	relType_11=punct	pos_7=,	pos_14=NN	relType_22=advmod	lemma_3=quinine	relType_3=conj	pos_18=VB	pos_16=-RRB-	relType_5=conj	lpib=disopyramide_NN	pos_19=VBN	lemma_6=warfarin	lemma_18=have	wib=disopyramide	relType_14=conj	relType_7=conj	lemma_17=may	relType_12=conj	lemma_13=alfentanyl	relType_9=conj	path1=dapsone_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	relType_13=punct	lemma_22=when	relType_9=compound	relType_6=punct	pos_9=NNS	lemma_16=triazolam	lemma_21=concentration	relation_33=beneficial	pos_4=NN	lemma_16=)	relType_18=aux	relType_5=punct	relType_15=cc	pos_11=,	relType_23=advcl	relType_9=punct	pos_6=,	lemma_12=fentanyl	eib=True	relType_20=compound	lemma_20=plasma	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	relType_16=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e3	null	lemma_1=,	path=disopyramide_conj<eg_dep>quinine_conj	path2=quinine_conj	lpib=quinine_NN	eib=False	path1=disopyramide_conj	lib=quinine	pos_1=,	relType_1=punct	wib=quinine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e4	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lpib=quinine_NN	path1=disopyramide_conj	lemma_2=,	lib=quinine	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	path=disopyramide_conj<eg_dep>amiodarone_conj	path2=amiodarone_conj	wib=quinine	lemma_2=quinine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e5	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	path1=disopyramide_conj	relType_2=conj	lemma_2=,	wib=quinine	lemma_3=,	lpib=quinine_NN	relType_3=conj	path2=quinidine_conj	lib=quinine	lemma_3=amiodarone	relType_3=punct	lemma_2=quinine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	path=disopyramide_conj<eg_dep>quinidine_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e6	null	lemma_1=,	pos_2=NN	path=disopyramide_conj<eg_dep>warfarin_conj	pos_1=,	relType_2=punct	pos_4=,	path1=disopyramide_conj	relType_2=conj	pos_4=NN	lemma_2=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	relType_3=conj	lib=quinine	lemma_3=amiodarone	lemma_4=,	lemma_2=quinine	path2=warfarin_conj	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	pos_2=NN	lemma_5=warfarin	pos_5=,	pos_1=,	relType_2=punct	path2=tacrolimus_conj	pos_4=,	path1=disopyramide_conj	relType_2=conj	pos_4=NN	lemma_2=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	lib=quinine	lemma_3=amiodarone	lemma_4=,	relType_5=conj	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	path=disopyramide_conj<eg_dep>tacrolimus_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	pos_2=NN	lemma_5=warfarin	pos_5=,	path2=cyclosporine_conj	pos_1=,	lemma_6=,	path=disopyramide_conj<eg_dep>cyclosporine_conj	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	path1=disopyramide_conj	relType_6=punct	lemma_6=tacrolimus	relType_2=conj	pos_4=NN	lemma_2=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	lib=quinine	lemma_3=amiodarone	lemma_4=,	relType_5=conj	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	lemma_5=warfarin	pos_5=,	pos_1=,	lemma_6=,	path=disopyramide_conj<eg_dep>derivative_conj	lemma_8=ergot	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	path1=disopyramide_conj	relType_6=punct	lemma_7=cyclosporine	pos_7=,	path2=derivative_conj	lemma_6=tacrolimus	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lib=quinine	lemma_3=amiodarone	lemma_4=,	relType_5=conj	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	path=disopyramide_conj<eg_dep>pimozide_conj	lemma_5=warfarin	pos_5=,	pos_1=,	lemma_6=,	lemma_8=ergot	relType_8=punct	lemma_8=,	pos_8=NNS	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_8=derivative	pos_4=,	path1=disopyramide_conj	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_6=tacrolimus	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lib=quinine	lemma_3=amiodarone	lemma_4=,	relType_5=conj	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	relType_9=conj	lemma_5=warfarin	pos_5=,	pos_1=,	lemma_6=,	lemma_8=ergot	relType_8=punct	lemma_9=,	path=disopyramide_conj<eg_dep>carbamazepine_conj	lemma_8=,	pos_8=NNS	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_8=derivative	pos_4=,	path1=disopyramide_conj	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_6=tacrolimus	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	wib=quinine	relType_4=punct	lemma_3=,	lemma_9=pimozide	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lib=quinine	lemma_3=amiodarone	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_5=warfarin	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lemma_8=ergot	relType_8=punct	lemma_9=,	path2=fentanyl_conj	lemma_8=,	path=disopyramide_conj<eg_dep>fentanyl_conj	pos_8=NNS	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_8=derivative	pos_4=,	relType_10=conj	path1=disopyramide_conj	relType_6=punct	lemma_7=cyclosporine	pos_7=,	lemma_6=tacrolimus	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	wib=quinine	relType_4=punct	lemma_3=,	lemma_9=pimozide	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lib=quinine	lemma_3=amiodarone	lemma_10=carbamazepine	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_11=,	lemma_5=warfarin	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lemma_8=ergot	relType_8=punct	lemma_9=,	lemma_8=,	pos_8=NNS	relType_2=punct	relType_11=conj	pos_6=NN	pos_8=NN	relType_6=conj	lemma_8=derivative	lemma_11=fentanyl	pos_4=,	relType_10=conj	path1=disopyramide_conj	relType_6=punct	relType_11=punct	path2=alfentanyl_conj	lemma_7=cyclosporine	pos_7=,	lemma_6=tacrolimus	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	wib=quinine	relType_4=punct	lemma_3=,	lemma_9=pimozide	lpib=quinine_NN	relType_3=conj	lemma_5=,	relType_5=punct	relType_8=compound	lib=quinine	lemma_3=amiodarone	lemma_10=carbamazepine	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	pos_6=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_11=NN	pos_3=,	pos_10=,	eib=True	path=disopyramide_conj<eg_dep>alfentanyl_conj	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e14	null	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_8=NNS	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	lemma_7=cyclosporine	path=disopyramide_conj<eg_dep>alprazolam_conj	pos_10=NN	lemma_7=,	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	path2=alprazolam_conj	lemma_8=derivative	lemma_1=,	pos_1=,	relType_2=punct	pos_8=NN	relType_10=conj	lemma_6=tacrolimus	relType_12=punct	relType_2=conj	pos_9=NN	lemma_2=,	lemma_3=amiodarone	lemma_4=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_11=,	lemma_5=warfarin	lemma_8=,	relType_11=conj	lemma_11=fentanyl	pos_4=,	path1=disopyramide_conj	relType_11=punct	pos_7=,	relType_3=conj	relType_8=compound	lib=quinine	lemma_10=carbamazepine	relType_5=conj	relType_7=conj	relType_12=conj	relType_9=conj	lemma_8=ergot	relType_6=punct	pos_4=NN	lemma_9=pimozide	relType_5=punct	lemma_12=alfentanyl	pos_11=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e15	null	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_8=NNS	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	lemma_7=cyclosporine	pos_10=NN	lemma_7=,	pos_13=NN	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	lemma_5=,	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	lemma_8=derivative	pos_13=,	lemma_1=,	pos_1=,	relType_2=punct	pos_8=NN	relType_10=conj	lemma_6=tacrolimus	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_3=amiodarone	lemma_4=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_11=NN	lemma_14=and	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_11=,	lemma_5=warfarin	lemma_8=,	relType_11=conj	lemma_11=fentanyl	pos_4=,	path1=disopyramide_conj	relType_11=punct	pos_7=,	relType_3=conj	relType_8=compound	lib=quinine	lemma_10=carbamazepine	relType_5=conj	relType_7=conj	relType_12=conj	relType_9=conj	relType_13=punct	lemma_8=ergot	lemma_13=alprazolam	relType_6=punct	path=disopyramide_conj<eg_dep>triazolam_conj	pos_4=NN	lemma_9=pimozide	relType_5=punct	lemma_12=alfentanyl	relType_14=cc	pos_11=,	relType_9=punct	pos_6=,	path2=triazolam_conj	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e2	DDI-DrugBank.d124.s26.e16	mechanism	pos_2=NN	pos_14=CC	lemma_13=,	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_22=coadminister	pos_8=NNS	pos_6=NN	lemma_12=,	relType_6=conj	pos_16=MD	pos_12=,	lemma_7=cyclosporine	lemma_20=concentration	pos_10=NN	lemma_7=,	pos_13=NN	relType_20=obj	wib=quinine	relType_4=punct	lemma_3=,	lpib=quinine_NN	lemma_5=,	lemma_18=elevate	lemma_21=when	pos_3=,	pos_10=,	lemma_16=may	relType_8=conj	pos_2=,	relType_17=aux	lemma_8=derivative	pos_15=-RRB-	pos_13=,	lemma_1=,	relation_31=beneficial	pos_1=,	path2=coadminister_advcl>saquinavir_obl	relType_2=punct	pos_8=NN	lemma_19=plasma	relType_10=conj	relType_21=advmod	relType_18=ROOT	lemma_6=tacrolimus	relType_12=punct	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	relType_19=compound	lemma_3=amiodarone	lemma_4=,	lemma_2=quinine	pos_5=NN	lemma_4=quinidine	pos_11=NN	lemma_14=and	pos_23=IN	pos_21=WRB	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_11=,	lemma_5=warfarin	lemma_8=,	relType_11=conj	lemma_11=fentanyl	pos_4=,	relType_11=punct	pos_7=,	lemma_17=have	relType_15=punct	relType_3=conj	relType_8=compound	lib=quinine	lemma_10=carbamazepine	relType_5=conj	relType_23=case	pos_18=VBN	relType_15=conj	path1=disopyramide_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	relType_7=conj	relType_12=conj	relType_9=conj	relType_13=punct	lemma_8=ergot	lemma_23=with	pos_22=VBN	relType_22=advcl	lemma_13=alprazolam	relType_6=punct	relType_16=aux	pos_19=NN	pos_4=NN	pos_15=NN	lemma_9=pimozide	relType_5=punct	pos_17=VB	pos_20=NNS	lemma_15=)	lemma_12=alfentanyl	relType_14=cc	pos_11=,	lemma_15=triazolam	relType_9=punct	path=disopyramide_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_6=,	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e4	null	wib=amiodarone	path=quinine_conj<eg_dep>amiodarone_conj	lemma_1=,	eib=False	path1=quinine_conj	pos_1=,	lib=amiodarone	lpib=amiodarone_NN	relType_1=punct	path2=amiodarone_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e5	null	wib=amiodarone	lemma_1=,	pos_2=NN	eib=True	lemma_2=,	path1=quinine_conj	path2=quinidine_conj	pos_1=,	pos_2=,	lemma_2=amiodarone	lib=amiodarone	lpib=amiodarone_NN	relType_1=punct	relType_2=conj	path=quinine_conj<eg_dep>quinidine_conj	relType_2=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e6	null	lemma_1=,	pos_2=NN	pos_1=,	lib=amiodarone	relType_2=punct	lemma_2=amiodarone	lpib=amiodarone_NN	path=quinine_conj<eg_dep>warfarin_conj	relType_2=conj	lemma_2=,	wib=amiodarone	lemma_3=,	relType_3=conj	lemma_3=quinidine	path2=warfarin_conj	pos_3=,	eib=True	pos_3=NN	path1=quinine_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	pos_2=NN	pos_1=,	lib=amiodarone	relType_2=punct	path2=tacrolimus_conj	pos_4=,	lemma_2=amiodarone	lpib=amiodarone_NN	relType_2=conj	pos_4=NN	lemma_2=,	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_3=quinidine	lemma_4=,	pos_3=,	eib=True	pos_3=NN	path1=quinine_conj	pos_2=,	relType_4=conj	relType_1=punct	path=quinine_conj<eg_dep>tacrolimus_conj	lemma_4=warfarin	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	pos_2=NN	pos_5=,	path2=cyclosporine_conj	pos_1=,	lib=amiodarone	relType_2=punct	pos_4=,	lemma_2=amiodarone	lpib=amiodarone_NN	path=quinine_conj<eg_dep>cyclosporine_conj	relType_2=conj	pos_4=NN	lemma_2=,	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	pos_5=NN	pos_3=,	eib=True	lemma_5=tacrolimus	pos_3=NN	path1=quinine_conj	pos_2=,	relType_4=conj	relType_1=punct	lemma_4=warfarin	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e9	null	lemma_6=cyclosporine	relType_7=compound	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lib=amiodarone	relType_2=punct	lemma_7=ergot	pos_6=NN	relType_6=conj	pos_4=,	path=quinine_conj<eg_dep>derivative_conj	relType_6=punct	path2=derivative_conj	lemma_2=amiodarone	lpib=amiodarone_NN	relType_2=conj	pos_4=NN	lemma_2=,	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	pos_3=,	eib=True	lemma_5=tacrolimus	pos_3=NN	path1=quinine_conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	lemma_4=warfarin	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e10	null	pos_7=NNS	lemma_6=cyclosporine	relType_7=compound	path2=pimozide_conj	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lib=amiodarone	path=quinine_conj<eg_dep>pimozide_conj	relType_2=punct	lemma_7=ergot	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_2=amiodarone	lpib=amiodarone_NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	pos_6=,	lemma_7=derivative	pos_5=NN	pos_3=,	eib=True	lemma_5=tacrolimus	pos_3=NN	relType_7=punct	path1=quinine_conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	lemma_4=warfarin	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e11	null	pos_7=NNS	lemma_6=cyclosporine	relType_7=compound	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lib=amiodarone	lemma_8=,	relType_2=punct	lemma_7=ergot	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_2=amiodarone	lpib=amiodarone_NN	lemma_8=pimozide	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	pos_6=,	lemma_7=derivative	path=quinine_conj<eg_dep>carbamazepine_conj	pos_5=NN	pos_3=,	eib=True	lemma_5=tacrolimus	pos_3=NN	relType_7=punct	path1=quinine_conj	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	lemma_4=warfarin	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e12	null	pos_7=NNS	lemma_6=cyclosporine	relType_7=compound	lemma_1=,	pos_2=NN	relType_9=conj	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lib=amiodarone	lemma_9=,	path2=fentanyl_conj	lemma_8=,	relType_2=punct	lemma_7=ergot	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	path=quinine_conj<eg_dep>fentanyl_conj	relType_6=punct	pos_7=,	lemma_2=amiodarone	lpib=amiodarone_NN	lemma_9=carbamazepine	lemma_8=pimozide	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lemma_7=derivative	pos_5=NN	pos_3=,	eib=True	lemma_5=tacrolimus	pos_3=NN	relType_7=punct	path1=quinine_conj	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lemma_4=warfarin	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e13	null	pos_7=NNS	lemma_6=cyclosporine	relType_7=compound	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lib=amiodarone	lemma_9=,	lemma_8=,	relType_2=punct	lemma_7=ergot	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	path2=alfentanyl_conj	pos_7=,	lemma_2=amiodarone	lpib=amiodarone_NN	lemma_9=carbamazepine	lemma_8=pimozide	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	pos_10=NN	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	lemma_7=derivative	path=quinine_conj<eg_dep>alfentanyl_conj	pos_5=NN	lemma_10=fentanyl	pos_3=,	pos_10=,	eib=True	lemma_5=tacrolimus	pos_3=NN	relType_7=punct	path1=quinine_conj	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lemma_4=warfarin	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e14	null	pos_7=NNS	lemma_6=cyclosporine	relType_7=compound	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_11=,	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lemma_11=alfentanyl	relType_8=punct	lib=amiodarone	lemma_9=,	lemma_8=,	relType_11=conj	relType_2=punct	lemma_7=ergot	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	relType_11=punct	path=quinine_conj<eg_dep>alprazolam_conj	pos_7=,	lemma_2=amiodarone	lpib=amiodarone_NN	lemma_9=carbamazepine	lemma_8=pimozide	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	pos_10=NN	wib=amiodarone	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_3=quinidine	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	pos_6=,	lemma_7=derivative	pos_5=NN	lemma_10=fentanyl	pos_11=NN	pos_3=,	pos_10=,	eib=True	lemma_5=tacrolimus	pos_3=NN	relType_7=punct	path1=quinine_conj	relType_8=conj	pos_8=,	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	lemma_4=warfarin	path2=alprazolam_conj	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e15	null	lemma_6=cyclosporine	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lib=amiodarone	lemma_9=,	lemma_7=ergot	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	lemma_13=and	pos_10=NN	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_10=fentanyl	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	pos_7=NNS	lemma_1=,	lemma_12=alprazolam	pos_1=,	lemma_11=alfentanyl	relType_2=punct	pos_8=NN	relType_10=conj	lemma_2=amiodarone	relType_12=punct	relType_2=conj	pos_9=NN	lemma_2=,	relType_13=cc	wib=amiodarone	lemma_4=,	lemma_7=derivative	pos_5=NN	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_11=,	lemma_8=,	relType_11=conj	pos_4=,	relType_11=punct	pos_7=,	lemma_9=carbamazepine	relType_3=conj	relType_5=conj	pos_13=CC	lemma_5=tacrolimus	path1=quinine_conj	lemma_4=warfarin	relType_7=conj	relType_7=compound	relType_12=conj	relType_9=conj	path=quinine_conj<eg_dep>triazolam_conj	relType_6=punct	lpib=amiodarone_NN	lemma_8=pimozide	pos_4=NN	relType_5=punct	lemma_3=quinidine	pos_11=,	relType_9=punct	pos_6=,	path2=triazolam_conj	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e3	DDI-DrugBank.d124.s26.e16	mechanism	lemma_6=cyclosporine	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lib=amiodarone	lemma_9=,	lemma_7=ergot	pos_6=NN	lemma_12=,	relType_6=conj	pos_12=,	lemma_13=and	pos_10=NN	lemma_7=,	pos_22=IN	pos_18=NN	relType_4=punct	lemma_3=,	path1=quinine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	lemma_5=,	lemma_10=fentanyl	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	pos_7=NNS	lemma_1=,	lemma_19=concentration	lemma_12=alprazolam	pos_1=,	lemma_11=alfentanyl	path2=coadminister_advcl>saquinavir_obl	pos_19=NNS	relType_2=punct	pos_8=NN	lemma_14=triazolam	relType_10=conj	pos_16=VB	lemma_2=amiodarone	relType_12=punct	relType_22=case	relType_2=conj	pos_9=NN	lemma_2=,	relType_13=cc	lemma_18=plasma	lemma_20=when	wib=amiodarone	lemma_4=,	lemma_22=with	lemma_7=derivative	pos_21=VBN	pos_5=NN	pos_11=NN	lemma_16=have	relation_29=beneficial	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_14=punct	relType_10=punct	lemma_11=,	lemma_8=,	path=quinine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_17=VBN	relType_11=conj	pos_4=,	lemma_21=coadminister	pos_14=-RRB-	relType_11=punct	pos_7=,	lemma_9=carbamazepine	pos_14=NN	lemma_14=)	relType_3=conj	relType_5=conj	pos_13=CC	lemma_17=elevate	lemma_5=tacrolimus	relType_19=obj	lemma_4=warfarin	relType_14=conj	relType_7=conj	relType_7=compound	relType_12=conj	relType_9=conj	lemma_15=may	pos_15=MD	relType_17=ROOT	relType_20=advmod	relType_6=punct	relType_15=aux	relType_16=aux	lpib=amiodarone_NN	lemma_8=pimozide	pos_4=NN	relType_21=advcl	relType_5=punct	lemma_3=quinidine	pos_11=,	relType_9=punct	pos_6=,	pos_20=WRB	eib=True	pos_3=NN	relType_7=punct	relType_18=compound	relType_4=conj	pos_12=NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e5	null	lpib=quinidine_NN	lib=quinidine	lemma_1=,	eib=False	path2=quinidine_conj	path=amiodarone_conj<eg_dep>quinidine_conj	pos_1=,	relType_1=punct	path1=amiodarone_conj	wib=quinidine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e6	null	path2=warfarin_conj	lpib=quinidine_NN	lib=quinidine	lemma_1=,	lemma_2=quinidine	pos_2=NN	relType_2=punct	eib=True	path=amiodarone_conj<eg_dep>warfarin_conj	pos_1=,	pos_2=,	relType_1=punct	relType_2=conj	lemma_2=,	path1=amiodarone_conj	wib=quinidine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	pos_2=NN	pos_1=,	path1=amiodarone_conj	relType_2=punct	lpib=quinidine_NN	lib=quinidine	path2=tacrolimus_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lemma_3=warfarin	wib=quinidine	lemma_2=quinidine	pos_3=,	eib=True	pos_3=NN	path=amiodarone_conj<eg_dep>tacrolimus_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	pos_2=NN	path2=cyclosporine_conj	path=amiodarone_conj<eg_dep>cyclosporine_conj	pos_1=,	path1=amiodarone_conj	relType_2=punct	lpib=quinidine_NN	lib=quinidine	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	relType_4=punct	lemma_3=,	relType_3=conj	lemma_3=warfarin	lemma_4=,	wib=quinidine	lemma_2=quinidine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	path=amiodarone_conj<eg_dep>derivative_conj	path1=amiodarone_conj	relType_2=punct	pos_6=NN	lpib=quinidine_NN	lib=quinidine	pos_4=,	path2=derivative_conj	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_6=ergot	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=cyclosporine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	path=amiodarone_conj<eg_dep>pimozide_conj	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	path1=amiodarone_conj	relType_2=punct	pos_6=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	relType_6=punct	lemma_6=derivative	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_6=ergot	pos_3=,	eib=True	pos_3=NN	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_5=cyclosporine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	path=amiodarone_conj<eg_dep>carbamazepine_conj	lemma_1=,	pos_2=NN	pos_5=,	lemma_7=pimozide	pos_1=,	lemma_6=,	path1=amiodarone_conj	relType_2=punct	pos_6=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	relType_6=punct	lemma_6=derivative	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_6=ergot	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_6=NNS	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	pos_2=NN	pos_5=,	lemma_7=pimozide	pos_1=,	lemma_6=,	relType_8=punct	path2=fentanyl_conj	lemma_8=,	path1=amiodarone_conj	relType_2=punct	pos_6=NN	pos_8=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	path=amiodarone_conj<eg_dep>fentanyl_conj	relType_6=punct	lemma_6=derivative	pos_7=,	lemma_8=carbamazepine	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_6=ergot	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	pos_2=NN	relType_9=conj	pos_5=,	lemma_7=pimozide	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	path1=amiodarone_conj	relType_2=punct	pos_6=NN	pos_8=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	relType_6=punct	lemma_6=derivative	path2=alfentanyl_conj	pos_7=,	lemma_8=carbamazepine	lemma_9=fentanyl	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	pos_9=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_6=ergot	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	lemma_5=cyclosporine	relType_7=conj	path=amiodarone_conj<eg_dep>alfentanyl_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	pos_5=,	lemma_7=pimozide	lemma_10=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_9=,	lemma_8=,	path1=amiodarone_conj	relType_2=punct	pos_6=NN	pos_8=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	lemma_6=derivative	pos_7=,	lemma_8=carbamazepine	lemma_9=fentanyl	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_4=tacrolimus	pos_9=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_4=,	relType_5=conj	relType_9=punct	path=amiodarone_conj<eg_dep>alprazolam_conj	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_10=alfentanyl	lemma_6=ergot	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	path2=alprazolam_conj	relType_3=punct	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	lemma_11=,	pos_5=,	lemma_7=pimozide	lemma_10=,	pos_1=,	lemma_6=,	relType_12=cc	relType_8=punct	lemma_9=,	pos_12=CC	lemma_8=,	path1=amiodarone_conj	relType_11=conj	relType_2=punct	pos_6=NN	pos_8=NN	lpib=quinidine_NN	lib=quinidine	relType_6=conj	pos_4=,	relType_10=conj	relType_6=punct	relType_11=punct	lemma_6=derivative	pos_7=,	lemma_8=carbamazepine	lemma_9=fentanyl	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	path=amiodarone_conj<eg_dep>triazolam_conj	lemma_4=tacrolimus	pos_9=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	lemma_3=warfarin	relType_5=punct	lemma_11=alprazolam	lemma_4=,	relType_5=conj	pos_11=,	relType_9=punct	pos_6=,	wib=quinidine	pos_5=NN	relType_6=compound	lemma_2=quinidine	lemma_10=alfentanyl	path2=triazolam_conj	pos_3=,	lemma_6=ergot	eib=True	pos_10=,	pos_11=NN	pos_3=NN	relType_7=punct	pos_8=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_4=conj	lemma_12=and	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	lemma_5=cyclosporine	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e4	DDI-DrugBank.d124.s26.e16	mechanism	lemma_17=plasma	lemma_18=concentration	pos_2=NN	pos_5=,	lemma_10=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_12=CC	relType_19=advmod	lemma_16=elevate	pos_6=NN	relType_6=conj	relType_17=compound	pos_10=NN	lemma_7=,	pos_13=NN	pos_16=VBN	relType_4=punct	lemma_3=,	lemma_5=,	pos_19=WRB	relType_21=case	relType_6=compound	lemma_10=alfentanyl	pos_3=,	pos_10=,	pos_6=NNS	relType_8=conj	pos_2=,	relType_18=obj	lemma_1=,	pos_18=NNS	lemma_7=pimozide	pos_1=,	path2=coadminister_advcl>saquinavir_obl	pos_20=VBN	relType_2=punct	pos_8=NN	lemma_20=coadminister	relType_10=conj	relType_13=conj	relType_2=conj	pos_9=NN	lemma_2=,	lemma_4=,	pos_5=NN	pos_11=NN	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_11=,	path1=amiodarone_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	relType_12=cc	lemma_8=,	relType_11=conj	pos_17=NN	pos_4=,	relType_11=punct	pos_7=,	lemma_9=fentanyl	pos_21=IN	relType_20=advcl	lemma_4=tacrolimus	relType_3=conj	lemma_11=alprazolam	relType_5=conj	pos_13=-RRB-	lemma_2=quinidine	lemma_12=and	path=amiodarone_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	relType_7=conj	lemma_19=when	relType_9=conj	relation_27=beneficial	relType_13=punct	relType_16=ROOT	lemma_15=have	lpib=quinidine_NN	lib=quinidine	relType_6=punct	relType_15=aux	lemma_6=derivative	lemma_8=carbamazepine	lemma_21=with	pos_4=NN	lemma_14=may	pos_15=VB	lemma_3=warfarin	relType_5=punct	relType_14=aux	pos_11=,	relType_9=punct	pos_6=,	wib=quinidine	pos_14=MD	lemma_6=ergot	eib=True	lemma_13=)	pos_3=NN	relType_7=punct	relType_4=conj	lemma_13=triazolam	lemma_5=cyclosporine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e6	null	lib=warfarin	path2=warfarin_conj	path=quinidine_conj<eg_dep>warfarin_conj	lemma_1=,	lpib=warfarin_NN	eib=False	pos_1=,	path1=quinidine_conj	wib=warfarin	relType_1=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e7	null	lib=warfarin	lemma_2=warfarin	lemma_1=,	lpib=warfarin_NN	path2=tacrolimus_conj	eib=True	pos_2=NN	path=quinidine_conj<eg_dep>tacrolimus_conj	pos_1=,	path1=quinidine_conj	pos_2=,	wib=warfarin	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e8	null	lib=warfarin	lemma_1=,	pos_2=NN	path2=cyclosporine_conj	pos_1=,	relType_2=punct	lemma_3=tacrolimus	lpib=warfarin_NN	wib=warfarin	relType_2=conj	lemma_2=,	path=quinidine_conj<eg_dep>cyclosporine_conj	lemma_3=,	relType_3=conj	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	path1=quinidine_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e9	null	lib=warfarin	lemma_1=,	pos_2=NN	pos_1=,	relType_5=compound	relType_2=punct	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	path=quinidine_conj<eg_dep>derivative_conj	wib=warfarin	path2=derivative_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=ergot	lemma_4=,	lemma_4=cyclosporine	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	path1=quinidine_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e10	null	lib=warfarin	path2=pimozide_conj	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	relType_5=compound	lemma_5=derivative	relType_2=punct	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	pos_5=NNS	wib=warfarin	relType_2=conj	pos_4=NN	lemma_2=,	path=quinidine_conj<eg_dep>pimozide_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=ergot	lemma_4=,	relType_5=conj	lemma_4=cyclosporine	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	path1=quinidine_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e11	null	lib=warfarin	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_5=compound	lemma_5=derivative	relType_2=punct	pos_6=NN	relType_6=conj	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	pos_5=NNS	relType_6=punct	wib=warfarin	relType_2=conj	pos_4=NN	lemma_2=,	path=quinidine_conj<eg_dep>carbamazepine_conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=ergot	lemma_4=,	relType_5=conj	lemma_4=cyclosporine	pos_6=,	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	path1=quinidine_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_6=pimozide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e12	null	lib=warfarin	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_5=compound	path=quinidine_conj<eg_dep>fentanyl_conj	lemma_5=derivative	path2=fentanyl_conj	relType_2=punct	pos_6=NN	relType_6=conj	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	pos_5=NNS	relType_6=punct	pos_7=,	wib=warfarin	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_7=conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=ergot	lemma_4=,	relType_5=conj	lemma_4=cyclosporine	pos_6=,	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	relType_7=punct	path1=quinidine_conj	pos_2=,	relType_4=conj	lemma_7=carbamazepine	relType_1=punct	pos_7=NN	relType_3=punct	lemma_6=pimozide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e13	null	lib=warfarin	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_5=compound	relType_8=punct	lemma_5=derivative	lemma_8=,	relType_2=punct	path=quinidine_conj<eg_dep>alfentanyl_conj	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	lemma_8=fentanyl	pos_5=NNS	relType_6=punct	path2=alfentanyl_conj	pos_7=,	wib=warfarin	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	relType_7=conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=ergot	lemma_4=,	relType_5=conj	lemma_4=cyclosporine	pos_6=,	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	path1=quinidine_conj	pos_2=,	relType_4=conj	lemma_7=carbamazepine	relType_1=punct	pos_7=NN	relType_3=punct	lemma_6=pimozide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e14	null	lib=warfarin	lemma_1=,	pos_2=NN	relType_9=conj	pos_5=,	pos_1=,	lemma_6=,	relType_5=compound	relType_8=punct	lemma_5=derivative	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	lemma_8=fentanyl	pos_5=NNS	relType_6=punct	pos_7=,	wib=warfarin	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	relType_7=conj	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_5=ergot	lemma_9=alfentanyl	path=quinidine_conj<eg_dep>alprazolam_conj	lemma_4=,	relType_5=conj	relType_9=punct	lemma_4=cyclosporine	pos_6=,	pos_5=NN	lemma_2=warfarin	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	path1=quinidine_conj	pos_2=,	relType_4=conj	lemma_7=carbamazepine	pos_9=,	relType_1=punct	pos_7=NN	path2=alprazolam_conj	relType_3=punct	lemma_6=pimozide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e15	null	lib=warfarin	lemma_1=,	relType_10=punct	pos_2=NN	relType_9=conj	relType_11=cc	pos_5=,	lemma_10=,	pos_1=,	lemma_6=,	lemma_10=alprazolam	relType_5=compound	relType_8=punct	lemma_5=derivative	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	lemma_3=tacrolimus	lpib=warfarin_NN	pos_4=,	lemma_8=fentanyl	relType_10=conj	pos_5=NNS	relType_6=punct	pos_7=,	wib=warfarin	pos_10=NN	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_9=NN	relType_7=conj	relType_4=punct	lemma_3=,	lemma_11=and	relType_3=conj	lemma_5=,	relType_5=punct	pos_11=CC	lemma_5=ergot	lemma_9=alfentanyl	lemma_4=,	relType_5=conj	relType_9=punct	path=quinidine_conj<eg_dep>triazolam_conj	lemma_4=cyclosporine	pos_6=,	pos_5=NN	lemma_2=warfarin	path2=triazolam_conj	pos_3=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	path1=quinidine_conj	pos_2=,	relType_4=conj	lemma_7=carbamazepine	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	lemma_6=pimozide
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e5	DDI-DrugBank.d124.s26.e16	mechanism	pos_2=NN	relType_11=cc	pos_5=,	lemma_12=triazolam	lemma_10=,	lemma_6=,	relType_8=punct	lemma_5=derivative	lemma_9=,	pos_6=NN	relType_6=conj	pos_10=NN	lemma_7=,	lemma_14=have	relType_4=punct	lemma_3=,	lemma_11=and	lemma_5=,	relation_25=beneficial	lemma_4=cyclosporine	lemma_19=coadminister	pos_3=,	pos_10=,	relType_8=conj	pos_2=,	relType_15=ROOT	lib=warfarin	lemma_1=,	pos_1=,	lemma_10=alprazolam	path2=coadminister_advcl>saquinavir_obl	relType_2=punct	pos_8=NN	relType_20=case	lpib=warfarin_NN	path=quinidine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	relType_10=conj	relType_12=punct	pos_15=VBN	relType_2=conj	pos_9=NN	lemma_2=,	lemma_18=when	lemma_9=alfentanyl	pos_14=VB	lemma_4=,	path1=quinidine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	pos_16=NN	pos_5=NN	relType_17=obj	lemma_17=concentration	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	lemma_8=,	pos_12=-RRB-	pos_20=IN	pos_4=,	lemma_8=fentanyl	pos_7=,	wib=warfarin	relType_3=conj	pos_11=CC	lemma_5=ergot	relType_5=conj	relType_19=advcl	pos_17=NNS	pos_19=VBN	lemma_7=carbamazepine	lemma_15=elevate	relType_7=conj	relType_12=conj	relType_9=conj	relType_5=compound	relType_16=compound	lemma_16=plasma	lemma_3=tacrolimus	pos_5=NNS	relType_6=punct	relType_13=aux	lemma_13=may	pos_4=NN	relType_5=punct	relType_14=aux	pos_18=WRB	lemma_12=)	relType_9=punct	pos_6=,	lemma_2=warfarin	lemma_6=pimozide	lemma_20=with	eib=True	relType_18=advmod	pos_3=NN	relType_7=punct	relType_4=conj	pos_12=NN	pos_13=MD
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e7	null	lemma_1=,	lpib=tacrolimus_NN	path2=tacrolimus_conj	eib=False	pos_1=,	lib=tacrolimus	path1=warfarin_conj	wib=tacrolimus	relType_1=punct	path=warfarin_conj<eg_dep>tacrolimus_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	lpib=tacrolimus_NN	pos_2=NN	eib=True	path=warfarin_conj<eg_dep>cyclosporine_conj	path2=cyclosporine_conj	lemma_2=tacrolimus	pos_1=,	lib=tacrolimus	path1=warfarin_conj	pos_2=,	wib=tacrolimus	relType_1=punct	relType_2=conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_1=,	wib=tacrolimus	relType_2=punct	path2=derivative_conj	relType_2=conj	pos_4=NN	lemma_2=,	lemma_3=,	relType_3=conj	relType_4=compound	path=warfarin_conj<eg_dep>derivative_conj	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	eib=True	pos_3=NN	lemma_2=tacrolimus	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_1=,	path=warfarin_conj<eg_dep>pimozide_conj	wib=tacrolimus	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	relType_4=compound	lemma_4=derivative	lemma_4=,	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	eib=True	pos_3=NN	lemma_2=tacrolimus	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_5=,	pos_1=,	wib=tacrolimus	relType_2=punct	pos_4=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_4=derivative	lemma_4=,	relType_5=conj	path=warfarin_conj<eg_dep>carbamazepine_conj	pos_5=NN	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	lemma_5=pimozide	eib=True	pos_3=NN	lemma_2=tacrolimus	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e12	null	path=warfarin_conj<eg_dep>fentanyl_conj	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_5=,	pos_1=,	lemma_6=,	wib=tacrolimus	path2=fentanyl_conj	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=carbamazepine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_4=derivative	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	lemma_5=pimozide	eib=True	pos_3=NN	lemma_2=tacrolimus	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_5=,	lemma_7=fentanyl	pos_1=,	lemma_6=,	path=warfarin_conj<eg_dep>alfentanyl_conj	wib=tacrolimus	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	path2=alfentanyl_conj	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=carbamazepine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_4=derivative	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	lemma_5=pimozide	eib=True	pos_3=NN	relType_7=punct	lemma_2=tacrolimus	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	pos_2=NN	lemma_4=ergot	pos_5=,	lemma_7=fentanyl	path=warfarin_conj<eg_dep>alprazolam_conj	pos_1=,	lemma_6=,	lemma_8=alfentanyl	wib=tacrolimus	relType_8=punct	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=carbamazepine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	relType_4=compound	lemma_4=derivative	lemma_4=,	relType_5=conj	pos_6=,	pos_5=NN	lemma_3=cyclosporine	lpib=tacrolimus_NN	pos_3=,	lemma_5=pimozide	eib=True	pos_3=NN	relType_7=punct	lemma_2=tacrolimus	pos_8=,	relType_8=conj	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	relType_1=punct	pos_7=NN	path2=alprazolam_conj	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	lemma_4=ergot	relType_9=conj	pos_5=,	relType_10=cc	lemma_7=fentanyl	pos_1=,	path=warfarin_conj<eg_dep>triazolam_conj	lemma_6=,	lemma_8=alfentanyl	wib=tacrolimus	relType_8=punct	lemma_9=,	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_10=CC	pos_7=,	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	pos_4=NNS	lemma_6=carbamazepine	pos_9=NN	lemma_10=and	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_9=alprazolam	relType_4=compound	lemma_4=derivative	lemma_4=,	relType_5=conj	relType_9=punct	pos_6=,	pos_5=NN	lemma_3=cyclosporine	lpib=tacrolimus_NN	path2=triazolam_conj	pos_3=,	eib=True	lemma_5=pimozide	pos_3=NN	relType_7=punct	lemma_2=tacrolimus	pos_8=,	relType_8=conj	lib=tacrolimus	path1=warfarin_conj	pos_2=,	relType_4=conj	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e6	DDI-DrugBank.d124.s26.e16	mechanism	pos_2=NN	pos_5=,	lemma_6=,	relType_8=punct	lemma_9=,	pos_6=NN	relType_6=conj	lemma_7=,	lemma_15=plasma	lemma_11=triazolam	path1=warfarin_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	path=warfarin_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	lemma_10=and	lemma_19=with	relType_4=punct	lemma_3=,	lemma_5=,	pos_11=-RRB-	relType_15=compound	pos_14=VBN	lemma_16=concentration	lemma_3=cyclosporine	relType_18=advcl	pos_3=,	relType_8=conj	pos_2=,	lemma_1=,	lemma_4=ergot	lemma_17=when	pos_1=,	lemma_12=may	path2=coadminister_advcl>saquinavir_obl	pos_16=NNS	relType_2=punct	pos_8=NN	lemma_11=)	relType_2=conj	lemma_6=carbamazepine	lemma_2=,	pos_9=NN	lemma_4=,	pos_5=NN	pos_11=NN	relType_19=case	pos_9=,	relType_1=punct	lemma_13=have	pos_7=NN	relType_3=punct	pos_8=,	relType_10=cc	lemma_7=fentanyl	lemma_8=,	relType_11=conj	pos_4=,	pos_10=CC	relType_11=punct	relType_14=ROOT	pos_7=,	pos_13=VB	relation_23=beneficial	relType_3=conj	lemma_4=derivative	relType_16=obj	relType_5=conj	pos_12=MD	lemma_5=pimozide	lpib=tacrolimus_NN	pos_18=VBN	lemma_2=tacrolimus	lemma_14=elevate	relType_7=conj	pos_19=IN	relType_9=conj	lemma_8=alfentanyl	wib=tacrolimus	relType_6=punct	relType_12=aux	relType_13=aux	pos_4=NN	pos_4=NNS	pos_15=NN	lemma_9=alprazolam	relType_5=punct	relType_4=compound	relType_17=advmod	relType_9=punct	pos_6=,	pos_17=WRB	eib=True	pos_3=NN	relType_7=punct	lib=tacrolimus	relType_4=conj	lemma_18=coadminister
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e8	null	lemma_1=,	lpib=cyclosporine_NN	eib=False	path2=cyclosporine_conj	pos_1=,	path1=tacrolimus_conj	lib=cyclosporine	path=tacrolimus_conj<eg_dep>cyclosporine_conj	wib=cyclosporine	relType_1=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e9	null	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=cyclosporine	relType_2=punct	lib=cyclosporine	path2=derivative_conj	relType_2=conj	lemma_2=,	lpib=cyclosporine_NN	wib=cyclosporine	eib=True	pos_3=NN	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_1=punct	lemma_3=ergot	path=tacrolimus_conj<eg_dep>derivative_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=cyclosporine	path=tacrolimus_conj<eg_dep>pimozide_conj	relType_2=punct	pos_3=NNS	lemma_3=derivative	lib=cyclosporine	relType_2=conj	lemma_2=,	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	wib=cyclosporine	pos_3=,	eib=True	pos_3=NN	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_1=punct	lemma_3=ergot	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	pos_2=NN	pos_1=,	lemma_2=cyclosporine	relType_2=punct	pos_3=NNS	lemma_3=derivative	lemma_4=pimozide	pos_4=,	lib=cyclosporine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_4=,	wib=cyclosporine	pos_3=,	eib=True	pos_3=NN	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_4=conj	path=tacrolimus_conj<eg_dep>carbamazepine_conj	relType_1=punct	lemma_3=ergot	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_2=cyclosporine	path2=fentanyl_conj	relType_2=punct	pos_3=NNS	lemma_3=derivative	lemma_4=pimozide	pos_4=,	lib=cyclosporine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	wib=cyclosporine	lemma_5=carbamazepine	pos_5=NN	pos_3=,	eib=True	pos_3=NN	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_4=conj	path=tacrolimus_conj<eg_dep>fentanyl_conj	relType_1=punct	lemma_3=ergot	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	pos_2=NN	path=tacrolimus_conj<eg_dep>alfentanyl_conj	pos_5=,	pos_1=,	lemma_6=,	lemma_2=cyclosporine	relType_2=punct	lemma_6=fentanyl	pos_6=NN	relType_6=conj	pos_3=NNS	lemma_3=derivative	lemma_4=pimozide	pos_4=,	relType_6=punct	path2=alfentanyl_conj	lib=cyclosporine	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	wib=cyclosporine	lemma_5=carbamazepine	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	lemma_3=ergot	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lemma_2=cyclosporine	relType_2=punct	lemma_6=fentanyl	pos_6=NN	relType_6=conj	pos_3=NNS	lemma_3=derivative	lemma_4=pimozide	pos_4=,	relType_6=punct	pos_7=,	lib=cyclosporine	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=alfentanyl	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	wib=cyclosporine	lemma_5=carbamazepine	pos_6=,	pos_5=NN	pos_3=,	eib=True	pos_3=NN	relType_7=punct	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_4=conj	relType_1=punct	pos_7=NN	lemma_3=ergot	path2=alprazolam_conj	relType_3=punct	path=tacrolimus_conj<eg_dep>alprazolam_conj	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_8=punct	lemma_2=cyclosporine	lemma_8=,	relType_2=punct	lemma_6=fentanyl	pos_6=NN	pos_8=NN	relType_6=conj	pos_3=NNS	lemma_3=derivative	lemma_4=pimozide	pos_4=,	relType_6=punct	pos_7=,	lib=cyclosporine	lemma_7=,	relType_2=conj	pos_4=NN	lemma_2=,	lemma_7=alfentanyl	pos_9=CC	lemma_9=and	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	relType_3=conj	lemma_5=,	relType_5=punct	path=tacrolimus_conj<eg_dep>triazolam_conj	lemma_4=,	relType_5=conj	wib=cyclosporine	lemma_8=alprazolam	lemma_5=carbamazepine	pos_6=,	pos_5=NN	path2=triazolam_conj	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_8=,	relType_8=conj	path1=tacrolimus_conj	pos_2=,	relType_3=compound	relType_4=conj	relType_9=cc	relType_1=punct	pos_7=NN	lemma_3=ergot	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e7	DDI-DrugBank.d124.s26.e16	mechanism	pos_2=NN	pos_5=,	lemma_6=,	relType_8=punct	pos_13=VBN	relType_18=case	pos_6=NN	relType_6=conj	pos_3=NNS	pos_10=NN	lemma_7=,	lemma_14=plasma	pos_9=CC	relType_4=punct	lemma_3=,	lpib=cyclosporine_NN	lemma_5=,	relType_17=advcl	lemma_11=may	lemma_8=alprazolam	lemma_5=carbamazepine	lemma_10=)	pos_3=,	relation_21=beneficial	relType_8=conj	pos_2=,	lemma_1=,	pos_1=,	path2=coadminister_advcl>saquinavir_obl	lemma_2=cyclosporine	relType_2=punct	lemma_6=fentanyl	pos_8=NN	relType_10=conj	relType_2=conj	lemma_2=,	lemma_4=,	pos_5=NN	relType_3=compound	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	relType_10=punct	pos_11=MD	lemma_8=,	pos_17=VBN	pos_4=,	lemma_4=pimozide	relType_11=aux	pos_7=,	lib=cyclosporine	pos_14=NN	pos_18=IN	relType_16=advmod	relType_3=conj	relType_5=conj	pos_12=VB	relType_15=obj	path1=tacrolimus_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	lemma_17=coadminister	pos_16=WRB	relType_7=conj	relType_13=ROOT	lemma_10=triazolam	relType_14=compound	lemma_13=elevate	lemma_3=derivative	lemma_15=concentration	relType_6=punct	relType_12=aux	pos_4=NN	lemma_7=alfentanyl	lemma_9=and	relType_5=punct	wib=cyclosporine	pos_6=,	lemma_16=when	lemma_18=with	pos_15=NNS	eib=True	lemma_12=have	pos_3=NN	relType_7=punct	pos_10=-RRB-	relType_4=conj	path=tacrolimus_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	lemma_3=ergot	relType_9=cc
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e9	null	path=cyclosporine_conj<eg_dep>derivative_conj	lemma_1=,	pos_2=NN	eib=True	relType_2=compound	pos_1=,	path2=derivative_conj	path1=cyclosporine_conj	relType_1=punct	lemma_2=ergot	wib=ergot	lpib=ergot_NN	lib=ergot
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	relType_2=conj	lemma_2=derivative	lemma_2=,	wib=ergot	lpib=ergot_NN	relType_2=compound	lemma_2=ergot	path=cyclosporine_conj<eg_dep>pimozide_conj	lib=ergot	pos_2=NNS	eib=True	pos_2=,	path1=cyclosporine_conj	relType_1=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	path=cyclosporine_conj<eg_dep>carbamazepine_conj	lemma_1=,	pos_2=NN	pos_1=,	lemma_3=pimozide	relType_2=punct	relType_2=conj	lemma_2=derivative	lemma_2=,	wib=ergot	lpib=ergot_NN	lemma_3=,	relType_3=conj	relType_2=compound	lemma_2=ergot	lib=ergot	pos_2=NNS	pos_3=,	eib=True	pos_3=NN	pos_2=,	path1=cyclosporine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e12	null	lemma_4=carbamazepine	lemma_1=,	pos_2=NN	pos_1=,	lemma_3=pimozide	path2=fentanyl_conj	relType_2=punct	pos_4=,	lemma_2=derivative	relType_2=conj	lemma_2=,	wib=ergot	lpib=ergot_NN	pos_4=NN	relType_4=punct	lemma_3=,	relType_3=conj	relType_2=compound	lemma_4=,	lemma_2=ergot	lib=ergot	pos_2=NNS	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	path=cyclosporine_conj<eg_dep>fentanyl_conj	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e13	null	lemma_4=carbamazepine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_3=pimozide	relType_2=punct	pos_4=,	path2=alfentanyl_conj	relType_2=conj	lemma_2=derivative	lemma_2=,	wib=ergot	lpib=ergot_NN	pos_4=NN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	lemma_2=ergot	lib=ergot	path=cyclosporine_conj<eg_dep>alfentanyl_conj	pos_2=NNS	pos_5=NN	pos_3=,	lemma_5=fentanyl	eib=True	pos_3=NN	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e14	null	lemma_4=carbamazepine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lemma_3=pimozide	relType_2=punct	pos_6=NN	relType_6=conj	path=cyclosporine_conj<eg_dep>alprazolam_conj	pos_4=,	relType_6=punct	lemma_2=derivative	relType_2=conj	lemma_2=,	wib=ergot	lpib=ergot_NN	pos_4=NN	lemma_6=alfentanyl	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	lemma_2=ergot	pos_6=,	lib=ergot	pos_2=NNS	pos_5=NN	pos_3=,	lemma_5=fentanyl	eib=True	pos_3=NN	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	path2=alprazolam_conj	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e15	null	lemma_4=carbamazepine	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	lemma_3=pimozide	lemma_7=alprazolam	relType_2=punct	pos_6=NN	relType_6=conj	pos_4=,	relType_6=punct	pos_7=,	pos_8=CC	lemma_7=,	relType_2=conj	lemma_2=derivative	lemma_2=,	wib=ergot	lpib=ergot_NN	pos_4=NN	lemma_6=alfentanyl	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_2=compound	relType_5=punct	lemma_4=,	relType_5=conj	lemma_2=ergot	pos_6=,	lib=ergot	lemma_8=and	pos_2=NNS	pos_5=NN	path2=triazolam_conj	path=cyclosporine_conj<eg_dep>triazolam_conj	pos_3=,	eib=True	lemma_5=fentanyl	pos_3=NN	relType_7=punct	pos_2=,	relType_4=conj	path1=cyclosporine_conj	relType_1=punct	pos_7=NN	relType_8=cc	relType_3=punct	relType_7=conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e8	DDI-DrugBank.d124.s26.e16	mechanism	lemma_9=)	pos_2=NN	pos_5=,	pos_15=WRB	lemma_6=,	lemma_7=alprazolam	pos_6=NN	relType_6=conj	pos_13=NN	lemma_7=,	lemma_2=derivative	lemma_6=alfentanyl	relType_12=ROOT	pos_16=VBN	relType_4=punct	lemma_3=,	lemma_5=,	lemma_2=ergot	lib=ergot	pos_3=,	pos_11=VB	pos_2=,	pos_14=NNS	lemma_4=carbamazepine	lemma_1=,	relType_16=advcl	pos_1=,	lemma_3=pimozide	path2=coadminister_advcl>saquinavir_obl	relType_2=punct	lemma_14=concentration	pos_10=MD	path1=cyclosporine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	relType_2=conj	pos_9=NN	lemma_2=,	lpib=ergot_NN	lemma_11=have	lemma_15=when	lemma_4=,	lemma_8=and	pos_5=NN	lemma_10=may	lemma_5=fentanyl	pos_12=VBN	relType_1=punct	pos_7=NN	relType_3=punct	pos_17=IN	lemma_17=with	pos_4=,	relType_14=obj	relType_10=aux	relType_11=aux	pos_7=,	pos_8=CC	path=cyclosporine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	relType_17=case	lemma_12=elevate	relType_3=conj	relType_5=conj	lemma_9=triazolam	lemma_16=coadminister	relType_8=cc	relType_7=conj	relType_9=conj	relation_19=beneficial	relType_6=punct	pos_4=NN	wib=ergot	pos_9=-RRB-	relType_13=compound	relType_2=compound	relType_5=punct	lemma_13=plasma	relType_9=punct	pos_6=,	pos_2=NNS	eib=True	pos_3=NN	relType_7=punct	relType_4=conj	relType_15=advmod
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e10	null	path2=pimozide_conj	lib=pimozide	lemma_1=,	eib=False	path=derivative_conj<eg_dep>pimozide_conj	pos_1=,	wib=pimozide	path1=derivative_conj	relType_1=punct	lpib=pimozide_NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e11	null	lemma_2=pimozide	path2=carbamazepine_conj	lib=pimozide	lemma_1=,	pos_2=NN	eib=True	relType_2=punct	pos_1=,	wib=pimozide	path1=derivative_conj	pos_2=,	relType_1=punct	path=derivative_conj<eg_dep>carbamazepine_conj	relType_2=conj	lemma_2=,	lpib=pimozide_NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	pos_2=NN	pos_1=,	path2=fentanyl_conj	relType_2=punct	lemma_2=pimozide	lib=pimozide	wib=pimozide	path1=derivative_conj	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path=derivative_conj<eg_dep>fentanyl_conj	lemma_3=carbamazepine	lpib=pimozide_NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	pos_2=NN	pos_1=,	path=derivative_conj<eg_dep>alfentanyl_conj	lemma_4=fentanyl	relType_2=punct	lemma_2=pimozide	lib=pimozide	pos_4=,	path2=alfentanyl_conj	wib=pimozide	path1=derivative_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	lemma_3=carbamazepine	lpib=pimozide_NN	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_4=fentanyl	relType_2=punct	lemma_2=pimozide	lib=pimozide	pos_4=,	path=derivative_conj<eg_dep>alprazolam_conj	wib=pimozide	path1=derivative_conj	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	lemma_3=carbamazepine	lpib=pimozide_NN	pos_5=NN	pos_3=,	eib=True	lemma_5=alfentanyl	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	path2=alprazolam_conj	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	pos_5=,	pos_1=,	lemma_6=,	relType_7=cc	lemma_4=fentanyl	relType_2=punct	lemma_2=pimozide	pos_6=NN	relType_6=conj	lib=pimozide	pos_4=,	relType_6=punct	wib=pimozide	path1=derivative_conj	lemma_6=alprazolam	relType_2=conj	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_4=,	relType_5=conj	pos_6=,	lemma_3=carbamazepine	lpib=pimozide_NN	pos_5=NN	path2=triazolam_conj	pos_3=,	eib=True	lemma_5=alfentanyl	pos_3=NN	lemma_7=and	pos_2=,	relType_4=conj	path=derivative_conj<eg_dep>triazolam_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e9	DDI-DrugBank.d124.s26.e16	mechanism	lemma_1=,	pos_2=NN	pos_16=IN	pos_5=,	relType_11=ROOT	pos_13=NNS	pos_1=,	lemma_6=,	relType_7=cc	path2=coadminister_advcl>saquinavir_obl	relType_8=punct	relType_9=aux	lemma_13=concentration	pos_14=WRB	lemma_4=fentanyl	relType_2=punct	lemma_2=pimozide	pos_6=NN	pos_8=NN	relType_6=conj	path1=derivative_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	lib=pimozide	relType_14=advmod	pos_4=,	relType_12=compound	relType_10=aux	relType_6=punct	relation_16=beneficial	wib=pimozide	pos_9=MD	pos_12=NN	lemma_6=alprazolam	pos_8=-RRB-	lemma_11=elevate	pos_15=VBN	lemma_12=plasma	relType_2=conj	pos_4=NN	lemma_2=,	pos_10=VB	lemma_16=with	relType_15=advcl	lemma_8=)	relType_4=punct	lemma_3=,	pos_7=CC	relType_3=conj	lemma_5=,	relType_5=punct	path=derivative_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	lemma_9=may	lemma_4=,	pos_11=VBN	relType_5=conj	pos_6=,	lemma_3=carbamazepine	lpib=pimozide_NN	pos_5=NN	relType_16=case	pos_3=,	eib=True	lemma_5=alfentanyl	pos_3=NN	lemma_7=and	relType_8=conj	pos_2=,	relType_4=conj	relType_13=obj	lemma_10=have	relType_1=punct	lemma_8=triazolam	lemma_14=when	relType_3=punct	lemma_15=coadminister
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e11	null	path2=carbamazepine_conj	lemma_1=,	lpib=carbamazepine_NN	eib=False	wib=carbamazepine	pos_1=,	relType_1=punct	path=pimozide_conj<eg_dep>carbamazepine_conj	path1=pimozide_conj	lib=carbamazepine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	pos_2=NN	eib=True	lpib=carbamazepine_NN	wib=carbamazepine	path=pimozide_conj<eg_dep>fentanyl_conj	pos_1=,	pos_2=,	relType_2=conj	relType_1=punct	lemma_2=carbamazepine	path2=fentanyl_conj	lemma_2=,	path1=pimozide_conj	relType_2=punct	lib=carbamazepine
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_1=,	relType_2=punct	wib=carbamazepine	path2=alfentanyl_conj	lemma_2=carbamazepine	lemma_3=fentanyl	relType_2=conj	lemma_2=,	lib=carbamazepine	path=pimozide_conj<eg_dep>alfentanyl_conj	lemma_3=,	relType_3=conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	path1=pimozide_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_1=,	relType_2=punct	path=pimozide_conj<eg_dep>alprazolam_conj	pos_4=,	wib=carbamazepine	lemma_2=carbamazepine	lemma_3=fentanyl	relType_2=conj	lemma_2=,	pos_4=NN	lib=carbamazepine	relType_4=punct	lemma_3=,	relType_3=conj	lemma_4=,	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	path2=alprazolam_conj	relType_3=punct	lemma_4=alfentanyl	path1=pimozide_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_5=,	pos_1=,	path=pimozide_conj<eg_dep>triazolam_conj	relType_2=punct	pos_4=,	lemma_5=alprazolam	wib=carbamazepine	lemma_2=carbamazepine	lemma_3=fentanyl	relType_2=conj	lemma_2=,	pos_4=NN	lib=carbamazepine	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_4=,	relType_5=conj	pos_5=NN	path2=triazolam_conj	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_4=conj	relType_1=punct	relType_3=punct	lemma_4=alfentanyl	path1=pimozide_conj	relType_6=cc
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e10	DDI-DrugBank.d124.s26.e16	mechanism	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_5=,	pos_1=,	lemma_7=triazolam	lemma_12=concentration	path2=coadminister_advcl>saquinavir_obl	pos_9=VB	relType_14=advcl	relType_9=aux	pos_13=WRB	relType_2=punct	path1=pimozide_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	lemma_15=with	pos_4=,	lemma_14=coadminister	lemma_5=alprazolam	pos_8=MD	wib=carbamazepine	relType_12=obj	lemma_2=carbamazepine	lemma_3=fentanyl	relType_2=conj	lemma_2=,	pos_4=NN	lemma_9=have	lib=carbamazepine	lemma_10=elevate	relType_10=ROOT	relType_15=case	relType_13=advmod	relType_4=punct	lemma_3=,	pos_6=CC	relType_3=conj	lemma_5=,	relType_5=punct	lemma_6=and	lemma_11=plasma	pos_12=NNS	lemma_4=,	relType_5=conj	pos_7=-RRB-	pos_15=IN	pos_5=NN	pos_14=VBN	path=pimozide_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_11=NN	pos_3=,	eib=True	relType_11=compound	pos_3=NN	relType_7=punct	pos_10=VBN	relation_14=beneficial	lemma_13=when	pos_2=,	relType_4=conj	lemma_8=may	relType_8=aux	relType_1=punct	pos_7=NN	relType_3=punct	lemma_4=alfentanyl	lemma_7=)	relType_7=conj	relType_6=cc
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e11	DDI-DrugBank.d124.s26.e12	null	lemma_1=,	eib=False	wib=fentanyl	pos_1=,	path=carbamazepine_conj<eg_dep>fentanyl_conj	lpib=fentanyl_NN	lib=fentanyl	relType_1=punct	path2=fentanyl_conj	path1=carbamazepine_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e11	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	wib=fentanyl	path=carbamazepine_conj<eg_dep>alfentanyl_conj	path2=alfentanyl_conj	pos_1=,	pos_2=,	relType_2=conj	lpib=fentanyl_NN	lib=fentanyl	relType_1=punct	lemma_2=fentanyl	lemma_2=,	path1=carbamazepine_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e11	DDI-DrugBank.d124.s26.e14	null	path=carbamazepine_conj<eg_dep>alprazolam_conj	lemma_1=,	pos_2=NN	pos_1=,	lpib=fentanyl_NN	relType_2=punct	wib=fentanyl	relType_2=conj	lemma_2=,	lemma_2=fentanyl	path1=carbamazepine_conj	lemma_3=,	relType_3=conj	lemma_3=alfentanyl	pos_3=,	eib=True	pos_3=NN	pos_2=,	lib=fentanyl	relType_1=punct	path2=alprazolam_conj	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e11	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	pos_5=CC	pos_1=,	lpib=fentanyl_NN	lemma_4=alprazolam	relType_2=punct	relType_5=cc	pos_4=,	wib=fentanyl	relType_2=conj	pos_4=NN	lemma_2=,	path1=carbamazepine_conj	relType_4=punct	lemma_3=,	relType_3=conj	path=carbamazepine_conj<eg_dep>triazolam_conj	lemma_3=alfentanyl	lemma_4=,	path2=triazolam_conj	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	lib=fentanyl	relType_1=punct	lemma_2=fentanyl	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e11	DDI-DrugBank.d124.s26.e16	mechanism	lemma_1=,	pos_2=NN	pos_5=CC	pos_12=WRB	lemma_14=with	lemma_8=have	pos_1=,	relType_13=advcl	relType_7=aux	path2=coadminister_advcl>saquinavir_obl	lpib=fentanyl_NN	lemma_4=alprazolam	relType_10=compound	relType_11=obj	pos_13=VBN	relType_2=punct	path1=carbamazepine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	pos_6=NN	relType_9=ROOT	lemma_11=concentration	relType_5=cc	relType_6=conj	lemma_13=coadminister	pos_4=,	relType_12=advmod	wib=fentanyl	relType_6=punct	pos_11=NNS	path=carbamazepine_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_7=MD	lemma_7=may	pos_9=VBN	pos_10=NN	relType_2=conj	pos_4=NN	lemma_2=,	lemma_6=triazolam	lemma_6=)	pos_8=VB	pos_14=IN	relType_4=punct	lemma_3=,	relType_3=conj	lemma_3=alfentanyl	lemma_4=,	lemma_12=when	pos_6=-RRB-	pos_3=,	eib=True	lemma_5=and	pos_3=NN	pos_2=,	relType_4=conj	relType_8=aux	lemma_9=elevate	lemma_10=plasma	lib=fentanyl	relType_1=punct	relType_14=case	lemma_2=fentanyl	relType_3=punct	relation_12=beneficial
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e12	DDI-DrugBank.d124.s26.e13	null	lemma_1=,	wib=alfentanyl	lib=alfentanyl	eib=False	lpib=alfentanyl_NN	path=fentanyl_conj<eg_dep>alfentanyl_conj	path2=alfentanyl_conj	pos_1=,	path1=fentanyl_conj	relType_1=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e12	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	pos_2=NN	wib=alfentanyl	lib=alfentanyl	eib=True	lpib=alfentanyl_NN	lemma_2=alfentanyl	pos_1=,	pos_2=,	relType_2=conj	path1=fentanyl_conj	relType_1=punct	path=fentanyl_conj<eg_dep>alprazolam_conj	path2=alprazolam_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e12	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	pos_2=NN	wib=alfentanyl	lib=alfentanyl	lpib=alfentanyl_NN	lemma_2=alfentanyl	pos_1=,	relType_4=cc	relType_2=punct	lemma_3=alprazolam	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	path=fentanyl_conj<eg_dep>triazolam_conj	path2=triazolam_conj	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	path1=fentanyl_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e12	DDI-DrugBank.d124.s26.e16	mechanism	pos_7=VB	lemma_1=,	pos_2=NN	lemma_9=plasma	wib=alfentanyl	lib=alfentanyl	lpib=alfentanyl_NN	lemma_6=may	pos_8=VBN	lemma_2=alfentanyl	pos_1=,	lemma_13=with	relType_7=aux	path2=coadminister_advcl>saquinavir_obl	relType_4=cc	lemma_10=concentration	relType_2=punct	path=fentanyl_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_10=NNS	relType_9=compound	relType_12=advcl	lemma_3=alprazolam	lemma_11=when	pos_13=IN	relType_11=advmod	relType_2=conj	pos_9=NN	lemma_2=,	relType_10=obj	lemma_5=)	lemma_7=have	lemma_12=coadminister	pos_11=WRB	lemma_5=triazolam	relType_13=case	lemma_3=,	pos_5=-RRB-	relType_3=conj	relType_6=aux	relType_5=punct	relation_10=beneficial	relType_8=ROOT	relType_5=conj	pos_6=MD	pos_5=NN	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	path1=fentanyl_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	pos_2=,	lemma_8=elevate	pos_12=VBN	relType_1=punct	relType_3=punct
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e13	DDI-DrugBank.d124.s26.e14	null	lemma_1=,	eib=False	lib=alprazolam	pos_1=,	path=alfentanyl_conj<eg_dep>alprazolam_conj	relType_1=punct	path2=alprazolam_conj	wib=alprazolam	lpib=alprazolam_NN	path1=alfentanyl_conj
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e13	DDI-DrugBank.d124.s26.e15	null	lemma_1=,	lemma_2=alprazolam	pos_2=NN	pos_3=CC	pos_1=,	path=alfentanyl_conj<eg_dep>triazolam_conj	relType_3=cc	relType_2=punct	relType_2=conj	lemma_2=,	lpib=alprazolam_NN	path1=alfentanyl_conj	path2=triazolam_conj	eib=True	lib=alprazolam	pos_2=,	lemma_3=and	relType_1=punct	wib=alprazolam
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e13	DDI-DrugBank.d124.s26.e16	mechanism	pos_10=WRB	lemma_1=,	lemma_2=alprazolam	pos_2=NN	pos_6=VB	lemma_7=elevate	pos_3=CC	lemma_11=coadminister	path=alfentanyl_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_1=,	relType_12=case	path1=alfentanyl_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	path2=coadminister_advcl>saquinavir_obl	relType_3=cc	relType_2=punct	pos_8=NN	relation_8=beneficial	lemma_5=may	lemma_4=triazolam	lemma_9=concentration	lemma_10=when	pos_4=-RRB-	pos_9=NNS	relType_10=advmod	lemma_6=have	relType_5=aux	relType_2=conj	pos_4=NN	lemma_2=,	pos_12=IN	lemma_12=with	pos_5=MD	relType_4=punct	relType_7=ROOT	relType_6=aux	relType_8=compound	relType_9=obj	lemma_8=plasma	pos_11=VBN	lemma_4=)	relType_11=advcl	lpib=alprazolam_NN	pos_7=VBN	eib=True	lib=alprazolam	pos_2=,	lemma_3=and	relType_4=conj	relType_1=punct	wib=alprazolam
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e14	DDI-DrugBank.d124.s26.e15	null	lemma_2=and	lib=triazolam	path2=triazolam_conj	lemma_1=,	eib=False	wib=triazolam	path1=alprazolam_conj	pos_2=CC	pos_1=,	path=alprazolam_conj<eg_dep>triazolam_conj	relType_1=punct	relType_2=cc	lpib=triazolam_NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e14	DDI-DrugBank.d124.s26.e16	mechanism	lemma_8=concentration	relType_7=compound	lemma_1=,	relType_9=advmod	pos_1=,	path2=coadminister_advcl>saquinavir_obl	lemma_4=may	relType_2=cc	pos_8=NNS	relType_11=case	lemma_5=have	lemma_11=with	lemma_2=and	pos_5=VB	lib=triazolam	pos_9=WRB	path1=alprazolam_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	lemma_6=elevate	pos_4=MD	relType_8=obj	lemma_7=plasma	pos_6=VBN	relType_5=aux	lemma_3=triazolam	pos_11=IN	path=alprazolam_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	relType_6=ROOT	relType_3=conj	wib=triazolam	relType_4=aux	relation_6=beneficial	lemma_3=)	lemma_10=coadminister	eib=True	pos_3=-RRB-	pos_3=NN	pos_10=VBN	pos_2=CC	relType_10=advcl	relType_1=punct	pos_7=NN	relType_3=punct	lemma_9=when	lpib=triazolam_NN
DDI-DrugBank.d124.s26	DDI-DrugBank.d124.s26.e15	DDI-DrugBank.d124.s26.e16	mechanism	path=triazolam_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj<elevate_ROOT>coadminister_advcl>saquinavir_obl	pos_8=VBN	pos_2=MD	relation_3=beneficial	relType_8=advcl	relType_5=compound	pos_9=IN	path2=coadminister_advcl>saquinavir_obl	pos_3=VB	lemma_1=)	pos_7=WRB	path1=triazolam_conj<eg_dep<metabolize_acl:relcl<coadministration_nsubj	eib=False	relType_2=aux	relType_9=case	lemma_8=coadminister	lib=have	pos_4=VBN	lpib=have_VB	pos_1=-RRB-	lemma_4=elevate	lemma_5=plasma	relType_4=ROOT	relType_6=obj	pos_5=NN	lemma_9=with	wib=have	pos_6=NNS	lemma_7=when	lemma_2=may	relType_3=aux	lemma_6=concentration	relType_7=advmod	relType_1=punct	lemma_3=have
DDI-DrugBank.d124.s28	DDI-DrugBank.d124.s28.e0	DDI-DrugBank.d124.s28.e1	advise	path1=INVIRASE_nsubj:pass	pos_2=VBN	lib=be	pos_1=VBZ	pos_3=IN	eib=False	path2=ritonavir_obl	relType_1=aux:pass	lemma_1=be	lpib=be_VBZ	relType_2=advcl	lemma_3=with	lemma_2=coadminister	path=INVIRASE_nsubj:pass<coadminister_advcl>ritonavir_obl	relType_3=case	wib=is
DDI-DrugBank.d124.s28	DDI-DrugBank.d124.s28.e0	DDI-DrugBank.d124.s28.e2	null	pos_2=VBN	pos_3=IN	relType_1=aux:pass	relType_2=advcl	pos_4=,	path1=INVIRASE_nsubj:pass<coadminister_advcl	lemma_1=be	lemma_4=ritonavir	lemma_2=coadminister	path2=label_nsubj:pass>ritonavir_compound	pos_4=NN	relType_4=obl	lib=be	relType_4=punct	relType_5=det	lemma_3=with	lemma_4=,	relType_3=case	path=INVIRASE_nsubj:pass<coadminister_advcl<review_ROOT>label_nsubj:pass>ritonavir_compound	wib=is	lemma_5=the	pos_1=VBZ	eib=True	pos_5=DT	lpib=be_VBZ
DDI-DrugBank.d124.s28	DDI-DrugBank.d124.s28.e1	DDI-DrugBank.d124.s28.e2	null	pos_2=DT	lemma_1=,	wib=ritonavir	lemma_2=the	eib=False	relType_2=det	pos_1=,	lib=ritonavir	path1=ritonavir_obl<coadminister_advcl	relType_1=punct	path2=label_nsubj:pass>ritonavir_compound	path=ritonavir_obl<coadminister_advcl<review_ROOT>label_nsubj:pass>ritonavir_compound	lpib=ritonavir_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e0	DDI-DrugBank.d124.s30.e1	null	path=phenobarbital_dep<eg_dep>phenytoin_dep	lemma_1=,	lib=phenytoin	path1=phenobarbital_dep	wib=phenytoin	eib=False	pos_1=,	path2=phenytoin_dep	relType_1=punct	lpib=phenytoin_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e0	DDI-DrugBank.d124.s30.e2	null	path=phenobarbital_dep<eg_dep>dexamethasone_dep	relType_2=dep	lemma_1=,	lib=phenytoin	path1=phenobarbital_dep	pos_2=NN	eib=True	wib=phenytoin	path2=dexamethasone_dep	lemma_2=,	pos_1=,	lemma_2=phenytoin	pos_2=,	relType_1=punct	lpib=phenytoin_NN	relType_2=punct
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e0	DDI-DrugBank.d124.s30.e3	null	relType_3=dep	lemma_1=,	pos_2=NN	path2=carbamazepine_dep	pos_1=,	relType_2=punct	path=phenobarbital_dep<eg_dep>carbamazepine_dep	lib=phenytoin	path1=phenobarbital_dep	wib=phenytoin	lemma_2=phenytoin	lemma_2=,	relType_2=dep	lemma_3=,	lemma_3=dexamethasone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e0	DDI-DrugBank.d124.s30.e4	mechanism	relType_3=dep	lemma_4=carbamazepine	lemma_1=,	relType_4=dep	pos_2=NN	pos_6=VB	relType_7=case	lemma_9=plasma	relType_8=amod	pos_8=VBN	path2=level_obl>saquinavir_nmod	pos_1=,	relType_11=case	relType_2=punct	pos_10=NNS	lib=phenytoin	lemma_5=may	relType_9=compound	wib=phenytoin	pos_4=-RRB-	lemma_2=phenytoin	relType_5=aux	pos_9=NN	pos_4=NN	lemma_2=,	pos_11=IN	path1=phenobarbital_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj	relType_6=ROOT	relType_2=dep	lemma_10=level	pos_5=MD	relType_4=punct	lemma_3=,	relation_10=adverse	lemma_8=decrease	lemma_4=)	lemma_6=result	lemma_3=dexamethasone	pos_3=,	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	path=phenobarbital_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj<result_ROOT>level_obl>saquinavir_nmod	lemma_11=of	pos_2=,	relType_1=punct	relType_10=obl	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e1	DDI-DrugBank.d124.s30.e2	null	lib=dexamethasone	lemma_1=,	eib=False	path2=dexamethasone_dep	path=phenytoin_dep<eg_dep>dexamethasone_dep	pos_1=,	relType_1=punct	path1=phenytoin_dep	wib=dexamethasone	lpib=dexamethasone_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e1	DDI-DrugBank.d124.s30.e3	null	relType_2=dep	lib=dexamethasone	lemma_1=,	pos_2=NN	eib=True	path2=carbamazepine_dep	lemma_2=dexamethasone	pos_1=,	pos_2=,	path=phenytoin_dep<eg_dep>carbamazepine_dep	relType_1=punct	path1=phenytoin_dep	lemma_2=,	wib=dexamethasone	relType_2=punct	lpib=dexamethasone_NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e1	DDI-DrugBank.d124.s30.e4	mechanism	relType_3=dep	lemma_1=,	pos_2=NN	path2=level_obl>saquinavir_nmod	pos_1=,	lemma_10=of	relType_9=obl	lemma_4=may	relType_6=case	relType_2=punct	pos_8=NN	pos_5=VB	lib=dexamethasone	relation_8=adverse	pos_6=IN	path1=phenytoin_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj	pos_9=NNS	pos_4=MD	lemma_5=result	relType_10=case	lemma_6=in	lemma_2=,	wib=dexamethasone	relType_2=dep	relType_7=amod	lemma_2=dexamethasone	relType_8=compound	relType_4=aux	lemma_7=decrease	lemma_8=plasma	lemma_9=level	pos_10=IN	lemma_3=)	lpib=dexamethasone_NN	lemma_3=carbamazepine	pos_7=VBN	eib=True	pos_3=-RRB-	path=phenytoin_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj<result_ROOT>level_obl>saquinavir_nmod	pos_3=NN	pos_2=,	relType_1=punct	relType_5=ROOT	relType_3=punct
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e2	DDI-DrugBank.d124.s30.e3	null	lemma_1=,	path2=carbamazepine_dep	lpib=carbamazepine_NN	eib=False	path=dexamethasone_dep<eg_dep>carbamazepine_dep	path1=dexamethasone_dep	wib=carbamazepine	pos_1=,	relType_1=punct	lib=carbamazepine
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e2	DDI-DrugBank.d124.s30.e4	mechanism	lemma_2=)	relType_7=compound	lemma_1=,	lemma_5=in	pos_2=NN	lpib=carbamazepine_NN	path2=level_obl>saquinavir_nmod	pos_1=,	lemma_3=may	pos_9=IN	relType_5=case	lemma_4=result	relType_2=punct	pos_8=NNS	relType_8=obl	relation_6=adverse	relType_6=amod	wib=carbamazepine	pos_3=MD	lemma_7=plasma	lemma_2=carbamazepine	pos_6=VBN	relType_9=case	path1=dexamethasone_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj	lib=carbamazepine	relType_2=dep	lemma_8=level	pos_5=IN	lemma_6=decrease	relType_4=ROOT	eib=True	pos_2=-RRB-	lemma_9=of	pos_4=VB	relType_3=aux	path=dexamethasone_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj<result_ROOT>level_obl>saquinavir_nmod	relType_1=punct	pos_7=NN
DDI-DrugBank.d124.s30	DDI-DrugBank.d124.s30.e3	DDI-DrugBank.d124.s30.e4	mechanism	pos_7=NNS	relType_8=case	relation_4=adverse	path2=level_obl>saquinavir_nmod	pos_2=MD	lemma_4=in	pos_3=VB	lemma_1=)	pos_6=NN	lemma_6=plasma	eib=False	relType_2=aux	lemma_3=result	pos_8=IN	lemma_7=level	path1=carbamazepine_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj	relType_5=amod	relType_3=ROOT	pos_4=IN	pos_1=-RRB-	relType_4=case	wib=result	relType_6=compound	relType_7=obl	path=carbamazepine_dep<eg_dep<cyp3a4_nmod<inducer_acl:relcl<compound_nmod<Coadministration_nsubj<result_ROOT>level_obl>saquinavir_nmod	lemma_5=decrease	lib=result	lemma_2=may	relType_1=punct	lemma_8=of	pos_5=VBN	lpib=result_VB
DDI-DrugBank.d694.s0	DDI-DrugBank.d694.s0.e0	DDI-DrugBank.d694.s0.e1	null	relType_28=appos	relType_22=compound	lemma_6=increase	path=<Digoxin_ROOT>be_parataxis>mean_conj>concentration_obj>digoxin_nmod	pos_25=NNP	pos_6=NN	relType_4=det	lemma_25=Cmax	lemma_3=be	pos_1=:	pos_19=CC	relType_3=parataxis	lemma_30=of	relType_11=det	lemma_16=11	pos_28=NN	pos_7=IN	lemma_7=in	lemma_10=under	lemma_12=curve	pos_30=IN	relType_23=obj	pos_8=DT	relType_7=case	lemma_4=a	pos_21=JJ	pos_22=NN	path1=	lemma_20=mean	pos_24=-LRB-	lemma_29=)	relType_20=conj	relType_12=nmod	relType_17=dep	lemma_19=and	pos_9=NN	relType_2=expl	lemma_9=area	lemma_13=(	lemma_15=,	relType_27=nummod	relType_16=nummod	lemma_11=the	lemma_18=)	pos_2=EX	pos_27=CD	lemma_22=drug	relType_25=dep	relType_26=punct	relType_1=punct	lpib=be_VBD	path2=be_parataxis>mean_conj>concentration_obj>digoxin_nmod	relation_5=beneficial	pos_20=VB	relType_24=punct	lemma_27=18	pos_23=NN	pos_17=NN	pos_18=-RRB-	pos_15=,	pos_3=VBD	pos_14=NN	relType_15=punct	lemma_1=:	pos_16=CD	lib=be	relType_5=amod	lemma_5=slight	lemma_17=%	pos_10=IN	lemma_14=auc	relType_8=det	relType_6=nsubj	relType_30=case	pos_29=-RRB-	lemma_23=concentration	lemma_2=there	relType_13=punct	relType_9=nmod	eib=False	relType_21=amod	relType_10=case	lemma_21=peak	pos_4=DT	pos_5=JJ	lemma_8=the	relType_18=punct	relType_29=punct	relType_14=appos	pos_11=DT	relType_19=cc	wib=was	pos_13=-LRB-	lemma_28=%	pos_26=,	lemma_24=(	lemma_26=,	pos_12=NN
DDI-DrugBank.d694.s0	DDI-DrugBank.d694.s0.e0	DDI-DrugBank.d694.s0.e2	null	relType_28=appos	relType_22=compound	lemma_6=increase	pos_35=NN	pos_25=NNP	pos_6=NN	lemma_38=mg	relType_4=det	lemma_32=the	pos_32=DT	pos_36=IN	lemma_25=Cmax	lemma_3=be	pos_1=:	pos_19=CC	relType_3=parataxis	lemma_30=of	relType_11=det	lemma_16=11	pos_28=NN	pos_7=IN	lemma_7=in	relType_34=punct	lemma_10=under	lemma_12=curve	pos_30=IN	lemma_31=with	relType_23=obj	pos_8=DT	relType_7=case	relType_37=nummod	lemma_4=a	pos_21=JJ	pos_22=NN	path1=	lemma_20=mean	pos_24=-LRB-	lemma_35=administration	lemma_29=)	relType_20=conj	relType_12=nmod	relType_17=dep	lemma_19=and	pos_9=NN	relType_2=expl	lemma_9=area	lemma_13=(	lemma_15=,	relType_27=nummod	lemma_36=of	relType_16=nummod	relType_32=det	lemma_11=the	lemma_18=)	pos_2=EX	path=<Digoxin_ROOT>be_parataxis>mean_conj>concentration_obj>digoxin_nmod>administration_nmod>sitagliptin_nmod	pos_27=CD	pos_31=NN	lemma_22=drug	relType_25=dep	relType_26=punct	relType_1=punct	lpib=be_VBD	relation_5=beneficial	pos_20=VB	relType_24=punct	lemma_31=digoxin	lemma_27=18	pos_31=IN	pos_23=NN	lemma_34=-	pos_17=NN	pos_18=-RRB-	pos_15=,	pos_3=VBD	pos_14=NN	relType_15=punct	lemma_1=:	pos_16=CD	lib=be	relType_5=amod	lemma_5=slight	lemma_17=%	pos_38=NNS	pos_10=IN	lemma_33=co	lemma_14=auc	relType_35=nmod	pos_34=HYPH	relType_8=det	relType_6=nsubj	relType_30=case	pos_33=NN	pos_29=-RRB-	lemma_23=concentration	lemma_2=there	relType_13=punct	relType_31=case	relType_9=nmod	path2=be_parataxis>mean_conj>concentration_obj>digoxin_nmod>administration_nmod>sitagliptin_nmod	relType_38=compound	pos_37=CD	relType_21=amod	relType_31=nmod	relType_33=compound	relType_10=case	lemma_21=peak	pos_4=DT	pos_5=JJ	lemma_37=100	lemma_8=the	relType_18=punct	relType_29=punct	relType_14=appos	pos_11=DT	relType_19=cc	wib=was	pos_13=-LRB-	lemma_28=%	eib=True	pos_26=,	lemma_24=(	lemma_26=,	pos_12=NN	relType_36=case
DDI-DrugBank.d694.s0	DDI-DrugBank.d694.s0.e1	DDI-DrugBank.d694.s0.e2	mechanism	lemma_7=100	pos_2=DT	path=<digoxin_nmod>administration_nmod>sitagliptin_nmod	relType_1=case	lemma_2=the	path1=	lemma_4=-	pos_7=CD	lemma_6=of	pos_4=HYPH	relType_6=case	pos_8=NNS	eib=False	relType_7=nummod	pos_6=IN	lpib=co_NN	pos_1=IN	relType_4=punct	path2=administration_nmod>sitagliptin_nmod	relType_8=compound	relType_5=nmod	lemma_8=mg	lemma_3=co	lemma_1=with	pos_5=NN	pos_3=NN	relType_2=det	wib=co	relType_3=compound	lib=co	lemma_5=administration
DDI-DrugBank.d694.s2	DDI-DrugBank.d694.s2.e0	DDI-DrugBank.d694.s2.e1	null	relType_1=cc	path2=JANUVIA_conj	pos_1=CC	lpib=januvia_NNP	wib=JANUVIA	eib=False	path=<digoxin_nmod>JANUVIA_conj	path1=	lib=januvia	lemma_1=or
DDI-DrugBank.d65.s0	DDI-DrugBank.d65.s0.e0	DDI-DrugBank.d65.s0.e1	int	path=Sulfacetamide_compound<preparation_nsubj<incompatible_ROOT>preparation_obl>silver_compound	lemma_3=incompatible	path2=preparation_obl>silver_compound	relType_2=cop	eib=False	lpib=preparation_NNS	path1=Sulfacetamide_compound<preparation_nsubj	lemma_4=with	lib=preparation	wib=preparations	relType_3=ROOT	pos_4=IN	relType_1=nsubj	relType_4=case	lemma_1=preparation	pos_2=VBP	pos_1=NNS	pos_3=JJ	lemma_2=be
DDI-DrugBank.d179.s1	DDI-DrugBank.d179.s1.e0	DDI-DrugBank.d179.s1.e1	int	lib=interact	pos_3=IN	relType_1=aux	lemma_1=may	pos_6=DT	wib=interact	pos_8=:	pos_7=VBG	path1=Sulfapyridine_nsubj	relType_8=punct	lemma_9=-	lemma_4=any	lemma_5=of	relType_5=case	path2=any_obl>acetaminophen_dep	pos_9=HYPH	eib=False	lemma_6=the	relation_1=adverse	pos_2=VB	pos_4=DT	relType_4=obl	relType_7=amod	relType_2=ROOT	pos_5=IN	lemma_3=with	pos_1=MD	relType_9=punct	relType_3=case	lpib=interact_VB	path=Sulfapyridine_nsubj<interact_ROOT>any_obl>acetaminophen_dep	lemma_7=follow	relType_6=nmod	lemma_8=:	lemma_2=interact
DDI-DrugBank.d179.s1	DDI-DrugBank.d179.s1.e0	DDI-DrugBank.d179.s1.e2	int	pos_13=,	relType_10=punct	lib=interact	pos_3=IN	lemma_10=acetaminophen	relType_1=aux	lemma_1=may	pos_6=DT	wib=interact	pos_8=:	lemma_13=,	relType_13=punct	pos_7=VBG	path1=Sulfapyridine_nsubj	relType_8=punct	lemma_9=-	lemma_4=any	relType_10=dep	lemma_5=of	relType_5=case	pos_9=HYPH	pos_10=-LRB-	lemma_6=the	lemma_11=e.	relation_1=adverse	pos_12=NN	pos_2=VB	pos_10=NN	path=Sulfapyridine_nsubj<interact_ROOT>any_obl>acetaminophen_dep>g._dep>Tylenol_dep	pos_4=DT	relType_4=obl	path2=any_obl>acetaminophen_dep>g._dep>Tylenol_dep	relType_7=amod	relType_2=ROOT	lemma_10=(	pos_5=IN	lemma_3=with	pos_1=MD	relType_9=punct	relType_3=case	lpib=interact_VB	lemma_12=g.	pos_11=NN	eib=True	relType_11=compound	relType_12=dep	lemma_7=follow	relType_6=nmod	lemma_8=:	lemma_2=interact
DDI-DrugBank.d179.s1	DDI-DrugBank.d179.s1.e1	DDI-DrugBank.d179.s1.e2	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<acetaminophen_dep>g._dep>Tylenol_dep	path2=g._dep>Tylenol_dep	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s2	DDI-DrugBank.d179.s2.e0	DDI-DrugBank.d179.s2.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	path=<amiodarone_ROOT>g._dep>cordarone_dep	relType_1=punct	path2=g._dep>cordarone_dep
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e1	null	lemma_1=(	lib=nandrolone	path=<steroid_ROOT>nandrolone_dep	eib=False	path1=	lpib=nandrolone_NN	wib=nandrolone	relType_1=punct	path2=nandrolone_dep	pos_1=-LRB-
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e2	null	relType_4=dep	pos_2=NN	pos_5=,	path2=nandrolone_dep>g._dep>Anabolin_appos	path1=	lpib=nandrolone_NN	wib=nandrolone	relType_2=punct	lemma_1=(	lemma_3=e.	lib=nandrolone	pos_2=-LRB-	pos_4=NN	lemma_2=nandrolone	relType_2=dep	lemma_5=,	relType_5=punct	lemma_2=[	path=<steroid_ROOT>nandrolone_dep>g._dep>Anabolin_appos	pos_1=-LRB-	lemma_4=g.	eib=True	pos_3=NN	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e3	null	relType_4=dep	pos_2=NN	path=<steroid_ROOT>nandrolone_dep>oxandrolone_conj	pos_5=,	path1=	lpib=nandrolone_NN	wib=nandrolone	relType_2=punct	lemma_1=(	lemma_3=e.	lib=nandrolone	pos_6=NNP	relType_6=punct	lemma_6=]	pos_2=-LRB-	pos_7=,	lemma_7=,	pos_4=NN	lemma_2=nandrolone	relType_2=dep	lemma_5=,	relType_5=punct	lemma_6=Anabolin	path2=nandrolone_dep>oxandrolone_conj	lemma_2=[	pos_1=-LRB-	pos_6=-RRB-	lemma_4=g.	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e4	null	relType_4=dep	pos_2=NN	lemma_11=,	pos_5=,	path1=	lpib=nandrolone_NN	wib=nandrolone	path=<steroid_ROOT>nandrolone_dep>oxandrolone_conj>g._dep>Anavar_appos	relType_8=punct	relType_10=dep	lemma_10=g.	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	lib=nandrolone	relType_9=compound	pos_6=NNP	relType_6=punct	lemma_6=]	relType_11=punct	pos_2=-LRB-	pos_7=,	lemma_8=oxandrolone	path2=nandrolone_dep>oxandrolone_conj>g._dep>Anavar_appos	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	pos_8=-LRB-	lemma_2=nandrolone	relType_2=dep	lemma_5=,	relType_5=punct	lemma_6=Anabolin	lemma_2=[	lemma_9=e.	pos_11=,	pos_1=-LRB-	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	relType_8=conj	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e5	null	relType_4=dep	pos_13=,	pos_2=NN	lemma_13=,	lemma_11=,	pos_5=,	path1=	lpib=nandrolone_NN	relType_13=punct	wib=nandrolone	relType_8=punct	relType_10=dep	lemma_10=g.	pos_12=-RRB-	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	lemma_12=Anavar	lib=nandrolone	relType_9=compound	pos_6=NNP	relType_6=punct	lemma_6=]	relType_11=punct	pos_2=-LRB-	pos_7=,	lemma_8=oxandrolone	relType_12=punct	pos_10=NN	lemma_7=,	path2=nandrolone_dep>oxymetholone_conj	pos_4=NN	pos_9=NN	pos_8=-LRB-	lemma_2=nandrolone	relType_2=dep	lemma_5=,	relType_5=punct	lemma_6=Anabolin	lemma_2=[	lemma_9=e.	pos_11=,	pos_1=-LRB-	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_6=appos	eib=True	pos_12=NNP	relType_12=appos	pos_3=NN	relType_7=punct	lemma_12=]	relType_8=conj	relType_3=compound	relType_1=punct	path=<steroid_ROOT>nandrolone_dep>oxymetholone_conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e6	null	relType_4=dep	pos_13=,	relType_14=punct	pos_2=NN	lemma_13=,	lemma_11=,	pos_5=,	relType_17=punct	path1=	lpib=nandrolone_NN	relType_13=punct	wib=nandrolone	relType_8=punct	lemma_16=g.	relType_10=dep	lemma_10=g.	pos_12=-RRB-	lemma_15=e.	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	lemma_12=Anavar	lib=nandrolone	relType_9=compound	lemma_17=,	pos_6=NNP	relType_6=punct	lemma_6=]	relType_11=punct	pos_2=-LRB-	pos_7=,	lemma_8=oxandrolone	relType_12=punct	pos_14=NN	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	pos_8=-LRB-	lemma_2=nandrolone	pos_17=,	relType_2=dep	pos_14=-LRB-	pos_15=NN	lemma_5=,	relType_5=punct	lemma_6=Anabolin	lemma_14=oxymetholone	lemma_2=[	lemma_9=e.	pos_16=NN	pos_11=,	pos_1=-LRB-	pos_6=-RRB-	lemma_8=[	relType_15=compound	path=<steroid_ROOT>nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	lemma_4=g.	relType_6=appos	eib=True	pos_12=NNP	relType_12=appos	pos_3=NN	relType_7=punct	lemma_12=]	relType_16=dep	relType_8=conj	relType_3=compound	lemma_14=[	relType_1=punct	path2=nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	relType_14=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e7	null	pos_2=NN	path=<steroid_ROOT>nandrolone_dep>stanozolol_conj	lemma_13=,	pos_5=,	lpib=nandrolone_NN	relType_8=punct	lemma_16=g.	relType_10=dep	lemma_3=e.	lemma_8=oxandrolone	pos_10=NN	lemma_7=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	pos_1=-LRB-	relType_15=compound	relType_6=appos	relType_12=appos	relType_8=conj	pos_13=,	path1=	lemma_15=e.	relType_2=punct	pos_8=NN	lemma_12=Anavar	lib=nandrolone	path2=nandrolone_dep>stanozolol_conj	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	lemma_14=oxymetholone	pos_19=,	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	pos_12=NNP	lemma_12=]	lemma_19=,	relType_3=compound	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	pos_18=-RRB-	pos_6=NNP	relType_11=punct	pos_7=,	lemma_18=Anadrol	pos_14=NN	relType_18=appos	pos_17=,	lemma_6=Anabolin	relType_14=conj	pos_18=NNP	relType_13=punct	wib=nandrolone	lemma_10=g.	relType_9=compound	lemma_17=,	relType_6=punct	lemma_6=]	pos_4=NN	pos_8=-LRB-	lemma_2=nandrolone	pos_15=NN	relType_5=punct	relType_18=punct	lemma_2=[	pos_11=,	eib=True	pos_3=NN	relType_7=punct	relType_16=dep	lemma_14=[
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e0	DDI-DrugBank.d179.s3.e8	null	pos_20=-LRB-	pos_2=NN	lemma_13=,	pos_5=,	lpib=nandrolone_NN	relType_8=punct	lemma_16=g.	relType_10=dep	lemma_3=e.	pos_20=NN	lemma_8=oxandrolone	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	pos_1=-LRB-	relType_15=compound	relType_6=appos	relType_22=appos	relType_12=appos	relType_8=conj	lemma_20=[	pos_13=,	pos_22=NN	path1=	lemma_15=e.	relType_2=punct	pos_8=NN	lemma_12=Anavar	lib=nandrolone	relType_20=conj	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	lemma_21=e.	lemma_14=oxymetholone	pos_19=,	relType_21=compound	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	pos_12=NNP	lemma_12=]	lemma_19=,	relType_3=compound	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	pos_18=-RRB-	pos_6=NNP	relType_11=punct	lemma_22=g.	pos_7=,	lemma_18=Anadrol	pos_14=NN	relType_18=appos	pos_17=,	lemma_6=Anabolin	path=<steroid_ROOT>nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	path2=nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	relType_20=punct	relType_14=conj	relType_23=punct	pos_18=NNP	relType_13=punct	wib=nandrolone	lemma_10=g.	relType_9=compound	lemma_17=,	relType_6=punct	lemma_6=]	lemma_20=stanozolol	pos_4=NN	pos_8=-LRB-	lemma_2=nandrolone	pos_15=NN	relType_5=punct	relType_18=punct	lemma_2=[	pos_11=,	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_14=[	pos_21=NN
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e2	null	relType_3=dep	path=<nandrolone_dep>g._dep>Anabolin_appos	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	path2=g._dep>Anabolin_appos	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e3	null	path=<nandrolone_dep>oxandrolone_conj	relType_3=dep	pos_2=NN	path1=	lemma_6=,	lib=e.	lemma_3=g.	pos_4=,	path2=oxandrolone_conj	relType_6=punct	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_5=Anabolin	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e4	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	path1=	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=oxandrolone	lemma_7=[	lemma_5=]	path=<nandrolone_dep>oxandrolone_conj>g._dep>Anavar_appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_5=Anabolin	pos_10=,	eib=True	pos_3=NN	path2=oxandrolone_conj>g._dep>Anavar_appos	relType_7=punct	lemma_8=e.	lemma_9=g.	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e5	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	path1=	lemma_6=,	pos_11=NNP	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=oxandrolone	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	path2=oxymetholone_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	path=<nandrolone_dep>oxymetholone_conj	pos_6=,	lemma_11=Anavar	pos_11=-RRB-	lemma_5=Anabolin	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e6	null	relType_3=dep	relType_10=punct	path=<nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	pos_2=NN	lemma_10=,	path1=	lemma_6=,	relType_13=punct	pos_11=NNP	lib=e.	relType_14=compound	lemma_13=oxymetholone	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_7=oxandrolone	lemma_16=,	lemma_7=[	lemma_5=]	path2=oxymetholone_conj>g._dep>Anadrol_appos	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	lemma_11=Anavar	pos_11=-RRB-	lemma_5=Anabolin	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e7	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	path1=	lemma_6=,	relType_13=punct	lemma_17=Anadrol	path2=stanozolol_conj	pos_11=NNP	lib=e.	relType_14=compound	lemma_13=oxymetholone	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_7=oxandrolone	lemma_16=,	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	lemma_11=Anavar	pos_11=-RRB-	lemma_5=Anabolin	pos_10=,	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	path=<nandrolone_dep>stanozolol_conj	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e1	DDI-DrugBank.d179.s3.e8	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	lemma_7=oxandrolone	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	path2=stanozolol_conj>g._appos>Winstrol_dep	relType_3=dep	path=<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	lemma_11=Anavar	relType_17=appos	lemma_19=stanozolol	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_17=Anadrol	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	lemma_5=Anabolin	relType_21=appos	relType_7=conj	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_13=oxymetholone	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e3	null	eib=False	path2=oxandrolone_conj	path=Anabolin_appos<g._dep<nandrolone_dep>oxandrolone_conj	pos_1=-RRB-	lpib=oxandrolone_NN	lemma_1=]	pos_2=,	wib=oxandrolone	relType_1=punct	path1=Anabolin_appos<g._dep	relType_2=punct	lemma_2=,	lib=oxandrolone
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e4	null	lemma_3=[	lemma_6=,	wib=oxandrolone	relType_2=punct	lemma_3=oxandrolone	relType_6=punct	path=Anabolin_appos<g._dep<nandrolone_dep>oxandrolone_conj>g._dep>Anavar_appos	lemma_4=e.	lemma_1=]	pos_3=-LRB-	path1=Anabolin_appos<g._dep	relType_5=dep	pos_4=NN	lemma_2=,	relType_3=conj	pos_1=-RRB-	relType_4=compound	pos_6=,	lib=oxandrolone	pos_5=NN	eib=True	pos_3=NN	path2=oxandrolone_conj>g._dep>Anavar_appos	lpib=oxandrolone_NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e5	null	lemma_3=[	relType_7=appos	lemma_6=,	relType_8=punct	wib=oxandrolone	lemma_8=,	relType_2=punct	path=Anabolin_appos<g._dep<nandrolone_dep>oxymetholone_conj	lemma_3=oxandrolone	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=Anavar	lemma_7=]	pos_3=-LRB-	path1=Anabolin_appos<g._dep	relType_5=dep	pos_4=NN	lemma_2=,	relType_3=conj	path2=oxymetholone_conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	pos_6=,	lib=oxandrolone	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	lpib=oxandrolone_NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e6	null	lemma_3=[	lemma_9=oxymetholone	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	wib=oxandrolone	lemma_8=,	relType_2=punct	lemma_12=,	lemma_3=oxandrolone	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=Anavar	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	path1=Anabolin_appos<g._dep	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	path=Anabolin_appos<g._dep<nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	relType_12=punct	path2=oxymetholone_conj>g._dep>Anadrol_appos	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	lib=oxandrolone	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lpib=oxandrolone_NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e7	null	lemma_3=[	relType_14=punct	lemma_9=oxymetholone	relType_7=appos	relType_9=conj	lemma_13=Anadrol	relType_13=punct	lemma_6=,	lemma_9=[	path2=stanozolol_conj	relType_8=punct	wib=oxandrolone	lemma_8=,	path=Anabolin_appos<g._dep<nandrolone_dep>stanozolol_conj	pos_13=NNP	relType_2=punct	lemma_12=,	lemma_3=oxandrolone	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=Anavar	lemma_7=]	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	path1=Anabolin_appos<g._dep	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_12=punct	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	lib=oxandrolone	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lpib=oxandrolone_NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e2	DDI-DrugBank.d179.s3.e8	null	lemma_3=[	relType_14=punct	lemma_9=oxymetholone	relType_7=appos	relType_9=conj	lemma_13=Anadrol	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	wib=oxandrolone	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	lemma_3=oxandrolone	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=Anavar	lemma_7=]	pos_14=,	lemma_16=e.	path=Anabolin_appos<g._dep<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	pos_3=-LRB-	pos_10=NN	path1=Anabolin_appos<g._dep	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_10=compound	relType_12=punct	relType_15=punct	pos_18=,	pos_15=NN	lemma_15=stanozolol	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	lib=oxandrolone	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	relType_15=conj	lpib=oxandrolone_NN	lemma_17=g.	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	path2=stanozolol_conj>g._appos>Winstrol_dep	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e3	DDI-DrugBank.d179.s3.e4	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path=<oxandrolone_conj>g._dep>Anavar_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	path2=g._dep>Anavar_appos	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e3	DDI-DrugBank.d179.s3.e5	null	relType_3=dep	pos_2=NN	lemma_6=,	lib=e.	lemma_3=g.	pos_4=,	relType_6=punct	path1=oxandrolone_conj	path=oxandrolone_conj<nandrolone_dep>oxymetholone_conj	lemma_5=]	relType_4=punct	pos_5=-RRB-	path2=oxymetholone_conj	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct	lemma_5=Anavar
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e3	DDI-DrugBank.d179.s3.e6	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	lemma_7=oxymetholone	pos_8=NN	lemma_3=g.	pos_4=,	path=oxandrolone_conj<nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	relType_6=punct	path1=oxandrolone_conj	pos_9=NN	lemma_7=[	lemma_5=]	path2=oxymetholone_conj>g._dep>Anadrol_appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	lemma_5=Anavar	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e3	DDI-DrugBank.d179.s3.e7	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	path2=stanozolol_conj	pos_11=NNP	lib=e.	relType_9=dep	pos_7=-LRB-	lemma_7=oxymetholone	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	lemma_11=Anadrol	path1=oxandrolone_conj	relType_12=punct	pos_9=NN	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	path=oxandrolone_conj<nandrolone_dep>stanozolol_conj	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_5=Anavar	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e3	DDI-DrugBank.d179.s3.e8	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	path=oxandrolone_conj<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	pos_7=-LRB-	lemma_7=oxymetholone	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	lemma_11=Anadrol	pos_16=,	path1=oxandrolone_conj	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_13=stanozolol	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	relType_15=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	path2=stanozolol_conj>g._appos>Winstrol_dep	lemma_5=Anavar	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e4	DDI-DrugBank.d179.s3.e5	null	lib=oxymetholone	wib=oxymetholone	path1=Anavar_appos<g._dep<oxandrolone_conj	eib=False	path2=oxymetholone_conj	pos_1=-RRB-	path=Anavar_appos<g._dep<oxandrolone_conj<nandrolone_dep>oxymetholone_conj	lemma_1=]	lpib=oxymetholone_NN	pos_2=,	relType_1=punct	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e4	DDI-DrugBank.d179.s3.e6	null	lemma_3=[	wib=oxymetholone	path1=Anavar_appos<g._dep<oxandrolone_conj	lemma_6=,	relType_2=punct	lib=oxymetholone	relType_6=punct	lemma_4=e.	lemma_1=]	lpib=oxymetholone_NN	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path2=oxymetholone_conj>g._dep>Anadrol_appos	relType_3=conj	pos_1=-RRB-	relType_4=compound	pos_6=,	pos_5=NN	path=Anavar_appos<g._dep<oxandrolone_conj<nandrolone_dep>oxymetholone_conj>g._dep>Anadrol_appos	eib=True	lemma_3=oxymetholone	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e4	DDI-DrugBank.d179.s3.e7	null	lemma_3=[	wib=oxymetholone	path1=Anavar_appos<g._dep<oxandrolone_conj	relType_7=appos	lemma_6=,	path2=stanozolol_conj	relType_8=punct	lemma_8=,	relType_2=punct	lib=oxymetholone	relType_6=punct	lemma_4=e.	path=Anavar_appos<g._dep<oxandrolone_conj<nandrolone_dep>stanozolol_conj	lemma_1=]	lpib=oxymetholone_NN	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Anadrol	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	pos_6=,	pos_5=NN	eib=True	lemma_3=oxymetholone	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e4	DDI-DrugBank.d179.s3.e8	null	lemma_3=[	wib=oxymetholone	path1=Anavar_appos<g._dep<oxandrolone_conj	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lib=oxymetholone	lemma_12=,	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	path=Anavar_appos<g._dep<oxandrolone_conj<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	lpib=oxymetholone_NN	lemma_7=]	pos_12=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_7=Anadrol	relType_11=appos	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_9=stanozolol	lemma_11=g.	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	lemma_3=oxymetholone	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	path2=stanozolol_conj>g._appos>Winstrol_dep	pos_8=,
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e5	DDI-DrugBank.d179.s3.e6	null	path=<oxymetholone_conj>g._dep>Anadrol_appos	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Anadrol_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e5	DDI-DrugBank.d179.s3.e7	null	relType_3=dep	pos_2=NN	lemma_6=,	path2=stanozolol_conj	lib=e.	lemma_3=g.	pos_4=,	path1=oxymetholone_conj	relType_6=punct	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	path=oxymetholone_conj<nandrolone_dep>stanozolol_conj	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_5=Anadrol	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e5	DDI-DrugBank.d179.s3.e8	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	pos_7=-LRB-	pos_8=NN	lemma_7=stanozolol	lemma_3=g.	pos_4=,	path1=oxymetholone_conj	relType_6=punct	pos_9=NN	relType_9=appos	lemma_7=[	lemma_5=]	relType_4=punct	path=oxymetholone_conj<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_5=Anadrol	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	path2=stanozolol_conj>g._appos>Winstrol_dep	relType_7=conj
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e6	DDI-DrugBank.d179.s3.e7	null	path1=Anadrol_appos<g._dep<oxymetholone_conj	eib=False	lpib=stanozolol_NN	pos_1=-RRB-	lib=stanozolol	lemma_2=,	lemma_1=]	pos_2=,	path=Anadrol_appos<g._dep<oxymetholone_conj<nandrolone_dep>stanozolol_conj	path2=stanozolol_conj	relType_1=punct	wib=stanozolol	relType_2=punct
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e6	DDI-DrugBank.d179.s3.e8	null	lemma_3=[	lib=stanozolol	lemma_6=,	wib=stanozolol	relType_2=punct	lpib=stanozolol_NN	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	pos_4=NN	lemma_2=,	path1=Anadrol_appos<g._dep<oxymetholone_conj	relType_3=conj	pos_1=-RRB-	relType_4=compound	relType_5=appos	pos_6=,	path=Anadrol_appos<g._dep<oxymetholone_conj<nandrolone_dep>stanozolol_conj>g._appos>Winstrol_dep	pos_5=NN	eib=True	pos_3=NN	lemma_3=stanozolol	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	path2=stanozolol_conj>g._appos>Winstrol_dep
DDI-DrugBank.d179.s3	DDI-DrugBank.d179.s3.e7	DDI-DrugBank.d179.s3.e8	null	path2=g._appos>Winstrol_dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	relType_3=appos	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path=<stanozolol_conj>g._appos>Winstrol_dep	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s6	DDI-DrugBank.d179.s6.e0	DDI-DrugBank.d179.s6.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	path=<carbamazepine_ROOT>g._dep>Tegretol_appos	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Tegretol_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s7	DDI-DrugBank.d179.s7.e0	DDI-DrugBank.d179.s7.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>bicnu_dep	path1=	lib=e.	path=<carmustine_ROOT>g._dep>bicnu_dep	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s8	DDI-DrugBank.d179.s8.e0	DDI-DrugBank.d179.s8.e1	null	relType_3=dep	pos_2=NN	path1=	path2=g._dep>Aralen_appos	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<chloroquine_ROOT>g._dep>Aralen_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s9	DDI-DrugBank.d179.s9.e0	DDI-DrugBank.d179.s9.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	path=<dantrolene_ROOT>g._dep>Dantrium_appos	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	path2=g._dep>Dantrium_appos	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s10	DDI-DrugBank.d179.s10.e0	DDI-DrugBank.d179.s10.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>cerubidine_dep	path1=	path=<daunorubicin_ROOT>g._dep>cerubidine_dep	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s11	DDI-DrugBank.d179.s11.e0	DDI-DrugBank.d179.s11.e1	null	relType_3=dep	pos_2=NN	path1=	path2=g._dep>antabuse_dep	lib=e.	lemma_1=(	path=<disulfiram_ROOT>g._dep>antabuse_dep	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s12	DDI-DrugBank.d179.s12.e0	DDI-DrugBank.d179.s12.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>depakote_dep	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct	path=<divalproex_ROOT>g._dep>depakote_dep
DDI-DrugBank.d179.s14	DDI-DrugBank.d179.s14.e0	DDI-DrugBank.d179.s14.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<etretinate_ROOT>g._dep>Tegison_appos	relType_4=punct	relType_2=compound	path2=g._dep>Tegison_appos	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s16	DDI-DrugBank.d179.s16.e0	DDI-DrugBank.d179.s16.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>Plaquenil_appos	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<hydroxychloroquine_ROOT>g._dep>Plaquenil_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s17	DDI-DrugBank.d179.s17.e0	DDI-DrugBank.d179.s17.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	path=<mercaptopurine_ROOT>g._dep>purinethol_dep	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	path2=g._dep>purinethol_dep	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s18	DDI-DrugBank.d179.s18.e0	DDI-DrugBank.d179.s18.e1	null	relType_3=dep	pos_2=NN	path1=	path=<naltrexone_ROOT>g._dep>Trexan_dep	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	path2=g._dep>Trexan_dep	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s19	DDI-DrugBank.d179.s19.e0	DDI-DrugBank.d179.s19.e1	null	wib=birth	relType_4=dep	pos_2=NN	path2=contain_acl>estrogen_obj	path1=	lpib=birth_NN	lemma_1=(	pos_6=VBG	eib=False	relation_2=neutral	lemma_3=control	lemma_4=pill	pos_4=NNS	lemma_5=)	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_6=acl	lemma_2=birth	pos_1=-LRB-	lib=birth	pos_3=NN	relType_3=compound	relType_1=punct	lemma_6=contain	path=<contraceptive_ROOT>contain_acl>estrogen_obj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e1	null	lemma_1=(	eib=False	wib=acetophenazine	path1=	pos_1=-LRB-	lib=acetophenazine	lpib=acetophenazine_NN	relType_1=punct	path2=acetophenazine_dep	path=<phenothiazine_ROOT>acetophenazine_dep
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e2	null	relType_4=dep	path2=acetophenazine_dep>g._dep>Tindal_appos	pos_2=NN	pos_5=,	path=<phenothiazine_ROOT>acetophenazine_dep>g._dep>Tindal_appos	path1=	lpib=acetophenazine_NN	relType_2=punct	lemma_1=(	lemma_3=e.	pos_2=-LRB-	lemma_2=acetophenazine	pos_4=NN	relType_2=dep	lemma_5=,	relType_5=punct	wib=acetophenazine	lemma_2=[	lib=acetophenazine	pos_1=-LRB-	lemma_4=g.	eib=True	pos_3=NN	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e3	null	relType_4=dep	pos_2=NN	pos_5=,	path1=	path2=acetophenazine_dep>chlorpromazine_conj	lpib=acetophenazine_NN	relType_2=punct	lemma_1=(	lemma_3=e.	pos_6=NNP	relType_6=punct	lemma_6=]	pos_2=-LRB-	lemma_2=acetophenazine	pos_7=,	lemma_7=,	path=<phenothiazine_ROOT>acetophenazine_dep>chlorpromazine_conj	pos_4=NN	relType_2=dep	lemma_5=,	relType_5=punct	wib=acetophenazine	lemma_2=[	lib=acetophenazine	pos_1=-LRB-	lemma_6=Tindal	pos_6=-RRB-	lemma_4=g.	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e4	null	relType_4=dep	pos_2=NN	lemma_11=,	pos_5=,	path1=	lpib=acetophenazine_NN	relType_8=punct	path2=acetophenazine_dep>chlorpromazine_conj>g._appos>thorazine_dep	lemma_10=g.	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	relType_9=compound	pos_6=NNP	relType_6=punct	lemma_6=]	relType_10=appos	relType_11=punct	pos_2=-LRB-	lemma_2=acetophenazine	pos_7=,	path=<phenothiazine_ROOT>acetophenazine_dep>chlorpromazine_conj>g._appos>thorazine_dep	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	relType_2=dep	lemma_5=,	relType_5=punct	wib=acetophenazine	lemma_2=[	lib=acetophenazine	lemma_9=e.	pos_11=,	pos_1=-LRB-	lemma_6=Tindal	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	relType_8=conj	relType_3=compound	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e5	null	relType_4=dep	pos_13=,	pos_2=NN	lemma_13=,	lemma_11=,	pos_5=,	path1=	relType_13=punct	lpib=acetophenazine_NN	relType_8=punct	lemma_10=g.	pos_12=-RRB-	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	relType_9=compound	pos_6=NNP	relType_6=punct	lemma_6=]	relType_10=appos	relType_11=punct	pos_2=-LRB-	lemma_2=acetophenazine	pos_7=,	relType_12=punct	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	relType_2=dep	lemma_5=,	relType_5=punct	wib=acetophenazine	lemma_2=[	lib=acetophenazine	lemma_9=e.	pos_11=,	lemma_12=thorazine	pos_1=-LRB-	lemma_6=Tindal	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_6=appos	eib=True	relType_12=dep	pos_3=NN	relType_7=punct	lemma_12=]	path=<phenothiazine_ROOT>acetophenazine_dep>fluphenazine_conj	relType_8=conj	path2=acetophenazine_dep>fluphenazine_conj	relType_3=compound	relType_1=punct	pos_12=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e6	null	relType_4=dep	pos_13=,	relType_14=punct	pos_2=NN	lemma_13=,	lemma_11=,	pos_5=,	relType_17=punct	path1=	relType_13=punct	lpib=acetophenazine_NN	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	lemma_10=g.	pos_12=-RRB-	lemma_15=e.	relType_2=punct	lemma_1=(	lemma_3=e.	pos_8=NN	relType_9=compound	lemma_17=,	pos_6=NNP	relType_6=punct	lemma_6=]	relType_10=appos	path2=acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos	pos_2=-LRB-	lemma_2=acetophenazine	pos_7=,	relType_11=punct	relType_12=punct	pos_14=NN	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	pos_17=,	relType_2=dep	pos_14=-LRB-	pos_15=NN	lemma_5=,	relType_5=punct	wib=acetophenazine	lemma_2=[	lib=acetophenazine	lemma_9=e.	pos_16=NN	pos_11=,	lemma_12=thorazine	pos_1=-LRB-	lemma_6=Tindal	pos_6=-RRB-	lemma_8=[	relType_15=compound	lemma_4=g.	relType_6=appos	eib=True	relType_12=dep	pos_3=NN	relType_7=punct	lemma_12=]	relType_16=dep	relType_8=conj	relType_3=compound	lemma_14=[	relType_1=punct	pos_12=NN	relType_14=conj	path=<phenothiazine_ROOT>acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e7	null	pos_2=NN	lemma_13=,	pos_5=,	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	lemma_3=e.	pos_10=NN	lemma_7=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	lib=acetophenazine	pos_1=-LRB-	relType_15=compound	relType_6=appos	relType_8=conj	pos_13=,	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	pos_19=,	lemma_9=e.	pos_16=NN	path=<phenothiazine_ROOT>acetophenazine_dep>mesoridazine_conj	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	lemma_19=,	relType_3=compound	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	pos_18=-RRB-	pos_6=NNP	relType_11=punct	path2=acetophenazine_dep>mesoridazine_conj	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	lemma_6=Tindal	relType_14=conj	pos_18=NNP	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	pos_15=NN	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	pos_11=,	lemma_12=thorazine	eib=True	pos_3=NN	relType_7=punct	relType_16=dep	lemma_14=[	pos_12=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e8	null	pos_20=-LRB-	pos_2=NN	lemma_13=,	pos_5=,	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	pos_20=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	lib=acetophenazine	pos_1=-LRB-	relType_15=compound	relType_6=appos	relType_8=conj	lemma_20=[	lemma_20=mesoridazine	pos_13=,	path2=acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	path=<phenothiazine_ROOT>acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_12=punct	lemma_18=]	pos_9=NN	lemma_21=e.	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	lemma_19=,	relType_3=compound	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	pos_18=-RRB-	pos_6=NNP	relType_11=punct	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	lemma_6=Tindal	relType_20=punct	relType_14=conj	relType_23=punct	pos_18=NNP	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	pos_15=NN	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	pos_11=,	lemma_12=thorazine	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_14=[	pos_12=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e9	null	pos_24=NNP	pos_20=-LRB-	pos_2=NN	lemma_13=,	pos_5=,	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	pos_20=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	lib=acetophenazine	lemma_25=,	pos_1=-LRB-	relType_15=compound	relType_6=appos	relType_8=conj	lemma_20=[	lemma_20=mesoridazine	pos_13=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	path=<phenothiazine_ROOT>acetophenazine_dep>perphenazine_conj	pos_9=NN	lemma_21=e.	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	lemma_19=,	relType_3=compound	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	pos_18=-RRB-	pos_6=NNP	relType_11=punct	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	lemma_6=Tindal	relType_20=punct	relType_14=conj	relType_23=punct	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	path2=acetophenazine_dep>perphenazine_conj	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	lemma_14=[	pos_12=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e10	null	path2=acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	lemma_13=,	pos_5=,	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	lib=acetophenazine	lemma_25=,	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_6=appos	relType_8=conj	lemma_20=[	lemma_20=mesoridazine	pos_13=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	lemma_21=e.	pos_27=NN	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	path=<phenothiazine_ROOT>acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	relType_19=punct	pos_12=-RRB-	lemma_1=(	lemma_26=[	pos_18=-RRB-	pos_6=NNP	lemma_29=,	relType_11=punct	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	pos_29=,	lemma_6=Tindal	pos_26=-LRB-	relType_20=punct	relType_14=conj	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	relType_9=compound	lemma_17=,	relType_26=conj	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	pos_4=NN	pos_8=-LRB-	lemma_8=chlorpromazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	lemma_14=[	pos_12=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e11	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	lemma_13=,	pos_5=,	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	pos_30=-RRB-	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	relType_8=conj	lemma_20=[	lemma_20=mesoridazine	pos_13=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	lemma_21=e.	pos_27=NN	pos_31=,	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	path2=acetophenazine_dep>prochlorperazine_conj	lemma_1=(	lemma_26=[	pos_18=-RRB-	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	pos_29=,	lemma_31=,	lemma_6=Tindal	pos_26=-LRB-	relType_20=punct	relType_14=conj	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	lemma_27=e.	path=<phenothiazine_ROOT>acetophenazine_dep>prochlorperazine_conj	lemma_26=perphenazine	lemma_30=]	relType_9=compound	lemma_17=,	relType_26=conj	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	lemma_14=[	pos_12=NN	lemma_30=Trilafon	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e12	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	pos_30=-RRB-	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	relType_32=conj	relType_8=conj	lemma_20=[	lemma_20=mesoridazine	pos_13=,	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	lemma_21=e.	pos_27=NN	pos_31=,	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	lemma_33=e.	pos_6=-RRB-	lemma_8=[	lemma_4=g.	path=<phenothiazine_ROOT>acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	relType_12=dep	lemma_12=]	relType_25=punct	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	relType_34=dep	pos_29=,	lemma_31=,	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	relType_20=punct	relType_14=conj	pos_33=NN	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	path2=acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e13	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	lemma_3=e.	lemma_36=Compazine	pos_30=-RRB-	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_9=NN	path2=acetophenazine_dep>promazine_conj	lemma_21=e.	pos_27=NN	pos_31=,	relType_21=compound	pos_19=,	lemma_9=e.	pos_16=NN	lemma_33=e.	pos_37=,	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	path=<phenothiazine_ROOT>acetophenazine_dep>promazine_conj	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	relType_34=dep	lemma_36=]	pos_29=,	lemma_31=,	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	relType_20=punct	relType_14=conj	pos_33=NN	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e14	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	path2=acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	lemma_16=g.	relType_22=dep	relType_38=conj	lemma_3=e.	lemma_36=Compazine	pos_30=-RRB-	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_38=-LRB-	pos_9=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	lemma_38=[	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	relType_34=dep	lemma_36=]	pos_38=NN	pos_29=,	lemma_31=,	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	pos_41=,	relType_20=punct	relType_14=conj	pos_33=NN	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	path=<phenothiazine_ROOT>acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_9=compound	lemma_17=,	relType_26=conj	relType_6=punct	lemma_6=]	lemma_18=Prolixin	lemma_34=g.	pos_36=NNP	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	lemma_38=promazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e15	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	relType_38=conj	lemma_3=e.	lemma_36=Compazine	pos_30=-RRB-	pos_20=NN	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_38=-LRB-	pos_9=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	lemma_38=[	pos_6=-RRB-	lemma_8=[	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	pos_14=NN	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	pos_29=,	path2=acetophenazine_dep>promethazine_conj	lemma_31=,	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	pos_41=,	relType_20=punct	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	relType_13=punct	path=<phenothiazine_ROOT>acetophenazine_dep>promethazine_conj	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	lemma_38=promazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e16	null	pos_24=NNP	relType_28=dep	path2=acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	pos_30=-RRB-	pos_20=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	relType_12=punct	lemma_18=]	pos_38=-LRB-	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_44=conj	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	relType_47=punct	pos_14=NN	lemma_44=promethazine	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	pos_29=,	lemma_31=,	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	pos_41=,	lemma_44=[	relType_20=punct	path=<phenothiazine_ROOT>acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	relType_13=punct	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	relType_46=dep	relType_24=appos	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e17	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	pos_5=,	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	pos_30=-RRB-	pos_48=-RRB-	pos_20=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_12=punct	lemma_18=]	pos_38=-LRB-	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	path2=acetophenazine_dep>thioridazine_conj	relType_44=conj	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_22=g.	pos_7=,	relType_47=punct	pos_14=NN	lemma_44=promethazine	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	pos_29=,	lemma_31=,	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	pos_26=-LRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	relType_13=punct	relType_48=punct	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	path=<phenothiazine_ROOT>acetophenazine_dep>thioridazine_conj	lemma_38=promazine	pos_15=NN	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	eib=True	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e18	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	pos_30=-RRB-	pos_48=-RRB-	pos_20=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	pos_14=-LRB-	lemma_5=,	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_44=conj	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_12=-RRB-	lemma_1=(	path2=acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_14=NN	lemma_44=promethazine	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	pos_29=,	lemma_31=,	path=<phenothiazine_ROOT>acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_33=compound	pos_35=,	pos_4=NN	relType_51=compound	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	relType_50=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e19	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	relType_32=punct	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	pos_30=-RRB-	pos_48=-RRB-	pos_20=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	path=<phenothiazine_ROOT>acetophenazine_dep>trifluoperazine_conj	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	lemma_41=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	relType_44=conj	relType_4=dep	relType_14=punct	lemma_11=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_54=NNP	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_14=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_29=,	lemma_31=,	lemma_39=e.	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	relType_33=compound	pos_35=,	pos_4=NN	relType_51=compound	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	path2=acetophenazine_dep>trifluoperazine_conj	pos_49=,	pos_24=-RRB-	relType_50=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e20	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	path=<phenothiazine_ROOT>acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_13=,	pos_34=NN	pos_39=NN	pos_5=,	lemma_50=[	pos_52=NN	relType_32=punct	pos_57=NN	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	relType_59=punct	pos_30=-RRB-	relType_57=compound	pos_48=-RRB-	pos_20=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	lemma_57=e.	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	relType_56=punct	lemma_56=trifluoperazine	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	relType_58=appos	lemma_41=,	lemma_59=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	lemma_12=]	relType_25=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	pos_56=-LRB-	relType_44=conj	relType_4=dep	relType_14=punct	pos_58=NN	lemma_11=,	pos_59=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_54=NNP	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_14=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_29=,	lemma_31=,	lemma_39=e.	lemma_56=[	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	path2=acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	pos_26=-LRB-	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	lemma_58=g.	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	relType_33=compound	pos_35=,	pos_4=NN	relType_51=compound	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	relType_56=conj	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	relType_50=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e21	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	path=<phenothiazine_ROOT>acetophenazine_dep>triflupromazine_conj	relType_32=punct	pos_57=NN	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	relType_59=punct	relType_60=dep	pos_30=-RRB-	relType_57=compound	pos_48=-RRB-	pos_20=NN	pos_60=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	lemma_57=e.	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lemma_60=stelazine	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	lemma_60=]	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	path1=	lpib=acetophenazine_NN	relType_56=punct	lemma_56=trifluoperazine	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	relType_21=compound	pos_19=,	relType_58=appos	lemma_41=,	lemma_59=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	lemma_12=]	relType_25=punct	relType_61=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	pos_56=-LRB-	relType_44=conj	relType_4=dep	relType_14=punct	lemma_61=,	pos_58=NN	lemma_11=,	pos_59=,	relType_17=punct	relType_24=punct	relType_19=punct	pos_54=NNP	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_61=,	pos_14=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_60=-RRB-	pos_29=,	lemma_31=,	lemma_39=e.	lemma_56=[	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	path2=acetophenazine_dep>triflupromazine_conj	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	lemma_58=g.	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	relType_33=compound	pos_35=,	pos_4=NN	relType_51=compound	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	relType_56=conj	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	relType_50=punct	relType_60=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e22	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	relType_32=punct	pos_57=NN	lemma_64=g.	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	relType_59=punct	relType_60=dep	pos_30=-RRB-	relType_65=punct	relType_57=compound	pos_48=-RRB-	pos_20=NN	path=<phenothiazine_ROOT>acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	pos_60=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	lemma_57=e.	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lemma_60=stelazine	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	lemma_60=]	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	relType_63=compound	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	relType_64=dep	path1=	lpib=acetophenazine_NN	relType_56=punct	lemma_56=trifluoperazine	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_65=,	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	pos_64=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	pos_62=-LRB-	relType_21=compound	pos_19=,	relType_58=appos	lemma_41=,	lemma_59=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	pos_65=,	lemma_12=]	relType_25=punct	relType_61=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	pos_56=-LRB-	relType_44=conj	relType_4=dep	relType_14=punct	lemma_61=,	pos_58=NN	lemma_11=,	pos_59=,	path2=acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_17=punct	relType_24=punct	lemma_63=e.	relType_19=punct	pos_54=NNP	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_62=NN	pos_61=,	pos_14=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_62=conj	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_60=-RRB-	lemma_62=triflupromazine	pos_29=,	lemma_31=,	lemma_39=e.	lemma_56=[	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	relType_62=punct	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	lemma_58=g.	pos_43=,	lemma_10=g.	lemma_27=e.	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	relType_33=compound	pos_35=,	pos_4=NN	relType_51=compound	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	relType_56=conj	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	relType_50=punct	relType_60=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	pos_63=NN	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	lemma_62=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e23	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	relType_32=punct	pos_57=NN	lemma_64=g.	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	relType_59=punct	relType_60=dep	pos_30=-RRB-	relType_65=punct	relType_57=compound	pos_48=-RRB-	pos_20=NN	pos_60=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	relType_2=dep	lemma_57=e.	pos_66=-RRB-	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lemma_60=stelazine	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	lemma_60=]	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	lemma_66=]	relType_63=compound	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	relType_64=dep	path1=	lpib=acetophenazine_NN	relType_56=punct	lemma_56=trifluoperazine	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_67=,	lemma_65=,	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	pos_64=NN	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	pos_62=-LRB-	relType_21=compound	pos_19=,	relType_58=appos	lemma_41=,	lemma_59=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	pos_65=,	lemma_12=]	relType_25=punct	relType_61=punct	pos_40=NN	lemma_19=,	relType_3=compound	relType_26=punct	relType_1=punct	path2=acetophenazine_dep>trimeprazine_conj	pos_56=-LRB-	relType_67=punct	relType_44=conj	relType_4=dep	relType_14=punct	lemma_61=,	pos_58=NN	lemma_11=,	pos_59=,	relType_17=punct	relType_24=punct	lemma_63=e.	relType_66=punct	relType_19=punct	pos_54=NNP	pos_12=-RRB-	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	lemma_32=prochlorperazine	lemma_48=Phenergan	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	pos_50=NN	lemma_22=g.	pos_7=,	relType_47=punct	pos_62=NN	pos_61=,	pos_14=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_62=conj	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_60=-RRB-	lemma_62=triflupromazine	pos_29=,	lemma_31=,	lemma_39=e.	lemma_56=[	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	relType_62=punct	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	path=<phenothiazine_ROOT>acetophenazine_dep>trimeprazine_conj	pos_18=NNP	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	lemma_58=g.	pos_43=,	lemma_10=g.	lemma_27=e.	pos_66=NNP	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	relType_33=compound	pos_35=,	lemma_66=Vesprin	pos_4=NN	relType_51=compound	pos_67=,	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	relType_56=conj	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	relType_50=punct	relType_60=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	relType_66=appos	pos_63=NN	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	lemma_62=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e0	DDI-DrugBank.d179.s21.e24	null	pos_24=NNP	relType_28=dep	pos_20=-LRB-	pos_2=NN	pos_34=NN	lemma_13=,	pos_39=NN	lemma_50=[	pos_5=,	pos_52=NN	relType_32=punct	pos_57=NN	lemma_64=g.	lemma_70=g.	relType_8=punct	lemma_14=fluphenazine	lemma_16=g.	relType_22=dep	pos_47=,	lemma_48=]	pos_68=NN	relType_38=conj	lemma_3=e.	lemma_36=Compazine	relType_45=compound	lemma_51=e.	lemma_52=g.	relType_59=punct	relType_60=dep	pos_30=-RRB-	relType_69=compound	relType_65=punct	relType_57=compound	pos_48=-RRB-	pos_20=NN	pos_60=NN	lemma_47=,	pos_26=NN	pos_10=NN	lemma_7=,	lemma_23=,	relType_43=punct	pos_69=NN	relType_2=dep	lemma_57=e.	pos_66=-RRB-	pos_14=-LRB-	lemma_5=,	lemma_54=Mellaril	relType_30=appos	lemma_60=stelazine	lib=acetophenazine	lemma_25=,	pos_32=NN	pos_42=NNP	pos_1=-LRB-	pos_46=NN	relType_15=compound	pos_28=NN	relType_30=punct	relType_6=appos	pos_42=-RRB-	lemma_60=]	relType_32=conj	relType_8=conj	relType_36=punct	lemma_20=[	lemma_66=]	relType_63=compound	lemma_71=,	relType_37=punct	relType_49=punct	lemma_20=mesoridazine	pos_13=,	lemma_37=,	lemma_46=g.	lemma_35=,	pos_22=NN	relType_64=dep	path1=	lpib=acetophenazine_NN	relType_56=punct	lemma_56=trifluoperazine	lemma_15=e.	relType_2=punct	relType_38=punct	pos_8=NN	lemma_67=,	lemma_65=,	lemma_54=]	relType_20=conj	relType_10=appos	pos_2=-LRB-	lemma_49=,	relType_55=punct	relType_12=punct	lemma_18=]	pos_38=-LRB-	relType_52=dep	pos_9=NN	pos_44=NN	pos_64=NN	relType_71=punct	lemma_40=g.	lemma_21=e.	pos_27=NN	pos_31=,	relType_42=appos	pos_62=-LRB-	relType_21=compound	pos_19=,	relType_58=appos	lemma_41=,	lemma_59=,	lemma_9=e.	pos_16=NN	relType_41=punct	lemma_33=e.	pos_37=,	pos_48=NNP	pos_68=-LRB-	lemma_38=[	pos_6=-RRB-	lemma_8=[	relType_44=punct	lemma_4=g.	relType_53=punct	relType_12=dep	pos_65=,	lemma_12=]	relType_25=punct	relType_61=punct	pos_40=NN	lemma_19=,	relType_3=compound	pos_71=,	relType_26=punct	relType_1=punct	pos_56=-LRB-	relType_67=punct	relType_44=conj	relType_4=dep	relType_14=punct	lemma_61=,	pos_58=NN	lemma_11=,	pos_59=,	path=<phenothiazine_ROOT>acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_17=punct	relType_24=punct	lemma_63=e.	relType_66=punct	relType_19=punct	pos_54=NNP	pos_70=NN	pos_12=-RRB-	relType_68=punct	lemma_1=(	relType_39=compound	lemma_26=[	pos_18=-RRB-	path2=acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_32=prochlorperazine	pos_6=NNP	lemma_29=,	pos_30=NNP	relType_11=punct	pos_32=-LRB-	lemma_48=Phenergan	lemma_22=g.	pos_7=,	relType_47=punct	pos_50=NN	pos_61=,	pos_14=NN	pos_62=NN	lemma_44=promethazine	relType_54=punct	relType_18=appos	pos_17=,	relType_42=punct	relType_62=conj	relType_34=dep	lemma_36=]	pos_38=NN	lemma_55=,	pos_60=-RRB-	lemma_62=triflupromazine	pos_29=,	lemma_31=,	relType_68=conj	lemma_39=e.	lemma_56=[	lemma_6=Tindal	lemma_32=[	relType_35=punct	lemma_53=,	pos_26=-LRB-	relType_62=punct	pos_54=-RRB-	pos_41=,	lemma_44=[	relType_20=punct	lemma_45=e.	relType_14=conj	pos_33=NN	lemma_43=,	lemma_42=Sparine	relType_23=punct	relType_27=compound	pos_18=NNP	lemma_68=trimeprazine	pos_25=,	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	lemma_58=g.	pos_43=,	lemma_10=g.	lemma_27=e.	pos_66=NNP	lemma_26=perphenazine	lemma_30=]	pos_36=-RRB-	pos_50=-LRB-	relType_9=compound	lemma_17=,	relType_26=conj	lemma_34=g.	relType_6=punct	lemma_6=]	lemma_18=Prolixin	pos_36=NNP	relType_48=appos	lemma_2=acetophenazine	relType_54=appos	lemma_68=[	relType_33=compound	pos_35=,	lemma_66=Vesprin	pos_4=NN	relType_51=compound	pos_67=,	pos_8=-LRB-	relType_31=punct	lemma_8=chlorpromazine	pos_44=-LRB-	lemma_38=promazine	relType_56=conj	pos_55=,	pos_15=NN	lemma_50=thioridazine	lemma_24=Serentil	relType_5=punct	wib=acetophenazine	lemma_2=[	relType_18=punct	relType_29=punct	lemma_28=g.	relType_40=dep	relType_70=appos	pos_11=,	lemma_12=thorazine	pos_53=,	relType_46=dep	relType_24=appos	pos_49=,	pos_24=-RRB-	lemma_69=e.	relType_50=punct	relType_60=punct	eib=True	relType_50=conj	pos_23=,	pos_3=NN	relType_7=punct	relType_16=dep	lemma_24=]	relType_36=appos	relType_66=appos	pos_63=NN	lemma_14=[	pos_12=NN	lemma_30=Trilafon	lemma_42=]	lemma_62=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e2	null	relType_3=dep	pos_2=NN	path=<acetophenazine_dep>g._dep>Tindal_appos	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Tindal_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e3	null	relType_3=dep	pos_2=NN	path1=	lemma_6=,	lib=e.	lemma_3=g.	pos_4=,	relType_6=punct	lemma_5=]	lemma_5=Tindal	relType_4=punct	pos_5=-RRB-	path=<acetophenazine_dep>chlorpromazine_conj	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct	path2=chlorpromazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e4	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	path1=	lemma_6=,	path=<acetophenazine_dep>chlorpromazine_conj>g._appos>thorazine_dep	lib=e.	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	lemma_7=chlorpromazine	pos_9=NN	relType_9=appos	lemma_7=[	lemma_5=]	lemma_5=Tindal	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	path2=chlorpromazine_conj>g._appos>thorazine_dep	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e5	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	path1=	lemma_6=,	lib=e.	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	lemma_11=thorazine	relType_11=punct	pos_12=,	path=<acetophenazine_dep>fluphenazine_conj	relType_12=punct	lemma_7=chlorpromazine	path2=fluphenazine_conj	pos_9=NN	relType_9=appos	lemma_7=[	lemma_5=]	lemma_5=Tindal	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_11=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e6	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	path1=	lemma_6=,	relType_13=punct	lib=e.	relType_14=compound	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	path2=fluphenazine_conj>g._dep>Prolixin_appos	relType_6=punct	lemma_11=thorazine	relType_11=punct	pos_12=,	lemma_14=e.	relType_15=dep	lemma_13=fluphenazine	pos_16=,	relType_12=punct	lemma_7=chlorpromazine	pos_13=NN	relType_13=conj	pos_9=NN	relType_9=appos	pos_14=NN	lemma_16=,	lemma_7=[	lemma_5=]	lemma_5=Tindal	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_11=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path=<acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e7	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	path1=	lemma_6=,	relType_13=punct	lib=e.	relType_14=compound	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	lemma_11=thorazine	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	lemma_13=fluphenazine	relType_12=punct	path2=mesoridazine_conj	lemma_7=chlorpromazine	pos_13=NN	pos_9=NN	relType_9=appos	relType_13=conj	pos_14=NN	lemma_16=,	lemma_7=[	lemma_5=]	lemma_5=Tindal	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_11=NN	pos_10=,	lemma_17=Prolixin	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	path=<acetophenazine_dep>mesoridazine_conj	lemma_8=e.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e8	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	path2=mesoridazine_conj>g._dep>Serentil_appos	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_19=mesoridazine	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_5=Tindal	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	pos_11=NN	relType_17=appos	relType_1=punct	pos_7=NN	path=<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_9=appos	relType_8=compound	lemma_1=[	relType_19=conj	relType_7=conj	relType_13=punct	relType_14=compound	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	pos_19=NN	lemma_7=chlorpromazine	lemma_5=]	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e9	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_19=mesoridazine	lemma_17=]	lemma_21=g.	path1=	lib=e.	path=<acetophenazine_dep>perphenazine_conj	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_5=Tindal	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	pos_11=NN	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_9=appos	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	path2=perphenazine_conj	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	relType_14=compound	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	pos_19=NN	lemma_7=chlorpromazine	lemma_5=]	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e10	null	path=<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	lemma_9=g.	lemma_25=perphenazine	lemma_28=,	lemma_13=[	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	pos_11=NN	relType_17=appos	relType_25=punct	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	path2=perphenazine_conj>g._dep>Trilafon_appos	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	relType_14=compound	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	lemma_5=]	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e11	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	path2=prochlorperazine_conj	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	lemma_9=g.	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	pos_11=NN	relType_17=appos	lemma_29=Trilafon	relType_25=punct	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NNP	pos_4=,	path=<acetophenazine_dep>prochlorperazine_conj	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	relType_14=compound	lemma_30=,	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	lemma_5=]	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e12	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	lemma_9=g.	relType_31=conj	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_5=Tindal	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	relType_33=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	path=<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	relType_14=compound	lemma_30=,	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e13	null	pos_2=NN	pos_24=,	lemma_10=,	path=<acetophenazine_dep>promazine_conj	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	path2=promazine_conj	lemma_5=Tindal	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	relType_33=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_29=appos	relType_8=compound	lemma_35=Compazine	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	relType_14=compound	lemma_30=,	relType_6=punct	lemma_11=thorazine	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e14	null	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	relType_37=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	relType_33=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_40=,	relType_24=punct	path=<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	relType_14=compound	lemma_30=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	path2=promazine_conj>g._dep>Sparine_appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e15	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	relType_37=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	relType_5=appos	relType_33=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	path=<acetophenazine_dep>promethazine_conj	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	lemma_41=Sparine	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_13=punct	relType_14=compound	lemma_30=,	path2=promethazine_conj	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e16	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	path=<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_5=Tindal	path2=promethazine_conj>g._dep>Phenergan_appos	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	relType_5=appos	relType_33=dep	relType_45=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_9=appos	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	relType_13=punct	relType_14=compound	lemma_30=,	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e17	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	relType_5=appos	path2=thioridazine_conj	relType_33=dep	relType_45=dep	pos_11=NN	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_9=appos	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	path=<acetophenazine_dep>thioridazine_conj	lemma_41=Sparine	lemma_43=promethazine	pos_47=NNP	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_14=compound	lemma_30=,	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e18	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	path=<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	relType_5=appos	relType_33=dep	relType_45=dep	pos_11=NN	pos_31=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_25=punct	relType_44=compound	relType_49=conj	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_9=appos	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e19	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Serentil	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	path=<acetophenazine_dep>trifluoperazine_conj	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_54=punct	relType_9=appos	pos_54=,	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=Mellaril	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e20	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	lemma_23=Serentil	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_55=trifluoperazine	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_55=punct	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_54=punct	relType_9=appos	lemma_58=,	pos_54=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	pos_38=NN	relType_8=compound	path=<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	pos_25=NN	lemma_35=Compazine	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=Mellaril	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e21	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	lemma_23=Serentil	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	lemma_59=stelazine	path=<acetophenazine_dep>triflupromazine_conj	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_55=trifluoperazine	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_55=punct	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	pos_59=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	path2=triflupromazine_conj	relType_59=dep	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_54=punct	relType_9=appos	lemma_58=,	pos_54=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=Mellaril	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e22	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	lemma_23=Serentil	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	pos_64=,	lemma_33=g.	lemma_47=]	relType_63=dep	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	lemma_59=stelazine	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	lemma_25=perphenazine	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_55=trifluoperazine	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	pos_61=-LRB-	pos_47=-RRB-	lib=e.	path=<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_64=punct	relType_55=punct	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	pos_59=NN	lemma_7=[	lemma_5=Tindal	pos_27=NN	pos_37=NN	pos_61=NN	relType_59=dep	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_61=[	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_61=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_61=triflupromazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_61=conj	relType_54=punct	pos_62=NN	relType_9=appos	lemma_58=,	pos_54=,	lemma_64=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	lemma_62=e.	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	lemma_63=g.	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	relType_62=compound	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=Mellaril	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	pos_17=-RRB-	pos_63=NN	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e23	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	lemma_23=Serentil	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	pos_64=,	lemma_33=g.	lemma_47=]	relType_63=dep	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	lemma_59=stelazine	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	pos_65=NNP	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	pos_65=-RRB-	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_55=trifluoperazine	lemma_25=[	lemma_17=]	lemma_21=g.	path1=	relType_65=punct	pos_61=-LRB-	pos_47=-RRB-	lib=e.	lemma_65=]	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_64=punct	relType_55=punct	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	pos_59=NN	lemma_7=[	path2=trimeprazine_conj	pos_66=,	lemma_5=Tindal	pos_27=NN	pos_37=NN	pos_61=NN	relType_59=dep	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_61=[	lemma_66=,	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_61=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_66=punct	lemma_61=triflupromazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_61=conj	relType_54=punct	pos_62=NN	relType_9=appos	lemma_58=,	pos_54=,	lemma_64=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	lemma_62=e.	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_31=[	path=<acetophenazine_dep>trimeprazine_conj	relType_27=dep	pos_35=NNP	lemma_63=g.	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_57=g.	relType_65=appos	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	relType_62=compound	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	lemma_65=Vesprin	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=Mellaril	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	pos_17=-RRB-	pos_63=NN	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e1	DDI-DrugBank.d179.s21.e24	null	relType_41=appos	lemma_47=Phenergan	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	pos_68=NN	lemma_23=Serentil	pos_55=NN	lemma_24=,	lemma_67=trimeprazine	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	pos_64=,	lemma_33=g.	lemma_47=]	relType_63=dep	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	lemma_59=stelazine	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	pos_70=,	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	relType_56=compound	pos_69=NN	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_68=compound	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	lemma_17=Prolixin	pos_10=,	relType_30=punct	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	pos_65=NNP	relType_36=punct	relType_34=punct	lemma_25=perphenazine	lemma_28=,	lemma_13=[	pos_34=,	pos_65=-RRB-	lemma_37=promazine	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	lemma_19=mesoridazine	relType_25=conj	lemma_55=trifluoperazine	lemma_25=[	lemma_67=[	lemma_17=]	lemma_21=g.	path1=	relType_65=punct	pos_61=-LRB-	pos_47=-RRB-	lib=e.	lemma_65=]	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_64=punct	relType_55=punct	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	pos_59=NN	relType_70=punct	lemma_7=[	pos_66=,	lemma_5=Tindal	pos_27=NN	pos_37=NN	pos_61=NN	relType_59=dep	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_61=[	lemma_66=,	relType_5=appos	relType_53=appos	relType_33=dep	relType_45=dep	pos_11=NN	relType_53=punct	pos_31=NN	relType_17=appos	lemma_29=Trilafon	lemma_38=e.	relType_44=compound	relType_25=punct	relType_61=punct	relType_49=conj	lemma_34=,	lemma_53=]	lemma_70=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	pos_53=NNP	relType_67=punct	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_66=punct	lemma_61=triflupromazine	relType_19=punct	pos_67=NN	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_61=conj	relType_54=punct	pos_62=NN	relType_9=appos	lemma_58=,	pos_54=,	lemma_64=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	pos_38=NN	relType_8=compound	lemma_35=Compazine	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	pos_67=-LRB-	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_49=thioridazine	lemma_62=e.	pos_36=,	pos_40=,	lemma_43=promethazine	lemma_41=Sparine	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	lemma_63=g.	relType_23=appos	lemma_31=prochlorperazine	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_57=g.	lemma_69=g.	relType_65=appos	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	relType_14=compound	lemma_30=,	pos_49=-LRB-	relType_62=compound	lemma_42=,	relType_6=punct	lemma_11=thorazine	relType_38=compound	pos_16=,	lemma_13=fluphenazine	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_7=chlorpromazine	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	pos_18=,	lemma_65=Vesprin	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	relType_69=appos	path=<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	pos_6=,	relType_39=dep	relType_46=punct	lemma_53=Mellaril	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	relType_67=conj	lemma_68=e.	pos_17=-RRB-	pos_63=NN	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e3	null	path=Tindal_appos<g._dep<acetophenazine_dep>chlorpromazine_conj	lpib=chlorpromazine_NN	eib=False	pos_1=-RRB-	lemma_1=]	pos_2=,	relType_1=punct	wib=chlorpromazine	relType_2=punct	lib=chlorpromazine	lemma_2=,	path1=Tindal_appos<g._dep	path2=chlorpromazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e4	null	lemma_3=[	lemma_6=,	wib=chlorpromazine	lib=chlorpromazine	relType_2=punct	relType_6=punct	lemma_4=e.	path=Tindal_appos<g._dep<acetophenazine_dep>chlorpromazine_conj>g._appos>thorazine_dep	lemma_1=]	pos_3=-LRB-	pos_4=NN	lemma_2=,	path1=Tindal_appos<g._dep	relType_3=conj	pos_1=-RRB-	relType_4=compound	relType_5=appos	pos_6=,	pos_5=NN	lpib=chlorpromazine_NN	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	lemma_3=chlorpromazine	relType_1=punct	path2=chlorpromazine_conj>g._appos>thorazine_dep	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e5	null	lemma_3=[	lemma_6=,	relType_8=punct	wib=chlorpromazine	lemma_8=,	lib=chlorpromazine	relType_2=punct	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	pos_3=-LRB-	path2=fluphenazine_conj	pos_4=NN	lemma_2=,	lemma_7=thorazine	path1=Tindal_appos<g._dep	relType_3=conj	pos_1=-RRB-	relType_4=compound	pos_7=-RRB-	relType_5=appos	pos_6=,	pos_5=NN	relType_7=dep	lpib=chlorpromazine_NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	path=Tindal_appos<g._dep<acetophenazine_dep>fluphenazine_conj	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e6	null	lemma_3=[	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	wib=chlorpromazine	lemma_8=,	lib=chlorpromazine	relType_2=punct	lemma_12=,	path2=fluphenazine_conj>g._dep>Prolixin_appos	relType_6=punct	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	lemma_9=fluphenazine	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	pos_9=NN	pos_4=NN	lemma_2=,	lemma_7=thorazine	path1=Tindal_appos<g._dep	relType_3=conj	path=Tindal_appos<g._dep<acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos	pos_1=-RRB-	lemma_11=g.	relType_4=compound	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	relType_5=appos	pos_6=,	pos_5=NN	pos_11=NN	relType_7=dep	lpib=chlorpromazine_NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e7	null	lemma_3=[	relType_14=punct	relType_9=conj	relType_13=punct	lemma_6=,	lemma_9=[	relType_8=punct	wib=chlorpromazine	lemma_8=,	lib=chlorpromazine	pos_13=NNP	relType_2=punct	lemma_12=,	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_9=fluphenazine	relType_10=compound	path2=mesoridazine_conj	pos_3=-LRB-	pos_10=NN	pos_9=NN	pos_4=NN	lemma_2=,	lemma_7=thorazine	relType_12=punct	path1=Tindal_appos<g._dep	relType_3=conj	pos_1=-RRB-	lemma_11=g.	relType_4=compound	lemma_13=Prolixin	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	relType_5=appos	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lpib=chlorpromazine_NN	eib=True	pos_3=NN	relType_7=punct	path=Tindal_appos<g._dep<acetophenazine_dep>mesoridazine_conj	pos_2=,	lemma_5=g.	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e8	null	lemma_3=[	relType_14=punct	relType_9=conj	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	wib=chlorpromazine	lemma_8=,	lib=chlorpromazine	path=Tindal_appos<g._dep<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	pos_13=NNP	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_16=e.	lemma_9=fluphenazine	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	pos_9=NN	pos_4=NN	lemma_2=,	lemma_7=thorazine	relType_15=punct	path1=Tindal_appos<g._dep	path2=mesoridazine_conj>g._dep>Serentil_appos	relType_17=dep	pos_18=,	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	lemma_11=g.	relType_4=compound	relType_18=punct	lemma_13=Prolixin	relType_11=dep	pos_9=-LRB-	lemma_15=mesoridazine	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	relType_5=appos	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lpib=chlorpromazine_NN	eib=True	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e9	null	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	lemma_15=mesoridazine	pos_2=,	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	path=Tindal_appos<g._dep<acetophenazine_dep>perphenazine_conj	pos_9=-LRB-	pos_13=-RRB-	lpib=chlorpromazine_NN	path2=perphenazine_conj	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	path1=Tindal_appos<g._dep	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e10	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	lemma_15=mesoridazine	pos_2=,	relType_21=punct	path=Tindal_appos<g._dep<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	lemma_21=[	pos_22=NN	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lemma_3=chlorpromazine	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	path2=perphenazine_conj>g._dep>Trilafon_appos	lemma_5=g.	path1=Tindal_appos<g._dep	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	lemma_21=perphenazine	pos_18=,	pos_15=NN	lemma_18=,	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e11	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	path2=prochlorperazine_conj	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	lemma_15=mesoridazine	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	path=Tindal_appos<g._dep<acetophenazine_dep>prochlorperazine_conj	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	relType_25=punct	lemma_3=chlorpromazine	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	path1=Tindal_appos<g._dep	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	lemma_21=perphenazine	pos_18=,	pos_15=NN	lemma_18=,	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e12	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	path=Tindal_appos<g._dep<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	lemma_15=mesoridazine	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_27=prochlorperazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	pos_27=-LRB-	relType_25=punct	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	path1=Tindal_appos<g._dep	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	lemma_21=perphenazine	relType_28=compound	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	lemma_18=,	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e13	null	relType_22=compound	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	lemma_31=]	pos_31=-RRB-	lemma_15=mesoridazine	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_27=prochlorperazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	path2=promazine_conj	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	pos_27=-LRB-	relType_25=punct	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	path1=Tindal_appos<g._dep	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	path=Tindal_appos<g._dep<acetophenazine_dep>promazine_conj	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e14	null	relType_22=compound	relType_33=conj	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_27=prochlorperazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	path=Tindal_appos<g._dep<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	path2=promazine_conj>g._dep>Sparine_appos	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e15	null	relType_22=compound	relType_33=conj	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	path=Tindal_appos<g._dep<acetophenazine_dep>promethazine_conj	lemma_15=mesoridazine	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	path2=promethazine_conj	pos_13=NNP	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e16	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	lemma_7=thorazine	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	path=Tindal_appos<g._dep<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	lemma_21=[	pos_22=NN	lemma_39=promethazine	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	pos_5=NN	lemma_14=,	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e17	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	path=Tindal_appos<g._dep<acetophenazine_dep>thioridazine_conj	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	path2=thioridazine_conj	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e18	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	path=Tindal_appos<g._dep<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e19	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	pos_38=,	lemma_31=]	path2=trifluoperazine_conj	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	relType_5=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	pos_14=,	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	path=Tindal_appos<g._dep<acetophenazine_dep>trifluoperazine_conj	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e20	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_52=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	lemma_53=g.	pos_38=,	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	path=Tindal_appos<g._dep<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	lemma_51=trifluoperazine	lemma_54=,	relType_5=appos	relType_53=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_51=-LRB-	pos_37=NNP	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e21	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_52=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	pos_55=NN	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	relType_55=dep	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	lemma_53=g.	pos_38=,	pos_55=-RRB-	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	path2=triflupromazine_conj	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	lemma_51=trifluoperazine	lemma_54=,	relType_5=appos	relType_53=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	path=Tindal_appos<g._dep<acetophenazine_dep>triflupromazine_conj	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_51=-LRB-	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	lemma_55=stelazine	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_52=NN	pos_24=,	lemma_58=e.	lemma_6=,	relType_32=punct	pos_57=NN	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	pos_55=NN	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	relType_55=dep	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	lemma_53=g.	pos_38=,	pos_55=-RRB-	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	wib=chlorpromazine	lib=chlorpromazine	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	pos_59=NN	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	path=Tindal_appos<g._dep<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_59=dep	pos_1=-RRB-	lemma_47=g.	lemma_60=,	relType_11=dep	relType_57=conj	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	lemma_51=trifluoperazine	lemma_54=,	relType_5=appos	relType_53=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	lemma_57=[	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	pos_58=NN	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_57=-LRB-	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_51=-LRB-	pos_37=NNP	pos_36=,	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_57=triflupromazine	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	lemma_55=stelazine	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	lemma_59=g.	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_60=,	pos_4=NN	pos_20=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	relType_60=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	relType_58=compound	pos_19=NNP	lemma_26=,	lemma_36=,	relType_57=punct	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_52=NN	pos_24=,	lemma_58=e.	lemma_6=,	relType_32=punct	pos_57=NN	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	pos_55=NN	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	relType_55=dep	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	lemma_53=g.	pos_38=,	pos_55=-RRB-	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_61=Vesprin	lemma_15=mesoridazine	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	wib=chlorpromazine	pos_62=,	lib=chlorpromazine	lemma_25=]	lemma_61=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	pos_59=NN	relType_23=dep	path2=trimeprazine_conj	pos_53=NN	pos_27=NN	pos_32=,	relType_59=dep	pos_1=-RRB-	lemma_47=g.	lemma_60=,	relType_11=dep	relType_57=conj	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	lemma_51=trifluoperazine	lemma_54=,	relType_5=appos	relType_53=appos	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_61=punct	lemma_57=[	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	path=Tindal_appos<g._dep<acetophenazine_dep>trimeprazine_conj	lemma_3=[	relType_14=punct	pos_58=NN	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_57=-LRB-	pos_61=-RRB-	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_51=-LRB-	pos_37=NNP	pos_61=NNP	pos_36=,	relType_62=punct	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_57=triflupromazine	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	lemma_55=stelazine	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	pos_21=-LRB-	lemma_42=,	lemma_59=g.	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_60=,	pos_4=NN	pos_20=,	lemma_62=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_61=appos	relType_50=punct	relType_60=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	relType_58=compound	pos_19=NNP	lemma_26=,	lemma_36=,	relType_57=punct	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e2	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	pos_49=-RRB-	relType_33=conj	pos_39=NN	pos_34=NN	lemma_31=Compazine	pos_52=NN	pos_24=,	lemma_58=e.	lemma_6=,	relType_32=punct	pos_57=NN	pos_63=-LRB-	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	pos_55=NN	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_25=Trilafon	pos_47=NN	relType_55=dep	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	path=Tindal_appos<g._dep<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_9=fluphenazine	pos_3=-LRB-	pos_10=NN	relType_43=punct	lemma_7=thorazine	lemma_53=g.	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_38=,	pos_55=-RRB-	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	lemma_61=Vesprin	lemma_15=mesoridazine	pos_33=-LRB-	pos_65=NN	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	relType_63=conj	relType_64=compound	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_43=Phenergan	lemma_28=e.	lemma_27=prochlorperazine	relType_37=punct	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	lemma_39=promethazine	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	wib=chlorpromazine	pos_62=,	lib=chlorpromazine	lemma_25=]	lemma_61=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_33=promazine	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	pos_59=NN	pos_64=NN	relType_23=dep	pos_66=,	pos_53=NN	pos_27=NN	pos_32=,	relType_59=dep	pos_1=-RRB-	lemma_47=g.	lemma_60=,	lemma_63=trimeprazine	lemma_65=g.	relType_11=dep	relType_57=conj	pos_16=NN	lemma_19=Serentil	pos_7=-RRB-	lemma_35=g.	lemma_51=trifluoperazine	lemma_54=,	relType_5=appos	relType_53=appos	lemma_66=,	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	relType_7=dep	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_61=punct	lemma_57=[	relType_29=dep	lemma_3=chlorpromazine	pos_30=,	relType_26=punct	relType_1=punct	pos_7=NN	lemma_37=Sparine	pos_50=,	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	pos_58=NN	lemma_49=Mellaril	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	relType_66=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	relType_49=appos	lemma_63=[	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	lemma_13=Prolixin	pos_57=-LRB-	pos_61=-RRB-	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_45=thioridazine	pos_51=-LRB-	pos_37=NNP	pos_61=NNP	pos_36=,	relType_62=punct	lpib=chlorpromazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_57=triflupromazine	lemma_5=g.	relType_27=punct	pos_43=NNP	lemma_37=]	relType_65=appos	path1=Tindal_appos<g._dep	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	lemma_55=stelazine	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_64=e.	pos_21=-LRB-	lemma_42=,	lemma_59=g.	relType_63=punct	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_60=,	pos_4=NN	pos_20=,	lemma_62=,	relType_31=punct	lemma_21=perphenazine	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_41=g.	relType_9=punct	pos_6=,	relType_61=appos	relType_50=punct	relType_60=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	relType_58=compound	pos_63=NN	pos_19=NNP	lemma_26=,	lemma_36=,	relType_57=punct	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e4	null	pos_2=NN	path2=g._appos>thorazine_dep	path1=	lib=e.	lemma_3=g.	eib=False	relType_3=appos	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	path=<chlorpromazine_conj>g._appos>thorazine_dep	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e5	null	pos_2=NN	lemma_6=,	lib=e.	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	lemma_5=thorazine	path1=chlorpromazine_conj	path2=fluphenazine_conj	relType_5=dep	lemma_5=]	path=chlorpromazine_conj<acetophenazine_dep>fluphenazine_conj	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e6	null	path=chlorpromazine_conj<acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_7=fluphenazine	lemma_3=g.	relType_3=appos	pos_4=,	path2=fluphenazine_conj>g._dep>Prolixin_appos	relType_6=punct	lemma_5=thorazine	path1=chlorpromazine_conj	relType_5=dep	pos_9=NN	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_6=,	pos_5=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e7	null	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lemma_11=Prolixin	pos_11=NNP	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_7=fluphenazine	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	path2=mesoridazine_conj	lemma_5=thorazine	path1=chlorpromazine_conj	relType_5=dep	pos_9=NN	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	path=chlorpromazine_conj<acetophenazine_dep>mesoridazine_conj	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_5=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e8	null	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	lemma_11=Prolixin	pos_11=NNP	lemma_13=mesoridazine	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_7=fluphenazine	lemma_3=g.	path=chlorpromazine_conj<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_3=appos	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	lemma_5=thorazine	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	pos_9=NN	relType_13=conj	pos_14=NN	lemma_16=,	lemma_7=[	lemma_5=]	path2=mesoridazine_conj>g._dep>Serentil_appos	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_16=punct	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_5=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e9	null	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	lemma_11=Prolixin	pos_11=NNP	lemma_13=mesoridazine	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_7=fluphenazine	pos_17=NNP	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	path=chlorpromazine_conj<acetophenazine_dep>perphenazine_conj	relType_11=punct	pos_12=,	lemma_14=e.	relType_15=dep	pos_16=,	relType_12=punct	lemma_5=thorazine	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	pos_9=NN	relType_13=conj	pos_14=NN	lemma_16=,	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_16=punct	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_5=NN	pos_10=,	eib=True	path2=perphenazine_conj	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e10	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	pos_5=NN	relType_17=appos	relType_1=punct	pos_7=NN	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	path=chlorpromazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	lemma_1=[	relType_19=conj	path2=perphenazine_conj>g._dep>Trilafon_appos	relType_7=conj	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	lemma_7=fluphenazine	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e11	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	path2=prochlorperazine_conj	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	path=chlorpromazine_conj<acetophenazine_dep>prochlorperazine_conj	pos_10=,	lemma_9=g.	lemma_13=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_17=appos	relType_1=punct	pos_7=NN	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	lemma_7=fluphenazine	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e12	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	path=chlorpromazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_28=,	lemma_13=[	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_17=appos	relType_25=punct	relType_1=punct	pos_7=NN	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	lemma_7=fluphenazine	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e13	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	lemma_16=,	pos_13=NN	path1=chlorpromazine_conj	path=chlorpromazine_conj<acetophenazine_dep>promazine_conj	relType_5=dep	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_28=,	lemma_13=[	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	path2=promazine_conj	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_17=appos	relType_25=punct	pos_30=,	relType_1=punct	pos_7=NN	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e14	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_31=promazine	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_19=perphenazine	path=chlorpromazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	path2=promazine_conj>g._dep>Sparine_appos	relType_11=appos	pos_15=NN	pos_18=,	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e15	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_31=promazine	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	path=chlorpromazine_conj<acetophenazine_dep>promethazine_conj	lemma_20=e.	relType_17=punct	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	path2=promethazine_conj	lemma_29=Compazine	lemma_7=fluphenazine	relType_6=punct	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e16	null	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	path=chlorpromazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_31=promazine	lemma_7=[	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_23=Trilafon	pos_5=NN	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e17	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_31=promazine	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_41=Phenergan	path2=thioridazine_conj	lemma_23=Trilafon	pos_5=NN	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	path=chlorpromazine_conj<acetophenazine_dep>thioridazine_conj	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e18	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	path=chlorpromazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	pos_31=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e19	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	path=chlorpromazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_47=NNP	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e20	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_51=g.	relType_31=conj	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_27=NN	pos_37=NN	lemma_49=trifluoperazine	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	path=chlorpromazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	pos_40=,	pos_47=NNP	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e21	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_37=promethazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_51=g.	relType_31=conj	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_53=NN	pos_27=NN	pos_37=NN	lemma_49=trifluoperazine	path2=triflupromazine_conj	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_53=dep	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_54=punct	pos_54=,	relType_42=punct	lemma_37=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	pos_53=-RRB-	path=chlorpromazine_conj<acetophenazine_dep>triflupromazine_conj	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_47=NNP	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=stelazine	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e22	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	lemma_37=promethazine	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	relType_57=dep	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_51=g.	relType_31=conj	lemma_52=,	relType_36=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_55=punct	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_53=NN	pos_27=NN	pos_37=NN	lemma_49=trifluoperazine	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_53=dep	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_54=punct	lemma_58=,	pos_54=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	pos_53=-RRB-	path=chlorpromazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_47=NNP	relType_58=punct	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_55=triflupromazine	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=stelazine	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e23	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	lemma_37=promethazine	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	lemma_16=,	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	relType_43=punct	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	relType_57=dep	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_51=g.	relType_31=conj	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	lemma_59=Vesprin	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_55=punct	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	path=chlorpromazine_conj<acetophenazine_dep>trimeprazine_conj	lemma_7=[	path2=trimeprazine_conj	pos_53=NN	pos_27=NN	pos_37=NN	lemma_49=trifluoperazine	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_41=Phenergan	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_53=dep	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_54=punct	lemma_58=,	pos_54=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	pos_53=-RRB-	relType_59=appos	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_47=NNP	pos_59=NNP	relType_58=punct	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_55=triflupromazine	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_29=Compazine	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=stelazine	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e3	DDI-DrugBank.d179.s21.e24	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_59=-RRB-	lemma_37=promethazine	pos_55=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	relType_59=punct	pos_19=-LRB-	relType_28=punct	pos_64=,	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	path1=chlorpromazine_conj	relType_5=dep	lemma_16=,	relType_43=punct	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	pos_5=-RRB-	lemma_59=]	pos_22=,	pos_35=-RRB-	lemma_35=Sparine	pos_32=NN	relType_57=dep	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_51=g.	relType_31=conj	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_25=conj	lemma_25=[	path=chlorpromazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_17=]	lemma_21=g.	lemma_43=thioridazine	lemma_59=Vesprin	pos_61=-LRB-	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_64=punct	relType_55=punct	lemma_22=,	relType_12=punct	lemma_5=thorazine	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_31=promazine	lemma_7=[	pos_53=NN	pos_27=NN	pos_37=NN	lemma_49=trifluoperazine	pos_61=NN	relType_63=appos	lemma_15=g.	lemma_19=[	lemma_60=,	lemma_2=e.	lpib=e._NN	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_41=Phenergan	lemma_61=[	lemma_23=Trilafon	pos_5=NN	relType_33=dep	relType_45=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_61=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	lemma_61=trimeprazine	relType_1=punct	pos_7=NN	relType_35=appos	relType_53=dep	lemma_19=perphenazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	lemma_11=Prolixin	relType_24=punct	lemma_13=mesoridazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_3=appos	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_61=conj	pos_14=NN	pos_62=NN	relType_54=punct	lemma_58=,	pos_54=,	lemma_64=,	relType_42=punct	lemma_37=[	lemma_55=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	pos_53=-RRB-	relType_59=appos	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_62=e.	pos_36=,	pos_40=,	pos_47=NNP	pos_59=NNP	relType_58=punct	pos_23=-RRB-	lemma_47=Mellaril	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	lemma_63=g.	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_55=triflupromazine	lemma_57=g.	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	pos_56=NN	relType_47=appos	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_29=Compazine	relType_62=compound	lemma_7=fluphenazine	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_60=,	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_17=Serentil	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	lemma_53=stelazine	relType_60=punct	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_25=prochlorperazine	lemma_11=]	lemma_36=,	pos_63=NN	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e5	null	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>fluphenazine_conj	path1=thorazine_dep<g._appos<chlorpromazine_conj	eib=False	lpib=fluphenazine_NN	pos_1=-RRB-	lib=fluphenazine	lemma_1=]	pos_2=,	wib=fluphenazine	relType_1=punct	path2=fluphenazine_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e6	null	lemma_3=fluphenazine	lemma_3=[	lemma_6=,	relType_2=punct	lpib=fluphenazine_NN	path2=fluphenazine_conj>g._dep>Prolixin_appos	lemma_4=e.	relType_6=punct	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	relType_3=conj	pos_1=-RRB-	relType_4=compound	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>fluphenazine_conj>g._dep>Prolixin_appos	pos_6=,	pos_5=NN	eib=True	pos_3=NN	lib=fluphenazine	pos_2=,	lemma_5=g.	wib=fluphenazine	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e7	null	lemma_3=fluphenazine	lemma_3=[	relType_7=appos	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lpib=fluphenazine_NN	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>mesoridazine_conj	lemma_4=e.	relType_6=punct	lemma_1=]	lemma_7=]	path2=mesoridazine_conj	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	lib=fluphenazine	pos_2=,	lemma_5=g.	wib=fluphenazine	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e8	null	lemma_3=fluphenazine	lemma_3=[	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	lpib=fluphenazine_NN	relType_6=punct	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	path2=mesoridazine_conj>g._dep>Serentil_appos	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	lemma_9=mesoridazine	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lib=fluphenazine	pos_2=,	lemma_5=g.	wib=fluphenazine	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e9	null	lemma_3=fluphenazine	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	relType_13=punct	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>perphenazine_conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	lpib=fluphenazine_NN	relType_6=punct	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_13=Serentil	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	lemma_9=mesoridazine	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	path2=perphenazine_conj	pos_3=NN	relType_7=punct	lib=fluphenazine	pos_2=,	lemma_5=g.	wib=fluphenazine	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e10	null	lemma_3=fluphenazine	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	lpib=fluphenazine_NN	relType_6=punct	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	lemma_16=e.	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_13=Serentil	relType_15=punct	relType_17=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	pos_18=,	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	lemma_15=perphenazine	pos_6=,	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lib=fluphenazine	relType_15=conj	lemma_17=g.	pos_2=,	path2=perphenazine_conj>g._dep>Trilafon_appos	lemma_5=g.	wib=fluphenazine	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e11	null	lemma_6=,	relType_8=punct	path2=prochlorperazine_conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	pos_2=,	lemma_3=fluphenazine	lemma_9=[	relType_2=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Serentil	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>prochlorperazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e12	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	pos_2=,	relType_21=punct	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Serentil	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e13	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	pos_2=,	relType_21=punct	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	lemma_9=[	lemma_25=]	relType_2=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	path2=promazine_conj	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_25=punct	relType_26=punct	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_19=appos	relType_15=punct	lemma_13=Serentil	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>promazine_conj	pos_13=-RRB-	lemma_23=g.	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e14	null	relType_22=compound	lemma_27=promazine	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_19=appos	relType_15=punct	lemma_13=Serentil	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_28=compound	path2=promazine_conj>g._dep>Sparine_appos	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e15	null	relType_22=compound	lemma_27=promazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	pos_28=NN	relType_30=punct	pos_2=,	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>promethazine_conj	relType_21=punct	lemma_28=e.	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_19=appos	relType_15=punct	lemma_13=Serentil	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	path2=promethazine_conj	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e16	null	relType_22=compound	lemma_27=promazine	relType_33=conj	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	pos_32=,	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_35=dep	relType_24=punct	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_19=punct	lemma_8=,	lemma_33=promethazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_19=appos	relType_15=punct	lemma_13=Serentil	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e17	null	relType_22=compound	lemma_27=promazine	relType_33=conj	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	path2=thioridazine_conj	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	relType_15=punct	lemma_13=Serentil	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>thioridazine_conj	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e18	null	relType_22=compound	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_3=fluphenazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_2=punct	relType_31=appos	relType_38=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_15=punct	lemma_13=Serentil	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e19	null	relType_22=compound	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	path2=trifluoperazine_conj	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	lemma_43=Mellaril	pos_1=-RRB-	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_15=punct	lemma_13=Serentil	relType_42=punct	lemma_29=g.	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e20	null	relType_22=compound	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	lemma_43=Mellaril	pos_1=-RRB-	lemma_47=g.	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	lemma_45=trifluoperazine	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_15=punct	lemma_13=Serentil	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e21	null	relType_22=compound	pos_49=-RRB-	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	relType_49=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_49=stelazine	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	lemma_43=Mellaril	path2=triflupromazine_conj	pos_1=-RRB-	lemma_47=g.	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	lemma_45=trifluoperazine	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	relType_49=dep	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_15=punct	lemma_13=Serentil	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>triflupromazine_conj	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	pos_49=-RRB-	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_52=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	lemma_53=g.	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	lemma_7=Prolixin	relType_51=conj	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	lemma_51=triflupromazine	relType_39=conj	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_36=punct	relType_52=compound	lemma_28=e.	relType_37=punct	relType_49=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_49=stelazine	lpib=fluphenazine_NN	relType_13=appos	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	lemma_43=Mellaril	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	pos_1=-RRB-	lemma_47=g.	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_54=,	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	lemma_45=trifluoperazine	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	relType_3=punct	relType_53=dep	lemma_27=[	pos_8=,	relType_49=dep	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	relType_51=punct	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_54=punct	relType_15=punct	lemma_13=Serentil	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_51=-LRB-	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	pos_49=-RRB-	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_52=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_55=appos	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	lemma_53=g.	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	pos_55=-RRB-	lemma_7=Prolixin	relType_51=conj	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	lemma_51=triflupromazine	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	relType_52=compound	lemma_28=e.	relType_37=punct	relType_49=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_49=stelazine	lpib=fluphenazine_NN	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	path2=trimeprazine_conj	pos_53=NN	pos_27=NN	pos_32=,	lemma_43=Mellaril	pos_55=NNP	pos_1=-RRB-	lemma_47=g.	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>trimeprazine_conj	relType_11=dep	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_54=,	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	lemma_45=trifluoperazine	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	relType_3=punct	relType_53=dep	lemma_27=[	pos_8=,	relType_49=dep	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	lemma_55=Vesprin	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	relType_51=punct	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_54=punct	relType_15=punct	lemma_13=Serentil	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_51=-LRB-	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_4=NN	pos_20=,	relType_31=punct	lemma_37=Phenergan	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e4	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	pos_49=-RRB-	lemma_27=promazine	relType_33=conj	pos_39=NN	pos_34=NN	pos_52=NN	pos_24=,	lemma_58=e.	lemma_6=,	relType_32=punct	relType_55=appos	pos_57=NN	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_56=,	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	lemma_19=Trilafon	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	lemma_53=g.	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_38=,	path1=thorazine_dep<g._appos<chlorpromazine_conj	pos_55=-RRB-	lemma_7=Prolixin	relType_51=conj	lemma_21=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	lemma_51=triflupromazine	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	relType_52=compound	lemma_28=e.	relType_37=punct	relType_49=punct	lemma_3=fluphenazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_56=punct	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lemma_49=stelazine	lpib=fluphenazine_NN	relType_13=appos	relType_55=punct	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	pos_59=NN	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	lemma_43=Mellaril	pos_55=NNP	pos_1=-RRB-	lemma_47=g.	lemma_60=,	relType_11=dep	relType_57=conj	lemma_9=mesoridazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_54=,	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	lemma_45=trifluoperazine	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	lemma_57=[	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	relType_3=punct	relType_53=dep	lemma_27=[	pos_8=,	relType_49=dep	lemma_3=[	relType_14=punct	relType_7=appos	pos_58=NN	lemma_15=[	lemma_40=e.	pos_56=,	relType_35=dep	relType_24=punct	lemma_55=Vesprin	relType_19=punct	lemma_8=,	lemma_33=promethazine	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	relType_51=punct	lemma_16=e.	lemma_25=Compazine	relType_37=appos	relType_19=appos	lemma_39=[	relType_54=punct	relType_15=punct	lemma_13=Serentil	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	relType_59=appos	pos_57=-LRB-	pos_9=-LRB-	lemma_15=perphenazine	pos_13=-RRB-	lemma_23=g.	pos_51=-LRB-	pos_37=NNP	pos_36=,	lib=fluphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	wib=fluphenazine	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	lemma_55=]	lemma_57=trimeprazine	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_31=Sparine	pos_21=-LRB-	lemma_42=,	lemma_59=g.	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	lemma_50=,	lemma_52=e.	pos_60=,	pos_4=NN	pos_20=,	path=thorazine_dep<g._appos<chlorpromazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_31=punct	relType_28=compound	lemma_37=Phenergan	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_39=thioridazine	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	relType_60=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	relType_58=compound	pos_19=NNP	lemma_26=,	lemma_36=,	relType_57=punct	pos_19=-RRB-	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e6	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path=<fluphenazine_conj>g._dep>Prolixin_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	path2=g._dep>Prolixin_appos	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e7	null	relType_3=dep	pos_2=NN	path=fluphenazine_conj<acetophenazine_dep>mesoridazine_conj	lemma_6=,	path1=fluphenazine_conj	lib=e.	lemma_3=g.	pos_4=,	relType_6=punct	path2=mesoridazine_conj	lemma_5=]	relType_4=punct	pos_5=-RRB-	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e8	null	relType_3=dep	relType_10=punct	pos_2=NN	pos_7=NN	lemma_10=,	lemma_6=,	path1=fluphenazine_conj	lib=e.	lemma_7=mesoridazine	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=[	lemma_5=]	path2=mesoridazine_conj>g._dep>Serentil_appos	relType_4=punct	pos_5=-RRB-	lemma_5=Prolixin	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path=fluphenazine_conj<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_1=punct	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e9	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	path1=fluphenazine_conj	lib=e.	lemma_7=mesoridazine	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	lemma_5=Prolixin	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_11=Serentil	relType_5=appos	pos_1=-LRB-	path=fluphenazine_conj<acetophenazine_dep>perphenazine_conj	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	path2=perphenazine_conj	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e10	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	path1=fluphenazine_conj	lib=e.	lemma_13=perphenazine	relType_14=compound	lemma_7=mesoridazine	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	path=fluphenazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	pos_12=,	lemma_14=e.	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_5=Prolixin	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_11=Serentil	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_13=-LRB-	pos_11=-RRB-	relType_16=punct	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path2=perphenazine_conj>g._dep>Trilafon_appos	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e11	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	pos_11=NNP	path1=fluphenazine_conj	path2=prochlorperazine_conj	lib=e.	lemma_13=perphenazine	relType_14=compound	lemma_7=mesoridazine	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_5=Prolixin	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_18=,	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	path=fluphenazine_conj<acetophenazine_dep>prochlorperazine_conj	lemma_11=Serentil	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_13=-LRB-	pos_11=-RRB-	relType_16=punct	pos_10=,	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	pos_17=-RRB-	lemma_17=Trilafon	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e12	null	pos_2=NN	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	lemma_19=prochlorperazine	relType_8=compound	lemma_1=[	relType_19=conj	lemma_17=Trilafon	relType_7=conj	relType_13=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	path=fluphenazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e13	null	lemma_23=Compazine	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	path=fluphenazine_conj<acetophenazine_dep>promazine_conj	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	path2=promazine_conj	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	lemma_19=prochlorperazine	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_17=Trilafon	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e14	null	lemma_23=Compazine	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_25=promazine	lemma_9=g.	lemma_28=,	lemma_13=[	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_17=appos	relType_25=punct	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_19=prochlorperazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_17=Trilafon	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	path2=promazine_conj>g._dep>Sparine_appos	relType_11=appos	pos_15=NN	pos_18=,	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	path=fluphenazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e15	null	lemma_23=Compazine	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	lemma_9=g.	lemma_28=,	lemma_13=[	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_17=appos	relType_25=punct	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	path=fluphenazine_conj<acetophenazine_dep>promethazine_conj	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_29=appos	lemma_19=prochlorperazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_17=Trilafon	relType_27=dep	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	relType_9=dep	path2=promethazine_conj	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e16	null	lemma_23=Compazine	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	lemma_9=g.	relType_31=conj	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	path=fluphenazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_29=appos	lemma_19=prochlorperazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_17=Trilafon	relType_27=dep	lemma_31=[	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e17	null	lemma_23=Compazine	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	path2=thioridazine_conj	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_29=appos	lemma_19=prochlorperazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_23=-RRB-	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	lemma_35=Phenergan	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	relType_6=punct	path=fluphenazine_conj<acetophenazine_dep>thioridazine_conj	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e18	null	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	path=fluphenazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	lemma_37=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_37=thioridazine	relType_13=punct	lemma_35=Phenergan	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e19	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_42=punct	lemma_37=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	lemma_37=thioridazine	relType_13=punct	lemma_35=Phenergan	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	lemma_42=,	relType_6=punct	path=fluphenazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e20	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_42=punct	lemma_37=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_45=appos	lemma_37=thioridazine	pos_45=NN	relType_13=punct	lemma_35=Phenergan	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	lemma_42=,	path=fluphenazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_43=trifluoperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e21	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_47=NN	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	path=fluphenazine_conj<acetophenazine_dep>triflupromazine_conj	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	pos_27=NN	pos_37=NN	path2=triflupromazine_conj	lemma_15=g.	lemma_19=[	lemma_47=stelazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	lemma_29=Sparine	relType_42=punct	lemma_37=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_45=appos	relType_47=dep	lemma_37=thioridazine	pos_45=NN	relType_13=punct	lemma_35=Phenergan	relType_48=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_43=trifluoperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_48=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e22	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_47=NN	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	lemma_49=triflupromazine	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_47=stelazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_11=Serentil	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	lemma_29=Sparine	relType_42=punct	lemma_37=[	path=fluphenazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_19=prochlorperazine	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_45=appos	relType_47=dep	lemma_37=thioridazine	pos_45=NN	pos_51=NN	relType_13=punct	lemma_35=Phenergan	relType_48=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	pos_49=-LRB-	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_43=trifluoperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e23	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_47=NN	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	pos_47=-RRB-	lib=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	lemma_22=,	lemma_49=triflupromazine	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	path2=trimeprazine_conj	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_47=stelazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_11=Serentil	relType_5=appos	relType_53=appos	relType_33=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_53=Vesprin	pos_53=NNP	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_54=punct	pos_54=,	lemma_29=Sparine	relType_42=punct	lemma_37=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	path=fluphenazine_conj<acetophenazine_dep>trimeprazine_conj	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_45=appos	relType_47=dep	lemma_37=thioridazine	pos_45=NN	pos_51=NN	relType_13=punct	lemma_35=Phenergan	relType_48=punct	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	pos_49=-LRB-	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_43=trifluoperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e5	DDI-DrugBank.d179.s21.e24	null	relType_41=appos	lemma_23=Compazine	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_57=NN	pos_55=NN	lemma_7=mesoridazine	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_47=NN	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	relType_56=compound	relType_4=punct	lemma_41=Mellaril	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_25=promazine	lemma_29=]	pos_37=-LRB-	relType_37=conj	lemma_9=g.	pos_42=,	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	pos_47=-RRB-	lib=e.	lemma_56=e.	pos_8=NN	lemma_23=]	lemma_49=[	lemma_3=g.	relType_55=punct	lemma_22=,	lemma_49=triflupromazine	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_47=stelazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	lemma_54=,	lemma_11=Serentil	relType_5=appos	relType_53=appos	relType_33=dep	relType_53=punct	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	lemma_53=]	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	lemma_53=Vesprin	pos_53=NNP	relType_10=punct	lemma_55=trimeprazine	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	lemma_13=perphenazine	relType_19=punct	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	pos_58=,	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	relType_51=dep	pos_14=NN	relType_54=punct	lemma_58=,	pos_54=,	lemma_29=Sparine	relType_42=punct	lemma_37=[	lemma_55=[	relType_29=appos	lemma_19=prochlorperazine	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	pos_53=-RRB-	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	pos_36=,	pos_40=,	relType_58=punct	pos_23=-RRB-	lemma_41=]	lemma_17=Trilafon	relType_27=dep	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	lemma_48=,	relType_7=conj	relType_50=compound	pos_23=NNP	relType_23=punct	pos_41=NNP	pos_29=-RRB-	relType_45=appos	lemma_57=g.	relType_47=dep	lemma_37=thioridazine	pos_45=NN	pos_51=NN	relType_13=punct	lemma_35=Phenergan	relType_48=punct	pos_56=NN	pos_11=NNP	path1=fluphenazine_conj	relType_14=compound	lemma_30=,	lemma_31=promethazine	relType_9=dep	pos_49=-LRB-	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	lemma_43=trifluoperazine	pos_28=,	relType_31=punct	path=fluphenazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_5=Prolixin	relType_2=compound	relType_5=punct	lemma_18=,	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	pos_55=-LRB-	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	relType_55=conj	pos_3=NN	relType_7=punct	relType_57=appos	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e7	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lpib=mesoridazine_NN	lib=mesoridazine	eib=False	pos_1=-RRB-	lemma_1=]	pos_2=,	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>mesoridazine_conj	path2=mesoridazine_conj	relType_1=punct	wib=mesoridazine	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e8	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_3=[	lemma_6=,	lemma_3=mesoridazine	relType_2=punct	lpib=mesoridazine_NN	lib=mesoridazine	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>mesoridazine_conj>g._dep>Serentil_appos	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path2=mesoridazine_conj>g._dep>Serentil_appos	relType_3=conj	pos_1=-RRB-	relType_4=compound	pos_6=,	pos_5=NN	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	wib=mesoridazine	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e9	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_3=[	relType_7=appos	lemma_6=,	lemma_3=mesoridazine	relType_8=punct	lemma_8=,	relType_2=punct	lpib=mesoridazine_NN	lib=mesoridazine	lemma_7=Serentil	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>perphenazine_conj	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	pos_6=,	pos_5=NN	eib=True	path2=perphenazine_conj	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	wib=mesoridazine	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e10	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_3=[	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	lemma_3=mesoridazine	relType_8=punct	lemma_8=,	lemma_9=perphenazine	relType_2=punct	lpib=mesoridazine_NN	lib=mesoridazine	lemma_12=,	lemma_7=Serentil	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	path2=perphenazine_conj>g._dep>Trilafon_appos	lemma_5=g.	relType_1=punct	wib=mesoridazine	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e11	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	relType_13=punct	lemma_6=,	lemma_9=[	lemma_3=mesoridazine	path2=prochlorperazine_conj	relType_8=punct	lemma_8=,	lemma_9=perphenazine	relType_2=punct	pos_13=NNP	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>prochlorperazine_conj	lpib=mesoridazine_NN	lib=mesoridazine	lemma_12=,	lemma_7=Serentil	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	lemma_13=Trilafon	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e12	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	lemma_3=mesoridazine	relType_8=punct	lemma_8=,	lemma_9=perphenazine	relType_2=punct	pos_13=NNP	lpib=mesoridazine_NN	lib=mesoridazine	lemma_12=,	pos_15=-LRB-	lemma_7=Serentil	pos_17=NN	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_16=e.	relType_17=dep	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_15=punct	pos_18=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	lemma_15=prochlorperazine	pos_16=NN	pos_7=-RRB-	lemma_13=Trilafon	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e13	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	lemma_19=Compazine	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_19=-RRB-	pos_2=,	lemma_9=[	relType_2=punct	lpib=mesoridazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	path2=promazine_conj	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	wib=mesoridazine	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_17=NN	pos_15=-LRB-	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	lib=mesoridazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>promazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e14	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_22=compound	lemma_19=Compazine	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	lpib=mesoridazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	wib=mesoridazine	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	path2=promazine_conj>g._dep>Sparine_appos	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e15	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	lemma_19=Compazine	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	lemma_25=]	relType_2=punct	lpib=mesoridazine_NN	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_25=punct	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>promethazine_conj	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	path2=promethazine_conj	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e16	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	lemma_19=Compazine	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e17	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	lemma_19=Compazine	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_31=]	pos_31=-RRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	path2=thioridazine_conj	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>thioridazine_conj	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e18	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_33=conj	lemma_19=Compazine	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_25=]	relType_2=punct	relType_31=appos	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e19	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_33=conj	lemma_19=Compazine	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	lemma_31=]	path2=trifluoperazine_conj	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>trifluoperazine_conj	lemma_15=[	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_14=,	lemma_16=e.	relType_37=appos	relType_19=appos	relType_15=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_15=prochlorperazine	lemma_13=Trilafon	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e20	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_41=appos	relType_33=conj	pos_39=NN	lemma_19=Compazine	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_39=trifluoperazine	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_15=prochlorperazine	lemma_13=Trilafon	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e21	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_41=appos	relType_33=conj	pos_39=NN	lemma_19=Compazine	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>triflupromazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	path2=triflupromazine_conj	relType_43=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_39=trifluoperazine	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	pos_44=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_43=NN	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	lemma_1=]	lemma_43=stelazine	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	lemma_15=prochlorperazine	lemma_13=Trilafon	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e22	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_41=appos	relType_33=conj	pos_39=NN	lemma_19=Compazine	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_45=triflupromazine	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	relType_43=dep	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_39=trifluoperazine	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	pos_44=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_43=NN	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_1=]	lemma_43=stelazine	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_15=prochlorperazine	lemma_13=Trilafon	lemma_41=g.	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e23	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_41=appos	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>trimeprazine_conj	relType_33=conj	pos_39=NN	lemma_19=Compazine	pos_34=NN	pos_49=-RRB-	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_45=triflupromazine	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	path2=trimeprazine_conj	pos_27=NN	pos_32=,	relType_43=dep	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_39=trifluoperazine	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	pos_44=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_39=-LRB-	relType_49=appos	pos_14=,	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_43=NN	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	lemma_1=]	lemma_43=stelazine	relType_10=compound	lemma_50=,	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_15=prochlorperazine	lemma_13=Trilafon	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_49=Vesprin	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e6	DDI-DrugBank.d179.s21.e24	null	path1=Prolixin_appos<g._dep<fluphenazine_conj	relType_22=compound	relType_41=appos	pos_49=-RRB-	relType_33=conj	pos_39=NN	lemma_19=Compazine	pos_34=NN	pos_52=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_31=Phenergan	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	lemma_53=g.	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_38=,	relType_51=conj	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lemma_43=]	relType_52=compound	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_45=triflupromazine	relType_49=punct	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	lpib=mesoridazine_NN	lemma_27=promethazine	relType_13=appos	relType_17=dep	lemma_51=[	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	pos_53=NN	pos_27=NN	pos_32=,	relType_43=dep	pos_1=-RRB-	lemma_47=g.	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	lemma_54=,	relType_53=appos	lemma_39=trifluoperazine	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	lemma_51=trimeprazine	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	pos_50=,	relType_26=punct	relType_1=punct	wib=mesoridazine	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_3=mesoridazine	relType_19=punct	lemma_8=,	pos_44=,	lemma_9=perphenazine	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lemma_21=promazine	lemma_7=Serentil	pos_39=-LRB-	relType_49=appos	pos_14=,	relType_51=punct	pos_49=NNP	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_54=punct	relType_15=punct	pos_54=,	relType_42=punct	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_43=NN	pos_51=-LRB-	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	path=Prolixin_appos<g._dep<fluphenazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_13=]	pos_33=NN	lemma_48=,	relType_47=dep	relType_9=conj	pos_25=-RRB-	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_16=compound	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_25=Sparine	pos_21=-LRB-	lib=mesoridazine	lemma_42=,	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_37=Mellaril	lemma_1=]	lemma_43=stelazine	relType_10=compound	lemma_50=,	lemma_52=e.	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	lemma_49=]	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	lemma_15=prochlorperazine	lemma_13=Trilafon	lemma_41=g.	relType_9=punct	pos_6=,	relType_50=punct	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_49=Vesprin	pos_19=NNP	lemma_26=,	lemma_36=,	lemma_33=thioridazine	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e8	null	relType_3=dep	pos_2=NN	path1=	lib=e.	path2=g._dep>Serentil_appos	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct	path=<mesoridazine_conj>g._dep>Serentil_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e9	null	relType_3=dep	pos_2=NN	lemma_5=Serentil	lemma_6=,	path=mesoridazine_conj<acetophenazine_dep>perphenazine_conj	lib=e.	lemma_3=g.	pos_4=,	relType_6=punct	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	path2=perphenazine_conj	pos_3=NN	relType_1=punct	path1=mesoridazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e10	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_5=Serentil	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	lemma_7=perphenazine	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path=mesoridazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	path2=perphenazine_conj>g._dep>Trilafon_appos	relType_1=punct	pos_7=NN	path1=mesoridazine_conj	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e11	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_5=Serentil	lemma_6=,	pos_11=NNP	path2=prochlorperazine_conj	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=[	lemma_5=]	lemma_11=Trilafon	relType_11=appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	lemma_7=perphenazine	pos_3=NN	relType_7=punct	lemma_9=g.	path=mesoridazine_conj<acetophenazine_dep>prochlorperazine_conj	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	path1=mesoridazine_conj	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e12	null	relType_3=dep	path=mesoridazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	relType_10=punct	pos_2=NN	lemma_13=prochlorperazine	lemma_10=,	lemma_5=Serentil	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	lemma_11=Trilafon	relType_11=appos	path2=prochlorperazine_conj>g._dep>Compazine_appos	relType_4=punct	pos_5=-RRB-	pos_15=NN	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	lemma_7=perphenazine	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	path1=mesoridazine_conj	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e13	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_13=prochlorperazine	pos_7=NN	lemma_17=]	lemma_10=,	lemma_5=Serentil	relType_13=punct	lemma_6=,	relType_17=punct	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	path2=promazine_conj	lemma_5=]	lemma_11=Trilafon	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	lemma_7=perphenazine	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_17=Compazine	pos_17=-RRB-	lemma_11=]	path=mesoridazine_conj<acetophenazine_dep>promazine_conj	relType_1=punct	lemma_13=[	path1=mesoridazine_conj	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e14	null	pos_2=NN	lemma_19=promazine	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_17=Compazine	lemma_13=[	relType_3=dep	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_11=Trilafon	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_1=punct	pos_7=NN	path=mesoridazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	path1=mesoridazine_conj	relType_7=conj	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	path2=promazine_conj>g._dep>Sparine_appos	relType_11=appos	pos_15=NN	pos_18=,	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e15	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_17=Compazine	lemma_13=[	relType_3=dep	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_11=Trilafon	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_23=appos	path1=mesoridazine_conj	relType_7=conj	path=mesoridazine_conj<acetophenazine_dep>promethazine_conj	pos_23=NNP	relType_23=punct	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	path2=promethazine_conj	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e16	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_17=Compazine	lemma_28=,	lemma_13=[	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_11=Trilafon	pos_27=NN	path2=promethazine_conj>g._dep>Phenergan_appos	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_25=punct	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_27=dep	relType_23=appos	path1=mesoridazine_conj	relType_7=conj	pos_23=NNP	relType_23=punct	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	path=mesoridazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e17	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_17=Compazine	lemma_28=,	lemma_13=[	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_11=Trilafon	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path2=thioridazine_conj	relType_17=appos	relType_25=punct	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_27=dep	relType_23=appos	path1=mesoridazine_conj	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	path=mesoridazine_conj<acetophenazine_dep>thioridazine_conj	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e18	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	path=mesoridazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_11=Trilafon	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_33=dep	pos_31=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e19	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_11=Trilafon	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	lemma_35=Mellaril	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_25=promethazine	path=mesoridazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	pos_36=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e20	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	path=mesoridazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	relType_37=conj	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_11=Trilafon	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_37=trifluoperazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	lemma_35=Mellaril	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_40=,	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	relType_39=appos	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e21	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_41=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_41=stelazine	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	lemma_11=Trilafon	pos_27=NN	pos_37=NN	path2=triflupromazine_conj	lemma_15=g.	lemma_19=[	lemma_37=trifluoperazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	relType_5=appos	lemma_35=Mellaril	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	relType_39=appos	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	path=mesoridazine_conj<acetophenazine_dep>triflupromazine_conj	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	relType_41=dep	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e22	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_41=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	lemma_43=triflupromazine	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	lemma_46=,	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_36=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_41=stelazine	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_11=Trilafon	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_37=trifluoperazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	relType_5=appos	lemma_35=Mellaril	relType_33=dep	relType_45=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	path=mesoridazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	relType_39=appos	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	pos_45=NN	relType_13=punct	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	relType_41=dep	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e23	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_41=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	lemma_39=g.	relType_22=punct	lemma_43=triflupromazine	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	lemma_46=,	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_17=Compazine	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	pos_47=-RRB-	lib=e.	lemma_47=Vesprin	pos_8=NN	lemma_23=]	lemma_41=stelazine	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	path2=trimeprazine_conj	lemma_11=Trilafon	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_37=trifluoperazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	relType_5=appos	lemma_35=Mellaril	relType_33=dep	relType_45=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	relType_39=appos	pos_36=,	pos_40=,	pos_47=NNP	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	lemma_48=,	pos_23=NNP	relType_23=punct	pos_29=-RRB-	lemma_13=prochlorperazine	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	pos_11=NNP	path=mesoridazine_conj<acetophenazine_dep>trimeprazine_conj	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	relType_41=dep	lemma_11=]	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e7	DDI-DrugBank.d179.s21.e24	null	lemma_23=Sparine	pos_2=NN	lemma_19=promazine	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_41=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_47=]	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	lemma_43=triflupromazine	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_31=thioridazine	pos_1=-LRB-	lemma_46=,	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	lemma_17=Compazine	relType_31=conj	lemma_51=g.	lemma_52=,	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	relType_49=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_5=Serentil	lemma_21=g.	pos_47=-RRB-	lib=e.	lemma_47=Vesprin	pos_8=NN	lemma_23=]	lemma_41=stelazine	lemma_49=[	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	lemma_11=Trilafon	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_37=trifluoperazine	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	relType_5=appos	lemma_35=Mellaril	relType_33=dep	relType_45=dep	path=mesoridazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_44=compound	relType_25=punct	relType_49=conj	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	lemma_40=,	relType_24=punct	relType_19=punct	lemma_25=promethazine	pos_17=NNP	relType_40=punct	pos_4=,	pos_50=NN	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	relType_47=punct	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_51=appos	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	relType_52=punct	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	relType_39=appos	pos_36=,	pos_40=,	pos_47=NNP	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	pos_35=NNP	relType_23=appos	path1=mesoridazine_conj	pos_33=NN	relType_7=conj	lemma_48=,	pos_23=NNP	relType_23=punct	relType_50=compound	pos_29=-RRB-	lemma_49=trimeprazine	lemma_13=prochlorperazine	pos_45=NN	pos_51=NN	relType_13=punct	relType_48=punct	relType_47=appos	pos_11=NNP	lemma_29=Phenergan	relType_14=compound	lemma_30=,	relType_9=dep	pos_49=-LRB-	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_48=,	pos_52=,	relType_43=conj	pos_13=-LRB-	pos_6=,	relType_46=punct	eib=True	lemma_7=perphenazine	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	relType_41=dep	lemma_11=]	lemma_36=,	lemma_43=[	lemma_50=e.	pos_49=NN	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e9	null	wib=perphenazine	lib=perphenazine	eib=False	path2=perphenazine_conj	pos_1=-RRB-	lpib=perphenazine_NN	lemma_1=]	lemma_2=,	pos_2=,	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_1=punct	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>perphenazine_conj	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e10	null	lemma_3=[	lemma_6=,	relType_2=punct	lib=perphenazine	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	wib=perphenazine	relType_3=conj	pos_1=-RRB-	relType_4=compound	path1=Serentil_appos<g._dep<mesoridazine_conj	pos_6=,	pos_5=NN	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>perphenazine_conj>g._dep>Trilafon_appos	eib=True	pos_3=NN	lpib=perphenazine_NN	lemma_3=perphenazine	pos_2=,	path2=perphenazine_conj>g._dep>Trilafon_appos	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e11	null	lemma_3=[	relType_7=appos	lemma_6=,	relType_8=punct	path2=prochlorperazine_conj	lemma_8=,	relType_2=punct	lemma_7=Trilafon	lib=perphenazine	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	wib=perphenazine	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	path1=Serentil_appos<g._dep<mesoridazine_conj	pos_7=-RRB-	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>prochlorperazine_conj	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	lpib=perphenazine_NN	lemma_3=perphenazine	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e12	null	lemma_3=[	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	relType_2=punct	lemma_7=Trilafon	lemma_12=,	lib=perphenazine	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_9=prochlorperazine	path2=prochlorperazine_conj>g._dep>Compazine_appos	wib=perphenazine	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	path1=Serentil_appos<g._dep<mesoridazine_conj	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lpib=perphenazine_NN	lemma_3=perphenazine	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e13	null	lemma_3=[	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>promazine_conj	relType_14=punct	relType_7=appos	relType_9=conj	relType_13=punct	lemma_6=,	lemma_9=[	relType_8=punct	lemma_13=Compazine	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_7=Trilafon	lemma_12=,	lib=perphenazine	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	path2=promazine_conj	lemma_9=prochlorperazine	wib=perphenazine	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	path1=Serentil_appos<g._dep<mesoridazine_conj	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	lpib=perphenazine_NN	lemma_3=perphenazine	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e14	null	lemma_3=[	relType_14=punct	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_7=appos	relType_9=conj	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	lemma_13=Compazine	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_7=Trilafon	lemma_12=,	pos_17=NN	pos_15=-LRB-	lib=perphenazine	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_16=e.	relType_17=dep	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_15=punct	lemma_9=prochlorperazine	path2=promazine_conj>g._dep>Sparine_appos	pos_18=,	pos_15=NN	wib=perphenazine	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	pos_16=NN	path1=Serentil_appos<g._dep<mesoridazine_conj	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	lpib=perphenazine_NN	lemma_3=perphenazine	relType_15=conj	pos_2=,	lemma_5=g.	lemma_17=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e15	null	lemma_19=Sparine	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>promethazine_conj	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	lpib=perphenazine_NN	pos_2=,	lemma_9=[	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	wib=perphenazine	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	lemma_13=Compazine	path2=promethazine_conj	lemma_7=Trilafon	pos_13=NNP	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e16	null	relType_22=compound	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	lpib=perphenazine_NN	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	path2=promethazine_conj>g._dep>Phenergan_appos	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	relType_13=punct	relType_16=compound	lemma_13=Compazine	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e17	null	relType_22=compound	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	lpib=perphenazine_NN	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	lemma_25=]	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	path2=thioridazine_conj	pos_5=NN	lemma_14=,	pos_11=NN	relType_25=punct	relType_26=punct	relType_1=punct	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>thioridazine_conj	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e18	null	relType_22=compound	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	pos_28=NN	relType_30=punct	lpib=perphenazine_NN	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	wib=perphenazine	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_27=thioridazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e19	null	relType_22=compound	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	lemma_31=]	path2=trifluoperazine_conj	pos_31=-RRB-	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_28=NN	relType_30=punct	lpib=perphenazine_NN	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	lemma_13=]	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e20	null	relType_22=compound	relType_33=conj	pos_34=NN	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_9=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	lpib=perphenazine_NN	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_21=[	pos_22=NN	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_27=conj	lemma_9=[	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	lemma_33=trifluoperazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_36=,	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	lemma_13=]	pos_33=NN	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e21	null	relType_22=compound	relType_33=conj	pos_34=NN	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	lemma_9=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	lpib=perphenazine_NN	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_37=dep	relType_23=dep	pos_27=NN	pos_37=NN	pos_32=,	path2=triflupromazine_conj	pos_1=-RRB-	relType_11=dep	lemma_33=trifluoperazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	lemma_37=stelazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	path1=Serentil_appos<g._dep<mesoridazine_conj	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>triflupromazine_conj	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	lemma_9=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	lpib=perphenazine_NN	relType_39=conj	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_37=dep	relType_23=dep	pos_27=NN	pos_37=NN	pos_32=,	pos_1=-RRB-	lemma_39=triflupromazine	relType_11=dep	lemma_33=trifluoperazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_24=punct	relType_19=punct	lemma_8=,	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	lemma_37=]	lemma_13=]	pos_33=NN	lemma_37=stelazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_42=,	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	path1=Serentil_appos<g._dep<mesoridazine_conj	lemma_41=g.	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>trimeprazine_conj	relType_5=dep	relType_43=punct	pos_38=,	lemma_9=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	lpib=perphenazine_NN	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	pos_9=NN	lemma_38=,	lemma_2=,	relType_37=dep	relType_23=dep	path2=trimeprazine_conj	pos_27=NN	pos_37=NN	pos_32=,	pos_1=-RRB-	lemma_39=triflupromazine	relType_11=dep	lemma_33=trifluoperazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_43=Vesprin	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_37=stelazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_42=,	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	path1=Serentil_appos<g._dep<mesoridazine_conj	lemma_41=g.	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e8	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_19=Sparine	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	pos_47=NN	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_43=punct	relType_5=dep	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_38=,	lemma_9=prochlorperazine	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_46=NN	pos_28=NN	lemma_45=[	relType_30=punct	pos_42=,	relType_45=punct	lpib=perphenazine_NN	lemma_43=]	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	lemma_44=,	pos_22=NN	relType_27=conj	relType_46=compound	lemma_9=[	relType_40=compound	relType_39=punct	lemma_31=Mellaril	lemma_25=]	relType_2=punct	relType_31=appos	relType_38=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_46=e.	pos_9=NN	lemma_38=,	lemma_2=,	relType_37=dep	relType_23=dep	pos_27=NN	pos_37=NN	pos_32=,	pos_1=-RRB-	lemma_39=triflupromazine	lemma_47=g.	relType_11=dep	lemma_33=trifluoperazine	pos_16=NN	pos_7=-RRB-	lemma_35=g.	relType_44=punct	pos_5=NN	lemma_14=,	pos_43=-RRB-	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_45=conj	pos_40=NN	relType_29=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_24=punct	relType_19=punct	lemma_8=,	pos_44=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	lib=perphenazine	pos_14=,	lemma_16=e.	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	wib=perphenazine	relType_3=conj	lemma_11=g.	lemma_43=Vesprin	path=Serentil_appos<g._dep<mesoridazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_21=promethazine	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	pos_36=,	lemma_3=perphenazine	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_25=Phenergan	relType_27=punct	pos_43=NNP	lemma_37=]	lemma_13=]	pos_33=NN	lemma_45=trimeprazine	lemma_48=,	lemma_37=stelazine	relType_9=conj	pos_25=-RRB-	pos_45=NN	relType_13=punct	relType_48=punct	relType_47=appos	relType_16=compound	lemma_13=Compazine	lemma_30=,	pos_45=-LRB-	pos_13=NNP	lemma_7=Trilafon	pos_21=-LRB-	lemma_42=,	lemma_27=thioridazine	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_43=appos	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	pos_48=,	path1=Serentil_appos<g._dep<mesoridazine_conj	lemma_41=g.	relType_9=punct	pos_6=,	lemma_15=promazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	relType_41=dep	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e10	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	path2=g._dep>Trilafon_appos	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	path=<perphenazine_conj>g._dep>Trilafon_appos	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e11	null	relType_3=dep	pos_2=NN	lemma_6=,	path2=prochlorperazine_conj	lib=e.	path1=perphenazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	lemma_5=]	path=perphenazine_conj<acetophenazine_dep>prochlorperazine_conj	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	lemma_5=Trilafon	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e12	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	path1=perphenazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=prochlorperazine	lemma_7=[	lemma_5=]	path2=prochlorperazine_conj>g._dep>Compazine_appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	pos_3=NN	lemma_5=Trilafon	relType_7=punct	lemma_8=e.	lemma_9=g.	relType_1=punct	pos_7=NN	path=perphenazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e13	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	lib=e.	path1=perphenazine_conj	relType_9=dep	path=perphenazine_conj<acetophenazine_dep>promazine_conj	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=prochlorperazine	lemma_7=[	path2=promazine_conj	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_11=Compazine	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	lemma_5=Trilafon	relType_7=punct	lemma_8=e.	lemma_9=g.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e14	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	path1=perphenazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	lemma_13=promazine	path=perphenazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	relType_12=punct	pos_13=NN	relType_13=conj	pos_9=NN	pos_14=NN	lemma_16=,	lemma_7=prochlorperazine	lemma_7=[	lemma_5=]	path2=promazine_conj>g._dep>Sparine_appos	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_11=Compazine	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	lemma_5=Trilafon	relType_7=punct	lemma_8=e.	lemma_9=g.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e15	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	path1=perphenazine_conj	relType_9=dep	path2=promethazine_conj	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	lemma_17=Sparine	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	lemma_13=promazine	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=prochlorperazine	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_11=Compazine	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	relType_17=appos	pos_3=NN	lemma_5=Trilafon	relType_7=punct	path=perphenazine_conj<acetophenazine_dep>promethazine_conj	lemma_8=e.	lemma_9=g.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e16	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	path2=promethazine_conj>g._dep>Phenergan_appos	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	lemma_5=Trilafon	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	relType_7=conj	lemma_19=promethazine	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	path=perphenazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_6=punct	pos_16=,	lemma_13=promazine	pos_19=NN	lemma_7=prochlorperazine	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e17	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	path=perphenazine_conj<acetophenazine_dep>thioridazine_conj	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path2=thioridazine_conj	relType_17=appos	lemma_5=Trilafon	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_23=appos	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	lemma_13=promazine	pos_19=NN	lemma_7=prochlorperazine	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e18	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_28=,	lemma_13=[	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	lemma_5=Trilafon	relType_25=punct	path=perphenazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_25=thioridazine	pos_23=-RRB-	relType_27=dep	relType_23=appos	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e19	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_28=,	lemma_13=[	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	lemma_5=Trilafon	relType_25=punct	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	path=perphenazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_25=thioridazine	pos_23=-RRB-	relType_27=dep	relType_23=appos	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e20	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path=perphenazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	pos_31=NN	relType_17=appos	lemma_5=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_31=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	path2=trifluoperazine_conj>g._appos>stelazine_dep	lemma_25=thioridazine	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_33=appos	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e21	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_35=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	path=perphenazine_conj<acetophenazine_dep>triflupromazine_conj	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	path2=triflupromazine_conj	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	pos_31=NN	relType_17=appos	lemma_5=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_31=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	relType_35=dep	relType_24=punct	relType_19=punct	path1=perphenazine_conj	pos_17=NNP	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	lemma_25=thioridazine	pos_36=,	lemma_35=stelazine	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_33=appos	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	lemma_35=]	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e22	null	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_35=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	path=perphenazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	pos_31=NN	relType_17=appos	lemma_38=e.	lemma_5=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_31=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	relType_35=dep	relType_24=punct	lemma_40=,	relType_19=punct	lemma_37=triflupromazine	path1=perphenazine_conj	pos_17=NNP	relType_40=punct	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	lemma_25=thioridazine	pos_36=,	pos_40=,	lemma_35=stelazine	pos_23=-RRB-	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_33=appos	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e23	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_35=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	lemma_39=g.	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	path2=trimeprazine_conj	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	relType_5=appos	pos_31=NN	relType_17=appos	lemma_38=e.	lemma_5=Trilafon	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_31=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	relType_35=dep	relType_24=punct	lemma_40=,	relType_19=punct	lemma_37=triflupromazine	path1=perphenazine_conj	pos_17=NNP	relType_40=punct	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	lemma_25=thioridazine	pos_36=,	pos_40=,	lemma_35=stelazine	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	pos_41=NNP	relType_33=appos	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	lemma_41=Vesprin	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	pos_6=,	relType_39=dep	eib=True	relType_20=compound	path=perphenazine_conj<acetophenazine_dep>trimeprazine_conj	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_23=Phenergan	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e9	DDI-DrugBank.d179.s21.e24	null	relType_41=appos	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	pos_35=NN	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_46=,	pos_26=NN	pos_13=NN	lemma_16=,	relType_43=punct	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	lemma_43=trimeprazine	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_46=,	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	pos_42=,	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	pos_34=,	lemma_45=g.	relType_37=punct	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_29=Mellaril	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	pos_44=NN	lemma_7=[	pos_27=NN	pos_37=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_41=punct	lemma_44=e.	relType_5=appos	pos_31=NN	relType_17=appos	lemma_38=e.	lemma_5=Trilafon	relType_44=compound	relType_25=punct	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	lemma_31=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	pos_41=-RRB-	relType_35=dep	relType_24=punct	lemma_40=,	relType_19=punct	lemma_37=triflupromazine	path1=perphenazine_conj	pos_17=NNP	relType_40=punct	pos_4=,	lemma_17=Sparine	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_42=punct	lemma_37=[	relType_29=appos	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_43=NN	relType_35=punct	pos_43=-LRB-	lemma_25=thioridazine	pos_36=,	pos_40=,	lemma_35=stelazine	pos_23=-RRB-	lemma_41=]	lemma_31=[	relType_27=dep	relType_23=appos	pos_33=NN	relType_7=conj	lemma_19=promethazine	pos_23=NNP	relType_23=punct	pos_29=-RRB-	pos_41=NNP	relType_45=appos	relType_33=appos	pos_45=NN	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	lemma_42=,	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	lemma_13=promazine	pos_19=NN	pos_25=-LRB-	lemma_7=prochlorperazine	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	lemma_41=Vesprin	relType_18=punct	relType_29=punct	lemma_11=Compazine	pos_13=-LRB-	relType_43=conj	pos_6=,	relType_46=punct	relType_39=dep	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	path=perphenazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_23=Phenergan	lemma_36=,	lemma_43=[	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e11	null	lib=prochlorperazine	eib=False	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>prochlorperazine_conj	pos_1=-RRB-	path1=Trilafon_appos<g._dep<perphenazine_conj	wib=prochlorperazine	lpib=prochlorperazine_NN	lemma_1=]	pos_2=,	path2=prochlorperazine_conj	relType_1=punct	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e12	null	lemma_3=[	lemma_6=,	relType_2=punct	lemma_3=prochlorperazine	lib=prochlorperazine	relType_6=punct	lemma_4=e.	path1=Trilafon_appos<g._dep<perphenazine_conj	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path2=prochlorperazine_conj>g._dep>Compazine_appos	relType_3=conj	pos_1=-RRB-	wib=prochlorperazine	relType_4=compound	lpib=prochlorperazine_NN	pos_6=,	pos_5=NN	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>prochlorperazine_conj>g._dep>Compazine_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e13	null	lemma_3=[	relType_7=appos	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lemma_3=prochlorperazine	lib=prochlorperazine	relType_6=punct	lemma_4=e.	path1=Trilafon_appos<g._dep<perphenazine_conj	lemma_1=]	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path2=promazine_conj	relType_3=conj	pos_1=-RRB-	pos_7=NNP	wib=prochlorperazine	relType_4=compound	lpib=prochlorperazine_NN	pos_7=-RRB-	pos_6=,	lemma_7=Compazine	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e14	null	lemma_3=[	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	lemma_3=prochlorperazine	lib=prochlorperazine	relType_6=punct	lemma_10=e.	lemma_4=e.	path1=Trilafon_appos<g._dep<perphenazine_conj	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	pos_9=NN	path2=promazine_conj>g._dep>Sparine_appos	relType_3=conj	pos_1=-RRB-	pos_7=NNP	wib=prochlorperazine	relType_4=compound	lpib=prochlorperazine_NN	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	lemma_7=Compazine	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_9=promazine	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e15	null	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	relType_13=punct	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	path2=promethazine_conj	relType_2=punct	pos_13=NNP	lemma_13=Sparine	lemma_12=,	lemma_3=prochlorperazine	lib=prochlorperazine	relType_6=punct	lemma_10=e.	lemma_4=e.	path1=Trilafon_appos<g._dep<perphenazine_conj	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>promethazine_conj	relType_3=conj	pos_1=-RRB-	pos_7=NNP	wib=prochlorperazine	relType_4=compound	lpib=prochlorperazine_NN	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	lemma_7=Compazine	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	lemma_9=promazine	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e16	null	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	lemma_15=[	lemma_15=promethazine	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_13=Sparine	lemma_12=,	pos_17=NN	pos_15=-LRB-	lemma_3=prochlorperazine	lib=prochlorperazine	relType_6=punct	lemma_10=e.	lemma_4=e.	path1=Trilafon_appos<g._dep<perphenazine_conj	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	lemma_16=e.	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_15=punct	relType_17=dep	path2=promethazine_conj>g._dep>Phenergan_appos	pos_18=,	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	wib=prochlorperazine	relType_4=compound	lpib=prochlorperazine_NN	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	lemma_7=Compazine	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_1=punct	relType_3=punct	lemma_13=]	lemma_9=promazine	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e17	null	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_2=,	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>thioridazine_conj	lemma_9=[	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	path2=thioridazine_conj	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	lemma_13=Sparine	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	lemma_9=promazine	relType_9=conj	lemma_15=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	relType_9=punct	pos_6=,	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e18	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_2=,	relType_21=punct	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	lemma_9=promazine	relType_9=conj	lemma_15=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e19	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path2=trifluoperazine_conj	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	lemma_25=]	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_25=punct	lemma_25=Mellaril	relType_26=punct	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	lemma_9=promazine	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e20	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	lemma_27=trifluoperazine	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	lemma_25=Mellaril	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	path2=trifluoperazine_conj>g._appos>stelazine_dep	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	lemma_9=promazine	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e21	null	relType_22=compound	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_31=]	pos_31=-RRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	path2=triflupromazine_conj	lemma_27=trifluoperazine	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_31=NN	pos_27=-LRB-	relType_25=punct	lemma_25=Mellaril	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_31=stelazine	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_11=g.	pos_9=-LRB-	relType_31=dep	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	lemma_9=promazine	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>triflupromazine_conj	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	lemma_32=,	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	relType_33=conj	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_36=punct	lemma_28=e.	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	lemma_33=triflupromazine	pos_9=NN	lemma_2=,	relType_23=dep	pos_27=NN	pos_32=,	lemma_27=trifluoperazine	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	pos_31=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	lemma_25=Mellaril	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_31=stelazine	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_11=g.	pos_9=-LRB-	relType_31=dep	pos_13=-RRB-	lemma_23=g.	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	lemma_9=promazine	pos_33=NN	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_3=prochlorperazine	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	lemma_32=,	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	relType_33=conj	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_38=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_33=triflupromazine	pos_9=NN	lemma_38=,	lemma_2=,	relType_23=dep	path2=trimeprazine_conj	pos_27=NN	pos_32=,	lemma_27=trifluoperazine	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	pos_31=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	lemma_25=Mellaril	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_35=dep	relType_24=punct	relType_19=punct	lemma_8=,	lemma_31=stelazine	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	relType_19=appos	relType_15=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_11=g.	pos_9=-LRB-	relType_31=dep	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	lemma_9=promazine	pos_33=NN	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_37=Vesprin	lemma_3=prochlorperazine	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>trimeprazine_conj	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	lemma_32=,	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e10	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	relType_41=appos	relType_33=conj	pos_39=NN	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	pos_41=NN	relType_34=compound	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lib=prochlorperazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_38=,	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	pos_28=NN	relType_30=punct	pos_42=,	relType_39=conj	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	relType_37=punct	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	relType_40=compound	relType_39=punct	lemma_25=]	relType_2=punct	relType_38=punct	path1=Trilafon_appos<g._dep<perphenazine_conj	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_37=-RRB-	lemma_33=triflupromazine	pos_9=NN	lemma_38=,	lemma_2=,	path=Trilafon_appos<g._dep<perphenazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_23=dep	pos_27=NN	pos_32=,	lemma_27=trifluoperazine	pos_1=-RRB-	lpib=prochlorperazine_NN	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	pos_31=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	pos_40=NN	lemma_25=Mellaril	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_40=e.	relType_35=dep	relType_24=punct	lemma_39=trimeprazine	relType_19=punct	lemma_8=,	lemma_31=stelazine	lemma_19=]	lemma_13=Sparine	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_39=-LRB-	pos_14=,	lemma_16=e.	relType_37=appos	lemma_39=[	relType_19=appos	relType_15=punct	relType_42=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_11=g.	pos_9=-LRB-	relType_31=dep	pos_13=-RRB-	lemma_23=g.	pos_37=NNP	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_37=]	lemma_13=]	lemma_9=promazine	pos_33=NN	relType_9=conj	pos_25=-RRB-	lemma_15=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	lemma_37=Vesprin	lemma_3=prochlorperazine	lemma_42=,	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	wib=prochlorperazine	relType_4=compound	relType_18=punct	lemma_19=Phenergan	lemma_32=,	lemma_41=g.	relType_9=punct	pos_6=,	lemma_21=thioridazine	lemma_7=Compazine	eib=True	pos_3=NN	relType_7=punct	pos_26=,	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e12	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Compazine_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	path=<prochlorperazine_conj>g._dep>Compazine_appos	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e13	null	relType_3=dep	pos_2=NN	lemma_6=,	lib=e.	path1=prochlorperazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	path=prochlorperazine_conj<acetophenazine_dep>promazine_conj	path2=promazine_conj	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct	lemma_5=Compazine
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e14	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lemma_7=promazine	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	path1=prochlorperazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=[	lemma_5=]	path2=promazine_conj>g._dep>Sparine_appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	lemma_5=Compazine	relType_7=conj	path=prochlorperazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e15	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	lemma_7=promazine	lib=e.	relType_9=dep	path2=promethazine_conj	lemma_11=Sparine	pos_7=-LRB-	pos_8=NN	lemma_12=,	path1=prochlorperazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	path=prochlorperazine_conj<acetophenazine_dep>promethazine_conj	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_5=Compazine	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e16	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lemma_7=promazine	lib=e.	relType_14=compound	relType_9=dep	lemma_11=Sparine	lemma_13=[	pos_7=-LRB-	pos_8=NN	lemma_12=,	path1=prochlorperazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_13=promethazine	lemma_7=[	lemma_5=]	path2=promethazine_conj>g._dep>Phenergan_appos	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	path=prochlorperazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_5=Compazine	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e17	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	lemma_17=Phenergan	pos_11=NNP	path=prochlorperazine_conj<acetophenazine_dep>thioridazine_conj	lemma_7=promazine	lib=e.	relType_14=compound	relType_9=dep	lemma_11=Sparine	lemma_13=[	pos_7=-LRB-	pos_8=NN	lemma_12=,	path1=prochlorperazine_conj	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_13=promethazine	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=thioridazine_conj	pos_11=-RRB-	relType_16=punct	pos_10=,	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_5=Compazine	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e18	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	lemma_5=Compazine	relType_3=dep	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	path1=prochlorperazine_conj	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path2=thioridazine_conj>g._dep>Mellaril_appos	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	lemma_13=promethazine	relType_8=compound	lemma_1=[	relType_19=conj	lemma_19=thioridazine	relType_7=conj	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	path=prochlorperazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e19	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	path2=trifluoperazine_conj	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	lemma_5=Compazine	relType_3=dep	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	lemma_13=promethazine	path=prochlorperazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_19=thioridazine	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e20	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	lemma_25=trifluoperazine	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_28=,	lemma_13=[	lemma_5=Compazine	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	relType_27=appos	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_25=punct	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_13=promethazine	relType_8=compound	pos_25=NN	lemma_1=[	path=prochlorperazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_19=conj	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_23=-RRB-	lemma_19=thioridazine	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e21	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	lemma_25=trifluoperazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	lemma_28=,	lemma_13=[	lemma_5=Compazine	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	path=prochlorperazine_conj<acetophenazine_dep>triflupromazine_conj	lemma_22=,	pos_29=NN	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	relType_27=appos	path2=triflupromazine_conj	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_17=appos	relType_25=punct	relType_29=dep	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_13=promethazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_29=stelazine	pos_23=-RRB-	lemma_19=thioridazine	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e22	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	lemma_25=trifluoperazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_34=punct	lemma_28=,	lemma_13=[	lemma_5=Compazine	pos_34=,	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	lemma_31=triflupromazine	path=prochlorperazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	lemma_22=,	pos_29=NN	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	relType_27=appos	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	relType_29=dep	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_13=promethazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_29=stelazine	pos_23=-RRB-	lemma_19=thioridazine	lemma_31=[	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e23	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_25=trifluoperazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_29=]	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	lemma_5=Compazine	pos_34=,	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	lemma_31=triflupromazine	lemma_22=,	pos_29=NN	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	path2=trimeprazine_conj	pos_27=NN	relType_27=appos	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	path=prochlorperazine_conj<acetophenazine_dep>trimeprazine_conj	lemma_4=,	pos_5=NNP	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	relType_25=punct	lemma_34=,	relType_29=dep	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_13=promethazine	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	lemma_29=stelazine	pos_36=,	pos_23=-RRB-	lemma_19=thioridazine	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	lemma_35=Vesprin	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e11	DDI-DrugBank.d179.s21.e24	null	pos_2=NN	pos_39=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_39=g.	relType_22=punct	relType_4=punct	path=prochlorperazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	pos_5=-RRB-	pos_22=,	pos_35=-RRB-	pos_32=NN	wib=e.	relType_16=punct	lemma_25=trifluoperazine	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	pos_37=-LRB-	lemma_29=]	relType_37=conj	lemma_9=g.	relType_31=conj	relType_36=punct	relType_34=punct	lemma_28=,	lemma_13=[	lemma_5=Compazine	pos_34=,	relType_37=punct	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lemma_17=Phenergan	lib=e.	pos_8=NN	lemma_23=]	path1=prochlorperazine_conj	lemma_3=g.	lemma_31=triflupromazine	lemma_22=,	pos_29=NN	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	relType_32=compound	lemma_7=[	pos_27=NN	pos_37=NN	relType_27=appos	lemma_23=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	relType_33=dep	pos_31=NN	relType_17=appos	lemma_38=e.	relType_25=punct	lemma_34=,	relType_29=dep	pos_30=,	relType_1=punct	pos_7=NN	relType_35=appos	relType_10=punct	lemma_20=e.	relType_17=punct	lemma_40=,	relType_24=punct	relType_19=punct	lemma_11=Sparine	pos_17=NNP	relType_40=punct	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	lemma_37=trimeprazine	lemma_13=promethazine	lemma_37=[	pos_38=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	relType_35=punct	lemma_29=stelazine	relType_39=appos	pos_36=,	pos_40=,	pos_23=-RRB-	lemma_19=thioridazine	lemma_31=[	pos_35=NNP	relType_23=appos	pos_33=NN	relType_7=conj	pos_23=NNP	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	lemma_7=promazine	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	relType_38=compound	pos_16=,	lemma_35=]	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	lemma_35=Vesprin	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	lemma_36=,	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e13	null	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>promazine_conj	lib=promazine	lpib=promazine_NN	eib=False	wib=promazine	pos_1=-RRB-	lemma_1=]	pos_2=,	relType_1=punct	path1=Compazine_appos<g._dep<prochlorperazine_conj	lemma_2=,	relType_2=punct	path2=promazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e14	null	lemma_3=[	lib=promazine	lemma_3=promazine	lemma_6=,	relType_2=punct	relType_6=punct	wib=promazine	lemma_4=e.	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	path2=promazine_conj>g._dep>Sparine_appos	lpib=promazine_NN	relType_3=conj	pos_1=-RRB-	relType_4=compound	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_6=,	pos_5=NN	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>promazine_conj>g._dep>Sparine_appos	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e15	null	lemma_3=[	lib=promazine	relType_7=appos	lemma_3=promazine	lemma_6=,	relType_8=punct	lemma_8=,	path2=promethazine_conj	relType_2=punct	relType_6=punct	wib=promazine	lemma_4=e.	lemma_1=]	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Sparine	lpib=promazine_NN	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_7=-RRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>promethazine_conj	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e16	null	lemma_9=promethazine	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	lemma_3=[	lib=promazine	relType_7=appos	relType_9=conj	lemma_3=promazine	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	relType_6=punct	wib=promazine	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Sparine	pos_9=NN	path2=promethazine_conj>g._dep>Phenergan_appos	lpib=promazine_NN	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e17	null	lemma_9=promethazine	lemma_3=[	relType_14=punct	lib=promazine	relType_7=appos	relType_9=conj	relType_13=punct	lemma_3=promazine	lemma_6=,	lemma_9=[	relType_8=punct	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>thioridazine_conj	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	relType_6=punct	wib=promazine	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Sparine	pos_9=NN	lemma_13=Phenergan	lpib=promazine_NN	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	path2=thioridazine_conj	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e18	null	lemma_9=promethazine	lemma_3=[	relType_14=punct	lib=promazine	relType_7=appos	relType_9=conj	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	lemma_15=[	relType_13=punct	lemma_3=promazine	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	relType_6=punct	wib=promazine	lemma_4=e.	lemma_10=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_13=appos	pos_14=,	lemma_16=e.	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Sparine	pos_9=NN	relType_15=punct	relType_17=dep	lemma_13=Phenergan	pos_18=,	lpib=promazine_NN	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	lemma_15=thioridazine	pos_16=NN	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e19	null	lemma_6=,	relType_8=punct	lemma_19=Mellaril	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path2=trifluoperazine_conj	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_2=,	lemma_9=[	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Phenergan	relType_3=conj	lemma_11=g.	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	lemma_9=promethazine	lib=promazine	relType_9=conj	relType_13=punct	lemma_3=promazine	relType_16=compound	pos_13=NNP	relType_6=punct	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>trifluoperazine_conj	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e20	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_19=Mellaril	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Phenergan	relType_3=conj	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_11=g.	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	lemma_23=g.	path2=trifluoperazine_conj>g._appos>stelazine_dep	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_23=appos	lemma_13=]	lemma_9=promethazine	lib=promazine	relType_9=conj	relType_13=punct	lemma_3=promazine	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	lemma_21=trifluoperazine	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e21	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_19=Mellaril	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	lemma_25=]	relType_2=punct	relType_13=appos	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	path2=triflupromazine_conj	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_25=punct	relType_25=dep	relType_26=punct	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>triflupromazine_conj	relType_15=punct	lemma_13=Phenergan	relType_3=conj	lemma_11=g.	pos_25=NN	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_23=appos	lemma_13=]	lemma_9=promethazine	lib=promazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	lemma_3=promazine	relType_16=compound	lemma_25=stelazine	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_21=trifluoperazine	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_19=Mellaril	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	lemma_28=e.	lemma_27=triflupromazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	pos_9=NN	lemma_2=,	pos_27=NN	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	relType_25=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Phenergan	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_25=NN	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	relType_23=appos	lemma_13=]	lemma_9=promethazine	lib=promazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	lemma_3=promazine	relType_16=compound	lemma_30=,	lemma_25=stelazine	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	relType_28=compound	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_21=trifluoperazine	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	lemma_19=Mellaril	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_31=]	pos_31=-RRB-	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	lemma_28=e.	lemma_27=triflupromazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	path2=trimeprazine_conj	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	pos_27=-LRB-	relType_25=punct	relType_29=dep	relType_25=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>trimeprazine_conj	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_31=Vesprin	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Phenergan	lemma_29=g.	relType_3=conj	lemma_11=g.	pos_25=NN	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	relType_23=appos	lemma_13=]	lemma_9=promethazine	lib=promazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	lemma_3=promazine	relType_16=compound	lemma_30=,	lemma_25=stelazine	pos_13=NNP	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_21=trifluoperazine	pos_19=NNP	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e12	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	relType_33=conj	pos_34=NN	pos_24=,	lemma_6=,	relType_32=punct	relType_8=punct	pos_35=NN	relType_34=compound	lemma_19=Mellaril	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	wib=promazine	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_31=]	pos_31=-RRB-	relType_33=punct	pos_33=-LRB-	path1=Compazine_appos<g._dep<prochlorperazine_conj	pos_28=NN	relType_30=punct	pos_2=,	relType_21=punct	relType_36=punct	lemma_28=e.	lemma_27=triflupromazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	lemma_25=]	relType_2=punct	relType_31=appos	relType_13=appos	relType_17=dep	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	pos_27=NN	pos_32=,	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_35=g.	pos_5=NN	lemma_14=,	pos_11=NN	lemma_34=e.	pos_27=-LRB-	relType_25=punct	relType_29=dep	relType_25=dep	pos_30=,	relType_26=punct	relType_1=punct	relType_35=appos	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_31=Vesprin	lemma_16=e.	relType_19=appos	relType_15=punct	lemma_13=Phenergan	lemma_29=g.	relType_3=conj	lemma_33=trimeprazine	lemma_11=g.	pos_25=NN	pos_9=-LRB-	lemma_15=thioridazine	pos_13=-RRB-	lemma_23=g.	pos_36=,	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	relType_23=appos	lemma_13=]	pos_33=NN	lemma_9=promethazine	lib=promazine	relType_9=conj	pos_25=-RRB-	relType_13=punct	lemma_3=promazine	relType_16=compound	lemma_30=,	lemma_25=stelazine	pos_13=NNP	pos_21=-LRB-	relType_6=punct	pos_31=NNP	lemma_4=e.	lemma_1=]	relType_10=compound	pos_4=NN	lemma_7=Sparine	pos_20=,	relType_31=punct	relType_28=compound	pos_18=,	lpib=promazine_NN	pos_15=NN	lemma_33=[	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_32=,	relType_9=punct	pos_6=,	path=Compazine_appos<g._dep<prochlorperazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	eib=True	pos_3=NN	relType_7=punct	pos_26=,	lemma_21=trifluoperazine	pos_19=NNP	lemma_26=,	lemma_36=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e14	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	path=<promazine_conj>g._dep>Sparine_appos	relType_4=punct	path2=g._dep>Sparine_appos	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e15	null	path=promazine_conj<acetophenazine_dep>promethazine_conj	relType_3=dep	pos_2=NN	lemma_6=,	lib=e.	path2=promethazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	path1=promazine_conj	eib=True	pos_3=NN	lemma_5=Sparine	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e16	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=[	lemma_5=]	lemma_7=promethazine	path2=promethazine_conj>g._dep>Phenergan_appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	path1=promazine_conj	pos_10=,	path=promazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	eib=True	pos_3=NN	lemma_5=Sparine	relType_7=punct	lemma_8=e.	lemma_9=g.	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e17	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=[	lemma_5=]	lemma_7=promethazine	relType_11=appos	relType_4=punct	pos_5=-RRB-	path=promazine_conj<acetophenazine_dep>thioridazine_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=thioridazine_conj	path1=promazine_conj	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	lemma_5=Sparine	relType_7=punct	lemma_8=e.	lemma_9=g.	lemma_11=Phenergan	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e18	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	lemma_7=promethazine	relType_7=conj	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	path1=promazine_conj	pos_11=-RRB-	relType_16=punct	pos_10=,	eib=True	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_3=NN	lemma_5=Sparine	relType_7=punct	lemma_8=e.	lemma_9=g.	lemma_11=Phenergan	lemma_13=thioridazine	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	path=promazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e19	null	path=promazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	lemma_17=Mellaril	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=[	lemma_5=]	lemma_7=promethazine	relType_11=appos	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	path2=trifluoperazine_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	path1=promazine_conj	pos_11=-RRB-	relType_16=punct	pos_10=,	eib=True	relType_17=appos	pos_3=NN	lemma_5=Sparine	relType_7=punct	lemma_8=e.	lemma_9=g.	lemma_11=Phenergan	lemma_13=thioridazine	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e20	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	lemma_17=Mellaril	pos_13=NN	lemma_16=,	relType_22=punct	lemma_7=promethazine	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_19=trifluoperazine	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	path=promazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path1=promazine_conj	relType_17=appos	lemma_11=Phenergan	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	path2=trifluoperazine_conj>g._appos>stelazine_dep	lemma_5=Sparine	relType_21=appos	lemma_13=thioridazine	relType_7=conj	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e21	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	lemma_17=Mellaril	pos_13=NN	lemma_16=,	relType_22=punct	lemma_7=promethazine	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_23=stelazine	lemma_9=g.	lemma_19=trifluoperazine	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	relType_23=dep	path2=triflupromazine_conj	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path1=promazine_conj	relType_17=appos	lemma_11=Phenergan	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_23=NN	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	lemma_5=Sparine	relType_21=appos	lemma_13=thioridazine	relType_7=conj	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	path=promazine_conj<acetophenazine_dep>triflupromazine_conj	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e22	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	lemma_17=Mellaril	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	lemma_7=promethazine	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_23=stelazine	lemma_9=g.	path2=triflupromazine_conj>g._dep>Vesprin_appos	lemma_19=trifluoperazine	lemma_13=[	lemma_28=,	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	relType_23=dep	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path1=promazine_conj	relType_17=appos	path=promazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_25=punct	lemma_11=Phenergan	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_23=NN	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_25=triflupromazine	pos_23=-RRB-	lemma_5=Sparine	relType_27=dep	relType_21=appos	lemma_13=thioridazine	relType_7=conj	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e23	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	lemma_17=Mellaril	pos_26=NN	pos_13=NN	lemma_16=,	relType_22=punct	lemma_7=promethazine	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_23=stelazine	lemma_29=]	lemma_9=g.	lemma_19=trifluoperazine	lemma_13=[	lemma_28=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_29=Vesprin	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	path=promazine_conj<acetophenazine_dep>trimeprazine_conj	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	path2=trimeprazine_conj	relType_23=dep	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path1=promazine_conj	relType_17=appos	relType_25=punct	lemma_11=Phenergan	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_23=NN	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_25=triflupromazine	pos_23=-RRB-	lemma_5=Sparine	relType_27=dep	relType_21=appos	lemma_13=thioridazine	relType_7=conj	relType_23=punct	pos_29=-RRB-	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e13	DDI-DrugBank.d179.s21.e24	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_33=g.	lemma_14=e.	pos_12=,	pos_20=NN	lemma_17=Mellaril	pos_26=NN	pos_13=NN	lemma_16=,	path2=trimeprazine_conj>g._appos>Temaril_dep	relType_22=punct	lemma_7=promethazine	relType_4=punct	pos_5=-RRB-	pos_22=,	pos_32=NN	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	relType_30=punct	pos_10=,	lemma_23=stelazine	lemma_29=]	lemma_9=g.	relType_31=conj	relType_34=punct	lemma_19=trifluoperazine	lemma_13=[	lemma_28=,	pos_34=,	pos_29=NNP	relType_3=dep	relType_25=conj	lemma_25=[	lemma_29=Vesprin	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_22=,	relType_12=punct	relType_13=conj	pos_9=NN	relType_32=compound	lemma_7=[	relType_23=dep	pos_27=NN	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_5=appos	path1=promazine_conj	pos_31=NN	relType_17=appos	relType_25=punct	lemma_11=Phenergan	lemma_34=,	pos_30=,	relType_1=punct	pos_7=NN	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_23=NN	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_31=-LRB-	relType_26=compound	lemma_27=g.	pos_14=NN	relType_29=appos	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	lemma_25=triflupromazine	pos_23=-RRB-	lemma_5=Sparine	lemma_31=[	relType_27=dep	pos_33=NN	relType_21=appos	lemma_13=thioridazine	relType_7=conj	relType_23=punct	pos_29=-RRB-	lemma_31=trimeprazine	relType_33=appos	relType_13=punct	pos_11=NNP	relType_14=compound	lemma_30=,	relType_9=dep	path=promazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	relType_31=punct	lemma_5=]	lemma_32=e.	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	relType_29=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e15	null	lpib=promethazine_NN	eib=False	pos_1=-RRB-	wib=promethazine	lemma_1=]	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>promethazine_conj	relType_1=punct	lib=promethazine	lemma_2=,	path2=promethazine_conj	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e16	null	lemma_3=[	wib=promethazine	lemma_6=,	relType_2=punct	lpib=promethazine_NN	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_3=promethazine	path2=promethazine_conj>g._dep>Phenergan_appos	relType_3=conj	pos_1=-RRB-	relType_4=compound	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>promethazine_conj>g._dep>Phenergan_appos	pos_6=,	pos_5=NN	eib=True	pos_3=NN	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	lib=promethazine	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e17	null	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>thioridazine_conj	lemma_3=[	relType_7=appos	wib=promethazine	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lpib=promethazine_NN	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_3=promethazine	relType_3=conj	lemma_7=Phenergan	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	pos_6=,	path2=thioridazine_conj	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	lib=promethazine	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e18	null	lemma_9=thioridazine	lemma_3=[	relType_7=appos	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_9=conj	wib=promethazine	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	lpib=promethazine_NN	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_3=promethazine	relType_3=conj	lemma_7=Phenergan	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_3=NN	relType_7=punct	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	lib=promethazine	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e19	null	lemma_9=thioridazine	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	wib=promethazine	relType_13=punct	lemma_6=,	lemma_9=[	lemma_13=Mellaril	relType_8=punct	lemma_8=,	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_13=NNP	relType_2=punct	lemma_12=,	lpib=promethazine_NN	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_3=promethazine	relType_3=conj	lemma_7=Phenergan	path2=trifluoperazine_conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_14=,	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	lib=promethazine	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e20	null	lemma_9=thioridazine	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	wib=promethazine	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	lemma_13=Mellaril	relType_8=punct	relType_16=compound	lemma_8=,	pos_13=NNP	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	lpib=promethazine_NN	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_16=e.	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	relType_15=punct	lemma_3=promethazine	pos_18=,	pos_15=NN	relType_3=conj	lemma_7=Phenergan	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	relType_11=dep	pos_9=-LRB-	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	pos_6=,	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_5=NN	lemma_14=,	lemma_15=trifluoperazine	pos_11=NN	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	path1=Sparine_appos<g._dep<promazine_conj	pos_2=,	lemma_5=g.	relType_1=punct	lib=promethazine	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e21	null	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_15=trifluoperazine	pos_2=,	lib=promethazine	lemma_9=thioridazine	lemma_9=[	relType_19=dep	relType_2=punct	lpib=promethazine_NN	relType_13=appos	relType_12=punct	pos_9=NN	lemma_2=,	lemma_3=promethazine	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>triflupromazine_conj	path2=triflupromazine_conj	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_17=appos	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	lemma_13=Mellaril	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_15=punct	relType_3=conj	lemma_7=Phenergan	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	lemma_19=stelazine	wib=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	relType_6=punct	lemma_4=e.	lemma_1=]	pos_19=NN	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	path1=Sparine_appos<g._dep<promazine_conj	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e22	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_15=trifluoperazine	pos_2=,	relType_21=punct	path2=triflupromazine_conj>g._dep>Vesprin_appos	lib=promethazine	lemma_9=thioridazine	lemma_21=triflupromazine	lemma_21=[	pos_22=NN	lemma_9=[	relType_19=dep	relType_2=punct	lpib=promethazine_NN	relType_13=appos	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	lemma_3=promethazine	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_17=appos	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_13=Mellaril	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_15=punct	relType_3=conj	lemma_7=Phenergan	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	lemma_19=stelazine	wib=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	pos_19=NN	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	path1=Sparine_appos<g._dep<promazine_conj	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e23	null	relType_22=compound	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>trimeprazine_conj	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	lemma_15=trifluoperazine	pos_2=,	relType_21=punct	lib=promethazine	lemma_9=thioridazine	lemma_21=triflupromazine	lemma_21=[	pos_22=NN	lemma_9=[	relType_19=dep	lemma_25=]	relType_2=punct	lpib=promethazine_NN	relType_13=appos	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	path2=trimeprazine_conj	lemma_3=promethazine	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_25=Vesprin	pos_5=NN	lemma_14=,	pos_11=NN	relType_17=appos	relType_25=punct	relType_26=punct	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_13=Mellaril	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_15=punct	relType_3=conj	lemma_7=Phenergan	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	lemma_19=stelazine	pos_25=-RRB-	wib=promethazine	relType_13=punct	relType_16=compound	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	pos_19=NN	relType_10=compound	pos_4=NN	pos_20=,	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	path1=Sparine_appos<g._dep<promazine_conj	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e14	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	pos_25=NNP	lemma_20=,	lemma_12=,	lemma_27=trimeprazine	lemma_10=e.	relType_25=appos	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	relType_5=dep	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_28=NN	lemma_15=trifluoperazine	relType_30=punct	path=Sparine_appos<g._dep<promazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	pos_2=,	relType_21=punct	lemma_28=e.	lib=promethazine	lemma_9=thioridazine	lemma_21=triflupromazine	lemma_21=[	pos_22=NN	relType_27=conj	lemma_9=[	relType_19=dep	lemma_25=]	relType_2=punct	lpib=promethazine_NN	relType_13=appos	pos_29=NN	relType_12=punct	pos_9=NN	lemma_2=,	relType_23=dep	lemma_3=promethazine	pos_27=NN	pos_1=-RRB-	relType_11=dep	pos_16=NN	pos_7=-RRB-	lemma_25=Vesprin	pos_5=NN	lemma_14=,	pos_11=NN	relType_17=appos	pos_27=-LRB-	relType_25=punct	pos_30=,	relType_26=punct	relType_1=punct	relType_3=punct	lemma_27=[	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lemma_15=[	relType_24=punct	lemma_13=Mellaril	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_15=punct	lemma_29=g.	relType_29=appos	relType_3=conj	lemma_7=Phenergan	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_27=punct	lemma_13=]	relType_9=conj	lemma_19=stelazine	pos_25=-RRB-	wib=promethazine	relType_13=punct	relType_16=compound	lemma_30=,	pos_13=NNP	pos_21=-LRB-	relType_6=punct	lemma_4=e.	lemma_1=]	pos_19=NN	relType_10=compound	pos_4=NN	pos_20=,	relType_28=compound	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	relType_9=punct	pos_6=,	eib=True	pos_3=NN	relType_7=punct	pos_26=,	path1=Sparine_appos<g._dep<promazine_conj	lemma_26=,	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e16	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	path2=g._dep>Phenergan_appos	path=<promethazine_conj>g._dep>Phenergan_appos	lpib=e._NN	lemma_2=e.	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e17	null	relType_3=dep	pos_2=NN	lemma_6=,	lib=e.	path1=promethazine_conj	lemma_3=g.	pos_4=,	relType_6=punct	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	path=promethazine_conj<acetophenazine_dep>thioridazine_conj	lemma_4=,	lemma_5=Phenergan	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=thioridazine_conj	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e18	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	path1=promethazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	lemma_7=thioridazine	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_5=Phenergan	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_10=,	eib=True	path2=thioridazine_conj>g._dep>Mellaril_appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path=promethazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e19	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	path=promethazine_conj<acetophenazine_dep>trifluoperazine_conj	lib=e.	path1=promethazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	pos_9=NN	lemma_7=thioridazine	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	lemma_11=Mellaril	pos_5=-RRB-	path2=trifluoperazine_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_5=Phenergan	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e20	null	lemma_13=trifluoperazine	relType_3=dep	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	path1=promethazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=thioridazine	lemma_7=[	lemma_5=]	relType_11=appos	relType_4=punct	lemma_11=Mellaril	pos_5=-RRB-	pos_15=NN	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_5=Phenergan	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_10=,	eib=True	relType_15=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj	path=promethazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e21	null	lemma_13=trifluoperazine	relType_3=dep	relType_10=punct	pos_2=NN	lemma_17=]	lemma_10=,	relType_17=punct	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	path1=promethazine_conj	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NN	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	pos_16=,	lemma_17=stelazine	relType_17=dep	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	pos_9=NN	lemma_16=,	lemma_7=thioridazine	lemma_7=[	lemma_5=]	relType_11=appos	pos_18=,	relType_4=punct	lemma_11=Mellaril	pos_5=-RRB-	pos_15=NN	path2=triflupromazine_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_18=,	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	lemma_5=Phenergan	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_10=,	eib=True	relType_15=appos	pos_3=NN	path=promethazine_conj<acetophenazine_dep>triflupromazine_conj	relType_7=punct	lemma_8=e.	lemma_9=g.	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e22	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	lemma_7=thioridazine	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	path2=triflupromazine_conj>g._dep>Vesprin_appos	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	path1=promethazine_conj	pos_8=NN	lemma_3=g.	lemma_17=stelazine	relType_17=dep	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	lemma_11=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_5=Phenergan	relType_5=appos	relType_15=appos	lemma_19=triflupromazine	relType_1=punct	pos_7=NN	lemma_13=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	path=promethazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_19=punct	pos_17=NN	pos_4=,	relType_11=punct	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	relType_7=conj	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e23	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Vesprin	lemma_24=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	pos_13=NN	lemma_16=,	lemma_7=thioridazine	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	path1=promethazine_conj	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_17=stelazine	relType_17=dep	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	path2=trimeprazine_conj	lemma_11=Mellaril	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_5=Phenergan	relType_5=appos	relType_15=appos	lemma_19=triflupromazine	relType_1=punct	pos_7=NN	lemma_13=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	path=promethazine_conj<acetophenazine_dep>trimeprazine_conj	relType_19=punct	pos_17=NN	pos_4=,	relType_11=punct	pos_14=NN	relType_8=compound	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e15	DDI-DrugBank.d179.s21.e24	null	pos_2=NN	pos_24=,	lemma_10=,	lemma_6=,	lemma_23=Vesprin	lemma_24=,	lemma_26=e.	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	relType_28=punct	lemma_14=e.	pos_12=,	pos_20=NN	pos_26=NN	pos_13=NN	lemma_16=,	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_7=thioridazine	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	path=promethazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_28=,	lemma_13=[	relType_3=dep	relType_25=conj	lemma_25=[	lemma_17=]	lemma_21=g.	lib=e.	path1=promethazine_conj	pos_8=NN	lemma_23=]	lemma_3=g.	lemma_17=stelazine	relType_17=dep	lemma_22=,	relType_12=punct	relType_13=conj	relType_21=dep	pos_9=NN	lemma_7=[	pos_27=NN	lemma_11=Mellaril	relType_27=appos	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	lemma_5=Phenergan	relType_5=appos	relType_15=appos	lemma_19=triflupromazine	lemma_25=trimeprazine	relType_25=punct	relType_1=punct	pos_7=NN	lemma_13=trifluoperazine	relType_10=punct	lemma_20=e.	relType_17=punct	relType_24=punct	relType_19=punct	pos_17=NN	pos_4=,	relType_11=punct	relType_26=compound	lemma_27=g.	pos_14=NN	relType_8=compound	pos_25=NN	lemma_1=[	relType_19=conj	pos_23=-RRB-	relType_23=appos	relType_7=conj	pos_23=NNP	relType_23=punct	relType_13=punct	pos_11=NNP	relType_14=compound	relType_9=dep	relType_6=punct	pos_16=,	pos_19=NN	pos_25=-LRB-	pos_28=,	lemma_5=]	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e17	null	lpib=thioridazine_NN	path1=Phenergan_appos<g._dep<promethazine_conj	lib=thioridazine	eib=False	wib=thioridazine	pos_1=-RRB-	lemma_1=]	pos_2=,	relType_1=punct	relType_2=punct	lemma_2=,	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>thioridazine_conj	path2=thioridazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e18	null	lemma_3=[	lib=thioridazine	lemma_6=,	relType_2=punct	path1=Phenergan_appos<g._dep<promethazine_conj	relType_6=punct	lemma_4=e.	lemma_1=]	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>thioridazine_conj>g._dep>Mellaril_appos	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	relType_3=conj	pos_1=-RRB-	relType_4=compound	lemma_3=thioridazine	pos_6=,	pos_5=NN	lpib=thioridazine_NN	eib=True	path2=thioridazine_conj>g._dep>Mellaril_appos	wib=thioridazine	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e19	null	lemma_3=[	relType_7=appos	lib=thioridazine	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	path1=Phenergan_appos<g._dep<promethazine_conj	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>trifluoperazine_conj	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	relType_3=conj	path2=trifluoperazine_conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	pos_7=-RRB-	lemma_3=thioridazine	pos_6=,	pos_5=NN	lemma_7=Mellaril	lpib=thioridazine_NN	eib=True	wib=thioridazine	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e20	null	lemma_3=[	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_7=appos	lib=thioridazine	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	path1=Phenergan_appos<g._dep<promethazine_conj	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	lemma_9=trifluoperazine	relType_11=appos	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	pos_9=-LRB-	pos_7=-RRB-	lemma_3=thioridazine	relType_9=punct	pos_6=,	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_5=NN	lemma_7=Mellaril	lpib=thioridazine_NN	pos_11=NN	eib=True	wib=thioridazine	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e21	null	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	lib=thioridazine	relType_13=dep	lemma_13=stelazine	lemma_6=,	lemma_9=[	relType_13=punct	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>triflupromazine_conj	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	path1=Phenergan_appos<g._dep<promethazine_conj	relType_6=punct	lemma_10=e.	lemma_4=e.	pos_14=,	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	pos_13=NN	lemma_9=trifluoperazine	relType_11=appos	relType_3=conj	path2=triflupromazine_conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	pos_9=-LRB-	pos_7=-RRB-	lemma_3=thioridazine	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_7=Mellaril	lemma_14=,	lpib=thioridazine_NN	pos_11=NN	eib=True	wib=thioridazine	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e22	null	lemma_3=[	relType_14=punct	relType_7=appos	relType_9=conj	lib=thioridazine	relType_13=dep	lemma_15=[	lemma_13=stelazine	lemma_6=,	lemma_9=[	relType_13=punct	relType_16=compound	relType_8=punct	lemma_8=,	relType_2=punct	lemma_12=,	pos_17=NN	pos_15=-LRB-	path1=Phenergan_appos<g._dep<promethazine_conj	lemma_15=triflupromazine	relType_6=punct	lemma_10=e.	lemma_4=e.	pos_14=,	lemma_1=]	pos_12=,	lemma_7=]	lemma_16=e.	relType_17=dep	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	pos_9=NN	pos_13=NN	relType_15=punct	lemma_9=trifluoperazine	relType_11=appos	pos_18=,	pos_15=NN	relType_3=conj	lemma_18=,	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	relType_18=punct	pos_9=-LRB-	pos_16=NN	pos_7=-RRB-	lemma_3=thioridazine	relType_9=punct	pos_13=-RRB-	pos_6=,	pos_5=NN	lemma_7=Mellaril	lemma_14=,	lpib=thioridazine_NN	pos_11=NN	eib=True	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	wib=thioridazine	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_1=punct	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e23	null	relType_13=dep	lemma_6=,	relType_8=punct	lemma_20=,	lemma_12=,	path1=Phenergan_appos<g._dep<promethazine_conj	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	pos_13=NN	relType_5=dep	lemma_9=trifluoperazine	wib=thioridazine	pos_2=,	lemma_9=[	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>trimeprazine_conj	relType_2=punct	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	path2=trimeprazine_conj	pos_1=-RRB-	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lib=thioridazine	lemma_15=[	relType_19=punct	lemma_8=,	lemma_19=]	pos_17=NN	pos_15=-LRB-	pos_14=,	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lpib=thioridazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	lemma_13=]	relType_9=conj	lemma_13=stelazine	relType_13=punct	relType_16=compound	lemma_15=triflupromazine	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_19=Vesprin	relType_10=compound	pos_4=NN	pos_20=,	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_3=thioridazine	relType_9=punct	pos_6=,	lemma_7=Mellaril	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e16	DDI-DrugBank.d179.s21.e24	null	relType_22=compound	relType_13=dep	pos_24=,	lemma_6=,	relType_8=punct	lemma_24=,	relType_21=conj	lemma_20=,	lemma_12=,	path1=Phenergan_appos<g._dep<promethazine_conj	lemma_10=e.	pos_12=,	lemma_7=]	pos_3=-LRB-	pos_10=NN	pos_13=NN	relType_5=dep	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_9=trifluoperazine	wib=thioridazine	pos_2=,	relType_21=punct	lemma_21=[	pos_22=NN	lemma_9=[	relType_2=punct	relType_17=dep	relType_12=punct	pos_9=NN	lemma_2=,	pos_1=-RRB-	pos_16=NN	pos_7=-RRB-	pos_5=NN	lemma_14=,	pos_11=NN	relType_1=punct	relType_3=punct	pos_8=,	lemma_3=[	relType_14=punct	relType_7=appos	lib=thioridazine	lemma_15=[	relType_24=punct	relType_19=punct	lemma_8=,	lemma_19=]	pos_23=NN	pos_17=NN	lemma_22=e.	pos_15=-LRB-	pos_14=,	path=Phenergan_appos<g._dep<promethazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_16=e.	relType_19=appos	relType_15=punct	relType_3=conj	lemma_11=g.	pos_9=-LRB-	pos_13=-RRB-	lemma_23=g.	lpib=thioridazine_NN	relType_15=conj	lemma_17=g.	relType_20=punct	lemma_5=g.	relType_23=appos	lemma_13=]	relType_9=conj	lemma_21=trimeprazine	lemma_13=stelazine	relType_13=punct	relType_16=compound	pos_21=-LRB-	lemma_15=triflupromazine	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_19=Vesprin	relType_10=compound	pos_4=NN	pos_20=,	relType_11=appos	pos_18=,	pos_15=NN	lemma_18=,	pos_7=NNP	relType_4=compound	relType_18=punct	lemma_3=thioridazine	relType_9=punct	pos_6=,	lemma_7=Mellaril	eib=True	pos_3=NN	relType_7=punct	pos_19=NNP	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e18	null	relType_3=dep	pos_2=NN	path1=	lib=e.	path2=g._dep>Mellaril_appos	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path=<thioridazine_conj>g._dep>Mellaril_appos	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e19	null	relType_3=dep	pos_2=NN	lemma_6=,	lib=e.	lemma_3=g.	pos_4=,	relType_6=punct	path1=thioridazine_conj	lemma_5=Mellaril	lemma_5=]	relType_4=punct	pos_5=-RRB-	path2=trifluoperazine_conj	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	path=thioridazine_conj<acetophenazine_dep>trifluoperazine_conj	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e20	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_7=trifluoperazine	lemma_10=,	lemma_6=,	lib=e.	pos_7=-LRB-	pos_8=NN	lemma_3=g.	pos_4=,	relType_6=punct	path1=thioridazine_conj	lemma_5=Mellaril	pos_9=NN	relType_9=appos	lemma_7=[	path=thioridazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e21	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_11=stelazine	lemma_7=trifluoperazine	lemma_10=,	lemma_6=,	lib=e.	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	path1=thioridazine_conj	lemma_5=Mellaril	relType_12=punct	pos_9=NN	relType_9=appos	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	path2=triflupromazine_conj	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	relType_5=appos	pos_1=-LRB-	pos_6=,	pos_11=-RRB-	path=thioridazine_conj<acetophenazine_dep>triflupromazine_conj	pos_11=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e22	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_11=stelazine	lemma_7=trifluoperazine	lemma_10=,	relType_13=punct	lemma_6=,	lib=e.	relType_14=compound	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	path1=thioridazine_conj	lemma_5=Mellaril	relType_12=punct	pos_13=NN	pos_9=NN	relType_9=appos	relType_13=conj	pos_14=NN	lemma_16=,	lemma_7=[	lemma_5=]	relType_4=punct	pos_15=NN	pos_5=-RRB-	path=thioridazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_2=compound	relType_5=punct	relType_8=compound	lemma_13=triflupromazine	lemma_15=g.	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_11=NN	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path2=triflupromazine_conj>g._dep>Vesprin_appos	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e23	null	relType_3=dep	relType_10=punct	pos_2=NN	lemma_11=stelazine	lemma_7=trifluoperazine	lemma_10=,	relType_13=punct	lemma_6=,	lemma_17=]	relType_17=punct	lib=e.	relType_14=compound	pos_7=-LRB-	pos_8=NN	lemma_12=,	pos_17=NNP	lemma_3=g.	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	relType_15=dep	pos_16=,	path1=thioridazine_conj	lemma_5=Mellaril	relType_12=punct	pos_13=NN	pos_9=NN	relType_9=appos	relType_13=conj	pos_14=NN	lemma_16=,	lemma_7=[	path2=trimeprazine_conj	lemma_5=]	pos_18=,	relType_4=punct	pos_15=NN	pos_5=-RRB-	lemma_18=,	relType_2=compound	relType_5=punct	relType_8=compound	lemma_13=triflupromazine	lemma_15=g.	relType_18=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_11=dep	pos_13=-LRB-	relType_5=appos	pos_1=-LRB-	pos_6=,	relType_16=punct	pos_11=-RRB-	pos_11=NN	pos_10=,	lemma_17=Vesprin	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path=thioridazine_conj<acetophenazine_dep>trimeprazine_conj	pos_17=-RRB-	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e17	DDI-DrugBank.d179.s21.e24	null	pos_2=NN	lemma_10=,	lemma_6=,	pos_7=-LRB-	lemma_12=,	pos_19=-LRB-	lemma_14=e.	pos_12=,	pos_20=NN	lemma_5=Mellaril	pos_13=NN	lemma_16=,	path2=trimeprazine_conj>g._appos>Temaril_dep	relType_22=punct	relType_4=punct	pos_5=-RRB-	pos_22=,	lemma_13=triflupromazine	wib=e.	relType_16=punct	pos_1=-LRB-	pos_11=-RRB-	pos_10=,	lemma_9=g.	lemma_13=[	relType_3=dep	lemma_17=]	lemma_21=g.	lib=e.	pos_8=NN	lemma_3=g.	lemma_22=,	path1=thioridazine_conj	relType_12=punct	relType_13=conj	pos_9=NN	lemma_7=[	lemma_15=g.	lemma_19=[	lemma_2=e.	lpib=e._NN	pos_5=NNP	lemma_4=,	relType_11=dep	relType_5=appos	pos_11=NN	lemma_17=Vesprin	relType_17=appos	relType_1=punct	pos_7=NN	path=thioridazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_10=punct	lemma_20=e.	relType_17=punct	relType_19=punct	pos_17=NNP	pos_4=,	relType_11=punct	relType_15=dep	pos_14=NN	relType_9=appos	relType_8=compound	lemma_1=[	relType_19=conj	relType_21=appos	relType_7=conj	lemma_11=stelazine	lemma_7=trifluoperazine	relType_13=punct	relType_14=compound	relType_6=punct	pos_16=,	pos_19=NN	lemma_5=]	pos_18=,	pos_15=NN	lemma_18=,	relType_2=compound	relType_5=punct	lemma_19=trimeprazine	relType_18=punct	pos_13=-LRB-	pos_6=,	eib=True	relType_20=compound	pos_3=NN	relType_7=punct	lemma_8=e.	pos_17=-RRB-	lemma_11=]	pos_21=NN
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e19	null	path1=Mellaril_appos<g._dep<thioridazine_conj	wib=trifluoperazine	lpib=trifluoperazine_NN	eib=False	path2=trifluoperazine_conj	pos_1=-RRB-	lemma_1=]	pos_2=,	relType_1=punct	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>trifluoperazine_conj	lib=trifluoperazine	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e20	null	lemma_3=[	lpib=trifluoperazine_NN	lemma_6=,	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>trifluoperazine_conj>g._appos>stelazine_dep	relType_2=punct	path1=Mellaril_appos<g._dep<thioridazine_conj	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	lib=trifluoperazine	lemma_2=,	pos_4=NN	wib=trifluoperazine	relType_3=conj	pos_1=-RRB-	relType_4=compound	relType_5=appos	pos_6=,	lemma_3=trifluoperazine	path2=trifluoperazine_conj>g._appos>stelazine_dep	pos_5=NN	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e21	null	lemma_3=[	lpib=trifluoperazine_NN	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>triflupromazine_conj	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	path1=Mellaril_appos<g._dep<thioridazine_conj	relType_6=punct	lemma_4=e.	lemma_1=]	lemma_7=]	pos_3=-LRB-	lemma_7=stelazine	lib=trifluoperazine	lemma_2=,	pos_4=NN	wib=trifluoperazine	relType_3=conj	path2=triflupromazine_conj	pos_1=-RRB-	relType_4=compound	pos_7=-RRB-	relType_5=appos	pos_6=,	lemma_3=trifluoperazine	pos_5=NN	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e22	null	lemma_3=[	relType_9=conj	lpib=trifluoperazine_NN	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	relType_2=punct	path1=Mellaril_appos<g._dep<thioridazine_conj	lemma_12=,	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	pos_12=,	lemma_7=]	relType_10=compound	pos_3=-LRB-	lemma_7=stelazine	pos_10=NN	pos_9=NN	lib=trifluoperazine	lemma_2=,	pos_4=NN	relType_12=punct	wib=trifluoperazine	relType_3=conj	pos_1=-RRB-	lemma_11=g.	relType_4=compound	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	relType_5=appos	pos_6=,	lemma_3=trifluoperazine	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	pos_5=NN	lemma_9=triflupromazine	pos_11=NN	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e23	null	lemma_3=[	relType_14=punct	relType_9=conj	lpib=trifluoperazine_NN	relType_13=punct	lemma_6=,	lemma_9=[	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	path1=Mellaril_appos<g._dep<thioridazine_conj	lemma_12=,	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	relType_10=compound	pos_3=-LRB-	lemma_7=stelazine	pos_10=NN	pos_9=NN	lib=trifluoperazine	lemma_2=,	pos_4=NN	relType_12=punct	lemma_13=Vesprin	path2=trimeprazine_conj	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>trimeprazine_conj	wib=trifluoperazine	relType_3=conj	pos_1=-RRB-	lemma_11=g.	relType_4=compound	relType_11=dep	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	relType_5=appos	pos_6=,	lemma_3=trifluoperazine	pos_5=NN	lemma_9=triflupromazine	lemma_14=,	pos_11=NN	relType_7=dep	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	relType_1=punct	pos_7=NN	relType_3=punct	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e18	DDI-DrugBank.d179.s21.e24	null	lemma_3=[	relType_14=punct	relType_9=conj	path=Mellaril_appos<g._dep<thioridazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lpib=trifluoperazine_NN	lemma_15=[	relType_13=punct	lemma_6=,	lemma_9=[	relType_16=compound	relType_8=punct	lemma_8=,	pos_13=NNP	relType_2=punct	path1=Mellaril_appos<g._dep<thioridazine_conj	lemma_12=,	pos_17=NN	pos_15=-LRB-	relType_6=punct	lemma_10=e.	lemma_4=e.	relType_13=appos	lemma_1=]	pos_12=,	lemma_7=]	pos_14=,	lemma_16=e.	relType_10=compound	pos_3=-LRB-	lemma_7=stelazine	pos_10=NN	pos_9=NN	lib=trifluoperazine	lemma_2=,	path2=trimeprazine_conj>g._appos>Temaril_dep	pos_4=NN	relType_12=punct	lemma_13=Vesprin	relType_15=punct	pos_18=,	pos_15=NN	wib=trifluoperazine	relType_3=conj	lemma_18=,	pos_1=-RRB-	lemma_11=g.	relType_4=compound	relType_18=punct	relType_11=dep	pos_9=-LRB-	pos_16=NN	pos_7=-RRB-	relType_9=punct	pos_13=-RRB-	relType_5=appos	pos_6=,	lemma_3=trifluoperazine	pos_5=NN	lemma_9=triflupromazine	lemma_14=,	pos_11=NN	relType_7=dep	eib=True	relType_17=appos	pos_3=NN	relType_7=punct	relType_15=conj	lemma_17=g.	pos_2=,	lemma_5=g.	relType_1=punct	pos_7=NN	relType_3=punct	lemma_15=trimeprazine	lemma_13=]	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e19	DDI-DrugBank.d179.s21.e20	null	pos_2=NN	path1=	path2=g._appos>stelazine_dep	lib=e.	lemma_3=g.	eib=False	relType_3=appos	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path=<trifluoperazine_conj>g._appos>stelazine_dep	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e19	DDI-DrugBank.d179.s21.e21	null	pos_2=NN	lemma_6=,	lib=e.	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	relType_5=dep	lemma_5=]	relType_4=punct	pos_5=-RRB-	path2=triflupromazine_conj	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path1=trifluoperazine_conj	pos_6=,	pos_5=NN	eib=True	lemma_5=stelazine	pos_3=NN	relType_1=punct	path=trifluoperazine_conj<acetophenazine_dep>triflupromazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e19	DDI-DrugBank.d179.s21.e22	null	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	relType_5=dep	pos_9=NN	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path1=trifluoperazine_conj	pos_6=,	pos_5=NN	pos_10=,	eib=True	lemma_5=stelazine	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	path2=triflupromazine_conj>g._dep>Vesprin_appos	relType_1=punct	pos_7=NN	path=trifluoperazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_7=conj	lemma_7=triflupromazine
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e19	DDI-DrugBank.d179.s21.e23	null	path=trifluoperazine_conj<acetophenazine_dep>trimeprazine_conj	relType_10=punct	pos_2=NN	lemma_10=,	lemma_6=,	pos_11=NNP	lib=e.	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	relType_11=punct	pos_12=,	relType_12=punct	relType_5=dep	pos_9=NN	lemma_11=Vesprin	lemma_7=[	path2=trimeprazine_conj	lemma_5=]	relType_11=appos	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	path1=trifluoperazine_conj	pos_6=,	pos_11=-RRB-	pos_5=NN	pos_10=,	eib=True	lemma_5=stelazine	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	relType_7=conj	lemma_7=triflupromazine
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e19	DDI-DrugBank.d179.s21.e24	null	relType_10=punct	pos_2=NN	lemma_10=,	relType_13=punct	lemma_6=,	pos_11=NNP	lib=e.	relType_14=compound	relType_9=dep	pos_7=-LRB-	pos_8=NN	lemma_12=,	lemma_3=g.	relType_3=appos	pos_4=,	relType_6=punct	relType_11=punct	lemma_14=e.	pos_12=,	pos_16=,	relType_12=punct	relType_13=conj	pos_13=NN	pos_14=NN	path=trifluoperazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	relType_5=dep	pos_9=NN	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_11=Vesprin	lemma_7=[	lemma_5=]	lemma_16=,	relType_11=appos	relType_4=punct	pos_15=NN	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_15=g.	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_13=-LRB-	relType_16=punct	pos_1=-LRB-	path1=trifluoperazine_conj	pos_6=,	pos_11=-RRB-	lemma_13=trimeprazine	pos_5=NN	pos_10=,	eib=True	lemma_5=stelazine	relType_15=appos	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	lemma_11=]	relType_1=punct	pos_7=NN	lemma_13=[	relType_7=conj	lemma_7=triflupromazine
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e20	DDI-DrugBank.d179.s21.e21	null	lib=triflupromazine	eib=False	path2=triflupromazine_conj	path=stelazine_dep<g._appos<trifluoperazine_conj<acetophenazine_dep>triflupromazine_conj	pos_1=-RRB-	lemma_1=]	wib=triflupromazine	lpib=triflupromazine_NN	pos_2=,	path1=stelazine_dep<g._appos<trifluoperazine_conj	relType_1=punct	lemma_2=,	relType_2=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e20	DDI-DrugBank.d179.s21.e22	null	lemma_3=[	lemma_6=,	path=stelazine_dep<g._appos<trifluoperazine_conj<acetophenazine_dep>triflupromazine_conj>g._dep>Vesprin_appos	relType_2=punct	lib=triflupromazine	relType_6=punct	lemma_4=e.	lemma_1=]	wib=triflupromazine	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_3=triflupromazine	relType_3=conj	pos_1=-RRB-	relType_4=compound	lpib=triflupromazine_NN	pos_6=,	pos_5=NN	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	path2=triflupromazine_conj>g._dep>Vesprin_appos	path1=stelazine_dep<g._appos<trifluoperazine_conj	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e20	DDI-DrugBank.d179.s21.e23	null	lemma_3=[	relType_7=appos	lemma_6=,	relType_8=punct	lemma_8=,	relType_2=punct	lib=triflupromazine	relType_6=punct	lemma_4=e.	lemma_1=]	wib=triflupromazine	lemma_7=]	pos_3=-LRB-	relType_5=dep	pos_4=NN	lemma_2=,	lemma_7=Vesprin	path2=trimeprazine_conj	lemma_3=triflupromazine	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lpib=triflupromazine_NN	pos_7=-RRB-	pos_6=,	pos_5=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	path1=stelazine_dep<g._appos<trifluoperazine_conj	relType_1=punct	path=stelazine_dep<g._appos<trifluoperazine_conj<acetophenazine_dep>trimeprazine_conj	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e20	DDI-DrugBank.d179.s21.e24	null	lemma_3=[	relType_7=appos	relType_9=conj	lemma_6=,	lemma_9=[	relType_8=punct	path=stelazine_dep<g._appos<trifluoperazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	lemma_8=,	relType_2=punct	lemma_12=,	lib=triflupromazine	relType_6=punct	lemma_10=e.	lemma_4=e.	lemma_1=]	wib=triflupromazine	lemma_7=]	pos_12=,	relType_10=compound	pos_3=-LRB-	pos_10=NN	relType_12=punct	relType_5=dep	pos_4=NN	lemma_2=,	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_7=Vesprin	pos_9=NN	relType_11=appos	lemma_3=triflupromazine	relType_3=conj	pos_1=-RRB-	pos_7=NNP	relType_4=compound	lemma_11=g.	lpib=triflupromazine_NN	lemma_9=trimeprazine	pos_9=-LRB-	pos_7=-RRB-	relType_9=punct	pos_6=,	pos_5=NN	pos_11=NN	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=g.	path1=stelazine_dep<g._appos<trifluoperazine_conj	relType_1=punct	relType_3=punct	pos_8=,
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e21	DDI-DrugBank.d179.s21.e22	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	path=<triflupromazine_conj>g._dep>Vesprin_appos	relType_1=punct	path2=g._dep>Vesprin_appos
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e21	DDI-DrugBank.d179.s21.e23	null	relType_3=dep	pos_2=NN	path1=triflupromazine_conj	lemma_6=,	lib=e.	lemma_5=Vesprin	lemma_3=g.	pos_4=,	relType_6=punct	path2=trimeprazine_conj	lemma_5=]	relType_4=punct	path=triflupromazine_conj<acetophenazine_dep>trimeprazine_conj	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e21	DDI-DrugBank.d179.s21.e24	null	relType_3=dep	relType_10=punct	pos_2=NN	path1=triflupromazine_conj	lemma_10=,	lemma_6=,	lib=e.	path=triflupromazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	pos_7=-LRB-	pos_8=NN	lemma_5=Vesprin	lemma_3=g.	pos_4=,	relType_6=punct	pos_9=NN	relType_9=appos	path2=trimeprazine_conj>g._appos>Temaril_dep	lemma_7=[	lemma_5=]	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	relType_8=compound	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_1=[	lemma_4=,	relType_5=appos	pos_1=-LRB-	pos_6=,	lemma_7=trimeprazine	pos_10=,	eib=True	pos_3=NN	relType_7=punct	lemma_9=g.	lemma_8=e.	relType_1=punct	pos_7=NN	relType_7=conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e22	DDI-DrugBank.d179.s21.e23	null	lib=trimeprazine	path1=Vesprin_appos<g._dep<triflupromazine_conj	eib=False	lpib=trimeprazine_NN	pos_1=-RRB-	wib=trimeprazine	lemma_1=]	pos_2=,	relType_1=punct	lemma_2=,	path=Vesprin_appos<g._dep<triflupromazine_conj<acetophenazine_dep>trimeprazine_conj	relType_2=punct	path2=trimeprazine_conj
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e22	DDI-DrugBank.d179.s21.e24	null	lemma_3=[	path1=Vesprin_appos<g._dep<triflupromazine_conj	lpib=trimeprazine_NN	lemma_6=,	relType_2=punct	relType_6=punct	lemma_4=e.	lemma_1=]	pos_3=-LRB-	pos_4=NN	lemma_2=,	path2=trimeprazine_conj>g._appos>Temaril_dep	lib=trimeprazine	relType_3=conj	pos_1=-RRB-	wib=trimeprazine	relType_4=compound	lemma_3=trimeprazine	relType_5=appos	pos_6=,	pos_5=NN	path=Vesprin_appos<g._dep<triflupromazine_conj<acetophenazine_dep>trimeprazine_conj>g._appos>Temaril_dep	eib=True	pos_3=NN	pos_2=,	lemma_5=g.	relType_1=punct	relType_3=punct
DDI-DrugBank.d179.s21	DDI-DrugBank.d179.s21.e23	DDI-DrugBank.d179.s21.e24	null	path2=g._appos>Temaril_dep	path=<trimeprazine_conj>g._appos>Temaril_dep	pos_2=NN	path1=	lib=e.	lemma_3=g.	eib=False	relType_3=appos	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_1=[	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s22	DDI-DrugBank.d179.s22.e0	DDI-DrugBank.d179.s22.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	path=<plicamycin_ROOT>g._dep>mithracin_dep	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	path2=g._dep>mithracin_dep	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s23	DDI-DrugBank.d179.s23.e0	DDI-DrugBank.d179.s23.e1	null	relType_3=dep	pos_2=NN	path1=	wib=acid	lemma_1=(	path2=increase_dep>use_nsubj>acid_compound>g._dep>depakene_dep	relType_1=compound	lemma_3=g.	pos_4=,	path=<valproic_ROOT>increase_dep>use_nsubj>acid_compound>g._dep>depakene_dep	lemma_1=acid	pos_1=NN	relType_4=punct	relType_2=compound	lemma_2=e.	lemma_4=,	pos_1=-LRB-	lib=acid	lpib=acid_NN	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s23	DDI-DrugBank.d179.s23.e0	DDI-DrugBank.d179.s23.e2	null	relType_3=dep	path2=increase_dep>use_nsubj>sulfapyridine_nmod	pos_2=NN	relType_7=case	path1=	wib=acid	lemma_1=(	pos_6=NN	relType_1=compound	lemma_3=g.	pos_4=,	path=<valproic_ROOT>increase_dep>use_nsubj>sulfapyridine_nmod	lemma_1=acid	relType_5=dep	pos_1=NN	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_6=use	lemma_2=e.	lemma_4=,	pos_1=-LRB-	lib=acid	lemma_7=of	lpib=acid_NN	pos_5=NN	eib=True	lemma_5=depakene	pos_7=IN	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s23	DDI-DrugBank.d179.s23.e1	DDI-DrugBank.d179.s23.e2	null	lib=use	pos_2=NN	pos_3=IN	relType_2=nsubj	eib=False	path=depakene_dep<g._dep<acid_compound<use_nsubj>sulfapyridine_nmod	path2=sulfapyridine_nmod	pos_1=-RRB-	lpib=use_NN	lemma_1=)	lemma_3=of	relType_1=punct	path1=depakene_dep<g._dep<acid_compound	relType_3=case	wib=Use	lemma_2=use
DDI-DrugBank.d179.s24	DDI-DrugBank.d179.s24.e0	DDI-DrugBank.d179.s24.e1	null	relType_3=dep	pos_2=NN	path2=acid_dep>g._dep>Lithostat_appos	path1=	wib=acid	lemma_1=(	lemma_3=g.	pos_4=,	relType_1=dep	lemma_1=acid	pos_1=NN	path=<acetohydroxamic_ROOT>acid_dep>g._dep>Lithostat_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lemma_4=,	pos_1=-LRB-	lib=acid	lpib=acid_NN	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s26	DDI-DrugBank.d179.s26.e0	DDI-DrugBank.d179.s26.e1	null	relType_3=dep	pos_2=NN	path=<furazolidone_ROOT>g._dep>Furoxone_appos	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct	path2=g._dep>Furoxone_appos
DDI-DrugBank.d179.s27	DDI-DrugBank.d179.s27.e0	DDI-DrugBank.d179.s27.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Furadantin_appos	path=<nitrofurantoin_ROOT>g._dep>Furadantin_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s29	DDI-DrugBank.d179.s29.e0	DDI-DrugBank.d179.s29.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path=<procainamide_ROOT>g._dep>Pronestyl_appos	relType_4=punct	path2=g._dep>Pronestyl_appos	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s30	DDI-DrugBank.d179.s30.e0	DDI-DrugBank.d179.s30.e1	null	relType_3=dep	pos_2=NN	path1=	path=<quinidine_ROOT>g._dep>Quinidex_appos	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>Quinidex_appos	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s31	DDI-DrugBank.d179.s31.e0	DDI-DrugBank.d179.s31.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	path2=g._dep>Quinamm_appos	path=<quinine_ROOT>g._dep>Quinamm_appos	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s32	DDI-DrugBank.d179.s32.e0	DDI-DrugBank.d179.s32.e1	null	relType_3=dep	pos_2=NN	path1=	path=<sulfoxone_ROOT>g._dep>diasone_dep	lib=e.	lemma_1=(	lemma_3=g.	eib=False	path2=g._dep>diasone_dep	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e0	DDI-DrugBank.d179.s33.e1	null	relType_3=dep	path=<k_nsubj>g._dep>AquaMEPHYTON_appos	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	path2=g._dep>AquaMEPHYTON_appos	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e0	DDI-DrugBank.d179.s33.e2	null	lemma_5=AquaMEPHYTON	relType_3=dep	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_1=(	lemma_3=g.	pos_4=,	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	path2=g._dep>Synkayvite_appos	path=<k_nsubj>g._dep>Synkayvite_appos	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	eib=True	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e0	DDI-DrugBank.d179.s33.e3	null	lemma_5=AquaMEPHYTON	relType_3=dep	relType_8=case	pos_2=NN	pos_5=,	path1=	lib=e.	lemma_1=(	lemma_3=g.	pos_4=,	pos_6=NNP	relType_6=punct	lemma_6=)	pos_8=IN	path2=Use_dep>sulfapyridine_nmod	relType_4=punct	lemma_5=,	relType_2=compound	relType_5=punct	pos_7=NNP	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_4=,	lemma_7=Use	relType_5=appos	pos_1=-LRB-	pos_6=-RRB-	path=<k_nsubj>Use_dep>sulfapyridine_nmod	relType_6=appos	relType_7=dep	eib=True	pos_3=NN	relType_1=punct	lemma_6=Synkayvite	lemma_8=of
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e1	DDI-DrugBank.d179.s33.e2	null	path2=Synkayvite_appos	lemma_1=,	eib=False	wib=Synkayvite	lpib=synkayvite_NNP	pos_1=,	lib=synkayvite	relType_1=punct	path1=AquaMEPHYTON_appos	path=AquaMEPHYTON_appos<g._dep>Synkayvite_appos
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e1	DDI-DrugBank.d179.s33.e3	null	lemma_2=)	path=AquaMEPHYTON_appos<g._dep<k_nsubj>Use_dep>sulfapyridine_nmod	relType_3=dep	lemma_1=,	pos_1=,	pos_3=NNP	relType_2=punct	pos_2=NNP	wib=Synkayvite	lemma_3=Use	path2=Use_dep>sulfapyridine_nmod	lemma_2=Synkayvite	pos_4=IN	relType_4=case	path1=AquaMEPHYTON_appos<g._dep	relType_2=appos	eib=True	pos_2=-RRB-	lpib=synkayvite_NNP	lib=synkayvite	relType_1=punct	lemma_4=of
DDI-DrugBank.d179.s33	DDI-DrugBank.d179.s33.e2	DDI-DrugBank.d179.s33.e3	null	relType_2=dep	path2=Use_dep>sulfapyridine_nmod	lib=use	lemma_2=Use	pos_3=IN	pos_2=NNP	eib=False	path1=Synkayvite_appos<g._dep	lpib=use_NNP	pos_1=-RRB-	lemma_3=of	relType_1=punct	lemma_1=)	relType_3=case	wib=Use	path=Synkayvite_appos<g._dep<k_nsubj>Use_dep>sulfapyridine_nmod
DDI-DrugBank.d179.s35	DDI-DrugBank.d179.s35.e0	DDI-DrugBank.d179.s35.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	path2=g._dep>peganone_dep	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct	path=<ethotoin_ROOT>g._dep>peganone_dep
DDI-DrugBank.d179.s36	DDI-DrugBank.d179.s36.e0	DDI-DrugBank.d179.s36.e1	null	relType_3=dep	pos_2=NN	path2=g._dep>Mesantoin_appos	path1=	path=<mephenytoin_dep>g._dep>Mesantoin_appos	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	relType_1=punct
DDI-DrugBank.d179.s36	DDI-DrugBank.d179.s36.e0	DDI-DrugBank.d179.s36.e2	null	relType_3=dep	pos_2=NN	relType_7=case	lemma_5=Mesantoin	lib=e.	path=mephenytoin_dep<increase_ROOT>Use_nsubj>sulfapyridine_nmod	lemma_1=(	lemma_3=g.	pos_4=,	pos_6=NNP	lemma_6=Use	path2=Use_nsubj>sulfapyridine_nmod	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	lemma_7=of	eib=True	pos_7=IN	pos_3=NN	path1=mephenytoin_dep	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s36	DDI-DrugBank.d179.s36.e1	DDI-DrugBank.d179.s36.e2	null	lib=use	lemma_2=Use	pos_3=IN	pos_2=NNP	eib=False	relType_2=nsubj	lpib=use_NNP	pos_1=-RRB-	path=Mesantoin_appos<g._dep<mephenytoin_dep<increase_ROOT>Use_nsubj>sulfapyridine_nmod	path1=Mesantoin_appos<g._dep<mephenytoin_dep	path2=Use_nsubj>sulfapyridine_nmod	lemma_3=of	relType_1=punct	lemma_1=)	relType_3=case	wib=Use
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e0	DDI-DrugBank.d179.s37.e1	null	relType_8=case	lemma_1=,	lib=oral	relType_10=punct	path=<antidiabetic_ROOT>increase_parataxis>use_nsubj>antidiabetic_nmod	path1=	pos_1=,	relType_12=case	relType_9=obl	pos_2=JJ	lemma_5=medicine	lemma_12=of	lemma_6=you	eib=False	relType_13=amod	lemma_9=mouth	lemma_3=(	path2=increase_parataxis>use_nsubj>antidiabetic_nmod	relType_11=nsubj	pos_3=-LRB-	lemma_11=use	relType_5=dep	pos_4=NN	pos_9=NN	pos_8=IN	lemma_7=take	pos_12=IN	lemma_2=oral	pos_13=JJ	lemma_8=by	relType_2=amod	relType_4=compound	lemma_13=oral	lpib=oral_JJ	pos_6=PRP	pos_5=NN	lemma_10=)	relType_7=dep	pos_11=NN	wib=oral	pos_10=-RRB-	lemma_4=diabetes	relType_1=punct	pos_7=VBP	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e0	DDI-DrugBank.d179.s37.e2	null	relType_8=case	lemma_1=,	lib=oral	relType_10=punct	lemma_14=with	path1=	pos_1=,	relType_12=case	relType_9=obl	pos_2=JJ	lemma_5=medicine	lemma_12=of	lemma_6=you	lemma_14=antidiabetic	relType_13=amod	lemma_9=mouth	lemma_3=(	relType_11=nsubj	pos_3=-LRB-	lemma_11=use	path=<antidiabetic_ROOT>increase_parataxis>use_nsubj>sulfapyridine_nmod	relType_5=dep	pos_4=NN	pos_9=NN	pos_8=IN	lemma_7=take	pos_12=IN	pos_14=IN	lemma_2=oral	pos_13=JJ	lemma_8=by	relType_2=amod	relType_4=compound	lemma_13=oral	path2=increase_parataxis>use_nsubj>sulfapyridine_nmod	lpib=oral_JJ	pos_6=PRP	pos_5=NN	lemma_10=)	relType_7=dep	pos_11=NN	eib=True	wib=oral	pos_10=-RRB-	lemma_4=diabetes	pos_14=NNS	relType_14=case	relType_1=punct	relType_14=nmod	pos_7=VBP	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e0	DDI-DrugBank.d179.s37.e3	null	relType_27=cc	relation_31=neutral	relType_28=det	relType_9=obl	pos_2=JJ	pos_21=NNS	relType_17=det	relType_23=det	pos_20=NN	lemma_26=/	pos_26=HYPH	pos_3=-LRB-	relType_32=amod	relType_5=dep	pos_18=NN	relType_30=conj	lemma_8=by	lemma_29=side	lemma_32=oral	relType_24=obj	pos_6=PRP	pos_31=CC	lemma_18=chance	lemma_10=)	pos_14=NNS	relType_18=obj	relType_14=nmod	relType_8=case	lemma_24=blood	lemma_1=,	pos_30=NNS	relation_23=neutral	path1=	pos_1=,	relType_22=acl	relType_31=cc	relation_22=neutral	lemma_6=you	lemma_31=or	pos_32=JJ	lemma_14=antidiabetic	lemma_28=the	relType_13=amod	pos_16=VB	pos_28=DT	lemma_3=(	pos_29=NN	lemma_11=use	lemma_20=side	pos_9=NN	pos_12=IN	pos_8=IN	pos_14=IN	path2=increase_parataxis>chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	lemma_13=oral	lemma_17=the	relType_15=nmod	pos_5=NN	pos_11=NN	relType_7=dep	lemma_22=affect	relType_19=case	lemma_15=sulfapyridine	relType_26=punct	relType_1=punct	relType_3=punct	relType_10=punct	pos_17=DT	lemma_14=with	relType_12=case	pos_24=NN	relType_21=nmod	relType_29=compound	lemma_5=medicine	lemma_12=of	lemma_25=and	lemma_30=effect	lemma_19=of	pos_25=CC	pos_13=JJ	path=<antidiabetic_ROOT>increase_parataxis>chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	relType_2=amod	lemma_16=increase	pos_27=CC	lemma_4=diabetes	relType_14=case	pos_7=VBP	relType_6=nsubj	relType_16=parataxis	pos_19=IN	lib=oral	lemma_15=may	pos_15=MD	pos_22=VBG	relType_15=aux	lemma_9=mouth	relType_11=nsubj	pos_4=NN	lemma_7=take	relType_25=cc	lemma_2=oral	pos_15=NN	relType_4=compound	pos_23=DT	lemma_21=effect	lpib=oral_JJ	lemma_27=or	eib=True	relType_20=compound	wib=oral	pos_10=-RRB-	lemma_23=the	relation_17=beneficial
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e1	DDI-DrugBank.d179.s37.e2	effect	lemma_1=with	relType_1=case	path=antidiabetic_nmod<use_nsubj>sulfapyridine_nmod	eib=False	path1=antidiabetic_nmod	wib=sulfapyridine	lib=sulfapyridine	lpib=sulfapyridine_NN	pos_1=IN	path2=sulfapyridine_nmod
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e1	DDI-DrugBank.d179.s37.e3	null	lemma_18=or	relType_1=case	lemma_3=increase	relType_7=compound	pos_2=NN	pos_14=CC	relType_10=det	pos_7=NN	lemma_13=/	pos_2=MD	relation_9=neutral	relType_13=punct	relType_12=cc	relation_3=beneficial	lemma_5=chance	lemma_6=of	relType_16=compound	pos_3=VB	pos_12=CC	relType_11=obj	lemma_14=or	relType_6=case	relType_18=cc	pos_8=NNS	pos_13=HYPH	relType_17=conj	relation_8=neutral	lemma_2=sulfapyridine	relType_2=nmod	lemma_15=the	pos_6=IN	pos_19=JJ	lemma_10=the	lpib=sulfapyridine_NN	pos_1=IN	relType_2=aux	pos_18=CC	pos_15=DT	pos_9=VBG	path1=antidiabetic_nmod<use_nsubj	pos_4=DT	lemma_4=the	lemma_7=side	lemma_16=side	relType_3=parataxis	wib=sulfapyridine	lib=sulfapyridine	relType_14=cc	pos_16=NN	lemma_19=oral	relType_19=amod	lemma_1=with	pos_5=NN	relType_9=acl	lemma_11=blood	pos_11=NN	relation_17=neutral	pos_10=DT	eib=True	relType_8=nmod	pos_17=NNS	relType_5=obj	path2=chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	path=antidiabetic_nmod<use_nsubj<increase_parataxis>chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	lemma_8=effect	lemma_12=and	lemma_2=may	lemma_17=effect	relType_4=det	relType_15=det	lemma_9=affect
DDI-DrugBank.d179.s37	DDI-DrugBank.d179.s37.e2	DDI-DrugBank.d179.s37.e3	null	pos_7=NNS	relType_17=cc	relType_11=cc	relType_1=aux	lemma_1=may	relType_18=amod	lemma_18=oral	pos_16=NNS	lemma_5=of	relType_5=case	relation_1=beneficial	relation_6=neutral	pos_6=NN	path1=sulfapyridine_nmod<use_nsubj	eib=False	lemma_7=effect	lemma_12=/	lemma_13=or	pos_9=DT	relType_14=det	pos_2=VB	relType_12=punct	pos_18=JJ	pos_10=NN	relType_3=det	lemma_14=the	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	lemma_6=side	relType_13=cc	lemma_10=blood	relation_15=neutral	pos_15=NN	lemma_11=and	lemma_15=side	pos_8=VBG	pos_11=CC	pos_5=IN	wib=increase	relType_7=nmod	pos_1=MD	lemma_16=effect	relType_8=acl	lemma_17=or	pos_14=DT	pos_13=CC	relType_15=compound	relation_7=neutral	relType_6=compound	lpib=increase_VB	pos_3=DT	lemma_9=the	path2=chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	lemma_3=the	pos_12=HYPH	path=sulfapyridine_nmod<use_nsubj<increase_parataxis>chance_obj>effect_nmod>affect_acl>blood_obj>antidiabetic_conj	pos_17=CC	relType_2=parataxis	relType_9=det	relType_10=obj	relType_16=conj	lemma_4=chance	lemma_8=affect
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e0	DDI-DrugBank.d179.s38.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	path2=g._dep>mexate_dep	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	path=<methotrexate_dep>g._dep>mexate_dep	relType_1=punct
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e0	DDI-DrugBank.d179.s38.e2	null	path2=use_nsubj>methotrexate_nmod	path=methotrexate_dep<increase_ROOT>use_nsubj>methotrexate_nmod	relType_3=dep	pos_2=NN	relType_7=case	path1=methotrexate_dep	lib=e.	lemma_1=(	pos_6=NN	lemma_3=g.	pos_4=,	lemma_5=mexate	relType_5=dep	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_6=use	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	lemma_7=of	pos_5=NN	eib=True	pos_7=IN	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e0	DDI-DrugBank.d179.s38.e3	null	relType_8=case	relType_3=dep	pos_2=NN	relType_7=case	lemma_8=methotrexate	path1=methotrexate_dep	lib=e.	lemma_1=(	pos_6=NN	pos_8=NN	lemma_3=g.	pos_4=,	lemma_5=mexate	lemma_8=with	relType_5=dep	pos_8=IN	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_6=use	lemma_2=e.	lpib=e._NN	wib=e.	path2=use_nsubj>sulfapyridine_nmod	lemma_4=,	pos_1=-LRB-	lemma_7=of	pos_5=NN	path=methotrexate_dep<increase_ROOT>use_nsubj>sulfapyridine_nmod	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e0	DDI-DrugBank.d179.s38.e4	null	lemma_12=chance	lemma_16=affect	pos_2=NN	relType_21=cc	pos_6=NN	lemma_13=of	pos_20=HYPH	relType_17=det	lemma_5=mexate	relType_5=dep	relType_23=compound	pos_18=NN	pos_24=NNS	relType_4=punct	relType_16=acl	pos_5=-RRB-	lemma_25=of	lemma_22=the	pos_16=VBG	pos_19=CC	lemma_9=may	wib=e.	pos_1=-LRB-	relType_11=det	pos_7=IN	relType_18=obj	relType_8=case	relType_3=dep	relType_7=case	lemma_8=methotrexate	lib=e.	relType_9=aux	relType_25=case	pos_8=NN	lemma_3=g.	lemma_10=increase	lemma_15=effect	pos_9=MD	lemma_9=sulfapyridine	lemma_19=and	pos_9=NN	pos_10=VB	pos_8=IN	lemma_5=)	lemma_6=use	lemma_14=side	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_17=the	lemma_11=the	relType_15=nmod	pos_22=DT	pos_5=NN	relation_17=neutral	pos_25=IN	relType_1=punct	lemma_21=or	pos_17=DT	lemma_20=/	lemma_1=(	pos_23=NN	pos_4=,	lemma_8=with	pos_14=NN	pos_13=IN	path=methotrexate_dep<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	relType_13=case	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	relType_22=det	relType_20=punct	relType_6=nsubj	relation_18=neutral	path1=methotrexate_dep	relType_14=compound	relType_9=nmod	relType_12=obj	lemma_18=liver	lemma_24=effect	relType_10=ROOT	relType_2=compound	relType_5=punct	relType_24=conj	pos_11=DT	relType_19=cc	relation_26=neutral	lemma_7=of	pos_21=CC	lemma_23=side	pos_15=NNS	eib=True	relType_8=nmod	pos_3=NN	pos_12=NN	relation_12=beneficial
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e1	DDI-DrugBank.d179.s38.e2	null	path2=use_nsubj>methotrexate_nmod	lib=use	pos_2=NN	pos_3=IN	relType_2=nsubj	eib=False	pos_1=-RRB-	lpib=use_NN	path=mexate_dep<g._dep<methotrexate_dep<increase_ROOT>use_nsubj>methotrexate_nmod	lemma_3=of	relType_1=punct	lemma_1=)	path1=mexate_dep<g._dep<methotrexate_dep	relType_3=case	wib=Use	lemma_2=use
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e1	DDI-DrugBank.d179.s38.e3	null	lib=use	pos_2=NN	pos_3=IN	path=mexate_dep<g._dep<methotrexate_dep<increase_ROOT>use_nsubj>sulfapyridine_nmod	relType_4=nmod	lemma_1=)	lemma_2=use	relType_2=nsubj	lpib=use_NN	pos_4=NN	wib=Use	lemma_4=methotrexate	lemma_4=with	pos_4=IN	pos_1=-RRB-	relType_4=case	path2=use_nsubj>sulfapyridine_nmod	relType_3=case	eib=True	lemma_3=of	relType_1=punct	path1=mexate_dep<g._dep<methotrexate_dep
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e1	DDI-DrugBank.d179.s38.e4	null	pos_2=NN	lemma_6=increase	pos_16=HYPH	lemma_2=use	relation_13=neutral	lpib=use_NN	relType_9=case	pos_10=NN	relType_6=ROOT	relType_16=punct	lemma_15=and	relType_21=case	relation_7=beneficial	relation_12=neutral	lemma_11=effect	relType_13=det	pos_15=CC	relType_12=acl	pos_6=VB	relType_17=cc	relType_4=nmod	lemma_12=affect	pos_8=NN	pos_18=DT	relType_2=nsubj	relType_20=conj	lemma_8=chance	lemma_4=methotrexate	relType_19=compound	pos_5=MD	lemma_16=/	pos_1=-RRB-	lemma_5=sulfapyridine	pos_5=NN	path=mexate_dep<g._dep<methotrexate_dep<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	relType_18=det	pos_17=CC	relType_11=nmod	relType_1=punct	lemma_21=of	lemma_18=the	lib=use	pos_3=IN	pos_12=VBG	relType_7=det	lemma_5=may	relType_14=obj	relType_8=obj	pos_21=IN	pos_14=NN	relType_5=aux	pos_7=DT	lemma_4=with	pos_4=IN	lemma_17=or	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	lemma_19=side	path1=mexate_dep<g._dep<methotrexate_dep	lemma_13=the	pos_13=DT	pos_9=IN	relation_21=neutral	lemma_1=)	pos_11=NNS	pos_19=NN	relType_10=compound	lemma_20=effect	pos_4=NN	wib=Use	relType_4=case	relType_5=nmod	pos_20=NNS	relType_15=cc	relType_3=case	eib=True	lemma_9=of	lemma_14=liver	lemma_7=the	lemma_3=of	lemma_10=side
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e2	DDI-DrugBank.d179.s38.e3	effect	lemma_1=with	path1=methotrexate_nmod	relType_1=case	eib=False	wib=sulfapyridine	lib=sulfapyridine	lpib=sulfapyridine_NN	pos_1=IN	path2=sulfapyridine_nmod	path=methotrexate_nmod<use_nsubj>sulfapyridine_nmod
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e2	DDI-DrugBank.d179.s38.e4	null	path=methotrexate_nmod<use_nsubj<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	relType_1=case	lemma_3=increase	relType_7=compound	pos_2=NN	pos_14=CC	relType_10=det	pos_7=NN	lemma_13=/	pos_2=MD	relation_9=neutral	relType_13=punct	relType_12=cc	relation_3=beneficial	lemma_5=chance	lemma_6=of	relType_16=compound	pos_3=VB	pos_12=CC	relType_11=obj	lemma_14=or	relType_6=case	relation_8=neutral	pos_8=NNS	pos_13=HYPH	relType_17=conj	relType_18=case	lemma_2=sulfapyridine	relType_2=nmod	lemma_15=the	pos_6=IN	lemma_10=the	lpib=sulfapyridine_NN	pos_1=IN	relType_2=aux	pos_15=DT	lemma_11=liver	pos_18=IN	lemma_18=of	pos_9=VBG	pos_4=DT	relType_3=ROOT	lemma_4=the	lemma_7=side	lemma_16=side	wib=sulfapyridine	lib=sulfapyridine	relType_14=cc	path1=methotrexate_nmod<use_nsubj	pos_16=NN	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	lemma_1=with	pos_5=NN	relType_9=acl	relation_17=neutral	pos_11=NN	pos_10=DT	eib=True	relType_8=nmod	pos_17=NNS	relType_5=obj	lemma_8=effect	lemma_12=and	lemma_2=may	lemma_17=effect	relType_4=det	relType_15=det	lemma_9=affect
DDI-DrugBank.d179.s38	DDI-DrugBank.d179.s38.e3	DDI-DrugBank.d179.s38.e4	null	pos_7=NNS	relType_11=cc	relType_1=aux	lemma_1=may	pos_16=NNS	lemma_5=of	relType_5=case	lemma_10=liver	relation_1=beneficial	relation_6=neutral	pos_6=NN	pos_17=IN	path1=sulfapyridine_nmod<use_nsubj	eib=False	lemma_7=effect	lemma_12=/	lemma_13=or	path=sulfapyridine_nmod<use_nsubj<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	pos_9=DT	relType_14=det	pos_2=VB	relType_12=punct	pos_10=NN	relType_3=det	lemma_14=the	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	lemma_6=side	relType_13=cc	relType_17=case	relation_15=neutral	pos_15=NN	lemma_11=and	lemma_15=side	relType_2=ROOT	pos_8=VBG	pos_11=CC	pos_5=IN	wib=increase	relType_7=nmod	lemma_17=of	pos_1=MD	lemma_16=effect	relType_8=acl	pos_14=DT	pos_13=CC	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>methotrexate_nmod	relType_15=compound	relation_7=neutral	relType_6=compound	lpib=increase_VB	pos_3=DT	lemma_9=the	lemma_3=the	pos_12=HYPH	relType_9=det	relType_10=obj	relType_16=conj	lemma_4=chance	lemma_8=affect
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e0	DDI-DrugBank.d179.s39.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	path=<methyldopa_dep>g._dep>Aldomet_appos	pos_3=NN	relType_1=punct	path2=g._dep>Aldomet_appos
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e0	DDI-DrugBank.d179.s39.e2	null	relType_3=dep	pos_2=NN	relType_7=case	path1=methyldopa_dep	lib=e.	lemma_1=(	lemma_3=g.	pos_4=,	pos_6=NNP	path2=Use_nsubj>methyldopa_nmod	lemma_6=Use	lemma_5=Aldomet	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	path=methyldopa_dep<increase_ROOT>Use_nsubj>methyldopa_nmod	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_4=,	relType_5=appos	pos_1=-LRB-	lemma_7=of	eib=True	pos_7=IN	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e0	DDI-DrugBank.d179.s39.e3	null	relType_8=case	relType_3=dep	pos_2=NN	relType_7=case	path1=methyldopa_dep	lib=e.	lemma_1=(	pos_8=NN	lemma_3=g.	path=methyldopa_dep<increase_ROOT>Use_nsubj>sulfapyridine_nmod	pos_4=,	pos_6=NNP	lemma_6=Use	path2=Use_nsubj>sulfapyridine_nmod	lemma_8=with	pos_8=IN	lemma_5=Aldomet	lemma_5=)	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_2=e.	lpib=e._NN	pos_5=NNP	wib=e.	lemma_4=,	lemma_8=methyldopa	relType_5=appos	pos_1=-LRB-	lemma_7=of	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e1	DDI-DrugBank.d179.s39.e2	null	lib=use	lemma_2=Use	pos_3=IN	pos_2=NNP	eib=False	relType_2=nsubj	path2=Use_nsubj>methyldopa_nmod	lpib=use_NNP	pos_1=-RRB-	path1=Aldomet_appos<g._dep<methyldopa_dep	path=Aldomet_appos<g._dep<methyldopa_dep<increase_ROOT>Use_nsubj>methyldopa_nmod	lemma_3=of	relType_1=punct	lemma_1=)	relType_3=case	wib=Use
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e1	DDI-DrugBank.d179.s39.e3	null	lib=use	pos_3=IN	relType_4=nmod	lemma_1=)	pos_2=NNP	relType_2=nsubj	lpib=use_NNP	path2=Use_nsubj>sulfapyridine_nmod	pos_4=NN	wib=Use	lemma_4=with	lemma_2=Use	pos_4=IN	pos_1=-RRB-	path1=Aldomet_appos<g._dep<methyldopa_dep	path=Aldomet_appos<g._dep<methyldopa_dep<increase_ROOT>Use_nsubj>sulfapyridine_nmod	relType_4=case	relType_3=case	eib=True	lemma_4=methyldopa	lemma_3=of	relType_1=punct
DDI-DrugBank.d179.s39	DDI-DrugBank.d179.s39.e2	DDI-DrugBank.d179.s39.e3	effect	path=methyldopa_nmod<Use_nsubj>sulfapyridine_nmod	lemma_1=with	relType_1=case	path1=methyldopa_nmod	eib=False	wib=sulfapyridine	lib=sulfapyridine	lpib=sulfapyridine_NN	pos_1=IN	path2=sulfapyridine_nmod
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e0	DDI-DrugBank.d179.s40.e1	null	relType_3=dep	pos_2=NN	path1=	lib=e.	path2=g._dep>dilantin_dep	lemma_1=(	lemma_3=g.	eib=False	pos_4=,	relType_4=punct	relType_2=compound	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	pos_1=-LRB-	pos_3=NN	path=<phenytoin_dep>g._dep>dilantin_dep	relType_1=punct
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e0	DDI-DrugBank.d179.s40.e2	null	relType_3=dep	pos_2=NN	relType_7=case	lemma_5=dilantin	lib=e.	lemma_1=(	pos_6=NN	lemma_3=g.	pos_4=,	path=phenytoin_dep<increase_ROOT>use_nsubj>phenytoin_nmod	relType_5=dep	lemma_5=)	relType_4=punct	pos_5=-RRB-	path2=use_nsubj>phenytoin_nmod	relType_2=compound	relType_5=punct	lemma_6=use	lemma_2=e.	lpib=e._NN	wib=e.	lemma_4=,	path1=phenytoin_dep	pos_1=-LRB-	lemma_7=of	pos_5=NN	eib=True	pos_7=IN	pos_3=NN	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e0	DDI-DrugBank.d179.s40.e3	null	relType_8=case	relType_3=dep	pos_2=NN	relType_7=case	lemma_5=dilantin	lib=e.	lemma_1=(	pos_6=NN	pos_8=NN	lemma_3=g.	pos_4=,	lemma_8=with	relType_5=dep	pos_8=IN	lemma_5=)	path=phenytoin_dep<increase_ROOT>use_nsubj>sulfapyridine_nmod	relType_4=punct	pos_5=-RRB-	relType_2=compound	relType_5=punct	lemma_6=use	lemma_2=e.	lpib=e._NN	wib=e.	path2=use_nsubj>sulfapyridine_nmod	lemma_4=,	path1=phenytoin_dep	pos_1=-LRB-	lemma_7=of	pos_5=NN	eib=True	pos_7=IN	relType_8=nmod	pos_3=NN	lemma_8=phenytoin	relType_1=punct	relType_6=nsubj
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e0	DDI-DrugBank.d179.s40.e4	null	lemma_12=chance	lemma_16=affect	pos_2=NN	lemma_5=dilantin	relType_21=cc	pos_6=NN	lemma_13=of	pos_20=HYPH	relType_17=det	relType_5=dep	relType_23=compound	pos_18=NN	pos_24=NNS	relType_4=punct	relType_16=acl	pos_5=-RRB-	lemma_25=of	lemma_22=the	pos_16=VBG	pos_19=CC	lemma_9=may	wib=e.	pos_1=-LRB-	relType_11=det	pos_7=IN	lemma_8=phenytoin	relType_18=obj	path=phenytoin_dep<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	relType_8=case	relType_3=dep	relType_7=case	lib=e.	relType_9=aux	relType_25=case	pos_8=NN	lemma_3=g.	lemma_10=increase	lemma_15=effect	pos_9=MD	lemma_9=sulfapyridine	lemma_19=and	pos_9=NN	pos_10=VB	pos_8=IN	lemma_5=)	lemma_6=use	lemma_14=side	lemma_2=e.	lpib=e._NN	lemma_4=,	lemma_17=the	lemma_11=the	path1=phenytoin_dep	relType_15=nmod	pos_22=DT	pos_5=NN	relation_17=neutral	pos_25=IN	relType_1=punct	lemma_21=or	pos_17=DT	lemma_20=/	lemma_1=(	pos_23=NN	pos_4=,	lemma_8=with	pos_14=NN	pos_13=IN	relType_13=case	relType_22=det	relType_20=punct	relType_6=nsubj	relation_18=neutral	relType_14=compound	relType_9=nmod	relType_12=obj	lemma_18=liver	lemma_24=effect	relType_10=ROOT	relType_2=compound	relType_5=punct	relType_24=conj	pos_11=DT	relType_19=cc	relation_26=neutral	lemma_7=of	pos_21=CC	lemma_23=side	pos_15=NNS	eib=True	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	relType_8=nmod	pos_3=NN	pos_12=NN	relation_12=beneficial
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e1	DDI-DrugBank.d179.s40.e2	null	lib=use	pos_2=NN	pos_3=IN	path1=dilantin_dep<g._dep<phenytoin_dep	eib=False	path2=use_nsubj>phenytoin_nmod	relType_2=nsubj	pos_1=-RRB-	lpib=use_NN	lemma_3=of	relType_1=punct	lemma_1=)	path=dilantin_dep<g._dep<phenytoin_dep<increase_ROOT>use_nsubj>phenytoin_nmod	relType_3=case	wib=Use	lemma_2=use
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e1	DDI-DrugBank.d179.s40.e3	null	lib=use	pos_2=NN	pos_3=IN	lemma_4=phenytoin	relType_4=nmod	lemma_1=)	lemma_2=use	relType_2=nsubj	lpib=use_NN	pos_4=NN	wib=Use	lemma_4=with	pos_4=IN	pos_1=-RRB-	relType_4=case	path2=use_nsubj>sulfapyridine_nmod	relType_3=case	path=dilantin_dep<g._dep<phenytoin_dep<increase_ROOT>use_nsubj>sulfapyridine_nmod	eib=True	path1=dilantin_dep<g._dep<phenytoin_dep	lemma_3=of	relType_1=punct
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e1	DDI-DrugBank.d179.s40.e4	null	pos_2=NN	lemma_6=increase	pos_16=HYPH	lemma_2=use	relation_13=neutral	lpib=use_NN	relType_9=case	pos_10=NN	relType_6=ROOT	relType_16=punct	lemma_15=and	relType_21=case	relation_7=beneficial	relation_12=neutral	path1=dilantin_dep<g._dep<phenytoin_dep	lemma_11=effect	relType_13=det	pos_15=CC	relType_12=acl	pos_6=VB	relType_17=cc	relType_4=nmod	lemma_12=affect	pos_8=NN	pos_18=DT	relType_2=nsubj	relType_20=conj	lemma_8=chance	relType_19=compound	pos_5=MD	lemma_16=/	pos_1=-RRB-	lemma_5=sulfapyridine	pos_5=NN	relType_18=det	pos_17=CC	relType_11=nmod	relType_1=punct	lemma_21=of	lemma_18=the	lib=use	pos_3=IN	pos_12=VBG	relType_7=det	lemma_5=may	relType_14=obj	relType_8=obj	pos_21=IN	pos_14=NN	relType_5=aux	path=dilantin_dep<g._dep<phenytoin_dep<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	pos_7=DT	lemma_4=with	pos_4=IN	lemma_17=or	lemma_19=side	lemma_13=the	lemma_4=phenytoin	pos_13=DT	pos_9=IN	relation_21=neutral	lemma_1=)	pos_11=NNS	pos_19=NN	relType_10=compound	lemma_20=effect	pos_4=NN	wib=Use	relType_4=case	relType_5=nmod	pos_20=NNS	relType_15=cc	relType_3=case	eib=True	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	lemma_9=of	lemma_14=liver	lemma_7=the	lemma_3=of	lemma_10=side
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e2	DDI-DrugBank.d179.s40.e3	effect	lemma_1=with	relType_1=case	eib=False	path1=phenytoin_nmod	wib=sulfapyridine	lib=sulfapyridine	lpib=sulfapyridine_NN	pos_1=IN	path2=sulfapyridine_nmod	path=phenytoin_nmod<use_nsubj>sulfapyridine_nmod
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e2	DDI-DrugBank.d179.s40.e4	null	relType_1=case	lemma_3=increase	relType_7=compound	pos_2=NN	pos_14=CC	relType_10=det	pos_7=NN	lemma_13=/	pos_2=MD	relation_9=neutral	relType_13=punct	relType_12=cc	relation_3=beneficial	lemma_5=chance	lemma_6=of	relType_16=compound	pos_3=VB	pos_12=CC	relType_11=obj	lemma_14=or	relType_6=case	relation_8=neutral	pos_8=NNS	pos_13=HYPH	relType_17=conj	relType_18=case	lemma_2=sulfapyridine	relType_2=nmod	lemma_15=the	pos_6=IN	lemma_10=the	lpib=sulfapyridine_NN	pos_1=IN	relType_2=aux	pos_15=DT	lemma_11=liver	pos_18=IN	lemma_18=of	pos_9=VBG	pos_4=DT	relType_3=ROOT	lemma_4=the	lemma_7=side	lemma_16=side	wib=sulfapyridine	lib=sulfapyridine	relType_14=cc	pos_16=NN	lemma_1=with	pos_5=NN	relType_9=acl	relation_17=neutral	pos_11=NN	pos_10=DT	eib=True	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	relType_8=nmod	pos_17=NNS	relType_5=obj	path=phenytoin_nmod<use_nsubj<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	lemma_8=effect	lemma_12=and	lemma_2=may	path1=phenytoin_nmod<use_nsubj	lemma_17=effect	relType_4=det	relType_15=det	lemma_9=affect
DDI-DrugBank.d179.s40	DDI-DrugBank.d179.s40.e3	DDI-DrugBank.d179.s40.e4	null	pos_7=NNS	relType_11=cc	relType_1=aux	lemma_1=may	pos_16=NNS	lemma_5=of	relType_5=case	lemma_10=liver	relation_1=beneficial	relation_6=neutral	pos_6=NN	pos_17=IN	path=sulfapyridine_nmod<use_nsubj<increase_ROOT>chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	path1=sulfapyridine_nmod<use_nsubj	eib=False	lemma_7=effect	lemma_12=/	lemma_13=or	pos_9=DT	relType_14=det	pos_2=VB	relType_12=punct	pos_10=NN	relType_3=det	lemma_14=the	pos_4=NN	lib=increase	relType_4=obj	lemma_2=increase	lemma_6=side	relType_13=cc	relType_17=case	relation_15=neutral	pos_15=NN	lemma_11=and	lemma_15=side	relType_2=ROOT	pos_8=VBG	pos_11=CC	pos_5=IN	wib=increase	relType_7=nmod	lemma_17=of	pos_1=MD	lemma_16=effect	relType_8=acl	pos_14=DT	pos_13=CC	relType_15=compound	relation_7=neutral	relType_6=compound	lpib=increase_VB	path2=chance_obj>effect_nmod>affect_acl>liver_obj>effect_conj>phenytoin_nmod	pos_3=DT	lemma_9=the	lemma_3=the	pos_12=HYPH	relType_9=det	relType_10=obj	relType_16=conj	lemma_4=chance	lemma_8=affect
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e1	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	lemma_11=,	path1=sutent_nmod	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_7=family	pos_6=NN	pos_3=NNS	relType_9=compound	eib=False	relType_11=punct	lemma_2=strong	pos_1=IN	pos_10=NN	pos_9=NN	lemma_3=inhibitor	pos_8=-LRB-	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>ketoconazole_appos	pos_11=,	lemma_1=with	relType_6=compound	lemma_5=the	lib=strong	pos_5=DT	lpib=strong_JJ	pos_7=NN	lemma_4=of	path2=inhibitor_nmod>g._dep>ketoconazole_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e2	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	lemma_11=,	path1=sutent_nmod	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_7=family	pos_6=NN	lemma_12=,	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	relType_11=punct	lemma_2=strong	pos_12=,	pos_12=NN	pos_1=IN	relType_12=punct	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>itraconazole_appos	pos_10=NN	pos_9=NN	lemma_3=inhibitor	pos_8=-LRB-	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	pos_11=,	lemma_1=with	relType_6=compound	lemma_5=the	path2=inhibitor_nmod>g._dep>itraconazole_appos	eib=True	relType_12=appos	lib=strong	pos_5=DT	lpib=strong_JJ	pos_7=NN	lemma_4=of
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e3	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	pos_13=,	lemma_13=,	lemma_11=,	path1=sutent_nmod	relType_13=punct	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_7=family	pos_6=NN	lemma_12=,	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	relType_11=punct	lemma_2=strong	pos_12=,	relType_13=appos	pos_12=NN	pos_1=IN	relType_12=punct	pos_10=NN	pos_13=NN	pos_9=NN	lemma_3=inhibitor	pos_8=-LRB-	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>clarithromycin_appos	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	pos_11=,	lemma_1=with	relType_6=compound	lemma_5=the	eib=True	relType_12=appos	lib=strong	path2=inhibitor_nmod>g._dep>clarithromycin_appos	pos_5=DT	lpib=strong_JJ	pos_7=NN	lemma_13=itraconazole	lemma_4=of
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e4	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	pos_13=,	relType_14=punct	lemma_13=,	lemma_11=,	path1=sutent_nmod	relType_13=punct	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_7=family	pos_6=NN	lemma_12=,	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	pos_14=,	relType_11=punct	lemma_2=strong	pos_12=,	relType_13=appos	pos_12=NN	pos_1=IN	relType_12=punct	pos_10=NN	pos_13=NN	pos_9=NN	lemma_3=inhibitor	pos_14=NN	pos_8=-LRB-	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	relType_14=appos	pos_11=,	lemma_1=with	relType_6=compound	lemma_14=,	path2=inhibitor_nmod>g._dep>atazanavir_appos	lemma_5=the	eib=True	relType_12=appos	lib=strong	lemma_14=clarithromycin	pos_5=DT	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>atazanavir_appos	lpib=strong_JJ	pos_7=NN	lemma_13=itraconazole	lemma_4=of
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e5	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	pos_13=,	relType_14=punct	lemma_13=,	lemma_11=,	path1=sutent_nmod	relType_13=punct	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>indinavir_appos	lemma_7=family	pos_6=NN	lemma_12=,	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	pos_15=,	pos_14=,	relType_11=punct	lemma_2=strong	pos_12=,	relType_13=appos	pos_12=NN	pos_1=IN	relType_12=punct	pos_10=NN	pos_13=NN	pos_9=NN	lemma_3=inhibitor	pos_14=NN	relType_15=punct	pos_8=-LRB-	pos_15=NN	lemma_15=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	relType_14=appos	pos_11=,	lemma_1=with	relType_6=compound	lemma_14=,	lemma_5=the	eib=True	path2=inhibitor_nmod>g._dep>indinavir_appos	relType_12=appos	lib=strong	lemma_14=clarithromycin	pos_5=DT	relType_15=appos	lemma_15=atazanavir	lpib=strong_JJ	pos_7=NN	lemma_13=itraconazole	lemma_4=of
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e6	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	pos_13=,	relType_14=punct	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>nefazodone_appos	lemma_11=,	lemma_13=,	path1=sutent_nmod	relType_13=punct	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_7=family	pos_6=NN	lemma_12=,	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	pos_15=,	pos_14=,	relType_11=punct	lemma_2=strong	pos_12=,	relType_13=appos	pos_16=,	pos_12=NN	path2=inhibitor_nmod>g._dep>nefazodone_appos	pos_1=IN	pos_10=NN	relType_12=punct	pos_9=NN	lemma_3=inhibitor	pos_13=NN	pos_14=NN	pos_8=-LRB-	relType_15=punct	lemma_16=,	pos_15=NN	lemma_15=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	relType_14=appos	pos_16=NN	pos_11=,	relType_16=punct	lemma_16=indinavir	lemma_1=with	relType_6=compound	lemma_14=,	lemma_5=the	eib=True	relType_12=appos	relType_15=appos	lib=strong	lemma_14=clarithromycin	pos_5=DT	lemma_15=atazanavir	lpib=strong_JJ	pos_7=NN	lemma_13=itraconazole	lemma_4=of	relType_16=appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e7	mechanism	relType_1=case	lemma_6=cyp3a4	lemma_8=(	pos_13=,	relType_14=punct	lemma_13=,	lemma_11=,	path1=sutent_nmod	relType_17=punct	relType_13=punct	wib=strong	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_10=g.	lemma_17=nefazodone	lemma_7=family	path2=inhibitor_nmod>g._dep>nelfinavir_appos	pos_6=NN	lemma_12=,	pos_17=NN	pos_3=NNS	relType_9=compound	lemma_12=ketoconazole	lemma_17=,	pos_15=,	pos_14=,	relType_11=punct	lemma_2=strong	pos_12=,	relType_13=appos	pos_16=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_10=NN	pos_13=NN	pos_9=NN	lemma_3=inhibitor	pos_14=NN	relType_15=punct	pos_8=-LRB-	lemma_16=,	pos_17=,	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>nelfinavir_appos	pos_15=NN	lemma_15=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	relType_4=case	relType_7=nmod	lemma_9=e.	relType_14=appos	pos_16=NN	pos_11=,	relType_16=punct	lemma_16=indinavir	lemma_1=with	relType_6=compound	lemma_14=,	lemma_5=the	eib=True	relType_12=appos	relType_15=appos	lib=strong	lemma_14=clarithromycin	pos_5=DT	relType_17=appos	lemma_15=atazanavir	lpib=strong_JJ	pos_7=NN	lemma_13=itraconazole	lemma_4=of	relType_16=appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e8	mechanism	lemma_13=,	path1=sutent_nmod	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_17=nefazodone	pos_6=NN	lemma_12=,	pos_3=NNS	pos_12=,	pos_10=NN	pos_13=NN	lemma_16=,	pos_18=NN	relType_16=punct	lemma_16=indinavir	relType_6=compound	relType_12=appos	lemma_14=clarithromycin	lemma_13=itraconazole	relType_1=case	lemma_6=cyp3a4	pos_13=,	lemma_12=ketoconazole	lemma_2=strong	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_15=,	relType_7=nmod	lemma_9=e.	pos_16=NN	lemma_14=,	lemma_5=the	relType_17=appos	relType_15=appos	lpib=strong_JJ	pos_7=NN	relType_14=punct	lemma_8=(	lemma_11=,	relType_17=punct	wib=strong	lemma_7=family	pos_17=NN	pos_15=,	pos_14=,	relType_11=punct	pos_14=NN	relType_15=punct	relType_18=appos	pos_17=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>ritonavir_appos	pos_5=DT	lemma_15=atazanavir	lemma_4=of	relType_16=appos	path2=inhibitor_nmod>g._dep>ritonavir_appos	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	pos_16=,	lemma_3=inhibitor	pos_8=-LRB-	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	relType_14=appos	pos_11=,	lemma_1=with	eib=True	lib=strong	pos_12=NN	lemma_18=nelfinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e9	mechanism	lemma_13=,	path1=sutent_nmod	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_17=nefazodone	pos_6=NN	lemma_12=,	pos_3=NNS	pos_12=,	pos_10=NN	pos_13=NN	lemma_16=,	pos_18=NN	relType_16=punct	lemma_16=indinavir	relType_6=compound	relType_12=appos	lemma_14=clarithromycin	lemma_13=itraconazole	relType_1=case	lemma_6=cyp3a4	pos_13=,	lemma_12=ketoconazole	path2=inhibitor_nmod>g._dep>saquinavir_appos	lemma_2=strong	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_15=,	pos_19=,	relType_7=nmod	lemma_9=e.	pos_16=NN	lemma_14=,	lemma_5=the	relType_17=appos	relType_15=appos	lemma_19=,	lpib=strong_JJ	pos_7=NN	relType_14=punct	lemma_8=(	lemma_11=,	relType_17=punct	wib=strong	relType_19=punct	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>saquinavir_appos	lemma_7=family	pos_17=NN	pos_15=,	pos_14=,	relType_11=punct	relType_19=appos	pos_14=NN	relType_15=punct	relType_18=appos	pos_17=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	lemma_19=ritonavir	pos_5=DT	lemma_15=atazanavir	lemma_4=of	relType_16=appos	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	pos_16=,	pos_19=NN	lemma_3=inhibitor	pos_8=-LRB-	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	relType_14=appos	pos_11=,	lemma_1=with	eib=True	lib=strong	pos_12=NN	lemma_18=nelfinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e10	mechanism	lemma_13=,	path1=sutent_nmod	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_17=nefazodone	pos_6=NN	lemma_20=,	lemma_12=,	pos_3=NNS	pos_12=,	pos_20=NN	pos_10=NN	pos_13=NN	lemma_16=,	path2=inhibitor_nmod>g._dep>telithromycin_appos	pos_18=NN	relType_20=appos	relType_16=punct	lemma_16=indinavir	relType_6=compound	relType_12=appos	lemma_14=clarithromycin	lemma_13=itraconazole	relType_1=case	lemma_6=cyp3a4	pos_13=,	lemma_12=ketoconazole	lemma_2=strong	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_15=,	pos_19=,	relType_7=nmod	lemma_9=e.	pos_16=NN	lemma_14=,	lemma_5=the	relType_17=appos	relType_15=appos	lemma_20=saquinavir	lemma_19=,	lpib=strong_JJ	pos_7=NN	relType_14=punct	lemma_8=(	lemma_11=,	relType_17=punct	wib=strong	relType_19=punct	lemma_7=family	pos_17=NN	pos_15=,	pos_14=,	relType_11=punct	relType_19=appos	pos_14=NN	relType_15=punct	relType_18=appos	pos_17=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	lemma_19=ritonavir	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>telithromycin_appos	pos_5=DT	lemma_15=atazanavir	relType_20=punct	lemma_4=of	relType_16=appos	relType_13=punct	lemma_10=g.	relType_9=compound	lemma_17=,	pos_16=,	pos_19=NN	lemma_3=inhibitor	pos_20=,	pos_8=-LRB-	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	relType_14=appos	pos_11=,	lemma_1=with	eib=True	lib=strong	pos_12=NN	lemma_18=nelfinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e11	mechanism	lemma_13=,	path1=sutent_nmod	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_17=nefazodone	pos_6=NN	lemma_20=,	lemma_12=,	lemma_21=telithromycin	pos_3=NNS	pos_12=,	pos_20=NN	pos_10=NN	pos_13=NN	lemma_16=,	pos_18=NN	relType_20=appos	relType_16=punct	lemma_16=indinavir	lemma_21=,	relType_6=compound	path=sutent_nmod<administration_nsubj>inhibitor_nmod>g._dep>voriconizole_appos	relType_12=appos	lemma_14=clarithromycin	relType_21=punct	lemma_13=itraconazole	relType_1=case	lemma_6=cyp3a4	pos_13=,	lemma_12=ketoconazole	lemma_2=strong	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_15=,	pos_19=,	relType_7=nmod	lemma_9=e.	pos_16=NN	lemma_14=,	lemma_5=the	relType_17=appos	relType_15=appos	lemma_20=saquinavir	lemma_19=,	lpib=strong_JJ	pos_7=NN	relType_14=punct	lemma_8=(	lemma_11=,	relType_17=punct	wib=strong	relType_19=punct	lemma_7=family	pos_17=NN	pos_15=,	pos_14=,	relType_11=punct	relType_19=appos	pos_14=NN	relType_15=punct	relType_18=appos	pos_17=,	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	lemma_19=ritonavir	pos_5=DT	lemma_15=atazanavir	relType_20=punct	lemma_4=of	relType_16=appos	relType_21=appos	relType_13=punct	lemma_10=g.	path2=inhibitor_nmod>g._dep>voriconizole_appos	pos_21=,	relType_9=compound	lemma_17=,	pos_16=,	pos_19=NN	lemma_3=inhibitor	pos_20=,	pos_8=-LRB-	pos_18=,	pos_15=NN	lemma_18=,	relType_18=punct	relType_4=case	relType_14=appos	pos_11=,	lemma_1=with	eib=True	lib=strong	pos_12=NN	lemma_18=nelfinavir	pos_21=NN
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e0	DDI-DrugBank.d639.s0.e12	null	pos_23=MD	lemma_13=,	relType_8=punct	relType_10=dep	pos_2=JJ	lemma_17=nefazodone	pos_6=NN	lemma_20=,	lemma_12=,	lemma_21=telithromycin	pos_3=NNS	pos_12=,	pos_20=NN	path1=sutent_nmod<administration_nsubj	pos_10=NN	pos_13=NN	lemma_16=,	pos_18=NN	relType_22=punct	pos_24=NNS	relType_20=appos	relType_16=punct	lemma_16=indinavir	lemma_21=,	relType_6=compound	lemma_22=)	relType_22=appos	relType_12=appos	lemma_14=clarithromycin	relType_21=punct	lemma_13=itraconazole	pos_22=-RRB-	relType_1=case	lemma_6=cyp3a4	pos_13=,	pos_22=NN	lemma_12=ketoconazole	lemma_2=strong	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_15=,	pos_19=,	relType_7=nmod	lemma_9=e.	pos_16=NN	lemma_14=,	relType_23=aux	lemma_5=the	relType_17=appos	relType_15=appos	lemma_20=saquinavir	relType_24=nsubj	lemma_19=,	lpib=strong_JJ	pos_7=NN	relType_14=punct	lemma_8=(	lemma_11=,	relType_17=punct	wib=strong	path=sutent_nmod<administration_nsubj<sunitinib_ROOT>	relType_19=punct	lemma_7=family	pos_17=NN	pos_15=,	pos_14=,	relType_11=punct	path2=	pos_14=NN	relType_19=appos	relType_15=punct	lemma_24=increase	relType_18=appos	pos_17=,	lemma_23=may	pos_4=IN	relType_2=amod	relType_5=det	relType_3=nmod	lemma_19=ritonavir	pos_5=DT	lemma_15=atazanavir	relType_20=punct	lemma_4=of	relType_16=appos	relType_21=appos	relType_13=punct	lemma_10=g.	pos_21=,	relType_9=compound	lemma_17=,	pos_16=,	pos_19=NN	lemma_3=inhibitor	pos_20=,	pos_8=-LRB-	pos_18=,	pos_15=NN	lemma_18=,	lemma_22=voriconizole	relType_18=punct	relType_4=case	relType_14=appos	pos_11=,	relation_34=beneficial	lemma_1=with	eib=True	lib=strong	pos_12=NN	lemma_18=nelfinavir	pos_21=NN
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e2	null	lemma_1=,	wib=itraconazole	eib=False	path1=ketoconazole_appos	pos_1=,	lpib=itraconazole_NN	lib=itraconazole	relType_1=punct	path2=itraconazole_appos	path=ketoconazole_appos<g._dep>itraconazole_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e3	null	path2=clarithromycin_appos	lemma_1=,	pos_2=NN	wib=itraconazole	eib=True	lemma_2=itraconazole	path1=ketoconazole_appos	pos_1=,	path=ketoconazole_appos<g._dep>clarithromycin_appos	pos_2=,	lpib=itraconazole_NN	lib=itraconazole	relType_1=punct	relType_2=appos	lemma_2=,	relType_2=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e4	null	lemma_1=,	pos_2=NN	pos_1=,	lpib=itraconazole_NN	relType_2=punct	path2=atazanavir_appos	path=ketoconazole_appos<g._dep>atazanavir_appos	relType_3=appos	lib=itraconazole	lemma_2=,	lemma_3=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_2=appos	pos_3=,	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e5	null	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	lpib=itraconazole_NN	path=ketoconazole_appos<g._dep>indinavir_appos	relType_2=punct	pos_4=,	relType_3=appos	lib=itraconazole	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_3=clarithromycin	path1=ketoconazole_appos	path2=indinavir_appos	lemma_4=,	relType_2=appos	pos_3=,	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	lemma_4=atazanavir	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e6	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	lemma_5=indinavir	lpib=itraconazole_NN	relType_2=punct	pos_4=,	relType_3=appos	lib=itraconazole	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_5=punct	path=ketoconazole_appos<g._dep>nefazodone_appos	lemma_4=,	relType_2=appos	relType_5=appos	pos_5=NN	path2=nefazodone_appos	pos_3=,	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	lemma_4=atazanavir	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e7	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	lemma_5=indinavir	lpib=itraconazole_NN	path2=nelfinavir_appos	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	lib=itraconazole	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_5=punct	path=ketoconazole_appos<g._dep>nelfinavir_appos	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	lemma_4=atazanavir	pos_2=,	relType_1=punct	lemma_6=nefazodone	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e8	null	lemma_1=,	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	lemma_5=indinavir	lpib=itraconazole_NN	path2=ritonavir_appos	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	path=ketoconazole_appos<g._dep>ritonavir_appos	pos_7=,	lib=itraconazole	lemma_7=,	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	relType_7=punct	lemma_4=atazanavir	pos_2=,	relType_1=punct	pos_7=NN	lemma_6=nefazodone	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e9	null	lemma_1=,	pos_2=NN	relType_7=appos	path=ketoconazole_appos<g._dep>saquinavir_appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	lemma_5=indinavir	lpib=itraconazole_NN	relType_8=punct	relType_8=appos	lemma_8=,	lemma_8=ritonavir	relType_2=punct	pos_6=NN	pos_8=NN	pos_4=,	relType_3=appos	relType_6=punct	pos_7=,	lib=itraconazole	lemma_7=,	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	relType_4=punct	lemma_3=,	lemma_5=,	path2=saquinavir_appos	path1=ketoconazole_appos	lemma_3=clarithromycin	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	relType_7=punct	lemma_4=atazanavir	pos_2=,	relType_1=punct	pos_7=NN	lemma_6=nefazodone	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e10	null	lemma_1=,	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	lemma_5=indinavir	lpib=itraconazole_NN	path=ketoconazole_appos<g._dep>telithromycin_appos	relType_8=punct	lemma_9=,	relType_8=appos	lemma_8=,	lemma_8=ritonavir	relType_2=punct	pos_6=NN	pos_8=NN	pos_4=,	relType_3=appos	relType_6=punct	pos_7=,	lib=itraconazole	lemma_7=,	pos_9=NN	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	relType_9=appos	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_5=punct	lemma_4=,	relType_2=appos	path2=telithromycin_appos	relType_9=punct	relType_5=appos	pos_6=,	pos_5=NN	lemma_9=saquinavir	pos_3=,	relType_6=appos	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	relType_7=punct	lemma_4=atazanavir	pos_2=,	pos_9=,	relType_1=punct	pos_7=NN	lemma_6=nefazodone	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e11	null	lemma_1=,	relType_10=punct	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	lemma_10=,	pos_1=,	lemma_6=,	lemma_5=indinavir	lpib=itraconazole_NN	relType_8=punct	lemma_9=,	relType_8=appos	lemma_8=,	path2=voriconizole_appos	lemma_8=ritonavir	relType_2=punct	path=ketoconazole_appos<g._dep>voriconizole_appos	pos_6=NN	pos_8=NN	pos_4=,	relType_3=appos	relType_6=punct	relType_10=appos	pos_7=,	lib=itraconazole	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	lemma_2=,	lemma_7=nelfinavir	relType_9=appos	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=clarithromycin	path1=ketoconazole_appos	relType_5=punct	lemma_10=telithromycin	lemma_4=,	relType_2=appos	relType_9=punct	relType_5=appos	pos_6=,	pos_5=NN	lemma_9=saquinavir	pos_3=,	relType_6=appos	wib=itraconazole	eib=True	lemma_2=itraconazole	pos_3=NN	relType_7=punct	pos_10=,	lemma_4=atazanavir	pos_2=,	pos_9=,	relType_1=punct	pos_7=NN	lemma_6=nefazodone	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e1	DDI-DrugBank.d639.s0.e12	null	pos_2=NN	pos_5=,	lemma_10=,	pos_13=NNS	lemma_6=,	lpib=itraconazole_NN	relType_8=punct	lemma_9=,	pos_6=NN	pos_10=NN	lemma_7=,	relType_4=punct	lemma_3=,	lemma_5=,	pos_11=-RRB-	pos_3=,	relType_6=appos	pos_10=,	pos_2=,	lemma_1=,	pos_1=,	lemma_12=may	relType_8=appos	lemma_8=ritonavir	relType_2=punct	pos_8=NN	relType_10=appos	lemma_11=)	lib=itraconazole	pos_9=NN	lemma_2=,	relType_13=nsubj	lemma_3=clarithromycin	lemma_4=,	relType_5=appos	path=ketoconazole_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	pos_5=NN	lemma_9=saquinavir	pos_11=NN	lemma_2=itraconazole	pos_9=,	relType_1=punct	pos_7=NN	lemma_6=nefazodone	relType_3=punct	pos_8=,	relType_10=punct	relType_7=appos	relType_4=appos	lemma_5=indinavir	lemma_11=voriconizole	lemma_8=,	pos_4=,	relType_3=appos	relType_11=punct	pos_7=,	path2=	relType_9=appos	lemma_10=telithromycin	path1=ketoconazole_appos<g._dep<inhibitor_nmod<administration_nsubj	lemma_13=increase	pos_12=MD	lemma_4=atazanavir	relation_22=beneficial	relType_6=punct	relType_12=aux	pos_4=NN	lemma_7=nelfinavir	relType_11=appos	relType_5=punct	relType_2=appos	relType_9=punct	pos_6=,	wib=itraconazole	eib=True	pos_3=NN	relType_7=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e3	null	path2=clarithromycin_appos	lemma_1=,	eib=False	lpib=clarithromycin_NN	path=itraconazole_appos<g._dep>clarithromycin_appos	lib=clarithromycin	pos_1=,	wib=clarithromycin	relType_1=punct	path1=itraconazole_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e4	null	lemma_1=,	path2=atazanavir_appos	pos_2=NN	eib=True	lpib=clarithromycin_NN	lib=clarithromycin	pos_1=,	wib=clarithromycin	pos_2=,	path=itraconazole_appos<g._dep>atazanavir_appos	relType_1=punct	lemma_2=clarithromycin	relType_2=appos	lemma_2=,	relType_2=punct	path1=itraconazole_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e5	null	lemma_1=,	pos_2=NN	lib=clarithromycin	pos_1=,	relType_2=punct	lemma_3=atazanavir	relType_3=appos	wib=clarithromycin	path=itraconazole_appos<g._dep>indinavir_appos	lemma_2=,	path1=itraconazole_appos	lemma_3=,	path2=indinavir_appos	lemma_2=clarithromycin	relType_2=appos	pos_3=,	eib=True	lpib=clarithromycin_NN	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e6	null	path=itraconazole_appos<g._dep>nefazodone_appos	lemma_1=,	pos_2=NN	lemma_4=indinavir	relType_4=appos	lib=clarithromycin	pos_1=,	relType_2=punct	lemma_3=atazanavir	pos_4=,	relType_3=appos	wib=clarithromycin	pos_4=NN	lemma_2=,	path1=itraconazole_appos	relType_4=punct	lemma_3=,	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	path2=nefazodone_appos	pos_3=,	eib=True	lpib=clarithromycin_NN	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e7	null	lemma_1=,	pos_2=NN	lemma_4=indinavir	pos_5=,	relType_4=appos	lib=clarithromycin	path=itraconazole_appos<g._dep>nelfinavir_appos	pos_1=,	path2=nelfinavir_appos	relType_2=punct	lemma_3=atazanavir	pos_4=,	relType_3=appos	wib=clarithromycin	pos_4=NN	lemma_2=,	path1=itraconazole_appos	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	relType_5=appos	pos_5=NN	pos_3=,	eib=True	lpib=clarithromycin_NN	pos_3=NN	pos_2=,	lemma_5=nefazodone	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e8	null	lemma_1=,	pos_2=NN	lemma_4=indinavir	pos_5=,	relType_4=appos	lib=clarithromycin	pos_1=,	lemma_6=,	path2=ritonavir_appos	relType_2=punct	pos_6=NN	lemma_3=atazanavir	pos_4=,	relType_3=appos	relType_6=punct	wib=clarithromycin	lemma_6=nelfinavir	pos_4=NN	lemma_2=,	path1=itraconazole_appos	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	lpib=clarithromycin_NN	pos_3=NN	path=itraconazole_appos<g._dep>ritonavir_appos	pos_2=,	lemma_5=nefazodone	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e9	null	lemma_7=ritonavir	lemma_1=,	pos_2=NN	relType_7=appos	lemma_4=indinavir	pos_5=,	relType_4=appos	lib=clarithromycin	pos_1=,	lemma_6=,	relType_2=punct	pos_6=NN	lemma_3=atazanavir	pos_4=,	relType_3=appos	relType_6=punct	wib=clarithromycin	pos_7=,	lemma_6=nelfinavir	lemma_7=,	pos_4=NN	lemma_2=,	path1=itraconazole_appos	relType_4=punct	lemma_3=,	lemma_5=,	path2=saquinavir_appos	relType_5=punct	path=itraconazole_appos<g._dep>saquinavir_appos	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	lpib=clarithromycin_NN	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=nefazodone	relType_1=punct	pos_7=NN	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e10	null	lemma_7=ritonavir	lemma_1=,	pos_2=NN	relType_7=appos	lemma_4=indinavir	pos_5=,	relType_4=appos	lib=clarithromycin	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=saquinavir	relType_8=appos	lemma_8=,	relType_2=punct	pos_6=NN	pos_8=NN	lemma_3=atazanavir	pos_4=,	relType_3=appos	relType_6=punct	wib=clarithromycin	pos_7=,	lemma_6=nelfinavir	lemma_7=,	pos_4=NN	lemma_2=,	path1=itraconazole_appos	relType_4=punct	path=itraconazole_appos<g._dep>telithromycin_appos	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	path2=telithromycin_appos	relType_5=appos	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	lpib=clarithromycin_NN	pos_3=NN	relType_7=punct	pos_2=,	lemma_5=nefazodone	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e11	null	lemma_7=ritonavir	lemma_1=,	pos_2=NN	relType_7=appos	lemma_4=indinavir	pos_5=,	relType_4=appos	lib=clarithromycin	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=saquinavir	lemma_9=,	relType_8=appos	lemma_8=,	path2=voriconizole_appos	relType_2=punct	pos_6=NN	pos_8=NN	lemma_3=atazanavir	pos_4=,	relType_3=appos	relType_6=punct	wib=clarithromycin	pos_7=,	lemma_6=nelfinavir	lemma_7=,	pos_9=NN	pos_4=NN	lemma_2=,	relType_9=appos	path1=itraconazole_appos	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	relType_9=punct	relType_5=appos	pos_6=,	lemma_9=telithromycin	pos_5=NN	pos_3=,	relType_6=appos	eib=True	lpib=clarithromycin_NN	pos_3=NN	relType_7=punct	pos_2=,	path=itraconazole_appos<g._dep>voriconizole_appos	lemma_5=nefazodone	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e2	DDI-DrugBank.d639.s0.e12	null	lemma_7=ritonavir	lemma_1=,	relType_10=punct	pos_2=NN	relType_7=appos	relation_20=beneficial	lemma_4=indinavir	pos_5=,	relType_4=appos	pos_11=MD	path1=itraconazole_appos<g._dep<inhibitor_nmod<administration_nsubj	lib=clarithromycin	pos_1=,	lemma_6=,	relType_8=punct	lemma_8=saquinavir	lemma_9=,	relType_8=appos	lemma_8=,	relType_2=punct	path=itraconazole_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	pos_6=NN	pos_8=NN	lemma_3=atazanavir	pos_4=,	relType_3=appos	relType_6=punct	relType_11=aux	relType_10=appos	wib=clarithromycin	pos_7=,	lemma_6=nelfinavir	path2=	pos_10=NN	lemma_7=,	pos_9=NN	pos_4=NN	lemma_2=,	relType_9=appos	relType_4=punct	lemma_3=,	lemma_12=increase	pos_12=NNS	lemma_5=,	relType_5=punct	lemma_4=,	lemma_2=clarithromycin	relType_2=appos	lemma_11=may	relType_9=punct	relType_5=appos	pos_6=,	lemma_9=telithromycin	relType_12=nsubj	pos_5=NN	lemma_10=)	pos_3=,	relType_6=appos	eib=True	lpib=clarithromycin_NN	pos_3=NN	relType_7=punct	pos_10=-RRB-	lemma_10=voriconizole	pos_2=,	lemma_5=nefazodone	pos_9=,	relType_1=punct	pos_7=NN	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e4	null	lpib=atazanavir_NN	path2=atazanavir_appos	lemma_1=,	eib=False	path1=clarithromycin_appos	lib=atazanavir	pos_1=,	relType_1=punct	path=clarithromycin_appos<g._dep>atazanavir_appos	wib=atazanavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e5	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	eib=True	lib=atazanavir	path1=clarithromycin_appos	path2=indinavir_appos	pos_1=,	lemma_2=atazanavir	pos_2=,	lemma_2=,	relType_1=punct	relType_2=appos	wib=atazanavir	path=clarithromycin_appos<g._dep>indinavir_appos	relType_2=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e6	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	pos_1=,	wib=atazanavir	relType_2=punct	path=clarithromycin_appos<g._dep>nefazodone_appos	relType_3=appos	lemma_2=atazanavir	lemma_2=,	lemma_3=,	relType_2=appos	path2=nefazodone_appos	lemma_3=indinavir	pos_3=,	eib=True	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e7	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	path2=nelfinavir_appos	wib=atazanavir	relType_2=punct	pos_4=,	relType_3=appos	lemma_2=atazanavir	lemma_4=nefazodone	pos_4=NN	lemma_2=,	path=clarithromycin_appos<g._dep>nelfinavir_appos	relType_4=punct	lemma_3=,	lemma_4=,	relType_2=appos	lemma_3=indinavir	pos_3=,	eib=True	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e8	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	path=clarithromycin_appos<g._dep>ritonavir_appos	relType_4=appos	pos_5=,	pos_1=,	path2=ritonavir_appos	wib=atazanavir	relType_2=punct	lemma_5=nelfinavir	pos_4=,	relType_3=appos	lemma_2=atazanavir	lemma_4=nefazodone	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_5=NN	lemma_3=indinavir	pos_3=,	eib=True	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e9	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	wib=atazanavir	relType_2=punct	path=clarithromycin_appos<g._dep>saquinavir_appos	pos_6=NN	lemma_5=nelfinavir	pos_4=,	relType_3=appos	relType_6=punct	lemma_2=atazanavir	lemma_4=nefazodone	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	path2=saquinavir_appos	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	lemma_6=ritonavir	pos_5=NN	lemma_3=indinavir	pos_3=,	relType_6=appos	eib=True	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e10	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	path=clarithromycin_appos<g._dep>telithromycin_appos	pos_1=,	lemma_6=,	wib=atazanavir	relType_2=punct	pos_6=NN	lemma_5=nelfinavir	pos_4=,	relType_3=appos	relType_6=punct	lemma_2=atazanavir	pos_7=,	lemma_4=nefazodone	lemma_7=,	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	path2=telithromycin_appos	relType_5=appos	pos_6=,	lemma_6=ritonavir	pos_5=NN	lemma_3=indinavir	pos_3=,	relType_6=appos	eib=True	lemma_7=saquinavir	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	relType_7=punct	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e11	null	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	relType_8=punct	relType_8=appos	lemma_8=,	wib=atazanavir	path2=voriconizole_appos	relType_2=punct	pos_6=NN	pos_8=NN	lemma_5=nelfinavir	pos_4=,	relType_3=appos	relType_6=punct	lemma_2=atazanavir	pos_7=,	lemma_4=nefazodone	lemma_7=,	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path=clarithromycin_appos<g._dep>voriconizole_appos	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	lemma_6=ritonavir	pos_5=NN	lemma_3=indinavir	pos_3=,	relType_6=appos	eib=True	lemma_7=saquinavir	pos_3=NN	lib=atazanavir	path1=clarithromycin_appos	relType_7=punct	pos_2=,	relType_1=punct	pos_7=NN	lemma_8=telithromycin	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e3	DDI-DrugBank.d639.s0.e12	null	lemma_9=)	lpib=atazanavir_NN	lemma_1=,	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	relType_8=punct	relType_8=appos	lemma_8=,	wib=atazanavir	relType_2=punct	pos_6=NN	pos_8=NN	relation_18=beneficial	pos_10=MD	lemma_5=nelfinavir	pos_4=,	relType_3=appos	relType_10=aux	relType_6=punct	lemma_2=atazanavir	pos_7=,	pos_11=NNS	relType_11=nsubj	path2=	lemma_4=nefazodone	lemma_7=,	pos_4=NN	lemma_2=,	pos_9=NN	relType_9=appos	pos_9=-RRB-	relType_4=punct	path=clarithromycin_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	path1=clarithromycin_appos<g._dep<inhibitor_nmod<administration_nsubj	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	lemma_9=voriconizole	relType_9=punct	relType_5=appos	pos_6=,	lemma_6=ritonavir	pos_5=NN	lemma_11=increase	lemma_3=indinavir	lemma_10=may	pos_3=,	relType_6=appos	eib=True	lemma_7=saquinavir	pos_3=NN	lib=atazanavir	relType_7=punct	pos_2=,	relType_1=punct	pos_7=NN	lemma_8=telithromycin	relType_3=punct	pos_8=,
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e5	null	lemma_1=,	eib=False	path2=indinavir_appos	wib=indinavir	pos_1=,	lpib=indinavir_NN	path1=atazanavir_appos	relType_1=punct	lib=indinavir	path=atazanavir_appos<g._dep>indinavir_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e6	null	path2=nefazodone_appos	path=atazanavir_appos<g._dep>nefazodone_appos	lemma_1=,	pos_2=NN	eib=True	wib=indinavir	lemma_2=,	pos_1=,	lpib=indinavir_NN	path1=atazanavir_appos	pos_2=,	relType_1=punct	relType_2=appos	lib=indinavir	lemma_2=indinavir	relType_2=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e7	null	lemma_1=,	pos_2=NN	pos_1=,	path1=atazanavir_appos	path2=nelfinavir_appos	relType_2=punct	relType_3=appos	wib=indinavir	path=atazanavir_appos<g._dep>nelfinavir_appos	lemma_2=,	lib=indinavir	lemma_2=indinavir	lemma_3=,	lpib=indinavir_NN	relType_2=appos	lemma_3=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e8	null	lemma_1=,	pos_2=NN	lemma_4=nelfinavir	relType_4=appos	pos_1=,	path1=atazanavir_appos	path2=ritonavir_appos	relType_2=punct	path=atazanavir_appos<g._dep>ritonavir_appos	pos_4=,	relType_3=appos	wib=indinavir	pos_4=NN	lemma_2=,	lib=indinavir	lemma_2=indinavir	relType_4=punct	lemma_3=,	lpib=indinavir_NN	lemma_4=,	relType_2=appos	lemma_3=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e9	null	lemma_1=,	pos_2=NN	pos_5=,	lemma_4=nelfinavir	relType_4=appos	pos_1=,	path1=atazanavir_appos	relType_2=punct	pos_4=,	relType_3=appos	wib=indinavir	path=atazanavir_appos<g._dep>saquinavir_appos	lemma_5=ritonavir	pos_4=NN	lemma_2=,	lib=indinavir	lemma_2=indinavir	relType_4=punct	lemma_3=,	lemma_5=,	path2=saquinavir_appos	relType_5=punct	lpib=indinavir_NN	lemma_4=,	relType_2=appos	relType_5=appos	pos_5=NN	lemma_3=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e10	null	path=atazanavir_appos<g._dep>telithromycin_appos	lemma_1=,	pos_2=NN	lemma_6=saquinavir	pos_5=,	lemma_4=nelfinavir	relType_4=appos	pos_1=,	lemma_6=,	path1=atazanavir_appos	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	wib=indinavir	lemma_5=ritonavir	pos_4=NN	lemma_2=,	lib=indinavir	lemma_2=indinavir	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lpib=indinavir_NN	lemma_4=,	relType_2=appos	path2=telithromycin_appos	relType_5=appos	pos_6=,	pos_5=NN	lemma_3=nefazodone	pos_3=,	relType_6=appos	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e11	null	lemma_1=,	pos_2=NN	relType_7=appos	lemma_6=saquinavir	pos_5=,	lemma_4=nelfinavir	relType_4=appos	pos_1=,	lemma_6=,	path1=atazanavir_appos	path2=voriconizole_appos	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	wib=indinavir	pos_7=,	lemma_5=ritonavir	lemma_7=telithromycin	lemma_7=,	pos_4=NN	lemma_2=,	lib=indinavir	lemma_2=indinavir	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lpib=indinavir_NN	path=atazanavir_appos<g._dep>voriconizole_appos	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=,	pos_5=NN	lemma_3=nefazodone	pos_3=,	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e4	DDI-DrugBank.d639.s0.e12	null	lemma_1=,	pos_2=NN	relType_7=appos	path1=atazanavir_appos<g._dep<inhibitor_nmod<administration_nsubj	lemma_6=saquinavir	pos_5=,	lemma_4=nelfinavir	relType_4=appos	pos_1=,	lemma_6=,	relType_8=punct	relType_9=aux	relType_8=appos	relType_2=punct	pos_6=NN	pos_8=NN	pos_10=NNS	pos_4=,	relType_3=appos	lemma_10=increase	relType_6=punct	relation_16=beneficial	wib=indinavir	pos_7=,	pos_9=MD	path2=	lemma_5=ritonavir	lemma_7=telithromycin	pos_8=-RRB-	lemma_7=,	pos_4=NN	lemma_2=,	path=atazanavir_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	lib=indinavir	lemma_2=indinavir	lemma_8=voriconizole	lemma_8=)	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lpib=indinavir_NN	lemma_9=may	lemma_4=,	relType_2=appos	relType_10=nsubj	relType_5=appos	pos_6=,	pos_5=NN	lemma_3=nefazodone	pos_3=,	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e6	null	lib=nefazodone	path2=nefazodone_appos	lemma_1=,	eib=False	pos_1=,	path1=indinavir_appos	relType_1=punct	lpib=nefazodone_NN	wib=nefazodone	path=indinavir_appos<g._dep>nefazodone_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e7	null	lib=nefazodone	path=indinavir_appos<g._dep>nelfinavir_appos	lemma_1=,	pos_2=NN	lemma_2=nefazodone	eib=True	pos_1=,	pos_2=,	path1=indinavir_appos	relType_1=punct	relType_2=appos	lpib=nefazodone_NN	path2=nelfinavir_appos	lemma_2=,	wib=nefazodone	relType_2=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e8	null	lib=nefazodone	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	pos_1=,	path2=ritonavir_appos	relType_2=punct	path=indinavir_appos<g._dep>ritonavir_appos	relType_3=appos	path1=indinavir_appos	lpib=nefazodone_NN	lemma_2=,	lemma_3=,	relType_2=appos	wib=nefazodone	lemma_2=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e9	null	lib=nefazodone	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	relType_4=appos	pos_1=,	path=indinavir_appos<g._dep>saquinavir_appos	relType_2=punct	pos_4=,	relType_3=appos	path1=indinavir_appos	lemma_4=ritonavir	lpib=nefazodone_NN	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	path2=saquinavir_appos	lemma_4=,	relType_2=appos	wib=nefazodone	lemma_2=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e10	null	lib=nefazodone	lemma_1=,	path=indinavir_appos<g._dep>telithromycin_appos	pos_2=NN	lemma_3=nelfinavir	pos_5=,	relType_4=appos	pos_1=,	relType_2=punct	pos_4=,	relType_3=appos	path1=indinavir_appos	lemma_4=ritonavir	lemma_5=saquinavir	lpib=nefazodone_NN	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	path2=telithromycin_appos	relType_5=appos	wib=nefazodone	pos_5=NN	lemma_2=nefazodone	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e11	null	lib=nefazodone	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	path2=voriconizole_appos	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	path1=indinavir_appos	lemma_4=ritonavir	lemma_5=saquinavir	lpib=nefazodone_NN	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	wib=nefazodone	pos_6=,	pos_5=NN	lemma_2=nefazodone	pos_3=,	lemma_6=telithromycin	eib=True	relType_6=appos	pos_3=NN	path=indinavir_appos<g._dep>voriconizole_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e5	DDI-DrugBank.d639.s0.e12	null	lib=nefazodone	lemma_1=,	lemma_3=nelfinavir	pos_2=NN	relType_7=appos	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	lemma_9=increase	relType_2=punct	lemma_7=voriconizole	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	pos_8=MD	pos_9=NNS	lemma_4=ritonavir	path2=	lemma_5=saquinavir	lpib=nefazodone_NN	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	pos_7=-RRB-	relType_5=appos	wib=nefazodone	pos_6=,	pos_5=NN	path1=indinavir_appos<g._dep<inhibitor_nmod<administration_nsubj	lemma_2=nefazodone	pos_3=,	lemma_6=telithromycin	eib=True	relType_6=appos	relType_9=nsubj	pos_3=NN	relType_7=punct	relation_14=beneficial	pos_2=,	lemma_8=may	relType_8=aux	relType_1=punct	pos_7=NN	path=indinavir_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	relType_3=punct	lemma_7=)
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e7	null	lemma_1=,	lpib=nelfinavir_NN	eib=False	path=nefazodone_appos<g._dep>nelfinavir_appos	pos_1=,	wib=nelfinavir	relType_1=punct	path2=nelfinavir_appos	lib=nelfinavir	path1=nefazodone_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e8	null	lemma_1=,	relType_2=punct	pos_2=NN	eib=True	lpib=nelfinavir_NN	path=nefazodone_appos<g._dep>ritonavir_appos	pos_1=,	wib=nelfinavir	pos_2=,	relType_1=punct	lemma_2=nelfinavir	relType_2=appos	path2=ritonavir_appos	lemma_2=,	lib=nelfinavir	path1=nefazodone_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e9	null	lemma_1=,	pos_2=NN	pos_1=,	wib=nelfinavir	lemma_3=ritonavir	lemma_2=nelfinavir	path=nefazodone_appos<g._dep>saquinavir_appos	relType_2=punct	path1=nefazodone_appos	relType_3=appos	lemma_2=,	lib=nelfinavir	lemma_3=,	path2=saquinavir_appos	relType_2=appos	pos_3=,	eib=True	lpib=nelfinavir_NN	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e10	null	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	wib=nelfinavir	lemma_3=ritonavir	lemma_2=nelfinavir	relType_2=punct	path1=nefazodone_appos	path=nefazodone_appos<g._dep>telithromycin_appos	pos_4=,	relType_3=appos	pos_4=NN	lemma_2=,	lib=nelfinavir	relType_4=punct	lemma_3=,	lemma_4=,	relType_2=appos	path2=telithromycin_appos	pos_3=,	eib=True	lpib=nelfinavir_NN	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_4=saquinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e11	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	wib=nelfinavir	lemma_3=ritonavir	lemma_2=nelfinavir	path2=voriconizole_appos	relType_2=punct	path1=nefazodone_appos	lemma_5=telithromycin	pos_4=,	relType_3=appos	path=nefazodone_appos<g._dep>voriconizole_appos	pos_4=NN	lemma_2=,	lib=nelfinavir	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_5=NN	pos_3=,	eib=True	lpib=nelfinavir_NN	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_4=saquinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e6	DDI-DrugBank.d639.s0.e12	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	relType_8=nsubj	lemma_6=voriconizole	pos_1=,	wib=nelfinavir	lemma_3=ritonavir	relType_7=aux	lemma_2=nelfinavir	pos_8=NNS	relType_2=punct	pos_6=NN	lemma_5=telithromycin	pos_4=,	relType_3=appos	relType_6=punct	path2=	pos_7=MD	lemma_7=may	pos_4=NN	lemma_2=,	lemma_6=)	lib=nelfinavir	lemma_8=increase	path1=nefazodone_appos<g._dep<inhibitor_nmod<administration_nsubj	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	pos_6=-RRB-	pos_5=NN	pos_3=,	relType_6=appos	eib=True	lpib=nelfinavir_NN	path=nefazodone_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lemma_4=saquinavir	relation_12=beneficial
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e7	DDI-DrugBank.d639.s0.e8	null	lemma_1=,	wib=ritonavir	eib=False	path=nelfinavir_appos<g._dep>ritonavir_appos	pos_1=,	path1=nelfinavir_appos	lib=ritonavir	relType_1=punct	path2=ritonavir_appos	lpib=ritonavir_NN
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e7	DDI-DrugBank.d639.s0.e9	null	lemma_2=ritonavir	lemma_1=,	wib=ritonavir	pos_2=NN	eib=True	path=nelfinavir_appos<g._dep>saquinavir_appos	path2=saquinavir_appos	pos_1=,	path1=nelfinavir_appos	pos_2=,	lib=ritonavir	relType_1=punct	relType_2=appos	lemma_2=,	relType_2=punct	lpib=ritonavir_NN
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e7	DDI-DrugBank.d639.s0.e10	null	lemma_2=ritonavir	lemma_1=,	pos_2=NN	lemma_3=saquinavir	pos_1=,	lib=ritonavir	path=nelfinavir_appos<g._dep>telithromycin_appos	relType_2=punct	lpib=ritonavir_NN	relType_3=appos	lemma_2=,	wib=ritonavir	lemma_3=,	relType_2=appos	path2=telithromycin_appos	pos_3=,	eib=True	pos_3=NN	path1=nelfinavir_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e7	DDI-DrugBank.d639.s0.e11	null	lemma_2=ritonavir	lemma_1=,	pos_2=NN	relType_4=appos	lemma_3=saquinavir	pos_1=,	lib=ritonavir	path2=voriconizole_appos	relType_2=punct	lpib=ritonavir_NN	pos_4=,	relType_3=appos	pos_4=NN	lemma_2=,	wib=ritonavir	relType_4=punct	lemma_3=,	lemma_4=,	relType_2=appos	lemma_4=telithromycin	pos_3=,	eib=True	pos_3=NN	path1=nelfinavir_appos	pos_2=,	relType_1=punct	relType_3=punct	path=nelfinavir_appos<g._dep>voriconizole_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e7	DDI-DrugBank.d639.s0.e12	null	pos_7=NNS	lemma_2=ritonavir	lemma_1=,	pos_2=NN	lemma_6=may	relType_4=appos	lemma_3=saquinavir	pos_1=,	lib=ritonavir	relType_2=punct	lpib=ritonavir_NN	pos_4=,	relType_3=appos	lemma_7=increase	path2=	pos_4=NN	lemma_2=,	lemma_5=)	wib=ritonavir	relType_4=punct	lemma_3=,	pos_5=-RRB-	relType_6=aux	relation_10=beneficial	relType_5=punct	lemma_4=,	relType_2=appos	lemma_4=telithromycin	pos_6=MD	relType_5=appos	pos_5=NN	pos_3=,	eib=True	lemma_5=voriconizole	pos_3=NN	pos_2=,	relType_7=nsubj	relType_1=punct	relType_3=punct	path=nelfinavir_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	path1=nelfinavir_appos<g._dep<inhibitor_nmod<administration_nsubj
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e8	DDI-DrugBank.d639.s0.e9	null	lpib=saquinavir_NN	lib=saquinavir	lemma_1=,	path1=ritonavir_appos	eib=False	path2=saquinavir_appos	path=ritonavir_appos<g._dep>saquinavir_appos	pos_1=,	relType_1=punct	wib=saquinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e8	DDI-DrugBank.d639.s0.e10	null	lpib=saquinavir_NN	lib=saquinavir	lemma_1=,	pos_2=NN	path1=ritonavir_appos	eib=True	lemma_2=saquinavir	path=ritonavir_appos<g._dep>telithromycin_appos	pos_1=,	pos_2=,	relType_1=punct	relType_2=appos	path2=telithromycin_appos	lemma_2=,	relType_2=punct	wib=saquinavir
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e8	DDI-DrugBank.d639.s0.e11	null	lemma_1=,	pos_2=NN	lemma_2=saquinavir	pos_1=,	path2=voriconizole_appos	relType_2=punct	wib=saquinavir	lib=saquinavir	lemma_3=telithromycin	path1=ritonavir_appos	relType_3=appos	lemma_2=,	lpib=saquinavir_NN	lemma_3=,	relType_2=appos	path=ritonavir_appos<g._dep>voriconizole_appos	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e8	DDI-DrugBank.d639.s0.e12	null	path=ritonavir_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	lemma_1=,	pos_2=NN	lemma_2=saquinavir	relType_4=appos	pos_1=,	lemma_6=increase	relType_2=punct	wib=saquinavir	lib=saquinavir	lemma_3=telithromycin	relation_8=beneficial	lemma_5=may	relType_3=appos	pos_4=-RRB-	path2=	relType_5=aux	pos_4=NN	lemma_2=,	lpib=saquinavir_NN	pos_5=MD	relType_4=punct	lemma_3=,	lemma_4=)	relType_2=appos	path1=ritonavir_appos<g._dep<inhibitor_nmod<administration_nsubj	pos_3=,	eib=True	pos_3=NN	lemma_4=voriconizole	pos_6=NNS	pos_2=,	relType_1=punct	relType_3=punct	relType_6=nsubj
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e9	DDI-DrugBank.d639.s0.e10	null	wib=telithromycin	path=saquinavir_appos<g._dep>telithromycin_appos	lemma_1=,	eib=False	pos_1=,	relType_1=punct	path2=telithromycin_appos	lib=telithromycin	lpib=telithromycin_NN	path1=saquinavir_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e9	DDI-DrugBank.d639.s0.e11	null	wib=telithromycin	lemma_2=telithromycin	lemma_1=,	pos_2=NN	eib=True	path=saquinavir_appos<g._dep>voriconizole_appos	pos_1=,	path2=voriconizole_appos	pos_2=,	relType_1=punct	relType_2=appos	lib=telithromycin	lemma_2=,	lpib=telithromycin_NN	relType_2=punct	path1=saquinavir_appos
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e9	DDI-DrugBank.d639.s0.e12	null	path=saquinavir_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	lemma_1=,	pos_2=NN	pos_1=,	relType_5=nsubj	lemma_4=may	lemma_5=increase	relType_2=punct	lemma_2=telithromycin	relType_3=appos	pos_5=NNS	pos_4=MD	path2=	lemma_2=,	lemma_3=voriconizole	relType_4=aux	relType_2=appos	relation_6=beneficial	lib=telithromycin	lemma_3=)	wib=telithromycin	eib=True	pos_3=-RRB-	pos_3=NN	pos_2=,	path1=saquinavir_appos<g._dep<inhibitor_nmod<administration_nsubj	relType_1=punct	relType_3=punct	lpib=telithromycin_NN
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e10	DDI-DrugBank.d639.s0.e11	null	lemma_1=,	eib=False	pos_1=,	lib=voriconizole	path2=voriconizole_appos	path1=telithromycin_appos	path=telithromycin_appos<g._dep>voriconizole_appos	relType_1=punct	lpib=voriconizole_NN	wib=voriconizole
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e10	DDI-DrugBank.d639.s0.e12	null	lemma_2=)	lemma_1=,	pos_2=NN	relation_4=beneficial	pos_1=,	lemma_3=may	path=telithromycin_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	lemma_2=voriconizole	lpib=voriconizole_NN	relType_2=punct	path1=telithromycin_appos<g._dep<inhibitor_nmod<administration_nsubj	pos_3=MD	lemma_4=increase	path2=	relType_4=nsubj	pos_4=NNS	wib=voriconizole	relType_2=appos	eib=True	pos_2=-RRB-	lib=voriconizole	relType_3=aux	relType_1=punct
DDI-DrugBank.d639.s0	DDI-DrugBank.d639.s0.e11	DDI-DrugBank.d639.s0.e12	null	lemma_3=increase	pos_3=NNS	eib=False	pos_1=-RRB-	pos_2=MD	lemma_2=may	lpib=increase_NNS	wib=increases	path2=	relType_1=punct	lemma_1=)	relType_2=aux	relation_2=beneficial	lib=increase	relType_3=nsubj	path=voriconizole_appos<g._dep<inhibitor_nmod<administration_nsubj<sunitinib_ROOT>	path1=voriconizole_appos<g._dep<inhibitor_nmod<administration_nsubj
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e1	mechanism	lemma_6=family	path=sutent_nmod<administration_nsubj>g._dep>dexamethasone_appos	relType_1=case	lemma_7=(	pos_3=IN	relType_10=punct	path1=sutent_nmod	lemma_10=,	relType_5=compound	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	eib=False	relType_2=nmod	lib=inducer	pos_1=IN	pos_9=NN	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	lemma_4=the	relType_8=compound	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_10=,	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	path2=g._dep>dexamethasone_appos	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e2	mechanism	lemma_6=family	relType_1=case	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	path1=sutent_nmod	lemma_10=,	relType_5=compound	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	relType_2=nmod	lib=inducer	relType_11=punct	pos_1=IN	pos_9=NN	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	path=sutent_nmod<administration_nsubj>g._dep>phenytoin_appos	lemma_4=the	relType_8=compound	pos_11=,	relType_3=case	path2=g._dep>phenytoin_appos	pos_2=NNS	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	eib=True	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e3	mechanism	lemma_6=family	relType_1=case	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	path1=sutent_nmod	lemma_10=,	relType_5=compound	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_12=phenytoin	lemma_12=,	relType_2=nmod	lib=inducer	relType_11=punct	pos_12=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_9=NN	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	lemma_4=the	relType_8=compound	path=sutent_nmod<administration_nsubj>g._dep>carbamazepine_appos	pos_11=,	path2=g._dep>carbamazepine_appos	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	pos_11=NN	pos_10=,	eib=True	relType_12=appos	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e4	mechanism	lemma_6=family	relType_1=case	pos_13=,	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	lemma_13=,	path1=sutent_nmod	lemma_10=,	relType_13=punct	relType_5=compound	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_12=phenytoin	lemma_12=,	relType_2=nmod	lib=inducer	relType_11=punct	relType_13=appos	pos_12=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_13=NN	pos_9=NN	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	lemma_13=carbamazepine	path2=g._dep>rifampin_appos	lemma_4=the	relType_8=compound	pos_11=,	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	path=sutent_nmod<administration_nsubj>g._dep>rifampin_appos	pos_10=,	pos_11=NN	eib=True	relType_12=appos	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e5	mechanism	lemma_6=family	relType_1=case	pos_13=,	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	lemma_13=,	path1=sutent_nmod	relType_14=punct	lemma_10=,	relType_13=punct	relType_5=compound	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_12=phenytoin	path=sutent_nmod<administration_nsubj>g._dep>rifabutin_appos	lemma_12=,	relType_2=nmod	lib=inducer	pos_14=,	relType_11=punct	relType_13=appos	pos_12=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_13=NN	pos_14=NN	pos_9=NN	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	lemma_13=carbamazepine	lemma_14=rifampin	lemma_4=the	relType_8=compound	relType_14=appos	pos_11=,	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	lemma_14=,	pos_11=NN	pos_10=,	path2=g._dep>rifabutin_appos	eib=True	relType_12=appos	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e6	mechanism	lemma_6=family	relType_1=case	pos_13=,	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	lemma_13=,	path1=sutent_nmod	relType_14=punct	lemma_10=,	relType_13=punct	relType_5=compound	lemma_15=rifabutin	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_12=phenytoin	lemma_12=,	relType_2=nmod	lib=inducer	pos_14=,	relType_11=punct	relType_13=appos	pos_12=,	pos_15=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_13=NN	path=sutent_nmod<administration_nsubj>g._dep>rifapentin_appos	pos_9=NN	pos_14=NN	relType_15=punct	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	path2=g._dep>rifapentin_appos	pos_15=NN	lemma_13=carbamazepine	lemma_15=,	lemma_14=rifampin	lemma_4=the	relType_8=compound	relType_14=appos	pos_11=,	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	lemma_14=,	pos_11=NN	pos_10=,	eib=True	relType_12=appos	relType_15=appos	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_3=of	relType_4=det	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e7	mechanism	lemma_6=family	relType_1=case	pos_13=,	lemma_7=(	pos_3=IN	relType_10=punct	lemma_11=dexamethasone	lemma_11=,	lemma_13=,	path1=sutent_nmod	relType_14=punct	lemma_10=,	relType_13=punct	relType_5=compound	lemma_15=rifabutin	relType_9=dep	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_12=phenytoin	lemma_12=,	path2=g._dep>phenobarbital_appos	relType_2=nmod	lib=inducer	pos_14=,	relType_11=punct	path=sutent_nmod<administration_nsubj>g._dep>phenobarbital_appos	pos_12=,	relType_13=appos	pos_15=,	pos_16=,	pos_12=NN	pos_1=IN	relType_12=punct	pos_13=NN	pos_14=NN	pos_9=NN	relType_15=punct	lemma_16=,	wib=inducers	lemma_5=cyp3a4	pos_4=DT	relType_6=nmod	relType_11=appos	pos_15=NN	lemma_15=,	lemma_13=carbamazepine	lemma_14=rifampin	lemma_4=the	relType_8=compound	relType_14=appos	pos_16=NN	pos_11=,	relType_16=punct	relType_3=case	pos_2=NNS	lemma_1=with	pos_5=NN	lemma_14=,	pos_11=NN	pos_10=,	eib=True	relType_12=appos	relType_15=appos	lemma_9=g.	relType_7=punct	lemma_8=e.	lpib=inducer_NNS	lemma_16=rifapentin	lemma_3=of	relType_4=det	lemma_2=inducer	relType_16=appos
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e0	DDI-DrugBank.d639.s2.e8	null	lemma_13=,	lemma_10=,	lemma_15=rifabutin	pos_21=-RRB-	pos_6=NN	pos_7=-LRB-	lemma_12=,	relType_4=det	lemma_20=Wort	pos_12=,	path1=sutent_nmod<administration_nsubj	pos_13=NN	lemma_16=,	wib=inducers	lemma_17=phenobarbital	lemma_13=carbamazepine	relType_20=appos	relType_23=ROOT	path=sutent_nmod<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	relType_16=punct	pos_10=,	relType_12=appos	lemma_9=g.	relType_21=punct	relType_1=case	pos_13=,	relation_29=adverse	path2=concentration_obj>sunitinib_compound	pos_23=VB	pos_8=NN	lemma_12=phenytoin	lib=inducer	relType_13=appos	pos_1=IN	relType_12=punct	pos_9=NN	lemma_5=cyp3a4	relType_19=compound	lemma_15=,	pos_16=NN	pos_5=NN	lemma_14=,	pos_11=NN	relType_17=appos	relType_15=appos	lemma_21=)	lemma_6=family	relType_14=punct	relType_10=punct	pos_3=IN	lemma_11=,	relType_17=punct	lemma_19=Johns	pos_17=NN	relType_2=nmod	pos_15=,	pos_14=,	relType_11=punct	pos_14=NN	relType_15=punct	pos_17=,	lemma_14=rifampin	lemma_4=the	relType_8=compound	lemma_22=may	pos_22=MD	lpib=inducer_NNS	lemma_16=rifapentin	lemma_18=St.	relType_6=nmod	relType_16=appos	lemma_23=decrease	lemma_7=(	lemma_11=dexamethasone	pos_18=NNP	relType_13=punct	relType_5=compound	relType_9=dep	lemma_17=,	pos_16=,	pos_4=DT	relType_11=appos	pos_15=NN	relType_22=aux	relType_14=appos	pos_11=,	relType_3=case	pos_2=NNS	lemma_1=with	eib=True	relType_7=punct	lemma_8=e.	relType_18=compound	pos_20=NNP	lemma_3=of	pos_19=NNP	pos_12=NN	lemma_2=inducer
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e2	null	lemma_1=,	lib=phenytoin	wib=phenytoin	eib=False	path2=phenytoin_appos	path=dexamethasone_appos<g._dep>phenytoin_appos	pos_1=,	relType_1=punct	lpib=phenytoin_NN	path1=dexamethasone_appos
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e3	null	lemma_1=,	lib=phenytoin	path2=carbamazepine_appos	path=dexamethasone_appos<g._dep>carbamazepine_appos	eib=True	wib=phenytoin	pos_2=NN	lemma_2=,	pos_1=,	lemma_2=phenytoin	pos_2=,	relType_1=punct	relType_2=appos	lpib=phenytoin_NN	path1=dexamethasone_appos	relType_2=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e4	null	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	lib=phenytoin	wib=phenytoin	relType_3=appos	lemma_2=phenytoin	lemma_2=,	lemma_3=,	path2=rifampin_appos	relType_2=appos	path1=dexamethasone_appos	lemma_3=carbamazepine	path=dexamethasone_appos<g._dep>rifampin_appos	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e5	null	path2=rifabutin_appos	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	relType_2=punct	lib=phenytoin	pos_4=,	wib=phenytoin	relType_3=appos	lemma_2=phenytoin	lemma_4=rifampin	pos_4=NN	lemma_2=,	relType_4=punct	lemma_3=,	lemma_4=,	relType_2=appos	path1=dexamethasone_appos	lemma_3=carbamazepine	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN	path=dexamethasone_appos<g._dep>rifabutin_appos
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e6	null	lemma_1=,	pos_2=NN	pos_5=,	relType_4=appos	pos_1=,	relType_2=punct	lib=phenytoin	pos_4=,	wib=phenytoin	path=dexamethasone_appos<g._dep>rifapentin_appos	relType_3=appos	lemma_2=phenytoin	lemma_4=rifampin	pos_4=NN	lemma_2=,	lemma_5=rifabutin	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	lemma_4=,	relType_2=appos	relType_5=appos	path1=dexamethasone_appos	lemma_3=carbamazepine	pos_5=NN	pos_3=,	eib=True	path2=rifapentin_appos	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e7	null	lemma_1=,	pos_2=NN	path=dexamethasone_appos<g._dep>phenobarbital_appos	lemma_6=rifapentin	pos_5=,	relType_4=appos	pos_1=,	lemma_6=,	relType_2=punct	pos_6=NN	lib=phenytoin	pos_4=,	wib=phenytoin	relType_3=appos	relType_6=punct	lemma_2=phenytoin	lemma_4=rifampin	pos_4=NN	lemma_2=,	lemma_5=rifabutin	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	path2=phenobarbital_appos	lemma_4=,	relType_2=appos	relType_5=appos	path1=dexamethasone_appos	lemma_3=carbamazepine	pos_6=,	pos_5=NN	pos_3=,	relType_6=appos	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e1	DDI-DrugBank.d639.s2.e8	null	lemma_1=,	pos_2=NN	relType_7=appos	pos_9=NNP	lemma_6=rifapentin	pos_5=,	relType_4=appos	relType_13=ROOT	path2=concentration_obj>sunitinib_compound	pos_1=,	lemma_6=,	lemma_12=may	path=dexamethasone_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	relType_2=punct	pos_6=NN	lib=phenytoin	relType_9=compound	pos_4=,	wib=phenytoin	relType_3=appos	relType_6=punct	relType_10=appos	lemma_11=)	lemma_2=phenytoin	relType_11=punct	pos_7=,	relType_12=aux	lemma_4=rifampin	lemma_7=,	pos_4=NN	lemma_2=,	lemma_5=rifabutin	pos_13=VB	lemma_13=decrease	pos_8=NNP	relType_4=punct	lemma_3=,	lemma_5=,	relType_5=punct	relType_8=compound	lemma_4=,	relType_2=appos	path1=dexamethasone_appos<g._dep<administration_nsubj	lemma_9=Johns	relType_5=appos	pos_6=,	lemma_3=carbamazepine	pos_10=NNP	pos_11=-RRB-	pos_12=MD	pos_5=NN	relation_18=adverse	lemma_8=St.	lemma_10=Wort	pos_3=,	relType_6=appos	eib=True	pos_3=NN	relType_7=punct	lemma_7=phenobarbital	pos_2=,	relType_1=punct	pos_7=NN	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e3	null	path=phenytoin_appos<g._dep>carbamazepine_appos	lemma_1=,	path2=carbamazepine_appos	lpib=carbamazepine_NN	eib=False	path1=phenytoin_appos	wib=carbamazepine	pos_1=,	relType_1=punct	lib=carbamazepine
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e4	null	lemma_1=,	path=phenytoin_appos<g._dep>rifampin_appos	pos_2=NN	eib=True	lpib=carbamazepine_NN	path1=phenytoin_appos	wib=carbamazepine	path2=rifampin_appos	pos_1=,	pos_2=,	relType_1=punct	lemma_2=carbamazepine	relType_2=appos	lemma_2=,	relType_2=punct	lib=carbamazepine
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e5	null	path2=rifabutin_appos	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_1=,	relType_2=punct	relType_3=appos	path1=phenytoin_appos	wib=carbamazepine	lemma_2=carbamazepine	lemma_2=,	lib=carbamazepine	lemma_3=,	lemma_3=rifampin	relType_2=appos	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct	path=phenytoin_appos<g._dep>rifabutin_appos
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e6	null	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	relType_4=appos	pos_1=,	relType_2=punct	pos_4=,	relType_3=appos	path1=phenytoin_appos	wib=carbamazepine	path=phenytoin_appos<g._dep>rifapentin_appos	lemma_2=carbamazepine	pos_4=NN	lemma_2=,	lib=carbamazepine	relType_4=punct	lemma_3=,	lemma_3=rifampin	lemma_4=,	relType_2=appos	lemma_4=rifabutin	pos_3=,	eib=True	path2=rifapentin_appos	pos_3=NN	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e7	null	lemma_1=,	pos_2=NN	lpib=carbamazepine_NN	pos_5=,	relType_4=appos	pos_1=,	relType_2=punct	pos_4=,	relType_3=appos	path1=phenytoin_appos	wib=carbamazepine	lemma_2=carbamazepine	pos_4=NN	lemma_2=,	lib=carbamazepine	lemma_5=rifapentin	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=rifampin	relType_5=punct	path2=phenobarbital_appos	lemma_4=,	relType_2=appos	relType_5=appos	pos_5=NN	lemma_4=rifabutin	pos_3=,	eib=True	pos_3=NN	path=phenytoin_appos<g._dep>phenobarbital_appos	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e2	DDI-DrugBank.d639.s2.e8	null	relType_7=compound	lemma_1=,	relType_10=punct	pos_2=NN	lemma_6=phenobarbital	pos_9=NNP	lpib=carbamazepine_NN	pos_5=,	relType_4=appos	lemma_9=Wort	path2=concentration_obj>sunitinib_compound	pos_1=,	lemma_6=,	lemma_7=St.	pos_11=MD	relType_2=punct	pos_6=NN	pos_4=,	relType_3=appos	relType_6=punct	relType_11=aux	wib=carbamazepine	path=phenytoin_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	lemma_2=carbamazepine	pos_4=NN	lemma_2=,	relType_9=appos	lib=carbamazepine	relType_12=ROOT	lemma_5=rifapentin	pos_8=NNP	relType_4=punct	lemma_3=,	lemma_5=,	lemma_3=rifampin	relType_5=punct	pos_7=NNP	relType_8=compound	relation_16=adverse	path1=phenytoin_appos<g._dep<administration_nsubj	lemma_4=,	relType_2=appos	lemma_11=may	relType_5=appos	pos_6=,	lemma_8=Johns	pos_12=VB	pos_5=NN	lemma_4=rifabutin	lemma_10=)	pos_3=,	relType_6=appos	eib=True	lemma_12=decrease	pos_3=NN	pos_10=-RRB-	pos_2=,	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e3	DDI-DrugBank.d639.s2.e4	null	wib=rifampin	lemma_1=,	eib=False	path=carbamazepine_appos<g._dep>rifampin_appos	path1=carbamazepine_appos	lpib=rifampin_NN	pos_1=,	path2=rifampin_appos	lib=rifampin	relType_1=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e3	DDI-DrugBank.d639.s2.e5	null	path2=rifabutin_appos	wib=rifampin	lemma_1=,	pos_2=NN	eib=True	path1=carbamazepine_appos	lpib=rifampin_NN	pos_1=,	lemma_2=rifampin	pos_2=,	lib=rifampin	relType_1=punct	relType_2=appos	lemma_2=,	path=carbamazepine_appos<g._dep>rifabutin_appos	relType_2=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e3	DDI-DrugBank.d639.s2.e6	null	wib=rifampin	lemma_1=,	pos_2=NN	pos_1=,	relType_2=punct	path=carbamazepine_appos<g._dep>rifapentin_appos	relType_3=appos	path1=carbamazepine_appos	lpib=rifampin_NN	lemma_2=,	lemma_3=,	lib=rifampin	relType_2=appos	pos_3=,	eib=True	path2=rifapentin_appos	pos_3=NN	lemma_2=rifampin	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=rifabutin
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e3	DDI-DrugBank.d639.s2.e7	null	wib=rifampin	lemma_1=,	pos_2=NN	relType_4=appos	pos_1=,	relType_2=punct	pos_4=,	relType_3=appos	path1=carbamazepine_appos	lpib=rifampin_NN	pos_4=NN	lemma_2=,	lemma_4=rifapentin	relType_4=punct	lemma_3=,	path=carbamazepine_appos<g._dep>phenobarbital_appos	path2=phenobarbital_appos	lib=rifampin	lemma_4=,	relType_2=appos	pos_3=,	eib=True	pos_3=NN	lemma_2=rifampin	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=rifabutin
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e3	DDI-DrugBank.d639.s2.e8	null	lemma_9=)	wib=rifampin	lemma_1=,	relType_7=compound	pos_2=NN	lemma_5=phenobarbital	pos_5=,	relType_4=appos	relType_11=ROOT	path2=concentration_obj>sunitinib_compound	pos_1=,	relation_14=adverse	path=carbamazepine_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	relType_8=appos	relType_2=punct	pos_10=MD	pos_4=,	relType_3=appos	pos_6=NNP	path1=carbamazepine_appos<g._dep<administration_nsubj	relType_10=aux	lpib=rifampin_NN	lemma_8=Wort	pos_4=NN	lemma_2=,	pos_9=-RRB-	lemma_4=rifapentin	pos_8=NNP	relType_4=punct	lemma_3=,	lemma_7=Johns	lemma_5=,	relType_5=punct	pos_7=NNP	lemma_6=St.	lib=rifampin	lemma_4=,	relType_2=appos	relType_9=punct	relType_5=appos	pos_5=NN	relType_6=compound	lemma_10=may	pos_3=,	eib=True	pos_11=VB	pos_3=NN	lemma_2=rifampin	pos_2=,	relType_1=punct	lemma_11=decrease	relType_3=punct	lemma_3=rifabutin
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e4	DDI-DrugBank.d639.s2.e5	null	path2=rifabutin_appos	path1=rifampin_appos	lemma_1=,	eib=False	path=rifampin_appos<g._dep>rifabutin_appos	pos_1=,	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	lib=rifabutin
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e4	DDI-DrugBank.d639.s2.e6	null	path1=rifampin_appos	lemma_1=,	pos_2=NN	eib=True	path2=rifapentin_appos	lemma_2=,	pos_1=,	pos_2=,	lpib=rifabutin_NN	wib=rifabutin	path=rifampin_appos<g._dep>rifapentin_appos	relType_1=punct	lemma_2=rifabutin	lib=rifabutin	relType_2=appos	relType_2=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e4	DDI-DrugBank.d639.s2.e7	null	lemma_1=,	pos_2=NN	pos_1=,	lib=rifabutin	relType_2=punct	path1=rifampin_appos	relType_3=appos	lemma_3=rifapentin	lemma_2=,	lemma_3=,	path=rifampin_appos<g._dep>phenobarbital_appos	path2=phenobarbital_appos	lemma_2=rifabutin	relType_2=appos	pos_3=,	eib=True	pos_3=NN	pos_2=,	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	relType_3=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e4	DDI-DrugBank.d639.s2.e8	null	lemma_1=,	pos_2=NN	lemma_5=St.	relType_7=appos	relType_4=appos	path1=rifampin_appos<g._dep<administration_nsubj	path2=concentration_obj>sunitinib_compound	pos_1=,	relType_5=compound	relType_8=punct	relType_9=aux	lib=rifabutin	relType_2=punct	relation_12=adverse	pos_4=,	relType_3=appos	pos_6=NNP	lemma_3=rifapentin	pos_9=MD	pos_8=-RRB-	pos_4=NN	lemma_2=,	pos_10=VB	relType_10=ROOT	lemma_8=)	lemma_6=Johns	relType_4=punct	lemma_3=,	pos_7=NNP	lemma_9=may	pos_5=NNP	lemma_4=,	lemma_2=rifabutin	relType_2=appos	lemma_4=phenobarbital	relType_6=compound	path=rifampin_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	pos_3=,	eib=True	pos_3=NN	pos_2=,	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	relType_3=punct	lemma_10=decrease	lemma_7=Wort
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e5	DDI-DrugBank.d639.s2.e6	null	lemma_1=,	path2=rifapentin_appos	eib=False	wib=rifapentin	path1=rifabutin_appos	pos_1=,	lib=rifapentin	path=rifabutin_appos<g._dep>rifapentin_appos	relType_1=punct	lpib=rifapentin_NN
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e5	DDI-DrugBank.d639.s2.e7	null	lemma_2=rifapentin	lemma_1=,	pos_2=NN	eib=True	wib=rifapentin	path2=phenobarbital_appos	path1=rifabutin_appos	path=rifabutin_appos<g._dep>phenobarbital_appos	pos_1=,	lib=rifapentin	pos_2=,	relType_1=punct	relType_2=appos	lpib=rifapentin_NN	lemma_2=,	relType_2=punct
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e5	DDI-DrugBank.d639.s2.e8	null	lemma_1=,	pos_2=NN	path1=rifabutin_appos<g._dep<administration_nsubj	path2=concentration_obj>sunitinib_compound	pos_1=,	relType_5=compound	pos_9=VB	relType_2=punct	relType_9=ROOT	relType_3=appos	pos_6=NNP	lemma_6=Wort	pos_8=MD	lib=rifapentin	lemma_2=,	lemma_2=rifapentin	lemma_7=)	lemma_3=,	relation_10=adverse	path=rifabutin_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	lemma_9=decrease	relType_4=compound	pos_5=NNP	relType_2=appos	pos_7=-RRB-	lpib=rifapentin_NN	lemma_3=phenobarbital	pos_3=,	relType_6=appos	eib=True	wib=rifapentin	pos_3=NN	relType_7=punct	pos_4=NNP	pos_2=,	lemma_5=Johns	lemma_8=may	relType_8=aux	relType_1=punct	relType_3=punct	lemma_4=St.
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e6	DDI-DrugBank.d639.s2.e7	null	lemma_1=,	eib=False	path=rifapentin_appos<g._dep>phenobarbital_appos	lpib=phenobarbital_NN	path1=rifapentin_appos	wib=phenobarbital	path2=phenobarbital_appos	pos_1=,	relType_1=punct	lib=phenobarbital
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e6	DDI-DrugBank.d639.s2.e8	null	lemma_4=Johns	lemma_1=,	pos_2=NN	lemma_5=Wort	path2=concentration_obj>sunitinib_compound	pos_1=,	pos_3=NNP	relType_7=aux	relType_2=punct	path=rifapentin_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	relation_8=adverse	relType_6=punct	pos_7=MD	lemma_7=may	lemma_6=)	lemma_2=,	pos_8=VB	path1=rifapentin_appos<g._dep<administration_nsubj	lemma_8=decrease	wib=phenobarbital	relType_4=compound	pos_5=NNP	relType_8=ROOT	relType_2=appos	relType_5=appos	pos_6=-RRB-	lemma_2=phenobarbital	lemma_3=St.	eib=True	lpib=phenobarbital_NN	pos_4=NNP	pos_2=,	relType_3=compound	relType_1=punct	lib=phenobarbital
DDI-DrugBank.d639.s2	DDI-DrugBank.d639.s2.e7	DDI-DrugBank.d639.s2.e8	null	lpib=st._NNP	pos_7=VB	lemma_1=,	lemma_3=Johns	lemma_6=may	relType_4=appos	path2=concentration_obj>sunitinib_compound	pos_1=,	pos_3=NNP	path1=phenobarbital_appos<g._dep<administration_nsubj	wib=St.	lemma_2=St.	pos_2=NNP	eib=False	relation_6=adverse	lib=st.	path=phenobarbital_appos<g._dep<administration_nsubj<decrease_ROOT>concentration_obj>sunitinib_compound	lemma_5=)	relType_7=ROOT	pos_5=-RRB-	relType_6=aux	relType_2=compound	relType_5=punct	lemma_7=decrease	pos_6=MD	lemma_4=Wort	pos_4=NNP	relType_3=compound	relType_1=punct
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e0	DDI-DrugBank.d723.s0.e1	null	lemma_1=(	eib=False	path=<chloride_nmod>Miochol_appos	path1=	path2=Miochol_appos	relType_1=punct	lib=miochol	wib=Miochol	pos_1=-LRB-	lpib=miochol_NNP
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e0	DDI-DrugBank.d723.s0.e2	null	lemma_2=)	pos_3=CC	path1=	relType_3=cc	relType_2=punct	lemma_1=(	pos_2=NNP	lpib=miochol_NNP	path2=carbachol_conj	lemma_2=Miochol	path=<chloride_nmod>carbachol_conj	relType_2=appos	lib=miochol	pos_1=-LRB-	eib=True	pos_2=-RRB-	lemma_3=and	relType_1=punct	wib=Miochol
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e0	DDI-DrugBank.d723.s0.e3	null	lemma_2=)	pos_3=CC	path1=	path2=carbachol_conj>carboptic_dep	relType_3=cc	relType_2=punct	path=<chloride_nmod>carbachol_conj>carboptic_dep	lemma_1=(	pos_2=NNP	pos_4=-LRB-	pos_4=NN	lemma_4=carbachol	lemma_4=(	lpib=miochol_NNP	relType_4=punct	lemma_2=Miochol	relType_2=appos	lib=miochol	pos_1=-LRB-	eib=True	pos_2=-RRB-	lemma_3=and	relType_4=conj	relType_1=punct	wib=Miochol
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e0	DDI-DrugBank.d723.s0.e4	null	lemma_2=)	pos_3=CC	pos_5=,	path1=	relType_2=punct	relType_3=cc	lemma_1=(	pos_2=NNP	lemma_5=carboptic	pos_4=-LRB-	pos_6=NNP	relType_5=dep	pos_4=NN	lemma_4=carbachol	lemma_4=(	lpib=miochol_NNP	relType_4=punct	lemma_5=,	lemma_2=Miochol	relType_5=punct	path=<chloride_nmod>carbachol_conj>carboptic_dep>Carbachol_appos	relType_2=appos	path2=carbachol_conj>carboptic_dep>Carbachol_appos	lib=miochol	pos_1=-LRB-	pos_5=NN	relType_6=compound	eib=True	pos_2=-RRB-	lemma_3=and	relType_4=conj	lemma_6=Isopto	relType_1=punct	wib=Miochol
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e0	DDI-DrugBank.d723.s0.e5	effect	lemma_2=)	path2=effect_obj>ophthalmic_nmod>suprofen_amod	path=chloride_nmod<drop_nsubj<decrease_ROOT>effect_obj>ophthalmic_nmod>suprofen_amod	pos_3=CC	pos_5=,	path1=chloride_nmod<drop_nsubj	relType_7=aux	relType_11=case	relType_3=cc	relType_2=punct	lemma_1=(	pos_10=NNS	relation_12=adverse	pos_2=NNP	lemma_5=carboptic	pos_4=-LRB-	pos_6=NNP	relType_6=punct	pos_9=DT	pos_7=MD	lemma_7=may	lemma_10=effect	relType_5=dep	pos_4=NN	lemma_4=carbachol	lemma_4=(	lemma_6=)	lpib=miochol_NNP	pos_8=VB	relType_10=obj	pos_11=IN	lemma_6=Carbachol	relType_4=punct	lemma_5=,	lemma_2=Miochol	relType_5=punct	lemma_8=decrease	relType_8=ROOT	relType_2=appos	relation_14=neutral	lib=miochol	pos_1=-LRB-	pos_6=-RRB-	pos_5=NN	relType_6=compound	relType_6=appos	eib=True	pos_2=-RRB-	lemma_9=the	lemma_11=of	lemma_3=and	relType_4=conj	lemma_6=Isopto	relType_1=punct	wib=Miochol	relType_9=det
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e1	DDI-DrugBank.d723.s0.e2	null	lemma_2=and	path2=carbachol_conj	wib=carbachol	eib=False	path=Miochol_appos<chloride_nmod>carbachol_conj	pos_1=-RRB-	pos_2=CC	path1=Miochol_appos	relType_1=punct	lemma_1=)	relType_2=cc	lpib=carbachol_NN	lib=carbachol
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e1	DDI-DrugBank.d723.s0.e3	null	lemma_1=)	relType_2=cc	lpib=carbachol_NN	path2=carbachol_conj>carboptic_dep	lemma_2=and	lemma_3=(	path1=Miochol_appos	pos_3=-LRB-	lemma_3=carbachol	path=Miochol_appos<chloride_nmod>carbachol_conj>carboptic_dep	relType_3=conj	pos_1=-RRB-	lib=carbachol	wib=carbachol	eib=True	pos_3=NN	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e1	DDI-DrugBank.d723.s0.e4	null	relType_4=dep	relType_5=compound	lemma_1=)	relType_2=cc	lpib=carbachol_NN	lemma_2=and	pos_4=,	lemma_3=(	path=Miochol_appos<chloride_nmod>carbachol_conj>carboptic_dep>Carbachol_appos	path1=Miochol_appos	pos_3=-LRB-	lemma_5=Isopto	pos_4=NN	lemma_3=carbachol	lemma_4=carboptic	relType_4=punct	relType_3=conj	pos_1=-RRB-	pos_5=NNP	lemma_4=,	path2=carbachol_conj>carboptic_dep>Carbachol_appos	lib=carbachol	wib=carbachol	eib=True	pos_3=NN	pos_2=CC	relType_1=punct	relType_3=punct
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e1	DDI-DrugBank.d723.s0.e5	effect	relType_4=dep	lemma_5=Carbachol	path2=effect_obj>ophthalmic_nmod>suprofen_amod	pos_7=VB	pos_8=DT	lemma_6=may	path1=Miochol_appos<chloride_nmod<drop_nsubj	relType_5=compound	lemma_10=of	lemma_1=)	relType_2=cc	lpib=carbachol_NN	lemma_2=and	pos_4=,	pos_9=NNS	lemma_3=(	path=Miochol_appos<chloride_nmod<drop_nsubj<decrease_ROOT>effect_obj>ophthalmic_nmod>suprofen_amod	pos_3=-LRB-	lemma_5=Isopto	relType_10=case	pos_4=NN	lemma_5=)	lemma_3=carbachol	lemma_4=carboptic	relType_7=ROOT	relType_4=punct	pos_5=-RRB-	relType_3=conj	relType_6=aux	relType_5=punct	pos_1=-RRB-	lemma_8=the	relation_10=adverse	relType_9=obj	lemma_7=decrease	pos_5=NNP	lemma_4=,	pos_10=IN	pos_6=MD	lib=carbachol	relType_5=appos	relation_12=neutral	wib=carbachol	eib=True	pos_3=NN	pos_2=CC	relType_8=det	lemma_9=effect	relType_1=punct	relType_3=punct
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e2	DDI-DrugBank.d723.s0.e3	null	lemma_1=(	lpib=carboptic_NN	wib=Carboptic	lib=carboptic	eib=False	path1=	path=<carbachol_conj>carboptic_dep	relType_1=punct	path2=carboptic_dep	pos_1=-LRB-
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e2	DDI-DrugBank.d723.s0.e4	null	pos_2=NN	lib=carboptic	path1=	pos_3=NNP	relType_2=punct	lemma_1=(	wib=Carboptic	lemma_2=,	path2=carboptic_dep>Carbachol_appos	lpib=carboptic_NN	relType_2=dep	pos_1=-LRB-	lemma_3=Isopto	eib=True	lemma_2=carboptic	pos_2=,	relType_3=compound	relType_1=punct	path=<carbachol_conj>carboptic_dep>Carbachol_appos
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e2	DDI-DrugBank.d723.s0.e5	effect	pos_7=NNS	relType_8=case	path2=effect_obj>ophthalmic_nmod>suprofen_amod	pos_2=NN	lib=carboptic	pos_6=DT	relation_9=neutral	pos_3=NNP	lemma_4=may	relType_2=punct	lemma_1=(	pos_5=VB	wib=Carboptic	relType_3=appos	lemma_7=effect	lemma_6=the	lemma_3=Carbachol	relType_7=obj	path=carbachol_conj<chloride_nmod<drop_nsubj<decrease_ROOT>effect_obj>ophthalmic_nmod>suprofen_amod	pos_4=MD	relation_7=adverse	lemma_2=,	pos_8=IN	lpib=carboptic_NN	relType_2=dep	relType_4=aux	lemma_3=)	pos_1=-LRB-	relType_6=det	lemma_3=Isopto	eib=True	pos_3=-RRB-	lemma_5=decrease	lemma_2=carboptic	pos_2=,	relType_3=compound	relType_1=punct	relType_5=ROOT	path1=carbachol_conj<chloride_nmod<drop_nsubj	lemma_8=of	relType_3=punct
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e3	DDI-DrugBank.d723.s0.e4	null	lib=isopto	lemma_1=,	wib=Isopto	eib=True	pos_2=NNP	relType_2=compound	path1=	pos_1=,	lemma_2=Isopto	lpib=isopto_NNP	path2=Carbachol_appos	relType_1=punct	path=<carboptic_dep>Carbachol_appos
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e3	DDI-DrugBank.d723.s0.e5	effect	lemma_2=)	lib=isopto	path2=effect_obj>ophthalmic_nmod>suprofen_amod	lemma_1=,	lemma_2=Carbachol	relType_7=case	path1=carboptic_dep<carbachol_conj<chloride_nmod<drop_nsubj	pos_1=,	lemma_3=may	relation_5=adverse	relType_2=punct	pos_2=NNP	pos_3=MD	relType_2=compound	relType_5=det	lpib=isopto_NNP	lemma_6=effect	relType_2=appos	relType_4=ROOT	lemma_7=of	relType_6=obj	relation_7=neutral	lemma_5=the	wib=Isopto	eib=True	pos_2=-RRB-	pos_7=IN	pos_4=VB	pos_5=DT	pos_6=NNS	lemma_2=Isopto	relType_3=aux	relType_1=punct	lemma_4=decrease	path=carboptic_dep<carbachol_conj<chloride_nmod<drop_nsubj<decrease_ROOT>effect_obj>ophthalmic_nmod>suprofen_amod
DDI-DrugBank.d723.s0	DDI-DrugBank.d723.s0.e4	DDI-DrugBank.d723.s0.e5	effect	path2=effect_obj>ophthalmic_nmod>suprofen_amod	pos_2=MD	lemma_6=of	pos_3=VB	lemma_1=)	relType_6=case	path1=Carbachol_appos<carboptic_dep<carbachol_conj<chloride_nmod<drop_nsubj	lemma_3=decrease	eib=False	pos_5=NNS	pos_6=IN	lpib=decrease_VB	relType_2=aux	lemma_5=effect	pos_4=DT	relType_3=ROOT	wib=decrease	pos_1=-RRB-	lemma_4=the	path=Carbachol_appos<carboptic_dep<carbachol_conj<chloride_nmod<drop_nsubj<decrease_ROOT>effect_obj>ophthalmic_nmod>suprofen_amod	relation_2=adverse	relType_5=obj	relation_4=neutral	lemma_2=may	relType_1=punct	relType_4=det	lib=decrease
DDI-DrugBank.d704.s0	DDI-DrugBank.d704.s0.e0	DDI-DrugBank.d704.s0.e1	null	path1=FLOMAX_compound	relType_4=amod	pos_4=JJ	relType_4=obl:npmod	path2=agent_conj	lemma_4=-	lemma_1=capsule	relType_2=cc	pos_4=HYPH	lemma_3=other	path=FLOMAX_compound<capsule_nmod>agent_conj	lemma_4=adrenergic	lemma_2=and	lemma_4=blocking	wib=capsules	lpib=capsule_NNS	relType_1=nmod	pos_4=NN	relType_4=punct	relType_3=amod	lib=capsule	relType_4=compound	pos_1=NNS	pos_3=JJ	eib=True	pos_2=CC	lemma_4=alpha
DDI-DrugBank.d704.s1	DDI-DrugBank.d704.s1.e0	DDI-DrugBank.d704.s1.e1	advise	relType_8=case	relType_10=punct	pos_3=RB	relType_3=advmod	lemma_4=be	pos_2=MD	relType_10=amod	lemma_3=not	lemma_1=capsule	relType_6=case	pos_9=JJ	lemma_10=blocking	path2=combination_obl>agent_nmod	lemma_9=other	pos_6=IN	path=flomax_compound<capsule_nsubj:pass<use_conj>combination_obl>agent_nmod	lemma_8=with	wib=capsules	relType_2=aux	relType_9=amod	lpib=capsule_NNS	lemma_6=in	pos_10=NN	relType_10=compound	pos_8=IN	lemma_10=-	relType_10=obl:npmod	lib=capsule	lemma_2=should	pos_10=JJ	pos_10=HYPH	relType_4=aux:pass	relType_5=conj	lemma_5=use	lemma_7=combination	relType_7=obl	pos_1=NNS	eib=True	pos_4=VB	lemma_10=adrenergic	relType_1=nsubj:pass	lemma_10=alpha	pos_7=NN	pos_5=VBN	path1=flomax_compound<capsule_nsubj:pass
DDI-DrugBank.d704.s2	DDI-DrugBank.d704.s2.e0	DDI-DrugBank.d704.s2.e1	null	relType_1=cc	pos_1=CC	path=<cimetidine_nmod>flomax_conj	lpib=flomax_NN	eib=False	path1=	lib=flomax	wib=FLOMAX	path2=flomax_conj	lemma_1=and
DDI-DrugBank.d704.s4	DDI-DrugBank.d704.s4.e0	DDI-DrugBank.d704.s4.e1	advise	relType_7=case	pos_2=MD	lemma_1=capsule	path1=FLOMAX_compound<capsule_nsubj:pass	pos_9=IN	pos_3=VB	lemma_4=use	relType_3=aux:pass	relType_5=case	relType_8=obl	pos_6=NN	pos_8=NN	relType_6=obl	path2=combination_obl>cimetidine_nmod	eib=False	lemma_5=with	lemma_8=combination	wib=capsules	relType_2=aux	relType_9=case	lpib=capsule_NNS	path=FLOMAX_compound<capsule_nsubj:pass<use_ROOT>combination_obl>cimetidine_nmod	pos_4=VBN	lib=capsule	lemma_2=should	lemma_6=caution	lemma_3=be	pos_5=IN	relType_4=ROOT	lemma_9=with	pos_1=NNS	pos_7=IN	lemma_7=in	relType_1=nsubj:pass
DDI-DrugBank.d704.s5	DDI-DrugBank.d704.s5.e0	DDI-DrugBank.d704.s5.e1	null	relType_1=cc	lib=warfarin	path2=warfarin_conj	pos_1=CC	path=<hci_nmod>warfarin_conj	lpib=warfarin_NN	eib=False	path1=	wib=warfarin	lemma_1=and
DDI-DrugBank.d704.s6	DDI-DrugBank.d704.s6.e0	DDI-DrugBank.d704.s6.e1	advise	relType_1=cc	pos_1=CC	path=<warfarin_nmod>flomax_conj	lpib=flomax_NN	eib=False	path1=	lib=flomax	wib=FLOMAX	path2=flomax_conj	lemma_1=and
DDI-DrugBank.d658.s0	DDI-DrugBank.d658.s0.e0	DDI-DrugBank.d658.s0.e1	effect	pos_6=JJ	relType_1=aux	lemma_1=may	lemma_5=of	relType_5=case	path1=testolactone_nsubj	relation_1=beneficial	path2=effect_obj>anticoagulant_nmod	eib=False	relType_6=amod	pos_2=VB	relType_3=det	lib=increase	pos_4=NNS	relType_4=obj	lemma_2=increase	relation_3=neutral	lemma_6=oral	relType_2=ROOT	path=testolactone_nsubj<increase_ROOT>effect_obj>anticoagulant_nmod	pos_5=IN	wib=increase	pos_1=MD	lemma_4=effect	lpib=increase_VB	pos_3=DT	lemma_3=the
DDI-DrugBank.d766.s0	DDI-DrugBank.d766.s0.e0	DDI-DrugBank.d766.s0.e1	null	path=trimetrexate_nsubj:pass<metabolize_advcl<elicit_ROOT>interaction_obj>alter_acl:relcl>concentration_obj>trimetrexate_compound	relType_22=compound	relation_27=neutral	pos_19=MD	lemma_27=may	lemma_26=that	relType_2=advcl	relType_8=punct	pos_12=CC	pos_13=VBP	pos_6=NN	relType_17=compound	pos_18=NN	relType_24=compound	pos_10=WDT	pos_16=VBG	pos_28=VB	pos_26=WDT	relType_6=compound	pos_1=VBZ	relType_18=obj	lemma_13=inhibit	lemma_4=a	pos_21=JJ	pos_22=NN	relType_25=obj	relType_16=amod	relation_12=adverse	lemma_24=drug	pos_25=NNS	relType_13=conj	pos_23=HYPH	lemma_15=drug	lemma_21=important	lemma_28=alter	pos_5=NN	relType_7=obl	lemma_22=drug	pos_7=NN	pos_8=,	pos_2=VBN	pos_3=IN	pos_20=VB	relType_11=acl:relcl	relType_12=cc	pos_24=NN	lemma_8=,	pos_17=NN	lemma_16=metabolize	lemma_1=be	relType_15=dep	lemma_20=elicit	relType_20=ROOT	lemma_18=system	lemma_12=or	lib=be	lemma_23=-	lemma_6=enzyme	relType_28=acl:relcl	relType_19=aux	path2=interaction_obj>alter_acl:relcl>concentration_obj>trimetrexate_compound	lemma_17=enzyme	pos_14=DT	wib=is	lemma_11=induce	lemma_10=that	lemma_14=this	lemma_5=p450	relType_23=punct	relType_1=aux:pass	lemma_9=drug	relType_27=aux	relation_10=neutral	relType_5=compound	lemma_19=may	path1=trimetrexate_nsubj:pass<metabolize_advcl	lemma_3=by	eib=False	pos_27=MD	pos_9=NNS	relType_21=amod	relType_14=det	lemma_25=interaction	pos_11=VBP	pos_4=DT	lemma_7=system	pos_15=NN	relType_10=nsubj	relType_3=case	relType_9=nsubj	lemma_2=metabolize	lpib=be_VBZ	relType_26=nsubj	relType_4=det
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e0	DDI-DrugBank.d766.s1.e1	effect	relType_1=case	lemma_1=in	relType_10=det	pos_9=VB	path=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj<include_ROOT>erythromycin_obj	relType_11=obj	relType_6=obl	pos_3=NNS	pos_2=NNP	eib=False	pos_8=MD	lib=aids	pos_12=VBP	lemma_4=for	pos_1=IN	wib=AIDS	pos_7=WDT	relType_9=acl:relcl	lemma_5=other	path1=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj	lemma_7=that	relType_12=ROOT	pos_5=JJ	relType_5=amod	relType_2=compound	pos_4=IN	lemma_6=indication	relType_3=nmod	relType_4=case	path2=erythromycin_obj	lemma_10=this	lemma_2=AIDS	pos_11=NN	lemma_11=activity	lemma_12=include	lpib=aids_NNP	pos_6=NNS	relType_8=aux	relType_7=nsubj	lemma_8=could	lemma_9=elicit	lemma_3=patient	pos_10=DT
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e0	DDI-DrugBank.d766.s1.e2	effect	relType_1=case	pos_13=,	lemma_1=in	lemma_13=,	relType_10=det	relType_13=punct	pos_9=VB	relType_11=obj	relType_6=obl	pos_3=NNS	pos_2=NNP	pos_8=MD	lib=aids	pos_12=VBP	lemma_4=for	pos_1=IN	pos_13=NN	wib=AIDS	path2=erythromycin_obj>rifampin_conj	pos_7=WDT	relType_9=acl:relcl	lemma_5=other	path1=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj	lemma_7=that	relType_12=ROOT	pos_5=JJ	relType_5=amod	lemma_13=erythromycin	relType_2=compound	pos_4=IN	lemma_6=indication	relType_3=nmod	relType_4=case	lemma_10=this	lemma_2=AIDS	pos_11=NN	lemma_11=activity	lemma_12=include	eib=True	lpib=aids_NNP	pos_6=NNS	relType_8=aux	relType_7=nsubj	relType_13=obj	lemma_8=could	path=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj<include_ROOT>erythromycin_obj>rifampin_conj	lemma_9=elicit	lemma_3=patient	pos_10=DT
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e0	DDI-DrugBank.d766.s1.e3	effect	relType_1=case	pos_13=,	lemma_1=in	relType_14=punct	lemma_13=,	relType_10=det	relType_13=punct	path2=erythromycin_obj>rifabutin_conj	pos_9=VB	relType_11=obj	relType_6=obl	pos_3=NNS	pos_2=NNP	pos_8=MD	pos_14=,	lib=aids	pos_12=VBP	path=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj<include_ROOT>erythromycin_obj>rifabutin_conj	lemma_4=for	pos_1=IN	pos_14=NN	pos_13=NN	wib=AIDS	pos_7=WDT	relType_9=acl:relcl	lemma_5=other	path1=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj	lemma_7=that	relType_12=ROOT	pos_5=JJ	relType_5=amod	lemma_13=erythromycin	relType_2=compound	pos_4=IN	lemma_6=indication	lemma_14=rifampin	relType_3=nmod	relType_4=case	lemma_10=this	lemma_2=AIDS	lemma_14=,	pos_11=NN	lemma_11=activity	lemma_12=include	eib=True	lpib=aids_NNP	pos_6=NNS	relType_14=conj	relType_8=aux	relType_7=nsubj	relType_13=obj	lemma_8=could	lemma_9=elicit	lemma_3=patient	pos_10=DT
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e0	DDI-DrugBank.d766.s1.e4	effect	relType_1=case	pos_13=,	lemma_1=in	relType_14=punct	lemma_13=,	relType_10=det	relType_13=punct	pos_9=VB	path2=erythromycin_obj>ketoconazole_conj	relType_11=obj	lemma_15=rifabutin	relType_6=obl	pos_3=NNS	pos_2=NNP	pos_8=MD	pos_14=,	lib=aids	pos_12=VBP	pos_15=,	lemma_4=for	pos_1=IN	pos_14=NN	path=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj<include_ROOT>erythromycin_obj>ketoconazole_conj	wib=AIDS	pos_7=WDT	pos_13=NN	relType_9=acl:relcl	relType_15=punct	lemma_5=other	path1=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj	lemma_7=that	relType_12=ROOT	pos_5=JJ	relType_5=amod	pos_15=NN	lemma_15=,	lemma_13=erythromycin	relType_2=compound	pos_4=IN	lemma_6=indication	lemma_14=rifampin	relType_3=nmod	relType_4=case	lemma_10=this	lemma_2=AIDS	lemma_14=,	pos_11=NN	lemma_11=activity	lemma_12=include	eib=True	lpib=aids_NNP	pos_6=NNS	relType_14=conj	relType_8=aux	relType_15=conj	relType_7=nsubj	relType_13=obj	lemma_8=could	lemma_9=elicit	lemma_3=patient	pos_10=DT
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e0	DDI-DrugBank.d766.s1.e5	effect	relType_1=case	pos_13=,	lemma_1=in	relType_14=punct	lemma_16=ketoconazole	lemma_13=,	relType_10=det	relType_17=cc	path=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj<include_ROOT>erythromycin_obj>fluconazole_conj	relType_13=punct	pos_9=VB	relType_11=obj	lemma_15=rifabutin	relType_6=obl	pos_3=NNS	pos_2=NNP	pos_8=MD	pos_14=,	lib=aids	pos_12=VBP	pos_15=,	lemma_4=for	pos_16=,	pos_1=IN	pos_14=NN	pos_13=NN	wib=AIDS	pos_7=WDT	relType_15=punct	relType_9=acl:relcl	lemma_16=,	lemma_5=other	path1=trimetrexate_obl<coadminister_acl:relcl<agent_nsubj	lemma_7=that	relType_12=ROOT	pos_5=JJ	relType_5=amod	pos_15=NN	lemma_15=,	lemma_13=erythromycin	relType_2=compound	pos_4=IN	lemma_6=indication	lemma_14=rifampin	relType_3=nmod	relType_4=case	lemma_17=and	pos_16=NN	lemma_10=this	relType_16=punct	lemma_2=AIDS	lemma_14=,	pos_11=NN	lemma_11=activity	lemma_12=include	eib=True	path2=erythromycin_obj>fluconazole_conj	lpib=aids_NNP	pos_6=NNS	relType_14=conj	relType_8=aux	relType_15=conj	relType_7=nsubj	relType_13=obj	pos_17=CC	lemma_8=could	lemma_9=elicit	relType_16=conj	lemma_3=patient	pos_10=DT
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e1	DDI-DrugBank.d766.s1.e2	null	wib=rifampin	lemma_1=,	eib=False	lpib=rifampin_NN	path1=	pos_1=,	lib=rifampin	path=<erythromycin_obj>rifampin_conj	relType_1=punct	path2=rifampin_conj
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e1	DDI-DrugBank.d766.s1.e3	null	path=<erythromycin_obj>rifabutin_conj	wib=rifampin	lemma_1=,	pos_2=NN	eib=True	lpib=rifampin_NN	path1=	pos_1=,	lemma_2=rifampin	pos_2=,	lib=rifampin	relType_1=punct	relType_2=conj	path2=rifabutin_conj	lemma_2=,	relType_2=punct
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e1	DDI-DrugBank.d766.s1.e4	null	wib=rifampin	path2=ketoconazole_conj	lemma_1=,	pos_2=NN	path=<erythromycin_obj>ketoconazole_conj	path1=	pos_1=,	relType_2=punct	lpib=rifampin_NN	relType_2=conj	lemma_2=,	lemma_3=,	relType_3=conj	lib=rifampin	pos_3=,	eib=True	pos_3=NN	lemma_2=rifampin	pos_2=,	relType_1=punct	relType_3=punct	lemma_3=rifabutin
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e1	DDI-DrugBank.d766.s1.e5	null	wib=rifampin	lemma_1=,	pos_2=NN	pos_5=CC	path1=	pos_1=,	relType_2=punct	relType_5=cc	pos_4=,	lpib=rifampin_NN	relType_2=conj	pos_4=NN	lemma_2=,	path2=fluconazole_conj	lemma_3=,	relType_4=punct	relType_3=conj	lib=rifampin	lemma_4=,	pos_3=,	eib=True	lemma_5=and	pos_3=NN	lemma_2=rifampin	pos_2=,	relType_4=conj	path=<erythromycin_obj>fluconazole_conj	relType_1=punct	relType_3=punct	lemma_4=ketoconazole	lemma_3=rifabutin
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e2	DDI-DrugBank.d766.s1.e3	null	lemma_1=,	eib=False	pos_1=,	path2=rifabutin_conj	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	lib=rifabutin	path=rifampin_conj<erythromycin_obj>rifabutin_conj	path1=rifampin_conj
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e2	DDI-DrugBank.d766.s1.e4	null	path2=ketoconazole_conj	lemma_1=,	pos_2=NN	eib=True	path=rifampin_conj<erythromycin_obj>ketoconazole_conj	pos_1=,	pos_2=,	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	lemma_2=rifabutin	relType_2=conj	lib=rifabutin	lemma_2=,	path1=rifampin_conj	relType_2=punct
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e2	DDI-DrugBank.d766.s1.e5	null	lemma_1=,	pos_2=NN	pos_1=,	relType_4=cc	lib=rifabutin	relType_2=punct	relType_2=conj	lemma_2=,	path1=rifampin_conj	path2=fluconazole_conj	lemma_3=,	relType_3=conj	lemma_2=rifabutin	path=rifampin_conj<erythromycin_obj>fluconazole_conj	lemma_3=ketoconazole	pos_3=,	eib=True	pos_4=CC	pos_3=NN	lemma_4=and	pos_2=,	lpib=rifabutin_NN	wib=rifabutin	relType_1=punct	relType_3=punct
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e3	DDI-DrugBank.d766.s1.e4	null	path=rifabutin_conj<erythromycin_obj>ketoconazole_conj	path2=ketoconazole_conj	lemma_1=,	eib=False	pos_1=,	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	relType_1=punct	path1=rifabutin_conj
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e3	DDI-DrugBank.d766.s1.e5	null	lemma_1=,	pos_2=NN	pos_3=CC	pos_1=,	lib=ketoconazole	relType_2=punct	path=rifabutin_conj<erythromycin_obj>fluconazole_conj	relType_3=cc	lemma_2=ketoconazole	relType_2=conj	lemma_2=,	path1=rifabutin_conj	path2=fluconazole_conj	wib=ketoconazole	eib=True	pos_2=,	lemma_3=and	lpib=ketoconazole_NN	relType_1=punct
DDI-DrugBank.d766.s1	DDI-DrugBank.d766.s1.e4	DDI-DrugBank.d766.s1.e5	null	path=ketoconazole_conj<erythromycin_obj>fluconazole_conj	lpib=fluconazole_NN	lemma_2=and	lemma_1=,	path1=ketoconazole_conj	path2=fluconazole_conj	eib=False	pos_2=CC	wib=fluconazole	pos_1=,	lib=fluconazole	relType_1=punct	relType_2=cc
DDI-DrugBank.d766.s2	DDI-DrugBank.d766.s2.e0	DDI-DrugBank.d766.s2.e1	mechanism	pos_2=DT	lemma_5=in	lemma_2=a	relType_5=case	lib=cause	wib=caused	pos_1=VBD	eib=False	lemma_3=significant	pos_4=NN	path2=reduction_obj>metabolism_nmod>trimetrexate_compound	path=cimetidine_nsubj<cause_ccomp>reduction_obj>metabolism_nmod>trimetrexate_compound	relType_4=obj	relation_0=neutral	relType_3=amod	relType_1=ccomp	pos_5=IN	pos_3=JJ	relType_2=det	lemma_4=reduction	path1=cimetidine_nsubj	lpib=cause_VBD	lemma_1=cause
DDI-DrugBank.d766.s2	DDI-DrugBank.d766.s2.e0	DDI-DrugBank.d766.s2.e2	null	pos_2=DT	lemma_5=in	lemma_6=trimetrexate	relType_7=cc	lemma_2=a	relType_5=case	path=cimetidine_nsubj<cause_ccomp>alter_conj>acetaminophen_nsubj	lib=cause	pos_6=NN	wib=caused	pos_1=VBD	lemma_3=significant	pos_4=NN	relType_4=obj	pos_8=IN	relation_0=neutral	relType_3=amod	pos_7=CC	relType_8=mark	relType_1=ccomp	pos_5=IN	relType_6=compound	pos_3=JJ	eib=True	lemma_6=metabolism	lemma_7=and	relType_2=det	lemma_4=reduction	path1=cimetidine_nsubj	path2=alter_conj>acetaminophen_nsubj	lemma_8=that	relType_6=nmod	lpib=cause_VBD	lemma_1=cause
DDI-DrugBank.d766.s2	DDI-DrugBank.d766.s2.e1	DDI-DrugBank.d766.s2.e2	null	path1=trimetrexate_compound<metabolism_nmod<reduction_obj	lemma_2=and	lemma_3=that	pos_3=IN	eib=False	pos_2=CC	lib=metabolism	lemma_1=metabolism	lpib=metabolism_NN	path2=alter_conj>acetaminophen_nsubj	relType_3=mark	relType_2=cc	relType_1=nmod	path=trimetrexate_compound<metabolism_nmod<reduction_obj<cause_ccomp>alter_conj>acetaminophen_nsubj	wib=metabolism	pos_1=NN
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e0	DDI-DrugBank.d766.s3.e1	null	lemma_1=(	lib=clotrimazole	eib=False	path1=	wib=clotrimazole	path2=clotrimazole_dep	relType_1=punct	lpib=clotrimazole_NN	pos_1=-LRB-	path=<drug_nsubj>clotrimazole_dep
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e0	DDI-DrugBank.d766.s3.e2	null	lemma_1=(	relType_2=dep	lib=clotrimazole	pos_2=NN	eib=True	path=<drug_nsubj>clotrimazole_dep>ketoconazole_appos	path2=clotrimazole_dep>ketoconazole_appos	path1=	wib=clotrimazole	pos_2=,	relType_1=punct	lpib=clotrimazole_NN	relType_2=punct	lemma_2=,	pos_1=-LRB-	lemma_2=clotrimazole
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e0	DDI-DrugBank.d766.s3.e3	null	pos_2=NN	path1=	relType_2=punct	lemma_1=(	lib=clotrimazole	relType_3=appos	wib=clotrimazole	lemma_2=,	relType_2=dep	lemma_3=,	pos_1=-LRB-	path2=clotrimazole_dep>miconazole_appos	path=<drug_nsubj>clotrimazole_dep>miconazole_appos	lemma_3=ketoconazole	pos_3=,	eib=True	pos_3=NN	pos_2=,	relType_1=punct	lpib=clotrimazole_NN	relType_3=punct	lemma_2=clotrimazole
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e0	DDI-DrugBank.d766.s3.e4	mechanism	path1=drug_nsubj	pos_2=NN	pos_6=JJ	relType_5=cop	path2=inhibitor_obj>metabolism_nmod>trimetrexate_compound	relType_4=appos	relType_10=amod	relType_12=case	lemma_9=-	relType_11=obj	relType_2=punct	lemma_12=of	lemma_1=(	pos_9=HYPH	lib=clotrimazole	lemma_8=non	relType_3=appos	pos_4=-RRB-	wib=clotrimazole	pos_11=NNS	pos_7=,	pos_8=AFX	lemma_5=be	lemma_7=,	pos_4=NN	lemma_2=,	pos_12=IN	relType_6=ROOT	relType_2=dep	relType_4=punct	lemma_3=,	lemma_4=miconazole	pos_10=JJ	lemma_11=inhibitor	relType_8=obl:npmod	lemma_4=)	relType_9=punct	pos_1=-LRB-	pos_5=VBD	lemma_3=ketoconazole	pos_3=,	eib=True	pos_3=NN	relType_7=punct	pos_2=,	lemma_6=potent	relType_1=punct	lpib=clotrimazole_NN	relType_3=punct	path=drug_nsubj<potent_ROOT>inhibitor_obj>metabolism_nmod>trimetrexate_compound	lemma_2=clotrimazole	lemma_10=competitive
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e1	DDI-DrugBank.d766.s3.e2	null	lemma_1=,	path2=ketoconazole_appos	eib=False	path=<clotrimazole_dep>ketoconazole_appos	path1=	pos_1=,	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	relType_1=punct
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e1	DDI-DrugBank.d766.s3.e3	null	lemma_1=,	pos_2=NN	eib=True	path=<clotrimazole_dep>miconazole_appos	lemma_2=ketoconazole	path1=	pos_1=,	pos_2=,	lpib=ketoconazole_NN	wib=ketoconazole	lib=ketoconazole	relType_1=punct	path2=miconazole_appos	relType_2=appos	lemma_2=,	relType_2=punct
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e1	DDI-DrugBank.d766.s3.e4	mechanism	path=clotrimazole_dep<drug_nsubj<potent_ROOT>inhibitor_obj>metabolism_nmod>trimetrexate_compound	lemma_1=,	pos_2=NN	lemma_4=be	path2=inhibitor_obj>metabolism_nmod>trimetrexate_compound	lemma_10=inhibitor	pos_1=,	lemma_6=,	relType_8=punct	lib=ketoconazole	relType_11=case	relType_2=punct	relType_4=cop	pos_9=JJ	lemma_9=competitive	pos_10=NNS	pos_7=AFX	relType_3=appos	lemma_3=miconazole	relType_6=punct	lemma_2=ketoconazole	pos_8=HYPH	relType_9=amod	relType_10=obj	lemma_2=,	pos_11=IN	pos_5=JJ	lemma_7=non	wib=ketoconazole	relType_2=appos	lemma_3=)	pos_6=,	relType_7=obl:npmod	pos_4=VBD	eib=True	pos_3=-RRB-	pos_3=NN	path1=clotrimazole_dep<drug_nsubj	lemma_8=-	lemma_5=potent	lemma_11=of	pos_2=,	lpib=ketoconazole_NN	relType_1=punct	relType_5=ROOT	relType_3=punct
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e2	DDI-DrugBank.d766.s3.e3	null	path=ketoconazole_appos<clotrimazole_dep>miconazole_appos	lemma_1=,	eib=False	lib=miconazole	path1=ketoconazole_appos	lpib=miconazole_NN	wib=miconazole	pos_1=,	relType_1=punct	path2=miconazole_appos
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e2	DDI-DrugBank.d766.s3.e4	mechanism	lemma_2=)	lemma_1=,	pos_4=JJ	pos_2=NN	relType_8=amod	path2=inhibitor_obj>metabolism_nmod>trimetrexate_compound	pos_5=,	pos_1=,	lemma_10=of	path1=ketoconazole_appos<clotrimazole_dep<drug_nsubj	relType_2=punct	lemma_6=non	pos_8=JJ	lemma_7=-	lpib=miconazole_NN	pos_3=VBD	pos_6=AFX	pos_9=NNS	path=ketoconazole_appos<clotrimazole_dep<drug_nsubj<potent_ROOT>inhibitor_obj>metabolism_nmod>trimetrexate_compound	relType_10=case	lemma_4=potent	pos_7=HYPH	lemma_8=competitive	lemma_5=,	relType_5=punct	lemma_3=be	relType_9=obj	relType_6=obl:npmod	pos_10=IN	relType_2=appos	relType_4=ROOT	eib=True	pos_2=-RRB-	lib=miconazole	lemma_9=inhibitor	relType_7=punct	wib=miconazole	relType_1=punct	relType_3=cop	lemma_2=miconazole
DDI-DrugBank.d766.s3	DDI-DrugBank.d766.s3.e3	DDI-DrugBank.d766.s3.e4	mechanism	relType_5=obl:npmod	path2=inhibitor_obj>metabolism_nmod>trimetrexate_compound	pos_9=IN	lemma_1=)	lemma_7=competitive	pos_8=NNS	pos_6=HYPH	wib=were	relType_2=cop	pos_4=,	eib=False	pos_5=AFX	relType_6=punct	relType_8=obj	pos_2=VBD	relType_9=case	lemma_5=non	path1=miconazole_appos<clotrimazole_dep<drug_nsubj	lemma_6=-	relType_7=amod	lib=be	relType_4=punct	relType_3=ROOT	pos_1=-RRB-	lemma_8=inhibitor	lemma_4=,	path=miconazole_appos<clotrimazole_dep<drug_nsubj<potent_ROOT>inhibitor_obj>metabolism_nmod>trimetrexate_compound	pos_3=JJ	lemma_3=potent	lemma_9=of	pos_7=JJ	lemma_2=be	relType_1=punct	lpib=be_VBD
DDI-DrugBank.d328.s0	DDI-DrugBank.d328.s0.e0	DDI-DrugBank.d328.s0.e1	null	pos_2=VBN	pos_3=CC	relType_1=aux:pass	lemma_3=both	relType_3=cc:preconj	wib=were	pos_1=VBD	lemma_2=perform	eib=False	lemma_1=be	path=valdecoxib_nmod<study_nsubj:pass<perform_ROOT>valdecoxib_obl	lemma_4=with	lib=be	relType_2=ROOT	pos_4=IN	relType_4=case	path1=valdecoxib_nmod<study_nsubj:pass	path2=valdecoxib_obl	lpib=be_VBD
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e0	DDI-DrugBank.d328.s4.e1	null	path1=	lemma_3=administration	pos_2=JJ	lib=concomitant	wib=Concomitant	eib=False	lpib=concomitant_JJ	lemma_1=:	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	path=<aspirin_ROOT>result_parataxis>administration_nsubj>aspirin_nmod	relType_3=nsubj	path2=result_parataxis>administration_nsubj>aspirin_nmod	pos_3=NN	relType_1=punct	lemma_4=of
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e0	DDI-DrugBank.d328.s4.e2	null	path1=	lemma_3=administration	pos_2=JJ	relType_5=case	lib=concomitant	wib=Concomitant	path=<aspirin_ROOT>result_parataxis>administration_nsubj>valdecoxib_nmod	lemma_5=with	lpib=concomitant_JJ	lemma_1=:	lemma_2=concomitant	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	relType_3=nsubj	lemma_5=aspirin	pos_5=NN	eib=True	pos_3=NN	relType_1=punct	lemma_4=of	path2=result_parataxis>administration_nsubj>valdecoxib_nmod
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e0	DDI-DrugBank.d328.s4.e3	null	relType_8=case	pos_7=VB	lemma_6=may	lemma_9=a	relType_10=amod	path1=	relType_12=case	lemma_3=administration	lemma_11=risk	lemma_14=ulceration	relType_14=nmod	pos_2=JJ	pos_16=NNS	relType_5=case	pos_17=VBN	lemma_12=of	relType_18=case	pos_6=NN	lib=concomitant	lemma_8=in	wib=Concomitant	lemma_17=compare	lemma_10=increase	lemma_5=with	pos_9=DT	lpib=concomitant_JJ	lemma_13=gi	pos_14=NN	pos_13=NN	relType_16=conj	pos_18=IN	pos_12=IN	lemma_1=:	pos_8=IN	relType_17=case	lemma_2=concomitant	path=<aspirin_ROOT>result_parataxis>risk_obl>valdecoxib_nmod	relType_13=compound	relType_6=aux	pos_4=IN	relType_2=amod	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	relType_15=cc	lemma_18=to	pos_6=MD	lemma_6=valdecoxib	relType_11=obl	relType_3=nsubj	lemma_15=and	lemma_5=aspirin	pos_5=NN	path2=result_parataxis>risk_obl>valdecoxib_nmod	pos_11=NN	eib=True	pos_3=NN	pos_10=VBN	pos_15=CC	relation_11=beneficial	lemma_16=complication	lemma_7=result	relType_1=punct	relType_6=nmod	lemma_4=of	relType_7=parataxis	relType_9=det
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e1	DDI-DrugBank.d328.s4.e2	effect	lemma_1=with	relType_1=case	lib=valdecoxib	wib=valdecoxib	path=aspirin_nmod<administration_nsubj>valdecoxib_nmod	eib=False	lpib=valdecoxib_NN	path1=aspirin_nmod	path2=valdecoxib_nmod	pos_1=IN
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e1	DDI-DrugBank.d328.s4.e3	null	relType_8=case	path1=aspirin_nmod<administration_nsubj	wib=valdecoxib	path2=risk_obl>valdecoxib_nmod	path=aspirin_nmod<administration_nsubj<result_parataxis>risk_obl>valdecoxib_nmod	relType_1=case	pos_2=NN	relType_11=cc	relType_12=conj	pos_2=MD	lemma_4=in	lemma_6=increase	pos_3=VB	pos_13=VBN	lemma_12=complication	lemma_5=a	lib=valdecoxib	relType_10=nmod	relType_9=compound	lemma_13=compare	lemma_14=to	lpib=valdecoxib_NN	relType_2=nmod	lemma_7=risk	relType_6=amod	lemma_9=gi	pos_1=IN	relType_2=aux	lemma_3=result	pos_6=VBN	pos_9=NN	pos_10=NN	lemma_10=ulceration	pos_8=IN	pos_14=IN	relType_13=case	lemma_11=and	pos_12=NNS	pos_4=IN	relType_5=det	pos_11=CC	relType_4=case	relType_3=parataxis	relation_6=beneficial	lemma_1=with	relType_7=obl	lemma_2=valdecoxib	eib=True	pos_5=DT	lemma_2=may	relType_14=case	pos_7=NN	lemma_8=of
DDI-DrugBank.d328.s4	DDI-DrugBank.d328.s4.e2	DDI-DrugBank.d328.s4.e3	null	path2=risk_obl>valdecoxib_nmod	pos_3=IN	relation_4=beneficial	relType_7=case	relType_1=aux	lemma_1=may	lemma_4=a	relType_10=cc	relType_12=case	relType_9=nmod	lemma_5=increase	relType_11=conj	pos_6=NN	pos_8=NN	relType_6=obl	lemma_12=compare	eib=False	pos_10=CC	pos_11=NNS	pos_2=VB	pos_13=IN	pos_9=NN	lemma_13=to	lemma_6=risk	pos_4=DT	lemma_10=and	relType_13=case	relType_5=amod	lemma_11=complication	relType_8=compound	wib=result	pos_1=MD	relType_3=case	lemma_2=result	lemma_7=of	lemma_8=gi	pos_7=IN	path=valdecoxib_nmod<administration_nsubj<result_parataxis>risk_obl>valdecoxib_nmod	lib=result	lemma_9=ulceration	path1=valdecoxib_nmod<administration_nsubj	relType_2=parataxis	pos_12=VBN	relType_4=det	lemma_3=in	pos_5=VBN	lpib=result_VB
DDI-DrugBank.d328.s5	DDI-DrugBank.d328.s5.e0	DDI-DrugBank.d328.s5.e1	null	path2=aspirin_nmod	path=valdecoxib_nmod<lack_obl<substitute_ROOT>aspirin_nmod	lemma_4=substitute	lemma_5=for	relType_5=case	pos_2=RB	eib=False	relType_2=advmod	lemma_1=be	relType_3=det	lemma_3=a	pos_4=NN	lib=be	pos_5=IN	relType_4=ROOT	wib=is	relType_1=cop	pos_1=VBZ	pos_3=DT	path1=valdecoxib_nmod<lack_obl	lpib=be_VBZ	lemma_2=not
DDI-DrugBank.d328.s6	DDI-DrugBank.d328.s6.e0	DDI-DrugBank.d328.s6.e1	null	lemma_9=)	relType_1=case	relType_2=nummod	lemma_8=10	relType_8=dep	relType_17=punct	lemma_10=vs	pos_6=NN	lemma_6=n	pos_15=CD	pos_3=NNS	lib=mg	lemma_13=n	eib=False	lemma_17=,	pos_2=CD	pos_12=-LRB-	relType_15=dep	lemma_5=(	lemma_1=at	pos_1=IN	relType_10=case	lemma_11=placebo	relType_12=punct	pos_13=NN	lemma_14==	lpib=mg_NNS	pos_9=-RRB-	lemma_16=)	pos_7=SYM	lemma_15=9	pos_17=,	relType_4=obl	pos_14=SYM	relType_13=nsubj	relType_5=punct	path1=valdecoxib_nmod<form_obj<compare_acl<study_obl	pos_16=-RRB-	relType_14=dep	pos_10=IN	relType_9=punct	relType_16=punct	path2=valdecoxib_nsubj	lemma_7==	pos_11=NN	relType_7=dep	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	lemma_3=mg	relType_11=nmod	pos_8=CD	lemma_2=40	path=valdecoxib_nmod<form_obj<compare_acl<study_obl<have_ROOT>valdecoxib_nsubj	relType_6=nsubj	lemma_12=(	pos_5=-LRB-
DDI-DrugBank.d328.s6	DDI-DrugBank.d328.s6.e0	DDI-DrugBank.d328.s6.e2	null	lemma_9=)	pos_6=NN	pos_15=CD	pos_3=NNS	lib=mg	lemma_18=valdecoxib	pos_20=NN	lemma_1=at	pos_13=NN	relType_20=obj	pos_18=NN	pos_7=SYM	pos_14=SYM	relType_16=punct	relType_21=case	lemma_7==	relation_20=neutral	lemma_4=BID	lemma_23=vitro	relType_19=det	lemma_11=placebo	relType_1=case	relType_2=nummod	path=valdecoxib_nmod<form_obj<compare_acl<study_obl<have_ROOT>effect_obj>inhibition_nmod>mediate_amod>aspirin_obl	lemma_10=vs	relType_18=ROOT	lemma_5=(	pos_1=IN	relType_12=punct	lemma_14==	pos_23=FW	relType_23=dep	lemma_15=9	relType_4=obl	relType_13=nsubj	lemma_19=no	path1=valdecoxib_nmod<form_obj<compare_acl<study_obl	pos_11=NN	relType_7=dep	pos_4=NNP	relType_3=compound	relType_11=nmod	pos_8=CD	pos_12=-LRB-	lemma_2=40	lemma_22=in	lemma_12=(	pos_19=DT	lemma_8=10	relType_8=dep	pos_22=FW	relType_17=punct	path2=effect_obj>inhibition_nmod>mediate_amod>aspirin_obl	lemma_13=n	relType_15=dep	pos_21=IN	pos_17=,	pos_16=-RRB-	pos_10=IN	relType_22=amod	relType_18=nsubj	lemma_18=have	lemma_21=on	relType_6=nsubj	pos_5=-LRB-	lemma_6=n	lemma_17=,	pos_2=CD	lemma_20=effect	relType_10=case	lpib=mg_NNS	pos_9=-RRB-	lemma_16=)	relType_5=punct	relType_14=dep	relType_9=punct	eib=True	wib=mg	lemma_3=mg	pos_18=VBD
DDI-DrugBank.d328.s6	DDI-DrugBank.d328.s6.e1	DDI-DrugBank.d328.s6.e2	null	pos_2=DT	lemma_5=in	pos_6=FW	path1=valdecoxib_nsubj	path2=effect_obj>inhibition_nmod>mediate_amod>aspirin_obl	lemma_2=no	lpib=have_VBD	lemma_3=effect	pos_1=VBD	relType_6=dep	eib=False	relation_2=neutral	lemma_4=on	lemma_1=have	lib=have	wib=had	path=valdecoxib_nsubj<have_ROOT>effect_obj>inhibition_nmod>mediate_amod>aspirin_obl	relType_5=amod	pos_4=IN	relType_4=case	pos_5=FW	relType_1=ROOT	pos_3=NN	relType_2=det	relType_3=obj	lemma_6=vitro
DDI-DrugBank.d328.s7	DDI-DrugBank.d328.s7.e0	DDI-DrugBank.d328.s7.e2	null	relType_14=amod	relType_2=nummod	pos_2=NN	pos_6=DT	relType_10=det	pos_16=IN	path1=	relation_10=neutral	relType_5=parataxis	pos_9=IN	lpib=valdecoxib_NNP	pos_8=NN	pos_5=VB	lemma_5=show	lib=valdecoxib	pos_4=RB	lemma_9=on	lemma_12=exposure	pos_2=NNP	relType_2=nsubj	lemma_6=a	pos_2=CD	lemma_13=or	lemma_2=10	pos_3=VBD	relType_12=nmod	lemma_10=the	relType_8=obj	relType_9=case	lemma_16=of	lemma_1=:	lemma_4=not	relType_13=cc	lemma_2=BID	relType_7=amod	lemma_11=plasma	pos_15=NN	lemma_7=significant	lemma_3=do	relType_2=compound	relType_4=advmod	pos_1=:	lemma_14=renal	lemma_2=mg	pos_13=CC	relType_6=det	relType_16=case	pos_11=NN	pos_10=DT	eib=True	relType_11=compound	lemma_8=effect	pos_7=JJ	relType_15=conj	lemma_2=Valdecoxib	path2=show_parataxis>effect_obj>exposure_nmod>clearance_conj>methotrexate_nmod	relType_3=aux	pos_14=JJ	relType_1=punct	pos_12=NN	lemma_15=clearance	wib=Valdecoxib	path=<Methotrexate_ROOT>show_parataxis>effect_obj>exposure_nmod>clearance_conj>methotrexate_nmod
DDI-DrugBank.d328.s8	DDI-DrugBank.d328.s8.e0	DDI-DrugBank.d328.s8.e1	null	relType_4=mark	wib=Reports	path1=	path2=suggest_parataxis>diminish_ccomp>nsaid_nsubj	relType_2=nsubj	eib=False	lemma_2=report	lemma_1=:	pos_4=IN	pos_1=:	relType_3=parataxis	pos_2=NNS	lemma_4=that	lib=report	relType_1=punct	path=<inhibitor_ROOT>suggest_parataxis>diminish_ccomp>nsaid_nsubj	lemma_3=suggest	lpib=report_NNS	pos_3=VBP
DDI-DrugBank.d328.s8	DDI-DrugBank.d328.s8.e0	DDI-DrugBank.d328.s8.e2	null	relType_4=mark	pos_6=VB	wib=Reports	relType_7=det	relType_8=amod	relation_9=neutral	path1=	relType_5=nsubj	lemma_10=of	lemma_11=-	pos_11=HYPH	path2=suggest_parataxis>diminish_ccomp>effect_obj>inhibitor_nmod	pos_8=JJ	lemma_6=diminish	lemma_5=may	relType_2=nsubj	pos_5=NNS	lemma_5=nsaid	relType_11=punct	relType_10=case	lemma_2=report	relType_5=aux	path=<inhibitor_ROOT>suggest_parataxis>diminish_ccomp>effect_obj>inhibitor_nmod	pos_9=NN	pos_7=DT	lemma_1=:	pos_5=MD	pos_4=IN	pos_1=:	relType_6=ccomp	relType_9=obj	relType_3=parataxis	pos_10=IN	lemma_11=ace	pos_2=NNS	lemma_8=antihypertensive	pos_11=NN	eib=True	relType_11=compound	lemma_4=that	lemma_7=the	lib=report	relType_1=punct	lemma_9=effect	lemma_3=suggest	lpib=report_NNS	pos_3=VBP
DDI-DrugBank.d328.s8	DDI-DrugBank.d328.s8.e1	DDI-DrugBank.d328.s8.e2	effect	path=nsaid_nsubj<diminish_ccomp>effect_obj>inhibitor_nmod	lemma_2=diminish	relType_4=amod	pos_4=JJ	relType_7=compound	relType_1=aux	lemma_1=may	lemma_6=of	relType_6=case	lemma_4=antihypertensive	lemma_7=-	pos_6=IN	lib=diminish	pos_2=VB	relType_3=det	lemma_7=ace	lemma_5=effect	pos_7=HYPH	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	path2=effect_obj>inhibitor_nmod	pos_3=DT	relType_5=obj	lpib=diminish_VB	relType_7=punct	lemma_3=the	relation_4=neutral	pos_7=NN	wib=diminish	path1=nsaid_nsubj
DDI-DrugBank.d328.s9	DDI-DrugBank.d328.s9.e0	DDI-DrugBank.d328.s9.e1	advise	wib=concomitantly	lpib=concomitantly_RB	pos_2=IN	path=bextra_obj<take_acl>inhibitor_obl	lemma_2=with	lemma_1=concomitantly	lemma_3=-	path2=inhibitor_obl	relType_1=advmod	lemma_3=ace	lib=concomitantly	relType_2=case	eib=True	pos_1=RB	pos_3=NN	pos_3=HYPH	relType_3=compound	path1=bextra_obj	relType_3=punct
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e0	DDI-DrugBank.d328.s10.e1	null	lemma_10=marketing	path1=	lib=clinical	wib=Clinical	lemma_9=-	lemma_11=observation	pos_2=JJ	relType_11=conj	pos_13=VBP	pos_8=NN	lemma_12=,	relType_5=cc	pos_9=HYPH	pos_3=NNS	pos_4=,	eib=False	path2=show_parataxis>reduce_ccomp>nsaid_nsubj	relType_15=mark	pos_12=,	pos_11=NNS	lemma_6=well	lemma_7=as	relType_13=aux	relType_10=compound	relType_12=punct	pos_10=NN	lemma_15=that	lemma_1=:	relType_4=punct	relType_6=fixed	relType_2=amod	pos_5=RB	pos_1=:	relType_8=compound	lemma_4=,	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>nsaid_nsubj	pos_6=RB	relType_9=punct	relType_3=nsubj	relType_7=fixed	pos_15=IN	lemma_8=post	pos_14=VBN	lpib=clinical_JJ	lemma_2=clinical	lemma_3=study	pos_7=IN	lemma_14=show	relType_1=punct	lemma_13=have	relType_14=parataxis	lemma_5=as
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e0	DDI-DrugBank.d328.s10.e2	null	lemma_17=reduce	pos_20=NN	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod	lemma_10=marketing	relation_17=adverse	path1=	lib=clinical	wib=Clinical	lemma_9=-	lemma_11=observation	pos_2=JJ	pos_16=NNS	relType_11=conj	pos_13=VBP	pos_8=NN	lemma_12=,	relType_5=cc	pos_9=HYPH	pos_16=MD	pos_3=NNS	pos_18=DT	pos_4=,	relType_15=mark	lemma_19=natriuretic	relType_17=ccomp	lemma_16=nsaid	pos_12=,	pos_11=NNS	lemma_16=can	lemma_6=well	lemma_7=as	relType_13=aux	relType_10=compound	relType_12=punct	pos_10=NN	lemma_15=that	relType_16=aux	lemma_20=effect	relType_20=obj	lemma_1=:	pos_21=IN	path2=show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod	relType_4=punct	pos_19=JJ	relType_6=fixed	lemma_21=of	relType_2=amod	pos_5=RB	pos_1=:	relType_8=compound	relType_16=nsubj	pos_17=VB	lemma_4=,	relType_19=amod	pos_6=RB	relType_9=punct	relType_3=nsubj	relType_21=case	relType_7=fixed	pos_15=IN	relation_20=neutral	lemma_8=post	pos_14=VBN	lpib=clinical_JJ	lemma_2=clinical	eib=True	lemma_3=study	pos_7=IN	lemma_14=show	relType_18=det	relType_1=punct	lemma_13=have	relType_14=parataxis	lemma_5=as	lemma_18=the
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e0	DDI-DrugBank.d328.s10.e3	null	pos_2=JJ	pos_13=VBP	lemma_12=,	relType_5=cc	pos_9=HYPH	pos_16=MD	pos_3=NNS	relType_15=mark	pos_12=,	pos_20=NN	lemma_16=can	lemma_6=well	pos_10=NN	relType_20=obj	relType_4=punct	pos_1=:	relType_21=case	relation_20=neutral	pos_14=VBN	pos_7=IN	lemma_17=reduce	relType_22=nmod	pos_22=NN	path=<Furosemide_ROOT>show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	path1=	lib=clinical	wib=Clinical	lemma_11=observation	pos_16=NNS	path2=show_parataxis>reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	pos_8=NN	pos_18=DT	lemma_19=natriuretic	lemma_16=nsaid	pos_19=JJ	relType_12=punct	lemma_15=that	lemma_4=,	relType_19=amod	pos_6=RB	pos_15=IN	lpib=clinical_JJ	relType_18=det	relType_1=punct	lemma_21=of	lemma_13=have	lemma_18=the	lemma_10=marketing	relation_17=adverse	lemma_9=-	relType_11=conj	pos_4=,	relType_22=cc	pos_21=IN	lemma_1=:	relType_2=amod	relType_8=compound	relType_16=nsubj	relType_3=nsubj	relType_7=fixed	lemma_8=post	lemma_2=clinical	relType_14=parataxis	pos_22=CC	lemma_22=furosemide	relType_17=ccomp	pos_11=NNS	relType_16=aux	lemma_7=as	relType_13=aux	relType_10=compound	lemma_20=effect	relType_6=fixed	pos_5=RB	pos_17=VB	relType_9=punct	lemma_3=study	eib=True	lemma_14=show	lemma_22=and	lemma_5=as
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e1	DDI-DrugBank.d328.s10.e2	effect	relType_4=amod	pos_4=JJ	path=nsaid_nsubj<reduce_ccomp>effect_obj>furosemide_nmod	relType_1=aux	lib=reduce	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	eib=False	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	lpib=reduce_VB	pos_1=MD	path2=effect_obj>furosemide_nmod	relType_2=ccomp	pos_5=NN	pos_3=DT	relType_5=obj	lemma_3=the	relation_4=neutral	path1=nsaid_nsubj
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e1	DDI-DrugBank.d328.s10.e3	effect	relType_4=amod	pos_4=JJ	relType_1=aux	lib=reduce	path2=effect_obj>furosemide_nmod>thiazide_conj	relType_7=cc	lemma_4=natriuretic	lemma_6=of	lemma_2=reduce	relType_6=case	path=nsaid_nsubj<reduce_ccomp>effect_obj>furosemide_nmod>thiazide_conj	pos_6=IN	wib=reduce	relation_1=adverse	pos_2=VB	relType_3=det	lemma_5=effect	lemma_1=can	lpib=reduce_VB	pos_7=CC	relType_7=nmod	pos_1=MD	relType_2=ccomp	pos_5=NN	eib=True	pos_3=DT	relType_5=obj	lemma_7=and	lemma_3=the	relation_4=neutral	pos_7=NN	lemma_7=furosemide	path1=nsaid_nsubj
DDI-DrugBank.d328.s10	DDI-DrugBank.d328.s10.e2	DDI-DrugBank.d328.s10.e3	null	relType_1=cc	wib=thiazides	lpib=thiazide_NNS	pos_1=CC	path2=thiazide_conj	eib=False	path1=	lib=thiazide	path=<furosemide_nmod>thiazide_conj	lemma_1=and
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e0	DDI-DrugBank.d328.s12.e1	null	lemma_1=(	lib=phenytoin	eib=False	path2=phenytoin_appos	path1=	wib=Phenytoin	relType_1=punct	path=<anticonvulsant_ROOT>phenytoin_appos	lpib=phenytoin_NN	pos_1=-LRB-
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e0	DDI-DrugBank.d328.s12.e2	null	lemma_2=)	relType_4=amod	pos_4=JJ	lemma_8=(	pos_2=NN	relType_10=punct	path1=	lemma_5=state	relType_5=compound	wib=Phenytoin	relType_8=punct	relType_11=case	relType_2=punct	lemma_1=(	pos_6=NN	lemma_6=plasma	lib=phenytoin	lemma_3=:	lemma_2=phenytoin	lemma_4=steady	relType_7=nsubj:pass	path2=decrease_parataxis>exposure_nsubj:pass>valdecoxib_nmod	path=<anticonvulsant_ROOT>decrease_parataxis>exposure_nsubj:pass>valdecoxib_nmod	pos_9=NN	relType_9=appos	pos_8=-LRB-	pos_11=IN	pos_3=:	relType_2=appos	lemma_7=exposure	pos_1=-LRB-	pos_5=NN	relType_6=compound	lemma_9=auc	lemma_10=)	eib=True	pos_2=-RRB-	pos_10=-RRB-	lemma_11=of	relType_1=punct	pos_7=NN	relType_3=punct	lpib=phenytoin_NN
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e0	DDI-DrugBank.d328.s12.e3	null	pos_2=NN	relType_21=parataxis	lemma_22=by	relType_32=punct	wib=Phenytoin	relType_8=punct	pos_35=NN	lemma_20=be	relType_34=compound	lemma_40=of	lemma_24=%	pos_6=NN	lemma_28=administer	relType_31=obl	relType_20=aux:pass	pos_23=CD	pos_26=NN	pos_22=IN	relType_30=amod	pos_36=IN	pos_3=:	path2=decrease_parataxis>administer_advcl>dose_obl>phenytoin_nmod	lemma_7=exposure	pos_1=-LRB-	pos_17=CD	pos_40=IN	relType_6=compound	lemma_10=)	relType_26=dep	pos_14=NNS	relType_4=amod	lemma_15=BID	pos_13=CD	pos_15=NNP	pos_18=NNS	relType_37=nummod	relation_22=adverse	path1=	relType_39=punct	pos_29=IN	relType_11=case	relType_2=punct	lib=phenytoin	lemma_17=12	relType_12=nmod	relType_12=punct	relType_22=case	pos_9=NN	pos_33=CD	lemma_32=(	relType_40=case	relType_25=advmod	pos_27=HYPH	pos_21=VBN	pos_5=NN	pos_25=WRB	relType_16=case	relType_15=appos	lemma_21=decrease	relType_1=punct	pos_12=-LRB-	pos_7=NN	relType_18=nmod	relType_3=punct	lemma_16=for	lemma_12=(	lemma_8=(	relType_10=punct	lemma_12=valdecoxib	relType_24=obl	pos_16=IN	relType_29=case	pos_34=NNS	relType_35=dep	lemma_5=state	pos_24=NN	relType_19=punct	lemma_18=day	lemma_1=(	lemma_39=)	pos_30=JJ	pos_32=-LRB-	lemma_13=40	relType_13=nummod	lemma_27=-	lemma_4=steady	relType_7=nsubj:pass	lemma_37=12	lemma_23=27	relType_9=appos	pos_11=IN	path=<anticonvulsant_ROOT>decrease_parataxis>administer_advcl>dose_obl>phenytoin_nmod	pos_38=NNS	pos_2=-RRB-	lemma_11=of	lemma_19=)	relType_27=punct	lemma_31=dose	lemma_29=with	lemma_2=)	pos_4=JJ	relType_23=nummod	lemma_14=mg	relType_38=nmod	lemma_36=for	relType_5=compound	relType_14=compound	lemma_25=when	lemma_6=plasma	relType_33=nummod	relType_17=nummod	lemma_3=:	pos_20=VBD	pos_28=VBN	lemma_2=phenytoin	pos_37=CD	lemma_26=co	relType_28=advcl	pos_8=-LRB-	pos_39=-RRB-	pos_31=NNS	relType_2=appos	lemma_30=multiple	lemma_38=day	lemma_34=mg	lemma_9=auc	eib=True	lemma_35=qd	pos_10=-RRB-	lemma_33=300	pos_12=NN	relType_36=case	pos_19=-RRB-	lpib=phenytoin_NN
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e1	DDI-DrugBank.d328.s12.e2	null	lemma_9=)	lemma_7=(	lemma_10=of	relType_5=compound	lemma_4=state	lemma_1=)	relType_8=appos	relType_2=punct	pos_6=NN	pos_7=-LRB-	pos_8=NN	lemma_2=:	eib=False	path1=phenytoin_appos	lib=steady	lpib=steady_JJ	lemma_3=steady	relType_10=case	path2=decrease_parataxis>exposure_nsubj:pass>valdecoxib_nmod	pos_4=NN	pos_9=-RRB-	path=phenytoin_appos<anticonvulsant_ROOT>decrease_parataxis>exposure_nsubj:pass>valdecoxib_nmod	relType_3=amod	pos_1=-RRB-	relType_4=compound	relType_6=nsubj:pass	pos_2=:	lemma_5=plasma	pos_10=IN	relType_9=punct	wib=Steady	pos_5=NN	lemma_6=exposure	pos_3=JJ	relType_7=punct	lemma_8=auc	relType_1=punct
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e1	DDI-DrugBank.d328.s12.e3	null	lemma_34=qd	lemma_9=)	pos_34=NN	pos_13=NNS	pos_12=CD	lemma_10=of	lemma_13=mg	pos_6=NN	pos_7=-LRB-	lib=steady	pos_26=HYPH	lemma_12=40	lemma_26=-	relType_3=amod	path2=decrease_parataxis>administer_advcl>dose_obl>phenytoin_nmod	relType_6=nsubj:pass	relType_21=case	lemma_16=12	wib=Steady	lemma_15=for	pos_3=JJ	pos_27=VBN	lemma_8=auc	relation_20=adverse	pos_19=VBD	lemma_17=day	relType_27=advcl	pos_30=NNS	lemma_22=27	pos_20=VBN	relType_8=appos	relType_2=punct	relType_38=punct	pos_8=NN	lemma_2=:	lemma_19=be	relType_22=nummod	lemma_14=BID	lemma_39=of	pos_36=CD	relType_23=obl	relType_37=nmod	relType_15=case	relType_24=advmod	pos_1=-RRB-	lemma_37=day	lemma_5=plasma	relType_16=nummod	lemma_11=valdecoxib	relType_19=aux:pass	lemma_18=)	lemma_23=%	pos_15=IN	pos_5=NN	pos_11=NN	relType_25=dep	relType_11=nmod	relType_26=punct	relType_1=punct	pos_32=CD	pos_14=NNP	pos_29=JJ	lemma_4=state	relType_30=obl	path=phenytoin_appos<anticonvulsant_ROOT>decrease_parataxis>administer_advcl>dose_obl>phenytoin_nmod	pos_23=NN	relType_29=amod	pos_18=-RRB-	path1=phenytoin_appos	relType_11=punct	lemma_27=administer	lpib=steady_JJ	pos_31=-LRB-	lemma_3=steady	pos_21=IN	pos_16=CD	lemma_20=decrease	relType_34=dep	lemma_11=(	pos_25=NN	pos_10=IN	lemma_29=multiple	relType_17=nmod	lemma_21=by	relType_36=nummod	lemma_6=exposure	relType_28=case	pos_17=NNS	lemma_31=(	pos_24=WRB	pos_38=-RRB-	relType_20=parataxis	relType_39=case	pos_39=IN	lemma_7=(	lemma_32=300	relType_5=compound	lemma_1=)	lemma_28=with	pos_22=CD	pos_11=-LRB-	relType_33=compound	relType_10=case	pos_4=NN	lemma_24=when	pos_9=-RRB-	relType_31=punct	relType_13=compound	lemma_30=dose	relType_18=punct	relType_4=compound	lemma_36=12	pos_2=:	relType_14=appos	pos_37=NNS	lemma_33=mg	relType_9=punct	eib=True	relType_7=punct	pos_28=IN	lemma_35=for	pos_35=IN	relType_12=nummod	relType_35=case	lemma_38=)	lemma_25=co	pos_33=NNS	relType_32=nummod
DDI-DrugBank.d328.s12	DDI-DrugBank.d328.s12.e2	DDI-DrugBank.d328.s12.e3	mechanism	pos_12=CD	relType_8=punct	pos_16=HYPH	relType_5=case	relType_18=case	pos_3=NNS	lib=mg	relType_28=punct	relType_27=nmod	pos_13=NN	lemma_15=co	lemma_24=qd	relType_23=compound	path=valdecoxib_nmod<exposure_nsubj:pass<decrease_parataxis>administer_advcl>dose_obl>phenytoin_nmod	lemma_11=by	relType_17=advcl	relType_16=punct	pos_1=-LRB-	lemma_4=BID	relType_21=punct	lemma_14=when	pos_7=NNS	path2=administer_advcl>dose_obl>phenytoin_nmod	relType_2=nummod	relType_9=aux:pass	relation_9=adverse	pos_29=IN	pos_14=WRB	relType_11=case	lemma_12=27	relType_25=case	relType_14=advmod	relType_22=nummod	pos_19=JJ	lemma_27=day	pos_28=-RRB-	relType_6=nummod	pos_5=IN	relType_7=nmod	lemma_16=-	relType_19=amod	lemma_17=administer	lemma_22=300	pos_10=VBN	pos_4=NNP	pos_25=IN	relType_3=compound	relType_20=obl	relType_1=punct	lemma_2=40	relType_29=case	relType_26=nummod	relType_4=appos	lemma_25=for	pos_24=NN	pos_17=VBN	lemma_28=)	lemma_1=(	relType_13=obl	pos_27=NNS	relType_15=dep	pos_18=IN	pos_11=IN	lemma_8=)	pos_23=NNS	lemma_19=multiple	pos_9=VBD	path1=valdecoxib_nmod<exposure_nsubj:pass	lemma_6=12	pos_6=CD	lemma_29=of	lemma_5=for	pos_26=CD	relType_10=parataxis	pos_21=-LRB-	pos_22=CD	eib=False	lemma_13=%	pos_2=CD	pos_8=-RRB-	relType_24=dep	lpib=mg_NNS	pos_15=NN	lemma_26=12	lemma_21=(	pos_20=NNS	lemma_7=day	lemma_9=be	lemma_18=with	lemma_20=dose	wib=mg	relType_12=nummod	lemma_3=mg	lemma_23=mg	lemma_10=decrease
DDI-DrugBank.d328.s13	DDI-DrugBank.d328.s13.e0	DDI-DrugBank.d328.s13.e1	advise	lemma_3=closely	path2=loss_obl>coadministration_nmod>phenytoin_compound	pos_3=RB	relType_3=advmod	relType_1=aux	relType_7=case	lemma_10=with	lemma_8=symptom	lemma_1=should	lemma_5=for	relType_9=nmod	relation_8=neutral	relType_5=case	wib=be	pos_6=NN	relType_6=obl	pos_8=NN	lemma_6=loss	eib=False	path1=valdecoxib_obl<stabilize_csubj:pass	pos_2=VB	relType_10=case	pos_9=NN	pos_4=VBN	lemma_9=control	lib=be	relType_8=compound	relType_2=aux:pass	pos_5=IN	pos_10=IN	pos_1=MD	lpib=be_VB	relType_4=ROOT	lemma_7=of	path=valdecoxib_obl<stabilize_csubj:pass<monitor_ROOT>loss_obl>coadministration_nmod>phenytoin_compound	pos_7=IN	lemma_2=be	lemma_4=monitor
DDI-DrugBank.d328.s14	DDI-DrugBank.d328.s14.e0	DDI-DrugBank.d328.s14.e1	null	relType_8=case	path1=Valdecoxib_nsubj	pos_6=JJ	path=Valdecoxib_nsubj<have_ROOT>effect_obj>pharmacokinetic_nmod>phenytoin_nmod	relType_1=aux	lemma_4=a	lemma_5=statistically	pos_7=NN	wib=did	pos_3=VB	relType_11=case	relation_6=neutral	pos_2=RB	pos_1=VBD	relType_10=nmod	eib=False	relType_2=advmod	path2=effect_obj>pharmacokinetic_nmod>phenytoin_nmod	lemma_1=do	relType_6=amod	lemma_7=effect	relType_7=obj	pos_9=DT	lemma_3=have	pos_8=IN	lemma_8=on	pos_11=IN	pos_4=DT	relType_3=ROOT	pos_5=RB	lpib=do_VBD	relType_5=advmod	lib=do	lemma_6=significant	lemma_9=the	lemma_11=of	relType_4=det	lemma_10=pharmacokinetic	pos_10=NNS	lemma_2=not	relType_9=det
DDI-DrugBank.d328.s17	DDI-DrugBank.d328.s17.e0	DDI-DrugBank.d328.s17.e1	null	lpib=dextromethorphan_NNP	lib=dextromethorphan	eib=False	path2=metabolize_dep>Dextromethorphan_nsubj:pass	path1=	pos_1=:	path=<Dextromethorphan_ROOT>metabolize_dep>Dextromethorphan_nsubj:pass	lemma_1=:	relType_1=punct	wib=Dextromethorphan
DDI-DrugBank.d328.s18	DDI-DrugBank.d328.s18.e0	DDI-DrugBank.d328.s18.e1	mechanism	pos_7=NNS	relType_2=nummod	relType_4=appos	lemma_11=a	pos_6=CD	relType_8=punct	lemma_5=for	path1=valdecoxib_nmod<Coadministration_nsubj	relType_5=case	path2=increase_obl>level_nmod>dextromethorphan_compound	lemma_1=(	relType_9=ROOT	pos_12=JJ	relType_13=obl	pos_3=NNS	lib=mg	eib=False	pos_2=CD	relType_12=amod	pos_8=-RRB-	relType_10=case	pos_13=NN	lemma_14=in	path=valdecoxib_nmod<Coadministration_nsubj<result_ROOT>increase_obl>level_nmod>dextromethorphan_compound	lpib=mg_NNS	pos_14=IN	lemma_6=7	lemma_8=)	lemma_10=in	relType_6=nummod	pos_5=IN	relType_7=nmod	lemma_9=result	lemma_7=day	pos_10=IN	pos_11=DT	pos_1=-LRB-	relType_11=det	lemma_13=increase	lemma_12=significant	pos_9=VBD	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	lemma_3=mg	relType_14=case	relType_1=punct	lemma_2=40	relation_12=beneficial
DDI-DrugBank.d328.s18	DDI-DrugBank.d328.s18.e0	DDI-DrugBank.d328.s18.e2	null	relType_16=nmod	relType_8=punct	path1=valdecoxib_nmod<Coadministration_nsubj	relType_5=case	relType_9=ROOT	lemma_17=suggest	pos_3=NNS	lib=mg	path=valdecoxib_nmod<Coadministration_nsubj<result_ROOT>increase_obl>suggest_acl>inhibitor_ccomp>valdecoxib_nsubj	lemma_14=in	pos_13=NN	lemma_23=,	lemma_15=plasma	lemma_10=in	pos_1=-LRB-	relType_11=det	relType_15=compound	relType_18=mark	lemma_4=BID	relType_22=obl	pos_7=NNS	relType_2=nummod	pos_16=NNS	relType_17=acl	relType_20=case	relType_12=amod	pos_14=IN	lemma_18=that	relType_21=det	pos_19=,	relType_6=nummod	pos_5=IN	relType_7=nmod	lemma_21=this	pos_4=NNP	lemma_19=,	relType_3=compound	relType_1=punct	lemma_2=40	relType_4=appos	lemma_22=dose	relType_19=punct	pos_20=IN	lemma_1=(	relType_13=obl	path2=increase_obl>suggest_acl>inhibitor_ccomp>valdecoxib_nsubj	pos_18=IN	lemma_8=)	pos_10=IN	lemma_13=increase	lemma_12=significant	pos_9=VBD	relType_14=case	relType_23=punct	lemma_11=a	pos_6=CD	lemma_5=for	pos_12=JJ	pos_2=CD	pos_17=VBG	pos_8=-RRB-	relType_10=case	lpib=mg_NNS	lemma_6=7	pos_15=NN	pos_22=NNS	lemma_16=level	lemma_9=result	lemma_7=day	pos_11=DT	eib=True	pos_23=,	wib=mg	lemma_3=mg	lemma_15=dextromethorphan	pos_21=DT	relation_12=beneficial	lemma_20=at
DDI-DrugBank.d328.s18	DDI-DrugBank.d328.s18.e1	DDI-DrugBank.d328.s18.e2	null	relType_4=mark	lemma_1=plasma	relType_7=det	pos_5=,	lemma_9=,	lemma_6=at	lemma_8=dose	relType_6=case	pos_8=NNS	relType_8=obl	path1=dextromethorphan_compound<level_nmod	relType_1=compound	eib=False	relType_2=nmod	relType_3=acl	pos_6=IN	lemma_7=this	pos_3=VBG	pos_1=NN	pos_7=DT	wib=plasma	lpib=plasma_NN	lemma_5=,	pos_4=IN	relType_5=punct	lib=plasma	path=dextromethorphan_compound<level_nmod<increase_obl>suggest_acl>inhibitor_ccomp>valdecoxib_nsubj	path2=suggest_acl>inhibitor_ccomp>valdecoxib_nsubj	relType_9=punct	lemma_2=level	pos_2=NNS	lemma_4=that	pos_9=,	lemma_3=suggest
DDI-DrugBank.d328.s19	DDI-DrugBank.d328.s19.e0	DDI-DrugBank.d328.s19.e1	mechanism	lemma_1=plasma	pos_3=IN	lemma_7=high	pos_9=IN	lemma_6=of	lemma_8=dose	relType_6=case	pos_8=NNS	relType_1=compound	relType_2=nsubj	eib=False	path2=presence_nmod>dose_nmod>valdecoxib_nmod	pos_6=IN	relType_9=case	lemma_5=presence	pos_1=NN	wib=plasma	pos_4=DT	lpib=plasma_NN	relType_7=amod	lemma_2=concentration	lemma_4=the	lib=plasma	relType_5=nmod	path=dextromethorphan_amod<concentration_nsubj>presence_nmod>dose_nmod>valdecoxib_nmod	relType_3=case	pos_2=NNS	pos_5=NN	relType_8=nmod	lemma_9=of	pos_7=JJ	relType_4=det	lemma_3=in	path1=dextromethorphan_amod
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e0	DDI-DrugBank.d328.s20.e1	null	lib=valdecoxib	eib=False	path=<lithium_ROOT>produce_parataxis>BID_nsubj>Valdecoxib_compound	path2=produce_parataxis>BID_nsubj>Valdecoxib_compound	path1=	pos_1=:	relType_1=punct	lpib=valdecoxib_NNP	lemma_1=:	wib=Valdecoxib
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e0	DDI-DrugBank.d328.s20.e2	null	pos_7=NNS	relType_2=nummod	path1=	pos_6=CD	lpib=valdecoxib_NNP	lemma_5=for	relation_8=neutral	relType_5=case	lemma_8=produce	relType_11=case	pos_9=JJ	lib=valdecoxib	pos_2=NNP	pos_2=CD	relType_9=amod	lemma_11=in	relType_4=nsubj	relType_8=parataxis	relType_10=obj	lemma_1=:	path2=produce_parataxis>decrease_obj>clearance_nmod>lithium_compound	pos_8=VBD	path=<lithium_ROOT>produce_parataxis>decrease_obj>clearance_nmod>lithium_compound	pos_11=IN	lemma_6=7	relation_10=adverse	relType_2=compound	pos_1=:	relType_6=nummod	pos_5=IN	lemma_7=day	lemma_9=significant	relType_7=obl	eib=True	pos_3=NN	lemma_4=BID	pos_4=NNP	lemma_2=Valdecoxib	relType_3=compound	lemma_3=mg	relType_1=punct	lemma_2=40	pos_10=NNS	lemma_10=decrease	wib=Valdecoxib
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e0	DDI-DrugBank.d328.s20.e3	null	lpib=valdecoxib_NNP	relType_5=case	relType_31=obl	pos_15=CD	lib=valdecoxib	pos_2=NNP	relType_12=compound	lemma_12=lithium	pos_20=NN	lemma_16=%	pos_18=CC	pos_13=NN	lemma_20=clearance	pos_14=-LRB-	relType_15=nummod	pos_1=:	pos_28=NN	lemma_29=high	relType_30=compound	lemma_4=BID	lemma_2=Valdecoxib	relType_21=punct	relType_32=case	pos_7=NNS	relType_2=nummod	pos_29=JJR	lemma_22=30	path1=	relation_8=neutral	lemma_8=produce	relType_11=case	pos_30=NN	relType_25=case	relType_20=conj	relType_22=nummod	pos_19=JJ	lemma_11=in	lemma_33=to	lemma_24=)	path2=produce_parataxis>exposure_obl>lithium_nmod	relType_27=nummod	relType_6=nummod	pos_5=IN	lemma_31=exposure	pos_16=NN	relType_19=amod	lemma_23=%	relType_7=obl	pos_27=CD	pos_31=NN	pos_4=NNP	pos_25=IN	relType_3=compound	relType_1=punct	lemma_2=40	relType_10=obj	wib=Valdecoxib	relType_14=punct	lemma_13=clearance	lemma_27=34	path=<lithium_ROOT>produce_parataxis>exposure_obl>lithium_nmod	relType_17=punct	relType_24=punct	lemma_25=with	lemma_26=a	relType_18=cc	pos_23=NN	relType_29=amod	relType_9=amod	relType_8=parataxis	lemma_1=:	pos_8=VBD	pos_11=IN	pos_33=IN	pos_26=DT	lemma_32=compare	pos_32=VBN	relType_23=appos	relType_16=appos	lemma_30=serum	relType_28=obl:npmod	lemma_12=serum	relType_33=case	pos_6=CD	lemma_5=for	lemma_19=renal	lemma_14=(	relType_13=nmod	pos_21=-LRB-	pos_9=JJ	pos_22=CD	pos_2=CD	relType_4=nsubj	lemma_15=25	lemma_6=7	relation_10=adverse	relType_2=compound	lemma_21=(	lemma_7=day	lemma_9=significant	lemma_28=%	lemma_17=)	pos_24=-RRB-	lemma_18=and	eib=True	relType_26=det	pos_3=NN	pos_17=-RRB-	lemma_3=mg	pos_12=NN	pos_10=NNS	lemma_10=decrease
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e1	DDI-DrugBank.d328.s20.e2	mechanism	relType_1=nummod	pos_2=NN	relType_8=amod	pos_3=NNP	relation_6=neutral	pos_8=JJ	pos_5=CD	relType_6=obl	lib=mg	pos_1=CD	eib=False	lemma_5=7	relation_8=adverse	lpib=mg_NN	lemma_6=day	pos_9=NNS	lemma_4=for	lemma_1=40	relType_10=case	lemma_8=significant	lemma_10=in	relType_5=nummod	relType_2=compound	pos_4=IN	lemma_9=decrease	pos_7=VBD	relType_4=case	relType_9=obj	lemma_7=produce	pos_10=IN	lemma_2=mg	relType_3=nsubj	path=Valdecoxib_compound<BID_nsubj<produce_parataxis>decrease_obj>clearance_nmod>lithium_compound	path2=decrease_obj>clearance_nmod>lithium_compound	lemma_3=BID	pos_6=NNS	wib=mg	path1=Valdecoxib_compound<BID_nsubj	relType_7=parataxis
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e1	DDI-DrugBank.d328.s20.e3	null	relType_1=nummod	pos_20=-LRB-	pos_2=NN	pos_8=JJ	pos_5=CD	relType_24=case	lib=mg	pos_32=IN	lemma_10=in	lemma_26=34	lemma_14=25	pos_24=IN	relType_25=det	lemma_22=%	relType_16=punct	lemma_28=high	lemma_11=lithium	pos_31=VBN	relType_22=appos	lemma_19=clearance	pos_6=NNS	relType_21=nummod	pos_14=CD	relType_32=case	relType_17=cc	lemma_29=serum	pos_22=NN	pos_3=NNP	pos_30=NN	relType_12=nmod	pos_29=NN	lemma_11=serum	pos_21=CD	pos_27=NN	lemma_13=(	lemma_8=significant	relType_5=nummod	lemma_2=mg	lemma_24=with	pos_11=NN	relType_15=appos	lemma_3=BID	pos_17=CC	relType_28=amod	path1=Valdecoxib_compound<BID_nsubj	relType_26=nummod	relType_29=compound	relType_30=obl	relType_6=obl	path=Valdecoxib_compound<BID_nsubj<produce_parataxis>exposure_obl>lithium_nmod	lemma_5=7	lemma_27=%	relation_8=adverse	lpib=mg_NN	lemma_6=day	lemma_30=exposure	lemma_18=renal	lemma_15=%	pos_4=IN	lemma_9=decrease	lemma_23=)	pos_7=VBD	relType_9=obj	pos_16=-RRB-	lemma_7=produce	pos_10=IN	relType_19=conj	relType_3=nsubj	relType_14=nummod	pos_23=-RRB-	lemma_25=a	relType_20=punct	relType_23=punct	relType_8=amod	lemma_31=compare	relType_18=amod	relType_13=punct	lemma_32=to	path2=exposure_obl>lithium_nmod	relType_31=case	lemma_20=(	pos_26=CD	relType_27=obl:npmod	relation_6=neutral	lemma_12=clearance	pos_25=DT	pos_1=CD	pos_9=NNS	lemma_4=for	lemma_1=40	pos_18=JJ	pos_19=NN	relType_10=case	lemma_16=)	pos_28=JJR	pos_15=NN	relType_2=compound	relType_4=case	lemma_17=and	pos_13=-LRB-	lemma_21=30	eib=True	relType_11=compound	wib=mg	pos_12=NN	relType_7=parataxis
DDI-DrugBank.d328.s20	DDI-DrugBank.d328.s20.e2	DDI-DrugBank.d328.s20.e3	null	relType_10=punct	pos_2=NN	relType_9=conj	relType_8=amod	lemma_12=%	lemma_14=with	relType_18=amod	relType_13=punct	relType_7=cc	pos_18=JJR	path2=exposure_obl>lithium_nmod	lemma_4=25	path=lithium_compound<clearance_nmod<decrease_obj<produce_parataxis>exposure_obl>lithium_nmod	lemma_15=a	lemma_2=clearance	wib=serum	pos_8=JJ	lemma_1=serum	pos_17=NN	pos_10=-LRB-	relType_1=compound	lemma_16=34	eib=False	relType_2=nmod	relType_6=punct	lemma_20=exposure	pos_20=NN	lemma_3=(	pos_19=NN	pos_3=-LRB-	pos_22=IN	relType_22=case	pos_9=NN	lemma_6=)	pos_1=NN	lemma_9=clearance	pos_15=DT	pos_4=CD	pos_14=IN	relType_19=compound	lemma_11=30	pos_16=CD	relType_11=nummod	lemma_22=to	lemma_8=renal	lemma_5=%	pos_7=CC	lemma_10=(	path1=lithium_compound<clearance_nmod<decrease_obj	relType_16=nummod	lemma_17=%	pos_11=CD	relType_5=appos	pos_13=-RRB-	relType_4=nummod	pos_6=-RRB-	pos_21=VBN	relType_17=obl:npmod	pos_5=NN	relType_21=case	lib=serum	lpib=serum_NN	relType_12=appos	lemma_19=serum	lemma_13=)	lemma_21=compare	lemma_7=and	lemma_18=high	relType_14=case	relType_20=obl	pos_12=NN	relType_15=det	relType_3=punct
DDI-DrugBank.d328.s21	DDI-DrugBank.d328.s21.e0	DDI-DrugBank.d328.s21.e1	null	lemma_4=be	relType_8=amod	relation_9=neutral	lemma_11=therapy	relType_12=case	pos_7=WRB	lemma_3=should	wib=serum	lemma_1=serum	pos_5=VBN	relType_1=compound	eib=False	relType_10=conj	pos_3=MD	path1=lithium_compound<concentration_nsubj:pass	lemma_10=change	relType_2=nsubj:pass	lemma_12=with	pos_1=NN	lemma_6=closely	pos_12=IN	lemma_5=monitor	pos_9=CC	lemma_2=concentration	lemma_8=initiate	pos_8=VBG	lemma_9=or	relType_4=aux:pass	relType_11=dep	pos_6=RB	pos_2=NNS	lib=serum	pos_11=NN	relType_7=dep	lpib=serum_NN	pos_4=VB	pos_10=VBG	lemma_7=when	relType_3=aux	relType_9=cc	path2=when_dep>therapy_dep>bextra_nmod	relType_5=ROOT	relType_6=advmod	path=lithium_compound<concentration_nsubj:pass<monitor_ROOT>when_dep>therapy_dep>bextra_nmod
DDI-DrugBank.d328.s21	DDI-DrugBank.d328.s21.e0	DDI-DrugBank.d328.s21.e2	null	lemma_15=receive	lemma_4=be	relType_8=amod	relation_9=neutral	lemma_11=therapy	relType_12=case	relType_14=nmod	pos_7=WRB	lemma_3=should	wib=serum	relType_13=nmod	lemma_1=serum	path=lithium_compound<concentration_nsubj:pass<monitor_ROOT>when_dep>therapy_dep>bextra_nmod>patient_nmod>receive_acl>lithium_obj	relType_1=compound	lemma_13=bextra	relType_10=conj	pos_3=MD	lemma_14=patient	path1=lithium_compound<concentration_nsubj:pass	pos_13=IN	lemma_10=change	pos_13=NN	relType_2=nsubj:pass	lemma_12=with	pos_1=NN	lemma_6=closely	pos_12=IN	relType_13=case	lemma_5=monitor	pos_9=CC	lemma_2=concentration	lemma_8=initiate	path2=when_dep>therapy_dep>bextra_nmod>patient_nmod>receive_acl>lithium_obj	pos_15=VBG	pos_8=VBG	lemma_9=or	relType_4=aux:pass	relType_11=dep	lemma_13=in	pos_6=RB	relType_15=acl	pos_2=NNS	lib=serum	pos_11=NN	relType_7=dep	lpib=serum_NN	eib=True	pos_4=VB	pos_10=VBG	lemma_7=when	pos_14=NNS	relType_3=aux	relType_9=cc	relType_5=ROOT	relType_6=advmod	pos_5=VBN
DDI-DrugBank.d328.s21	DDI-DrugBank.d328.s21.e1	DDI-DrugBank.d328.s21.e2	advise	pos_2=NNS	wib=patients	relType_1=case	lemma_1=in	lpib=patient_NNS	eib=False	lemma_2=patient	relType_2=nmod	lib=patient	relType_3=acl	path1=	path2=patient_nmod>receive_acl>lithium_obj	path=<bextra_nmod>patient_nmod>receive_acl>lithium_obj	lemma_3=receive	pos_1=IN	pos_3=VBG
DDI-DrugBank.d328.s22	DDI-DrugBank.d328.s22.e0	DDI-DrugBank.d328.s22.e1	null	pos_7=NNS	relType_2=nummod	path2=effect_obj>pharmacokinetic_nmod>valdecoxib_compound	relType_10=det	lemma_12=on	relType_4=appos	relType_12=case	relation_10=neutral	pos_6=CD	relType_8=punct	lemma_5=for	relType_11=obj	relType_5=case	lemma_1=(	path1=carbonate_nsubj	relType_9=ROOT	pos_3=NNS	lib=mg	eib=False	pos_2=CD	pos_8=-RRB-	pos_12=IN	lpib=mg_NNS	lemma_6=7	lemma_8=)	relType_6=nummod	pos_5=IN	relType_7=nmod	lemma_7=day	pos_1=-LRB-	pos_11=NN	lemma_2=450	pos_9=VBD	lemma_11=effect	path=carbonate_nsubj<have_ROOT>effect_obj>pharmacokinetic_nmod>valdecoxib_compound	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	lemma_3=mg	relType_1=punct	lemma_9=have	lemma_10=no	pos_10=DT
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e0	DDI-DrugBank.d328.s23.e1	null	pos_2=DT	lemma_2=the	path1=	relType_3=nsubj:pass	lemma_3=effect	eib=False	relation_2=neutral	lpib=effect_NN	lemma_1=:	path=<Warfarin_ROOT>study_parataxis>effect_nsubj:pass>valdecoxib_nmod	wib=effect	path2=study_parataxis>effect_nsubj:pass>valdecoxib_nmod	pos_4=IN	pos_1=:	relType_4=case	pos_3=NN	relType_2=det	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e0	DDI-DrugBank.d328.s23.e2	null	pos_2=DT	lemma_2=the	pos_6=DT	path1=	path2=study_parataxis>effect_nsubj:pass>effect_nmod>warfarin_nmod	path=<Warfarin_ROOT>study_parataxis>effect_nsubj:pass>effect_nmod>warfarin_nmod	pos_9=IN	relType_3=nsubj:pass	relation_8=neutral	relType_5=case	lemma_3=effect	pos_8=NN	lemma_6=the	relation_2=neutral	relType_9=case	lpib=effect_NN	lemma_1=:	lemma_7=anticoagulant	relType_7=amod	wib=effect	pos_4=IN	pos_1=:	relType_4=case	relType_5=nmod	pos_5=IN	lemma_5=valdecoxib	relType_6=det	pos_5=NN	eib=True	lemma_5=on	relType_8=nmod	pos_3=NN	lemma_9=of	relType_2=det	pos_7=JJ	lemma_8=effect	lib=effect	relType_1=punct	lemma_4=of
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e0	DDI-DrugBank.d328.s23.e3	null	relType_18=aux:pass	lemma_16=day	relType_16=nmod	relType_3=nsubj:pass	relType_5=case	pos_10=-LRB-	relType_10=nmod	pos_12=SYM	lemma_18=be	relType_9=case	pos_10=NN	lemma_22=subject	lemma_25=of	pos_1=:	pos_7=JJ	lib=effect	relType_22=obl	pos_2=DT	lemma_2=the	pos_13=CD	pos_15=SYM	pos_21=JJ	path1=	relation_8=neutral	relType_25=case	pos_8=NN	relType_20=case	lemma_12=-	wib=effect	lemma_10=(	pos_5=IN	pos_16=NN	pos_11=CD	relType_6=det	pos_5=NN	relType_12=dep	lemma_8=effect	pos_25=IN	pos_23=IN	relType_1=punct	lemma_13=8	lemma_23=by	relType_10=punct	pos_6=DT	relType_24=obl	relType_17=punct	pos_24=NN	pos_20=IN	lemma_6=the	relation_2=neutral	relType_13=nummod	relType_15=dep	path2=study_parataxis>coadministration_obl>BID_nmod>BEXTRA_compound	relType_19=parataxis	pos_14=NN	lemma_1=:	lemma_7=anticoagulant	lemma_24=coadministration	relType_7=amod	lemma_21=healthy	pos_4=IN	relType_23=case	pos_19=VBN	lemma_10=warfarin	lemma_4=of	lemma_14=mg	pos_9=IN	lemma_19=study	lemma_15=/	lemma_3=effect	relType_21=amod	lemma_11=1	lpib=effect_NN	pos_22=NNS	relType_4=case	lemma_20=in	relType_5=nmod	relType_14=dep	lemma_5=valdecoxib	lemma_17=)	eib=True	path=<Warfarin_ROOT>study_parataxis>coadministration_obl>BID_nmod>BEXTRA_compound	lemma_5=on	pos_3=NN	relType_8=nmod	relType_2=det	lemma_9=of	relType_11=compound	pos_17=-RRB-	pos_18=VBD
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e1	DDI-DrugBank.d328.s23.e2	null	pos_2=DT	relType_1=case	lemma_2=the	lemma_3=anticoagulant	relType_4=nmod	lemma_5=of	relType_5=case	eib=False	pos_1=IN	pos_4=NN	relation_3=neutral	lpib=anticoagulant_JJ	wib=anticoagulant	path=valdecoxib_nmod<effect_nsubj:pass>effect_nmod>warfarin_nmod	relType_3=amod	lib=anticoagulant	pos_5=IN	lemma_4=effect	pos_3=JJ	path1=valdecoxib_nmod	relType_2=det	path2=effect_nmod>warfarin_nmod	lemma_1=on
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e1	DDI-DrugBank.d328.s23.e3	null	pos_2=DT	relType_1=case	relType_7=compound	lemma_16=in	lemma_2=the	relType_8=dep	pos_18=NNS	pos_19=IN	pos_16=IN	relType_13=punct	pos_7=CD	lemma_3=anticoagulant	relType_4=nmod	lemma_6=(	pos_17=JJ	relType_10=dep	lemma_5=of	relType_5=case	relType_9=nummod	pos_6=NN	lemma_19=by	pos_6=-LRB-	relType_18=obl	lemma_20=coadministration	relType_6=punct	relType_12=nmod	lemma_10=mg	pos_20=NN	pos_12=NN	path2=coadministration_obl>BID_nmod>BEXTRA_compound	pos_1=IN	relType_14=aux:pass	pos_10=NN	pos_15=VBN	pos_21=IN	pos_4=NN	relation_3=neutral	lemma_17=healthy	lemma_14=be	lemma_18=subject	lpib=anticoagulant_JJ	wib=anticoagulant	lemma_11=/	relType_3=amod	lemma_21=of	lemma_12=day	lib=anticoagulant	pos_5=IN	pos_8=SYM	relType_11=dep	pos_11=SYM	relType_15=parataxis	pos_13=-RRB-	relType_21=case	relType_17=amod	relType_16=case	lemma_4=effect	pos_3=JJ	pos_9=CD	eib=True	path1=valdecoxib_nmod<effect_nsubj:pass	lemma_13=)	lemma_8=-	relType_19=case	path=valdecoxib_nmod<effect_nsubj:pass<study_parataxis>coadministration_obl>BID_nmod>BEXTRA_compound	relType_2=det	pos_14=VBD	lemma_6=warfarin	relType_20=obl	lemma_15=study	relType_6=nmod	lemma_7=1	lemma_9=8	lemma_1=on
DDI-DrugBank.d328.s23	DDI-DrugBank.d328.s23.e2	DDI-DrugBank.d328.s23.e3	null	relType_3=dep	relType_9=aux:pass	pos_16=IN	pos_13=NNS	path1=warfarin_nmod<effect_nmod<effect_nsubj:pass	relType_8=punct	lemma_15=coadministration	lemma_2=1	relType_11=case	relType_10=parataxis	lemma_1=(	pos_3=SYM	pos_12=JJ	relType_13=obl	relType_6=dep	lib=mg	eib=False	pos_2=CD	lpib=mg_NN	lemma_3=-	lemma_10=study	relType_12=amod	path2=coadministration_obl>BID_nmod>BEXTRA_compound	pos_8=-RRB-	lemma_11=in	lemma_14=by	lemma_16=of	relType_5=dep	pos_4=CD	pos_11=IN	pos_14=IN	lemma_8=)	relType_15=obl	pos_15=NN	pos_6=SYM	relType_2=compound	lemma_13=subject	relType_7=nmod	lemma_4=8	lemma_7=day	lemma_9=be	lemma_12=healthy	lemma_5=mg	lemma_6=/	pos_1=-LRB-	relType_4=nummod	pos_5=NN	relType_16=case	path=warfarin_nmod<effect_nmod<effect_nsubj:pass<study_parataxis>coadministration_obl>BID_nmod>BEXTRA_compound	pos_9=VBD	pos_10=VBN	wib=mg	relType_14=case	relType_1=punct	pos_7=NN
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e0	DDI-DrugBank.d328.s24.e1	mechanism	path2=increase_obj>exposure_nmod>of_acl>warfarin_dep	pos_2=DT	relType_4=amod	pos_4=JJ	path1=Valdecoxib_nsubj	pos_3=RB	relType_3=advmod	relType_7=compound	relType_10=punct	relation_4=beneficial	lemma_8=exposure	pos_9=IN	lemma_2=a	relType_6=case	lib=cause	lemma_5=increase	pos_8=NNS	wib=caused	pos_1=VBD	lemma_4=significant	pos_6=IN	path=Valdecoxib_nsubj<cause_ROOT>increase_obj>exposure_nmod>of_acl>warfarin_dep	lemma_7=plasma	lemma_6=in	pos_10=NN	relType_10=compound	lemma_3=statistically	lemma_10=-	relation_0=neutral	pos_10=HYPH	lemma_10=r	relType_1=ROOT	pos_5=NN	relType_9=acl	eib=True	relType_8=nmod	lemma_9=of	relType_5=obj	relType_2=det	pos_7=NN	lpib=cause_VBD	lemma_1=cause
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e0	DDI-DrugBank.d328.s24.e2	mechanism	pos_2=DT	relType_4=amod	path=Valdecoxib_nsubj<cause_ROOT>increase_obj>exposure_nmod>of_acl>warfarin_dep>warfarin_conj	path1=Valdecoxib_nsubj	pos_3=RB	relType_3=advmod	pos_4=JJ	relType_7=compound	relType_10=punct	relation_4=beneficial	relType_10=cc	lemma_11=s	lemma_8=exposure	pos_9=IN	lemma_2=a	lemma_11=-	relType_10=dep	relType_6=case	lib=cause	lemma_5=increase	pos_8=NNS	pos_11=HYPH	wib=caused	pos_1=VBD	lemma_4=significant	pos_6=IN	pos_10=CC	relType_11=punct	path2=increase_obj>exposure_nmod>of_acl>warfarin_dep>warfarin_conj	lemma_7=plasma	relType_10=compound	lemma_6=in	pos_10=NN	lemma_3=statistically	lemma_10=-	lemma_10=and	relation_0=neutral	pos_10=HYPH	lemma_10=r	relType_1=ROOT	pos_5=NN	relType_9=acl	pos_11=NN	eib=True	relType_8=nmod	lemma_9=of	relType_11=compound	relType_5=obj	relType_2=det	lemma_10=warfarin	pos_7=NN	lpib=cause_VBD	lemma_1=cause
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e0	DDI-DrugBank.d328.s24.e3	effect	relType_28=dep	relType_13=dep	pos_14=CC	lemma_32=inr	lemma_11=s	lemma_8=exposure	pos_12=CD	relType_10=dep	lemma_30=measure	relType_21=cc	pos_8=NNS	lemma_20=,	pos_15=CD	pos_18=RB	relType_23=det	lemma_16=%	pos_22=IN	pos_10=NN	pos_13=NN	lemma_28=time	lemma_10=and	relType_15=nummod	relType_33=punct	lemma_18=respectively	pos_32=NN	pos_28=NN	relType_9=acl	relType_30=acl	relType_5=obj	lemma_34=of	lemma_26=(	pos_2=DT	relType_4=amod	relType_25=conj	lemma_11=warfarin	relType_6=case	lib=cause	lemma_5=increase	pos_1=VBD	pos_6=IN	pos_25=NNS	lemma_6=in	relType_22=case	pos_27=NN	relation_0=neutral	pos_16=NN	relType_24=amod	pos_5=NN	pos_11=NN	lemma_14=and	relType_26=punct	pos_30=VBN	pos_7=NN	relType_34=case	lemma_22=in	relType_10=punct	pos_3=RB	relation_4=beneficial	lemma_12=12	relType_10=cc	relType_17=punct	lpib=cause_VBD	lemma_11=-	relType_19=punct	pos_24=JJ	relType_11=conj	pos_31=IN	wib=caused	lemma_4=significant	lemma_29=,	pos_10=CC	relType_11=punct	lemma_7=plasma	pos_17=,	lemma_31=as	lemma_11=(	lemma_24=pharmacodynamic	lemma_10=r	pos_29=,	lemma_27=prothrombin	pos_26=-LRB-	lemma_21=and	relType_20=punct	lemma_10=warfarin	lemma_19=)	lemma_15=15	lemma_1=cause	relType_27=compound	relType_7=compound	pos_4=JJ	path1=Valdecoxib_nsubj	relType_3=advmod	pos_33=-RRB-	pos_9=IN	relType_31=case	lemma_2=a	lemma_25=effect	relation_30=neutral	pos_11=HYPH	lemma_33=)	lemma_17=,	lemma_13=%	pos_11=-LRB-	relType_10=compound	pos_20=,	lemma_3=statistically	lemma_10=-	pos_10=HYPH	relType_29=punct	pos_23=DT	relType_14=cc	pos_21=CC	relType_1=ROOT	eib=True	relType_8=nmod	lemma_9=of	relType_11=compound	relType_18=advmod	relType_2=det	lemma_23=the	relType_32=obl	path2=increase_obj>exposure_nmod>of_acl>warfarin_dep>effect_conj>warfarin_nmod	relType_12=nummod	pos_19=-RRB-	relType_16=conj	pos_34=IN	path=Valdecoxib_nsubj<cause_ROOT>increase_obj>exposure_nmod>of_acl>warfarin_dep>effect_conj>warfarin_nmod
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e1	DDI-DrugBank.d328.s24.e2	null	relType_1=cc	path2=warfarin_conj	pos_1=CC	path=<warfarin_dep>warfarin_conj	pos_2=NN	eib=True	lemma_2=-	relType_2=compound	lib=s	path1=	lpib=s_NN	lemma_2=s	wib=S	pos_2=HYPH	lemma_1=and	relType_2=punct
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e1	DDI-DrugBank.d328.s24.e3	null	relType_1=cc	pos_2=NN	relType_8=punct	pos_12=CC	lemma_20=,	relType_5=cc	lemma_22=as	lemma_7=%	pos_22=IN	pos_18=NN	lemma_25=of	lemma_21=measure	lemma_10=)	lemma_5=and	lemma_17=(	lemma_2=(	lemma_6=15	lemma_23=inr	relType_9=advmod	path1=	relType_19=dep	pos_16=NNS	lemma_9=respectively	relType_2=punct	relType_25=case	lemma_2=-	pos_2=-LRB-	lemma_14=the	relType_22=case	relType_2=conj	relType_23=obl	lemma_24=)	relType_6=nummod	lemma_13=in	pos_17=-LRB-	pos_21=VBN	pos_25=IN	pos_7=NN	path=<warfarin_dep>effect_conj>warfarin_nmod	lemma_1=and	lemma_18=prothrombin	pos_8=,	relType_4=dep	lemma_4=%	relType_10=punct	lemma_11=,	lib=s	relType_17=punct	relType_12=cc	relType_24=punct	lpib=s_NN	pos_2=HYPH	lemma_8=,	pos_23=NN	relType_11=punct	pos_13=IN	relType_13=case	pos_9=RB	lemma_16=effect	pos_14=DT	lemma_12=and	lemma_15=pharmacodynamic	relType_20=punct	wib=S	relType_7=conj	pos_1=CC	pos_15=JJ	pos_5=CC	relType_15=amod	relation_18=neutral	path2=effect_conj>warfarin_nmod	pos_6=CD	relType_21=acl	relType_14=det	pos_19=NN	pos_4=NN	pos_20=,	pos_3=CD	relType_2=compound	lemma_19=time	relType_3=nummod	pos_11=,	lemma_3=12	lemma_2=warfarin	pos_24=-RRB-	eib=True	pos_10=-RRB-	relType_18=compound	lemma_2=s	relType_16=conj
DDI-DrugBank.d328.s24	DDI-DrugBank.d328.s24.e2	DDI-DrugBank.d328.s24.e3	null	relType_18=dep	lemma_9=)	relType_14=amod	relType_11=cc	lemma_10=,	pos_6=NN	pos_5=CD	relType_6=conj	relType_24=case	relType_17=compound	lemma_7=,	relType_8=advmod	pos_18=NN	lemma_11=and	lemma_3=%	pos_24=IN	relType_16=punct	relType_21=case	pos_1=-LRB-	lemma_12=in	pos_10=,	lemma_17=prothrombin	lemma_4=and	relType_13=det	relType_22=obl	lemma_16=(	relType_3=dep	wib=%	relType_2=nummod	pos_22=NN	pos_16=-LRB-	pos_20=VBN	lemma_8=respectively	lemma_15=effect	pos_12=IN	lemma_20=measure	relType_5=nummod	pos_19=,	lemma_5=15	relation_14=neutral	path=warfarin_conj<warfarin_dep>effect_conj>warfarin_nmod	lemma_19=,	relType_1=punct	relType_10=punct	lib=%	relType_12=case	relType_19=punct	lemma_24=of	lemma_22=inr	lemma_1=(	pos_17=NN	pos_8=RB	pos_7=,	pos_21=IN	lemma_23=)	pos_11=CC	pos_4=CC	pos_23=-RRB-	relType_20=acl	relType_15=conj	path1=warfarin_conj	pos_14=JJ	relType_23=punct	lemma_13=the	path2=effect_conj>warfarin_nmod	lemma_21=as	pos_13=DT	relType_4=cc	lemma_14=pharmacodynamic	lpib=%_NN	eib=False	pos_2=CD	lemma_6=%	lemma_18=time	pos_9=-RRB-	lemma_2=12	relType_9=punct	pos_15=NNS	pos_3=NN	relType_7=punct
DDI-DrugBank.d328.s26	DDI-DrugBank.d328.s26.e0	DDI-DrugBank.d328.s26.e1	null	relType_14=amod	pos_8=DT	relType_7=case	pos_16=IN	pos_5=,	pos_2=MD	relType_10=amod	lpib=therapy_NN	lemma_11=week	pos_3=VB	relType_3=aux:pass	pos_9=JJ	lemma_12=,	eib=False	path2=therapy_obl>bextra_nmod	pos_12=,	pos_11=NNS	lemma_1=therapy	relType_2=aux	relType_9=amod	lemma_9=first	relType_12=punct	pos_13=IN	lemma_16=with	pos_1=NN	lemma_15=therapy	pos_4=VBN	path=anticoagulant_amod<therapy_nsubj:pass<monitor_ROOT>therapy_obl>bextra_nmod	path1=anticoagulant_amod<therapy_nsubj:pass	lemma_13=after	relType_13=case	relType_15=obl	pos_15=NN	lemma_2=should	lemma_5=,	relType_5=punct	lemma_8=the	pos_10=JJ	lemma_3=be	pos_14=VBG	lib=therapy	lemma_10=few	relType_11=obl	pos_6=RB	relType_4=ROOT	lemma_7=during	relType_16=case	pos_7=IN	lemma_6=particularly	relType_1=nsubj:pass	relType_8=det	lemma_14=initiate	relType_6=advmod	wib=therapy	lemma_4=monitor
DDI-DrugBank.d328.s26	DDI-DrugBank.d328.s26.e0	DDI-DrugBank.d328.s26.e2	null	path2=therapy_obl>patient_nmod>receive_acl>warfarin_obj	relType_14=amod	pos_8=DT	relType_7=case	pos_18=NNS	pos_16=IN	pos_5=,	pos_2=MD	relType_10=amod	lpib=therapy_NN	lemma_11=week	pos_3=VB	relType_3=aux:pass	pos_17=IN	pos_9=JJ	lemma_12=,	pos_17=NN	lemma_17=bextra	lemma_18=patient	pos_12=,	pos_11=NNS	lemma_1=therapy	relType_2=aux	relType_9=amod	lemma_9=first	relType_12=punct	pos_13=IN	lemma_16=with	pos_1=NN	lemma_15=therapy	pos_4=VBN	path1=anticoagulant_amod<therapy_nsubj:pass	lemma_13=after	relType_17=case	relType_13=case	relType_15=obl	pos_15=NN	lemma_2=should	lemma_5=,	relType_5=punct	lemma_8=the	pos_10=JJ	lemma_3=be	pos_14=VBG	lib=therapy	lemma_10=few	relType_11=obl	lemma_17=in	pos_6=RB	relType_17=nmod	relType_4=ROOT	lemma_7=during	pos_19=VBG	lemma_19=receive	relType_16=case	relType_19=acl	eib=True	pos_7=IN	lemma_6=particularly	path=anticoagulant_amod<therapy_nsubj:pass<monitor_ROOT>therapy_obl>patient_nmod>receive_acl>warfarin_obj	relType_1=nsubj:pass	relType_8=det	lemma_14=initiate	relType_18=nmod	relType_6=advmod	wib=therapy	lemma_4=monitor
DDI-DrugBank.d328.s26	DDI-DrugBank.d328.s26.e1	DDI-DrugBank.d328.s26.e2	advise	pos_2=NNS	wib=patients	relType_1=case	lemma_1=in	lpib=patient_NNS	eib=False	lemma_2=patient	relType_2=nmod	path1=bextra_nmod	lib=patient	relType_3=acl	path=bextra_nmod<therapy_obl>patient_nmod>receive_acl>warfarin_obj	path2=patient_nmod>receive_acl>warfarin_obj	lemma_3=receive	pos_1=IN	pos_3=VBG
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e0	DDI-DrugBank.d328.s27.e1	null	relType_1=cc	wib=Ketoconazole	path2=Ketoconazole_conj	pos_1=CC	eib=False	path=<Fluconazole_ROOT>Ketoconazole_conj	path1=	lpib=ketoconazole_NNP	lib=ketoconazole	lemma_1=and
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e0	DDI-DrugBank.d328.s27.e2	null	relType_1=cc	wib=Ketoconazole	path=<Fluconazole_ROOT>3a4_parataxis>Ketoconazole_nsubj	pos_1=CC	lemma_2=:	eib=True	pos_2=NNP	path1=	pos_2=:	lpib=ketoconazole_NNP	lemma_2=Ketoconazole	path2=3a4_parataxis>Ketoconazole_nsubj	lib=ketoconazole	relType_2=conj	lemma_1=and	relType_2=punct
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e0	DDI-DrugBank.d328.s27.e3	null	relType_1=cc	wib=Ketoconazole	pos_1=CC	path=<Fluconazole_ROOT>3a4_parataxis>Ketoconazole_nsubj>fluconazole_conj	pos_3=CC	path2=3a4_parataxis>Ketoconazole_nsubj>fluconazole_conj	path1=	pos_3=NNP	lemma_2=Ketoconazole	lib=ketoconazole	relType_2=punct	relType_3=cc	lemma_2=:	pos_2=NNP	relType_2=conj	pos_2=:	relType_3=nsubj	eib=True	lemma_3=and	lpib=ketoconazole_NNP	lemma_3=Ketoconazole	lemma_1=and
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e1	DDI-DrugBank.d328.s27.e2	null	wib=Ketoconazole	eib=False	path1=Ketoconazole_conj	pos_1=:	lpib=ketoconazole_NNP	path2=3a4_parataxis>Ketoconazole_nsubj	lib=ketoconazole	relType_1=punct	path=Ketoconazole_conj<Fluconazole_ROOT>3a4_parataxis>Ketoconazole_nsubj	lemma_1=:
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e1	DDI-DrugBank.d328.s27.e3	null	wib=Ketoconazole	lemma_2=and	path=Ketoconazole_conj<Fluconazole_ROOT>3a4_parataxis>Ketoconazole_nsubj>fluconazole_conj	eib=True	pos_2=NNP	relType_2=nsubj	path2=3a4_parataxis>Ketoconazole_nsubj>fluconazole_conj	pos_2=CC	path1=Ketoconazole_conj	pos_1=:	lpib=ketoconazole_NNP	lemma_2=Ketoconazole	lib=ketoconazole	relType_1=punct	relType_2=cc	lemma_1=:
DDI-DrugBank.d328.s27	DDI-DrugBank.d328.s27.e2	DDI-DrugBank.d328.s27.e3	null	relType_1=cc	lpib=fluconazole_NN	pos_1=CC	path2=fluconazole_conj	eib=False	path=<Ketoconazole_nsubj>fluconazole_conj	path1=	wib=fluconazole	lib=fluconazole	lemma_1=and
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e0	DDI-DrugBank.d328.s28.e1	mechanism	relType_4=amod	relType_1=nummod	pos_4=JJ	pos_2=NN	pos_3=IN	lemma_6=of	relType_6=case	lib=mg	pos_1=CD	eib=False	pos_5=NNS	lpib=mg_NN	pos_6=IN	lemma_4=multiple	relType_2=dep	relType_5=nmod	lemma_3=with	lemma_2=mg	path=valdecoxib_nmod<administration_nsubj>mg_dep>dose_nmod>ketoconazole_nmod	relType_3=case	lemma_5=dose	path1=valdecoxib_nmod	wib=mg	path2=mg_dep>dose_nmod>ketoconazole_nmod	lemma_1=20
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e0	DDI-DrugBank.d328.s28.e2	mechanism	relType_4=amod	relType_1=nummod	pos_4=JJ	pos_2=NN	pos_3=IN	relType_7=cc	lemma_6=of	path=valdecoxib_nmod<administration_nsubj>fluconazole_conj	relType_6=case	lib=mg	pos_1=CD	lemma_7=ketoconazole	pos_5=NNS	lpib=mg_NN	pos_6=IN	lemma_4=multiple	relType_2=dep	path2=fluconazole_conj	pos_7=CC	relType_5=nmod	relType_7=nmod	lemma_3=with	lemma_2=mg	relType_3=case	lemma_5=dose	path1=valdecoxib_nmod	eib=True	lemma_7=and	wib=mg	pos_7=NN	lemma_1=20
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e0	DDI-DrugBank.d328.s28.e3	null	relType_4=amod	relType_1=nummod	pos_4=JJ	pos_2=NN	pos_3=IN	relation_12=beneficial	relation_9=neutral	lemma_9=a	relType_10=amod	relType_12=case	relType_7=cc	lemma_6=of	relType_11=obj	relType_6=case	lemma_8=produce	relType_13=nmod	pos_8=NN	lib=mg	pos_1=CD	lemma_7=ketoconazole	pos_5=NNS	lpib=mg_NN	pos_6=IN	lemma_4=multiple	lemma_10=significant	pos_9=DT	pos_13=NN	pos_12=IN	pos_8=VBD	pos_14=IN	relType_2=dep	pos_7=CC	pos_10=JJ	relType_5=nmod	relType_7=nmod	relType_8=ROOT	path=valdecoxib_nmod<administration_nsubj<produce_ROOT>increase_obj>exposure_nmod>valdecoxib_nmod	lemma_3=with	lemma_13=exposure	lemma_2=mg	lemma_8=fluconazole	relType_3=case	lemma_5=dose	lemma_11=increase	lemma_12=in	pos_11=NN	eib=True	lemma_7=and	lemma_14=of	relType_8=conj	wib=mg	path1=valdecoxib_nmod<administration_nsubj	relType_14=case	pos_7=NN	path2=increase_obj>exposure_nmod>valdecoxib_nmod	lemma_1=20	relType_9=det
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e1	DDI-DrugBank.d328.s28.e2	null	relType_1=cc	lpib=fluconazole_NN	pos_1=CC	path2=fluconazole_conj	eib=False	wib=fluconazole	path1=ketoconazole_nmod<dose_nmod<mg_dep	lib=fluconazole	path=ketoconazole_nmod<dose_nmod<mg_dep<administration_nsubj>fluconazole_conj	lemma_1=and
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e1	DDI-DrugBank.d328.s28.e3	null	relType_1=cc	relType_8=case	lpib=fluconazole_NN	pos_1=CC	pos_4=JJ	relType_4=amod	pos_2=NN	relation_5=beneficial	wib=fluconazole	lemma_2=produce	lemma_2=fluconazole	relType_6=case	lemma_5=increase	path=ketoconazole_nmod<dose_nmod<mg_dep<administration_nsubj<produce_ROOT>increase_obj>exposure_nmod>valdecoxib_nmod	lemma_4=significant	pos_6=IN	relation_2=neutral	pos_2=VBD	lemma_6=in	relType_3=det	lemma_3=a	relType_2=conj	pos_8=IN	relType_2=ROOT	path1=ketoconazole_nmod<dose_nmod<mg_dep<administration_nsubj	relType_7=nmod	lib=fluconazole	lemma_7=exposure	pos_5=NN	eib=True	pos_3=DT	relType_5=obj	pos_7=NN	path2=increase_obj>exposure_nmod>valdecoxib_nmod	lemma_8=of	lemma_1=and
DDI-DrugBank.d328.s28	DDI-DrugBank.d328.s28.e2	DDI-DrugBank.d328.s28.e3	null	pos_2=DT	lib=produce	lemma_5=in	path1=fluconazole_conj<administration_nsubj	relType_7=case	relation_3=beneficial	lemma_2=a	relType_5=case	lemma_1=produce	lpib=produce_VBD	pos_6=NN	pos_1=VBD	eib=False	lemma_4=increase	lemma_3=significant	pos_4=NN	wib=produced	relType_4=obj	relation_0=neutral	relType_3=amod	pos_5=IN	lemma_7=of	path=fluconazole_conj<administration_nsubj<produce_ROOT>increase_obj>exposure_nmod>valdecoxib_nmod	relType_1=ROOT	lemma_6=exposure	pos_3=JJ	pos_7=IN	relType_2=det	relType_6=nmod	path2=increase_obj>exposure_nmod>valdecoxib_nmod
DDI-DrugBank.d328.s29	DDI-DrugBank.d328.s29.e0	DDI-DrugBank.d328.s29.e1	mechanism	pos_2=VBN	lemma_4=%	path2=coadminister_advcl>fluconazole_obl	relType_7=case	relType_1=aux:pass	lemma_3=62	lemma_7=with	relation_1=beneficial	pos_1=VBD	eib=False	lemma_1=be	lemma_5=when	pos_6=VBN	relType_6=advcl	pos_4=NN	relType_4=obj	lemma_2=increase	pos_5=WRB	lib=be	pos_3=CD	relType_2=ROOT	lemma_6=coadminister	relType_3=nummod	wib=was	relType_5=advmod	path=valdecoxib_nmod<exposure_nsubj:pass<increase_ROOT>coadminister_advcl>fluconazole_obl	pos_7=IN	lpib=be_VBD	path1=valdecoxib_nmod<exposure_nsubj:pass
DDI-DrugBank.d328.s29	DDI-DrugBank.d328.s29.e0	DDI-DrugBank.d328.s29.e2	mechanism	pos_2=VBN	lemma_4=%	relType_7=case	relType_1=aux:pass	lemma_13=with	lemma_3=62	lemma_7=with	relType_8=obl	relType_9=nummod	relation_1=beneficial	pos_8=NN	path2=coadminister_advcl>coadminister_advcl>ketoconazole_obl	pos_1=VBD	relType_10=conj	relType_12=advcl	lemma_1=be	lemma_5=when	lemma_11=when	pos_6=VBN	relType_6=advcl	pos_8=CC	pos_10=NN	pos_4=NN	relType_11=advmod	relType_4=obj	lemma_2=increase	pos_5=WRB	pos_13=IN	lemma_12=coadminister	pos_11=WRB	relType_13=case	lib=be	lemma_9=38	pos_3=CD	relType_2=ROOT	lemma_6=coadminister	relType_3=nummod	wib=was	lemma_8=fluconazole	relType_5=advmod	lemma_8=and	lemma_10=%	pos_9=CD	eib=True	pos_7=IN	path=valdecoxib_nmod<exposure_nsubj:pass<increase_ROOT>coadminister_advcl>coadminister_advcl>ketoconazole_obl	pos_12=VBN	lpib=be_VBD	path1=valdecoxib_nmod<exposure_nsubj:pass	relType_8=cc
DDI-DrugBank.d328.s29	DDI-DrugBank.d328.s29.e1	DDI-DrugBank.d328.s29.e2	null	relType_1=cc	wib=%	pos_1=CC	relType_2=nummod	path2=coadminister_advcl>ketoconazole_obl	lib=%	relType_6=case	lpib=%_NN	relType_5=advcl	eib=False	pos_2=CD	pos_6=IN	lemma_2=38	lemma_5=coadminister	relType_3=conj	lemma_3=%	relType_4=advmod	path1=fluconazole_obl	path=fluconazole_obl<coadminister_advcl>coadminister_advcl>ketoconazole_obl	lemma_6=with	pos_4=WRB	pos_3=NN	lemma_4=when	pos_5=VBN	lemma_1=and
DDI-DrugBank.d328.s30	DDI-DrugBank.d328.s30.e0	DDI-DrugBank.d328.s30.e1	null	path2=substrate_appos>glyburide_nsubj	eib=False	path=<glyburide_ROOT>substrate_appos>glyburide_nsubj	path1=	wib=Glyburide	lpib=glyburide_NN	pos_1=:	relType_1=punct	lib=glyburide	lemma_1=:
DDI-DrugBank.d328.s31	DDI-DrugBank.d328.s31.e0	DDI-DrugBank.d328.s31.e1	null	pos_7=NNS	relType_2=nummod	relType_4=appos	pos_6=CD	pos_9=IN	relType_8=punct	lemma_5=for	relType_5=case	lemma_1=(	pos_3=NNS	lib=mg	eib=False	pos_2=CD	lemma_2=10	pos_8=-RRB-	relType_9=case	lpib=mg_NNS	path=valdecoxib_nmod<Coadministration_nsubj>glyburide_nmod	lemma_6=7	lemma_8=)	relType_6=nummod	pos_5=IN	relType_7=nmod	lemma_7=day	pos_1=-LRB-	lemma_9=with	path1=valdecoxib_nmod	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	path2=glyburide_nmod	lemma_3=mg	relType_1=punct
DDI-DrugBank.d328.s31	DDI-DrugBank.d328.s31.e0	DDI-DrugBank.d328.s31.e2	null	pos_14=CC	relType_8=punct	path1=valdecoxib_nmod<Coadministration_nsubj	relType_5=case	pos_15=CD	pos_10=-LRB-	relType_10=nmod	pos_3=NNS	lib=mg	relType_12=compound	relType_9=case	pos_10=NN	lemma_10=glyburide	pos_13=NN	relType_15=nummod	lemma_15=10	lemma_22=the	relType_21=ROOT	pos_1=-LRB-	lemma_4=BID	lemma_12=mg	pos_19=VBD	relType_23=obj	pos_7=NNS	lemma_21=affect	relType_2=nummod	path2=pharmacokinetic_obj>glyburide_nmod	pos_24=-LRB-	pos_16=NNS	relType_13=appos	lemma_16=mg	path=valdecoxib_nmod<Coadministration_nsubj<affect_ROOT>pharmacokinetic_obj>glyburide_nmod	lemma_10=(	relType_6=nummod	pos_5=IN	relType_7=nmod	pos_21=VB	lemma_17=BID	pos_11=CD	lemma_18=)	pos_22=DT	pos_4=NNP	relType_3=compound	relType_25=dep	relType_26=punct	relType_1=punct	lemma_11=5	relType_10=punct	relType_4=appos	lemma_27=of	relType_24=punct	lemma_14=or	lemma_1=(	pos_17=NNP	pos_18=-RRB-	lemma_2=10	lemma_8=)	relType_11=nummod	lemma_13=qd	pos_23=NNS	pos_25=NN	relType_19=aux	lemma_26=)	relType_22=det	pos_20=RB	relType_27=case	lemma_19=do	pos_26=-RRB-	pos_6=CD	pos_9=IN	relType_16=compound	relation_21=neutral	lemma_5=for	relType_17=conj	lemma_25=exposure	relType_20=advmod	pos_2=CD	pos_8=-RRB-	pos_27=IN	lemma_23=pharmacokinetic	lpib=mg_NNS	lemma_6=7	pos_12=NNS	relType_18=punct	lemma_7=day	relType_14=cc	lemma_9=with	eib=True	wib=mg	lemma_24=(	lemma_3=mg	lemma_20=not
DDI-DrugBank.d328.s31	DDI-DrugBank.d328.s31.e1	DDI-DrugBank.d328.s31.e2	null	pos_7=NNS	lemma_9=)	relType_7=compound	lemma_13=the	relType_2=nummod	lemma_11=not	pos_5=CC	path2=pharmacokinetic_obj>glyburide_nmod	relType_4=appos	relType_17=punct	pos_6=CD	pos_13=DT	lemma_6=10	lemma_12=affect	relType_18=case	lemma_1=(	relType_5=cc	pos_15=-LRB-	pos_3=NNS	lib=mg	relType_14=obj	eib=False	relType_10=aux	pos_2=CD	lemma_4=qd	relType_11=advmod	lemma_18=of	pos_4=NN	relType_15=punct	pos_18=IN	lpib=mg_NNS	pos_9=-RRB-	relType_12=ROOT	lemma_7=mg	lemma_2=5	pos_8=NNP	pos_10=VBD	lemma_15=(	relType_6=nummod	relation_11=neutral	path=glyburide_nmod<Coadministration_nsubj<affect_ROOT>pharmacokinetic_obj>glyburide_nmod	pos_16=NN	lemma_14=pharmacokinetic	pos_11=RB	relType_9=punct	pos_1=-LRB-	pos_12=VB	lemma_17=)	lemma_10=do	path1=glyburide_nmod<Coadministration_nsubj	relType_16=dep	relType_8=conj	wib=mg	lemma_8=BID	relType_3=compound	lemma_3=mg	relType_13=det	pos_14=NNS	relType_1=punct	pos_17=-RRB-	lemma_16=exposure	lemma_5=or
DDI-DrugBank.d328.s32	DDI-DrugBank.d328.s32.e0	DDI-DrugBank.d328.s32.e1	null	relType_12=conj	relType_2=nummod	relType_4=appos	lemma_17=7	relType_13=punct	pos_7=CD	relType_8=punct	relType_19=punct	pos_16=HYPH	lemma_15=2	pos_20=IN	lemma_1=(	pos_6=NN	pos_15=CD	relType_20=case	pos_3=NNS	lib=mg	pos_18=-RRB-	eib=False	relType_7=nummod	pos_2=CD	lemma_14=day	lemma_6=day	lemma_11=mg	relType_6=obl:tmod	relType_15=dep	lemma_5=(	pos_12=NN	pos_8=-RRB-	lpib=mg_NNS	path2=qd_conj>affect_dep>glyburide_obl	lemma_8=)	pos_9=CC	lemma_9=and	lemma_13=(	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	relType_14=dep	pos_19=-RRB-	lemma_16=-	relType_17=nmod	pos_13=-LRB-	relType_10=nummod	pos_1=-LRB-	lemma_12=qd	relType_16=punct	pos_17=CD	lemma_18=)	pos_11=NN	lemma_20=with	path1=valdecoxib_nmod	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>affect_dep>glyburide_obl	relType_11=compound	lemma_4=BID	pos_4=NNP	wib=mg	pos_14=NNS	relType_3=compound	lemma_3=mg	lemma_19=)	relType_1=punct	lemma_2=40	relType_9=cc	lemma_7=1	pos_5=-LRB-
DDI-DrugBank.d328.s32	DDI-DrugBank.d328.s32.e0	DDI-DrugBank.d328.s32.e2	null	relType_28=dep	lemma_37=pharmacodynamic	pos_39=NN	lemma_17=7	lemma_30=the	relType_32=punct	relType_8=punct	pos_16=HYPH	relType_35=cc	pos_6=NN	pos_15=CD	lemma_33=exposure	lemma_28=affect	pos_3=NNS	lib=mg	lemma_29=either	relType_6=obl:tmod	lemma_24=qd	relType_23=compound	pos_9=CC	relType_31=obj	pos_28=VB	lemma_39=blood	relType_16=punct	pos_17=CD	pos_1=-LRB-	lemma_38=(	path1=valdecoxib_nmod	relType_37=conj	lemma_4=BID	pos_14=NNS	relType_21=punct	relType_9=cc	relType_34=punct	lemma_7=1	relType_2=nummod	lemma_45=of	relation_28=neutral	relType_45=case	lemma_15=2	relType_38=punct	lemma_23=mg	relType_20=case	pos_43=NNS	lemma_14=day	relType_22=nummod	lemma_11=mg	lemma_5=(	pos_38=-LRB-	lemma_13=(	lemma_32=(	lemma_16=-	lemma_31=pharmacokinetic	pos_41=CC	lemma_22=5	lemma_18=)	relType_44=punct	relType_21=obl	relType_33=dep	pos_11=NN	lemma_41=and	pos_26=VBD	relType_25=punct	pos_4=NNP	pos_40=NN	pos_42=NN	lemma_44=)	relType_3=compound	relType_1=punct	lemma_2=40	lemma_27=not	path2=qd_conj>affect_dep>pharmacokinetic_obj>pharmacodynamic_conj>glyburide_nmod	lemma_21=glyburide	relType_4=appos	lemma_36=the	pos_24=NN	relType_19=punct	pos_20=IN	lemma_1=(	relType_29=cc:preconj	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>affect_dep>pharmacokinetic_obj>pharmacodynamic_conj>glyburide_nmod	relType_39=compound	pos_18=-RRB-	relType_42=compound	relType_7=nummod	pos_32=-LRB-	relType_41=cc	pos_36=DT	lemma_6=day	relType_15=dep	pos_29=CC	relType_36=det	lemma_8=)	pos_45=IN	pos_23=NNS	lemma_26=do	relType_17=nmod	lemma_12=qd	lemma_25=)	lemma_19=)	pos_30=DT	pos_33=NN	pos_5=-LRB-	relType_12=conj	pos_34=-RRB-	pos_25=-RRB-	lemma_34=)	relType_13=punct	pos_7=CD	lemma_42=insulin	pos_21=-LRB-	pos_22=CD	pos_44=-RRB-	lemma_35=or	pos_2=CD	relType_26=aux	pos_27=RB	pos_8=-RRB-	relType_27=advmod	lpib=mg_NNS	lemma_9=and	pos_35=CC	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	lemma_21=(	relType_14=dep	pos_31=NNS	relType_40=dep	pos_37=NNS	relType_43=conj	pos_13=-LRB-	relType_10=nummod	relType_24=appos	lemma_20=with	eib=True	relType_11=compound	wib=mg	lemma_43=level	lemma_3=mg	pos_12=NN	lemma_40=glucose	pos_19=-RRB-	relType_30=det	pos_21=NN
DDI-DrugBank.d328.s32	DDI-DrugBank.d328.s32.e1	DDI-DrugBank.d328.s32.e2	null	relType_22=compound	lemma_7=not	relType_13=dep	pos_16=DT	pos_6=VBD	relType_21=cc	lemma_16=the	pos_3=NNS	lib=mg	pos_7=RB	pos_20=NN	pos_13=NN	lemma_11=pharmacokinetic	pos_8=VB	pos_18=-LRB-	pos_9=CC	lemma_25=of	lemma_22=insulin	pos_5=-RRB-	lemma_15=or	pos_1=-LRB-	path1=glyburide_obl	lemma_18=(	pos_15=CC	lemma_17=pharmacodynamic	lemma_8=affect	relType_2=nummod	pos_22=NN	relType_25=case	path=glyburide_obl<affect_dep>pharmacokinetic_obj>pharmacodynamic_conj>glyburide_nmod	relType_12=punct	relType_23=conj	lemma_5=)	relType_19=compound	lemma_24=)	lemma_20=glucose	pos_25=IN	relType_3=compound	relType_1=punct	pos_12=-LRB-	lemma_12=(	relType_14=punct	relType_8=dep	relType_10=det	lemma_6=do	relType_4=appos	relType_24=punct	relType_11=obj	path2=pharmacokinetic_obj>pharmacodynamic_conj>glyburide_nmod	lemma_1=(	lemma_9=either	pos_14=-RRB-	lemma_10=the	lemma_14=)	relType_6=aux	pos_23=NNS	lemma_13=exposure	relation_7=neutral	pos_17=NNS	lemma_21=and	relType_9=cc:preconj	relType_7=advmod	pos_10=DT	relType_16=det	relType_17=conj	relType_20=dep	lemma_19=blood	eib=False	pos_2=CD	lemma_4=qd	pos_11=NNS	pos_19=NN	pos_4=NN	lpib=mg_NNS	lemma_2=5	relType_5=punct	relType_18=punct	relType_15=cc	lemma_23=level	pos_21=CC	pos_24=-RRB-	wib=mg	lemma_3=mg
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e0	DDI-DrugBank.d328.s33.e1	mechanism	relType_12=conj	relType_2=nummod	relType_4=appos	lemma_17=7	relType_13=punct	pos_7=CD	relType_8=punct	relType_19=punct	pos_16=HYPH	lemma_15=2	pos_20=IN	lemma_1=(	pos_6=NN	pos_15=CD	relType_20=case	pos_3=NNS	lib=mg	pos_18=-RRB-	eib=False	relType_7=nummod	pos_2=CD	lemma_14=day	lemma_6=day	lemma_11=mg	relType_6=obl:tmod	relType_15=dep	lemma_5=(	pos_12=NN	pos_8=-RRB-	lpib=mg_NNS	lemma_8=)	lemma_9=and	pos_9=CC	lemma_13=(	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	relType_14=dep	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>result_dep>glyburide_obl	lemma_16=-	pos_19=-RRB-	relType_17=nmod	pos_13=-LRB-	relType_10=nummod	pos_1=-LRB-	lemma_12=qd	relType_16=punct	pos_17=CD	lemma_18=)	path2=qd_conj>result_dep>glyburide_obl	pos_11=NN	lemma_20=with	path1=valdecoxib_nmod	relType_11=compound	lemma_4=BID	pos_4=NNP	wib=mg	pos_14=NNS	relType_3=compound	lemma_3=mg	lemma_19=)	relType_1=punct	lemma_2=40	relType_9=cc	lemma_7=1	pos_5=-LRB-
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e0	DDI-DrugBank.d328.s33.e2	null	lemma_17=7	relType_8=punct	pos_16=HYPH	pos_6=NN	pos_15=CD	pos_3=NNS	lib=mg	relType_6=obl:tmod	relType_23=compound	pos_9=CC	relType_16=punct	pos_17=CD	pos_1=-LRB-	path1=valdecoxib_nmod	lemma_4=BID	pos_14=NNS	relType_21=punct	relType_9=cc	lemma_7=1	relType_2=nummod	lemma_15=2	lemma_23=mg	relType_20=case	lemma_14=day	relType_22=nummod	lemma_11=mg	lemma_5=(	lemma_13=(	lemma_16=-	lemma_18=)	relType_21=obl	pos_11=NN	pos_4=NNP	relType_3=compound	relType_1=punct	lemma_2=40	lemma_21=glyburide	relType_4=appos	relType_19=punct	pos_20=IN	lemma_1=(	pos_23=NN	pos_18=-RRB-	relType_7=nummod	lemma_6=day	relType_15=dep	lemma_8=)	path2=qd_conj>result_dep>glyburide_obl>BID_appos>glyburide_compound	relType_17=nmod	lemma_12=qd	lemma_22=10	lemma_19=)	pos_5=-LRB-	relType_12=conj	relType_13=punct	pos_7=CD	pos_21=-LRB-	pos_22=CD	pos_2=CD	pos_8=-RRB-	lpib=mg_NNS	lemma_9=and	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	lemma_21=(	relType_14=dep	pos_13=-LRB-	relType_10=nummod	lemma_20=with	eib=True	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>result_dep>glyburide_obl>BID_appos>glyburide_compound	relType_11=compound	wib=mg	lemma_3=mg	pos_12=NN	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e0	DDI-DrugBank.d328.s33.e3	null	pos_24=NNP	lemma_17=7	path2=qd_conj>result_dep>increase_obl>auc0_nmod>glyburide_compound	relType_8=punct	pos_16=HYPH	pos_6=NN	pos_15=CD	pos_3=NNS	lib=mg	relType_6=obl:tmod	relType_23=compound	relType_24=compound	pos_9=CC	relType_16=punct	pos_17=CD	pos_1=-LRB-	relType_26=dep	path1=valdecoxib_nmod	lemma_4=BID	pos_14=NNS	relType_21=punct	relType_9=cc	lemma_7=1	relType_2=nummod	relation_31=beneficial	relType_28=nummod	lemma_15=2	pos_30=NN	lemma_23=mg	relType_20=case	lemma_14=day	relType_22=nummod	lemma_31=in	lemma_11=mg	lemma_5=(	pos_29=NN	lemma_13=(	lemma_16=-	lemma_26=result	lemma_18=)	relType_21=obl	pos_11=NN	pos_26=VBD	relType_25=punct	pos_4=NNP	lemma_24=glyburide	relType_3=compound	relType_1=punct	lemma_2=40	lemma_21=glyburide	relType_4=appos	pos_24=NN	relType_19=punct	relType_29=compound	relType_30=obl	pos_20=IN	pos_31=IN	lemma_1=(	pos_23=NN	pos_18=-RRB-	relType_7=nummod	lemma_6=day	relType_15=dep	lemma_29=%	lemma_8=)	relType_17=nmod	lemma_12=qd	lemma_25=)	lemma_22=10	lemma_19=)	relType_27=case	lemma_24=BID	pos_5=-LRB-	relType_12=conj	lemma_30=increase	pos_25=-RRB-	relType_13=punct	pos_7=CD	relType_31=case	pos_28=CD	pos_21=-LRB-	pos_22=CD	pos_2=CD	lemma_27=in	pos_8=-RRB-	pos_27=IN	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>result_dep>increase_obl>auc0_nmod>glyburide_compound	lpib=mg_NNS	lemma_9=and	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	lemma_21=(	relType_14=dep	pos_13=-LRB-	relType_10=nummod	relType_24=appos	lemma_20=with	eib=True	relType_11=compound	wib=mg	lemma_3=mg	lemma_28=21	pos_12=NN	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e0	DDI-DrugBank.d328.s33.e4	null	pos_24=NNP	pos_39=NN	lemma_17=7	relType_8=punct	relType_32=nmod	pos_16=HYPH	relType_35=cc	pos_6=NN	lemma_35=and	pos_15=CD	pos_3=NNS	lib=mg	relType_6=obl:tmod	relType_23=compound	relType_24=compound	pos_9=CC	relType_33=punct	pos_32=NN	relType_16=punct	pos_17=CD	pos_1=-LRB-	pos_40=IN	relType_26=dep	pos_34=CD	path1=valdecoxib_nmod	lemma_4=BID	relType_39=conj	pos_14=NNS	relType_21=punct	relType_9=cc	lemma_7=1	lemma_32=auc0	relType_2=nummod	relType_37=nummod	relation_31=beneficial	relType_28=nummod	lemma_15=2	pos_30=NN	relType_34=nummod	lemma_36=a	lemma_23=mg	relType_20=case	lemma_14=day	relType_22=nummod	lemma_31=in	lemma_33=-	lemma_11=mg	lemma_5=(	pos_29=NN	relType_32=compound	lemma_13=(	relType_40=case	lemma_16=-	lemma_26=result	path2=qd_conj>result_dep>increase_obl>increase_conj>Cmax_nmod>glyburide_compound	lemma_18=)	relation_41=beneficial	relType_21=obl	pos_33=HYPH	pos_11=NN	lemma_39=increase	pos_26=VBD	relType_25=punct	pos_4=NNP	lemma_24=glyburide	relType_3=compound	relType_1=punct	lemma_2=40	lemma_37=16	lemma_21=glyburide	relType_4=appos	pos_24=NN	relType_19=punct	relType_29=compound	relType_30=obl	pos_20=IN	pos_31=IN	lemma_1=(	pos_23=NN	pos_18=-RRB-	lemma_38=%	relType_7=nummod	pos_36=DT	lemma_6=day	relType_15=dep	lemma_29=%	relType_36=det	lemma_8=)	pos_38=NN	lemma_32=glyburide	relType_17=nmod	lemma_12=qd	lemma_25=)	lemma_22=10	lemma_40=in	path=valdecoxib_nmod<Coadministration_ROOT>qd_conj>result_dep>increase_obl>increase_conj>Cmax_nmod>glyburide_compound	lemma_19=)	relType_27=case	lemma_24=BID	pos_5=-LRB-	lemma_34=12	relType_12=conj	lemma_30=increase	pos_25=-RRB-	relType_13=punct	pos_7=CD	relType_31=case	pos_28=CD	pos_21=-LRB-	pos_22=CD	pos_2=CD	relType_38=compound	pos_37=CD	lemma_27=in	pos_8=-RRB-	pos_27=IN	lpib=mg_NNS	lemma_9=and	pos_35=CC	pos_10=CD	relType_5=punct	relType_18=punct	lemma_10=40	lemma_21=(	relType_14=dep	pos_13=-LRB-	relType_10=nummod	relType_24=appos	lemma_20=with	eib=True	relType_11=compound	wib=mg	lemma_3=mg	lemma_28=21	pos_12=NN	pos_19=-RRB-	pos_21=NN
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e1	DDI-DrugBank.d328.s33.e2	null	path=<glyburide_obl>BID_appos>glyburide_compound	lemma_1=(	relType_2=nummod	lib=mg	eib=False	path2=BID_appos>glyburide_compound	pos_2=CD	lpib=mg_NN	lemma_2=10	pos_3=NN	path1=	wib=mg	relType_3=compound	lemma_3=mg	relType_1=punct	pos_1=-LRB-
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e1	DDI-DrugBank.d328.s33.e3	null	relType_8=nummod	relType_2=nummod	relType_7=case	relType_4=appos	lemma_9=%	pos_6=VBD	relType_11=case	lemma_1=(	relType_6=dep	lib=mg	relType_9=compound	lemma_10=increase	pos_2=CD	lpib=mg_NN	lemma_2=10	lemma_11=in	pos_10=NN	pos_9=NN	pos_4=NN	lemma_5=)	pos_11=IN	relation_10=beneficial	pos_5=-RRB-	relType_5=punct	relType_4=compound	lemma_4=glyburide	pos_1=-LRB-	lemma_6=result	path=glyburide_obl<result_dep>increase_obl>auc0_nmod>glyburide_compound	path1=glyburide_obl	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	lemma_8=21	path2=increase_obl>auc0_nmod>glyburide_compound	pos_4=NNP	lemma_4=BID	wib=mg	relType_3=compound	lemma_3=mg	pos_8=CD	relType_1=punct	relType_10=obl
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e1	DDI-DrugBank.d328.s33.e4	null	relType_8=nummod	relType_2=nummod	relation_20=beneficial	relType_7=case	relType_4=appos	relType_13=punct	pos_16=DT	lemma_9=%	lemma_13=-	relType_16=det	pos_6=VBD	relType_11=case	pos_13=HYPH	pos_20=IN	lemma_1=(	relType_20=case	lemma_16=a	relType_6=dep	lib=mg	relType_9=compound	relType_12=compound	lemma_10=increase	pos_2=CD	lpib=mg_NN	lemma_2=10	lemma_17=16	relType_12=nmod	relType_17=nummod	lemma_18=%	pos_19=NN	lemma_11=in	pos_10=NN	pos_9=NN	pos_4=NN	lemma_5=)	pos_11=IN	pos_18=NN	lemma_19=increase	relation_10=beneficial	pos_5=-RRB-	lemma_12=auc0	relType_5=punct	relType_4=compound	lemma_20=in	relType_15=cc	lemma_4=glyburide	lemma_14=12	lemma_15=and	pos_1=-LRB-	lemma_6=result	relType_14=nummod	pos_17=CD	relType_19=conj	lemma_12=glyburide	path=glyburide_obl<result_dep>increase_obl>increase_conj>Cmax_nmod>glyburide_compound	path1=glyburide_obl	eib=True	pos_7=IN	lemma_7=in	pos_3=NN	lemma_8=21	lemma_4=BID	pos_4=NNP	relType_18=compound	wib=mg	pos_15=CC	relType_3=compound	lemma_3=mg	pos_8=CD	relType_1=punct	pos_12=NN	relType_10=obl	pos_14=CD	path2=increase_obl>increase_conj>Cmax_nmod>glyburide_compound
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e2	DDI-DrugBank.d328.s33.e3	null	lemma_2=)	relType_8=case	relType_3=dep	lpib=bid_NNP	pos_7=NN	wib=BID	lemma_4=in	relType_2=punct	pos_6=NN	pos_5=CD	lemma_8=in	path1=glyburide_compound<BID_appos<glyburide_obl	eib=False	pos_3=VBD	lemma_7=increase	lemma_3=result	lemma_6=%	pos_8=IN	lemma_5=21	relType_1=appos	relType_5=nummod	pos_4=IN	relType_4=case	lib=bid	relation_6=beneficial	pos_1=NNP	path=glyburide_compound<BID_appos<glyburide_obl<result_dep>increase_obl>auc0_nmod>glyburide_compound	relType_6=compound	relType_7=obl	pos_2=-RRB-	path2=increase_obl>auc0_nmod>glyburide_compound	lemma_1=BID
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e2	DDI-DrugBank.d328.s33.e4	null	lemma_2=)	relType_8=case	relType_3=dep	relType_10=punct	lemma_13=a	lpib=bid_NNP	lemma_11=12	pos_7=NN	wib=BID	relType_12=cc	lemma_4=in	pos_13=DT	lemma_9=auc0	pos_12=CC	relType_9=nmod	relType_2=punct	pos_6=NN	pos_17=IN	pos_5=CD	lemma_8=in	relType_9=compound	path1=glyburide_compound<BID_appos<glyburide_obl	relation_16=beneficial	pos_3=VBD	lemma_7=increase	lemma_3=result	lemma_9=glyburide	lemma_6=%	pos_9=NN	pos_8=IN	relType_17=case	lemma_10=-	lemma_5=21	relType_1=appos	relType_11=nummod	pos_15=NN	relType_5=nummod	lemma_15=%	pos_4=IN	pos_10=HYPH	relType_4=case	path=glyburide_compound<BID_appos<glyburide_obl<result_dep>increase_obl>increase_conj>Cmax_nmod>glyburide_compound	pos_16=NN	lib=bid	lemma_17=in	relation_6=beneficial	pos_11=CD	pos_1=NNP	lemma_16=increase	relType_14=nummod	relType_15=compound	relType_6=compound	relType_7=obl	eib=True	pos_2=-RRB-	lemma_12=and	relType_13=det	lemma_14=16	lemma_1=BID	pos_14=CD	relType_16=conj	path2=increase_obl>increase_conj>Cmax_nmod>glyburide_compound
DDI-DrugBank.d328.s33	DDI-DrugBank.d328.s33.e3	DDI-DrugBank.d328.s33.e4	null	relType_7=compound	pos_7=NN	pos_6=CD	pos_9=IN	relType_4=cc	path=glyburide_compound<auc0_nmod<increase_obl>increase_conj>Cmax_nmod>glyburide_compound	pos_2=HYPH	relType_2=punct	lemma_5=a	pos_8=NN	lemma_2=-	eib=False	lemma_7=%	relType_9=case	relType_1=nmod	pos_1=NN	lemma_1=auc0	lemma_8=increase	lpib=auc0_NN	pos_3=CD	relType_5=det	relType_6=nummod	relType_3=nummod	lemma_3=12	relation_7=beneficial	lib=auc0	path1=glyburide_compound<auc0_nmod	lemma_6=16	pos_4=CC	lemma_4=and	pos_5=DT	relType_8=conj	path2=increase_conj>Cmax_nmod>glyburide_compound	wib=AUC0	lemma_9=in
DDI-DrugBank.d328.s35	DDI-DrugBank.d328.s35.e0	DDI-DrugBank.d328.s35.e1	null	pos_3=IN	relType_8=amod	pos_11=VBD	path2=adjustment_nsubj:pass>glyburide_nmod	lemma_3=within	relType_22=case	relType_7=cc	lemma_11=be	lemma_10=concentration	relType_21=nsubj:pass	pos_16=NNS	lemma_12=above	relType_19=punct	path=valdecoxib_compound<coadministration_nmod<change_nsubj<variability_advcl<indicate_ROOT>adjustment_nsubj:pass>glyburide_nmod	pos_6=NN	pos_8=JJ	lemma_21=adjustment	pos_15=CD	relType_2=cop	relType_14=advmod	relType_9=compound	eib=False	relType_10=conj	relType_12=advmod	wib=coadministration	lemma_13=or	pos_17=SYM	pos_20=NN	relType_17=dep	pos_2=VBD	relType_11=aux:pass	lemma_16=mg	relType_6=advcl	relType_16=conj	relType_1=nmod	path1=valdecoxib_compound<coadministration_nmod<change_nsubj<variability_advcl	lib=coadministration	pos_1=NN	pos_9=NN	pos_22=IN	pos_18=NN	relType_13=cc	lemma_14=near	pos_4=DT	pos_5=JJ	pos_14=RB	relType_5=amod	relType_15=nummod	pos_7=CC	pos_12=RB	lemma_1=coadministration	lemma_4=the	pos_19=,	lemma_5=normal	lemma_22=for	lemma_15=70	relType_3=case	pos_13=CC	relType_20=compound	lemma_7=and	lpib=coadministration_NN	lemma_20=dose	lemma_6=variability	lemma_9=glucose	lemma_2=be	lemma_19=,	relType_4=det	relType_18=nmod	pos_10=NNS	lemma_8=individual	lemma_18=dl	pos_21=NN	lemma_17=/
DDI-DrugBank.d328.s35	DDI-DrugBank.d328.s35.e0	DDI-DrugBank.d328.s35.e2	null	relType_27=cc	pos_23=-LRB-	lemma_3=within	pos_24=CD	lemma_10=concentration	lemma_12=above	pos_29=NNS	pos_6=NN	pos_8=JJ	pos_15=CD	pos_20=NN	relType_24=nummod	relType_11=aux:pass	pos_26=NN	relType_6=advcl	pos_22=IN	relType_1=nmod	path1=valdecoxib_compound<coadministration_nmod<change_nsubj<variability_advcl	lemma_31=)	pos_32=IN	pos_18=NN	pos_14=RB	relType_15=nummod	relType_30=conj	pos_12=RB	pos_31=-RRB-	lemma_29=mg	path2=adjustment_nsubj:pass>glyburide_nmod>coadministration_nmod>valdecoxib_compound	lemma_23=(	lpib=coadministration_NN	lemma_6=variability	lemma_32=with	relType_32=case	lemma_11=be	pos_16=NNS	relType_28=nummod	lemma_21=adjustment	relType_14=advmod	relType_10=conj	lemma_13=or	relType_17=dep	pos_25=NNS	lemma_16=mg	relType_26=appos	relType_22=case	pos_9=NN	lib=coadministration	lemma_22=for	relType_13=cc	lemma_14=near	pos_19=,	lemma_19=,	lemma_2=be	relType_18=nmod	lemma_18=dl	path=valdecoxib_compound<coadministration_nmod<change_nsubj<variability_advcl<indicate_ROOT>adjustment_nsubj:pass>glyburide_nmod>coadministration_nmod>valdecoxib_compound	lemma_27=and	pos_3=IN	lemma_23=glyburide	relType_7=cc	relType_21=nsubj:pass	relType_19=punct	relType_29=compound	pos_23=NN	relType_12=advmod	pos_17=SYM	wib=coadministration	pos_30=NNP	lemma_8=individual	pos_1=NN	relType_23=nmod	relType_25=compound	relType_5=amod	lemma_28=10	lemma_4=the	lemma_15=70	pos_13=CC	lemma_24=5	lemma_30=BID	pos_27=CC	relType_23=punct	relType_8=amod	pos_11=VBD	pos_28=CD	relType_2=cop	relType_9=compound	lemma_25=mg	pos_2=VBD	relType_31=punct	pos_4=DT	pos_5=JJ	pos_7=CC	lemma_1=coadministration	lemma_26=qd	lemma_5=normal	relType_3=case	eib=True	relType_20=compound	lemma_7=and	lemma_20=dose	lemma_9=glucose	relType_4=det	pos_10=NNS	relType_16=conj	pos_21=NN	lemma_17=/
DDI-DrugBank.d328.s35	DDI-DrugBank.d328.s35.e1	DDI-DrugBank.d328.s35.e2	advise	pos_7=NNS	lemma_9=)	relType_7=compound	relType_2=nummod	pos_5=CC	lemma_10=with	path=<glyburide_nmod>coadministration_nmod>valdecoxib_compound	relType_4=appos	path1=	path2=coadministration_nmod>valdecoxib_compound	pos_6=CD	lemma_6=10	lemma_1=(	relType_5=cc	pos_3=NNS	lib=mg	eib=False	pos_2=CD	lemma_4=qd	relType_10=case	pos_4=NN	lpib=mg_NNS	pos_9=-RRB-	lemma_7=mg	lemma_2=5	pos_8=NNP	relType_6=nummod	pos_10=IN	relType_9=punct	pos_1=-LRB-	lemma_5=and	relType_8=conj	wib=mg	lemma_8=BID	relType_3=compound	lemma_3=mg	relType_1=punct
DDI-DrugBank.d328.s36	DDI-DrugBank.d328.s36.e0	DDI-DrugBank.d328.s36.e1	null	relType_1=case	lemma_2=dose	path=glyburide_nmod<Coadministration_nsubj:pass>dose_nmod>high_amod>valdecoxib_obl	path1=glyburide_nmod	pos_6=NN	pos_5=CD	eib=False	relType_2=nmod	pos_1=IN	lemma_6=mg	wib=doses	pos_3=JJR	relType_3=amod	relType_5=nummod	pos_4=IN	path2=dose_nmod>high_amod>valdecoxib_obl	relType_4=case	lib=dose	lemma_3=high	pos_2=NNS	lemma_1=with	lemma_5=40	relType_6=compound	lpib=dose_NNS	lemma_4=than
DDI-DrugBank.d328.s37	DDI-DrugBank.d328.s37.e0	DDI-DrugBank.d328.s37.e1	null	wib=Omeprazole	lib=omeprazole	eib=False	path1=	pos_1=:	path2=substrate_parataxis>Omeprazole_nsubj	path=<Omeprazole_ROOT>substrate_parataxis>Omeprazole_nsubj	relType_1=punct	lemma_1=:	lpib=omeprazole_NNP
DDI-DrugBank.d328.s38	DDI-DrugBank.d328.s38.e0	DDI-DrugBank.d328.s38.e1	null	pos_7=NNS	lemma_9=)	relType_7=compound	pos_2=NN	lemma_11=not	pos_15=JJ	relType_15=amod	lemma_14=with	pos_6=CD	pos_1=JJ	relType_16=obl	relType_8=appos	pos_16=NNS	path2=dose_obl>omeprazole_nmod	lemma_12=affect	pos_17=IN	lemma_3=plasma	relType_10=aux:pass	lemma_13=significantly	path1=Valdecoxib_compound<concentration_nsubj:pass	lemma_16=dose	eib=False	lib=steady	lpib=steady_JJ	relType_4=nsubj:pass	lemma_5=(	pos_13=RB	relType_11=advmod	pos_4=NNS	relType_17=case	pos_9=-RRB-	relType_12=ROOT	pos_14=IN	lemma_7=mg	pos_8=NNP	relType_13=advmod	relType_2=compound	relType_5=punct	pos_10=VBD	lemma_15=multiple	relType_6=nummod	relation_11=neutral	lemma_17=of	lemma_1=steady	relType_9=punct	pos_11=RB	path=Valdecoxib_compound<concentration_nsubj:pass<affect_ROOT>dose_obl>omeprazole_nmod	lemma_2=state	pos_3=NN	lemma_8=BID	relType_3=compound	relType_1=amod	relType_14=case	pos_12=VBN	lemma_4=concentration	lemma_6=40	lemma_10=be	wib=steady	pos_5=-LRB-
DDI-DrugBank.d328.s39	DDI-DrugBank.d328.s39.e0	DDI-DrugBank.d328.s39.e1	mechanism	relType_1=ROOT	path2=exposure_obj>omeprazole_nmod	relation_0=beneficial	pos_1=VBD	pos_2=NN	lemma_2=exposure	lemma_1=increase	eib=False	wib=increased	relType_2=obj	pos_3=IN	relType_3=case	path=valdecoxib_nmod<Coadministration_nsubj<increase_ROOT>exposure_obj>omeprazole_nmod	lemma_3=of	lpib=increase_VBD	lib=increase	path1=valdecoxib_nmod<Coadministration_nsubj
DDI-DrugBank.d328.s40	DDI-DrugBank.d328.s40.e0	DDI-DrugBank.d328.s40.e1	null	relType_1=cc	pos_1=CC	lib=valdecoxib	wib=valdecoxib	path=<omeprazole_nmod>valdecoxib_conj	eib=False	lpib=valdecoxib_NN	path1=	path2=valdecoxib_conj	lemma_1=and
DDI-DrugBank.d328.s41	DDI-DrugBank.d328.s41.e0	DDI-DrugBank.d328.s41.e1	null	lemma_9=)	pos_2=VBN	lemma_7=(	pos_3=IN	lemma_11=,	lpib=be_VBP	relType_1=aux:pass	lemma_4=Zollinger	relType_2=advcl	relType_8=appos	relType_12=det	lemma_12=no	lemma_14=adjustment	lemma_8=ZE	pos_7=-LRB-	relType_6=obl	lemma_13=dose	eib=False	pos_6=NNP	relType_11=punct	lemma_1=be	pos_5=HYPH	pos_14=NN	pos_13=NN	relType_10=nsubj:pass	wib=are	pos_9=-RRB-	relType_15=case	pos_8=NNP	lib=be	lemma_2=tolerate	path=omeprazole_nmod<dose_nsubj:pass<tolerate_advcl<recommend_ROOT>patient_nsubj:pass>adjustment_appos>omeprazole_nmod	relType_13=compound	relType_5=punct	relType_4=compound	path2=patient_nsubj:pass>adjustment_appos>omeprazole_nmod	relType_14=appos	path1=omeprazole_nmod<dose_nsubj:pass<tolerate_advcl	pos_11=,	pos_1=VBP	relType_9=punct	relType_3=case	pos_15=IN	lemma_6=Ellison	lemma_15=for	relType_7=punct	pos_4=NNP	pos_12=DT	lemma_5=-	lemma_3=in	pos_10=NNS	lemma_10=patient
DDI-DrugBank.d328.s42	DDI-DrugBank.d328.s42.e0	DDI-DrugBank.d328.s42.e1	null	relType_1=case	relType_7=compound	lemma_2=dose	pos_6=NN	pos_5=CD	eib=False	relType_2=nmod	path2=dose_nmod>high_amod>omeprazole_obl	pos_1=IN	lemma_6=mg	wib=doses	pos_3=JJR	path=valdecoxib_nmod<Coadministration_nsubj:pass>dose_nmod>high_amod>omeprazole_obl	lemma_7=qd	relType_3=amod	relType_5=nummod	pos_4=IN	relType_4=case	lib=dose	lemma_3=high	pos_2=NNS	lemma_1=with	lemma_5=40	relType_6=compound	lpib=dose_NNS	path1=valdecoxib_nmod	lemma_4=than	pos_7=NN
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e0	DDI-DrugBank.d328.s43.e1	null	path2=Valdecoxib_dep	path=<contraceptive_nsubj>Valdecoxib_dep	lib=valdecoxib	eib=False	path1=	pos_1=:	relType_1=punct	lpib=valdecoxib_NNP	lemma_1=:	wib=Valdecoxib
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e0	DDI-DrugBank.d328.s43.e2	null	lemma_13=the	pos_15=JJ	relType_10=det	relType_15=amod	lemma_9=induce	path1=contraceptive_nsubj	relation_9=neutral	relType_12=case	pos_13=DT	relType_7=aux	pos_9=VB	lpib=valdecoxib_NNP	relType_11=obj	relType_14=compound	relType_2=punct	lemma_12=of	relType_9=ROOT	lib=valdecoxib	pos_2=NNP	path=contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep>contraceptive_compound	relType_6=punct	pos_8=RB	pos_2=-LRB-	lemma_8=not	lemma_10=the	lemma_14=combination	pos_14=NN	lemma_6=)	pos_4=NNS	lemma_1=:	relType_8=advmod	pos_12=IN	relType_2=dep	pos_3=CD	lemma_4=mg	relType_4=compound	pos_1=:	lemma_3=40	pos_7=VBD	lemma_7=do	pos_5=NNP	relType_3=nummod	lemma_5=BID	relType_5=appos	pos_6=-RRB-	path2=metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep>contraceptive_compound	pos_11=NN	eib=True	relType_13=det	lemma_2=Valdecoxib	lemma_15=oral	relType_1=punct	lemma_2=(	lemma_11=metabolism	wib=Valdecoxib	pos_10=DT
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e0	DDI-DrugBank.d328.s43.e3	null	lemma_13=the	pos_15=JJ	relType_10=det	relType_15=amod	lemma_9=induce	path1=contraceptive_nsubj	path=contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep	relType_12=case	relation_9=neutral	pos_13=DT	relType_7=aux	relType_16=compound	pos_9=VB	lpib=valdecoxib_NNP	relType_11=obj	relType_14=compound	relType_2=punct	lemma_12=of	relType_9=ROOT	lib=valdecoxib	pos_2=NNP	relType_6=punct	pos_8=RB	pos_2=-LRB-	lemma_8=not	lemma_10=the	lemma_14=combination	pos_14=NN	lemma_6=)	pos_4=NNS	lemma_1=:	relType_8=advmod	pos_12=IN	relType_2=dep	lemma_16=contraceptive	pos_3=CD	lemma_4=mg	relType_4=compound	pos_1=:	lemma_3=40	pos_7=VBD	lemma_7=do	pos_5=NNP	relType_3=nummod	pos_16=NN	lemma_5=BID	relType_5=appos	pos_6=-RRB-	pos_11=NN	eib=True	path2=metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep	relType_13=det	lemma_2=Valdecoxib	lemma_15=oral	relType_1=punct	lemma_2=(	lemma_11=metabolism	wib=Valdecoxib	pos_10=DT
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e0	DDI-DrugBank.d328.s43.e4	null	lemma_13=the	pos_15=JJ	relType_10=det	relType_15=amod	lemma_9=induce	path1=contraceptive_nsubj	relation_9=neutral	relType_12=case	pos_13=DT	relType_7=aux	relType_16=compound	pos_9=VB	lpib=valdecoxib_NNP	relType_11=obj	relType_14=compound	pos_16=HYPH	relType_2=punct	lemma_12=of	relType_9=ROOT	pos_17=NN	path=contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod	lib=valdecoxib	pos_2=NNP	relType_6=punct	pos_8=RB	pos_2=-LRB-	lemma_8=not	lemma_10=the	lemma_14=combination	pos_14=NN	relType_17=compound	lemma_6=)	pos_4=NNS	lemma_1=:	relType_8=advmod	pos_12=IN	relType_2=dep	lemma_16=contraceptive	pos_3=CD	lemma_16=/	lemma_17=ethinyl	lemma_4=mg	path2=metabolism_obj>estradiol_nmod	relType_4=compound	pos_1=:	lemma_3=40	pos_7=VBD	lemma_7=do	pos_5=NNP	relType_3=nummod	pos_16=NN	lemma_5=BID	relType_16=punct	relType_5=appos	pos_6=-RRB-	pos_11=NN	eib=True	relType_16=dep	relType_13=det	lemma_2=Valdecoxib	lemma_15=oral	relType_1=punct	lemma_2=(	lemma_16=norethindrone	lemma_11=metabolism	wib=Valdecoxib	pos_10=DT
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e0	DDI-DrugBank.d328.s43.e5	null	relation_9=neutral	pos_24=,	pos_9=VB	lpib=valdecoxib_NNP	pos_16=HYPH	lemma_24=,	pos_25=NNP	relType_9=ROOT	lib=valdecoxib	pos_2=NNP	relType_17=compound	relType_8=advmod	relType_2=dep	lemma_17=ethinyl	pos_1=:	lemma_5=BID	path2=metabolism_obj>estradiol_nmod>mg_appos>Novum_dep	relType_16=punct	relType_13=det	lemma_2=Valdecoxib	lemma_17=(	lemma_25=Ortho	relType_21=nummod	lemma_2=(	lemma_11=metabolism	relType_22=nmod	pos_22=NN	relType_18=nummod	relType_2=punct	pos_2=-LRB-	lemma_14=combination	pos_21=CD	pos_12=IN	relType_23=dep	lemma_22=mcg	lemma_16=/	lemma_3=40	pos_5=NNP	pos_16=NN	pos_17=-LRB-	relType_5=appos	pos_6=-RRB-	pos_20=SYM	pos_11=NN	relType_25=punct	relType_1=punct	wib=Valdecoxib	relType_10=det	lemma_20=/	lemma_9=induce	path1=contraceptive_nsubj	relType_17=punct	relType_12=case	relType_24=punct	relType_7=aux	lemma_17=estradiol	relType_11=obj	lemma_18=1	lemma_23=combination	lemma_12=of	pos_23=NN	pos_17=NN	pos_8=RB	lemma_8=not	lemma_10=the	relType_19=appos	pos_14=NN	lemma_25=-	lemma_6=)	lemma_1=:	relType_25=compound	lemma_16=contraceptive	path=contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>mg_appos>Novum_dep	pos_7=VBD	relType_17=nmod	pos_25=HYPH	lemma_15=oral	lemma_21=35	pos_10=DT	lemma_13=the	pos_15=JJ	relType_15=amod	pos_13=DT	relType_16=compound	relType_14=compound	relType_20=dep	relType_6=punct	pos_19=NN	pos_4=NNS	pos_18=CD	pos_3=CD	lemma_4=mg	relType_4=compound	lemma_7=do	relType_3=nummod	lemma_19=mg	eib=True	relType_16=dep	lemma_16=norethindrone
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e1	DDI-DrugBank.d328.s43.e2	null	relType_14=amod	relType_2=nummod	path1=Valdecoxib_dep<contraceptive_nsubj	lemma_7=not	lemma_6=do	relType_4=appos	pos_6=VBD	relType_12=det	relType_11=case	lemma_1=(	path=Valdecoxib_dep<contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep>contraceptive_compound	pos_3=NNS	lib=mg	pos_7=RB	eib=False	pos_2=CD	pos_9=DT	pos_10=NN	pos_13=NN	lemma_13=combination	lpib=mg_NNS	lemma_5=)	pos_8=VB	pos_11=IN	lemma_12=the	relType_13=compound	pos_5=-RRB-	relType_6=aux	relType_5=punct	lemma_8=induce	lemma_10=metabolism	relType_8=ROOT	pos_1=-LRB-	relation_7=neutral	path2=metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep>contraceptive_compound	lemma_9=the	lemma_4=BID	pos_4=NNP	lemma_11=of	wib=mg	pos_14=JJ	relType_3=compound	lemma_3=mg	pos_12=DT	relType_7=advmod	relType_1=punct	lemma_2=40	lemma_14=oral	relType_10=obj	relType_9=det
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e1	DDI-DrugBank.d328.s43.e3	null	relType_14=amod	relType_2=nummod	path1=Valdecoxib_dep<contraceptive_nsubj	lemma_7=not	lemma_6=do	relType_4=appos	pos_6=VBD	relType_12=det	relType_11=case	lemma_1=(	pos_3=NNS	lib=mg	pos_7=RB	pos_2=CD	pos_9=DT	pos_10=NN	pos_13=NN	lemma_13=combination	path=Valdecoxib_dep<contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep	lpib=mg_NNS	lemma_5=)	pos_8=VB	pos_11=IN	lemma_12=the	relType_13=compound	pos_15=NN	pos_5=-RRB-	relType_6=aux	relType_5=punct	lemma_8=induce	lemma_10=metabolism	relType_8=ROOT	lemma_15=contraceptive	pos_1=-LRB-	relType_15=compound	relation_7=neutral	eib=True	path2=metabolism_obj>estradiol_nmod>ethinyl_compound>norethindrone_dep	lemma_9=the	lemma_4=BID	pos_4=NNP	lemma_11=of	wib=mg	pos_14=JJ	relType_3=compound	lemma_3=mg	pos_12=DT	relType_7=advmod	relType_1=punct	lemma_2=40	lemma_14=oral	relType_10=obj	relType_9=det
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e1	DDI-DrugBank.d328.s43.e4	null	relType_14=amod	relType_2=nummod	path1=Valdecoxib_dep<contraceptive_nsubj	lemma_7=not	lemma_6=do	relType_4=appos	path=Valdecoxib_dep<contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod	relType_16=compound	pos_6=VBD	relType_12=det	relType_11=case	lemma_15=/	lemma_1=(	pos_3=NNS	lib=mg	pos_7=RB	pos_2=CD	relType_15=dep	pos_9=DT	pos_10=NN	pos_13=NN	lemma_13=combination	relType_15=punct	lemma_16=ethinyl	lpib=mg_NNS	lemma_5=)	pos_8=VB	pos_11=IN	lemma_12=the	relType_13=compound	pos_15=NN	pos_5=-RRB-	relType_6=aux	relType_5=punct	path2=metabolism_obj>estradiol_nmod	lemma_8=induce	lemma_10=metabolism	relType_8=ROOT	lemma_15=contraceptive	pos_16=NN	pos_1=-LRB-	relType_15=compound	relation_7=neutral	eib=True	lemma_9=the	lemma_4=BID	pos_4=NNP	lemma_11=of	wib=mg	pos_14=JJ	relType_3=compound	lemma_3=mg	pos_12=DT	relType_7=advmod	relType_1=punct	lemma_2=40	lemma_15=norethindrone	lemma_14=oral	relType_10=obj	pos_15=HYPH	relType_9=det
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e1	DDI-DrugBank.d328.s43.e5	null	relType_14=amod	pos_24=NNP	lemma_7=not	path1=Valdecoxib_dep<contraceptive_nsubj	relType_16=nmod	relType_22=dep	pos_6=VBD	pos_3=NNS	lib=mg	pos_7=RB	pos_10=NN	pos_13=NN	lemma_23=,	lemma_12=the	pos_8=VB	pos_18=NN	relType_24=compound	pos_5=-RRB-	path2=metabolism_obj>estradiol_nmod>mg_appos>Novum_dep	relType_16=punct	pos_1=-LRB-	pos_17=CD	relType_15=compound	lemma_4=BID	pos_12=DT	lemma_15=norethindrone	lemma_16=estradiol	pos_15=HYPH	lemma_16=(	lemma_24=Ortho	relType_2=nummod	pos_22=NN	pos_16=-LRB-	relType_19=dep	pos_20=CD	relType_11=case	lemma_13=combination	lemma_5=)	relType_8=ROOT	pos_16=NN	path=Valdecoxib_dep<contraceptive_nsubj<induce_ROOT>metabolism_obj>estradiol_nmod>mg_appos>Novum_dep	pos_4=NNP	relType_3=compound	relType_1=punct	lemma_2=40	lemma_14=oral	relType_10=obj	pos_24=HYPH	lemma_6=do	relType_4=appos	relType_20=nummod	relType_24=punct	relType_21=nmod	relType_12=det	lemma_1=(	lemma_22=combination	pos_21=NN	relType_15=dep	pos_9=DT	lemma_16=ethinyl	relType_15=punct	pos_11=IN	lemma_17=1	relType_18=appos	relType_6=aux	lemma_18=mg	lemma_24=-	relation_7=neutral	pos_19=SYM	lemma_21=mcg	lemma_9=the	lemma_11=of	pos_14=JJ	relType_7=advmod	relType_23=punct	relType_16=compound	lemma_15=/	relType_17=nummod	pos_2=CD	lemma_20=35	lpib=mg_NNS	relType_13=compound	pos_15=NN	relType_5=punct	lemma_8=induce	lemma_10=metabolism	lemma_15=contraceptive	eib=True	lemma_19=/	pos_23=,	wib=mg	lemma_3=mg	relType_9=det
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e2	DDI-DrugBank.d328.s43.e3	null	eib=False	path=contraceptive_compound<norethindrone_dep>	path2=	path1=contraceptive_compound
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e2	DDI-DrugBank.d328.s43.e4	null	lib=norethindrone	lpib=norethindrone_NN	pos_2=NN	lemma_1=/	eib=True	lemma_2=ethinyl	relType_2=compound	lemma_1=norethindrone	relType_1=dep	path2=	wib=norethindrone	pos_1=HYPH	relType_1=punct	pos_1=NN	path=contraceptive_compound<norethindrone_dep<ethinyl_compound<estradiol_nmod>	path1=contraceptive_compound<norethindrone_dep<ethinyl_compound
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e2	DDI-DrugBank.d328.s43.e5	null	lemma_3=1	relType_10=punct	pos_2=NN	relType_8=dep	lemma_2=ethinyl	relType_4=appos	pos_7=NN	pos_6=CD	lemma_10=Ortho	pos_1=HYPH	lemma_6=35	lemma_9=,	relType_2=punct	pos_8=NN	relType_2=nmod	lemma_7=mcg	lemma_1=norethindrone	pos_2=-LRB-	relType_1=dep	lemma_8=combination	relType_10=compound	path=contraceptive_compound<norethindrone_dep<ethinyl_compound<estradiol_nmod>mg_appos>Novum_dep	pos_4=NN	pos_1=NN	relType_5=dep	lemma_10=-	lib=norethindrone	pos_3=CD	relType_2=compound	lemma_4=mg	pos_10=HYPH	path2=mg_appos>Novum_dep	relType_6=nummod	relType_7=nmod	relType_3=nummod	wib=norethindrone	relType_9=punct	pos_10=NNP	lemma_2=estradiol	lemma_1=/	lpib=norethindrone_NN	eib=True	lemma_5=/	pos_9=,	relType_1=punct	lemma_2=(	pos_5=SYM	path1=contraceptive_compound<norethindrone_dep<ethinyl_compound
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e3	DDI-DrugBank.d328.s43.e4	null	lpib=ethinyl_NN	path1=norethindrone_dep<ethinyl_compound	pos_2=NN	eib=True	lemma_2=ethinyl	relType_2=compound	path2=	pos_1=HYPH	lemma_1=/	relType_1=punct	path=norethindrone_dep<ethinyl_compound<estradiol_nmod>	lib=ethinyl	wib=ethinyl
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e3	DDI-DrugBank.d328.s43.e5	null	lemma_3=1	relType_10=punct	pos_2=NN	relType_8=dep	lemma_2=ethinyl	relType_4=appos	pos_7=NN	path=norethindrone_dep<ethinyl_compound<estradiol_nmod>mg_appos>Novum_dep	pos_6=CD	lemma_10=Ortho	pos_1=HYPH	lemma_6=35	lemma_9=,	relType_2=punct	pos_8=NN	relType_2=nmod	lemma_7=mcg	pos_2=-LRB-	lemma_8=combination	relType_10=compound	relType_5=dep	pos_4=NN	lib=ethinyl	lemma_10=-	path1=norethindrone_dep<ethinyl_compound	pos_3=CD	relType_2=compound	lemma_4=mg	pos_10=HYPH	path2=mg_appos>Novum_dep	relType_6=nummod	relType_7=nmod	relType_3=nummod	relType_9=punct	pos_10=NNP	lemma_2=estradiol	lemma_1=/	wib=ethinyl	lpib=ethinyl_NN	eib=True	lemma_5=/	pos_9=,	relType_1=punct	lemma_2=(	pos_5=SYM
DDI-DrugBank.d328.s43	DDI-DrugBank.d328.s43.e4	DDI-DrugBank.d328.s43.e5	null	relType_4=dep	relType_2=nummod	pos_9=NNP	pos_7=NN	lemma_6=mcg	path1=	relType_8=punct	lemma_9=-	lemma_8=,	lemma_2=1	path=<estradiol_nmod>mg_appos>Novum_dep	lemma_1=(	pos_6=NN	pos_5=CD	pos_9=HYPH	lib=mg	relType_9=compound	relType_3=appos	pos_2=CD	lpib=mg_NN	pos_4=SYM	lemma_9=Ortho	relType_5=nummod	path2=mg_appos>Novum_dep	lemma_4=/	lemma_5=35	lemma_7=combination	relType_9=punct	pos_1=-LRB-	relType_7=dep	eib=True	pos_3=NN	wib=mg	lemma_3=mg	relType_1=punct	relType_6=nmod	pos_8=,
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e0	DDI-DrugBank.d328.s44.e1	mechanism	relType_1=cc	lpib=ortho_NNP	pos_1=CC	lemma_2=Ortho	wib=Ortho	eib=True	pos_2=NNP	lemma_2=-	relType_2=compound	path1=	path2=Novum_conj	lib=ortho	path=<valdecoxib_nmod>Novum_conj	pos_2=HYPH	lemma_1=and	relType_2=punct
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e0	DDI-DrugBank.d328.s44.e2	null	relType_1=cc	relType_8=case	relType_3=dep	lpib=ortho_NNP	pos_1=CC	relType_2=nummod	wib=Ortho	pos_6=DT	pos_7=NN	lib=ortho	pos_2=HYPH	lemma_2=1	path1=valdecoxib_nmod<Coadministration_nsubj	lemma_5=increase	relType_2=punct	pos_3=SYM	lemma_2=Ortho	pos_2=NNP	lemma_2=-	pos_2=CD	lemma_6=the	relType_7=obj	lemma_3=/	lemma_4=35	relType_2=conj	pos_8=IN	pos_4=CD	relType_2=compound	path=valdecoxib_nmod<Coadministration_nsubj<increase_ROOT>exposure_obj>norethindrone_nmod	lemma_7=exposure	relType_4=nummod	pos_5=VBD	relation_7=beneficial	relType_6=det	path2=exposure_obj>norethindrone_nmod	lemma_2=Novum	eib=True	relType_5=ROOT	lemma_8=of	lemma_1=and
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e0	DDI-DrugBank.d328.s44.e3	null	relType_1=cc	relType_8=case	relType_3=dep	lpib=ortho_NNP	pos_1=CC	relType_2=nummod	wib=Ortho	pos_6=DT	pos_7=NN	lib=ortho	pos_2=HYPH	relType_9=nmod	lemma_2=1	path1=valdecoxib_nmod<Coadministration_nsubj	lemma_5=increase	relType_2=punct	pos_3=SYM	lemma_2=Ortho	pos_2=NNP	lemma_2=-	pos_2=CD	path=valdecoxib_nmod<Coadministration_nsubj<increase_ROOT>exposure_obj>norethindrone_nmod>estradiol_conj	lemma_6=the	relType_7=obj	lemma_3=/	relType_10=compound	pos_10=NN	lemma_4=35	relType_2=conj	pos_9=NN	pos_8=IN	pos_4=CD	lemma_9=and	pos_9=CC	relType_2=compound	lemma_7=exposure	path2=exposure_obj>norethindrone_nmod>estradiol_conj	relType_4=nummod	pos_5=VBD	lemma_10=ethinyl	relType_6=det	relation_7=beneficial	lemma_2=Novum	lemma_9=norethindrone	eib=True	relType_5=ROOT	lemma_8=of	relType_9=cc	lemma_1=and
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e1	DDI-DrugBank.d328.s44.e2	null	relType_1=nummod	lemma_2=/	relType_7=case	relation_3=beneficial	pos_6=NN	pos_1=CD	eib=False	wib=increased	lemma_4=increase	lib=increase	relType_2=dep	path1=Novum_conj<valdecoxib_nmod<Coadministration_nsubj	pos_3=CD	relType_5=det	relType_3=nummod	lpib=increase_VBD	relType_4=ROOT	pos_2=SYM	lemma_7=of	relType_6=obj	path2=exposure_obj>norethindrone_nmod	pos_4=VBD	lemma_6=exposure	lemma_5=the	pos_7=IN	pos_5=DT	lemma_3=35	lemma_1=1	path=Novum_conj<valdecoxib_nmod<Coadministration_nsubj<increase_ROOT>exposure_obj>norethindrone_nmod
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e1	DDI-DrugBank.d328.s44.e3	null	relType_1=nummod	lemma_2=/	relType_7=case	relation_3=beneficial	pos_6=NN	pos_8=NN	relType_9=compound	pos_1=CD	wib=increased	lemma_4=increase	pos_8=CC	pos_9=NN	lib=increase	relType_2=dep	path1=Novum_conj<valdecoxib_nmod<Coadministration_nsubj	pos_3=CD	relType_5=det	lemma_9=ethinyl	relType_3=nummod	lpib=increase_VBD	relType_4=ROOT	pos_2=SYM	path2=exposure_obj>norethindrone_nmod>estradiol_conj	lemma_8=and	lemma_7=of	relType_6=obj	lemma_6=exposure	pos_4=VBD	lemma_5=the	eib=True	pos_7=IN	relType_8=nmod	pos_5=DT	path=Novum_conj<valdecoxib_nmod<Coadministration_nsubj<increase_ROOT>exposure_obj>norethindrone_nmod>estradiol_conj	lemma_3=35	relType_8=cc	lemma_8=norethindrone	lemma_1=1
DDI-DrugBank.d328.s44	DDI-DrugBank.d328.s44.e2	DDI-DrugBank.d328.s44.e3	null	relType_1=cc	lpib=ethinyl_NN	pos_1=CC	pos_2=NN	eib=True	lemma_2=ethinyl	relType_2=compound	path1=	path2=estradiol_conj	path=<norethindrone_nmod>estradiol_conj	lemma_1=and	lib=ethinyl	wib=ethinyl
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e0	DDI-DrugBank.d328.s46.e1	null	relType_1=cc	lpib=ethinyl_NN	pos_1=CC	pos_2=NN	eib=True	lemma_2=ethinyl	relType_2=compound	path1=	path2=estradiol_conj	path=<norethindrone_nmod>estradiol_conj	lemma_1=and	lib=ethinyl	wib=ethinyl
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e0	DDI-DrugBank.d328.s46.e2	null	relType_1=cc	lemma_5=into	pos_1=CC	pos_2=NN	lemma_2=ethinyl	lemma_9=a	path2=select_advcl>contraceptive_obj	path=norethindrone_nmod<exposure_obj<increase_csubj:pass<take_ROOT>select_advcl>contraceptive_obj	pos_2=MD	relType_10=amod	relType_8=advcl	pos_3=VB	relType_3=aux:pass	pos_7=WRB	relType_5=case	lemma_6=consideration	pos_6=NN	relType_6=obl	pos_9=DT	relType_2=aux	path1=norethindrone_nmod<exposure_obj<increase_csubj:pass	relType_2=conj	lib=ethinyl	pos_4=VBN	lemma_2=should	pos_10=JJ	relType_2=compound	pos_8=VBG	lemma_3=be	pos_5=IN	relType_4=ROOT	lemma_2=estradiol	lemma_4=take	wib=ethinyl	lpib=ethinyl_NN	eib=True	lemma_7=when	lemma_10=oral	relType_7=advmod	lemma_8=select	lemma_1=and	relType_9=det
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e0	DDI-DrugBank.d328.s46.e3	null	relType_1=cc	pos_13=VBG	lemma_5=into	pos_1=CC	relType_12=obl	pos_2=NN	lemma_2=ethinyl	lemma_9=a	pos_2=MD	relType_10=amod	relType_13=acl	relType_8=advcl	lemma_11=contraceptive	pos_3=VB	relType_11=obj	relType_3=aux:pass	pos_7=WRB	relType_5=case	relType_11=case	lemma_6=consideration	pos_6=NN	relType_6=obl	pos_9=DT	relType_2=aux	lemma_13=take	path1=norethindrone_nmod<exposure_obj<increase_csubj:pass	relType_2=conj	lib=ethinyl	pos_4=VBN	pos_11=IN	lemma_11=for	lemma_2=should	pos_10=JJ	relType_2=compound	pos_8=VBG	pos_12=NNS	lemma_3=be	pos_5=IN	path=norethindrone_nmod<exposure_obj<increase_csubj:pass<take_ROOT>select_advcl>woman_obl>take_acl>valdecoxib_obj	lemma_12=woman	relType_4=ROOT	lemma_2=estradiol	lemma_4=take	wib=ethinyl	lpib=ethinyl_NN	path2=select_advcl>woman_obl>take_acl>valdecoxib_obj	pos_11=NN	eib=True	lemma_7=when	lemma_10=oral	relType_7=advmod	lemma_8=select	lemma_1=and	relType_9=det
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e1	DDI-DrugBank.d328.s46.e2	null	pos_8=DT	lemma_3=take	relType_1=aux	path2=select_advcl>contraceptive_obj	pos_3=VBN	lemma_7=select	pos_7=VBG	path=estradiol_conj<norethindrone_nmod<exposure_obj<increase_csubj:pass<take_ROOT>select_advcl>contraceptive_obj	lemma_1=should	pos_6=WRB	wib=be	relType_7=advcl	pos_9=JJ	eib=False	lemma_9=oral	lemma_8=a	lemma_6=when	pos_2=VB	path1=estradiol_conj<norethindrone_nmod<exposure_obj<increase_csubj:pass	lemma_5=consideration	relType_9=amod	lib=be	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_1=MD	lpib=be_VB	pos_5=NN	lemma_4=into	lemma_2=be	relType_8=det	relType_6=advmod
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e1	DDI-DrugBank.d328.s46.e3	null	pos_8=DT	lemma_3=take	relType_1=aux	pos_12=VBG	lemma_11=woman	pos_3=VBN	lemma_12=take	lemma_7=select	pos_7=VBG	lemma_10=contraceptive	lemma_1=should	pos_6=WRB	wib=be	relType_7=advcl	pos_9=JJ	lemma_9=oral	lemma_8=a	pos_11=NNS	lemma_6=when	pos_2=VB	path1=estradiol_conj<norethindrone_nmod<exposure_obj<increase_csubj:pass	lemma_5=consideration	relType_9=amod	pos_10=NN	relType_10=case	lib=be	relType_3=ROOT	pos_4=IN	relType_4=case	relType_2=aux:pass	relType_5=obl	pos_10=IN	pos_1=MD	relType_11=obl	lpib=be_VB	pos_5=NN	path2=select_advcl>woman_obl>take_acl>valdecoxib_obj	eib=True	lemma_4=into	path=estradiol_conj<norethindrone_nmod<exposure_obj<increase_csubj:pass<take_ROOT>select_advcl>woman_obl>take_acl>valdecoxib_obj	lemma_2=be	relType_12=acl	relType_8=det	lemma_10=for	relType_6=advmod	relType_10=obj
DDI-DrugBank.d328.s46	DDI-DrugBank.d328.s46.e2	DDI-DrugBank.d328.s46.e3	advise	pos_2=NNS	wib=women	relType_1=case	lib=woman	path=contraceptive_obj<select_advcl>woman_obl>take_acl>valdecoxib_obj	eib=False	lemma_3=take	relType_3=acl	path2=woman_obl>take_acl>valdecoxib_obj	lemma_1=for	pos_1=IN	pos_3=VBG	lemma_2=woman	path1=contraceptive_obj	relType_2=obl	lpib=woman_NNS
DDI-DrugBank.d328.s47	DDI-DrugBank.d328.s47.e0	DDI-DrugBank.d328.s47.e1	null	lpib=diazepam_NN	path=<diazepam_ROOT>3a4_appos>diazepam_nsubj	lib=diazepam	eib=False	path1=	pos_1=:	relType_1=punct	wib=Diazepam	path2=3a4_appos>diazepam_nsubj	lemma_1=:
DDI-DrugBank.d328.s47	DDI-DrugBank.d328.s47.e0	DDI-DrugBank.d328.s47.e2	null	lpib=diazepam_NN	pos_2=NN	lemma_2=(	eib=True	lib=diazepam	relType_2=nsubj	lemma_2=diazepam	path1=	pos_1=:	pos_2=-LRB-	lemma_1=:	relType_1=punct	path2=3a4_appos>diazepam_nsubj>Valium_appos	wib=Diazepam	path=<diazepam_ROOT>3a4_appos>diazepam_nsubj>Valium_appos	relType_2=punct
DDI-DrugBank.d328.s47	DDI-DrugBank.d328.s47.e1	DDI-DrugBank.d328.s47.e2	null	lemma_1=(	wib=Valium	path=<diazepam_nsubj>Valium_appos	path2=Valium_appos	eib=False	path1=	relType_1=punct	lpib=valium_NNP	pos_1=-LRB-	lib=valium
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e0	DDI-DrugBank.d328.s48.e1	mechanism	relType_6=aux:pass	relType_8=case	relType_12=obl	relType_2=nummod	relType_4=appos	path1=diazepam_nmod<exposure_nsubj:pass	path2=administration_obl>valdecoxib_nmod	pos_6=VBD	relType_11=case	lemma_6=be	relType_9=nummod	lemma_1=(	lemma_12=administration	lemma_13=of	pos_3=NNS	lib=mg	eib=False	pos_2=CD	lemma_2=10	lemma_9=28	lemma_7=increase	pos_13=IN	pos_10=NN	pos_8=IN	lpib=mg_NNS	lemma_5=)	relType_13=case	relType_7=ROOT	pos_5=-RRB-	relType_5=punct	lemma_8=by	pos_11=VBG	relation_6=beneficial	pos_1=-LRB-	lemma_10=%	pos_7=VBN	lemma_11=follow	pos_9=CD	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	path=diazepam_nmod<exposure_nsubj:pass<increase_ROOT>administration_obl>valdecoxib_nmod	lemma_3=mg	relType_1=punct	pos_12=NN	relType_10=obl
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e0	DDI-DrugBank.d328.s48.e2	null	relType_6=aux:pass	lemma_19=for	pos_6=VBD	relType_9=nummod	pos_21=NNS	lemma_13=of	pos_15=CD	pos_3=NNS	lib=mg	pos_10=NN	relType_22=punct	relType_24=compound	pos_14=-LRB-	relType_15=nummod	pos_5=-RRB-	lemma_20=12	pos_22=,	lemma_8=by	pos_11=VBG	pos_1=-LRB-	pos_26=IN	lemma_4=BID	relType_14=nmod	relType_8=case	relType_2=nummod	lemma_23=while	pos_16=NNS	pos_20=CD	relType_11=case	lemma_6=be	lemma_22=,	lemma_16=mg	pos_8=IN	lemma_5=)	lemma_17=BID	lemma_18=)	lemma_10=%	relType_21=obl	relType_17=appos	relType_19=case	pos_4=NNP	pos_23=IN	relType_3=compound	relType_1=punct	path2=increase_advcl>exposure_nsubj:pass>valdecoxib_nmod	relType_14=punct	relType_4=appos	relType_20=nummod	pos_24=NN	relType_23=mark	lemma_1=(	pos_17=NNP	pos_18=-RRB-	lemma_2=10	lemma_7=increase	pos_14=NN	pos_13=IN	relType_13=case	lemma_24=plasma	pos_25=NN	lemma_14=valdecoxib	relType_25=nsubj:pass	lemma_26=of	relation_6=beneficial	lemma_11=follow	pos_9=CD	relType_10=obl	pos_19=IN	relType_12=obl	relType_26=case	path1=diazepam_nmod<exposure_nsubj:pass	relType_16=compound	lemma_14=(	lemma_25=exposure	lemma_12=administration	pos_2=CD	lemma_15=40	lemma_9=28	lpib=mg_NNS	relType_7=ROOT	relType_5=punct	path=diazepam_nmod<exposure_nsubj:pass<increase_ROOT>increase_advcl>exposure_nsubj:pass>valdecoxib_nmod	relType_18=punct	lemma_21=day	pos_7=VBN	eib=True	wib=mg	lemma_3=mg	pos_12=NN
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e0	DDI-DrugBank.d328.s48.e3	null	relType_6=aux:pass	lemma_36=follow	relType_33=advmod	lemma_19=for	pos_6=VBD	pos_29=NNS	lemma_32=be	relType_9=nummod	pos_21=NNS	lemma_13=of	relType_34=advmod	pos_15=CD	relType_32=aux:pass	pos_3=NNS	lib=mg	relType_27=nmod	pos_10=NN	lemma_31=)	relType_22=punct	relType_24=compound	pos_14=-LRB-	relType_15=nummod	pos_5=-RRB-	lemma_20=12	pos_22=,	lemma_8=by	pos_31=-RRB-	relType_30=appos	pos_11=VBG	lemma_29=mg	pos_1=-LRB-	pos_38=IN	path2=increase_advcl>administration_obl>diazepam_nmod	pos_26=IN	lemma_4=BID	relType_14=nmod	relType_8=case	relType_2=nummod	lemma_23=while	lemma_35=increase	lemma_28=40	pos_16=NNS	relType_28=nummod	pos_20=CD	relType_11=case	lemma_6=be	lemma_33=not	lemma_34=substantially	lemma_22=,	lemma_16=mg	pos_8=IN	lemma_5=)	pos_27=NN	pos_37=NN	lemma_17=BID	pos_34=RB	lemma_18=)	lemma_10=%	relType_21=obl	relType_17=appos	relType_19=case	pos_27=-LRB-	pos_4=NNP	pos_23=IN	relType_3=compound	relType_1=punct	relType_14=punct	relType_38=case	relType_4=appos	relType_20=nummod	pos_24=NN	relType_23=mark	relType_29=compound	lemma_1=(	lemma_38=of	pos_17=NNP	pos_18=-RRB-	pos_30=NNP	lemma_2=10	lemma_7=increase	pos_14=NN	pos_13=IN	pos_32=VBD	relType_13=case	lemma_24=plasma	pos_35=VBN	pos_25=NN	lemma_14=valdecoxib	relType_25=nsubj:pass	lemma_26=of	relation_6=beneficial	pos_36=VBG	lemma_30=BID	lemma_11=follow	pos_9=CD	relation_36=beneficial	relType_27=punct	lemma_27=valdecoxib	relType_10=obl	pos_19=IN	relType_12=obl	relType_26=case	path1=diazepam_nmod<exposure_nsubj:pass	relType_16=compound	relType_35=advcl	lemma_14=(	pos_28=CD	lemma_25=exposure	lemma_12=administration	path=diazepam_nmod<exposure_nsubj:pass<increase_ROOT>increase_advcl>administration_obl>diazepam_nmod	pos_2=CD	lemma_15=40	lemma_9=28	lpib=mg_NNS	relType_31=punct	relType_7=ROOT	pos_33=RB	relType_5=punct	relType_18=punct	lemma_21=day	lemma_27=(	lemma_37=administration	pos_7=VBN	eib=True	wib=mg	lemma_3=mg	pos_12=NN	relType_36=case	relType_37=obl
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e1	DDI-DrugBank.d328.s48.e2	null	relType_2=nummod	relType_10=mark	relType_4=appos	pos_7=CD	lemma_9=,	relType_6=case	pos_8=NNS	relType_8=obl	lemma_1=(	path=valdecoxib_nmod<administration_obl<increase_ROOT>increase_advcl>exposure_nsubj:pass>valdecoxib_nmod	lemma_13=of	lemma_12=exposure	lemma_6=for	pos_3=NNS	lib=mg	eib=False	relType_7=nummod	pos_2=CD	pos_6=IN	relType_12=nsubj:pass	pos_12=NN	pos_13=IN	lpib=mg_NNS	lemma_5=)	lemma_10=while	relType_13=case	pos_5=-RRB-	relType_5=punct	pos_10=IN	lemma_7=12	relType_9=punct	pos_1=-LRB-	pos_11=NN	relType_11=compound	lemma_4=BID	pos_4=NNP	wib=mg	relType_3=compound	lemma_3=mg	lemma_8=day	relType_1=punct	lemma_2=40	pos_9=,	path1=valdecoxib_nmod<administration_obl	path2=increase_advcl>exposure_nsubj:pass>valdecoxib_nmod	lemma_11=plasma
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e1	DDI-DrugBank.d328.s48.e3	null	lemma_9=,	pos_8=NNS	lemma_13=of	pos_15=CD	pos_3=NNS	lib=mg	lemma_25=of	pos_14=-LRB-	relType_15=nummod	pos_5=-RRB-	pos_1=-LRB-	lemma_21=substantially	path2=increase_advcl>administration_obl>diazepam_nmod	lemma_24=administration	lemma_4=BID	lemma_23=follow	relType_14=nmod	pos_19=VBD	lemma_22=increase	relType_2=nummod	pos_16=NNS	relType_6=case	relType_25=case	lemma_19=be	pos_6=IN	relType_21=advmod	lemma_16=mg	lemma_5=)	lemma_7=12	lemma_17=BID	relType_19=aux:pass	lemma_18=)	pos_11=NN	relType_17=appos	pos_4=NNP	pos_25=IN	relType_3=compound	lemma_8=day	relType_1=punct	lemma_2=40	pos_9=,	relType_14=punct	relType_10=mark	relType_24=obl	relType_4=appos	pos_24=NN	lemma_1=(	lemma_6=for	pos_17=NNP	pos_18=-RRB-	relType_7=nummod	pos_14=NN	pos_13=IN	lemma_10=while	path=valdecoxib_nmod<administration_obl<increase_ROOT>increase_advcl>administration_obl>diazepam_nmod	relType_13=case	pos_23=VBG	lemma_14=valdecoxib	pos_10=IN	relType_23=case	pos_20=RB	path1=valdecoxib_nmod<administration_obl	pos_7=CD	relType_16=compound	relation_22=beneficial	lemma_14=(	relType_8=obl	pos_22=VBN	relType_22=advcl	lemma_12=exposure	relType_20=advmod	pos_2=CD	relType_12=nsubj:pass	lemma_15=40	lpib=mg_NNS	relType_5=punct	relType_18=punct	relType_9=punct	pos_21=RB	eib=True	relType_11=compound	wib=mg	lemma_3=mg	pos_12=NN	lemma_20=not	lemma_11=plasma
DDI-DrugBank.d328.s48	DDI-DrugBank.d328.s48.e2	DDI-DrugBank.d328.s48.e3	null	relType_6=aux:pass	relType_2=nummod	lemma_7=not	lemma_8=substantially	relType_4=appos	lemma_9=increase	relType_12=case	pos_6=VBD	lemma_6=be	lemma_12=of	path=valdecoxib_nmod<exposure_nsubj:pass<increase_advcl>administration_obl>diazepam_nmod	lemma_1=(	relType_9=advcl	pos_3=NNS	lib=mg	pos_7=RB	eib=False	relation_8=beneficial	pos_2=CD	pos_8=RB	relType_10=case	pos_9=VBN	lemma_11=administration	relType_8=advmod	pos_12=IN	lpib=mg_NNS	lemma_5=)	pos_5=-RRB-	relType_5=punct	relType_11=obl	pos_1=-LRB-	pos_11=NN	lemma_4=BID	pos_4=NNP	pos_10=VBG	wib=mg	relType_3=compound	lemma_3=mg	lemma_10=follow	relType_7=advmod	relType_1=punct	lemma_2=40	path1=valdecoxib_nmod<exposure_nsubj:pass	path2=administration_obl>diazepam_nmod
DDI-DrugBank.d328.s49	DDI-DrugBank.d328.s49.e0	DDI-DrugBank.d328.s49.e1	null	lemma_1=plasma	pos_2=NN	relType_3=advmod	relType_4=acl:relcl	relType_5=case	path2=coadminister_acl:relcl>valdecoxib_obl	relType_1=compound	eib=False	relType_2=nmod	lemma_4=coadminister	lemma_5=with	pos_1=NN	pos_4=VBN	wib=plasma	lpib=plasma_NN	lemma_2=exposure	lib=plasma	pos_5=IN	path1=diazepam_compound<exposure_nmod<change_nmod	pos_3=WRB	path=diazepam_compound<exposure_nmod<change_nmod<magnitude_nsubj>coadminister_acl:relcl>valdecoxib_obl	lemma_3=when
DDI-DrugBank.d328.s49	DDI-DrugBank.d328.s49.e0	DDI-DrugBank.d328.s49.e2	null	pos_2=NN	lemma_7=not	lemma_13=,	lemma_22=by	relType_5=case	pos_6=VBD	pos_6=NN	pos_8=JJ	pos_7=RB	lemma_4=coadminister	lemma_10=warrant	lemma_14=patient	pos_22=IN	relType_20=obj	lemma_25=of	relation_20=neutral	pos_14=NNS	pos_13=,	relType_8=advcl	lemma_12=adjustment	lemma_6=be	relType_25=case	pos_9=TO	pos_23=VBN	pos_16=VB	relType_22=case	pos_10=VB	pos_4=VBN	relType_19=compound	wib=plasma	lemma_2=exposure	pos_5=IN	relType_17=amod	relType_9=mark	pos_21=VBN	pos_3=WRB	pos_11=NN	relType_10=xcomp	pos_25=IN	relType_24=obl	pos_24=NN	relType_23=amod	pos_17=VBN	relType_6=obl	lemma_23=increase	relType_2=nmod	lemma_5=with	pos_1=NN	relation_23=beneficial	lemma_17=enhance	lemma_11=dosage	lemma_6=valdecoxib	lemma_16=experience	lemma_19=side	lemma_18=sedative	relType_7=advmod	lemma_21=cause	lemma_3=when	lemma_1=plasma	relType_3=advmod	path1=diazepam_compound<exposure_nmod<change_nmod<magnitude_nsubj<sufficient_advcl	lemma_15=may	relType_18=amod	relType_13=punct	relType_4=acl:relcl	pos_15=MD	relation_21=neutral	relType_21=acl	relType_16=ROOT	relType_1=compound	relType_15=aux	path2=effect_obj>cause_acl>exposure_obl>diazepam_nmod	lemma_9=to	relType_12=obj	relType_6=cop	pos_18=JJ	pos_19=NN	lemma_20=effect	lemma_24=exposure	path=diazepam_compound<exposure_nmod<change_nmod<magnitude_nsubj<sufficient_advcl<experience_ROOT>effect_obj>cause_acl>exposure_obl>diazepam_nmod	lpib=plasma_NN	pos_12=NNS	lib=plasma	pos_20=NNS	lemma_8=sufficient	eib=True	relType_11=compound	relType_14=nsubj	relation_17=beneficial
DDI-DrugBank.d328.s49	DDI-DrugBank.d328.s49.e1	DDI-DrugBank.d328.s49.e2	effect	relType_4=mark	pos_7=NNS	path=valdecoxib_obl<coadminister_acl:relcl<magnitude_nsubj<sufficient_advcl<experience_ROOT>effect_obj>cause_acl>exposure_obl>diazepam_nmod	relType_5=xcomp	relType_11=ROOT	relType_18=amod	lemma_12=enhance	relType_8=punct	lemma_19=exposure	relType_14=compound	lemma_8=,	pos_20=IN	wib=were	pos_6=NN	pos_17=IN	pos_2=RB	pos_5=VB	relType_20=case	pos_1=VBD	pos_10=MD	eib=False	relType_2=advmod	relType_10=aux	relType_13=amod	lemma_15=effect	lemma_1=be	path2=effect_obj>cause_acl>exposure_obl>diazepam_nmod	relType_7=obj	pos_9=NNS	lemma_18=increase	relType_12=amod	lemma_17=by	path1=valdecoxib_obl<coadminister_acl:relcl<magnitude_nsubj<sufficient_advcl	pos_14=NN	lemma_6=dosage	pos_19=NN	relation_15=neutral	lemma_7=adjustment	relType_17=case	pos_16=VBN	lib=be	relType_3=advcl	pos_13=JJ	lemma_16=cause	lemma_4=to	relType_16=acl	lemma_14=side	lemma_11=experience	lemma_13=sedative	relation_14=neutral	lemma_20=of	pos_4=TO	relType_15=obj	relType_6=compound	relType_1=cop	lemma_9=patient	pos_3=JJ	lemma_10=may	relType_9=nsubj	lemma_3=sufficient	pos_11=VB	pos_15=NNS	pos_18=VBN	relType_19=obl	relation_11=beneficial	relation_17=beneficial	pos_12=VBN	lpib=be_VBD	lemma_2=not	pos_8=,	lemma_5=warrant
DDI-DrugBank.d759.s0	DDI-DrugBank.d759.s0.e0	DDI-DrugBank.d759.s0.e1	mechanism	relation_1=neutral	path2=intensity_obj>action_nmod>bishydroxycoumarin_nmod	pos_5=CC	relType_1=aux	lemma_1=may	relType_7=case	path=acid_nsubj<influence_ccomp>intensity_obj>action_nmod>bishydroxycoumarin_nmod	pos_9=IN	lemma_6=duration	pos_6=NN	lemma_2=influence	wib=influence	relType_5=cc	relType_6=conj	pos_8=NN	eib=False	lemma_8=action	pos_2=VB	relType_9=case	relType_3=det	pos_4=NN	relType_4=obj	path1=acid_nsubj	lpib=influence_VB	pos_1=MD	relType_2=ccomp	lemma_7=of	lemma_4=intensity	relType_8=nmod	pos_3=DT	lemma_5=and	pos_7=IN	lemma_9=of	lemma_3=the	lib=influence
